Gene	"Gene synonym"	Ensembl	"Gene description"	Uniprot	Chromosome	Position	"Protein class"	"Biological process"	"Molecular function"	"Disease involvement"	Evidence	"HPA evidence"	"UniProt evidence"	"NeXtProt evidence"	"RNA tissue specificity"	"RNA tissue distribution"	"RNA tissue specificity score"	"RNA tissue specific nTPM"	"RNA single cell type specificity"	"RNA single cell type distribution"	"RNA single cell type specificity score"	"RNA single cell type specific nTPM"	"RNA cancer specificity"	"RNA cancer distribution"	"RNA cancer specificity score"	"RNA cancer specific FPKM"	"RNA brain regional specificity"	"RNA brain regional distribution"	"RNA brain regional specificity score"	"RNA brain regional specific nTPM"	"RNA blood cell specificity"	"RNA blood cell distribution"	"RNA blood cell specificity score"	"RNA blood cell specific nTPM"	"RNA blood lineage specificity"	"RNA blood lineage distribution"	"RNA blood lineage specificity score"	"RNA blood lineage specific nTPM"	"RNA cell line specificity"	"RNA cell line distribution"	"RNA cell line specificity score"	"RNA cell line specific nTPM"	"RNA mouse brain regional specificity"	"RNA mouse brain regional distribution"	"RNA mouse brain regional specificity score"	"RNA mouse brain regional specific nTPM"	"RNA pig brain regional specificity"	"RNA pig brain regional distribution"	"RNA pig brain regional specificity score"	"RNA pig brain regional specific nTPM"	Antibody	"Reliability (IH)"	"Reliability (Mouse Brain)"	"Reliability (IF)"	"Subcellular location"	"Secretome location"	"CCD Protein"	"CCD Transcript"	"Blood concentration - Conc. blood IM [pg/L]"	"Blood concentration - Conc. blood MS [pg/L]"	"Blood expression cluster"	"Tissue expression cluster"	"Cell line expression cluster"	"Single cell expression cluster"	"Subcellular main location"	"Subcellular additional location"	"Antibody RRID"	"Pathology prognostics - Breast cancer"	"Pathology prognostics - Cervical cancer"	"Pathology prognostics - Colorectal cancer"	"Pathology prognostics - Endometrial cancer"	"Pathology prognostics - Glioma"	"Pathology prognostics - Head and neck cancer"	"Pathology prognostics - Liver cancer"	"Pathology prognostics - Lung cancer"	"Pathology prognostics - Melanoma"	"Pathology prognostics - Ovarian cancer"	"Pathology prognostics - Pancreatic cancer"	"Pathology prognostics - Prostate cancer"	"Pathology prognostics - Renal cancer"	"Pathology prognostics - Stomach cancer"	"Pathology prognostics - Testis cancer"	"Pathology prognostics - Thyroid cancer"	"Pathology prognostics - Urothelial cancer"	"Tissue RNA - adipose tissue [nTPM]"	"Tissue RNA - adrenal gland [nTPM]"	"Tissue RNA - amygdala [nTPM]"	"Tissue RNA - appendix [nTPM]"	"Tissue RNA - basal ganglia [nTPM]"	"Tissue RNA - bone marrow [nTPM]"	"Tissue RNA - breast [nTPM]"	"Tissue RNA - cerebellum [nTPM]"	"Tissue RNA - cerebral cortex [nTPM]"	"Tissue RNA - cervix [nTPM]"	"Tissue RNA - choroid plexus [nTPM]"	"Tissue RNA - colon [nTPM]"	"Tissue RNA - duodenum [nTPM]"	"Tissue RNA - endometrium 1 [nTPM]"	"Tissue RNA - epididymis [nTPM]"	"Tissue RNA - esophagus [nTPM]"	"Tissue RNA - fallopian tube [nTPM]"	"Tissue RNA - gallbladder [nTPM]"	"Tissue RNA - heart muscle [nTPM]"	"Tissue RNA - hippocampal formation [nTPM]"	"Tissue RNA - hypothalamus [nTPM]"	"Tissue RNA - kidney [nTPM]"	"Tissue RNA - liver [nTPM]"	"Tissue RNA - lung [nTPM]"	"Tissue RNA - lymph node [nTPM]"	"Tissue RNA - medulla oblongata [nTPM]"	"Tissue RNA - midbrain [nTPM]"	"Tissue RNA - ovary [nTPM]"	"Tissue RNA - pancreas [nTPM]"	"Tissue RNA - parathyroid gland [nTPM]"	"Tissue RNA - pituitary gland [nTPM]"	"Tissue RNA - placenta [nTPM]"	"Tissue RNA - pons [nTPM]"	"Tissue RNA - prostate [nTPM]"	"Tissue RNA - rectum [nTPM]"	"Tissue RNA - retina [nTPM]"	"Tissue RNA - salivary gland [nTPM]"	"Tissue RNA - seminal vesicle [nTPM]"	"Tissue RNA - skeletal muscle [nTPM]"	"Tissue RNA - skin 1 [nTPM]"	"Tissue RNA - small intestine [nTPM]"	"Tissue RNA - smooth muscle [nTPM]"	"Tissue RNA - spinal cord [nTPM]"	"Tissue RNA - spleen [nTPM]"	"Tissue RNA - stomach 1 [nTPM]"	"Tissue RNA - testis [nTPM]"	"Tissue RNA - thalamus [nTPM]"	"Tissue RNA - thymus [nTPM]"	"Tissue RNA - thyroid gland [nTPM]"	"Tissue RNA - tongue [nTPM]"	"Tissue RNA - tonsil [nTPM]"	"Tissue RNA - urinary bladder [nTPM]"	"Tissue RNA - vagina [nTPM]"	"Tissue RNA - white matter [nTPM]"	"Cell RNA - A-431 [nTPM]"	"Cell RNA - A549 [nTPM]"	"Cell RNA - AF22 [nTPM]"	"Cell RNA - AN3-CA [nTPM]"	"Cell RNA - ASC diff [nTPM]"	"Cell RNA - ASC TERT1 [nTPM]"	"Cell RNA - BEWO [nTPM]"	"Cell RNA - BJ [nTPM]"	"Cell RNA - BJ hTERT+ [nTPM]"	"Cell RNA - BJ hTERT+ SV40 Large T+ [nTPM]"	"Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [nTPM]"	"Cell RNA - CACO-2 [nTPM]"	"Cell RNA - CAPAN-2 [nTPM]"	"Cell RNA - Daudi [nTPM]"	"Cell RNA - EFO-21 [nTPM]"	"Cell RNA - fHDF/TERT166 [nTPM]"	"Cell RNA - GAMG [nTPM]"	"Cell RNA - HaCaT [nTPM]"	"Cell RNA - HAP1 [nTPM]"	"Cell RNA - HBEC3-KT [nTPM]"	"Cell RNA - HBF TERT88 [nTPM]"	"Cell RNA - HDLM-2 [nTPM]"	"Cell RNA - HEK 293 [nTPM]"	"Cell RNA - HEL [nTPM]"	"Cell RNA - HeLa [nTPM]"	"Cell RNA - Hep G2 [nTPM]"	"Cell RNA - HHSteC [nTPM]"	"Cell RNA - HL-60 [nTPM]"	"Cell RNA - HMC-1 [nTPM]"	"Cell RNA - HSkMC [nTPM]"	"Cell RNA - hTCEpi [nTPM]"	"Cell RNA - hTEC/SVTERT24-B [nTPM]"	"Cell RNA - hTERT-HME1 [nTPM]"	"Cell RNA - hTERT-RPE1 [nTPM]"	"Cell RNA - HUVEC TERT2 [nTPM]"	"Cell RNA - JURKAT [nTPM]"	"Cell RNA - K-562 [nTPM]"	"Cell RNA - Karpas-707 [nTPM]"	"Cell RNA - LHCN-M2 [nTPM]"	"Cell RNA - MCF7 [nTPM]"	"Cell RNA - MOLT-4 [nTPM]"	"Cell RNA - NB-4 [nTPM]"	"Cell RNA - NTERA-2 [nTPM]"	"Cell RNA - OE19 [nTPM]"	"Cell RNA - PC-3 [nTPM]"	"Cell RNA - REH [nTPM]"	"Cell RNA - RH-30 [nTPM]"	"Cell RNA - RPMI-8226 [nTPM]"	"Cell RNA - RPTEC TERT1 [nTPM]"	"Cell RNA - RT4 [nTPM]"	"Cell RNA - SCLC-21H [nTPM]"	"Cell RNA - SH-SY5Y [nTPM]"	"Cell RNA - SiHa [nTPM]"	"Cell RNA - SK-BR-3 [nTPM]"	"Cell RNA - SK-MEL-30 [nTPM]"	"Cell RNA - SuSa [nTPM]"	"Cell RNA - T-47d [nTPM]"	"Cell RNA - THP-1 [nTPM]"	"Cell RNA - TIME [nTPM]"	"Cell RNA - U-138 MG [nTPM]"	"Cell RNA - U-2 OS [nTPM]"	"Cell RNA - U-2197 [nTPM]"	"Cell RNA - U-251 MG [nTPM]"	"Cell RNA - U-266/70 [nTPM]"	"Cell RNA - U-266/84 [nTPM]"	"Cell RNA - U-698 [nTPM]"	"Cell RNA - U-87 MG [nTPM]"	"Cell RNA - U-937 [nTPM]"	"Cell RNA - WM-115 [nTPM]"	"Blood RNA - basophil [nTPM]"	"Blood RNA - classical monocyte [nTPM]"	"Blood RNA - eosinophil [nTPM]"	"Blood RNA - gdT-cell [nTPM]"	"Blood RNA - intermediate monocyte [nTPM]"	"Blood RNA - MAIT T-cell [nTPM]"	"Blood RNA - memory B-cell [nTPM]"	"Blood RNA - memory CD4 T-cell [nTPM]"	"Blood RNA - memory CD8 T-cell [nTPM]"	"Blood RNA - myeloid DC [nTPM]"	"Blood RNA - naive B-cell [nTPM]"	"Blood RNA - naive CD4 T-cell [nTPM]"	"Blood RNA - naive CD8 T-cell [nTPM]"	"Blood RNA - neutrophil [nTPM]"	"Blood RNA - NK-cell [nTPM]"	"Blood RNA - non-classical monocyte [nTPM]"	"Blood RNA - plasmacytoid DC [nTPM]"	"Blood RNA - T-reg [nTPM]"	"Blood RNA - total PBMC [nTPM]"	"Brain RNA - amygdala [nTPM]"	"Brain RNA - basal ganglia [nTPM]"	"Brain RNA - cerebellum [nTPM]"	"Brain RNA - cerebral cortex [nTPM]"	"Brain RNA - hippocampal formation [nTPM]"	"Brain RNA - hypothalamus [nTPM]"	"Brain RNA - medulla oblongata [nTPM]"	"Brain RNA - midbrain [nTPM]"	"Brain RNA - pons [nTPM]"	"Brain RNA - spinal cord [nTPM]"	"Brain RNA - thalamus [nTPM]"	"Brain RNA - white matter [nTPM]"	"Single Cell Type RNA - Adipocytes [nTPM]"	"Single Cell Type RNA - Alveolar cells type 1 [nTPM]"	"Single Cell Type RNA - Alveolar cells type 2 [nTPM]"	"Single Cell Type RNA - Astrocytes [nTPM]"	"Single Cell Type RNA - B-cells [nTPM]"	"Single Cell Type RNA - Basal keratinocytes [nTPM]"	"Single Cell Type RNA - Basal prostatic cells [nTPM]"	"Single Cell Type RNA - Basal respiratory cells [nTPM]"	"Single Cell Type RNA - Basal squamous epithelial cells [nTPM]"	"Single Cell Type RNA - Bipolar cells [nTPM]"	"Single Cell Type RNA - Breast glandular cells [nTPM]"	"Single Cell Type RNA - Breast myoepithelial cells [nTPM]"	"Single Cell Type RNA - Cardiomyocytes [nTPM]"	"Single Cell Type RNA - Cholangiocytes [nTPM]"	"Single Cell Type RNA - Club cells [nTPM]"	"Single Cell Type RNA - Collecting duct cells [nTPM]"	"Single Cell Type RNA - Cone photoreceptor cells [nTPM]"	"Single Cell Type RNA - Cytotrophoblasts [nTPM]"	"Single Cell Type RNA - dendritic cells [nTPM]"	"Single Cell Type RNA - Distal enterocytes [nTPM]"	"Single Cell Type RNA - Distal tubular cells [nTPM]"	"Single Cell Type RNA - Ductal cells [nTPM]"	"Single Cell Type RNA - Early spermatids [nTPM]"	"Single Cell Type RNA - Endometrial ciliated cells [nTPM]"	"Single Cell Type RNA - Endometrial stromal cells [nTPM]"	"Single Cell Type RNA - Endothelial cells [nTPM]"	"Single Cell Type RNA - Enteroendocrine cells [nTPM]"	"Single Cell Type RNA - Erythroid cells [nTPM]"	"Single Cell Type RNA - Excitatory neurons [nTPM]"	"Single Cell Type RNA - Exocrine glandular cells [nTPM]"	"Single Cell Type RNA - Extravillous trophoblasts [nTPM]"	"Single Cell Type RNA - Fibroblasts [nTPM]"	"Single Cell Type RNA - Gastric mucus-secreting cells [nTPM]"	"Single Cell Type RNA - Glandular and luminal cells [nTPM]"	"Single Cell Type RNA - granulocytes [nTPM]"	"Single Cell Type RNA - Granulosa cells [nTPM]"	"Single Cell Type RNA - Hepatic stellate cells [nTPM]"	"Single Cell Type RNA - Hepatocytes [nTPM]"	"Single Cell Type RNA - Hofbauer cells [nTPM]"	"Single Cell Type RNA - Horizontal cells [nTPM]"	"Single Cell Type RNA - Inhibitory neurons [nTPM]"	"Single Cell Type RNA - Intestinal goblet cells [nTPM]"	"Single Cell Type RNA - Ionocytes [nTPM]"	"Single Cell Type RNA - Kupffer cells [nTPM]"	"Single Cell Type RNA - Langerhans cells [nTPM]"	"Single Cell Type RNA - Late spermatids [nTPM]"	"Single Cell Type RNA - Leydig cells [nTPM]"	"Single Cell Type RNA - Macrophages [nTPM]"	"Single Cell Type RNA - Melanocytes [nTPM]"	"Single Cell Type RNA - Microglial cells [nTPM]"	"Single Cell Type RNA - monocytes [nTPM]"	"Single Cell Type RNA - Muller glia cells [nTPM]"	"Single Cell Type RNA - NK-cells [nTPM]"	"Single Cell Type RNA - Oligodendrocyte precursor cells [nTPM]"	"Single Cell Type RNA - Oligodendrocytes [nTPM]"	"Single Cell Type RNA - Pancreatic endocrine cells [nTPM]"	"Single Cell Type RNA - Paneth cells [nTPM]"	"Single Cell Type RNA - Peritubular cells [nTPM]"	"Single Cell Type RNA - Plasma cells [nTPM]"	"Single Cell Type RNA - Prostatic glandular cells [nTPM]"	"Single Cell Type RNA - Proximal enterocytes [nTPM]"	"Single Cell Type RNA - Proximal tubular cells [nTPM]"	"Single Cell Type RNA - Respiratory ciliated cells [nTPM]"	"Single Cell Type RNA - Rod photoreceptor cells [nTPM]"	"Single Cell Type RNA - Sertoli cells [nTPM]"	"Single Cell Type RNA - Skeletal myocytes [nTPM]"	"Single Cell Type RNA - Smooth muscle cells [nTPM]"	"Single Cell Type RNA - Spermatocytes [nTPM]"	"Single Cell Type RNA - Spermatogonia [nTPM]"	"Single Cell Type RNA - Squamous epithelial cells [nTPM]"	"Single Cell Type RNA - Suprabasal keratinocytes [nTPM]"	"Single Cell Type RNA - Syncytiotrophoblasts [nTPM]"	"Single Cell Type RNA - T-cells [nTPM]"	"Single Cell Type RNA - Theca cells [nTPM]"	"Single Cell Type RNA - Undifferentiated cells [nTPM]"	"Single Cell Type RNA - Urothelial cells [nTPM]"
A1CF	"ACF, ACF64, ACF65, APOBEC1CF, ASP"	ENSG00000148584	"APOBEC1 complementation factor"	Q9NQ94	10	50799409-50885675	"Predicted intracellular proteins"	"mRNA processing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"liver: 144.0"	"Cell type enhanced"	"Detected in some"		"Cholangiocytes: 150.2;Distal enterocytes: 71.3;Enteroendocrine cells: 116.5;Hepatocytes: 337.9;Paneth cells: 83.8;Proximal enterocytes: 147.5;Proximal tubular cells: 118.4"	"Cancer enriched"	"Detected in some"	6	"liver cancer: 18.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	24	"CACO-2: 23.5;Hep G2: 60.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"HPA037779, HPA044079"	Enhanced		Supported	Nucleoplasm		NA	NA				"Cluster 85: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 2: Hepatocytes - Metabolism"	Nucleoplasm		"HPA037779: AB_10670529, HPA044079: AB_2678800"	"unprognostic (3.87e-3)"	"unprognostic (7.86e-2)"	"unprognostic (2.34e-1)"	"unprognostic (2.21e-3)"	"unprognostic (2.73e-1)"	"unprognostic (4.61e-3)"	"unprognostic (1.71e-1)"	"unprognostic (7.38e-3)"		"unprognostic (1.30e-2)"	"unprognostic (2.46e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.90e-3)"	"unprognostic (1.97e-2)"	"unprognostic (2.77e-1)"	"unprognostic (2.19e-2)"	"unprognostic (8.50e-4)"	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	11.1	23.4	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	12.5	144.0	0.0	0.0	0.0	0.0	0.1	7.5	0.0	0.0	0.0	0.0	0.0	10.3	0.1	0.0	0.0	0.0	0.0	26.8	0.3	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.2	60.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	2.1	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.6	150.2	0.0	3.7	2.1	0.0	0.0	71.3	9.8	1.2	0.0	0.0	0.0	0.6	116.5	5.3	0.4	11.4	0.0	0.0	0.0	0.0	0.0	0.0	6.1	337.9	0.0	0.0	0.3	52.0	0.0	8.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	10.1	83.8	0.0	0.0	0.1	147.5	118.4	0.0	1.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.8	0.0	35.1	0.1
AAGAB	"FLJ11506, p34"	ENSG00000103591	"Alpha and gamma adaptin binding protein"	Q6PD74	15	67200667-67255195	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Protein transport, Transport"		"Palmoplantar keratoderma"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039371, HPA040174"	Supported		Supported	"Nuclear speckles,Cytosol"		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Nuclear speckles, Cytosol"		"HPA039371: AB_10805476, HPA040174: AB_10805605"	"unprognostic (1.48e-2)"	"unprognostic (1.50e-1)"	"unprognostic (8.25e-2)"	"unprognostic (3.27e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.10e-2)"	"unprognostic (2.84e-2)"	"unprognostic (4.52e-2)"	"unprognostic (9.10e-2)"	"unprognostic (5.28e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.10e-1)"	"prognostic favorable (1.36e-4)"	"unprognostic (9.88e-2)"	"unprognostic (3.05e-1)"	"prognostic unfavorable (9.48e-4)"	"unprognostic (1.53e-1)"	15.1	19.1	10.5	19.2	13.3	19.8	22.5	7.2	14.5	17.9	12.7	27.8	15.8	14.8	25.9	20.5	16.5	18.5	15.8	12.9	15.7	27.4	18.1	15.6	19.9	9.8	11.5	8.0	17.0	35.2	19.0	15.8	11.5	18.8	33.8	22.1	15.4	20.5	32.8	12.9	19.5	21.2	9.5	15.4	23.9	21.9	15.7	29.9	33.0	23.0	25.9	27.5	13.2	12.2	49.7	89.9	63.2	64.8	60.0	49.3	31.1	51.4	74.7	60.6	68.7	66.8	52.9	48.1	51.1	52.9	74.4	98.2	129.9	59.4	62.9	65.0	62.0	46.2	63.2	26.8	66.0	78.8	51.2	48.6	80.6	45.8	94.3	41.0	47.8	59.7	96.5	63.7	60.2	61.3	47.6	32.7	53.1	61.7	31.5	53.1	81.1	57.7	55.9	116.1	89.7	57.3	60.7	44.0	75.7	54.7	71.5	59.2	51.7	54.2	64.5	50.0	73.0	33.7	119.3	69.2	52.7	71.8	55.4	56.4	27.0	28.2	31.3	35.4	36.2	22.0	28.2	29.7	33.2	17.3	23.7	25.0	14.6	42.7	38.1	25.4	37.3	30.2	10.5	13.3	7.2	14.5	12.9	15.7	9.8	11.5	11.5	9.5	15.7	12.2	10.8	3.2	7.7	26.1	19.0	12.0	18.8	19.4	15.9	13.4	17.8	10.3	12.9	4.3	19.0	27.6	27.1	16.3	8.8	33.4	17.6	28.6	14.6	14.5	11.6	12.0	15.7	10.9	45.4	31.2	14.8	14.1	22.4	18.0	10.8	8.2	8.2	12.7	17.0	18.5	33.1	17.3	14.2	15.5	8.4	8.6	7.8	11.6	7.2	30.0	21.3	14.4	16.5	26.2	31.9	25.3	20.9	11.3	15.5	22.9	15.3	19.1	20.5	19.4	13.1	10.5	10.2	43.0	33.8	17.6	13.8	16.6	17.8	25.3	15.7	24.5
AAMP		ENSG00000127837	"Angio associated migratory cell protein"	Q13685	2	218264129-218270178	"Plasma proteins, Predicted intracellular proteins"	"Angiogenesis, Differentiation"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017717, HPA031868"	Approved		Supported	Microtubules,Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 35: Non-specific - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Microtubules	Cytosol	"CAB017717: , HPA031868: AB_2674078"	"unprognostic (1.57e-1)"	"unprognostic (6.12e-2)"	"unprognostic (8.11e-3)"	"prognostic unfavorable (1.62e-4)"	"unprognostic (1.39e-2)"	"unprognostic (5.04e-2)"	"prognostic unfavorable (4.94e-7)"	"unprognostic (8.94e-2)"	"unprognostic (7.79e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.23e-1)"	"unprognostic (4.22e-2)"	"unprognostic (5.51e-2)"	"unprognostic (1.23e-3)"	"unprognostic (5.26e-2)"	"unprognostic (1.92e-1)"	"unprognostic (9.09e-2)"	66.5	66.4	65.0	46.2	66.1	27.5	65.2	67.1	80.1	62.6	63.2	76.3	62.8	61.7	43.8	75.1	60.8	56.1	65.4	65.7	67.2	60.2	77.5	46.6	47.8	69.2	66.6	79.8	70.7	72.7	62.1	54.9	66.4	58.0	58.0	38.4	66.9	58.7	90.4	76.6	61.7	50.7	67.5	53.0	86.9	53.8	67.1	54.0	66.6	62.0	52.6	70.0	57.4	70.3	126.1	104.6	75.1	102.2	111.9	75.7	146.0	89.6	136.3	167.1	124.5	226.2	100.1	64.6	121.8	112.6	158.8	94.3	150.7	133.4	129.3	103.5	200.9	147.4	108.2	237.4	158.9	139.3	92.4	97.8	152.7	172.2	149.7	99.7	97.6	124.3	202.6	82.4	108.9	198.0	112.4	234.9	121.0	182.4	75.4	90.6	97.5	105.8	100.3	160.5	96.2	92.9	59.4	128.7	134.7	119.1	99.1	104.6	84.7	110.2	82.3	81.2	106.8	105.7	198.1	108.4	111.0	88.6	77.4	75.9	166.2	60.3	101.1	209.2	105.1	100.3	90.1	94.9	191.4	105.7	111.1	100.7	26.2	114.9	210.6	114.1	109.3	179.4	65.0	66.1	67.1	80.1	65.7	67.2	69.2	66.6	66.4	67.5	67.1	70.3	57.8	41.7	35.2	11.4	50.4	90.5	86.1	122.9	66.0	47.7	50.7	45.2	35.5	41.5	74.0	42.3	12.5	160.0	42.2	74.3	103.7	95.7	3.5	33.5	46.4	50.6	75.5	34.0	11.5	95.4	130.3	63.4	80.5	38.2	34.8	57.6	42.5	46.2	91.9	63.9	12.9	89.9	93.6	37.0	65.3	8.8	83.3	38.5	62.2	5.6	64.8	80.2	41.2	8.0	10.5	86.6	72.0	74.9	51.2	116.0	99.5	85.3	47.4	37.1	65.7	38.4	86.5	72.0	53.3	70.2	97.3	202.6	44.4	62.5	103.5	119.9
AANAT	SNAT	ENSG00000129673	"Aralkylamine N-acetyltransferase"	Q16613	17	76453351-76470117	"Enzymes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"	"Biological rhythms, Melatonin biosynthesis"	"Acyltransferase, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"retina: 11.0;testis: 4.7"	"Cell type enriched"	"Detected in some"	10	"Bipolar cells: 302.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 2.5;Daudi: 2.0;SCLC-21H: 3.2;U-266/70: 2.3;U-266/84: 2.7;U-698: 3.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA054321			Supported	Cytosol	"Intracellular and membrane"	NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 56: Bipolar cells - Visual perception"	Cytosol		"HPA054321: AB_2682449"	"unprognostic (7.89e-2)"	"unprognostic (2.62e-1)"	"unprognostic (1.41e-1)"	"unprognostic (2.44e-1)"	"unprognostic (1.83e-2)"	"unprognostic (2.03e-2)"	"unprognostic (1.05e-2)"	"unprognostic (3.09e-1)"	"unprognostic (1.01e-2)"	"unprognostic (3.61e-1)"	"unprognostic (9.30e-2)"	"unprognostic (4.19e-1)"	"unprognostic (2.81e-7)"	"unprognostic (1.04e-1)"	"unprognostic (6.00e-2)"	"unprognostic (4.47e-2)"	"unprognostic (1.34e-2)"	0.1	0.2	0.7	1.6	0.7	1.2	0.0	0.8	1.1	0.1	0.2	0.1	0.1	0.1	0.1	0.3	0.2	0.7	0.1	0.9	0.9	0.3	0.0	0.2	1.5	2.1	1.7	0.2	0.2	0.0	0.3	0.0	2.0	0.1	0.0	11.0	0.1	0.0	0.1	1.4	0.4	0.0	1.2	1.0	0.2	4.7	2.1	0.0	0.4	0.0	0.1	0.2	0.1	1.4	0.5	2.5	0.3	0.2	0.0	0.0	0.2	0.0	0.2	0.1	0.0	0.0	1.7	2.0	0.3	0.0	0.3	0.6	0.0	0.0	0.1	0.0	0.6	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.6	0.2	0.0	1.0	0.2	0.3	0.0	0.1	0.6	0.8	0.2	0.1	0.1	1.1	0.0	0.0	3.2	0.2	0.0	0.1	0.8	0.3	1.5	0.3	0.0	0.0	0.9	0.1	0.0	2.3	2.7	3.6	0.6	0.2	0.4	0.7	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.4	0.0	0.3	0.0	0.0	0.7	0.7	0.8	1.1	0.9	0.9	2.1	1.7	2.0	1.2	2.1	1.4	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	302.1	0.1	0.4	0.3	0.0	0.0	0.0	12.5	0.3	0.2	0.0	0.0	0.0	7.5	0.2	0.1	0.6	1.2	0.0	0.9	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.1	6.7	0.6	0.1	0.0	0.3	0.0	19.4	0.3	0.1	0.0	0.0	0.0	13.2	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.0	0.4	0.0	30.2	0.0	0.0	0.0	3.1	1.1	0.0	0.0	0.1	0.0	0.1	0.1	0.1
AARS1	"AARS, AlaRS, CMT2N"	ENSG00000090861	"Alanyl-tRNA synthetase 1"	P49588	16	70251983-70289707	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase, RNA-binding, tRNA-binding"	"Charcot-Marie-Tooth disease, Disease variant, Epilepsy, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"Cardiomyocytes: 25.1;Cytotrophoblasts: 63.0;Extravillous trophoblasts: 29.9;Hofbauer cells: 27.1;Syncytiotrophoblasts: 52.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034261, HPA040870, HPA044223"	Supported		Supported	Cytosol		NA	NA		620000	"Cluster 27: Non-specific - Gene expression"	"Cluster 22: Non-specific - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 47: Cytotrophoblasts - Unknown function"	Cytosol		"CAB034261: AB_1562673, HPA040870: AB_10794995, HPA044223: AB_2678862"	"unprognostic (1.98e-2)"	"unprognostic (6.87e-2)"	"unprognostic (8.02e-2)"	"unprognostic (5.72e-2)"	"unprognostic (3.58e-1)"	"unprognostic (2.50e-2)"	"unprognostic (7.99e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.99e-1)"	"unprognostic (1.76e-1)"	"unprognostic (8.33e-2)"	"unprognostic (2.92e-1)"	"unprognostic (3.42e-2)"	"unprognostic (3.75e-2)"	"unprognostic (2.05e-3)"	"unprognostic (8.22e-2)"	"unprognostic (3.83e-3)"	43.7	54.7	60.1	33.4	64.3	7.9	41.4	73.3	88.6	42.1	49.2	48.9	26.0	49.8	49.6	29.5	40.4	22.3	47.9	62.8	71.7	43.6	72.0	45.3	30.0	78.6	68.6	37.3	75.8	74.9	50.1	35.6	84.9	40.0	26.2	59.3	53.3	47.2	62.4	28.8	32.7	47.8	66.3	38.3	51.8	23.8	74.8	36.4	66.6	39.7	35.5	45.9	32.8	83.9	123.7	192.8	52.9	205.7	127.3	115.0	125.7	97.7	135.3	119.7	151.8	162.5	163.2	140.4	127.2	99.3	90.8	137.2	160.5	133.1	170.7	63.2	54.7	135.6	78.0	152.2	348.0	74.4	77.2	133.9	193.8	228.1	508.4	91.4	120.3	209.3	176.0	173.4	91.3	282.0	89.4	85.0	104.3	160.0	108.5	170.4	36.1	317.0	84.7	60.3	67.9	57.3	269.5	62.3	246.1	75.8	197.7	181.3	75.2	85.2	82.9	84.9	78.8	233.8	174.2	258.2	155.4	124.9	175.9	6.5	7.8	2.7	11.9	13.2	13.0	12.8	9.7	11.7	11.9	9.1	11.2	12.2	0.1	22.7	14.1	7.0	8.0	12.6	60.1	64.3	73.3	88.6	62.8	71.7	78.6	68.6	84.9	66.3	74.8	83.9	6.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	25.1	0.0	0.0	0.0	0.0	63.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	29.9	4.5	0.0	0.0	0.0	0.0	0.0	0.0	27.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	52.0	0.2	0.0	0.0	0.0
AATF	"BFR2, CHE-1, CHE1, DED"	ENSG00000275700	"Apoptosis antagonizing transcription factor"	Q9NY61	17	36948925-37056871	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Syncytiotrophoblasts: 163.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004940, HPA075963"	Uncertain		Supported	Nucleoplasm,Nucleoli		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 50: Non-specific - Ribosome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 25: Spermatids - Spermatogenesis"	Nucleoli	Nucleoplasm	"HPA004940: AB_1078075, HPA075963: "	"unprognostic (1.10e-1)"	"unprognostic (5.46e-3)"	"unprognostic (1.30e-3)"	"unprognostic (2.30e-3)"	"unprognostic (5.54e-2)"	"unprognostic (1.94e-2)"	"prognostic unfavorable (6.62e-5)"	"unprognostic (3.06e-2)"	"unprognostic (4.10e-2)"	"unprognostic (2.84e-1)"	"unprognostic (2.48e-2)"	"unprognostic (1.01e-1)"	"prognostic unfavorable (4.14e-5)"	"unprognostic (2.18e-2)"	"unprognostic (1.51e-1)"	"unprognostic (7.53e-3)"	"unprognostic (3.21e-3)"	29.8	24.4	22.2	26.3	25.6	34.7	26.6	23.6	24.9	24.6	19.8	28.3	18.5	25.6	17.5	24.4	24.7	15.4	26.1	21.0	23.2	22.1	22.5	23.4	34.1	24.0	23.4	29.5	37.5	20.3	15.9	23.2	24.5	20.3	24.0	17.3	21.0	24.1	40.8	37.1	24.2	24.5	22.8	27.1	30.0	22.9	23.5	35.3	20.4	14.2	39.2	31.2	23.4	26.8	107.2	174.2	37.0	73.8	49.3	57.0	67.3	61.2	50.4	76.0	67.3	120.3	74.3	178.2	79.5	60.5	123.4	89.9	141.8	80.0	102.6	83.4	97.3	77.1	65.6	85.8	59.4	121.9	73.4	49.5	138.7	98.4	88.4	68.2	56.6	92.3	114.4	51.7	68.6	81.6	162.4	105.0	46.0	62.8	63.3	104.0	96.7	105.6	62.6	93.7	79.0	33.8	90.9	40.8	95.5	79.6	69.6	72.3	50.4	58.1	96.2	122.5	211.9	61.3	83.1	124.2	72.2	101.9	107.1	48.9	55.2	90.2	60.0	74.0	59.6	46.8	53.9	64.0	51.0	51.0	48.1	47.7	67.5	58.1	77.7	45.5	75.7	57.2	22.2	25.6	23.6	24.9	21.0	23.2	24.0	23.4	24.5	22.8	23.5	26.8	24.5	22.4	34.6	25.1	41.2	43.7	46.3	39.7	29.6	13.4	14.7	13.1	17.8	32.9	37.8	25.8	22.9	72.9	48.5	26.4	9.8	41.6	32.0	23.4	22.9	30.1	16.1	33.7	28.5	48.1	59.8	30.3	23.0	22.0	47.5	37.4	14.6	16.9	46.8	18.5	24.6	26.4	6.1	33.9	30.3	62.0	23.6	33.4	28.4	30.0	54.9	34.3	53.5	29.1	57.7	51.1	26.3	23.3	38.4	52.1	48.8	52.0	31.1	24.0	32.9	32.3	39.0	52.5	40.8	28.2	43.9	163.9	44.3	27.4	31.9	43.6
ABAT	"GABA-T, GABAT"	ENSG00000183044	"4-aminobutyrate aminotransferase"	P80404	16	8674596-8784575	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Neurotransmitter degradation"	"Aminotransferase, Transferase"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 137.9;kidney: 133.3;liver: 345.6;pancreas: 138.3"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 268.2;Inhibitory neurons: 95.0;Oligodendrocyte precursor cells: 76.9;Proximal tubular cells: 94.9"	"Cancer enhanced"	"Detected in all"		"glioma: 27.3;liver cancer: 26.8"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Hep G2: 127.5;MCF7: 81.9;RH-30: 67.4;T-47d: 42.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041528, HPA041690"	Enhanced	Supported	Supported	Mitochondria		No	No		2100000	"Cluster 14: Monocytes - Unknown function"	"Cluster 22: Non-specific - Unknown function"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Mitochondria		"HPA041528: AB_10795690, HPA041690: AB_10794674"	"unprognostic (1.77e-2)"	"unprognostic (3.27e-1)"	"unprognostic (1.00e-1)"	"unprognostic (2.71e-1)"	"unprognostic (2.90e-1)"	"unprognostic (2.05e-1)"	"prognostic favorable (5.36e-5)"	"prognostic favorable (5.93e-4)"	"unprognostic (1.71e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.56e-2)"	"unprognostic (1.04e-1)"	"prognostic favorable (5.44e-8)"	"unprognostic (2.10e-1)"	"unprognostic (2.48e-2)"	"unprognostic (3.80e-1)"	"unprognostic (1.50e-2)"	3.3	27.7	94.6	4.7	105.4	2.2	5.1	85.2	103.4	3.8	70.7	7.6	43.6	3.8	9.6	7.7	6.2	4.4	14.1	90.2	120.7	133.3	345.6	4.5	5.0	90.8	107.4	10.5	138.3	8.2	55.8	3.4	137.6	21.7	7.8	29.6	6.5	3.5	1.6	2.7	20.1	2.7	88.1	4.1	7.4	13.4	137.9	4.2	29.3	1.4	5.9	9.9	4.1	70.9	0.7	0.2	32.1	18.7	5.0	1.7	2.0	4.2	2.2	1.8	0.7	12.7	0.9	4.0	1.4	2.3	1.2	8.3	2.1	7.7	2.4	2.3	2.1	5.5	0.1	127.5	8.1	1.3	8.3	6.5	3.4	3.2	1.4	0.9	0.6	10.7	1.1	2.6	0.6	81.9	2.1	0.6	2.8	23.2	0.3	9.7	67.4	1.8	1.2	20.9	5.1	15.7	1.9	1.0	0.2	6.2	42.6	3.4	0.6	0.8	5.7	2.7	0.1	3.0	0.3	0.8	0.8	5.7	4.2	0.7	1.9	2.7	1.5	2.2	0.7	0.6	1.0	1.1	1.2	1.2	0.7	1.1	6.1	1.2	4.2	0.2	1.1	1.2	94.6	105.4	85.2	103.4	90.2	120.7	90.8	107.4	137.6	88.1	137.9	70.9	1.7	0.0	6.9	39.5	6.1	1.5	4.0	3.3	2.2	27.3	9.1	5.0	10.8	20.0	5.8	1.8	4.2	1.4	5.3	8.9	23.5	1.6	13.0	12.9	6.2	2.4	15.6	13.9	41.8	6.2	1.5	3.2	5.6	12.9	1.3	59.5	7.1	268.2	5.2	35.3	95.0	3.9	2.0	15.7	7.4	8.7	3.7	8.2	1.8	19.7	6.5	48.6	9.2	76.9	17.7	6.8	6.1	4.5	1.0	7.4	15.7	94.9	3.6	5.8	0.0	4.3	3.8	3.7	0.9	9.5	0.6	1.4	6.3	2.3	6.9	5.0
ABCA2	ABC2	ENSG00000107331	"ATP binding cassette subfamily A member 2"	Q9BZC7	9	137007234-137028922	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport	Translocase	"Disease variant, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	23	"brain: 543.0"	"Cell type enriched"	"Detected in many"	10	"Oligodendrocytes: 388.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"T-47d: 66.4"	"Low region specificity"	"Detected in all"							HPA042886	Approved		Supported	Vesicles		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 6: T47d - Mammary gland"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Vesicles		"HPA042886: AB_2678213"	"unprognostic (1.01e-2)"	"unprognostic (9.21e-3)"	"unprognostic (9.59e-2)"	"unprognostic (6.15e-2)"	"unprognostic (1.02e-1)"	"unprognostic (8.08e-2)"	"unprognostic (2.20e-2)"	"unprognostic (1.13e-2)"	"unprognostic (5.61e-3)"	"unprognostic (1.76e-1)"	"unprognostic (2.93e-2)"	"unprognostic (2.74e-2)"	"unprognostic (6.78e-3)"	"unprognostic (3.14e-3)"	"unprognostic (1.37e-1)"	"unprognostic (2.80e-1)"	"unprognostic (1.36e-1)"	9.0	6.0	90.2	4.2	269.7	6.7	6.3	194.3	189.0	5.9	0.0	7.9	3.0	4.3	4.5	3.3	6.2	5.9	9.1	92.4	101.3	7.1	7.4	6.2	4.6	284.9	211.4	3.2	9.3	13.4	23.4	3.1	255.1	7.1	2.2	2.7	8.4	4.7	7.3	6.6	6.5	2.4	135.7	9.5	11.6	2.9	204.9	2.9	15.2	3.5	1.8	5.6	5.3	543.0	8.6	9.2	4.5	18.2	11.1	11.8	7.9	9.5	3.8	4.2	1.5	2.8	10.3	0.4	26.2	10.2	4.1	14.4	2.9	6.9	0.8	6.4	5.9	0.8	26.2	3.5	5.5	13.3	14.5	5.0	6.3	3.0	0.9	15.3	2.4	2.7	2.2	1.5	5.3	25.7	0.1	29.1	2.4	10.9	9.5	13.3	4.6	13.0	2.9	2.0	17.4	20.0	10.1	19.6	7.2	0.3	66.4	17.4	11.9	11.2	6.1	16.0	3.9	0.3	0.2	0.1	19.0	2.6	5.8	0.0	0.0	0.0	0.4	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.1	0.2	0.0	0.6	0.2	0.3	90.2	269.7	194.3	189.0	92.4	101.3	284.9	211.4	255.1	135.7	204.9	543.0	7.2	0.0	0.0	26.1	2.3	3.3	1.5	7.1	3.4	12.6	6.2	9.1	5.1	17.2	2.3	1.8	14.6	1.0	24.0	15.2	1.9	2.9	1.0	6.7	4.8	4.7	34.7	6.6	23.4	1.5	1.2	6.4	5.1	6.9	0.0	12.6	6.1	8.6	1.2	37.0	20.8	7.0	2.0	3.5	4.6	1.6	22.1	2.7	5.4	4.7	0.9	12.8	24.7	12.5	388.7	2.3	7.1	23.7	6.7	2.4	11.6	1.4	4.9	7.9	0.0	11.4	4.7	0.5	4.7	1.7	2.7	0.8	13.2	2.8	11.0	1.3
ABCA7	ABCX	ENSG00000064687	"ATP binding cassette subfamily A member 7"	Q8IZY2	19	1039997-1065572	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Phagocytosis, Transport"	Translocase	"Alzheimer disease, Amyloidosis, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 27.4;pituitary gland: 28.7"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 73.7;Bipolar cells: 70.6;Cone photoreceptor cells: 175.2;Extravillous trophoblasts: 303.3;Rod photoreceptor cells: 149.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HeLa: 20.4;HMC-1: 40.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			HPA041564	Enhanced		Supported	"Golgi apparatus,Plasma membrane,Cell Junctions"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 20: Retina & Lymphoid tissues - Unknown function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 38: Extravillous trophoblasts - Unknown function"	"Golgi apparatus, Plasma membrane"	"Cell Junctions"	"HPA041564: AB_2677550"	"unprognostic (1.52e-1)"	"unprognostic (1.12e-1)"	"prognostic unfavorable (7.26e-4)"	"prognostic favorable (1.12e-4)"	"unprognostic (8.88e-2)"	"unprognostic (1.13e-2)"	"unprognostic (2.25e-1)"	"unprognostic (4.00e-2)"	"unprognostic (1.04e-1)"	"unprognostic (2.24e-2)"	"unprognostic (1.51e-3)"	"unprognostic (3.68e-2)"	"unprognostic (8.99e-3)"	"unprognostic (2.08e-2)"	"unprognostic (3.66e-1)"	"unprognostic (7.88e-2)"	"unprognostic (7.85e-2)"	4.4	3.0	3.4	5.5	3.9	27.4	3.3	4.0	6.1	3.2	11.5	3.8	2.3	1.2	0.2	7.6	2.1	2.1	3.1	3.6	3.7	6.4	4.2	9.5	8.5	5.8	4.5	0.5	7.7	2.7	28.7	1.2	5.3	5.3	1.2	25.5	8.6	1.1	3.8	5.9	10.1	0.5	3.0	26.6	3.8	1.7	4.1	10.0	5.7	0.3	3.2	2.3	2.8	3.2	4.7	6.4	0.5	4.4	7.2	2.2	7.3	0.8	1.0	0.4	0.6	5.2	2.8	13.9	5.6	1.3	0.6	8.0	1.3	6.2	0.4	10.2	2.5	6.7	20.4	5.6	1.8	3.9	40.3	3.8	1.8	0.9	1.2	4.4	1.4	7.7	10.2	6.9	1.3	2.2	4.3	2.2	0.9	3.3	2.5	3.1	0.8	11.6	3.8	6.0	0.3	1.3	8.2	1.9	1.2	1.1	4.6	7.1	2.2	0.4	1.6	3.7	0.8	9.9	6.6	5.7	2.1	7.4	2.0	2.8	1.4	5.9	1.8	1.2	1.1	0.6	0.9	1.2	2.1	0.9	0.8	1.5	3.3	1.1	1.3	7.3	0.4	1.3	3.4	3.9	4.0	6.1	3.6	3.7	5.8	4.5	5.3	3.0	4.1	3.2	4.1	73.7	21.9	8.5	13.2	3.3	0.8	10.7	5.2	70.6	4.8	2.2	6.0	4.3	14.0	5.5	175.2	4.6	9.1	14.7	1.9	2.7	7.3	8.9	1.4	2.9	3.5	13.3	12.9	2.5	303.3	1.5	5.6	6.9	10.1	2.0	2.5	4.9	7.9	15.2	11.5	4.7	16.2	12.6	7.5	4.8	0.0	12.7	0.0	4.7	19.6	13.1	9.2	1.5	2.4	7.0	9.6	0.0	12.0	1.5	1.7	1.3	17.5	149.1	0.0	2.7	2.7	0.7	2.0	6.6	3.4	25.7	12.6	1.0	5.3	1.9
ABCB4	"GBD1, MDR2, MDR3, PFIC-3, PGY3"	ENSG00000005471	"ATP binding cassette subfamily B member 4"	P21439	7	87401696-87480435	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Lipid transport, Transport"	Translocase	"Disease variant, Intrahepatic cholestasis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	16	"liver: 123.2"	"Cell type enriched"	"Detected in some"	6	"Hepatocytes: 256.1"	"Cancer enriched"	"Detected in some"	11	"liver cancer: 16.3"	"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in some"	5	"memory B-cell: 4.4;naive B-cell: 8.1"	"Lineage enriched"	"Detected in many"	7	"B-cells: 8.1"	"Group enriched"	"Detected in some"	5	"SH-SY5Y: 12.9;WM-115: 25.7"	"Low region specificity"	"Detected in many"							"HPA049395, HPA053288"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Actin filaments,Focal adhesion sites"		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 62: Liver - Hemostasis"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 2: Hepatocytes - Metabolism"	"Nucleoplasm, Plasma membrane, Actin filaments"	"Focal adhesion sites"	"HPA049395: AB_2680745, HPA053288: AB_2682102"	"unprognostic (7.92e-2)"	"unprognostic (8.87e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.90e-1)"	"unprognostic (8.95e-2)"	"unprognostic (1.06e-2)"	"unprognostic (2.35e-3)"	"unprognostic (9.91e-2)"	"unprognostic (3.53e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.44e-3)"	"unprognostic (8.43e-2)"	"unprognostic (2.83e-2)"	"unprognostic (8.01e-3)"	"unprognostic (7.12e-2)"	"unprognostic (2.11e-2)"	"unprognostic (2.47e-1)"	0.7	7.4	0.8	2.5	0.6	0.9	0.5	0.6	0.9	0.3	0.4	1.1	0.4	0.2	0.6	0.6	0.2	0.8	6.6	0.8	0.6	0.6	123.2	0.2	5.9	0.9	0.6	0.4	0.1	0.0	0.2	0.2	1.0	0.5	1.2	0.4	0.6	0.4	7.5	1.4	2.1	0.3	0.6	5.0	0.6	1.0	0.7	0.7	0.5	4.8	5.2	1.2	0.5	0.7	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.1	2.3	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.4	0.4	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.2	12.9	0.0	0.6	2.6	0.5	0.2	0.6	0.0	0.2	1.7	0.1	0.0	0.0	0.0	3.2	0.2	0.0	25.7	0.0	0.0	0.0	0.0	0.0	0.0	4.4	0.0	0.0	1.2	8.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.8	0.6	0.6	0.9	0.8	0.6	0.9	0.6	1.0	0.6	0.7	0.7	1.3	0.0	0.5	0.3	22.0	1.0	0.0	0.0	0.0	0.0	0.0	0.1	10.2	0.0	0.0	1.8	0.0	1.1	0.1	0.2	0.0	0.1	0.6	0.2	0.2	1.0	0.0	0.4	0.6	0.0	0.3	2.0	0.0	0.2	0.0	0.0	3.3	256.1	0.5	38.7	1.8	0.0	0.0	5.0	1.2	0.4	0.0	1.0	10.6	3.7	0.1	0.0	0.0	0.5	0.0	0.1	0.1	0.4	0.3	0.0	0.5	0.7	0.0	0.2	0.0	0.6	1.2	1.2	0.2	0.0	0.4	0.1	0.7	0.0	0.2	0.0
ABCB6	"EST45597, MTABC3, umat"	ENSG00000115657	"ATP binding cassette subfamily B member 6 (Langereis blood group)"	Q9NP58	2	219209772-219218994	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	Transport	Translocase	"Disease variant, Dyskeratosis congenita, Microphthalmia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Astrocytes: 14.7;Excitatory neurons: 12.9;Gastric mucus-secreting cells: 5.1;Inhibitory neurons: 10.9;Oligodendrocyte precursor cells: 13.6;Oligodendrocytes: 5.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Hep G2: 65.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046723, HPA058011"	Approved		Supported	"Nucleoplasm,Golgi apparatus,Plasma membrane,Mitochondria,Cytosol"	"Intracellular and membrane"	NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 59: Non-specific - Translation"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Golgi apparatus"	"Nucleoplasm, Plasma membrane, Mitochondria, Cytosol"	"HPA046723: AB_10960288, HPA058011: AB_2683578"	"unprognostic (8.04e-2)"	"unprognostic (3.22e-2)"	"unprognostic (4.53e-3)"	"unprognostic (3.19e-2)"	"unprognostic (2.55e-1)"	"unprognostic (9.11e-2)"	"prognostic unfavorable (9.45e-7)"	"unprognostic (2.26e-1)"	"unprognostic (3.62e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.18e-4)"	"unprognostic (3.02e-3)"	"prognostic unfavorable (1.52e-7)"	"unprognostic (1.51e-1)"	"unprognostic (9.55e-2)"	"unprognostic (7.75e-2)"	"unprognostic (2.30e-1)"	10.2	8.7	4.3	3.4	3.9	10.4	7.6	3.2	4.6	7.7	4.4	6.5	6.9	8.4	8.2	11.4	9.6	7.1	8.5	4.0	5.1	5.2	15.9	5.9	1.9	4.4	4.2	12.9	5.7	4.8	6.0	3.1	6.2	8.0	3.3	3.0	6.2	8.6	30.4	6.8	6.3	7.9	4.1	3.9	7.9	18.0	5.7	2.6	10.7	9.8	2.9	14.9	7.9	5.0	0.3	22.9	4.7	28.8	30.8	11.1	27.6	8.5	7.9	9.2	9.2	35.5	5.0	0.3	42.8	8.6	5.0	49.1	0.6	3.6	3.0	15.0	4.7	36.3	24.9	65.8	37.0	0.0	12.0	16.3	4.2	6.2	0.1	13.9	16.3	4.8	31.4	4.4	6.3	12.0	2.3	0.1	7.2	53.6	9.2	12.3	14.3	1.6	5.1	0.4	16.6	17.8	17.6	41.4	18.7	17.4	12.4	0.8	7.5	12.5	0.5	16.9	10.3	11.2	9.6	0.1	14.0	0.4	17.0	0.7	0.4	0.0	0.7	0.4	0.2	1.0	0.5	0.2	0.3	0.8	1.2	0.8	0.0	0.4	0.3	2.3	0.5	1.0	4.3	3.9	3.2	4.6	4.0	5.1	4.4	4.2	6.2	4.1	5.7	5.0	0.2	0.0	0.0	14.7	0.3	0.3	0.0	0.5	1.2	1.0	0.2	0.0	0.2	0.0	1.3	0.0	0.0	0.2	0.2	0.1	0.0	0.8	1.2	0.3	0.6	0.4	0.0	1.3	12.9	0.0	0.1	0.7	5.1	0.2	0.0	0.5	0.0	0.4	0.1	0.0	10.9	0.3	0.0	0.3	0.4	1.0	0.3	0.3	0.0	3.7	0.0	0.3	0.0	13.6	5.6	0.3	0.0	0.4	0.5	0.0	0.5	0.2	2.2	0.8	0.0	0.4	0.3	1.0	0.3	2.8	0.3	0.3	0.1	0.4	0.2	0.1
ABCB8	"EST328128, M-ABC1, MABC1, MITOSUR"	ENSG00000197150	"ATP binding cassette subfamily B member 8"	Q9NUT2	7	151028422-151047782	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Potassium transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Syncytiotrophoblasts: 81.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045187	Approved		Supported	Nucleoplasm,Mitochondria		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 40: Granulosa cells - Unknown function"	Mitochondria	Nucleoplasm	"HPA045187: AB_10964281"	"unprognostic (5.29e-2)"	"unprognostic (9.17e-3)"	"unprognostic (8.28e-2)"	"unprognostic (8.32e-2)"	"unprognostic (8.63e-3)"	"prognostic favorable (5.91e-4)"	"unprognostic (4.76e-2)"	"unprognostic (3.75e-1)"	"unprognostic (1.55e-1)"	"unprognostic (2.43e-2)"	"prognostic favorable (3.34e-4)"	"unprognostic (2.26e-1)"	"prognostic favorable (5.88e-4)"	"unprognostic (7.52e-3)"	"unprognostic (1.76e-1)"	"unprognostic (1.64e-2)"	"unprognostic (1.23e-1)"	10.3	20.4	9.3	8.4	10.3	8.1	8.6	9.7	13.7	16.6	11.3	12.1	10.9	14.9	7.9	18.3	11.0	6.0	13.2	9.5	8.6	15.0	22.3	10.8	7.5	11.5	10.3	11.6	10.0	11.5	19.6	8.4	12.2	11.0	5.3	8.7	8.9	6.6	7.9	10.6	11.3	7.1	8.3	11.2	12.2	12.4	11.1	7.2	15.6	5.8	6.2	8.9	10.6	14.3	26.1	40.1	10.1	32.3	15.8	9.2	20.0	13.6	13.8	20.6	21.9	16.1	42.7	13.8	17.7	14.4	25.2	27.1	15.0	28.1	9.3	17.2	16.5	10.9	16.2	19.7	10.3	8.5	25.9	15.7	20.8	25.1	10.3	7.8	21.4	29.5	57.8	18.3	16.1	58.4	32.3	15.9	6.9	19.6	45.8	14.8	6.4	49.0	14.2	10.9	9.8	19.6	14.5	40.4	13.0	7.9	15.6	11.0	13.3	19.3	5.1	14.1	20.6	18.7	9.8	9.8	27.6	19.9	20.2	11.8	3.2	2.5	4.9	4.7	3.4	2.8	3.4	3.9	4.3	2.1	3.1	4.4	0.7	3.0	3.3	7.1	3.8	2.8	9.3	10.3	9.7	13.7	9.5	8.6	11.5	10.3	12.2	8.3	11.1	14.3	7.3	12.8	1.1	16.6	12.1	3.7	6.6	10.6	6.2	24.9	6.4	4.7	7.0	7.2	7.2	11.0	37.5	36.2	12.0	28.5	3.9	15.9	3.1	14.8	12.8	4.8	0.0	13.7	15.9	20.0	22.5	9.8	36.7	12.1	49.6	57.8	6.1	25.2	28.0	30.3	17.8	14.0	18.3	6.0	3.9	2.8	6.5	8.2	8.8	2.8	9.7	9.0	17.5	7.1	11.8	21.5	8.5	12.4	22.9	7.0	20.6	14.3	8.8	36.6	26.3	8.9	9.5	9.9	13.5	12.0	7.4	81.8	11.3	28.1	18.7	7.6
ABCB9	EST122234	ENSG00000150967	"ATP binding cassette subfamily B member 9"	Q9NP78	12	122920951-122981649	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Peptide transport, Protein transport, Transport"	Translocase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 20.4;testis: 17.8"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 46.3;Inhibitory neurons: 41.7;Plasma cells: 92.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"basophil: 2.6;memory B-cell: 2.5"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"GAMG: 25.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB033052, HPA035113, HPA035114"	Approved		Supported	Vesicles		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 6: Brain - Smell perception"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 55: Plasma cells - Humoral immune response"	Vesicles		"CAB033052: AB_2273463, HPA035113: AB_2674470, HPA035114: AB_10601329"	"unprognostic (1.47e-2)"	"unprognostic (6.46e-4)"	"unprognostic (3.96e-2)"	"unprognostic (2.73e-1)"	"prognostic unfavorable (5.65e-4)"	"unprognostic (1.46e-1)"	"unprognostic (2.67e-2)"	"unprognostic (2.35e-1)"	"unprognostic (4.08e-2)"	"unprognostic (6.07e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.37e-2)"	"unprognostic (6.97e-2)"	"unprognostic (1.70e-1)"	"unprognostic (3.58e-3)"	"unprognostic (2.71e-2)"	3.0	3.1	11.9	1.6	10.4	3.4	3.9	19.7	20.4	3.1	0.0	2.4	2.7	3.0	4.9	2.9	2.9	2.5	4.9	8.2	7.5	3.6	1.2	1.6	1.6	7.3	9.1	4.0	3.2	2.8	11.6	1.8	6.0	3.5	2.1	7.3	5.6	2.8	1.6	3.3	3.4	2.0	2.1	3.6	3.4	17.8	16.0	1.3	3.0	1.2	1.9	1.9	3.1	10.6	4.7	8.6	4.7	4.5	2.0	3.8	2.2	3.0	4.3	5.1	3.2	3.7	5.3	5.2	3.4	2.8	25.9	4.3	3.5	7.2	2.0	1.0	7.0	22.9	7.7	5.9	2.2	1.1	9.0	5.3	2.8	7.5	2.3	12.5	5.7	5.1	4.6	3.8	2.9	10.6	1.7	2.2	1.5	5.0	8.4	6.4	1.3	5.0	2.6	3.1	5.0	1.5	1.5	10.7	10.7	1.8	12.6	1.6	2.5	3.6	12.2	11.5	8.8	12.3	7.4	1.5	6.3	2.5	20.2	2.6	0.3	0.3	0.3	0.1	0.8	2.5	0.3	0.3	0.2	0.5	0.6	0.6	0.7	0.2	0.1	0.1	0.2	0.8	11.9	10.4	19.7	20.4	8.2	7.5	7.3	9.1	6.0	2.1	16.0	10.6	9.7	6.4	4.6	13.4	15.9	3.2	2.8	1.5	8.6	10.7	3.9	5.0	2.0	0.0	2.5	3.7	14.6	5.2	3.4	1.9	0.0	3.8	8.9	2.6	2.6	4.0	1.2	2.1	46.3	1.5	1.8	2.0	4.1	5.6	2.5	3.0	2.9	1.2	1.1	6.7	41.7	1.1	0.0	1.0	2.1	23.2	2.8	1.8	5.4	7.5	0.3	20.0	2.1	4.0	18.1	2.5	0.1	2.6	92.2	2.1	4.1	0.9	0.7	5.3	6.6	2.1	3.7	9.6	3.5	3.3	3.1	1.4	3.9	2.9	2.6	1.8
ABCC1	"GS-X, MRP, MRP1"	ENSG00000103222	"ATP binding cassette subfamily C member 1"	P33527	16	15949138-16143257	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted membrane proteins, Transporters"	Transport	"Hydrolase, Translocase"	"Cancer-related genes, Deafness, FDA approved drug targets, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Gastric mucus-secreting cells: 49.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"EFO-21: 79.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002380, HPA076011"	Uncertain		Supported	"Plasma membrane,Cell Junctions"		NA	NA				"Cluster 72: Non-specific - Transcription"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 44: Endometrium - Transcription"	"Plasma membrane"	"Cell Junctions"	"HPA002380: AB_1844432, HPA076011: "	"unprognostic (9.97e-2)"	"unprognostic (2.06e-1)"	"unprognostic (2.05e-2)"	"unprognostic (2.94e-1)"	"unprognostic (4.89e-2)"	"unprognostic (1.15e-1)"	"prognostic unfavorable (5.42e-5)"	"unprognostic (3.42e-1)"	"unprognostic (3.31e-1)"	"unprognostic (4.07e-2)"	"unprognostic (9.78e-3)"	"unprognostic (7.19e-2)"	"prognostic unfavorable (1.55e-6)"	"unprognostic (1.84e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.43e-2)"	"unprognostic (1.80e-2)"	10.4	11.6	0.3	4.0	0.2	3.6	8.6	0.3	0.7	10.4	4.1	16.1	1.1	11.0	0.1	22.8	7.0	3.1	11.2	0.3	0.5	8.0	2.3	15.5	4.4	1.1	0.8	8.9	8.9	3.6	7.2	2.0	0.7	15.2	0.7	0.4	9.2	0.9	21.2	9.7	12.4	6.3	0.5	15.7	15.0	13.1	0.6	4.3	21.0	0.1	1.1	15.4	12.8	0.9	4.3	43.7	0.3	11.7	3.2	4.5	0.5	15.4	19.0	13.1	13.8	6.7	34.8	7.0	79.6	29.6	11.0	12.1	3.4	12.4	4.6	22.2	4.4	16.4	22.0	16.3	25.1	5.9	39.5	15.0	9.0	1.1	2.3	3.8	10.2	28.6	17.8	6.8	0.5	5.4	12.0	0.9	3.5	1.8	8.2	41.9	7.8	5.3	0.7	15.2	6.4	11.8	18.9	17.8	3.6	11.9	6.2	0.8	3.5	0.4	2.0	11.4	11.9	13.5	7.4	3.3	6.6	0.6	0.7	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.3	0.7	0.3	0.5	1.1	0.8	0.7	0.5	0.6	0.9	8.6	25.6	5.6	10.7	13.1	8.8	8.5	18.2	9.6	3.1	4.4	3.7	6.0	4.3	14.4	5.5	22.9	0.9	9.8	2.7	3.9	9.1	11.0	15.7	12.9	8.6	18.6	16.0	26.6	6.2	3.2	12.3	49.5	17.8	22.1	16.8	8.6	0.4	8.5	5.0	38.5	6.6	14.2	21.4	9.1	14.3	7.5	12.2	3.6	11.2	10.5	1.2	5.2	12.1	15.9	11.2	4.5	6.8	15.7	18.7	0.5	1.1	9.9	8.8	0.0	6.4	5.1	4.9	6.6	18.1	5.1	0.5	17.4	37.1	3.7	11.6
ABCC3	"cMOAT2, EST90757, MLP2, MOAT-D, MRP3"	ENSG00000108846	"ATP binding cassette subfamily C member 3"	O15438	17	50634777-50692253	"Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport	Translocase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 59.1;liver: 50.4"	"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 231.6;Distal enterocytes: 265.1;Gastric mucus-secreting cells: 271.7;Hepatocytes: 192.9;Paneth cells: 194.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"intermediate monocyte: 5.1;non-classical monocyte: 6.4"	"Lineage enriched"	"Detected in many"	5	"monocytes: 6.4"	"Cell line enhanced"	"Detected in many"		"A549: 79.4;CAPAN-2: 60.6;HeLa: 36.9;OE19: 89.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB037136, HPA048483"	Enhanced		Supported	"Plasma membrane"		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 21: OE19 - Mitochondria"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Plasma membrane"		"CAB037136: AB_477165, HPA048483: AB_2680414"	"unprognostic (1.57e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.65e-2)"	"unprognostic (9.67e-3)"	"unprognostic (6.19e-3)"	"unprognostic (7.44e-3)"	"unprognostic (8.20e-2)"	"unprognostic (3.18e-1)"	"unprognostic (5.13e-2)"	"prognostic unfavorable (9.57e-4)"	"unprognostic (1.60e-3)"	"prognostic unfavorable (4.68e-6)"	"unprognostic (3.42e-1)"	"unprognostic (4.77e-2)"	"unprognostic (4.44e-2)"	"unprognostic (1.57e-3)"	3.1	59.1	0.1	3.4	1.8	0.8	4.2	0.2	0.7	2.1	0.0	18.9	12.0	1.1	1.8	7.5	1.0	11.9	0.9	0.3	0.3	8.0	50.4	4.8	1.9	5.9	0.8	0.7	22.6	0.8	0.8	1.1	3.5	5.9	8.7	0.4	7.0	5.5	0.2	7.1	11.9	1.3	1.7	3.4	17.1	1.0	2.5	0.3	5.5	0.0	1.7	6.3	3.6	2.4	5.7	79.4	0.0	0.3	4.4	6.9	0.1	10.4	13.1	0.7	0.7	4.2	60.6	0.0	8.0	20.6	14.5	14.5	0.0	1.0	1.0	0.0	0.0	1.7	36.9	24.2	17.2	0.0	0.0	7.5	5.6	2.9	6.2	8.5	1.4	0.0	0.2	0.0	8.0	18.9	0.0	0.0	0.1	89.7	10.1	0.1	0.0	0.3	33.4	34.2	0.1	0.6	19.2	3.1	0.0	0.1	2.6	0.0	17.3	0.5	3.4	0.2	8.5	0.1	0.0	0.0	8.2	0.0	0.9	0.2	2.3	0.0	0.0	5.1	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	1.0	0.3	6.4	0.1	0.5	5.4	0.1	1.8	0.2	0.7	0.3	0.3	5.9	0.8	3.5	1.7	2.5	2.4	0.7	19.2	5.5	0.0	1.8	9.4	122.2	47.1	42.7	1.6	1.9	6.9	3.1	231.6	19.5	14.7	0.0	0.4	0.0	265.1	5.9	100.1	82.9	5.9	8.8	2.7	23.5	0.0	4.3	106.1	3.7	3.6	271.7	30.5	0.0	3.1	3.9	192.9	26.1	1.7	0.9	96.2	12.2	33.0	11.4	118.6	9.0	31.6	3.6	2.8	8.7	2.9	1.0	0.5	0.5	105.9	194.7	3.0	2.1	104.6	57.2	10.8	2.7	0.3	0.0	1.9	5.6	0.9	0.8	12.7	10.5	1.0	2.6	0.1	111.0	118.4
ABCC4	"EST170205, MOAT-B, MOATB, MRP4"	ENSG00000125257	"ATP binding cassette subfamily C member 4"	O15439	13	95019835-95301475	"Enzymes, Metabolic proteins, Plasma proteins, Predicted membrane proteins, Transporters"	Transport	Translocase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"prostate: 41.1"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 51.3;granulocytes: 53.9;Microglial cells: 203.3"	"Cancer enriched"	"Detected in all"	8	"prostate cancer: 90.8"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"HEL: 245.7;HMC-1: 256.3;RPTEC TERT1: 69.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002476	Enhanced		Supported	"Nucleoli,Golgi apparatus,Plasma membrane"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Plasma membrane"	"Nucleoli, Golgi apparatus"	"HPA002476: AB_1844434"	"unprognostic (8.77e-2)"	"unprognostic (1.94e-2)"	"unprognostic (1.48e-1)"	"prognostic unfavorable (9.89e-4)"	"unprognostic (2.83e-2)"	"unprognostic (1.23e-1)"	"unprognostic (7.45e-3)"	"unprognostic (2.40e-2)"	"unprognostic (9.96e-2)"	"unprognostic (2.60e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.55e-2)"	"prognostic favorable (2.25e-10)"	"unprognostic (7.44e-3)"	"unprognostic (1.67e-1)"	"unprognostic (5.55e-2)"	"unprognostic (2.35e-2)"	2.2	1.3	2.5	6.1	2.3	4.1	6.9	2.5	2.5	4.9	7.2	9.2	4.9	3.4	18.8	2.0	10.2	6.1	2.0	2.3	5.4	18.0	1.3	7.6	3.9	4.3	3.7	3.7	3.3	22.5	1.4	2.1	4.6	41.1	8.5	0.9	1.5	5.5	5.3	2.9	5.4	6.3	4.9	4.1	5.2	4.7	3.2	3.9	7.7	1.7	6.3	15.4	1.8	5.1	18.5	31.7	5.3	9.4	9.5	12.3	1.3	14.4	14.3	12.6	10.9	43.8	13.2	10.2	9.3	19.5	9.0	24.0	7.9	7.1	15.8	30.7	12.1	245.7	8.8	8.8	19.2	28.6	256.3	9.4	3.2	9.1	18.5	17.9	16.4	11.3	25.8	0.4	17.1	5.9	5.4	4.6	6.2	22.3	7.9	7.7	14.3	26.9	69.3	40.4	12.5	9.3	4.8	1.2	10.1	5.9	0.0	15.1	27.0	13.3	8.6	11.2	17.3	0.1	0.0	4.0	25.4	16.0	6.6	0.2	0.5	0.2	1.3	0.6	1.1	1.4	1.0	1.5	1.8	1.6	0.6	1.5	0.3	1.9	2.3	0.3	1.5	1.3	2.5	2.3	2.5	2.5	2.3	5.4	4.3	3.7	4.6	4.9	3.2	5.1	4.6	9.6	32.7	28.4	5.8	4.2	7.0	7.3	4.0	0.1	0.6	0.6	4.5	8.6	9.1	23.9	22.9	0.1	2.0	2.7	0.0	6.9	3.8	4.2	11.3	19.8	0.0	51.3	13.6	3.1	0.4	5.7	6.1	6.0	53.9	9.5	2.9	0.6	4.5	0.0	10.3	4.0	0.0	2.5	8.1	2.0	6.8	10.7	1.8	203.3	13.5	0.5	4.1	16.1	2.5	2.9	8.3	1.9	8.3	27.1	0.5	26.4	4.7	0.8	0.0	8.2	3.1	0.9	8.3	3.4	7.5	0.3	6.4	17.3	9.2	4.5
ABCC6	"ARA, EST349056, MLP1, MRP6, PXE, URG7"	ENSG00000091262	"ATP binding cassette subfamily C member 6"	O95255	16	16149565-16223522	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Sensory transduction, Transport, Vision"	Translocase	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"liver: 134.2"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 31.5;Distal tubular cells: 45.0;Hepatocytes: 77.9;Proximal enterocytes: 33.7;Proximal tubular cells: 151.1"	"Group enriched"	"Detected in many"	5	"liver cancer: 16.7;renal cancer: 5.0"	"Low region specificity"	"Detected in single"			"Immune cell enriched"	"Detected in single"	6	"classical monocyte: 3.4"	"Lineage enriched"	"Detected in single"	7	"monocytes: 3.4"	"Cell line enriched"	"Detected in some"	8	"Hep G2: 68.4"	"Not detected"	"Not detected"							HPA038105			Supported	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 85: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Plasma membrane"	Nucleoplasm	"HPA038105: AB_2675835"	"unprognostic (1.32e-1)"	"unprognostic (1.11e-1)"	"unprognostic (5.98e-2)"	"unprognostic (3.15e-2)"	"unprognostic (1.59e-1)"	"unprognostic (3.09e-1)"	"prognostic favorable (3.82e-4)"	"unprognostic (6.54e-3)"	"unprognostic (3.64e-1)"	"unprognostic (9.10e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.12e-3)"	"unprognostic (3.42e-1)"	"unprognostic (2.00e-1)"	"unprognostic (4.91e-2)"	"unprognostic (1.41e-1)"	5.6	3.6	0.7	0.3	0.7	0.7	3.8	0.7	1.1	1.0	0.8	5.7	13.2	0.3	0.6	0.3	1.5	2.9	2.6	0.7	0.7	27.4	134.2	7.4	0.0	0.8	0.9	1.0	17.2	2.1	0.9	0.2	0.8	2.9	2.8	0.3	12.7	1.0	4.6	0.4	7.9	0.3	0.7	0.7	6.4	0.4	0.8	0.0	5.6	0.1	0.0	0.4	0.7	0.7	0.0	1.5	0.7	0.0	0.0	0.8	1.8	0.0	0.4	1.0	1.6	7.1	2.3	0.0	0.8	0.0	0.2	0.0	0.7	0.1	0.6	0.0	0.7	1.8	0.2	68.4	0.4	0.0	0.0	2.7	0.1	0.1	0.0	0.8	0.0	0.0	0.0	0.0	0.1	0.1	0.0	1.5	0.2	0.6	0.0	0.0	0.0	0.0	2.3	0.0	0.1	1.0	0.0	0.8	0.1	0.3	8.4	5.5	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	3.4	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.6	0.7	0.7	0.7	1.1	0.7	0.7	0.8	0.9	0.8	0.7	0.8	0.7	0.3	28.9	31.5	2.9	1.9	0.1	0.5	3.2	0.0	1.0	4.3	3.6	3.3	18.6	8.7	9.2	0.0	0.0	0.0	13.7	45.0	2.2	0.5	4.8	1.0	0.8	3.0	2.7	1.0	7.9	0.0	1.7	13.3	1.0	1.3	1.9	1.8	77.9	1.0	0.0	1.1	10.9	0.0	3.5	0.0	0.7	1.5	1.8	1.8	3.7	3.1	1.5	0.0	1.0	0.4	2.2	8.1	5.7	0.3	2.0	33.7	151.1	25.4	0.6	0.0	0.3	1.2	0.4	0.3	0.2	0.9	0.0	1.4	1.8	11.9	0.7
ABCG1	ABC8	ENSG00000160179	"ATP binding cassette subfamily G member 1"	P45844	21	42199689-42297244	"Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Lipid transport, Transport"	Translocase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Rod photoreceptor cells: 122.6;Syncytiotrophoblasts: 63.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"eosinophil: 35.5;neutrophil: 36.6"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 36.6"	"Cell line enhanced"	"Detected in many"		"hTCEpi: 25.5;JURKAT: 38.4;MCF7: 33.2;MOLT-4: 31.5;OE19: 54.9;RPMI-8226: 25.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031470, HPA031471"	Approved		Supported	"Golgi apparatus,Vesicles"		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 46: Photoreceptor cells - Phototransduction"	"Golgi apparatus, Vesicles"		"HPA031470: AB_10599188, HPA031471: AB_10600201"	"unprognostic (2.89e-2)"	"unprognostic (2.53e-2)"	"unprognostic (9.96e-2)"	"unprognostic (4.20e-3)"	"unprognostic (2.87e-1)"	"unprognostic (3.09e-2)"	"unprognostic (5.74e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.66e-3)"	"unprognostic (3.66e-3)"	"unprognostic (6.37e-2)"	"prognostic favorable (7.16e-6)"	"unprognostic (1.40e-2)"	"unprognostic (2.00e-2)"	"unprognostic (1.66e-1)"	"unprognostic (2.42e-2)"	17.2	37.7	18.3	12.1	25.5	8.1	15.2	14.4	20.2	8.1	20.0	14.1	17.5	4.9	3.9	4.1	6.3	13.8	10.5	15.5	17.0	10.2	6.3	29.4	18.1	12.0	19.9	6.3	5.3	24.4	10.7	13.7	13.3	6.2	15.0	29.1	16.1	7.0	19.6	16.8	22.0	4.0	12.2	31.2	15.9	1.1	20.3	18.9	8.5	6.2	12.1	12.9	5.0	24.7	0.0	6.0	4.6	2.3	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.1	3.1	1.9	0.8	0.0	0.7	0.9	0.0	8.8	0.0	8.5	0.5	10.2	19.2	0.0	17.4	0.0	0.4	2.0	25.5	0.1	3.9	0.0	18.2	38.4	0.0	0.1	0.0	33.2	31.5	0.2	1.4	54.9	10.3	0.4	0.0	25.8	0.0	2.8	22.3	5.8	3.7	13.5	0.0	0.4	5.7	0.9	11.8	0.0	4.7	0.1	0.0	13.1	4.2	0.0	0.1	3.3	0.5	1.7	1.7	35.5	3.0	0.5	5.6	5.5	6.1	6.0	1.1	7.0	5.8	5.0	36.6	7.4	0.3	2.5	7.4	2.1	18.3	25.5	14.4	20.2	15.5	17.0	12.0	19.9	13.3	12.2	20.3	24.7	38.2	6.4	8.2	0.3	21.3	8.9	6.9	3.2	5.7	48.4	4.1	6.9	9.5	4.3	5.9	25.8	50.1	7.0	7.0	33.4	3.9	2.6	4.5	21.6	6.3	33.8	3.5	5.7	13.2	1.2	1.8	7.5	11.2	45.3	0.0	1.2	42.8	0.6	16.0	11.8	17.8	12.1	8.2	44.5	23.4	7.6	0.3	20.9	3.6	7.5	4.3	16.1	3.1	43.2	40.6	2.3	8.3	1.9	4.0	3.0	36.6	1.1	4.5	122.6	6.6	1.6	3.5	0.6	0.5	1.0	6.7	63.1	21.4	10.4	1.1	9.1
ABHD11	"PP1226, WBSCR21"	ENSG00000106077	"Abhydrolase domain containing 11"	Q8NFV4	7	73736094-73738867	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		Hydrolase	"Williams-Beuren syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 156.9;Urothelial cells: 241.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"MCF7: 92.6;SK-BR-3: 113.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024042, HPA049641"	Approved		Supported	Mitochondria		NA	NA		31000	"Cluster 7: Monocytes - Unknown function"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Mitochondria		"HPA024042: AB_1844445, HPA049641: AB_2680838"	"unprognostic (4.74e-2)"	"unprognostic (8.62e-3)"	"unprognostic (1.42e-1)"	"unprognostic (2.51e-2)"	"unprognostic (3.56e-3)"	"unprognostic (1.73e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.81e-3)"	"unprognostic (1.91e-2)"	"unprognostic (9.32e-2)"	"unprognostic (7.79e-2)"	"unprognostic (1.74e-1)"	"prognostic favorable (3.66e-7)"	"unprognostic (3.61e-3)"	"unprognostic (4.44e-2)"	"unprognostic (1.02e-1)"	"unprognostic (7.29e-2)"	7.5	13.5	9.3	5.6	9.8	4.5	12.2	10.6	11.3	9.3	16.4	31.3	15.9	7.2	5.8	13.6	13.8	8.6	21.6	9.1	9.9	29.4	9.5	9.5	4.0	11.4	11.1	3.9	25.7	12.9	16.4	7.6	11.0	23.2	17.4	3.0	21.3	8.2	11.3	13.3	19.8	3.5	10.4	8.1	9.0	7.2	12.3	3.3	28.1	10.3	5.4	8.5	6.9	10.4	46.9	10.7	7.1	16.4	3.7	5.0	39.7	21.1	8.9	12.7	14.9	13.1	51.4	22.2	6.2	9.0	17.3	20.2	3.2	12.1	8.8	8.2	15.4	10.8	6.7	8.3	6.5	11.8	11.4	4.6	5.0	16.4	7.6	4.6	9.2	7.4	15.1	11.8	12.0	92.6	9.2	14.9	8.3	29.5	39.1	5.0	11.4	41.0	29.7	21.8	18.3	7.6	17.1	113.0	7.1	5.1	36.8	7.8	9.1	10.8	10.2	46.5	22.2	7.3	4.2	14.8	17.3	11.2	20.3	10.2	19.1	19.3	8.2	32.7	6.8	10.1	9.1	8.7	19.4	12.7	8.4	5.9	15.2	14.9	33.5	9.2	6.3	11.9	9.3	9.8	10.6	11.3	9.1	9.9	11.4	11.1	11.0	10.4	12.3	10.4	7.9	44.8	15.7	3.3	10.6	5.5	60.3	39.8	10.2	16.6	43.1	21.7	16.9	54.3	60.7	57.0	4.2	86.3	8.7	156.9	72.4	52.1	1.2	98.9	17.3	9.7	62.6	9.4	5.8	40.8	120.1	9.9	35.7	98.1	15.2	6.3	4.6	8.7	28.0	5.0	4.0	106.8	95.6	11.3	10.5	2.3	9.0	13.7	14.2	4.7	10.4	26.6	14.4	3.0	3.7	38.2	151.7	3.4	10.5	53.1	128.2	55.3	127.6	15.2	0.0	10.3	14.4	6.8	7.1	23.3	6.3	127.7	9.6	22.1	128.9	241.3
ABHD14B	"CIB, MGC15429"	ENSG00000114779	"Abhydrolase domain containing 14B"	Q96IU4	3	51968510-51983409	"Plasma proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Proximal enterocytes: 313.2;Proximal tubular cells: 265.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RPMI-8226: 190.8"	"Low region specificity"	"Detected in all"							"HPA036444, HPA036642"	Supported		Approved	Nucleoplasm,Nucleoli,Cytosol		NA	NA		2100000	"Cluster 44: Non-specific - Transcription"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Nucleoli	"Nucleoplasm, Cytosol"	"HPA036444: AB_10672221, HPA036642: AB_10672225"	"unprognostic (8.97e-2)"	"prognostic favorable (6.92e-5)"	"unprognostic (1.84e-1)"	"prognostic favorable (5.42e-5)"	"unprognostic (1.07e-1)"	"unprognostic (2.21e-2)"	"unprognostic (2.06e-3)"	"unprognostic (1.35e-3)"	"unprognostic (3.95e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.20e-1)"	"unprognostic (2.95e-2)"	"prognostic favorable (2.93e-5)"	"unprognostic (1.16e-1)"	"unprognostic (3.55e-1)"	"unprognostic (9.70e-2)"	"unprognostic (3.70e-2)"	69.2	81.9	21.3	26.1	22.3	37.4	66.0	21.4	25.3	49.7	29.9	60.0	81.5	39.3	44.7	46.1	58.3	35.2	31.0	20.2	21.4	97.3	155.6	37.8	48.3	22.2	22.2	51.2	65.2	51.3	36.5	15.4	22.7	48.5	55.3	40.4	64.8	36.6	25.1	42.7	74.8	26.9	22.4	47.1	51.0	9.6	22.9	39.0	57.1	22.6	43.1	47.9	42.9	22.3	37.6	32.9	2.7	37.3	100.6	91.3	9.2	14.5	18.4	27.2	32.5	25.3	72.6	41.7	11.4	54.2	12.6	18.5	23.5	22.2	21.0	57.6	27.2	66.6	30.6	106.6	55.3	37.8	64.9	115.1	74.4	27.8	36.9	41.9	34.0	64.2	39.1	66.8	55.8	40.5	16.8	29.9	3.5	43.6	88.5	42.1	5.2	190.8	51.8	16.7	15.2	16.6	37.3	68.0	121.8	5.7	97.7	25.8	31.5	13.8	64.8	32.3	8.7	82.1	41.6	17.4	30.4	118.9	24.8	41.7	24.3	10.9	42.2	19.9	63.3	58.3	53.0	52.0	38.1	42.9	52.4	49.2	1.9	24.5	12.9	28.4	42.4	37.5	21.3	22.3	21.4	25.3	20.2	21.4	22.2	22.2	22.7	22.4	22.9	22.3	40.4	6.4	26.2	7.8	69.4	30.2	62.4	68.5	38.1	12.7	88.1	81.0	4.7	72.9	28.7	69.9	14.6	16.7	50.7	79.6	146.8	34.8	1.4	19.6	22.4	36.8	75.9	41.2	10.1	46.8	19.0	43.4	35.2	20.9	50.8	14.8	39.7	122.1	55.4	8.4	10.8	97.1	42.7	60.7	36.3	2.4	65.0	39.0	55.2	14.0	37.7	14.8	50.4	4.5	9.4	30.0	74.5	46.6	37.4	39.6	313.2	265.3	25.2	39.9	39.5	34.7	35.6	0.4	3.9	57.1	30.4	11.8	63.9	47.7	127.9	64.4
ABHD5	"CGI-58, NCIE2"	ENSG00000011198	"Abhydrolase domain containing 5, lysophosphatidic acid acyltransferase"	Q8WTS1	3	43690108-43734371	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Differentiation, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	"Acyltransferase, Transferase"	"Cataract, Deafness, Disease variant, Ichthyosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Syncytiotrophoblasts: 205.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 67.8;neutrophil: 42.5"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 67.8"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB020685, HPA035851, HPA035852"	Approved		Supported	Nucleoplasm,Vesicles,Cytosol		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 31: Skin - Epidermis development"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 7: Non-specific - Mitochondria"	"Vesicles, Cytosol"	Nucleoplasm	"CAB020685: , HPA035851: AB_10671942, HPA035852: AB_10672073"	"unprognostic (2.58e-1)"	"unprognostic (2.73e-1)"	"prognostic favorable (8.89e-4)"	"unprognostic (1.07e-1)"	"unprognostic (1.75e-2)"	"unprognostic (2.26e-1)"	"unprognostic (6.13e-2)"	"unprognostic (2.40e-2)"	"unprognostic (5.33e-2)"	"unprognostic (3.50e-3)"	"unprognostic (2.56e-2)"	"unprognostic (4.13e-3)"	"prognostic favorable (9.17e-5)"	"unprognostic (2.48e-1)"	"unprognostic (8.87e-2)"	"unprognostic (4.18e-2)"	"unprognostic (4.18e-2)"	38.8	12.5	6.7	8.5	8.6	39.6	27.9	10.5	8.9	9.8	6.0	12.3	9.9	5.7	4.1	31.1	5.1	11.6	13.4	6.8	7.4	12.0	21.7	16.4	3.4	9.2	8.2	4.6	16.0	12.2	5.6	10.2	9.1	7.1	7.5	6.3	27.4	8.4	15.0	38.0	10.5	9.3	9.3	9.4	12.1	10.8	8.4	6.8	15.5	18.5	7.9	16.7	16.9	11.9	18.9	6.8	8.2	9.7	32.0	12.8	17.1	77.4	27.1	18.8	14.9	9.4	6.4	16.2	10.9	23.2	15.8	5.8	16.5	18.5	22.6	58.4	13.2	36.6	24.4	7.5	15.7	9.2	13.2	13.0	64.6	31.3	28.5	18.8	33.3	10.8	23.9	14.2	46.9	11.0	7.6	6.9	22.8	16.7	20.4	3.1	24.1	8.6	27.9	40.4	10.6	13.6	36.9	20.5	9.8	9.8	18.9	8.9	19.3	18.1	13.6	35.0	34.5	11.1	34.0	7.7	20.3	17.3	16.0	67.8	14.7	9.5	2.3	7.9	1.7	3.5	1.7	2.7	6.8	4.0	1.6	2.5	42.5	2.0	5.7	1.9	4.8	5.3	6.7	8.6	10.5	8.9	6.8	7.4	9.2	8.2	9.1	9.3	8.4	11.9	117.5	25.6	51.8	12.7	44.8	39.9	27.5	25.9	88.8	11.9	149.9	116.2	10.3	14.3	49.6	27.6	27.1	16.7	80.3	65.0	33.2	57.5	19.5	47.5	49.0	34.6	36.2	69.0	24.1	61.5	24.9	53.7	67.8	114.0	16.5	8.8	18.2	12.7	18.0	3.3	24.1	23.7	34.6	44.1	17.4	17.1	5.3	79.8	7.2	11.2	35.9	11.0	12.3	18.1	28.8	75.2	49.8	5.7	41.8	25.5	98.5	39.8	19.1	17.4	0.0	32.0	46.4	47.3	41.9	111.7	40.9	205.4	42.6	15.2	21.9	71.6
ABI2	"ABI-2, ABI2B, AblBP3, AIP-1, argBPIA, SSH3BP2"	ENSG00000138443	"Abl interactor 2"	Q9NYB9	2	203328280-203447728	"Predicted intracellular proteins"	"Host-virus interaction, Neurogenesis"		"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA070567	Enhanced		Supported	Nucleoplasm,Vesicles,Cytosol		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 68: Epididymis - Unknown function"	"Cluster 12: NES - Nervous system development"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm	"Vesicles, Cytosol"	"HPA070567: AB_2686281"	"unprognostic (5.26e-3)"	"unprognostic (5.26e-3)"	"unprognostic (1.86e-1)"	"unprognostic (4.11e-3)"	"unprognostic (2.13e-1)"	"unprognostic (1.97e-2)"	"unprognostic (1.81e-3)"	"unprognostic (7.05e-2)"	"unprognostic (8.03e-2)"	"unprognostic (8.56e-3)"	"unprognostic (6.19e-3)"	"unprognostic (1.95e-1)"	"unprognostic (4.47e-2)"	"unprognostic (4.24e-2)"	"unprognostic (2.94e-1)"	"unprognostic (9.21e-2)"	"unprognostic (1.73e-1)"	10.5	13.2	31.0	9.5	41.9	3.3	15.2	22.9	38.4	19.0	10.0	18.7	5.7	28.0	18.7	11.9	22.5	13.4	32.7	40.4	33.0	20.9	7.4	16.1	8.2	16.3	24.1	27.9	7.5	20.4	20.5	19.4	17.3	18.7	10.7	30.0	8.6	23.0	7.4	7.6	8.9	25.2	21.3	12.9	9.3	27.5	36.0	22.2	26.5	15.8	8.7	14.6	11.9	22.5	19.3	29.4	102.5	64.4	23.9	40.5	22.6	33.0	29.0	27.9	32.2	27.3	35.5	0.0	22.0	39.0	38.8	20.9	47.1	34.6	54.8	9.5	27.4	47.9	30.9	21.4	36.3	20.6	21.1	28.8	16.5	51.2	39.5	80.5	52.6	54.1	34.7	41.8	49.7	35.0	52.8	20.4	53.5	18.2	64.8	34.5	51.4	3.5	29.3	19.6	43.2	55.3	6.2	19.2	37.4	76.8	25.0	23.9	39.9	50.4	43.0	27.8	36.2	29.3	28.7	26.6	54.7	8.5	33.2	0.2	1.4	0.0	3.3	1.6	3.6	1.4	3.7	3.7	4.0	1.3	4.4	3.9	0.2	3.9	3.8	12.7	4.4	3.2	31.0	41.9	22.9	38.4	40.4	33.0	16.3	24.1	17.3	21.3	36.0	22.5	39.7	54.5	26.5	123.4	14.7	30.1	55.7	37.7	34.1	111.9	39.5	38.7	56.7	28.6	32.8	53.3	162.6	23.7	33.1	10.1	33.2	24.3	128.2	62.3	68.4	43.6	49.2	30.3	201.3	13.1	15.7	54.1	25.0	72.3	15.8	100.0	65.7	12.3	16.7	102.6	128.6	10.9	20.3	11.4	62.3	81.6	46.6	22.1	49.8	57.1	18.6	67.6	26.8	114.1	94.2	15.5	19.4	63.2	18.3	44.2	11.1	38.5	83.1	89.6	26.3	70.5	67.9	89.0	52.4	22.0	26.1	19.7	21.7	69.9	17.0	37.5
ABLIM1	"ABLIM, LIMAB1, limatin"	ENSG00000099204	"Actin binding LIM protein 1"	O14639	10	114431113-114768061	"Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 875.6;Cardiomyocytes: 592.5;Peritubular cells: 413.0;Squamous epithelial cells: 481.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"naive CD4 T-cell: 139.1"	"Group enriched"	"Detected in many"	7	"B-cells: 52.2;NK-cells: 63.6;T-cells: 139.1"	"Cell line enhanced"	"Detected in many"		"hTCEpi: 164.1;OE19: 159.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038951, HPA038952"	Approved		Supported	Cytosol		NA	NA		6000	"Cluster 32: T-cells - Unknown function"	"Cluster 38: Heart - Muscle contraction"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 61: Squamous epithelial cells - Keratinization"	Cytosol		"HPA038951: AB_10673017, HPA038952: AB_10670915"	"unprognostic (2.25e-2)"	"unprognostic (3.96e-2)"	"unprognostic (2.91e-1)"	"unprognostic (1.26e-1)"	"unprognostic (5.89e-3)"	"unprognostic (1.07e-2)"	"unprognostic (3.19e-2)"	"unprognostic (5.07e-2)"	"unprognostic (4.39e-2)"	"unprognostic (1.05e-1)"	"unprognostic (3.20e-2)"	"unprognostic (3.23e-1)"	"prognostic favorable (2.72e-5)"	"unprognostic (2.77e-2)"	"unprognostic (1.92e-1)"	"unprognostic (3.22e-1)"	"unprognostic (5.87e-2)"	73.3	93.4	71.0	35.7	67.6	13.6	54.8	277.3	59.4	44.4	76.2	46.7	37.3	37.3	26.7	205.6	51.3	33.5	268.6	58.5	78.3	54.7	28.3	54.5	50.0	90.5	65.1	233.6	32.1	42.3	22.0	31.5	74.9	24.0	57.8	110.1	98.2	26.5	75.1	97.5	34.2	29.3	85.2	20.1	120.7	41.3	67.0	56.8	112.9	111.6	89.1	42.0	89.4	73.2	48.2	34.7	120.2	27.2	1.1	0.4	1.5	9.6	3.2	2.4	6.7	49.0	76.7	61.8	128.7	11.1	18.1	101.4	41.1	66.2	3.1	21.2	35.5	0.5	96.0	128.8	0.5	24.6	0.4	1.5	164.1	18.1	52.1	50.3	47.5	21.4	0.2	93.3	0.5	17.5	5.0	10.8	47.0	159.5	38.4	2.1	29.3	80.3	38.4	105.6	41.7	51.4	40.4	59.2	21.0	60.0	30.7	0.3	32.1	0.1	43.1	1.1	18.3	0.5	0.3	140.0	2.3	54.0	0.9	11.9	0.2	0.8	28.6	0.2	55.5	40.9	53.9	32.8	0.4	52.2	139.1	91.0	2.4	63.6	0.3	0.4	33.7	48.1	71.0	67.6	277.3	59.4	58.5	78.3	90.5	65.1	74.9	85.2	67.0	73.2	218.9	317.3	36.0	875.6	47.1	86.8	42.2	35.7	306.2	54.5	27.6	29.5	592.5	51.5	97.1	53.3	18.8	1.5	43.2	59.8	35.2	37.8	110.7	88.4	32.7	107.3	16.8	7.4	236.0	54.5	0.8	126.1	225.3	30.9	1.3	119.6	55.6	51.4	0.6	58.9	326.0	101.7	16.2	1.3	18.4	133.7	227.7	9.4	21.4	213.6	4.3	54.7	27.8	50.3	9.2	59.6	34.7	413.0	22.7	49.8	46.7	42.1	79.3	96.7	0.0	155.8	22.0	3.9	4.7	481.0	189.4	0.7	62.8	53.6	51.4	164.0
ABRAXAS1	"ABRA1, ABRAXAS, CCDC98, FAM175A, FLJ13614"	ENSG00000163322	"Abraxas 1, BRCA1 A complex subunit"	Q6UWZ7	4	83459517-83523348	"Disease related genes, Predicted intracellular proteins"	"DNA damage, DNA repair"	"Chromatin regulator"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 43.0;Endometrial stromal cells: 20.7;Proximal tubular cells: 30.1;Respiratory ciliated cells: 21.9;Theca cells: 26.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"K-562: 36.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037654	Uncertain		Supported	"Nuclear bodies"		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 71: Testis - DNA repair"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 7: Non-specific - Mitochondria"	"Nuclear bodies"		"HPA037654: AB_2675588"	"unprognostic (1.44e-1)"	"unprognostic (2.46e-2)"	"unprognostic (2.42e-2)"	"unprognostic (1.81e-1)"	"unprognostic (8.57e-3)"	"unprognostic (6.99e-2)"	"unprognostic (4.98e-4)"	"unprognostic (3.47e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.73e-1)"	"unprognostic (2.35e-1)"	"unprognostic (6.98e-2)"	"prognostic favorable (1.53e-4)"	"unprognostic (2.24e-3)"	"unprognostic (9.34e-3)"	"unprognostic (5.58e-2)"	"unprognostic (6.57e-2)"	4.4	3.9	2.9	3.9	2.0	7.9	3.8	7.7	3.0	5.1	12.0	3.3	3.7	6.4	2.1	5.2	4.8	5.7	3.7	2.4	1.4	4.1	2.2	3.8	8.0	2.2	2.2	14.8	3.4	2.2	1.1	2.9	2.4	2.7	2.8	3.6	3.5	2.2	6.4	5.7	3.1	2.9	0.5	4.1	3.6	10.8	2.6	4.8	7.4	2.0	3.8	3.8	3.5	5.1	5.6	3.4	6.8	8.2	6.1	25.2	3.6	4.1	5.1	1.9	2.9	7.6	9.0	22.1	3.3	4.3	4.2	2.9	3.7	2.9	3.5	8.8	2.4	12.9	4.6	9.1	4.9	15.3	11.1	10.9	2.5	2.7	2.4	10.2	8.7	12.9	36.7	13.2	4.7	3.7	17.2	5.6	11.5	6.3	5.0	9.3	7.6	5.5	4.2	4.6	6.3	5.1	5.3	2.2	9.6	5.5	6.3	6.3	11.5	7.4	7.6	7.4	6.0	11.5	8.4	16.1	6.7	12.8	5.3	4.0	2.5	2.1	2.0	2.3	2.6	2.1	3.5	2.4	1.9	3.3	5.4	4.2	3.2	5.0	2.3	1.5	3.2	1.9	2.9	2.0	7.7	3.0	2.4	1.4	2.2	2.2	2.4	0.5	2.6	5.1	14.3	16.0	12.4	0.0	4.6	0.0	0.0	0.0	0.0	0.0	11.4	13.0	0.0	0.0	8.6	12.9	0.0	5.2	8.8	0.0	43.0	9.2	0.0	11.9	20.7	5.7	0.0	0.0	0.0	6.5	6.9	9.1	0.0	5.9	6.3	12.3	0.0	0.0	12.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.3	0.0	0.0	7.2	0.0	0.0	0.0	0.0	7.4	0.0	0.0	1.7	0.0	0.0	30.1	21.9	0.0	0.0	0.0	9.6	0.0	0.0	0.0	0.0	2.9	6.2	26.8	0.0	0.0
ABRAXAS2	"ABRO1, Em:AC068896.4, FAM175B, KIAA0157"	ENSG00000165660	"Abraxas 2, BRISC complex subunit"	Q15018	10	124801819-124836667	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 25.6;Collecting duct cells: 23.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037591, HPA037592, HPA074089"	Approved		Supported	Cytosol		Yes	No			"Cluster 41: Basophils - Cellular respiration"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 7: Non-specific - Mitochondria"	Cytosol		"HPA037591: AB_10671877, HPA037592: AB_2675566, HPA074089: AB_2686659"	"unprognostic (2.78e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.66e-1)"	"unprognostic (6.47e-2)"	"unprognostic (1.08e-1)"	"unprognostic (3.51e-2)"	"unprognostic (5.52e-2)"	"unprognostic (2.19e-1)"	"unprognostic (2.99e-1)"	"unprognostic (6.81e-2)"	"unprognostic (3.72e-2)"	"unprognostic (2.09e-2)"	"unprognostic (1.80e-3)"	"unprognostic (3.09e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.66e-1)"	9.1	10.5	8.0	10.3	8.3	12.3	12.2	8.0	9.9	8.8	6.6	9.9	10.2	9.4	9.3	9.8	9.0	8.2	10.0	8.4	8.6	12.3	13.7	9.3	12.5	7.8	8.4	10.4	8.3	12.7	3.9	10.3	8.5	9.5	10.3	5.3	8.5	8.8	19.0	11.6	10.8	10.5	7.7	10.0	9.5	6.7	8.2	12.9	12.7	16.2	13.3	9.7	6.8	7.9	22.2	14.9	15.7	21.6	19.9	19.6	13.5	22.4	35.1	26.2	24.1	12.1	20.9	24.7	18.6	24.4	14.2	24.4	25.0	21.0	27.5	21.6	17.2	18.8	11.8	15.0	25.4	32.6	18.9	21.6	25.1	25.8	46.4	28.3	20.1	21.7	20.0	16.6	21.6	14.5	25.1	29.1	13.5	20.0	13.8	20.0	16.6	15.1	19.5	11.1	10.8	19.8	17.9	17.0	24.4	15.8	14.0	22.2	17.4	14.0	11.2	16.5	27.1	17.2	17.1	23.6	18.3	15.9	10.1	22.8	10.5	9.8	7.6	14.5	10.5	10.5	8.8	10.6	12.9	11.6	9.3	10.3	4.1	7.7	11.8	8.7	11.4	7.0	8.0	8.3	8.0	9.9	8.4	8.6	7.8	8.4	8.5	7.7	8.2	7.9	15.1	25.6	14.3	0.0	3.5	0.0	0.0	0.0	0.0	0.0	9.4	10.3	0.0	0.0	6.2	23.9	0.0	16.9	7.0	0.0	17.6	13.7	0.0	11.1	15.6	6.3	0.0	0.0	0.0	12.5	13.0	5.5	0.0	12.3	12.6	12.4	0.0	0.0	16.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.1	0.0	0.0	20.7	0.0	0.0	0.0	0.0	10.2	0.0	0.0	1.6	0.0	0.0	18.6	12.4	0.0	0.0	0.0	6.8	0.0	0.0	0.0	0.0	16.0	4.3	13.5	0.0	0.0
ABTB1	"BPOZ, Btb3, BTBD21, EF1ABP"	ENSG00000114626	"Ankyrin repeat and BTB domain containing 1"	Q969K4	3	127672935-127680926	"Predicted intracellular proteins"	"Protein biosynthesis"	"Elongation factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in all"	5	"neutrophil: 822.3"	"Lineage enriched"	"Detected in all"	13	"granulocytes: 822.3"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035022, HPA035023"	Uncertain		Supported	Nucleoli,Cytosol		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	Cytosol	Nucleoli	"HPA035022: AB_10669998, HPA035023: AB_10602104"	"unprognostic (6.76e-2)"	"unprognostic (9.18e-3)"	"unprognostic (2.11e-2)"	"unprognostic (6.34e-2)"	"unprognostic (6.51e-2)"	"unprognostic (2.00e-3)"	"unprognostic (4.43e-2)"	"unprognostic (2.12e-2)"	"unprognostic (9.81e-2)"	"unprognostic (4.48e-3)"	"unprognostic (4.55e-3)"	"unprognostic (2.86e-1)"	"prognostic unfavorable (1.13e-4)"	"unprognostic (2.88e-1)"	"unprognostic (1.81e-2)"	"unprognostic (3.98e-2)"	"unprognostic (7.92e-3)"	38.4	18.7	30.6	18.8	35.8	51.1	33.4	38.0	42.4	42.0	28.9	38.9	12.3	29.7	5.3	13.4	37.2	18.1	40.5	32.7	25.9	25.5	17.3	32.0	22.0	28.7	27.2	30.3	17.7	9.0	31.4	12.2	27.1	31.0	4.6	8.7	24.5	13.6	44.7	24.9	31.8	7.6	24.7	89.7	27.5	8.1	29.1	21.5	21.8	26.2	7.4	32.9	31.2	30.7	4.3	10.7	0.9	2.0	10.0	8.7	7.8	6.8	12.2	4.5	6.5	0.3	8.9	1.9	11.9	5.1	6.0	2.2	0.2	5.1	1.0	20.7	2.5	3.1	19.4	2.5	7.5	0.5	9.5	12.0	5.6	4.5	1.5	15.2	4.8	8.3	0.1	13.5	4.9	6.6	4.9	13.4	0.9	4.9	11.7	3.0	5.6	13.8	6.7	3.3	9.5	6.0	4.8	6.6	25.0	2.6	1.4	3.7	9.1	4.8	4.0	8.5	2.3	11.5	3.8	0.6	11.1	4.0	7.8	40.7	64.5	161.8	17.0	48.2	16.6	17.8	19.0	17.1	28.6	21.1	16.6	14.3	822.3	25.2	44.5	18.1	46.3	46.2	30.6	35.8	38.0	42.4	32.7	25.9	28.7	27.2	27.1	24.7	29.1	30.7	45.3	19.2	13.0	10.7	31.7	11.7	15.6	14.2	7.4	10.4	9.9	15.6	8.1	22.8	5.3	7.3	18.8	8.1	34.2	11.3	15.6	15.1	0.5	9.9	11.1	20.8	23.9	58.7	26.1	16.8	22.3	21.0	23.0	10.1	14.7	10.1	27.5	8.9	21.3	3.3	12.2	15.0	12.2	64.7	16.4	1.7	33.8	37.4	10.6	18.7	74.3	18.0	35.0	6.6	12.8	25.9	21.4	22.6	25.2	12.8	26.3	23.0	6.9	31.1	65.7	16.1	36.8	1.0	8.6	4.2	9.2	15.9	38.6	10.6	10.3	11.8
ABTB2	"ABTB2A, BTBD22, DKFZP586C1619"	ENSG00000166016	"Ankyrin repeat and BTB domain containing 2"	Q8N961	11	34150987-34358010	"Metabolic proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 24.1"	"Cell type enhanced"	"Detected in many"		"Oligodendrocyte precursor cells: 50.3;Oligodendrocytes: 126.2;Syncytiotrophoblasts: 28.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	13	"eosinophil: 5.0;plasmacytoid DC: 1.6"	"Group enriched"	"Detected in many"	14	"dendritic cells: 1.6;granulocytes: 5.0"	"Cell line enhanced"	"Detected in many"		"SK-BR-3: 24.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020065, HPA030699"	Approved		Supported	Nucleoplasm,Vesicles		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 70: Brain - Nervous system development"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Nucleoplasm	Vesicles	"HPA020065: AB_1844459, HPA030699: AB_2673576"	"unprognostic (3.00e-1)"	"prognostic unfavorable (5.70e-5)"	"unprognostic (2.61e-1)"	"unprognostic (9.09e-2)"	"unprognostic (3.17e-2)"	"unprognostic (2.40e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.23e-2)"	"unprognostic (2.04e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.24e-3)"	"unprognostic (2.86e-1)"	"prognostic favorable (3.51e-5)"	"unprognostic (1.50e-1)"	"unprognostic (1.42e-1)"	"unprognostic (3.81e-2)"	"unprognostic (6.58e-2)"	2.3	13.0	7.9	2.0	12.6	2.5	2.0	18.1	6.7	8.1	1.2	3.4	8.8	6.1	4.4	4.1	4.6	2.1	12.8	5.3	8.5	9.4	11.6	2.9	2.1	24.1	16.3	2.5	2.3	0.5	3.5	3.2	16.7	4.9	2.5	2.6	6.7	4.3	16.9	6.8	7.0	2.5	12.7	0.9	2.5	2.7	15.9	2.4	2.0	7.2	2.0	3.6	5.6	20.3	5.6	16.2	6.4	1.8	1.7	0.1	6.4	3.2	2.5	2.8	5.3	4.0	4.0	0.2	5.3	4.1	16.5	10.5	3.6	3.7	2.3	0.2	8.8	0.1	9.8	17.4	1.0	8.9	1.2	0.9	2.0	5.6	2.4	10.1	0.0	0.7	1.9	0.5	1.8	13.8	0.3	10.7	8.0	8.1	8.8	1.7	3.8	6.3	10.0	13.0	8.1	6.6	8.1	24.6	6.5	4.2	5.3	3.8	0.9	3.1	0.5	9.8	5.8	0.9	0.4	0.1	7.1	2.5	9.7	0.0	0.1	5.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	1.6	0.0	0.0	7.9	12.6	18.1	6.7	5.3	8.5	24.1	16.3	16.7	12.7	15.9	20.3	0.7	0.0	2.3	18.9	1.1	4.7	3.2	1.3	1.2	2.1	3.0	3.3	10.0	2.8	1.1	12.9	0.0	2.7	2.5	12.2	5.9	4.6	1.2	3.4	4.5	0.9	7.2	0.0	4.0	4.5	1.1	5.8	4.6	10.7	1.3	0.3	0.0	6.8	0.8	0.0	8.9	2.3	4.1	0.8	6.1	0.3	1.2	1.2	1.8	6.5	9.3	7.5	0.0	50.3	126.2	10.5	9.1	6.0	2.1	9.3	15.5	2.0	0.3	0.6	0.0	4.3	2.4	0.5	1.1	1.0	4.8	28.3	2.9	0.4	2.9	7.5
AC004556.3		ENSG00000276345	"39S ribosomal protein L23, mitochondrial"		Unmapped	2585-11802	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Tissue enhanced"	"Detected in many"		"heart muscle: 24.0"	"Group enriched"	"Detected in some"	6	"Extravillous trophoblasts: 35.6;Hofbauer cells: 23.3"					"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"CACO-2: 94.7;K-562: 75.5;MOLT-4: 85.4;NB-4: 160.6;PC-3: 141.1;WM-115: 113.7"									HPA050406	Uncertain		Supported	"Nucleoli fibrillar center,Mitochondria"		NA	NA			"Cluster 31: Non-specific - Inflammatory response"		"Cluster 24: NB-4 - Immune response"	"Cluster 38: Extravillous trophoblasts - Unknown function"	Mitochondria	"Nucleoli fibrillar center"	"HPA050406: AB_2681116"																		3.8	0.0	2.5	4.0	3.0	0.0	19.4	2.8	3.2	0.0	2.6	10.3	0.1	5.0	14.3	0.0	4.9	5.9	24.0	2.4	2.7	6.7	8.5	1.6	0.0	3.1	3.7	6.3	6.8	0.0		2.1	3.4	5.0	0.0	1.2	7.5	0.3	14.5	5.1	9.9	0.5	2.4	4.1	5.0	2.4	2.8	9.9	2.6	0.0	0.1	4.5		2.8	0.2	0.0	0.1	0.1	0.0	0.0	42.0	27.8	43.4	46.5	33.2	94.7	0.8	0.1	0.1	0.0	0.0	0.6	0.7	0.3	18.0	0.2	1.9	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	51.1	0.0	31.4	48.3	75.5	42.5	0.4	0.4	85.4	160.6	0.0	0.2	141.1	0.5	22.8	0.2	44.0	27.1	0.2	0.6	0.0	0.2	0.1	0.0	70.4	0.0	0.0	0.0	0.1	0.3	0.4	0.5	0.3	0.1	0.8	0.3	113.7	12.3	3.4	2.2	1.7	6.2	1.4	1.7	2.5	3.5	3.0	2.0	2.6	2.9	1.0	2.1	2.8	2.8	4.0	2.1	2.5	3.0	2.8	3.2	2.4	2.7	3.1	3.7	3.4	2.4	2.8	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	35.6	0.5	0.0	0.0	0.0	0.0	0.0	0.0	23.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0
AC012254.7		ENSG00000288631	"Elongin A3"	Q8NG57	18	47028202-47029842	"Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	44	"brain: 3.9;choroid plexus: 4.7"	"Not detected"	"Not detected"							"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA048971, HPA049178, HPA050086, HPA053158"	Uncertain		Supported	Nucleoplasm,Nucleoli,Cytosol		NA	NA							Nucleoplasm	"Nucleoli, Cytosol"	"HPA048971: AB_2680578, HPA049178: AB_2680664, HPA050086: AB_2681009, HPA053158: "																		0.0	0.0	2.0	0.0	2.8	0.0	0.0	1.5	1.8	0.0	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	1.9	0.0	0.0	0.0	0.0	3.9	3.8	0.0	0.0	0.0		0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.0		1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	2.8	1.5	1.8	1.6	1.9	3.9	3.8	2.7	1.1	3.9	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AC058822.1		ENSG00000282278	"Novel FIP1L1-PDGFRA fusion protein"		4	53377839-54295272	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Low tissue specificity"	"Detected in some"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC TERT1: 4.7;BJ hTERT+: 10.2;fHDF/TERT166: 17.2;HSkMC: 9.8;U-138 MG: 5.4;U-2197: 7.7"									HPA058202			Supported	Nucleoplasm		NA	NA				"Cluster 78: Testis - Spermatogenesis"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 11: Alveolar cells - Smell perception"	Nucleoplasm		"HPA058202: AB_2683636"																		0.9	0.0	1.0	2.0	1.5	0.0	0.0	0.4	1.7	0.3	1.5	0.4	0.5	0.3	0.0	1.3	0.1	0.4	1.6	0.9	0.7	0.3	0.3	0.8	0.0	1.6	0.7	1.2	0.8	0.0	0.0	1.2	1.3	0.2	0.0	0.8	0.0	0.0	0.3	0.0	1.0	0.9	0.5	0.2	0.8	2.2	0.5	0.1	0.0	2.0	0.1	0.2	0.0	1.2	0.0	0.0	0.0	0.0	0.8	4.7	0.0	1.5	10.2	0.0	0.1	0.9	0.0	0.0	0.0	17.2	0.0	0.0	1.5	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.8	0.0	0.0	9.8	0.0	3.8	0.1	0.5	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.4	0.1	0.0	0.1	5.4	0.1	7.7	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.0	1.5	0.4	1.7	0.9	0.7	1.6	0.7	1.3	0.5	0.5	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
AC139530.2		ENSG00000262660	"Novel protein"		17	81703371-81720539	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Tissue enhanced"	"Detected in some"		"intestine: 2.4;skeletal muscle: 1.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 5.5;Karpas-707: 6.8;MOLT-4: 18.0;SK-BR-3: 6.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022853, HPA023043, HPA023048"	Approved		Supported	Mitochondria		NA	NA				"Cluster 8: Non-specific - Mitochondria"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 11: Alveolar cells - Smell perception"	Mitochondria		"HPA022853: AB_1854099, HPA023043: AB_1854100, HPA023048: AB_2301950"		"unprognostic (2.36e-3)"					"unprognostic (1.17e-1)"		"unprognostic (2.87e-1)"								"unprognostic (3.83e-1)"	0.1	0.5	0.1	0.1	0.1	0.0	0.0	0.0	0.5	0.0	0.4	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.2	0.1	0.2	0.1	0.1	0.1	0.1	0.0	0.2	0.0	0.3	0.1	0.0	0.0	0.3	0.1	0.0	1.0	0.0	0.8	0.0	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.3	0.0	0.1	0.0	0.0	1.3	0.6	1.6	5.5	0.0	0.0	0.9	0.0	0.0	0.0	0.6	0.3	0.5	0.9	0.3	0.0	1.6	2.8	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.6	0.2	0.0	0.5	0.6	0.2	0.1	0.0	6.8	0.0	0.8	18.0	0.8	1.0	0.7	0.0	3.9	0.6	1.4	0.0	0.0	3.3	1.5	0.0	6.6	1.8	0.4	3.2	1.5	0.0	0.5	1.1	1.1	1.8	0.6	0.0	0.7	1.4	0.5	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.5	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ACAA1		ENSG00000060971	"Acetyl-CoA acyltransferase 1"	P09110	3	38103129-38137242	"Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	"Acyltransferase, Transferase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"kidney: 212.6;liver: 659.3"	"Cell type enhanced"	"Detected in all"		"Distal enterocytes: 356.8;Hepatocytes: 686.0;Proximal enterocytes: 441.1;Proximal tubular cells: 721.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"OE19: 224.0;SK-BR-3: 342.9"					"Low region specificity"	"Detected in all"			"HPA006764, HPA007244"	Enhanced		Supported	Peroxisomes		NA	NA		4700000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 85: Liver - Metabolism"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Peroxisomes		"HPA006764: AB_1078085, HPA007244: AB_1078084"	"prognostic favorable (3.00e-4)"	"unprognostic (5.57e-2)"	"unprognostic (4.54e-2)"	"prognostic favorable (7.53e-4)"	"unprognostic (2.63e-1)"	"prognostic favorable (1.23e-4)"	"unprognostic (9.35e-3)"	"unprognostic (2.91e-2)"	"unprognostic (8.11e-2)"	"unprognostic (2.22e-1)"	"unprognostic (2.24e-1)"	"unprognostic (4.90e-1)"	"prognostic favorable (6.99e-9)"	"unprognostic (1.72e-1)"	"unprognostic (1.99e-1)"	"unprognostic (2.50e-2)"	"unprognostic (1.65e-2)"	42.8	54.1	47.5	24.0	54.4	44.7	41.2	54.3	49.5	28.3	42.3	56.9	101.0	20.8	44.6	56.7	19.4	29.8	84.8	44.6	48.7	212.6	659.3	34.9	26.1	54.2	50.4	20.9	59.3	47.9	24.8	17.2	53.0	55.1	51.2	4.9	38.9	25.3	48.2	30.7	89.5	18.7	50.9	41.3	42.1	15.5	53.6	28.0	32.1	53.8	30.0	43.7	33.5	54.9	35.5	39.8	13.0	40.7	55.6	32.2	44.6	32.2	47.0	36.3	34.5	52.8	38.8	21.1	22.6	52.0	17.4	24.5	34.9	54.0	20.0	31.0	37.2	27.0	35.4	155.5	35.3	63.3	59.8	59.0	39.3	31.2	22.5	23.9	49.9	49.7	26.2	24.2	41.3	49.2	60.3	45.3	13.3	224.0	47.0	13.9	25.0	34.3	103.4	110.4	10.9	16.5	31.7	342.9	23.7	18.0	35.1	48.9	36.8	21.9	21.1	43.2	44.2	31.9	21.7	16.1	34.8	54.4	34.7	79.9	114.4	130.4	48.8	159.1	41.2	33.9	45.7	47.4	178.1	36.0	45.2	42.5	76.3	71.9	187.7	104.5	77.2	82.1	47.5	54.4	54.3	49.5	44.6	48.7	54.2	50.4	53.0	50.9	53.6	54.9	30.7	41.7	38.7	50.6	45.6	33.3	56.5	57.6	40.9	36.9	48.7	37.1	3.2	98.7	44.3	66.2	14.6	91.6	61.7	356.8	166.3	98.0	4.5	40.7	38.6	25.4	55.1	40.4	25.6	78.4	64.5	34.4	76.5	39.1	19.0	32.5	37.1	686.0	81.7	8.4	24.7	73.1	48.8	93.5	86.8	9.6	35.8	83.2	58.7	14.0	89.5	43.1	53.5	12.5	30.9	100.9	270.6	33.1	44.5	60.6	441.1	721.8	26.3	16.7	32.9	28.5	27.4	19.8	11.7	48.1	35.5	99.3	44.4	186.7	84.3	87.0
ACAA2	DSAEC	ENSG00000167315	"Acetyl-CoA acyltransferase 2"	P42765	18	49782164-49813953	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	"Acyltransferase, Hydrolase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 1011.9"	"Cell type enhanced"	"Detected in all"		"Distal enterocytes: 331.1;Hepatocytes: 810.5;Proximal tubular cells: 708.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042303	Approved		Supported	Mitochondria		NA	NA		3800000	"Cluster 16: MAIT-cells - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Mitochondria		"HPA042303: AB_10794046"	"unprognostic (7.94e-2)"	"unprognostic (3.14e-2)"	"unprognostic (2.20e-3)"	"prognostic unfavorable (8.53e-4)"	"unprognostic (2.92e-2)"	"unprognostic (2.28e-2)"	"unprognostic (7.63e-2)"	"unprognostic (1.70e-1)"	"unprognostic (7.97e-2)"	"unprognostic (8.03e-3)"	"unprognostic (1.72e-1)"	"unprognostic (3.84e-1)"	"prognostic favorable (1.36e-10)"	"unprognostic (1.39e-1)"	"unprognostic (2.24e-1)"	"unprognostic (8.26e-3)"	"unprognostic (3.41e-1)"	126.3	74.2	56.9	44.4	64.9	32.5	79.1	63.7	63.9	24.9	68.4	168.7	170.0	29.0	29.8	30.3	24.4	46.9	223.7	53.2	59.8	378.2	1011.9	48.9	36.6	65.1	61.4	34.8	54.1	35.1	34.9	29.6	64.0	26.4	109.6	31.9	20.3	34.0	165.3	28.0	165.2	44.5	62.8	33.6	37.4	37.7	64.3	39.9	55.8	236.6	31.9	41.6	28.6	64.2	3.9	70.5	110.0	97.5	129.9	69.5	57.4	35.2	52.4	53.6	41.2	146.3	58.9	61.1	73.5	117.5	56.7	4.8	176.8	21.0	51.4	190.5	50.4	45.5	79.0	171.4	62.5	0.7	78.3	91.7	6.7	84.8	26.2	44.6	90.0	87.7	42.5	54.7	147.5	81.8	2.7	89.7	101.5	24.8	26.7	150.8	233.0	217.6	177.7	2.8	163.4	130.9	2.7	76.2	5.6	82.1	45.7	60.0	48.1	49.8	60.5	67.8	36.4	112.3	139.7	157.3	35.0	85.7	47.1	53.0	87.4	96.1	99.2	106.5	123.0	43.2	58.3	88.7	103.2	36.3	50.2	73.2	8.3	120.0	108.1	50.1	76.4	112.7	56.9	64.9	63.7	63.9	53.2	59.8	65.1	61.4	64.0	62.8	64.3	64.2	28.4	38.5	47.3	11.8	31.4	3.6	14.2	15.5	11.4	6.7	25.0	25.5	189.9	234.4	23.7	55.2	4.2	36.5	48.2	331.1	295.4	148.5	71.2	7.9	33.9	30.0	40.1	53.6	1.7	45.7	56.0	47.3	23.9	7.7	45.1	63.3	41.4	810.5	109.6	1.7	4.6	73.0	24.4	64.8	18.5	153.9	48.1	50.6	19.6	13.1	57.2	62.2	106.1	4.5	8.7	101.8	161.2	37.2	41.2	9.8	226.6	708.0	26.4	29.5	19.7	42.1	34.9	51.1	42.7	11.1	4.8	27.0	52.2	93.0	144.8	9.6
ACACA	"ACAC, ACC, ACC1"	ENSG00000278540	"Acetyl-CoA carboxylase alpha"	Q13085	17	37084992-37406836	"Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism"	"Allosteric enzyme, Ligase, Multifunctional enzyme"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Astrocytes: 138.1;Excitatory neurons: 230.7;Inhibitory neurons: 197.8;Oligodendrocyte precursor cells: 181.0;Oligodendrocytes: 186.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013715, HPA036650, HPA063018"	Approved		Supported	"Nucleoli fibrillar center,Actin filaments,Cytosol"		NA	NA		110000	"Cluster 30: Non-specific - Translation"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Cytosol	"Nucleoli fibrillar center, Actin filaments"	"CAB013715: , HPA036650: AB_2675228, HPA063018: AB_2684922"	"unprognostic (1.96e-2)"	"unprognostic (1.07e-2)"	"unprognostic (3.04e-2)"	"unprognostic (1.10e-1)"	"unprognostic (4.86e-2)"	"unprognostic (1.19e-1)"	"prognostic unfavorable (1.24e-5)"	"unprognostic (8.81e-2)"	"unprognostic (6.56e-2)"	"unprognostic (2.38e-3)"	"unprognostic (3.38e-1)"	"unprognostic (2.24e-1)"	"unprognostic (6.72e-2)"	"unprognostic (1.18e-1)"	"unprognostic (4.89e-1)"	"unprognostic (4.49e-2)"	"unprognostic (2.03e-2)"	16.2	25.4	10.8	3.7	10.8	4.9	22.2	9.0	15.8	11.5	11.3	14.4	5.2	12.1	13.8	25.2	10.8	4.8	7.7	9.5	11.2	13.6	23.3	13.3	2.0	11.1	9.9	11.3	10.5	10.9	19.2	3.8	11.1	26.2	6.4	8.0	14.6	9.6	15.1	15.4	9.6	8.0	8.6	7.3	12.6	16.4	10.3	3.7	8.9	3.6	5.5	19.9	14.6	12.3	34.7	7.0	39.8	42.6	54.7	53.2	13.9	15.2	21.3	15.9	27.5	27.4	5.9	5.0	12.0	24.3	39.4	33.9	7.5	51.1	23.7	13.6	23.2	27.3	15.5	28.0	9.2	14.8	5.3	43.4	29.0	40.2	30.0	18.8	27.5	25.1	66.5	3.2	2.1	27.3	16.3	22.8	30.4	21.5	22.1	24.1	25.3	6.4	36.1	38.5	45.0	17.0	27.8	12.3	12.7	34.8	24.9	16.8	23.8	12.7	20.6	17.3	3.9	8.7	11.5	42.0	11.7	12.3	17.2	0.5	0.8	0.1	0.6	1.3	0.6	0.7	0.7	0.7	1.0	1.1	1.1	0.8	0.3	0.6	0.8	0.7	1.0	0.6	10.8	10.8	9.0	15.8	9.5	11.2	11.1	9.9	11.1	8.6	10.3	12.3	6.8	32.1	51.7	138.1	8.0	11.6	20.8	14.8	22.2	17.2	17.3	11.7	8.0	2.8	16.5	11.0	27.1	16.0	7.0	5.3	9.8	6.7	66.3	19.1	15.6	8.3	9.0	10.7	230.7	8.3	7.6	10.4	15.8	15.9	7.0	19.5	6.4	17.3	5.8	23.5	197.8	7.3	14.2	3.8	4.3	51.2	9.9	6.1	10.6	58.1	4.3	18.2	4.1	181.0	186.9	7.2	6.4	15.8	9.3	22.8	4.8	7.0	10.5	11.8	6.6	10.0	7.8	20.8	20.5	27.8	15.9	16.3	6.4	43.2	10.0	22.0
ACADS	"ACAD3, SCAD"	ENSG00000122971	"Acyl-CoA dehydrogenase short chain"	P16219	12	120725774-120740008	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	Oxidoreductase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 245.5;skeletal muscle: 158.2"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 303.1;Hepatocytes: 203.3;Paneth cells: 185.7;Proximal enterocytes: 435.0;Undifferentiated cells: 185.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HMC-1: 36.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004799, CAB019284, HPA022271"	Enhanced		Supported	Mitochondria		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 45: Enterocytes - Digestion"	Mitochondria		"CAB019284: , HPA004799: AB_1844471, HPA022271: AB_1844472"	"unprognostic (7.14e-2)"	"unprognostic (3.03e-3)"	"unprognostic (8.15e-2)"	"prognostic favorable (5.05e-4)"	"unprognostic (1.11e-3)"	"unprognostic (5.75e-2)"	"prognostic favorable (2.43e-4)"	"unprognostic (5.65e-2)"	"unprognostic (1.22e-1)"	"unprognostic (2.14e-1)"	"unprognostic (2.69e-2)"	"unprognostic (4.04e-2)"	"prognostic favorable (3.33e-6)"	"unprognostic (1.23e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.21e-1)"	"prognostic favorable (6.34e-5)"	50.3	52.7	13.3	11.1	15.4	14.3	40.9	13.6	16.6	11.2	13.7	74.0	84.8	10.2	0.9	14.1	10.2	8.5	90.5	12.3	13.8	51.9	245.5	13.4	6.4	14.6	14.2	8.6	33.1	4.7	9.2	7.5	13.1	13.9	21.3	0.9	19.2	7.2	158.2	13.7	73.2	5.8	14.0	31.6	34.5	20.3	16.0	6.6	21.9	79.7	3.4	18.0	12.7	14.8	3.2	11.4	0.6	9.7	12.9	5.1	11.1	4.7	4.6	6.0	4.5	8.9	8.0	0.3	11.9	3.9	2.7	5.2	6.6	2.1	0.8	16.7	8.2	8.2	3.6	19.3	9.3	0.7	36.0	15.4	3.1	2.6	0.2	1.8	6.1	20.6	6.9	0.1	2.7	6.8	11.7	19.2	2.0	10.6	4.6	8.6	4.2	2.2	11.3	18.2	1.1	6.0	9.7	0.0	15.8	0.9	7.7	13.1	6.9	0.2	4.7	4.5	0.9	15.3	9.3	4.1	10.2	7.0	4.1	8.3	15.3	7.5	13.7	16.3	9.3	6.3	12.2	14.2	13.2	8.9	15.3	14.4	1.4	19.9	10.2	11.0	14.7	12.8	13.3	15.4	13.6	16.6	12.3	13.8	14.6	14.2	13.1	14.0	16.0	14.8	18.8	12.8	13.7	10.1	6.7	6.6	9.5	21.1	4.0	1.0	25.0	14.9	44.0	27.1	13.0	18.4	0.0	78.8	9.8	303.1	50.9	35.2	23.5	12.8	8.2	13.4	45.6	38.5	2.3	32.6	31.3	18.1	28.5	10.8	19.1	12.8	19.2	203.3	55.1	1.7	2.8	105.3	20.3	21.0	8.9	36.5	21.5	15.3	17.8	0.0	26.1	13.6	18.6	3.0	3.6	26.7	185.7	18.0	7.9	8.3	435.0	94.8	7.3	0.6	6.6	13.2	12.7	41.5	8.1	9.4	4.5	75.5	11.9	140.6	185.9	12.7
ACADSB	"ACAD7, SBCAD"	ENSG00000196177	"Acyl-CoA dehydrogenase short/branched chain"	P45954	10	123008979-123058290	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	Oxidoreductase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 360.1"	"Cell type enhanced"	"Detected in all"		"Hepatocytes: 499.5;Proximal tubular cells: 137.9"	"Cancer enhanced"	"Detected in all"		"liver cancer: 32.5"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Hep G2: 54.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041458, HPA063555"	Enhanced		Supported	Mitochondria		NA	NA		37000	"Cluster 2: Granulocytes - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 2: Hepatocytes - Metabolism"	Mitochondria		"HPA041458: AB_2677491, HPA063555: "	"unprognostic (1.53e-2)"	"unprognostic (1.31e-1)"	"unprognostic (3.91e-3)"	"unprognostic (2.02e-1)"	"unprognostic (1.25e-1)"	"unprognostic (4.87e-2)"	"unprognostic (4.15e-2)"	"unprognostic (1.32e-3)"	"unprognostic (1.30e-1)"	"unprognostic (3.67e-1)"	"prognostic favorable (3.40e-4)"	"unprognostic (9.37e-3)"	"prognostic favorable (6.37e-12)"	"unprognostic (2.69e-1)"	"unprognostic (7.20e-2)"	"unprognostic (1.60e-3)"	"unprognostic (7.14e-2)"	14.8	27.4	8.0	7.1	8.5	3.8	23.9	13.9	10.3	7.8	13.1	15.9	52.4	9.9	7.7	12.6	9.7	7.6	38.5	8.6	6.7	90.2	360.1	12.7	8.2	6.3	7.6	12.8	15.8	33.4	8.8	5.1	6.8	22.7	16.8	12.4	15.7	11.2	42.4	9.8	11.0	8.5	5.9	6.4	14.0	8.4	8.0	7.4	12.3	69.1	10.3	10.8	8.1	8.4	15.4	10.9	7.9	14.5	10.6	13.1	7.0	9.3	18.8	9.2	9.1	9.6	4.9	16.0	6.3	7.9	5.6	6.3	12.5	6.5	15.1	10.6	12.9	8.3	3.3	54.8	7.5	12.0	7.6	9.7	6.5	5.8	5.3	13.5	9.0	13.2	8.1	11.5	11.5	7.1	11.4	9.8	4.8	8.5	6.7	13.4	16.6	5.1	13.1	16.9	1.4	9.1	14.3	4.2	14.4	7.5	12.9	5.8	9.5	4.9	4.4	11.4	11.4	12.9	15.5	8.5	7.6	11.1	3.8	17.4	4.5	11.8	8.8	4.7	10.2	5.5	8.1	7.6	6.4	5.7	7.4	8.3	2.9	8.5	2.9	3.8	7.1	5.7	8.0	8.5	13.9	10.3	8.6	6.7	6.3	7.6	6.8	5.9	8.0	8.4	7.7	28.9	53.1	29.4	11.6	9.3	9.2	8.2	14.2	17.4	58.6	27.8	80.7	37.1	21.1	11.0	10.4	20.1	8.7	11.2	46.9	7.3	7.0	6.8	9.1	8.2	12.1	21.4	39.8	4.8	3.5	10.6	10.7	18.8	3.8	29.1	15.4	499.5	7.3	21.9	49.6	13.7	26.4	17.4	5.9	8.1	13.4	7.1	7.2	12.2	7.9	12.0	7.2	15.6	38.3	4.6	13.1	10.9	9.1	19.8	9.2	137.9	15.2	7.7	19.7	12.3	11.0	8.5	3.7	14.7	13.8	30.1	13.3	18.9	18.3	12.0
ACADVL	"ACAD6, LCACD, VLCAD"	ENSG00000072778	"Acyl-CoA dehydrogenase very long chain"	P49748	17	7217125-7225266	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	Oxidoreductase	"Cardiomyopathy, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 850.4"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019006, HPA020595"	Enhanced		Supported	Nucleoplasm,Nucleoli,Mitochondria		NA	NA		98000	"Cluster 26: Non-specific - Mitochondria"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 20: HeLa - Mitochondria"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Mitochondria	"Nucleoplasm, Nucleoli"	"HPA019006: AB_1844478, HPA020595: AB_1844479"	"unprognostic (4.81e-2)"	"unprognostic (2.86e-1)"	"unprognostic (2.21e-2)"	"unprognostic (1.09e-2)"	"unprognostic (6.63e-3)"	"unprognostic (1.51e-1)"	"unprognostic (1.89e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.07e-1)"	"unprognostic (3.21e-1)"	"prognostic favorable (6.87e-4)"	"unprognostic (3.55e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.58e-1)"	"unprognostic (4.01e-1)"	"unprognostic (2.84e-3)"	197.9	405.2	120.1	78.7	131.0	103.5	142.9	128.4	126.7	110.5	170.6	157.3	306.2	98.5	44.4	181.0	94.0	92.6	576.8	117.8	125.0	215.3	517.4	106.7	52.0	127.5	125.3	80.9	236.5	159.6	189.6	112.0	124.8	133.2	131.6	34.9	158.5	113.9	850.4	135.7	270.6	110.6	118.2	132.2	186.4	75.9	132.0	83.4	159.3	817.1	82.9	137.1	115.3	122.7	193.7	162.5	65.8	92.4	271.2	99.2	135.9	156.5	169.0	136.9	84.5	67.2	155.3	90.4	109.0	260.0	49.7	147.9	43.8	135.5	119.6	295.9	47.1	50.6	120.9	101.1	131.2	49.0	129.5	112.5	122.0	114.7	178.5	212.6	124.8	111.3	73.3	110.2	222.7	65.3	49.6	68.4	34.3	178.4	91.9	70.4	78.3	227.2	305.1	155.0	19.1	47.3	206.8	224.8	110.8	60.6	102.8	74.9	151.5	127.5	101.6	75.9	149.9	104.5	59.1	5.2	230.7	85.7	94.9	24.2	96.1	121.3	39.1	57.8	35.7	25.2	32.5	43.8	99.9	24.6	23.7	29.1	20.2	37.8	39.3	80.4	31.8	79.4	120.1	131.0	128.4	126.7	117.8	125.0	127.5	125.3	124.8	118.2	132.0	122.7	109.9	60.9	81.9	143.3	72.3	87.3	336.0	322.4	91.6	42.0	157.7	104.5	451.4	138.7	206.7	202.3	62.6	482.9	87.7	484.2	185.9	310.8	133.0	87.2	52.7	77.4	179.3	65.2	40.9	77.0	197.8	118.6	406.7	88.5	88.4	121.1	53.6	365.4	182.4	33.7	33.4	251.8	233.9	67.9	94.6	249.9	124.5	101.5	81.8	34.7	274.9	40.7	73.2	23.1	24.5	106.1	388.9	132.8	172.3	369.0	489.8	345.8	144.1	41.3	105.2	88.3	147.4	114.3	47.8	113.8	87.5	663.3	75.5	169.2	316.8	367.5
ACBD3	"GCP60, GOCAP1, GOLPH1, PAP7"	ENSG00000182827	"Acyl-CoA binding domain containing 3"	Q9H3P7	1	226144679-226186741	"Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015594	Approved		Supported	"Golgi apparatus"		NA	NA		29000	"Cluster 37: B-cells - Transcription"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 18: U-2197 - ECM organization"	"Cluster 36: Stromal cells - Cell proliferation"	"Golgi apparatus"		"HPA015594: AB_1844491"	"unprognostic (1.82e-3)"	"unprognostic (1.53e-2)"	"unprognostic (7.43e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.85e-1)"	"unprognostic (5.34e-2)"	"unprognostic (2.78e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.93e-2)"	"unprognostic (2.87e-1)"	"unprognostic (4.66e-3)"	"unprognostic (1.79e-1)"	"unprognostic (3.41e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.29e-1)"	"unprognostic (2.80e-3)"	"unprognostic (2.54e-3)"	21.6	16.9	11.6	20.4	12.4	25.9	24.4	13.1	13.0	27.6	16.6	23.2	17.5	22.8	20.6	30.8	17.8	23.5	21.4	10.9	13.7	20.2	24.3	22.4	21.3	12.6	13.9	23.2	22.7	28.0	14.6	31.7	12.9	22.8	25.4	16.1	24.1	16.4	21.5	19.3	17.5	21.7	13.1	17.8	31.7	18.8	13.1	18.0	28.8	20.3	25.7	26.9	20.2	13.5	43.7	29.3	24.3	15.1	73.6	65.4	47.2	53.7	55.7	31.5	40.3	38.0	53.2	46.3	48.0	69.7	28.5	33.5	34.6	35.2	43.9	19.4	40.4	22.5	30.3	34.8	47.2	36.5	26.7	48.7	46.0	39.1	51.1	44.7	36.6	22.2	42.6	32.0	51.3	22.1	27.2	28.5	36.1	72.5	38.0	25.0	53.3	47.1	29.4	39.2	27.6	39.8	47.8	52.7	53.0	34.0	54.2	41.5	46.2	31.4	22.0	76.7	51.5	60.4	67.4	57.3	37.3	24.2	52.8	2.1	1.4	1.4	0.9	1.8	1.6	5.0	1.3	0.9	1.0	4.4	1.4	1.3	1.5	1.0	1.5	1.4	1.7	0.7	11.6	12.4	13.1	13.0	10.9	13.7	12.6	13.9	12.9	13.1	13.1	13.5	53.5	67.3	41.5	14.0	50.4	52.0	63.4	17.9	38.7	35.1	50.6	37.2	35.7	27.1	37.9	35.0	56.3	45.3	44.2	46.1	15.6	25.0	24.0	56.6	84.0	47.6	43.5	10.7	29.8	34.7	60.7	55.8	50.4	85.8	24.6	29.8	28.2	52.0	37.9	26.9	31.3	71.9	28.5	25.1	51.0	7.3	40.7	39.4	49.8	20.6	18.0	52.1	18.6	27.6	29.2	39.0	28.4	32.7	87.3	61.7	26.7	32.1	26.9	39.4	32.9	46.6	51.4	72.1	55.8	46.7	77.7	62.4	34.0	33.1	35.6	98.3
ACBD6	MGC2404	ENSG00000230124	"Acyl-CoA binding domain containing 6"	Q9BR61	1	180269653-180502954	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028179, HPA028457"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 24: NB-4 - Immune response"	"Cluster 47: Cytotrophoblasts - Unknown function"	Nucleoplasm	Cytosol	"HPA028179: AB_10601788, HPA028457: "	"unprognostic (3.12e-1)"	"unprognostic (4.38e-2)"	"unprognostic (1.66e-1)"	"unprognostic (7.66e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.66e-1)"	"unprognostic (2.93e-3)"	"unprognostic (1.75e-2)"	"unprognostic (2.03e-2)"	"unprognostic (2.73e-2)"	"unprognostic (7.05e-2)"	"unprognostic (2.11e-1)"	"prognostic unfavorable (4.02e-7)"	"unprognostic (1.26e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.21e-1)"	"unprognostic (2.51e-1)"	19.5	19.0	11.5	15.0	11.3	25.9	18.4	14.9	13.8	20.5	10.7	21.1	15.2	21.5	15.1	15.1	17.7	17.7	22.3	10.6	12.3	17.7	15.5	15.2	19.0	10.7	10.5	24.7	19.5	25.0	14.4	28.2	10.7	16.4	13.6	7.2	17.3	17.4	24.0	20.7	13.8	18.5	10.3	17.8	15.4	33.0	11.1	20.5	20.0	20.6	18.1	19.5	17.3	13.5	69.4	56.4	47.6	33.2	33.9	57.4	91.1	31.3	69.7	57.6	52.0	80.1	52.8	60.0	62.2	35.3	27.5	47.0	36.2	62.7	38.3	44.5	56.8	48.3	51.9	48.2	82.2	85.5	41.2	51.1	89.5	35.9	59.0	52.4	66.2	49.9	74.5	48.9	48.4	70.7	68.1	84.1	47.8	53.2	20.3	67.3	38.0	119.4	51.4	40.8	68.0	86.0	44.4	74.6	44.9	48.6	75.6	65.4	50.4	40.8	45.3	49.5	71.0	88.1	55.7	137.4	43.4	50.7	47.7	3.1	13.1	4.4	13.6	20.0	15.4	18.1	11.6	11.8	22.0	11.6	13.9	16.3	0.9	27.3	16.3	17.7	11.7	12.2	11.5	11.3	14.9	13.8	10.6	12.3	10.7	10.5	10.7	10.3	11.1	13.5	31.5	32.1	33.0	60.4	32.7	21.3	29.9	38.7	42.7	64.2	23.6	33.3	42.3	21.5	35.4	16.5	39.6	165.0	38.7	3.8	41.1	43.7	106.9	22.2	38.0	31.9	19.4	25.0	124.9	41.6	41.7	35.6	19.9	23.3	20.2	52.2	23.9	13.4	44.6	52.2	118.1	15.7	34.6	17.8	18.6	59.2	51.3	25.0	37.4	60.9	30.0	37.8	26.8	98.0	109.3	36.2	12.9	50.8	48.4	27.2	19.6	51.2	27.4	6.6	59.2	38.4	53.4	143.6	64.6	40.5	22.4	84.4	29.4	63.2	19.2	24.8
ACIN1	"ACINUS, fSAP152, KIAA0670"	ENSG00000100813	"Apoptotic chromatin condensation inducer 1"	Q9UKV3	14	23058564-23095614	"Plasma proteins, Predicted intracellular proteins, Transporters"	"Apoptosis, mRNA processing, mRNA splicing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000657	Supported		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA		30000	"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 60: Granulocytes - Receptor signaling"	Nucleoplasm	"Plasma membrane, Cytosol"	"HPA000657: AB_1078091"	"unprognostic (2.54e-3)"	"unprognostic (1.99e-1)"	"unprognostic (1.38e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.10e-1)"	"unprognostic (4.89e-3)"	"prognostic unfavorable (4.88e-5)"	"unprognostic (1.49e-3)"	"unprognostic (9.70e-2)"	"unprognostic (4.11e-2)"	"unprognostic (1.00e-2)"	"unprognostic (6.64e-3)"	"unprognostic (1.35e-3)"	"unprognostic (4.34e-2)"	"unprognostic (2.78e-2)"	"unprognostic (2.28e-2)"	"unprognostic (7.33e-2)"	41.5	57.7	58.3	35.0	60.2	66.7	36.6	64.3	64.6	46.1	62.7	42.6	28.6	41.5	30.1	50.9	39.3	24.3	44.1	57.5	63.4	51.3	47.5	33.8	45.2	60.9	60.6	48.7	45.1	41.4	48.5	37.2	59.9	45.8	33.2	39.0	39.1	27.8	53.0	39.5	46.0	38.9	55.7	66.4	45.3	47.6	61.6	52.8	47.1	36.5	47.4	41.9	41.3	64.4	77.1	77.6	120.0	97.7	73.3	58.5	120.2	83.8	58.8	98.9	80.0	103.8	87.8	141.8	48.4	69.7	65.0	82.6	167.4	95.6	100.7	100.2	74.3	124.5	82.9	144.8	41.8	136.6	106.4	69.0	58.0	101.5	84.8	81.0	87.9	103.4	117.2	55.1	75.7	96.5	156.1	134.6	135.1	84.6	73.3	139.7	93.0	75.8	82.9	133.3	79.7	58.6	111.2	71.7	69.1	86.7	59.2	109.0	90.7	67.3	67.3	64.7	78.5	57.9	70.2	144.0	59.9	101.8	74.8	5.3	4.0	5.1	4.2	3.5	3.2	3.8	2.9	3.2	3.4	5.4	3.8	3.7	10.8	7.5	3.2	5.5	3.5	2.6	58.3	60.2	64.3	64.6	57.5	63.4	60.9	60.6	59.9	55.7	61.6	64.4	49.8	70.5	123.0	44.4	61.6	37.3	30.2	52.7	64.9	38.1	43.4	40.8	67.9	32.9	67.2	35.0	27.1	58.0	65.0	64.4	17.6	53.4	42.5	70.5	97.6	55.5	58.3	76.2	41.0	49.3	66.8	60.3	85.1	90.1	130.6	79.4	35.0	28.8	47.1	15.2	43.6	50.1	42.7	38.1	40.8	10.9	46.0	52.5	26.6	44.0	53.4	26.1	54.6	45.8	65.6	59.4	49.7	38.4	65.4	43.5	37.7	21.6	82.6	43.3	6.6	52.4	66.9	42.1	39.2	58.5	46.5	69.2	65.2	86.1	55.8	38.4
ACKR2	"CCBP2, CCR10, CCR9, CMKBR9, D6"	ENSG00000144648	"Atypical chemokine receptor 2"	O00590	3	42804752-42887974	"G-protein coupled receptors, Predicted membrane proteins"	"Inflammatory response"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 9.4;placenta: 16.0"	"Group enriched"	"Detected in many"	7	"Cytotrophoblasts: 33.0;Extravillous trophoblasts: 106.2;Syncytiotrophoblasts: 73.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"eosinophil: 3.9;NK-cell: 1.1"	"Group enriched"	"Detected in many"	7	"granulocytes: 3.9;NK-cells: 1.1"	"Cell line enhanced"	"Detected in some"		"BEWO: 51.2;HEL: 17.1;SK-BR-3: 28.0;U-937: 10.7"	"Group enriched"	"Detected in many"	5	"amygdala: 2.2;basal ganglia: 7.9;cerebral cortex: 4.9;hippocampal formation: 2.4"	"Low region specificity"	"Detected in all"			"HPA013819, HPA073493"	Enhanced		Supported	Nucleoplasm,Vesicles,Cytosol		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 38: Extravillous trophoblasts - Unknown function"	"Vesicles, Cytosol"	Nucleoplasm	"HPA013819: AB_1846126, HPA073493: AB_2686610"	"unprognostic (1.12e-1)"	"unprognostic (2.51e-1)"	"unprognostic (1.90e-2)"	"unprognostic (8.15e-2)"	"unprognostic (7.51e-2)"	"unprognostic (1.54e-2)"	"unprognostic (1.21e-3)"	"unprognostic (1.74e-1)"	"unprognostic (2.99e-1)"	"unprognostic (6.20e-2)"	"unprognostic (8.47e-2)"	"unprognostic (8.45e-2)"	"unprognostic (1.13e-4)"	"unprognostic (5.13e-3)"	"unprognostic (3.22e-1)"	"unprognostic (5.58e-3)"	"unprognostic (6.09e-2)"	6.7	1.0	1.5	1.0	1.0	0.7	2.8	1.5	1.3	1.7	0.9	1.9	0.9	0.9	2.8	1.6	2.3	1.3	1.3	1.0	0.5	1.5	9.4	1.6	1.1	1.4	1.4	0.4	0.9	0.4	0.5	16.0	1.3	0.6	2.1	0.7	2.2	0.4	0.6	2.6	1.1	1.1	0.6	0.7	1.1	0.8	1.1	0.4	2.9	0.9	2.1	1.8	2.3	1.3	0.1	0.0	0.2	0.4	2.4	0.2	51.2	0.1	0.0	0.0	0.0	0.5	0.1	1.2	0.1	0.1	0.2	0.4	0.0	0.2	0.1	0.1	0.2	17.1	0.4	3.1	0.1	0.2	1.9	0.5	0.5	0.0	0.1	0.0	0.1	0.5	2.2	0.4	0.3	0.3	0.0	0.2	0.1	0.7	0.2	0.1	0.0	0.1	0.7	7.5	0.3	0.1	1.3	28.0	0.1	2.9	2.8	0.3	0.1	0.1	0.1	0.2	0.1	0.6	0.1	0.1	0.1	10.7	0.1	0.4	0.1	3.9	0.2	0.2	0.0	0.1	0.0	0.0	0.2	0.3	0.1	0.1	0.4	1.1	0.3	0.1	0.0	0.1	1.5	1.0	1.5	1.3	1.0	0.5	1.4	1.4	1.3	0.6	1.1	1.3	1.0	0.0	0.0	9.8	0.1	0.1	0.1	0.3	0.0	0.7	1.2	0.3	0.8	1.5	3.3	0.0	2.1	33.0	0.3	3.0	1.9	0.1	3.0	3.7	0.8	3.3	1.8	0.0	2.0	0.0	106.2	2.1	0.0	5.9	2.5	2.5	4.6	7.0	5.3	1.7	1.2	0.6	0.0	0.6	0.4	1.8	0.3	0.4	0.0	5.6	0.1	2.6	0.0	1.0	4.5	0.8	0.5	1.2	0.1	0.4	1.6	0.5	3.4	1.0	0.0	0.4	0.3	4.8	5.4	0.0	0.0	73.6	0.5	0.5	1.1	0.6
ACKR3	"CMKOR1, CXCR7, GPR159, RDC1"	ENSG00000144476	"Atypical chemokine receptor 3"	P25106	2	236567787-236582354	"Cancer-related genes, G-protein coupled receptors, Predicted membrane proteins"	"Cell adhesion, Host-virus interaction"	"Developmental protein, G-protein coupled receptor, Receptor, Transducer"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 39.6;Endothelial cells: 59.8;Fibroblasts: 171.2;Smooth muscle cells: 37.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	7	"NK-cells: 4.7;T-cells: 3.8"	"Cell line enhanced"	"Detected in many"		"HeLa: 103.7;MCF7: 80.0;RT4: 312.3;SiHa: 97.0;U-2197: 328.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA032003, HPA049718"	Approved		Supported	"Vesicles,Plasma membrane"		NA	NA			"Cluster 22: NK-cells - Unknown function"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 18: U-2197 - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Vesicles, Plasma membrane"		"HPA032003: AB_2674107, HPA049718: AB_2680859"	"unprognostic (1.65e-2)"	"prognostic unfavorable (4.64e-4)"	"unprognostic (2.50e-1)"	"unprognostic (1.92e-3)"	"unprognostic (2.10e-1)"	"unprognostic (1.23e-1)"	"unprognostic (7.34e-3)"	"unprognostic (1.55e-2)"	"unprognostic (1.85e-2)"	"unprognostic (1.35e-1)"	"unprognostic (9.70e-3)"	"unprognostic (6.69e-2)"	"prognostic unfavorable (1.76e-6)"	"prognostic unfavorable (2.01e-4)"	"unprognostic (9.71e-2)"	"unprognostic (8.57e-3)"	"prognostic unfavorable (2.93e-4)"	116.2	5.2	13.0	14.3	13.5	3.5	70.4	13.1	15.6	29.2	18.3	38.7	11.8	17.3	10.5	25.0	33.7	30.8	68.5	13.7	18.9	11.3	28.3	26.3	10.5	22.3	16.0	15.9	37.9	5.0	24.4	123.3	14.4	20.1	24.7	1.7	21.4	16.8	35.4	38.1	34.1	24.2	14.3	56.0	27.9	14.6	14.5	6.4	58.1	37.9	5.6	107.0	38.2	13.6	0.0	0.1	6.3	0.0	10.5	0.2	44.9	2.6	1.4	2.3	4.6	0.5	0.1	0.0	5.1	0.2	16.9	68.0	0.2	24.0	0.4	0.1	0.0	0.1	103.7	0.2	0.1	0.2	0.1	3.2	61.0	0.3	0.0	15.4	11.2	0.3	1.2	0.1	0.0	80.0	0.2	0.2	11.0	0.0	0.7	0.1	7.6	0.8	0.0	312.3	0.4	0.1	97.0	0.5	0.0	23.9	0.0	0.3	0.0	0.8	23.3	328.5	0.1	1.4	0.0	0.1	1.2	6.6	0.5	0.0	0.1	0.0	2.5	0.2	3.8	0.3	1.3	3.2	0.1	0.6	1.1	1.5	0.0	4.7	0.4	0.0	2.0	0.5	13.0	13.5	13.1	15.6	13.7	18.9	22.3	16.0	14.4	14.3	14.5	13.6	33.2	9.6	4.8	20.5	1.1	22.0	0.2	39.6	1.2	1.7	0.2	1.0	9.1	0.0	24.8	0.0	0.0	0.1	0.7	1.0	0.0	0.2	0.9	13.5	24.2	59.8	0.0	0.0	0.7	10.4	0.8	171.2	1.1	24.8	6.3	6.3	33.5	2.5	0.8	0.0	2.3	0.1	6.1	4.1	10.1	0.4	1.5	6.9	1.8	12.2	0.8	0.1	1.0	1.0	0.1	1.3	5.3	1.2	0.5	0.5	3.3	0.9	5.8	0.1	0.0	35.7	37.1	0.2	0.3	1.1	15.9	0.3	1.5	1.1	0.2	2.6
ACKR4	"CCBP2, CCR11, CCRL1, CCX-CKR, PPR1, VSHK1"	ENSG00000129048	"Atypical chemokine receptor 4"	Q9NPB9	3	132597270-132618967	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 15.8"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 38.5;Fibroblasts: 21.4;Proximal enterocytes: 19.1;Respiratory ciliated cells: 15.7"	"Cancer enhanced"	"Detected in many"		"stomach cancer: 2.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	6	"BJ hTERT+: 285.1"	"Group enriched"	"Detected in some"	7	"cerebellum: 4.7;pons and medulla: 1.5"	"Low region specificity"	"Detected in all"			HPA054926			Approved	Vesicles,Mitochondria		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 31: Skin - Epidermis development"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Vesicles, Mitochondria"		"HPA054926: "	"unprognostic (1.50e-1)"	"unprognostic (1.89e-1)"	"unprognostic (2.62e-2)"	"unprognostic (8.27e-2)"	"unprognostic (5.17e-2)"	"unprognostic (4.55e-3)"	"unprognostic (8.93e-2)"	"unprognostic (2.26e-1)"	"unprognostic (4.85e-2)"	"unprognostic (4.20e-3)"	"unprognostic (1.03e-3)"	"unprognostic (2.69e-3)"	"unprognostic (1.95e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.86e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.22e-1)"	11.1	1.4	0.6	1.0	0.2	0.8	5.5	0.3	0.3	0.7	0.9	1.9	15.8	3.7	1.7	1.4	2.0	6.5	5.7	0.4	0.0	1.1	1.0	8.0	2.1	0.3	0.5	1.0	2.6	0.0	6.7	0.2	0.3	0.5	1.3	0.6	7.1	1.9	0.5	8.9	13.0	2.2	0.3	1.6	10.2	0.4	0.1	0.5	1.4	1.0	1.6	4.6	1.1	0.2	0.2	0.0	0.2	0.2	19.9	10.7	0.1	47.7	285.1	2.8	7.9	0.2	0.4	3.3	0.0	29.9	0.2	0.1	0.0	0.0	1.8	1.1	0.1	0.1	0.2	0.1	0.0	0.1	0.0	0.2	0.0	1.3	0.0	0.0	4.9	0.1	0.2	0.6	0.1	0.0	0.1	0.2	0.1	0.0	0.1	0.1	0.1	0.5	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.1	1.0	0.1	0.1	0.2	0.0	0.5	0.1	0.7	0.1	0.1	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.2	0.3	0.3	0.4	0.0	0.3	0.5	0.3	0.3	0.1	0.2	1.6	38.5	1.1	0.7	0.1	6.5	0.6	1.3	0.0	1.6	0.3	0.3	0.7	1.5	2.3	5.5	6.2	0.2	0.1	1.1	0.0	0.2	2.9	2.9	0.6	3.9	0.0	0.0	0.6	12.1	0.1	21.4	10.7	0.6	0.0	0.7	9.7	0.2	0.4	1.7	0.5	0.8	0.0	0.3	5.1	0.4	2.1	0.3	1.8	1.9	6.8	0.9	0.0	0.0	0.3	5.1	0.1	2.6	0.5	0.4	19.1	3.0	15.7	3.4	0.0	1.3	2.6	0.1	0.1	0.6	6.5	0.3	0.5	12.5	3.7	1.2
ACLY	"ACL, ATPCL, CLATP"	ENSG00000131473	"ATP citrate lyase"	P53396	17	41866917-41930542	"Cancer-related genes, Citric acid cycle related proteins, Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Lipid biosynthesis, Lipid metabolism"	Transferase	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB007783, HPA022434, HPA022953, HPA022959, HPA028758"	Enhanced		Supported	Nucleoplasm,Cytosol		No	No		3100000	"Cluster 44: Non-specific - Transcription"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 29: Early spermatids - Spermatogenesis"	Cytosol	Nucleoplasm	"CAB007783: AB_562242, HPA022434: AB_1844513, HPA022953: AB_1844514, HPA022959: AB_1844515, HPA028758: AB_10603575"	"unprognostic (2.21e-2)"	"prognostic unfavorable (1.79e-4)"	"unprognostic (1.41e-1)"	"unprognostic (1.21e-2)"	"unprognostic (2.83e-1)"	"unprognostic (8.94e-3)"	"prognostic unfavorable (3.66e-4)"	"unprognostic (3.38e-3)"	"unprognostic (4.11e-2)"	"unprognostic (5.94e-3)"	"unprognostic (2.13e-2)"	"unprognostic (3.01e-2)"	"unprognostic (3.88e-3)"	"unprognostic (1.66e-1)"	"unprognostic (9.36e-2)"	"unprognostic (3.90e-2)"	"unprognostic (4.67e-3)"	64.9	30.2	24.0	43.9	27.2	34.7	46.7	33.6	55.5	33.2	22.5	35.4	49.3	34.4	34.7	30.5	36.0	31.1	27.1	24.7	66.5	47.5	27.5	35.3	42.7	80.3	48.6	21.3	46.3	37.4	22.4	42.4	76.5	62.6	35.7	23.2	39.1	28.5	15.3	28.9	43.7	42.5	34.2	39.1	38.9	32.2	43.1	48.4	30.8	14.9	40.3	36.7	29.2	43.7	127.1	423.2	194.8	168.8	296.1	274.4	178.3	174.0	188.0	213.7	266.3	217.9	141.8	204.7	108.8	245.2	200.6	197.2	253.9	298.0	177.8	184.9	243.0	117.3	228.3	227.5	136.9	191.9	147.1	219.8	88.3	376.9	75.6	140.0	228.7	155.0	147.4	158.5	180.4	130.0	317.8	107.6	127.6	84.8	75.7	205.2	236.2	262.2	221.0	222.4	364.7	200.2	124.5	382.8	133.7	167.6	229.4	181.0	248.4	165.7	135.5	169.0	291.0	91.9	127.0	193.0	280.3	145.7	137.5	32.2	29.2	36.5	30.9	30.9	29.1	21.6	24.4	27.7	33.0	18.3	18.1	20.3	14.6	24.0	39.8	19.1	34.3	33.8	24.0	27.2	33.6	55.5	24.7	66.5	80.3	48.6	76.5	34.2	43.1	43.7	28.2	28.9	26.2	12.4	20.5	25.0	10.0	25.4	12.5	12.1	38.6	21.6	12.6	31.5	21.0	23.9	4.2	22.6	25.9	26.7	11.7	33.8	73.3	31.6	35.3	33.4	65.9	34.3	10.9	33.6	46.5	28.9	23.4	29.2	15.2	28.7	41.4	53.0	31.0	18.5	14.7	54.0	20.3	39.0	25.9	17.5	61.8	27.6	32.0	16.9	42.9	7.6	25.7	11.6	13.6	42.9	16.2	51.1	17.4	35.9	40.4	87.0	31.1	9.4	13.1	17.6	25.7	17.9	36.0	21.6	33.0	22.2	25.1	49.0	22.2	15.5
ACO1	"IREB1, IREBP, IRP1"	ENSG00000122729	"Aconitase 1"	P21399	9	32384603-32454769	"Cancer-related genes, Citric acid cycle related proteins, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Tricarboxylic acid cycle"	"Lyase, RNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 134.5"	"Cell type enhanced"	"Detected in all"		"Hepatocytes: 194.4;Proximal tubular cells: 183.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"ASC diff: 194.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019371, HPA024157"	Enhanced		Supported	Mitochondria,Cytosol		NA	NA		10000000	"Cluster 38: Basophils - Unknown function"	"Cluster 81: Kidney & Liver - Metabolism"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Mitochondria, Cytosol"		"HPA019371: AB_1844519, HPA024157: AB_1844520"	"unprognostic (2.11e-1)"	"unprognostic (5.61e-2)"	"unprognostic (8.38e-2)"	"unprognostic (9.12e-2)"	"unprognostic (2.63e-1)"	"unprognostic (3.12e-2)"	"unprognostic (4.25e-3)"	"unprognostic (2.61e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.55e-1)"	"unprognostic (3.08e-1)"	"prognostic favorable (5.73e-5)"	"unprognostic (2.54e-1)"	"unprognostic (6.58e-2)"	"unprognostic (1.65e-1)"	"unprognostic (3.23e-2)"	96.6	50.5	15.2	16.1	15.4	3.5	50.1	14.6	15.3	19.8	19.1	23.7	48.6	19.2	30.2	15.4	14.6	15.6	36.3	14.0	16.2	89.2	134.5	20.3	8.8	15.8	15.8	17.4	37.6	22.8	13.1	16.1	14.9	21.9	20.6	12.9	16.6	19.1	25.1	12.0	35.8	22.9	15.3	9.3	28.7	17.6	16.9	13.6	34.5	37.8	7.1	24.4	13.7	14.1	37.5	33.7	25.7	40.7	194.5	104.8	11.6	69.3	169.1	31.2	24.5	36.0	11.4	7.4	21.6	73.1	84.9	5.1	51.3	66.3	62.3	23.8	13.8	54.7	33.4	39.3	97.4	5.1	21.2	91.7	20.1	80.4	56.1	95.6	81.7	28.4	20.0	15.7	89.9	9.9	29.5	26.4	26.9	23.3	35.5	22.8	38.0	7.8	118.9	34.1	3.3	10.5	71.9	2.8	7.6	27.1	16.7	13.5	89.2	112.5	38.2	38.2	18.2	7.8	15.5	14.7	78.7	18.2	10.2	33.2	11.3	3.3	9.2	11.3	8.0	5.6	6.2	6.9	9.3	5.0	8.1	8.2	1.2	6.7	10.0	4.3	3.9	8.4	15.2	15.4	14.6	15.3	14.0	16.2	15.8	15.8	14.9	15.3	16.9	14.1	16.3	3.2	25.7	43.8	6.7	4.5	7.9	11.9	9.1	21.4	17.8	7.4	45.5	38.6	11.7	23.9	22.9	50.8	6.2	26.4	19.6	19.0	8.7	10.0	30.7	18.7	4.9	11.6	24.6	41.0	22.1	29.7	39.3	13.9	2.5	17.1	15.7	194.4	15.1	33.7	46.5	27.7	10.2	14.8	6.7	6.9	23.6	15.6	7.2	20.6	8.6	25.7	8.2	22.1	24.1	19.4	23.7	23.3	7.2	10.1	56.1	183.4	10.7	14.3	19.7	30.5	22.2	9.8	19.4	10.3	5.4	53.5	7.5	22.2	34.6	8.7
ACOT11	"BFIT, BFIT1, KIAA0707, STARD14, THEA, THEM1"	ENSG00000162390	"Acyl-CoA thioesterase 11"	Q8WXI4	1	54542257-54639192	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	"Hydrolase, Serine esterase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"choroid plexus: 44.4;intestine: 36.0"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 134.8;Distal enterocytes: 71.3;Late spermatids: 150.6;Proximal enterocytes: 106.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"eosinophil: 4.6"	"Lineage enriched"	"Detected in single"	6	"granulocytes: 4.6"	"Cell line enhanced"	"Detected in many"		"HaCaT: 18.9;OE19: 27.3;RT4: 40.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041047	Enhanced		Supported	Cytosol		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 15: RT4 - Unknown function"	"Cluster 31: Spermatids - Spermatogenesis"	Cytosol		"HPA041047: AB_2677273"	"unprognostic (9.73e-2)"	"unprognostic (1.28e-1)"	"prognostic favorable (9.37e-4)"	"unprognostic (3.61e-4)"	"unprognostic (5.42e-2)"	"unprognostic (1.94e-1)"	"unprognostic (2.20e-3)"	"unprognostic (5.12e-4)"	"unprognostic (1.05e-1)"	"unprognostic (2.84e-2)"	"unprognostic (9.60e-2)"	"unprognostic (1.02e-1)"	"prognostic favorable (3.07e-8)"	"unprognostic (5.89e-2)"	"unprognostic (1.08e-1)"	"unprognostic (3.83e-2)"	"unprognostic (8.49e-3)"	1.4	3.4	4.6	2.4	5.9	3.7	1.1	7.0	5.2	3.8	44.4	13.8	36.0	2.6	3.1	15.9	3.0	2.4	30.4	5.4	4.9	16.3	1.2	1.9	1.7	7.1	12.3	5.2	3.1	21.2	8.0	1.5	6.1	3.5	11.6	7.9	9.4	3.4	9.2	2.8	29.3	2.5	3.6	1.5	11.1	2.5	7.6	0.6	10.1	10.6	3.3	6.5	6.3	3.9	6.7	4.2	2.0	1.2	0.8	1.9	3.4	3.7	0.2	1.1	0.8	6.4	16.9	1.4	5.6	3.0	4.0	18.9	0.8	3.3	0.6	3.9	1.4	16.0	6.2	2.7	0.3	1.8	2.1	2.0	3.7	0.4	1.6	1.7	3.4	1.1	0.9	1.9	4.0	2.0	0.7	2.4	3.3	27.3	0.9	1.2	11.1	1.5	0.7	40.1	4.2	4.2	1.8	1.2	0.8	6.8	1.6	5.1	3.5	2.5	2.4	1.7	1.4	1.9	1.0	1.5	1.2	11.7	1.3	1.1	0.6	4.6	0.3	0.3	0.3	0.3	0.3	0.2	0.7	0.5	0.4	0.4	1.3	0.4	0.5	0.4	0.3	0.3	4.6	5.9	7.0	5.2	5.4	4.9	7.1	12.3	6.1	3.6	7.6	3.9	0.5	0.0	7.8	134.8	1.4	4.8	16.6	7.3	2.8	46.4	3.4	0.9	24.7	10.0	7.2	25.8	0.0	2.0	0.2	71.3	11.7	4.4	22.6	11.4	1.7	2.1	47.5	3.0	11.7	2.6	6.2	3.5	33.6	14.1	15.2	3.3	3.9	0.4	8.3	15.2	6.0	38.8	10.2	8.0	7.4	150.6	13.7	6.1	8.8	10.3	2.9	46.4	0.0	19.6	3.9	4.7	37.0	17.7	0.5	6.6	106.1	48.0	8.5	5.3	0.0	19.1	2.5	0.6	1.0	5.3	2.8	2.5	1.2	16.4	44.8	26.3
ACOT12	"Cach, STARD15, THEAL"	ENSG00000172497	"Acyl-CoA thioesterase 12"	Q8WYK0	5	81329996-81394179	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Transporters"	"Fatty acid metabolism, Lipid metabolism"	"Hydrolase, Serine esterase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	36	"liver: 100.7"	"Cell type enriched"	"Detected in some"	4	"Hepatocytes: 36.2"	"Cancer enriched"	"Detected in single"	76	"liver cancer: 13.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			HPA037723			Approved	"Nucleoplasm,Cytokinetic bridge,Cytosol"		Yes	NA				"Cluster 62: Liver - Hemostasis"		"Cluster 2: Hepatocytes - Metabolism"	Cytosol	"Nucleoplasm, Cytokinetic bridge"	"HPA037723: AB_10672606"	"unprognostic (6.06e-2)"				"unprognostic (1.39e-1)"		"prognostic favorable (5.30e-4)"		"unprognostic (7.68e-2)"	"unprognostic (8.22e-2)"	"unprognostic (5.68e-3)"	"unprognostic (2.46e-1)"	"unprognostic (6.86e-2)"	"unprognostic (1.46e-2)"	"unprognostic (3.07e-1)"	"unprognostic (1.06e-1)"		0.0	0.0	0.6	0.0	0.7	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.5	2.7	100.7	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.1	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.2	0.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.7	0.0	0.5	0.3	0.5	0.3	0.3	0.6	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	2.8	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.1	0.0	8.0	0.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	36.2	0.5	0.0	1.2	0.0	0.0	1.4	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.4	0.0	0.0	3.4	4.2	0.0	0.0	0.0	0.4	0.0	0.6	0.2	0.0	0.0	0.0	0.1	0.0	0.1	0.0
ACOT7	"ACH1, ACT, BACH, CTE-II, hBACH, LACH1, MGC1126"	ENSG00000097021	"Acyl-CoA thioesterase 7"	O00154	1	6264269-6393767	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	"Hydrolase, Serine esterase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 128.7"	"Cell type enhanced"	"Detected in many"		"granulocytes: 137.2;Late spermatids: 160.8;Proximal enterocytes: 179.4;Proximal tubular cells: 253.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"NK-cell: 40.2;plasmacytoid DC: 35.7"	"Group enriched"	"Detected in many"	5	"dendritic cells: 35.7;NK-cells: 40.2"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA025735, HPA025762"	Enhanced		Supported	Nucleoplasm,Cytosol		No	No		26000	"Cluster 40: NK-cells - Unknown function"	"Cluster 45: Intestine - Brush border"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Cytosol	Nucleoplasm	"HPA025735: AB_1844523, HPA025762: AB_1844524"	"unprognostic (3.94e-2)"	"unprognostic (1.74e-1)"	"unprognostic (7.09e-2)"	"unprognostic (4.33e-2)"	"unprognostic (4.10e-2)"	"unprognostic (5.06e-2)"	"prognostic unfavorable (2.31e-5)"	"prognostic unfavorable (1.29e-4)"	"unprognostic (2.35e-2)"	"unprognostic (4.05e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.73e-1)"	"prognostic unfavorable (2.55e-6)"	"unprognostic (2.68e-2)"	"unprognostic (1.45e-1)"	"unprognostic (9.06e-2)"	"unprognostic (3.72e-2)"	11.3	20.4	72.8	18.7	72.8	14.7	9.9	56.2	108.2	17.8	16.7	32.7	55.1	18.2	5.5	35.0	11.0	8.2	17.3	75.1	107.2	47.8	22.0	17.9	22.4	96.1	88.5	11.2	9.0	3.8	65.1	10.4	128.7	12.9	21.4	24.5	11.9	6.9	5.2	27.1	56.1	23.5	46.9	20.7	19.2	38.1	83.9	28.3	6.1	4.7	19.4	18.0	23.5	68.4	117.6	100.0	96.6	104.6	21.7	35.6	36.4	98.6	50.6	142.7	85.1	347.7	37.0	142.4	70.6	80.4	110.3	113.0	156.9	263.2	53.2	126.0	136.7	75.2	74.4	124.9	88.7	88.8	59.9	32.1	49.6	118.2	139.2	38.1	81.2	174.8	62.3	29.8	76.8	136.6	187.0	94.0	48.5	116.9	228.2	219.9	110.6	95.6	80.9	44.2	52.6	149.1	88.9	134.5	317.9	47.3	47.9	41.2	133.0	129.1	75.4	129.6	158.9	24.9	110.6	202.1	81.8	153.7	80.3	0.0	0.3	0.2	7.3	1.2	1.8	2.1	5.8	6.2	5.4	0.7	2.0	3.9	0.7	40.2	0.9	35.7	8.2	5.3	72.8	72.8	56.2	108.2	75.1	107.2	96.1	88.5	128.7	46.9	83.9	68.4	3.4	6.4	16.4	9.4	4.9	31.7	16.5	24.2	12.5	46.8	4.1	7.5	9.8	8.6	14.9	9.2	10.4	20.9	14.4	45.4	15.6	22.7	95.5	4.0	6.1	19.1	4.8	26.5	38.6	7.2	29.7	11.5	19.9	7.6	137.2	13.2	8.6	16.8	30.1	47.1	38.9	110.2	36.7	4.8	85.9	160.8	3.7	13.4	39.2	5.6	15.7	12.8	8.2	22.6	21.0	23.2	41.8	7.2	9.3	9.5	179.4	253.7	7.1	24.4	0.0	6.7	17.6	37.8	28.0	26.2	29.5	17.2	21.7	13.7	51.3	19.6
ACOT8	"hACTE-III, hTE, NAP1, PTE-2, PTE1"	ENSG00000101473	"Acyl-CoA thioesterase 8"	O14734	20	45841721-45857405	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Fatty acid metabolism, Host-virus interaction, Lipid metabolism, Peroxisome biogenesis"	"Hydrolase, Serine esterase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal enterocytes: 104.2;Late spermatids: 90.3;Proximal enterocytes: 105.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB010261	Approved		Supported	Vesicles,Mitochondria		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Vesicles	Mitochondria	"CAB010261: AB_2221664"	"unprognostic (2.36e-2)"	"unprognostic (6.95e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.28e-2)"	"unprognostic (2.13e-1)"	"unprognostic (4.27e-1)"	"unprognostic (1.03e-3)"	"unprognostic (2.92e-2)"	"unprognostic (4.70e-1)"	"unprognostic (1.72e-1)"	"unprognostic (2.28e-2)"	"unprognostic (2.03e-2)"	"prognostic favorable (3.18e-4)"	"unprognostic (2.79e-1)"	"unprognostic (1.23e-1)"	"unprognostic (4.61e-2)"	"unprognostic (2.98e-1)"	8.3	31.7	27.8	8.6	29.8	18.1	7.6	28.2	35.2	9.3	24.3	18.5	21.1	8.5	11.0	17.5	10.7	9.2	28.1	29.8	28.6	21.3	26.0	11.0	12.6	27.0	28.5	8.0	15.6	15.1	15.4	7.1	28.7	12.7	12.8	9.2	12.8	5.9	28.7	17.0	20.5	6.4	26.0	12.3	21.3	20.2	28.7	13.1	11.4	17.8	9.7	11.0	10.4	28.1	16.8	20.2	6.8	13.4	18.3	11.0	11.7	11.1	9.5	15.1	13.7	29.2	22.7	20.8	48.2	16.3	35.4	32.3	13.0	27.8	6.6	15.5	22.3	21.2	25.1	28.5	16.9	19.9	19.3	12.9	21.3	15.1	10.9	22.6	9.4	23.6	18.8	24.2	11.0	47.4	28.7	27.0	11.8	32.4	52.2	14.0	12.2	37.6	16.5	19.1	23.1	10.8	24.9	61.7	39.5	10.6	34.4	48.8	11.6	37.9	8.5	19.5	18.9	20.7	33.8	14.0	46.3	21.2	20.8	34.3	34.3	43.6	24.8	34.6	21.8	27.5	23.2	21.9	36.7	27.9	20.0	21.6	25.0	16.3	34.2	23.3	31.9	26.7	27.8	29.8	28.2	35.2	29.8	28.6	27.0	28.5	28.7	26.0	28.7	28.1	8.2	35.3	14.1	5.9	17.9	6.1	12.3	21.9	8.6	19.2	9.8	10.9	9.3	11.5	17.7	12.9	16.7	34.2	11.8	104.2	64.6	21.6	38.5	14.2	10.4	10.9	19.2	17.0	12.3	21.0	20.9	11.4	19.9	14.0	14.0	27.6	11.4	25.5	27.8	8.4	12.0	37.3	10.2	18.6	7.1	90.3	9.9	17.5	10.6	3.7	27.5	17.8	34.0	5.0	9.6	21.6	68.4	8.6	21.3	11.3	105.4	81.5	27.1	22.8	13.1	5.8	12.8	27.0	10.2	16.1	8.0	19.4	13.9	37.6	30.3	16.0
ACOX2	"BRCACOX, BRCOX, THCCox"	ENSG00000168306	"Acyl-CoA oxidase 2"	Q99424	3	58505136-58537283	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	Oxidoreductase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"liver: 177.3"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 89.0;Proximal enterocytes: 27.9;Proximal tubular cells: 51.0"	"Cancer enhanced"	"Detected in many"		"liver cancer: 25.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 16.4;ASC TERT1: 25.9;fHDF/TERT166: 9.2;Hep G2: 10.8;HSkMC: 17.4"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA038280, HPA064845"	Enhanced		Approved	Vesicles,Cytosol		No	No		29000		"Cluster 85: Liver - Metabolism"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 2: Hepatocytes - Metabolism"	Vesicles	Cytosol	"HPA038280: AB_10672623, HPA064845: AB_2685368"	"unprognostic (6.62e-2)"	"unprognostic (2.10e-1)"	"unprognostic (1.08e-1)"	"unprognostic (2.51e-2)"	"unprognostic (8.34e-2)"	"unprognostic (1.48e-2)"	"unprognostic (8.67e-3)"	"unprognostic (6.45e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.70e-3)"	"unprognostic (1.26e-2)"	"unprognostic (1.68e-3)"	"unprognostic (4.00e-3)"	"unprognostic (2.34e-1)"	"unprognostic (1.26e-1)"	"unprognostic (5.63e-3)"	8.8	8.3	4.1	2.1	4.6	0.1	5.8	4.4	4.5	9.3	16.8	12.9	25.4	9.4	5.8	6.3	10.8	8.2	16.7	4.3	4.5	42.1	177.3	6.2	1.7	5.3	4.8	11.2	4.6	9.6	4.6	3.4	4.4	10.8	8.3	1.8	7.2	9.8	8.2	2.9	21.6	11.2	4.5	1.4	4.0	4.9	4.9	4.0	16.1	17.0	1.2	8.7	6.0	4.1	0.0	0.0	0.2	0.0	16.4	25.9	4.7	3.1	0.2	0.0	0.4	0.8	0.0	0.0	0.0	9.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.8	2.3	0.0	0.0	17.4	0.0	0.0	0.0	2.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	4.6	4.4	4.5	4.3	4.5	5.3	4.8	4.4	4.5	4.9	4.1	1.9	3.2	5.8	11.1	0.6	0.6	7.6	0.5	5.7	0.3	1.3	3.8	14.3	4.3	0.9	3.7	0.0	0.7	0.0	4.2	15.6	0.3	0.1	0.4	1.3	1.6	3.0	2.7	0.6	1.9	0.4	8.6	2.0	0.2	1.3	8.6	6.1	89.0	5.2	1.7	0.6	5.1	0.0	1.9	0.4	1.8	10.8	1.7	0.0	1.0	0.5	10.8	0.0	0.5	0.0	0.4	0.8	8.6	0.1	0.6	27.9	51.0	0.0	0.8	6.6	7.0	5.2	0.4	0.4	3.0	0.3	0.8	0.3	9.6	4.6	3.8
ACOX3		ENSG00000087008	"Acyl-CoA oxidase 3, pristanoyl"	O15254	4	8366282-8440723	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Syncytiotrophoblasts: 74.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035840, HPA035841"	Uncertain		Supported	Peroxisomes		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	Peroxisomes		"HPA035840: AB_10696514, HPA035841: AB_10671940"	"unprognostic (3.07e-2)"	"unprognostic (5.51e-2)"	"unprognostic (1.12e-1)"	"prognostic favorable (2.16e-4)"	"unprognostic (5.52e-2)"	"unprognostic (1.81e-3)"	"unprognostic (2.21e-1)"	"unprognostic (3.37e-2)"	"unprognostic (2.27e-1)"	"unprognostic (4.43e-2)"	"unprognostic (4.81e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.46e-2)"	"unprognostic (3.58e-2)"	"unprognostic (2.84e-1)"	"unprognostic (1.69e-1)"	"unprognostic (2.65e-1)"	7.7	8.8	5.8	6.4	5.2	4.4	12.2	3.8	7.2	9.5	5.9	8.4	8.9	5.6	4.3	26.6	6.6	5.9	16.2	5.3	4.9	6.5	14.9	7.2	6.6	5.9	4.6	7.5	12.0	7.1	4.5	8.4	4.7	10.5	6.3	3.8	15.4	8.4	6.4	12.5	8.9	11.4	4.2	5.3	10.1	2.9	5.0	4.6	8.5	5.6	8.5	10.1	13.7	7.1	8.9	9.6	10.5	14.1	11.0	18.7	17.2	11.1	15.1	18.5	16.1	4.8	11.7	11.9	11.7	22.8	25.0	5.4	4.6	14.4	14.3	4.1	4.5	5.2	8.2	14.8	18.3	10.7	9.4	18.9	12.1	16.7	6.5	13.3	22.1	13.1	7.0	10.6	16.1	8.2	11.4	15.6	5.9	11.3	16.4	11.8	17.3	14.3	11.2	12.4	5.1	11.7	14.2	7.2	7.3	8.6	7.2	14.9	21.7	18.2	5.9	7.5	11.8	7.9	5.6	5.4	23.2	13.1	11.8	0.1	13.2	3.3	6.1	15.2	6.3	5.4	7.1	7.8	17.8	4.9	6.5	6.7	3.1	9.5	14.4	21.4	10.4	9.4	5.8	5.2	3.8	7.2	5.3	4.9	5.9	4.6	4.7	4.2	5.0	7.1	6.2	6.4	5.9	14.7	4.8	4.5	7.6	12.3	8.6	8.2	11.6	7.6	9.4	10.0	9.8	11.0	33.3	23.9	7.7	10.9	3.9	17.3	4.4	13.1	4.2	5.6	1.8	3.0	13.2	13.7	9.3	6.6	10.2	10.0	0.0	21.7	4.6	14.2	10.2	1.7	14.2	4.9	14.2	4.1	4.4	3.3	6.8	5.3	5.4	6.5	7.6	3.8	2.1	12.5	14.5	16.9	7.4	11.3	5.6	9.1	18.3	8.2	11.2	18.6	0.0	3.8	6.9	2.4	2.3	14.1	5.8	74.6	6.0	6.0	7.5	11.4
ACOXL	FLJ11042	ENSG00000153093	"Acyl-CoA oxidase like"	Q9NUZ1	2	110732539-111120610	"Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in many"		"epididymis: 7.2;lung: 9.3"	"Cell type enriched"	"Detected in some"	5	"Alveolar cells type 2: 41.9"	"Group enriched"	"Detected in some"	6	"lung cancer: 0.6;prostate cancer: 1.1;testis cancer: 2.1;urothelial cancer: 2.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"A-431: 12.1;RPMI-8226: 22.0;RT4: 29.3;U-266/70: 18.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA035392, HPA035393"			Supported	Nucleoli,Cytosol		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 68: Epididymis - Unknown function"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 11: Alveolar cells - Smell perception"	Cytosol	Nucleoli	"HPA035392: AB_2674604, HPA035393: AB_2674605"	"unprognostic (1.62e-1)"	"unprognostic (7.30e-2)"	"unprognostic (6.77e-4)"	"unprognostic (2.93e-7)"	"unprognostic (1.32e-2)"	"unprognostic (7.84e-5)"	"unprognostic (1.28e-1)"	"unprognostic (1.53e-2)"	"unprognostic (1.29e-1)"	"unprognostic (7.31e-2)"	"unprognostic (7.24e-2)"	"unprognostic (3.24e-1)"	"unprognostic (1.72e-1)"	"unprognostic (2.11e-1)"	"unprognostic (2.73e-1)"	"unprognostic (1.72e-1)"	"prognostic favorable (6.48e-4)"	1.1	0.6	0.4	0.5	0.7	1.5	0.1	0.2	0.4	0.4	0.0	0.5	0.5	0.5	7.2	0.4	0.3	0.6	1.2	0.3	0.1	0.5	0.3	9.3	0.9	0.4	0.4	0.2	1.0	2.9	0.3	0.7	0.3	3.2	0.3	0.7	0.6	0.0	1.3	0.7	0.6	0.1	0.0	0.6	0.5	3.2	0.2	0.3	0.8	0.0	1.2	4.6	0.1	0.5	12.1	0.2	0.3	0.2	0.1	0.0	0.8	0.1	0.0	0.0	0.0	0.9	0.7	0.3	0.5	0.1	0.3	1.3	0.0	0.1	0.0	0.3	3.5	0.2	0.5	0.5	0.0	0.0	0.3	0.1	1.2	0.0	0.1	0.3	0.0	0.6	1.8	1.8	0.1	4.4	0.9	0.4	4.2	0.0	0.3	0.6	0.2	22.0	0.0	29.3	2.5	1.0	0.3	0.5	0.1	0.6	0.4	1.2	0.3	0.2	1.0	0.2	0.1	18.7	4.8	0.7	0.0	0.1	0.1	0.7	0.3	0.3	0.1	0.1	0.1	0.2	0.1	0.1	0.0	0.1	0.1	0.0	0.9	0.2	0.2	0.2	0.1	0.1	0.4	0.7	0.2	0.4	0.3	0.1	0.4	0.4	0.3	0.0	0.2	0.5	0.3	0.0	41.9	0.0	1.0	0.3	0.3	0.0	0.0	0.6	0.1	0.3	0.5	0.0	0.7	0.0	0.0	0.0	0.1	1.3	0.0	0.2	5.4	0.2	0.1	0.2	1.2	0.0	2.2	0.0	0.0	0.4	0.0	0.8	0.0	5.9	0.0	0.0	0.1	0.0	2.0	0.3	0.0	0.0	0.8	8.1	0.0	0.2	0.0	0.0	0.0	0.1	1.0	1.0	1.3	0.1	2.3	0.0	7.5	0.8	0.0	0.1	0.1	0.3	0.0	0.2	0.3	1.6	2.7	0.0	0.3	0.0	1.1	0.0	0.2	0.8
ACSBG2	"BGR, DKFZp434K1635, PRTD-NY3"	ENSG00000130377	"Acyl-CoA synthetase bubblegum family member 2"	Q5FVE4	19	6135247-6193094	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Differentiation, Fatty acid metabolism, Lipid metabolism, Spermatogenesis"	"Developmental protein, Ligase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	89	"testis: 129.3"	"Group enriched"	"Detected in some"	75	"Early spermatids: 533.6;Late spermatids: 1782.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA043421, HPA051013"	Enhanced		Supported	Cytosol		NA	NA				"Cluster 74: Testis - Spermatogenesis"		"Cluster 25: Spermatids - Spermatogenesis"	Cytosol		"HPA043421: AB_10794182, HPA051013: AB_2681311"	"unprognostic (4.13e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.47e-1)"	"unprognostic (3.27e-2)"	"unprognostic (4.33e-2)"	"unprognostic (1.92e-4)"	"unprognostic (1.96e-2)"	"unprognostic (4.17e-2)"	"unprognostic (2.07e-1)"	"unprognostic (2.62e-1)"	"unprognostic (6.88e-3)"	"unprognostic (3.13e-2)"	"unprognostic (3.91e-3)"	"unprognostic (2.20e-1)"	"unprognostic (9.23e-2)"	"unprognostic (8.78e-2)"	"unprognostic (4.70e-4)"	0.1	0.0	0.2	0.0	0.2	0.0	0.2	1.4	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.1	0.7	0.3	0.0	0.0	0.0	0.5	0.0	0.2	0.2	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	129.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	1.4	0.2	0.3	0.1	0.7	0.3	0.2	0.1	0.2	0.9	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	533.6	0.0	0.1	0.6	0.0	0.0	2.1	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	2.7	0.0	0.0	0.0	0.0	1782.3	11.8	0.8	0.0	1.9	0.0	0.0	0.0	1.5	3.1	0.0	0.0	7.2	0.0	0.0	0.0	1.9	0.0	0.0	6.6	0.0	0.1	15.4	9.8	0.0	0.0	1.4	0.0	0.0	0.0	0.0
ACSF3		ENSG00000176715	"Acyl-CoA synthetase family member 3"	Q4G176	16	89088375-89164121	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Fatty acid metabolism, Lipid metabolism"	Ligase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"JURKAT: 242.9;U-698: 113.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008322			Supported	Nucleoplasm,Mitochondria		NA	NA			"Cluster 30: Non-specific - Translation"	"Cluster 9: Intestine - Unknown function"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Mitochondria	Nucleoplasm	"HPA008322: AB_1845294"	"unprognostic (1.94e-1)"	"unprognostic (3.35e-1)"	"unprognostic (4.66e-2)"	"unprognostic (1.56e-2)"	"unprognostic (1.14e-1)"	"unprognostic (7.87e-2)"	"unprognostic (5.68e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.89e-1)"	"unprognostic (1.96e-1)"	"prognostic favorable (3.76e-5)"	"unprognostic (3.36e-2)"	"prognostic favorable (5.97e-6)"	"unprognostic (2.33e-1)"	"unprognostic (5.09e-1)"	"unprognostic (3.67e-1)"	"unprognostic (2.00e-3)"	8.9	20.5	8.0	15.9	8.2	11.6	9.4	9.9	11.4	9.2	9.6	17.1	30.7	9.6	9.7	10.5	9.5	9.7	9.8	8.0	7.1	11.6	19.2	7.9	21.7	9.1	8.2	8.9	15.6	18.5	7.7	6.1	9.3	8.6	11.4	5.9	13.2	6.5	13.1	10.5	26.4	7.8	7.1	13.3	12.6	7.8	10.6	37.6	9.8	16.5	13.9	10.2	8.7	12.0	12.8	17.8	8.4	14.4	14.5	13.3	19.6	16.5	6.1	16.2	10.4	16.2	20.9	33.2	21.5	14.2	10.5	20.9	8.6	19.4	10.0	12.3	20.6	25.8	16.6	23.8	35.2	8.1	13.3	19.4	22.0	12.4	18.1	18.5	11.7	242.9	36.4	10.1	9.0	32.7	45.6	25.7	9.8	24.8	30.0	53.2	7.2	14.1	15.9	17.2	20.6	15.3	26.6	6.8	26.2	13.5	23.1	28.6	11.6	17.3	12.8	10.2	12.5	11.7	17.3	113.0	15.4	29.8	14.5	7.0	23.0	17.2	22.7	22.8	25.2	29.8	18.5	16.5	21.7	20.6	19.5	17.4	9.0	10.8	21.3	24.6	19.6	17.9	8.0	8.2	9.9	11.4	8.0	7.1	9.1	8.2	9.3	7.1	10.6	12.0	9.2	0.0	11.4	9.4	22.5	3.2	7.6	11.9	4.0	20.2	8.5	7.5	9.1	11.5	15.5	5.5	31.3	11.9	17.5	29.9	15.6	16.1	13.8	10.3	9.3	10.3	16.8	14.3	10.1	10.7	3.8	9.3	17.3	8.1	2.5	44.7	7.9	12.5	18.6	21.9	9.5	19.4	28.5	19.5	14.2	20.4	12.2	14.0	7.2	14.0	18.6	9.3	13.4	9.0	11.2	16.3	20.8	10.1	21.2	8.9	54.7	13.5	10.0	19.0	39.5	11.1	9.7	8.8	8.5	8.2	4.5	7.3	17.0	20.1	31.1	7.4
ACSL5	"ACS2, ACS5, FACL5"	ENSG00000197142	"Acyl-CoA synthetase long chain family member 5"	Q9ULC5	10	112374018-112428380	"Enzymes, Metabolic proteins, Plasma proteins, Predicted membrane proteins"	"Fatty acid metabolism, Lipid metabolism"	Ligase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"epididymis: 217.8;intestine: 418.0;liver: 165.5"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 164.9;Endometrial ciliated cells: 159.9;Glandular and luminal cells: 292.3;Proximal enterocytes: 462.5"	"Cancer enhanced"	"Detected in all"		"colorectal cancer: 87.1"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 138.8;RT4: 143.3;U-937: 70.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007162, CAB035986, CAB062546"	Enhanced		Supported	Nucleoplasm,Mitochondria		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 9: Intestine - Unknown function"	"Cluster 15: RT4 - Unknown function"	"Cluster 44: Endometrium - Transcription"	Mitochondria	Nucleoplasm	"CAB035986: AB_941506, CAB062546: AB_2665614, HPA007162: AB_2667761"	"unprognostic (5.75e-3)"	"unprognostic (2.06e-1)"	"unprognostic (3.08e-2)"	"prognostic favorable (1.13e-4)"	"unprognostic (2.45e-1)"	"unprognostic (2.13e-2)"	"unprognostic (4.92e-2)"	"unprognostic (5.90e-2)"	"unprognostic (1.67e-1)"	"unprognostic (4.06e-2)"	"unprognostic (4.18e-3)"	"unprognostic (7.40e-2)"	"unprognostic (5.25e-3)"	"unprognostic (2.11e-1)"	"unprognostic (1.10e-1)"	"unprognostic (5.92e-3)"	"unprognostic (1.08e-3)"	23.8	4.2	13.1	29.0	12.6	16.2	21.3	13.0	15.5	51.4	10.4	111.7	358.9	30.3	217.8	7.9	45.0	21.5	9.4	12.1	13.4	9.0	165.5	35.6	28.0	14.4	13.1	17.0	5.5	2.2	2.6	8.6	14.9	12.3	116.6	1.5	5.5	20.3	3.9	3.4	418.0	15.5	14.0	25.7	44.2	9.6	15.3	16.4	7.2	8.8	28.0	76.3	7.6	13.2	38.6	0.9	0.7	0.1	2.5	0.4	3.3	1.1	7.3	0.3	0.6	34.8	138.8	46.7	8.4	1.9	6.8	0.3	0.0	0.2	0.8	39.4	0.0	36.5	1.3	60.9	8.8	57.3	59.2	5.9	0.0	0.8	0.0	2.7	2.8	0.0	0.1	20.6	0.1	0.0	0.1	26.3	0.1	32.2	1.3	12.9	0.2	28.6	3.8	143.3	0.1	0.9	55.8	21.0	0.1	0.1	0.1	31.7	40.5	0.5	0.4	2.2	2.5	14.8	0.1	22.6	1.2	70.5	0.1	27.4	15.1	27.5	25.2	27.9	24.9	16.3	20.4	27.8	31.1	13.1	13.8	21.4	3.9	26.1	27.7	9.8	41.5	21.1	13.1	12.6	13.0	15.5	12.1	13.4	14.4	13.1	14.9	14.0	15.3	13.2	23.4	12.8	51.3	0.0	20.1	3.8	10.3	10.7	8.6	0.1	7.0	4.6	1.7	12.8	23.6	0.0	4.2	1.8	10.5	164.9	0.0	13.3	92.6	159.9	37.6	24.7	40.8	10.7	1.3	6.4	2.6	5.7	41.8	292.3	17.2	0.5	16.1	88.6	18.9	0.0	1.1	79.0	0.0	22.4	57.8	42.6	15.8	24.9	3.6	17.8	11.5	0.1	16.5	1.0	1.0	48.0	122.4	12.0	20.3	7.1	462.5	0.2	8.2	1.2	0.0	0.8	3.3	4.0	1.9	3.3	1.7	0.7	24.0	6.4	103.3	50.0
ACSS3	FLJ21963	ENSG00000111058	"Acyl-CoA synthetase short chain family member 3"	Q9H6R3	12	80936414-81261210	"Enzymes, Metabolic proteins, Predicted membrane proteins"		Ligase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 40.0"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 46.5;Astrocytes: 167.8;Early spermatids: 52.9;Hepatocytes: 53.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	14	"basophil: 7.0;neutrophil: 2.2"	"Lineage enriched"	"Detected in single"	70	"granulocytes: 7.0"	"Cell line enhanced"	"Detected in many"		"ASC diff: 14.3;ASC TERT1: 16.1;Hep G2: 42.6;hTERT-RPE1: 14.0;RH-30: 19.1;SK-BR-3: 18.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA039353, HPA047956, HPA061517"	Approved		Supported	Mitochondria		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 81: Kidney & Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 64: Astrocytes - Nervous system maintenance"	Mitochondria		"HPA039353: AB_2676460, HPA047956: AB_2680223, HPA061517: AB_2684549"	"unprognostic (8.59e-2)"	"unprognostic (9.29e-4)"	"unprognostic (1.47e-1)"	"unprognostic (9.37e-3)"	"unprognostic (2.46e-2)"	"unprognostic (2.21e-1)"	"unprognostic (9.25e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.34e-1)"	"unprognostic (7.18e-3)"	"unprognostic (1.68e-1)"	"unprognostic (7.79e-2)"	"prognostic favorable (0.00e+0)"	"unprognostic (6.16e-4)"	"unprognostic (1.63e-1)"	"unprognostic (2.00e-1)"	"unprognostic (2.00e-4)"	22.7	14.5	5.2	1.5	5.1	0.1	7.3	5.2	5.3	8.3	9.3	2.2	0.7	9.1	12.1	1.5	8.0	8.1	6.8	4.7	4.9	25.9	40.0	6.4	1.5	5.5	6.4	16.7	2.0	13.7	4.4	4.0	5.2	5.7	1.0	4.8	12.1	5.5	3.5	1.7	1.5	6.3	4.9	2.1	1.4	2.3	6.5	1.1	8.8	5.7	1.1	2.8	5.0	5.5	0.0	0.2	3.4	0.0	14.3	16.1	0.1	2.2	11.0	1.7	1.9	0.4	0.1	0.0	0.0	5.0	5.2	0.1	0.0	0.0	1.0	0.0	2.2	0.0	0.0	42.6	4.8	0.1	0.0	10.8	0.0	0.5	0.0	14.0	0.4	0.0	0.0	0.0	7.8	1.0	0.1	0.2	4.8	0.0	0.0	0.0	19.1	2.7	0.1	0.1	3.1	0.0	0.0	18.0	0.1	7.1	7.9	0.5	0.0	2.8	2.7	0.2	1.2	0.1	0.1	0.1	3.5	0.0	3.4	7.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	5.2	5.1	5.2	5.3	4.7	4.9	5.5	6.4	5.2	4.9	6.5	5.5	1.3	22.4	46.5	167.8	0.2	0.9	9.5	0.0	2.2	37.8	5.6	3.0	21.8	14.3	3.2	12.9	4.2	1.5	0.1	0.1	5.9	6.4	52.9	3.9	14.8	1.5	0.0	0.0	1.5	2.9	0.8	12.1	0.0	2.7	0.0	8.8	1.8	53.6	0.7	28.6	1.6	0.1	0.0	3.2	0.6	9.4	23.9	0.8	0.0	35.6	0.1	16.4	0.0	16.6	0.7	0.1	0.1	23.7	0.0	3.0	1.1	31.7	3.7	5.3	6.6	18.6	9.9	4.6	0.6	0.4	0.1	0.5	0.6	13.2	1.2	3.7
ACTA2	ACTSA	ENSG00000107796	"Actin alpha 2, smooth muscle"	P62736	10	88935074-88991339	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"		"Muscle protein"	"Aortic aneurysm, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"endometrium 1: 6678.8;seminal vesicle: 5920.3;smooth muscle: 8099.9"	"Cell type enhanced"	"Detected in many"		"Breast myoepithelial cells: 1007.7;Peritubular cells: 5290.7;Sertoli cells: 3030.6;Smooth muscle cells: 2394.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"T-reg: 58.7"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 390.6;fHDF/TERT166: 641.1;HHSteC: 625.8;HSkMC: 345.1;hTERT-RPE1: 743.4;SuSa: 296.8"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"midbrain: 101.0"	"CAB000002, CAB003761, CAB013531, HPA041264, HPA041271"	Enhanced		Supported	"Actin filaments"		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 48: Smooth muscle cells - ECM organization"	"Actin filaments"		"CAB000002: AB_2223500, CAB003761: AB_562031, CAB013531: , HPA041264: AB_2677383, HPA041271: AB_2677386"	"unprognostic (7.05e-2)"	"unprognostic (2.54e-1)"	"unprognostic (2.30e-3)"	"unprognostic (3.18e-2)"	"unprognostic (3.33e-2)"	"unprognostic (6.19e-2)"	"unprognostic (2.36e-2)"	"unprognostic (1.71e-2)"	"unprognostic (4.25e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.44e-1)"	"unprognostic (6.93e-2)"	"prognostic unfavorable (1.37e-8)"	"unprognostic (1.87e-3)"	"unprognostic (2.30e-1)"	"unprognostic (7.91e-2)"	"unprognostic (2.09e-3)"	1035.2	241.6	54.0	728.1	61.4	3.9	838.4	52.7	121.1	2000.3	61.4	2755.1	248.9	6678.8	1360.1	1509.9	3104.3	906.1	1069.2	53.4	54.6	312.2	161.8	732.8	173.7	59.0	55.9	798.0	91.4	80.6	60.8	771.3	55.3	2642.8	866.4	8.2	414.7	5920.3	202.1	355.7	701.6	8099.9	54.1	452.1	1427.1	263.9	56.1	56.5	312.0	214.0	48.4	3002.5	1367.0	52.9	3.9	19.0	49.3	102.7	198.1	390.6	9.5	109.8	136.8	11.9	45.4	0.0	8.8	7.2	11.5	641.1	8.6	1.4	1.8	25.4	11.3	60.6	11.3	0.4	5.6	119.3	625.8	0.8	3.2	345.1	44.9	73.9	28.5	743.4	11.3	3.0	0.0	7.1	128.8	10.8	1.0	28.3	2.5	0.2	1.2	1.4	0.2	4.6	27.1	5.0	0.7	7.6	10.2	7.9	1.0	296.8	32.4	1.0	27.9	24.0	4.0	30.2	9.3	21.1	1.6	0.6	29.6	10.2	26.1	28.1	12.3	17.5	17.6	8.7	13.8	6.0	14.1	19.8	10.8	1.8	1.5	10.7	11.1	4.0	14.2	0.4	58.7	10.7	54.0	61.4	52.7	121.1	53.4	54.6	59.0	55.9	55.3	54.1	56.1	52.9	65.4	9.6	6.1	5.5	4.4	43.2	23.4	16.5	22.8	1.1	22.7	1007.7	25.1	2.8	5.2	0.0	6.2	16.3	7.3	1.9	1.9	1.8	11.1	11.1	225.4	41.1	0.0	4.0	3.6	0.9	16.8	316.3	10.7	8.2	5.7	448.9	474.0	4.6	37.7	0.0	1.1	2.7	4.1	5.4	67.6	48.8	141.4	12.6	55.2	61.8	4.2	13.4	4.1	1.0	0.3	2.0	3.0	5290.7	3.7	17.5	3.4	9.5	10.9	1.4	3030.6	72.0	2394.6	4.0	13.8	11.1	40.5	23.7	16.5	36.0	5.7	10.4
ACTN4	FSGS1	ENSG00000130402	"Actinin alpha 4"	O43707	19	38647649-38731589	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Protein transport, Transport"	Actin-binding	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal enterocytes: 626.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"A549: 947.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001873, HPA006035"	Supported		Approved	"Nuclear bodies,Actin filaments,Cytosol"		NA	NA		71000000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 72: Non-specific - Transcription"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Nuclear bodies, Actin filaments"	Cytosol	"HPA001873: AB_1078096, HPA006035: AB_1078095"	"unprognostic (1.03e-1)"	"unprognostic (6.34e-2)"	"unprognostic (2.97e-2)"	"unprognostic (2.52e-2)"	"unprognostic (2.37e-1)"	"unprognostic (3.34e-2)"	"unprognostic (2.21e-2)"	"prognostic unfavorable (8.82e-4)"	"unprognostic (1.70e-1)"	"unprognostic (5.85e-3)"	"prognostic unfavorable (5.65e-4)"	"unprognostic (2.99e-1)"	"prognostic favorable (5.25e-5)"	"unprognostic (6.59e-2)"	"unprognostic (1.91e-1)"	"unprognostic (6.75e-3)"	"unprognostic (6.52e-2)"	176.5	160.8	22.9	63.9	42.0	74.2	151.4	42.9	42.2	165.2	58.5	168.5	128.7	269.4	11.8	232.8	163.2	46.8	89.0	19.5	27.8	166.7	85.0	174.7	37.5	45.9	42.4	102.5	90.6	42.2	80.0	85.7	44.8	115.6	42.2	26.0	148.1	59.0	52.2	183.4	150.3	73.1	30.2	118.1	120.9	23.6	38.1	18.5	105.4	18.8	24.2	150.2	181.3	63.4	364.6	947.0	92.9	48.6	37.7	50.6	237.2	198.7	162.5	178.8	143.9	335.9	265.1	99.0	409.1	260.6	117.4	185.1	57.4	203.8	38.3	238.3	69.5	139.7	356.1	240.4	103.4	101.7	145.2	95.3	63.4	157.5	79.6	146.9	116.4	26.3	165.0	71.8	127.5	221.2	27.2	44.1	78.4	197.8	177.3	89.5	109.4	43.8	174.6	396.3	83.0	49.8	366.3	210.5	94.7	64.0	94.5	78.8	309.7	249.3	138.7	135.3	476.1	44.1	84.5	67.8	231.7	90.6	476.7	7.6	8.1	17.8	13.2	7.7	9.8	3.2	5.7	13.2	7.0	3.0	0.9	4.4	16.9	24.8	6.7	10.8	9.5	10.6	22.9	42.0	42.9	42.2	19.5	27.8	45.9	42.4	44.8	30.2	38.1	63.4	315.2	179.5	120.0	21.5	45.8	234.8	266.4	155.1	153.7	25.6	134.0	148.1	9.2	143.0	119.4	152.6	14.6	123.7	150.7	626.1	19.6	413.5	2.5	272.0	145.7	206.2	162.0	59.3	46.0	419.3	256.7	77.3	219.7	346.4	73.5	75.9	130.6	108.5	72.6	23.5	22.6	365.5	73.2	65.9	103.7	4.5	41.3	75.4	46.2	48.7	162.2	122.4	120.5	35.2	83.6	532.3	425.2	71.5	91.2	322.1	315.5	104.0	122.1	32.3	190.7	97.2	251.0	36.2	23.7	189.3	202.7	168.0	119.4	115.3	280.6	284.7
ACTR8	"ARP8, INO80N"	ENSG00000113812	"Actin related protein 8"	Q9H981	3	53867066-53882152	"Predicted intracellular proteins"	"Cell cycle, Cell division, DNA damage, DNA recombination, DNA repair, Mitosis, Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 44.3;Late spermatids: 85.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 56.2"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA065236			Supported	Nucleoplasm,Centrosome		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm	Centrosome	"HPA065236: AB_2685442"	"unprognostic (9.05e-2)"	"unprognostic (2.06e-1)"	"prognostic favorable (2.21e-4)"	"unprognostic (2.97e-1)"	"unprognostic (5.67e-2)"	"unprognostic (1.88e-1)"	"prognostic unfavorable (5.11e-6)"	"unprognostic (2.24e-2)"	"unprognostic (4.68e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.82e-1)"	"unprognostic (5.68e-2)"	"prognostic favorable (7.88e-9)"	"unprognostic (3.68e-1)"	"unprognostic (3.35e-1)"	"unprognostic (2.84e-1)"	"unprognostic (1.15e-1)"	8.4	6.8	7.8	9.8	8.6	9.4	9.3	10.5	9.0	9.2	13.0	9.3	7.4	9.8	9.0	9.2	9.0	8.1	18.5	8.3	9.3	13.0	8.7	9.2	13.9	8.6	9.6	10.3	9.4	14.7	7.2	11.0	8.5	9.0	12.0	7.6	8.8	8.6	9.0	9.2	7.2	11.0	8.8	9.4	9.6	21.5	9.3	13.4	12.1	12.6	14.8	11.5	7.3	9.6	11.9	14.4	27.5	22.9	22.2	27.6	20.6	27.4	34.8	36.3	28.7	22.6	14.1	36.1	7.9	37.9	26.7	9.9	21.0	18.8	34.1	14.7	8.7	35.2	21.9	24.3	26.1	38.6	30.8	21.8	19.1	37.6	23.4	28.0	28.4	18.9	16.4	12.2	37.0	13.8	12.9	23.0	25.7	17.0	22.7	16.8	17.3	21.8	27.5	32.7	8.1	23.5	17.8	15.4	16.1	25.9	9.9	21.1	19.7	27.5	17.8	25.6	25.2	33.9	46.4	36.3	20.4	27.7	17.6	56.2	8.2	10.5	9.2	12.0	9.2	9.8	8.5	8.8	10.7	6.1	8.9	9.6	4.3	15.1	7.4	7.8	15.0	8.0	7.8	8.6	10.5	9.0	8.3	9.3	8.6	9.6	8.5	8.8	9.3	9.6	6.3	3.2	7.7	6.5	9.4	7.8	6.0	12.3	5.7	6.8	5.4	5.1	19.5	10.0	8.6	3.7	4.2	12.7	11.6	5.7	21.5	15.1	44.3	5.9	12.0	8.8	10.8	7.8	7.1	15.6	11.3	7.8	12.2	7.6	5.7	10.9	8.2	5.4	11.5	1.7	8.5	10.6	12.2	7.6	6.9	85.9	10.8	10.0	5.4	4.7	11.9	7.6	13.4	8.0	6.2	15.5	3.5	9.8	13.6	6.3	5.9	24.1	5.0	5.3	0.0	5.5	20.8	27.6	20.3	7.3	6.5	10.3	11.5	13.5	6.3	6.5
ADA	ADA1	ENSG00000196839	"Adenosine deaminase"	P00813	20	44619522-44652233	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Cell adhesion, Nucleotide metabolism"	Hydrolase	"Disease variant, FDA approved drug targets, Hereditary hemolytic anemia, SCID"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	8	"intestine: 507.2;lymphoid tissue: 259.0"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 76.4;Extravillous trophoblasts: 128.2;NK-cells: 56.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"intermediate monocyte: 168.5;NK-cell: 94.5;non-classical monocyte: 362.8;plasmacytoid DC: 218.6"	"Group enriched"	"Detected in all"	4	"dendritic cells: 218.6;monocytes: 362.8;NK-cells: 94.5"	"Group enriched"	"Detected in many"	5	"JURKAT: 570.9;MOLT-4: 1915.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA001399, CAB004307, HPA023884"	Enhanced		Supported	"Plasma membrane,Cytosol"		No	No		470000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 9: Intestine - Unknown function"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 38: Extravillous trophoblasts - Unknown function"	"Plasma membrane"	Cytosol	"CAB004307: AB_626634, HPA001399: AB_1078099, HPA023884: AB_1844573"	"unprognostic (4.30e-2)"	"unprognostic (6.89e-2)"	"unprognostic (3.96e-2)"	"prognostic unfavorable (1.23e-7)"	"unprognostic (9.33e-2)"	"unprognostic (9.07e-3)"	"prognostic unfavorable (6.77e-5)"	"prognostic unfavorable (2.20e-4)"	"unprognostic (1.59e-1)"	"unprognostic (2.16e-1)"	"unprognostic (3.66e-2)"	"unprognostic (3.48e-1)"	"prognostic unfavorable (2.94e-14)"	"unprognostic (2.29e-1)"	"unprognostic (1.04e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.82e-1)"	16.6	6.3	6.9	18.5	8.2	20.2	10.9	6.8	9.4	7.3	5.6	5.7	507.2	3.8	1.7	9.0	5.6	9.2	17.8	6.9	7.0	3.3	4.4	6.2	33.4	7.2	8.2	2.1	5.3	1.5	1.3	4.6	7.2	4.3	3.6	0.3	4.7	2.8	5.3	6.0	17.9	5.7	6.1	17.5	46.0	2.4	8.7	259.0	5.8	6.4	26.4	9.3	5.4	8.8	14.0	37.7	19.2	13.2	35.6	48.7	30.5	13.7	7.8	13.2	9.3	17.5	14.8	38.4	15.8	17.9	24.7	2.2	13.2	55.1	7.3	2.9	17.2	7.8	6.6	13.5	15.0	6.3	20.3	234.3	23.2	5.1	9.0	12.6	50.3	570.9	20.4	30.7	6.0	33.1	1915.5	28.9	5.2	17.2	13.5	102.3	25.8	95.0	2.3	0.0	0.7	9.3	20.2	4.4	24.2	24.0	4.5	19.1	16.9	10.1	18.6	20.5	2.8	40.1	27.3	82.3	3.5	32.5	9.0	0.5	9.8	1.2	43.3	168.5	27.8	7.5	35.5	51.0	35.2	7.6	27.3	38.6	2.5	94.5	362.8	218.6	29.8	57.4	6.9	8.2	6.8	9.4	6.9	7.0	7.2	8.2	7.2	6.1	8.7	8.8	18.2	0.0	1.9	2.9	13.5	12.9	3.4	10.0	13.6	0.0	2.7	3.2	2.1	0.0	4.8	1.8	0.0	2.9	76.4	0.8	0.0	3.7	0.4	0.7	9.1	17.0	0.0	10.7	0.2	19.7	128.2	19.7	14.8	0.8	0.0	3.5	7.1	3.6	28.5	0.0	0.2	1.5	10.2	20.8	25.5	1.8	42.3	27.6	8.8	3.7	37.4	3.8	56.7	0.5	9.4	10.7	0.3	2.6	31.4	6.0	0.7	3.0	2.4	0.0	13.1	1.9	14.1	0.3	6.2	12.9	13.9	3.7	30.9	6.8	4.9	2.7
ADAM10	"CD156C, HsT18717, kuz, MADM"	ENSG00000137845	"ADAM metallopeptidase domain 10"	O14672	15	58588809-58749791	"Cancer-related genes, CD markers, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Notch signaling pathway"	"Hydrolase, Metalloprotease, Protease"	"Alzheimer disease, Amyloidosis, Cancer-related genes, Disease variant, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 377.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-2197: 296.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB001709, HPA050670"	Approved		Supported	"Vesicles,Plasma membrane"	"Intracellular and membrane"	NA	NA		690000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 18: U-2197 - ECM organization"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Vesicles, Plasma membrane"		"CAB001709: , HPA050670: "	"unprognostic (1.43e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.77e-1)"	"unprognostic (5.04e-2)"	"unprognostic (3.09e-1)"	"unprognostic (2.70e-3)"	"unprognostic (7.48e-2)"	"prognostic unfavorable (8.46e-5)"	"unprognostic (3.99e-2)"	"unprognostic (1.19e-1)"	"prognostic unfavorable (1.90e-4)"	"unprognostic (6.69e-2)"	"unprognostic (2.57e-2)"	"unprognostic (2.57e-3)"	"unprognostic (9.14e-2)"	"unprognostic (2.09e-2)"	"unprognostic (1.60e-2)"	14.9	8.7	11.4	19.0	18.6	18.7	15.2	20.2	15.0	16.0	9.7	22.2	15.9	16.3	7.7	15.4	13.9	18.9	12.1	12.2	12.7	18.0	16.1	21.0	22.2	18.2	17.6	14.1	8.8	7.9	8.2	29.0	17.5	25.2	17.2	10.8	9.3	12.2	6.1	16.9	17.5	13.3	13.7	29.0	20.3	8.5	15.5	42.7	28.6	7.1	16.4	28.0	10.4	25.2	48.4	88.5	27.6	31.2	34.8	49.8	70.0	39.0	116.0	28.6	39.1	39.9	62.6	22.7	118.0	35.2	49.2	95.9	16.8	43.5	37.0	30.1	19.3	38.7	35.1	42.1	40.8	25.0	103.8	44.4	30.0	19.9	29.2	41.1	55.6	45.0	24.5	57.9	50.4	15.4	89.5	32.0	40.2	15.4	14.6	36.4	91.6	57.1	66.6	121.4	29.9	20.3	44.0	52.8	73.1	60.0	30.4	55.0	41.4	37.1	41.2	296.6	39.6	30.7	70.7	23.5	54.1	50.8	67.3	30.9	36.2	19.2	12.8	41.1	19.2	8.3	12.7	11.6	23.6	9.6	12.7	10.8	51.5	17.7	48.6	10.2	18.2	25.8	11.4	18.6	20.2	15.0	12.2	12.7	18.2	17.6	17.5	13.7	15.5	25.2	60.1	83.3	50.8	83.2	37.9	26.6	30.7	33.3	33.0	22.7	61.6	30.9	40.0	30.0	46.7	80.9	27.1	35.6	69.4	79.0	1.9	56.0	21.2	39.5	56.4	72.5	36.1	20.8	106.1	31.8	57.8	36.1	53.0	74.0	30.3	31.5	71.4	36.2	63.8	45.4	96.2	43.6	36.7	90.1	28.9	19.4	18.0	77.9	46.2	147.1	69.0	30.6	44.3	75.9	377.6	48.9	48.1	17.0	51.0	89.1	45.1	23.7	41.2	33.4	13.1	34.4	42.8	20.3	17.8	39.5	22.3	26.5	51.3	34.1	39.5	83.9
ADAM12	"MCMPMltna, MLTN"	ENSG00000148848	"ADAM metallopeptidase domain 12"	O43184	10	126012381-126388455	"Predicted membrane proteins, Predicted secreted proteins, Transporters"	"Cell adhesion"	"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"placenta: 166.5"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 102.2;Extravillous trophoblasts: 400.8;Oligodendrocyte precursor cells: 99.0;Syncytiotrophoblasts: 129.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	5	"MAIT T-cell: 6.1"	"Lineage enriched"	"Detected in single"	62	"T-cells: 6.1"	"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 154.2;hTEC/SVTERT24-B: 94.3;U-2197: 93.2;U-251 MG: 86.2;U-87 MG: 70.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA030866, HPA030867, HPA030868"	Enhanced		Supported	"Plasma membrane"	"Secreted in female reproductive system"	NA	NA		14000000	"Cluster 16: MAIT-cells - Unknown function"	"Cluster 28: Placenta - Pregnancy"	"Cluster 18: U-2197 - ECM organization"	"Cluster 38: Extravillous trophoblasts - Unknown function"	"Plasma membrane"		"HPA030866: AB_2673636, HPA030867: AB_10602428, HPA030868: AB_2673638"	"unprognostic (3.35e-1)"	"unprognostic (1.05e-3)"	"unprognostic (3.52e-2)"	"unprognostic (2.47e-2)"	"unprognostic (3.34e-2)"	"unprognostic (2.16e-1)"	"unprognostic (2.91e-6)"	"unprognostic (2.17e-2)"	"unprognostic (4.85e-2)"	"unprognostic (1.30e-2)"	"unprognostic (2.53e-2)"	"unprognostic (1.09e-1)"	"prognostic unfavorable (2.39e-14)"	"unprognostic (3.11e-3)"	"unprognostic (9.06e-3)"	"unprognostic (4.70e-3)"	"unprognostic (3.47e-3)"	11.4	0.1	2.0	6.0	4.0	0.1	4.6	1.6	2.1	18.2	3.5	0.4	0.2	6.3	0.0	0.4	0.2	11.8	0.7	1.0	2.5	1.0	0.2	1.3	3.2	6.0	2.7	8.8	0.5	0.1	1.1	166.5	3.1	0.3	0.6	0.3	1.1	0.0	0.1	0.4	0.5	4.3	1.8	1.6	0.5	0.9	10.4	1.8	0.3	0.0	3.5	11.6	0.5	3.0	16.8	2.5	6.5	0.1	18.7	38.3	0.0	42.7	3.5	14.2	35.5	0.0	0.0	0.0	0.0	154.2	30.0	0.0	0.2	1.4	15.5	1.9	0.6	0.2	25.1	0.0	2.9	0.0	33.2	47.0	0.0	94.3	2.9	27.1	0.0	0.0	0.0	0.2	11.8	0.0	0.0	0.0	0.1	0.0	2.8	0.0	4.8	4.4	0.4	44.1	0.5	28.4	5.0	0.0	0.7	2.5	0.1	0.1	0.0	50.9	16.9	93.2	86.2	0.0	0.5	0.0	70.7	0.1	32.3	0.0	0.0	0.0	0.3	0.0	6.1	0.0	0.2	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.1	2.0	4.0	1.6	2.1	1.0	2.5	6.0	2.7	3.1	1.8	10.4	3.0	0.5	0.0	1.9	22.5	0.3	1.5	0.4	3.0	0.0	2.1	1.7	3.6	2.3	0.0	0.5	0.0	102.2	14.0	0.5	0.7	0.0	8.0	10.9	10.7	16.6	1.6	0.0	0.0	7.4	1.1	400.8	34.5	0.5	1.8	49.5	7.8	2.5	0.2	15.5	6.7	19.0	1.0	4.1	0.6	3.1	1.7	16.8	0.8	1.8	14.0	9.0	3.3	1.0	99.0	52.2	2.2	0.1	0.7	0.3	1.0	0.7	0.4	6.5	30.5	0.0	5.1	13.4	6.0	5.0	0.0	0.6	129.2	4.7	28.1	0.9	0.5
ADAM17	"CD156B, cSVP, TACE"	ENSG00000151694	"ADAM metallopeptidase domain 17"	P78536	2	9488486-9556732	"CD markers, Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Notch signaling pathway"	"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Suprabasal keratinocytes: 154.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010738, HPA051575"	Approved		Supported	Cytosol		NA	NA		300000	"Cluster 7: Monocytes - Unknown function"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 41: Macrophages - Immune response"	Cytosol		"HPA010738: AB_1078100, HPA051575: AB_2681539"	"unprognostic (2.28e-1)"	"unprognostic (1.29e-3)"	"unprognostic (1.28e-1)"	"unprognostic (3.51e-3)"	"unprognostic (1.57e-1)"	"unprognostic (5.15e-2)"	"unprognostic (2.12e-3)"	"unprognostic (1.55e-1)"	"unprognostic (4.09e-2)"	"unprognostic (3.69e-1)"	"unprognostic (3.53e-3)"	"unprognostic (3.13e-1)"	"unprognostic (3.82e-3)"	"unprognostic (8.63e-2)"	"unprognostic (2.61e-1)"	"unprognostic (4.48e-2)"	"prognostic unfavorable (4.23e-5)"	10.3	5.5	8.7	9.1	8.6	5.8	10.4	7.8	10.6	8.7	9.5	5.4	4.1	7.2	11.4	10.0	6.5	9.0	6.7	8.6	9.4	4.7	4.6	14.6	8.5	9.7	8.3	8.9	4.1	7.9	4.2	20.1	9.4	4.0	6.8	4.5	6.2	6.3	6.9	11.1	6.1	8.6	8.3	9.3	5.1	9.9	9.1	9.6	6.6	6.8	12.7	10.4	7.1	10.4	10.0	18.2	23.2	25.9	45.9	34.7	45.4	8.6	25.4	16.1	24.6	19.2	31.6	33.4	18.1	18.8	42.1	21.9	16.4	29.4	22.6	8.4	12.1	15.8	14.7	13.9	68.0	20.7	17.8	41.2	32.2	25.1	47.5	26.6	46.0	8.7	30.0	12.3	17.3	8.7	8.5	23.4	19.2	13.7	4.6	14.3	21.6	20.5	25.8	18.7	11.7	28.6	14.9	16.5	30.1	27.0	6.6	19.4	29.0	25.5	12.0	19.1	22.1	15.1	17.5	29.6	20.2	11.1	31.1	5.0	3.7	2.8	1.0	3.7	1.9	1.7	0.9	1.1	2.3	0.9	0.9	1.0	5.5	1.2	2.5	0.7	1.1	0.9	8.7	8.6	7.8	10.6	8.6	9.4	9.7	8.3	9.4	8.3	9.1	10.4	53.8	48.1	66.9	19.6	34.5	130.0	48.2	37.0	19.9	25.2	40.8	26.4	3.6	27.1	38.8	31.3	54.2	29.8	37.7	20.7	5.9	23.7	72.1	30.0	32.0	45.1	19.7	16.8	66.7	19.4	45.1	44.1	13.7	51.5	30.9	31.3	41.4	13.5	34.6	10.1	46.2	13.8	12.2	80.4	84.5	16.0	19.0	76.9	40.9	42.2	40.3	12.9	16.5	26.7	41.5	20.9	18.3	16.1	23.2	57.2	12.9	7.0	37.2	41.4	39.5	79.4	27.3	35.7	35.2	33.7	154.7	56.0	30.1	17.7	15.4	104.3
ADAM28	"ADAM23, eMDCII, MDC-Lm, MDC-Ls"	ENSG00000042980	"ADAM metallopeptidase domain 28"	Q9UKQ2	8	24294069-24359014	"Plasma proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters"		"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"epididymis: 357.5;stomach 1: 110.3"	"Cell type enhanced"	"Detected in many"		"B-cells: 240.9;Club cells: 62.9;Gastric mucus-secreting cells: 141.7;Microglial cells: 233.3"	"Cancer enhanced"	"Detected in many"		"pancreatic cancer: 9.9"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"memory B-cell: 71.6;naive B-cell: 87.0"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"CAPAN-2: 27.8;OE19: 8.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA074034	Enhanced		Approved	"Plasma membrane,Mitochondria"	"Secreted to blood"	NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 30: Epididymis - Antimicrobial activity"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 57: B-cells - Immune response"	"Plasma membrane"	Mitochondria	"HPA074034: AB_2686654"	"unprognostic (4.23e-2)"	"unprognostic (1.01e-2)"	"unprognostic (2.06e-2)"	"prognostic favorable (3.17e-4)"	"unprognostic (2.89e-1)"	"unprognostic (2.55e-2)"	"unprognostic (5.59e-2)"	"unprognostic (1.53e-1)"	"unprognostic (4.71e-1)"	"unprognostic (1.35e-2)"	"unprognostic (3.77e-3)"	"unprognostic (7.77e-2)"	"unprognostic (3.97e-3)"	"unprognostic (1.71e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.60e-1)"	"unprognostic (1.62e-1)"	2.2	2.2	5.9	24.7	4.6	9.3	3.9	7.1	5.0	16.1	4.0	14.3	8.8	6.9	357.5	2.8	12.3	40.2	1.0	5.8	8.8	5.1	1.2	3.9	26.7	12.0	9.3	2.3	3.5	1.1	18.5	3.7	11.7	5.3	12.1	1.3	15.9	5.7	0.3	3.3	24.7	2.9	9.8	19.9	110.3	0.7	10.1	5.1	1.9	0.4	32.3	11.3	1.7	18.6	0.0	0.4	0.1	0.0	0.0	0.4	0.1	0.1	0.2	0.0	0.0	1.1	27.8	0.3	0.8	0.0	0.9	0.1	0.0	0.8	0.1	0.1	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.2	3.7	0.7	8.8	0.1	0.1	0.0	0.4	0.6	0.8	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.1	0.0	0.5	0.3	0.1	0.1	1.2	2.5	0.1	2.1	1.0	0.2	42.4	2.5	18.5	0.0	0.6	0.0	71.6	0.1	0.0	21.0	87.0	0.1	0.0	4.3	2.7	0.2	1.1	0.1	2.5	5.9	4.6	7.1	5.0	5.8	8.8	12.0	9.3	11.7	9.8	10.1	18.6	1.5	3.2	6.0	0.7	240.9	0.9	3.0	36.9	0.0	0.1	2.3	2.2	2.0	28.6	62.9	3.7	0.0	0.4	9.9	0.7	0.0	7.9	1.3	7.6	1.0	3.7	0.0	8.2	4.3	3.5	8.7	3.9	141.7	18.4	2.5	0.0	0.0	0.0	9.4	0.0	2.7	0.4	28.5	12.3	30.9	1.8	0.6	46.4	5.4	233.3	7.8	0.1	23.7	3.5	1.6	55.7	0.1	0.4	43.3	1.5	0.6	4.4	13.1	0.1	6.6	0.0	1.1	0.4	0.2	0.7	0.6	0.5	9.0	6.4	1.3	7.6
ADAMTS4	"ADAMTS-2, ADMP-1, KIAA0688"	ENSG00000158859	"ADAM metallopeptidase with thrombospondin type 1 motif 4"	O75173	1	161184302-161199054	"Cancer-related genes, Enzymes, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters"		"Hydrolase, Metalloprotease, Protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 116.8;ovary: 95.9"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 80.3;Endothelial cells: 115.5;Fibroblasts: 88.8;Oligodendrocytes: 56.0;Sertoli cells: 52.6;Smooth muscle cells: 313.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	8	"plasmacytoid DC: 4.4"	"Lineage enriched"	"Detected in single"	8	"dendritic cells: 4.4"	"Cell line enhanced"	"Detected in some"		"hTEC/SVTERT24-B: 11.8;HUVEC TERT2: 14.4;SH-SY5Y: 7.9;TIME: 12.2;U-138 MG: 7.4;U-251 MG: 10.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB025876, HPA051296, HPA068374"	Uncertain		Supported	"Nuclear speckles"	"Secreted to extracellular matrix"	NA	NA		11000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 48: Smooth muscle cells - ECM organization"	"Nuclear speckles"		"CAB025876: , HPA051296: AB_2681426, HPA068374: AB_2685978"	"unprognostic (2.70e-2)"	"unprognostic (8.10e-3)"	"unprognostic (3.00e-3)"	"unprognostic (2.75e-1)"	"unprognostic (9.95e-3)"	"unprognostic (1.19e-1)"	"unprognostic (1.07e-1)"	"prognostic unfavorable (5.00e-4)"	"unprognostic (1.20e-2)"	"unprognostic (9.59e-3)"	"unprognostic (2.48e-2)"	"unprognostic (1.59e-1)"	"prognostic unfavorable (7.27e-7)"	"unprognostic (1.10e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.44e-3)"	"unprognostic (3.13e-2)"	116.8	9.8	6.1	16.3	31.5	0.7	43.4	31.1	19.2	16.4	5.8	18.2	0.8	15.0	0.2	6.2	34.6	14.3	53.6	8.1	15.2	26.0	8.7	50.3	1.6	38.2	29.6	95.9	9.0	2.1	13.0	3.2	31.6	16.9	2.0	1.5	5.2	0.5	13.3	5.0	9.4	10.5	28.3	1.8	22.8	1.8	26.2	1.1	21.3	0.4	0.3	31.8	12.2	48.0	0.0	0.0	0.2	0.1	6.4	4.0	0.6	5.4	0.2	0.5	3.0	0.2	0.2	0.2	4.4	1.7	0.0	0.1	0.0	0.0	1.9	0.1	0.3	0.2	0.5	1.3	0.6	0.0	0.1	4.5	0.0	11.8	0.1	0.0	14.4	0.1	0.2	0.3	0.4	0.1	0.0	0.2	5.3	0.0	0.0	0.1	5.1	0.1	0.0	0.1	0.1	7.9	0.0	0.1	0.1	0.3	0.2	0.5	12.2	7.4	0.1	0.4	10.8	0.2	0.1	0.1	2.2	0.1	0.1	0.5	0.1	0.1	0.2	0.0	0.1	0.1	0.1	0.1	0.0	0.2	0.1	0.1	0.4	0.2	0.0	4.4	0.2	0.1	6.1	31.5	31.1	19.2	8.1	15.2	38.2	29.6	31.6	28.3	26.2	48.0	80.3	0.0	4.1	0.0	0.2	31.2	3.2	0.0	2.2	2.2	8.6	5.5	5.5	0.0	0.6	0.0	0.0	0.3	0.5	0.2	0.0	0.3	0.0	0.3	13.0	115.5	0.0	0.0	0.4	0.0	0.3	88.8	0.5	0.5	0.0	0.3	43.2	0.9	1.0	3.3	0.1	0.0	0.0	1.0	32.6	0.2	0.3	3.2	35.6	2.8	1.0	0.5	0.0	0.0	56.0	0.0	0.0	1.2	0.7	9.8	0.0	0.1	0.0	1.0	52.6	21.2	313.7	2.7	0.6	2.7	19.0	0.4	3.7	1.6	0.3	7.7
ADAMTS5	"ADAMTS11, ADMP-2"	ENSG00000154736	"ADAM metallopeptidase with thrombospondin type 1 motif 5"	Q9UNA0	21	26917922-26967088	"Cancer-related genes, Predicted secreted proteins"		"Hydrolase, Metalloprotease, Protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 26.2"	"Cell type enhanced"	"Detected in many"		"Breast myoepithelial cells: 38.2;Endometrial stromal cells: 72.1;Fibroblasts: 88.6;Leydig cells: 62.7;Skeletal myocytes: 110.2;Smooth muscle cells: 44.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 31.6;ASC TERT1: 13.9;fHDF/TERT166: 11.9;RH-30: 33.1;U-87 MG: 13.0"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			"HPA005661, CAB025996, HPA030906, HPA030908"	Approved		Supported	Nucleoplasm	"Secreted to extracellular matrix"	NA	NA		28000		"Cluster 5: Breast - Unknown function"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	Nucleoplasm		"CAB025996: , HPA005661: AB_1078101, HPA030906: AB_2673654, HPA030908: AB_2673655"	"unprognostic (1.97e-1)"	"unprognostic (2.88e-3)"	"unprognostic (2.69e-2)"	"unprognostic (4.01e-2)"	"unprognostic (4.67e-1)"	"unprognostic (2.10e-2)"	"unprognostic (4.38e-8)"	"unprognostic (1.11e-3)"	"unprognostic (7.66e-2)"	"unprognostic (6.17e-2)"	"unprognostic (8.13e-2)"	"unprognostic (7.76e-2)"	"prognostic unfavorable (2.46e-4)"	"unprognostic (6.69e-3)"	"unprognostic (3.01e-1)"	"prognostic unfavorable (8.54e-4)"	"unprognostic (1.15e-1)"	17.5	0.8	0.3	1.0	0.6	0.0	10.8	3.3	0.3	8.8	2.6	2.7	0.8	12.5	2.4	1.6	4.2	1.6	3.3	0.5	0.9	2.5	1.4	1.0	0.6	1.4	0.9	16.6	0.4	1.5	0.4	26.2	0.9	3.0	1.3	0.6	2.0	1.8	2.0	4.2	3.4	7.5	1.5	7.7	2.2	0.8	0.4	0.3	6.8	3.7	0.1	4.2	3.6	1.2	0.0	0.0	0.0	0.0	31.6	13.9	0.0	1.7	0.2	1.4	0.6	0.0	0.0	0.0	0.0	11.9	0.0	0.0	0.0	0.0	2.3	0.0	1.3	0.0	0.3	0.0	3.5	0.1	0.0	8.0	0.0	1.1	0.2	0.2	0.0	0.0	0.0	0.0	7.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	33.1	0.0	3.4	0.0	0.0	0.7	0.0	0.0	0.0	0.4	0.0	0.0	0.0	8.3	0.4	1.9	0.9	0.0	0.0	0.0	13.0	0.1	1.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.6	3.3	0.3	0.5	0.9	1.4	0.9	0.9	1.5	0.4	1.2	24.3	0.0	0.5	0.3	0.1	2.9	0.2	0.4	0.0	9.8	1.5	38.2	2.7	0.0	0.6	3.7	0.0	1.1	0.3	0.0	0.0	0.0	6.4	2.0	72.1	10.6	1.8	0.0	0.5	0.2	1.6	88.6	0.0	1.3	0.0	3.0	3.3	0.0	1.9	0.0	11.6	0.0	0.0	0.0	4.6	1.0	62.7	1.4	3.6	3.7	4.0	0.1	0.0	12.5	0.2	0.0	0.0	9.1	0.0	0.3	0.0	2.2	0.0	0.2	13.1	110.2	44.9	0.3	0.9	0.4	3.0	2.7	0.8	20.0	0.0	0.1
ADAMTS7	"ADAM-TS7, DKFZp434H204"	ENSG00000136378	"ADAM metallopeptidase with thrombospondin type 1 motif 7"	Q9UKP4	15	78759206-78811464	"Plasma proteins, Predicted secreted proteins"		"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"heart muscle: 30.6"	"Cell type enriched"	"Detected in some"	4	"Theca cells: 44.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in many"	9	"HMC-1: 259.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"HPA045284, HPA048453"	Uncertain		Supported	Vesicles	"Secreted to extracellular matrix"	NA	NA				"Cluster 46: Fibroblasts - ECM organization"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 52: Non-specific - Transcription"	Vesicles		"HPA045284: AB_2679285, HPA048453: AB_2680399"	"unprognostic (5.94e-3)"	"unprognostic (9.94e-3)"	"unprognostic (2.76e-2)"	"unprognostic (7.09e-2)"	"unprognostic (3.38e-1)"	"unprognostic (1.93e-1)"	"unprognostic (5.88e-4)"	"unprognostic (3.34e-3)"	"unprognostic (2.89e-2)"	"unprognostic (3.31e-2)"	"unprognostic (1.83e-2)"	"unprognostic (3.79e-1)"	"unprognostic (1.34e-2)"	"prognostic unfavorable (9.53e-4)"	"unprognostic (1.59e-1)"	"unprognostic (2.66e-2)"	"unprognostic (8.86e-2)"	6.6	5.3	0.5	1.8	0.4	0.1	3.8	0.3	0.5	6.0	0.6	4.2	1.1	7.2	0.1	0.9	2.2	2.3	30.6	0.4	0.5	2.2	1.1	6.3	0.9	0.5	0.5	6.1	0.5	0.4	0.8	2.1	0.4	1.8	0.2	0.5	1.3	0.4	1.1	1.8	2.6	1.4	0.2	5.2	2.2	4.1	0.7	0.1	2.1	0.5	0.2	3.0	2.5	0.6	0.0	1.1	16.5	7.5	6.9	8.2	20.9	3.7	1.3	1.0	0.6	0.0	0.1	0.0	4.8	0.4	1.0	0.4	0.4	2.0	0.0	0.3	0.6	2.1	0.5	0.1	6.9	0.0	259.9	3.3	2.0	1.9	1.0	5.3	24.0	0.0	0.3	0.7	5.6	0.0	0.1	4.9	4.7	0.0	1.4	17.3	7.7	0.3	0.5	0.9	0.3	23.9	4.8	0.0	0.6	4.0	3.2	0.4	29.8	9.4	1.0	3.3	0.0	0.1	0.0	0.0	1.6	0.1	6.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.4	0.3	0.5	0.4	0.5	0.5	0.5	0.4	0.2	0.7	0.6	7.5	0.0	0.0	3.6	0.3	0.4	0.2	0.7	0.0	0.3	0.1	0.5	9.8	0.0	0.3	0.0	0.0	0.3	0.2	0.1	0.0	0.1	4.9	0.8	7.5	10.5	0.0	0.0	0.1	0.0	0.3	10.1	0.5	0.9	3.8	7.2	2.9	0.3	0.7	0.0	0.2	0.0	2.0	0.0	0.8	2.7	1.5	0.1	1.8	1.0	0.1	1.3	0.0	9.5	1.4	0.3	0.0	1.9	0.0	0.3	0.0	0.1	0.3	0.1	0.0	3.7	5.0	2.6	2.0	0.2	0.1	0.3	0.5	44.9	0.1	0.3
ADAMTS9	KIAA1312	ENSG00000163638	"ADAM metallopeptidase with thrombospondin type 1 motif 9"	Q9P2N4	3	64515654-64688000	"Cancer-related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"ER-Golgi transport, Protein transport, Transport"	"Hydrolase, Metalloprotease, Protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 41.2"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 166.3;Astrocytes: 84.2;Basal prostatic cells: 87.2;Endometrial stromal cells: 179.1;Endothelial cells: 221.0;Prostatic glandular cells: 115.7;Smooth muscle cells: 94.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HUVEC TERT2: 23.6;RPTEC TERT1: 27.1;SH-SY5Y: 128.3;SuSa: 40.5;WM-115: 28.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA028567, HPA028577, HPA028601"	Approved		Approved	"Endoplasmic reticulum,Vesicles"	"Secreted to extracellular matrix"	No	NA				"Cluster 82: Adipose tissue - ECM organization"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 48: Smooth muscle cells - ECM organization"	Vesicles	"Endoplasmic reticulum"	"HPA028567: AB_10599275, HPA028577: AB_10600330, HPA028601: AB_2672694"	"unprognostic (2.21e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.41e-1)"	"unprognostic (4.83e-2)"	"unprognostic (3.08e-1)"	"unprognostic (1.37e-2)"	"unprognostic (7.80e-3)"	"unprognostic (5.85e-2)"	"unprognostic (2.77e-1)"	"unprognostic (2.64e-1)"	"unprognostic (1.11e-1)"	"unprognostic (7.67e-2)"	"unprognostic (3.16e-3)"	"unprognostic (1.46e-2)"	"unprognostic (3.01e-1)"	"unprognostic (1.98e-3)"	"unprognostic (5.00e-3)"	41.2	4.8	4.0	12.2	5.0	0.1	19.0	5.5	5.3	16.2	7.9	8.1	1.2	13.2	1.1	5.3	10.2	7.8	15.6	4.4	5.6	9.5	2.7	13.6	1.9	10.8	8.1	7.3	9.8	6.3	2.2	31.7	8.5	7.9	2.7	1.4	3.2	3.7	7.4	2.6	3.7	12.1	8.0	4.1	4.7	0.8	8.1	1.0	7.3	7.3	1.1	22.5	9.0	6.4	0.0	1.2	13.9	0.0	0.6	0.1	1.3	0.2	0.0	0.0	0.0	1.9	0.0	0.0	2.3	0.3	0.4	0.0	1.5	0.0	0.0	0.0	0.7	0.0	0.0	0.0	1.9	0.0	8.8	2.6	0.0	0.0	0.5	0.0	23.6	0.0	0.5	0.0	0.3	0.1	0.0	0.0	7.5	1.1	0.0	0.0	2.4	0.1	27.1	0.3	0.1	128.3	0.0	0.0	0.0	40.5	0.0	0.7	5.4	0.8	0.4	0.0	0.8	0.0	0.0	0.0	0.5	0.0	28.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	5.0	5.5	5.3	4.4	5.6	10.8	8.1	8.5	8.0	8.1	6.4	166.3	3.2	4.8	84.2	0.0	17.5	87.2	0.0	4.6	0.0	6.9	15.9	6.6	2.8	2.6	38.6	2.1	1.0	0.2	1.1	0.0	69.7	0.9	13.2	179.1	221.0	1.2	0.0	4.2	3.3	0.6	31.4	1.5	33.8	0.0	8.4	27.1	0.3	7.5	0.0	14.3	1.1	0.0	0.3	20.1	0.4	2.5	2.7	26.6	21.5	0.0	0.2	0.0	26.7	0.6	45.5	1.0	2.2	0.0	115.7	0.0	10.8	0.1	0.1	0.0	20.7	94.8	0.3	0.7	1.3	13.5	1.6	3.2	12.1	0.9	36.7
ADAP1	"CENTA1, GCS1L"	ENSG00000105963	"ArfGAP with dual PH domains 1"	O75689	7	897900-955407	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 85.9;intestine: 43.2"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 97.7;Intestinal goblet cells: 42.5;Oligodendrocytes: 43.6;Paneth cells: 64.4;Proximal enterocytes: 48.5;Undifferentiated cells: 50.6"	"Cancer enhanced"	"Detected in all"		"colorectal cancer: 15.1"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"A-431: 108.1;CAPAN-2: 74.1;HMC-1: 71.0;OE19: 191.5;THP-1: 122.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007033, HPA012049"	Enhanced		Supported	"Plasma membrane,Cytosol"		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 45: Intestine - Brush border"	"Cluster 21: OE19 - Mitochondria"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Plasma membrane, Cytosol"		"HPA007033: AB_1846529, HPA012049: AB_1846527"	"unprognostic (2.45e-1)"	"unprognostic (7.15e-2)"	"prognostic unfavorable (5.25e-4)"	"unprognostic (4.41e-2)"	"unprognostic (1.97e-1)"	"prognostic unfavorable (9.13e-4)"	"unprognostic (3.06e-1)"	"unprognostic (9.10e-3)"	"unprognostic (1.70e-2)"	"unprognostic (1.38e-1)"	"unprognostic (5.74e-2)"	"unprognostic (1.69e-1)"	"prognostic favorable (4.13e-5)"	"unprognostic (5.88e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.79e-2)"	4.9	3.8	51.2	11.2	55.8	9.8	3.4	57.3	73.6	4.1	11.2	43.2	19.7	6.0	0.6	9.0	8.8	6.0	8.1	59.4	42.9	22.3	3.6	10.4	3.8	63.5	63.1	1.5	13.3	6.1	4.7	2.7	56.9	6.6	22.8	1.6	4.6	2.9	0.7	3.9	26.8	8.3	48.7	17.2	19.6	1.1	55.4	0.9	7.6	0.5	2.1	8.9	3.8	85.9	108.1	4.0	0.1	3.7	1.4	0.2	1.1	3.6	0.1	0.7	0.1	43.1	74.1	0.2	10.3	0.5	0.2	44.5	5.9	8.1	0.5	0.6	4.7	0.0	6.0	25.4	1.7	0.7	71.0	1.8	21.4	0.2	0.0	0.1	0.0	3.1	0.4	0.0	0.0	33.2	0.1	30.1	3.2	191.5	0.0	14.4	0.2	0.4	4.7	25.0	3.1	1.0	3.3	1.3	0.5	0.4	25.9	122.6	0.6	0.8	2.8	0.1	0.3	0.0	0.2	0.0	0.2	22.3	3.3	1.0	6.5	3.3	6.0	7.3	2.8	1.1	1.6	5.5	5.1	0.9	0.5	2.6	3.1	1.6	11.7	0.3	0.8	4.0	51.2	55.8	57.3	73.6	59.4	42.9	63.5	63.1	56.9	48.7	55.4	85.9	0.4	0.0	10.3	2.9	3.6	1.0	2.9	3.3	2.8	4.7	2.5	1.5	8.5	7.2	2.9	7.3	0.0	0.3	19.4	97.7	9.8	3.9	0.2	8.6	0.9	0.5	16.2	0.0	13.2	4.6	0.9	1.5	17.9	7.6	7.0	1.3	0.0	0.6	12.2	0.0	12.6	42.5	4.1	23.0	15.7	0.4	0.0	22.1	10.6	2.8	13.2	1.3	15.5	3.0	43.6	17.5	64.4	0.0	2.6	3.0	48.5	7.1	8.2	1.1	0.0	0.1	1.9	0.3	1.2	1.1	1.3	0.7	9.0	0.0	50.6	5.5
ADARB1	"ADAR2, ADAR2a, ADAR2a-L1, ADAR2a-L2, ADAR2a-L3, ADAR2b, ADAR2c, ADAR2d, ADAR2g, DRABA2, DRADA2, hRED1, RED1"	ENSG00000197381	"Adenosine deaminase RNA specific B1"	P78563	21	45073853-45226560	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Antiviral defense, Immunity, Innate immunity, mRNA processing"	"Hydrolase, RNA-binding"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Bipolar cells: 62.9;Excitatory neurons: 54.1;Horizontal cells: 69.0;Inhibitory neurons: 85.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HeLa: 65.8;HHSteC: 65.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029645			Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 20: HeLa - Mitochondria"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm	Cytosol	"HPA029645: AB_10602106"	"unprognostic (2.69e-1)"	"unprognostic (7.65e-2)"	"prognostic unfavorable (8.16e-5)"	"unprognostic (1.82e-2)"	"unprognostic (1.07e-2)"	"unprognostic (9.07e-2)"	"unprognostic (3.29e-2)"	"unprognostic (6.97e-2)"	"unprognostic (3.82e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.28e-1)"	"unprognostic (3.44e-1)"	"prognostic unfavorable (3.56e-4)"	"unprognostic (4.57e-2)"	"unprognostic (3.06e-1)"	"unprognostic (2.73e-2)"	"unprognostic (2.38e-2)"	15.4	7.0	14.9	10.3	13.2	5.2	11.4	39.1	26.5	14.7	29.6	35.7	3.0	23.0	6.3	7.4	13.6	8.1	10.1	20.0	17.9	9.5	7.0	35.2	13.4	30.6	17.2	7.8	6.1	9.3	6.1	12.3	30.8	17.9	4.8	28.6	6.8	8.1	13.6	15.9	10.8	11.7	8.7	16.1	19.0	4.5	22.7	5.7	6.6	11.8	8.7	60.4	11.9	12.7	7.0	1.0	5.3	6.2	6.3	4.3	7.2	4.6	7.6	14.4	9.0	10.9	1.1	2.2	12.1	22.6	7.9	0.6	7.8	19.1	15.9	1.7	7.0	15.2	65.8	7.2	65.7	10.5	7.2	23.7	8.1	5.1	14.9	5.4	15.4	20.4	3.5	0.8	42.2	5.1	6.8	10.0	8.6	3.4	10.1	2.0	5.0	7.1	3.2	2.3	30.6	8.2	36.4	1.6	11.6	8.5	3.5	8.2	16.3	4.7	5.7	19.4	17.5	6.6	3.1	1.8	4.3	24.1	25.8	0.7	0.0	2.4	0.4	0.2	0.8	1.0	1.1	0.7	0.0	2.6	0.7	0.6	0.1	0.3	0.2	1.0	0.8	0.2	14.9	13.2	39.1	26.5	20.0	17.9	30.6	17.2	30.8	8.7	22.7	12.7	29.0	0.0	1.1	10.7	12.0	11.1	2.9	3.4	2.8	62.9	6.2	7.1	21.6	1.5	1.9	0.0	12.5	0.5	5.9	0.9	0.0	1.3	2.7	1.6	8.8	21.2	0.0	2.1	54.1	0.5	1.2	9.4	2.6	1.6	8.2	5.5	14.3	6.3	5.9	69.0	85.7	0.9	0.0	3.4	4.9	2.9	3.7	3.2	5.4	37.5	5.0	34.2	2.1	16.1	4.8	1.0	0.1	5.7	4.0	5.5	0.3	2.7	0.7	16.0	0.0	32.9	12.7	11.4	17.7	1.5	7.2	1.0	13.7	1.4	1.2	2.3
ADAT1		ENSG00000065457	"Adenosine deaminase tRNA specific 1"	Q9BUB4	16	75596868-75623300	"Enzymes, Predicted intracellular proteins"	"tRNA processing"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"Early spermatids: 101.9;Late spermatids: 213.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040713, HPA040903"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 43: Testis - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 25: Spermatids - Spermatogenesis"	Nucleoplasm		"HPA040713: AB_10795371, HPA040903: AB_10794071"	"unprognostic (7.71e-3)"	"unprognostic (5.35e-2)"	"unprognostic (7.62e-2)"	"unprognostic (9.00e-2)"	"unprognostic (9.99e-2)"	"unprognostic (4.69e-2)"	"unprognostic (4.54e-2)"	"unprognostic (6.65e-3)"	"unprognostic (3.38e-1)"	"unprognostic (1.14e-2)"	"unprognostic (9.75e-2)"	"unprognostic (2.97e-1)"	"unprognostic (4.60e-3)"	"unprognostic (7.21e-2)"	"unprognostic (4.92e-1)"	"unprognostic (5.58e-3)"	"unprognostic (8.27e-2)"	13.8	16.4	11.0	9.5	11.1	7.8	14.1	11.5	15.1	12.0	10.5	11.6	5.1	14.0	12.7	11.7	11.8	6.6	11.5	10.8	10.5	19.8	18.5	12.8	10.8	11.5	11.2	10.3	12.6	14.6	14.2	7.3	11.7	15.3	9.1	9.6	12.1	8.6	9.5	14.1	14.0	6.0	10.6	20.4	12.0	26.9	11.5	11.8	14.8	5.2	8.7	13.1	11.6	13.0	14.7	23.1	15.0	15.5	26.4	20.3	11.5	20.2	21.0	26.1	17.7	15.4	22.4	15.7	19.8	20.6	14.0	17.6	16.4	25.0	24.6	11.7	8.6	8.8	16.0	13.3	21.2	19.6	19.6	21.7	23.8	42.7	32.1	7.5	23.1	24.7	13.7	7.6	21.2	35.9	18.8	14.3	12.2	19.8	10.7	23.6	12.1	21.5	24.6	22.0	18.1	18.6	47.8	12.2	11.2	15.0	24.6	9.3	16.3	32.4	14.6	17.1	16.9	15.1	24.3	58.9	16.3	15.6	28.5	8.5	4.3	11.5	8.5	6.4	11.3	7.9	7.3	11.3	5.8	7.3	4.5	6.3	4.9	10.8	9.9	4.6	9.0	6.2	11.0	11.1	11.5	15.1	10.8	10.5	11.5	11.2	11.7	10.6	11.5	13.0	9.9	9.6	5.8	2.3	11.6	4.6	5.9	5.7	6.8	13.5	10.7	6.6	5.6	11.5	6.6	7.3	27.1	11.8	9.8	6.8	17.6	8.6	101.9	11.8	8.2	11.9	14.4	16.0	6.0	7.6	8.9	6.4	8.6	10.5	8.2	12.6	6.1	10.5	10.3	13.5	6.4	4.7	10.2	14.4	10.6	213.0	9.9	10.2	3.6	2.8	12.8	7.8	15.5	3.0	8.0	9.8	3.3	7.9	8.1	8.3	6.9	11.3	9.9	21.6	6.6	6.8	7.0	17.5	13.4	8.4	5.4	9.7	14.8	12.9	9.1	7.6
ADD2	ADDB	ENSG00000075340	"Adducin 2"	P35612	2	70607618-70768225	"Predicted intracellular proteins"		"Actin-binding, Calmodulin-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 66.5;brain: 52.8"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 31.7;Erythroid cells: 74.1;Excitatory neurons: 70.1;Horizontal cells: 139.7;Inhibitory neurons: 51.8;Late spermatids: 62.4"	"Group enriched"	"Detected in many"	5	"glioma: 5.2;testis cancer: 11.1"	"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"memory B-cell: 2.2;non-classical monocyte: 2.3"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HAP1: 33.9;JURKAT: 33.1;K-562: 46.5;NTERA-2: 86.7;RPMI-8226: 41.7;SCLC-21H: 42.8;U-251 MG: 47.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009796, HPA034509, HPA034510"	Supported		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA		18000	"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 62: Horizontal cells - Visual perception"	"Nucleoplasm, Cytosol"	"Plasma membrane"	"CAB009796: AB_2223572, HPA034509: AB_2674201, HPA034510: AB_2674202"	"unprognostic (3.58e-2)"	"unprognostic (2.68e-4)"	"unprognostic (3.83e-2)"	"unprognostic (3.01e-4)"	"unprognostic (1.94e-1)"	"unprognostic (2.25e-3)"	"unprognostic (1.35e-1)"	"unprognostic (3.26e-1)"	"unprognostic (3.49e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.20e-2)"	"unprognostic (8.93e-2)"	"unprognostic (4.47e-7)"	"unprognostic (2.81e-4)"	"unprognostic (1.77e-1)"	"unprognostic (1.71e-3)"	"unprognostic (1.31e-3)"	1.8	1.7	19.5	1.9	21.0	66.5	0.9	14.6	52.8	0.7	0.0	0.9	0.1	0.5	0.3	1.4	0.7	0.3	0.9	18.7	10.8	0.4	0.2	0.9	2.5	14.0	0.2	0.2	1.7	0.2	4.0	0.7	9.5	0.5	0.3	16.0	0.2	0.2	0.8	0.3	0.9	1.0	0.0	1.2	0.3	2.8	0.9	0.7	1.4	1.0	2.2	0.5	0.6	9.6	17.6	20.5	0.8	0.3	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	10.5	2.7	12.3	0.0	33.9	0.0	0.0	0.1	20.1	1.7	0.2	0.0	0.0	4.7	0.1	0.0	0.0	0.0	0.0	8.0	0.0	33.1	46.5	0.0	0.0	0.1	0.2	1.6	86.7	0.0	0.4	0.0	0.5	41.7	5.7	0.0	42.8	19.3	21.6	0.1	0.1	9.4	0.1	10.7	0.8	0.2	0.9	0.0	47.1	14.1	17.0	0.0	0.7	7.1	7.9	0.0	0.0	0.0	0.0	1.2	0.0	2.2	0.0	0.0	0.0	1.7	0.8	0.4	0.0	0.0	2.3	0.0	0.0	0.3	19.5	21.0	14.6	52.8	18.7	10.8	14.0	0.2	9.5	0.0	0.9	9.6	2.8	0.0	0.5	1.0	4.2	0.1	0.3	0.0	0.0	23.3	0.2	0.0	2.5	0.0	0.0	0.0	2.1	0.1	0.0	0.1	0.0	0.1	31.7	0.1	0.2	3.9	0.0	74.1	70.1	1.1	0.2	1.0	1.1	0.1	0.0	0.0	2.9	0.0	0.2	139.7	51.8	0.0	0.0	1.0	0.4	62.4	0.9	0.6	1.8	2.8	0.8	0.8	0.0	17.6	1.8	0.3	0.0	0.7	0.1	0.6	0.0	0.0	0.0	8.7	0.0	0.6	0.3	3.5	6.8	0.0	0.1	0.3	0.5	1.5	0.0	1.3
ADD3	ADDL	ENSG00000148700	"Adducin 3"	Q9UEY8	10	109996368-110135565	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		"Actin-binding, Calmodulin-binding"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Astrocytes: 449.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 313.2;ASC TERT1: 292.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009797, HPA035696"	Supported		Supported	"Plasma membrane"		NA	NA		260000	"Cluster 2: Granulocytes - Unknown function"	"Cluster 45: Intestine - Brush border"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Plasma membrane"		"CAB009797: AB_2223583, HPA035696: AB_2674740"	"unprognostic (2.66e-1)"	"unprognostic (2.63e-2)"	"unprognostic (1.46e-3)"	"unprognostic (1.64e-1)"	"unprognostic (2.65e-2)"	"unprognostic (1.75e-2)"	"unprognostic (1.57e-3)"	"unprognostic (6.42e-2)"	"unprognostic (5.73e-2)"	"unprognostic (2.37e-2)"	"unprognostic (7.58e-2)"	"unprognostic (9.12e-2)"	"unprognostic (2.34e-3)"	"unprognostic (1.36e-1)"	"unprognostic (4.03e-1)"	"unprognostic (3.68e-2)"	"unprognostic (5.92e-2)"	57.7	21.7	105.6	38.8	97.2	37.5	89.4	88.6	129.3	57.6	65.9	58.2	71.9	24.9	62.4	39.0	47.6	72.0	59.9	113.3	108.1	102.7	27.8	38.4	70.9	107.3	94.8	46.4	67.9	18.8	25.3	36.6	102.0	32.7	66.0	99.4	59.1	31.8	9.6	33.6	85.4	23.9	105.2	40.0	63.7	51.5	95.6	87.4	87.7	25.6	65.4	42.3	40.1	122.4	29.2	6.0	41.7	19.8	313.2	292.1	17.7	41.2	110.9	25.4	49.9	60.3	90.6	89.9	45.2	63.9	26.4	10.0	37.3	27.1	39.5	9.0	46.5	8.8	28.5	45.9	35.5	30.5	66.0	142.5	12.9	63.3	2.6	96.4	37.8	109.9	23.5	48.7	46.7	0.8	32.3	31.0	25.8	69.2	15.3	27.7	58.2	4.8	65.7	14.2	6.1	67.9	27.6	8.9	66.5	62.2	10.7	11.4	9.5	16.0	42.0	33.5	9.1	68.9	31.5	82.7	47.8	16.2	27.7	139.5	29.6	98.0	68.8	26.5	55.7	51.4	72.9	59.1	24.8	42.9	83.2	67.6	47.1	73.4	32.6	16.3	73.3	94.9	105.6	97.2	88.6	129.3	113.3	108.1	107.3	94.8	102.0	105.2	95.6	122.4	67.3	22.4	52.9	449.2	110.6	55.7	35.9	77.4	38.7	26.8	56.0	34.4	128.2	74.4	85.5	36.8	60.5	55.6	112.7	125.2	60.7	27.2	51.4	70.3	76.0	77.7	102.4	32.6	83.4	61.1	12.1	182.4	100.9	56.0	26.0	18.8	126.7	12.2	25.7	116.1	141.1	71.6	48.8	88.5	41.1	25.7	226.5	66.3	58.7	70.3	65.3	339.0	151.4	236.8	279.6	59.8	167.1	251.3	68.4	38.4	135.2	162.2	151.9	121.7	65.7	27.6	36.2	122.7	62.1	53.2	50.6	22.3	111.5	30.9	166.7	98.6
ADGRB2	BAI2	ENSG00000121753	"Adhesion G protein-coupled receptor B2"	O60241	1	31727117-31764893	"G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"brain: 61.4"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 20.9;Bipolar cells: 16.0;Excitatory neurons: 55.7;Inhibitory neurons: 13.8;Oligodendrocyte precursor cells: 20.6;Oligodendrocytes: 13.2"	"Cancer enriched"	"Detected in many"	4	"glioma: 20.5"	"Region enhanced"	"Detected in many"		"hippocampal formation: 61.4"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HeLa: 37.7;SH-SY5Y: 25.1;T-47d: 29.5;U-2 OS: 27.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA069175			Supported	"Plasma membrane"		NA	NA		32000		"Cluster 10: Brain - Neuronal signaling"	"Cluster 20: HeLa - Mitochondria"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Plasma membrane"		"HPA069175: "	"prognostic favorable (6.46e-4)"	"unprognostic (1.74e-1)"	"unprognostic (7.98e-2)"	"unprognostic (4.34e-2)"	"unprognostic (1.90e-1)"	"unprognostic (2.40e-1)"	"unprognostic (8.17e-4)"	"prognostic unfavorable (4.02e-5)"	"unprognostic (2.31e-2)"	"unprognostic (1.54e-2)"	"unprognostic (1.48e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.80e-3)"	"unprognostic (1.63e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.75e-3)"	"unprognostic (7.98e-2)"	1.5	3.8	30.6	0.4	30.1	0.2	1.3	0.0	41.1	2.4	0.0	1.6	4.0	2.9	0.2	0.6	1.3	1.1	4.5	61.4	0.0	0.8	0.0	0.7	0.4	0.0	0.2	1.5	0.5	1.2	8.0	2.7	0.0	1.9	0.1	2.9	0.5	1.8	0.7	0.7	3.8	1.3	0.0	0.8	1.1	2.9	1.0	8.7	2.7	0.4	0.2	1.5	1.0	12.2	1.0	7.5	6.9	20.1	1.9	1.2	3.3	4.8	7.6	4.6	8.1	0.4	2.3	0.0	4.7	2.1	7.7	0.8	3.1	0.4	0.8	5.4	3.2	0.0	37.7	0.0	0.1	0.0	2.6	1.2	0.5	6.4	0.0	14.4	0.7	14.7	0.8	0.2	5.2	0.6	13.9	0.1	8.7	0.2	2.1	20.8	0.8	0.7	0.0	9.7	5.2	25.1	11.0	0.7	0.8	2.4	29.5	0.0	0.2	3.6	27.5	0.5	1.3	0.0	0.0	0.8	11.0	0.1	8.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	30.6	30.1	0.0	41.1	61.4	0.0	0.0	0.2	0.0	0.0	1.0	12.2	0.1	0.0	0.0	20.9	0.3	0.0	0.5	0.0	0.0	16.0	2.0	1.3	4.3	0.0	0.0	0.0	6.2	1.0	1.2	0.0	0.0	0.1	3.6	1.4	0.6	0.1	1.2	0.0	55.7	0.0	1.4	2.3	0.5	0.4	0.0	1.5	0.0	0.0	0.4	8.4	13.8	0.9	0.0	0.0	0.0	12.0	1.2	0.0	0.0	4.7	0.0	11.4	4.1	20.6	13.2	0.1	0.1	1.9	0.1	0.5	5.7	2.5	0.0	5.2	0.0	1.4	0.7	0.9	4.5	0.0	0.0	0.3	0.4	0.8	0.5	1.3
ADGRD1	"DKFZp434B1272, GPR133, PGR25"	ENSG00000111452	"Adhesion G protein-coupled receptor D1"	Q6QNK2	12	130953907-131141469	"G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 62.4"	"Group enriched"	"Detected in many"	4	"Alveolar cells type 1: 22.4;Alveolar cells type 2: 30.5;Cardiomyocytes: 47.0;Early spermatids: 16.2;Endometrial stromal cells: 50.2;Fibroblasts: 32.7;Late spermatids: 21.4;Leydig cells: 13.7;Microglial cells: 25.3;Peritubular cells: 15.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"classical monocyte: 2.0;intermediate monocyte: 2.3;myeloid DC: 1.1;non-classical monocyte: 1.8"	"Group enriched"	"Detected in many"	6	"dendritic cells: 1.1;monocytes: 2.3"	"Cell line enhanced"	"Detected in some"		"BJ: 4.1;fHDF/TERT166: 4.7;HeLa: 7.6;HHSteC: 4.9;HMC-1: 13.0;U-2 OS: 6.1"	"Region enhanced"	"Detected in some"		"basal ganglia: 5.1"	"Low region specificity"	"Detected in all"			"HPA042395, HPA076279"	Uncertain		Approved	"Nucleoplasm,Plasma membrane"		NA	NA		1400000	"Cluster 7: Monocytes - Unknown function"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 50: Fibroblasts - ECM organization"	"Nucleoplasm, Plasma membrane"		"HPA042395: AB_10796906, HPA076279: "	"unprognostic (3.21e-1)"	"unprognostic (1.49e-4)"	"unprognostic (1.32e-2)"	"unprognostic (1.63e-1)"	"unprognostic (4.40e-3)"	"unprognostic (1.28e-1)"	"prognostic unfavorable (9.27e-4)"	"unprognostic (2.55e-3)"	"unprognostic (1.63e-2)"	"unprognostic (6.94e-2)"	"unprognostic (1.11e-2)"	"unprognostic (3.98e-2)"	"unprognostic (4.79e-5)"	"unprognostic (1.31e-3)"	"unprognostic (4.58e-1)"	"unprognostic (2.15e-2)"	"unprognostic (1.77e-3)"	26.4	1.9	1.9	1.3	2.0	0.3	10.3	1.2	2.5	20.6	1.0	10.6	1.9	15.4	7.3	6.9	17.7	12.9	62.4	1.4	3.2	3.4	10.3	35.6	0.4	2.0	2.6	17.9	12.0	0.3	6.3	25.7	2.2	15.3	1.8	0.8	2.9	1.0	7.3	7.0	12.1	7.1	2.0	2.3	20.7	7.5	3.6	0.4	11.2	8.5	1.0	40.3	16.3	1.7	0.0	0.7	0.0	2.0	0.0	0.0	0.1	4.1	0.0	0.0	0.4	0.0	0.0	0.3	0.0	4.7	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	7.6	0.0	4.9	0.0	13.0	0.2	0.0	0.0	0.0	0.0	0.0	1.1	0.4	0.0	0.0	0.8	0.0	0.1	0.2	2.1	0.5	0.6	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	2.2	0.0	0.3	0.0	0.4	6.1	1.5	0.1	0.1	1.7	0.8	0.1	0.0	0.0	0.0	2.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.3	1.8	0.0	0.0	0.8	1.9	2.0	1.2	2.5	1.4	3.2	2.0	2.6	2.2	2.0	3.6	1.7	2.0	22.4	30.5	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.1	47.0	0.0	5.0	1.8	0.0	1.3	0.0	0.0	0.0	0.0	16.2	1.3	50.2	3.4	0.0	0.0	1.1	0.4	0.6	32.7	0.5	1.0	1.3	0.3	1.8	3.6	2.3	0.0	1.4	0.0	0.0	1.5	0.0	21.4	13.7	1.5	0.0	25.3	3.5	0.0	0.0	0.0	0.1	0.3	0.0	15.8	0.0	0.0	0.0	0.1	2.2	0.7	6.6	2.2	3.5	4.3	6.5	0.1	0.0	1.0	0.6	0.2	0.1	0.3
ADGRG2	"EDDM6, GPR64, HE6, TM7LN2"	ENSG00000173698	"Adhesion G protein-coupled receptor G2"	Q8IZP9	X	18989307-19122637	"Disease related genes, G-protein coupled receptors, Human disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"epididymis: 1227.7"	"Cell type enhanced"	"Detected in some"		"Cholangiocytes: 7.2;Endometrial stromal cells: 5.4;Fibroblasts: 5.3;Gastric mucus-secreting cells: 9.2;Oligodendrocyte precursor cells: 10.1;Oligodendrocytes: 7.0"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 4.9"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 6.0;BEWO: 7.3;HeLa: 5.9;NTERA-2: 6.4;RPMI-8226: 4.5;SH-SY5Y: 6.6;U-2197: 14.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"HPA001478, HPA050029"	Enhanced		Approved	"Plasma membrane,Cytosol"		NA	NA		22000000		"Cluster 30: Epididymis - Antimicrobial activity"	"Cluster 18: U-2197 - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Plasma membrane, Cytosol"		"HPA001478: AB_1078923, HPA050029: AB_2680996"	"unprognostic (3.33e-2)"	"unprognostic (3.20e-1)"	"unprognostic (2.40e-1)"	"unprognostic (2.55e-2)"	"unprognostic (1.58e-1)"	"unprognostic (4.43e-3)"	"unprognostic (2.63e-4)"	"unprognostic (2.66e-1)"	"unprognostic (1.27e-3)"	"unprognostic (1.12e-1)"	"unprognostic (1.78e-2)"	"unprognostic (1.07e-1)"	"unprognostic (3.54e-7)"	"unprognostic (6.37e-2)"	"unprognostic (3.19e-1)"	"unprognostic (2.83e-1)"	"unprognostic (1.35e-1)"	3.9	0.3	0.1	0.9	0.1	0.0	2.0	0.0	1.1	1.0	0.0	0.5	0.5	1.0	1227.7	0.5	16.5	1.6	1.3	0.8	0.7	0.4	0.7	1.3	5.0	0.4	1.5	0.2	1.2	163.4	1.1	0.5	0.6	2.1	0.4	0.9	8.5	3.6	0.2	0.4	1.1	0.4	0.1	2.4	9.0	1.9	0.3	6.6	1.6	1.1	3.7	0.8	1.0	0.2	0.2	6.0	0.0	0.0	0.1	0.9	7.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.0	2.4	0.0	5.9	0.2	0.8	0.0	0.0	0.1	0.1	0.0	1.1	0.0	0.0	0.0	0.0	0.2	0.0	1.0	0.0	2.2	6.4	0.0	2.0	0.0	0.0	4.5	0.0	1.2	2.2	6.6	1.5	0.1	0.0	1.1	0.1	0.1	0.1	0.2	0.4	14.6	2.5	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	1.1	0.8	0.7	0.4	1.5	0.6	0.1	0.3	0.2	0.6	0.0	0.0	3.6	0.1	0.0	0.1	0.0	0.0	0.6	1.2	1.1	1.0	7.2	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.4	0.1	1.1	5.4	0.6	0.0	0.0	4.4	0.2	0.3	5.3	9.2	3.2	0.0	0.2	1.4	0.4	0.0	3.3	5.0	0.1	0.0	0.0	0.0	0.2	1.2	0.1	0.0	4.7	0.0	4.8	0.0	10.1	7.0	3.1	0.0	1.5	0.0	3.4	0.0	0.1	2.2	0.7	0.0	1.6	0.6	0.1	1.4	0.1	0.0	0.0	0.3	0.3	0.0	0.3
ADH1C	ADH3	ENSG00000248144	"Alcohol dehydrogenase 1C (class I), gamma polypeptide"	P00326	4	99336497-99352746	"Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	21	"intestine: 598.1;liver: 2062.2;stomach 1: 570.6"	"Cell type enhanced"	"Detected in many"		"Exocrine glandular cells: 699.4;Gastric mucus-secreting cells: 611.2;Hepatocytes: 440.6;Undifferentiated cells: 420.5"	"Cancer enriched"	"Detected in many"	7	"liver cancer: 238.2"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 2.1;ASC TERT1: 3.6;HSkMC: 11.9;RPMI-8226: 2.1"									"HPA047814, HPA060902"	Supported		Supported	"Plasma membrane,Cytosol"		NA	NA		31000000		"Cluster 85: Liver - Metabolism"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 1: Pancreatic cells - Digestion"	"Plasma membrane, Cytosol"		"HPA047814: AB_2680163, HPA060902: AB_2684384"	"unprognostic (3.98e-2)"	"unprognostic (9.88e-3)"	"unprognostic (7.04e-2)"	"unprognostic (1.90e-1)"	"unprognostic (5.14e-1)"	"unprognostic (1.57e-1)"	"prognostic favorable (4.55e-4)"	"prognostic favorable (2.99e-4)"	"unprognostic (8.25e-2)"	"unprognostic (8.89e-3)"	"unprognostic (7.95e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.70e-1)"	"unprognostic (9.37e-2)"	22.9	0.8	0.1	29.8	0.1	0.0	19.2	0.1	0.1	4.7	0.0	329.5	598.1	5.1	7.2	5.1	5.8	51.6	5.9	0.1	0.0	19.6	2062.2	2.9	0.6	0.1	0.1	4.0	16.7	0.1	1.6	0.1	0.1	9.4	191.9	0.0	19.3	6.2	23.9	0.7	190.7	16.3	0.1	0.7	570.6	0.8	0.1	0.5	2.9	31.1	0.5	5.9	3.6	0.2	0.0	2.1	0.0	0.0	1.4	3.6	0.9	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.4	0.3	0.0	0.2	1.1	0.3	11.9	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.3	0.8	0.2	0.0	0.1	0.1	0.8	2.1	0.8	0.0	0.3	1.1	0.5	0.7	0.0	0.0	0.2	0.0	0.1	0.0	0.4	0.3	0.1	0.1	0.0	0.3	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.2	2.1	3.2	7.3	0.7	1.3	0.0	4.0	0.0	25.0	0.0	0.1	0.3	1.0	64.3	24.8	29.5	0.0	0.0	0.1	108.4	0.0	159.5	2.3	1.3	0.8	1.2	21.6	29.5	0.3	699.4	0.0	21.1	611.2	1.3	0.0	0.0	13.2	440.6	0.0	0.0	0.2	86.3	0.0	13.2	0.0	1.0	10.5	0.8	0.0	0.0	2.0	0.0	0.0	0.5	0.1	66.3	120.8	0.0	0.6	3.1	59.4	1.4	43.7	0.0	0.0	1.3	2.0	0.0	0.7	10.6	0.0	0.0	1.8	1.6	420.5	3.6
ADH7	ADH-4	ENSG00000196344	"Alcohol dehydrogenase 7 (class IV), mu or sigma polypeptide"	P40394	4	99412261-99435737	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"esophagus: 196.3"	"Group enriched"	"Detected in some"	4	"Basal respiratory cells: 89.0;Club cells: 64.1;Squamous epithelial cells: 209.1"	"Cancer enhanced"	"Detected in some"		"cervical cancer: 18.4;head and neck cancer: 18.9;lung cancer: 22.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"ASC TERT1: 1.0;HaCaT: 1.2"	"Not detected"	"Not detected"							HPA039695	Enhanced		Supported	"Plasma membrane,Cytosol"		NA	NA				"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 61: Squamous epithelial cells - Keratinization"	"Plasma membrane, Cytosol"		"HPA039695: AB_10795681"		"unprognostic (1.02e-2)"			"unprognostic (8.64e-2)"	"unprognostic (4.86e-2)"	"unprognostic (5.66e-3)"	"unprognostic (4.50e-2)"	"unprognostic (1.66e-1)"					"unprognostic (2.02e-1)"			"unprognostic (1.88e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	196.3	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	22.8	0.0	0.0	0.7	0.0	0.0	0.0	0.0	27.3	0.0	0.0	0.2	0.0	0.0	38.1	0.3	4.6	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	89.0	21.1	0.0	0.0	0.0	0.2	0.0	64.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.0	0.0	0.1	7.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	18.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.2	0.6	0.0	0.0	26.2	0.0	0.0	0.0	2.3	0.0	0.0	209.1	0.0	0.0	0.0	0.0	0.0	1.0
ADIRF	"AFRO, APM2, C10orf116"	ENSG00000148671	"Adipogenesis regulatory factor"	Q15847	10	86968432-86983934	"Plasma proteins, Predicted intracellular proteins"	"Differentiation, Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adipose tissue: 1238.9"	"Cell type enriched"	"Detected in many"	4	"Proximal enterocytes: 12067.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"naive CD4 T-cell: 2.5;naive CD8 T-cell: 1.9"	"Lineage enriched"	"Detected in single"	8	"T-cells: 2.5"	"Cell line enhanced"	"Detected in many"		"HaCaT: 847.5;PC-3: 680.7;RT4: 1035.2"					"Low region specificity"	"Detected in all"			HPA026810	Approved		Supported	Nucleoplasm,Cytosol		NA	NA		760000	"Cluster 32: T-cells - Unknown function"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 15: RT4 - Unknown function"	"Cluster 45: Enterocytes - Digestion"	"Nucleoplasm, Cytosol"		"HPA026810: AB_2672003"																		1238.9	58.8	253.4	50.9	238.3	1.0	246.1	221.8	380.1	201.9	226.1	114.2	476.9	114.1	49.1	114.2	235.9	46.7	90.6	251.6	278.5	147.2	82.5	209.5	15.5	259.4	237.0	252.6	73.2	26.9	55.1	28.4	241.8	312.5	48.1	29.0	296.8	233.8	87.5	115.6	491.6	75.8	239.8	73.6	75.2	27.2	242.7	25.8	116.6	131.9	44.7	242.9	171.1	247.4	259.8	4.9	0.1	0.1	123.3	224.9	16.1	97.0	166.9	1.7	0.4	6.5	29.5	0.0	3.4	209.9	8.4	847.5	0.0	39.7	1.0	9.1	0.0	0.0	22.5	1.8	19.9	0.2	3.4	1.9	132.0	0.6	70.1	6.7	50.4	3.6	0.3	36.3	4.0	130.4	0.6	6.5	0.0	6.4	680.7	0.5	0.0	3.4	14.6	1035.2	11.8	3.0	36.0	222.0	1.7	0.0	270.7	2.7	132.6	3.4	17.4	13.2	0.6	4.0	3.3	0.4	6.3	0.0	5.1	0.0	0.2	0.0	0.0	0.0	0.6	0.0	1.0	0.0	0.3	0.0	2.5	1.9	0.0	0.0	0.0	0.0	0.5	0.3	253.4	238.3	221.8	380.1	251.6	278.5	259.4	237.0	241.8	239.8	242.7	247.4	1215.2	1842.9	476.5	3.9	15.0	528.4	141.9	309.7	39.9	5.4	651.4	253.2	0.0	58.6	614.4	187.6	2.1	299.2	14.3	658.7	1352.0	29.9	9.6	55.7	63.9	944.9	30.0	37.5	0.1	272.1	16.9	508.0	121.3	195.1	48.9	11.7	1691.7	257.4	26.4	0.0	0.3	418.7	128.1	17.3	492.0	48.4	1309.5	25.3	610.1	10.3	99.9	703.9	0.0	1.0	0.2	336.8	1115.3	469.8	3.4	481.9	12067.2	1144.8	88.2	16.5	1472.6	705.4	2422.0	3.2	6.2	35.0	438.6	166.8	40.7	2.4	443.5	1160.7
ADK	AK	ENSG00000156110	"Adenosine kinase"	P55263	10	74151202-74709963	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Purine salvage"	"Kinase, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 151.2"	"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 245.3;Inhibitory neurons: 287.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB032876, HPA038391, HPA038409, HPA075222"	Approved		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA		920000	"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Nucleoplasm, Cytosol"	"Plasma membrane"	"CAB032876: AB_2242229, HPA038391: AB_2675990, HPA038409: AB_10675798, HPA075222: "	"unprognostic (1.55e-3)"	"unprognostic (1.09e-1)"	"unprognostic (1.88e-1)"	"unprognostic (2.62e-2)"	"unprognostic (2.52e-2)"	"prognostic unfavorable (1.93e-4)"	"prognostic favorable (9.91e-4)"	"unprognostic (2.64e-1)"	"unprognostic (2.88e-1)"	"unprognostic (1.55e-1)"	"unprognostic (8.15e-3)"	"unprognostic (2.51e-1)"	"unprognostic (1.89e-3)"	"unprognostic (2.03e-1)"	"unprognostic (2.88e-2)"	"unprognostic (4.97e-3)"	"unprognostic (2.95e-2)"	23.9	15.5	13.0	16.9	18.7	28.6	27.4	13.5	17.7	17.5	11.6	17.9	16.9	10.8	16.5	47.3	16.5	11.4	27.2	13.9	15.2	35.8	151.2	24.4	22.8	14.0	15.0	8.3	18.8	44.2	14.9	26.6	16.5	14.9	19.5	16.1	20.0	16.0	41.5	33.9	12.4	14.8	14.2	15.0	12.1	15.5	14.1	27.0	38.2	47.1	34.5	24.5	24.7	15.8	177.3	37.4	37.2	50.5	37.1	54.7	88.2	140.8	105.4	103.8	114.5	114.0	172.6	86.3	34.2	57.7	51.3	151.1	44.1	150.1	167.0	59.1	51.3	55.6	59.8	122.8	41.7	87.6	22.5	51.1	95.5	77.4	191.7	79.0	91.2	38.7	41.8	28.4	78.8	101.7	102.5	129.0	9.9	80.0	276.3	100.6	63.7	69.4	117.1	92.7	29.5	33.8	63.6	239.7	49.5	34.7	159.7	69.3	82.8	34.3	67.0	93.2	123.0	40.5	48.3	98.1	65.0	127.6	22.1	2.3	34.2	4.1	12.9	65.5	29.9	103.7	28.2	24.1	83.1	155.0	21.3	19.2	11.1	20.7	80.4	57.6	55.7	36.3	13.0	18.7	13.5	17.7	13.9	15.2	14.0	15.0	16.5	14.2	14.1	15.8	9.8	83.3	75.8	136.5	84.2	94.2	73.5	102.0	105.9	16.3	26.2	26.0	67.8	38.6	72.4	31.3	56.3	136.7	25.9	11.0	92.0	83.2	80.7	40.6	18.8	14.9	10.8	27.7	245.3	67.5	139.5	27.0	23.0	55.6	21.5	9.7	17.2	130.1	39.3	11.8	287.7	12.1	44.7	25.2	50.0	26.9	16.8	33.7	48.0	198.6	44.1	14.1	11.3	140.8	165.4	62.7	10.4	12.0	39.1	92.1	5.0	64.5	33.5	25.0	6.6	20.4	26.0	17.4	14.3	96.7	97.0	107.3	32.7	17.0	20.5	66.3
ADORA1	RDC7	ENSG00000163485	"Adenosine A1 receptor"	P30542	1	203090654-203167405	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 54.8;testis: 21.4"	"Cell type enhanced"	"Detected in some"		"Excitatory neurons: 18.1;granulocytes: 22.3;Muller glia cells: 44.4;Oligodendrocyte precursor cells: 35.2;Oligodendrocytes: 31.5"	"Cancer enhanced"	"Detected in many"		"glioma: 24.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"CACO-2: 40.3;MCF7: 24.4;RH-30: 65.4;RPTEC TERT1: 31.7;SK-BR-3: 35.2;U-138 MG: 20.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044383			Supported	"Plasma membrane"		NA	NA				"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 5: Muller glia cells - Visual perception"	"Plasma membrane"		"HPA044383: AB_2678921"	"unprognostic (3.93e-3)"	"unprognostic (8.16e-2)"	"unprognostic (6.16e-2)"	"unprognostic (2.38e-3)"	"unprognostic (2.25e-2)"	"unprognostic (2.34e-1)"	"unprognostic (4.64e-2)"	"unprognostic (4.17e-2)"	"unprognostic (3.04e-1)"	"unprognostic (4.80e-3)"	"unprognostic (1.42e-1)"	"unprognostic (2.98e-1)"	"unprognostic (2.96e-3)"	"unprognostic (1.54e-1)"	"unprognostic (1.27e-1)"	"unprognostic (4.13e-2)"	"unprognostic (5.76e-4)"	3.7	0.2	31.9	1.6	34.6	0.0	4.6	28.6	33.8	1.0	0.0	1.0	1.0	1.2	0.6	1.1	1.2	0.9	11.4	29.6	23.0	9.3	0.4	1.7	0.6	35.7	35.0	0.3	13.2	8.0	1.9	6.8	41.8	1.0	0.6	4.8	6.4	0.4	1.7	4.6	1.2	0.4	23.6	6.3	1.0	21.4	54.8	0.4	2.2	2.5	0.5	1.6	0.7	41.5	0.3	3.0	0.6	0.2	0.2	1.6	0.2	2.0	3.0	0.7	0.4	40.3	0.7	0.0	8.9	7.3	4.8	0.1	0.7	0.0	0.2	0.0	1.1	0.0	0.4	0.0	0.6	0.0	0.1	0.9	0.0	0.9	0.0	6.4	0.0	6.4	0.0	0.1	6.2	24.4	0.1	0.0	10.2	0.0	0.0	0.0	65.4	2.3	31.7	0.0	0.8	0.7	4.4	35.2	0.5	3.6	2.0	1.0	0.0	20.9	10.6	0.0	11.7	0.0	0.2	0.0	10.5	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	31.9	34.6	28.6	33.8	29.6	23.0	35.7	35.0	41.8	23.6	54.8	41.5	0.0	0.0	0.0	11.1	0.0	0.0	0.0	0.0	0.0	1.1	9.4	6.9	3.1	7.2	0.0	3.7	0.0	0.1	0.1	0.1	0.0	11.7	0.1	0.0	0.4	0.3	0.0	0.0	18.1	3.3	1.3	1.1	0.0	0.1	22.3	0.8	0.0	0.0	0.9	0.0	2.9	0.0	0.0	1.0	1.0	0.5	0.0	0.6	1.8	1.9	0.2	44.4	0.0	35.2	31.5	0.5	0.0	0.7	0.0	0.0	0.0	3.0	0.0	1.6	0.0	0.0	0.6	0.1	0.3	0.0	0.0	0.1	0.1	0.0	0.0	0.1
ADRA1A	"ADRA1C, ADRA1L1"	ENSG00000120907	"Adrenoceptor alpha 1A"	P35348	8	26748150-26867278	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 42.6;liver: 60.1"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 105.4;Early spermatids: 51.3;Inhibitory neurons: 123.2;Late spermatids: 28.3;Oligodendrocyte precursor cells: 114.1"	"Cancer enhanced"	"Detected in some"		"liver cancer: 0.9;prostate cancer: 0.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA029678, HPA029679, HPA076693"	Approved	Supported	Supported	Nucleoplasm,Vesicles,Cytosol		NA	NA				"Cluster 15: Liver - Metabolism"		"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Cytosol	"Nucleoplasm, Vesicles"	"HPA029678: AB_10602108, HPA029679: AB_2673143, HPA076693: "	"unprognostic (1.27e-1)"		"unprognostic (1.68e-2)"		"unprognostic (1.99e-1)"	"unprognostic (3.57e-1)"	"unprognostic (5.04e-4)"	"unprognostic (1.97e-1)"	"unprognostic (9.55e-2)"	"unprognostic (3.08e-1)"	"unprognostic (1.58e-2)"	"unprognostic (7.47e-2)"	"unprognostic (1.71e-2)"	"unprognostic (6.06e-3)"	"unprognostic (7.41e-2)"	"unprognostic (1.52e-2)"	"unprognostic (1.30e-1)"	21.8	0.5	13.3	1.1	11.1	0.0	3.6	3.0	22.6	0.7	0.0	1.4	0.9	1.4	0.6	0.8	0.2	0.3	7.6	42.6	20.8	0.7	60.1	3.9	1.7	9.3	4.9	0.9	0.0	0.0	0.1	0.0	9.5	12.4	0.5	0.3	6.2	13.5	0.2	0.6	1.1	2.9	1.5	9.2	0.9	0.1	4.2	0.1	0.1	1.4	0.4	0.4	0.3	6.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.3	11.1	3.0	22.6	42.6	20.8	9.3	4.9	9.5	1.5	4.2	6.9	0.0	0.0	0.0	105.4	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	51.3	0.0	0.0	0.1	0.0	0.0	15.5	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.7	16.2	0.0	0.0	123.2	0.0	0.0	0.0	0.5	28.3	0.6	0.0	0.0	9.4	0.0	0.0	0.0	114.1	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	1.4	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0
ADRA1B		ENSG00000170214	"Adrenoceptor alpha 1B"	P35368	5	159865080-159973012	"Cancer-related genes, FDA approved drug targets, G-protein coupled receptors, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 36.9;liver: 11.4;lymphoid tissue: 11.6"	"Group enriched"	"Detected in some"	7	"Excitatory neurons: 41.5;Inhibitory neurons: 32.6"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"midbrain: 36.9"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 11.9;HaCaT: 5.8;TIME: 9.8;U-2 OS: 7.9;U-251 MG: 6.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA074416			Supported	"Plasma membrane"		NA	NA				"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Plasma membrane"		"HPA074416: AB_2686688"	"unprognostic (4.93e-3)"	"unprognostic (2.94e-2)"	"unprognostic (1.79e-1)"	"prognostic unfavorable (6.00e-5)"	"prognostic unfavorable (6.98e-4)"	"unprognostic (4.08e-3)"	"unprognostic (1.67e-3)"	"unprognostic (1.68e-1)"	"unprognostic (6.12e-2)"	"prognostic favorable (2.67e-4)"	"unprognostic (2.28e-1)"	"unprognostic (1.37e-1)"	"prognostic unfavorable (1.40e-6)"	"unprognostic (5.24e-4)"	"unprognostic (2.54e-1)"	"prognostic favorable (3.19e-5)"	"unprognostic (1.59e-2)"	4.2	1.8	3.4	0.3	16.1	0.0	1.9	0.0	7.9	0.4	0.0	0.7	0.4	0.9	1.4	0.3	3.0	0.5	2.0	6.0	3.4	3.9	11.4	4.0	1.2	0.0	36.9	2.9	0.4	0.5	0.6	0.3	6.3	0.6	0.3	0.5	0.3	0.7	0.7	0.9	1.4	0.4	0.0	11.6	0.7	0.2	4.5	0.1	1.5	0.7	0.3	0.4	0.6	5.2	0.4	4.5	0.3	0.0	1.9	0.8	0.1	0.5	0.1	0.5	0.2	0.0	3.8	0.0	11.9	3.4	4.4	5.8	0.0	0.5	0.3	0.0	0.2	0.0	1.7	0.0	4.1	0.0	0.0	2.2	0.0	0.0	0.1	1.5	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.7	0.0	3.8	0.0	0.4	0.0	0.0	0.3	0.3	1.7	0.1	0.0	9.8	0.1	7.9	0.0	6.6	0.0	0.0	0.0	2.9	0.0	4.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	16.1	0.0	7.9	6.0	3.4	0.0	36.9	6.3	0.0	4.5	5.2	0.1	0.0	0.0	5.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	41.5	0.0	0.0	0.7	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	32.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.0	0.0	0.0	0.0	1.5	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ADRA2B	"ADRA2L1, ADRA2RL1, ADRARL1"	ENSG00000274286	"Adrenoceptor alpha 2B"	P18089	2	96112876-96116571	"Disease related genes, FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Glandular and luminal cells: 9.0;Langerhans cells: 8.0;Sertoli cells: 32.9;Smooth muscle cells: 13.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 1.5;EFO-21: 1.0"	"Group enriched"	"Detected in some"	6	"basal ganglia: 2.5;cerebellum: 1.0;thalamus: 3.2"	"Low region specificity"	"Detected in some"			"HPA066029, HPA074948"	Approved		Supported	Vesicles,Cytosol		NA	NA				"Cluster 18: Non-specific - Mitochondria"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 48: Smooth muscle cells - ECM organization"	Vesicles	Cytosol	"HPA066029: AB_2685599, HPA074948: "	"unprognostic (6.16e-2)"	"unprognostic (1.31e-2)"	"unprognostic (1.76e-2)"	"unprognostic (4.93e-4)"	"unprognostic (1.84e-2)"	"unprognostic (5.24e-2)"	"unprognostic (6.80e-5)"	"unprognostic (4.85e-2)"	"unprognostic (1.69e-1)"	"unprognostic (3.16e-2)"	"unprognostic (8.34e-2)"	"unprognostic (2.54e-1)"	"unprognostic (2.21e-1)"	"unprognostic (4.43e-2)"	"unprognostic (3.39e-1)"	"unprognostic (1.36e-1)"	"unprognostic (6.55e-2)"	6.4	2.1	1.5	0.3	1.7	0.8	3.0	1.4	2.7	1.5	4.9	2.3	0.3	1.9	3.8	0.7	3.0	0.6	10.1	1.2	1.4	5.1	7.0	0.5	0.2	1.8	1.6	1.7	0.8	0.5	0.5	0.8	1.7	1.4	0.3	0.0	2.2	1.5	6.4	1.9	2.6	0.7	1.3	8.6	2.2	1.6	2.6	0.2	1.3	5.0	0.1	2.5	1.8	2.4	0.0	0.0	0.2	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.4	0.0	0.0	0.3	0.0	0.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	1.7	1.4	2.7	1.2	1.4	1.8	1.6	1.7	1.3	2.6	2.4	2.9	0.0	0.0	0.0	0.9	1.1	0.7	0.7	0.6	0.0	0.9	0.9	2.5	0.0	1.5	1.8	0.0	0.8	2.9	0.1	0.0	0.2	0.0	2.2	1.0	2.4	2.4	0.0	0.0	0.6	0.2	1.0	1.1	9.0	0.0	0.0	2.5	0.0	0.3	0.0	0.0	0.2	0.0	0.3	8.0	0.0	1.8	5.1	1.8	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.4	0.4	0.7	0.0	0.1	1.4	0.0	32.9	0.7	13.3	0.0	0.3	0.6	1.4	0.4	2.8	0.1	0.1	0.3
ADRM1	"ARM1, GP110, Rpn13"	ENSG00000130706	"Adhesion regulating molecule 1"	Q16186	20	62302093-62308862	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 369.5"	"Cell type enhanced"	"Detected in all"		"Late spermatids: 1655.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"CACO-2: 727.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042266	Supported		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA		28000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 33: Striated muscle - Muscle contraction"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 25: Spermatids - Spermatogenesis"	"Nucleoplasm, Plasma membrane, Cytosol"		"HPA042266: AB_10794044"	"unprognostic (5.49e-2)"	"unprognostic (5.14e-3)"	"unprognostic (7.34e-2)"	"unprognostic (6.16e-2)"	"unprognostic (2.06e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.77e-3)"	"unprognostic (2.14e-2)"	"unprognostic (3.56e-2)"	"unprognostic (2.13e-3)"	"unprognostic (8.98e-2)"	"unprognostic (3.50e-1)"	"prognostic unfavorable (9.02e-6)"	"unprognostic (4.15e-2)"	"unprognostic (1.09e-1)"	"unprognostic (3.22e-1)"	"unprognostic (8.47e-2)"	76.9	92.7	44.9	53.4	45.6	78.0	68.3	48.7	63.7	57.8	38.1	78.7	52.0	80.6	14.6	99.0	58.4	33.5	109.0	44.0	48.4	65.1	119.5	67.3	54.2	52.0	45.7	44.5	83.2	23.5	52.6	39.6	51.0	59.5	16.1	11.9	61.3	35.1	369.5	93.9	63.4	23.3	44.4	83.2	68.6	128.5	47.3	38.9	51.7	66.9	29.7	73.0	64.4	46.4	219.9	241.8	66.8	142.6	62.5	45.8	178.1	138.9	95.4	260.1	104.0	727.1	227.8	117.4	250.3	82.1	148.3	243.6	84.3	209.9	79.8	136.7	170.1	284.4	177.4	392.0	105.6	149.3	261.1	57.0	126.3	170.9	67.7	43.4	101.4	113.0	211.4	125.6	61.7	296.1	187.5	290.8	225.1	106.6	354.0	149.2	115.5	186.7	71.3	163.9	118.5	146.5	151.5	241.7	174.0	44.9	168.1	163.3	149.4	258.5	274.4	252.4	289.1	261.5	223.4	158.6	272.6	148.7	192.3	195.4	208.7	233.5	200.4	262.1	179.9	260.2	180.8	192.9	219.2	265.2	132.4	151.4	200.2	184.8	227.8	205.6	265.8	260.8	44.9	45.6	48.7	63.7	44.0	48.4	52.0	45.7	51.0	44.4	47.3	46.4	91.4	35.3	25.2	7.5	91.3	148.2	115.6	275.4	98.4	34.7	62.0	62.0	19.4	52.9	119.3	66.2	18.8	230.4	83.3	156.4	115.4	186.9	359.1	61.7	43.9	105.6	57.8	74.3	5.2	211.3	173.6	73.3	51.0	56.9	42.5	55.8	87.1	101.7	150.2	33.7	4.9	87.1	156.6	77.6	154.2	1655.0	72.4	89.8	97.8	3.7	126.5	73.0	83.4	4.0	8.5	247.5	129.7	86.9	118.2	145.7	118.6	139.0	96.2	31.7	65.7	49.9	177.0	135.2	204.2	108.0	148.0	423.0	86.1	57.5	95.2	144.6
AEBP1	ACLP	ENSG00000106624	"AE binding protein 1"	Q8IUX7	7	44104345-44114562	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"	"Transcription, Transcription regulation"	"Calmodulin-binding, DNA-binding, Repressor"	"Disease variant, Ehlers-Danlos syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 103.0;Fibroblasts: 263.2;Leydig cells: 151.6;Peritubular cells: 508.9;Smooth muscle cells: 173.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	5	"plasmacytoid DC: 7.6"	"Lineage enriched"	"Detected in many"	5	"dendritic cells: 7.6"	"Cell line enhanced"	"Detected in many"		"ASC diff: 141.1;BJ: 193.0;BJ hTERT+: 126.0;fHDF/TERT166: 208.9;JURKAT: 145.0;WM-115: 117.9"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"spinal cord: 57.6"	"CAB009966, HPA047724, HPA063595, HPA064970"	Supported		Supported	Nucleoplasm,Vesicles,Cytosol	"Secreted - unknown location"	NA	NA		2700000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	Vesicles	"Nucleoplasm, Cytosol"	"CAB009966: AB_2225690, HPA047724: AB_2680132, HPA063595: AB_2685052, HPA064970: AB_2685394"	"unprognostic (1.70e-2)"	"unprognostic (5.42e-2)"	"unprognostic (1.66e-2)"	"unprognostic (1.45e-1)"	"prognostic unfavorable (1.60e-4)"	"unprognostic (1.13e-1)"	"unprognostic (7.00e-2)"	"unprognostic (8.79e-2)"	"unprognostic (2.52e-1)"	"unprognostic (3.27e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.94e-1)"	"prognostic unfavorable (9.31e-9)"	"unprognostic (2.88e-3)"	"unprognostic (9.58e-2)"	"unprognostic (1.17e-2)"	"unprognostic (6.28e-3)"	190.5	59.9	45.0	59.8	56.0	10.6	153.0	38.6	44.8	312.1	28.0	95.3	19.2	268.8	59.6	65.7	199.8	155.9	156.7	47.3	92.9	68.7	20.3	166.0	45.5	114.7	81.5	253.7	28.9	10.1	43.3	89.0	79.6	112.1	25.0	1.3	50.7	213.5	21.3	84.8	79.1	119.3	74.3	54.4	71.2	40.4	52.1	73.3	83.7	14.1	16.7	138.7	198.0	66.6	0.6	0.0	44.5	0.1	141.1	49.6	1.0	193.0	126.0	21.6	4.5	0.0	0.1	5.3	20.9	208.9	0.2	0.1	2.4	3.5	9.1	0.6	0.0	13.3	0.1	0.0	39.6	0.1	0.3	75.8	0.0	72.9	0.1	1.1	9.7	145.0	8.3	0.3	0.0	0.2	86.9	16.1	19.1	0.0	0.4	71.3	1.7	1.7	5.0	0.0	4.9	25.3	0.1	0.3	85.9	41.9	0.4	14.4	34.1	0.0	86.2	0.5	0.3	1.0	0.9	102.8	0.4	0.2	117.9	0.0	0.0	0.0	0.3	0.0	0.2	1.5	0.2	0.0	0.0	1.4	0.9	0.5	0.0	0.1	0.0	7.6	0.0	0.3	45.0	56.0	38.6	44.8	47.3	92.9	114.7	81.5	79.6	74.3	52.1	66.6	23.6	0.0	2.5	32.3	11.8	34.5	5.7	1.3	1.8	0.8	2.0	14.6	26.4	1.5	1.4	7.3	0.0	2.0	22.7	0.0	0.0	0.9	3.1	3.3	103.0	18.0	0.0	1.3	0.1	0.0	3.3	263.2	8.6	2.9	2.5	33.3	30.4	0.6	3.6	0.0	0.3	0.0	0.0	1.8	42.0	18.0	151.6	3.2	85.4	17.8	1.0	0.2	1.0	6.0	0.3	0.4	0.0	508.9	9.7	16.9	0.0	2.2	2.2	0.8	39.5	23.6	173.4	4.0	4.6	1.5	27.4	3.4	4.8	28.7	0.0	2.4
AEN	"FLJ12484, FLJ12562, ISG20L1"	ENSG00000181026	"Apoptosis enhancing nuclease"	Q8WTP8	15	88621337-88632281	"Predicted intracellular proteins"	"Apoptosis, DNA damage"	"Exonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Late spermatids: 62.7"	"Cancer enhanced"	"Detected in all"		"testis cancer: 38.4"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048599			Supported	"Nucleoplasm,Nuclear membrane,Nucleoli"		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 31: Spermatids - Spermatogenesis"	"Nucleoplasm, Nucleoli"	"Nuclear membrane"	"HPA048599: AB_2756313"	"unprognostic (8.64e-2)"	"unprognostic (1.94e-1)"	"unprognostic (2.16e-2)"	"prognostic favorable (1.72e-4)"	"unprognostic (1.52e-2)"	"unprognostic (4.40e-2)"	"unprognostic (4.08e-2)"	"unprognostic (9.42e-2)"	"unprognostic (4.28e-2)"	"unprognostic (1.17e-2)"	"unprognostic (9.00e-2)"	"unprognostic (7.88e-2)"	"unprognostic (8.58e-3)"	"unprognostic (3.39e-2)"	"unprognostic (2.73e-1)"	"unprognostic (8.71e-2)"	"unprognostic (6.10e-2)"	9.1	12.2	6.8	10.7	7.1	17.7	6.0	6.6	6.8	6.8	7.0	8.4	5.1	7.6	9.6	9.6	7.0	12.5	7.3	6.3	11.5	9.0	13.5	10.1	12.8	8.6	7.7	8.0	20.9	4.4	22.4	6.9	7.7	12.1	8.6	1.0	8.3	8.2	15.1	7.2	9.1	10.1	8.1	15.2	13.2	9.8	9.5	10.7	10.3	3.7	11.9	11.5	5.9	7.7	14.9	64.5	39.6	34.2	17.4	20.7	83.7	51.5	46.8	39.1	47.8	53.8	28.2	63.6	16.1	28.3	35.0	20.9	148.0	42.1	32.6	15.7	58.2	34.0	26.4	89.9	42.0	28.5	32.8	25.6	36.4	48.5	39.7	14.0	33.0	20.6	54.6	35.2	48.3	34.4	35.5	24.0	96.0	30.8	36.9	45.4	28.2	46.9	16.5	31.9	31.1	28.5	20.8	23.7	40.1	90.7	19.7	32.0	29.9	39.5	55.1	16.2	70.5	67.0	48.5	54.7	36.0	31.5	79.1	0.0	2.3	0.8	6.2	3.7	12.0	10.9	10.8	8.4	5.2	10.3	11.6	10.6	0.6	3.9	4.9	3.1	19.6	9.2	6.8	7.1	6.6	6.8	6.3	11.5	8.6	7.7	7.7	8.1	9.5	7.7	6.9	6.4	8.1	4.2	21.0	18.6	25.8	6.2	12.0	1.2	21.4	15.4	3.9	8.6	12.9	1.8	0.0	4.7	8.4	5.6	3.9	11.4	23.6	22.5	5.3	7.6	9.0	11.8	20.5	7.6	16.3	9.0	11.7	17.7	2.5	12.3	2.5	6.3	4.5	1.7	16.0	9.9	26.4	4.7	26.4	62.7	4.4	7.8	14.2	3.7	14.2	3.1	9.2	9.0	2.5	11.5	6.2	2.6	26.9	27.8	2.3	5.5	5.4	0.9	13.1	12.0	11.6	10.2	18.2	10.9	28.3	6.2	14.9	6.8	9.7	25.4
AFAP1	"AFAP, AFAP-110"	ENSG00000196526	"Actin filament associated protein 1"	Q8N556	4	7758714-7939926	"Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"Early spermatids: 170.5;Extravillous trophoblasts: 116.3;Inhibitory neurons: 117.2;Late spermatids: 373.8;Oligodendrocyte precursor cells: 125.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"eosinophil: 2.9"	"Group enriched"	"Detected in many"	5	"granulocytes: 2.9;T-cells: 1.2"	"Cell line enhanced"	"Detected in many"		"TIME: 126.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015642, CAB024712"	Enhanced		Supported	"Actin filaments,Focal adhesion sites,Cytosol"		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 71: Testis - DNA repair"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Actin filaments, Cytosol"	"Focal adhesion sites"	"CAB024712: , HPA015642: AB_1844632"	"unprognostic (1.12e-1)"	"unprognostic (2.78e-2)"	"unprognostic (3.97e-1)"	"unprognostic (7.29e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.93e-1)"	"unprognostic (3.30e-1)"	"prognostic unfavorable (2.84e-4)"	"unprognostic (2.00e-1)"	"unprognostic (3.39e-2)"	"unprognostic (3.40e-2)"	"unprognostic (1.38e-1)"	"prognostic unfavorable (8.18e-4)"	"unprognostic (1.40e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.85e-1)"	"unprognostic (2.44e-2)"	12.6	3.1	7.0	8.7	5.8	0.7	9.7	4.5	6.9	8.7	2.9	17.6	5.6	15.4	2.0	11.0	8.5	9.4	10.8	5.8	4.5	4.9	1.2	8.5	4.4	3.7	2.7	7.1	3.8	14.7	7.9	12.6	2.8	7.7	9.8	3.4	8.6	10.2	3.5	5.3	7.7	15.4	3.4	4.0	6.7	22.0	3.5	3.1	7.4	2.4	4.8	14.2	8.3	3.5	31.9	23.2	16.2	12.9	15.4	27.8	21.3	46.4	68.1	43.6	40.0	7.4	7.2	0.1	15.2	75.5	72.3	15.1	8.6	18.7	28.6	0.9	5.7	0.0	33.2	4.5	43.0	0.0	0.4	17.2	13.8	54.4	35.5	72.2	53.0	4.8	0.7	6.8	23.0	10.3	0.6	0.0	7.0	13.2	44.3	0.0	12.1	1.5	4.7	4.1	31.8	53.0	15.9	10.9	12.4	21.4	4.1	0.3	126.7	53.0	11.8	69.6	23.0	0.0	0.2	0.0	18.9	0.1	61.9	0.0	0.4	2.9	0.4	0.1	0.5	0.0	0.6	0.6	0.0	0.0	1.2	0.5	1.0	0.0	0.0	0.0	0.5	0.7	7.0	5.8	4.5	6.9	5.8	4.5	3.7	2.7	2.8	3.4	3.5	3.5	22.5	6.4	2.0	4.6	0.2	2.9	9.7	16.2	7.4	1.2	10.2	8.9	5.9	10.0	12.7	11.0	4.2	5.6	2.3	14.8	0.0	19.2	170.5	7.5	17.6	20.1	14.5	0.0	24.7	7.7	116.3	21.1	11.2	8.8	0.0	4.4	14.3	0.0	8.5	0.0	117.2	20.6	0.0	0.3	3.6	373.8	11.1	6.0	1.8	30.9	0.6	10.2	0.0	125.2	5.4	29.9	8.6	12.4	0.6	13.5	6.4	4.2	6.4	0.7	6.6	8.0	13.4	12.5	10.0	6.2	4.3	8.8	7.3	2.6	13.9	9.9
AFAP1L2	"Em:AC005383.4, FLJ14564, KIAA1914, XB130"	ENSG00000169129	"Actin filament associated protein 1 like 2"	Q8N4X5	10	114294824-114404756	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 64.5;parathyroid gland: 68.7;thyroid gland: 82.2"	"Cell type enhanced"	"Detected in many"		"Collecting duct cells: 40.5;Microglial cells: 34.7;Oligodendrocyte precursor cells: 122.6"	"Cancer enhanced"	"Detected in all"		"thyroid cancer: 39.0"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"B-cells: 1.6;T-cells: 1.8"	"Cell line enhanced"	"Detected in many"		"A-431: 74.4;CAPAN-2: 77.4;EFO-21: 56.4;HaCaT: 98.7;RPMI-8226: 51.3;RPTEC TERT1: 59.7"	"Low region specificity"	"Detected in all"							HPA037843	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 68: Oligodendrocytes - Mixed function"	"Plasma membrane, Cytosol"		"HPA037843: AB_10669990"	"unprognostic (2.31e-3)"	"unprognostic (1.30e-1)"	"unprognostic (2.02e-1)"	"unprognostic (5.06e-3)"	"unprognostic (4.14e-2)"	"unprognostic (9.80e-2)"	"unprognostic (9.88e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.32e-1)"	"prognostic unfavorable (3.76e-4)"	"unprognostic (2.08e-1)"	"prognostic unfavorable (1.55e-5)"	"unprognostic (1.11e-1)"	"unprognostic (3.88e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.86e-1)"	7.6	2.4	15.7	4.2	12.9	0.1	10.2	21.5	13.1	21.8	5.9	13.0	3.9	23.9	13.2	9.3	22.9	4.5	4.7	11.8	12.4	17.6	1.7	5.3	4.3	12.9	12.8	15.1	11.9	68.7	2.4	18.4	13.6	13.1	5.1	3.7	6.9	23.9	3.0	9.8	6.4	18.9	13.6	64.5	5.9	1.4	13.3	13.5	82.2	4.4	7.6	5.9	14.7	13.5	74.4	10.8	10.0	0.1	0.0	0.0	0.0	0.0	0.5	0.4	0.4	0.1	77.4	0.1	56.4	0.6	1.1	98.7	0.2	27.2	0.2	1.5	0.1	0.0	0.7	0.0	3.0	0.0	2.7	0.0	28.9	8.1	7.1	0.3	0.3	2.8	0.0	0.2	0.0	3.1	1.9	0.1	0.5	2.0	0.5	0.9	0.8	51.3	59.7	0.6	0.3	0.5	2.3	1.7	2.9	16.0	0.0	0.1	0.0	0.0	0.4	0.0	0.4	0.0	0.0	0.2	0.1	0.0	0.1	0.0	0.0	0.0	0.5	0.0	1.1	1.6	1.1	1.2	0.0	1.6	0.3	0.9	0.1	0.4	0.0	0.1	1.8	0.6	15.7	12.9	21.5	13.1	11.8	12.4	12.9	12.8	13.6	13.6	13.3	13.5	14.6	0.0	0.0	0.7	1.2	12.4	7.3	3.1	5.2	0.8	1.8	5.3	2.2	0.0	1.8	40.5	0.0	1.5	2.4	8.1	0.0	0.6	1.0	5.3	7.4	14.5	0.0	0.8	6.5	14.3	1.2	10.7	3.1	9.5	0.0	0.3	13.2	0.0	0.5	1.7	10.1	1.8	0.0	0.0	3.7	3.0	3.1	0.5	5.4	34.7	0.6	3.2	0.0	122.6	0.6	23.2	1.7	1.9	0.1	3.7	2.2	0.4	1.5	0.6	19.7	21.4	24.7	0.0	0.8	2.3	6.8	0.3	3.4	2.4	2.2	4.3
AFDN	"AF-6, AF6, MLLT4"	ENSG00000130396	"Afadin, adherens junction formation factor"	P55196	6	167826922-167972023	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"	"Cell adhesion"		"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 173.8;Alveolar cells type 1: 169.9;Breast glandular cells: 119.1;Endometrial ciliated cells: 194.3;Glandular and luminal cells: 273.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"memory B-cell: 1.1"	"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013496, HPA030212, HPA030213, HPA030214, HPA030215, HPA049868"	Approved		Enhanced	"Nucleoplasm,Plasma membrane,Cell Junctions"		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 37: Intestine - Unknown function"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 44: Endometrium - Transcription"	"Plasma membrane, Cell Junctions"	Nucleoplasm	"CAB013496: , HPA030212: AB_10599291, HPA030213: AB_10601340, HPA030214: AB_10601005, HPA030215: AB_10601556, HPA049868: AB_2680924"	"prognostic unfavorable (7.43e-5)"	"unprognostic (2.66e-3)"	"unprognostic (2.07e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.13e-1)"	"unprognostic (9.06e-2)"	"unprognostic (4.12e-1)"	"unprognostic (3.12e-2)"	"unprognostic (4.12e-1)"	"unprognostic (1.09e-3)"	"unprognostic (1.75e-1)"	"unprognostic (1.73e-2)"	"unprognostic (5.56e-2)"	"unprognostic (5.43e-3)"	"unprognostic (1.59e-1)"	"unprognostic (4.72e-2)"	"unprognostic (5.68e-2)"	39.7	15.0	25.1	23.1	34.8	5.5	49.5	27.2	27.9	46.0	35.1	55.3	53.1	35.8	39.8	126.3	63.8	33.6	47.3	21.0	29.7	45.0	66.8	57.0	10.9	30.2	30.0	31.2	61.2	32.8	38.3	44.9	29.5	47.0	62.7	47.1	79.0	28.6	34.0	54.7	71.1	23.9	12.3	34.2	50.6	31.3	31.2	7.3	51.4	28.4	27.3	29.2	61.8	35.3	67.7	20.7	141.2	50.8	13.5	11.3	104.8	26.8	13.7	22.7	27.9	88.8	41.1	12.0	48.3	16.3	35.5	31.8	59.2	55.1	40.3	76.1	61.1	0.4	9.1	67.9	20.3	7.7	30.8	8.0	36.2	38.1	89.0	36.1	42.8	25.6	137.4	45.5	14.9	29.2	0.8	0.6	34.7	95.6	9.5	43.6	37.1	51.2	41.3	32.5	65.1	39.6	27.2	101.7	40.5	131.1	12.2	2.8	62.9	10.6	50.5	45.7	44.9	0.8	59.3	24.5	31.4	15.4	93.7	0.0	0.1	0.0	0.3	0.1	0.2	1.1	0.3	0.1	0.2	0.7	0.0	0.1	0.9	0.0	0.1	0.0	0.2	0.0	25.1	34.8	27.2	27.9	21.0	29.7	30.2	30.0	29.5	12.3	31.2	35.3	173.8	169.9	89.3	0.0	6.4	0.0	0.0	0.0	0.0	0.0	119.1	83.3	0.0	0.0	40.9	95.6	0.0	30.6	4.7	0.0	21.5	70.1	0.0	194.3	42.0	36.3	0.0	0.0	0.0	39.4	35.0	20.5	0.0	273.4	8.8	65.0	0.0	0.0	20.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.8	0.0	0.0	10.9	0.0	0.0	0.0	0.0	65.7	0.0	0.0	4.5	0.0	0.0	35.0	46.7	0.0	0.0	0.0	8.1	0.0	0.0	0.0	0.0	42.1	5.6	13.2	0.0	0.0
AFF3	"LAF4, MLLT2-like"	ENSG00000144218	"AF4/FMR2 family member 3"	P51826	2	99545419-100192428	"Cancer-related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"B-cells: 154.9;Excitatory neurons: 491.3;Inhibitory neurons: 300.7;Oligodendrocyte precursor cells: 211.6"	"Group enriched"	"Detected in many"	5	"breast cancer: 11.4;prostate cancer: 7.3"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	6	"memory B-cell: 31.0;naive B-cell: 44.2;plasmacytoid DC: 23.9"	"Group enriched"	"Detected in many"	17	"B-cells: 44.2;dendritic cells: 23.9"	"Cell line enhanced"	"Detected in many"		"Daudi: 51.1;U-698: 56.5"	"Low region specificity"	"Detected in all"							"HPA044512, HPA053379"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Nucleoplasm	Cytosol	"HPA044512: AB_10795984, HPA053379: AB_2682133"	"unprognostic (1.05e-2)"	"unprognostic (3.01e-2)"	"unprognostic (2.30e-1)"	"unprognostic (4.88e-3)"	"unprognostic (1.02e-1)"	"unprognostic (4.98e-5)"	"unprognostic (1.11e-3)"	"unprognostic (3.04e-2)"	"unprognostic (8.75e-2)"	"unprognostic (3.07e-1)"	"unprognostic (1.95e-3)"	"unprognostic (7.57e-2)"	"prognostic unfavorable (5.64e-4)"	"unprognostic (6.40e-3)"	"unprognostic (6.79e-2)"	"unprognostic (3.69e-2)"	"unprognostic (7.87e-3)"	3.3	1.6	3.1	6.2	3.9	11.2	11.6	17.4	13.2	3.5	0.0	5.1	1.1	7.7	0.8	3.5	4.5	2.2	4.3	9.7	5.0	1.4	1.7	6.5	14.2	2.2	0.0	6.3	0.4	0.1	4.4	6.2	1.8	16.2	2.2	4.2	1.9	2.5	0.7	0.9	6.0	5.9	0.0	7.3	4.6	5.4	0.0	7.7	1.2	0.7	12.2	6.7	2.2	9.8	0.2	0.0	18.0	6.4	0.0	0.6	0.0	2.8	0.7	5.6	1.9	0.0	0.0	51.1	0.1	3.8	12.4	0.2	0.5	0.0	4.0	14.3	6.3	0.0	0.0	0.0	0.4	0.2	12.4	0.8	0.0	12.8	0.2	13.8	0.0	2.2	0.3	0.1	0.0	0.1	4.3	0.3	1.8	0.0	3.2	7.5	0.0	0.3	0.0	0.0	17.4	6.5	0.0	0.3	11.0	1.5	17.9	16.5	6.7	19.1	3.4	0.5	2.9	0.8	0.1	56.5	15.9	1.5	2.0	0.6	0.5	0.1	0.0	0.5	0.3	31.0	0.2	0.0	5.1	44.2	1.9	0.0	0.0	1.0	0.4	23.9	0.0	0.8	3.1	3.9	17.4	13.2	9.7	5.0	2.2	0.0	1.8	0.0	0.0	9.8	1.2	6.4	40.9	41.8	154.9	1.8	0.4	0.0	1.8	21.8	78.9	37.7	11.1	0.0	3.7	0.0	12.5	0.4	32.8	0.1	0.0	0.0	33.9	0.9	19.8	6.0	22.9	3.4	491.3	0.0	0.2	13.5	1.1	1.1	0.0	31.6	0.7	1.2	1.8	47.1	300.7	0.5	0.0	9.2	18.2	38.5	10.8	16.5	14.2	66.5	5.2	6.8	0.0	211.6	46.7	0.0	0.1	21.1	0.8	14.3	0.1	1.9	0.0	1.7	0.0	1.1	8.5	10.5	9.8	0.0	1.3	0.1	6.1	5.7	0.6	0.3
AFF4	"AF5Q31, MCEF"	ENSG00000072364	"AF4/FMR2 family member 4"	Q9UHB7	5	132875395-132963634	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"		"Cancer-related genes, Disease variant, Dwarfism, Obesity, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023690, HPA029634"	Approved		Supported	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm	"Nucleoli fibrillar center"	"HPA023690: AB_1844633, HPA029634: AB_2673129"	"unprognostic (3.24e-2)"	"unprognostic (1.86e-2)"	"unprognostic (6.17e-3)"	"unprognostic (1.45e-1)"	"unprognostic (1.99e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.56e-2)"	"unprognostic (7.37e-2)"	"unprognostic (1.18e-1)"	"unprognostic (6.13e-2)"	"unprognostic (4.94e-2)"	"unprognostic (3.52e-1)"	"unprognostic (1.16e-2)"	"unprognostic (2.77e-2)"	"unprognostic (3.25e-2)"	"prognostic unfavorable (6.44e-4)"	"unprognostic (1.69e-1)"	21.4	28.2	10.9	16.9	13.3	43.4	22.8	20.2	15.3	20.3	9.9	18.5	14.4	26.7	18.2	26.8	16.4	26.0	16.5	11.3	18.7	24.3	21.1	19.7	15.4	11.5	16.1	28.9	24.9	36.3	19.5	20.5	10.6	25.1	17.6	47.3	19.1	21.3	25.4	18.5	15.0	23.6	7.8	16.8	25.1	18.0	19.0	19.0	33.2	25.6	17.1	23.1	19.3	15.6	42.5	33.5	45.2	50.3	34.1	40.9	35.3	44.8	47.9	40.4	51.2	49.8	27.2	21.5	51.7	59.2	49.0	20.8	36.8	55.5	67.3	15.4	23.7	26.6	44.6	17.8	43.6	9.4	26.5	48.2	36.2	70.2	70.7	43.5	39.4	19.2	19.4	17.7	51.2	16.0	26.1	10.0	17.4	12.6	13.6	17.3	44.1	8.1	35.0	58.8	35.2	37.0	50.9	12.3	50.4	62.0	26.2	15.0	55.9	48.3	40.8	43.0	48.2	24.3	45.3	19.3	45.2	17.2	33.7	13.0	1.8	3.2	4.0	1.5	3.0	6.2	3.7	2.8	2.2	6.3	3.8	3.3	4.1	3.0	4.1	4.1	1.9	1.3	10.9	13.3	20.2	15.3	11.3	18.7	11.5	16.1	10.6	7.8	19.0	15.6	134.3	80.1	43.9	62.3	98.7	79.7	79.8	52.0	140.0	74.8	94.1	76.7	65.2	57.2	70.8	58.8	158.4	36.4	75.9	69.9	7.9	51.1	244.1	136.4	147.8	79.3	97.6	29.2	99.5	46.2	47.8	98.0	197.2	229.0	43.1	222.1	54.3	25.2	41.9	79.1	85.1	59.1	50.8	62.3	123.7	200.5	69.3	100.9	69.4	60.9	41.6	61.9	39.1	73.9	106.0	75.8	65.5	67.4	93.0	97.3	56.1	35.7	53.2	135.1	78.9	126.5	103.8	34.2	21.5	130.6	86.5	69.9	68.9	89.6	47.2	120.0
AFG3L2	"SCA28, SPAX5"	ENSG00000141385	"AFG3 like matrix AAA peptidase subunit 2"	Q9Y4W6	18	12328944-12377227	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins"		"Hydrolase, Metalloprotease, Protease"	"Disease variant, Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA004479, HPA004480"	Enhanced		Supported	Mitochondria		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 21: OE19 - Mitochondria"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Mitochondria		"HPA004479: AB_1078109, HPA004480: AB_1078108"	"unprognostic (1.11e-1)"	"unprognostic (7.49e-2)"	"unprognostic (1.67e-1)"	"prognostic unfavorable (8.68e-4)"	"unprognostic (1.31e-1)"	"unprognostic (5.06e-3)"	"unprognostic (1.61e-1)"	"unprognostic (2.33e-1)"	"unprognostic (5.35e-2)"	"unprognostic (1.54e-2)"	"unprognostic (4.05e-2)"	"unprognostic (3.00e-2)"	"prognostic favorable (6.05e-14)"	"unprognostic (5.90e-2)"	"unprognostic (9.41e-2)"	"unprognostic (5.74e-3)"	"unprognostic (2.22e-1)"	26.1	25.9	16.4	21.9	17.0	32.4	29.2	18.2	19.0	24.1	30.8	60.8	79.9	22.1	17.5	41.5	23.8	18.3	88.0	17.0	18.7	62.7	51.0	21.8	23.7	17.7	16.6	24.1	41.1	76.0	18.6	23.5	18.8	24.6	54.1	20.3	30.8	24.4	145.4	29.8	58.7	25.4	15.8	18.5	39.1	18.5	19.0	24.3	39.2	155.8	31.0	30.9	19.6	17.6	56.5	56.6	39.7	44.8	45.2	48.6	52.7	61.9	61.1	86.6	63.1	88.1	34.1	161.3	66.3	56.6	76.8	55.6	101.4	71.3	70.3	38.1	43.5	48.5	59.3	83.5	61.1	185.0	69.8	54.3	76.3	82.1	107.7	47.8	64.0	57.0	111.3	92.8	43.6	89.0	66.7	58.5	55.3	277.4	41.9	74.0	125.1	135.2	74.9	123.6	73.7	51.3	97.0	103.8	90.0	50.5	47.8	84.5	49.0	102.4	88.6	98.7	81.7	64.7	80.7	104.1	56.2	71.4	48.0	3.8	16.5	12.4	11.6	17.6	13.9	14.0	13.8	17.9	21.8	10.3	17.2	20.2	1.1	28.4	16.2	11.5	9.5	13.4	16.4	17.0	18.2	19.0	17.0	18.7	17.7	16.6	18.8	15.8	19.0	17.6	24.3	41.7	49.2	23.2	36.6	22.2	45.3	21.5	42.7	50.2	36.5	36.2	74.9	50.1	28.1	35.0	50.1	58.5	29.1	85.2	72.4	39.5	5.5	37.8	52.3	27.7	39.1	61.0	21.1	37.4	37.9	31.2	53.5	46.1	14.5	41.3	21.8	85.6	37.0	30.3	26.8	82.6	18.3	32.6	14.4	5.5	32.9	34.2	23.2	12.2	27.6	26.9	40.2	14.1	17.7	47.8	43.1	30.1	38.8	43.1	88.7	100.0	22.1	58.3	26.3	53.6	26.9	50.9	65.0	75.8	31.3	92.8	28.4	60.8	94.9	38.2
AFTPH	"FLJ20080, FLJ23793, MGC33965, Nbla10388"	ENSG00000119844	Aftiphilin	Q6ULP2	2	64524305-64593005	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034990, HPA034991"	Approved		Supported	"Golgi apparatus,Vesicles,Cytosol"		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 59: Non-specific - Transcription"	Cytosol	"Golgi apparatus, Vesicles"	"HPA034990: AB_2674398, HPA034991: AB_10603577"	"unprognostic (7.30e-2)"	"unprognostic (4.72e-2)"	"unprognostic (9.16e-2)"	"unprognostic (8.54e-2)"	"unprognostic (3.24e-1)"	"unprognostic (4.25e-2)"	"unprognostic (2.54e-2)"	"unprognostic (1.75e-2)"	"unprognostic (1.52e-1)"	"unprognostic (8.44e-2)"	"unprognostic (3.42e-2)"	"unprognostic (4.65e-2)"	"prognostic favorable (2.37e-5)"	"prognostic favorable (8.44e-4)"	"unprognostic (3.12e-1)"	"unprognostic (1.74e-1)"	"prognostic favorable (1.83e-4)"	15.9	20.2	24.6	21.1	24.9	21.3	32.4	31.2	38.4	22.5	28.3	30.5	23.1	18.8	43.7	29.6	22.9	21.9	12.0	25.3	25.6	56.1	33.6	21.9	37.2	24.6	24.6	19.3	31.6	38.0	25.1	15.0	24.5	34.5	33.7	36.8	28.9	18.6	15.4	33.2	24.5	17.3	24.8	26.4	33.7	24.6	25.4	29.3	25.3	12.9	41.4	25.5	22.4	26.2	29.8	19.3	14.1	17.1	17.8	15.1	23.4	16.7	24.9	26.9	20.1	22.4	21.9	43.9	16.0	20.7	31.1	23.5	24.6	23.3	34.8	42.8	13.5	21.0	12.0	26.5	18.8	40.5	34.5	7.5	48.6	17.4	39.6	19.8	21.4	21.8	16.0	38.7	16.8	16.9	21.9	49.1	13.0	55.9	14.3	17.7	22.6	28.8	48.9	31.5	25.9	13.1	17.7	39.9	35.7	18.0	24.0	30.6	18.5	20.0	23.0	17.0	18.8	43.3	27.8	66.7	15.1	45.3	22.6	40.5	9.3	16.6	7.4	9.3	8.7	21.8	9.3	9.1	12.2	20.3	8.8	6.9	16.3	7.1	14.7	15.8	12.8	5.9	24.6	24.9	31.2	38.4	25.3	25.6	24.6	24.6	24.5	24.8	25.4	26.2	24.6	25.6	39.7	43.1	75.4	122.6	29.6	21.5	55.8	24.2	43.8	23.0	16.0	40.0	33.6	20.2	20.9	13.8	40.5	60.7	37.2	25.5	34.8	44.6	17.8	27.1	46.6	52.0	72.1	25.7	12.4	23.6	35.2	55.9	46.9	17.8	17.5	36.8	20.8	37.0	62.9	40.3	20.3	45.2	77.9	55.1	15.8	52.1	23.2	65.6	60.8	35.0	26.8	52.3	67.0	27.3	43.0	20.7	60.5	42.6	29.0	70.5	40.2	32.9	26.3	25.3	21.2	43.1	21.9	59.0	123.5	27.2	36.5	10.2	40.3	46.1
AGAP2	CENTG1	ENSG00000135439	"ArfGAP with GTPase domain, ankyrin repeat and PH domain 2"	Q99490	12	57723761-57742157	"Predicted intracellular proteins"	"Protein transport, Transport"	"GTPase activation"	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"brain: 219.9"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 16.4;Excitatory neurons: 22.2;Inhibitory neurons: 12.3;NK-cells: 17.5;Sertoli cells: 32.9;Smooth muscle cells: 16.2;T-cells: 16.4"	"Cancer enriched"	"Detected in many"	12	"glioma: 20.6"	"Region enhanced"	"Detected in many"		"cerebral cortex: 219.9"	"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HMC-1: 40.3;Karpas-707: 39.8;RH-30: 98.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023474, HPA075831"	Enhanced		Supported	"Nucleoplasm,Midbody ring,Cytosol"		Yes	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 48: Smooth muscle cells - ECM organization"	"Nucleoplasm, Cytosol"	"Midbody ring"	"HPA023474: AB_1855378, HPA075831: "	"unprognostic (1.87e-1)"	"unprognostic (2.46e-3)"	"unprognostic (9.26e-2)"	"unprognostic (5.56e-4)"	"unprognostic (3.95e-1)"	"unprognostic (1.14e-2)"	"unprognostic (5.00e-2)"	"unprognostic (2.36e-2)"	"unprognostic (3.39e-1)"	"unprognostic (2.80e-1)"	"unprognostic (1.93e-3)"	"unprognostic (4.18e-1)"	"unprognostic (4.81e-9)"	"unprognostic (3.30e-1)"	"unprognostic (2.72e-2)"	"unprognostic (3.07e-1)"	"unprognostic (5.75e-2)"	6.3	2.5	85.4	10.0	69.0	14.5	1.8	0.6	219.9	0.8	0.0	2.2	2.9	2.0	0.3	2.3	1.0	4.3	23.5	162.1	0.0	0.8	1.1	3.4	16.9	0.0	0.0	1.5	3.7	1.8	7.5	2.5	0.0	1.9	1.5	4.6	2.3	0.8	15.1	3.2	5.8	1.0	0.0	11.4	3.3	1.0	0.0	15.0	2.5	9.9	11.3	3.2	1.0	38.7	7.3	10.5	19.8	5.8	0.0	0.0	11.3	4.8	0.9	0.1	0.5	1.2	6.6	18.4	1.5	0.0	3.6	4.4	0.1	0.2	0.0	20.3	3.1	20.5	1.6	3.4	0.1	21.2	40.3	0.0	0.0	0.1	0.1	8.4	0.0	21.3	0.0	39.8	0.0	12.6	37.4	13.5	3.2	2.3	10.6	15.5	98.8	13.4	0.0	6.0	5.6	20.5	2.6	3.6	4.3	0.1	2.6	14.8	11.2	5.5	9.0	10.5	3.6	16.8	10.9	9.4	9.8	13.9	9.4	3.8	0.5	0.6	2.7	0.8	2.9	1.2	2.8	3.0	0.8	0.8	1.1	1.7	3.8	1.4	0.4	0.8	4.2	1.1	85.4	69.0	0.6	219.9	162.1	0.0	0.0	0.0	0.0	0.0	0.0	38.7	3.6	3.2	1.1	0.0	5.7	0.0	0.3	0.0	0.0	10.0	0.8	0.5	5.8	1.5	0.6	0.0	0.0	0.1	16.4	0.2	0.0	0.1	0.4	0.1	0.7	4.2	0.0	2.1	22.2	0.0	0.2	0.9	2.0	0.2	2.5	0.0	1.1	0.1	1.3	8.4	12.3	0.5	0.0	2.2	1.1	1.1	0.0	3.0	0.0	1.9	3.9	0.5	17.5	5.0	1.2	0.1	0.1	0.7	11.4	0.3	0.3	0.1	0.0	2.3	32.9	2.2	16.2	0.8	0.4	0.2	0.4	0.0	16.4	0.3	0.2	0.0
AGBL5	"CCP5, FLJ21839"	ENSG00000084693	"ATP/GTP binding protein like 5"	Q8NDL9	2	27042364-27070622	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"		"Carboxypeptidase, Hydrolase, Metalloprotease, Protease"	"Disease variant, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"parathyroid gland: 49.9;testis: 192.9"	"Group enriched"	"Detected in many"	6	"Early spermatids: 302.7;Late spermatids: 338.0;Spermatocytes: 156.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030981	Uncertain		Supported	"Microtubules,Cytokinetic bridge,Cytosol"		Yes	No			"Cluster 34: Basophils - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 25: Spermatids - Spermatogenesis"	"Cytokinetic bridge"	"Microtubules, Cytosol"	"HPA030981: AB_10611673"	"unprognostic (1.29e-2)"	"unprognostic (8.70e-2)"	"unprognostic (2.26e-1)"	"unprognostic (3.13e-3)"	"unprognostic (1.95e-1)"	"unprognostic (1.07e-1)"	"prognostic unfavorable (6.87e-5)"	"unprognostic (1.86e-1)"	"unprognostic (4.34e-1)"	"unprognostic (6.20e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.20e-1)"	"unprognostic (3.41e-2)"	"unprognostic (5.56e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.69e-2)"	"unprognostic (4.50e-2)"	8.8	16.7	8.4	8.0	7.4	13.6	12.4	7.8	8.2	14.4	9.5	16.2	8.8	14.0	26.0	18.3	20.8	14.3	12.7	7.3	11.3	22.5	7.2	11.2	10.7	8.3	7.8	14.4	15.0	49.9	12.5	11.2	8.9	15.2	11.5	16.3	21.2	16.5	7.1	20.5	9.9	14.6	6.1	8.5	11.8	192.9	9.1	15.6	28.5	6.5	8.6	14.9	7.3	7.5	55.0	34.7	55.4	37.2	11.6	23.0	62.9	10.9	23.5	30.9	31.9	30.2	40.5	30.3	34.0	18.9	43.4	24.6	44.8	49.4	33.9	25.9	66.8	44.5	42.0	65.7	23.6	21.6	14.4	24.4	36.7	27.1	22.0	46.9	32.8	43.5	38.9	23.8	30.3	21.5	63.2	32.3	39.4	39.4	23.7	64.5	62.9	48.0	31.9	13.6	37.1	53.6	21.5	16.7	35.0	53.9	24.9	16.3	16.4	28.6	39.2	13.8	23.9	47.7	27.2	62.4	31.8	24.4	26.1	8.8	1.8	4.5	3.3	1.1	2.5	4.6	4.1	4.6	4.1	2.3	3.6	2.2	1.1	8.5	0.7	2.3	2.8	3.8	8.4	7.4	7.8	8.2	7.3	11.3	8.3	7.8	8.9	6.1	9.1	7.5	3.6	0.0	10.1	5.2	6.3	3.3	8.3	7.2	13.6	5.7	8.6	6.7	6.7	10.0	6.8	9.2	0.0	14.7	1.8	5.9	19.6	8.3	302.7	13.0	3.9	4.9	2.4	11.6	7.9	6.0	7.9	6.4	5.6	5.8	1.3	14.1	6.4	4.1	5.2	0.0	9.1	8.4	6.1	3.1	3.5	338.0	10.5	8.0	7.2	6.5	4.9	6.8	0.0	10.1	10.1	5.0	7.6	11.3	17.1	6.0	6.3	25.0	10.7	10.0	0.0	4.2	7.0	156.8	41.2	16.3	2.7	8.3	5.0	9.4	8.6	10.5
AGER	"RAGE, SCARJ1"	ENSG00000204305	"Advanced glycosylation end-product specific receptor"	Q15109	6	32180968-32184322	"Cancer-related genes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters"	"Inflammatory response"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	19	"lung: 728.3"	"Cell type enriched"	"Detected in many"	22	"Alveolar cells type 1: 2394.2"	"Cancer enhanced"	"Detected in all"		"lung cancer: 27.2;thyroid cancer: 20.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEK 293: 2.5;JURKAT: 3.0;RPTEC TERT1: 2.2;U-266/70: 2.4;U-266/84: 2.0"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"CAB011682, HPA064436, HPA069474"	Enhanced		Approved	"Nucleoli fibrillar center,Plasma membrane,Cell Junctions"	"Secreted in other tissues"	NA	NA	5360000	100000		"Cluster 19: Lung - Lung function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 11: Alveolar cells - Smell perception"	"Plasma membrane, Cell Junctions"	"Nucleoli fibrillar center"	"CAB011682: AB_2258049, HPA064436: AB_2685264, HPA069474: "	"unprognostic (9.37e-2)"	"unprognostic (3.70e-1)"	"unprognostic (2.37e-2)"	"unprognostic (1.14e-1)"	"unprognostic (4.55e-2)"	"unprognostic (1.59e-3)"	"unprognostic (4.36e-2)"	"unprognostic (1.00e-1)"	"unprognostic (4.38e-2)"	"unprognostic (1.27e-1)"	"prognostic favorable (3.41e-4)"	"unprognostic (1.24e-1)"	"prognostic unfavorable (9.01e-7)"	"unprognostic (3.57e-1)"	"unprognostic (3.70e-2)"	"unprognostic (4.44e-2)"	"prognostic favorable (2.74e-6)"	2.2	1.7	0.1	1.1	0.1	0.5	1.6	0.1	0.4	4.4	0.2	3.9	0.6	2.5	1.9	2.1	4.5	0.1	2.7	0.2	0.1	6.4	2.7	728.3	0.6	0.2	0.1	4.8	1.7	0.0	5.0	0.4	0.2	4.9	0.8	0.4	1.6	0.0	1.0	2.0	3.2	0.1	0.1	7.0	2.0	2.2	0.2	0.8	39.2	0.1	0.5	2.9	3.2	0.3	0.1	0.0	0.0	0.3	0.1	0.9	1.5	0.0	0.1	0.0	0.1	0.0	0.2	0.1	1.0	0.2	0.0	1.0	0.1	0.3	0.2	0.2	2.5	0.7	0.0	0.0	0.0	0.3	1.1	0.0	0.1	0.0	0.1	0.2	0.1	3.0	0.0	0.3	0.1	1.3	0.1	0.9	0.0	0.1	0.0	0.0	0.1	0.1	2.2	0.0	0.0	0.2	0.0	0.0	1.1	0.0	0.5	0.0	0.1	0.0	0.6	0.8	0.1	2.4	2.0	0.9	1.1	0.3	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.4	0.2	0.1	0.2	0.1	0.2	0.1	0.2	0.3	5.4	2394.2	107.9	5.9	4.9	0.9	1.5	2.0	2.8	5.1	1.5	2.9	3.0	4.3	20.9	1.8	0.0	1.1	2.7	1.1	0.0	1.5	0.4	1.1	2.6	4.1	0.0	4.4	0.5	1.0	0.9	3.0	1.5	1.9	17.7	3.1	2.9	2.0	1.3	6.7	0.6	1.3	0.0	5.3	6.5	1.2	1.8	5.3	1.8	4.7	4.8	4.6	2.1	2.5	1.3	1.1	2.7	1.2	3.3	2.6	0.8	0.3	5.6	3.4	6.6	1.2	2.6	0.1	1.2	1.6	1.8	2.2	6.2	1.7	1.2	0.9
AGFG1	"HRB, RAB, RIP"	ENSG00000173744	"ArfGAP with FG repeats 1"	P52594	2	227472152-227561217	"Predicted intracellular proteins"	"Differentiation, mRNA transport, Spermatogenesis, Transport"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 333.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008741	Approved		Supported	Vesicles		NA	NA		120000	"Cluster 7: Monocytes - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 25: Spermatids - Spermatogenesis"	Vesicles		"HPA008741: AB_1850752"	"unprognostic (5.76e-2)"	"prognostic unfavorable (7.13e-4)"	"unprognostic (8.73e-3)"	"unprognostic (6.31e-3)"	"prognostic favorable (6.10e-4)"	"unprognostic (9.30e-3)"	"prognostic unfavorable (7.31e-6)"	"prognostic unfavorable (1.85e-4)"	"unprognostic (1.30e-1)"	"prognostic unfavorable (3.43e-5)"	"unprognostic (2.03e-2)"	"unprognostic (5.78e-2)"	"prognostic unfavorable (6.92e-4)"	"unprognostic (1.25e-1)"	"unprognostic (2.37e-1)"	"unprognostic (1.98e-1)"	"unprognostic (4.24e-3)"	69.4	39.4	30.4	48.4	31.6	155.5	51.1	29.3	36.0	25.3	23.8	32.2	43.4	25.7	20.1	47.2	27.3	38.9	36.2	32.4	27.0	36.9	36.2	54.6	47.1	34.6	29.0	26.1	35.0	41.6	17.9	75.8	33.4	21.0	33.0	47.7	27.9	23.4	33.9	36.3	36.2	39.3	33.6	46.5	33.2	92.8	34.5	48.6	34.3	38.6	53.3	65.7	32.2	47.3	60.5	97.9	50.8	49.6	84.8	62.1	191.6	78.4	74.6	92.0	81.2	77.4	67.6	42.7	58.3	86.8	123.8	62.2	87.9	101.7	118.6	72.3	48.9	94.1	80.8	144.3	90.9	64.7	57.0	38.3	106.4	116.7	109.5	70.3	93.7	43.3	100.3	112.0	111.8	85.8	77.8	58.0	79.3	80.4	50.4	70.8	83.6	30.3	91.7	81.5	47.0	36.7	64.1	82.5	74.7	87.6	35.3	72.4	92.7	78.8	63.0	114.7	70.0	64.5	46.9	59.6	85.6	54.4	92.5	4.1	5.3	1.9	1.6	4.3	3.2	2.0	1.8	1.5	3.3	3.5	1.5	2.8	5.6	1.1	4.2	2.3	2.3	1.6	30.4	31.6	29.3	36.0	32.4	27.0	34.6	29.0	33.4	33.6	34.5	47.3	36.6	25.6	23.6	45.7	27.2	33.1	37.5	18.0	18.2	37.7	29.3	22.1	23.3	17.2	19.6	22.0	25.0	31.0	26.5	28.2	15.6	17.5	162.3	32.7	34.9	29.1	34.1	13.3	114.2	21.5	17.5	26.8	39.8	65.8	12.7	30.4	23.6	22.9	24.1	43.7	74.9	20.4	12.2	92.8	33.6	333.2	15.5	67.3	19.6	119.9	48.4	43.3	19.6	109.6	116.0	32.6	18.0	11.7	22.7	39.4	31.3	27.4	15.5	35.4	19.7	83.8	21.7	72.6	18.4	25.0	32.1	39.7	24.0	20.6	22.2	57.9
AGK	"FLJ10842, MULK"	ENSG00000006530	"Acylglycerol kinase"	Q53H12	7	141551278-141655244	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		"Kinase, Transferase"	"Cardiomyopathy, Cataract, Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 43.4;Inhibitory neurons: 43.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"NK-cell: 97.3"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020959, HPA053471"	Supported		Supported	Vesicles,Mitochondria	"Intracellular and membrane"	NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	Mitochondria	Vesicles	"HPA020959: AB_1854206, HPA053471: AB_2682164"	"unprognostic (1.11e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.79e-1)"	"unprognostic (1.28e-2)"	"unprognostic (9.47e-3)"	"unprognostic (5.43e-2)"	"unprognostic (2.15e-2)"	"unprognostic (3.68e-2)"	"unprognostic (2.03e-1)"	"unprognostic (3.43e-2)"	"unprognostic (1.14e-1)"	"unprognostic (6.24e-3)"	"unprognostic (7.90e-2)"	"unprognostic (9.29e-2)"	"unprognostic (9.65e-2)"	"unprognostic (3.30e-1)"	"unprognostic (1.18e-1)"	10.1	14.7	9.4	8.5	10.9	5.6	11.9	8.3	12.8	11.5	10.2	11.8	5.9	11.7	14.5	12.2	12.2	7.8	30.4	11.1	10.8	15.7	14.1	11.6	12.1	8.0	8.8	11.3	10.1	21.5	13.7	10.0	9.0	12.8	13.1	12.7	13.7	11.4	8.6	9.6	12.0	15.4	8.2	16.6	12.2	6.6	10.0	14.0	12.7	10.0	14.7	10.8	11.5	9.0	23.7	25.6	26.7	21.8	21.2	29.4	16.2	23.5	29.3	44.5	50.9	24.7	18.3	26.3	24.0	26.8	40.5	18.7	41.6	32.8	51.0	33.8	32.7	26.1	10.7	18.7	34.1	15.6	12.5	29.9	26.9	36.3	33.1	19.8	34.1	32.3	36.3	36.9	25.3	24.6	47.3	9.1	25.6	19.9	32.4	29.2	4.2	80.1	33.1	20.8	23.3	29.6	24.6	29.7	27.1	26.1	16.3	20.2	19.5	18.9	14.1	23.8	38.1	29.5	31.9	14.4	30.7	9.1	50.4	0.4	7.1	1.2	22.1	13.9	15.3	10.8	17.3	26.0	16.2	6.5	12.8	23.5	1.2	97.3	8.2	6.3	18.9	15.7	9.4	10.9	8.3	12.8	11.1	10.8	8.0	8.8	9.0	8.2	10.0	9.0	8.4	0.0	6.0	22.5	11.4	3.1	5.6	7.9	5.2	11.8	5.5	5.1	18.1	2.8	6.6	12.9	8.4	15.7	15.8	3.0	9.8	6.6	9.9	7.4	9.0	7.5	0.0	11.8	43.4	6.9	8.2	7.7	10.7	6.6	8.2	9.9	4.2	4.1	7.0	15.2	43.0	3.9	12.2	5.1	4.9	12.0	6.8	5.6	7.2	26.2	12.4	11.2	27.8	38.7	37.9	6.1	2.1	10.5	22.1	2.9	2.4	8.2	7.6	17.4	0.0	6.2	8.0	6.2	4.9	11.3	2.7	9.2	15.0	14.2	5.6	3.8
AGL		ENSG00000162688	"Amylo-alpha-1, 6-glucosidase, 4-alpha-glucanotransferase"	P35573	1	99850361-99924023	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted membrane proteins"	"Glycogen biosynthesis"	"Glycosidase, Glycosyltransferase, Hydrolase, Multifunctional enzyme, Transferase"	"Disease variant, Glycogen storage disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"skeletal muscle: 257.6;tongue: 212.0"	"Cell type enhanced"	"Detected in all"		"Muller glia cells: 160.5;Theca cells: 159.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028498, HPA054340"	Approved		Supported	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA		450000	"Cluster 15: NK-cells - Transcription"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 5: Muller glia cells - Visual perception"	Nucleoplasm	"Nuclear bodies, Cytosol"	"HPA028498: AB_10600975, HPA054340: AB_2682455"	"unprognostic (2.90e-1)"	"unprognostic (5.34e-2)"	"unprognostic (3.99e-3)"	"unprognostic (2.18e-2)"	"unprognostic (6.46e-3)"	"unprognostic (5.13e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.92e-2)"	"unprognostic (9.37e-3)"	"unprognostic (1.11e-1)"	"unprognostic (8.10e-3)"	"unprognostic (7.61e-2)"	"prognostic favorable (1.73e-10)"	"unprognostic (6.38e-2)"	"unprognostic (2.89e-1)"	"unprognostic (1.15e-1)"	"unprognostic (7.13e-2)"	11.9	6.7	4.1	7.1	4.9	6.1	9.1	6.9	5.6	6.1	6.0	10.0	8.8	7.3	7.6	16.4	5.4	5.2	22.8	3.7	5.1	13.3	42.8	5.9	7.3	4.7	5.6	5.9	4.3	17.6	4.5	11.7	4.4	13.8	10.6	23.3	7.7	9.6	257.6	5.3	7.1	9.7	4.9	8.0	7.7	4.7	4.8	7.9	10.5	212.0	8.5	8.9	5.0	5.6	20.4	5.9	7.0	11.4	11.0	10.4	23.4	6.3	9.2	5.5	9.8	22.3	6.8	26.4	11.7	10.8	4.9	11.3	40.5	12.4	10.2	14.2	12.9	15.5	18.9	12.4	7.3	13.7	8.9	12.8	7.9	7.5	6.2	7.5	8.5	9.2	26.3	2.0	5.5	6.2	16.3	4.3	10.9	8.9	7.7	0.0	2.3	1.3	16.3	26.7	17.2	12.1	18.2	17.3	9.9	12.8	12.6	9.0	9.4	6.6	9.3	8.9	6.3	7.3	6.1	30.5	11.7	3.6	3.5	0.0	0.4	1.4	1.5	0.6	1.4	1.0	1.1	1.0	0.9	1.0	1.1	1.1	0.5	2.4	0.3	0.8	1.3	0.8	4.1	4.9	6.9	5.6	3.7	5.1	4.7	5.6	4.4	4.9	4.8	5.6	12.8	22.4	26.8	96.6	28.5	10.6	18.1	24.6	18.2	34.6	18.8	18.0	119.6	18.6	25.8	16.5	54.2	107.9	18.8	23.2	23.5	13.7	1.2	18.8	23.6	13.9	16.8	15.6	45.6	12.9	20.3	28.5	31.1	18.6	10.8	45.0	14.6	111.0	17.9	52.2	56.0	15.8	12.2	19.1	8.8	2.5	10.2	13.5	16.0	23.4	14.1	160.5	21.6	36.2	34.4	17.7	14.3	21.4	20.4	13.0	15.2	19.2	26.0	46.9	6.6	41.4	18.4	8.7	11.9	40.0	9.2	29.1	25.7	159.1	23.5	20.1
AGO1	"EIF2C1, hAGO1"	ENSG00000092847	"Argonaute RISC component 1"	Q9UL18	1	35869808-35930532	"Predicted intracellular proteins"	"RNA-mediated gene silencing, Transcription, Transcription regulation, Translation regulation"	"Repressor, Ribonucleoprotein, RNA-binding"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA067849			Supported	"Cytosol,Cytoplasmic bodies"		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	"Cytoplasmic bodies"	Cytosol	"HPA067849: "	"unprognostic (2.35e-1)"	"unprognostic (3.14e-2)"	"unprognostic (1.27e-2)"	"unprognostic (8.66e-3)"	"unprognostic (1.20e-1)"	"unprognostic (3.71e-2)"	"prognostic unfavorable (4.57e-5)"	"unprognostic (3.61e-2)"	"unprognostic (6.08e-2)"	"unprognostic (1.88e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.34e-1)"	"prognostic favorable (2.60e-4)"	"unprognostic (7.52e-2)"	"unprognostic (1.74e-1)"	"unprognostic (7.57e-2)"	"unprognostic (5.77e-3)"	6.2	6.6	10.7	7.6	9.5	6.5	6.5	7.1	8.6	7.0	7.5	6.5	6.7	7.1	5.0	5.8	6.6	4.8	7.2	8.9	9.3	6.2	4.7	6.4	6.7	9.1	9.7	8.0	5.7	10.1	5.1	5.1	9.1	8.1	7.0	6.7	6.5	8.6	8.6	11.0	7.4	7.9	11.3	8.9	6.4	5.2	8.4	9.0	6.0	7.9	8.4	5.1	4.4	9.1	14.2	9.4	21.1	18.7	14.4	8.6	23.2	7.3	11.1	12.6	11.9	19.2	9.9	16.0	9.0	14.6	8.7	7.5	30.4	11.7	15.3	14.9	10.0	32.4	15.4	16.8	6.4	19.4	12.5	7.1	5.5	21.3	10.9	8.0	18.2	13.7	24.0	8.9	10.3	10.9	20.4	10.0	47.6	19.1	8.0	15.3	15.9	6.8	5.5	17.8	26.1	11.6	25.6	10.5	8.4	23.7	8.5	7.7	14.9	9.8	21.6	13.7	13.9	9.1	7.9	7.4	10.3	11.6	12.7	1.9	3.8	1.8	1.9	5.1	1.7	1.6	1.4	1.7	1.6	1.4	1.6	1.5	2.4	1.4	4.1	1.6	1.3	4.5	10.7	9.5	7.1	8.6	8.9	9.3	9.1	9.7	9.1	11.3	8.4	9.1	10.1	3.2	9.3	11.4	11.8	13.9	7.2	6.4	17.6	34.0	13.0	9.9	15.8	12.8	9.1	14.7	39.6	5.2	25.4	12.6	1.9	11.5	5.2	11.6	12.4	13.3	25.9	5.5	15.3	13.2	4.7	10.6	9.7	7.7	16.5	12.5	10.0	13.4	13.3	35.3	15.6	15.5	6.1	30.5	20.0	6.7	14.9	19.2	5.4	4.7	23.9	12.9	20.6	13.6	14.5	11.3	11.1	20.7	7.9	10.6	29.4	10.1	11.4	30.5	13.1	13.1	15.5	12.7	16.8	10.8	14.5	2.3	10.7	14.7	16.2	7.2
AGO2	"CASC7, EIF2C2, hAGO2, LINC00980, Q10"	ENSG00000123908	"Argonaute RISC catalytic component 2"	Q9UKV8	8	140520156-140635633	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"RNA-mediated gene silencing, Transcription, Transcription regulation, Translation regulation"	"Endonuclease, Hydrolase, Nuclease, Repressor, Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB019309, HPA067849"	Approved		Supported	"Cytosol,Cytoplasmic bodies"		NA	NA		65000	"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 44: Endometrium - Transcription"	"Cytoplasmic bodies"	Cytosol	"CAB019309: , HPA067849: "	"unprognostic (2.75e-2)"	"unprognostic (1.79e-3)"	"unprognostic (1.27e-1)"	"prognostic unfavorable (1.21e-4)"	"unprognostic (2.46e-1)"	"unprognostic (2.15e-1)"	"unprognostic (1.49e-3)"	"unprognostic (8.86e-2)"	"unprognostic (2.21e-1)"	"unprognostic (8.50e-2)"	"unprognostic (3.47e-2)"	"unprognostic (2.73e-1)"	"prognostic unfavorable (1.82e-5)"	"unprognostic (1.32e-1)"	"unprognostic (2.77e-1)"	"unprognostic (1.32e-1)"	"unprognostic (3.02e-1)"	7.8	4.1	6.9	6.2	11.5	11.3	5.9	12.4	9.2	6.9	2.4	8.6	3.2	7.7	5.9	6.3	8.3	5.1	7.3	5.7	11.4	5.9	3.8	9.1	6.1	14.0	10.1	9.5	5.0	7.0	8.0	5.8	11.3	5.8	4.0	6.8	4.8	4.6	17.5	8.5	6.2	5.2	5.9	5.2	6.6	3.3	10.8	7.6	6.3	9.1	5.4	6.6	6.7	19.2	18.9	15.2	15.3	17.6	9.9	11.5	12.9	11.6	8.4	5.1	6.3	17.0	5.5	21.5	14.1	11.3	5.5	12.4	26.2	12.5	11.3	12.2	13.7	25.2	28.7	11.0	8.9	10.5	8.2	7.9	11.0	14.1	14.6	7.0	12.0	13.4	26.9	13.2	16.8	28.5	18.2	8.3	11.4	12.9	26.3	18.5	12.9	9.7	6.5	19.3	18.0	13.0	18.1	6.1	12.8	15.7	15.7	15.1	16.9	8.8	24.5	14.0	18.9	11.5	4.0	14.7	6.5	18.7	13.2	0.7	0.8	0.2	0.8	0.7	0.9	0.4	0.8	0.7	0.7	0.7	0.8	0.8	2.2	0.8	0.8	0.5	0.7	0.6	6.9	11.5	12.4	9.2	5.7	11.4	14.0	10.1	11.3	5.9	10.8	19.2	30.8	22.4	25.1	50.3	40.7	21.9	74.8	5.7	17.6	26.5	34.5	24.5	22.2	8.6	22.6	14.7	43.8	46.5	63.1	14.8	7.9	25.6	21.2	73.1	54.3	37.8	24.2	122.9	32.6	18.2	21.5	44.3	28.5	129.4	17.1	31.6	27.5	14.6	14.9	42.1	36.4	19.1	2.0	26.0	48.5	14.9	37.3	53.0	5.4	32.8	36.0	26.1	32.0	51.3	83.2	37.9	18.6	46.3	46.6	115.0	12.7	9.4	15.4	29.7	32.9	65.9	44.5	3.1	4.0	31.8	23.9	79.1	49.1	12.0	19.3	100.1
AGO3	"EIF2C3, FLJ12765, hAGO3"	ENSG00000126070	"Argonaute RISC catalytic component 3"	Q9H9G7	1	35930718-36072500	"Enzymes, Predicted intracellular proteins"	"RNA-mediated gene silencing, Translation regulation"	"Endonuclease, Hydrolase, Nuclease, Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Oligodendrocytes: 155.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA048342, HPA067849, HPA075436"	Uncertain		Supported	"Nucleoplasm,Cytosol,Cytoplasmic bodies"		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	"Cytoplasmic bodies"	"Nucleoplasm, Cytosol"	"HPA048342: AB_2680365, HPA067849: , HPA075436: AB_2686750"	"unprognostic (4.10e-2)"	"unprognostic (7.10e-2)"	"unprognostic (4.94e-2)"	"prognostic unfavorable (5.70e-4)"	"unprognostic (1.89e-2)"	"unprognostic (2.12e-2)"	"unprognostic (4.39e-4)"	"unprognostic (5.14e-2)"	"unprognostic (2.37e-3)"	"unprognostic (1.30e-1)"	"unprognostic (4.97e-2)"	"unprognostic (2.96e-2)"	"unprognostic (9.28e-3)"	"unprognostic (1.61e-1)"	"unprognostic (4.45e-2)"	"unprognostic (9.06e-2)"	"unprognostic (1.81e-1)"	3.6	2.8	4.5	2.6	8.4	7.4	2.9	6.9	6.9	3.3	7.4	3.0	1.4	2.9	3.2	2.7	2.7	1.9	3.4	4.6	6.9	2.5	4.3	3.5	3.0	8.5	7.2	3.7	2.9	3.3	6.2	3.5	7.4	3.2	2.0	5.1	2.5	2.2	3.2	3.8	2.5	2.7	6.8	2.8	2.8	5.6	8.0	3.3	3.2	4.4	3.1	3.0	3.0	14.0	6.6	4.4	5.5	4.4	7.5	4.6	6.7	5.2	5.4	7.9	8.4	4.9	7.2	7.2	6.5	5.4	9.1	5.3	5.9	3.8	10.5	9.9	3.7	8.8	8.3	3.7	4.0	8.5	7.2	2.2	3.4	11.4	7.2	3.1	6.8	7.4	9.8	10.2	7.0	2.5	6.5	4.6	9.6	3.4	7.8	7.5	7.4	7.1	2.5	6.2	6.7	4.2	9.4	2.3	3.3	8.3	3.5	3.5	5.4	5.5	13.9	4.9	6.4	5.6	10.5	9.9	2.8	5.4	5.4	9.8	4.3	13.2	4.9	4.1	3.1	6.5	3.1	3.4	4.8	6.4	4.4	4.3	13.0	5.4	6.1	4.2	3.4	2.3	4.5	8.4	6.9	6.9	4.6	6.9	8.5	7.2	7.4	6.8	8.0	14.0	32.2	86.6	43.2	80.6	32.6	38.7	35.9	17.8	35.3	69.1	26.1	17.8	19.1	17.2	23.0	25.8	112.6	11.8	36.6	13.2	0.0	15.8	56.0	26.6	43.0	33.8	46.7	18.7	103.8	12.2	14.8	42.3	19.9	35.6	55.9	31.6	36.8	24.7	16.4	42.1	101.1	16.0	20.3	31.7	45.1	76.7	37.9	29.7	23.2	70.3	36.9	35.2	27.8	141.8	155.9	17.3	9.1	41.3	24.7	41.1	15.0	8.8	17.5	89.6	19.7	64.4	29.9	37.5	22.1	20.0	33.5	12.9	35.3	31.0	17.5	27.9
AGO4	"EIF2C4, FLJ20033, hAGO4, KIAA1567"	ENSG00000134698	"Argonaute RISC component 4"	Q9HCK5	1	35808016-35857890	"Predicted intracellular proteins"	"RNA-mediated gene silencing, Translation regulation"	"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 60.6;Inhibitory neurons: 72.0;Microglial cells: 63.7;Oligodendrocyte precursor cells: 87.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 7.5"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"THP-1: 24.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012179, HPA067849"	Approved		Supported	"Cytosol,Cytoplasmic bodies"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	"Cytoplasmic bodies"	Cytosol	"CAB012179: , HPA067849: "	"unprognostic (2.67e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.06e-1)"	"unprognostic (5.01e-2)"	"unprognostic (1.76e-1)"	"prognostic favorable (5.70e-5)"	"unprognostic (3.92e-3)"	"unprognostic (3.99e-3)"	"unprognostic (2.32e-2)"	"unprognostic (9.28e-2)"	"unprognostic (3.16e-1)"	"unprognostic (2.45e-3)"	"unprognostic (4.91e-3)"	"unprognostic (4.96e-2)"	"unprognostic (2.58e-1)"	"unprognostic (3.96e-1)"	"unprognostic (1.58e-2)"	8.8	4.9	7.2	8.8	7.1	20.4	7.7	8.6	7.9	8.4	8.6	9.6	4.7	8.9	6.6	7.3	7.2	6.2	9.9	6.8	6.8	5.0	7.5	11.4	7.0	7.4	7.1	7.0	8.6	6.5	5.8	8.9	7.4	8.1	6.4	18.1	8.4	6.1	13.3	20.1	7.8	9.8	6.8	14.2	9.7	7.3	7.3	7.3	5.5	11.8	6.8	8.2	8.5	7.6	6.0	1.5	11.3	6.5	5.8	6.6	5.7	4.5	4.4	4.6	5.3	0.8	9.0	9.6	6.0	6.6	4.7	2.4	4.9	3.6	4.3	10.7	4.5	4.9	4.2	2.8	5.5	5.6	7.2	4.3	7.6	2.5	3.8	8.8	7.9	11.5	3.7	3.7	6.2	0.9	9.1	6.2	3.7	3.8	2.7	9.0	10.1	1.2	4.5	7.4	5.0	7.3	4.1	3.7	12.7	9.6	3.0	24.6	9.5	3.5	1.7	3.6	3.4	5.4	1.8	1.4	4.3	7.0	3.2	1.3	2.7	3.0	0.8	1.5	1.4	0.6	0.7	1.1	2.0	0.4	0.3	0.4	7.5	0.6	1.4	0.4	0.2	0.8	7.2	7.1	8.6	7.9	6.8	6.8	7.4	7.1	7.4	6.8	7.3	7.6	16.4	19.2	21.7	54.9	6.7	9.8	4.7	5.4	9.6	28.2	8.5	7.1	21.8	12.8	9.2	11.0	22.9	4.2	17.9	5.5	1.9	5.6	2.0	12.7	9.4	11.6	12.6	5.0	60.6	5.6	4.7	7.2	10.7	10.9	2.5	11.4	22.1	11.5	13.5	6.7	72.0	8.4	2.0	42.3	10.0	1.6	5.0	28.9	3.6	63.7	33.6	6.5	6.2	87.4	54.8	14.4	11.7	5.7	4.3	9.0	10.0	1.5	10.3	32.2	19.7	6.8	8.5	11.3	1.6	5.9	12.8	4.1	10.3	3.6	5.7	6.7
AGPAT1	LPAAT-alpha	ENSG00000204310	"1-acylglycerol-3-phosphate O-acyltransferase 1"	Q99943	6	32168212-32178096	"Enzymes, Metabolic proteins, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Late spermatids: 91.7"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"cerebral cortex: 47.1"	"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA048478, HPA073355"	Approved		Supported	"Endoplasmic reticulum,Rods & Rings"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 72: Non-specific - Transcription"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 45: Enterocytes - Digestion"	"Endoplasmic reticulum"	"Rods & Rings"	"HPA048478: AB_2680411, HPA073355: AB_2686596"	"prognostic unfavorable (1.93e-4)"	"unprognostic (9.35e-3)"	"unprognostic (1.87e-3)"	"prognostic unfavorable (5.21e-4)"	"unprognostic (4.79e-2)"	"unprognostic (7.05e-2)"	"unprognostic (7.16e-3)"	"unprognostic (1.55e-1)"	"unprognostic (3.79e-1)"	"unprognostic (4.24e-3)"	"unprognostic (1.84e-3)"	"unprognostic (1.77e-1)"	"unprognostic (6.58e-2)"	"unprognostic (1.97e-2)"	"unprognostic (2.16e-1)"	"unprognostic (9.92e-3)"	"unprognostic (7.00e-2)"	46.6	60.3	3.0	5.9	7.2	6.6	42.6	2.5	47.1	58.2	2.9	61.3	28.2	64.3	42.9	33.9	56.5	18.9	66.9	4.0	25.5	61.6	60.2	44.2	10.9	3.8	9.5	67.2	37.5	9.3	53.8	15.9	4.4	53.2	20.1	12.5	34.1	0.0	67.7	35.1	53.0	1.5	2.5	39.8	58.4	79.3	3.3	18.4	54.1	33.5	12.5	58.2	42.7	4.7	0.0	0.4	51.2	0.3	127.5	85.2	49.4	0.0	0.0	0.0	0.0	104.5	0.0	0.0	46.1	128.0	36.4	13.4	108.5	39.4	0.0	0.4	83.6	0.0	0.0	111.7	0.0	0.0	101.5	51.0	47.6	0.0	46.0	105.9	31.6	86.7	78.5	66.0	109.2	28.8	0.4	26.8	0.0	0.1	18.0	0.6	0.0	0.5	32.8	0.0	0.0	0.1	51.3	16.1	70.4	51.6	63.4	0.0	25.9	0.0	20.3	0.0	0.2	45.9	41.1	18.0	64.3	0.1	0.3	3.4	5.6	12.4	7.6	8.2	7.4	5.3	5.0	8.6	9.3	5.0	4.3	6.4	9.4	8.7	5.8	11.6	7.2	6.9	3.0	7.2	2.5	47.1	4.0	25.5	3.8	9.5	4.4	2.5	3.3	4.7	32.1	16.0	18.6	11.1	14.3	9.1	14.0	20.6	16.5	26.1	26.2	21.6	4.0	14.3	12.0	36.8	12.5	35.2	24.5	28.7	5.9	17.9	63.9	14.1	24.9	21.3	29.4	12.0	13.8	14.3	29.9	19.6	16.3	11.4	12.7	22.7	27.1	31.2	24.7	32.0	17.7	24.3	18.3	22.3	20.6	91.7	13.4	24.9	8.8	11.2	13.0	38.5	21.6	10.1	14.8	17.0	22.3	21.4	16.9	10.2	73.6	29.4	12.9	17.9	0.0	18.3	22.9	44.8	22.1	9.5	3.7	15.3	13.8	21.5	20.8	12.1
AGPAT5	"FLJ11210, LPAAT-e, LPAAT-epsilon"	ENSG00000155189	"1-acylglycerol-3-phosphate O-acyltransferase 5"	Q9NUQ2	8	6708642-6761503	"Enzymes, Metabolic proteins, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Glandular and luminal cells: 83.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010644, HPA010950, HPA011646"	Approved		Supported	Mitochondria		NA	NA			"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 43: Testis - Unknown function"	"Cluster 36: HEL - Hemostasis"	"Cluster 44: Endometrium - Transcription"	Mitochondria		"HPA010644: AB_1844647, HPA010950: AB_1844648, HPA011646: "	"unprognostic (1.05e-3)"	"unprognostic (4.69e-1)"	"prognostic favorable (8.82e-4)"	"unprognostic (2.05e-2)"	"unprognostic (2.99e-1)"	"unprognostic (1.44e-2)"	"prognostic unfavorable (4.57e-4)"	"unprognostic (4.92e-1)"	"unprognostic (1.82e-1)"	"unprognostic (2.98e-2)"	"unprognostic (6.33e-2)"	"unprognostic (2.91e-1)"	"unprognostic (6.62e-2)"	"unprognostic (2.83e-1)"	"unprognostic (3.60e-1)"	"unprognostic (1.53e-2)"	"unprognostic (5.09e-3)"	5.4	11.8	6.7	2.9	6.8	2.3	4.9	7.2	8.3	6.5	6.1	8.0	3.1	6.6	7.9	8.5	7.4	1.8	3.4	6.6	7.4	7.2	10.0	4.5	4.1	7.8	7.4	5.8	6.4	3.3	10.3	4.1	7.6	6.0	4.2	5.2	5.0	5.6	11.3	3.5	6.7	2.9	7.6	4.8	6.9	22.5	7.1	4.7	4.0	2.7	3.7	4.7	5.8	8.7	8.5	7.0	15.3	6.8	3.4	5.2	9.4	4.3	4.6	7.9	7.0	4.6	7.3	21.8	3.2	3.3	10.8	11.0	9.5	9.5	11.2	4.6	6.6	27.4	7.0	10.5	9.1	12.4	10.0	7.6	10.0	6.7	9.8	8.2	13.6	9.5	19.9	10.7	11.4	6.3	23.5	20.1	20.4	13.6	5.8	15.0	15.0	8.2	7.9	13.1	24.4	14.8	4.1	7.9	9.4	8.1	3.6	20.5	5.5	10.8	5.4	4.4	12.4	4.0	12.8	11.3	7.3	13.8	12.9	1.8	1.9	1.2	0.7	2.4	1.6	4.4	1.3	1.4	1.2	5.1	0.9	1.1	0.2	2.7	2.2	4.4	1.2	1.4	6.7	6.8	7.2	8.3	6.6	7.4	7.8	7.4	7.6	7.6	7.1	8.7	15.7	3.2	4.4	58.8	46.5	9.1	18.8	14.2	19.4	7.8	14.2	10.5	5.8	11.5	9.0	7.3	2.1	9.4	23.5	17.4	3.9	11.2	40.0	30.0	27.9	22.3	22.1	50.0	45.0	10.0	14.2	10.4	27.0	83.6	18.9	10.6	10.4	41.9	12.2	6.7	46.8	10.1	14.2	16.0	4.6	34.7	15.8	12.6	7.2	33.7	7.5	42.3	6.2	56.8	60.2	10.2	16.0	15.4	22.3	30.4	9.8	22.5	14.6	9.8	6.6	14.0	24.7	26.2	10.9	30.9	10.4	18.5	17.4	15.0	25.2	11.9
AGPS	"ADAP-S, ADAS, ADHAPS, ADPS, ALDHPSY"	ENSG00000018510	"Alkylglycerone phosphate synthase"	O00116	2	177392746-177567024	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Lipid biosynthesis, Lipid metabolism"	Transferase	"Cataract, Disease variant, Dwarfism, Rhizomelic chondrodysplasia punctata"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 262.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030209, HPA030210, HPA030211"	Supported		Supported	Peroxisomes	"Intracellular and membrane"	NA	NA		69000	"Cluster 26: Non-specific - Mitochondria"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	Peroxisomes		"HPA030209: AB_10600634, HPA030210: AB_10600202, HPA030211: AB_10602195"	"unprognostic (7.10e-2)"	"unprognostic (1.20e-2)"	"unprognostic (1.76e-3)"	"unprognostic (3.79e-2)"	"unprognostic (8.34e-2)"	"unprognostic (3.78e-2)"	"prognostic unfavorable (8.62e-6)"	"unprognostic (1.23e-2)"	"unprognostic (7.23e-2)"	"unprognostic (5.41e-2)"	"prognostic unfavorable (8.35e-4)"	"unprognostic (7.74e-2)"	"prognostic favorable (9.45e-4)"	"unprognostic (7.18e-2)"	"unprognostic (3.46e-1)"	"unprognostic (4.94e-3)"	"unprognostic (1.92e-2)"	14.3	9.2	4.4	15.6	6.9	19.6	13.9	7.1	6.9	14.3	4.6	20.1	11.1	14.6	6.5	12.7	9.8	11.3	10.4	4.7	6.6	18.1	19.3	13.7	11.9	8.9	7.0	7.8	11.4	18.5	3.4	13.2	8.2	7.0	21.9	6.4	8.3	8.8	11.7	4.5	13.1	21.1	7.8	8.7	9.9	16.3	6.3	16.1	12.6	12.6	12.8	14.6	5.2	11.9	43.1	36.3	23.3	19.0	32.2	33.2	33.3	29.6	21.9	34.5	34.8	70.6	34.0	58.5	59.5	45.0	46.3	47.5	64.4	45.1	47.8	51.4	16.7	77.6	56.5	75.8	31.9	82.3	63.5	28.6	28.7	58.6	44.6	33.3	75.3	42.1	44.9	26.3	45.7	0.1	59.9	22.4	33.3	42.7	30.9	47.0	65.1	32.7	60.0	65.0	22.0	31.3	66.2	5.8	43.0	58.1	0.4	35.4	70.0	29.4	61.9	26.8	64.2	28.7	59.0	23.6	29.4	43.1	11.8	2.6	3.3	5.8	1.9	4.0	2.9	1.7	3.0	2.4	3.6	1.1	2.7	1.6	1.5	2.8	3.6	0.1	4.3	2.2	4.4	6.9	7.1	6.9	4.7	6.6	8.9	7.0	8.2	7.8	6.3	11.9	20.2	16.0	13.1	29.4	10.7	10.8	6.5	15.5	12.0	11.5	19.2	6.7	20.0	20.0	13.0	14.7	2.1	14.1	15.5	25.6	13.7	20.9	262.2	25.2	17.2	14.0	19.8	20.8	53.0	23.2	20.6	23.0	18.8	25.4	64.1	16.6	11.7	31.0	31.8	15.2	61.7	30.4	16.2	30.0	31.8	41.4	14.6	28.7	14.2	56.2	36.0	12.0	21.6	45.8	83.8	23.9	17.4	13.9	14.1	3.8	15.3	46.5	21.6	7.6	6.6	16.8	16.4	41.7	22.2	16.2	9.8	7.0	19.0	22.7	26.0	6.1
AGR2	"AG2, HAG-2, PDIA17, XAG-2"	ENSG00000106541	"Anterior gradient 2, protein disulphide isomerase family member"	O95994	7	16791811-16833433	"Predicted intracellular proteins"			Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix: 638.7;intestine: 1224.0;stomach 1: 1402.3"	"Cell type enhanced"	"Detected in many"		"Club cells: 1515.8;Distal enterocytes: 1026.4;Gastric mucus-secreting cells: 2605.5;Intestinal goblet cells: 3710.4;Paneth cells: 1101.6;Undifferentiated cells: 1543.1;Urothelial cells: 1017.8"	"Cancer enhanced"	"Detected in many"		"stomach cancer: 475.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in many"	15	"OE19: 20084.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA007912	Enhanced		Supported	"Endoplasmic reticulum"	"Intracellular and membrane"	NA	NA		38000		"Cluster 37: Intestine - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 27: Mucus-secreting cells - Mucin production"	"Endoplasmic reticulum"		"HPA007912: AB_1844879"	"unprognostic (6.19e-2)"	"unprognostic (1.91e-1)"	"unprognostic (9.05e-2)"	"unprognostic (2.59e-2)"	"unprognostic (2.23e-1)"	"unprognostic (2.10e-3)"	"prognostic unfavorable (1.15e-4)"	"unprognostic (1.49e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.08e-2)"	"unprognostic (3.24e-1)"	"unprognostic (2.22e-2)"	"prognostic unfavorable (8.79e-5)"	"unprognostic (6.98e-2)"	"unprognostic (2.38e-1)"	"unprognostic (2.38e-1)"	"unprognostic (3.22e-3)"	2.1	0.7	0.0	66.6	0.0	0.0	72.3	0.2	0.5	638.7	0.0	768.1	486.0	14.1	389.1	16.2	306.4	275.8	0.2	0.1	0.0	11.2	0.9	50.7	0.6	0.0	0.1	0.3	22.1	0.1	31.4	1.6	0.0	227.3	1224.0	0.0	475.3	181.0	0.2	2.5	379.2	45.2	0.0	0.9	1402.3	0.9	0.0	1.7	7.4	0.1	7.2	160.8	4.0	0.1	0.3	265.5	0.0	0.3	0.0	0.1	2.6	0.0	0.0	0.0	0.0	43.5	39.7	0.0	0.2	0.0	6.6	25.2	0.0	34.5	0.2	0.0	0.0	0.0	0.9	3.8	0.0	0.0	1.0	0.0	88.5	0.0	11.4	0.4	0.4	0.3	0.0	0.0	0.2	44.7	1.3	1.8	0.8	20084.0	154.2	1.0	0.0	5.2	631.3	371.6	1.7	2.1	0.0	98.8	0.0	1.0	1319.9	0.0	0.0	0.7	1.2	0.9	0.2	1.2	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	1.1	51.3	293.1	0.0	19.0	2.8	127.1	539.8	0.6	0.0	169.3	137.4	0.2	268.8	1515.8	80.9	0.0	6.0	0.4	1026.4	0.0	74.1	4.6	301.9	33.9	4.8	522.1	0.0	0.1	835.1	4.5	6.0	2605.5	365.3	43.9	0.0	0.0	1.7	240.8	0.0	0.1	3710.4	386.6	0.8	0.3	0.4	0.3	6.5	3.6	0.0	1.0	0.0	0.0	0.0	0.0	303.1	1101.6	0.0	2.6	426.9	517.9	0.2	781.0	0.0	0.0	0.0	76.9	0.4	0.2	5.3	2.8	3.3	13.1	0.0	1543.1	1017.8
AGR3	"BCMP11, hAG-3, HAG3, PDIA18"	ENSG00000173467	"Anterior gradient 3, protein disulphide isomerase family member"	Q8TD06	7	16859412-16881987	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 225.2;intestine: 237.6;lung: 152.7"	"Cell type enhanced"	"Detected in many"		"Endometrial ciliated cells: 861.1;Intestinal goblet cells: 701.9;Paneth cells: 744.5;Proximal enterocytes: 1051.2;Respiratory ciliated cells: 1771.2;Undifferentiated cells: 495.4"	"Cancer enhanced"	"Detected in many"		"breast cancer: 104.5"	"Region enhanced"	"Detected in some"		"midbrain: 3.4"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	28	"OE19: 109.8;T-47d: 339.3"	"Region enriched"	"Detected in some"	5	"olfactory bulb: 4.6"					HPA053942	Enhanced		Supported	"Endoplasmic reticulum,Vesicles"	"Intracellular and membrane"	NA	NA		67000		"Cluster 9: Intestine - Unknown function"	"Cluster 6: T47d - Mammary gland"	"Cluster 49: Ciliated cells - Cilium organization"	"Endoplasmic reticulum"	Vesicles	"HPA053942: AB_2682317"	"unprognostic (2.18e-2)"	"unprognostic (2.02e-1)"	"unprognostic (2.13e-1)"	"unprognostic (9.59e-2)"	"unprognostic (3.32e-3)"	"unprognostic (3.08e-2)"		"unprognostic (1.49e-1)"		"unprognostic (1.46e-1)"	"unprognostic (7.29e-2)"	"unprognostic (1.13e-1)"	"unprognostic (8.56e-3)"	"unprognostic (2.32e-1)"	"unprognostic (2.96e-1)"	"unprognostic (6.66e-2)"	"unprognostic (1.57e-1)"	0.6	0.1	0.0	11.0	0.0	0.0	69.6	0.0	0.2	25.0	0.1	219.9	167.2	8.7	0.0	1.5	225.2	48.3	0.1	0.1	0.4	2.5	0.3	152.7	0.2	2.0	3.4	0.3	10.7	0.0	21.2	0.8	1.0	4.8	214.9	0.0	30.9	0.8	0.0	1.5	237.6	8.7	0.7	0.3	99.9	0.2	0.2	0.0	7.3	0.0	0.8	27.6	0.2	0.5	0.0	0.6	0.0	0.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	5.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.7	0.2	109.8	0.0	0.0	0.0	2.3	8.1	0.0	1.3	0.4	0.0	0.6	0.0	0.0	339.3	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.4	2.0	3.4	1.0	0.7	0.2	0.5	0.7	333.3	408.1	0.3	1.4	2.7	12.5	108.5	0.0	0.0	105.1	51.9	0.1	31.5	319.9	29.5	0.0	3.4	0.7	380.0	1.9	30.4	0.0	861.1	7.4	1.9	112.7	0.0	0.2	71.4	3.3	5.3	71.4	39.2	20.8	0.0	0.0	0.0	0.5	0.0	0.2	701.9	134.3	0.0	0.3	0.0	0.3	2.3	0.0	0.0	0.6	0.0	0.0	0.0	0.1	16.6	744.5	0.0	0.4	7.1	1051.2	0.0	1771.2	0.0	0.0	0.0	27.9	0.0	0.1	0.0	9.8	2.2	4.1	0.0	495.4	117.9
AGTRAP	ATRAP	ENSG00000177674	"Angiotensin II receptor associated protein"	Q6RW13	1	11736084-11754802	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Exocrine glandular cells: 446.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-937: 196.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044120	Enhanced		Supported	"Golgi apparatus,Vesicles"		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 1: Pancreatic cells - Digestion"	Vesicles	"Golgi apparatus"	"HPA044120: AB_10960748"	"unprognostic (1.08e-3)"	"unprognostic (2.98e-3)"	"unprognostic (6.10e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.69e-1)"	"unprognostic (7.92e-3)"	"prognostic unfavorable (6.57e-7)"	"unprognostic (4.44e-2)"	"unprognostic (7.96e-2)"	"unprognostic (4.31e-2)"	"unprognostic (1.61e-2)"	"unprognostic (7.22e-2)"	"unprognostic (1.61e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.33e-3)"	"unprognostic (5.89e-2)"	44.1	50.3	26.6	30.2	28.5	132.3	44.3	27.1	32.4	34.6	44.0	29.3	11.2	24.7	47.7	53.6	48.3	25.2	37.0	24.5	30.5	65.8	29.5	62.3	23.4	37.3	28.8	26.9	67.3	25.7	31.2	22.0	31.3	79.1	9.3	3.4	39.0	21.0	54.3	38.8	25.7	20.3	28.4	83.4	33.7	24.7	31.8	11.3	40.8	12.4	13.3	43.9	43.3	31.1	55.9	66.7	16.7	36.9	27.5	34.9	30.5	28.6	49.0	34.8	30.2	42.0	129.7	5.4	126.7	35.4	87.3	45.8	27.9	135.3	10.7	3.1	61.5	1.6	38.4	51.8	84.9	27.6	64.3	34.6	105.4	112.9	59.2	42.4	46.9	17.3	73.8	52.8	19.8	44.6	13.7	80.9	29.7	24.0	67.3	4.6	15.0	27.5	56.7	5.2	14.6	22.0	52.5	26.4	48.4	22.3	59.8	57.4	26.0	44.1	30.8	70.3	30.9	19.6	24.2	33.3	111.7	196.1	20.7	483.4	844.2	694.6	185.7	442.7	90.4	47.0	66.9	109.8	312.2	38.2	72.0	93.5	756.8	73.0	385.2	25.5	90.8	577.4	26.6	28.5	27.1	32.4	24.5	30.5	37.3	28.8	31.3	28.4	31.8	31.1	46.2	22.4	27.4	3.9	12.1	11.6	30.7	112.4	16.5	1.0	54.8	56.0	12.0	32.9	41.6	36.8	6.2	15.7	60.1	6.9	9.8	95.5	20.6	75.3	30.8	36.1	7.2	21.0	0.2	446.7	92.4	45.3	11.2	41.1	88.0	19.1	42.1	7.7	118.3	3.3	0.2	12.3	20.3	143.5	18.9	23.4	37.9	97.8	28.4	1.9	107.4	19.4	122.6	0.5	7.0	96.9	22.5	27.1	8.6	66.5	8.6	55.3	78.5	5.6	13.1	13.0	23.8	3.5	36.1	34.4	13.5	13.1	45.0	50.4	18.2	25.2
AGXT	"AGT, AGT1, AGXT1, PH1, SPAT, SPT"	ENSG00000172482	"Alanine--glyoxylate and serine--pyruvate aminotransferase"	P21549	2	240868824-240880502	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Aminotransferase, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	315	"liver: 2199.2"	"Cell type enriched"	"Detected in some"	5	"Hepatocytes: 2037.9"	"Cancer enriched"	"Detected in some"	425	"liver cancer: 253.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"Hep G2: 5.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA035370, HPA035371"	Enhanced		Supported	Vesicles		NA	NA		4700000		"Cluster 62: Liver - Hemostasis"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 2: Hepatocytes - Metabolism"	Vesicles		"HPA035370: AB_10673218, HPA035371: AB_2674593"	"unprognostic (3.14e-2)"	"unprognostic (2.58e-1)"	"unprognostic (3.37e-4)"	"unprognostic (1.04e-1)"	"unprognostic (1.23e-2)"	"unprognostic (9.56e-2)"	"prognostic favorable (5.92e-5)"	"unprognostic (8.28e-2)"	"unprognostic (2.77e-1)"	"unprognostic (5.39e-2)"	"unprognostic (1.55e-1)"	"unprognostic (7.57e-3)"	"unprognostic (2.54e-1)"	"unprognostic (9.22e-2)"	"unprognostic (1.37e-1)"		"unprognostic (3.26e-2)"	0.5	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	6.9	2199.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	2.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	5.2	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.0	0.3	1.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	44.3	0.1	7.3	0.0	0.7	0.0	7.6	23.5	0.1	0.1	0.2	0.0	2.8	9.0	128.4	0.0	1.7	26.7	0.4	0.0	0.4	0.0	0.0	52.5	2037.9	0.2	0.0	0.0	8.1	4.1	53.5	0.0	1.6	0.9	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	12.8	0.4	0.0	0.8	1.9	343.9	0.1	0.0	0.0	2.7	0.1	0.1	0.0	0.0	0.0	1.9	5.2	0.1	1.5	0.4
AHCTF1	ELYS	ENSG00000153207	"AT-hook containing transcription factor 1"	Q8WYP5	1	246839098-246931948	"Metabolic proteins, Predicted intracellular proteins, Transporters"	"Cell cycle, Cell division, mRNA transport, Protein transport, Translocation, Transport"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 116.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"neutrophil: 3.0"	"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031658	Uncertain		Supported	"Nuclear membrane"		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 51: Myeloid cells - Hemostasis"	"Nuclear membrane"		"HPA031658: AB_10601968"	"unprognostic (3.10e-1)"	"unprognostic (1.10e-2)"	"unprognostic (2.20e-1)"	"unprognostic (6.11e-2)"	"unprognostic (7.96e-2)"	"unprognostic (2.42e-1)"	"unprognostic (3.12e-2)"	"unprognostic (8.50e-2)"	"unprognostic (2.06e-3)"	"unprognostic (2.53e-2)"	"unprognostic (7.12e-2)"	"unprognostic (2.39e-1)"	"prognostic unfavorable (3.49e-8)"	"unprognostic (7.65e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.91e-2)"	"unprognostic (8.52e-2)"	12.6	7.5	4.4	8.4	6.4	16.9	9.7	11.4	6.2	9.1	5.7	9.1	6.5	8.8	6.6	9.2	7.0	7.4	6.6	4.7	6.2	9.8	10.9	7.2	9.1	3.3	5.6	16.2	10.0	13.1	6.4	8.8	3.7	7.6	6.9	8.1	6.8	7.9	11.0	8.0	6.6	7.9	3.8	9.2	8.5	32.5	7.0	12.2	13.7	15.7	9.0	10.3	7.1	4.8	37.9	25.9	24.6	20.7	24.3	23.6	32.4	24.2	19.3	29.1	24.2	26.5	19.4	37.6	24.6	21.6	16.4	34.1	40.3	20.9	49.7	21.0	9.0	26.4	29.0	24.2	17.4	40.8	17.8	22.8	18.5	37.9	38.4	13.9	21.9	18.5	61.2	24.4	27.8	12.5	31.5	19.2	42.4	34.1	18.4	30.4	32.6	32.1	18.3	28.0	22.1	28.6	34.9	19.5	20.3	18.3	22.1	29.2	20.1	26.3	22.5	33.2	55.7	25.8	38.9	45.4	19.5	27.0	26.2	0.3	0.2	0.7	0.5	0.1	0.5	0.7	0.7	0.6	0.2	0.4	0.8	0.6	3.0	0.4	0.4	0.4	0.8	0.3	4.4	6.4	11.4	6.2	4.7	6.2	3.3	5.6	3.7	3.8	7.0	4.8	53.7	35.3	35.0	37.2	32.9	30.0	22.4	10.3	40.5	19.8	15.9	21.7	21.1	7.2	20.7	5.5	8.4	14.1	27.4	15.7	3.9	12.5	63.7	29.1	30.9	25.9	21.6	20.8	62.2	12.4	10.8	30.5	21.9	28.8	12.0	20.3	17.2	14.3	9.3	18.5	55.7	12.9	10.2	13.2	13.8	23.7	36.1	57.4	3.6	29.0	17.7	8.9	26.8	46.8	51.3	16.2	13.0	39.1	35.8	27.7	11.9	8.8	20.4	17.1	32.9	70.9	26.1	116.7	37.6	27.3	30.7	13.5	31.3	21.4	12.4	26.2
AHCY	SAHH	ENSG00000101444	Adenosylhomocysteinase	P23526	20	34280268-34311802	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"One-carbon metabolism"	Hydrolase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Proximal tubular cells: 275.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041225, HPA044675"	Approved		Supported	Cytosol		NA	NA		5000000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Cytosol		"HPA041225: AB_2677371, HPA044675: AB_2679041"	"unprognostic (3.35e-1)"	"unprognostic (2.17e-1)"	"unprognostic (2.41e-2)"	"unprognostic (1.32e-2)"	"unprognostic (7.74e-2)"	"unprognostic (3.15e-2)"	"unprognostic (7.34e-3)"	"unprognostic (1.10e-1)"	"unprognostic (8.88e-2)"	"unprognostic (2.61e-1)"	"unprognostic (4.21e-2)"	"unprognostic (1.24e-1)"	"unprognostic (5.27e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.88e-1)"	"unprognostic (2.93e-3)"	44.9	56.7	38.5	34.3	41.1	59.3	71.0	41.7	40.1	69.2	45.2	61.8	72.7	55.8	65.7	140.9	75.8	31.1	67.1	38.8	42.8	155.5	187.4	41.5	45.4	42.1	42.2	116.4	161.5	65.5	45.4	39.5	43.3	83.9	58.0	24.6	57.7	49.6	109.3	50.9	54.8	43.6	42.5	39.9	75.8	82.0	42.5	51.7	95.1	63.6	55.9	59.3	66.9	44.6	270.8	345.9	143.6	254.7	163.6	174.8	164.4	108.1	153.9	235.5	186.1	942.0	226.2	417.0	188.0	139.4	152.0	301.2	340.7	606.4	150.3	55.6	207.6	503.9	157.3	612.7	175.5	238.1	158.3	364.1	271.2	146.9	233.8	125.9	162.9	152.0	250.1	102.7	126.8	285.2	313.3	224.2	185.0	343.0	332.7	231.8	364.6	294.1	212.7	188.3	247.8	164.8	216.1	252.6	364.5	112.8	380.3	217.9	104.5	203.3	215.5	104.1	207.6	151.7	239.0	252.3	150.2	144.4	111.3	9.0	32.9	1.0	8.9	60.7	15.0	20.5	13.0	11.5	48.8	19.4	13.8	16.1	2.7	11.6	40.8	55.1	16.4	28.2	38.5	41.1	41.7	40.1	38.8	42.8	42.1	42.2	43.3	42.5	42.5	44.6	13.2	41.7	23.2	5.5	35.3	36.7	88.2	106.1	68.9	11.7	77.6	82.0	47.8	44.3	43.2	27.6	0.0	109.0	31.4	36.6	58.7	73.5	76.5	30.9	110.6	27.1	21.0	60.8	9.0	82.4	165.3	35.6	83.6	42.8	21.0	42.8	19.6	70.4	115.7	11.8	8.4	73.5	30.5	52.2	32.4	187.4	42.6	34.5	26.6	2.8	26.4	42.4	5.2	5.0	16.4	60.4	41.2	40.6	66.2	95.8	51.4	275.0	17.9	15.2	13.1	27.8	34.6	43.5	45.3	100.8	39.5	91.9	19.8	84.3	117.1	82.6
AHR	bHLHe76	ENSG00000106546	"Aryl hydrocarbon receptor"	P35869	7	16916359-17346152	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Cell cycle, Transcription, Transcription regulation"	"Activator, DNA-binding, Receptor, Repressor"	"Cancer-related genes, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Langerhans cells: 262.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"hTCEpi: 71.0;hTERT-HME1: 73.8;OE19: 61.2;RT4: 63.2"									"CAB005072, HPA029722, HPA029723"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 85: Liver - Metabolism"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 41: Macrophages - Immune response"	Cytosol	Nucleoplasm	"CAB005072: AB_633731, HPA029722: AB_10599189, HPA029723: AB_10599025"	"unprognostic (1.29e-2)"	"unprognostic (1.21e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.39e-2)"	"unprognostic (7.28e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.44e-1)"	"unprognostic (3.39e-1)"	"unprognostic (4.32e-2)"	"unprognostic (9.98e-2)"	"unprognostic (1.24e-3)"	"unprognostic (2.89e-1)"	"unprognostic (7.53e-3)"	"unprognostic (2.00e-1)"	"unprognostic (2.82e-3)"	"unprognostic (3.25e-2)"	"unprognostic (9.45e-2)"	22.3	15.0	1.4	25.8	2.7	44.1	19.5	1.4	2.8	14.5	2.3	13.7	16.4	8.8	7.0	17.4	10.5	33.7	9.5	1.9	1.3	7.1	45.0	37.6	15.4	5.4	1.9	6.9	5.8	6.6	3.0	17.7	3.9	11.0	16.3	4.0	10.5	11.2	2.2	22.0	14.5	15.2	2.8	18.7	25.2	2.9	2.7	9.7	12.7	6.5	19.8	49.5	15.0	5.8	8.2	6.6	2.6	0.0	19.2	13.1	1.2	16.5	23.9	7.5	10.8	8.2	17.5	0.0	5.0	24.4	29.7	21.8	1.6	15.1	19.7	0.4	3.6	4.8	8.1	7.3	35.5	8.1	11.5	18.1	71.0	28.8	73.8	33.8	25.3	0.0	0.7	0.2	34.3	4.2	0.0	12.6	2.1	61.2	10.3	0.0	0.0	0.3	23.5	63.2	2.4	0.0	12.4	13.0	12.5	19.0	9.4	2.7	4.3	3.1	0.1	40.7	0.0	3.3	0.1	0.0	51.6	30.6	51.9	0.8	5.6	4.2	0.5	2.6	0.7	0.6	1.7	1.0	6.9	0.7	0.9	0.7	0.6	2.1	1.0	1.6	2.1	1.7	1.4	2.7	1.4	2.8	1.9	1.3	5.4	1.9	3.9	2.8	2.7	5.8	78.3	150.6	76.2	1.6	15.2	75.3	47.6	67.9	104.2	37.0	23.4	30.0	14.7	34.3	84.9	7.3	8.4	3.3	13.6	23.9	0.0	19.3	6.2	39.1	8.4	78.1	5.4	8.6	18.0	15.7	1.8	57.0	56.1	78.8	133.1	0.6	52.1	48.3	24.4	43.7	39.2	12.9	30.5	88.4	262.6	3.2	3.7	107.1	71.2	8.4	70.1	0.9	5.2	1.5	40.6	33.3	19.8	2.6	16.7	48.6	9.9	6.8	51.3	6.1	6.6	14.8	37.8	2.8	2.2	38.3	89.2	21.5	54.7	3.3	19.3	116.1
AHRR	"AHH, AHHR, bHLHe77, KIAA1234"	ENSG00000063438	"Aryl-hydrocarbon receptor repressor"	A9YTQ3	5	321759-438291	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"testis: 46.4"	"Group enriched"	"Detected in some"	10	"Early spermatids: 299.1;Late spermatids: 168.8;Spermatocytes: 123.7"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HeLa: 59.6;HMC-1: 76.8;NB-4: 91.1;WM-115: 53.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			HPA021483			Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 83: Testis - Spermatogenesis"	"Cluster 24: NB-4 - Immune response"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm	Cytosol	"HPA021483: AB_1855110"	"unprognostic (2.06e-4)"	"unprognostic (3.48e-2)"	"unprognostic (8.71e-3)"	"unprognostic (2.23e-1)"	"unprognostic (1.09e-1)"	"unprognostic (9.33e-4)"	"unprognostic (4.08e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.02e-5)"	"unprognostic (1.87e-1)"	"unprognostic (5.07e-2)"	"unprognostic (1.65e-6)"	"unprognostic (1.70e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.20e-1)"	"unprognostic (3.55e-2)"	1.4	0.7	2.2	0.6	1.8	0.4	0.8	0.0	6.0	3.8	1.1	2.1	0.7	1.6	0.5	2.2	0.7	1.2	0.5	5.0	1.7	1.6	0.7	2.2	0.4	0.4	0.7	2.6	0.6	0.1	1.5	2.0	0.0	1.0	1.1	0.1	0.7	0.1	0.5	5.9	1.9	0.3	0.0	5.7	1.1	46.4	2.6	0.2	1.4	0.0	0.4	3.4	2.2	0.0	0.4	5.8	1.4	1.0	6.1	11.9	11.0	22.5	30.0	10.7	18.4	0.6	6.7	0.6	10.1	38.6	2.2	0.5	0.9	0.5	5.1	1.2	2.8	8.6	59.6	0.9	3.5	1.6	76.8	1.4	0.8	7.3	1.3	17.3	3.4	0.8	1.0	0.6	11.8	0.7	0.3	91.1	0.5	2.6	8.9	1.3	0.5	0.4	0.5	0.2	10.0	0.4	27.6	3.7	14.7	0.1	0.5	36.4	6.1	20.5	1.6	21.5	0.4	2.6	3.6	0.8	8.3	0.8	53.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.2	1.8	0.0	6.0	5.0	1.7	0.4	0.7	0.0	0.0	2.6	0.0	0.6	0.0	0.0	2.0	0.2	2.2	0.0	0.1	0.0	0.4	0.2	0.3	1.2	0.0	0.0	0.0	0.0	0.3	0.1	0.1	0.0	0.2	299.1	0.3	0.8	3.6	0.0	0.0	11.1	0.2	5.8	2.7	0.5	0.7	0.0	0.3	0.0	0.0	0.8	0.0	9.5	0.1	0.0	0.0	9.7	168.8	3.4	1.5	19.6	3.7	5.7	0.2	0.0	3.5	2.9	0.2	0.0	1.2	0.1	0.3	0.1	0.1	0.2	0.2	6.6	0.0	3.0	123.7	6.9	0.1	1.4	0.8	1.2	0.7	0.1	0.2
AHSA1	"Aha1, C14orf3, hAha1, p38"	ENSG00000100591	"Activator of HSP90 ATPase activity 1"	O95433	14	77457870-77469472	"Plasma proteins, Predicted intracellular proteins, Transporters"	"Host-virus interaction, Stress response"	Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 345.7"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000903, CAB006244"	Supported		Supported	Cytosol		NA	NA		120000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 22: Epithelial cell types - Mixed function"	Cytosol		"CAB006244: AB_425858, HPA000903: AB_1078112"	"unprognostic (3.91e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.69e-1)"	"unprognostic (3.48e-1)"	"unprognostic (1.49e-3)"	"prognostic unfavorable (5.04e-6)"	"unprognostic (3.63e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.88e-1)"	"unprognostic (2.63e-2)"	"unprognostic (2.16e-2)"	"unprognostic (1.33e-1)"	"unprognostic (3.06e-2)"	"unprognostic (1.44e-2)"	"unprognostic (3.01e-1)"	70.9	99.1	134.7	51.8	136.1	51.0	55.4	142.0	345.7	63.9	135.3	82.4	44.8	80.1	72.3	72.6	120.9	39.4	116.7	134.9	139.1	73.2	71.8	60.8	71.6	141.8	139.3	69.8	50.3	65.5	66.7	76.5	144.0	64.4	71.8	39.1	56.7	70.3	140.2	59.8	54.9	85.0	139.4	55.7	61.9	99.4	142.5	65.2	47.1	118.3	91.4	76.9	61.1	156.2	185.0	356.7	103.1	131.9	159.1	110.3	175.1	131.2	111.6	223.0	165.3	277.0	163.4	361.3	103.0	145.1	258.4	204.7	386.2	186.5	231.8	131.8	207.5	156.1	181.6	343.3	113.7	102.6	230.8	98.3	244.9	150.7	72.2	133.1	209.9	225.3	205.5	115.6	138.5	522.6	278.6	207.8	170.6	347.7	372.9	210.2	110.3	178.1	178.2	187.1	155.0	161.4	119.2	302.9	115.8	154.4	174.4	152.6	100.3	115.3	162.1	126.2	198.7	103.7	241.6	273.8	169.1	211.3	131.1	82.7	51.5	67.9	66.4	74.0	76.9	81.0	59.8	68.0	67.2	63.7	69.0	70.6	39.8	88.7	92.5	66.4	77.2	52.2	134.7	136.1	142.0	345.7	134.9	139.1	141.8	139.3	144.0	139.4	142.5	156.2	46.6	35.3	21.6	10.1	59.4	156.0	208.2	82.8	74.0	36.0	49.9	46.6	92.2	42.9	57.0	27.6	85.5	153.4	66.8	60.0	74.3	74.2	40.6	112.6	60.8	54.9	78.3	55.8	14.6	48.8	113.3	68.3	25.5	59.6	76.2	55.2	28.9	41.0	93.5	18.5	14.7	70.5	65.1	26.7	117.5	34.2	67.7	52.6	90.7	12.2	58.5	46.6	61.8	10.1	23.6	67.8	65.6	66.5	54.1	145.4	56.4	87.0	132.2	54.1	98.6	46.9	135.0	92.0	57.3	67.7	140.1	136.7	92.3	86.0	85.2	120.1
AIFM1	"AIF, AUNX1, CMTX4, DFNX5, NAMSD, PDCD8"	ENSG00000156709	"Apoptosis inducing factor mitochondria associated 1"	O95831	X	130124666-130165879	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	Apoptosis	"DNA-binding, Oxidoreductase"	"Charcot-Marie-Tooth disease, Deafness, Disease variant, Dwarfism, Mental retardation, Neurodegeneration, Neuropathy, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 165.4;Proximal tubular cells: 326.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003764, HPA030611"	Enhanced		Supported	Mitochondria		NA	NA		230000	"Cluster 27: Non-specific - Gene expression"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Mitochondria		"CAB003764: AB_289587, HPA030611: AB_2673549"	"unprognostic (3.00e-3)"	"unprognostic (1.34e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.10e-2)"	"unprognostic (3.15e-3)"	"unprognostic (1.46e-1)"	"unprognostic (1.14e-2)"	"unprognostic (1.43e-1)"	"unprognostic (3.11e-2)"	"unprognostic (2.54e-3)"	"unprognostic (2.81e-3)"	"prognostic favorable (4.42e-10)"	"unprognostic (1.76e-2)"	"unprognostic (1.14e-1)"	"unprognostic (5.04e-2)"	"unprognostic (2.11e-2)"	21.0	65.2	10.5	17.6	11.2	11.8	17.8	11.9	12.8	15.7	24.7	34.3	52.9	15.3	8.9	20.8	22.1	10.1	107.7	10.9	11.6	97.3	110.6	13.9	16.2	11.3	11.0	11.9	27.8	29.7	16.2	10.3	11.4	14.8	15.9	8.5	18.6	7.6	68.9	15.2	29.9	10.1	11.2	20.3	41.2	30.3	12.1	18.5	14.7	25.2	11.0	18.4	13.4	11.6	52.8	95.4	22.6	85.2	24.1	14.6	50.0	28.6	19.0	33.5	25.2	55.8	36.4	105.0	113.3	17.5	39.3	47.2	61.3	33.3	12.7	48.2	73.4	61.6	59.1	68.9	34.0	51.5	63.5	26.1	21.7	34.5	22.0	12.1	27.2	83.4	62.6	50.7	13.1	96.7	57.6	74.5	24.4	53.6	65.1	55.6	31.7	132.7	60.8	36.6	46.0	28.2	35.5	68.0	67.5	13.2	46.0	40.8	31.7	20.5	20.4	63.9	58.7	24.2	45.0	47.5	25.3	86.4	33.4	4.1	21.0	14.1	11.8	26.6	13.1	14.6	12.8	14.6	31.7	10.3	12.7	12.6	2.4	20.7	24.8	14.7	17.9	12.4	10.5	11.2	11.9	12.8	10.9	11.6	11.3	11.0	11.4	11.2	12.1	11.6	12.6	16.0	20.1	17.0	17.1	8.7	8.2	25.0	9.1	19.3	13.0	8.3	165.4	22.8	21.2	40.5	22.9	58.0	14.2	31.6	92.0	24.9	1.8	36.7	17.3	11.5	9.6	26.3	10.8	20.5	29.0	16.4	27.0	50.4	10.8	33.1	14.3	92.3	38.0	15.2	12.1	24.0	34.6	14.4	7.4	4.9	17.4	16.8	10.6	8.4	16.6	17.2	20.6	8.0	19.6	18.0	18.9	17.3	19.2	7.9	45.6	326.1	21.3	48.1	6.6	11.3	39.3	10.2	32.0	17.1	6.8	39.7	15.8	45.9	37.2	9.8
AIFM2	"AMID, FLJ14497, PRG3"	ENSG00000042286	"Apoptosis inducing factor mitochondria associated 2"	Q9BRQ8	10	70098223-70132934	"Predicted intracellular proteins"		"DNA-binding, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 53.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Hep G2: 173.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028961, HPA042309, HPA075576"	Approved		Supported	"Vesicles,Plasma membrane,Cytosol"		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Vesicles	"Plasma membrane, Cytosol"	"HPA028961: AB_2672844, HPA042309: AB_10796575, HPA075576: "	"unprognostic (6.62e-2)"	"unprognostic (2.73e-1)"	"unprognostic (4.29e-1)"	"prognostic favorable (2.80e-4)"	"unprognostic (7.26e-3)"	"unprognostic (2.57e-2)"	"unprognostic (7.95e-3)"	"unprognostic (2.80e-1)"	"unprognostic (5.31e-2)"	"unprognostic (8.90e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.53e-1)"	"unprognostic (4.49e-1)"	"unprognostic (4.59e-3)"	"unprognostic (2.17e-1)"	"unprognostic (1.11e-1)"	"prognostic favorable (2.92e-4)"	39.6	13.5	7.5	6.3	8.1	1.9	31.2	7.3	8.0	6.9	8.6	12.9	9.3	7.8	9.0	13.3	6.8	5.0	17.0	6.9	7.7	10.4	21.9	9.3	5.1	8.2	7.3	7.9	5.0	3.2	5.6	4.1	6.9	9.9	7.1	2.4	7.6	7.7	9.8	5.6	11.5	5.0	6.2	7.7	9.9	3.9	8.3	2.4	14.6	7.3	3.6	12.0	6.3	6.5	26.5	45.2	1.1	11.3	26.2	9.8	0.3	10.4	25.5	21.0	23.6	35.3	49.8	3.8	25.8	14.5	27.5	27.9	12.7	3.8	5.9	50.8	1.9	0.2	27.3	173.3	56.1	0.3	6.4	13.3	8.4	33.8	7.2	13.2	9.5	1.7	20.5	21.9	11.0	33.5	1.2	1.3	4.5	21.2	14.6	0.8	4.2	12.4	11.4	19.2	3.6	0.8	19.1	16.6	29.8	1.8	0.7	7.2	12.0	0.5	25.3	15.6	30.8	16.2	32.7	7.3	14.0	0.9	13.9	1.0	0.5	0.5	1.8	0.5	1.5	1.7	0.6	1.5	0.4	1.5	0.8	1.3	0.5	4.0	0.5	0.2	1.3	0.7	7.5	8.1	7.3	8.0	6.9	7.7	8.2	7.3	6.9	6.2	8.3	6.5	11.6	6.4	14.1	7.2	5.0	2.3	15.0	8.4	2.8	5.7	5.5	4.7	13.8	8.6	10.5	18.4	0.0	13.9	1.4	53.1	3.9	40.7	24.1	6.0	7.7	4.8	12.0	7.0	8.2	21.9	3.0	11.2	14.3	6.2	11.4	22.3	1.8	25.0	10.2	1.7	5.2	7.1	14.2	3.3	3.3	47.0	5.3	6.7	8.8	4.7	34.4	4.8	1.0	5.5	3.5	40.8	22.7	4.5	17.0	14.6	28.7	22.6	9.5	2.1	19.7	11.8	12.8	6.2	3.9	5.1	1.4	18.6	3.8	8.8	13.7	20.4
AIFM3	"AIFL, FLJ30473"	ENSG00000183773	"Apoptosis inducing factor mitochondria associated 3"	Q96NN9	22	20965108-20981360	"Predicted intracellular proteins"	"Apoptosis, Electron transport, Transport"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"brain: 70.4;choroid plexus: 136.0"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 92.1;Distal enterocytes: 76.5;Intestinal goblet cells: 31.3;Muller glia cells: 25.3;Paneth cells: 27.5;Undifferentiated cells: 37.9"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 7.2"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	12	"classical monocyte: 1.1;intermediate monocyte: 3.0;myeloid DC: 1.9;non-classical monocyte: 1.9"	"Group enriched"	"Detected in many"	24	"dendritic cells: 1.9;monocytes: 3.0"	"Cell line enhanced"	"Detected in some"		"Hep G2: 7.6;HMC-1: 10.8;T-47d: 5.3;THP-1: 7.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001271			Supported	Mitochondria		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Mitochondria		"HPA001271: AB_1078114"	"unprognostic (1.39e-1)"	"unprognostic (1.97e-1)"	"unprognostic (7.49e-2)"	"unprognostic (9.99e-2)"	"unprognostic (6.79e-2)"	"unprognostic (2.03e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.73e-3)"	"unprognostic (3.28e-1)"	"unprognostic (1.56e-1)"	"unprognostic (4.13e-3)"	"unprognostic (5.13e-2)"	"unprognostic (7.99e-2)"	"unprognostic (6.78e-2)"	"unprognostic (1.47e-1)"	"unprognostic (3.37e-1)"	"prognostic favorable (7.13e-5)"	0.5	0.4	41.5	3.1	36.8	3.7	0.4	39.6	52.9	0.3	136.0	24.8	2.5	0.4	0.0	0.4	0.5	0.6	0.3	29.9	31.4	0.8	0.3	1.1	0.6	46.2	43.7	0.3	0.4	0.5	4.4	0.4	43.2	1.0	8.4	1.8	1.0	0.7	0.1	0.1	1.9	0.8	38.0	2.1	0.5	0.6	70.4	0.1	0.3	0.0	0.0	1.2	0.3	24.9	1.0	1.7	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.1	0.0	0.0	1.2	0.1	0.0	0.0	0.2	0.0	1.9	0.0	7.6	0.2	0.0	10.8	0.5	0.6	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	3.0	0.0	0.1	0.0	0.3	0.0	0.1	0.0	1.3	0.0	1.3	1.4	0.9	0.8	0.1	0.0	0.1	5.3	7.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	3.0	0.0	0.1	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	1.9	0.1	0.0	0.5	41.5	36.8	39.6	52.9	29.9	31.4	46.2	43.7	43.2	38.0	70.4	24.9	1.0	0.0	1.5	92.1	1.0	0.6	1.9	1.7	0.6	14.5	3.1	2.4	2.9	0.0	1.4	1.8	6.2	1.0	0.0	76.5	11.7	0.7	0.0	1.7	0.4	0.5	10.3	0.0	12.5	0.6	0.7	0.6	1.5	1.4	1.3	0.5	1.4	2.4	3.6	0.0	8.1	31.3	2.0	3.2	1.9	0.1	0.0	2.5	0.0	4.7	3.2	25.3	0.0	2.5	1.6	0.5	27.5	0.0	0.3	2.2	4.8	8.1	1.9	3.7	0.0	0.2	1.2	0.4	1.9	0.7	0.9	0.8	0.2	0.3	37.9	2.8
AIM2	PYHIN4	ENSG00000163568	"Absent in melanoma 2"	O14862	1	159062484-159147096	"Predicted intracellular proteins"	"Apoptosis, Immunity, Inflammatory response, Innate immunity"	DNA-binding	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 15.5;lymphoid tissue: 50.3"	"Group enriched"	"Detected in some"	4	"B-cells: 64.2;Early spermatids: 24.0;Late spermatids: 33.3;Plasma cells: 40.1"	"Cancer enhanced"	"Detected in many"		"cervical cancer: 15.1"	"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in many"	5	"memory B-cell: 143.8;naive B-cell: 63.7"	"Lineage enriched"	"Detected in many"	7	"B-cells: 143.8"	"Cell line enhanced"	"Detected in some"		"Daudi: 94.6;HDLM-2: 132.5;Karpas-707: 50.4;U-266/70: 41.7;U-266/84: 34.2;U-87 MG: 38.6"	"Low region specificity"	"Detected in many"							"HPA031365, HPA040309"	Uncertain		Supported	Nucleoplasm,Mitochondria,Cytosol		NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 57: B-cells - Immune response"	Mitochondria	"Nucleoplasm, Cytosol"	"HPA031365: AB_10601332, HPA040309: AB_2676925"	"unprognostic (6.05e-2)"	"unprognostic (7.68e-2)"	"unprognostic (4.24e-3)"	"unprognostic (2.08e-2)"	"unprognostic (6.94e-2)"	"unprognostic (3.44e-1)"	"unprognostic (3.20e-1)"	"unprognostic (1.35e-1)"	"unprognostic (4.27e-2)"	"unprognostic (1.28e-3)"	"unprognostic (7.10e-3)"	"unprognostic (1.13e-1)"	"unprognostic (1.23e-12)"	"unprognostic (1.01e-1)"	"unprognostic (3.91e-2)"	"unprognostic (2.28e-1)"	"unprognostic (2.32e-3)"	1.2	0.6	0.9	21.6	0.6	1.2	0.9	0.9	0.9	0.6	8.1	2.4	1.8	0.4	0.3	1.6	0.4	2.3	0.3	0.8	0.6	0.5	1.7	1.7	50.3	1.3	0.9	0.2	0.4	0.0	9.8	0.9	1.1	0.9	2.2	0.4	1.3	0.1	0.3	0.6	15.5	0.8	0.8	24.9	3.2	2.5	0.8	4.1	0.7	1.0	49.4	14.0	0.5	0.7	15.8	0.0	0.9	0.0	0.0	12.5	0.0	0.0	1.6	1.1	1.0	0.0	0.0	94.6	0.1	0.0	0.1	0.1	0.0	0.0	1.0	132.5	0.0	3.3	0.1	0.0	0.0	0.0	0.0	5.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	50.4	0.0	0.0	0.0	0.3	0.9	0.0	0.4	0.0	0.0	8.9	0.0	8.3	8.6	0.0	0.2	0.1	0.1	0.3	0.0	0.2	0.0	0.0	0.1	17.9	0.3	41.7	34.2	0.8	38.6	3.4	6.7	20.7	8.2	0.0	2.0	7.0	5.4	143.8	5.3	3.5	4.2	63.7	0.5	1.3	16.3	0.0	8.2	0.0	11.9	5.0	0.9	0.6	0.9	0.9	0.8	0.6	1.3	0.9	1.1	0.8	0.8	0.7	0.4	0.0	0.0	0.0	64.2	0.0	0.1	0.2	0.0	0.7	0.1	0.3	0.3	0.0	0.7	0.0	0.0	0.0	2.8	0.0	0.0	0.0	24.0	0.0	0.0	0.9	0.0	0.4	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.4	1.5	0.0	0.4	0.0	0.0	3.2	1.9	33.3	0.3	3.2	3.6	0.0	4.0	0.3	0.0	0.5	0.0	0.1	0.1	0.7	40.1	0.0	0.0	0.1	0.0	0.1	0.0	0.2	0.1	1.7	0.4	1.4	0.0	0.0	10.0	0.0	0.0	0.4
AIP	"ARA9, FKBP16, FKBP37, XAP2"	ENSG00000110711	"Aryl hydrocarbon receptor interacting protein"	O00170	11	67483026-67491103	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			"Cushing syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB033674, HPA050217, CAB069477"	Approved		Supported	Cytosol		NA	NA		13000	"Cluster 44: Non-specific - Transcription"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 63: NK-cells & T-cells - Immune response"	Cytosol		"CAB033674: AB_2224981, CAB069477: AB_10002466, HPA050217: AB_2681055"	"unprognostic (2.59e-1)"	"unprognostic (1.43e-2)"	"prognostic unfavorable (1.93e-4)"	"unprognostic (8.15e-2)"	"unprognostic (9.54e-2)"	"unprognostic (4.02e-2)"	"unprognostic (2.17e-2)"	"unprognostic (1.14e-1)"	"unprognostic (6.19e-3)"	"unprognostic (2.18e-1)"	"unprognostic (9.75e-2)"	"unprognostic (1.16e-1)"	"unprognostic (5.28e-2)"	"unprognostic (3.10e-1)"	"unprognostic (2.70e-1)"	"unprognostic (2.40e-2)"	"unprognostic (9.45e-2)"	62.9	58.1	72.5	47.4	77.6	40.4	58.5	74.7	82.4	84.5	66.7	78.4	33.7	71.0	32.4	38.9	66.9	39.4	72.1	70.3	74.3	68.0	51.6	62.3	89.5	75.9	72.7	77.9	48.8	35.4	51.1	33.5	74.6	60.8	20.1	22.9	40.6	36.0	46.4	39.5	64.7	28.8	71.8	85.1	57.0	29.7	73.1	78.7	63.6	45.8	49.1	73.1	62.6	80.4	80.8	91.1	51.6	49.9	64.8	64.2	39.3	49.7	61.2	83.6	60.9	143.7	77.9	142.2	118.1	55.3	63.5	63.9	59.2	51.9	32.1	209.3	63.5	86.5	98.7	87.0	67.1	87.5	145.1	77.8	48.3	74.6	48.4	81.4	43.0	138.6	50.0	83.6	55.5	153.7	187.7	214.6	49.0	122.0	115.7	82.2	78.5	126.5	59.5	47.2	81.4	81.3	64.4	45.5	204.3	19.9	60.9	87.2	71.5	73.4	71.1	108.9	46.3	67.4	99.8	112.7	100.4	67.4	57.7	192.5	117.9	135.6	194.3	144.6	212.0	241.6	227.4	227.6	179.8	221.5	203.4	194.7	78.2	165.3	175.0	207.9	352.4	182.4	72.5	77.6	74.7	82.4	70.3	74.3	75.9	72.7	74.6	71.8	73.1	80.4	57.2	32.1	25.6	6.8	69.4	30.3	35.8	54.2	31.9	36.8	24.6	33.1	23.1	30.0	33.7	49.7	4.2	56.4	61.9	50.1	82.2	46.8	25.3	12.7	31.0	54.0	31.8	22.5	4.0	42.2	63.5	51.0	23.4	18.0	77.3	51.7	45.7	23.3	66.7	37.0	4.9	34.7	48.8	65.0	54.6	14.2	53.1	56.1	56.9	5.6	72.5	49.6	76.2	5.0	10.5	41.2	53.5	35.3	50.2	42.7	86.1	98.3	17.4	29.4	39.5	36.4	86.5	21.7	28.4	19.4	21.2	59.5	90.6	42.0	25.4	52.2
AK1		ENSG00000106992	"Adenylate kinase 1"	P00568	9	127866486-127877675	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Kinase, Transferase"	"Disease variant, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 1346.2;tongue: 783.3"	"Cell type enhanced"	"Detected in all"		"Early spermatids: 281.3;Late spermatids: 1031.8;Muller glia cells: 287.6;Peritubular cells: 386.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"U-2197: 163.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006456, CAB009893"	Enhanced		Supported	Cytosol		NA	NA		24000000	"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 18: U-2197 - ECM organization"	"Cluster 31: Spermatids - Spermatogenesis"	Cytosol		"CAB009893: AB_2225151, HPA006456: AB_1078116"	"unprognostic (6.07e-3)"	"unprognostic (1.44e-2)"	"unprognostic (2.36e-2)"	"unprognostic (1.03e-1)"	"unprognostic (3.44e-1)"	"unprognostic (3.09e-1)"	"unprognostic (1.52e-2)"	"unprognostic (3.12e-2)"	"unprognostic (2.19e-1)"	"unprognostic (5.74e-2)"	"unprognostic (6.65e-3)"	"unprognostic (2.07e-1)"	"unprognostic (1.81e-2)"	"prognostic favorable (7.31e-4)"	"unprognostic (2.62e-1)"	"unprognostic (8.40e-3)"	"unprognostic (6.99e-3)"	28.5	34.5	81.3	11.5	79.2	28.4	17.0	87.9	95.1	37.5	145.8	33.8	17.9	14.3	28.5	32.0	342.2	22.5	270.0	79.5	88.5	31.4	26.5	74.6	5.0	97.4	99.8	45.0	14.9	47.0	33.8	7.6	99.0	17.1	39.5	29.0	33.1	35.9	1346.2	14.2	12.1	21.9	105.0	20.8	23.9	63.1	89.4	3.9	34.8	783.3	12.6	19.7	19.4	97.2	56.7	23.6	30.1	40.4	71.2	142.9	27.4	38.3	38.2	66.7	40.4	18.0	34.9	1.5	40.8	79.4	44.1	79.2	0.3	43.1	26.6	9.0	26.1	8.3	65.2	31.6	40.1	0.0	1.0	110.9	81.8	49.9	35.5	36.8	90.3	0.8	33.7	2.3	76.7	53.5	0.1	1.1	10.6	139.7	74.2	1.3	30.0	12.6	44.8	4.1	48.3	30.4	101.0	57.4	29.8	15.3	45.8	33.3	75.9	45.9	18.8	163.8	37.3	3.5	0.6	0.2	57.7	0.3	32.4	0.2	0.0	0.1	0.3	0.0	0.2	0.0	0.1	0.2	0.0	0.2	0.0	0.2	0.5	0.2	0.1	0.9	0.0	0.3	81.3	79.2	87.9	95.1	79.5	88.5	97.4	99.8	99.0	105.0	89.4	97.2	12.8	41.7	148.1	25.8	2.6	26.4	17.2	84.5	6.2	54.6	11.5	7.9	49.7	28.6	79.4	7.3	16.7	7.5	5.7	210.1	17.6	116.7	281.3	7.3	8.0	39.8	106.3	97.0	11.1	60.9	46.8	37.3	46.4	4.8	1.3	2.7	49.2	77.3	59.3	48.8	12.0	62.7	120.1	3.7	22.3	1031.8	226.5	7.9	83.6	2.8	2.3	287.6	10.3	4.5	9.7	57.2	132.7	386.3	4.2	14.4	22.8	8.2	186.5	69.5	26.3	107.2	56.4	20.2	16.7	33.6	28.4	13.5	7.1	83.4	65.5	25.3
AK3	"AK3L1, AK6, AKL3L1"	ENSG00000147853	"Adenylate kinase 3"	Q9UIJ7	9	4709556-4742043	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 242.8"	"Cell type enhanced"	"Detected in all"		"Hepatocytes: 305.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HDLM-2: 485.4;HEL: 273.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA063324	Enhanced		Supported	Mitochondria		NA	NA		31000	"Cluster 15: NK-cells - Transcription"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"HPA063324: AB_2684985"	"unprognostic (1.30e-2)"	"unprognostic (2.25e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.06e-1)"	"unprognostic (6.55e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.21e-3)"	"unprognostic (6.44e-2)"	"unprognostic (2.81e-2)"	"unprognostic (9.81e-3)"	"unprognostic (1.90e-1)"	"unprognostic (2.76e-2)"	"prognostic favorable (6.07e-9)"	"unprognostic (1.24e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.55e-3)"	75.5	62.9	30.1	23.7	36.9	20.1	39.7	33.5	34.9	41.0	56.2	67.4	68.3	41.9	31.2	61.2	34.4	35.9	100.6	27.0	40.6	101.4	199.9	34.9	29.6	32.8	38.1	47.8	38.9	66.8	22.2	35.1	33.7	49.2	59.6	16.8	38.7	42.6	242.8	47.4	62.5	41.7	33.5	33.0	69.5	11.2	37.9	35.1	49.9	159.6	34.4	48.7	39.7	36.5	44.1	30.7	55.5	22.6	75.3	55.5	4.9	60.4	116.1	30.4	45.5	5.7	43.6	39.5	20.4	63.5	16.6	29.3	40.8	48.0	51.2	485.4	37.1	273.3	56.1	91.3	58.5	28.7	14.1	87.9	41.4	26.4	36.0	70.4	91.2	38.2	22.1	49.6	91.8	22.5	27.5	65.6	53.3	77.1	15.4	38.2	21.1	19.2	82.1	55.7	98.3	63.6	65.7	18.5	35.1	53.7	26.5	53.2	65.9	25.7	28.8	70.1	43.6	15.5	10.5	50.3	46.9	19.9	18.9	13.3	10.2	32.2	27.6	8.1	25.5	12.1	21.6	25.7	19.6	12.3	28.4	29.2	2.8	27.4	6.5	26.3	31.8	21.1	30.1	36.9	33.5	34.9	27.0	40.6	32.8	38.1	33.7	33.5	37.9	36.5	58.3	57.7	80.3	78.0	34.0	74.2	76.4	87.4	84.2	10.7	58.8	28.3	182.9	68.6	71.0	66.2	22.9	95.5	34.6	129.9	258.2	84.8	3.7	40.7	30.6	65.7	109.6	68.1	23.4	69.6	17.0	83.4	87.1	37.8	46.2	75.8	79.2	305.6	47.5	15.2	55.8	104.2	73.2	46.9	41.4	4.5	108.7	34.7	74.7	22.5	40.9	28.2	33.0	44.7	87.0	67.3	78.7	149.7	62.8	166.7	111.8	183.5	52.8	11.0	105.2	76.0	60.8	6.4	14.1	152.5	104.4	214.0	36.4	68.5	145.5	151.6
AK4	"AK3, AK3L1"	ENSG00000162433	"Adenylate kinase 4"	P27144	1	65147549-65232145	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 183.5;liver: 104.0"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 242.6;Proximal tubular cells: 595.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"classical monocyte: 3.1;myeloid DC: 2.7"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Hep G2: 208.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042753, HPA049461"	Enhanced		Supported	Mitochondria	"Intracellular and membrane"	NA	Yes		39000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 81: Kidney & Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Mitochondria		"HPA042753: AB_2678146, HPA049461: AB_2680776"	"unprognostic (3.73e-2)"	"prognostic unfavorable (4.17e-4)"	"unprognostic (2.25e-1)"	"unprognostic (3.05e-3)"	"unprognostic (1.48e-2)"	"prognostic unfavorable (8.83e-4)"	"unprognostic (1.16e-3)"	"unprognostic (3.89e-2)"	"unprognostic (4.03e-1)"	"unprognostic (5.39e-2)"	"prognostic unfavorable (4.34e-5)"	"unprognostic (6.71e-2)"	"prognostic unfavorable (4.36e-4)"	"prognostic unfavorable (4.87e-4)"	"unprognostic (2.69e-1)"	"unprognostic (7.07e-2)"	"unprognostic (7.57e-2)"	24.7	1.9	19.5	6.6	21.0	4.9	26.6	17.8	20.8	6.1	17.5	19.7	4.3	7.0	4.2	23.4	7.6	13.7	51.7	21.4	21.2	183.5	104.0	2.8	1.6	19.0	22.8	4.6	1.2	18.3	4.7	8.3	22.8	16.2	14.0	21.9	9.6	12.7	1.7	27.4	6.6	21.4	18.5	1.2	15.0	11.3	22.7	5.7	2.5	38.8	3.3	19.1	11.8	21.1	73.2	5.0	5.6	23.9	51.6	48.7	12.0	12.1	15.0	25.6	70.8	108.1	8.6	39.1	31.0	19.0	32.1	46.1	18.8	89.9	101.9	33.0	21.5	37.9	21.9	208.6	2.5	29.9	4.6	27.2	49.6	25.1	73.0	42.2	0.9	12.2	48.0	0.6	39.6	31.2	1.1	1.3	24.6	1.0	42.5	0.2	41.0	7.1	37.8	3.2	20.5	15.4	21.6	1.5	16.7	25.8	29.7	12.9	4.2	42.4	36.2	3.3	20.9	39.5	18.8	2.1	68.7	10.9	2.5	0.9	3.1	0.0	0.1	0.6	0.2	0.2	0.1	0.2	2.7	0.1	0.1	0.1	0.4	0.3	0.1	0.4	0.0	0.8	19.5	21.0	17.8	20.8	21.4	21.2	19.0	22.8	22.8	18.5	22.7	21.1	11.2	0.0	0.5	51.2	4.7	49.7	23.6	44.2	63.7	24.5	48.9	44.7	105.7	52.9	14.3	31.3	2.1	2.2	0.6	15.8	56.7	18.6	3.4	30.1	8.2	19.6	5.4	13.9	17.1	12.1	21.1	11.4	27.5	52.2	0.0	36.4	11.7	242.6	3.3	16.8	7.7	8.7	24.4	7.8	9.2	5.8	4.1	6.9	24.9	3.7	5.7	32.7	0.0	9.5	2.5	31.9	4.3	9.4	0.4	38.7	18.8	595.5	12.3	6.5	6.6	5.6	18.8	1.8	9.5	43.1	74.3	4.9	3.6	0.7	23.1	20.4
AK5		ENSG00000154027	"Adenylate kinase 5"	Q9Y6K8	1	77282019-77559966	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"brain: 121.0"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 150.5;Excitatory neurons: 403.7;Inhibitory neurons: 167.3;Oligodendrocytes: 706.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"myeloid DC: 13.6;naive CD4 T-cell: 16.3"	"Group enriched"	"Detected in many"	12	"dendritic cells: 13.6;T-cells: 16.3"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 93.7;BJ: 67.8;fHDF/TERT166: 77.5;LHCN-M2: 189.9;U-2 OS: 58.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019128, HPA057255"	Enhanced		Supported	"Centriolar satellite,Cytosol"		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Cytosol	"Centriolar satellite"	"HPA019128: AB_1844682, HPA057255: AB_2683383"	"unprognostic (4.07e-2)"	"unprognostic (4.23e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.85e-2)"	"unprognostic (1.03e-1)"	"unprognostic (6.04e-2)"	"unprognostic (2.20e-1)"	"unprognostic (2.01e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.91e-2)"	"prognostic favorable (3.88e-4)"	"unprognostic (3.56e-3)"	"unprognostic (6.17e-4)"	"unprognostic (1.18e-1)"	"unprognostic (5.96e-2)"	"unprognostic (6.76e-2)"	1.0	1.6	75.9	1.5	101.2	3.9	18.9	19.4	115.0	1.3	0.8	2.6	1.0	0.7	0.6	1.0	1.0	1.0	1.0	121.0	31.5	1.4	0.1	0.4	2.3	27.2	30.2	0.5	1.6	0.7	3.4	1.2	25.6	2.3	1.0	3.0	3.0	2.1	0.3	2.0	1.0	0.8	31.0	2.1	2.4	9.4	31.7	0.8	1.1	0.8	1.5	0.7	0.7	81.1	0.2	3.6	2.9	0.1	34.8	93.7	1.2	67.8	14.4	10.8	4.6	0.5	1.7	0.6	0.5	77.5	4.4	0.4	0.2	0.0	5.5	2.6	0.7	0.5	1.2	0.4	1.8	0.6	0.2	11.6	0.5	2.1	4.3	37.9	31.5	0.3	0.9	0.7	189.9	0.7	0.0	0.6	3.9	18.4	24.5	1.7	7.1	1.6	29.3	1.1	15.3	3.5	0.2	0.2	4.4	0.3	0.3	0.5	7.9	26.1	58.4	1.6	2.2	15.2	14.7	0.3	5.2	3.5	9.8	1.2	0.8	0.1	3.8	0.2	0.5	0.9	3.6	1.9	13.6	0.9	16.3	9.1	0.6	0.2	0.2	1.5	1.7	2.3	75.9	101.2	19.4	115.0	121.0	31.5	27.2	30.2	25.6	31.0	31.7	81.1	0.7	0.0	0.0	10.7	0.4	0.3	0.4	0.0	1.2	1.3	54.0	27.3	1.1	0.0	0.0	1.8	0.0	1.9	5.6	0.3	7.9	0.3	150.5	1.1	0.1	1.3	12.0	0.8	403.7	0.6	56.3	1.5	1.1	1.7	0.0	0.0	0.4	0.0	2.4	13.5	167.3	0.3	0.0	0.0	0.6	29.2	1.2	0.4	3.6	41.2	1.9	0.0	47.4	60.8	706.6	0.1	1.1	0.7	0.1	2.9	0.0	7.8	0.0	0.3	0.0	1.2	6.3	10.2	91.0	0.0	0.3	2.9	4.2	0.1	0.2	0.1
AK6	CINAP	ENSG00000085231	"Adenylate kinase 6"	Q9Y3D8	5	69350984-69370013	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 185.9;Late spermatids: 275.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"CAB005361, HPA070217"	Supported		Supported	"Nuclear speckles,Centrosome,Cytosol"		No	No			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 16: U-266 - Nucleosome"	"Cluster 25: Spermatids - Spermatogenesis"	"Nuclear speckles"	"Centrosome, Cytosol"	"CAB005361: AB_2302969, HPA070217: "	"unprognostic (5.47e-2)"	"unprognostic (1.54e-2)"	"unprognostic (1.48e-1)"	"unprognostic (8.58e-2)"	"unprognostic (8.73e-2)"	"unprognostic (4.09e-2)"	"prognostic unfavorable (9.54e-4)"	"unprognostic (1.79e-1)"	"unprognostic (3.41e-2)"	"unprognostic (6.21e-2)"	"unprognostic (2.55e-2)"	"unprognostic (2.25e-2)"	"unprognostic (1.14e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.84e-1)"	"unprognostic (2.22e-1)"	"unprognostic (2.55e-2)"	46.0	58.0	18.7	12.5	19.6	11.6	40.0	20.6	27.1	26.1	19.8	40.8	15.2	32.4	21.6	29.7	29.6	7.7	48.4	19.8	20.3	54.9	46.6	29.5	13.0	19.7	20.1	32.6	35.8	11.6	28.6	12.1	19.5	32.9	12.6	23.2	30.9	8.3	79.8	20.6	30.1	9.5	18.7	28.0	36.4	43.3	19.5	13.3	33.0	23.3	12.5	35.5	28.0	20.7	40.3	18.8	28.0	42.6	43.6	26.3	51.1	59.3	18.6	23.8	30.7	56.0	35.5	82.1	54.9	23.4	62.2	14.0	37.2	23.3	40.0	33.1	15.7	40.7	47.8	44.9	33.0	49.5	17.1	14.0	33.3	23.0	37.0	25.0	14.8	45.8	36.6	29.3	28.6	42.1	50.2	31.4	25.0	17.9	10.5	55.8	34.5	44.5	40.3	31.3	14.4	13.3	28.2	26.4	44.6	21.3	25.1	54.7	29.5	20.4	34.6	41.4	47.6	33.1	74.4	75.3	29.8	69.3	28.9	25.2	16.8	20.1	19.2	22.1	20.3	29.8	22.8	24.9	24.8	26.1	24.5	26.3	2.7	24.1	21.0	29.9	25.8	13.3	18.7	19.6	20.6	27.1	19.8	20.3	19.7	20.1	19.5	18.7	19.5	20.7	51.5	22.4	30.0	14.0	33.9	0.0	95.7	0.0	33.6	19.8	57.3	86.6	55.6	18.6	16.7	23.9	10.4	86.7	27.2	16.8	185.9	75.6	174.9	36.4	34.6	38.6	9.7	29.2	14.8	78.5	95.1	47.3	16.8	30.2	21.5	31.7	30.7	42.5	71.3	20.2	15.4	21.3	0.0	30.6	0.0	275.9	33.5	32.2	0.0	6.5	42.4	58.7	34.0	13.0	17.0	59.1	25.5	32.0	29.4	116.6	48.6	149.8	18.2	29.3	52.6	40.9	50.0	56.5	37.9	24.3	0.0	66.2	27.6	44.7	32.9	88.1
AKAP1	"AKAP121, AKAP149, AKAP84, D-AKAP1, PPP1R43, PRKA1, S-AKAP84, SAKAP84, TDRD17"	ENSG00000121057	"A-kinase anchoring protein 1"	Q92667	17	57085092-57121346	"Predicted intracellular proteins, Predicted membrane proteins"		RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 207.8"	"Group enriched"	"Detected in all"	9	"Early spermatids: 584.7;Late spermatids: 2219.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008620, HPA008691, CAB019286"	Supported		Supported	Mitochondria		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 25: Spermatids - Spermatogenesis"	Mitochondria		"CAB019286: , HPA008620: AB_2668104, HPA008691: AB_1078119"	"unprognostic (5.52e-2)"	"unprognostic (1.83e-1)"	"unprognostic (6.96e-3)"	"unprognostic (1.78e-1)"	"unprognostic (1.79e-2)"	"unprognostic (6.38e-2)"	"unprognostic (7.19e-2)"	"unprognostic (1.48e-2)"	"unprognostic (8.14e-2)"	"unprognostic (2.36e-2)"	"unprognostic (3.22e-1)"	"unprognostic (3.00e-1)"	"prognostic favorable (7.86e-9)"	"unprognostic (6.82e-2)"	"unprognostic (2.46e-1)"	"unprognostic (5.74e-2)"	"unprognostic (1.38e-1)"	40.6	15.5	31.6	17.8	35.2	6.9	35.2	29.1	35.2	23.7	17.2	76.1	54.8	24.5	19.7	36.4	31.5	18.0	82.6	28.5	26.5	26.2	49.9	19.6	10.8	26.7	27.1	20.0	22.2	48.1	17.1	7.1	26.9	34.7	48.9	34.7	33.6	24.8	207.8	27.3	55.8	26.3	21.9	11.3	55.4	112.9	29.8	11.4	36.3	137.9	9.5	46.8	25.5	28.0	46.1	54.3	80.7	27.5	18.2	12.8	46.8	19.0	18.3	24.2	16.8	61.2	42.2	74.1	52.3	14.5	26.5	74.6	50.1	44.4	24.7	40.6	63.5	63.1	51.4	118.1	19.4	59.9	23.8	11.7	41.8	26.2	39.2	14.4	25.7	22.9	42.3	28.6	14.8	39.8	76.1	24.1	28.7	97.9	61.7	58.2	32.8	61.0	17.1	61.9	58.9	40.3	15.8	45.1	23.9	16.6	31.4	61.4	18.8	24.3	24.2	28.3	45.0	28.9	36.9	55.8	14.0	47.5	19.7	1.6	1.0	0.4	2.6	2.0	2.3	1.8	2.0	2.1	2.3	1.2	4.0	2.1	0.1	3.3	0.5	4.0	1.7	1.3	31.6	35.2	29.1	35.2	28.5	26.5	26.7	27.1	26.9	21.9	29.8	28.0	34.5	35.3	49.9	26.4	16.6	22.6	23.5	11.9	32.5	33.0	29.4	42.3	154.9	28.6	32.1	5.5	47.9	21.5	10.6	89.1	1.9	16.3	584.7	16.8	12.6	16.4	45.9	12.6	14.9	16.3	13.8	12.2	54.0	37.8	3.8	21.0	11.4	60.2	9.5	37.0	26.3	86.6	8.2	9.0	9.5	2219.5	19.6	10.9	7.2	4.7	8.7	8.2	3.1	10.6	9.6	12.7	68.5	13.9	13.2	32.3	65.6	7.4	6.5	77.1	46.0	17.9	54.4	18.3	14.9	44.9	19.7	6.8	11.5	13.3	117.6	17.0
AKAP10	"D-AKAP2, MGC9414, PRKA10"	ENSG00000108599	"A-kinase anchoring protein 10"	O43572	17	19904302-19978343	"Disease related genes, Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 78.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SuSa: 84.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028901	Approved		Supported	"Plasma membrane,Cytosol"		Yes	No			"Cluster 1: Neutrophils - Mixed function"	"Cluster 34: Non-specific - Transcription"	"Cluster 12: NES - Nervous system development"	"Cluster 52: Non-specific - Transcription"	"Plasma membrane, Cytosol"		"HPA028901: AB_10602227"	"unprognostic (2.17e-2)"	"unprognostic (3.48e-2)"	"unprognostic (5.33e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.50e-1)"	"unprognostic (5.51e-2)"	"unprognostic (1.59e-3)"	"unprognostic (3.88e-1)"	"unprognostic (7.69e-3)"	"unprognostic (1.89e-1)"	"unprognostic (3.59e-2)"	"unprognostic (3.21e-2)"	"unprognostic (3.21e-2)"	"unprognostic (2.49e-2)"	"unprognostic (7.15e-2)"	"unprognostic (2.16e-2)"	"unprognostic (5.20e-2)"	11.4	13.3	10.5	12.3	12.4	10.6	12.3	11.4	13.6	11.5	15.1	11.4	9.5	12.4	8.8	10.6	10.4	10.7	7.4	11.3	11.6	13.1	8.1	11.0	16.0	9.9	10.7	13.5	8.4	15.1	7.5	12.2	10.6	10.9	11.6	15.3	9.8	11.7	7.2	9.5	10.1	13.3	10.4	14.9	11.1	14.2	13.8	14.1	15.1	9.4	12.5	11.3	10.2	14.7	18.1	21.3	13.9	9.7	18.0	22.5	25.7	20.6	21.9	22.4	26.7	23.2	10.6	15.4	13.6	16.4	19.4	18.8	18.1	17.2	30.4	12.8	15.4	13.2	20.2	11.4	17.0	9.7	20.7	19.1	21.1	20.5	25.1	25.0	18.3	18.5	8.6	7.5	23.6	13.1	18.1	14.3	9.1	25.1	7.2	11.8	45.5	8.1	18.7	11.3	4.7	14.1	23.6	11.0	19.7	84.8	26.7	10.7	16.1	17.2	14.2	14.8	19.3	9.3	10.7	18.8	22.8	11.5	17.0	4.9	9.7	12.6	8.6	14.4	8.0	8.4	8.4	9.4	8.5	9.2	10.0	8.9	33.8	7.6	13.9	6.3	7.1	4.3	10.5	12.4	11.4	13.6	11.3	11.6	9.9	10.7	10.6	10.4	13.8	14.7	13.4	3.2	12.3	71.2	24.4	7.0	9.7	8.9	10.2	24.6	11.1	9.0	8.4	21.5	11.9	5.5	16.7	14.9	16.8	15.8	1.9	9.9	12.8	11.0	14.8	12.6	7.2	15.2	55.1	7.2	11.1	11.7	14.8	10.8	10.1	18.0	16.8	13.6	16.5	33.7	54.6	9.9	12.2	35.1	10.5	13.9	15.2	21.4	5.4	61.8	32.3	11.7	25.7	51.8	78.5	7.9	15.2	13.9	11.2	15.6	14.6	5.7	15.3	23.2	19.7	10.5	11.2	23.1	23.6	11.0	7.7	14.0	19.0	15.6	11.8	12.1
AKAP11	"AKAP220, DKFZp781I12161, FLJ11304, KIAA0629, PPP1R44, PRKA11"	ENSG00000023516	"A-kinase anchoring protein 11"	Q9UKA4	13	42272152-42323261	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039089	Enhanced		Approved	"Nucleoli,Plasma membrane,Cytosol"		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 58: Brain - Synaptic function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Nucleoli, Plasma membrane, Cytosol"		"HPA039089: AB_10674279"	"unprognostic (6.43e-2)"	"prognostic unfavorable (9.26e-4)"	"unprognostic (4.91e-1)"	"unprognostic (6.89e-2)"	"unprognostic (1.92e-1)"	"unprognostic (7.34e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.83e-1)"	"unprognostic (7.91e-2)"	"unprognostic (2.15e-3)"	"unprognostic (3.02e-2)"	"unprognostic (1.35e-1)"	"unprognostic (7.49e-3)"	"unprognostic (7.44e-2)"	"unprognostic (1.49e-1)"	"unprognostic (6.02e-2)"	"unprognostic (1.10e-1)"	12.6	13.9	14.2	11.5	27.3	3.7	11.6	10.9	19.9	16.6	0.0	10.0	7.5	13.5	15.4	10.6	10.4	10.2	11.6	22.7	12.7	13.3	10.7	10.9	15.8	8.7	15.3	14.7	6.9	11.7	9.3	7.7	8.5	11.3	10.5	32.5	8.0	12.3	5.6	9.9	8.4	12.2	11.5	13.3	10.4	20.6	16.4	13.2	14.0	10.9	13.8	10.4	8.6	18.9	15.2	15.3	18.4	11.0	23.6	28.7	8.0	20.2	16.7	11.9	11.1	16.9	12.4	31.2	7.6	22.7	12.5	17.7	16.1	16.9	22.7	33.4	7.5	8.8	10.6	8.4	18.5	22.2	20.8	21.2	17.0	24.4	21.2	17.5	17.8	15.5	29.5	12.3	24.3	11.4	13.0	7.2	10.9	22.3	7.1	10.7	12.9	15.1	11.9	11.1	7.8	11.3	15.5	10.1	7.1	8.5	8.7	11.8	24.8	20.1	10.4	30.7	15.4	4.7	6.3	15.8	25.7	11.1	14.4	1.7	0.3	0.4	0.5	0.3	0.7	0.9	0.8	0.5	0.3	1.1	0.6	0.6	0.1	1.6	0.5	0.5	1.0	0.2	14.2	27.3	10.9	19.9	22.7	12.7	8.7	15.3	8.5	11.5	16.4	18.9	41.9	25.6	30.5	58.8	42.8	12.2	13.7	15.4	14.8	67.3	20.4	14.6	44.9	12.8	32.6	29.5	37.5	4.4	21.2	12.9	1.9	12.7	14.0	24.3	33.1	25.5	21.0	16.6	105.4	9.5	3.8	27.5	24.5	25.7	34.2	25.9	29.3	22.6	12.5	42.1	105.4	14.9	20.3	24.8	21.6	14.6	21.8	25.0	8.8	46.9	21.6	69.8	16.5	69.9	91.3	12.7	15.4	33.4	27.0	12.2	9.4	20.5	33.1	38.3	19.7	33.9	27.1	49.2	32.8	20.6	16.9	2.5	25.4	28.3	12.3	13.4
AKAP13	"AKAP-Lbc, ARHGEF13, BRX, c-lbc, HA-3, Ht31, LBC, PROTO-LB"	ENSG00000170776	"A-kinase anchoring protein 13"	Q12802	15	85380571-85749358	"Plasma proteins, Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"	Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HMC-1: 161.8"	"Low region specificity"	"Detected in all"							HPA019773	Approved		Supported	Cytosol		NA	NA		14000	"Cluster 2: Granulocytes - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 65: Plasmacytoid DCs - Unknown function"	Cytosol		"HPA019773: AB_1844686"	"unprognostic (4.61e-2)"	"unprognostic (1.16e-1)"	"unprognostic (3.96e-2)"	"unprognostic (2.78e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.58e-1)"	"unprognostic (5.33e-2)"	"unprognostic (7.72e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.11e-1)"	"unprognostic (3.99e-2)"	"unprognostic (3.92e-1)"	"unprognostic (6.69e-2)"	"unprognostic (4.88e-2)"	"unprognostic (4.80e-2)"	"unprognostic (1.46e-1)"	"unprognostic (3.81e-3)"	37.7	18.9	10.0	38.7	9.2	56.1	32.1	1.7	9.3	28.5	66.1	25.9	16.7	83.0	20.7	25.6	22.7	44.6	66.6	11.0	17.7	14.4	22.2	54.1	47.6	16.7	17.6	26.7	54.5	11.8	18.5	26.0	13.9	20.3	21.3	8.3	23.9	23.5	83.9	24.7	32.5	40.3	9.7	38.3	34.4	20.0	15.0	46.3	32.7	60.3	46.5	32.9	26.7	16.3	13.2	29.0	20.8	7.8	31.3	34.6	11.2	10.6	23.5	9.4	9.0	11.3	11.0	62.0	14.6	19.2	23.8	26.5	23.9	9.9	9.0	45.2	11.0	83.8	20.0	8.6	17.3	17.2	161.8	25.6	25.5	11.6	39.8	10.6	25.2	22.4	5.5	29.6	14.7	6.3	24.7	12.8	13.5	22.8	11.5	16.7	20.6	23.5	15.3	27.0	13.1	23.4	27.9	8.3	14.5	22.7	6.0	14.3	30.2	11.4	7.8	6.7	10.7	46.1	30.1	48.9	6.8	55.2	9.0	282.9	66.0	181.4	122.2	54.9	68.3	74.9	81.6	93.3	38.8	68.8	68.2	75.5	104.3	108.2	77.5	100.6	73.2	48.0	10.0	9.2	1.7	9.3	11.0	17.7	16.7	17.6	13.9	9.7	15.0	16.3	110.5	125.0	431.2	88.2	186.8	75.7	105.2	29.1	57.5	18.6	50.2	39.9	215.2	91.5	71.6	40.5	41.7	36.7	336.8	143.3	5.9	83.4	258.9	155.6	327.0	121.5	63.5	37.0	51.2	69.6	27.6	119.6	170.2	323.6	279.5	65.6	75.7	53.7	79.2	13.5	13.0	57.8	36.7	147.1	276.3	166.3	77.6	257.9	99.6	290.4	197.3	45.8	252.4	123.6	13.2	101.2	118.7	63.6	205.8	77.0	68.6	10.5	60.1	17.9	85.5	139.6	117.4	23.3	37.2	77.6	79.0	23.4	269.7	30.5	61.7	179.6
AKAP17A	"721P, CCDC133, CXYorf3, DXYS155E, MGC39904, SFRS17A, XE7, XE7Y"	ENSG00000197976	"A-kinase anchoring protein 17A"	Q02040	X	1591604-1602520	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Theca cells: 131.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"basophil: 4.5"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 4.5"	"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA043247, HPA051020"	Supported		Supported	"Nuclear speckles,Cytosol"		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 52: Non-specific - Transcription"	"Nuclear speckles"	Cytosol	"HPA043247: AB_10964776, HPA051020: AB_2681314"	"unprognostic (4.55e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.74e-1)"	"prognostic favorable (3.40e-4)"	"unprognostic (5.38e-2)"	"unprognostic (1.59e-2)"	"unprognostic (9.73e-3)"	"unprognostic (6.25e-2)"	"unprognostic (2.09e-1)"	"unprognostic (7.91e-3)"	"prognostic favorable (2.42e-4)"	"unprognostic (1.55e-3)"	"prognostic unfavorable (3.52e-7)"	"unprognostic (1.86e-2)"	"unprognostic (2.71e-1)"	"unprognostic (4.03e-2)"	"prognostic favorable (1.11e-5)"	35.2	46.9	13.7	33.8	15.0	44.6	37.3	12.3	15.2	45.6	15.1	38.6	30.9	35.2	20.1	38.5	39.5	16.5	34.9	13.0	11.9	39.3	70.1	51.5	36.0	16.4	14.1	73.0	66.4	12.6	46.6	17.3	13.5	50.7	9.9	7.5	41.5	15.9	17.4	35.6	49.4	7.6	12.1	83.0	41.3	31.8	16.3	27.2	62.7	9.2	20.1	32.2	38.0	20.3	23.8	29.8	23.4	26.5	11.3	14.4	57.1	25.1	10.2	19.8	16.6	33.3	21.3	35.5	15.8	12.6	27.9	20.4	14.3	12.6	11.8	29.3	49.2	44.3	32.6	31.3	24.1	17.3	71.3	12.8	22.8	14.8	16.4	23.6	13.8	17.7	28.2	21.8	11.7	15.6	38.5	74.4	35.0	5.5	25.6	28.9	27.9	30.0	13.2	16.3	26.1	38.1	19.7	31.5	31.5	19.2	20.6	31.3	26.9	30.8	14.0	26.9	22.1	93.7	17.0	49.1	12.5	27.7	8.4	4.5	0.5	0.9	0.3	0.2	0.4	0.9	0.4	0.7	0.3	0.5	0.3	0.3	1.9	0.7	0.4	0.8	0.2	0.2	13.7	15.0	12.3	15.2	13.0	11.9	16.4	14.1	13.5	12.1	16.3	20.3	41.2	25.6	25.3	1.3	53.5	44.4	36.1	10.6	36.5	24.1	41.5	29.8	12.0	12.8	19.4	12.9	10.4	25.1	67.0	39.9	13.7	21.2	52.1	29.6	32.7	35.1	22.6	14.5	0.8	15.5	32.4	31.5	39.3	41.1	25.4	49.8	32.2	21.3	22.8	16.8	0.8	38.7	12.2	25.7	54.5	18.9	38.8	37.4	40.9	0.0	38.0	21.5	54.6	2.0	2.7	24.4	35.9	31.6	65.0	41.9	22.6	7.9	14.4	15.4	0.0	28.4	23.2	20.6	27.6	31.7	47.2	72.7	51.1	131.7	28.6	46.2
AKAP8	"AKAP95, DKFZp586B1222"	ENSG00000105127	"A-kinase anchoring protein 8"	O43823	19	15353385-15379815	"Plasma proteins, Predicted intracellular proteins"	"Immunity, Innate immunity, Protein transport, Transcription, Transcription regulation, Transport"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in single"		"cerebral cortex: 1.0"	"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004776	Supported		Supported	Nucleoplasm		NA	NA		10000	"Cluster 27: Non-specific - Gene expression"	"Cluster 72: Non-specific - Transcription"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm		"HPA004776: AB_1078122"	"unprognostic (9.04e-3)"	"unprognostic (3.67e-3)"	"unprognostic (1.03e-1)"	"unprognostic (4.17e-2)"	"unprognostic (8.03e-2)"	"unprognostic (1.77e-2)"	"unprognostic (4.13e-2)"	"unprognostic (3.17e-2)"	"unprognostic (3.34e-3)"	"unprognostic (1.27e-1)"	"unprognostic (2.82e-1)"	"unprognostic (1.78e-3)"	"unprognostic (5.04e-3)"	"unprognostic (1.22e-2)"	"unprognostic (3.57e-1)"	"unprognostic (6.06e-2)"	"unprognostic (3.83e-2)"	13.6	10.4	0.1	1.5	0.1	3.1	12.3	0.2	1.0	10.2	0.1	11.7	5.4	12.3	0.0	11.6	11.0	0.0	10.0	0.1	0.1	8.8	12.5	10.3	0.3	0.1	0.1	10.9	10.5	1.5	7.5	0.4	0.1	9.5	0.1	0.3	11.2	1.1	23.0	14.6	12.8	0.4	0.0	13.3	10.7	7.4	0.1	1.8	10.1	2.5	0.2	10.7	10.2	0.1	18.2	12.2	8.4	5.6	2.6	2.3	12.2	10.1	7.1	7.2	7.2	19.4	10.6	19.9	10.2	8.9	6.8	8.5	5.1	12.3	0.4	17.9	12.8	21.1	11.7	18.8	4.3	28.0	8.0	4.5	2.7	7.8	0.0	0.6	7.3	11.5	15.1	6.4	2.3	23.7	15.1	5.7	17.8	9.7	15.8	12.1	12.3	16.8	0.0	22.5	10.5	11.4	13.0	9.9	8.9	1.5	4.3	2.2	18.8	12.4	10.1	7.0	21.0	12.9	12.8	21.0	9.8	10.4	11.5	0.0	4.4	0.9	4.4	4.6	4.7	3.8	4.0	4.8	6.5	4.2	2.9	3.6	0.3	4.1	6.3	4.4	5.6	3.0	0.1	0.1	0.2	1.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	25.6	12.8	28.1	17.0	24.6	19.2	21.0	14.5	19.9	14.7	16.0	14.7	18.0	10.0	22.3	12.9	27.1	30.0	25.9	26.0	5.9	18.9	3.6	22.8	24.1	20.9	10.8	28.2	14.4	21.6	23.9	17.6	20.9	39.9	30.4	14.3	10.4	13.8	13.1	21.9	14.0	21.9	2.0	13.5	16.1	2.7	19.0	19.8	12.4	10.3	21.3	16.5	12.3	12.1	15.3	18.6	13.1	13.9	25.6	16.7	14.8	9.7	22.1	19.5	6.6	26.3	22.5	19.6	23.2	21.3	16.1	40.2	25.6	15.4	22.6	20.9
AKAP8L	"HAP95, NAKAP95"	ENSG00000011243	"A-kinase anchoring protein 8 like"	Q9ULX6	19	15380050-15419141	"Predicted intracellular proteins"	"Host-virus interaction, mRNA processing, mRNA splicing, Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042485, HPA042546"	Enhanced		Supported	"Nuclear speckles"		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 6: Erythroid cells - Oxygen transport"	"Nuclear speckles"		"HPA042485: AB_2678019, HPA042546: AB_2678046"	"unprognostic (9.52e-3)"	"unprognostic (5.23e-2)"	"prognostic unfavorable (3.49e-4)"	"unprognostic (1.08e-2)"	"unprognostic (3.25e-1)"	"unprognostic (3.53e-2)"	"unprognostic (1.38e-2)"	"unprognostic (2.87e-2)"	"unprognostic (1.08e-1)"	"unprognostic (3.57e-2)"	"prognostic favorable (8.04e-4)"	"unprognostic (1.01e-2)"	"prognostic unfavorable (1.08e-7)"	"unprognostic (2.77e-1)"	"unprognostic (1.07e-1)"	"unprognostic (8.80e-2)"	"unprognostic (2.34e-3)"	27.2	32.8	25.1	4.0	25.5	32.3	26.9	26.0	32.2	34.8	21.8	32.7	2.5	23.5	11.9	23.4	31.8	7.5	41.5	24.4	25.3	29.3	28.8	33.5	9.4	24.1	24.4	36.2	22.5	11.1	40.4	9.3	24.7	32.3	5.8	37.4	23.2	6.3	60.5	34.5	24.0	6.4	25.0	31.5	24.7	48.8	25.8	20.6	33.9	24.1	10.8	26.8	28.1	26.1	25.4	25.8	32.3	17.2	32.3	34.0	18.8	21.0	25.1	34.0	30.9	41.5	35.2	23.2	38.8	23.4	31.8	29.9	51.2	28.3	29.8	39.8	44.2	40.3	21.9	34.0	57.3	38.8	26.6	29.6	52.0	27.2	35.3	31.3	25.4	38.0	51.3	41.9	21.3	34.3	39.0	32.6	31.9	32.0	41.9	46.6	22.8	25.2	28.7	8.5	37.2	23.5	26.2	28.3	37.5	42.4	20.8	42.2	30.4	20.5	15.4	34.4	36.7	60.1	48.0	49.5	19.2	39.8	23.5	0.1	1.8	1.7	0.9	0.8	1.8	1.7	0.8	1.0	1.5	2.3	1.3	1.2	3.5	0.5	1.0	1.4	2.8	0.8	25.1	25.5	26.0	32.2	24.4	25.3	24.1	24.4	24.7	25.0	25.8	26.1	34.7	6.4	15.9	55.5	39.1	31.6	48.2	22.6	26.2	60.9	34.6	29.3	7.7	17.2	30.0	35.0	77.2	35.6	47.3	22.5	25.4	32.6	34.6	52.7	33.7	29.8	25.6	114.9	59.1	31.8	28.6	26.0	50.0	42.6	13.9	69.6	17.5	17.0	16.3	79.1	45.1	22.0	26.4	18.6	32.8	9.9	26.4	31.3	26.6	19.7	24.0	42.0	30.9	29.7	38.5	32.5	19.9	29.3	38.2	33.2	13.6	17.3	32.1	83.2	26.3	27.8	45.2	83.3	63.9	26.4	39.2	62.4	44.0	60.2	18.3	40.2
AKAP9	"AKAP350, AKAP450, CG-NAP, HYPERION, KIAA0803, LQT11, MU-RMS-40.16A, PPP1R45, PRKA9, YOTIAO"	ENSG00000127914	"A-kinase anchoring protein 9"	Q99996	7	91940840-92110673	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			"Cancer-related genes, Disease variant, Long QT syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cone photoreceptor cells: 2230.9;Rod photoreceptor cells: 1279.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008548, CAB012909, HPA026109"	Supported		Enhanced	"Golgi apparatus,Vesicles,Centrosome"		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 54: Non-specific - Microtubule organization"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 9: Photoreceptor cells - Phototransduction"	"Golgi apparatus"	"Vesicles, Centrosome"	"CAB012909: AB_2533235, HPA008548: AB_1078121, HPA026109: AB_1844688"	"unprognostic (9.57e-2)"	"unprognostic (1.66e-1)"	"unprognostic (2.13e-1)"	"unprognostic (5.97e-3)"	"unprognostic (1.20e-1)"	"unprognostic (1.47e-1)"	"unprognostic (4.75e-2)"	"unprognostic (1.31e-2)"	"unprognostic (1.28e-1)"	"unprognostic (6.59e-2)"	"unprognostic (7.59e-2)"	"unprognostic (6.32e-2)"	"prognostic favorable (2.10e-6)"	"unprognostic (8.89e-2)"	"unprognostic (1.73e-1)"	"unprognostic (7.77e-2)"	"unprognostic (3.96e-2)"	7.1	8.3	8.6	6.2	9.0	8.6	11.0	15.3	14.1	6.5	15.5	16.0	16.5	6.4	3.9	7.9	8.4	10.4	6.5	8.6	11.0	13.2	16.2	7.8	5.8	8.8	9.6	11.9	9.5	12.7	8.6	5.4	9.0	7.5	14.6	31.4	9.6	3.8	16.2	6.8	18.6	4.0	7.7	5.0	9.4	4.1	11.9	9.3	9.3	10.0	5.3	5.5	7.2	9.7	11.7	8.1	9.6	5.8	11.6	11.3	6.2	8.7	6.3	4.9	5.9	10.3	8.0	9.2	12.5	7.3	7.5	8.3	10.5	5.6	9.2	9.8	8.2	10.9	11.6	7.3	4.0	18.5	9.6	6.2	6.2	9.1	8.8	7.7	10.3	10.6	19.3	13.0	7.4	14.1	10.4	7.0	8.3	6.5	8.4	7.6	18.2	6.2	4.9	11.5	13.3	11.0	19.0	16.9	10.1	11.1	5.1	9.8	17.5	9.5	11.2	14.5	12.6	7.3	13.0	13.6	6.2	7.8	9.4	1.1	0.6	0.9	1.3	0.6	0.9	1.9	1.1	1.1	0.4	1.6	1.2	1.0	0.7	1.2	0.6	3.2	1.0	0.2	8.6	9.0	15.3	14.1	8.6	11.0	8.8	9.6	9.0	7.7	11.9	9.7	123.3	525.6	357.0	141.3	143.3	103.5	126.5	112.6	170.8	273.5	165.4	150.9	253.2	297.4	208.4	176.6	2230.9	141.4	201.5	293.4	101.8	131.0	22.5	392.3	157.7	115.9	185.1	129.4	142.6	92.6	81.9	123.5	152.9	185.0	136.6	386.1	98.2	153.5	57.2	360.1	182.6	350.8	136.3	78.3	88.4	17.5	173.4	101.6	58.7	115.2	121.5	155.7	119.4	169.9	187.1	102.4	218.9	135.8	193.5	91.4	298.5	47.2	506.3	1279.6	138.1	206.1	116.1	83.0	129.0	87.3	111.8	333.8	145.7	135.8	171.4	97.6
AKIP1	"BCA3, C11orf17"	ENSG00000166452	"A-kinase interacting protein 1"	Q9NQ31	11	8911139-8920084	"Predicted intracellular proteins"			Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA061391			Supported	Nucleoplasm		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 18: U-2197 - ECM organization"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Nucleoplasm		"HPA061391: AB_2684499"	"unprognostic (7.79e-3)"	"unprognostic (5.65e-2)"	"unprognostic (1.60e-1)"	"prognostic favorable (5.15e-4)"	"unprognostic (6.58e-2)"	"unprognostic (7.81e-2)"	"prognostic unfavorable (6.24e-9)"	"unprognostic (1.03e-1)"	"unprognostic (5.97e-2)"	"unprognostic (5.77e-2)"	"unprognostic (6.63e-2)"	"unprognostic (8.88e-2)"	"unprognostic (6.74e-3)"	"unprognostic (1.15e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.71e-3)"	"unprognostic (1.19e-1)"	16.0	33.0	21.3	12.4	21.6	11.0	14.9	20.8	21.9	22.1	21.4	22.2	13.7	22.7	17.3	22.4	19.2	13.5	27.1	21.2	22.8	22.7	15.5	17.2	11.3	21.8	24.6	19.6	13.0	13.9	18.7	16.0	21.9	17.3	11.3	16.4	14.6	14.9	37.7	10.3	14.2	14.9	22.4	25.5	16.7	17.6	22.2	16.0	18.6	22.1	9.1	18.8	17.3	22.7	81.5	73.2	31.1	30.4	29.2	37.0	25.0	58.6	45.6	35.0	33.4	39.2	48.1	14.7	45.2	42.5	36.9	53.4	15.6	28.3	24.2	72.4	40.3	25.1	39.7	34.9	34.3	33.6	29.1	31.7	37.8	17.2	62.9	26.8	32.2	29.0	52.2	15.3	65.3	26.6	27.3	31.2	26.3	39.3	54.6	28.5	22.9	18.7	35.7	33.4	22.0	21.6	67.2	29.3	31.7	20.1	33.7	27.6	53.1	49.0	44.5	84.2	56.7	23.0	63.0	3.6	51.0	40.5	52.6	3.1	31.5	1.4	15.3	29.0	16.1	9.2	17.8	17.4	41.1	8.5	11.9	21.0	1.9	13.1	14.5	43.7	58.8	18.1	21.3	21.6	20.8	21.9	21.2	22.8	21.8	24.6	21.9	22.4	22.2	22.7	16.1	19.2	9.9	6.8	7.8	10.7	15.1	54.0	16.5	15.9	13.2	17.0	11.7	20.0	22.2	20.2	10.4	40.9	12.5	7.0	25.4	41.4	54.6	7.6	20.6	24.5	2.4	15.3	8.3	36.0	41.5	22.0	9.2	10.7	49.4	25.9	22.9	15.2	65.9	25.2	10.3	9.8	75.3	25.5	17.3	28.0	22.1	25.6	16.0	8.4	33.4	32.3	7.2	9.5	5.2	33.1	18.6	48.2	9.0	8.3	11.5	21.0	15.7	15.5	19.7	15.4	22.2	39.8	35.1	18.5	7.1	11.8	14.7	48.9	13.7	11.8
AKIRIN1	"C1orf108, FLJ12666"	ENSG00000174574	"Akirin 1"	Q9H9L7	1	38991276-39006059	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	8	"Early spermatids: 1546.1;Late spermatids: 1455.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051871	Approved		Approved	"Nucleoplasm,Nuclear membrane"		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 34: Spermatids - Unknown function"	Nucleoplasm	"Nuclear membrane"	"HPA051871: AB_2681646"	"unprognostic (1.16e-1)"	"unprognostic (2.13e-2)"	"unprognostic (1.05e-1)"	"unprognostic (5.35e-3)"	"unprognostic (1.40e-1)"	"unprognostic (1.39e-3)"	"prognostic unfavorable (5.39e-7)"	"unprognostic (3.53e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.51e-2)"	"unprognostic (9.49e-3)"	"unprognostic (1.47e-2)"	"unprognostic (3.89e-2)"	"unprognostic (1.22e-1)"	"unprognostic (7.13e-2)"	"unprognostic (3.77e-3)"	"unprognostic (5.17e-2)"	46.0	29.9	37.5	33.5	41.3	77.2	23.1	41.8	43.8	21.9	41.3	35.1	24.2	28.7	42.3	29.2	25.0	41.8	38.5	38.6	47.4	42.9	53.2	30.0	42.3	45.9	45.1	19.6	27.7	43.2	40.0	26.5	47.2	36.3	36.2	37.5	24.4	35.8	30.1	17.3	26.8	41.9	42.4	31.7	33.3	83.2	49.8	41.5	36.1	30.4	42.1	41.2	18.6	48.1	61.4	28.0	117.3	96.9	56.3	66.2	83.8	70.0	73.1	69.2	70.1	73.2	49.5	48.3	63.3	67.1	49.6	41.8	114.7	62.8	110.8	72.2	58.3	142.7	41.6	92.5	74.2	137.5	75.3	68.5	80.5	90.4	73.6	61.6	64.9	61.8	99.0	46.6	87.8	25.2	58.5	60.2	248.2	45.9	47.1	92.4	85.4	48.2	77.7	73.9	81.3	55.2	77.8	41.4	160.1	182.8	37.9	70.6	58.3	42.3	68.4	46.2	72.1	67.1	92.5	102.6	72.7	80.4	73.3	35.7	39.3	83.7	33.4	33.9	50.6	33.7	54.4	51.7	55.4	30.2	63.3	42.0	102.8	72.0	38.8	41.7	54.7	53.1	37.5	41.3	41.8	43.8	38.6	47.4	45.9	45.1	47.2	42.4	49.8	48.1	48.5	64.1	43.9	25.1	83.8	137.9	77.1	34.0	56.9	48.1	69.0	48.6	45.1	31.5	40.1	38.6	47.9	72.9	111.6	48.6	93.9	45.6	1546.1	108.2	56.7	43.5	94.8	57.9	32.9	40.5	76.9	49.9	37.2	93.9	47.6	55.1	35.0	37.3	45.5	55.5	26.6	49.6	36.7	39.9	109.9	1455.5	44.1	65.2	42.7	16.9	85.1	52.1	42.2	23.6	73.2	50.5	37.2	45.5	53.2	67.8	23.9	41.8	38.9	45.0	52.6	61.3	77.5	77.3	103.9	43.4	138.5	167.5	99.9	34.0	41.8	81.4
AKIRIN2	"C6orf166, dJ486L4.2, FLJ10342"	ENSG00000135334	"Akirin 2"	Q53H80	6	87674860-87702233	"Predicted intracellular proteins"	"Immunity, Innate immunity, Transcription, Transcription regulation"	"Developmental protein, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			HPA064239			Supported	Nucleoplasm		No	Yes			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 41: Macrophages - Immune response"	Nucleoplasm		"HPA064239: AB_2685222"	"unprognostic (9.65e-2)"	"unprognostic (2.56e-1)"	"unprognostic (8.25e-2)"	"unprognostic (8.09e-2)"	"unprognostic (3.58e-1)"	"unprognostic (1.87e-2)"	"unprognostic (1.07e-1)"	"unprognostic (5.38e-2)"	"unprognostic (6.17e-2)"	"unprognostic (6.60e-3)"	"unprognostic (1.62e-2)"	"unprognostic (2.56e-1)"	"unprognostic (1.48e-2)"	"unprognostic (9.62e-2)"	"unprognostic (9.55e-2)"	"unprognostic (2.23e-3)"	"unprognostic (1.02e-1)"	32.9	37.1	29.0	23.8	32.5	70.5	26.0	26.5	37.6	22.7	27.8	19.8	12.7	24.6	23.7	33.2	22.6	15.3	30.9	34.0	34.0	20.8	31.2	33.2	28.4	26.9	28.8	25.6	13.2	17.8	23.4	18.5	26.4	17.0	12.5	29.7	24.5	11.7	97.4	22.9	22.9	16.4	29.5	49.0	16.8	24.1	35.7	31.2	17.2	42.6	30.3	23.2	25.0	30.9	23.9	24.7	71.0	40.1	43.1	29.6	41.4	41.1	25.7	33.2	32.3	39.7	18.0	62.2	44.1	42.1	55.1	36.2	39.1	29.6	37.9	79.2	48.5	36.3	21.8	89.7	47.1	31.4	30.2	34.6	29.9	41.0	40.2	32.5	36.6	24.3	71.2	42.2	43.5	30.7	9.9	64.9	51.0	20.3	38.1	38.7	50.2	25.7	41.7	20.8	53.0	50.3	24.9	14.8	44.2	40.1	17.9	73.9	47.6	27.5	18.8	23.5	54.6	40.9	48.4	38.8	30.4	40.2	45.1	76.1	57.8	64.8	28.1	73.2	29.2	41.6	27.4	27.6	55.0	32.6	21.4	23.1	144.4	36.6	75.6	75.1	39.1	35.0	29.0	32.5	26.5	37.6	34.0	34.0	26.9	28.8	26.4	29.5	35.7	30.9	49.9	25.6	19.8	10.4	88.2	96.5	192.2	101.9	80.8	13.0	31.8	28.8	22.5	35.8	43.7	18.4	8.4	45.1	94.4	17.1	45.0	30.9	58.0	44.9	34.3	45.6	12.1	45.4	15.6	14.7	71.0	51.1	16.3	39.9	33.6	47.2	44.6	29.9	77.0	11.8	14.8	10.9	69.2	104.4	167.0	100.9	35.8	142.8	74.7	19.7	46.7	80.5	33.0	17.6	15.1	29.6	21.7	28.2	69.4	119.7	19.0	53.5	17.9	17.0	6.6	62.2	39.9	70.6	63.0	92.6	92.9	136.5	99.5	54.2	12.6	191.0
AKNA	KIAA1968	ENSG00000106948	"AT-hook transcription factor"	Q7Z591	9	114334156-114394405	"Predicted intracellular proteins"	"Neurogenesis, Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 110.6"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 148.0;dendritic cells: 240.0;NK-cells: 265.7;Plasma cells: 137.3;Rod photoreceptor cells: 140.1;T-cells: 145.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 108.4;MOLT-4: 98.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA052367, HPA063993"			Supported	Nucleoplasm,Centrosome		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Nucleoplasm, Centrosome"		"HPA052367: AB_2681801, HPA063993: AB_2685169"	"unprognostic (5.19e-3)"	"prognostic favorable (1.22e-4)"	"unprognostic (5.38e-3)"	"prognostic favorable (2.14e-5)"	"unprognostic (3.12e-1)"	"prognostic favorable (1.25e-4)"	"unprognostic (1.88e-1)"	"unprognostic (3.28e-2)"	"unprognostic (4.13e-2)"	"unprognostic (6.62e-2)"	"unprognostic (5.85e-2)"	"unprognostic (1.10e-1)"	"prognostic unfavorable (2.55e-5)"	"unprognostic (1.19e-2)"	"unprognostic (6.61e-3)"	"unprognostic (2.93e-1)"	"prognostic favorable (2.29e-4)"	23.3	8.5	13.1	54.5	14.3	50.6	18.9	12.9	14.9	49.6	21.0	20.5	16.2	37.2	5.8	8.8	37.4	14.6	8.4	11.1	14.5	10.3	19.2	32.0	82.4	22.7	21.2	28.0	10.4	2.9	11.4	8.5	17.2	16.9	11.9	36.0	9.2	11.0	3.0	7.7	52.5	22.6	16.3	110.6	21.4	7.8	15.2	75.2	11.5	3.6	61.6	17.6	18.3	14.1	4.7	4.8	5.9	3.7	36.9	4.4	25.1	5.0	6.2	4.8	4.0	7.8	4.9	57.9	4.7	4.3	8.2	10.7	3.7	1.4	1.3	108.4	2.3	6.0	2.4	5.6	42.2	57.5	59.5	8.0	8.1	4.0	3.8	6.7	8.7	49.9	5.3	61.9	2.0	7.5	98.0	63.2	20.1	10.2	5.8	60.4	1.0	12.8	40.3	2.3	2.7	5.2	1.3	4.0	13.4	6.3	11.5	29.2	14.2	2.2	4.8	0.8	4.2	12.5	15.4	47.0	2.8	27.6	2.2	11.5	7.9	12.6	18.9	5.7	14.8	7.6	10.3	16.9	5.0	7.9	9.0	12.1	19.6	14.6	5.5	10.5	8.7	10.3	13.1	14.3	12.9	14.9	11.1	14.5	22.7	21.2	17.2	16.3	15.2	14.1	13.5	12.8	22.8	2.6	76.0	5.2	6.9	1.6	6.2	36.4	7.4	5.3	4.1	4.3	8.3	23.9	148.0	9.5	240.0	9.5	0.0	3.7	17.5	34.8	14.4	9.7	12.7	34.3	2.6	8.1	6.2	8.8	17.9	12.4	33.5	16.6	12.1	9.6	18.2	5.0	8.4	18.9	2.0	59.1	31.5	26.2	14.6	43.0	5.4	19.7	67.2	7.0	265.7	20.1	4.9	5.4	9.2	6.8	137.3	7.8	12.6	0.9	40.7	140.1	0.0	5.8	13.6	1.1	0.9	1.9	3.4	3.4	145.7	2.8	13.4	9.3
AKR1A1	"ALR, DD3"	ENSG00000117448	"Aldo-keto reductase family 1 member A1"	P14550	1	45550543-45570049	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Proximal enterocytes: 872.9;Proximal tubular cells: 1215.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB006246, HPA017919, HPA019649, HPA027734"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA		7600000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Cytosol	Nucleoplasm	"CAB006246: AB_425840, HPA017919: AB_1844695, HPA019649: AB_1844696, HPA027734: AB_10600976"	"unprognostic (1.73e-1)"	"prognostic favorable (2.66e-6)"	"unprognostic (4.03e-1)"	"prognostic favorable (2.92e-4)"	"unprognostic (1.17e-1)"	"unprognostic (1.77e-2)"	"unprognostic (6.54e-3)"	"unprognostic (1.31e-3)"	"unprognostic (2.52e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.83e-1)"	"unprognostic (8.43e-2)"	"unprognostic (4.51e-2)"	"unprognostic (1.56e-2)"	"unprognostic (2.46e-1)"	"unprognostic (2.89e-2)"	"unprognostic (4.57e-2)"	68.8	72.7	37.6	73.4	41.4	48.6	123.1	41.3	38.9	84.0	49.1	106.6	188.7	59.9	90.7	151.9	88.9	61.7	67.6	37.2	41.0	323.5	323.7	75.8	97.3	44.0	39.3	61.8	158.1	60.8	99.4	63.9	44.1	75.9	115.4	23.2	123.0	60.0	46.5	73.5	171.6	79.0	43.3	92.5	112.9	21.1	44.4	77.3	80.7	42.6	117.0	72.3	70.9	53.2	74.3	94.5	91.2	73.7	173.1	124.8	67.9	78.3	178.0	68.8	133.5	40.1	50.3	179.5	68.5	86.2	71.6	94.5	94.0	118.3	60.0	74.3	92.6	101.2	82.2	167.8	152.0	132.4	102.7	140.2	104.7	87.0	157.4	123.4	154.7	125.1	59.4	131.2	77.1	49.1	147.3	61.2	106.0	219.4	68.2	170.1	119.5	211.9	185.5	89.3	117.5	65.3	71.8	271.1	108.5	113.2	80.3	72.3	97.2	30.2	72.0	113.1	54.2	97.0	140.5	87.6	59.1	168.7	26.6	141.8	229.5	45.4	65.3	224.5	71.6	99.8	59.6	63.5	196.8	108.9	51.4	52.4	11.1	66.1	174.8	170.0	81.9	182.7	37.6	41.4	41.3	38.9	37.2	41.0	44.0	39.3	44.1	43.3	44.4	53.2	53.0	48.1	57.3	7.2	96.6	49.2	99.3	210.0	87.6	21.2	121.0	94.7	46.1	95.8	173.8	79.1	37.5	115.2	45.1	113.7	181.9	195.9	5.4	48.7	49.1	58.6	118.4	48.0	8.3	156.5	142.1	82.0	135.5	54.7	112.1	59.2	78.1	294.5	399.3	16.8	7.1	201.9	118.0	141.8	153.7	9.6	68.3	142.1	81.8	20.6	140.3	33.6	49.4	9.0	16.2	123.6	199.9	56.1	187.2	115.1	872.9	1215.0	131.6	38.0	6.6	40.3	132.5	5.9	32.2	158.5	47.0	67.9	49.5	59.0	198.5	129.6
AKR1B1	"ALDR1, AR"	ENSG00000085662	"Aldo-keto reductase family 1 member B"	P15121	7	134442356-134459284	"Cancer-related genes, Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	8	"adrenal gland: 3039.1"	"Cell type enhanced"	"Detected in many"		"Collecting duct cells: 649.2;Cytotrophoblasts: 1105.1;Extravillous trophoblasts: 1284.9;Ionocytes: 697.8;Syncytiotrophoblasts: 2022.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"A549: 1667.3;BJ hTERT+: 3096.2;RPTEC TERT1: 1447.8;U-87 MG: 1343.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026425, CAB027391, CAB047353, HPA052751"	Enhanced		Supported	Nucleoplasm,Cytosol		No	No		1500000	"Cluster 44: Non-specific - Transcription"	"Cluster 17: Adrenal gland - Steroid metabolism"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 38: Extravillous trophoblasts - Unknown function"	Cytosol	Nucleoplasm	"CAB027391: , CAB047353: , HPA026425: AB_10601563, HPA052751: AB_2681935"	"unprognostic (2.76e-2)"	"unprognostic (2.84e-2)"	"unprognostic (2.02e-2)"	"unprognostic (1.37e-2)"	"unprognostic (6.81e-2)"	"unprognostic (2.26e-1)"	"unprognostic (4.18e-2)"	"unprognostic (5.09e-2)"	"unprognostic (2.51e-3)"	"unprognostic (2.47e-1)"	"unprognostic (2.98e-2)"	"unprognostic (8.78e-2)"	"unprognostic (2.81e-2)"	"prognostic unfavorable (2.44e-5)"	"unprognostic (2.03e-1)"	"unprognostic (1.39e-1)"	"prognostic unfavorable (7.00e-4)"	65.1	3039.1	83.1	38.4	89.3	21.9	52.3	91.8	97.4	41.4	80.9	40.1	20.5	42.4	44.0	28.2	38.7	40.2	208.2	84.1	92.5	218.0	19.3	55.0	74.6	101.6	96.9	60.5	34.4	111.2	76.5	203.7	104.9	34.4	30.9	36.5	41.9	332.7	330.0	26.6	50.8	39.6	91.4	62.8	51.4	44.9	88.7	54.9	44.3	396.9	62.5	67.3	35.0	101.4	184.2	1667.3	186.5	261.4	785.9	212.3	494.6	177.2	3096.2	259.3	335.0	75.8	170.6	0.0	79.2	301.5	1143.3	78.6	204.0	175.3	206.6	65.2	168.2	93.4	225.0	230.1	1117.9	0.1	0.8	196.9	133.4	367.6	98.3	252.8	370.3	181.1	0.1	62.4	292.4	3.5	283.3	131.0	309.2	13.9	1.8	292.9	116.5	138.8	1447.8	915.5	137.1	301.6	1261.5	1.5	134.3	121.3	0.6	140.6	289.6	254.5	116.0	22.7	195.6	168.2	196.9	470.0	1343.5	0.7	153.0	125.7	106.4	5.6	147.6	72.3	135.2	133.0	124.7	144.5	145.3	121.7	162.9	156.7	8.5	119.7	39.2	20.4	94.9	230.2	83.1	89.3	91.8	97.4	84.1	92.5	101.6	96.9	104.9	91.4	88.7	101.4	34.1	12.8	19.4	9.1	50.3	20.6	55.3	66.1	20.5	36.2	11.7	27.9	202.4	25.8	26.4	649.2	8.4	1105.1	35.1	2.3	164.4	112.7	5.0	6.1	20.9	50.9	31.0	20.2	10.5	41.5	1284.9	100.3	20.4	5.9	53.8	59.8	82.1	2.6	394.1	72.3	18.7	15.1	697.8	172.8	53.9	14.5	79.2	127.7	30.2	14.0	76.3	49.3	66.9	5.5	12.4	51.0	4.5	77.5	72.6	25.6	0.3	60.2	24.9	24.1	59.2	98.9	54.5	22.6	100.2	10.5	11.6	2022.4	49.9	70.5	6.7	54.2
AKR1B10	"AKR1B11, AKR1B12, ALDRLn, ARL-1, ARL1, HIS, HSI"	ENSG00000198074	"Aldo-keto reductase family 1 member B10"	O60218	7	134527567-134541412	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted secreted proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 224.5;intestine: 614.8;stomach 1: 432.5"	"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 193.0;Distal enterocytes: 201.0;Gastric mucus-secreting cells: 542.3;Proximal enterocytes: 327.1"	"Cancer enhanced"	"Detected in many"		"liver cancer: 353.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	104	"A549: 2959.1;Hep G2: 835.6;OE19: 3141.0"	"Low region specificity"	"Detected in all"							"HPA020280, CAB070163, HPA073633"	Enhanced		Supported	"Plasma membrane,Cytosol"	"Secreted to digestive system"	NA	NA		67000000		"Cluster 37: Intestine - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 45: Enterocytes - Digestion"	Cytosol	"Plasma membrane"	"CAB070163: AB_10008614, HPA020280: AB_10602228, HPA073633: AB_2686620"	"unprognostic (1.29e-2)"	"unprognostic (1.50e-1)"	"prognostic favorable (1.91e-4)"	"unprognostic (6.03e-2)"	"unprognostic (4.67e-2)"	"unprognostic (2.57e-1)"	"unprognostic (2.16e-3)"	"unprognostic (1.01e-1)"	"unprognostic (1.47e-1)"	"unprognostic (3.18e-2)"	"unprognostic (4.65e-3)"	"unprognostic (1.54e-1)"	"prognostic unfavorable (4.80e-9)"	"unprognostic (2.12e-1)"	"unprognostic (2.12e-1)"	"unprognostic (1.43e-2)"	"unprognostic (1.25e-1)"	0.9	5.5	0.1	7.9	0.0	0.2	0.4	0.3	0.1	73.9	0.0	73.4	614.8	0.5	0.1	224.5	0.9	176.1	0.2	0.1	0.1	12.2	40.0	0.4	0.3	0.0	0.0	0.2	0.7	0.0	4.8	0.1	0.1	1.3	45.6	0.1	32.4	0.2	3.7	7.7	354.8	3.2	0.1	0.1	432.5	0.6	0.0	5.5	0.6	5.9	7.7	65.8	145.6	0.2	0.0	2959.1	0.0	0.0	0.7	2.3	9.0	0.3	1.1	0.2	0.0	5.9	0.9	0.0	1.1	1.6	4.6	6.2	0.0	4.0	0.2	0.1	0.0	0.0	1.9	835.6	0.7	0.0	0.6	0.1	13.8	0.7	0.0	4.0	0.5	0.0	0.0	0.0	0.6	5.4	0.1	1.3	0.5	3141.0	2.3	0.3	0.0	2.7	1.5	2.7	1.0	1.5	1.8	1.3	0.1	0.1	0.0	0.1	1.9	1.2	1.2	0.2	1.0	0.4	0.1	0.0	22.2	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.1	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.2	0.1	0.0	0.0	0.0	1.0	2.8	2.1	52.1	3.4	0.0	0.1	0.0	0.7	193.0	13.5	0.0	0.0	0.3	0.0	201.0	0.0	31.5	0.7	2.9	0.1	0.2	3.5	2.7	0.0	27.5	0.1	4.4	542.3	1.0	0.0	0.0	2.2	62.9	0.0	0.0	0.1	29.5	4.1	0.6	0.3	0.7	3.4	0.3	0.0	0.0	0.6	0.0	0.0	0.0	0.0	66.9	42.5	1.9	1.7	1.0	327.1	3.8	4.8	0.0	0.0	3.7	1.5	0.0	0.1	96.0	10.4	0.3	0.5	0.0	73.0	11.4
AKR1B15		ENSG00000227471	"Aldo-keto reductase family 1 member B15"	C9JRZ8	7	134549110-134579875	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"breast: 166.7"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 2.2;Fibroblasts: 2.9;Late spermatids: 3.6;Skeletal myocytes: 12.5;Syncytiotrophoblasts: 10.4"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 5.1"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 15.8;HDLM-2: 12.8;Hep G2: 11.2;SK-BR-3: 5.1;U-87 MG: 6.7"									"HPA020280, HPA073633"	Uncertain		Supported	"Plasma membrane,Cytosol"		NA	NA				"Cluster 5: Breast - Unknown function"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 50: Fibroblasts - ECM organization"	Cytosol	"Plasma membrane"	"HPA020280: AB_10602228, HPA073633: AB_2686620"	"unprognostic (2.35e-1)"	"unprognostic (3.85e-2)"	"unprognostic (9.74e-3)"	"unprognostic (2.74e-2)"	"unprognostic (2.08e-1)"	"prognostic favorable (8.36e-4)"	"prognostic unfavorable (1.80e-5)"	"unprognostic (5.04e-2)"	"unprognostic (2.39e-1)"	"unprognostic (2.75e-1)"	"unprognostic (2.14e-3)"	"unprognostic (1.24e-1)"	"unprognostic (1.22e-7)"	"unprognostic (6.88e-2)"	"unprognostic (4.29e-1)"	"unprognostic (2.99e-3)"	"prognostic unfavorable (1.90e-5)"	0.4	0.1	0.4	0.2	1.4	0.0	166.7	0.3	0.5	1.1	0.0	0.8	14.0	0.0	0.2	3.2	0.0	5.2	0.1	0.4	1.1	0.1	2.1	0.0	0.0	0.6	1.1	0.0	0.0	0.0	0.0	0.8	0.6	0.3	0.6	0.3	1.8	0.0	7.8	1.1	4.5	0.0	0.7	0.0	12.0	0.5	1.4	0.2	0.1	18.8	0.3	0.9	2.6	1.5	0.1	15.8	0.1	0.0	0.6	0.5	0.9	0.0	0.4	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.7	0.1	0.0	0.1	0.0	12.8	0.0	0.1	0.2	11.2	0.0	0.2	0.5	0.0	0.2	0.0	0.1	0.1	0.0	0.1	0.2	0.5	0.0	0.0	0.2	0.2	3.1	0.4	0.0	0.1	0.2	0.3	0.1	0.1	0.1	0.1	0.6	5.1	0.0	0.1	0.0	0.3	0.0	0.1	0.7	0.3	0.0	0.2	0.2	0.2	6.7	0.2	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1.4	0.3	0.5	0.4	1.1	0.6	1.1	0.6	0.7	1.4	1.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.8	0.0	0.0	0.5	0.0	0.0	0.0	0.0	2.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	2.9	0.0	0.0	0.0	0.9	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.4	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	12.5	0.1	0.0	0.7	0.0	0.3	10.4	0.1	0.0	0.0	0.1
AKR1C3	"DDX, HAKRB, HSD17B5, KIAA0119, PGFS"	ENSG00000196139	"Aldo-keto reductase family 1 member C3"	P42330	10	5035354-5107686	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 441.3"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 393.1;Exocrine glandular cells: 722.5;Proximal enterocytes: 576.9;Proximal tubular cells: 601.8"	"Cancer enhanced"	"Detected in all"		"liver cancer: 83.8"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"basophil: 244.0;gdT-cell: 102.6"	"Group enriched"	"Detected in many"	4	"granulocytes: 244.0;T-cells: 102.6"	"Cell line enhanced"	"Detected in many"		"A549: 1615.1;ASC diff: 811.9;Hep G2: 699.6;OE19: 3025.3;RT4: 639.2"									"CAB010874, HPA068265"	Enhanced		Approved	"Nucleoplasm,Nucleoli fibrillar center,Endoplasmic reticulum,Cytosol"		NA	NA		19000000	"Cluster 38: Basophils - Unknown function"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 21: OE19 - Mitochondria"	"Cluster 1: Pancreatic cells - Digestion"	"Nucleoplasm, Cytosol"	"Nucleoli fibrillar center, Endoplasmic reticulum"	"CAB010874: AB_476751, HPA068265: AB_2685966"	"unprognostic (4.20e-3)"	"unprognostic (2.70e-2)"	"unprognostic (8.92e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.81e-3)"	"prognostic unfavorable (1.96e-4)"	"unprognostic (1.41e-1)"	"unprognostic (6.74e-2)"	"unprognostic (5.08e-2)"	"unprognostic (1.31e-1)"	"unprognostic (4.33e-2)"	"prognostic unfavorable (1.22e-4)"	"unprognostic (4.45e-1)"	"unprognostic (3.70e-2)"	"unprognostic (1.79e-3)"	"unprognostic (4.24e-3)"	164.4	50.2	31.1	25.4	34.6	42.3	115.2	32.1	42.4	21.9	30.2	185.9	441.3	25.9	4.4	53.2	42.1	261.1	42.9	31.5	35.6	177.7	268.0	48.3	7.6	30.3	33.9	17.8	36.4	22.5	10.4	4.7	32.3	10.3	98.0	19.1	40.5	19.4	116.9	27.0	270.9	39.2	30.3	3.8	237.4	10.0	31.5	37.4	26.4	34.8	6.6	84.7	22.2	31.1	0.1	1615.1	1.1	413.0	811.9	292.2	1.0	0.0	21.4	0.4	1.4	47.6	24.5	0.2	78.7	19.4	45.0	11.5	1.5	28.8	1.1	3.0	0.5	3.2	438.4	699.6	4.3	0.7	0.2	160.9	57.1	20.0	0.7	25.8	28.1	3.4	10.8	0.0	42.6	3.8	9.8	2.6	0.7	3025.3	4.3	3.3	9.6	43.7	149.0	639.2	1.0	2.9	232.2	0.0	0.3	0.9	0.5	0.2	221.7	5.2	4.7	87.8	3.1	0.7	0.7	0.3	45.8	62.8	4.4	244.0	2.9	4.8	102.6	0.9	6.9	0.0	19.0	18.7	2.1	0.5	11.6	8.9	7.3	21.1	1.4	39.6	21.4	42.4	31.1	34.6	32.1	42.4	31.5	35.6	30.3	33.9	32.3	30.3	31.5	31.1	144.2	44.8	5.3	4.9	4.3	12.0	3.7	393.1	2.8	2.0	15.8	5.5	3.9	0.0	172.9	36.8	0.0	0.4	64.4	133.8	43.0	114.6	3.3	67.5	4.5	67.5	19.2	34.9	2.5	722.5	0.0	44.3	158.0	66.4	5.7	0.1	0.0	0.0	1.6	1.7	3.2	65.9	61.1	0.0	14.0	4.9	78.3	14.8	21.4	7.5	4.1	132.7	202.9	14.6	0.0	266.1	219.6	106.8	3.1	1.3	576.9	601.8	112.8	5.3	26.3	15.5	20.3	0.5	4.3	20.2	10.7	0.0	14.4	7.8	196.9	46.4
AKR1D1	SRD5B1	ENSG00000122787	"Aldo-keto reductase family 1 member D1"	P51857	7	138002324-138118305	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"	"Bile acid catabolism, Lipid degradation, Lipid metabolism, Steroid metabolism"	Oxidoreductase	"Disease variant, FDA approved drug targets, Intrahepatic cholestasis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	83	"liver: 426.9"	"Group enriched"	"Detected in some"	31	"Early spermatids: 65.4;Hepatocytes: 110.3;Late spermatids: 126.1"	"Cancer enriched"	"Detected in single"	77	"liver cancer: 20.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	21	"Hep G2: 12.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA057002	Enhanced		Approved	Nucleoplasm,Cytosol		No	NA		61000	"Cluster 17: Basophils - Unknown function"	"Cluster 62: Liver - Hemostasis"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 2: Hepatocytes - Metabolism"	Nucleoplasm	Cytosol	"HPA057002: AB_2683308"	"unprognostic (2.38e-1)"	"unprognostic (1.65e-2)"			"unprognostic (1.02e-2)"	"unprognostic (1.52e-2)"	"prognostic favorable (9.91e-5)"	"unprognostic (6.11e-2)"	"unprognostic (2.31e-1)"	"unprognostic (1.30e-1)"	"unprognostic (6.87e-2)"	"unprognostic (2.94e-1)"	"unprognostic (9.68e-3)"	"unprognostic (2.90e-1)"	"unprognostic (5.80e-2)"	"unprognostic (3.11e-1)"	"unprognostic (1.67e-2)"	0.0	0.1	0.2	0.0	0.1	0.2	5.1	0.3	0.3	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.2	0.0	0.1	426.9	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	12.6	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.7	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.1	0.1	0.1	0.0	0.0	0.2	0.1	0.3	0.3	0.2	0.0	0.2	0.1	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.3	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	65.4	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.1	0.0	0.0	1.4	110.3	0.4	0.0	0.2	0.2	0.0	3.2	0.4	126.1	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.9	0.1	1.6	0.3	0.0	0.0	0.3	0.3	0.0	0.0	0.2
AKR1E2	"AKR1CL2, AKRDC1, htAKR, HTSP1, MGC10612"	ENSG00000165568	"Aldo-keto reductase family 1 member E2"	Q96JD6	10	4786629-4848062	"Enzymes, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"testis: 19.0"	"Group enriched"	"Detected in some"	5	"Early spermatids: 153.8;Late spermatids: 174.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"JURKAT: 12.3;RT4: 10.4;U-2197: 19.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037821, HPA037822"	Enhanced		Supported	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 18: U-2197 - ECM organization"	"Cluster 34: Spermatids - Unknown function"	"Nucleoplasm, Golgi apparatus"		"HPA037821: AB_2675687, HPA037822: AB_10671722"	"unprognostic (2.33e-2)"	"unprognostic (2.59e-2)"	"unprognostic (1.68e-2)"	"unprognostic (8.27e-2)"	"unprognostic (7.33e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.44e-1)"	"unprognostic (7.42e-3)"	"unprognostic (7.47e-2)"	"unprognostic (2.77e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.53e-1)"	"unprognostic (3.06e-2)"	"unprognostic (2.74e-1)"	"unprognostic (2.04e-2)"	"unprognostic (1.62e-4)"	"unprognostic (5.62e-2)"	2.0	0.8	1.7	0.7	1.8	2.1	3.1	1.5	2.3	1.8	0.0	1.3	1.4	1.1	0.9	1.4	1.0	1.3	1.9	2.0	2.4	0.9	0.5	2.0	0.8	1.6	2.0	0.7	2.1	1.0	0.5	1.8	2.7	0.9	1.2	3.5	1.1	1.8	1.5	1.2	1.0	2.1	0.5	1.2	1.5	19.0	1.6	0.7	3.3	0.8	0.5	1.1	1.3	1.6	0.5	5.9	2.2	1.0	0.0	0.0	0.1	2.3	0.2	0.1	0.1	9.0	0.8	0.0	0.0	6.0	0.0	0.7	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	2.7	0.0	0.0	1.1	6.2	1.1	0.0	0.0	6.5	12.3	5.6	0.0	0.0	5.4	0.7	0.0	2.2	6.9	4.4	0.0	0.0	0.0	1.6	10.4	0.0	4.8	8.2	2.4	4.7	2.4	4.6	2.6	4.1	0.0	2.0	19.5	0.0	2.8	0.0	0.0	0.1	0.0	1.4	0.9	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.3	0.1	0.0	0.0	0.0	0.4	0.0	0.0	1.7	1.8	1.5	2.3	2.0	2.4	1.6	2.0	2.7	0.5	1.6	1.6	0.9	0.0	0.0	1.6	0.2	0.0	0.1	0.5	0.6	0.2	1.1	0.6	0.8	0.0	0.6	1.8	0.0	0.1	0.1	0.0	0.0	0.3	153.8	0.5	0.7	1.4	0.0	1.3	7.1	0.0	0.0	2.2	0.0	0.6	0.0	0.6	2.2	0.0	1.2	1.7	8.9	0.1	0.0	0.6	0.6	174.2	2.8	0.8	3.6	5.6	0.6	0.3	0.0	9.0	0.0	0.1	0.1	1.5	0.0	0.2	0.0	0.5	0.3	1.2	0.0	0.8	1.2	32.0	10.0	0.7	0.1	0.0	0.2	0.2	0.1	0.5
AKR7A2	AFAR	ENSG00000053371	"Aldo-keto reductase family 7 member A2"	O43488	1	19303965-19312144	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Proximal tubular cells: 711.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"CAB032587, CAB032841, HPA064638"	Enhanced		Supported	"Golgi apparatus,Cytosol"		NA	NA		950000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Cytosol	"Golgi apparatus"	"CAB032587: AB_673379, CAB032841: AB_2224545, HPA064638: AB_2685307"	"unprognostic (1.06e-1)"	"unprognostic (3.48e-2)"	"unprognostic (7.23e-2)"	"unprognostic (5.76e-2)"	"unprognostic (9.92e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.14e-2)"	"unprognostic (3.14e-3)"	"unprognostic (1.99e-1)"	"unprognostic (2.50e-2)"	"unprognostic (5.11e-2)"	"unprognostic (7.11e-2)"	"prognostic favorable (2.67e-4)"	"unprognostic (3.72e-2)"	"unprognostic (8.53e-2)"	"unprognostic (1.01e-1)"	"prognostic unfavorable (8.59e-4)"	33.3	67.9	45.3	17.5	48.0	25.0	33.8	47.4	44.2	57.2	66.2	46.4	81.1	34.7	22.4	47.8	48.4	29.1	39.1	45.9	46.1	76.7	62.7	24.6	25.3	48.8	49.4	45.7	47.9	32.7	32.6	19.0	44.9	31.6	27.5	16.0	31.4	27.7	55.4	37.1	56.8	22.6	49.2	28.3	42.7	33.1	48.2	31.3	28.6	39.6	20.5	29.6	38.5	54.1	65.3	40.2	43.3	40.2	67.0	64.7	28.8	47.6	57.6	65.0	58.2	51.5	53.6	46.8	49.6	64.2	36.6	50.8	48.7	71.5	30.5	37.5	77.4	29.4	37.5	83.3	51.9	32.9	22.9	64.8	55.5	50.0	30.6	61.5	55.8	60.2	43.6	42.6	67.7	64.9	64.2	31.9	12.4	90.8	50.1	66.7	54.0	83.2	64.2	28.3	80.9	30.2	51.8	46.1	84.6	24.6	91.9	112.7	44.2	40.6	42.7	44.0	36.2	51.4	34.8	57.9	87.6	74.4	58.5	0.7	82.2	40.6	61.4	69.7	71.7	63.8	54.4	54.2	113.5	57.6	61.7	54.1	9.5	69.4	54.1	98.8	78.9	73.7	45.3	48.0	47.4	44.2	45.9	46.1	48.8	49.4	44.9	49.2	48.2	54.1	47.6	16.0	22.3	15.3	42.6	24.3	73.2	56.4	37.5	33.1	94.6	98.8	27.7	98.7	31.7	77.3	6.2	167.5	52.8	95.0	254.3	64.0	94.6	85.8	35.8	35.3	99.7	33.4	8.6	36.2	99.8	67.9	44.9	33.4	10.2	62.5	43.2	90.6	104.6	21.9	7.5	97.9	46.8	58.4	34.2	57.6	77.3	47.6	53.4	5.6	64.6	128.7	63.8	5.5	9.2	39.4	131.5	67.7	36.3	39.3	273.8	711.5	61.0	30.1	46.0	57.8	54.4	56.3	24.9	76.0	34.1	102.6	40.4	88.4	136.4	62.3
AKR7A3		ENSG00000162482	"Aldo-keto reductase family 7 member A3"	O95154	1	19282573-19288770	"Metabolic proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 248.9;liver: 154.6;pancreas: 288.4;stomach 1: 224.4"	"Group enriched"	"Detected in many"	5	"Gastric mucus-secreting cells: 348.1;Proximal enterocytes: 1132.3;Proximal tubular cells: 766.6"	"Cancer enhanced"	"Detected in many"		"liver cancer: 36.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"OE19: 15.9;SK-BR-3: 25.0"									HPA064638			Supported	"Golgi apparatus,Cytosol"		NA	NA		1900000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Cytosol	"Golgi apparatus"	"HPA064638: AB_2685307"	"unprognostic (7.78e-2)"	"unprognostic (5.07e-2)"	"unprognostic (6.08e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.10e-2)"	"unprognostic (8.84e-2)"	"unprognostic (3.85e-3)"	"unprognostic (7.70e-3)"	"unprognostic (2.72e-1)"	"unprognostic (2.50e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.98e-1)"	"prognostic favorable (8.80e-7)"	"unprognostic (4.53e-2)"	"unprognostic (5.58e-2)"	"unprognostic (2.85e-1)"	"unprognostic (2.35e-1)"	1.6	4.0	2.3	2.6	2.4	0.3	4.2	2.8	3.2	2.3	16.7	29.2	248.9	1.4	0.4	1.8	1.8	38.0	0.6	3.3	2.6	71.1	154.6	1.0	0.4	2.7	2.9	2.6	288.4	0.3	2.2	0.2	2.6	1.9	17.4	1.5	3.5	0.3	0.4	2.6	144.8	1.4	2.5	1.3	224.4	2.1	2.9	0.1	1.8	0.1	0.2	1.0	1.6	2.6	0.5	0.0	0.5	0.3	0.5	0.2	1.8	0.1	0.1	0.2	0.1	0.5	1.9	0.2	0.3	0.4	0.0	0.8	0.0	0.0	0.0	0.2	0.5	0.2	0.7	0.8	0.2	0.2	0.2	0.3	0.3	0.3	0.0	0.2	0.0	0.3	0.2	0.3	0.1	0.7	0.5	1.7	0.3	15.9	0.6	0.7	0.1	1.6	0.0	0.1	0.9	1.4	0.3	25.0	0.6	0.1	4.1	0.5	0.4	0.3	0.2	0.9	0.3	1.2	0.3	0.3	0.5	0.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	2.3	2.4	2.8	3.2	3.3	2.6	2.7	2.9	2.6	2.5	2.9	2.6	0.4	0.0	0.0	7.5	3.3	0.8	0.7	0.2	0.6	1.0	13.8	9.5	0.8	140.2	0.3	29.5	0.0	0.5	0.5	133.3	119.3	3.9	3.5	0.5	0.4	0.8	20.8	11.2	4.1	31.8	0.3	0.5	348.1	0.4	4.5	0.9	4.2	119.0	0.3	0.0	3.6	87.6	4.1	3.5	0.0	4.7	0.3	4.4	0.0	1.9	0.1	3.6	0.0	2.5	1.9	18.3	125.0	0.4	0.8	1.2	1132.3	766.6	3.2	1.1	0.0	0.7	0.4	1.8	1.1	1.1	0.6	0.5	3.0	0.7	130.2	0.4
AKT1	"AKT, PKB, PRKBA, RAC, RAC-alpha"	ENSG00000142208	"AKT serine/threonine kinase 1"	P31749	14	104769349-104795751	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins, Transporters"	"Apoptosis, Carbohydrate metabolism, Glucose metabolism, Glycogen biosynthesis, Glycogen metabolism, Neurogenesis, Sugar transport, Translation regulation, Transport"	"Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Disease variant, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"eosinophil: 61.5"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 61.5"	"Cell line enhanced"	"Detected in all"		"MCF7: 558.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002891, CAB003765"	Supported		Supported	Nucleoplasm,Microtubules		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 30: Mammary glandular cells - Lactation"	Nucleoplasm	Microtubules	"CAB003765: AB_562035, HPA002891: AB_1078123"	"unprognostic (3.30e-2)"	"unprognostic (4.27e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.84e-1)"	"unprognostic (3.70e-1)"	"unprognostic (9.17e-3)"	"unprognostic (1.55e-3)"	"unprognostic (1.21e-1)"	"unprognostic (1.47e-1)"	"prognostic favorable (4.83e-4)"	"unprognostic (3.58e-2)"	"unprognostic (1.90e-2)"	"prognostic favorable (2.12e-4)"	"unprognostic (7.14e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.41e-1)"	71.5	102.7	45.9	57.7	45.5	51.2	61.2	43.7	53.2	52.0	50.4	85.0	50.8	59.5	23.2	70.7	53.7	50.0	105.9	45.2	44.3	54.3	97.3	69.2	51.9	50.5	45.7	43.7	94.3	53.0	35.9	55.4	45.0	67.2	39.6	25.1	67.7	73.0	58.1	45.0	53.3	63.4	47.4	63.7	77.8	23.9	48.0	52.4	52.3	64.9	40.3	72.6	48.4	43.3	77.3	150.5	124.6	186.9	95.2	97.7	136.9	142.3	171.5	204.6	163.6	96.8	92.8	91.2	105.5	196.6	102.8	99.4	89.5	131.9	90.1	214.3	36.2	70.6	90.4	103.2	104.6	117.5	178.0	140.0	109.1	102.9	68.1	98.2	154.4	87.5	62.1	102.2	134.1	558.3	145.3	146.8	32.6	153.5	107.2	137.5	111.9	60.5	94.8	189.5	141.2	117.2	117.3	152.2	88.9	56.8	195.7	170.2	123.5	133.2	63.2	192.3	145.1	105.4	52.6	80.7	113.7	96.7	162.0	6.4	9.9	61.5	10.0	10.3	7.2	5.5	8.7	11.4	7.0	7.2	4.6	10.1	22.6	11.0	12.4	10.0	9.0	6.3	45.9	45.5	43.7	53.2	45.2	44.3	50.5	45.7	45.0	47.4	48.0	43.3	45.8	16.0	27.4	16.6	13.7	12.4	20.0	17.3	15.9	26.3	58.0	39.9	16.1	32.9	17.7	22.0	12.5	19.4	54.2	40.9	13.7	23.6	1.9	17.9	28.1	27.5	30.0	11.3	8.2	35.2	31.8	24.0	26.0	24.8	2.5	40.4	23.2	42.9	23.2	42.1	13.0	37.3	22.4	23.3	21.4	3.3	28.6	28.0	10.6	6.5	23.1	51.2	24.7	8.0	9.6	53.3	22.1	30.9	10.3	38.8	23.5	17.9	14.2	26.6	26.3	24.9	29.1	1.8	5.3	16.2	13.9	23.4	23.3	34.0	33.7	33.4
AKT1S1	"Lobe, MGC2865, PRAS40"	ENSG00000204673	"AKT1 substrate 1"	Q96B36	19	49869033-49878459	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Syncytiotrophoblasts: 130.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB021903, HPA043590, HPA064427"	Uncertain		Supported	Cytosol		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Cytosol		"CAB021903: , HPA043590: AB_2678569, HPA064427: AB_2685261"	"unprognostic (2.11e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.64e-1)"	"unprognostic (2.21e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.04e-1)"	"prognostic unfavorable (3.70e-4)"	"unprognostic (1.41e-2)"	"unprognostic (1.41e-1)"	"unprognostic (3.18e-1)"	"prognostic favorable (6.60e-4)"	"unprognostic (5.48e-2)"	"prognostic unfavorable (7.34e-6)"	"unprognostic (3.20e-2)"	"unprognostic (2.84e-1)"	"unprognostic (1.36e-1)"	"unprognostic (3.65e-1)"	39.0	54.0	35.6	14.2	37.9	14.3	34.9	37.2	41.0	33.1	28.6	40.3	21.8	39.1	14.3	53.2	32.6	12.4	47.1	34.7	36.6	36.2	65.9	25.6	8.7	40.5	41.4	33.1	39.2	24.4	34.2	16.7	40.5	35.0	14.1	6.6	32.8	20.0	118.3	54.0	29.3	17.6	33.9	24.6	40.5	24.0	39.5	8.2	31.4	45.4	9.7	38.5	33.2	39.4	70.9	83.8	24.1	56.0	50.2	53.4	42.5	62.2	69.4	57.4	49.4	45.7	46.0	14.1	31.1	70.6	43.5	47.9	41.9	70.5	33.5	32.2	116.6	17.0	48.2	43.5	44.6	14.9	26.8	65.9	64.0	62.3	70.2	43.0	53.9	16.8	57.0	18.2	52.5	49.5	14.0	36.7	63.0	85.7	120.9	17.1	33.8	43.2	57.9	49.3	56.2	65.4	53.2	93.7	39.9	28.1	49.1	28.9	52.5	118.1	61.7	34.2	62.1	26.4	69.8	15.2	68.4	27.2	57.5	0.1	1.1	0.9	0.7	1.4	0.4	0.4	0.5	0.7	0.8	0.7	0.4	0.7	1.7	0.7	1.6	1.2	1.0	0.6	35.6	37.9	37.2	41.0	34.7	36.6	40.5	41.4	40.5	33.9	39.5	39.4	20.7	0.0	3.3	7.2	15.1	14.7	22.9	33.8	18.8	12.6	31.2	22.6	6.2	27.1	15.5	11.0	2.1	64.0	10.7	56.1	45.0	36.8	24.8	18.2	22.9	20.6	30.0	42.5	4.1	40.2	52.3	23.5	32.1	25.3	4.5	18.6	17.9	42.8	31.1	10.1	4.9	38.8	30.5	20.7	22.8	10.8	23.9	16.6	12.4	4.7	26.9	32.9	15.5	2.5	8.1	34.5	32.9	28.6	17.1	43.3	57.1	55.8	7.2	11.7	26.3	23.7	25.3	12.3	19.3	32.1	20.0	130.0	9.4	26.5	38.1	31.3
AKT2	PKBβ	ENSG00000105221	"AKT serine/threonine kinase 2"	P31751	19	40230317-40285536	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins"	"Apoptosis, Carbohydrate metabolism, Glucose metabolism, Glycogen biosynthesis, Glycogen metabolism, Sugar transport, Translation regulation, Transport"	"Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Diabetes mellitus, Disease variant, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004204, HPA064521"	Uncertain		Supported	Nucleoplasm,Vesicles,Cytosol		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 52: Non-specific - Ribosome"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 52: Non-specific - Transcription"	"Nucleoplasm, Vesicles, Cytosol"		"CAB004204: AB_626659, HPA064521: AB_2685278"	"unprognostic (6.13e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.56e-1)"	"prognostic unfavorable (1.05e-6)"	"unprognostic (2.85e-1)"	"unprognostic (6.40e-3)"	"unprognostic (9.59e-2)"	"unprognostic (1.22e-2)"	"unprognostic (2.98e-2)"	"unprognostic (2.49e-2)"	"unprognostic (3.02e-1)"	"prognostic unfavorable (4.74e-4)"	"unprognostic (1.30e-2)"	"unprognostic (1.89e-1)"	"unprognostic (3.28e-1)"	"unprognostic (6.16e-2)"	"unprognostic (2.00e-1)"	62.8	40.0	31.7	37.3	31.3	48.4	38.6	58.3	40.0	49.8	55.1	42.3	24.5	43.5	49.4	42.5	46.1	25.1	40.8	31.5	24.5	52.2	59.2	30.7	38.1	32.0	26.0	53.9	41.9	58.5	47.8	27.6	26.3	41.2	23.3	41.2	32.5	45.0	101.3	39.4	35.6	34.2	22.1	38.1	33.1	29.7	28.0	53.4	100.1	118.7	37.0	39.8	41.5	35.2	66.2	160.1	63.1	61.5	72.0	88.9	32.5	41.7	63.5	87.6	77.9	71.8	60.8	67.4	36.8	96.3	37.2	28.2	66.8	90.0	56.1	62.5	74.3	43.4	116.5	44.7	45.8	50.7	50.5	82.7	53.6	58.6	56.4	71.9	19.0	73.0	57.3	67.5	49.8	54.6	81.1	24.7	31.7	73.7	41.5	54.2	32.1	48.5	68.3	105.7	82.7	49.8	43.3	75.0	35.0	62.5	59.8	64.9	18.8	52.7	51.5	47.3	67.6	61.5	59.0	56.4	52.6	59.7	44.3	5.7	2.6	2.1	2.2	1.2	2.2	1.9	1.8	1.5	1.7	2.9	1.7	2.6	4.0	1.7	1.6	4.9	1.6	1.7	31.7	31.3	58.3	40.0	31.5	24.5	32.0	26.0	26.3	22.1	28.0	35.2	18.1	16.0	15.9	51.2	33.0	23.8	23.9	20.9	26.2	67.6	25.3	23.9	31.2	30.0	18.1	60.7	41.7	31.3	26.0	23.7	21.5	19.7	5.5	26.2	26.7	17.4	19.2	19.1	30.4	30.4	25.2	27.9	20.9	25.8	14.0	44.2	13.9	87.5	22.3	60.6	25.3	20.1	22.4	23.2	17.5	10.5	42.9	20.0	23.2	23.4	21.7	46.2	50.4	41.7	40.6	24.8	16.9	26.7	30.4	29.7	21.8	24.8	24.9	97.4	19.7	29.3	25.0	14.8	15.6	31.1	27.4	38.7	23.1	56.9	23.3	29.4
AKT3	"PKBG, PRKBG, RAC-gamma"	ENSG00000117020	"AKT serine/threonine kinase 3"	Q9Y243	1	243488233-243851079	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 59.9"	"Group enriched"	"Detected in many"	6	"Astrocytes: 457.4;Excitatory neurons: 756.1;Inhibitory neurons: 514.5;Microglial cells: 414.1;Oligodendrocyte precursor cells: 633.3;Oligodendrocytes: 475.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013090, HPA026441"	Approved		Supported	Cytosol		NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 21: Non-specific - Transcription"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Cytosol		"CAB013090: AB_2533692, HPA026441: AB_1844711"	"unprognostic (1.33e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.40e-2)"	"unprognostic (8.45e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.96e-1)"	"unprognostic (3.77e-1)"	"unprognostic (2.32e-1)"	"unprognostic (2.28e-1)"	"unprognostic (5.47e-3)"	"unprognostic (1.37e-1)"	"unprognostic (6.71e-2)"	"unprognostic (3.64e-3)"	"unprognostic (1.29e-1)"	"unprognostic (8.14e-2)"	"prognostic unfavorable (9.27e-4)"	19.3	9.7	13.4	6.0	17.0	3.8	15.5	59.9	36.6	20.0	0.0	24.5	2.6	22.7	8.6	5.9	20.3	8.2	11.8	22.8	5.6	11.2	4.7	15.3	5.9	1.2	3.9	26.4	4.5	7.4	13.9	13.1	7.4	15.8	4.9	17.0	5.1	15.6	5.9	6.3	11.8	15.7	0.8	8.1	10.2	9.7	20.3	7.0	14.4	11.5	4.6	18.8	14.8	31.1	30.8	7.2	31.0	0.4	16.9	20.6	13.9	20.8	22.5	11.8	12.9	1.1	13.9	0.5	3.0	28.9	12.1	1.2	16.3	8.5	18.9	9.0	15.3	1.0	1.0	0.3	11.7	0.6	6.5	11.3	0.3	15.5	16.9	30.3	30.2	7.2	0.5	1.1	9.0	0.9	7.6	3.3	14.4	0.3	5.1	4.2	19.7	0.6	4.8	4.1	31.4	41.9	1.3	0.5	40.1	19.1	1.9	21.5	25.6	22.7	17.7	1.1	19.5	4.6	4.6	7.1	19.4	5.2	25.3	1.3	0.8	0.1	0.6	0.1	1.1	0.6	0.6	0.6	0.3	0.8	0.6	0.7	0.7	1.4	0.3	0.5	0.1	0.3	13.4	17.0	59.9	36.6	22.8	5.6	1.2	3.9	7.4	0.8	20.3	31.1	65.4	3.2	2.2	457.4	22.2	2.4	15.0	1.3	17.1	43.6	6.1	5.1	5.4	4.3	2.7	27.6	33.3	11.0	24.4	0.0	0.0	11.6	82.8	1.7	35.5	43.7	0.0	5.0	756.1	1.7	8.0	27.9	2.6	1.1	5.1	29.7	48.2	0.6	2.9	42.1	514.5	0.0	2.0	10.5	12.5	72.8	27.4	9.5	7.2	414.1	8.6	20.1	19.6	633.3	475.9	0.7	0.0	35.3	14.4	27.0	0.0	6.9	0.3	35.0	19.7	40.1	35.6	15.0	14.6	1.7	1.7	12.4	27.8	8.3	0.0	12.2
AL035078.4		ENSG00000285283	"Novel protein"		11	31812391-32104665	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Tissue enhanced"	"Detected in many"		"intestine: 8.8;lymphoid tissue: 5.7;retina: 7.4"	"Not detected"	"Not detected"							"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"BJ: 224.4;RH-30: 110.7;RT4: 139.0;TIME: 116.0"									HPA038474	Uncertain		Supported	"Endoplasmic reticulum"		NA	NA			"Cluster 40: NK-cells - Unknown function"		"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 49: Ciliated cells - Cilium organization"	"Endoplasmic reticulum"		"HPA038474: AB_10672595"																		1.3	0.0	0.4	5.7	0.7	0.5	0.0	2.5	1.4	0.3	0.0	8.8	0.0	2.3	0.1	2.2	0.7	0.0	0.0	0.4	1.3	0.3	1.6	1.0	0.0	1.5	1.2	1.1	0.0	0.0		0.4	1.1	0.2	0.2	7.4	0.0	0.0	4.1	0.0	1.5	0.2	1.0	0.2	2.1	0.5	0.8	0.3	0.0	0.0	0.5	0.1		1.6	14.7	33.3	4.9	22.6	2.8	0.0	0.6	224.4	40.6	18.6	9.5	11.2	25.0	0.0	46.0	12.7	14.3	7.1	21.8	12.1	14.7	13.1	0.8	13.4	24.1	0.0	0.0	11.3	1.8	0.0	0.0	23.7	6.4	3.8	4.4	0.1	3.7	13.5	0.0	0.2	13.8	0.0	2.6	0.0	0.3	8.7	110.7	2.7	0.0	139.0	12.9	3.7	36.6	1.4	16.3	0.0	13.9	0.5	116.0	62.2	27.3	30.4	64.6	0.0	0.1	0.6	74.6	2.9	24.7	0.0	0.8	0.0	0.3	0.4	0.4	0.2	0.0	0.2	1.0	0.0	0.0	0.1	0.1	0.8	0.3	0.1	0.0	0.4	0.4	0.7	2.5	1.4	0.4	1.3	1.5	1.2	1.1	1.0	0.8	1.6	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ALAS1	"ALAS, ALAS3"	ENSG00000023330	"5'-aminolevulinate synthase 1"	P13196	3	52198086-52214327	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Heme biosynthesis"	"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 720.5;liver: 548.8"	"Cell type enhanced"	"Detected in all"		"Hepatocytes: 243.1;Syncytiotrophoblasts: 309.2;Theca cells: 187.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 233.9"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 233.9"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017498, HPA035860"	Enhanced		Supported	Nucleoplasm,Mitochondria		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 15: RT4 - Unknown function"	"Cluster 15: Hepatocytes - Hemostasis"	Mitochondria	Nucleoplasm	"CAB017498: AB_2225629, HPA035860: AB_10672992"	"unprognostic (1.17e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.50e-1)"	"unprognostic (7.09e-2)"	"unprognostic (2.33e-1)"	"unprognostic (6.21e-2)"	"prognostic favorable (1.82e-5)"	"unprognostic (3.98e-2)"	"unprognostic (1.26e-1)"	"unprognostic (2.31e-2)"	"unprognostic (9.86e-2)"	"unprognostic (5.64e-2)"	"prognostic favorable (6.06e-7)"	"unprognostic (8.45e-2)"	"unprognostic (3.91e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.75e-2)"	34.5	720.5	24.8	23.9	25.1	176.7	28.7	37.9	82.5	20.5	35.7	43.6	44.9	19.0	28.1	36.4	15.3	32.7	116.2	26.6	28.1	45.7	548.8	47.8	22.9	27.2	25.4	17.1	19.6	60.3	15.7	36.8	33.2	23.1	41.6	20.6	42.8	27.2	110.9	24.3	39.3	23.9	24.9	19.5	45.9	18.6	31.8	23.5	22.1	106.6	28.2	73.8	23.5	28.3	36.2	55.0	38.0	35.4	57.9	43.1	103.1	51.8	47.7	67.6	65.3	73.6	66.2	33.6	12.7	36.4	137.0	20.9	55.1	42.6	54.7	65.9	21.6	43.2	41.2	56.4	81.8	70.8	83.0	54.0	39.1	107.7	35.7	25.0	62.8	57.7	25.8	27.0	62.4	29.5	33.9	107.3	33.0	41.1	93.4	20.0	23.9	53.3	59.8	213.9	20.2	13.3	83.9	40.9	47.2	30.5	23.5	99.9	45.7	37.6	37.1	78.5	76.2	39.5	73.8	50.5	42.1	75.5	61.1	233.9	33.4	103.2	22.9	42.9	37.4	23.1	23.9	26.0	29.8	21.5	21.1	23.3	49.6	30.9	39.0	17.1	35.7	25.1	24.8	25.1	37.9	82.5	26.6	28.1	27.2	25.4	33.2	24.9	31.8	28.3	28.4	35.3	60.3	5.2	14.9	17.3	17.2	36.1	15.9	16.6	28.6	19.6	107.5	25.8	37.7	23.9	4.2	81.9	25.1	68.5	56.7	35.5	10.2	20.2	9.3	27.6	34.6	11.2	6.2	31.3	28.2	19.6	42.3	25.3	95.4	13.1	18.5	243.1	69.1	11.8	6.2	24.3	34.6	13.0	20.8	4.1	13.4	36.4	5.4	8.4	49.1	9.7	11.3	4.0	8.4	42.3	28.1	16.6	14.0	16.0	35.6	36.1	40.6	9.2	13.1	9.1	27.5	25.5	22.3	21.4	16.2	309.2	25.1	187.2	24.3	26.4
ALDH1A3	"ALDH6, RALDH3"	ENSG00000184254	"Aldehyde dehydrogenase 1 family member A3"	P47895	15	100877714-100916626	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase	"Disease variant, Microphthalmia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"prostate: 134.5;urinary bladder: 125.1"	"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 175.4;Endometrial stromal cells: 247.9;Leydig cells: 194.5;Prostatic glandular cells: 580.3;Urothelial cells: 468.7"	"Cancer enriched"	"Detected in many"	5	"prostate cancer: 80.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A-431: 363.3;HaCaT: 441.7;HBEC3-KT: 1096.9;hTERT-RPE1: 347.7;U-2197: 619.0;U-87 MG: 484.7;WM-115: 516.1"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"olfactory bulb: 4.5;spinal cord: 15.8"	"HPA046271, HPA064749"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 22: Epithelial cell types - Mixed function"	Nucleoplasm	Cytosol	"HPA046271: AB_10965992, HPA064749: AB_2685344"	"unprognostic (6.87e-2)"	"unprognostic (2.23e-1)"	"unprognostic (6.20e-3)"	"unprognostic (1.21e-3)"	"unprognostic (1.76e-2)"	"unprognostic (1.14e-1)"	"unprognostic (6.28e-2)"	"unprognostic (5.46e-2)"	"unprognostic (9.62e-2)"	"unprognostic (4.53e-2)"	"unprognostic (3.64e-2)"	"unprognostic (2.56e-1)"	"unprognostic (1.25e-2)"	"unprognostic (2.61e-2)"	"unprognostic (2.12e-1)"	"unprognostic (7.34e-2)"	"unprognostic (6.07e-3)"	83.7	11.4	3.0	41.5	2.7	0.6	30.5	4.7	5.2	37.1	16.2	16.6	15.0	8.2	30.3	28.7	24.9	17.0	12.4	3.1	1.9	8.2	5.3	9.8	3.0	4.8	3.4	6.1	15.0	9.0	7.5	8.4	2.6	134.5	8.9	0.3	93.7	49.3	5.9	3.9	25.2	40.8	2.8	3.1	12.8	16.6	3.3	1.6	2.5	6.9	15.7	125.1	22.3	3.9	363.3	43.5	0.6	0.7	75.0	32.8	1.4	3.2	3.2	1.9	0.8	1.0	285.8	2.6	4.7	97.1	55.7	441.7	8.8	1096.9	6.7	0.1	2.0	1.7	20.1	0.3	25.5	1.4	1.9	23.5	29.8	24.4	4.5	347.7	4.0	0.0	0.7	2.4	1.8	3.8	0.2	1.2	9.0	9.6	316.3	0.7	4.2	2.3	0.2	283.6	0.3	25.4	113.9	94.9	33.3	3.6	9.3	3.2	58.3	0.3	1.0	619.0	14.2	0.7	3.4	1.5	484.7	0.2	516.1	0.3	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	3.0	2.7	4.7	5.2	3.1	1.9	4.8	3.4	2.6	2.8	3.3	3.9	10.0	16.0	6.3	0.3	0.5	0.6	175.4	70.5	4.6	0.0	64.6	18.9	2.0	1.5	141.6	103.0	0.0	9.6	0.9	1.0	3.9	70.5	1.2	20.6	247.9	11.6	3.5	0.0	2.9	1.4	0.5	48.9	1.1	11.7	5.7	0.0	1.8	0.1	1.2	0.0	2.3	2.1	30.5	0.0	1.3	8.5	194.5	3.3	0.0	1.0	0.6	0.0	0.0	36.7	4.6	29.4	0.0	135.4	0.0	580.3	0.1	0.7	78.7	0.0	13.1	20.4	11.5	0.5	0.9	2.9	1.6	4.9	2.0	1.5	0.8	468.7
ALDH1B1	"ALDH5, ALDHX"	ENSG00000137124	"Aldehyde dehydrogenase 1 family member B1"	P30837	9	38392702-38398661	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 172.7;smooth muscle: 128.0"	"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 85.8;Ductal cells: 64.1;Hepatocytes: 128.1;Proximal tubular cells: 165.0;Theca cells: 91.7;Undifferentiated cells: 71.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"OE19: 183.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA021037, HPA077080"	Enhanced		Supported	Nucleoplasm,Mitochondria,Cytosol		NA	NA		500000	"Cluster 27: Non-specific - Gene expression"	"Cluster 85: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria	"Nucleoplasm, Cytosol"	"HPA021037: AB_1844724, HPA077080: "	"unprognostic (4.16e-1)"	"unprognostic (1.98e-2)"	"unprognostic (5.84e-2)"	"unprognostic (1.55e-3)"	"unprognostic (2.47e-2)"	"unprognostic (4.48e-3)"	"unprognostic (2.84e-3)"	"unprognostic (2.70e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.35e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.00e-1)"	"prognostic favorable (2.05e-4)"	"unprognostic (1.04e-1)"	"unprognostic (1.63e-1)"	"prognostic unfavorable (1.17e-5)"	"unprognostic (2.89e-2)"	21.2	10.4	3.2	31.4	3.2	2.9	8.9	4.1	4.0	8.5	6.4	61.5	22.9	57.7	5.7	32.7	34.9	29.0	14.7	2.7	4.8	59.2	172.7	7.3	5.1	3.5	3.3	12.6	11.3	8.5	2.5	5.2	4.3	36.9	35.5	1.5	11.1	54.5	55.8	6.3	24.8	128.0	3.4	7.2	28.2	8.3	4.0	5.1	15.4	35.9	5.6	85.1	10.5	4.1	72.2	65.5	19.8	31.8	27.6	32.5	15.8	33.6	16.9	27.8	28.3	44.2	13.7	45.2	19.7	47.4	42.0	10.0	66.0	71.4	27.4	50.8	28.5	22.4	44.7	132.2	20.0	36.0	24.0	39.0	15.3	22.6	19.5	56.6	26.8	10.6	65.6	42.8	42.8	27.3	0.1	14.4	59.1	183.3	29.0	14.9	119.9	34.5	25.1	31.7	43.3	19.9	25.7	16.7	19.4	20.6	15.9	27.9	18.2	31.9	52.4	26.9	42.5	6.5	13.2	17.8	16.4	36.0	22.1	0.3	4.2	0.2	6.7	9.2	9.6	5.5	6.5	6.1	9.5	2.6	5.1	6.2	1.0	8.0	11.9	1.2	5.0	5.3	3.2	3.2	4.1	4.0	2.7	4.8	3.5	3.3	4.3	3.4	4.0	4.1	3.3	9.6	1.7	0.0	3.7	1.0	5.7	9.4	2.2	1.2	3.7	4.2	6.6	85.8	3.8	16.5	2.1	2.0	1.2	12.8	17.6	64.1	0.6	2.3	6.4	4.7	15.6	12.8	0.5	6.9	46.6	6.6	8.2	3.4	8.9	12.8	8.9	128.1	7.2	0.0	1.1	25.5	6.1	4.1	2.4	2.2	6.5	4.2	0.0	0.0	5.5	2.1	0.0	0.5	0.5	15.0	7.7	6.8	3.7	6.1	10.3	165.0	0.3	0.7	0.0	6.0	16.1	0.6	0.8	2.1	1.0	1.8	3.3	91.7	71.7	2.8
ALDH4A1	"ALDH4, P5CDh"	ENSG00000159423	"Aldehyde dehydrogenase 4 family member A1"	P30038	1	18871430-18902724	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Proline metabolism"	Oxidoreductase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 200.4;liver: 436.6"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 78.0;Hepatocytes: 385.1;Proximal tubular cells: 279.4;Syncytiotrophoblasts: 86.6"	"Cancer enhanced"	"Detected in all"		"liver cancer: 72.0"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"Hep G2: 83.7;SK-BR-3: 85.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004645, HPA006401, HPA072759"	Enhanced		Supported	Mitochondria		NA	NA		58000	"Cluster 7: Monocytes - Unknown function"	"Cluster 15: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Mitochondria		"CAB004645: AB_425775, HPA006401: AB_1844731, HPA072759: "	"unprognostic (1.17e-1)"	"prognostic favorable (5.06e-4)"	"unprognostic (1.38e-2)"	"unprognostic (4.16e-2)"	"unprognostic (3.15e-1)"	"unprognostic (7.67e-2)"	"unprognostic (1.28e-1)"	"unprognostic (6.18e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.09e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.06e-1)"	"unprognostic (4.27e-3)"	"unprognostic (9.41e-3)"	"unprognostic (3.83e-1)"	"unprognostic (2.69e-3)"	"unprognostic (9.34e-2)"	70.8	16.1	73.9	3.9	88.9	11.7	21.6	73.8	95.9	12.6	106.5	6.8	1.6	9.8	4.7	36.3	8.3	5.5	33.0	68.2	73.8	200.4	436.6	6.2	3.4	72.9	82.8	7.3	4.6	23.0	9.7	13.2	70.0	29.5	2.7	6.5	9.1	27.1	74.2	19.2	4.7	7.1	65.6	7.5	12.5	3.2	92.4	11.7	7.1	74.8	4.2	19.3	16.8	66.1	12.7	17.8	9.5	29.2	40.0	5.7	25.2	13.1	7.1	11.8	9.5	13.7	8.9	8.8	16.6	15.6	5.7	34.0	16.7	35.4	4.5	4.8	15.9	5.9	5.0	83.7	12.6	4.4	15.1	15.6	19.2	6.5	6.6	9.0	13.5	14.0	21.0	5.7	8.1	32.3	4.3	20.2	4.7	26.0	10.1	27.9	8.4	10.0	12.1	32.0	19.6	7.6	21.9	85.0	16.1	14.7	38.7	6.3	11.3	10.2	14.0	12.2	4.5	7.1	17.9	2.5	3.4	33.7	13.5	0.0	2.7	1.5	0.6	3.6	0.5	0.8	0.3	0.8	4.4	0.7	0.2	0.5	0.3	0.1	2.0	1.5	0.6	1.5	73.9	88.9	73.8	95.9	68.2	73.8	72.9	82.8	70.0	65.6	92.4	66.1	2.6	0.0	2.8	27.1	4.3	7.5	17.9	12.5	17.6	3.7	9.8	8.5	20.9	34.3	2.9	46.0	10.4	78.0	2.0	2.0	46.9	6.5	0.5	1.1	1.7	3.1	2.4	32.2	1.2	0.9	12.6	3.2	7.7	3.9	4.5	2.1	15.4	385.1	13.8	20.2	1.6	3.6	6.1	17.2	1.4	0.6	1.2	4.7	3.6	1.9	10.9	14.0	1.0	5.5	1.3	2.5	1.8	2.6	4.4	12.0	0.3	279.4	1.7	4.8	6.6	2.6	4.7	2.2	3.9	21.7	5.4	86.6	2.6	4.5	4.0	9.5
ALDH5A1	"SSADH, SSDH"	ENSG00000112294	"Aldehyde dehydrogenase 5 family member A1"	P51649	6	24494867-24537207	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 98.8"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 90.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Daudi: 136.6;U-698: 173.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029715, HPA029716"	Enhanced		Supported	Mitochondria		NA	NA		50000	"Cluster 30: Non-specific - Translation"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Mitochondria		"HPA029715: AB_10599994, HPA029716: AB_10601876"	"unprognostic (7.43e-2)"	"unprognostic (1.12e-3)"	"unprognostic (1.80e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.23e-1)"	"unprognostic (3.27e-1)"	"prognostic favorable (7.61e-6)"	"unprognostic (2.38e-2)"	"unprognostic (2.17e-2)"	"prognostic favorable (6.20e-4)"	"unprognostic (1.43e-2)"	"unprognostic (1.21e-1)"	"prognostic favorable (3.68e-4)"	"unprognostic (1.04e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.00e-2)"	"unprognostic (1.08e-2)"	9.4	6.1	27.8	5.9	28.9	4.4	5.2	25.0	32.7	5.4	18.8	8.5	11.8	4.8	3.7	7.3	19.0	5.1	14.5	26.5	32.8	27.8	98.8	6.4	13.6	26.7	35.0	7.3	8.2	19.4	5.8	2.4	27.3	8.2	7.1	11.0	5.2	5.2	57.9	9.5	8.0	3.1	29.4	6.8	7.7	4.5	34.0	26.8	17.0	33.8	12.9	6.7	8.4	24.9	11.5	9.3	6.5	10.1	0.1	0.0	11.7	0.8	2.0	2.4	1.6	35.1	2.5	136.6	21.1	1.0	2.2	0.1	10.5	1.3	1.5	14.7	20.2	20.7	5.9	42.4	1.6	32.2	2.7	1.0	4.4	0.2	0.0	7.1	0.1	34.7	10.4	0.0	1.8	23.3	40.4	19.0	2.7	18.4	5.5	46.1	1.4	1.3	7.7	19.6	11.7	10.5	12.1	1.2	13.2	2.8	19.4	17.5	0.2	1.1	6.7	0.3	7.1	19.4	32.2	173.7	0.2	9.8	1.4	0.3	0.0	0.1	1.0	0.0	1.9	2.2	1.4	1.5	0.1	2.0	3.8	3.4	0.2	0.8	0.1	2.4	0.9	0.7	27.8	28.9	25.0	32.7	26.5	32.8	26.7	35.0	27.3	29.4	34.0	24.9	2.9	16.0	25.3	14.0	9.7	1.7	5.6	8.2	2.2	12.9	7.5	3.4	34.8	11.5	9.4	7.3	16.7	6.1	7.4	6.1	1.9	1.6	0.8	15.2	5.0	3.7	8.4	16.0	18.1	1.0	5.2	3.5	5.6	5.4	7.0	13.5	6.8	90.7	3.9	16.8	32.4	11.7	2.0	3.8	1.8	0.3	3.4	1.7	1.8	8.4	0.2	11.8	3.1	11.6	2.4	1.3	7.7	4.5	12.2	4.1	13.4	26.8	12.8	6.9	0.0	6.9	2.3	1.7	6.6	8.7	3.0	1.9	5.4	8.0	17.0	13.1
ALDH7A1	"ATQ1, EPD, PDE"	ENSG00000164904	"Aldehyde dehydrogenase 7 family member A1"	P49419	5	126531200-126595362	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase	"Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 162.2"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 414.1;Proximal tubular cells: 302.1;Syncytiotrophoblasts: 222.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"plasmacytoid DC: 6.4"	"Lineage enriched"	"Detected in many"	5	"dendritic cells: 6.4"	"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 256.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023296, HPA053675"	Enhanced		Supported	Mitochondria,Cytosol		Yes	No		430000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 15: Liver - Metabolism"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 47: Cytotrophoblasts - Unknown function"	Mitochondria	Cytosol	"HPA023296: AB_1844738, HPA053675: "	"unprognostic (1.37e-1)"	"unprognostic (9.67e-2)"	"unprognostic (2.07e-2)"	"unprognostic (2.20e-2)"	"unprognostic (4.15e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.58e-3)"	"unprognostic (9.49e-3)"	"unprognostic (7.61e-2)"	"unprognostic (7.08e-2)"	"unprognostic (2.10e-1)"	"unprognostic (1.33e-1)"	"prognostic favorable (3.08e-4)"	"unprognostic (1.51e-1)"	"unprognostic (3.70e-1)"	"unprognostic (3.10e-3)"	"unprognostic (4.93e-2)"	23.7	38.3	46.6	9.1	47.6	1.8	47.1	43.7	45.8	32.7	40.7	29.5	23.7	25.1	8.8	35.9	28.8	19.1	27.9	44.7	43.2	115.1	162.2	15.7	8.6	43.1	43.5	65.3	27.0	34.0	8.8	44.9	42.6	42.0	27.4	19.7	40.6	27.9	12.2	29.4	21.0	23.6	44.8	7.0	23.6	12.3	44.0	18.3	47.6	26.5	17.1	18.1	20.9	45.2	64.9	41.9	116.6	193.4	95.5	56.4	147.8	76.1	93.4	86.5	110.5	118.6	60.7	0.0	75.5	60.0	36.1	47.1	36.5	256.2	78.8	0.1	44.6	12.3	63.1	102.1	46.3	0.2	0.0	69.0	59.2	67.3	47.7	64.2	70.0	0.0	0.0	0.1	77.1	42.1	2.6	0.3	79.4	47.5	35.2	38.9	131.8	0.0	81.2	48.4	39.4	47.2	0.0	41.1	44.7	89.0	75.2	2.7	86.1	24.8	75.6	28.8	53.1	0.1	0.1	0.4	13.4	0.2	40.6	0.7	0.2	0.1	0.1	0.0	0.2	0.8	0.2	0.1	1.8	0.6	1.2	0.6	0.1	0.1	0.0	6.4	0.0	0.4	46.6	47.6	43.7	45.8	44.7	43.2	43.1	43.5	42.6	44.8	44.0	45.2	17.6	16.0	29.3	99.3	5.0	25.9	59.5	110.0	87.0	23.6	40.6	91.1	39.9	27.1	43.5	42.3	22.9	414.1	3.7	15.2	76.3	43.5	31.4	18.7	44.3	19.1	21.7	5.2	16.0	13.8	107.8	34.0	27.0	21.4	7.0	50.4	18.9	74.6	51.1	25.2	21.5	25.9	20.3	9.4	7.6	41.7	25.4	9.1	55.2	12.2	7.5	102.1	0.0	41.7	30.0	12.6	15.6	37.2	2.0	27.5	23.4	302.1	23.4	13.6	19.7	19.4	25.8	1.0	5.1	59.2	16.1	222.3	4.6	39.3	46.4	50.4
ALK	CD246	ENSG00000171094	"ALK receptor tyrosine kinase"	Q9UM73	2	29192774-29921586	"Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease variant, FDA approved drug targets, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"brain: 10.9"	"Group enriched"	"Detected in some"	5	"Inhibitory neurons: 274.2;Oligodendrocyte precursor cells: 433.8"	"Group enriched"	"Detected in some"	5	"glioma: 1.0;melanoma: 1.5;ovarian cancer: 0.7;thyroid cancer: 1.3"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	6	"SH-SY5Y: 31.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA010694	Approved		Supported	"Plasma membrane"		NA	NA				"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Plasma membrane"		"HPA010694: AB_1078133"	"unprognostic (4.96e-2)"	"unprognostic (1.11e-2)"	"unprognostic (1.45e-1)"	"unprognostic (4.56e-7)"	"unprognostic (7.17e-2)"	"unprognostic (1.71e-1)"	"unprognostic (9.07e-3)"	"unprognostic (6.29e-3)"	"unprognostic (1.18e-1)"	"unprognostic (1.01e-1)"	"unprognostic (2.67e-4)"	"unprognostic (3.70e-2)"	"unprognostic (2.06e-2)"	"unprognostic (7.15e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.38e-1)"	"unprognostic (3.61e-2)"	0.3	0.6	2.2	0.2	2.4	0.0	0.1	0.7	2.8	0.1	0.8	0.6	0.1	0.0	0.0	0.0	0.0	0.2	0.0	1.5	3.9	0.0	0.0	0.1	0.0	4.4	6.8	0.0	0.0	0.0	1.3	0.0	10.9	0.0	0.2	0.7	0.1	0.1	0.0	0.1	0.3	0.1	2.9	0.0	0.1	1.2	2.7	0.0	0.3	0.0	0.0	0.0	0.0	2.1	0.1	0.0	0.5	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.6	0.0	4.3	0.0	0.0	0.1	0.4	31.7	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	3.7	0.0	5.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	2.4	0.7	2.8	1.5	3.9	4.4	6.8	10.9	2.9	2.7	2.1	0.0	0.0	0.0	66.6	0.0	0.0	0.0	0.0	0.0	1.9	0.2	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	42.1	0.5	0.1	0.2	0.0	0.0	12.5	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	3.4	0.0	274.2	0.0	0.0	0.0	0.0	41.2	0.0	0.5	0.0	7.5	0.0	0.6	0.0	433.8	21.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.1	0.1	0.8	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0
ALKBH1	"ABH, alkB, ALKBH, hABH"	ENSG00000100601	"AlkB homolog 1, histone H2A dioxygenase"	Q13686	14	77672404-77708023	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, RNA repair, Translation regulation"	"Dioxygenase, Lyase, Multifunctional enzyme, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044087, HPA060061"	Approved		Supported	"Nucleoplasm,Endoplasmic reticulum"	"Intracellular and membrane"	NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm	"Endoplasmic reticulum"	"HPA044087: AB_2678803, HPA060061: "	"unprognostic (1.92e-2)"	"unprognostic (8.38e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.37e-3)"	"unprognostic (3.41e-2)"	"unprognostic (5.03e-2)"	"unprognostic (3.74e-3)"	"unprognostic (7.45e-3)"	"unprognostic (2.68e-2)"	"unprognostic (3.95e-2)"	"unprognostic (5.05e-3)"	"unprognostic (2.16e-2)"	"prognostic favorable (1.80e-4)"	"unprognostic (1.65e-3)"	"unprognostic (1.46e-1)"	"unprognostic (2.63e-1)"	"unprognostic (2.44e-2)"	2.7	2.7	2.8	1.8	3.2	1.2	3.5	3.9	3.5	3.4	2.7	2.8	2.5	2.3	2.1	2.6	2.9	2.2	4.1	3.0	3.5	3.0	3.6	2.2	3.5	2.8	3.2	2.9	2.6	3.3	1.5	3.9	2.9	3.1	3.4	2.9	2.1	3.1	5.7	2.6	2.1	2.9	3.0	2.3	2.5	3.0	3.2	4.4	3.1	7.4	4.1	3.1	2.2	3.3	5.2	7.5	6.0	4.1	6.3	6.8	7.4	5.3	6.8	11.3	12.7	7.7	3.1	7.9	2.9	4.8	5.3	4.5	13.2	5.7	13.2	5.4	5.1	4.2	4.0	6.4	8.9	4.5	2.6	5.8	9.2	6.6	10.5	5.0	9.4	6.1	6.6	4.4	6.1	8.1	6.0	5.7	6.6	7.7	9.6	6.0	6.0	5.3	6.4	4.5	7.6	5.7	4.3	4.5	5.7	4.9	10.9	4.5	4.3	4.7	4.7	5.2	4.3	5.4	9.4	7.6	3.2	6.3	4.7	10.7	3.0	1.4	2.9	3.5	2.4	3.4	2.7	2.8	3.0	2.7	2.8	2.2	0.8	3.6	2.4	1.6	3.3	2.2	2.8	3.2	3.9	3.5	3.0	3.5	2.8	3.2	2.9	3.0	3.2	3.3	6.5	0.0	3.9	13.1	7.3	8.4	5.7	6.2	6.8	4.1	5.4	4.4	7.5	1.5	4.5	1.8	2.1	9.9	3.5	4.2	9.8	6.2	4.8	4.4	4.5	5.7	2.4	4.2	15.9	7.0	8.8	5.5	2.6	3.8	9.5	6.1	2.2	3.9	7.6	0.0	15.8	4.9	6.1	5.2	5.0	4.2	6.5	7.7	5.4	5.6	6.6	7.8	4.1	16.1	19.4	6.8	1.5	5.3	4.9	4.5	7.0	6.5	5.5	5.3	6.6	4.2	5.6	21.1	15.9	4.4	5.4	12.2	5.6	5.1	4.8	3.7
ALKBH6	MGC15677	ENSG00000239382	"AlkB homolog 6"	Q3KRA9	19	36009120-36014239	"Cancer-related genes, Predicted intracellular proteins"		"Dioxygenase, Oxidoreductase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA073835, HPA074340"	Approved		Supported	"Nucleoplasm,Focal adhesion sites"		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 58: T-cells - T-cell receptor"	Nucleoplasm	"Focal adhesion sites"	"HPA073835: AB_2686637, HPA074340: AB_2686680"	"unprognostic (1.90e-3)"	"unprognostic (1.82e-1)"	"unprognostic (5.16e-3)"	"unprognostic (1.12e-2)"	"unprognostic (1.24e-1)"	"unprognostic (5.86e-5)"	"unprognostic (6.21e-2)"	"unprognostic (4.53e-2)"	"unprognostic (3.95e-1)"	"unprognostic (3.56e-2)"	"unprognostic (8.78e-4)"	"unprognostic (1.77e-2)"	"unprognostic (2.31e-5)"	"unprognostic (9.34e-2)"	"unprognostic (2.15e-1)"	"unprognostic (3.82e-1)"	"unprognostic (1.05e-3)"	5.4	8.4	9.3	3.1	8.3	3.3	5.3	9.7	12.4	6.6	6.9	9.8	2.9	7.6	2.3	7.6	6.7	2.1	6.8	9.3	12.3	7.2	11.5	5.5	4.3	15.7	10.3	5.6	4.4	4.7	9.9	2.7	15.0	7.6	1.9	2.7	6.1	4.0	6.4	6.3	7.3	3.7	8.3	7.9	7.8	4.5	12.7	4.1	6.6	3.9	3.8	7.9	6.0	10.6	12.5	13.1	4.9	7.2	7.4	4.5	8.2	12.1	8.0	13.9	14.0	5.4	6.4	10.8	18.8	6.7	7.2	4.9	5.1	14.0	7.2	17.2	9.4	6.2	5.1	5.9	8.4	5.4	18.3	6.8	9.9	11.5	3.9	4.8	9.5	16.2	9.9	8.0	7.5	13.1	13.1	7.0	3.8	12.8	8.3	8.4	6.7	7.9	10.3	5.5	5.9	6.0	8.2	9.8	10.8	6.8	7.8	12.1	4.1	7.2	10.5	16.6	12.0	14.9	9.6	7.8	15.5	6.1	7.8	58.5	18.2	47.8	26.2	26.0	20.4	32.9	23.8	25.4	16.0	24.6	20.2	19.3	16.0	28.8	20.7	22.7	34.4	16.0	9.3	8.3	9.7	12.4	9.3	12.3	15.7	10.3	15.0	8.3	12.7	10.6	6.1	3.2	1.7	6.8	16.5	6.8	11.1	4.5	9.1	5.6	8.0	6.5	2.0	10.0	3.3	18.4	0.0	17.7	13.1	9.5	5.9	10.4	7.6	6.8	5.0	5.9	13.1	14.5	8.1	9.2	15.8	8.1	14.3	6.3	0.0	7.1	7.9	12.7	11.0	10.1	7.2	11.9	2.0	5.3	7.7	5.4	11.1	9.1	8.8	3.7	15.2	5.5	23.7	2.0	6.5	13.3	13.6	4.5	12.1	7.1	7.8	11.8	2.3	3.3	6.6	4.1	10.1	3.6	2.4	8.7	5.1	19.0	15.5	6.4	9.5	9.5
ALKBH7	"MGC10974, SPATA11"	ENSG00000125652	"AlkB homolog 7"	Q9BT30	19	6372794-6375250	"Predicted intracellular proteins"	Necrosis	"Dioxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 517.8"	"Group enriched"	"Detected in all"	4	"Early spermatids: 3004.6;Late spermatids: 8717.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008539, HPA039571, HPA039872"	Approved		Supported	Mitochondria		NA	NA			"Cluster 30: Non-specific - Translation"	"Cluster 43: Testis - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 31: Spermatids - Spermatogenesis"	Mitochondria		"HPA008539: , HPA039571: AB_2676577, HPA039872: AB_10697710"	"unprognostic (5.38e-2)"	"unprognostic (3.58e-2)"	"unprognostic (2.20e-1)"	"unprognostic (1.15e-2)"	"unprognostic (7.79e-2)"	"unprognostic (3.56e-3)"	"unprognostic (1.06e-1)"	"unprognostic (1.35e-1)"	"unprognostic (3.02e-1)"	"unprognostic (6.83e-2)"	"unprognostic (1.72e-3)"	"unprognostic (1.54e-1)"	"prognostic favorable (7.83e-6)"	"unprognostic (7.07e-2)"	"unprognostic (2.00e-1)"	"unprognostic (2.57e-1)"	"unprognostic (1.10e-2)"	48.9	64.5	59.8	19.2	62.3	31.1	51.3	65.7	74.2	54.6	69.5	72.5	65.8	48.4	14.6	66.1	55.4	19.2	157.2	56.6	61.3	86.0	152.9	40.4	26.9	64.0	61.3	68.8	112.3	44.9	67.5	14.3	61.0	70.1	20.0	15.8	65.2	30.5	154.4	61.0	61.5	12.8	63.6	46.6	68.4	517.8	61.6	28.1	73.0	67.4	15.9	52.1	51.6	68.5	28.9	25.2	21.4	37.1	11.8	32.7	30.9	20.5	18.0	18.1	19.1	44.0	18.3	42.1	68.4	26.2	12.8	22.1	9.6	17.1	3.5	40.9	38.9	24.5	17.6	41.4	34.5	12.4	31.3	37.6	33.8	15.7	12.3	17.5	22.5	40.7	26.2	80.0	13.9	58.3	63.5	42.6	30.8	33.9	106.1	46.6	13.4	84.2	20.4	22.1	30.3	46.3	13.8	36.1	76.4	10.1	41.0	44.7	20.3	18.0	25.0	66.9	20.1	129.2	98.1	27.7	33.9	41.9	15.9	38.3	106.4	17.3	52.7	91.6	72.9	113.4	91.4	72.5	127.6	103.0	137.4	111.1	64.4	66.1	72.0	143.9	85.7	91.5	59.8	62.3	65.7	74.2	56.6	61.3	64.0	61.3	61.0	63.6	61.6	68.5	84.8	60.9	74.4	3.3	109.0	83.7	154.4	129.1	160.5	93.1	221.6	335.4	106.3	112.9	83.9	66.2	66.7	97.6	79.3	516.1	313.1	110.1	3004.6	76.1	73.0	84.8	220.4	54.0	2.4	245.2	149.6	88.0	77.5	85.1	66.0	108.3	113.2	302.0	196.8	42.1	3.5	400.4	71.2	168.6	96.2	8717.7	103.2	128.6	133.4	1.9	192.6	166.1	69.0	3.0	9.3	116.0	528.2	88.8	121.0	121.1	856.4	433.6	52.7	152.4	92.1	97.2	104.1	1180.3	76.7	171.2	100.6	108.9	87.4	143.4	410.5	215.6
ALKBH8	"MGC10235, TRM9, TRMT9A"	ENSG00000137760	"AlkB homolog 8, tRNA methyltransferase"	Q96BT7	11	107502727-107565742	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		"Methyltransferase, Multifunctional enzyme, RNA-binding, Transferase"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 25.2;Inhibitory neurons: 27.4;Oligodendrocyte precursor cells: 23.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038724, HPA038725, HPA061514"	Approved		Supported	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 16: Immune cells - Immune response"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Nuclear bodies"	Nucleoplasm	"HPA038724: AB_2676176, HPA038725: AB_10674838, HPA061514: AB_2684547"	"unprognostic (2.66e-2)"	"unprognostic (3.82e-1)"	"unprognostic (8.19e-2)"	"unprognostic (3.76e-1)"	"unprognostic (4.04e-2)"	"unprognostic (2.97e-1)"	"unprognostic (1.22e-2)"	"unprognostic (1.95e-1)"	"unprognostic (4.45e-2)"	"unprognostic (7.67e-2)"	"unprognostic (1.89e-2)"	"unprognostic (7.95e-2)"	"unprognostic (2.81e-1)"	"unprognostic (2.03e-1)"	"unprognostic (2.04e-1)"	"unprognostic (2.34e-3)"	"unprognostic (1.01e-1)"	3.1	2.9	2.4	4.0	3.0	3.3	5.0	2.6	2.8	2.9	1.7	3.0	3.2	3.8	3.2	3.1	2.9	2.8	3.8	2.4	2.6	3.9	4.5	3.6	6.0	2.2	2.6	4.4	2.3	4.1	1.7	3.3	2.5	3.5	3.6	3.3	2.9	3.3	5.1	4.6	2.6	3.6	2.2	4.6	3.3	2.8	2.3	4.6	5.2	4.7	5.9	3.5	2.8	2.3	5.4	6.5	6.6	7.2	3.6	7.9	5.4	10.2	7.5	7.4	8.0	12.1	9.7	12.6	5.8	10.0	10.2	9.6	9.9	8.5	9.6	11.4	6.6	10.6	2.5	5.6	5.3	13.7	12.6	4.9	9.2	9.5	12.0	3.8	9.3	9.9	15.2	4.1	5.9	4.9	12.4	6.8	8.7	10.5	10.6	11.1	10.2	8.7	5.9	5.8	6.0	6.7	5.9	4.4	4.5	4.0	7.2	4.1	8.8	16.1	9.6	5.3	12.9	3.8	4.3	9.7	4.5	9.0	16.1	0.0	1.1	0.3	2.2	2.1	2.1	0.9	1.6	1.9	1.7	1.9	3.0	2.6	0.0	2.8	1.5	1.0	1.8	1.1	2.4	3.0	2.6	2.8	2.4	2.6	2.2	2.6	2.5	2.2	2.3	2.3	4.4	0.0	5.3	4.6	8.5	2.0	1.7	1.5	7.4	5.7	3.2	3.0	11.2	5.7	3.5	1.8	6.2	2.3	3.0	1.3	0.0	1.9	0.4	2.4	4.6	4.2	1.2	4.6	25.2	3.3	2.7	4.3	7.7	2.3	10.1	5.1	2.9	6.6	2.8	1.7	27.4	2.8	2.0	3.8	2.2	0.2	2.8	4.1	3.6	14.0	4.7	3.0	3.1	23.1	14.3	2.7	5.2	4.1	3.8	1.3	1.3	3.6	0.8	3.8	0.0	4.0	3.0	1.8	3.2	6.9	4.1	0.8	6.6	5.2	3.5	0.6
ALOX12	12S-LOX	ENSG00000108839	"Arachidonate 12-lipoxygenase, 12S type"	P18054	17	6996049-7010754	"Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	"Dioxygenase, Hydrolase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix: 34.6;esophagus: 49.4;vagina: 105.7"	"Cell type enriched"	"Detected in some"	6	"Macrophages: 17.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"neutrophil: 4.5"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"A-431: 25.5;HEL: 40.4"	"Region enriched"	"Detected in single"	5	"olfactory bulb: 4.4"					"HPA010691, CAB019287, HPA064819"	Enhanced		Supported	"Nuclear speckles,Vesicles,Cytosol"		NA	NA		49000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 36: HEL - Hemostasis"	"Cluster 51: Myeloid cells - Hemostasis"	Cytosol	"Nuclear speckles, Vesicles"	"CAB019287: , HPA010691: AB_1844756, HPA064819: "	"unprognostic (3.61e-3)"	"unprognostic (6.93e-2)"	"unprognostic (7.17e-5)"	"unprognostic (9.43e-2)"	"unprognostic (6.06e-2)"	"unprognostic (2.25e-3)"	"unprognostic (2.45e-1)"	"unprognostic (3.16e-1)"	"unprognostic (3.02e-2)"	"unprognostic (1.59e-2)"	"unprognostic (3.96e-5)"	"unprognostic (4.01e-3)"	"unprognostic (2.25e-2)"	"unprognostic (1.56e-1)"	"unprognostic (2.87e-1)"	"unprognostic (5.90e-2)"	"unprognostic (3.47e-2)"	1.0	1.5	0.9	3.2	1.5	4.7	0.3	0.1	1.4	34.6	0.6	0.4	1.8	2.2	0.0	49.4	1.2	3.1	1.4	0.4	0.4	0.5	0.2	1.1	3.9	1.3	0.7	1.3	1.9	0.0	0.1	1.1	1.0	0.8	0.1	3.1	20.2	0.0	1.6	21.7	2.0	0.2	0.1	3.3	1.1	1.3	1.2	0.0	1.9	0.1	3.8	1.5	105.7	3.4	25.5	4.2	1.9	1.4	0.0	0.0	1.7	1.6	0.0	0.0	0.0	3.7	0.9	1.3	0.9	0.0	1.4	3.2	0.0	0.1	0.0	2.8	3.2	40.4	6.8	2.8	0.1	0.4	6.5	0.0	0.1	0.0	0.0	2.4	0.0	2.8	2.7	1.4	0.0	0.3	0.5	0.9	1.3	0.2	0.8	1.4	0.8	0.7	0.0	3.2	0.1	0.9	0.7	0.8	0.4	2.4	1.5	1.1	4.6	2.2	1.2	2.1	1.1	0.8	0.3	0.7	1.2	3.0	1.0	2.1	0.9	1.8	0.7	0.4	0.5	1.1	0.5	0.7	0.7	0.6	0.2	0.3	4.5	0.7	0.4	1.3	0.3	13.6	0.9	1.5	0.1	1.4	0.4	0.4	1.3	0.7	1.0	0.1	1.2	3.4	0.0	0.0	0.0	2.0	0.0	0.1	0.2	0.2	0.0	0.0	0.0	0.0	2.2	0.0	0.1	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.2	0.1	0.1	0.1	0.0	0.0	1.1	0.0	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	1.0	0.0	0.0	0.0	0.0	0.1	0.0	17.3	0.0	1.0	0.8	0.0	0.0	2.5	2.4	0.2	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	2.5	1.1	0.0	0.1	0.1	0.0	2.0
ALOX12B	12R-LOX	ENSG00000179477	"Arachidonate 12-lipoxygenase, 12R type"	O75342	17	8072636-8087716	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	"Dioxygenase, Isomerase, Lyase, Oxidoreductase"	"Disease variant, Ichthyosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"skin 1: 90.2"	"Cell type enhanced"	"Detected in some"		"Horizontal cells: 1.7;Rod photoreceptor cells: 1.2;Spermatogonia: 1.2;Suprabasal keratinocytes: 1.8"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 11.2"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	6	"basophil: 4.3"	"Lineage enriched"	"Detected in single"	6	"granulocytes: 4.3"	"Cell line enhanced"	"Detected in some"		"A549: 1.1;HEK 293: 1.3;hTCEpi: 1.6;JURKAT: 2.7;OE19: 1.8"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA024002	Supported		Supported	Vesicles,Cytosol		NA	NA		7000	"Cluster 46: Basophils - DNA binding"	"Cluster 31: Skin - Epidermis development"	"Cluster 21: OE19 - Mitochondria"	"Cluster 62: Horizontal cells - Visual perception"	Cytosol	Vesicles	"HPA024002: AB_1844757"	"unprognostic (1.27e-2)"	"unprognostic (1.59e-2)"	"unprognostic (4.28e-3)"	"unprognostic (1.38e-2)"	"unprognostic (3.94e-3)"	"unprognostic (1.18e-2)"		"unprognostic (1.26e-1)"	"unprognostic (3.04e-1)"	"unprognostic (4.40e-2)"	"unprognostic (9.55e-2)"	"unprognostic (6.66e-3)"	"unprognostic (2.27e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.02e-1)"	"unprognostic (8.01e-2)"	"unprognostic (3.46e-2)"	0.0	0.0	0.4	0.1	0.5	0.1	2.1	0.4	0.6	5.7	0.0	0.1	0.3	0.0	0.0	5.6	0.2	0.0	0.0	0.4	0.2	0.2	0.0	0.0	0.5	0.4	0.2	0.0	0.2	1.2	0.1	0.0	0.5	0.4	0.1	0.6	0.8	0.0	0.4	90.2	0.2	0.0	0.1	0.2	0.2	0.2	0.4	0.6	0.0	0.0	19.1	0.0	15.0	0.1	0.5	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.4	0.2	0.3	0.0	0.0	0.0	1.3	0.0	0.4	0.1	0.0	0.2	0.0	0.0	1.6	0.1	0.5	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.1	0.0	0.2	1.8	0.0	0.9	0.0	0.4	0.4	0.0	0.4	0.5	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.4	0.0	0.0	0.1	1.0	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.2	0.0	0.4	0.6	0.1	0.2	0.0	0.1	0.5	0.7	0.0	0.1	0.0	0.1	0.0	0.1	0.4	0.5	0.4	0.6	0.4	0.2	0.4	0.2	0.5	0.1	0.4	0.1	0.0	0.0	0.0	0.3	0.3	0.1	0.2	0.5	0.0	0.2	0.1	0.1	0.3	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.4	0.3	0.0	0.1	0.0	0.0	0.7	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.7	0.5	0.3	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.3	0.0	0.8	0.0	1.2	0.0	0.0	0.0	0.8	1.2	0.0	1.8	0.0	0.0	0.0	0.1	0.1
ALOX15B	15-LOX-2	ENSG00000179593	"Arachidonate 15-lipoxygenase type B"	O15296	17	8039034-8049134	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Lipid metabolism"	"Dioxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"breast: 111.7;prostate: 73.1"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 2: 75.8;Basal respiratory cells: 22.0;Kupffer cells: 42.2;monocytes: 87.9;Prostatic glandular cells: 25.6;Squamous epithelial cells: 44.4"	"Cancer enriched"	"Detected in all"	5	"prostate cancer: 91.2"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	8	"classical monocyte: 3.9;myeloid DC: 4.3"	"Group enriched"	"Detected in many"	8	"dendritic cells: 4.3;monocytes: 3.9"	"Cell line enhanced"	"Detected in some"		"HHSteC: 7.7;HSkMC: 16.6;hTCEpi: 35.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA010562	Enhanced		Supported	"Plasma membrane,Cytosol"		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 3: Monocytes - Immune response regulation"	"Plasma membrane, Cytosol"		"HPA010562: AB_2668305"	"unprognostic (1.76e-2)"	"unprognostic (6.47e-2)"	"unprognostic (2.56e-1)"	"unprognostic (2.28e-3)"	"unprognostic (1.67e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.52e-1)"	"unprognostic (2.28e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.44e-2)"	"unprognostic (4.59e-1)"	"unprognostic (1.59e-2)"	"unprognostic (9.37e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.32e-2)"	"unprognostic (9.49e-2)"	2.2	1.7	0.7	1.3	0.7	0.4	111.7	0.6	2.5	12.0	0.5	2.3	0.1	1.1	0.9	39.1	1.6	0.7	0.7	0.7	0.8	0.5	0.4	24.5	2.9	1.8	0.9	0.7	1.4	0.2	0.5	1.2	1.6	73.1	0.3	0.3	3.7	0.1	0.3	36.9	3.7	0.1	0.9	3.8	4.4	0.5	0.9	0.7	1.9	0.1	7.6	1.7	33.4	1.9	0.1	0.0	0.0	0.1	0.5	0.7	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	7.7	0.0	0.0	16.6	35.1	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.2	0.5	0.0	0.1	0.0	0.9	0.7	0.7	0.6	2.5	0.7	0.8	1.8	0.9	1.6	0.9	0.9	1.9	1.4	0.0	75.8	0.0	0.3	3.1	0.6	22.0	7.4	0.0	19.8	12.3	0.3	1.5	8.2	0.0	0.0	0.2	0.2	0.2	0.0	0.1	1.3	0.0	0.8	0.4	0.0	0.0	0.2	0.4	0.0	0.2	0.0	0.2	1.3	0.0	0.7	0.3	4.2	0.0	0.0	0.0	2.0	42.2	1.1	0.8	0.0	15.4	5.4	0.0	87.9	0.0	0.0	0.0	0.0	0.3	0.0	0.0	1.4	25.6	0.0	0.0	2.2	0.0	0.0	0.1	1.3	0.6	0.8	44.4	1.1	0.8	0.0	0.0	0.0	2.2
ALOX5	5-LOX	ENSG00000012779	"Arachidonate 5-lipoxygenase"	P09917	10	45374176-45446119	"Enzymes, FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins"	"Leukotriene biosynthesis"	"Dioxygenase, Hydrolase, Oxidoreductase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 72.8;lymphoid tissue: 93.9"	"Cell type enhanced"	"Detected in many"		"B-cells: 63.7;granulocytes: 201.3;Hofbauer cells: 85.0;Kupffer cells: 78.5;Macrophages: 86.5;monocytes: 59.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"BEWO: 13.9;Daudi: 40.9;HMC-1: 24.0;U-266/70: 30.8;U-698: 11.0"	"Region enriched"	"Detected in single"	4	"white matter: 2.9"	"Low region specificity"	"Detected in all"			HPA071285	Enhanced		Supported	Nucleoplasm		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 64: Macrophages - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 57: B-cells - Immune response"	Nucleoplasm		"HPA071285: AB_2686379"	"unprognostic (2.57e-2)"	"unprognostic (2.81e-1)"	"unprognostic (4.82e-2)"	"unprognostic (1.75e-2)"	"unprognostic (7.98e-3)"	"unprognostic (1.26e-1)"	"unprognostic (5.32e-2)"	"unprognostic (8.69e-2)"	"unprognostic (1.86e-2)"	"unprognostic (6.91e-2)"	"unprognostic (5.04e-2)"	"unprognostic (3.42e-1)"	"prognostic unfavorable (1.80e-5)"	"unprognostic (5.59e-3)"	"unprognostic (4.22e-2)"	"unprognostic (1.53e-1)"	"prognostic favorable (7.18e-4)"	16.8	8.4	1.4	8.4	1.1	31.1	12.7	2.8	2.9	6.1	1.0	11.0	3.0	6.9	0.3	10.7	11.1	3.4	6.7	1.2	1.8	8.3	5.5	72.8	6.7	4.1	2.5	2.6	23.2	0.9	3.2	3.6	2.7	11.8	2.3	0.1	14.1	1.5	2.1	5.6	35.8	4.9	2.5	93.9	9.3	2.1	2.2	2.6	4.7	3.7	8.9	40.0	7.9	4.2	0.0	0.0	0.0	0.0	0.0	0.0	13.9	0.0	0.0	0.0	0.0	0.0	7.4	40.9	0.7	0.0	0.0	0.3	0.3	0.0	0.0	0.3	0.1	8.6	0.0	0.0	0.0	0.0	24.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	5.0	0.0	0.0	0.0	0.3	0.0	1.0	0.0	0.1	0.0	2.7	0.0	5.2	0.7	0.0	0.0	0.2	0.0	0.1	0.1	0.6	0.0	0.0	2.2	0.0	0.0	30.8	2.8	11.0	0.0	0.1	0.0	462.5	225.6	317.6	0.3	198.4	0.6	133.9	5.3	1.7	119.7	98.5	0.7	0.5	457.8	0.2	210.5	2.4	1.2	136.1	1.4	1.1	2.8	2.9	1.2	1.8	4.1	2.5	2.7	2.5	2.2	4.2	0.7	16.0	38.4	1.3	63.7	1.1	7.3	0.2	1.2	1.3	7.3	4.3	2.2	12.8	9.5	9.2	2.1	0.7	1.7	1.7	0.0	20.9	0.5	0.7	0.5	3.0	7.1	1.7	2.8	21.6	2.0	1.7	13.7	4.4	201.3	2.2	3.6	1.1	85.0	0.0	1.1	2.0	14.2	78.5	17.8	1.1	0.3	86.5	0.0	47.8	59.5	0.7	4.1	4.0	1.4	18.4	0.6	0.0	13.8	4.0	9.4	0.2	2.6	0.3	13.1	0.3	1.1	0.3	1.1	9.2	1.4	4.1	5.9	0.7	3.2	45.3
ALX1	CART1	ENSG00000180318	"ALX homeobox 1"	Q15699	12	85280220-85301784	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"epididymis: 3.9;kidney: 6.1"	"Cell type enriched"	"Detected in some"	5	"Melanocytes: 32.0"	"Cancer enriched"	"Detected in some"	10	"melanoma: 16.2"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HAP1: 10.4;HEK 293: 23.3;HUVEC TERT2: 17.2;SK-MEL-30: 29.5;THP-1: 18.0;WM-115: 14.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA001598, HPA018905"	Uncertain		Supported	"Nucleoplasm,Nuclear bodies,Golgi apparatus"		NA	NA				"Cluster 1: Thyroid gland - Transcription"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 29: Early spermatids - Spermatogenesis"	"Nuclear bodies"	"Nucleoplasm, Golgi apparatus"	"HPA001598: AB_1078400, HPA018905: AB_1844783"	"unprognostic (4.92e-3)"	"unprognostic (8.09e-2)"		"unprognostic (1.09e-3)"	"unprognostic (1.84e-1)"	"unprognostic (6.24e-2)"		"unprognostic (2.05e-2)"	"unprognostic (9.27e-2)"	"unprognostic (1.22e-1)"	"unprognostic (3.57e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.55e-5)"		"unprognostic (8.97e-2)"		"unprognostic (1.43e-1)"	0.2	0.0	0.2	0.0	0.2	0.0	0.2	0.1	0.3	1.0	0.4	0.0	0.0	0.7	3.9	0.0	2.3	0.0	0.0	0.2	0.3	6.1	0.0	0.0	0.0	0.2	0.2	1.6	0.0	0.0	0.7	0.0	0.2	0.1	0.0	0.2	1.9	0.9	0.0	1.6	0.0	0.3	0.2	0.0	0.0	0.8	0.2	0.0	0.0	0.8	0.0	0.4	0.3	0.2	0.0	6.0	0.0	0.0	0.7	0.7	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.5	0.0	3.6	0.0	10.4	0.5	0.0	0.0	23.3	0.0	4.1	0.0	0.3	0.0	0.0	0.0	0.0	3.1	0.0	9.3	17.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.0	0.0	0.0	0.0	8.4	0.0	0.0	0.0	2.7	5.8	0.0	0.0	29.5	4.1	0.0	18.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	6.3	0.0	14.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.1	0.3	0.2	0.3	0.2	0.2	0.2	0.2	0.2	0.2	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.0	5.5	0.2	0.0	0.1	0.0	0.0	0.0	0.0	1.5	0.6	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	2.1	0.0	0.0	32.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.1	0.0	0.0	2.2	0.2	1.0	0.1	0.0	0.6	0.0	0.0	0.1	0.0	0.0
ALX4	"FPP, KIAA1788, PFM, PFM2"	ENSG00000052850	"ALX homeobox 4"	Q9H161	11	44260440-44310139	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"	"Craniosynostosis, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"breast: 1.8;choroid plexus: 1.9"	"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 20.4;Fibroblasts: 4.3;Leydig cells: 4.7;Microglial cells: 6.5;Skeletal myocytes: 5.5"	"Cancer enhanced"	"Detected in some"		"testis cancer: 1.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 4.0;BJ: 3.4;HAP1: 4.7;HEK 293: 4.8;HEL: 6.8;K-562: 3.2;SiHa: 7.0"	"Region enriched"	"Detected in some"	8	"olfactory bulb: 9.0"	"Region enriched"	"Detected in single"	31	"olfactory bulb: 9.0"	HPA001903			Supported	Nucleoplasm		NA	NA				"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 36: HEL - Hemostasis"	"Cluster 43: Cardiomyocytes - Nuclear processes"	Nucleoplasm		"HPA001903: AB_2666495"	"unprognostic (7.56e-5)"	"unprognostic (1.69e-1)"	"unprognostic (5.40e-2)"	"unprognostic (2.74e-1)"	"unprognostic (7.24e-3)"	"unprognostic (2.63e-4)"	"unprognostic (1.95e-1)"	"unprognostic (2.89e-2)"	"unprognostic (2.33e-4)"	"unprognostic (5.13e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.34e-6)"	"unprognostic (3.62e-2)"	"unprognostic (2.85e-1)"	"unprognostic (2.02e-3)"	"unprognostic (2.03e-1)"	0.4	0.0	0.1	0.0	0.1	0.0	1.8	0.1	0.4	0.4	1.9	0.0	0.0	0.6	0.0	0.0	0.2	0.0	0.1	0.2	0.0	0.2	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.1	0.0	0.0	0.1	0.5	0.0	0.0	0.7	0.0	1.0	0.9	0.0	0.3	0.1	0.0	0.0	0.5	0.0	0.0	0.1	0.6	0.0	0.0	0.0	0.1	0.0	0.5	0.0	4.0	0.0	0.0	0.0	3.4	0.1	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	4.7	0.0	0.0	1.0	4.8	6.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	7.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.4	0.2	0.0	0.2	0.3	0.1	0.1	0.0	0.1	0.4	0.0	0.0	0.3	0.4	0.0	0.0	0.0	0.0	0.0	1.1	1.3	20.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.6	0.0	0.0	0.3	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.3	0.6	4.7	0.1	0.0	6.5	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.5	0.9	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1
AMACR	"P504S, RACE"	ENSG00000242110	"Alpha-methylacyl-CoA racemase"	Q9UHK6	5	33986165-34008104	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Isomerase	"Disease variant, Intrahepatic cholestasis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 134.3;liver: 180.6"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 19.7;Hepatocytes: 21.6;Late spermatids: 21.6;Proximal tubular cells: 38.5"	"Group enriched"	"Detected in all"	4	"liver cancer: 8.8;prostate cancer: 34.5;renal cancer: 14.7"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-266/70: 175.4;U-266/84: 98.0"	"Low region specificity"	"Detected in all"							"CAB001809, HPA019527, HPA020912"	Enhanced		Supported	"Vesicles,Plasma membrane"		NA	NA		70000	"Cluster 14: Monocytes - Unknown function"	"Cluster 81: Kidney & Liver - Metabolism"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Vesicles, Plasma membrane"		"CAB001809: AB_2305454, HPA019527: AB_10669651, HPA020912: AB_10670034"	"unprognostic (8.96e-2)"	"unprognostic (5.20e-3)"	"prognostic favorable (7.11e-4)"	"unprognostic (9.55e-2)"	"unprognostic (1.39e-1)"	"unprognostic (9.12e-3)"	"unprognostic (1.68e-1)"	"unprognostic (5.41e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.60e-1)"	"unprognostic (5.59e-5)"	"unprognostic (1.95e-2)"	"unprognostic (5.52e-3)"	"unprognostic (6.32e-2)"	"unprognostic (3.41e-1)"	"unprognostic (2.18e-1)"	"unprognostic (1.50e-1)"	8.6	15.0	5.9	5.0	5.5	3.0	6.4	4.6	6.0	6.5	4.6	40.0	18.0	4.7	9.6	15.6	6.2	20.5	10.1	5.4	7.8	134.3	180.6	9.2	3.6	5.9	6.4	7.8	13.8	13.0	5.7	7.7	6.6	39.3	42.9	12.0	60.7	12.5	19.2	4.9	15.9	7.0	5.8	5.4	34.8	4.3	8.4	4.8	8.3	14.9	5.6	8.8	8.5	5.8	12.7	20.2	11.1	14.3	7.7	11.9	19.1	16.6	12.2	7.6	5.7	66.1	15.1	4.1	8.7	23.6	28.6	5.8	2.8	12.0	7.7	12.7	10.9	9.8	13.7	19.0	5.4	6.0	3.0	18.1	6.0	9.7	3.6	10.7	8.5	8.3	3.8	14.7	22.4	9.6	5.0	7.6	10.0	9.4	32.9	6.0	18.6	6.5	33.2	62.4	6.1	8.7	27.6	19.3	16.9	9.1	14.9	5.9	15.6	24.6	5.4	6.2	13.6	175.4	98.0	7.4	7.0	12.1	18.8	0.3	6.0	9.3	8.3	8.0	7.0	7.1	7.2	6.4	8.9	5.2	6.6	4.8	10.0	8.7	14.2	4.6	7.9	6.0	5.9	5.5	4.6	6.0	5.4	7.8	5.9	6.4	6.6	5.8	8.4	5.8	0.8	3.2	4.1	0.0	2.2	0.4	0.4	0.9	1.8	4.3	1.4	0.9	1.1	8.6	3.7	1.8	0.0	1.0	2.2	19.7	5.9	0.8	8.9	2.3	1.2	3.0	4.2	2.1	0.0	3.8	1.0	2.9	4.1	1.5	0.0	1.2	1.1	21.6	1.1	5.0	0.0	5.1	4.1	0.9	0.2	21.6	0.6	1.2	0.0	0.0	1.5	9.3	3.1	0.0	0.0	2.6	4.5	2.2	1.6	0.6	4.7	38.5	3.1	0.9	0.0	1.7	3.7	0.7	0.7	3.4	0.6	0.3	1.5	1.2	4.4	0.4
AMER1	"FAM123B, FLJ39827, RP11-403E24.2, WTX"	ENSG00000184675	"APC membrane recruitment protein 1"	Q5JTC6	X	64185117-64205708	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Wnt signaling pathway"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"tongue: 15.3"	"Cell type enhanced"	"Detected in many"		"Sertoli cells: 6.6;Theca cells: 6.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"NTERA-2: 15.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA065214, HPA065265"	Approved		Supported	"Nuclear bodies,Vesicles,Plasma membrane"		NA	NA				"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 10: Non-specific - Unknown function"	"Nuclear bodies"	"Vesicles, Plasma membrane"	"HPA065214: AB_2685435, HPA065265: AB_2685450"	"unprognostic (1.56e-2)"	"unprognostic (8.85e-2)"	"unprognostic (6.86e-2)"	"unprognostic (2.74e-1)"	"unprognostic (2.12e-2)"	"unprognostic (1.86e-1)"	"unprognostic (3.57e-2)"	"unprognostic (1.48e-1)"	"unprognostic (8.02e-2)"	"unprognostic (1.75e-1)"	"unprognostic (6.31e-2)"	"unprognostic (3.43e-1)"	"unprognostic (4.69e-4)"	"unprognostic (1.26e-1)"	"unprognostic (1.13e-1)"	"unprognostic (6.19e-2)"	"unprognostic (2.89e-1)"	1.1	1.4	1.6	1.3	1.5	1.2	1.3	1.8	1.6	1.9	0.1	1.5	1.5	1.9	4.0	2.8	2.2	1.0	1.3	1.0	1.6	1.8	2.1	1.2	1.2	1.5	1.4	6.3	2.0	1.6	0.7	0.8	1.5	1.7	1.3	1.3	2.2	2.2	4.1	2.2	1.3	2.8	0.7	1.3	1.6	0.4	1.9	1.6	1.4	15.3	1.6	1.3	1.3	1.0	3.1	2.2	5.8	4.6	2.2	2.1	4.7	1.4	1.2	2.1	1.3	7.3	1.1	5.9	1.8	3.0	1.6	4.3	12.5	4.1	2.0	2.5	2.5	3.7	4.9	4.9	1.6	7.7	0.9	3.0	5.3	1.6	3.2	1.7	1.2	4.6	5.6	5.9	1.1	3.7	5.2	4.0	15.6	4.0	4.4	11.7	9.4	4.3	0.9	1.0	2.6	3.9	3.7	5.0	1.9	4.8	1.6	2.1	0.8	2.5	5.8	6.7	1.9	3.0	2.2	4.4	1.2	8.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.6	1.5	1.8	1.6	1.0	1.6	1.5	1.4	1.5	0.7	1.9	1.0	0.9	0.0	0.0	1.0	1.5	2.2	0.6	0.9	2.8	5.0	1.7	1.5	2.6	4.3	0.3	0.0	2.1	1.1	3.4	1.1	0.0	1.2	0.1	3.3	2.6	1.5	1.2	0.8	0.8	1.6	0.8	1.8	3.6	2.0	0.0	3.9	1.4	2.6	0.4	0.0	1.3	1.0	0.0	1.0	0.3	0.2	2.5	0.5	1.8	1.0	1.2	0.2	0.0	1.0	0.6	0.7	0.5	4.1	2.4	1.2	0.8	0.8	0.0	1.0	6.6	2.3	4.4	0.0	0.2	3.6	2.6	0.7	0.9	6.4	1.6	0.7
AMER2	"FAM123A, FLJ25477"	ENSG00000165566	"APC membrane recruitment protein 2"	Q8N7J2	13	25161679-25172288	"Predicted intracellular proteins"	"Wnt signaling pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"brain: 114.8"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 99.3;Bipolar cells: 105.5;Cone photoreceptor cells: 81.3;Horizontal cells: 153.1;Muller glia cells: 313.0;Oligodendrocytes: 337.1;Rod photoreceptor cells: 112.1"	"Cancer enriched"	"Detected in single"	24	"glioma: 4.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"AF22: 3.3;SCLC-21H: 2.3;SuSa: 2.3;U-266/70: 5.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039458	Enhanced		Supported	"Plasma membrane"		NA	NA				"Cluster 70: Brain - Nervous system development"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 5: Muller glia cells - Visual perception"	"Plasma membrane"		"HPA039458: AB_10795677"	"unprognostic (1.69e-2)"	"unprognostic (4.13e-2)"		"unprognostic (7.43e-3)"	"unprognostic (2.32e-1)"	"unprognostic (3.00e-3)"		"unprognostic (5.00e-3)"	"unprognostic (7.28e-2)"	"unprognostic (2.34e-2)"	"unprognostic (5.90e-4)"	"unprognostic (1.60e-2)"	"unprognostic (1.20e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.34e-1)"		0.2	0.1	36.7	0.0	72.0	0.0	0.0	37.9	52.2	0.0	2.3	0.2	0.0	0.0	0.0	0.0	0.6	0.0	0.0	41.2	37.7	0.0	0.0	0.1	0.0	58.9	49.1	0.0	0.0	0.0	4.1	0.0	41.9	0.1	0.0	25.8	0.0	0.2	0.2	0.1	0.0	0.0	36.8	0.0	0.0	1.2	49.1	0.0	0.0	0.0	0.0	0.0	0.0	114.8	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.1	0.2	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	36.7	72.0	37.9	52.2	41.2	37.7	58.9	49.1	41.9	36.8	49.1	114.8	0.0	0.0	0.0	99.3	0.1	0.1	0.0	0.0	0.0	105.5	0.1	0.1	1.1	0.0	0.0	0.0	81.3	0.1	0.0	0.1	0.0	0.0	2.3	0.0	0.6	0.8	0.0	0.0	21.3	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	153.1	24.4	0.0	0.0	0.0	0.0	1.2	0.0	0.0	1.8	4.7	0.0	313.0	0.0	28.6	337.1	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	112.1	0.0	0.2	0.0	2.8	1.4	0.0	0.0	0.0	0.0	0.1	0.0	0.1
AMER3	"FAM123C, FLJ38377"	ENSG00000178171	"APC membrane recruitment protein 3"	Q8N944	2	130755540-130768134	"Predicted intracellular proteins"	"Wnt signaling pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"brain: 14.6"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 8.2;Enteroendocrine cells: 15.1;Excitatory neurons: 6.6;Horizontal cells: 3.3;Inhibitory neurons: 5.7;Rod photoreceptor cells: 4.9"	"Cancer enhanced"	"Detected in single"		"pancreatic cancer: 0.5"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"SCLC-21H: 9.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA045593, HPA054230"	Uncertain		Approved	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA				"Cluster 6: Brain - Smell perception"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 17: Intestinal endocrine cells - Hormone signaling"	"Nuclear bodies"	"Nucleoplasm, Cytosol"	"HPA045593: AB_10965021, HPA054230: AB_2682423"	"unprognostic (6.68e-2)"		"unprognostic (3.73e-1)"	"unprognostic (2.17e-2)"	"unprognostic (1.83e-1)"					"unprognostic (2.71e-1)"	"unprognostic (5.33e-3)"	"unprognostic (1.51e-1)"		"unprognostic (2.71e-1)"	"unprognostic (1.02e-1)"	"unprognostic (6.46e-3)"		0.0	0.6	4.0	0.0	4.5	0.1	0.0	14.6	8.1	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	3.7	3.2	0.0	0.0	0.0	0.0	1.2	0.2	0.0	0.9	0.0	2.8	0.0	1.0	0.0	0.1	2.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.6	0.3	1.6	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.7	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	4.0	4.5	14.6	8.1	3.7	3.2	1.2	0.2	1.0	0.0	1.6	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.2	0.0	0.0	0.6	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	15.1	0.0	6.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	5.7	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.9	0.0	0.5	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.9	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AMFR	"gp78, RNF45"	ENSG00000159461	"Autocrine motility factor receptor"	Q9UKV5	16	56361452-56425545	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Ubl conjugation pathway, Wnt signaling pathway"	"Receptor, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 154.5;Hepatocytes: 166.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB026381, HPA029018, HPA077835"	Approved		Supported	"Endoplasmic reticulum,Golgi apparatus"		NA	NA			"Cluster 42: Non-specific - Transcription"	"Cluster 54: Non-specific - Microtubule organization"	"Cluster 6: T47d - Mammary gland"	"Cluster 2: Hepatocytes - Metabolism"	"Endoplasmic reticulum, Golgi apparatus"		"CAB026381: , HPA029018: AB_2672869, HPA077835: AB_2686856"	"unprognostic (1.72e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.62e-2)"	"unprognostic (2.43e-2)"	"unprognostic (3.60e-3)"	"unprognostic (6.06e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.26e-3)"	"unprognostic (1.28e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.97e-1)"	"unprognostic (4.16e-2)"	"unprognostic (5.52e-3)"	"unprognostic (1.45e-1)"	"unprognostic (1.68e-1)"	"unprognostic (1.91e-1)"	"unprognostic (2.28e-1)"	29.6	53.1	49.7	22.8	58.0	36.9	27.5	56.6	48.0	34.4	78.5	29.1	47.5	33.6	51.5	44.2	31.7	29.2	32.1	50.2	56.7	64.8	75.4	27.1	40.2	62.1	58.4	40.1	29.2	70.6	24.2	41.0	62.6	28.0	25.0	57.6	25.6	37.4	159.4	24.9	36.0	33.9	65.3	26.9	24.6	83.7	57.2	20.6	33.8	56.5	43.5	25.8	29.4	75.7	55.5	75.2	32.4	59.2	98.2	54.7	28.4	56.8	71.2	77.0	60.1	66.4	49.4	142.0	65.3	79.1	45.2	50.3	49.9	45.1	72.9	31.7	51.2	40.9	29.2	73.4	85.7	33.2	45.6	64.1	64.3	61.7	73.1	53.6	45.6	41.0	45.7	18.8	56.9	33.7	50.7	35.8	15.3	28.2	51.1	57.0	64.8	53.6	47.9	57.0	32.2	24.6	135.6	47.3	45.5	30.3	142.3	35.0	59.4	72.3	39.4	36.9	39.7	40.7	38.5	75.8	52.7	23.4	33.7	37.1	10.0	14.4	7.9	12.5	11.2	21.7	9.9	8.3	9.9	17.9	10.1	10.9	12.5	14.2	17.9	13.2	11.4	5.5	49.7	58.0	56.6	48.0	50.2	56.7	62.1	58.4	62.6	65.3	57.2	75.7	25.7	9.6	9.0	23.8	34.0	25.7	18.1	11.0	10.8	17.7	58.9	23.0	19.9	28.6	11.7	99.3	39.6	27.5	17.4	53.6	25.4	20.8	154.5	16.4	26.4	23.5	24.7	29.0	20.5	43.0	6.8	31.9	8.6	32.4	8.8	31.8	38.9	166.4	17.0	32.0	23.7	23.6	12.2	69.1	33.2	118.7	41.0	25.5	30.2	23.4	25.5	50.1	10.3	27.6	31.5	35.6	25.3	34.3	12.0	36.0	53.4	54.3	9.2	43.3	13.1	29.4	24.1	30.5	11.7	12.0	20.9	24.4	17.1	34.1	22.9	29.7
AMMECR1		ENSG00000101935	"AMMECR nuclear protein 1"	Q9Y4X0	X	110194186-110440318	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Alport syndrome, Deafness, Disease variant, Elliptocytosis, Hereditary hemolytic anemia, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Erythroid cells: 83.1;Excitatory neurons: 92.8;Inhibitory neurons: 108.7;Rod photoreceptor cells: 87.3;Syncytiotrophoblasts: 86.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA000590, HPA051762"	Uncertain		Supported	Nucleoplasm,Mitochondria		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm	Mitochondria	"HPA000590: AB_2666037, HPA051762: AB_2681596"	"unprognostic (7.77e-2)"	"unprognostic (1.93e-1)"	"unprognostic (2.06e-1)"	"unprognostic (5.17e-2)"	"unprognostic (1.25e-1)"	"unprognostic (6.87e-2)"	"unprognostic (1.66e-3)"	"unprognostic (6.55e-2)"	"unprognostic (5.98e-2)"	"prognostic favorable (6.62e-5)"	"unprognostic (3.61e-2)"	"unprognostic (3.96e-2)"	"unprognostic (2.43e-3)"	"unprognostic (3.33e-1)"	"unprognostic (1.02e-1)"	"prognostic favorable (8.44e-4)"	"unprognostic (7.82e-2)"	3.6	2.9	1.7	3.7	1.7	13.4	3.4	1.8	2.0	2.9	8.5	3.7	3.1	2.3	2.1	7.9	3.3	2.3	1.1	1.5	1.7	3.4	3.3	2.8	4.2	1.3	1.3	5.5	2.0	2.2	2.0	7.0	1.2	2.2	3.9	14.5	2.8	1.9	1.3	7.4	3.3	2.9	1.0	3.7	3.7	1.6	1.7	4.5	2.4	1.7	5.7	4.8	4.5	1.5	20.3	9.8	7.1	3.4	7.9	11.8	7.8	13.8	12.3	11.1	16.2	15.9	14.4	12.0	6.4	18.4	9.0	9.5	22.7	15.7	11.3	8.4	10.1	16.7	21.7	3.3	19.9	13.5	6.7	6.6	27.3	12.7	22.6	6.0	8.9	5.9	47.1	34.8	8.5	17.2	6.5	4.8	32.6	17.4	19.1	13.7	7.6	21.2	18.8	16.8	11.3	5.3	23.2	22.7	19.9	8.5	5.6	13.3	4.1	7.6	4.6	22.8	12.6	7.1	8.6	18.9	11.6	27.5	25.9	0.6	0.9	0.8	1.6	0.6	2.1	1.6	3.2	2.6	1.5	2.2	2.1	1.9	0.4	0.6	2.7	0.6	2.3	1.0	1.7	1.7	1.8	2.0	1.5	1.7	1.3	1.3	1.2	1.0	1.7	1.5	4.4	0.0	9.8	17.9	11.5	9.6	3.9	10.5	5.7	35.3	7.5	4.4	4.2	8.6	8.9	3.7	52.1	27.2	9.5	8.9	23.5	9.2	0.5	10.5	7.7	9.6	15.0	83.1	92.8	12.0	9.9	12.8	13.7	13.4	2.5	14.4	19.6	8.4	7.1	1.7	108.7	11.2	12.2	7.6	3.1	2.1	12.8	7.3	3.6	21.5	9.4	7.1	14.4	35.7	19.2	11.5	3.7	17.3	8.0	9.1	10.3	10.2	10.4	87.3	13.1	6.7	8.4	2.2	6.9	17.4	26.7	86.5	13.0	34.7	10.5	15.7
AMOT	KIAA1071	ENSG00000126016	Angiomotin	Q4VCS5	X	112774503-112840889	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 145.6;tongue: 53.5"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 57.5;Collecting duct cells: 29.5;Cytotrophoblasts: 46.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 22.5;HAP1: 25.1;OE19: 21.2;SuSa: 34.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA067290, HPA067853"	Enhanced		Supported	"Nucleoplasm,Cell Junctions"		NA	NA				"Cluster 68: Epididymis - Unknown function"	"Cluster 12: NES - Nervous system development"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Cell Junctions"	Nucleoplasm	"HPA067290: AB_2685819, HPA067853: AB_2732773"	"unprognostic (1.08e-2)"	"unprognostic (5.51e-2)"	"unprognostic (2.38e-2)"	"unprognostic (3.36e-1)"	"unprognostic (3.20e-1)"	"unprognostic (8.95e-2)"	"unprognostic (3.82e-2)"	"prognostic favorable (3.94e-4)"	"unprognostic (4.46e-2)"	"unprognostic (3.79e-1)"	"unprognostic (2.17e-1)"	"unprognostic (5.60e-2)"	"prognostic favorable (4.21e-9)"	"unprognostic (9.54e-2)"	"unprognostic (2.59e-2)"	"unprognostic (4.50e-2)"	"unprognostic (6.44e-2)"	4.3	1.6	29.0	1.3	24.7	0.3	6.5	23.4	21.9	9.2	0.6	3.5	2.9	4.9	145.6	4.0	12.2	2.8	4.0	23.7	31.6	10.4	2.1	2.7	0.8	32.8	34.4	5.7	2.3	14.3	7.2	20.7	24.1	6.3	4.3	1.7	6.9	25.7	39.0	2.3	3.7	3.2	20.6	1.5	3.0	2.3	36.4	4.4	3.8	53.5	1.0	2.8	4.1	18.2	4.3	0.0	22.5	1.0	0.5	0.5	8.8	0.7	0.0	0.0	0.0	10.5	0.8	0.5	4.7	3.5	0.0	8.4	25.1	0.0	0.0	0.0	6.3	0.0	0.0	0.2	0.2	0.0	1.1	0.2	0.0	5.1	0.6	4.9	0.2	0.4	0.0	0.0	0.6	0.4	6.8	0.3	10.5	21.2	0.1	8.4	6.6	0.1	11.2	11.0	0.0	8.0	0.1	0.0	9.8	34.9	0.8	0.2	0.1	2.9	6.8	0.0	9.4	0.7	0.0	0.0	1.0	0.1	6.1	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	29.0	24.7	23.4	21.9	23.7	31.6	32.8	34.4	24.1	20.6	36.4	18.2	2.2	3.2	2.0	57.5	0.9	1.8	2.7	2.5	2.8	1.1	9.7	6.9	2.0	1.5	7.2	29.5	0.0	46.2	1.1	4.9	1.9	5.1	0.2	7.2	6.3	3.7	15.8	0.4	8.9	1.9	3.8	7.2	4.1	7.1	0.0	1.5	4.2	4.0	6.2	0.0	2.0	7.2	6.1	1.6	2.1	0.5	6.8	1.0	3.6	17.8	1.7	4.9	4.1	2.0	3.5	3.2	5.6	6.4	0.0	6.6	4.7	16.8	10.1	0.5	6.6	3.9	4.0	0.4	3.2	3.0	1.1	15.9	0.9	0.8	7.3	2.5
AMPH		ENSG00000078053	Amphiphysin	P49418	7	38383704-38631420	"Cancer-related genes, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 48.9;pituitary gland: 21.3;retina: 65.9"	"Group enriched"	"Detected in many"	5	"Bipolar cells: 72.2;Cone photoreceptor cells: 87.6;Excitatory neurons: 228.2;Inhibitory neurons: 198.4;Oligodendrocyte precursor cells: 96.5;Rod photoreceptor cells: 59.4"	"Cancer enhanced"	"Detected in many"		"glioma: 3.8"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 64.6;ASC TERT1: 37.8;BJ hTERT+ SV40 Large T+: 25.4;BJ hTERT+ SV40 Large T+ RasG12V: 29.9;GAMG: 44.8;HBF TERT88: 23.1;U-138 MG: 24.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB008559, HPA019828, HPA019829"	Enhanced		Supported	"Plasma membrane,Cytosol"		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 58: Brain - Synaptic function"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Cytosol	"Plasma membrane"	"CAB008559: AB_1611845, HPA019828: AB_1844801, HPA019829: AB_1844802"	"unprognostic (1.76e-2)"	"unprognostic (1.59e-1)"	"unprognostic (5.94e-2)"	"unprognostic (7.36e-2)"	"unprognostic (3.24e-3)"	"unprognostic (2.92e-1)"	"unprognostic (4.90e-2)"	"unprognostic (2.55e-2)"	"unprognostic (4.37e-1)"	"unprognostic (1.08e-1)"	"prognostic favorable (9.96e-4)"	"unprognostic (5.06e-2)"	"unprognostic (5.81e-5)"	"unprognostic (1.23e-2)"	"unprognostic (5.63e-2)"	"unprognostic (8.03e-2)"	"unprognostic (1.68e-3)"	6.5	1.3	19.2	1.5	21.9	0.0	5.9	7.2	48.9	5.8	0.0	3.7	0.5	4.0	3.4	3.2	4.7	3.0	5.4	27.3	28.8	2.6	0.4	1.0	0.4	11.2	0.8	0.9	1.8	0.3	21.3	0.0	10.9	1.4	1.4	65.9	2.5	2.9	3.6	1.3	1.8	3.8	7.9	1.9	2.8	2.5	5.4	0.7	1.7	9.6	0.2	2.4	2.9	17.5	0.0	0.0	16.7	0.0	64.6	37.8	0.0	2.4	0.0	25.4	29.9	0.0	0.0	0.0	0.0	4.8	44.8	0.0	0.0	0.0	23.1	0.0	2.0	0.2	0.0	0.0	0.0	0.3	0.1	22.4	0.0	0.0	0.0	0.1	2.0	0.6	0.0	0.5	0.1	0.3	0.0	0.3	8.5	0.0	0.0	0.0	0.0	1.9	0.0	0.1	4.9	0.0	0.0	0.0	0.7	0.5	0.1	0.0	0.0	24.6	17.1	8.8	9.8	0.1	0.3	0.0	16.8	0.3	22.6	0.0	0.2	0.0	0.6	0.0	0.4	0.0	0.2	0.3	0.0	0.0	0.1	0.4	0.0	0.2	0.0	0.4	0.0	0.0	19.2	21.9	7.2	48.9	27.3	28.8	11.2	0.8	10.9	7.9	5.4	17.5	0.8	0.0	0.0	22.5	0.6	0.3	0.1	0.0	0.0	72.2	3.1	2.2	7.9	0.0	0.0	0.0	87.6	0.0	0.3	0.0	1.9	0.3	9.9	0.4	3.2	1.1	0.0	0.0	228.2	0.0	0.0	8.6	0.0	0.3	0.0	0.2	3.9	0.1	0.1	1.7	198.4	0.0	0.0	13.0	1.1	15.0	2.8	0.7	0.0	22.5	0.5	7.6	3.1	96.5	5.5	0.1	0.0	4.9	0.1	0.0	0.0	0.0	0.0	59.4	6.6	8.3	8.4	4.7	2.8	0.0	0.3	0.0	0.6	2.0	0.0	0.0
AMT	"GCST, NKH"	ENSG00000145020	Aminomethyltransferase	P48728	3	49416778-49422685	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Aminotransferase, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 49.1"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 42.4;Proximal enterocytes: 33.3;Undifferentiated cells: 31.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"NK-cell: 7.9"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"BEWO: 17.1;Hep G2: 47.5;NTERA-2: 8.0;SH-SY5Y: 14.9;SuSa: 9.0"									HPA005566	Supported		Supported	Nucleoplasm,Mitochondria		NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Mitochondria	Nucleoplasm	"HPA005566: AB_1844811"	"unprognostic (2.10e-2)"	"unprognostic (1.65e-2)"	"unprognostic (1.82e-1)"	"unprognostic (9.14e-3)"	"unprognostic (4.04e-1)"	"unprognostic (1.11e-2)"	"unprognostic (2.81e-1)"	"unprognostic (2.17e-3)"	"unprognostic (1.94e-1)"	"unprognostic (3.29e-1)"	"unprognostic (7.17e-3)"	"unprognostic (1.88e-1)"	"prognostic favorable (3.90e-8)"	"unprognostic (4.40e-1)"	"unprognostic (1.91e-1)"	"unprognostic (3.60e-1)"	"unprognostic (1.98e-3)"	4.7	12.8	9.8	1.2	10.3	8.8	5.6	10.7	11.7	11.8	13.1	12.2	13.8	6.8	8.2	3.5	10.1	5.8	21.6	9.4	9.6	23.2	49.1	5.4	2.1	9.8	10.2	12.5	19.5	14.2	11.9	2.3	9.8	11.3	11.8	6.5	10.6	8.5	3.1	4.8	12.1	3.7	9.9	6.3	11.1	3.0	10.0	3.8	5.8	4.2	1.5	8.0	6.4	9.9	0.1	0.7	1.4	0.4	0.6	0.0	17.1	0.0	0.4	0.1	0.3	0.5	0.6	0.0	0.2	0.4	0.0	0.3	0.1	0.7	0.1	0.3	0.0	0.0	0.5	47.5	1.8	0.0	0.0	0.6	1.8	0.0	0.7	1.3	0.6	0.2	0.0	0.0	0.2	0.4	0.1	0.1	8.0	0.0	0.2	0.0	0.5	1.0	0.8	0.4	0.0	14.9	0.2	0.0	1.1	9.0	0.1	0.3	0.6	0.1	0.0	0.3	0.0	1.0	0.0	0.0	0.0	0.3	0.0	0.0	2.1	3.2	0.0	1.7	0.0	0.5	0.0	0.0	4.2	0.2	1.2	0.9	0.1	7.9	0.5	0.3	0.0	1.3	9.8	10.3	10.7	11.7	9.4	9.6	9.8	10.2	9.8	9.9	10.0	9.9	1.2	3.2	9.2	11.4	3.6	2.8	12.1	3.1	3.4	17.4	1.2	1.3	21.8	14.3	6.3	0.0	20.9	25.6	1.4	13.8	0.0	0.8	2.5	0.7	1.6	3.2	12.7	8.8	8.7	0.7	8.8	4.5	15.8	1.0	7.6	2.0	3.9	42.4	5.0	8.4	8.5	18.4	2.0	3.8	2.9	1.6	10.5	2.6	5.4	7.5	1.8	26.0	7.2	6.0	6.6	0.6	18.9	6.4	1.1	6.7	33.3	1.1	6.6	19.3	6.6	5.2	3.1	1.9	0.3	2.2	2.7	10.3	3.8	1.0	31.6	10.9
AMZ2		ENSG00000196704	"Archaelysin family metallopeptidase 2"	Q86W34	17	68205481-68257712	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Astrocytes: 477.3;Early spermatids: 736.8;Late spermatids: 1665.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023299, HPA052406"	Enhanced		Supported	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 43: Testis - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 25: Spermatids - Spermatogenesis"	Nucleoplasm	"Nuclear bodies, Cytosol"	"HPA023299: AB_2226909, HPA052406: AB_2681818"	"unprognostic (3.04e-1)"	"unprognostic (3.68e-2)"	"unprognostic (3.93e-2)"	"unprognostic (3.27e-3)"	"unprognostic (3.32e-1)"	"unprognostic (1.79e-2)"	"prognostic unfavorable (1.32e-5)"	"unprognostic (2.43e-1)"	"unprognostic (3.92e-2)"	"unprognostic (2.83e-3)"	"unprognostic (3.59e-3)"	"unprognostic (3.37e-1)"	"prognostic unfavorable (3.14e-4)"	"unprognostic (2.37e-1)"	"unprognostic (2.95e-1)"	"unprognostic (3.28e-1)"	"unprognostic (7.62e-2)"	52.3	51.8	54.5	32.6	66.4	36.4	45.0	57.1	87.2	41.2	50.0	57.8	26.2	44.5	53.4	38.4	52.5	37.9	77.0	59.5	56.6	59.2	38.1	32.9	54.0	58.8	56.7	48.7	45.3	64.4	59.1	29.5	58.0	41.6	32.9	78.5	40.0	51.2	95.6	43.1	36.9	41.7	55.3	43.3	39.7	194.4	60.0	53.2	53.3	86.8	51.7	48.5	36.5	61.4	94.6	98.9	87.5	72.9	65.6	113.4	140.0	71.0	88.3	116.1	93.7	42.3	60.4	142.6	74.9	104.8	107.0	46.0	68.6	198.5	154.0	50.2	67.7	52.8	38.6	83.1	124.9	49.8	86.9	96.9	213.9	107.5	206.2	113.0	118.9	121.7	54.6	86.5	150.9	67.3	110.2	45.4	43.5	51.1	98.5	41.3	238.9	106.7	71.2	50.1	85.7	67.2	64.8	125.5	130.9	184.6	100.7	33.5	65.2	143.8	72.0	55.8	74.8	121.9	121.9	255.7	105.1	69.0	79.1	76.6	25.2	35.3	34.8	30.3	46.2	30.7	43.2	46.0	30.3	41.3	37.8	40.4	45.1	63.7	40.9	28.1	58.3	36.9	54.5	66.4	57.1	87.2	59.5	56.6	58.8	56.7	58.0	55.3	60.0	61.4	18.5	12.8	15.6	477.3	38.7	18.6	31.6	58.4	30.1	13.8	29.7	34.3	81.4	21.5	32.8	23.9	8.4	64.0	58.0	9.4	109.5	28.8	736.8	28.4	17.2	24.4	21.1	21.0	36.4	26.0	66.9	28.2	14.8	18.5	34.1	28.9	21.4	15.5	41.8	18.5	30.0	16.7	40.7	26.1	71.0	1665.0	36.1	39.0	56.9	27.2	46.4	65.7	69.0	56.8	47.7	25.4	10.8	32.7	46.2	17.7	15.2	69.0	61.8	12.8	19.7	26.5	26.8	274.4	59.4	26.4	22.6	34.2	49.3	26.1	15.1	24.5
ANAPC16	"APC16, bA570G20.3, C10orf104, CENP-27, FLJ33728"	ENSG00000166295	"Anaphase promoting complex subunit 16"	Q96DE5	10	72216000-72235860	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"hTCEpi: 93.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037815	Approved		Supported	Cytosol		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 39: Non-specific - Basic cellular processes"	Cytosol		"HPA037815: AB_10672288"	"unprognostic (2.87e-1)"	"unprognostic (4.35e-3)"	"unprognostic (2.01e-2)"	"unprognostic (7.12e-3)"	"unprognostic (2.16e-1)"	"unprognostic (6.20e-3)"	"unprognostic (1.51e-2)"	"unprognostic (2.00e-1)"	"unprognostic (1.82e-1)"	"unprognostic (3.10e-2)"	"unprognostic (1.90e-2)"	"unprognostic (2.11e-1)"	"unprognostic (2.75e-3)"	"unprognostic (7.77e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.35e-3)"	20.5	25.2	12.4	15.0	13.4	14.1	21.9	16.6	15.2	19.7	15.5	23.6	15.7	18.2	22.3	14.9	23.5	12.6	43.6	12.5	12.8	24.2	27.2	18.9	25.4	13.6	12.8	24.3	33.7	33.1	15.9	11.9	13.4	21.5	17.9	20.6	32.3	21.8	62.7	15.0	19.6	17.8	12.4	22.7	25.8	8.4	13.1	32.3	23.5	43.2	25.7	19.5	15.1	14.6	24.9	12.1	12.1	14.3	33.0	15.7	9.3	8.5	17.3	11.7	11.0	14.6	31.1	24.3	13.6	12.7	14.1	19.0	10.9	21.9	11.0	29.0	18.0	12.5	10.6	14.4	39.6	21.0	14.7	20.5	93.9	10.6	34.8	25.8	14.3	35.1	18.4	28.1	13.6	15.0	17.9	21.1	9.3	18.2	6.8	10.2	10.8	24.2	29.4	10.4	17.4	16.0	14.8	37.9	29.5	15.2	12.2	21.9	18.6	5.9	13.8	9.5	13.1	28.6	26.8	25.1	16.4	40.3	7.0	41.1	21.5	38.8	31.4	23.1	35.2	60.5	35.2	31.3	18.1	66.1	48.6	38.6	19.7	34.4	24.9	45.7	34.7	36.3	12.4	13.4	16.6	15.2	12.5	12.8	13.6	12.8	13.4	12.4	13.1	14.6	191.0	157.0	209.5	41.8	303.7	111.7	246.7	322.0	150.8	81.0	288.6	316.5	435.4	280.2	234.9	222.5	37.5	198.4	240.1	166.8	684.8	239.8	91.9	188.9	98.9	179.8	161.8	155.0	47.8	291.9	191.2	142.0	108.1	145.9	202.0	110.1	203.1	481.3	226.5	33.7	57.2	258.0	254.3	310.0	111.9	53.4	233.6	160.4	193.9	36.5	322.4	192.4	363.5	43.2	75.9	196.9	239.9	250.1	208.2	218.1	262.6	548.7	217.0	144.5	230.1	162.0	219.9	158.7	126.2	189.9	140.9	149.3	268.6	145.6	214.1	240.9
ANG	"RAA1, RNASE5"	ENSG00000214274	Angiogenin	P03950	14	20684177-20698971	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins"	"Angiogenesis, Differentiation, Stress response"	"Developmental protein, DNA-binding, Endonuclease, Hydrolase, Nuclease, Protein synthesis inhibitor"	"Amyotrophic lateral sclerosis, Cancer-related genes, Disease variant, Neurodegeneration"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	52	"liver: 3018.1"	"Cell type enriched"	"Detected in many"	24	"Hepatocytes: 4816.3"	"Cancer enriched"	"Detected in all"	17	"liver cancer: 279.2"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"classical monocyte: 24.5;myeloid DC: 14.5"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"Hep G2: 152.2;OE19: 116.1"	"Low region specificity"	"Detected in all"							HPA055896			Approved	"Nucleoli,Nucleoli rim,Mitotic chromosome,Actin filaments"	"Secreted to blood"	Yes	No	308000000	410000000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 62: Liver - Hemostasis"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 2: Hepatocytes - Metabolism"	"Nucleoli, Nucleoli rim, Mitotic chromosome"	"Actin filaments"	"HPA055896: "	"unprognostic (2.50e-2)"	"unprognostic (1.82e-1)"	"unprognostic (9.77e-2)"	"prognostic favorable (6.85e-4)"	"unprognostic (5.71e-3)"	"unprognostic (6.99e-2)"	"prognostic favorable (7.83e-5)"	"unprognostic (1.16e-1)"	"unprognostic (3.20e-3)"	"unprognostic (9.19e-3)"	"unprognostic (1.31e-1)"	"unprognostic (3.69e-1)"	"unprognostic (6.65e-2)"	"unprognostic (1.03e-1)"	"unprognostic (3.39e-1)"	"unprognostic (2.00e-1)"	"unprognostic (3.09e-1)"	37.6	3.0	3.6	6.0	3.5	1.0	37.8	3.5	4.9	38.2	5.6	32.6	23.2	23.4	17.9	9.8	30.5	28.5	16.9	3.6	4.9	18.4	3018.1	18.5	3.5	4.5	4.2	58.1	30.8	5.3	5.0	3.8	4.3	32.7	45.7	2.2	52.6	13.3	6.2	27.4	27.1	10.4	4.5	7.4	58.2	10.2	3.7	1.5	8.8	10.5	4.1	24.8	31.4	4.8	3.7	9.9	2.3	0.0	23.9	27.8	0.3	4.8	8.8	1.1	4.0	5.9	5.1	0.4	1.5	12.0	8.0	3.8	2.8	3.1	1.3	18.4	3.8	0.9	5.1	152.2	5.0	4.0	0.5	22.2	2.5	1.5	5.1	11.8	5.7	4.2	0.2	27.0	3.5	0.7	0.9	1.2	0.7	116.1	10.7	0.7	3.9	11.3	2.3	2.9	0.0	0.4	4.6	1.7	6.5	5.1	4.0	0.7	6.0	1.9	2.8	1.7	0.7	5.9	4.8	0.5	3.2	2.0	5.0	0.0	24.5	0.0	0.6	2.9	0.4	5.8	1.2	1.1	14.5	4.9	0.3	0.2	0.4	0.0	0.1	2.3	0.8	7.1	3.6	3.5	3.5	4.9	3.6	4.9	4.5	4.2	4.3	4.5	3.7	4.8	9.7	28.9	17.7	0.0	9.7	27.1	43.3	39.2	14.2	0.1	33.8	24.8	0.8	194.5	24.6	11.0	0.0	1.6	0.7	32.5	11.7	40.0	1.0	6.2	9.7	11.0	71.0	27.8	0.0	31.6	5.3	48.8	56.1	24.9	0.0	10.7	62.4	4816.3	15.9	0.0	0.0	171.9	12.2	95.9	18.7	2.9	71.1	13.8	23.2	0.0	4.9	10.1	0.0	0.0	0.0	21.6	33.3	24.0	11.7	43.7	91.3	61.2	76.5	0.6	13.1	29.7	17.7	1.0	1.3	9.4	52.4	9.3	5.6	0.5	51.6	39.2
ANK2	"CFAP87, FAP87, LQT4"	ENSG00000145362	"Ankyrin 2"	Q01484	4	112818032-113384221	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Endocytosis, Protein transport, Transport"		"Disease variant, Long QT syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 165.7;retina: 191.2;skeletal muscle: 171.7;tongue: 150.5"	"Group enriched"	"Detected in many"	4	"Astrocytes: 1101.2;Bipolar cells: 376.6;Cone photoreceptor cells: 479.6;Excitatory neurons: 1282.0;Horizontal cells: 1431.8;Inhibitory neurons: 1060.7;Oligodendrocyte precursor cells: 497.1;Oligodendrocytes: 1351.0;Rod photoreceptor cells: 484.4"	"Cancer enhanced"	"Detected in many"		"glioma: 10.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 29.2;ASC TERT1: 32.2;RH-30: 49.6;SH-SY5Y: 24.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008007, CAB015178, HPA035970"	Enhanced	Approved	Supported	"Plasma membrane"		NA	NA				"Cluster 54: Non-specific - Microtubule organization"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Plasma membrane"		"CAB015178: AB_2242828, HPA008007: AB_2667965, HPA035970: AB_2674893"	"unprognostic (8.33e-2)"	"unprognostic (9.47e-2)"	"unprognostic (1.33e-2)"	"unprognostic (7.63e-2)"	"unprognostic (2.73e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.54e-1)"	"unprognostic (2.15e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.79e-3)"	"unprognostic (2.94e-2)"	"prognostic unfavorable (2.41e-6)"	"unprognostic (1.18e-2)"	"unprognostic (3.16e-1)"	"unprognostic (1.51e-3)"	"unprognostic (2.04e-3)"	31.0	13.6	94.9	11.2	109.0	0.1	18.3	63.1	165.7	31.6	0.0	30.1	8.5	15.8	5.9	12.9	9.6	22.5	119.5	103.9	77.5	110.1	2.4	7.2	9.2	130.2	61.1	27.3	3.2	1.2	19.3	2.1	119.5	7.8	11.4	191.2	6.7	13.3	171.7	8.7	12.7	24.9	51.9	28.3	8.3	9.4	84.8	4.4	9.6	150.5	7.2	9.5	12.3	116.2	0.1	2.9	18.7	5.2	29.2	32.2	0.1	1.5	3.4	0.9	2.6	4.2	0.0	6.9	2.1	5.9	4.1	0.1	11.0	0.6	1.0	2.3	7.3	4.0	0.0	2.9	1.7	1.9	1.2	15.2	3.0	1.2	6.0	3.9	0.0	0.4	0.0	9.3	5.8	0.3	0.2	0.1	9.4	0.1	2.0	0.7	49.6	0.0	0.2	0.0	13.6	24.1	0.2	0.7	8.1	11.7	0.1	1.1	0.0	4.7	2.2	0.4	3.0	6.8	1.8	0.9	20.1	0.6	7.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	94.9	109.0	63.1	165.7	103.9	77.5	130.2	61.1	119.5	51.9	84.8	116.2	6.9	0.0	3.9	1101.2	1.1	10.5	0.0	0.0	1.8	376.6	0.2	0.6	188.5	0.0	1.3	20.2	479.6	0.1	0.0	0.0	15.6	0.0	111.2	36.4	6.0	6.4	66.0	0.0	1282.0	1.6	0.1	79.0	2.0	7.2	1.3	81.8	0.0	0.4	1.0	1431.8	1060.7	0.4	8.2	0.0	19.7	49.8	36.4	2.9	17.8	90.9	0.6	44.5	0.0	497.1	1351.0	0.1	5.0	30.1	0.9	0.4	0.1	127.9	0.8	484.4	6.6	24.3	26.5	2.3	1.5	0.8	9.5	0.0	1.9	2.6	0.3	0.2
ANK3		ENSG00000151150	"Ankyrin 3"	Q12955	10	60026298-60733490	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			"Autism spectrum disorder, Cancer-related genes, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Bipolar cells: 490.2;Excitatory neurons: 859.2;Inhibitory neurons: 881.3;Oligodendrocyte precursor cells: 592.6;Oligodendrocytes: 1579.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"RT4: 50.3;SK-BR-3: 49.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013249, CAB015179, HPA038455"	Enhanced		Supported	"Plasma membrane"		NA	NA			"Cluster 30: Non-specific - Translation"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Plasma membrane"		"CAB013249: AB_2533145, CAB015179: AB_633909, HPA038455: AB_2676020"	"unprognostic (1.91e-1)"	"unprognostic (5.33e-3)"	"unprognostic (6.76e-3)"	"unprognostic (1.94e-1)"	"unprognostic (1.13e-1)"	"unprognostic (3.70e-3)"	"unprognostic (3.47e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.89e-1)"	"unprognostic (1.21e-2)"	"unprognostic (3.83e-1)"	"unprognostic (2.28e-2)"	"prognostic favorable (8.88e-16)"	"unprognostic (5.75e-2)"	"unprognostic (2.59e-1)"	"unprognostic (1.00e-1)"	"unprognostic (2.83e-2)"	6.3	6.7	45.5	6.5	86.5	2.1	21.5	144.9	82.3	12.0	0.0	26.0	39.3	23.0	125.2	16.9	19.1	21.5	81.1	60.8	86.1	95.4	16.6	24.6	6.1	82.7	61.3	11.6	11.2	131.8	14.5	15.6	97.0	20.0	20.9	123.2	42.6	40.5	80.5	39.9	27.2	13.2	21.2	10.8	15.5	8.0	87.3	9.1	41.6	94.1	7.4	10.8	14.1	114.4	8.7	4.9	30.3	0.4	0.0	1.8	23.3	0.6	0.4	0.1	0.6	22.2	16.6	0.5	9.8	0.6	0.9	12.1	16.4	14.9	0.5	0.5	11.0	0.2	9.7	0.1	6.2	0.1	0.4	14.6	9.3	7.8	0.4	26.1	3.6	0.0	4.3	20.6	6.9	29.0	0.2	1.0	13.8	23.3	26.6	0.1	21.7	4.3	5.4	50.3	15.6	2.8	0.6	49.4	0.0	33.6	28.7	0.1	10.0	0.9	2.9	13.3	1.5	0.9	0.2	0.2	5.5	0.2	18.9	1.6	0.2	0.5	2.7	0.2	2.4	4.1	4.6	1.5	0.1	1.1	5.0	1.2	0.7	1.5	0.3	2.5	0.8	1.0	45.5	86.5	144.9	82.3	60.8	86.1	82.7	61.3	97.0	21.2	87.3	114.4	0.9	44.8	174.3	20.2	14.5	19.1	21.9	17.8	38.7	490.2	26.8	20.6	189.3	12.8	42.5	53.3	225.2	38.8	3.4	62.9	19.6	10.6	28.3	139.8	26.2	3.9	30.6	0.0	859.2	8.6	9.9	13.2	15.8	153.3	12.6	66.9	7.9	0.5	4.7	43.7	881.3	12.1	14.2	4.8	1.4	11.5	28.0	3.3	8.8	23.4	4.4	41.4	0.0	592.6	1579.5	4.8	41.8	5.7	3.4	12.2	62.5	51.3	66.7	216.6	0.0	30.2	11.7	1.1	2.3	35.9	18.2	25.0	18.5	4.5	17.8	18.4
ANKIB1	"DKFZP434A0225, KIAA1386"	ENSG00000001629	"Ankyrin repeat and IBR domain containing 1"	Q9P2G1	7	92245974-92401383	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 85.5"	"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 182.5;Inhibitory neurons: 218.0;Oligodendrocyte precursor cells: 176.5;Oligodendrocytes: 590.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019358, HPA021780"	Uncertain		Supported	"Plasma membrane,Cytosol"		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 70: Brain - Nervous system development"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Plasma membrane, Cytosol"		"HPA019358: AB_1844831, HPA021780: AB_2670819"	"unprognostic (1.77e-1)"	"unprognostic (5.96e-3)"	"unprognostic (1.23e-1)"	"unprognostic (4.97e-3)"	"unprognostic (2.75e-1)"	"unprognostic (7.67e-2)"	"unprognostic (4.88e-3)"	"unprognostic (2.14e-1)"	"unprognostic (4.24e-2)"	"unprognostic (1.87e-2)"	"unprognostic (1.52e-3)"	"unprognostic (1.48e-1)"	"unprognostic (1.06e-3)"	"unprognostic (4.05e-2)"	"unprognostic (3.00e-1)"	"unprognostic (3.00e-2)"	"unprognostic (3.20e-1)"	12.6	10.6	28.4	10.0	56.8	6.9	12.3	21.2	42.0	12.6	0.0	12.9	11.1	12.0	15.9	11.8	9.8	14.9	10.2	19.0	54.6	25.6	10.6	11.0	13.2	32.9	32.4	12.6	12.2	23.9	7.5	12.7	34.5	10.0	12.8	9.9	13.9	11.2	7.7	14.4	12.0	13.6	14.0	12.4	11.7	20.8	36.3	14.5	17.2	9.9	11.7	13.2	9.0	85.5	35.7	20.9	18.7	27.3	32.0	34.9	19.2	27.1	30.0	25.4	34.0	15.8	52.0	20.0	23.4	39.7	66.8	16.5	16.5	28.1	38.0	35.1	14.0	13.1	23.7	12.1	22.0	18.8	26.5	23.1	22.8	31.0	38.2	34.6	28.7	17.4	16.9	41.8	30.0	27.5	39.6	17.0	19.6	23.9	23.7	14.6	22.8	21.9	26.6	30.7	25.5	29.4	39.2	41.8	22.4	34.8	17.5	10.2	26.2	48.5	40.2	55.3	27.8	26.7	52.3	25.4	27.7	21.9	56.2	1.4	0.4	1.2	0.9	0.7	0.7	1.7	0.9	1.3	0.4	2.0	0.7	1.0	0.2	1.2	0.6	1.6	1.9	0.4	28.4	56.8	21.2	42.0	19.0	54.6	32.9	32.4	34.5	14.0	36.3	85.5	24.1	25.6	30.4	97.6	21.8	18.6	17.5	16.4	13.1	20.8	25.6	20.2	33.4	24.3	22.3	27.6	18.8	13.4	27.8	20.7	1.9	21.5	52.8	21.5	37.2	22.4	41.9	8.8	182.5	19.2	25.2	25.9	14.3	27.0	26.6	47.4	27.8	15.1	13.5	30.3	218.0	24.8	10.2	22.2	16.1	61.1	33.2	20.4	17.8	87.1	20.6	27.3	34.0	176.5	590.8	33.5	11.8	40.6	23.4	26.5	20.8	37.3	18.8	16.2	19.7	34.8	26.1	70.9	50.4	20.3	22.7	14.0	22.7	31.2	21.7	21.9
ANKLE1	"ANKRD41, FLJ39369, LEMD6"	ENSG00000160117	"Ankyrin repeat and LEM domain containing 1"	Q8NAG6	19	17281645-17287646	"Predicted intracellular proteins, Predicted membrane proteins"	"DNA damage, DNA repair"	"Endonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"bone marrow: 25.6;brain: 8.8"	"Cell type enriched"	"Detected in some"	10	"Erythroid cells: 70.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Daudi: 77.2;HL-60: 34.6;NB-4: 41.7;U-937: 57.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA026789, HPA073498"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 32: U-937 - Innate immune response"	"Cluster 6: Erythroid cells - Oxygen transport"	"Nucleoplasm, Cytosol"		"HPA026789: AB_10611675, HPA073498: AB_2686612"	"unprognostic (5.66e-2)"	"unprognostic (2.21e-1)"	"unprognostic (6.90e-2)"	"prognostic unfavorable (4.86e-5)"	"unprognostic (2.73e-1)"	"unprognostic (1.72e-3)"	"unprognostic (2.19e-2)"	"unprognostic (2.09e-2)"	"unprognostic (1.31e-2)"	"unprognostic (2.28e-1)"	"unprognostic (7.89e-4)"	"unprognostic (5.86e-2)"	"unprognostic (0.00e+0)"	"unprognostic (2.03e-1)"	"unprognostic (1.61e-1)"	"unprognostic (2.00e-3)"	"unprognostic (4.30e-2)"	0.7	0.9	4.5	2.3	2.7	25.6	0.6	8.8	5.5	0.7	0.6	0.5	0.9	1.0	1.2	0.7	0.6	0.7	1.0	3.2	2.3	0.4	0.6	0.8	4.1	1.6	1.4	1.5	1.7	0.4	0.5	1.2	1.7	0.7	0.5	3.6	1.5	0.6	0.3	2.4	0.8	0.8	0.4	2.2	0.8	1.5	3.3	1.3	0.9	0.5	3.1	0.7	0.4	2.7	0.9	0.8	3.7	1.7	0.4	0.6	3.2	1.1	0.3	0.6	0.6	17.1	1.5	77.2	0.7	0.5	0.6	1.5	28.4	0.4	0.6	22.3	3.4	29.1	13.1	0.6	0.3	34.6	12.5	0.3	1.0	2.7	0.2	0.9	0.6	6.4	4.2	9.2	0.4	0.9	24.2	41.7	10.2	0.3	2.6	17.3	1.0	8.7	0.4	1.7	1.2	7.1	6.8	0.9	0.7	1.5	0.6	20.1	1.4	1.0	1.2	1.4	1.0	1.3	0.9	27.8	0.7	57.2	1.3	0.9	0.9	0.6	0.5	1.9	0.3	1.6	0.4	0.5	1.1	0.9	0.5	0.4	1.5	0.3	1.4	0.9	0.4	0.6	4.5	2.7	8.8	5.5	3.2	2.3	1.6	1.4	1.7	0.4	3.3	2.7	0.4	0.0	0.5	0.7	1.1	0.8	0.8	0.3	0.0	1.9	0.5	0.6	0.8	0.0	0.1	0.0	0.0	1.6	0.4	0.4	0.0	0.2	0.3	0.2	0.4	0.4	0.0	70.7	1.4	0.2	0.7	0.6	0.0	0.8	1.3	1.1	0.0	0.1	0.8	0.0	1.6	0.5	0.0	0.9	1.3	0.0	1.8	1.1	0.0	1.0	3.0	0.5	1.0	1.0	1.6	0.3	0.1	1.5	0.9	0.5	0.0	0.1	0.9	1.5	6.6	0.6	0.4	0.5	1.0	0.0	0.4	0.4	0.5	0.3	0.3	0.2
ANKLE2	"KIAA0692, Lem4, LEMD7"	ENSG00000176915	"Ankyrin repeat and LEM domain containing 2"	Q86XL3	12	132725503-132761832	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Cell cycle, Cell division, Mitosis"		"Disease variant, Primary microcephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 215.7;Urothelial cells: 168.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003602, HPA074838"	Uncertain		Supported	"Endoplasmic reticulum,Plasma membrane"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 71: Testis - DNA repair"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 44: Endometrium - Transcription"	"Endoplasmic reticulum, Plasma membrane"		"HPA003602: AB_1858349, HPA074838: "	"unprognostic (4.43e-2)"	"unprognostic (6.92e-2)"	"unprognostic (7.97e-2)"	"unprognostic (9.84e-3)"	"unprognostic (1.97e-2)"	"unprognostic (5.81e-2)"	"prognostic unfavorable (3.97e-6)"	"unprognostic (3.19e-2)"	"unprognostic (1.11e-2)"	"unprognostic (2.49e-1)"	"unprognostic (4.76e-2)"	"unprognostic (6.10e-2)"	"prognostic unfavorable (1.90e-8)"	"unprognostic (1.42e-1)"	"unprognostic (1.42e-1)"	"unprognostic (6.92e-3)"	"unprognostic (2.09e-1)"	30.0	37.6	12.4	27.0	13.3	38.4	27.8	15.2	16.6	25.4	21.9	23.8	17.8	24.9	19.0	33.6	25.2	17.4	22.0	13.8	14.1	21.8	22.9	31.3	31.6	12.3	12.4	27.1	24.6	17.9	23.1	20.4	12.3	23.9	16.1	12.3	26.1	15.6	29.3	36.9	33.3	21.9	12.0	37.9	24.1	55.7	14.3	26.2	23.3	18.3	31.2	25.0	27.6	13.2	50.7	46.4	47.3	29.5	26.9	42.1	59.1	60.2	44.7	59.0	45.0	53.2	33.6	39.5	30.7	53.1	39.5	59.2	41.8	54.8	56.2	17.0	51.6	50.1	84.0	25.2	29.9	54.6	34.0	39.1	54.9	56.2	41.3	108.8	42.8	32.0	46.1	15.1	61.2	36.4	51.1	89.4	40.1	24.8	43.9	58.0	31.1	16.7	42.6	64.9	57.9	35.6	77.7	32.4	27.1	44.1	56.9	39.1	61.5	70.5	50.9	38.0	68.1	27.9	29.5	47.9	54.7	35.8	40.5	0.9	1.2	4.4	1.8	1.1	2.4	2.7	2.6	2.8	1.7	2.8	2.4	2.0	0.7	2.7	1.3	1.7	2.6	0.7	12.4	13.3	15.2	16.6	13.8	14.1	12.3	12.4	12.3	12.0	14.3	13.2	38.0	73.7	31.2	18.3	43.2	67.3	92.0	38.2	32.5	32.3	31.2	27.1	24.6	27.1	51.3	31.3	45.9	29.2	41.1	33.8	1.9	33.2	109.1	58.6	52.4	36.3	20.8	23.1	21.0	32.7	35.5	35.7	35.2	119.2	18.4	38.3	22.9	12.9	20.1	32.0	17.8	18.0	24.4	19.7	47.6	24.5	25.1	35.5	33.8	16.9	40.6	21.9	47.4	18.1	18.4	101.9	24.8	28.2	47.6	116.9	18.8	8.5	32.3	39.7	26.3	39.2	40.5	215.7	61.8	44.8	72.9	36.5	44.7	31.6	24.0	168.7
ANKRA2		ENSG00000164331	"Ankyrin repeat family A member 2"	Q9H9E1	5	73552190-73565667	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003968, HPA065263"	Approved		Supported	"Nucleoplasm,Plasma membrane,Cell Junctions"		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 51: Non-specific - Unknown function"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Plasma membrane"	"Nucleoplasm, Cell Junctions"	"HPA003968: , HPA065263: AB_2685449"	"unprognostic (1.75e-1)"	"unprognostic (5.78e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.86e-1)"	"unprognostic (3.31e-1)"	"unprognostic (3.89e-2)"	"unprognostic (5.68e-2)"	"unprognostic (6.19e-2)"	"unprognostic (3.47e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.06e-2)"	"unprognostic (1.79e-1)"	"unprognostic (9.80e-3)"	"unprognostic (3.36e-1)"	"unprognostic (3.31e-1)"	"unprognostic (6.65e-2)"	"unprognostic (1.13e-3)"	7.8	11.3	4.6	5.7	5.1	14.0	10.1	5.7	5.4	9.4	5.2	8.9	9.6	12.4	13.1	7.5	11.4	9.7	8.2	4.2	5.1	5.9	10.8	7.0	9.9	5.0	4.9	14.1	8.3	8.0	7.5	10.0	5.3	12.4	10.4	9.9	10.9	8.4	7.6	9.1	9.6	8.3	5.1	8.8	10.0	6.7	5.2	10.0	14.3	6.6	8.1	7.4	7.7	6.2	6.6	4.5	6.6	7.5	12.3	19.3	20.6	9.0	13.2	7.6	11.0	1.4	9.4	6.2	7.0	8.8	7.3	4.5	3.1	15.4	10.9	11.9	5.5	5.4	3.6	6.5	9.6	3.1	9.3	19.8	21.0	9.1	9.2	13.6	8.7	6.7	5.3	9.9	8.6	3.8	5.6	8.5	3.9	2.5	3.7	3.5	7.1	8.7	5.6	8.2	9.0	6.9	6.9	5.3	11.0	10.2	8.2	5.0	11.2	3.0	3.4	4.9	6.3	19.7	15.1	5.3	7.5	5.1	8.8	19.9	5.1	11.2	7.6	4.5	9.3	9.9	8.9	10.7	4.6	8.0	13.3	12.4	8.4	7.3	7.8	5.3	11.5	6.8	4.6	5.1	5.7	5.4	4.2	5.1	5.0	4.9	5.3	5.1	5.2	6.2	10.7	3.2	11.5	10.4	23.5	15.8	30.1	29.8	26.2	26.2	20.7	15.9	8.9	31.5	22.7	18.4	10.4	26.3	27.1	16.0	27.4	14.1	1.3	18.1	11.0	12.8	24.1	21.5	10.0	16.6	22.2	13.8	10.7	13.4	19.0	18.8	15.7	23.8	10.5	23.5	12.9	22.6	36.7	18.5	6.7	2.2	32.6	11.1	12.4	16.9	15.1	16.2	17.5	21.1	22.3	16.9	20.0	29.0	14.6	25.7	21.5	18.0	21.4	21.2	26.3	11.3	17.8	25.6	15.9	16.0	12.4	48.8	20.4	16.3	17.0	36.8
ANKRD1	"ALRP, C-193, CARP, CVARP, MCARP"	ENSG00000148677	"Ankyrin repeat domain 1"	Q15327	10	90912096-90921087	"Metabolic proteins, Predicted intracellular proteins"			"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	11	"heart muscle: 6540.8"	"Cell type enriched"	"Detected in some"	15	"Cardiomyocytes: 13820.4"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 7.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"CACO-2: 474.5;EFO-21: 1248.9;hTERT-RPE1: 679.8;LHCN-M2: 1573.6;SuSa: 469.1;TIME: 2206.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA038736	Enhanced		Approved	"Nucleoplasm,Nucleoli fibrillar center"		NA	Yes				"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 54: Cardiomyocytes - Muscle contraction"	"Nucleoli fibrillar center"	Nucleoplasm	"HPA038736: AB_2676184"	"unprognostic (2.45e-1)"	"unprognostic (6.14e-3)"	"unprognostic (2.24e-1)"	"unprognostic (4.39e-1)"	"unprognostic (9.14e-3)"	"prognostic unfavorable (1.95e-4)"	"unprognostic (1.28e-2)"	"unprognostic (6.63e-3)"	"unprognostic (2.19e-1)"	"unprognostic (3.27e-1)"	"unprognostic (4.51e-2)"	"unprognostic (3.40e-1)"	"unprognostic (2.72e-5)"	"unprognostic (3.40e-2)"	"unprognostic (2.79e-1)"	"unprognostic (7.22e-2)"	"unprognostic (3.16e-3)"	0.9	0.7	0.0	0.4	0.0	0.0	1.8	0.2	0.3	0.6	0.6	0.7	0.0	0.4	0.0	0.6	0.1	1.3	6540.8	0.0	0.2	0.7	1.6	48.6	2.5	0.0	0.2	0.7	4.8	0.2	1.1	4.2	0.0	6.8	0.0	0.0	8.7	0.1	571.0	2.3	0.6	2.1	0.0	0.5	1.0	0.9	0.8	1.5	1.7	20.5	0.0	1.2	0.5	0.1	37.2	10.8	6.6	0.3	5.8	6.7	0.5	21.5	2.2	6.0	10.8	474.5	17.9	0.3	1248.9	1.8	48.5	13.3	2.3	3.1	15.7	1.4	1.2	0.2	2.9	148.5	27.7	0.0	0.0	44.2	0.1	9.5	21.6	679.8	437.8	0.0	0.3	0.0	1573.6	0.4	0.0	0.0	1.3	2.7	0.3	0.0	104.3	0.0	3.9	0.5	0.1	0.0	0.3	0.4	1.2	469.1	0.3	1.9	2206.7	4.1	163.9	3.2	175.0	0.0	1.2	3.0	0.9	0.6	0.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.2	0.0	0.2	0.0	0.0	0.8	0.1	0.0	913.5	42.0	0.0	0.0	0.0	3.5	18.5	0.0	0.0	0.0	0.0	13820.4	7.2	6.6	0.0	0.0	0.6	0.0	0.0	0.0	66.3	5.7	9.4	0.2	83.6	0.0	0.0	0.0	0.2	0.2	243.5	0.0	4.6	3.8	1.3	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.6	0.0	0.0	0.6	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.4	0.0	0.1	1.0	0.0	0.0	74.5	100.9	0.0	0.0	0.0	0.0	0.5	0.6	0.0	0.0	0.1
ANKRD10	FLJ20093	ENSG00000088448	"Ankyrin repeat domain 10"	Q9NXR5	13	110878540-110915069	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034211, HPA038878, HPA038879"	Uncertain		Supported	Nucleoplasm		NA	NA			"Cluster 30: Non-specific - Translation"	"Cluster 59: Non-specific - Translation"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm		"CAB034211: AB_2058024, HPA038878: AB_2676252, HPA038879: AB_2676253"	"unprognostic (3.29e-2)"	"unprognostic (2.38e-1)"	"unprognostic (9.26e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.89e-3)"	"unprognostic (2.49e-1)"	"unprognostic (4.97e-3)"	"unprognostic (9.60e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.61e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.92e-2)"	"prognostic unfavorable (1.25e-6)"	"unprognostic (1.95e-1)"	"unprognostic (2.68e-1)"	"unprognostic (8.32e-2)"	"prognostic favorable (6.41e-6)"	78.2	60.3	61.9	42.2	69.8	88.7	75.6	65.9	85.2	109.1	71.4	97.2	43.8	87.4	89.9	37.6	90.7	53.5	74.3	62.6	68.8	93.9	84.1	91.7	63.3	72.5	65.8	99.6	94.9	25.5	97.5	36.4	75.5	108.1	50.2	77.6	70.3	42.4	176.6	48.9	88.1	49.0	66.3	138.9	75.0	40.8	67.7	52.4	82.1	73.4	50.4	79.2	68.3	80.1	36.1	29.6	66.7	56.2	50.2	48.4	29.6	24.0	50.0	23.5	28.9	31.0	68.8	49.5	51.1	18.2	38.2	81.1	29.2	22.6	31.7	119.1	43.2	59.0	73.3	64.9	20.0	85.9	49.4	46.2	33.7	16.5	24.4	49.1	32.1	48.8	26.4	33.1	64.2	10.8	49.9	95.3	37.0	79.1	18.3	76.0	24.5	49.6	64.9	39.4	53.2	39.7	18.2	31.7	39.9	49.7	22.7	108.0	28.0	27.6	23.0	13.7	24.7	40.8	46.9	28.9	51.7	41.5	44.2	39.0	25.8	22.7	30.4	21.1	26.3	42.9	29.2	25.3	33.8	44.7	30.9	33.7	16.1	31.8	22.3	31.5	39.9	26.8	61.9	69.8	65.9	85.2	62.6	68.8	72.5	65.8	75.5	66.3	67.7	80.1	77.6	16.0	65.4	83.6	69.3	94.3	39.0	25.9	129.1	33.3	72.2	55.0	32.0	45.8	45.3	38.6	54.2	45.1	54.4	43.4	19.6	52.1	8.5	59.0	79.2	83.3	41.9	30.3	118.7	49.2	51.8	78.3	51.5	105.4	30.4	65.3	40.7	48.8	46.6	32.0	105.8	55.2	57.0	46.5	99.7	7.3	39.1	60.4	72.9	145.2	44.7	28.6	35.0	158.3	203.6	38.7	46.2	51.6	58.5	62.5	40.9	45.1	40.8	55.4	52.6	105.6	88.8	28.0	23.6	44.3	77.7	38.9	58.9	44.9	59.6	53.2
ANKRD12	"FLJ20053, GAC-1, KIAA0874"	ENSG00000101745	"Ankyrin repeat domain 12"	Q6UB98	18	9136228-9285985	"Cancer-related genes, Predicted intracellular proteins"			"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Karpas-707: 106.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040705	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	Cytosol	"HPA040705: AB_10673301"	"unprognostic (2.20e-1)"	"unprognostic (1.14e-1)"	"unprognostic (3.59e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.46e-1)"	"unprognostic (3.41e-3)"	"unprognostic (7.25e-2)"	"unprognostic (6.17e-2)"	"prognostic unfavorable (6.71e-4)"	"unprognostic (1.24e-2)"	"unprognostic (1.55e-1)"	"unprognostic (3.38e-1)"	"unprognostic (2.39e-2)"	"unprognostic (4.62e-1)"	"unprognostic (1.56e-1)"	"unprognostic (3.03e-1)"	"unprognostic (1.03e-2)"	15.8	9.3	17.1	20.5	21.4	20.5	13.7	59.9	26.0	11.1	2.2	13.0	12.9	11.8	9.5	14.4	6.2	14.6	11.9	13.9	18.4	13.0	13.8	11.5	22.4	11.2	13.4	14.1	11.9	10.5	5.9	14.1	13.2	12.2	12.0	29.8	12.3	10.6	26.7	20.2	13.4	9.1	10.4	19.9	14.5	27.7	15.8	11.4	16.4	12.3	18.5	13.5	8.0	32.3	10.1	6.7	9.0	6.0	14.2	14.5	7.3	15.3	14.2	5.4	7.4	6.1	7.6	13.9	8.7	10.6	16.4	9.1	6.8	6.0	14.5	14.8	8.1	6.4	4.7	9.0	10.5	15.0	19.7	7.6	13.1	7.7	12.4	12.2	9.2	8.0	14.7	106.4	13.2	5.7	10.1	10.2	3.4	24.7	6.8	9.0	12.6	51.1	7.1	15.8	20.9	7.7	15.0	7.4	11.1	8.0	9.2	12.4	19.9	39.5	18.1	32.1	14.4	30.8	52.0	25.9	19.4	7.9	15.2	102.0	26.4	85.1	42.4	24.1	47.9	63.6	54.9	42.0	19.2	56.2	55.9	43.4	157.3	30.4	37.2	60.6	44.0	18.3	17.1	21.4	59.9	26.0	13.9	18.4	11.2	13.4	13.2	10.4	15.8	32.3	235.1	278.9	261.5	198.5	246.9	108.2	205.9	83.3	116.7	301.0	87.5	108.5	138.6	94.4	137.7	68.0	523.3	46.3	267.2	163.1	19.6	99.7	204.9	144.3	91.9	136.8	92.7	90.7	172.1	83.5	41.1	126.8	64.2	292.9	187.2	76.3	121.7	74.0	67.8	286.0	218.1	90.4	107.8	99.7	126.2	230.9	134.8	149.3	90.7	161.1	178.2	125.5	244.1	184.5	347.4	93.0	147.1	141.4	210.1	196.8	126.1	37.0	88.5	315.4	111.7	173.2	150.0	239.5	152.8	70.9	96.0	78.1	298.3	63.0	71.0	170.7
ANKRD13A	"ANKRD13, NY-REN-25"	ENSG00000076513	"Ankyrin repeat domain 13A"	Q8IZ07	12	109999186-110039763	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 160.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"fHDF/TERT166: 205.4;HBF TERT88: 200.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039488, HPA043218"	Enhanced		Supported	"Plasma membrane"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 16: Immune cells - Immune response"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 57: B-cells - Immune response"	"Plasma membrane"		"HPA039488: AB_10673612, HPA043218: AB_2678367"	"unprognostic (1.54e-1)"	"unprognostic (3.94e-3)"	"unprognostic (5.81e-1)"	"unprognostic (1.62e-2)"	"unprognostic (1.05e-1)"	"prognostic favorable (7.70e-6)"	"unprognostic (5.68e-2)"	"unprognostic (1.31e-2)"	"unprognostic (2.19e-1)"	"prognostic unfavorable (6.77e-4)"	"unprognostic (9.71e-3)"	"unprognostic (1.67e-1)"	"unprognostic (2.67e-2)"	"unprognostic (2.57e-1)"	"unprognostic (2.13e-2)"	"unprognostic (1.08e-1)"	"unprognostic (5.29e-2)"	13.2	10.9	6.3	36.5	10.0	36.0	16.4	8.8	8.1	14.1	6.1	21.8	14.3	11.9	6.6	31.7	12.3	22.9	10.7	7.1	7.4	17.6	15.3	26.9	54.0	8.4	8.7	16.3	12.3	17.4	4.6	24.4	9.0	17.9	22.4	8.7	27.5	24.6	6.9	22.6	17.6	24.4	7.5	32.8	17.1	60.9	8.4	27.9	28.2	8.7	66.7	25.9	13.2	15.0	163.7	7.3	16.9	15.6	25.4	25.1	20.8	160.9	150.5	149.8	79.3	21.2	10.3	107.8	12.4	205.4	18.7	19.0	21.7	24.0	200.3	122.3	19.2	39.9	15.6	17.4	22.2	46.8	46.2	21.9	24.9	63.8	36.5	37.3	23.0	24.9	31.6	17.2	66.5	5.8	41.3	19.5	9.3	11.7	34.1	35.8	47.3	42.7	21.2	20.7	34.7	16.5	29.6	57.0	19.5	11.4	26.0	38.5	29.2	111.6	20.0	62.2	87.4	36.8	23.3	144.1	54.3	31.7	16.5	1.5	1.2	5.6	0.5	2.5	1.5	2.0	1.3	0.6	1.5	1.2	0.7	1.0	3.5	0.9	1.1	1.0	0.6	0.7	6.3	10.0	8.8	8.1	7.1	7.4	8.4	8.7	9.0	7.5	8.4	15.0	15.7	48.1	32.5	13.4	75.5	29.3	18.7	11.0	15.4	24.4	23.1	16.9	13.0	28.6	30.5	57.0	14.6	16.9	31.2	30.3	21.5	29.2	104.7	22.0	12.3	14.9	18.7	19.4	15.9	17.6	21.0	15.5	16.3	29.5	13.3	18.5	15.7	17.3	15.4	25.2	26.9	9.4	4.1	37.1	26.9	160.4	11.8	33.7	14.2	16.9	34.2	9.7	21.6	17.6	46.0	20.8	12.5	21.8	33.0	16.2	16.0	9.8	37.6	14.2	32.9	50.3	18.0	71.1	15.0	23.9	37.8	37.6	31.8	16.9	17.0	25.7
ANKRD13B	FLJ25555	ENSG00000198720	"Ankyrin repeat domain 13B"	Q86YJ7	17	29589769-29614761	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 27.4;Endometrial stromal cells: 24.2;Excitatory neurons: 19.4;Horizontal cells: 16.8;Late spermatids: 44.7;Oligodendrocytes: 17.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"SCLC-21H: 52.0;SH-SY5Y: 57.6;SK-BR-3: 48.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051886, HPA063748"	Uncertain		Supported	Vesicles		NA	NA				"Cluster 43: Testis - Unknown function"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 36: Stromal cells - Cell proliferation"	Vesicles		"HPA051886: AB_2681652, HPA063748: AB_2685112"	"unprognostic (1.61e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.66e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.45e-1)"	"unprognostic (3.10e-4)"	"unprognostic (1.84e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.03e-2)"	"prognostic favorable (7.58e-4)"	"unprognostic (3.94e-2)"	"prognostic unfavorable (5.92e-6)"	"unprognostic (9.93e-2)"	"unprognostic (1.18e-1)"	"unprognostic (3.94e-2)"	"unprognostic (5.36e-3)"	12.0	3.7	12.5	1.7	14.3	0.7	7.5	11.9	15.9	16.3	0.0	10.2	0.8	13.6	0.8	6.5	12.0	3.7	10.3	13.9	6.2	2.8	1.2	5.5	1.6	13.4	9.4	15.1	3.7	1.6	14.6	0.9	10.4	7.7	0.6	2.0	4.3	1.8	9.6	7.5	4.5	2.9	7.2	2.6	4.9	18.9	10.8	0.9	5.8	1.3	0.3	10.0	11.6	22.9	6.6	11.5	13.3	35.4	8.2	8.0	5.1	2.0	1.2	1.4	2.7	6.1	1.4	7.4	6.4	2.8	4.9	24.3	7.2	7.8	0.2	14.8	23.5	2.3	22.3	5.3	3.5	2.4	4.6	7.9	10.2	2.2	5.8	6.4	10.1	12.8	6.0	6.1	1.9	5.9	16.0	7.5	11.4	6.8	9.7	33.4	9.5	23.4	3.0	2.2	52.0	57.6	3.9	48.0	4.3	1.2	7.4	4.4	6.7	7.4	7.2	5.2	7.2	11.4	15.7	9.2	5.2	12.1	4.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.5	14.3	11.9	15.9	13.9	6.2	13.4	9.4	10.4	7.2	10.8	22.9	2.6	0.0	0.0	6.8	0.1	1.7	1.0	0.7	3.4	4.5	1.8	2.7	2.3	0.0	0.4	0.0	2.1	0.1	0.6	0.6	1.9	1.6	27.4	0.9	24.2	2.4	3.0	1.7	19.4	0.6	0.2	5.5	2.6	1.0	0.0	3.8	1.4	0.6	0.1	16.8	14.6	0.8	0.0	0.3	1.6	44.7	14.6	0.3	0.0	0.0	0.0	1.8	0.0	11.1	17.8	0.5	0.0	7.5	0.5	3.2	0.1	0.2	0.0	5.2	0.0	2.4	2.5	6.0	4.7	2.6	1.7	0.1	0.7	1.0	1.1	1.5
ANKRD17	"FLJ22206, GTAR, KIAA0697, MASK2, NY-BR-16"	ENSG00000132466	"Ankyrin repeat domain 17"	O75179	4	73073376-73258798	"Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, Immunity, Innate immunity"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 337.8;Inhibitory neurons: 315.8;Oligodendrocyte precursor cells: 275.0;Oligodendrocytes: 296.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045024, HPA063731"	Approved		Supported	"Nucleoplasm,Nuclear membrane"		No	No			"Cluster 15: NK-cells - Transcription"	"Cluster 54: Non-specific - Microtubule organization"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm	"Nuclear membrane"	"HPA045024: AB_10964778, HPA063731: AB_2685106"	"unprognostic (3.86e-3)"	"unprognostic (3.59e-2)"	"unprognostic (1.70e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.73e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.63e-3)"	"unprognostic (3.29e-2)"	"unprognostic (3.10e-2)"	"unprognostic (1.78e-1)"	"unprognostic (8.79e-2)"	"unprognostic (2.92e-2)"	"unprognostic (3.98e-3)"	"unprognostic (9.06e-2)"	"unprognostic (2.13e-1)"	"unprognostic (4.00e-2)"	"unprognostic (4.07e-1)"	13.7	13.5	15.6	13.6	16.7	9.2	20.0	23.1	20.4	16.8	16.8	15.8	14.8	14.7	18.5	14.5	18.2	12.4	14.5	16.2	21.1	19.6	20.6	14.2	15.1	15.7	15.9	17.8	18.0	24.5	14.4	19.0	16.0	15.1	19.0	36.0	16.7	13.7	23.2	17.2	15.2	16.4	12.3	15.1	15.7	11.1	18.5	27.2	17.9	26.1	17.7	17.7	12.8	20.1	25.6	27.7	43.1	34.2	47.4	41.5	23.5	36.9	43.1	32.5	31.1	33.9	32.8	69.2	29.9	38.0	17.1	20.9	54.4	32.6	44.6	27.1	23.1	47.1	29.5	49.4	25.4	62.2	27.9	35.2	34.8	46.6	36.9	33.6	43.8	27.9	67.2	24.8	39.4	23.7	51.3	22.1	28.0	33.0	27.6	40.5	47.3	28.8	34.5	38.1	41.6	28.2	35.7	39.7	18.9	33.5	21.3	24.3	53.2	34.0	32.6	30.8	29.3	20.5	11.1	51.5	27.6	26.8	35.6	1.6	1.7	1.8	3.0	1.1	1.5	1.8	1.8	2.0	1.4	2.6	1.7	2.0	1.9	5.6	1.3	4.4	1.2	1.1	15.6	16.7	23.1	20.4	16.2	21.1	15.7	15.9	16.0	12.3	18.5	20.1	42.9	48.1	52.9	194.9	30.9	76.1	36.9	33.9	67.2	57.2	38.6	31.2	82.2	35.8	45.5	40.5	123.0	31.8	40.0	52.8	7.9	30.9	12.7	46.0	57.9	52.2	45.1	36.1	337.8	28.9	24.6	44.8	51.5	60.8	31.6	53.4	43.9	49.7	27.3	69.0	315.8	45.6	26.4	31.2	34.7	5.5	35.1	35.0	28.4	181.8	34.8	30.5	50.4	275.0	296.5	30.2	25.7	37.6	44.2	52.8	39.4	25.4	30.5	84.1	19.7	58.5	48.5	28.1	30.8	64.9	81.3	33.8	32.4	47.6	48.3	48.4
ANKRD23	"DARP, FLJ32449, MARP3"	ENSG00000163126	"Ankyrin repeat domain 23"	Q86SG2	2	96824526-96857934	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	39	"skeletal muscle: 1438.6;tongue: 448.6"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 5.0;Respiratory ciliated cells: 7.4;Rod photoreceptor cells: 5.2;Skeletal myocytes: 6.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	8	"Karpas-707: 38.5"	"Low region specificity"	"Detected in many"							HPA036201	Approved		Approved	"Nucleoplasm,Actin filaments,Cytosol"		NA	NA				"Cluster 33: Striated muscle - Muscle contraction"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 37: Myocytes - Muscle contraction"	"Nucleoplasm, Cytosol"	"Actin filaments"	"HPA036201: AB_10673347"	"unprognostic (2.48e-1)"	"unprognostic (7.83e-4)"	"unprognostic (4.93e-4)"	"unprognostic (1.21e-2)"	"unprognostic (4.28e-1)"	"unprognostic (3.28e-1)"	"unprognostic (3.27e-2)"	"unprognostic (6.66e-2)"	"unprognostic (2.46e-2)"	"unprognostic (3.59e-2)"	"unprognostic (1.81e-4)"	"unprognostic (1.43e-1)"	"unprognostic (2.04e-6)"	"unprognostic (2.70e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.54e-1)"	"unprognostic (2.70e-4)"	0.8	0.9	1.6	0.4	2.1	0.7	1.2	2.2	2.1	1.4	0.6	1.3	0.8	1.8	0.0	6.0	2.5	0.2	24.2	1.5	1.4	0.7	2.2	1.0	0.6	2.5	1.6	1.7	1.6	0.3	10.4	0.2	1.8	5.3	0.1	0.1	18.5	0.3	1438.6	2.5	1.3	0.2	1.5	2.3	0.7	0.7	1.9	0.6	1.1	448.6	0.4	1.2	1.1	2.3	0.5	0.7	0.4	0.8	0.0	0.2	1.1	0.3	0.1	0.2	0.1	0.1	0.2	0.4	0.2	0.1	0.3	0.3	0.3	0.3	0.2	1.1	1.0	0.5	0.8	0.2	0.1	0.8	1.8	0.3	0.3	0.6	0.0	0.2	0.1	1.5	0.9	38.5	0.3	0.9	0.5	0.8	0.4	0.1	0.3	1.4	0.0	5.0	0.2	0.9	1.4	0.2	0.3	0.7	0.0	0.2	1.1	0.0	0.3	0.5	0.6	0.7	0.1	1.7	0.7	0.3	0.4	1.1	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.6	2.1	2.2	2.1	1.5	1.4	2.5	1.6	1.8	1.5	1.9	2.3	1.1	0.0	1.1	2.0	0.5	0.8	0.5	0.4	0.6	2.6	0.8	2.3	5.0	0.0	1.5	0.0	2.1	0.4	2.1	0.9	0.0	0.3	3.3	1.3	1.9	0.8	0.0	0.4	2.8	1.1	0.2	1.3	0.5	0.7	1.3	1.1	1.4	1.2	0.2	1.7	2.7	1.0	0.0	0.6	0.3	1.8	1.5	0.6	0.0	1.0	0.2	1.1	1.0	0.5	2.9	0.1	0.3	3.0	0.4	0.3	0.6	0.2	7.4	5.2	0.0	6.1	1.6	1.3	0.4	0.4	1.3	0.3	1.1	0.7	0.9	0.2
ANKRD27	"DKFZp434L0718, FLJ00040, VARP"	ENSG00000105186	"Ankyrin repeat domain 27"	Q96NW4	19	32597006-32676597	"Predicted intracellular proteins"	"Protein transport, Transport"	"GTPase activation, Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HEL: 137.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042769	Approved		Supported	Vesicles,Cytosol		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 49: Ciliated cells - Cilium organization"	"Cluster 36: HEL - Hemostasis"	"Cluster 59: Non-specific - Transcription"	Vesicles	Cytosol	"HPA042769: AB_10796584"	"unprognostic (2.16e-3)"	"unprognostic (6.04e-2)"	"unprognostic (1.01e-1)"	"prognostic unfavorable (8.68e-4)"	"unprognostic (1.63e-1)"	"unprognostic (1.21e-2)"	"prognostic unfavorable (1.21e-5)"	"unprognostic (9.02e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.61e-2)"	"unprognostic (2.90e-2)"	"unprognostic (6.22e-3)"	"unprognostic (3.74e-2)"	"unprognostic (2.14e-1)"	"unprognostic (4.94e-2)"	"unprognostic (4.07e-1)"	"unprognostic (2.26e-2)"	8.9	7.4	10.8	8.9	12.9	10.4	8.7	12.1	12.6	10.3	21.5	17.2	7.6	10.0	8.8	14.3	8.0	7.7	9.6	11.8	9.8	9.7	4.4	10.3	11.1	12.0	12.9	8.3	7.2	9.3	6.8	13.6	12.4	12.3	11.9	11.7	9.7	13.5	20.7	12.4	10.7	11.6	8.9	9.0	11.0	17.3	12.1	16.7	13.3	10.8	11.5	16.9	11.1	11.8	32.0	36.0	11.5	20.8	23.5	18.0	28.1	18.0	18.0	19.4	25.4	28.8	19.0	34.7	16.5	23.0	20.4	19.4	29.6	22.3	32.0	47.3	15.1	137.9	13.7	23.9	29.4	53.5	47.6	13.1	28.8	20.9	33.8	13.5	19.7	25.3	37.5	76.3	15.1	31.5	20.8	46.2	6.0	40.2	13.8	30.6	15.6	12.7	15.6	30.5	21.3	8.6	17.6	29.6	21.0	15.2	12.4	25.7	18.5	21.1	22.4	19.6	28.0	19.7	12.7	23.8	21.0	51.8	13.8	36.5	11.1	28.5	13.9	15.7	17.5	7.5	14.3	15.6	12.6	6.9	10.9	11.7	9.0	30.6	13.3	6.2	13.2	13.3	10.8	12.9	12.1	12.6	11.8	9.8	12.0	12.9	12.4	8.9	12.1	11.8	6.8	16.0	9.4	18.3	10.0	15.6	5.5	5.6	14.2	9.4	9.0	5.1	9.2	7.2	5.7	9.2	20.9	14.9	9.7	9.3	0.0	3.3	5.1	7.5	9.4	7.1	9.1	26.5	35.5	5.9	10.6	7.6	5.6	11.6	12.0	10.1	4.6	4.8	8.4	11.8	16.3	9.6	8.2	12.0	12.1	16.2	10.8	8.7	16.0	12.2	6.0	5.8	9.2	11.1	18.7	7.1	10.3	9.4	8.0	10.0	10.8	7.7	7.1	14.7	0.0	6.8	9.3	4.1	17.1	14.7	15.5	15.2	14.0	7.2	8.9	8.4
ANKRD34B	DP58	ENSG00000189127	"Ankyrin repeat domain 34B"	A5PLL1	5	80556755-80570280	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	24	"brain: 40.7"	"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 2.0;Collecting duct cells: 3.7;Enteroendocrine cells: 1.8;Inhibitory neurons: 6.0;Kupffer cells: 1.2"	"Cancer enhanced"	"Detected in some"		"prostate cancer: 2.3"	"Region enhanced"	"Detected in many"		"thalamus: 40.7"	"Immune cell enriched"	"Detected in single"	5	"neutrophil: 3.8"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 3.8"	"Cell line enriched"	"Detected in some"	29	"RPTEC TERT1: 97.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA043327	Uncertain		Approved	Nucleoplasm,Mitochondria,Cytosol		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Nucleoplasm, Mitochondria"	Cytosol	"HPA043327: AB_10794180"	"unprognostic (1.05e-1)"	"unprognostic (4.16e-6)"		"unprognostic (2.07e-4)"	"unprognostic (1.05e-1)"	"unprognostic (3.03e-1)"		"unprognostic (8.25e-4)"	"unprognostic (6.44e-2)"	"unprognostic (1.80e-1)"	"unprognostic (9.41e-2)"	"unprognostic (6.52e-3)"	"unprognostic (1.93e-1)"	"unprognostic (4.28e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.33e-1)"	"unprognostic (2.94e-2)"	0.0	0.0	2.8	0.4	15.8	1.7	0.0	3.4	3.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	7.4	0.7	0.0	0.1	0.9	4.0	2.4	0.0	0.0	0.1	0.1	0.0	2.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.7	0.0	0.2	40.7	0.0	0.0	0.0	1.3	0.0	0.0	0.6	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	1.2	0.0	0.1	0.0	1.2	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.3	0.1	0.0	0.0	0.0	0.2	97.9	0.1	0.3	0.4	0.0	0.3	0.0	0.1	3.3	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.1	2.8	15.8	3.4	3.6	1.1	7.4	4.0	2.4	2.0	1.6	40.7	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.1	0.1	2.0	0.0	0.1	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.6	0.0	0.1	1.8	0.0	0.6	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.8	0.0	6.0	0.0	0.0	1.2	0.0	0.7	0.0	0.6	0.0	0.0	0.5	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0
ANKRD37	Lrp2bp	ENSG00000186352	"Ankyrin repeat domain 37"	Q7Z713	4	185396021-185400628	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"retina: 93.7"	"Cell type enhanced"	"Detected in all"		"Club cells: 257.6;Endometrial ciliated cells: 271.9;Respiratory ciliated cells: 263.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 23.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036626, HPA058127"	Uncertain		Supported	Nucleoplasm,Mitochondria,Cytosol		NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 54: Non-specific - Microtubule organization"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Nucleoplasm, Cytosol"	Mitochondria	"HPA036626: AB_10671963, HPA058127: AB_2683614"	"unprognostic (9.08e-2)"	"unprognostic (2.85e-3)"	"unprognostic (3.89e-2)"	"unprognostic (2.36e-3)"	"unprognostic (1.19e-1)"	"unprognostic (2.27e-1)"	"unprognostic (7.51e-2)"	"unprognostic (9.12e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.09e-1)"	"unprognostic (7.36e-2)"	"unprognostic (9.69e-3)"	"unprognostic (2.81e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.41e-1)"	"unprognostic (6.45e-3)"	"unprognostic (1.08e-1)"	16.9	10.3	30.7	4.3	31.7	3.3	13.4	32.2	58.7	36.6	45.2	11.2	7.8	6.1	3.7	69.5	11.7	6.7	27.4	31.5	31.9	14.3	26.2	9.9	4.1	33.7	32.9	29.1	17.5	1.4	21.8	15.1	32.1	35.2	9.5	93.7	31.2	5.7	30.2	14.9	6.4	4.4	33.9	7.1	9.0	11.2	34.7	5.1	23.9	13.3	7.5	10.8	29.6	32.4	12.6	1.6	1.1	5.4	7.4	4.5	4.9	4.8	3.7	3.7	6.8	2.9	3.4	4.3	2.4	8.4	6.4	4.3	6.5	6.2	4.2	12.4	0.7	2.8	5.8	8.3	3.3	2.4	7.6	1.2	6.4	3.0	3.6	23.8	3.9	2.9	5.0	8.2	9.4	2.6	2.6	12.1	1.7	1.1	8.3	0.5	1.5	13.4	4.5	1.1	7.2	12.9	3.7	4.1	14.4	4.6	4.1	2.3	5.1	6.6	5.0	4.2	5.1	13.3	5.2	2.2	20.9	2.8	6.9	0.5	3.3	8.3	4.1	3.2	3.9	6.8	3.6	6.7	2.0	6.9	2.4	3.4	1.2	3.9	3.3	3.4	4.5	2.5	30.7	31.7	32.2	58.7	31.5	31.9	33.7	32.9	32.1	33.9	34.7	32.4	39.3	22.4	28.7	9.1	104.2	59.4	41.8	197.9	42.7	29.9	66.9	92.3	1.8	11.5	257.6	9.2	29.2	25.0	69.8	93.8	25.4	25.2	6.2	271.9	18.9	44.7	119.9	8.4	8.0	23.3	43.0	28.6	142.2	96.5	61.7	7.7	12.1	25.8	15.4	10.1	7.9	186.6	89.5	8.1	170.2	3.2	9.3	53.3	142.3	12.2	17.7	99.8	1.0	4.0	4.6	32.3	53.3	11.7	223.5	38.5	60.9	31.5	263.3	115.2	6.6	27.3	38.7	32.1	28.4	54.0	48.2	84.4	65.8	7.4	50.8	20.2
ANKS1B	"AIDA-1, ANKS2, cajalin-2, EB-1"	ENSG00000185046	"Ankyrin repeat and sterile alpha motif domain containing 1B"	Q7Z6G8	12	98726457-99984654	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 77.0;skeletal muscle: 34.2"	"Group enriched"	"Detected in many"	6	"Excitatory neurons: 2224.0;Inhibitory neurons: 1545.5;Oligodendrocyte precursor cells: 1318.0;Oligodendrocytes: 1000.1"	"Cancer enhanced"	"Detected in some"		"glioma: 1.6"	"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"AF22: 10.3;ASC TERT1: 5.8;SCLC-21H: 11.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA078230	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Centrosome"		NA	NA			"Cluster 42: Non-specific - Transcription"	"Cluster 47: Non-specific - Unknown function"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Nucleoplasm	"Plasma membrane, Centrosome"	"HPA078230: "	"unprognostic (5.50e-2)"	"unprognostic (3.26e-2)"	"unprognostic (1.01e-2)"	"unprognostic (6.87e-3)"	"unprognostic (1.18e-1)"	"unprognostic (1.14e-4)"	"unprognostic (7.94e-2)"	"unprognostic (2.47e-1)"	"unprognostic (1.84e-2)"	"unprognostic (3.03e-2)"	"unprognostic (4.97e-4)"	"unprognostic (2.81e-1)"	"unprognostic (1.14e-3)"	"unprognostic (1.64e-2)"	"unprognostic (1.15e-2)"	"unprognostic (1.09e-2)"	"unprognostic (3.75e-3)"	1.6	3.6	36.2	0.7	50.4	0.1	2.7	40.2	77.0	2.9	0.0	4.0	0.5	2.3	1.4	2.9	3.6	1.2	1.4	51.8	5.2	4.6	1.1	1.0	0.6	0.0	7.9	8.9	1.1	0.8	10.1	1.8	2.0	3.1	1.0	6.2	3.1	2.7	34.2	1.0	1.1	2.3	0.4	1.1	1.4	7.6	13.8	1.0	5.6	1.8	0.3	2.1	1.7	71.6	0.2	2.2	10.3	2.4	4.0	5.8	0.5	0.0	1.1	0.7	0.8	0.2	0.7	0.8	0.4	1.5	3.1	0.4	0.1	0.0	0.2	1.2	0.7	0.1	0.7	0.0	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.1	0.2	0.0	0.3	0.7	0.1	0.6	0.4	0.5	2.9	0.0	1.9	0.7	0.0	0.2	0.1	0.0	11.1	1.1	0.9	3.2	1.2	0.8	3.7	0.1	0.1	0.9	0.9	0.6	0.6	0.0	0.7	0.5	0.9	0.2	0.9	3.7	0.6	1.1	0.7	1.0	1.1	0.9	1.3	0.7	0.6	0.9	1.0	1.0	1.9	1.5	1.6	1.2	4.3	0.6	36.2	50.4	40.2	77.0	51.8	5.2	0.0	7.9	2.0	0.4	13.8	71.6	0.5	3.2	3.9	228.8	0.8	1.1	1.1	0.2	4.6	32.9	6.3	2.4	2.4	0.0	1.3	9.2	18.8	0.4	0.5	0.0	0.0	0.5	142.2	2.6	0.8	0.8	0.0	0.0	2224.0	0.0	0.3	5.7	1.1	0.9	1.3	0.3	0.4	0.5	0.6	30.3	1545.5	0.0	0.0	0.0	1.9	92.0	1.2	0.4	5.4	84.3	0.2	1.7	1.0	1318.0	1000.1	0.0	1.1	6.0	0.3	0.5	0.0	5.0	3.1	3.4	6.6	12.1	1.8	31.8	3.9	2.6	1.4	0.8	2.1	0.5	0.1	0.6
ANO1	"DOG1, FLJ10261, ORAOV2, TAOS2, TMEM16A"	ENSG00000131620	"Anoctamin 1"	Q5XXA6	11	70078302-70189528	"FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Chloride channel, Developmental protein, Ion channel"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 181.7;salivary gland: 180.5;seminal vesicle: 209.2"	"Cell type enhanced"	"Detected in many"		"Breast myoepithelial cells: 70.2;Early spermatids: 54.9;Hepatocytes: 141.3;Late spermatids: 75.1;Sertoli cells: 46.0;Smooth muscle cells: 52.5;Suprabasal keratinocytes: 46.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"A-431: 140.2;CAPAN-2: 207.9;HaCaT: 254.0;OE19: 182.2"	"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"spinal cord: 6.6"	"HPA032148, HPA057356"	Enhanced		Supported	"Nucleoplasm,Plasma membrane"		NA	NA				"Cluster 30: Epididymis - Antimicrobial activity"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 2: Hepatocytes - Metabolism"	"Plasma membrane"	Nucleoplasm	"HPA032148: AB_2674180, HPA057356: AB_2732610"	"unprognostic (2.73e-1)"	"unprognostic (7.91e-2)"	"unprognostic (3.66e-2)"	"prognostic favorable (4.58e-6)"	"unprognostic (1.90e-1)"	"prognostic unfavorable (7.28e-5)"	"unprognostic (1.16e-3)"	"prognostic unfavorable (2.40e-4)"	"unprognostic (2.13e-2)"	"unprognostic (3.51e-1)"	"prognostic unfavorable (1.70e-4)"	"unprognostic (1.21e-1)"	"prognostic unfavorable (4.09e-6)"	"unprognostic (1.56e-1)"	"unprognostic (1.06e-1)"	"unprognostic (8.85e-3)"	"unprognostic (1.81e-1)"	16.3	2.2	0.3	3.6	1.6	0.1	86.8	0.8	1.3	46.7	0.1	14.3	3.6	40.0	181.7	12.7	59.1	54.4	21.9	0.5	0.1	6.4	108.5	16.1	3.4	1.0	0.2	2.9	9.1	48.0	4.4	5.2	1.1	17.1	11.0	0.9	180.5	209.2	12.7	97.4	4.6	30.1	0.2	1.2	48.3	10.4	0.1	1.5	35.4	33.0	4.0	6.7	12.8	0.5	140.2	5.3	0.3	4.5	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.1	207.9	0.0	2.5	0.0	0.3	254.0	0.0	0.7	0.0	0.4	0.2	0.1	0.1	0.0	0.0	0.3	0.2	0.0	0.1	0.4	0.2	0.0	0.6	0.0	0.0	0.1	0.0	1.0	0.5	0.3	1.1	182.2	19.6	0.3	0.0	0.7	0.0	0.2	7.3	0.2	0.1	43.1	0.8	1.4	16.2	0.5	0.5	0.3	1.1	0.0	3.5	0.1	0.3	0.2	0.2	0.0	14.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.6	0.8	1.3	0.5	0.1	1.0	0.2	1.1	0.2	0.1	0.5	7.2	0.0	0.0	0.7	0.4	17.7	21.5	4.2	0.0	0.0	30.5	70.2	3.5	17.2	2.0	0.0	0.0	1.3	0.2	0.4	0.0	4.1	54.9	10.0	27.5	5.6	0.0	2.7	0.7	0.0	0.6	4.2	36.7	18.5	4.5	0.0	3.3	141.3	0.2	0.0	20.4	13.3	0.0	1.6	3.0	75.1	1.8	0.7	5.4	2.8	0.0	0.8	0.0	1.5	0.7	1.0	0.5	1.5	0.3	22.6	0.0	0.7	0.3	0.4	46.0	1.1	52.5	1.4	2.3	1.4	46.7	4.1	0.7	0.1	0.4	20.9
ANO10	"FLJ10375, MGC47890, SCAR10, TMEM16K"	ENSG00000160746	"Anoctamin 10"	Q9NW15	3	43354859-43691594	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"			"Disease variant, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 123.3;Excitatory neurons: 77.4;Inhibitory neurons: 97.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016624, HPA051569"	Approved		Supported	"Vesicles,Plasma membrane"		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 37: Intestine - Unknown function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Plasma membrane"	Vesicles	"HPA016624: , HPA051569: AB_2681537"	"unprognostic (1.51e-3)"	"unprognostic (1.38e-2)"	"prognostic favorable (6.70e-4)"	"prognostic favorable (1.11e-4)"	"unprognostic (4.23e-1)"	"unprognostic (2.69e-2)"	"prognostic unfavorable (3.19e-4)"	"unprognostic (7.99e-3)"	"unprognostic (1.03e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.33e-1)"	"prognostic favorable (6.41e-6)"	"unprognostic (9.83e-3)"	"unprognostic (1.22e-1)"	"unprognostic (5.19e-3)"	"unprognostic (5.71e-2)"	26.6	14.1	17.6	15.1	18.6	33.0	21.8	23.9	20.9	22.3	18.4	39.4	61.1	21.6	13.6	25.3	13.9	19.4	12.7	18.1	21.1	29.9	14.1	16.9	7.6	22.7	22.9	13.9	15.2	23.7	13.9	18.1	23.2	14.2	33.7	10.1	28.6	20.2	15.5	32.0	54.7	28.0	19.6	9.1	13.5	13.0	19.8	7.1	24.5	11.6	9.7	18.1	21.5	24.1	30.6	23.6	26.1	27.4	101.1	53.5	31.2	87.7	141.1	42.0	54.4	16.2	27.5	3.1	27.4	114.8	43.1	16.3	20.6	47.0	52.6	33.6	14.2	39.4	28.7	17.7	43.9	7.2	31.1	50.5	36.3	53.6	71.8	79.4	100.3	18.7	30.8	24.9	95.2	20.8	7.8	5.2	31.3	23.7	28.6	6.3	18.7	10.2	85.5	31.4	6.4	19.4	34.4	27.0	19.8	45.3	59.5	14.5	84.7	66.2	24.4	70.2	40.7	15.7	22.9	1.1	60.2	14.6	44.2	7.4	19.0	1.4	6.7	11.1	3.8	2.7	4.6	4.5	13.1	2.5	3.9	6.0	32.8	9.7	12.7	2.3	5.4	7.0	17.6	18.6	23.9	20.9	18.1	21.1	22.7	22.9	23.2	19.6	19.8	24.1	24.3	6.4	3.2	70.2	4.1	5.6	5.8	6.9	8.0	8.0	18.2	8.4	5.2	8.6	13.2	14.7	0.0	14.4	3.7	38.5	123.3	21.6	2.9	11.8	23.6	17.8	9.6	11.8	77.4	17.8	19.5	10.6	10.2	31.2	2.5	6.8	23.6	10.7	11.6	10.1	97.9	23.8	10.2	9.6	5.3	5.2	5.6	9.1	14.2	69.3	9.2	17.1	5.2	71.4	46.4	11.7	22.1	10.1	2.6	4.4	58.4	19.0	4.0	3.6	6.6	19.1	15.7	17.1	23.6	8.7	6.1	17.1	5.8	6.2	26.9	4.8
ANO2	"C12orf3, TMEM16B"	ENSG00000047617	"Anoctamin 2"	Q9NQ90	12	5531869-5946232	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Chloride channel, Ion channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	22	"retina: 226.0"	"Cell type enhanced"	"Detected in some"		"Cone photoreceptor cells: 81.3;Early spermatids: 57.3;Late spermatids: 283.2;Microglial cells: 143.4;Rod photoreceptor cells: 179.9"	"Cancer enhanced"	"Detected in some"		"testis cancer: 2.4"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	5	"basophil: 1.8"	"Lineage enriched"	"Detected in single"	19	"granulocytes: 1.8"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 9.6;HUVEC TERT2: 9.5;U-2 OS: 24.1"	"Region enriched"	"Detected in many"	4	"basal ganglia: 19.6"					"HPA036276, HPA057499"	Enhanced		Supported	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 79: Retina - Phototransduction"	"Cluster 9: U-2 OS - Unknown function"	"Cluster 46: Photoreceptor cells - Phototransduction"	"Plasma membrane"	Nucleoplasm	"HPA036276: AB_10670713, HPA057499: AB_2732613"	"unprognostic (6.32e-2)"	"unprognostic (1.01e-1)"	"unprognostic (3.77e-1)"	"unprognostic (1.25e-2)"	"unprognostic (1.55e-1)"	"unprognostic (4.05e-3)"	"unprognostic (2.86e-1)"	"unprognostic (2.62e-1)"	"unprognostic (1.11e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.84e-3)"	"unprognostic (3.78e-3)"	"unprognostic (1.04e-2)"	"unprognostic (1.10e-2)"	"unprognostic (9.93e-2)"	"unprognostic (2.27e-1)"	"unprognostic (2.17e-1)"	8.8	0.3	3.8	0.4	4.4	0.0	6.6	2.2	3.3	4.3	5.0	1.9	0.7	1.8	1.4	1.7	3.2	1.1	8.0	2.5	2.4	1.2	0.2	7.2	0.1	3.2	3.2	1.5	0.9	1.3	0.6	4.1	3.4	2.5	0.6	226.0	1.3	1.0	2.0	1.1	1.7	1.5	3.0	3.4	2.2	10.1	3.9	0.3	2.4	4.4	0.2	2.4	3.5	2.8	2.5	0.0	4.4	0.0	0.0	0.2	2.0	0.0	9.6	0.5	1.0	0.0	0.2	0.2	0.3	0.0	0.1	0.3	0.0	0.1	0.7	0.3	0.1	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	9.5	0.0	0.0	1.9	0.0	1.0	0.0	0.0	4.6	2.3	0.0	1.9	0.0	1.0	0.1	0.1	0.0	0.0	2.3	1.6	0.0	3.9	1.3	0.0	0.2	0.0	24.1	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	3.8	4.4	2.2	3.3	2.5	2.4	3.2	3.2	3.4	3.0	3.9	2.8	9.7	0.0	0.0	4.2	0.0	0.0	0.0	0.0	0.6	11.5	0.3	0.1	1.9	0.0	0.0	0.0	81.3	1.4	0.0	0.0	0.0	0.0	57.3	0.4	0.4	9.1	0.0	0.0	1.7	0.0	2.0	0.3	0.0	0.5	0.0	0.0	4.6	0.0	0.2	10.1	2.0	0.0	0.0	0.0	0.0	283.2	0.3	0.1	0.0	143.4	0.0	13.0	0.0	31.2	9.9	0.0	0.0	1.5	0.0	0.0	0.0	0.1	0.0	179.9	0.0	1.3	0.6	1.4	1.8	0.0	0.1	2.5	0.0	0.2	0.2	0.0
ANO6	"DKFZp313M0720, TMEM16F"	ENSG00000177119	"Anoctamin 6"	Q4KMQ2	12	45215987-45482280	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Lipid transport, Transport"	"Chloride channel, Ion channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038958	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA		47000	"Cluster 14: Monocytes - Unknown function"	"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 32: U-937 - Innate immune response"	"Cluster 2: Hepatocytes - Metabolism"	"Plasma membrane, Cytosol"		"HPA038958: AB_10672835"	"prognostic unfavorable (7.56e-5)"	"prognostic unfavorable (3.82e-4)"	"unprognostic (2.16e-1)"	"unprognostic (1.75e-2)"	"unprognostic (1.29e-1)"	"unprognostic (9.82e-3)"	"unprognostic (7.43e-2)"	"unprognostic (3.01e-3)"	"unprognostic (7.55e-2)"	"unprognostic (2.84e-3)"	"unprognostic (1.41e-3)"	"unprognostic (3.02e-1)"	"unprognostic (2.68e-2)"	"unprognostic (1.26e-3)"	"unprognostic (1.26e-1)"	"unprognostic (4.20e-2)"	"unprognostic (1.28e-1)"	86.4	25.9	7.4	16.8	8.0	9.8	27.5	7.9	8.4	28.9	13.8	29.9	36.2	38.9	25.6	25.0	27.2	31.6	27.7	7.2	10.5	36.2	56.9	40.2	13.4	10.4	8.5	56.6	25.3	58.8	6.9	50.5	10.1	29.9	15.0	3.6	25.4	37.1	56.0	12.0	51.4	48.4	9.0	16.0	13.8	11.8	9.1	24.9	13.2	46.3	12.8	35.0	16.0	9.3	41.5	44.3	25.7	35.4	119.1	61.7	97.4	57.4	72.5	38.4	36.3	71.9	61.5	21.1	52.2	92.0	34.9	54.0	24.1	32.3	45.6	31.4	16.9	25.0	17.8	62.1	37.8	39.5	19.4	51.7	31.9	33.0	48.7	95.4	52.6	44.5	19.3	34.0	42.7	11.2	41.5	13.2	28.6	0.0	18.0	23.4	33.3	24.4	36.9	63.1	11.7	39.9	59.9	36.8	27.9	67.7	43.3	62.8	70.6	41.2	26.1	41.8	29.3	18.3	21.5	25.8	37.3	122.8	33.4	3.1	5.9	1.4	2.4	6.9	2.5	1.4	2.2	2.0	5.5	1.2	2.0	1.3	0.6	2.3	7.1	2.7	3.0	4.2	7.4	8.0	7.9	8.4	7.2	10.5	10.4	8.5	10.1	9.0	9.1	9.3	65.1	60.9	11.8	54.9	10.0	30.5	20.3	27.7	23.3	1.1	23.0	18.7	23.4	30.0	21.5	18.4	0.0	34.0	14.5	2.5	3.9	38.4	1.3	13.3	32.1	37.5	8.4	8.0	49.8	37.4	28.0	44.2	21.4	26.0	12.7	20.2	52.5	88.3	19.9	0.0	49.0	11.5	12.2	56.3	22.9	3.5	51.3	46.0	17.8	68.4	29.1	8.2	15.5	110.6	3.0	73.3	10.0	40.6	12.2	29.5	70.3	23.4	16.5	0.3	39.5	45.9	52.1	3.5	4.3	25.1	22.0	24.6	17.3	6.7	14.6	30.5
ANP32A	"C15orf1, I1PP2A, LANP, MAPM, mapmodulin, PHAPI, PP32"	ENSG00000140350	"Acidic nuclear phosphoprotein 32 family member A"	P39687	15	68778535-68820897	"Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005231, HPA063133, HPA067561"	Supported		Enhanced	Nucleoplasm,Centrosome,Cytosol		NA	NA		770000	"Cluster 52: Eosinophils - Transcription"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Nucleoplasm, Centrosome"	Cytosol	"CAB005231: AB_2289588, HPA063133: AB_2684947, HPA067561: AB_2685861"	"unprognostic (1.41e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.46e-1)"	"unprognostic (3.03e-1)"	"unprognostic (6.96e-2)"	"unprognostic (2.29e-2)"	"unprognostic (1.04e-2)"	"unprognostic (4.44e-2)"	"unprognostic (4.00e-2)"	"unprognostic (3.74e-2)"	"unprognostic (1.20e-1)"	"unprognostic (7.83e-2)"	"unprognostic (4.16e-2)"	"unprognostic (3.24e-2)"	"unprognostic (2.38e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.17e-1)"	50.8	34.7	50.2	87.3	60.5	137.0	71.6	62.3	59.1	54.0	33.3	81.0	70.8	59.1	50.7	65.8	75.1	59.8	127.9	48.8	57.3	75.1	76.4	71.0	156.2	60.0	56.5	57.8	53.7	61.4	27.5	101.5	65.4	75.4	89.0	106.0	54.0	66.8	62.4	36.1	76.9	57.0	62.7	85.5	78.9	20.8	54.3	203.0	73.6	64.5	141.2	76.4	43.6	71.0	196.4	234.7	303.2	263.2	104.2	90.9	200.5	101.0	134.3	193.5	161.8	195.3	358.0	629.8	184.5	114.5	114.2	279.9	709.5	206.6	230.8	286.6	241.2	478.6	192.7	247.8	64.5	380.8	247.4	72.9	143.1	106.3	210.2	126.6	285.9	300.0	354.5	239.1	168.2	136.1	386.1	311.6	270.1	192.5	118.2	531.7	280.7	375.3	170.5	304.5	399.8	247.8	153.7	170.8	282.7	301.1	227.2	491.4	129.0	199.0	313.5	139.3	275.2	143.8	433.9	733.8	132.2	632.1	186.7	12.9	26.4	44.9	16.8	30.6	14.2	18.7	13.8	17.8	30.0	17.9	16.5	14.9	27.2	28.8	27.5	26.8	17.2	16.0	50.2	60.5	62.3	59.1	48.8	57.3	60.0	56.5	65.4	62.7	54.3	71.0	100.2	109.0	118.0	20.2	98.1	64.7	67.7	147.0	91.0	92.2	57.3	70.6	80.0	60.1	105.4	69.9	35.5	258.2	119.7	57.1	107.6	112.5	6.7	61.2	67.7	91.8	78.5	144.2	16.8	96.1	172.4	57.5	69.3	70.1	92.4	63.6	78.1	81.8	194.1	65.6	17.4	92.1	114.0	150.1	112.6	6.3	34.8	111.6	78.2	37.5	158.9	103.7	84.5	15.6	55.4	79.8	57.0	29.7	92.6	59.7	99.3	148.0	113.7	87.2	26.3	49.9	75.1	8.8	18.2	86.4	34.9	232.5	99.5	82.5	94.7	52.0
ANP32B	"APRIL, PHAPI2, SSP29"	ENSG00000136938	"Acidic nuclear phosphoprotein 32 family member B"	Q92688	9	97983341-98015943	"Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction"	Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Erythroid cells: 709.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA063133, HPA067561, HPA069657"	Supported		Enhanced	Nucleoplasm,Centrosome,Cytosol		NA	NA		570000	"Cluster 44: Non-specific - Transcription"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	"Centrosome, Cytosol"	"HPA063133: AB_2684947, HPA067561: AB_2685861, HPA069657: "	"unprognostic (2.82e-1)"	"unprognostic (2.05e-2)"	"unprognostic (4.57e-2)"	"unprognostic (6.74e-2)"	"unprognostic (1.85e-1)"	"unprognostic (5.52e-2)"	"prognostic unfavorable (1.98e-7)"	"unprognostic (6.76e-3)"	"unprognostic (5.70e-2)"	"unprognostic (7.16e-2)"	"unprognostic (3.50e-1)"	"unprognostic (6.39e-2)"	"unprognostic (9.22e-3)"	"unprognostic (5.20e-2)"	"unprognostic (2.36e-1)"	"unprognostic (3.67e-2)"	"unprognostic (1.78e-2)"	144.0	77.1	134.8	124.0	155.9	365.7	138.6	134.0	187.6	161.6	112.0	145.5	95.1	116.2	104.7	140.9	127.2	60.4	92.3	113.7	150.0	100.2	103.5	122.4	222.6	171.4	149.8	168.5	156.4	68.7	68.1	110.5	158.5	98.6	118.7	46.2	110.6	71.4	109.6	148.0	127.3	78.0	155.6	123.8	131.9	59.6	142.6	271.5	96.9	50.6	248.4	132.5	146.6	173.4	659.7	347.4	378.6	318.4	208.1	365.2	344.4	332.6	292.4	349.2	291.9	438.3	313.1	798.2	194.2	224.6	266.3	423.9	516.1	375.2	397.1	523.0	290.9	692.4	289.1	478.4	266.9	1201.9	386.8	278.7	268.8	280.9	574.0	283.2	307.9	701.5	1359.2	548.8	272.6	875.7	913.5	1062.0	148.2	638.8	341.2	537.8	589.5	381.7	228.8	269.9	304.2	265.8	390.4	376.2	364.5	185.3	213.2	444.0	377.0	226.5	367.3	288.3	355.5	493.2	601.3	469.1	209.7	472.7	432.1	91.3	83.6	118.8	65.2	95.5	89.3	106.1	122.5	92.8	100.5	93.0	143.8	112.1	34.2	74.1	149.7	96.4	162.5	85.3	134.8	155.9	134.0	187.6	113.7	150.0	171.4	149.8	158.5	155.6	142.6	173.4	127.9	86.6	101.8	7.8	227.7	180.7	201.3	180.0	208.9	61.1	100.4	126.0	85.8	112.9	120.7	75.4	25.0	345.5	159.5	159.1	97.8	144.9	114.9	73.8	176.3	146.9	149.9	709.4	5.8	171.6	537.9	121.9	123.3	117.5	119.7	247.9	159.5	96.6	284.7	119.5	6.2	242.2	75.3	310.6	152.0	95.2	146.3	222.5	128.1	14.0	263.5	68.9	149.3	8.0	18.8	137.1	151.1	145.2	266.5	260.6	177.7	101.9	56.3	42.1	151.2	113.4	189.4	204.3	339.0	243.0	154.1	333.1	217.6	188.9	302.7	234.1
ANP32D	PP32R2	ENSG00000139223	"Acidic nuclear phosphoprotein 32 family member D"	O95626	12	48472559-48473622	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 1.6;Smooth muscle cells: 1.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA063133, HPA067561"	Uncertain		Enhanced	Nucleoplasm,Centrosome,Cytosol		NA	NA						"Cluster 10: Non-specific - Unknown function"	"Nucleoplasm, Centrosome"	Cytosol	"HPA063133: AB_2684947, HPA067561: AB_2685861"		"unprognostic (2.20e-1)"	"unprognostic (3.75e-1)"	"unprognostic (3.18e-1)"	"unprognostic (3.23e-2)"	"unprognostic (5.11e-2)"		"unprognostic (1.72e-3)"		"unprognostic (2.30e-2)"		"unprognostic (3.62e-3)"		"unprognostic (2.76e-2)"		"unprognostic (3.48e-1)"		0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.1	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.0	0.0	0.0	0.2	1.0	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.1
ANP32E	"LANP-L, LANPL, MGC5350"	ENSG00000143401	"Acidic nuclear phosphoprotein 32 family member E"	Q9BTT0	1	150218417-150236156	"Predicted intracellular proteins"		"Chaperone, Chromatin regulator"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Erythroid cells: 222.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB021114, HPA063133, HPA067561"	Supported		Enhanced	Nucleoplasm,Centrosome,Cytosol		NA	NA		280000	"Cluster 44: Non-specific - Transcription"	"Cluster 20: Retina & Lymphoid tissues - Unknown function"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 12: Non-specific - Cell cycle regulation"	"Nucleoplasm, Centrosome"	Cytosol	"CAB021114: AB_10057407, HPA063133: AB_2684947, HPA067561: AB_2685861"	"unprognostic (1.04e-1)"	"unprognostic (2.40e-1)"	"unprognostic (2.51e-1)"	"unprognostic (8.95e-2)"	"unprognostic (1.69e-2)"	"unprognostic (1.47e-3)"	"prognostic unfavorable (4.50e-5)"	"unprognostic (1.64e-1)"	"unprognostic (6.58e-2)"	"unprognostic (3.91e-2)"	"unprognostic (7.73e-3)"	"unprognostic (2.47e-1)"	"prognostic unfavorable (3.82e-8)"	"unprognostic (1.76e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.77e-1)"	"unprognostic (3.52e-1)"	20.0	30.4	36.1	38.9	37.8	75.7	18.1	54.9	45.0	20.5	30.4	19.9	22.5	26.3	34.4	18.7	21.2	20.2	35.1	32.8	39.9	30.8	29.0	23.0	71.0	43.5	41.5	23.3	8.9	33.1	16.4	21.6	40.5	16.2	18.2	98.6	12.9	24.5	49.8	21.6	25.7	21.0	39.7	33.1	17.3	10.3	40.7	88.2	30.5	26.0	62.2	21.8	16.2	35.6	224.0	141.7	289.7	144.0	22.3	32.7	109.8	117.7	66.6	111.8	106.0	105.6	154.0	405.1	101.8	68.3	66.3	76.6	164.9	73.6	158.4	466.1	101.3	280.7	175.6	153.2	21.1	572.0	136.6	26.8	11.9	104.1	95.4	54.8	84.6	193.3	274.8	231.2	103.6	232.3	231.5	148.3	292.5	72.9	64.8	245.4	161.2	214.1	80.2	88.8	94.5	161.2	245.4	39.6	70.7	127.5	105.3	287.7	87.4	56.7	158.4	59.1	239.1	297.6	325.6	388.7	64.5	403.6	105.5	56.6	20.8	35.9	35.0	15.6	53.2	54.5	46.4	38.5	17.4	39.5	32.6	40.7	14.7	31.5	20.3	12.2	56.2	36.5	36.1	37.8	54.9	45.0	32.8	39.9	43.5	41.5	40.5	39.7	40.7	35.6	48.7	12.8	84.0	16.3	88.9	97.3	37.6	36.8	40.5	117.5	33.8	37.7	99.9	24.3	32.8	73.5	33.3	58.4	98.2	12.1	86.1	36.4	1.4	52.5	64.0	52.3	14.4	222.5	7.9	26.5	133.1	57.6	20.9	41.9	63.3	28.4	39.7	59.0	52.3	63.9	9.9	19.9	28.5	48.0	108.9	1.9	30.4	54.3	67.6	6.5	57.0	134.3	60.8	3.0	6.6	27.0	14.2	33.4	116.3	21.6	20.4	58.6	59.6	135.1	26.3	56.8	75.1	12.4	22.7	55.2	98.5	40.6	108.9	27.9	37.8	25.8
ANPEP	"CD13, gp150, LAP1, p150, PEPN"	ENSG00000166825	"Alanyl aminopeptidase, membrane"	P15144	15	89784895-89815401	"CD markers, Enzymes, Metabolic proteins, Plasma proteins, Predicted membrane proteins"	"Angiogenesis, Differentiation, Host-virus interaction"	"Aminopeptidase, Developmental protein, Host cell receptor for virus entry, Hydrolase, Metalloprotease, Protease, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"intestine: 2384.1;pancreas: 675.0"	"Cell type enriched"	"Detected in many"	14	"Proximal enterocytes: 6315.2"	"Low cancer specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"cerebral cortex: 9.2;thalamus: 17.4"	"Immune cell enriched"	"Detected in many"	4	"neutrophil: 227.1"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 227.1"	"Cell line enhanced"	"Detected in many"		"ASC diff: 613.7;ASC TERT1: 764.2;BJ: 738.4;BJ hTERT+: 1135.6;fHDF/TERT166: 703.8;HMC-1: 660.3;HSkMC: 670.0;HUVEC TERT2: 874.8;TIME: 815.1;U-2197: 891.4"	"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in many"	5	"spinal cord: 14.8"	"CAB002417, HPA004625"	Enhanced		Supported	"Plasma membrane"		NA	NA		1200000000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 56: Intestine - Transmembrane transport"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 45: Enterocytes - Digestion"	"Plasma membrane"		"CAB002417: AB_563491, HPA004625: AB_2667199"	"unprognostic (6.31e-2)"	"unprognostic (7.94e-3)"	"unprognostic (6.91e-2)"	"unprognostic (2.16e-1)"	"unprognostic (2.50e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.23e-2)"	"unprognostic (1.89e-1)"	"unprognostic (2.50e-1)"	"unprognostic (7.73e-2)"	"unprognostic (5.28e-3)"	"unprognostic (3.96e-1)"	"unprognostic (4.04e-3)"	"unprognostic (3.20e-2)"	"unprognostic (2.01e-2)"	"unprognostic (4.61e-3)"	"unprognostic (1.99e-2)"	55.4	7.0	1.6	36.6	1.6	103.4	55.9	1.3	9.2	41.4	3.4	266.8	2384.1	3.6	1.7	4.8	8.0	120.3	6.9	1.3	1.5	249.7	271.8	34.3	12.8	1.5	2.1	1.9	675.0	0.8	1.9	33.1	2.5	94.0	59.9	0.0	42.1	5.5	2.5	32.5	1970.6	29.7	1.3	25.9	8.0	2.0	17.4	7.1	8.2	3.8	4.7	16.8	15.0	1.2	0.1	45.6	0.0	0.5	613.7	764.2	6.2	738.4	1135.6	95.3	81.6	5.8	0.4	0.2	8.4	703.8	0.0	0.6	5.6	0.2	38.6	0.1	0.1	137.3	4.6	122.8	352.0	11.4	660.3	670.0	1.4	302.3	0.3	4.4	874.8	0.0	3.8	0.8	37.8	0.1	0.6	355.4	1.9	0.0	49.9	0.3	0.1	9.5	449.2	0.0	1.2	7.2	0.1	1.3	0.1	1.8	0.5	72.1	815.1	385.3	0.6	891.4	0.1	0.4	0.1	0.1	0.9	0.9	20.5	22.2	56.3	41.1	0.1	27.4	0.0	0.2	0.0	0.0	26.2	0.2	0.0	0.0	227.1	0.0	49.7	0.7	0.0	25.7	1.6	1.6	1.3	9.2	1.3	1.5	1.5	2.1	2.5	1.3	17.4	1.2	2.4	0.0	3.0	0.0	5.2	9.9	2.8	1.4	0.6	0.0	35.7	12.8	1.2	391.7	19.7	20.2	0.0	13.0	0.7	429.8	43.0	15.4	0.2	0.5	10.1	8.4	3.0	6.6	0.3	386.2	16.3	31.0	0.0	0.4	24.1	0.3	79.2	192.4	37.5	0.0	0.3	199.6	2.0	54.1	63.2	0.2	2.8	71.9	3.6	0.0	38.3	0.0	0.0	0.0	0.1	75.5	316.9	1.5	2.1	20.9	6315.2	435.0	3.3	0.0	26.3	0.8	8.1	0.3	0.5	0.2	5.8	6.4	3.7	187.8	290.9	1.4
ANXA1	"ANX1, LPC1"	ENSG00000135046	"Annexin A1"	P04083	9	73151865-73170393	"Cancer-related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins, Transporters"	"Adaptive immunity, Immunity, Inflammatory response, Innate immunity"	"Phospholipase A2 inhibitor"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 7527.7"	"Cell type enhanced"	"Detected in many"		"Squamous epithelial cells: 3632.9;Syncytiotrophoblasts: 7071.8;Urothelial cells: 4808.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 2816.9"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011271, HPA011272, CAB013023, CAB035987, CAB058693"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cytosol"	"Secreted to blood"	NA	Yes		3000000000	"Cluster 2: Granulocytes - Unknown function"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 22: Epithelial cell types - Mixed function"	"Plasma membrane, Cytosol"	Nucleoplasm	"CAB013023: AB_2533983, CAB035987: , CAB058693: AB_2665585, HPA011271: AB_1844883, HPA011272: AB_1844884"	"unprognostic (2.53e-2)"	"unprognostic (1.31e-1)"	"unprognostic (9.08e-2)"	"prognostic favorable (5.71e-5)"	"unprognostic (1.53e-2)"	"unprognostic (4.28e-2)"	"unprognostic (1.82e-2)"	"unprognostic (1.30e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.14e-1)"	"unprognostic (2.54e-3)"	"unprognostic (1.47e-1)"	"unprognostic (9.82e-3)"	"unprognostic (1.13e-1)"	"unprognostic (8.55e-2)"	"prognostic favorable (4.57e-5)"	"prognostic unfavorable (6.19e-6)"	719.8	60.3	27.5	268.3	35.1	2132.2	442.6	24.8	44.4	952.0	32.8	152.7	64.1	116.2	58.6	7527.7	264.6	329.4	145.3	28.4	53.4	67.9	54.7	470.4	67.9	55.5	46.4	109.4	61.8	28.2	98.1	559.4	36.5	165.3	103.2	6.5	1547.5	154.9	47.6	213.8	88.7	261.5	40.4	79.6	90.2	17.9	45.9	109.9	206.8	89.1	1485.5	386.3	1536.1	43.2	960.2	1485.7	65.8	68.4	905.8	855.6	4.2	1614.6	1008.5	656.3	441.9	43.5	841.0	2.2	520.1	1426.5	1441.9	1147.7	142.6	984.1	516.8	541.6	10.3	73.2	398.5	1.4	719.4	160.9	34.7	495.7	800.6	664.7	1294.6	604.0	947.8	85.4	309.3	39.5	822.6	4.3	287.0	87.7	82.6	379.7	597.6	0.9	369.1	3.2	1495.9	200.4	1.0	0.7	556.6	14.7	377.9	862.7	3.5	24.3	1176.2	761.8	478.9	1058.2	845.1	6.8	2.0	3.6	1757.9	147.8	1171.2	2816.9	1237.6	2227.6	744.1	328.7	757.0	13.7	662.7	664.5	1513.3	3.3	190.7	348.5	128.4	443.6	324.0	53.2	134.5	2021.5	27.5	35.1	24.8	44.4	28.4	53.4	55.5	46.4	36.5	40.4	45.9	43.2	447.4	583.3	415.2	1.6	39.0	846.7	2486.8	2417.6	1748.3	0.1	225.0	417.1	22.5	58.6	2214.7	62.5	0.0	1543.4	602.1	32.2	0.0	167.4	8.2	2037.4	241.6	362.2	5.3	81.2	3.7	23.1	1747.7	732.0	86.6	1993.5	2550.6	0.1	136.7	6.5	593.8	0.0	0.1	20.8	1330.6	545.0	1190.3	7.3	222.4	901.7	307.7	29.0	575.0	0.2	319.3	0.5	0.6	733.2	5.5	9.4	140.4	1552.2	0.1	5.7	1996.9	0.0	65.7	728.2	413.3	2.3	4.0	3632.9	597.7	7071.8	1348.3	3.0	12.6	4808.1
ANXA11	ANX11	ENSG00000122359	"Annexin A11"	P50995	10	80150889-80205572	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Cell cycle, Cell division"		"Amyotrophic lateral sclerosis, Cancer-related genes, Disease variant, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"eosinophil: 443.8"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004851, HPA027545"	Supported		Supported	Nucleoplasm,Cytosol		NA	NA		210000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm	Cytosol	"CAB004851: AB_626682, HPA027545: AB_1844851"	"unprognostic (1.85e-2)"	"unprognostic (2.85e-2)"	"unprognostic (5.35e-3)"	"unprognostic (5.06e-2)"	"unprognostic (8.18e-3)"	"unprognostic (1.99e-1)"	"unprognostic (4.01e-3)"	"unprognostic (6.28e-2)"	"unprognostic (2.32e-2)"	"unprognostic (4.88e-2)"	"unprognostic (3.46e-2)"	"unprognostic (2.56e-2)"	"prognostic favorable (6.69e-8)"	"unprognostic (2.69e-3)"	"unprognostic (1.84e-1)"	"unprognostic (6.79e-2)"	"unprognostic (2.02e-1)"	139.9	29.5	39.0	99.4	40.6	192.9	107.6	27.5	46.8	86.6	52.8	130.3	138.0	74.3	107.5	210.2	109.0	84.8	236.2	47.3	29.0	144.7	47.7	109.5	81.2	26.4	26.6	78.2	95.4	81.8	27.2	91.1	23.9	100.3	120.7	4.8	94.1	81.8	188.9	75.6	137.2	86.0	25.4	76.2	139.3	24.5	24.6	100.2	61.4	166.2	101.7	148.1	102.8	30.4	221.7	195.7	10.4	53.9	220.2	201.1	119.6	149.5	397.3	95.7	98.8	168.7	338.2	13.1	113.6	236.7	8.1	277.7	44.6	136.2	54.2	384.3	76.0	84.4	98.9	131.5	129.4	92.0	212.3	222.9	74.6	57.8	39.4	178.9	143.9	117.9	82.1	163.7	76.8	127.3	119.8	200.9	19.6	211.5	367.7	91.7	14.9	344.0	155.1	191.8	5.1	37.9	65.0	269.9	156.4	83.4	80.6	120.6	160.0	68.7	101.4	157.6	84.4	91.7	145.6	96.0	66.6	155.4	47.4	130.8	66.8	443.8	72.9	52.4	75.0	64.9	92.5	100.5	49.4	54.2	83.7	74.4	231.8	61.3	59.1	78.5	126.5	85.4	39.0	40.6	27.5	46.8	47.3	29.0	26.4	26.6	23.9	25.4	24.6	30.4	150.5	96.1	78.4	17.3	101.4	51.2	266.4	219.4	92.8	1.6	58.8	50.4	293.3	203.0	227.1	220.7	0.0	271.7	137.1	457.7	332.6	429.2	4.5	180.6	49.7	82.7	77.5	29.9	29.5	352.5	309.8	113.1	175.8	265.7	116.1	81.4	91.4	40.8	228.1	3.3	15.5	186.9	97.6	149.7	167.4	9.6	92.9	155.0	90.7	24.4	208.2	38.9	159.6	3.0	2.3	420.6	461.0	92.6	98.2	414.9	367.7	156.8	229.0	2.8	92.1	56.4	137.9	2.8	51.5	98.4	42.1	185.5	131.9	50.8	227.8	581.4
ANXA13	ANX13	ENSG00000104537	"Annexin A13"	P27216	8	123680794-123737402	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 144.3;intestine: 293.6"	"Cell type enhanced"	"Detected in some"		"Cholangiocytes: 180.1;Enteroendocrine cells: 44.9;Intestinal goblet cells: 161.1;Paneth cells: 58.1;Proximal enterocytes: 125.2;Undifferentiated cells: 38.5"	"Group enriched"	"Detected in many"	13	"colorectal cancer: 7.8;liver cancer: 8.5;pancreatic cancer: 6.1;renal cancer: 7.0;stomach cancer: 7.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"A549: 27.8;HDLM-2: 14.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA018535, HPA019569, HPA019650, CAB025135"	Enhanced		Supported	"Nucleoplasm,Plasma membrane"		NA	NA				"Cluster 56: Intestine - Transmembrane transport"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 27: Mucus-secreting cells - Mucin production"	"Plasma membrane"	Nucleoplasm	"CAB025135: , HPA018535: AB_1844854, HPA019569: AB_1844855, HPA019650: AB_1844856"	"unprognostic (6.47e-3)"	"unprognostic (1.95e-1)"	"unprognostic (3.50e-2)"	"unprognostic (1.83e-1)"	"unprognostic (5.66e-2)"	"unprognostic (4.05e-2)"	"unprognostic (5.48e-2)"	"unprognostic (2.86e-3)"	"unprognostic (2.06e-1)"	"unprognostic (9.11e-2)"	"unprognostic (2.48e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.57e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.03e-1)"	"unprognostic (5.79e-2)"	"unprognostic (4.79e-2)"	0.2	0.0	1.1	1.6	2.6	0.0	0.4	2.6	2.2	0.4	1.1	21.6	293.6	1.5	2.2	0.2	58.4	144.3	0.1	1.1	1.5	7.0	20.2	0.2	0.2	4.1	2.9	0.4	0.4	0.0	0.0	0.0	3.3	0.5	36.1	4.3	0.1	24.3	0.0	0.1	219.5	2.9	3.3	0.0	0.8	4.2	2.1	0.1	0.0	0.0	0.0	0.5	0.1	5.3	0.0	27.8	0.0	0.0	0.0	0.1	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	14.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	3.0	0.0	0.0	0.0	1.7	1.6	0.0	0.1	0.9	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	2.6	2.6	2.2	1.1	1.5	4.1	2.9	3.3	3.3	2.1	5.3	0.0	0.0	0.0	0.0	0.0	1.0	0.1	0.1	0.0	0.2	0.1	1.1	0.4	180.1	0.0	0.0	0.0	0.0	0.0	6.2	3.9	1.4	1.1	4.5	3.6	0.2	44.9	2.7	0.9	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	1.1	0.2	0.0	1.0	161.1	0.0	0.0	0.0	1.4	1.2	0.3	0.0	0.0	0.0	0.3	0.0	0.5	1.2	0.1	58.1	0.0	0.0	0.0	125.2	27.6	2.9	10.9	0.0	0.2	0.1	0.0	0.1	0.0	0.6	0.0	0.4	0.1	38.5	0.1
ANXA3	ANX3	ENSG00000138772	"Annexin A3"	P12429	4	78551747-78610451	"FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Phospholipase A2 inhibitor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 337.7"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 322.7;Alveolar cells type 1: 589.7;Ductal cells: 434.5;Exocrine glandular cells: 305.3;Pancreatic endocrine cells: 754.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	320	"neutrophil: 207.7"	"Lineage enriched"	"Detected in single"	327	"granulocytes: 207.7"	"Cell line enhanced"	"Detected in many"		"A-431: 419.5;CACO-2: 403.5;CAPAN-2: 563.7;EFO-21: 334.7;hTERT-HME1: 566.3;OE19: 502.1;RPTEC TERT1: 477.8"	"Low region specificity"	"Detected in all"							"HPA013398, HPA013431"	Enhanced		Supported	"Plasma membrane"		NA	NA		6400000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	"Plasma membrane"		"HPA013398: AB_1844861, HPA013431: AB_1844862"	"unprognostic (2.66e-1)"	"unprognostic (5.65e-3)"	"unprognostic (4.92e-3)"	"unprognostic (8.67e-2)"	"unprognostic (2.41e-1)"	"unprognostic (5.02e-3)"	"unprognostic (4.17e-2)"	"unprognostic (1.87e-1)"	"unprognostic (5.09e-2)"	"unprognostic (2.10e-3)"	"prognostic unfavorable (1.28e-4)"	"unprognostic (4.82e-2)"	"prognostic favorable (8.48e-6)"	"unprognostic (2.23e-1)"	"unprognostic (2.02e-2)"	"unprognostic (7.20e-2)"	"unprognostic (3.30e-2)"	52.9	3.1	16.5	22.7	17.3	337.7	43.8	14.5	28.2	19.6	11.7	27.7	15.8	12.5	3.7	55.2	16.8	17.3	51.2	14.2	21.6	24.9	3.9	144.4	2.4	19.9	16.1	2.5	32.7	34.0	5.9	81.5	20.8	68.0	26.7	1.6	119.5	12.9	28.3	10.0	13.3	20.1	14.6	21.6	90.5	1.9	19.9	7.1	83.7	36.7	12.7	10.2	15.6	14.7	419.5	77.7	1.3	0.9	1.0	0.9	0.6	4.9	0.4	11.0	10.9	403.5	563.7	0.1	334.7	14.4	0.4	161.6	0.1	300.0	16.0	1.4	3.3	36.4	142.0	23.9	45.9	5.9	0.2	2.4	262.6	4.1	566.3	60.1	118.9	9.0	0.7	0.3	1.9	15.9	1.7	0.2	13.0	502.1	55.4	0.0	0.8	0.0	477.8	45.2	0.3	0.3	235.5	58.2	16.6	186.1	9.9	4.3	153.2	0.6	52.6	0.2	93.0	3.1	5.1	2.2	0.0	0.4	0.1	0.6	0.2	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.4	0.1	0.0	207.7	0.1	0.6	0.1	0.0	2.9	16.5	17.3	14.5	28.2	14.2	21.6	19.9	16.1	20.8	14.6	19.9	14.7	322.7	589.7	47.3	0.0	1.1	24.9	81.8	144.9	1.8	0.2	27.6	85.9	8.6	55.8	175.2	38.6	0.0	212.6	1.0	35.4	17.6	434.5	1.1	33.7	4.4	84.6	5.4	3.2	0.9	305.3	106.2	16.9	99.9	58.1	5.1	0.1	23.2	0.6	18.9	0.0	0.3	33.4	122.1	0.3	0.3	0.3	3.1	6.9	5.4	42.2	21.0	1.2	0.0	1.0	0.6	754.2	61.6	0.4	0.6	158.6	11.5	5.5	89.6	0.4	0.0	7.6	18.7	1.1	0.6	21.9	6.7	62.8	2.3	1.3	29.7	46.7
AP1AR	"2C18, C4orf16, gamma-BAR, PRO0971"	ENSG00000138660	"Adaptor related protein complex 1 associated regulatory protein"	Q63HQ0	4	112231740-112273110	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 91.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035863, HPA058115"	Approved		Supported	"Golgi apparatus"		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 29: Early spermatids - Spermatogenesis"	"Golgi apparatus"		"HPA035863: AB_10672098, HPA058115: AB_2683610"	"unprognostic (1.11e-1)"	"unprognostic (1.99e-1)"	"unprognostic (2.49e-3)"	"unprognostic (9.14e-2)"	"unprognostic (2.19e-1)"	"unprognostic (9.16e-2)"	"unprognostic (1.86e-2)"	"unprognostic (2.78e-3)"	"unprognostic (1.00e-1)"	"unprognostic (2.45e-1)"	"unprognostic (2.69e-2)"	"unprognostic (6.15e-2)"	"prognostic favorable (4.05e-7)"	"unprognostic (2.50e-2)"	"unprognostic (1.36e-1)"	"unprognostic (2.10e-3)"	"prognostic favorable (7.79e-4)"	9.0	15.7	6.4	12.6	7.6	3.7	16.9	9.4	9.7	8.4	5.7	18.0	22.2	11.3	8.2	13.3	6.5	12.8	7.9	8.7	8.4	22.1	20.5	9.1	12.1	6.2	7.2	11.6	8.3	40.9	4.8	12.0	6.5	9.0	16.3	7.6	12.1	10.0	7.4	14.2	23.8	9.8	5.9	13.2	13.0	14.5	7.6	10.9	10.8	7.5	12.1	13.0	9.9	7.9	20.7	10.1	24.5	23.8	20.7	15.2	22.3	18.9	45.9	13.6	16.2	10.0	39.0	46.0	15.3	12.7	16.2	9.2	24.4	14.5	23.2	53.1	13.3	15.5	13.6	32.8	31.9	38.0	23.9	16.9	32.3	11.9	33.7	11.1	21.2	24.2	16.7	38.5	13.5	19.6	34.7	23.5	18.2	47.0	10.8	30.0	26.2	23.5	26.4	14.5	24.5	32.1	12.7	45.2	34.5	12.2	14.9	12.8	19.0	18.1	23.1	27.4	15.2	34.5	68.0	56.2	19.0	14.4	16.3	6.7	7.4	2.6	4.0	10.0	5.6	6.8	6.3	6.4	9.5	5.9	8.5	8.9	1.1	9.0	8.4	4.4	7.5	5.2	6.4	7.6	9.4	9.7	8.7	8.4	6.2	7.2	6.5	5.9	7.6	7.9	21.3	9.6	19.5	9.4	12.9	21.0	8.9	7.0	22.2	8.9	34.2	22.7	20.5	17.2	14.9	16.5	2.1	5.5	14.5	38.4	11.7	9.8	91.7	21.3	17.2	17.7	31.7	6.3	24.8	10.1	3.8	15.2	18.3	29.5	6.3	8.2	9.3	27.3	15.7	10.1	20.6	16.0	6.1	20.1	16.5	59.9	4.7	17.4	23.2	15.0	12.0	12.3	1.0	13.6	16.3	12.7	24.0	10.1	6.8	13.1	24.9	28.6	16.0	8.0	0.0	16.0	20.4	9.6	12.2	28.2	31.3	3.1	12.5	15.2	20.8	14.7
AP1B1	"ADTB1, AP105A, BAM22, CLAPB2"	ENSG00000100280	"Adaptor related protein complex 1 subunit beta 1"	Q10567	22	29327680-29388583	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Protein transport, Transport"		"Deafness, Disease variant, Ichthyosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Hofbauer cells: 138.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA065226, HPA068520"	Approved		Supported	"Golgi apparatus,Vesicles,Cytosol"		NA	NA		660000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 15: RT4 - Unknown function"	"Cluster 4: Macrophages - Innate immune response"	"Golgi apparatus"	"Vesicles, Cytosol"	"HPA065226: AB_2685438, HPA068520: AB_2685998"	"unprognostic (1.78e-1)"	"prognostic favorable (4.81e-4)"	"unprognostic (2.40e-1)"	"unprognostic (2.21e-2)"	"unprognostic (2.37e-1)"	"unprognostic (1.03e-1)"	"prognostic unfavorable (5.55e-5)"	"unprognostic (4.99e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.27e-1)"	"unprognostic (4.98e-3)"	"unprognostic (1.60e-1)"	"prognostic favorable (7.24e-6)"	"unprognostic (1.85e-2)"	"unprognostic (3.78e-2)"	"unprognostic (2.94e-2)"	"unprognostic (3.76e-2)"	30.7	46.7	38.0	47.2	38.3	45.8	26.4	37.3	45.2	22.8	35.6	34.9	43.3	22.7	12.1	63.0	23.5	30.4	23.9	36.1	40.8	34.8	34.8	30.1	57.8	44.2	44.6	17.5	38.3	67.0	39.2	44.8	43.7	38.3	30.1	35.3	40.3	25.9	24.5	47.2	45.6	27.1	41.4	52.6	40.9	24.7	52.7	34.2	29.6	20.5	54.4	39.4	32.2	48.8	84.6	47.5	49.3	50.2	37.0	27.0	60.0	59.8	65.5	71.2	68.2	74.4	33.2	46.1	37.2	68.4	33.0	74.6	71.5	97.6	45.2	58.2	102.0	79.1	60.8	42.0	38.9	114.1	99.9	38.6	36.0	67.5	55.0	33.0	98.7	17.2	54.6	54.9	48.3	93.7	45.5	36.8	37.3	124.8	53.3	89.0	54.3	119.9	50.2	194.5	75.9	52.2	74.0	82.5	36.4	33.5	66.7	49.5	84.6	79.1	48.8	46.0	62.1	60.4	32.5	84.6	56.1	48.1	46.7	0.0	29.3	5.7	9.2	29.2	9.1	16.2	6.3	7.9	28.7	18.2	4.9	5.2	3.0	7.2	31.7	9.0	8.8	24.2	38.0	38.3	37.3	45.2	36.1	40.8	44.2	44.6	43.7	41.4	52.7	48.8	17.8	12.8	16.4	27.7	53.0	7.1	9.3	16.7	16.5	26.3	26.2	20.8	16.1	21.5	16.4	22.0	39.6	52.3	15.1	69.6	23.5	41.2	7.5	16.4	11.6	19.8	21.6	40.0	24.1	40.7	30.1	12.1	33.6	30.1	5.1	13.2	35.3	34.3	138.9	45.4	25.6	24.9	18.3	95.5	24.2	13.1	11.8	65.7	12.4	51.5	29.8	28.4	9.2	16.1	14.0	65.9	33.2	12.4	28.5	17.5	51.2	30.1	14.5	42.1	6.6	17.8	12.7	23.5	17.6	33.0	9.1	68.3	17.0	39.6	36.2	18.1
AP1M2	"AP1-mu2, HSMU1B, mu2"	ENSG00000129354	"Adaptor related protein complex 1 subunit mu 2"	Q9Y6Q5	19	10572671-10587315	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Proximal enterocytes: 162.0;Proximal tubular cells: 373.6"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in some"		"basophil: 4.3;neutrophil: 7.6"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 7.6"	"Cell line enhanced"	"Detected in many"		"CACO-2: 172.8;Hep G2: 313.8;MCF7: 268.3;OE19: 156.7;RT4: 164.9;U-2 OS: 166.7"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			HPA054999			Supported	Vesicles		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Vesicles		"HPA054999: AB_2682666"	"unprognostic (8.31e-2)"	"unprognostic (2.38e-1)"	"unprognostic (1.87e-1)"	"prognostic favorable (2.07e-4)"	"unprognostic (2.07e-1)"	"unprognostic (7.76e-2)"	"unprognostic (2.11e-3)"	"unprognostic (4.83e-2)"	"unprognostic (1.93e-1)"	"unprognostic (2.49e-2)"	"unprognostic (2.65e-1)"	"unprognostic (2.23e-2)"	"prognostic favorable (3.73e-6)"	"unprognostic (1.80e-2)"	"unprognostic (8.10e-2)"	"unprognostic (2.05e-2)"	"unprognostic (1.06e-1)"	3.4	0.1	0.8	6.4	0.3	0.9	32.9	0.6	0.8	27.1	0.3	67.1	64.0	6.6	61.8	51.9	46.6	22.7	0.4	0.5	0.4	76.3	1.5	19.2	0.4	0.7	0.6	0.3	55.9	62.4	34.8	16.2	0.4	30.8	63.4	0.1	41.5	24.0	0.3	42.1	54.8	3.0	0.3	0.6	59.1	9.6	0.7	4.2	58.8	0.3	9.5	23.4	19.1	0.6	144.2	71.1	0.4	10.4	0.0	0.0	65.0	0.2	0.0	2.3	1.6	172.8	82.1	0.4	64.7	1.2	43.4	97.6	0.1	109.0	3.2	0.6	1.0	6.7	48.5	313.8	1.3	0.3	0.8	0.2	81.6	3.9	0.1	5.0	0.0	0.4	0.3	0.6	1.2	268.3	0.6	1.8	31.4	156.7	0.0	2.4	9.3	0.7	2.7	164.9	67.3	0.2	0.0	120.0	0.6	34.6	123.3	0.4	0.0	0.4	166.7	0.9	2.2	0.4	0.9	1.4	0.2	0.4	0.2	4.3	0.4	2.7	0.0	0.5	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	7.6	0.0	1.4	0.2	0.0	2.7	0.8	0.3	0.6	0.8	0.5	0.4	0.7	0.6	0.4	0.3	0.7	0.6	0.4	28.9	34.8	0.0	1.9	6.9	19.2	68.9	13.1	0.0	49.3	30.0	0.5	47.1	64.2	86.5	0.0	123.0	0.5	112.2	137.0	141.3	43.4	52.4	5.4	1.7	74.4	0.0	0.3	115.8	101.0	1.5	73.4	57.7	2.5	0.0	0.7	0.0	9.8	0.0	0.2	95.5	97.6	0.8	0.0	19.9	1.5	2.6	3.6	0.0	1.7	0.0	0.0	0.0	0.2	130.2	125.6	0.7	0.0	37.6	162.0	373.6	61.5	0.0	0.0	0.0	6.2	16.9	4.1	39.1	13.1	66.1	2.8	0.0	131.4	48.3
AP1S1	"AP19, CLAPS1, EKV3, SIGMA1A, WUGSC:H_DJ0747G18.2"	ENSG00000106367	"Adaptor related protein complex 1 subunit sigma 1"	P61966	7	101154456-101161596	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Protein transport, Transport"		"Deafness, Ichthyosis, Mental retardation, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 344.4;Proximal enterocytes: 241.3;Proximal tubular cells: 304.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA060945	Supported		Supported	"Golgi apparatus,Vesicles"		NA	Yes			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 65: Brain - Ion transport"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Basic cellular processes"	"Golgi apparatus, Vesicles"		"HPA060945: AB_2684393"	"unprognostic (1.98e-2)"	"unprognostic (5.41e-3)"	"unprognostic (1.02e-1)"	"unprognostic (3.34e-2)"	"unprognostic (2.98e-3)"	"unprognostic (8.70e-3)"	"unprognostic (7.06e-3)"	"unprognostic (1.12e-1)"	"unprognostic (1.76e-1)"	"unprognostic (7.79e-2)"	"unprognostic (1.34e-1)"	"unprognostic (3.75e-2)"	"unprognostic (2.81e-2)"	"unprognostic (2.14e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.49e-1)"	"unprognostic (2.75e-1)"	14.4	24.6	72.2	13.9	75.7	5.8	17.2	43.7	82.6	18.3	34.6	28.6	39.0	16.9	17.0	34.2	13.8	12.8	11.8	85.2	59.6	41.2	36.2	14.7	11.9	53.6	51.9	13.5	21.9	22.8	31.0	15.9	53.4	22.2	22.4	14.6	20.3	9.3	6.4	39.2	30.3	12.7	46.1	20.2	22.0	16.4	62.5	19.1	15.2	8.5	13.6	20.1	19.5	62.7	121.0	87.3	63.3	118.4	42.8	70.4	138.2	76.8	51.1	50.8	52.8	47.3	147.5	24.9	127.5	84.6	97.1	59.0	35.3	116.0	45.6	57.0	56.6	16.8	52.0	61.4	54.2	46.8	87.7	79.1	91.0	49.4	20.6	76.7	76.8	54.1	56.7	103.2	129.9	292.1	40.4	107.8	97.8	177.0	188.2	24.9	27.2	54.6	127.8	88.8	47.5	157.7	40.4	121.1	151.4	101.6	50.7	46.8	79.0	74.1	132.3	27.6	55.2	21.4	51.4	48.4	195.2	50.1	152.9	0.5	3.3	0.3	2.3	3.1	2.2	2.6	3.2	2.5	4.6	2.0	1.9	1.8	1.2	1.3	1.8	5.0	3.3	2.4	72.2	75.7	43.7	82.6	85.2	59.6	53.6	51.9	53.4	46.1	62.5	62.7	34.4	6.4	0.0	2.3	17.9	38.7	29.7	173.0	46.7	30.7	54.8	49.0	1.1	45.8	72.9	55.2	8.4	170.7	19.8	88.4	344.4	128.2	2.5	28.8	34.2	36.7	90.3	16.2	21.2	111.7	101.3	27.7	42.8	31.9	5.7	85.3	28.9	43.0	95.2	30.3	10.3	96.5	116.0	24.8	21.6	3.4	35.1	27.3	53.4	7.5	58.0	34.1	17.5	2.5	9.8	183.3	86.1	21.8	17.4	34.9	241.3	304.8	34.9	22.3	19.7	11.4	38.4	13.1	70.9	51.4	45.5	60.5	19.5	157.4	119.9	38.2
AP1S2	"MRX59, MRXS5, PGS, SIGMA1B"	ENSG00000182287	"Adaptor related protein complex 1 subunit sigma 2"	P56377	X	15825806-15854931	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Protein transport, Transport"		"Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	7	"epididymis: 663.3"	"Cell type enhanced"	"Detected in all"		"Hofbauer cells: 259.8;Kupffer cells: 392.6;Langerhans cells: 609.2;Macrophages: 362.7;monocytes: 630.0"	"Group enriched"	"Detected in all"	4	"endometrial cancer: 13.1;glioma: 22.0;melanoma: 49.7"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"classical monocyte: 326.8;intermediate monocyte: 325.0;myeloid DC: 221.1;non-classical monocyte: 175.4;plasmacytoid DC: 82.2"	"Group enriched"	"Detected in all"	5	"dendritic cells: 221.1;monocytes: 326.8"	"Cell line enhanced"	"Detected in all"		"Karpas-707: 298.0;SK-MEL-30: 442.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049894, HPA060945"	Enhanced		Supported	"Golgi apparatus,Vesicles"		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 30: Epididymis - Antimicrobial activity"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	"Golgi apparatus, Vesicles"		"HPA049894: AB_2680939, HPA060945: AB_2684393"	"prognostic favorable (9.86e-4)"	"unprognostic (4.62e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.68e-1)"	"unprognostic (2.47e-3)"	"unprognostic (3.85e-1)"	"unprognostic (2.03e-3)"	"unprognostic (5.76e-2)"	"unprognostic (1.43e-2)"	"prognostic favorable (5.53e-6)"	"unprognostic (1.85e-2)"	"unprognostic (5.61e-2)"	"unprognostic (5.08e-2)"	"unprognostic (6.35e-2)"	"unprognostic (3.13e-1)"	"unprognostic (9.34e-2)"	"unprognostic (6.47e-2)"	28.3	21.4	24.6	36.7	28.4	38.3	15.0	32.0	36.9	31.6	27.3	42.1	11.9	52.2	663.3	21.4	13.5	20.1	74.8	25.1	48.0	13.1	15.9	25.8	33.2	42.7	35.8	8.8	7.8	16.7	19.4	42.0	47.0	11.6	22.0	43.7	9.5	30.5	70.1	14.0	20.1	76.3	34.4	43.0	19.5	23.4	29.6	28.7	12.5	93.7	28.8	26.1	12.7	33.8	12.0	14.2	130.1	78.4	29.5	19.1	5.0	47.1	22.7	31.1	41.1	9.6	11.1	22.6	183.0	72.6	50.4	16.1	31.7	10.8	57.0	30.1	64.9	15.3	16.7	14.7	24.2	63.1	16.9	12.2	11.2	36.0	33.1	50.4	78.1	19.1	14.3	298.0	72.4	8.7	12.9	39.5	171.0	6.4	42.5	29.5	116.7	50.6	37.4	2.5	14.8	69.2	18.4	4.8	442.2	84.1	52.7	69.2	43.9	67.8	21.2	92.5	41.9	25.5	58.7	37.3	33.6	28.0	159.7	50.9	326.8	34.6	21.1	325.0	24.8	30.8	25.5	20.6	221.1	28.0	18.5	18.1	52.8	27.9	175.4	82.2	38.1	228.0	24.6	28.4	32.0	36.9	25.1	48.0	42.7	35.8	47.0	34.4	29.6	33.8	130.8	3.2	13.1	37.2	77.0	55.2	12.7	9.1	8.6	34.7	12.0	11.4	195.6	12.8	3.2	9.2	12.5	5.3	114.2	9.2	33.2	13.7	5.1	50.4	32.6	166.3	26.9	32.6	15.1	6.4	18.9	38.0	7.7	78.0	78.6	15.6	147.4	8.6	259.8	11.8	73.2	8.4	12.2	392.6	609.2	17.5	17.4	362.7	149.4	31.9	630.0	21.1	62.8	19.1	85.0	10.3	14.0	7.2	26.0	19.0	6.5	9.0	1.6	39.3	39.5	26.7	39.1	55.7	28.8	10.6	51.6	5.6	58.3	4.0	8.5	6.7
AP1S3		ENSG00000152056	"Adaptor related protein complex 1 subunit sigma 3"	Q96PC3	2	223751686-223838027	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Protein transport, Transport"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 52.8"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 64.6;Cytotrophoblasts: 48.2;Pancreatic endocrine cells: 44.2;Urothelial cells: 69.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"B-cells: 4.9;dendritic cells: 4.0;granulocytes: 4.9"	"Cell line enhanced"	"Detected in many"		"CACO-2: 151.1;RPTEC TERT1: 56.8;RT4: 52.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA066782	Approved		Supported	Vesicles		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 30: Epididymis - Antimicrobial activity"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 22: Epithelial cell types - Mixed function"	Vesicles		"HPA066782: AB_2685720"	"unprognostic (9.45e-3)"	"unprognostic (1.79e-1)"	"unprognostic (7.52e-2)"	"unprognostic (5.80e-2)"	"unprognostic (4.37e-2)"	"unprognostic (4.89e-1)"	"unprognostic (1.65e-3)"	"prognostic unfavorable (3.36e-5)"	"unprognostic (1.81e-1)"	"unprognostic (1.47e-1)"	"prognostic unfavorable (2.08e-5)"	"unprognostic (1.56e-1)"	"unprognostic (2.33e-1)"	"unprognostic (2.50e-2)"	"unprognostic (1.90e-1)"	"unprognostic (2.32e-2)"	"unprognostic (4.61e-2)"	0.7	0.8	3.4	3.3	3.2	4.0	2.1	3.9	3.5	2.2	0.5	2.7	5.3	0.9	52.8	4.8	2.3	5.2	0.5	2.8	3.0	5.6	1.4	4.7	4.2	2.0	1.6	0.5	2.4	3.8	1.1	6.6	1.5	2.9	2.6	5.7	1.6	5.4	0.9	1.9	5.0	0.7	1.1	2.8	9.8	0.9	3.2	1.6	14.4	0.3	5.2	8.1	1.2	2.1	28.7	17.7	2.4	12.0	1.5	0.6	13.5	11.5	2.4	4.9	4.2	151.1	21.8	11.0	8.0	1.7	5.8	43.8	6.4	30.3	6.8	15.3	8.9	1.2	33.7	15.7	0.6	3.4	1.3	0.6	31.2	9.1	30.1	11.2	3.4	5.8	1.8	2.9	2.9	12.3	0.6	0.9	3.8	32.8	15.5	4.3	0.1	4.5	56.8	52.1	7.4	2.1	5.4	11.8	3.8	6.1	5.0	6.3	2.0	1.6	4.6	3.1	9.2	10.2	9.0	28.2	4.4	2.0	6.0	4.9	0.5	0.3	0.6	0.4	0.5	4.9	0.4	0.4	1.2	2.7	0.4	0.5	1.8	0.6	0.2	4.0	1.0	0.4	3.4	3.2	3.9	3.5	2.8	3.0	2.0	1.6	1.5	1.1	3.2	2.1	0.4	35.3	6.7	8.8	24.2	4.2	32.6	15.3	4.0	3.3	4.3	1.8	1.7	0.0	15.8	11.0	64.6	48.2	13.6	3.6	9.8	17.5	0.2	8.1	2.1	2.1	2.4	0.0	19.3	18.1	3.4	3.5	11.7	26.1	3.8	0.8	0.7	0.4	4.7	6.7	9.6	3.6	16.2	1.6	38.1	0.0	0.3	7.5	3.6	4.7	7.4	1.9	6.2	10.6	4.0	44.2	4.6	0.0	10.7	26.6	5.4	4.5	10.3	5.9	0.0	1.1	1.8	0.3	1.9	6.3	4.1	13.1	6.9	1.0	4.7	69.6
AP2A1	"ADTAA, CLAPA1"	ENSG00000196961	"Adaptor related protein complex 2 subunit alpha 1"	O95782	19	49767001-49807114	"Predicted intracellular proteins, Transporters"	"Endocytosis, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Late spermatids: 165.0;Syncytiotrophoblasts: 241.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"non-classical monocyte: 20.5"	"Lineage enriched"	"Detected in all"	4	"monocytes: 20.5"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB004306	Approved		Supported	Vesicles		NA	NA		61000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 59: Non-specific - Translation"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	Vesicles		"CAB004306: AB_2274034"	"unprognostic (4.33e-2)"	"unprognostic (1.52e-1)"	"unprognostic (4.61e-1)"	"unprognostic (7.18e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.92e-2)"	"unprognostic (5.85e-3)"	"unprognostic (4.84e-1)"	"prognostic unfavorable (2.91e-4)"	"unprognostic (2.82e-2)"	"unprognostic (2.38e-2)"	"prognostic unfavorable (2.83e-9)"	"unprognostic (2.63e-1)"	"unprognostic (1.45e-1)"	"unprognostic (7.90e-2)"	"unprognostic (1.72e-3)"	47.0	87.4	37.4	25.2	47.9	54.4	41.2	20.6	49.2	48.1	9.0	42.2	24.7	56.6	7.4	46.5	48.2	19.6	52.2	44.2	31.8	33.3	51.1	37.2	19.5	45.8	31.4	57.1	33.8	13.9	34.3	31.4	45.3	33.0	9.9	13.9	28.9	18.6	89.6	54.2	34.0	21.4	17.8	47.6	36.3	88.8	50.0	15.4	30.5	26.9	13.2	46.0	43.6	35.8	70.9	100.3	33.8	78.7	59.5	72.2	69.0	82.0	55.3	49.7	51.8	52.0	43.5	31.5	30.6	85.2	41.9	62.8	25.7	59.0	21.1	50.1	58.4	46.6	66.1	56.8	65.3	37.7	75.0	113.6	42.3	55.4	28.7	44.2	59.5	51.3	118.5	42.7	47.6	55.8	41.6	50.2	34.6	66.6	101.8	46.6	79.7	40.4	29.6	88.1	25.7	34.7	90.1	61.1	34.3	36.1	52.1	52.9	82.9	128.4	70.6	54.6	59.3	63.1	83.5	33.1	90.5	54.8	55.1	0.3	5.3	3.4	2.0	12.8	1.4	1.2	1.2	1.2	4.6	1.0	0.9	1.3	4.0	2.3	20.5	1.4	1.6	4.8	37.4	47.9	20.6	49.2	44.2	31.8	45.8	31.4	45.3	17.8	50.0	35.8	22.9	0.0	2.3	19.6	18.5	13.8	19.0	18.5	14.8	45.1	26.7	19.0	2.9	14.3	11.7	14.7	43.8	90.8	21.8	39.1	11.7	16.1	129.9	23.0	57.1	22.4	2.4	106.5	24.2	29.4	35.3	36.0	22.4	16.0	8.9	33.2	39.3	36.6	31.3	50.5	25.5	17.4	8.2	56.2	21.3	165.0	53.4	34.0	19.6	14.0	40.4	31.5	63.8	14.1	21.8	27.3	19.0	61.7	28.1	16.3	41.2	50.4	14.9	30.2	59.2	23.2	28.5	54.7	59.2	22.1	13.9	241.6	23.2	48.6	23.9	24.3
AP2A2	"ADTAB, CLAPA2, DKFZP564D1864, HIP9, HYPJ, KIAA0899"	ENSG00000183020	"Adaptor related protein complex 2 subunit alpha 2"	O94973	11	924894-1012245	"Plasma proteins, Predicted intracellular proteins, Transporters"	"Endocytosis, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017514, HPA043040"	Supported		Supported	Nucleoplasm,Vesicles		NA	NA		10000000	"Cluster 41: Basophils - Cellular respiration"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 4: Macrophages - Innate immune response"	Vesicles	Nucleoplasm	"CAB017514: AB_2056344, HPA043040: AB_2678283"	"unprognostic (1.90e-1)"	"unprognostic (1.54e-1)"	"unprognostic (2.20e-1)"	"unprognostic (2.09e-2)"	"unprognostic (1.28e-2)"	"unprognostic (5.72e-2)"	"prognostic unfavorable (9.27e-5)"	"unprognostic (1.34e-2)"	"unprognostic (4.09e-1)"	"unprognostic (1.70e-1)"	"prognostic favorable (4.57e-4)"	"unprognostic (2.41e-1)"	"unprognostic (2.86e-3)"	"unprognostic (1.05e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.40e-1)"	"unprognostic (2.08e-2)"	20.1	18.0	3.5	1.3	5.1	4.5	16.6	10.8	9.9	20.3	1.4	23.0	5.4	17.9	1.5	12.7	18.1	2.0	19.1	5.5	3.5	34.4	29.9	18.9	3.2	0.9	2.1	17.5	25.3	3.7	25.6	5.2	3.0	20.3	4.9	5.8	14.6	4.0	14.1	14.5	19.6	5.6	0.0	57.6	20.6	15.5	3.3	3.8	13.9	1.6	2.5	19.0	15.7	1.4	7.5	2.9	3.7	10.7	13.8	14.2	9.1	10.2	3.3	6.0	4.9	1.3	7.3	7.4	8.7	12.3	5.7	8.9	8.9	5.6	3.9	5.5	23.2	2.1	10.4	3.9	5.3	2.8	4.9	16.8	6.1	3.1	6.1	14.8	8.5	5.0	5.9	4.7	6.3	0.4	2.6	3.2	2.0	9.1	17.9	4.2	2.6	8.1	9.2	6.2	12.3	10.0	11.4	9.2	1.7	6.3	5.4	0.8	13.3	1.9	2.3	2.8	5.2	4.3	3.9	5.3	4.0	3.7	3.1	1.5	1.7	1.5	1.1	1.7	0.5	0.5	1.1	0.6	1.4	1.0	1.1	1.2	2.1	1.1	1.4	1.3	2.1	0.6	3.5	5.1	10.8	9.9	5.5	3.5	0.9	2.1	3.0	0.0	3.3	1.4	38.1	38.5	21.8	29.4	14.3	14.3	12.4	13.3	7.4	50.9	27.2	23.0	12.9	21.5	15.9	62.5	60.5	42.1	17.3	45.3	39.2	37.5	46.7	64.0	44.6	36.6	35.2	27.1	37.2	18.0	45.2	28.7	16.3	86.7	27.3	31.0	80.3	59.8	82.8	101.0	36.4	32.3	18.3	104.7	26.9	28.3	34.5	51.8	8.8	41.2	31.2	30.4	39.1	23.1	21.9	25.8	24.2	27.8	13.6	16.9	43.5	70.4	23.5	69.2	26.3	20.7	22.6	72.7	28.0	11.2	11.4	28.5	19.7	30.5	37.0	11.5
AP2B1	"ADTB2, CLAPB1"	ENSG00000006125	"Adaptor related protein complex 2 subunit beta 1"	P63010	17	35578046-35726413	"Cancer-related genes, Predicted intracellular proteins, Transporters"	"Endocytosis, Protein transport, Transport"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 503.9;Late spermatids: 739.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017631, HPA056733, HPA067983"	Approved		Supported	Vesicles		NA	NA		380000	"Cluster 2: Granulocytes - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 31: Spermatids - Spermatogenesis"	Vesicles		"CAB017631: AB_2058201, HPA056733: AB_2683219, HPA067983: AB_2732777"	"unprognostic (1.49e-2)"	"unprognostic (4.04e-3)"	"unprognostic (2.15e-3)"	"unprognostic (1.48e-1)"	"unprognostic (1.16e-1)"	"unprognostic (3.01e-2)"	"unprognostic (1.51e-3)"	"unprognostic (2.64e-2)"	"unprognostic (1.06e-1)"	"unprognostic (4.73e-2)"	"unprognostic (2.58e-2)"	"unprognostic (2.50e-1)"	"prognostic favorable (2.62e-4)"	"unprognostic (1.70e-1)"	"unprognostic (1.10e-1)"	"unprognostic (3.25e-2)"	"unprognostic (1.57e-2)"	46.4	42.4	77.0	38.2	87.8	49.2	58.3	69.9	88.7	54.1	76.6	67.6	33.5	41.7	70.7	25.1	46.7	42.3	67.6	92.1	83.5	69.0	35.0	53.4	38.6	69.8	78.6	57.2	33.2	126.4	55.0	66.8	76.8	40.9	84.0	76.1	41.9	50.1	57.5	29.9	38.8	56.0	80.3	42.0	48.4	93.5	78.7	59.7	65.1	61.0	45.5	46.8	34.4	95.0	188.8	233.9	113.7	132.0	184.4	202.8	51.6	94.3	138.9	131.0	141.1	129.0	154.6	90.5	81.1	175.3	168.8	173.2	162.5	264.8	190.8	108.6	147.0	117.7	161.8	71.0	104.7	119.3	80.8	128.9	104.3	134.5	209.3	151.2	211.4	111.8	190.6	126.9	206.9	36.9	113.7	58.7	94.2	98.9	164.5	94.3	165.1	64.7	166.2	108.3	94.4	114.1	114.5	39.6	126.9	273.3	161.5	78.5	211.5	99.3	93.4	109.8	142.1	53.0	106.1	84.7	124.1	86.9	112.5	19.6	11.8	16.7	16.0	15.3	16.9	12.1	13.9	14.3	10.7	11.9	6.3	8.0	13.3	9.6	16.8	10.7	20.5	11.0	77.0	87.8	69.9	88.7	92.1	83.5	69.8	78.6	76.8	80.3	78.7	95.0	76.5	16.0	17.0	49.3	45.9	31.1	26.3	57.4	70.6	67.6	88.9	50.9	62.5	68.6	37.4	112.2	56.3	29.7	70.7	97.4	117.4	105.0	503.9	74.5	83.7	56.8	71.3	214.7	105.5	120.2	42.8	47.1	36.2	85.4	41.2	46.5	79.9	64.5	44.1	69.0	109.8	79.4	28.5	54.3	25.9	739.2	58.7	37.2	16.0	60.0	47.3	52.6	74.2	81.4	89.0	177.9	46.6	68.4	32.1	37.4	39.4	102.5	30.4	40.9	59.2	25.3	37.6	258.8	60.0	19.6	14.6	32.8	49.2	37.3	89.8	29.1
AP2M1	"AP50, CLAPM1, mu2"	ENSG00000161203	"Adaptor related protein complex 2 subunit mu 1"	Q96CW1	3	184174689-184184091	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Endocytosis, Protein transport, Transport"		"Disease variant, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036849, HPA069870"	Uncertain		Supported	"Plasma membrane"		NA	NA		7500	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 10: Non-specific - Unknown function"	"Plasma membrane"		"HPA036849: AB_10672101, HPA069870: AB_2686217"	"unprognostic (1.16e-1)"	"unprognostic (1.35e-2)"	"unprognostic (5.28e-3)"	"unprognostic (4.96e-3)"	"unprognostic (1.79e-1)"	"unprognostic (2.88e-2)"	"prognostic unfavorable (9.12e-4)"	"unprognostic (3.80e-3)"	"unprognostic (2.09e-1)"	"unprognostic (5.53e-2)"	"unprognostic (4.11e-2)"	"unprognostic (9.18e-2)"	"prognostic unfavorable (7.45e-6)"	"unprognostic (2.61e-2)"	"unprognostic (4.09e-2)"	"unprognostic (1.60e-2)"	"unprognostic (1.28e-1)"	191.8	364.2	233.5	164.7	250.3	231.3	164.6	211.3	257.3	222.8	196.3	232.4	167.5	216.4	104.2	218.1	178.6	166.5	366.2	261.1	249.0	196.0	140.9	180.0	148.2	234.8	211.1	198.6	106.4	224.8	224.9	243.3	248.9	183.2	141.1	230.4	167.2	231.8	181.2	157.2	156.2	243.7	200.9	162.5	156.3	106.4	235.4	158.4	148.0	194.0	157.6	223.7	192.4	225.6	436.3	327.5	275.7	311.8	432.1	450.8	284.3	714.3	412.5	788.5	550.5	355.1	309.9	198.2	851.3	1076.1	516.1	480.0	376.3	482.9	647.1	409.8	470.4	512.2	365.8	317.9	508.9	254.8	311.5	577.0	269.4	501.1	318.5	711.0	595.3	258.3	250.0	377.1	750.1	993.6	330.1	151.2	674.1	388.1	484.7	302.7	351.5	393.7	489.7	389.3	292.0	212.6	561.3	696.4	335.1	427.5	934.4	305.7	645.0	497.1	400.1	492.4	960.2	336.9	318.7	441.6	937.1	369.9	331.7	194.4	294.8	244.9	137.5	238.8	136.2	114.3	127.6	134.0	268.7	112.7	107.7	111.8	127.7	170.2	206.8	134.1	185.4	441.0	233.5	250.3	211.3	257.3	261.1	249.0	234.8	211.1	248.9	200.9	235.4	225.6	146.8	54.5	50.7	41.4	84.8	124.9	177.2	275.1	97.9	174.2	108.0	98.2	195.9	112.9	133.5	114.0	70.9	400.9	117.3	155.9	375.6	243.7	326.6	69.3	131.2	172.2	140.8	277.8	62.0	161.3	327.1	161.5	71.4	78.5	149.1	173.6	182.4	78.0	576.9	277.6	63.4	119.0	201.4	137.1	162.9	347.8	164.7	185.1	199.3	34.7	369.4	199.4	130.7	26.2	46.1	232.1	153.1	214.8	100.2	138.8	253.8	290.7	58.3	125.9	197.2	106.9	278.0	83.3	101.7	128.5	126.6	513.6	102.6	278.1	154.1	185.1
AP4S1	"AP47B, CLA20, SPG52"	ENSG00000100478	"Adaptor related protein complex 4 subunit sigma 1"	Q9Y587	14	31025106-31130996	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	"Protein transport, Transport"		"Hereditary spastic paraplegia, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 36.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039963	Approved		Supported	Vesicles		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 21: Non-specific - Transcription"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 66: Spermatocytes - Spermatogenesis"	Vesicles		"HPA039963: AB_10795240"	"unprognostic (4.03e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.65e-1)"	"unprognostic (2.43e-1)"	"unprognostic (1.14e-1)"	"unprognostic (8.00e-3)"	"unprognostic (1.03e-1)"	"prognostic favorable (7.44e-4)"	"unprognostic (3.79e-2)"	"unprognostic (8.62e-3)"	"unprognostic (1.15e-2)"	"unprognostic (3.02e-1)"	"prognostic favorable (2.87e-6)"	"unprognostic (2.20e-3)"	"unprognostic (5.44e-2)"	"unprognostic (7.75e-2)"	"unprognostic (5.59e-2)"	4.8	6.3	9.8	6.6	10.6	6.0	5.7	14.1	12.8	6.5	5.6	8.6	3.9	7.7	7.0	4.9	7.3	5.4	8.7	9.5	10.2	7.8	6.2	5.4	8.1	6.3	6.5	10.7	7.9	6.5	8.5	6.7	6.1	6.2	4.1	11.9	5.2	6.7	12.6	4.6	4.4	7.9	5.4	8.0	4.3	18.4	9.0	6.6	8.8	7.2	7.7	6.2	4.8	10.1	9.0	12.6	11.0	3.2	4.4	7.9	8.5	6.0	10.4	9.6	9.5	12.2	14.5	10.6	5.5	7.3	7.2	9.7	7.6	9.4	15.9	9.1	4.4	16.4	5.5	19.0	9.5	14.1	9.2	6.3	5.9	9.6	12.0	6.4	11.7	8.0	8.4	7.0	10.3	12.5	9.7	7.8	13.1	10.5	10.9	10.3	9.8	1.4	10.5	12.4	6.1	6.1	10.7	5.1	16.3	7.3	10.8	6.5	8.8	7.3	6.5	5.0	5.2	8.6	17.0	15.9	4.2	4.4	5.7	3.4	1.3	2.4	2.5	3.5	3.7	3.3	3.8	3.0	1.2	3.4	3.7	4.5	2.6	5.8	2.8	3.3	6.6	1.7	9.8	10.6	14.1	12.8	9.5	10.2	6.3	6.5	6.1	5.4	9.0	10.1	7.1	9.6	7.7	10.7	8.1	3.4	6.5	6.5	1.2	12.1	4.0	4.3	16.5	4.3	3.1	5.5	31.3	9.1	7.6	3.9	5.9	7.6	21.9	5.2	8.8	6.7	6.0	3.8	29.4	4.8	5.3	6.2	7.1	5.8	7.6	7.8	10.8	4.0	7.4	6.7	24.9	3.8	4.1	5.4	4.1	17.0	6.8	6.0	3.6	12.2	7.5	9.3	5.2	25.1	16.4	2.8	6.2	8.6	4.2	4.0	5.0	7.7	8.1	24.4	6.6	8.5	8.1	36.0	8.3	3.0	2.8	11.5	7.3	8.2	4.0	5.2
AP5S1	"C20orf29, FLJ11168"	ENSG00000125843	"Adaptor related protein complex 5 subunit sigma 1"	Q9NUS5	20	3820524-3828838	"Predicted intracellular proteins, Predicted membrane proteins"	"DNA damage, DNA repair, Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034200, HPA043533, HPA048244"	Uncertain		Approved	Nucleoplasm,Cytosol		No	No			"Cluster 39: Non-specific - mRNA processing"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Nucleoplasm, Cytosol"		"CAB034200: AB_1564201, HPA043533: AB_2732507, HPA048244: AB_2680328"	"unprognostic (1.07e-2)"	"unprognostic (1.43e-1)"	"unprognostic (8.52e-2)"	"unprognostic (2.74e-2)"	"unprognostic (1.34e-1)"	"unprognostic (2.05e-2)"	"unprognostic (5.49e-2)"	"unprognostic (7.76e-2)"	"unprognostic (1.33e-1)"	"unprognostic (8.91e-2)"	"unprognostic (5.15e-3)"	"unprognostic (8.17e-2)"	"prognostic favorable (5.53e-5)"	"unprognostic (2.92e-1)"	"unprognostic (1.62e-1)"	"unprognostic (6.09e-3)"	"unprognostic (5.08e-2)"	6.0	11.5	7.1	5.5	7.7	7.4	5.8	6.4	8.2	4.8	8.1	6.2	6.3	5.7	3.0	7.4	4.7	4.6	11.3	7.3	6.7	9.4	14.6	5.4	5.5	6.8	6.5	5.8	7.5	7.8	7.5	5.4	6.5	6.9	4.4	3.4	8.7	3.6	19.2	5.3	6.4	3.9	6.3	8.2	6.4	11.2	6.6	4.3	9.4	10.0	3.8	5.4	5.1	6.5	18.1	33.8	4.6	3.1	6.2	8.0	5.7	10.8	8.6	10.4	8.3	28.5	18.9	10.4	11.3	11.4	19.7	15.9	3.9	17.4	3.6	5.7	10.9	17.3	10.1	25.3	10.7	12.0	10.0	13.7	9.7	13.0	10.3	7.0	12.4	12.4	12.4	19.8	14.0	29.4	28.0	10.5	4.2	13.0	27.3	11.7	7.8	10.8	11.8	14.4	14.2	5.7	10.6	32.4	18.2	3.1	15.9	5.9	16.9	21.7	10.3	11.3	20.6	10.6	12.6	5.7	7.5	10.6	19.0	2.2	7.5	4.6	10.2	11.9	7.8	5.4	8.5	8.4	9.9	7.0	7.8	7.3	1.7	6.2	6.7	7.7	9.9	6.5	7.1	7.7	6.4	8.2	7.3	6.7	6.8	6.5	6.5	6.3	6.6	6.5	4.0	0.0	10.6	2.3	5.9	1.7	4.4	8.0	7.4	15.3	4.9	4.3	11.2	11.5	5.9	3.7	10.4	19.4	3.8	8.4	11.7	11.1	3.7	5.1	6.2	8.6	12.6	9.9	1.9	12.7	13.3	6.8	14.8	5.2	14.0	6.6	6.1	9.4	15.5	25.2	2.1	7.3	8.2	6.9	2.0	3.6	5.9	7.3	5.4	4.7	11.0	12.8	8.2	2.5	1.7	10.2	8.8	4.1	8.6	3.6	11.2	8.5	4.5	20.8	13.1	5.8	4.5	19.4	10.9	6.8	1.0	18.5	6.2	10.9	7.4	3.0
AP5Z1	"KIAA0415, SPG48, zeta"	ENSG00000242802	"Adaptor related protein complex 5 subunit zeta 1"	O43299	7	4775615-4794397	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"DNA damage, DNA repair, Protein transport, Transport"		"Hereditary spastic paraplegia, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"NB-4: 15.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035693	Supported		Supported	"Nucleoplasm,Nuclear speckles"		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 24: NB-4 - Immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Nuclear speckles"	Nucleoplasm	"HPA035693: AB_10960687"	"unprognostic (1.64e-1)"	"unprognostic (5.22e-2)"	"unprognostic (3.01e-3)"	"unprognostic (4.24e-2)"	"unprognostic (2.43e-3)"	"unprognostic (5.19e-1)"	"prognostic unfavorable (1.35e-5)"	"unprognostic (1.50e-1)"	"unprognostic (2.03e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.10e-3)"	"unprognostic (1.26e-2)"	"unprognostic (5.32e-3)"	"unprognostic (8.28e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.95e-2)"	"unprognostic (2.22e-1)"	14.8	18.5	7.0	0.7	7.1	1.5	11.8	7.3	10.0	12.4	5.8	13.2	1.1	13.4	1.0	11.0	11.0	0.8	7.7	6.9	5.7	9.2	9.2	12.9	1.8	8.3	6.5	11.8	9.9	0.7	9.8	1.1	7.4	11.7	0.4	0.6	12.4	0.7	8.5	21.8	15.5	0.4	5.9	22.9	12.0	8.6	7.4	0.9	11.2	0.2	0.6	13.4	10.9	7.3	2.8	4.2	0.7	2.4	1.0	0.9	4.3	1.3	1.9	2.0	1.7	5.2	3.5	1.6	1.8	0.9	5.1	5.4	0.7	0.5	0.6	1.8	3.5	2.4	4.5	4.6	3.0	2.5	5.1	2.2	1.6	1.8	1.3	0.7	0.5	2.2	3.4	1.1	1.2	7.7	0.3	15.0	5.9	0.3	4.3	2.9	2.6	4.8	1.0	4.4	1.7	3.0	1.8	8.7	6.4	0.5	6.4	8.9	3.8	2.3	4.4	6.5	1.7	8.5	7.4	2.3	1.7	5.6	3.6	1.9	2.3	2.9	2.4	2.8	1.4	1.9	1.8	2.4	1.2	1.8	2.5	2.2	2.2	2.4	2.5	2.4	1.8	1.3	7.0	7.1	7.3	10.0	6.9	5.7	8.3	6.5	7.4	5.9	7.4	7.3	12.4	9.6	15.0	7.5	18.2	6.9	2.9	8.8	8.0	10.5	5.7	5.8	4.3	15.7	6.6	11.0	4.2	11.5	20.3	20.1	0.0	14.1	2.2	9.9	10.1	11.6	12.0	5.0	12.4	13.6	7.7	9.9	21.4	16.4	17.1	14.3	12.5	8.1	28.7	18.5	10.7	15.1	10.2	12.3	10.7	1.5	13.4	16.3	14.2	13.1	23.4	8.2	21.6	10.6	12.6	20.6	15.9	10.9	19.8	4.9	14.7	6.8	8.3	9.4	0.0	5.8	9.5	8.1	10.8	7.6	11.1	16.6	15.6	12.6	14.1	3.8
APAF1	"APAF-1, CED4"	ENSG00000120868	"Apoptotic peptidase activating factor 1"	O14727	12	98645290-98735433	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transporters"	Apoptosis		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 32.0"	"Cell type enhanced"	"Detected in many"		"monocytes: 54.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 71.1"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031373, CAB069399"	Enhanced		Supported	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 41: Macrophages - Immune response"	"Nucleoplasm, Cytosol"	"Golgi apparatus"	"CAB069399: AB_1611908, HPA031373: AB_10602230"	"unprognostic (1.32e-1)"	"unprognostic (5.12e-2)"	"prognostic favorable (5.90e-4)"	"unprognostic (2.21e-1)"	"unprognostic (3.94e-1)"	"unprognostic (8.21e-3)"	"unprognostic (2.03e-3)"	"unprognostic (1.35e-1)"	"unprognostic (2.26e-2)"	"unprognostic (5.92e-3)"	"unprognostic (5.63e-2)"	"unprognostic (6.04e-2)"	"unprognostic (9.93e-3)"	"unprognostic (3.47e-2)"	"unprognostic (2.53e-1)"	"unprognostic (3.53e-2)"	"unprognostic (3.07e-2)"	4.5	2.8	2.4	8.9	2.8	32.0	5.0	2.5	2.7	5.5	1.2	8.5	5.1	5.5	3.5	3.2	4.0	7.3	2.6	2.8	1.3	3.7	4.7	6.7	9.4	2.3	1.2	7.7	4.0	2.8	3.1	7.6	2.2	3.9	9.6	5.8	4.6	3.4	3.4	5.7	7.1	5.0	1.9	9.7	6.6	3.1	2.2	7.7	4.7	3.1	8.8	5.8	3.9	4.3	6.8	8.7	30.3	11.6	9.4	18.2	8.3	17.3	12.1	11.7	11.6	6.3	4.8	9.8	4.5	12.7	4.4	11.3	20.2	11.4	13.9	7.3	8.0	18.5	9.6	7.7	3.5	18.6	22.7	7.5	3.5	12.1	5.5	14.1	19.6	7.3	9.1	5.2	18.7	1.8	9.4	19.0	8.1	7.5	5.8	11.9	22.8	3.1	7.1	11.5	4.1	7.4	13.5	5.3	4.6	18.6	9.2	25.7	17.7	7.5	6.6	9.0	5.4	3.5	7.1	11.5	3.3	25.4	11.5	16.8	18.1	17.0	4.0	8.0	3.1	5.5	2.8	2.3	14.3	6.2	2.9	1.9	71.1	2.9	8.5	10.4	2.1	3.9	2.4	2.8	2.5	2.7	2.8	1.3	2.3	1.2	2.2	1.9	2.2	4.3	11.7	12.8	8.2	10.4	13.8	3.8	5.7	8.7	8.6	5.8	6.4	6.5	1.5	1.5	7.8	7.3	14.6	3.8	21.4	22.3	0.0	9.4	0.7	5.9	11.6	11.1	12.0	7.6	12.8	8.0	8.0	9.1	14.8	8.7	6.3	18.6	13.2	6.7	12.3	5.0	13.8	18.9	4.1	34.7	25.3	1.3	5.9	34.1	10.6	30.9	54.6	2.7	20.6	14.1	11.2	19.7	20.3	5.3	8.9	8.7	9.2	2.7	8.9	9.8	0.0	6.9	8.1	6.9	10.0	8.7	3.3	1.9	14.6	4.3	13.3	15.0
APBA1	"D9S411E, MINT1, X11"	ENSG00000107282	"Amyloid beta precursor protein binding family A member 1"	Q02410	9	69427532-69672371	"Predicted intracellular proteins, Transporters"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 16.5"	"Group enriched"	"Detected in many"	7	"Astrocytes: 53.5;Excitatory neurons: 130.3;Horizontal cells: 69.0;Inhibitory neurons: 181.6;Microglial cells: 78.7;Oligodendrocyte precursor cells: 141.3;Oligodendrocytes: 106.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ: 7.2;BJ hTERT+: 6.0;HAP1: 17.2;SCLC-21H: 6.5;TIME: 7.8;U-138 MG: 6.9;U-266/70: 7.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA061287			Supported	"Golgi apparatus"		NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Golgi apparatus"		"HPA061287: AB_2684467"	"unprognostic (4.02e-2)"	"unprognostic (4.64e-2)"	"unprognostic (7.29e-2)"	"unprognostic (8.94e-3)"	"unprognostic (1.06e-1)"	"unprognostic (1.53e-1)"	"unprognostic (4.21e-3)"	"unprognostic (8.49e-3)"	"unprognostic (2.22e-1)"	"unprognostic (2.33e-1)"	"unprognostic (2.46e-5)"	"unprognostic (1.60e-1)"	"unprognostic (3.09e-2)"	"unprognostic (4.99e-3)"	"unprognostic (3.14e-2)"	"unprognostic (2.28e-1)"	"unprognostic (4.66e-3)"	2.9	1.2	14.1	0.7	13.1	0.0	2.5	0.0	16.5	3.6	0.0	2.9	0.6	4.1	0.1	1.8	2.5	1.3	3.0	16.0	9.5	2.2	11.9	1.4	0.6	15.1	13.8	5.3	1.9	6.8	6.3	1.4	16.1	1.9	1.9	3.2	2.9	1.1	2.0	3.9	1.8	0.8	0.0	3.8	2.0	2.8	7.9	0.2	2.0	0.6	0.3	2.8	3.6	0.9	0.0	0.0	0.6	0.0	3.1	2.2	0.1	7.2	6.0	0.1	0.1	0.0	0.0	0.0	3.2	3.0	0.0	0.1	17.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.7	0.0	0.0	0.0	0.1	0.9	0.3	0.0	0.0	2.9	0.1	0.0	0.0	0.5	0.1	0.0	0.0	0.3	0.0	0.0	2.5	6.5	4.2	0.4	0.9	0.1	0.2	0.0	0.0	7.8	6.9	0.8	0.0	0.5	7.1	3.3	0.0	0.1	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.1	13.1	0.0	16.5	16.0	9.5	15.1	13.8	16.1	0.0	7.9	0.9	1.0	0.0	0.0	53.5	0.0	1.8	1.2	0.2	0.0	15.4	2.0	2.2	4.9	0.0	0.2	0.0	4.2	0.8	0.0	3.7	0.0	0.1	0.3	0.9	1.7	1.4	4.2	0.0	130.3	0.0	0.6	1.7	0.0	1.0	0.0	1.3	3.3	5.8	3.1	69.0	181.6	1.6	0.0	3.7	1.4	0.6	2.5	1.4	0.0	78.7	1.0	3.2	0.0	141.3	106.2	0.2	0.4	10.9	0.0	0.6	0.0	0.4	0.1	9.1	0.0	1.6	2.3	1.1	1.3	0.5	2.4	0.4	0.5	6.0	1.2	0.4
APBB1	"Fe65, RIR"	ENSG00000166313	"Amyloid beta precursor protein binding family B member 1"	O00213	11	6395124-6419414	"Plasma proteins, Predicted intracellular proteins"	"Apoptosis, DNA damage, Transcription, Transcription regulation"	"Activator, Chromatin regulator, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 152.9"	"Cell type enhanced"	"Detected in many"		"Oligodendrocytes: 102.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"naive CD4 T-cell: 85.6"	"Lineage enriched"	"Detected in all"	5	"T-cells: 85.6"	"Cell line enhanced"	"Detected in many"		"SCLC-21H: 68.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038521, HPA038522"	Approved		Supported	"Plasma membrane"		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 58: T-cells - T-cell receptor"	"Plasma membrane"		"HPA038521: AB_2676058, HPA038522: AB_2676059"	"unprognostic (4.76e-2)"	"unprognostic (1.98e-1)"	"unprognostic (4.46e-3)"	"unprognostic (1.97e-2)"	"unprognostic (6.84e-2)"	"unprognostic (1.75e-1)"	"prognostic unfavorable (2.44e-4)"	"unprognostic (7.30e-2)"	"unprognostic (3.22e-3)"	"unprognostic (2.36e-1)"	"prognostic favorable (1.86e-5)"	"unprognostic (2.21e-1)"	"prognostic favorable (7.44e-13)"	"unprognostic (1.32e-2)"	"unprognostic (2.71e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.09e-2)"	18.1	23.8	101.7	11.9	119.4	2.7	18.0	116.6	121.1	39.5	65.1	43.3	7.0	43.5	4.3	14.9	38.3	11.4	42.0	123.3	105.3	21.5	3.8	22.5	13.9	123.9	106.0	39.2	16.3	21.4	61.3	8.6	135.0	23.7	4.7	23.3	13.4	25.9	42.3	12.2	19.2	33.2	109.4	13.8	19.4	12.7	112.1	28.9	19.1	54.0	11.1	31.2	23.5	152.9	0.0	14.9	50.6	22.8	26.7	27.4	0.2	24.6	41.7	41.2	51.4	26.4	10.3	0.0	3.6	44.3	36.9	0.5	44.4	7.5	19.4	27.8	33.7	0.3	9.3	0.9	19.3	0.2	9.9	24.8	1.9	19.4	2.9	35.3	51.7	1.2	1.1	0.7	15.3	0.5	0.5	0.1	18.3	0.8	15.5	0.2	2.0	0.2	1.7	0.2	68.1	37.6	3.6	3.0	15.9	15.2	2.1	3.4	22.8	4.2	24.8	27.5	5.0	13.8	6.8	2.0	21.1	0.0	14.3	8.4	1.7	0.3	23.2	1.5	25.2	6.7	32.5	30.2	1.7	16.2	85.6	51.7	1.6	16.5	0.6	0.3	48.7	29.9	101.7	119.4	116.6	121.1	123.3	105.3	123.9	106.0	135.0	109.4	112.1	152.9	9.6	19.2	5.4	22.9	7.5	5.0	12.1	3.6	12.0	45.8	6.6	5.7	50.5	11.5	5.4	5.5	22.9	0.4	4.6	1.1	25.4	18.2	5.6	7.6	9.5	13.9	19.3	4.0	47.1	4.2	0.7	15.2	4.6	2.3	1.3	10.8	15.7	3.3	1.2	40.4	44.8	1.2	0.0	1.9	4.0	13.1	9.6	1.8	8.8	7.5	3.2	24.7	9.2	49.3	102.3	8.0	1.7	19.2	1.4	8.3	0.4	21.6	17.3	20.1	6.6	10.0	17.3	6.9	13.7	3.2	2.8	0.8	20.1	7.0	1.3	5.4
APBB3	FE65L2	ENSG00000113108	"Amyloid beta precursor protein binding family B member 3"	O95704	5	140558268-140564781	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 63.1;Late spermatids: 43.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"basophil: 5.6"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"SCLC-21H: 6.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005571, HPA076196"	Approved		Approved	"Actin filaments,Cytosol"		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 43: Testis - Unknown function"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 34: Spermatids - Unknown function"	"Actin filaments, Cytosol"		"HPA005571: AB_1844912, HPA076196: "	"unprognostic (7.63e-2)"	"unprognostic (4.58e-2)"	"unprognostic (1.13e-2)"	"unprognostic (1.36e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.40e-3)"	"unprognostic (1.44e-1)"	"unprognostic (5.06e-2)"	"unprognostic (7.22e-2)"	"unprognostic (1.98e-1)"	"prognostic favorable (6.79e-4)"	"unprognostic (9.65e-2)"	"prognostic unfavorable (2.06e-6)"	"unprognostic (1.06e-1)"	"unprognostic (4.59e-1)"	"unprognostic (9.38e-2)"	"unprognostic (4.67e-2)"	2.2	3.9	7.2	0.0	7.6	0.7	2.3	7.3	10.1	2.0	3.7	2.0	0.2	2.5	1.5	1.5	2.6	0.5	2.3	8.1	9.6	2.5	3.1	1.4	0.5	8.2	6.0	2.5	2.6	1.6	9.9	1.4	8.8	1.9	0.7	6.4	2.5	1.7	2.3	2.0	2.1	0.9	4.9	2.2	2.6	8.5	7.2	0.6	3.1	1.2	0.7	2.2	1.8	5.9	0.4	0.4	0.2	2.0	0.0	0.8	3.3	1.0	1.2	1.3	2.6	1.0	1.1	1.3	2.0	1.7	0.8	0.7	0.0	1.4	0.4	1.6	0.6	0.6	4.0	0.1	2.2	0.7	0.8	5.0	0.6	1.2	1.0	0.3	0.8	3.6	0.1	4.4	1.5	0.9	0.2	1.3	0.8	0.5	2.5	0.3	0.4	1.1	1.2	1.0	6.4	3.0	2.8	0.9	3.7	0.2	2.7	2.8	0.7	0.3	0.6	0.0	0.2	1.7	1.3	0.1	0.8	0.4	0.5	5.6	0.7	0.0	0.7	1.8	0.4	0.2	0.4	0.6	0.6	0.6	0.3	0.6	1.9	0.4	0.3	1.0	0.5	0.6	7.2	7.6	7.3	10.1	8.1	9.6	8.2	6.0	8.8	4.9	7.2	5.9	8.3	3.2	9.3	25.8	6.8	2.8	3.4	5.7	4.0	29.4	9.4	8.3	2.1	14.3	10.1	5.5	0.0	11.7	6.3	5.4	5.9	3.9	63.1	3.9	6.8	6.1	5.4	5.2	13.1	1.5	11.9	7.8	15.3	5.3	10.8	6.2	7.1	17.0	14.5	18.5	13.5	2.8	14.2	18.0	14.2	43.6	5.6	13.8	7.2	8.4	12.6	13.5	5.2	8.5	15.6	2.4	3.7	4.9	3.9	2.3	8.6	3.3	5.6	16.5	0.0	6.4	7.2	19.2	6.9	2.9	2.8	11.8	5.2	4.9	3.6	3.1
APC2	APCL	ENSG00000115266	"APC regulator of WNT signaling pathway 2"	O95996	19	1446302-1473244	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Wnt signaling pathway"		"Disease variant, Lissencephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	10	"brain: 64.5"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 142.4;Bipolar cells: 50.4;Excitatory neurons: 26.8;Horizontal cells: 45.4;Inhibitory neurons: 27.5;Muller glia cells: 29.4;Oligodendrocyte precursor cells: 28.1"	"Cancer enriched"	"Detected in some"	27	"glioma: 17.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 7.8;SCLC-21H: 9.3;SH-SY5Y: 31.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA078002			Supported	"Cytokinetic bridge,Midbody,Cytosol"		Yes	No				"Cluster 70: Brain - Nervous system development"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 64: Astrocytes - Nervous system maintenance"	"Cytokinetic bridge, Midbody"	Cytosol	"HPA078002: AB_2686874"	"unprognostic (1.78e-3)"	"unprognostic (1.65e-1)"	"unprognostic (2.88e-5)"	"unprognostic (3.64e-2)"	"unprognostic (3.59e-1)"	"unprognostic (1.52e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.86e-1)"	"unprognostic (1.38e-2)"	"unprognostic (1.30e-2)"	"unprognostic (3.45e-2)"	"unprognostic (9.49e-3)"	"unprognostic (7.39e-2)"	"unprognostic (3.70e-2)"	"unprognostic (4.99e-2)"	"unprognostic (1.98e-3)"	0.1	2.4	41.5	0.0	27.3	0.0	0.0	41.4	42.4	0.1	0.0	0.9	0.5	0.0	0.0	0.0	0.0	0.1	0.3	37.1	20.8	0.0	0.0	0.0	0.0	64.5	42.3	0.0	0.3	0.0	6.2	0.0	54.9	0.1	0.0	2.7	0.2	0.0	0.2	0.1	0.4	0.1	38.3	0.0	0.3	1.0	54.6	0.0	0.1	0.0	0.0	0.1	0.2	49.0	0.2	0.6	7.8	0.4	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.9	0.0	0.1	0.1	0.0	0.5	0.2	0.1	0.0	0.0	1.0	0.1	0.0	0.4	0.0	0.2	0.1	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.3	0.5	0.2	0.1	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.6	0.0	0.0	9.3	31.7	1.1	0.0	0.5	0.1	0.1	0.0	0.0	0.4	0.6	0.1	0.1	1.7	0.5	0.2	0.7	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	41.5	27.3	41.4	42.4	37.1	20.8	64.5	42.3	54.9	38.3	54.6	49.0	0.3	0.0	0.0	142.4	0.3	0.0	0.2	0.2	1.2	50.4	0.4	0.4	3.4	0.0	0.0	0.0	0.0	0.2	0.1	0.2	0.0	0.0	0.1	0.5	0.5	0.5	0.0	0.0	26.8	0.0	0.1	0.3	0.0	0.6	0.0	0.2	0.0	0.0	0.1	45.4	27.5	0.0	0.0	0.0	0.0	0.7	0.3	0.1	0.0	3.7	0.0	29.4	2.1	28.1	17.8	0.0	0.0	0.7	0.0	0.1	0.2	0.2	0.0	11.1	0.0	0.6	0.4	0.4	0.7	2.4	0.0	0.0	0.3	0.2	0.1	0.2
APEX1	"APE, APE-1, APEN, APEX, APX, HAP1, REF-1, REF1"	ENSG00000100823	"Apurinic/apyrimidinic endodeoxyribonuclease 1"	P27695	14	20455191-20457772	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA recombination, DNA repair, Transcription, Transcription regulation"	"Activator, DNA-binding, Endonuclease, Exonuclease, Hydrolase, Nuclease, Repressor, RNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000956, HPA002564, CAB004294, CAB047307"	Supported		Supported	Nucleoplasm		Yes	No		330000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 50: Non-specific - Ribosome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 32: Non-specific - Translation"	Nucleoplasm		"CAB004294: AB_626685, CAB047307: , HPA000956: AB_2666158, HPA002564: AB_1078174"	"unprognostic (2.80e-3)"	"unprognostic (1.39e-1)"	"unprognostic (1.55e-2)"	"unprognostic (4.74e-3)"	"unprognostic (1.97e-2)"	"unprognostic (5.88e-2)"	"prognostic unfavorable (7.82e-5)"	"unprognostic (4.21e-2)"	"unprognostic (3.14e-2)"	"unprognostic (2.46e-2)"	"unprognostic (2.42e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.83e-2)"	"unprognostic (2.54e-1)"	"unprognostic (7.08e-2)"	83.9	103.6	56.9	82.8	58.1	154.9	103.2	60.0	67.5	80.4	57.9	89.1	107.5	97.2	66.5	80.5	99.1	79.7	76.6	57.5	60.3	82.8	104.6	61.0	112.4	58.9	58.3	146.3	92.2	88.3	39.3	57.3	59.5	69.3	92.7	52.9	66.0	80.2	102.9	83.4	73.0	95.7	59.5	68.9	85.4	21.5	60.1	125.0	93.2	71.9	121.2	103.8	65.8	62.6	249.3	296.8	267.8	247.2	180.9	259.3	226.5	227.3	245.7	333.3	287.4	216.9	240.7	477.9	198.4	176.4	178.1	262.5	317.5	242.1	304.8	214.7	135.9	195.5	162.8	368.9	189.5	623.1	193.2	270.6	261.6	217.6	212.6	267.2	282.3	193.9	228.4	153.6	270.7	240.0	404.7	264.7	260.3	282.4	269.5	441.5	297.7	200.8	281.7	327.1	315.2	201.8	248.5	305.2	253.1	185.0	186.4	276.7	186.0	175.0	292.8	177.9	216.6	203.1	375.8	327.7	77.8	390.7	224.7	0.9	106.7	7.5	79.6	93.4	108.4	154.8	98.9	95.4	208.6	140.5	133.1	117.7	6.8	97.6	60.1	235.6	65.8	200.3	56.9	58.1	60.0	67.5	57.5	60.3	58.9	58.3	59.5	59.5	60.1	62.6	63.8	64.1	57.6	11.8	120.3	106.4	101.1	192.9	136.1	57.5	131.3	136.8	50.1	111.5	117.1	68.0	41.7	200.1	114.1	32.4	150.6	152.7	19.9	65.0	161.1	75.6	120.0	135.6	20.6	104.5	212.6	88.7	72.9	82.0	81.6	165.5	42.1	70.8	175.6	28.6	19.5	85.4	138.4	96.7	89.4	5.8	80.5	95.2	64.0	11.2	121.9	77.4	75.2	22.6	19.4	78.2	73.1	64.3	71.1	60.4	66.2	170.1	64.6	51.6	52.6	87.5	174.2	8.5	43.0	106.4	97.0	101.5	75.1	198.4	157.6	76.8
APEX2	"APE2, APEXL2, XTH2, ZGRF2"	ENSG00000169188	"Apurinic/apyrimidinic endodeoxyribonuclease 2"	Q9UBZ4	X	55000363-55009057	"Predicted intracellular proteins"	"Cell cycle, DNA damage, DNA recombination, DNA repair"	"DNA-binding, Endonuclease, Exonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 52.7;Syncytiotrophoblasts: 47.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048577			Supported	"Nucleoplasm,Nucleoli fibrillar center,Vesicles"		NA	Yes			"Cluster 48: NK-cells - Unknown function"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Nucleoplasm, Nucleoli fibrillar center"	Vesicles	"HPA048577: AB_2680448"	"unprognostic (2.90e-2)"	"prognostic favorable (6.17e-4)"	"unprognostic (4.32e-2)"	"unprognostic (2.39e-1)"	"unprognostic (1.62e-1)"	"unprognostic (5.62e-2)"	"prognostic unfavorable (6.13e-7)"	"unprognostic (5.89e-2)"	"unprognostic (4.87e-2)"	"prognostic favorable (5.21e-4)"	"unprognostic (7.46e-2)"	"unprognostic (3.16e-1)"	"unprognostic (6.86e-2)"	"unprognostic (1.03e-2)"	"unprognostic (3.17e-2)"	"unprognostic (1.40e-1)"	"prognostic favorable (6.63e-4)"	7.2	8.9	6.1	8.8	6.3	10.0	7.2	6.0	6.6	7.6	6.5	8.9	8.9	7.4	8.5	15.5	7.3	6.3	9.0	5.9	6.4	10.8	11.0	7.2	11.3	6.4	6.3	9.6	7.4	7.1	7.0	9.0	6.3	7.8	10.5	2.3	7.0	6.6	7.5	12.2	9.1	7.0	6.3	11.2	7.9	4.1	6.6	10.9	6.3	7.3	13.5	10.2	9.4	6.7	36.9	32.4	12.5	18.3	17.9	11.9	21.3	14.8	19.8	28.0	27.2	17.8	30.0	24.1	22.7	14.0	33.0	26.9	29.1	28.2	21.0	19.7	22.1	29.4	31.6	18.3	11.5	18.3	26.6	11.8	22.6	39.6	14.2	13.2	22.6	25.3	15.4	15.9	21.2	35.7	24.9	23.8	25.0	17.4	38.6	21.8	20.8	26.4	15.2	18.1	11.6	12.7	28.0	33.4	14.7	28.5	26.4	14.1	13.1	16.6	23.9	33.7	19.6	16.4	22.9	19.9	17.7	30.9	20.1	16.2	11.5	13.1	10.2	14.4	8.6	8.2	9.6	10.2	13.7	8.5	8.5	8.4	4.1	42.0	13.4	7.4	11.6	10.1	6.1	6.3	6.0	6.6	5.9	6.4	6.4	6.3	6.3	6.3	6.6	6.7	6.1	3.2	11.8	1.6	12.7	12.9	12.5	20.1	6.8	3.6	7.2	7.1	5.9	15.7	14.9	11.0	0.0	52.7	7.1	17.9	15.6	31.5	0.3	6.0	5.7	11.5	6.1	31.5	0.8	15.1	35.3	7.6	10.2	9.7	8.8	13.1	10.4	11.4	24.2	6.7	0.7	10.1	10.2	10.9	11.1	1.1	5.9	12.0	0.0	1.9	21.7	5.2	16.5	1.0	1.9	20.5	19.1	8.6	9.8	10.5	16.6	21.6	11.8	2.1	19.7	4.4	6.9	1.4	10.6	13.8	12.6	47.6	11.6	12.4	13.7	13.2
APLF	"C2orf13, MGC47799, Xip1, ZCCHH1"	ENSG00000169621	"Aprataxin and PNKP like factor"	Q8IW19	2	68467572-68655862	"Predicted intracellular proteins, Predicted membrane proteins"	"DNA damage, DNA repair"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"Early spermatids: 103.7;Late spermatids: 164.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"basophil: 7.0"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 7.0"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029396, HPA034642, HPA034643"	Uncertain		Supported	Nucleoplasm		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 65: Brain - Ion transport"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 34: Spermatids - Unknown function"	Nucleoplasm		"HPA029396: AB_10610285, HPA034642: AB_2674259, HPA034643: AB_10602431"	"unprognostic (9.37e-2)"	"unprognostic (1.04e-1)"	"unprognostic (2.14e-1)"	"unprognostic (4.29e-3)"	"unprognostic (5.18e-3)"	"unprognostic (2.39e-3)"	"unprognostic (3.24e-1)"	"unprognostic (1.46e-1)"	"unprognostic (4.00e-2)"	"unprognostic (2.78e-1)"	"unprognostic (1.25e-3)"	"unprognostic (3.28e-1)"	"unprognostic (5.02e-3)"	"unprognostic (8.44e-2)"	"unprognostic (5.95e-2)"	"unprognostic (1.35e-2)"	"unprognostic (1.85e-3)"	1.2	1.1	2.0	0.8	3.2	0.7	1.4	0.1	2.2	1.1	0.0	1.1	0.6	1.3	1.0	1.5	0.5	1.0	0.9	2.7	1.9	0.9	1.5	0.9	1.2	0.7	2.2	0.9	0.6	0.9	0.4	1.8	1.0	1.1	0.8	0.4	1.1	1.3	1.1	2.3	0.5	1.1	0.9	0.8	0.7	1.0	1.5	0.8	1.1	1.3	1.2	1.0	1.4	3.2	1.8	0.3	1.7	1.8	3.4	4.4	1.0	1.7	3.6	1.1	1.4	0.7	1.1	3.4	1.1	1.7	2.2	0.5	0.3	2.7	2.7	2.9	0.4	2.5	0.1	0.4	1.5	0.8	2.4	2.4	2.2	1.7	2.5	2.2	0.8	1.7	0.2	2.8	1.2	0.2	1.3	3.1	1.1	1.8	0.9	1.5	0.6	1.6	2.4	1.0	0.4	1.1	1.8	0.0	1.7	2.6	0.0	0.6	1.2	3.4	0.6	1.5	1.3	2.0	0.9	2.4	1.5	0.8	2.0	7.0	0.5	1.9	0.4	0.7	0.6	0.6	0.8	0.7	0.8	0.5	0.8	0.4	0.0	1.0	0.6	0.7	1.4	0.5	2.0	3.2	0.1	2.2	2.7	1.9	0.7	2.2	1.0	0.9	1.5	3.2	3.6	3.2	2.6	14.0	3.1	2.4	2.4	4.4	8.0	0.5	2.4	3.6	3.5	0.0	2.9	0.0	2.1	6.3	2.6	0.3	0.0	3.5	103.7	1.4	4.0	3.1	3.5	3.4	21.8	1.9	2.2	3.2	4.6	1.7	0.0	3.9	2.2	1.2	2.2	3.3	3.2	0.7	2.0	1.9	2.6	164.1	4.4	2.3	0.0	9.4	4.2	0.5	3.1	22.6	29.0	1.4	0.5	1.9	6.4	2.8	0.2	2.2	1.3	0.2	0.0	4.8	4.7	7.7	4.8	5.0	3.3	4.9	1.8	2.2	0.7	1.5
APOB		ENSG00000084674	"Apolipoprotein B"	P04114	2	21001429-21044073	"Candidate cardiovascular disease genes, Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted secreted proteins"	"Cholesterol metabolism, Lipid metabolism, Lipid transport, Steroid metabolism, Sterol metabolism, Transport"	Heparin-binding	"Atherosclerosis, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	143	"intestine: 304.3;liver: 1191.0"	"Group enriched"	"Detected in some"	8	"Hepatocytes: 2967.4;Proximal enterocytes: 1585.9"	"Cancer enriched"	"Detected in some"	99	"liver cancer: 295.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	30	"Hep G2: 1079.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB016070, HPA049793"	Supported		Supported	Vesicles,Cytosol	"Secreted to blood"	NA	NA	1490000000000	100000000000		"Cluster 85: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 2: Hepatocytes - Metabolism"	"Vesicles, Cytosol"		"CAB016070: AB_626690, HPA049793: AB_2680885"	"unprognostic (1.63e-2)"	"unprognostic (2.71e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.04e-2)"	"unprognostic (7.31e-2)"	"unprognostic (1.46e-2)"	"unprognostic (6.53e-3)"	"unprognostic (4.43e-2)"	"unprognostic (8.89e-3)"	"unprognostic (3.01e-1)"	"unprognostic (4.59e-3)"	"unprognostic (3.60e-3)"	"unprognostic (2.89e-2)"	"unprognostic (2.38e-1)"	"unprognostic (2.99e-1)"	"unprognostic (6.23e-2)"	2.7	0.0	0.1	0.2	0.2	0.1	0.9	0.1	0.1	0.7	0.2	0.4	181.4	0.2	0.0	0.1	0.1	0.5	5.2	0.1	0.3	0.3	1191.0	0.0	0.2	0.2	0.2	0.1	0.1	0.0	0.0	0.0	0.3	0.2	0.1	0.0	0.0	0.1	0.1	0.5	304.3	0.2	0.2	0.5	0.3	0.2	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	1.0	0.0	0.5	0.0	0.0	0.0	0.0	35.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	1079.8	0.0	0.6	0.1	0.8	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.5	0.0	0.0	0.0	0.5	0.6	0.0	0.6	0.1	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.1	0.1	0.3	0.2	0.2	0.3	0.2	0.2	0.3	0.0	0.0	0.0	0.0	7.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.4	277.4	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.2	0.0	1.6	3.5	0.0	104.2	0.1	0.0	0.1	0.5	0.0	0.1	0.0	0.1	52.8	2967.4	0.1	0.0	0.2	30.8	0.0	69.4	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	32.5	1.5	0.0	0.0	1585.9	0.6	0.0	0.0	0.0	1.1	0.2	0.5	0.3	0.0	0.0	0.0	3.9	0.9	14.5	0.0
APOBEC3H	ARP10	ENSG00000100298	"Apolipoprotein B mRNA editing enzyme catalytic subunit 3H"	Q6NTF7	22	39097224-39104067	"Enzymes, Predicted intracellular proteins"	"Antiviral defense, Immunity, Innate immunity"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Cytotrophoblasts: 6.6;dendritic cells: 9.6;Hofbauer cells: 4.9;monocytes: 10.5;NK-cells: 6.2;T-cells: 20.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in many"	9	"gdT-cell: 23.2;MAIT T-cell: 9.4;memory CD4 T-cell: 12.1;memory CD8 T-cell: 19.4;naive CD8 T-cell: 8.9;NK-cell: 19.7;T-reg: 11.9"	"Group enriched"	"Detected in many"	13	"NK-cells: 19.7;T-cells: 23.2"	"Cell line enhanced"	"Detected in some"		"Daudi: 2.8;HDLM-2: 2.7;Karpas-707: 6.9;U-266/70: 4.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021492, HPA058565"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Nucleoplasm, Cytosol"		"HPA021492: AB_10964888, HPA058565: "	"unprognostic (7.09e-3)"	"prognostic favorable (1.20e-4)"	"unprognostic (1.05e-1)"	"unprognostic (6.81e-4)"	"unprognostic (3.40e-1)"	"unprognostic (1.54e-3)"	"unprognostic (2.30e-2)"	"unprognostic (1.36e-2)"	"unprognostic (2.17e-1)"	"unprognostic (3.83e-2)"	"unprognostic (5.07e-2)"	"unprognostic (5.36e-2)"	"prognostic unfavorable (8.73e-12)"	"unprognostic (1.05e-1)"	"unprognostic (1.03e-1)"	"unprognostic (6.55e-3)"	"prognostic favorable (8.43e-7)"	0.7	0.8	0.3	2.3	0.5	3.6	0.6	1.0	0.7	0.7	0.0	1.8	0.5	0.8	3.6	1.1	1.3	1.6	0.5	0.3	0.3	0.8	0.6	2.4	3.8	0.7	0.4	0.5	0.3	0.6	0.7	1.0	0.6	0.7	3.3	0.6	0.9	1.5	0.6	0.5	1.2	1.2	0.2	3.1	0.9	1.6	0.5	2.9	0.7	0.0	2.1	1.4	0.6	0.5	0.0	0.5	0.0	0.0	0.0	0.2	2.0	0.0	0.1	0.2	0.0	0.0	0.2	2.8	1.0	0.3	0.0	0.1	0.0	0.6	0.0	2.7	0.3	0.7	0.1	0.0	0.2	0.0	2.0	1.8	1.6	0.2	0.2	0.2	0.0	0.1	0.0	6.9	0.9	0.9	1.4	0.2	0.0	0.0	0.0	1.6	0.0	0.2	0.0	1.3	0.0	0.0	0.1	0.0	0.0	1.0	0.1	0.5	0.0	0.0	0.1	0.0	0.0	4.8	0.7	0.2	0.2	1.2	0.1	0.1	0.3	0.0	23.2	0.5	9.4	1.4	12.1	19.4	0.2	0.4	0.6	8.9	0.0	19.7	1.6	0.0	11.9	4.7	0.3	0.5	1.0	0.7	0.3	0.3	0.7	0.4	0.6	0.2	0.5	0.5	0.4	0.0	4.2	0.0	1.6	0.1	0.6	0.9	1.2	0.0	0.2	0.3	0.1	0.0	2.4	0.0	0.0	6.6	9.6	0.1	0.0	0.2	0.0	0.2	0.1	0.3	0.0	0.4	0.3	0.0	0.6	0.1	0.5	0.1	3.8	0.1	0.4	0.2	4.9	0.0	0.2	0.0	2.0	1.0	0.6	0.5	0.0	1.0	0.0	0.0	10.5	0.0	6.2	0.0	0.1	0.0	0.0	0.0	2.7	0.1	0.0	0.1	0.3	0.0	0.0	0.4	0.9	0.1	0.2	0.2	0.0	1.5	20.8	0.0	0.0	0.5
APOH	"B2G1, BG"	ENSG00000091583	"Apolipoprotein H"	P02749	17	66212033-66256525	"Candidate cardiovascular disease genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		Heparin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	563	"liver: 17965.3"	"Cell type enriched"	"Detected in some"	41	"Hepatocytes: 7680.6"	"Cancer enriched"	"Detected in many"	232	"liver cancer: 2878.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	21	"Hep G2: 1253.3"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA001654, HPA003732, CAB022214"	Enhanced		Supported	"Golgi apparatus"	"Secreted to blood"	NA	NA	247000000000	41000000000		"Cluster 62: Liver - Hemostasis"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 2: Hepatocytes - Metabolism"	"Golgi apparatus"		"CAB022214: , HPA001654: AB_1078181, HPA003732: AB_1078183"			"unprognostic (2.11e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.28e-1)"		"prognostic favorable (2.39e-7)"	"unprognostic (1.26e-1)"		"unprognostic (5.99e-2)"	"unprognostic (2.88e-3)"		"prognostic unfavorable (1.10e-6)"	"unprognostic (1.26e-2)"	"unprognostic (5.76e-2)"			0.9	0.3	0.0	0.1	0.1	0.4	0.2	0.1	0.2	0.2	0.3	0.8	2.5	0.1	1.0	0.2	0.8	2.8	0.6	0.2	0.0	31.9	17965.3	5.6	0.3	0.2	0.1	0.2	10.9	0.0	0.2	0.4	0.1	0.2	0.7	0.2	0.1	0.3	0.1	0.2	1.0	0.0	0.1	4.3	3.8	0.3	0.1	0.1	0.2	0.0	0.1	0.1	0.1	0.2	0.0	33.5	0.1	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	60.8	0.0	1.4	0.1	0.0	1.7	1.1	0.0	0.0	0.0	0.4	0.0	2.6	1.4	1253.3	0.0	6.4	0.7	0.0	0.0	0.1	0.0	0.1	0.0	0.1	1.4	0.5	0.2	0.0	0.2	0.1	0.6	31.5	0.0	0.8	6.4	0.1	0.0	0.9	0.4	0.0	3.4	0.1	0.2	0.0	0.0	0.0	1.7	0.2	0.1	0.1	0.0	0.8	0.1	2.9	15.3	2.4	0.2	0.2	0.2	0.1	0.2	0.0	0.1	0.1	0.1	0.1	0.0	0.2	0.1	0.1	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.2	0.2	0.0	0.2	0.1	0.1	0.1	0.1	0.2	0.0	0.0	12.3	0.0	12.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	183.0	0.6	0.0	0.0	0.0	0.0	0.2	3.9	0.8	0.2	0.2	0.0	5.2	0.0	109.7	0.2	2.3	0.6	0.0	0.0	0.1	0.0	0.0	120.0	7680.6	0.5	0.0	0.2	0.4	0.0	182.4	0.0	0.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.2	0.8	0.0	0.0	0.0	0.4	25.6	0.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.7	8.8	0.0	0.8	0.0
APOL6	"APOL-VI, APOLVI"	ENSG00000221963	"Apolipoprotein L6"	Q9BWW8	22	35648446-35668404	"Predicted membrane proteins"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 46.5"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 135.9;NK-cells: 126.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"CAB028574, HPA029165, HPA029167"	Approved		Supported	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 85: Liver - Metabolism"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 24: Non-specific - Transcription regulation"	"Nucleoplasm, Nuclear bodies"	Cytosol	"CAB028574: , HPA029165: AB_10670037, HPA029167: AB_10670832"	"unprognostic (7.25e-3)"	"unprognostic (2.67e-2)"	"unprognostic (1.09e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.76e-1)"	"unprognostic (1.55e-1)"	"unprognostic (2.32e-2)"	"unprognostic (8.29e-2)"	"unprognostic (3.76e-2)"	"unprognostic (6.26e-3)"	"unprognostic (1.46e-3)"	"unprognostic (1.46e-1)"	"unprognostic (6.65e-3)"	"unprognostic (2.49e-2)"	"unprognostic (4.17e-2)"	"unprognostic (1.71e-2)"	"prognostic favorable (6.61e-4)"	23.4	7.3	4.1	15.8	4.3	16.1	10.0	3.4	4.0	6.8	3.3	13.2	19.2	5.5	5.5	5.9	6.6	9.1	4.2	3.9	5.1	6.4	46.5	15.5	15.5	8.7	5.0	12.2	2.9	2.6	2.4	7.8	5.8	7.9	11.8	2.6	14.0	5.1	3.1	4.5	19.7	7.4	6.7	18.2	14.0	2.3	4.9	10.1	8.5	3.9	10.4	13.2	3.7	5.4	12.8	4.1	0.3	1.5	30.1	15.0	17.3	5.3	14.2	17.3	21.7	2.0	14.2	17.7	2.6	14.0	12.6	16.2	0.1	8.6	4.5	33.6	0.1	7.4	2.6	4.0	23.7	10.4	12.4	19.3	5.7	5.9	3.3	3.9	3.6	8.0	0.8	31.2	3.2	1.3	14.6	3.2	0.5	0.9	5.3	6.1	6.8	8.7	7.6	28.9	0.4	0.2	8.5	7.2	10.0	1.1	1.2	12.1	3.9	4.3	2.6	3.0	2.8	16.4	14.2	1.7	8.1	16.2	6.1	7.5	4.8	2.6	7.3	7.6	6.1	1.0	4.8	5.8	2.4	0.7	4.6	5.3	7.5	5.0	8.5	0.3	5.5	4.2	4.1	4.3	3.4	4.0	3.9	5.1	8.7	5.0	5.8	6.7	4.9	5.4	58.6	70.5	34.3	6.8	15.7	8.0	10.8	14.7	13.6	0.2	16.8	10.8	7.3	34.3	38.6	12.9	0.0	8.3	79.1	101.1	9.8	33.6	10.5	18.4	48.9	33.4	47.3	11.6	0.2	41.9	35.6	33.4	41.8	17.2	36.8	12.2	39.3	135.9	34.9	0.0	1.3	55.3	20.3	58.1	19.9	7.4	26.1	50.5	8.8	17.8	68.5	3.8	126.7	9.5	2.1	45.7	43.7	18.8	51.0	43.2	88.6	31.6	47.4	0.0	0.0	25.3	22.0	0.5	0.2	15.6	5.3	2.5	67.7	6.0	35.9	62.0
APPBP2	"Hs.84084, KIAA0228, PAT1"	ENSG00000062725	"Amyloid beta precursor protein binding protein 2"	Q92624	17	60443158-60526242	"Cancer-related genes, Predicted intracellular proteins"	"Protein transport, Transport"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 391.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"MCF7: 110.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA066852, HPA078370"	Supported		Supported	Nucleoplasm		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 21: Non-specific - Transcription"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 29: Early spermatids - Spermatogenesis"	Nucleoplasm		"HPA066852: , HPA078370: "	"unprognostic (1.43e-1)"	"unprognostic (1.89e-1)"	"unprognostic (1.40e-3)"	"unprognostic (2.97e-2)"	"unprognostic (2.93e-2)"	"unprognostic (4.53e-2)"	"prognostic unfavorable (3.65e-4)"	"unprognostic (7.67e-2)"	"unprognostic (9.24e-2)"	"unprognostic (2.39e-1)"	"unprognostic (2.90e-3)"	"unprognostic (6.87e-2)"	"unprognostic (5.07e-2)"	"unprognostic (1.03e-1)"	"unprognostic (3.84e-1)"	"unprognostic (1.31e-1)"	"unprognostic (9.36e-2)"	14.9	11.2	13.6	10.2	15.3	4.1	11.3	14.9	15.4	11.7	11.9	10.4	7.3	12.8	9.5	10.3	10.0	11.6	7.0	12.0	14.1	13.1	11.0	9.5	8.7	12.6	13.6	19.6	11.5	14.4	8.0	12.2	13.8	13.7	9.1	17.3	8.5	10.1	9.4	8.7	7.2	11.8	14.6	12.0	10.8	23.5	14.4	10.3	12.8	9.8	8.2	10.0	8.8	22.0	16.5	21.9	22.6	19.0	23.7	24.7	12.6	25.4	17.5	13.9	17.6	10.7	14.0	17.0	41.7	21.4	24.0	13.8	16.2	8.8	24.4	15.3	12.4	21.6	20.1	22.5	25.2	18.1	23.1	24.4	11.4	14.6	14.1	21.6	21.9	10.5	16.5	19.3	20.4	110.4	25.5	9.2	5.0	17.9	9.7	16.8	37.8	20.0	21.5	26.7	24.6	21.0	22.0	3.7	18.2	12.5	30.4	12.3	28.4	31.1	37.6	21.7	19.5	20.5	70.8	14.3	20.6	10.5	22.4	13.8	9.5	12.0	7.4	7.1	8.4	7.2	8.7	8.2	9.3	9.7	11.8	8.9	11.9	12.5	12.2	5.6	9.3	7.5	13.6	15.3	14.9	15.4	12.0	14.1	12.6	13.6	13.8	14.6	14.4	22.0	32.8	28.9	24.0	55.5	20.9	18.0	15.6	18.6	21.6	59.4	18.8	15.0	27.3	20.0	20.8	14.7	18.8	27.4	24.0	17.0	19.6	19.7	391.3	21.3	33.6	29.3	33.0	5.9	57.8	16.6	8.9	30.1	13.7	27.3	22.9	40.6	40.0	21.7	19.8	37.0	65.4	22.1	20.3	19.4	14.9	126.2	35.4	17.7	17.8	44.0	22.5	44.4	16.5	55.8	132.0	16.9	13.2	39.1	17.1	24.7	15.9	30.2	19.5	34.9	39.5	32.1	31.6	56.3	33.3	15.3	18.5	63.2	20.8	42.0	20.4	18.1
APPL1	APPL	ENSG00000157500	"Adaptor protein, phosphotyrosine interacting with PH domain and leucine zipper 1"	Q9UKG1	3	57227726-57278105	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cell cycle"		"Diabetes mellitus, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"naive B-cell: 28.3"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA011138	Approved		Approved	"Vesicles,Plasma membrane,Actin filaments,Cytosol"		NA	No		10000	"Cluster 37: B-cells - Transcription"	"Cluster 52: Non-specific - Ribosome"	"Cluster 32: U-937 - Innate immune response"	"Cluster 57: B-cells - Immune response"	"Vesicles, Plasma membrane"	"Actin filaments, Cytosol"	"HPA011138: AB_1844959"	"unprognostic (1.39e-1)"	"unprognostic (3.45e-2)"	"unprognostic (1.06e-2)"	"unprognostic (2.01e-1)"	"unprognostic (3.68e-2)"	"unprognostic (2.31e-3)"	"unprognostic (1.30e-3)"	"unprognostic (1.81e-2)"	"unprognostic (1.05e-1)"	"unprognostic (8.36e-2)"	"unprognostic (9.05e-3)"	"unprognostic (5.55e-2)"	"prognostic favorable (7.26e-5)"	"unprognostic (3.99e-2)"	"unprognostic (8.76e-2)"	"unprognostic (1.12e-2)"	"unprognostic (1.55e-1)"	15.6	11.6	9.5	14.8	9.7	15.1	18.9	12.9	11.3	17.1	6.8	14.2	12.6	17.1	10.6	16.9	11.7	13.0	24.7	9.7	11.3	16.5	12.9	13.6	16.7	9.8	10.1	22.7	29.6	25.1	7.8	14.3	10.1	15.0	14.0	13.5	15.2	14.4	44.2	20.1	14.6	15.3	10.4	15.8	15.2	8.0	10.2	18.9	19.8	26.6	19.6	13.4	11.9	10.7	30.2	12.9	12.2	45.4	21.2	29.7	26.2	15.5	9.5	15.4	17.8	14.9	17.5	47.3	6.2	24.6	24.7	5.9	33.7	27.3	26.6	36.1	15.0	27.6	19.5	16.1	22.7	59.6	19.1	21.8	24.3	19.3	21.3	31.3	25.3	30.2	9.0	30.0	17.8	10.4	48.7	15.4	19.5	21.6	21.7	1.7	49.1	26.1	27.7	16.7	12.5	26.5	21.1	32.3	21.0	16.7	15.7	39.6	23.4	25.1	17.5	37.4	29.9	27.0	41.8	33.2	27.4	29.1	17.1	2.0	5.3	3.8	3.7	4.5	4.9	17.9	3.8	3.3	10.9	28.3	3.3	2.5	1.4	7.4	3.6	18.0	1.9	2.7	9.5	9.7	12.9	11.3	9.7	11.3	9.8	10.1	10.1	10.4	10.2	10.7	82.9	51.3	45.5	19.6	106.6	52.9	47.3	46.9	83.6	40.5	67.2	92.8	100.1	47.1	47.4	42.3	31.3	46.9	70.9	29.0	58.7	58.6	42.5	35.4	92.8	66.2	45.6	20.0	49.7	60.3	44.7	68.6	40.2	59.4	23.4	60.8	40.0	44.1	52.2	52.2	50.4	36.2	42.7	68.6	50.6	22.1	73.0	71.0	19.6	33.7	87.8	56.6	56.7	43.2	62.2	51.7	25.5	76.0	62.8	38.7	41.0	58.8	18.1	55.4	52.6	94.3	61.2	64.9	44.2	105.7	69.6	28.0	45.4	73.7	49.1	25.8
APRT		ENSG00000198931	"Adenine phosphoribosyltransferase"	P07741	16	88809339-88811937	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Purine salvage"	"Glycosyltransferase, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026681	Approved		Approved	Nucleoplasm,Cytosol		NA	NA		1600000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 32: Non-specific - Translation"	"Nucleoplasm, Cytosol"		"HPA026681: AB_1844964"	"unprognostic (5.87e-2)"	"unprognostic (5.10e-2)"	"unprognostic (1.98e-1)"	"unprognostic (3.67e-2)"	"unprognostic (1.78e-1)"	"unprognostic (2.50e-3)"	"unprognostic (1.72e-3)"	"unprognostic (6.90e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.82e-1)"	"unprognostic (6.78e-2)"	"unprognostic (8.74e-2)"	"unprognostic (9.58e-3)"	"unprognostic (1.14e-1)"	"unprognostic (2.51e-1)"	"unprognostic (4.75e-2)"	"unprognostic (1.48e-2)"	118.5	161.2	30.1	73.6	30.1	103.1	112.3	32.0	39.5	109.6	39.3	121.0	72.2	81.2	25.5	231.1	87.6	31.4	70.2	29.9	32.0	128.7	190.4	85.8	83.8	32.9	31.3	73.3	169.4	66.1	64.9	37.0	32.1	113.6	40.2	5.1	119.8	44.6	62.7	240.1	106.8	29.8	33.7	128.6	131.8	35.2	35.1	77.2	96.9	23.8	64.5	95.7	153.7	35.7	157.9	228.3	44.9	200.4	54.2	106.0	232.2	117.1	105.0	136.0	52.6	237.6	189.0	145.5	221.9	68.4	65.0	165.3	74.8	195.4	27.5	102.9	417.7	124.3	106.5	253.0	168.1	87.4	97.7	113.1	207.6	109.0	139.4	63.7	172.6	244.6	266.6	107.9	71.4	586.0	242.1	254.7	169.4	169.5	288.8	259.2	69.2	351.5	156.3	107.0	218.2	132.4	223.5	130.7	131.2	41.9	427.9	171.1	111.4	122.5	104.9	99.5	118.0	205.9	186.5	408.8	179.9	228.4	110.5	77.7	544.5	202.8	474.5	473.5	631.7	501.1	612.0	510.3	562.4	517.3	557.8	475.3	31.8	501.8	322.1	731.6	551.8	998.0	30.1	30.1	32.0	39.5	29.9	32.0	32.9	31.3	32.1	33.7	35.1	35.7	146.5	115.4	147.4	5.9	247.0	319.0	320.0	375.7	207.7	19.9	346.2	479.7	46.9	230.2	206.8	92.0	6.2	265.0	262.3	273.1	406.9	404.3	11.8	124.6	180.3	163.1	210.8	150.6	5.1	442.6	401.5	170.3	192.7	148.4	131.9	154.9	147.8	309.6	348.0	15.2	4.4	386.4	160.7	253.9	336.1	35.4	239.9	214.6	297.1	3.7	449.4	78.7	355.3	2.5	7.2	392.3	228.3	135.4	171.6	404.3	349.2	647.9	125.5	20.4	39.5	135.6	186.5	18.4	126.9	358.8	494.7	172.7	285.7	339.5	426.7	385.2
APTX	"AOA, AOA1, AXA1, EAOH, EOAHA, FLJ20157"	ENSG00000137074	Aprataxin	Q7Z2E3	9	32886601-33025130	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair"	"DNA-binding, Hydrolase"	"Disease variant, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA064930	Supported		Supported	Nucleoplasm,Nucleoli		No	No			"Cluster 27: Non-specific - Gene expression"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	"Nucleoplasm, Nucleoli"		"HPA064930: AB_2685386"	"unprognostic (9.18e-2)"	"unprognostic (2.65e-2)"	"unprognostic (3.61e-2)"	"unprognostic (1.73e-2)"	"unprognostic (4.04e-1)"	"unprognostic (8.16e-2)"	"unprognostic (2.26e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.32e-2)"	"unprognostic (2.78e-3)"	"unprognostic (3.48e-3)"	"unprognostic (3.49e-2)"	"prognostic favorable (6.01e-5)"	"unprognostic (7.87e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.13e-1)"	"unprognostic (6.50e-2)"	9.7	14.8	14.6	7.0	14.8	11.0	10.4	14.8	20.2	9.1	13.9	10.2	8.6	8.6	7.6	14.7	8.9	4.9	9.9	14.8	15.0	13.6	15.6	9.3	8.1	14.7	14.6	8.5	9.6	12.1	7.6	7.8	15.0	9.6	11.2	8.0	9.0	6.6	9.8	15.3	8.3	8.6	14.2	8.9	9.7	14.7	15.2	9.3	7.0	6.9	11.0	10.4	9.6	15.0	36.2	26.1	18.4	17.1	19.0	17.4	25.6	24.8	26.0	28.7	31.5	35.1	12.7	27.8	14.6	21.1	18.4	19.4	33.7	32.8	35.1	39.2	11.2	17.9	32.5	37.8	24.4	29.4	15.1	23.8	36.3	32.5	37.9	16.9	26.8	20.2	27.0	24.2	26.0	15.6	24.4	43.2	33.5	24.4	29.0	21.2	14.4	21.5	25.2	21.2	15.6	11.1	21.4	18.0	15.5	17.9	23.0	11.4	17.7	16.2	21.1	29.9	25.0	11.1	21.2	27.5	23.4	23.8	13.2	3.3	14.7	13.4	12.2	15.6	15.2	16.3	12.8	14.6	17.6	16.1	16.0	12.1	5.9	23.1	21.7	15.2	17.3	16.1	14.6	14.8	14.8	20.2	14.8	15.0	14.7	14.6	15.0	14.2	15.2	15.0	14.8	19.2	29.0	31.3	16.9	16.7	23.1	32.9	22.2	15.2	17.9	17.0	14.9	21.5	23.1	9.2	10.4	27.7	15.1	12.6	29.4	25.3	55.6	19.7	18.3	13.3	16.8	20.0	27.3	28.2	27.7	15.6	19.4	18.1	16.5	17.8	8.9	21.4	18.8	13.5	29.0	15.3	34.6	14.7	9.9	48.7	13.4	15.0	14.2	15.9	19.3	18.3	15.5	23.6	43.0	31.9	6.8	10.5	28.3	24.0	13.9	31.7	25.4	16.6	13.1	13.5	20.2	42.2	26.9	25.8	21.2	27.9	15.9	20.5	16.3	23.1
AQP1	"CHIP28, CO"	ENSG00000240583	"Aquaporin 1 (Colton blood group)"	P29972	7	30911853-30925517	"Blood group antigen proteins, Metabolic proteins, Predicted membrane proteins, Transporters"	Transport	"Blood group antigen"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 727.9;Alveolar cells type 2: 231.8;Cholangiocytes: 358.9;Endothelial cells: 606.7;Hepatic stellate cells: 325.6;Proximal tubular cells: 319.7"	"Cancer enhanced"	"Detected in all"		"glioma: 336.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 34.7;HeLa: 12.5;SH-SY5Y: 14.7;U-2 OS: 14.9;WM-115: 76.4"					"Group enriched"	"Detected in some"	6	"medulla oblongata: 5.5;spinal cord: 22.0"	"CAB001707, HPA019206"	Enhanced		Supported	"Plasma membrane"		NA	NA		49000		"Cluster 57: Non-specific - Angiogenesis"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Plasma membrane"		"CAB001707: , HPA019206: AB_1844965"	"unprognostic (4.18e-2)"	"unprognostic (7.82e-3)"	"unprognostic (1.10e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.02e-1)"	"prognostic favorable (6.52e-4)"	"unprognostic (1.95e-3)"	"unprognostic (1.66e-1)"	"unprognostic (3.00e-2)"	"unprognostic (3.80e-2)"	"unprognostic (4.16e-1)"	"unprognostic (2.05e-2)"	"prognostic favorable (1.32e-8)"	"unprognostic (3.43e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.09e-1)"	"unprognostic (7.21e-2)"	385.9	30.5	86.5	29.3	149.4	50.7	250.3	106.2	79.1	148.9	277.7	97.7	51.0	160.8	41.7	143.5	165.8	162.3	206.8	141.0	124.4	522.9	12.9	413.9	45.5	512.3	181.1	28.1	257.6	48.2	15.2	36.9	199.5	83.8	32.6	0.7	114.0	84.4	199.0	112.6	90.8	142.4	357.3	12.6	80.4	7.8	138.8	39.0	113.2	388.6	34.2	138.5	143.2	432.4	0.1	0.5	0.3	0.6	0.3	1.3	0.7	2.4	0.5	0.0	0.0	0.2	0.8	0.1	34.7	1.9	0.1	0.4	0.0	0.0	0.0	0.3	0.3	0.5	12.5	0.0	0.3	0.3	0.1	4.9	0.1	0.3	0.0	0.1	5.1	0.1	2.3	0.1	0.0	0.0	0.0	0.9	0.7	1.0	0.0	0.0	8.9	0.3	0.9	0.0	0.3	14.7	1.9	1.2	0.0	4.6	0.3	0.1	0.0	0.0	14.9	1.1	0.5	0.8	0.6	0.6	0.0	0.1	76.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	86.5	149.4	106.2	79.1	141.0	124.4	512.3	181.1	199.5	357.3	138.8	432.4	727.9	179.5	231.8	75.7	3.6	91.5	1.2	0.3	5.2	0.7	11.5	29.0	78.0	358.9	3.9	31.3	8.4	3.4	3.7	3.7	29.4	53.3	2.3	2.5	1.2	606.7	7.3	86.9	3.5	2.5	4.8	67.6	0.0	0.9	1.3	0.5	325.6	2.0	3.7	0.0	1.0	28.6	0.0	5.1	107.7	2.1	1.2	6.0	88.9	0.0	1.6	0.4	0.0	0.5	0.2	2.4	14.5	3.4	3.7	1.2	90.6	319.7	6.2	0.4	13.1	23.1	42.3	0.3	1.5	2.6	78.7	7.3	8.1	4.7	67.8	1.0
AQP10		ENSG00000143595	"Aquaporin 10"	Q96PS8	1	154321090-154325325	"Metabolic proteins, Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	15	"intestine: 68.5"	"Cell type enhanced"	"Detected in some"		"Cholangiocytes: 1.5;Erythroid cells: 1.3;granulocytes: 5.7;Hepatic stellate cells: 1.4;Macrophages: 4.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEL: 18.0;HMC-1: 7.1;K-562: 21.0;SH-SY5Y: 4.8"					"Not detected"	"Not detected"			"HPA062621, HPA065947"	Enhanced		Supported	"Vesicles,Plasma membrane"		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 56: Intestine - Transmembrane transport"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 51: Myeloid cells - Hemostasis"	"Plasma membrane"	Vesicles	"HPA062621: , HPA065947: AB_2685584"	"unprognostic (6.84e-2)"	"unprognostic (4.97e-2)"		"unprognostic (4.19e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.09e-1)"	"unprognostic (8.45e-4)"	"unprognostic (1.63e-1)"	"unprognostic (3.07e-1)"	"unprognostic (4.08e-2)"	"unprognostic (3.99e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.68e-1)"		"unprognostic (7.64e-3)"	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.1	0.0	0.0	0.0	68.5	0.0	0.1	0.1	4.6	0.1	0.4	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	49.7	0.0	0.0	0.7	0.6	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	18.0	0.0	0.0	0.0	0.0	7.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	21.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.6	0.0	0.0	0.1	4.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.4	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.4	1.5	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.3	0.5	0.0	1.3	0.1	0.0	0.0	0.1	0.0	0.1	5.7	0.2	1.4	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.2	0.2	0.0	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.2	0.0	0.5	0.0	0.0	0.0	0.1	0.4	0.4	0.0	0.1	0.0	0.4	0.1	0.0	0.1
AQP3	GIL	ENSG00000165272	"Aquaporin 3 (Gill blood group)"	Q92482	9	33441156-33447596	"Blood group antigen proteins, Metabolic proteins, Plasma proteins, Predicted membrane proteins"	Transport	"Blood group antigen"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 1526.1;skin 1: 581.9;urinary bladder: 688.6"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 1923.3;Basal prostatic cells: 982.0;Collecting duct cells: 1609.3;Prostatic glandular cells: 1430.8;Squamous epithelial cells: 2189.3;Suprabasal keratinocytes: 2485.4;Urothelial cells: 2455.4"	"Group enriched"	"Detected in all"	5	"cervical cancer: 319.0;head and neck cancer: 283.7;lung cancer: 146.8;urothelial cancer: 221.3"	"Group enriched"	"Detected in many"	4	"hippocampal formation: 5.3;medulla oblongata: 16.0;pons: 21.0"	"Immune cell enhanced"	"Detected in many"		"MAIT T-cell: 181.7;T-reg: 205.4"	"Lineage enriched"	"Detected in many"	18	"T-cells: 205.4"	"Cell line enhanced"	"Detected in many"		"HaCaT: 127.1;HeLa: 213.2;JURKAT: 130.7;RT4: 216.6;SK-BR-3: 149.7;U-266/70: 151.2;U-266/84: 213.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA014924	Enhanced		Supported	"Plasma membrane"		NA	NA			"Cluster 13: T-cells - Unknown function"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 15: RT4 - Unknown function"	"Cluster 22: Epithelial cell types - Mixed function"	"Plasma membrane"		"HPA014924: AB_2669120"	"unprognostic (4.29e-2)"	"prognostic favorable (5.31e-4)"	"unprognostic (1.15e-1)"	"unprognostic (3.26e-2)"	"unprognostic (1.84e-2)"	"unprognostic (1.11e-2)"	"unprognostic (9.95e-2)"	"unprognostic (1.64e-1)"	"unprognostic (3.46e-1)"	"unprognostic (9.06e-2)"	"unprognostic (4.87e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.54e-2)"	"unprognostic (1.16e-2)"	"unprognostic (2.59e-1)"	"unprognostic (3.73e-2)"	"unprognostic (4.51e-2)"	10.9	2.1	1.5	16.8	0.4	19.7	36.6	2.4	3.4	173.3	1.4	10.3	73.4	10.9	2.9	1526.1	25.4	9.4	31.5	5.3	0.4	131.7	118.6	114.0	16.1	16.0	1.6	12.1	43.1	2.0	2.8	6.0	21.0	85.6	10.1	1.7	399.7	36.8	5.3	581.9	100.5	3.2	0.2	110.1	35.9	2.8	0.8	233.9	2.3	26.7	172.5	688.6	529.9	0.9	0.6	38.6	1.9	0.0	67.7	12.2	1.0	0.3	0.9	0.9	1.1	20.5	12.0	0.5	9.1	0.0	0.5	127.1	6.2	0.7	0.2	61.6	6.0	4.3	213.2	1.9	0.4	1.3	1.3	1.9	6.5	0.5	0.2	0.2	0.5	130.7	67.4	58.8	6.9	29.1	60.4	23.0	5.3	88.6	0.7	0.9	94.3	10.8	1.3	216.6	1.7	4.7	32.3	149.7	0.1	8.0	0.9	10.6	1.2	0.0	1.0	0.4	0.4	151.2	213.6	14.5	0.5	0.4	0.2	1.6	0.5	0.1	20.2	0.4	181.7	11.3	171.9	52.8	0.3	3.0	97.3	47.1	2.3	3.0	0.5	11.1	205.4	43.0	1.5	0.4	2.4	3.4	5.3	0.4	16.0	1.6	21.0	0.2	0.8	0.9	9.2	38.5	249.9	0.0	42.4	1923.3	982.0	381.4	811.0	9.7	56.8	27.8	3.4	157.3	436.3	1609.3	2.1	0.9	21.6	2.7	0.0	37.4	2.2	82.3	21.4	37.1	8.3	71.4	0.3	48.9	2.0	27.5	16.3	96.2	20.8	0.2	16.4	137.3	2.2	0.0	0.1	104.0	315.3	3.5	122.9	0.6	33.2	15.3	158.3	0.0	1.6	0.4	4.1	0.5	0.2	28.5	8.1	1.2	246.9	1430.8	343.1	31.9	546.0	0.5	0.0	10.2	35.8	0.7	1.9	2189.3	2485.4	50.2	73.4	1.6	7.3	2455.4
AQP4	MIWC	ENSG00000171885	"Aquaporin 4"	P55087	18	26852043-26865771	"Human disease related genes, Metabolic proteins, Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 440.5;lung: 114.8"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 1102.6;Alveolar cells type 2: 342.3;Astrocytes: 487.7;Muller glia cells: 227.2"	"Cancer enriched"	"Detected in some"	22	"glioma: 223.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 2.4;RPTEC TERT1: 1.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005079, HPA014784, CAB058689"	Enhanced	Supported	Supported	"Plasma membrane,Cell Junctions"		NA	NA				"Cluster 70: Brain - Nervous system development"	"Cluster 12: NES - Nervous system development"	"Cluster 11: Alveolar cells - Smell perception"	"Plasma membrane"	"Cell Junctions"	"CAB005079: AB_2274338, CAB058689: AB_2665579, HPA014784: AB_1844967"	"unprognostic (7.23e-5)"	"unprognostic (1.55e-1)"		"unprognostic (3.19e-8)"	"unprognostic (3.68e-1)"	"unprognostic (1.96e-1)"	"unprognostic (2.69e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.34e-1)"	"unprognostic (5.38e-3)"	"unprognostic (1.64e-3)"	"unprognostic (8.98e-2)"	"unprognostic (1.22e-1)"	"unprognostic (4.14e-2)"	"unprognostic (1.35e-1)"	"unprognostic (4.10e-2)"		0.1	0.1	272.7	0.0	298.7	0.0	0.3	282.0	246.3	0.6	62.9	0.3	0.0	0.0	0.8	0.9	1.1	0.1	2.8	283.6	440.5	2.3	0.9	114.8	0.3	250.5	351.2	2.5	0.2	2.2	3.7	0.0	333.3	0.4	0.0	60.2	0.7	0.2	60.1	0.1	0.1	0.0	333.0	0.5	11.4	0.5	387.1	0.2	14.7	20.9	0.1	0.1	0.1	376.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.2	0.1	0.3	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	272.7	298.7	282.0	246.3	283.6	440.5	250.5	351.2	333.3	333.0	387.1	376.0	0.0	1102.6	342.3	487.7	0.0	0.0	0.8	0.6	0.0	3.1	0.8	0.9	13.9	4.3	76.6	3.7	6.2	0.0	0.0	0.1	3.9	0.3	0.0	0.7	0.1	1.8	0.0	0.0	3.0	0.0	0.0	0.8	0.0	0.0	3.8	0.0	0.0	0.5	0.0	1.7	1.1	0.0	0.0	0.0	0.3	0.0	5.0	0.8	0.0	9.4	0.0	227.2	0.0	12.1	1.6	0.0	0.0	0.0	0.0	0.7	0.0	0.0	23.1	9.1	0.0	4.3	0.1	0.0	0.0	0.0	0.0	0.1	1.1	0.0	0.0	2.0
AR	"AIS, DHTR, HUMARA, NR3C4, SBMA, SMAX1"	ENSG00000169083	"Androgen receptor"	P10275	X	67544021-67730619	"Cancer-related genes, Disease related genes, FDA approved drug targets, Human disease related genes, Nuclear receptors, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Receptor"	"Cancer-related genes, Disease variant, FDA approved drug targets, Neurodegeneration, Pseudohermaphroditism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 38.2"	"Cell type enhanced"	"Detected in many"		"Breast glandular cells: 93.7;Granulosa cells: 104.8;Hepatocytes: 269.2;Leydig cells: 77.9;Peritubular cells: 86.5;Skeletal myocytes: 75.0"	"Cancer enhanced"	"Detected in many"		"breast cancer: 15.6;prostate cancer: 16.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 13.3;BJ hTERT+: 10.3;HAP1: 14.9;LHCN-M2: 16.1;RH-30: 23.6;T-47d: 10.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB000001, HPA004733, CAB065764"	Enhanced		Supported	Cytosol		NA	NA				"Cluster 85: Liver - Metabolism"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 35: Glandular cells - Unknown function"	Cytosol		"CAB000001: AB_2060174, CAB065764: AB_10620739, HPA004733: "	"unprognostic (1.34e-1)"	"unprognostic (8.10e-3)"	"unprognostic (2.49e-2)"	"unprognostic (5.95e-2)"	"unprognostic (1.04e-2)"	"unprognostic (3.35e-2)"	"prognostic favorable (8.77e-4)"	"unprognostic (4.99e-2)"	"unprognostic (1.72e-1)"	"unprognostic (7.79e-2)"	"unprognostic (2.30e-1)"	"unprognostic (2.29e-1)"	"prognostic favorable (1.03e-8)"	"unprognostic (8.23e-3)"	"unprognostic (8.90e-2)"	"unprognostic (4.23e-2)"	"unprognostic (7.97e-2)"	6.7	1.0	1.1	0.5	1.3	0.0	8.7	1.7	1.1	23.6	0.2	2.0	0.2	18.6	16.1	1.2	20.7	2.0	5.8	1.0	3.5	3.6	38.2	1.5	0.3	3.5	2.6	14.6	0.8	0.1	1.9	0.1	2.7	16.5	0.6	0.2	1.4	18.2	13.9	5.2	0.9	9.5	2.1	1.3	1.5	3.9	4.8	2.7	2.1	6.1	0.5	3.5	12.9	2.0	0.0	4.8	13.3	0.0	0.0	0.0	0.0	7.3	10.3	0.3	0.1	0.1	0.0	0.0	0.0	1.0	0.0	0.0	14.9	0.0	0.0	0.0	2.4	0.0	1.5	0.0	0.8	0.0	0.0	5.5	0.0	1.8	0.0	0.0	3.9	0.1	4.6	2.2	16.1	1.5	0.0	0.0	5.4	0.0	0.0	0.0	23.6	0.1	0.4	0.0	0.0	0.0	0.0	0.3	0.0	3.6	10.9	7.6	0.3	0.3	2.2	0.0	3.5	0.0	0.0	0.0	5.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	1.3	1.7	1.1	1.0	3.5	3.5	2.6	2.7	2.1	4.8	2.0	3.1	0.0	5.0	28.4	0.4	9.7	17.8	0.2	15.9	0.7	93.7	33.7	37.4	14.3	10.7	3.7	0.0	3.5	14.0	0.0	1.9	11.3	1.1	2.9	49.1	10.5	0.0	5.3	7.7	0.0	0.2	39.4	0.0	5.8	1.3	104.8	36.0	269.2	0.8	0.0	17.8	0.3	0.0	2.2	4.2	4.4	77.9	3.3	10.6	1.0	1.7	0.2	0.0	26.7	0.2	0.6	0.0	86.5	0.0	36.5	0.6	27.7	3.6	0.3	65.7	75.0	20.8	0.8	3.3	12.7	16.1	1.0	1.7	37.8	0.2	22.0
ARCN1	COPD	ENSG00000095139	"Archain 1"	P48444	11	118572390-118603033	"Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"ER-Golgi transport, Protein transport, Transport"		Dwarfism	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037573, HPA044874"	Approved		Supported	"Golgi apparatus,Vesicles,Cytosol"		NA	NA		140000	"Cluster 18: Basophils - Vesicular transport"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 55: Plasma cells - Humoral immune response"	Vesicles	"Golgi apparatus, Cytosol"	"HPA037573: AB_10696938, HPA044874: AB_2679126"	"unprognostic (1.46e-2)"	"unprognostic (4.97e-2)"	"unprognostic (1.66e-1)"	"unprognostic (3.20e-1)"	"unprognostic (9.99e-2)"	"unprognostic (2.30e-2)"	"prognostic unfavorable (2.97e-5)"	"unprognostic (3.10e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.67e-3)"	"unprognostic (9.39e-2)"	"unprognostic (3.56e-2)"	"unprognostic (7.99e-2)"	"unprognostic (9.20e-2)"	"unprognostic (4.14e-3)"	"unprognostic (5.56e-3)"	75.4	67.7	47.5	53.8	51.0	30.4	67.5	52.0	60.5	78.0	61.2	65.0	59.2	69.2	111.1	72.5	60.5	51.6	75.6	46.8	50.9	58.3	91.6	62.6	53.2	51.2	51.3	65.5	119.7	61.9	88.7	54.7	51.1	68.8	67.1	39.2	79.6	64.5	51.1	60.9	64.9	71.0	50.0	57.9	71.8	46.2	50.5	58.8	65.2	55.0	62.2	66.4	60.9	57.2	90.9	72.6	135.3	98.9	174.0	172.7	66.6	244.8	208.5	102.4	120.7	239.4	116.6	96.4	199.7	275.7	148.0	123.7	160.5	139.5	151.5	128.0	66.3	211.6	56.7	151.4	197.1	140.4	121.8	157.8	117.6	175.0	168.7	149.3	162.2	95.0	106.8	139.2	201.3	157.0	123.2	130.8	85.3	207.7	92.4	107.9	134.2	147.4	137.3	107.0	88.3	86.6	130.2	129.0	70.1	132.5	155.9	111.4	144.0	129.4	65.1	118.4	109.5	79.9	78.5	147.6	74.3	122.6	161.4	118.1	49.8	50.7	52.7	59.8	69.0	39.5	51.7	51.3	54.0	35.4	48.0	44.7	41.5	64.5	64.5	44.9	53.9	55.8	47.5	51.0	52.0	60.5	46.8	50.9	51.2	51.3	51.1	50.0	50.5	57.2	43.6	35.3	47.9	12.4	32.2	31.6	38.5	31.5	23.9	22.4	39.4	27.9	46.5	24.3	41.9	31.3	4.2	17.2	45.6	68.4	9.8	34.3	11.1	38.4	72.2	43.1	40.2	14.9	15.4	37.8	36.1	44.9	39.3	50.4	39.3	31.9	31.4	55.7	30.3	18.5	17.7	80.2	22.4	36.0	37.6	8.5	48.1	35.3	23.2	11.2	49.0	17.3	26.8	17.1	20.2	46.9	35.8	41.3	68.3	51.5	56.2	30.5	46.2	13.6	19.7	52.7	45.7	44.8	47.6	30.4	34.7	30.2	38.4	43.9	42.6	51.6
ARF6		ENSG00000165527	"ADP ribosylation factor 6"	P62330	14	49893082-49897054	"Predicted intracellular proteins, RAS pathway related proteins"	"Cell cycle, Cell division, Differentiation, Neurogenesis, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Langerhans cells: 716.1;Suprabasal keratinocytes: 673.3;Urothelial cells: 703.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002778, CAB079914"	Approved		Supported	Cytosol		NA	NA		310000	"Cluster 44: Non-specific - Transcription"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 22: Epithelial cell types - Mixed function"	Cytosol		"CAB002778: , CAB079914: AB_2539861"	"unprognostic (1.21e-1)"	"unprognostic (2.75e-3)"	"unprognostic (1.80e-1)"	"unprognostic (7.02e-2)"	"unprognostic (2.85e-1)"	"unprognostic (1.83e-1)"	"unprognostic (4.12e-3)"	"unprognostic (2.16e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.41e-1)"	"prognostic unfavorable (3.10e-5)"	"unprognostic (1.61e-1)"	"unprognostic (1.67e-1)"	"unprognostic (8.37e-3)"	"unprognostic (1.22e-1)"	"unprognostic (2.37e-1)"	"unprognostic (1.49e-2)"	32.1	25.3	13.4	43.6	14.2	83.1	32.6	15.2	15.3	35.7	16.3	53.4	46.4	21.7	26.6	108.2	28.3	32.8	18.3	11.8	14.3	29.7	46.1	31.5	62.0	14.7	14.3	15.3	24.7	20.4	12.6	36.3	15.4	32.2	51.0	13.2	36.3	19.2	26.1	66.0	51.2	23.8	15.6	49.6	46.7	15.8	15.9	45.2	21.1	17.1	66.7	46.8	55.7	15.6	141.5	58.2	38.4	44.8	51.5	68.4	78.3	86.5	62.6	60.3	62.2	42.6	96.2	91.3	43.7	72.7	46.3	101.7	43.7	69.3	71.3	181.4	34.9	47.2	30.6	38.3	58.1	87.2	60.7	53.7	81.5	48.9	93.7	72.1	67.6	58.3	45.9	176.9	84.7	101.5	77.7	76.5	42.0	75.9	82.8	59.4	50.1	53.9	157.6	112.9	56.4	37.4	68.9	102.3	89.0	46.5	78.0	70.0	90.0	111.9	57.4	66.7	66.1	94.3	104.4	68.6	40.1	50.9	81.3	34.2	20.7	21.1	34.7	33.0	37.6	33.5	33.7	35.3	23.9	26.6	23.0	29.6	14.7	29.1	31.4	15.8	36.2	23.4	13.4	14.2	15.2	15.3	11.8	14.3	14.7	14.3	15.4	15.6	15.9	15.6	102.9	51.3	29.9	2.9	233.7	599.8	529.1	47.9	231.6	22.9	154.4	80.1	18.5	127.2	47.6	101.2	2.1	152.7	298.8	276.0	158.5	125.4	5.8	95.6	98.5	117.1	99.3	140.1	5.3	80.0	208.1	94.9	115.7	143.7	79.9	40.3	108.5	143.3	168.0	33.7	5.9	167.0	20.3	195.6	716.1	8.3	33.5	184.5	304.1	15.0	204.9	42.2	192.6	6.0	8.9	130.4	161.6	32.7	182.4	443.4	190.8	166.5	30.3	21.6	46.0	68.8	90.7	62.7	48.7	361.4	673.3	202.9	311.0	52.6	182.5	703.8
ARFGAP2	"FLJ14576, IRZ, Zfp289, ZNF289"	ENSG00000149182	"ADP ribosylation factor GTPase activating protein 2"	Q8N6H7	11	47164299-47177125	"Predicted intracellular proteins"	"ER-Golgi transport, Protein transport, Transport"	"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016649, HPA018152"	Enhanced		Supported	"Golgi apparatus"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	"Golgi apparatus"		"HPA016649: AB_1844980, HPA018152: AB_1844979"	"unprognostic (1.69e-2)"	"unprognostic (9.11e-2)"	"unprognostic (5.91e-2)"	"unprognostic (3.75e-2)"	"unprognostic (2.20e-2)"	"unprognostic (1.12e-1)"	"unprognostic (4.81e-3)"	"unprognostic (1.23e-1)"	"unprognostic (1.25e-1)"	"unprognostic (2.41e-1)"	"unprognostic (3.42e-2)"	"unprognostic (7.00e-2)"	"prognostic favorable (7.65e-7)"	"unprognostic (2.05e-1)"	"unprognostic (9.36e-2)"	"unprognostic (1.06e-1)"	"unprognostic (9.20e-2)"	38.0	51.4	62.1	36.3	63.9	82.2	41.7	63.2	68.3	42.3	57.2	49.4	40.0	43.3	35.5	60.8	49.3	32.1	58.7	62.5	60.1	47.6	76.8	40.7	51.9	65.1	61.8	44.6	69.7	48.2	38.7	39.9	61.8	51.4	39.4	38.9	56.1	41.7	115.9	78.7	43.8	38.8	60.6	51.2	55.7	30.7	63.1	49.8	47.4	81.4	50.5	44.7	43.3	70.3	55.7	36.4	54.9	43.3	45.9	37.3	51.6	51.2	48.1	64.1	48.4	41.3	45.3	91.3	32.4	58.7	40.8	82.3	47.2	74.6	40.3	45.0	46.1	77.6	85.5	50.8	53.7	107.0	84.4	56.7	82.3	33.3	71.1	46.1	60.4	65.6	111.8	67.8	58.5	102.5	50.8	87.8	43.6	98.3	48.4	78.8	94.8	116.8	60.3	79.3	53.0	47.0	58.7	81.7	38.8	26.1	126.8	78.8	48.7	55.2	43.3	50.5	68.6	58.6	60.7	78.3	38.6	81.2	56.4	108.5	69.1	92.8	74.0	77.3	66.6	59.0	57.1	66.2	65.9	63.1	63.0	63.4	41.8	69.2	98.4	35.4	71.8	108.1	62.1	63.9	63.2	68.3	62.5	60.1	65.1	61.8	61.8	60.6	63.1	70.3	23.8	35.3	45.9	25.1	46.5	22.2	31.4	22.1	29.6	73.6	30.9	25.8	13.0	20.0	41.2	31.3	114.7	64.3	40.7	38.6	25.4	38.7	2.7	20.3	26.4	29.8	45.4	47.1	16.2	36.6	47.1	29.7	34.1	27.0	60.8	44.9	31.1	44.0	36.8	74.0	15.1	35.0	38.7	33.6	25.4	6.6	34.2	28.6	28.4	15.9	58.1	51.1	71.1	13.0	23.7	39.2	45.0	26.4	31.7	26.4	41.0	26.3	34.1	115.4	39.5	33.0	28.0	24.7	35.9	30.3	26.7	91.8	43.7	40.3	36.3	34.0
ARFGAP3	ARFGAP1	ENSG00000242247	"ADP ribosylation factor GTPase activating protein 3"	Q9NP61	22	42796502-42858106	"Predicted intracellular proteins"	"ER-Golgi transport, Protein transport, Transport"	"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000638	Approved		Supported	"Golgi apparatus,Cytosol"		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 22: Epithelial cell types - Mixed function"	Cytosol	"Golgi apparatus"	"HPA000638: AB_1078188"	"unprognostic (3.29e-2)"	"unprognostic (6.08e-2)"	"unprognostic (3.22e-1)"	"prognostic favorable (8.97e-6)"	"unprognostic (5.83e-2)"	"unprognostic (8.85e-3)"	"unprognostic (5.00e-3)"	"unprognostic (1.00e-1)"	"unprognostic (2.05e-1)"	"unprognostic (1.31e-1)"	"unprognostic (9.06e-3)"	"unprognostic (1.67e-1)"	"unprognostic (1.87e-1)"	"unprognostic (2.52e-2)"	"unprognostic (2.08e-1)"	"prognostic unfavorable (2.65e-4)"	"unprognostic (1.73e-1)"	30.1	88.9	16.5	34.1	17.4	47.8	30.9	19.5	20.4	56.1	23.2	26.9	36.5	32.2	53.3	22.1	22.9	36.6	23.6	17.9	20.6	53.2	49.2	32.3	28.1	20.5	18.7	20.7	85.8	38.0	38.1	34.8	20.3	64.7	30.6	35.5	68.5	40.2	31.3	20.7	51.1	30.8	19.0	26.0	43.2	49.5	19.6	25.9	61.3	21.8	32.6	45.2	23.4	21.0	59.6	19.3	41.1	24.7	57.2	94.1	17.3	111.8	76.4	50.5	60.9	23.5	32.8	30.1	24.5	102.9	41.8	14.4	18.7	33.0	54.7	18.5	25.4	35.7	27.6	37.4	79.6	31.9	53.2	42.0	57.6	42.6	75.9	71.9	52.4	27.4	16.1	132.0	89.6	15.7	49.4	17.5	6.7	32.7	23.2	31.1	92.3	38.3	80.7	27.5	14.6	9.0	54.3	21.5	46.0	30.6	22.7	24.4	67.0	58.7	42.5	52.1	30.7	94.7	48.2	33.1	41.9	34.0	46.7	86.2	33.2	36.8	45.1	44.4	58.8	27.1	29.7	39.8	32.5	26.1	19.2	27.2	50.8	49.4	50.9	53.1	28.8	30.1	16.5	17.4	19.5	20.4	17.9	20.6	20.5	18.7	20.3	19.0	19.6	21.0	40.8	38.5	54.8	27.4	41.7	26.6	86.9	43.0	19.9	42.8	43.1	29.5	26.5	37.1	62.1	57.0	18.8	18.8	67.3	36.4	66.5	65.9	19.1	60.5	89.9	42.4	49.1	17.5	26.1	64.3	23.7	58.1	30.1	96.3	65.9	28.4	30.4	37.3	28.7	33.7	28.8	53.0	46.8	21.7	89.3	15.0	48.1	68.2	69.4	35.6	33.7	40.5	38.1	43.7	40.0	83.0	15.6	45.5	110.0	121.5	70.9	62.9	65.5	33.7	39.5	80.0	65.5	178.7	67.6	14.6	26.7	59.9	49.6	39.0	22.7	86.7
ARFGEF2	BIG2	ENSG00000124198	"ADP ribosylation factor guanine nucleotide exchange factor 2"	Q9Y6D5	20	48921711-49036693	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Protein transport, Transport"	"Guanine-nucleotide releasing factor"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"parathyroid gland: 81.5"	"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 102.6;Inhibitory neurons: 96.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026078, CAB026382"	Supported		Supported	"Golgi apparatus,Vesicles,Cytosol"		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Golgi apparatus"	"Vesicles, Cytosol"	"CAB026382: , HPA026078: AB_1844983"	"unprognostic (1.50e-2)"	"unprognostic (9.56e-3)"	"unprognostic (4.14e-2)"	"unprognostic (4.94e-3)"	"unprognostic (5.30e-2)"	"unprognostic (6.94e-2)"	"unprognostic (1.57e-2)"	"unprognostic (2.99e-1)"	"unprognostic (8.47e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.12e-2)"	"unprognostic (1.11e-1)"	"prognostic favorable (6.15e-7)"	"unprognostic (1.68e-1)"	"unprognostic (1.56e-1)"	"unprognostic (2.85e-1)"	"unprognostic (3.90e-2)"	9.1	20.2	2.8	8.7	4.1	10.4	15.8	1.9	5.8	11.5	7.9	14.2	13.7	9.0	5.9	11.0	7.5	8.5	13.4	4.5	3.9	15.3	12.4	7.8	9.8	2.6	3.2	7.7	19.2	81.5	8.7	9.2	3.5	10.6	15.7	6.8	11.0	9.7	11.8	11.1	10.9	9.5	1.9	10.4	16.2	13.6	3.5	11.3	23.8	18.2	14.2	11.1	8.2	5.0	18.3	16.5	8.9	5.1	18.0	14.8	21.8	15.5	19.5	36.6	19.0	37.1	19.8	25.5	22.1	19.7	33.8	21.0	18.6	23.6	33.8	9.0	7.6	17.5	17.9	25.4	19.7	22.6	19.7	15.0	21.6	23.9	27.6	12.7	28.4	11.7	15.0	22.3	20.8	6.3	13.0	6.8	8.3	20.5	17.4	14.0	25.5	30.3	13.6	23.4	7.1	9.0	42.6	66.0	23.4	10.3	26.6	18.6	34.5	35.6	16.5	18.2	13.1	35.9	35.0	18.7	23.4	10.7	11.6	1.1	0.6	0.2	0.5	0.4	0.6	0.5	0.5	0.4	0.7	0.9	0.8	0.7	0.3	0.3	0.3	0.9	0.1	0.3	2.8	4.1	1.9	5.8	4.5	3.9	2.6	3.2	3.5	1.9	3.5	5.0	16.6	19.2	26.0	37.2	21.2	11.3	12.2	11.0	11.4	15.3	27.7	14.7	40.7	17.2	20.0	11.0	14.6	10.5	14.7	30.4	1.9	10.9	16.6	19.5	17.1	19.5	12.5	14.3	102.6	13.3	10.0	12.6	16.3	24.7	15.2	11.0	20.7	27.8	10.8	11.8	96.7	23.3	8.2	15.7	13.9	24.6	10.2	17.8	10.6	60.9	15.6	5.4	10.3	43.2	57.0	15.5	21.6	11.3	29.0	24.1	18.6	11.5	17.2	16.1	6.6	14.2	12.5	32.6	20.4	17.5	15.5	30.0	13.2	16.6	21.0	21.2
ARFIP1	HSU52521	ENSG00000164144	"ADP ribosylation factor interacting protein 1"	P53367	4	152779937-152918463	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005080, HPA037375, HPA063759"	Enhanced		Supported	"Nucleoplasm,Golgi apparatus,Vesicles"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 44: Endometrium - Transcription"	"Golgi apparatus, Vesicles"	Nucleoplasm	"CAB005080: AB_2058797, HPA037375: AB_2675440, HPA063759: AB_2685114"	"unprognostic (1.06e-1)"	"unprognostic (1.19e-1)"	"prognostic favorable (5.75e-5)"	"unprognostic (1.49e-3)"	"unprognostic (4.32e-1)"	"unprognostic (1.24e-1)"	"unprognostic (3.54e-2)"	"unprognostic (5.34e-1)"	"unprognostic (1.03e-2)"	"unprognostic (3.56e-1)"	"unprognostic (3.60e-2)"	"unprognostic (1.82e-2)"	"prognostic favorable (2.83e-10)"	"unprognostic (1.83e-1)"	"unprognostic (1.32e-1)"	"unprognostic (7.02e-2)"	"unprognostic (4.22e-3)"	16.8	14.8	7.9	15.8	8.7	3.7	23.4	9.9	10.8	22.5	9.9	28.1	23.2	21.7	20.5	20.9	18.5	19.9	10.2	7.3	9.3	19.8	15.4	16.8	15.1	9.3	8.0	17.6	10.5	22.4	10.5	18.0	9.5	21.1	27.8	20.2	13.7	17.2	6.6	17.3	21.3	19.8	9.4	18.3	22.7	12.1	8.3	12.0	20.1	10.4	14.8	23.5	15.2	11.4	25.8	18.4	25.1	25.7	37.2	37.9	30.6	29.5	40.5	28.7	26.9	21.3	51.3	20.6	9.9	40.5	22.7	18.1	26.3	29.1	35.3	16.9	16.2	20.0	18.0	20.5	26.1	38.2	41.7	26.6	30.9	24.8	23.8	30.7	26.4	11.8	23.5	43.3	39.8	28.6	22.7	19.8	21.8	29.9	18.5	12.6	14.7	19.2	50.7	32.1	32.8	26.0	22.1	40.7	30.2	23.5	37.7	19.6	17.3	27.8	20.1	26.8	21.4	48.2	42.8	28.1	35.3	38.2	40.0	31.5	27.3	42.2	14.5	31.1	14.6	19.0	11.2	12.2	24.8	17.7	8.7	11.8	81.6	29.1	30.7	3.1	18.5	18.7	7.9	8.7	9.9	10.8	7.3	9.3	9.3	8.0	9.5	9.4	8.3	11.4	28.5	6.4	31.8	40.5	20.3	29.6	18.4	30.7	34.1	17.2	26.2	19.7	10.2	20.0	29.1	38.6	0.0	28.6	15.6	40.9	27.4	27.4	46.3	42.2	33.0	23.8	38.9	12.0	44.5	18.3	27.0	28.8	40.2	50.7	22.8	14.2	17.2	19.8	22.1	18.5	42.8	39.1	34.6	23.8	18.0	21.6	22.4	24.5	21.4	89.9	19.5	35.9	23.7	76.4	75.6	24.4	28.2	21.8	11.8	23.6	23.8	34.2	31.9	24.2	32.9	20.6	27.8	31.7	29.5	31.9	34.0	43.9	17.7	89.2	31.7	30.3
ARFRP1	"ARL18, ARP, Arp1"	ENSG00000101246	"ADP ribosylation factor related protein 1"	Q13795	20	63698642-63708025	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047028, HPA050634"	Approved		Supported	"Golgi apparatus"		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Golgi apparatus"		"HPA047028: AB_2679908, HPA050634: AB_2681196"	"unprognostic (6.33e-2)"	"unprognostic (2.12e-2)"	"unprognostic (1.95e-2)"	"unprognostic (6.03e-2)"	"unprognostic (1.19e-2)"	"unprognostic (2.18e-1)"	"unprognostic (1.36e-3)"	"unprognostic (2.13e-2)"	"unprognostic (9.70e-2)"	"unprognostic (2.25e-2)"	"unprognostic (3.22e-2)"	"unprognostic (6.53e-2)"	"unprognostic (5.58e-2)"	"unprognostic (3.93e-2)"	"unprognostic (1.72e-2)"	"unprognostic (5.48e-2)"	"unprognostic (3.39e-1)"	26.8	27.8	23.4	14.0	23.4	10.0	25.0	22.8	29.1	31.8	22.4	29.3	18.9	29.3	5.3	36.2	27.9	8.8	41.0	22.7	22.7	34.1	36.5	26.0	17.8	23.1	23.2	29.3	24.4	12.6	25.1	11.6	23.1	32.4	8.4	5.5	22.4	16.0	31.8	22.9	27.2	10.1	22.7	42.0	24.6	20.1	24.5	17.7	25.6	15.5	11.2	29.5	28.3	23.9	26.5	31.9	10.1	10.6	10.0	10.8	14.6	31.8	21.1	67.7	24.6	60.0	22.4	32.4	21.6	18.8	27.3	35.8	11.0	35.5	11.9	11.3	16.5	23.8	36.1	52.2	34.7	27.3	21.5	15.1	45.2	17.8	21.6	17.9	25.1	30.5	36.0	24.1	16.9	14.9	54.0	37.7	15.8	19.5	46.7	42.3	14.0	33.4	14.5	21.7	16.9	17.3	32.3	46.5	11.4	6.1	20.5	34.8	20.0	39.6	15.9	14.9	32.6	24.9	11.1	25.1	26.5	17.9	22.8	44.3	30.9	23.5	41.5	31.6	34.7	32.6	37.5	39.8	28.3	33.7	46.8	41.5	15.7	37.6	34.7	49.2	32.3	36.5	23.4	23.4	22.8	29.1	22.7	22.7	23.1	23.2	23.1	22.7	24.5	23.9	40.7	12.8	11.9	12.4	25.9	13.9	25.5	26.1	19.4	44.6	20.8	28.7	34.0	8.6	15.8	25.8	20.9	42.2	28.0	48.9	39.2	31.2	12.8	13.5	27.0	34.3	26.4	25.7	10.6	20.4	25.5	31.6	18.3	10.7	24.7	28.4	24.3	18.4	36.9	37.0	10.6	31.6	18.3	20.7	15.3	10.5	23.9	24.1	24.9	5.6	41.0	40.8	29.9	4.0	11.9	51.6	34.6	29.7	23.4	22.9	52.4	33.4	12.3	42.3	19.7	21.8	35.1	44.5	32.7	22.4	14.2	30.2	30.7	35.7	33.1	17.0
ARG2		ENSG00000081181	"Arginase 2"	P78540	14	67619920-67651708	"Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Adaptive immunity, Arginine metabolism, Immunity, Innate immunity, Urea cycle"	Hydrolase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"parathyroid gland: 220.0;prostate: 108.5;thyroid gland: 105.0"	"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 190.1;Collecting duct cells: 165.5;Glandular and luminal cells: 145.2;Proximal tubular cells: 220.9;Syncytiotrophoblasts: 601.3;Urothelial cells: 165.2"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 49.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HAP1: 58.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA000663, CAB009435"	Enhanced		Supported	Mitochondria		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	Mitochondria		"CAB009435: AB_2059089, HPA000663: AB_1078192"	"unprognostic (8.74e-3)"	"unprognostic (3.06e-2)"	"unprognostic (1.35e-2)"	"unprognostic (2.29e-1)"	"unprognostic (2.30e-1)"	"unprognostic (9.13e-2)"	"unprognostic (1.10e-2)"	"unprognostic (3.43e-3)"	"unprognostic (4.62e-3)"	"unprognostic (5.37e-2)"	"unprognostic (4.66e-3)"	"unprognostic (1.72e-1)"	"unprognostic (9.39e-2)"	"unprognostic (4.26e-1)"	"unprognostic (2.31e-1)"	"unprognostic (4.34e-1)"	"unprognostic (1.26e-1)"	2.8	7.3	5.6	2.9	6.1	0.5	4.8	6.9	13.9	17.0	7.9	2.7	3.7	7.0	3.6	16.3	1.8	9.3	3.4	6.3	11.6	64.0	3.8	3.8	0.5	6.4	7.7	18.7	5.0	220.0	45.6	8.8	9.2	108.5	1.4	22.3	17.0	5.8	35.7	2.1	15.3	3.7	5.1	0.9	3.2	3.4	6.5	3.0	105.0	52.6	1.7	17.8	9.9	5.6	8.9	1.5	14.4	9.4	2.1	0.1	20.1	6.7	17.4	20.6	34.5	36.3	4.5	14.6	1.9	4.3	9.4	2.1	58.2	26.8	24.9	0.7	14.6	6.7	2.6	41.9	6.2	1.8	37.8	1.1	33.6	10.2	49.7	1.6	35.4	37.7	19.4	0.1	1.4	4.4	2.5	1.4	27.2	4.0	0.5	0.8	2.0	16.8	16.8	14.3	31.5	12.2	4.2	4.2	6.4	32.9	15.1	1.2	7.3	6.4	15.9	0.7	5.0	1.3	2.4	4.9	12.8	7.5	10.9	0.1	0.4	0.7	0.3	0.1	0.1	0.2	0.1	0.3	0.5	0.7	0.2	0.2	0.6	0.1	0.4	0.0	0.9	1.0	5.6	6.1	6.9	13.9	6.3	11.6	6.4	7.7	9.2	5.1	6.5	5.6	3.9	0.0	5.8	5.5	8.4	8.8	190.1	17.0	7.4	5.2	41.6	28.7	6.3	4.3	20.3	165.5	10.4	86.5	14.6	9.0	37.2	8.4	16.5	75.1	18.7	5.9	36.8	8.8	20.3	3.3	6.2	5.6	37.8	145.2	7.0	23.9	2.9	1.3	14.7	10.1	41.8	24.5	12.2	0.6	3.6	3.2	0.3	9.3	10.6	7.5	0.9	40.5	1.0	9.0	9.2	5.0	5.0	0.4	5.7	95.4	72.8	220.9	3.0	17.6	6.6	6.2	8.9	8.4	3.4	9.7	5.4	601.3	15.1	2.2	8.7	165.2
ARHGAP17	"FLJ10308, FLJ13219, NADRIN, RICH1, WBP15"	ENSG00000140750	"Rho GTPase activating protein 17"	Q68EM7	16	24919389-25015666	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041703, HPA075891"	Approved		Supported	"Plasma membrane,Cytosol"		NA	NA		21000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 12: NES - Nervous system development"	"Cluster 44: Endometrium - Transcription"	"Plasma membrane, Cytosol"		"HPA041703: AB_10794304, HPA075891: "	"unprognostic (1.79e-1)"	"unprognostic (8.98e-2)"	"unprognostic (8.11e-2)"	"prognostic favorable (3.59e-4)"	"unprognostic (4.42e-2)"	"unprognostic (3.49e-2)"	"prognostic unfavorable (4.95e-4)"	"unprognostic (3.02e-2)"	"unprognostic (6.62e-2)"	"unprognostic (8.81e-3)"	"unprognostic (4.99e-2)"	"unprognostic (3.45e-2)"	"unprognostic (1.38e-2)"	"unprognostic (1.94e-1)"	"unprognostic (3.91e-2)"	"unprognostic (1.26e-1)"	"prognostic unfavorable (3.76e-4)"	46.0	40.5	8.2	15.2	9.8	9.2	37.2	9.2	10.2	29.9	9.6	32.7	11.3	28.9	7.9	33.6	28.6	11.9	48.1	7.9	9.2	25.9	22.9	31.8	24.9	10.6	9.5	24.8	24.1	9.3	30.3	15.3	10.4	23.6	12.2	2.3	21.3	7.9	41.0	34.3	39.2	11.6	8.7	66.8	28.9	25.5	9.7	12.0	28.2	11.1	20.9	25.6	29.8	11.6	28.5	16.7	21.9	23.1	22.0	23.0	23.7	18.1	19.3	20.9	20.4	25.9	11.5	13.0	12.0	36.4	19.9	7.7	21.8	12.8	22.2	20.0	26.1	10.8	37.8	43.3	25.0	15.5	10.7	29.4	7.7	22.6	16.3	15.0	35.7	11.7	14.3	0.0	23.6	20.8	14.3	19.8	25.2	8.1	13.7	68.1	17.9	5.2	25.9	6.4	14.6	14.5	18.6	20.5	8.2	17.5	11.1	40.2	46.7	15.5	11.9	35.6	15.1	13.0	17.3	7.5	19.1	22.6	14.1	5.6	9.7	9.0	6.3	17.5	5.7	25.3	5.5	6.3	14.6	22.8	6.2	6.1	4.8	6.2	15.8	25.9	8.0	8.1	8.2	9.8	9.2	10.2	7.9	9.2	10.6	9.5	10.4	8.7	9.7	11.6	33.8	9.6	11.0	26.8	46.3	14.5	6.8	8.9	14.2	6.4	11.0	9.7	24.9	7.2	9.1	5.5	10.4	11.1	36.3	49.5	3.9	13.3	6.3	30.6	21.8	32.3	21.0	16.2	28.8	16.0	18.9	16.0	15.3	66.4	7.0	16.9	26.7	6.8	27.1	10.1	33.0	21.8	8.2	30.3	21.7	10.8	13.4	25.2	16.0	59.0	22.8	6.4	14.4	40.2	68.9	17.6	27.2	11.7	11.5	11.1	35.4	5.0	8.5	7.5	26.3	15.5	43.8	7.0	11.7	24.7	24.0	15.7	21.1	15.9	19.7	12.2
ARHGAP18	"bA307O14.2, MacGAP"	ENSG00000146376	"Rho GTPase activating protein 18"	Q8N392	6	129576132-129710177	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"granulocytes: 253.6;Respiratory ciliated cells: 265.3;Syncytiotrophoblasts: 212.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HMC-1: 395.8;LHCN-M2: 113.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031595	Approved		Supported	"Nuclear speckles,Plasma membrane,Cytosol"		NA	NA		1900000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 51: Myeloid cells - Hemostasis"	Cytosol	"Nuclear speckles, Plasma membrane"	"HPA031595: AB_10959905"	"unprognostic (6.39e-2)"	"unprognostic (1.60e-1)"	"unprognostic (5.45e-2)"	"unprognostic (5.49e-2)"	"unprognostic (3.05e-1)"	"unprognostic (3.17e-1)"	"unprognostic (9.32e-3)"	"unprognostic (1.25e-2)"	"unprognostic (2.98e-2)"	"unprognostic (3.12e-2)"	"prognostic unfavorable (2.54e-4)"	"unprognostic (4.08e-1)"	"unprognostic (2.29e-3)"	"unprognostic (2.22e-1)"	"unprognostic (3.05e-2)"	"unprognostic (5.52e-2)"	"unprognostic (1.08e-1)"	20.5	37.2	3.4	13.0	2.5	4.3	13.4	2.4	2.8	14.9	15.1	14.8	24.8	6.7	20.2	6.0	28.3	15.4	6.0	2.9	4.1	28.4	6.3	28.7	9.4	4.7	5.7	6.0	33.2	14.2	6.7	20.8	4.3	9.9	15.0	2.6	14.6	8.4	10.6	4.0	27.3	10.6	3.5	9.0	27.9	8.3	6.4	6.1	23.0	13.0	7.9	12.6	4.1	3.7	8.6	18.8	1.9	2.6	17.8	25.0	15.1	64.0	48.8	27.7	18.5	10.0	14.1	7.1	30.6	43.2	8.8	11.0	13.4	20.9	51.3	7.0	5.7	46.7	13.8	57.3	25.4	6.9	395.8	15.9	3.2	50.4	44.7	57.8	79.8	0.0	25.3	17.4	113.1	2.3	0.1	6.8	2.0	16.0	4.5	0.3	8.5	13.7	84.6	4.8	0.0	0.1	5.3	8.8	32.3	9.3	9.7	8.1	61.6	28.8	4.1	2.3	51.8	7.8	6.0	4.8	9.7	12.7	40.9	12.0	5.1	13.5	4.9	5.8	3.1	2.9	2.5	5.5	4.8	1.7	0.4	2.6	3.9	2.5	3.2	11.8	2.8	6.0	3.4	2.5	2.4	2.8	2.9	4.1	4.7	5.7	4.3	3.5	6.4	3.7	139.5	57.7	33.3	1.6	13.0	13.0	17.7	15.7	10.8	0.7	53.4	14.7	4.1	17.2	39.5	38.6	2.1	92.7	31.0	19.0	150.6	48.2	20.7	176.1	5.8	89.2	13.1	10.9	16.8	120.5	24.9	45.3	63.2	35.7	253.6	34.7	11.0	5.0	110.4	0.0	23.1	22.1	63.1	48.4	112.4	21.2	3.7	163.9	7.2	43.1	23.9	16.4	28.8	12.5	2.2	102.4	25.0	1.2	26.4	18.5	69.8	31.7	265.3	0.9	26.3	38.9	32.5	10.6	1.1	11.2	12.9	212.3	35.9	69.1	31.3	19.1
ARHGAP21	"ARHGAP10, KIAA1424"	ENSG00000107863	"Rho GTPase activating protein 21"	Q5T5U3	10	24583609-24723887	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 111.2"	"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 266.5;Oligodendrocyte precursor cells: 336.7;Oligodendrocytes: 827.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036610, HPA057861"	Approved		Supported	"Plasma membrane,Cell Junctions,Actin filaments"		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 68: Oligodendrocytes - Mixed function"	"Cell Junctions, Actin filaments"	"Plasma membrane"	"HPA036610: AB_10669910, HPA057861: AB_2683546"	"unprognostic (7.65e-2)"	"unprognostic (1.61e-2)"	"unprognostic (1.88e-1)"	"unprognostic (5.84e-2)"	"unprognostic (2.69e-1)"	"unprognostic (3.59e-1)"	"unprognostic (1.12e-3)"	"unprognostic (5.35e-2)"	"unprognostic (9.75e-2)"	"unprognostic (3.34e-2)"	"unprognostic (2.65e-3)"	"unprognostic (3.23e-1)"	"unprognostic (3.14e-2)"	"unprognostic (1.53e-1)"	"unprognostic (3.32e-1)"	"unprognostic (1.43e-2)"	"unprognostic (2.61e-2)"	28.4	18.0	44.3	10.3	77.7	7.2	16.1	56.7	58.1	19.7	0.0	16.6	12.9	19.9	8.6	10.8	17.5	17.9	21.2	49.1	48.3	11.0	13.1	21.7	5.3	76.3	63.1	31.9	14.9	14.6	12.1	16.6	66.7	10.8	18.5	41.3	24.5	11.5	17.7	6.8	16.3	17.8	48.4	8.9	27.1	14.6	58.0	11.4	12.8	23.0	6.0	13.8	9.0	111.2	59.0	25.1	60.9	52.3	42.2	59.1	21.6	41.6	26.6	24.5	34.0	18.4	36.8	10.9	14.0	64.3	37.7	38.1	31.6	40.4	35.9	38.0	20.5	64.9	54.7	13.8	25.5	0.0	9.9	24.4	45.0	32.1	34.4	36.9	42.3	16.1	27.9	96.3	50.0	11.6	30.2	2.3	9.7	20.8	13.6	7.0	21.4	6.2	17.2	10.2	10.5	10.9	27.9	16.0	32.6	18.1	16.3	9.1	47.8	35.3	22.7	40.0	30.6	11.0	20.3	7.8	36.2	11.4	24.7	0.9	0.2	0.4	0.1	0.4	0.1	0.0	0.2	0.3	0.3	0.0	0.6	0.3	0.0	0.2	0.2	0.4	0.4	0.2	44.3	77.7	56.7	58.1	49.1	48.3	76.3	63.1	66.7	48.4	58.0	111.2	47.9	86.6	33.1	246.8	6.5	29.6	13.2	23.6	14.8	144.0	17.5	26.0	37.4	24.3	45.0	5.5	68.8	23.8	6.9	44.6	1.9	21.4	5.0	36.2	148.7	34.9	16.2	15.2	266.5	27.6	21.0	73.0	82.0	54.2	17.1	135.8	26.0	20.9	14.6	132.9	153.8	28.3	14.2	32.8	31.8	8.3	92.9	38.9	19.6	171.4	11.0	194.0	2.1	336.7	827.4	37.1	34.6	59.5	15.2	27.4	21.9	6.5	30.3	53.5	26.3	60.4	43.2	27.4	35.6	18.1	20.2	12.6	11.8	62.2	29.0	29.5
ARHGAP22	RhoGAP2	ENSG00000128805	"Rho GTPase activating protein 22"	Q7Z5H3	10	48446036-48656265	"Predicted intracellular proteins"	"Angiogenesis, Differentiation, Transcription, Transcription regulation"	"Developmental protein, GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 22.6"	"Cell type enhanced"	"Detected in many"		"Late spermatids: 122.7;Microglial cells: 227.7;Oligodendrocyte precursor cells: 141.8;Oligodendrocytes: 200.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"classical monocyte: 1.1"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 68.8;LHCN-M2: 64.8;TIME: 66.2;U-87 MG: 82.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB020696, HPA040391, HPA064439"	Uncertain		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 70: Brain - Nervous system development"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Nucleoplasm, Cytosol"	"Plasma membrane"	"CAB020696: , HPA040391: AB_2676957, HPA064439: AB_2685266"	"unprognostic (1.87e-1)"	"unprognostic (3.98e-2)"	"unprognostic (2.38e-2)"	"unprognostic (2.62e-1)"	"unprognostic (1.07e-1)"	"unprognostic (6.74e-3)"	"unprognostic (4.81e-3)"	"unprognostic (2.78e-1)"	"unprognostic (1.66e-1)"	"unprognostic (3.03e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.02e-1)"	"prognostic unfavorable (2.16e-8)"	"unprognostic (7.40e-2)"	"unprognostic (1.60e-1)"	"unprognostic (9.39e-2)"	"unprognostic (3.66e-2)"	2.6	1.9	12.0	3.0	15.7	1.4	1.6	17.6	14.5	1.6	7.7	2.0	0.6	1.1	0.7	1.4	1.8	1.8	4.4	11.9	12.7	1.3	0.8	2.0	2.7	22.6	17.0	4.8	1.7	0.9	2.0	0.8	20.1	3.3	1.0	0.4	2.0	1.1	1.9	2.2	1.6	1.4	16.9	2.8	1.2	4.8	17.0	2.8	6.6	1.6	2.2	2.1	2.2	22.2	6.2	1.4	0.4	0.0	5.1	20.8	4.3	31.9	15.1	3.0	4.1	7.0	0.9	0.0	1.2	13.1	2.1	12.4	0.4	11.2	5.4	0.6	11.5	18.2	0.2	0.1	2.7	2.0	2.0	5.0	11.2	37.1	3.0	68.8	20.6	0.0	17.4	3.0	64.8	0.2	0.2	0.1	7.2	0.0	0.5	0.1	0.0	7.9	6.5	0.7	1.1	6.4	1.5	0.1	0.6	0.6	0.4	0.3	66.2	30.1	0.4	3.8	23.8	0.0	0.0	0.0	82.5	0.3	4.9	0.0	1.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.9	0.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	12.0	15.7	17.6	14.5	11.9	12.7	22.6	17.0	20.1	16.9	17.0	22.2	0.9	0.0	1.7	4.2	2.9	3.4	4.1	6.8	4.6	1.1	0.8	3.0	2.9	1.5	2.9	0.0	2.1	11.6	3.2	0.2	0.0	2.8	53.6	0.7	1.6	2.4	0.0	10.9	51.7	4.4	0.7	6.5	0.5	1.0	0.0	4.4	1.8	0.0	10.3	0.0	29.8	0.3	2.0	7.6	14.2	122.7	2.8	15.6	1.8	227.7	14.8	1.8	0.0	141.8	200.8	2.5	0.0	6.0	0.5	1.9	0.0	0.2	3.8	1.4	0.0	1.6	4.2	1.6	4.3	0.4	0.6	1.0	0.7	10.6	0.1	0.6
ARHGAP28	"FLJ10312, KIAA1314"	ENSG00000088756	"Rho GTPase activating protein 28"	Q9P2N2	18	6729716-6915716	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"placenta: 25.9;testis: 77.5"	"Group enriched"	"Detected in many"	14	"Early spermatids: 536.8;Late spermatids: 488.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in single"	4	"neutrophil: 3.0"	"Lineage enriched"	"Detected in single"	11	"granulocytes: 3.0"	"Cell line enhanced"	"Detected in many"		"AF22: 30.4;CACO-2: 32.8;SuSa: 22.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA030413, HPA030414, HPA030415"	Enhanced		Supported	"Cell Junctions"		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 83: Testis - Spermatogenesis"	"Cluster 12: NES - Nervous system development"	"Cluster 34: Spermatids - Unknown function"	"Cell Junctions"		"HPA030413: AB_10601455, HPA030414: AB_10670042, HPA030415: AB_10669598"	"unprognostic (8.33e-2)"	"unprognostic (8.79e-3)"	"unprognostic (3.15e-3)"	"unprognostic (6.94e-5)"	"unprognostic (1.49e-1)"	"unprognostic (2.92e-2)"	"unprognostic (1.11e-3)"	"unprognostic (1.10e-1)"	"unprognostic (7.56e-3)"	"unprognostic (9.52e-4)"	"unprognostic (1.43e-2)"	"unprognostic (3.12e-1)"	"unprognostic (4.53e-3)"	"unprognostic (3.59e-3)"	"unprognostic (6.00e-2)"	"unprognostic (3.61e-2)"	"unprognostic (2.76e-2)"	4.7	1.9	1.1	1.7	1.2	0.8	2.7	1.7	1.6	8.6	0.8	1.9	1.7	2.9	8.7	1.9	3.1	6.6	2.0	1.5	1.6	8.4	0.9	4.6	1.7	0.4	0.2	10.4	3.8	3.0	0.8	25.9	0.5	3.9	2.3	1.4	0.8	2.2	4.9	2.1	1.8	1.4	0.1	12.6	2.1	77.5	1.1	3.8	2.9	1.6	0.9	5.4	3.0	0.8	0.2	0.2	30.4	3.1	6.3	10.5	4.9	2.2	5.1	2.5	5.3	32.8	0.2	0.2	1.0	0.4	1.7	1.4	0.1	0.8	3.7	1.0	1.8	0.1	2.9	0.2	1.1	0.1	0.1	12.6	0.6	2.7	0.2	0.3	7.8	0.5	0.8	2.5	4.1	0.5	0.5	0.3	9.6	0.4	1.4	0.1	2.7	0.2	0.0	2.9	2.9	11.9	0.1	2.8	0.5	22.6	0.2	0.1	1.3	0.5	13.1	10.1	0.4	0.2	0.1	0.1	5.0	0.3	1.1	0.7	0.2	0.3	0.1	0.1	0.1	0.0	0.0	0.1	0.0	0.2	0.1	0.1	3.0	0.1	0.0	0.2	0.0	0.0	1.1	1.2	1.7	1.6	1.5	1.6	0.4	0.2	0.5	0.1	1.1	0.8	8.3	0.0	1.9	6.2	0.1	1.9	1.3	0.2	0.0	1.5	0.9	0.5	1.8	0.0	0.7	1.8	20.9	14.9	0.0	0.0	0.0	1.1	536.8	0.5	14.6	7.9	0.0	0.0	7.1	2.7	2.7	16.1	0.0	0.4	0.0	25.8	4.2	0.2	2.1	0.0	34.4	0.1	0.0	0.3	0.4	488.0	18.3	0.5	0.0	12.2	0.0	0.2	0.0	24.6	3.6	0.7	0.0	14.3	0.1	4.7	0.0	3.8	0.0	0.8	0.0	11.0	5.4	14.3	3.7	0.8	1.4	6.6	0.3	23.7	0.0	1.3
ARHGAP30	FLJ00267	ENSG00000186517	"Rho GTPase activating protein 30"	Q7Z6I6	1	161046946-161069970	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 57.6;lymphoid tissue: 77.0"	"Cell type enhanced"	"Detected in many"		"B-cells: 71.6;dendritic cells: 103.4;Kupffer cells: 77.8;Macrophages: 79.1;monocytes: 133.0;NK-cells: 268.8;T-cells: 105.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"Daudi: 118.2;HL-60: 92.5;HMC-1: 123.4;Karpas-707: 93.1;MOLT-4: 75.8;THP-1: 90.9;U-266/70: 138.6;U-266/84: 97.7;U-698: 97.9;U-937: 72.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA036300	Enhanced		Supported	Vesicles		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 16: Immune cells - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	Vesicles		"HPA036300: AB_10601117"	"unprognostic (7.31e-2)"	"unprognostic (8.83e-3)"	"unprognostic (7.46e-3)"	"unprognostic (1.77e-3)"	"unprognostic (7.41e-2)"	"unprognostic (1.68e-3)"	"unprognostic (3.05e-1)"	"unprognostic (6.78e-3)"	"unprognostic (1.94e-2)"	"unprognostic (3.89e-2)"	"unprognostic (7.91e-2)"	"unprognostic (3.09e-1)"	"prognostic unfavorable (9.78e-4)"	"unprognostic (1.18e-1)"	"unprognostic (1.08e-2)"	"unprognostic (6.64e-2)"	"unprognostic (2.65e-2)"	12.1	4.9	3.1	55.9	3.6	57.6	5.3	3.7	4.3	3.4	3.3	8.1	9.5	2.9	2.8	14.1	4.5	10.2	2.8	2.9	3.6	3.4	6.6	25.2	77.0	6.1	4.5	2.0	2.4	1.4	1.8	7.0	5.4	3.4	8.4	0.6	6.4	2.3	2.6	19.8	23.9	8.0	5.0	75.5	11.6	2.3	6.3	63.7	2.9	2.7	61.2	13.8	6.5	6.8	0.8	0.1	0.2	0.0	0.0	0.0	1.4	0.1	0.0	0.0	0.0	0.3	1.2	118.2	0.6	0.0	0.1	2.3	0.0	0.0	0.2	55.3	0.2	39.7	0.2	0.0	0.0	92.5	123.4	0.0	1.2	0.1	0.0	0.1	0.0	56.8	0.3	93.1	0.0	1.0	75.8	21.3	0.1	0.7	0.1	46.8	0.6	1.6	0.0	1.0	0.7	0.3	0.2	0.7	0.2	0.7	0.8	90.9	0.9	0.1	0.7	0.2	0.5	138.6	97.7	97.9	0.4	72.3	0.1	7.1	29.6	33.1	32.9	32.2	25.1	11.9	21.9	27.1	21.8	12.6	17.9	25.0	48.5	19.3	46.4	15.0	23.8	33.5	3.1	3.6	3.7	4.3	2.9	3.6	6.1	4.5	5.4	5.0	6.3	6.8	1.5	3.2	20.5	0.3	71.6	5.6	3.3	6.8	0.0	0.5	5.2	2.9	1.3	2.8	13.8	0.0	4.2	0.6	103.4	0.5	0.0	3.4	2.2	6.6	1.2	2.3	0.0	14.5	0.3	6.0	1.9	1.9	3.1	13.7	68.3	0.0	6.1	1.7	55.5	0.0	0.3	0.4	8.2	77.8	44.6	0.7	0.3	79.1	5.4	14.0	133.0	0.1	268.8	0.5	1.2	12.5	0.2	0.0	49.8	5.4	0.0	0.5	15.3	3.0	0.0	1.0	1.9	0.1	0.1	9.9	24.6	4.5	105.1	0.2	0.5	16.7
ARHGAP32	"GC-GAP, GRIT, KIAA0712, MGC1892, RICS"	ENSG00000134909	"Rho GTPase activating protein 32"	A7KAX9	11	128965060-129279324	"Cancer-related genes, Predicted intracellular proteins"		"GTPase activation"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 240.6;Excitatory neurons: 403.4;Inhibitory neurons: 239.7;Oligodendrocyte precursor cells: 170.9"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in many"		"cerebral cortex: 26.6"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"OE19: 36.6;RT4: 39.5;SK-BR-3: 42.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038382, HPA038389, HPA061505"	Approved		Approved	"Nucleoplasm,Nucleoli fibrillar center,Golgi apparatus"		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 45: Intestine - Brush border"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Golgi apparatus"	"Nucleoplasm, Nucleoli fibrillar center"	"HPA038382: AB_2675984, HPA038389: AB_10670972, HPA061505: AB_2684544"	"unprognostic (1.17e-1)"	"unprognostic (3.58e-2)"	"unprognostic (2.54e-2)"	"unprognostic (1.82e-1)"	"unprognostic (3.89e-2)"	"unprognostic (5.64e-2)"	"unprognostic (1.52e-1)"	"unprognostic (5.97e-2)"	"unprognostic (7.32e-2)"	"unprognostic (1.34e-1)"	"prognostic unfavorable (6.64e-4)"	"unprognostic (1.47e-1)"	"unprognostic (6.17e-3)"	"unprognostic (1.17e-1)"	"unprognostic (4.01e-1)"	"unprognostic (5.80e-2)"	"unprognostic (1.64e-2)"	4.7	7.5	2.6	3.4	8.2	2.1	10.3	0.0	26.6	11.9	0.0	14.1	21.1	8.1	9.0	26.3	13.3	7.6	4.3	15.1	0.0	7.0	5.0	5.8	1.6	0.0	0.0	10.9	15.2	10.7	6.1	8.6	0.0	6.4	15.8	33.5	15.8	4.2	7.6	20.1	20.6	5.9	0.0	3.0	12.0	10.7	0.0	10.5	3.8	4.3	6.9	9.4	17.1	5.1	12.2	6.4	19.7	0.1	6.3	6.3	14.2	4.5	6.3	2.8	3.4	14.9	24.7	0.1	6.7	8.7	14.1	27.2	9.0	11.4	5.4	0.0	3.1	0.2	3.4	5.6	3.1	0.0	0.0	6.1	14.4	2.7	16.3	6.2	3.5	10.2	0.6	0.2	4.9	9.5	10.2	0.2	5.4	36.6	6.8	24.9	5.9	2.5	3.0	39.5	19.3	7.9	6.8	42.3	8.0	7.5	21.9	3.9	6.6	9.9	5.2	5.9	8.9	0.3	0.0	0.1	4.3	27.4	6.4	0.0	0.1	0.0	0.0	0.4	0.2	0.0	0.0	0.1	0.2	0.2	0.2	0.0	0.1	0.7	0.1	0.3	0.1	0.1	2.6	8.2	0.0	26.6	15.1	0.0	0.0	0.0	0.0	0.0	0.0	5.1	5.3	6.4	16.8	240.6	3.4	18.2	12.7	29.1	16.5	31.6	36.5	17.1	4.3	14.3	46.6	11.0	123.0	23.1	4.8	48.7	1.9	8.3	19.0	27.7	10.0	5.6	40.7	2.5	403.4	27.2	4.2	14.1	35.2	25.4	1.3	9.8	5.0	16.2	6.5	18.5	239.7	61.9	20.3	4.1	4.2	12.3	6.8	5.7	16.0	103.0	2.9	113.6	0.0	170.9	95.0	24.5	44.2	13.2	1.5	22.7	52.7	9.9	61.6	37.9	19.7	19.4	9.5	8.6	9.6	55.4	31.1	28.5	2.0	4.0	54.0	59.5
ARHGAP35	"GRF-1, GRLF1, KIAA1722, P190A, p190ARhoGAP, p190RhoGAP"	ENSG00000160007	"Rho GTPase activating protein 35"	Q9NRY4	19	46860997-47005077	"Cancer-related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"DNA-binding, GTPase activation, Repressor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"Early spermatids: 186.4;Late spermatids: 651.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB037311, HPA055184, HPA056470"	Approved		Supported	"Nuclear bodies,Aggresome"		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 15: RT4 - Unknown function"	"Cluster 31: Spermatids - Spermatogenesis"	"Nuclear bodies"	Aggresome	"CAB037311: AB_477435, HPA055184: AB_2682730, HPA056470: AB_2683142"	"unprognostic (5.47e-3)"	"unprognostic (1.38e-1)"	"unprognostic (1.80e-1)"	"unprognostic (2.40e-2)"	"unprognostic (2.01e-2)"	"unprognostic (7.78e-3)"	"unprognostic (9.82e-3)"	"unprognostic (4.41e-2)"	"unprognostic (2.71e-1)"	"unprognostic (2.73e-2)"	"unprognostic (3.25e-2)"	"unprognostic (1.92e-1)"	"prognostic favorable (5.55e-8)"	"unprognostic (2.78e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.16e-1)"	13.6	10.1	35.7	8.0	31.5	5.3	16.1	16.8	31.1	12.9	9.2	14.8	12.9	12.8	10.6	15.7	12.8	9.1	25.8	37.0	27.3	19.1	22.3	14.9	8.7	26.0	32.3	17.3	13.6	31.3	14.1	7.8	34.5	13.4	12.3	16.6	15.7	15.7	29.4	11.6	16.3	12.9	19.8	8.8	10.9	40.3	33.3	10.8	20.2	24.2	9.0	13.1	9.0	25.1	52.0	56.7	37.9	34.0	33.9	27.9	6.4	27.3	38.7	27.1	31.0	30.6	18.0	27.4	19.1	112.0	41.2	30.8	34.8	35.3	36.9	19.3	14.7	37.2	40.1	24.1	31.7	22.3	30.4	28.3	35.1	30.6	32.5	37.9	24.7	18.2	25.2	9.9	31.4	30.3	21.8	35.4	19.9	37.4	20.8	24.1	26.0	8.5	23.0	100.0	37.9	36.1	50.5	47.5	20.0	23.4	44.6	27.1	31.3	23.9	18.9	26.2	33.0	10.1	19.6	21.7	53.6	22.8	59.7	0.3	0.2	0.2	0.6	0.2	0.6	0.1	0.6	0.7	0.3	0.2	0.2	0.2	0.1	0.2	0.3	0.3	0.2	0.3	35.7	31.5	16.8	31.1	37.0	27.3	26.0	32.3	34.5	19.8	33.3	25.1	15.7	44.8	38.4	47.7	8.6	15.2	13.9	20.1	19.4	31.9	35.2	23.0	58.2	27.1	21.4	25.8	25.0	3.7	14.8	61.0	7.9	14.6	186.4	17.8	19.0	19.5	31.2	16.6	42.4	20.0	1.0	19.1	19.9	34.1	9.5	30.9	27.8	89.7	15.0	69.0	48.8	18.5	14.2	19.5	7.8	651.3	23.3	11.0	21.4	32.8	14.2	28.2	18.6	37.2	58.2	20.9	21.4	25.6	6.7	23.3	44.5	22.6	10.4	22.0	19.7	22.6	24.9	45.9	23.5	24.4	16.6	1.6	16.1	29.5	25.7	17.0
ARHGAP4	"C1, KIAA0131, p115, RhoGAP4, SrGAP4"	ENSG00000089820	"Rho GTPase activating protein 4"	P98171	X	153907367-153934999	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 119.1;lymphoid tissue: 120.9"	"Cell type enhanced"	"Detected in many"		"B-cells: 65.3;dendritic cells: 70.0;Hofbauer cells: 86.6;Kupffer cells: 77.2;Macrophages: 76.0;NK-cells: 70.0;T-cells: 69.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 103.0;HL-60: 76.7;Karpas-707: 90.8;MOLT-4: 93.0;RPMI-8226: 180.7;THP-1: 83.7;U-698: 90.4;U-937: 79.9"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"HPA000301, HPA001012, HPA001083"	Enhanced		Supported	Cytosol		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 2: Immune cells - Immune response"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 57: B-cells - Immune response"	Cytosol		"HPA000301: , HPA001012: AB_1078201, HPA001083: AB_1078199"	"unprognostic (3.54e-2)"	"prognostic favorable (3.94e-5)"	"prognostic unfavorable (1.97e-5)"	"unprognostic (5.79e-2)"	"unprognostic (9.42e-2)"	"prognostic favorable (3.31e-4)"	"unprognostic (5.72e-3)"	"unprognostic (1.39e-1)"	"unprognostic (3.27e-1)"	"unprognostic (1.37e-1)"	"unprognostic (7.81e-3)"	"unprognostic (1.45e-1)"	"prognostic unfavorable (2.49e-4)"	"unprognostic (8.47e-3)"	"unprognostic (2.01e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.99e-1)"	20.0	12.5	5.2	52.2	5.4	119.1	13.4	6.9	6.5	9.9	15.0	18.6	14.2	9.7	3.1	7.0	12.9	14.4	10.3	5.7	6.3	22.6	8.6	36.2	73.8	10.9	8.3	5.4	5.9	1.7	8.6	21.2	9.3	11.1	6.9	1.2	9.2	3.8	4.3	5.0	49.7	6.5	8.2	120.9	12.6	7.2	8.5	42.7	10.9	1.5	33.7	11.6	9.2	10.0	1.5	0.6	1.0	5.9	0.2	0.0	2.5	1.0	0.4	0.1	0.2	0.4	42.8	103.0	5.9	0.1	0.8	1.2	4.6	0.2	0.0	27.8	3.4	44.4	0.5	1.7	3.6	76.7	59.7	0.2	0.4	0.0	0.3	0.5	9.1	22.4	0.5	90.8	0.5	4.6	93.0	1.5	3.7	0.4	0.3	44.6	12.0	180.7	0.4	0.7	8.4	12.1	0.9	2.1	0.9	1.2	19.0	83.7	1.9	0.3	1.3	0.9	0.5	60.1	55.8	90.4	0.7	79.9	0.2	10.9	26.1	35.4	26.2	42.4	18.6	18.0	18.8	21.1	25.5	16.9	17.4	17.4	22.4	16.0	59.4	31.6	23.5	26.1	5.2	5.4	6.9	6.5	5.7	6.3	10.9	8.3	9.3	8.2	8.5	10.0	16.0	9.6	22.7	2.6	65.3	3.4	0.6	0.2	0.0	13.7	2.4	6.1	48.3	1.5	2.7	18.4	4.2	1.9	70.0	9.5	5.9	0.9	0.1	2.4	1.4	13.0	4.8	11.3	2.1	0.6	1.9	3.5	7.1	1.5	34.2	7.7	4.2	0.5	86.6	3.3	1.4	6.6	0.0	77.2	31.5	0.2	0.9	76.0	10.6	19.7	42.5	1.9	70.0	2.0	0.7	0.2	0.5	0.0	32.9	0.5	3.0	0.8	8.7	4.6	0.0	7.1	2.6	0.7	5.2	1.6	1.7	1.4	69.5	1.1	5.0	0.4
ARHGAP40	"C20orf95, dJ1100H13.4"	ENSG00000124143	"Rho GTPase activating protein 40"	Q5TG30	20	38601934-38651035	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Group enriched"	"Detected in many"	4	"breast: 32.4;epididymis: 35.7;esophagus: 28.7;skin 1: 45.3"	"Cell type enhanced"	"Detected in some"		"Breast glandular cells: 14.7;Breast myoepithelial cells: 8.6;Club cells: 4.3;Collecting duct cells: 3.7;Early spermatids: 7.2;Late spermatids: 4.3;Respiratory ciliated cells: 3.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 8.3;HBEC3-KT: 13.6;RPTEC TERT1: 11.7;SK-BR-3: 12.7;T-47d: 15.4"	"Not detected"	"Not detected"							"HPA042636, HPA042840"	Uncertain		Supported	"Nucleoplasm,Plasma membrane,Centrosome,Cytosol"		No	NA				"Cluster 30: Epididymis - Antimicrobial activity"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 35: Glandular cells - Unknown function"	"Plasma membrane, Cytosol"	"Nucleoplasm, Centrosome"	"HPA042636: AB_10962149, HPA042840: AB_10963929"	"unprognostic (9.89e-3)"	"unprognostic (2.57e-1)"	"unprognostic (1.93e-1)"	"unprognostic (1.24e-3)"	"unprognostic (3.11e-2)"	"unprognostic (1.89e-1)"	"unprognostic (2.50e-3)"	"unprognostic (1.69e-1)"	"unprognostic (3.09e-2)"	"unprognostic (4.35e-2)"	"unprognostic (5.63e-3)"	"unprognostic (2.52e-1)"	"prognostic unfavorable (2.89e-4)"	"unprognostic (2.24e-1)"	"unprognostic (7.42e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.54e-1)"	0.1	0.0	0.3	0.0	1.3	0.0	32.4	0.1	0.6	3.2	0.2	0.0	1.7	0.7	35.7	28.7	0.1	0.1	0.0	0.2	0.3	5.6	0.1	0.8	0.0	0.3	1.8	0.0	0.3	0.0	0.0	0.0	0.8	4.6	0.0	0.0	3.6	7.9	0.4	45.3	0.0	0.0	0.2	0.0	4.6	2.7	0.6	0.0	0.9	0.0	3.7	3.2	7.4	0.2	4.5	0.0	0.0	0.0	0.0	0.0	8.3	0.1	0.0	0.0	0.1	0.2	0.9	0.0	3.6	0.0	0.0	0.0	0.0	13.6	0.2	0.0	0.0	0.2	0.0	3.4	0.0	0.0	0.0	0.0	4.7	0.0	0.0	0.0	0.5	0.5	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	11.7	0.0	0.0	0.0	0.0	12.7	0.0	1.6	15.4	0.5	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.3	0.1	0.6	0.2	0.3	0.3	1.8	0.8	0.2	0.6	0.2	0.1	0.0	1.5	0.7	0.0	0.3	0.0	1.8	0.0	0.0	14.7	8.6	0.1	0.0	4.3	3.7	0.0	0.0	0.2	0.0	0.0	0.0	7.2	0.4	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	4.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.1	0.0	0.0	0.0	0.7	0.0	0.4	3.4	0.0	0.0	0.0	0.3	0.7	2.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3
ARHGAP45	"HA-1, HMHA1, KIAA0223"	ENSG00000180448	"Rho GTPase activating protein 45"	Q92619	19	1065923-1086628	"Plasma proteins, Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"bone marrow: 68.3;intestine: 53.2;lung: 39.5;lymphoid tissue: 106.1"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 48.1;Cytotrophoblasts: 40.1;dendritic cells: 62.7;Extravillous trophoblasts: 56.6;Hofbauer cells: 40.0;monocytes: 72.4;Syncytiotrophoblasts: 75.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 73.7;Karpas-707: 100.4;RPMI-8226: 74.7;THP-1: 92.3;U-266/70: 130.8;U-937: 72.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA019816, HPA079252"	Enhanced		Supported	"Plasma membrane,Cytosol"		NA	NA		1200000	"Cluster 32: T-cells - Unknown function"	"Cluster 2: Immune cells - Immune response"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 7: Non-specific - Mitochondria"	"Plasma membrane, Cytosol"		"HPA019816: AB_1853923, HPA079252: "	"unprognostic (1.34e-1)"	"unprognostic (5.13e-3)"	"unprognostic (5.17e-3)"	"prognostic favorable (6.02e-4)"	"unprognostic (2.26e-1)"	"prognostic favorable (7.82e-4)"	"unprognostic (1.59e-2)"	"unprognostic (2.17e-2)"	"unprognostic (3.55e-1)"	"unprognostic (4.78e-2)"	"unprognostic (2.43e-1)"	"unprognostic (2.05e-2)"	"unprognostic (1.00e-1)"	"unprognostic (4.59e-1)"	"unprognostic (5.19e-2)"	"unprognostic (3.24e-2)"	"unprognostic (5.33e-2)"	11.2	5.5	3.6	43.1	3.4	68.3	5.5	4.4	7.5	4.2	5.1	12.4	7.2	3.5	0.5	5.5	6.7	5.0	4.4	3.3	4.4	7.8	7.4	39.5	58.4	9.1	5.4	2.0	2.7	0.8	4.5	6.0	6.9	5.9	2.6	8.7	6.4	1.5	2.1	3.9	53.2	2.2	7.6	106.1	10.9	3.5	8.1	32.9	9.0	0.8	18.6	6.6	5.5	11.4	11.2	2.1	0.1	12.1	0.0	0.0	27.8	0.1	0.0	0.0	0.0	29.2	13.9	73.7	3.0	0.0	0.4	9.6	2.1	0.6	0.0	54.7	1.0	10.1	22.6	3.5	0.4	48.6	56.2	0.0	2.9	0.1	0.0	0.0	0.1	46.8	6.8	100.4	0.0	0.6	54.5	43.4	7.6	1.9	5.4	52.0	0.3	74.7	0.0	0.2	0.6	0.2	16.8	0.0	4.5	0.7	3.5	92.3	4.8	0.2	1.9	0.2	0.3	130.8	60.2	58.8	0.3	72.1	5.4	6.7	24.4	25.3	45.7	21.2	38.8	15.9	52.2	54.1	22.5	18.3	68.9	53.6	37.0	28.0	20.9	13.3	43.5	59.8	3.6	3.4	4.4	7.5	3.3	4.4	9.1	5.4	6.9	7.6	8.1	11.4	2.0	48.1	8.4	0.0	17.8	0.0	0.0	0.0	0.0	0.0	15.2	11.0	0.0	0.0	1.8	11.0	0.0	40.1	62.7	0.0	0.0	2.6	0.0	4.5	0.7	1.6	0.0	0.0	0.0	3.8	56.6	1.3	0.0	3.5	3.8	0.2	0.0	0.0	40.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	29.0	0.0	0.0	72.4	0.0	0.0	0.0	0.0	7.8	0.0	0.0	15.2	0.0	0.0	7.9	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	75.5	30.2	0.1	0.0	0.0
ARHGAP5	"GFI2, p190-B, p190BRhoGAP, RhoGAP5"	ENSG00000100852	"Rho GTPase activating protein 5"	Q13017	14	32076114-32159728	"Plasma proteins, Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Astrocytes: 381.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046993, HPA056507"	Approved		Supported	"Endoplasmic reticulum,Cytosol"		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 15: RT4 - Unknown function"	"Cluster 64: Astrocytes - Nervous system maintenance"	"Endoplasmic reticulum, Cytosol"		"HPA046993: AB_2679895, HPA056507: AB_2683158"	"unprognostic (1.79e-1)"	"unprognostic (2.03e-1)"	"unprognostic (2.66e-3)"	"unprognostic (6.77e-2)"	"unprognostic (1.69e-1)"	"unprognostic (3.75e-2)"	"unprognostic (1.55e-2)"	"unprognostic (6.23e-2)"	"unprognostic (2.88e-1)"	"unprognostic (2.18e-1)"	"unprognostic (1.28e-2)"	"unprognostic (6.63e-2)"	"prognostic favorable (3.97e-8)"	"unprognostic (9.79e-2)"	"unprognostic (2.21e-1)"	"unprognostic (2.13e-1)"	"unprognostic (1.00e-2)"	23.7	27.3	54.3	19.8	55.5	10.9	27.3	66.4	53.6	26.2	12.1	29.5	35.3	28.0	24.7	66.5	23.2	32.7	62.8	47.5	52.7	43.0	31.8	28.0	14.6	42.9	52.0	47.3	29.7	48.1	10.0	37.1	43.2	30.5	26.3	57.8	59.8	29.3	14.0	30.8	38.9	23.4	45.6	42.9	29.4	46.5	50.6	18.3	68.5	24.7	18.5	32.8	15.7	80.4	61.0	48.5	47.3	69.8	60.7	42.4	27.3	37.1	45.6	22.1	32.9	62.2	58.0	17.9	32.1	47.0	37.2	63.3	46.0	39.9	42.7	18.0	26.6	26.9	30.1	91.2	41.5	16.5	15.5	47.5	78.8	20.7	77.1	54.3	27.4	33.3	24.3	51.8	36.3	31.9	36.4	0.8	23.7	67.1	57.7	38.9	58.2	3.5	48.4	159.5	73.2	28.6	99.6	52.7	74.6	52.5	54.8	1.1	44.6	40.8	60.6	33.9	27.6	19.7	41.5	2.8	20.5	17.5	113.1	2.2	1.4	0.0	3.1	0.7	3.8	6.1	5.5	3.0	5.3	5.3	5.7	3.5	0.5	5.9	1.2	7.6	5.0	2.0	54.3	55.5	66.4	53.6	47.5	52.7	42.9	52.0	43.2	45.6	50.6	80.4	50.9	192.3	71.9	381.9	40.7	94.2	144.2	52.1	130.9	97.2	52.8	53.3	301.2	58.6	70.2	58.8	114.7	27.5	27.0	85.0	54.8	50.2	42.0	92.1	77.9	42.9	61.8	28.6	81.7	46.1	14.5	65.1	59.7	136.3	5.1	30.0	37.5	51.1	19.0	65.6	140.7	56.8	46.8	19.0	45.4	66.8	104.4	44.2	67.6	65.6	18.6	103.3	14.4	139.7	205.6	75.0	93.5	100.4	35.7	104.2	89.6	60.1	78.4	92.7	59.2	103.1	65.9	128.5	75.6	94.0	70.3	13.4	29.2	77.3	51.1	180.9
ARHGAP6	rhoGAPX-1	ENSG00000047648	"Rho GTPase activating protein 6"	O43182	X	11117651-11665920	"Plasma proteins, Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Inhibitory neurons: 44.3;Microglial cells: 127.4;Oligodendrocyte precursor cells: 60.3;Prostatic glandular cells: 54.4;Sertoli cells: 46.0;Skeletal myocytes: 62.3;Smooth muscle cells: 44.4"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 12.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 26.2;ASC TERT1: 34.2;HEL: 36.4;HMC-1: 24.7;HSkMC: 33.8;K-562: 26.5;RT4: 20.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA001798, HPA036779, HPA064390"	Enhanced		Supported	Cytosol	"Intracellular and membrane"	NA	NA		350000		"Cluster 89: Fibroblasts - ECM organization"	"Cluster 36: HEL - Hemostasis"	"Cluster 51: Myeloid cells - Hemostasis"	Cytosol		"HPA001798: , HPA036779: AB_10672229, HPA064390: AB_2685253"	"unprognostic (2.36e-1)"	"unprognostic (1.68e-2)"	"unprognostic (3.49e-2)"	"unprognostic (7.31e-2)"	"unprognostic (6.34e-2)"	"unprognostic (1.69e-2)"	"unprognostic (4.70e-2)"	"unprognostic (2.79e-1)"	"unprognostic (1.70e-1)"	"unprognostic (7.46e-4)"	"unprognostic (1.53e-1)"	"unprognostic (1.59e-1)"	"prognostic favorable (1.55e-8)"	"unprognostic (1.60e-2)"	"unprognostic (5.96e-2)"	"unprognostic (1.28e-2)"	"unprognostic (7.99e-4)"	10.8	1.1	9.0	1.7	5.1	0.7	5.6	2.0	4.2	7.6	3.2	13.9	2.1	10.5	8.2	3.8	8.4	4.2	4.0	5.0	5.8	6.5	0.9	9.6	1.2	3.2	4.0	16.4	1.9	1.2	3.2	7.0	3.2	27.6	3.9	1.0	2.6	30.9	9.6	2.5	4.7	12.9	2.6	5.9	4.1	1.9	6.1	1.0	25.4	8.1	0.8	10.4	5.7	3.8	0.0	0.0	2.4	0.0	26.2	34.2	0.6	0.4	0.6	1.4	0.9	0.4	0.0	0.0	0.0	5.0	0.0	0.1	0.9	0.0	1.2	0.6	0.5	36.4	0.4	0.0	9.7	0.1	24.7	33.8	0.0	2.5	0.1	3.1	0.7	0.1	26.5	12.3	1.5	0.0	0.0	0.2	0.7	0.2	0.4	0.1	11.6	15.7	8.3	20.3	0.0	1.6	0.0	0.0	0.0	1.0	0.0	0.4	0.3	1.6	0.7	7.1	0.2	0.7	0.0	0.0	0.5	0.2	4.0	0.2	0.0	0.1	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.5	9.0	5.1	2.0	4.2	5.0	5.8	3.2	4.0	3.2	2.6	6.1	3.8	9.6	0.0	1.7	10.4	5.3	2.0	16.9	0.3	2.8	4.3	2.3	3.3	4.7	0.0	2.6	33.1	0.0	0.6	0.4	0.0	25.4	0.0	0.1	0.1	5.1	9.2	1.2	2.1	5.5	1.1	0.7	29.1	3.6	0.2	40.0	3.0	8.2	0.0	4.9	0.0	44.3	0.4	0.0	2.2	18.9	0.9	16.1	29.1	5.4	127.4	3.4	7.2	0.0	60.3	3.5	0.7	0.0	10.1	4.9	54.4	0.0	7.4	5.6	0.7	46.0	62.3	44.4	0.2	0.4	4.5	1.7	0.0	1.2	2.1	0.0	22.3
ARHGDIA	"GDIA1, RHOGDI"	ENSG00000141522	"Rho GDP dissociation inhibitor alpha"	P52565	17	81867721-81871378	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"		"GTPase activation"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010005, HPA021407"	Approved		Supported	Cytosol		NA	NA		21000000	"Cluster 52: Eosinophils - Transcription"	"Cluster 72: Non-specific - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	Cytosol		"CAB010005: AB_2227516, HPA021407: AB_1856267"	"unprognostic (1.08e-1)"	"unprognostic (2.29e-2)"	"unprognostic (1.13e-1)"	"unprognostic (3.05e-2)"	"unprognostic (5.00e-2)"	"unprognostic (8.39e-3)"	"unprognostic (1.39e-2)"	"prognostic unfavorable (7.63e-4)"	"unprognostic (5.32e-2)"	"unprognostic (4.67e-2)"	"unprognostic (2.67e-2)"	"unprognostic (6.62e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.76e-1)"	"unprognostic (3.29e-1)"	"unprognostic (6.88e-3)"	274.5	196.2	116.6	154.7	122.9	219.4	227.6	92.6	173.4	215.5	64.6	215.7	177.7	222.0	23.8	265.1	191.2	64.3	181.1	122.2	141.1	236.2	220.7	266.1	116.9	136.3	148.9	174.8	195.2	69.6	187.3	101.9	158.2	206.0	52.9	14.6	180.0	78.7	131.9	198.6	225.6	72.4	105.0	243.9	194.3	92.0	131.4	83.4	173.4	32.8	66.9	203.4	212.2	112.9	472.6	455.1	146.6	233.1	131.8	162.9	167.2	396.0	251.3	292.1	216.0	229.0	173.7	249.4	164.9	299.8	254.9	252.3	160.3	302.6	120.7	192.3	422.2	266.3	267.7	303.0	270.6	418.3	367.4	211.1	137.0	213.5	180.5	147.7	450.1	204.1	221.5	334.8	235.8	285.4	611.3	432.9	173.0	159.8	405.3	274.2	185.4	200.6	193.7	289.5	193.0	568.8	208.5	522.2	386.9	105.3	247.5	335.7	499.7	575.1	494.2	539.3	681.4	292.8	164.9	256.5	497.7	249.9	399.8	39.5	47.9	87.5	64.3	72.5	60.8	35.8	53.6	62.5	47.9	27.4	34.5	42.1	30.2	45.2	101.9	55.3	55.4	60.4	116.6	122.9	92.6	173.4	122.2	141.1	136.3	148.9	158.2	105.0	131.4	112.9	146.0	38.5	59.1	14.0	152.2	127.2	201.5	173.0	63.2	18.3	78.8	65.4	2.9	62.9	86.7	79.1	10.4	130.1	164.6	289.7	135.0	234.2	8.3	66.4	97.5	134.6	134.6	34.9	13.9	265.0	263.4	98.2	120.8	124.1	118.6	76.4	112.1	82.7	243.2	52.2	10.4	173.7	101.7	167.1	157.8	19.5	86.6	167.4	193.9	15.0	243.9	82.6	187.4	9.5	17.5	424.5	286.3	74.1	171.3	183.5	300.7	157.5	46.0	11.9	118.3	70.6	121.4	38.9	44.1	88.5	116.1	221.9	169.3	78.6	156.2	222.2
ARHGDIB	"GDIA2, GDID4, Ly-GDI, RAP1GN1, RhoGDI2"	ENSG00000111348	"Rho GDP dissociation inhibitor beta"	P52566	12	14942031-14961728	"Plasma proteins, Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"bone marrow: 1579.9;lymphoid tissue: 1075.8"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 703.8;Extravillous trophoblasts: 667.6;granulocytes: 700.2;Hofbauer cells: 915.2;Kupffer cells: 742.6;Macrophages: 672.9;NK-cells: 999.0;T-cells: 895.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEL: 1636.5;HL-60: 1927.3;HMC-1: 2070.0;JURKAT: 1421.7;MOLT-4: 2313.6;REH: 1912.5;U-698: 1750.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB018584, HPA051235"	Enhanced		Supported	Cytosol		NA	NA		61000000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	Cytosol		"CAB018584: AB_647972, HPA051235: AB_2681398"	"unprognostic (2.29e-3)"	"unprognostic (8.10e-2)"	"unprognostic (2.09e-1)"	"unprognostic (1.39e-2)"	"unprognostic (9.16e-2)"	"unprognostic (1.90e-2)"	"unprognostic (2.44e-1)"	"unprognostic (1.47e-2)"	"unprognostic (3.46e-1)"	"unprognostic (2.47e-2)"	"unprognostic (2.19e-2)"	"unprognostic (1.10e-1)"	"prognostic unfavorable (1.08e-4)"	"unprognostic (1.74e-1)"	"unprognostic (4.42e-3)"	"unprognostic (4.97e-2)"	"prognostic favorable (3.42e-4)"	188.8	74.1	48.7	521.0	51.2	1579.9	170.4	56.0	77.6	85.4	57.9	112.9	79.6	68.0	48.4	82.9	85.3	165.9	110.7	49.4	56.4	95.9	139.0	280.3	905.3	68.5	65.4	27.6	32.2	54.1	35.4	143.8	68.4	68.8	142.4	5.3	122.3	66.3	56.3	74.2	201.6	144.3	61.8	592.6	108.1	19.5	65.6	1075.8	110.6	79.0	1036.8	290.4	67.4	79.6	147.8	5.5	5.8	327.3	23.7	17.6	2.1	6.0	1.8	2.3	1.6	19.3	156.9	1210.9	74.3	28.0	1.9	171.1	0.0	270.8	17.9	2.3	0.0	1636.5	3.5	0.7	5.2	1927.3	2070.0	2.5	37.5	0.8	24.2	5.6	929.0	1421.7	8.7	454.5	28.8	0.8	2313.6	1382.4	7.1	3.3	1.7	1912.5	21.3	540.3	52.7	845.5	1.3	1.4	1.8	205.7	2.5	14.1	10.9	1385.1	1171.8	4.6	11.5	2.2	36.2	74.5	13.0	1750.9	5.3	1339.7	2.4	5890.8	2659.3	6464.2	2731.2	3085.1	2695.1	2676.3	3099.3	3090.3	2210.1	2532.9	2986.0	3120.5	5422.5	2408.4	3802.9	955.6	5589.7	9860.2	48.7	51.2	56.0	77.6	49.4	56.4	68.5	65.4	68.4	61.8	65.6	79.6	189.6	60.9	143.0	0.7	575.2	68.2	51.9	11.1	5.7	0.6	99.7	64.5	14.0	11.5	79.5	58.8	0.0	89.6	703.8	5.3	17.6	21.9	1.5	3.2	6.1	175.6	1.2	182.1	0.7	342.7	667.6	47.3	42.3	3.6	700.2	0.4	342.3	11.1	915.2	0.0	0.2	2.2	8.2	742.6	487.7	4.1	53.4	672.9	90.7	26.2	451.3	3.3	999.0	0.5	0.1	53.5	16.3	58.6	292.5	6.9	0.2	9.2	39.0	1.2	243.3	10.3	187.9	1.2	2.3	5.5	56.1	68.0	895.2	14.9	6.7	94.7
ARHGDIG	RHOGDI-3	ENSG00000242173	"Rho GDP dissociation inhibitor gamma"	Q99819	16	280450-283010	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 249.4;pancreas: 112.7"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 12.1;Excitatory neurons: 27.8;Inhibitory neurons: 32.1;Proximal enterocytes: 64.0"	"Cancer enhanced"	"Detected in many"		"glioma: 3.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HAP1: 7.6;HEK 293: 26.6;MCF7: 34.9;SCLC-21H: 10.9;SH-SY5Y: 13.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA078260			Approved	"Plasma membrane,Cytosol"		NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 45: Enterocytes - Digestion"	"Plasma membrane, Cytosol"		"HPA078260: AB_2732375"	"unprognostic (1.11e-2)"	"unprognostic (5.69e-2)"	"unprognostic (7.98e-2)"	"unprognostic (2.66e-2)"	"unprognostic (9.04e-2)"	"unprognostic (2.13e-2)"	"unprognostic (1.49e-1)"	"unprognostic (2.75e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.44e-2)"	"unprognostic (3.18e-1)"	"unprognostic (2.94e-1)"	"unprognostic (5.86e-6)"	"unprognostic (2.81e-2)"	"unprognostic (4.34e-1)"	"unprognostic (2.15e-1)"	"unprognostic (6.32e-2)"	4.5	2.8	116.5	1.1	138.7	0.2	1.3	118.2	249.4	0.5	49.9	5.9	16.7	0.1	0.9	0.5	0.5	0.1	10.2	130.1	121.2	0.3	0.2	0.5	0.0	110.3	106.1	0.3	112.7	0.6	10.1	2.2	109.8	0.9	0.4	4.0	0.4	0.3	1.9	0.2	6.9	0.6	84.9	0.1	26.8	3.6	112.6	0.0	0.3	1.4	0.4	0.4	1.1	134.9	0.0	0.8	0.2	2.9	0.0	0.4	0.0	0.1	0.0	0.4	0.0	0.4	0.1	0.0	0.9	0.1	0.0	0.1	7.6	0.0	0.0	0.0	26.6	0.0	0.4	0.2	0.7	0.0	0.1	0.2	0.0	0.0	0.0	1.3	0.3	0.0	1.8	0.1	0.0	34.9	0.0	0.0	3.1	1.6	0.0	0.0	0.0	0.3	0.0	0.0	10.9	13.9	0.2	0.1	0.0	0.4	2.6	0.0	0.3	0.0	0.8	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	116.5	138.7	118.2	249.4	130.1	121.2	110.3	106.1	109.8	84.9	112.6	134.9	0.1	0.0	0.0	12.1	0.0	0.4	0.0	0.0	0.0	4.0	0.0	0.3	1.4	0.0	0.0	0.0	2.1	0.1	0.0	0.7	0.0	0.2	0.4	0.0	0.4	0.1	1.2	2.7	27.8	11.7	0.2	2.5	6.1	0.0	0.0	0.2	1.4	0.0	0.4	0.0	32.1	3.7	0.0	0.0	0.0	0.6	0.3	0.0	0.0	8.4	0.0	2.2	0.0	6.6	10.9	3.9	3.9	0.0	0.0	0.1	64.0	0.1	0.0	3.7	0.0	0.0	0.4	0.2	3.9	0.0	0.0	0.4	0.0	0.0	7.0	0.1
ARHGEF1	"LBCL2, P115-RHOGEF, SUB1.5"	ENSG00000076928	"Rho guanine nucleotide exchange factor 1"	Q92888	19	41883173-41930150	"Disease related genes, Plasma proteins, Predicted intracellular proteins"		"GTPase activation, Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 168.4"	"Cell type enhanced"	"Detected in all"		"dendritic cells: 156.2;NK-cells: 187.4;T-cells: 159.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009502, HPA012924, HPA060784"	Enhanced		Enhanced	"Plasma membrane,Cytosol"		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 2: Immune cells - Immune response"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Plasma membrane, Cytosol"		"CAB009502: AB_667785, HPA012924: AB_1845000, HPA060784: AB_2684363"	"prognostic favorable (5.92e-4)"	"unprognostic (2.09e-1)"	"unprognostic (8.29e-3)"	"unprognostic (8.10e-3)"	"unprognostic (7.63e-2)"	"unprognostic (7.59e-3)"	"unprognostic (4.99e-2)"	"unprognostic (7.28e-2)"	"unprognostic (5.88e-2)"	"unprognostic (1.84e-2)"	"unprognostic (6.59e-2)"	"unprognostic (3.29e-3)"	"prognostic unfavorable (3.36e-8)"	"unprognostic (3.54e-1)"	"unprognostic (1.95e-1)"	"unprognostic (8.00e-2)"	"unprognostic (4.65e-2)"	50.2	20.9	17.1	79.1	21.8	113.5	39.9	19.1	21.9	37.2	17.8	37.5	26.8	33.4	3.6	34.1	36.4	23.5	26.2	16.1	18.2	31.9	30.0	67.7	127.5	24.1	20.2	32.9	27.4	12.6	25.9	18.3	22.0	32.1	10.4	5.6	28.8	11.8	15.4	37.6	87.1	13.4	19.0	168.4	34.9	10.9	21.4	96.5	36.7	8.9	48.9	33.9	33.2	27.9	58.8	69.9	15.8	19.9	21.9	22.9	18.4	30.1	45.7	37.4	32.8	21.5	49.2	77.9	54.6	27.8	19.8	33.8	20.3	46.9	11.8	74.1	23.6	63.1	30.6	28.4	31.9	68.4	100.8	27.8	30.5	36.3	23.5	19.9	36.2	68.2	25.5	46.7	21.8	40.4	48.0	52.9	17.9	46.4	54.0	71.8	29.7	46.3	23.2	31.8	10.3	43.8	42.3	18.7	36.0	8.1	21.9	114.4	49.6	49.7	33.2	26.8	47.7	63.0	43.2	68.4	40.5	107.6	80.2	10.4	20.5	29.2	47.0	39.5	37.2	20.1	35.6	49.4	21.5	19.5	36.1	39.4	27.4	32.1	57.5	11.3	38.7	36.4	17.1	21.8	19.1	21.9	16.1	18.2	24.1	20.2	22.0	19.0	21.4	27.9	46.6	6.4	22.0	35.3	97.3	14.5	13.9	15.0	20.5	18.7	13.1	12.4	4.2	8.6	8.8	7.3	27.1	13.3	156.2	21.7	3.9	23.6	1.4	12.2	16.7	29.0	21.7	23.8	8.0	24.9	22.8	17.7	56.6	16.8	31.7	19.3	26.7	9.3	38.2	11.8	7.9	29.2	16.2	52.5	31.9	1.8	19.3	58.9	19.6	18.7	39.0	8.8	187.4	13.6	27.6	55.9	22.7	16.6	66.4	15.7	10.1	7.3	6.3	19.1	26.3	17.6	17.3	7.3	10.1	17.3	14.8	10.1	159.0	20.4	26.4	11.1
ARHGEF11	"GTRAP48, KIAA0380, PDZ-RHOGEF"	ENSG00000132694	"Rho guanine nucleotide exchange factor 11"	O15085	1	156934840-157045742	"Predicted intracellular proteins"		"GTPase activation, Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 68.6;Cone photoreceptor cells: 93.8;Excitatory neurons: 102.4;Inhibitory neurons: 122.5;Oligodendrocyte precursor cells: 78.4;Rod photoreceptor cells: 58.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"WM-115: 69.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011026, HPA012037, HPA014658"	Enhanced		Supported	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Plasma membrane"	Nucleoplasm	"HPA011026: AB_1850426, HPA012037: AB_1850430, HPA014658: AB_1850428"	"unprognostic (2.19e-1)"	"unprognostic (9.10e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.17e-1)"	"unprognostic (2.00e-1)"	"unprognostic (4.94e-3)"	"unprognostic (3.30e-2)"	"unprognostic (9.40e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.58e-1)"	"prognostic favorable (1.72e-4)"	"unprognostic (3.38e-1)"	"unprognostic (2.41e-2)"	"unprognostic (5.11e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.08e-1)"	"unprognostic (4.73e-2)"	10.9	10.9	10.3	9.5	8.6	4.3	8.1	4.1	22.6	10.0	0.8	12.3	13.1	12.0	9.6	11.5	10.3	10.2	12.1	9.4	10.2	7.2	6.3	11.4	5.3	12.7	11.1	13.2	9.9	25.0	12.2	11.1	12.0	9.2	11.2	17.6	8.6	11.6	12.3	10.0	14.9	13.3	4.0	9.3	10.7	19.2	16.9	3.6	13.0	11.2	5.7	10.4	8.1	11.1	13.5	26.6	22.0	16.9	28.5	14.6	25.0	13.4	19.4	20.0	14.6	17.9	14.0	1.8	22.6	23.0	15.3	14.4	15.0	13.5	10.8	19.6	9.3	6.7	15.9	11.5	16.4	13.7	23.0	22.7	14.4	18.3	14.2	14.9	14.5	5.7	11.1	1.2	13.3	17.4	3.5	7.2	27.6	21.0	16.0	0.5	10.9	7.4	9.5	21.9	4.2	25.1	28.3	22.6	23.3	18.8	20.3	30.3	22.4	20.6	12.9	18.3	13.7	18.7	12.2	1.3	13.1	1.8	69.7	0.0	0.4	0.0	0.0	0.8	0.0	0.1	0.1	0.0	0.2	0.0	0.1	0.2	0.9	0.0	0.4	0.0	0.0	0.2	10.3	8.6	4.1	22.6	9.4	10.2	12.7	11.1	12.0	4.0	16.9	11.1	6.2	3.2	4.2	68.6	0.5	1.1	2.8	0.4	0.0	48.0	5.0	5.8	15.3	7.2	1.6	1.8	93.8	1.8	0.0	26.0	1.9	1.1	8.6	7.7	10.9	5.0	5.4	0.4	102.4	1.6	0.6	5.5	10.2	7.8	8.9	6.6	5.3	5.2	4.0	21.9	122.5	7.3	0.0	8.8	3.9	10.5	4.7	7.1	1.8	37.5	6.8	9.7	0.0	78.4	47.2	1.2	10.8	4.5	2.9	4.0	10.6	1.3	1.4	58.7	0.0	6.7	6.9	3.1	4.8	1.8	2.0	1.5	0.9	9.2	9.8	3.3
ARHGEF15	"ARGEF15, FLJ13791, KIAA0915, MGC44868, Vsm-RhoGEF"	ENSG00000198844	"Rho guanine nucleotide exchange factor 15"	O94989	17	8310241-8322514	"Predicted intracellular proteins"		"GTPase activation, Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 47.7;breast: 41.6"	"Group enriched"	"Detected in some"	4	"Adipocytes: 66.4;Endothelial cells: 48.9;Hepatic stellate cells: 37.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	48	"HUVEC TERT2: 40.4;TIME: 49.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA044443, HPA063495"			Supported	"Plasma membrane"		NA	NA				"Cluster 82: Adipose tissue - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Plasma membrane"		"HPA044443: AB_10960424, HPA063495: AB_2685023"	"unprognostic (3.02e-1)"	"unprognostic (2.97e-1)"	"unprognostic (1.18e-2)"	"unprognostic (7.09e-3)"	"unprognostic (3.82e-1)"	"unprognostic (7.29e-4)"	"unprognostic (1.43e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.42e-1)"	"unprognostic (3.40e-1)"	"unprognostic (1.06e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.23e-3)"	"unprognostic (4.88e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.89e-1)"	"unprognostic (9.56e-3)"	47.7	5.9	4.6	4.1	4.2	0.0	41.6	4.1	4.7	8.7	3.0	6.9	3.1	10.9	1.6	4.8	9.8	7.3	35.5	4.1	4.1	15.8	2.9	22.1	3.1	4.7	4.5	3.8	4.2	3.4	4.0	14.7	4.8	8.0	2.0	0.2	5.1	3.5	13.2	7.7	6.5	7.2	4.0	7.9	6.9	2.2	5.2	1.6	12.4	10.9	1.8	12.3	8.3	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	40.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	49.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	4.2	4.1	4.7	4.1	4.1	4.7	4.5	4.8	4.0	5.2	3.6	66.4	0.0	3.0	0.3	0.5	2.8	0.3	0.0	0.6	0.8	0.5	0.4	8.9	2.8	0.0	1.8	0.0	0.0	0.2	0.1	0.0	0.0	3.3	0.4	0.2	48.9	0.0	0.0	0.2	0.0	0.1	1.0	0.0	1.3	0.0	0.0	37.1	0.0	0.1	0.0	0.5	0.0	0.0	1.4	2.8	4.4	0.0	0.5	7.2	11.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.4	0.0	0.0	0.0	0.1	0.0	1.6	1.5	0.4	0.2	0.2	1.0	0.1	0.3	0.7	0.0	0.3
ARHGEF26	"DKFZP434D146, SGEF"	ENSG00000114790	"Rho guanine nucleotide exchange factor 26"	Q96DR7	3	154121003-154257827	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"Alveolar cells type 1: 339.7;Astrocytes: 248.8"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 19.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"U-251 MG: 26.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017722, HPA049195"	Approved		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA				"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 30: Mammary glandular cells - Lactation"	"Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA017722: AB_1856800, HPA049195: AB_2680671"	"unprognostic (1.41e-1)"	"unprognostic (1.43e-3)"	"unprognostic (3.55e-1)"	"unprognostic (7.99e-3)"	"unprognostic (2.82e-1)"	"unprognostic (9.42e-3)"	"prognostic favorable (9.74e-4)"	"unprognostic (7.06e-2)"	"unprognostic (1.16e-1)"	"unprognostic (6.01e-5)"	"unprognostic (1.44e-3)"	"unprognostic (4.36e-2)"	"unprognostic (2.22e-1)"	"unprognostic (5.53e-3)"	"unprognostic (3.11e-1)"	"unprognostic (1.07e-1)"	"unprognostic (5.24e-3)"	8.0	2.1	5.8	1.8	5.7	0.3	6.0	4.1	5.3	5.0	7.7	18.3	7.3	4.3	1.2	7.4	6.2	5.5	3.2	4.6	5.0	1.7	15.5	16.3	0.3	5.9	7.3	3.9	6.0	9.9	1.7	3.4	5.8	3.4	2.6	7.1	3.1	4.8	0.4	6.2	6.6	7.1	5.4	0.8	8.7	5.1	6.1	0.8	3.1	1.4	0.9	5.1	6.4	4.8	8.5	3.7	10.6	6.8	5.1	1.4	0.3	0.3	0.0	3.1	4.3	6.5	0.8	5.0	0.5	0.6	4.9	8.9	6.7	4.4	3.9	0.0	8.8	0.1	2.6	1.5	4.7	1.6	0.2	1.3	0.4	4.0	0.5	1.8	0.6	5.4	0.0	0.0	2.0	8.1	2.0	0.1	6.7	2.4	3.0	0.0	12.9	0.0	0.7	4.1	3.2	1.1	1.7	14.4	1.5	4.6	10.1	0.5	0.0	1.1	5.3	0.1	26.6	4.5	0.7	0.0	2.5	0.0	9.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.8	5.7	4.1	5.3	4.6	5.0	5.9	7.3	5.8	5.4	6.1	4.8	5.0	339.7	26.8	248.8	1.7	19.5	9.0	2.7	17.6	11.6	54.2	6.6	1.8	20.0	10.8	3.7	4.2	1.8	4.3	1.5	0.0	2.2	11.9	4.7	4.5	4.3	0.0	2.7	4.2	2.5	1.1	12.0	14.3	2.1	5.1	3.6	8.6	60.8	0.6	5.0	10.1	7.9	6.1	2.5	3.4	3.4	10.5	1.3	3.6	7.5	2.7	58.1	12.3	41.7	5.1	2.0	6.9	18.8	0.7	7.5	21.4	0.1	14.9	47.8	0.0	14.1	3.7	4.7	37.0	11.7	23.7	6.2	4.7	2.5	8.1	5.7
ARHGEF40	"FLJ10357, solo"	ENSG00000165801	"Rho guanine nucleotide exchange factor 40"	Q8TER5	14	21070273-21090248	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"neutrophil: 6.2"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 6.2"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 37.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030745, HPA030746, HPA030757"	Uncertain		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	"Plasma membrane, Cytosol"		"HPA030745: , HPA030746: AB_10599613, HPA030757: AB_10600203"	"unprognostic (6.30e-2)"	"unprognostic (1.94e-1)"	"unprognostic (2.36e-1)"	"unprognostic (5.91e-2)"	"unprognostic (2.55e-1)"	"unprognostic (8.16e-3)"	"unprognostic (1.27e-2)"	"unprognostic (9.84e-3)"	"unprognostic (1.33e-1)"	"unprognostic (8.80e-2)"	"unprognostic (1.64e-2)"	"unprognostic (2.53e-1)"	"unprognostic (6.01e-3)"	"unprognostic (1.14e-2)"	"unprognostic (1.38e-2)"	"unprognostic (2.33e-1)"	"unprognostic (8.95e-2)"	21.0	47.2	9.6	5.3	11.1	1.6	18.5	10.0	9.2	24.8	6.2	14.5	3.7	18.9	12.2	3.5	13.2	14.8	12.3	8.9	11.1	10.1	26.9	14.2	2.3	13.5	10.5	19.3	24.0	10.7	9.0	6.5	10.5	12.3	6.2	2.8	20.2	18.6	10.5	7.4	7.9	9.7	10.1	27.8	9.5	4.3	12.1	3.1	15.8	6.1	1.7	13.8	13.3	12.1	3.3	2.9	30.8	5.8	24.5	37.1	1.1	11.4	28.1	12.1	9.4	1.4	7.5	0.0	1.8	20.9	12.2	5.0	2.6	3.7	4.3	6.6	1.1	4.6	3.4	9.0	3.5	3.0	16.5	15.5	2.4	10.3	3.1	22.6	0.0	0.0	1.4	1.3	9.6	0.3	0.0	8.6	8.1	0.8	0.5	1.0	23.2	1.4	7.6	4.1	0.7	11.6	6.4	0.6	8.9	6.0	2.7	10.1	5.9	25.4	17.5	11.9	5.9	2.6	0.0	0.0	8.8	4.2	7.5	0.0	1.0	2.0	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	6.2	0.1	0.0	0.1	0.0	0.4	9.6	11.1	10.0	9.2	8.9	11.1	13.5	10.5	10.5	10.1	12.1	12.1	12.7	6.4	5.0	32.0	2.5	4.8	8.0	5.8	1.8	9.2	6.6	11.3	13.4	47.1	3.2	14.7	0.0	1.4	0.5	10.0	19.6	21.2	1.0	17.6	13.1	11.0	7.8	1.7	0.3	10.2	0.9	20.4	18.3	3.5	38.0	11.6	8.2	31.5	14.1	5.0	6.2	9.1	4.1	46.9	14.6	2.3	24.2	22.0	23.2	17.8	23.6	24.6	1.0	21.1	8.9	16.4	6.6	24.0	3.1	6.3	1.0	7.1	1.7	6.8	26.3	18.6	21.9	3.1	2.8	0.6	4.4	1.2	3.5	14.6	18.7	6.1
ARHGEF5	"GEF5, P60, TIM, TIM1"	ENSG00000050327	"Rho guanine nucleotide exchange factor 5"	Q12774	7	144355288-144380632	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"	Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skin 1: 47.1"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 61.7;Glandular and luminal cells: 47.4;Paneth cells: 53.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"A-431: 29.4;CAPAN-2: 21.9;HaCaT: 16.7;hTCEpi: 18.0;RPTEC TERT1: 17.5;WM-115: 17.7"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA020980, HPA029504, HPA044188, HPA045619, HPA045699"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 31: Skin - Epidermis development"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 44: Endometrium - Transcription"	"Plasma membrane, Cytosol"	Nucleoplasm	"HPA020980: AB_1845007, HPA029504: AB_10602231, HPA044188: AB_2678850, HPA045619: AB_2679393, HPA045699: AB_2679423"	"unprognostic (1.45e-1)"	"unprognostic (2.05e-1)"	"unprognostic (1.87e-2)"	"unprognostic (1.94e-1)"	"unprognostic (9.45e-2)"	"unprognostic (2.69e-2)"	"unprognostic (9.95e-3)"	"unprognostic (9.21e-2)"	"unprognostic (1.05e-2)"	"unprognostic (2.27e-1)"	"unprognostic (3.67e-2)"	"unprognostic (2.12e-1)"	"prognostic favorable (3.28e-7)"	"unprognostic (4.67e-2)"	"unprognostic (4.86e-1)"	"unprognostic (2.36e-1)"	"unprognostic (7.76e-2)"	5.1	2.6	1.8	1.6	2.4	2.4	12.3	1.5	1.7	11.5	5.7	16.4	10.1	3.4	6.9	36.6	4.7	4.7	3.5	0.9	1.8	20.9	14.4	8.4	2.2	2.1	2.7	5.6	19.0	7.3	9.5	3.2	1.8	14.7	5.6	1.8	18.1	2.0	0.7	47.1	13.1	1.2	1.3	3.8	13.8	2.0	2.0	1.8	24.0	0.2	3.1	5.3	17.6	1.4	29.4	3.3	0.0	0.0	0.0	0.0	8.7	3.8	2.3	1.5	1.9	11.5	21.9	0.1	10.3	0.9	0.3	16.7	0.0	10.6	1.5	0.1	3.8	0.0	4.2	0.8	3.1	0.0	0.0	5.5	18.0	0.7	9.9	4.8	0.1	0.0	0.0	0.0	1.5	9.7	0.1	0.0	4.5	7.9	5.2	1.1	0.0	0.4	17.5	1.3	0.1	0.1	11.5	13.4	5.1	2.3	6.8	0.3	0.2	0.5	0.8	0.0	0.1	0.0	0.1	0.1	0.6	0.0	17.7	0.0	0.0	0.0	0.3	0.0	0.4	0.8	0.8	0.7	0.0	0.9	0.9	0.2	0.3	0.0	0.0	0.0	1.5	0.1	1.8	2.4	1.5	1.7	0.9	1.8	2.1	2.7	1.8	1.3	2.0	1.4	3.0	6.4	14.8	0.3	2.3	18.5	37.3	9.4	26.2	0.0	17.5	18.7	1.4	11.5	12.1	22.0	4.2	11.8	1.4	61.7	5.9	14.8	2.3	28.9	5.5	1.6	9.6	2.7	0.0	16.5	15.2	3.6	37.2	47.4	0.0	4.0	1.8	7.5	1.8	0.0	0.0	24.0	6.1	0.3	1.9	0.6	1.5	1.2	5.4	0.0	0.0	2.7	0.0	0.5	0.1	27.7	53.7	1.5	3.1	14.3	42.0	5.4	13.5	3.1	0.0	1.1	1.8	0.7	1.5	28.7	16.8	14.2	2.5	1.1	23.5	33.6
ARHGEF9	"KIAA0424, PEM-2"	ENSG00000131089	"Cdc42 guanine nucleotide exchange factor 9"	O43307	X	63634967-63809274	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"	"Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"retina: 88.1"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 184.3;Cone photoreceptor cells: 233.5;Rod photoreceptor cells: 320.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"RH-30: 48.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035419, HPA055291"	Approved		Supported	Cytosol		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 58: Brain - Synaptic function"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 9: Photoreceptor cells - Phototransduction"	Cytosol		"HPA035419: AB_10669859, HPA055291: AB_2682774"	"unprognostic (3.19e-1)"	"unprognostic (6.15e-2)"	"unprognostic (4.02e-2)"	"unprognostic (2.67e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.14e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.98e-3)"	"unprognostic (1.33e-2)"	"unprognostic (3.79e-2)"	"unprognostic (1.08e-3)"	"unprognostic (1.67e-1)"	"prognostic favorable (1.02e-5)"	"unprognostic (4.56e-2)"	"unprognostic (9.27e-2)"	"unprognostic (3.15e-2)"	"unprognostic (8.98e-2)"	7.7	15.6	32.6	6.4	39.3	4.1	10.6	5.1	51.0	8.4	5.2	13.6	15.8	9.3	7.1	11.2	7.7	8.0	35.9	46.2	36.6	13.2	5.6	6.3	6.3	13.1	14.3	16.2	5.2	15.0	15.7	5.8	14.3	13.8	14.3	88.1	6.3	14.6	5.9	9.1	13.4	17.2	10.0	6.9	8.9	2.8	26.7	9.5	8.2	8.9	7.3	14.3	6.5	27.2	6.3	9.7	20.2	10.3	7.6	11.1	1.2	12.3	11.8	12.8	9.8	0.6	6.8	14.1	8.7	8.0	10.8	0.2	8.4	14.5	15.1	18.5	6.6	13.7	4.5	0.6	4.5	6.7	4.2	12.2	6.9	5.9	18.5	11.9	7.1	14.8	1.5	20.8	14.0	10.0	12.6	3.3	16.4	6.2	12.1	22.9	48.2	13.5	7.8	6.0	0.1	5.1	5.6	9.8	6.7	8.4	7.5	8.9	3.4	7.1	6.4	34.6	5.1	7.8	6.5	10.2	8.7	10.7	5.1	0.8	1.4	1.3	4.5	2.0	3.2	2.2	2.7	3.1	2.2	2.9	3.3	2.9	1.1	8.4	1.4	1.8	2.6	1.9	32.6	39.3	5.1	51.0	46.2	36.6	13.1	14.3	14.3	10.0	26.7	27.2	9.2	9.6	11.4	59.4	20.3	5.7	6.5	8.7	12.5	184.3	26.0	17.4	45.9	7.2	10.0	11.0	233.5	5.0	19.4	18.2	13.7	6.3	2.0	6.5	9.8	10.8	20.9	3.8	105.9	8.8	1.4	11.8	24.5	6.0	14.5	20.0	11.7	10.7	10.5	82.4	90.5	16.0	12.2	5.7	6.3	6.2	15.5	8.2	14.2	33.7	3.8	29.9	34.0	89.0	50.5	7.9	14.5	15.4	12.4	4.3	19.1	17.3	9.3	320.8	0.0	12.7	22.0	1.9	3.4	11.2	6.0	4.4	21.8	39.6	21.8	6.1
ARID1B	"6A3-5, BAF250b, DAN15, ELD/OSA1, KIAA1235, p250R"	ENSG00000049618	"AT-rich interaction domain 1B"	Q8NFD5	6	156776020-157210779	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Neurogenesis, Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding"	"Cancer-related genes, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 404.3;Inhibitory neurons: 475.4;Microglial cells: 327.0;Oligodendrocyte precursor cells: 417.7;Oligodendrocytes: 503.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016511, HPA075291"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 50: Non-specific - Ribosome"	"Cluster 14: REH - Unknown function"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Nucleoplasm		"HPA016511: AB_1845008, HPA075291: AB_2686743"	"prognostic unfavorable (1.04e-4)"	"unprognostic (9.82e-2)"	"unprognostic (1.73e-1)"	"unprognostic (5.42e-2)"	"unprognostic (7.47e-2)"	"unprognostic (1.40e-2)"	"unprognostic (2.73e-2)"	"unprognostic (2.89e-1)"	"unprognostic (1.18e-1)"	"prognostic unfavorable (4.16e-4)"	"unprognostic (2.53e-1)"	"unprognostic (5.33e-2)"	"unprognostic (1.07e-3)"	"unprognostic (2.46e-1)"	"unprognostic (1.80e-1)"	"unprognostic (3.53e-1)"	"unprognostic (1.16e-1)"	15.2	12.0	14.6	14.5	13.4	28.7	15.6	29.0	16.0	19.0	2.2	15.9	14.2	17.0	11.3	15.7	18.6	14.4	14.4	20.4	10.1	13.2	9.7	14.6	18.2	13.4	10.9	27.5	17.1	28.2	12.2	11.7	11.1	14.6	12.1	11.7	20.4	12.7	33.6	23.2	15.3	15.8	7.3	18.4	12.5	9.8	12.5	25.4	22.0	25.4	18.8	17.4	17.4	17.2	13.0	19.4	29.6	41.2	24.7	21.5	20.4	14.6	18.6	18.1	18.0	17.7	20.0	43.0	8.1	23.9	22.4	16.5	25.2	23.3	18.1	40.4	18.1	30.6	19.6	22.1	17.1	25.3	21.8	25.5	18.4	27.1	24.6	20.4	25.6	26.8	35.8	32.3	13.2	15.9	29.1	30.5	15.3	18.3	10.5	66.3	12.7	22.9	12.7	24.3	28.0	34.7	28.3	29.4	15.8	15.7	19.6	40.2	26.4	23.4	23.6	22.0	27.5	21.8	18.2	52.7	19.7	30.3	32.0	5.0	2.3	2.3	4.1	1.9	3.7	5.3	3.5	2.8	1.8	6.9	2.9	4.1	4.2	2.4	2.1	9.4	3.7	1.2	14.6	13.4	29.0	16.0	20.4	10.1	13.4	10.9	11.1	7.3	12.5	17.2	85.7	48.1	51.8	282.7	83.3	47.5	22.3	22.3	41.5	36.0	70.9	44.4	36.9	27.1	32.6	126.9	29.2	14.7	103.7	21.8	7.9	40.8	15.0	70.8	124.5	43.9	40.8	37.8	404.3	34.5	7.5	49.9	31.1	78.0	38.7	137.1	33.9	27.3	14.1	47.1	475.4	33.7	20.3	32.6	36.1	19.4	56.8	49.1	30.2	327.0	59.4	21.9	24.7	417.7	503.7	46.6	26.9	62.8	70.2	28.1	26.8	18.4	29.5	29.6	46.0	43.1	56.7	8.0	12.2	39.7	55.7	17.5	51.9	72.9	36.3	27.1
ARID2	"BAF200, DKFZp686G052, FLJ30619, KIAA1557"	ENSG00000189079	"AT-rich interaction domain 2"	Q68CP9	12	45729706-45908040	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding"	"Cancer-related genes, Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 525.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA063044			Supported	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 29: Early spermatids - Spermatogenesis"	Nucleoplasm	"Plasma membrane"	"HPA063044: AB_2684929"	"unprognostic (8.41e-2)"	"unprognostic (1.03e-1)"	"unprognostic (4.02e-2)"	"unprognostic (3.94e-2)"	"unprognostic (4.15e-2)"	"prognostic favorable (5.75e-4)"	"unprognostic (1.26e-2)"	"unprognostic (9.71e-2)"	"unprognostic (9.04e-2)"	"unprognostic (5.57e-2)"	"unprognostic (1.34e-1)"	"unprognostic (2.47e-1)"	"unprognostic (1.12e-2)"	"unprognostic (9.21e-2)"	"unprognostic (3.02e-1)"	"unprognostic (2.00e-1)"	"unprognostic (6.53e-2)"	6.4	5.2	4.6	6.7	7.8	12.6	7.5	13.8	6.9	8.5	10.2	6.8	5.0	6.9	6.5	8.4	6.4	5.4	6.0	5.0	7.3	6.3	5.4	7.8	7.5	7.8	6.4	8.3	7.2	11.7	5.0	7.2	7.6	7.4	6.0	13.2	6.7	6.2	5.9	10.0	6.6	6.1	6.0	6.9	6.2	26.1	6.2	18.7	8.8	7.7	8.9	6.8	8.0	9.8	10.3	14.5	25.3	11.1	10.5	7.3	13.7	7.0	9.9	9.6	8.9	20.7	10.4	19.8	12.7	9.8	7.0	12.1	20.6	11.8	13.6	8.8	9.8	26.1	15.9	10.1	7.2	20.7	11.5	6.0	8.8	12.1	19.1	13.4	10.0	29.1	22.4	19.9	8.6	13.4	29.9	14.7	15.1	0.0	7.7	22.9	18.0	19.0	9.1	16.9	13.6	17.4	11.4	13.0	11.1	14.5	20.0	40.8	11.8	10.3	12.3	7.0	9.2	13.2	11.8	53.6	7.9	53.2	7.4	9.4	1.1	2.7	2.4	1.3	2.5	1.0	2.1	2.5	1.5	1.1	2.0	1.9	1.4	2.1	3.4	3.3	2.0	0.9	4.6	7.8	13.8	6.9	5.0	7.3	7.8	6.4	7.6	6.0	6.2	9.8	23.3	28.9	28.4	110.4	30.8	33.8	14.4	16.3	36.5	51.6	21.7	15.4	15.6	14.3	17.3	29.5	68.8	15.5	49.0	21.3	7.9	13.2	525.4	23.2	23.8	21.1	21.0	35.1	56.7	10.0	10.5	22.0	24.5	27.7	22.1	29.3	19.2	17.3	11.2	32.0	60.3	19.0	22.4	29.8	36.7	149.3	24.8	25.6	14.2	128.4	22.4	19.9	45.3	144.3	157.9	18.8	24.6	22.6	33.8	23.7	19.1	7.4	15.4	66.2	26.3	27.0	27.2	80.2	17.0	39.3	41.3	23.4	34.8	16.4	17.9	21.0
ARID3A	"BRIGHT, DRIL1"	ENSG00000116017	"AT-rich interaction domain 3A"	Q99856	19	925781-975939	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 23.4;testis: 17.0"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 191.8;Extravillous trophoblasts: 492.4;Langerhans cells: 163.7;Syncytiotrophoblasts: 518.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"plasmacytoid DC: 6.4"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BEWO: 206.5;CACO-2: 72.3;Hep G2: 65.8;K-562: 95.6;THP-1: 66.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA004793, HPA076330"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 28: Placenta - Pregnancy"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 38: Extravillous trophoblasts - Unknown function"	Nucleoplasm	Cytosol	"HPA004793: AB_1847870, HPA076330: AB_2732309"	"unprognostic (1.34e-1)"	"unprognostic (2.62e-3)"	"unprognostic (4.08e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.31e-3)"	"unprognostic (5.67e-2)"	"unprognostic (3.40e-3)"	"unprognostic (1.38e-1)"	"unprognostic (5.22e-2)"	"unprognostic (2.54e-1)"	"prognostic favorable (1.95e-5)"	"unprognostic (4.00e-1)"	"prognostic unfavorable (3.22e-4)"	"unprognostic (3.29e-1)"	"unprognostic (2.67e-3)"	"unprognostic (1.30e-1)"	"unprognostic (8.95e-2)"	3.4	1.8	2.3	4.9	1.6	10.3	2.2	3.4	3.8	2.5	2.7	2.4	3.2	2.2	0.7	3.0	2.3	0.8	1.9	1.9	1.2	3.9	2.1	4.4	3.5	2.0	1.6	1.2	3.1	2.1	3.3	23.4	2.1	1.9	1.2	0.8	2.0	0.7	1.7	3.1	3.6	1.3	1.7	6.6	2.6	17.0	2.2	2.5	1.6	1.1	2.7	2.2	3.0	1.8	3.8	5.0	17.2	4.3	7.2	5.4	206.5	16.5	10.7	8.8	5.8	72.3	0.6	1.6	3.8	5.6	2.2	1.5	7.0	3.9	3.8	22.5	5.0	7.2	6.5	65.8	3.1	25.1	17.8	7.7	5.5	5.5	1.4	1.4	2.9	5.7	95.6	20.3	2.6	5.8	9.8	28.5	16.6	2.6	1.0	21.9	5.4	13.9	1.1	3.7	8.3	15.8	5.3	4.3	3.1	37.7	7.6	66.7	4.9	5.8	7.8	8.4	1.9	47.0	45.3	12.5	3.8	14.5	4.0	0.7	1.6	1.1	0.3	1.4	0.3	0.9	0.2	0.3	1.0	0.6	0.3	0.1	4.1	1.3	2.1	6.4	0.2	0.7	2.3	1.6	3.4	3.8	1.9	1.2	2.0	1.6	2.1	1.7	2.2	1.8	4.7	6.4	2.8	2.9	30.2	14.8	8.0	8.9	9.6	8.4	7.4	7.5	8.0	0.0	2.4	14.7	8.4	191.8	56.0	4.0	9.8	5.7	41.3	14.8	19.0	14.1	46.9	9.9	8.5	3.3	492.4	18.9	5.1	15.2	3.8	11.4	11.4	7.6	98.2	6.7	8.0	11.3	4.1	41.0	163.7	4.7	7.2	41.0	16.0	24.4	60.4	2.2	13.4	6.6	2.7	14.3	0.3	6.4	50.9	6.9	10.8	5.7	1.1	4.4	0.0	3.2	10.5	2.9	9.9	8.1	15.3	518.3	10.7	8.2	5.5	2.1
ARID3B	"BDP, DRIL2"	ENSG00000179361	"AT-rich interaction domain 3B"	Q8IVW6	15	74541206-74598131	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 24.6"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 43.8;Early spermatids: 45.4;Glandular and luminal cells: 45.6;Late spermatids: 65.8;Rod photoreceptor cells: 50.8;Syncytiotrophoblasts: 64.0"	"Cancer enhanced"	"Detected in all"		"testis cancer: 10.9"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"NTERA-2: 87.8;SuSa: 95.4;U-266/70: 53.0"	"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in all"	5	"cerebellum: 28.8"	HPA050320	Enhanced		Supported	Nucleoplasm		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm		"HPA050320: AB_2681085"	"unprognostic (2.97e-1)"	"unprognostic (5.91e-2)"	"unprognostic (6.41e-2)"	"unprognostic (8.15e-2)"	"unprognostic (8.42e-2)"	"unprognostic (1.13e-1)"	"unprognostic (3.33e-3)"	"unprognostic (3.95e-1)"	"unprognostic (1.41e-1)"	"unprognostic (2.60e-1)"	"unprognostic (1.27e-2)"	"unprognostic (1.64e-2)"	"unprognostic (1.42e-2)"	"unprognostic (4.71e-2)"	"unprognostic (3.52e-2)"	"unprognostic (9.45e-3)"	"unprognostic (2.20e-1)"	2.8	2.4	3.1	6.1	2.4	24.6	2.6	5.2	3.4	3.3	6.6	4.9	4.4	2.3	1.9	6.2	2.5	2.4	2.3	3.3	4.4	3.6	4.0	7.3	7.2	2.9	3.4	1.5	5.7	1.7	6.2	15.7	2.9	4.6	4.0	18.7	3.8	1.7	3.4	3.2	7.0	1.6	2.3	9.5	7.1	22.1	3.7	6.0	3.8	2.2	6.3	3.2	3.9	2.8	7.6	3.1	40.7	8.9	1.5	0.8	43.8	1.8	2.0	2.5	2.7	49.9	3.6	0.7	2.0	1.9	14.3	9.0	49.8	6.8	2.2	47.7	11.6	29.5	6.0	13.7	1.0	4.7	18.5	1.0	3.0	4.2	4.3	2.0	4.3	11.7	26.1	16.8	0.7	1.8	12.9	15.7	87.8	3.2	2.7	5.7	1.6	12.1	2.4	7.9	10.4	18.4	2.2	4.5	8.8	95.4	5.8	8.5	2.7	3.4	4.3	2.7	5.6	53.0	36.1	5.3	1.8	7.3	1.3	2.6	1.9	7.0	5.0	1.5	3.0	3.1	2.9	3.8	1.4	1.4	2.2	2.9	13.0	4.0	2.0	1.9	4.4	3.4	3.1	2.4	5.2	3.4	3.3	4.4	2.9	3.4	2.9	2.3	3.7	2.8	3.5	3.2	5.6	10.7	11.8	5.2	5.2	3.5	3.4	23.9	4.4	2.3	1.2	4.3	1.9	0.0	43.8	36.0	10.2	10.2	0.0	2.5	45.4	20.5	4.4	4.8	5.4	9.7	7.3	3.5	20.6	2.3	8.6	45.6	2.5	4.2	4.2	2.5	8.3	11.8	7.8	6.0	0.0	8.7	9.1	65.8	2.8	9.5	3.6	5.6	6.4	5.9	18.6	5.5	7.8	7.6	8.4	3.0	19.2	7.8	7.0	1.7	3.8	50.8	0.0	1.5	1.8	17.2	19.4	10.4	3.3	64.0	12.8	5.5	4.0	8.0
ARID4A	"RBBP1, RBP-1, RBP1"	ENSG00000032219	"AT-rich interaction domain 4A"	P29374	14	58298504-58373887	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Spermatogenesis, Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048899			Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm	"Plasma membrane, Cytosol"	"HPA048899: "	"unprognostic (1.57e-1)"	"unprognostic (9.39e-2)"	"unprognostic (5.17e-2)"	"unprognostic (2.69e-1)"	"unprognostic (3.70e-2)"	"prognostic favorable (1.91e-4)"	"unprognostic (2.71e-1)"	"prognostic favorable (7.82e-4)"	"unprognostic (2.08e-2)"	"unprognostic (6.92e-2)"	"unprognostic (3.27e-1)"	"unprognostic (3.72e-2)"	"unprognostic (9.32e-2)"	"unprognostic (2.32e-1)"	"unprognostic (2.64e-1)"	"unprognostic (4.11e-2)"	"unprognostic (3.52e-2)"	9.8	6.9	8.6	11.1	9.2	34.7	9.1	14.8	10.0	8.6	8.9	7.7	8.8	9.5	6.8	7.4	6.8	9.0	8.7	8.0	11.7	9.4	18.7	10.3	14.9	7.9	7.7	12.5	7.4	9.8	5.4	9.8	7.6	8.6	8.8	14.0	6.7	7.6	5.4	8.7	9.1	8.2	6.8	14.0	8.9	6.9	12.3	14.5	10.6	6.3	11.2	8.4	7.5	10.7	8.5	7.0	19.2	9.5	9.3	11.2	9.7	9.9	8.4	6.6	10.4	8.3	13.1	20.4	10.3	8.4	6.3	9.6	8.6	4.8	9.6	14.3	5.5	9.2	8.2	8.0	5.6	19.7	12.8	8.4	5.2	6.4	6.6	10.5	10.6	11.6	10.7	16.3	7.1	11.5	14.3	17.7	3.8	8.2	8.7	14.5	16.6	6.1	7.1	14.9	16.5	14.3	16.9	8.4	12.0	9.4	14.3	17.8	15.3	11.2	8.7	9.1	4.6	5.3	4.2	18.3	6.7	12.3	5.8	65.8	19.5	59.1	20.6	20.1	23.3	31.5	25.3	22.1	14.9	42.3	27.0	26.5	109.4	29.1	40.8	19.8	19.8	10.1	8.6	9.2	14.8	10.0	8.0	11.7	7.9	7.7	7.6	6.8	12.3	10.7	57.7	83.3	100.9	68.9	73.5	38.4	21.2	22.1	64.3	111.0	29.5	35.8	55.0	24.3	32.3	27.6	52.1	19.9	74.0	33.0	19.6	23.3	18.2	40.5	37.6	47.1	22.8	45.8	94.2	21.7	21.3	40.1	26.0	52.6	65.2	39.9	37.5	41.9	34.7	112.7	78.6	35.5	20.3	47.7	49.5	8.8	36.4	59.3	26.6	63.7	75.8	63.9	49.4	86.5	91.4	24.9	38.6	36.1	55.1	20.9	43.4	14.9	11.2	64.2	19.7	40.0	43.0	38.6	33.8	55.4	33.4	20.4	77.0	34.1	32.9	17.7
ARID4B	"BCAA, BRCAA1, RBP1L1, SAP180"	ENSG00000054267	"AT-rich interaction domain 4B"	Q4LE39	1	235131634-235328219	"Metabolic proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 486.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027205, HPA027333"	Approved		Approved	Nucleoplasm,Mitochondria,Cytosol		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 34: Non-specific - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 31: Spermatids - Spermatogenesis"	"Mitochondria, Cytosol"	Nucleoplasm	"HPA027205: , HPA027333: AB_1845013"	"unprognostic (2.62e-1)"	"unprognostic (2.38e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.87e-3)"	"unprognostic (7.75e-2)"	"unprognostic (1.27e-1)"	"unprognostic (4.16e-2)"	"unprognostic (1.30e-2)"	"unprognostic (1.03e-1)"	"unprognostic (5.69e-2)"	"unprognostic (1.23e-1)"	"prognostic unfavorable (2.23e-4)"	"unprognostic (1.42e-2)"	"unprognostic (1.25e-1)"	"unprognostic (3.52e-2)"	"unprognostic (8.84e-3)"	11.3	10.9	9.6	14.1	11.2	33.0	13.5	12.8	13.0	15.0	7.8	10.2	8.1	15.9	14.4	9.8	10.9	13.2	7.4	8.4	9.5	10.6	11.9	12.0	21.0	10.4	10.5	17.2	11.4	13.6	10.9	12.7	10.8	14.3	9.1	14.6	11.5	10.8	9.0	9.0	10.3	10.2	9.9	18.4	13.2	17.1	9.6	21.4	16.9	9.8	17.0	12.9	10.6	13.0	15.8	10.5	18.0	16.5	15.3	15.5	17.5	17.6	15.1	11.3	10.9	12.2	16.9	18.1	19.9	12.0	8.7	13.4	16.4	7.4	17.8	23.5	17.3	14.7	14.7	10.9	11.9	15.8	21.0	10.8	10.4	13.5	12.7	16.1	18.2	11.4	19.3	25.4	11.9	7.5	21.9	15.3	18.9	12.1	8.2	9.4	13.4	15.3	14.1	13.2	15.9	22.4	22.1	20.3	18.3	6.2	19.1	27.4	21.6	14.4	11.5	18.2	17.7	25.1	22.1	18.2	9.8	11.9	19.4	61.7	13.7	41.1	29.9	15.0	27.5	32.2	31.6	26.0	13.8	34.0	31.2	26.7	72.5	33.8	25.6	23.6	28.3	12.6	9.6	11.2	12.8	13.0	8.4	9.5	10.4	10.5	10.8	9.9	9.6	13.0	156.8	102.5	106.8	107.7	150.1	124.3	83.8	61.2	103.0	125.5	86.2	78.5	77.4	47.1	91.7	31.3	120.9	64.0	218.9	47.9	19.6	76.4	334.7	119.3	127.9	128.9	90.1	45.2	157.0	47.9	70.2	101.6	59.1	169.2	110.1	78.0	67.8	27.6	44.4	112.7	158.4	53.2	65.1	61.2	127.6	486.5	101.2	97.3	83.6	107.7	122.8	67.7	204.9	144.8	304.2	68.6	57.3	77.5	104.1	108.7	48.3	20.6	82.3	150.7	46.0	130.2	121.4	236.7	161.9	66.5	106.4	156.7	209.8	84.8	44.7	149.6
ARID5A	"MRF-1, RP11-363D14"	ENSG00000196843	"AT-rich interaction domain 5A"	Q03989	2	96536743-96552634	"Predicted intracellular proteins, Transcription factors"	"Immunity, Innate immunity, Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Langerhans cells: 137.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"HDLM-2: 295.3;RPMI-8226: 117.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA002860, HPA023879"	Approved		Supported	Nucleoplasm,Nucleoli		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 64: Macrophages - Immune response"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 48: Smooth muscle cells - ECM organization"	Nucleoplasm	Nucleoli	"HPA002860: , HPA023879: AB_1845014"	"prognostic favorable (2.05e-6)"	"unprognostic (1.08e-3)"	"unprognostic (1.69e-2)"	"unprognostic (3.89e-3)"	"unprognostic (1.90e-2)"	"unprognostic (3.38e-2)"	"unprognostic (3.03e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.24e-3)"	"unprognostic (2.46e-1)"	"unprognostic (1.56e-3)"	"unprognostic (1.17e-1)"	"prognostic unfavorable (4.24e-8)"	"unprognostic (2.74e-2)"	"unprognostic (9.79e-2)"	"unprognostic (1.06e-1)"	"unprognostic (5.13e-2)"	32.6	4.5	8.1	19.5	8.9	11.8	38.8	8.7	11.1	18.5	7.7	25.9	5.0	25.2	2.0	7.8	24.1	12.3	28.8	7.8	8.7	12.3	8.5	48.1	19.0	14.3	10.8	10.8	6.9	2.2	9.3	9.6	11.5	23.2	2.3	2.2	10.2	2.6	23.5	11.3	19.8	7.3	10.6	22.8	14.6	5.6	10.2	10.3	13.0	2.3	9.9	19.9	15.4	9.6	3.4	1.9	1.6	5.4	2.7	3.0	7.5	5.1	17.2	6.1	5.3	3.1	0.9	1.1	3.8	2.9	9.1	4.6	1.4	0.3	2.1	295.3	4.1	6.9	1.1	5.8	3.4	4.7	4.9	2.1	5.7	5.0	0.9	5.3	5.4	8.1	5.4	38.5	2.4	2.9	8.7	16.1	3.3	1.5	0.2	12.2	11.3	117.5	0.7	2.5	2.2	1.1	0.5	0.6	4.3	1.3	0.2	10.0	6.0	5.4	6.7	6.2	4.6	24.7	21.5	3.1	3.0	11.1	4.9	10.5	7.9	32.8	15.3	6.9	14.9	5.9	13.1	14.6	10.3	6.5	14.1	14.4	21.5	27.5	5.5	18.4	16.0	14.9	8.1	8.9	8.7	11.1	7.8	8.7	14.3	10.8	11.5	10.6	10.2	9.6	97.1	3.2	18.3	3.9	59.9	52.4	46.5	17.0	5.7	24.8	80.3	44.7	14.7	8.6	14.7	3.7	31.3	4.9	121.1	10.8	3.9	33.7	14.2	16.7	26.8	82.2	0.0	3.4	1.5	30.9	9.0	41.2	11.2	32.4	61.9	2.1	38.6	28.7	72.6	0.0	1.6	10.7	20.3	41.5	137.1	36.7	3.7	61.6	58.7	15.9	66.6	6.5	123.6	3.5	1.3	29.1	23.9	6.4	54.5	28.2	0.6	10.6	8.3	25.7	46.0	49.1	120.1	3.2	17.9	1.1	32.5	4.0	98.2	2.1	7.8	26.9
ARIH1	"ARI, HARI, HHARI, UBCH7BP"	ENSG00000166233	"Ariadne RBR E3 ubiquitin protein ligase 1"	Q9Y4X5	15	72474330-72602987	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 47.8;testis: 42.5"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003295	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 18: U-2197 - ECM organization"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm		"HPA003295: AB_1845017"	"unprognostic (3.31e-2)"	"unprognostic (1.92e-1)"	"unprognostic (2.25e-1)"	"unprognostic (3.18e-2)"	"unprognostic (8.21e-2)"	"unprognostic (5.45e-2)"	"unprognostic (1.73e-1)"	"unprognostic (9.43e-2)"	"unprognostic (7.92e-2)"	"unprognostic (1.37e-1)"	"unprognostic (4.96e-2)"	"unprognostic (9.19e-2)"	"unprognostic (1.78e-1)"	"unprognostic (2.93e-1)"	"unprognostic (3.19e-1)"	"unprognostic (1.04e-1)"	"unprognostic (5.70e-2)"	8.5	7.9	2.5	10.1	3.9	16.5	6.0	7.0	5.8	6.4	7.1	8.2	9.5	7.5	3.2	6.8	5.4	4.4	11.4	4.4	4.0	5.2	6.2	7.3	4.9	3.4	2.7	9.0	6.6	3.9	5.9	6.5	3.6	5.8	3.3	10.4	4.3	4.8	47.8	7.6	7.4	6.3	3.0	6.0	6.3	42.5	3.8	3.9	5.0	8.5	4.1	7.6	6.5	4.3	17.6	18.0	17.5	10.2	8.9	6.2	20.6	19.3	7.0	8.6	5.9	18.3	14.6	17.2	28.4	8.3	30.3	24.8	18.1	10.1	4.8	30.6	12.4	13.0	22.5	12.4	6.3	19.6	14.4	7.4	3.4	9.5	12.2	8.2	6.4	12.4	13.8	19.7	8.5	11.5	18.9	7.5	18.9	6.3	6.5	21.4	21.3	9.8	4.8	29.0	16.3	18.4	25.1	11.2	31.4	23.0	9.0	22.0	16.7	14.1	19.6	54.8	27.4	20.7	45.2	20.6	9.2	17.5	15.2	1.6	0.2	0.7	0.5	0.4	0.4	0.2	0.3	0.3	0.2	0.6	0.4	0.4	1.0	0.6	0.2	0.3	0.8	0.1	2.5	3.9	7.0	5.8	4.4	4.0	3.4	2.7	3.6	3.0	3.8	4.3	79.5	19.2	37.7	88.5	64.0	66.3	52.7	13.3	76.2	63.3	74.9	53.3	46.9	30.0	25.7	18.4	91.8	18.4	83.3	32.9	3.9	18.4	110.3	108.7	84.8	50.7	46.5	24.8	141.6	18.9	21.8	43.3	63.7	148.4	43.2	43.7	40.0	28.5	19.0	62.2	152.0	31.2	8.2	30.5	42.1	55.4	28.6	67.5	16.0	104.0	24.2	25.7	27.8	129.7	135.1	24.7	19.1	27.4	60.9	55.8	20.8	13.9	33.0	58.8	19.7	96.8	59.9	45.3	32.1	68.8	59.8	40.8	68.3	36.8	27.0	63.7
ARL1	ARFL1	ENSG00000120805	"ADP ribosylation factor like GTPase 1"	P40616	12	101393116-101407772	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA062656, HPA073012"	Approved		Supported	"Golgi apparatus"		NA	NA		13000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Golgi apparatus"		"HPA062656: AB_2684821, HPA073012: AB_2686564"	"unprognostic (5.52e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.38e-1)"	"prognostic favorable (1.61e-4)"	"unprognostic (6.41e-2)"	"unprognostic (3.15e-2)"	"unprognostic (2.62e-3)"	"unprognostic (1.69e-1)"	"unprognostic (1.97e-1)"	"unprognostic (4.82e-2)"	"unprognostic (2.28e-1)"	"unprognostic (4.54e-2)"	"unprognostic (1.04e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.74e-1)"	"unprognostic (6.22e-2)"	"unprognostic (3.46e-2)"	46.4	66.0	25.3	40.0	27.0	16.5	62.5	26.6	31.6	86.5	41.8	56.6	48.0	51.3	71.2	49.1	50.1	43.6	65.5	27.1	33.6	76.6	68.6	36.6	33.2	30.1	29.3	65.2	44.6	92.6	59.1	51.5	31.9	73.4	60.5	48.7	73.9	69.1	51.9	27.8	43.2	59.7	28.5	28.9	57.5	32.8	28.0	32.8	84.7	56.7	48.7	53.0	35.9	27.7	64.9	61.2	58.8	51.6	162.0	161.5	77.8	129.2	155.2	85.9	81.9	71.4	46.9	58.4	77.3	150.7	76.4	44.3	67.1	88.6	98.0	47.0	51.5	54.9	32.9	110.7	120.2	63.7	40.2	97.7	77.1	85.6	135.7	146.1	93.1	39.7	74.1	33.5	113.3	76.1	55.4	63.4	56.6	93.9	82.5	40.8	58.8	67.1	130.5	128.6	38.8	25.5	62.1	80.5	104.2	82.6	136.0	43.5	70.4	65.1	37.3	88.5	56.4	55.5	59.5	58.9	93.3	47.4	71.5	50.4	25.3	18.2	21.8	30.7	32.5	30.1	25.8	28.4	32.8	28.8	25.6	20.1	2.5	23.7	34.2	39.6	34.1	24.6	25.3	27.0	26.6	31.6	27.1	33.6	30.1	29.3	31.9	28.5	28.0	27.7	57.0	41.7	46.7	13.4	39.4	51.2	71.4	175.5	38.7	42.1	65.1	64.4	75.2	41.5	119.1	69.9	18.8	102.6	30.5	42.3	125.2	97.0	90.2	54.8	68.4	44.6	47.5	24.6	14.5	64.3	119.4	88.4	36.2	60.6	37.4	37.4	36.8	50.2	65.8	32.0	19.5	125.6	75.3	27.7	31.9	31.8	78.6	31.6	55.2	6.5	39.6	81.9	25.7	12.5	15.8	62.1	52.2	71.1	79.3	117.2	70.4	131.3	100.0	48.9	46.0	51.2	75.7	134.6	86.1	46.2	55.4	135.3	28.8	54.6	65.7	100.1
ARL14EP	"ARF7EP, C11orf46, FLJ38968"	ENSG00000152219	"ADP ribosylation factor like GTPase 14 effector protein"	Q8N8R7	11	30323104-30338223	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 130.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039634, HPA048127"	Approved		Supported	"Nucleoplasm,Vesicles,Focal adhesion sites,Cytosol"		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Vesicles, Focal adhesion sites, Cytosol"	Nucleoplasm	"HPA039634: AB_2676606, HPA048127: AB_2680277"	"prognostic favorable (2.50e-5)"	"unprognostic (8.93e-2)"	"unprognostic (6.19e-3)"	"unprognostic (1.34e-1)"	"unprognostic (1.67e-1)"	"unprognostic (3.09e-1)"	"prognostic unfavorable (5.26e-4)"	"unprognostic (2.50e-2)"	"unprognostic (6.50e-3)"	"unprognostic (5.76e-2)"	"unprognostic (8.86e-2)"	"unprognostic (1.04e-1)"	"unprognostic (8.57e-3)"	"unprognostic (1.60e-1)"	"unprognostic (3.47e-1)"	"unprognostic (4.50e-2)"	"prognostic favorable (7.49e-4)"	13.9	22.5	13.5	13.2	15.6	8.0	20.0	15.9	17.3	17.0	14.9	11.8	9.5	18.9	23.2	11.6	16.4	13.1	22.9	15.7	14.2	17.4	19.7	10.9	22.5	12.4	13.3	20.5	12.9	26.1	12.0	11.5	12.1	19.7	10.8	15.9	19.1	19.9	20.6	12.6	9.7	14.5	13.9	20.8	15.7	14.6	13.3	15.6	24.7	20.8	21.4	14.5	8.1	13.8	10.8	15.4	16.9	14.8	27.1	29.2	8.5	20.8	26.0	18.4	20.2	8.5	4.1	43.8	13.9	15.0	20.5	17.8	24.8	17.5	25.9	35.2	30.7	13.3	12.0	15.0	42.6	24.0	14.7	30.5	34.7	8.7	32.8	26.7	20.6	17.9	21.4	23.2	32.5	10.4	21.9	19.6	19.6	24.1	21.3	18.8	41.2	18.0	24.7	14.8	19.2	20.4	16.2	21.4	25.8	15.0	22.8	13.4	18.1	20.8	11.2	41.7	20.1	36.0	21.9	28.5	20.0	14.8	20.4	12.7	19.2	6.4	23.3	20.0	55.5	35.9	28.2	25.9	26.3	28.9	25.7	25.0	3.5	52.9	15.5	18.9	20.3	23.1	13.5	15.6	15.9	17.3	15.7	14.2	12.4	13.3	12.1	13.9	13.3	13.8	27.3	28.9	33.6	14.4	39.7	12.4	46.6	35.1	8.0	34.0	19.9	30.4	68.1	24.3	23.8	25.8	14.6	19.1	29.2	5.9	76.3	27.3	130.1	25.8	41.0	29.2	14.5	13.2	31.1	22.5	12.7	33.4	12.8	19.0	27.8	33.5	15.4	29.8	25.7	32.0	26.4	11.7	32.6	27.1	29.3	66.3	27.4	28.4	26.6	18.7	45.4	36.1	38.1	27.6	19.9	21.9	8.4	25.2	25.4	46.0	9.4	42.1	27.5	32.4	13.1	33.1	29.8	111.4	37.6	13.8	11.1	11.1	29.6	33.0	12.6	28.4
ARL2BP	"BART, BART1, RP66"	ENSG00000102931	"ADP ribosylation factor like GTPase 2 binding protein"	Q9Y2Y0	16	57245259-57253635	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Ciliopathy, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 264.6;Late spermatids: 503.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043066, HPA048440"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 43: Testis - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 34: Spermatids - Unknown function"	"Nucleoplasm, Cytosol"		"HPA043066: AB_2678302, HPA048440: AB_2680393"	"unprognostic (1.17e-1)"	"unprognostic (4.05e-2)"	"unprognostic (3.32e-2)"	"unprognostic (1.74e-1)"	"unprognostic (3.33e-3)"	"unprognostic (1.26e-2)"	"unprognostic (1.47e-1)"	"prognostic unfavorable (9.06e-5)"	"unprognostic (2.38e-1)"	"unprognostic (3.06e-1)"	"unprognostic (2.07e-1)"	"unprognostic (4.10e-2)"	"unprognostic (2.71e-3)"	"unprognostic (1.44e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.47e-2)"	"unprognostic (6.78e-2)"	48.5	42.6	49.8	30.1	51.6	35.7	37.4	51.1	58.1	35.5	51.9	36.0	20.8	45.0	34.8	49.6	44.1	36.2	54.4	51.5	52.2	44.0	32.7	44.5	37.7	50.1	51.9	50.6	29.6	48.0	27.6	37.4	51.6	34.9	36.0	37.2	25.4	46.0	31.8	31.3	24.8	59.3	51.1	49.4	27.5	57.1	51.6	44.8	29.9	46.1	46.3	39.9	29.9	52.1	74.2	49.4	93.3	48.7	82.6	106.0	23.2	91.2	105.4	104.2	65.9	37.4	28.9	61.9	104.0	126.3	48.8	48.5	60.3	74.0	97.8	28.5	57.8	54.9	36.3	64.2	112.3	50.8	113.6	91.6	94.8	75.4	103.3	77.4	127.5	46.7	42.5	23.3	73.0	28.7	52.3	63.9	32.7	25.7	98.7	71.3	91.7	120.8	113.8	26.4	29.2	61.1	140.1	66.1	82.8	58.1	48.8	66.6	114.6	61.2	37.8	53.3	70.8	58.8	49.6	58.9	79.8	33.2	60.2	35.5	46.1	27.3	40.5	45.3	42.3	37.6	36.7	44.1	56.5	29.8	49.5	42.0	7.6	63.6	51.3	16.3	33.7	55.1	49.8	51.6	51.1	58.1	51.5	52.2	50.1	51.9	51.6	51.1	51.6	52.1	60.3	51.3	27.4	9.8	47.0	36.7	43.3	57.0	42.7	44.4	30.6	27.8	0.2	40.0	28.7	36.8	4.2	51.0	50.5	23.4	76.3	46.2	264.6	49.2	57.8	63.7	26.4	105.7	20.6	58.0	30.2	66.6	30.1	58.7	74.3	105.7	62.8	34.3	63.3	55.5	22.5	21.5	46.8	52.8	36.5	503.7	82.3	42.2	48.0	7.5	71.2	66.0	66.9	42.7	33.9	44.6	18.5	109.1	50.3	24.0	23.2	65.8	32.9	38.0	13.1	39.7	45.5	122.2	51.8	66.8	37.1	22.3	60.8	170.2	23.6	22.6
ARL3	ARFL3	ENSG00000138175	"ADP ribosylation factor like GTPase 3"	P36405	10	102673731-102714397	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cell cycle, Cell division, Protein transport, Transport"		"Ciliopathy, Disease variant, Joubert syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"retina: 96.3"	"Cell type enhanced"	"Detected in all"		"Muller glia cells: 289.1;Rod photoreceptor cells: 318.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036292, HPA063596"	Approved		Supported	Nucleoplasm,Centrosome		NA	NA		44000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 77: Retina - Visual perception"	"Cluster 6: T47d - Mammary gland"	"Cluster 46: Photoreceptor cells - Phototransduction"	Centrosome	Nucleoplasm	"HPA036292: AB_10673618, HPA063596: AB_2685053"	"unprognostic (1.36e-1)"	"unprognostic (2.89e-3)"	"unprognostic (4.19e-2)"	"unprognostic (7.58e-2)"	"unprognostic (2.98e-2)"	"unprognostic (3.24e-2)"	"unprognostic (2.45e-2)"	"unprognostic (7.69e-2)"	"unprognostic (4.00e-2)"	"unprognostic (3.21e-1)"	"unprognostic (3.99e-3)"	"unprognostic (5.58e-2)"	"prognostic favorable (1.71e-6)"	"unprognostic (5.62e-2)"	"unprognostic (3.09e-2)"	"unprognostic (4.21e-2)"	"unprognostic (1.03e-1)"	8.1	8.9	20.2	4.2	21.3	1.7	8.1	20.8	25.1	12.4	19.1	11.3	4.2	11.5	10.6	4.6	15.2	5.2	13.5	20.8	19.5	15.4	5.2	8.3	3.6	19.3	19.1	16.8	6.4	19.8	21.0	4.9	19.7	8.7	4.6	96.3	6.3	9.0	5.6	7.2	6.1	8.7	18.5	4.5	8.8	11.0	20.5	5.7	11.4	5.9	4.7	9.8	8.3	19.5	14.7	25.0	33.6	24.7	15.2	22.7	5.9	11.4	17.3	13.6	14.7	8.7	7.4	6.1	10.8	18.5	16.4	10.7	12.7	15.3	16.9	16.1	13.4	9.9	16.9	8.3	16.4	4.6	9.5	11.5	12.6	18.8	11.0	36.1	15.8	12.0	4.5	6.0	23.0	15.1	9.5	7.3	13.0	9.2	9.8	7.9	24.8	5.4	18.1	7.7	11.8	25.7	8.7	1.8	14.1	18.5	45.1	4.6	9.1	9.2	12.9	18.9	16.0	4.2	8.9	11.3	24.4	13.6	8.1	2.0	7.2	2.6	3.7	6.1	9.4	4.5	6.5	5.5	7.1	3.9	3.9	4.7	13.4	4.4	5.4	5.2	4.9	5.4	20.2	21.3	20.8	25.1	20.8	19.5	19.3	19.1	19.7	18.5	20.5	19.5	46.0	54.5	39.3	47.7	16.7	32.1	70.4	144.3	29.0	167.6	48.2	57.5	135.5	31.5	85.8	62.5	116.7	45.5	12.1	9.4	234.8	70.7	46.5	250.5	85.2	41.6	74.8	9.4	30.8	43.6	37.8	61.7	19.4	84.6	33.0	94.1	43.9	25.5	64.7	97.6	37.6	31.6	73.2	16.4	33.6	25.8	60.6	26.8	76.5	13.1	67.3	289.1	13.4	31.7	23.4	31.1	13.5	104.2	18.6	54.2	23.1	225.8	268.3	318.6	26.3	50.8	122.0	145.6	43.4	11.9	31.7	32.3	20.8	58.6	25.4	50.5
ARL4A	ARL4	ENSG00000122644	"ADP ribosylation factor like GTPase 4A"	P40617	7	12686856-12690958	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 191.1"	"Group enriched"	"Detected in all"	4	"Early spermatids: 1523.0;Late spermatids: 3892.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 261.3;K-562: 328.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA064513			Supported	Nucleoplasm,Cytosol		NA	Yes			"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 71: Testis - DNA repair"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 25: Spermatids - Spermatogenesis"	Nucleoplasm	Cytosol	"HPA064513: AB_2685276"	"unprognostic (8.29e-2)"	"unprognostic (1.34e-1)"	"unprognostic (3.94e-1)"	"unprognostic (4.97e-2)"	"unprognostic (3.88e-2)"	"unprognostic (7.43e-2)"	"unprognostic (1.34e-2)"	"unprognostic (6.56e-2)"	"unprognostic (9.97e-2)"	"unprognostic (2.23e-1)"	"unprognostic (3.02e-2)"	"unprognostic (3.57e-2)"	"unprognostic (7.27e-3)"	"unprognostic (1.74e-1)"	"unprognostic (9.29e-2)"	"unprognostic (9.42e-3)"	"unprognostic (9.49e-3)"	31.6	7.9	17.1	16.8	20.1	98.4	55.3	14.3	25.8	38.0	22.5	40.7	29.9	16.8	13.8	60.0	27.7	19.2	15.5	23.0	15.4	8.9	15.6	19.4	18.6	14.4	14.3	8.0	7.2	5.3	9.2	23.6	14.5	21.0	34.7	6.7	86.6	16.5	9.1	88.5	62.7	25.1	14.7	21.0	24.5	191.1	15.4	22.7	19.2	8.7	15.9	21.4	63.8	18.6	45.0	46.7	121.5	261.3	19.3	31.8	0.3	17.9	16.2	28.7	17.2	41.6	32.9	0.3	7.5	25.4	73.4	12.6	27.3	22.6	28.9	9.8	20.4	9.2	61.7	39.3	39.8	39.6	16.0	14.3	88.3	16.7	74.2	18.1	69.0	17.7	328.1	42.5	29.4	19.3	2.2	55.6	44.2	129.2	53.1	0.0	42.4	20.8	37.8	21.3	22.3	20.8	29.5	31.1	6.3	31.3	15.3	32.0	24.3	11.5	40.6	43.5	73.1	19.4	27.2	10.3	29.7	16.5	46.4	8.1	14.8	0.7	11.3	25.7	31.7	41.0	26.8	17.7	14.4	44.7	12.9	10.8	2.2	13.0	32.1	12.8	17.8	13.6	17.1	20.1	14.3	25.8	23.0	15.4	14.4	14.3	14.5	14.7	15.4	18.6	134.0	22.4	20.3	1.0	96.9	339.7	179.1	144.5	70.0	20.9	217.9	230.0	15.8	64.3	86.6	20.2	85.5	152.9	61.0	236.6	27.4	47.8	1523.0	179.1	41.5	162.5	62.6	249.9	11.6	29.6	18.7	46.1	63.2	86.5	80.5	27.7	157.1	21.7	59.5	3.3	3.4	107.1	337.7	168.2	171.1	3892.8	69.0	170.9	120.9	17.8	38.7	11.0	3.1	36.7	8.7	55.3	118.0	26.7	24.4	53.4	641.5	14.6	102.5	125.9	13.1	59.5	55.3	564.1	57.5	134.9	234.7	444.0	98.0	32.4	124.2	89.1
ARL4C	"ARL7, LAK"	ENSG00000188042	"ADP ribosylation factor like GTPase 4C"	P56559	2	234493041-234497081	"Predicted intracellular proteins"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 74.0"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 610.9;Langerhans cells: 474.5;NK-cells: 437.7;T-cells: 349.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 149.4;RPTEC TERT1: 284.8;U-2197: 168.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028927	Uncertain		Supported	"Plasma membrane,Cytosol"		NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 24: Non-specific - Transcription regulation"	"Plasma membrane"	Cytosol	"HPA028927: AB_10602387"	"unprognostic (1.93e-1)"	"unprognostic (1.14e-1)"	"unprognostic (3.20e-3)"	"prognostic unfavorable (2.90e-7)"	"unprognostic (8.01e-3)"	"unprognostic (3.35e-2)"	"unprognostic (9.26e-2)"	"unprognostic (2.68e-2)"	"unprognostic (2.10e-1)"	"unprognostic (4.34e-2)"	"unprognostic (3.17e-3)"	"unprognostic (1.21e-1)"	"prognostic unfavorable (3.69e-8)"	"unprognostic (8.57e-2)"	"unprognostic (4.64e-2)"	"unprognostic (1.20e-1)"	"prognostic unfavorable (6.99e-5)"	15.1	10.6	15.4	31.7	14.6	65.0	17.3	17.8	18.6	11.4	45.3	9.1	6.6	5.8	9.5	23.2	11.9	31.8	5.1	13.1	21.9	12.2	12.8	16.1	55.3	21.9	17.1	2.1	5.5	10.8	7.4	16.5	21.3	10.3	11.2	9.7	21.6	5.4	1.5	24.1	13.2	5.9	12.8	51.0	13.6	1.2	18.5	74.0	3.7	1.7	32.1	25.5	18.0	13.8	32.3	97.4	12.0	1.6	10.4	3.0	31.6	3.2	13.8	3.8	6.6	45.4	60.4	0.1	8.0	7.7	109.0	23.5	12.0	66.4	4.1	30.4	4.2	0.0	0.6	0.6	10.7	0.1	2.8	6.4	42.2	36.6	21.2	149.4	6.4	78.4	0.4	102.4	16.4	4.4	93.7	0.3	12.6	22.5	21.9	0.3	54.1	18.0	284.8	35.2	44.1	8.1	1.1	7.1	4.7	18.2	0.9	1.9	14.8	60.0	23.2	168.2	61.6	51.1	19.7	1.6	101.9	0.1	32.0	79.8	1.2	27.4	86.7	1.6	85.6	18.1	60.0	69.5	10.3	18.3	53.5	59.1	2.2	61.2	0.9	55.2	83.8	30.0	15.4	14.6	17.8	18.6	13.1	21.9	21.9	17.1	21.3	12.8	18.5	13.8	12.3	73.7	15.9	8.8	63.6	124.8	120.7	18.4	145.1	156.6	40.4	64.6	10.9	67.2	27.0	14.7	8.4	30.0	610.9	2.3	0.0	19.6	7.8	73.9	19.2	23.4	1.8	6.1	15.5	5.7	5.4	23.7	19.9	186.3	27.8	1.1	11.0	3.4	31.4	107.7	103.0	2.5	0.0	208.4	474.5	6.5	0.3	182.1	42.7	6.5	41.8	32.2	437.7	6.0	2.5	16.5	0.1	0.0	132.6	60.4	0.1	0.9	4.7	13.1	0.0	7.0	19.3	0.7	1.9	65.4	42.9	14.6	349.8	0.4	1.2	46.6
ARMC7	FLJ22160	ENSG00000125449	"Armadillo repeat containing 7"	Q9H6L4	17	75109952-75130272	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 39.5"	"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 35.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024229, HPA053076"	Uncertain		Supported	Cytosol		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Cytosol		"HPA024229: AB_2059152, HPA053076: AB_2682036"	"unprognostic (1.35e-1)"	"prognostic favorable (2.98e-4)"	"unprognostic (7.73e-2)"	"unprognostic (5.84e-2)"	"unprognostic (4.15e-2)"	"unprognostic (5.32e-2)"	"prognostic unfavorable (2.24e-5)"	"unprognostic (2.84e-2)"	"unprognostic (3.68e-1)"	"unprognostic (4.28e-2)"	"unprognostic (3.40e-2)"	"unprognostic (4.86e-2)"	"prognostic favorable (1.27e-4)"	"unprognostic (1.93e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.98e-2)"	7.4	6.7	7.3	5.8	7.5	4.1	7.4	12.7	9.0	7.7	7.7	12.4	9.6	7.0	4.8	11.2	6.6	4.7	8.8	7.6	7.7	39.5	13.2	12.3	7.0	7.3	7.1	5.2	7.0	6.6	7.0	5.8	7.6	11.8	6.9	2.7	8.9	6.4	5.5	12.0	11.9	4.0	7.0	14.0	11.4	7.3	7.9	8.2	9.9	3.9	6.4	8.7	9.3	7.9	15.2	30.2	8.9	8.5	7.0	4.3	9.4	8.3	9.0	15.9	14.3	25.3	14.7	9.0	10.8	7.7	8.7	12.4	14.6	6.1	7.6	8.7	23.2	17.5	13.4	15.9	15.5	13.5	16.1	5.6	11.4	10.0	5.8	7.7	14.6	14.5	15.8	17.6	5.3	21.7	25.9	14.8	4.5	32.8	22.6	14.6	18.0	16.8	35.6	27.4	8.3	11.9	15.6	15.7	18.6	15.2	18.4	12.9	11.3	16.1	14.9	6.4	13.1	14.7	5.5	12.7	7.2	9.6	11.8	31.7	13.7	28.5	18.0	9.9	15.8	13.4	12.9	15.1	12.7	10.0	9.8	14.9	18.6	15.7	7.9	11.1	20.8	11.7	7.3	7.5	12.7	9.0	7.6	7.7	7.3	7.1	7.6	7.0	7.9	7.9	6.6	12.8	8.8	1.3	10.4	4.6	2.8	5.8	2.2	6.0	6.0	5.1	2.5	7.2	5.2	22.0	0.0	14.1	10.1	28.6	35.2	8.7	6.2	4.6	3.0	9.0	6.0	1.7	3.0	9.4	8.3	4.1	8.6	5.1	10.8	4.4	14.3	4.6	15.2	0.0	2.9	9.8	6.1	7.5	3.3	12.2	5.3	9.7	12.4	1.9	13.9	3.3	11.3	2.5	1.8	11.3	27.1	3.8	6.4	4.8	15.8	15.4	7.2	3.4	19.7	2.2	4.6	3.8	5.9	4.4	4.5	4.9	8.7	6.6	12.4	3.8
ARMC8	"DKFZP434A043, GID5, HSPC056, VID28"	ENSG00000114098	"Armadillo repeat containing 8"	Q8IUR7	3	138187248-138298384	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocyte precursor cells: 128.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036996, HPA044869"	Approved		Supported	Nucleoplasm,Vesicles,Cytosol		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 68: Oligodendrocytes - Mixed function"	Nucleoplasm	"Vesicles, Cytosol"	"HPA036996: AB_10672786, HPA044869: AB_2679123"	"unprognostic (2.04e-1)"	"unprognostic (1.60e-2)"	"unprognostic (1.44e-1)"	"prognostic unfavorable (2.05e-4)"	"unprognostic (3.51e-2)"	"unprognostic (2.39e-2)"	"prognostic unfavorable (8.90e-5)"	"unprognostic (1.96e-1)"	"unprognostic (2.04e-2)"	"unprognostic (7.48e-3)"	"unprognostic (1.64e-1)"	"prognostic unfavorable (2.15e-4)"	"unprognostic (3.27e-2)"	"unprognostic (2.03e-1)"	"unprognostic (4.06e-2)"	"unprognostic (5.51e-2)"	"unprognostic (1.18e-1)"	20.8	14.3	14.6	18.0	16.6	60.6	16.4	41.2	18.5	14.7	25.6	16.8	12.0	17.6	12.2	21.0	15.7	15.3	17.4	13.3	16.9	18.9	16.9	16.3	21.2	16.0	15.8	16.0	14.2	21.3	12.3	19.8	17.5	16.5	18.3	26.2	12.5	17.5	38.7	12.8	13.5	24.4	15.9	15.9	15.4	18.4	16.7	22.2	21.3	34.8	22.9	22.2	13.4	19.4	46.2	22.0	28.5	23.2	35.2	30.7	37.9	34.8	33.4	46.7	45.3	34.3	23.7	43.2	35.0	30.2	54.6	23.5	37.1	33.9	57.4	29.3	25.7	77.2	14.3	23.9	44.3	60.6	82.5	46.2	21.2	30.0	42.9	25.4	37.0	37.0	29.3	23.8	58.6	40.5	42.7	28.6	39.2	34.8	19.1	33.0	45.7	34.6	30.7	42.3	33.0	24.0	50.0	17.2	29.1	36.8	33.8	31.6	40.4	24.8	20.2	33.1	25.9	45.0	37.5	65.2	22.4	28.4	25.2	79.7	39.7	74.8	38.6	43.5	44.6	48.8	35.2	41.1	45.9	43.3	41.1	40.6	27.9	48.8	46.0	20.3	50.4	37.4	14.6	16.6	41.2	18.5	13.3	16.9	16.0	15.8	17.5	15.9	16.7	19.4	25.0	28.9	14.1	56.2	38.2	31.0	31.9	29.0	25.0	34.9	17.7	14.9	23.1	24.3	27.2	12.9	33.3	29.9	35.6	25.1	11.7	20.2	7.3	16.2	22.3	23.4	23.4	59.6	101.9	14.6	27.6	23.4	31.1	19.5	35.4	24.1	24.3	24.6	22.5	43.7	93.6	16.9	30.5	32.7	39.2	7.3	30.4	35.2	19.6	70.3	27.2	25.0	39.1	128.2	120.8	14.8	17.2	22.2	26.8	28.1	17.0	26.1	17.4	47.0	13.1	30.2	31.5	43.4	32.2	22.3	28.4	34.1	30.9	19.6	17.4	28.3
ARMCX1	"ALEX1, GASP7"	ENSG00000126947	"Armadillo repeat containing X-linked 1"	Q9P291	X	101550547-101554700	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"myeloid DC: 7.7"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 74.9;ASC TERT1: 66.9;BJ hTERT+ SV40 Large T+ RasG12V: 78.2;LHCN-M2: 70.7;RH-30: 87.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000268, HPA005685, CAB020695"	Supported		Supported	Nucleoplasm,Mitochondria,Cytosol		No	No			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 48: Smooth muscle cells - ECM organization"	Mitochondria	"Nucleoplasm, Cytosol"	"CAB020695: , HPA000268: , HPA005685: AB_10600781"	"unprognostic (2.31e-1)"	"prognostic unfavorable (3.62e-4)"	"unprognostic (2.65e-2)"	"unprognostic (2.32e-2)"	"unprognostic (2.25e-2)"	"unprognostic (2.39e-1)"	"unprognostic (2.18e-3)"	"unprognostic (2.13e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.02e-1)"	"prognostic favorable (7.32e-5)"	"unprognostic (1.02e-1)"	"unprognostic (2.85e-2)"	"unprognostic (2.20e-3)"	"unprognostic (8.77e-2)"	"unprognostic (2.12e-2)"	"unprognostic (1.09e-2)"	24.4	34.0	16.8	8.8	18.4	3.1	21.9	14.9	21.9	32.3	18.2	31.4	7.0	30.4	21.2	11.4	25.2	17.5	32.8	18.0	19.5	13.7	4.0	16.5	5.5	16.2	17.9	48.3	12.8	16.9	25.9	14.9	18.8	24.3	7.6	12.0	14.1	23.0	27.7	10.9	12.0	21.2	15.6	14.1	14.8	5.9	17.7	6.3	16.4	25.5	3.4	23.2	21.7	17.9	2.1	0.6	16.0	0.0	74.9	66.9	0.2	25.5	49.7	31.4	78.2	0.0	0.4	0.0	21.3	39.3	34.2	2.1	0.0	3.7	17.7	0.1	0.0	14.9	5.1	0.0	39.6	0.0	0.2	56.5	4.8	23.8	0.0	25.9	19.2	0.0	0.3	0.3	70.7	1.0	0.0	0.1	23.1	0.0	0.2	0.0	87.8	0.1	21.6	0.0	15.8	13.1	0.0	0.3	45.9	4.4	2.5	11.0	25.6	18.9	10.0	55.5	0.3	0.0	0.3	0.0	18.6	0.0	12.1	0.0	3.3	0.4	0.0	3.1	0.5	0.0	0.4	0.3	7.7	0.2	1.1	2.7	0.1	1.8	0.9	4.0	0.8	1.6	16.8	18.4	14.9	21.9	18.0	19.5	16.2	17.9	18.8	15.6	17.7	17.9	27.6	25.6	7.4	8.5	0.7	33.1	22.9	5.0	18.2	32.2	19.1	17.4	59.7	7.2	4.1	23.9	6.2	1.6	3.7	0.6	13.7	21.1	0.3	10.4	23.2	29.9	5.4	4.2	9.5	7.1	2.6	53.2	9.2	11.2	24.1	20.0	20.7	0.8	27.9	21.9	11.8	2.2	2.0	9.5	33.4	2.0	47.2	17.5	58.7	4.7	5.7	36.0	0.0	11.1	8.4	5.6	0.1	44.4	0.4	20.6	0.6	13.6	3.6	13.9	46.0	60.6	39.9	1.6	0.7	3.8	21.7	2.6	2.3	35.6	2.5	7.5
ARMCX6	"FLJ20811, GASP10"	ENSG00000198960	"Armadillo repeat containing X-linked 6"	Q7L4S7	X	101615118-101618001	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043030, HPA048125"	Approved		Supported	"Nucleoplasm,Nuclear membrane,Cytosol"		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 68: Epididymis - Unknown function"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 51: Myeloid cells - Hemostasis"	Cytosol	"Nucleoplasm, Nuclear membrane"	"HPA043030: AB_2678277, HPA048125: AB_2680275"	"unprognostic (1.20e-1)"	"unprognostic (2.80e-1)"	"unprognostic (8.82e-3)"	"unprognostic (1.04e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.80e-2)"	"unprognostic (1.73e-3)"	"unprognostic (1.92e-3)"	"unprognostic (4.13e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.26e-2)"	"unprognostic (3.31e-1)"	"unprognostic (3.74e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.85e-1)"	"unprognostic (7.82e-3)"	"unprognostic (2.38e-2)"	9.4	14.6	11.8	9.6	12.1	8.2	11.7	13.0	13.8	14.2	11.9	11.1	6.2	15.8	22.7	9.3	12.6	10.5	15.3	11.7	12.7	13.0	7.6	9.6	12.8	13.9	12.6	19.1	17.4	26.3	17.1	15.7	13.5	13.7	8.1	5.3	24.5	18.3	6.7	10.7	9.0	14.8	12.9	19.2	9.5	4.4	12.4	13.8	14.2	8.3	13.8	11.2	11.3	14.6	13.7	15.7	24.2	13.8	48.4	28.6	4.8	28.0	27.0	24.5	47.5	9.4	12.8	14.4	28.0	26.4	25.5	13.9	23.8	11.3	19.1	12.6	14.4	13.5	22.6	12.8	22.2	13.4	16.4	17.9	11.3	15.1	7.8	34.3	25.4	7.4	11.3	18.0	37.3	33.0	19.8	0.2	17.5	17.7	3.1	20.0	32.5	5.5	17.7	1.8	13.3	12.5	16.4	0.1	21.0	18.3	11.4	6.4	19.8	29.7	13.4	41.8	6.6	22.1	12.6	0.0	8.9	3.5	9.9	11.3	3.7	6.1	5.8	6.7	7.5	13.2	6.1	6.4	7.6	9.0	7.3	6.9	0.4	8.3	5.1	13.2	3.6	6.2	11.8	12.1	13.0	13.8	11.7	12.7	13.9	12.6	13.5	12.9	12.4	14.6	23.9	9.6	9.1	5.2	28.5	13.4	14.4	28.3	26.2	5.5	39.3	44.4	9.7	14.3	16.3	31.3	16.7	37.8	40.6	2.2	23.5	44.2	0.6	21.9	23.7	27.2	16.4	13.0	1.9	27.7	17.3	24.6	19.9	38.0	14.5	30.2	25.4	15.7	67.9	10.1	3.3	14.2	16.2	29.0	32.3	2.2	18.6	40.8	37.4	5.6	28.5	30.3	36.0	8.5	4.9	26.5	11.2	19.9	23.8	18.3	7.6	25.0	5.5	4.6	26.3	13.1	22.4	2.6	2.3	32.7	16.1	34.5	26.0	29.5	11.7	20.8
ARNT	"bHLHe2, HIF-1beta"	ENSG00000143437	"Aryl hydrocarbon receptor nuclear translocator"	P27540	1	150809713-150876708	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in many"	7	"U-698: 397.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001759, CAB004318"	Supported		Supported	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 85: Liver - Metabolism"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 2: Hepatocytes - Metabolism"	"Nucleoplasm, Nuclear bodies"		"CAB004318: AB_626698, HPA001759: AB_1078213"	"unprognostic (1.81e-1)"	"unprognostic (8.14e-2)"	"unprognostic (6.87e-2)"	"unprognostic (5.76e-2)"	"unprognostic (1.86e-1)"	"unprognostic (4.10e-2)"	"unprognostic (9.43e-2)"	"unprognostic (5.27e-3)"	"unprognostic (5.05e-1)"	"unprognostic (3.42e-2)"	"unprognostic (1.22e-1)"	"unprognostic (9.52e-2)"	"unprognostic (1.85e-3)"	"unprognostic (2.68e-1)"	"unprognostic (4.67e-1)"	"unprognostic (6.45e-2)"	"unprognostic (6.92e-2)"	25.8	20.4	9.6	18.1	9.6	17.1	22.7	16.2	12.2	31.8	16.5	19.5	15.0	27.4	14.8	19.2	25.0	20.5	20.7	8.9	10.7	17.8	42.9	24.7	17.5	10.4	9.5	37.7	28.6	19.6	12.5	31.2	10.2	16.3	21.2	39.1	15.5	17.6	32.3	23.9	17.0	29.0	8.0	19.5	19.0	17.3	10.9	20.4	19.6	28.1	22.4	21.3	24.0	11.2	17.1	17.2	25.6	19.5	53.4	50.9	34.2	19.0	36.9	25.2	22.7	15.1	17.0	18.3	16.5	34.0	12.4	19.1	24.2	21.3	21.9	29.3	13.8	21.4	28.7	17.6	31.0	26.4	24.7	39.9	20.0	30.7	26.9	30.6	31.3	24.4	27.9	34.9	26.3	33.8	21.1	15.0	21.2	30.9	13.0	26.1	30.8	25.5	20.6	17.4	17.6	25.1	36.6	25.3	15.2	34.4	32.6	59.4	22.6	20.9	18.8	16.8	16.8	39.8	30.8	397.5	25.5	0.9	14.4	46.6	23.6	21.2	12.1	21.6	11.1	8.7	10.0	11.7	18.7	8.7	9.5	9.8	11.9	12.0	23.4	7.8	11.1	16.2	9.6	9.6	16.2	12.2	8.9	10.7	10.4	9.5	10.2	8.0	10.9	11.2	14.8	12.8	10.3	28.1	14.9	14.1	9.9	11.0	8.0	23.6	10.2	6.9	12.8	24.3	11.6	11.0	54.2	24.5	12.6	13.3	3.9	11.2	5.0	10.3	23.3	14.8	20.4	16.6	41.6	9.7	37.1	25.4	8.6	20.6	3.8	17.1	30.0	47.7	20.3	6.7	47.5	16.5	8.2	39.1	20.1	4.3	32.3	20.0	10.6	39.4	27.9	7.9	13.4	41.7	50.9	9.6	8.1	32.7	13.0	8.8	10.1	13.1	9.7	38.3	13.1	17.0	19.4	18.4	16.7	11.0	15.3	29.6	12.7	20.7	9.0	10.0
ARNT2	"bHLHe1, KIAA0307"	ENSG00000172379	"Aryl hydrocarbon receptor nuclear translocator 2"	Q9HBZ2	15	80404350-80597933	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"brain: 128.0"	"Group enriched"	"Detected in many"	4	"Astrocytes: 209.6;Excitatory neurons: 204.7;Inhibitory neurons: 301.5;Microglial cells: 98.4;Oligodendrocyte precursor cells: 232.7;Oligodendrocytes: 136.9"	"Cancer enhanced"	"Detected in all"		"glioma: 27.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 28.4;BJ hTERT+ SV40 Large T+ RasG12V: 28.2;hTERT-RPE1: 29.7;LHCN-M2: 26.0;SK-MEL-30: 30.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001056, CAB005081"	Enhanced		Supported	Nucleoplasm		NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm		"CAB005081: AB_2243005, HPA001056: AB_1845042"	"unprognostic (2.04e-3)"	"unprognostic (8.32e-2)"	"unprognostic (2.10e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.11e-1)"	"unprognostic (5.65e-2)"	"unprognostic (2.61e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.74e-2)"	"unprognostic (3.00e-1)"	"prognostic favorable (1.46e-6)"	"unprognostic (2.20e-1)"	"prognostic favorable (7.51e-4)"	"unprognostic (2.53e-1)"	"unprognostic (2.31e-1)"	"unprognostic (3.39e-1)"	"unprognostic (3.62e-2)"	2.2	2.1	94.4	2.1	100.6	0.4	1.4	47.8	111.7	5.6	29.8	5.8	1.7	5.9	8.2	2.0	5.3	2.5	4.1	128.0	64.2	21.7	0.4	5.0	2.3	61.8	70.5	10.7	3.4	6.4	11.5	1.1	53.6	5.5	2.1	8.1	1.2	5.0	9.7	2.1	2.7	3.9	60.2	3.5	4.1	9.9	84.0	2.2	7.0	6.0	3.0	4.3	2.0	66.7	0.4	16.1	28.4	0.0	0.1	3.6	0.1	12.2	17.3	13.9	28.2	0.0	0.0	0.0	3.0	14.7	7.2	0.4	10.5	0.6	17.7	0.0	2.9	0.5	0.0	1.0	0.9	0.0	7.2	13.2	0.5	6.1	0.3	29.7	0.0	0.0	0.0	0.1	26.0	14.0	0.0	0.0	5.7	0.0	0.2	0.0	0.3	0.0	6.0	20.5	14.9	20.6	1.5	0.2	30.8	1.8	0.6	0.0	0.0	22.2	4.4	0.6	14.7	0.0	0.0	0.0	8.4	0.0	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	94.4	100.6	47.8	111.7	128.0	64.2	61.8	70.5	53.6	60.2	84.0	66.7	0.1	0.0	2.3	209.6	0.0	1.3	1.2	1.5	4.0	17.0	3.2	3.4	7.6	2.8	4.7	3.7	8.4	0.2	0.1	0.2	13.7	6.0	36.7	8.5	2.7	1.8	22.9	0.0	204.7	0.2	3.6	2.7	3.1	4.4	2.5	5.7	0.4	0.0	0.2	1.7	301.5	2.6	8.2	0.0	1.6	39.8	0.6	0.4	7.2	98.4	0.1	5.9	2.1	232.7	136.9	2.4	2.3	3.0	0.0	2.2	0.3	1.0	1.6	9.3	6.6	2.6	2.5	2.1	3.0	0.5	0.3	2.7	0.6	1.9	1.3	1.4
ARNTL	"bHLHe5, BMAL1, JAP3, MOP3, PASD3"	ENSG00000133794	"Aryl hydrocarbon receptor nuclear translocator like"	O00327	11	13276652-13387266	"Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 63.6"	"Cancer enhanced"	"Detected in all"		"thyroid cancer: 11.1"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB045962, HPA050938"	Supported		Supported	Nucleoplasm,Vesicles	"Intracellular and membrane"	NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 59: Non-specific - Translation"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm	Vesicles	"CAB045962: AB_11124144, HPA050938: AB_2681282"	"unprognostic (1.89e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.95e-2)"	"unprognostic (1.63e-1)"	"unprognostic (9.00e-2)"	"unprognostic (1.77e-1)"	"unprognostic (3.72e-1)"	"unprognostic (3.76e-2)"	"unprognostic (8.92e-2)"	"unprognostic (2.86e-2)"	"unprognostic (3.16e-1)"	"unprognostic (7.80e-2)"	"unprognostic (1.34e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.77e-2)"	"unprognostic (3.11e-2)"	"unprognostic (7.08e-2)"	15.0	13.3	3.2	5.1	4.8	7.4	14.1	4.8	8.3	10.5	3.2	12.4	5.2	11.6	1.6	10.5	11.5	4.0	9.5	5.5	1.9	7.2	19.4	15.0	5.8	1.6	2.6	19.7	10.3	1.5	12.3	4.4	2.2	8.5	4.1	23.4	12.7	3.4	27.0	17.6	12.4	5.6	1.9	11.6	10.9	10.9	4.4	14.1	18.9	8.2	6.4	9.3	11.5	7.4	8.2	9.0	7.5	4.0	15.0	9.0	5.7	9.5	8.1	8.6	9.7	3.7	10.9	0.1	2.6	5.2	10.4	3.4	5.3	10.3	7.7	13.6	6.3	3.9	6.6	1.8	23.7	1.8	16.2	10.1	21.3	3.7	14.1	5.9	6.2	12.6	2.5	14.9	6.9	4.7	4.7	0.9	1.6	5.4	4.3	5.1	11.4	3.4	5.7	1.8	1.2	12.2	6.1	0.7	7.6	7.1	5.7	7.0	11.5	6.2	6.8	20.3	5.5	4.1	12.0	0.0	6.4	4.1	8.3	4.3	8.3	17.9	18.1	9.0	25.2	2.6	16.8	15.6	8.4	3.1	9.4	11.1	24.5	14.1	8.9	1.1	11.1	10.7	3.2	4.8	4.8	8.3	5.5	1.9	1.6	2.6	2.2	1.9	4.4	7.4	4.9	25.6	21.0	49.9	9.0	30.8	13.4	7.3	10.2	28.3	6.1	5.0	8.8	10.0	11.1	1.8	16.7	17.6	34.8	8.6	17.6	6.8	1.5	6.1	14.2	6.6	1.2	3.0	63.6	6.4	2.2	10.3	11.7	12.9	2.5	6.9	10.8	22.9	8.2	30.3	30.5	4.6	4.1	14.0	12.3	4.2	12.8	11.9	3.6	18.7	13.1	18.8	32.0	34.2	11.9	8.3	9.3	19.9	11.5	8.0	13.5	11.3	5.3	30.9	13.1	6.6	10.7	4.7	5.4	9.4	32.4	6.3	33.0	4.7	4.5	12.0
ARNTL2	"bHLHe6, BMAL2, CLIF, MOP9, PASD9"	ENSG00000029153	"Aryl hydrocarbon receptor nuclear translocator like 2"	Q8WYA1	12	27332854-27425289	"Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 28.1;lymphoid tissue: 22.2"	"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 45.6;Excitatory neurons: 78.8;Pancreatic endocrine cells: 86.9;Prostatic glandular cells: 109.0;Urothelial cells: 128.2"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"basal ganglia: 6.4"	"Immune cell enhanced"	"Detected in single"		"basophil: 1.3"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 121.9;U-2197: 159.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA059074	Uncertain		Supported	Nucleoplasm,Nucleoli		No	No			"Cluster 17: Basophils - Unknown function"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 18: U-2197 - ECM organization"	"Cluster 22: Epithelial cell types - Mixed function"	"Nucleoplasm, Nucleoli"		"HPA059074: AB_2683897"	"unprognostic (6.86e-2)"	"unprognostic (6.16e-2)"	"unprognostic (5.88e-3)"	"unprognostic (1.01e-2)"	"unprognostic (3.34e-2)"	"unprognostic (1.34e-1)"	"unprognostic (2.84e-3)"	"unprognostic (2.97e-3)"	"unprognostic (1.49e-1)"	"unprognostic (2.28e-1)"	"prognostic unfavorable (5.29e-6)"	"unprognostic (5.26e-2)"	"prognostic unfavorable (1.56e-5)"	"unprognostic (7.81e-3)"	"unprognostic (2.77e-1)"	"unprognostic (1.21e-1)"	"unprognostic (2.79e-1)"	3.0	1.0	1.3	10.0	6.4	2.3	2.1	0.0	3.6	5.8	0.0	2.5	2.8	1.2	0.2	28.1	0.9	3.6	0.8	2.8	1.6	1.1	4.7	2.3	5.2	0.0	0.5	0.2	1.3	1.5	0.8	2.8	0.0	1.1	3.2	0.4	7.2	0.6	0.2	7.6	2.6	4.6	0.0	1.0	10.9	2.7	0.6	4.4	0.6	0.8	22.2	14.7	11.9	2.2	76.0	19.2	4.2	1.6	3.6	11.0	58.3	26.3	34.5	16.8	26.2	18.2	57.4	0.6	14.4	12.6	51.9	30.6	12.3	92.1	42.7	121.9	15.7	14.6	11.7	15.2	4.8	29.6	6.1	4.0	8.1	58.8	45.6	28.9	80.0	17.7	7.5	29.8	19.6	9.2	16.2	16.2	32.1	25.7	65.8	29.8	68.2	4.7	14.1	42.8	13.6	2.2	13.5	2.1	0.4	10.0	2.9	9.7	54.6	54.2	31.4	159.5	110.0	4.4	8.4	0.1	46.5	23.5	10.9	1.3	0.1	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.4	0.1	0.0	0.0	0.5	0.1	0.0	0.0	0.5	0.0	1.3	6.4	0.0	3.6	2.8	1.6	0.0	0.5	0.0	0.0	0.6	2.2	2.1	3.2	1.3	1.3	0.4	0.8	45.6	8.6	1.2	0.9	1.6	0.8	0.9	11.5	7.5	9.2	0.0	1.9	0.3	1.5	0.0	22.1	3.8	7.9	0.7	6.9	1.2	3.4	78.8	27.4	4.0	3.2	28.1	11.8	0.0	5.3	2.5	3.5	1.4	0.0	24.8	3.3	2.0	2.5	5.4	4.4	0.0	2.9	1.8	7.5	15.7	0.0	0.0	8.5	2.3	86.9	1.4	0.0	3.4	109.0	1.7	0.6	2.7	0.1	0.0	1.7	3.6	3.1	4.7	6.6	2.3	4.2	1.3	0.2	2.1	128.2
ARPC1B	"ARC41, p40-ARC, p41-ARC"	ENSG00000130429	"Actin related protein 2/3 complex subunit 1B"	O15143	7	99374249-99394816	"Disease related genes, Plasma proteins, Predicted intracellular proteins"		Actin-binding	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 317.3"	"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 948.7;Hofbauer cells: 1088.1;Kupffer cells: 1035.5;monocytes: 1029.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SK-MEL-30: 899.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004832	Enhanced		Supported	Vesicles,Cytosol		NA	NA		13000000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 64: Macrophages - Immune response"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 51: Myeloid cells - Hemostasis"	"Vesicles, Cytosol"		"HPA004832: AB_1845044"	"unprognostic (5.94e-2)"	"unprognostic (2.40e-2)"	"unprognostic (2.84e-3)"	"unprognostic (2.47e-2)"	"unprognostic (1.43e-2)"	"unprognostic (2.69e-2)"	"prognostic unfavorable (2.57e-4)"	"unprognostic (4.37e-2)"	"unprognostic (7.76e-2)"	"unprognostic (1.02e-2)"	"unprognostic (1.56e-1)"	"unprognostic (4.86e-1)"	"prognostic unfavorable (1.62e-6)"	"unprognostic (1.18e-1)"	"unprognostic (1.87e-2)"	"unprognostic (1.24e-1)"	"unprognostic (7.27e-2)"	132.2	71.6	19.6	173.3	20.4	209.8	99.1	20.5	25.9	71.7	23.9	104.4	106.6	71.0	14.2	51.6	73.9	48.9	70.1	18.2	21.7	84.4	81.7	169.5	202.1	28.9	23.5	30.1	51.4	14.3	52.4	66.4	26.8	67.4	32.5	1.1	72.4	30.1	18.6	43.2	160.2	39.4	27.3	317.3	66.2	20.4	33.3	62.2	90.1	19.5	95.5	85.1	57.5	28.4	124.3	219.3	16.1	47.5	62.9	225.0	167.9	165.8	170.5	68.7	60.5	146.3	477.8	215.4	308.2	188.5	146.9	93.1	22.4	152.5	27.5	175.5	59.9	157.0	61.6	98.4	179.7	159.5	515.8	125.7	77.3	96.2	94.3	134.6	181.5	113.3	177.9	508.0	100.2	574.5	158.8	332.5	59.6	148.9	435.5	139.5	14.6	536.2	141.2	59.7	13.2	42.1	116.4	506.3	899.5	54.4	119.7	322.4	262.0	190.1	155.8	339.0	216.6	91.4	190.1	263.5	189.9	411.0	350.4	1026.1	2400.1	1973.2	770.3	2458.8	723.9	786.7	883.0	857.2	2054.4	699.1	510.2	680.0	1963.4	633.5	2382.6	1172.9	1315.9	4198.2	19.6	20.4	20.5	25.9	18.2	21.7	28.9	23.5	26.8	27.3	33.3	28.4	182.2	41.7	86.6	1.0	279.2	60.5	141.3	587.9	58.1	9.6	50.8	34.3	9.1	107.2	260.2	130.6	8.4	588.4	416.3	264.9	25.4	407.1	3.2	37.7	37.2	265.5	112.7	84.9	3.2	414.5	948.7	99.7	62.7	41.3	192.2	31.0	226.3	54.5	1088.1	1.7	2.3	97.6	203.4	1035.5	422.8	8.4	37.3	789.1	179.7	28.1	1029.7	21.4	498.5	0.5	1.6	405.1	268.7	18.0	154.0	132.4	516.0	110.9	214.0	14.7	92.1	29.5	238.5	2.7	15.5	26.3	37.1	303.2	324.4	20.4	161.1	187.6
ARPC2	"ARC34, p34-Arc"	ENSG00000163466	"Actin related protein 2/3 complex subunit 2"	O15144	2	218217141-218254356	"Plasma proteins, Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB001994, HPA008352, HPA052703"	Approved		Supported	Nucleoplasm		NA	NA		6600000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 3: Monocytes - Immune response regulation"	Nucleoplasm		"CAB001994: , HPA008352: AB_1854887, HPA052703: "	"unprognostic (7.42e-2)"	"unprognostic (4.07e-1)"	"unprognostic (1.50e-1)"	"unprognostic (3.28e-3)"	"unprognostic (2.77e-1)"	"unprognostic (1.03e-1)"	"prognostic unfavorable (3.63e-5)"	"unprognostic (3.23e-2)"	"unprognostic (1.90e-2)"	"unprognostic (4.07e-2)"	"unprognostic (3.95e-3)"	"unprognostic (6.25e-2)"	"prognostic unfavorable (1.07e-7)"	"unprognostic (1.97e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.01e-2)"	"unprognostic (7.41e-2)"	205.4	121.8	114.0	361.4	125.6	544.1	163.5	109.4	130.8	163.1	117.4	252.8	200.3	153.3	161.8	460.5	146.3	211.3	167.3	135.2	123.1	155.0	152.8	259.7	505.2	115.1	114.7	121.3	122.1	115.4	94.7	295.0	116.4	132.1	274.8	77.4	163.6	176.0	385.3	293.4	226.5	291.2	117.8	294.6	251.5	149.7	118.2	298.3	115.3	250.8	626.0	402.0	231.7	125.4	438.3	188.3	264.1	198.0	346.6	463.6	489.4	680.5	640.7	551.2	549.5	588.6	452.0	358.6	347.6	764.7	396.8	492.3	362.6	985.4	645.4	284.2	296.5	362.1	279.0	325.8	386.8	764.2	968.9	310.2	784.1	552.0	454.6	515.1	731.3	294.1	179.5	681.4	858.6	304.3	416.8	888.6	310.8	500.8	201.1	307.2	235.0	488.7	556.8	787.8	156.3	278.8	246.7	265.8	590.0	544.4	192.7	689.2	642.1	709.5	268.1	321.9	507.8	359.8	418.8	624.7	515.1	472.9	548.2	1728.0	1318.5	1975.5	930.7	1773.7	626.1	785.9	720.7	913.6	1330.1	658.5	505.7	750.0	2200.3	698.9	2060.4	734.3	1039.0	2503.2	114.0	125.6	109.4	130.8	135.2	123.1	115.1	114.7	116.4	117.8	118.2	125.4	334.8	285.2	326.6	21.2	506.7	928.5	691.0	1140.2	425.2	89.8	150.3	189.7	145.3	200.1	465.4	172.9	56.3	944.5	902.3	595.0	342.4	585.8	604.0	220.6	288.5	363.5	319.7	144.9	48.5	658.7	1509.4	301.7	242.6	222.4	414.5	600.6	281.3	98.4	1094.0	58.9	33.1	329.4	364.2	779.9	1321.0	759.3	214.0	896.1	414.4	53.4	1721.9	175.3	1336.7	30.7	33.7	919.8	604.5	326.5	529.9	762.7	510.9	342.8	249.6	95.3	302.4	131.6	571.2	324.4	227.9	645.2	970.6	1045.8	694.1	285.6	337.6	1126.5
ARRB1	ARR1	ENSG00000137486	"Arrestin beta 1"	P49407	11	75260122-75351705	"Predicted intracellular proteins, Transporters"	"Protein transport, Transcription, Transcription regulation, Transport"	"Signal transduction inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"non-classical monocyte: 136.8"	"Group enriched"	"Detected in many"	5	"dendritic cells: 42.5;granulocytes: 49.5;monocytes: 136.8"	"Cell line enhanced"	"Detected in many"		"HEL: 168.9;RH-30: 114.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003763, HPA049318, HPA070249"	Approved		Supported	Nucleoplasm		NA	NA		1500000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 36: HEL - Hemostasis"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm		"CAB003763: AB_562248, HPA049318: AB_2680711, HPA070249: AB_2732151"	"unprognostic (3.40e-1)"	"unprognostic (8.37e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.88e-1)"	"unprognostic (2.35e-1)"	"unprognostic (3.27e-3)"	"unprognostic (1.33e-2)"	"unprognostic (1.15e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.35e-1)"	"unprognostic (2.73e-1)"	"unprognostic (9.35e-2)"	"unprognostic (2.34e-2)"	"unprognostic (2.29e-1)"	"unprognostic (7.10e-2)"	"unprognostic (3.90e-1)"	"unprognostic (1.26e-1)"	30.7	7.1	49.7	21.9	49.4	15.7	24.1	28.3	49.5	10.0	0.0	26.4	21.9	10.2	6.1	19.0	15.9	12.9	17.6	54.3	43.6	14.2	10.1	53.0	15.3	41.1	55.6	16.2	24.5	3.8	4.1	25.1	49.4	16.3	22.5	5.3	12.7	9.7	11.4	16.8	27.2	21.8	23.2	40.1	33.9	4.3	49.9	9.9	8.8	10.9	10.3	16.5	11.0	36.7	5.1	23.6	24.2	12.0	20.2	17.6	48.8	5.0	17.2	6.2	4.3	34.5	23.9	2.0	58.9	4.5	4.7	1.1	9.5	0.1	2.4	0.2	5.5	168.9	3.3	20.6	5.5	5.1	63.9	8.9	1.2	10.3	0.0	7.4	70.4	6.1	83.5	0.2	12.2	14.1	3.1	58.4	17.8	76.9	7.1	18.8	114.4	6.8	26.8	20.4	12.5	13.5	8.7	61.7	15.0	49.3	44.8	27.6	61.0	4.7	5.9	19.3	0.6	0.1	0.1	0.1	3.5	78.0	5.8	33.7	65.7	45.9	11.6	106.5	4.3	0.4	5.5	6.6	42.5	0.2	5.0	6.6	49.5	14.8	136.8	0.9	5.7	41.1	49.7	49.4	28.3	49.5	54.3	43.6	41.1	55.6	49.4	23.2	49.9	36.7	24.2	28.9	14.8	52.2	1.9	1.9	2.0	1.9	2.8	3.1	9.0	14.7	4.6	8.6	5.8	3.7	6.2	41.7	10.7	38.5	1.9	5.0	2.6	0.8	4.3	19.4	5.4	10.3	35.6	8.4	4.1	9.1	17.3	0.9	23.5	2.3	25.7	2.1	39.6	0.0	48.9	11.1	8.2	55.2	17.9	21.4	15.8	31.2	3.6	55.3	42.1	0.2	29.9	8.0	23.9	9.2	19.1	16.6	1.0	3.6	29.9	0.2	4.7	1.1	13.1	4.5	7.7	0.2	0.8	1.0	3.0	33.7	5.9	9.4	20.0	2.8
ARRB2	"ARR2, BARR2, DKFZp686L0365"	ENSG00000141480	"Arrestin beta 2"	P32121	17	4710596-4721499	"Predicted intracellular proteins, Transporters"	"Protein transport, Transport"	"Signal transduction inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 263.6;lymphoid tissue: 168.3"	"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 262.0;Kupffer cells: 242.5;Langerhans cells: 164.2;Macrophages: 226.4;monocytes: 311.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HEL: 195.8;HMC-1: 315.9;NB-4: 199.2;U-937: 279.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA075177			Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 4: Macrophages - Innate immune response"	"Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA075177: "	"unprognostic (1.12e-1)"	"prognostic favorable (2.93e-5)"	"unprognostic (1.09e-1)"	"unprognostic (1.47e-1)"	"unprognostic (7.43e-2)"	"unprognostic (3.37e-2)"	"unprognostic (2.62e-3)"	"unprognostic (3.85e-2)"	"unprognostic (3.05e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.66e-3)"	"prognostic unfavorable (2.61e-5)"	"unprognostic (1.32e-2)"	"unprognostic (8.61e-2)"	"unprognostic (4.92e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.88e-1)"	48.6	39.7	54.4	110.0	53.8	263.6	26.1	48.2	62.2	19.3	49.1	29.5	50.5	17.4	10.8	15.1	29.0	31.4	25.0	63.8	67.7	25.2	35.6	94.8	59.4	61.6	58.3	17.5	19.4	16.4	24.9	35.5	59.5	19.5	27.6	16.9	20.9	11.7	12.7	14.6	51.1	29.6	55.4	168.3	35.0	7.2	59.5	45.2	15.8	18.1	38.0	41.6	17.6	66.5	17.3	88.7	34.7	32.9	6.8	9.5	18.6	13.7	18.0	38.4	48.0	31.0	14.2	49.1	12.2	10.3	18.3	28.5	58.0	18.4	39.4	116.6	85.0	195.8	46.8	55.6	10.2	89.2	315.9	8.8	23.5	47.9	18.7	24.9	29.6	89.1	13.5	46.4	8.9	30.5	87.9	199.2	18.9	44.9	18.4	104.3	31.0	53.8	13.2	9.2	36.0	49.2	30.8	50.8	23.6	14.2	24.6	40.0	26.1	14.3	29.1	25.1	51.5	19.8	28.6	27.6	37.9	279.4	21.6	116.2	145.5	269.7	49.1	151.1	35.1	10.1	31.1	51.3	84.9	9.0	29.3	38.7	250.6	29.9	168.6	20.7	28.8	93.5	54.4	53.8	48.2	62.2	63.8	67.7	61.6	58.3	59.5	55.4	59.5	66.5	7.7	22.4	32.3	5.5	26.4	11.5	7.7	16.6	3.4	20.5	9.6	12.3	8.3	14.3	47.9	3.7	2.1	7.5	83.8	7.4	15.6	11.2	0.6	1.5	3.6	10.1	8.4	33.9	20.4	7.3	12.0	8.7	19.4	1.8	94.9	7.8	19.2	12.4	262.0	21.9	18.2	17.0	50.8	242.5	164.2	3.5	5.0	226.4	10.6	42.2	311.3	5.8	89.6	7.1	8.4	6.3	22.0	4.9	23.4	4.4	35.5	17.5	24.4	8.7	19.7	10.9	8.5	1.1	13.1	6.8	8.4	6.0	77.2	3.5	11.4	11.7
ARRDC4	FLJ36045	ENSG00000140450	"Arrestin domain containing 4"	Q8NCT1	15	97960703-97973833	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 82.8"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 105.7;Paneth cells: 82.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"basophil: 1.1;classical monocyte: 2.5;eosinophil: 1.5;intermediate monocyte: 1.7;myeloid DC: 1.1;neutrophil: 1.4"	"Group enriched"	"Detected in many"	8	"dendritic cells: 1.1;granulocytes: 1.5;monocytes: 2.5"	"Cell line enhanced"	"Detected in many"		"BJ: 103.2;HSkMC: 55.8;hTCEpi: 86.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039934, HPA042109"	Approved		Supported	"Vesicles,Plasma membrane"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 70: Brain - Nervous system development"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Plasma membrane"	Vesicles	"HPA039934: , HPA042109: AB_10795606"	"unprognostic (2.13e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.32e-1)"	"unprognostic (5.60e-3)"	"unprognostic (4.49e-3)"	"unprognostic (8.23e-2)"	"unprognostic (1.16e-2)"	"unprognostic (2.78e-1)"	"unprognostic (7.65e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.01e-2)"	"unprognostic (1.42e-2)"	"unprognostic (2.02e-3)"	"unprognostic (2.90e-2)"	"unprognostic (1.65e-1)"	"unprognostic (3.04e-2)"	"unprognostic (6.77e-2)"	12.5	12.2	21.6	16.5	24.6	11.5	19.8	24.1	22.4	16.2	16.9	43.9	15.8	14.6	15.6	10.0	14.5	17.2	12.1	30.5	39.1	25.1	30.2	19.8	7.5	76.6	24.1	7.3	34.7	6.3	8.9	18.3	73.9	10.9	23.0	4.5	8.1	16.4	14.8	35.5	22.6	18.1	45.9	8.0	26.9	14.7	20.5	5.7	17.3	9.6	5.1	14.9	10.8	82.8	5.8	0.2	0.8	15.0	6.6	47.7	0.0	103.2	45.8	13.5	6.0	6.2	3.6	0.0	14.2	4.8	1.2	6.0	3.7	36.0	21.6	0.0	9.6	10.1	1.9	4.1	2.6	7.0	15.2	55.8	86.9	15.4	17.9	18.8	0.7	2.9	14.4	0.0	4.9	19.2	1.2	5.8	3.0	17.4	2.1	0.1	0.9	0.2	26.3	12.7	5.0	8.8	15.7	5.7	29.5	3.1	2.1	10.6	0.1	4.0	2.9	21.2	5.0	0.0	0.0	0.2	8.7	1.2	10.6	1.1	2.5	1.5	0.0	1.7	0.0	0.2	0.0	0.0	1.1	0.1	0.0	0.0	1.4	0.0	0.2	0.2	0.0	0.4	21.6	24.6	24.1	22.4	30.5	39.1	76.6	24.1	73.9	45.9	20.5	82.8	5.7	3.2	10.4	19.9	4.0	25.4	3.1	11.0	23.9	1.6	14.4	8.3	12.9	8.6	9.4	22.0	6.2	0.3	1.4	105.7	7.9	2.7	4.5	21.5	17.6	5.9	38.3	4.4	8.1	8.2	0.2	12.3	15.8	18.0	23.5	1.4	6.4	17.1	21.5	0.0	6.0	29.5	10.2	23.9	10.5	10.9	5.0	19.7	24.9	3.7	13.4	0.7	3.1	38.7	3.4	12.0	82.4	8.2	0.2	12.2	30.2	3.1	15.6	3.5	0.0	7.8	12.5	2.0	12.6	11.8	31.1	0.7	1.3	17.5	31.3	12.2
ARSL	"ARSE, CDPX, CDPX1"	ENSG00000157399	"Arylsulfatase L"	P51690	X	2934521-2968475	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		Hydrolase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 36.6;liver: 86.3;pancreas: 105.2"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in many"		"liver cancer: 34.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A549: 68.9;CACO-2: 42.7;GAMG: 30.8;Hep G2: 64.1;NTERA-2: 33.6"					"Low region specificity"	"Detected in all"			"HPA060518, HPA070651"	Approved		Supported	"Golgi apparatus"		NA	NA				"Cluster 29: Non-specific - Vesicular transport"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 33: Fibroblasts - ECM organization"	"Golgi apparatus"		"HPA060518: AB_2684301, HPA070651: AB_2732160"	"unprognostic (2.07e-1)"	"unprognostic (6.60e-3)"	"prognostic favorable (8.95e-4)"	"unprognostic (8.74e-3)"	"unprognostic (1.14e-3)"	"unprognostic (3.48e-2)"	"unprognostic (2.38e-1)"	"unprognostic (8.27e-2)"	"unprognostic (5.45e-2)"	"unprognostic (2.25e-1)"	"unprognostic (2.27e-1)"	"unprognostic (2.37e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.28e-1)"	"unprognostic (5.94e-2)"	"unprognostic (4.76e-2)"	0.4	0.7	2.6	2.2	2.7	0.3	1.1	2.1	2.8	1.7	4.5	20.8	17.9	3.2	2.2	0.4	4.1	8.2	1.0	2.8	2.6	36.6	86.3	2.7	0.1	2.8	2.8	7.1	105.2	0.0	0.7	0.7	2.9	0.5	16.7	0.3	1.3	2.9	0.2	0.2	13.6	1.9	2.4	0.0	2.9	0.4	2.6	0.0	0.2	0.3	0.1	0.5	1.6	2.3	4.5	68.9	8.2	0.0	3.3	4.0	1.3	3.9	6.4	4.0	4.0	42.7	0.0	0.0	13.7	0.1	30.8	0.0	0.0	0.9	2.3	0.0	4.5	0.0	0.0	64.1	1.8	0.0	0.1	9.6	0.0	3.8	0.0	7.3	3.8	0.0	0.0	0.1	10.5	0.1	0.0	0.0	33.6	2.4	0.2	2.8	1.1	0.3	7.1	0.0	0.1	0.2	0.0	0.0	2.6	13.7	0.0	0.2	5.0	0.1	0.2	0.0	7.4	0.0	0.0	0.1	9.1	0.1	17.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	2.7	2.1	2.8	2.8	2.6	2.8	2.8	2.9	2.4	2.6	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0
ASAP2	"CENTB3, DDEF2, KIAA0400, PAP, SHAG1"	ENSG00000151693	"ArfGAP with SH3 domain, ankyrin repeat and PH domain 2"	O43150	2	9206765-9405683	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 46.8"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 141.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in single"	7	"basophil: 2.7"	"Lineage enriched"	"Detected in single"	7	"granulocytes: 2.7"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB018615	Approved		Supported	Cytosol		NA	NA		260000	"Cluster 10: Basophils - Unknown function"	"Cluster 45: Intestine - Brush border"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Cytosol		"CAB018615: AB_2242947"	"unprognostic (1.19e-1)"	"unprognostic (2.66e-2)"	"unprognostic (8.50e-2)"	"prognostic unfavorable (1.61e-4)"	"unprognostic (1.95e-1)"	"unprognostic (1.18e-1)"	"unprognostic (3.06e-2)"	"unprognostic (1.08e-3)"	"unprognostic (1.69e-1)"	"unprognostic (2.07e-1)"	"prognostic unfavorable (4.68e-4)"	"unprognostic (8.33e-2)"	"unprognostic (1.58e-3)"	"unprognostic (3.14e-1)"	"unprognostic (3.16e-1)"	"unprognostic (2.64e-2)"	"unprognostic (3.24e-2)"	12.4	3.3	3.9	5.6	11.8	0.7	6.8	11.0	9.1	11.4	4.7	17.7	13.8	12.8	10.0	8.8	10.7	10.1	9.6	6.3	7.0	23.7	3.8	10.0	2.8	8.1	6.1	7.7	7.8	9.9	9.5	10.4	8.9	5.2	16.1	8.8	5.6	9.2	2.5	13.1	13.6	13.9	0.8	1.5	24.3	46.8	3.2	2.7	19.1	6.4	3.1	8.5	7.8	7.0	34.8	19.9	35.8	21.2	26.0	35.9	5.9	34.4	27.7	24.9	24.9	13.9	51.0	0.1	29.8	39.2	54.7	32.8	19.9	60.6	30.6	25.1	8.1	8.0	15.4	24.1	63.1	0.0	2.4	13.6	24.5	30.1	96.8	74.5	51.9	6.4	3.7	3.6	97.8	21.1	10.2	2.0	16.9	49.5	23.2	19.5	53.7	6.5	48.7	26.7	15.6	59.6	28.7	18.9	30.7	18.7	13.1	5.5	81.8	41.6	1.9	32.5	31.7	0.0	0.2	0.1	30.4	0.2	54.2	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	3.9	11.8	11.0	9.1	6.3	7.0	8.1	6.1	8.9	0.8	3.2	7.0	41.0	19.2	8.3	141.0	1.4	37.2	22.8	16.6	14.8	28.2	8.4	7.7	1.6	4.3	12.9	35.0	0.0	1.6	0.3	60.7	50.9	15.4	67.0	14.9	20.8	36.1	9.1	0.0	76.2	14.0	0.3	26.0	52.5	26.8	1.3	9.7	51.8	4.4	12.8	6.7	46.5	40.8	20.3	4.4	12.9	50.7	2.8	10.6	33.8	39.4	7.9	20.4	0.0	48.2	55.0	62.1	45.4	3.8	0.2	33.8	21.6	31.1	12.9	5.3	26.3	24.9	35.3	39.8	8.9	5.5	32.1	0.4	1.2	1.6	21.4	53.3
ASAP3	"CENTB6, DDEFL1, FLJ20199, UPLC1"	ENSG00000088280	"ArfGAP with SH3 domain, ankyrin repeat and PH domain 3"	Q8TDY4	1	23428563-23484568	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 35.9;Extravillous trophoblasts: 43.3;Granulosa cells: 28.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 31.8;ASC TERT1: 29.9;HSkMC: 38.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020537, HPA020546"	Approved		Supported	Nucleoplasm,Vesicles		NA	NA				"Cluster 50: Non-specific - Ribosome"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 40: Granulosa cells - Unknown function"	Vesicles	Nucleoplasm	"HPA020537: AB_2670467, HPA020546: AB_2670470"	"unprognostic (2.51e-1)"	"unprognostic (2.70e-2)"	"unprognostic (4.35e-3)"	"prognostic unfavorable (5.56e-4)"	"unprognostic (3.87e-1)"	"unprognostic (2.24e-2)"	"unprognostic (1.19e-3)"	"prognostic favorable (2.80e-4)"	"unprognostic (1.88e-2)"	"prognostic unfavorable (8.30e-4)"	"unprognostic (2.24e-1)"	"unprognostic (1.18e-1)"	"prognostic favorable (5.12e-5)"	"unprognostic (3.39e-3)"	"unprognostic (3.92e-2)"	"unprognostic (2.02e-2)"	"unprognostic (7.27e-2)"	24.1	39.1	11.5	3.2	11.6	0.1	21.9	12.5	12.4	32.6	10.0	18.4	1.6	18.6	4.2	32.3	24.3	5.1	30.1	10.5	11.2	21.4	19.8	15.9	1.6	14.5	12.7	58.3	22.2	11.7	18.6	8.0	13.2	31.0	5.2	3.0	38.0	8.0	42.9	52.9	11.0	5.9	12.7	5.0	25.4	18.2	13.4	1.0	29.0	11.7	4.2	21.3	33.4	12.1	1.8	1.8	17.6	11.6	31.8	29.9	21.6	3.2	3.8	4.9	6.3	1.3	0.1	9.2	3.7	6.3	2.9	8.4	12.2	2.9	2.8	0.4	1.6	0.5	4.8	11.8	17.1	0.0	0.9	38.4	4.4	7.9	7.1	14.6	3.9	1.3	6.4	0.0	3.1	3.9	1.3	0.1	3.0	5.0	4.2	4.9	1.9	0.0	3.4	3.7	0.6	6.0	14.1	3.5	3.5	8.7	13.2	0.1	1.4	2.1	5.2	5.9	0.2	3.9	4.2	1.1	0.8	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	11.5	11.6	12.5	12.4	10.5	11.2	14.5	12.7	13.2	12.7	13.4	12.1	4.5	9.6	6.7	35.9	0.3	2.0	1.5	2.0	2.8	1.1	6.3	3.7	15.5	0.0	4.1	3.7	0.0	2.1	0.0	6.7	3.9	5.8	5.1	2.4	7.3	6.6	1.2	0.0	7.6	6.1	43.3	12.2	10.2	4.4	1.3	28.3	3.9	4.0	1.8	0.0	4.9	8.5	2.0	0.0	1.3	8.1	12.5	0.4	0.0	7.5	0.1	8.3	0.0	18.1	4.2	2.5	2.1	13.5	0.2	2.4	0.8	5.4	4.3	0.6	0.0	2.0	3.4	8.2	11.8	3.7	4.3	1.4	0.2	15.9	5.2	2.1
ASCC3	"ASC1p200, dJ121G13.4, dJ467N11.1, HELIC1, RNAH"	ENSG00000112249	"Activating signal cointegrator 1 complex subunit 3"	Q8N3C0	6	100508194-100881372	"Enzymes, Predicted intracellular proteins"	"DNA damage, DNA repair, Transcription, Transcription regulation"	"Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 166.0;Inhibitory neurons: 166.2;Oligodendrocyte precursor cells: 150.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031608, HPA031609, HPA031610"	Enhanced		Supported	"Golgi apparatus,Cytosol"		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Cytosol	"Golgi apparatus"	"HPA031608: AB_10599970, HPA031609: AB_10600777, HPA031610: AB_10611526"	"unprognostic (6.79e-2)"	"unprognostic (1.46e-2)"	"unprognostic (2.96e-3)"	"unprognostic (1.12e-1)"	"unprognostic (9.70e-3)"	"unprognostic (4.56e-2)"	"unprognostic (1.50e-1)"	"unprognostic (5.14e-2)"	"unprognostic (4.02e-1)"	"unprognostic (3.34e-1)"	"unprognostic (5.08e-3)"	"unprognostic (1.16e-1)"	"unprognostic (9.91e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.55e-2)"	6.0	6.6	4.1	10.0	5.3	11.2	9.2	6.6	4.2	10.2	7.7	9.3	8.2	7.9	8.5	8.4	5.8	7.5	6.5	3.9	5.2	5.0	12.5	7.1	10.1	4.7	4.3	5.9	6.4	10.7	6.2	12.9	5.1	9.2	11.3	5.7	6.3	8.1	6.0	7.2	8.5	8.5	4.7	8.3	8.6	8.6	4.6	12.7	7.2	5.4	11.0	14.8	7.4	6.0	16.8	21.1	30.1	18.6	32.9	41.7	48.0	71.5	45.5	24.1	27.6	43.3	13.0	52.1	14.4	48.3	19.0	37.6	26.2	63.5	38.7	35.2	23.2	38.7	36.0	27.8	30.1	41.0	28.5	38.1	31.7	35.4	44.2	22.6	45.1	20.5	47.1	23.0	67.3	16.5	21.1	12.7	15.9	31.8	16.4	24.7	23.3	18.7	23.7	46.6	20.2	15.3	30.1	26.7	12.5	53.3	14.7	23.2	64.2	26.9	20.6	23.3	30.4	9.9	11.3	46.4	19.4	30.6	29.0	6.2	2.7	1.8	4.3	4.3	5.2	4.2	3.8	4.0	2.9	5.7	4.3	4.2	0.2	4.4	3.8	6.4	3.1	1.4	4.1	5.3	6.6	4.2	3.9	5.2	4.7	4.3	5.1	4.7	4.6	6.0	32.7	32.1	24.9	58.1	45.4	25.5	41.3	33.3	19.4	27.0	24.1	24.0	32.0	20.0	37.7	3.7	22.9	24.4	49.0	17.3	11.7	23.1	11.3	30.1	77.3	25.2	13.8	20.8	166.0	25.1	66.3	32.2	46.9	35.0	22.1	29.9	10.4	30.3	17.7	28.6	166.2	22.8	22.4	17.2	12.5	3.7	23.0	27.5	5.4	103.0	26.2	14.6	29.9	150.8	132.3	28.6	14.4	17.3	66.4	66.9	17.5	10.6	32.0	31.1	6.6	39.6	30.0	50.2	30.3	38.2	27.4	38.0	43.7	42.6	23.5	65.4
ASF1B	FLJ10604	ENSG00000105011	"Anti-silencing function 1B histone chaperone"	Q9NVP2	19	14119512-14136613	"Predicted intracellular proteins"	"Differentiation, Spermatogenesis, Transcription, Transcription regulation"	"Chaperone, Chromatin regulator, Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 23.2;testis: 32.0"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 36.1;Early spermatids: 36.4;Erythroid cells: 43.6;Extravillous trophoblasts: 35.4;Spermatocytes: 73.2;Spermatogonia: 87.8"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in many"	7	"neutrophil: 60.1"	"Lineage enriched"	"Detected in all"	7	"granulocytes: 60.1"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA054036, HPA069385"	Enhanced		Supported	Nucleoplasm		NA	Yes			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"HPA054036: AB_2682350, HPA069385: "	"unprognostic (3.14e-1)"	"prognostic favorable (4.45e-5)"	"unprognostic (2.41e-3)"	"unprognostic (2.40e-1)"	"unprognostic (2.15e-1)"	"unprognostic (2.27e-2)"	"prognostic unfavorable (2.03e-4)"	"unprognostic (2.87e-2)"	"unprognostic (1.33e-3)"	"unprognostic (1.52e-1)"	"prognostic unfavorable (1.98e-4)"	"unprognostic (8.48e-3)"	"prognostic unfavorable (2.22e-16)"	"prognostic favorable (2.49e-4)"	"unprognostic (1.27e-1)"	"unprognostic (3.92e-2)"	"unprognostic (4.31e-2)"	0.9	1.4	0.2	5.6	0.3	11.7	1.3	0.3	0.2	2.2	0.1	7.4	5.3	1.0	0.1	10.3	0.7	0.7	0.7	0.1	0.2	1.0	1.3	2.1	12.5	0.3	0.2	0.7	0.7	0.3	0.7	3.6	0.3	0.8	7.7	0.0	1.9	0.3	0.5	3.2	6.0	2.0	0.2	6.7	3.2	32.0	0.3	23.2	0.6	0.4	14.7	1.8	3.2	0.3	64.6	25.3	37.7	28.9	3.8	3.6	16.2	33.1	28.3	63.8	79.5	26.5	31.6	59.1	30.0	17.5	26.5	38.0	41.8	24.1	49.7	54.0	26.9	55.5	48.7	18.6	0.2	39.0	35.1	0.7	1.7	35.8	12.4	7.2	25.1	44.1	50.2	83.8	31.8	75.7	80.8	34.3	17.3	69.1	56.7	77.0	56.0	51.6	20.1	28.3	46.0	16.5	39.8	29.2	17.4	10.3	22.1	41.5	10.6	36.0	21.6	91.0	56.6	43.2	46.5	80.3	28.0	71.9	36.1	0.7	6.2	1.5	1.7	8.0	0.9	1.1	1.5	2.0	1.2	0.9	0.9	1.7	60.1	1.7	8.5	0.5	5.1	3.2	0.2	0.3	0.3	0.2	0.1	0.2	0.3	0.2	0.3	0.2	0.3	0.3	1.0	0.0	0.6	0.3	5.6	2.5	2.4	4.5	1.2	0.1	4.8	8.5	1.2	1.5	1.1	0.0	0.0	36.1	3.8	11.7	0.0	1.0	36.4	2.1	1.3	2.1	1.2	43.6	0.5	1.2	35.4	4.1	23.4	2.3	4.5	9.2	0.4	0.3	21.5	0.0	0.4	9.9	8.2	5.6	5.6	29.1	0.0	5.0	1.8	1.0	2.1	0.3	4.1	0.0	0.5	1.1	2.2	0.7	20.1	1.0	2.4	0.3	0.2	0.9	0.0	1.1	3.3	73.2	87.8	8.3	1.1	10.4	5.3	3.0	20.9	2.4
ASGR1	CLEC4H1	ENSG00000141505	"Asialoglycoprotein receptor 1"	P07306	17	7173431-7179564	"Predicted intracellular proteins, Predicted secreted proteins"	"Endocytosis, Host-virus interaction"	Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	41	"liver: 1092.3"	"Cell type enriched"	"Detected in many"	4	"Hepatocytes: 1107.9"	"Cancer enriched"	"Detected in many"	90	"liver cancer: 131.6"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"classical monocyte: 115.2;intermediate monocyte: 55.5;myeloid DC: 41.2"	"Group enriched"	"Detected in many"	8	"dendritic cells: 41.2;monocytes: 115.2"	"Cell line enriched"	"Detected in some"	29	"Hep G2: 493.2"	"Region enriched"	"Detected in all"	9	"cerebellum: 44.1"	"Not detected"	"Not detected"			"HPA011954, HPA012852"	Enhanced		Supported	"Vesicles,Cell Junctions"	"Secreted to blood"	NA	NA		10000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 62: Liver - Hemostasis"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 2: Hepatocytes - Metabolism"	Vesicles	"Cell Junctions"	"HPA011954: AB_1845079, HPA012852: AB_1845080"	"unprognostic (3.56e-3)"	"unprognostic (3.57e-1)"	"unprognostic (8.76e-2)"	"unprognostic (4.05e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.86e-2)"	"unprognostic (5.37e-2)"	"unprognostic (2.15e-1)"	"unprognostic (2.39e-1)"	"unprognostic (8.55e-5)"	"unprognostic (1.55e-1)"	"unprognostic (8.33e-11)"	"unprognostic (1.45e-1)"	"unprognostic (2.00e-1)"	"unprognostic (1.73e-3)"	"unprognostic (4.46e-3)"	2.6	1.5	7.7	3.7	7.8	2.5	1.8	17.0	10.9	1.6	7.0	1.2	2.2	1.3	0.6	1.7	1.8	2.9	1.1	7.9	7.6	1.4	1092.3	3.9	1.3	8.0	8.2	1.1	0.9	7.0	2.9	0.5	8.3	1.7	0.5	4.8	0.9	0.3	1.5	4.4	1.4	1.3	6.0	4.8	1.4	26.5	7.8	0.4	5.8	0.4	0.3	1.7	1.5	8.7	0.3	0.7	9.2	4.2	0.0	0.2	0.8	0.8	0.9	0.9	1.6	16.8	0.5	0.3	1.1	0.2	0.4	0.2	0.3	0.2	0.4	0.3	0.8	1.2	1.4	493.2	0.1	0.8	1.7	1.2	0.2	0.5	0.1	0.6	8.4	7.4	1.1	0.6	0.5	0.4	0.7	1.2	1.7	0.2	0.4	0.9	3.5	0.2	0.1	0.7	0.6	3.5	0.7	0.3	0.6	1.5	0.5	0.2	1.2	0.9	3.4	0.7	0.4	0.2	0.3	0.5	0.6	0.4	0.3	10.0	115.2	0.4	0.2	55.5	1.1	0.5	0.2	0.2	41.2	0.5	0.3	0.4	3.3	0.5	14.9	1.8	0.3	36.7	7.7	7.8	17.0	10.9	7.9	7.6	8.0	8.2	8.3	6.0	7.8	8.7	6.0	0.0	4.7	2.9	2.6	3.2	1.7	2.0	3.4	37.8	5.6	6.0	1.5	55.8	2.0	3.7	160.6	3.6	2.9	1.4	3.9	0.9	235.4	4.2	3.6	13.2	15.6	16.8	4.6	0.2	3.7	1.9	3.6	16.5	0.0	5.1	27.5	1107.9	39.9	15.2	4.8	2.3	2.0	97.4	11.9	115.8	2.5	52.6	0.0	1.9	77.2	3.6	0.0	2.0	0.6	0.3	1.3	1.2	0.0	0.9	0.2	6.8	1.6	42.3	0.0	0.8	1.9	6.5	9.7	9.9	4.8	12.4	1.4	1.6	1.3	2.4
ASGR2	CLEC4H2	ENSG00000161944	"Asialoglycoprotein receptor 2"	P07307	17	7101322-7115700	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Endocytosis, Host-virus interaction"	Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	48	"liver: 840.7"	"Cell type enriched"	"Detected in some"	5	"Hepatocytes: 878.6"	"Cancer enriched"	"Detected in many"	66	"liver cancer: 214.2"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	8	"classical monocyte: 110.0;myeloid DC: 64.1"	"Group enriched"	"Detected in many"	51	"dendritic cells: 64.1;monocytes: 110.0"	"Cell line enriched"	"Detected in some"	9	"Hep G2: 528.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA014899, HPA015998"	Enhanced		Supported	"Endoplasmic reticulum,Plasma membrane"		NA	NA		14000000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 60: Liver - Hemostasis & Lipid metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 15: Hepatocytes - Hemostasis"	"Endoplasmic reticulum, Plasma membrane"		"HPA014899: AB_1845085, HPA015998: AB_1845084"	"unprognostic (6.76e-2)"	"unprognostic (7.45e-7)"	"unprognostic (1.61e-1)"	"unprognostic (2.55e-2)"	"unprognostic (1.03e-2)"	"unprognostic (4.99e-2)"	"unprognostic (1.16e-3)"	"unprognostic (1.32e-1)"	"unprognostic (1.81e-1)"	"unprognostic (9.74e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.66e-1)"	"unprognostic (9.35e-4)"	"unprognostic (1.54e-3)"	"unprognostic (6.95e-2)"	"unprognostic (1.86e-1)"	"unprognostic (7.31e-2)"	1.5	0.3	0.8	7.9	1.0	7.0	0.5	0.9	1.3	0.4	1.3	0.5	0.3	0.3	0.1	0.5	0.6	17.6	0.5	0.8	1.0	1.2	840.7	2.5	0.9	1.0	1.1	0.2	0.5	0.1	0.2	0.5	1.2	0.4	0.4	0.0	0.5	0.2	0.2	5.2	0.6	1.3	1.0	6.8	0.5	0.5	1.4	0.5	0.3	0.1	1.0	2.0	0.4	1.2	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	62.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.2	528.3	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	42.3	0.1	0.0	0.0	0.1	0.5	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.3	0.0	1.0	110.0	0.8	0.1	11.2	0.2	0.0	0.0	0.0	64.1	0.0	0.1	0.0	1.7	0.1	0.1	1.6	0.3	31.8	0.8	1.0	0.9	1.3	0.8	1.0	1.0	1.1	1.2	1.0	1.4	1.2	0.0	0.0	5.1	0.3	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	150.2	0.0	0.0	0.0	0.1	0.0	0.1	1.9	0.0	0.4	0.0	0.0	1.3	7.1	19.6	1.9	0.0	0.2	0.1	0.0	0.1	2.5	0.0	16.1	878.6	8.4	0.0	0.1	0.1	0.0	41.1	7.7	0.7	0.0	19.6	0.0	0.0	15.3	0.0	1.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	6.6	0.0	0.0	0.0	0.1	0.0	0.0	1.1	0.0	0.3	0.4	1.4	0.0	0.0	0.1
ASH1L	"ASH1, ASH1L1, huASH1, KMT2H"	ENSG00000116539	"ASH1 like histone lysine methyltransferase"	Q9NR48	1	155335268-155563162	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, Chromatin regulator, Methyltransferase, Transferase"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004806	Approved		Supported	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 52: Non-specific - Transcription"	"Nucleoplasm, Golgi apparatus"		"HPA004806: AB_1845087"	"unprognostic (2.98e-1)"	"unprognostic (3.15e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.70e-2)"	"unprognostic (2.05e-2)"	"unprognostic (4.75e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.87e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.07e-1)"	"unprognostic (6.84e-2)"	"prognostic favorable (3.80e-4)"	"unprognostic (2.95e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.45e-2)"	"unprognostic (1.94e-1)"	14.1	12.8	21.3	8.5	23.4	11.9	16.8	27.0	25.7	14.4	14.8	13.0	9.7	14.4	20.8	9.2	11.4	9.0	12.6	23.8	19.2	13.9	10.0	10.3	10.9	18.7	19.8	21.3	9.9	18.2	8.4	10.3	18.9	15.7	11.5	26.2	14.8	15.4	30.3	20.4	10.2	12.7	19.3	10.5	11.9	6.8	20.7	12.1	15.8	24.3	9.7	11.7	10.0	23.4	17.2	12.3	9.5	9.4	28.0	22.8	9.6	14.7	13.5	8.3	6.5	10.5	12.3	5.4	14.2	17.0	5.4	19.2	13.6	12.6	13.6	7.6	8.9	8.0	13.2	9.8	14.5	8.8	6.6	16.2	18.0	13.6	15.0	17.1	11.0	6.0	12.3	8.3	18.8	19.0	6.4	8.8	8.3	28.8	13.1	6.1	18.5	10.4	18.6	16.0	9.1	14.3	20.1	25.9	12.9	9.3	16.6	26.6	17.4	13.6	15.8	13.4	17.9	8.0	5.3	8.9	10.7	9.1	13.1	1.0	0.4	0.8	0.7	0.2	0.5	0.9	0.5	0.5	0.2	0.8	0.8	0.5	1.0	0.6	0.1	0.7	0.9	0.2	21.3	23.4	27.0	25.7	23.8	19.2	18.7	19.8	18.9	19.3	20.7	23.4	96.5	60.9	103.2	171.7	108.3	103.9	97.4	52.9	109.3	147.6	75.9	58.3	107.8	50.1	82.7	51.5	202.3	53.6	83.3	76.2	17.6	41.5	25.9	72.0	107.4	77.6	67.5	46.7	220.6	39.8	25.2	93.7	101.4	87.9	81.1	72.3	63.1	39.0	24.6	114.4	211.8	59.0	26.4	42.1	106.9	22.8	102.2	69.1	53.4	203.3	85.2	68.4	89.6	190.5	265.0	37.5	64.8	118.8	110.1	112.0	68.9	31.0	47.1	116.7	98.6	134.4	104.6	85.6	56.1	80.9	112.0	76.2	98.7	87.3	60.2	111.6
ASH2L	"ASH2, ASH2L1, ASH2L2, Bre2"	ENSG00000129691	"ASH2 like, histone lysine methyltransferase complex subunit"	Q9UBL3	8	38105493-38144076	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 69.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HEL: 200.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042289	Approved		Supported	"Nucleoplasm,Plasma membrane"		Yes	No			"Cluster 2: Granulocytes - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 36: HEL - Hemostasis"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm	"Plasma membrane"	"HPA042289: AB_10795608"	"unprognostic (9.39e-2)"	"unprognostic (5.58e-3)"	"unprognostic (2.67e-3)"	"unprognostic (5.40e-3)"	"unprognostic (2.87e-1)"	"unprognostic (2.66e-2)"	"unprognostic (4.04e-1)"	"unprognostic (9.15e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.12e-1)"	"unprognostic (5.10e-2)"	"unprognostic (9.73e-3)"	"prognostic favorable (4.25e-4)"	"unprognostic (9.95e-2)"	"unprognostic (1.27e-1)"	"unprognostic (7.69e-3)"	"unprognostic (2.54e-1)"	28.9	18.9	19.7	17.9	20.3	31.6	21.4	19.2	21.5	19.9	14.7	22.5	18.2	22.0	17.1	23.8	20.1	17.4	21.3	20.2	17.4	23.3	23.6	18.5	27.9	16.7	16.1	26.2	17.7	24.8	12.0	22.1	16.7	19.9	22.3	21.7	20.6	21.0	32.4	20.4	18.3	24.2	16.5	18.9	22.1	41.3	19.0	33.6	21.1	27.7	28.3	18.5	16.1	18.1	45.6	23.3	39.8	39.8	26.3	34.0	49.8	44.1	45.7	53.5	47.0	24.9	21.1	51.4	38.2	37.1	27.2	27.5	49.0	24.8	50.4	20.3	22.4	200.3	22.9	51.7	39.4	32.0	41.3	28.6	22.9	25.0	27.7	28.1	43.9	48.0	138.2	40.0	53.7	26.1	91.9	40.7	51.7	39.3	15.6	38.2	42.9	23.4	28.9	33.1	18.3	32.4	33.5	22.5	38.4	37.1	27.4	40.4	33.5	35.3	35.0	50.4	37.6	37.8	48.7	44.9	35.2	44.7	49.7	39.9	23.0	55.9	16.8	26.8	18.1	19.6	18.8	20.0	27.7	19.2	19.3	18.4	19.2	26.1	25.8	15.8	21.3	21.6	19.7	20.3	19.2	21.5	20.2	17.4	16.7	16.1	16.7	16.5	19.0	18.1	11.1	12.8	15.8	18.3	14.3	6.9	9.3	13.3	10.8	12.9	9.6	8.0	18.1	8.6	15.9	12.9	10.4	37.0	15.9	11.5	7.9	21.2	10.8	12.7	13.2	14.0	10.8	62.1	19.7	28.7	37.2	17.3	8.6	10.8	19.6	38.2	12.8	11.9	24.2	6.7	21.4	11.6	12.2	17.2	5.7	13.0	23.3	17.0	23.2	15.9	29.2	17.8	19.6	17.6	16.5	21.3	8.9	20.7	8.4	6.2	12.8	17.1	18.0	15.5	13.1	14.6	20.7	69.6	33.9	11.6	6.8	30.9	11.9	37.3	10.9	7.4
ASIC1	"ACCN2, BNaC2, hBNaC2"	ENSG00000110881	"Acid sensing ion channel subunit 1"	P78348	12	50057548-50083611	"Predicted membrane proteins"	"Calcium transport, Ion transport, Sodium transport, Transport"	"Ion channel, Sodium channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 24.9"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 31.3;Inhibitory neurons: 16.4;Oligodendrocyte precursor cells: 64.8;Oligodendrocytes: 11.2"	"Cancer enhanced"	"Detected in many"		"glioma: 12.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 34.8;SH-SY5Y: 27.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA058870			Supported	"Golgi apparatus,Plasma membrane"		NA	NA				"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 68: Oligodendrocytes - Mixed function"	"Golgi apparatus, Plasma membrane"		"HPA058870: AB_2683841"	"unprognostic (5.32e-3)"	"unprognostic (1.70e-1)"	"unprognostic (4.00e-2)"	"unprognostic (3.56e-2)"	"unprognostic (2.41e-1)"	"unprognostic (3.48e-3)"	"unprognostic (2.92e-3)"	"unprognostic (3.00e-2)"	"unprognostic (1.72e-1)"	"unprognostic (9.37e-2)"	"unprognostic (2.34e-2)"	"unprognostic (2.86e-3)"	"unprognostic (6.97e-7)"	"unprognostic (7.19e-2)"	"unprognostic (3.73e-1)"	"unprognostic (2.78e-3)"	"unprognostic (8.27e-5)"	1.6	0.7	19.3	0.9	22.2	0.1	1.6	14.4	19.8	3.2	6.4	6.3	0.8	1.9	0.0	2.3	3.0	2.5	2.6	18.2	21.0	0.7	0.2	0.6	0.4	18.0	24.9	1.1	0.5	5.0	0.8	0.6	15.9	2.8	1.2	1.0	3.5	1.9	0.3	0.9	2.5	2.3	13.7	0.3	2.8	0.7	23.7	1.5	0.5	0.0	0.2	1.9	1.7	13.8	3.3	7.2	8.7	19.7	2.7	4.2	4.9	2.2	6.1	4.0	4.0	4.8	2.3	2.1	4.7	1.1	2.4	3.2	8.7	7.7	2.3	1.9	25.1	6.2	9.0	3.2	3.8	9.5	22.7	10.7	3.7	0.4	1.0	34.8	0.5	22.8	4.3	0.0	3.3	4.0	8.8	18.3	3.9	6.9	12.5	9.3	8.5	4.0	2.0	0.1	13.4	27.4	5.3	1.8	3.2	1.4	11.0	6.5	0.3	4.1	12.8	2.5	1.2	0.1	0.0	0.0	5.1	7.6	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.3	22.2	14.4	19.8	18.2	21.0	18.0	24.9	15.9	13.7	23.7	13.8	0.3	0.0	0.0	31.3	0.0	0.0	0.4	0.5	0.0	2.8	2.0	2.8	0.9	0.0	2.1	1.8	0.0	0.4	0.1	0.1	0.0	0.2	0.1	0.0	0.7	0.1	0.0	0.0	7.0	0.0	0.9	3.0	0.0	0.1	0.0	0.1	0.0	0.0	0.4	3.3	16.4	0.1	0.0	0.0	0.3	0.0	1.5	0.1	0.0	1.9	0.0	1.4	0.0	64.8	11.2	0.2	0.0	1.2	0.2	0.5	0.0	3.2	6.0	0.5	0.0	1.3	0.7	0.1	0.9	2.3	0.0	0.3	0.9	0.4	0.0	0.2
ASIP	"AGTIL, ASP"	ENSG00000101440	"Agouti signaling protein"	P42127	20	34194569-34269344	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"epididymis: 14.8;heart muscle: 28.0;ovary: 41.7"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 27.4;dendritic cells: 44.1;Hofbauer cells: 15.1;Leydig cells: 12.5;Peritubular cells: 10.5"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	356	"plasmacytoid DC: 134.8"	"Lineage enriched"	"Detected in single"	356	"dendritic cells: 134.8"	"Cell line enhanced"	"Detected in some"		"CACO-2: 3.2;HSkMC: 2.4;SK-MEL-30: 1.9;U-698: 1.9"	"Not detected"	"Not detected"							HPA048636	Uncertain		Supported	Vesicles	"Secreted to blood"	NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 65: Plasmacytoid DCs - Unknown function"	Vesicles		"HPA048636: AB_2680471"	"unprognostic (4.81e-2)"	"unprognostic (7.46e-2)"	"unprognostic (1.97e-3)"	"unprognostic (3.26e-2)"	"unprognostic (2.24e-1)"	"unprognostic (3.07e-2)"	"unprognostic (5.13e-2)"	"unprognostic (4.57e-2)"	"unprognostic (4.52e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.48e-1)"	"unprognostic (5.53e-6)"	"unprognostic (1.02e-1)"	"unprognostic (3.09e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.33e-1)"	1.4	0.6	0.2	0.0	0.5	0.3	2.4	0.1	0.4	4.2	0.0	0.5	0.0	2.0	14.8	0.1	4.0	0.1	28.0	0.1	0.1	0.9	1.3	0.3	0.4	0.2	0.1	41.7	0.1	0.0	0.6	0.2	0.6	1.5	0.0	0.3	0.7	0.2	0.9	5.7	0.8	0.0	0.0	0.3	0.3	1.5	0.2	0.2	0.3	1.2	0.5	0.5	1.1	0.3	0.0	1.1	0.4	0.4	0.2	0.7	0.1	0.1	0.0	0.0	0.0	3.2	0.0	1.2	0.2	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.7	1.7	0.3	0.5	0.0	0.0	0.4	2.4	0.0	0.0	0.0	0.1	0.0	0.7	0.6	0.9	0.0	0.3	0.2	1.7	0.0	0.1	0.6	0.3	0.3	1.4	0.0	0.1	0.2	0.2	0.0	0.2	1.9	0.5	0.3	0.2	0.3	0.5	0.5	0.0	0.3	0.4	0.4	1.9	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.3	0.1	0.0	0.1	0.0	0.0	134.8	0.0	0.6	0.2	0.5	0.1	0.4	0.1	0.1	0.2	0.1	0.6	0.0	0.2	0.3	0.4	0.0	0.6	1.3	0.8	2.5	0.0	0.0	0.0	0.0	0.3	0.5	27.4	0.0	0.0	0.0	0.0	0.2	44.1	0.0	1.9	0.0	1.1	0.3	9.2	1.2	0.0	0.0	2.1	0.0	0.2	5.6	0.0	0.4	0.0	0.2	2.5	5.8	15.1	0.0	1.8	0.0	0.0	0.8	7.0	1.7	12.5	2.1	1.8	1.0	0.3	0.0	0.0	2.5	2.5	0.1	0.0	10.5	0.0	0.1	0.0	8.3	0.0	0.0	6.6	0.1	0.6	1.7	1.9	0.2	3.1	0.8	0.6	1.0	0.0	0.1
ASPA	"ACY2, ASP"	ENSG00000108381	Aspartoacylase	P45381	17	3472374-3503405	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		Hydrolase	"Disease variant, Leukodystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 69.0;kidney: 38.2"	"Cell type enhanced"	"Detected in many"		"Leydig cells: 49.7;Melanocytes: 46.2;Oligodendrocytes: 217.0;Peritubular cells: 48.2;Proximal enterocytes: 37.5;Proximal tubular cells: 74.8"	"Cancer enhanced"	"Detected in some"		"renal cancer: 7.7"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"ASC diff: 5.4;ASC TERT1: 4.1;CACO-2: 3.8;HSkMC: 7.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022142, HPA022145"	Enhanced		Supported	Cytosol		NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 45: Intestine - Brush border"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Cytosol		"HPA022142: AB_1845102, HPA022145: AB_1845103"	"unprognostic (4.42e-2)"	"unprognostic (4.79e-2)"	"unprognostic (2.02e-2)"	"unprognostic (2.79e-3)"	"unprognostic (4.36e-2)"	"unprognostic (5.01e-1)"	"unprognostic (1.08e-3)"	"unprognostic (3.57e-1)"	"unprognostic (4.17e-1)"	"unprognostic (3.43e-1)"	"unprognostic (5.27e-2)"	"unprognostic (6.27e-2)"	"unprognostic (1.25e-1)"	"unprognostic (7.07e-4)"	"unprognostic (2.77e-1)"	"unprognostic (4.68e-1)"	"unprognostic (1.49e-1)"	13.9	4.3	25.9	1.8	46.4	1.8	4.1	27.6	40.9	7.5	14.2	4.3	11.2	4.5	6.0	4.9	5.5	3.6	2.7	25.8	27.7	38.2	15.0	3.5	1.5	30.4	35.4	2.9	1.0	0.8	0.8	3.5	29.5	4.1	4.9	2.8	1.8	5.0	11.9	5.2	15.6	3.1	24.7	5.4	4.4	6.6	42.4	0.6	2.1	15.0	0.7	6.3	4.3	69.0	0.2	0.1	0.5	0.5	5.4	4.1	0.3	0.2	0.1	0.2	0.1	3.8	0.2	0.6	0.2	0.7	0.3	0.3	0.3	0.1	0.2	2.0	0.1	0.4	0.7	0.2	0.5	0.4	0.4	7.5	0.3	0.4	0.1	0.1	0.1	0.4	0.3	1.1	0.2	0.2	0.2	0.6	0.4	0.2	0.3	0.3	0.3	0.6	0.2	1.1	0.4	0.3	1.1	0.3	0.9	0.4	0.3	0.2	0.4	0.6	0.4	0.4	0.3	0.7	0.4	0.4	0.2	0.4	0.5	1.1	0.1	0.2	0.2	0.1	0.2	0.2	0.2	0.2	0.1	0.3	0.2	0.2	0.7	0.3	0.1	0.2	0.1	0.0	25.9	46.4	27.6	40.9	25.8	27.7	30.4	35.4	29.5	24.7	42.4	69.0	5.1	9.6	1.5	12.1	0.1	5.2	1.5	1.6	6.2	5.5	2.1	0.8	1.3	2.8	1.0	25.8	0.0	0.0	0.0	0.3	7.9	0.2	5.0	0.1	4.1	1.1	2.4	2.7	0.6	0.2	0.1	15.0	2.0	0.2	0.0	0.1	3.9	11.5	0.2	8.4	0.4	0.8	2.0	0.8	1.5	2.5	49.7	0.8	46.2	3.7	0.0	4.1	0.0	1.5	217.0	0.0	2.5	48.2	0.2	0.4	37.5	74.8	0.1	0.5	0.0	8.5	11.6	11.1	0.6	0.7	1.7	0.1	0.4	28.3	1.8	2.7
ASPSCR1	"ASPL, ASPS, TUG, UBXD9, UBXN9"	ENSG00000169696	"ASPSCR1 tether for SLC2A4, UBX domain containing"	Q9BZE9	17	81976807-82017406	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"			"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Extravillous trophoblasts: 222.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in all"	5	"Hep G2: 298.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026749	Approved		Supported	"Nucleoplasm,Vesicles,Plasma membrane"		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 38: Extravillous trophoblasts - Unknown function"	Nucleoplasm	"Vesicles, Plasma membrane"	"HPA026749: AB_1845114"	"unprognostic (5.01e-2)"	"unprognostic (1.19e-3)"	"unprognostic (7.61e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.36e-1)"	"prognostic favorable (8.55e-4)"	"unprognostic (2.02e-1)"	"unprognostic (2.07e-2)"	"unprognostic (3.43e-1)"	"unprognostic (1.71e-3)"	"prognostic favorable (2.67e-4)"	"unprognostic (1.13e-1)"	"prognostic unfavorable (1.26e-4)"	"unprognostic (3.16e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.27e-1)"	"unprognostic (1.01e-2)"	16.5	20.4	16.6	8.4	17.0	15.0	16.9	16.5	20.4	16.2	17.7	16.0	13.6	15.6	7.9	16.8	14.0	7.7	26.1	16.2	15.5	27.3	57.9	17.3	12.2	20.1	16.6	13.4	22.8	14.8	30.6	12.9	18.3	21.6	4.6	5.7	18.3	6.7	44.3	20.5	18.1	5.2	14.7	20.7	22.7	30.0	17.2	8.3	25.9	5.8	6.4	16.0	14.2	21.5	19.3	33.3	13.0	17.9	7.5	9.3	55.4	17.7	12.6	19.3	19.5	20.3	21.3	19.2	18.1	12.4	16.3	9.8	12.0	13.1	6.2	12.9	41.0	21.4	28.7	298.1	25.5	19.1	29.9	10.9	13.9	9.5	6.6	10.0	19.5	16.0	22.0	25.0	11.6	65.0	16.9	41.8	15.5	32.8	23.5	19.2	18.7	39.4	18.0	17.0	32.4	34.8	14.6	42.2	35.2	12.3	27.2	41.4	16.6	35.7	24.5	26.4	22.8	20.2	12.5	21.6	19.2	19.3	21.3	24.0	11.7	8.6	6.6	8.0	3.7	9.0	10.0	8.8	14.7	9.0	7.7	5.8	2.7	8.0	10.4	9.3	5.3	5.6	16.6	17.0	16.5	20.4	16.2	15.5	20.1	16.6	18.3	14.7	17.2	21.5	13.9	9.6	44.7	19.9	24.1	13.4	23.7	24.4	23.3	23.3	19.6	15.6	13.6	27.1	19.8	14.7	41.7	73.7	25.8	29.3	39.2	24.2	49.1	16.2	14.9	16.1	25.0	17.9	12.4	26.2	222.6	17.5	46.9	20.1	21.5	31.0	12.8	56.1	44.7	50.5	12.1	31.5	20.3	26.7	18.6	96.0	11.8	21.7	19.6	1.9	23.8	57.8	19.6	10.6	14.1	17.6	25.8	17.7	27.3	24.9	42.5	58.3	18.5	39.4	13.1	14.7	37.4	41.7	51.0	20.3	14.3	59.4	18.4	23.6	33.3	23.1
ASS1	"ASS, CTLN1"	ENSG00000130707	"Argininosuccinate synthase 1"	P00966	9	130444961-130501274	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Amino-acid biosynthesis, Arginine biosynthesis, Urea cycle"	Ligase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"kidney: 1284.8;liver: 2037.7"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 398.7;Hepatocytes: 1062.0;Proximal enterocytes: 618.2;Proximal tubular cells: 1408.9;Urothelial cells: 413.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	15	"plasmacytoid DC: 1.5"	"Lineage enriched"	"Detected in single"	15	"dendritic cells: 1.5"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 893.9;HaCaT: 850.4;hTCEpi: 817.8;RPMI-8226: 1444.5;THP-1: 1061.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020896, HPA020934"	Enhanced		Supported	Nucleoplasm,Cytosol		No	No		6400000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 81: Kidney & Liver - Metabolism"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Cytosol	Nucleoplasm	"HPA020896: AB_1845117, HPA020934: AB_1845118"	"unprognostic (3.73e-2)"	"unprognostic (1.77e-2)"	"unprognostic (2.78e-1)"	"prognostic unfavorable (8.14e-9)"	"unprognostic (3.06e-1)"	"unprognostic (1.05e-2)"	"unprognostic (2.93e-2)"	"unprognostic (3.71e-2)"	"unprognostic (3.27e-2)"	"unprognostic (1.22e-1)"	"unprognostic (4.02e-2)"	"unprognostic (4.24e-2)"	"unprognostic (2.92e-3)"	"unprognostic (1.41e-2)"	"unprognostic (1.05e-1)"	"unprognostic (3.14e-1)"	"unprognostic (4.72e-3)"	215.0	146.8	29.6	51.3	29.7	0.2	168.2	25.0	31.0	67.0	61.7	157.2	124.5	111.3	124.8	51.1	166.3	110.2	66.5	31.5	38.3	1284.8	2037.7	52.9	7.5	40.2	42.2	57.2	68.4	11.4	45.0	50.6	51.7	56.2	167.9	6.9	119.4	132.6	74.4	131.3	194.8	61.2	28.4	20.0	53.2	35.9	38.4	7.8	92.3	71.4	15.6	288.7	66.6	25.3	124.5	11.9	13.7	23.1	88.4	223.1	43.6	146.2	893.9	28.2	85.5	52.5	34.0	0.4	95.9	300.2	8.2	850.4	59.9	5.2	19.5	21.7	27.1	0.3	18.3	137.3	305.4	18.3	1.6	148.2	817.8	45.4	81.2	0.3	1.1	384.0	5.3	530.6	28.8	619.8	7.2	262.7	19.2	635.9	26.7	1.7	15.4	1444.5	78.8	61.3	342.4	5.8	515.4	534.7	41.5	53.5	366.1	1061.5	0.4	11.3	68.3	2.3	13.0	88.1	91.5	32.1	219.0	137.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	29.6	29.7	25.0	31.0	31.5	38.3	40.2	42.2	51.7	28.4	38.4	25.3	72.1	25.6	28.6	2.6	21.3	70.5	55.7	179.8	53.5	0.1	23.7	17.3	5.4	138.7	104.4	47.8	0.0	178.5	0.4	398.7	133.1	116.5	1.2	4.7	30.5	68.0	12.0	93.7	2.2	110.5	8.9	21.5	20.4	6.2	5.7	55.5	65.7	1062.0	14.7	0.0	8.0	186.8	24.4	40.1	6.5	7.8	31.1	8.0	3.6	7.5	1.6	10.6	0.0	0.0	0.2	70.8	310.4	124.8	11.7	104.0	618.2	1408.9	32.7	0.4	0.0	18.7	13.4	1.4	2.6	23.5	17.5	144.1	11.5	62.0	165.6	413.2
ATAD2B	KIAA1240	ENSG00000119778	"ATPase family AAA domain containing 2B"	Q9ULI0	2	23748664-23927123	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 93.0;Inhibitory neurons: 95.5;Oligodendrocyte precursor cells: 143.7;Oligodendrocytes: 125.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA034555	Uncertain		Supported	Nucleoplasm		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 68: Oligodendrocytes - Mixed function"	Nucleoplasm		"HPA034555: AB_10601665"	"unprognostic (2.40e-1)"	"unprognostic (4.36e-2)"	"unprognostic (2.58e-1)"	"unprognostic (2.16e-1)"	"unprognostic (1.62e-2)"	"unprognostic (5.93e-3)"	"unprognostic (5.57e-3)"	"unprognostic (2.22e-2)"	"unprognostic (1.85e-2)"	"unprognostic (1.23e-1)"	"unprognostic (9.14e-2)"	"unprognostic (7.56e-3)"	"prognostic unfavorable (2.35e-5)"	"unprognostic (2.46e-1)"	"unprognostic (2.68e-1)"	"unprognostic (2.67e-2)"	"unprognostic (1.98e-1)"	4.8	3.1	4.9	5.9	6.1	9.8	4.5	8.1	5.5	5.9	11.0	4.2	5.1	4.9	2.6	6.0	4.6	3.5	3.7	4.0	6.1	3.7	4.1	4.8	7.3	6.5	5.7	5.8	4.3	3.3	4.1	4.0	5.7	4.3	4.3	9.4	4.8	2.3	4.4	8.3	5.2	2.8	4.8	5.1	3.9	4.3	5.9	10.3	5.2	2.8	6.5	4.0	6.6	7.7	4.1	3.4	11.0	5.0	3.1	3.4	8.5	2.7	2.2	3.5	2.4	5.5	2.0	13.4	2.4	2.5	1.6	5.3	8.6	3.0	2.9	8.8	4.1	11.3	4.5	6.6	3.4	10.2	8.1	2.7	5.2	2.1	3.4	2.9	4.8	7.4	12.2	5.8	2.7	7.0	9.5	11.9	6.5	6.8	1.9	10.8	11.8	3.1	3.8	9.1	5.1	8.4	7.4	9.0	4.2	6.0	4.4	10.0	4.6	3.5	4.0	3.0	3.2	6.0	2.9	10.0	1.9	11.5	3.3	15.8	7.9	5.1	3.9	4.7	4.4	8.5	3.6	3.5	7.6	6.4	5.2	4.2	12.0	6.0	6.2	11.0	3.4	1.8	4.9	6.1	8.1	5.5	4.0	6.1	6.5	5.7	5.7	4.8	5.9	7.7	18.4	3.2	16.0	93.0	26.1	10.7	7.7	6.4	13.1	27.6	9.5	7.1	11.3	10.0	12.2	9.2	47.9	8.4	33.8	15.2	0.0	7.7	60.2	10.1	20.1	14.6	15.6	11.1	60.3	12.2	7.4	14.7	19.9	17.0	13.3	21.2	11.7	10.7	8.2	10.1	95.5	11.0	10.2	14.4	17.6	36.1	12.5	23.8	3.6	85.3	30.9	13.0	22.6	143.7	125.3	8.9	18.6	10.9	14.0	10.8	17.2	2.4	8.5	45.4	6.6	19.1	13.5	23.5	16.8	20.0	17.5	10.9	22.6	13.1	11.3	16.5
ATE1		ENSG00000107669	"Arginyltransferase 1"	O95260	10	121740424-121928492	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Oligodendrocyte precursor cells: 137.7;Oligodendrocytes: 220.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038444, HPA057549"	Approved		Supported	Nucleoplasm		NA	NA		83000	"Cluster 18: Basophils - Vesicular transport"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Nucleoplasm		"HPA038444: AB_10672745, HPA057549: AB_2683463"	"unprognostic (1.37e-1)"	"unprognostic (5.19e-2)"	"unprognostic (2.75e-3)"	"unprognostic (2.40e-1)"	"unprognostic (4.67e-2)"	"unprognostic (6.65e-3)"	"unprognostic (1.85e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.00e-1)"	"unprognostic (2.52e-1)"	"unprognostic (5.69e-2)"	"prognostic favorable (2.67e-4)"	"unprognostic (3.20e-1)"	"unprognostic (8.08e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.02e-1)"	10.1	11.7	8.1	8.5	8.5	7.4	10.4	7.3	9.2	12.1	17.3	13.5	11.4	10.6	8.4	10.7	9.0	10.4	22.2	8.4	11.0	18.2	18.2	9.5	9.5	6.7	7.3	10.0	6.2	15.4	4.8	11.0	7.5	12.7	14.6	15.6	7.8	10.0	18.3	6.7	11.1	11.7	7.4	10.4	8.8	13.3	10.6	13.0	16.0	15.4	10.6	12.7	6.6	8.7	13.0	19.5	15.4	15.0	15.1	16.8	12.3	12.0	24.0	13.1	13.2	23.6	19.1	16.1	9.5	14.3	8.8	16.1	14.5	14.2	16.3	20.3	13.1	5.8	8.8	31.1	15.5	26.7	13.4	11.9	15.2	13.8	32.0	19.3	18.7	9.0	7.8	29.4	14.5	7.9	14.0	15.2	7.5	19.6	11.4	13.1	18.1	10.6	23.4	11.2	4.8	19.4	17.2	12.9	28.2	11.3	8.9	9.2	19.2	8.2	7.0	12.5	21.1	28.0	33.6	12.0	12.6	20.6	7.4	12.8	3.8	6.1	5.3	4.5	6.3	4.5	5.0	5.3	3.4	4.2	5.5	5.6	2.3	5.1	3.5	4.8	6.7	4.0	8.1	8.5	7.3	9.2	8.4	11.0	6.7	7.3	7.5	7.4	10.6	8.7	23.0	9.6	22.0	76.4	17.3	8.4	12.8	9.4	24.5	31.3	17.5	14.6	75.6	11.5	12.7	20.2	12.5	7.2	20.9	42.8	17.6	11.3	6.5	15.8	19.4	19.3	22.1	16.2	100.5	13.3	10.5	25.0	29.6	16.4	12.6	13.5	20.0	26.6	10.0	23.5	93.8	17.7	10.2	14.8	7.2	7.7	20.5	23.6	14.2	74.0	12.8	21.7	27.8	137.7	220.4	15.6	18.3	25.9	24.8	21.0	19.5	39.4	11.5	35.8	0.0	23.4	21.1	26.9	40.2	30.7	17.5	8.6	17.9	29.1	16.8	16.6
ATF3		ENSG00000162772	"Activating transcription factor 3"	P18847	1	212565334-212620777	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 1462.0;Endometrial ciliated cells: 1049.4;Glandular and luminal cells: 1429.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"basophil: 6.4;intermediate monocyte: 4.0;myeloid DC: 1.6;non-classical monocyte: 6.3"	"Group enriched"	"Detected in many"	15	"dendritic cells: 1.6;granulocytes: 6.4;monocytes: 6.3"	"Cell line enhanced"	"Detected in many"		"BEWO: 131.5;HDLM-2: 100.4;SuSa: 155.0"	"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"spinal cord: 9.3"	HPA001562	Approved		Supported	Nucleoplasm,Nucleoli		Yes	Yes			"Cluster 7: Monocytes - Unknown function"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 12: NES - Nervous system development"	"Cluster 7: Non-specific - Mitochondria"	"Nucleoplasm, Nucleoli"		"HPA001562: AB_1078233"	"unprognostic (2.66e-2)"	"unprognostic (1.52e-2)"	"unprognostic (2.80e-1)"	"unprognostic (4.27e-3)"	"unprognostic (3.29e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.73e-1)"	"unprognostic (9.31e-2)"	"unprognostic (8.65e-3)"	"unprognostic (8.75e-2)"	"unprognostic (1.52e-1)"	"unprognostic (6.97e-2)"	"unprognostic (3.31e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.04e-2)"	"unprognostic (2.08e-2)"	176.1	82.8	14.2	63.3	17.7	45.3	97.6	16.5	18.7	106.2	17.1	66.6	21.0	108.6	9.3	128.4	122.6	135.0	113.7	14.4	20.2	98.1	139.9	116.0	20.8	21.1	16.7	40.2	67.2	48.8	45.0	66.3	17.2	116.3	60.0	16.2	33.1	24.1	30.7	154.9	45.6	313.0	15.4	24.4	104.8	3.9	18.8	84.5	181.1	30.0	3.1	281.2	55.2	25.0	21.1	1.2	40.7	8.7	3.9	10.4	131.5	14.7	11.9	12.5	29.8	27.7	15.5	0.4	6.5	0.9	68.0	11.6	24.6	4.0	20.5	100.4	24.6	1.6	11.6	10.0	72.9	9.0	22.7	18.3	65.3	34.9	80.4	2.4	2.6	23.9	10.0	77.0	1.9	2.8	27.5	5.9	29.2	11.5	9.2	8.1	27.1	18.4	1.8	3.0	18.3	18.4	19.1	34.2	59.0	155.0	19.9	6.5	2.4	3.6	19.5	12.3	6.7	60.4	27.9	7.4	11.9	4.8	10.8	6.4	0.7	0.0	0.3	4.0	0.3	0.0	0.0	0.0	1.6	0.2	0.0	0.0	0.2	0.0	6.3	0.8	0.0	0.7	14.2	17.7	16.5	18.7	14.4	20.2	21.1	16.7	17.2	15.4	18.8	25.0	568.2	423.1	146.5	1.6	55.3	202.8	866.2	236.1	1462.0	4.4	753.9	510.9	689.3	92.9	136.0	55.2	0.0	178.9	100.3	611.7	1.9	186.2	3.7	1049.4	318.2	176.2	889.6	2.7	2.6	122.7	330.8	452.6	966.9	1429.3	78.6	5.6	30.7	25.8	103.7	1.7	2.4	758.4	114.0	29.8	282.8	2.8	17.4	351.8	174.3	3.7	32.3	39.9	0.0	1.5	10.8	185.7	484.8	1.2	161.0	457.5	421.3	3.3	133.2	5.3	98.6	279.4	573.7	2.2	3.1	474.6	202.7	420.6	97.1	5.8	349.6	263.6
ATF4	"CREB-2, TAXREB67, TXREB"	ENSG00000128272	"Activating transcription factor 4"	P18848	22	39519695-39522683	"Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB011596	Approved		Supported	"Centriolar satellite,Cytosol"		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 59: Non-specific - Translation"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Centriolar satellite, Cytosol"		"CAB011596: AB_725569"	"unprognostic (2.51e-2)"	"unprognostic (7.36e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.09e-1)"	"unprognostic (4.45e-2)"	"unprognostic (6.17e-2)"	"prognostic unfavorable (4.07e-4)"	"unprognostic (4.43e-2)"	"unprognostic (1.97e-1)"	"unprognostic (5.16e-2)"	"unprognostic (1.50e-1)"	"unprognostic (4.41e-1)"	"prognostic unfavorable (9.77e-5)"	"unprognostic (7.06e-2)"	"unprognostic (9.78e-2)"	"unprognostic (6.40e-2)"	"unprognostic (1.95e-1)"	582.7	408.4	322.1	204.1	337.9	888.2	488.9	349.4	416.4	362.4	319.2	853.9	215.2	389.2	232.2	391.5	381.8	245.6	389.9	316.2	328.3	393.7	492.9	438.0	223.9	353.2	336.7	346.1	629.0	202.6	304.7	247.8	346.6	454.8	218.4	497.5	472.4	278.6	789.2	370.6	362.7	347.4	336.5	351.1	574.5	154.1	339.1	243.7	317.8	420.8	280.6	572.8	363.9	366.3	398.5	230.6	412.3	532.3	450.0	437.1	670.3	470.5	726.2	366.8	462.1	508.5	300.0	760.2	100.7	358.0	300.6	305.1	676.3	551.9	463.7	475.2	461.0	518.9	259.5	516.8	962.7	992.0	479.4	733.3	1172.0	654.3	973.2	658.2	365.8	825.3	560.4	790.7	288.6	241.8	599.2	713.8	354.8	828.1	288.3	612.0	268.5	793.5	491.0	328.0	605.3	254.3	214.8	559.3	1405.8	374.4	342.4	1191.5	290.4	221.5	645.9	250.8	323.8	1004.7	1100.7	888.7	244.9	497.5	506.3	46.5	36.9	24.8	20.0	31.6	26.4	37.9	27.6	26.5	44.3	28.7	28.6	26.6	17.8	26.8	34.9	27.0	31.6	28.8	322.1	337.9	349.4	416.4	316.2	328.3	353.2	336.7	346.6	336.5	339.1	366.3	201.0	169.9	176.0	19.2	181.8	443.9	344.3	171.2	205.5	120.5	286.8	211.5	167.9	143.0	148.7	44.1	93.8	140.1	156.9	357.9	66.5	200.9	20.9	154.2	122.8	229.9	266.7	140.4	19.2	765.1	309.0	198.0	184.5	191.7	223.0	119.0	146.7	190.9	112.7	69.0	16.6	371.4	101.7	174.3	348.4	21.1	185.1	215.7	238.3	22.5	239.5	94.7	92.7	16.6	34.7	396.0	335.7	206.9	223.7	378.5	265.0	85.8	92.3	311.3	335.2	306.5	279.0	72.3	61.5	155.3	335.7	218.4	175.5	115.0	284.5	401.1
ATF5		ENSG00000169136	"Activating transcription factor 5"	Q9Y2D1	19	49928702-49933935	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	21	"liver: 2479.9"	"Cell type enriched"	"Detected in many"	5	"Hepatocytes: 1412.6"	"Cancer enriched"	"Detected in all"	7	"liver cancer: 200.0"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"classical monocyte: 24.0;intermediate monocyte: 22.4;myeloid DC: 14.3;plasmacytoid DC: 38.5"	"Group enriched"	"Detected in all"	9	"dendritic cells: 38.5;monocytes: 24.0"	"Cell line enhanced"	"Detected in all"		"HDLM-2: 313.2;Karpas-707: 523.4;THP-1: 452.4;U-266/84: 715.6;U-698: 316.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030187	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 62: Liver - Hemostasis"	"Cluster 16: U-266 - Nucleosome"	"Cluster 15: Hepatocytes - Hemostasis"	Nucleoplasm	Cytosol	"HPA030187: AB_10601666"	"unprognostic (2.09e-2)"	"prognostic favorable (1.14e-4)"	"unprognostic (9.38e-3)"	"prognostic unfavorable (1.16e-4)"	"unprognostic (1.18e-1)"	"unprognostic (1.03e-2)"	"unprognostic (2.52e-1)"	"unprognostic (6.70e-2)"	"unprognostic (3.11e-2)"	"unprognostic (2.36e-1)"	"unprognostic (4.83e-2)"	"unprognostic (2.96e-3)"	"prognostic unfavorable (3.39e-7)"	"unprognostic (3.06e-2)"	"unprognostic (8.06e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.51e-1)"	40.7	61.4	11.7	31.7	11.6	21.4	35.6	10.7	15.2	14.9	9.3	19.6	28.3	16.2	9.8	18.0	22.9	14.4	17.3	12.2	14.7	26.1	2479.9	17.0	23.3	14.5	17.0	14.1	29.1	10.0	14.7	12.3	15.7	23.2	10.3	12.5	21.1	10.3	30.6	17.7	23.2	10.2	13.6	27.3	24.5	44.3	12.4	13.1	118.7	9.5	20.0	24.4	14.3	15.3	68.5	47.3	17.8	12.0	18.3	15.5	17.8	48.6	40.8	49.4	30.2	35.7	36.5	60.7	24.3	28.6	34.0	24.2	22.7	20.0	23.5	313.2	22.6	41.7	14.8	27.4	12.5	162.7	113.6	108.3	31.5	36.5	8.5	12.2	21.4	132.6	38.1	523.4	24.7	64.3	23.5	35.9	8.8	18.6	62.6	194.2	19.1	24.9	56.6	90.9	28.2	20.1	113.2	47.8	34.9	6.6	39.2	452.4	36.6	95.5	61.3	11.3	49.8	13.8	715.6	316.2	75.1	63.6	36.4	0.4	24.0	1.0	1.4	22.4	2.0	1.6	1.4	1.7	14.3	0.8	1.2	1.8	3.6	3.2	6.0	38.5	1.9	4.7	11.7	11.6	10.7	15.2	12.2	14.7	14.5	17.0	15.7	13.6	12.4	15.3	16.3	12.8	11.9	2.6	41.7	22.6	12.3	11.1	39.9	3.8	31.9	29.3	7.4	38.6	9.4	16.5	6.2	33.9	23.5	22.0	13.7	13.1	260.8	36.5	17.4	21.1	21.5	64.2	1.2	29.8	19.4	27.3	34.1	35.3	6.3	27.1	40.0	1412.6	82.5	92.5	1.8	21.0	2.0	59.4	172.3	134.3	13.4	51.2	40.9	2.8	259.9	17.4	8.2	0.5	1.6	20.0	20.6	16.6	118.1	24.8	49.0	47.9	9.6	7.5	13.1	18.0	24.2	15.0	11.3	37.7	24.0	35.6	15.1	23.4	23.4	18.4
ATG12	"APG12, APG12L"	ENSG00000145782	"Autophagy related 12"	O94817	5	115828200-115841837	"Predicted intracellular proteins, Transporters"	"Autophagy, Host-virus interaction, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013272, HPA068989"	Uncertain		Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 15: Liver - Metabolism"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 24: Non-specific - Transcription regulation"	"Nucleoplasm, Vesicles"		"CAB013272: AB_2533272, HPA068989: "	"unprognostic (2.48e-2)"	"unprognostic (1.40e-1)"	"unprognostic (2.38e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.25e-2)"	"prognostic unfavorable (1.36e-4)"	"unprognostic (2.72e-2)"	"unprognostic (2.87e-2)"	"unprognostic (5.51e-2)"	"unprognostic (9.36e-2)"	"unprognostic (1.48e-1)"	"prognostic unfavorable (1.54e-7)"	"unprognostic (1.27e-1)"	"unprognostic (1.93e-1)"	"prognostic unfavorable (4.99e-4)"	"unprognostic (5.11e-2)"	15.5	10.5	12.3	10.7	12.7	11.3	10.2	12.9	16.9	12.0	10.5	10.4	11.6	10.8	11.9	11.3	9.8	11.6	9.7	12.6	13.3	7.1	18.4	10.4	13.6	13.2	13.2	12.0	9.5	7.4	8.7	13.6	13.7	10.8	11.1	9.6	7.9	10.9	11.1	9.0	11.9	12.7	12.7	11.2	8.8	9.4	12.8	14.0	8.6	12.6	11.6	11.8	8.8	15.0	20.7	10.9	26.3	24.1	42.9	57.4	20.0	34.9	38.3	22.6	36.5	15.8	16.5	17.8	14.5	32.1	35.3	11.3	20.5	29.4	36.4	93.2	20.2	11.5	13.0	14.8	33.7	12.8	22.0	43.0	31.5	25.1	29.6	26.3	27.6	19.0	16.8	24.4	43.5	13.5	27.2	20.2	17.9	15.7	23.6	19.8	25.4	25.7	15.7	13.7	25.8	27.6	37.3	14.7	36.6	20.0	20.3	19.2	28.3	41.3	18.9	38.2	36.0	18.7	31.5	28.9	37.7	27.2	39.6	15.4	11.5	19.3	11.8	13.6	16.5	12.3	14.3	11.7	10.3	12.2	14.6	14.1	20.9	14.4	17.4	13.8	12.3	11.0	12.3	12.7	12.9	16.9	12.6	13.3	13.2	13.2	13.7	12.7	12.8	15.0	52.5	44.8	41.0	17.0	82.8	85.8	65.4	81.6	44.3	42.3	46.8	36.1	45.2	38.6	56.9	25.8	77.2	61.8	92.3	50.3	37.2	60.6	28.7	49.0	60.7	55.1	41.8	23.8	28.5	81.6	134.1	75.2	36.2	55.8	96.9	48.8	47.5	57.9	68.2	30.3	26.5	54.5	59.0	72.1	69.8	14.9	64.0	53.7	53.4	19.7	76.8	34.1	99.9	26.7	35.5	105.5	45.8	53.8	50.1	68.4	56.3	44.3	49.7	59.2	26.3	39.5	50.5	50.0	45.1	40.0	84.7	88.7	78.8	45.1	46.0	78.1
ATG2A	KIAA0404	ENSG00000110046	"Autophagy related 2A"	Q2TAZ0	11	64894546-64917211	"Predicted intracellular proteins, Transporters"	Autophagy			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	6	"neutrophil: 16.9"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 16.9"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038715	Uncertain		Supported	Nucleoplasm,Vesicles	"Intracellular and membrane"	NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 7: Non-specific - Mitochondria"	Vesicles	Nucleoplasm	"HPA038715: AB_10673474"	"unprognostic (3.05e-2)"	"unprognostic (2.33e-1)"	"unprognostic (7.55e-2)"	"unprognostic (1.18e-1)"	"unprognostic (3.42e-1)"	"unprognostic (9.23e-3)"	"unprognostic (1.88e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.37e-1)"	"unprognostic (2.68e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.66e-2)"	"prognostic favorable (4.79e-5)"	"unprognostic (2.92e-2)"	"unprognostic (2.69e-1)"	"unprognostic (3.37e-1)"	"unprognostic (1.15e-1)"	16.4	20.1	11.4	6.5	10.9	60.2	16.9	8.6	40.1	19.9	11.4	18.9	7.5	18.2	1.8	15.7	19.2	4.2	18.4	11.5	9.8	22.0	59.2	24.2	6.1	13.9	12.3	24.9	22.7	4.9	21.6	4.9	12.7	21.6	2.6	1.9	15.2	5.7	26.7	34.9	21.4	3.3	9.0	25.7	23.2	15.3	11.4	5.4	19.3	4.4	3.3	17.7	15.6	10.4	13.2	12.6	4.4	12.0	5.7	4.0	12.3	7.1	10.3	9.4	6.8	11.0	9.9	9.3	14.7	6.0	12.0	10.8	4.5	8.3	2.5	9.1	15.7	8.7	19.1	10.0	8.4	6.5	18.2	10.9	7.1	11.8	6.3	5.4	7.9	9.5	16.1	7.3	4.1	21.3	7.8	21.9	5.1	3.5	14.3	8.6	7.1	13.5	5.0	10.9	16.5	6.7	10.6	14.6	13.3	3.3	14.3	8.1	10.1	9.0	8.6	18.3	5.3	14.7	5.5	6.5	13.0	5.2	5.6	3.0	2.0	2.2	2.5	2.1	2.1	0.8	1.7	2.2	1.4	0.9	1.3	2.4	16.9	1.8	1.7	2.4	0.9	1.2	11.4	10.9	8.6	40.1	11.5	9.8	13.9	12.3	12.7	9.0	11.4	10.4	9.8	9.6	16.2	20.2	17.0	28.9	8.7	35.7	16.5	16.6	15.8	10.3	8.1	7.2	17.6	9.2	33.3	12.7	40.1	38.8	1.9	10.2	2.5	12.4	9.2	10.2	35.9	16.2	7.6	10.3	5.3	12.6	16.8	24.4	9.5	15.4	7.9	23.2	10.9	13.5	8.4	17.6	24.4	20.1	19.9	3.6	12.8	24.2	30.2	5.6	11.9	12.3	19.6	6.6	7.1	14.9	21.7	10.1	27.3	12.2	26.8	6.6	13.3	26.0	13.1	11.6	10.6	9.0	6.2	16.3	38.4	66.9	40.2	27.2	19.0	15.9
ATG3	"APG3L, DKFZp564M1178, FLJ22125, MGC15201, PC3-96"	ENSG00000144848	"Autophagy related 3"	Q9NT62	3	112532510-112562046	"Predicted intracellular proteins, Transporters"	"Autophagy, Protein transport, Transport, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 657.9;Spermatocytes: 341.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB037260, HPA040471"	Enhanced		Supported	"Plasma membrane,Cytosol"		NA	NA		140000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 10: Non-specific - Unknown function"	"Plasma membrane, Cytosol"		"CAB037260: AB_1078236, HPA040471: AB_2677000"	"unprognostic (2.77e-2)"	"prognostic favorable (6.82e-4)"	"unprognostic (4.90e-3)"	"unprognostic (1.30e-1)"	"unprognostic (2.63e-1)"	"unprognostic (1.44e-1)"	"prognostic unfavorable (9.35e-6)"	"unprognostic (6.79e-2)"	"unprognostic (6.67e-2)"	"unprognostic (6.99e-2)"	"unprognostic (2.56e-2)"	"prognostic unfavorable (1.59e-4)"	"unprognostic (7.52e-3)"	"unprognostic (4.66e-2)"	"unprognostic (6.02e-2)"	"unprognostic (3.48e-2)"	"unprognostic (5.25e-2)"	33.1	38.7	41.4	49.1	50.1	94.1	34.7	51.3	53.5	28.3	38.2	38.2	38.2	24.7	24.7	34.8	23.2	24.7	33.3	39.7	46.8	41.6	43.3	31.1	48.4	49.1	48.2	25.6	41.8	44.8	30.6	33.6	48.5	23.2	40.3	29.1	29.4	28.3	29.5	29.8	36.6	29.9	48.2	48.2	37.7	85.3	45.6	51.2	42.2	33.6	46.3	38.7	26.3	55.7	105.0	55.9	51.5	52.6	66.6	54.5	57.5	89.8	65.3	86.9	78.9	78.9	60.6	130.3	66.6	78.0	106.6	74.1	84.9	78.0	120.9	22.8	40.9	82.0	52.3	51.0	102.9	145.2	67.0	50.6	58.3	85.5	130.2	56.8	82.2	81.2	71.6	108.8	92.9	91.4	86.4	68.2	56.3	135.8	109.7	74.9	45.9	110.5	72.6	56.1	88.1	34.7	74.7	70.5	109.5	48.4	79.8	107.5	66.7	92.3	75.8	39.4	80.1	70.2	72.0	201.3	84.4	133.2	69.4	64.4	167.7	121.9	39.4	258.8	49.4	61.8	48.0	49.2	169.4	59.2	46.2	46.3	174.2	50.5	327.9	36.3	75.6	138.2	41.4	50.1	51.3	53.5	39.7	46.8	49.1	48.2	48.5	48.2	45.6	55.7	45.6	48.1	39.0	10.1	53.3	74.1	42.4	74.3	37.5	22.5	32.0	50.2	86.2	37.1	51.3	25.8	12.5	73.1	45.3	47.0	117.4	73.7	657.9	37.9	40.8	54.1	31.2	90.0	11.7	86.1	85.0	42.6	36.7	45.2	39.9	42.0	40.0	40.0	121.3	18.5	11.4	53.3	75.3	106.3	131.1	146.5	42.6	134.8	69.4	11.2	185.8	42.1	54.6	13.0	33.7	70.9	49.2	43.2	70.4	39.1	76.0	87.5	37.3	22.2	59.2	45.5	77.6	341.0	119.7	57.4	70.6	122.3	55.0	68.6	69.8	54.2
ATG4D	"APG4-D, APG4D, AUTL4"	ENSG00000130734	"Autophagy related 4D cysteine peptidase"	Q86TL0	19	10543895-10553418	"Enzymes, Predicted intracellular proteins, Transporters"	"Apoptosis, Autophagy, Protein transport, Transport, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 103.9;Proximal enterocytes: 109.3;Spermatocytes: 100.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"NB-4: 57.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA067683	Approved		Supported	Nucleoplasm,Mitochondria		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 59: Non-specific - Translation"	"Cluster 24: NB-4 - Immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Nucleoplasm, Mitochondria"		"HPA067683: AB_2685886"	"unprognostic (2.85e-1)"	"prognostic favorable (3.18e-5)"	"unprognostic (2.73e-1)"	"unprognostic (3.67e-1)"	"unprognostic (2.18e-1)"	"unprognostic (1.15e-2)"	"unprognostic (3.52e-2)"	"unprognostic (1.23e-1)"	"unprognostic (4.28e-2)"	"unprognostic (7.30e-2)"	"prognostic favorable (9.95e-4)"	"unprognostic (1.52e-1)"	"prognostic favorable (2.39e-7)"	"prognostic favorable (5.03e-4)"	"unprognostic (3.78e-2)"	"unprognostic (2.29e-1)"	"unprognostic (3.18e-3)"	7.3	15.6	4.2	7.3	4.7	33.2	7.4	8.3	8.6	9.4	8.2	22.3	21.8	8.1	1.6	27.3	7.6	3.9	23.2	4.5	4.0	20.8	13.2	10.6	8.3	5.2	4.7	9.5	16.3	10.7	16.6	4.9	5.3	14.0	5.2	2.5	16.6	4.4	36.9	24.6	23.2	2.1	3.1	17.0	13.7	24.5	5.4	12.0	13.4	10.8	4.6	9.7	15.0	6.1	13.8	8.7	11.7	16.5	2.1	1.8	9.9	9.2	7.8	11.1	12.2	14.9	4.3	9.2	16.2	0.9	8.6	20.8	7.3	6.8	1.4	10.4	23.5	23.1	22.3	8.2	7.4	9.4	22.1	1.8	14.2	9.8	3.4	2.8	3.3	18.1	17.8	19.8	3.6	21.9	27.6	57.8	18.9	6.1	29.0	20.0	8.2	15.1	6.4	17.8	45.3	17.8	12.6	22.6	11.3	2.1	14.0	21.6	6.4	16.8	11.0	34.7	20.4	19.2	15.4	10.8	14.4	18.0	19.5	1.6	0.8	3.7	1.1	1.0	1.5	1.0	1.3	1.2	0.6	0.4	1.2	1.7	0.2	1.3	0.4	4.2	2.2	0.8	4.2	4.7	8.3	8.6	4.5	4.0	5.2	4.7	5.3	3.1	5.4	6.1	6.3	9.6	6.6	9.1	14.4	30.5	19.8	14.9	24.5	14.9	14.1	10.2	0.5	14.3	8.1	1.8	14.6	27.9	38.7	103.9	13.7	16.1	83.6	9.6	5.5	5.3	22.2	43.6	8.4	16.5	6.7	8.2	26.5	10.1	7.0	10.9	6.1	11.9	13.4	28.6	9.1	38.5	20.3	15.0	12.1	16.3	8.7	10.0	12.4	4.7	15.7	11.8	22.6	4.5	8.4	20.5	72.4	4.5	17.6	21.6	109.3	25.4	5.2	20.1	13.1	9.1	14.2	100.7	21.2	33.4	31.3	36.5	19.6	10.6	33.2	36.4
ATG7	"APG7L, DKFZp434N0735, GSA7"	ENSG00000197548	"Autophagy related 7"	O95352	3	11272309-11557665	"Predicted intracellular proteins, Transporters"	"Autophagy, Biological rhythms, Protein transport, Transport, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 160.0;Excitatory neurons: 178.7;Inhibitory neurons: 176.4;Late spermatids: 119.1;Microglial cells: 132.1;Oligodendrocytes: 137.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"basophil: 60.1;classical monocyte: 136.6;eosinophil: 88.4;intermediate monocyte: 79.4;myeloid DC: 82.4;neutrophil: 107.4;non-classical monocyte: 60.8"	"Group enriched"	"Detected in all"	5	"dendritic cells: 82.4;granulocytes: 107.4;monocytes: 136.6"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007639, CAB018771"	Supported		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA		33000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Cytosol	"Nucleoplasm, Plasma membrane"	"CAB018771: AB_2062165, HPA007639: AB_1845162"	"unprognostic (3.97e-2)"	"unprognostic (2.83e-2)"	"prognostic favorable (9.66e-4)"	"unprognostic (1.18e-2)"	"unprognostic (2.79e-1)"	"unprognostic (5.19e-2)"	"prognostic unfavorable (1.41e-4)"	"unprognostic (1.82e-1)"	"unprognostic (2.40e-1)"	"unprognostic (1.80e-3)"	"unprognostic (2.30e-2)"	"unprognostic (2.67e-1)"	"prognostic favorable (9.55e-4)"	"unprognostic (1.61e-1)"	"unprognostic (3.65e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.50e-1)"	16.8	13.5	11.2	25.0	13.1	47.6	18.0	7.3	21.8	14.5	17.0	17.3	13.0	14.9	16.7	16.7	18.7	16.6	10.8	12.4	9.5	13.7	13.2	20.9	23.9	15.0	15.0	12.2	10.9	21.2	7.5	21.0	13.1	11.6	19.2	10.3	12.2	11.9	13.0	18.0	13.8	20.0	12.4	16.4	14.4	22.5	15.4	13.1	13.0	13.5	25.0	20.3	12.0	21.3	48.5	37.1	16.7	9.2	28.0	36.7	80.4	44.5	56.8	43.1	49.9	16.0	42.5	22.1	26.5	39.2	45.1	14.5	18.3	62.0	73.8	19.8	23.5	16.0	33.6	19.6	36.9	46.8	50.8	38.0	28.2	83.6	52.0	45.4	60.5	14.0	24.1	17.9	60.6	31.3	13.7	21.3	13.0	22.2	47.9	17.1	19.6	19.9	32.5	34.2	14.6	14.5	31.6	26.4	17.5	20.1	28.8	44.7	42.5	36.0	25.7	23.6	63.2	11.1	31.8	38.1	57.8	43.1	49.9	60.1	136.6	88.4	15.9	79.4	12.3	13.0	12.9	15.1	82.4	12.3	11.7	13.7	107.4	21.3	60.8	14.7	12.4	56.8	11.2	13.1	7.3	21.8	12.4	9.5	15.0	15.0	13.1	12.4	15.4	21.3	6.4	0.0	9.8	160.0	11.4	11.1	7.3	21.6	9.6	18.1	7.4	3.6	4.2	4.3	12.5	7.3	18.8	16.5	7.9	8.3	7.9	12.3	44.2	10.6	9.5	14.6	11.4	9.5	178.7	12.9	16.8	11.0	10.7	13.2	14.7	12.4	19.6	9.0	57.6	20.2	176.4	7.6	22.4	25.8	12.1	119.1	10.2	28.8	3.6	132.1	30.6	8.1	13.4	99.0	137.2	17.4	7.3	9.8	10.8	6.4	8.4	6.8	16.5	12.5	6.6	11.7	10.6	22.4	11.9	9.8	7.7	19.2	10.1	9.9	7.6	7.4
ATG9A	"APG9L1, FLJ22169"	ENSG00000198925	"Autophagy related 9A"	Q7Z3C6	2	219219380-219229717	"Predicted membrane proteins, Transporters"	"Autophagy, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 83.8;Late spermatids: 105.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059551	Uncertain		Supported	Vesicles		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 6: Erythroid cells - Oxygen transport"	Vesicles		"HPA059551: AB_2684060"	"unprognostic (1.53e-2)"	"unprognostic (4.03e-1)"	"unprognostic (1.46e-2)"	"unprognostic (5.04e-2)"	"unprognostic (4.80e-1)"	"unprognostic (1.92e-1)"	"prognostic unfavorable (2.18e-5)"	"unprognostic (8.99e-3)"	"unprognostic (2.07e-1)"	"unprognostic (3.55e-3)"	"unprognostic (4.67e-2)"	"unprognostic (4.21e-1)"	"unprognostic (2.23e-2)"	"unprognostic (4.84e-2)"	"unprognostic (3.15e-1)"	"unprognostic (5.61e-2)"	"unprognostic (1.95e-2)"	25.6	23.6	27.2	17.3	29.0	44.7	19.2	27.8	36.6	19.5	10.0	25.6	31.4	24.1	14.2	31.4	18.8	21.8	42.1	30.0	24.3	20.0	25.9	23.7	19.4	29.0	26.7	20.4	28.1	31.2	17.6	30.7	26.2	21.6	21.8	24.6	23.9	22.8	116.8	32.1	29.7	28.1	24.3	21.7	22.8	62.2	27.6	15.7	18.4	62.7	21.2	22.7	22.7	28.6	29.4	35.7	26.9	64.0	50.3	55.1	35.9	52.1	56.1	67.3	60.2	52.9	38.8	7.7	43.7	79.8	54.7	58.0	43.2	56.9	49.6	22.6	70.7	55.7	90.1	63.9	54.9	14.1	40.6	56.7	91.4	68.7	63.0	60.9	68.2	18.6	75.6	27.0	46.2	38.3	12.2	33.4	19.5	28.5	26.9	16.9	36.7	30.2	40.0	38.6	42.6	25.7	52.0	46.7	46.5	52.0	17.3	39.3	52.5	67.0	32.3	28.7	47.1	15.5	14.7	11.2	55.7	33.9	37.2	6.5	12.4	6.3	7.2	18.0	7.2	5.6	5.6	9.1	8.5	3.6	5.4	6.1	11.2	9.7	22.6	4.1	7.1	11.6	27.2	29.0	27.8	36.6	30.0	24.3	29.0	26.7	26.2	24.3	27.6	28.6	0.3	0.0	4.5	12.7	8.2	7.8	7.6	10.6	8.6	18.9	0.3	0.3	33.2	17.2	7.1	0.0	14.6	26.8	4.1	44.0	0.0	0.2	83.8	0.6	1.5	10.0	13.8	34.7	15.2	0.5	24.4	9.1	11.7	0.8	10.2	0.3	16.8	37.1	11.5	21.9	14.1	17.6	6.1	13.3	7.0	105.9	14.0	4.8	10.6	5.6	7.0	20.5	9.2	9.5	12.5	0.3	27.6	8.6	6.7	13.4	39.3	0.3	4.7	15.7	13.1	7.1	5.5	54.9	13.8	14.2	11.1	34.8	7.5	0.8	18.5	10.5
ATL2	ARL6IP2	ENSG00000119787	"Atlastin GTPase 2"	Q8NHH9	2	38293954-38377285	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029108, HPA075302"	Approved		Supported	"Endoplasmic reticulum"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 59: Non-specific - Translation"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Endoplasmic reticulum"		"HPA029108: AB_10670557, HPA075302: AB_2732289"	"unprognostic (5.80e-2)"	"unprognostic (2.23e-1)"	"unprognostic (3.57e-3)"	"prognostic unfavorable (4.51e-4)"	"unprognostic (3.64e-2)"	"unprognostic (1.18e-1)"	"unprognostic (9.10e-2)"	"unprognostic (1.42e-2)"	"unprognostic (9.81e-3)"	"unprognostic (1.09e-2)"	"unprognostic (1.27e-3)"	"unprognostic (8.22e-2)"	"unprognostic (6.86e-2)"	"unprognostic (4.28e-2)"	"unprognostic (2.09e-1)"	"unprognostic (6.33e-2)"	"unprognostic (1.84e-1)"	19.1	32.4	15.0	16.9	20.4	32.5	41.6	26.6	18.0	29.1	16.8	52.5	33.7	33.4	19.5	41.9	29.5	18.5	16.7	17.1	14.2	28.1	40.2	22.9	19.2	13.5	13.6	37.0	15.7	15.8	13.5	16.8	12.0	31.4	26.7	25.4	51.8	31.2	53.7	50.0	31.4	36.0	11.2	20.3	31.7	17.9	16.3	27.9	54.9	46.2	35.1	27.4	33.2	14.7	84.3	36.0	51.0	37.2	44.8	27.9	61.1	31.5	25.0	33.9	38.7	40.8	65.2	61.6	33.7	20.2	47.4	94.8	64.7	32.2	56.4	74.5	44.7	38.9	26.6	58.7	24.5	47.1	35.8	20.3	68.6	32.7	45.2	21.7	34.6	23.5	60.3	37.5	28.7	31.1	56.0	46.1	64.1	89.5	22.4	46.9	50.4	45.4	25.9	43.6	26.1	44.2	32.0	40.3	38.2	39.0	22.1	28.7	21.9	34.8	52.4	33.2	57.8	48.8	48.3	79.0	23.4	47.9	42.7	1.3	2.7	10.6	2.3	2.1	3.8	2.8	2.7	2.7	3.4	4.3	4.1	3.3	3.3	2.5	3.8	2.0	3.6	2.4	15.0	20.4	26.6	18.0	17.1	14.2	13.5	13.6	12.0	11.2	16.3	14.7	18.5	12.8	32.4	62.7	18.7	36.8	32.5	25.9	14.8	20.6	40.8	33.8	7.6	11.5	44.8	7.3	14.6	15.7	14.9	12.0	7.9	11.7	22.1	12.3	17.4	17.0	6.6	22.9	66.3	5.0	14.7	16.5	11.7	17.8	4.5	14.3	14.3	34.4	10.8	21.9	55.5	11.7	77.3	8.5	16.1	19.5	14.3	12.9	12.4	59.0	8.2	8.6	7.2	46.3	20.4	5.7	8.7	16.6	13.1	23.9	17.8	12.6	23.5	21.1	32.9	16.9	19.4	16.7	21.3	46.4	46.9	14.6	13.6	9.0	12.7	31.3
ATM	"ATA, ATC, ATD, ATDC, TEL1, TELO1"	ENSG00000149311	"ATM serine/threonine kinase"	Q13315	11	108222832-108369102	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, DNA damage"	"DNA-binding, Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Disease variant, Neurodegeneration, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cone photoreceptor cells: 210.6;NK-cells: 339.8;Oligodendrocytes: 217.6;Rod photoreceptor cells: 200.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-698: 78.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000102, HPA067142"	Supported		Supported	Nucleoplasm,Vesicles		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 20: Retina & Lymphoid tissues - Unknown function"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	Nucleoplasm	Vesicles	"CAB000102: , HPA067142: AB_2685789"	"unprognostic (9.77e-2)"	"unprognostic (1.47e-1)"	"unprognostic (3.04e-1)"	"unprognostic (2.36e-1)"	"unprognostic (5.70e-2)"	"unprognostic (2.86e-2)"	"unprognostic (6.32e-3)"	"unprognostic (1.05e-1)"	"unprognostic (8.19e-2)"	"unprognostic (1.63e-1)"	"unprognostic (7.68e-2)"	"unprognostic (6.16e-2)"	"unprognostic (2.17e-3)"	"unprognostic (3.10e-1)"	"unprognostic (7.87e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.81e-1)"	6.2	7.4	8.2	17.5	15.0	16.2	8.5	17.0	12.3	8.7	16.1	6.7	5.2	10.0	9.9	4.0	7.5	8.2	7.0	7.3	11.3	5.8	7.8	7.6	33.7	15.8	13.1	15.8	14.8	9.3	12.1	8.0	17.0	6.3	7.0	20.6	11.4	6.1	4.4	7.5	12.6	6.9	10.3	22.2	8.6	5.2	12.7	18.2	8.8	6.0	25.9	7.1	6.9	28.8	4.3	6.8	14.8	7.6	20.2	29.1	3.1	10.9	13.5	6.4	11.3	7.1	10.3	18.3	14.0	10.2	9.6	7.7	11.6	10.8	9.0	12.3	5.7	15.2	8.7	10.2	10.5	16.4	17.0	18.3	6.3	10.0	21.2	15.2	14.1	16.5	12.4	9.9	14.3	3.4	10.6	18.5	9.8	8.6	7.4	9.7	9.7	24.9	8.1	7.5	9.0	10.5	11.1	4.7	20.6	13.2	9.3	10.1	23.7	15.8	8.4	7.3	9.0	6.2	7.0	78.3	7.0	19.0	18.8	21.3	5.5	4.0	16.5	5.7	11.1	11.6	11.7	12.5	2.6	13.0	21.1	20.4	9.9	9.7	13.3	6.2	6.1	5.3	8.2	15.0	17.0	12.3	7.3	11.3	15.8	13.1	17.0	10.3	12.7	28.8	23.7	38.5	20.8	62.7	146.4	12.6	17.5	21.1	28.5	111.0	19.6	14.2	39.9	12.8	19.5	22.0	210.6	16.9	140.2	4.2	5.9	9.9	19.2	14.4	52.1	25.9	20.4	39.1	70.2	12.3	13.2	39.0	12.8	20.9	13.3	45.9	32.9	23.3	29.1	60.6	82.8	14.9	26.4	96.4	34.0	5.1	39.4	69.2	26.6	178.9	63.2	27.3	339.8	85.5	217.6	7.6	7.6	27.8	96.5	9.1	8.9	11.1	16.0	200.1	26.3	41.4	29.2	31.5	37.4	15.8	12.4	4.2	147.7	52.3	11.5	10.2
ATMIN	"ASCIZ, KIAA0431, ZNF822"	ENSG00000166454	"ATM interactor"	O43313	16	81035842-81047350	"Predicted intracellular proteins"	"DNA damage, Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"Early spermatids: 180.6;Late spermatids: 288.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054967, HPA066900"	Approved		Supported	"Nuclear bodies"	"Intracellular and membrane"	NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 34: Spermatids - Unknown function"	"Nuclear bodies"		"HPA054967: AB_2682654, HPA066900: AB_2685744"	"unprognostic (9.92e-2)"	"unprognostic (3.31e-1)"	"unprognostic (4.47e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.23e-1)"	"unprognostic (9.32e-2)"	"unprognostic (4.69e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.46e-1)"	"unprognostic (6.51e-3)"	"unprognostic (1.48e-1)"	"unprognostic (4.26e-2)"	"prognostic favorable (6.80e-4)"	"unprognostic (1.08e-1)"	"unprognostic (5.94e-2)"	"unprognostic (1.24e-1)"	"unprognostic (4.60e-1)"	15.9	12.7	18.9	11.4	19.6	7.9	14.4	18.2	23.5	13.5	14.6	12.9	12.8	13.8	18.0	18.9	11.4	11.5	14.2	19.6	21.6	19.7	17.9	10.7	13.9	19.6	21.7	14.3	16.1	27.0	13.1	20.4	22.8	17.6	13.7	10.3	12.8	14.8	16.0	17.6	12.9	13.7	17.6	12.9	12.7	22.6	21.5	15.6	20.6	17.0	15.0	14.2	12.0	18.4	26.7	22.0	28.6	33.7	30.6	21.3	42.8	17.1	24.8	15.9	8.8	14.9	14.9	20.8	21.8	25.6	18.3	25.3	28.1	14.7	20.3	13.8	15.6	14.3	13.3	17.4	28.3	24.7	21.6	22.7	24.7	15.4	24.7	26.7	16.6	20.0	22.8	12.4	22.9	42.9	19.9	18.0	33.6	16.6	16.3	34.5	13.8	12.2	25.0	27.5	22.8	29.5	54.3	16.8	14.3	23.7	28.5	22.0	22.0	20.3	20.6	19.9	16.2	19.7	31.6	50.4	18.7	16.1	19.3	0.5	0.8	0.5	1.9	0.6	1.4	1.5	2.0	1.7	0.8	1.6	1.7	1.9	0.2	1.9	0.6	1.0	2.2	0.6	18.9	19.6	18.2	23.5	19.6	21.6	19.6	21.7	22.8	17.6	21.5	18.4	38.6	9.6	19.2	10.7	11.7	12.0	16.3	10.0	10.2	24.9	20.7	16.9	18.6	20.0	15.5	23.9	20.9	42.3	25.8	21.4	11.7	12.6	180.6	13.3	37.2	19.3	11.5	7.4	16.1	14.0	38.4	17.9	15.8	22.4	16.5	15.2	22.9	21.6	29.7	13.5	17.7	13.7	6.1	23.9	6.0	288.9	19.9	14.3	14.2	3.7	19.2	32.5	12.3	8.0	16.9	18.5	11.2	19.5	15.0	15.1	19.9	20.8	7.5	16.6	13.1	24.2	18.0	28.6	25.4	17.2	15.3	30.1	15.5	21.6	16.0	18.4
ATOH8	"bHLHa21, FLJ14708, HATH6"	ENSG00000168874	"Atonal bHLH transcription factor 8"	Q96SQ7	2	85751344-85791383	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 54.7"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 123.8;Endothelial cells: 41.7;Hepatocytes: 39.1;Muller glia cells: 32.3"	"Cancer enriched"	"Detected in many"	5	"thyroid cancer: 15.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 6.2;fHDF/TERT166: 6.8;hTERT-RPE1: 5.0;RH-30: 9.5;RT4: 5.6;TIME: 7.9;U-2197: 5.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA028406			Supported	Nucleoplasm		NA	NA				"Cluster 89: Fibroblasts - ECM organization"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Nucleoplasm		"HPA028406: AB_2672587"	"unprognostic (7.70e-2)"	"unprognostic (1.82e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.84e-3)"	"unprognostic (2.01e-1)"	"unprognostic (2.50e-2)"	"unprognostic (1.78e-1)"	"unprognostic (6.28e-3)"	"unprognostic (1.56e-1)"	"prognostic favorable (8.98e-6)"	"unprognostic (3.32e-2)"	"prognostic favorable (3.80e-5)"	"unprognostic (1.36e-1)"	"unprognostic (2.45e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.91e-2)"	33.8	1.8	2.1	0.3	2.2	0.0	29.9	2.7	1.6	20.9	0.5	8.8	0.2	25.9	0.2	5.6	19.4	0.4	30.6	1.5	5.1	7.3	25.1	25.6	0.8	5.7	4.9	15.0	4.2	0.2	5.4	0.3	5.3	17.4	0.4	0.6	5.2	1.9	54.7	19.9	8.9	1.3	1.6	12.2	9.4	2.1	3.1	0.2	48.5	2.0	0.1	21.7	20.6	3.3	0.0	1.1	4.1	6.2	3.0	0.4	0.0	3.4	0.5	0.8	0.3	0.0	0.0	0.0	1.1	6.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.8	0.1	1.6	0.0	0.0	2.1	0.0	0.0	0.0	5.0	0.6	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	1.2	0.0	0.0	9.5	0.0	0.0	5.6	3.0	1.4	0.6	0.0	0.6	0.0	0.0	0.0	7.9	1.2	0.0	5.5	0.0	0.0	0.0	0.0	0.8	0.0	2.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	2.2	2.7	1.6	1.5	5.1	5.7	4.9	5.3	1.6	3.1	3.3	123.8	9.6	18.3	10.7	0.3	2.5	8.5	11.8	0.6	0.4	0.5	0.8	13.2	5.7	17.5	1.8	0.0	0.1	0.1	1.1	0.0	11.9	13.6	5.9	5.7	41.7	4.2	0.0	0.3	2.3	0.6	11.4	1.1	20.5	1.3	5.3	5.7	39.1	3.2	0.0	0.3	2.2	6.1	3.1	4.0	25.9	3.4	4.3	1.8	5.6	0.6	32.3	0.0	14.6	3.1	1.0	5.5	0.4	0.0	4.5	0.0	0.6	2.4	1.3	0.0	12.2	11.6	3.0	2.7	0.2	1.4	0.3	0.5	0.1	1.0	2.3
ATP10D	"ATPVD, KIAA1487"	ENSG00000145246	"ATPase phospholipid transporting 10D (putative)"	Q9P241	4	47485275-47593486	"Enzymes, Predicted membrane proteins, Transporters"	"Lipid transport, Transport"	Translocase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Syncytiotrophoblasts: 176.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	12	"basophil: 84.3"	"Lineage enriched"	"Detected in all"	12	"granulocytes: 84.3"	"Cell line enhanced"	"Detected in many"		"HAP1: 41.6"					"Low region specificity"	"Detected in all"			HPA050808	Approved		Supported	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 28: Placenta - Pregnancy"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	"Nucleoplasm, Plasma membrane"		"HPA050808: AB_2681242"	"unprognostic (1.62e-1)"	"unprognostic (2.97e-1)"	"unprognostic (4.93e-2)"	"unprognostic (1.47e-2)"	"unprognostic (1.16e-1)"	"unprognostic (4.23e-2)"	"unprognostic (1.65e-2)"	"unprognostic (8.05e-2)"	"unprognostic (3.48e-2)"	"unprognostic (3.54e-2)"	"unprognostic (3.04e-1)"	"unprognostic (2.43e-1)"	"prognostic favorable (5.00e-8)"	"unprognostic (3.97e-2)"	"unprognostic (4.47e-3)"	"unprognostic (1.11e-2)"	"unprognostic (3.37e-2)"	4.9	6.0	2.6	5.0	2.9	1.3	4.2	1.9	2.7	7.0	15.9	3.7	3.9	7.4	7.2	10.2	4.7	7.4	4.2	1.8	4.1	10.2	2.4	6.1	6.2	3.1	3.7	8.1	4.5	10.4	3.1	14.9	2.9	4.6	3.8	4.1	3.4	6.4	1.0	9.9	4.5	9.7	2.4	10.0	5.1	2.0	5.0	4.5	9.1	2.7	7.9	7.3	6.5	2.9	2.6	1.8	4.0	2.8	11.1	12.0	0.7	17.9	21.5	8.4	15.1	9.4	15.4	8.1	6.5	29.1	14.3	4.6	41.6	15.0	12.9	3.2	3.2	6.5	2.8	0.5	9.8	2.1	3.9	10.3	11.2	16.4	10.9	27.5	14.4	4.0	0.1	4.3	23.2	1.0	4.4	1.2	1.4	0.0	2.2	4.9	9.0	0.1	15.0	3.1	2.6	4.9	8.4	2.1	5.2	8.7	3.8	2.1	21.9	20.7	4.1	1.9	7.8	1.9	1.5	0.0	10.2	11.9	6.8	84.3	3.1	0.4	1.1	5.0	1.9	2.7	0.5	0.8	4.0	6.7	0.1	0.9	1.5	2.3	6.9	2.4	0.8	1.6	2.6	2.9	1.9	2.7	1.8	4.1	3.1	3.7	2.9	2.4	5.0	2.9	22.9	9.6	7.5	39.2	27.8	19.2	9.2	21.9	23.9	12.2	6.7	8.4	4.9	4.3	8.5	16.5	31.3	48.5	17.1	1.6	1.9	5.5	4.4	4.8	29.5	16.1	9.6	4.0	25.7	4.6	11.0	22.4	14.3	7.0	2.5	21.3	18.2	6.6	13.0	13.5	42.8	4.6	18.3	21.7	7.9	1.5	62.1	17.7	7.2	47.8	15.7	21.9	15.5	52.3	24.1	2.7	3.4	25.2	23.0	5.7	1.9	9.2	6.2	9.2	26.3	12.8	23.6	0.6	2.8	35.4	27.0	176.8	15.5	51.7	4.1	8.1
ATP11A	"ATPIH, ATPIS, KIAA1021"	ENSG00000068650	"ATPase phospholipid transporting 11A"	P98196	13	112690329-112887168	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Lipid transport, Transport"	Translocase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 218.0;Alveolar cells type 2: 215.0;Cone photoreceptor cells: 235.6;Glandular and luminal cells: 176.3;Oligodendrocytes: 138.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035583, HPA035584"	Approved		Supported	"Golgi apparatus,Vesicles"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 44: Endometrium - Transcription"	Vesicles	"Golgi apparatus"	"HPA035583: AB_10671106, HPA035584: AB_10672096"	"unprognostic (1.67e-1)"	"unprognostic (5.06e-3)"	"unprognostic (1.58e-1)"	"unprognostic (5.27e-2)"	"unprognostic (6.58e-2)"	"unprognostic (8.84e-2)"	"unprognostic (5.87e-3)"	"unprognostic (1.80e-2)"	"unprognostic (6.97e-2)"	"unprognostic (1.54e-3)"	"unprognostic (3.93e-2)"	"unprognostic (4.23e-1)"	"prognostic favorable (7.44e-4)"	"unprognostic (3.85e-2)"	"unprognostic (3.69e-1)"	"unprognostic (3.26e-2)"	"unprognostic (7.40e-3)"	10.2	10.4	12.3	8.9	22.0	18.2	6.1	18.3	16.8	13.0	5.7	4.4	9.9	10.1	5.8	7.0	8.7	15.0	21.4	9.7	12.5	12.7	10.1	39.5	5.8	25.3	22.2	6.5	12.4	23.1	16.2	10.1	22.9	4.3	3.2	14.9	9.0	3.9	13.1	8.9	8.3	9.1	15.7	8.9	5.3	8.9	21.9	8.2	13.9	17.3	6.1	6.5	5.9	40.2	28.0	14.0	17.5	20.5	8.7	11.7	30.9	13.0	7.6	10.9	8.8	44.5	31.5	14.1	15.5	11.0	14.0	23.2	15.8	10.8	10.5	14.2	14.9	16.3	11.9	23.3	13.6	30.8	25.5	7.9	8.2	13.2	8.0	8.8	29.0	12.6	11.4	2.3	7.7	10.5	14.1	19.4	7.5	31.8	9.9	12.2	7.1	8.1	59.3	6.4	27.8	7.7	12.7	16.3	10.7	22.4	6.2	40.4	19.2	0.0	23.3	14.1	9.9	7.4	15.5	5.9	4.8	28.3	12.2	0.0	1.1	1.7	0.4	1.6	0.3	0.6	0.2	0.2	0.6	1.8	0.3	0.2	3.1	0.0	1.5	0.5	0.0	0.3	12.3	22.0	18.3	16.8	9.7	12.5	25.3	22.2	22.9	15.7	21.9	40.2	25.6	218.0	215.0	22.2	11.3	10.8	3.4	4.9	1.2	42.0	5.2	3.7	42.3	31.5	29.4	16.5	235.6	1.7	7.0	2.4	5.9	32.7	0.9	51.2	24.2	34.2	12.0	3.8	35.0	11.4	32.2	16.5	8.6	176.3	12.0	62.2	27.1	16.5	20.7	13.5	32.5	3.5	14.2	33.6	16.9	1.9	11.1	29.3	10.6	48.7	36.9	11.0	6.2	33.7	138.3	24.3	6.1	4.9	7.7	7.7	10.5	15.7	13.3	44.8	0.0	9.5	12.8	4.0	10.1	6.3	9.7	8.6	8.4	8.7	5.9	3.9
ATP12A	"ATP1AL1, H-K-ATPase, HK"	ENSG00000075673	"ATPase H+/K+ transporting non-gastric alpha2 subunit"	P54707	13	24680408-24712472	"Enzymes, Metabolic proteins, Plasma proteins, Predicted membrane proteins, Transporters"	"Hydrogen ion transport, Ion transport, Potassium transport, Sodium transport, Transport"	Translocase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"esophagus: 11.2;kidney: 5.4;lymphoid tissue: 14.8;placenta: 5.6;skin 1: 6.2"	"Group enriched"	"Detected in some"	4	"Basal respiratory cells: 75.6;Club cells: 49.2"	"Cancer enhanced"	"Detected in many"		"testis cancer: 12.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	7	"SuSa: 4.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA039526	Approved		Approved	"Plasma membrane,Actin filaments,Cytosol"		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 12: NES - Nervous system development"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Plasma membrane, Actin filaments"	Cytosol	"HPA039526: AB_10673534"	"unprognostic (8.33e-3)"	"unprognostic (3.58e-2)"	"unprognostic (2.93e-1)"	"unprognostic (5.21e-3)"	"unprognostic (2.58e-1)"	"unprognostic (1.21e-2)"		"unprognostic (8.03e-3)"	"unprognostic (2.64e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.18e-1)"	"unprognostic (3.39e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.67e-1)"	"unprognostic (6.80e-2)"	"unprognostic (8.22e-3)"	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	11.2	0.0	0.0	0.0	0.1	0.0	5.4	0.0	0.6	0.0	0.0	0.1	0.0	0.1	0.6	0.0	5.6	0.0	0.2	2.0	0.0	0.1	0.0	0.0	6.2	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.3	0.0	0.0	14.8	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	1.7	1.0	0.0	0.0	0.0	75.6	0.0	0.0	0.2	0.3	0.4	0.0	49.2	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.1	0.3	0.5	0.0	0.0	0.0	0.9	0.0	0.0	0.4	0.0	2.2	1.3	0.0	0.0	0.0	0.0	0.0	0.7	0.2	8.2	0.0	0.0	0.1	0.3	0.1	0.0	1.0	0.0	0.0	0.0	1.0	0.6	0.1	1.2	0.0	0.0	0.2	0.0	0.1	13.6	0.0	0.0	0.0	1.8	1.0	1.1	0.0	0.0	0.0	0.1	0.0	0.1	1.3
ATP1B3	"CD298, FLJ29027"	ENSG00000069849	"ATPase Na+/K+ transporting subunit beta 3"	P54709	3	141876124-141926549	"CD markers, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Potassium transport, Sodium transport, Sodium/potassium transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal enterocytes: 982.6;Late spermatids: 930.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB020697, HPA048963"	Enhanced		Supported	"Plasma membrane"		NA	NA		33000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 31: Skin - Epidermis development"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 41: Macrophages - Immune response"	"Plasma membrane"		"CAB020697: , HPA048963: AB_2680574"	"unprognostic (2.31e-1)"	"unprognostic (1.11e-3)"	"unprognostic (2.75e-1)"	"prognostic favorable (5.19e-5)"	"unprognostic (2.60e-2)"	"unprognostic (3.31e-2)"	"prognostic unfavorable (6.32e-6)"	"unprognostic (8.11e-3)"	"unprognostic (6.99e-2)"	"unprognostic (5.37e-3)"	"unprognostic (1.48e-2)"	"unprognostic (1.43e-1)"	"prognostic unfavorable (1.29e-5)"	"unprognostic (5.14e-2)"	"unprognostic (2.04e-1)"	"unprognostic (7.19e-3)"	"unprognostic (6.15e-2)"	229.4	349.6	62.2	81.0	62.8	63.0	87.0	78.5	78.8	98.4	100.5	146.7	112.7	75.7	37.6	182.3	96.2	55.4	102.8	63.6	74.7	128.4	24.5	191.0	41.3	71.1	66.6	180.0	36.7	20.3	168.7	96.7	76.5	102.0	168.0	43.6	85.8	46.2	26.7	259.3	125.0	71.4	68.7	65.7	66.3	75.8	70.6	51.4	75.8	16.0	57.1	101.0	161.2	62.2	280.8	170.1	155.5	145.6	411.7	118.0	354.7	322.2	287.6	224.2	252.1	253.7	136.5	223.3	278.2	243.5	328.4	595.8	157.0	152.2	253.4	120.4	190.0	195.7	161.4	156.8	161.7	164.9	149.1	126.5	355.1	179.1	169.7	162.4	245.7	156.3	135.9	193.7	233.8	114.6	165.6	275.0	213.6	384.5	76.1	225.0	116.4	227.1	191.1	186.7	127.6	86.0	413.2	188.5	455.9	270.7	145.6	197.2	170.7	196.4	76.3	298.8	189.8	138.0	197.6	367.5	259.5	176.5	165.2	69.7	104.1	35.4	70.4	174.3	51.7	39.7	56.3	74.8	103.3	30.4	32.6	59.6	6.7	32.0	260.4	64.8	68.4	103.7	62.2	62.8	78.5	78.8	63.6	74.7	71.1	66.6	76.5	68.7	70.6	62.2	114.7	57.7	41.9	38.2	143.4	492.8	428.3	535.9	326.7	35.9	53.0	46.4	19.7	17.2	177.6	220.7	25.0	281.3	464.5	982.6	41.1	73.9	465.9	86.0	72.2	199.2	56.1	147.1	107.5	60.6	226.8	164.1	24.5	127.2	130.7	94.3	100.6	9.0	305.9	25.2	91.2	65.2	164.8	148.0	678.3	930.5	84.8	455.3	222.3	37.5	364.8	46.3	75.2	46.3	54.7	70.6	321.1	68.4	153.1	396.5	413.3	41.5	33.3	28.4	124.9	99.5	265.2	69.0	200.2	178.4	414.4	391.4	216.1	122.2	134.9	370.2
ATP23	"KUB3, XRCC6BP1"	ENSG00000166896	"ATP23 metallopeptidase and ATP synthase assembly factor homolog"	Q9Y6H3	12	57906039-57959148	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 27.8"	"Cell type enhanced"	"Detected in many"		"Breast myoepithelial cells: 12.7;Cytotrophoblasts: 14.4;Distal tubular cells: 17.6;Extravillous trophoblasts: 15.2;Proximal tubular cells: 26.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Immune cell enriched"	"Detected in single"	4	"neutrophil: 1.6"	"Lineage enriched"	"Detected in single"	4	"granulocytes: 1.6"	"Cell line enhanced"	"Detected in some"		"A549: 1.0;Karpas-707: 2.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035804, HPA043204"	Uncertain		Enhanced	"Vesicles,Plasma membrane,Cell Junctions,Cytosol"		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 71: Testis - DNA repair"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 7: Non-specific - Mitochondria"	"Vesicles, Plasma membrane"	"Cell Junctions, Cytosol"	"HPA035804: AB_10601026, HPA043204: AB_2678361"	"unprognostic (2.56e-1)"	"unprognostic (1.31e-2)"	"unprognostic (8.82e-2)"	"unprognostic (2.92e-2)"	"unprognostic (2.30e-2)"	"unprognostic (6.16e-2)"	"unprognostic (1.20e-1)"	"unprognostic (5.28e-2)"	"unprognostic (5.41e-3)"	"unprognostic (1.03e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.06e-1)"	"prognostic unfavorable (1.44e-5)"	"unprognostic (4.36e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.80e-1)"	"unprognostic (2.27e-1)"	7.5	4.9	0.6	0.4	0.5	0.1	5.6	0.6	0.9	4.1	0.5	8.1	0.2	3.1	0.0	5.6	3.2	0.0	4.6	1.0	0.3	4.0	5.2	2.6	0.1	0.4	0.2	3.1	5.9	0.0	2.8	0.1	0.4	3.3	0.0	0.5	3.6	0.0	12.4	4.4	4.3	0.0	0.3	3.2	4.2	27.8	0.5	0.0	3.5	0.0	0.1	4.7	4.0	0.3	0.6	1.0	0.0	0.3	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.5	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.2	0.0	0.9	0.2	0.0	0.0	0.4	0.1	0.0	0.3	0.0	0.1	0.0	0.0	0.6	2.6	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.3	0.6	0.8	0.1	0.0	0.4	0.4	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.4	0.3	0.0	0.4	0.0	0.0	0.4	0.0	0.6	0.1	0.2	0.0	0.2	0.2	0.2	0.2	0.1	0.3	0.0	0.3	0.2	0.2	1.6	0.1	0.1	0.1	0.1	0.0	0.6	0.5	0.6	0.9	1.0	0.3	0.4	0.2	0.4	0.3	0.5	0.3	8.0	0.0	9.2	0.0	2.3	0.0	0.0	0.0	0.0	0.0	7.4	12.7	0.0	0.0	1.8	3.7	0.0	14.4	4.2	0.0	17.6	6.1	0.0	5.6	4.9	2.8	0.0	0.0	0.0	10.7	15.2	2.3	0.0	6.0	11.4	6.8	0.0	0.0	10.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.2	0.0	0.0	1.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.9	0.0	0.0	26.1	0.7	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	3.4	3.0	9.5	0.0	0.0
ATP2B1	PMCA1	ENSG00000070961	"ATPase plasma membrane Ca2+ transporting 1"	P20020	12	89588049-89709300	"Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted membrane proteins, Transporters"	"Calcium transport, Ion transport, Transport"	"Calmodulin-binding, Translocase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 106.8"	"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 781.6;Langerhans cells: 435.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"hTERT-HME1: 314.6;LHCN-M2: 501.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005605, HPA011166, HPA012945"	Enhanced	Supported	Supported	"Plasma membrane"		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 41: Macrophages - Immune response"	"Plasma membrane"		"CAB005605: AB_2061563, HPA011166: AB_1855484, HPA012945: AB_1855483"	"unprognostic (6.78e-2)"	"unprognostic (5.27e-2)"	"unprognostic (1.57e-2)"	"unprognostic (8.23e-2)"	"unprognostic (1.72e-1)"	"unprognostic (6.44e-2)"	"prognostic unfavorable (7.74e-4)"	"unprognostic (2.77e-2)"	"unprognostic (2.46e-2)"	"unprognostic (7.82e-2)"	"unprognostic (5.98e-2)"	"unprognostic (2.68e-1)"	"unprognostic (4.60e-2)"	"unprognostic (1.92e-2)"	"unprognostic (2.31e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.13e-2)"	18.5	11.2	33.0	25.6	92.0	106.8	19.6	14.0	59.1	18.8	0.0	33.1	40.8	18.2	12.1	14.7	18.6	25.2	11.0	52.7	4.9	16.4	22.7	21.3	29.2	0.0	14.4	13.1	17.1	21.5	11.0	27.3	0.0	13.9	32.3	71.2	11.5	14.9	24.4	26.0	30.1	19.7	0.0	30.7	29.0	23.0	10.9	18.4	14.4	24.1	28.8	37.0	10.6	34.9	24.0	117.8	45.5	22.1	64.5	102.2	20.9	71.2	232.6	67.5	106.8	47.7	21.6	46.8	4.9	99.3	77.6	21.0	40.3	19.7	187.5	16.2	46.9	16.6	39.8	41.9	209.6	70.7	26.6	85.0	36.9	210.8	314.6	78.9	17.5	17.6	27.9	16.6	501.1	37.6	22.1	30.1	35.6	32.9	55.6	31.1	146.4	19.7	64.4	108.5	42.9	23.4	82.6	22.9	20.2	91.7	33.9	7.8	12.5	181.8	29.4	67.6	78.9	12.7	21.2	49.1	82.6	19.6	41.0	9.4	39.4	22.3	20.9	42.5	26.4	84.5	36.3	26.8	51.3	84.4	13.2	16.8	127.1	27.0	86.1	9.0	53.7	21.8	33.0	92.0	14.0	59.1	52.7	4.9	0.0	14.4	0.0	0.0	10.9	34.9	46.0	44.8	46.0	90.8	226.4	201.6	71.0	29.3	76.2	370.9	30.9	109.7	20.3	45.8	30.0	53.3	154.3	176.8	139.8	181.5	1.9	27.6	2.3	29.3	61.0	63.6	91.6	31.5	781.6	28.5	42.1	91.6	44.9	59.4	31.6	45.5	49.6	39.5	193.5	302.9	279.1	30.7	16.2	116.0	435.1	9.6	29.2	285.4	55.2	126.5	157.1	96.4	50.4	193.5	91.9	25.5	80.6	32.0	133.9	54.7	75.0	22.1	20.6	113.3	32.9	97.0	69.5	44.5	130.7	30.4	204.7	228.8	125.1	76.0	65.9	90.2
ATP2B4	"ATP2B2, MXRA1, PMCA4"	ENSG00000058668	"ATPase plasma membrane Ca2+ transporting 4"	P23634	1	203626787-203744081	"Enzymes, FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Calcium transport, Ion transport, Transport"	"Calmodulin-binding, Translocase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"smooth muscle: 175.3"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 171.6;Oligodendrocyte precursor cells: 199.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"BJ: 200.0;BJ hTERT+: 276.4;fHDF/TERT166: 212.8;SuSa: 222.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016118, HPA040431"	Enhanced		Supported	"Plasma membrane"		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Plasma membrane"		"CAB016118: AB_2061729, HPA040431: AB_2676980"	"unprognostic (7.43e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.60e-2)"	"unprognostic (8.17e-2)"	"unprognostic (2.53e-2)"	"unprognostic (9.23e-3)"	"unprognostic (8.68e-2)"	"unprognostic (3.81e-2)"	"unprognostic (9.74e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.64e-2)"	"unprognostic (1.12e-1)"	"prognostic unfavorable (1.21e-4)"	"unprognostic (3.52e-3)"	"unprognostic (2.61e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.56e-3)"	58.9	25.0	39.7	25.6	36.3	16.0	16.6	0.0	33.5	47.5	0.3	58.2	12.5	104.5	20.1	32.5	48.4	25.2	59.5	40.2	13.3	9.9	9.3	35.1	12.8	8.0	8.0	40.6	9.9	11.8	3.8	40.6	11.2	33.0	30.2	42.5	7.1	69.7	14.4	54.8	14.4	175.3	0.2	12.2	15.4	27.4	44.7	21.7	15.1	27.7	19.4	37.2	15.3	2.6	45.7	7.8	15.6	15.1	120.4	175.1	84.5	200.0	276.4	32.1	27.4	3.8	22.8	9.8	28.8	212.8	43.5	43.5	22.6	27.7	34.3	126.5	8.0	28.7	37.4	2.5	43.1	42.0	51.3	130.5	26.9	102.9	16.2	81.6	63.5	57.1	12.9	20.3	25.1	2.5	44.3	14.5	9.7	8.7	24.2	22.3	11.6	16.7	11.3	4.0	4.6	6.7	68.3	10.5	30.2	222.1	9.3	21.4	54.9	80.5	11.4	136.6	48.3	13.4	20.9	5.4	80.7	31.0	24.5	3.2	2.0	0.0	8.7	1.3	6.4	0.9	5.4	7.2	2.2	0.3	1.3	3.4	4.0	3.8	2.2	3.7	5.7	2.7	39.7	36.3	0.0	33.5	40.2	13.3	8.0	8.0	11.2	0.2	44.7	2.6	171.6	89.8	68.2	127.6	9.9	97.1	18.9	43.1	41.5	4.8	11.2	9.4	76.5	7.2	35.0	18.4	2.1	27.9	56.2	2.2	0.0	35.3	5.8	78.0	92.4	67.6	23.9	35.9	55.9	14.9	18.9	56.0	13.7	89.7	10.1	30.6	58.9	18.2	38.5	117.8	9.8	2.4	14.2	14.7	38.8	4.8	43.8	20.4	26.6	37.5	18.1	136.1	66.9	199.0	40.4	31.4	11.1	38.0	27.6	48.2	7.2	3.3	39.7	7.8	19.7	50.7	81.2	21.7	2.8	54.7	150.9	26.0	59.7	8.0	3.3	62.0
ATP2C1	"ATP2C1A, BCPM, KIAA1347, PMR1, SPCA1"	ENSG00000017260	"ATPase secretory pathway Ca2+ transporting 1"	P98194	3	130850595-131016712	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted membrane proteins, Transporters"	"Calcium transport, Ion transport, Transport"	Translocase	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Astrocytes: 162.6;Excitatory neurons: 172.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010207, HPA035116, HPA069684"	Supported		Supported	"Golgi apparatus"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Golgi apparatus"		"CAB010207: AB_2061744, HPA035116: AB_10673106, HPA069684: AB_2686169"	"unprognostic (1.52e-1)"	"unprognostic (1.37e-1)"	"unprognostic (2.74e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.99e-1)"	"unprognostic (1.32e-2)"	"prognostic unfavorable (5.06e-6)"	"unprognostic (7.66e-2)"	"unprognostic (6.52e-2)"	"unprognostic (2.45e-1)"	"prognostic unfavorable (1.52e-4)"	"unprognostic (8.44e-2)"	"prognostic favorable (1.55e-4)"	"unprognostic (2.19e-1)"	"unprognostic (1.95e-1)"	"unprognostic (3.73e-2)"	"unprognostic (3.06e-1)"	32.2	32.7	34.0	25.3	36.6	38.6	32.9	31.8	42.8	33.4	76.9	36.5	23.9	30.9	28.0	23.6	37.2	27.2	31.9	40.7	38.6	44.7	28.5	51.4	21.9	37.0	38.9	28.8	22.6	78.0	22.7	32.7	40.3	85.8	35.9	59.4	29.2	25.2	28.1	31.9	26.9	31.0	33.6	19.5	31.5	25.2	48.8	36.2	35.0	21.1	26.2	31.6	18.1	48.6	133.1	51.1	49.9	48.5	136.7	110.0	53.9	141.2	186.8	69.4	87.0	83.5	106.3	47.6	95.6	134.4	96.4	153.6	95.1	77.9	100.8	104.4	34.2	127.2	51.5	39.0	87.2	51.2	148.4	86.8	76.6	73.2	82.2	126.3	74.6	59.3	37.3	84.1	86.7	59.0	50.6	40.9	57.0	71.7	54.8	36.3	49.9	75.6	127.5	87.7	76.7	45.9	121.4	37.8	72.8	70.8	55.7	41.7	102.6	73.3	40.8	95.5	65.8	54.6	71.1	69.9	75.8	38.0	62.6	30.6	8.9	15.9	7.4	7.6	7.0	5.6	7.3	6.6	9.5	3.6	4.9	4.9	4.3	11.5	9.6	8.2	9.3	6.5	34.0	36.6	31.8	42.8	40.7	38.6	37.0	38.9	40.3	33.6	48.8	48.6	30.2	38.5	53.0	162.6	17.4	39.4	34.5	34.8	26.7	25.9	34.4	22.4	30.2	35.8	41.1	46.0	20.9	16.3	15.5	39.0	5.9	35.3	17.5	26.9	34.1	27.8	35.6	23.3	172.5	38.0	27.6	25.9	33.1	55.8	28.5	28.2	26.7	27.4	27.7	82.4	136.5	32.4	36.7	26.2	34.8	18.9	16.1	39.5	21.4	128.4	20.5	26.4	19.6	148.3	154.3	51.1	27.5	14.7	18.5	69.0	16.3	19.8	52.7	33.4	6.6	27.7	25.9	16.2	14.1	24.7	52.8	17.6	19.5	17.3	31.2	36.9
ATP5F1A	"ATP5A, ATP5A1, ATP5AL2, ATPM, hATP1, OMR, ORM"	ENSG00000152234	"ATP synthase F1 subunit alpha"	P25705	18	46080248-46104334	"Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"ATP synthesis, Hydrogen ion transport, Ion transport, Transport"		"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"tongue: 1760.3"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 784.3;Distal tubular cells: 1173.9;Extravillous trophoblasts: 463.0;Proximal tubular cells: 939.6;Syncytiotrophoblasts: 578.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013067, HPA040622, HPA044202"	Enhanced		Supported	Mitochondria		NA	NA		8800000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 7: Non-specific - Mitochondria"	Mitochondria		"CAB013067: AB_221511, HPA040622: AB_2677048, HPA044202: AB_2678855"	"unprognostic (3.08e-2)"	"unprognostic (9.13e-2)"	"unprognostic (1.84e-2)"	"unprognostic (3.54e-1)"	"unprognostic (6.36e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.89e-2)"	"unprognostic (6.79e-2)"	"unprognostic (8.31e-2)"	"unprognostic (4.79e-2)"	"unprognostic (7.30e-3)"	"unprognostic (1.50e-2)"	"prognostic favorable (1.22e-15)"	"unprognostic (4.60e-3)"	"unprognostic (2.06e-1)"	"unprognostic (1.77e-1)"	"unprognostic (4.87e-3)"	251.3	453.6	198.6	177.7	209.2	210.5	260.4	233.0	251.4	195.5	401.9	414.0	438.9	192.6	225.6	362.6	227.2	146.3	1498.3	207.7	246.0	730.4	441.6	175.1	223.7	234.6	237.8	211.1	299.9	868.5	277.4	201.7	226.0	211.4	419.8	465.4	307.4	265.9	1602.0	290.3	335.0	233.0	205.4	226.8	419.1	167.6	226.7	277.3	261.4	1760.3	337.6	244.9	224.7	209.6	355.2	353.0	459.6	434.3	546.0	601.8	508.6	399.5	562.4	601.0	522.8	532.7	271.9	833.2	238.9	487.4	322.3	641.7	801.1	614.1	556.4	373.0	450.3	551.7	413.3	667.2	357.1	1182.7	501.6	559.2	422.3	434.6	448.2	481.3	630.4	442.5	454.0	477.2	521.8	367.6	612.8	579.7	432.3	344.5	367.6	596.5	533.8	1131.4	816.2	849.7	465.7	434.7	293.3	361.5	506.9	428.6	466.3	679.3	370.4	328.7	282.7	174.9	354.9	542.5	501.5	533.0	328.1	698.0	358.7	119.1	573.9	162.7	353.6	511.8	455.9	492.3	422.7	388.4	959.5	392.9	503.3	421.7	55.9	414.5	485.1	468.3	527.4	1339.1	198.6	209.2	233.0	251.4	207.7	246.0	234.6	237.8	226.0	205.4	226.7	209.6	79.2	169.9	167.8	0.0	49.9	0.0	0.0	0.0	0.0	0.0	205.7	169.8	0.0	0.0	100.3	171.0	0.0	784.3	86.3	0.0	1173.9	358.3	0.0	125.3	163.3	73.0	0.0	0.0	0.0	269.7	463.0	97.8	0.0	119.3	89.6	198.7	0.0	0.0	409.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	87.5	0.0	0.0	179.9	0.0	0.0	0.0	0.0	199.1	0.0	0.0	24.0	0.0	0.0	939.6	95.5	0.0	0.0	0.0	87.1	0.0	0.0	0.0	0.0	578.2	54.6	319.2	0.0	0.0
ATP5MD	"bA792D24.4, DAPIT, MGC14697, USMG5"	ENSG00000173915	"ATP synthase membrane subunit DAPIT"	Q96IX5	10	103389041-103396492	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted membrane proteins"			"Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 1340.2;Ductal cells: 705.9;Exocrine glandular cells: 723.1;Pancreatic endocrine cells: 884.5;Proximal tubular cells: 1879.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044798			Supported	Mitochondria		NA	NA		55000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 7: Non-specific - Mitochondria"	Mitochondria		"HPA044798: AB_2679091"	"unprognostic (4.41e-2)"	"unprognostic (3.08e-2)"	"unprognostic (2.59e-1)"	"unprognostic (7.93e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.95e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.51e-1)"	"unprognostic (5.67e-2)"	"unprognostic (1.57e-2)"	"unprognostic (7.41e-2)"	"unprognostic (1.01e-1)"	"unprognostic (3.32e-2)"	"unprognostic (1.74e-1)"	"unprognostic (4.66e-2)"	"unprognostic (7.46e-2)"	"unprognostic (1.03e-2)"	332.3	343.0	502.9	155.1	517.7	193.0	324.6	514.9	721.8	215.1	515.2	484.6	273.5	176.9	410.2	426.1	194.3	140.8	1229.7	526.1	539.0	546.7	587.1	215.3	180.3	501.2	501.9	157.5	321.4	519.2	309.2	157.4	506.1	254.2	449.6	245.3	234.8	236.4	1019.3	204.6	261.7	229.8	511.8	185.4	369.8	142.5	509.3	319.0	191.2	1325.5	251.0	284.7	258.9	518.0	557.8	559.4	528.4	648.2	570.2	696.0	348.3	523.2	612.7	501.0	556.6	925.2	605.3	312.4	288.9	575.3	398.6	559.4	502.2	522.7	697.9	414.7	887.3	331.8	682.1	1057.7	545.7	688.3	491.3	569.2	801.1	456.4	715.7	849.2	661.5	470.0	441.5	517.5	849.4	842.0	552.0	1167.5	397.8	830.1	959.1	355.8	326.0	495.3	1218.4	878.4	203.7	464.8	269.4	419.7	824.9	723.5	373.4	619.9	388.6	255.2	394.2	394.0	692.8	537.2	958.4	543.5	545.2	678.2	200.3	575.3	271.2	395.8	214.7	384.0	248.0	301.6	296.3	259.8	314.1	219.1	251.4	256.7	231.1	230.5	375.3	456.3	307.9	304.4	502.9	517.7	514.9	721.8	526.1	539.0	501.2	501.9	506.1	511.8	509.3	518.0	169.1	211.5	173.2	0.0	40.9	0.0	0.0	0.0	0.0	0.0	323.4	417.6	0.0	0.0	91.0	388.1	0.0	298.0	76.3	0.0	1340.2	705.9	0.0	406.0	245.4	114.5	0.0	0.0	0.0	723.1	439.4	81.8	0.0	424.5	118.6	176.9	0.0	0.0	543.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	166.4	0.0	0.0	432.6	0.0	0.0	0.0	0.0	884.5	0.0	0.0	0.0	0.0	0.0	1879.7	121.0	0.0	0.0	0.0	127.9	0.0	0.0	0.0	0.0	305.8	69.4	209.9	0.0	0.0
ATP5ME	ATP5I	ENSG00000169020	"ATP synthase membrane subunit e"	P56385	4	672436-674330	"Metabolic proteins, Predicted intracellular proteins"	"ATP synthesis, Hydrogen ion transport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 2048.3"	"Cell type enhanced"	"Detected in many"		"Collecting duct cells: 886.5;Distal tubular cells: 1729.5;Proximal tubular cells: 2485.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035010	Enhanced		Supported	Mitochondria		NA	NA		280000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 7: Non-specific - Mitochondria"	Mitochondria		"HPA035010: AB_10669853"	"unprognostic (1.42e-1)"	"unprognostic (4.93e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.66e-1)"	"unprognostic (3.44e-1)"	"unprognostic (1.23e-1)"	"unprognostic (6.95e-2)"	"unprognostic (7.92e-2)"	"unprognostic (3.32e-1)"	"unprognostic (1.35e-3)"	"unprognostic (1.21e-2)"	"unprognostic (2.41e-2)"	"unprognostic (2.46e-3)"	"unprognostic (6.89e-2)"	"unprognostic (2.18e-1)"	"unprognostic (2.48e-1)"	"unprognostic (6.45e-3)"	360.1	412.7	940.1	212.2	960.8	312.4	277.4	981.5	1172.2	263.3	926.5	555.7	460.3	237.4	242.7	511.9	218.8	94.5	1507.7	932.5	968.9	572.0	591.7	235.6	174.6	980.1	955.6	257.5	330.9	774.8	312.8	144.8	972.5	262.0	331.4	336.4	304.8	220.4	2048.3	297.8	436.7	172.8	952.6	281.3	414.9	130.6	960.4	315.7	270.1	1688.5	223.8	293.5	323.8	998.1	542.0	560.8	781.7	599.5	622.4	544.4	390.7	561.8	445.4	407.4	359.4	525.4	548.4	299.0	472.8	612.4	683.8	361.8	668.9	924.1	241.4	249.9	1082.7	854.6	1107.9	1435.2	659.0	1118.6	368.0	721.6	533.5	472.2	491.0	665.5	503.3	608.1	756.0	314.4	464.7	904.5	972.6	1337.3	861.9	1071.7	1438.9	584.4	555.0	620.7	863.9	1053.2	667.7	530.1	401.6	525.0	620.2	502.7	590.4	695.7	580.2	348.0	340.7	308.2	730.9	739.7	1273.2	947.0	528.0	712.7	391.3	1049.3	1044.5	1188.8	742.1	920.0	776.3	1470.4	909.2	839.0	1067.0	1131.6	837.1	811.9	962.2	943.5	822.7	1179.7	1086.3	1456.6	940.1	960.8	981.5	1172.2	932.5	968.9	980.1	955.6	972.5	952.6	960.4	998.1	311.8	153.8	199.7	0.0	88.6	0.0	0.0	0.0	0.0	0.0	461.7	421.8	0.0	0.0	121.9	886.5	0.0	404.9	188.8	0.0	1729.5	467.4	0.0	468.6	315.6	125.1	0.0	0.0	0.0	692.9	335.8	139.4	0.0	484.2	122.4	311.8	0.0	0.0	676.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	201.6	0.0	0.0	278.1	0.0	0.0	0.0	0.0	509.6	0.0	0.0	50.1	0.0	0.0	2485.3	183.6	0.0	0.0	0.0	156.7	0.0	0.0	0.0	0.0	274.9	97.8	146.6	0.0	0.0
ATP5MF	"ATP5J2, ATP5JL"	ENSG00000241468	"ATP synthase membrane subunit f"	P56134	7	99448475-99466186	"Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"ATP synthesis, Hydrogen ion transport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 777.4;Distal tubular cells: 1430.2;Exocrine glandular cells: 578.8;Extravillous trophoblasts: 636.3;Hofbauer cells: 787.4;Pancreatic endocrine cells: 589.5;Proximal tubular cells: 1616.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA067267, HPA070412"	Approved		Supported	"Nuclear membrane,Mitochondria"		NA	NA		60000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 7: Non-specific - Mitochondria"	Mitochondria	"Nuclear membrane"	"HPA067267: AB_2685815, HPA070412: AB_2686266"	"unprognostic (2.43e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.23e-2)"	"unprognostic (1.90e-1)"	"unprognostic (4.55e-3)"	"prognostic unfavorable (2.58e-4)"	"unprognostic (1.28e-2)"	"unprognostic (3.77e-2)"	"unprognostic (6.19e-2)"	"unprognostic (2.31e-3)"	"unprognostic (2.58e-1)"	"unprognostic (3.65e-2)"	"unprognostic (6.88e-3)"	"unprognostic (9.24e-2)"	"unprognostic (4.90e-2)"	"unprognostic (2.52e-1)"	"unprognostic (5.78e-2)"	328.8	423.5	636.9	268.7	655.2	404.4	310.8	658.3	868.4	247.8	671.0	470.9	442.7	188.3	299.1	526.6	191.7	143.8	1184.8	658.1	663.7	559.3	561.2	241.8	293.1	657.5	648.0	179.1	271.6	509.6	332.1	235.7	647.0	315.5	367.9	320.7	317.8	205.9	1337.1	287.0	384.6	192.0	637.6	281.8	354.7	310.5	652.7	439.3	241.4	1439.0	301.2	303.1	303.5	641.3	1251.5	1130.6	905.3	1400.5	752.1	739.2	561.1	799.3	705.9	947.2	994.6	1226.2	1091.7	1161.7	822.7	548.5	1513.9	735.7	1064.0	981.3	1021.4	831.0	1333.6	800.1	1584.6	1555.4	530.7	1324.4	824.4	835.6	944.9	766.6	858.9	760.5	919.8	1009.4	1681.6	1213.0	1057.4	3128.1	1984.5	2396.1	1228.2	2594.9	1410.9	874.9	741.6	1985.9	1936.7	1376.1	845.3	925.9	1073.7	2519.4	773.1	1365.1	644.9	1687.5	703.0	706.0	1142.1	1197.3	1181.5	685.7	1795.6	2432.4	829.7	1325.8	1131.8	1020.3	904.1	1069.1	440.2	912.7	425.6	597.7	508.3	494.8	1122.9	512.2	445.1	468.3	428.0	555.2	731.2	890.5	754.9	1505.3	636.9	655.2	658.3	868.4	658.1	663.7	657.5	648.0	647.0	637.6	652.7	641.3	147.7	22.4	44.9	0.0	57.9	0.0	0.0	0.0	0.0	0.0	252.4	289.6	0.0	0.0	36.5	386.2	0.0	777.4	125.6	0.0	1430.2	460.9	0.0	302.6	225.3	82.0	0.0	0.0	0.0	578.8	636.3	110.5	0.0	278.3	64.3	188.1	0.0	0.0	787.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	190.2	0.0	0.0	339.1	0.0	0.0	0.0	0.0	589.5	0.0	0.0	18.6	0.0	0.0	1616.3	51.0	0.0	0.0	0.0	114.8	0.0	0.0	0.0	0.0	436.3	64.0	206.4	0.0	0.0
ATP5MG	"ATP5JG, ATP5L"	ENSG00000167283	"ATP synthase membrane subunit g"	O75964	11	118401606-118431496	"Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"ATP synthesis, Hydrogen ion transport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 1407.2;Distal tubular cells: 2907.4;Hofbauer cells: 1367.3;Proximal tubular cells: 2520.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA044629	Approved		Supported	Mitochondria		NA	NA		44000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 7: Non-specific - Mitochondria"	Mitochondria		"HPA044629: AB_2679028"	"unprognostic (1.70e-1)"	"unprognostic (2.40e-2)"	"unprognostic (2.21e-1)"	"unprognostic (5.45e-2)"	"unprognostic (1.61e-1)"	"unprognostic (3.27e-2)"	"unprognostic (3.90e-2)"	"unprognostic (8.19e-2)"	"unprognostic (5.13e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.90e-1)"	"unprognostic (7.41e-2)"	"prognostic favorable (4.09e-5)"	"unprognostic (6.26e-2)"	"unprognostic (2.56e-1)"	"unprognostic (1.50e-2)"	"unprognostic (3.05e-2)"	119.8	137.2	154.2	103.3	158.5	165.6	132.5	158.5	184.3	81.1	168.3	153.6	146.4	79.3	143.3	116.9	96.5	68.1	329.8	157.2	160.8	205.1	154.5	77.9	150.0	155.5	153.1	112.0	110.9	140.7	49.5	83.7	154.0	83.5	164.3	100.8	133.9	92.2	340.7	55.3	118.2	95.2	153.6	86.0	112.3	46.9	155.5	204.1	87.5	373.6	183.1	105.3	41.5	154.7	163.1	87.9	209.3	183.1	167.6	198.0	200.1	149.0	175.9	138.4	146.6	259.9	259.9	314.3	352.7	167.5	206.2	190.4	204.4	214.8	155.3	247.6	138.0	472.8	112.5	197.4	175.3	279.3	210.2	207.1	203.4	169.0	162.9	164.1	189.8	216.6	227.4	253.1	199.5	305.8	365.2	497.3	130.1	427.9	224.0	247.0	174.9	422.9	371.1	260.3	184.3	161.9	232.3	361.1	161.9	221.6	303.0	307.7	172.8	123.0	144.7	109.2	190.9	112.8	184.8	402.1	93.8	353.0	154.7	325.4	437.2	299.0	241.8	360.8	339.7	462.7	398.8	321.5	481.2	378.5	472.9	379.7	214.8	357.2	333.3	534.3	464.5	1112.1	154.2	158.5	158.5	184.3	157.2	160.8	155.5	153.1	154.0	153.6	155.5	154.7	324.3	362.2	364.1	0.0	211.2	0.0	0.0	0.0	0.0	0.0	893.9	1061.2	0.0	0.0	166.5	610.6	0.0	1407.2	378.3	0.0	2907.4	748.6	0.0	449.8	327.9	188.9	0.0	0.0	0.0	986.0	935.6	204.7	0.0	404.6	258.6	368.2	0.0	0.0	1367.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	427.7	0.0	0.0	678.1	0.0	0.0	0.0	0.0	922.2	0.0	0.0	94.9	0.0	0.0	2520.3	188.0	0.0	0.0	0.0	217.5	0.0	0.0	0.0	0.0	1001.4	224.2	370.0	0.0	0.0
ATP5MPL	"6.8PL, C14orf2, MLQ, MP68"	ENSG00000156411	"ATP synthase membrane subunit 6.8PL"	P56378	14	103912288-103928269	"Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 1602.3;Extravillous trophoblasts: 671.4;Hofbauer cells: 920.9;Proximal tubular cells: 1883.7;Syncytiotrophoblasts: 710.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA058978, HPA060520"	Approved		Supported	"Nucleoli fibrillar center,Mitochondria"		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 7: Non-specific - Mitochondria"	Mitochondria	"Nucleoli fibrillar center"	"HPA058978: AB_2683867, HPA060520: AB_2684302"	"unprognostic (1.37e-1)"	"unprognostic (1.42e-3)"	"unprognostic (1.55e-1)"	"unprognostic (2.30e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.20e-2)"	"unprognostic (1.75e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.62e-1)"	"prognostic favorable (6.80e-4)"	"unprognostic (1.34e-2)"	"unprognostic (5.48e-2)"	"unprognostic (1.34e-3)"	"unprognostic (9.26e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.57e-1)"	"unprognostic (4.14e-2)"	107.8	166.9	304.6	75.7	318.3	177.4	127.5	305.8	446.6	94.9	306.0	165.2	165.1	80.5	139.6	159.4	87.0	48.8	548.2	321.9	313.4	205.2	181.9	79.9	94.4	301.2	297.7	98.3	113.8	257.3	159.9	77.1	302.4	108.5	167.5	169.9	100.9	87.8	489.6	106.1	128.9	78.9	303.1	108.7	135.6	83.4	305.5	135.0	111.5	471.6	122.5	103.0	101.1	304.1	244.6	278.5	233.6	222.8	275.0	284.2	228.5	185.2	211.7	228.6	199.5	240.6	167.4	254.4	187.9	191.2	183.4	201.1	306.4	225.3	310.0	207.9	306.8	280.4	227.5	380.4	180.4	346.2	188.4	298.6	301.5	155.7	164.2	260.8	264.4	330.6	176.7	264.7	253.7	730.8	333.1	493.9	182.1	560.5	523.7	211.5	202.7	231.2	358.4	345.0	201.2	238.4	155.9	289.0	371.4	256.2	355.3	401.7	142.7	87.9	137.9	242.0	153.2	199.3	372.5	360.2	207.8	195.7	152.3	405.1	512.8	336.0	204.9	409.1	232.9	309.5	261.1	234.1	367.0	261.9	295.5	260.0	517.5	206.2	401.4	355.4	282.2	656.9	304.6	318.3	305.8	446.6	321.9	313.4	301.2	297.7	302.4	303.1	305.5	304.1	88.0	221.2	225.1	0.0	47.9	0.0	0.0	0.0	0.0	0.0	369.7	334.4	0.0	0.0	92.2	413.8	0.0	609.1	63.1	0.0	1602.3	504.6	0.0	341.3	245.9	104.1	0.0	0.0	0.0	572.6	671.4	113.8	0.0	297.7	93.4	207.9	0.0	0.0	920.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	210.3	0.0	0.0	335.5	0.0	0.0	0.0	0.0	570.5	0.0	0.0	0.0	0.0	0.0	1883.7	146.5	0.0	0.0	0.0	104.8	0.0	0.0	0.0	0.0	710.1	70.2	228.6	0.0	0.0
ATP5PB	ATP5F1	ENSG00000116459	"ATP synthase peripheral stalk-membrane subunit b"	P24539	1	111448864-111462773	"Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Hydrogen ion transport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 135.8;tongue: 131.0"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 346.5;Distal tubular cells: 461.8;Extravillous trophoblasts: 405.2;Hofbauer cells: 373.0;Proximal tubular cells: 434.6;Syncytiotrophoblasts: 347.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046067, HPA057347"	Enhanced		Supported	Mitochondria	"Intracellular and membrane"	NA	NA		170000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 7: Non-specific - Mitochondria"	Mitochondria		"HPA046067: AB_10960850, HPA057347: AB_2683416"	"unprognostic (4.18e-1)"	"unprognostic (6.83e-2)"	"unprognostic (1.10e-3)"	"unprognostic (1.73e-2)"	"unprognostic (3.56e-2)"	"unprognostic (8.18e-2)"	"unprognostic (8.52e-3)"	"unprognostic (8.82e-2)"	"unprognostic (3.67e-2)"	"unprognostic (7.18e-3)"	"unprognostic (3.29e-1)"	"unprognostic (2.92e-1)"	"prognostic favorable (3.26e-9)"	"prognostic favorable (8.07e-4)"	"unprognostic (1.60e-1)"	"unprognostic (2.62e-1)"	"unprognostic (1.93e-1)"	19.3	15.7	10.3	11.5	12.5	15.3	18.8	14.5	27.4	17.4	3.9	51.6	28.8	16.6	16.0	26.8	23.9	16.3	109.0	12.1	10.2	40.3	40.2	13.7	24.0	13.4	12.0	19.2	18.5	33.8	7.1	21.6	14.9	22.3	33.6	28.5	29.8	18.7	135.8	15.7	19.0	17.9	9.6	15.2	22.6	15.5	12.8	15.7	31.1	131.0	22.4	21.9	7.4	14.1	55.6	17.6	44.1	36.9	35.6	34.2	34.1	57.0	68.9	67.3	54.7	31.8	29.1	84.9	52.3	45.5	14.3	56.1	69.4	79.5	65.1	61.9	33.2	76.1	21.3	21.5	26.0	98.3	70.8	30.3	40.9	69.3	66.9	17.7	60.0	11.9	78.7	33.6	46.3	35.4	153.3	30.0	34.9	19.2	90.5	41.2	143.6	34.0	54.7	26.0	37.2	13.4	49.4	72.7	55.6	12.6	54.8	46.0	50.6	32.0	49.1	59.4	61.2	41.8	44.5	172.1	70.8	77.6	60.8	3.5	15.4	7.1	14.8	10.0	12.2	12.9	15.1	13.3	16.1	15.2	16.9	10.4	4.8	9.8	9.0	9.2	15.1	44.2	10.3	12.5	14.5	27.4	12.1	10.2	13.4	12.0	14.9	9.6	12.8	14.1	73.2	67.3	83.8	0.0	31.5	0.0	0.0	0.0	0.0	0.0	112.9	155.3	0.0	0.0	57.6	125.0	0.0	346.5	56.4	0.0	461.8	237.3	0.0	132.5	111.0	58.8	0.0	0.0	0.0	196.7	405.2	57.0	0.0	125.4	89.6	82.1	0.0	0.0	373.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	81.8	0.0	0.0	98.8	0.0	0.0	0.0	0.0	162.6	0.0	0.0	9.8	0.0	0.0	434.6	74.3	0.0	0.0	0.0	58.0	0.0	0.0	0.0	0.0	347.7	41.8	208.0	0.0	0.0
ATP5PD	"ATP5H, ATP5JD, ATPQ"	ENSG00000167863	"ATP synthase peripheral stalk subunit d"	O75947	17	75038863-75046985	"Metabolic proteins, Predicted intracellular proteins"	"Hydrogen ion transport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 1142.6;Hofbauer cells: 465.0;Proximal tubular cells: 1059.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042777, HPA048459"	Enhanced		Supported	Mitochondria		NA	NA		60000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 21: OE19 - Mitochondria"	"Cluster 7: Non-specific - Mitochondria"	Mitochondria		"HPA042777: AB_2678160, HPA048459: AB_2680402"	"unprognostic (1.37e-1)"	"unprognostic (4.41e-2)"	"unprognostic (1.70e-3)"	"unprognostic (1.32e-1)"	"unprognostic (1.54e-1)"	"unprognostic (4.81e-2)"	"unprognostic (7.21e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.29e-1)"	"unprognostic (2.03e-2)"	"unprognostic (2.72e-1)"	"unprognostic (8.72e-2)"	"unprognostic (2.56e-2)"	"unprognostic (1.42e-1)"	"unprognostic (3.26e-1)"	"unprognostic (1.73e-1)"	"unprognostic (4.29e-2)"	253.8	271.0	253.5	156.0	260.5	187.2	228.8	270.5	385.7	190.7	282.9	337.1	295.1	170.7	279.9	355.9	173.5	140.1	985.5	261.9	271.1	465.2	454.2	174.0	166.0	264.8	256.9	147.5	222.2	427.1	203.9	174.1	260.8	177.9	323.6	256.0	240.8	200.5	1102.8	264.7	257.4	211.3	260.2	155.0	307.4	93.8	262.3	175.2	263.7	1025.5	221.2	230.3	221.5	261.7	522.8	445.4	335.6	439.8	532.6	647.4	449.1	437.2	571.3	478.5	452.2	351.8	397.1	349.8	282.5	550.2	450.2	462.2	409.0	571.6	637.5	171.6	346.0	359.1	340.2	703.1	524.2	463.5	225.8	555.3	444.8	390.7	552.7	380.9	646.8	268.5	380.1	462.6	595.1	503.3	461.8	515.6	257.1	1185.3	626.9	322.3	970.4	652.3	1007.3	499.7	335.8	368.5	515.5	811.0	730.7	496.9	805.1	463.2	337.4	591.1	413.2	520.0	520.4	369.0	315.5	360.8	530.2	455.4	390.3	410.8	440.7	481.0	274.8	540.9	320.8	364.5	467.5	341.7	509.7	292.8	416.1	388.9	253.0	301.6	458.0	453.6	492.8	495.9	253.5	260.5	270.5	385.7	261.9	271.1	264.8	256.9	260.8	260.2	262.3	261.7	173.8	173.1	156.4	0.0	35.0	0.0	0.0	0.0	0.0	0.0	159.6	234.2	0.0	0.0	102.8	259.3	0.0	384.3	74.0	0.0	1142.6	313.6	0.0	188.2	153.6	70.4	0.0	0.0	0.0	379.5	328.4	82.7	0.0	207.6	88.3	84.6	0.0	0.0	465.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	125.1	0.0	0.0	208.8	0.0	0.0	0.0	0.0	284.3	0.0	0.0	13.8	0.0	0.0	1059.2	101.3	0.0	0.0	0.0	88.3	0.0	0.0	0.0	0.0	336.3	54.4	155.9	0.0	0.0
ATP5PF	"ATP5, ATP5A, ATP5J, ATPM, CF6"	ENSG00000154723	"ATP synthase peripheral stalk subunit F6"	P18859	21	25716503-25735673	"Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Hydrogen ion transport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"tongue: 1595.8"	"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 2375.2;Proximal tubular cells: 1906.2;Syncytiotrophoblasts: 708.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031069	Supported		Supported	Mitochondria		NA	NA		820000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 32: U-937 - Innate immune response"	"Cluster 7: Non-specific - Mitochondria"	Mitochondria		"HPA031069: AB_10603676"	"unprognostic (3.52e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.46e-1)"	"unprognostic (4.57e-2)"	"unprognostic (1.14e-1)"	"unprognostic (7.87e-2)"	"unprognostic (1.43e-1)"	"unprognostic (6.32e-2)"	"unprognostic (1.48e-1)"	"unprognostic (4.87e-2)"	"unprognostic (1.77e-1)"	"unprognostic (8.83e-2)"	"prognostic favorable (2.37e-5)"	"unprognostic (1.93e-1)"	"unprognostic (9.20e-2)"	"unprognostic (1.56e-1)"	"unprognostic (2.15e-2)"	274.6	276.3	291.2	136.4	295.4	175.1	205.5	302.5	424.4	156.3	316.1	333.5	276.4	128.8	368.1	258.1	129.9	129.7	1052.1	295.2	306.2	489.5	756.3	110.8	166.4	299.3	297.8	127.2	188.2	458.8	140.4	171.5	295.7	160.1	314.4	249.5	214.6	228.5	1161.7	113.6	250.6	189.8	298.7	111.2	226.9	131.5	299.4	217.5	166.0	1595.8	210.9	194.9	138.4	299.6	355.9	260.0	314.5	351.4	344.8	313.5	389.4	305.8	373.0	305.8	300.8	607.6	274.4	439.3	194.2	312.9	467.8	191.5	441.3	379.2	339.2	373.1	441.1	910.6	520.6	618.4	386.8	673.2	284.5	303.1	471.2	284.0	258.6	399.9	363.0	412.2	582.2	522.9	458.2	416.3	468.6	683.2	562.3	824.0	460.7	358.0	606.5	840.0	669.8	504.6	360.2	394.1	516.5	521.7	493.0	449.4	376.5	590.5	260.6	219.6	266.6	209.3	265.9	501.7	954.7	568.2	341.5	707.8	283.1	444.8	447.0	443.7	293.3	487.1	316.1	475.1	385.5	368.6	531.9	399.7	377.4	370.7	292.3	389.9	505.7	504.0	520.3	661.3	291.2	295.4	302.5	424.4	295.2	306.2	299.3	297.8	295.7	298.7	299.4	299.6	532.1	169.9	179.3	0.0	56.0	0.0	0.0	0.0	0.0	0.0	346.3	468.4	0.0	0.0	105.9	419.3	0.0	652.7	116.4	0.0	2375.2	447.0	0.0	299.2	257.6	150.6	0.0	0.0	0.0	472.5	522.8	135.6	0.0	308.5	109.7	341.2	0.0	0.0	522.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	154.2	0.0	0.0	226.4	0.0	0.0	0.0	0.0	427.1	0.0	0.0	21.4	0.0	0.0	1906.2	142.1	0.0	0.0	0.0	161.4	0.0	0.0	0.0	0.0	708.2	79.2	387.8	0.0	0.0
ATP6V0A1	"a1, ATP6N1, ATP6N1A, Stv1, Vph1, VPP1"	ENSG00000033627	"ATPase H+ transporting V0 subunit a1"	Q93050	17	42458844-42522582	"Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Hydrogen ion transport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 130.7"	"Cell type enhanced"	"Detected in all"		"Cone photoreceptor cells: 294.0;Rod photoreceptor cells: 403.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA022144	Enhanced		Approved	"Nuclear speckles,Golgi apparatus,Vesicles,Cytosol"		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 58: Brain - Synaptic function"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 46: Photoreceptor cells - Phototransduction"	"Golgi apparatus, Vesicles"	"Nuclear speckles, Cytosol"	"HPA022144: AB_1845189"	"unprognostic (3.93e-2)"	"unprognostic (2.02e-1)"	"unprognostic (4.35e-2)"	"unprognostic (2.22e-2)"	"unprognostic (1.60e-2)"	"unprognostic (8.69e-2)"	"unprognostic (1.84e-2)"	"unprognostic (8.82e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.85e-1)"	"prognostic favorable (2.05e-4)"	"unprognostic (3.25e-1)"	"prognostic favorable (1.28e-4)"	"unprognostic (3.07e-1)"	"unprognostic (3.68e-2)"	"unprognostic (2.62e-2)"	"prognostic unfavorable (6.90e-4)"	17.7	28.2	30.6	18.0	35.2	21.5	16.3	16.8	42.7	13.4	0.0	22.1	34.6	20.9	19.6	17.4	17.1	22.7	18.9	43.6	44.1	37.4	21.0	24.1	13.1	25.6	26.2	20.0	17.4	86.0	39.0	21.2	34.6	17.4	20.5	130.7	13.5	18.6	59.3	28.1	24.3	21.5	12.1	21.8	16.3	18.7	30.9	15.2	30.3	25.3	14.9	11.9	12.8	27.2	18.4	37.0	22.1	40.1	36.5	31.7	12.9	12.7	23.3	26.4	34.2	23.9	39.9	3.4	22.6	26.2	36.2	38.7	34.5	21.5	30.4	28.3	36.2	29.2	27.3	19.0	22.7	12.8	50.9	23.5	30.3	42.4	18.0	32.6	18.9	13.2	108.0	111.3	39.7	15.8	5.1	11.3	14.3	23.9	0.4	0.2	23.0	51.2	30.2	14.4	60.9	32.0	19.7	17.7	37.1	28.8	43.0	19.0	11.4	22.3	0.9	33.0	15.3	45.0	66.1	6.8	29.7	0.2	26.5	21.6	14.5	11.2	1.0	4.4	1.6	4.7	0.7	0.2	12.2	7.3	1.2	0.9	18.7	0.1	3.3	6.2	3.7	6.6	30.6	35.2	16.8	42.7	43.6	44.1	25.6	26.2	34.6	12.1	30.9	27.2	20.0	19.2	48.0	47.0	23.0	19.8	56.7	15.7	32.5	164.8	15.7	16.5	21.1	28.6	18.3	14.7	294.0	34.3	16.7	46.2	11.7	16.3	4.0	32.8	27.4	22.2	84.9	45.8	125.0	18.5	15.7	31.0	23.4	74.0	24.1	74.5	16.4	37.8	53.8	95.9	112.3	27.3	12.2	37.8	29.2	3.9	17.4	42.8	40.9	38.4	17.7	59.3	3.1	61.3	80.5	24.2	37.6	23.7	13.8	32.7	56.9	32.5	11.4	403.4	6.6	39.4	32.3	38.8	18.2	21.7	20.2	99.9	6.9	35.0	24.5	14.9
ATP6V0A2	"a2, ATP6a2, ATP6N1D, J6B7, Stv1, TJ6, TJ6M, TJ6s, Vph1"	ENSG00000185344	"ATPase H+ transporting V0 subunit a2"	Q9Y487	12	123712353-123761755	"Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Hydrogen ion transport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"granulocytes: 75.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"eosinophil: 13.7"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HMC-1: 51.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044279	Approved		Supported	"Vesicles,Plasma membrane,Focal adhesion sites"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 60: Granulocytes - Receptor signaling"	"Plasma membrane"	"Vesicles, Focal adhesion sites"	"HPA044279: AB_10961274"	"unprognostic (2.60e-1)"	"unprognostic (8.79e-3)"	"unprognostic (3.60e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.70e-1)"	"unprognostic (2.29e-2)"	"unprognostic (2.06e-4)"	"unprognostic (1.40e-1)"	"unprognostic (3.77e-2)"	"unprognostic (1.75e-1)"	"unprognostic (8.85e-3)"	"unprognostic (1.63e-1)"	"unprognostic (1.26e-1)"	"unprognostic (7.48e-2)"	"unprognostic (1.12e-1)"	"unprognostic (3.47e-1)"	"unprognostic (1.58e-1)"	6.6	4.4	5.6	7.0	6.2	10.4	5.7	7.4	6.5	4.7	6.9	5.5	8.7	6.0	3.9	4.3	4.8	3.8	4.7	6.0	6.0	3.8	4.2	6.3	8.3	6.6	5.8	4.1	5.7	3.7	4.9	3.7	6.5	4.7	5.8	6.7	7.6	4.0	6.5	9.4	7.0	5.1	5.6	6.6	8.8	4.9	6.2	7.5	4.8	3.5	8.2	5.3	4.5	7.9	4.8	10.3	12.0	17.8	9.2	7.0	6.7	6.2	6.2	5.4	5.8	6.9	2.7	18.0	4.2	7.6	5.5	9.0	16.1	6.2	4.5	11.4	10.2	27.9	9.2	5.4	10.2	16.8	51.0	6.7	4.4	5.9	7.4	9.0	5.0	15.0	14.5	3.4	8.1	8.4	15.4	24.8	11.5	6.6	6.5	15.7	9.9	6.4	8.3	10.4	7.2	13.6	9.3	6.9	9.4	6.6	5.9	14.4	8.3	8.0	3.1	10.8	9.1	10.8	12.8	14.9	9.4	12.1	6.5	6.3	0.7	13.7	1.7	0.9	1.0	0.9	1.7	1.5	0.8	3.7	1.6	1.8	2.0	1.7	1.5	2.8	1.0	0.8	5.6	6.2	7.4	6.5	6.0	6.0	6.6	5.8	6.5	5.6	6.2	7.9	13.0	6.4	11.0	3.9	20.4	10.1	10.8	4.6	11.4	20.5	7.9	5.3	8.8	12.8	8.3	9.2	12.5	5.2	27.9	17.9	0.0	8.1	10.2	11.0	11.9	10.6	13.2	50.3	21.2	10.9	5.7	11.3	18.3	12.3	75.3	8.7	18.2	11.4	8.4	11.8	19.3	9.8	2.0	9.4	17.2	4.5	8.7	11.3	1.8	7.5	13.2	9.0	25.7	10.6	17.1	9.2	9.0	9.4	19.7	15.7	11.1	4.0	13.5	28.8	6.6	12.4	10.9	23.6	12.6	9.6	14.2	6.8	21.8	5.7	11.4	11.4
ATP6V1A	"ATP6A1, ATP6V1A1, VA68, Vma1, VPP2"	ENSG00000114573	"ATPase H+ transporting V1 subunit A"	P38606	3	113747033-113812056	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Transporters"	"Hydrogen ion transport, Ion transport, Transport"	Translocase	"Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 463.7;Late spermatids: 870.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 79.2"	"Group enriched"	"Detected in all"	6	"dendritic cells: 38.8;granulocytes: 79.2;monocytes: 37.0"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB006910, HPA035084"	Approved		Supported	Nucleoplasm,Vesicles,Cytosol		NA	NA		700000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 31: Spermatids - Spermatogenesis"	"Vesicles, Cytosol"	Nucleoplasm	"CAB006910: , HPA035084: AB_2674454"	"unprognostic (1.32e-1)"	"unprognostic (8.68e-2)"	"unprognostic (5.87e-2)"	"unprognostic (4.70e-2)"	"unprognostic (1.36e-1)"	"unprognostic (2.00e-1)"	"unprognostic (3.43e-2)"	"unprognostic (2.90e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.25e-1)"	"unprognostic (1.36e-2)"	"unprognostic (5.19e-3)"	"prognostic favorable (3.82e-12)"	"unprognostic (8.82e-2)"	"unprognostic (2.46e-3)"	"unprognostic (2.43e-1)"	"unprognostic (1.52e-2)"	18.1	32.2	40.1	21.6	46.4	16.6	24.5	14.7	53.0	25.3	62.4	22.1	18.5	14.2	15.1	22.7	19.0	20.9	9.0	47.5	58.5	92.7	36.4	24.5	25.1	39.6	23.0	11.3	20.9	60.1	17.1	24.5	39.0	20.9	22.5	58.7	37.5	14.9	7.9	25.0	15.9	15.8	16.9	26.5	22.1	18.1	28.4	22.9	40.8	11.0	28.0	19.6	14.2	21.9	61.7	27.4	33.9	29.7	70.0	30.9	36.0	32.7	49.4	33.7	46.1	52.4	48.3	50.4	75.5	48.0	37.3	39.1	77.5	43.2	43.8	23.1	21.4	44.8	39.3	40.6	57.6	33.2	50.0	42.0	29.1	43.7	30.2	52.0	55.7	25.1	52.0	37.0	50.5	40.5	24.4	14.9	42.8	42.9	34.3	20.8	24.6	57.4	92.5	58.0	65.4	24.1	57.3	38.6	44.9	46.4	58.5	26.6	51.4	31.1	23.1	21.7	19.8	38.4	44.5	46.2	61.1	41.2	35.3	26.8	37.0	12.8	6.3	27.7	5.9	8.2	5.6	6.0	38.8	6.8	5.4	6.2	79.2	9.2	23.9	10.8	8.1	16.7	40.1	46.4	14.7	53.0	47.5	58.5	39.6	23.0	39.0	16.9	28.4	21.9	18.8	28.9	35.0	43.4	24.2	30.3	15.9	30.3	23.9	94.1	27.9	17.1	10.4	31.5	32.9	99.3	41.7	22.0	20.8	38.3	82.2	29.5	463.7	41.7	24.5	26.8	55.8	49.6	119.4	27.5	22.6	17.9	20.9	100.6	10.8	19.4	36.0	74.3	74.3	101.0	107.7	25.4	197.4	104.7	73.3	870.3	18.0	70.9	46.2	34.7	82.8	45.6	11.3	54.3	53.2	27.1	30.5	23.0	23.6	25.6	24.1	80.8	38.3	44.4	6.6	15.3	21.6	28.7	15.7	40.8	47.9	43.9	19.0	25.8	27.2	26.8
ATP6V1B2	"ATP6B2, HO57, VATB, Vma2, VPP3"	ENSG00000147416	"ATPase H+ transporting V1 subunit B2"	P21281	8	20197381-20226819	"Disease related genes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, Transporters"	"Hydrogen ion transport, Ion transport, Transport"	Hydrolase	"Deafness, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Proximal tubular cells: 256.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 1130.7"	"Group enriched"	"Detected in all"	10	"dendritic cells: 336.8;granulocytes: 1130.7;monocytes: 682.0"	"Cell line enhanced"	"Detected in all"		"SK-MEL-30: 317.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008147	Enhanced		Supported	Vesicles		NA	NA		310000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 58: Brain - Synaptic function"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Vesicles		"HPA008147: AB_1845195"	"unprognostic (1.90e-1)"	"unprognostic (7.24e-3)"	"unprognostic (3.62e-2)"	"unprognostic (2.57e-1)"	"unprognostic (2.84e-2)"	"unprognostic (5.59e-3)"	"unprognostic (1.76e-2)"	"unprognostic (3.78e-2)"	"unprognostic (4.68e-2)"	"unprognostic (4.23e-3)"	"unprognostic (1.29e-2)"	"unprognostic (1.34e-1)"	"prognostic favorable (8.41e-4)"	"unprognostic (2.41e-1)"	"unprognostic (2.09e-2)"	"unprognostic (2.47e-2)"	"unprognostic (5.25e-2)"	46.4	76.4	112.6	71.9	111.2	45.7	35.3	72.8	126.0	30.1	72.5	38.0	43.9	29.4	31.0	51.3	32.8	39.0	38.2	124.0	135.5	145.8	49.2	72.7	54.1	103.4	120.0	27.5	34.5	71.4	74.5	50.5	138.2	28.1	43.0	205.7	40.4	27.0	66.7	62.5	57.8	40.1	74.8	66.1	32.8	67.8	100.3	50.2	33.4	64.7	48.9	44.5	36.1	99.5	44.2	71.5	87.4	29.2	117.7	72.3	79.1	96.6	61.5	121.5	125.2	81.7	25.4	77.7	38.4	93.1	123.7	36.8	70.1	64.6	129.0	32.9	47.2	54.2	29.9	63.6	137.6	39.0	108.0	65.0	57.9	76.0	69.3	134.1	77.2	101.2	82.0	72.8	132.5	25.0	114.6	46.2	65.6	64.6	31.5	46.6	113.4	40.8	112.9	68.2	68.0	97.9	46.9	62.7	317.9	72.4	81.6	70.7	82.8	61.1	46.3	101.9	78.5	29.4	42.7	90.9	84.6	91.6	158.4	183.7	682.0	485.9	52.9	618.6	57.7	50.2	54.1	56.8	336.8	44.5	54.4	53.7	1130.7	50.8	576.1	82.7	73.0	622.6	112.6	111.2	72.8	126.0	124.0	135.5	103.4	120.0	138.2	74.8	100.3	99.5	16.6	25.6	20.7	20.5	28.1	58.0	28.4	52.1	33.0	106.1	18.5	15.6	17.6	25.8	28.8	29.5	102.2	109.2	38.9	23.3	80.3	43.2	40.8	20.2	13.6	24.1	74.4	35.8	64.3	38.5	56.4	38.8	25.0	35.9	22.2	22.3	25.7	34.7	178.5	190.1	68.0	21.4	36.7	185.2	178.7	24.4	19.6	167.6	104.9	30.0	169.1	51.5	20.6	27.6	29.0	45.2	19.7	28.2	20.7	17.4	75.0	256.7	18.0	137.8	13.1	29.3	34.2	121.6	55.3	43.3	71.6	124.6	27.1	23.1	24.7	20.1
ATP6V1H	"CGI-11, SFD, SFDalpha, SFDbeta, VMA13"	ENSG00000047249	"ATPase H+ transporting V1 subunit H"	Q9UI12	8	53715543-53843558	"Metabolic proteins, Predicted intracellular proteins, Transporters"	"Host-virus interaction, Hydrogen ion transport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009532, HPA023421"	Approved		Supported	"Plasma membrane,Actin filaments,Cytosol"		NA	NA		8300	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 44: Endometrium - Transcription"	"Actin filaments, Cytosol"	"Plasma membrane"	"CAB009532: AB_667834, HPA023421: AB_1845202"	"unprognostic (1.67e-3)"	"unprognostic (2.53e-2)"	"unprognostic (1.41e-2)"	"unprognostic (2.16e-2)"	"unprognostic (2.38e-1)"	"unprognostic (2.25e-2)"	"prognostic unfavorable (7.81e-4)"	"unprognostic (2.01e-1)"	"unprognostic (1.95e-1)"	"unprognostic (6.39e-3)"	"unprognostic (1.56e-1)"	"unprognostic (5.30e-2)"	"prognostic favorable (1.46e-7)"	"unprognostic (1.06e-1)"	"unprognostic (3.37e-2)"	"unprognostic (1.38e-2)"	"unprognostic (1.64e-1)"	24.1	44.6	42.5	15.9	46.7	25.6	26.0	27.5	58.8	23.9	30.2	31.6	12.9	25.4	32.9	34.1	22.6	20.7	31.2	57.4	38.0	60.5	19.1	24.2	21.4	30.5	30.2	24.1	17.4	47.7	42.4	23.9	32.7	30.2	20.4	37.4	28.7	27.4	37.8	35.2	19.1	24.1	29.4	20.3	31.8	18.5	31.0	26.6	52.4	27.3	22.0	28.5	26.4	37.9	42.8	35.6	29.8	31.8	50.9	32.9	23.4	40.5	44.5	54.8	56.7	33.5	54.1	27.2	38.7	40.9	69.7	67.8	52.6	58.9	56.1	39.9	35.8	28.8	34.3	40.9	69.1	19.6	31.8	46.5	82.3	37.2	66.4	52.5	37.8	28.9	39.4	14.0	81.6	36.0	30.6	32.5	27.4	37.0	17.4	28.2	10.6	18.6	88.4	67.4	23.5	34.9	28.7	54.6	79.5	34.4	64.0	16.3	43.2	24.4	19.7	54.6	25.5	25.9	30.4	32.3	57.8	27.4	27.5	25.7	14.8	36.2	13.2	16.6	14.9	13.6	14.3	15.4	20.2	12.0	14.4	16.0	14.5	22.6	23.4	15.9	20.7	11.8	42.5	46.7	27.5	58.8	57.4	38.0	30.5	30.2	32.7	29.4	31.0	37.9	18.2	38.5	27.4	84.2	39.0	29.6	40.1	55.5	42.1	72.8	27.8	21.0	28.9	38.6	50.3	58.8	112.6	76.0	35.9	39.0	105.7	49.1	8.3	94.1	27.7	25.4	35.3	27.0	154.7	31.1	43.6	23.6	26.0	145.7	15.8	22.0	28.9	21.9	64.7	62.2	105.8	17.4	75.3	43.0	103.6	8.5	43.2	52.9	30.2	42.2	35.1	48.4	37.0	58.3	57.7	44.1	30.1	48.2	20.9	32.5	31.4	64.9	39.6	76.4	19.7	16.8	24.6	28.5	52.9	37.6	31.4	100.0	38.1	36.4	21.8	41.4
ATP7A	MNK	ENSG00000165240	"ATPase copper transporting alpha"	Q04656	X	77910656-78050395	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Copper transport, Ion transport, Transport"	Translocase	"Disease variant, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Ionocytes: 61.1;Microglial cells: 44.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012887, HPA048107"	Approved		Supported	"Golgi apparatus"		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 31: Skin - Epidermis development"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 59: Non-specific - Transcription"	"Golgi apparatus"		"HPA012887: AB_1845205, HPA048107: AB_2680266"	"unprognostic (3.14e-2)"	"unprognostic (3.48e-1)"	"unprognostic (4.90e-2)"	"unprognostic (1.49e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.03e-1)"	"unprognostic (7.17e-3)"	"unprognostic (2.59e-2)"	"unprognostic (3.17e-2)"	"unprognostic (2.47e-1)"	"unprognostic (2.30e-2)"	"unprognostic (1.14e-1)"	"prognostic favorable (8.38e-4)"	"unprognostic (1.06e-1)"	"unprognostic (2.16e-1)"	"unprognostic (3.69e-1)"	"unprognostic (2.52e-1)"	3.0	4.3	1.2	3.6	1.7	5.9	6.3	2.3	2.1	3.9	1.6	3.4	3.9	3.6	5.0	4.9	3.5	3.6	2.5	1.3	2.1	4.4	2.3	4.5	4.1	2.1	2.1	3.6	2.4	7.3	2.5	4.0	3.8	5.3	3.4	3.0	5.1	3.4	1.8	11.1	3.4	3.2	1.1	4.7	5.5	1.6	1.6	4.7	4.6	2.9	4.6	3.9	2.8	2.9	3.2	8.3	5.4	5.5	5.0	5.3	0.9	4.8	6.6	2.8	5.7	1.0	3.6	4.7	6.9	4.8	3.3	3.8	7.1	3.9	5.2	7.0	4.8	2.4	7.8	0.8	6.3	4.1	4.1	5.6	1.6	5.9	1.8	6.5	7.3	4.7	19.6	17.4	5.2	2.8	4.6	1.4	1.5	11.2	1.7	3.7	9.0	15.8	4.6	8.8	1.6	20.4	11.9	2.8	6.0	3.3	2.2	1.3	9.4	3.7	3.6	5.2	1.9	5.6	10.7	5.2	6.0	2.5	5.7	7.1	1.5	4.5	1.8	1.5	0.9	1.8	1.2	1.2	1.0	1.4	1.4	2.1	8.1	1.2	1.9	1.0	0.4	1.0	1.2	1.7	2.3	2.1	1.3	2.1	2.1	2.1	3.8	1.1	1.6	2.9	14.3	0.0	8.4	15.7	12.6	7.4	5.1	5.8	13.1	6.4	17.3	10.0	5.1	1.5	8.2	9.2	4.2	2.0	15.0	4.5	1.9	5.6	0.5	5.3	9.2	9.7	4.8	22.5	11.1	13.6	2.2	9.4	20.4	8.8	9.5	6.4	14.6	3.6	14.3	1.7	12.5	4.8	61.1	11.7	6.7	1.1	7.2	12.6	19.6	44.0	5.5	4.4	11.3	37.7	35.0	6.2	4.1	9.8	10.5	4.8	4.1	5.5	10.2	4.1	32.9	10.3	8.7	1.8	5.4	20.5	16.6	2.2	13.8	6.7	5.2	6.6
ATP7B	WND	ENSG00000123191	"ATPase copper transporting beta"	P35670	13	51930436-52012125	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Copper transport, Ion transport, Transport"	Translocase	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 22.9;Early spermatids: 30.2;Excitatory neurons: 24.5;Hepatocytes: 23.6;Inhibitory neurons: 25.4;Late spermatids: 74.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BEWO: 32.8;CACO-2: 21.1;HEL: 53.0;RPTEC TERT1: 22.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA009137, HPA013187"	Supported		Supported	"Golgi apparatus"		NA	NA				"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 36: HEL - Hemostasis"	"Cluster 9: Photoreceptor cells - Phototransduction"	"Golgi apparatus"		"HPA009137: AB_2668214, HPA013187: AB_1845206"	"unprognostic (1.13e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.15e-1)"	"prognostic unfavorable (5.01e-4)"	"unprognostic (3.49e-1)"	"unprognostic (5.51e-2)"	"unprognostic (1.55e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.24e-1)"	"unprognostic (5.77e-2)"	"unprognostic (8.29e-2)"	"unprognostic (1.17e-1)"	"unprognostic (3.26e-3)"	"unprognostic (4.66e-2)"	"unprognostic (3.54e-1)"	"unprognostic (6.21e-3)"	"unprognostic (1.40e-1)"	3.6	0.9	1.3	0.6	1.2	2.2	1.7	2.0	2.1	1.8	0.8	2.9	10.6	1.5	0.1	0.7	2.0	7.0	2.1	2.5	1.4	2.2	8.6	1.4	0.3	0.8	1.2	1.9	2.0	6.4	1.2	7.1	1.1	2.0	2.7	3.7	3.0	0.9	1.1	1.0	6.0	1.7	0.5	0.4	4.4	8.4	1.7	0.7	1.2	1.8	0.2	1.6	1.2	0.7	0.8	2.8	5.2	4.5	1.0	0.8	32.8	1.5	0.5	1.6	1.2	21.1	0.1	0.1	0.6	2.7	3.6	0.3	4.0	4.4	1.0	0.4	7.5	53.0	0.5	14.7	1.4	0.6	11.8	1.9	4.7	0.2	2.0	2.1	3.7	3.7	14.4	0.2	1.5	1.0	0.2	0.9	1.7	6.6	1.8	2.0	1.4	0.0	22.5	3.4	3.3	2.2	1.9	2.8	1.8	5.5	8.0	0.5	2.0	0.3	1.7	2.8	0.6	0.6	0.7	0.2	0.1	0.2	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	1.2	2.0	2.1	2.5	1.4	0.8	1.2	1.1	0.5	1.7	0.7	5.4	6.4	0.0	10.7	0.9	0.4	0.7	1.7	0.0	3.1	2.3	1.8	2.1	4.3	5.2	1.8	22.9	14.3	1.8	6.6	0.0	1.6	30.2	2.4	1.3	2.7	2.4	4.2	24.5	1.0	5.5	2.1	9.2	4.2	0.0	13.3	3.9	23.6	2.3	0.0	25.4	3.4	4.1	0.8	0.3	74.2	2.1	0.2	1.8	15.0	0.2	0.2	0.0	12.1	4.3	2.0	3.0	0.7	0.2	1.3	11.4	2.2	4.3	6.1	6.6	1.0	1.4	2.2	1.7	0.7	0.4	4.5	0.2	0.4	5.0	1.2
ATP8A1	ATPIA	ENSG00000124406	"ATPase phospholipid transporting 8A1"	Q9Y2Q0	4	42408373-42657105	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Lipid transport, Transport"	Translocase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 84.5"	"Cell type enriched"	"Detected in many"	4	"Oligodendrocytes: 1218.1"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 13.5"	"Region enhanced"	"Detected in all"		"white matter: 84.5"	"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 27.5;Daudi: 46.3;HEL: 16.4;REH: 16.1;SH-SY5Y: 14.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052935	Enhanced		Supported	Vesicles		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Vesicles		"HPA052935: AB_2681992"	"unprognostic (8.63e-2)"	"unprognostic (3.43e-2)"	"unprognostic (1.16e-2)"	"unprognostic (7.61e-2)"	"unprognostic (6.59e-2)"	"unprognostic (6.82e-3)"	"unprognostic (7.69e-2)"	"unprognostic (2.02e-3)"	"unprognostic (3.99e-1)"	"unprognostic (2.99e-3)"	"unprognostic (4.39e-2)"	"unprognostic (9.71e-2)"	"prognostic favorable (5.54e-10)"	"unprognostic (2.43e-1)"	"unprognostic (3.25e-1)"	"unprognostic (8.21e-2)"	"unprognostic (2.25e-1)"	2.8	8.9	5.8	9.5	26.7	23.4	3.7	3.6	18.3	2.1	0.0	12.8	4.2	2.4	12.2	2.2	2.4	2.5	8.4	14.5	11.7	3.8	1.7	11.8	15.0	9.5	4.4	16.2	7.0	36.0	2.2	2.4	9.5	8.3	11.7	19.4	4.4	5.3	10.0	1.7	8.9	2.8	18.1	9.0	12.5	2.1	9.5	9.9	39.7	15.6	11.8	2.5	1.5	84.5	0.0	0.1	0.4	27.5	0.1	0.1	0.1	0.1	0.0	0.0	0.0	3.0	0.4	46.3	12.6	0.2	0.0	2.4	6.5	0.1	0.0	7.4	4.5	16.4	1.6	0.7	0.1	4.0	0.3	0.4	0.0	0.0	0.0	0.6	0.2	10.3	0.0	5.1	0.0	2.0	6.0	1.4	2.0	1.9	0.6	16.1	0.0	5.3	9.5	0.6	4.9	14.8	0.3	9.4	0.0	1.1	3.1	0.0	0.4	0.0	2.0	0.5	0.0	1.7	0.0	9.4	0.7	5.6	0.2	0.0	0.6	0.6	3.7	0.2	1.9	1.5	1.1	4.1	0.6	2.5	1.7	4.4	0.5	2.2	2.5	2.4	1.0	0.6	5.8	26.7	3.6	18.3	14.5	11.7	9.5	4.4	9.5	18.1	9.5	84.5	26.1	28.9	80.1	136.1	23.3	1.5	1.8	0.6	2.2	19.7	4.0	1.5	14.4	0.0	5.3	5.5	81.3	0.0	52.9	48.4	3.9	0.2	4.6	1.3	1.3	13.6	84.6	13.9	295.9	2.5	0.1	4.8	19.9	4.2	8.2	26.5	16.8	1.1	1.6	62.2	255.9	28.6	0.0	8.8	4.6	2.9	3.4	8.9	3.6	31.9	5.1	2.2	33.0	144.8	1218.1	0.6	10.2	1.9	37.6	9.6	45.6	2.0	0.3	38.1	0.0	6.3	2.7	1.5	3.6	5.0	1.4	0.0	51.6	8.6	25.0	3.0
ATP8A2	"ATPIB, ML-1"	ENSG00000132932	"ATPase phospholipid transporting 8A2"	Q9NTI2	13	25371974-26025851	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted membrane proteins"	"Lipid transport, Transport"	Translocase	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"brain: 21.6;pituitary gland: 15.2;retina: 17.2"	"Group enriched"	"Detected in many"	6	"Excitatory neurons: 518.7;Inhibitory neurons: 727.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HMC-1: 19.9;JURKAT: 9.8;MOLT-4: 3.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039926, HPA040033"	Supported		Supported	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 58: Brain - Synaptic function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Plasma membrane"	Nucleoplasm	"HPA039926: AB_10794205, HPA040033: AB_2676809"	"unprognostic (3.79e-2)"	"unprognostic (4.28e-2)"	"unprognostic (3.32e-2)"	"unprognostic (1.95e-4)"	"unprognostic (3.57e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.31e-2)"	"unprognostic (2.97e-3)"	"unprognostic (2.77e-1)"	"unprognostic (3.66e-1)"	"unprognostic (4.96e-4)"	"unprognostic (1.24e-1)"	"unprognostic (1.18e-2)"	"unprognostic (4.20e-5)"	"unprognostic (9.10e-2)"	"unprognostic (2.95e-1)"	"unprognostic (7.22e-2)"	0.1	2.1	5.5	0.3	6.7	0.0	0.6	8.0	21.6	0.2	0.0	0.4	0.3	0.6	1.8	0.0	0.0	0.1	0.1	8.7	19.3	0.3	0.0	0.8	0.6	12.8	4.6	0.2	0.6	0.0	15.2	0.2	12.1	0.1	0.2	17.2	0.1	0.0	0.3	0.1	0.3	0.1	0.2	0.3	0.6	2.9	6.6	1.0	0.1	0.1	0.2	0.2	0.0	6.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.7	1.0	0.0	0.0	0.2	1.5	0.0	0.0	0.0	0.1	0.8	0.0	0.0	0.0	0.0	19.9	0.1	0.0	0.0	0.0	0.6	0.5	9.8	0.0	0.0	1.7	0.1	3.9	0.0	2.0	0.0	0.7	0.0	2.7	0.9	0.2	0.0	3.2	0.0	0.2	0.2	0.1	0.2	0.0	0.4	0.2	0.0	1.0	0.3	0.4	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.5	0.7	0.0	0.0	0.0	0.0	0.2	0.1	5.5	6.7	8.0	21.6	8.7	19.3	12.8	4.6	12.1	0.2	6.6	6.8	0.7	0.0	12.2	9.4	0.8	1.0	0.2	0.3	0.0	21.5	1.5	0.3	2.5	1.5	0.4	0.0	95.9	1.5	0.4	0.0	0.0	0.3	39.0	1.2	23.6	2.6	0.0	0.8	518.7	0.0	0.4	1.7	1.1	0.9	5.1	3.7	0.0	0.0	3.2	21.9	727.7	0.0	0.0	0.0	0.7	30.3	0.9	0.3	0.0	9.4	0.0	7.2	1.0	88.4	24.7	0.0	0.0	1.2	0.1	0.2	0.0	1.3	0.3	91.6	13.1	0.3	0.8	19.8	12.5	0.0	0.4	1.1	1.8	10.1	0.1	0.1
ATP8B1	"ATPIC, BRIC, FIC1, PFIC, PFIC1"	ENSG00000081923	"ATPase phospholipid transporting 8B1"	O43520	18	57646426-57803315	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Hearing, Lipid transport, Transport"	Translocase	"Disease variant, Intrahepatic cholestasis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 76.2"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 279.7;Intestinal goblet cells: 180.5;Paneth cells: 116.7;Undifferentiated cells: 185.7;Urothelial cells: 119.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 90.2;RT4: 168.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA018673, HPA018674"	Enhanced		Supported	"Nucleoplasm,Nuclear bodies,Plasma membrane,Cytosol"		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 37: Intestine - Unknown function"	"Cluster 15: RT4 - Unknown function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Plasma membrane, Cytosol"	"Nucleoplasm, Nuclear bodies"	"HPA018673: AB_1845207, HPA018674: AB_1845208"	"unprognostic (1.83e-1)"	"unprognostic (1.32e-1)"	"prognostic favorable (2.60e-4)"	"unprognostic (8.81e-2)"	"unprognostic (1.32e-3)"	"unprognostic (2.06e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.02e-1)"	"unprognostic (9.62e-3)"	"unprognostic (1.97e-1)"	"unprognostic (3.30e-3)"	"unprognostic (4.55e-3)"	"prognostic favorable (6.35e-4)"	"unprognostic (1.88e-1)"	"unprognostic (2.22e-1)"	"unprognostic (3.25e-1)"	"unprognostic (8.60e-3)"	9.1	5.4	1.3	8.5	2.0	1.2	9.5	3.6	3.9	16.3	3.0	76.2	30.3	5.9	3.5	14.8	10.6	18.0	4.4	1.7	1.1	6.6	7.7	8.3	2.2	2.1	1.1	2.1	23.3	9.7	2.7	6.9	2.0	17.6	61.7	0.6	20.6	11.5	1.9	8.4	38.2	8.3	1.0	4.6	46.1	0.6	1.9	1.5	22.0	1.8	3.6	30.0	13.0	3.0	32.0	10.7	0.1	0.6	10.5	19.2	11.9	62.6	63.6	67.4	40.4	8.0	24.3	1.5	19.3	90.2	22.3	44.9	0.2	13.9	64.3	0.2	1.1	0.2	2.6	2.5	2.2	0.4	0.6	2.9	12.6	20.8	34.0	39.5	33.0	0.3	0.3	0.7	34.1	15.6	0.1	0.3	0.3	35.5	3.3	0.3	0.2	0.0	7.9	168.1	0.8	0.7	1.3	32.5	0.1	0.5	10.3	0.6	35.3	48.3	2.0	7.7	14.2	0.4	0.4	0.5	1.1	0.4	2.8	0.2	0.2	0.1	0.1	0.0	0.1	0.2	0.1	0.0	0.0	0.4	0.1	0.2	0.6	0.0	0.2	0.1	0.0	0.0	1.3	2.0	3.6	3.9	1.7	1.1	2.1	1.1	2.0	1.0	1.9	3.0	25.9	19.2	27.0	11.1	4.1	7.8	66.7	20.6	10.2	0.7	28.4	10.4	5.4	27.1	48.9	40.5	0.0	25.6	0.6	279.7	0.0	27.0	2.8	26.3	4.0	30.8	68.4	0.4	61.2	53.1	2.7	7.1	98.4	40.1	4.5	0.9	33.2	19.1	2.4	6.7	11.7	180.5	22.4	2.8	4.0	0.4	0.3	1.0	7.2	37.5	0.9	0.1	0.0	20.6	10.7	38.5	116.7	0.0	0.9	70.8	58.2	0.2	44.7	1.2	13.1	2.8	20.7	0.3	1.5	28.0	16.3	10.9	1.7	2.3	185.7	119.2
ATP8B2	"ATPID, KIAA1137"	ENSG00000143515	"ATPase phospholipid transporting 8B2"	P98198	1	154325525-154351304	"Enzymes, Metabolic proteins, Predicted membrane proteins"	"Lipid transport, Transport"	Translocase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 26.8;Excitatory neurons: 28.5;Inhibitory neurons: 31.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	6	"granulocytes: 2.8;T-cells: 3.7"	"Cell line enhanced"	"Detected in many"		"ASC diff: 120.9;fHDF/TERT166: 112.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046680, HPA061103"	Approved		Supported	"Nucleoli,Plasma membrane,Cytosol"		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 36: Stromal cells - Cell proliferation"	"Plasma membrane"	"Nucleoli, Cytosol"	"HPA046680: AB_2679749, HPA061103: "	"unprognostic (1.68e-1)"	"unprognostic (3.68e-1)"	"unprognostic (8.40e-2)"	"unprognostic (5.16e-2)"	"unprognostic (4.52e-1)"	"unprognostic (8.17e-2)"	"unprognostic (2.27e-2)"	"unprognostic (6.93e-3)"	"unprognostic (2.57e-1)"	"unprognostic (1.69e-1)"	"prognostic favorable (1.60e-4)"	"unprognostic (2.82e-1)"	"unprognostic (1.89e-3)"	"unprognostic (7.77e-3)"	"unprognostic (6.58e-2)"	"unprognostic (3.19e-2)"	"prognostic unfavorable (5.29e-5)"	17.2	9.5	8.2	22.7	7.8	5.4	14.0	18.8	11.0	28.7	20.7	17.8	12.5	39.2	17.7	11.0	30.8	18.2	15.2	10.8	9.2	6.3	3.4	18.0	25.4	8.9	8.1	35.3	5.9	10.5	19.3	15.3	9.6	18.9	9.1	2.1	7.2	21.2	3.5	8.5	17.6	39.7	5.6	19.5	14.5	16.3	8.8	18.4	15.0	7.4	19.6	19.7	17.9	7.7	2.1	15.6	20.0	20.5	120.9	80.4	0.3	41.8	77.4	26.1	30.5	0.3	0.6	1.9	21.4	112.4	17.7	9.2	23.0	5.5	19.3	46.6	16.8	19.7	20.4	18.9	37.2	0.1	14.8	53.4	1.3	40.6	38.7	35.6	40.0	25.1	37.6	47.8	22.7	21.8	36.2	2.5	43.7	0.4	17.4	39.9	12.7	71.5	5.3	0.4	17.4	22.7	11.3	2.8	30.3	28.3	14.9	15.3	34.7	40.2	19.2	51.4	13.5	58.0	75.7	11.1	14.1	2.2	24.7	2.8	0.0	1.7	1.1	0.0	0.7	0.3	1.7	1.9	0.0	0.2	1.4	1.2	0.0	0.5	0.0	0.3	3.7	0.5	8.2	7.8	18.8	11.0	10.8	9.2	8.9	8.1	9.6	5.6	8.8	7.7	6.4	3.2	4.5	26.8	7.7	2.5	1.4	0.9	0.0	4.5	1.9	2.3	6.2	0.0	1.9	0.0	2.1	0.1	16.0	0.1	0.0	1.6	0.6	6.5	20.5	9.0	0.0	0.4	28.5	0.2	0.5	12.8	0.5	2.4	7.6	10.8	13.6	0.8	0.4	8.4	31.7	0.2	0.0	1.0	4.2	1.4	11.5	1.3	7.2	4.7	0.9	3.4	7.2	4.0	4.2	0.9	0.0	14.7	13.9	5.6	0.0	0.2	4.4	0.5	0.0	9.5	11.2	2.6	4.3	0.6	1.6	0.3	17.2	6.7	0.1	0.8
ATR	"FRP1, MEC1, SCKL, SCKL1"	ENSG00000175054	"ATR serine/threonine kinase"	Q13535	3	142449007-142578733	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins"	"DNA damage, DNA repair"	"DNA-binding, Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Disease variant, Dwarfism, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 93.0;Inhibitory neurons: 94.4;Microglial cells: 73.1;Oligodendrocyte precursor cells: 65.4;Oligodendrocytes: 71.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054320			Supported	"Nucleoplasm,Golgi apparatus"		No	No			"Cluster 15: NK-cells - Transcription"	"Cluster 17: Adrenal gland - Steroid metabolism"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm	"Golgi apparatus"	"HPA054320: AB_2682448"	"unprognostic (1.47e-1)"	"unprognostic (8.90e-2)"	"unprognostic (2.90e-1)"	"unprognostic (4.23e-2)"	"unprognostic (2.25e-2)"	"unprognostic (6.42e-2)"	"prognostic unfavorable (8.39e-5)"	"unprognostic (3.44e-1)"	"unprognostic (1.67e-1)"	"unprognostic (3.02e-1)"	"prognostic unfavorable (1.23e-5)"	"unprognostic (1.94e-1)"	"unprognostic (5.61e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.55e-1)"	"unprognostic (1.69e-2)"	"unprognostic (1.43e-1)"	3.0	8.6	0.7	4.1	1.1	1.2	3.2	0.9	1.4	3.8	3.7	2.7	1.7	3.3	2.3	3.1	3.3	3.4	2.3	1.2	1.9	3.7	3.6	2.9	4.8	1.5	1.2	2.7	3.8	5.2	3.7	3.1	1.4	3.0	2.9	2.9	3.5	2.5	2.9	2.7	3.1	3.2	1.0	4.2	2.8	5.2	1.2	4.9	5.0	1.4	4.6	4.1	2.7	1.2	28.6	13.2	7.1	7.0	9.6	13.6	8.8	14.8	8.4	10.1	9.7	6.4	6.8	19.9	14.6	10.1	14.6	16.1	10.9	12.8	15.0	7.5	7.9	11.9	8.2	4.1	4.2	20.5	5.3	9.8	4.8	9.5	10.3	5.8	11.6	8.7	8.2	7.5	9.6	7.5	13.9	2.6	7.3	15.6	9.6	11.8	12.5	13.5	6.3	11.1	5.2	5.1	28.6	8.3	8.0	7.8	12.0	5.4	14.6	10.5	4.9	12.3	15.2	10.8	7.4	18.5	13.8	6.5	8.5	0.0	0.3	0.0	0.5	0.4	1.0	0.1	0.3	0.5	0.7	0.3	0.4	0.4	0.0	1.3	0.2	0.2	0.4	0.2	0.7	1.1	0.9	1.4	1.2	1.9	1.5	1.2	1.4	1.0	1.2	1.2	11.5	6.4	10.6	39.2	22.4	4.0	7.2	8.8	14.2	14.1	9.2	6.5	7.6	5.7	10.1	3.7	37.5	7.7	14.9	3.5	0.0	5.9	16.4	18.8	18.6	10.2	7.7	14.5	93.0	4.9	3.6	8.3	14.8	10.3	1.3	16.3	7.9	7.3	6.4	8.4	94.4	4.8	14.2	9.4	4.0	8.7	6.5	12.8	10.6	73.1	12.0	6.0	9.2	65.4	71.9	6.4	1.8	7.2	23.1	8.1	1.9	6.5	25.4	23.6	0.0	14.6	9.8	50.1	18.5	14.7	4.5	5.1	15.1	13.8	7.6	6.1
ATRIP	"FLJ12343, MGC20625, MGC21482, MGC26740"	ENSG00000164053	"ATR interacting protein"	Q8WXE1	3	48446710-48467645	"Metabolic proteins, Predicted intracellular proteins"	"DNA damage, DNA repair"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 14.9"	"Low cell type specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB033109, HPA047590"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 20: HeLa - Mitochondria"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm		"CAB033109: AB_634993, HPA047590: AB_2680094"	"unprognostic (5.43e-3)"	"unprognostic (1.29e-1)"	"unprognostic (2.85e-1)"	"unprognostic (8.87e-2)"	"unprognostic (2.34e-1)"	"unprognostic (4.79e-3)"	"unprognostic (4.72e-2)"	"unprognostic (8.88e-3)"	"unprognostic (2.66e-1)"	"unprognostic (7.94e-2)"	"unprognostic (2.53e-2)"	"unprognostic (7.05e-2)"	"unprognostic (2.01e-1)"	"unprognostic (8.89e-2)"	"unprognostic (2.59e-1)"	"unprognostic (1.40e-2)"	"unprognostic (8.52e-2)"	3.8	2.6	2.0	3.7	2.1	5.0	3.8	3.9	2.3	3.9	2.2	3.1	2.4	3.4	1.4	3.7	3.0	2.0	2.4	2.0	1.7	3.1	2.5	3.6	3.6	2.0	1.9	3.6	2.7	4.0	1.8	3.2	1.9	3.0	3.5	2.7	2.5	3.6	4.7	4.4	2.6	3.0	1.6	3.0	2.8	14.9	2.0	4.9	5.4	3.0	4.9	3.3	3.5	2.3	8.7	3.7	9.7	7.4	5.6	9.5	10.2	13.1	6.0	15.7	12.8	5.1	6.3	19.3	5.9	5.4	7.3	9.2	10.9	10.2	15.1	11.5	5.6	14.9	19.1	3.7	3.2	15.0	9.7	3.8	3.1	8.5	4.0	3.5	7.0	7.1	12.0	9.6	14.7	4.9	12.6	5.4	7.5	4.4	10.5	8.5	8.7	13.7	5.3	4.3	4.7	6.9	10.4	10.5	3.9	8.5	8.8	5.7	8.1	10.7	7.0	13.0	15.3	11.6	20.0	13.6	5.7	11.2	6.0	0.2	0.7	0.0	1.1	0.3	0.1	0.3	0.9	0.5	0.5	0.2	0.7	1.0	0.5	0.5	0.6	1.1	1.2	0.7	2.0	2.1	3.9	2.3	2.0	1.7	2.0	1.9	1.9	1.6	2.0	2.3	4.3	0.0	1.5	2.0	0.9	2.9	0.0	0.9	0.0	1.0	4.1	4.7	1.6	0.0	2.0	0.0	2.1	0.2	4.4	2.4	0.0	3.6	0.0	3.8	6.4	2.3	0.0	0.4	3.2	3.9	0.1	2.2	1.5	5.8	0.0	5.5	0.0	0.0	0.1	1.7	3.2	1.7	2.0	0.0	0.5	0.0	0.0	2.5	0.0	1.9	1.6	0.5	3.1	2.0	3.3	4.1	1.1	0.0	0.7	0.0	0.0	2.1	3.6	2.1	0.0	0.0	4.5	0.0	0.0	0.0	3.8	0.1	2.2	4.2	1.3	0.0
ATRX	"JMS, MRX52, RAD54, XH2, XNP"	ENSG00000085224	"ATRX chromatin remodeler"	P46100	X	77504880-77786233	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Transcription factors"	"DNA damage, DNA repair, Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding, Helicase, Hydrolase"	"Cancer-related genes, Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001906, CAB009372, HPA064684, CAB068176"	Supported		Supported	"Nuclear bodies"		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 52: Non-specific - Transcription"	"Nuclear bodies"		"CAB009372: AB_2061023, CAB068176: AB_2665665, HPA001906: AB_1078249, HPA064684: AB_2685321"	"unprognostic (1.77e-2)"	"unprognostic (1.55e-1)"	"unprognostic (6.65e-2)"	"unprognostic (4.37e-2)"	"unprognostic (1.67e-1)"	"unprognostic (9.69e-2)"	"unprognostic (8.11e-2)"	"unprognostic (1.15e-2)"	"unprognostic (6.04e-2)"	"unprognostic (2.35e-2)"	"unprognostic (1.09e-1)"	"unprognostic (5.80e-2)"	"unprognostic (5.14e-3)"	"unprognostic (1.50e-1)"	"unprognostic (6.19e-2)"	"unprognostic (1.76e-2)"	"unprognostic (2.24e-1)"	18.0	15.9	17.3	17.6	20.4	29.9	18.1	32.9	20.4	18.0	21.4	12.7	11.2	21.2	14.8	13.3	11.8	14.7	15.5	19.2	19.8	16.9	13.2	13.4	22.6	15.0	20.1	24.9	13.4	23.2	8.5	16.6	16.6	19.2	13.5	26.8	14.0	14.8	19.1	15.6	10.9	15.6	16.4	22.8	16.5	6.6	22.6	25.7	20.0	26.9	18.6	14.1	9.9	19.7	36.0	55.1	60.1	45.0	31.8	38.1	21.2	29.4	27.3	21.8	25.9	19.6	30.7	48.5	29.9	32.5	39.9	30.0	44.6	18.1	37.5	27.3	30.8	29.3	67.2	16.2	16.1	38.4	10.2	25.5	20.2	32.2	30.4	29.4	41.9	30.3	34.9	53.3	29.3	27.6	30.2	25.0	42.0	17.6	42.5	48.6	76.3	26.0	25.6	46.4	33.1	55.5	60.5	23.1	21.9	37.2	18.6	20.8	55.8	32.8	76.1	34.4	21.0	16.3	52.9	42.1	23.0	30.9	27.8	44.0	10.5	22.7	26.0	13.3	25.2	31.2	24.0	20.9	8.1	32.4	24.6	20.1	33.2	23.2	20.0	20.7	22.2	9.7	17.3	20.4	32.9	20.4	19.2	19.8	15.0	20.1	16.6	16.4	22.6	19.7	201.0	160.3	230.1	157.4	176.6	92.4	112.2	71.3	114.9	220.1	87.8	86.7	277.8	60.1	101.5	71.7	212.7	72.2	176.9	49.0	23.5	91.8	4.7	103.1	195.5	162.8	126.8	105.8	197.8	83.1	51.0	134.3	114.2	137.3	113.1	261.4	97.8	56.7	70.9	158.2	246.9	78.0	69.2	87.0	101.6	12.7	162.4	113.1	62.2	195.8	149.0	112.3	183.4	202.5	237.1	92.0	47.6	208.0	183.9	120.8	49.2	37.2	102.6	245.4	92.1	174.7	160.0	19.8	52.8	78.7	84.4	59.8	158.0	312.4	73.3	112.0
ATXN1	"ATX1, D6S504E, SCA1"	ENSG00000124788	"Ataxin 1"	P54253	6	16299112-16761491	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"DNA-binding, Repressor, RNA-binding"	"Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 582.5;Inhibitory neurons: 519.0;Oligodendrocyte precursor cells: 318.2;Oligodendrocytes: 466.8"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in many"		"cerebral cortex: 14.4"	"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"U-266/70: 30.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008335, HPA070756"	Approved		Supported	Nucleoplasm,Nucleoli,Cytosol		Yes	No			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Nucleoplasm	"Nucleoli, Cytosol"	"HPA008335: AB_1845129, HPA070756: AB_2686306"	"unprognostic (1.01e-1)"	"unprognostic (4.77e-2)"	"unprognostic (1.23e-1)"	"unprognostic (5.64e-3)"	"unprognostic (4.54e-1)"	"unprognostic (1.95e-2)"	"unprognostic (7.74e-2)"	"unprognostic (4.51e-2)"	"unprognostic (4.06e-1)"	"unprognostic (1.11e-2)"	"unprognostic (3.87e-2)"	"unprognostic (2.69e-2)"	"unprognostic (1.41e-3)"	"unprognostic (1.67e-3)"	"unprognostic (2.33e-1)"	"unprognostic (1.06e-1)"	"unprognostic (3.29e-3)"	4.1	4.0	3.2	5.9	5.3	2.6	4.1	0.0	14.4	8.4	0.0	8.8	3.8	10.9	4.3	5.0	6.2	5.7	5.8	8.4	0.0	4.1	4.7	6.9	4.2	0.0	1.3	5.4	4.8	5.5	6.5	4.9	0.0	7.4	3.8	13.9	4.6	6.2	14.6	5.7	4.8	7.5	0.0	5.7	5.3	3.0	3.9	2.6	6.1	14.8	3.1	6.7	6.6	0.8	4.5	2.6	0.9	0.0	4.4	5.9	5.8	4.8	11.2	2.9	3.3	2.8	2.8	0.2	6.3	9.3	3.7	4.2	0.3	3.0	4.2	2.6	4.7	0.7	4.4	9.0	7.0	4.2	7.0	4.6	5.7	6.1	5.1	11.2	5.9	0.9	0.0	5.3	2.4	2.3	0.3	4.8	0.9	1.4	4.3	0.3	5.8	4.0	4.0	7.6	0.3	2.5	4.4	5.5	9.1	8.4	3.6	7.2	9.1	4.0	6.1	4.8	4.4	30.7	19.2	0.2	2.6	4.3	10.0	0.2	0.5	0.1	0.7	0.4	0.5	0.1	0.5	0.7	0.2	0.0	0.0	0.4	1.3	0.0	0.2	0.1	0.4	0.3	3.2	5.3	0.0	14.4	8.4	0.0	0.0	1.3	0.0	0.0	3.9	0.8	16.0	48.1	25.9	206.3	20.7	91.4	72.2	22.8	48.9	39.8	20.7	14.4	35.9	25.8	26.0	11.0	100.1	0.6	48.4	23.6	7.9	16.7	4.3	80.5	144.4	21.7	1.2	5.7	582.5	8.5	4.0	32.9	22.4	75.8	38.7	67.4	17.2	25.2	22.4	38.7	519.0	16.5	2.0	39.6	79.1	3.3	10.5	41.7	32.0	217.4	42.3	24.1	33.0	318.2	466.8	32.3	16.3	28.2	82.6	56.6	13.9	8.8	33.2	99.9	52.6	19.0	41.6	1.0	6.9	60.9	48.7	0.4	61.5	6.4	7.7	63.8
ATXN10	"E46L, FLJ37990, SCA10"	ENSG00000130638	"Ataxin 10"	Q9UBB4	22	45671798-45845307	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Ciliopathy, Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049531	Approved		Supported	"Plasma membrane,Cytosol"		NA	NA		40000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Cytosol	"Plasma membrane"	"HPA049531: AB_2680806"	"unprognostic (5.73e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.27e-2)"	"unprognostic (5.76e-2)"	"unprognostic (3.01e-2)"	"unprognostic (7.50e-2)"	"unprognostic (1.19e-3)"	"unprognostic (3.18e-1)"	"unprognostic (2.15e-2)"	"unprognostic (5.07e-2)"	"unprognostic (8.38e-2)"	"unprognostic (3.51e-1)"	"unprognostic (1.23e-2)"	"unprognostic (1.18e-1)"	"unprognostic (6.22e-2)"	"unprognostic (7.48e-2)"	"unprognostic (6.98e-2)"	40.9	59.5	42.2	34.7	46.1	41.9	41.7	35.3	56.8	50.6	26.9	43.7	23.8	50.0	39.0	46.4	56.1	39.6	74.5	50.2	49.6	53.5	64.8	38.2	48.3	37.6	40.1	57.7	57.4	64.9	56.1	48.8	42.1	46.5	36.3	55.1	41.6	40.9	70.6	34.9	27.8	50.2	42.5	34.2	34.4	57.3	46.5	65.9	63.0	59.3	51.6	51.1	45.8	44.5	163.4	84.9	156.2	95.0	70.5	107.6	85.4	181.0	194.3	128.1	139.4	42.9	106.4	169.3	73.2	184.5	66.4	94.4	114.3	121.3	137.7	32.8	119.4	78.9	141.7	79.8	101.9	213.1	56.4	109.0	82.9	66.5	103.1	153.1	96.3	76.2	58.7	89.8	197.2	69.6	116.7	95.6	104.2	90.8	64.0	166.2	60.7	135.9	162.6	152.3	86.9	136.6	113.5	67.2	129.2	119.8	101.4	111.9	87.6	127.5	47.7	46.0	61.4	87.8	57.3	136.8	79.5	88.5	138.5	80.5	99.9	91.8	69.0	121.7	92.3	72.1	68.0	84.3	163.9	72.6	74.4	71.9	4.7	86.2	138.5	58.1	70.8	120.2	42.2	46.1	35.3	56.8	50.2	49.6	37.6	40.1	42.1	42.5	46.5	44.5	38.1	35.3	33.3	127.3	50.6	50.5	124.2	156.0	68.9	66.3	45.4	50.0	94.2	65.8	76.7	58.8	20.9	101.9	32.3	17.1	68.4	91.1	69.2	53.7	53.7	44.4	60.3	63.1	148.6	69.5	106.3	70.7	34.1	49.8	39.9	93.5	36.4	54.9	72.2	70.7	157.9	35.4	79.3	49.0	36.5	40.6	57.5	48.3	24.9	103.0	67.9	79.3	27.8	186.5	168.1	51.6	24.0	75.6	53.3	115.2	18.6	66.9	67.6	53.6	46.0	45.1	54.6	133.8	108.3	65.1	41.5	52.3	47.8	102.2	44.5	102.0
AUNIP	"AIBp, C1orf135, MGC2603"	ENSG00000127423	"Aurora kinase A and ninein interacting protein"	Q9H7T9	1	25831913-25859458	"Predicted intracellular proteins"	"DNA damage, DNA repair"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"bone marrow: 6.2;testis: 16.0"	"Group enriched"	"Detected in some"	5	"Early spermatids: 52.8;Late spermatids: 127.0;Spermatocytes: 54.9;Spermatogonia: 47.4"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA028730	Uncertain		Supported	Centrosome		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 36: HEL - Hemostasis"	"Cluster 34: Spermatids - Unknown function"	Centrosome		"HPA028730: AB_10670830"	"unprognostic (8.05e-2)"	"unprognostic (1.98e-2)"	"unprognostic (3.96e-3)"	"prognostic unfavorable (3.94e-4)"	"unprognostic (9.51e-2)"	"unprognostic (8.86e-2)"	"unprognostic (9.70e-6)"	"unprognostic (5.00e-3)"	"unprognostic (9.06e-3)"	"unprognostic (4.59e-3)"	"unprognostic (1.42e-3)"	"unprognostic (1.12e-2)"	"unprognostic (1.01e-6)"	"unprognostic (3.61e-2)"	"unprognostic (4.41e-2)"	"unprognostic (4.70e-2)"	"unprognostic (3.62e-1)"	0.2	0.9	0.5	0.9	0.4	6.2	0.4	0.8	0.9	0.3	0.0	0.7	0.9	0.3	0.5	1.4	0.2	0.2	0.6	0.6	0.0	0.4	0.5	0.3	1.2	0.3	0.0	0.2	0.2	0.0	0.4	1.8	0.4	0.3	0.9	0.9	0.3	0.1	0.7	0.5	0.8	0.3	0.0	0.7	0.5	16.0	0.1	1.3	0.2	0.0	1.7	0.3	0.5	0.6	19.8	5.6	8.8	11.3	0.4	0.6	8.5	11.1	5.1	22.0	17.9	4.7	15.0	19.0	8.3	4.0	7.7	15.7	23.9	10.8	17.6	11.0	17.7	42.0	8.8	7.3	0.2	20.7	18.3	0.5	5.3	13.5	9.2	1.7	5.0	14.7	25.7	9.5	6.2	10.5	15.2	17.3	15.2	13.1	6.6	12.4	16.3	12.1	6.9	6.4	12.3	5.9	15.4	17.5	12.4	9.7	6.3	10.8	2.1	6.5	9.7	13.5	10.0	3.6	7.6	14.2	4.5	34.3	10.6	1.5	0.7	0.5	0.1	1.0	0.1	0.2	0.2	0.2	0.6	0.3	0.2	0.3	0.5	0.3	0.6	0.4	0.8	0.3	0.5	0.4	0.8	0.9	0.6	0.0	0.3	0.0	0.4	0.0	0.1	0.6	0.1	0.0	0.0	1.6	0.3	0.4	0.1	1.4	0.6	0.0	0.3	0.6	1.4	0.0	0.2	0.0	2.1	8.9	0.3	0.2	0.0	0.4	52.8	0.3	0.4	0.5	0.0	13.0	3.8	0.5	11.1	0.7	0.0	0.3	0.0	1.4	0.0	0.0	2.1	0.0	1.7	0.5	0.0	0.3	1.2	127.0	2.1	0.7	0.0	0.0	1.1	0.2	0.0	1.5	0.8	0.6	0.0	0.7	1.1	0.2	0.0	0.2	0.0	0.3	0.0	0.1	0.5	54.9	47.4	1.7	0.4	7.4	0.5	0.4	1.0	0.2
AURKA	"AIK, ARK1, AurA, BTAK, PPP1R47, STK15, STK6, STK7"	ENSG00000087586	"Aurora kinase A"	O14965	20	56369389-56392337	"Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Cilium biogenesis/degradation, Mitosis"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 22.1;testis: 30.8"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 81.6;Extravillous trophoblasts: 67.1;granulocytes: 54.1;Spermatocytes: 168.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB001454, HPA002636"	Enhanced		Approved	"Nucleoplasm,Mitotic spindle,Centrosome,Cytosol"		Yes	Yes			"Cluster 7: Monocytes - Unknown function"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Nucleoplasm, Centrosome"	"Mitotic spindle, Cytosol"	"CAB001454: AB_563420, HPA002636: AB_1845217"	"unprognostic (7.73e-2)"	"unprognostic (2.46e-2)"	"unprognostic (2.76e-2)"	"prognostic unfavorable (9.40e-5)"	"unprognostic (1.92e-1)"	"unprognostic (2.11e-2)"	"prognostic unfavorable (1.49e-4)"	"unprognostic (4.69e-3)"	"unprognostic (2.42e-1)"	"unprognostic (6.88e-2)"	"prognostic unfavorable (6.13e-4)"	"unprognostic (1.40e-1)"	"prognostic unfavorable (1.47e-8)"	"unprognostic (1.67e-1)"	"unprognostic (6.83e-2)"	"unprognostic (9.00e-2)"	"unprognostic (5.14e-2)"	1.3	2.3	1.3	10.4	1.6	15.3	2.2	2.4	1.4	1.4	0.6	10.8	11.7	1.5	0.8	7.5	1.2	2.0	5.3	0.8	1.0	2.3	5.0	2.2	20.9	1.7	1.2	8.4	2.0	1.8	0.6	8.1	1.4	1.1	12.9	3.0	1.9	1.3	8.7	3.5	9.3	4.9	1.3	5.2	4.9	30.8	1.6	20.2	1.4	8.2	22.1	2.9	2.6	1.3	179.9	127.2	84.5	61.2	4.9	10.8	106.3	145.2	66.8	339.7	142.9	361.4	124.8	58.4	96.2	59.2	176.2	142.2	152.4	96.4	360.0	52.4	57.5	102.6	128.9	229.8	2.8	140.4	140.4	5.1	10.1	117.3	104.5	26.7	80.7	93.2	121.8	45.3	146.9	182.1	85.3	108.9	78.3	145.6	129.8	62.9	163.4	65.9	56.0	46.8	73.9	39.6	200.5	228.8	94.2	77.3	137.9	86.1	47.1	149.7	145.3	83.0	208.6	62.3	78.9	100.5	80.5	80.9	127.0	0.2	3.5	4.3	1.2	5.9	1.8	2.5	2.0	1.1	3.7	0.8	0.9	0.9	2.3	1.4	3.4	0.8	4.7	1.7	1.3	1.6	2.4	1.4	0.8	1.0	1.7	1.2	1.4	1.3	1.6	1.3	2.5	0.0	2.8	0.3	7.4	1.1	1.2	5.6	0.6	1.0	4.3	6.2	5.6	1.5	2.3	3.7	2.1	34.5	8.3	8.3	1.9	4.0	33.9	2.0	2.3	3.1	6.0	81.6	1.1	4.9	67.1	7.0	13.7	3.4	54.1	12.3	3.6	2.6	17.5	1.7	1.5	10.8	2.0	3.5	7.6	16.3	1.5	11.7	0.0	1.0	12.0	3.7	3.1	1.0	2.0	5.2	2.8	0.4	10.1	2.0	5.1	4.2	1.5	2.7	6.6	2.2	7.7	168.2	30.8	8.3	1.1	8.2	8.0	8.7	15.5	1.5
AURKAIP1	"AIP, AKIP, FLJ20608"	ENSG00000175756	"Aurora kinase A interacting protein 1"	Q9NWT8	1	1373730-1375495	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 1314.3;Late spermatids: 3668.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031821	Approved		Supported	Nucleoplasm,Mitochondria		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 31: Spermatids - Spermatogenesis"	"Nucleoplasm, Mitochondria"		"HPA031821: AB_10601458"	"unprognostic (9.54e-2)"	"unprognostic (1.86e-2)"	"unprognostic (2.77e-1)"	"unprognostic (4.77e-2)"	"unprognostic (2.68e-1)"	"unprognostic (2.98e-2)"	"unprognostic (3.31e-1)"	"unprognostic (9.52e-2)"	"unprognostic (2.76e-1)"	"unprognostic (9.91e-2)"	"unprognostic (3.39e-2)"	"unprognostic (3.34e-1)"	"prognostic favorable (8.11e-4)"	"unprognostic (1.01e-1)"	"unprognostic (1.09e-1)"	"unprognostic (7.18e-2)"	"unprognostic (1.84e-1)"	98.0	129.1	116.2	43.4	117.6	51.5	90.0	125.2	142.4	64.9	130.2	110.5	71.7	70.0	23.5	118.0	64.1	26.1	260.8	113.4	116.3	151.8	215.8	67.2	41.4	125.6	116.8	58.2	120.1	73.4	92.3	35.8	116.1	85.9	27.5	23.6	88.2	38.7	281.3	91.0	85.6	22.4	116.9	85.8	121.4	300.6	128.4	37.9	83.1	171.3	27.2	87.2	72.9	118.4	197.8	116.9	62.9	113.6	54.6	68.2	115.7	116.8	76.8	180.7	127.6	206.3	177.5	103.2	169.3	79.6	90.7	142.4	86.5	154.6	51.9	124.7	245.8	83.6	156.1	194.0	106.7	109.0	109.0	90.4	68.6	127.1	51.3	52.8	99.2	96.3	167.2	138.5	106.6	150.3	134.7	386.9	119.1	123.2	329.1	154.8	77.5	222.7	145.9	51.6	200.7	150.6	83.7	288.4	295.1	38.1	125.0	250.7	75.5	111.3	144.4	134.1	175.7	179.1	177.0	223.4	155.3	159.2	77.1	279.1	231.8	266.6	171.6	200.3	162.7	190.6	178.4	181.7	207.4	202.7	166.6	161.1	291.7	142.4	177.7	294.0	230.1	225.6	116.2	117.6	125.2	142.4	113.4	116.3	125.6	116.8	116.1	116.9	128.4	118.4	118.9	48.1	73.5	18.9	137.4	162.3	166.4	271.4	87.0	109.8	228.1	240.2	231.3	180.1	149.6	165.5	64.6	384.1	134.7	642.0	677.0	310.2	1314.3	145.6	119.3	127.6	203.9	125.2	11.2	418.4	458.6	121.0	178.4	141.8	87.5	144.6	121.1	390.5	294.6	104.3	12.8	415.1	238.0	154.8	175.5	3668.5	136.1	149.7	217.1	5.6	208.1	299.8	166.9	13.0	17.9	425.2	484.3	118.5	240.5	272.5	607.4	780.2	142.2	124.5	157.8	104.4	152.4	572.4	149.2	190.4	197.6	438.1	116.3	181.0	414.3	270.1
AXIN1	PPP1R49	ENSG00000103126	"Axin 1"	O15169	16	287440-352723	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Wnt signaling pathway"	"Developmental protein"	"Cancer-related genes, Disease variant, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB012987	Approved		Supported	Nucleoli,Vesicles		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 63: NK-cells & T-cells - Immune response"	"Nucleoli, Vesicles"		"CAB012987: AB_2533178"	"unprognostic (3.81e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.90e-1)"	"unprognostic (7.64e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.06e-1)"	"prognostic unfavorable (3.38e-5)"	"unprognostic (1.23e-1)"	"unprognostic (3.58e-1)"	"unprognostic (1.56e-1)"	"unprognostic (4.58e-2)"	"unprognostic (2.02e-2)"	"unprognostic (1.57e-1)"	"unprognostic (4.41e-2)"	"unprognostic (1.94e-1)"	"unprognostic (1.23e-2)"	"unprognostic (1.03e-1)"	11.9	9.3	10.5	9.2	10.8	23.0	11.5	14.8	12.5	12.9	9.1	17.1	12.3	13.2	3.1	16.3	11.8	6.2	11.6	10.0	9.2	11.6	11.2	13.7	10.5	10.2	10.2	13.8	13.0	7.2	12.6	5.8	9.8	12.9	6.9	2.6	11.5	6.0	21.1	20.1	15.0	5.4	9.2	15.0	12.9	11.8	10.1	12.5	11.9	7.0	6.6	14.5	13.1	11.9	18.1	25.6	13.4	23.7	9.8	9.0	28.0	11.9	10.8	16.1	13.8	37.9	20.4	27.7	18.0	12.3	19.4	25.4	21.1	18.5	7.2	27.5	34.6	18.0	21.9	27.6	16.6	20.9	19.3	9.0	31.7	16.6	20.3	14.1	10.7	19.8	45.6	14.8	7.4	48.1	22.7	14.5	30.6	21.6	15.4	42.4	12.2	38.8	12.2	10.5	30.4	18.6	22.6	24.9	38.3	10.0	16.5	26.1	12.4	15.9	17.0	18.5	17.5	17.3	18.1	34.2	7.5	13.7	15.9	1.2	0.9	5.0	8.3	0.8	7.6	1.5	2.4	5.8	0.7	1.2	2.4	3.4	2.7	3.5	0.6	1.2	2.6	2.3	10.5	10.8	14.8	12.5	10.0	9.2	10.2	10.2	9.8	9.2	10.1	11.9	7.9	3.2	8.6	4.9	5.7	18.4	7.6	8.5	5.7	4.3	11.2	9.5	4.9	5.7	7.2	3.7	0.0	3.5	30.1	27.4	0.0	7.2	1.4	10.2	7.0	6.3	10.8	8.6	18.5	6.9	27.5	6.7	15.3	14.4	10.8	10.5	5.7	5.1	7.5	5.0	12.7	15.1	6.1	6.2	9.0	2.1	5.3	6.7	10.6	1.0	5.7	4.5	28.8	8.5	8.9	11.0	12.2	4.9	7.0	13.4	11.1	2.4	7.7	5.7	13.1	8.7	7.6	5.5	8.8	7.2	15.2	3.7	12.4	5.0	15.7	10.5
AXL	"ARK, JTK11, Tyro7, UFO"	ENSG00000167601	"AXL receptor tyrosine kinase"	P30530	19	41219223-41261766	"Disease related genes, Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted membrane proteins"	"Differentiation, Host-virus interaction, Immunity, Innate immunity"	"Host cell receptor for virus entry, Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"FDA approved drug targets, Oncogene, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Fibroblasts: 147.2;Kupffer cells: 187.5;Langerhans cells: 185.5;Prostatic glandular cells: 123.4;Sertoli cells: 210.4;Smooth muscle cells: 171.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"NK-cell: 11.1;plasmacytoid DC: 25.7"	"Group enriched"	"Detected in many"	12	"dendritic cells: 25.7;NK-cells: 11.1"	"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 501.2;U-251 MG: 540.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB032501, HPA037422, HPA037423, HPA075217"	Uncertain		Supported	"Vesicles,Plasma membrane,Actin filaments"		NA	Yes	12100000	72000000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 48: Smooth muscle cells - ECM organization"	"Plasma membrane"	"Vesicles, Actin filaments"	"CAB032501: AB_2062572, HPA037422: AB_10672347, HPA037423: AB_2675470, HPA075217: "	"unprognostic (2.20e-1)"	"unprognostic (2.02e-1)"	"unprognostic (6.79e-3)"	"unprognostic (1.01e-1)"	"unprognostic (1.40e-1)"	"unprognostic (8.49e-3)"	"unprognostic (2.42e-1)"	"unprognostic (1.74e-1)"	"unprognostic (3.15e-2)"	"unprognostic (2.82e-2)"	"unprognostic (9.57e-3)"	"unprognostic (1.98e-1)"	"prognostic unfavorable (2.53e-7)"	"unprognostic (1.16e-3)"	"unprognostic (1.52e-2)"	"unprognostic (5.56e-2)"	"unprognostic (4.83e-3)"	43.6	18.8	17.5	15.5	22.6	1.7	26.6	19.7	17.7	36.1	12.4	42.5	11.7	34.4	8.7	17.6	25.4	22.4	26.7	16.6	18.8	9.8	15.0	25.9	6.2	26.8	20.6	24.7	6.3	10.7	7.3	34.2	22.1	19.2	12.6	5.8	10.6	24.6	9.4	20.0	19.0	37.1	20.9	37.7	21.4	18.6	24.0	7.2	16.6	11.3	5.0	32.5	25.2	21.9	408.0	160.0	9.7	1.3	34.6	34.7	0.5	314.5	280.2	450.9	278.2	8.5	185.5	0.2	124.7	501.2	235.3	33.3	0.4	211.8	384.8	0.7	0.3	0.0	100.4	6.3	125.0	0.3	0.3	26.4	3.8	266.7	409.5	254.8	169.8	0.1	15.8	0.5	284.6	0.5	0.2	0.4	4.1	1.0	76.3	0.2	165.3	0.3	202.3	0.2	0.1	0.1	81.5	0.6	1.8	57.4	0.9	7.2	351.8	317.8	214.6	307.7	540.8	0.5	0.9	1.0	211.5	0.5	241.8	1.5	0.3	0.2	0.1	0.4	0.2	0.1	0.3	0.1	6.0	0.1	0.3	0.3	0.3	11.1	0.2	25.7	0.4	0.3	17.5	22.6	19.7	17.7	16.6	18.8	26.8	20.6	22.1	20.9	24.0	21.9	13.5	9.6	3.6	35.9	1.9	41.7	88.3	10.3	3.4	0.5	2.3	14.2	8.6	1.5	4.4	5.5	0.0	4.2	0.8	0.1	0.0	6.9	8.7	6.0	45.8	17.7	0.0	0.0	0.8	0.2	2.1	147.2	1.5	5.4	0.0	17.3	11.0	1.2	28.8	1.7	1.1	0.1	2.0	187.5	185.5	5.5	61.5	61.4	26.6	30.9	3.1	26.8	0.0	11.1	0.5	14.5	0.1	79.7	0.8	123.4	0.3	0.1	2.8	1.2	210.4	38.1	171.1	1.9	2.0	1.2	29.1	11.5	3.6	2.5	0.1	28.0
AZIN2	"ADC, KIAA1945, ODC-p, ODC1L, ODCp"	ENSG00000142920	"Antizyme inhibitor 2"	Q96A70	1	33081104-33123492	"Metabolic proteins, Predicted intracellular proteins"	"Polyamine biosynthesis, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 32.1"	"Group enriched"	"Detected in many"	6	"Early spermatids: 233.2;Late spermatids: 855.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	8	"basophil: 6.4;plasmacytoid DC: 18.9"	"Group enriched"	"Detected in many"	8	"dendritic cells: 18.9;granulocytes: 6.4"	"Cell line enhanced"	"Detected in some"		"hTERT-RPE1: 11.0;SK-MEL-30: 14.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028527			Approved	Cytosol		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 25: Spermatids - Spermatogenesis"	Cytosol		"HPA028527: AB_10602077"	"unprognostic (5.33e-2)"	"unprognostic (1.60e-1)"	"unprognostic (2.16e-3)"	"unprognostic (7.50e-2)"	"unprognostic (8.28e-2)"	"unprognostic (4.56e-2)"	"unprognostic (1.15e-4)"	"unprognostic (9.19e-3)"	"unprognostic (3.89e-2)"	"unprognostic (1.54e-2)"	"unprognostic (1.06e-3)"	"unprognostic (2.16e-1)"	"unprognostic (3.18e-1)"	"unprognostic (6.91e-2)"	"unprognostic (2.91e-1)"	"unprognostic (9.45e-2)"	"unprognostic (2.41e-1)"	1.4	3.8	7.1	0.8	8.4	0.1	2.1	8.4	9.4	3.8	5.4	3.5	0.4	2.4	1.1	0.9	4.3	1.9	3.6	7.5	7.3	2.7	0.7	1.3	1.0	8.3	7.8	6.3	1.6	3.3	3.5	0.5	8.0	2.2	1.1	3.0	2.2	1.7	1.0	1.4	1.3	1.4	9.8	1.1	1.0	32.1	7.6	1.1	2.5	1.9	1.2	1.4	2.1	12.9	0.5	0.0	1.8	0.3	0.9	3.0	0.2	0.6	1.8	1.3	1.1	0.0	1.5	0.0	0.8	0.5	1.0	0.2	0.9	0.2	0.7	0.0	0.0	0.4	0.0	0.0	3.6	0.0	1.6	3.5	2.0	1.5	1.3	11.0	0.3	0.3	0.0	0.1	1.4	0.0	0.2	0.4	0.8	0.3	0.0	0.2	2.1	0.1	2.1	0.2	0.2	1.3	0.5	0.0	14.0	1.2	0.0	0.3	0.1	0.0	0.8	1.1	0.2	0.8	0.0	0.0	3.2	0.0	0.6	6.4	0.0	0.0	1.4	0.0	1.3	0.1	1.6	1.4	0.0	0.0	1.6	1.6	0.1	0.0	0.0	18.9	0.0	0.8	7.1	8.4	8.4	9.4	7.5	7.3	8.3	7.8	8.0	9.8	7.6	12.9	2.6	0.0	3.0	24.2	2.3	0.0	2.9	0.0	2.8	6.5	3.8	5.2	1.0	0.0	0.6	1.8	18.8	0.5	11.4	10.8	0.0	1.7	233.2	1.7	1.5	2.6	1.2	0.0	45.4	1.4	0.4	4.8	7.7	0.3	0.0	2.0	1.8	0.1	1.2	6.7	27.3	1.4	0.0	0.6	0.0	855.9	6.2	2.8	0.0	44.0	1.7	12.2	0.0	23.6	86.0	1.5	5.2	7.5	1.0	1.5	0.8	3.1	2.2	7.9	6.6	2.9	2.7	22.2	5.8	0.5	0.0	0.3	3.3	2.1	3.3	1.0
B4GALNT3	"B4GalNac-T3, FLJ16224, FLJ40362"	ENSG00000139044	"Beta-1,4-N-acetyl-galactosaminyltransferase 3"	Q6L9W6	12	459939-563509	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"stomach 1: 61.0"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 81.1;Gastric mucus-secreting cells: 128.0;Glandular and luminal cells: 47.4;Late spermatids: 89.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BEWO: 33.5;HDLM-2: 13.2;HEK 293: 12.5;NTERA-2: 14.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA011404	Enhanced		Supported	"Golgi apparatus,Vesicles"	"Intracellular and membrane"	NA	NA				"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 25: Spermatids - Spermatogenesis"	"Golgi apparatus"	Vesicles	"HPA011404: AB_1845242"	"unprognostic (2.38e-2)"	"unprognostic (9.59e-3)"	"unprognostic (1.38e-1)"	"prognostic favorable (1.69e-10)"	"unprognostic (4.22e-2)"	"unprognostic (4.63e-2)"	"unprognostic (1.46e-2)"	"unprognostic (9.53e-3)"	"unprognostic (3.29e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.02e-1)"	"unprognostic (5.46e-2)"	"unprognostic (9.99e-3)"	"unprognostic (2.82e-1)"	"unprognostic (2.48e-2)"	"unprognostic (2.98e-1)"	0.2	7.0	0.5	3.2	0.7	2.1	1.3	0.0	1.0	7.4	1.0	18.4	1.0	6.2	2.7	7.5	3.7	2.2	23.9	0.5	0.0	4.6	0.1	5.2	0.1	0.0	0.0	0.4	2.6	16.9	9.3	0.1	0.0	2.0	12.5	0.1	4.8	0.7	1.5	14.8	2.0	2.2	0.0	0.3	61.0	8.0	0.0	2.3	2.3	0.1	0.7	1.4	5.6	0.7	0.0	0.0	0.3	1.2	0.0	0.0	33.5	0.0	0.0	0.0	0.0	8.0	6.6	0.0	0.9	0.0	0.7	3.6	8.0	1.1	0.1	13.2	12.5	0.0	0.0	1.8	0.0	0.1	5.3	0.0	5.3	0.0	0.0	0.1	0.0	0.9	0.1	0.0	0.0	0.4	0.0	0.1	14.8	10.5	0.6	0.5	5.0	0.0	7.1	6.8	3.8	2.7	0.8	0.3	1.0	4.9	0.8	2.9	0.0	0.0	2.7	0.2	0.9	0.0	0.0	0.0	0.0	9.2	6.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.7	0.0	1.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	7.0	1.3	0.3	7.5	6.0	3.4	0.0	0.6	2.9	0.6	15.1	1.5	6.2	9.2	0.0	0.0	0.6	81.1	0.0	12.0	26.3	20.4	4.8	0.6	10.3	0.0	32.6	4.8	0.1	1.6	128.0	47.4	0.0	0.1	0.0	0.1	0.7	0.0	5.2	18.6	2.0	0.0	1.1	89.2	0.0	0.5	0.0	2.8	0.6	0.0	0.0	1.0	3.6	16.6	33.4	0.0	0.2	12.7	1.9	0.2	9.1	0.2	0.0	0.2	0.8	2.8	1.3	0.9	17.3	0.0	1.5	1.9	26.1	14.4
B4GALT2	beta4Gal-T2	ENSG00000117411	"Beta-1,4-galactosyltransferase 2"	O60909	1	43978943-43991170	"Enzymes, Metabolic proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007620, HPA047739"	Supported		Supported	"Golgi apparatus,Vesicles"		NA	NA		3100000	"Cluster 16: MAIT-cells - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 7: Non-specific - Mitochondria"	"Golgi apparatus, Vesicles"		"HPA007620: AB_2667879, HPA047739: AB_2680141"	"unprognostic (1.11e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.15e-1)"	"unprognostic (7.59e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.35e-1)"	"prognostic unfavorable (2.96e-5)"	"unprognostic (1.12e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.08e-2)"	"unprognostic (4.23e-3)"	"unprognostic (7.58e-2)"	"prognostic unfavorable (3.62e-5)"	"unprognostic (6.54e-2)"	"unprognostic (1.52e-1)"	"unprognostic (7.66e-2)"	"unprognostic (3.12e-3)"	29.0	19.0	61.4	13.0	55.0	6.6	24.6	48.0	70.1	28.4	44.0	43.7	12.5	31.0	9.6	32.4	20.0	14.9	40.8	58.4	51.6	24.6	38.8	19.6	5.9	53.6	53.6	19.6	51.5	14.2	24.7	10.1	53.0	31.2	10.2	8.9	27.3	23.8	61.0	32.8	15.2	26.3	52.6	12.0	22.4	22.6	55.2	3.1	14.3	33.2	6.8	37.0	26.8	52.6	61.6	38.4	45.3	76.0	51.3	54.5	37.8	54.2	55.9	54.8	50.9	30.4	51.4	38.4	31.6	112.3	52.5	39.9	36.8	72.8	14.0	39.6	80.2	23.2	37.8	66.9	43.2	20.6	0.8	47.0	79.1	39.3	71.4	55.3	65.5	15.9	51.7	25.3	46.7	45.3	15.3	18.6	65.6	35.7	56.7	44.3	48.2	62.7	33.9	29.3	72.7	58.5	31.1	89.4	38.5	16.9	38.6	17.5	39.3	90.8	102.4	63.8	78.5	7.6	17.8	15.9	40.4	16.9	64.6	0.0	0.0	0.0	0.0	0.0	0.6	0.2	0.1	0.2	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	61.4	55.0	48.0	70.1	58.4	51.6	53.6	53.6	53.0	52.6	55.2	52.6	9.7	0.0	8.8	7.5	2.2	7.8	10.3	10.8	1.8	13.3	15.0	18.9	14.0	7.2	7.4	14.7	4.2	2.0	1.2	10.2	1.9	13.3	16.4	6.2	16.2	10.4	16.3	1.3	8.0	20.6	8.0	15.2	13.7	8.7	0.0	23.8	6.1	18.7	2.3	18.5	5.6	22.6	2.0	1.0	3.3	6.7	16.4	1.5	3.6	1.0	1.6	15.0	0.0	5.0	9.8	27.3	6.1	12.4	5.0	25.9	6.4	8.8	4.4	12.2	6.6	9.8	14.3	6.2	15.6	7.6	12.6	0.5	1.7	21.1	15.3	16.1
B4GALT3	beta4Gal-T3	ENSG00000158850	"Beta-1,4-galactosyltransferase 3"	O60512	1	161171310-161177968	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Plasma cells: 114.8;Syncytiotrophoblasts: 114.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-266/70: 246.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA010793	Approved		Supported	"Golgi apparatus,Cytosol"		NA	NA		130000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 55: Plasma cells - Humoral immune response"	"Golgi apparatus"	Cytosol	"HPA010793: AB_1078256"	"unprognostic (5.67e-3)"	"unprognostic (7.68e-3)"	"unprognostic (1.20e-2)"	"unprognostic (8.15e-3)"	"unprognostic (3.91e-1)"	"unprognostic (1.10e-2)"	"prognostic unfavorable (5.87e-5)"	"unprognostic (3.11e-2)"	"unprognostic (3.13e-1)"	"unprognostic (4.64e-2)"	"unprognostic (1.41e-1)"	"unprognostic (3.69e-1)"	"prognostic unfavorable (7.12e-7)"	"unprognostic (1.86e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.38e-1)"	28.4	21.9	20.0	16.0	20.5	19.0	21.6	17.9	21.1	21.8	18.6	19.4	17.2	14.7	18.3	25.1	19.0	14.4	24.9	20.5	22.0	27.7	22.5	25.1	23.4	18.4	19.3	29.0	34.0	21.9	32.5	21.7	19.1	21.8	17.5	8.0	32.3	12.3	24.6	24.6	18.6	10.6	18.2	31.2	27.6	19.4	22.9	16.9	21.9	16.3	20.7	23.7	21.4	19.3	35.2	22.3	32.8	43.6	47.5	24.7	52.5	19.2	34.7	39.6	36.3	44.8	68.4	32.2	54.2	22.1	37.8	34.3	34.9	21.7	22.8	34.1	42.5	18.6	14.2	35.8	34.1	37.0	48.6	33.7	31.1	36.5	39.6	47.0	45.2	41.3	60.3	69.3	32.2	35.4	24.1	34.4	40.9	70.3	48.0	28.5	18.2	79.4	33.5	20.9	46.6	54.7	19.7	50.4	41.7	44.2	50.7	64.8	18.9	19.5	35.4	22.4	57.7	246.6	146.5	43.0	28.5	31.2	32.0	10.7	14.9	12.6	27.0	17.2	24.3	26.2	25.9	26.0	18.0	21.2	25.0	23.2	9.7	25.9	23.3	37.4	43.1	21.0	20.0	20.5	17.9	21.1	20.5	22.0	18.4	19.3	19.1	18.2	22.9	19.3	18.1	19.2	20.0	1.6	34.7	38.5	36.6	26.2	19.9	17.3	32.8	19.9	10.2	15.7	17.7	25.8	2.1	44.8	30.3	15.3	5.9	28.7	10.1	8.2	7.8	24.4	28.8	34.5	6.2	22.9	91.7	24.7	15.3	10.9	9.5	21.0	27.8	13.2	29.7	26.9	7.1	20.7	26.4	16.6	17.9	5.7	9.6	16.2	23.2	4.7	10.2	9.4	47.4	5.0	4.5	31.4	20.0	7.2	114.8	46.1	19.0	20.9	12.4	8.6	26.3	11.1	24.7	14.9	46.9	21.7	41.9	114.2	29.5	11.8	22.7	51.4
B4GALT4	beta4Gal-T4	ENSG00000121578	"Beta-1,4-galactosyltransferase 4"	O60513	3	119211732-119240946	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"epididymis: 76.0"	"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 123.6;Urothelial cells: 171.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"BJ: 125.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046819, HPA063546"	Approved		Supported	"Golgi apparatus"	"Intracellular and membrane"	NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 37: Intestine - Unknown function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Golgi apparatus"		"HPA046819: AB_2679824, HPA063546: AB_2685036"	"unprognostic (4.07e-2)"	"unprognostic (1.78e-2)"	"unprognostic (3.27e-2)"	"unprognostic (1.14e-3)"	"unprognostic (4.59e-2)"	"unprognostic (1.20e-1)"	"prognostic unfavorable (4.04e-4)"	"unprognostic (6.30e-2)"	"unprognostic (1.20e-1)"	"unprognostic (3.58e-1)"	"unprognostic (6.10e-3)"	"unprognostic (2.26e-2)"	"unprognostic (2.76e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.18e-1)"	"unprognostic (2.37e-1)"	"unprognostic (1.11e-1)"	12.4	9.1	6.8	10.7	8.4	20.1	11.1	6.5	8.1	16.4	8.7	30.6	28.6	14.8	76.0	17.7	21.8	33.2	12.9	7.0	6.9	24.1	16.6	9.9	9.9	6.9	6.7	18.4	19.5	15.1	18.2	25.7	6.9	13.7	35.2	9.9	12.2	14.7	6.3	14.1	32.5	13.6	7.0	9.4	29.3	8.3	7.5	7.4	16.4	6.5	11.5	37.6	10.5	7.2	60.1	100.3	12.8	9.8	36.0	31.1	65.3	125.8	54.4	54.4	56.2	65.4	18.3	11.8	23.9	61.3	32.2	78.6	20.7	15.0	59.9	23.5	6.8	15.1	20.3	31.7	25.3	8.9	15.7	21.2	21.4	23.0	19.3	21.6	5.8	8.0	11.2	11.7	25.5	18.4	5.3	10.7	17.6	34.0	27.2	4.9	11.8	4.7	31.2	60.3	10.9	24.0	29.4	14.6	27.9	28.2	30.2	5.7	4.9	27.3	24.0	15.2	13.5	27.2	21.5	16.1	23.5	10.1	23.5	20.1	4.1	8.3	13.3	5.2	7.3	4.2	7.3	7.9	5.5	3.2	13.6	7.1	2.5	14.8	5.0	3.4	2.7	5.7	6.8	8.4	6.5	8.1	7.0	6.9	6.9	6.7	6.9	7.0	7.5	7.2	8.5	0.0	9.4	7.2	17.1	10.7	22.2	48.9	12.0	10.8	14.9	12.4	9.2	61.5	69.1	7.3	4.2	36.2	46.0	43.2	1.9	30.7	2.1	40.1	16.9	8.4	13.8	7.8	11.9	33.2	123.6	24.0	36.2	74.5	13.3	35.0	3.9	10.8	14.4	18.5	11.1	78.7	16.2	9.8	14.8	2.4	14.9	14.9	14.2	6.5	10.9	22.2	39.1	10.6	10.2	40.5	50.2	28.2	27.4	30.7	59.3	22.6	52.6	10.2	19.7	13.9	16.9	1.7	8.4	14.0	10.5	52.3	23.1	20.0	23.6	171.6
BAALC		ENSG00000164929	"BAALC binder of MAP3K1 and KLF4"	Q8WXS3	8	103140713-103230305	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	8	"brain: 300.9;choroid plexus: 108.2"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 67.8;Astrocytes: 198.2;Excitatory neurons: 131.4;Inhibitory neurons: 62.3;Muller glia cells: 132.4;Oligodendrocyte precursor cells: 125.7"	"Cancer enriched"	"Detected in many"	8	"glioma: 139.4"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	28	"NK-cell: 3.7"	"Lineage enriched"	"Detected in single"	28	"NK-cells: 3.7"	"Cell line enhanced"	"Detected in many"		"AF22: 51.7;BJ hTERT+: 18.1;SCLC-21H: 27.9;SH-SY5Y: 20.5;U-87 MG: 75.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027132, HPA068307"	Approved		Supported	Nucleoplasm,Cytosol		No	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Cytosol	Nucleoplasm	"HPA027132: AB_10600985, HPA068307: AB_2685971"	"unprognostic (1.68e-1)"	"unprognostic (9.17e-3)"	"unprognostic (1.40e-2)"	"unprognostic (4.62e-4)"	"unprognostic (1.75e-2)"	"unprognostic (2.84e-2)"	"unprognostic (1.39e-1)"	"unprognostic (7.87e-2)"	"unprognostic (2.00e-1)"	"unprognostic (4.99e-2)"	"unprognostic (4.17e-2)"	"unprognostic (2.18e-2)"	"unprognostic (7.58e-2)"	"unprognostic (2.51e-3)"	"unprognostic (2.76e-2)"	"unprognostic (1.70e-1)"	"unprognostic (9.27e-3)"	9.3	15.6	196.7	2.1	209.2	3.4	7.0	182.2	226.6	1.6	108.2	3.1	0.9	1.7	0.4	0.7	3.8	1.6	3.1	201.1	206.8	4.3	2.9	7.3	1.4	240.0	237.4	3.3	2.1	0.4	25.9	5.3	219.5	1.1	1.6	19.4	1.0	0.9	2.0	2.0	2.7	1.8	229.2	14.5	2.4	1.3	300.9	0.6	4.5	1.4	0.8	2.5	1.4	205.3	0.5	3.0	51.7	0.5	0.5	14.9	0.0	2.6	18.1	0.1	0.2	0.5	0.1	0.2	0.5	10.1	0.2	0.8	0.9	0.1	0.1	0.1	3.1	0.5	0.8	0.1	1.2	0.0	1.1	3.0	2.9	0.6	0.0	2.7	0.4	0.1	0.0	0.4	0.1	0.4	0.0	0.2	1.3	0.4	1.0	0.2	0.3	1.2	0.0	0.1	27.9	20.5	0.6	0.0	0.1	4.5	0.2	0.3	3.0	16.0	1.0	0.4	1.0	0.0	0.2	0.2	75.7	0.3	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.2	196.7	209.2	182.2	226.6	201.1	206.8	240.0	237.4	219.5	229.2	300.9	205.3	67.8	0.0	1.8	198.2	0.3	5.5	0.7	4.5	0.6	2.1	2.0	1.1	0.8	17.2	5.9	0.0	0.0	0.1	2.1	0.3	7.9	32.0	2.9	15.6	2.3	33.4	17.8	6.1	131.4	25.6	0.1	1.6	0.0	34.0	0.0	0.0	23.6	0.8	0.9	0.0	62.3	3.4	22.4	1.3	6.2	8.7	1.5	2.1	14.2	18.7	4.6	132.4	2.1	125.7	46.1	4.1	1.2	0.0	0.8	0.8	0.1	0.1	21.7	3.3	0.0	2.1	8.1	0.1	0.1	0.3	4.0	0.0	1.3	0.3	0.1	1.1
BABAM2	"BRCC4, BRCC45, BRE"	ENSG00000158019	"BRISC and BRCA1 A complex member 2"	Q9NXR7	2	27889941-28338901	"Metabolic proteins, Predicted intracellular proteins"	"Apoptosis, Cell cycle, Cell division, DNA damage, DNA repair, Mitosis, Ubl conjugation pathway"	"Chromatin regulator"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"adrenal gland: 380.0"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 46.1;Distal tubular cells: 84.1;Ductal cells: 53.4;Proximal tubular cells: 84.1;Syncytiotrophoblasts: 48.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017926, HPA048867"	Enhanced		Supported	Cytosol		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 17: Adrenal gland - Steroid metabolism"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 7: Non-specific - Mitochondria"	Cytosol		"HPA017926: AB_1845443, HPA048867: "	"unprognostic (1.28e-1)"	"unprognostic (2.30e-1)"	"unprognostic (1.53e-3)"	"unprognostic (1.61e-3)"	"unprognostic (1.89e-1)"	"unprognostic (2.68e-3)"	"prognostic unfavorable (6.33e-4)"	"unprognostic (1.03e-1)"	"unprognostic (2.38e-2)"	"unprognostic (8.98e-2)"	"unprognostic (2.13e-1)"	"unprognostic (6.52e-2)"	"unprognostic (4.41e-3)"	"unprognostic (1.02e-1)"	"unprognostic (4.74e-2)"	"unprognostic (2.91e-2)"	"unprognostic (1.22e-2)"	30.9	380.0	22.1	21.2	25.2	41.6	27.5	22.9	28.4	31.8	24.6	27.2	18.3	32.1	33.5	24.5	31.0	32.0	54.2	27.4	28.4	54.2	28.6	24.9	20.5	22.4	23.4	36.3	21.7	35.1	32.8	23.3	30.9	24.9	26.2	26.2	20.5	29.0	73.8	25.9	23.0	36.9	18.6	28.6	25.2	27.2	21.1	21.4	24.0	54.8	26.3	31.2	25.3	21.6	39.5	42.8	33.6	35.7	42.4	56.5	33.2	19.4	49.0	36.0	37.2	36.5	39.4	44.4	64.1	47.3	28.9	25.7	27.7	50.9	52.5	37.8	37.1	53.2	17.5	40.9	61.3	28.1	41.5	139.0	43.6	50.3	51.9	45.1	38.7	41.0	27.7	47.3	50.7	33.3	32.8	34.2	25.7	51.4	27.8	29.9	53.6	42.9	104.2	20.4	22.0	35.0	23.0	39.9	40.3	33.9	28.6	36.5	31.7	34.1	45.2	31.7	27.1	53.5	55.8	57.7	63.5	75.6	36.4	106.3	65.6	27.8	57.9	53.1	64.6	50.6	48.7	55.3	86.3	37.6	45.7	43.6	34.3	59.0	55.3	34.4	62.2	56.9	22.1	25.2	22.9	28.4	27.4	28.4	22.4	23.4	30.9	18.6	21.1	21.6	26.7	3.2	19.6	0.0	7.0	0.0	0.0	0.0	0.0	0.0	16.0	18.0	0.0	0.0	5.6	40.5	0.0	46.1	19.0	0.0	84.1	53.4	0.0	22.6	17.4	10.0	0.0	0.0	0.0	44.3	36.8	11.0	0.0	32.5	31.5	23.1	0.0	0.0	38.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.4	0.0	0.0	25.8	0.0	0.0	0.0	0.0	20.2	0.0	0.0	4.0	0.0	0.0	84.1	8.7	0.0	0.0	0.0	10.1	0.0	0.0	0.0	0.0	48.2	9.7	44.5	0.0	0.0
BACE1	BACE	ENSG00000186318	"Beta-secretase 1"	P56817	11	117285207-117316259	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"Aspartyl protease, Hydrolase, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"brain: 119.1;pancreas: 271.5"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 118.9;Early spermatids: 99.9;Late spermatids: 343.0;Oligodendrocytes: 99.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 88.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB016358	Approved		Supported	"Plasma membrane"		NA	NA				"Cluster 22: Non-specific - Unknown function"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 31: Spermatids - Spermatogenesis"	"Plasma membrane"		"CAB016358: AB_626716"	"unprognostic (7.96e-3)"	"unprognostic (8.05e-2)"	"unprognostic (3.55e-2)"	"unprognostic (3.05e-3)"	"unprognostic (8.94e-2)"	"unprognostic (3.39e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.60e-1)"	"unprognostic (4.54e-2)"	"unprognostic (8.04e-2)"	"unprognostic (8.09e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.35e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.27e-1)"	"prognostic unfavorable (6.76e-4)"	15.4	16.0	34.3	8.0	68.5	3.3	11.7	68.7	44.0	18.3	11.9	13.7	6.1	19.7	8.8	13.5	15.9	19.1	11.4	34.3	44.5	14.8	25.6	14.4	5.1	89.7	67.0	20.5	271.5	18.5	10.7	13.8	76.6	13.4	7.6	44.7	11.0	18.3	12.5	11.4	7.7	21.3	61.6	12.4	9.8	11.2	59.9	3.8	12.2	9.1	5.0	12.4	14.3	119.1	11.5	10.7	22.9	37.3	80.9	82.3	1.0	62.9	44.4	24.4	19.0	4.5	16.4	1.4	14.6	88.3	18.4	17.9	24.3	12.1	20.5	3.1	12.1	6.0	17.3	5.1	36.5	2.5	1.7	68.1	20.2	29.7	31.8	68.0	21.4	3.8	2.7	1.1	46.5	33.4	2.5	2.1	15.5	10.6	25.9	6.4	11.6	1.6	12.2	5.9	31.7	36.7	22.5	2.6	5.9	23.5	26.2	7.6	31.4	45.2	5.0	48.2	19.4	0.7	1.0	1.1	23.8	2.0	34.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	34.3	68.5	68.7	44.0	34.3	44.5	89.7	67.0	76.6	61.6	59.9	119.1	12.1	19.2	10.1	16.3	0.3	4.7	4.1	3.4	9.1	53.7	8.7	9.0	8.7	18.6	13.3	5.5	118.9	1.0	0.1	2.0	5.9	7.4	99.9	5.1	32.1	8.3	21.7	1.7	24.9	20.0	1.3	19.5	3.1	8.9	2.5	15.8	6.8	38.6	9.4	57.2	32.0	5.1	2.0	17.2	7.7	343.0	19.3	7.9	3.6	14.0	4.0	17.9	0.0	22.1	99.8	4.3	6.3	22.2	0.1	2.4	1.7	6.3	3.4	55.2	6.6	18.1	14.2	3.4	1.7	10.6	3.4	0.8	1.2	68.0	4.5	3.4
BACH2	BTBD25	ENSG00000112182	"BTB domain and CNC homolog 2"	Q9BYV9	6	89926528-90296908	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 11.7;lymphoid tissue: 17.0"	"Group enriched"	"Detected in many"	4	"Astrocytes: 81.3;B-cells: 93.1;Excitatory neurons: 95.2;Horizontal cells: 198.5;Inhibitory neurons: 293.9;Oligodendrocyte precursor cells: 169.9;Oligodendrocytes: 253.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"naive B-cell: 14.1"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in many"	6	"Daudi: 139.5;U-698: 78.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA051384, HPA058384"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm	Cytosol	"HPA051384: AB_2681462, HPA058384: AB_2683700"	"unprognostic (4.00e-3)"	"unprognostic (3.17e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.47e-4)"	"unprognostic (1.49e-1)"	"unprognostic (2.29e-1)"	"unprognostic (3.42e-2)"	"unprognostic (8.92e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.06e-2)"	"unprognostic (3.12e-3)"	"unprognostic (4.22e-1)"	"unprognostic (9.87e-3)"	"unprognostic (2.10e-2)"	"unprognostic (1.83e-1)"	"unprognostic (2.03e-1)"	"unprognostic (3.87e-4)"	1.3	0.8	2.0	4.9	3.7	11.7	1.7	3.2	4.0	1.9	0.1	0.9	0.3	2.6	0.6	0.6	1.1	0.9	1.2	2.3	3.3	0.6	2.5	2.4	17.0	4.9	2.9	3.3	1.6	1.6	0.6	1.0	3.2	1.3	0.5	1.3	1.3	0.8	3.2	2.2	2.7	1.1	1.9	4.4	0.6	1.7	2.7	12.3	0.6	2.3	12.8	1.4	1.3	7.7	1.0	0.1	5.1	0.5	0.2	0.0	0.8	0.0	0.2	0.1	0.6	0.0	0.2	139.5	0.2	0.0	0.1	0.1	0.8	1.7	0.4	0.0	1.7	0.0	0.1	0.0	0.0	0.2	0.4	1.1	0.4	0.1	3.0	0.0	0.1	8.6	5.8	11.6	0.0	0.4	3.0	0.0	1.4	0.0	1.1	19.3	3.6	2.5	0.0	0.3	4.5	12.8	0.5	0.1	0.9	1.7	0.2	0.1	0.4	0.0	1.9	0.0	0.1	8.9	0.4	78.8	0.6	1.4	1.0	2.4	0.0	0.8	0.3	0.0	0.8	2.5	0.8	0.7	0.2	14.1	3.6	2.5	0.0	1.7	0.0	0.2	0.1	0.5	2.0	3.7	3.2	4.0	2.3	3.3	4.9	2.9	3.2	1.9	2.7	7.7	4.0	0.0	0.5	81.3	93.1	7.5	11.4	1.7	15.9	5.9	5.4	7.7	2.2	0.0	2.2	3.7	41.7	0.2	10.2	0.1	0.0	6.2	19.9	2.9	7.2	2.9	0.0	2.5	95.2	2.8	0.3	8.4	1.5	11.4	0.0	0.7	2.2	3.1	0.5	198.5	293.9	0.2	0.0	0.3	11.8	10.6	5.9	3.0	3.6	38.4	2.5	0.7	20.6	169.9	253.9	3.4	0.0	4.5	7.6	20.0	0.0	0.3	0.7	1.8	0.0	13.5	4.2	0.1	2.4	3.8	7.7	0.0	23.6	0.5	0.1	3.5
BAG1		ENSG00000107262	"BAG cochaperone 1"	Q99933	9	33247820-33264720	"Cancer-related genes, Predicted intracellular proteins"	Apoptosis	Chaperone	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 1043.2;Late spermatids: 2944.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HeLa: 437.5;NB-4: 417.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002486, HPA018121, HPA073236"	Supported		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 20: HeLa - Mitochondria"	"Cluster 34: Spermatids - Unknown function"	Nucleoplasm	Cytosol	"CAB002486: AB_563422, HPA018121: AB_1845255, HPA073236: "	"unprognostic (4.49e-3)"	"unprognostic (4.52e-2)"	"unprognostic (2.33e-2)"	"unprognostic (1.32e-3)"	"unprognostic (5.46e-2)"	"unprognostic (3.67e-3)"	"unprognostic (2.10e-1)"	"unprognostic (1.34e-2)"	"unprognostic (4.62e-2)"	"unprognostic (7.21e-2)"	"unprognostic (4.24e-1)"	"unprognostic (2.23e-1)"	"prognostic favorable (2.22e-16)"	"unprognostic (4.45e-2)"	"unprognostic (4.03e-1)"	"unprognostic (7.64e-3)"	"unprognostic (1.07e-2)"	79.7	76.3	96.6	36.3	106.7	85.0	72.3	102.2	112.3	65.0	106.0	122.5	59.3	59.8	53.9	103.2	54.8	39.1	192.9	86.4	102.8	151.6	83.4	82.5	35.5	107.4	105.2	45.6	91.7	139.6	99.3	47.1	98.8	88.0	75.4	82.2	97.4	68.4	297.7	113.8	66.1	42.7	100.2	66.0	102.5	87.9	104.3	45.1	71.6	206.1	55.2	121.5	78.8	101.6	56.0	56.1	46.8	103.3	69.9	40.9	63.6	46.5	64.6	68.4	69.8	39.7	54.1	181.2	33.6	46.6	24.5	69.8	54.8	37.9	45.0	96.5	52.1	90.2	437.5	62.5	58.9	210.1	110.0	41.5	205.6	32.3	76.8	32.2	82.4	48.0	108.7	92.1	57.8	89.7	152.4	417.0	90.8	73.9	81.2	78.7	63.7	119.6	87.1	164.8	149.1	88.5	192.7	176.9	46.0	18.7	80.5	261.8	44.1	30.5	37.8	89.9	78.0	74.9	125.3	100.4	25.5	114.1	17.7	29.1	20.7	57.9	10.0	22.2	9.0	14.7	11.2	11.9	26.1	25.6	15.7	9.1	10.2	15.3	22.3	33.9	15.2	10.2	96.6	106.7	102.2	112.3	86.4	102.8	107.4	105.2	98.8	100.2	104.3	101.6	107.7	89.8	67.5	5.2	69.4	429.9	279.4	193.3	172.4	84.0	134.1	123.6	144.4	127.2	157.0	218.8	58.4	154.7	113.7	211.4	397.2	135.6	1043.2	109.3	72.2	86.6	198.1	259.1	5.9	189.0	59.9	79.4	104.5	193.3	41.9	36.7	66.8	72.8	104.9	38.7	7.1	287.8	170.9	86.4	162.7	2944.9	85.7	93.9	163.7	2.8	81.0	123.9	88.6	4.5	9.7	131.1	259.2	88.8	110.3	505.4	247.9	286.1	71.8	131.3	98.6	98.5	109.9	87.9	64.4	261.1	561.5	245.9	69.6	103.7	222.4	531.4
BAG2		ENSG00000112208	"BAG cochaperone 2"	O95816	6	57172326-57189833	"Plasma proteins, Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 32.6"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 73.3;Early spermatids: 152.3;Spermatocytes: 93.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018862, HPA019918"	Enhanced		Supported	"Intermediate filaments,Cytosol"		NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 33: Fibroblasts - ECM organization"	Cytosol	"Intermediate filaments"	"HPA018862: AB_2669957, HPA019918: AB_2670317"	"unprognostic (3.93e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.60e-1)"	"unprognostic (1.33e-1)"	"unprognostic (5.63e-2)"	"unprognostic (8.32e-3)"	"prognostic unfavorable (6.72e-6)"	"unprognostic (1.10e-1)"	"unprognostic (7.79e-5)"	"unprognostic (6.20e-3)"	"unprognostic (4.71e-2)"	"unprognostic (6.56e-2)"	"unprognostic (6.07e-3)"	"unprognostic (5.97e-3)"	"unprognostic (8.77e-2)"	"prognostic unfavorable (1.26e-4)"	"unprognostic (6.24e-3)"	3.7	4.4	2.5	6.6	2.7	1.5	1.7	2.8	4.0	11.4	3.0	32.6	2.1	25.1	3.9	7.2	9.1	7.3	9.1	2.5	2.7	2.8	4.1	5.0	2.7	2.3	2.7	8.5	1.6	0.4	2.0	7.6	2.4	11.2	4.5	4.9	1.0	15.9	9.2	1.3	6.5	29.0	2.3	1.1	7.8	6.4	2.6	1.3	4.6	6.5	2.1	22.5	5.9	3.0	17.2	9.3	3.9	13.8	9.4	26.9	10.9	27.2	25.8	19.2	18.2	12.1	8.6	5.7	25.3	43.2	15.7	3.1	22.5	2.4	18.3	18.3	16.4	16.7	13.3	27.5	14.5	14.8	3.7	13.1	1.2	15.8	14.6	11.4	15.2	13.0	34.1	7.9	19.1	1.3	10.5	12.4	14.8	0.3	9.6	9.5	10.9	11.4	23.2	2.8	4.9	4.4	12.2	0.9	10.1	17.8	2.1	12.7	20.8	10.9	17.9	23.2	27.4	5.3	5.5	12.5	9.7	5.8	1.0	0.1	0.2	0.5	1.9	0.2	2.2	3.5	1.7	1.9	0.9	3.0	3.4	2.9	0.1	2.1	0.0	0.3	2.0	1.1	2.5	2.7	2.8	4.0	2.5	2.7	2.3	2.7	2.4	2.3	2.6	3.0	2.4	3.2	3.7	4.6	16.7	2.4	4.6	5.0	1.8	6.9	4.1	2.7	40.0	0.0	3.8	3.7	12.5	73.3	8.0	0.6	1.9	11.6	152.3	11.0	35.5	3.1	1.8	12.2	8.1	3.7	18.2	46.2	3.1	4.2	4.5	25.6	2.2	15.8	15.8	10.1	10.0	0.3	14.2	2.6	6.6	35.9	31.1	5.1	7.2	5.6	9.1	8.2	3.1	10.6	10.6	5.4	1.3	38.7	13.0	6.2	0.4	33.9	9.1	16.9	6.6	32.1	31.0	93.5	9.8	1.3	3.8	18.9	12.2	30.6	1.3	2.1
BAG3		ENSG00000151929	"BAG cochaperone 3"	O95817	10	119651380-119677819	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	Apoptosis	Chaperone	"Cardiomyopathy, Disease variant, Myofibrillar myopathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 349.1;skeletal muscle: 514.4"	"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 882.2;Basal squamous epithelial cells: 414.9;Squamous epithelial cells: 370.2;Urothelial cells: 488.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"naive CD4 T-cell: 4.1"	"Lineage enriched"	"Detected in single"	6	"T-cells: 4.1"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018493, HPA020586"	Enhanced		Supported	Cytosol		NA	NA		460000	"Cluster 32: T-cells - Unknown function"	"Cluster 47: Non-specific - Unknown function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 22: Epithelial cell types - Mixed function"	Cytosol		"HPA018493: AB_1845257, HPA020586: AB_1845258"	"unprognostic (1.18e-1)"	"unprognostic (1.68e-1)"	"unprognostic (2.12e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.82e-2)"	"unprognostic (5.31e-3)"	"unprognostic (4.51e-3)"	"unprognostic (3.32e-2)"	"unprognostic (1.98e-2)"	"unprognostic (1.46e-2)"	"unprognostic (1.30e-2)"	"unprognostic (1.49e-1)"	"unprognostic (2.18e-3)"	"unprognostic (4.21e-2)"	"unprognostic (1.34e-1)"	"unprognostic (8.46e-2)"	"unprognostic (3.03e-2)"	73.5	40.3	81.6	16.1	80.6	5.1	40.5	96.9	349.1	41.7	61.3	72.4	12.3	45.2	20.4	86.0	37.7	35.1	153.3	82.1	124.3	42.2	38.4	77.9	8.2	127.2	100.2	33.3	20.5	53.6	36.6	36.0	101.3	39.1	12.6	12.6	50.1	24.5	514.4	61.9	25.9	43.3	106.3	15.9	72.4	23.1	84.1	5.7	31.1	187.8	17.3	60.4	55.3	95.5	100.1	111.2	30.5	39.6	77.2	53.9	56.9	89.1	74.7	66.6	56.8	47.5	47.6	3.8	41.4	76.9	86.6	145.2	31.5	157.2	45.7	49.1	51.8	5.4	28.6	60.1	65.2	0.3	22.1	54.6	89.0	48.6	76.2	70.5	75.5	17.1	43.3	24.0	67.2	142.7	5.5	22.3	12.0	33.1	125.8	0.3	43.2	17.2	50.7	22.3	5.6	5.1	35.4	61.9	47.2	32.9	38.8	13.4	94.8	35.0	30.1	47.8	129.5	22.1	14.0	2.4	65.2	1.5	27.1	0.0	0.6	0.0	0.6	0.7	1.1	0.1	2.4	0.8	0.4	0.0	4.1	1.4	0.2	0.1	0.3	0.1	1.7	0.6	81.6	80.6	96.9	349.1	82.1	124.3	127.2	100.2	101.3	106.3	84.1	95.5	77.8	22.4	43.2	34.9	10.9	79.4	882.2	51.0	414.9	6.1	48.3	62.9	196.0	18.6	48.1	7.3	18.8	41.4	4.9	61.7	27.4	19.4	29.3	56.7	60.0	107.0	38.5	0.8	1.3	25.3	57.0	142.7	51.5	89.1	23.6	7.3	22.5	15.3	33.7	1.7	2.5	87.0	46.8	8.7	95.4	32.8	22.4	146.9	55.2	10.3	4.7	32.6	3.1	1.0	1.2	37.3	69.2	24.0	29.5	225.1	8.3	42.8	39.4	1.7	19.7	141.6	134.3	21.8	18.7	370.2	76.1	73.5	85.6	10.0	53.9	488.1
BAHD1	KIAA0945	ENSG00000140320	"Bromo adjacent homology domain containing 1"	Q8TBE0	15	40439721-40468236	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041196			Supported	Nucleoplasm		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 71: Testis - DNA repair"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm		"HPA041196: AB_10803999"	"prognostic unfavorable (1.55e-4)"	"unprognostic (4.08e-1)"	"unprognostic (3.00e-2)"	"unprognostic (1.56e-2)"	"unprognostic (1.35e-2)"	"unprognostic (1.04e-1)"	"unprognostic (7.19e-2)"	"unprognostic (1.12e-2)"	"unprognostic (2.06e-2)"	"unprognostic (2.00e-2)"	"unprognostic (3.49e-3)"	"unprognostic (4.81e-2)"	"prognostic favorable (1.29e-10)"	"unprognostic (4.95e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.11e-1)"	9.6	21.9	10.8	8.0	11.5	8.1	9.2	8.6	10.5	11.0	9.9	12.3	9.1	12.5	10.2	12.0	13.6	6.3	14.3	11.9	9.8	14.2	11.6	12.5	9.8	10.3	9.5	21.4	13.8	13.0	13.3	8.7	9.4	10.3	5.8	5.2	12.6	10.2	12.6	11.0	12.0	7.2	9.1	12.6	12.7	18.6	10.9	11.6	16.5	7.6	9.1	12.3	9.1	10.1	16.9	8.5	14.7	24.5	11.7	9.1	32.0	13.3	9.5	14.4	14.0	23.1	7.9	12.5	17.6	12.0	17.6	32.6	24.2	10.1	8.0	24.2	15.2	32.9	13.2	11.5	11.1	14.4	24.0	12.0	10.2	8.8	8.7	12.8	12.5	15.8	32.8	10.4	8.6	16.0	16.2	21.8	14.6	19.7	15.6	27.3	16.6	10.4	15.9	19.7	23.0	13.9	8.2	42.8	9.7	9.1	34.4	23.1	14.8	15.6	17.4	22.4	14.1	15.5	18.4	14.2	16.3	22.1	10.7	0.6	0.3	1.4	1.3	0.6	0.6	0.5	0.9	0.7	0.3	0.7	1.2	1.0	0.3	1.4	1.2	0.6	0.3	0.4	10.8	11.5	8.6	10.5	11.9	9.8	10.3	9.5	9.4	9.1	10.9	10.1	9.7	19.2	7.0	7.8	4.9	8.3	3.7	4.1	6.8	3.9	11.4	9.4	11.7	5.7	7.7	11.0	2.1	5.5	5.6	20.7	1.9	5.4	1.0	6.1	4.9	8.4	7.8	2.5	10.3	7.4	7.3	4.7	2.0	8.4	8.9	5.6	9.7	12.0	5.7	16.8	8.1	7.4	2.0	12.0	4.6	2.7	10.2	5.4	0.0	7.5	6.7	5.2	10.3	9.0	8.9	6.7	8.9	5.7	1.6	5.3	11.6	5.0	5.0	4.7	6.6	6.1	5.5	6.3	10.9	6.9	7.7	4.1	5.8	7.6	8.0	4.9
BANF1	BAF	ENSG00000175334	"BAF nuclear assembly factor 1"	O75531	11	66002228-66004149	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction"	DNA-binding	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB032896, HPA039242"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA		690000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	Cytosol	"CAB032896: AB_2061090, HPA039242: AB_2676409"	"unprognostic (1.69e-1)"	"unprognostic (4.46e-3)"	"unprognostic (2.04e-1)"	"unprognostic (9.59e-3)"	"unprognostic (1.23e-1)"	"unprognostic (3.70e-3)"	"unprognostic (6.16e-3)"	"unprognostic (8.39e-3)"	"unprognostic (2.31e-1)"	"unprognostic (5.07e-2)"	"unprognostic (1.76e-2)"	"unprognostic (4.57e-1)"	"unprognostic (7.36e-3)"	"unprognostic (3.06e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.83e-3)"	"unprognostic (6.39e-2)"	116.4	149.0	252.8	144.8	256.8	127.2	151.4	261.0	312.9	135.4	248.4	153.7	107.2	168.0	248.5	136.0	279.6	100.9	272.2	249.9	259.6	115.6	174.0	111.3	178.5	258.4	254.4	207.6	132.5	148.8	69.0	120.8	261.1	139.2	155.9	98.7	148.2	169.7	582.1	121.0	105.0	190.0	258.5	116.0	92.7	111.1	254.8	220.7	164.6	394.8	211.9	140.6	82.4	274.5	665.5	712.0	452.8	427.9	237.7	306.5	220.5	364.7	349.4	715.9	447.0	415.3	496.1	606.5	651.8	503.3	544.0	433.5	641.7	600.1	559.1	476.4	411.5	699.5	431.3	537.0	296.0	503.4	480.4	292.5	404.6	453.8	418.1	404.6	494.6	526.5	552.5	459.6	687.5	1196.3	607.7	1023.8	494.7	410.4	525.6	507.0	447.1	1297.4	647.9	361.7	362.9	458.0	399.1	636.4	469.4	352.9	698.8	378.6	350.4	535.8	574.2	601.8	515.8	313.6	680.4	771.1	442.7	420.2	485.5	112.7	231.7	82.2	165.2	239.1	159.1	243.7	139.0	160.5	252.9	234.6	166.0	174.4	28.7	219.7	266.2	238.2	125.5	324.0	252.8	256.8	261.0	312.9	249.9	259.6	258.4	254.4	261.1	258.5	254.8	274.5	135.8	54.5	41.9	11.4	112.7	126.8	154.6	301.2	142.9	52.8	164.8	230.0	32.1	102.9	153.6	196.8	25.0	296.5	101.4	70.7	326.8	196.8	17.1	164.8	147.2	126.5	142.8	144.5	12.3	177.3	346.6	126.6	86.6	116.2	140.2	199.7	79.9	130.8	324.5	50.5	13.4	171.4	223.8	80.6	169.8	41.9	142.0	124.7	186.7	8.4	155.9	123.8	186.4	9.0	22.2	170.3	107.1	123.8	110.8	126.8	77.4	251.5	187.7	57.8	72.3	123.9	145.5	250.2	325.1	227.0	118.1	174.7	104.9	172.6	196.2	148.9
BANP	"BEND1, DKFZp761H172, FLJ10177, FLJ20538, SMAR1, SMARBP1"	ENSG00000172530	"BTG3 associated nuclear protein"	Q8N9N5	16	87949244-88077318	"Predicted intracellular proteins"	"Cell cycle, Transcription, Transcription regulation"	"Chromatin regulator, Developmental protein, DNA-binding, Repressor"	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047164	Approved		Supported	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 65: Plasmacytoid DCs - Unknown function"	Nucleoplasm	"Nuclear bodies"	"HPA047164: AB_2679964"	"unprognostic (1.82e-1)"	"unprognostic (7.84e-3)"	"unprognostic (4.73e-2)"	"unprognostic (2.14e-1)"	"unprognostic (1.55e-1)"	"unprognostic (3.35e-2)"	"unprognostic (4.95e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.19e-1)"	"unprognostic (8.17e-2)"	"unprognostic (3.53e-3)"	"unprognostic (1.68e-3)"	"unprognostic (4.98e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.62e-2)"	"unprognostic (5.89e-2)"	8.8	9.3	8.1	9.5	8.8	12.1	7.8	16.0	9.5	10.2	11.3	8.8	5.1	9.6	3.3	7.5	9.6	4.9	8.0	9.1	8.9	9.0	13.9	7.4	9.6	10.6	9.0	12.3	8.7	6.2	9.9	7.7	9.8	8.1	3.6	6.4	7.9	5.1	10.2	8.0	8.7	4.3	7.3	12.1	7.5	11.0	10.3	10.4	8.0	5.1	6.4	9.3	8.3	12.1	12.5	19.7	9.6	14.4	8.4	10.1	32.2	14.8	7.4	14.3	9.7	21.6	17.0	16.8	19.6	3.5	13.0	14.2	14.4	6.7	5.2	13.1	15.5	10.5	12.9	18.0	7.1	11.2	8.3	3.0	10.7	8.8	6.3	12.9	8.9	10.9	17.9	9.3	8.8	14.5	15.5	14.6	16.5	9.7	23.6	16.4	11.1	12.4	8.5	5.9	14.2	11.7	18.8	11.0	13.8	14.1	13.5	14.3	11.0	15.4	10.7	9.1	14.8	7.6	13.9	25.7	9.2	17.2	15.1	22.9	19.9	40.7	22.2	18.2	18.7	25.1	23.5	19.9	24.7	21.5	24.9	22.3	64.5	24.5	22.5	29.7	23.0	19.5	8.1	8.8	16.0	9.5	9.1	8.9	10.6	9.0	9.8	7.3	10.3	12.1	12.0	9.6	8.3	15.0	28.6	14.9	11.8	7.4	6.2	14.2	14.1	13.2	5.8	10.0	5.1	16.5	4.2	19.4	42.2	9.2	3.9	12.5	5.8	10.7	9.7	13.6	12.1	4.4	32.7	8.0	27.3	16.3	4.1	13.4	8.2	17.9	5.3	10.3	12.4	26.9	28.3	8.9	2.0	11.1	48.3	8.2	10.8	22.6	19.6	20.6	16.0	11.6	22.6	23.1	28.6	11.0	8.6	10.9	21.2	16.2	10.0	7.8	6.3	17.2	13.1	10.8	22.7	33.7	22.7	6.2	21.3	56.6	19.1	10.2	8.9	17.2
BARD1		ENSG00000138376	"BRCA1 associated RING domain 1"	Q99728	2	214725646-214809683	"Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, Ubl conjugation pathway"	Transferase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 68.6;Basal prostatic cells: 62.2;Suprabasal keratinocytes: 74.4;Urothelial cells: 67.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB034106, HPA035354, HPA044864"	Enhanced		Supported	"Nucleoplasm,Nuclear speckles,Cytoplasmic bodies"		No	Yes			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 22: Epithelial cell types - Mixed function"	"Nucleoplasm, Nuclear speckles"	"Cytoplasmic bodies"	"CAB034106: AB_2061237, HPA035354: AB_2674585, HPA044864: AB_2679119"	"unprognostic (4.85e-2)"	"unprognostic (1.87e-2)"	"unprognostic (1.74e-2)"	"unprognostic (8.37e-3)"	"unprognostic (2.57e-2)"	"unprognostic (1.03e-2)"	"unprognostic (6.25e-4)"	"unprognostic (1.99e-1)"	"unprognostic (2.16e-2)"	"unprognostic (3.92e-3)"	"unprognostic (2.80e-2)"	"unprognostic (7.41e-2)"	"unprognostic (1.94e-8)"	"unprognostic (3.94e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.08e-1)"	1.8	0.6	3.0	2.7	4.6	11.4	2.9	2.2	2.7	3.1	0.2	2.9	2.3	3.3	2.6	5.1	1.9	2.0	1.5	2.3	4.1	0.8	1.0	2.5	5.5	3.8	3.2	2.3	1.6	2.3	1.2	2.3	3.9	2.9	3.6	2.0	1.9	3.6	4.2	8.8	2.1	3.9	3.9	2.6	1.9	6.6	4.1	7.0	1.4	2.3	6.6	2.1	3.8	4.2	12.3	8.8	20.2	9.3	2.7	4.0	12.0	17.3	10.6	17.8	21.8	12.0	12.2	12.6	7.6	8.5	9.5	12.7	16.5	10.5	22.7	11.5	6.4	12.5	13.8	8.7	0.9	13.9	12.7	4.7	1.1	15.0	8.1	4.5	6.1	14.7	7.9	36.0	13.7	10.7	27.9	12.5	14.3	7.9	3.7	24.7	19.8	11.2	3.9	14.0	5.8	8.8	15.0	14.7	5.3	10.9	16.3	13.4	4.7	18.0	14.0	11.7	13.6	10.2	12.6	28.0	7.6	11.3	13.4	3.9	2.0	5.8	4.6	4.0	3.2	9.7	5.4	5.5	3.6	8.2	2.4	4.0	0.3	7.3	3.8	6.9	17.1	2.3	3.0	4.6	2.2	2.7	2.3	4.1	3.8	3.2	3.9	3.9	4.1	4.2	12.3	6.4	2.2	14.7	13.0	68.6	62.2	13.0	14.2	3.3	9.9	14.1	17.4	17.2	12.7	9.2	0.0	18.2	11.3	8.2	3.9	8.0	9.2	13.3	11.9	9.6	1.2	34.5	5.5	6.9	16.0	10.0	10.2	18.0	15.2	28.2	10.0	4.2	12.5	1.7	15.4	13.1	8.2	10.1	12.2	5.7	6.2	11.2	3.6	15.9	16.6	4.4	9.2	19.6	31.7	6.5	6.5	10.1	22.0	22.9	3.2	0.7	12.3	6.8	19.7	15.4	16.9	27.6	43.4	28.6	74.4	5.1	13.4	10.5	14.7	67.2
BARX2		ENSG00000043039	"BARX homeobox 2"	Q9UMQ3	11	129375848-129452279	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 158.0;salivary gland: 131.4;vagina: 72.2"	"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 128.5;Breast glandular cells: 50.4;Squamous epithelial cells: 136.4;Suprabasal keratinocytes: 82.5;Urothelial cells: 84.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"HDLM-2: 163.7"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"cerebral cortex: 2.8;hippocampal formation: 1.7"	"CAB033311, HPA064966, HPA068414"	Enhanced		Supported	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA				"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 61: Squamous epithelial cells - Keratinization"	Nucleoplasm	"Golgi apparatus, Cytosol"	"CAB033311: AB_781574, HPA064966: , HPA068414: AB_2685984"	"unprognostic (4.25e-2)"	"unprognostic (2.89e-1)"	"unprognostic (2.46e-1)"	"unprognostic (1.22e-5)"	"unprognostic (3.85e-2)"	"unprognostic (9.29e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.43e-3)"	"unprognostic (4.80e-1)"	"unprognostic (1.71e-2)"	"unprognostic (4.35e-3)"	"unprognostic (1.15e-1)"	"unprognostic (8.39e-2)"	"unprognostic (3.48e-1)"	"unprognostic (8.37e-2)"	"unprognostic (2.14e-2)"	"prognostic unfavorable (3.06e-4)"	0.3	0.0	0.1	1.3	0.3	0.0	14.9	1.1	0.3	24.2	5.5	7.0	17.9	0.1	0.2	158.0	16.7	4.7	0.2	0.3	0.4	5.4	0.0	0.3	0.7	3.0	1.6	0.0	10.3	0.3	1.7	3.6	3.2	4.8	4.9	0.2	131.4	0.6	2.2	34.8	13.0	0.2	1.8	0.0	6.4	2.4	0.4	0.4	0.3	39.3	8.8	0.4	72.2	2.9	23.7	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	8.1	0.0	0.3	0.0	1.0	20.9	0.0	5.1	0.0	163.7	8.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	7.1	0.0	3.9	0.0	6.2	0.0	0.0	0.0	20.6	0.9	0.0	0.0	39.8	0.0	0.3	0.2	0.0	0.0	19.4	0.1	0.4	3.8	0.1	0.0	0.0	1.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	1.1	0.3	0.3	0.4	3.0	1.6	3.2	1.8	0.4	2.9	0.2	0.0	1.1	0.3	0.5	43.1	128.5	8.7	3.4	0.6	50.4	16.9	0.5	4.3	8.0	0.0	0.0	13.4	0.8	29.4	7.9	23.7	7.2	11.3	0.6	1.2	1.8	0.0	1.8	0.7	5.8	2.7	6.6	4.6	0.0	0.0	0.0	0.2	1.9	0.0	0.3	13.4	0.0	0.3	2.2	1.6	0.0	0.7	10.6	0.0	0.1	0.7	0.0	0.0	0.3	6.2	29.8	0.4	0.9	25.6	34.0	3.4	11.8	0.3	0.0	0.6	1.7	0.1	5.3	136.4	82.5	4.2	1.7	0.0	19.4	84.8
BATF3	"JDP1, JUNDM1, SNFT"	ENSG00000123685	"Basic leucine zipper ATF-like transcription factor 3"	Q9NR55	1	212686417-212699840	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"choroid plexus: 9.1"	"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 41.0;Langerhans cells: 50.4;Macrophages: 24.4;monocytes: 65.7;Smooth muscle cells: 20.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"intermediate monocyte: 65.9;myeloid DC: 55.3;non-classical monocyte: 99.3"	"Group enriched"	"Detected in many"	34	"dendritic cells: 55.3;monocytes: 99.3"	"Cell line enriched"	"Detected in many"	11	"HDLM-2: 497.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA075858			Supported	Nucleoplasm,Nucleoli,Cytosol		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 41: Macrophages - Immune response"	Nucleoli	"Nucleoplasm, Cytosol"	"HPA075858: "	"unprognostic (3.87e-2)"	"unprognostic (2.10e-2)"	"unprognostic (4.29e-2)"	"unprognostic (6.85e-2)"	"unprognostic (6.33e-2)"	"unprognostic (3.15e-2)"	"unprognostic (3.84e-2)"	"unprognostic (6.59e-2)"	"unprognostic (3.08e-1)"	"unprognostic (6.47e-2)"	"unprognostic (1.28e-2)"	"unprognostic (1.75e-1)"	"unprognostic (6.43e-10)"	"unprognostic (9.88e-2)"	"unprognostic (5.19e-2)"	"unprognostic (3.90e-1)"	"unprognostic (7.08e-2)"	5.9	1.1	1.9	3.6	2.9	3.0	3.0	1.4	2.8	1.8	9.1	1.7	0.6	1.3	0.0	1.1	2.0	2.0	2.1	2.2	1.9	5.1	1.1	5.8	5.9	1.8	1.8	0.6	1.7	0.4	0.9	2.5	1.9	1.8	0.6	0.0	0.9	0.4	0.5	0.9	2.3	1.8	2.3	7.3	1.5	0.5	1.7	4.2	1.6	0.6	2.6	4.9	1.4	2.0	2.4	6.6	0.7	0.0	0.2	3.1	4.3	2.3	7.4	6.5	7.0	0.0	1.7	0.0	0.9	0.4	10.6	0.0	7.0	1.1	4.5	497.4	12.5	0.1	1.9	0.0	1.2	22.6	3.9	0.5	0.0	12.5	1.8	1.0	0.1	43.5	1.1	6.5	1.3	0.0	17.8	9.3	2.7	0.0	8.4	3.5	2.4	0.3	6.0	0.0	1.4	0.9	1.6	0.0	0.5	2.3	0.0	17.8	0.0	2.7	11.1	0.5	13.4	0.5	1.4	2.7	8.7	21.3	6.2	0.0	13.6	0.0	0.0	65.9	0.0	0.7	0.2	0.3	55.3	0.0	0.0	0.0	2.2	1.5	99.3	0.2	1.8	8.8	1.9	2.9	1.4	2.8	2.2	1.9	1.8	1.8	1.9	2.3	1.7	2.0	9.6	3.2	0.6	0.3	2.4	5.7	2.3	0.9	0.0	0.2	5.2	5.5	0.5	0.0	1.6	0.0	0.0	2.1	0.7	0.0	0.0	0.7	0.7	1.5	3.1	8.2	0.0	0.4	4.5	0.4	41.0	6.8	0.0	2.3	5.1	1.0	6.1	0.4	5.8	0.0	0.6	0.1	0.0	14.4	50.4	0.8	0.9	24.4	1.8	7.5	65.7	0.1	0.0	0.5	0.9	1.1	0.0	0.0	0.0	18.9	0.0	0.4	2.7	0.4	0.0	5.2	20.0	1.0	4.1	0.1	2.8	4.5	1.9	0.1	0.0	1.4
BAZ1B	"WBSCR10, WBSCR9, WSTF"	ENSG00000009954	"Bromodomain adjacent to zinc finger domain 1B"	Q9UIG0	7	73440406-73522293	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"DNA damage, Transcription, Transcription regulation"	"Kinase, Transferase, Tyrosine-protein kinase"	"Williams-Beuren syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB037081, CAB037158, HPA058068"	Supported		Supported	Nucleoplasm		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"CAB037081: AB_477637, CAB037158: AB_477636, HPA058068: "	"unprognostic (1.17e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.06e-2)"	"unprognostic (1.37e-1)"	"unprognostic (5.72e-2)"	"unprognostic (1.10e-3)"	"unprognostic (1.89e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.50e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.12e-1)"	"unprognostic (7.13e-2)"	"unprognostic (1.03e-1)"	"unprognostic (4.41e-2)"	"unprognostic (1.09e-1)"	"unprognostic (3.16e-1)"	22.6	19.4	24.1	22.1	28.3	24.7	16.7	28.6	25.2	22.5	21.5	23.0	16.0	24.4	17.7	18.0	19.3	16.0	19.6	21.9	26.9	16.8	24.1	20.3	27.9	25.1	26.5	30.8	21.0	27.6	19.2	22.7	24.7	22.6	20.5	28.3	17.1	25.4	28.0	14.2	18.2	24.7	23.8	23.4	18.9	17.3	25.5	40.6	23.8	30.7	29.6	21.9	17.5	29.1	75.6	76.1	102.5	115.3	52.0	55.1	34.1	71.7	54.7	67.4	70.5	62.4	55.6	141.6	16.3	64.1	102.6	51.7	126.1	47.7	100.9	80.3	63.8	84.4	89.3	54.3	57.9	128.8	68.5	39.6	45.5	83.2	101.6	50.4	54.5	75.9	149.9	86.4	76.7	71.7	132.8	59.1	66.7	57.6	56.2	133.1	89.9	94.5	38.5	58.2	102.4	87.2	102.1	112.4	59.8	87.1	69.1	63.6	64.4	116.1	66.5	70.6	123.2	49.7	84.7	235.7	65.9	119.1	107.7	4.0	1.5	1.0	3.0	1.1	2.6	1.2	2.3	2.2	1.1	2.5	1.7	1.9	1.1	2.8	0.8	3.1	2.5	0.9	24.1	28.3	28.6	25.2	21.9	26.9	25.1	26.5	24.7	23.8	25.5	29.1	46.3	76.9	129.8	28.7	52.8	29.8	34.5	16.7	38.1	69.9	28.1	24.6	81.7	27.1	59.0	20.2	43.8	57.3	50.4	33.1	7.9	35.5	8.4	47.4	72.2	53.5	34.7	89.8	35.0	23.1	59.6	58.7	34.7	52.6	51.8	59.5	34.6	59.1	33.0	60.6	35.3	34.6	22.4	33.4	24.8	12.5	61.2	38.7	12.4	34.7	47.3	54.4	61.8	28.6	43.9	26.5	13.6	76.3	65.3	40.5	25.2	12.9	49.2	53.8	32.9	67.1	57.5	75.7	127.0	47.0	25.3	34.6	56.5	46.1	43.3	35.2
BCAS2	"DAM1, Snt309, SPF27"	ENSG00000116752	"BCAS2 pre-mRNA processing factor"	O75934	1	114567557-114581629	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"MCF7: 613.4"	"Low region specificity"	"Detected in all"							HPA067881	Supported		Supported	"Nuclear speckles,Centrosome"		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 7: Non-specific - Mitochondria"	"Nuclear speckles, Centrosome"		"HPA067881: AB_2685915"	"unprognostic (6.93e-2)"	"unprognostic (1.88e-2)"	"unprognostic (8.58e-3)"	"unprognostic (4.74e-2)"	"unprognostic (2.49e-1)"	"unprognostic (2.99e-3)"	"prognostic unfavorable (8.23e-7)"	"unprognostic (1.16e-1)"	"unprognostic (8.51e-3)"	"prognostic favorable (7.96e-4)"	"unprognostic (1.57e-2)"	"prognostic unfavorable (4.27e-4)"	"prognostic favorable (6.49e-4)"	"unprognostic (2.25e-3)"	"unprognostic (1.03e-1)"	"prognostic unfavorable (5.24e-4)"	"unprognostic (1.87e-1)"	31.9	40.6	32.8	28.0	35.4	76.2	38.2	36.7	45.3	27.1	34.6	31.6	25.5	35.1	49.7	34.1	24.9	31.8	39.3	35.7	38.8	44.6	51.3	26.9	38.5	34.9	37.6	32.5	28.8	41.3	33.1	27.8	37.8	35.6	32.1	40.4	29.6	27.2	56.4	29.8	26.1	27.8	34.7	26.1	28.7	31.8	34.6	32.2	42.4	25.9	36.2	41.5	23.4	37.7	100.0	35.6	70.8	69.9	37.8	43.8	108.8	71.3	57.0	95.6	97.4	50.8	40.6	88.8	93.9	46.9	64.3	47.8	85.5	72.7	133.3	76.7	75.7	45.0	67.2	74.6	68.8	117.8	48.1	39.2	79.4	97.5	121.3	44.2	63.7	95.0	89.6	64.5	80.5	613.4	103.1	87.5	125.6	60.8	80.8	73.9	127.6	62.2	68.1	85.9	93.5	62.2	90.3	70.3	114.3	59.6	62.3	91.0	52.8	58.2	74.7	116.9	138.2	68.5	76.9	143.4	113.4	94.7	223.9	54.4	36.8	65.3	56.0	45.2	78.9	63.3	71.6	70.6	39.7	58.0	73.8	71.9	34.7	75.0	51.0	51.2	77.6	72.8	32.8	35.4	36.7	45.3	35.7	38.8	34.9	37.6	37.8	34.7	34.6	37.7	51.6	28.9	45.4	11.1	110.1	77.9	114.2	155.9	91.0	62.6	36.7	49.1	76.0	27.1	85.4	49.7	37.5	76.6	99.0	26.4	95.9	66.6	30.3	79.0	51.5	46.9	50.0	30.5	16.4	66.8	89.8	60.0	25.0	139.1	99.1	46.0	28.2	31.3	66.9	38.7	15.1	43.1	103.7	34.9	93.3	17.7	39.7	80.8	67.6	12.2	50.6	98.3	55.6	15.1	18.1	51.2	37.9	43.6	176.7	49.8	29.4	103.9	55.6	67.1	39.5	55.5	71.4	80.8	40.6	95.7	63.4	101.2	117.4	64.2	36.0	114.2
BCAT2	"BCAM, BCT2"	ENSG00000105552	"Branched chain amino acid transaminase 2"	O15382	19	48795062-48811029	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Amino-acid biosynthesis, Branched-chain amino acid biosynthesis"	"Aminotransferase, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RT4: 254.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054091	Enhanced		Approved	Nucleoplasm,Mitochondria		NA	NA		25000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 15: RT4 - Unknown function"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Nucleoplasm, Mitochondria"		"HPA054091: AB_2682374"	"unprognostic (2.58e-2)"	"unprognostic (1.23e-2)"	"unprognostic (2.16e-1)"	"unprognostic (2.51e-3)"	"unprognostic (1.54e-1)"	"unprognostic (2.97e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.17e-2)"	"unprognostic (2.98e-2)"	"unprognostic (1.03e-1)"	"unprognostic (8.32e-3)"	"unprognostic (1.06e-1)"	"prognostic favorable (3.68e-5)"	"unprognostic (1.87e-3)"	"unprognostic (1.35e-1)"	"unprognostic (2.42e-1)"	"unprognostic (7.50e-3)"	27.2	85.4	27.5	11.4	27.8	6.1	25.2	34.6	34.5	29.7	72.3	38.8	14.8	27.0	5.3	33.7	30.2	10.7	63.4	29.0	26.5	40.5	22.1	30.4	14.0	28.2	29.7	53.3	76.7	20.1	30.7	12.4	27.8	38.4	17.4	5.6	29.1	17.0	58.7	28.0	23.7	13.5	26.1	19.7	66.4	20.2	30.8	12.0	28.9	29.4	16.5	56.6	29.0	29.2	62.9	73.3	19.3	40.6	78.1	26.3	34.2	27.3	13.8	32.7	31.7	74.5	37.4	73.3	30.2	24.3	10.1	28.8	29.8	47.4	16.5	46.0	76.0	27.0	32.7	5.0	75.3	36.9	24.2	38.5	29.8	24.2	35.0	31.8	45.5	55.3	34.9	43.8	12.2	74.8	50.4	38.9	16.9	98.5	35.7	75.2	33.1	80.8	30.8	254.3	102.6	29.4	41.0	66.7	20.7	13.3	42.3	17.9	25.9	31.5	30.3	37.6	34.3	40.8	58.4	35.8	17.2	56.7	21.0	0.0	14.4	3.0	14.3	16.1	20.1	23.5	17.5	18.8	25.6	20.3	15.7	14.1	0.6	14.8	6.2	28.9	24.9	12.3	27.5	27.8	34.6	34.5	29.0	26.5	28.2	29.7	27.8	26.1	30.8	29.2	13.1	28.9	44.8	59.7	14.1	6.0	28.3	32.3	14.2	10.4	23.5	17.9	25.5	31.5	20.6	12.9	20.9	67.6	11.0	28.8	72.4	38.6	8.0	16.2	22.4	13.5	19.9	6.3	11.2	21.3	25.2	15.3	32.6	23.8	23.5	18.3	12.8	11.2	26.2	1.7	10.6	30.4	38.7	7.9	10.5	10.2	17.4	7.5	24.9	8.4	21.6	7.3	7.2	9.0	11.2	15.8	17.7	30.1	15.1	16.1	13.9	39.4	13.2	13.4	19.7	9.9	17.3	8.0	19.5	32.6	7.1	45.8	9.5	21.9	33.9	47.7
BCCIP	"BCCIPalpha, TOK-1"	ENSG00000107949	"BRCA2 and CDKN1A interacting protein"	Q9P287	10	125823546-125853695	"Predicted intracellular proteins"	"Cell cycle, DNA damage, DNA repair"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038011			Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm	Cytosol	"HPA038011: AB_2675784"	"unprognostic (1.05e-1)"	"unprognostic (2.38e-2)"	"unprognostic (2.29e-1)"	"unprognostic (2.96e-2)"	"unprognostic (3.54e-2)"	"unprognostic (1.38e-2)"	"unprognostic (1.93e-3)"	"unprognostic (2.51e-1)"	"unprognostic (3.04e-2)"	"unprognostic (6.62e-3)"	"unprognostic (1.88e-1)"	"unprognostic (1.30e-3)"	"unprognostic (1.90e-3)"	"unprognostic (4.75e-2)"	"unprognostic (1.58e-1)"	"unprognostic (7.39e-2)"	"unprognostic (9.91e-2)"	40.0	35.1	37.7	38.3	39.1	62.4	52.4	41.1	43.4	31.4	42.3	37.6	32.3	31.0	54.6	38.5	33.0	26.6	48.0	37.5	38.7	55.3	67.9	27.2	49.3	38.3	38.3	42.8	47.1	41.6	24.8	32.5	39.2	42.4	41.1	55.7	58.2	28.6	77.5	31.8	31.7	31.4	38.7	29.8	42.8	48.3	39.0	50.0	39.8	63.6	48.7	55.9	30.1	40.8	225.6	114.4	126.9	141.3	70.9	77.2	105.9	117.9	112.1	142.3	131.2	188.2	146.4	156.6	72.1	108.6	107.1	121.4	219.3	167.0	197.6	145.3	148.5	157.9	97.5	210.0	89.4	219.7	96.1	79.9	98.7	170.1	178.3	108.0	137.7	145.1	177.7	78.1	122.5	134.7	142.7	220.4	98.2	188.0	170.2	134.7	133.5	94.3	126.6	106.0	67.2	68.5	88.1	142.4	149.9	102.7	76.9	96.3	93.0	65.9	116.9	98.2	215.9	79.3	94.9	233.0	129.7	112.5	52.0	30.3	68.3	41.1	56.2	86.6	77.8	76.8	63.7	61.9	75.2	71.4	71.1	64.4	11.2	68.2	94.3	65.0	75.6	48.1	37.7	39.1	41.1	43.4	37.5	38.7	38.3	38.3	39.2	38.7	39.0	40.8	21.6	64.1	67.9	16.6	46.9	66.9	59.3	60.6	58.1	24.2	32.2	27.3	80.4	28.6	67.0	23.9	22.9	41.4	28.2	16.7	78.2	52.7	14.7	37.6	36.6	30.4	25.8	47.3	21.3	44.1	38.0	43.2	40.2	33.2	27.1	33.6	23.2	50.4	35.8	16.8	21.0	23.1	42.7	28.9	22.2	9.4	37.0	29.3	23.2	11.2	36.2	30.2	28.8	22.1	25.7	45.1	19.6	31.2	57.7	51.9	22.7	62.4	74.7	25.1	26.3	47.5	37.5	105.3	117.2	57.8	52.1	33.8	38.6	28.3	33.3	55.5
BCDIN3D		ENSG00000186666	"BCDIN3 domain containing RNA methyltransferase"	Q7Z5W3	12	49836043-49843106	"Metabolic proteins, Predicted intracellular proteins"		"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 22.1"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 32.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039911	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 30: Non-specific - Translation"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 6: T47d - Mammary gland"	"Cluster 11: Alveolar cells - Smell perception"	Cytosol	Nucleoplasm	"HPA039911: AB_10673021"	"unprognostic (2.21e-2)"	"unprognostic (6.64e-2)"	"unprognostic (2.70e-3)"	"unprognostic (1.73e-2)"	"unprognostic (1.68e-1)"	"unprognostic (2.84e-2)"	"unprognostic (9.96e-3)"	"prognostic favorable (3.24e-4)"	"unprognostic (2.30e-3)"	"unprognostic (1.62e-3)"	"unprognostic (2.12e-3)"	"unprognostic (1.84e-1)"	"prognostic favorable (1.03e-5)"	"unprognostic (2.31e-2)"	"unprognostic (3.15e-2)"	"unprognostic (1.06e-1)"	"prognostic favorable (1.06e-4)"	2.0	2.9	5.4	2.8	5.5	1.1	4.0	6.0	6.8	2.9	5.3	2.3	2.4	2.5	3.7	2.7	3.9	2.4	2.6	5.4	5.2	3.3	3.7	2.1	4.8	5.5	5.2	3.8	3.5	4.3	2.2	2.3	5.5	3.8	2.8	2.6	4.2	2.7	22.1	3.8	2.8	2.6	5.3	3.2	3.1	2.5	5.3	4.2	3.9	3.0	4.2	2.4	1.9	6.4	2.8	4.0	3.8	5.8	8.0	4.7	3.8	3.9	5.1	4.1	4.2	2.1	7.0	2.5	4.2	1.8	3.0	3.4	3.9	2.3	2.2	8.7	5.1	3.3	3.1	1.3	6.3	4.0	3.3	2.5	9.2	2.9	4.1	5.1	1.9	5.3	6.4	6.7	2.6	7.2	4.5	6.4	3.8	6.3	7.1	4.7	3.6	5.0	4.0	2.6	5.2	7.2	4.6	7.4	5.7	3.0	8.9	4.4	2.1	3.2	2.4	5.0	2.1	6.3	5.7	4.8	3.5	2.9	2.2	4.0	3.0	1.6	4.5	4.0	6.0	6.7	5.7	4.4	3.2	5.7	6.4	5.9	2.4	4.4	4.2	1.7	5.3	3.0	5.4	5.5	6.0	6.8	5.4	5.2	5.5	5.2	5.5	5.3	5.3	6.4	4.0	32.1	25.0	2.9	9.4	2.2	7.3	7.6	5.2	6.8	7.4	6.7	2.4	5.7	10.2	1.8	0.0	12.6	4.8	3.6	13.7	10.1	1.7	5.9	6.0	4.6	1.8	9.5	3.3	9.8	7.4	6.8	5.1	5.0	10.8	4.6	3.9	7.7	5.8	5.0	5.2	5.6	6.1	4.1	1.2	0.9	8.4	4.3	0.0	2.8	3.1	7.2	13.4	4.0	11.0	6.4	4.8	6.4	4.9	5.7	6.9	8.7	14.2	6.2	0.0	4.7	4.5	11.8	8.7	5.1	3.1	7.7	9.1	6.8	5.1	2.8
BCKDHB		ENSG00000083123	"Branched chain keto acid dehydrogenase E1 subunit beta"	P21953	6	80106647-80346270	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase	"Disease variant, Maple syrup urine disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 78.4"	"Cell type enhanced"	"Detected in all"		"Astrocytes: 296.5;Early spermatids: 110.9;Inhibitory neurons: 94.9;Oligodendrocyte precursor cells: 98.5;Oligodendrocytes: 101.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031580, HPA031956"	Approved		Supported	Nucleoplasm,Nucleoli,Mitochondria	"Intracellular and membrane"	Yes	No			"Cluster 15: NK-cells - Transcription"	"Cluster 85: Liver - Metabolism"	"Cluster 32: U-937 - Innate immune response"	"Cluster 64: Astrocytes - Nervous system maintenance"	Mitochondria	"Nucleoplasm, Nucleoli"	"HPA031580: AB_10696054, HPA031956: "	"unprognostic (4.23e-1)"	"unprognostic (1.61e-1)"	"unprognostic (9.50e-3)"	"unprognostic (9.37e-3)"	"unprognostic (1.66e-1)"	"unprognostic (6.03e-2)"	"unprognostic (6.84e-3)"	"unprognostic (2.30e-2)"	"unprognostic (1.94e-1)"	"unprognostic (7.32e-3)"	"unprognostic (2.67e-1)"	"unprognostic (4.65e-2)"	"prognostic favorable (5.54e-9)"	"unprognostic (2.67e-1)"	"unprognostic (1.12e-1)"	"unprognostic (8.02e-2)"	"unprognostic (1.49e-2)"	19.7	10.7	7.3	7.6	8.3	8.2	22.3	11.5	7.8	11.7	11.6	22.5	11.5	9.2	7.1	10.3	11.5	7.8	18.8	8.8	7.0	31.8	78.4	7.3	8.8	10.7	9.2	14.6	12.9	19.7	7.2	4.8	13.1	15.9	20.7	7.9	26.6	11.3	10.9	8.5	12.4	9.4	11.8	6.3	17.6	13.1	8.7	9.1	15.5	15.3	9.1	11.2	7.6	16.0	13.8	5.1	18.8	25.3	18.6	16.1	14.9	9.7	19.8	15.4	21.0	8.3	18.5	38.9	10.1	23.1	18.0	13.6	10.6	12.7	21.5	48.8	15.6	19.4	12.6	11.3	20.7	27.7	8.3	15.6	12.8	10.7	13.3	13.8	18.6	29.8	16.6	33.8	35.0	7.6	10.3	16.3	14.0	30.1	6.5	25.5	58.3	33.8	43.2	20.7	12.6	17.8	16.2	13.4	9.9	20.6	17.3	21.1	8.0	9.2	6.3	8.5	13.0	24.0	25.2	12.9	11.3	20.4	14.2	3.4	4.2	1.0	10.1	5.1	13.3	10.6	8.3	8.5	8.3	12.7	11.0	11.6	0.8	17.4	5.9	12.9	20.3	6.1	7.3	8.3	11.5	7.8	8.8	7.0	10.7	9.2	13.1	11.8	8.7	16.0	8.4	9.6	21.0	296.5	11.5	8.5	12.5	21.1	15.9	7.8	19.6	14.7	29.3	8.6	18.0	5.5	2.1	17.0	9.1	17.5	27.4	8.2	110.9	8.3	10.3	8.0	12.0	10.3	72.0	10.4	8.3	13.7	15.3	17.6	16.5	19.2	11.0	66.5	12.2	3.3	94.9	31.3	10.2	9.1	9.0	13.7	8.7	5.4	16.0	59.0	7.3	15.5	10.3	98.5	101.7	5.4	10.4	8.6	8.4	6.2	11.5	33.1	13.5	8.7	6.6	11.1	9.4	15.2	5.6	20.1	12.4	10.4	9.9	15.5	17.4	10.9
BCKDK		ENSG00000103507	"Branched chain keto acid dehydrogenase kinase"	O14874	16	31106107-31112791	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		"Kinase, Transferase"	"Autism, Autism spectrum disorder, Disease variant, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"dendritic cells: 95.9;granulocytes: 89.7;monocytes: 115.0"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017995, HPA056067"	Supported		Supported	Mitochondria		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 4: Macrophages - Innate immune response"	Mitochondria		"HPA017995: AB_1845309, HPA056067: AB_2683024"	"unprognostic (1.37e-1)"	"unprognostic (2.57e-1)"	"unprognostic (6.94e-2)"	"unprognostic (5.20e-2)"	"unprognostic (5.39e-2)"	"unprognostic (3.61e-2)"	"unprognostic (1.01e-1)"	"unprognostic (5.47e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.35e-1)"	"unprognostic (3.24e-2)"	"unprognostic (2.66e-3)"	"unprognostic (4.85e-2)"	"unprognostic (3.93e-2)"	"unprognostic (1.00e-1)"	"unprognostic (4.97e-2)"	32.3	56.4	18.4	19.2	18.6	14.5	29.0	17.4	23.8	25.1	18.0	31.4	16.0	27.7	16.7	29.4	24.8	17.9	78.6	18.8	17.8	43.8	76.4	21.7	15.6	20.6	20.7	27.5	70.5	22.9	16.4	15.3	19.3	29.3	12.5	6.3	47.0	21.8	81.3	45.4	24.1	19.5	17.1	30.2	42.0	17.4	18.5	9.8	22.4	69.7	13.6	30.2	24.6	17.5	47.5	49.1	27.1	41.8	32.8	32.5	31.1	40.4	46.3	57.3	55.9	32.1	29.1	41.5	58.9	47.5	28.0	31.4	19.3	65.6	36.5	34.4	60.1	45.2	32.6	59.5	57.5	23.5	41.9	48.3	26.2	49.2	40.6	52.6	62.4	31.1	23.4	39.4	87.7	75.8	22.9	32.4	23.0	20.5	39.1	45.8	39.6	78.8	44.3	30.1	42.1	38.7	31.3	72.4	24.6	22.9	44.5	24.6	41.1	44.2	26.1	45.8	32.2	44.5	15.7	15.1	50.3	33.7	42.6	58.1	115.0	85.2	17.7	97.6	17.2	22.8	16.5	13.9	95.9	19.0	13.6	16.1	89.7	22.8	71.2	19.3	24.5	53.1	18.4	18.6	17.4	23.8	18.8	17.8	20.6	20.7	19.3	17.1	18.5	17.5	27.2	19.2	18.1	5.9	20.0	18.5	24.6	61.0	22.2	11.6	30.9	27.6	39.1	25.8	28.5	20.2	0.0	55.4	9.0	31.5	80.3	68.6	2.5	14.6	24.3	29.2	19.9	16.4	5.1	78.0	71.1	24.9	25.5	20.0	33.0	35.4	25.4	43.8	93.0	11.8	4.4	22.3	42.7	44.5	50.3	7.8	20.8	53.1	12.4	1.9	79.3	22.6	9.2	4.5	4.5	54.8	48.4	25.6	51.7	30.9	66.9	95.2	19.6	9.8	46.0	18.4	33.2	25.8	14.1	25.7	27.4	69.4	12.1	45.5	26.0	27.0
BCL11A	"BCL11A-L, BCL11A-S, BCL11A-XL, CTIP1, EVI9, HBFQTL5, ZNF856"	ENSG00000119866	"BAF chromatin remodeling complex subunit BCL11A"	Q9H165	2	60450520-60554467	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	Repressor	"Cancer-related genes, Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 47.8;lymphoid tissue: 40.9"	"Cell type enhanced"	"Detected in many"		"B-cells: 149.0;Basal squamous epithelial cells: 118.4;dendritic cells: 140.3;Excitatory neurons: 180.8;Inhibitory neurons: 153.2;Squamous epithelial cells: 120.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"memory B-cell: 312.7;naive B-cell: 415.7;plasmacytoid DC: 899.0"	"Group enriched"	"Detected in all"	15	"B-cells: 415.7;dendritic cells: 899.0"	"Cell line enhanced"	"Detected in many"		"Daudi: 51.1;MOLT-4: 49.0;REH: 48.3;U-698: 106.7;U-937: 34.0"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"basal ganglia: 52.5;cerebral cortex: 82.3;hippocampal formation: 69.2;olfactory bulb: 66.7"	"CAB014891, HPA029003, HPA075941"	Enhanced		Supported	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 65: Plasmacytoid DCs - Unknown function"	Nucleoplasm	"Nuclear bodies"	"CAB014891: , HPA029003: AB_2672863, HPA075941: "	"unprognostic (4.10e-3)"	"unprognostic (6.72e-2)"	"unprognostic (4.50e-2)"	"unprognostic (9.41e-3)"	"unprognostic (2.37e-1)"	"unprognostic (4.47e-3)"	"unprognostic (2.53e-2)"	"unprognostic (1.68e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.45e-1)"	"unprognostic (4.27e-4)"	"unprognostic (1.23e-2)"	"unprognostic (2.35e-2)"	"unprognostic (3.59e-2)"	"unprognostic (2.26e-1)"	"unprognostic (4.40e-2)"	"unprognostic (2.99e-2)"	0.7	2.1	31.4	11.3	34.7	25.3	7.1	10.5	47.8	5.2	9.7	18.4	9.7	2.1	1.4	18.4	5.7	2.5	8.0	38.7	15.5	1.0	0.5	2.1	29.2	31.6	15.3	0.6	10.8	1.7	3.0	0.9	31.0	7.8	6.1	1.7	13.8	1.9	1.7	33.2	13.9	3.4	15.9	19.6	4.8	2.0	15.9	33.9	2.3	0.2	40.9	3.3	11.5	38.7	0.6	0.0	4.2	0.1	0.8	0.8	0.3	1.5	0.0	0.1	0.0	0.0	0.2	51.1	0.2	0.2	0.0	10.5	15.4	7.4	0.2	0.9	15.2	0.1	0.6	0.2	0.0	18.7	0.1	1.7	4.1	0.0	2.5	4.0	2.6	17.1	0.8	0.3	0.1	0.1	49.0	19.9	28.6	7.7	0.2	48.3	1.3	19.7	0.0	0.9	20.1	4.8	0.3	0.4	0.3	8.0	0.3	9.1	1.0	0.3	11.6	0.3	0.1	0.8	0.2	106.7	0.1	34.0	1.6	4.5	23.8	5.1	0.5	44.1	1.1	312.7	0.5	0.5	89.9	415.7	1.3	1.1	11.0	8.4	33.7	899.0	1.1	11.4	31.4	34.7	10.5	47.8	38.7	15.5	31.6	15.3	31.0	15.9	15.9	38.7	0.6	0.0	7.4	3.6	149.0	46.3	16.0	34.0	118.4	2.5	31.6	28.6	18.2	4.3	11.7	1.8	0.0	0.6	140.3	7.5	5.9	9.5	12.0	3.9	2.0	1.4	19.8	69.6	180.8	6.4	0.5	3.6	5.1	4.8	10.1	67.4	0.7	0.1	43.2	52.2	153.2	13.6	6.1	7.0	86.1	5.0	0.3	20.5	16.0	11.2	16.0	0.3	0.0	3.5	4.6	4.7	12.5	0.0	6.0	11.7	16.2	0.5	5.5	0.3	0.0	0.2	2.0	2.9	6.9	120.3	69.9	0.8	4.6	1.0	28.9	5.8
BCL2	"Bcl-2, PPP1R50"	ENSG00000171791	"BCL2 apoptosis regulator"	P10415	18	63123346-63320128	"Cancer-related genes, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Apoptosis		"Cancer-related genes, Disease variant, FDA approved drug targets, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 271.6;Inhibitory neurons: 102.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	18	"B-cells: 5.4;T-cells: 8.5"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 44.2;HL-60: 43.7;Karpas-707: 72.9;U-266/70: 217.4"	"Low region specificity"	"Detected in all"							"CAB000003, HPA055295"	Enhanced		Supported	"Nucleoplasm,Nuclear membrane"		NA	NA			"Cluster 13: T-cells - Unknown function"	"Cluster 52: Non-specific - Ribosome"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 64: Astrocytes - Nervous system maintenance"	"Nuclear membrane"	Nucleoplasm	"CAB000003: AB_2064429, HPA055295: AB_2682776"	"unprognostic (1.11e-3)"	"prognostic favorable (5.13e-5)"	"unprognostic (5.49e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.89e-1)"	"unprognostic (3.05e-3)"	"unprognostic (2.88e-1)"	"unprognostic (1.93e-3)"	"unprognostic (4.78e-2)"	"unprognostic (2.08e-1)"	"unprognostic (2.23e-2)"	"unprognostic (8.51e-2)"	"prognostic favorable (1.29e-8)"	"unprognostic (6.67e-2)"	"unprognostic (1.19e-1)"	"prognostic unfavorable (2.47e-4)"	"unprognostic (2.63e-1)"	12.8	1.9	5.5	10.2	7.8	5.0	9.6	4.7	3.4	10.7	0.0	6.2	4.4	11.6	2.9	5.9	11.8	6.5	5.3	2.9	6.6	6.7	2.1	3.7	14.7	11.2	7.9	14.5	3.1	13.0	4.7	4.6	7.5	6.4	5.5	2.1	3.7	7.0	16.5	4.8	8.1	6.6	7.9	17.9	3.8	1.5	8.2	18.3	24.0	8.8	14.6	5.4	7.7	5.7	1.7	0.3	6.8	5.9	6.7	1.3	2.4	1.0	0.7	2.4	2.0	3.5	0.4	0.3	1.1	0.9	4.7	0.4	6.7	0.9	1.5	44.2	1.6	0.5	2.0	0.7	2.0	43.7	5.6	1.7	0.8	3.3	5.8	1.1	0.7	4.3	0.8	72.9	2.2	1.4	9.8	10.7	1.5	0.8	1.3	39.5	1.9	26.5	7.4	8.5	7.2	6.4	0.3	0.3	8.5	1.4	0.3	29.9	0.3	9.9	3.3	0.9	5.1	217.4	40.1	2.9	1.9	24.9	6.0	0.3	0.0	0.0	1.9	0.0	7.6	5.4	6.3	3.4	0.1	3.1	3.3	3.2	0.0	0.2	0.3	0.2	8.5	1.3	5.5	7.8	4.7	3.4	2.9	6.6	11.2	7.9	7.5	7.9	8.2	5.7	7.1	0.0	1.1	271.6	84.9	19.5	33.6	1.6	13.6	1.9	39.7	19.7	17.4	18.6	2.4	7.3	0.0	14.0	39.9	2.7	15.6	3.7	0.4	9.8	9.8	5.9	5.4	3.8	60.7	0.0	0.7	15.8	5.6	24.9	15.8	38.8	3.9	1.2	9.4	0.0	102.3	10.5	24.4	15.0	29.6	1.9	8.7	29.0	46.2	88.1	19.7	18.8	18.6	76.4	56.7	0.2	5.9	13.9	50.1	41.6	0.9	18.0	0.1	0.6	26.3	48.8	19.7	0.3	1.3	6.2	17.6	49.1	76.1	24.1	9.8	76.2
BCL2L11	"BIM, BimEL, BimL, BimS, BOD"	ENSG00000153094	"BCL2 like 11"	O43521	2	111119378-111168445	"Predicted intracellular proteins, Transporters"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 118.3;Plasma cells: 137.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-266/70: 91.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB026332, CAB079899"	Approved		Supported	Mitochondria		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 34: Non-specific - Transcription"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 65: Plasmacytoid DCs - Unknown function"	Mitochondria		"CAB026332: AB_566386, CAB079899: AB_10981505"	"unprognostic (1.43e-1)"	"unprognostic (9.46e-3)"	"unprognostic (1.88e-1)"	"unprognostic (1.50e-2)"	"unprognostic (1.20e-1)"	"unprognostic (3.08e-3)"	"unprognostic (1.05e-1)"	"unprognostic (5.63e-2)"	"unprognostic (2.39e-1)"	"unprognostic (3.43e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.00e-1)"	"unprognostic (2.55e-2)"	"unprognostic (9.71e-3)"	"unprognostic (8.15e-3)"	"unprognostic (7.86e-2)"	8.1	7.4	4.2	16.4	5.0	38.8	12.5	3.7	3.7	7.2	4.6	11.0	7.2	6.5	4.9	9.8	7.0	8.8	5.7	3.0	3.9	10.7	14.3	8.5	24.2	4.3	4.0	10.3	10.3	18.8	9.4	6.0	4.5	7.8	11.9	12.1	10.1	7.1	12.3	5.8	11.7	4.8	3.9	16.3	7.0	8.1	4.4	18.9	16.6	7.3	23.0	8.9	8.2	6.7	8.0	2.4	10.8	10.4	9.1	4.7	29.1	1.2	2.3	3.3	3.3	6.6	24.9	32.0	6.5	1.2	18.9	9.5	10.0	3.9	2.0	24.9	18.2	39.7	8.1	10.5	3.9	14.6	8.8	4.8	10.5	3.7	3.8	7.0	4.6	14.2	20.8	46.6	0.7	5.2	15.3	14.7	13.2	6.3	7.5	19.5	10.3	40.7	4.5	13.0	9.3	24.0	11.0	14.5	8.3	7.1	5.0	31.2	1.9	1.7	11.4	3.7	4.3	91.2	19.5	45.3	2.7	10.1	1.5	5.2	3.7	1.8	1.7	2.6	1.8	3.3	2.3	1.9	1.9	1.9	1.5	1.5	5.2	1.7	5.7	0.4	5.9	1.5	4.2	5.0	3.7	3.7	3.0	3.9	4.3	4.0	4.5	3.9	4.4	6.7	33.9	3.2	9.9	2.9	61.3	17.5	18.2	7.0	34.7	7.4	19.5	29.2	19.3	12.8	10.3	9.2	10.4	4.6	43.9	37.6	13.7	9.7	118.3	36.6	10.8	18.0	21.5	26.5	2.2	6.5	7.8	11.6	8.6	54.7	11.4	5.9	14.6	11.3	10.9	0.0	4.8	15.2	12.2	26.8	52.6	39.2	5.9	34.8	23.2	6.5	41.0	12.1	5.2	3.0	5.3	8.8	16.4	3.8	137.9	15.9	16.6	6.4	15.2	21.1	0.0	11.8	11.9	7.3	17.7	66.1	10.9	5.7	41.0	2.5	12.3	16.0
BCL3	"BCL4, D19S37"	ENSG00000069399	"BCL3 transcription coactivator"	P20749	19	44747705-44760044	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	Activator	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 161.8"	"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 172.4;Squamous epithelial cells: 146.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"eosinophil: 5.5;neutrophil: 19.8"	"Lineage enriched"	"Detected in all"	6	"granulocytes: 19.8"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 67.3;Karpas-707: 54.1;SiHa: 69.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"CAB002051, HPA047514"	Approved		Supported	Nucleoplasm,Vesicles,Midbody		Yes	No			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 85: Liver - Metabolism"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm	"Vesicles, Midbody"	"CAB002051: AB_563428, HPA047514: AB_2680074"	"prognostic favorable (9.67e-4)"	"unprognostic (8.82e-2)"	"unprognostic (2.81e-1)"	"unprognostic (7.54e-2)"	"prognostic unfavorable (4.01e-4)"	"unprognostic (3.49e-2)"	"unprognostic (2.34e-3)"	"unprognostic (2.79e-1)"	"prognostic favorable (3.74e-4)"	"unprognostic (2.09e-2)"	"unprognostic (9.23e-2)"	"unprognostic (1.81e-1)"	"prognostic unfavorable (3.13e-14)"	"unprognostic (8.24e-2)"	"unprognostic (1.36e-1)"	"unprognostic (3.77e-2)"	"unprognostic (3.04e-2)"	65.1	43.6	6.7	25.0	6.3	54.0	37.2	6.4	7.8	26.8	7.9	39.7	32.2	26.8	1.7	67.5	35.9	13.4	36.3	5.9	7.2	56.6	161.8	87.3	11.6	11.6	7.8	23.7	37.4	3.1	25.2	7.9	8.1	43.4	9.3	1.3	40.9	8.9	17.8	28.3	44.2	11.7	8.0	58.7	35.9	9.6	8.5	6.6	36.8	4.9	12.7	37.6	37.7	6.4	9.8	33.5	0.7	17.5	6.1	12.6	1.7	5.8	6.3	3.7	5.3	6.9	17.8	9.5	13.4	11.5	18.5	10.5	2.4	9.9	2.3	67.3	0.6	1.1	18.9	9.3	14.6	0.7	28.2	22.5	7.8	8.1	9.9	16.6	10.0	0.0	1.2	54.1	2.2	8.4	0.0	7.4	0.9	15.1	12.8	4.3	6.5	3.4	16.5	19.9	0.0	0.9	69.7	35.7	1.9	1.1	12.7	7.6	16.8	11.8	11.6	18.5	2.2	50.1	21.4	10.1	22.1	1.2	9.2	0.4	2.7	5.5	0.8	1.8	1.1	1.5	1.0	1.3	2.6	1.3	0.5	0.7	19.8	2.3	1.1	3.1	1.7	1.0	6.7	6.3	6.4	7.8	5.9	7.2	11.6	7.8	8.1	8.0	8.5	6.4	56.3	19.2	51.3	2.6	43.9	46.7	38.8	22.4	172.4	2.3	106.8	62.0	3.0	42.9	28.6	12.9	0.0	0.6	33.4	60.6	9.8	31.8	11.8	49.4	34.2	76.3	21.5	4.2	0.5	68.7	6.8	47.8	128.0	70.0	38.0	1.4	38.9	35.5	16.1	8.4	0.8	56.2	8.2	30.5	110.8	2.7	13.4	86.6	40.9	1.0	28.4	2.2	2.1	0.0	0.1	43.0	40.0	4.5	100.4	58.9	56.6	17.7	20.5	0.6	6.6	43.3	40.1	0.5	2.0	146.0	61.1	1.4	46.2	0.3	34.5	51.2
BCL6	"BCL5, BCL6A, LAZ3, ZBTB27, ZNF51"	ENSG00000113916	"BCL6 transcription repressor"	P41182	3	187721377-187745725	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Immunity, Inflammatory response, Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 485.9"	"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 205.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"neutrophil: 269.1;non-classical monocyte: 76.4"	"Group enriched"	"Detected in all"	7	"granulocytes: 269.1;monocytes: 76.4"	"Cell line enhanced"	"Detected in many"		"Daudi: 166.4;HSkMC: 113.9;U-698: 231.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000307, HPA004899, HPA050645"	Enhanced		Supported	Nucleoplasm		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 59: Non-specific - Translation"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 50: Fibroblasts - ECM organization"	Nucleoplasm		"CAB000307: AB_2063451, HPA004899: AB_1078273, HPA050645: AB_2681199"	"unprognostic (5.36e-2)"	"unprognostic (3.29e-2)"	"unprognostic (1.63e-3)"	"unprognostic (2.49e-1)"	"unprognostic (2.85e-1)"	"unprognostic (6.34e-3)"	"unprognostic (2.62e-2)"	"unprognostic (3.33e-3)"	"unprognostic (8.75e-2)"	"unprognostic (2.04e-2)"	"unprognostic (1.63e-3)"	"unprognostic (1.29e-1)"	"prognostic unfavorable (1.27e-9)"	"unprognostic (5.22e-2)"	"unprognostic (7.82e-2)"	"unprognostic (5.67e-2)"	"unprognostic (2.58e-2)"	143.0	49.4	54.3	53.9	53.4	123.7	126.9	85.9	57.9	100.0	35.0	87.1	7.5	68.1	16.4	44.6	140.7	45.6	72.1	50.9	68.7	37.0	65.3	110.5	56.0	104.1	69.4	65.6	49.2	11.3	44.8	15.3	74.2	57.5	10.3	34.2	70.3	22.2	485.9	160.7	34.4	43.0	55.9	106.3	58.4	18.6	69.0	43.2	50.4	96.6	47.7	90.6	81.5	64.1	5.1	13.8	14.4	3.2	98.1	78.0	14.9	16.5	39.2	18.4	19.4	9.4	7.6	166.4	11.5	21.0	11.7	7.7	4.4	10.6	15.3	33.8	5.1	0.2	6.7	22.5	51.5	2.1	0.9	113.9	68.8	22.7	32.9	60.1	10.2	4.2	1.6	27.6	18.2	5.7	5.5	1.3	1.4	3.0	10.3	45.4	7.0	0.8	13.6	23.2	3.1	0.2	18.8	8.1	11.0	30.2	35.3	5.9	21.2	43.7	7.1	16.6	7.5	21.2	7.2	231.6	24.2	6.0	31.7	8.8	33.0	18.9	5.5	37.3	5.4	6.6	3.4	5.0	24.6	15.3	2.1	2.3	269.1	3.9	76.4	4.0	3.1	30.7	54.3	53.4	85.9	57.9	50.9	68.7	104.1	69.4	74.2	55.9	69.0	64.1	35.7	19.2	67.4	66.0	22.7	47.3	14.7	18.8	205.5	10.9	55.3	54.6	71.4	14.3	28.9	16.5	20.9	1.4	36.0	3.5	0.0	12.2	13.3	36.2	26.7	25.0	4.8	3.2	7.6	12.5	2.7	57.3	12.2	51.4	11.4	9.4	15.0	51.2	11.9	0.0	19.6	2.3	16.2	67.5	74.4	8.6	28.9	48.1	35.6	7.5	16.8	39.1	1.0	50.8	7.8	7.9	0.3	18.8	14.2	27.9	1.2	1.5	29.5	9.7	32.9	77.0	84.9	0.4	1.2	72.4	61.5	4.1	30.0	10.3	2.8	29.7
BCORL1	"CXorf10, FLJ11362"	ENSG00000085185	"BCL6 corepressor like 1"	Q5H9F3	X	129981107-130058071	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, Repressor"	"Autism spectrum disorder, Cancer-related genes, Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enriched"	"Detected in many"	6	"Syncytiotrophoblasts: 93.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 29.6;HAP1: 44.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031775, HPA031777, HPA068568"	Uncertain		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	Nucleoplasm	"Plasma membrane"	"HPA031775: AB_10602332, HPA031777: AB_10671578, HPA068568: AB_2686007"	"unprognostic (8.07e-2)"	"unprognostic (2.78e-2)"	"unprognostic (7.09e-2)"	"prognostic unfavorable (2.20e-5)"	"unprognostic (4.58e-1)"	"unprognostic (1.68e-3)"	"unprognostic (1.96e-3)"	"unprognostic (5.56e-3)"	"unprognostic (2.39e-1)"	"unprognostic (8.02e-2)"	"unprognostic (4.46e-2)"	"unprognostic (2.04e-1)"	"prognostic unfavorable (5.00e-4)"	"unprognostic (9.18e-2)"	"unprognostic (2.60e-2)"	"unprognostic (3.09e-1)"	"unprognostic (1.41e-2)"	3.5	3.1	2.4	2.6	2.5	5.6	2.1	4.5	2.6	3.5	0.4	2.9	2.6	4.5	2.2	2.6	4.3	2.0	2.8	2.4	2.7	2.6	2.0	2.9	1.7	2.9	2.1	5.5	4.5	5.8	2.6	11.3	1.9	3.2	2.0	2.0	3.3	3.7	3.3	2.9	2.8	4.3	1.4	2.8	2.2	6.5	2.1	2.3	4.5	3.3	1.7	2.6	2.6	1.9	3.4	8.0	18.7	29.6	10.6	8.0	5.3	4.5	5.2	5.7	6.5	9.6	2.2	1.5	9.9	8.8	5.5	2.0	44.2	1.8	5.2	3.4	6.7	16.2	3.9	3.1	5.2	3.8	4.8	4.9	3.6	11.0	0.6	8.3	6.8	5.2	7.7	16.4	3.6	1.9	6.0	11.3	5.2	2.6	5.9	12.6	7.5	2.2	3.0	0.4	3.2	10.9	2.3	0.7	3.0	9.4	6.7	5.9	5.9	4.5	6.0	5.7	4.5	5.1	10.1	2.5	2.9	7.8	2.2	0.0	0.3	0.6	0.2	0.0	0.2	0.2	0.2	0.1	0.3	0.2	0.1	0.1	0.7	0.2	0.1	0.1	0.0	0.2	2.4	2.5	4.5	2.6	2.4	2.7	2.9	2.1	1.9	1.4	2.1	1.9	5.4	0.0	2.8	6.8	2.9	11.9	2.8	2.2	10.8	1.7	12.5	7.5	7.1	4.3	1.9	7.3	0.0	14.1	6.1	3.7	0.0	3.0	0.5	3.7	7.0	7.9	12.0	2.5	4.6	1.1	4.8	6.9	2.6	4.7	7.0	4.3	4.6	2.8	3.2	8.4	4.4	2.4	2.0	2.2	5.9	1.2	4.7	2.7	7.2	5.6	3.0	2.3	4.1	4.5	8.5	2.6	1.9	3.8	3.2	3.8	4.2	2.3	2.9	1.3	6.6	8.0	6.1	3.4	6.9	9.2	11.5	93.4	4.9	0.9	3.6	2.8
BDH2	"DHRS6, FLJ13261, PRO20933, SDR15C1, UCPA-OR, UNQ6308"	ENSG00000164039	"3-hydroxybutyrate dehydrogenase 2"	Q9BUT1	4	103077592-103099870	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 162.1"	"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 211.3;Proximal tubular cells: 795.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RPTEC TERT1: 46.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036028, HPA036029"	Enhanced		Supported	Cytosol		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 81: Kidney & Liver - Metabolism"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Cytosol		"HPA036028: AB_10670674, HPA036029: AB_2674909"	"unprognostic (2.12e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.64e-1)"	"prognostic favorable (5.21e-4)"	"unprognostic (3.92e-1)"	"unprognostic (2.28e-1)"	"unprognostic (3.82e-2)"	"prognostic favorable (1.20e-4)"	"unprognostic (1.71e-1)"	"unprognostic (2.04e-1)"	"unprognostic (4.37e-1)"	"unprognostic (1.95e-1)"	"prognostic favorable (4.45e-13)"	"unprognostic (2.54e-2)"	"unprognostic (1.60e-1)"	"prognostic favorable (7.75e-4)"	"unprognostic (9.69e-3)"	45.0	96.6	23.3	4.3	25.8	3.5	39.7	27.0	27.3	46.6	27.1	31.8	39.4	31.2	16.6	27.2	43.4	14.9	46.6	20.3	27.8	162.1	70.5	35.9	6.7	28.4	26.5	54.8	23.2	30.8	29.2	7.7	27.0	31.9	10.3	8.5	32.8	14.1	24.6	26.1	39.6	9.6	25.2	21.2	38.9	14.8	28.2	17.5	62.9	16.7	7.3	37.1	37.3	26.5	3.1	5.3	26.5	10.0	30.4	29.4	3.4	6.7	17.8	6.9	10.6	3.4	11.8	12.4	11.1	10.2	2.1	1.5	17.3	10.1	8.2	8.2	8.5	1.5	6.4	8.1	15.0	7.4	2.1	24.8	9.1	10.6	2.6	23.0	20.7	14.3	8.0	5.5	24.1	1.0	37.2	6.3	9.6	2.0	2.1	24.5	30.7	7.9	46.4	3.6	4.5	12.0	12.8	6.7	7.9	9.6	5.7	5.3	9.9	10.7	3.4	5.5	3.7	8.1	7.9	12.5	11.8	8.9	5.4	2.6	2.5	0.2	7.6	1.4	8.8	4.8	6.6	6.0	3.2	6.7	9.8	10.4	0.4	6.5	0.2	5.0	10.2	4.0	23.3	25.8	27.0	27.3	20.3	27.8	28.4	26.5	27.0	25.2	28.2	26.5	37.7	32.1	57.8	33.6	10.2	30.3	47.1	59.4	36.5	2.5	31.9	36.1	9.6	64.3	46.9	108.5	0.0	7.9	19.0	18.0	211.3	58.2	1.9	60.6	45.5	30.3	22.9	16.4	1.2	21.3	18.5	75.2	41.8	27.9	19.6	39.1	27.8	71.6	20.4	3.3	3.8	24.4	46.8	10.9	16.9	4.8	69.9	12.5	23.2	14.0	14.9	50.4	14.4	3.5	21.8	23.0	18.6	77.8	8.0	18.9	162.3	795.7	48.7	3.8	13.1	40.9	36.5	0.9	4.0	25.9	26.7	3.4	18.2	52.6	37.6	37.5
BDKRB2	BK-2	ENSG00000168398	"Bradykinin receptor B2"	P30411	14	96204679-96244166	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"urinary bladder: 41.1"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 19.3;Endothelial cells: 18.2;Fibroblasts: 25.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 49.2;BJ hTERT+: 94.5;U-87 MG: 39.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA003551, HPA050841"	Approved		Supported	"Golgi apparatus,Vesicles,Plasma membrane"		NA	NA				"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Plasma membrane"	"Golgi apparatus, Vesicles"	"HPA003551: , HPA050841: AB_2681254"	"unprognostic (1.03e-1)"	"unprognostic (7.90e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.83e-1)"	"unprognostic (8.79e-3)"	"unprognostic (2.68e-2)"	"unprognostic (1.93e-1)"	"unprognostic (4.66e-2)"	"unprognostic (1.94e-1)"	"unprognostic (2.84e-2)"	"unprognostic (3.19e-1)"	"unprognostic (1.72e-1)"	"unprognostic (3.32e-3)"	"unprognostic (3.11e-2)"	"unprognostic (9.40e-2)"	"unprognostic (9.90e-2)"	"unprognostic (1.49e-2)"	14.0	1.4	0.8	5.5	1.0	0.0	5.8	3.8	1.1	15.6	0.9	12.4	7.9	6.7	2.4	17.2	7.2	20.8	1.2	0.9	0.8	13.4	0.7	2.5	0.3	4.9	1.3	1.0	9.4	0.9	0.8	1.3	5.0	4.8	12.2	0.0	3.5	6.2	0.9	5.4	9.7	10.2	1.0	0.1	4.9	0.2	1.5	0.9	3.6	1.8	1.7	41.1	15.4	1.2	1.7	6.1	0.1	11.0	16.2	49.2	0.0	5.5	94.5	3.2	3.7	0.3	10.4	0.0	0.2	8.7	3.7	14.8	0.0	2.4	2.8	1.2	0.1	0.0	1.1	0.0	7.8	0.0	0.0	15.1	7.5	9.4	4.7	0.0	0.0	0.0	0.0	0.0	0.0	7.9	0.0	0.1	0.1	20.4	0.0	0.0	2.2	0.0	3.2	0.0	3.4	1.1	1.8	15.6	0.1	2.1	1.0	0.0	0.0	0.3	0.3	3.3	0.1	0.2	0.0	0.0	39.7	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.8	1.0	3.8	1.1	0.9	0.8	4.9	1.3	5.0	1.0	1.5	1.2	8.2	3.2	3.1	0.0	0.0	9.2	0.7	5.3	6.8	0.0	0.2	0.5	0.6	10.0	11.6	9.2	0.0	1.2	0.0	19.3	7.9	11.5	0.0	7.5	16.1	18.2	7.1	0.0	1.8	3.8	3.6	25.8	1.1	4.6	0.0	0.0	3.3	0.2	0.2	0.0	0.4	7.2	8.2	0.0	15.2	0.0	0.9	0.4	5.4	0.0	0.0	0.0	0.0	1.0	1.9	6.9	6.2	1.2	0.0	1.0	10.6	0.2	12.5	0.0	0.0	4.5	1.2	0.0	0.0	15.3	5.8	4.0	0.3	0.1	0.9	2.9
BDNF		ENSG00000176697	"Brain derived neurotrophic factor"	P23560	11	27654893-27722058	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins"		"Growth factor"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 8.2"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 38.5;Bipolar cells: 13.8;Cardiomyocytes: 9.1;Excitatory neurons: 22.3;Smooth muscle cells: 25.8;Theca cells: 9.3"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ: 36.6;BJ hTERT+ SV40 Large T+: 28.0;BJ hTERT+ SV40 Large T+ RasG12V: 20.9;HBF TERT88: 26.5;U-138 MG: 37.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB009564, HPA031440, HPA056104"	Enhanced		Supported	"Nuclear speckles,Mitochondria"	"Secreted to blood"	NA	Yes	16000000	24000		"Cluster 10: Brain - Neuronal signaling"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 10: Non-specific - Unknown function"	"Nuclear speckles, Mitochondria"		"CAB009564: AB_2064213, HPA031440: AB_2673883, HPA056104: AB_2683038"	"unprognostic (1.25e-2)"	"unprognostic (2.84e-1)"	"unprognostic (4.35e-2)"	"unprognostic (2.54e-2)"	"unprognostic (1.01e-2)"	"unprognostic (6.82e-2)"	"unprognostic (2.39e-2)"	"unprognostic (2.21e-1)"	"unprognostic (3.20e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.22e-2)"	"unprognostic (2.65e-1)"	"unprognostic (3.22e-2)"	"unprognostic (3.88e-2)"	"unprognostic (5.88e-2)"	"unprognostic (1.40e-1)"	"unprognostic (2.84e-3)"	0.4	0.5	1.9	0.2	2.4	0.2	0.2	3.3	5.3	0.6	0.1	0.4	0.3	0.2	3.3	0.6	0.1	0.7	3.6	8.2	1.9	0.6	0.1	2.0	0.1	3.3	2.1	0.5	0.4	0.0	1.2	1.6	2.5	2.0	0.1	0.7	0.3	1.8	0.4	0.9	0.1	0.1	0.4	0.1	0.3	0.6	1.6	0.3	1.0	0.0	0.1	2.1	0.6	0.8	2.9	12.2	0.3	0.0	3.7	2.2	0.0	36.6	7.9	28.0	20.9	0.1	4.0	0.0	3.7	11.8	0.5	1.4	0.1	0.2	26.5	0.2	0.1	0.0	3.5	0.0	17.4	0.2	0.2	9.2	4.2	6.8	3.7	18.1	1.3	0.1	0.0	0.1	4.8	0.0	0.0	0.0	4.0	0.1	2.9	0.0	2.0	0.0	4.5	0.0	0.2	1.1	7.8	0.1	0.1	1.7	0.2	0.0	11.0	37.6	6.9	14.4	9.2	0.5	0.1	0.0	14.1	1.3	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	2.4	3.3	5.3	8.2	1.9	3.3	2.1	2.5	0.4	1.6	0.8	0.2	38.5	0.5	1.6	0.0	0.6	0.4	0.5	1.8	13.8	0.5	0.9	9.1	0.0	0.4	1.8	4.2	0.4	0.0	0.1	0.0	0.8	1.8	0.3	0.3	0.2	0.0	0.0	22.3	0.0	0.5	6.1	0.0	0.1	1.3	1.9	0.0	0.0	0.3	0.0	0.6	0.0	0.0	0.0	0.4	1.5	0.3	0.9	1.8	0.0	0.0	0.2	0.0	2.0	2.2	0.2	0.0	0.0	0.0	0.8	0.0	1.5	0.1	1.8	0.0	1.8	25.8	3.7	0.8	2.3	0.0	0.7	0.0	9.3	0.1	0.1
BECN1	"ATG6, VPS30"	ENSG00000126581	"Beclin 1"	Q14457	17	42810134-42833350	"Predicted intracellular proteins"	"Antiviral defense, Apoptosis, Autophagy, Cell cycle, Cell division, Endocytosis, Host-virus interaction"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003949, CAB010143, HPA028949"	Supported		Supported	"Nuclear bodies,Cytosol"		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 27: Mucus-secreting cells - Mucin production"	Cytosol	"Nuclear bodies"	"CAB010143: AB_626746, HPA003949: , HPA028949: AB_2672839"	"unprognostic (1.97e-1)"	"unprognostic (2.66e-2)"	"unprognostic (9.97e-2)"	"unprognostic (3.80e-3)"	"unprognostic (1.46e-1)"	"unprognostic (2.01e-2)"	"unprognostic (5.16e-3)"	"unprognostic (1.31e-1)"	"unprognostic (1.72e-1)"	"unprognostic (2.59e-2)"	"unprognostic (4.33e-2)"	"unprognostic (1.81e-1)"	"unprognostic (2.34e-1)"	"unprognostic (1.02e-1)"	"unprognostic (4.63e-2)"	"unprognostic (1.09e-1)"	"unprognostic (5.49e-2)"	45.3	41.4	26.9	41.8	27.7	50.7	43.9	27.4	37.8	35.7	30.9	70.3	56.6	31.5	47.7	49.5	36.1	34.4	58.9	28.5	29.1	47.9	43.7	39.6	47.9	27.4	27.9	26.7	39.5	41.7	20.5	26.2	27.8	42.3	64.8	26.5	36.0	41.3	95.8	36.4	50.1	44.4	28.4	39.8	53.0	24.2	28.3	41.4	36.7	77.6	56.2	49.2	29.7	28.5	47.4	79.0	27.9	48.7	95.7	56.8	54.9	95.1	104.2	69.5	73.8	61.4	61.9	68.9	69.3	118.9	70.0	52.7	48.9	85.3	123.4	105.0	59.4	58.0	74.9	105.5	71.4	111.0	114.3	76.8	99.1	69.4	66.0	61.8	90.2	75.4	50.5	67.1	86.4	40.1	66.1	61.1	29.0	88.5	40.6	56.3	100.6	69.3	74.1	88.6	33.5	34.9	52.0	43.5	100.7	61.4	72.0	92.9	121.6	82.8	38.8	57.0	99.7	103.8	84.8	57.4	84.3	54.0	106.7	154.1	133.2	122.1	103.1	152.1	105.1	112.6	114.4	111.6	120.2	123.7	96.4	100.2	191.0	107.8	144.2	75.7	180.1	171.8	26.9	27.7	27.4	37.8	28.5	29.1	27.4	27.9	27.8	28.4	28.3	28.5	43.7	38.5	46.1	11.8	38.7	29.7	26.7	40.1	39.3	12.3	38.3	22.7	6.0	30.0	39.1	12.9	10.4	23.5	37.8	59.5	58.7	46.2	18.2	35.0	28.3	33.9	28.3	36.2	12.1	69.6	32.3	23.1	42.3	31.5	43.1	20.5	31.4	46.2	38.8	21.9	11.7	60.2	30.5	65.4	36.8	11.9	21.5	43.1	42.7	3.7	67.2	26.9	50.4	5.5	9.8	53.6	45.4	26.7	51.2	37.8	49.1	40.3	51.7	13.4	26.3	25.6	36.0	31.6	14.9	44.9	37.6	38.0	39.8	33.8	51.1	46.7
BET1L	"GOLIM3, GS15"	ENSG00000177951	"Bet1 golgi vesicular membrane trafficking protein like"	Q9NYM9	11	167784-207428	"Predicted intracellular proteins, Predicted membrane proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 142.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA039819	Approved		Supported	"Nucleoplasm,Golgi apparatus"		No	No			"Cluster 52: Eosinophils - Transcription"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 31: Spermatids - Spermatogenesis"	"Golgi apparatus"	Nucleoplasm	"HPA039819: AB_10673020"	"unprognostic (1.68e-1)"	"unprognostic (2.07e-1)"	"unprognostic (2.14e-3)"	"unprognostic (2.56e-3)"	"prognostic unfavorable (9.80e-4)"	"unprognostic (1.18e-1)"	"prognostic unfavorable (2.20e-4)"	"unprognostic (1.82e-1)"	"unprognostic (1.52e-1)"	"unprognostic (3.08e-2)"	"unprognostic (2.65e-1)"	"unprognostic (2.08e-1)"	"unprognostic (1.03e-1)"	"unprognostic (9.10e-2)"	"unprognostic (1.69e-1)"	"unprognostic (3.75e-2)"	"unprognostic (8.49e-2)"	36.2	38.2	26.8	29.4	28.2	18.0	35.5	26.5	27.6	43.2	33.2	37.0	29.1	37.0	37.3	30.1	38.8	27.5	34.3	25.6	27.1	40.4	53.5	35.4	32.9	31.0	28.5	53.6	79.9	39.9	56.0	29.8	28.0	43.4	29.8	17.1	52.9	41.6	22.5	36.1	39.4	31.3	27.5	39.4	43.1	33.0	27.5	28.2	37.5	23.4	35.7	37.4	33.2	30.1	46.2	37.6	22.0	27.3	66.5	58.3	31.8	48.1	62.8	50.6	51.5	47.3	43.4	40.5	22.9	87.7	36.4	42.1	25.6	44.0	38.3	31.6	27.7	37.5	21.5	48.2	61.4	43.2	70.2	66.2	58.1	29.8	79.6	58.7	34.7	28.2	55.7	41.3	32.7	25.0	31.7	27.3	33.6	66.8	42.3	32.6	32.6	27.7	41.8	20.3	23.9	29.0	42.9	68.5	47.7	31.5	35.2	33.6	38.6	39.0	18.0	16.0	24.0	72.2	35.9	35.6	52.7	35.6	36.4	58.5	19.0	66.0	28.4	27.5	34.1	31.9	32.5	29.1	19.0	25.0	37.4	29.6	43.5	27.9	25.8	22.1	27.4	32.5	26.8	28.2	26.5	27.6	25.6	27.1	31.0	28.5	28.0	27.5	27.5	30.1	9.8	12.8	17.0	3.9	23.0	9.3	16.8	12.8	16.5	6.8	21.3	19.0	14.5	15.7	10.7	14.7	8.4	15.8	16.9	24.4	21.5	12.8	58.8	8.6	13.2	10.6	7.8	12.0	3.6	23.4	28.2	19.4	20.9	10.1	38.0	10.2	18.2	39.3	22.7	3.3	4.4	23.1	14.2	16.4	12.7	142.9	22.1	18.4	7.2	2.8	14.8	9.1	10.3	4.0	4.7	18.6	26.1	18.8	68.3	29.2	39.2	28.7	12.6	10.4	6.6	12.8	15.9	47.2	21.8	11.9	11.6	26.3	19.4	8.9	17.1	29.3
BEX3	"Bex, DXS6984E, HGR74, NADE, NGFRAP1"	ENSG00000166681	"Brain expressed X-linked 3"	Q00994	X	103376395-103378164	"Predicted intracellular proteins"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 1607.8;Distal tubular cells: 1453.7;Granulosa cells: 700.3;Proximal tubular cells: 688.0;Syncytiotrophoblasts: 804.2;Theca cells: 696.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"naive CD4 T-cell: 150.9;T-reg: 137.1"	"Lineage enriched"	"Detected in all"	5	"T-cells: 150.9"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018886	Approved		Supported	Cytosol		NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 68: Epididymis - Unknown function"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 47: Cytotrophoblasts - Unknown function"	Cytosol		"HPA018886: AB_1854453"	"unprognostic (7.74e-2)"	"unprognostic (6.56e-2)"	"unprognostic (8.15e-3)"	"prognostic unfavorable (7.23e-5)"	"unprognostic (2.70e-1)"	"unprognostic (1.93e-3)"	"unprognostic (7.15e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.10e-2)"	"unprognostic (3.85e-3)"	"unprognostic (2.00e-1)"	"prognostic favorable (1.28e-4)"	"prognostic unfavorable (3.48e-4)"	"unprognostic (1.38e-1)"	"unprognostic (3.32e-2)"	"unprognostic (8.68e-2)"	106.8	345.8	382.4	39.6	395.3	31.1	111.0	353.0	432.9	144.6	462.7	123.4	31.2	149.1	499.4	72.8	150.9	77.1	244.7	401.5	491.6	263.6	92.8	116.8	29.3	368.8	392.1	463.7	120.0	231.1	373.7	207.0	384.1	166.7	53.0	135.9	99.5	224.9	19.8	61.6	56.3	116.5	364.9	97.3	94.6	139.9	419.3	97.0	274.6	44.5	28.4	107.8	104.6	365.7	218.5	305.3	561.5	222.3	508.5	567.3	256.6	244.7	409.8	299.5	475.0	317.9	238.1	0.3	427.8	288.7	222.0	85.3	394.1	302.5	299.4	0.8	280.6	98.7	502.9	87.4	396.2	0.8	37.4	613.4	252.2	397.3	348.0	533.6	469.5	225.0	0.1	1.0	542.2	486.1	227.2	2.7	750.5	0.1	232.3	0.4	350.3	0.5	317.9	365.3	377.3	391.4	264.7	3.2	380.3	359.8	142.4	31.8	291.5	191.6	123.3	374.6	110.0	2.2	1.0	1.6	395.3	0.3	189.1	0.3	3.7	1.1	4.1	0.9	2.2	4.6	71.8	19.1	6.4	1.2	150.9	70.8	13.9	28.9	0.8	14.5	137.1	66.5	382.4	395.3	353.0	432.9	401.5	491.6	368.8	392.1	384.1	364.9	419.3	365.7	118.5	326.9	227.7	0.0	12.6	0.0	0.0	0.0	0.0	0.0	217.4	433.2	0.0	0.0	104.0	518.6	0.0	1607.8	4.7	0.0	1453.7	201.3	0.0	187.0	284.8	132.3	0.0	0.0	0.0	70.9	471.7	189.2	0.0	144.1	16.4	700.3	0.0	0.0	172.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.7	0.0	0.0	2.0	0.0	0.0	0.0	0.0	49.0	0.0	0.0	1.7	0.0	0.0	688.0	23.3	0.0	0.0	0.0	117.8	0.0	0.0	0.0	0.0	804.2	12.8	696.8	0.0	0.0
BEX4	"BEXL1, FLJ10097"	ENSG00000102409	"Brain expressed X-linked 4"	Q9NWD9	X	103215108-103217246	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 309.3;Syncytiotrophoblasts: 364.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEL: 162.5;HMC-1: 188.1;K-562: 232.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045105, HPA051935"	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 68: Epididymis - Unknown function"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Nucleoplasm, Cytosol"		"HPA045105: AB_10966792, HPA051935: AB_2681667"	"unprognostic (1.45e-1)"	"unprognostic (2.12e-1)"	"unprognostic (1.01e-2)"	"unprognostic (2.55e-3)"	"unprognostic (1.75e-3)"	"unprognostic (3.69e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.06e-3)"	"unprognostic (3.03e-1)"	"unprognostic (6.33e-2)"	"prognostic favorable (9.41e-4)"	"unprognostic (1.62e-2)"	"prognostic favorable (2.54e-14)"	"unprognostic (1.62e-3)"	"unprognostic (2.60e-2)"	"unprognostic (1.13e-1)"	"unprognostic (5.33e-2)"	32.2	99.9	186.5	24.8	187.5	71.4	56.3	173.4	225.0	53.0	154.9	63.6	17.0	70.3	265.9	48.0	65.7	40.2	101.9	188.8	209.2	97.6	13.5	44.0	32.9	185.7	185.7	102.6	34.7	126.0	134.0	60.6	184.6	80.2	26.4	92.0	74.6	83.1	6.8	26.6	32.2	56.4	183.7	68.7	36.2	46.1	195.1	57.0	131.1	13.6	34.8	46.6	44.3	188.2	0.0	0.2	96.4	0.0	24.1	16.6	86.5	23.2	19.8	42.6	77.7	0.0	1.4	0.3	38.1	16.2	36.0	0.7	39.1	5.3	46.8	0.1	36.8	162.5	0.0	0.1	73.7	123.0	188.1	62.3	12.9	22.3	0.0	47.3	50.2	62.2	232.5	0.5	13.1	0.5	86.4	1.0	117.0	0.0	6.9	0.2	28.0	0.6	39.1	2.4	71.7	109.3	8.1	1.5	5.1	93.0	3.9	1.3	1.3	5.5	34.3	0.8	0.3	12.5	6.0	0.2	16.0	0.0	4.9	118.6	23.1	42.3	31.6	30.0	26.5	37.6	38.2	32.0	51.3	33.7	65.5	52.2	5.2	100.5	26.4	79.0	40.3	43.9	186.5	187.5	173.4	225.0	188.8	209.2	185.7	185.7	184.6	183.7	195.1	188.2	45.7	35.3	40.4	25.5	38.7	27.3	133.8	86.0	87.0	174.9	99.0	105.4	81.3	81.5	64.0	99.3	25.0	309.3	47.5	6.8	299.3	66.4	4.7	31.2	35.5	59.2	63.1	35.1	70.0	13.7	156.0	65.1	19.4	38.1	109.2	147.8	73.2	0.7	88.3	222.1	69.6	37.2	52.9	55.5	53.2	12.9	63.3	68.9	115.6	22.5	118.4	217.8	34.0	34.2	64.3	10.8	23.3	61.3	22.2	118.1	8.1	186.5	33.2	81.0	52.6	64.4	57.4	27.4	14.3	42.5	24.2	364.3	37.2	115.0	28.7	111.7
BFSP1	"CP115, CP94, filensin, LIFL-H"	ENSG00000125864	"Beaded filament structural protein 1"	Q12934	20	17493905-17569220	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		"Eye lens protein"	Cataract	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Late spermatids: 5.7;NK-cells: 17.5;Spermatogonia: 11.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"gdT-cell: 2.5"	"Lineage enhanced"	"Detected in single"		"T-cells: 2.5"	"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 10.8;RPTEC TERT1: 19.5;SK-BR-3: 10.6"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"amygdala: 2.5;cerebral cortex: 3.2;hippocampal formation: 3.6"	"HPA040748, HPA042038"	Enhanced		Supported	"Plasma membrane,Cytosol"		No	No			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 43: Testis - Unknown function"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	"Plasma membrane, Cytosol"		"HPA040748: AB_10963786, HPA042038: AB_10964054"	"unprognostic (2.24e-3)"	"unprognostic (1.99e-1)"	"unprognostic (1.63e-1)"	"prognostic favorable (1.39e-4)"	"unprognostic (1.07e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.22e-6)"	"unprognostic (5.11e-2)"	"unprognostic (5.53e-1)"	"unprognostic (2.10e-4)"	"unprognostic (1.75e-1)"	"unprognostic (8.81e-2)"	"unprognostic (3.35e-4)"	"unprognostic (4.45e-2)"	"unprognostic (2.73e-2)"	"unprognostic (1.78e-2)"	"unprognostic (7.50e-2)"	1.1	1.3	2.0	0.5	2.2	0.4	1.1	1.6	2.1	1.3	2.0	1.3	0.3	1.8	1.4	1.1	1.3	1.3	0.7	2.2	2.1	3.7	0.3	1.7	0.3	1.7	1.8	1.5	1.9	1.0	0.9	1.9	1.8	1.2	0.5	0.4	1.5	1.1	0.3	1.0	0.7	1.1	1.5	0.4	0.9	3.8	2.1	0.2	2.5	0.4	0.3	1.3	0.9	2.4	0.8	8.1	2.6	0.3	0.7	2.6	0.4	2.0	9.5	1.3	1.2	3.7	7.0	0.0	1.6	1.2	5.1	1.2	2.8	1.6	1.0	1.8	2.1	0.6	1.2	1.1	1.5	0.5	0.9	3.1	4.9	0.7	2.3	10.8	5.7	0.5	0.3	0.4	4.2	1.6	0.0	1.2	6.1	5.2	2.2	0.0	1.8	0.4	19.5	1.5	2.7	0.3	2.4	10.6	4.3	1.2	5.2	1.8	6.5	0.3	0.6	0.7	2.0	0.0	0.1	0.0	1.4	0.0	1.6	0.0	0.0	0.0	2.5	0.0	0.1	0.0	0.6	0.4	0.0	0.0	0.0	0.2	0.3	0.7	0.0	0.0	0.0	0.2	2.0	2.2	1.6	2.1	2.2	2.1	1.7	1.8	1.8	1.5	2.1	2.4	3.8	3.2	1.7	0.7	0.0	0.9	0.5	0.7	0.0	0.2	1.9	1.5	1.2	1.5	0.4	0.0	0.0	1.2	2.6	0.1	1.9	0.8	1.3	1.1	0.4	3.1	0.0	0.8	2.1	0.9	1.7	1.2	1.5	0.6	0.0	0.2	3.9	0.2	0.5	0.0	1.2	0.2	0.0	0.0	0.8	5.7	1.8	0.2	1.8	2.8	0.0	1.0	17.5	0.5	1.1	0.8	0.0	0.0	0.4	0.4	0.0	0.3	1.8	0.1	0.0	0.5	1.0	1.1	11.9	1.1	0.9	0.4	1.0	0.4	0.3	0.5
BHLHB9	"GASP3, KIAA1701, p60TRP"	ENSG00000198908	"Basic helix-loop-helix family member b9"	Q6PI77	X	102720688-102753540	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 24.6;Inhibitory neurons: 28.5;Oligodendrocyte precursor cells: 17.6;Oligodendrocytes: 16.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"NK-cell: 1.7"	"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"											HPA000887			Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 68: Epididymis - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Cytosol	Nucleoplasm	"HPA000887: AB_2666130"	"unprognostic (4.07e-2)"	"unprognostic (4.15e-2)"	"unprognostic (4.87e-2)"	"unprognostic (1.70e-3)"	"unprognostic (6.42e-3)"	"unprognostic (2.36e-1)"	"unprognostic (2.40e-3)"	"unprognostic (5.06e-3)"	"unprognostic (2.65e-1)"	"unprognostic (7.65e-2)"	"unprognostic (2.74e-2)"	"unprognostic (4.27e-2)"	"unprognostic (1.29e-3)"	"unprognostic (1.43e-1)"	"unprognostic (7.46e-2)"	"unprognostic (4.95e-2)"	"unprognostic (8.88e-2)"	1.6	3.0	6.6	0.8	7.6	1.7	1.9	5.0	7.1	3.6	2.3	2.5	1.2	3.6	2.6	1.2	2.2	1.4	2.4	7.4	8.8	3.4	2.1	1.3	0.8	6.8	4.8	4.4	1.8	3.4	4.5	2.6	7.1	3.6	1.3	6.9	2.0	3.9	3.0	1.7	1.3	3.5	5.1	1.4	1.4	2.5	7.2	2.4	3.2	2.4	1.0	2.4	2.3	5.3	0.4	3.1	8.6	2.6	2.4	1.4	4.1	2.8	3.7	4.7	8.6	2.9	2.0	0.0	2.9	3.3	2.3	2.3	4.7	3.4	5.4	0.0	2.8	0.9	1.8	0.4	5.5	0.6	0.6	3.1	2.4	1.9	0.3	3.5	4.6	0.1	2.6	3.1	3.6	1.9	1.9	0.2	6.0	0.8	1.9	0.9	2.5	0.0	3.2	5.0	4.6	4.1	2.8	0.8	0.2	3.4	2.7	1.5	4.9	0.8	2.8	1.4	2.6	1.6	4.2	0.0	2.0	0.5	1.7	0.4	0.0	0.0	0.3	0.0	0.3	0.1	0.2	0.6	0.0	0.1	0.3	0.5	0.2	1.7	0.0	0.0	0.5	0.1	6.6	7.6	5.0	7.1	7.4	8.8	6.8	4.8	7.1	5.1	7.2	5.3	3.4	6.4	1.5	12.1	0.6	1.8	1.2	0.7	4.6	11.3	1.9	1.7	6.9	2.8	1.0	3.7	12.5	4.3	0.5	0.7	7.9	1.2	0.2	1.2	5.3	3.5	4.8	0.8	24.6	0.8	0.8	5.4	0.5	1.0	0.0	7.3	3.9	1.4	1.4	3.3	28.5	0.7	0.0	1.3	0.0	0.9	2.8	0.2	0.0	1.9	0.7	12.5	2.1	17.6	16.9	0.4	0.5	2.6	0.1	1.4	0.8	1.9	0.3	5.8	6.6	3.7	2.8	9.1	7.5	2.1	1.1	1.4	1.6	3.6	1.1	0.6
BHLHE40	"BHLHB2, Clast5, DEC1, SHARP2, STRA13"	ENSG00000134107	"Basic helix-loop-helix family member e40"	O14503	3	4979437-4985323	"Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Glandular and luminal cells: 386.7;granulocytes: 439.2;Squamous epithelial cells: 517.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 101.4"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 488.2;Karpas-707: 228.4;U-87 MG: 218.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028922	Uncertain		Supported	"Nuclear bodies"		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 61: Squamous epithelial cells - Keratinization"	"Nuclear bodies"		"HPA028922: AB_2672828"	"unprognostic (8.64e-3)"	"unprognostic (5.21e-2)"	"unprognostic (1.03e-2)"	"unprognostic (1.39e-1)"	"unprognostic (8.58e-3)"	"unprognostic (7.95e-2)"	"unprognostic (2.90e-1)"	"unprognostic (2.88e-3)"	"unprognostic (1.31e-1)"	"unprognostic (2.52e-2)"	"prognostic unfavorable (8.74e-4)"	"unprognostic (5.45e-2)"	"unprognostic (3.36e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.33e-1)"	"unprognostic (5.95e-2)"	"unprognostic (7.03e-3)"	154.1	99.0	38.5	52.9	38.4	188.2	200.0	36.1	48.7	141.6	41.4	67.9	30.8	67.6	34.6	353.2	61.5	100.4	153.4	38.1	32.8	151.4	187.9	112.1	52.4	52.0	47.5	76.0	79.8	67.5	92.6	72.2	39.3	98.1	47.4	118.3	117.3	32.5	251.7	207.2	42.6	65.2	40.5	26.9	43.5	14.1	49.6	40.6	82.7	46.8	50.7	172.1	272.3	37.0	40.4	53.4	0.1	14.7	30.8	23.8	78.6	7.5	19.7	7.7	30.2	3.4	39.7	0.2	19.6	14.2	118.9	31.5	6.6	108.0	13.2	488.2	4.7	9.8	39.6	11.9	29.7	25.5	192.8	55.1	63.3	88.9	25.4	53.4	30.0	1.7	53.9	228.4	20.3	28.4	3.9	10.8	2.9	45.6	87.1	0.7	17.6	23.0	74.4	7.9	0.8	1.7	132.6	34.2	40.0	45.9	78.6	38.8	39.7	30.4	29.3	28.9	50.0	175.9	82.8	1.6	218.0	19.8	15.3	101.4	9.7	54.5	24.7	4.9	24.9	7.7	13.1	16.6	15.2	4.5	2.9	10.1	14.3	54.9	0.5	19.9	0.9	11.9	38.5	38.4	36.1	48.7	38.1	32.8	52.0	47.5	39.3	40.5	49.6	37.0	172.5	67.3	191.3	32.3	24.9	165.4	112.8	330.5	373.3	15.4	136.6	74.7	65.0	40.0	297.7	46.0	0.0	32.0	159.8	52.9	11.7	75.2	0.3	210.2	69.6	161.6	10.7	2.5	36.6	72.5	89.3	102.6	68.3	386.7	439.2	0.5	75.0	56.5	38.3	10.1	4.5	32.6	136.3	52.1	354.0	1.7	7.2	117.9	108.5	27.2	42.9	95.1	44.3	11.1	3.3	138.8	37.9	3.8	38.0	61.1	8.8	23.1	102.1	11.5	6.6	55.3	94.4	0.2	0.4	517.2	262.0	158.4	97.8	0.3	24.4	129.4
BHMT	BHMT1	ENSG00000145692	"Betaine--homocysteine S-methyltransferase"	Q93088	5	79111809-79132288	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	83	"kidney: 778.9;liver: 1141.8"	"Group enriched"	"Detected in some"	10	"Hepatocytes: 604.2;Proximal tubular cells: 996.1"	"Group enriched"	"Detected in some"	4	"liver cancer: 90.6;renal cancer: 50.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Hep G2: 3.6;NTERA-2: 1.4"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA038285, HPA058310"	Enhanced		Supported	Cytosol		No	NA		10000000		"Cluster 81: Kidney & Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Cytosol		"HPA038285: AB_10675791, HPA058310: AB_2683675"	"unprognostic (2.61e-2)"	"unprognostic (4.12e-1)"	"unprognostic (4.45e-1)"	"unprognostic (4.14e-3)"	"unprognostic (5.62e-2)"	"unprognostic (4.14e-1)"	"prognostic favorable (7.32e-4)"	"unprognostic (5.33e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.13e-1)"	"unprognostic (9.66e-4)"	"unprognostic (6.42e-2)"	"unprognostic (8.26e-3)"	"unprognostic (1.77e-1)"	"unprognostic (3.22e-1)"	"unprognostic (3.60e-2)"	"unprognostic (2.30e-3)"	0.7	0.3	0.3	0.0	0.8	0.0	0.5	0.0	0.5	0.3	0.1	0.6	1.2	0.2	1.8	0.1	0.2	0.2	0.2	0.5	0.3	778.9	1141.8	0.1	0.0	0.1	0.2	0.1	0.1	0.0	0.5	0.0	0.1	0.3	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.2	0.1	0.1	3.2	0.3	0.3	0.5	0.4	0.0	0.0	11.6	0.5	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	3.6	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.9	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.8	0.0	0.5	0.5	0.3	0.1	0.2	0.1	0.1	0.3	0.2	0.1	0.0	0.0	1.0	5.2	0.0	0.1	0.0	0.0	0.4	0.0	0.1	0.3	4.3	0.0	16.5	0.0	0.0	0.0	0.0	78.2	0.0	0.5	0.1	0.8	0.8	0.0	13.5	0.9	0.0	0.1	0.1	8.2	0.2	0.0	0.1	8.9	604.2	0.0	0.0	0.2	0.4	0.0	12.2	0.0	0.5	0.9	3.5	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.0	0.0	2.6	0.0	0.0	0.0	996.1	0.0	0.4	0.0	0.2	0.1	0.2	1.0	0.0	0.0	0.1	4.2	0.5	0.1	0.3
BICD2	KIAA0699	ENSG00000185963	"BICD cargo adaptor 2"	Q8TD16	9	92711363-92764833	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"mRNA transport, Protein transport, Translocation, Transport"		"Disease variant, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skin 1: 63.4"	"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 83.6;Squamous epithelial cells: 103.2;Suprabasal keratinocytes: 130.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023013, HPA024452"	Enhanced		Supported	"Golgi apparatus,Plasma membrane,Cytosol"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 31: Skin - Epidermis development"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 61: Squamous epithelial cells - Keratinization"	"Golgi apparatus, Plasma membrane, Cytosol"		"HPA023013: AB_1845352, HPA024452: AB_1845353"	"unprognostic (9.99e-3)"	"unprognostic (1.98e-1)"	"unprognostic (7.84e-3)"	"unprognostic (2.81e-2)"	"unprognostic (4.33e-2)"	"unprognostic (2.86e-1)"	"unprognostic (2.37e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.04e-1)"	"unprognostic (6.54e-3)"	"unprognostic (8.12e-2)"	"unprognostic (1.48e-1)"	"prognostic favorable (1.39e-4)"	"unprognostic (1.25e-1)"	"unprognostic (2.26e-1)"	"unprognostic (3.95e-1)"	"unprognostic (1.39e-2)"	15.4	10.6	11.4	13.5	10.0	12.0	10.9	10.9	10.5	20.8	7.8	18.5	4.6	15.5	6.0	47.0	12.8	9.4	19.8	11.1	8.6	9.1	8.5	16.0	14.7	11.0	9.8	12.5	8.9	17.7	6.0	10.4	10.3	11.3	5.0	6.5	14.6	13.1	22.3	63.4	10.4	13.7	10.5	17.3	9.5	9.4	10.0	13.8	10.0	15.3	16.8	15.2	30.9	12.3	32.6	26.5	19.2	19.8	36.6	25.1	27.1	30.8	22.2	17.2	13.6	15.6	14.4	36.3	19.5	34.4	22.0	99.4	21.8	49.1	19.4	17.4	23.5	19.2	25.6	21.7	21.8	26.9	30.0	25.8	67.1	28.8	22.0	20.4	26.0	15.4	19.3	27.5	38.1	21.4	25.6	16.7	13.3	23.8	32.0	27.8	41.8	19.3	27.8	27.0	13.4	20.7	21.7	19.9	14.3	19.2	8.2	12.3	34.9	31.8	21.1	53.9	33.9	22.5	17.5	31.9	26.9	16.3	28.4	1.6	3.4	4.4	1.2	3.6	1.2	1.8	1.4	1.6	3.8	2.0	1.3	1.2	7.5	1.1	5.9	3.2	0.9	1.7	11.4	10.0	10.9	10.5	11.1	8.6	11.0	9.8	10.3	10.5	10.0	12.3	21.7	28.9	12.7	14.7	27.6	73.7	17.1	19.2	83.6	12.8	11.4	10.2	54.5	8.6	16.2	7.3	6.2	8.5	26.1	3.4	3.9	10.1	6.5	21.3	26.7	26.4	10.8	16.0	16.2	5.1	6.5	26.0	5.6	21.1	24.1	13.0	19.2	7.5	14.2	15.2	14.0	1.9	12.2	32.4	30.2	7.6	21.1	40.7	16.0	19.7	38.9	22.0	7.2	9.5	18.5	8.5	3.6	33.4	22.1	18.7	0.8	6.7	14.0	6.4	19.7	23.0	33.1	9.7	8.4	103.2	130.8	7.3	17.2	13.8	3.6	20.3
BICDL1	"BICDR-1, CCDC64, FLJ26450"	ENSG00000135127	"BICD family like cargo adaptor 1"	Q6ZP65	12	119989869-120094494	"Predicted intracellular proteins"	"Neurogenesis, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 128.7;pituitary gland: 80.2"	"Cell type enhanced"	"Detected in some"		"Collecting duct cells: 12.9;dendritic cells: 13.7;Distal tubular cells: 23.5;Plasma cells: 12.8;Proximal tubular cells: 27.3;T-cells: 17.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"hTCEpi: 48.9;MCF7: 27.7;OE19: 25.2;SCLC-21H: 30.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA061116	Enhanced		Approved	Nucleoplasm,Vesicles,Cytosol		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 24: Non-specific - Transcription regulation"	"Nucleoplasm, Cytosol"	Vesicles	"HPA061116: AB_2684433"	"unprognostic (2.17e-1)"	"prognostic favorable (6.50e-4)"	"unprognostic (1.68e-3)"	"unprognostic (3.05e-2)"	"unprognostic (6.81e-4)"	"prognostic favorable (3.15e-4)"	"prognostic unfavorable (6.84e-4)"	"unprognostic (5.11e-2)"	"unprognostic (3.18e-2)"	"unprognostic (4.63e-2)"	"unprognostic (3.31e-3)"	"unprognostic (7.26e-2)"	"prognostic favorable (3.93e-5)"	"prognostic favorable (1.21e-5)"	"unprognostic (1.36e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.15e-1)"	24.8	2.7	7.6	10.8	8.8	3.0	2.9	5.4	13.3	7.4	0.2	3.2	4.0	0.7	37.5	35.8	4.2	4.1	2.9	7.6	10.9	128.7	5.6	6.0	23.8	5.6	3.4	1.1	7.7	2.5	80.2	1.1	5.6	4.9	3.1	67.6	8.3	1.0	0.4	64.2	7.3	0.6	2.6	7.1	20.9	40.8	6.9	18.2	24.4	0.0	15.5	3.1	21.5	6.6	3.5	10.6	0.6	0.0	0.9	0.0	12.6	0.0	0.0	0.0	0.0	9.5	5.9	16.8	4.4	0.0	9.1	7.9	1.3	1.6	0.0	1.2	1.7	0.1	4.7	18.3	0.0	2.1	17.1	0.0	48.9	0.0	0.6	0.0	0.0	14.1	0.5	2.1	0.0	27.7	12.3	0.2	21.1	25.2	5.0	1.3	0.9	4.5	6.2	8.4	30.8	2.2	3.6	9.7	2.6	5.1	22.4	8.3	0.0	0.1	2.9	0.0	0.2	4.2	17.1	6.5	0.6	2.4	1.7	0.3	0.0	0.0	1.2	0.0	0.4	0.1	1.2	1.0	0.0	0.1	0.9	0.7	0.0	0.0	0.3	0.0	0.2	0.2	7.6	8.8	5.4	13.3	7.6	10.9	5.6	3.4	5.6	2.6	6.9	6.6	0.6	0.0	1.3	0.0	6.8	0.0	0.0	0.0	0.0	0.0	2.8	2.2	0.0	0.0	1.3	12.9	0.0	1.0	13.7	0.0	23.5	1.1	0.0	3.1	1.0	0.1	0.0	0.0	0.0	3.5	0.6	2.7	0.0	7.7	1.3	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.6	0.0	0.0	0.0	0.0	2.9	0.0	0.0	12.8	0.0	0.0	27.3	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.4	17.6	0.7	0.0	0.0
BICRA	GLTSCR1	ENSG00000063169	"BRD4 interacting chromatin remodeling complex associated protein"	Q9NZM4	19	47608196-47703277	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 9.6;Alveolar cells type 2: 6.5;Breast myoepithelial cells: 6.1;Collecting duct cells: 7.3;Endometrial stromal cells: 6.4;Glandular and luminal cells: 6.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA056211	Approved		Supported	Nucleoplasm		NA	NA				"Cluster 59: Non-specific - Translation"	"Cluster 24: NB-4 - Immune response"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm		"HPA056211: AB_2683068"	"unprognostic (2.36e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.41e-2)"	"unprognostic (9.58e-2)"	"unprognostic (7.75e-2)"	"prognostic favorable (1.34e-4)"	"unprognostic (8.38e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.47e-2)"	"unprognostic (1.56e-3)"	"unprognostic (2.21e-3)"	"prognostic unfavorable (1.82e-4)"	"unprognostic (9.72e-2)"	"unprognostic (7.98e-2)"	"unprognostic (1.61e-1)"	"prognostic favorable (9.34e-4)"	6.7	5.0	1.6	5.0	2.1	5.3	6.9	4.3	3.6	9.6	0.9	9.1	6.5	10.6	1.6	6.9	9.1	2.4	6.2	3.6	1.1	3.9	4.9	7.0	3.9	1.9	0.5	8.6	4.4	4.0	5.6	4.8	1.0	8.2	3.6	4.2	7.0	4.1	13.7	9.9	7.3	5.3	0.0	6.1	6.3	3.0	2.2	5.6	7.5	5.5	3.5	8.6	8.3	5.5	6.8	6.6	12.3	9.5	6.0	6.1	7.0	5.8	4.9	6.4	4.3	7.3	3.5	7.3	3.0	6.7	5.4	6.9	7.7	4.1	6.4	7.5	6.5	4.3	5.3	3.1	7.7	5.1	7.5	5.2	5.6	7.0	6.3	5.3	6.5	6.2	6.7	8.4	3.9	4.8	9.1	16.3	8.6	8.7	5.4	9.7	4.2	2.1	2.5	4.6	7.4	9.6	14.4	8.3	3.7	10.0	3.4	4.0	8.1	5.3	10.8	4.4	7.9	6.8	11.8	7.1	1.2	3.6	8.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.2	0.0	0.0	1.6	2.1	4.3	3.6	3.6	1.1	1.9	0.5	1.0	0.0	2.2	5.5	5.1	9.6	6.5	0.0	0.7	0.0	0.0	0.0	0.0	0.0	5.2	6.1	0.0	0.0	0.6	7.3	0.0	4.3	3.8	0.0	0.0	3.2	0.0	4.9	6.4	2.0	0.0	0.0	0.0	3.8	3.9	1.6	0.0	6.0	1.3	4.2	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	1.6	0.0	0.0	0.0	0.0	3.7	0.0	0.0	1.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	5.5	2.0	3.3	0.0	0.0
BICRAL	"GLTSCR1L, KIAA0240"	ENSG00000112624	"BRD4 interacting chromatin remodeling complex associated protein like"	Q6AI39	6	42746958-42868560	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 10.3;Alveolar cells type 1: 9.6;Alveolar cells type 2: 9.4;Breast glandular cells: 10.2;Breast myoepithelial cells: 9.1;dendritic cells: 11.6;Endometrial stromal cells: 9.6;Glandular and luminal cells: 9.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029390, HPA029391"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 21: OE19 - Mitochondria"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm		"HPA029390: AB_10599730, HPA029391: AB_10599949"	"unprognostic (2.30e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.15e-2)"	"unprognostic (3.46e-2)"	"unprognostic (9.25e-2)"	"prognostic favorable (5.47e-4)"	"unprognostic (2.74e-1)"	"unprognostic (6.17e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.04e-2)"	"unprognostic (1.55e-1)"	"unprognostic (7.24e-2)"	"unprognostic (1.54e-3)"	"unprognostic (4.71e-2)"	"unprognostic (2.60e-1)"	"unprognostic (1.29e-1)"	"unprognostic (6.54e-2)"	8.5	5.7	4.5	8.3	4.4	7.7	9.5	15.9	6.9	9.4	1.1	7.6	6.1	11.3	7.7	6.5	10.2	7.2	7.0	4.2	5.0	6.1	5.7	7.8	12.2	4.8	4.0	16.2	7.0	10.4	5.8	5.2	5.1	9.2	9.5	14.3	8.3	8.1	8.0	8.7	6.7	9.6	2.9	9.8	7.5	5.0	4.0	11.6	11.3	9.4	12.2	7.7	7.3	7.4	6.2	4.9	4.3	6.9	8.7	10.0	3.7	5.4	5.6	4.7	3.6	2.2	4.4	14.4	4.8	9.1	7.2	4.8	4.2	5.6	7.7	10.8	2.7	10.1	4.9	6.3	4.6	8.6	8.8	6.2	10.6	4.6	8.4	8.9	4.9	8.4	9.8	12.5	5.6	7.4	1.4	4.9	4.8	24.3	3.0	8.9	2.5	14.3	4.8	4.0	14.6	7.8	6.1	8.7	6.1	4.1	7.6	10.0	5.7	6.5	6.4	4.3	5.4	11.3	7.0	21.6	3.9	10.8	4.7	2.3	0.5	2.8	2.2	0.4	1.9	1.2	1.3	2.1	0.4	1.3	1.2	1.6	3.7	1.6	0.8	0.7	1.6	0.6	4.5	4.4	15.9	6.9	4.2	5.0	4.8	4.0	5.1	2.9	4.0	7.4	10.3	9.6	9.4	0.0	4.2	0.0	0.0	0.0	0.0	0.0	10.2	9.1	0.0	0.0	4.3	3.7	0.0	2.3	11.6	0.0	0.0	3.8	0.0	6.2	9.6	3.1	0.0	0.0	0.0	3.8	2.1	3.9	0.0	9.8	1.3	8.4	0.0	0.0	5.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	1.6	0.0	0.0	0.0	0.0	3.6	0.0	0.0	3.5	0.0	0.0	4.3	2.9	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	1.4	5.0	5.2	0.0	0.0
BID		ENSG00000015475	"BH3 interacting domain death agonist"	P55957	22	17734138-17774770	"Predicted intracellular proteins"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 103.5"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 273.2;Langerhans cells: 658.8;monocytes: 491.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Group enriched"	"Detected in all"	6	"dendritic cells: 345.8;granulocytes: 925.5;monocytes: 985.3"	"Cell line enhanced"	"Detected in all"		"MCF7: 241.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000722, CAB003771"	Enhanced		Supported	Cytosol		NA	NA		800000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 3: Monocytes - Immune response regulation"	Cytosol		"CAB003771: AB_365478, HPA000722: AB_1078283"	"unprognostic (1.59e-1)"	"unprognostic (5.51e-2)"	"unprognostic (5.02e-2)"	"unprognostic (3.04e-2)"	"unprognostic (4.27e-3)"	"unprognostic (1.11e-2)"	"unprognostic (3.84e-2)"	"unprognostic (5.21e-3)"	"unprognostic (1.44e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.12e-2)"	"unprognostic (1.97e-1)"	"prognostic unfavorable (3.50e-13)"	"unprognostic (4.66e-3)"	"unprognostic (1.59e-1)"	"unprognostic (3.55e-3)"	"unprognostic (2.18e-2)"	13.6	6.9	19.4	30.5	20.9	103.5	10.7	19.2	22.4	6.0	12.8	14.7	15.1	5.7	7.2	7.5	6.2	14.7	17.4	20.0	19.5	10.0	28.2	12.0	35.6	19.9	19.8	5.7	9.5	3.5	6.4	7.9	20.8	8.1	11.0	36.9	8.1	4.1	23.3	7.6	17.5	6.8	20.1	30.0	12.2	3.6	22.0	26.4	5.8	7.8	16.7	34.4	7.5	20.2	117.5	90.6	14.4	43.7	15.2	27.7	20.4	59.1	45.4	44.8	38.4	55.4	67.2	22.8	41.5	25.7	52.3	97.8	14.5	14.7	24.7	37.0	73.4	101.3	39.7	81.3	19.1	110.4	107.0	26.7	31.4	49.8	11.3	35.6	46.8	64.8	84.0	27.2	23.0	241.6	161.0	148.2	47.2	130.2	62.8	76.6	37.3	32.8	12.0	141.2	91.3	65.9	12.5	38.2	37.1	6.2	80.3	132.9	80.4	26.0	36.0	43.9	46.7	39.8	57.2	75.7	74.6	113.0	33.8	156.9	417.0	691.4	82.1	748.3	81.7	53.0	75.8	92.5	345.8	33.0	61.2	72.2	925.5	124.1	985.3	245.8	108.0	428.1	19.4	20.9	19.2	22.4	20.0	19.5	19.9	19.8	20.8	20.1	22.0	20.2	49.0	16.0	14.5	16.0	34.5	71.9	53.1	273.2	21.1	3.0	30.0	30.5	17.5	17.2	142.6	9.2	2.1	9.3	70.3	25.1	7.9	67.9	0.6	10.5	14.5	47.4	34.1	23.3	17.6	51.4	5.6	24.9	13.7	11.4	25.3	34.3	23.2	44.0	134.1	0.0	15.6	38.7	63.1	69.1	658.8	1.6	5.3	164.2	58.7	13.1	491.3	3.0	65.9	4.5	2.1	78.5	85.1	4.1	45.2	186.4	16.5	28.6	59.7	1.7	0.0	12.0	24.3	1.3	11.9	13.2	64.5	5.1	38.3	13.6	49.8	213.0
BIN1	"AMPH2, AMPHL, SH3P9"	ENSG00000136717	"Bridging integrator 1"	O00499	2	127048027-127107288	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Differentiation, Endocytosis, Host-virus interaction"	"Developmental protein"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"skeletal muscle: 2105.3;tongue: 803.2"	"Cell type enhanced"	"Detected in all"		"Hofbauer cells: 164.9;NK-cells: 176.1;Oligodendrocytes: 186.4;Proximal tubular cells: 255.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	9	"gdT-cell: 186.6;MAIT T-cell: 163.9;memory B-cell: 165.9;memory CD4 T-cell: 192.1;memory CD8 T-cell: 187.4;naive B-cell: 181.2;naive CD4 T-cell: 177.1;naive CD8 T-cell: 171.1;NK-cell: 178.9;T-reg: 249.8"	"Group enriched"	"Detected in all"	9	"B-cells: 181.2;NK-cells: 178.9;T-cells: 249.8"	"Cell line enhanced"	"Detected in many"		"RPTEC TERT1: 126.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB001945, HPA003894, HPA005437"	Enhanced		Supported	Cytosol		NA	NA		430000	"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 37: Myocytes - Muscle contraction"	Cytosol		"CAB001945: , HPA003894: AB_1845360, HPA005437: AB_1078284"	"unprognostic (2.20e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.65e-2)"	"unprognostic (9.65e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.08e-1)"	"unprognostic (3.06e-2)"	"unprognostic (2.21e-1)"	"unprognostic (3.52e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.02e-3)"	"unprognostic (1.85e-1)"	"unprognostic (1.42e-3)"	"unprognostic (1.26e-2)"	"unprognostic (2.57e-1)"	"unprognostic (2.41e-3)"	"unprognostic (3.22e-3)"	43.7	93.2	178.8	25.7	232.8	12.0	37.3	162.6	209.6	53.8	85.9	35.2	17.4	38.7	16.8	33.5	53.5	22.6	16.5	174.2	160.6	83.4	34.7	22.7	41.0	204.2	194.8	34.4	21.5	19.6	41.0	23.5	189.8	58.1	13.1	53.7	42.6	24.0	2105.3	14.8	31.5	19.6	155.4	54.7	45.0	10.4	199.2	18.4	28.5	803.2	27.5	89.0	36.6	310.5	52.0	27.9	32.8	39.3	95.9	76.5	11.4	15.3	33.1	35.8	23.4	107.6	31.3	0.0	46.0	28.9	20.8	6.8	14.6	25.0	9.5	5.9	4.1	15.1	46.9	7.1	86.2	0.2	2.8	70.2	6.1	77.3	14.0	46.4	49.1	5.1	3.2	1.6	44.8	1.1	4.9	43.3	24.8	114.2	31.4	11.8	36.3	4.8	126.7	0.1	22.4	61.9	55.5	21.2	17.7	34.7	1.3	9.7	59.3	40.9	39.9	52.8	52.1	1.3	1.4	0.3	60.3	2.6	19.2	1.2	3.1	0.6	186.6	2.0	163.9	165.9	192.1	187.4	15.1	181.2	177.1	171.1	6.0	178.9	3.2	21.5	249.8	133.5	178.8	232.8	162.6	209.6	174.2	160.6	204.2	194.8	189.8	155.4	199.2	310.5	15.6	9.6	10.0	10.7	80.1	18.6	10.0	3.3	1.2	144.1	10.7	9.1	5.6	44.3	5.5	14.7	125.1	1.8	98.3	18.6	37.2	15.2	16.1	11.7	46.2	21.9	46.0	11.6	36.9	29.4	4.2	68.7	29.0	19.0	2.5	28.7	15.0	18.3	164.9	30.3	47.2	28.0	10.2	27.0	62.3	55.8	78.6	50.1	23.2	58.1	10.4	25.3	176.1	11.6	186.4	16.7	18.1	30.5	14.6	26.2	14.3	255.7	1.4	133.4	13.1	75.7	28.8	2.6	10.9	1.6	8.9	2.9	98.2	40.0	50.1	9.8
BIRC2	"API1, c-IAP1, cIAP1, hiap-2, MIHB, RNF48"	ENSG00000110330	"Baculoviral IAP repeat containing 2"	Q13490	11	102347211-102378670	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	"Apoptosis, Transcription, Transcription regulation, Ubl conjugation pathway"	"Activator, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005513, CAB020661"	Supported		Supported	"Nucleoplasm,Nucleoli fibrillar center,Cytosol"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 34: Non-specific - Transcription"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 2: Hepatocytes - Metabolism"	"Nucleoli fibrillar center, Cytosol"	Nucleoplasm	"CAB020661: , HPA005513: AB_1846746"	"unprognostic (1.36e-1)"	"unprognostic (3.29e-1)"	"unprognostic (9.52e-3)"	"unprognostic (1.62e-1)"	"unprognostic (1.37e-1)"	"unprognostic (7.02e-2)"	"unprognostic (2.72e-2)"	"unprognostic (1.04e-2)"	"unprognostic (1.17e-2)"	"unprognostic (9.59e-2)"	"unprognostic (1.05e-2)"	"unprognostic (3.02e-2)"	"unprognostic (1.84e-2)"	"unprognostic (1.07e-1)"	"unprognostic (9.20e-2)"	"unprognostic (5.00e-2)"	"unprognostic (1.64e-2)"	23.2	27.6	18.4	25.8	19.6	36.4	28.2	20.0	23.4	27.5	22.5	27.2	23.6	25.7	30.2	18.1	19.7	24.8	23.6	17.9	19.9	28.8	44.3	22.6	34.5	19.7	19.4	21.8	33.7	20.4	18.8	29.4	19.8	21.4	26.0	22.2	21.1	16.1	29.7	18.2	25.2	21.6	20.1	26.7	23.5	24.6	18.8	50.6	22.2	32.9	27.1	30.4	20.4	24.9	34.0	24.7	37.3	29.3	46.1	63.3	23.9	128.3	48.8	71.9	43.4	30.9	81.7	37.1	123.5	59.2	40.3	36.7	24.5	33.8	85.7	50.0	12.6	37.2	17.6	37.8	46.9	22.9	23.0	40.8	64.4	41.2	52.3	66.2	50.1	22.2	34.4	0.2	131.0	10.9	24.3	20.1	18.1	40.1	23.7	11.9	48.4	24.9	55.4	38.5	15.5	20.3	44.7	26.9	40.7	56.7	42.5	27.3	82.7	150.7	34.4	46.2	84.2	14.9	21.9	25.0	32.6	28.2	112.5	97.2	43.3	104.4	22.9	42.2	18.9	15.7	21.5	21.3	33.8	15.1	27.4	27.7	67.6	34.3	46.7	20.4	33.2	27.5	18.4	19.6	20.0	23.4	17.9	19.9	19.7	19.4	19.8	20.1	18.8	24.9	61.8	41.7	41.1	17.0	52.6	67.2	109.2	53.6	39.9	24.4	52.3	52.8	58.6	67.2	49.5	64.4	29.2	38.4	77.9	85.7	43.0	49.8	20.8	63.2	54.0	51.0	48.5	80.0	22.4	73.7	27.8	55.9	28.5	85.7	62.7	43.7	59.3	182.1	41.5	20.2	21.7	54.3	46.8	84.3	71.5	11.2	36.4	71.1	51.6	26.2	81.2	34.3	55.6	21.6	33.1	54.5	71.1	29.0	49.2	75.0	82.1	110.1	56.6	31.0	26.3	45.7	48.9	44.7	42.4	28.4	62.8	35.2	57.1	36.4	44.2	82.5
BIRC3	"API2, c-IAP2, cIAP2, hiap-1, MALT2, MIHC, RNF49"	ENSG00000023445	"Baculoviral IAP repeat containing 3"	Q13489	11	102317450-102339403	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Apoptosis, Ubl conjugation pathway"	Transferase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 89.0;lymphoid tissue: 141.5"	"Cell type enhanced"	"Detected in many"		"granulocytes: 554.8;Langerhans cells: 1400.9;monocytes: 1117.0;Proximal enterocytes: 817.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"memory B-cell: 209.0;naive B-cell: 159.9"	"Group enriched"	"Detected in all"	13	"B-cells: 209.0;T-cells: 83.6"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 146.5;Daudi: 140.7;EFO-21: 74.3;HDLM-2: 140.1;hTERT-HME1: 140.2;U-266/70: 89.2;U-266/84: 85.8"	"Low region specificity"	"Detected in all"							HPA002317	Enhanced	Approved	Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 16: Immune cells - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 3: Monocytes - Immune response regulation"	"Nucleoplasm, Cytosol"		"HPA002317: AB_1846748"	"prognostic favorable (3.60e-4)"	"unprognostic (2.89e-1)"	"prognostic favorable (9.35e-4)"	"unprognostic (3.28e-2)"	"prognostic unfavorable (7.28e-4)"	"unprognostic (5.83e-3)"	"unprognostic (2.23e-1)"	"unprognostic (3.88e-3)"	"unprognostic (9.62e-2)"	"unprognostic (1.29e-1)"	"prognostic unfavorable (3.03e-4)"	"unprognostic (3.21e-1)"	"prognostic unfavorable (6.66e-6)"	"unprognostic (6.42e-2)"	"unprognostic (6.23e-3)"	"unprognostic (1.00e-1)"	"unprognostic (3.85e-2)"	9.0	14.7	2.7	104.8	2.9	26.3	18.4	1.6	3.4	19.1	3.4	24.9	26.6	10.5	3.7	16.0	8.5	51.0	7.7	2.8	3.5	12.6	26.3	24.6	141.5	2.6	2.7	6.6	12.0	4.3	3.6	5.3	2.3	10.6	24.7	0.6	12.7	11.4	2.7	8.1	89.0	10.7	2.5	73.2	54.3	8.2	2.7	59.2	3.9	4.3	134.4	46.9	4.8	3.6	26.4	24.5	0.2	0.4	0.7	3.9	2.4	2.5	17.5	3.3	3.7	4.6	146.5	140.7	74.3	1.4	22.8	13.0	0.1	4.6	7.8	140.1	0.3	0.5	7.3	1.4	30.7	2.4	3.7	3.5	18.1	8.4	140.2	4.9	0.4	10.2	0.5	0.0	3.0	0.1	8.3	1.3	0.3	14.2	1.0	0.1	0.8	6.8	34.3	12.9	0.1	0.3	2.1	2.1	1.8	0.5	6.4	1.8	7.5	25.6	3.4	1.4	28.3	89.2	85.8	48.8	4.0	7.4	3.0	8.6	3.9	2.2	5.8	10.1	9.8	209.0	41.7	14.1	3.6	159.9	28.4	8.3	2.6	9.9	11.0	1.7	83.6	11.9	2.7	2.9	1.6	3.4	2.8	3.5	2.6	2.7	2.3	2.5	2.7	3.6	41.2	144.2	70.8	0.0	420.1	101.2	324.9	267.2	51.2	0.3	26.6	22.9	12.5	134.4	146.9	40.5	0.0	2.0	71.2	142.4	7.9	230.3	1.8	231.3	16.8	101.4	15.0	23.6	1.1	179.7	0.5	63.4	184.5	289.4	554.8	1.8	6.4	4.4	11.7	0.0	3.2	38.0	75.3	25.4	1400.9	2.1	5.0	170.0	192.1	2.8	1117.0	0.5	14.4	0.0	0.4	207.4	281.1	2.2	288.4	455.1	817.3	19.5	88.1	0.0	0.0	60.8	90.9	0.7	0.5	31.8	84.5	0.5	278.0	0.7	49.4	193.3
BIRC5	"API4, EPR-1, survivin"	ENSG00000089685	"Baculoviral IAP repeat containing 5"	O15392	17	78214186-78225636	"Cancer-related genes, Predicted intracellular proteins"	"Apoptosis, Cell cycle, Cell division, Chromosome partition, Mitosis, Transcription, Transcription regulation"	"Protease inhibitor, Repressor, Thiol protease inhibitor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 37.9;lymphoid tissue: 41.0;testis: 19.6"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 74.7;Early spermatids: 94.1;Erythroid cells: 166.7;Extravillous trophoblasts: 162.0;Spermatocytes: 191.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Immune cell enhanced"	"Detected in some"		"T-reg: 14.1"	"Lineage enriched"	"Detected in many"	6	"T-cells: 14.1"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA002830, CAB004270"	Enhanced		Supported	"Cytokinetic bridge"		Yes	Yes			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Cytokinetic bridge"		"CAB004270: AB_628302, HPA002830: AB_1857672"	"unprognostic (8.04e-2)"	"unprognostic (3.51e-2)"	"unprognostic (4.48e-3)"	"unprognostic (2.72e-3)"	"unprognostic (3.37e-1)"	"unprognostic (3.84e-2)"	"prognostic unfavorable (5.28e-6)"	"prognostic unfavorable (4.49e-4)"	"unprognostic (3.56e-3)"	"unprognostic (4.53e-3)"	"unprognostic (2.87e-3)"	"unprognostic (6.67e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (3.77e-2)"	"unprognostic (4.70e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.16e-1)"	0.9	1.1	0.3	8.5	0.5	37.9	5.1	0.6	0.6	1.9	0.4	6.7	7.9	1.6	0.0	12.8	0.6	1.1	0.5	0.4	0.4	0.7	2.1	1.9	16.2	0.6	0.6	0.4	0.6	0.2	0.2	6.1	0.5	0.6	8.0	0.1	1.8	0.2	1.1	5.8	7.6	4.3	0.4	5.8	3.7	19.6	1.0	41.0	0.4	0.1	16.3	2.6	3.2	0.8	139.1	126.2	111.3	121.5	6.7	11.3	41.0	103.6	57.5	144.0	94.2	104.0	52.9	140.7	41.5	60.5	108.7	71.9	113.6	66.6	125.2	48.2	157.5	93.2	71.4	123.1	0.8	90.8	67.0	3.9	4.5	79.8	59.2	21.0	103.5	104.3	118.8	116.0	112.6	79.7	195.5	86.2	83.4	96.3	218.0	100.5	180.2	108.4	34.5	50.2	136.8	94.8	80.3	88.6	71.7	54.1	117.5	84.8	39.5	173.1	152.6	76.0	150.4	83.3	72.2	163.3	63.3	37.8	154.4	0.0	0.0	0.0	0.7	0.0	0.1	2.4	4.1	2.8	0.8	0.2	0.0	0.4	0.5	2.4	0.0	0.2	14.1	3.1	0.3	0.5	0.6	0.6	0.4	0.4	0.6	0.6	0.5	0.4	1.0	0.8	1.2	0.0	20.0	0.0	15.9	8.2	3.7	12.2	2.8	0.7	7.7	8.6	2.3	2.8	10.8	0.0	0.0	74.7	3.3	10.7	0.0	2.0	94.1	5.4	5.1	8.8	3.0	166.7	0.4	0.0	162.0	15.1	8.6	6.9	9.5	42.7	12.8	2.7	52.1	0.0	0.2	17.1	10.2	13.7	13.8	68.4	3.1	9.6	1.8	0.0	0.6	0.4	7.2	0.0	0.3	0.4	2.5	0.7	50.2	2.8	3.2	0.1	2.6	0.5	6.6	0.9	15.2	191.1	58.2	31.3	6.5	19.2	10.1	3.4	38.8	6.3
BIRC6	BRUCE	ENSG00000115760	"Baculoviral IAP repeat containing 6"	Q9NR09	2	32357028-32618899	"Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Cell cycle, Cell division, Mitosis, Ubl conjugation pathway"	"Protease inhibitor, Thiol protease inhibitor, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 272.0;Inhibitory neurons: 291.3;Oligodendrocytes: 361.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	5	"basophil: 9.7"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 9.7"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA074409, HPA074738"	Approved		Supported	"Golgi apparatus,Vesicles,Mitotic spindle"		Yes	No			"Cluster 18: Basophils - Vesicular transport"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	"Golgi apparatus, Vesicles"	"Mitotic spindle"	"HPA074409: , HPA074738: AB_2686710"	"unprognostic (3.38e-2)"	"unprognostic (8.13e-3)"	"unprognostic (8.88e-2)"	"unprognostic (7.06e-3)"	"unprognostic (6.69e-3)"	"unprognostic (9.01e-2)"	"unprognostic (4.51e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.86e-1)"	"unprognostic (4.49e-2)"	"unprognostic (4.00e-2)"	"unprognostic (2.07e-2)"	"unprognostic (1.30e-1)"	"unprognostic (4.61e-1)"	"unprognostic (7.32e-2)"	"unprognostic (3.37e-1)"	4.6	4.7	3.1	6.7	9.7	11.3	8.9	13.9	5.7	7.7	6.3	7.6	5.0	6.8	5.2	5.3	6.2	5.8	4.9	4.6	3.7	7.6	8.9	5.4	9.6	6.4	5.5	12.0	14.7	10.9	2.9	6.9	7.3	6.2	7.5	15.5	5.5	5.9	6.1	6.7	5.4	6.1	4.4	8.5	7.1	6.8	5.6	14.7	11.4	8.8	9.7	7.2	3.1	16.3	21.7	17.8	16.1	7.9	14.9	19.1	11.3	10.8	14.1	11.0	11.3	14.2	5.7	23.6	7.3	19.7	13.2	10.1	22.9	15.1	13.9	18.8	10.5	31.2	11.3	10.7	7.9	32.4	11.9	12.4	6.9	18.0	16.2	10.1	17.7	5.4	25.6	10.0	11.9	9.3	15.5	7.5	11.7	9.2	10.5	14.6	26.6	8.2	9.2	23.4	11.7	18.4	18.6	10.8	8.2	12.5	6.4	11.5	28.7	13.0	13.3	9.1	15.3	13.9	20.0	30.6	10.1	15.1	8.7	9.7	0.9	0.6	1.3	0.7	1.8	0.8	1.0	1.2	0.7	1.8	1.1	1.4	1.5	1.6	1.5	1.6	1.0	0.5	3.1	9.7	13.9	5.7	4.6	3.7	6.4	5.5	7.3	4.4	5.6	16.3	53.9	32.1	30.5	239.3	74.8	46.0	28.6	34.7	41.5	60.8	40.0	23.4	45.8	38.6	42.7	36.8	191.8	35.0	93.4	70.1	1.9	26.9	45.9	39.3	58.0	49.8	32.5	34.3	272.0	31.2	22.0	39.7	68.3	63.1	29.9	52.1	45.7	47.5	29.8	69.0	291.3	43.3	26.4	54.7	60.0	17.6	45.4	59.1	23.2	202.4	67.2	34.9	64.9	231.8	361.3	34.3	30.3	59.0	70.9	46.4	48.5	22.6	30.6	88.2	39.5	56.0	49.1	53.7	46.2	49.7	54.8	38.0	72.4	52.8	45.3	44.0
BIVM	FLJ20159	ENSG00000134897	"Basic, immunoglobulin-like variable motif containing"	Q86UB2	13	102799119-102841533	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"NK-cell: 7.6"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"											HPA050126	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 17: Intestinal endocrine cells - Hormone signaling"	Nucleoplasm		"HPA050126: AB_2681027"	"unprognostic (8.86e-2)"	"unprognostic (1.02e-1)"	"unprognostic (3.55e-1)"	"unprognostic (2.77e-1)"	"unprognostic (1.19e-2)"	"unprognostic (1.83e-3)"	"unprognostic (1.37e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.91e-2)"	"unprognostic (1.30e-1)"	"unprognostic (6.89e-3)"	"unprognostic (6.66e-2)"	"unprognostic (1.97e-1)"	"unprognostic (2.79e-2)"	"unprognostic (2.73e-1)"	"unprognostic (7.29e-2)"	"unprognostic (3.33e-2)"	7.4	7.1	8.2	3.6	8.6	3.6	8.8	10.9	10.6	8.6	7.6	7.1	6.3	9.2	11.5	5.5	7.7	6.9	19.4	8.3	7.8	16.3	18.8	6.7	4.5	7.5	7.9	9.2	10.4	9.1	8.9	7.7	7.7	7.8	8.2	9.0	6.1	7.6	17.8	7.2	6.3	8.9	6.8	7.4	8.6	2.3	8.5	10.4	8.0	18.9	4.3	7.4	6.5	9.1	16.8	4.6	19.9	18.7	24.2	37.4	4.1	19.3	23.9	14.5	16.5	6.1	7.7	0.1	8.2	22.1	10.3	11.5	17.9	16.3	17.5	17.1	16.3	14.7	14.2	8.8	19.5	16.8	22.2	28.2	18.8	7.9	20.5	25.4	20.2	22.7	14.4	0.0	25.7	3.7	19.3	16.1	4.3	24.1	12.9	0.0	9.0	6.4	50.0	7.2	23.8	21.1	8.5	9.2	12.3	7.2	13.3	22.7	12.9	13.0	4.3	9.4	11.8	12.5	5.6	0.1	21.2	0.0	25.9	5.5	0.4	1.1	2.2	0.2	5.2	0.5	1.4	2.9	1.6	0.5	0.7	1.4	0.3	7.6	0.0	0.4	1.0	1.0	8.2	8.6	10.9	10.6	8.3	7.8	7.5	7.9	7.7	6.8	8.5	9.1	9.3	9.6	12.8	2.9	2.6	3.7	3.8	7.0	11.4	19.0	7.7	6.1	30.7	21.5	11.2	18.4	14.6	7.1	3.8	5.6	29.4	6.5	0.5	5.1	11.8	11.0	21.8	9.2	13.9	5.5	7.8	11.8	6.1	4.9	6.3	15.2	17.2	34.0	7.0	23.5	16.8	15.3	6.1	5.0	3.4	0.4	13.7	3.3	3.6	4.7	2.4	8.1	5.2	9.0	6.3	4.1	9.3	11.3	4.5	4.9	9.7	30.8	8.9	12.4	19.7	10.4	9.8	2.0	12.6	11.4	4.8	2.5	8.1	10.3	15.2	3.4
BLM	"BS, RECQ2, RECQL3"	ENSG00000197299	"BLM RecQ like helicase"	P54132	15	90717346-90816166	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair, DNA replication"	"DNA-binding, Helicase, Hydrolase"	"Cancer-related genes, Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 5.7;lymphoid tissue: 7.9;salivary gland: 7.8"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 18.3;Oligodendrocyte precursor cells: 58.3;Plasma cells: 20.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005689	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	Cytosol	"HPA005689: AB_1845372"	"unprognostic (2.77e-1)"	"unprognostic (3.82e-3)"	"unprognostic (4.03e-2)"	"unprognostic (2.98e-2)"	"unprognostic (4.75e-2)"	"unprognostic (9.89e-2)"	"unprognostic (6.12e-5)"	"unprognostic (2.82e-2)"	"unprognostic (4.55e-3)"	"unprognostic (5.24e-3)"	"unprognostic (1.80e-3)"	"unprognostic (9.12e-2)"	"unprognostic (1.55e-15)"	"unprognostic (6.53e-3)"	"unprognostic (6.55e-2)"	"unprognostic (2.43e-1)"	"unprognostic (1.83e-2)"	0.3	0.2	0.9	3.6	1.1	5.7	0.5	2.3	0.9	0.1	0.3	1.4	1.0	0.4	0.4	0.6	0.3	0.3	0.3	0.8	1.1	0.1	0.1	0.4	6.4	1.2	1.4	0.1	0.2	0.0	0.6	1.2	1.1	0.1	1.7	2.4	7.8	0.0	0.5	0.4	1.6	0.4	1.0	1.6	1.1	2.2	0.9	7.9	0.3	0.1	6.2	1.0	0.2	1.0	13.0	14.4	20.4	12.6	0.1	0.9	14.6	9.4	3.2	11.1	13.4	11.7	10.1	35.1	5.9	2.6	14.1	20.4	25.7	7.1	15.1	19.1	20.5	36.4	14.8	3.9	0.0	33.7	17.3	0.3	0.1	10.6	4.7	1.3	7.9	16.9	32.7	9.9	11.0	7.4	28.3	14.5	22.2	24.9	4.2	25.4	39.1	14.7	2.3	18.9	14.6	14.7	8.5	11.5	4.8	18.1	7.2	23.4	3.7	8.6	13.6	9.6	21.0	6.4	30.4	39.5	5.6	25.8	15.7	1.7	0.6	2.6	1.6	0.8	2.6	4.6	1.4	2.1	0.7	2.3	1.0	1.1	0.7	3.1	1.0	0.7	3.2	0.9	0.9	1.1	2.3	0.9	0.8	1.1	1.2	1.4	1.1	1.0	0.9	1.0	0.9	3.2	8.9	1.0	12.9	0.3	0.5	0.5	0.6	3.6	1.3	1.0	7.9	0.0	4.2	0.0	2.1	5.5	6.9	2.2	1.9	1.0	2.7	1.3	1.3	2.0	0.0	18.3	0.7	0.7	6.8	1.8	3.6	1.7	13.3	8.1	2.2	0.6	5.7	0.0	8.6	1.3	0.0	7.7	1.3	1.6	0.0	7.7	0.0	7.5	2.7	1.7	10.3	58.3	2.6	1.2	0.3	0.4	20.6	0.7	0.2	0.0	5.4	7.1	0.0	0.9	1.7	17.1	12.9	2.2	0.6	1.0	10.2	0.7	4.0	0.4
BLMH	BH	ENSG00000108578	"Bleomycin hydrolase"	Q13867	17	30248203-30292056	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Protease, Thiol protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skin 1: 130.3"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039548, HPA064307"	Enhanced		Supported	"Nucleoplasm,Nuclear bodies,Cytosol"		No	No		42000000	"Cluster 16: MAIT-cells - Unknown function"	"Cluster 31: Skin - Epidermis development"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 24: Non-specific - Transcription regulation"	"Nucleoplasm, Nuclear bodies, Cytosol"		"HPA039548: AB_10805479, HPA064307: AB_2685241"	"unprognostic (6.85e-2)"	"unprognostic (2.79e-1)"	"unprognostic (1.48e-1)"	"unprognostic (2.46e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.54e-2)"	"unprognostic (3.91e-3)"	"unprognostic (2.07e-1)"	"unprognostic (2.05e-3)"	"unprognostic (6.69e-3)"	"unprognostic (1.95e-3)"	"unprognostic (2.14e-2)"	"unprognostic (2.14e-2)"	"unprognostic (1.22e-3)"	"unprognostic (1.05e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.44e-1)"	20.6	13.5	13.4	18.2	15.0	18.1	20.4	15.9	17.6	19.1	14.5	18.8	12.4	21.2	21.1	28.3	14.7	18.4	15.6	13.5	15.2	22.0	14.0	16.0	26.0	15.6	14.1	13.9	26.8	21.7	9.7	27.4	15.4	14.4	15.4	14.7	15.6	14.4	28.8	130.3	18.3	22.4	14.7	20.6	16.2	15.9	14.2	36.3	16.5	19.0	26.9	17.9	21.5	16.2	40.3	62.9	61.5	41.6	40.6	43.8	27.8	36.5	24.0	59.1	50.8	93.2	11.9	119.5	63.3	31.1	26.1	27.1	135.5	52.8	50.1	31.5	101.4	73.5	54.6	80.0	58.3	136.1	43.2	50.5	3.5	46.5	26.5	47.1	87.2	98.2	157.9	47.6	24.6	31.0	168.1	98.6	57.2	0.0	29.2	143.0	154.5	78.9	46.8	35.6	135.1	48.4	32.6	63.2	42.2	106.6	42.9	68.5	54.5	35.0	69.2	16.0	66.0	55.8	124.1	159.3	26.7	0.2	47.6	0.0	8.8	1.5	15.3	6.2	25.3	6.5	18.2	20.2	10.1	7.3	16.4	17.8	1.2	16.3	3.3	10.1	20.0	9.9	13.4	15.0	15.9	17.6	13.5	15.2	15.6	14.1	15.4	14.7	14.2	16.2	21.0	3.2	12.6	13.4	8.8	15.9	16.7	10.6	19.4	20.2	10.3	6.6	17.8	12.8	4.0	11.0	12.5	49.6	15.6	7.6	7.9	17.4	8.4	7.4	28.2	24.0	18.0	22.5	19.0	14.2	38.0	18.3	11.2	7.0	43.8	30.5	25.7	6.9	25.0	13.5	20.9	8.4	6.1	18.9	7.1	6.6	16.1	13.0	10.6	18.7	12.2	9.9	22.6	29.1	22.6	7.2	9.6	24.8	20.0	13.0	11.5	20.0	5.5	15.7	6.6	12.9	19.7	14.9	29.1	24.0	12.6	27.5	20.9	34.8	11.5	7.6
BLNK	"BASH, bca, BLNK-s, Ly57, SLP-65, SLP65"	ENSG00000095585	"B cell linker"	Q8WV28	10	96189171-96271587	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"B-cell activation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 70.5"	"Cell type enhanced"	"Detected in many"		"B-cells: 94.2;dendritic cells: 64.0;Microglial cells: 157.4;Plasma cells: 80.4;Proximal enterocytes: 64.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	9	"memory B-cell: 161.2;naive B-cell: 140.5;plasmacytoid DC: 231.5"	"Group enriched"	"Detected in many"	101	"B-cells: 161.2;dendritic cells: 231.5"	"Group enriched"	"Detected in some"	6	"Daudi: 68.7;REH: 168.4;RPMI-8226: 94.4;U-698: 251.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB009333, CAB016291, HPA038309, HPA038310"	Enhanced		Supported	"Vesicles,Plasma membrane"		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 57: B-cells - Immune response"	"Plasma membrane"	Vesicles	"CAB009333: AB_2290422, CAB016291: AB_626752, HPA038309: AB_2675945, HPA038310: AB_2675946"	"unprognostic (4.86e-2)"	"unprognostic (6.05e-3)"	"unprognostic (1.00e-2)"	"unprognostic (2.73e-2)"	"unprognostic (2.29e-1)"	"unprognostic (1.63e-3)"	"unprognostic (1.08e-2)"	"unprognostic (5.19e-2)"	"unprognostic (2.97e-1)"	"unprognostic (1.02e-1)"	"unprognostic (8.94e-2)"	"unprognostic (3.73e-1)"	"unprognostic (1.84e-2)"	"unprognostic (5.23e-2)"	"unprognostic (9.76e-2)"	"unprognostic (1.46e-3)"	"prognostic favorable (2.67e-6)"	2.2	3.2	3.8	27.5	3.4	10.1	6.3	2.4	4.1	7.1	13.9	16.9	38.9	2.4	30.1	39.9	6.1	10.8	1.0	3.5	5.1	28.5	39.2	6.6	57.6	4.7	4.0	1.5	12.1	17.4	1.8	6.4	5.0	7.3	18.2	1.4	10.9	13.2	0.5	8.0	34.0	3.0	3.8	54.0	29.2	1.3	4.9	10.6	11.6	1.1	70.5	9.9	15.8	5.2	0.3	0.1	0.1	0.2	0.0	0.1	0.8	0.1	0.0	0.0	0.0	0.2	0.2	68.7	0.4	0.0	0.3	0.6	0.1	0.8	0.1	5.5	0.2	0.3	0.3	0.1	0.0	0.1	1.4	0.1	8.7	0.0	0.0	0.1	0.0	0.8	0.3	6.4	0.0	0.7	0.4	0.2	0.2	0.2	0.0	168.4	0.3	94.4	0.9	13.0	0.3	0.3	0.2	15.1	0.1	0.2	23.7	1.1	0.2	0.2	0.8	0.1	0.2	5.4	0.4	251.4	0.1	0.5	0.1	0.3	1.6	0.2	0.3	1.3	0.1	161.2	0.3	0.2	20.6	140.5	0.1	0.1	1.1	1.9	0.1	231.5	0.6	8.1	3.8	3.4	2.4	4.1	3.5	5.1	4.7	4.0	5.0	3.8	4.9	5.2	0.4	6.4	7.7	0.7	94.2	1.1	21.0	13.1	21.1	0.0	4.1	3.4	1.2	30.0	7.3	40.5	0.0	23.0	64.0	9.2	27.4	14.6	3.1	14.4	1.9	0.3	4.9	5.3	1.0	13.8	17.5	0.7	35.7	22.9	1.3	0.0	2.9	27.8	22.8	0.0	1.3	19.4	30.5	9.0	13.8	1.1	0.3	18.2	1.8	157.4	4.8	0.0	0.0	2.5	0.9	4.4	22.4	0.0	80.4	5.1	64.6	2.3	3.4	0.0	6.6	0.3	0.7	1.6	0.1	34.7	1.4	41.5	3.6	0.5	22.5	23.8
BLOC1S5	"dJ303A1.3, MU, MUTED"	ENSG00000188428	"Biogenesis of lysosomal organelles complex 1 subunit 5"	Q8TDH9	6	8013567-8064396	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Proximal tubular cells: 41.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"CAB025613, HPA077525"	Uncertain		Supported	Vesicles		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Vesicles		"CAB025613: , HPA077525: AB_2686843"	"unprognostic (1.54e-1)"	"unprognostic (8.21e-2)"	"unprognostic (1.26e-2)"	"unprognostic (1.24e-2)"	"unprognostic (1.92e-1)"	"unprognostic (5.06e-2)"	"prognostic unfavorable (8.12e-4)"	"unprognostic (4.24e-2)"	"unprognostic (1.20e-2)"	"unprognostic (1.47e-2)"	"unprognostic (2.87e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.62e-3)"	"unprognostic (1.83e-1)"	"unprognostic (1.13e-1)"	"unprognostic (6.16e-2)"	"unprognostic (7.60e-3)"	6.8	7.0	3.6	6.3	4.2	3.9	10.5	3.9	4.7	8.1	3.0	6.4	4.2	7.0	6.9	6.6	6.4	6.1	6.0	3.3	4.7	15.7	11.4	5.9	9.9	4.4	4.2	9.9	4.7	9.6	3.1	6.8	4.5	6.5	5.8	5.2	4.7	9.2	6.5	6.4	5.0	6.6	4.0	7.4	6.0	3.7	3.9	15.6	10.1	8.6	10.6	6.2	5.3	4.6	6.1	7.0	14.7	18.9	15.7	18.8	9.6	6.7	9.4	9.5	9.4	13.6	5.8	21.8	43.9	8.6	10.8	5.4	10.8	5.4	13.6	20.6	11.5	13.1	4.8	25.8	13.4	23.2	14.8	8.4	13.4	9.6	14.4	14.5	17.3	17.3	27.7	3.9	13.6	6.7	26.6	15.1	7.9	14.3	9.4	21.5	17.0	33.8	17.6	5.4	13.5	7.2	6.8	10.3	21.3	26.4	12.9	11.8	7.2	15.1	10.7	8.9	5.9	16.5	37.3	19.7	6.2	17.9	15.9	16.2	9.4	18.3	11.8	12.3	15.7	18.9	15.3	15.2	16.6	17.7	15.2	15.9	2.3	19.6	6.7	7.2	15.2	11.8	3.6	4.2	3.9	4.7	3.3	4.7	4.4	4.2	4.5	4.0	3.9	4.6	18.1	12.8	6.9	0.0	14.6	6.0	8.3	6.8	8.6	7.0	7.1	9.9	7.3	0.0	7.9	25.8	2.1	12.5	15.6	5.9	35.2	9.9	7.5	11.5	12.4	10.7	1.8	7.2	0.0	8.7	9.2	10.6	7.7	19.5	16.5	14.5	0.0	0.0	7.8	6.7	0.0	6.9	2.0	0.0	6.1	7.8	9.6	11.0	3.6	0.0	10.7	13.2	12.3	0.0	0.0	10.1	3.9	12.4	7.3	8.4	6.7	41.8	7.7	8.4	0.0	12.4	9.3	5.8	14.4	8.9	7.5	8.2	12.7	22.5	6.6	7.5
BLVRA	BLVR	ENSG00000106605	"Biliverdin reductase A"	P53004	7	43758680-43807342	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 259.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019709, HPA042865, HPA054322"	Approved		Supported	Cytosol		NA	NA		1200000	"Cluster 7: Monocytes - Unknown function"	"Cluster 68: Epididymis - Unknown function"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 4: Macrophages - Innate immune response"	Cytosol		"HPA019709: AB_2670239, HPA042865: AB_10797024, HPA054322: AB_2682450"	"unprognostic (2.47e-2)"	"unprognostic (8.38e-3)"	"unprognostic (1.79e-2)"	"unprognostic (2.16e-3)"	"unprognostic (6.45e-3)"	"unprognostic (5.01e-2)"	"unprognostic (1.63e-2)"	"prognostic favorable (8.65e-4)"	"unprognostic (1.42e-1)"	"unprognostic (1.75e-2)"	"unprognostic (2.93e-1)"	"unprognostic (9.27e-2)"	"unprognostic (1.15e-2)"	"unprognostic (5.63e-3)"	"unprognostic (3.18e-1)"	"unprognostic (2.13e-3)"	"unprognostic (4.56e-2)"	53.2	28.0	31.4	39.7	33.4	65.6	49.9	32.0	40.1	44.3	31.4	61.4	12.5	38.5	129.9	67.5	40.9	33.4	52.7	32.3	34.7	41.3	14.6	62.7	58.6	34.1	33.6	46.6	23.5	54.9	26.2	28.9	34.2	38.4	19.8	25.4	36.5	46.0	59.7	33.4	27.7	54.1	33.1	82.0	35.3	13.1	34.0	43.0	31.3	69.3	52.6	43.5	40.4	32.0	48.6	92.2	26.2	110.5	55.0	72.7	1.3	32.3	99.3	54.0	65.4	22.2	28.3	0.3	60.6	51.5	190.7	62.1	82.1	81.7	46.2	227.3	56.8	104.1	86.6	138.1	139.5	11.8	37.5	49.9	135.7	57.2	37.8	108.5	92.7	51.1	70.2	55.7	41.4	52.5	37.0	6.3	35.9	11.0	104.7	80.4	45.6	261.4	121.1	26.6	34.0	104.4	65.9	65.1	55.2	46.2	146.7	77.7	57.0	49.3	53.9	21.8	56.0	74.7	63.2	0.2	80.8	46.9	78.4	51.1	291.9	169.2	39.1	374.9	36.7	26.9	75.7	64.9	135.4	17.0	39.7	31.0	26.5	22.4	368.4	20.1	82.2	208.5	31.4	33.4	32.0	40.1	32.3	34.7	34.1	33.6	34.2	33.1	34.0	32.0	22.0	60.9	85.0	7.5	10.7	29.1	64.2	102.4	34.1	18.0	29.6	36.1	59.4	17.2	75.7	35.0	2.1	9.7	9.3	0.3	56.7	52.6	0.7	31.6	20.2	27.3	0.0	74.7	8.4	35.1	8.1	39.7	8.2	41.4	111.5	17.2	24.3	1.9	259.1	8.4	11.5	0.4	59.0	136.5	53.7	1.6	37.0	80.4	46.2	2.8	147.3	36.6	13.4	7.5	4.3	25.2	1.2	29.0	16.6	87.9	7.1	110.5	69.6	13.0	46.0	23.0	50.6	3.0	14.2	52.9	34.4	5.2	23.4	4.9	0.6	48.7
BLVRB	"FLR, SDR43U1"	ENSG00000090013	"Biliverdin reductase B"	P30043	19	40447765-40465764	"Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 625.2"	"Cell type enhanced"	"Detected in all"		"Erythroid cells: 3131.8;Hofbauer cells: 1099.2;Proximal enterocytes: 864.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"classical monocyte: 465.2"	"Group enriched"	"Detected in all"	7	"dendritic cells: 343.3;monocytes: 465.2"	"Cell line enhanced"	"Detected in many"		"A549: 506.6;K-562: 506.8;OE19: 451.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041698, HPA041937"	Enhanced		Supported	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"		No	No		370000000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 6: Erythroid cells - Oxygen transport"	Cytosol	"Nucleoplasm, Vesicles, Plasma membrane"	"HPA041698: AB_10796781, HPA041937: AB_10794308"	"unprognostic (1.86e-1)"	"unprognostic (1.14e-2)"	"unprognostic (4.23e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.08e-1)"	"unprognostic (2.46e-1)"	"unprognostic (9.92e-2)"	"unprognostic (1.20e-2)"	"unprognostic (8.56e-2)"	"unprognostic (1.35e-1)"	"prognostic unfavorable (3.90e-4)"	"unprognostic (2.30e-1)"	"unprognostic (2.70e-1)"	"unprognostic (2.02e-1)"	"unprognostic (5.11e-2)"	"unprognostic (1.25e-1)"	"unprognostic (3.92e-2)"	115.7	76.8	46.6	48.2	46.9	625.2	93.8	49.4	61.0	86.2	52.1	78.5	75.1	59.0	20.5	188.8	69.3	50.9	125.6	44.5	48.0	103.1	266.2	102.8	58.9	56.0	48.6	66.7	73.2	46.1	25.2	52.1	58.5	74.3	30.3	5.5	89.4	42.2	210.4	83.9	72.2	31.7	49.8	166.7	138.4	10.2	52.3	27.5	64.5	94.1	25.3	81.0	96.5	53.4	227.9	506.6	7.3	77.7	73.7	70.2	57.3	28.0	88.7	39.3	75.4	103.4	203.8	74.3	212.3	56.3	126.8	73.1	30.4	64.6	10.5	123.8	20.0	114.9	73.4	62.4	169.8	1.6	32.2	69.2	119.4	52.4	34.2	40.1	41.8	27.4	506.8	137.0	51.0	359.2	6.1	7.2	1.9	451.4	133.8	54.0	23.4	120.3	50.9	146.5	0.4	10.5	84.5	224.5	84.4	13.2	221.5	17.6	39.2	99.4	103.9	156.4	15.9	71.7	92.1	28.5	259.1	46.2	39.0	45.5	465.2	18.0	29.2	220.9	27.0	58.2	24.3	24.5	343.3	37.5	24.7	19.3	58.4	27.4	117.7	75.8	37.3	259.4	46.6	46.9	49.4	61.0	44.5	48.0	56.0	48.6	58.5	49.8	52.3	53.4	74.6	221.2	164.5	9.4	34.4	129.4	348.5	337.9	103.6	11.2	93.8	143.0	130.5	164.5	184.2	97.5	6.2	84.9	39.5	343.6	266.1	234.2	10.0	56.5	46.3	51.1	44.9	3131.8	5.2	267.3	94.7	112.5	280.3	83.1	43.1	31.0	57.1	680.8	1099.2	10.1	5.1	223.5	158.7	627.7	165.4	23.6	124.2	286.7	144.1	13.1	219.8	88.0	32.0	2.0	5.6	260.4	464.0	94.0	25.7	229.7	864.3	488.3	139.1	13.5	32.9	65.4	146.0	2.6	4.0	160.3	130.4	74.7	34.5	34.7	191.0	260.5
BLZF1	JEM-1	ENSG00000117475	"Basic leucine zipper nuclear factor 1"	Q9H2G9	1	169367970-169396540	"Predicted intracellular proteins"	"ER-Golgi transport, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 131.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 85.6"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA025703, HPA027331, HPA067113"	Supported		Supported	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Golgi apparatus"	Nucleoplasm	"HPA025703: AB_1845379, HPA027331: AB_1845380, HPA067113: AB_2685781"	"unprognostic (5.25e-2)"	"unprognostic (9.03e-2)"	"unprognostic (9.31e-3)"	"unprognostic (1.48e-2)"	"unprognostic (4.66e-1)"	"unprognostic (4.00e-1)"	"unprognostic (2.34e-2)"	"unprognostic (4.52e-3)"	"unprognostic (1.07e-1)"	"unprognostic (8.72e-2)"	"unprognostic (1.81e-3)"	"unprognostic (4.86e-2)"	"prognostic unfavorable (2.33e-4)"	"unprognostic (3.28e-1)"	"unprognostic (3.06e-2)"	"unprognostic (7.53e-2)"	"unprognostic (2.18e-1)"	14.9	13.1	8.2	12.5	10.3	25.6	19.4	11.3	10.3	14.6	9.4	13.9	12.3	15.6	14.3	32.4	11.3	16.3	16.0	8.9	9.0	17.0	14.9	13.0	11.8	9.9	9.4	14.5	9.5	15.1	8.7	18.2	9.7	15.6	15.6	22.8	12.7	16.0	11.3	18.0	12.7	17.9	9.7	12.5	13.1	35.0	9.3	13.7	18.7	11.0	16.2	16.6	14.7	14.3	52.8	16.6	16.5	13.6	24.9	37.6	26.2	46.6	32.0	48.1	52.5	19.5	33.3	7.5	26.8	31.6	30.7	38.6	16.6	30.3	37.4	16.8	16.1	13.7	20.0	13.6	26.4	27.2	18.9	27.6	36.9	35.8	31.7	27.3	25.1	14.9	25.6	20.0	46.0	10.8	12.1	12.7	19.9	38.2	25.2	6.8	26.0	16.6	48.1	17.5	9.3	30.6	30.3	41.3	36.9	28.3	44.8	20.4	30.5	28.9	22.5	26.7	39.6	20.4	26.1	19.5	22.1	11.7	44.6	85.6	12.2	51.5	12.2	16.2	16.0	11.3	15.0	14.1	10.8	10.4	13.2	14.4	25.1	19.8	15.8	8.2	23.9	10.9	8.2	10.3	11.3	10.3	8.9	9.0	9.9	9.4	9.7	9.7	9.3	14.3	14.7	22.4	16.4	34.9	11.7	18.4	46.7	22.6	16.5	14.3	18.0	12.1	29.6	11.5	24.4	11.0	14.6	18.3	15.2	18.2	23.5	24.2	131.4	28.0	18.6	11.9	12.6	16.0	30.2	13.2	17.3	18.7	22.4	28.5	26.0	12.3	12.5	4.8	14.3	33.7	32.8	11.7	14.2	10.7	6.8	72.8	14.6	11.6	14.2	17.8	10.3	21.2	17.5	30.2	57.8	36.7	11.6	17.7	13.9	17.0	15.4	22.4	31.6	27.9	0.0	23.0	21.7	84.9	25.8	16.7	15.6	20.1	18.8	17.1	11.6	65.3
BMP2K	"BIKe, DKFZp434K0614"	ENSG00000138756	"BMP2 inducible kinase"	Q9NSY1	4	78776342-78916365	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 242.9;granulocytes: 129.2;Hofbauer cells: 140.4;Microglial cells: 351.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in all"		"fHDF/TERT166: 50.1;HEL: 73.6;HMC-1: 80.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026436, HPA026451, HPA026501"	Approved		Supported	"Nuclear speckles"		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 4: Macrophages - Innate immune response"	"Nuclear speckles"		"HPA026436: AB_10600102, HPA026451: AB_10600228, HPA026501: AB_10601341"	"unprognostic (7.96e-2)"	"unprognostic (3.68e-1)"	"prognostic favorable (1.74e-4)"	"unprognostic (9.08e-2)"	"unprognostic (1.97e-1)"	"unprognostic (9.73e-3)"	"unprognostic (1.51e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.98e-1)"	"unprognostic (7.60e-2)"	"unprognostic (1.39e-1)"	"unprognostic (9.60e-2)"	"unprognostic (9.90e-2)"	"unprognostic (9.45e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.55e-2)"	"unprognostic (3.18e-2)"	6.0	4.2	8.5	13.5	8.2	11.9	7.4	7.3	7.2	6.5	3.8	9.5	5.6	4.4	5.4	7.4	6.0	7.4	8.0	7.2	18.6	4.9	6.7	7.7	16.5	12.1	11.2	3.1	3.5	4.3	0.6	9.2	13.5	3.3	11.9	6.5	3.5	3.5	2.2	9.9	6.9	6.6	10.9	12.2	4.7	10.2	9.8	10.9	7.7	4.5	16.3	7.1	1.4	16.5	11.4	3.2	6.0	7.5	12.0	11.1	4.8	10.8	14.4	10.3	13.7	6.4	6.4	13.2	5.6	50.1	9.9	2.9	6.7	8.5	19.4	3.5	2.3	73.6	5.0	3.5	13.2	15.9	80.6	15.9	11.0	16.4	15.6	7.3	14.4	10.0	19.8	36.5	12.1	2.4	9.5	7.4	2.9	8.8	2.1	13.5	10.3	3.7	13.3	5.2	8.4	5.2	14.2	7.8	10.4	7.9	2.7	10.0	14.7	10.6	4.2	18.4	11.9	7.7	3.2	4.8	9.9	21.4	7.7	0.1	0.5	0.3	0.0	0.2	0.0	0.6	0.0	0.0	0.4	0.6	0.1	0.0	0.9	0.1	0.8	0.3	0.0	0.1	8.5	8.2	7.3	7.2	7.2	18.6	12.1	11.2	13.5	10.9	9.8	16.5	10.7	28.9	16.2	242.9	31.5	25.0	4.3	5.4	10.2	10.9	27.4	15.2	6.5	2.8	7.7	7.3	4.2	5.0	6.1	24.6	0.0	7.5	15.9	18.6	12.7	17.6	6.7	105.4	53.2	8.8	14.2	13.7	6.6	25.0	129.2	32.1	22.1	19.7	140.4	10.1	59.0	48.2	6.1	65.9	68.2	11.1	8.1	65.4	28.4	351.3	34.6	37.0	1.0	49.3	59.1	14.6	43.0	6.8	7.6	6.3	19.9	18.0	12.3	8.4	6.6	22.3	11.7	26.1	11.2	17.1	31.4	3.4	7.6	5.4	24.0	3.2
BMPR2	"BMPR-II, BMPR3, BRK-3, PPH1, T-ALK"	ENSG00000204217	"Bone morphogenetic protein receptor type 2"	Q13873	2	202376327-202567751	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted membrane proteins"		"Kinase, Receptor, Serine/threonine-protein kinase, Transferase"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 202.2;Inhibitory neurons: 190.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017385, HPA049014"	Approved		Supported	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 40: Granulosa cells - Unknown function"	"Nucleoplasm, Plasma membrane"		"HPA017385: AB_1845397, HPA049014: AB_2680599"	"unprognostic (2.17e-1)"	"unprognostic (9.00e-2)"	"unprognostic (2.35e-1)"	"unprognostic (2.73e-1)"	"unprognostic (1.67e-1)"	"unprognostic (2.55e-1)"	"unprognostic (4.30e-2)"	"unprognostic (1.11e-1)"	"unprognostic (3.18e-2)"	"unprognostic (1.10e-2)"	"unprognostic (2.13e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.29e-2)"	"unprognostic (1.21e-3)"	"unprognostic (9.20e-2)"	"unprognostic (1.18e-1)"	"unprognostic (3.40e-1)"	18.5	21.6	8.2	10.9	14.1	2.2	13.2	3.2	16.8	22.6	0.3	13.6	8.5	20.0	11.3	12.4	14.9	17.3	21.5	16.0	14.8	17.4	15.6	29.1	7.2	6.2	7.7	16.8	10.4	17.5	8.5	34.0	10.0	17.1	13.0	26.7	11.0	13.9	10.9	10.9	8.6	24.3	3.9	13.1	11.7	11.3	10.6	9.0	18.2	23.1	9.4	20.6	12.4	5.9	13.3	12.3	12.6	19.7	34.2	31.9	23.8	27.2	28.3	23.6	23.9	10.8	19.6	4.7	30.7	58.2	19.9	24.5	16.8	21.4	41.6	13.8	11.2	14.2	12.6	16.8	22.7	4.0	10.7	24.2	21.5	17.1	22.8	40.6	73.9	5.6	9.3	22.5	33.8	24.8	3.4	3.6	6.9	6.6	11.1	9.1	24.3	7.1	21.3	27.9	12.6	12.7	28.9	17.7	32.7	32.0	13.2	9.5	75.9	48.0	24.4	16.3	16.7	3.1	4.1	1.3	11.3	9.0	13.9	0.1	0.6	0.2	0.9	0.5	0.6	0.3	0.3	0.5	0.6	0.4	0.7	0.3	0.1	0.3	0.9	0.7	1.0	0.3	8.2	14.1	3.2	16.8	16.0	14.8	6.2	7.7	10.0	3.9	10.6	5.9	116.9	105.8	40.3	104.5	15.2	33.4	18.0	34.9	13.6	54.3	29.2	29.7	55.5	15.7	38.8	20.2	81.3	16.9	17.8	25.2	1.9	27.2	2.8	23.1	54.5	152.2	25.1	6.9	202.2	28.1	22.6	47.7	16.8	36.4	23.5	155.1	143.1	19.9	18.7	35.3	190.2	16.3	20.3	24.2	31.7	4.6	33.8	23.5	42.7	170.5	20.2	39.9	16.5	152.8	55.1	46.8	21.1	42.9	9.5	23.9	16.4	12.4	28.0	31.7	65.7	48.8	62.4	33.2	25.0	21.2	35.9	20.0	13.1	0.8	15.5	24.8
BMX	"ETK, PSCTK3"	ENSG00000102010	"BMX non-receptor tyrosine kinase"	P51813	X	15464246-15556529	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Apoptosis, Cell adhesion, Stress response"	"Kinase, Transferase, Tyrosine-protein kinase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	12	"epididymis: 102.6"	"Group enriched"	"Detected in some"	4	"Endothelial cells: 28.2;Hepatic stellate cells: 93.9"	"Cancer enhanced"	"Detected in many"		"melanoma: 3.2"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	16	"neutrophil: 7.6"	"Lineage enriched"	"Detected in single"	77	"granulocytes: 7.6"	"Cell line enriched"	"Detected in some"	119	"HUVEC TERT2: 353.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA001048, CAB032495"	Enhanced		Supported	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 30: Epididymis - Antimicrobial activity"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Plasma membrane"	Nucleoplasm	"CAB032495: AB_2290760, HPA001048: AB_1078289"	"unprognostic (7.80e-2)"	"unprognostic (4.92e-3)"	"unprognostic (1.16e-2)"	"unprognostic (4.07e-3)"	"unprognostic (2.69e-1)"	"unprognostic (2.14e-1)"	"unprognostic (1.06e-3)"	"unprognostic (2.36e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.26e-2)"	"unprognostic (1.84e-2)"	"unprognostic (3.64e-2)"	"unprognostic (1.26e-1)"	"unprognostic (2.81e-2)"	7.7	0.3	0.3	1.7	0.5	7.1	4.9	0.3	0.6	1.7	1.1	3.8	4.4	2.3	102.6	2.3	2.6	2.6	8.8	0.3	0.3	0.6	0.7	3.0	1.5	0.3	0.4	0.9	0.9	0.3	0.2	4.7	0.3	0.9	2.4	0.0	1.1	0.9	1.3	1.6	4.8	2.6	0.3	2.2	1.4	0.2	0.4	0.7	2.0	2.2	0.4	2.6	2.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	353.0	0.0	0.2	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.9	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.6	0.0	0.0	0.0	0.0	0.0	0.3	0.5	0.3	0.6	0.3	0.3	0.3	0.4	0.3	0.3	0.4	0.4	14.1	0.0	1.1	1.3	0.0	0.4	0.7	0.0	0.0	0.0	0.1	0.0	1.6	0.0	0.0	1.8	0.0	0.1	0.0	0.1	0.0	0.0	0.0	3.2	0.0	28.2	4.2	3.2	1.3	0.2	0.0	1.1	4.6	0.2	0.0	0.1	93.9	0.7	0.1	0.0	1.2	0.1	2.0	0.0	1.1	0.0	0.3	0.1	0.0	1.0	0.0	0.0	0.0	0.5	1.5	0.0	0.0	0.0	0.1	0.8	0.1	0.0	0.8	0.0	0.0	0.3	0.8	0.2	0.1	0.2	0.0	0.1	0.2	0.1	0.4	0.4
BNC2	"BSN2, FLJ20043"	ENSG00000173068	"Basonuclin 2"	Q6ZN30	9	16409503-16870843	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"endometrium 1: 26.9;ovary: 31.7;smooth muscle: 31.7"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 46.7;Leydig cells: 90.1;Microglial cells: 230.5;Peritubular cells: 67.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	5	"gdT-cell: 2.5"	"Lineage enriched"	"Detected in single"	5	"T-cells: 2.5"	"Cell line enhanced"	"Detected in many"		"HSkMC: 31.9;Karpas-707: 40.4;RPMI-8226: 28.0"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"HPA018525, HPA059419"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 50: Fibroblasts - ECM organization"	Nucleoplasm		"HPA018525: AB_1845402, HPA059419: AB_2732637"	"unprognostic (2.68e-1)"	"unprognostic (2.89e-1)"	"unprognostic (3.64e-2)"	"unprognostic (1.14e-2)"	"unprognostic (1.56e-2)"	"unprognostic (5.07e-2)"	"unprognostic (2.81e-2)"	"unprognostic (2.50e-1)"	"unprognostic (1.94e-2)"	"unprognostic (6.05e-2)"	"unprognostic (5.99e-2)"	"unprognostic (3.87e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.36e-2)"	"unprognostic (1.62e-1)"	"unprognostic (6.74e-2)"	"unprognostic (1.14e-3)"	5.6	1.0	1.4	3.7	2.5	0.7	3.3	2.3	4.4	12.1	8.2	10.1	1.3	26.9	2.1	4.6	18.4	7.2	2.9	2.6	2.7	6.4	0.3	3.1	0.8	4.7	6.0	31.7	0.5	2.9	1.7	3.4	3.9	3.7	3.0	0.8	1.3	4.8	3.5	3.4	3.3	31.7	3.5	0.7	3.0	6.9	4.7	2.5	2.1	1.9	1.1	6.3	5.8	4.9	0.3	1.7	1.2	0.1	17.5	21.1	2.7	11.4	19.5	7.8	6.4	0.1	0.0	0.0	3.7	7.8	5.8	0.1	5.1	0.0	7.9	0.2	2.0	0.1	5.3	0.0	13.4	0.1	0.5	31.9	0.0	16.6	0.1	13.7	18.0	0.0	0.0	40.4	11.1	0.0	0.0	2.8	6.6	0.1	10.2	0.0	12.5	28.0	6.0	0.3	0.2	1.0	0.1	0.1	18.6	8.3	0.1	0.0	17.7	18.6	13.5	15.1	20.9	0.2	0.0	0.1	7.6	2.5	2.5	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.5	0.0	0.0	0.0	1.5	1.4	2.5	2.3	4.4	2.6	2.7	4.7	6.0	3.9	3.5	4.7	4.9	5.5	0.0	2.2	46.7	0.0	10.1	0.6	0.0	33.6	8.2	0.2	0.4	4.8	0.0	0.6	0.0	0.0	3.2	10.7	0.1	0.0	1.0	7.2	2.2	9.1	10.5	0.0	0.0	1.6	0.4	1.2	38.6	3.1	2.0	22.2	25.1	10.4	0.3	7.3	0.0	1.9	1.1	6.1	1.6	2.3	4.5	90.1	4.2	10.6	230.5	0.1	2.6	30.9	1.0	1.6	0.1	0.0	67.7	3.9	0.7	5.7	35.5	0.7	0.3	6.6	31.5	5.1	0.9	13.5	5.7	5.5	1.2	3.1	36.5	1.8	0.1
BNIP1	"Nip1, SEC20"	ENSG00000113734	"BCL2 interacting protein 1"	Q12981	5	173144442-173164387	"Predicted intracellular proteins, Predicted membrane proteins"	"Apoptosis, ER-Golgi transport, Host-virus interaction, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008009, HPA008149"	Supported		Supported	"Endoplasmic reticulum"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 55: Plasma cells - Humoral immune response"	"Endoplasmic reticulum"		"HPA008009: AB_1078291, HPA008149: AB_2667993"	"unprognostic (2.11e-1)"	"unprognostic (1.72e-1)"	"unprognostic (5.89e-2)"	"unprognostic (3.08e-1)"	"unprognostic (2.57e-1)"	"unprognostic (2.94e-2)"	"unprognostic (2.71e-2)"	"unprognostic (1.50e-1)"	"unprognostic (7.38e-2)"	"unprognostic (2.70e-2)"	"unprognostic (1.84e-2)"	"unprognostic (2.28e-1)"	"unprognostic (4.40e-3)"	"unprognostic (2.10e-1)"	"unprognostic (2.13e-1)"	"unprognostic (5.61e-2)"	"unprognostic (3.07e-2)"	9.5	13.0	14.2	6.6	14.2	34.2	11.3	14.5	16.6	8.3	13.3	9.6	8.7	8.3	12.0	10.2	8.9	7.7	11.6	14.2	15.6	12.4	12.6	8.9	10.3	14.9	14.9	8.6	19.3	10.9	12.3	11.3	15.1	9.1	11.0	12.3	8.8	7.0	13.5	8.8	7.9	9.1	14.0	10.1	10.7	14.9	15.3	11.9	10.9	15.8	9.7	10.3	7.8	15.1	18.2	15.9	18.6	23.2	11.2	26.1	20.7	15.0	23.5	31.4	31.3	27.6	24.3	19.4	17.3	22.5	32.7	14.0	24.4	42.6	31.7	31.8	19.5	17.4	10.6	14.6	29.7	28.1	20.9	14.7	21.1	29.0	36.3	14.8	24.2	27.8	17.1	22.8	25.8	42.3	31.3	24.7	8.2	22.0	18.8	20.4	15.0	23.8	18.0	10.9	23.5	14.6	13.3	16.7	33.5	12.9	28.3	22.1	19.4	26.8	20.0	23.4	30.7	17.3	21.8	30.1	24.8	28.5	17.8	0.1	10.1	4.4	16.9	11.4	14.2	10.5	14.5	12.2	12.6	11.6	12.1	11.9	0.4	11.9	9.8	15.6	14.0	10.1	14.2	14.2	14.5	16.6	14.2	15.6	14.9	14.9	15.1	14.0	15.3	15.1	9.3	3.2	11.4	2.9	10.9	11.6	10.0	13.4	5.2	13.5	9.4	9.5	5.8	7.2	9.7	5.5	4.2	24.2	15.4	7.4	27.4	14.7	3.4	11.5	11.6	9.1	7.2	2.5	3.9	12.3	20.2	9.0	10.7	14.0	1.3	12.6	6.1	6.7	15.6	10.1	4.7	13.7	2.0	7.1	4.9	6.6	8.7	7.9	3.6	4.7	10.1	12.4	13.4	5.5	8.3	8.8	7.4	11.7	10.8	12.4	9.5	15.7	9.8	11.2	0.0	6.1	9.0	32.4	11.3	10.8	10.9	30.1	11.5	14.0	11.5	9.4
BNIP2	"BNIP-2, Nip2"	ENSG00000140299	"BCL2 interacting protein 2"	Q12982	15	59659146-59689534	"Predicted intracellular proteins, Predicted membrane proteins"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 131.6"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026843	Approved		Supported	Nucleoli,Cytosol		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	Cytosol	Nucleoli	"HPA026843: AB_1845403"	"unprognostic (3.41e-2)"	"unprognostic (2.26e-1)"	"unprognostic (4.51e-2)"	"prognostic favorable (8.42e-4)"	"unprognostic (6.70e-2)"	"unprognostic (4.81e-2)"	"unprognostic (2.47e-1)"	"unprognostic (1.19e-1)"	"unprognostic (6.44e-2)"	"unprognostic (1.26e-1)"	"unprognostic (4.72e-2)"	"unprognostic (6.73e-2)"	"prognostic unfavorable (2.19e-5)"	"unprognostic (4.68e-3)"	"unprognostic (1.81e-1)"	"unprognostic (2.10e-2)"	"unprognostic (1.01e-1)"	49.6	22.4	14.2	41.0	15.8	131.6	30.7	14.7	13.5	28.7	10.6	20.8	16.4	36.9	19.2	30.5	20.5	27.8	47.7	11.9	16.8	19.3	46.5	41.4	48.6	17.2	15.9	31.2	13.9	17.5	10.3	42.7	17.2	26.6	23.2	27.3	20.5	29.4	32.6	20.9	20.3	41.4	16.7	46.5	18.0	22.8	16.2	43.4	18.9	48.8	48.1	41.2	21.2	18.1	39.4	35.9	45.9	37.8	70.8	57.9	40.2	60.3	85.0	54.3	61.9	29.0	18.2	67.9	39.5	87.9	74.4	72.7	48.9	70.1	73.4	49.3	31.1	83.0	52.6	30.8	77.6	107.3	91.7	68.6	71.9	49.4	85.0	51.2	91.1	78.9	48.3	70.8	88.5	22.6	50.5	44.6	41.2	7.7	25.8	55.3	57.5	87.7	56.9	87.3	36.9	50.2	39.5	52.7	104.4	66.4	43.7	112.9	72.2	58.3	71.0	38.0	60.2	52.6	112.7	90.0	46.5	98.1	60.5	50.6	46.6	72.2	29.6	46.9	35.1	31.9	31.1	31.8	43.1	28.9	31.8	32.1	81.5	34.8	40.1	34.5	36.3	43.8	14.2	15.8	14.7	13.5	11.9	16.8	17.2	15.9	17.2	16.7	16.2	18.1	116.7	73.7	44.0	20.2	87.9	86.7	98.8	56.0	70.6	32.5	35.3	29.6	81.9	28.6	43.0	14.7	47.9	64.0	82.6	31.3	37.2	31.5	9.0	41.8	44.5	105.6	15.5	57.7	15.4	26.8	76.8	68.0	46.9	65.8	96.4	31.0	87.8	49.6	91.7	50.5	17.5	24.3	32.6	115.6	106.7	6.1	43.5	125.6	51.6	25.3	120.8	55.3	64.9	20.6	28.2	36.9	22.1	57.2	63.1	75.1	20.0	16.6	45.4	50.2	78.9	56.2	68.1	28.8	32.2	64.4	92.5	193.9	73.5	42.3	19.4	136.8
BNIP3L	"BNIP3a, Nix"	ENSG00000104765	"BCL2 interacting protein 3 like"	O60238	8	26383054-26505636	"Cancer-related genes, Predicted membrane proteins, Transporters"	"Apoptosis, Host-virus interaction"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Erythroid cells: 913.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015652, CAB025371"	Enhanced		Supported	"Nuclear speckles,Mitochondria"		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 34: Non-specific - Transcription"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 6: Erythroid cells - Oxygen transport"	Mitochondria	"Nuclear speckles"	"CAB025371: , HPA015652: AB_1845406"	"unprognostic (1.02e-1)"	"unprognostic (2.90e-1)"	"unprognostic (2.00e-1)"	"unprognostic (8.36e-2)"	"unprognostic (6.24e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.64e-3)"	"unprognostic (1.46e-2)"	"unprognostic (5.04e-2)"	"unprognostic (2.02e-1)"	"unprognostic (2.06e-2)"	"unprognostic (2.97e-2)"	"prognostic unfavorable (5.92e-5)"	"unprognostic (8.72e-3)"	"unprognostic (5.16e-2)"	"prognostic unfavorable (3.95e-4)"	"unprognostic (7.59e-3)"	130.6	53.4	42.7	37.2	60.4	192.6	77.9	55.6	62.0	63.9	38.9	39.6	22.2	52.8	66.3	48.3	50.5	54.7	63.2	50.0	49.6	79.4	45.4	62.9	39.4	60.7	54.0	119.7	20.1	55.1	25.4	104.5	58.4	44.4	28.2	146.5	44.1	64.4	38.9	71.5	28.4	51.3	46.6	40.7	28.9	68.6	48.8	39.9	41.9	31.7	52.1	48.9	49.5	80.8	90.6	33.8	79.1	53.9	214.5	134.0	66.8	89.0	259.9	81.9	179.6	15.3	42.7	27.7	82.5	169.0	113.4	44.8	39.6	114.5	270.0	17.8	21.8	114.9	32.0	26.9	119.3	10.3	191.1	162.5	89.2	92.9	55.3	269.2	106.2	66.9	52.6	65.0	173.7	39.1	72.7	38.5	26.2	56.7	36.6	38.4	99.9	55.6	85.3	58.3	83.9	74.4	43.2	8.8	70.0	85.9	43.7	21.7	140.4	152.2	64.6	96.2	20.5	93.2	46.0	36.8	232.6	20.6	35.1	334.9	298.3	182.9	39.5	154.8	34.9	68.4	58.4	43.3	166.9	78.0	89.3	65.5	369.0	47.6	104.1	38.0	86.1	239.3	42.7	60.4	55.6	62.0	50.0	49.6	60.7	54.0	58.4	46.6	48.8	80.8	118.3	86.6	157.4	28.7	72.2	98.8	56.0	231.7	82.6	142.5	90.6	85.3	34.0	50.1	126.4	103.0	33.3	33.2	55.6	32.7	49.0	115.4	194.1	173.5	140.8	101.2	120.6	913.9	50.6	39.1	166.5	179.9	38.7	341.2	120.9	96.5	167.0	32.2	132.1	82.4	39.4	46.8	118.0	221.3	300.4	206.7	320.3	233.6	106.7	30.0	165.0	406.4	32.0	29.1	75.8	154.1	39.8	347.5	64.6	83.6	44.0	306.4	107.6	64.0	144.7	59.1	183.9	154.4	110.7	65.4	126.6	162.5	67.0	117.6	27.6	79.3
BOC	CDON2	ENSG00000144857	"BOC cell adhesion associated, oncogene regulated"	Q9BWV1	3	113211003-113287459	"Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 71.8;Basal squamous epithelial cells: 112.1;Fibroblasts: 55.4;Leydig cells: 84.8;Peritubular cells: 47.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 79.2;ASC diff: 113.6;BJ hTERT+: 41.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB025806	Uncertain		Approved	"Nucleoplasm,Nuclear bodies,Plasma membrane"	"Intracellular and membrane"	NA	No		7900000		"Cluster 57: Non-specific - Angiogenesis"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 50: Fibroblasts - ECM organization"	"Nuclear bodies, Plasma membrane"	Nucleoplasm	"CAB025806: "	"unprognostic (6.89e-3)"	"unprognostic (1.34e-2)"	"unprognostic (2.62e-3)"	"unprognostic (1.03e-2)"	"unprognostic (5.03e-3)"	"prognostic favorable (4.89e-4)"	"unprognostic (8.66e-5)"	"unprognostic (1.10e-1)"	"unprognostic (1.19e-2)"	"unprognostic (4.78e-3)"	"unprognostic (3.42e-2)"	"unprognostic (1.10e-1)"	"unprognostic (3.65e-3)"	"unprognostic (4.94e-3)"	"unprognostic (1.11e-1)"	"unprognostic (1.66e-1)"	"prognostic unfavorable (1.18e-5)"	41.6	5.8	15.8	10.4	15.5	0.2	29.8	13.1	12.1	26.0	33.2	49.1	4.9	46.6	10.1	24.9	63.2	19.3	14.3	17.1	15.2	9.7	1.0	6.6	3.6	53.2	30.1	35.2	16.1	2.7	20.8	2.2	23.2	33.8	4.6	3.2	23.8	21.3	6.3	34.9	18.3	32.6	32.3	4.6	19.0	5.0	26.3	5.7	24.6	9.0	3.1	32.5	25.8	23.4	0.0	7.6	27.6	79.2	113.6	6.0	0.9	12.8	41.9	3.2	2.7	0.0	0.0	0.1	7.8	21.8	1.7	0.0	5.6	2.7	1.1	0.0	3.4	0.0	2.3	0.0	0.6	0.3	0.2	19.7	1.8	1.7	0.2	25.7	0.0	0.0	0.1	0.0	0.6	2.1	0.2	1.4	7.0	0.0	6.9	0.2	12.3	0.0	0.7	0.1	8.2	11.7	0.1	0.5	0.3	8.1	3.4	0.4	0.0	4.5	7.3	0.1	4.2	0.0	0.0	0.0	9.6	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.8	15.5	13.1	12.1	17.1	15.2	53.2	30.1	23.2	32.3	26.3	23.4	9.6	0.0	0.5	71.8	0.0	21.2	3.1	3.6	112.1	0.6	3.7	17.3	1.1	1.5	0.7	5.5	0.0	4.8	0.2	0.0	0.0	0.1	1.4	12.6	10.5	5.6	1.8	0.0	8.8	0.0	4.3	55.4	0.5	11.7	0.0	5.7	3.3	0.1	0.8	0.0	2.5	0.0	0.0	0.3	5.5	3.3	84.8	1.0	10.6	6.5	0.0	12.2	0.0	24.1	0.7	0.3	0.0	47.8	0.6	3.3	0.0	0.0	0.3	0.5	0.0	18.0	13.5	1.5	3.2	11.5	11.1	1.9	0.8	1.1	0.0	0.9
BOLA3		ENSG00000163170	"BolA family member 3"	Q53S33	2	74135400-74147912	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"tongue: 173.9"	"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 313.2;Distal tubular cells: 352.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046393, HPA053162"	Uncertain		Supported	"Nuclear bodies,Mitochondria,Cytosol"		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	"Nuclear bodies, Mitochondria"	Cytosol	"HPA046393: , HPA053162: AB_2682063"	"unprognostic (1.38e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.83e-2)"	"unprognostic (4.23e-2)"	"unprognostic (9.35e-2)"	"unprognostic (3.55e-2)"	"unprognostic (1.01e-2)"	"unprognostic (3.86e-3)"	"unprognostic (8.03e-2)"	"unprognostic (1.60e-2)"	"unprognostic (4.03e-1)"	"unprognostic (2.75e-1)"	"prognostic unfavorable (9.90e-5)"	"unprognostic (1.19e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.33e-1)"	"unprognostic (4.40e-1)"	35.6	39.3	52.1	22.6	54.3	40.8	31.4	58.9	66.1	20.2	55.0	46.5	33.8	24.5	25.1	31.7	20.8	11.9	101.0	52.7	56.5	59.8	33.7	23.5	22.2	57.0	53.8	16.6	44.7	56.2	29.6	14.2	56.0	25.4	37.6	35.7	39.7	23.7	117.8	16.6	28.9	22.6	54.7	21.9	41.1	15.8	53.7	24.8	28.8	173.9	21.6	27.1	24.3	55.3	102.8	134.0	44.8	46.2	81.5	78.3	113.9	92.5	54.5	104.0	72.0	176.6	45.4	67.2	79.7	82.4	99.3	53.2	107.9	135.4	95.8	126.5	172.8	85.4	88.3	269.8	76.1	167.3	39.0	62.2	96.6	100.9	124.2	45.9	79.4	144.3	183.2	73.7	116.0	163.6	136.4	123.1	66.9	196.8	198.6	88.5	120.1	132.0	138.8	106.2	70.4	40.7	68.3	106.8	123.3	62.0	62.6	102.8	42.6	83.9	142.9	93.8	185.4	67.5	135.3	92.7	87.6	131.8	73.8	14.7	14.2	3.9	68.3	29.9	75.7	45.4	92.7	72.6	37.8	44.5	79.3	68.7	3.0	51.7	33.5	65.1	91.2	40.6	52.1	54.3	58.9	66.1	52.7	56.5	57.0	53.8	56.0	54.7	53.7	55.3	54.7	9.6	29.8	8.5	33.2	22.7	44.5	111.8	43.3	29.9	82.0	109.5	313.2	44.3	50.1	84.6	16.7	54.9	42.8	125.4	352.1	93.2	20.0	67.0	46.2	45.5	76.1	138.2	14.3	111.4	167.5	48.6	58.1	61.5	25.4	31.9	36.4	113.3	113.9	26.9	15.0	128.3	83.4	32.1	28.9	10.2	32.9	32.2	99.6	3.7	59.4	61.8	62.8	7.5	7.7	95.0	70.9	46.3	76.1	50.9	85.6	266.4	51.2	52.6	19.7	39.6	64.4	66.8	80.5	101.0	16.9	22.3	45.1	83.0	176.2	52.0
BOP1	KIAA0124	ENSG00000261236	"BOP1 ribosomal biogenesis factor"	Q14137	8	144262045-144291438	"Predicted intracellular proteins"	"Ribosome biogenesis, rRNA processing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 76.6"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"PC-3: 223.5"	"Low region specificity"	"Detected in all"							"HPA047869, HPA066764"	Approved		Enhanced	"Nucleoplasm,Nucleoli,Nucleoli rim,Mitotic chromosome"		Yes	No			"Cluster 26: Non-specific - Mitochondria"	"Cluster 59: Non-specific - Translation"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoli, Nucleoli rim"	"Nucleoplasm, Mitotic chromosome"	"HPA047869: AB_2680193, HPA066764: AB_2685716"	"unprognostic (6.92e-2)"	"unprognostic (5.03e-3)"	"unprognostic (6.78e-2)"	"unprognostic (2.06e-3)"	"unprognostic (3.32e-1)"	"unprognostic (2.16e-2)"	"prognostic unfavorable (3.35e-5)"	"unprognostic (2.25e-2)"	"unprognostic (4.14e-1)"	"unprognostic (3.31e-1)"	"unprognostic (2.26e-2)"	"unprognostic (7.00e-2)"	"prognostic unfavorable (2.23e-7)"	"unprognostic (7.83e-2)"	"unprognostic (4.33e-1)"	"unprognostic (8.49e-2)"	"unprognostic (4.06e-3)"	18.1	17.8	6.8	8.8	6.9	9.7	16.3	7.7	10.9	16.1	3.5	17.3	5.6	18.2	1.0	26.0	13.2	2.8	24.4	7.6	5.5	16.7	21.5	13.3	8.0	7.1	6.0	11.1	32.0	5.6	16.9	3.7	6.5	15.3	1.9	1.1	13.2	3.1	76.6	21.4	14.9	3.1	4.7	20.4	15.4	20.1	6.2	5.4	17.0	8.1	3.6	19.3	16.5	6.1	45.0	87.4	11.8	50.6	6.4	7.7	41.4	30.5	6.5	30.3	19.1	66.3	25.4	54.1	50.1	11.6	11.5	34.9	21.2	36.2	6.9	47.8	82.5	68.4	54.4	49.7	15.1	30.8	35.6	15.5	17.0	25.2	22.1	5.7	18.8	48.3	70.1	18.1	11.9	112.8	82.4	37.6	28.3	45.1	223.5	61.4	17.6	82.2	12.5	30.1	64.7	25.8	32.5	41.9	20.3	5.5	30.6	27.7	36.6	27.8	83.3	37.1	88.5	16.5	11.7	45.6	20.3	48.6	36.7	0.0	2.2	1.3	1.9	2.3	2.1	2.5	2.2	2.5	3.0	1.8	2.0	1.8	0.1	1.8	2.0	2.0	2.0	1.2	6.8	6.9	7.7	10.9	7.6	5.5	7.1	6.0	6.5	4.7	6.2	6.1	12.8	9.6	5.1	3.9	16.7	0.5	18.7	0.0	13.1	9.8	12.7	13.8	7.2	10.0	3.7	11.0	0.0	25.2	20.9	18.7	5.9	25.8	11.2	7.5	10.7	12.0	26.9	22.1	4.4	21.7	45.3	13.2	17.3	8.3	10.2	13.5	4.6	14.8	21.5	15.2	3.5	11.5	0.0	11.1	0.0	24.3	10.5	12.8	0.0	1.0	16.2	16.7	18.6	5.0	2.8	26.4	11.3	9.8	25.4	39.5	11.3	17.2	1.5	4.6	13.1	12.9	15.1	13.9	53.4	25.7	0.1	17.8	11.8	29.6	31.8	14.3
BORCS5	"LOH12CR1, LOH1CR12"	ENSG00000165714	"BLOC-1 related complex subunit 5"	Q969J3	12	12357078-12471233	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"dendritic cells: 42.6;T-cells: 39.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039509, HPA043627"	Approved		Approved	"Vesicles,Plasma membrane"		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 7: Non-specific - Mitochondria"	"Vesicles, Plasma membrane"		"HPA039509: AB_2676550, HPA043627: AB_2678588"	"unprognostic (1.82e-1)"	"unprognostic (2.87e-1)"	"unprognostic (2.81e-1)"	"unprognostic (2.41e-1)"	"unprognostic (8.00e-2)"	"unprognostic (1.45e-1)"	"prognostic unfavorable (3.47e-4)"	"unprognostic (6.78e-2)"	"unprognostic (6.16e-2)"	"unprognostic (2.79e-2)"	"unprognostic (6.36e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.12e-3)"	"unprognostic (1.50e-2)"	"unprognostic (2.14e-1)"	"unprognostic (1.72e-1)"	"unprognostic (9.51e-2)"	6.3	8.1	5.1	2.5	7.1	6.2	6.1	5.2	6.4	6.6	2.3	5.8	1.7	5.8	5.8	8.0	5.7	2.4	7.1	4.1	5.8	5.9	8.5	6.5	2.9	5.6	5.4	4.9	7.2	3.8	7.1	2.7	6.2	5.9	2.2	2.8	5.4	1.9	8.4	8.7	4.7	3.0	4.7	6.2	5.9	9.1	5.4	3.1	4.6	3.3	3.9	5.6	6.8	8.2	3.9	4.1	2.9	3.0	6.4	8.7	3.3	3.4	3.9	4.1	5.1	10.0	3.9	4.9	2.0	5.5	2.9	2.7	5.0	4.9	4.4	14.0	4.5	2.7	3.9	5.7	6.1	2.9	3.8	4.9	3.5	5.6	6.5	6.5	4.9	6.1	3.8	6.6	5.4	8.4	4.2	3.0	9.0	4.1	2.6	3.4	4.1	5.3	5.1	2.6	3.6	4.1	3.3	3.0	7.5	9.6	2.3	3.1	4.1	2.7	6.1	3.5	3.1	3.4	3.2	11.1	5.8	4.4	4.6	2.8	6.1	9.5	10.1	10.3	11.9	7.7	11.5	11.2	7.3	5.9	7.6	7.7	6.7	12.4	6.7	5.1	14.2	7.0	5.1	7.1	5.2	6.4	4.1	5.8	5.6	5.4	6.2	4.7	5.4	8.2	11.1	9.6	2.3	0.0	37.9	0.0	11.9	0.0	10.8	16.9	10.5	8.4	0.0	10.0	2.5	7.3	12.5	9.2	42.6	2.2	9.8	9.5	5.6	8.8	9.0	6.7	4.9	5.9	0.0	12.4	11.7	8.3	19.9	8.9	2.5	7.4	6.1	5.1	14.5	13.5	0.0	3.8	0.0	11.0	0.0	3.9	5.3	26.3	0.0	0.0	19.0	12.5	14.4	0.0	0.0	9.5	3.5	7.2	33.0	9.1	10.3	14.1	2.9	16.6	26.3	8.3	8.1	23.4	8.6	14.6	0.0	14.5	39.5	7.5	4.6	8.3
BPIFB4	"C20orf186, dJ726C3.5, LPLUNC4"	ENSG00000186191	"BPI fold containing family B member 4"	P59827	20	33079644-33111751	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	12	"pituitary gland: 8.4"	"Cell type enhanced"	"Detected in single"		"Basal respiratory cells: 2.5"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"HSkMC: 2.3;U-2 OS: 3.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA047388			Approved	"Actin filaments,Cytosol"	"Secreted - unknown location"	NA	NA				"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 9: U-2 OS - Unknown function"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Actin filaments, Cytosol"		"HPA047388: "		"unprognostic (1.32e-1)"		"unprognostic (1.16e-1)"	"unprognostic (1.61e-1)"	"unprognostic (2.75e-2)"	"unprognostic (1.31e-3)"	"unprognostic (4.70e-2)"	"unprognostic (3.42e-2)"	"unprognostic (2.03e-1)"	"unprognostic (3.98e-4)"			"unprognostic (1.31e-1)"	"unprognostic (1.82e-1)"		"unprognostic (8.97e-2)"	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	8.4	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.6	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.3	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1
BPNT2	"FLJ20421, gPAPP, IMPA3, IMPAD1"	ENSG00000104331	"3'(2'), 5'-bisphosphate nucleotidase 2"	Q9NX62	8	56957931-56993867	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		Hydrolase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Adipocytes: 22.6;Cardiomyocytes: 53.8;Cytotrophoblasts: 18.0;dendritic cells: 16.2;Extravillous trophoblasts: 91.8;Hofbauer cells: 26.6;Syncytiotrophoblasts: 33.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA009411	Supported		Supported	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA		480000	"Cluster 27: Non-specific - Gene expression"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 24: Non-specific - Transcription regulation"	"Golgi apparatus"	"Nucleoplasm, Cytosol"	"HPA009411: AB_1079138"	"unprognostic (1.62e-2)"	"unprognostic (7.89e-3)"	"unprognostic (6.58e-2)"	"unprognostic (6.42e-2)"	"unprognostic (2.00e-1)"	"unprognostic (8.59e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.67e-2)"	"unprognostic (2.09e-1)"	"unprognostic (4.53e-2)"	"unprognostic (4.24e-3)"	"unprognostic (1.41e-1)"	"unprognostic (1.43e-2)"	"unprognostic (1.68e-3)"	"unprognostic (2.89e-1)"	"unprognostic (1.68e-1)"	"unprognostic (1.05e-1)"	37.6	37.3	14.8	16.1	19.9	12.4	19.3	19.2	19.8	25.5	8.9	17.4	13.3	21.9	16.2	19.1	13.4	16.5	29.4	16.0	17.9	23.4	36.2	17.2	12.3	17.2	17.6	11.8	19.6	35.6	13.7	24.9	17.7	31.0	17.6	19.7	21.9	23.6	37.4	14.3	12.7	25.7	15.3	15.5	16.9	16.5	18.0	15.4	27.1	30.1	13.3	22.4	12.2	29.3	42.4	34.5	26.0	26.9	78.2	53.3	35.7	62.9	60.9	44.1	38.3	17.4	29.2	26.3	47.0	67.3	31.2	33.7	31.8	42.5	65.0	36.4	22.7	51.4	23.0	31.2	48.5	33.0	35.1	43.2	41.6	39.7	63.9	40.8	59.5	24.3	22.5	46.1	48.9	22.1	40.6	19.8	19.2	48.1	12.7	27.9	23.4	29.7	46.0	24.9	10.1	28.1	35.3	42.9	36.3	27.1	38.4	23.9	50.1	59.3	34.2	59.2	45.8	47.5	42.5	27.8	81.0	27.0	37.3	1.8	0.9	0.5	0.9	0.6	0.7	0.7	0.6	0.5	0.7	0.9	0.6	1.1	2.5	3.2	2.6	1.0	0.4	0.3	14.8	19.9	19.2	19.8	16.0	17.9	17.2	17.6	17.7	15.3	18.0	29.3	22.6	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	53.8	0.0	0.0	0.0	0.0	18.0	16.2	0.0	0.0	0.0	0.0	0.0	0.0	6.3	0.0	0.0	0.0	0.0	91.8	14.4	0.0	0.0	0.0	0.0	0.0	0.0	26.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.1	0.0	0.0	0.0	0.0	33.8	1.8	0.0	0.0	0.0
BRAF	BRAF1	ENSG00000157764	"B-Raf proto-oncogene, serine/threonine kinase"	P15056	7	140719327-140924929	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"		"Allosteric enzyme, Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Cardiomyopathy, Deafness, Disease variant, Ectodermal dysplasia, FDA approved drug targets, Mental retardation, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 252.3;Inhibitory neurons: 242.4;Oligodendrocyte precursor cells: 206.1;Oligodendrocytes: 202.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001328, CAB004552, HPA071048"	Approved		Approved	Vesicles,Cytosol		No	No			"Cluster 15: NK-cells - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 52: Non-specific - Transcription"	Vesicles	Cytosol	"CAB004552: AB_626760, HPA001328: AB_1078296, HPA071048: AB_2686336"	"unprognostic (2.98e-3)"	"unprognostic (5.66e-2)"	"unprognostic (2.20e-2)"	"unprognostic (2.66e-3)"	"unprognostic (2.44e-1)"	"unprognostic (1.48e-2)"	"unprognostic (2.07e-2)"	"unprognostic (4.23e-2)"	"unprognostic (4.07e-2)"	"unprognostic (1.58e-2)"	"unprognostic (6.53e-2)"	"unprognostic (1.91e-2)"	"unprognostic (3.79e-3)"	"unprognostic (2.08e-1)"	"unprognostic (1.76e-1)"	"unprognostic (8.01e-2)"	"unprognostic (5.46e-2)"	8.8	5.8	6.3	5.6	7.7	15.9	8.8	12.5	8.7	8.2	5.4	8.6	4.7	8.3	8.3	7.5	8.0	5.8	7.6	8.3	6.7	7.6	6.6	9.9	6.9	4.0	3.6	9.8	8.3	11.5	9.0	7.2	4.6	8.2	5.4	17.0	7.2	5.9	8.6	10.4	6.9	6.0	3.1	6.7	7.8	13.7	5.2	8.7	10.2	8.4	6.4	9.9	8.5	6.7	6.3	5.2	7.7	9.4	9.1	11.8	12.3	6.8	7.5	5.4	7.6	5.7	6.7	10.8	5.0	7.3	8.4	3.4	6.8	5.5	10.0	9.8	5.4	7.1	5.1	5.2	7.6	11.7	6.8	7.9	6.1	6.0	12.0	8.2	6.6	7.7	11.3	19.1	9.8	3.3	15.6	12.0	6.9	6.2	3.1	10.1	6.5	8.9	5.3	11.9	8.9	7.3	7.9	4.9	7.3	7.5	4.5	7.8	9.7	5.9	4.3	12.9	5.5	21.6	12.9	16.7	9.7	11.3	6.6	1.9	1.0	4.1	1.5	0.9	1.0	1.3	1.5	1.2	0.8	1.1	2.6	1.3	2.0	3.5	1.3	1.0	1.5	0.6	6.3	7.7	12.5	8.7	8.3	6.7	4.0	3.6	4.6	3.1	5.2	6.7	43.4	22.4	45.7	151.1	58.4	21.5	24.6	6.0	23.3	29.7	31.2	21.2	19.8	10.0	18.7	25.8	35.5	15.7	73.5	8.8	7.9	14.3	68.6	50.6	37.4	23.4	19.2	14.9	252.3	9.8	12.9	22.0	21.9	69.2	24.7	45.5	9.3	9.6	9.4	25.2	242.4	9.8	8.2	13.6	37.1	36.5	16.4	30.1	16.0	126.5	14.6	11.3	15.5	206.1	202.6	15.4	8.1	10.1	48.7	23.8	8.0	13.4	20.0	33.0	6.6	24.1	24.7	43.8	26.0	14.5	24.0	75.5	41.4	30.9	8.7	33.4
BRAP	"BRAP2, IMP, RNF52"	ENSG00000089234	"BRCA1 associated protein"	Q7Z569	12	111642146-111685956	"Enzymes, Metabolic proteins, Predicted intracellular proteins, RAS pathway related proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 67.2"	"Group enriched"	"Detected in all"	7	"Early spermatids: 319.6;Late spermatids: 380.1;Spermatocytes: 147.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040357, HPA058820"	Approved		Supported	"Nuclear membrane,Cytosol"		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 31: Spermatids - Spermatogenesis"	Cytosol	"Nuclear membrane"	"HPA040357: AB_10967924, HPA058820: AB_2683827"	"unprognostic (7.02e-2)"	"unprognostic (2.37e-3)"	"unprognostic (5.33e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.69e-1)"	"prognostic unfavorable (7.65e-6)"	"unprognostic (2.14e-1)"	"unprognostic (9.24e-3)"	"unprognostic (2.80e-1)"	"unprognostic (1.81e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.19e-1)"	"unprognostic (3.66e-2)"	"unprognostic (1.58e-1)"	"unprognostic (3.57e-2)"	"unprognostic (8.08e-2)"	9.6	8.8	7.8	7.9	9.2	33.6	9.2	9.8	9.8	8.0	7.3	9.6	9.2	8.8	6.9	9.5	8.5	7.5	9.7	8.1	8.8	8.5	10.0	8.0	10.5	8.8	9.2	9.8	8.2	10.5	6.2	10.6	8.8	8.3	9.2	9.1	8.4	8.3	19.8	12.8	8.8	9.4	8.5	9.0	7.7	67.2	8.4	12.8	9.9	14.0	10.8	9.2	8.1	10.6	14.6	21.1	16.9	19.5	17.7	14.8	28.2	20.0	16.7	22.8	17.5	28.6	10.0	28.0	11.7	19.1	12.9	17.6	23.8	16.4	24.2	18.0	15.4	34.8	12.9	19.4	22.2	30.7	22.5	16.9	22.8	19.7	31.8	19.6	20.0	19.0	36.7	8.9	19.0	18.6	25.7	29.6	22.8	15.4	22.1	23.6	18.4	25.1	15.0	30.3	20.9	15.5	23.5	19.8	19.5	19.3	21.7	19.3	18.8	14.6	13.5	13.3	14.4	22.6	30.9	30.4	13.8	16.8	16.3	22.7	16.8	32.3	17.5	17.5	17.3	16.1	18.5	17.9	15.1	16.5	17.1	17.6	32.7	23.1	14.6	10.9	24.7	16.1	7.8	9.2	9.8	9.8	8.1	8.8	8.8	9.2	8.8	8.5	8.4	10.6	11.6	22.4	11.2	14.7	14.9	11.2	8.9	9.7	12.0	8.9	8.8	7.5	12.7	17.2	10.8	11.0	29.2	13.7	13.7	15.4	5.9	13.5	319.6	11.9	11.6	11.4	9.6	22.9	24.7	7.7	14.9	12.3	15.3	12.4	8.2	13.3	10.4	9.1	10.9	3.3	23.3	12.9	14.2	9.8	11.5	380.1	13.4	11.7	3.6	10.3	19.7	8.6	17.5	13.0	23.3	14.5	12.7	13.5	15.0	13.4	13.5	14.6	13.8	11.8	6.6	11.6	15.1	147.8	38.6	15.4	12.6	22.4	13.5	10.2	11.0	14.5
BRAT1	"BAAT1, C7orf27, MGC22916"	ENSG00000106009	"BRCA1 associated ATM activator 1"	Q6PJG6	7	2537810-2555694	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"DNA damage"		"Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029455, HPA076508"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 71: Testis - DNA repair"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA029455: AB_10600761, HPA076508: AB_2686803"	"unprognostic (2.53e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.19e-2)"	"unprognostic (7.04e-3)"	"unprognostic (6.07e-3)"	"unprognostic (8.95e-2)"	"prognostic unfavorable (8.02e-4)"	"unprognostic (2.03e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.46e-1)"	"unprognostic (1.10e-3)"	"unprognostic (4.69e-2)"	"prognostic unfavorable (3.90e-4)"	"unprognostic (5.37e-2)"	"unprognostic (3.12e-2)"	"unprognostic (8.88e-2)"	"unprognostic (3.71e-2)"	17.4	31.0	10.7	6.8	10.9	7.9	17.8	10.4	14.3	22.5	9.6	16.2	8.8	19.4	2.2	15.1	19.2	3.7	14.5	10.4	11.2	15.2	20.7	12.2	7.2	13.5	11.4	21.6	20.2	5.2	19.8	4.5	10.1	24.5	1.3	0.9	17.4	6.6	14.8	21.6	16.6	2.5	10.6	21.1	19.6	31.5	11.2	5.0	18.7	3.7	2.1	17.6	18.8	10.5	35.1	31.1	7.5	27.2	6.8	6.3	24.5	11.7	6.5	10.1	8.5	22.5	21.5	26.3	18.1	7.8	19.4	35.1	8.8	13.7	1.6	10.4	44.4	12.2	23.5	14.3	8.7	16.5	18.2	10.6	9.5	10.2	3.0	5.8	11.4	20.2	39.1	9.6	7.1	50.0	11.8	77.9	35.3	8.8	47.0	28.6	21.9	25.5	6.5	11.3	19.5	30.2	17.1	29.8	12.9	3.5	26.5	33.4	11.8	13.8	43.3	28.5	23.2	20.7	17.3	19.0	15.2	32.8	33.2	5.1	30.8	17.5	21.9	28.2	19.3	18.6	19.8	22.6	32.4	15.2	16.3	17.9	25.4	15.9	27.1	22.7	18.4	22.8	10.7	10.9	10.4	14.3	10.4	11.2	13.5	11.4	10.1	10.6	11.2	10.5	10.1	12.8	6.4	19.9	11.1	7.8	17.5	22.6	16.5	12.8	11.3	8.9	6.8	15.7	14.8	9.2	12.5	21.1	15.0	14.8	15.6	10.6	20.8	7.1	12.3	13.0	11.4	10.3	14.2	13.8	12.9	12.8	26.0	7.5	14.0	34.9	15.4	15.3	34.2	3.3	16.2	14.8	8.2	13.1	6.7	9.4	22.7	13.3	7.2	12.2	17.6	14.4	9.2	13.6	11.3	12.0	12.1	22.2	14.4	9.1	15.0	16.6	8.1	11.9	6.6	9.4	10.7	28.8	39.5	8.0	6.8	14.6	11.9	31.7	17.9	7.6
BRCA1	"BRCC1, FANCS, PPP1R53, RNF53"	ENSG00000012048	"BRCA1 DNA repair associated"	P38398	17	43044295-43170245	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, DNA damage, DNA recombination, DNA repair, Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Transcription, Transcription regulation, Ubl conjugation pathway"	"Activator, DNA-binding, Transferase"	"Cancer-related genes, Disease variant, Fanconi anemia, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Erythroid cells: 42.5;Granulosa cells: 38.2;Spermatocytes: 105.8;Spermatogonia: 73.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"basophil: 6.8;classical monocyte: 14.7;intermediate monocyte: 4.7;myeloid DC: 10.9;neutrophil: 11.3"	"Group enriched"	"Detected in all"	6	"dendritic cells: 10.9;granulocytes: 11.3;monocytes: 14.7"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB001946, HPA004840, HPA034966, HPA057371"	Approved		Supported	"Nucleoplasm,Nuclear bodies"		NA	Yes			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Nucleoplasm, Nuclear bodies"		"CAB001946: , HPA004840: , HPA034966: AB_10795287, HPA057371: AB_2732611"	"unprognostic (7.87e-3)"	"unprognostic (6.97e-2)"	"unprognostic (3.53e-3)"	"unprognostic (2.39e-1)"	"unprognostic (5.42e-2)"	"unprognostic (7.07e-3)"	"unprognostic (1.56e-3)"	"unprognostic (4.14e-3)"	"unprognostic (9.62e-3)"	"unprognostic (2.47e-1)"	"unprognostic (5.53e-3)"	"unprognostic (1.28e-1)"	"unprognostic (1.08e-4)"	"unprognostic (1.08e-3)"	"unprognostic (1.48e-1)"	"unprognostic (2.12e-1)"	"unprognostic (8.31e-2)"	3.1	1.8	4.2	7.5	7.2	13.0	3.6	4.7	5.2	2.7	2.7	6.8	3.2	3.1	2.2	4.0	3.7	1.9	3.0	3.6	4.1	2.0	5.6	3.2	10.3	5.6	5.0	2.8	2.8	5.9	2.8	3.8	6.0	2.4	7.4	8.2	3.2	1.6	4.2	6.0	5.1	3.9	3.7	3.9	3.6	13.0	5.5	14.5	7.8	3.7	11.2	2.8	2.4	10.8	44.1	69.1	37.8	30.1	6.0	13.4	36.6	50.6	21.5	41.9	39.3	42.3	33.4	100.8	9.1	19.0	49.0	49.5	51.9	28.3	69.5	46.9	38.0	48.1	54.0	37.1	1.3	86.0	39.9	3.8	4.5	63.1	20.0	10.6	22.3	46.6	73.7	42.2	39.7	30.0	72.0	27.8	20.5	29.1	18.7	49.0	79.8	40.8	15.4	42.1	25.8	27.4	38.8	12.5	19.4	25.5	33.9	39.6	13.8	37.2	29.6	49.0	53.2	20.1	51.2	75.5	29.6	49.6	39.4	6.8	14.7	2.2	1.5	4.7	1.5	1.2	1.5	1.2	10.9	2.1	1.3	1.5	11.3	1.5	2.0	1.7	0.5	17.5	4.2	7.2	4.7	5.2	3.6	4.1	5.6	5.0	6.0	3.7	5.5	10.8	5.0	0.0	2.8	9.4	5.8	2.9	4.5	1.9	1.2	10.3	4.4	5.2	10.1	5.7	3.5	1.8	22.9	12.8	8.1	6.2	0.0	3.0	11.9	14.0	6.3	4.7	0.0	42.5	3.0	1.1	18.2	7.4	6.1	4.2	8.2	38.2	5.3	18.3	10.1	11.8	4.4	7.5	0.0	3.9	2.8	8.0	2.5	6.4	0.0	4.7	4.9	2.4	5.2	3.0	18.7	1.7	2.4	1.5	16.6	2.3	1.1	1.0	10.0	22.8	6.6	13.7	5.5	105.8	73.5	8.2	2.3	4.0	4.7	9.7	12.7	3.4
BRCA2	"BRCC2, FACD, FAD, FAD1, FANCD, FANCD1, XRCC11"	ENSG00000139618	"BRCA2 DNA repair associated"	P51587	13	32315086-32400268	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cell cycle, DNA damage, DNA recombination, DNA repair"	DNA-binding	"Cancer-related genes, Disease variant, Fanconi anemia, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 5.8;lymphoid tissue: 3.1;testis: 2.7"	"Cell type enhanced"	"Detected in many"		"Spermatocytes: 115.4;Spermatogonia: 85.6"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"							HPA026815	Uncertain		Supported	Nucleoplasm,Cytosol		Yes	No			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	Cytosol	"HPA026815: AB_10602692"	"unprognostic (9.36e-2)"	"unprognostic (2.50e-1)"	"unprognostic (4.50e-3)"	"unprognostic (1.06e-2)"	"unprognostic (5.40e-2)"	"unprognostic (2.26e-2)"	"unprognostic (1.37e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.60e-2)"	"unprognostic (2.01e-1)"	"unprognostic (6.97e-3)"	"unprognostic (4.06e-2)"	"unprognostic (3.07e-9)"	"unprognostic (2.36e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.88e-1)"	"unprognostic (1.32e-1)"	0.2	0.1	0.0	1.3	0.0	5.8	0.5	0.0	0.0	0.2	0.2	0.7	0.5	0.3	0.0	0.5	0.1	0.3	0.0	0.0	0.0	0.1	0.3	0.3	2.1	0.1	0.1	0.1	0.1	0.0	0.0	1.0	0.1	0.1	0.8	0.0	0.2	0.0	0.0	0.7	0.5	0.3	0.1	0.9	0.6	2.7	0.2	3.1	0.2	0.0	2.0	0.5	0.2	0.1	4.7	4.0	6.0	5.0	0.6	1.4	7.0	4.8	3.1	5.5	5.0	10.6	6.0	15.9	3.2	2.1	7.6	6.1	5.5	2.9	10.5	10.5	3.1	10.3	2.5	3.5	0.1	15.4	4.9	0.2	0.0	10.3	6.9	0.4	4.5	8.1	7.0	5.5	6.4	5.1	11.8	8.3	8.3	4.9	2.3	11.4	17.3	3.0	1.4	5.4	2.4	4.6	5.9	2.4	2.2	2.2	2.9	7.3	1.3	6.3	6.8	7.0	6.7	2.0	3.3	8.0	2.7	5.7	5.8	0.0	0.3	1.5	0.5	0.7	0.1	1.7	0.4	0.4	0.3	2.2	0.5	0.4	0.8	0.5	0.8	3.0	1.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.2	0.1	4.4	9.6	2.6	0.0	12.4	2.5	3.3	2.5	2.2	0.0	4.3	3.3	1.9	0.0	1.8	0.0	0.0	14.1	10.5	4.8	0.0	2.5	5.2	4.4	6.3	5.5	1.2	29.5	0.7	1.6	12.7	5.8	10.7	4.6	3.8	26.9	1.4	0.8	9.5	0.0	0.5	4.4	0.0	7.5	11.0	4.4	2.1	14.4	3.6	4.7	20.1	0.3	0.0	0.0	0.6	1.2	1.8	1.2	27.8	1.2	1.0	0.6	2.9	0.0	13.1	8.3	5.3	115.4	85.6	8.0	1.3	5.5	7.9	4.2	7.8	2.3
BRCC3	"BRCC36, C6.1A, CXorf53"	ENSG00000185515	"BRCA1/BRCA2-containing complex subunit 3"	P46736	X	155071420-155123077	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, Cell division, DNA damage, DNA repair, Mitosis, Ubl conjugation pathway"	"Chromatin regulator, Hydrolase, Metalloprotease, Protease"	Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048737			Supported	Nucleoplasm		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"HPA048737: AB_2680504"	"unprognostic (1.16e-2)"	"unprognostic (2.40e-2)"	"unprognostic (5.99e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.88e-2)"	"unprognostic (4.48e-2)"	"unprognostic (6.47e-3)"	"unprognostic (1.33e-1)"	"unprognostic (9.68e-2)"	"unprognostic (1.35e-3)"	"unprognostic (3.72e-2)"	"unprognostic (3.71e-3)"	"unprognostic (7.14e-3)"	"unprognostic (1.57e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.90e-1)"	9.9	12.9	6.8	12.1	6.6	15.6	15.8	9.2	7.7	12.8	6.8	22.3	19.3	9.2	18.5	18.4	11.6	8.4	11.2	6.6	7.0	17.8	13.8	9.8	15.4	5.9	7.1	8.1	11.4	14.7	5.2	14.0	6.7	14.6	23.3	12.9	18.5	10.9	17.8	11.1	16.9	10.6	5.4	11.0	15.6	2.3	7.4	13.4	15.2	17.6	15.5	12.6	6.3	6.6	95.6	45.1	24.4	19.6	20.9	17.7	37.9	35.9	25.8	24.1	52.3	44.0	40.1	84.1	62.8	22.1	36.1	36.3	54.4	33.6	38.0	45.4	42.1	17.7	76.1	41.4	15.8	62.8	25.5	17.3	16.9	35.1	28.5	23.1	30.1	32.2	27.4	24.9	24.6	33.6	25.8	28.8	22.3	101.9	41.9	36.2	43.3	42.0	36.8	36.5	38.0	17.3	25.6	43.6	27.3	31.5	25.2	33.7	31.5	20.4	32.1	27.6	53.8	30.0	56.1	114.5	28.2	61.5	25.3	36.8	18.8	34.0	20.0	22.9	23.4	17.6	19.3	18.2	21.2	16.7	14.8	16.6	10.5	28.4	24.1	13.3	25.4	16.9	6.8	6.6	9.2	7.7	6.6	7.0	5.9	7.1	6.7	5.4	7.4	6.6	12.0	32.1	23.3	16.6	14.0	5.5	7.0	13.8	6.8	13.0	15.0	14.0	27.2	10.0	28.5	7.3	14.6	26.7	17.6	25.5	19.6	22.9	0.6	13.8	13.7	10.6	9.6	17.1	31.9	19.8	26.6	11.3	12.8	15.9	26.6	13.7	8.6	8.6	17.4	8.4	35.2	22.6	16.2	9.5	7.0	1.3	5.9	14.5	5.4	15.9	22.3	12.9	20.6	26.7	29.2	14.7	16.8	12.0	21.1	10.3	16.3	18.0	25.1	14.5	19.7	12.6	22.9	1.2	1.3	26.2	6.5	13.5	14.9	18.3	27.3	8.3
BRD1	"BRL, BRPF2"	ENSG00000100425	"Bromodomain containing 1"	O95696	22	49773283-49827512	"Predicted intracellular proteins"	"Erythrocyte maturation"	"Chromatin regulator"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"dendritic cells: 76.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000807, HPA001063"	Enhanced		Supported	"Nuclear speckles"		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 71: Testis - DNA repair"	"Cluster 14: REH - Unknown function"	"Cluster 24: Non-specific - Transcription regulation"	"Nuclear speckles"		"HPA000807: AB_1078298, HPA001063: AB_1078297"	"unprognostic (1.96e-1)"	"unprognostic (2.99e-2)"	"unprognostic (1.07e-1)"	"unprognostic (5.11e-3)"	"unprognostic (1.07e-1)"	"unprognostic (2.47e-2)"	"unprognostic (2.18e-2)"	"unprognostic (9.98e-2)"	"unprognostic (2.73e-2)"	"unprognostic (3.28e-2)"	"unprognostic (2.02e-3)"	"unprognostic (1.64e-3)"	"unprognostic (5.87e-2)"	"unprognostic (7.50e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.26e-1)"	"unprognostic (3.95e-3)"	11.4	7.3	3.1	8.1	3.0	15.0	10.8	12.0	5.0	12.5	3.6	14.7	11.7	15.8	2.8	12.8	13.7	7.7	7.5	3.4	3.2	5.4	6.9	10.0	9.4	3.2	2.8	16.0	13.2	8.5	11.2	8.3	2.9	8.7	5.8	6.1	12.1	8.0	16.7	23.2	12.0	6.7	1.5	12.0	11.5	30.7	3.2	14.0	10.2	8.9	7.6	11.8	12.3	4.5	12.7	12.7	22.8	12.8	9.2	8.2	19.3	13.7	9.3	14.2	11.1	19.3	8.3	13.3	7.9	11.4	5.2	17.9	14.7	9.8	6.1	13.4	26.6	13.2	20.3	11.8	17.8	30.5	18.2	12.2	15.1	8.3	10.5	10.3	10.4	15.9	15.3	14.3	7.3	20.8	23.0	15.9	15.7	9.4	10.1	33.6	19.9	13.9	5.5	18.2	14.6	25.8	17.6	22.7	18.4	10.5	10.6	24.9	12.9	13.1	14.1	9.9	12.7	16.8	4.3	18.9	9.3	10.7	11.8	0.3	0.6	0.7	0.5	0.2	1.0	0.4	0.8	1.0	0.4	0.7	0.8	1.0	0.6	0.8	2.9	0.9	0.3	0.5	3.1	3.0	12.0	5.0	3.4	3.2	3.2	2.8	2.9	1.5	3.2	4.5	25.9	22.4	27.6	16.3	13.8	15.8	5.7	7.1	8.6	26.6	14.0	14.7	8.4	5.7	12.7	3.7	29.2	6.7	76.8	13.3	0.0	6.7	7.5	32.4	37.1	13.9	16.2	8.2	25.3	9.3	6.6	17.2	14.8	47.7	10.1	28.3	14.3	12.3	6.7	33.7	22.2	13.9	4.1	13.3	14.0	6.7	11.8	15.4	12.4	16.9	11.2	13.8	7.2	19.1	21.9	9.5	8.7	13.9	43.1	9.1	10.6	3.2	11.3	36.1	0.0	25.4	20.1	42.6	19.7	10.7	18.5	10.1	40.6	26.4	11.3	9.0
BRD8	"p120, SMAP"	ENSG00000112983	"Bromodomain containing 8"	Q9H0E9	5	138139770-138178953	"Predicted intracellular proteins"	"Growth regulation, Transcription, Transcription regulation"	"Chromatin regulator"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 120.8;Spermatocytes: 226.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001841	Supported		Supported	Nucleoplasm,Mitochondria		NA	Yes			"Cluster 15: NK-cells - Transcription"	"Cluster 68: Epididymis - Unknown function"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm	Mitochondria	"HPA001841: AB_1845438"	"unprognostic (1.25e-1)"	"unprognostic (1.20e-1)"	"unprognostic (2.81e-3)"	"unprognostic (2.31e-2)"	"unprognostic (9.01e-2)"	"unprognostic (3.56e-2)"	"prognostic unfavorable (1.09e-6)"	"unprognostic (1.73e-1)"	"unprognostic (7.01e-2)"	"unprognostic (6.06e-2)"	"unprognostic (1.51e-2)"	"unprognostic (4.87e-2)"	"prognostic unfavorable (7.80e-4)"	"unprognostic (4.29e-1)"	"unprognostic (1.28e-1)"	"unprognostic (2.22e-1)"	"unprognostic (2.07e-2)"	21.8	21.5	23.4	15.4	24.2	22.4	25.1	27.4	28.5	30.1	21.5	30.5	15.5	28.4	41.3	23.5	26.6	16.4	19.5	22.0	23.4	25.0	25.4	19.5	20.6	21.5	21.1	32.7	30.6	26.2	46.6	24.9	22.2	27.3	24.8	38.7	25.1	23.9	27.8	23.6	23.3	25.1	20.8	27.6	24.9	83.1	22.7	38.0	34.3	25.1	22.1	24.3	24.8	29.6	28.7	36.8	63.1	101.8	45.0	42.0	57.0	43.4	47.9	61.6	64.4	55.4	62.6	28.6	42.2	40.3	62.9	32.9	67.4	41.5	65.9	50.3	50.1	38.5	93.6	38.0	25.0	23.6	39.2	31.4	27.2	48.7	44.1	49.3	39.7	52.2	35.2	35.8	41.3	31.8	48.4	37.6	28.6	32.9	18.8	46.4	52.2	35.1	41.4	41.3	55.7	27.9	51.9	22.4	40.1	85.0	38.5	43.2	25.0	30.2	34.7	21.2	38.1	31.5	37.9	39.1	23.1	34.7	28.5	16.2	10.8	14.1	14.6	8.0	15.8	10.7	12.7	13.2	12.0	11.0	15.9	16.0	20.2	23.8	8.8	8.4	13.0	9.8	23.4	24.2	27.4	28.5	22.0	23.4	21.5	21.1	22.2	20.8	22.7	29.6	21.0	25.6	38.3	28.1	17.8	6.9	10.6	16.4	31.9	33.7	19.8	20.3	44.8	14.3	27.0	27.6	37.5	27.7	19.0	17.0	19.6	19.5	120.8	30.1	51.1	24.3	31.2	26.5	26.2	12.4	13.2	32.5	20.9	29.7	24.0	43.2	13.6	17.2	11.9	30.3	23.7	23.3	14.2	14.8	9.8	43.9	31.4	14.3	24.9	12.2	31.3	27.1	19.6	27.6	30.8	16.0	16.8	24.0	21.8	18.1	15.4	22.4	29.0	34.9	26.3	23.2	31.7	226.9	65.0	23.2	7.0	25.3	19.1	41.9	18.6	10.1
BRF2	"BRFU, FLJ11052, TFIIIB50"	ENSG00000104221	"BRF2 RNA polymerase III transcription initiation factor subunit"	Q9HAW0	8	37843268-37849861	"Predicted intracellular proteins"	"Stress response, Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB019269, HPA023378"	Supported		Supported	Nucleoli		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 44: Endometrium - Transcription"	Nucleoli		"CAB019269: , HPA023378: AB_1845446"	"unprognostic (9.85e-3)"	"unprognostic (2.74e-1)"	"unprognostic (2.95e-2)"	"unprognostic (2.00e-1)"	"unprognostic (2.51e-1)"	"unprognostic (1.07e-3)"	"unprognostic (3.91e-2)"	"unprognostic (2.35e-2)"	"unprognostic (9.68e-2)"	"unprognostic (3.31e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.00e-1)"	"unprognostic (2.13e-2)"	"unprognostic (2.52e-3)"	"unprognostic (1.33e-1)"	"unprognostic (1.93e-1)"	"unprognostic (7.41e-2)"	12.0	8.0	6.6	4.6	7.2	14.3	11.0	6.6	7.6	15.2	6.4	11.3	4.1	12.6	6.3	8.2	11.9	4.6	10.8	7.8	6.7	9.8	7.9	7.6	6.7	6.9	7.1	12.8	8.4	6.5	9.7	7.6	7.7	13.7	5.3	5.9	7.9	7.0	28.5	11.2	7.7	5.7	6.6	9.8	8.9	7.8	7.1	11.0	7.2	12.8	5.4	14.0	10.7	7.4	13.1	9.9	9.6	12.4	13.0	9.5	11.2	15.1	12.0	20.1	13.7	12.9	9.2	16.0	21.3	9.6	7.6	13.3	12.5	9.5	10.0	10.0	12.5	19.7	8.3	10.6	13.6	7.9	11.3	12.8	12.3	20.1	8.5	9.8	6.6	14.0	24.6	13.9	6.6	7.5	25.2	9.9	16.1	9.6	13.1	14.7	10.4	8.1	7.4	8.7	8.1	9.7	7.1	10.5	18.3	11.6	22.1	15.0	8.8	10.0	13.7	25.5	15.4	16.5	24.8	18.8	14.5	10.3	18.2	13.9	10.1	11.7	13.5	9.5	13.7	14.2	14.3	13.8	7.9	14.9	20.3	16.6	4.2	20.0	8.7	9.5	13.7	11.7	6.6	7.2	6.6	7.6	7.8	6.7	6.9	7.1	7.7	6.6	7.1	7.4	6.9	12.8	4.8	2.0	4.2	4.5	4.2	6.4	0.6	9.8	6.9	7.5	0.3	7.2	4.7	9.2	0.0	22.6	6.2	5.5	7.9	8.7	0.4	14.2	7.9	7.8	6.6	8.6	3.3	11.0	10.4	8.1	5.6	24.7	2.5	8.6	6.8	2.1	11.6	8.4	3.1	8.6	8.2	7.1	5.4	1.4	9.3	3.9	3.6	1.0	7.1	11.4	10.3	2.5	2.3	6.5	2.2	10.5	7.2	4.3	9.3	5.8	7.1	6.9	6.6	5.5	7.5	12.5	12.4	4.6	3.8	14.1	7.5	11.5	7.2	3.0
BRIP1	"BACH1, FANCJ, OF"	ENSG00000136492	"BRCA1 interacting protein C-terminal helicase 1"	Q9BX63	17	61679139-61863528	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair"	"Helicase, Hydrolase"	"Cancer-related genes, Disease variant, Fanconi anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 7.2;lymphoid tissue: 5.9;testis: 7.0"	"Group enriched"	"Detected in many"	12	"Early spermatids: 186.2;Late spermatids: 194.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"MCF7: 88.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA005474	Approved		Supported	"Nucleoplasm,Nuclear membrane"		NA	Yes			"Cluster 26: Non-specific - Mitochondria"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	"Nucleoplasm, Nuclear membrane"		"HPA005474: AB_2667333"	"unprognostic (1.88e-1)"	"unprognostic (1.55e-2)"	"prognostic favorable (3.45e-5)"	"unprognostic (6.85e-4)"	"unprognostic (3.09e-1)"	"prognostic favorable (3.62e-4)"	"unprognostic (2.60e-3)"	"unprognostic (5.60e-2)"	"unprognostic (5.66e-3)"	"unprognostic (6.71e-2)"	"unprognostic (1.50e-3)"	"unprognostic (2.75e-2)"	"unprognostic (3.41e-12)"	"unprognostic (1.19e-2)"	"unprognostic (2.25e-1)"	"unprognostic (3.96e-2)"	"unprognostic (3.62e-3)"	0.3	0.3	0.8	1.7	0.6	7.2	0.9	1.3	0.9	0.4	0.0	1.7	2.0	0.8	0.4	1.5	0.3	0.6	0.1	0.5	0.2	0.3	1.6	0.4	2.8	0.3	0.0	1.1	0.3	0.1	0.0	0.8	0.4	0.4	1.9	0.5	0.4	0.2	0.1	2.0	1.9	0.9	0.0	0.7	0.9	7.0	0.2	5.9	0.3	0.1	3.3	0.7	0.6	0.8	26.6	9.4	25.0	14.1	0.9	2.1	5.5	23.6	13.3	24.6	31.8	9.5	8.0	14.9	5.2	4.9	7.7	9.2	12.8	4.5	33.3	3.8	15.8	15.5	14.4	10.5	0.2	20.3	8.8	0.6	0.4	20.2	5.1	3.4	5.0	14.8	11.6	10.5	14.4	88.9	32.5	6.7	5.3	5.9	7.3	19.7	50.1	7.1	3.0	12.8	10.0	24.2	9.4	3.0	3.3	9.1	8.3	7.3	4.5	36.9	26.5	13.5	26.6	6.3	13.3	16.6	7.3	9.3	8.8	1.0	0.1	0.4	0.1	0.0	0.1	0.5	0.3	0.1	0.1	0.6	0.4	0.2	0.3	0.1	0.1	0.1	1.0	0.1	0.8	0.6	1.3	0.9	0.5	0.2	0.3	0.0	0.4	0.0	0.2	0.8	0.2	0.0	0.5	1.0	1.6	2.3	1.3	0.8	0.6	0.3	1.1	1.8	0.6	0.0	4.0	0.0	0.0	2.0	2.0	1.8	0.0	0.3	186.2	0.7	1.7	0.8	0.0	7.4	4.6	0.2	3.0	2.0	2.0	1.6	0.0	15.5	0.4	3.4	1.7	0.0	3.3	1.8	0.0	0.8	1.1	194.1	1.2	1.0	3.6	2.8	0.6	0.2	1.0	1.5	1.0	0.8	0.1	1.2	4.8	0.4	1.4	0.2	0.8	0.2	0.0	2.5	1.8	12.1	6.0	2.9	0.4	0.3	2.3	2.1	4.7	0.7
BRMS1L	"BRMS1, FLJ39177, MGC11296"	ENSG00000100916	"BRMS1 like transcriptional repressor"	Q5PSV4	14	35826338-35932325	"Predicted intracellular proteins"	"Growth regulation, Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046623	Uncertain		Supported	Nucleoplasm		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 48: Smooth muscle cells - ECM organization"	Nucleoplasm		"HPA046623: AB_2679724"	"prognostic unfavorable (5.78e-4)"	"unprognostic (1.86e-1)"	"unprognostic (2.03e-1)"	"unprognostic (1.69e-3)"	"unprognostic (2.66e-2)"	"unprognostic (2.27e-2)"	"prognostic unfavorable (1.34e-4)"	"unprognostic (2.56e-2)"	"unprognostic (2.02e-2)"	"unprognostic (8.04e-2)"	"unprognostic (6.50e-2)"	"unprognostic (1.66e-1)"	"prognostic favorable (6.55e-5)"	"unprognostic (2.06e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.36e-1)"	"prognostic unfavorable (6.87e-6)"	6.2	10.1	8.3	3.8	9.0	2.6	6.2	7.6	11.2	6.0	5.4	5.1	3.2	6.3	5.5	6.4	5.1	4.2	11.6	8.9	7.8	8.9	6.1	4.8	3.0	7.4	8.2	7.2	3.0	9.8	4.4	7.3	7.9	6.5	3.6	8.2	4.2	6.2	13.6	5.9	3.1	7.0	7.7	3.5	4.3	5.3	8.2	3.5	7.2	13.7	3.9	5.8	5.4	9.4	10.1	10.1	17.1	9.9	15.2	19.1	25.5	10.3	9.9	15.7	15.3	6.5	8.3	8.1	10.3	14.4	7.4	12.6	13.7	18.7	22.3	9.0	16.8	7.4	10.1	28.6	10.7	3.7	5.9	13.4	12.5	12.1	10.2	8.2	11.4	4.7	3.6	6.3	17.7	13.5	4.3	6.0	6.8	14.2	14.8	4.4	19.1	6.2	12.7	11.4	5.1	13.1	12.0	13.7	12.2	13.0	15.7	5.2	7.0	14.9	9.1	8.6	10.2	5.8	8.2	5.0	3.7	8.1	9.2	0.0	0.5	0.3	1.0	1.2	0.8	0.7	1.0	1.3	0.3	0.5	1.4	1.2	0.0	0.4	1.4	0.9	1.4	0.7	8.3	9.0	7.6	11.2	8.9	7.8	7.4	8.2	7.9	7.7	8.2	9.4	11.6	9.6	13.9	13.7	10.5	18.6	10.2	10.4	19.9	18.5	8.4	7.1	19.2	2.8	10.6	7.3	4.2	19.3	15.7	2.3	7.9	4.9	3.5	6.7	13.0	11.2	4.8	1.3	21.2	6.9	15.4	15.3	6.1	6.3	14.7	6.9	6.8	6.3	5.1	16.8	22.3	3.8	12.2	2.8	9.5	3.2	11.1	3.9	8.8	6.5	6.6	21.4	3.1	20.6	26.2	4.4	3.0	9.8	8.8	14.0	1.7	19.2	6.7	17.5	19.7	17.5	20.0	6.5	16.6	12.6	16.2	22.4	11.4	11.8	3.7	7.1
BRPF1	BR140	ENSG00000156983	"Bromodomain and PHD finger containing 1"	P55201	3	9731729-9748015	"Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, Chromatin regulator, DNA-binding"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"BEWO: 82.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003359	Enhanced		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 10: Non-specific - Unknown function"	"Plasma membrane, Cytosol"		"HPA003359: AB_1078217"	"unprognostic (4.18e-2)"	"unprognostic (2.21e-2)"	"unprognostic (6.47e-2)"	"unprognostic (9.10e-2)"	"unprognostic (3.42e-1)"	"unprognostic (2.33e-2)"	"prognostic unfavorable (3.20e-5)"	"unprognostic (3.00e-1)"	"unprognostic (3.72e-1)"	"unprognostic (3.26e-3)"	"unprognostic (4.27e-2)"	"prognostic unfavorable (5.28e-4)"	"unprognostic (1.51e-3)"	"unprognostic (4.86e-2)"	"unprognostic (3.55e-1)"	"unprognostic (6.87e-2)"	"unprognostic (9.67e-3)"	8.0	7.1	4.7	6.9	6.9	23.5	7.7	9.9	7.4	8.2	3.8	8.3	4.8	9.5	4.4	8.6	8.8	5.5	7.3	6.7	3.8	6.2	5.5	7.9	8.9	4.7	4.2	9.3	7.3	7.7	6.7	6.5	4.3	7.5	4.0	4.0	9.1	5.0	9.5	10.9	8.3	5.4	3.1	10.5	7.5	14.4	5.2	11.9	9.0	6.8	7.6	7.9	7.8	5.5	9.9	17.2	12.5	8.2	8.9	8.6	82.4	12.6	7.5	14.3	10.2	12.1	8.3	18.6	6.0	11.6	13.5	8.2	15.3	12.0	9.0	20.1	17.9	21.4	33.8	9.8	11.4	30.6	20.0	8.5	9.8	19.8	13.1	7.2	10.8	17.5	25.2	15.9	8.3	24.3	19.8	25.7	20.6	6.7	15.9	28.7	10.6	12.3	6.7	14.5	8.9	15.2	12.7	9.0	10.1	8.2	9.8	31.4	14.1	15.9	13.6	14.5	24.0	13.4	18.1	31.5	13.1	25.9	15.1	1.0	0.9	1.4	1.3	0.8	2.0	0.6	0.9	1.2	0.8	0.5	1.1	1.3	0.8	4.2	0.7	1.9	0.7	0.8	4.7	6.9	9.9	7.4	6.7	3.8	4.7	4.2	4.3	3.1	5.2	5.5	7.9	16.0	10.0	2.6	6.8	14.1	5.1	3.9	8.0	4.6	9.2	7.0	3.7	2.8	6.2	7.3	6.2	4.2	13.0	9.4	0.0	4.1	3.9	4.2	6.9	9.7	10.2	9.7	3.4	5.5	5.5	5.8	7.7	7.0	8.8	7.3	11.0	3.5	6.4	8.4	2.4	5.0	2.0	5.6	9.2	1.2	6.5	6.9	1.8	2.8	6.3	5.2	5.2	4.0	2.9	6.1	3.1	6.0	7.9	5.1	4.9	2.1	4.3	5.1	6.6	11.3	7.7	16.6	13.9	9.9	18.5	3.7	10.8	5.6	6.1	6.8
BRSK1	KIAA1811	ENSG00000160469	"BR serine/threonine kinase 1"	Q8TDC3	19	55282072-55312562	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell cycle, DNA damage, Neurogenesis"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 141.8;pituitary gland: 53.0"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 34.8;Excitatory neurons: 30.1;Horizontal cells: 38.7;Inhibitory neurons: 27.6;Oligodendrocyte precursor cells: 17.1;Oligodendrocytes: 29.4;Proximal enterocytes: 23.6"	"Cancer enhanced"	"Detected in all"		"glioma: 12.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"SCLC-21H: 56.4;SH-SY5Y: 51.8;WM-115: 46.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021212, HPA061719"	Enhanced		Supported	"Nucleoplasm,Cell Junctions"		NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 45: Enterocytes - Digestion"	Nucleoplasm	"Cell Junctions"	"HPA021212: AB_1845455, HPA061719: AB_2684593"	"unprognostic (1.42e-3)"	"unprognostic (2.92e-2)"	"unprognostic (1.20e-1)"	"unprognostic (6.69e-3)"	"unprognostic (2.71e-1)"	"unprognostic (4.21e-2)"	"unprognostic (3.06e-6)"	"unprognostic (4.24e-1)"	"unprognostic (2.06e-2)"	"unprognostic (3.04e-1)"	"prognostic favorable (1.02e-4)"	"unprognostic (3.00e-1)"	"prognostic unfavorable (7.98e-6)"	"unprognostic (1.16e-1)"	"unprognostic (6.61e-3)"	"unprognostic (1.34e-1)"	"unprognostic (2.09e-1)"	1.5	12.0	75.0	3.7	90.1	0.5	2.6	47.5	141.8	5.9	0.0	11.8	3.8	8.3	4.0	3.2	5.4	4.4	12.8	103.2	66.1	2.4	0.7	1.9	2.7	70.4	54.8	5.5	2.8	16.9	53.0	1.1	66.8	8.3	1.6	20.4	2.3	5.0	0.7	1.5	4.7	5.6	32.9	1.8	4.9	11.4	74.1	2.3	3.1	1.4	1.4	6.3	4.6	105.5	0.8	2.8	33.2	17.6	0.1	1.4	0.3	5.9	7.7	7.1	10.3	13.1	5.9	7.0	3.7	6.2	6.6	0.3	7.0	0.3	6.6	33.3	28.0	4.6	4.0	1.4	7.0	1.5	12.8	4.6	0.6	7.3	0.0	27.4	0.3	17.9	6.6	40.8	6.5	1.9	9.0	1.7	24.9	0.7	2.3	20.4	8.5	1.1	0.5	0.0	56.4	51.8	0.1	1.0	12.8	9.2	2.9	3.8	0.0	13.7	15.2	7.7	10.8	37.9	28.0	16.6	13.8	3.1	46.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	75.0	90.1	47.5	141.8	103.2	66.1	70.4	54.8	66.8	32.9	74.1	105.5	0.3	0.0	1.3	9.4	5.2	0.1	1.0	0.1	1.2	34.8	0.9	2.2	1.2	0.0	0.6	1.8	2.1	0.0	1.2	10.4	0.0	0.4	1.2	0.3	3.8	0.9	3.5	0.0	30.1	0.0	0.0	1.2	0.5	0.3	0.0	2.3	0.0	0.0	1.6	38.7	27.6	1.6	0.0	6.6	0.4	0.3	0.6	1.0	0.0	1.0	2.3	4.1	3.1	17.1	29.4	0.5	0.1	4.9	9.8	1.0	23.6	0.9	0.2	10.1	0.0	0.6	2.1	3.9	7.0	0.0	0.0	0.0	1.1	2.8	1.9	0.2
BRWD1	"C21orf107, DCAF19, FLJ11315, N143, WDR9"	ENSG00000185658	"Bromodomain and WD repeat domain containing 1"	Q9NSI6	21	39184176-39321559	"Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030943, HPA030944, HPA030945, CAB034184"	Approved		Approved	Nucleoplasm,Nucleoli,Cytosol		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 6: Brain - Smell perception"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	"Nucleoplasm, Nucleoli"	Cytosol	"CAB034184: AB_2243666, HPA030943: AB_2673666, HPA030944: AB_2673667, HPA030945: AB_10670161"	"unprognostic (6.00e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.27e-1)"	"unprognostic (8.39e-3)"	"unprognostic (4.94e-2)"	"unprognostic (5.01e-2)"	"unprognostic (8.90e-2)"	"unprognostic (2.26e-1)"	"unprognostic (4.82e-3)"	"unprognostic (5.45e-2)"	"unprognostic (2.58e-3)"	"unprognostic (6.48e-2)"	"unprognostic (1.19e-1)"	"unprognostic (3.88e-2)"	"unprognostic (2.56e-2)"	13.6	18.8	35.7	10.2	37.5	18.6	17.5	40.9	37.3	12.9	27.2	12.5	9.7	14.5	22.6	11.9	13.1	11.0	15.5	37.6	32.9	15.7	25.8	13.2	15.7	23.4	27.5	17.7	19.9	13.1	13.3	17.4	24.8	14.3	12.3	38.6	11.7	11.5	21.9	14.6	11.4	11.1	27.2	10.9	12.1	21.0	40.4	14.9	19.7	24.0	15.0	12.5	12.5	34.4	19.3	7.8	18.6	9.5	10.4	17.2	17.9	11.0	12.7	8.5	9.7	7.1	12.5	59.8	11.0	15.0	9.9	9.1	17.5	12.3	12.9	14.8	14.2	40.9	13.6	12.3	13.7	23.4	11.1	11.2	19.0	11.2	29.0	18.1	11.9	38.7	32.4	30.7	11.5	13.4	15.8	26.8	19.5	23.1	10.7	28.5	14.4	19.4	9.5	12.2	13.9	18.0	23.8	25.0	15.7	6.2	20.7	31.8	14.3	10.6	5.2	6.2	8.1	32.7	24.5	30.1	12.5	24.3	8.7	3.5	4.2	9.7	8.0	5.0	6.1	7.3	6.8	8.3	5.8	4.8	8.2	6.8	4.3	8.4	3.1	5.4	8.5	3.4	35.7	37.5	40.9	37.3	37.6	32.9	23.4	27.5	24.8	27.2	40.4	34.4	42.5	48.1	49.9	147.6	46.1	63.2	43.8	26.6	52.9	65.5	43.2	24.9	59.0	34.3	39.2	18.4	116.7	64.6	45.0	40.1	45.0	28.9	53.5	46.0	48.2	41.6	35.4	37.6	213.9	34.5	45.2	43.3	57.6	54.8	32.9	42.7	32.2	41.1	24.8	74.0	190.0	34.7	48.8	36.8	52.2	20.7	43.2	35.0	30.2	127.4	37.5	43.1	51.5	170.9	201.9	37.8	34.1	44.8	63.2	63.0	39.2	33.1	48.3	109.1	26.3	47.8	41.4	86.1	81.9	52.8	70.3	99.9	51.1	51.1	36.6	67.1
BSPRY	FLJ20150	ENSG00000119411	"B-box and SPRY domain containing"	Q5W0U4	9	113349541-113371233	"Predicted intracellular proteins"	"Calcium transport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"parathyroid gland: 447.2"	"Cell type enhanced"	"Detected in many"		"Breast glandular cells: 61.9;Ductal cells: 66.8;Exocrine glandular cells: 65.8;Pancreatic endocrine cells: 48.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	21	"plasmacytoid DC: 4.4"	"Lineage enriched"	"Detected in single"	21	"dendritic cells: 4.4"	"Cell line enhanced"	"Detected in many"		"A-431: 41.8;CAPAN-2: 25.9;MCF7: 62.0;OE19: 70.9;RPMI-8226: 32.3;SK-BR-3: 29.9;T-47d: 30.3"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	6	"cerebellum: 3.8"	"HPA042889, HPA077485"	Approved		Uncertain	Nucleoplasm,Cytosol		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 21: OE19 - Mitochondria"	"Cluster 1: Pancreatic cells - Digestion"	Nucleoplasm	Cytosol	"HPA042889: AB_10795515, HPA077485: "	"unprognostic (1.32e-1)"	"unprognostic (3.09e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.20e-3)"	"unprognostic (1.68e-1)"	"unprognostic (2.10e-3)"	"unprognostic (4.29e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.71e-1)"	"unprognostic (2.28e-1)"	"unprognostic (1.95e-2)"	"prognostic favorable (4.56e-14)"	"unprognostic (1.15e-3)"	"unprognostic (2.36e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.70e-1)"	0.3	3.1	3.7	2.6	11.3	5.9	14.6	5.9	4.2	6.5	1.2	12.0	8.8	1.1	10.9	30.1	4.4	4.4	1.5	2.5	3.0	14.4	0.8	5.6	0.8	2.1	4.8	0.0	41.7	447.2	8.3	1.7	1.7	5.0	11.0	6.9	81.6	4.5	0.0	26.3	7.0	0.7	1.7	0.5	24.7	2.8	5.9	1.8	30.3	0.1	3.1	3.0	7.6	2.5	41.8	0.0	0.0	0.0	0.0	0.0	15.8	0.0	0.0	0.0	0.0	8.6	25.9	0.0	0.4	0.0	0.0	3.6	0.4	0.0	0.0	4.6	3.1	0.2	0.0	0.2	0.0	0.1	0.0	0.0	1.2	0.0	0.0	0.0	0.0	20.8	0.3	0.0	0.0	62.0	0.7	0.0	1.0	70.9	0.0	0.9	0.0	32.3	4.0	8.8	13.7	0.0	0.0	29.9	0.0	1.7	30.3	4.3	0.0	0.0	0.0	0.1	0.0	9.7	13.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	4.4	0.0	0.0	3.7	11.3	5.9	4.2	2.5	3.0	2.1	4.8	1.7	1.7	5.9	2.5	0.3	6.4	6.9	0.0	2.5	1.0	2.0	4.4	0.0	1.8	61.9	31.2	2.8	17.2	9.5	27.6	6.2	9.2	9.9	20.8	39.2	66.8	0.5	11.3	1.6	0.9	20.4	15.6	1.0	65.8	1.1	0.7	21.4	17.3	3.8	1.5	0.0	0.8	1.4	0.0	3.2	19.1	12.2	0.3	0.3	0.6	0.0	0.5	10.6	0.0	1.0	0.8	3.1	0.5	0.2	48.6	14.5	0.0	2.5	13.8	13.5	21.2	9.7	12.1	0.0	0.0	1.7	0.6	4.3	26.4	14.2	6.7	1.3	0.1	24.9	17.7
BST2	"CD317, tetherin"	ENSG00000130303	"Bone marrow stromal cell antigen 2"	Q10589	19	17402939-17405630	"CD markers, Plasma proteins, Predicted membrane proteins, Transporters"	"Antiviral defense, B-cell activation, Host-virus interaction, Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"ovary: 694.2"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 1193.2;Hepatic stellate cells: 455.8;Theca cells: 490.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+ RasG12V: 615.0;Karpas-707: 603.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA017060, HPA073472"	Enhanced		Supported	"Golgi apparatus,Vesicles"		NA	NA		260000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 72: Non-specific - Transcription"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Golgi apparatus, Vesicles"		"HPA017060: AB_1845467, HPA073472: "	"prognostic favorable (6.69e-4)"	"unprognostic (1.75e-1)"	"unprognostic (8.42e-3)"	"unprognostic (8.93e-3)"	"unprognostic (4.87e-2)"	"unprognostic (2.25e-1)"	"unprognostic (2.26e-1)"	"unprognostic (1.07e-1)"	"unprognostic (3.25e-1)"	"unprognostic (6.46e-2)"	"unprognostic (6.56e-3)"	"unprognostic (1.64e-1)"	"prognostic unfavorable (3.56e-9)"	"unprognostic (1.05e-1)"	"prognostic unfavorable (4.22e-4)"	"unprognostic (1.08e-1)"	"unprognostic (2.46e-2)"	226.0	509.8	86.7	95.6	87.6	103.7	152.9	84.0	125.7	93.4	81.7	94.1	47.4	58.7	59.5	40.3	248.0	109.4	111.2	85.1	84.5	160.1	227.8	141.4	128.0	101.5	85.9	694.2	26.3	13.8	56.8	203.0	88.4	88.6	33.3	2.0	77.7	105.2	46.1	24.8	109.1	76.0	97.0	238.5	84.1	35.4	91.1	123.5	54.0	50.8	65.8	82.9	88.6	90.8	327.0	0.5	0.9	145.6	0.0	1.0	49.6	1.3	24.9	459.5	615.0	150.5	286.1	252.2	338.2	197.6	14.6	1.3	212.9	23.9	14.3	279.1	1.8	3.6	525.7	149.8	256.7	120.1	304.7	1.3	0.0	153.0	0.1	4.4	119.0	6.0	146.3	603.4	0.0	89.5	57.7	208.6	158.0	0.1	407.9	105.5	0.8	530.7	110.1	1.5	0.6	1.4	325.5	12.3	410.5	12.3	243.1	166.3	1.5	1.9	11.4	0.5	3.3	308.3	439.3	168.0	1.3	470.8	2.2	229.7	345.3	125.3	171.4	385.5	163.0	115.2	143.2	160.0	283.8	146.5	114.8	132.6	113.3	353.2	359.3	421.7	143.3	367.9	86.7	87.6	84.0	125.7	85.1	84.5	101.5	85.9	88.4	97.0	91.1	90.8	1193.2	57.7	13.6	4.9	90.7	33.1	19.6	255.7	48.9	0.2	86.2	168.5	7.0	50.1	68.5	49.7	0.0	7.8	184.2	1.5	37.2	18.7	10.7	27.8	11.2	420.2	1.2	74.0	0.0	1.2	61.5	152.4	14.8	50.1	227.8	260.9	455.8	211.1	388.9	0.0	0.0	2.8	28.5	189.4	187.6	12.0	346.7	220.4	74.7	32.8	214.5	1.3	211.2	0.5	0.3	3.3	4.8	419.4	192.8	10.3	3.7	1.3	27.4	2.1	164.3	30.7	146.3	1.3	1.2	15.5	26.1	13.1	135.8	490.6	5.0	28.6
BTAF1	"MOT1, TAF-172, TAF(II)170, TAF172, TAFII170"	ENSG00000095564	"B-TFIID TATA-box binding protein associated factor 1"	O14981	10	91923770-92030325	"Plasma proteins, Predicted intracellular proteins"		"DNA-binding, Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 91.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA070682			Supported	Nucleoplasm,Vesicles		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm	Vesicles	"HPA070682: AB_2686294"	"unprognostic (2.41e-1)"	"unprognostic (1.29e-1)"	"unprognostic (5.39e-2)"	"unprognostic (1.20e-1)"	"unprognostic (3.92e-1)"	"prognostic favorable (5.07e-4)"	"unprognostic (2.72e-1)"	"unprognostic (9.28e-2)"	"unprognostic (1.16e-1)"	"unprognostic (7.34e-2)"	"unprognostic (9.70e-3)"	"unprognostic (4.27e-2)"	"prognostic unfavorable (4.04e-5)"	"unprognostic (6.45e-2)"	"unprognostic (1.10e-1)"	"unprognostic (4.79e-2)"	"unprognostic (1.98e-1)"	20.4	13.2	5.2	20.1	7.3	32.1	19.2	8.5	8.6	18.4	5.9	20.4	16.2	20.7	21.1	17.2	23.4	15.2	14.4	6.1	5.5	11.8	15.4	19.1	32.0	6.1	5.3	25.4	18.1	14.7	13.3	13.7	6.0	16.8	15.9	34.3	19.2	12.7	14.8	50.4	22.0	14.0	5.9	22.0	18.4	17.9	5.8	21.7	17.3	9.2	25.5	20.1	19.9	10.4	28.9	13.8	31.7	38.7	16.5	25.8	15.8	16.5	19.6	16.0	23.7	19.1	17.2	30.8	10.3	16.3	9.9	30.4	21.5	14.6	23.8	21.2	23.2	21.9	35.7	20.0	16.8	33.3	22.0	18.4	18.5	24.3	35.1	34.3	15.6	25.9	18.2	34.5	16.6	12.6	25.8	21.0	14.4	8.3	10.8	20.6	19.7	14.5	14.9	17.5	12.2	14.3	15.8	8.0	20.3	20.8	16.2	21.9	16.9	14.3	11.4	19.5	23.7	39.7	19.6	24.9	22.4	30.1	3.8	4.4	2.7	1.5	2.5	1.9	2.2	2.5	1.9	1.8	2.1	3.1	2.3	1.8	1.9	2.2	3.6	4.9	1.6	1.4	5.2	7.3	8.5	8.6	6.1	5.5	6.1	5.3	6.0	5.9	5.8	10.4	18.3	19.2	31.5	58.4	29.5	21.7	12.1	7.3	21.6	26.7	16.2	11.9	13.6	7.2	14.6	20.2	45.9	6.6	34.8	7.9	1.9	6.8	12.9	33.3	28.0	15.6	16.2	13.9	78.5	6.6	9.8	17.3	35.2	46.6	24.1	22.4	8.9	8.7	7.1	18.5	66.4	7.1	6.1	9.7	19.8	5.1	11.8	27.1	5.4	67.5	16.4	13.9	14.4	68.3	91.5	6.7	6.3	11.7	52.1	15.7	9.6	3.3	24.9	35.5	6.6	25.7	22.8	24.7	12.2	20.4	29.8	14.6	24.7	11.4	9.3	16.4
BTBD1		ENSG00000064726	"BTB domain containing 1"	Q9H0C5	15	83016423-83067252	"Predicted intracellular proteins"	"Differentiation, Myogenesis, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 325.0;tongue: 230.8"	"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 84.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024263, HPA067671"	Enhanced		Supported	"Nucleoplasm,Cytosol,Cytoplasmic bodies"		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Cytoplasmic bodies"	"Nucleoplasm, Cytosol"	"HPA024263: , HPA067671: AB_2685882"	"unprognostic (1.63e-1)"	"unprognostic (4.61e-2)"	"unprognostic (1.35e-1)"	"unprognostic (5.54e-2)"	"unprognostic (1.80e-1)"	"unprognostic (3.17e-2)"	"unprognostic (4.80e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.73e-1)"	"unprognostic (1.07e-1)"	"prognostic favorable (6.21e-7)"	"unprognostic (8.94e-3)"	"unprognostic (8.27e-2)"	"unprognostic (7.71e-2)"	"unprognostic (1.89e-2)"	36.8	26.7	39.8	24.9	41.0	36.3	28.8	40.4	48.1	24.8	26.2	33.4	32.5	24.2	25.7	30.4	31.5	28.7	107.2	41.3	43.8	37.8	34.3	23.9	36.7	40.7	41.4	23.6	17.2	46.4	22.1	24.1	38.5	30.1	35.5	28.4	21.0	24.0	325.0	16.5	29.9	26.5	44.4	25.9	23.9	58.4	46.8	35.5	37.1	230.8	34.2	36.2	18.2	46.0	45.8	43.1	37.3	37.0	57.5	98.2	19.5	64.9	88.0	54.8	60.6	27.4	46.4	91.0	78.4	73.2	45.6	56.4	82.7	52.0	64.4	73.4	67.1	77.7	62.6	39.6	67.6	74.2	82.9	80.6	45.8	37.2	55.4	71.0	82.0	35.2	70.2	49.9	117.2	24.1	55.8	38.5	52.2	39.9	47.0	57.1	94.4	45.5	55.0	106.7	64.9	46.6	75.1	61.6	111.2	50.7	46.5	61.6	82.9	61.9	46.1	86.0	91.2	50.6	84.0	88.4	66.7	123.6	43.8	1.3	2.9	5.7	3.1	3.2	2.7	2.7	2.9	4.0	5.2	3.4	3.2	3.2	1.6	2.4	4.2	2.2	3.0	1.3	39.8	41.0	40.4	48.1	41.3	43.8	40.7	41.4	38.5	44.4	46.8	46.0	24.2	16.0	5.8	30.7	22.0	15.2	13.7	9.6	13.6	9.4	11.4	6.9	84.9	8.6	18.1	11.0	6.2	8.4	23.6	20.8	17.6	14.2	35.8	19.9	16.6	16.8	23.3	18.7	36.0	10.5	13.5	15.8	18.8	14.5	17.7	11.0	17.2	11.0	18.0	11.8	38.4	10.8	14.2	23.6	24.6	24.5	8.7	21.2	12.4	37.5	22.8	11.1	9.2	32.2	28.6	15.1	19.8	11.3	22.6	11.8	15.8	15.7	24.7	8.6	6.6	21.0	15.3	46.2	14.9	16.0	12.1	8.1	18.8	22.0	18.4	18.7
BTBD10	"GMRP-1, GMRP1, MGC13007"	ENSG00000148925	"BTB domain containing 10"	Q9BSF8	11	13388008-13463297	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 116.5;Spermatocytes: 121.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046777	Approved		Supported	"Nucleoplasm,Nucleoli fibrillar center"		NA	Yes			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Nucleoplasm, Nucleoli fibrillar center"		"HPA046777: AB_2679801"	"unprognostic (2.38e-1)"	"unprognostic (4.25e-1)"	"unprognostic (1.75e-1)"	"unprognostic (9.76e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.84e-2)"	"prognostic unfavorable (1.37e-4)"	"unprognostic (1.07e-1)"	"unprognostic (2.52e-1)"	"unprognostic (3.00e-1)"	"unprognostic (1.29e-3)"	"unprognostic (1.15e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.32e-1)"	"unprognostic (2.02e-1)"	"unprognostic (6.98e-2)"	"unprognostic (1.27e-1)"	13.8	12.2	19.8	13.6	30.9	13.4	13.3	18.8	27.9	15.0	3.2	18.1	13.1	16.5	12.0	28.6	11.8	15.2	17.7	25.9	18.6	11.4	9.8	13.0	15.7	12.0	15.7	14.1	8.7	13.2	14.1	17.4	16.2	15.0	20.3	18.8	10.8	17.4	14.6	13.1	11.7	21.1	10.0	12.6	17.7	38.3	14.5	18.5	13.6	18.4	17.4	27.1	17.8	22.2	55.9	40.2	34.3	23.2	30.4	29.5	43.5	57.5	33.3	43.5	39.4	37.7	64.0	38.1	27.1	42.2	43.9	44.0	26.3	61.4	50.8	38.7	27.1	20.7	13.9	22.5	46.9	27.6	45.4	25.3	68.0	25.2	57.3	33.0	89.1	26.8	11.8	38.2	46.0	33.7	28.3	15.2	14.9	50.0	34.9	24.8	29.4	23.8	69.7	44.3	14.8	20.9	34.4	27.5	20.5	38.9	19.7	14.7	81.7	44.7	37.2	43.4	33.6	14.2	52.6	25.5	30.6	23.6	38.9	41.1	24.8	38.2	18.1	39.7	21.7	18.4	17.1	20.1	29.2	17.2	19.1	19.3	64.9	25.7	50.5	12.7	23.6	18.3	19.8	30.9	18.8	27.9	25.9	18.6	12.0	15.7	16.2	10.0	14.5	22.2	20.5	16.0	7.0	35.9	16.9	28.2	40.7	27.0	15.9	13.9	9.6	8.6	14.0	12.8	19.7	5.5	4.2	24.3	18.1	15.7	5.9	31.8	95.7	14.3	12.5	22.6	16.3	9.0	116.5	25.2	54.3	15.3	27.5	19.1	22.8	11.1	11.7	5.9	22.9	8.4	74.2	14.2	28.5	16.4	13.0	26.3	9.9	13.0	17.8	38.4	22.2	9.9	18.6	61.9	62.4	50.2	14.2	18.4	12.0	30.1	8.7	10.5	19.9	14.1	6.6	13.4	20.6	121.3	59.7	27.8	35.8	62.1	17.8	9.2	13.3	64.6
BTBD11	"ABTB2B, FLJ33957"	ENSG00000151136	"BTB domain containing 11"	A6QL63	12	107318421-107659642	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"parathyroid gland: 100.3"	"Cell type enriched"	"Detected in many"	9	"Inhibitory neurons: 266.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"MAIT T-cell: 3.5"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"A549: 25.0;Hep G2: 13.6;MOLT-4: 17.9;PC-3: 12.3;RT4: 11.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055898, HPA061334"			Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm	Cytosol	"HPA055898: AB_2682964, HPA061334: "	"unprognostic (3.40e-2)"	"unprognostic (4.06e-1)"	"unprognostic (2.37e-1)"	"unprognostic (7.85e-2)"	"unprognostic (8.78e-3)"	"unprognostic (4.82e-2)"	"unprognostic (3.52e-1)"	"unprognostic (2.12e-1)"	"unprognostic (1.52e-1)"	"unprognostic (5.92e-2)"	"unprognostic (5.33e-2)"	"unprognostic (1.78e-1)"	"unprognostic (4.92e-8)"	"unprognostic (2.66e-1)"	"unprognostic (1.55e-1)"	"unprognostic (3.33e-2)"	"unprognostic (9.07e-3)"	0.4	0.7	7.2	2.7	4.3	4.4	2.9	5.5	10.9	8.1	5.9	0.6	0.7	0.9	1.2	29.4	0.3	0.9	0.6	2.9	13.2	4.2	1.1	0.6	2.9	24.3	16.0	0.1	0.8	100.3	3.5	2.0	24.4	3.4	0.6	1.9	5.6	1.3	0.5	11.1	1.4	0.5	11.4	1.4	0.6	0.7	21.7	17.2	18.9	0.2	3.3	1.7	11.1	5.3	0.1	25.0	5.0	0.0	1.8	0.5	0.0	0.6	0.0	0.2	0.0	0.3	4.0	0.0	6.1	0.1	2.4	9.2	5.1	9.5	0.3	0.0	1.6	0.0	0.1	13.6	0.0	0.2	0.1	2.0	4.0	0.0	2.9	3.8	0.7	10.5	0.0	0.0	0.2	0.9	17.9	2.0	5.3	0.5	12.3	0.0	8.1	0.0	0.0	11.4	6.8	2.5	0.0	0.2	0.0	0.4	0.5	0.7	1.0	0.1	0.2	0.0	2.0	0.1	0.0	0.1	6.4	2.6	0.0	0.9	0.4	0.5	1.0	0.1	3.5	0.0	1.1	0.6	0.7	0.1	1.4	1.3	1.3	0.1	0.3	0.1	0.6	0.6	7.2	4.3	5.5	10.9	2.9	13.2	24.3	16.0	24.4	11.4	21.7	5.3	0.3	0.0	0.0	17.3	0.3	5.2	3.7	2.5	6.8	3.5	0.7	3.2	2.9	0.0	3.0	0.0	0.0	0.2	1.2	0.0	0.0	0.8	0.0	1.2	1.9	0.3	3.5	1.3	8.7	0.0	0.0	1.5	0.0	2.3	0.0	0.0	0.0	0.9	0.3	1.7	266.4	0.4	0.0	0.6	4.3	0.0	0.6	1.7	0.0	1.0	1.8	0.2	3.1	12.5	1.9	0.3	0.0	4.1	0.7	2.8	0.2	0.9	0.3	0.4	0.0	0.0	1.1	0.1	0.2	27.5	7.7	0.4	4.5	3.4	0.4	3.4
BTBD3	"dJ742J24.1, KIAA0952"	ENSG00000132640	"BTB domain containing 3"	Q9Y2F9	20	11890723-11926609	"Predicted intracellular proteins"	Neurogenesis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 80.9"	"Cell type enhanced"	"Detected in all"		"Endometrial stromal cells: 223.0;Oligodendrocytes: 254.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"non-classical monocyte: 3.5"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 241.1;HeLa: 186.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041424, HPA042048"	Uncertain		Supported	Vesicles		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 6: Brain - Smell perception"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 36: Stromal cells - Cell proliferation"	Vesicles		"HPA041424: AB_10794667, HPA042048: AB_10796469"	"unprognostic (3.93e-2)"	"unprognostic (2.25e-1)"	"unprognostic (1.32e-1)"	"unprognostic (3.56e-3)"	"unprognostic (4.24e-3)"	"unprognostic (8.45e-2)"	"prognostic unfavorable (2.51e-5)"	"prognostic unfavorable (6.94e-4)"	"unprognostic (4.87e-2)"	"unprognostic (2.95e-1)"	"unprognostic (1.07e-2)"	"unprognostic (7.05e-2)"	"unprognostic (6.66e-2)"	"unprognostic (7.68e-3)"	"unprognostic (1.67e-1)"	"unprognostic (6.29e-2)"	"unprognostic (1.37e-2)"	11.2	22.1	20.6	7.1	34.2	12.2	12.7	66.2	80.9	16.9	12.3	21.4	10.7	18.7	7.9	9.9	15.4	13.4	13.9	79.6	30.9	11.6	7.7	12.2	4.1	30.5	24.7	11.5	13.7	11.2	8.9	42.0	23.1	15.1	17.5	42.5	13.9	10.6	15.9	20.7	10.9	16.5	24.2	7.8	27.3	14.7	23.7	10.8	11.5	13.2	3.1	18.4	10.1	64.7	7.0	19.5	52.1	241.1	10.6	11.3	14.0	21.9	14.0	24.3	15.5	11.2	10.7	2.0	18.1	31.7	9.6	18.1	27.2	15.4	39.1	0.1	24.1	7.1	186.9	23.9	11.1	11.6	4.2	20.2	18.8	21.8	17.5	13.4	13.8	12.0	12.7	18.8	24.3	5.1	14.0	10.7	25.0	29.0	5.5	18.4	10.4	7.0	22.2	34.0	22.7	40.0	60.8	24.6	53.3	27.9	14.4	11.5	10.7	13.2	33.6	12.4	24.6	6.9	9.9	0.3	8.6	3.2	87.6	0.0	1.2	0.1	0.0	1.7	0.0	0.0	0.0	0.0	1.4	0.1	0.3	0.0	0.3	0.7	3.5	1.0	0.0	0.6	20.6	34.2	66.2	80.9	79.6	30.9	30.5	24.7	23.1	24.2	23.7	64.7	17.4	16.0	8.4	24.5	2.8	16.6	10.8	8.0	18.8	15.3	15.2	11.9	16.5	10.0	8.3	5.5	79.2	23.3	1.0	41.0	3.9	9.8	8.3	51.3	223.0	25.0	20.9	4.6	46.9	8.3	4.0	15.6	28.5	55.8	2.5	9.4	33.5	8.5	8.5	65.6	38.0	9.4	10.2	4.8	13.4	13.6	16.4	6.5	14.2	39.4	3.2	17.7	1.0	61.9	254.9	9.7	25.9	8.6	2.7	13.2	11.4	6.6	24.1	56.9	6.6	19.9	18.6	10.0	16.1	11.7	17.2	21.8	1.8	42.0	13.3	11.3
BTBD8		ENSG00000189195	"BTB domain containing 8"	"Q5XKL5, Q9UPP5"	1	92080305-92184725	"Predicted intracellular proteins"	Endocytosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"brain: 13.4;retina: 18.0;testis: 5.1"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 21.9;Inhibitory neurons: 38.3;Oligodendrocyte precursor cells: 29.7;Oligodendrocytes: 46.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC TERT1: 3.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024216, HPA035311"	Enhanced		Supported	Nucleoplasm		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 58: Brain - Synaptic function"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm		"HPA024216: AB_1852385, HPA035311: AB_10671933"	"unprognostic (2.94e-1)"	"unprognostic (2.97e-2)"	"unprognostic (1.99e-1)"	"unprognostic (3.06e-2)"	"unprognostic (1.83e-1)"	"unprognostic (3.17e-2)"	"unprognostic (2.72e-2)"	"unprognostic (7.56e-2)"	"unprognostic (1.36e-2)"	"unprognostic (2.97e-1)"	"unprognostic (2.82e-2)"	"unprognostic (8.42e-2)"	"unprognostic (3.73e-3)"	"unprognostic (5.04e-2)"	"unprognostic (9.49e-2)"	"unprognostic (2.39e-2)"	"unprognostic (3.15e-1)"	0.9	1.5	2.6	0.5	4.5	0.1	1.2	6.6	13.4	0.7	0.0	0.8	0.5	1.3	1.1	0.4	1.5	0.8	0.9	5.9	0.9	0.9	0.5	1.1	0.5	0.1	1.8	2.0	0.5	1.5	0.3	0.9	3.1	1.2	0.8	18.0	0.4	1.0	0.4	0.4	0.7	0.6	0.4	0.5	0.9	5.1	2.1	0.7	1.6	0.7	0.3	0.8	0.2	7.1	1.3	0.8	0.6	0.0	1.1	3.5	2.8	0.6	1.1	0.6	0.7	0.3	0.9	0.4	2.2	0.7	2.5	0.3	0.5	1.2	1.1	1.2	0.7	1.2	0.3	0.4	0.1	0.5	0.5	2.3	1.0	0.4	0.7	2.3	0.7	1.0	1.1	0.3	1.0	0.9	0.3	0.4	0.7	1.6	0.7	0.9	0.5	0.1	0.9	0.9	0.3	0.3	1.0	0.5	0.5	1.1	0.9	0.8	0.6	0.6	0.5	0.3	0.2	1.0	0.3	0.0	0.5	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.3	0.1	0.0	0.1	0.1	0.1	0.1	0.0	2.6	4.5	6.6	13.4	5.9	0.9	0.1	1.8	3.1	0.4	2.1	7.1	5.9	0.0	4.1	19.9	0.9	0.4	1.0	0.3	0.0	9.5	6.0	2.7	0.7	2.8	3.6	5.5	6.2	2.4	2.5	1.2	1.9	4.7	7.6	10.3	5.9	2.8	0.0	2.5	21.9	2.9	1.2	3.7	2.0	8.1	0.0	13.8	1.4	1.1	0.7	3.3	38.3	2.4	6.1	1.5	0.6	1.7	5.9	1.8	1.8	10.3	2.6	4.7	5.2	29.7	46.0	3.8	4.4	3.8	2.1	1.7	3.1	1.7	4.3	15.3	0.0	2.4	2.8	8.1	9.0	0.6	0.6	1.4	2.0	9.4	2.0	1.4
BTF3	"BTF3a, BTF3b, NACB"	ENSG00000145741	"Basic transcription factor 3"	P20290	5	73498408-73505635	"Plasma proteins, Predicted intracellular proteins"	"Protein transport, Transcription, Transcription regulation, Transport"	Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013007, HPA056420"	Approved		Supported	Cytosol		NA	Yes		180000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 50: Non-specific - Ribosome"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 32: Non-specific - Translation"	Cytosol		"CAB013007: , HPA056420: AB_2683125"	"unprognostic (3.48e-3)"	"unprognostic (2.11e-1)"	"unprognostic (2.87e-3)"	"unprognostic (1.86e-1)"	"unprognostic (6.25e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.90e-3)"	"unprognostic (1.78e-2)"	"unprognostic (8.20e-3)"	"unprognostic (5.18e-2)"	"unprognostic (8.47e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.36e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.87e-1)"	"unprognostic (1.26e-2)"	"unprognostic (2.16e-1)"	633.3	440.1	241.0	373.7	251.2	861.1	763.0	250.7	307.9	658.2	234.9	593.6	460.9	547.0	422.0	735.8	584.3	376.6	477.8	230.9	261.7	469.8	522.5	416.4	644.4	256.5	247.8	1180.8	609.6	401.9	288.1	429.5	259.1	441.1	540.1	183.9	509.2	390.8	880.0	782.4	446.7	459.1	256.5	393.7	534.8	181.7	242.0	629.3	440.1	600.1	758.9	624.2	626.6	272.0	1148.3	747.2	798.7	1145.9	779.6	1301.4	1246.4	781.1	1084.9	1327.8	1267.4	972.1	1267.3	1719.2	1203.2	816.0	963.9	787.9	1176.6	2011.7	1517.2	716.2	1502.5	976.3	652.7	1280.2	1132.7	934.0	754.5	1139.7	1597.0	857.6	1572.3	1512.0	1227.4	975.3	924.1	1087.8	1134.7	1037.8	1410.0	1735.0	1017.4	423.0	742.0	1061.5	944.4	2147.0	1414.6	1126.0	930.6	1239.4	767.0	861.7	1650.4	744.4	1108.4	1884.6	894.7	569.6	780.5	690.2	2142.1	1020.7	1114.3	1607.2	757.0	1405.3	862.8	261.1	883.1	221.9	535.6	684.0	907.0	957.3	906.7	754.3	1140.2	788.4	986.3	892.7	116.0	878.6	556.1	637.6	1146.0	2128.9	241.0	251.2	250.7	307.9	230.9	261.7	256.5	247.8	259.1	256.5	242.0	272.0	753.2	246.8	324.7	17.0	889.7	1962.5	2039.6	2425.9	1664.7	138.9	1675.6	2355.4	357.8	566.2	908.0	323.7	43.8	1370.6	740.7	648.3	909.8	971.1	718.0	502.1	809.7	864.3	592.8	968.4	25.2	1219.7	2062.4	753.8	465.3	646.9	417.7	935.1	742.8	439.4	1066.3	85.8	29.3	1169.4	787.3	968.7	1357.2	464.2	1248.3	803.3	791.5	29.0	1487.9	376.5	726.1	20.6	49.6	1221.7	998.2	846.3	540.1	1626.5	1308.9	1229.5	432.9	137.6	644.2	1023.8	1051.0	333.7	238.2	1582.0	1953.2	1712.1	868.7	1029.7	1337.1	2269.9
BTK	"AGMX1, ATK, IMD1, PSCTK1, XLA"	ENSG00000010671	"Bruton tyrosine kinase"	Q06187	X	101349447-101390796	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Adaptive immunity, Apoptosis, Immunity, Innate immunity, Transcription, Transcription regulation"	"Kinase, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease variant, Dwarfism, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 32.6;lymphoid tissue: 78.0"	"Cell type enhanced"	"Detected in some"		"B-cells: 84.7;granulocytes: 211.4;Hofbauer cells: 56.6;Kupffer cells: 63.5;Macrophages: 61.1;monocytes: 71.1;Plasma cells: 43.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	4	"basophil: 557.5"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 557.5"	"Cell line enhanced"	"Detected in some"		"Daudi: 206.7;HEL: 287.4;HMC-1: 990.3;U-937: 149.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA001198, HPA002028, CAB016689"	Enhanced		Supported	"Plasma membrane,Cytosol"		NA	NA		2300000	"Cluster 38: Basophils - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 57: B-cells - Immune response"	"Plasma membrane, Cytosol"		"CAB016689: AB_1611894, HPA001198: AB_1078305, HPA002028: AB_1078306"	"unprognostic (3.19e-2)"	"unprognostic (2.51e-3)"	"unprognostic (1.06e-2)"	"unprognostic (3.66e-2)"	"unprognostic (5.69e-2)"	"unprognostic (3.76e-3)"	"unprognostic (6.55e-2)"	"unprognostic (3.58e-3)"	"unprognostic (6.02e-2)"	"unprognostic (3.12e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.41e-1)"	"unprognostic (2.08e-3)"	"unprognostic (7.80e-2)"	"unprognostic (1.29e-2)"	"unprognostic (1.56e-2)"	"unprognostic (8.14e-2)"	6.3	2.9	2.3	30.7	2.6	32.6	4.4	2.8	3.4	3.9	3.1	6.6	4.8	2.5	1.5	3.6	1.9	7.6	1.6	2.3	3.1	1.3	5.4	19.6	55.5	4.7	3.6	0.8	1.2	0.9	0.9	7.0	4.7	1.9	9.1	0.3	2.8	2.3	0.6	2.9	14.7	7.1	3.8	38.4	7.0	1.4	3.9	9.3	1.3	2.0	78.0	9.3	1.5	6.5	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.0	206.7	0.0	0.0	0.1	0.5	0.0	0.0	0.1	0.0	0.3	287.4	0.0	0.0	0.0	116.7	990.3	0.0	0.0	0.1	0.0	0.0	0.0	0.2	61.9	2.3	0.0	0.0	0.6	81.5	1.6	0.0	0.0	87.2	0.1	13.2	0.0	0.0	0.2	0.0	0.3	0.1	0.5	1.0	0.0	68.5	0.4	0.0	0.3	0.2	0.1	2.6	1.4	98.3	0.5	149.8	0.3	557.5	62.2	110.5	0.2	99.9	0.2	72.4	0.2	0.1	72.7	73.0	0.4	0.1	24.7	0.2	123.9	33.1	0.1	38.4	2.3	2.6	2.8	3.4	2.3	3.1	4.7	3.6	4.7	3.8	3.9	6.5	1.5	3.2	8.9	0.3	84.7	1.0	0.2	0.0	0.6	0.0	0.9	1.4	0.6	0.0	0.6	0.0	0.0	1.4	30.1	0.1	0.0	0.0	0.2	1.3	0.3	0.8	0.0	27.1	0.5	0.0	0.5	0.9	1.1	2.3	211.4	0.0	0.7	0.3	56.6	0.0	0.3	0.3	0.0	63.5	31.0	0.1	0.3	61.1	3.6	10.3	71.1	0.0	2.1	0.0	0.1	0.1	0.5	0.0	43.8	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.5	0.7	1.7	0.5	0.3	1.9	5.7	0.2	0.1	0.1
BUB1	"BUB1A, BUB1L, hBUB1"	ENSG00000169679	"BUB1 mitotic checkpoint serine/threonine kinase"	O43683	2	110637528-110678063	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Apoptosis, Cell cycle, Cell division, Chromosome partition, Host-virus interaction, Mitosis"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"bone marrow: 11.9;lymphoid tissue: 27.5;testis: 30.3"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 24.8;Granulosa cells: 66.1;Plasma cells: 35.2;Spermatocytes: 85.6;Spermatogonia: 20.0"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HEL: 221.5"	"Region enhanced"	"Detected in single"		"white matter: 1.7"	"Not detected"	"Not detected"			HPA006123			Supported	Nucleoplasm,Cytosol		NA	Yes			"Cluster 46: Basophils - DNA binding"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 36: HEL - Hemostasis"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	Cytosol	"HPA006123: AB_1845498"	"unprognostic (7.74e-2)"	"unprognostic (3.45e-2)"	"unprognostic (9.72e-3)"	"prognostic unfavorable (3.65e-4)"	"unprognostic (1.61e-1)"	"unprognostic (5.62e-3)"	"prognostic unfavorable (1.03e-5)"	"prognostic unfavorable (3.94e-4)"	"unprognostic (1.26e-3)"	"unprognostic (1.15e-1)"	"prognostic unfavorable (2.37e-5)"	"unprognostic (1.76e-1)"	"unprognostic (0.00e+0)"	"unprognostic (2.45e-2)"	"unprognostic (3.64e-1)"	"unprognostic (5.01e-2)"	"unprognostic (1.28e-1)"	0.5	0.4	0.1	8.4	0.3	11.9	1.2	0.1	0.1	0.9	0.0	4.3	4.0	1.0	3.5	4.7	0.5	0.9	0.6	0.1	0.1	0.3	0.6	1.2	15.9	0.1	0.6	0.4	0.2	0.7	0.0	3.2	0.3	0.3	5.7	0.1	0.9	0.1	0.1	2.7	3.5	2.2	0.0	5.6	1.9	30.3	0.4	27.5	0.4	0.2	17.0	2.4	1.6	0.3	96.0	29.4	68.5	46.8	3.8	5.3	38.8	50.9	32.9	85.6	62.3	58.3	55.0	64.7	30.9	30.1	80.1	43.2	93.9	35.0	105.7	51.4	45.6	221.5	26.2	50.6	0.8	63.5	57.0	1.7	2.8	65.2	33.1	12.7	49.8	73.2	96.8	126.5	76.8	33.7	126.3	39.0	71.2	39.4	55.3	69.3	64.2	102.7	18.3	27.0	48.3	21.4	34.2	31.4	27.2	44.1	24.0	60.6	19.1	39.7	57.5	28.8	69.0	67.3	65.5	75.4	24.2	48.6	69.8	1.1	0.0	0.2	0.2	0.0	0.3	0.5	0.9	0.5	0.1	0.5	0.6	0.4	0.0	0.5	0.0	0.9	1.5	0.3	0.1	0.3	0.1	0.1	0.1	0.1	0.1	0.6	0.3	0.0	0.4	0.3	0.2	0.0	1.5	0.0	5.5	0.5	0.5	2.0	0.6	0.0	0.9	0.8	1.1	0.0	1.6	0.0	0.0	5.8	2.5	2.4	0.0	0.3	13.5	4.5	1.5	1.1	0.0	24.8	0.2	0.0	9.8	2.2	2.0	2.2	0.0	66.1	1.8	0.3	8.1	0.0	0.2	3.1	4.1	1.6	1.4	7.5	0.3	2.0	0.0	0.0	0.6	0.0	0.0	0.5	1.0	0.1	0.0	0.4	35.2	0.5	0.3	0.1	1.8	0.0	6.6	0.2	3.7	85.6	20.0	4.0	0.4	0.7	2.9	0.5	5.9	0.9
BUB1B	"Bub1A, BUBR1, MAD3L, SSK1"	ENSG00000156970	"BUB1 mitotic checkpoint serine/threonine kinase B"	O60566	15	40161023-40221123	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Apoptosis, Cell cycle, Cell division, Mitosis"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Disease variant, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 17.8;lymphoid tissue: 35.7;testis: 22.2"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 23.5;Spermatocytes: 79.2;Spermatogonia: 26.8"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in single"		"naive B-cell: 1.1"	"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"							HPA008419			Supported	Cytosol		Yes	Yes			"Cluster 24: B-cells - Unknown function"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Cytosol		"HPA008419: AB_1078308"	"unprognostic (4.40e-2)"	"unprognostic (2.23e-1)"	"unprognostic (4.65e-2)"	"unprognostic (2.44e-3)"	"unprognostic (9.66e-2)"	"unprognostic (3.52e-2)"	"prognostic unfavorable (7.43e-6)"	"prognostic unfavorable (3.56e-4)"	"unprognostic (3.69e-3)"	"unprognostic (2.32e-1)"	"prognostic unfavorable (1.79e-4)"	"unprognostic (1.76e-2)"	"unprognostic (0.00e+0)"	"unprognostic (3.75e-2)"	"unprognostic (4.66e-2)"	"unprognostic (2.20e-1)"	"unprognostic (3.94e-2)"	0.4	0.5	0.1	6.7	0.1	17.8	1.6	0.3	0.2	1.0	7.7	4.6	4.7	1.2	0.3	5.2	0.6	0.6	0.3	0.3	0.1	0.3	0.4	1.0	12.6	0.0	0.1	0.2	0.2	0.2	0.1	3.4	0.1	0.4	6.0	0.1	0.9	0.2	0.0	3.5	4.1	2.1	0.0	3.1	2.4	22.2	0.2	35.7	0.5	0.0	15.0	1.5	1.7	0.0	66.5	32.8	103.0	41.5	2.5	7.1	33.2	60.9	34.2	64.6	55.7	48.1	25.0	59.7	33.5	22.7	59.0	72.6	98.8	33.2	70.5	51.8	52.1	86.4	83.6	45.5	0.2	79.0	45.7	1.6	2.0	39.2	37.1	12.9	47.7	66.5	76.4	61.7	65.6	22.5	62.5	48.9	70.2	55.6	36.8	66.5	83.7	45.2	19.9	33.1	67.1	40.8	38.0	35.9	13.3	45.1	41.9	40.9	27.6	49.3	51.8	49.2	55.5	32.1	58.2	95.6	26.3	87.8	65.4	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.2	0.1	0.2	1.1	0.0	0.1	0.0	0.1	0.0	0.8	0.0	0.1	0.1	0.1	0.3	0.2	0.3	0.1	0.0	0.1	0.1	0.0	0.2	0.0	0.1	3.2	1.1	0.3	1.8	0.8	0.3	1.0	1.8	0.7	0.9	2.0	0.8	0.0	1.9	0.0	0.0	5.4	0.6	1.8	0.0	0.4	3.0	0.9	1.4	1.0	0.0	23.5	0.7	0.0	6.7	2.4	5.6	2.1	0.0	12.9	1.1	0.3	5.2	0.0	0.7	2.5	0.0	1.9	1.7	3.3	1.5	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	1.5	0.4	12.6	0.3	0.3	0.1	0.2	0.2	6.6	0.2	1.7	79.2	26.8	6.9	0.3	0.8	1.8	0.8	5.4	0.6
BUB3	BUB3L	ENSG00000154473	"BUB3 mitotic checkpoint protein"	O43684	10	123154402-123170467	"Predicted intracellular proteins"	"Cell cycle, Cell division, Chromosome partition, Meiosis, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003601, CAB037075"	Supported		Supported	Nucleoplasm		NA	Yes		39000	"Cluster 44: Non-specific - Transcription"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"CAB037075: AB_1078310, HPA003601: AB_1078309"	"unprognostic (7.82e-2)"	"prognostic favorable (2.04e-4)"	"unprognostic (9.07e-2)"	"unprognostic (1.83e-1)"	"unprognostic (7.93e-2)"	"unprognostic (8.60e-2)"	"prognostic unfavorable (4.45e-5)"	"unprognostic (6.04e-3)"	"unprognostic (9.41e-2)"	"unprognostic (6.30e-3)"	"unprognostic (2.69e-2)"	"unprognostic (1.37e-2)"	"prognostic unfavorable (3.81e-7)"	"unprognostic (8.80e-2)"	"unprognostic (7.64e-2)"	"unprognostic (1.51e-1)"	"unprognostic (7.71e-2)"	36.6	49.8	27.3	63.3	34.5	102.9	41.1	35.0	35.0	36.0	30.7	49.0	42.2	35.7	35.2	56.6	37.6	35.8	28.0	31.9	36.4	32.6	34.9	33.5	99.9	34.1	50.6	42.9	30.1	32.6	36.0	38.2	39.6	30.6	49.1	25.5	39.5	28.8	36.9	44.1	47.7	36.4	35.7	52.9	38.4	58.5	33.0	100.6	37.4	33.5	87.2	49.5	40.4	48.6	309.8	302.5	190.4	211.5	105.4	100.3	166.2	316.2	329.5	340.3	268.8	266.3	203.2	275.9	116.3	145.2	163.6	195.9	285.1	343.0	349.9	228.8	294.2	173.0	355.1	291.8	110.1	338.1	206.8	86.5	132.9	307.9	382.4	182.1	232.7	228.9	216.1	266.7	308.4	264.1	281.8	206.9	117.6	159.0	293.0	378.6	96.2	175.7	156.3	333.1	141.4	143.1	179.2	116.6	151.9	77.5	135.0	173.4	188.5	262.4	163.9	167.6	473.8	143.0	220.6	433.9	143.0	333.2	113.2	200.3	113.2	165.7	246.0	122.2	224.1	216.7	223.0	251.0	119.1	209.7	237.9	249.3	56.1	241.6	112.3	127.6	366.9	294.0	27.3	34.5	35.0	35.0	31.9	36.4	34.1	50.6	39.6	35.7	33.0	48.6	55.8	25.6	36.5	15.3	99.7	130.5	65.5	154.6	73.4	30.8	53.4	48.8	39.2	44.3	66.9	38.6	10.4	108.1	119.0	37.1	70.5	68.8	160.8	26.1	41.4	62.1	40.7	93.6	14.4	58.9	136.5	62.6	34.7	28.1	50.7	56.3	45.0	43.0	80.7	10.1	12.9	57.3	118.0	58.1	68.6	159.3	45.1	53.1	96.0	16.9	140.4	55.7	97.9	21.6	35.9	64.1	40.2	46.3	107.1	64.7	44.5	78.4	51.2	25.1	105.2	42.2	70.6	199.8	145.4	86.3	133.3	65.0	150.3	84.1	67.8	62.9
BUD23	"MERM1, MGC19709, MGC2022, MGC5140, PP3381, WBMT, WBSCR22"	ENSG00000071462	"BUD23 rRNA methyltransferase and ribosome maturation factor"	O43709	7	73683025-73705161	"Human disease related genes, Metabolic proteins, Predicted intracellular proteins"	"Ribosome biogenesis, rRNA processing, Transcription, Transcription regulation"	"Chromatin regulator, Methyltransferase, Transferase"	"Williams-Beuren syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Ductal cells: 119.9;Endometrial ciliated cells: 133.6;Exocrine glandular cells: 140.8;Pancreatic endocrine cells: 126.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RPMI-8226: 712.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052185	Approved		Supported	Nucleoplasm,Nucleoli		Yes	No			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 7: Non-specific - Mitochondria"	"Nucleoplasm, Nucleoli"		"HPA052185: AB_2681753"	"unprognostic (2.49e-1)"	"unprognostic (1.87e-1)"	"unprognostic (2.67e-2)"	"unprognostic (4.79e-2)"	"unprognostic (3.62e-3)"	"unprognostic (8.54e-2)"	"prognostic unfavorable (9.92e-4)"	"unprognostic (1.17e-1)"	"unprognostic (9.16e-2)"	"unprognostic (9.20e-2)"	"unprognostic (6.71e-2)"	"unprognostic (4.20e-2)"	"prognostic unfavorable (1.46e-4)"	"unprognostic (5.15e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.46e-1)"	"unprognostic (3.13e-3)"	39.8	49.2	34.5	40.0	36.7	58.7	43.4	36.4	39.8	36.3	41.0	48.6	47.0	38.6	72.3	41.7	58.9	34.5	87.9	36.1	39.0	53.3	47.2	38.5	52.6	37.0	36.1	37.8	70.8	49.2	45.1	30.7	36.3	37.8	47.7	20.3	55.9	42.2	128.0	43.8	40.3	41.4	36.4	42.1	44.9	130.0	36.6	44.7	56.5	78.4	51.7	51.9	32.8	38.5	142.1	151.8	53.6	429.2	72.0	64.2	91.1	95.1	83.3	118.5	96.1	211.4	182.6	163.6	48.9	99.5	204.0	97.0	124.8	91.0	108.4	116.6	147.1	72.0	174.8	86.7	91.2	200.3	98.8	57.3	102.2	103.2	93.9	59.7	77.4	130.3	285.4	288.9	103.7	219.6	128.0	277.8	130.2	317.8	172.2	110.5	106.8	712.0	132.5	100.2	163.4	124.4	126.3	329.2	146.5	53.0	207.9	159.0	85.2	101.8	130.3	130.0	208.3	99.5	192.6	275.5	232.3	155.6	218.0	54.8	64.9	60.6	112.0	74.2	124.9	175.3	127.1	122.5	122.9	153.5	132.8	121.5	11.9	125.4	68.0	190.9	150.6	132.6	34.5	36.7	36.4	39.8	36.1	39.0	37.0	36.1	36.3	36.4	36.6	38.5	67.0	44.8	64.5	0.0	26.5	0.0	0.0	0.0	0.0	0.0	75.4	85.7	0.0	0.0	42.7	46.0	0.0	75.7	64.1	0.0	97.8	119.9	0.0	133.6	51.2	28.6	0.0	0.0	0.0	140.8	82.7	24.5	0.0	79.6	46.7	49.2	0.0	0.0	70.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	32.8	0.0	0.0	21.2	0.0	0.0	0.0	0.0	126.0	0.0	0.0	16.5	0.0	0.0	103.5	78.7	0.0	0.0	0.0	26.4	0.0	0.0	0.0	0.0	106.7	28.1	73.0	0.0	0.0
BVES	"HBVES, POP1, POPDC1"	ENSG00000112276	"Blood vessel epicardial substance"	Q8NE79	6	105096822-105137157	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Cell adhesion"	"Developmental protein"	"Limb-girdle muscular dystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 27.8;skeletal muscle: 43.9;tongue: 29.3"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 34.2;Early spermatids: 36.1;Late spermatids: 55.3;Oligodendrocytes: 17.8;Spermatocytes: 24.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"RH-30: 29.7;WM-115: 30.2"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA014788, HPA018176"	Enhanced		Supported	"Plasma membrane,Cell Junctions"		Yes	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 25: Spermatids - Spermatogenesis"	"Plasma membrane, Cell Junctions"		"HPA014788: AB_1845504, HPA018176: AB_1845503"	"unprognostic (2.91e-1)"	"unprognostic (2.45e-1)"	"unprognostic (2.79e-2)"	"unprognostic (1.73e-2)"	"unprognostic (5.46e-2)"	"unprognostic (3.66e-2)"	"unprognostic (5.21e-2)"	"unprognostic (2.22e-2)"	"unprognostic (8.37e-2)"	"unprognostic (4.49e-2)"	"unprognostic (2.29e-2)"	"unprognostic (8.92e-2)"	"unprognostic (5.84e-3)"	"unprognostic (3.77e-2)"	"unprognostic (1.78e-1)"	"unprognostic (2.02e-2)"	"unprognostic (3.24e-4)"	2.9	0.7	2.6	2.3	7.1	0.2	1.5	5.8	3.6	2.5	4.6	14.9	1.4	5.8	1.7	5.3	2.8	1.8	27.8	2.7	4.3	1.6	0.3	1.9	0.6	7.3	5.6	1.0	0.6	0.7	2.4	3.5	7.4	5.2	3.3	0.2	1.4	10.0	43.9	0.7	3.0	17.7	5.2	0.3	6.9	11.5	5.2	0.2	1.3	29.3	0.4	9.3	2.2	10.8	1.3	2.0	7.6	1.3	10.9	14.9	3.3	5.8	4.1	8.8	11.6	0.5	0.0	0.0	0.0	10.9	14.7	0.1	3.3	2.0	8.1	0.0	2.8	0.0	1.0	0.3	2.4	0.0	0.6	8.7	6.9	13.6	1.1	6.6	4.0	3.3	0.1	19.3	19.7	0.1	0.2	1.0	1.6	0.0	0.0	5.7	29.7	0.0	0.0	0.0	9.9	17.1	3.7	0.1	7.7	5.5	0.0	20.0	8.9	14.0	0.0	0.0	15.3	1.8	0.8	0.0	8.3	0.0	30.2	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	2.6	7.1	5.8	3.6	2.7	4.3	7.3	5.6	7.4	5.2	5.2	10.8	2.1	0.0	0.0	1.6	0.0	0.3	0.4	0.1	0.6	0.0	0.4	1.0	34.2	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	36.1	1.9	4.4	3.1	0.0	0.0	3.3	0.0	0.2	2.6	0.0	6.0	0.0	0.9	2.2	0.1	2.3	0.0	0.6	0.0	0.0	0.0	1.9	55.3	1.2	0.5	0.0	3.7	1.0	0.0	0.0	5.0	17.8	0.1	0.0	3.4	0.0	0.5	0.1	0.1	0.1	0.0	13.1	11.8	4.4	24.4	5.4	0.1	0.9	0.1	0.2	1.3	0.0	0.3
C10orf90	"bA422P15.2, FATS, FLJ32938"	ENSG00000154493	"Chromosome 10 open reading frame 90"	Q96M02	10	126424997-126798708	"Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	10	"brain: 112.1"	"Cell type enriched"	"Detected in some"	4	"Oligodendrocytes: 819.4"	"Cancer enriched"	"Detected in some"	5	"melanoma: 4.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"SK-MEL-30: 118.8;U-2197: 36.1;U-266/84: 27.2;U-87 MG: 37.0;WM-115: 29.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038648, HPA075229"	Approved		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Nucleoplasm, Plasma membrane, Cytosol"		"HPA038648: AB_10672721, HPA075229: "	"unprognostic (1.21e-2)"	"unprognostic (3.34e-1)"	"unprognostic (7.50e-2)"	"unprognostic (2.05e-2)"	"unprognostic (1.66e-1)"	"unprognostic (9.30e-2)"	"unprognostic (1.98e-3)"	"unprognostic (5.06e-2)"	"unprognostic (9.34e-3)"	"unprognostic (3.73e-2)"	"unprognostic (9.52e-2)"	"unprognostic (1.22e-1)"	"unprognostic (5.06e-11)"	"unprognostic (2.69e-3)"	"unprognostic (9.91e-3)"	"unprognostic (1.26e-1)"	"unprognostic (2.88e-1)"	0.7	0.0	30.4	0.1	74.4	0.0	4.7	41.9	47.7	0.1	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.2	0.0	29.9	37.4	0.3	0.1	0.0	0.0	60.4	53.8	0.1	0.2	0.0	0.3	0.3	57.0	0.0	0.1	0.0	10.6	0.0	0.1	1.1	0.1	0.0	29.8	0.0	0.0	6.5	68.0	1.1	0.3	0.4	0.7	0.0	0.0	112.1	0.3	0.1	0.0	0.0	0.8	2.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	2.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.1	2.3	0.0	1.6	0.0	0.9	0.0	0.0	0.0	0.1	1.6	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.1	0.0	2.6	0.0	0.0	0.0	0.0	118.8	0.0	0.0	0.2	0.0	4.7	0.0	36.1	0.7	0.0	27.2	0.0	37.0	0.0	29.7	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	30.4	74.4	41.9	47.7	29.9	37.4	60.4	53.8	57.0	29.8	68.0	112.1	0.2	0.0	0.0	24.5	0.1	0.0	0.0	0.0	0.0	0.0	3.0	2.7	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	120.5	0.0	0.0	0.1	0.0	0.0	2.2	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	1.6	0.0	0.0	0.0	0.0	142.7	0.3	0.0	0.0	3.7	0.0	0.0	0.0	181.0	819.4	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.1	1.3	0.5	0.0	0.0	4.2	0.1	0.0	0.0	0.0
C11orf24	DM4E3	ENSG00000171067	"Chromosome 11 open reading frame 24"	Q96F05	11	68261338-68272001	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Hepatocytes: 107.7;Proximal enterocytes: 162.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SK-MEL-30: 222.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012411, HPA012748"	Uncertain		Approved	"Nucleoplasm,Golgi apparatus,Vesicles"		NA	NA			"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 45: Enterocytes - Digestion"	"Nucleoplasm, Golgi apparatus"	Vesicles	"HPA012411: , HPA012748: AB_1845526"	"unprognostic (1.13e-2)"	"unprognostic (2.03e-2)"	"unprognostic (1.19e-1)"	"unprognostic (8.22e-2)"	"prognostic unfavorable (7.38e-4)"	"unprognostic (2.31e-2)"	"unprognostic (7.91e-2)"	"prognostic unfavorable (6.05e-4)"	"unprognostic (1.56e-1)"	"unprognostic (2.68e-2)"	"unprognostic (4.99e-2)"	"unprognostic (1.55e-1)"	"prognostic unfavorable (1.60e-9)"	"unprognostic (2.18e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.21e-1)"	"unprognostic (8.67e-3)"	25.0	17.6	8.9	20.7	12.2	4.7	21.0	12.1	12.7	23.3	8.2	29.2	53.8	39.2	7.3	15.5	22.2	17.6	31.5	9.7	10.5	17.0	87.4	24.1	15.5	14.4	11.6	19.3	27.3	7.3	14.5	16.1	12.5	22.9	17.4	3.0	34.0	17.6	13.7	15.4	59.4	32.6	11.0	20.8	23.6	14.6	12.8	6.4	17.0	15.2	16.7	22.3	19.4	15.2	44.8	45.5	26.4	51.6	62.1	62.5	29.7	105.4	67.5	51.8	53.1	96.2	26.9	20.1	31.7	131.3	47.2	49.4	39.1	47.4	33.2	22.1	23.1	21.4	44.8	65.3	50.1	18.3	68.7	52.1	34.6	78.8	32.0	31.0	21.2	10.6	37.9	32.2	44.6	55.7	4.5	26.4	44.2	72.1	53.8	8.2	44.8	104.1	23.9	21.1	17.3	31.8	33.3	27.1	222.8	21.8	25.6	15.3	23.3	80.8	50.2	103.3	47.3	39.4	41.4	18.8	65.1	14.1	79.9	16.7	12.1	12.6	14.0	19.0	9.4	26.7	7.9	8.9	19.5	35.7	7.3	7.7	1.8	9.9	14.1	26.7	8.4	12.6	8.9	12.2	12.1	12.7	9.7	10.5	14.4	11.6	12.5	11.0	12.8	15.2	6.8	9.6	3.6	3.3	25.5	14.0	12.2	11.7	9.6	4.8	8.2	8.9	10.4	11.5	6.9	9.2	2.1	11.9	12.4	36.2	1.9	21.9	3.5	5.3	17.8	6.6	4.8	9.1	4.1	31.5	30.7	21.1	18.3	6.8	45.0	5.0	9.3	107.7	15.8	0.0	4.2	50.0	6.1	12.9	23.5	7.1	14.0	12.3	28.4	5.6	14.9	6.8	18.6	6.6	8.5	26.9	16.6	16.1	67.0	13.0	162.5	10.6	9.4	2.9	13.1	11.2	20.2	20.7	27.1	9.6	11.2	10.5	6.5	9.6	15.5	10.6
C11orf91		ENSG00000205177	"Chromosome 11 open reading frame 91"	Q3C1V1	11	33698261-33700801	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 9.5"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 16.6;Late spermatids: 4.0;Sertoli cells: 6.6;Spermatocytes: 12.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HBEC3-KT: 16.2;hTERT-HME1: 10.0;HUVEC TERT2: 8.2;TIME: 12.6;U-2197: 10.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA047064, HPA050487"	Uncertain		Supported	Vesicles		NA	NA				"Cluster 83: Testis - Spermatogenesis"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 66: Spermatocytes - Spermatogenesis"	Vesicles		"HPA047064: AB_2679920, HPA050487: AB_2681142"	"unprognostic (9.22e-3)"	"unprognostic (1.51e-2)"	"unprognostic (1.76e-1)"	"unprognostic (6.60e-2)"	"unprognostic (1.62e-2)"	"unprognostic (3.63e-2)"	"unprognostic (2.31e-1)"	"unprognostic (5.68e-3)"	"unprognostic (7.41e-2)"	"unprognostic (2.97e-2)"	"unprognostic (1.99e-2)"	"unprognostic (3.01e-1)"	"unprognostic (8.33e-2)"	"unprognostic (4.06e-2)"	"unprognostic (3.95e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.21e-1)"	4.8	0.2	0.3	0.6	0.3	1.0	1.5	1.2	2.0	0.1	0.0	0.4	0.0	0.2	0.1	2.9	0.3	4.7	0.8	0.2	0.5	1.4	0.2	1.1	0.2	0.3	0.5	0.2	1.5	0.0	0.1	0.5	0.6	0.2	0.0	0.2	0.5	0.2	0.5	1.0	0.3	0.8	0.4	0.0	2.1	9.5	0.3	0.2	0.4	0.0	0.4	1.4	0.3	0.6	0.2	0.0	0.2	1.5	0.0	0.0	0.0	1.8	0.0	0.9	0.4	0.3	0.6	0.0	0.1	1.9	0.2	0.7	0.5	16.2	1.3	0.5	0.0	0.0	4.0	0.9	0.3	0.0	0.0	0.0	0.1	1.2	10.0	0.5	8.2	0.2	0.0	2.5	3.9	0.0	0.0	0.3	0.0	0.1	5.0	0.0	0.0	0.0	1.1	2.1	0.0	0.3	0.0	1.6	0.1	0.5	0.0	0.0	12.6	1.2	0.3	10.3	0.3	0.7	0.6	0.0	2.1	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	1.2	2.0	0.2	0.5	0.3	0.5	0.6	0.4	0.3	0.6	1.2	0.0	0.0	0.3	0.0	0.0	2.2	0.0	0.0	0.0	0.4	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	16.6	0.4	0.2	0.6	0.0	0.0	0.2	0.4	0.0	0.1	0.0	0.2	0.0	0.2	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.8	0.0	0.3	0.1	0.0	6.6	0.1	0.3	12.3	0.4	0.3	0.0	0.1	0.0	0.0	0.0	1.5
C12orf66	FLJ32549	ENSG00000174206	"Chromosome 12 open reading frame 66"	Q96MD2	12	64186316-64222296	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046743, HPA052855"	Uncertain		Supported	"Lysosomes,Cytokinetic bridge"		Yes	No			"Cluster 30: Non-specific - Translation"	"Cluster 35: Non-specific - Unknown function"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 57: B-cells - Immune response"	Lysosomes	"Cytokinetic bridge"	"HPA046743: AB_2679782, HPA052855: AB_2681973"	"unprognostic (7.44e-3)"	"unprognostic (2.38e-1)"	"unprognostic (6.20e-2)"	"unprognostic (2.70e-1)"	"unprognostic (2.31e-1)"	"unprognostic (4.62e-2)"	"unprognostic (3.45e-2)"	"unprognostic (2.08e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.94e-1)"	"unprognostic (1.93e-1)"	"unprognostic (3.60e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.10e-1)"	"unprognostic (7.46e-2)"	"unprognostic (4.07e-2)"	2.9	4.2	3.6	3.4	5.3	1.7	5.4	4.0	4.8	2.8	1.9	2.8	3.1	2.6	4.8	4.2	3.9	2.5	2.3	3.5	4.3	5.5	8.6	2.8	4.9	4.0	4.4	3.9	5.2	5.7	2.6	2.1	4.5	2.3	3.1	1.6	2.9	2.3	4.4	5.6	2.5	2.3	3.7	5.0	3.0	3.4	4.3	3.3	5.6	3.2	4.8	2.6	3.0	6.8	5.5	8.7	1.6	4.7	4.3	7.2	4.5	3.0	3.7	4.4	2.7	2.7	4.3	17.4	4.1	2.4	7.1	6.3	6.9	5.3	4.7	13.3	4.6	6.3	2.1	2.5	5.6	6.9	3.6	5.6	9.0	5.7	10.3	5.0	3.2	12.0	8.8	11.3	4.4	10.6	7.9	6.0	7.7	6.5	6.8	4.0	4.9	13.4	6.6	6.4	3.8	3.8	4.9	6.7	4.8	4.2	10.8	4.4	2.5	4.4	2.9	4.4	2.9	14.9	13.2	9.7	6.6	5.9	5.0	0.5	2.6	0.2	3.3	2.6	5.7	8.5	6.4	5.0	4.3	7.2	8.7	8.4	0.2	4.0	1.8	3.1	10.8	4.2	3.6	5.3	4.0	4.8	3.5	4.3	4.0	4.4	4.5	3.7	4.3	6.8	3.4	3.2	2.7	5.5	9.3	2.4	8.8	3.4	7.4	2.1	5.9	4.1	2.7	7.2	5.5	9.2	2.1	6.3	4.0	1.9	9.8	4.1	9.2	3.3	4.0	3.9	4.2	3.4	7.1	5.2	3.9	3.5	7.1	3.6	1.3	3.6	1.8	10.8	4.9	0.0	5.5	2.7	4.1	6.3	2.6	7.3	4.7	4.3	1.8	1.0	2.1	2.5	1.0	3.5	17.4	2.6	2.6	1.9	2.8	4.7	2.1	12.9	2.4	1.6	0.0	7.4	2.8	4.4	8.8	6.9	4.3	1.8	5.8	4.3	3.7	4.3
C14orf119	FLJ20671	ENSG00000179933	"Chromosome 14 open reading frame 119"	Q9NWQ9	14	23095505-23100456	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003638	Uncertain		Supported	Mitochondria,Cytosol		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Mitochondria	Cytosol	"HPA003638: AB_2243669"	"unprognostic (2.10e-2)"	"unprognostic (4.29e-2)"	"unprognostic (5.89e-3)"	"unprognostic (2.91e-1)"	"unprognostic (2.33e-2)"	"unprognostic (5.26e-3)"	"prognostic unfavorable (5.42e-5)"	"unprognostic (1.23e-1)"	"unprognostic (3.36e-2)"	"unprognostic (1.65e-2)"	"unprognostic (4.08e-3)"	"unprognostic (1.25e-1)"	"unprognostic (5.54e-2)"	"unprognostic (2.06e-2)"	"unprognostic (3.61e-2)"	"prognostic favorable (3.30e-5)"	"unprognostic (1.63e-1)"	41.5	49.2	26.7	34.3	28.6	15.5	46.9	30.3	32.0	41.1	34.7	42.8	33.6	40.1	42.3	45.6	33.2	27.5	36.6	26.8	29.7	49.4	37.2	38.1	34.2	30.3	29.6	33.6	31.6	35.3	38.4	33.7	30.6	30.6	51.3	25.5	36.2	38.5	32.9	30.9	41.2	48.8	29.7	47.1	41.0	25.2	31.5	40.4	33.9	31.1	50.8	47.5	33.9	32.2	53.9	52.5	77.4	47.2	166.8	144.3	62.1	88.5	129.9	114.1	134.6	41.9	81.3	40.9	44.8	144.2	138.0	89.9	74.6	117.4	157.6	65.2	36.5	61.6	41.4	180.8	130.7	93.2	91.9	177.0	104.1	96.3	70.5	104.0	126.6	72.7	41.9	44.4	127.2	77.8	44.3	72.1	48.7	124.5	79.2	38.6	57.5	47.0	130.8	85.9	37.1	33.8	73.7	68.6	81.0	85.5	46.4	53.2	103.0	54.0	47.0	81.6	40.6	41.5	52.6	50.5	49.4	58.3	49.2	317.0	160.8	302.7	122.6	106.0	140.9	143.9	138.9	137.3	150.7	121.0	144.0	142.6	94.5	131.0	74.4	102.2	188.7	203.2	26.7	28.6	30.3	32.0	26.8	29.7	30.3	29.6	30.6	29.7	31.5	32.2	50.9	48.1	47.7	4.2	41.9	26.5	89.0	144.5	23.9	28.6	41.9	50.5	23.7	34.3	75.9	31.3	8.4	89.0	53.5	44.1	129.1	95.9	22.6	39.0	45.2	56.2	28.3	65.4	3.8	84.3	105.5	42.9	30.5	33.2	54.4	39.6	46.4	29.6	107.8	20.2	4.4	57.4	81.4	38.9	32.1	15.1	64.0	53.1	48.0	5.6	93.2	36.1	58.7	2.0	11.5	97.0	42.4	48.5	31.4	59.8	61.5	100.3	48.3	21.5	32.9	18.6	47.1	52.7	25.6	33.5	34.0	143.1	46.5	81.3	51.7	83.2
C17orf50		ENSG00000270806	"Chromosome 17 open reading frame 50"	Q8WW18	17	35760887-35765079	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	82	"testis: 105.6"	"Group enriched"	"Detected in some"	45	"Early spermatids: 769.0;Late spermatids: 1197.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	6	"HaCaT: 3.7;MOLT-4: 1.0"	"Not detected"	"Not detected"							"HPA043184, HPA063464"			Supported	Nucleoplasm		Yes	NA			"Cluster 29: Plasmacytoid DCs - Unknown function"	"Cluster 74: Testis - Spermatogenesis"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 25: Spermatids - Spermatogenesis"	Nucleoplasm		"HPA043184: AB_2678358, HPA063464: "	"unprognostic (2.21e-1)"	"unprognostic (1.07e-1)"	"unprognostic (4.36e-2)"	"unprognostic (4.01e-2)"	"unprognostic (5.84e-2)"	"unprognostic (5.12e-3)"		"unprognostic (2.04e-2)"		"unprognostic (1.97e-2)"	"unprognostic (7.94e-2)"	"unprognostic (5.36e-2)"	"unprognostic (1.14e-2)"	"unprognostic (2.71e-1)"	"unprognostic (6.68e-2)"	"unprognostic (4.67e-2)"	"unprognostic (1.54e-2)"	0.1	0.1	1.2	0.0	0.9	0.0	0.1	0.0	1.0	0.0	0.0	0.2	0.0	0.0	0.3	0.1	0.3	0.0	0.0	0.8	0.7	0.1	0.0	0.1	0.0	0.4	0.7	0.0	0.2	0.0	0.3	0.0	0.1	0.1	0.0	0.3	0.0	0.1	0.1	0.2	0.2	0.0	0.0	0.1	0.1	105.6	0.6	0.1	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.4	1.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.3	0.7	0.8	0.7	0.4	0.0	0.7	1.2	1.4	0.0	0.1	0.0	1.4	0.0	0.2	1.2	0.9	0.0	1.0	0.8	0.7	0.4	0.7	0.1	0.0	0.6	0.0	0.0	0.0	0.0	1.3	0.1	0.0	0.0	0.2	0.0	0.4	0.5	0.6	0.3	0.0	0.1	9.2	0.0	0.0	0.2	0.4	0.0	0.0	769.0	1.8	0.0	0.5	1.2	0.0	0.6	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.7	0.4	2.0	0.0	0.0	1197.7	8.4	0.4	0.0	0.0	0.1	1.2	0.0	0.0	0.0	0.0	0.2	5.7	0.0	0.1	0.4	1.0	1.5	0.2	6.6	0.0	0.2	21.8	7.2	0.0	0.0	0.0	0.1	0.1	0.5	0.1
C19orf12	"DKFZP762D096, MGC10922, MPAN, NBIA4, SPG43"	ENSG00000131943	"Chromosome 19 open reading frame 12"	Q9NSK7	19	29698886-29715789	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Disease variant, Hereditary spastic paraplegia, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adipose tissue: 118.9;tongue: 105.5"	"Cell type enhanced"	"Detected in all"		"Hepatocytes: 62.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046930	Approved		Supported	Cytosol		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 2: Hepatocytes - Metabolism"	Cytosol		"HPA046930: AB_10962836"	"unprognostic (1.76e-1)"	"unprognostic (2.22e-1)"	"unprognostic (2.13e-1)"	"unprognostic (1.01e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.31e-1)"	"unprognostic (9.01e-2)"	"unprognostic (1.54e-1)"	"unprognostic (9.94e-3)"	"unprognostic (7.93e-3)"	"unprognostic (5.27e-2)"	"unprognostic (1.69e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.23e-1)"	"unprognostic (3.22e-1)"	"unprognostic (1.22e-3)"	118.9	25.3	22.1	14.4	25.8	4.4	40.8	16.6	24.8	13.8	12.6	16.8	19.5	14.3	9.0	13.2	12.8	12.9	30.9	23.9	22.7	20.8	69.3	11.3	21.2	20.5	20.3	14.7	17.1	15.4	14.5	13.2	21.7	14.1	9.3	8.5	18.1	12.4	62.2	14.7	17.6	13.4	16.8	16.0	12.9	7.3	23.1	14.1	10.7	105.5	13.6	15.2	11.7	19.9	19.9	39.4	18.4	23.2	45.0	27.5	28.8	23.1	22.7	22.5	29.2	19.1	8.1	16.1	24.1	29.1	20.4	8.5	15.7	9.5	15.1	42.8	28.3	18.0	13.5	33.2	25.1	14.0	22.8	31.8	20.2	13.7	10.9	18.0	20.1	9.8	14.0	20.3	23.7	13.8	9.9	10.1	11.1	17.3	9.9	19.2	19.1	12.3	17.2	20.1	11.3	23.8	13.9	17.8	37.0	18.8	7.6	15.4	20.9	47.4	37.0	19.5	21.2	28.4	27.1	12.0	28.3	8.4	20.3	1.1	2.3	1.4	16.0	2.5	9.4	4.6	9.1	11.6	2.2	3.6	9.2	11.5	2.8	7.1	2.7	5.0	11.9	8.0	22.1	25.8	16.6	24.8	23.9	22.7	20.5	20.3	21.7	16.8	23.1	19.9	9.6	12.8	13.7	9.4	13.7	12.7	11.1	8.2	14.8	15.8	13.2	9.4	30.1	2.8	7.3	9.2	6.2	29.2	21.7	9.2	15.6	17.1	1.8	8.5	16.0	10.4	3.6	9.5	19.5	23.1	25.5	20.0	8.2	8.8	16.5	16.2	14.6	62.4	15.6	5.0	18.3	7.5	8.2	12.5	9.9	1.8	28.9	8.7	10.6	8.4	20.1	15.8	41.2	12.1	17.4	20.0	11.0	29.3	20.7	12.8	24.0	37.5	6.6	9.6	6.6	24.6	13.3	4.6	5.3	10.1	7.7	21.9	21.6	23.8	8.2	7.8
C19orf33	"H2RSP, IMUP, IMUP-1, IMUP-2"	ENSG00000167644	"Chromosome 19 open reading frame 33"	Q9GZP8	19	38304164-38305006	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 515.3;skin 1: 331.1"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 2060.3;Pancreatic endocrine cells: 2590.4;Paneth cells: 1697.3;Proximal enterocytes: 1756.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	10	"myeloid DC: 22.2"	"Lineage enriched"	"Detected in many"	10	"dendritic cells: 22.2"	"Cell line enhanced"	"Detected in many"		"A-431: 745.5;A549: 1228.0;CAPAN-2: 767.1;HBEC3-KT: 744.6;hTCEpi: 799.2;OE19: 678.3;PC-3: 659.8"	"Not detected"	"Not detected"							"HPA054406, HPA059696"	Uncertain		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		No	No		460000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	Nucleoplasm	"Plasma membrane, Cytosol"	"HPA054406: AB_2682478, HPA059696: AB_2684105"	"unprognostic (9.31e-2)"	"unprognostic (2.06e-1)"	"unprognostic (4.34e-2)"	"unprognostic (1.44e-2)"	"unprognostic (3.92e-3)"	"unprognostic (2.37e-2)"	"unprognostic (9.49e-2)"	"prognostic unfavorable (5.42e-4)"	"unprognostic (2.09e-1)"	"unprognostic (1.74e-2)"	"prognostic unfavorable (5.05e-4)"	"unprognostic (6.92e-2)"	"unprognostic (5.50e-2)"	"unprognostic (4.82e-2)"	"unprognostic (1.61e-1)"	"unprognostic (3.63e-2)"	"unprognostic (6.01e-2)"	43.1	5.0	2.8	17.6	3.1	3.6	25.5	2.9	4.4	82.4	2.9	187.5	186.7	6.1	0.6	515.3	91.5	49.5	32.9	2.3	2.6	28.2	1.3	91.3	0.9	3.1	3.0	4.6	8.9	0.5	12.7	7.9	3.4	26.2	104.1	0.1	123.3	18.3	3.9	331.1	189.5	4.0	2.5	10.7	151.5	1.5	3.8	4.1	18.9	4.3	30.8	102.2	224.3	2.5	745.5	1228.0	0.0	0.6	0.0	0.0	1.2	1.0	0.0	0.0	0.0	77.1	767.1	0.0	394.2	0.0	0.7	300.1	0.0	744.6	0.0	0.4	0.5	0.4	244.2	20.0	5.4	0.0	0.2	0.0	799.2	0.3	493.3	3.3	10.2	0.9	0.4	0.5	0.8	220.4	0.1	1.9	0.4	678.3	659.8	0.2	0.2	2.8	469.5	255.2	0.8	0.8	416.6	340.8	0.8	1.6	103.7	2.3	141.6	0.5	201.9	0.7	2.8	0.7	2.4	3.7	0.1	0.2	0.2	2.1	0.6	2.2	0.2	0.0	0.4	0.1	0.5	0.1	22.2	1.4	0.7	0.3	1.0	0.4	0.1	1.8	0.0	18.2	2.8	3.1	2.9	4.4	2.3	2.6	3.1	3.0	3.4	2.5	3.8	2.5	29.1	535.2	172.9	0.0	5.4	225.3	28.4	508.7	436.5	0.0	32.5	25.5	2.4	267.4	418.0	55.2	0.0	8.6	1.7	2060.3	1.9	207.7	0.7	144.3	26.0	18.4	76.1	3.6	0.1	753.8	1.3	44.7	353.7	273.2	38.2	3.7	3.6	0.4	1.3	0.0	0.0	842.0	99.7	1.4	15.1	5.1	4.1	32.9	1.8	0.0	4.9	0.0	0.0	0.0	0.0	2590.4	1697.3	0.0	5.7	35.7	1756.4	51.7	212.5	0.0	0.0	0.4	14.3	1.8	1.9	629.0	348.4	3.1	7.9	0.0	691.9	188.4
C1D	"LRP1, Rrp47, SUN-CoR, SUNCOR"	ENSG00000197223	"C1D nuclear receptor corepressor"	Q13901	2	68041130-68110948	"Predicted intracellular proteins"	"Apoptosis, rRNA processing, Transcription, Transcription regulation"	"DNA-binding, Repressor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037413, HPA037588"	Approved		Supported	Nucleoplasm,Nucleoli		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 24: NB-4 - Immune response"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoplasm, Nucleoli"		"HPA037413: AB_2675463, HPA037588: AB_10672907"	"unprognostic (1.84e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.06e-1)"	"unprognostic (3.71e-3)"	"unprognostic (2.03e-1)"	"unprognostic (1.49e-2)"	"unprognostic (4.01e-3)"	"unprognostic (1.46e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.98e-1)"	"unprognostic (3.90e-2)"	"unprognostic (1.29e-2)"	"unprognostic (4.24e-3)"	"unprognostic (6.18e-2)"	"unprognostic (2.50e-1)"	"unprognostic (8.80e-2)"	"unprognostic (1.01e-1)"	21.7	25.3	11.6	17.0	11.8	48.1	21.4	11.9	19.0	19.9	12.8	19.1	16.6	20.0	17.0	19.3	18.3	14.7	22.2	12.0	12.8	31.5	33.4	19.0	21.4	11.3	11.8	19.3	15.8	24.0	15.3	17.5	11.6	19.5	14.7	16.6	18.7	15.5	46.9	17.5	18.5	13.7	12.0	21.7	21.4	14.8	12.0	17.5	19.6	31.9	16.5	17.4	28.2	13.9	36.6	20.3	22.0	21.0	22.2	27.0	29.6	48.7	28.1	29.3	22.4	40.8	45.0	45.2	27.2	28.9	28.1	18.0	24.7	20.4	43.1	43.0	36.6	43.5	17.6	46.3	22.3	68.1	54.4	25.0	32.4	22.1	20.9	36.3	22.0	41.4	44.8	41.1	26.6	22.2	51.3	69.6	25.4	29.8	24.4	29.6	28.3	39.9	28.2	29.2	20.5	25.4	15.1	30.0	51.6	26.7	22.2	41.2	30.9	27.9	34.5	34.0	38.9	38.0	40.8	58.6	38.9	41.3	34.2	45.3	17.6	43.7	19.0	23.3	22.5	24.2	22.0	16.6	20.6	21.3	23.4	24.3	34.9	30.3	25.2	19.2	25.3	15.2	11.6	11.8	11.9	19.0	12.0	12.8	11.3	11.8	11.6	12.0	12.0	13.9	65.2	76.9	47.9	13.1	70.7	85.0	83.2	132.8	33.6	34.3	52.9	58.4	36.5	64.3	86.3	64.4	22.9	98.9	76.2	48.1	234.8	83.4	52.4	53.7	47.2	42.9	51.6	121.2	17.7	59.4	82.7	60.2	44.9	46.6	44.3	32.8	43.5	81.7	87.5	35.3	15.9	42.6	109.9	61.9	46.1	21.7	55.6	66.9	56.9	8.4	80.1	57.4	88.6	14.1	21.9	65.6	63.3	59.0	58.5	78.1	57.0	251.4	95.4	36.8	98.6	54.2	65.3	164.5	100.3	44.5	86.2	107.8	62.9	52.2	32.8	109.0
C1orf109	FLJ20508	ENSG00000116922	"Chromosome 1 open reading frame 109"	Q9NX04	1	37681570-37692249	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 50.2;Suprabasal keratinocytes: 62.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027110, HPA027127"	Supported		Supported	Nucleoplasm,Nucleoli,Cytosol		NA	NA			"Cluster 29: Plasmacytoid DCs - Unknown function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 6: Erythroid cells - Oxygen transport"	Cytosol	"Nucleoplasm, Nucleoli"	"HPA027110: AB_10611813, HPA027127: AB_1845628"	"unprognostic (1.37e-1)"	"unprognostic (3.65e-2)"	"unprognostic (2.43e-1)"	"unprognostic (3.30e-3)"	"unprognostic (1.71e-2)"	"unprognostic (7.13e-3)"	"prognostic unfavorable (1.76e-7)"	"unprognostic (1.93e-1)"	"unprognostic (1.48e-2)"	"unprognostic (8.38e-2)"	"unprognostic (1.73e-1)"	"unprognostic (3.79e-3)"	"unprognostic (9.96e-2)"	"unprognostic (1.66e-2)"	"unprognostic (2.25e-1)"	"unprognostic (7.96e-3)"	"unprognostic (1.69e-1)"	8.8	10.7	7.7	7.3	6.8	8.0	9.7	7.1	7.5	8.9	5.9	7.2	8.2	10.2	10.0	10.1	9.8	6.9	8.3	7.0	7.5	9.2	7.8	5.5	11.9	7.0	8.1	13.4	14.6	15.0	6.1	10.4	7.6	10.6	5.6	5.3	12.3	10.1	9.7	10.5	5.7	8.2	7.9	7.7	6.9	8.3	10.3	9.1	11.4	10.0	9.7	8.1	7.9	8.2	17.7	20.1	16.9	27.8	14.5	10.4	38.5	20.9	14.7	30.7	22.6	30.8	20.8	25.0	24.4	9.2	14.2	25.3	31.5	21.2	31.3	40.3	35.1	28.3	20.7	19.5	27.9	31.6	18.0	14.2	25.7	30.4	39.8	13.4	15.7	21.6	57.2	29.5	17.7	12.1	30.9	13.9	52.9	18.1	38.0	30.2	35.4	69.0	16.4	14.9	50.8	24.4	18.4	27.9	43.1	16.9	15.7	13.9	10.6	30.7	19.3	25.0	40.8	24.0	29.0	52.0	15.4	30.4	33.0	3.5	9.7	6.9	18.9	7.9	29.9	21.2	22.8	18.3	11.6	18.7	28.8	25.0	1.9	24.8	8.8	54.1	12.5	15.0	7.7	6.8	7.1	7.5	7.0	7.5	7.0	8.1	7.6	7.9	10.3	8.2	10.9	6.4	7.9	4.2	12.9	50.2	24.1	5.9	22.8	10.1	15.6	15.1	5.5	5.7	10.8	3.7	10.4	14.9	12.2	6.7	13.7	10.5	1.5	5.8	12.8	11.5	4.2	45.3	9.5	7.3	14.0	14.4	6.1	6.2	11.4	9.6	6.4	6.6	5.4	16.8	7.2	5.1	8.2	4.4	9.0	1.0	9.9	4.8	12.4	4.7	7.3	10.4	17.5	5.0	5.0	10.2	8.1	13.9	10.9	21.3	5.5	8.9	5.6	14.6	0.0	17.5	8.5	25.7	25.5	15.5	62.1	7.9	12.0	11.9	8.3	13.2
C1orf198	"DKFZp667D152, FLJ14525, FLJ16283, FLJ38847, MGC10710"	ENSG00000119280	"Chromosome 1 open reading frame 198"	Q9H425	1	230837119-230869589	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 131.3"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 192.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	4	"basophil: 13.1"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 13.1"	"Cell line enhanced"	"Detected in all"		"fHDF/TERT166: 138.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004798	Approved		Supported	Cytosol	"Intracellular and membrane"	NA	NA		80000	"Cluster 34: Basophils - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 48: Smooth muscle cells - ECM organization"	Cytosol		"HPA004798: AB_1848722"	"unprognostic (7.44e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.17e-2)"	"unprognostic (6.61e-2)"	"unprognostic (2.33e-1)"	"unprognostic (2.64e-2)"	"unprognostic (2.46e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.65e-1)"	"unprognostic (2.32e-1)"	"unprognostic (3.75e-2)"	"unprognostic (1.46e-1)"	"prognostic unfavorable (4.50e-5)"	"unprognostic (3.53e-2)"	"unprognostic (4.95e-2)"	"unprognostic (1.38e-1)"	"unprognostic (3.77e-2)"	39.7	13.4	77.5	11.0	106.4	5.3	30.0	93.3	83.7	36.5	41.1	35.2	11.8	38.8	14.9	14.9	32.7	32.3	45.4	72.6	85.0	17.3	14.7	66.9	15.5	108.4	105.1	27.3	27.9	20.1	7.6	31.1	108.9	21.4	11.4	9.8	23.4	32.3	106.2	34.0	13.9	46.1	97.8	18.0	29.9	6.8	94.5	6.6	34.9	26.1	9.1	33.2	26.4	131.3	22.4	16.7	44.9	30.8	81.9	59.9	76.7	40.4	63.7	20.4	20.6	53.0	12.3	26.8	24.5	138.1	10.3	14.1	23.5	8.9	15.0	87.5	22.3	4.2	15.0	17.9	35.7	13.9	4.0	72.9	13.4	8.1	8.9	43.7	12.9	16.9	8.7	9.0	14.1	15.0	11.0	6.6	52.6	49.5	13.7	25.6	32.1	6.0	16.2	26.7	26.0	41.5	20.5	27.2	14.2	23.6	34.6	11.8	10.3	32.9	32.8	7.7	24.5	16.0	7.7	8.0	8.7	8.7	95.3	13.1	1.3	0.3	2.0	2.7	2.4	1.9	1.3	0.8	1.7	1.2	2.6	2.3	1.0	2.9	1.3	0.2	0.6	4.7	77.5	106.4	93.3	83.7	72.6	85.0	108.4	105.1	108.9	97.8	94.5	131.3	11.1	192.3	23.2	35.3	1.2	26.0	13.1	6.4	7.4	2.0	32.7	23.7	36.4	32.9	17.3	11.0	10.4	17.5	1.3	2.6	1.9	41.9	11.4	8.2	8.9	11.6	5.4	9.9	2.6	26.3	32.2	33.2	3.6	10.6	2.5	15.1	8.6	4.5	11.0	25.2	5.3	9.0	8.2	1.8	19.4	8.3	13.4	11.6	65.8	13.1	3.6	12.8	0.0	6.0	67.5	31.1	3.7	9.1	2.5	21.3	2.8	7.4	12.2	4.6	32.9	26.8	45.1	10.4	5.7	8.9	29.0	12.9	3.4	5.2	6.9	18.7
C1orf43	"DKFZp586G1722, NICE-3"	ENSG00000143612	"Chromosome 1 open reading frame 43"	Q9BWL3	1	154206696-154220637	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA010725	Approved		Supported	Mitochondria,Cytosol		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria	Cytosol	"HPA010725: AB_1078341"	"unprognostic (3.90e-2)"	"unprognostic (1.22e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.12e-1)"	"unprognostic (6.87e-2)"	"unprognostic (6.15e-3)"	"prognostic unfavorable (6.57e-4)"	"unprognostic (1.72e-1)"	"unprognostic (2.78e-1)"	"unprognostic (2.64e-2)"	"unprognostic (3.51e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.87e-2)"	"unprognostic (1.69e-1)"	"unprognostic (2.89e-1)"	"unprognostic (1.75e-2)"	"unprognostic (1.23e-1)"	126.7	131.9	148.0	72.6	160.4	77.3	119.7	158.9	168.6	90.5	145.1	109.3	118.4	80.7	115.3	107.7	100.5	86.7	179.7	141.7	158.3	187.7	222.0	106.3	82.0	153.0	152.6	77.1	149.7	149.6	85.7	67.6	151.6	94.9	121.2	135.7	99.1	90.2	477.6	105.8	106.1	90.6	152.4	81.6	117.2	62.0	154.2	92.0	108.7	368.2	99.0	113.9	85.7	169.3	183.5	188.4	156.5	185.1	231.1	230.7	96.2	180.2	309.4	205.0	188.4	127.7	249.8	237.9	268.1	162.9	177.5	182.4	218.5	163.3	147.2	191.1	232.1	184.9	182.6	168.1	357.9	235.4	209.6	187.1	376.6	219.8	449.7	278.6	239.9	262.6	199.1	220.1	268.4	287.5	177.4	212.1	302.3	414.8	282.3	159.8	145.8	435.9	256.0	180.6	254.8	333.5	161.1	420.8	624.9	180.8	416.6	513.5	164.4	157.9	133.6	193.3	229.7	403.5	424.1	227.6	263.4	234.4	430.9	189.9	204.8	134.3	85.9	185.4	102.4	100.3	98.7	93.3	211.5	90.0	102.8	86.8	114.9	83.3	174.6	156.2	154.3	242.7	148.0	160.4	158.9	168.6	141.7	158.3	153.0	152.6	151.6	152.4	154.2	169.3	107.2	115.4	100.8	27.1	92.1	94.2	128.4	155.3	81.4	112.6	132.9	114.4	135.8	128.7	115.4	71.7	29.2	87.2	86.8	106.1	252.4	171.5	247.1	69.6	62.1	105.4	122.0	110.0	27.3	202.0	125.1	80.2	77.5	58.1	62.1	79.5	100.6	146.9	178.9	58.9	30.8	133.9	116.0	162.5	116.1	171.8	65.0	131.5	124.5	16.9	155.4	107.0	64.9	26.2	50.5	162.8	131.6	74.9	104.1	186.1	218.3	262.1	85.7	89.5	72.3	75.8	86.6	70.7	59.2	113.9	100.6	126.1	76.7	117.4	133.6	167.5
C21orf58		ENSG00000160298	"Chromosome 21 open reading frame 58"	P58505	21	46300181-46323875	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 26.4;pituitary gland: 20.7"	"Cell type enhanced"	"Detected in many"		"Endometrial ciliated cells: 141.9;Enteroendocrine cells: 69.4;Erythroid cells: 80.2;Respiratory ciliated cells: 164.1;Spermatocytes: 80.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	4	"basophil: 4.4"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 4.4"	"Cell line enhanced"	"Detected in many"		"REH: 62.0"	"Not detected"	"Not detected"							"HPA035110, HPA035111"	Uncertain		Supported	"Nucleoplasm,Nuclear bodies"		NA	Yes			"Cluster 46: Basophils - DNA binding"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 14: REH - Unknown function"	"Cluster 49: Ciliated cells - Cilium organization"	Nucleoplasm	"Nuclear bodies"	"HPA035110: AB_10603683, HPA035111: AB_2674468"	"unprognostic (2.19e-1)"	"unprognostic (6.74e-3)"	"unprognostic (2.51e-1)"	"unprognostic (6.31e-3)"	"unprognostic (1.08e-2)"	"prognostic favorable (7.00e-4)"	"unprognostic (4.74e-3)"	"unprognostic (6.14e-2)"	"prognostic unfavorable (7.48e-4)"	"unprognostic (1.38e-1)"	"prognostic favorable (4.20e-4)"	"unprognostic (1.27e-1)"	"unprognostic (1.01e-10)"	"unprognostic (1.04e-1)"	"unprognostic (1.70e-1)"	"unprognostic (2.51e-1)"	"unprognostic (6.07e-2)"	1.5	1.7	1.9	3.6	2.4	13.1	2.0	2.6	2.3	3.5	3.0	3.2	4.7	2.0	0.7	3.9	26.4	1.0	1.3	1.8	1.9	1.5	1.7	4.8	6.3	2.8	4.6	2.6	2.5	1.2	20.7	2.0	2.0	2.9	2.6	2.5	2.3	1.5	1.7	5.3	4.4	1.3	1.8	3.4	3.5	7.1	2.5	12.8	2.1	0.7	3.8	2.1	2.7	3.2	26.0	11.6	30.2	19.0	2.9	4.0	16.7	15.7	5.7	10.8	10.5	5.4	18.6	18.6	3.8	4.4	12.5	20.3	8.1	6.7	3.2	19.9	17.8	29.9	35.2	3.1	0.7	8.6	16.6	1.7	1.4	7.7	1.9	4.0	6.8	45.4	17.4	48.1	8.9	10.6	42.7	11.6	13.0	7.2	5.7	62.0	13.6	16.6	3.4	4.8	24.7	15.4	11.7	8.3	3.7	6.4	20.5	17.1	4.7	6.6	18.4	6.6	9.6	19.3	9.3	8.8	11.6	37.1	17.4	4.4	0.2	0.6	0.4	0.1	0.2	0.1	0.5	0.6	0.0	0.9	0.9	0.7	0.3	0.3	0.1	1.0	0.8	0.5	1.9	2.4	2.6	2.3	1.8	1.9	2.8	4.6	2.0	1.8	2.5	3.2	2.1	3.2	2.6	4.2	3.1	0.9	1.6	7.0	2.8	19.5	6.2	8.8	3.0	0.0	16.6	1.8	27.1	7.7	9.4	13.9	0.0	1.7	17.3	141.9	7.7	2.3	69.4	80.2	2.7	1.0	5.9	5.9	11.7	4.5	2.5	21.4	2.2	1.5	4.0	5.0	2.5	12.8	14.2	1.6	1.9	32.5	5.3	6.2	0.0	0.0	1.3	5.9	5.2	1.5	4.2	1.2	4.1	2.6	4.8	2.0	3.0	0.7	164.1	28.2	0.0	2.6	5.5	80.8	45.3	8.5	1.4	1.4	3.7	3.9	16.8	0.9
C2CD2L	"KIAA0285, TMEM24"	ENSG00000172375	"C2CD2 like"	O14523	11	119102198-119118544	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 37.5;Distal enterocytes: 40.6;Proximal enterocytes: 33.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"HMC-1: 50.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011044, HPA075369"	Approved		Supported	"Plasma membrane"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Plasma membrane"		"HPA011044: AB_2668414, HPA075369: "	"unprognostic (3.43e-2)"	"unprognostic (2.81e-2)"	"unprognostic (1.03e-3)"	"prognostic favorable (4.92e-4)"	"unprognostic (3.18e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.25e-3)"	"unprognostic (3.37e-3)"	"unprognostic (5.28e-2)"	"unprognostic (2.09e-1)"	"unprognostic (3.99e-3)"	"unprognostic (8.19e-2)"	"prognostic unfavorable (1.75e-4)"	"unprognostic (8.02e-2)"	"unprognostic (8.32e-3)"	"unprognostic (4.10e-2)"	"unprognostic (2.60e-1)"	6.6	8.2	26.9	6.5	27.6	13.6	5.8	15.5	28.9	6.4	15.3	11.1	16.1	6.2	4.8	10.8	8.8	5.3	10.2	26.8	19.6	11.6	13.1	10.3	8.1	18.0	18.4	6.0	11.0	5.7	23.9	3.9	18.4	7.1	7.3	14.1	9.6	5.3	15.3	15.3	17.1	5.1	15.2	14.9	8.1	4.3	21.4	8.5	6.7	7.3	5.7	7.0	6.6	23.7	6.1	4.5	6.0	12.5	7.7	3.2	3.9	9.0	7.8	8.7	7.2	7.3	6.3	9.1	23.1	6.3	9.1	13.4	7.6	3.9	3.4	14.3	6.2	35.7	5.9	5.3	10.2	10.5	50.5	3.7	7.9	16.4	6.1	9.8	5.4	13.5	15.1	16.1	8.3	16.2	11.9	24.9	2.2	15.0	11.8	7.4	5.3	10.5	8.7	3.8	18.7	10.5	3.8	20.1	5.9	2.3	35.3	13.9	6.7	8.1	2.8	9.9	16.1	6.8	4.5	3.5	4.9	17.6	9.1	0.5	1.3	2.7	0.2	1.4	0.4	0.1	0.6	0.6	0.5	0.0	0.6	0.3	0.4	0.8	2.0	0.3	0.6	0.5	26.9	27.6	15.5	28.9	26.8	19.6	18.0	18.4	18.4	15.2	21.4	23.7	5.1	6.4	4.2	9.4	3.7	10.7	1.6	2.3	10.2	15.6	6.8	5.0	2.4	2.8	4.3	1.8	37.5	0.9	7.4	40.6	3.9	3.4	5.4	12.1	2.6	5.7	1.2	7.0	15.1	2.8	1.7	2.5	3.6	4.6	2.5	2.2	11.4	5.4	9.4	21.9	15.0	8.0	0.0	13.9	16.1	1.3	2.1	11.4	7.2	5.6	15.3	5.9	7.2	4.5	8.4	5.1	10.4	1.5	7.2	3.2	33.0	4.0	21.9	29.9	6.6	2.1	3.6	3.7	2.0	10.3	10.9	1.1	8.6	3.6	5.5	1.9
C2CD3	DKFZP586P0123	ENSG00000168014	"C2 domain containing 3 centriole elongation regulator"	Q4AC94	11	74012718-74171210	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cilium biogenesis/degradation"		"Ciliopathy, Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 70.5;Alveolar cells type 2: 114.6;Excitatory neurons: 57.4;Respiratory ciliated cells: 57.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 17.8"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RH-30: 60.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038552, HPA038553, HPA040433"	Approved		Approved	Nucleoplasm,Centrosome		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 11: Alveolar cells - Smell perception"	"Nucleoplasm, Centrosome"		"HPA038552: AB_10669542, HPA038553: AB_2676080, HPA040433: AB_2676981"	"unprognostic (3.94e-1)"	"unprognostic (7.89e-2)"	"unprognostic (3.68e-2)"	"unprognostic (8.86e-3)"	"unprognostic (1.31e-1)"	"unprognostic (1.18e-1)"	"unprognostic (8.48e-5)"	"unprognostic (1.99e-1)"	"unprognostic (4.96e-3)"	"unprognostic (2.20e-1)"	"unprognostic (1.74e-1)"	"unprognostic (5.86e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.91e-1)"	"unprognostic (3.11e-1)"	"unprognostic (1.18e-1)"	"unprognostic (2.92e-1)"	3.9	4.7	15.4	5.1	14.8	9.9	3.7	21.7	22.9	4.2	16.7	4.0	3.9	4.8	4.5	3.9	7.8	3.7	2.9	18.5	14.4	4.9	5.8	4.2	5.0	16.9	13.8	4.7	2.2	6.2	3.7	5.9	15.3	4.3	5.2	8.2	4.3	3.5	3.5	6.0	4.2	4.2	11.2	5.9	4.3	11.0	15.8	7.7	7.0	3.4	5.4	3.9	2.7	19.4	9.3	14.3	11.7	14.3	5.2	4.8	5.6	13.7	8.8	16.0	13.0	24.4	7.4	9.0	9.2	5.2	15.5	13.9	14.7	3.8	19.3	12.4	7.0	12.4	21.3	10.8	8.8	12.0	16.9	4.8	4.8	13.4	9.7	5.1	9.0	11.1	14.2	15.7	13.3	7.7	14.1	8.3	9.4	17.8	7.7	14.3	60.4	9.0	4.6	13.0	15.6	9.2	22.4	8.4	21.2	11.9	16.5	7.8	12.7	10.3	17.0	10.1	11.0	11.7	8.5	26.1	4.0	6.0	11.1	17.8	2.0	3.0	2.2	2.3	2.0	2.3	1.4	1.8	1.3	4.4	2.1	2.1	12.6	2.9	4.7	2.0	1.0	0.7	15.4	14.8	21.7	22.9	18.5	14.4	16.9	13.8	15.3	11.2	15.8	19.4	6.5	70.5	114.6	28.1	10.5	5.2	3.6	4.8	9.6	8.7	6.2	5.8	5.1	4.3	36.0	9.2	4.2	3.8	5.6	7.6	0.0	4.0	33.0	18.4	9.4	9.8	7.7	12.2	57.4	2.6	2.9	9.6	15.3	8.9	36.6	8.5	5.0	3.0	5.0	11.8	52.1	5.0	4.1	7.6	6.6	24.7	4.4	12.7	7.2	26.2	4.9	4.8	10.3	37.7	38.5	3.8	2.8	6.4	9.5	3.4	3.4	1.8	57.1	14.8	6.6	7.2	5.2	11.1	6.9	6.4	4.5	2.3	14.0	5.4	5.4	4.7
C2CD4A	"FAM148A, NLF1"	ENSG00000198535	"C2 calcium dependent domain containing 4A"	Q8NCU7	15	62066977-62070917	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"kidney: 5.1;pituitary gland: 13.5"	"Cell type enriched"	"Detected in many"	5	"Glandular and luminal cells: 107.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	19	"OE19: 34.4;RPTEC TERT1: 29.9"									HPA078864			Supported	Nucleoplasm,Nucleoli		NA	NA				"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 21: OE19 - Mitochondria"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm	Nucleoli	"HPA078864: "	"unprognostic (3.85e-2)"	"unprognostic (6.68e-2)"	"unprognostic (5.00e-3)"	"unprognostic (1.73e-1)"	"unprognostic (1.32e-1)"	"unprognostic (5.38e-3)"	"unprognostic (5.49e-3)"	"unprognostic (3.85e-1)"	"unprognostic (1.67e-1)"	"unprognostic (9.21e-2)"	"unprognostic (3.89e-2)"	"unprognostic (2.99e-1)"	"prognostic unfavorable (4.15e-4)"	"unprognostic (4.72e-2)"	"unprognostic (2.07e-2)"	"unprognostic (6.26e-2)"	"unprognostic (3.35e-1)"	0.2	0.4	0.2	0.6	0.2	0.2	0.2	0.2	2.2	0.7	0.3	0.5	1.0	1.3	0.0	0.1	0.0	0.4	0.1	0.2	2.5	5.1	2.4	0.5	0.2	1.0	0.8	0.1	4.0	0.0	13.5	0.1	0.7	0.6	0.6	0.2	1.2	0.1	0.3	0.5	0.5	0.0	0.1	0.1	2.0	0.1	0.3	2.1	0.1	0.0	0.5	3.6	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.1	1.6	0.0	0.0	0.2	1.1	0.0	0.0	0.0	0.4	0.1	0.2	0.3	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.1	0.1	0.2	0.0	0.2	0.0	0.1	0.0	0.1	0.1	34.4	0.2	0.1	0.0	0.2	29.9	0.7	1.3	0.0	0.1	0.3	0.0	0.0	0.2	0.1	0.1	0.1	0.2	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.1	0.0	0.1	0.2	0.0	0.2	0.2	0.2	2.2	0.2	2.5	1.0	0.8	0.7	0.1	0.3	0.1	0.6	0.0	0.0	0.3	0.3	0.5	1.8	3.8	0.0	0.9	4.3	6.2	1.4	0.0	2.7	0.0	0.0	0.0	0.0	1.2	1.9	2.8	0.0	11.7	14.6	3.9	20.8	0.0	0.0	6.6	0.0	1.2	3.6	107.1	0.0	0.0	0.0	0.0	0.1	0.0	0.2	5.2	14.2	0.0	0.8	0.0	0.0	0.8	0.0	0.0	1.0	0.3	0.0	0.0	0.0	3.7	0.0	0.0	0.8	2.2	0.3	0.0	1.1	0.2	0.0	1.0	1.4	0.0	0.0	0.0	1.1	0.0	1.1	0.1	1.0	1.1
C2CD5	"CDP138, KIAA0528"	ENSG00000111731	"C2 calcium dependent domain containing 5"	Q86YS7	12	22448583-22544546	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 244.6;Inhibitory neurons: 253.4;Oligodendrocyte precursor cells: 149.3;Oligodendrocytes: 103.0"	"Cancer enriched"	"Detected in all"	5	"testis cancer: 39.0"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046194	Approved		Supported	"Centriolar satellite,Cytosol"		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Cytosol	"Centriolar satellite"	"HPA046194: AB_10965327"	"unprognostic (2.59e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.23e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.97e-3)"	"unprognostic (1.08e-3)"	"unprognostic (1.17e-2)"	"unprognostic (8.47e-2)"	"unprognostic (1.71e-1)"	"unprognostic (2.69e-2)"	"unprognostic (2.50e-2)"	"unprognostic (1.51e-2)"	"unprognostic (3.81e-2)"	"unprognostic (2.19e-1)"	"unprognostic (2.05e-1)"	"unprognostic (1.87e-3)"	13.3	15.9	14.4	17.1	17.5	20.2	19.6	32.1	22.6	17.8	3.6	27.3	26.4	22.4	17.2	13.5	22.1	22.5	11.7	16.0	9.2	22.3	12.0	16.7	22.7	10.1	7.4	24.0	16.7	28.0	20.8	14.1	11.7	14.5	28.5	56.2	15.5	13.8	10.1	17.6	22.3	18.3	4.4	19.2	27.8	20.0	7.7	26.9	22.3	16.3	21.8	13.0	13.8	18.8	18.6	18.0	39.2	21.4	25.3	33.4	24.9	20.1	21.4	36.6	43.3	19.9	24.0	20.9	8.7	18.9	20.4	16.2	25.2	16.4	50.7	34.2	26.3	25.9	19.8	17.9	23.3	35.4	29.9	19.3	11.7	23.6	41.1	34.6	26.9	28.5	17.2	13.2	23.9	19.8	33.5	53.9	78.3	36.0	13.5	28.9	43.3	28.5	21.7	14.9	18.1	15.7	18.1	17.5	19.3	57.5	23.2	23.4	23.4	21.9	17.5	19.9	21.5	10.6	8.8	33.4	13.5	26.4	16.4	23.2	6.7	3.3	5.6	14.9	7.6	7.6	8.4	5.6	6.8	5.1	7.3	5.9	6.9	14.2	17.1	3.9	9.1	4.9	14.4	17.5	32.1	22.6	16.0	9.2	10.1	7.4	11.7	4.4	7.7	18.8	12.4	9.6	19.6	41.1	14.8	6.9	4.3	4.1	10.2	30.4	8.0	6.6	16.2	14.3	16.3	5.5	52.1	3.9	13.6	16.9	5.9	3.5	72.2	14.3	13.2	11.2	16.2	17.1	244.6	4.6	2.6	11.5	30.1	11.7	17.7	18.8	16.8	6.7	8.3	18.5	253.4	20.4	6.1	33.8	6.7	17.6	8.7	17.3	7.2	84.3	9.1	6.4	10.3	149.3	103.0	3.4	11.4	7.9	12.0	3.9	13.6	6.4	17.4	42.9	6.6	12.0	11.7	14.1	7.8	13.3	5.5	2.6	11.5	9.4	16.5	4.6
C2orf49	"asw, MGC5509"	ENSG00000135974	"Chromosome 2 open reading frame 49"	Q9BVC5	2	105337532-105349211	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043846, HPA060814"	Approved		Supported	Nucleoplasm,Mitochondria		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	Mitochondria	"HPA043846: AB_2678698, HPA060814: AB_2684372"	"unprognostic (4.19e-2)"	"unprognostic (1.49e-1)"	"unprognostic (3.06e-1)"	"unprognostic (6.16e-3)"	"unprognostic (2.57e-3)"	"unprognostic (8.75e-3)"	"unprognostic (1.89e-3)"	"unprognostic (6.51e-2)"	"unprognostic (5.01e-2)"	"unprognostic (2.07e-1)"	"unprognostic (2.56e-1)"	"unprognostic (5.94e-2)"	"prognostic unfavorable (5.06e-5)"	"unprognostic (1.22e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.39e-1)"	"unprognostic (6.04e-2)"	11.3	9.3	9.6	10.6	11.9	19.3	11.1	12.0	12.9	12.5	6.2	9.1	9.4	14.6	7.8	11.8	12.4	9.5	15.3	8.9	10.7	8.7	10.1	8.6	12.6	11.2	11.5	19.9	11.0	10.5	5.5	12.0	11.3	11.3	9.9	24.9	9.1	11.0	19.9	9.5	10.1	12.2	10.2	11.1	13.8	13.0	10.6	16.0	12.6	21.0	13.3	11.3	10.5	13.8	20.0	13.9	17.2	17.5	19.4	23.6	30.7	19.6	20.6	17.0	23.3	30.7	19.5	23.3	23.9	17.1	45.6	18.7	23.9	16.7	22.2	30.6	18.1	25.3	11.6	23.8	23.6	21.3	20.1	17.1	28.7	24.0	21.6	24.3	15.8	18.1	35.9	18.7	24.3	15.4	25.9	24.5	22.6	13.5	16.8	17.1	25.4	27.1	19.2	18.9	20.3	16.2	17.3	15.5	23.8	19.2	15.2	23.8	25.4	17.9	25.1	13.0	16.1	23.6	20.5	24.6	18.1	21.3	17.6	15.4	13.2	12.0	9.0	8.3	8.9	14.5	10.1	9.0	9.2	17.6	11.0	9.3	17.8	9.2	11.9	19.1	12.7	6.7	9.6	11.9	12.0	12.9	8.9	10.7	11.2	11.5	11.3	10.2	10.6	13.8	27.0	16.0	14.3	7.5	26.3	29.1	13.4	21.8	15.4	37.1	24.8	22.9	30.9	18.6	22.0	25.8	29.2	21.2	31.6	16.5	25.4	22.9	40.6	43.1	34.7	19.3	11.3	21.2	10.8	18.2	26.5	22.8	12.8	33.9	16.5	18.1	19.6	22.4	16.1	23.5	11.2	22.5	12.2	18.5	13.5	35.8	27.7	15.5	7.2	10.3	21.1	39.6	28.8	7.1	15.8	21.0	17.5	29.0	19.0	16.2	21.8	22.3	36.1	44.3	19.7	17.3	19.8	45.8	28.1	13.7	24.7	36.8	22.4	16.6	14.8	15.8
C4orf19	FLJ11017	ENSG00000154274	"Chromosome 4 open reading frame 19"	Q8IY42	4	37453925-37623495	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 36.0"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 45.4;Distal enterocytes: 61.3;Exocrine glandular cells: 51.8;Oligodendrocyte precursor cells: 46.8;Pancreatic endocrine cells: 53.6;Paneth cells: 67.2;Proximal enterocytes: 52.3;Syncytiotrophoblasts: 47.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"neutrophil: 8.6"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 8.6"	"Group enriched"	"Detected in some"	5	"OE19: 64.6;RT4: 81.0;SK-BR-3: 32.6;T-47d: 113.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043458, HPA052894"	Enhanced		Supported	"Cell Junctions"		No	No			"Cluster 1: Neutrophils - Mixed function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 6: T47d - Mammary gland"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Cell Junctions"		"HPA043458: AB_10960696, HPA052894: AB_2681982"	"unprognostic (8.83e-2)"	"unprognostic (7.86e-2)"	"unprognostic (3.00e-3)"	"unprognostic (2.04e-2)"	"unprognostic (2.23e-1)"	"unprognostic (3.59e-3)"	"unprognostic (5.55e-2)"	"unprognostic (2.29e-1)"	"unprognostic (6.66e-2)"	"unprognostic (9.96e-2)"	"unprognostic (1.35e-1)"	"unprognostic (4.38e-2)"	"prognostic favorable (1.49e-11)"	"unprognostic (1.33e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.63e-3)"	"unprognostic (8.19e-3)"	3.4	0.3	2.7	3.0	2.9	3.8	3.8	5.3	4.3	10.2	5.9	25.5	17.7	6.7	0.2	2.1	2.8	9.2	0.4	3.5	4.2	12.4	36.0	3.7	0.5	4.9	4.9	0.2	24.9	16.0	1.2	7.6	4.2	1.7	23.7	4.6	28.2	6.8	0.2	1.6	19.6	4.0	4.5	0.3	20.7	1.4	4.9	0.2	1.5	0.4	4.3	8.8	2.9	4.1	0.1	0.2	3.2	0.3	0.0	0.0	4.2	0.7	0.0	0.0	0.0	12.6	5.2	0.1	3.0	0.0	0.1	0.4	0.2	0.8	0.1	0.0	0.4	0.0	8.3	0.1	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.2	0.1	14.3	0.2	0.2	0.5	64.6	1.7	0.1	7.8	0.2	12.7	81.0	0.9	0.3	0.5	32.6	1.0	4.0	113.1	0.7	0.6	0.4	4.5	0.2	1.6	0.2	0.1	0.5	0.0	6.9	5.6	0.9	1.4	2.1	0.6	0.2	0.4	0.2	0.3	0.4	0.2	0.5	0.5	0.8	8.6	0.8	0.1	1.6	0.7	0.3	2.7	2.9	5.3	4.3	3.5	4.2	4.9	4.9	4.2	4.5	4.9	4.1	0.3	0.0	12.6	45.4	0.7	0.3	7.8	4.9	0.0	0.6	7.1	3.9	0.2	27.1	10.1	11.0	0.0	6.7	0.2	61.3	11.7	25.2	1.2	9.5	0.4	0.9	9.6	0.0	2.3	51.8	4.7	0.3	33.6	5.5	0.0	0.0	0.0	13.1	0.7	0.0	2.4	28.0	4.1	0.0	0.3	2.4	0.0	0.2	3.6	22.5	0.6	5.3	0.0	46.8	1.8	53.6	67.2	0.0	0.0	7.8	52.3	9.2	12.3	1.0	0.0	0.2	0.9	0.3	0.2	0.5	0.0	47.5	0.4	0.1	31.8	19.1
C5AR1	"C5A, C5AR, C5R1, CD88"	ENSG00000197405	"Complement C5a receptor 1"	P21730	19	47290023-47322066	"CD markers, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Chemotaxis	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 125.5;lymphoid tissue: 84.8"	"Group enriched"	"Detected in many"	4	"Hofbauer cells: 130.9;Kupffer cells: 228.3;Langerhans cells: 122.4;Macrophages: 446.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 394.0"	"Group enriched"	"Detected in many"	42	"granulocytes: 394.0;monocytes: 115.9"	"Cell line enhanced"	"Detected in some"		"A549: 3.9;CAPAN-2: 4.1;HMC-1: 4.7;U-87 MG: 6.2;U-937: 6.5"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"CAB002720, HPA014520, HPA048012"	Approved		Approved	"Golgi apparatus,Vesicles"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 32: U-937 - Innate immune response"	"Cluster 41: Macrophages - Immune response"	"Golgi apparatus"	Vesicles	"CAB002720: , HPA014520: AB_1846337, HPA048012: "	"unprognostic (5.95e-2)"	"prognostic favorable (4.71e-4)"	"unprognostic (1.70e-2)"	"unprognostic (1.25e-1)"	"unprognostic (4.08e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.80e-2)"	"unprognostic (4.41e-2)"	"unprognostic (5.45e-2)"	"prognostic unfavorable (9.55e-4)"	"unprognostic (2.02e-1)"	"unprognostic (9.56e-2)"	"prognostic unfavorable (1.16e-4)"	"unprognostic (1.96e-3)"	"prognostic unfavorable (7.99e-4)"	"unprognostic (1.82e-2)"	"unprognostic (6.54e-2)"	72.7	18.2	3.3	84.8	3.1	125.5	8.5	2.4	9.0	11.8	21.6	9.8	2.5	7.5	1.4	8.3	23.9	38.8	11.7	3.9	8.2	9.7	18.0	43.1	11.5	8.9	6.9	5.0	8.9	4.8	51.8	31.8	8.4	5.3	4.2	4.4	5.1	2.5	1.9	2.3	5.8	28.1	5.7	38.2	7.2	2.6	10.5	7.1	3.6	5.8	4.3	37.1	4.6	11.6	1.0	3.9	0.1	0.1	0.7	0.2	0.6	0.7	0.5	0.2	0.1	0.2	4.1	0.3	0.7	0.9	0.4	1.4	0.2	0.5	0.2	0.7	0.5	0.1	3.8	0.6	0.4	1.5	4.7	0.3	2.2	0.4	0.3	0.6	0.0	0.2	0.2	1.7	0.1	1.1	0.2	2.5	1.2	0.2	0.3	0.2	0.1	0.3	1.3	0.9	0.0	0.0	0.3	0.3	0.6	0.5	0.2	2.2	0.0	0.1	2.1	0.3	0.1	0.2	0.3	0.3	6.2	6.5	0.2	41.6	53.8	38.8	0.4	80.4	0.3	0.4	0.3	0.2	6.1	0.6	0.3	0.3	394.0	0.5	115.9	1.1	0.3	19.3	3.3	3.1	2.4	9.0	3.9	8.2	8.9	6.9	8.4	5.7	10.5	11.6	4.4	3.2	20.8	0.0	5.1	5.1	1.0	3.4	2.8	1.0	2.1	4.4	2.9	1.5	15.3	1.8	2.1	0.8	1.5	1.6	3.9	0.0	1.3	17.3	1.8	6.3	0.0	0.4	1.5	0.0	1.5	5.3	1.1	4.6	25.2	0.1	2.9	8.3	130.9	0.0	0.6	0.8	4.1	228.3	122.4	1.3	0.6	446.7	5.4	5.6	56.3	0.2	0.0	1.0	0.3	0.1	0.1	0.0	4.9	0.5	0.7	1.3	40.7	4.3	13.1	4.1	2.8	0.5	0.9	1.4	3.0	1.5	3.3	0.0	1.3	0.5
C5orf24	FLJ37562	ENSG00000181904	"Chromosome 5 open reading frame 24"	Q7Z6I8	5	134845680-134859735	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA057749, HPA062502"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 81: Kidney & Liver - Metabolism"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Nucleoplasm		"HPA057749: AB_2683515, HPA062502: AB_2684785"	"unprognostic (8.10e-2)"	"unprognostic (1.59e-1)"	"unprognostic (8.33e-3)"	"unprognostic (2.03e-1)"	"unprognostic (2.72e-2)"	"unprognostic (9.45e-2)"	"unprognostic (3.27e-2)"	"unprognostic (3.31e-2)"	"unprognostic (1.72e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.54e-2)"	"unprognostic (1.82e-1)"	"prognostic unfavorable (5.86e-4)"	"unprognostic (6.55e-2)"	"unprognostic (2.37e-1)"	"unprognostic (5.04e-2)"	"unprognostic (4.75e-2)"	24.1	25.9	17.3	17.8	20.7	24.9	20.2	26.3	31.2	20.2	16.2	21.2	22.1	28.9	15.8	21.0	17.5	21.3	19.5	18.4	18.3	41.0	43.2	22.9	16.3	19.5	18.7	20.0	13.2	26.8	15.4	28.6	18.9	21.5	18.4	19.3	18.3	18.3	21.5	19.1	17.1	26.7	19.8	16.7	16.1	12.4	18.7	15.0	29.8	26.6	14.6	22.1	16.8	23.4	26.0	21.5	43.8	63.7	53.0	62.3	15.7	54.7	38.5	29.6	35.3	28.7	29.0	24.0	46.4	39.1	37.6	17.3	25.0	37.9	51.3	18.0	35.3	27.1	50.4	33.9	40.1	11.8	30.8	51.6	45.0	42.9	48.9	59.5	55.2	39.5	19.0	29.1	64.7	14.8	26.0	20.4	9.8	16.1	21.8	29.4	41.6	27.4	75.4	23.9	27.0	51.5	56.7	15.0	82.2	19.4	30.8	38.1	61.4	59.4	25.7	43.8	39.5	30.3	23.2	30.3	43.6	33.2	44.9	4.5	9.0	9.6	5.5	6.9	4.4	6.7	3.7	4.5	7.8	6.4	6.9	4.3	1.7	5.5	5.7	10.5	4.9	4.2	17.3	20.7	26.3	31.2	18.4	18.3	19.5	18.7	18.9	19.8	18.7	23.4	71.8	86.6	34.1	21.2	44.1	43.1	34.7	50.0	56.9	47.2	64.3	56.8	33.2	64.3	34.8	106.7	37.5	33.4	45.9	26.4	58.7	52.0	18.6	33.0	85.6	83.6	53.9	45.0	31.1	43.7	35.4	60.1	27.0	48.2	21.5	48.0	78.1	94.4	32.2	69.0	33.9	32.4	28.5	33.6	47.9	10.8	70.5	33.3	64.0	22.5	40.3	28.2	68.0	22.6	44.3	83.9	34.7	71.5	32.3	44.7	42.4	132.8	29.1	45.9	72.3	61.3	88.0	66.9	44.6	67.8	49.3	22.2	37.6	34.6	35.0	25.0
C5orf51	LOC285636	ENSG00000205765	"Chromosome 5 open reading frame 51"	A6NDU8	5	41904188-41921636	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 34.3"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043779, HPA063816"	Uncertain		Enhanced	Nucleoplasm,Cytosol		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 68: Epididymis - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm	Cytosol	"HPA043779: AB_2678666, HPA063816: AB_2685130"	"unprognostic (6.64e-2)"	"unprognostic (2.24e-2)"	"unprognostic (9.92e-2)"	"unprognostic (6.92e-3)"	"unprognostic (3.93e-2)"	"unprognostic (3.41e-2)"	"prognostic unfavorable (1.90e-4)"	"unprognostic (4.98e-2)"	"unprognostic (1.59e-1)"	"unprognostic (4.90e-3)"	"unprognostic (2.10e-2)"	"unprognostic (4.58e-2)"	"unprognostic (1.01e-1)"	"unprognostic (3.97e-1)"	"unprognostic (3.75e-1)"	"unprognostic (2.30e-2)"	"unprognostic (1.67e-2)"	11.0	8.7	10.4	9.8	13.2	2.7	11.5	12.6	14.3	9.9	6.0	8.0	7.8	10.2	15.3	10.8	7.9	8.8	9.6	10.1	12.3	10.9	10.4	7.9	10.5	12.4	12.4	15.5	8.8	15.3	5.0	12.9	12.4	11.5	9.0	15.6	8.9	10.5	4.5	9.1	7.8	12.2	12.0	9.8	7.5	7.1	12.0	15.9	13.7	7.5	10.6	10.5	7.4	16.7	14.8	11.2	22.3	46.9	44.7	35.0	24.3	17.1	29.6	23.7	25.2	11.3	14.9	15.9	20.7	19.2	41.3	9.4	29.8	16.2	34.2	21.4	9.1	15.4	33.0	17.0	54.0	19.8	11.2	34.2	23.0	27.9	31.9	15.1	20.8	19.0	27.8	26.5	25.4	15.5	18.7	20.2	22.4	9.0	6.0	16.2	31.0	24.7	15.9	14.1	13.5	21.2	54.9	25.9	29.0	19.9	28.9	20.0	15.1	28.0	16.7	21.5	16.8	13.3	23.2	15.7	31.2	34.1	20.4	34.3	8.0	7.8	4.9	6.2	6.4	5.6	5.7	5.4	7.8	5.8	7.6	5.2	5.3	6.5	9.2	4.5	4.4	9.8	10.4	13.2	12.6	14.3	10.1	12.3	12.4	12.4	12.4	12.0	12.0	16.7	13.3	32.1	11.5	12.7	16.6	9.9	8.7	10.4	21.6	11.5	13.9	12.4	14.5	8.6	9.5	14.7	6.2	12.5	10.4	7.1	9.8	12.0	13.1	8.1	14.4	11.9	10.8	14.1	11.8	7.6	12.4	19.2	11.2	10.0	5.1	10.3	10.4	20.2	15.0	8.4	13.8	9.1	6.1	17.6	7.9	11.8	9.0	13.0	7.2	4.7	13.8	18.6	10.3	16.6	20.9	8.1	7.3	7.9	11.0	11.6	5.7	12.8	9.6	11.2	13.1	12.8	16.5	9.0	8.3	30.1	13.2	16.8	10.6	9.0	7.1	9.9
C7orf25	MGC2821	ENSG00000136197	"Chromosome 7 open reading frame 25"	Q9BPX7	7	42908726-42912305	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Collecting duct cells: 3.7;Cone photoreceptor cells: 4.2;Excitatory neurons: 4.6;Inhibitory neurons: 4.7;Oligodendrocytes: 7.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 36.6"	"Lineage enriched"	"Detected in all"	15	"granulocytes: 36.6"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020120, HPA049635"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 21: Non-specific - Transcription"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 51: Myeloid cells - Hemostasis"	Nucleoplasm	Cytosol	"HPA020120: AB_1845755, HPA049635: AB_2680837"	"unprognostic (6.29e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.56e-2)"	"unprognostic (4.83e-2)"	"unprognostic (1.13e-3)"	"unprognostic (2.23e-2)"	"unprognostic (5.23e-2)"	"unprognostic (3.29e-1)"	"unprognostic (1.66e-2)"	"unprognostic (1.73e-1)"	"unprognostic (5.25e-2)"	"unprognostic (2.34e-1)"	"unprognostic (1.26e-2)"	"unprognostic (1.26e-1)"	"unprognostic (2.66e-1)"	"unprognostic (3.87e-2)"	"unprognostic (3.05e-3)"	1.5	1.6	2.4	0.6	2.9	0.7	2.0	2.6	4.5	1.6	1.7	1.6	0.5	1.7	3.2	1.6	2.0	1.9	2.1	2.8	3.2	2.7	1.6	1.5	1.6	3.4	3.0	2.2	1.7	3.1	1.4	2.0	3.5	2.6	1.0	1.9	1.6	2.8	1.7	1.4	1.2	1.9	1.9	1.8	1.9	3.7	2.7	1.6	2.7	1.9	1.2	1.2	0.9	4.5	2.7	8.5	2.2	3.7	2.9	2.0	2.5	5.9	2.0	3.4	3.0	4.9	3.9	7.4	3.7	5.2	4.3	4.1	1.7	5.0	4.2	3.3	7.3	4.0	8.2	3.2	6.2	3.2	2.2	2.9	3.4	3.3	3.3	1.4	2.6	4.8	5.0	1.5	3.3	6.1	1.7	2.5	3.0	1.7	9.8	1.7	2.8	3.7	2.1	6.9	2.8	3.9	8.3	2.9	2.7	3.3	3.3	2.1	7.3	3.6	3.8	4.3	3.3	4.0	9.1	2.2	3.7	3.5	8.3	36.6	1.6	15.7	1.5	2.0	2.3	2.2	1.0	1.5	1.0	1.6	1.6	1.7	8.8	2.2	2.3	0.8	0.8	1.1	2.4	2.9	2.6	4.5	2.8	3.2	3.4	3.0	3.5	1.9	2.7	4.5	0.4	0.0	1.1	2.3	0.7	0.3	0.4	0.1	0.6	0.9	0.4	0.5	0.6	0.0	0.1	3.7	4.2	0.7	0.3	0.1	1.9	0.9	0.1	0.4	0.6	0.7	0.0	0.4	4.6	1.1	0.4	0.6	0.0	0.2	0.0	0.6	1.1	0.5	0.2	0.0	4.7	0.2	0.0	0.0	0.4	0.3	0.6	1.2	0.0	2.8	0.3	0.7	2.1	3.0	7.9	0.9	0.3	0.7	0.2	0.3	0.7	1.5	1.0	0.4	0.0	0.3	0.8	1.7	1.3	0.4	0.4	0.8	0.5	1.0	0.2	0.1
C8orf34	"vest-1, VEST1"	ENSG00000165084	"Chromosome 8 open reading frame 34"	Q49A92	8	68330955-68819023	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 10.2;fallopian tube: 9.1;parathyroid gland: 7.4"	"Cell type enriched"	"Detected in some"	5	"Inhibitory neurons: 396.6"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 2.3;HEK 293: 2.3;LHCN-M2: 2.7;RH-30: 2.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044420, HPA053065"	Uncertain		Supported	"Nucleoplasm,Nucleoli,Golgi apparatus"		No	NA				"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Nucleoplasm, Nucleoli"	"Golgi apparatus"	"HPA044420: AB_10963791, HPA053065: AB_2682030"	"unprognostic (1.75e-1)"	"unprognostic (2.20e-1)"	"unprognostic (3.30e-2)"	"unprognostic (5.59e-3)"	"unprognostic (3.07e-1)"	"unprognostic (2.85e-2)"	"unprognostic (3.35e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.80e-1)"	"unprognostic (1.74e-1)"	"unprognostic (8.55e-2)"	"unprognostic (5.86e-2)"	"unprognostic (1.80e-4)"	"unprognostic (5.21e-2)"	"unprognostic (8.87e-2)"	"unprognostic (2.84e-4)"	"unprognostic (1.33e-1)"	2.7	0.3	4.0	0.2	5.4	0.5	0.7	3.6	3.9	2.1	2.0	0.2	0.2	0.6	0.6	1.0	9.1	0.6	0.7	6.2	3.8	0.4	0.2	2.5	0.2	6.4	10.2	0.4	1.1	7.4	1.7	0.3	4.6	2.1	0.3	1.0	0.6	1.0	0.3	0.9	0.2	0.1	4.0	0.2	0.8	0.7	6.7	0.8	0.4	0.9	0.2	0.4	0.2	6.1	0.1	0.0	0.3	0.1	0.6	1.0	0.1	0.9	2.3	0.3	0.3	0.1	0.2	0.1	0.3	0.5	0.1	0.1	0.1	0.3	0.1	0.0	2.3	0.3	0.5	0.2	0.1	0.0	0.2	0.1	0.3	0.4	0.8	0.1	0.0	0.3	0.1	0.4	2.7	0.3	0.0	0.2	1.0	0.0	0.0	0.1	2.7	0.0	0.2	0.2	0.5	0.0	0.1	0.1	0.0	0.2	1.4	0.1	0.0	0.4	0.2	1.6	0.0	0.4	0.0	0.0	0.1	0.1	0.4	0.5	0.1	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.0	0.3	0.2	0.3	0.5	0.2	0.1	0.4	0.1	0.1	4.0	5.4	3.6	3.9	6.2	3.8	6.4	10.2	4.6	4.0	6.7	6.1	0.2	16.0	18.7	9.4	0.0	1.7	0.8	0.2	0.0	1.5	0.2	0.0	1.2	0.0	3.9	0.0	0.0	0.5	0.1	0.0	0.0	0.3	0.5	26.4	0.7	0.5	0.0	0.0	79.2	0.0	0.3	1.9	0.0	4.3	1.3	0.1	0.0	0.0	0.3	0.0	396.6	0.1	0.0	0.0	1.2	1.3	0.3	0.4	1.8	3.7	0.1	0.0	0.0	9.5	10.1	0.5	0.0	0.4	0.0	0.8	0.0	0.0	20.8	0.7	0.0	0.6	1.7	0.6	0.4	0.1	0.9	0.4	0.4	0.2	0.0	0.4
C9orf72	"DENND9, DENNL72, MGC23980"	ENSG00000147894	"C9orf72-SMCR8 complex subunit"	Q96LT7	9	27535640-27573866	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	Autophagy	"Guanine-nucleotide releasing factor"	"Amyotrophic lateral sclerosis, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Langerhans cells: 127.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	7	"basophil: 24.3;classical monocyte: 32.0;intermediate monocyte: 44.7;myeloid DC: 25.2;neutrophil: 34.3;non-classical monocyte: 36.9"	"Group enriched"	"Detected in all"	8	"dendritic cells: 25.2;granulocytes: 34.3;monocytes: 44.7"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023873	Uncertain		Supported	"Vesicles,Midbody ring,Cytosol"	"Intracellular and membrane"	Yes	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 12: NES - Nervous system development"	"Cluster 41: Macrophages - Immune response"	"Vesicles, Cytosol"	"Midbody ring"	"HPA023873: AB_1845834"	"unprognostic (1.78e-2)"	"unprognostic (5.01e-2)"	"unprognostic (7.63e-2)"	"unprognostic (9.78e-3)"	"unprognostic (1.46e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.99e-3)"	"unprognostic (2.45e-1)"	"unprognostic (2.05e-2)"	"unprognostic (2.16e-2)"	"unprognostic (9.81e-2)"	"unprognostic (1.44e-2)"	"unprognostic (9.29e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.89e-2)"	"unprognostic (9.13e-2)"	11.7	12.1	9.5	16.6	9.5	25.3	9.4	21.0	12.5	9.8	12.4	8.8	6.8	12.0	11.3	7.6	16.0	10.2	9.3	9.7	13.5	7.0	16.0	17.7	9.2	14.6	11.9	24.2	9.6	6.9	16.2	12.1	12.5	14.2	7.8	31.3	6.7	5.8	14.9	8.8	8.3	8.6	12.4	16.8	7.8	17.6	11.3	11.1	13.1	9.9	8.8	9.2	8.5	14.5	4.4	3.7	28.7	4.4	5.7	7.0	4.4	5.9	4.9	3.5	1.8	0.4	1.4	10.2	3.7	5.3	7.5	3.1	9.4	7.2	2.5	19.8	3.6	4.9	11.0	3.0	8.9	3.4	5.2	7.3	8.6	0.8	16.1	3.5	7.6	11.1	9.8	18.6	4.3	0.8	6.6	5.0	14.2	6.8	16.0	2.4	9.5	5.1	2.8	3.3	9.9	24.4	4.0	4.4	3.7	10.9	3.7	2.9	6.6	0.0	14.5	8.6	4.0	4.8	15.8	6.8	11.4	11.0	3.8	24.3	32.0	2.4	1.9	44.7	3.3	3.4	2.7	2.5	25.2	2.5	4.6	2.9	34.3	4.3	36.9	3.9	4.0	10.0	9.5	9.5	21.0	12.5	9.7	13.5	14.6	11.9	12.5	12.4	11.3	14.5	15.4	16.0	14.7	19.2	43.2	35.9	50.7	15.0	26.2	22.1	7.2	6.6	15.6	4.3	15.2	7.3	20.9	21.2	11.7	5.0	1.9	8.4	2.6	94.4	11.8	15.0	11.4	3.0	53.0	9.3	7.3	18.7	16.8	57.6	16.5	18.4	8.2	9.3	25.8	11.8	58.9	12.5	10.2	71.9	127.8	4.2	6.2	94.8	19.6	42.2	58.2	45.2	3.1	30.2	60.9	8.6	11.1	3.8	10.7	30.0	4.1	5.4	80.7	27.5	0.0	17.5	20.6	29.2	20.9	15.2	29.1	34.6	18.2	7.9	5.1	37.6
CA5B		ENSG00000169239	"Carbonic anhydrase 5B"	Q9Y2D0	X	15688830-15788411	"Enzymes, FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins"		Lyase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"dendritic cells: 37.9;Muller glia cells: 35.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 22.3;fHDF/TERT166: 27.0;hTERT-HME1: 34.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA012618	Uncertain		Supported	Mitochondria		NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 24: Non-specific - Transcription regulation"	Mitochondria		"HPA012618: AB_1846000"	"unprognostic (1.62e-2)"	"unprognostic (2.10e-3)"	"unprognostic (2.86e-1)"	"unprognostic (1.55e-3)"	"unprognostic (1.16e-2)"	"unprognostic (4.59e-5)"	"unprognostic (2.50e-1)"	"unprognostic (6.89e-4)"	"unprognostic (4.11e-1)"	"unprognostic (3.89e-3)"	"unprognostic (1.54e-1)"	"unprognostic (1.17e-1)"	"prognostic favorable (6.66e-6)"	"unprognostic (2.43e-1)"	"unprognostic (1.38e-1)"	"unprognostic (8.94e-2)"	"unprognostic (3.08e-1)"	5.9	3.1	5.3	4.2	5.8	3.5	8.3	3.9	5.4	21.5	5.8	2.8	1.6	7.3	2.6	6.5	7.5	7.3	4.0	3.9	7.3	4.8	2.1	6.0	5.6	8.4	6.5	11.9	3.4	9.1	2.4	3.1	6.9	4.8	3.6	10.5	4.5	4.6	1.6	5.7	2.6	7.6	6.3	4.3	4.4	10.3	6.1	4.3	7.2	5.4	6.8	5.2	5.5	4.6	4.3	2.6	2.9	4.8	8.5	22.3	1.7	4.4	5.6	3.2	4.6	1.3	2.8	1.2	4.5	27.0	6.1	4.6	10.3	5.0	5.7	1.2	4.8	2.3	3.3	1.1	8.3	3.0	5.0	5.3	5.3	4.3	34.2	5.7	4.8	3.5	1.2	3.0	15.4	2.3	2.5	2.3	1.2	0.8	18.6	1.4	2.1	2.2	4.9	3.1	2.6	5.3	6.1	2.2	3.8	3.4	3.1	3.0	6.5	3.8	2.5	20.4	2.5	2.2	2.4	1.4	4.2	6.0	7.2	4.4	3.9	0.4	16.7	4.8	14.5	4.6	16.6	15.5	4.7	5.0	12.1	10.4	2.2	11.0	3.1	0.7	14.3	10.0	5.3	5.8	3.9	5.4	3.9	7.3	8.4	6.5	6.9	6.3	6.1	4.6	9.6	0.0	7.9	14.0	19.1	4.2	6.3	3.4	6.2	9.5	7.3	5.2	2.4	0.0	7.1	1.8	16.7	1.8	37.9	1.6	1.9	4.4	1.1	9.6	7.1	13.9	3.0	11.2	11.5	4.0	1.8	10.5	11.7	6.2	2.5	6.7	6.1	2.7	1.9	1.7	11.8	2.2	8.2	9.3	11.1	1.8	7.8	10.8	3.6	19.7	9.1	35.9	32.0	8.5	10.6	4.1	1.6	5.3	18.7	11.5	1.2	2.9	12.2	7.8	6.6	8.1	8.3	4.2	5.6	5.5	4.5	1.9	30.0	12.1	1.5	7.9
CA9	"CAIX, MN"	ENSG00000107159	"Carbonic anhydrase 9"	Q16790	9	35673918-35681159	"Enzymes, FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		Lyase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	12	"stomach 1: 289.3"	"Cell type enhanced"	"Detected in some"		"Basal respiratory cells: 275.3;Cholangiocytes: 62.9;Early spermatids: 205.8;Gastric mucus-secreting cells: 259.5"	"Cancer enhanced"	"Detected in many"		"renal cancer: 85.9"	"Region enriched"	"Detected in single"	9	"cerebellum: 5.6"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	10	"A-431: 189.3;HDLM-2: 98.1;hTERT-RPE1: 113.1;U-87 MG: 374.4"	"Region enhanced"	"Detected in many"		"cerebellum: 12.3"	"Low region specificity"	"Detected in all"			"CAB005100, CAB017107, HPA055207"	Enhanced		Supported	"Plasma membrane"	"Intracellular and membrane"	NA	NA				"Cluster 4: Stomach - Digestion"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Plasma membrane"		"CAB005100: AB_2066539, CAB017107: , HPA055207: AB_2682738"	"unprognostic (8.01e-3)"	"unprognostic (1.34e-2)"	"unprognostic (2.28e-1)"	"unprognostic (2.00e-2)"	"unprognostic (1.59e-2)"	"unprognostic (1.15e-1)"	"prognostic unfavorable (1.71e-5)"	"unprognostic (1.47e-2)"	"unprognostic (3.90e-2)"	"unprognostic (1.29e-1)"	"unprognostic (6.24e-3)"	"unprognostic (1.13e-1)"	"prognostic unfavorable (2.22e-7)"	"unprognostic (7.29e-2)"	"prognostic favorable (9.50e-4)"	"unprognostic (2.97e-3)"	"unprognostic (8.67e-2)"	3.8	0.4	0.0	0.2	0.0	0.0	0.1	5.6	0.6	0.5	0.0	0.6	14.5	0.2	0.1	0.8	0.4	24.4	2.0	0.2	0.1	0.2	1.3	0.2	0.0	0.0	0.1	0.7	6.6	0.0	0.5	0.0	0.2	0.5	0.0	1.0	0.1	0.1	0.1	8.2	13.6	0.1	0.0	0.0	289.3	5.5	0.5	0.0	0.0	0.0	0.0	0.7	0.7	0.0	189.3	0.3	0.0	0.0	0.0	0.0	0.0	0.2	3.6	0.3	2.5	0.0	0.1	0.0	0.1	0.0	0.5	5.7	0.0	0.9	1.5	98.1	0.0	0.0	0.7	0.4	0.0	0.0	0.2	0.4	0.0	0.0	0.3	113.1	0.1	0.0	0.0	0.3	0.1	0.0	0.0	0.1	0.3	0.2	0.5	0.0	0.0	10.6	0.0	0.6	1.6	0.0	0.0	0.1	0.7	0.0	0.0	0.2	0.0	18.9	0.4	0.0	4.7	0.0	0.4	0.1	374.4	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	5.6	0.6	0.2	0.1	0.0	0.1	0.2	0.0	0.5	0.0	0.2	0.0	0.0	0.0	0.2	4.5	0.7	275.3	0.0	0.4	0.1	0.0	0.4	62.9	28.1	0.0	0.0	0.0	0.0	0.1	0.0	49.1	205.8	0.0	0.1	0.2	0.0	0.0	0.1	50.9	0.6	1.2	259.5	0.2	0.0	0.4	0.7	0.0	0.1	0.0	0.6	4.0	18.3	0.0	0.0	19.6	1.5	0.1	0.0	0.0	0.6	1.3	0.0	0.0	0.0	26.6	0.0	0.7	0.3	0.8	0.7	0.1	5.5	0.0	0.0	0.0	1.5	0.9	4.0	0.0	3.1	0.3	0.1	0.7	5.3	0.4
CABIN1	"KIAA0330, PPP3IN"	ENSG00000099991	"Calcineurin binding protein 1"	Q9Y6J0	22	24011192-24178628	"Plasma proteins, Predicted intracellular proteins"		"Chromatin regulator"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cone photoreceptor cells: 89.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043296	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 35: Non-specific - Unknown function"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 9: Photoreceptor cells - Phototransduction"	"Nucleoplasm, Cytosol"		"HPA043296: AB_10794657"	"unprognostic (8.52e-2)"	"unprognostic (3.16e-1)"	"unprognostic (2.74e-2)"	"prognostic favorable (9.57e-5)"	"unprognostic (3.43e-2)"	"unprognostic (3.06e-3)"	"unprognostic (1.04e-2)"	"unprognostic (2.92e-2)"	"unprognostic (6.21e-2)"	"unprognostic (3.75e-1)"	"unprognostic (3.46e-3)"	"unprognostic (1.01e-1)"	"prognostic favorable (2.94e-4)"	"unprognostic (1.06e-1)"	"unprognostic (1.24e-1)"	"unprognostic (8.50e-3)"	"unprognostic (7.79e-2)"	27.2	28.7	28.9	15.5	29.1	30.9	24.3	33.3	40.9	33.3	32.6	37.0	13.6	32.4	8.7	23.4	35.9	10.1	30.9	28.8	25.6	36.0	28.2	28.5	19.6	28.0	27.5	27.3	28.1	15.6	46.2	8.2	28.1	34.0	8.4	13.3	22.1	14.1	17.4	24.7	33.1	11.0	23.1	37.2	31.9	34.4	29.2	19.5	50.3	7.0	10.0	29.7	27.1	28.9	24.7	17.7	23.6	20.8	20.9	24.1	33.3	20.4	17.5	16.0	18.1	22.0	11.9	28.6	11.0	20.5	20.8	23.1	28.4	18.5	14.2	48.3	27.8	24.6	21.1	46.8	9.9	57.1	25.6	20.5	11.6	19.6	14.7	19.2	27.1	25.1	52.1	15.2	9.2	32.0	27.1	62.1	14.7	34.5	12.6	26.3	17.3	36.0	14.6	24.8	30.2	25.9	25.2	17.4	26.1	21.3	15.6	25.6	22.3	37.0	28.6	14.3	14.9	26.5	17.1	16.9	17.3	27.3	15.8	7.2	3.9	15.5	5.7	2.7	6.3	2.5	4.3	7.5	2.6	4.1	5.2	4.8	17.4	5.4	1.9	3.0	3.7	2.5	28.9	29.1	33.3	40.9	28.8	25.6	28.0	27.5	28.1	23.1	29.2	28.9	14.5	22.4	37.5	37.5	22.7	8.3	8.9	11.0	13.1	33.3	14.2	10.8	18.5	4.3	9.1	9.2	89.6	17.4	24.6	19.9	7.9	11.6	16.6	43.6	19.6	15.1	14.8	18.3	54.2	9.7	6.9	16.4	29.6	26.8	17.7	21.1	13.2	9.4	21.7	33.7	39.4	13.0	20.3	12.6	16.2	16.0	21.5	16.1	10.6	20.6	19.2	14.5	44.3	21.1	35.9	10.8	6.6	19.9	24.4	7.1	8.8	7.9	24.4	50.1	19.7	14.6	32.6	60.7	41.6	13.6	9.5	22.4	36.5	18.4	13.8	7.3
CABLES1	"FLJ35924, HsT2563"	ENSG00000134508	"Cdk5 and Abl enzyme substrate 1"	Q8TDN4	18	23134564-23260467	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division"	Cyclin		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 70.2"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 258.2;Glandular and luminal cells: 54.3;Oligodendrocyte precursor cells: 163.3"	"Cancer enriched"	"Detected in all"	5	"melanoma: 38.7"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	8	"NK-cell: 1.2"	"Lineage enriched"	"Detected in single"	8	"NK-cells: 1.2"	"Cell line enhanced"	"Detected in many"		"SK-MEL-30: 154.3;U-266/70: 216.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA073649			Supported	"Nucleoplasm,Nuclear bodies"	"Intracellular and membrane"	NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 64: Astrocytes - Nervous system maintenance"	"Nucleoplasm, Nuclear bodies"		"HPA073649: AB_2732233"	"unprognostic (1.27e-1)"	"unprognostic (2.03e-1)"	"unprognostic (1.97e-1)"	"unprognostic (4.24e-3)"	"unprognostic (1.56e-1)"	"unprognostic (2.56e-3)"	"unprognostic (3.24e-2)"	"unprognostic (1.10e-3)"	"unprognostic (1.42e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.01e-1)"	"prognostic favorable (4.71e-6)"	"unprognostic (1.00e-1)"	"unprognostic (1.60e-1)"	"unprognostic (4.80e-2)"	"unprognostic (7.81e-2)"	17.1	3.3	63.9	2.1	67.9	2.6	13.8	36.8	54.8	6.9	17.1	5.2	7.5	9.4	3.2	6.9	10.9	5.2	4.6	44.9	53.5	13.1	9.9	21.5	2.8	39.6	59.0	3.7	3.0	21.9	4.0	10.4	40.8	3.7	5.1	8.0	22.3	4.5	1.5	17.2	6.7	6.6	31.2	3.7	14.5	3.5	70.2	4.9	15.0	1.8	2.3	5.4	7.8	33.3	13.1	14.4	11.8	0.9	7.1	0.3	20.4	3.1	17.3	4.2	2.5	9.5	23.0	0.7	13.3	14.9	42.3	11.4	9.0	2.3	3.2	0.3	19.4	1.0	38.7	37.1	6.2	2.5	1.0	4.2	2.1	5.3	6.1	26.8	47.1	2.3	0.5	16.2	11.7	30.2	0.1	8.8	7.5	64.5	46.6	3.1	42.2	50.6	21.2	31.5	11.2	8.2	26.1	32.5	154.3	8.3	52.4	7.2	79.3	47.9	0.5	1.6	3.8	216.0	88.9	27.4	0.2	19.2	16.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.2	0.0	0.1	0.0	0.0	63.9	67.9	36.8	54.8	44.9	53.5	39.6	59.0	40.8	31.2	70.2	33.3	2.9	22.4	27.4	258.2	3.8	5.1	2.0	1.4	5.2	4.1	9.2	6.7	1.4	7.2	2.3	3.7	29.2	0.9	1.3	8.5	1.9	1.1	2.0	11.6	4.4	6.0	3.5	1.3	19.2	2.3	1.1	4.1	10.2	54.3	0.0	14.8	25.0	9.3	16.6	0.0	22.2	4.6	0.0	3.5	3.1	3.5	0.0	4.7	28.4	41.2	0.0	1.4	0.0	163.3	1.4	2.4	5.2	6.0	3.6	0.6	6.7	14.3	1.8	18.7	0.0	5.0	2.1	0.2	3.2	1.6	6.7	0.3	1.4	0.5	2.1	2.2
CABYR	"CBP86, CT88, FSP-2"	ENSG00000154040	"Calcium binding tyrosine phosphorylation regulated"	O75952	18	24138987-24161600	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	28	"testis: 303.5"	"Group enriched"	"Detected in many"	18	"Early spermatids: 2505.6;Late spermatids: 3543.7"	"Cancer enhanced"	"Detected in many"		"testis cancer: 8.9"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"basophil: 4.8;memory B-cell: 4.7;naive B-cell: 5.0;neutrophil: 1.9"	"Group enriched"	"Detected in many"	6	"B-cells: 5.0;granulocytes: 4.8"	"Cell line enhanced"	"Detected in many"		"SiHa: 26.8"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA040703, HPA047801"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 20: HeLa - Mitochondria"	"Cluster 25: Spermatids - Spermatogenesis"	"Nucleoplasm, Cytosol"		"HPA040703: AB_2677087, HPA047801: AB_2680159"	"unprognostic (1.18e-3)"	"unprognostic (4.18e-1)"	"unprognostic (1.73e-1)"	"unprognostic (2.65e-1)"	"unprognostic (5.26e-2)"	"unprognostic (9.07e-3)"	"prognostic unfavorable (4.75e-4)"	"unprognostic (1.46e-1)"	"unprognostic (1.45e-1)"	"unprognostic (2.37e-2)"	"unprognostic (7.24e-3)"	"unprognostic (1.58e-1)"	"unprognostic (3.21e-4)"	"unprognostic (2.52e-2)"	"unprognostic (5.96e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.67e-1)"	1.5	3.3	5.4	1.2	6.6	1.1	5.2	3.7	9.4	6.8	10.9	1.2	1.0	2.9	2.0	1.7	3.6	1.8	0.9	7.5	8.0	0.8	1.1	1.0	1.2	6.5	4.2	1.7	0.7	0.4	8.3	0.9	7.0	2.3	1.1	5.7	2.1	1.5	1.0	2.1	1.1	3.6	3.7	1.2	1.5	303.5	5.2	1.5	1.0	0.1	1.0	2.4	1.4	10.5	4.9	11.9	3.4	1.7	3.4	9.1	14.7	8.2	5.4	10.2	10.6	2.5	9.2	0.2	6.8	12.6	0.5	4.5	3.4	6.9	10.7	0.6	5.6	0.3	6.9	2.3	4.8	0.4	0.5	11.2	11.1	12.7	3.3	4.8	2.9	0.6	0.0	0.3	2.6	1.4	0.1	0.4	11.3	0.5	7.4	0.7	0.4	0.2	4.2	5.5	7.2	8.3	26.8	5.2	0.5	2.0	11.3	1.2	1.7	0.8	2.3	3.4	0.2	0.3	0.3	0.1	4.7	0.9	0.5	4.8	0.3	0.6	0.2	0.2	0.1	4.7	0.3	0.3	0.1	5.0	0.3	0.6	1.9	0.8	0.4	0.4	0.2	0.4	5.4	6.6	3.7	9.4	7.5	8.0	6.5	4.2	7.0	3.7	5.2	10.5	1.1	0.0	0.0	1.6	1.0	0.3	0.9	7.2	1.2	2.0	3.1	7.1	0.8	0.0	1.9	0.0	2.1	0.2	0.3	2.2	0.0	0.8	2505.6	76.2	3.3	2.0	0.0	0.4	10.7	0.2	0.5	0.9	0.0	5.1	0.0	0.9	0.4	0.0	0.6	0.0	9.9	1.9	6.1	0.0	0.7	3543.7	23.3	2.4	1.8	2.8	0.0	0.0	1.0	7.5	12.6	0.4	1.3	21.8	0.0	0.1	0.2	0.1	2.8	2.1	19.7	0.7	2.0	166.3	19.1	0.5	0.0	0.0	0.5	0.9	0.4	0.3
CACTIN	"C19orf29, fSAPc, NY-REN-24"	ENSG00000105298	"Cactin, spliceosome C complex subunit"	Q8WUQ7	19	3610645-3626815	"Predicted intracellular proteins"	"Immunity, Innate immunity, mRNA processing, mRNA splicing"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042504, HPA042548"	Approved		Supported	"Nucleoplasm,Nuclear speckles,Cytosol"		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 7: Non-specific - Mitochondria"	"Nucleoplasm, Nuclear speckles"	Cytosol	"HPA042504: AB_10797501, HPA042548: AB_10794760"	"unprognostic (1.18e-1)"	"unprognostic (7.90e-3)"	"unprognostic (1.09e-1)"	"prognostic favorable (3.69e-5)"	"unprognostic (5.93e-2)"	"unprognostic (2.87e-3)"	"unprognostic (3.38e-2)"	"unprognostic (1.01e-2)"	"unprognostic (3.84e-2)"	"unprognostic (1.38e-2)"	"unprognostic (1.17e-2)"	"unprognostic (7.22e-3)"	"unprognostic (3.88e-2)"	"unprognostic (4.98e-3)"	"unprognostic (5.78e-2)"	"unprognostic (3.08e-2)"	"unprognostic (5.55e-3)"	14.6	14.2	20.6	7.8	19.6	10.0	14.8	19.4	24.0	15.7	16.6	15.4	6.2	16.7	2.6	15.4	16.8	3.0	16.3	20.3	18.8	17.0	19.9	12.3	7.6	21.1	19.6	24.7	17.3	4.2	13.3	4.6	19.1	17.2	3.2	4.6	13.2	4.2	19.4	17.8	15.2	2.9	18.5	18.4	15.8	18.2	19.8	8.7	15.3	6.1	4.4	16.5	14.6	20.1	22.2	12.5	10.3	17.9	7.4	7.2	15.6	15.4	6.3	9.1	10.2	12.5	9.7	18.4	12.9	9.7	10.6	20.4	10.8	12.9	5.5	18.7	14.8	11.4	19.2	15.1	10.3	15.7	15.9	7.1	12.2	8.4	5.8	5.4	13.2	15.6	25.9	19.8	4.9	13.3	28.0	13.5	22.0	13.4	14.8	29.4	13.5	17.5	8.5	11.0	14.2	19.9	17.4	12.1	13.3	5.5	9.8	17.7	17.2	12.3	15.5	27.0	27.4	30.3	21.6	20.7	15.2	24.8	16.8	0.0	0.4	0.0	1.2	1.0	0.4	0.6	0.5	0.5	0.3	0.6	0.6	0.8	0.2	0.3	0.1	1.4	0.5	0.4	20.6	19.6	19.4	24.0	20.3	18.8	21.1	19.6	19.1	18.5	19.8	20.1	7.4	0.0	2.7	5.9	6.3	6.0	4.1	2.8	5.7	5.1	6.9	7.1	3.1	5.7	2.2	1.8	2.1	3.6	7.2	6.9	0.0	5.1	3.3	6.7	5.8	5.3	1.2	7.4	3.9	4.9	5.2	5.1	9.2	7.4	4.5	8.5	3.3	4.8	5.1	0.0	4.1	5.8	2.0	3.9	6.5	4.5	5.9	5.3	1.8	3.7	6.1	6.0	8.2	2.5	5.8	5.2	4.4	5.7	6.0	6.0	3.6	3.1	2.4	6.2	0.0	7.2	6.4	10.8	8.8	7.9	8.0	3.3	5.6	7.6	6.1	3.6
CAD	GATD4	ENSG00000084774	"Carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase"	P27708	2	27217369-27243943	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Pyrimidine biosynthesis"	"Allosteric enzyme, Hydrolase, Ligase, Multifunctional enzyme, Transferase"	"Cancer-related genes, Congenital disorder of glycosylation, Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB007781, HPA065158, HPA069341"	Supported		Supported	Cytosol		NA	No		260000	"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	Cytosol		"CAB007781: AB_562057, HPA065158: , HPA069341: AB_2686125"	"unprognostic (1.69e-1)"	"unprognostic (7.34e-2)"	"unprognostic (1.49e-1)"	"unprognostic (4.71e-3)"	"unprognostic (2.55e-1)"	"unprognostic (1.92e-1)"	"prognostic unfavorable (1.72e-11)"	"unprognostic (1.25e-1)"	"unprognostic (2.22e-1)"	"unprognostic (2.37e-1)"	"unprognostic (1.01e-1)"	"unprognostic (6.11e-2)"	"prognostic unfavorable (1.82e-4)"	"unprognostic (6.94e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.14e-1)"	"unprognostic (5.93e-3)"	15.0	13.5	12.7	12.4	14.1	9.0	14.9	12.7	15.5	19.8	12.2	16.5	8.5	23.8	9.9	19.2	19.3	7.7	11.6	12.3	12.8	18.0	27.8	12.3	14.9	13.8	13.5	22.3	22.3	5.9	18.7	7.5	14.5	15.2	7.8	5.0	12.3	8.8	10.3	18.7	16.1	11.9	12.7	20.1	14.0	22.2	14.2	11.6	15.8	5.9	10.5	16.9	15.8	15.2	75.2	66.4	28.9	58.4	46.1	37.6	22.9	31.0	21.4	38.3	27.0	75.7	29.2	66.4	27.4	28.5	29.6	41.4	85.7	41.1	28.5	43.8	69.2	95.2	55.0	40.0	23.0	75.7	46.2	28.8	33.1	55.7	63.0	17.8	41.6	60.6	68.3	36.0	34.2	74.8	48.7	112.0	69.7	31.3	49.7	84.0	86.5	69.5	28.6	37.6	57.9	29.1	43.3	30.5	37.4	21.3	23.9	31.3	37.7	57.7	47.5	45.5	63.5	74.0	51.8	135.2	23.3	71.7	51.0	0.0	0.8	0.4	3.1	1.5	2.5	3.4	4.4	5.2	1.9	3.1	2.8	2.8	0.5	2.7	0.9	3.4	5.9	2.0	12.7	14.1	12.7	15.5	12.3	12.8	13.8	13.5	14.5	12.7	14.2	15.2	4.2	3.2	3.9	12.7	5.3	3.7	4.3	5.0	5.7	10.6	7.1	8.6	8.3	10.0	4.7	1.8	16.7	5.9	3.9	3.9	0.0	6.1	1.5	2.9	7.9	5.1	6.6	9.7	5.6	3.7	6.6	7.0	6.1	4.3	4.5	16.9	3.3	6.6	7.7	6.7	5.7	5.8	0.0	3.0	1.9	1.9	6.2	3.6	3.6	6.5	4.7	4.1	5.2	8.5	7.4	5.9	1.9	9.8	7.3	8.0	2.5	2.0	3.5	6.8	0.0	8.2	5.2	5.6	12.1	6.2	3.4	2.2	5.1	9.7	7.5	2.2
CADM1	"BL2, IGSF4, IGSF4A, Necl-2, NECL2, RA175, ST17, SYNCAM, SYNCAM1, TSLC1"	ENSG00000182985	"Cell adhesion molecule 1"	Q9BY67	11	115169218-115504957	"Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Apoptosis, Cell adhesion, Differentiation, Host-virus interaction, Immunity, Spermatogenesis"	"Developmental protein"	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 287.7"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 464.8;Astrocytes: 980.7;Bipolar cells: 566.6;Muller glia cells: 489.9;Oligodendrocyte precursor cells: 676.5;Oligodendrocytes: 622.8;Rod photoreceptor cells: 759.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"gdT-cell: 8.0;myeloid DC: 8.1"	"Group enriched"	"Detected in many"	5	"dendritic cells: 8.1;T-cells: 8.0"	"Cell line enhanced"	"Detected in many"		"CACO-2: 294.7;WM-115: 187.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB037266	Enhanced		Supported	"Cell Junctions"		NA	NA		220000000	"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 77: Retina - Visual perception"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 56: Bipolar cells - Visual perception"	"Cell Junctions"		"CAB037266: AB_532287"	"unprognostic (1.50e-1)"	"unprognostic (2.15e-1)"	"unprognostic (1.92e-2)"	"prognostic favorable (1.32e-4)"	"unprognostic (4.11e-3)"	"unprognostic (1.50e-1)"	"unprognostic (2.75e-3)"	"unprognostic (1.13e-2)"	"unprognostic (1.77e-1)"	"unprognostic (2.67e-1)"	"unprognostic (6.61e-3)"	"unprognostic (9.22e-2)"	"unprognostic (2.92e-3)"	"unprognostic (1.77e-2)"	"unprognostic (1.54e-1)"	"unprognostic (3.67e-2)"	"unprognostic (5.40e-2)"	7.1	29.9	46.9	6.1	59.2	0.4	17.0	78.7	53.0	21.3	6.1	11.7	7.8	17.4	103.7	12.6	22.6	12.1	25.7	47.6	57.4	29.1	65.3	72.0	14.1	41.1	40.1	12.3	16.0	56.6	26.0	37.9	44.6	15.2	8.1	287.7	38.0	28.0	7.2	10.9	8.8	8.6	30.3	8.0	12.5	50.5	55.8	8.6	69.7	8.1	14.6	13.1	4.8	38.0	0.4	23.3	25.6	0.1	0.0	0.0	0.1	24.1	41.1	3.1	0.3	294.7	26.1	0.0	75.9	36.5	25.2	4.8	4.8	27.4	2.0	1.0	38.3	0.0	7.8	114.5	0.3	0.1	56.5	0.0	38.6	0.0	63.8	16.5	1.1	17.3	0.0	2.7	4.3	19.3	20.0	0.6	24.0	0.3	0.0	0.1	0.4	61.6	44.8	0.9	50.2	107.1	0.0	25.4	21.7	102.4	92.4	1.3	0.0	2.3	44.9	23.3	13.0	64.9	98.9	18.7	36.3	0.2	187.5	0.2	0.0	0.0	8.0	0.0	3.4	1.5	2.9	2.1	8.1	0.3	0.1	1.8	0.0	0.5	0.1	0.0	4.7	1.9	46.9	59.2	78.7	53.0	47.6	57.4	41.1	40.1	44.6	30.3	55.8	38.0	14.0	464.8	195.3	980.7	6.5	20.6	26.7	2.8	19.4	566.6	22.1	22.5	61.7	34.3	27.5	36.8	350.3	71.6	6.8	1.5	11.7	39.2	189.1	88.5	6.0	10.6	7.8	5.3	301.7	2.0	5.0	13.2	3.6	126.9	24.1	36.8	2.9	45.9	36.8	30.3	310.9	2.1	4.1	8.5	20.9	224.0	5.9	14.2	44.4	60.0	13.3	489.9	2.1	676.5	622.8	9.3	0.5	4.1	88.9	38.5	0.3	8.2	8.7	759.5	0.0	13.3	11.7	55.2	23.0	9.2	23.4	32.2	8.1	5.2	4.3	13.5
CADPS2	CAPS2	ENSG00000081803	"Calcium dependent secretion activator 2"	Q86UW7	7	122318411-122886759	"Predicted intracellular proteins"	"Exocytosis, Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 96.2"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 682.7;Microglial cells: 180.8;Oligodendrocyte precursor cells: 111.1"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"cerebellum: 96.2"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 43.5;Karpas-707: 56.3;OE19: 63.6"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"cerebellum: 159.9"	HPA056398			Approved	Nucleoplasm,Vesicles		NA	NA				"Cluster 21: Non-specific - Transcription"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Nucleoplasm, Vesicles"		"HPA056398: AB_2683117"	"unprognostic (1.93e-1)"	"unprognostic (5.05e-2)"	"unprognostic (1.91e-1)"	"unprognostic (3.67e-3)"	"unprognostic (8.69e-3)"	"unprognostic (9.13e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.33e-1)"	"unprognostic (4.07e-1)"	"unprognostic (4.33e-2)"	"unprognostic (3.93e-2)"	"unprognostic (1.30e-1)"	"prognostic favorable (1.01e-7)"	"unprognostic (9.93e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.71e-2)"	"unprognostic (3.45e-2)"	10.3	21.1	9.2	4.5	16.3	0.1	18.3	96.2	30.9	29.8	5.8	10.7	12.6	35.0	30.3	4.5	11.0	15.6	10.2	14.2	14.4	38.3	13.2	18.0	3.5	4.9	40.1	9.9	26.0	12.0	13.8	6.0	7.9	19.4	10.7	7.2	48.3	18.5	2.4	4.0	10.0	21.7	6.2	6.7	20.0	4.0	17.4	4.9	18.3	7.8	3.8	9.3	8.5	18.7	0.0	0.1	3.4	0.0	5.1	5.2	0.3	0.5	13.5	2.9	13.4	0.1	12.6	0.0	0.0	6.4	0.4	0.1	0.4	1.9	1.3	0.0	11.1	4.4	0.1	25.1	16.9	0.0	0.2	5.5	2.4	2.3	1.7	11.8	43.5	0.0	0.0	56.3	0.2	30.9	0.0	0.1	12.6	63.6	21.4	0.0	0.0	23.2	0.6	14.3	20.5	0.0	0.6	24.4	1.2	3.2	9.5	0.1	12.5	4.7	3.1	0.1	8.9	16.8	0.7	0.0	18.1	0.0	5.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.2	16.3	96.2	30.9	14.2	14.4	4.9	40.1	7.9	6.2	17.4	18.7	29.3	9.6	43.9	85.2	3.1	2.2	7.9	7.3	10.2	0.6	36.7	22.4	12.9	11.5	14.4	40.5	0.0	0.4	0.5	4.3	17.6	4.4	8.5	4.8	13.5	24.7	4.8	0.0	682.7	11.1	0.5	13.0	42.3	11.2	1.3	10.1	14.3	12.5	0.4	3.3	14.2	13.2	10.2	3.1	1.4	6.8	9.6	0.6	3.6	180.8	0.0	27.2	0.0	111.1	11.0	4.8	3.7	10.1	15.7	13.4	5.7	7.9	9.4	1.5	0.0	6.9	6.2	0.7	4.2	6.2	1.4	0.3	0.7	11.3	8.0	8.5
CALCOCO2	"MGC17318, NDP52"	ENSG00000136436	"Calcium binding and coiled-coil domain 2"	Q13137	17	48831018-48866522	"Predicted intracellular proteins"	Autophagy			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	4	"Early spermatids: 1127.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA022989, HPA023019, HPA023195"	Enhanced		Supported	Vesicles,Cytosol		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 21: OE19 - Mitochondria"	"Cluster 29: Early spermatids - Spermatogenesis"	Cytosol	Vesicles	"HPA022989: AB_1845914, HPA023019: AB_1845915, HPA023195: AB_1845916"	"unprognostic (3.71e-1)"	"unprognostic (2.87e-1)"	"unprognostic (3.84e-2)"	"unprognostic (3.37e-2)"	"unprognostic (4.90e-2)"	"unprognostic (4.46e-2)"	"unprognostic (2.05e-1)"	"unprognostic (2.28e-1)"	"unprognostic (3.88e-1)"	"unprognostic (2.15e-1)"	"unprognostic (2.41e-1)"	"unprognostic (4.03e-2)"	"unprognostic (3.52e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.80e-2)"	"unprognostic (7.57e-2)"	"unprognostic (5.65e-2)"	117.9	59.2	36.5	55.3	43.8	62.9	95.3	41.6	50.8	81.0	72.3	101.0	68.1	69.2	61.0	88.6	82.2	66.2	139.1	35.3	45.3	75.7	120.3	91.4	53.2	48.7	42.0	86.6	56.6	76.8	46.6	63.3	49.2	55.6	101.5	76.4	52.5	72.5	158.4	68.2	75.4	87.8	39.0	68.8	71.6	136.3	41.0	74.4	75.3	170.3	67.1	80.9	76.9	52.0	126.0	79.4	33.1	64.0	241.2	173.7	95.0	120.2	160.0	135.9	151.3	150.8	80.6	42.5	117.0	146.5	115.9	68.2	81.4	101.7	162.6	193.3	66.9	40.7	48.0	59.1	276.8	137.4	196.8	258.1	148.1	144.3	103.9	129.0	101.3	130.7	74.9	124.3	119.2	36.8	119.5	73.6	10.3	278.9	97.7	77.8	161.7	81.0	52.2	39.2	13.1	27.9	37.6	24.3	106.0	66.6	154.2	76.5	97.7	147.1	44.9	91.0	85.8	110.4	165.1	30.0	89.2	69.0	61.4	108.9	115.1	115.5	56.6	121.5	54.2	54.1	49.9	58.9	67.1	46.7	50.5	55.8	132.8	105.0	132.3	33.6	107.2	89.7	36.5	43.8	41.6	50.8	35.3	45.3	48.7	42.0	49.2	39.0	41.0	52.0	166.2	115.4	98.1	20.5	42.1	36.6	73.3	40.9	40.9	16.8	34.7	32.4	169.1	37.1	48.4	33.1	50.1	50.2	48.6	124.5	37.2	47.2	1127.4	37.4	89.7	104.6	50.4	40.8	31.0	42.2	45.3	79.1	31.6	44.0	100.0	29.8	110.3	58.9	27.6	8.4	21.2	44.7	24.4	119.2	54.3	233.3	70.2	70.7	26.6	28.1	57.4	45.9	64.9	26.7	27.3	37.7	54.6	74.1	56.2	57.6	81.5	48.9	28.4	72.7	72.3	69.6	76.2	152.5	32.7	55.6	46.9	81.3	54.6	96.3	66.1	66.1
CALCRL	"CGRPR, CRLR"	ENSG00000064989	"Calcitonin receptor like receptor"	Q16602	2	187341964-187448460	"Disease related genes, FDA approved drug targets, G-protein coupled receptors, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 70.7;lung: 76.8"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 138.3;Endometrial stromal cells: 92.7;Endothelial cells: 248.7;Hepatic stellate cells: 259.2;Oligodendrocyte precursor cells: 293.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"classical monocyte: 2.6;myeloid DC: 9.2;plasmacytoid DC: 2.6"	"Group enriched"	"Detected in many"	6	"dendritic cells: 9.2;monocytes: 2.6"	"Cell line enriched"	"Detected in some"	4	"HUVEC TERT2: 173.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008070, HPA046515"	Uncertain		Supported	"Plasma membrane"		NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Plasma membrane"		"HPA008070: AB_1845912, HPA046515: AB_2679681"	"unprognostic (7.06e-2)"	"unprognostic (5.71e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.13e-1)"	"unprognostic (3.44e-3)"	"unprognostic (7.60e-3)"	"unprognostic (9.25e-3)"	"unprognostic (4.14e-2)"	"unprognostic (7.71e-3)"	"unprognostic (3.32e-1)"	"unprognostic (3.77e-1)"	"unprognostic (3.44e-1)"	"unprognostic (1.51e-3)"	"unprognostic (1.90e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.30e-1)"	"unprognostic (2.50e-2)"	70.7	6.3	3.4	12.3	4.0	0.4	15.8	6.1	4.4	27.8	3.4	6.9	6.0	21.5	4.6	8.6	11.4	24.4	20.4	3.9	3.8	14.0	12.6	76.8	7.9	11.1	6.2	15.7	4.3	13.0	3.6	11.7	10.8	7.3	9.5	0.9	7.1	7.7	6.2	3.9	6.3	27.1	15.5	8.6	7.1	2.7	3.9	4.6	28.3	20.2	9.1	14.1	4.7	15.2	0.2	0.0	8.8	0.0	6.2	1.6	0.0	0.8	1.3	0.1	1.0	0.0	1.0	0.0	2.3	0.7	0.2	0.0	0.0	0.6	0.2	1.5	0.5	1.5	0.0	0.2	4.9	0.2	0.0	4.6	0.2	0.3	2.1	0.5	173.6	0.1	0.0	2.5	1.2	0.0	0.8	0.1	0.5	0.0	0.0	0.0	3.1	0.5	40.5	0.0	0.4	0.2	0.0	0.0	0.4	0.5	0.0	0.2	25.3	0.7	0.1	0.1	0.4	6.2	0.1	0.7	0.4	0.0	0.0	0.0	2.6	0.0	0.0	0.5	0.0	0.2	0.0	0.0	9.2	0.0	0.8	0.1	0.1	1.0	1.0	2.6	0.0	0.9	3.4	4.0	6.1	4.4	3.9	3.8	11.1	6.2	10.8	15.5	3.9	15.2	138.3	0.0	11.9	19.6	1.2	9.3	2.3	1.7	21.6	0.2	0.8	1.8	12.3	2.8	3.6	0.0	0.0	0.4	2.4	0.0	3.9	0.3	0.8	3.1	92.7	248.7	0.0	4.8	15.4	0.4	0.2	56.5	1.1	1.7	5.1	12.3	259.2	1.8	0.9	0.0	2.1	0.0	2.0	10.3	29.7	1.0	7.8	15.4	10.6	47.8	16.1	0.0	1.0	293.0	1.0	0.1	0.0	2.6	4.9	1.9	0.0	13.2	2.8	0.1	6.6	4.1	21.5	1.3	0.7	18.2	6.8	0.3	3.0	6.0	0.0	1.8
CALM1	"CALML2, CAMI, DD132, PHKD"	ENSG00000198668	"Calmodulin 1"	P0DP23	14	90396502-90408268	"Disease related genes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, RAS pathway related proteins"	"Host-virus interaction"		"Disease variant, FDA approved drug targets, Long QT syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB018558, HPA044999"	Supported		Supported	Cytosol		NA	NA		75000000	"Cluster 44: Non-specific - Transcription"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 7: Non-specific - Mitochondria"	Cytosol		"CAB018558: AB_2069454, HPA044999: AB_2679177"	"unprognostic (5.35e-3)"	"unprognostic (3.96e-1)"	"unprognostic (4.99e-3)"	"unprognostic (2.91e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.87e-2)"	"unprognostic (1.99e-3)"	"unprognostic (1.52e-1)"	"unprognostic (6.44e-2)"	"unprognostic (1.16e-3)"	"prognostic favorable (5.62e-4)"	"unprognostic (2.77e-1)"	"prognostic favorable (6.49e-4)"	"unprognostic (2.66e-1)"	"unprognostic (2.68e-1)"	"unprognostic (1.11e-2)"	"prognostic unfavorable (2.38e-5)"	264.2	143.5	429.9	152.3	537.5	349.1	123.1	442.8	839.7	134.2	259.8	332.9	289.6	105.1	209.7	304.6	251.4	153.8	287.0	635.9	371.6	326.3	210.9	209.1	165.7	466.2	374.6	104.4	121.7	225.5	143.9	207.4	447.5	169.5	312.2	241.6	188.0	215.3	588.9	104.0	279.2	227.2	328.7	166.6	202.2	123.6	443.5	146.5	118.0	185.6	210.5	191.6	125.2	527.2	189.3	256.3	308.0	115.7	332.2	286.5	256.9	347.4	295.3	260.0	283.2	278.1	320.9	200.8	171.1	413.0	123.4	309.4	194.6	490.1	431.0	398.3	119.7	212.4	211.0	264.1	185.9	327.6	167.2	188.0	232.7	261.6	93.1	173.6	592.9	140.3	101.3	270.0	353.9	653.7	112.4	316.2	178.4	521.1	351.6	216.9	264.9	134.4	215.3	574.5	621.2	259.1	292.3	507.7	195.5	254.0	335.6	112.0	363.1	212.9	137.7	224.8	289.0	149.5	371.0	222.2	335.9	267.6	301.5	1289.6	356.8	826.7	1005.3	420.4	1230.3	496.8	1039.1	1079.6	483.1	400.2	745.7	882.7	513.3	1036.9	647.3	453.3	1168.3	1477.9	429.9	537.5	442.8	839.7	635.9	371.6	466.2	374.6	447.5	328.7	443.5	527.2	1812.3	387.8	374.4	119.8	573.2	567.1	572.2	604.2	543.5	1729.1	343.7	514.8	867.5	346.0	523.1	399.1	123.0	427.7	1471.8	828.8	459.7	550.8	154.9	1026.1	249.0	996.0	599.8	143.5	367.6	444.7	984.2	521.4	317.0	377.6	490.3	148.5	652.5	333.7	795.1	604.0	258.9	513.9	730.4	286.5	837.4	101.5	210.6	639.9	627.9	131.2	856.3	1061.8	1100.9	108.0	188.9	534.2	615.8	500.2	591.8	287.7	1637.2	1430.5	1618.4	321.1	315.5	387.5	901.6	128.8	199.8	553.8	580.4	1147.6	1139.3	247.8	666.6	458.5
CALR	"cC1qR, CRT, FLJ26680, RO, SSA"	ENSG00000179218	Calreticulin	P27797	19	12938578-12944489	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"		Chaperone	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Extravillous trophoblasts: 1717.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB001513, HPA002242, CAB019952, CAB079775"	Enhanced		Supported	"Endoplasmic reticulum"	"Intracellular and membrane"	NA	NA		210000000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 32: U-937 - Innate immune response"	"Cluster 38: Extravillous trophoblasts - Unknown function"	"Endoplasmic reticulum"		"CAB001513: , CAB019952: AB_2069792, CAB079775: AB_303403, HPA002242: AB_1078384"	"unprognostic (1.49e-1)"	"unprognostic (1.57e-1)"	"unprognostic (8.46e-2)"	"unprognostic (4.25e-2)"	"unprognostic (9.44e-3)"	"unprognostic (6.93e-2)"	"unprognostic (2.47e-2)"	"unprognostic (4.60e-2)"	"unprognostic (2.61e-1)"	"prognostic favorable (1.10e-4)"	"unprognostic (2.07e-1)"	"unprognostic (3.76e-1)"	"prognostic unfavorable (1.11e-16)"	"unprognostic (2.37e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.37e-1)"	"unprognostic (5.27e-2)"	295.5	257.6	201.7	352.9	213.4	554.9	218.9	238.0	213.5	256.3	324.0	304.6	287.3	275.8	647.7	338.2	266.7	164.1	303.2	203.5	239.7	296.9	782.3	308.9	230.0	260.4	230.1	272.2	319.7	292.2	284.5	403.3	254.5	277.9	336.7	96.2	299.3	247.2	119.8	189.3	277.2	349.7	237.7	277.3	300.6	165.2	267.3	245.3	702.9	104.7	319.4	252.2	236.6	274.2	1681.4	673.6	832.5	1984.9	1110.8	861.5	724.6	2075.3	1160.8	839.6	1280.4	1044.2	1353.5	1087.2	1960.0	2528.4	1064.5	672.1	906.1	1476.5	800.7	730.0	588.1	894.3	689.0	1619.6	2667.5	3638.5	1171.8	946.8	638.7	1222.3	957.7	1472.5	1507.8	743.1	814.5	536.3	911.7	1222.3	1040.0	2511.9	808.7	952.0	970.1	777.0	770.8	1329.9	1138.3	846.9	312.4	668.4	1438.7	769.8	472.6	789.9	1014.4	1558.9	1460.6	1113.2	666.2	1533.6	938.3	644.3	569.7	985.8	1567.6	1616.3	1258.1	67.5	72.8	39.7	172.8	147.8	119.3	90.0	99.7	130.0	76.3	77.5	73.0	134.4	23.8	103.1	122.7	215.6	83.4	75.8	201.7	213.4	238.0	213.5	203.5	239.7	260.4	230.1	254.5	237.7	267.3	274.2	385.2	147.4	160.7	34.6	385.7	261.7	336.3	217.3	221.4	76.8	214.9	140.8	43.7	163.0	175.4	222.5	127.2	652.9	515.5	524.4	64.6	582.7	27.8	206.3	364.2	305.6	353.6	266.1	14.2	285.5	1717.5	422.5	289.5	348.2	207.4	341.6	312.7	612.4	789.3	35.3	23.8	595.1	93.6	208.8	433.2	30.6	318.7	378.4	213.5	31.9	229.9	316.5	360.5	28.6	31.1	410.2	462.8	311.1	1059.6	426.1	377.8	182.8	147.5	167.7	203.8	224.2	328.9	276.1	306.6	245.5	213.5	964.4	345.8	399.4	471.4	329.6
CALU		ENSG00000128595	Calumenin	O43852	7	128739292-128773400	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Extravillous trophoblasts: 504.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"fHDF/TERT166: 2467.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006018	Supported		Supported	"Endoplasmic reticulum"	"Intracellular and membrane"	NA	NA		21000000	"Cluster 27: Non-specific - Gene expression"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 38: Extravillous trophoblasts - Unknown function"	"Endoplasmic reticulum"		"HPA006018: AB_1845934"	"unprognostic (7.22e-3)"	"unprognostic (1.16e-3)"	"unprognostic (3.16e-1)"	"unprognostic (8.86e-2)"	"unprognostic (1.27e-1)"	"unprognostic (9.52e-3)"	"prognostic unfavorable (1.80e-4)"	"unprognostic (1.05e-3)"	"unprognostic (1.95e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.75e-3)"	"unprognostic (2.31e-1)"	"prognostic unfavorable (1.30e-11)"	"unprognostic (3.80e-3)"	"unprognostic (1.66e-1)"	"unprognostic (1.45e-1)"	"prognostic unfavorable (4.60e-5)"	115.8	56.6	20.6	137.9	22.7	22.8	66.2	22.8	28.5	133.5	54.7	97.5	37.6	113.6	61.1	60.4	57.1	92.7	236.9	24.5	23.5	45.1	74.2	68.5	38.8	24.1	22.2	54.8	52.6	85.0	28.8	211.8	24.2	113.0	81.3	19.6	67.7	150.1	82.1	29.9	40.0	328.4	22.3	47.5	62.5	39.8	33.2	31.0	77.1	117.1	45.2	160.1	48.2	26.6	257.8	207.4	486.6	152.7	1348.5	1229.5	270.9	1821.7	1378.1	577.5	770.7	238.6	388.3	100.0	351.5	2467.8	850.4	144.9	258.2	318.2	826.5	80.6	138.2	136.6	283.7	295.0	657.1	187.2	254.3	930.5	223.6	868.3	370.6	904.4	537.3	116.4	237.9	172.8	1131.8	141.0	130.2	95.5	305.2	247.0	197.3	122.9	333.3	164.5	243.5	132.7	44.3	238.2	595.4	481.5	753.1	932.2	106.2	145.6	799.8	1706.6	234.2	1350.8	754.6	306.8	385.7	224.8	1478.6	223.6	1857.2	21.7	38.8	23.5	28.3	41.4	27.9	23.7	19.5	22.0	33.4	16.6	17.1	20.0	4.5	26.2	35.7	32.9	23.4	31.2	20.6	22.7	22.8	28.5	24.5	23.5	24.1	22.2	24.2	22.3	33.2	26.6	67.3	22.4	38.5	25.5	29.9	81.3	68.1	82.0	31.3	28.2	51.7	42.7	247.0	25.8	62.7	25.8	18.8	116.8	25.0	14.4	17.6	69.5	11.4	37.5	186.3	104.0	19.7	42.3	37.7	60.5	504.7	198.8	37.2	72.8	59.6	62.6	113.2	54.2	136.9	28.6	47.0	55.9	22.4	58.9	70.7	9.3	100.3	44.6	120.9	27.2	26.3	32.4	21.6	31.2	32.2	71.5	11.4	118.8	140.9	110.6	12.6	17.7	57.2	12.8	59.2	64.9	162.8	27.1	41.9	30.9	76.9	243.0	30.9	69.7	26.1	90.5
CAMK2B	"CAM2, CAMK2, CAMKB, CaMKIIβ"	ENSG00000058404	"Calcium/calmodulin dependent protein kinase II beta"	Q13554	7	44217150-44334577	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Differentiation, Neurogenesis"	"Actin-binding, Calmodulin-binding, Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase"	"Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 248.8;skeletal muscle: 132.5"	"Cell type enriched"	"Detected in many"	7	"Bipolar cells: 857.4"	"Cancer enhanced"	"Detected in many"		"glioma: 6.0;thyroid cancer: 6.1"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in some"	7	"SCLC-21H: 75.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB006849, HPA026307, HPA051783, HPA051785, HPA053973"	Enhanced	Supported	Supported	"Plasma membrane,Cell Junctions,Cytosol"		NA	NA		600000	"Cluster 11: Basophils - Unknown function"	"Cluster 47: Non-specific - Unknown function"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 56: Bipolar cells - Visual perception"	"Plasma membrane"	"Cell Junctions, Cytosol"	"CAB006849: , HPA026307: AB_1845941, HPA051783: AB_2681608, HPA051785: AB_2681609, HPA053973: AB_2682328"	"unprognostic (1.88e-3)"	"unprognostic (4.49e-2)"	"unprognostic (3.55e-3)"	"unprognostic (1.36e-2)"	"unprognostic (5.25e-2)"	"unprognostic (2.90e-2)"	"unprognostic (8.78e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.71e-1)"	"unprognostic (1.17e-2)"	"unprognostic (1.60e-2)"	"unprognostic (5.23e-7)"	"unprognostic (7.04e-2)"	"unprognostic (2.34e-1)"	"unprognostic (3.15e-2)"	"unprognostic (3.95e-2)"	0.5	11.3	77.9	0.6	109.0	0.1	1.4	113.0	248.8	0.1	0.0	1.0	1.0	0.2	28.3	1.4	1.1	0.2	65.4	197.6	12.6	1.6	7.7	0.3	1.3	4.4	11.9	0.3	3.8	6.1	51.3	0.1	4.6	3.2	0.4	21.4	1.4	1.6	132.5	1.2	0.9	0.1	3.2	0.3	2.3	2.1	25.9	0.8	20.3	59.2	1.6	0.0	0.3	80.4	0.0	0.8	0.4	0.6	0.0	0.4	0.4	0.3	0.1	0.3	0.0	0.3	0.1	0.2	1.6	0.4	0.1	0.3	0.4	1.4	0.1	2.0	4.5	0.1	0.2	0.2	0.1	0.0	0.9	0.1	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.8	0.1	10.1	0.0	0.4	0.2	0.1	4.4	0.2	1.7	0.3	0.0	0.0	75.5	4.0	0.4	0.0	0.0	0.1	3.5	0.3	0.4	0.5	0.7	0.4	0.1	0.9	0.8	0.2	0.2	0.0	0.5	1.0	0.1	0.2	0.1	0.2	0.2	0.2	0.2	0.1	0.1	0.3	0.2	0.2	0.4	0.7	0.3	0.2	0.2	0.2	77.9	109.0	113.0	248.8	197.6	12.6	4.4	11.9	4.6	3.2	25.9	80.4	0.1	0.0	0.0	67.3	0.2	1.1	21.5	0.0	10.8	857.4	3.1	17.5	88.9	2.8	0.0	0.0	45.9	0.1	0.0	0.5	9.8	0.0	0.9	2.3	0.4	1.6	40.7	0.0	111.4	0.0	0.2	2.9	4.1	5.6	4.5	15.4	0.0	4.3	0.2	60.6	90.9	1.5	2.0	0.6	0.4	2.9	1.8	0.5	1.8	5.6	0.0	23.2	0.0	19.6	5.4	0.1	1.2	0.0	0.1	3.3	0.1	1.9	0.0	53.1	0.0	6.9	1.7	0.2	7.8	0.9	0.4	0.3	0.2	0.2	0.3	6.6
CAMK2N2	CaM-KIIN	ENSG00000163888	"Calcium/calmodulin dependent protein kinase II inhibitor 2"	Q96S95	3	184259213-184261553	"Predicted intracellular proteins"		"Protein kinase inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"brain: 104.3;pancreas: 33.6;pituitary gland: 39.6"	"Group enriched"	"Detected in some"	4	"Horizontal cells: 62.2;Inhibitory neurons: 45.3"	"Cancer enhanced"	"Detected in many"		"glioma: 7.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A-431: 21.2;REH: 33.4;SCLC-21H: 33.2;U-138 MG: 32.1"	"Low region specificity"	"Detected in all"							"HPA050835, HPA075200"	Approved		Supported	Nucleoplasm,Centrosome		NA	NA				"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 62: Horizontal cells - Visual perception"	"Nucleoplasm, Centrosome"		"HPA050835: AB_2681253, HPA075200: "	"unprognostic (7.28e-2)"	"prognostic favorable (9.77e-4)"	"unprognostic (1.24e-1)"	"unprognostic (4.69e-2)"	"unprognostic (1.32e-1)"	"unprognostic (6.09e-2)"	"unprognostic (2.20e-1)"	"unprognostic (1.29e-2)"	"unprognostic (1.88e-1)"	"unprognostic (4.21e-2)"	"unprognostic (5.98e-2)"	"unprognostic (9.72e-3)"	"unprognostic (5.17e-9)"	"unprognostic (3.47e-1)"	"unprognostic (2.39e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.76e-3)"	0.1	14.6	60.0	0.2	29.5	0.0	0.1	45.8	49.8	0.1	0.0	0.6	0.2	0.2	0.0	0.1	0.1	0.1	0.1	36.0	69.1	0.2	0.7	0.1	0.0	95.7	70.7	0.1	33.6	0.8	39.6	0.1	79.5	0.3	0.0	5.5	0.2	0.1	0.0	0.2	0.2	0.1	50.7	0.1	0.5	0.2	104.3	0.0	0.1	0.0	0.0	0.1	0.1	29.7	21.2	0.5	3.2	1.7	0.5	0.5	2.2	0.5	6.2	4.0	4.1	1.2	1.1	2.0	5.4	0.3	13.0	2.8	1.1	0.7	2.2	16.1	1.4	0.7	0.5	0.9	0.1	1.4	3.0	0.5	1.0	0.6	2.8	1.4	0.0	0.9	0.3	7.5	0.6	14.5	0.4	1.1	13.3	1.5	8.4	33.4	9.4	3.2	0.9	5.0	33.2	7.3	3.9	1.7	0.3	0.3	13.3	0.2	0.2	32.1	15.0	4.3	6.7	4.1	8.1	6.8	8.1	3.4	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	60.0	29.5	45.8	49.8	36.0	69.1	95.7	70.7	79.5	50.7	104.3	29.7	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	12.2	0.3	0.5	0.4	0.0	0.0	0.0	2.1	0.0	0.5	0.0	0.0	0.1	0.3	0.1	0.4	0.2	3.6	0.0	7.8	4.3	0.0	0.2	0.0	0.1	0.0	0.0	0.4	0.8	0.0	62.2	45.3	0.0	0.0	0.0	0.0	0.8	0.0	0.1	0.0	2.8	0.0	2.0	0.0	7.5	2.0	0.7	0.0	0.0	0.0	0.1	0.0	0.2	0.0	7.2	0.0	0.1	0.6	0.1	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.1
CAMK4	"CaMK-GR, CaMKIV"	ENSG00000152495	"Calcium/calmodulin dependent protein kinase IV"	Q16566	5	111223653-111494886	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Immunity, Inflammatory response"	"Calmodulin-binding, Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"brain: 70.4;lymphoid tissue: 55.4"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 70.9;Early spermatids: 306.2;Excitatory neurons: 212.2;Inhibitory neurons: 131.8;Late spermatids: 108.4;Oligodendrocyte precursor cells: 133.2;T-cells: 83.3"	"Low cancer specificity"	"Detected in some"			"Group enriched"	"Detected in many"	6	"basal ganglia: 30.6;cerebellum: 70.4"	"Group enriched"	"Detected in many"	4	"MAIT T-cell: 24.3;memory CD4 T-cell: 17.3;memory CD8 T-cell: 13.5;naive CD4 T-cell: 33.1;naive CD8 T-cell: 18.5;T-reg: 21.3"	"Lineage enriched"	"Detected in many"	23	"T-cells: 33.1"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 88.9;JURKAT: 61.3;MOLT-4: 27.9;SH-SY5Y: 33.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004347, HPA011753, HPA017206"	Approved		Supported	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 58: T-cells - T-cell receptor"	"Nucleoplasm, Nucleoli fibrillar center"		"CAB004347: AB_626793, HPA011753: AB_1845950, HPA017206: AB_1845949"	"unprognostic (2.99e-5)"	"unprognostic (7.19e-2)"	"unprognostic (3.43e-3)"	"unprognostic (5.11e-2)"	"unprognostic (4.75e-3)"	"unprognostic (3.48e-2)"	"unprognostic (7.66e-4)"	"unprognostic (7.22e-3)"	"unprognostic (2.49e-1)"	"unprognostic (2.92e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.46e-1)"	"unprognostic (2.23e-5)"	"unprognostic (2.42e-2)"	"unprognostic (3.01e-2)"	"unprognostic (1.66e-1)"	"unprognostic (9.99e-3)"	0.4	3.8	5.0	4.4	30.6	3.1	0.4	70.4	8.2	0.9	0.0	1.3	1.4	0.6	0.3	0.7	0.3	1.5	0.1	7.6	0.0	0.7	1.4	1.1	8.1	0.0	0.4	0.6	0.4	0.0	0.6	0.2	1.4	3.4	1.4	4.7	0.4	1.4	0.1	0.1	2.3	0.8	0.0	2.6	1.5	9.4	0.8	55.4	0.2	0.0	5.2	1.7	0.4	0.0	0.0	0.0	3.1	2.1	0.6	2.3	0.0	0.8	6.8	8.0	7.8	0.0	0.1	0.0	4.0	0.4	5.4	0.3	6.8	0.8	5.8	88.9	5.2	1.3	2.8	0.0	0.2	0.6	0.3	0.3	0.0	16.8	1.7	4.9	1.4	61.3	0.0	3.3	0.4	0.0	27.9	0.0	4.1	0.0	0.2	4.0	5.0	0.2	2.9	0.1	18.8	33.5	1.2	0.0	5.6	0.2	0.1	0.5	0.1	16.3	9.5	0.1	14.7	2.6	0.3	0.0	8.0	0.0	6.3	0.1	0.0	0.0	4.8	0.0	24.3	1.3	17.3	13.5	0.0	0.3	33.1	18.5	0.9	1.4	0.0	0.1	21.3	5.5	5.0	30.6	70.4	8.2	7.6	0.0	0.0	0.4	1.4	0.0	0.8	0.0	1.8	0.0	1.1	57.8	9.4	1.1	0.3	1.3	8.6	70.9	0.6	0.6	5.3	0.0	0.0	0.0	0.0	0.1	3.1	0.1	0.0	0.1	306.2	0.2	1.6	1.1	0.0	0.0	212.2	0.0	0.2	4.6	3.6	0.4	4.5	0.3	0.7	0.3	0.2	0.0	131.8	0.8	0.0	1.3	2.1	108.4	4.1	2.0	0.0	12.2	2.7	2.8	1.0	133.2	5.4	1.2	0.0	1.5	11.5	0.5	0.0	0.1	0.1	4.3	0.0	0.6	3.8	30.3	6.2	2.4	1.0	0.0	83.3	0.1	0.0	0.3
CAMKK1	"CAMKKA, DKFZp761M0423, MGC34095"	ENSG00000004660	"Calcium/calmodulin dependent protein kinase kinase 1"	Q8N5S9	17	3860315-3894891	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Calmodulin-binding, Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 54.4"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 41.9;Excitatory neurons: 52.7;Rod photoreceptor cells: 25.1"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"amygdala: 21.5;basal ganglia: 24.2;cerebral cortex: 54.4;hippocampal formation: 24.8;white matter: 31.9"	"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HeLa: 28.3;U-87 MG: 27.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009111, HPA028062"	Approved		Supported	Cytosol		No	No			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 20: HeLa - Mitochondria"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Cytosol		"CAB009111: AB_2068406, HPA028062: AB_1845954"	"unprognostic (1.39e-2)"	"unprognostic (2.13e-1)"	"unprognostic (8.66e-3)"	"unprognostic (4.40e-3)"	"unprognostic (2.94e-3)"	"unprognostic (4.79e-2)"	"unprognostic (1.98e-1)"	"unprognostic (4.47e-3)"	"unprognostic (8.23e-2)"	"unprognostic (1.03e-2)"	"prognostic favorable (2.65e-4)"	"unprognostic (1.98e-1)"	"unprognostic (1.59e-1)"	"unprognostic (7.19e-2)"	"unprognostic (8.70e-2)"	"unprognostic (8.36e-2)"	"unprognostic (3.10e-1)"	6.0	10.7	21.5	5.2	24.2	4.1	5.4	5.6	54.4	12.7	0.0	10.2	2.9	13.1	4.8	6.8	7.0	3.6	5.7	24.8	0.8	3.6	1.0	5.0	2.6	6.0	1.9	8.1	12.7	4.1	24.4	2.0	6.6	8.2	2.7	12.0	29.9	10.4	3.4	15.9	6.9	5.8	0.6	9.6	4.2	10.1	5.0	5.1	7.6	1.6	2.3	16.1	13.8	31.9	7.0	11.8	1.2	5.9	4.1	7.2	0.4	4.7	5.1	4.4	2.0	4.3	2.1	4.2	5.0	9.1	4.6	20.3	3.2	5.8	2.7	0.1	10.7	4.8	28.3	1.6	4.2	0.7	3.6	5.5	4.9	8.4	2.8	3.8	2.0	6.0	3.8	0.2	2.2	1.9	6.0	2.7	1.3	10.1	11.0	3.0	5.1	4.8	4.8	4.4	6.7	3.8	1.8	13.9	3.1	0.7	5.3	1.6	2.8	7.6	10.2	9.9	4.0	0.5	0.3	0.1	27.9	4.0	1.0	0.0	0.9	1.9	0.2	2.0	0.5	0.0	0.3	0.2	0.8	0.0	0.3	0.1	2.7	0.0	2.1	0.4	0.0	0.7	21.5	24.2	5.6	54.4	24.8	0.8	6.0	1.9	6.6	0.6	5.0	31.9	5.5	6.4	12.5	8.1	7.0	3.7	2.1	1.5	1.8	41.9	2.5	1.3	6.3	0.0	3.3	1.8	16.7	0.3	3.4	1.7	0.0	0.4	0.1	1.7	7.8	5.6	4.2	0.4	52.7	1.6	0.1	5.5	0.5	1.6	17.1	0.9	2.9	0.6	4.3	8.4	13.9	1.3	2.0	3.2	3.3	1.3	1.2	6.9	8.8	9.4	0.8	4.7	2.1	4.0	3.5	0.6	0.6	1.2	2.2	2.2	0.2	0.3	1.5	25.1	0.0	2.0	1.7	0.1	1.1	4.1	5.4	0.3	2.9	1.2	2.1	1.1
CAMKK2	"CAMKK, CAMKKB, KIAA0787, MGC15254"	ENSG00000110931	"Calcium/calmodulin dependent protein kinase kinase 2"	Q96RR4	12	121237675-121298308	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Calmodulin-binding, Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 135.4"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 64.8;Horizontal cells: 62.2;Late spermatids: 89.6"	"Cancer enriched"	"Detected in all"	5	"prostate cancer: 56.3"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"classical monocyte: 32.7;eosinophil: 62.1;intermediate monocyte: 42.3;myeloid DC: 15.9;neutrophil: 39.2;non-classical monocyte: 39.5"	"Group enriched"	"Detected in all"	5	"dendritic cells: 15.9;granulocytes: 62.1;monocytes: 42.3"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017389, HPA063713"	Approved	Supported	Supported	Cytosol		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 31: Spermatids - Spermatogenesis"	Cytosol		"HPA017389: AB_1845956, HPA063713: "	"unprognostic (5.08e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.38e-1)"	"unprognostic (3.08e-1)"	"unprognostic (1.88e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.62e-3)"	"unprognostic (2.80e-2)"	"unprognostic (1.93e-1)"	"unprognostic (7.76e-2)"	"unprognostic (5.01e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.75e-1)"	"unprognostic (4.13e-1)"	"unprognostic (3.34e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.38e-1)"	26.0	16.7	39.6	17.0	56.2	30.8	22.7	135.4	65.5	22.3	14.3	22.8	25.7	22.9	10.8	17.5	27.5	12.9	17.8	44.8	24.8	16.7	30.9	23.6	15.3	20.8	20.1	27.4	16.8	12.4	11.8	15.3	24.9	29.5	19.4	7.1	18.6	23.8	11.5	18.3	26.6	20.7	18.3	39.6	24.0	7.0	23.6	13.4	17.1	11.2	15.6	25.9	21.1	42.7	27.9	20.5	16.3	30.9	46.7	43.0	22.8	22.0	23.8	19.0	17.3	21.4	12.1	43.0	18.1	48.1	14.1	22.7	20.0	25.8	15.1	29.3	35.9	22.0	14.4	21.3	31.1	50.0	20.0	28.2	37.2	18.0	41.4	26.0	45.0	33.5	25.2	23.6	18.4	27.2	55.8	40.6	11.7	24.9	22.7	35.3	18.4	37.7	18.8	32.1	60.2	22.4	31.5	16.5	19.1	12.9	39.7	62.0	32.2	14.8	11.8	13.1	13.0	84.8	55.6	32.7	27.7	34.4	16.0	2.0	32.7	62.1	4.7	42.3	4.6	4.8	3.5	4.2	15.9	2.8	3.2	3.8	39.2	8.6	39.5	3.6	3.3	15.8	39.6	56.2	135.4	65.5	44.8	24.8	20.8	20.1	24.9	18.3	23.6	42.7	25.4	9.6	5.6	9.8	5.7	7.9	6.0	8.1	8.0	22.2	11.6	10.5	8.2	12.8	8.3	9.2	2.1	9.2	10.6	18.2	3.9	9.6	16.0	6.5	19.6	21.9	34.3	12.0	64.8	10.4	8.2	18.0	13.3	10.9	6.3	23.3	15.0	19.7	7.9	62.2	21.4	16.2	8.2	14.8	15.6	89.6	20.5	16.6	8.8	12.2	36.3	5.4	12.3	10.1	19.3	8.5	10.9	31.6	11.9	16.5	26.6	9.6	7.2	7.0	19.7	7.7	20.6	0.8	2.9	13.3	6.0	3.4	7.6	32.7	17.6	6.3
CAMKMT	"C2orf34, CLNMT"	ENSG00000143919	"Calmodulin-lysine N-methyltransferase"	Q7Z624	2	44361947-44772592	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 155.1;Excitatory neurons: 88.7;Inhibitory neurons: 93.7;Microglial cells: 114.3;Oligodendrocyte precursor cells: 121.2;Oligodendrocytes: 211.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA067912			Supported	Nucleoplasm		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Nucleoplasm		"HPA067912: AB_2685922"	"unprognostic (2.28e-1)"	"unprognostic (6.15e-2)"	"unprognostic (1.96e-1)"	"unprognostic (2.39e-2)"	"prognostic favorable (9.10e-4)"	"unprognostic (1.03e-1)"	"unprognostic (9.58e-3)"	"unprognostic (1.46e-3)"	"unprognostic (1.85e-1)"	"unprognostic (7.42e-2)"	"unprognostic (8.76e-2)"	"unprognostic (1.37e-1)"	"unprognostic (3.33e-1)"	"unprognostic (4.82e-2)"	"unprognostic (4.66e-2)"	"unprognostic (1.70e-1)"	"unprognostic (8.57e-2)"	4.2	5.3	15.9	3.9	21.1	10.2	5.3	19.4	21.1	5.9	17.8	7.0	5.3	4.1	6.5	6.1	4.9	5.7	5.0	15.5	17.1	7.5	4.8	3.9	5.4	17.7	16.4	3.9	9.8	9.8	5.6	3.3	17.3	3.5	6.8	8.5	4.8	3.9	7.8	5.8	5.7	3.9	15.5	3.7	5.8	13.2	17.9	6.2	7.3	3.3	5.4	4.5	4.7	20.4	10.2	6.2	7.4	6.8	8.0	8.1	15.0	7.4	6.0	4.3	5.5	11.9	9.0	9.6	8.6	5.6	5.3	8.3	10.6	13.2	7.6	35.2	13.3	14.2	12.1	22.4	3.1	9.4	9.5	2.6	8.0	5.9	10.9	6.1	6.4	9.9	10.4	17.1	7.1	10.9	17.6	19.1	13.9	24.6	6.1	10.3	8.3	19.4	20.8	11.6	14.0	13.4	7.6	24.1	9.2	7.0	8.8	7.7	7.6	5.5	6.4	6.1	5.9	13.3	11.5	18.2	6.1	16.5	3.9	13.1	8.2	6.2	11.1	6.9	11.5	20.9	11.2	9.7	9.7	14.7	16.9	13.4	5.2	8.7	8.4	10.1	18.3	6.9	15.9	21.1	19.4	21.1	15.5	17.1	17.7	16.4	17.3	15.5	17.9	20.4	5.4	6.4	3.1	155.1	11.0	5.2	7.9	10.9	9.1	5.3	6.6	5.2	2.2	10.0	5.5	9.2	0.0	3.3	6.9	4.5	23.5	13.3	74.3	8.2	7.2	4.0	0.0	13.3	88.7	15.6	4.5	6.2	11.7	10.0	5.7	2.0	3.3	6.3	5.8	1.7	93.7	5.5	20.3	1.9	4.9	39.0	8.1	4.3	10.6	114.3	6.4	20.3	13.4	121.2	211.7	8.6	8.3	5.7	13.3	5.8	7.2	14.5	7.4	3.0	0.0	3.6	5.0	35.5	5.8	10.7	7.4	2.6	9.2	7.9	8.1	6.0
CAMSAP1	"DKFZp434F195, FLJ31228"	ENSG00000130559	"Calmodulin regulated spectrin associated protein 1"	Q5T5Y3	9	135808487-135907546	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"retina: 105.5"	"Group enriched"	"Detected in many"	6	"Cone photoreceptor cells: 339.9;Rod photoreceptor cells: 236.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020527, HPA024161"	Approved		Supported	"Mitotic spindle,Cytosol"		Yes	No			"Cluster 34: Basophils - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 9: Photoreceptor cells - Phototransduction"	"Mitotic spindle, Cytosol"		"HPA020527: , HPA024161: AB_1845967"	"unprognostic (3.18e-3)"	"unprognostic (4.16e-2)"	"unprognostic (6.44e-2)"	"unprognostic (1.57e-2)"	"unprognostic (6.00e-2)"	"unprognostic (1.43e-2)"	"unprognostic (1.79e-3)"	"unprognostic (1.22e-1)"	"unprognostic (2.75e-1)"	"unprognostic (6.13e-2)"	"unprognostic (1.41e-1)"	"unprognostic (9.16e-2)"	"prognostic favorable (3.09e-5)"	"unprognostic (1.12e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.66e-3)"	6.7	7.4	12.5	5.5	12.7	10.3	5.4	12.7	12.6	9.2	2.5	7.4	3.2	7.5	5.2	20.0	7.7	5.2	7.8	14.1	9.8	5.1	4.3	6.8	5.8	8.3	9.3	10.7	7.9	6.1	8.7	5.2	8.8	6.2	3.5	105.5	7.5	6.5	32.8	10.4	4.4	6.9	5.6	5.3	5.0	18.1	11.5	11.1	4.4	17.5	6.9	7.4	11.7	11.6	15.4	22.3	36.0	25.5	8.2	7.1	17.6	12.2	10.2	13.0	9.8	19.7	13.2	7.1	17.0	15.4	16.7	30.8	19.0	13.2	9.7	24.0	10.5	10.3	24.9	9.9	12.4	18.0	14.8	9.5	16.3	16.6	22.6	12.3	14.8	15.5	21.4	15.0	17.1	27.5	16.8	11.0	20.4	18.2	15.8	32.5	29.7	17.4	12.8	18.7	39.1	38.2	15.6	11.2	17.0	11.7	15.9	14.6	18.3	24.6	19.0	18.3	20.9	7.3	14.7	19.2	16.0	12.0	14.5	1.5	0.3	0.0	0.2	0.4	0.4	0.6	0.4	0.3	0.2	0.1	0.3	0.4	0.1	0.2	0.3	0.2	0.3	0.3	12.5	12.7	12.7	12.6	14.1	9.8	8.3	9.3	8.8	5.6	11.5	11.6	6.3	6.4	3.9	31.6	5.5	22.7	17.4	10.8	9.6	34.4	11.8	9.8	14.0	4.3	15.7	3.7	339.9	12.6	5.8	4.5	0.0	11.8	13.1	41.5	13.2	8.8	12.6	6.6	37.7	8.9	3.5	6.6	8.2	32.4	6.3	20.4	7.5	8.2	10.3	16.8	34.1	4.4	10.2	8.1	13.5	15.8	5.9	11.7	12.4	25.3	12.2	19.2	4.1	27.2	35.9	15.7	3.0	6.0	11.9	14.2	2.7	4.3	37.1	236.1	13.1	16.8	11.7	24.4	34.4	35.2	31.7	5.6	6.5	15.6	4.5	24.8
CAMSAP2	"CAMSAP1L1, KIAA1078"	ENSG00000118200	"Calmodulin regulated spectrin associated protein family member 2"	Q08AD1	1	200739558-200860704	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 194.4;Inhibitory neurons: 189.1;Oligodendrocyte precursor cells: 275.5;Oligodendrocytes: 155.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"hTERT-HME1: 161.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026304, HPA026511, HPA027302"	Enhanced		Supported	"Microtubule ends,Cytosol"		NA	NA				"Cluster 21: Non-specific - Transcription"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 68: Oligodendrocytes - Mixed function"	"Microtubule ends"	Cytosol	"HPA026304: AB_1852376, HPA026511: AB_1852378, HPA027302: AB_1852380"	"unprognostic (1.19e-1)"	"unprognostic (9.98e-3)"	"unprognostic (1.44e-1)"	"unprognostic (9.52e-2)"	"unprognostic (7.96e-3)"	"unprognostic (4.82e-2)"	"prognostic unfavorable (2.11e-4)"	"unprognostic (1.34e-2)"	"unprognostic (5.41e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.66e-2)"	"unprognostic (1.56e-1)"	"unprognostic (2.92e-2)"	"unprognostic (1.38e-3)"	"unprognostic (1.95e-1)"	"unprognostic (8.23e-3)"	"unprognostic (9.56e-2)"	15.2	16.0	16.4	6.6	20.0	0.3	11.9	22.3	27.9	13.6	0.0	10.6	3.9	16.2	10.2	11.0	10.7	12.1	11.1	20.6	14.6	11.8	7.1	12.5	3.7	14.2	12.7	19.1	5.0	21.9	9.7	18.4	14.4	10.9	6.3	26.0	7.8	13.0	8.2	13.9	5.1	15.7	11.1	8.3	7.3	15.0	15.5	5.3	18.8	13.4	5.5	14.3	12.2	19.3	33.4	22.1	29.9	27.1	23.6	30.9	34.3	32.9	28.4	26.0	21.5	16.1	19.7	0.0	18.3	36.7	23.8	29.4	31.1	48.5	31.1	19.8	15.8	1.7	32.9	7.4	26.3	2.1	8.2	22.6	72.9	41.7	161.7	28.0	40.1	2.8	4.3	10.2	42.6	17.5	0.4	0.7	27.9	10.2	30.8	13.4	32.8	15.1	22.2	24.3	15.6	27.7	48.5	29.6	27.6	36.1	28.4	1.8	48.3	42.3	25.1	26.6	41.2	20.4	36.0	17.2	30.7	5.2	32.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	16.4	20.0	22.3	27.9	20.6	14.6	14.2	12.7	14.4	11.1	15.5	19.3	64.0	60.9	39.1	114.9	1.2	79.8	26.8	22.4	51.8	50.9	14.4	15.6	93.5	10.0	34.5	14.7	14.6	17.3	0.6	4.3	1.9	15.2	30.3	14.3	44.7	50.1	11.9	0.0	194.4	8.2	16.4	36.4	14.3	29.9	5.1	22.3	29.6	6.4	10.1	50.5	189.1	2.6	10.2	11.3	32.7	35.7	28.6	12.5	19.6	78.7	4.3	53.5	2.1	275.5	155.5	18.7	2.0	45.5	1.1	24.8	1.5	6.3	9.3	17.0	26.3	39.6	41.4	27.4	20.0	25.8	49.2	40.0	2.6	37.8	4.3	30.0
CAMSAP3	"KIAA1543, Nezha, PPP1R80"	ENSG00000076826	"Calmodulin regulated spectrin associated protein family member 3"	Q9P1Y5	19	7595863-7618304	"Plasma proteins, Predicted intracellular proteins"	"Cilium biogenesis/degradation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skin 1: 62.7"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 40.0;Gastric mucus-secreting cells: 38.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"CACO-2: 26.7;Hep G2: 15.6;MCF7: 13.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043830, HPA062149"	Enhanced		Approved	Nucleoplasm,Centrosome		NA	NA				"Cluster 31: Skin - Epidermis development"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 30: Mammary glandular cells - Lactation"	"Nucleoplasm, Centrosome"		"HPA043830: AB_10795879, HPA062149: AB_2684698"	"unprognostic (3.83e-2)"	"unprognostic (1.18e-1)"	"unprognostic (8.67e-2)"	"unprognostic (7.90e-3)"	"unprognostic (3.66e-1)"	"unprognostic (3.87e-3)"	"unprognostic (7.00e-2)"	"unprognostic (2.80e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.64e-1)"	"unprognostic (2.30e-2)"	"unprognostic (1.41e-1)"	"prognostic favorable (7.55e-7)"	"unprognostic (2.16e-2)"	"unprognostic (3.88e-2)"	"unprognostic (3.72e-2)"	"unprognostic (1.59e-3)"	0.4	3.3	3.2	0.8	4.4	0.0	5.3	2.5	9.0	7.7	0.1	10.3	14.9	0.5	2.3	24.8	3.1	1.6	0.4	4.2	0.7	12.0	24.3	4.6	0.2	2.5	0.0	0.5	20.6	2.7	8.2	0.4	0.4	10.2	2.4	3.2	18.1	4.5	0.2	62.7	11.5	0.1	0.0	0.6	15.5	13.0	0.2	0.5	11.1	0.0	1.1	3.6	13.4	2.4	11.2	1.8	0.3	0.9	0.0	0.0	2.0	0.0	0.0	0.0	0.0	26.7	5.8	3.1	4.5	0.0	1.2	9.7	4.3	2.8	0.0	2.0	10.1	0.0	0.5	15.6	0.0	0.0	4.4	0.0	5.5	0.0	0.4	0.4	0.0	4.5	0.9	0.0	0.0	13.0	0.2	0.2	6.6	8.4	4.7	0.7	0.0	3.7	1.9	6.0	8.2	8.7	1.3	12.5	0.0	1.6	10.4	1.7	0.0	0.0	2.0	0.0	0.4	5.0	1.0	0.2	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	4.4	2.5	9.0	4.2	0.7	2.5	0.0	0.4	0.0	0.2	2.4	0.2	9.6	19.2	3.3	1.1	9.8	2.7	2.4	3.4	22.7	19.3	12.1	1.5	20.0	5.3	9.2	0.0	0.5	0.2	40.0	3.9	5.7	4.4	9.6	1.4	1.5	13.1	0.0	9.1	11.8	0.7	0.2	38.7	13.5	5.7	8.6	0.4	24.8	0.2	10.1	10.1	22.4	0.0	1.9	1.2	2.9	1.5	1.0	0.0	1.9	0.0	1.5	0.0	4.5	0.6	13.1	28.4	0.0	0.6	6.2	29.2	15.6	2.9	13.4	0.0	0.0	1.1	0.4	2.8	9.8	18.9	0.5	0.9	1.5	18.4	8.0
CAMTA1	KIAA0833	ENSG00000171735	"Calmodulin binding transcription activator 1"	Q9Y6Y1	1	6785454-7769706	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	Activator	"Cancer-related genes, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036342, HPA036343"	Approved		Supported	Cytosol		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 39: Non-specific - Basic cellular processes"	Cytosol		"HPA036342: AB_2675072, HPA036343: AB_10671839"	"unprognostic (1.11e-1)"	"unprognostic (6.31e-2)"	"unprognostic (5.80e-2)"	"unprognostic (4.14e-3)"	"unprognostic (3.10e-2)"	"unprognostic (1.47e-2)"	"prognostic unfavorable (5.25e-4)"	"unprognostic (1.08e-2)"	"unprognostic (3.59e-1)"	"prognostic favorable (4.10e-4)"	"unprognostic (3.90e-3)"	"unprognostic (8.84e-2)"	"unprognostic (1.35e-3)"	"unprognostic (2.17e-2)"	"unprognostic (9.19e-3)"	"unprognostic (1.42e-1)"	"unprognostic (9.03e-3)"	37.1	43.7	56.2	23.6	55.3	26.5	38.7	63.4	75.8	33.0	29.4	71.8	52.8	40.1	81.7	37.5	36.0	30.4	114.0	55.0	68.6	68.4	70.5	36.7	27.3	69.4	66.0	35.4	26.4	43.3	35.5	26.4	68.7	47.0	48.5	68.2	50.5	50.5	101.6	26.0	41.1	42.4	61.5	30.7	45.2	44.5	66.4	31.9	52.0	104.7	33.5	56.5	35.2	60.8	67.6	37.2	101.2	51.7	51.2	77.6	28.4	71.0	54.7	75.3	63.1	45.1	83.2	55.5	54.6	75.2	50.3	40.8	53.6	73.7	106.5	41.8	57.8	62.7	85.1	89.6	83.0	48.2	43.6	52.5	50.2	54.5	83.0	64.6	85.1	77.7	44.8	73.2	87.9	65.0	64.6	130.9	70.2	85.2	43.2	42.5	90.2	123.7	103.4	38.7	104.2	83.7	50.4	74.1	113.9	72.3	40.2	59.4	50.1	53.1	44.9	55.3	45.2	55.2	74.3	153.2	79.6	107.4	30.7	80.1	74.7	70.5	25.8	48.5	28.3	48.1	39.8	32.0	73.4	41.8	32.2	28.1	15.4	26.7	37.9	77.5	45.6	46.3	56.2	55.3	63.4	75.8	55.0	68.6	69.4	66.0	68.7	61.5	66.4	60.8	142.1	54.5	48.8	314.7	74.3	309.7	340.6	306.6	169.0	106.7	231.7	283.2	565.2	101.5	135.3	191.3	252.3	69.8	44.3	198.3	418.7	180.1	166.1	84.1	80.3	155.8	130.8	81.8	346.1	206.3	144.9	134.4	63.2	99.8	55.2	205.4	106.1	239.0	106.3	158.2	479.3	185.8	223.8	95.5	254.0	137.9	76.4	122.0	238.3	117.1	172.9	112.3	38.1	330.3	227.5	184.2	234.5	128.6	87.9	486.4	251.7	750.7	117.1	156.2	138.1	91.1	233.2	151.0	211.0	158.9	282.7	88.1	68.2	137.8	186.5	413.7
CANT1	"SCAN-1, SHAPY"	ENSG00000171302	"Calcium activated nucleotidase 1"	Q8WVQ1	17	78991716-79009867	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		Hydrolase	"Cancer-related genes, Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal enterocytes: 139.5;Intestinal goblet cells: 155.6;Syncytiotrophoblasts: 101.5;Undifferentiated cells: 100.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"OE19: 445.4;T-47d: 282.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019627, HPA019639, HPA022818"	Enhanced		Supported	"Golgi apparatus"		NA	Yes		3300000	"Cluster 52: Eosinophils - Transcription"	"Cluster 37: Intestine - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 27: Mucus-secreting cells - Mucin production"	"Golgi apparatus"		"HPA019627: AB_1845969, HPA019639: AB_1845970, HPA022818: AB_1845971"	"unprognostic (1.98e-2)"	"unprognostic (2.49e-2)"	"unprognostic (1.50e-2)"	"unprognostic (5.36e-2)"	"unprognostic (2.13e-2)"	"unprognostic (2.21e-2)"	"prognostic unfavorable (1.41e-4)"	"prognostic unfavorable (2.90e-4)"	"unprognostic (1.76e-1)"	"unprognostic (9.00e-2)"	"unprognostic (3.30e-1)"	"unprognostic (2.49e-1)"	"prognostic unfavorable (6.21e-4)"	"unprognostic (7.04e-2)"	"unprognostic (5.06e-2)"	"unprognostic (1.16e-1)"	"unprognostic (7.23e-2)"	15.8	23.9	10.4	24.7	12.4	19.1	25.4	13.6	11.3	32.3	13.8	89.2	51.9	17.4	8.7	44.8	18.2	25.2	17.0	11.1	12.6	16.1	17.3	16.4	15.2	14.6	14.5	14.6	19.6	24.5	17.5	25.9	13.9	71.8	82.8	7.4	62.7	32.4	14.9	14.9	55.5	15.5	13.8	26.5	51.1	20.7	14.5	14.7	13.9	12.4	15.1	16.7	21.7	17.8	106.5	112.1	31.9	46.3	29.7	35.2	38.9	66.0	51.3	66.7	55.9	53.8	99.6	25.3	36.1	46.1	83.0	53.7	27.1	49.8	68.4	43.0	46.4	33.7	34.1	45.9	25.0	33.0	51.6	33.7	32.4	62.7	34.2	40.9	116.1	42.5	42.3	43.2	46.4	58.4	50.2	19.8	22.1	445.4	103.1	27.6	51.8	29.8	29.8	53.5	45.6	45.4	33.9	227.2	50.2	50.3	282.6	38.6	56.6	101.9	90.5	46.4	83.1	48.9	43.8	24.3	64.4	24.9	65.3	6.3	4.0	8.7	5.5	4.4	5.7	3.9	4.3	4.8	3.8	2.5	4.1	4.1	17.4	3.1	3.0	2.7	3.6	4.6	10.4	12.4	13.6	11.3	11.1	12.6	14.6	14.5	13.9	13.8	14.5	17.8	12.6	28.9	20.6	5.9	11.8	16.6	15.3	16.8	6.8	6.4	49.9	16.3	13.3	14.3	15.1	12.9	14.6	36.6	8.9	139.5	3.9	34.7	14.0	10.7	13.1	16.3	51.0	15.2	4.1	28.8	39.4	13.5	38.2	19.0	5.7	20.0	41.7	14.4	24.9	5.0	5.2	155.6	16.2	12.4	9.5	15.7	11.8	14.2	14.2	3.7	18.1	8.1	11.3	5.0	10.2	37.7	55.8	7.5	16.6	33.4	39.4	6.7	9.7	8.7	6.6	9.5	13.3	23.9	5.8	12.0	13.1	101.5	11.1	11.3	100.2	19.4
CAPN1	"CANP, CANPL1, muCANP, muCL"	ENSG00000014216	"Calpain 1"	P07384	11	65180566-65212006	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Hydrolase, Protease, Thiol protease"	"Disease variant, Hereditary spastic paraplegia, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 276.2"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RT4: 516.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005992	Enhanced		Supported	Cytosol		NA	NA		9100000	"Cluster 46: Basophils - DNA binding"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 15: RT4 - Unknown function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Cytosol		"HPA005992: AB_1845924"	"unprognostic (2.07e-1)"	"unprognostic (2.15e-1)"	"unprognostic (2.69e-1)"	"unprognostic (1.40e-1)"	"unprognostic (4.06e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.91e-2)"	"unprognostic (2.48e-2)"	"unprognostic (7.23e-2)"	"unprognostic (2.23e-2)"	"prognostic unfavorable (4.30e-4)"	"unprognostic (3.33e-1)"	"prognostic favorable (7.06e-8)"	"unprognostic (5.70e-3)"	"unprognostic (1.51e-1)"	"unprognostic (1.86e-1)"	"unprognostic (2.98e-1)"	44.8	43.1	27.8	51.9	26.1	66.5	48.4	29.7	30.1	80.9	28.3	78.6	80.4	56.3	27.5	276.2	92.3	55.5	53.1	27.7	33.0	53.1	44.3	56.9	57.0	41.4	31.5	44.5	71.7	36.6	40.8	56.2	43.4	62.1	57.6	9.6	118.7	67.4	84.8	125.1	88.1	45.3	33.9	50.2	65.5	6.1	37.9	49.5	71.5	55.3	86.4	83.4	117.4	27.4	285.6	147.9	42.9	97.2	77.9	104.3	127.0	84.1	144.2	103.0	74.9	94.8	250.2	71.2	136.0	179.3	111.1	409.8	60.9	366.9	32.2	76.4	44.1	170.8	80.4	93.7	76.2	40.6	228.0	107.3	196.8	85.9	43.2	92.6	178.5	50.6	103.1	55.9	87.4	181.8	83.1	130.6	120.5	145.2	133.8	80.7	43.0	43.2	138.1	516.5	76.2	55.7	87.4	331.4	80.3	45.8	142.8	77.9	147.1	73.1	50.5	159.0	38.5	33.8	26.9	86.6	127.5	48.8	82.3	87.6	57.5	77.9	39.4	51.2	31.0	30.8	30.7	35.8	48.4	31.7	17.6	24.9	33.1	34.8	30.4	38.1	35.9	74.8	27.8	26.1	29.7	30.1	27.7	33.0	41.4	31.5	43.4	33.9	37.9	27.4	27.3	25.6	27.9	21.5	39.6	59.9	127.3	120.5	56.9	10.7	44.7	36.6	22.0	74.4	81.0	77.3	20.9	238.5	61.4	184.2	39.2	180.5	0.5	41.9	26.3	31.3	44.3	58.3	15.9	115.8	111.7	39.6	57.6	58.2	46.9	48.6	37.9	36.7	88.7	21.9	15.2	76.9	59.0	51.2	34.0	2.0	43.5	67.1	48.0	14.0	112.7	38.5	61.8	6.6	1.9	179.4	124.1	50.8	17.7	78.6	155.6	34.6	71.1	16.2	39.5	25.3	36.7	0.5	2.8	102.0	68.9	196.6	40.2	35.4	125.3	156.6
CAPN2	"CANPL2, CANPml, mCANP"	ENSG00000162909	"Calpain 2"	P17655	1	223701593-223776018	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"TIME: 858.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024470	Approved	Approved	Supported	Cytosol		NA	NA		2800000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	Cytosol		"HPA024470: AB_1845925"	"unprognostic (2.77e-2)"	"unprognostic (1.27e-3)"	"unprognostic (2.03e-1)"	"unprognostic (3.39e-2)"	"unprognostic (2.12e-1)"	"unprognostic (3.32e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.85e-1)"	"unprognostic (1.96e-1)"	"prognostic unfavorable (2.50e-4)"	"unprognostic (1.21e-1)"	"prognostic favorable (2.19e-4)"	"unprognostic (1.61e-1)"	"unprognostic (2.63e-1)"	"unprognostic (2.62e-1)"	"prognostic unfavorable (6.21e-4)"	118.8	93.9	40.2	64.9	50.0	40.9	92.4	45.3	39.6	110.4	29.4	140.1	46.2	67.7	58.0	134.3	120.5	119.7	71.8	36.9	42.7	115.2	31.2	182.5	35.5	51.9	46.1	83.2	55.1	136.3	28.0	68.3	46.6	47.5	131.4	19.2	151.2	91.2	82.2	41.6	58.5	87.3	43.4	42.5	130.4	26.3	49.1	27.0	80.9	81.6	54.3	85.6	89.3	49.3	419.9	263.7	79.2	54.9	257.6	356.6	79.4	383.9	541.3	267.2	151.1	209.2	323.6	0.4	125.0	417.1	209.1	255.1	86.3	593.1	243.4	109.8	95.2	7.8	124.9	25.6	232.3	21.5	13.9	193.3	187.3	416.6	217.8	472.3	537.1	0.1	123.2	106.8	789.3	8.6	1.0	19.4	45.5	49.7	346.3	35.4	262.4	7.3	454.9	24.3	17.7	94.7	198.1	524.2	122.8	189.7	80.9	98.7	858.1	252.7	212.0	220.6	498.4	32.5	66.8	1.4	625.3	46.2	284.7	7.9	118.6	7.2	106.8	77.9	89.8	34.4	72.6	103.2	163.9	16.6	22.9	62.2	6.1	24.5	73.7	7.4	81.7	136.6	40.2	50.0	45.3	39.6	36.9	42.7	51.9	46.1	46.6	43.4	49.1	49.3	240.0	394.2	134.9	82.9	42.3	47.3	136.6	197.5	38.7	12.0	35.7	32.8	38.4	115.8	264.4	53.3	33.3	24.4	72.4	356.0	181.9	271.4	94.5	70.0	52.7	125.3	24.6	6.9	13.3	195.9	92.0	105.0	103.5	93.3	27.8	47.8	35.7	9.7	38.9	13.5	23.1	104.4	242.1	50.0	239.3	232.8	77.3	86.4	112.1	22.5	66.0	22.6	78.2	48.7	21.6	373.0	191.5	68.8	83.3	237.7	104.1	23.6	288.8	18.0	39.5	85.0	107.9	3.4	3.3	67.5	27.6	8.2	83.5	63.5	98.2	268.2
CAPN6	"CalpM, CANPX, CAPNX"	ENSG00000077274	"Calpain 6"	Q9Y6Q1	X	111245099-111270483	"Cancer-related genes, Enzymes, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"epididymis: 212.7;placenta: 83.1;seminal vesicle: 72.4"	"Group enriched"	"Detected in some"	4	"Extravillous trophoblasts: 198.5;Syncytiotrophoblasts: 140.5"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 25.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"HDLM-2: 10.8;NTERA-2: 16.3;SuSa: 14.3"	"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"spinal cord: 9.6"	HPA040259			Approved	"Nucleoplasm,Centriolar satellite,Cytosol"		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 30: Epididymis - Antimicrobial activity"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 38: Extravillous trophoblasts - Unknown function"	"Centriolar satellite"	"Nucleoplasm, Cytosol"	"HPA040259: "	"unprognostic (1.27e-3)"	"unprognostic (2.04e-1)"	"unprognostic (2.69e-2)"	"unprognostic (5.77e-3)"	"unprognostic (2.07e-1)"	"unprognostic (9.93e-2)"	"unprognostic (8.39e-3)"	"unprognostic (1.06e-1)"	"unprognostic (2.08e-1)"	"unprognostic (9.45e-3)"	"unprognostic (5.12e-1)"	"unprognostic (6.25e-2)"	"unprognostic (7.67e-2)"	"unprognostic (6.50e-2)"	"unprognostic (5.02e-3)"	"unprognostic (2.66e-1)"	"unprognostic (6.30e-2)"	2.1	0.0	0.0	7.2	0.0	0.0	12.7	0.0	0.0	11.9	0.0	5.6	1.8	22.5	212.7	2.3	3.2	8.4	0.3	0.0	0.0	11.5	0.3	0.5	2.8	0.0	0.0	2.6	7.5	0.1	0.2	83.1	0.0	10.6	8.6	0.0	14.1	72.4	3.0	1.0	1.7	8.2	0.0	1.7	12.9	2.0	0.0	1.8	1.5	9.0	4.7	3.8	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	10.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	16.3	0.0	0.0	0.0	0.0	0.1	1.4	0.0	0.1	0.3	0.4	0.3	0.0	14.3	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	1.1	0.0	1.2	0.0	0.6	2.0	0.3	7.2	0.0	7.3	0.0	39.9	0.1	0.1	3.9	8.3	0.0	18.0	4.3	0.4	0.0	0.0	0.0	0.7	198.5	12.9	6.6	40.1	0.0	0.0	0.0	0.0	7.6	0.0	0.1	1.2	0.0	0.0	0.3	0.5	0.9	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	22.2	0.1	0.4	0.0	0.2	0.0	0.0	0.0	1.0	0.5	0.1	0.1	0.9	0.0	140.5	0.3	0.9	0.5	0.3
CAPRIN2	"C1QDC1, caprin-2, EEG1, FLJ11391, FLJ22569, RNG140"	ENSG00000110888	"Caprin family member 2"	Q6IMN6	12	30709552-30754951	"Predicted intracellular proteins"	"Differentiation, Growth regulation"	"Protein synthesis inhibitor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 37.4"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 73.8;Inhibitory neurons: 68.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA039746	Supported		Supported	Nucleoplasm,Centrosome,Cytosol		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 58: Brain - Synaptic function"	"Cluster 18: U-2197 - ECM organization"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Cytosol	"Nucleoplasm, Centrosome"	"HPA039746: AB_10672902"	"unprognostic (7.45e-2)"	"unprognostic (6.38e-2)"	"unprognostic (2.83e-3)"	"unprognostic (1.08e-1)"	"unprognostic (5.03e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.64e-2)"	"unprognostic (1.92e-1)"	"unprognostic (8.91e-2)"	"unprognostic (9.90e-2)"	"unprognostic (3.09e-1)"	"unprognostic (3.30e-2)"	"prognostic unfavorable (3.50e-5)"	"unprognostic (1.91e-1)"	"unprognostic (3.49e-2)"	"unprognostic (1.82e-1)"	"prognostic favorable (8.36e-4)"	4.2	6.1	11.7	4.0	12.1	8.5	3.7	11.3	20.3	5.7	3.2	6.3	2.8	6.3	7.4	2.9	5.1	4.4	13.5	10.7	37.4	5.7	5.6	4.7	4.3	20.5	8.8	7.3	5.8	9.4	10.0	3.0	16.3	5.6	4.0	18.0	3.2	6.9	6.0	8.0	4.9	6.1	3.8	6.1	5.5	17.4	12.7	3.6	5.0	5.0	3.6	6.0	4.3	12.1	7.4	5.1	9.4	7.9	9.1	9.5	5.7	13.4	11.2	5.7	7.7	2.8	4.6	4.3	11.5	14.1	11.3	5.8	5.0	22.0	10.3	6.5	5.6	18.0	9.5	10.4	5.1	2.9	1.8	11.1	8.4	18.2	14.6	23.6	13.0	7.7	1.1	4.3	13.6	1.4	3.7	4.6	11.0	3.9	15.2	1.6	14.1	2.1	2.5	26.1	11.7	7.1	5.0	3.6	5.6	22.3	3.2	0.9	17.8	11.0	6.0	33.5	24.9	8.1	6.1	4.1	13.2	0.9	7.3	6.2	0.8	0.7	2.4	0.3	2.9	2.6	1.5	2.6	0.4	2.1	1.7	1.6	0.1	1.7	0.4	2.4	1.1	0.6	11.7	12.1	11.3	20.3	10.7	37.4	20.5	8.8	16.3	3.8	12.7	12.1	9.8	22.4	27.7	45.1	9.0	7.1	4.9	3.8	7.4	28.9	6.4	9.1	28.7	0.0	6.3	3.7	22.9	8.6	14.7	5.3	9.8	5.6	17.2	21.8	12.2	11.6	16.7	23.5	73.8	11.2	1.7	12.2	11.2	10.0	22.1	19.6	7.9	8.0	9.6	11.8	68.5	5.0	0.0	7.8	4.4	13.7	6.8	6.7	3.6	12.2	4.5	10.5	11.3	49.3	19.4	33.9	2.2	8.6	8.8	2.5	4.5	11.9	13.0	34.2	6.6	13.2	11.3	8.2	33.5	9.2	4.5	12.3	11.8	9.8	3.9	3.3
CARD14	"BIMP2, CARMA2, PSORS2"	ENSG00000141527	"Caspase recruitment domain family member 14"	Q9BXL6	17	80169992-80209331	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	Apoptosis		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 13.5;skin 1: 14.4;vagina: 7.3"	"Cell type enhanced"	"Detected in many"		"Kupffer cells: 8.2;Microglial cells: 6.5;Oligodendrocytes: 11.6"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"MCF7: 5.2;SK-BR-3: 6.9;T-47d: 10.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA023388			Supported	Aggresome,Cytosol		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 6: T47d - Mammary gland"	"Cluster 35: Glandular cells - Unknown function"	Cytosol	Aggresome	"HPA023388: AB_1846020"	"unprognostic (9.79e-3)"	"unprognostic (3.86e-2)"	"unprognostic (4.26e-1)"	"unprognostic (1.05e-5)"	"unprognostic (2.65e-2)"	"unprognostic (1.37e-2)"	"unprognostic (2.92e-4)"	"unprognostic (1.92e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.63e-1)"	"unprognostic (3.01e-1)"	"unprognostic (5.48e-2)"	"unprognostic (1.62e-8)"	"unprognostic (2.52e-1)"	"unprognostic (2.06e-1)"	"unprognostic (2.38e-1)"	"unprognostic (2.34e-1)"	0.3	1.1	0.3	0.6	0.3	0.2	2.6	0.1	0.4	4.9	0.1	0.4	1.1	0.3	0.3	13.5	0.6	0.4	0.2	0.3	0.3	0.6	0.3	0.6	0.6	0.5	0.3	0.4	0.4	0.0	0.5	0.2	0.4	2.5	0.0	0.3	3.3	0.0	0.4	14.4	0.8	0.0	0.1	1.5	0.5	1.2	0.4	0.0	0.5	0.0	1.6	1.0	7.3	0.4	1.7	0.4	0.3	0.2	0.0	0.0	1.9	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.3	0.0	0.3	0.3	0.0	0.0	0.0	0.8	0.6	0.0	1.9	0.2	0.0	0.3	0.3	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.3	0.9	0.0	5.2	0.0	0.0	0.1	1.0	0.1	0.0	1.1	0.4	0.0	1.6	0.4	0.1	0.0	6.9	0.8	0.4	10.4	0.0	0.4	0.1	0.3	0.3	0.0	2.2	0.1	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.1	0.4	0.3	0.3	0.5	0.3	0.4	0.1	0.4	0.4	0.3	0.0	1.1	1.6	0.1	1.8	4.0	2.1	0.0	0.6	4.5	2.2	0.9	2.8	2.0	0.0	0.0	0.2	0.2	0.1	0.0	0.6	0.7	1.3	0.2	0.9	0.0	0.0	0.9	2.2	0.4	0.5	0.0	1.5	0.0	0.4	0.7	0.0	0.8	0.0	0.8	0.1	0.0	8.2	0.8	0.1	0.3	0.6	1.8	6.5	0.1	1.4	0.0	1.0	11.6	1.8	0.1	0.4	0.1	3.2	0.9	0.3	3.6	0.8	0.0	0.2	0.3	1.3	0.4	5.0	3.0	1.5	0.3	0.7	0.5	3.6
CARD19	"bA370F5.1, BinCARD, C9orf89, MGC11115"	ENSG00000165233	"Caspase recruitment domain family member 19"	Q96LW7	9	93096217-93113283	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Macrophages: 142.0;Pancreatic endocrine cells: 121.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 134.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010921, HPA010990, HPA038297"	Approved		Supported	Mitochondria		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 72: Non-specific - Transcription"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 51: Myeloid cells - Hemostasis"	Mitochondria		"HPA010921: AB_10670295, HPA010990: AB_2668400, HPA038297: AB_2675938"	"unprognostic (7.26e-2)"	"unprognostic (1.15e-2)"	"unprognostic (2.97e-1)"	"unprognostic (2.66e-2)"	"prognostic unfavorable (7.47e-5)"	"unprognostic (2.22e-1)"	"prognostic unfavorable (1.32e-5)"	"unprognostic (1.21e-1)"	"unprognostic (1.36e-2)"	"unprognostic (2.65e-2)"	"unprognostic (1.98e-1)"	"unprognostic (9.13e-2)"	"unprognostic (6.82e-2)"	"unprognostic (2.29e-1)"	"unprognostic (5.48e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.41e-1)"	12.2	13.7	2.5	3.7	2.1	3.2	11.3	4.8	4.5	11.5	3.1	14.4	6.1	12.0	2.6	11.0	10.8	5.8	10.3	1.8	3.4	16.2	10.8	10.9	4.0	4.0	2.9	7.9	5.5	6.1	6.6	3.3	4.9	8.7	3.2	0.1	9.4	4.2	14.2	10.8	9.5	4.2	3.6	10.5	12.9	19.1	3.5	3.1	8.7	5.5	2.6	11.5	11.5	5.9	33.0	31.3	4.1	9.2	5.3	10.1	12.9	26.7	13.0	18.2	8.2	7.8	10.6	7.0	18.3	9.5	15.4	56.0	3.3	21.9	1.5	134.9	12.3	12.4	6.5	18.4	21.1	11.2	11.4	23.5	8.1	13.2	5.2	20.0	21.4	6.1	5.7	13.8	12.4	64.7	12.1	30.0	3.6	21.1	70.8	8.2	20.7	29.4	22.9	12.1	9.8	17.3	14.4	6.9	30.6	0.8	15.6	11.6	21.6	9.3	18.6	17.9	8.4	10.4	10.1	1.5	39.0	11.3	32.4	27.8	37.4	23.6	10.2	30.0	10.5	12.6	10.0	10.9	30.6	7.5	9.0	8.9	40.3	18.4	17.3	11.1	21.7	22.4	2.5	2.1	4.8	4.5	1.8	3.4	4.0	2.9	4.9	3.6	3.5	5.9	29.3	22.4	20.9	0.0	14.4	0.0	52.8	0.0	25.6	12.0	81.2	75.6	0.0	27.1	5.6	16.5	16.7	22.9	25.7	27.7	62.6	76.6	49.5	19.4	26.8	34.1	15.8	7.8	0.0	58.1	34.6	26.2	36.2	20.3	30.3	8.2	41.7	13.9	79.0	5.0	0.0	19.8	0.0	41.3	0.0	15.3	45.7	142.0	0.0	0.0	68.3	21.9	17.5	0.0	0.0	121.6	10.3	43.6	15.0	58.7	38.9	61.7	2.2	29.8	59.2	30.4	31.1	98.7	26.4	27.9	0.0	21.6	34.0	8.5	18.6	71.0
CARD8	"CARDINAL, Dakar, KIAA0955, NDPP, TUCAN"	ENSG00000105483	"Caspase recruitment domain family member 8"	Q9Y2G2	19	48180770-48255946	"Human disease related genes, Predicted intracellular proteins"	"Host-virus interaction, Immunity, Inflammatory response, Innate immunity, Necrosis"	"Hydrolase, Protease"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Adipocytes: 115.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HEL: 114.4;HUVEC TERT2: 154.6;NB-4: 131.8;TIME: 148.6"									"HPA042071, HPA043513"	Supported		Supported	Nucleoplasm		NA	NA			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 16: Immune cells - Immune response"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Nucleoplasm		"HPA042071: AB_2677831, HPA043513: AB_2678522"	"unprognostic (3.96e-2)"	"unprognostic (1.92e-1)"	"unprognostic (7.84e-2)"	"unprognostic (1.48e-1)"	"unprognostic (3.30e-2)"	"unprognostic (1.58e-2)"	"unprognostic (6.95e-2)"	"unprognostic (2.18e-2)"	"unprognostic (9.19e-2)"	"unprognostic (7.30e-2)"	"unprognostic (3.79e-2)"	"unprognostic (3.84e-2)"	"prognostic unfavorable (1.63e-8)"	"unprognostic (1.78e-1)"	"unprognostic (1.69e-1)"	"unprognostic (9.19e-2)"	"prognostic favorable (1.72e-5)"	27.7	8.7	7.8	29.1	9.6	23.7	17.1	9.0	8.7	13.1	11.0	11.2	12.7	10.9	7.8	8.2	8.9	14.4	12.9	7.5	9.3	8.9	12.4	19.1	38.2	10.8	9.6	8.5	11.5	9.7	5.8	23.6	10.6	7.1	11.9	5.4	8.0	7.8	16.3	7.7	14.7	15.9	9.8	38.8	13.8	10.6	11.5	31.3	13.0	20.1	36.9	15.4	7.7	11.1	13.4	31.1	28.1	9.1	10.0	15.3	10.9	12.4	15.6	19.0	29.1	10.8	20.1	28.7	15.8	11.9	12.8	8.2	16.9	9.2	17.1	43.8	14.9	114.4	17.0	21.6	11.8	59.2	87.3	11.2	7.0	10.8	11.7	16.5	154.6	28.6	16.8	32.5	15.6	9.5	24.4	131.8	7.1	27.9	7.8	40.9	13.4	7.1	11.2	17.1	9.7	14.6	20.4	14.2	18.5	13.6	8.9	52.2	148.6	11.3	14.3	5.0	21.2	28.9	78.3	18.0	5.2	42.1	21.2	104.9	45.8	76.8	29.2	63.5	33.8	30.7	29.4	34.4	39.9	31.2	27.4	29.5	167.3	28.1	68.2	27.9	45.0	32.2	7.8	9.6	9.0	8.7	7.5	9.3	10.8	9.6	10.6	9.8	11.5	11.1	115.7	3.2	29.2	11.4	38.9	9.3	4.9	6.5	2.2	8.9	11.4	8.3	9.9	12.8	8.6	12.9	12.5	26.9	50.9	5.1	5.9	7.9	25.3	5.8	10.3	68.6	5.4	36.2	2.0	10.8	11.2	12.1	7.1	6.7	34.1	25.6	73.5	25.9	41.9	6.7	2.7	7.4	6.1	79.5	30.9	59.3	7.8	61.6	21.4	55.3	47.6	4.2	79.3	13.6	17.3	11.2	6.7	7.9	40.1	3.5	9.7	11.7	9.3	3.4	6.6	11.2	11.3	19.6	14.2	6.5	7.1	15.5	55.6	8.6	7.0	3.4
CARMIL1	"CARMIL, dJ501N12.1, FLJ20048, LRRC16, LRRC16A"	ENSG00000079691	"Capping protein regulator and myosin 1 linker 1"	Q5VZK9	6	25279078-25620530	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 27.9;Collecting duct cells: 35.0;Distal tubular cells: 46.9;Endometrial ciliated cells: 37.3;Glandular and luminal cells: 39.3;Granulosa cells: 31.8;Proximal tubular cells: 58.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"RPMI-8226: 36.0;RPTEC TERT1: 34.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029038, HPA029039"	Enhanced		Supported	Cytosol		NA	NA			"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 50: Fibroblasts - ECM organization"	Cytosol		"HPA029038: AB_10601668, HPA029039: AB_10611382"	"unprognostic (2.34e-2)"	"unprognostic (9.45e-2)"	"unprognostic (2.07e-2)"	"unprognostic (4.71e-2)"	"unprognostic (3.94e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.66e-3)"	"unprognostic (3.82e-1)"	"unprognostic (4.02e-1)"	"unprognostic (7.15e-3)"	"unprognostic (8.25e-3)"	"unprognostic (5.86e-2)"	"unprognostic (1.28e-3)"	"unprognostic (3.08e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.31e-1)"	4.4	3.9	2.7	2.8	4.1	0.7	6.5	6.4	5.9	5.2	0.0	10.7	15.3	2.5	7.1	4.3	5.5	5.8	3.7	2.2	2.5	8.5	2.1	8.0	3.6	1.0	3.5	4.3	4.5	5.1	1.2	4.6	0.8	3.3	10.0	1.0	5.3	2.7	0.4	5.9	15.8	2.7	1.3	2.8	7.4	11.4	3.2	7.6	5.2	2.0	3.7	5.2	3.7	1.2	12.9	12.7	3.5	4.5	3.2	1.6	12.1	4.3	9.7	4.5	7.9	13.7	9.4	4.4	13.8	6.9	13.2	13.7	13.6	12.2	3.3	11.1	7.2	10.7	14.0	1.7	8.9	0.5	1.6	1.7	8.2	8.7	13.3	5.6	0.2	1.6	0.3	3.5	2.9	10.0	0.7	0.0	4.8	22.7	5.2	1.5	2.1	36.0	34.7	11.5	9.0	1.9	19.1	32.4	12.4	10.1	7.8	0.3	0.2	3.3	5.8	15.8	4.4	0.5	0.2	7.0	5.2	3.9	12.6	0.0	0.4	0.0	0.0	0.5	0.0	0.2	0.1	0.1	0.4	1.3	1.0	0.1	0.0	0.6	1.3	0.9	0.0	0.1	2.7	4.1	6.4	5.9	2.2	2.5	1.0	3.5	0.8	1.3	3.2	1.2	3.2	19.2	27.9	0.0	7.7	0.0	0.0	0.0	0.0	0.0	17.5	11.6	0.0	0.0	4.3	35.0	0.0	20.8	0.4	0.0	46.9	16.7	0.0	37.3	7.0	4.0	0.0	0.0	0.0	15.6	7.9	12.8	0.0	39.3	8.8	31.8	0.0	0.0	6.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	3.6	0.0	0.0	0.0	0.0	17.6	0.0	0.0	7.6	0.0	0.0	58.8	3.6	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	10.9	1.6	14.9	0.0	0.0
CASKIN2	"ANKS5B, FLJ21609, KIAA1139"	ENSG00000177303	"CASK interacting protein 2"	Q8WXE0	17	75500261-75515537	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 75.5;Endothelial cells: 42.2;Hepatic stellate cells: 56.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA071906, HPA075184"	Enhanced		Supported	"Plasma membrane"		NA	NA				"Cluster 82: Adipose tissue - ECM organization"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Plasma membrane"		"HPA071906: AB_2732191, HPA075184: AB_2732281"	"unprognostic (1.60e-1)"	"unprognostic (4.54e-2)"	"unprognostic (9.12e-3)"	"unprognostic (5.27e-3)"	"unprognostic (9.32e-2)"	"unprognostic (5.78e-2)"	"unprognostic (2.87e-2)"	"unprognostic (4.10e-2)"	"unprognostic (7.67e-2)"	"unprognostic (1.33e-1)"	"prognostic favorable (2.47e-5)"	"unprognostic (1.82e-2)"	"prognostic favorable (4.83e-8)"	"unprognostic (1.43e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.39e-1)"	"unprognostic (4.95e-2)"	33.8	22.7	19.4	4.9	22.6	0.4	30.0	19.7	18.6	15.1	4.6	16.5	9.0	21.0	2.7	10.8	21.7	11.2	28.2	16.7	17.2	26.9	11.3	42.3	2.9	22.6	21.7	12.0	10.8	9.4	13.6	11.8	18.7	14.9	2.9	4.8	11.5	8.7	15.3	12.7	11.4	10.4	18.1	30.8	15.0	5.6	20.0	2.9	22.6	9.9	1.5	16.0	14.3	23.1	13.3	17.2	10.2	14.4	6.6	4.1	11.2	6.6	8.7	15.8	10.2	19.0	5.6	0.5	7.4	7.7	10.5	12.0	8.2	7.7	3.9	4.7	10.8	9.4	17.2	7.5	7.7	0.5	12.6	3.5	10.4	8.2	5.9	5.3	16.2	13.3	6.9	1.6	5.0	31.1	24.3	0.7	7.5	10.3	17.5	12.8	21.8	2.1	10.2	13.4	10.4	10.2	13.9	18.7	11.0	8.7	13.7	4.0	13.9	16.1	14.6	7.9	8.7	1.2	5.9	1.5	5.6	0.3	11.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.4	22.6	19.7	18.6	16.7	17.2	22.6	21.7	18.7	18.1	20.0	23.1	75.5	3.2	2.2	11.1	1.3	8.0	2.5	3.5	6.8	6.5	5.8	5.0	11.4	2.8	1.8	9.2	10.4	2.2	0.6	11.7	3.9	5.1	0.5	2.8	4.4	42.2	7.7	8.0	1.3	5.3	1.9	6.0	8.2	5.7	0.0	14.9	56.7	6.8	2.7	3.3	1.7	4.3	8.2	4.1	3.1	2.3	8.1	1.2	1.8	7.5	2.0	28.2	0.0	15.1	8.3	6.0	6.0	11.3	1.6	2.5	8.4	3.1	1.4	6.8	0.0	5.5	6.4	2.7	4.4	4.5	7.0	2.2	0.5	5.7	4.6	2.2
CASP1	"ICE, IL1BC"	ENSG00000137752	"Caspase 1"	P29466	11	105025443-105035250	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	Apoptosis	"Hydrolase, Protease, Thiol protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 126.0;lymphoid tissue: 91.0"	"Cell type enhanced"	"Detected in many"		"Kupffer cells: 125.3;Langerhans cells: 120.7;Macrophages: 136.6;monocytes: 185.6;Proximal enterocytes: 116.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 112.7;HBEC3-KT: 53.8;HHSteC: 58.2;U-937: 136.2"	"Region enhanced"	"Detected in all"		"olfactory bulb: 18.4"	"Low region specificity"	"Detected in all"			"CAB002685, HPA003056"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 32: U-937 - Innate immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	Cytosol	Nucleoplasm	"CAB002685: , HPA003056: AB_1846037"	"unprognostic (1.21e-3)"	"unprognostic (3.02e-1)"	"unprognostic (9.47e-3)"	"unprognostic (1.43e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.21e-1)"	"unprognostic (5.24e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.66e-1)"	"unprognostic (6.67e-2)"	"unprognostic (2.75e-2)"	"unprognostic (1.35e-1)"	"prognostic unfavorable (3.11e-4)"	"unprognostic (9.03e-2)"	"unprognostic (2.30e-2)"	"unprognostic (3.18e-1)"	"unprognostic (5.19e-2)"	20.4	10.5	8.7	59.1	8.8	36.3	21.9	9.3	14.6	11.9	9.8	47.7	124.6	8.7	12.0	27.2	12.3	27.4	12.2	8.5	9.6	13.3	21.6	48.3	52.1	11.2	9.4	11.7	6.4	2.7	5.0	30.0	11.1	13.0	49.7	1.1	20.8	12.5	6.2	30.9	126.0	20.8	10.7	91.0	22.5	2.4	10.7	23.2	7.8	7.3	35.5	35.7	19.4	11.9	1.3	0.3	0.0	5.3	5.8	12.1	1.0	5.7	112.7	14.0	38.5	0.2	0.7	18.7	2.3	6.6	25.7	8.1	0.0	53.8	3.3	12.3	0.0	0.9	0.7	1.3	58.2	22.1	0.2	20.9	37.4	11.4	30.3	36.2	6.1	0.3	0.2	0.0	3.4	0.0	0.6	30.7	0.0	0.1	0.3	18.1	0.4	14.9	0.3	8.9	0.4	0.4	16.9	1.1	26.2	0.1	1.2	50.1	7.2	12.8	0.6	1.2	1.6	0.1	5.4	0.1	8.1	136.2	2.7	83.8	246.1	134.9	132.9	359.9	178.5	40.2	92.7	115.8	220.2	35.5	50.2	82.7	220.0	63.0	383.0	7.7	129.0	213.3	8.7	8.8	9.3	14.6	8.5	9.6	11.2	9.4	11.1	10.7	10.7	11.9	26.3	19.2	30.0	0.0	27.2	26.0	42.5	91.5	14.2	0.1	5.8	23.0	2.9	8.6	37.7	11.0	0.0	2.1	34.1	33.1	1.9	23.3	0.2	5.8	2.5	24.0	6.0	10.3	0.2	12.9	1.3	17.8	11.7	3.4	15.8	0.2	22.9	3.1	96.5	0.0	0.0	50.6	14.2	125.3	120.7	1.3	3.4	136.6	5.4	12.2	185.6	0.1	64.9	0.0	0.1	5.3	73.4	3.4	20.0	8.7	116.0	2.2	28.4	0.2	0.0	1.0	8.1	0.0	0.1	17.9	22.3	1.1	58.4	3.3	90.5	43.6
CASP14	"MGC119078, MGC119079, MICE"	ENSG00000105141	"Caspase 14"	P31944	19	15049480-15058293	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	Differentiation	"Hydrolase, Protease, Thiol protease"	Ichthyosis	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	24	"skin 1: 486.0"	"Cell type enriched"	"Detected in some"	5	"Suprabasal keratinocytes: 96.0"	"Cancer enhanced"	"Detected in many"		"cervical cancer: 62.8"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	7	"hTCEpi: 49.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB010059, HPA027062"	Enhanced		Supported	Nucleoplasm,Mitochondria,Cytosol		NA	NA		3600000		"Cluster 61: Skin - Cornification"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 28: Keratinocytes - Keratinization"	"Nucleoplasm, Cytosol"	Mitochondria	"CAB010059: AB_626800, HPA027062: AB_2672101"	"unprognostic (1.17e-2)"	"unprognostic (6.44e-3)"		"unprognostic (6.22e-2)"		"unprognostic (2.77e-1)"		"prognostic unfavorable (7.59e-4)"	"unprognostic (9.42e-2)"	"unprognostic (2.19e-2)"	"prognostic unfavorable (5.96e-4)"	"unprognostic (2.68e-1)"		"unprognostic (4.30e-2)"	"unprognostic (1.99e-1)"		"unprognostic (1.97e-1)"	0.6	0.0	0.1	0.0	0.4	0.4	7.8	0.4	0.2	3.9	0.2	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.2	0.1	0.1	0.1	0.1	0.0	0.3	0.1	0.0	0.6	0.1	0.0	0.0	0.3	0.8	0.0	0.1	1.1	4.2	1.4	486.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	1.0	0.0	0.0	0.0	0.0	19.9	1.0	1.1	0.2	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	6.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	49.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.9	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.1	0.4	0.4	0.2	0.2	0.1	0.3	0.1	0.3	0.0	0.3	1.0	0.0	0.0	0.0	0.0	0.0	19.1	1.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	4.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.4	2.8	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	96.0	0.7	0.1	0.0	0.0	0.8
CASP6	MCH2	ENSG00000138794	"Caspase 6"	P55212	4	109688622-109703583	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	Apoptosis	"Hydrolase, Protease, Thiol protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 40.8"	"Cell type enhanced"	"Detected in many"		"Granulosa cells: 112.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Karpas-707: 76.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003775, HPA011337, HPA024303"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 9: Intestine - Unknown function"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 40: Granulosa cells - Unknown function"	Cytosol	Nucleoplasm	"CAB003775: AB_562064, HPA011337: AB_1846053, HPA024303: AB_1846052"	"unprognostic (1.07e-1)"	"unprognostic (1.91e-1)"	"prognostic favorable (2.64e-5)"	"unprognostic (1.45e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.46e-1)"	"unprognostic (3.03e-3)"	"unprognostic (9.87e-2)"	"unprognostic (2.73e-2)"	"unprognostic (2.59e-3)"	"unprognostic (1.15e-2)"	"unprognostic (6.78e-2)"	"unprognostic (2.44e-1)"	"unprognostic (8.74e-3)"	"unprognostic (2.18e-1)"	"unprognostic (2.41e-1)"	"prognostic favorable (9.93e-4)"	6.5	6.7	3.9	8.4	4.0	10.8	10.5	4.3	5.4	7.6	4.0	35.3	40.8	7.7	5.1	7.4	7.6	9.3	5.6	3.8	4.0	11.5	18.1	7.8	9.6	3.7	3.7	8.3	13.3	4.8	4.2	4.8	3.8	9.1	31.5	3.0	8.6	6.5	3.3	10.7	36.8	7.4	3.8	8.0	15.8	1.8	3.7	11.5	8.5	2.4	7.7	8.1	7.0	4.3	26.6	8.4	16.5	14.8	11.0	11.2	24.3	15.3	9.2	12.4	13.4	13.8	50.3	2.7	16.4	14.7	17.3	12.1	19.7	21.8	8.4	43.5	13.0	22.8	7.1	12.9	9.4	23.5	15.7	12.6	15.1	12.4	2.8	17.1	22.9	30.1	29.9	76.1	19.2	13.7	62.0	14.4	12.7	17.1	16.1	20.5	10.8	13.3	39.6	24.8	17.2	13.2	15.0	25.7	8.8	19.6	11.0	8.0	20.3	12.8	14.6	6.6	16.7	11.4	23.0	2.8	17.1	26.9	7.1	16.3	6.9	8.9	6.3	6.9	7.0	6.1	23.8	12.3	8.8	8.6	28.0	16.1	1.4	7.5	11.2	11.6	24.8	9.4	3.9	4.0	4.3	5.4	3.8	4.0	3.7	3.7	3.8	3.8	3.7	4.3	10.5	16.0	14.6	5.2	7.7	10.8	10.2	26.7	12.0	6.9	23.6	16.0	4.1	28.6	23.2	20.2	6.2	20.9	7.6	54.0	9.8	40.8	2.6	19.8	9.5	12.2	59.2	19.7	6.4	46.4	41.1	13.4	18.3	23.3	10.1	112.3	9.7	20.4	19.8	0.0	7.3	53.9	32.6	8.7	9.3	1.7	12.8	14.5	1.8	2.8	17.9	16.0	6.2	5.5	5.8	45.9	52.5	9.8	8.8	7.4	71.7	35.7	18.6	1.3	6.6	7.6	12.3	1.9	8.6	10.8	11.6	5.7	17.5	12.4	74.2	8.0
CASZ1	"castor, cst, FLJ20321, SRG, ZNF693"	ENSG00000130940	"Castor zinc finger 1"	Q86V15	1	10636604-10796650	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skin 1: 49.0"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 608.8;Horizontal cells: 138.0;Rod photoreceptor cells: 477.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A-431: 12.4;HDLM-2: 13.4;SCLC-21H: 19.8;SK-BR-3: 18.9"					"Low region specificity"	"Detected in some"			"HPA028222, HPA029927"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 9: Photoreceptor cells - Phototransduction"	Nucleoplasm	Cytosol	"HPA028222: AB_10600106, HPA029927: AB_10601564"	"unprognostic (1.20e-1)"	"unprognostic (5.06e-2)"	"unprognostic (4.67e-2)"	"unprognostic (7.49e-3)"	"unprognostic (4.75e-2)"	"unprognostic (1.90e-2)"	"unprognostic (3.55e-4)"	"unprognostic (1.13e-2)"	"unprognostic (1.13e-1)"	"unprognostic (4.46e-2)"	"unprognostic (1.26e-1)"	"unprognostic (3.73e-2)"	"unprognostic (1.03e-5)"	"unprognostic (3.75e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.51e-2)"	"unprognostic (1.56e-1)"	2.1	2.0	0.6	2.2	0.8	4.6	7.0	0.1	1.1	5.9	2.4	20.6	12.0	7.8	0.8	15.3	5.6	2.7	20.1	0.2	1.2	7.4	2.7	11.3	1.3	1.0	0.7	0.9	6.0	0.2	2.1	1.7	0.8	18.2	3.3	35.1	19.9	5.8	34.4	49.0	11.6	3.3	2.3	2.2	17.3	1.7	0.9	1.3	3.4	5.8	1.9	10.7	11.6	0.1	12.4	1.0	2.2	2.2	0.0	0.0	0.5	0.4	0.1	0.4	0.4	2.6	2.8	0.5	2.5	0.5	1.0	10.5	2.3	2.4	0.2	13.4	4.1	0.8	2.0	2.8	0.3	1.4	3.8	0.1	8.7	0.1	0.8	0.0	0.4	1.9	0.0	0.0	0.1	6.6	0.7	8.9	0.2	6.4	0.6	1.0	1.5	0.1	2.0	5.0	19.8	1.8	3.2	18.9	0.3	0.8	10.1	1.3	0.1	0.0	1.6	1.0	0.2	0.0	0.0	1.3	0.1	3.8	0.2	0.6	0.0	0.3	0.4	0.0	0.1	0.1	0.1	0.2	0.1	0.1	0.0	0.1	0.1	0.4	0.6	0.8	0.0	0.1	0.6	0.8	0.1	1.1	0.2	1.2	1.0	0.7	0.8	2.3	0.9	0.1	12.9	28.9	21.7	1.6	6.1	33.0	20.1	21.2	30.7	12.7	57.9	30.4	25.2	17.2	17.8	14.7	608.8	0.7	15.3	60.4	3.9	14.1	0.6	41.8	5.6	14.4	41.3	1.3	1.6	8.9	1.2	2.3	57.6	66.7	4.5	4.5	5.0	5.1	1.1	138.0	0.9	39.1	16.2	0.3	5.1	1.6	0.0	1.8	1.8	1.9	6.7	28.4	9.2	0.5	0.3	18.1	40.8	6.8	6.1	33.4	46.3	1.1	41.2	477.7	0.0	6.8	5.1	2.5	3.5	31.0	61.2	0.7	7.6	1.5	27.1	27.6
CAV1	CAV	ENSG00000105974	"Caveolin 1"	Q03135	7	116524994-116561179	"Cancer-related genes, Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Host-virus interaction"		"Cancer-related genes, Congenital generalized lipodystrophy, Diabetes mellitus, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 2160.5;Alveolar cells type 1: 3557.7;Basal keratinocytes: 1375.3;Endothelial cells: 1024.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	10	"basophil: 14.6;memory B-cell: 5.1"	"Group enriched"	"Detected in many"	57	"B-cells: 5.1;granulocytes: 14.6"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 2140.5;BJ hTERT+: 2371.6;HBEC3-KT: 2333.7;LHCN-M2: 2372.1;U-138 MG: 1894.8"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"spinal cord: 122.1"	"CAB003791, HPA049326"	Enhanced		Supported	"Golgi apparatus"		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Golgi apparatus"		"CAB003791: AB_562068, HPA049326: AB_2680714"	"unprognostic (5.98e-2)"	"unprognostic (1.35e-3)"	"unprognostic (3.35e-1)"	"unprognostic (5.37e-2)"	"unprognostic (4.62e-3)"	"unprognostic (2.35e-3)"	"unprognostic (8.07e-2)"	"prognostic unfavorable (7.17e-5)"	"unprognostic (1.31e-1)"	"unprognostic (2.25e-1)"	"unprognostic (1.79e-3)"	"unprognostic (7.92e-2)"	"prognostic unfavorable (1.29e-4)"	"unprognostic (1.65e-3)"	"unprognostic (2.72e-1)"	"unprognostic (7.40e-2)"	"unprognostic (6.14e-3)"	621.1	17.4	12.7	44.7	15.3	0.6	284.5	14.3	21.6	267.0	11.8	298.8	32.3	190.9	72.5	135.1	152.5	148.2	276.5	12.2	13.9	18.4	26.6	592.0	30.3	15.1	13.4	137.4	24.6	21.4	6.8	449.2	14.6	110.3	93.6	31.4	58.0	175.5	102.9	104.9	89.4	274.2	14.3	199.1	120.8	25.8	16.1	25.2	168.4	184.6	20.3	202.0	124.1	16.2	458.7	344.3	9.5	3.7	1406.6	2140.5	20.6	1055.8	2371.6	566.0	591.2	3.0	652.4	0.1	365.8	1228.5	494.8	828.2	2.2	2333.7	840.3	36.0	19.5	0.4	128.7	0.3	196.9	0.1	2.1	736.9	481.6	805.7	536.0	539.0	1749.9	0.2	0.3	23.4	2372.1	45.2	0.5	0.8	33.7	1.2	173.9	5.2	25.2	251.0	317.0	2.0	1.0	0.6	328.3	20.1	52.3	137.8	1.6	3.9	1349.3	1894.8	212.4	730.6	298.9	96.8	15.8	1.9	758.4	0.9	701.0	14.6	0.0	0.0	0.0	0.0	0.0	5.1	0.1	0.1	0.0	0.9	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.8	12.7	15.3	14.3	21.6	12.2	13.9	15.1	13.4	14.6	14.3	16.1	16.2	2160.5	3557.7	123.0	0.0	15.8	1375.3	392.0	534.8	316.4	8.3	17.9	190.8	286.6	107.2	342.0	7.3	2.1	64.3	7.0	0.3	5.9	76.8	2.6	17.5	102.3	1024.0	1.8	16.0	0.4	0.7	449.5	326.8	1.5	21.3	13.9	6.3	450.5	5.2	15.0	0.0	0.5	7.0	20.3	11.0	187.1	13.4	377.2	10.7	439.4	19.7	3.7	249.0	0.0	1.0	1.3	43.1	0.1	565.4	56.2	512.7	0.7	0.3	30.6	7.7	558.8	152.4	751.4	2.1	5.7	39.4	610.9	117.0	16.7	59.7	2.4	93.3
CAVIN1	"cavin-1, CGL4, PTRF"	ENSG00000177469	"Caveolae associated protein 1"	Q6NZI2	17	42402449-42423256	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation, Transcription termination"	"RNA-binding, rRNA-binding"	"Congenital generalized lipodystrophy, Diabetes mellitus"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 575.1;Alveolar cells type 1: 429.5;Breast myoepithelial cells: 154.9;Cytotrophoblasts: 159.8;Endothelial cells: 217.4;Smooth muscle cells: 211.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ: 1105.9;fHDF/TERT166: 796.6;TIME: 920.9;U-138 MG: 912.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049838, HPA074213"	Supported		Supported	"Vesicles,Plasma membrane"		NA	NA		440000	"Cluster 11: Basophils - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 7: Non-specific - Mitochondria"	"Plasma membrane"	Vesicles	"HPA049838: AB_2680907, HPA074213: AB_2686674"	"unprognostic (1.59e-1)"	"unprognostic (4.46e-2)"	"prognostic unfavorable (6.36e-4)"	"unprognostic (1.56e-1)"	"unprognostic (1.76e-3)"	"unprognostic (6.33e-3)"	"unprognostic (1.72e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.43e-1)"	"prognostic unfavorable (5.92e-4)"	"unprognostic (7.18e-3)"	"unprognostic (2.36e-1)"	"unprognostic (3.44e-3)"	"unprognostic (4.24e-3)"	"unprognostic (3.21e-2)"	"unprognostic (2.07e-3)"	"prognostic unfavorable (5.87e-4)"	397.8	65.3	42.6	69.1	47.2	3.7	295.3	55.8	40.9	239.9	50.6	314.0	30.8	344.3	56.8	101.0	207.5	78.1	220.9	35.4	49.7	66.4	21.0	202.8	30.0	68.8	55.0	162.5	28.4	26.5	34.8	151.3	60.1	181.5	50.7	3.6	84.2	215.4	144.8	161.9	104.1	242.3	53.5	109.0	132.8	22.6	47.2	16.6	112.4	92.7	24.0	255.4	192.3	58.0	315.9	264.8	5.5	69.8	342.3	409.6	6.9	1105.9	477.8	432.2	340.5	134.6	20.1	0.5	216.3	796.6	177.4	509.7	46.8	331.6	351.0	1.1	9.5	137.5	154.8	66.1	215.8	0.3	1.2	283.0	120.5	340.8	115.8	230.2	592.3	0.4	95.5	1.3	187.9	5.0	7.4	1.6	25.8	48.1	1.8	0.6	173.3	0.6	186.1	1.6	0.4	2.0	371.9	6.4	91.7	145.2	29.8	2.0	920.9	912.0	429.5	330.9	407.9	0.8	0.9	1.6	270.7	0.5	104.8	0.8	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.0	0.4	0.1	0.0	0.1	0.0	0.0	42.6	47.2	55.8	40.9	35.4	49.7	68.8	55.0	60.1	53.5	47.2	58.0	575.1	429.5	117.5	0.0	0.5	0.0	0.0	0.0	0.0	0.0	55.4	154.9	0.0	0.0	50.8	23.9	0.0	159.8	3.4	0.0	3.9	45.6	0.0	11.7	130.4	217.4	0.0	0.0	0.0	4.4	11.3	114.2	0.0	16.9	63.1	116.3	0.0	0.0	16.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	108.5	0.0	0.0	0.5	0.0	0.0	1.1	3.6	0.0	0.0	0.0	211.7	0.0	0.0	0.0	0.0	77.2	4.5	6.6	0.0	0.0
CAVIN4	"cavin-4, MURC"	ENSG00000170681	"Caveolae associated protein 4"	Q5BKX8	9	100578079-100588389	"Predicted intracellular proteins"	"Differentiation, Myogenesis, Transcription, Transcription regulation"	"Activator, Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"skeletal muscle: 276.1;tongue: 92.4"	"Cell type enhanced"	"Detected in some"		"Cytotrophoblasts: 1.5;Endometrial ciliated cells: 1.2;Endometrial stromal cells: 1.8;Glandular and luminal cells: 1.9;Granulosa cells: 1.8;Pancreatic endocrine cells: 1.5"	"Cancer enhanced"	"Detected in some"		"head and neck cancer: 2.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"NTERA-2: 8.9;SCLC-21H: 13.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA020973, HPA020987, HPA021021"	Enhanced		Supported	"Nucleoplasm,Golgi apparatus,Plasma membrane"		NA	NA				"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 44: Endometrium - Transcription"	"Golgi apparatus, Plasma membrane"	Nucleoplasm	"HPA020973: AB_1853079, HPA020987: AB_1853080, HPA021021: AB_1853082"	"unprognostic (9.54e-5)"	"unprognostic (1.68e-2)"	"unprognostic (2.50e-2)"	"unprognostic (3.76e-2)"	"unprognostic (4.92e-2)"	"unprognostic (4.56e-3)"	"unprognostic (1.14e-4)"	"unprognostic (3.36e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.31e-1)"	"unprognostic (4.02e-1)"	"unprognostic (1.74e-8)"	"unprognostic (1.14e-1)"	"unprognostic (3.39e-1)"	"unprognostic (3.68e-3)"	"unprognostic (1.55e-3)"	0.2	0.1	1.6	0.2	2.9	0.1	0.1	2.0	5.6	0.4	0.4	0.4	0.0	0.5	0.1	4.3	0.1	0.3	45.9	1.7	2.5	0.2	0.2	0.4	0.1	2.7	2.7	0.2	0.1	0.0	0.2	0.3	2.7	4.5	0.1	0.3	2.4	0.1	276.1	0.2	0.1	0.3	1.8	0.1	0.3	3.7	2.7	0.4	0.5	92.4	0.1	0.3	0.2	3.5	0.5	0.3	6.1	2.2	1.4	2.0	4.3	1.1	0.9	0.8	1.0	0.0	0.4	0.2	0.3	0.6	2.1	0.3	3.1	0.1	1.7	1.4	2.0	0.1	1.0	0.0	0.4	0.2	0.4	5.0	0.3	0.8	0.5	1.5	1.1	1.5	0.2	0.2	3.9	0.1	1.8	0.3	8.9	1.0	0.7	2.6	5.8	0.0	0.8	0.3	13.2	3.4	0.2	0.2	1.1	4.1	0.1	0.2	1.1	1.5	1.2	1.0	1.0	0.3	1.1	0.6	1.7	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	2.9	2.0	5.6	1.7	2.5	2.7	2.7	2.7	1.8	2.7	3.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	1.5	0.1	0.0	0.0	0.7	0.0	1.2	1.8	0.3	0.0	0.0	0.0	0.5	0.4	0.5	0.0	1.9	0.0	1.8	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.8	0.0	0.1	0.0	0.0
CBLB	"Cbl-b, RNF56"	ENSG00000114423	"Cbl proto-oncogene B"	Q13191	3	105655461-105869552	"Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"dendritic cells: 113.7;Inhibitory neurons: 112.5;Oligodendrocyte precursor cells: 123.1;T-cells: 111.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-138 MG: 32.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018327, HPA019880"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 20: HeLa - Mitochondria"	"Cluster 24: Non-specific - Transcription regulation"	Cytosol	Nucleoplasm	"HPA018327: AB_1846097, HPA019880: AB_1846099"	"unprognostic (2.65e-1)"	"unprognostic (9.42e-2)"	"unprognostic (1.72e-2)"	"unprognostic (2.38e-1)"	"unprognostic (5.89e-3)"	"unprognostic (2.80e-2)"	"unprognostic (8.18e-2)"	"unprognostic (1.10e-1)"	"unprognostic (7.05e-2)"	"unprognostic (1.66e-1)"	"unprognostic (9.29e-2)"	"unprognostic (1.50e-2)"	"unprognostic (1.43e-2)"	"unprognostic (8.21e-2)"	"unprognostic (2.83e-1)"	"unprognostic (1.20e-2)"	"unprognostic (3.09e-2)"	17.3	5.8	5.6	6.7	4.6	11.9	11.0	17.4	5.9	6.8	5.8	6.3	6.2	6.3	4.3	3.5	8.8	8.4	12.2	5.2	7.3	4.3	4.4	9.9	14.5	4.4	5.3	10.0	3.6	2.3	3.8	6.5	5.7	4.7	5.1	9.2	6.7	2.3	7.8	6.8	8.2	3.0	2.0	8.5	8.3	6.4	6.5	4.3	9.1	5.1	6.9	10.0	6.5	4.0	2.4	3.2	10.7	5.4	11.8	12.1	6.8	7.6	4.0	2.3	3.7	4.1	2.6	5.2	5.4	4.2	3.6	3.9	1.5	1.4	2.8	3.8	4.0	2.8	16.1	2.7	17.7	2.0	2.0	11.9	4.3	6.2	16.7	8.5	7.9	5.2	3.0	15.5	5.0	2.8	2.9	1.3	3.6	2.9	4.4	6.1	3.1	0.9	5.9	10.2	8.2	8.9	9.5	1.1	11.9	7.3	2.4	4.3	4.8	32.0	2.6	4.5	2.0	8.8	0.7	8.3	8.6	1.7	2.1	0.7	1.4	2.8	8.9	0.9	7.9	2.1	4.6	5.1	1.3	4.8	3.9	7.0	1.0	10.2	2.0	3.1	5.7	1.7	5.6	4.6	17.4	5.9	5.2	7.3	4.4	5.3	5.7	2.0	6.5	4.0	26.0	16.0	6.1	57.8	43.1	10.8	6.9	35.6	25.6	42.6	12.0	9.7	43.7	2.8	13.7	12.9	27.1	10.1	113.7	12.8	5.9	8.4	34.1	20.9	47.0	34.0	12.6	10.8	48.9	7.8	83.2	55.2	43.8	26.4	8.8	21.3	33.2	8.1	13.9	3.3	112.5	18.8	6.1	13.5	17.1	14.4	7.5	14.6	16.0	74.9	9.0	7.5	59.8	123.1	100.3	15.5	8.6	10.9	53.1	8.9	17.6	3.9	20.2	28.9	6.6	23.6	28.9	11.1	13.3	10.3	7.0	45.4	111.5	5.5	9.9	7.0
CBLL1	"FLJ23109, HAKAI, RNF188"	ENSG00000105879	"Cbl proto-oncogene like 1"	Q75N03	7	107743949-107761667	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Developmental protein, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021773, HPA026699"	Enhanced		Supported	"Nuclear speckles"		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	"Nuclear speckles"		"HPA021773: AB_1846103, HPA026699: AB_1846104"	"unprognostic (1.90e-2)"	"unprognostic (2.25e-1)"	"unprognostic (8.57e-2)"	"unprognostic (3.79e-2)"	"unprognostic (8.16e-2)"	"unprognostic (7.20e-2)"	"unprognostic (1.37e-2)"	"unprognostic (3.96e-3)"	"unprognostic (4.28e-2)"	"unprognostic (2.16e-3)"	"unprognostic (1.29e-1)"	"unprognostic (1.31e-1)"	"unprognostic (2.12e-3)"	"unprognostic (9.12e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.09e-1)"	"unprognostic (8.71e-2)"	11.2	8.1	3.1	12.5	5.3	40.0	15.1	7.8	9.5	12.0	3.0	11.3	9.5	13.5	8.4	11.3	11.2	8.7	10.4	4.2	5.8	10.0	11.2	10.3	16.1	4.1	3.7	14.3	11.7	14.1	5.1	12.0	4.1	16.5	11.1	14.4	8.9	12.7	29.0	10.7	10.3	13.4	3.0	14.2	9.2	19.7	3.7	20.2	13.8	21.0	17.8	11.9	7.2	6.6	27.8	31.1	23.7	30.7	21.7	18.6	16.2	20.5	21.6	22.8	22.5	21.4	27.9	40.6	28.5	23.5	37.6	19.3	33.4	25.0	31.0	28.4	21.1	32.5	23.0	18.2	24.9	49.1	30.9	19.6	22.7	30.7	33.0	17.6	23.8	27.8	53.0	33.3	22.4	48.0	66.5	34.4	34.4	23.3	21.3	30.6	25.4	42.0	17.4	25.5	25.4	39.6	30.7	44.9	23.4	27.7	15.1	24.7	23.4	35.0	25.0	33.4	32.0	53.0	62.3	64.1	21.3	29.8	30.3	88.8	31.1	53.3	39.5	32.0	58.2	39.0	61.9	45.8	36.9	39.8	41.8	40.0	48.9	55.1	38.0	20.1	92.6	48.4	3.1	5.3	7.8	9.5	4.2	5.8	4.1	3.7	4.1	3.0	3.7	6.6	18.2	19.2	11.0	6.5	29.6	23.6	16.7	10.5	27.3	12.2	15.9	13.7	16.4	17.2	10.7	3.7	4.2	10.3	27.6	9.9	7.9	9.7	12.4	15.6	19.8	13.5	16.8	39.1	13.9	10.8	9.5	12.6	10.7	13.7	13.3	16.6	12.5	11.0	10.7	10.1	13.1	8.0	8.2	23.3	12.4	5.4	9.3	15.1	19.6	15.9	15.0	7.6	25.7	10.1	20.5	10.1	15.0	11.7	17.3	16.2	8.5	11.2	8.9	14.4	19.7	13.2	14.5	27.2	14.3	19.5	19.9	10.3	27.3	9.5	10.0	18.4
CBR1	"CBR, SDR21C1"	ENSG00000159228	"Carbonyl reductase 1"	P16152	21	36069941-36073166	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 583.9"	"Cell type enhanced"	"Detected in all"		"Basal squamous epithelial cells: 524.2;Distal tubular cells: 757.2;Proximal enterocytes: 1270.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA018433, CAB034291"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA		12000000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 45: Intestine - Brush border"	"Cluster 16: U-266 - Nucleosome"	"Cluster 45: Enterocytes - Digestion"	Nucleoplasm	Cytosol	"CAB034291: AB_2070856, HPA018433: AB_1846109"	"prognostic favorable (2.18e-4)"	"unprognostic (9.78e-2)"	"unprognostic (3.25e-2)"	"unprognostic (2.14e-1)"	"unprognostic (6.47e-3)"	"unprognostic (1.69e-1)"	"unprognostic (1.19e-1)"	"unprognostic (6.37e-2)"	"unprognostic (4.56e-2)"	"unprognostic (1.28e-1)"	"unprognostic (7.20e-2)"	"unprognostic (4.00e-1)"	"prognostic favorable (4.75e-4)"	"unprognostic (2.37e-1)"	"unprognostic (2.47e-1)"	"unprognostic (6.13e-3)"	"unprognostic (2.47e-2)"	32.4	95.3	150.0	25.6	200.0	10.1	29.5	186.1	174.1	52.7	207.0	68.6	583.9	41.3	50.5	189.5	34.6	47.1	29.5	154.6	166.7	125.6	252.8	41.1	28.3	173.1	175.1	28.8	36.1	38.6	35.3	27.6	175.6	48.7	50.9	10.2	101.8	42.2	33.6	111.8	345.9	34.4	166.2	39.9	133.5	18.1	180.3	22.7	46.4	23.3	36.7	51.0	85.3	266.6	114.4	180.4	22.6	55.9	115.0	115.3	1.2	123.6	97.0	72.4	86.4	68.9	67.8	28.2	78.7	128.1	137.3	84.6	46.3	132.3	55.7	133.8	95.3	82.5	105.1	48.1	65.7	49.1	77.5	56.1	165.6	70.7	30.8	83.0	78.4	0.0	0.0	21.3	67.6	121.2	24.7	50.7	0.4	0.0	123.3	0.4	0.4	80.5	195.7	60.9	60.5	52.1	121.3	186.3	157.3	17.6	86.1	69.4	71.1	78.8	30.8	202.9	96.1	131.8	268.9	0.7	144.0	48.6	115.6	7.1	134.0	68.6	64.4	198.5	54.6	67.2	79.7	60.8	109.6	61.2	102.6	75.4	9.2	77.3	156.9	39.6	89.0	162.1	150.0	200.0	186.1	174.1	154.6	166.7	173.1	175.1	175.6	166.2	180.3	266.6	26.4	121.8	69.3	17.9	22.5	128.2	63.1	295.2	524.2	11.6	27.7	98.8	20.9	77.2	117.1	95.6	2.1	116.6	15.7	91.2	757.2	93.7	8.9	31.7	45.5	23.1	38.6	32.0	6.5	70.0	80.4	65.7	127.4	45.1	34.9	30.8	41.7	277.2	85.1	3.3	6.8	94.4	396.7	66.6	27.5	4.3	122.7	49.5	90.7	4.7	79.2	69.8	23.7	16.6	128.2	91.8	146.6	132.4	41.3	66.4	1270.3	326.0	121.2	8.3	26.3	51.3	90.7	5.8	17.4	403.5	123.6	89.2	30.7	55.6	145.8	55.0
CBR3	SDR21C2	ENSG00000159231	"Carbonyl reductase 3"	O75828	21	36135079-36146562	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 56.3;salivary gland: 41.4"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 102.5;Basal squamous epithelial cells: 107.0;Peritubular cells: 75.6;Squamous epithelial cells: 230.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	9	"B-cells: 23.9;NK-cells: 11.5;T-cells: 33.7"	"Cell line enhanced"	"Detected in many"		"RPMI-8226: 64.9"	"Region enhanced"	"Detected in all"		"basal ganglia: 48.6"	"Low region specificity"	"Detected in many"			HPA018434	Uncertain		Supported	Nucleoplasm,Cytosol		Yes	NA		2800000	"Cluster 30: Non-specific - Translation"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 61: Squamous epithelial cells - Keratinization"	"Nucleoplasm, Cytosol"		"HPA018434: AB_1846110"	"unprognostic (3.64e-3)"	"unprognostic (2.32e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.46e-1)"	"unprognostic (2.16e-1)"	"unprognostic (1.18e-3)"	"unprognostic (1.22e-1)"	"unprognostic (2.22e-2)"	"unprognostic (6.12e-2)"	"unprognostic (2.98e-2)"	"unprognostic (3.75e-1)"	"unprognostic (9.10e-2)"	"prognostic unfavorable (5.95e-6)"	"unprognostic (3.13e-1)"	"unprognostic (1.80e-1)"	"unprognostic (3.99e-3)"	"unprognostic (1.94e-1)"	17.3	2.3	12.8	4.0	14.7	1.4	15.3	13.9	19.8	12.4	11.2	7.8	3.0	7.5	11.0	56.3	8.8	6.5	6.1	13.2	12.4	2.7	0.8	4.6	2.9	12.8	12.1	11.2	1.6	0.6	2.4	2.9	12.3	9.9	3.6	0.6	41.4	5.1	3.1	21.6	5.4	6.1	12.0	3.1	5.2	3.1	12.2	2.0	4.6	7.8	7.6	11.6	16.8	12.4	33.5	9.5	4.0	8.2	31.0	47.8	5.9	35.4	42.4	40.6	32.1	0.4	6.9	0.0	10.2	37.2	13.7	15.0	5.5	7.2	16.2	45.3	17.2	1.4	10.0	0.3	2.6	0.1	0.1	6.8	0.8	28.1	3.6	19.1	24.9	3.7	0.0	0.3	12.1	25.4	3.1	14.7	3.2	10.3	41.5	6.7	7.6	64.9	13.7	14.2	2.1	2.9	27.3	32.6	53.3	2.2	9.8	3.9	17.1	25.7	2.2	28.8	35.0	1.5	0.6	0.0	26.9	0.9	47.3	0.0	0.6	0.1	2.2	0.5	3.0	23.6	25.1	7.7	2.4	23.9	33.7	23.5	0.9	11.5	1.0	0.7	10.9	11.5	12.8	14.7	13.9	19.8	13.2	12.4	12.8	12.1	12.3	12.0	12.2	12.4	41.7	0.0	3.2	6.8	5.2	71.0	22.1	102.5	107.0	0.8	23.1	38.6	0.2	2.8	23.0	0.0	0.0	1.2	2.9	1.9	9.8	4.7	0.7	13.1	7.5	26.5	0.0	1.7	3.9	0.7	0.3	53.4	7.7	14.7	5.7	1.1	14.3	0.3	8.4	0.0	5.5	12.6	69.2	3.8	41.3	4.0	67.7	5.8	65.8	2.8	20.9	1.9	0.0	1.5	0.5	2.6	1.7	75.6	1.4	43.4	1.3	0.2	13.1	0.6	0.0	21.4	19.7	0.4	0.2	230.4	46.7	0.3	7.0	1.0	8.1	21.1
CBX1	"CBX, HP1-BETA, HP1Hs-beta, M31, MOD1"	ENSG00000108468	"Chromobox 1"	P83916	17	48070052-48101478	"Metabolic proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 350.8;Spermatogonia: 304.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB012265	Supported		Supported	"Nucleoplasm,Nuclear bodies"		NA	NA		120000	"Cluster 1: Neutrophils - Mixed function"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	"Nucleoplasm, Nuclear bodies"		"CAB012265: AB_297216"	"unprognostic (7.50e-2)"	"unprognostic (3.33e-1)"	"unprognostic (2.02e-1)"	"unprognostic (2.58e-2)"	"unprognostic (3.15e-1)"	"unprognostic (3.04e-1)"	"prognostic unfavorable (2.70e-4)"	"unprognostic (2.68e-2)"	"unprognostic (3.45e-2)"	"unprognostic (6.55e-2)"	"unprognostic (2.78e-1)"	"unprognostic (2.72e-2)"	"unprognostic (1.67e-2)"	"unprognostic (6.48e-3)"	"unprognostic (3.82e-1)"	"unprognostic (3.65e-1)"	"unprognostic (6.73e-2)"	30.9	31.4	60.3	35.5	59.9	16.5	37.2	61.6	73.2	53.6	54.5	40.7	19.0	66.5	47.9	36.8	40.2	27.9	32.1	59.8	63.9	37.9	21.6	26.9	35.0	63.2	59.7	77.5	22.3	43.8	34.8	34.7	64.0	38.0	33.1	59.5	29.7	47.1	68.4	28.8	24.0	55.6	64.9	33.7	26.6	69.1	60.3	73.6	39.5	46.0	46.9	36.4	37.9	67.3	217.3	121.1	392.4	185.6	78.0	69.3	217.7	197.0	95.1	188.0	200.6	319.2	84.5	148.4	204.5	155.6	144.8	85.3	146.3	124.6	329.2	273.8	118.1	119.8	121.1	119.3	47.5	115.5	71.9	49.8	68.4	140.3	178.3	144.7	157.1	176.6	152.0	67.2	153.8	135.7	325.9	79.8	150.6	118.8	156.9	241.8	322.7	95.8	110.3	121.7	138.5	345.6	135.0	44.6	75.5	281.8	211.0	82.5	110.7	260.2	238.9	112.0	201.1	94.0	227.9	140.4	71.4	50.4	119.0	5.1	12.2	16.0	12.4	12.7	10.0	16.1	11.2	10.4	9.9	15.7	11.5	9.7	33.6	9.5	9.3	10.6	12.4	5.9	60.3	59.9	61.6	73.2	59.8	63.9	63.2	59.7	64.0	64.9	60.3	67.3	32.9	67.3	27.6	7.8	31.4	43.6	30.5	46.1	36.5	46.9	48.0	54.7	70.9	18.6	33.6	42.3	20.9	66.4	27.5	19.2	35.2	68.7	26.8	40.8	78.9	40.2	40.3	34.3	13.0	29.7	86.6	61.5	10.2	39.6	39.9	65.3	30.0	15.6	69.6	50.5	15.5	27.3	42.7	33.5	24.5	59.5	80.2	26.7	40.9	7.5	47.7	106.6	42.2	12.5	13.7	34.7	12.9	91.7	20.0	51.1	9.6	30.9	32.2	36.3	39.5	33.3	71.8	350.8	304.0	26.7	36.2	27.8	25.6	35.8	28.6	20.1
CBX2	"CDCA6, MGC10561"	ENSG00000173894	"Chromobox 2"	Q14781	17	79778148-79787983	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Differentiation, Sexual differentiation, Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding, Repressor"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 7.3;testis: 12.8"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 32.5;Granulosa cells: 10.4;Late spermatids: 39.1;Spermatogonia: 14.3"	"Cancer enhanced"	"Detected in many"		"testis cancer: 20.4"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"REH: 96.4;SK-BR-3: 134.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA023083	Approved		Supported	Nucleoplasm		NA	NA				"Cluster 23: Testis - Cell cycle regulation"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Nucleoplasm		"HPA023083: AB_2671063"	"unprognostic (1.37e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.95e-1)"	"unprognostic (3.80e-2)"	"unprognostic (1.49e-1)"	"unprognostic (9.72e-2)"	"unprognostic (2.25e-11)"	"unprognostic (1.05e-1)"	"unprognostic (7.77e-2)"	"unprognostic (6.34e-3)"	"unprognostic (1.86e-3)"	"unprognostic (1.66e-1)"	"unprognostic (1.25e-8)"	"unprognostic (1.34e-1)"	"unprognostic (3.33e-2)"	"unprognostic (2.37e-3)"	"unprognostic (2.07e-1)"	1.4	0.3	1.1	0.7	0.9	2.2	1.2	0.8	0.9	1.3	0.5	0.5	0.4	1.2	1.8	4.2	1.0	0.6	2.3	0.8	0.7	1.6	0.4	1.2	1.3	1.0	0.9	2.1	1.3	0.5	0.2	2.2	1.1	0.6	0.2	0.5	0.9	0.5	0.7	2.1	0.6	0.7	0.8	1.6	0.5	12.8	1.0	7.3	0.5	1.1	1.3	1.0	1.6	1.0	7.5	20.5	37.0	67.4	0.4	0.5	13.2	2.7	1.2	1.3	2.4	21.2	1.7	29.7	5.8	0.3	4.7	3.8	43.0	1.2	0.9	4.3	23.3	1.5	24.0	14.2	1.4	9.0	6.1	0.7	2.6	0.7	1.7	1.6	7.5	31.3	20.8	2.3	1.4	31.3	47.3	22.1	36.8	10.3	23.4	96.4	27.7	18.0	1.5	10.5	45.1	69.8	11.7	134.7	8.0	17.6	24.5	13.4	5.4	13.1	38.4	4.0	5.3	8.7	4.8	18.3	0.5	24.1	15.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.9	0.8	0.9	0.8	0.7	1.0	0.9	1.1	0.8	1.0	1.0	5.3	0.0	0.0	0.3	0.1	1.0	0.3	0.4	0.0	1.0	0.6	1.8	2.5	0.0	0.3	1.8	2.1	0.4	2.9	0.4	1.9	3.6	32.5	0.9	1.8	8.6	0.0	5.9	0.1	0.9	1.4	0.8	1.1	1.8	0.0	10.4	3.6	1.1	1.2	0.0	0.0	0.8	0.0	0.6	0.9	39.1	0.6	0.5	3.6	0.0	0.8	4.3	0.0	0.0	0.3	1.1	0.0	0.7	0.5	0.7	0.0	0.8	0.1	0.4	0.0	0.3	1.0	1.6	14.3	4.1	1.4	0.3	1.2	0.9	0.5	0.9
CBX3	HP1Hs-gamma	ENSG00000122565	"Chromobox 3"	Q13185	7	26201162-26213607	"Plasma proteins, Predicted intracellular proteins"	"Biological rhythms, Transcription, Transcription regulation"	"Chromatin regulator, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"CAB001973, HPA004902"	Supported		Supported	"Nucleoplasm,Nuclear bodies"		NA	Yes		180000	"Cluster 49: Eosinophils - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	"Nuclear bodies"	"CAB001973: , HPA004902: AB_1850635"	"prognostic unfavorable (7.92e-4)"	"unprognostic (1.43e-1)"	"unprognostic (4.84e-2)"	"unprognostic (1.12e-2)"	"unprognostic (4.85e-2)"	"unprognostic (9.25e-3)"	"prognostic unfavorable (2.20e-8)"	"unprognostic (2.13e-2)"	"unprognostic (3.95e-2)"	"unprognostic (3.71e-3)"	"prognostic unfavorable (4.00e-4)"	"unprognostic (1.16e-1)"	"prognostic unfavorable (4.56e-7)"	"unprognostic (7.79e-2)"	"unprognostic (4.69e-2)"	"unprognostic (1.17e-1)"	"unprognostic (5.78e-2)"	76.2	93.0	55.5	99.2	57.8	168.8	98.5	58.8	74.1	65.0	56.6	75.3	105.8	76.7	79.7	63.9	62.9	58.5	64.2	54.2	63.2	87.6	84.9	62.1	145.7	60.2	61.0	79.5	56.3	51.5	40.5	88.8	60.7	56.6	87.2	122.7	61.3	59.8	87.2	54.7	99.0	65.9	60.2	82.0	61.7	99.6	58.2	190.4	55.3	68.6	140.4	84.1	55.7	63.6	365.4	156.3	330.0	332.2	115.0	205.8	257.8	275.9	209.1	205.2	207.2	185.8	296.8	544.1	218.7	183.9	440.6	283.0	275.7	231.2	332.1	151.8	209.1	312.8	201.0	208.5	126.1	508.3	294.7	153.9	197.5	163.2	231.2	253.9	281.7	343.2	506.1	263.9	351.7	207.5	489.4	625.9	424.4	311.3	225.1	313.6	303.9	452.3	303.8	201.4	401.1	448.2	230.5	482.6	274.9	345.3	412.4	455.1	212.0	186.0	340.5	222.1	376.8	394.6	596.5	929.3	163.2	422.3	864.3	135.7	85.9	137.7	77.3	116.3	96.9	86.8	114.4	96.1	89.1	77.7	118.4	119.6	92.6	99.2	123.2	72.4	148.3	87.2	55.5	57.8	58.8	74.1	54.2	63.2	60.2	61.0	60.7	60.2	58.2	63.6	139.1	109.0	98.4	16.3	158.5	143.6	93.3	128.0	105.3	101.8	223.8	181.0	124.1	133.0	119.7	64.4	77.2	176.3	138.7	111.2	140.8	167.6	162.2	132.4	215.4	142.6	110.2	306.6	27.4	141.4	362.1	123.6	81.1	129.0	222.0	166.2	145.3	289.2	143.1	50.5	26.8	156.6	107.8	254.9	200.0	41.9	136.4	157.6	104.9	15.0	183.3	155.9	166.9	23.1	35.8	166.3	103.8	98.2	129.1	135.1	112.6	187.4	107.3	132.1	78.9	60.0	110.1	274.5	388.6	112.5	107.8	270.8	155.2	133.1	205.9	110.9
CBX4	"hPC2, NBP16, PC2"	ENSG00000141582	"Chromobox 4"	O00257	17	79833156-79839440	"Predicted intracellular proteins"	"Transcription, Transcription regulation, Ubl conjugation pathway"	"Chromatin regulator, Repressor, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"bone marrow: 130.3"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"SK-BR-3: 110.8;SK-MEL-30: 130.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008228, HPA012021"	Approved		Enhanced	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm	"Nuclear bodies"	"HPA008228: AB_1078413, HPA012021: AB_2668603"	"unprognostic (1.30e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.72e-2)"	"unprognostic (1.86e-1)"	"unprognostic (3.97e-2)"	"unprognostic (8.80e-2)"	"unprognostic (5.39e-3)"	"unprognostic (1.49e-1)"	"unprognostic (2.55e-1)"	"unprognostic (1.40e-2)"	"unprognostic (7.62e-2)"	"unprognostic (2.34e-3)"	"prognostic unfavorable (8.72e-8)"	"unprognostic (7.49e-2)"	"unprognostic (2.87e-1)"	"unprognostic (3.99e-2)"	"unprognostic (1.07e-1)"	9.3	14.2	9.6	11.1	10.8	130.3	9.0	8.8	12.5	9.1	0.0	7.9	7.1	6.3	4.6	20.7	8.1	6.3	16.0	12.4	9.7	10.6	21.6	12.3	14.6	11.5	9.5	9.6	19.0	17.0	19.1	15.2	10.7	9.3	3.2	12.3	13.2	4.6	3.4	31.6	11.9	3.8	8.2	20.9	12.9	6.9	12.2	23.1	8.6	1.4	7.2	6.7	10.3	16.6	32.1	28.3	8.4	36.3	5.2	4.7	23.5	14.3	8.5	5.1	5.4	20.5	17.5	12.3	19.7	5.6	11.4	16.3	9.3	9.5	3.8	13.3	17.7	7.0	28.0	38.4	25.4	37.0	52.5	6.5	54.4	4.7	8.4	8.5	4.3	35.5	21.7	67.5	5.5	23.0	50.9	37.7	4.6	33.2	28.2	51.9	8.6	56.3	7.2	15.3	8.7	16.6	21.4	110.8	130.9	3.5	26.3	58.3	11.2	29.8	26.3	18.4	18.6	58.0	32.4	35.0	18.7	31.6	40.4	1.6	0.5	1.8	0.9	0.6	0.6	1.5	1.2	1.3	0.3	1.5	1.4	1.3	2.1	0.4	0.7	1.7	0.2	0.6	9.6	10.8	8.8	12.5	12.4	9.7	11.5	9.5	10.7	8.2	12.2	16.6	40.4	3.2	15.7	4.6	31.8	23.3	5.4	13.4	36.5	31.7	65.2	79.8	51.6	30.0	12.1	1.8	22.9	34.2	77.6	26.6	0.0	7.5	0.2	63.9	19.3	21.6	52.7	7.8	5.5	7.3	5.0	15.8	20.9	62.8	7.0	22.3	15.7	16.3	13.8	20.2	5.5	49.5	2.0	19.8	17.0	1.0	4.4	35.4	17.8	12.2	15.4	39.2	15.5	6.0	11.6	10.0	18.4	5.7	26.1	6.3	9.6	2.8	14.6	44.3	6.6	15.3	24.4	0.5	2.4	65.7	30.7	8.6	42.5	13.7	29.7	5.2
CBX7		ENSG00000100307	"Chromobox 7"	O95931	22	39120167-39152680	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 74.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 37.2;U-266/70: 30.7"	"Low region specificity"	"Detected in all"							"CAB011574, HPA048677, HPA056480"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 35: Non-specific - Unknown function"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	Cytosol	"CAB011574: AB_726005, HPA048677: AB_2680490, HPA056480: AB_2683146"	"prognostic favorable (6.18e-4)"	"prognostic favorable (3.63e-4)"	"prognostic unfavorable (3.73e-4)"	"unprognostic (9.18e-2)"	"unprognostic (2.32e-1)"	"unprognostic (1.48e-3)"	"unprognostic (4.76e-3)"	"unprognostic (1.45e-2)"	"unprognostic (3.86e-2)"	"unprognostic (1.11e-3)"	"prognostic favorable (1.04e-4)"	"unprognostic (3.03e-3)"	"prognostic favorable (2.45e-5)"	"unprognostic (3.90e-1)"	"unprognostic (1.26e-1)"	"unprognostic (3.10e-1)"	"unprognostic (1.63e-2)"	36.6	31.2	53.6	15.9	52.9	6.0	32.3	53.8	72.1	54.6	38.1	85.2	17.2	61.2	29.1	24.5	62.7	17.7	57.4	53.7	44.5	32.5	17.7	30.4	27.4	49.2	47.8	58.5	28.8	41.5	42.7	8.3	48.9	50.9	14.2	34.0	35.3	57.7	68.0	28.1	42.9	27.4	38.6	42.5	48.0	10.8	46.0	14.2	33.3	51.3	21.6	66.3	39.1	53.2	6.9	2.9	1.4	11.0	13.1	5.0	3.6	6.5	8.0	3.5	4.2	1.4	4.7	1.2	7.5	4.9	6.3	2.5	0.9	3.0	2.6	37.2	3.6	0.2	5.5	0.7	4.5	1.7	14.0	2.5	4.4	1.7	0.7	4.5	1.0	5.5	1.7	18.1	2.7	6.7	2.5	0.8	0.8	8.8	4.9	2.8	2.3	10.1	1.8	2.8	3.6	0.9	3.3	4.8	7.6	2.3	5.8	2.7	2.6	5.8	10.9	5.9	2.9	30.7	18.4	4.2	11.8	2.7	2.5	0.4	0.3	2.9	1.9	0.0	2.0	1.5	2.1	2.1	0.0	2.0	2.6	2.5	3.1	1.0	0.5	0.4	2.2	1.0	53.6	52.9	53.8	72.1	53.7	44.5	49.2	47.8	48.9	38.6	46.0	53.2	17.5	6.4	8.7	16.3	27.9	4.6	11.7	3.7	7.4	57.0	9.6	11.6	74.6	24.3	9.5	14.7	35.5	4.3	10.5	10.5	9.8	4.3	8.2	5.1	4.8	14.4	4.2	20.0	17.0	3.8	1.5	16.2	6.6	3.3	10.8	9.6	28.5	11.8	4.4	60.6	18.8	7.6	8.2	11.7	6.4	18.6	35.1	6.2	19.6	14.0	11.6	16.4	42.2	13.0	28.8	3.4	5.1	27.8	12.0	10.5	18.2	13.6	6.4	62.7	46.0	28.3	24.9	7.0	5.3	3.1	4.8	3.6	22.8	4.1	5.4	7.5
CC2D1A	"FLJ20241, Freud-1, MRT3"	ENSG00000132024	"Coiled-coil and C2 domain containing 1A"	Q6P1N0	19	13906201-13930879	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"	"Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005436, CAB015220"	Supported		Approved	"Nucleoli fibrillar center,Plasma membrane,Cytosol"		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 50: Non-specific - Ribosome"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Plasma membrane, Cytosol"	"Nucleoli fibrillar center"	"CAB015220: , HPA005436: AB_1078884"	"unprognostic (8.66e-2)"	"unprognostic (1.31e-2)"	"unprognostic (2.55e-1)"	"unprognostic (2.34e-1)"	"unprognostic (1.07e-1)"	"prognostic favorable (7.02e-4)"	"unprognostic (7.00e-2)"	"unprognostic (1.59e-3)"	"unprognostic (1.17e-1)"	"unprognostic (2.82e-2)"	"unprognostic (2.61e-3)"	"unprognostic (4.07e-2)"	"unprognostic (1.23e-3)"	"unprognostic (6.67e-3)"	"unprognostic (1.97e-1)"	"unprognostic (9.22e-2)"	"unprognostic (1.71e-2)"	16.8	16.4	11.6	3.8	11.3	3.7	21.3	10.1	18.1	19.4	10.3	37.4	16.2	16.2	2.1	33.3	19.8	2.9	20.5	11.8	11.9	22.9	26.9	16.0	3.2	11.3	11.4	18.7	34.3	7.9	31.8	3.1	11.8	25.8	4.7	4.1	27.4	5.2	28.3	35.5	33.1	3.4	9.8	17.7	24.7	15.9	13.2	2.6	20.6	3.9	3.1	21.2	24.8	10.8	22.0	8.5	2.3	9.9	5.1	3.1	9.3	6.9	8.1	10.2	10.4	14.5	6.8	11.2	11.4	6.1	6.4	15.2	5.3	10.1	3.3	17.0	30.9	5.2	11.0	6.9	9.0	4.1	15.2	4.7	12.5	7.2	4.3	6.5	7.2	11.5	6.4	8.5	3.4	22.4	11.6	12.1	7.1	18.5	16.7	11.2	6.3	8.9	6.5	16.3	10.2	7.1	9.8	13.3	12.2	1.6	10.4	9.8	6.3	8.3	4.4	20.9	8.9	15.2	7.3	6.6	10.8	14.3	7.8	0.5	0.3	0.8	0.4	0.7	0.1	0.2	0.2	0.2	0.4	0.1	0.0	0.2	0.1	0.2	0.5	0.3	0.3	0.3	11.6	11.3	10.1	18.1	11.8	11.9	11.3	11.4	11.8	9.8	13.2	10.8	20.6	9.6	8.3	23.8	12.6	9.1	14.2	15.6	19.4	66.6	19.2	64.6	8.4	21.5	16.5	11.0	93.8	22.3	11.7	103.4	9.8	22.0	2.2	10.1	6.7	13.2	33.5	18.7	38.4	27.7	10.7	10.5	63.7	11.3	17.7	29.3	12.8	12.4	14.5	30.3	43.3	46.6	24.4	12.2	13.0	6.5	64.3	11.3	7.2	10.3	16.3	15.6	23.7	31.2	24.1	26.0	77.6	87.3	12.3	13.0	97.9	6.8	16.7	93.2	13.1	8.0	9.3	10.2	12.4	24.8	13.8	21.3	14.8	16.1	64.3	18.8
CC2D1B	"Freud-2, KIAA1836"	ENSG00000154222	"Coiled-coil and C2 domain containing 1B"	Q5T0F9	1	52345723-52366205	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 10.4"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 10.4"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027500, HPA031426"	Uncertain		Supported	Nucleoplasm,Vesicles		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm	Vesicles	"HPA027500: AB_10600693, HPA031426: AB_2673876"	"unprognostic (1.11e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.38e-2)"	"unprognostic (2.50e-2)"	"unprognostic (5.85e-2)"	"unprognostic (2.04e-2)"	"prognostic unfavorable (1.45e-5)"	"unprognostic (3.39e-2)"	"unprognostic (4.75e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.13e-2)"	"unprognostic (2.63e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.37e-2)"	"unprognostic (1.87e-1)"	13.4	15.0	14.5	8.7	18.0	5.0	12.6	17.3	15.9	10.4	13.5	13.0	8.0	11.0	9.2	16.7	10.0	7.0	13.3	13.1	16.0	18.9	17.2	17.8	12.1	19.1	17.7	13.3	15.6	10.2	19.5	7.5	18.6	13.7	6.5	4.0	12.7	7.1	29.1	12.0	15.0	5.5	17.4	17.9	12.8	16.7	17.1	11.0	17.7	11.7	9.7	12.2	12.0	19.5	12.4	17.2	7.8	12.2	28.1	10.7	18.3	15.6	27.3	19.9	15.0	11.5	10.1	7.7	12.9	18.2	43.6	8.3	10.1	21.6	9.0	14.2	11.1	8.5	13.6	9.7	22.6	11.8	19.8	15.9	19.3	22.2	16.9	19.3	12.4	12.2	14.7	8.2	22.2	8.5	12.4	9.7	15.2	12.5	19.2	7.9	14.7	11.3	21.0	17.2	8.5	8.0	15.2	22.7	22.7	20.0	8.0	17.4	14.9	22.9	12.6	12.6	17.9	11.7	11.5	9.9	30.3	12.7	28.8	10.4	1.1	2.8	2.3	0.6	1.9	1.7	1.8	1.8	1.1	1.2	1.4	2.0	1.6	1.9	0.5	1.1	1.6	1.3	14.5	18.0	17.3	15.9	13.1	16.0	19.1	17.7	18.6	17.4	17.1	19.5	6.7	9.6	13.4	4.6	7.5	3.2	3.3	3.4	5.2	5.6	3.9	2.7	5.6	4.3	7.6	11.0	0.0	9.0	9.0	10.2	3.9	10.0	3.7	6.7	4.1	5.8	6.0	2.5	4.6	12.7	10.3	3.9	14.8	9.6	15.8	6.7	9.7	8.2	11.6	1.7	4.6	5.7	2.0	6.9	1.5	2.4	3.4	8.0	1.8	2.8	5.9	6.5	8.2	2.0	5.9	12.2	9.1	6.4	6.7	3.8	8.6	5.3	5.4	4.9	0.0	5.1	4.1	16.6	8.8	4.9	3.1	15.7	8.9	5.8	4.9	3.5
CCAR1	"CARP-1, CARP1, FLJ10590"	ENSG00000060339	"Cell division cycle and apoptosis regulator 1"	Q8IX12	10	68721012-68792377	"Cancer-related genes, Predicted intracellular proteins"	"Apoptosis, Cell cycle, Transcription, Transcription regulation"	"Activator, Repressor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007856, HPA048513"	Supported		Supported	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm	"Golgi apparatus"	"HPA007856: AB_1078415, HPA048513: AB_2680424"	"unprognostic (1.71e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.34e-2)"	"unprognostic (1.86e-1)"	"unprognostic (5.15e-3)"	"unprognostic (1.71e-2)"	"prognostic unfavorable (1.41e-5)"	"unprognostic (1.10e-1)"	"unprognostic (3.25e-2)"	"prognostic favorable (4.05e-5)"	"unprognostic (2.89e-2)"	"unprognostic (3.21e-3)"	"prognostic unfavorable (1.37e-4)"	"unprognostic (1.67e-1)"	"unprognostic (2.36e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.41e-2)"	17.4	21.4	14.4	20.2	16.0	23.4	17.2	21.1	25.4	15.9	15.2	17.9	16.8	16.7	16.1	20.1	14.5	16.5	15.6	13.6	17.0	18.4	19.1	15.9	30.3	16.9	14.9	19.9	20.4	15.9	14.5	21.7	16.4	17.3	22.2	20.9	18.5	13.5	20.6	23.9	19.4	16.0	13.2	21.5	17.8	14.3	16.8	29.8	18.2	17.9	28.7	21.7	17.0	19.2	64.0	64.8	73.9	49.7	31.4	30.3	57.7	56.0	47.4	59.3	40.0	87.2	50.8	74.7	29.9	39.1	29.8	49.3	78.4	44.3	64.8	51.5	48.2	60.1	46.1	54.5	35.7	96.2	67.5	30.5	54.2	50.1	61.7	36.7	48.5	37.5	83.5	46.8	58.8	46.5	64.2	60.7	74.1	49.7	58.4	74.2	44.1	44.7	52.5	48.6	42.7	36.9	55.1	89.1	57.1	57.6	60.6	58.9	48.1	36.8	46.3	40.1	61.4	32.2	45.5	78.5	30.8	63.8	35.6	6.1	14.6	14.3	16.3	13.0	14.6	14.2	11.3	15.8	21.0	17.3	13.5	14.3	3.3	10.6	15.5	13.1	18.4	11.3	14.4	16.0	21.1	25.4	13.6	17.0	16.9	14.9	16.4	13.2	16.8	19.2	50.5	35.3	85.5	61.4	69.2	37.0	49.6	54.7	66.0	51.0	36.1	40.0	65.5	41.5	49.0	46.0	58.4	73.1	62.9	44.1	23.5	68.0	28.8	55.2	68.5	54.0	46.1	61.2	49.7	78.1	83.8	49.2	45.3	62.2	67.2	76.8	39.3	40.4	49.2	55.5	51.2	55.1	30.5	47.4	36.3	14.5	53.7	49.8	21.4	41.2	65.4	36.5	66.9	47.7	66.1	77.7	34.2	50.4	61.0	45.3	36.0	18.3	49.1	68.7	65.7	53.2	62.3	128.7	77.2	50.4	37.4	109.5	61.3	83.2	67.2	49.4
CCBE1	"FLJ30681, KIAA1983"	ENSG00000183287	"Collagen and calcium binding EGF domains 1"	Q6UXH8	18	59430939-59697662	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	Angiogenesis	"Developmental protein"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ovary: 33.5"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 56.1;Rod photoreceptor cells: 38.2;Theca cells: 78.0"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in some"	6	"basophil: 9.2"	"Lineage enriched"	"Detected in single"	19	"granulocytes: 9.2"	"Cell line enhanced"	"Detected in many"		"BJ: 101.2;BJ hTERT+: 103.2;BJ hTERT+ SV40 Large T+ RasG12V: 96.4;HBF TERT88: 113.3;hTERT-HME1: 153.2;LHCN-M2: 176.9;TIME: 93.3"	"Group enriched"	"Detected in many"	5	"cerebral cortex: 2.7;hippocampal formation: 8.7"	"Low region specificity"	"Detected in many"			"HPA041361, HPA041374"	Uncertain		Supported	"Plasma membrane,Cytosol"	"Secreted to extracellular matrix"	NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Plasma membrane, Cytosol"		"HPA041361: AB_10796667, HPA041374: AB_10794515"	"unprognostic (3.09e-1)"	"unprognostic (5.01e-2)"	"unprognostic (9.54e-5)"	"unprognostic (1.66e-2)"	"unprognostic (2.40e-2)"	"unprognostic (5.68e-5)"	"unprognostic (2.31e-2)"	"unprognostic (2.03e-1)"	"unprognostic (4.54e-2)"	"unprognostic (1.21e-1)"	"unprognostic (7.39e-2)"	"unprognostic (2.17e-2)"	"unprognostic (3.62e-3)"	"unprognostic (4.04e-3)"	"unprognostic (1.64e-1)"	"unprognostic (7.45e-2)"	"unprognostic (2.02e-2)"	4.1	10.2	2.7	1.2	3.4	0.5	1.8	2.2	3.0	10.5	0.7	16.7	1.1	6.9	0.5	2.8	8.3	1.3	2.1	6.5	1.1	3.3	5.7	9.9	1.3	0.2	1.9	33.5	1.1	2.9	0.4	0.5	0.3	2.4	2.8	1.1	0.6	4.0	15.3	3.0	2.5	3.2	0.2	0.5	1.6	0.6	3.7	1.2	0.9	0.9	0.7	0.8	1.3	1.5	20.6	1.9	0.0	0.2	15.1	47.2	30.7	101.2	103.2	73.5	96.4	0.3	0.3	0.4	0.2	40.6	16.7	2.3	0.2	65.5	113.3	0.4	0.3	0.2	0.4	0.3	35.1	0.3	0.2	32.0	2.9	57.0	153.2	31.2	3.6	0.3	0.2	0.5	176.9	0.6	0.1	0.2	0.3	0.0	0.6	0.1	0.2	0.2	3.9	2.0	0.4	0.7	0.3	0.2	0.9	7.2	0.3	0.5	93.3	0.2	10.0	15.3	0.3	0.3	0.3	0.2	5.0	0.3	2.4	9.2	0.2	0.5	0.1	0.1	0.1	0.2	0.1	0.1	0.0	0.4	0.2	0.2	1.5	0.4	0.1	0.2	0.1	0.1	2.7	3.4	2.2	3.0	6.5	1.1	0.2	1.9	0.3	0.2	3.7	1.5	1.5	3.2	1.3	3.9	0.2	4.6	2.0	1.0	2.2	6.4	0.8	0.4	1.6	2.8	1.9	0.0	8.4	1.0	0.2	0.2	0.0	0.2	0.8	8.8	5.1	2.2	0.0	0.0	56.1	0.2	1.3	14.5	0.0	0.6	1.3	6.8	9.7	0.2	0.4	15.2	15.1	0.0	0.0	1.0	8.9	1.1	9.6	0.5	7.2	1.0	0.2	2.4	0.0	0.5	0.7	0.3	0.0	0.4	0.1	1.5	0.1	0.1	0.9	38.2	0.0	1.6	5.9	0.4	0.9	0.2	4.3	0.8	1.2	78.0	0.1	0.9
CCDC106	HSU79303	ENSG00000173581	"Coiled-coil domain containing 106"	Q9BWC9	19	55641062-55653161	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Proximal tubular cells: 69.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"naive B-cell: 9.6"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HEK 293: 82.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041925, HPA043219"	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 35: Non-specific - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Nucleoplasm	Cytosol	"HPA041925: AB_2677750, HPA043219: AB_2678368"	"unprognostic (5.74e-3)"	"unprognostic (1.34e-1)"	"unprognostic (1.71e-1)"	"unprognostic (5.16e-2)"	"unprognostic (9.19e-2)"	"unprognostic (2.82e-1)"	"unprognostic (8.11e-2)"	"unprognostic (1.21e-2)"	"unprognostic (4.88e-2)"	"unprognostic (8.74e-2)"	"prognostic favorable (2.23e-6)"	"unprognostic (2.28e-1)"	"prognostic favorable (7.54e-11)"	"unprognostic (5.03e-2)"	"unprognostic (7.88e-2)"	"unprognostic (3.26e-1)"	"unprognostic (8.69e-2)"	12.0	21.7	27.8	5.1	32.7	2.6	11.9	20.4	37.6	11.4	17.7	18.7	4.1	13.4	6.4	8.0	13.3	6.5	21.9	33.0	22.4	29.1	24.3	9.4	10.3	21.8	23.1	12.7	9.8	13.6	27.3	5.1	21.1	15.2	2.7	6.5	11.1	11.2	24.5	9.3	13.7	7.1	18.4	18.2	13.7	20.8	23.5	4.7	16.7	20.2	9.0	12.8	8.3	24.7	8.7	33.6	14.4	25.3	10.1	9.6	2.0	7.4	12.9	25.0	21.0	7.3	13.2	25.6	5.6	13.8	0.7	7.3	24.6	16.0	7.1	1.3	82.2	26.7	23.4	13.3	30.1	1.8	14.3	15.6	1.9	5.9	1.4	17.4	8.0	16.0	20.1	15.7	12.5	2.3	16.3	10.8	6.9	0.8	18.3	25.5	7.3	17.7	25.9	0.8	15.8	29.4	5.9	41.3	14.7	8.5	17.9	17.3	9.0	7.7	7.9	0.7	5.5	9.3	3.5	33.0	20.7	8.4	0.6	0.0	2.3	0.0	0.4	1.5	1.4	7.2	0.4	0.6	2.9	9.6	3.1	1.9	0.0	0.8	0.1	8.9	0.3	1.7	27.8	32.7	20.4	37.6	33.0	22.4	21.8	23.1	21.1	18.4	23.5	24.7	12.0	0.0	1.3	8.8	18.1	2.5	6.0	14.0	12.0	22.3	16.0	17.1	23.8	11.5	6.5	20.2	4.2	13.5	6.8	4.6	41.1	19.6	4.0	3.9	7.2	10.8	4.9	4.2	6.4	7.2	15.0	9.7	11.7	3.3	8.9	10.5	10.0	17.5	17.5	37.0	6.4	8.7	8.2	9.4	6.4	2.7	14.0	7.9	3.6	3.7	11.7	34.1	3.1	4.5	3.6	8.7	8.0	18.8	7.0	6.0	10.6	69.4	3.2	9.7	13.1	9.3	9.0	4.7	30.2	10.3	3.7	8.8	3.9	18.9	6.0	5.7
CCDC110	"CT52, KM-HN-1, MGC33607"	ENSG00000168491	"Coiled-coil domain containing 110"	Q8TBZ0	4	185445182-185471752	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	8	"pancreas: 30.7;testis: 100.0"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 796.2;Late spermatids: 175.5;Spermatocytes: 552.8"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"SCLC-21H: 8.4;U-266/70: 5.3;U-266/84: 8.8;U-87 MG: 4.0"					"Low region specificity"	"Detected in many"			HPA078808			Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 22: Non-specific - Unknown function"	"Cluster 16: U-266 - Nucleosome"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Nucleoplasm, Golgi apparatus"		"HPA078808: "	"unprognostic (1.18e-1)"	"unprognostic (7.26e-3)"	"unprognostic (5.42e-2)"	"unprognostic (9.84e-4)"	"unprognostic (3.72e-2)"	"unprognostic (3.08e-3)"	"unprognostic (1.95e-5)"	"unprognostic (4.92e-2)"	"unprognostic (5.81e-2)"	"unprognostic (9.94e-3)"	"unprognostic (1.43e-1)"	"unprognostic (2.64e-1)"	"prognostic favorable (1.08e-5)"	"unprognostic (1.37e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.21e-2)"	"unprognostic (1.21e-2)"	0.6	1.0	1.8	1.0	3.4	0.0	3.6	2.6	2.1	2.6	1.6	1.8	0.9	1.4	5.1	1.8	2.9	1.2	1.1	1.2	1.2	2.5	0.8	0.9	1.2	2.0	1.6	4.5	30.7	2.0	2.9	0.8	2.4	2.2	1.9	7.9	6.2	2.0	2.1	1.1	0.8	1.4	0.8	0.6	2.5	100.0	1.7	0.4	7.7	0.9	0.7	1.3	0.5	0.9	0.4	0.0	0.2	0.1	2.2	2.4	0.1	0.0	0.0	0.0	0.2	0.0	1.7	2.7	0.3	0.0	2.3	0.3	1.7	0.0	0.2	1.0	1.7	0.0	0.2	0.0	1.1	0.0	0.0	0.6	0.0	1.0	0.0	1.4	0.8	0.7	0.2	0.2	2.9	0.7	0.0	0.0	0.2	0.3	1.3	0.1	0.0	0.4	0.6	0.0	8.4	1.5	0.0	0.9	0.7	0.4	3.8	0.0	0.5	0.3	0.7	0.1	0.1	5.3	8.8	0.0	4.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	3.4	2.6	2.1	1.2	1.2	2.0	1.6	2.4	0.8	1.7	0.9	0.4	0.0	0.0	0.7	0.9	0.3	0.4	0.3	1.8	0.5	2.9	4.7	4.2	0.0	0.0	1.8	0.0	0.1	0.0	0.3	1.9	2.6	796.2	1.8	0.2	1.2	0.0	0.0	3.5	3.5	0.1	2.1	0.5	1.0	0.0	0.2	2.2	0.5	0.1	0.0	1.3	1.1	4.1	0.0	0.3	175.5	7.2	0.9	3.6	1.9	0.1	3.1	1.0	0.5	1.8	2.2	0.3	6.0	9.3	0.4	0.0	2.3	4.4	5.3	0.0	1.7	2.5	552.8	6.1	1.5	0.4	0.0	0.3	0.7	1.1	0.1
CCDC115	"ccp1, FLJ30131, MGC12981"	ENSG00000136710	"Coiled-coil domain containing 115"	Q96NT0	2	130337933-130342699	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Congenital disorder of glycosylation, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA034598	Approved		Supported	"Vesicles,Plasma membrane"		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 64: Macrophages - Immune response"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Plasma membrane"	Vesicles	"HPA034598: AB_10601697"	"prognostic favorable (7.59e-4)"	"unprognostic (1.28e-2)"	"unprognostic (1.10e-3)"	"unprognostic (6.80e-3)"	"unprognostic (3.23e-1)"	"unprognostic (1.08e-1)"	"unprognostic (4.20e-2)"	"unprognostic (8.13e-3)"	"unprognostic (2.63e-1)"	"unprognostic (4.29e-1)"	"unprognostic (2.87e-1)"	"unprognostic (1.91e-2)"	"unprognostic (1.19e-2)"	"unprognostic (1.07e-1)"	"unprognostic (7.83e-2)"	"unprognostic (2.16e-1)"	"unprognostic (3.16e-2)"	27.8	25.1	25.3	18.0	25.8	24.8	25.4	26.4	28.0	33.7	21.7	25.3	21.2	29.5	32.3	31.1	29.9	19.9	18.4	25.2	26.6	29.8	17.8	26.6	29.8	26.8	25.3	41.6	20.2	40.2	22.9	13.8	26.3	24.0	19.3	15.8	29.1	27.7	12.9	39.3	24.2	17.7	26.1	26.1	24.1	10.4	25.4	23.3	30.3	12.3	26.0	26.8	28.1	27.5	22.5	10.5	13.3	8.1	27.2	30.7	16.3	10.5	28.2	22.4	26.1	24.4	48.5	25.7	36.6	18.3	11.4	20.7	10.8	19.2	16.1	33.4	20.2	20.2	5.4	27.3	22.7	20.8	40.2	26.2	44.2	14.6	8.1	21.8	23.7	24.3	19.8	22.6	27.7	20.7	38.5	37.5	17.2	11.2	26.4	29.4	14.2	24.1	18.8	18.6	12.4	22.8	12.3	22.4	24.2	8.7	24.5	25.3	18.6	10.1	10.4	18.5	8.3	12.4	13.0	19.7	22.9	22.1	13.5	129.9	94.6	154.8	80.8	136.0	71.8	96.3	85.1	85.8	95.2	98.9	81.1	74.8	33.3	80.6	174.9	73.8	103.6	132.8	25.3	25.8	26.4	28.0	25.2	26.6	26.8	25.3	26.3	26.1	25.4	27.5	37.5	19.2	28.3	3.6	43.6	51.9	42.3	104.2	40.5	25.9	43.3	41.9	13.9	35.8	50.8	77.3	10.4	76.7	35.1	29.9	105.7	47.4	1.4	14.5	16.9	30.8	27.6	13.5	8.7	42.7	36.6	30.6	21.4	20.3	53.3	22.7	33.2	21.4	63.5	23.5	12.3	35.6	99.7	45.5	60.7	4.5	42.6	49.4	53.4	5.6	97.3	48.4	49.4	10.1	12.2	27.5	49.1	52.3	16.9	14.9	51.9	65.9	24.3	27.6	46.0	29.2	31.7	9.0	24.0	42.4	70.0	26.4	51.3	39.1	41.6	30.0
CCDC12	MGC23918	ENSG00000160799	"Coiled-coil domain containing 12"	Q8WUD4	3	46921726-46982010	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA056814, HPA060530"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 59: Non-specific - Translation"	"Cluster 16: U-266 - Nucleosome"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm		"HPA056814: AB_2683241, HPA060530: AB_2684309"	"unprognostic (1.47e-2)"	"unprognostic (1.79e-3)"	"unprognostic (2.27e-1)"	"unprognostic (1.32e-3)"	"unprognostic (1.65e-1)"	"unprognostic (4.24e-2)"	"unprognostic (6.15e-2)"	"unprognostic (4.27e-3)"	"unprognostic (1.88e-1)"	"unprognostic (4.35e-2)"	"unprognostic (1.50e-2)"	"unprognostic (4.08e-2)"	"prognostic favorable (1.15e-4)"	"unprognostic (2.06e-1)"	"unprognostic (2.11e-1)"	"unprognostic (8.86e-3)"	"unprognostic (4.65e-2)"	39.1	55.5	40.1	38.3	40.7	57.9	40.2	41.8	45.3	48.4	39.2	44.4	39.7	45.2	22.1	75.2	33.4	22.1	53.5	39.8	40.4	53.3	46.1	39.4	51.0	40.9	40.0	40.4	40.9	33.7	35.2	26.7	40.7	38.4	21.3	19.1	42.3	22.9	80.6	72.5	42.8	21.1	40.7	48.9	46.9	30.1	40.9	41.4	43.2	30.1	33.4	39.2	55.6	41.4	63.7	52.5	60.4	31.7	33.4	27.1	46.5	63.1	32.1	46.6	34.0	68.5	53.5	123.9	56.1	38.2	66.3	35.1	51.6	58.6	19.6	122.3	39.3	136.0	77.8	104.6	45.5	147.1	93.1	37.2	54.6	59.2	52.2	36.9	45.7	78.0	148.3	59.6	23.1	77.0	114.6	139.0	78.7	62.5	42.9	48.0	46.9	79.6	49.2	65.5	32.0	62.1	77.0	62.8	62.7	26.7	47.8	143.9	94.6	31.1	61.4	63.5	101.4	77.5	185.8	155.1	43.5	102.2	45.6	50.0	132.0	122.0	139.3	142.8	109.8	209.7	106.6	122.8	126.9	222.4	90.8	107.3	40.4	123.7	155.8	202.1	148.8	118.9	40.1	40.7	41.8	45.3	39.8	40.4	40.9	40.0	40.7	40.7	40.9	41.4	58.0	80.1	54.7	15.0	119.1	79.2	146.0	146.6	73.4	53.4	55.9	47.1	53.3	82.9	97.4	80.9	54.2	137.0	132.2	137.2	111.6	103.7	4.3	64.4	54.8	66.1	79.1	38.7	15.9	124.8	112.5	53.5	85.6	89.4	82.4	52.4	55.6	54.1	100.0	58.9	14.6	104.4	87.5	70.8	75.6	9.8	58.4	58.6	46.2	16.9	112.7	68.8	213.1	15.1	21.0	103.5	132.4	48.2	73.9	124.1	147.7	90.5	71.1	90.7	39.5	82.8	55.6	21.7	57.5	97.1	108.8	166.9	98.6	82.0	112.6	209.0
CCDC13	FLJ25467	ENSG00000244607	"Coiled-coil domain containing 13"	Q8IYE1	3	42705756-42773253	"Predicted intracellular proteins"	"Cilium biogenesis/degradation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"brain: 2.4;choroid plexus: 2.5;fallopian tube: 2.9;retina: 4.3;testis: 5.9"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 28.0;Distal tubular cells: 17.6;Early spermatids: 18.1;Endometrial ciliated cells: 23.3;Late spermatids: 18.4;Respiratory ciliated cells: 53.4"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA047429			Supported	"Nucleoplasm,Centriolar satellite,Cytosol"		NA	NA				"Cluster 77: Retina - Visual perception"		"Cluster 49: Ciliated cells - Cilium organization"	"Centriolar satellite"	"Nucleoplasm, Cytosol"	"HPA047429: AB_2680043"	"unprognostic (3.34e-2)"	"unprognostic (3.72e-2)"	"unprognostic (2.18e-2)"	"unprognostic (1.67e-3)"	"unprognostic (2.19e-2)"	"unprognostic (5.35e-2)"	"unprognostic (4.75e-2)"	"unprognostic (8.06e-2)"	"unprognostic (4.26e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.05e-2)"	"unprognostic (2.31e-1)"	"unprognostic (1.83e-7)"	"unprognostic (6.21e-2)"	"unprognostic (2.40e-1)"	"unprognostic (5.71e-2)"	"unprognostic (2.04e-2)"	0.2	0.1	1.0	0.0	1.9	0.0	0.1	1.1	1.4	0.5	2.5	0.3	0.0	0.2	0.3	0.1	2.9	0.0	0.4	1.1	0.9	0.4	0.8	0.8	0.0	1.9	2.1	0.0	0.2	0.0	0.7	0.0	1.6	0.3	0.1	4.3	0.1	0.0	0.3	0.0	0.2	0.0	1.5	0.1	0.3	5.9	1.4	0.0	0.6	0.0	0.0	0.2	0.2	2.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	1.9	1.1	1.4	1.1	0.9	1.9	2.1	1.6	1.5	1.4	2.4	0.3	0.0	0.6	7.2	0.4	1.0	0.4	2.8	0.6	28.0	0.8	0.5	1.2	1.5	5.6	3.7	4.2	0.1	0.3	0.9	17.6	0.9	18.1	23.3	2.1	0.6	0.0	0.0	6.0	0.2	0.5	0.8	0.0	1.1	1.3	0.2	0.4	0.4	2.6	0.0	4.0	0.4	0.0	1.6	2.8	18.4	1.5	1.4	1.8	3.7	2.7	1.8	1.0	2.0	4.6	0.2	2.4	0.7	0.0	1.0	0.0	4.6	53.4	5.4	0.0	0.0	1.7	13.3	3.7	0.1	1.1	0.0	0.5	1.0	0.1	0.7
CCDC50	"C3orf6, DFNA44, Ymer"	ENSG00000152492	"Coiled-coil domain containing 50"	Q8IVM0	3	191329085-191398659	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Deafness, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"dendritic cells: 363.7;Oligodendrocyte precursor cells: 365.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	5	"plasmacytoid DC: 630.7"	"Lineage enriched"	"Detected in all"	5	"dendritic cells: 630.7"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001336	Approved		Supported	Cytosol		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 65: Plasmacytoid DCs - Unknown function"	Cytosol		"HPA001336: AB_1078421"	"unprognostic (5.01e-2)"	"unprognostic (1.44e-1)"	"unprognostic (7.84e-2)"	"unprognostic (8.77e-3)"	"unprognostic (1.73e-2)"	"unprognostic (8.29e-2)"	"prognostic unfavorable (2.48e-5)"	"unprognostic (3.03e-2)"	"unprognostic (2.51e-2)"	"unprognostic (4.48e-2)"	"unprognostic (3.17e-3)"	"unprognostic (2.05e-2)"	"unprognostic (7.79e-2)"	"unprognostic (1.01e-1)"	"unprognostic (6.19e-2)"	"unprognostic (7.57e-2)"	"unprognostic (4.19e-1)"	63.2	28.3	19.6	34.3	20.7	10.3	30.6	21.5	19.1	24.1	18.8	26.9	24.2	33.0	24.8	27.9	24.3	34.8	39.7	17.6	23.3	32.4	56.5	31.6	42.2	24.1	22.0	46.2	35.1	27.6	13.5	34.9	24.1	26.2	25.4	11.8	23.7	33.3	19.0	18.4	25.8	48.1	23.2	45.0	24.3	29.6	21.3	17.7	27.4	26.1	41.0	36.7	18.6	24.7	74.9	24.5	93.6	24.7	82.3	72.1	32.3	135.4	135.2	95.4	95.0	52.6	28.9	14.6	163.0	76.8	70.6	83.6	75.6	60.5	141.9	109.0	37.8	10.0	31.7	60.3	120.8	36.8	37.8	58.2	79.3	75.6	169.7	82.2	148.7	0.0	33.9	77.3	85.4	26.0	0.2	23.1	33.2	7.6	103.0	56.3	51.9	73.1	104.3	31.9	21.8	33.2	48.2	51.6	95.8	67.3	35.6	32.9	153.3	93.4	78.4	68.4	176.3	118.6	54.9	0.9	50.5	0.1	76.9	0.1	22.1	2.1	5.9	20.8	2.4	128.5	6.1	3.9	44.3	76.5	1.3	1.5	2.2	24.0	12.1	630.7	22.1	18.0	19.6	20.7	21.5	19.1	17.6	23.3	24.1	22.0	24.1	23.2	21.3	24.7	143.5	25.6	54.5	40.5	134.5	46.9	52.5	30.7	30.7	27.2	32.5	37.5	48.4	58.6	34.7	51.5	27.1	28.1	363.7	44.1	31.3	120.4	183.0	97.3	58.1	134.0	22.8	11.2	15.8	78.5	36.3	66.6	41.8	79.0	2.5	58.5	175.6	79.5	84.4	25.2	41.3	33.8	38.7	59.4	78.3	92.1	69.3	61.4	53.4	98.4	101.4	32.1	5.2	365.4	28.9	174.7	33.9	75.6	102.7	69.8	37.6	71.8	26.3	14.4	59.2	74.1	65.7	73.2	26.6	24.0	32.5	33.5	22.4	49.5	33.7	62.4
CCDC51	FLJ12436	ENSG00000164051	"Coiled-coil domain containing 51"	Q96ER9	3	48432164-48440456	"FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Proximal tubular cells: 43.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010980, HPA011408"	Supported		Supported	Nucleoplasm,Centrosome,Mitochondria		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoplasm, Mitochondria"	Centrosome	"HPA010980: AB_1846155, HPA011408: AB_2072212"	"unprognostic (1.24e-2)"	"unprognostic (5.23e-2)"	"unprognostic (5.03e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.95e-1)"	"unprognostic (3.50e-1)"	"unprognostic (2.75e-3)"	"unprognostic (4.71e-3)"	"unprognostic (1.26e-2)"	"unprognostic (3.04e-1)"	"unprognostic (3.26e-2)"	"unprognostic (7.70e-2)"	"unprognostic (1.47e-3)"	"unprognostic (6.46e-3)"	"unprognostic (1.17e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.77e-1)"	10.1	13.7	10.7	7.3	10.9	5.0	8.7	10.8	11.6	8.3	22.2	12.2	11.0	8.0	10.1	13.8	8.8	5.4	11.9	11.1	10.6	13.9	13.0	6.7	9.6	11.3	10.8	7.7	5.4	9.4	6.1	8.2	11.3	6.7	13.6	7.7	7.0	9.0	15.5	10.1	8.6	9.0	10.7	12.6	7.6	7.8	11.7	9.9	10.3	11.7	11.8	9.0	9.5	10.7	22.7	26.7	15.7	18.7	23.1	24.2	43.6	14.6	13.4	28.6	23.2	42.9	36.9	48.6	20.5	11.7	21.6	32.2	39.5	47.8	17.4	22.9	25.6	41.4	44.1	32.7	35.3	20.4	18.2	18.4	106.8	35.6	38.8	15.7	16.7	28.0	23.4	13.7	27.7	21.4	24.1	26.5	34.8	48.2	42.8	16.5	18.6	37.7	39.3	27.8	13.1	27.2	24.2	26.2	39.9	14.7	28.2	31.3	12.6	16.5	22.3	41.6	28.5	22.0	34.8	25.5	22.0	43.8	16.0	3.0	14.1	7.0	15.5	14.9	15.8	28.1	14.5	19.7	25.5	23.0	14.8	17.4	6.0	16.5	9.1	21.1	19.8	14.6	10.7	10.9	10.8	11.6	11.1	10.6	11.3	10.8	11.3	10.7	11.7	10.7	7.1	12.8	2.6	2.6	5.9	4.7	3.7	28.8	17.6	7.3	6.6	8.1	8.2	15.7	12.8	9.2	0.0	40.1	5.0	12.6	23.5	15.1	3.3	19.4	7.3	5.9	5.4	5.9	2.4	12.4	22.0	10.0	6.6	16.5	3.8	10.1	4.6	13.1	15.9	8.4	2.4	7.6	14.2	3.8	3.3	2.7	12.2	4.4	14.2	1.9	9.1	11.0	11.3	3.5	3.2	15.2	8.0	13.2	5.1	5.4	21.6	43.4	9.3	10.7	6.6	4.0	6.2	7.2	16.3	13.0	4.7	6.7	4.8	20.0	13.4	3.4
CCDC6	"D10S170, H4, PTC, TPC, TST1"	ENSG00000108091	"Coiled-coil domain containing 6"	Q16204	10	59788747-59906556	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019049, HPA019051"	Enhanced		Supported	Cytosol		No	No		12000	"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 41: Macrophages - Immune response"	Cytosol		"HPA019049: AB_1846163, HPA019051: AB_1846164"	"unprognostic (1.88e-2)"	"unprognostic (1.72e-2)"	"unprognostic (4.41e-2)"	"unprognostic (1.25e-3)"	"unprognostic (5.98e-3)"	"prognostic favorable (5.48e-4)"	"prognostic unfavorable (1.11e-4)"	"unprognostic (7.39e-2)"	"unprognostic (2.45e-1)"	"unprognostic (2.28e-1)"	"prognostic unfavorable (3.95e-4)"	"unprognostic (4.08e-1)"	"unprognostic (4.69e-2)"	"unprognostic (2.23e-1)"	"unprognostic (2.56e-1)"	"unprognostic (9.95e-2)"	"unprognostic (4.19e-2)"	11.9	12.2	21.1	13.9	23.4	16.8	22.4	10.2	20.0	23.4	8.5	23.5	22.8	24.9	16.7	34.1	25.3	16.7	10.0	24.9	21.4	21.2	12.1	17.3	21.4	12.4	15.8	15.7	25.2	17.9	11.5	13.2	17.4	19.4	19.8	18.3	29.0	14.3	17.3	28.6	16.2	30.8	11.9	14.7	18.6	11.4	20.8	12.1	18.3	12.2	21.6	17.3	23.1	12.6	42.9	38.0	18.7	41.9	27.8	41.6	37.9	20.6	27.2	20.2	23.7	74.4	81.8	36.5	30.2	34.6	11.7	61.7	37.7	37.5	30.0	55.1	18.7	29.8	29.1	45.5	33.5	34.5	26.9	30.3	48.7	33.7	81.8	28.3	30.2	20.4	22.6	22.7	26.6	57.6	14.5	19.8	29.9	40.1	25.6	19.2	30.5	23.0	33.9	36.2	19.0	16.6	26.1	107.8	23.1	24.1	68.7	18.4	31.1	18.8	33.9	29.3	34.9	12.0	14.9	16.3	29.6	64.6	11.9	0.0	2.0	0.0	1.0	2.3	1.1	4.3	1.5	1.3	5.0	4.9	1.3	1.0	0.1	0.8	1.3	1.3	1.4	1.0	21.1	23.4	10.2	20.0	24.9	21.4	12.4	15.8	17.4	11.9	20.8	12.6	24.0	99.3	25.9	45.1	41.6	95.0	51.7	25.3	70.0	15.1	51.2	38.7	16.5	28.6	46.3	25.8	41.7	37.8	31.4	42.6	29.4	50.2	27.6	105.2	54.6	22.4	27.0	25.7	83.2	65.3	18.8	27.8	39.8	134.5	29.1	45.2	17.2	20.1	23.1	16.8	58.4	38.9	30.5	40.7	35.3	80.6	24.5	36.4	16.0	32.8	23.0	11.5	13.4	55.3	34.2	50.2	25.0	19.5	26.4	52.2	47.1	48.4	28.1	49.8	19.7	31.4	27.0	2.3	22.4	92.3	80.1	27.0	24.3	32.5	46.3	46.1
CCDC62	"CT109, ERAP75, FLJ40344, TSP-NY"	ENSG00000130783	"Coiled-coil domain containing 62"	Q6P9F0	12	122774526-122827528	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	35	"testis: 70.0"	"Group enriched"	"Detected in some"	13	"Early spermatids: 259.2;Late spermatids: 75.0;Spermatocytes: 188.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"U-2 OS: 2.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA039021, HPA058741"	Approved		Supported	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 9: U-2 OS - Unknown function"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Nucleoplasm, Plasma membrane"		"HPA039021: AB_10673604, HPA058741: AB_2683805"	"unprognostic (3.39e-2)"	"unprognostic (4.16e-2)"	"unprognostic (1.46e-2)"	"unprognostic (7.48e-2)"	"unprognostic (1.58e-2)"	"unprognostic (9.37e-2)"	"unprognostic (1.65e-1)"	"unprognostic (7.09e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.48e-1)"	"unprognostic (2.21e-4)"	"unprognostic (5.23e-1)"	"unprognostic (6.39e-6)"	"unprognostic (2.78e-2)"	"unprognostic (6.18e-2)"	"unprognostic (7.27e-2)"	"unprognostic (3.25e-4)"	0.2	0.3	1.2	0.2	1.3	0.2	0.1	0.7	1.8	0.3	0.0	0.1	0.2	0.1	0.1	0.2	0.1	0.2	0.1	1.3	0.5	0.1	0.1	0.1	0.3	0.6	0.4	0.1	0.1	0.3	0.7	0.0	0.7	0.1	0.1	1.4	0.1	0.1	0.7	0.4	0.2	0.1	0.2	0.5	0.1	70.0	0.5	0.2	0.1	0.3	0.3	0.1	0.1	2.0	0.1	0.1	0.1	0.3	0.0	0.3	0.3	0.0	0.1	0.3	0.1	0.0	0.2	0.8	0.0	0.0	0.1	0.0	0.2	0.0	0.1	0.2	0.3	0.9	0.1	0.0	0.0	0.6	0.8	0.1	0.3	0.4	0.1	0.1	0.0	0.7	0.3	0.2	0.4	0.1	0.0	1.2	0.1	0.0	0.5	0.8	0.2	0.0	0.2	0.1	0.5	0.0	0.0	0.3	0.4	0.2	0.0	0.6	0.1	0.2	2.9	0.1	0.1	0.3	0.3	0.2	0.0	0.3	0.1	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.3	0.1	0.0	0.1	0.3	0.0	1.2	1.3	0.7	1.8	1.3	0.5	0.6	0.4	0.7	0.2	0.5	2.0	0.5	0.0	0.0	9.1	2.1	0.5	0.2	0.1	0.6	1.4	0.4	0.5	1.0	0.0	0.0	0.0	4.2	0.1	0.6	0.1	0.0	0.3	259.2	0.5	0.4	0.4	0.0	0.0	11.7	0.2	0.6	0.2	0.0	0.7	0.0	0.2	0.0	0.0	0.1	1.7	8.1	0.2	0.0	0.3	1.7	75.0	3.1	1.3	1.8	3.7	0.2	0.5	1.0	5.0	8.0	0.1	0.0	2.6	0.3	0.5	0.1	0.0	0.0	1.3	13.1	0.5	0.2	188.2	2.9	0.4	0.9	0.0	0.3	0.2	0.3	0.2
CCDC66	DKFZp686C0433	ENSG00000180376	"Coiled-coil domain containing 66"	A2RUB6	3	56557161-56621837	"Predicted intracellular proteins"	"Cilium biogenesis/degradation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 202.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044185, HPA051937"	Approved		Supported	"Cell Junctions,Midbody ring,Centriolar satellite,Cytosol"		Yes	No			"Cluster 44: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 32: U-937 - Innate immune response"	"Cluster 52: Non-specific - Transcription"	"Centriolar satellite"	"Cell Junctions, Midbody ring, Cytosol"	"HPA044185: AB_10965852, HPA051937: "	"unprognostic (2.28e-2)"	"unprognostic (7.74e-2)"	"unprognostic (7.37e-2)"	"unprognostic (2.90e-1)"	"unprognostic (5.28e-2)"	"unprognostic (1.72e-2)"	"unprognostic (7.26e-3)"	"unprognostic (1.68e-3)"	"unprognostic (2.05e-2)"	"unprognostic (1.27e-1)"	"unprognostic (3.05e-3)"	"unprognostic (5.48e-3)"	"unprognostic (6.85e-3)"	"unprognostic (1.81e-1)"	"unprognostic (6.57e-2)"	"unprognostic (3.24e-1)"	"unprognostic (6.81e-3)"	2.7	3.1	3.8	3.6	3.7	3.0	5.2	3.7	4.3	4.8	4.2	4.0	3.0	4.1	5.3	2.5	5.7	3.4	2.9	3.7	4.2	4.1	2.0	3.6	4.9	3.8	3.7	6.0	3.3	5.4	4.5	3.3	3.9	4.0	4.1	7.8	3.3	3.6	4.5	2.5	2.8	4.9	3.8	4.3	3.2	3.7	3.7	5.1	4.9	2.6	4.9	3.7	3.1	3.8	5.6	2.0	5.8	3.7	8.9	5.2	4.6	6.8	6.4	9.1	7.8	4.3	4.3	15.6	1.6	3.8	5.8	2.8	3.4	6.5	10.1	5.6	4.0	9.5	9.0	4.6	6.2	12.8	3.3	4.9	8.8	7.7	5.1	8.0	6.0	7.7	9.3	2.4	7.2	4.7	10.0	7.5	9.7	4.8	7.5	3.4	5.2	8.6	5.3	1.9	2.2	4.2	8.7	5.5	5.2	4.9	1.9	5.2	3.1	6.6	5.2	6.3	9.9	4.7	5.3	8.0	4.9	14.3	5.5	10.0	1.5	3.5	4.1	2.0	5.4	2.7	7.0	5.0	1.1	1.6	8.0	5.8	0.3	5.1	2.4	1.0	14.8	2.6	3.8	3.7	3.7	4.3	3.7	4.2	3.8	3.7	3.9	3.8	3.7	3.8	39.7	22.4	22.6	42.7	41.3	28.2	20.1	30.5	15.9	68.5	18.5	21.0	30.5	30.0	29.0	22.0	108.4	23.0	51.5	7.7	29.4	23.7	202.5	58.1	33.5	28.8	21.0	40.8	93.2	10.5	14.6	29.9	18.8	13.9	34.2	38.3	37.9	8.5	18.4	52.2	95.8	11.4	22.4	35.8	27.9	109.6	54.0	20.7	26.6	51.5	56.1	36.8	105.0	70.9	96.7	14.1	9.8	47.8	28.1	25.5	11.5	20.3	51.5	111.5	32.9	38.6	30.9	55.8	46.8	12.1	29.5	16.4	51.7	33.6	14.5	11.4
CCDC85C		ENSG00000205476	"Coiled-coil domain containing 85C"	A6NKD9	14	99500190-99604207	"Predicted intracellular proteins"		"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 72.9"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 62.6;Rod photoreceptor cells: 51.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA058346, HPA061922"	Uncertain		Approved	"Nucleoplasm,Nucleoli rim,Nuclear bodies,Mitotic chromosome,Cell Junctions"		Yes	No			"Cluster 20: T-cells - T-cell receptor"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 44: Endometrium - Transcription"	"Nucleoli rim, Cell Junctions"	"Nucleoplasm, Nuclear bodies, Mitotic chromosome"	"HPA058346: AB_2683686, HPA061922: "	"unprognostic (7.17e-2)"	"unprognostic (2.23e-2)"	"unprognostic (3.64e-1)"	"prognostic unfavorable (1.44e-4)"	"unprognostic (5.70e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.68e-3)"	"unprognostic (4.80e-2)"	"unprognostic (1.45e-2)"	"unprognostic (8.75e-2)"	"unprognostic (3.30e-1)"	"unprognostic (1.68e-3)"	"prognostic favorable (2.60e-5)"	"unprognostic (4.14e-2)"	"unprognostic (1.95e-1)"	"unprognostic (8.74e-3)"	"unprognostic (9.81e-3)"	5.2	22.0	26.4	4.3	32.9	9.7	7.1	72.9	27.1	5.8	20.6	31.3	18.7	15.4	14.3	28.3	11.3	5.4	19.6	24.8	20.9	14.4	18.2	8.1	2.5	30.8	24.1	5.1	18.5	16.4	17.0	8.6	27.0	15.0	11.1	34.7	26.4	16.2	20.7	19.4	17.7	13.1	24.5	3.6	19.2	8.5	28.6	5.0	9.3	5.6	7.5	16.1	8.9	21.0	48.4	43.4	52.7	31.7	0.7	0.2	48.9	16.0	16.2	31.4	18.1	52.9	49.8	0.3	61.7	18.2	8.6	63.3	39.2	38.4	19.5	79.2	23.3	2.5	43.6	36.1	4.2	0.5	4.9	0.1	19.9	9.0	25.9	18.6	9.9	27.9	11.8	7.2	3.9	80.3	21.8	6.6	19.3	55.4	44.7	32.1	22.1	10.8	22.3	18.8	26.0	32.6	40.7	21.5	9.5	19.9	46.9	9.8	22.6	6.2	51.5	22.4	16.2	11.2	15.8	0.4	1.0	4.3	4.5	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.3	0.2	0.0	0.0	0.4	0.2	0.1	0.0	0.0	0.0	0.4	0.1	26.4	32.9	72.9	27.1	24.8	20.9	30.8	24.1	27.0	24.5	28.6	21.0	8.5	22.4	5.6	15.7	6.7	8.8	8.7	4.0	13.6	35.2	12.1	9.3	3.0	5.7	7.3	1.8	62.6	6.3	3.9	21.2	0.0	7.6	3.1	18.8	8.1	9.2	9.6	3.4	2.8	9.4	4.5	6.2	17.3	35.6	6.3	14.1	5.3	16.7	1.8	1.7	5.4	9.6	6.1	1.6	1.2	2.1	0.6	5.0	8.8	4.7	0.4	30.6	1.0	1.5	11.7	17.4	13.2	0.7	10.4	11.0	23.3	6.5	3.0	51.7	0.0	5.7	4.1	1.4	3.5	20.4	14.1	4.9	8.3	2.3	13.0	12.0
CCDC88B	"BRLZ, CCDC88, FLJ00354, FLJ37970, GIPIE, HkRP3"	ENSG00000168071	"Coiled-coil domain containing 88B"	A6NC98	11	64340204-64357534	"Predicted intracellular proteins"	"Stress response"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 47.6;lymphoid tissue: 86.1"	"Cell type enhanced"	"Detected in many"		"NK-cells: 64.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 21.7;HMC-1: 83.3;Karpas-707: 22.0;THP-1: 34.5;U-937: 25.3"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			HPA026652	Approved		Supported	Nucleoplasm,Centrosome,Cytosol	"Intracellular and membrane"	NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Centrosome, Cytosol"	Nucleoplasm	"HPA026652: AB_1846168"	"unprognostic (1.18e-2)"	"unprognostic (3.33e-3)"	"unprognostic (3.65e-1)"	"unprognostic (1.58e-2)"	"unprognostic (2.36e-1)"	"prognostic favorable (1.48e-4)"	"unprognostic (2.14e-2)"	"unprognostic (1.55e-2)"	"unprognostic (5.61e-2)"	"unprognostic (1.15e-1)"	"unprognostic (2.94e-1)"	"unprognostic (7.32e-2)"	"prognostic unfavorable (7.65e-5)"	"unprognostic (3.77e-2)"	"unprognostic (7.38e-2)"	"unprognostic (1.90e-1)"	"unprognostic (2.83e-2)"	8.5	6.7	14.9	15.1	15.1	47.6	5.3	20.1	21.6	5.6	15.3	17.8	4.0	3.5	0.3	12.9	6.5	8.5	5.5	15.3	15.0	6.5	7.3	21.1	28.6	17.2	15.5	3.1	4.1	0.9	4.5	1.7	17.5	7.8	3.6	1.4	14.4	2.5	1.2	4.5	34.1	1.2	15.4	86.1	8.9	17.4	15.4	17.4	5.4	0.8	13.8	8.3	7.7	15.9	0.3	1.3	0.0	0.0	0.0	0.0	2.6	0.0	0.6	0.0	0.0	0.0	3.4	19.7	2.9	1.1	0.5	1.6	0.1	0.6	0.0	21.7	0.0	15.0	4.6	1.1	0.8	9.4	83.3	0.0	0.0	0.2	0.0	1.3	0.5	6.3	0.5	22.0	0.7	0.9	12.7	7.7	0.7	3.7	0.5	11.9	0.3	18.5	0.3	0.3	4.8	0.0	0.0	0.5	1.1	0.1	2.6	34.5	0.0	0.0	0.7	0.1	0.2	4.7	1.5	15.8	1.0	25.3	0.4	2.9	4.6	6.7	3.5	3.6	1.0	1.6	2.0	2.9	1.6	2.0	1.8	2.2	9.2	6.5	2.5	2.7	0.6	1.3	14.9	15.1	20.1	21.6	15.3	15.0	17.2	15.5	17.5	15.4	15.4	15.9	3.3	0.0	10.7	5.2	30.3	2.7	4.5	10.5	0.6	45.2	5.7	4.8	13.5	4.3	9.9	9.2	0.0	2.9	34.9	46.0	0.0	12.8	11.1	8.7	2.6	4.4	18.0	7.0	2.6	28.9	5.8	3.1	51.0	6.8	26.6	2.2	6.1	10.4	14.5	0.0	2.0	24.4	8.2	26.0	26.6	15.8	1.5	27.3	5.4	12.2	35.0	15.4	64.9	2.0	0.6	35.0	33.2	0.7	24.9	2.9	36.1	3.2	22.7	4.7	0.0	2.8	2.8	13.7	8.7	2.0	1.6	1.4	31.7	10.0	32.4	15.7
CCDC91	"DKFZp779L1558, FLJ11088, p56"	ENSG00000123106	"Coiled-coil domain containing 91"	Q7Z6B0	12	28133249-28581511	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	18	"Early spermatids: 2093.1;Late spermatids: 7910.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038169	Approved		Supported	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 21: Non-specific - Transcription"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 25: Spermatids - Spermatogenesis"	"Golgi apparatus"	Nucleoplasm	"HPA038169: AB_10672506"	"unprognostic (6.25e-2)"	"unprognostic (4.25e-2)"	"unprognostic (3.67e-2)"	"unprognostic (1.91e-2)"	"unprognostic (6.71e-2)"	"unprognostic (1.48e-1)"	"prognostic unfavorable (1.05e-4)"	"unprognostic (4.98e-2)"	"unprognostic (2.44e-2)"	"unprognostic (4.62e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.74e-1)"	"prognostic unfavorable (7.69e-4)"	"unprognostic (1.05e-1)"	"unprognostic (2.44e-2)"	"unprognostic (5.85e-2)"	"unprognostic (2.38e-1)"	17.5	18.3	15.0	13.0	15.8	12.3	16.1	23.2	29.3	11.5	3.5	14.4	12.1	17.8	17.3	14.3	12.3	14.6	30.9	16.6	12.3	20.2	14.3	12.0	16.4	20.7	13.8	17.7	27.1	30.8	12.1	8.5	20.7	15.1	12.6	27.1	13.6	14.0	41.6	10.2	13.1	13.0	11.1	13.6	17.1	34.5	14.6	21.7	24.6	21.7	13.7	16.6	10.5	20.7	21.2	14.8	13.4	0.4	13.6	12.6	25.1	17.5	18.5	15.1	19.3	8.4	27.6	11.0	14.7	20.9	9.0	23.7	12.3	28.2	22.6	29.7	10.2	36.2	29.4	7.7	21.3	35.0	17.1	12.5	27.6	15.0	43.7	28.5	12.3	19.2	33.4	36.0	14.6	7.6	34.8	29.7	27.5	16.2	13.5	21.1	38.7	18.3	24.6	14.3	11.3	20.4	32.7	10.9	55.4	36.4	21.3	27.3	9.3	31.8	22.1	31.5	10.3	44.4	52.5	30.1	27.6	28.0	18.4	21.8	2.3	3.6	5.1	4.5	6.7	6.7	6.5	7.4	3.4	5.2	7.6	7.0	0.7	7.1	5.9	4.1	8.4	3.4	15.0	15.8	23.2	29.3	16.6	12.3	20.7	13.8	20.7	11.1	14.6	20.7	23.4	38.5	41.0	129.3	47.2	34.9	37.4	49.5	34.7	61.5	42.1	36.8	80.8	20.0	40.8	22.0	45.9	14.0	48.4	26.0	43.0	46.2	2093.1	36.9	19.0	19.7	38.4	19.1	199.3	47.3	16.3	24.8	21.4	26.2	40.4	21.9	11.7	26.7	30.6	45.4	266.0	23.9	28.5	35.0	39.3	7910.6	57.8	39.0	37.4	135.9	35.7	52.0	53.5	152.8	221.0	33.8	25.0	51.9	34.2	33.6	25.5	35.0	54.5	74.9	39.5	28.6	31.7	72.0	39.0	19.9	40.5	16.0	50.6	28.5	18.3	33.6
CCDC92	FLJ22471	ENSG00000119242	"Coiled-coil domain containing 92"	Q53HC0	12	123918660-123972831	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 89.2;Excitatory neurons: 123.0;Inhibitory neurons: 106.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038560, HPA057580"	Approved		Supported	Nucleoplasm,Centrosome		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Centrosome	Nucleoplasm	"HPA038560: AB_10672717, HPA057580: AB_2683476"	"unprognostic (4.77e-3)"	"unprognostic (1.52e-1)"	"unprognostic (1.27e-1)"	"prognostic favorable (7.15e-4)"	"unprognostic (4.82e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.45e-1)"	"unprognostic (5.01e-2)"	"unprognostic (5.69e-2)"	"unprognostic (7.14e-2)"	"prognostic favorable (4.59e-5)"	"unprognostic (1.24e-1)"	"unprognostic (1.39e-1)"	"unprognostic (3.08e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.07e-3)"	"unprognostic (4.99e-2)"	56.3	26.7	18.5	3.7	17.4	1.2	47.5	2.9	44.2	39.8	0.0	53.6	5.8	40.4	7.1	20.1	37.7	4.0	77.4	24.3	4.8	39.7	38.4	37.7	3.4	17.6	6.3	35.5	21.1	5.5	58.5	7.0	18.6	36.3	2.7	7.2	24.8	4.7	77.8	17.4	34.3	5.5	4.6	27.0	32.9	74.0	14.3	3.2	40.9	7.6	2.4	37.5	28.7	20.0	4.9	5.5	2.7	4.9	17.5	9.6	4.9	8.1	15.3	4.5	4.8	2.9	1.4	2.4	2.7	10.2	2.5	3.4	3.0	2.1	3.0	15.0	7.0	3.1	2.2	1.8	9.2	0.5	11.3	5.5	9.2	5.7	3.5	13.7	12.6	5.3	3.2	1.1	4.0	3.3	3.0	5.4	1.2	2.4	11.6	3.7	1.5	0.7	6.1	5.1	5.1	7.3	4.0	1.9	5.7	6.3	5.7	2.7	12.6	8.9	1.9	5.8	2.8	3.7	2.1	0.7	7.1	4.2	3.9	1.6	0.4	0.7	0.7	0.2	1.2	0.5	0.9	1.1	0.3	0.5	0.6	0.9	0.4	0.5	0.0	0.4	0.1	0.6	18.5	17.4	2.9	44.2	24.3	4.8	17.6	6.3	18.6	4.6	14.3	20.0	17.6	19.2	28.5	52.5	8.3	3.8	7.5	8.1	4.0	33.6	14.2	11.7	40.8	18.6	8.6	18.4	14.6	4.4	16.4	7.2	7.9	14.7	89.2	15.1	13.0	17.7	4.8	4.4	123.0	10.9	2.7	19.2	10.2	14.5	20.3	31.2	18.9	14.5	18.9	21.9	106.1	6.2	8.2	12.0	6.3	63.9	13.7	14.2	8.8	30.9	9.9	15.0	22.6	50.8	70.0	15.5	2.7	17.3	3.2	9.5	10.0	37.0	9.0	13.6	72.3	15.3	24.6	40.9	10.1	6.3	3.0	5.6	13.7	26.3	7.6	7.5
CCDC97	"FLJ40267, MGC20255"	ENSG00000142039	"Coiled-coil domain containing 97"	Q96F63	19	41310172-41324873	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043320, HPA043572"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm	"Plasma membrane, Cytosol"	"HPA043320: AB_10964344, HPA043572: AB_10962488"	"unprognostic (9.25e-3)"	"unprognostic (7.26e-2)"	"unprognostic (1.68e-1)"	"unprognostic (5.10e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.51e-2)"	"prognostic unfavorable (1.09e-4)"	"unprognostic (8.40e-2)"	"unprognostic (1.91e-2)"	"unprognostic (2.44e-1)"	"unprognostic (5.93e-3)"	"unprognostic (4.51e-2)"	"unprognostic (2.16e-1)"	"unprognostic (2.96e-1)"	"unprognostic (4.08e-1)"	"unprognostic (7.92e-2)"	"unprognostic (1.65e-2)"	14.6	12.9	19.0	17.8	21.3	23.0	14.3	17.7	17.7	20.3	14.4	14.0	14.2	17.3	23.4	20.2	21.9	12.3	15.6	16.5	18.2	12.0	11.8	14.3	23.8	23.5	20.2	24.0	17.7	15.8	13.7	10.5	19.9	16.2	11.2	10.7	18.0	14.6	30.6	20.2	16.6	14.2	18.1	20.0	15.7	32.1	20.4	21.9	16.3	20.5	22.2	14.8	17.2	20.5	25.2	54.1	28.2	32.9	36.2	28.7	20.3	16.6	13.4	25.7	21.9	32.4	23.6	23.9	17.4	13.9	17.3	16.7	38.8	33.1	19.5	44.1	37.6	21.9	25.5	21.5	27.5	36.6	45.3	28.1	41.7	30.0	25.0	21.1	18.0	25.8	28.5	44.4	24.9	18.3	33.6	8.9	13.2	30.5	19.3	37.5	22.4	17.5	23.7	47.3	25.1	22.2	37.0	40.3	16.5	18.6	27.5	27.6	21.6	22.1	22.0	11.5	27.8	45.3	42.2	22.7	21.0	26.7	30.0	9.4	7.2	8.5	12.0	7.6	13.4	9.1	8.1	8.7	5.8	10.0	8.7	7.8	11.9	10.4	12.6	6.3	7.2	8.1	19.0	21.3	17.7	17.7	16.5	18.2	23.5	20.2	19.9	18.1	20.4	20.5	7.3	12.8	6.7	5.2	22.3	4.6	11.4	11.3	6.2	11.8	11.2	8.8	6.7	7.2	8.9	9.2	12.5	11.1	23.9	13.5	7.9	13.1	3.7	9.3	8.6	8.4	11.5	7.8	4.1	26.1	4.5	10.0	15.3	9.8	16.5	11.2	9.7	6.5	15.3	10.1	4.7	12.1	18.3	10.0	7.9	8.4	12.8	12.3	1.8	3.7	16.1	7.1	25.7	1.0	6.6	20.5	5.9	11.3	18.6	10.0	16.7	9.3	12.2	8.5	0.0	13.1	8.5	22.5	12.9	10.8	5.8	18.3	20.1	7.2	10.7	13.3
CCHCR1	"C6orf18, HCR"	ENSG00000204536	"Coiled-coil alpha-helical rod protein 1"	Q8TD31	6	31142439-31158238	"Predicted intracellular proteins"	Differentiation	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"testis: 138.9"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 89.7;Endometrial ciliated cells: 68.0;Glandular and luminal cells: 161.9;Late spermatids: 160.7;Spermatocytes: 68.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"A-431: 38.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			HPA054167			Supported	Cytosol		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 71: Testis - DNA repair"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 44: Endometrium - Transcription"	Cytosol		"HPA054167: AB_2682403"	"unprognostic (6.68e-2)"	"unprognostic (7.98e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.88e-1)"	"unprognostic (3.11e-3)"	"unprognostic (2.23e-3)"	"unprognostic (1.99e-1)"	"unprognostic (2.74e-1)"	"unprognostic (5.36e-3)"	"unprognostic (1.65e-1)"	"unprognostic (2.07e-1)"	"unprognostic (3.85e-3)"	"unprognostic (1.06e-1)"	"unprognostic (4.35e-2)"	"unprognostic (3.57e-1)"	"unprognostic (4.17e-2)"	10.4	7.6	1.4	2.8	1.4	1.3	11.8	1.6	2.3	18.1	1.5	16.2	10.1	12.4	5.7	15.1	18.7	1.7	11.7	1.5	1.6	19.7	12.2	9.0	6.9	1.6	1.4	19.0	14.5	1.3	9.3	0.9	1.9	19.9	3.3	1.2	11.4	4.0	19.3	17.4	14.7	1.6	1.0	13.3	13.9	138.9	2.2	2.1	16.1	1.1	1.7	13.4	15.4	1.5	38.9	3.0	9.8	1.6	6.1	7.4	8.8	3.3	1.1	0.5	1.2	14.9	0.7	5.1	17.6	8.5	23.1	1.6	0.6	15.4	1.5	5.8	23.9	18.1	13.2	11.7	3.7	0.4	11.5	9.7	1.8	6.9	1.5	7.2	8.1	27.2	7.3	10.3	4.1	2.8	6.7	19.9	0.6	1.4	0.2	12.0	13.8	9.6	9.6	3.8	29.2	4.9	11.7	0.0	2.8	6.0	4.2	9.3	1.0	14.5	4.8	0.3	9.4	23.7	14.7	20.7	3.1	4.4	1.5	0.2	0.6	0.5	0.9	0.3	0.8	0.3	0.8	1.4	0.5	0.6	1.3	1.3	0.0	1.0	0.4	1.2	1.5	0.6	1.4	1.4	1.6	2.3	1.5	1.6	1.6	1.4	1.9	1.0	2.2	1.5	8.0	3.2	5.1	10.4	7.7	9.7	13.0	12.8	8.6	9.6	8.2	10.9	8.7	11.5	11.0	3.7	0.0	3.1	5.4	41.9	11.7	8.9	89.7	68.0	19.0	6.7	29.3	6.3	5.2	10.5	7.5	7.7	28.5	161.9	0.0	15.0	5.7	7.5	6.8	15.2	4.3	27.6	0.0	5.0	3.7	160.7	9.9	5.4	7.2	1.9	8.4	5.1	9.2	0.5	1.8	8.4	17.3	11.7	6.7	9.0	36.2	7.6	15.9	2.3	6.6	9.2	8.6	68.6	21.1	7.3	5.8	1.4	6.0	14.7	35.9	8.3
CCKAR		ENSG00000163394	"Cholecystokinin A receptor"	P32238	4	26481396-26490484	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 6.9;gallbladder: 29.2;stomach 1: 16.5"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in single"		"stomach cancer: 0.5"	"Group enriched"	"Detected in some"	5	"hypothalamus: 5.1;midbrain: 6.9"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"hypothalamus: 7.2"	"Region enhanced"	"Detected in all"		"midbrain: 12.6"	HPA073900			Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA				"Cluster 12: Smooth muscle tissue - Mixed function"		"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Plasma membrane, Cytosol"	Nucleoplasm	"HPA073900: "	"unprognostic (7.48e-2)"				"unprognostic (3.70e-2)"	"unprognostic (7.13e-2)"					"unprognostic (3.08e-2)"	"unprognostic (3.36e-1)"		"unprognostic (3.79e-1)"				0.0	0.0	0.5	0.0	0.4	0.0	0.1	0.0	0.4	0.0	0.0	0.3	1.6	0.0	0.0	0.0	0.0	29.2	0.0	0.6	5.1	0.1	0.0	0.0	0.0	0.8	6.9	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	16.5	0.1	1.1	0.3	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.4	0.0	0.4	0.6	5.1	0.8	6.9	0.6	0.6	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CCM2L	"C20orf160, dJ310O13.5"	ENSG00000101331	"CCM2 like scaffold protein"	Q9NUG4	20	32010438-32032180	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"lymphoid tissue: 141.6"	"Cell type enriched"	"Detected in some"	5	"Theca cells: 248.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 8.2;HUVEC TERT2: 9.0;NTERA-2: 4.6;RH-30: 3.2;SCLC-21H: 7.7;TIME: 4.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA008434, HPA071063"	Uncertain		Supported	Nucleoplasm		NA	NA				"Cluster 64: Macrophages - Immune response"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA008434: AB_1845671, HPA071063: AB_2686339"	"unprognostic (1.71e-1)"	"unprognostic (4.64e-2)"	"unprognostic (2.43e-3)"	"unprognostic (5.84e-3)"	"unprognostic (1.91e-1)"	"unprognostic (3.09e-3)"	"unprognostic (1.27e-3)"	"unprognostic (2.37e-1)"	"unprognostic (2.04e-1)"	"unprognostic (4.34e-2)"	"unprognostic (1.00e-3)"	"unprognostic (7.84e-2)"	"unprognostic (4.66e-3)"	"unprognostic (2.19e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.32e-1)"	15.9	5.4	7.2	1.6	7.3	0.0	15.0	9.5	6.8	8.7	4.2	4.6	1.3	8.9	0.6	3.7	7.7	2.5	23.2	6.1	5.8	13.3	2.2	11.8	1.5	6.8	6.4	3.6	2.6	1.4	4.1	7.8	7.0	5.8	1.1	0.4	3.4	1.8	4.8	3.9	5.4	3.3	6.1	141.6	4.2	1.6	7.3	0.8	10.2	4.8	0.9	6.4	6.3	5.2	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	8.2	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	9.0	0.9	0.0	0.0	0.0	2.4	0.0	0.0	4.6	0.1	0.0	0.6	3.2	0.1	0.0	0.0	7.7	0.9	0.2	0.0	0.0	1.1	2.5	0.0	4.8	0.0	1.3	0.0	0.0	0.1	0.0	0.1	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.2	7.3	9.5	6.8	6.1	5.8	6.8	6.4	7.0	6.1	7.3	5.2	45.8	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.6	0.5	0.6	4.6	2.8	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.1	0.2	32.1	0.0	0.0	2.9	0.2	0.0	1.0	0.0	0.2	0.0	4.3	24.3	0.0	0.0	3.3	2.4	0.0	0.0	0.3	0.3	0.4	0.0	0.2	0.0	13.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.6	1.8	0.3	0.6	0.1	0.3	0.0	0.1	248.7	0.0	0.1
CCN6	"WISP-3, WISP3"	ENSG00000112761	"Cellular communication network factor 6"	O95389	6	112054075-112069686	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins"		"Growth factor"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"epididymis: 10.2"	"Cell type enriched"	"Detected in single"	7	"Cardiomyocytes: 2.2"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	49	"RT4: 12.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA064196			Supported	Mitochondria	"Secreted to extracellular matrix"	NA	NA				"Cluster 30: Epididymis - Antimicrobial activity"	"Cluster 15: RT4 - Unknown function"	"Cluster 43: Cardiomyocytes - Nuclear processes"	Mitochondria		"HPA064196: AB_2685209"	"unprognostic (2.13e-2)"	"unprognostic (7.90e-3)"	"unprognostic (5.00e-2)"	"unprognostic (2.22e-2)"	"unprognostic (3.76e-1)"	"unprognostic (6.52e-2)"	"unprognostic (1.98e-3)"	"unprognostic (4.07e-3)"	"unprognostic (1.82e-1)"	"unprognostic (3.90e-1)"	"unprognostic (1.02e-2)"	"unprognostic (4.81e-2)"	"unprognostic (1.80e-2)"	"unprognostic (1.50e-2)"	"unprognostic (3.11e-1)"	"unprognostic (4.91e-2)"	"unprognostic (2.93e-2)"	0.0	0.0	0.0	0.0	0.2	0.0	1.6	0.0	0.0	0.3	0.0	0.0	0.1	0.0	10.2	0.0	2.3	0.1	0.0	0.0	0.0	1.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.1	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.2	0.2	0.0	0.9	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	12.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0
CCNB2	HsT17299	ENSG00000157456	"Cyclin B2"	O95067	15	59105126-59125045	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transporters"	"Cell cycle, Cell division, Mitosis"	Cyclin	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"bone marrow: 74.6;lymphoid tissue: 73.1;testis: 69.4"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 67.9;Early spermatids: 228.5;Erythroid cells: 123.6;Extravillous trophoblasts: 128.3;Spermatocytes: 288.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in many"	5	"T-reg: 22.7"	"Lineage enriched"	"Detected in many"	6	"T-cells: 22.7"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"HPA008873, CAB009575"	Enhanced		Enhanced	"Golgi apparatus,Cytosol"		Yes	Yes			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Cytosol	"Golgi apparatus"	"CAB009575: AB_2072392, HPA008873: AB_1078604"	"unprognostic (2.69e-2)"	"unprognostic (2.25e-1)"	"unprognostic (4.43e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.77e-1)"	"unprognostic (4.65e-2)"	"prognostic unfavorable (2.83e-4)"	"prognostic unfavorable (4.63e-4)"	"prognostic unfavorable (3.21e-5)"	"unprognostic (1.09e-1)"	"prognostic unfavorable (1.74e-5)"	"unprognostic (4.48e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (1.96e-1)"	"unprognostic (1.41e-1)"	"unprognostic (3.98e-2)"	"unprognostic (4.44e-1)"	1.0	1.1	0.4	12.2	1.1	74.6	2.9	0.7	0.7	2.9	1.1	14.3	14.1	2.6	0.3	16.1	1.1	1.9	0.7	0.6	0.7	1.1	1.4	2.2	33.0	1.3	1.0	0.8	0.7	0.2	0.3	11.4	1.0	1.6	16.8	0.3	2.8	0.4	0.7	9.4	12.0	6.4	0.7	7.1	5.6	69.4	1.1	73.1	1.0	0.4	43.7	3.6	5.6	2.2	132.5	112.1	188.6	47.1	8.5	16.6	97.5	104.8	69.9	165.2	135.6	187.8	81.1	122.1	75.4	71.8	97.2	160.1	181.4	92.6	157.8	124.1	92.4	153.1	127.3	108.1	2.5	118.1	98.6	6.3	12.6	71.4	91.9	32.7	114.1	147.0	163.1	194.5	128.2	96.5	137.9	177.2	138.6	58.5	65.2	157.5	260.0	124.4	53.3	91.9	115.2	75.9	148.9	80.2	97.3	147.9	139.4	120.4	58.5	81.6	134.4	90.5	210.5	84.2	133.2	213.8	53.6	267.1	117.9	0.0	0.1	0.7	0.1	0.0	0.3	2.1	4.6	5.0	3.0	1.7	0.0	0.1	0.8	3.6	0.1	0.1	22.7	2.1	0.4	1.1	0.7	0.7	0.6	0.7	1.3	1.0	1.0	0.7	1.1	2.2	0.3	0.0	0.6	0.0	6.8	4.8	2.8	11.5	1.8	0.2	2.5	3.3	0.5	0.0	3.2	0.0	0.0	67.9	1.6	4.1	0.0	0.7	228.5	5.3	3.1	3.9	3.0	123.6	0.7	0.2	128.3	7.2	7.1	5.9	0.0	29.9	6.1	1.1	29.9	0.0	0.8	10.1	20.3	10.6	3.3	53.5	4.4	7.9	0.0	0.0	2.4	0.2	1.0	0.0	1.4	0.4	1.9	1.9	18.7	2.3	2.1	0.0	1.8	0.3	0.0	1.0	5.7	288.7	32.1	20.3	6.1	16.3	4.4	4.1	23.4	5.0
CCNC	CycC	ENSG00000112237	"Cyclin C"	P24863	6	99542387-99568825	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, Cyclin, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010499, HPA069322"	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 22: Epithelial cell types - Mixed function"	Nucleoplasm	Cytosol	"CAB010499: AB_2244021, HPA069322: AB_2686120"	"unprognostic (1.48e-2)"	"unprognostic (1.21e-2)"	"unprognostic (1.85e-3)"	"unprognostic (6.34e-2)"	"unprognostic (1.92e-2)"	"unprognostic (1.95e-3)"	"unprognostic (2.09e-1)"	"unprognostic (3.86e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.64e-2)"	"unprognostic (1.92e-1)"	"unprognostic (7.10e-2)"	"prognostic favorable (8.12e-4)"	"unprognostic (1.91e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.41e-1)"	"unprognostic (3.83e-2)"	31.3	32.5	15.9	27.4	17.0	33.0	47.4	26.1	19.3	29.8	26.8	30.9	42.8	21.9	58.7	41.3	18.9	42.1	23.6	17.3	17.9	54.3	74.6	25.1	39.6	17.0	16.9	16.7	62.6	47.3	22.2	35.7	17.0	34.6	30.3	27.0	70.4	23.2	22.1	32.5	35.0	21.9	17.0	24.1	41.6	17.1	18.1	32.1	60.6	17.7	43.3	34.6	19.7	18.0	86.9	29.8	45.8	99.2	39.3	53.7	126.9	61.4	78.3	75.9	97.9	118.2	53.2	177.2	69.1	51.5	69.8	60.5	72.2	91.1	109.7	45.1	91.2	101.6	44.4	97.7	67.6	118.6	35.3	51.5	55.4	55.9	67.3	52.0	82.2	102.3	151.6	62.9	68.3	53.8	43.7	98.5	64.1	53.5	47.4	75.8	76.7	71.2	105.3	101.2	72.5	43.8	35.6	67.1	69.5	65.5	46.5	117.8	60.6	38.4	51.2	47.0	92.8	42.9	69.7	134.1	69.0	87.9	55.8	40.9	20.7	16.2	21.2	22.1	39.8	29.7	25.5	20.9	23.4	25.3	27.4	21.7	3.3	28.2	16.7	23.0	29.6	30.7	15.9	17.0	26.1	19.3	17.3	17.9	17.0	16.9	17.0	17.0	18.1	18.0	37.1	44.8	32.8	25.5	58.3	75.1	99.3	58.0	50.7	42.8	60.0	31.0	16.1	81.5	57.5	23.9	22.9	110.3	45.0	32.2	84.1	127.2	45.1	36.7	27.3	46.3	43.6	23.3	64.2	186.9	93.3	33.2	38.2	43.1	32.4	31.1	36.4	53.0	41.1	25.2	56.6	38.2	67.1	37.0	52.8	45.5	22.4	32.8	58.7	24.4	41.2	64.6	40.2	52.8	40.5	133.7	27.1	25.2	120.5	158.8	37.8	128.4	37.4	42.2	19.7	26.9	40.2	62.3	21.4	60.0	67.5	176.4	38.7	42.8	46.3	147.0
CCND1	"BCL1, D11S287E, PRAD1, U21B31"	ENSG00000110092	"Cyclin D1"	P24385	11	69641156-69654474	"Cancer-related genes, Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins"	"Cell cycle, Cell division, DNA damage, Transcription, Transcription regulation"	"Cyclin, Repressor"	"Cancer-related genes, FDA approved drug targets, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 499.7;Ductal cells: 504.0;Pancreatic endocrine cells: 622.1;Urothelial cells: 412.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"myeloid DC: 1.1"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"U-266/70: 874.2;WM-115: 1239.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000024, HPA027802"	Uncertain		Supported	Nucleoplasm		Yes	No			"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 1: Pancreatic cells - Digestion"	Nucleoplasm		"CAB000024: AB_563678, HPA027802: AB_2672390"	"unprognostic (4.90e-2)"	"unprognostic (1.54e-1)"	"unprognostic (7.62e-2)"	"unprognostic (1.39e-2)"	"unprognostic (2.18e-1)"	"prognostic unfavorable (5.51e-4)"	"unprognostic (1.38e-1)"	"unprognostic (2.53e-2)"	"unprognostic (9.46e-2)"	"unprognostic (4.84e-3)"	"prognostic unfavorable (1.96e-4)"	"unprognostic (4.39e-2)"	"unprognostic (2.61e-3)"	"unprognostic (4.38e-3)"	"unprognostic (1.16e-1)"	"unprognostic (6.40e-3)"	"unprognostic (2.57e-1)"	55.6	29.2	12.1	10.0	14.6	1.5	40.2	15.0	11.9	17.0	33.4	19.8	22.7	14.8	27.6	72.9	30.8	19.5	64.9	10.8	14.6	32.2	107.3	61.1	10.5	17.5	15.5	4.6	86.3	82.7	25.7	63.7	18.3	53.3	17.2	3.2	30.4	50.4	3.6	120.3	16.0	23.3	15.9	37.2	52.7	3.2	21.7	9.9	45.5	5.2	19.0	29.5	43.9	24.0	467.3	183.0	59.5	1.8	178.3	186.7	127.4	717.5	264.9	82.1	47.6	206.9	349.9	0.1	317.6	375.5	137.2	332.1	6.5	195.2	146.0	1.2	36.5	0.3	46.7	211.7	43.3	3.3	6.7	106.5	37.9	116.0	44.0	192.5	142.1	0.2	0.6	1.3	654.2	197.1	0.4	26.6	109.0	190.7	198.3	1.2	187.9	11.3	379.4	282.8	10.0	231.4	9.2	167.7	458.4	143.5	102.6	9.5	600.4	399.5	111.0	176.1	496.2	874.2	559.4	1.5	341.6	5.9	1239.0	0.2	0.0	0.0	0.2	0.0	0.0	0.9	0.1	0.0	1.1	0.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	12.1	14.6	15.0	11.9	10.8	14.6	17.5	15.5	18.3	15.9	21.7	24.0	84.6	182.7	115.6	0.3	8.3	202.5	234.7	499.7	133.1	2.3	163.4	140.0	80.0	92.9	271.6	125.0	2.1	10.9	2.4	44.8	31.3	504.0	0.4	104.2	23.5	141.0	56.5	2.5	0.5	142.6	1.2	67.6	127.4	199.5	29.1	0.0	98.2	165.2	75.0	0.0	2.2	42.6	75.3	18.8	61.9	2.0	4.1	23.6	51.6	17.8	2.4	79.1	0.0	49.8	0.3	622.1	118.0	57.6	0.5	262.0	19.4	57.1	85.9	3.1	131.5	13.0	184.8	0.5	23.4	292.3	351.1	2.5	8.8	3.4	82.2	412.6
CCND3		ENSG00000112576	"Cyclin D3"	P30281	6	41934934-42050357	"Cancer-related genes, Human disease related genes, Predicted intracellular proteins"	"Cell cycle, Cell division"	Cyclin	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 256.6"	"Cell type enhanced"	"Detected in all"		"NK-cells: 555.1;Syncytiotrophoblasts: 236.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"MOLT-4: 696.3;REH: 651.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000116, HPA042871"	Approved		Supported	Nucleoplasm		NA	Yes			"Cluster 10: Basophils - Unknown function"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 51: Myeloid cells - Hemostasis"	Nucleoplasm		"CAB000116: , HPA042871: "	"unprognostic (4.53e-2)"	"unprognostic (4.45e-2)"	"unprognostic (2.45e-1)"	"unprognostic (4.40e-3)"	"unprognostic (1.01e-1)"	"unprognostic (9.80e-2)"	"unprognostic (3.40e-2)"	"unprognostic (5.25e-2)"	"unprognostic (7.76e-2)"	"unprognostic (3.45e-1)"	"unprognostic (9.17e-2)"	"unprognostic (6.39e-2)"	"unprognostic (2.45e-3)"	"unprognostic (9.12e-2)"	"unprognostic (1.71e-1)"	"prognostic favorable (8.08e-6)"	"unprognostic (2.11e-1)"	74.3	137.6	84.8	63.1	84.6	220.2	64.8	80.0	94.5	36.9	78.4	45.6	40.6	35.4	15.3	39.6	43.2	34.4	68.1	86.2	88.6	42.4	22.1	102.5	143.3	87.4	82.5	36.0	31.6	23.7	33.3	55.4	84.0	50.4	27.0	10.3	50.4	25.6	18.2	52.3	78.5	28.6	79.7	170.4	66.1	11.1	86.4	256.6	58.7	32.5	83.6	45.4	44.3	80.8	67.7	242.2	24.6	54.8	43.7	88.6	286.1	77.1	43.7	77.7	57.1	45.9	29.7	288.9	127.8	51.9	68.9	40.5	65.8	93.4	39.2	49.2	43.4	458.8	106.6	37.3	94.9	75.9	385.2	84.7	59.8	76.0	27.9	23.5	96.6	188.3	236.7	27.2	111.6	92.0	696.3	354.6	10.9	202.8	51.5	651.8	96.3	32.2	179.1	44.9	83.8	21.8	65.8	83.3	38.6	30.6	51.5	288.4	162.9	86.2	47.9	74.7	88.1	17.9	15.2	458.5	50.4	157.6	53.3	1281.3	246.3	725.1	390.4	294.4	276.5	127.1	266.4	318.1	343.3	180.8	306.4	328.3	339.3	333.2	405.6	221.4	193.0	635.4	84.8	84.6	80.0	94.5	86.2	88.6	87.4	82.5	84.0	79.7	86.4	80.8	102.2	60.9	67.9	31.0	102.9	27.0	95.8	52.3	48.9	19.6	49.9	45.1	26.2	64.3	27.8	20.2	6.2	201.0	227.3	66.4	29.4	20.3	12.8	12.1	10.8	68.3	9.6	133.6	37.1	24.3	82.4	32.3	19.9	11.2	26.6	7.7	70.6	7.2	45.3	11.8	23.7	19.5	50.8	115.7	51.7	9.4	41.3	152.2	37.4	47.8	79.0	40.8	555.1	18.1	9.3	29.9	30.5	51.9	48.7	40.3	18.6	19.8	22.5	16.2	46.0	19.2	31.9	4.3	6.3	21.7	22.6	236.6	195.0	141.6	32.7	52.8
CCNF	"FBX1, FBXO1"	ENSG00000162063	"Cyclin F"	P41002	16	2429394-2458854	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, Ubl conjugation pathway"	Cyclin		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 15.1"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 37.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA060596, HPA070495, HPA071600"	Enhanced		Supported	Centrosome		NA	Yes			"Cluster 40: NK-cells - Unknown function"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Centrosome		"HPA060596: AB_2684329, HPA070495: AB_2686273, HPA071600: AB_2686424"	"unprognostic (3.87e-2)"	"unprognostic (2.21e-2)"	"unprognostic (1.57e-3)"	"unprognostic (3.70e-3)"	"unprognostic (1.24e-1)"	"unprognostic (1.13e-1)"	"prognostic unfavorable (7.46e-7)"	"unprognostic (2.45e-2)"	"unprognostic (1.75e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.01e-2)"	"unprognostic (1.58e-2)"	"unprognostic (0.00e+0)"	"unprognostic (1.22e-2)"	"unprognostic (1.10e-2)"	"unprognostic (4.25e-2)"	"unprognostic (2.74e-1)"	1.4	1.0	2.5	3.8	2.1	7.3	1.9	2.9	2.7	1.3	0.0	2.0	2.8	0.8	2.0	4.0	0.8	0.8	0.6	2.4	2.0	0.6	0.7	1.0	7.4	1.5	2.0	1.0	0.8	0.5	0.8	2.5	1.3	1.6	2.0	0.8	2.1	1.1	1.3	4.8	2.1	1.1	0.8	2.2	1.6	2.7	2.6	15.1	0.7	1.3	9.6	1.7	1.5	1.7	21.0	32.4	31.3	28.9	2.2	2.9	23.8	24.1	12.2	34.2	26.1	64.6	25.6	42.3	8.0	14.1	10.2	33.1	52.2	19.6	16.4	30.9	23.4	46.1	35.3	20.4	2.3	30.4	30.7	2.0	2.5	24.1	11.7	4.4	25.5	36.5	52.0	28.5	17.6	45.6	46.1	25.0	31.2	22.6	13.2	76.2	35.1	39.5	9.5	9.3	29.8	17.0	36.0	32.8	6.4	15.6	34.3	16.6	18.1	19.1	46.7	13.5	27.1	16.4	20.9	74.5	5.6	31.8	26.9	0.0	0.3	0.0	0.7	0.1	0.4	0.6	0.4	0.9	0.1	0.4	0.3	0.4	0.0	1.3	0.3	0.5	0.5	0.6	2.5	2.1	2.9	2.7	2.4	2.0	1.5	2.0	1.3	0.8	2.6	1.7	0.9	0.0	3.9	3.3	2.7	2.8	2.7	1.4	6.2	5.3	2.4	2.0	1.9	0.0	1.6	1.8	12.5	7.0	3.7	2.4	0.0	1.2	0.9	1.0	2.7	2.2	1.2	37.5	5.7	0.6	12.2	2.2	5.6	1.0	1.3	8.9	2.5	0.9	6.1	8.4	5.6	2.6	4.1	2.4	1.6	0.0	1.8	1.5	5.4	0.0	0.8	0.9	2.1	1.0	1.0	1.1	0.3	2.6	7.2	1.9	0.9	0.2	0.3	1.6	0.0	0.8	2.7	3.9	5.7	3.5	1.1	1.9	3.4	1.7	4.7	1.6
CCNG1	CCNG	ENSG00000113328	"Cyclin G1"	P51959	5	163437569-163446151	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	Cyclin	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Proximal tubular cells: 265.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB000350	Supported		Supported	Nucleoplasm		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm		"CAB000350: "	"unprognostic (2.49e-2)"	"unprognostic (1.64e-1)"	"prognostic favorable (7.00e-4)"	"unprognostic (2.92e-2)"	"unprognostic (9.04e-2)"	"unprognostic (2.26e-1)"	"unprognostic (6.25e-2)"	"unprognostic (1.58e-1)"	"unprognostic (6.15e-2)"	"unprognostic (1.45e-2)"	"unprognostic (1.29e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.38e-3)"	"unprognostic (1.46e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.19e-1)"	"unprognostic (7.89e-2)"	51.2	48.8	21.0	30.4	23.0	38.3	67.2	22.9	25.8	63.4	27.8	68.0	137.2	50.5	73.4	47.8	61.8	56.7	50.4	19.1	23.4	123.5	129.6	33.4	49.0	24.7	21.6	112.0	74.4	39.7	14.6	54.0	25.0	71.4	87.0	21.3	56.3	55.7	163.6	23.5	109.1	52.3	23.5	35.5	57.3	20.7	21.7	50.3	62.4	120.6	47.0	59.7	33.8	28.6	54.9	59.8	246.6	138.8	207.9	397.3	258.2	74.1	181.2	73.8	165.2	130.4	109.4	134.1	73.7	100.1	121.7	22.2	137.2	185.0	107.9	63.7	171.9	106.6	71.7	230.0	226.4	49.9	68.9	433.8	105.6	73.3	75.1	221.5	241.1	88.3	92.3	92.8	253.4	33.8	89.6	66.5	113.3	40.1	52.7	74.6	120.7	75.2	179.5	209.4	57.6	65.6	0.4	30.5	154.0	155.2	115.5	155.8	140.5	47.6	101.0	40.8	66.2	81.5	34.2	87.7	84.3	81.4	80.6	44.5	25.6	31.0	35.8	36.1	53.9	55.4	63.2	49.3	59.6	33.9	84.5	72.0	10.9	40.7	36.7	22.6	80.9	63.9	21.0	23.0	22.9	25.8	19.1	23.4	24.7	21.6	25.0	23.5	21.7	28.6	20.8	25.6	20.0	7.5	67.3	57.2	94.7	64.7	103.0	12.4	64.4	33.0	52.9	77.2	39.7	36.8	0.0	138.7	49.8	48.2	162.4	73.0	8.1	30.6	27.5	43.5	71.0	96.3	8.4	119.0	107.7	57.1	110.6	46.1	43.7	108.8	61.1	51.7	60.0	15.2	8.8	113.2	44.7	74.8	70.5	6.1	75.8	60.8	37.4	15.0	52.0	29.9	54.6	4.5	12.7	91.1	80.2	72.2	63.5	107.2	223.4	265.9	11.2	10.8	39.5	42.4	73.4	8.8	12.1	61.5	44.2	97.3	76.4	81.5	182.7	104.3
CCNH	"CycH, p34, p37"	ENSG00000134480	"Cyclin H"	P51946	5	87318416-87412930	"Cancer-related genes, Predicted intracellular proteins"	"Cell cycle, Transcription, Transcription regulation"	Cyclin	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 281.5;Plasma cells: 219.9;Spermatocytes: 202.6;T-cells: 207.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB019416, HPA044138"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm		"CAB019416: AB_2259936, HPA044138: AB_2678828"	"unprognostic (5.65e-2)"	"unprognostic (3.94e-3)"	"unprognostic (4.01e-3)"	"unprognostic (4.12e-1)"	"unprognostic (1.10e-1)"	"unprognostic (9.30e-2)"	"unprognostic (3.93e-2)"	"unprognostic (6.43e-2)"	"unprognostic (8.79e-2)"	"prognostic unfavorable (4.35e-4)"	"unprognostic (4.16e-2)"	"unprognostic (2.27e-2)"	"prognostic unfavorable (3.92e-5)"	"unprognostic (1.48e-1)"	"unprognostic (2.35e-1)"	"unprognostic (1.61e-1)"	"unprognostic (9.62e-2)"	36.6	26.6	6.9	18.8	7.6	38.3	29.0	15.6	10.9	19.4	6.9	16.0	17.6	14.9	24.2	17.7	17.6	24.6	22.0	8.7	9.0	24.5	37.5	25.8	24.1	7.7	6.3	26.9	23.0	29.9	27.1	15.6	6.9	26.5	19.9	11.4	20.4	18.4	29.1	15.4	16.6	15.6	7.1	18.4	17.6	54.1	6.7	36.8	26.9	22.6	25.9	27.3	18.3	10.3	62.6	26.6	27.1	18.1	39.3	27.5	28.1	44.4	54.8	73.8	101.2	46.7	35.0	40.5	15.8	66.4	77.7	31.1	32.5	67.5	68.4	42.9	39.9	73.1	44.8	46.4	69.3	61.9	57.6	37.0	25.4	38.6	93.8	37.8	65.6	38.7	50.0	70.7	61.7	35.1	42.4	49.5	11.6	15.7	99.4	34.5	63.3	60.9	62.5	32.8	27.8	18.1	23.3	21.7	53.8	16.3	51.7	46.8	45.6	70.9	29.3	41.9	39.4	25.1	23.9	63.4	45.6	55.7	33.6	49.3	37.7	58.8	26.4	47.2	37.4	36.7	35.4	34.8	44.5	32.0	34.4	36.2	28.0	35.4	50.2	26.1	44.8	36.9	6.9	7.6	15.6	10.9	8.7	9.0	7.7	6.3	6.9	7.1	6.7	10.3	67.5	35.3	33.7	15.0	111.2	37.3	64.3	55.1	40.5	29.0	30.1	24.3	13.2	20.0	37.7	18.4	16.7	21.0	154.2	14.7	41.1	40.1	281.5	28.0	25.2	37.6	24.0	33.7	28.3	34.5	25.6	52.5	41.3	24.2	57.1	19.9	30.0	19.9	45.3	18.5	43.7	15.2	36.7	67.9	73.4	41.4	29.5	125.2	48.0	20.6	25.5	44.9	41.2	20.1	23.5	31.1	15.8	25.2	219.9	31.7	27.0	53.8	34.4	32.9	52.6	43.3	120.0	202.6	48.3	22.3	34.5	30.1	207.8	35.7	19.4	41.0
CCNL1	ania-6a	ENSG00000163660	"Cyclin L1"	Q9UK58	3	157146508-157160760	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Cyclin	Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA057911			Supported	"Nucleoplasm,Nuclear bodies"	"Intracellular and membrane"	NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 7: Non-specific - Mitochondria"	"Nucleoplasm, Nuclear bodies"		"HPA057911: AB_2683553"	"unprognostic (1.03e-2)"	"unprognostic (3.66e-2)"	"unprognostic (1.38e-1)"	"unprognostic (6.90e-3)"	"unprognostic (1.79e-1)"	"unprognostic (6.58e-2)"	"unprognostic (3.16e-3)"	"unprognostic (7.50e-2)"	"unprognostic (5.54e-3)"	"unprognostic (3.37e-1)"	"unprognostic (3.06e-1)"	"unprognostic (2.40e-2)"	"prognostic unfavorable (1.01e-6)"	"unprognostic (3.71e-1)"	"unprognostic (2.24e-1)"	"unprognostic (5.62e-2)"	"prognostic favorable (6.96e-7)"	52.1	25.2	12.4	11.6	12.9	56.6	27.3	14.2	21.2	21.9	12.6	22.5	13.5	19.4	5.7	22.1	30.5	13.5	23.1	13.0	13.2	31.8	45.3	30.2	14.1	15.1	12.8	31.2	33.5	8.3	21.8	10.3	13.1	23.8	6.6	5.3	18.7	6.2	21.3	25.3	29.7	9.1	11.9	35.6	29.1	9.1	13.0	20.0	23.7	10.3	9.8	19.4	22.9	14.7	19.2	11.4	16.8	11.6	16.1	10.9	16.0	12.0	14.4	13.9	13.0	19.7	14.8	20.3	10.0	8.9	9.7	14.7	12.4	14.6	12.8	18.2	14.1	12.6	12.2	17.2	13.2	8.8	7.7	13.3	25.1	13.2	17.7	13.9	11.1	11.4	8.7	12.7	10.2	13.8	17.8	16.7	13.9	14.7	12.5	16.2	13.6	31.7	8.9	11.4	8.9	16.5	9.1	8.4	26.1	12.5	8.7	26.1	9.1	12.8	7.1	13.8	15.9	25.3	21.5	26.7	12.8	13.1	12.6	5.9	10.3	16.0	13.5	8.4	14.1	13.4	12.5	14.0	13.1	15.2	17.1	14.2	28.6	17.4	11.3	14.0	15.4	8.2	12.4	12.9	14.2	21.2	13.0	13.2	15.1	12.8	13.1	11.9	13.0	14.7	367.4	218.0	392.4	33.0	222.5	268.0	499.2	203.8	310.7	73.7	279.3	247.0	54.3	177.3	259.0	68.0	133.5	139.2	253.6	389.6	23.5	189.4	41.0	379.7	426.5	287.1	247.7	86.5	30.6	127.8	152.9	302.7	268.1	761.2	222.2	281.6	167.8	90.4	164.6	40.4	32.3	294.6	154.6	241.5	251.4	20.9	128.0	292.5	140.5	42.2	160.1	69.5	122.6	35.7	66.3	143.2	378.2	75.2	258.5	408.2	415.6	21.2	188.9	183.3	131.5	460.0	276.4	46.5	25.0	252.6	276.9	209.1	282.8	182.6	244.1	503.2
CCNL2	"ania-6b, CCNM, CCNS, HLA-ISO, PCEE, SB138"	ENSG00000221978	"Cyclin L2"	Q96S94	1	1385711-1399335	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Cyclin		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053137	Supported		Supported	Nucleoplasm	"Intracellular and membrane"	NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 72: Non-specific - Transcription"	"Cluster 20: HeLa - Mitochondria"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA053137: AB_2682053"	"unprognostic (3.08e-2)"	"unprognostic (2.60e-1)"	"unprognostic (1.14e-2)"	"unprognostic (1.45e-1)"	"unprognostic (8.97e-2)"	"unprognostic (1.59e-3)"	"unprognostic (2.06e-1)"	"unprognostic (3.91e-2)"	"unprognostic (1.67e-2)"	"unprognostic (1.15e-1)"	"unprognostic (7.08e-3)"	"unprognostic (2.91e-2)"	"prognostic unfavorable (1.12e-6)"	"unprognostic (4.61e-2)"	"unprognostic (6.17e-2)"	"unprognostic (3.71e-1)"	"prognostic favorable (1.46e-7)"	65.1	79.9	16.3	29.6	17.5	33.3	74.0	24.1	21.5	101.8	27.8	76.9	36.0	88.7	30.9	67.2	86.6	26.4	57.9	16.9	14.2	65.6	100.5	62.1	32.2	16.9	15.7	104.3	90.2	31.7	73.4	34.4	18.4	76.0	22.8	22.9	78.1	31.9	49.7	73.7	75.8	26.6	15.7	62.1	71.3	31.1	17.0	31.6	91.4	18.4	28.1	77.0	82.5	26.6	30.1	24.5	72.5	29.7	39.2	63.9	37.1	63.8	33.8	32.1	31.6	27.5	57.9	30.6	35.3	42.8	27.7	68.4	26.8	40.9	24.6	14.7	68.9	38.4	142.0	43.8	47.8	19.9	42.8	81.1	29.0	31.4	48.5	94.6	34.9	41.0	37.3	32.4	37.6	32.1	25.1	78.7	23.7	21.2	48.5	48.8	17.6	39.1	56.5	37.1	45.4	63.0	40.7	60.6	37.5	42.8	48.8	30.3	60.1	70.8	32.5	29.4	25.2	64.9	12.1	53.7	35.0	50.7	18.5	5.4	6.1	8.5	7.4	4.6	5.0	7.2	7.2	7.9	7.1	9.0	8.3	7.4	5.8	6.6	7.3	6.7	4.3	2.9	16.3	17.5	24.1	21.5	16.9	14.2	16.9	15.7	18.4	15.7	17.0	26.6	66.4	35.3	107.5	76.7	46.6	45.5	36.6	48.3	50.7	31.7	50.8	56.4	37.2	40.0	58.1	29.5	47.9	43.2	48.7	43.1	21.5	30.6	22.4	49.0	82.1	56.0	50.6	26.5	44.7	26.7	33.8	49.9	78.5	55.2	43.1	81.4	37.5	45.6	24.7	60.6	41.2	41.5	52.9	22.9	34.0	14.6	51.3	31.0	32.0	48.7	27.2	35.5	47.4	31.2	52.5	40.2	40.7	32.7	46.7	31.1	33.9	18.4	58.6	39.4	59.2	56.8	59.9	45.1	30.6	40.3	44.0	63.8	46.4	73.6	34.6	39.0
CCR10	GPR2	ENSG00000184451	"C-C motif chemokine receptor 10"	P46092	17	42678889-42683917	"Cancer-related genes, G-protein coupled receptors, Plasma proteins, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pituitary gland: 20.2"	"Cell type enhanced"	"Detected in many"		"B-cells: 14.1;Bipolar cells: 12.8;Plasma cells: 62.7;Sertoli cells: 19.7;Smooth muscle cells: 16.7"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"plasmacytoid DC: 24.7;T-reg: 72.4"	"Group enriched"	"Detected in many"	8	"dendritic cells: 24.7;T-cells: 72.4"	"Cell line enhanced"	"Detected in some"		"Karpas-707: 8.4;RPMI-8226: 6.5;U-266/70: 17.1;U-266/84: 8.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"CAB011684, HPA048007, HPA069188"	Uncertain		Supported	"Endoplasmic reticulum"		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 55: Plasma cells - Humoral immune response"	"Endoplasmic reticulum"		"CAB011684: AB_731502, HPA048007: AB_2680232, HPA069188: AB_2686100"	"unprognostic (3.25e-2)"	"unprognostic (2.71e-2)"	"unprognostic (5.70e-2)"	"unprognostic (2.41e-2)"	"unprognostic (5.25e-2)"	"unprognostic (2.23e-3)"	"unprognostic (5.18e-4)"	"unprognostic (1.15e-1)"	"unprognostic (9.55e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.21e-3)"	"unprognostic (1.01e-2)"	"unprognostic (2.32e-11)"	"unprognostic (2.84e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.88e-2)"	"unprognostic (1.87e-1)"	4.5	2.1	1.1	0.7	1.1	0.2	5.2	3.1	2.7	6.6	0.0	4.8	1.8	8.5	0.3	0.8	8.5	0.2	4.4	0.7	6.5	2.8	0.8	4.1	0.3	3.9	4.6	6.2	2.3	0.0	20.2	0.7	6.6	3.8	0.2	0.7	2.2	0.6	4.7	1.5	3.1	0.5	1.0	3.2	2.6	4.0	4.0	0.2	2.8	0.4	0.0	2.4	3.2	1.2	0.5	0.8	0.8	4.7	0.3	0.7	1.1	1.7	0.5	0.2	0.4	0.7	0.3	0.1	0.3	0.3	1.6	0.8	0.0	0.1	0.1	2.0	1.2	0.0	3.2	0.4	0.6	0.0	0.3	0.7	0.0	0.3	0.0	0.5	0.1	0.3	2.6	8.4	0.0	0.3	0.1	2.4	0.6	0.0	1.2	0.6	0.1	6.5	1.1	0.0	0.7	1.0	0.4	0.0	0.2	0.3	0.8	0.9	1.9	2.1	0.5	0.7	0.2	17.1	8.4	2.5	1.3	0.6	0.9	0.0	0.6	0.2	0.4	0.1	0.3	5.3	10.9	5.4	0.4	5.9	1.3	1.8	0.2	0.2	0.4	24.7	72.4	1.5	1.1	1.1	3.1	2.7	0.7	6.5	3.9	4.6	6.6	1.0	4.0	1.2	7.3	0.0	0.0	0.7	14.1	0.8	0.3	0.4	0.6	12.8	1.0	1.3	2.1	0.0	0.1	0.0	0.0	0.2	0.6	0.0	3.9	0.3	0.5	1.6	2.9	2.9	1.8	0.0	5.1	0.5	0.3	5.4	1.5	0.9	0.0	0.6	2.2	0.2	1.9	1.7	4.6	0.6	2.0	2.5	3.7	2.5	5.6	1.2	5.4	0.0	3.8	2.5	2.1	1.0	1.3	0.3	0.1	2.6	62.7	0.3	0.2	0.7	1.0	3.2	19.7	2.3	16.7	1.6	2.1	0.3	0.3	0.0	2.9	1.9	0.7	0.1
CCR2	"CC-CKR-2, CD192, CKR2, CMKBR2, FLJ78302, MCP-1-R"	ENSG00000121807	"C-C motif chemokine receptor 2"	P41597	3	46353744-46360940	"CD markers, G-protein coupled receptors, Human disease related genes, Predicted membrane proteins"	"Host-virus interaction, Inflammatory response"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 25.9"	"Cell type enhanced"	"Detected in some"		"dendritic cells: 40.4;Kupffer cells: 43.1;Macrophages: 25.2;monocytes: 34.9;Plasma cells: 26.2"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in many"		"basophil: 560.9"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"Karpas-707: 185.5;THP-1: 89.8;U-266/70: 416.5;U-266/84: 177.7"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"spinal cord: 2.4"	"CAB003793, HPA063255"	Approved		Supported	"Nucleoli fibrillar center,Plasma membrane"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 16: Immune cells - Immune response"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	"Plasma membrane"	"Nucleoli fibrillar center"	"CAB003793: AB_344889, HPA063255: "	"unprognostic (1.09e-2)"	"unprognostic (6.28e-4)"	"unprognostic (3.49e-2)"	"unprognostic (6.35e-4)"	"unprognostic (1.89e-2)"	"unprognostic (4.16e-4)"	"unprognostic (8.06e-2)"	"prognostic favorable (5.87e-4)"	"unprognostic (6.33e-2)"	"unprognostic (3.27e-2)"	"unprognostic (3.12e-1)"	"unprognostic (1.56e-1)"	"unprognostic (5.52e-3)"	"unprognostic (1.29e-1)"	"unprognostic (3.35e-2)"	"unprognostic (4.88e-2)"	"unprognostic (4.19e-1)"	2.6	1.9	0.1	25.9	0.1	1.9	3.1	0.1	0.2	1.6	0.3	4.6	7.5	1.2	0.9	1.2	1.2	3.4	1.1	0.1	0.1	1.2	2.1	5.8	11.6	0.4	0.2	1.1	0.8	0.3	0.2	0.8	0.2	1.2	5.1	0.0	3.1	1.7	0.5	1.9	5.7	7.1	0.3	20.4	5.2	1.0	0.2	4.3	1.1	0.5	7.2	5.5	1.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.0	0.1	0.0	0.1	0.0	0.0	2.7	0.0	185.5	0.0	0.0	0.1	1.2	0.0	0.0	0.0	0.2	0.0	1.8	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	89.8	0.0	0.0	0.0	0.0	0.3	416.5	177.7	0.0	0.1	3.3	0.1	560.9	146.2	2.6	11.9	12.8	89.2	7.9	24.3	20.2	145.2	1.8	0.6	0.7	3.8	14.0	0.4	113.6	11.4	81.6	0.1	0.1	0.1	0.2	0.1	0.1	0.4	0.2	0.2	0.3	0.2	0.3	0.1	0.0	1.3	0.0	5.8	0.3	0.0	0.0	0.6	0.0	0.1	0.1	0.3	1.5	0.0	0.0	0.0	0.1	40.4	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.0	4.4	0.0	0.0	0.0	0.4	1.1	0.1	0.0	0.0	1.8	0.9	0.8	0.0	0.0	0.0	0.0	43.1	10.5	0.7	0.0	25.2	0.0	0.0	34.9	0.0	1.0	0.0	0.0	0.0	0.0	0.0	26.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.2	0.0	0.0	8.2	0.1	0.1	0.0
CCR3	"CC-CKR-3, CD193, CKR3, CMKBR3"	ENSG00000183625	"C-C motif chemokine receptor 3"	P51677	3	46163604-46266706	"CD markers, G-protein coupled receptors, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Host-virus interaction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 2.6"	"Cell type enhanced"	"Detected in some"		"Cytotrophoblasts: 1.2;granulocytes: 1.3;Melanocytes: 1.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	25	"basophil: 3389.4;eosinophil: 2509.9"	"Lineage enriched"	"Detected in many"	109	"granulocytes: 3389.4"	"Cell line enriched"	"Detected in some"	10	"RPMI-8226: 29.6"	"Not detected"	"Not detected"							"CAB003795, HPA069514"	Uncertain		Supported	"Plasma membrane"		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 64: Macrophages - Immune response"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Plasma membrane"		"CAB003795: AB_562259, HPA069514: "	"unprognostic (1.56e-2)"	"unprognostic (6.65e-3)"	"unprognostic (1.01e-1)"	"unprognostic (3.98e-2)"	"unprognostic (1.41e-1)"	"unprognostic (3.25e-3)"	"unprognostic (3.11e-7)"	"unprognostic (4.36e-2)"	"unprognostic (3.35e-2)"	"unprognostic (3.43e-2)"	"unprognostic (4.81e-2)"	"unprognostic (3.94e-2)"	"unprognostic (3.17e-6)"	"unprognostic (1.35e-2)"	"unprognostic (1.72e-2)"	"unprognostic (2.41e-1)"	"unprognostic (9.81e-2)"	0.1	0.0	0.2	1.6	0.3	0.4	0.0	0.1	0.5	0.1	1.7	0.8	1.3	0.0	0.0	0.2	0.1	0.7	0.0	0.1	0.2	0.1	0.1	0.6	0.5	0.4	0.0	0.0	0.3	0.0	0.0	0.7	0.4	0.0	0.7	0.0	0.0	0.1	1.7	0.8	2.6	0.9	0.0	1.5	1.2	0.2	0.1	0.1	0.1	0.1	0.1	1.2	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.8	2.6	0.1	0.8	0.0	0.9	0.3	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.4	0.1	0.3	0.1	0.0	0.0	0.3	0.0	29.6	0.0	2.4	0.1	0.0	0.1	0.8	0.0	0.8	0.0	0.7	0.0	0.1	0.2	0.0	0.1	3.0	2.6	0.0	0.0	0.5	0.0	3389.4	1.0	2509.9	0.5	1.5	0.8	1.2	2.6	1.4	1.1	0.7	0.3	0.9	115.8	0.5	1.4	3.5	31.1	7.6	0.2	0.3	0.1	0.5	0.1	0.2	0.4	0.0	0.4	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.6	0.2	0.0	0.0	1.3	0.0	0.0	0.0	0.4	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.8	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.1	0.0	0.0
CCR4	"CC-CKR-4, CD194, ChemR13, CKR4, CMKBR4, k5-5"	ENSG00000183813	"C-C motif chemokine receptor 4"	P51679	3	32951644-32956349	"CD markers, FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 13.0;urinary bladder: 5.4"	"Cell type enhanced"	"Detected in some"		"granulocytes: 2.5;Horizontal cells: 5.0;Plasma cells: 2.1;Spermatogonia: 1.8;T-cells: 7.8"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in some"	5	"T-reg: 60.9"	"Lineage enriched"	"Detected in many"	41	"T-cells: 60.9"	"Cell line enriched"	"Detected in some"	17	"HDLM-2: 206.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA031613	Approved		Supported	"Plasma membrane"		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 24: Non-specific - Transcription regulation"	"Plasma membrane"		"HPA031613: AB_10601096"	"unprognostic (4.63e-3)"	"unprognostic (8.70e-3)"	"unprognostic (2.82e-3)"	"unprognostic (2.64e-3)"	"unprognostic (1.18e-1)"	"unprognostic (4.59e-7)"	"unprognostic (3.02e-1)"	"unprognostic (5.05e-3)"	"unprognostic (1.53e-2)"	"unprognostic (1.69e-2)"	"unprognostic (1.75e-1)"	"unprognostic (2.17e-1)"	"unprognostic (9.88e-3)"	"unprognostic (2.04e-1)"	"unprognostic (5.53e-4)"	"unprognostic (1.54e-1)"	"unprognostic (1.40e-1)"	0.5	0.2	0.3	8.6	0.3	1.7	0.6	0.8	0.7	0.6	0.2	0.9	0.6	0.4	0.3	1.2	0.2	3.3	0.2	0.4	0.4	0.3	0.6	1.7	7.0	0.2	0.1	0.2	0.3	0.2	0.0	0.1	0.4	0.8	1.2	0.1	0.5	0.1	2.0	2.1	1.5	0.6	0.0	3.2	1.4	0.8	0.2	13.0	0.3	0.1	8.0	5.4	0.2	0.7	0.3	0.2	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.4	0.0	0.3	0.4	0.2	0.1	0.0	0.0	0.3	0.0	0.1	0.0	206.5	0.0	12.2	0.7	0.1	0.0	0.1	0.3	0.0	0.0	0.2	0.0	0.2	0.0	5.8	3.2	0.8	0.0	0.0	1.8	0.2	0.1	0.0	0.1	0.1	0.0	0.2	0.1	0.5	0.0	0.1	0.7	0.1	0.0	0.1	0.1	0.1	0.3	0.2	0.3	0.4	0.3	0.2	0.1	0.2	0.2	0.2	0.0	1.4	0.3	0.3	0.4	0.3	0.4	0.3	11.5	3.4	0.1	0.4	0.3	0.3	1.1	0.3	0.3	0.4	60.9	1.7	0.3	0.3	0.8	0.7	0.4	0.4	0.2	0.1	0.4	0.0	0.2	0.7	0.1	0.0	0.6	0.0	0.4	0.4	0.7	0.0	0.0	0.2	0.1	0.1	0.4	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.4	0.1	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.1	2.5	0.0	0.4	0.1	0.1	5.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.7	0.0	0.0	0.7	0.8	0.0	0.5	0.2	0.0	1.8	0.0	0.1	0.0	7.8	0.0	0.0	0.6
CCT2	Cctb	ENSG00000166226	"Chaperonin containing TCP1 subunit 2"	P78371	12	69585426-69601570	"Plasma proteins, Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 1471.3;Spermatocytes: 625.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003197, HPA003198"	Enhanced		Supported	Cytosol		NA	NA		3500000	"Cluster 44: Non-specific - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 29: Early spermatids - Spermatogenesis"	Cytosol		"HPA003197: AB_1078425, HPA003198: AB_1078424"	"unprognostic (1.79e-3)"	"unprognostic (2.35e-1)"	"unprognostic (1.40e-3)"	"unprognostic (1.53e-1)"	"unprognostic (4.42e-2)"	"prognostic unfavorable (8.38e-4)"	"prognostic unfavorable (3.61e-9)"	"unprognostic (5.28e-3)"	"unprognostic (2.15e-2)"	"unprognostic (1.08e-2)"	"unprognostic (5.34e-2)"	"prognostic unfavorable (3.67e-4)"	"unprognostic (6.53e-3)"	"unprognostic (1.59e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.63e-1)"	"unprognostic (7.21e-2)"	64.0	69.9	56.8	77.7	61.3	140.5	85.5	62.4	70.6	51.9	68.4	70.6	53.2	66.9	43.7	69.4	69.5	54.7	68.6	60.6	64.4	92.9	72.2	46.6	94.9	62.4	59.5	65.2	53.3	71.6	37.8	70.2	62.5	57.9	85.9	57.5	45.4	52.5	103.9	55.9	51.5	83.3	62.2	51.5	52.0	216.0	59.8	100.7	56.1	73.2	108.8	106.6	49.6	63.8	266.1	388.1	343.8	330.7	154.2	174.5	392.3	280.4	203.8	448.0	276.1	529.7	121.7	572.6	266.2	222.9	281.8	250.2	538.2	313.0	536.6	319.1	398.6	418.7	313.5	331.8	171.8	520.1	255.5	152.7	195.3	425.9	248.1	308.7	296.4	311.4	519.2	165.0	410.2	378.9	496.0	446.7	482.4	273.2	403.7	389.3	375.9	373.1	369.4	476.9	334.1	281.3	291.0	314.2	289.2	284.3	411.4	371.6	196.0	231.4	292.2	275.0	427.3	203.5	409.6	614.6	201.9	354.8	290.8	36.6	41.0	12.5	47.3	66.0	72.7	74.2	54.0	61.5	72.9	60.7	62.2	68.5	3.7	65.3	62.1	66.9	63.7	70.0	56.8	61.3	62.4	70.6	60.6	64.4	62.4	59.5	62.5	62.2	59.8	63.8	80.4	35.3	47.4	17.3	97.2	136.6	233.9	173.8	126.3	51.1	70.1	89.7	81.5	57.2	110.8	80.9	79.2	189.1	93.3	48.1	92.0	198.8	1471.3	150.9	126.5	95.3	106.2	226.4	21.5	128.4	209.1	102.1	60.6	107.1	105.4	112.3	52.5	46.2	127.1	42.1	31.3	94.4	109.9	44.3	74.9	430.3	76.7	70.5	46.2	11.2	87.7	67.9	57.7	21.6	20.6	150.7	50.8	66.5	100.7	165.8	34.4	127.4	127.5	56.6	85.5	128.4	178.3	625.4	391.5	112.1	117.3	153.4	93.9	154.1	154.8	161.9
CCT4	Cctd	ENSG00000115484	"Chaperonin containing TCP1 subunit 4"	P50991	2	61868085-61888671	"Plasma proteins, Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029349	Supported		Supported	Nucleoplasm,Cytosol		NA	NA		1700000	"Cluster 44: Non-specific - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Cytosol	Nucleoplasm	"HPA029349: AB_10600800"	"prognostic unfavorable (2.03e-4)"	"unprognostic (2.80e-2)"	"unprognostic (6.46e-2)"	"unprognostic (1.74e-3)"	"unprognostic (5.03e-2)"	"unprognostic (1.40e-2)"	"prognostic unfavorable (9.37e-12)"	"unprognostic (1.28e-3)"	"unprognostic (2.48e-1)"	"unprognostic (1.56e-1)"	"unprognostic (4.88e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.10e-2)"	"unprognostic (5.18e-2)"	"unprognostic (2.00e-1)"	"unprognostic (3.96e-1)"	"unprognostic (2.14e-2)"	66.4	67.0	60.4	59.9	62.6	64.9	90.2	67.1	114.9	68.4	66.7	65.1	45.8	68.7	50.8	75.6	74.4	43.1	67.0	62.3	65.7	73.5	63.7	48.7	81.4	63.9	62.6	109.3	95.3	62.8	45.9	65.8	66.1	57.8	58.9	56.8	53.7	57.5	96.7	66.4	48.5	72.0	70.4	55.3	64.5	77.6	66.0	83.3	65.3	74.0	92.0	68.4	61.2	80.0	274.5	313.6	203.1	190.1	166.2	251.5	342.5	244.6	174.3	345.6	230.4	550.5	193.2	437.9	239.7	176.5	354.6	192.4	405.8	313.9	362.3	216.0	398.9	280.4	149.4	347.7	149.3	347.8	179.1	215.0	214.4	278.8	287.2	259.5	293.3	220.0	406.5	137.2	297.5	246.4	299.6	451.2	365.3	364.2	276.0	336.9	319.2	297.4	237.5	186.2	177.6	148.8	177.2	221.9	324.5	235.7	161.9	245.6	185.2	190.6	275.5	143.3	400.1	205.3	297.3	739.8	188.9	391.7	255.7	58.2	60.7	25.0	83.2	88.9	106.9	93.6	87.1	100.8	100.4	88.6	112.9	112.2	8.4	107.5	103.3	64.3	100.7	125.2	60.4	62.6	67.1	114.9	62.3	65.7	63.9	62.6	66.1	70.4	66.0	80.0	111.8	73.7	54.3	20.9	125.4	152.6	350.8	206.6	136.1	52.9	131.3	136.4	47.7	82.9	116.7	73.5	14.6	256.5	106.5	52.8	135.0	156.0	250.0	111.9	117.2	118.0	140.6	156.9	28.0	130.6	284.9	114.9	67.8	92.8	95.8	148.2	95.3	79.4	163.5	32.0	31.3	105.9	175.0	105.0	112.4	72.1	88.3	110.2	94.3	30.0	125.8	64.9	71.1	26.7	40.8	143.9	61.4	97.8	111.9	200.3	67.9	165.2	143.1	63.3	92.1	117.2	297.8	338.8	153.2	151.2	151.3	180.6	146.6	173.7	138.2	203.8
CCT8	"C21orf112, Cctq, PRED71"	ENSG00000156261	"Chaperonin containing TCP1 subunit 8"	P50990	21	29055805-29073797	"Plasma proteins, Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018520, HPA021051, HPA029426"	Enhanced		Approved	"Nucleoplasm,Intermediate filaments,Cytosol"		No	No		1100000	"Cluster 44: Non-specific - Transcription"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 36: HEL - Hemostasis"	"Cluster 10: Non-specific - Unknown function"	"Intermediate filaments"	"Nucleoplasm, Cytosol"	"HPA018520: AB_1846204, HPA021051: AB_1846205, HPA029426: AB_10601796"	"unprognostic (3.41e-3)"	"unprognostic (2.75e-2)"	"unprognostic (2.40e-3)"	"unprognostic (1.62e-1)"	"unprognostic (1.25e-1)"	"unprognostic (4.25e-3)"	"prognostic unfavorable (1.56e-5)"	"unprognostic (8.78e-2)"	"unprognostic (1.37e-1)"	"unprognostic (3.09e-1)"	"unprognostic (1.02e-2)"	"unprognostic (2.91e-1)"	"unprognostic (3.01e-2)"	"unprognostic (8.26e-2)"	"unprognostic (3.50e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.57e-1)"	72.7	125.0	62.5	99.1	67.0	99.5	100.4	70.3	84.0	78.5	78.0	87.9	77.9	74.8	88.2	83.7	80.9	64.3	116.3	66.9	74.7	102.7	92.7	70.1	140.8	64.5	65.3	88.0	95.3	100.0	40.6	107.0	69.0	77.1	102.1	71.3	70.7	72.5	121.1	75.0	78.6	85.5	66.7	88.9	68.8	79.1	68.7	141.2	78.5	145.2	154.3	122.3	50.3	66.1	437.4	243.1	319.4	233.3	220.4	302.3	350.9	340.5	219.1	386.2	317.5	548.6	269.0	858.8	229.1	237.1	466.8	174.4	632.2	391.7	441.1	364.0	348.1	1185.2	289.8	384.3	227.0	609.0	335.6	229.0	244.9	448.6	372.6	278.6	368.1	379.7	935.8	519.0	404.1	270.9	456.6	359.4	572.6	433.6	310.6	411.7	596.5	547.4	409.1	283.2	316.7	231.6	334.1	356.6	364.7	347.5	319.9	526.7	267.4	221.3	613.7	216.7	439.7	329.2	651.8	695.1	256.3	704.5	339.0	79.9	110.1	54.4	56.9	120.9	79.6	79.8	76.3	73.4	133.3	61.8	85.5	82.1	11.5	87.7	132.2	83.5	92.7	127.4	62.5	67.0	70.3	84.0	66.9	74.7	64.5	65.3	69.0	66.7	68.7	66.1	66.9	64.1	61.7	15.0	120.1	143.1	197.6	278.6	70.0	85.6	88.4	76.5	75.7	90.1	150.0	75.4	18.8	268.9	122.1	67.3	144.8	194.1	17.0	106.6	92.8	94.8	97.0	150.2	26.7	138.0	275.8	93.4	52.0	73.7	112.8	135.6	55.3	53.4	170.5	77.4	31.3	106.2	201.4	115.6	122.4	20.5	84.2	109.9	115.6	26.2	226.6	96.1	97.9	13.6	21.4	131.2	92.1	92.9	130.7	185.9	107.4	189.7	147.7	84.6	105.2	88.7	214.7	170.1	176.8	90.2	131.4	285.3	105.1	254.5	161.1	170.6
CD109	"CPAMD7, DKFZp762L1111, FLJ38569"	ENSG00000156535	"CD109 molecule"	Q6YHK3	6	73695785-73828316	"CD markers, Plasma proteins, Predicted membrane proteins"		"Protease inhibitor, Serine protease inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	17	"parathyroid gland: 330.4"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 65.3;Basal respiratory cells: 62.8;Hofbauer cells: 45.0;Squamous epithelial cells: 51.4;Suprabasal keratinocytes: 43.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 206.4;BJ hTERT+: 126.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA008992, HPA015723"	Enhanced		Supported	"Plasma membrane,Cytosol"		NA	NA		180000000		"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Plasma membrane"	Cytosol	"HPA008992: , HPA015723: AB_2732415"	"unprognostic (2.28e-1)"	"unprognostic (1.03e-1)"	"unprognostic (7.76e-2)"	"unprognostic (1.52e-2)"	"unprognostic (9.17e-3)"	"unprognostic (1.36e-1)"	"unprognostic (1.03e-3)"	"unprognostic (1.23e-3)"	"unprognostic (7.49e-2)"	"unprognostic (2.47e-1)"	"unprognostic (1.15e-3)"	"unprognostic (8.81e-2)"	"prognostic unfavorable (2.65e-4)"	"prognostic unfavorable (7.96e-5)"	"unprognostic (9.50e-2)"	"unprognostic (2.02e-1)"	"prognostic unfavorable (4.68e-4)"	8.6	1.1	2.3	2.4	2.5	2.8	5.5	2.1	2.1	9.9	0.7	6.9	1.3	12.5	5.6	10.2	3.2	4.1	5.8	2.0	4.0	7.0	1.1	6.6	1.0	3.2	3.6	0.7	0.5	330.4	0.4	6.5	3.5	3.6	2.9	0.2	3.4	2.5	1.2	18.9	2.2	12.6	3.7	2.1	1.1	1.8	2.5	3.1	1.3	3.3	2.2	4.5	7.4	3.1	35.6	29.4	1.5	0.1	48.2	206.4	0.0	30.5	126.0	9.0	18.4	0.1	20.2	0.0	19.7	63.5	19.5	96.5	3.5	60.9	12.1	8.5	5.5	11.5	21.0	5.8	10.1	0.0	0.3	60.7	52.4	18.6	68.7	34.2	71.6	3.9	0.0	0.2	45.0	0.8	0.8	0.0	2.4	0.3	18.9	2.6	8.4	40.6	4.8	3.6	0.0	0.1	68.6	0.7	30.8	1.3	0.8	5.8	68.7	96.8	10.1	17.2	28.5	0.7	17.9	0.1	40.3	0.1	89.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.1	0.0	0.2	0.0	0.0	2.3	2.5	2.1	2.1	2.0	4.0	3.2	3.6	3.5	3.7	2.5	3.1	65.3	3.2	1.7	39.8	1.1	41.4	8.4	62.8	35.9	0.3	2.2	2.2	13.0	0.0	16.3	0.0	0.0	0.4	1.2	0.1	1.9	0.1	23.4	10.8	10.5	38.0	0.0	7.6	4.0	0.0	0.5	25.0	0.5	15.0	2.5	0.0	21.0	0.6	45.0	0.0	3.3	0.1	4.1	2.7	28.5	21.0	0.6	13.5	23.2	19.7	3.3	0.0	0.0	1.5	1.0	0.4	0.0	0.0	1.7	10.8	0.0	23.5	16.0	0.2	0.0	7.4	13.2	1.0	3.5	51.4	43.8	1.4	4.6	1.4	0.2	7.2
CD163	"M130, MM130, SCARI1"	ENSG00000177575	"CD163 molecule"	Q86VB7	12	7470811-7503893	"CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Acute phase, Inflammatory response"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 240.5"	"Cell type enriched"	"Detected in many"	4	"Kupffer cells: 1756.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	11	"classical monocyte: 76.1;myeloid DC: 65.2"	"Group enriched"	"Detected in many"	40	"dendritic cells: 65.2;monocytes: 76.1"	"Cell line enhanced"	"Detected in some"		"GAMG: 1.8;HSkMC: 1.7"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"CAB002432, HPA046404, HPA051974"	Enhanced		Supported	"Plasma membrane"	"Secreted to blood"	NA	NA	903000000	1600000000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 64: Macrophages - Immune response"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 4: Macrophages - Innate immune response"	"Plasma membrane"		"CAB002432: AB_563510, HPA046404: AB_2679655, HPA051974: AB_2681678"	"unprognostic (1.13e-1)"	"unprognostic (2.13e-1)"	"unprognostic (5.02e-3)"	"unprognostic (2.72e-1)"	"unprognostic (6.17e-3)"	"unprognostic (2.09e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.21e-1)"	"unprognostic (2.78e-1)"	"prognostic unfavorable (7.27e-4)"	"unprognostic (1.04e-1)"	"unprognostic (6.50e-2)"	"unprognostic (1.84e-2)"	"unprognostic (8.77e-2)"	"unprognostic (4.95e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.20e-2)"	171.8	85.6	6.1	152.5	7.0	17.6	50.8	5.2	18.4	25.6	21.5	48.7	12.4	27.3	3.6	16.4	68.1	43.5	52.7	4.9	7.9	27.3	89.7	131.7	54.4	15.8	10.9	23.1	21.4	8.8	11.4	109.4	18.0	15.5	21.6	4.3	25.9	7.2	11.4	15.3	52.9	130.4	7.2	240.5	35.6	9.7	55.9	18.7	17.2	17.6	7.2	68.5	16.3	10.3	0.0	0.0	0.0	0.0	0.6	0.3	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	1.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	1.7	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.3	76.1	0.5	0.1	6.4	0.0	0.0	0.0	0.1	65.2	0.0	0.0	0.0	1.7	0.0	0.0	1.0	0.1	20.1	6.1	7.0	5.2	18.4	4.9	7.9	15.8	10.9	18.0	7.2	55.9	10.3	2.7	3.2	8.3	0.0	3.8	1.5	0.2	0.0	0.0	0.1	0.1	0.3	4.6	7.2	5.0	0.0	2.1	1.5	0.5	0.0	0.0	0.0	4.3	0.0	0.1	13.9	0.0	3.6	0.4	0.0	1.9	3.0	0.5	0.0	5.1	0.1	17.9	13.9	269.9	0.0	0.5	0.0	0.0	1756.1	30.9	6.4	5.0	387.9	0.0	2.8	41.1	0.9	1.0	0.0	0.0	0.0	0.0	1.2	1.0	0.1	0.0	0.2	1.6	0.2	118.3	1.7	4.0	3.9	2.6	0.5	1.0	3.0	1.3	0.0	0.0	0.1
CD180	"LY64, Ly78, RP105"	ENSG00000134061	"CD180 molecule"	Q99467	5	67179613-67196799	"CD markers, Predicted membrane proteins"	"Immunity, Inflammatory response, Innate immunity"	Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 23.3"	"Cell type enhanced"	"Detected in some"		"B-cells: 53.6;Hofbauer cells: 78.6;Kupffer cells: 23.5;Macrophages: 17.5;monocytes: 13.8;Plasma cells: 39.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"memory B-cell: 77.0;naive B-cell: 78.9"	"Group enriched"	"Detected in many"	25	"B-cells: 78.9;dendritic cells: 23.5;monocytes: 34.5"	"Group enriched"	"Detected in some"	10	"Daudi: 45.2;Karpas-707: 41.1;U-266/70: 33.1;U-266/84: 49.0;U-698: 12.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA003740	Enhanced		Approved	"Nucleoplasm,Nucleoli,Plasma membrane,Mitotic spindle"		Yes	NA			"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 16: Immune cells - Immune response"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 57: B-cells - Immune response"	"Plasma membrane"	"Nucleoplasm, Nucleoli, Mitotic spindle"	"HPA003740: AB_1078450"	"unprognostic (9.33e-2)"	"unprognostic (4.58e-2)"	"unprognostic (2.81e-3)"	"unprognostic (5.85e-3)"	"unprognostic (2.25e-2)"	"unprognostic (4.04e-3)"	"unprognostic (1.09e-1)"	"unprognostic (4.95e-2)"	"unprognostic (5.83e-2)"	"unprognostic (3.71e-1)"	"unprognostic (2.16e-1)"	"unprognostic (1.46e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.16e-1)"	"unprognostic (3.70e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.18e-2)"	1.6	0.7	0.7	9.7	0.7	2.4	6.7	0.6	1.2	0.5	0.4	2.1	2.0	0.5	0.2	0.4	0.4	1.6	0.4	0.8	0.7	0.3	2.5	1.6	23.2	1.5	1.5	0.2	0.3	0.2	0.1	3.2	2.0	0.5	2.7	0.3	1.1	0.4	0.1	0.2	3.9	1.8	1.0	12.9	2.2	0.4	1.8	2.5	0.3	0.2	23.3	3.0	0.1	2.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	45.2	0.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	41.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.2	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.1	0.6	0.2	33.1	49.0	12.3	0.0	2.7	0.0	0.3	11.8	0.9	0.0	20.4	0.0	77.0	0.1	0.1	22.1	78.9	0.0	0.0	0.9	1.8	34.5	23.5	0.1	8.5	0.7	0.7	0.6	1.2	0.8	0.7	1.5	1.5	2.0	1.0	1.8	2.1	0.1	0.0	0.5	0.3	53.6	0.4	0.1	0.0	0.0	0.1	1.8	1.1	0.7	1.5	0.0	0.0	0.0	0.4	4.0	0.0	0.0	0.0	2.2	0.1	0.0	0.6	0.0	1.7	0.0	0.2	0.3	0.4	0.0	0.1	2.5	0.0	0.0	0.3	78.6	0.0	0.0	0.0	0.0	23.5	8.0	1.0	0.0	17.5	0.0	1.9	13.8	0.1	0.0	0.0	0.0	0.3	0.0	0.0	39.6	0.0	0.0	0.1	0.7	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.7	2.2	0.0	0.1	0.1
CD1C	CD1	ENSG00000158481	"CD1c molecule"	P29017	1	158289923-158294774	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	11	"lymphoid tissue: 130.4"	"Cell type enriched"	"Detected in some"	6	"Langerhans cells: 551.4"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	4	"memory B-cell: 84.1;myeloid DC: 324.9"	"Group enriched"	"Detected in many"	8	"B-cells: 84.1;dendritic cells: 324.9"	"Group enriched"	"Detected in some"	10	"JURKAT: 14.8;MOLT-4: 49.4"									HPA068359			Approved	"Endoplasmic reticulum,Golgi apparatus,Vesicles"		NA	NA		200000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 41: Macrophages - Immune response"	"Golgi apparatus, Vesicles"	"Endoplasmic reticulum"	"HPA068359: "	"unprognostic (2.55e-3)"	"prognostic favorable (1.79e-5)"	"unprognostic (1.75e-5)"	"unprognostic (3.09e-5)"	"unprognostic (3.12e-2)"	"unprognostic (8.13e-3)"	"unprognostic (2.01e-1)"	"unprognostic (3.80e-3)"	"unprognostic (7.11e-3)"	"unprognostic (1.87e-1)"	"unprognostic (7.41e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.67e-1)"	"unprognostic (8.05e-2)"	"unprognostic (1.99e-1)"	2.7	0.8	0.0	17.3	0.0	1.1	5.0	0.0	0.2	2.3	0.0	3.4	2.0	2.4	0.6	4.5	1.8	7.7	2.0	0.0	0.0	1.2	4.1	6.5	26.2	0.0	0.0	0.9	0.7	0.6	0.2	0.1	0.0	1.8	9.4	0.0	2.8	1.3	1.0	12.2	12.0	3.1	0.0	23.0	3.7	0.9	0.0	130.4	0.7	1.1	38.2	4.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.8	0.0	0.0	0.0	0.0	49.4	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.9	0.0	0.6	26.8	0.1	0.1	24.7	0.3	84.1	0.1	0.0	324.9	49.1	0.2	0.0	1.1	4.1	3.7	1.5	0.5	15.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	5.2	0.0	26.6	13.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	4.1	0.0	0.1	1.5	0.0	0.8	0.0	0.0	0.1	1.4	0.0	0.0	3.8	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	7.1	551.4	4.5	0.0	91.2	19.6	0.0	11.8	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.1	1.5	0.0	0.0	0.2	0.4	0.1	0.3	0.0	7.4	0.0	1.9	0.0	0.0	0.0
CD1D		ENSG00000158473	"CD1d molecule"	P15813	1	158178030-158186427	"Cancer-related genes, CD markers, Predicted membrane proteins"	"Immunity, Innate immunity"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"intestine: 18.2;liver: 15.3;lymphoid tissue: 23.9"	"Cell type enhanced"	"Detected in many"		"B-cells: 22.2;Kupffer cells: 54.6;Macrophages: 40.8;monocytes: 45.4"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	6	"classical monocyte: 139.0;intermediate monocyte: 63.8;myeloid DC: 139.3"	"Group enriched"	"Detected in many"	8	"dendritic cells: 139.3;monocytes: 139.0"	"Cell line enhanced"	"Detected in some"		"HHSteC: 10.2;JURKAT: 49.4;MOLT-4: 13.6;THP-1: 8.8"					"Low region specificity"	"Detected in all"			"CAB016107, HPA072662"	Enhanced		Supported	"Endoplasmic reticulum"		NA	NA		880000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 64: Macrophages - Immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 57: B-cells - Immune response"	"Endoplasmic reticulum"		"CAB016107: AB_626960, HPA072662: AB_2686545"	"unprognostic (8.67e-2)"	"unprognostic (6.99e-2)"	"unprognostic (2.48e-1)"	"unprognostic (1.48e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.42e-1)"	"unprognostic (3.85e-1)"	"unprognostic (9.67e-3)"	"unprognostic (2.37e-1)"	"unprognostic (3.52e-1)"	"unprognostic (2.23e-2)"	"unprognostic (4.46e-2)"	"prognostic unfavorable (2.12e-5)"	"unprognostic (9.31e-3)"	"unprognostic (2.35e-1)"	"unprognostic (2.32e-2)"	"unprognostic (3.38e-1)"	2.7	2.0	0.1	7.5	0.2	3.1	2.0	0.1	0.4	1.5	0.7	4.4	7.4	2.2	0.5	0.8	2.1	1.8	3.3	0.1	0.2	2.2	15.3	3.4	4.7	0.3	0.2	0.6	1.9	0.3	1.0	0.4	0.3	2.2	2.9	0.3	1.1	0.7	1.1	0.3	18.2	2.3	0.1	23.9	2.3	2.5	0.2	9.4	2.7	0.6	3.0	1.8	1.0	0.4	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	2.3	0.0	0.0	3.5	0.0	6.0	0.0	0.0	0.1	0.2	0.0	0.0	10.2	0.1	0.0	3.9	0.6	0.0	0.7	0.0	0.0	49.4	0.0	0.0	0.0	0.0	13.6	1.4	0.6	0.0	0.0	0.0	0.0	0.0	0.7	0.0	1.2	0.0	0.0	0.0	0.0	0.1	0.0	8.8	0.0	0.0	2.0	0.0	0.0	0.3	0.0	0.3	0.0	3.7	0.4	0.2	139.0	0.4	0.2	63.8	0.5	17.6	0.1	0.1	139.3	13.4	0.1	0.0	7.2	0.3	11.0	1.4	0.2	80.7	0.1	0.2	0.1	0.4	0.1	0.2	0.3	0.2	0.3	0.1	0.2	0.4	9.4	0.0	3.6	0.0	22.2	0.3	0.5	0.8	0.6	0.7	0.1	0.9	0.7	2.8	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.4	5.6	0.4	2.0	2.4	2.4	1.7	0.0	0.0	0.2	0.5	0.0	0.3	1.3	0.1	3.3	6.3	11.3	1.7	0.2	2.0	0.0	54.6	0.8	2.1	0.0	40.8	0.0	0.0	45.4	0.6	1.0	0.0	0.0	0.0	6.4	0.0	3.7	0.1	7.3	0.1	0.0	0.3	0.0	1.2	0.4	1.0	2.1	0.0	0.1	0.1	0.6	0.1	4.5	0.1
CD1E		ENSG00000158488	"CD1e molecule"	P15812	1	158353696-158357553	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	69	"lymphoid tissue: 962.6"	"Cell type enriched"	"Detected in some"	13	"Langerhans cells: 549.5"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in some"	14	"myeloid DC: 62.5"	"Lineage enriched"	"Detected in many"	14	"dendritic cells: 62.5"	"Cell line enriched"	"Detected in some"	43	"MOLT-4: 1276.2"					"Not detected"	"Not detected"			"HPA057769, HPA070634"	Uncertain		Supported	"Nucleoli,Golgi apparatus"	"Intracellular and membrane"	NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 63: T-cells - Adaptive immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 41: Macrophages - Immune response"	"Golgi apparatus"	Nucleoli	"HPA057769: AB_2683522, HPA070634: "	"unprognostic (7.94e-3)"	"unprognostic (1.85e-5)"	"unprognostic (1.47e-2)"	"unprognostic (1.64e-2)"	"unprognostic (1.76e-2)"	"unprognostic (1.29e-2)"	"unprognostic (2.33e-1)"	"unprognostic (1.54e-3)"	"unprognostic (1.24e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.60e-1)"	"unprognostic (8.55e-2)"	"unprognostic (1.69e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.49e-1)"	"unprognostic (8.50e-2)"	"unprognostic (2.45e-1)"	0.7	0.5	0.0	4.4	0.0	0.0	1.8	0.0	0.0	2.1	0.0	2.1	2.2	1.1	0.4	7.9	0.9	4.8	1.0	0.0	0.0	0.8	1.5	3.1	6.4	0.0	0.0	0.6	0.3	0.5	0.1	0.0	0.0	1.1	5.6	0.0	1.5	0.6	0.4	13.9	2.8	0.9	0.0	5.1	4.7	0.5	0.0	962.6	0.8	0.2	9.9	2.8	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	29.8	0.1	0.0	0.0	0.5	1276.2	0.0	0.3	0.0	0.0	0.6	0.0	0.3	0.0	0.0	0.8	0.0	0.0	0.9	0.0	0.0	0.4	0.0	0.0	0.0	0.3	0.2	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.1	2.5	0.2	0.0	0.0	0.0	62.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	3.2	0.5	0.0	0.8	8.4	0.0	0.0	0.6	0.0	0.1	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.7	0.0	1.3	0.0	0.0	0.0	0.7	0.0	0.0	1.3	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	4.8	549.5	0.0	0.0	41.7	8.8	0.0	6.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.5	0.0	7.1	0.1	0.7	0.0	0.0	0.0
CD2	SRBC	ENSG00000116824	"CD2 molecule"	P06729	1	116754430-116769229	"CD markers, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"lymphoid tissue: 249.8"	"Group enriched"	"Detected in many"	6	"dendritic cells: 158.3;NK-cells: 178.2;T-cells: 476.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in all"	6	"gdT-cell: 421.8;MAIT T-cell: 403.1;memory CD4 T-cell: 610.2;memory CD8 T-cell: 714.1;naive CD4 T-cell: 316.3;naive CD8 T-cell: 486.2;NK-cell: 1108.0;T-reg: 655.2"	"Group enriched"	"Detected in all"	10	"NK-cells: 1108.0;T-cells: 714.1"	"Group enriched"	"Detected in some"	25	"HDLM-2: 224.1;JURKAT: 145.8;MOLT-4: 166.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB002430, HPA003883"	Enhanced		Supported	"Nucleoplasm,Golgi apparatus,Plasma membrane"		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 24: Non-specific - Transcription regulation"	"Plasma membrane"	"Nucleoplasm, Golgi apparatus"	"CAB002430: AB_442057, HPA003883: AB_1846263"	"prognostic favorable (4.36e-4)"	"prognostic favorable (1.47e-4)"	"unprognostic (3.34e-3)"	"prognostic favorable (1.69e-5)"	"unprognostic (1.52e-1)"	"prognostic favorable (7.46e-5)"	"unprognostic (9.32e-3)"	"unprognostic (1.61e-2)"	"prognostic favorable (3.97e-5)"	"prognostic favorable (7.72e-4)"	"unprognostic (4.18e-2)"	"unprognostic (3.31e-1)"	"prognostic unfavorable (4.82e-6)"	"unprognostic (6.16e-2)"	"unprognostic (6.61e-2)"	"unprognostic (2.73e-2)"	"unprognostic (7.63e-3)"	4.6	4.6	0.6	51.3	0.7	11.4	7.6	0.6	1.0	5.8	0.8	13.9	17.2	3.7	2.8	8.4	4.2	16.8	2.6	0.5	0.8	2.5	7.8	21.0	119.6	1.7	0.7	2.8	2.9	0.9	0.7	1.0	1.1	5.2	16.0	0.0	8.6	2.3	1.4	3.5	28.4	4.4	1.0	44.1	24.1	1.8	1.0	249.8	3.8	1.7	79.1	20.8	3.2	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	224.1	0.0	0.4	0.0	0.0	0.0	0.4	7.2	0.0	0.0	0.0	0.0	0.0	0.0	145.8	0.1	0.5	0.0	0.0	166.9	0.2	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.8	0.4	0.0	11.3	5.2	1.6	421.8	3.7	403.1	3.8	610.2	714.1	95.4	2.5	316.3	486.2	14.1	1108.0	2.8	21.0	655.2	565.1	0.6	0.7	0.6	1.0	0.5	0.8	1.7	0.7	1.1	1.0	1.0	1.1	5.0	3.2	17.5	0.0	12.3	5.0	0.4	0.0	2.2	0.0	4.0	4.7	2.1	0.0	2.5	3.7	0.0	0.1	158.3	0.2	0.0	0.5	23.5	1.1	1.0	2.9	3.0	24.0	0.0	0.0	0.0	2.5	10.7	0.9	5.1	0.0	8.2	1.5	0.6	0.0	0.0	0.0	0.0	10.9	16.6	7.8	0.6	19.1	1.8	1.0	15.5	0.0	178.2	0.0	0.0	0.0	0.0	0.4	42.3	0.1	0.0	1.7	0.0	0.0	0.0	2.9	4.1	0.3	0.2	0.4	3.7	0.0	476.8	0.0	0.5	0.2
CD200R1	"CD200R, HCRTR2, MOX2R, OX2R"	ENSG00000163606	"CD200 receptor 1"	Q8TD46	3	112921205-112975103	"Predicted intracellular proteins, Predicted membrane proteins"	"Host-virus interaction"	Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 7.9"	"Cell type enhanced"	"Detected in some"		"Basal squamous epithelial cells: 14.8;granulocytes: 15.2;Hepatic stellate cells: 14.6;Hofbauer cells: 31.8;Langerhans cells: 19.9;T-cells: 12.4"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in many"	4	"basophil: 234.9"	"Lineage enriched"	"Detected in all"	10	"granulocytes: 234.9"	"Cell line enriched"	"Detected in some"	8	"HEL: 25.5"									HPA068512			Supported	"Plasma membrane"	"Intracellular and membrane"	NA	NA		2000000	"Cluster 46: Basophils - DNA binding"	"Cluster 16: Immune cells - Immune response"	"Cluster 36: HEL - Hemostasis"	"Cluster 4: Macrophages - Innate immune response"	"Plasma membrane"		"HPA068512: AB_2732784"	"unprognostic (1.49e-2)"	"unprognostic (1.06e-2)"	"unprognostic (2.55e-1)"	"unprognostic (1.97e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.24e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.06e-3)"	"unprognostic (8.30e-2)"	"unprognostic (1.85e-1)"	"unprognostic (7.98e-2)"	"unprognostic (2.46e-1)"	"unprognostic (1.08e-5)"	"unprognostic (1.77e-1)"	"unprognostic (7.84e-3)"	"unprognostic (1.25e-1)"	"unprognostic (5.12e-3)"	1.7	1.2	0.3	3.0	0.4	1.7	1.4	0.2	0.6	0.7	0.7	1.5	1.6	0.7	0.3	3.8	0.5	1.9	0.6	0.4	0.3	0.5	2.4	1.9	4.4	0.3	0.2	0.3	0.5	0.5	0.2	5.3	0.3	0.6	2.3	0.1	0.6	0.7	0.1	2.6	2.0	1.1	0.2	7.9	1.5	0.7	0.2	3.4	0.5	0.9	4.6	1.9	0.5	0.2	0.7	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.6	0.9	0.3	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.3	25.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.2	0.0	0.1	0.2	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.2	0.0	0.0	0.1	0.0	0.0	0.1	0.8	0.0	0.0	1.2	0.0	234.9	2.9	53.6	4.0	1.3	7.0	9.9	13.8	7.9	22.9	5.6	13.4	6.1	0.8	2.5	0.4	0.5	4.3	5.2	0.3	0.4	0.2	0.6	0.4	0.3	0.3	0.2	0.3	0.2	0.2	0.2	0.2	0.0	1.1	1.6	4.4	1.9	0.1	0.0	14.8	0.0	0.2	0.3	0.3	0.0	0.1	0.0	0.0	0.3	1.9	0.0	0.0	0.0	0.1	1.0	0.1	0.5	0.0	4.0	5.7	0.0	0.2	0.9	0.0	0.1	15.2	0.0	14.6	0.1	31.8	0.0	2.2	0.0	0.0	6.7	19.9	0.0	0.0	9.1	5.4	5.6	5.2	0.0	0.0	1.0	0.7	0.1	0.0	0.0	2.7	0.1	0.0	0.1	1.2	0.0	0.0	0.3	0.4	0.8	0.3	5.8	0.9	0.7	12.4	0.0	0.0	0.2
CD226	"DNAM-1, DNAM1, PTA1, TLiSA1"	ENSG00000150637	"CD226 molecule"	Q15762	18	69831158-69961803	"CD markers, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"	Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"lymphoid tissue: 20.2;parathyroid gland: 62.4"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 52.1;Macrophages: 24.4;Microglial cells: 22.5;NK-cells: 90.6;Oligodendrocytes: 26.6;T-cells: 43.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	7	"gdT-cell: 36.6;MAIT T-cell: 13.4;memory CD4 T-cell: 28.8;memory CD8 T-cell: 22.5;naive CD4 T-cell: 15.8;naive CD8 T-cell: 17.3;NK-cell: 29.7;T-reg: 11.3"	"Group enriched"	"Detected in many"	11	"NK-cells: 29.7;T-cells: 36.6"	"Group enriched"	"Detected in some"	6	"HEL: 100.0;HMC-1: 42.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"HPA015715, HPA015865"	Supported		Supported	"Nucleoplasm,Plasma membrane,Centriolar satellite"		NA	No		20000000	"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 36: HEL - Hemostasis"	"Cluster 63: NK-cells & T-cells - Immune response"	"Plasma membrane"	"Nucleoplasm, Centriolar satellite"	"HPA015715: AB_1846278, HPA015865: "	"unprognostic (1.42e-4)"	"unprognostic (1.30e-3)"	"unprognostic (9.01e-3)"	"unprognostic (3.49e-5)"	"unprognostic (4.15e-1)"	"unprognostic (9.52e-4)"	"unprognostic (3.68e-3)"	"unprognostic (2.93e-2)"	"unprognostic (3.43e-1)"	"unprognostic (3.31e-3)"	"unprognostic (8.36e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.72e-3)"	"unprognostic (2.20e-1)"	"unprognostic (3.91e-2)"	"unprognostic (2.27e-1)"	"unprognostic (3.58e-2)"	1.1	0.6	1.1	5.7	6.4	4.4	1.5	1.5	2.4	1.1	0.0	1.8	2.3	1.3	0.5	1.6	1.3	3.0	0.5	0.7	2.0	1.5	4.2	4.2	9.7	3.1	3.3	0.9	0.5	62.4	0.6	0.5	3.2	1.0	2.4	1.4	1.5	0.4	0.7	0.3	3.1	1.6	2.2	20.2	3.2	1.2	5.5	6.4	0.7	0.6	7.1	3.1	0.4	3.2	0.0	0.1	0.3	0.3	0.0	0.0	0.1	0.6	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.2	0.1	0.2	0.2	0.4	0.2	5.3	0.1	100.0	0.3	0.1	0.0	0.7	42.6	0.0	1.1	0.2	0.6	0.2	0.0	0.9	0.3	9.3	0.4	0.0	0.8	0.4	0.0	0.0	0.4	0.1	0.0	0.2	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.3	0.0	0.1	0.5	0.8	0.3	0.1	0.2	11.5	0.4	0.0	0.3	0.2	0.5	0.3	0.1	1.2	36.6	1.0	13.4	0.8	28.8	22.5	2.9	0.1	15.8	17.3	1.6	29.7	1.3	0.1	11.3	13.2	1.1	6.4	1.5	2.4	0.7	2.0	3.1	3.3	3.2	2.2	5.5	3.2	0.6	3.2	3.6	3.3	3.2	0.0	0.3	0.0	0.0	3.4	0.5	0.8	2.5	0.0	0.7	0.0	0.0	0.1	52.1	0.2	0.0	0.0	8.4	0.9	1.7	1.0	0.0	3.2	4.6	0.4	0.0	1.3	3.1	0.5	13.9	1.3	3.3	0.4	1.6	0.0	3.1	0.1	0.0	16.7	2.7	8.2	0.9	24.4	0.0	22.5	14.7	0.8	90.6	2.0	26.6	0.2	0.1	0.7	13.4	0.3	0.0	0.3	1.5	3.6	0.0	1.8	0.6	0.4	0.8	0.0	0.4	0.0	43.2	0.5	0.1	0.2
CD274	"B7-H, B7-H1, B7H1, PD-L1, PDCD1LG1, PDL1"	ENSG00000120217	"CD274 molecule"	Q9NZQ7	9	5450503-5470566	"Cancer-related genes, CD markers, Disease related genes, FDA approved drug targets, Predicted membrane proteins"	"Adaptive immunity, Immunity"	Receptor	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 16.8"	"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 27.7;granulocytes: 28.4;Langerhans cells: 50.9;monocytes: 42.4;Syncytiotrophoblasts: 44.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"basophil: 6.6"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 6.6"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 89.6;HHSteC: 55.5;U-251 MG: 98.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA003528, CAB076385"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Actin filaments"		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 3: Monocytes - Immune response regulation"	"Plasma membrane, Actin filaments"	Nucleoplasm	"CAB076385: AB_2687655, HPA003528: "	"prognostic favorable (8.89e-4)"	"unprognostic (4.54e-2)"	"prognostic favorable (1.64e-5)"	"unprognostic (1.27e-2)"	"unprognostic (2.96e-2)"	"unprognostic (1.08e-1)"	"unprognostic (4.61e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.68e-2)"	"unprognostic (5.67e-4)"	"unprognostic (7.39e-3)"	"unprognostic (1.69e-2)"	"unprognostic (1.24e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.49e-2)"	"unprognostic (2.67e-1)"	"unprognostic (9.02e-2)"	2.6	2.0	1.0	10.3	0.9	1.9	1.5	0.9	1.2	1.8	0.6	1.4	2.7	1.5	1.8	2.5	1.8	4.0	8.9	0.8	1.9	2.6	3.4	16.8	6.6	1.8	1.6	1.5	1.9	5.0	2.6	6.8	2.0	2.0	2.1	1.2	1.5	1.5	4.5	0.7	1.9	2.2	1.7	10.2	1.9	0.9	1.6	13.0	3.5	4.3	5.3	7.2	1.3	1.1	15.6	0.2	0.0	0.5	0.1	0.1	0.0	30.5	25.7	7.7	10.4	0.0	5.0	0.2	0.6	0.8	3.8	0.6	0.0	13.2	24.6	89.6	0.0	9.0	0.3	0.0	55.5	0.0	0.0	0.5	0.1	15.7	22.9	7.7	15.0	0.9	0.0	2.9	23.4	0.0	0.4	0.1	0.0	0.0	0.3	0.1	4.2	0.8	1.6	0.3	0.0	0.3	0.4	2.4	1.9	2.2	0.1	0.3	28.1	16.1	5.1	0.5	98.1	0.5	0.2	0.3	5.4	0.3	0.2	6.6	0.0	0.2	0.7	0.1	1.2	0.5	1.4	1.1	0.0	0.1	0.7	0.4	3.6	0.3	0.0	0.0	0.7	0.4	1.0	0.9	0.9	1.2	0.8	1.9	1.8	1.6	2.0	1.7	1.6	1.1	3.0	12.8	11.4	0.7	1.9	4.6	1.5	4.4	1.8	1.4	1.4	1.3	7.8	0.0	2.9	0.0	0.0	6.1	2.4	2.6	0.0	5.9	1.0	1.4	0.3	5.5	0.0	3.2	1.9	4.4	27.7	1.9	0.5	0.9	28.4	0.2	7.1	0.8	5.7	0.0	3.3	0.5	4.1	2.9	50.9	0.2	0.3	4.2	3.6	8.4	42.4	0.5	1.0	1.0	0.9	19.0	0.1	0.4	2.2	2.1	1.9	0.4	4.0	0.2	0.0	2.3	0.9	1.0	0.8	1.2	2.6	44.5	3.1	0.1	0.4	2.0
CD2AP	CMS	ENSG00000198087	"CD2 associated protein"	Q9Y5K6	6	47477789-47627263	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal enterocytes: 204.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"plasmacytoid DC: 9.9"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003267, HPA003326, CAB004352"	Enhanced		Supported	"Plasma membrane,Centriolar satellite"		NA	NA		58000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Plasma membrane"	"Centriolar satellite"	"CAB004352: AB_627009, HPA003267: AB_1078458, HPA003326: AB_1078457"	"unprognostic (5.98e-2)"	"unprognostic (1.08e-2)"	"unprognostic (1.75e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.77e-2)"	"unprognostic (1.74e-3)"	"unprognostic (1.19e-1)"	"unprognostic (6.71e-2)"	"unprognostic (2.69e-2)"	"prognostic unfavorable (5.53e-5)"	"unprognostic (2.21e-1)"	"unprognostic (3.09e-3)"	"unprognostic (6.12e-3)"	"unprognostic (1.74e-1)"	"unprognostic (1.84e-1)"	"prognostic favorable (7.57e-5)"	14.0	10.5	3.4	15.0	3.4	14.3	17.8	6.3	4.6	18.1	8.8	40.0	56.9	12.0	13.2	19.2	14.1	15.0	7.7	2.7	3.8	34.1	20.2	17.1	15.9	4.3	3.9	6.4	20.2	35.6	6.0	21.6	4.7	19.7	36.9	6.9	17.0	13.5	6.9	18.0	59.5	10.9	4.3	13.7	40.4	9.4	3.9	34.0	18.2	10.3	17.4	30.1	10.1	4.6	58.0	22.5	6.9	14.3	9.4	13.6	54.8	13.9	16.9	18.5	23.3	37.3	39.9	74.5	56.9	18.2	24.0	21.2	23.0	34.7	29.9	29.9	37.2	41.3	18.4	33.6	12.5	23.3	15.4	9.7	32.1	17.7	25.5	35.7	30.1	24.4	73.5	23.2	16.9	18.2	44.6	8.7	20.3	69.6	8.1	23.6	17.6	34.1	115.6	101.7	20.9	8.1	27.9	36.9	27.7	31.1	35.0	14.8	36.2	36.9	30.8	12.0	39.9	17.5	31.3	52.6	39.4	12.4	19.2	1.8	0.5	3.2	1.2	0.4	1.8	0.9	1.0	1.1	1.2	1.0	0.9	1.5	0.1	3.1	0.4	9.9	0.9	0.5	3.4	3.4	6.3	4.6	2.7	3.8	4.3	3.9	4.7	4.3	3.9	4.6	81.7	96.1	67.1	32.0	40.5	32.2	52.1	26.5	39.9	10.0	40.4	26.4	17.2	35.8	68.9	71.7	16.7	53.0	96.1	204.1	21.5	84.6	10.4	97.9	25.0	56.6	55.8	42.9	40.7	98.0	17.1	20.6	101.4	136.7	24.1	28.5	37.5	24.2	17.4	15.2	45.3	97.3	40.7	26.2	12.6	10.5	16.8	30.6	14.2	83.4	18.0	12.5	22.6	28.6	30.8	151.3	114.0	10.9	27.7	89.0	182.3	67.4	60.0	13.0	26.3	34.9	27.8	38.9	27.2	44.2	41.1	40.9	29.4	48.0	68.8	143.6
CD2BP2	"LIN1, PPP1R59, Snu40, U5-52K"	ENSG00000169217	"CD2 cytoplasmic tail binding protein 2"	O95400	16	30350773-30355308	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041508, HPA061309"	Enhanced		Enhanced	"Nuclear speckles,Cytosol"		Yes	No			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 35: Non-specific - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 1: Pancreatic cells - Digestion"	"Nuclear speckles"	Cytosol	"HPA041508: AB_2677523, HPA061309: AB_2684476"	"unprognostic (5.66e-2)"	"unprognostic (7.50e-3)"	"unprognostic (1.47e-1)"	"unprognostic (2.82e-2)"	"unprognostic (1.65e-1)"	"unprognostic (2.78e-1)"	"prognostic unfavorable (1.84e-5)"	"unprognostic (1.71e-2)"	"unprognostic (1.16e-1)"	"unprognostic (9.76e-2)"	"unprognostic (2.30e-2)"	"unprognostic (7.47e-2)"	"unprognostic (2.09e-3)"	"unprognostic (1.44e-1)"	"unprognostic (3.22e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.66e-1)"	31.1	49.3	38.9	34.0	39.7	23.9	32.9	38.0	41.5	39.6	34.0	39.3	29.9	45.0	24.9	35.3	41.0	22.0	35.2	39.9	41.2	42.8	27.3	32.8	38.8	41.4	39.8	36.9	40.7	42.5	42.7	24.4	39.1	38.3	23.7	16.2	30.0	35.5	46.9	33.6	35.2	31.6	39.0	46.4	36.9	24.0	41.6	35.7	42.5	26.6	43.7	37.0	30.1	42.0	55.4	65.7	54.4	49.4	44.3	41.9	46.0	60.0	71.5	66.8	71.3	50.6	64.9	84.6	72.3	65.5	61.4	59.4	57.0	70.3	53.6	50.6	66.6	35.9	67.7	60.3	63.6	51.3	63.4	45.2	58.7	74.2	47.3	45.6	70.3	62.1	41.4	63.2	67.7	132.1	71.6	43.6	73.8	42.9	38.5	104.2	45.3	64.3	54.2	54.7	44.7	85.1	40.2	69.9	42.0	44.7	66.4	41.1	50.6	76.3	53.3	38.9	53.1	105.0	82.3	78.5	52.5	47.2	64.0	107.4	61.7	116.6	71.3	76.3	56.8	87.5	57.3	66.7	55.8	97.3	47.6	58.9	121.9	74.5	102.7	67.1	94.4	79.6	38.9	39.7	38.0	41.5	39.9	41.2	41.4	39.8	39.1	39.0	41.6	42.0	38.1	32.1	29.0	7.2	39.5	28.8	49.6	58.4	31.9	29.8	33.2	29.6	26.5	45.8	41.2	36.8	20.9	61.0	57.0	50.5	60.7	83.6	19.9	41.7	30.7	42.8	33.0	22.3	6.7	97.5	58.1	36.4	28.1	45.2	47.6	33.4	28.2	13.9	69.7	11.8	7.1	32.7	36.7	38.3	23.6	14.2	35.4	34.0	39.2	8.4	84.1	47.6	97.9	3.5	10.7	87.8	64.9	35.7	52.7	40.7	60.3	81.5	46.3	29.0	39.5	30.5	44.6	38.5	40.1	27.4	30.4	88.7	41.9	38.9	31.6	50.7
CD33	"FLJ00391, p67, SIGLEC-3, SIGLEC3"	ENSG00000105383	"CD33 molecule"	P20138	19	51225064-51243860	"CD markers, FDA approved drug targets, Plasma proteins, Predicted membrane proteins"	"Cell adhesion"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 32.4;lymphoid tissue: 23.9"	"Group enriched"	"Detected in some"	6	"granulocytes: 76.0;Hofbauer cells: 78.8;Kupffer cells: 131.2;Langerhans cells: 41.4;Macrophages: 53.5;monocytes: 65.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	7	"classical monocyte: 166.5;intermediate monocyte: 122.0;myeloid DC: 213.5;non-classical monocyte: 57.8"	"Group enriched"	"Detected in many"	9	"dendritic cells: 213.5;monocytes: 166.5"	"Cell line enhanced"	"Detected in some"		"HEL: 86.1;HL-60: 115.6;HMC-1: 82.4;NB-4: 55.2;RPMI-8226: 62.5;THP-1: 67.0;U-937: 84.1"									"CAB011442, HPA035832, HPA064807, CAB079996"	Enhanced		Approved	"Nucleoplasm,Plasma membrane"		NA	NA		3400000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 32: U-937 - Innate immune response"	"Cluster 4: Macrophages - Innate immune response"	"Nucleoplasm, Plasma membrane"		"CAB011442: , CAB079996: , HPA035832: AB_2674808, HPA064807: AB_2685356"	"unprognostic (1.18e-2)"	"unprognostic (1.45e-2)"	"unprognostic (2.80e-2)"	"unprognostic (7.14e-2)"	"unprognostic (3.71e-1)"	"unprognostic (9.43e-2)"	"unprognostic (2.59e-1)"	"unprognostic (5.90e-3)"	"unprognostic (1.76e-1)"	"unprognostic (1.56e-1)"	"unprognostic (2.53e-1)"	"unprognostic (6.28e-2)"	"unprognostic (6.88e-4)"	"unprognostic (7.79e-2)"	"unprognostic (3.35e-2)"	"unprognostic (6.49e-2)"	"unprognostic (1.67e-1)"	7.9	3.4	1.1	11.2	1.2	32.4	2.5	1.5	1.6	3.0	2.5	3.2	3.3	1.7	1.3	2.0	2.5	6.6	2.0	1.1	1.8	1.4	5.5	12.6	10.1	2.5	1.6	1.4	1.4	1.2	0.9	6.9	2.4	1.4	4.2	0.2	1.8	2.6	0.9	2.7	4.4	7.1	1.9	23.9	2.3	1.0	2.3	3.5	0.9	0.8	3.5	6.2	1.3	3.6	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.2	0.0	5.5	0.4	0.0	1.3	0.3	0.0	0.2	0.0	0.1	0.1	86.1	0.3	0.0	0.0	115.6	82.4	0.0	0.0	0.0	0.0	0.3	0.0	0.0	16.2	21.2	0.2	0.0	0.0	55.2	0.2	0.0	25.9	0.0	4.4	62.5	0.4	0.0	0.2	0.0	0.0	0.1	0.4	0.0	0.0	67.0	0.7	14.0	1.1	1.8	0.1	0.3	7.6	0.2	9.6	84.1	0.4	17.9	166.5	11.0	0.3	122.0	0.4	0.1	0.2	0.5	213.5	0.4	0.3	0.2	20.5	15.5	57.8	6.3	1.1	77.8	1.1	1.2	1.5	1.6	1.1	1.8	2.5	1.6	2.4	1.9	2.3	3.6	0.7	0.0	6.7	0.0	1.0	1.8	0.5	0.0	0.0	0.2	1.4	0.4	0.8	0.0	0.6	0.0	0.0	0.6	0.2	0.1	0.0	0.0	0.7	0.1	0.1	3.0	0.0	4.2	0.0	0.0	0.5	1.1	0.0	0.1	76.0	0.1	5.3	0.7	78.8	0.0	0.0	0.0	0.0	131.2	41.4	1.7	0.3	53.5	1.8	11.2	65.0	0.2	1.0	0.5	0.2	0.0	0.0	0.0	0.3	0.4	0.0	0.2	0.7	0.6	0.0	1.1	0.3	0.7	0.5	0.0	1.0	0.8	2.5	0.1	0.0	0.4
CD38		ENSG00000004468	"CD38 molecule"	P28907	4	15778275-15853232	"Cancer-related genes, CD markers, Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Hydrolase, Receptor, Transferase"	"Cancer-related genes, Diabetes mellitus"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 63.3"	"Cell type enriched"	"Detected in many"	4	"Plasma cells: 378.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"NK-cell: 18.3"	"Group enriched"	"Detected in all"	5	"B-cells: 9.9;dendritic cells: 5.8;NK-cells: 18.3"	"Cell line enhanced"	"Detected in some"		"Daudi: 128.0;Karpas-707: 34.7;MOLT-4: 32.6;REH: 26.0;RPMI-8226: 20.9;U-266/70: 26.9;U-698: 24.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002493, HPA022132, CAB025255, HPA052381"	Enhanced		Supported	"Plasma membrane"		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 55: Plasma cells - Humoral immune response"	"Plasma membrane"		"CAB002493: AB_563556, CAB025255: , HPA022132: AB_1846300, HPA052381: AB_2681807"	"unprognostic (1.27e-2)"	"unprognostic (8.06e-3)"	"unprognostic (1.06e-2)"	"prognostic favorable (9.68e-4)"	"unprognostic (1.13e-1)"	"unprognostic (1.82e-3)"	"unprognostic (2.74e-1)"	"unprognostic (8.51e-2)"	"unprognostic (5.87e-2)"	"unprognostic (6.15e-6)"	"unprognostic (5.23e-1)"	"unprognostic (4.34e-1)"	"unprognostic (6.63e-6)"	"unprognostic (1.79e-1)"	"unprognostic (5.74e-2)"	"unprognostic (2.12e-2)"	"unprognostic (2.13e-1)"	3.1	2.4	2.5	13.1	3.8	13.6	2.0	2.7	2.5	0.7	0.9	4.5	5.8	0.9	1.2	1.1	3.0	1.9	3.8	3.5	6.6	0.8	3.3	6.3	23.4	3.3	5.5	0.7	0.3	0.1	1.8	0.5	3.4	13.2	3.5	0.2	2.6	19.7	21.4	0.3	5.3	1.4	2.8	17.0	3.0	1.0	3.9	63.3	2.0	3.4	18.0	6.8	0.5	4.6	0.0	11.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	128.0	0.0	0.0	0.4	0.1	0.2	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.0	17.0	0.2	34.7	0.0	0.0	32.6	7.9	0.2	0.0	0.0	26.0	0.1	20.9	0.0	0.0	0.2	1.5	0.0	0.2	0.5	0.3	0.1	5.7	0.5	0.0	0.1	0.1	0.0	26.9	0.2	24.3	0.4	6.2	0.3	0.1	1.9	0.1	1.2	2.4	0.3	9.9	1.5	1.2	4.7	7.7	2.4	1.9	1.4	18.3	1.9	5.8	2.4	4.4	2.5	3.8	2.7	2.5	3.5	6.6	3.3	5.5	3.4	2.8	3.9	4.6	0.8	3.2	15.1	86.5	59.7	0.0	0.4	0.6	0.6	0.1	0.1	0.0	1.0	0.0	11.6	0.0	10.4	0.2	33.8	0.2	0.0	0.0	2.5	4.0	1.4	2.7	0.0	78.6	0.4	0.0	0.2	2.7	2.0	0.3	38.2	0.8	2.9	4.3	4.4	0.0	0.4	1.3	0.0	44.3	0.8	0.7	0.0	17.7	7.2	5.6	3.1	0.0	79.3	1.0	1.8	0.0	0.3	0.0	378.4	8.1	0.2	0.1	42.5	0.1	13.1	1.5	7.6	2.9	1.7	1.6	0.0	0.5	26.5	0.0	1.6	0.2
CD3E		ENSG00000198851	"CD3e molecule"	P07766	11	118304730-118316175	"CD markers, Disease related genes, FDA approved drug targets, Human disease related genes, Predicted membrane proteins, Transporters"	"Adaptive immunity, Immunity"	Receptor	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	17	"lymphoid tissue: 640.4"	"Group enriched"	"Detected in many"	7	"dendritic cells: 213.6;NK-cells: 154.5;T-cells: 601.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in all"	26	"gdT-cell: 490.6;MAIT T-cell: 420.8;memory CD4 T-cell: 414.4;memory CD8 T-cell: 463.5;naive CD4 T-cell: 491.7;naive CD8 T-cell: 501.3;NK-cell: 202.2;T-reg: 426.3"	"Group enriched"	"Detected in all"	21	"NK-cells: 202.2;T-cells: 501.3"	"Group enriched"	"Detected in some"	67	"JURKAT: 544.9;MOLT-4: 764.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"CAB000010, HPA040957, HPA043955, CAB072863, CAB072864"	Enhanced		Supported	"Endoplasmic reticulum,Golgi apparatus,Plasma membrane"		NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 63: T-cells - Adaptive immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 58: T-cells - T-cell receptor"	"Endoplasmic reticulum, Plasma membrane"	"Golgi apparatus"	"CAB000010: AB_2631163, CAB072863: AB_2665707, CAB072864: AB_2665708, HPA040957: AB_2677222, HPA043955: AB_2678747"	"prognostic favorable (1.72e-4)"	"prognostic favorable (1.62e-4)"	"unprognostic (1.51e-2)"	"prognostic favorable (2.30e-6)"	"unprognostic (4.31e-2)"	"prognostic favorable (1.32e-4)"	"unprognostic (3.60e-3)"	"unprognostic (3.85e-2)"	"prognostic favorable (1.18e-4)"	"unprognostic (6.11e-3)"	"unprognostic (1.59e-1)"	"unprognostic (3.59e-1)"	"prognostic unfavorable (1.12e-5)"	"unprognostic (5.46e-2)"	"unprognostic (9.28e-2)"	"unprognostic (3.13e-2)"	"unprognostic (1.12e-2)"	6.4	5.6	0.9	85.8	1.1	36.7	6.7	0.9	1.2	7.1	1.3	15.3	22.0	5.8	4.6	9.5	5.4	20.1	3.8	0.7	1.0	3.5	9.7	23.0	209.6	1.8	0.9	3.8	2.2	0.7	1.0	1.6	1.4	6.6	19.3	0.0	11.6	3.0	1.9	5.4	36.4	5.1	1.2	78.9	24.4	1.7	1.3	640.4	5.3	1.6	147.0	24.8	4.9	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	544.9	0.9	2.0	0.0	0.0	764.9	0.6	0.3	0.0	0.0	0.2	0.1	1.0	0.0	0.0	0.1	0.1	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.2	0.0	1.6	8.0	9.8	0.0	0.6	0.0	16.4	1.8	2.4	490.6	1.3	420.8	1.6	414.4	463.5	1.5	2.1	491.7	501.3	12.2	202.2	2.0	8.6	426.3	333.0	0.9	1.1	0.9	1.2	0.7	1.0	1.8	0.9	1.4	1.2	1.3	1.6	4.9	0.0	8.6	0.0	12.9	5.2	0.3	0.0	0.0	0.0	3.8	4.8	0.3	0.0	0.6	1.8	0.0	0.2	213.6	0.4	0.0	0.2	7.0	0.5	0.9	2.5	0.0	6.9	0.1	0.0	0.0	5.3	24.5	0.9	7.6	0.0	8.9	2.4	0.3	0.0	0.1	0.0	0.0	7.6	8.3	0.2	0.0	12.6	12.4	1.0	8.4	0.0	154.5	0.0	0.1	0.0	1.1	0.0	41.4	0.1	0.2	2.1	0.0	0.0	0.0	1.3	2.7	0.0	0.0	1.6	5.4	0.3	601.4	0.0	0.6	0.3
CD3G		ENSG00000160654	"CD3g molecule"	P09693	11	118344344-118355161	"CD markers, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Immunity"	Receptor	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"lymphoid tissue: 94.7"	"Group enriched"	"Detected in many"	11	"dendritic cells: 139.6;T-cells: 294.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in many"	21	"gdT-cell: 229.0;MAIT T-cell: 135.6;memory CD4 T-cell: 187.3;memory CD8 T-cell: 197.3;naive CD4 T-cell: 192.6;naive CD8 T-cell: 241.7;T-reg: 200.0"	"Lineage enriched"	"Detected in many"	26	"T-cells: 241.7"	"Group enriched"	"Detected in some"	52	"JURKAT: 70.9;MOLT-4: 193.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB017520, HPA038494"	Enhanced		Supported	"Plasma membrane,Cytosol"		NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Plasma membrane, Cytosol"		"CAB017520: AB_831094, HPA038494: AB_2676044"	"prognostic favorable (6.33e-4)"	"prognostic favorable (2.61e-4)"	"unprognostic (4.58e-3)"	"unprognostic (3.12e-5)"	"unprognostic (6.30e-2)"	"prognostic favorable (3.00e-4)"	"unprognostic (1.98e-2)"	"unprognostic (1.54e-2)"	"unprognostic (8.25e-3)"	"unprognostic (1.08e-3)"	"unprognostic (1.54e-2)"	"unprognostic (2.19e-1)"	"prognostic unfavorable (9.33e-5)"	"unprognostic (1.60e-1)"	"unprognostic (2.37e-2)"	"unprognostic (4.13e-2)"	"unprognostic (2.10e-3)"	0.7	0.8	0.6	10.5	0.8	1.3	1.0	1.1	0.8	0.7	1.1	2.3	3.3	0.5	0.6	1.4	0.9	2.5	0.5	0.5	0.4	0.6	1.6	2.8	27.9	0.9	0.6	0.4	0.5	0.2	0.0	0.3	0.8	0.9	2.7	0.4	1.6	0.3	10.5	0.9	4.6	0.6	0.3	11.5	4.1	0.4	0.8	94.7	0.6	0.3	20.4	3.0	0.4	1.9	0.2	0.2	0.1	0.2	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.2	0.2	0.7	0.2	0.0	0.3	0.2	0.0	0.0	0.0	0.6	0.6	0.0	0.4	0.2	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.1	0.0	70.9	2.5	0.3	0.0	0.6	193.8	1.3	0.2	0.0	0.1	0.2	0.0	0.3	0.0	0.1	0.5	0.2	0.0	1.1	0.1	0.0	0.6	0.2	0.0	0.2	0.2	0.2	0.1	0.2	0.7	0.3	0.2	0.2	0.1	9.2	1.2	1.2	229.0	0.6	135.6	0.8	187.3	197.3	0.6	0.9	192.6	241.7	6.4	1.4	1.2	1.5	200.0	90.4	0.6	0.8	1.1	0.8	0.5	0.4	0.9	0.6	0.8	0.3	0.8	1.9	3.2	3.2	6.9	0.0	7.8	2.3	0.1	0.0	1.8	0.2	2.0	2.9	0.8	1.5	1.9	0.0	0.0	0.1	139.6	0.4	0.0	0.3	1.0	0.4	0.4	1.4	0.0	3.4	0.1	0.0	0.0	2.3	13.7	0.4	6.3	0.0	4.2	1.7	0.1	0.0	0.1	0.2	0.0	3.8	5.8	1.4	0.0	7.7	5.4	1.0	8.1	0.0	14.4	0.0	0.3	0.0	0.1	0.0	18.5	0.0	0.0	0.6	0.7	0.8	0.0	1.3	1.6	0.2	0.4	0.6	2.4	0.3	294.0	0.1	0.3	0.0
CD40LG	"CD154, CD40L, gp39, hCD40L, HIGM1, IMD3, TNFSF5, TRAP"	ENSG00000102245	"CD40 ligand"	P29965	X	136648158-136660390	"Cancer-related genes, Candidate cardiovascular disease genes, CD markers, Disease related genes, Human disease related genes, Predicted membrane proteins, Predicted secreted proteins"		Cytokine	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 15.5"	"Cell type enriched"	"Detected in some"	8	"T-cells: 76.6"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"gdT-cell: 26.3;MAIT T-cell: 64.1;memory CD4 T-cell: 80.5;naive CD4 T-cell: 76.1"	"Lineage enriched"	"Detected in many"	39	"T-cells: 80.5"	"Cell line enriched"	"Detected in some"	15	"MOLT-4: 23.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA045827, HPA072480"	Enhanced		Approved	"Golgi apparatus,Plasma membrane"	"Secreted to blood"	NA	NA	776000	20000	"Cluster 32: T-cells - Unknown function"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 24: Non-specific - Transcription regulation"	"Golgi apparatus, Plasma membrane"		"HPA045827: AB_10959606, HPA072480: "	"unprognostic (1.94e-5)"	"unprognostic (1.24e-2)"	"unprognostic (3.26e-1)"	"unprognostic (1.27e-3)"	"unprognostic (4.71e-2)"	"unprognostic (3.56e-5)"	"unprognostic (3.66e-2)"	"unprognostic (5.48e-3)"	"unprognostic (2.77e-1)"	"unprognostic (2.14e-4)"	"unprognostic (1.87e-1)"	"unprognostic (1.55e-1)"	"unprognostic (6.70e-4)"	"unprognostic (2.15e-1)"	"unprognostic (5.19e-2)"	"unprognostic (2.36e-3)"	"unprognostic (2.92e-2)"	0.8	0.3	0.1	7.9	0.0	1.9	1.1	0.2	0.2	0.9	0.2	1.9	1.8	0.3	0.2	1.0	0.4	2.0	0.2	0.1	0.2	0.4	1.0	2.4	15.5	0.1	0.1	0.3	0.0	0.0	0.0	0.1	0.2	0.8	3.1	0.0	0.6	0.3	0.1	0.6	3.8	0.6	0.0	4.9	2.0	0.3	0.1	15.5	0.5	0.2	14.8	2.5	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	23.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.1	0.3	26.3	0.1	64.1	0.1	80.5	11.7	0.2	0.0	76.1	0.7	1.3	0.8	0.1	0.1	10.5	13.6	0.1	0.0	0.2	0.2	0.1	0.2	0.1	0.1	0.2	0.0	0.1	0.2	0.6	0.0	2.4	0.0	2.4	1.3	0.0	0.0	0.0	0.0	0.4	0.5	0.3	0.0	0.6	0.0	0.0	0.0	4.5	0.0	0.0	0.0	3.9	0.0	0.0	0.6	0.0	1.7	0.0	0.0	0.0	0.6	2.6	0.0	1.3	0.0	1.1	0.3	0.1	0.0	0.0	0.0	0.0	0.6	4.0	8.9	0.0	2.9	1.8	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.4	0.0	0.0	0.0	0.6	0.7	0.0	0.0	0.1	2.0	0.0	76.6	0.0	0.0	0.1
CD44	"CD44R, CSPG8, HCELL, IN, MC56, MDU2, MDU3, MIC4, Pgp1"	ENSG00000026508	"CD44 molecule (Indian blood group)"	P16070	11	35138882-35232402	"Blood group antigen proteins, Cancer-related genes, CD markers, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Cell adhesion"	"Blood group antigen, Receptor"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"salivary gland: 504.2"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 999.7;Ductal cells: 992.1;Exocrine glandular cells: 869.6;Langerhans cells: 1934.2;Suprabasal keratinocytes: 1024.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 1650.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000112, CAB000316, HPA005785"	Enhanced		Supported	"Golgi apparatus,Plasma membrane"	"Secreted to blood"	NA	NA		1200000000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 1: Pancreatic cells - Digestion"	"Plasma membrane"	"Golgi apparatus"	"CAB000112: , CAB000316: AB_2076596, HPA005785: AB_1078467"	"unprognostic (5.33e-2)"	"unprognostic (1.85e-1)"	"unprognostic (4.97e-2)"	"unprognostic (9.90e-3)"	"unprognostic (3.50e-3)"	"unprognostic (1.46e-2)"	"unprognostic (1.56e-2)"	"unprognostic (8.12e-2)"	"unprognostic (1.57e-1)"	"unprognostic (4.18e-2)"	"unprognostic (1.51e-3)"	"unprognostic (4.63e-2)"	"prognostic unfavorable (1.78e-8)"	"unprognostic (6.41e-2)"	"unprognostic (4.14e-2)"	"unprognostic (3.93e-2)"	"unprognostic (7.98e-2)"	143.7	42.4	29.2	218.0	33.9	308.1	164.7	63.0	25.1	146.0	16.8	91.1	53.0	200.4	20.1	227.8	69.0	129.7	30.4	33.0	116.5	31.3	31.0	214.1	108.8	114.9	102.3	11.7	263.2	6.0	8.1	74.1	118.3	87.3	111.5	38.0	504.2	57.0	17.1	433.3	60.8	175.8	114.3	83.8	61.5	6.6	62.8	64.2	76.2	27.7	188.7	235.2	193.4	114.9	493.0	448.6	4.3	1.2	252.6	691.5	1.6	962.2	740.3	521.3	288.2	30.4	150.4	0.7	126.5	1350.2	1065.4	820.1	9.9	1013.9	716.4	110.3	6.2	18.9	198.3	0.3	262.3	254.6	1124.3	315.4	778.3	693.2	552.7	1650.0	184.3	0.1	4.0	157.9	518.9	3.0	25.6	166.9	9.8	8.7	136.4	1.4	89.3	7.5	777.4	138.1	2.0	1.4	185.2	5.5	462.8	38.6	25.7	15.1	547.3	646.6	120.0	815.8	1006.0	281.6	327.7	3.7	980.4	145.1	969.8	127.4	403.0	35.4	140.6	257.8	196.5	122.5	210.1	186.5	229.0	90.0	179.7	153.6	92.6	322.3	356.1	79.9	309.7	437.3	29.2	33.9	63.0	25.1	33.0	116.5	114.9	102.3	118.3	114.3	62.8	114.9	41.0	96.1	361.8	54.5	250.1	999.7	297.7	335.3	228.2	0.6	139.6	71.2	8.6	27.1	125.6	20.2	2.1	4.5	257.0	14.0	1.9	992.1	41.3	43.6	395.4	50.9	100.1	94.4	0.4	869.6	3.6	282.2	39.8	196.9	763.2	25.2	13.2	3.6	226.6	0.0	0.4	93.3	30.5	474.3	1934.2	24.3	22.4	523.9	604.7	8.4	594.2	29.6	62.8	0.5	11.2	813.1	10.9	0.4	216.3	386.7	6.0	1.6	18.8	2.0	157.8	197.2	227.9	0.4	0.4	279.3	1024.9	17.9	430.8	1.0	79.1	330.7
CD47	"IAP, MER6, OA3"	ENSG00000196776	"CD47 molecule"	Q08722	3	108043091-108091862	"CD markers, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Ductal cells: 589.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016055, HPA044659"	Approved		Supported	"Vesicles,Plasma membrane"		NA	NA		49000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 20: Retina & Lymphoid tissues - Unknown function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 1: Pancreatic cells - Digestion"	"Plasma membrane"	Vesicles	"CAB016055: AB_627086, HPA044659: AB_2679040"	"unprognostic (3.54e-2)"	"unprognostic (4.74e-2)"	"unprognostic (3.19e-2)"	"prognostic unfavorable (2.44e-4)"	"unprognostic (4.49e-2)"	"unprognostic (2.14e-1)"	"unprognostic (2.05e-3)"	"unprognostic (8.77e-3)"	"unprognostic (7.35e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.69e-2)"	"unprognostic (2.87e-1)"	"prognostic unfavorable (1.69e-4)"	"unprognostic (7.37e-2)"	"unprognostic (3.78e-1)"	"prognostic favorable (7.29e-5)"	"unprognostic (1.83e-1)"	51.8	64.9	39.2	116.4	47.9	232.2	89.3	64.4	63.5	57.4	30.4	89.0	74.6	53.0	92.4	93.9	100.5	86.7	59.5	47.2	41.9	44.4	71.4	154.6	137.9	53.1	40.5	46.1	41.5	27.2	34.6	80.1	48.5	122.2	99.3	285.7	105.3	55.7	57.9	59.8	79.3	55.4	50.9	100.1	104.2	59.0	49.2	79.1	91.2	22.8	161.7	110.1	52.4	76.4	303.3	49.9	108.0	62.1	130.3	122.6	147.9	106.0	139.4	70.8	126.0	2.1	159.1	129.6	180.0	90.7	216.5	201.0	52.2	98.7	91.7	81.5	35.8	311.6	45.9	3.9	73.8	227.4	467.6	85.7	58.1	71.6	53.6	118.5	73.4	132.6	85.1	323.6	108.5	148.1	268.5	77.0	46.7	298.4	133.6	154.2	69.3	187.8	185.3	115.8	69.7	37.9	63.6	111.7	124.4	56.5	227.4	85.8	76.5	210.9	40.9	120.7	79.4	124.2	100.8	208.0	131.5	119.8	65.6	185.2	119.2	232.8	178.1	244.2	155.6	191.6	209.7	192.0	181.6	188.7	149.2	169.0	145.4	232.6	339.2	133.3	334.5	296.9	39.2	47.9	64.4	63.5	47.2	41.9	53.1	40.5	48.5	50.9	49.2	76.4	72.3	368.6	157.4	98.6	192.9	165.3	311.7	504.4	101.3	102.9	119.0	93.1	51.9	110.1	205.7	93.8	95.9	169.9	218.6	36.5	15.6	589.6	81.5	157.2	17.0	76.5	63.8	112.6	219.2	412.5	85.5	119.1	36.2	120.4	57.7	250.0	83.6	34.2	186.4	122.8	129.3	70.8	148.5	79.6	200.7	52.2	34.2	121.5	117.4	39.4	100.5	51.7	219.4	107.1	150.4	344.7	92.6	48.5	143.8	439.0	53.7	16.3	162.2	229.7	65.7	47.1	85.4	111.5	19.6	97.1	140.1	121.2	160.8	80.6	94.3	321.3
CD63	"ME491, MLA1, TSPAN30"	ENSG00000135404	"CD63 molecule"	P08962	12	55725323-55729707	"CD markers, Plasma proteins, Predicted membrane proteins, Transporters"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"eosinophil: 1857.5"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"ASC diff: 4897.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010088, CAB026356, HPA073506"	Supported		Supported	Vesicles	"Intracellular and membrane"	NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 68: Epididymis - Unknown function"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	Vesicles		"CAB026356: AB_629864, HPA010088: AB_1846323, HPA073506: "	"unprognostic (8.76e-3)"	"unprognostic (8.81e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.28e-3)"	"unprognostic (9.48e-2)"	"unprognostic (3.66e-3)"	"prognostic unfavorable (1.37e-4)"	"unprognostic (1.11e-1)"	"unprognostic (6.50e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.66e-2)"	"unprognostic (3.10e-1)"	"unprognostic (2.70e-2)"	"unprognostic (4.82e-2)"	"unprognostic (5.21e-2)"	"unprognostic (1.85e-3)"	"unprognostic (9.02e-2)"	954.0	882.1	509.4	457.9	526.5	747.2	769.6	532.6	717.1	715.6	611.8	809.3	394.5	854.6	1492.1	396.1	647.3	607.0	1152.2	508.5	565.7	625.3	565.1	882.2	325.0	564.7	539.9	645.9	830.1	524.7	486.6	588.0	544.3	520.0	736.0	269.1	871.6	547.4	919.3	410.0	559.3	744.5	534.9	597.7	790.8	224.3	583.6	193.3	657.7	587.4	284.9	835.3	539.7	561.7	481.0	669.0	432.6	430.8	4897.7	2932.4	577.5	1914.8	3104.6	979.2	1048.9	750.3	939.2	120.5	581.2	2608.7	787.7	436.3	301.7	732.6	1197.9	372.5	248.7	760.9	542.8	443.3	2006.7	338.5	1699.0	2315.1	639.7	1164.8	979.2	2305.1	1052.2	64.6	386.8	936.3	3062.5	626.3	64.1	439.5	395.7	1062.7	880.7	146.0	949.3	345.7	1699.3	1433.6	170.1	425.8	528.3	392.5	3348.6	630.4	546.4	1089.6	948.0	710.1	514.8	984.9	649.8	377.3	239.3	92.5	2023.9	208.1	1326.3	1279.9	610.3	1857.5	323.2	458.8	235.2	111.0	126.9	260.0	473.0	73.9	55.9	186.0	656.0	733.0	320.4	309.8	121.6	850.4	509.4	526.5	532.6	717.1	508.5	565.7	564.7	539.9	544.3	534.9	583.6	561.7	798.7	512.8	689.0	28.1	147.6	567.2	1382.5	3135.4	155.4	190.3	606.5	601.1	820.9	836.4	1789.7	875.4	152.2	608.3	322.0	1083.4	232.8	2621.2	16.7	446.7	766.7	916.3	581.1	97.0	8.8	3429.0	2756.5	1538.0	371.1	727.3	1030.0	531.6	739.6	423.9	3372.5	33.7	9.3	1251.6	1715.1	854.6	1698.3	65.5	1727.3	1146.7	1993.9	11.2	575.7	893.8	487.1	21.1	26.5	3437.4	1394.0	1157.0	326.9	2039.2	878.1	794.2	1012.6	258.8	1255.6	1845.2	1278.7	43.8	68.9	137.1	400.5	2708.1	310.4	645.8	761.6	1868.9
CD68	"DKFZp686M18236, GP110, LAMP4, macrosialin, SCARD1"	ENSG00000129226	"CD68 molecule"	P34810	17	7579491-7582111	"CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lung: 358.0;lymphoid tissue: 370.7"	"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 1820.4;Kupffer cells: 701.2;Langerhans cells: 341.5;Macrophages: 791.2;Proximal enterocytes: 335.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"classical monocyte: 3255.5;intermediate monocyte: 3655.9;non-classical monocyte: 3740.6"	"Group enriched"	"Detected in all"	11	"dendritic cells: 1378.6;monocytes: 3740.6"	"Cell line enhanced"	"Detected in all"		"ASC diff: 472.0;U-87 MG: 751.0"					"Low region specificity"	"Detected in all"			"CAB000051, CAB000066, HPA048982, CAB072861, CAB072862"	Enhanced		Supported	"Golgi apparatus,Vesicles"		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 64: Macrophages - Immune response"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 4: Macrophages - Innate immune response"	"Golgi apparatus, Vesicles"		"CAB000051: AB_2314148, CAB000066: AB_2074844, CAB072861: AB_2665705, CAB072862: AB_2665706, HPA048982: AB_2680587"	"unprognostic (2.16e-2)"	"unprognostic (1.47e-2)"	"unprognostic (6.46e-2)"	"unprognostic (1.49e-3)"	"unprognostic (1.78e-2)"	"unprognostic (1.97e-1)"	"unprognostic (4.75e-4)"	"unprognostic (2.83e-2)"	"unprognostic (1.31e-1)"	"unprognostic (6.85e-2)"	"unprognostic (1.04e-1)"	"unprognostic (2.59e-1)"	"prognostic unfavorable (1.14e-5)"	"unprognostic (1.58e-1)"	"unprognostic (8.91e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.65e-2)"	139.6	78.3	10.4	236.1	9.8	266.2	72.6	11.2	33.4	77.8	14.6	88.8	279.5	26.7	9.0	126.4	43.1	161.1	38.9	8.2	26.7	50.6	156.7	358.0	217.3	45.5	31.2	19.4	22.1	14.2	8.9	173.1	36.0	13.1	91.9	4.8	52.6	19.8	23.0	24.8	240.2	79.0	16.1	370.7	87.5	15.2	58.5	44.2	22.7	21.3	84.2	149.3	50.6	31.6	243.4	48.6	3.2	3.5	472.0	177.6	2.1	75.6	203.9	97.8	113.4	10.1	71.3	2.9	84.2	220.8	174.6	10.6	1.2	47.6	65.9	2.2	9.0	38.8	13.2	59.0	42.0	19.2	207.8	57.1	9.8	205.4	150.4	162.6	26.3	4.3	15.7	24.2	95.5	2.2	1.7	17.2	2.8	63.1	36.0	3.3	4.5	144.4	20.9	10.9	1.6	3.0	63.2	31.3	72.1	2.2	1.6	146.1	82.4	123.7	8.0	125.7	100.1	1.4	2.1	1.9	751.0	46.4	64.0	243.5	3255.5	21.4	9.1	3655.9	11.1	80.2	4.1	6.2	817.3	59.0	5.8	5.1	219.4	18.7	3740.6	1378.6	6.5	3324.3	10.4	9.8	11.2	33.4	8.2	26.7	45.5	31.2	36.0	16.1	58.5	31.6	10.4	0.0	19.7	1.3	20.5	15.7	39.0	58.8	3.4	0.2	7.2	9.8	0.0	12.8	53.2	5.5	0.0	8.9	110.3	22.5	5.9	82.1	0.8	8.3	11.3	15.9	4.9	6.6	0.3	156.8	58.1	45.6	29.6	18.7	43.6	0.9	16.4	23.9	1820.4	0.0	0.4	15.8	16.2	701.2	341.5	2.1	6.5	791.2	39.2	5.6	179.2	0.3	7.2	0.0	0.1	121.0	86.1	1.9	8.5	33.3	335.3	50.2	20.6	1.0	26.3	8.7	11.7	0.5	1.2	12.4	14.3	33.4	10.8	0.5	28.9	99.9
CD74	DHLAG	ENSG00000019582	"CD74 molecule"	P04233	5	150400041-150412969	"Cancer-related genes, CD markers, Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Adaptive immunity, Immunity"	Chaperone	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 5258.9"	"Cell type enhanced"	"Detected in many"		"B-cells: 10167.0;Kupffer cells: 5201.6;Langerhans cells: 23363.4;Macrophages: 7290.2;monocytes: 10305.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"classical monocyte: 11041.2;intermediate monocyte: 15961.1;memory B-cell: 26889.3;myeloid DC: 23750.6;naive B-cell: 27930.3;non-classical monocyte: 8003.3;plasmacytoid DC: 16940.0"	"Group enriched"	"Detected in all"	6	"B-cells: 27930.3;dendritic cells: 23750.6;monocytes: 15961.1"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 2171.7;Daudi: 3523.2;HDLM-2: 4787.6;REH: 3026.0;RPMI-8226: 2014.2;U-266/70: 1443.4;U-698: 1978.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002506, HPA010592, CAB079994"	Enhanced		Supported	"Golgi apparatus"		NA	NA		210000	"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 16: Immune cells - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 41: Macrophages - Immune response"	"Golgi apparatus"		"CAB002506: AB_563630, CAB079994: , HPA010592: AB_1078482"	"prognostic favorable (1.06e-4)"	"unprognostic (1.48e-2)"	"unprognostic (4.80e-3)"	"prognostic favorable (6.53e-6)"	"unprognostic (1.41e-1)"	"unprognostic (4.53e-2)"	"unprognostic (2.05e-1)"	"unprognostic (3.69e-3)"	"unprognostic (1.54e-2)"	"unprognostic (3.48e-2)"	"unprognostic (2.20e-2)"	"unprognostic (2.64e-1)"	"unprognostic (5.44e-3)"	"unprognostic (1.73e-1)"	"unprognostic (4.95e-2)"	"unprognostic (2.05e-1)"	"unprognostic (4.24e-2)"	1512.1	976.5	338.1	2741.2	301.9	984.3	1157.2	365.5	474.4	1562.8	429.1	992.3	1826.2	593.6	490.6	618.8	1139.0	1477.9	604.0	306.7	506.8	1271.1	1142.0	3786.3	4995.6	598.7	431.8	464.3	392.4	390.6	469.3	305.7	533.4	556.7	1155.8	58.1	1999.3	911.8	307.2	682.4	2438.8	1014.2	514.2	4897.4	1511.5	207.5	514.4	2160.2	853.5	374.2	5258.9	1557.5	483.5	771.8	35.7	0.3	1.5	2.4	2.3	2.5	11.0	0.0	0.0	0.7	0.6	443.0	2171.7	3523.2	124.2	0.0	9.2	9.4	0.0	0.0	0.1	4787.6	0.0	109.1	1.2	250.2	6.6	9.2	6.5	24.5	0.0	0.8	0.0	0.6	0.0	0.0	8.0	1270.7	0.4	0.0	4.2	14.0	5.3	0.0	0.1	3026.0	5.2	2014.2	9.0	133.5	5.1	8.2	5.5	4.7	94.9	19.2	81.2	414.4	5.6	10.3	9.9	9.0	4.5	1443.4	170.7	1978.6	745.9	154.2	678.6	410.8	11041.2	3996.9	808.7	15961.1	899.9	26889.3	688.4	1188.4	23750.6	27930.3	378.9	646.6	839.6	2378.1	8003.3	16940.0	2157.2	17779.7	338.1	301.9	365.5	474.4	306.7	506.8	598.7	431.8	533.4	514.2	514.4	771.8	2080.4	419.9	2160.4	0.7	10167.0	715.9	154.0	762.2	398.4	1.7	220.3	437.5	69.6	401.7	1063.3	502.1	0.0	28.3	3199.0	139.7	117.4	1264.4	10.4	111.3	11.5	1787.6	242.9	562.5	0.7	527.5	32.6	278.6	538.2	85.5	417.2	113.4	514.7	52.5	4361.8	1.7	0.6	475.7	390.6	5201.6	23363.4	31.3	117.1	7290.2	1197.1	137.7	10305.9	16.8	403.7	0.5	1.4	384.2	487.3	17.7	2068.3	174.9	5034.4	815.8	1153.1	10.0	164.3	45.1	146.7	2.8	12.6	170.9	575.8	41.6	790.7	12.9	450.7	743.4
CD79B	"B29, IGB"	ENSG00000007312	"CD79b molecule"	P40259	17	63928740-63932336	"Cancer-related genes, CD markers, Disease related genes, FDA approved drug targets, Human disease related genes, Predicted membrane proteins"	"Adaptive immunity, Immunity"		"Cancer-related genes, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"lymphoid tissue: 266.7"	"Cell type enriched"	"Detected in many"	4	"B-cells: 491.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in all"	4	"memory B-cell: 1132.1;naive B-cell: 1505.8"	"Lineage enriched"	"Detected in all"	5	"B-cells: 1505.8"	"Cell line enhanced"	"Detected in some"		"Daudi: 1060.0;REH: 350.2;U-698: 1475.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA009178, CAB009751, HPA044107"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 57: B-cells - Immune response"	"Plasma membrane"	"Nucleoplasm, Cytosol"	"CAB009751: AB_2275844, HPA009178: AB_1078483, HPA044107: "	"unprognostic (3.90e-3)"	"unprognostic (1.61e-3)"	"unprognostic (5.21e-2)"	"unprognostic (3.45e-3)"	"unprognostic (4.22e-3)"	"prognostic favorable (2.35e-4)"	"unprognostic (1.82e-1)"	"unprognostic (9.25e-3)"	"unprognostic (3.89e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.87e-2)"	"unprognostic (2.50e-3)"	"unprognostic (1.89e-1)"	"unprognostic (1.44e-1)"	"unprognostic (4.28e-2)"	"unprognostic (2.75e-1)"	5.0	1.7	0.9	70.5	0.9	54.6	3.4	0.9	1.4	1.9	1.7	7.7	4.7	1.4	1.6	2.6	1.5	6.8	12.3	0.9	0.9	4.7	3.4	4.9	266.7	1.0	0.9	0.6	0.7	0.7	25.3	3.8	0.9	2.5	7.2	0.0	7.8	0.8	3.4	2.4	66.2	2.6	0.9	147.7	10.7	1.0	1.0	27.1	4.1	5.8	208.4	13.4	2.2	1.0	1.8	0.0	0.5	0.0	0.0	0.0	0.0	0.6	0.0	0.2	0.4	0.0	0.0	1060.0	7.8	0.0	0.4	0.3	0.0	0.0	0.0	0.5	0.0	2.7	0.0	0.4	0.6	0.6	0.5	0.0	0.0	0.1	0.0	0.0	1.2	0.4	1.2	56.9	0.0	0.0	0.6	23.0	0.3	0.0	0.0	350.2	0.9	4.4	0.0	0.0	0.5	0.0	1.7	0.0	0.7	5.8	0.0	16.2	1.7	0.1	3.7	0.3	0.6	51.3	54.4	1475.5	0.0	2.2	0.0	6.2	13.0	1.1	44.9	192.2	51.3	1132.1	57.1	30.1	47.0	1505.8	38.4	23.2	5.8	42.4	304.3	6.7	107.9	112.1	0.9	0.9	0.9	1.4	0.9	0.9	1.0	0.9	0.9	0.9	1.0	1.0	24.9	0.0	1.3	0.0	491.9	4.5	0.4	0.0	1.8	0.0	1.1	4.4	1.4	1.5	0.0	0.0	0.0	0.2	24.2	0.3	0.0	0.1	0.6	0.3	1.0	25.2	1.2	8.6	0.0	0.0	0.4	3.3	0.5	0.3	15.2	0.0	51.4	1.3	5.8	0.0	0.0	0.4	0.0	14.8	5.1	1.4	1.2	13.4	21.4	0.0	14.3	0.0	36.0	0.0	0.0	0.0	0.1	1.9	99.6	0.4	0.0	1.0	0.0	0.0	0.0	4.4	5.4	1.2	0.3	0.7	3.1	0.4	27.0	0.5	0.8	0.2
CD81	"TAPA-1, TAPA1, TSPAN28"	ENSG00000110651	"CD81 molecule"	P60033	11	2376177-2397397	"CD markers, Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Adaptive immunity, Host-virus interaction, Immunity"	"Host cell receptor for virus entry, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Adipocytes: 1003.1;Endometrial stromal cells: 1050.9;Muller glia cells: 809.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"memory B-cell: 148.9;naive B-cell: 137.2"	"Lineage enriched"	"Detected in all"	4	"B-cells: 148.9"	"Cell line enhanced"	"Detected in many"		"ASC diff: 2960.6;fHDF/TERT166: 1752.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002507, HPA007234"	Supported		Supported	"Plasma membrane,Cytosol"		NA	NA		400000	"Cluster 43: B-cells - Humoral immune response"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Plasma membrane"	Cytosol	"CAB002507: AB_563639, HPA007234: AB_1846333"	"unprognostic (2.96e-1)"	"unprognostic (3.40e-1)"	"prognostic unfavorable (7.56e-4)"	"unprognostic (1.84e-2)"	"prognostic unfavorable (8.21e-5)"	"unprognostic (6.03e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.31e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.24e-1)"	"prognostic favorable (3.86e-4)"	"unprognostic (3.07e-3)"	"unprognostic (2.08e-1)"	"unprognostic (3.55e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.06e-1)"	"unprognostic (2.06e-1)"	892.1	299.1	560.6	270.7	598.4	77.8	773.6	614.8	590.2	952.7	498.9	992.0	150.7	1384.0	960.5	364.3	853.1	534.5	937.9	511.1	615.8	636.6	1175.7	768.4	429.0	665.7	640.8	656.8	449.5	258.3	409.1	441.0	651.1	634.0	234.4	75.9	531.1	1602.0	214.3	511.1	423.1	978.5	694.1	631.3	494.3	316.9	655.1	158.9	564.6	227.6	278.6	749.2	763.4	734.4	337.0	342.0	268.5	413.4	2960.6	1668.4	224.8	621.0	1361.6	490.3	492.2	322.8	1.8	285.4	218.3	1752.6	312.5	430.5	167.3	442.2	199.9	135.6	517.8	43.7	117.1	0.3	976.4	188.2	359.8	1222.3	619.9	201.1	302.1	757.9	476.6	204.0	198.7	484.9	696.4	257.2	160.7	239.1	324.4	304.7	274.2	324.7	135.5	183.3	529.1	223.3	288.8	319.2	198.4	514.4	383.8	214.3	171.0	337.8	641.3	249.0	181.6	471.2	216.6	356.9	88.1	529.1	361.3	111.0	435.0	0.9	3.3	22.9	21.1	5.8	34.4	148.9	14.9	33.0	2.6	137.2	9.2	16.9	1.0	14.7	7.3	7.7	12.0	10.7	560.6	598.4	614.8	590.2	511.1	615.8	665.7	640.8	651.1	694.1	655.1	734.4	1003.1	243.6	270.0	95.0	88.2	179.8	391.8	89.7	26.2	82.7	325.6	452.0	277.4	167.3	102.3	207.8	27.1	21.8	267.1	20.0	35.2	105.7	15.9	365.4	1050.9	344.5	71.9	30.7	19.0	55.1	31.7	560.4	21.4	462.7	81.7	204.0	293.4	603.9	251.5	148.0	32.4	48.2	50.8	232.7	179.7	50.2	389.2	277.6	151.2	60.0	23.0	809.2	45.3	145.8	93.6	61.3	14.7	251.3	50.7	147.6	5.0	29.9	85.8	76.1	118.3	356.9	423.6	15.6	19.4	30.6	164.9	20.1	136.8	379.0	41.5	298.1
CD86	"B7-2, B7.2, CD28LG2"	ENSG00000114013	"CD86 molecule"	P42081	3	122055362-122121139	"CD markers, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Host-virus interaction, Immunity"	"Host cell receptor for virus entry, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 34.5"	"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 121.3;Kupffer cells: 107.8;Langerhans cells: 148.3;Macrophages: 151.8;Microglial cells: 78.7;monocytes: 489.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	8	"classical monocyte: 79.9;intermediate monocyte: 79.0;memory B-cell: 41.0;myeloid DC: 78.8;naive B-cell: 28.5;non-classical monocyte: 85.2"	"Group enriched"	"Detected in many"	18	"B-cells: 41.0;dendritic cells: 78.8;monocytes: 85.2"	"Cell line enriched"	"Detected in some"	7	"HDLM-2: 296.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB004319, HPA026802"	Approved		Supported	"Plasma membrane,Centriolar satellite"		NA	NA		160000	"Cluster 7: Monocytes - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 3: Monocytes - Immune response regulation"	"Plasma membrane"	"Centriolar satellite"	"CAB004319: AB_627200, HPA026802: "	"unprognostic (1.81e-1)"	"unprognostic (3.78e-3)"	"unprognostic (3.04e-2)"	"unprognostic (3.52e-2)"	"unprognostic (1.36e-1)"	"unprognostic (2.79e-1)"	"unprognostic (1.15e-1)"	"unprognostic (8.56e-2)"	"unprognostic (7.72e-3)"	"unprognostic (1.21e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.98e-1)"	"prognostic unfavorable (9.83e-5)"	"unprognostic (9.72e-2)"	"unprognostic (1.70e-2)"	"unprognostic (9.78e-2)"	"unprognostic (8.67e-2)"	7.8	5.3	3.5	34.5	3.4	10.3	4.4	4.0	3.6	3.5	4.8	6.3	3.7	2.4	1.0	4.0	2.1	14.3	2.7	3.2	6.1	1.9	11.2	18.6	28.8	7.2	5.5	2.1	2.6	2.9	1.1	15.0	7.0	2.4	7.7	0.9	2.3	2.5	0.8	2.0	6.8	7.4	5.3	23.4	5.2	3.1	5.0	10.6	1.3	0.8	22.0	14.9	1.0	10.2	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	40.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	296.1	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	2.5	0.2	0.0	0.0	0.2	0.0	32.5	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.4	0.4	0.0	0.1	0.0	0.1	15.1	0.6	35.1	0.0	0.9	0.0	0.1	79.9	0.8	0.0	79.0	0.0	41.0	0.2	0.3	78.8	28.5	0.2	0.1	0.9	3.7	85.2	8.3	1.6	33.4	3.5	3.4	4.0	3.6	3.2	6.1	7.2	5.5	7.0	5.3	5.0	10.2	0.9	0.0	7.7	0.3	36.5	3.6	0.1	1.3	0.0	0.0	0.4	1.3	0.3	1.5	3.2	1.8	0.0	1.8	3.3	0.0	0.0	0.2	3.7	0.1	0.0	2.6	0.0	1.3	0.2	3.5	0.8	0.8	0.5	0.0	2.5	0.1	1.8	0.8	121.3	0.0	0.3	0.0	0.0	107.8	148.3	2.7	0.0	151.8	7.2	78.7	489.4	0.0	0.0	0.5	0.1	0.3	0.0	0.0	20.6	0.3	0.0	0.1	0.1	0.4	0.0	0.3	0.7	0.2	0.3	0.2	4.0	1.9	2.1	0.1	0.0	0.3
CD8A	CD8	ENSG00000153563	"CD8a molecule"	P01732	2	86784610-86808396	"CD markers, Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Immunity"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	16	"lymphoid tissue: 369.0"	"Group enriched"	"Detected in many"	4	"dendritic cells: 111.7;T-cells: 242.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	14	"MAIT T-cell: 234.4;memory CD8 T-cell: 523.0;naive CD8 T-cell: 476.8"	"Lineage enriched"	"Detected in many"	19	"T-cells: 523.0"	"Cell line enhanced"	"Detected in some"		"JURKAT: 4.0;MOLT-4: 15.2;RPMI-8226: 3.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB000012, HPA037756, CAB075722"	Enhanced		Supported	"Plasma membrane"	"Intracellular and membrane"	NA	NA		490000	"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 63: T-cells - Adaptive immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 58: T-cells - T-cell receptor"	"Plasma membrane"		"CAB000012: AB_2075537, CAB075722: AB_2665709, HPA037756: AB_2675648"	"unprognostic (1.29e-3)"	"prognostic favorable (4.54e-4)"	"unprognostic (9.26e-3)"	"prognostic favorable (6.15e-6)"	"unprognostic (7.28e-2)"	"unprognostic (2.79e-3)"	"unprognostic (1.03e-2)"	"unprognostic (2.00e-2)"	"unprognostic (1.35e-2)"	"unprognostic (4.50e-3)"	"unprognostic (1.09e-1)"	"unprognostic (1.14e-1)"	"prognostic unfavorable (1.91e-5)"	"unprognostic (1.36e-1)"	"unprognostic (1.48e-1)"	"unprognostic (6.74e-2)"	"unprognostic (1.56e-2)"	5.3	4.6	2.1	21.2	2.8	22.5	4.7	1.9	3.0	3.8	1.4	4.9	11.8	3.0	3.6	4.4	4.0	9.8	2.3	2.1	2.1	1.8	7.4	10.5	45.0	2.8	2.1	2.5	2.6	1.1	1.5	0.6	2.5	3.4	5.9	0.2	8.3	1.9	0.8	1.3	20.7	2.4	2.2	117.1	16.4	1.0	2.3	369.0	4.4	0.4	21.4	9.1	4.0	2.1	0.2	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.3	0.0	1.4	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	4.0	0.0	0.2	0.0	0.6	15.2	0.9	0.5	0.1	0.2	0.1	0.7	3.3	0.0	0.3	0.7	1.9	0.1	0.0	0.0	0.0	0.3	0.4	0.0	0.0	0.5	0.1	0.0	0.1	0.2	0.7	0.0	0.0	0.0	1.4	0.8	0.3	30.0	0.3	234.4	0.6	2.3	523.0	0.4	0.6	2.2	476.8	4.3	27.9	0.9	1.2	0.8	152.4	2.1	2.8	1.9	3.0	2.1	2.1	2.8	2.1	2.5	2.2	2.3	2.1	2.2	0.0	4.6	0.0	5.7	2.0	0.2	0.0	0.0	0.3	1.5	1.5	3.4	1.5	0.6	0.0	0.0	0.0	111.7	0.2	0.0	0.2	0.3	0.5	0.3	1.3	0.0	7.8	4.2	0.0	0.0	2.6	8.2	0.4	2.5	0.0	6.4	2.3	0.1	0.0	3.1	0.3	0.0	1.9	11.5	0.2	0.0	6.6	0.0	1.0	5.9	0.1	38.1	0.0	0.2	0.0	0.0	0.0	30.8	0.2	0.0	0.4	1.5	0.4	0.0	1.1	1.4	0.4	0.4	1.1	1.8	0.1	242.4	0.0	0.6	0.1
CD8B	CD8B1	ENSG00000172116	"CD8b molecule"	P10966	2	86815339-86861924	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	14	"lymphoid tissue: 459.6"	"Group enriched"	"Detected in many"	8	"dendritic cells: 53.2;T-cells: 162.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	10	"memory CD8 T-cell: 601.8;naive CD8 T-cell: 1053.9"	"Lineage enriched"	"Detected in all"	25	"T-cells: 1053.9"	"Cell line enriched"	"Detected in some"	60	"RPMI-8226: 1113.4"									"CAB004353, HPA029164"	Enhanced		Supported	"Plasma membrane"	"Intracellular and membrane"	NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 63: T-cells - Adaptive immune response"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Plasma membrane"		"CAB004353: AB_627211, HPA029164: AB_2672936"	"unprognostic (1.83e-3)"	"unprognostic (1.98e-3)"	"unprognostic (2.22e-2)"	"prognostic favorable (7.88e-7)"	"unprognostic (6.23e-2)"	"unprognostic (7.05e-3)"	"unprognostic (1.11e-2)"	"unprognostic (2.59e-2)"	"unprognostic (5.50e-3)"	"unprognostic (5.91e-2)"	"unprognostic (9.25e-2)"	"unprognostic (4.60e-1)"	"prognostic unfavorable (7.11e-6)"	"unprognostic (7.84e-2)"	"unprognostic (3.00e-1)"	"unprognostic (1.86e-2)"	"unprognostic (4.33e-2)"	1.9	1.9	0.4	10.6	0.3	8.3	2.9	1.1	0.6	33.4	0.1	2.1	5.0	1.2	1.1	1.6	1.5	4.3	1.0	0.1	1.2	1.0	1.6	4.2	25.9	5.0	2.1	0.9	0.9	4.6	8.8	0.3	4.8	1.7	3.0	0.0	2.4	1.0	0.6	1.4	15.1	1.1	0.7	15.6	5.1	0.4	2.4	459.6	2.0	0.4	15.1	3.4	1.9	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	18.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.4	0.0	0.0	0.0	0.0	7.0	0.0	0.0	0.0	0.1	0.2	0.0	1113.4	0.0	0.0	0.3	0.1	0.0	0.5	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	6.6	0.0	0.0	0.0	42.0	1.0	0.8	15.7	1.1	79.3	0.7	1.9	601.8	0.6	1.2	4.6	1053.9	6.1	1.1	1.7	1.0	2.2	427.6	0.4	0.3	1.1	0.6	0.1	1.2	5.0	2.1	4.8	0.7	2.4	0.5	1.3	6.4	5.5	0.0	4.4	4.0	2.2	0.0	0.6	0.0	2.2	2.8	1.0	1.5	0.0	0.0	0.0	0.1	53.2	0.1	0.0	0.1	0.5	0.2	0.5	0.7	0.0	1.7	0.4	0.0	0.0	2.0	7.1	0.2	0.0	0.0	0.7	0.5	0.1	0.0	0.5	4.6	0.0	4.0	4.3	0.5	0.0	4.1	5.4	5.6	7.5	0.0	10.3	0.0	0.1	0.0	0.1	0.0	10.8	0.7	12.4	0.2	0.0	0.0	0.0	2.0	1.2	0.2	0.1	0.5	2.8	0.0	162.9	0.0	7.5	0.3
CD9	"BA2, MIC3, MRP-1, P24, TSPAN29"	ENSG00000010278	"CD9 molecule"	P21926	12	6199715-6238271	"Cancer-related genes, CD markers, Plasma proteins, Predicted membrane proteins, Transporters"	"Cell adhesion, Fertilization"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 2822.0;Ionocytes: 4461.6;Urothelial cells: 2594.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	25	"basophil: 1957.3;eosinophil: 1156.4"	"Lineage enriched"	"Detected in all"	32	"granulocytes: 1957.3"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 1521.6;RT4: 1126.8;TIME: 2266.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB002490	Supported		Supported	"Plasma membrane"	"Intracellular and membrane"	NA	NA		1200000	"Cluster 2: Granulocytes - Unknown function"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Plasma membrane"		"CAB002490: AB_563643"	"unprognostic (1.38e-1)"	"unprognostic (6.36e-3)"	"unprognostic (8.27e-3)"	"unprognostic (6.98e-3)"	"unprognostic (3.89e-1)"	"unprognostic (2.81e-1)"	"unprognostic (1.32e-1)"	"unprognostic (2.08e-2)"	"unprognostic (2.90e-1)"	"unprognostic (2.60e-2)"	"prognostic unfavorable (1.59e-4)"	"unprognostic (2.30e-1)"	"prognostic favorable (6.49e-5)"	"unprognostic (6.10e-2)"	"unprognostic (1.77e-1)"	"prognostic favorable (8.93e-5)"	"unprognostic (9.26e-2)"	204.4	287.8	116.9	96.5	162.9	17.3	298.9	139.8	193.3	399.5	157.3	496.9	127.2	242.4	270.9	1000.2	242.3	102.4	267.5	124.3	132.3	294.2	79.4	403.0	37.4	165.8	141.0	69.0	93.4	881.8	98.1	85.4	160.2	488.5	466.2	32.6	614.5	456.4	74.4	455.3	211.2	197.0	139.2	69.5	178.2	26.4	146.5	66.1	338.0	116.6	289.4	373.1	566.4	207.1	417.6	173.7	3.5	108.7	167.7	170.8	150.1	241.1	477.8	80.8	121.9	128.5	1521.6	1.4	59.2	51.4	239.0	885.6	92.7	475.5	62.7	21.5	63.1	2.0	117.1	26.6	71.3	1.1	497.0	0.6	347.0	147.3	126.0	225.3	976.3	28.9	19.3	1.7	51.5	578.6	1.8	45.4	136.0	504.3	175.7	4.1	290.1	529.7	802.1	1126.8	0.5	34.0	240.9	195.8	215.8	789.0	91.1	42.1	2266.0	8.6	214.6	8.8	29.5	1.7	1.3	63.2	137.2	1.0	221.7	1957.3	61.1	1156.4	1.3	23.6	2.2	5.5	1.4	1.6	10.2	20.5	4.2	11.5	30.9	2.6	0.6	3.7	0.4	71.7	116.9	162.9	139.8	193.3	124.3	132.3	165.8	141.0	160.2	139.2	146.5	207.1	250.0	794.9	403.1	35.6	27.8	1037.8	1864.4	2822.0	804.1	4.9	433.5	379.5	20.9	84.4	1403.7	1075.9	0.0	21.5	8.7	929.9	137.0	599.1	3.0	457.8	66.8	496.5	172.9	10.5	0.4	178.2	271.0	356.9	60.6	722.6	653.4	42.3	522.6	43.1	618.0	0.0	0.6	744.8	4461.6	35.2	685.3	13.1	32.0	253.4	940.9	11.2	151.7	375.1	2.1	56.3	169.5	352.9	896.4	70.7	59.3	1576.4	330.0	21.7	1409.8	14.7	664.0	322.6	397.5	7.3	74.1	1214.3	1279.8	54.0	77.8	838.5	761.1	2594.9
CD99L2	"CD99B, MIC2L1"	ENSG00000102181	"CD99 molecule like 2"	Q8TCZ2	X	150766336-150898816	"Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 179.1"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 49.1;Horizontal cells: 52.2;Inhibitory neurons: 57.2;Oligodendrocytes: 60.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038782, HPA038783, HPA061400"	Enhanced		Supported	"Plasma membrane"		NA	NA		1200000	"Cluster 27: Non-specific - Gene expression"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Plasma membrane"		"HPA038782: AB_10795139, HPA038783: AB_10794734, HPA061400: AB_2732660"	"unprognostic (2.10e-2)"	"unprognostic (2.62e-3)"	"unprognostic (3.12e-3)"	"unprognostic (6.03e-3)"	"unprognostic (1.22e-1)"	"unprognostic (2.66e-1)"	"unprognostic (5.56e-2)"	"prognostic favorable (4.96e-4)"	"unprognostic (1.10e-1)"	"unprognostic (1.28e-1)"	"prognostic favorable (2.74e-5)"	"unprognostic (5.50e-2)"	"unprognostic (5.13e-2)"	"unprognostic (1.35e-1)"	"unprognostic (6.74e-2)"	"unprognostic (9.23e-2)"	"prognostic unfavorable (8.74e-4)"	46.1	28.1	68.5	14.8	69.5	7.3	29.7	71.0	99.6	33.4	26.8	40.1	10.0	39.9	24.5	14.5	30.5	19.2	61.6	69.9	80.4	24.9	47.3	25.2	13.2	104.7	77.9	38.9	18.7	14.6	23.8	21.5	107.2	25.8	10.6	43.4	14.8	32.6	179.1	13.4	19.2	32.4	71.5	26.9	21.8	11.2	91.6	14.5	16.8	99.2	10.7	29.4	21.0	80.2	8.1	79.8	29.5	36.9	153.3	95.2	8.7	65.2	76.1	32.3	46.3	5.5	10.2	29.3	154.0	114.6	24.2	13.0	40.4	44.4	26.6	68.5	31.9	12.7	17.8	8.2	41.2	21.4	23.3	90.3	14.5	24.0	45.4	50.3	38.6	22.4	8.9	74.9	41.1	17.3	18.9	31.1	12.4	6.9	42.7	18.8	24.2	40.5	31.7	5.4	38.9	19.9	25.8	21.9	29.6	21.6	6.2	36.6	45.8	47.5	14.4	62.2	48.0	62.6	112.3	28.3	59.6	42.3	36.4	7.3	8.6	5.9	6.2	7.6	5.4	4.5	5.8	6.3	8.1	4.8	5.5	6.0	2.1	7.2	12.5	5.8	4.4	7.0	68.5	69.5	71.0	99.6	69.9	80.4	104.7	77.9	107.2	71.5	91.6	80.2	14.1	16.0	7.8	21.5	8.2	3.1	2.3	3.6	4.6	26.8	3.7	3.2	42.8	11.5	6.4	12.9	18.8	10.1	7.4	2.0	5.9	4.4	0.3	5.6	10.1	13.8	8.4	6.5	49.1	5.3	3.9	15.9	7.1	3.6	7.6	12.6	17.2	26.6	10.2	52.2	57.2	2.9	8.2	16.4	6.8	2.8	20.8	8.6	10.6	23.4	8.1	18.2	2.1	21.6	60.7	3.6	3.1	30.1	12.5	3.4	5.3	11.3	5.0	18.7	0.0	15.9	12.0	2.8	4.9	3.3	1.3	13.5	6.4	11.8	3.3	1.3
CDAN1	"CDA-I, CDAI"	ENSG00000140326	"Codanin 1"	Q8IWY9	15	42723544-42737128	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"			"Congenital dyserythropoietic anemia, Disease variant, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Sertoli cells: 19.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in single"		"basophil: 1.0"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 1.0"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039404, HPA040787"	Supported		Enhanced	"Plasma membrane,Cytosol"		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 71: Testis - DNA repair"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 52: Non-specific - Transcription"	Cytosol	"Plasma membrane"	"HPA039404: AB_10673530, HPA040787: AB_2677137"	"unprognostic (1.11e-1)"	"unprognostic (1.24e-1)"	"unprognostic (5.79e-3)"	"unprognostic (1.24e-1)"	"unprognostic (2.10e-1)"	"unprognostic (7.71e-2)"	"prognostic unfavorable (1.07e-4)"	"unprognostic (7.17e-2)"	"unprognostic (9.82e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.95e-2)"	"unprognostic (1.26e-1)"	"unprognostic (4.35e-3)"	"unprognostic (2.05e-1)"	"unprognostic (1.16e-1)"	"unprognostic (9.20e-3)"	"unprognostic (2.04e-1)"	4.0	5.0	2.1	3.6	2.2	8.1	4.3	4.3	3.1	7.7	3.2	4.5	2.8	5.9	4.4	4.1	6.1	2.5	2.9	2.1	0.9	3.2	4.0	3.5	4.2	3.0	1.5	11.3	4.8	3.5	5.1	3.2	2.7	6.9	2.5	2.6	5.4	3.5	4.2	4.9	4.2	2.8	0.7	4.6	4.5	6.3	1.4	5.2	5.1	2.8	3.4	5.8	5.6	2.6	8.1	5.4	7.2	10.4	6.3	5.4	8.6	10.4	4.3	9.9	7.2	13.6	4.2	3.9	11.2	5.8	9.7	15.5	7.7	4.7	2.9	9.9	7.2	14.5	10.3	5.3	4.7	10.8	13.2	7.4	5.2	6.3	4.5	6.1	7.6	13.0	18.9	5.7	8.2	4.5	8.4	14.2	3.6	7.7	8.5	11.9	9.0	3.4	3.1	7.9	5.9	6.8	8.2	11.3	1.7	4.6	8.6	15.9	5.6	10.4	9.2	8.6	12.1	11.2	12.7	8.7	5.4	15.8	8.6	1.0	0.0	0.5	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.0	2.1	2.2	4.3	3.1	2.1	0.9	3.0	1.5	2.7	0.7	1.4	2.6	2.0	0.0	3.7	4.6	2.4	1.9	2.0	1.5	1.8	3.3	3.2	1.8	2.2	2.8	1.5	7.3	4.2	3.0	2.6	1.9	0.0	1.5	0.4	2.0	2.8	2.3	4.8	1.7	7.6	1.8	1.6	2.9	3.6	2.0	1.3	9.0	3.9	3.6	2.1	1.7	6.3	1.6	4.1	2.5	0.9	1.2	4.4	1.6	0.0	4.7	1.5	4.5	2.1	5.5	3.8	1.6	0.5	4.9	2.5	2.3	2.2	1.3	1.9	4.7	19.7	3.4	2.4	5.4	2.1	2.8	1.3	2.2	2.5	4.6	2.6	1.7
CDC14A	"cdc14, Cdc14A1, Cdc14A2, DFNB105, DFNB32"	ENSG00000079335	"Cell division cycle 14A"	Q9UNH5	1	100345001-100520277	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, Cell division, Hearing"	"Hydrolase, Protein phosphatase"	"Deafness, Disease variant, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 28.2"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 145.9;Early spermatids: 171.5;Late spermatids: 191.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"K-562: 44.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023783	Approved		Supported	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 34: Spermatids - Unknown function"	Nucleoplasm	"Nuclear bodies, Cytosol"	"HPA023783: AB_1846352"	"unprognostic (3.72e-2)"	"unprognostic (2.38e-2)"	"unprognostic (1.84e-2)"	"unprognostic (2.98e-2)"	"unprognostic (1.54e-3)"	"unprognostic (1.38e-1)"	"unprognostic (9.27e-4)"	"unprognostic (4.88e-3)"	"unprognostic (6.30e-2)"	"unprognostic (3.97e-3)"	"unprognostic (8.83e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.79e-3)"	"unprognostic (6.29e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.49e-2)"	"unprognostic (6.66e-2)"	3.6	1.5	3.9	4.6	3.1	15.5	11.3	2.7	4.2	5.4	5.2	6.0	7.3	5.3	2.7	2.2	13.0	3.3	2.3	3.7	4.5	6.3	1.8	5.9	7.2	4.3	4.9	4.6	2.0	6.0	3.6	5.1	3.3	7.6	6.0	5.5	3.4	3.0	2.6	3.8	10.7	4.7	3.5	6.7	5.8	28.2	3.6	6.4	5.8	2.8	4.4	4.4	3.3	3.2	3.3	2.6	8.1	9.3	2.9	2.1	5.7	4.1	2.7	3.9	3.1	8.9	2.7	1.6	3.0	2.4	3.2	2.5	5.6	2.3	4.0	3.4	13.7	5.8	2.3	2.9	1.1	7.8	9.8	1.8	0.6	4.3	1.4	2.0	7.0	3.3	44.7	4.8	5.8	1.4	6.3	8.7	5.1	2.1	3.3	6.8	10.6	1.7	2.8	7.2	1.5	2.7	4.3	4.1	5.6	3.9	1.9	10.0	3.1	2.2	4.9	3.8	2.5	2.4	0.9	2.5	2.7	7.3	1.3	12.2	3.6	9.0	6.9	3.3	12.5	4.5	10.9	8.2	3.5	2.9	10.2	5.5	5.4	4.4	2.3	6.2	6.0	4.1	3.9	3.1	2.7	4.2	3.7	4.5	4.3	4.9	3.3	3.5	3.6	3.2	14.1	3.2	5.5	145.9	10.6	3.7	4.5	1.7	4.6	0.4	15.8	11.0	6.6	0.0	4.4	1.8	4.2	2.7	23.2	18.4	0.0	3.0	171.5	48.3	11.8	13.5	4.8	3.8	4.3	1.9	1.0	7.0	6.6	51.1	15.2	4.8	7.1	1.0	2.8	0.0	1.4	4.0	2.0	5.5	7.3	191.7	5.0	11.1	5.4	51.5	9.3	11.4	6.2	53.8	3.6	3.1	11.2	0.7	13.5	5.2	22.9	2.5	22.5	3.8	0.0	6.2	6.0	2.3	3.6	4.9	2.4	2.2	44.1	3.0	3.7	4.1
CDC14B	"Cdc14B1, Cdc14B2, CDC14B3, hCDC14B"	ENSG00000081377	"Cell division cycle 14B"	O60729	9	96490241-96619843	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"DNA damage, DNA repair"	"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 27.3"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 86.5;Excitatory neurons: 83.5;Inhibitory neurons: 110.2;Oligodendrocyte precursor cells: 156.9;Oligodendrocytes: 273.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	5	"basophil: 10.4"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 10.4"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 30.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA064747			Supported	Nucleoplasm		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Nucleoplasm		"HPA064747: AB_2732719"	"unprognostic (5.69e-2)"	"unprognostic (9.09e-2)"	"unprognostic (3.50e-2)"	"unprognostic (8.08e-3)"	"unprognostic (4.24e-1)"	"unprognostic (1.19e-2)"	"unprognostic (1.11e-2)"	"unprognostic (4.49e-2)"	"unprognostic (1.63e-2)"	"unprognostic (2.27e-2)"	"unprognostic (2.35e-1)"	"unprognostic (2.75e-1)"	"prognostic favorable (2.97e-10)"	"unprognostic (2.01e-2)"	"unprognostic (2.61e-1)"	"prognostic unfavorable (2.82e-4)"	"unprognostic (7.40e-2)"	4.3	2.3	11.1	1.1	15.8	3.0	3.0	6.1	11.7	2.9	1.4	3.1	2.8	1.3	2.0	1.4	4.2	2.9	5.0	5.2	6.9	5.5	10.3	3.0	0.9	11.0	12.1	3.4	4.6	6.9	1.1	2.0	11.4	3.3	3.3	1.7	1.8	4.1	0.7	0.8	3.3	1.7	10.4	0.8	6.1	9.3	11.4	2.9	8.5	1.4	1.2	4.1	0.8	27.3	7.4	4.1	4.2	4.4	20.2	30.1	11.6	5.3	7.0	3.5	5.6	14.0	11.6	0.0	5.0	11.3	8.4	8.1	6.1	4.0	4.1	1.9	5.8	1.1	1.5	11.2	3.3	0.0	0.2	12.4	2.1	3.7	3.4	4.0	0.7	0.0	4.4	0.8	4.8	3.5	0.0	1.2	7.9	8.4	3.6	0.0	2.6	0.2	5.4	11.3	1.3	6.6	3.7	1.1	2.0	14.2	0.9	2.3	2.2	3.5	4.1	9.0	3.9	0.1	0.0	0.0	3.7	0.0	8.3	10.4	0.0	2.2	2.0	0.0	1.0	1.1	0.8	1.5	0.0	0.4	1.4	0.9	0.0	0.1	0.0	0.0	1.1	0.6	11.1	15.8	6.1	11.7	5.2	6.9	11.0	12.1	11.4	10.4	11.4	27.3	4.0	6.4	8.8	86.5	3.7	9.1	8.9	4.4	9.1	7.2	8.4	6.1	17.9	11.5	11.4	9.2	8.4	6.4	2.3	7.1	7.9	5.5	36.9	27.4	7.5	6.2	2.4	0.4	83.5	6.5	3.0	17.3	21.4	33.9	14.5	2.9	6.8	31.2	11.3	8.4	110.2	9.0	8.2	1.6	6.7	33.3	9.0	5.5	8.8	56.2	2.4	12.8	2.1	156.9	273.9	8.6	7.3	11.7	8.3	10.8	16.9	17.0	15.7	12.4	26.3	18.6	15.7	10.8	7.3	4.7	7.7	3.4	4.4	1.2	8.6	13.2
CDC34	"E2-CDC34, UBC3, UBE2R1"	ENSG00000099804	"Cell division cycle 34, ubiqiutin conjugating enzyme"	P49427	19	531760-542092	"Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Cell cycle, Ubl conjugation pathway"	Transferase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Late spermatids: 249.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002382, CAB005109, CAB047311, HPA074334"	Approved		Supported	"Nucleoplasm,Nuclear speckles,Cytosol"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 10: Non-specific - Unknown function"	"Nucleoplasm, Nuclear speckles"	Cytosol	"CAB005109: AB_2276050, CAB047311: , HPA002382: AB_1846370, HPA074334: "	"unprognostic (4.65e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.41e-1)"	"unprognostic (8.72e-2)"	"unprognostic (2.84e-1)"	"unprognostic (5.73e-2)"	"prognostic unfavorable (7.57e-4)"	"unprognostic (2.20e-1)"	"unprognostic (3.11e-1)"	"unprognostic (3.83e-2)"	"unprognostic (2.09e-2)"	"unprognostic (3.06e-2)"	"unprognostic (3.02e-2)"	"unprognostic (8.87e-3)"	"unprognostic (9.68e-2)"	"unprognostic (7.82e-3)"	"unprognostic (3.33e-2)"	35.1	36.7	52.0	13.3	51.2	34.5	34.2	51.5	63.0	36.9	47.5	62.5	17.8	33.5	14.1	40.5	33.6	10.1	80.0	52.7	48.7	32.1	88.0	32.1	12.5	51.0	50.7	35.6	58.5	18.7	43.4	29.2	50.8	36.9	11.5	28.2	34.2	19.3	105.0	51.8	27.6	18.5	48.2	31.0	38.6	100.2	52.7	16.4	26.7	63.2	9.7	43.7	34.2	52.7	54.8	54.6	66.4	54.7	29.2	28.4	68.5	47.8	36.1	50.2	51.9	86.1	32.8	29.5	49.3	34.1	30.1	36.9	52.1	40.2	25.0	49.2	146.0	27.8	35.5	94.5	73.6	39.0	32.4	36.4	58.9	42.2	43.6	38.8	60.6	41.2	120.3	57.5	33.8	80.7	53.3	53.6	85.3	39.4	51.7	49.1	35.1	51.2	38.0	32.4	87.2	65.9	41.5	42.1	85.2	53.2	34.0	57.4	50.5	36.5	43.7	86.2	65.2	57.7	47.3	40.1	50.0	55.6	38.8	3.2	2.5	4.7	1.6	2.7	1.1	2.3	2.1	2.9	2.0	1.0	1.6	1.6	8.2	1.2	3.5	1.6	2.5	1.0	52.0	51.2	51.5	63.0	52.7	48.7	51.0	50.7	50.8	48.2	52.7	52.7	39.4	0.0	5.4	21.9	11.4	46.8	17.5	5.4	16.5	35.5	43.4	47.1	27.7	27.1	3.5	14.7	25.0	44.3	30.9	47.4	13.7	24.9	63.9	29.6	28.3	27.7	13.2	77.7	8.3	20.5	55.4	21.4	16.8	42.3	0.0	28.1	15.7	41.1	27.9	16.8	6.3	34.0	14.2	14.5	38.6	249.4	18.0	20.6	19.6	2.8	15.1	68.9	20.6	6.6	12.9	45.0	27.0	15.1	25.0	34.8	25.9	18.9	5.5	44.3	13.1	22.6	34.9	22.4	54.6	15.2	54.7	63.1	22.0	27.1	23.7	27.9
CDC37	P50CDC37	ENSG00000105401	"Cell division cycle 37, HSP90 cochaperone"	Q16543	19	10391133-10420121	"Cancer-related genes, Predicted intracellular proteins, Transporters"		Chaperone	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003928, CAB004214"	Supported		Supported	Cytosol		NA	NA		610000	"Cluster 27: Non-specific - Gene expression"	"Cluster 59: Non-specific - Translation"	"Cluster 24: NB-4 - Immune response"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Cytosol		"CAB004214: AB_627232, HPA003928: AB_1846373"	"unprognostic (2.40e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.33e-2)"	"unprognostic (2.46e-3)"	"unprognostic (6.21e-2)"	"unprognostic (1.37e-1)"	"unprognostic (7.90e-2)"	"unprognostic (1.25e-1)"	"unprognostic (7.61e-3)"	"unprognostic (1.96e-2)"	"unprognostic (1.82e-2)"	"unprognostic (1.84e-2)"	"prognostic favorable (2.33e-4)"	"unprognostic (5.80e-2)"	"unprognostic (1.23e-1)"	"unprognostic (3.02e-2)"	149.9	93.6	82.2	81.3	84.6	89.5	130.6	75.0	104.2	111.4	72.1	109.9	58.1	110.0	34.2	125.7	98.5	39.8	186.0	86.3	85.8	123.2	102.2	129.9	66.5	85.9	85.8	105.9	100.3	59.3	74.6	62.7	88.1	105.0	48.2	34.6	96.6	52.2	313.2	100.9	96.3	50.2	75.7	137.5	102.8	77.5	82.5	69.3	100.8	222.6	52.4	110.3	103.0	87.8	279.2	181.2	95.5	137.5	128.8	111.8	122.9	322.8	144.6	198.3	168.8	209.1	106.7	165.3	254.7	198.3	117.2	169.9	130.6	208.7	136.4	133.6	387.2	313.9	147.2	300.9	202.5	183.9	137.9	136.9	112.5	231.8	104.0	113.5	258.1	142.2	248.2	193.8	156.1	265.3	184.3	450.2	234.6	175.5	317.8	181.0	128.3	190.3	185.1	178.2	111.5	161.9	151.5	158.1	143.1	72.7	108.4	195.7	290.0	230.8	133.9	319.9	262.2	261.3	276.5	204.4	181.4	294.1	191.2	77.2	110.8	97.1	114.4	107.9	103.1	73.2	91.8	103.5	105.2	62.9	70.0	81.8	60.2	101.1	112.6	89.4	106.8	145.6	82.2	84.6	75.0	104.2	86.3	85.8	85.9	85.8	88.1	75.7	82.5	87.8	420.1	54.5	95.5	51.6	163.7	148.6	119.3	149.0	127.5	78.0	85.0	75.8	71.3	75.8	114.8	64.4	39.6	188.9	166.1	192.3	101.8	199.8	119.0	88.2	120.5	267.5	81.3	89.8	35.0	199.0	430.2	108.3	226.8	126.4	134.3	90.8	172.1	45.3	210.2	89.2	24.6	181.3	105.8	83.9	313.8	253.8	106.2	165.6	138.7	29.0	165.1	75.8	135.9	21.1	32.5	297.6	183.5	103.4	170.5	120.1	117.9	89.7	78.2	84.4	78.9	94.4	138.6	72.4	73.5	138.1	133.7	242.4	164.2	123.0	186.1	156.1
CDC37L1	"CDC37B, FLJ20639, HARC"	ENSG00000106993	"Cell division cycle 37 like 1"	Q7L3B6	9	4679559-4708399	"Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 86.5"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in all"	4	"HDLM-2: 126.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021175	Approved		Supported	Cytosol		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 39: Non-specific - Basic cellular processes"	Cytosol		"HPA021175: AB_10959752"	"unprognostic (1.18e-2)"	"unprognostic (8.52e-2)"	"unprognostic (2.63e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.61e-1)"	"unprognostic (2.38e-2)"	"unprognostic (3.66e-3)"	"unprognostic (2.71e-2)"	"unprognostic (9.89e-2)"	"unprognostic (7.82e-3)"	"unprognostic (2.78e-2)"	"unprognostic (7.97e-2)"	"prognostic favorable (2.66e-7)"	"unprognostic (8.54e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.91e-2)"	"unprognostic (4.28e-2)"	20.4	15.6	10.6	9.5	10.9	8.0	13.8	12.2	13.1	14.2	11.6	13.8	10.1	12.9	13.8	19.9	13.2	14.6	31.2	14.0	12.8	16.6	55.0	10.5	13.1	11.1	12.0	15.0	19.6	11.6	10.1	9.6	12.4	15.9	7.9	12.9	12.5	12.0	86.5	10.2	10.4	12.3	11.2	8.4	11.8	14.2	11.9	9.8	14.7	52.5	9.4	17.6	11.1	12.0	17.1	15.2	7.8	12.7	27.9	20.4	12.1	19.6	13.4	11.7	13.3	4.9	10.4	10.8	5.4	14.3	7.8	7.4	8.8	11.9	11.3	126.8	7.6	28.7	15.8	13.3	16.7	11.6	11.3	13.3	15.3	8.7	13.7	12.9	8.5	9.7	3.4	16.2	13.1	8.2	9.2	24.0	20.0	11.2	5.3	7.3	9.6	6.2	16.6	6.9	22.5	11.2	14.6	11.7	9.8	10.0	9.6	10.9	9.1	17.5	8.2	9.9	13.1	12.5	21.2	7.8	15.6	8.2	5.7	26.5	7.7	15.7	17.0	7.5	16.7	14.1	17.0	18.1	7.5	15.0	25.8	23.5	9.0	12.3	10.0	8.6	17.4	10.6	10.6	10.9	12.2	13.1	14.0	12.8	11.1	12.0	12.4	11.2	11.9	12.0	17.7	28.9	18.3	23.2	19.6	65.9	48.0	31.9	31.9	28.3	24.7	19.0	80.4	25.8	26.3	16.5	33.3	19.7	27.9	15.1	49.0	33.5	9.8	25.9	23.3	20.7	17.9	5.7	24.2	41.2	17.0	35.1	19.9	16.1	23.5	12.9	17.5	103.9	11.3	20.2	29.4	20.0	40.7	13.6	25.1	5.1	36.1	14.8	40.9	9.4	14.9	36.7	18.6	21.1	23.0	27.3	17.3	36.5	20.9	76.5	15.7	66.0	25.3	22.6	32.9	27.8	43.0	77.3	58.1	25.0	57.4	33.8	31.9	15.5	12.0	44.0
CDC40	"EHB3, FLJ10564, PRP17, PRPF17"	ENSG00000168438	"Cell division cycle 40"	O60508	6	110180141-110254275	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 257.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046620			Supported	Nucleoplasm	"Intracellular and membrane"	NA	NA			"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 29: Early spermatids - Spermatogenesis"	Nucleoplasm		"HPA046620: AB_2679722"	"unprognostic (4.19e-3)"	"unprognostic (2.41e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.10e-2)"	"unprognostic (4.25e-2)"	"unprognostic (3.64e-2)"	"unprognostic (3.42e-2)"	"unprognostic (5.24e-1)"	"unprognostic (2.82e-1)"	"unprognostic (1.08e-1)"	"unprognostic (9.27e-2)"	"unprognostic (1.92e-1)"	"unprognostic (4.68e-2)"	"unprognostic (7.36e-2)"	"unprognostic (1.09e-1)"	"unprognostic (3.01e-1)"	"unprognostic (2.09e-1)"	11.1	14.7	6.9	13.3	10.3	38.2	13.6	6.5	10.9	11.3	7.3	11.1	11.1	11.7	10.4	10.7	11.0	10.4	10.5	10.2	6.1	16.3	16.9	11.0	19.6	4.7	5.0	16.1	12.4	14.0	9.4	9.9	5.0	12.5	12.1	14.8	11.0	9.4	11.6	10.6	11.0	10.1	5.2	16.0	11.4	11.8	5.2	18.6	15.9	11.6	18.6	12.6	8.5	9.2	11.3	10.4	18.2	31.8	18.3	18.8	14.8	21.5	26.4	21.3	26.9	22.8	11.3	37.8	23.7	19.2	22.7	15.8	28.2	17.5	30.1	30.5	21.3	31.0	14.4	12.4	24.2	40.2	39.8	17.1	16.4	22.5	18.1	15.9	21.6	24.3	31.5	22.0	21.3	11.0	29.9	14.9	18.1	15.1	11.2	26.0	21.4	13.1	15.5	23.6	19.4	19.1	15.8	13.8	15.9	16.6	12.8	38.1	24.5	11.5	11.4	27.3	24.1	11.0	15.9	33.8	18.6	33.2	17.4	28.6	18.7	20.4	13.8	20.3	13.7	29.5	13.7	14.3	15.9	28.3	16.2	14.1	20.8	16.5	23.4	24.9	16.8	10.2	6.9	10.3	6.5	10.9	10.2	6.1	4.7	5.0	5.0	5.2	5.2	9.2	38.9	32.1	37.6	18.3	85.7	26.4	26.2	43.1	36.5	94.4	32.2	32.8	21.5	30.0	37.5	27.6	43.8	32.9	79.2	20.9	56.7	35.8	257.8	34.6	48.4	35.5	26.4	44.2	65.4	37.3	30.9	35.8	35.2	30.4	49.4	43.0	38.9	56.6	37.8	94.2	25.6	29.8	22.4	44.9	28.6	84.6	67.4	49.6	10.6	24.4	76.0	46.1	57.7	27.2	43.6	28.5	28.9	45.1	27.8	23.4	29.1	74.0	31.0	84.0	78.9	38.2	39.3	20.9	22.5	37.6	27.1	28.7	59.0	70.6	35.5	22.4
CDC42	"CDC42Hs, G25K"	ENSG00000070831	"Cell division cycle 42"	P60953	1	22025511-22101360	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins"	"Differentiation, Neurogenesis"	Hydrolase	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004360, HPA069590"	Approved		Supported	"Microtubules,Cytokinetic bridge"		Yes	No		2700000	"Cluster 49: Eosinophils - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 10: Non-specific - Unknown function"	"Microtubules, Cytokinetic bridge"		"CAB004360: AB_627233, HPA069590: AB_2732138"	"unprognostic (9.40e-2)"	"unprognostic (1.37e-1)"	"unprognostic (9.45e-3)"	"unprognostic (5.11e-2)"	"unprognostic (1.73e-1)"	"unprognostic (9.72e-2)"	"prognostic unfavorable (5.28e-5)"	"unprognostic (1.09e-1)"	"unprognostic (7.92e-3)"	"unprognostic (1.86e-2)"	"unprognostic (3.90e-2)"	"unprognostic (9.41e-2)"	"unprognostic (9.72e-3)"	"unprognostic (2.71e-1)"	"unprognostic (3.88e-2)"	"unprognostic (6.38e-2)"	"unprognostic (2.09e-1)"	177.4	116.1	91.7	160.2	96.5	402.9	142.7	100.1	113.8	128.6	98.4	198.2	142.3	131.3	99.8	162.3	124.8	131.7	117.0	95.2	108.8	158.8	153.5	154.1	167.9	115.5	103.7	105.9	82.5	128.4	59.6	170.3	108.4	108.3	185.4	95.9	103.8	107.5	119.9	132.0	156.9	175.0	107.4	157.5	159.9	64.2	102.2	157.7	110.6	120.9	216.8	194.8	114.9	127.1	341.9	146.4	272.2	222.0	295.0	306.4	274.2	347.3	318.8	365.5	336.2	178.0	374.5	253.1	272.8	416.7	136.2	210.7	241.1	369.3	431.1	332.4	180.1	438.1	184.5	225.4	259.1	388.5	350.5	285.6	396.6	341.0	195.2	234.7	535.6	157.8	250.8	273.4	430.2	135.6	242.9	307.5	170.2	242.9	179.3	199.6	297.6	243.3	316.2	301.3	183.4	175.8	293.4	228.7	263.4	296.3	242.3	219.1	466.3	265.3	265.2	349.3	207.8	148.6	355.9	305.8	234.5	419.3	277.6	244.3	200.6	255.1	142.4	282.3	144.3	108.0	152.0	146.7	162.3	103.4	109.5	143.5	308.3	145.0	352.2	107.2	157.4	244.8	91.7	96.5	100.1	113.8	95.2	108.8	115.5	103.7	108.4	107.4	102.2	127.1	502.1	60.9	51.8	20.9	301.0	450.6	385.5	266.0	136.1	119.1	281.1	179.6	86.9	231.6	168.0	312.6	18.8	349.6	470.1	434.9	375.6	441.3	38.0	350.5	356.5	307.7	300.4	243.0	58.5	441.9	499.6	225.2	152.4	425.8	163.6	138.2	277.0	230.9	439.2	106.0	71.0	315.4	187.2	585.4	875.2	41.3	157.8	443.4	423.4	53.4	654.9	102.5	286.3	41.7	72.9	570.5	369.7	177.1	192.9	323.1	283.1	578.2	176.2	65.2	236.7	174.2	308.3	155.3	116.2	176.6	556.6	551.6	379.2	178.6	286.7	469.6
CDC42BPG	"DMPK2, HSMDPKIN, kappa-200, MRCKgamma"	ENSG00000171219	"CDC42 binding protein kinase gamma"	Q6DT37	11	64823052-64844653	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skin 1: 33.7"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 14.8;Gastric mucus-secreting cells: 23.0;Paneth cells: 18.3;Squamous epithelial cells: 19.3"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in some"	8	"cerebellum: 9.7"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BEWO: 29.3;HaCaT: 22.5;MCF7: 30.7;RT4: 18.4;SK-BR-3: 18.4;T-47d: 18.1"	"Region enriched"	"Detected in all"	4	"cerebellum: 10.5"	"Low region specificity"	"Detected in some"			"HPA027382, HPA061836"	Enhanced		Supported	Cytosol		NA	NA				"Cluster 31: Skin - Epidermis development"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 61: Squamous epithelial cells - Keratinization"	Cytosol		"HPA027382: AB_1846378, HPA061836: AB_2684622"	"unprognostic (3.26e-2)"	"unprognostic (1.58e-1)"	"unprognostic (6.00e-2)"	"unprognostic (2.60e-1)"	"unprognostic (1.21e-1)"	"unprognostic (2.50e-1)"	"unprognostic (4.68e-1)"	"unprognostic (5.27e-2)"	"unprognostic (3.91e-2)"	"unprognostic (3.65e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.81e-1)"	"prognostic favorable (5.99e-13)"	"unprognostic (2.60e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.14e-2)"	"unprognostic (3.99e-3)"	0.5	4.9	0.2	1.4	0.3	2.1	4.8	9.7	1.2	5.4	5.5	8.8	10.6	0.4	2.0	26.5	3.8	2.8	0.4	0.4	0.3	7.7	0.9	7.8	1.3	0.4	0.7	2.2	14.1	6.4	11.0	4.2	1.0	8.5	4.5	0.3	17.7	3.7	0.2	33.7	9.3	0.2	0.3	1.8	12.2	3.3	0.3	2.4	6.0	0.0	2.0	5.8	13.0	0.3	8.9	1.2	0.8	0.0	0.0	0.0	29.3	0.0	0.0	0.0	0.0	11.7	7.5	0.1	4.3	0.0	0.4	22.5	1.3	8.8	0.0	0.4	3.6	0.7	5.3	3.8	0.0	0.3	2.2	0.0	10.9	0.1	0.1	0.1	0.1	3.5	6.1	0.1	0.0	30.7	0.2	1.7	2.7	8.3	1.3	1.3	0.5	4.3	5.5	18.4	15.6	0.7	2.8	18.4	0.5	4.3	18.1	0.4	0.1	0.0	3.1	0.1	0.1	2.1	2.2	2.2	0.0	0.3	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	9.7	1.2	0.4	0.3	0.4	0.7	1.0	0.3	0.3	0.3	1.0	9.6	7.9	0.0	1.2	6.5	2.3	3.6	9.6	0.0	5.1	5.8	1.8	2.8	9.6	1.8	0.0	6.4	1.7	14.8	0.0	2.4	0.6	13.2	0.7	0.4	3.6	0.8	0.1	6.2	4.9	0.7	23.0	7.9	1.3	0.4	0.0	0.0	1.0	0.0	0.1	4.8	2.0	0.0	0.4	0.8	0.0	1.3	0.0	0.0	1.2	0.8	1.0	0.0	0.1	2.9	18.3	0.0	0.1	1.6	12.4	0.5	9.5	0.0	0.0	2.2	0.8	1.7	1.3	19.3	8.1	6.7	1.4	0.6	5.7	3.4
CDC42EP1	"Borg5, CEP1, MSE55"	ENSG00000128283	"CDC42 effector protein 1"	Q00587	22	37560480-37569405	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Ductal cells: 245.6;Exocrine glandular cells: 226.0;Pancreatic endocrine cells: 266.2;Urothelial cells: 161.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	8	"classical monocyte: 7.3;intermediate monocyte: 1.9;myeloid DC: 2.4"	"Group enriched"	"Detected in many"	10	"dendritic cells: 2.4;monocytes: 7.3"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006379, HPA076536"	Approved		Supported	"Nucleoplasm,Plasma membrane,Actin filaments"		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 22: Non-specific - Unknown function"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 1: Pancreatic cells - Digestion"	"Plasma membrane"	"Nucleoplasm, Actin filaments"	"HPA006379: AB_1078486, HPA076536: "	"unprognostic (1.32e-1)"	"unprognostic (1.81e-1)"	"unprognostic (2.44e-1)"	"unprognostic (3.79e-3)"	"unprognostic (5.82e-2)"	"unprognostic (4.06e-2)"	"unprognostic (4.38e-2)"	"unprognostic (5.57e-2)"	"unprognostic (9.45e-2)"	"unprognostic (1.63e-1)"	"unprognostic (2.06e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.86e-2)"	"unprognostic (2.85e-2)"	"unprognostic (3.85e-2)"	"unprognostic (3.81e-2)"	"unprognostic (1.09e-3)"	76.3	91.2	55.7	16.7	107.5	1.6	58.0	89.9	73.3	68.2	17.6	43.7	31.1	70.7	4.1	93.1	61.0	40.8	53.8	55.9	67.3	50.2	133.1	65.2	11.3	102.8	104.5	60.9	161.6	16.5	18.8	31.8	97.4	41.5	14.4	2.6	102.7	23.9	13.1	71.2	32.7	19.6	70.2	26.2	155.9	23.6	87.5	2.7	33.7	11.1	10.4	38.4	69.6	151.5	125.2	35.4	15.1	67.9	23.7	40.2	73.3	69.9	41.0	78.9	54.3	87.8	15.9	0.2	24.2	81.4	25.4	95.0	17.8	35.1	26.0	15.5	60.7	0.5	33.9	53.6	167.7	0.3	0.6	74.9	52.1	65.0	61.5	63.1	59.2	0.1	78.9	0.7	33.0	42.6	0.3	0.5	13.6	96.5	79.6	0.4	27.5	2.4	27.9	1.9	0.4	2.6	51.2	112.3	112.4	20.6	50.3	11.0	91.6	163.9	98.2	80.0	98.6	0.2	0.8	0.3	65.3	0.7	135.6	0.4	7.3	0.0	0.1	1.9	0.1	0.0	0.1	0.1	2.4	0.3	0.0	0.2	0.2	0.4	0.1	0.3	0.0	3.4	55.7	107.5	89.9	73.3	55.9	67.3	102.8	104.5	97.4	70.2	87.5	151.5	62.4	6.4	19.5	2.3	1.8	46.9	87.2	51.4	21.1	0.1	59.2	31.8	3.5	134.4	41.1	12.9	0.0	98.2	2.0	41.6	1.9	245.6	3.7	4.3	20.0	54.7	11.5	0.0	0.1	226.0	110.3	32.1	133.0	9.0	2.5	1.7	69.7	35.6	13.2	1.7	0.2	66.6	30.5	5.9	29.3	1.7	39.4	5.3	21.4	4.7	8.9	12.8	0.0	2.0	42.7	266.2	45.8	35.3	0.6	122.4	17.5	11.4	14.7	0.3	39.5	22.8	49.5	2.0	0.6	55.9	52.0	112.2	2.2	7.0	61.1	161.3
CDC42EP2	"BORG1, CEP2"	ENSG00000149798	"CDC42 effector protein 2"	O14613	11	65314866-65322417	"Predicted intracellular proteins"	"Cell shape"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Ductal cells: 50.5;Langerhans cells: 77.7;Pancreatic endocrine cells: 65.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	11	"classical monocyte: 50.4;intermediate monocyte: 118.8;neutrophil: 171.5;non-classical monocyte: 88.5"	"Group enriched"	"Detected in many"	15	"granulocytes: 171.5;monocytes: 118.8"	"Cell line enhanced"	"Detected in many"		"HHSteC: 51.5;PC-3: 61.0;U-2197: 55.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038562	Approved		Supported	Microtubules,Cytosol		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 18: U-2197 - ECM organization"	"Cluster 41: Macrophages - Immune response"	"Microtubules, Cytosol"		"HPA038562: AB_10671745"	"unprognostic (1.69e-1)"	"unprognostic (2.40e-2)"	"unprognostic (9.91e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.24e-2)"	"unprognostic (4.73e-3)"	"prognostic unfavorable (2.89e-5)"	"prognostic unfavorable (6.66e-4)"	"unprognostic (1.01e-1)"	"unprognostic (5.36e-2)"	"unprognostic (8.57e-3)"	"unprognostic (3.81e-1)"	"unprognostic (1.68e-1)"	"unprognostic (2.66e-2)"	"unprognostic (3.67e-2)"	"unprognostic (2.89e-2)"	"unprognostic (1.89e-2)"	42.1	5.7	15.4	7.7	25.1	0.4	23.1	20.7	20.0	13.9	5.8	15.4	9.1	16.6	1.7	7.7	15.3	15.2	22.4	15.7	17.0	15.3	4.1	19.1	1.8	24.9	23.6	10.8	5.8	0.6	5.0	11.6	22.3	10.2	1.6	1.9	4.9	4.5	6.6	5.6	13.0	6.8	17.5	18.4	14.5	2.1	21.4	0.4	16.8	5.6	1.2	18.6	9.4	44.3	7.1	6.6	0.9	4.3	14.6	26.4	1.3	7.4	28.8	5.5	6.2	19.8	16.7	0.5	20.9	19.9	2.0	8.9	2.5	26.0	1.2	1.0	3.8	1.3	12.8	14.8	51.5	0.4	0.5	11.5	2.7	20.3	28.8	4.5	22.4	1.0	2.6	4.3	7.1	10.7	0.8	1.6	3.7	18.5	61.0	0.8	0.7	0.5	19.5	4.9	0.5	1.7	18.0	14.7	1.1	0.7	2.5	0.4	30.6	6.7	5.6	55.9	3.1	0.1	1.7	0.6	11.2	0.3	2.7	0.0	50.4	2.1	0.1	118.8	0.1	1.2	0.0	0.1	9.9	0.0	0.1	0.0	171.5	0.0	88.5	0.4	0.0	17.8	15.4	25.1	20.7	20.0	15.7	17.0	24.9	23.6	22.3	17.5	21.4	44.3	25.8	0.0	0.0	0.0	1.5	12.7	11.0	25.8	6.8	15.3	12.1	6.3	6.3	2.8	17.0	12.9	0.0	0.5	1.6	10.0	3.9	50.5	0.5	6.0	11.6	36.4	1.8	2.7	0.6	40.3	3.5	32.3	9.7	11.1	5.7	1.5	26.7	0.9	1.3	3.3	0.4	8.0	8.2	18.7	77.7	1.9	18.6	33.3	12.4	1.0	18.3	1.0	0.0	0.0	10.6	65.1	15.6	13.5	1.8	7.4	21.2	3.7	6.3	5.3	39.5	16.6	16.2	1.7	3.4	4.8	10.1	1.6	1.4	1.8	8.4	36.4
CDC42EP3	"BORG2, CEP3, UB1"	ENSG00000163171	"CDC42 effector protein 3"	Q9UKI2	2	37641882-37738468	"Predicted intracellular proteins"	"Cell shape"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 233.5;Langerhans cells: 259.6;Melanocytes: 200.9"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in many"		"cerebral cortex: 24.8"	"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"LHCN-M2: 607.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034986, HPA061792"	Approved		Supported	"Plasma membrane,Actin filaments"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 22: Epithelial cell types - Mixed function"	"Plasma membrane, Actin filaments"		"HPA034986: AB_10602207, HPA061792: AB_2732670"	"unprognostic (1.13e-1)"	"unprognostic (1.60e-1)"	"unprognostic (3.92e-2)"	"unprognostic (4.11e-3)"	"unprognostic (2.38e-2)"	"unprognostic (2.72e-3)"	"unprognostic (1.41e-1)"	"unprognostic (5.76e-2)"	"unprognostic (2.68e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.84e-1)"	"unprognostic (3.81e-1)"	"unprognostic (3.14e-3)"	"unprognostic (7.30e-3)"	"unprognostic (1.97e-1)"	"unprognostic (2.97e-1)"	"unprognostic (4.53e-2)"	55.2	10.3	4.4	21.9	5.4	86.5	38.8	0.4	24.8	50.5	22.2	42.4	6.1	92.7	10.7	21.1	24.3	21.2	59.6	7.2	6.9	24.4	9.0	29.3	25.5	2.8	3.9	23.8	27.2	8.3	6.8	26.3	5.9	93.4	20.6	15.4	14.6	107.0	57.7	15.1	17.3	96.4	2.2	26.8	14.4	41.9	5.5	36.2	15.9	22.0	23.4	45.4	20.3	3.3	100.2	38.0	21.6	1.2	80.6	42.2	33.8	84.2	221.1	127.5	92.2	69.8	39.3	17.6	66.5	198.9	39.2	47.1	27.1	99.6	129.4	68.2	9.5	31.6	37.5	0.0	156.1	7.1	1.8	129.6	91.7	110.1	243.2	206.6	75.6	7.0	5.0	13.8	607.0	0.8	3.4	59.3	44.1	1.2	23.5	2.8	163.8	9.3	93.1	47.4	23.7	69.9	41.6	29.7	50.2	37.7	9.9	58.8	57.5	152.3	40.0	40.2	86.9	27.0	37.9	5.9	63.1	48.4	215.4	54.6	88.2	6.9	69.4	56.7	74.6	24.9	44.5	60.2	30.9	11.0	14.3	37.3	189.4	38.3	119.5	0.9	35.8	61.5	4.4	5.4	0.4	24.8	7.2	6.9	2.8	3.9	5.9	2.2	5.5	3.3	233.5	6.4	50.4	1.6	50.3	37.1	137.3	81.4	5.7	12.3	31.9	40.1	97.5	12.8	28.9	31.3	35.5	30.8	63.8	7.8	9.8	20.8	51.7	49.6	24.4	113.9	41.2	14.5	15.6	15.9	68.2	29.7	14.3	33.6	129.6	9.2	83.2	1.5	12.2	101.0	34.9	59.6	32.6	44.1	259.6	158.0	15.2	86.0	200.9	9.4	78.6	27.5	106.1	4.0	0.5	24.9	3.0	126.7	43.4	32.7	1.1	5.0	73.3	13.2	0.0	29.2	29.4	67.2	13.6	3.1	13.5	12.0	97.7	1.4	6.0	38.5
CDC42EP4	"BORG4, CEP4, KAIA1777, MGC17125, MGC3740"	ENSG00000179604	"CDC42 effector protein 4"	Q9H3Q1	17	73283624-73312005	"Predicted intracellular proteins"	"Cell shape"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"Horizontal cells: 753.7;Muller glia cells: 570.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"non-classical monocyte: 20.1"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023335, HPA024797"	Approved	Supported	Supported	"Plasma membrane,Actin filaments,Microtubules"		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 5: Muller glia cells - Visual perception"	"Actin filaments, Microtubules"	"Plasma membrane"	"HPA023335: AB_10603783, HPA024797: AB_10600696"	"unprognostic (8.76e-2)"	"unprognostic (4.38e-3)"	"unprognostic (1.49e-2)"	"unprognostic (5.43e-3)"	"unprognostic (6.29e-2)"	"unprognostic (9.01e-3)"	"unprognostic (2.44e-3)"	"unprognostic (1.08e-1)"	"unprognostic (8.00e-2)"	"unprognostic (2.41e-1)"	"unprognostic (4.16e-2)"	"unprognostic (6.73e-2)"	"unprognostic (3.97e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.94e-1)"	94.5	54.9	84.9	15.3	84.7	14.9	74.5	90.6	76.3	47.4	75.0	55.6	35.7	52.7	60.1	33.3	69.4	19.1	50.5	82.2	103.1	28.6	32.2	38.6	16.1	141.9	104.5	70.7	77.5	20.5	45.0	22.9	83.7	38.7	17.4	98.1	41.5	43.1	28.8	40.6	36.0	25.5	103.5	24.1	42.4	20.5	105.9	20.2	45.4	18.8	27.6	33.8	39.5	109.5	30.1	70.1	24.7	20.9	48.8	40.5	65.0	26.2	32.6	24.3	17.9	14.8	42.1	0.1	22.9	31.6	27.6	20.6	17.2	18.0	14.6	1.4	17.0	6.7	35.2	34.7	24.3	1.1	7.3	51.4	14.9	21.2	10.5	19.2	27.9	0.6	18.9	1.4	14.9	23.2	1.2	8.6	13.5	87.8	48.4	0.8	11.0	3.1	28.8	34.3	16.4	24.8	19.7	53.1	18.4	19.0	64.3	9.8	28.7	22.7	47.6	18.1	18.9	1.4	1.2	0.2	37.3	4.7	60.7	3.3	3.2	5.9	0.1	8.5	0.2	0.1	0.0	0.0	4.3	0.0	0.2	0.0	5.4	0.3	20.1	0.1	0.0	2.1	84.9	84.7	90.6	76.3	82.2	103.1	141.9	104.5	83.7	103.5	105.9	109.5	117.1	12.8	15.6	54.9	2.8	48.7	58.5	54.9	97.9	11.5	45.8	37.1	10.8	31.5	29.1	12.9	6.2	32.1	2.5	47.3	11.7	29.4	0.6	29.7	47.6	43.8	31.2	9.1	1.0	43.6	35.0	46.1	31.1	41.2	13.3	19.6	42.8	27.7	6.1	753.7	1.3	41.3	14.2	5.5	30.1	2.7	18.3	9.1	30.2	6.5	11.1	570.4	0.0	2.5	2.5	30.4	33.5	15.4	2.5	42.6	53.1	8.0	18.0	26.2	131.5	98.0	69.9	1.1	2.0	83.2	44.9	84.3	6.0	13.6	30.2	124.1
CDC42SE1	"SCIP1, SPEC1"	ENSG00000197622	"CDC42 small effector 1"	Q9NRR8	1	151050971-151070325	"Predicted intracellular proteins"	"Cell shape, Phagocytosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"dendritic cells: 320.7;NK-cells: 233.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-698: 453.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027634	Approved		Supported	"Cell Junctions"		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 64: Macrophages - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 24: Non-specific - Transcription regulation"	"Cell Junctions"		"HPA027634: AB_10600861"	"unprognostic (1.59e-2)"	"unprognostic (5.76e-2)"	"unprognostic (8.93e-3)"	"unprognostic (4.61e-3)"	"unprognostic (1.63e-1)"	"unprognostic (5.76e-2)"	"unprognostic (2.85e-2)"	"unprognostic (1.71e-1)"	"unprognostic (6.96e-3)"	"unprognostic (2.19e-1)"	"unprognostic (2.59e-2)"	"unprognostic (3.04e-1)"	"prognostic unfavorable (2.19e-6)"	"unprognostic (9.94e-2)"	"unprognostic (4.89e-2)"	"unprognostic (2.86e-3)"	"unprognostic (4.12e-2)"	54.4	48.0	39.2	63.8	40.7	81.6	41.9	41.0	48.7	46.0	38.1	40.2	20.0	35.0	26.8	97.4	44.0	37.2	44.8	38.8	40.5	59.2	30.0	73.2	84.3	43.1	42.2	44.0	36.5	71.5	37.2	48.6	43.7	56.1	33.7	20.6	54.1	33.2	21.9	61.6	58.7	37.3	42.9	122.3	44.6	11.1	43.2	56.4	46.0	19.2	84.5	65.7	64.1	44.1	61.5	28.5	48.4	30.5	37.0	35.5	73.9	45.6	47.1	51.1	43.5	27.6	64.3	44.2	36.2	51.3	27.4	74.9	51.6	79.8	44.6	69.9	27.7	71.6	30.2	13.6	49.1	64.1	110.0	39.8	125.7	64.3	49.6	71.8	64.6	43.9	114.1	100.8	58.2	91.3	46.8	46.1	54.5	56.2	30.5	41.1	40.8	49.6	64.5	97.2	20.7	49.3	39.4	83.6	82.8	75.9	93.1	113.1	61.7	49.5	36.6	38.5	84.2	65.6	56.1	453.9	35.8	47.8	111.8	124.6	43.9	228.5	88.5	80.7	70.0	44.0	75.5	81.0	58.3	44.9	62.9	78.4	369.7	91.1	82.7	21.9	123.2	38.1	39.2	40.7	41.0	48.7	38.8	40.5	43.1	42.2	43.7	42.9	43.2	44.1	76.4	38.5	56.2	22.2	110.5	66.2	54.4	41.0	42.1	28.3	94.1	64.1	8.1	27.1	44.8	55.2	25.0	57.9	320.7	36.1	21.5	41.3	85.0	23.4	38.0	50.5	35.3	24.4	30.5	37.0	72.1	40.0	33.1	35.1	71.7	19.0	65.0	33.9	73.2	26.9	29.1	29.9	50.8	138.8	204.1	16.6	11.5	115.0	55.2	32.8	159.8	23.0	233.8	36.7	44.9	66.7	39.3	24.0	93.8	41.9	19.4	27.5	21.8	24.2	32.9	47.9	46.5	35.0	18.7	59.6	93.6	114.8	142.7	22.2	21.4	73.4
CDC45	"CDC45L, CDC45L2"	ENSG00000093009	"Cell division cycle 45"	O75419	22	19479457-19520612	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, DNA replication"		"Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 25.4;lymphoid tissue: 20.4;testis: 23.4"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 120.5;Erythroid cells: 29.7;Spermatocytes: 72.3;Spermatogonia: 50.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in all"		"K-562: 370.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000614, CAB009459"	Enhanced		Supported	Nucleoplasm,Centrosome,Cytosol		NA	Yes			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	"Centrosome, Cytosol"	"CAB009459: AB_2078507, HPA000614: AB_1078487"	"unprognostic (5.56e-2)"	"unprognostic (6.12e-3)"	"unprognostic (1.17e-3)"	"unprognostic (3.42e-3)"	"unprognostic (3.57e-1)"	"unprognostic (7.42e-2)"	"prognostic unfavorable (6.95e-6)"	"unprognostic (6.01e-3)"	"unprognostic (1.85e-3)"	"unprognostic (1.47e-2)"	"prognostic unfavorable (8.94e-4)"	"unprognostic (7.28e-2)"	"unprognostic (0.00e+0)"	"unprognostic (7.62e-3)"	"unprognostic (2.02e-1)"	"unprognostic (8.52e-2)"	"unprognostic (1.10e-1)"	0.5	0.5	0.7	6.2	0.5	25.4	1.5	0.2	0.2	1.1	0.4	4.6	3.5	0.9	0.3	5.3	0.4	0.5	0.3	0.2	0.4	0.3	1.2	0.9	11.3	0.5	0.4	0.2	0.2	0.2	0.1	3.2	0.5	0.4	6.0	0.1	0.9	0.2	0.1	3.3	3.1	1.8	0.2	2.8	2.6	23.4	1.1	20.4	0.3	0.0	11.8	1.9	1.7	0.3	57.4	42.2	56.4	42.9	2.0	5.6	24.4	65.4	31.6	75.5	75.5	35.8	30.5	62.2	23.2	21.0	28.9	51.9	58.2	45.9	59.5	72.3	96.3	82.8	50.1	41.3	3.1	125.0	43.7	1.3	2.4	57.9	26.0	7.0	38.8	63.0	370.6	73.3	44.8	77.2	98.1	56.5	16.7	106.2	34.4	77.1	95.5	26.5	16.9	49.3	72.1	37.0	38.1	40.0	12.0	21.7	26.2	51.0	15.0	60.0	91.6	46.0	62.8	24.6	46.8	67.5	30.1	58.9	82.1	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.3	0.7	0.1	0.0	0.2	0.1	0.5	0.5	0.1	0.3	0.9	0.6	0.7	0.5	0.2	0.2	0.2	0.4	0.5	0.4	0.5	0.2	1.1	0.3	0.2	0.0	0.0	0.0	1.9	2.7	1.7	3.7	0.0	0.0	0.7	0.8	0.4	0.0	0.5	0.0	0.0	11.9	1.4	1.9	0.0	0.8	120.5	0.9	0.7	1.2	0.0	29.7	0.1	0.0	19.8	2.3	1.5	1.0	0.0	5.5	3.6	0.0	7.2	0.0	0.1	1.2	4.1	0.6	1.0	14.4	0.6	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.3	0.7	12.6	0.2	0.4	0.0	0.3	0.0	6.6	1.5	13.9	72.3	50.7	3.3	1.8	4.9	1.2	0.8	5.1	2.5
CDC5L	"CDC5, CEF1, hCDC5, PCDC5RP"	ENSG00000096401	"Cell division cycle 5 like"	Q99459	6	44387706-44450425	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Cell cycle, DNA damage, DNA repair, mRNA processing, mRNA splicing, Transcription, Transcription regulation"	"Activator, DNA-binding, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 291.8;Late spermatids: 285.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006302, HPA011361, CAB012275"	Supported		Supported	Nucleoplasm		NA	NA		22000	"Cluster 42: Non-specific - Transcription"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 21: OE19 - Mitochondria"	"Cluster 34: Spermatids - Unknown function"	Nucleoplasm		"CAB012275: , HPA006302: AB_1078488, HPA011361: AB_1846379"	"unprognostic (2.67e-1)"	"unprognostic (9.31e-2)"	"unprognostic (8.26e-3)"	"unprognostic (4.17e-3)"	"unprognostic (2.01e-2)"	"unprognostic (2.17e-1)"	"unprognostic (7.96e-2)"	"unprognostic (1.61e-1)"	"prognostic unfavorable (7.02e-5)"	"unprognostic (1.01e-2)"	"unprognostic (6.31e-2)"	"unprognostic (1.63e-1)"	"unprognostic (4.33e-2)"	"unprognostic (3.08e-2)"	"unprognostic (3.37e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.46e-1)"	11.5	11.9	6.7	10.7	7.1	21.3	13.5	10.1	9.4	10.3	7.0	10.5	9.4	12.0	13.2	10.9	9.7	8.7	13.8	7.3	7.0	10.5	18.7	9.6	13.4	6.7	6.8	14.0	10.1	19.8	5.7	12.0	7.1	11.8	11.3	13.2	9.7	9.4	17.8	8.5	9.4	11.7	6.9	10.5	9.7	13.2	6.9	15.3	10.8	22.5	14.1	12.1	8.1	8.7	43.0	16.5	39.8	32.5	16.0	20.7	22.5	30.6	23.8	37.9	41.5	21.7	14.4	40.8	24.8	24.7	30.8	26.6	41.8	24.2	56.4	34.5	37.6	54.5	15.4	28.1	14.6	41.3	28.2	15.9	20.9	37.0	31.9	21.7	25.0	20.7	42.6	23.3	34.7	29.0	38.4	28.1	28.0	103.5	15.1	29.6	45.7	26.4	21.5	25.2	43.8	38.0	24.7	16.5	33.3	25.4	23.2	39.6	23.0	32.4	32.8	25.5	43.7	19.9	25.8	73.8	20.9	35.3	33.2	20.2	13.1	17.5	10.4	15.7	11.8	9.9	10.0	11.7	13.0	11.3	10.7	10.4	19.9	14.8	18.1	11.2	14.6	8.5	6.7	7.1	10.1	9.4	7.3	7.0	6.7	6.8	7.1	6.9	6.9	8.7	57.3	73.7	50.3	14.7	48.5	44.2	69.2	58.0	55.8	36.4	26.7	29.5	82.2	30.0	80.5	23.9	31.3	57.5	58.2	26.8	39.2	53.4	291.8	63.7	64.2	51.5	36.1	48.1	20.6	55.2	49.4	52.2	28.5	72.1	71.0	58.8	26.7	44.7	45.3	32.0	34.7	40.7	52.9	38.6	29.8	285.9	61.5	53.1	19.6	18.7	74.3	65.8	45.3	14.1	33.0	47.8	34.5	55.3	37.7	49.0	18.6	28.6	78.6	38.1	65.7	67.9	76.2	48.2	98.7	35.6	38.4	71.7	46.8	59.8	40.8	62.5
CDC7	"CDC7L1, HsCdc7, Hsk1, huCdc7"	ENSG00000097046	"Cell division cycle 7"	O00311	1	91500851-91525764	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 16.9"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 37.8;Erythroid cells: 23.1;Spermatocytes: 30.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002669, HPA035831"	Enhanced		Supported	"Nucleoplasm,Cytokinetic bridge,Mitotic spindle"		Yes	No			"Cluster 20: T-cells - T-cell receptor"	"Cluster 20: Retina & Lymphoid tissues - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 30: Mammary glandular cells - Lactation"	Nucleoplasm	"Cytokinetic bridge, Mitotic spindle"	"CAB002669: , HPA035831: AB_2674807"	"unprognostic (6.84e-2)"	"unprognostic (6.01e-2)"	"unprognostic (4.64e-2)"	"unprognostic (7.02e-3)"	"unprognostic (5.57e-2)"	"unprognostic (3.57e-3)"	"prognostic unfavorable (3.15e-6)"	"unprognostic (6.52e-2)"	"unprognostic (2.23e-2)"	"unprognostic (1.36e-3)"	"unprognostic (2.04e-2)"	"unprognostic (1.75e-2)"	"prognostic unfavorable (1.89e-15)"	"unprognostic (9.44e-3)"	"unprognostic (2.49e-2)"	"unprognostic (1.09e-1)"	"unprognostic (5.39e-2)"	1.9	2.7	3.6	6.0	3.8	13.8	2.1	6.3	4.8	2.1	1.6	3.0	3.1	1.8	1.7	3.5	1.3	1.7	1.4	3.8	3.4	4.3	1.5	4.2	9.3	2.9	3.7	2.5	1.6	0.8	4.0	5.9	3.1	1.9	4.6	14.1	1.7	1.4	0.5	5.1	3.7	2.4	2.8	12.1	1.8	16.9	3.2	10.9	1.7	0.5	9.4	2.4	2.3	3.5	32.0	9.4	59.1	17.3	1.4	7.6	18.8	12.0	9.1	22.6	24.3	19.6	10.8	22.5	16.1	7.7	19.8	13.7	39.8	13.5	29.4	36.8	34.3	33.7	27.9	9.5	2.1	37.0	11.9	4.2	4.0	21.0	11.9	4.1	8.9	30.9	44.8	31.4	15.2	11.8	31.5	33.5	48.9	17.2	21.6	38.9	49.5	14.5	10.2	24.0	44.7	18.6	37.5	10.2	21.6	14.3	9.8	18.2	7.3	25.8	22.7	20.6	17.9	11.6	15.6	57.9	9.4	36.0	9.4	0.0	1.0	0.0	3.8	0.7	3.2	0.9	2.8	3.5	2.3	0.9	1.5	3.0	0.1	1.6	0.2	1.4	4.6	1.4	3.6	3.8	6.3	4.8	3.8	3.4	2.9	3.7	3.1	2.8	3.2	3.5	1.9	0.0	1.1	3.3	3.2	5.9	1.2	2.7	3.4	8.2	14.4	1.4	2.1	0.0	1.3	1.8	0.0	8.2	4.1	0.6	3.9	1.5	37.8	1.1	4.9	4.1	0.0	23.1	18.3	2.6	6.3	3.1	2.6	1.9	4.5	15.4	4.2	0.2	2.7	3.3	19.6	1.8	6.1	2.2	2.9	18.7	0.9	1.6	3.6	5.6	2.1	1.6	6.2	16.6	3.1	1.2	1.7	0.7	7.1	0.9	0.5	0.4	2.0	5.1	6.6	1.5	4.1	30.5	21.4	4.3	3.7	2.2	5.3	7.6	3.6	1.0
CDC73	"C1orf28, FIHP, HRPT1, HRPT2, parafibromin"	ENSG00000134371	"Cell division cycle 73"	Q6P1J9	1	193121983-193254815	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cell cycle, Transcription, Transcription regulation, Wnt signaling pathway"		"Cancer-related genes, Disease variant, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002326, CAB016359, HPA069324"	Supported		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm	Cytosol	"CAB016359: AB_628102, HPA002326: , HPA069324: "	"unprognostic (4.41e-2)"	"unprognostic (6.22e-2)"	"unprognostic (1.90e-2)"	"unprognostic (5.30e-2)"	"unprognostic (2.88e-3)"	"unprognostic (3.53e-2)"	"unprognostic (2.48e-3)"	"unprognostic (5.74e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.40e-1)"	"unprognostic (7.23e-3)"	"unprognostic (2.17e-1)"	"unprognostic (5.44e-3)"	"unprognostic (3.47e-1)"	"unprognostic (2.49e-1)"	"unprognostic (6.73e-3)"	"unprognostic (2.98e-3)"	11.3	9.5	5.8	7.3	6.9	8.9	10.7	6.1	7.3	11.1	4.5	10.2	5.6	10.3	8.5	8.4	7.2	5.9	9.6	4.6	8.1	10.4	9.2	7.9	7.5	6.9	7.2	11.5	6.4	12.9	5.6	9.4	7.9	15.1	9.0	10.1	7.7	9.7	12.2	7.0	7.7	10.3	7.9	8.6	7.0	5.9	6.5	10.6	13.1	5.6	7.9	9.7	8.5	8.3	9.3	2.4	16.6	11.5	18.3	18.9	4.9	6.7	16.1	19.5	16.4	6.5	12.3	10.5	5.2	20.4	8.8	10.7	16.8	14.9	24.7	6.1	4.1	7.3	8.1	7.2	16.1	16.0	11.6	13.7	16.0	14.9	17.7	20.6	17.8	11.1	8.1	14.2	28.8	3.5	13.9	9.2	11.9	21.9	2.5	10.6	7.0	15.0	26.6	8.2	3.9	12.3	8.6	26.8	22.3	21.0	18.3	14.0	9.2	19.3	2.2	16.4	12.6	12.2	7.2	7.6	11.9	10.2	30.1	2.2	0.5	0.7	0.8	1.0	1.2	0.9	1.1	0.6	0.6	0.5	1.4	1.2	0.3	1.3	0.8	1.0	0.9	0.4	5.8	6.9	6.1	7.3	4.6	8.1	6.9	7.2	7.9	7.9	6.5	8.3	44.5	35.3	25.4	54.5	44.9	37.2	35.6	38.4	36.5	30.4	24.4	21.8	44.5	25.8	27.2	33.1	35.5	25.0	48.0	18.2	33.2	37.5	19.7	24.6	39.6	38.0	11.4	40.8	71.9	32.2	42.0	39.1	28.1	30.8	41.1	17.6	25.4	17.2	31.6	21.9	76.4	15.8	34.6	27.4	49.1	8.5	33.5	38.3	28.4	54.4	46.0	35.2	41.2	78.4	112.3	35.5	16.9	36.1	50.3	34.9	19.2	36.3	20.6	36.7	26.3	49.0	48.3	55.6	33.0	36.8	34.9	38.0	44.4	30.3	18.6	27.9
CDCA2	"PPP1R81, Repo-Man"	ENSG00000184661	"Cell division cycle associated 2"	Q69YH5	8	25459199-25507911	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"bone marrow: 6.5;lymphoid tissue: 11.4;testis: 19.4"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 23.3;Early spermatids: 49.9;Erythroid cells: 19.0;Late spermatids: 24.2;Spermatocytes: 66.6;Spermatogonia: 27.8"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"HPA026293, HPA030049"	Enhanced		Supported	Nucleoplasm		Yes	Yes			"Cluster 15: NK-cells - Transcription"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"HPA026293: AB_1846384, HPA030049: AB_10600862"	"unprognostic (2.12e-1)"	"unprognostic (4.75e-3)"	"prognostic favorable (9.62e-4)"	"unprognostic (2.92e-2)"	"unprognostic (9.69e-2)"	"unprognostic (3.56e-2)"	"unprognostic (2.50e-5)"	"unprognostic (1.47e-3)"	"unprognostic (6.06e-2)"	"unprognostic (2.91e-3)"	"unprognostic (1.32e-3)"	"unprognostic (1.99e-1)"	"prognostic unfavorable (2.30e-14)"	"unprognostic (1.36e-2)"	"unprognostic (4.02e-1)"	"unprognostic (1.91e-1)"	"unprognostic (5.30e-2)"	0.2	0.0	0.0	2.6	0.0	6.5	0.6	0.1	0.0	0.2	0.1	1.9	1.6	0.3	0.0	1.4	0.1	0.3	0.3	0.0	0.1	0.0	0.1	0.2	5.3	0.2	0.2	0.0	0.0	0.0	0.0	1.2	0.2	0.1	2.2	0.1	0.2	0.0	0.0	1.1	1.8	0.8	0.0	0.8	0.9	19.4	0.3	11.4	0.1	0.1	6.7	0.6	0.3	0.1	36.5	30.2	29.4	24.2	2.3	4.5	20.2	37.7	22.6	32.9	32.4	25.7	15.8	42.6	16.0	16.2	34.6	31.6	42.9	20.0	48.5	16.2	12.0	43.2	22.4	15.2	0.6	18.4	19.4	2.5	1.0	23.5	15.8	3.3	24.5	24.5	33.6	45.8	30.6	13.9	54.5	8.7	31.0	24.1	14.5	26.3	33.4	15.2	9.2	18.7	12.0	13.3	33.3	16.1	14.3	14.7	17.4	9.4	16.6	23.9	39.3	44.7	35.6	7.1	16.5	44.4	17.7	24.3	40.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.4	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.2	0.2	0.0	0.3	0.1	0.2	0.0	1.1	0.0	2.7	1.1	0.5	1.7	0.0	0.7	0.9	0.8	23.3	0.0	0.2	0.0	0.0	7.2	0.5	1.8	0.0	0.2	49.9	0.8	1.2	1.1	0.0	19.0	0.2	0.0	13.4	2.5	4.1	1.4	0.0	8.8	1.1	0.1	4.1	0.0	0.1	1.3	0.0	2.9	0.6	24.2	1.2	2.1	0.0	0.0	0.6	0.1	2.1	0.5	0.6	0.2	0.1	0.0	15.8	0.5	0.5	1.2	0.9	0.5	13.1	0.1	2.1	66.6	27.8	10.7	0.9	1.6	2.9	1.3	3.6	0.5
CDCA4	"FLJ20764, Hepp"	ENSG00000170779	"Cell division cycle associated 4"	Q9BXL8	14	105009573-105021083	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 55.8"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 64.2;Cytotrophoblasts: 84.5;Extravillous trophoblasts: 154.5;Spermatogonia: 69.9;Suprabasal keratinocytes: 67.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA064971			Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	Yes			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 38: Extravillous trophoblasts - Unknown function"	Nucleoplasm	"Plasma membrane, Cytosol"	"HPA064971: AB_2685395"	"unprognostic (2.22e-3)"	"unprognostic (1.84e-1)"	"unprognostic (2.69e-1)"	"unprognostic (9.93e-3)"	"unprognostic (1.42e-1)"	"unprognostic (8.36e-2)"	"prognostic unfavorable (4.19e-4)"	"prognostic unfavorable (7.94e-4)"	"unprognostic (4.20e-2)"	"unprognostic (8.54e-2)"	"prognostic unfavorable (6.67e-4)"	"unprognostic (6.73e-2)"	"prognostic unfavorable (1.47e-6)"	"unprognostic (2.15e-1)"	"unprognostic (1.55e-1)"	"unprognostic (7.50e-2)"	"unprognostic (1.24e-2)"	3.9	2.6	1.9	7.4	2.0	55.8	4.2	3.0	2.1	8.7	2.1	4.6	4.7	5.4	1.8	18.6	4.1	2.6	2.7	1.7	1.8	3.4	2.7	3.6	11.6	2.1	1.9	4.1	3.2	1.8	1.7	9.2	2.1	3.8	2.9	1.3	5.5	2.2	1.4	24.7	4.9	3.5	1.9	6.6	3.8	11.6	2.0	14.6	3.3	1.5	8.5	4.2	10.2	2.0	40.6	41.3	46.7	35.6	7.9	13.2	61.1	59.0	18.0	45.2	39.7	50.9	50.2	52.9	31.5	20.9	34.5	63.5	32.9	68.0	27.1	58.2	26.1	33.4	33.9	43.2	9.7	59.8	27.0	9.4	20.8	35.2	32.7	15.1	31.4	45.0	37.5	53.0	32.1	98.8	56.2	40.1	34.8	35.1	94.0	53.6	68.1	19.7	15.9	46.2	27.2	33.5	56.6	22.3	46.8	20.5	44.0	39.8	48.8	39.9	50.5	55.3	79.5	19.5	25.9	54.4	33.5	30.2	67.5	1.1	4.3	10.6	11.9	4.9	14.8	8.4	12.7	16.7	4.7	5.4	7.4	8.9	1.6	12.9	5.6	5.1	11.1	7.0	1.9	2.0	3.0	2.1	1.7	1.8	2.1	1.9	2.1	1.9	2.0	2.0	5.4	0.0	2.2	0.7	7.4	64.2	26.5	36.6	13.1	3.4	8.7	8.3	0.6	0.0	9.0	1.8	0.0	84.5	11.5	4.3	3.9	12.7	8.1	9.0	9.0	10.9	3.0	53.0	1.8	7.0	154.5	10.2	3.1	12.5	28.6	15.1	7.9	2.2	24.3	13.5	1.3	6.6	6.1	5.9	22.6	6.8	8.4	8.4	17.8	2.8	9.3	4.6	9.2	1.0	1.8	12.3	3.3	6.0	11.8	16.1	1.9	1.8	7.7	2.6	6.6	4.6	12.5	43.0	69.9	21.3	67.1	25.9	17.7	3.6	9.5	43.2
CDCA7	"FLJ14736, JPO1"	ENSG00000144354	"Cell division cycle associated 7"	Q9BWT1	2	173354820-173368997	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Apoptosis, Transcription, Transcription regulation"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 32.4;lymphoid tissue: 50.1"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 45.7;Intestinal goblet cells: 40.7;Leydig cells: 53.7;Undifferentiated cells: 124.2"	"Cancer enhanced"	"Detected in all"		"colorectal cancer: 43.3"	"Low region specificity"	"Detected in some"			"Immune cell enhanced"	"Detected in many"		"T-reg: 7.9"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"MOLT-4: 279.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA005565			Supported	Nucleoplasm,Cytosol		No	Yes			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Nucleoplasm, Cytosol"		"HPA005565: AB_2078680"	"unprognostic (1.67e-3)"	"unprognostic (2.26e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.54e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.44e-2)"	"prognostic unfavorable (4.20e-4)"	"unprognostic (7.54e-2)"	"prognostic unfavorable (5.50e-4)"	"unprognostic (4.96e-2)"	"unprognostic (2.83e-1)"	"unprognostic (8.97e-3)"	"unprognostic (0.00e+0)"	"unprognostic (4.53e-3)"	"unprognostic (1.96e-1)"	"unprognostic (2.04e-1)"	"unprognostic (2.47e-2)"	1.7	0.3	0.7	13.1	0.6	23.0	2.4	0.5	0.7	12.6	6.5	25.5	30.7	13.8	3.3	10.1	3.8	1.5	0.8	0.7	1.2	0.5	0.3	1.6	37.5	0.7	0.9	1.1	1.7	0.3	0.1	7.4	0.7	3.0	29.5	0.4	2.5	1.2	3.1	11.7	32.4	3.4	0.7	2.4	14.3	6.0	1.2	50.1	0.5	0.8	41.2	2.8	6.7	1.0	44.2	33.3	76.4	83.3	3.6	14.0	79.9	26.0	9.2	60.3	67.2	51.6	54.4	122.1	32.2	15.8	23.5	45.0	122.4	46.6	87.0	59.2	67.4	27.6	24.6	66.0	3.8	181.2	25.1	11.4	3.9	32.8	27.3	7.8	28.0	158.1	67.4	27.2	17.7	35.4	279.7	181.7	90.4	103.4	22.7	194.4	58.2	77.3	29.5	38.2	22.3	39.2	40.8	13.4	22.0	67.9	0.3	70.5	13.0	39.3	16.8	12.9	48.5	7.4	17.1	173.0	24.4	99.8	34.0	0.0	0.5	0.0	1.1	0.0	0.4	1.9	3.0	5.9	3.5	0.3	0.2	1.0	0.2	3.2	0.0	0.5	7.9	2.3	0.7	0.6	0.5	0.7	0.7	1.2	0.7	0.9	0.7	0.7	1.2	1.0	1.0	0.0	0.6	0.7	3.0	20.3	14.9	3.3	14.8	0.0	2.6	6.5	1.1	0.0	0.3	0.0	0.0	45.7	1.6	17.1	0.0	0.2	0.9	3.2	33.0	3.4	12.2	33.6	0.1	0.2	29.9	4.1	22.4	6.8	0.0	18.5	0.0	0.2	10.4	0.0	10.5	40.7	4.1	1.0	4.4	2.2	53.7	2.3	3.6	0.0	1.2	0.7	0.0	0.5	0.1	1.0	11.1	34.6	3.8	5.3	11.9	0.0	0.1	0.0	0.0	1.1	7.2	13.8	28.9	21.8	15.9	10.1	9.1	2.7	124.2	3.8
CDCA7L	"JPO2, R1, RAM2"	ENSG00000164649	"Cell division cycle associated 7 like"	Q96GN5	7	21900899-21945903	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"B-cells: 51.0;Spermatogonia: 63.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"memory B-cell: 101.0;naive B-cell: 124.5"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Region enriched"	"Detected in many"	4	"olfactory bulb: 10.1"	"HPA027169, HPA074623"	Approved		Supported	Nucleoplasm,Nucleoli,Cytosol		No	Yes			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 57: B-cells - Immune response"	"Nucleoplasm, Nucleoli"	Cytosol	"HPA027169: AB_1856058, HPA074623: "	"unprognostic (5.13e-3)"	"unprognostic (5.94e-2)"	"unprognostic (1.91e-1)"	"unprognostic (4.63e-2)"	"unprognostic (2.33e-1)"	"unprognostic (2.15e-1)"	"prognostic unfavorable (4.36e-6)"	"unprognostic (4.09e-2)"	"unprognostic (2.86e-1)"	"unprognostic (3.87e-2)"	"unprognostic (3.22e-2)"	"unprognostic (2.34e-1)"	"prognostic unfavorable (1.98e-4)"	"unprognostic (2.00e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.73e-1)"	"unprognostic (2.83e-3)"	5.9	1.4	3.9	15.0	9.1	51.7	15.7	5.7	5.2	8.7	17.8	17.0	10.7	13.8	5.5	11.2	11.5	8.1	25.3	3.9	3.5	2.8	4.8	14.0	37.1	6.9	4.8	21.8	13.0	1.8	1.1	4.7	3.8	7.3	19.0	5.1	9.0	7.6	6.2	18.5	13.6	11.9	5.0	13.3	17.8	18.5	7.8	49.0	29.8	3.4	31.8	6.3	8.1	9.8	84.5	27.6	26.0	0.6	14.5	17.9	0.0	65.9	58.2	51.8	73.5	11.3	75.4	173.6	21.8	59.3	102.4	51.1	41.4	69.4	103.6	0.3	28.6	42.3	83.8	7.4	21.1	111.1	0.4	35.2	12.7	40.0	116.9	54.9	104.8	133.5	58.3	0.1	41.4	34.5	146.1	46.1	153.2	17.4	36.2	141.0	94.0	119.8	15.4	14.8	96.9	79.7	30.3	19.9	29.9	34.4	45.6	54.6	43.0	57.1	68.5	101.3	83.8	90.6	63.6	223.0	55.7	154.6	54.5	1.1	2.3	43.2	2.2	3.8	0.3	101.0	6.4	3.2	14.9	124.5	30.9	12.8	3.8	3.4	4.9	75.9	9.9	12.2	3.9	9.1	5.7	5.2	3.9	3.5	6.9	4.8	3.8	5.0	7.8	9.8	1.0	19.2	31.5	7.5	51.0	27.1	23.7	6.9	17.1	1.5	12.5	20.7	38.7	11.5	19.0	0.0	2.1	0.5	30.7	8.4	3.9	8.9	7.3	5.4	2.7	4.8	10.7	21.9	0.5	6.2	0.3	13.4	18.3	5.3	8.8	14.9	1.4	4.0	10.8	13.5	1.0	26.1	8.2	15.2	3.5	5.2	4.1	7.0	8.8	1.9	1.6	2.4	1.0	15.1	8.7	3.9	7.4	2.6	20.2	14.2	1.5	0.1	4.2	2.7	13.1	6.8	12.4	4.6	63.5	9.6	7.7	0.3	5.4	8.3	23.0	6.2
CDCA8	"BOR, DasraB, FLJ12042, MESRGP"	ENSG00000134690	"Cell division cycle associated 8"	Q53HL2	1	37692481-37709719	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 33.5;lymphoid tissue: 38.8;testis: 22.5"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 34.1;Extravillous trophoblasts: 26.0;Spermatocytes: 76.8;Spermatogonia: 42.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA028120, HPA028258, HPA028783, CAB040294"	Enhanced		Supported	"Nucleoplasm,Nucleoli,Cytokinetic bridge"		Yes	Yes			"Cluster 27: Non-specific - Gene expression"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoli	"Nucleoplasm, Cytokinetic bridge"	"CAB040294: , HPA028120: AB_10670556, HPA028258: AB_10669864, HPA028783: AB_10671092"	"unprognostic (8.36e-2)"	"unprognostic (2.00e-1)"	"unprognostic (8.39e-2)"	"unprognostic (7.75e-3)"	"unprognostic (2.34e-1)"	"unprognostic (5.42e-2)"	"prognostic unfavorable (4.93e-10)"	"unprognostic (4.30e-3)"	"prognostic unfavorable (6.04e-4)"	"unprognostic (3.00e-1)"	"prognostic unfavorable (8.32e-4)"	"unprognostic (3.78e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (6.39e-3)"	"unprognostic (2.99e-1)"	"unprognostic (3.18e-1)"	"unprognostic (1.67e-1)"	1.0	1.1	0.7	7.9	1.0	33.5	2.0	0.2	0.9	1.7	0.0	9.4	8.3	1.3	1.8	9.2	1.0	1.1	0.6	0.5	0.4	0.8	1.3	1.5	19.5	0.6	0.4	0.6	0.8	0.5	0.6	4.4	0.5	0.7	11.3	1.9	1.8	0.5	0.3	6.3	7.3	2.8	0.3	4.9	4.9	22.5	0.6	38.8	0.6	0.5	22.7	2.0	2.9	0.7	108.5	45.5	84.4	62.1	3.6	7.0	57.2	79.6	39.5	137.2	96.6	71.9	78.8	130.2	31.5	50.5	54.5	59.4	97.8	52.4	141.9	86.8	44.9	116.8	49.2	57.3	0.8	113.8	58.4	2.8	3.8	77.1	67.3	15.3	60.9	91.1	100.7	135.6	99.1	47.7	106.1	68.9	98.8	61.7	62.8	102.2	115.6	74.4	31.0	43.8	75.4	33.3	87.5	40.6	52.4	71.7	60.1	42.4	37.3	67.8	70.6	39.2	126.0	91.4	128.1	176.3	31.6	104.7	79.6	0.0	0.7	1.3	1.5	1.6	2.8	1.7	3.6	2.2	0.7	1.4	1.1	2.3	3.0	4.1	3.9	1.2	5.9	1.7	0.7	1.0	0.2	0.9	0.5	0.4	0.6	0.4	0.5	0.3	0.6	0.7	0.8	0.0	0.5	1.3	4.8	3.3	0.8	2.4	1.8	1.3	1.9	1.5	0.7	2.8	0.4	0.0	0.0	17.1	1.9	12.4	0.0	1.2	1.0	1.7	1.6	1.9	3.6	34.1	1.2	0.6	26.0	2.9	6.6	2.5	0.0	12.0	3.6	1.0	11.6	1.7	0.9	8.2	2.0	3.5	1.9	2.8	1.5	3.7	1.8	0.0	1.6	0.1	2.1	0.5	0.9	2.4	4.0	1.2	15.8	1.3	1.9	0.6	4.7	1.0	19.7	0.2	6.3	76.8	42.0	17.1	2.7	2.9	5.5	1.2	13.2	1.2
CDH1	"CD324, UVO, uvomorulin"	ENSG00000039068	"Cadherin 1"	P12830	16	68737292-68835537	"Cancer-related genes, CD markers, Disease related genes, Human disease related genes, Plasma proteins, Predicted membrane proteins"	"Cell adhesion"		"Cancer-related genes, Disease variant, Ectodermal dysplasia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"parathyroid gland: 197.8"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 451.6;Glandular and luminal cells: 321.0;Pancreatic endocrine cells: 264.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	13	"myeloid DC: 1.7;plasmacytoid DC: 4.7"	"Lineage enriched"	"Detected in single"	19	"dendritic cells: 4.7"	"Cell line enhanced"	"Detected in many"		"BEWO: 683.3;CACO-2: 241.9;CAPAN-2: 328.1;HaCaT: 318.7;hTCEpi: 217.2;MCF7: 199.6;OE19: 207.2;RT4: 237.7;T-47d: 209.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB000087, HPA004812, CAB028364, CAB072855, CAB072856, CAB072857"	Enhanced		Supported	"Golgi apparatus,Plasma membrane,Cell Junctions"		NA	NA		78000000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Plasma membrane, Cell Junctions"	"Golgi apparatus"	"CAB000087: AB_2533003, CAB028364: AB_2076812, CAB072855: AB_2665698, CAB072856: AB_2665699, CAB072857: AB_2665700, HPA004812: AB_1078369"	"unprognostic (3.95e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.12e-3)"	"unprognostic (1.13e-1)"	"unprognostic (1.42e-1)"	"unprognostic (2.78e-1)"	"unprognostic (5.04e-3)"	"unprognostic (1.63e-1)"	"unprognostic (5.47e-2)"	"unprognostic (2.85e-1)"	"unprognostic (1.19e-2)"	"unprognostic (3.61e-1)"	"prognostic favorable (2.06e-4)"	"unprognostic (1.21e-1)"	"unprognostic (2.62e-1)"	"unprognostic (2.51e-1)"	"unprognostic (5.92e-2)"	1.0	0.2	1.5	16.1	2.0	6.5	64.2	0.6	1.9	30.0	19.3	127.5	133.9	9.6	39.5	76.9	51.5	45.7	0.3	1.5	1.3	39.8	97.2	36.8	5.6	2.0	1.3	1.3	84.0	197.8	8.0	60.9	1.3	91.7	131.0	0.1	71.9	41.7	0.3	107.7	127.9	5.1	2.1	10.3	104.2	0.4	2.3	20.1	162.7	0.1	29.0	58.2	38.1	2.7	147.0	14.8	0.0	0.5	0.0	0.0	683.3	0.0	0.0	0.0	0.0	241.9	328.1	0.0	3.1	0.0	0.0	318.7	0.0	156.3	0.0	28.6	3.5	0.1	0.7	48.0	0.0	0.0	0.6	0.0	217.2	0.1	0.6	0.0	0.0	0.0	0.0	0.1	0.0	199.6	0.2	1.0	5.5	207.2	0.8	0.1	0.1	2.1	53.9	237.7	8.5	0.8	1.4	0.2	58.9	91.8	209.2	0.4	0.0	0.4	0.9	0.7	0.6	0.1	0.3	0.2	0.2	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.7	0.0	0.0	0.0	0.0	0.2	0.0	4.7	0.0	0.1	1.5	2.0	0.6	1.9	1.5	1.3	2.0	1.3	1.3	2.1	2.3	2.7	0.6	131.4	69.8	0.7	1.4	94.1	130.3	73.8	45.5	0.0	137.6	83.6	0.9	128.7	95.3	163.7	0.0	117.6	2.5	451.6	1.9	129.1	0.1	159.3	29.2	4.4	86.7	9.0	0.7	113.5	29.6	3.4	132.0	321.0	1.3	2.8	0.4	63.4	11.7	0.0	1.4	208.3	75.3	1.2	13.4	0.0	0.3	3.2	53.4	1.0	3.3	0.0	0.0	0.5	32.1	264.6	204.6	0.4	2.2	195.5	159.5	4.5	118.2	0.0	0.0	0.0	7.1	0.1	0.1	100.6	131.6	50.5	2.7	0.0	154.8	251.5
CDH13	CDHH	ENSG00000140945	"Cadherin 13"	P55290	16	82626965-83800640	"Plasma proteins, Predicted intracellular proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 57.1;skeletal muscle: 68.6;tongue: 57.7"	"Group enriched"	"Detected in many"	4	"Excitatory neurons: 328.8;Inhibitory neurons: 867.0;Oligodendrocyte precursor cells: 335.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"non-classical monocyte: 4.3"	"Group enriched"	"Detected in many"	6	"granulocytes: 2.2;monocytes: 4.3"	"Cell line enhanced"	"Detected in many"		"LHCN-M2: 222.2;U-138 MG: 279.2;U-87 MG: 244.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001380, CAB025863"	Enhanced		Supported	"Plasma membrane"	"Intracellular and membrane"	NA	NA		240000000	"Cluster 7: Monocytes - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Plasma membrane"		"CAB025863: , HPA001380: AB_1078371"	"unprognostic (2.50e-2)"	"unprognostic (2.75e-2)"	"unprognostic (5.61e-2)"	"unprognostic (4.06e-1)"	"unprognostic (4.88e-2)"	"unprognostic (3.30e-3)"	"unprognostic (3.01e-1)"	"unprognostic (5.76e-2)"	"unprognostic (3.49e-2)"	"unprognostic (3.34e-1)"	"unprognostic (2.21e-1)"	"unprognostic (3.26e-1)"	"prognostic unfavorable (1.73e-6)"	"unprognostic (5.16e-3)"	"unprognostic (2.01e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.21e-1)"	20.3	2.8	18.7	3.8	21.5	0.6	10.0	0.0	14.3	42.5	0.0	5.0	1.5	47.2	3.3	9.5	7.6	5.0	57.1	10.5	3.3	5.0	1.8	16.1	1.4	1.5	6.5	3.1	0.6	2.4	0.5	6.0	0.6	3.5	6.2	1.5	4.9	7.2	68.6	21.1	2.3	29.9	6.3	2.1	1.7	1.8	22.9	1.8	5.8	57.7	1.9	7.1	19.4	3.2	10.2	0.0	3.6	0.5	63.2	60.6	0.1	47.1	51.9	53.6	23.1	0.1	0.4	0.1	8.5	138.5	26.0	89.1	1.0	70.7	79.8	0.0	0.2	0.1	31.4	0.1	36.4	0.0	0.4	7.9	59.9	107.8	130.4	83.9	26.7	0.0	0.2	0.5	222.2	0.5	0.1	0.2	10.6	0.0	19.4	0.0	57.7	0.0	46.2	0.4	0.1	0.1	84.4	0.3	0.1	103.5	0.8	0.1	43.1	279.2	22.7	1.6	43.0	0.2	0.1	0.2	244.0	0.2	70.1	2.2	0.5	1.4	0.0	2.1	0.0	0.5	0.0	0.0	0.5	0.5	0.0	0.0	1.1	0.0	4.3	0.3	0.0	0.2	18.7	21.5	0.0	14.3	10.5	3.3	1.5	6.5	0.6	6.3	22.9	3.2	125.4	0.0	0.5	11.1	0.3	70.7	28.7	32.3	25.0	3.0	1.0	5.8	86.9	0.0	2.6	3.7	0.0	0.1	0.9	2.1	7.9	0.4	44.5	1.0	27.1	49.2	1.8	0.0	328.8	0.0	0.2	9.7	0.0	0.7	0.0	0.0	29.6	0.3	0.6	5.0	867.0	1.6	0.0	1.9	13.3	43.3	0.3	1.4	8.8	17.8	0.0	0.4	0.0	335.8	65.0	0.1	1.4	0.0	0.0	36.7	0.0	1.3	0.8	0.4	0.0	51.0	22.7	2.9	0.6	3.3	18.8	0.1	1.2	0.7	0.1	6.4
CDH17	"cadherin, HPT-1"	ENSG00000079112	"Cadherin 17"	Q12864	8	94127162-94217303	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion, Transport"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	11	"intestine: 314.2"	"Cell type enhanced"	"Detected in some"		"Distal enterocytes: 569.4;Enteroendocrine cells: 108.4;Intestinal goblet cells: 183.7;Paneth cells: 408.6;Proximal enterocytes: 336.9;Undifferentiated cells: 241.6"	"Group enriched"	"Detected in many"	6	"colorectal cancer: 156.4;stomach cancer: 54.9"	"Low region specificity"	"Detected in single"			"Immune cell enriched"	"Detected in some"	5	"neutrophil: 16.0"	"Lineage enriched"	"Detected in single"	17	"granulocytes: 16.0"	"Cell line enhanced"	"Detected in some"		"CACO-2: 98.8;OE19: 430.1;U-266/70: 157.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA023614, HPA023616, CAB025143, HPA026556"	Enhanced		Supported	"Nucleoplasm,Cell Junctions"		NA	NA		7500000	"Cluster 1: Neutrophils - Mixed function"	"Cluster 9: Intestine - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Cell Junctions"	Nucleoplasm	"CAB025143: , HPA023614: AB_1845896, HPA023616: AB_1845895, HPA026556: AB_1845897"	"unprognostic (2.08e-1)"	"unprognostic (5.00e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.09e-1)"	"unprognostic (3.02e-1)"	"unprognostic (3.06e-2)"	"unprognostic (5.60e-2)"	"unprognostic (3.38e-3)"	"unprognostic (2.11e-1)"	"unprognostic (1.74e-1)"	"unprognostic (5.47e-2)"	"unprognostic (3.74e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.31e-1)"	"unprognostic (7.33e-2)"	"unprognostic (1.46e-2)"	0.9	0.2	0.7	28.8	0.5	2.7	0.5	1.1	0.8	0.1	1.9	260.9	314.2	1.3	0.8	1.7	0.3	3.0	0.6	0.5	0.2	0.8	0.3	0.2	1.5	0.3	0.1	0.5	1.7	0.0	0.0	0.2	0.3	1.2	246.7	0.5	0.9	1.6	0.5	0.6	270.6	9.3	0.1	5.5	2.5	0.6	0.2	0.3	0.7	0.1	1.8	0.8	0.1	0.7	0.2	18.5	0.2	0.4	0.0	0.4	1.6	0.2	0.3	0.2	0.3	98.8	3.5	0.3	0.3	0.0	0.1	1.0	0.3	0.3	0.3	0.2	1.1	0.1	0.8	0.6	0.3	0.2	4.3	0.0	0.0	0.2	0.0	0.4	0.1	0.2	0.4	1.5	0.1	0.7	0.5	1.3	0.3	430.1	0.5	0.3	0.0	2.8	0.3	0.2	1.3	1.2	0.4	0.4	0.5	0.4	0.7	0.9	0.0	0.6	0.7	1.2	0.5	157.2	0.3	0.2	0.3	0.3	0.6	2.9	0.9	1.4	0.2	0.8	0.1	0.3	0.2	0.1	0.5	0.8	0.2	0.3	16.0	0.7	0.5	0.4	0.2	0.2	0.7	0.5	1.1	0.8	0.5	0.2	0.3	0.1	0.3	0.1	0.2	0.7	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.6	0.0	0.0	0.0	0.0	569.4	0.0	0.3	1.0	0.0	0.0	0.0	108.4	0.0	0.5	0.0	0.0	0.1	2.6	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.3	183.7	0.0	0.0	0.5	0.2	0.0	0.7	0.0	0.0	0.0	0.0	0.0	1.0	0.1	0.0	408.6	0.0	0.2	0.0	336.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	2.1	0.0	241.6	0.1
CDH2	"CD325, CDHN, NCAD"	ENSG00000170558	"Cadherin 2"	P19022	18	27932879-28177946	"CD markers, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"		"Cardiomyopathy, Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 196.0"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 217.7;Cardiomyocytes: 368.8;Excitatory neurons: 311.2;Granulosa cells: 312.5;Inhibitory neurons: 198.2;Muller glia cells: 157.9;Oligodendrocyte precursor cells: 267.9"	"Cancer enhanced"	"Detected in all"		"glioma: 39.3"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"basophil: 1.7;neutrophil: 1.3"	"Lineage enriched"	"Detected in single"	6	"granulocytes: 1.7"	"Cell line enhanced"	"Detected in many"		"AF22: 278.2;BJ: 230.7;fHDF/TERT166: 459.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000141, CAB018580, HPA058574, CAB078686"	Enhanced		Supported	"Plasma membrane,Cell Junctions"		NA	NA		160000000	"Cluster 10: Basophils - Unknown function"	"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 40: Granulosa cells - Unknown function"	"Plasma membrane, Cell Junctions"		"CAB000141: , CAB018580: AB_626778, CAB078686: AB_2665849, HPA058574: AB_2683760"	"unprognostic (9.42e-2)"	"unprognostic (2.69e-3)"	"unprognostic (9.07e-3)"	"unprognostic (5.45e-2)"	"unprognostic (1.14e-1)"	"unprognostic (9.30e-2)"	"unprognostic (3.97e-2)"	"unprognostic (2.53e-3)"	"unprognostic (6.70e-3)"	"unprognostic (1.00e-2)"	"unprognostic (7.53e-2)"	"unprognostic (3.51e-2)"	"unprognostic (3.02e-2)"	"unprognostic (1.93e-3)"	"unprognostic (6.69e-2)"	"unprognostic (1.33e-1)"	"unprognostic (2.59e-3)"	0.6	66.5	27.4	2.6	29.0	0.2	0.3	20.6	31.6	6.6	7.9	4.8	0.8	6.2	1.1	0.4	10.5	3.1	196.0	30.0	31.6	18.1	57.2	1.0	1.9	21.7	26.3	6.7	0.9	29.8	8.1	0.4	20.1	2.4	1.1	60.3	0.4	10.8	0.4	0.3	1.4	6.8	24.1	13.5	5.9	44.4	33.3	3.8	6.2	2.2	1.6	1.1	2.7	22.7	0.3	25.8	278.2	0.3	48.1	7.8	0.2	230.7	72.0	94.9	80.8	0.1	0.4	0.0	128.3	459.1	46.0	36.7	50.0	0.2	130.4	0.4	35.8	0.0	66.8	86.7	48.0	0.0	0.1	4.6	0.4	198.6	37.4	212.9	84.0	15.4	0.0	0.1	77.8	0.0	59.4	0.1	43.8	0.1	30.5	0.2	37.1	45.6	0.1	9.9	83.4	144.4	0.1	0.2	26.8	116.8	0.3	0.5	11.6	206.6	63.6	2.9	181.6	0.2	0.3	0.3	40.6	0.2	163.0	1.7	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.3	0.0	0.0	0.0	0.0	27.4	29.0	20.6	31.6	30.0	31.6	21.7	26.3	20.1	24.1	33.3	22.7	0.8	0.0	0.6	217.7	1.2	0.3	0.0	3.4	0.0	38.7	1.6	0.4	368.8	67.2	1.2	11.0	150.1	0.1	0.0	0.0	0.0	12.9	53.2	1.4	15.2	9.8	0.0	6.1	311.2	0.4	0.0	16.7	0.0	2.6	0.0	312.5	12.5	125.3	0.3	3.3	198.2	0.0	2.0	2.2	0.4	17.7	2.1	1.2	3.6	106.8	0.1	157.9	0.0	267.9	138.6	19.2	0.0	12.8	0.0	0.1	0.0	47.5	1.7	99.9	6.6	0.4	45.8	4.8	24.1	0.0	0.0	0.3	0.6	1.6	0.0	0.1
CDH26	VR20	ENSG00000124215	"Cadherin 26"	Q8IXH8	20	59958423-60034011	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"prostate: 8.0"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 17.9;Club cells: 18.7;Oligodendrocytes: 14.9;Respiratory ciliated cells: 39.6;Syncytiotrophoblasts: 14.9"	"Group enriched"	"Detected in some"	6	"cervical cancer: 1.5;head and neck cancer: 0.9;lung cancer: 2.3;prostate cancer: 3.6;urothelial cancer: 3.2"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"RT4: 36.4"	"Low region specificity"	"Detected in some"							"HPA015722, HPA047578"	Uncertain		Supported	"Plasma membrane,Microtubules"		NA	NA				"Cluster 27: Brain & Skin - Unknown function"	"Cluster 15: RT4 - Unknown function"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Plasma membrane"	Microtubules	"HPA015722: AB_2077659, HPA047578: AB_2680091"	"unprognostic (2.42e-1)"	"prognostic favorable (7.62e-4)"	"unprognostic (4.71e-4)"	"unprognostic (8.17e-2)"	"unprognostic (9.40e-2)"	"unprognostic (9.95e-3)"	"unprognostic (6.65e-2)"	"prognostic favorable (3.75e-4)"	"unprognostic (1.37e-1)"	"unprognostic (1.69e-1)"	"unprognostic (3.26e-4)"	"unprognostic (8.24e-3)"	"unprognostic (9.96e-7)"	"unprognostic (1.85e-2)"	"unprognostic (2.73e-1)"	"unprognostic (2.54e-2)"	"unprognostic (1.04e-1)"	0.9	0.4	1.0	0.3	1.5	1.0	0.8	1.2	2.0	2.0	0.3	0.7	0.4	0.6	0.4	3.4	2.0	0.4	0.7	0.9	1.8	0.5	0.3	2.1	0.4	1.6	1.7	0.3	0.5	0.3	1.7	0.4	1.5	8.0	0.3	0.4	2.0	0.5	1.0	0.6	0.8	0.4	0.6	0.8	1.2	0.7	1.9	0.9	0.6	0.3	3.0	2.7	1.3	2.6	0.0	0.7	0.2	0.0	0.6	0.2	0.4	0.2	0.0	0.1	0.0	0.8	0.8	0.1	0.5	0.0	0.0	1.9	0.0	0.0	0.0	0.2	0.1	7.9	0.1	0.1	0.0	0.3	0.3	0.1	1.1	0.1	0.0	0.0	0.0	0.4	0.0	0.3	0.3	0.3	0.3	0.4	0.4	0.0	0.1	0.0	0.0	0.7	0.1	36.4	0.8	0.1	0.4	0.2	0.1	0.4	0.2	0.4	0.2	0.0	0.0	1.0	0.0	0.3	0.2	0.0	0.0	1.1	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	1.5	1.2	2.0	0.9	1.8	1.6	1.7	1.5	0.6	1.9	2.6	4.3	6.4	6.1	17.9	0.1	0.1	1.2	6.6	0.0	0.5	1.6	0.5	0.7	0.0	18.7	0.0	0.0	1.7	0.0	0.2	0.0	0.0	3.2	2.1	0.4	2.1	0.0	2.5	9.3	0.0	0.0	0.3	0.0	0.4	1.3	0.0	0.7	0.1	0.6	0.0	8.4	0.0	6.1	1.3	0.4	1.7	0.0	1.4	0.0	7.5	0.6	0.2	1.0	7.1	14.9	0.0	0.0	0.0	0.4	10.9	0.2	0.1	39.6	0.0	0.0	0.5	2.4	0.9	0.2	0.2	0.0	14.9	0.2	0.1	0.2	7.4
CDH3	"CDHP, PCAD"	ENSG00000062038	"Cadherin 3"	P22223	16	68636189-68727468	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion, Sensory transduction, Vision"		"Disease variant, Ectodermal dysplasia, Hypotrichosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"choroid plexus: 47.1;ovary: 32.7"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 60.8;Basal prostatic cells: 67.2;Basal respiratory cells: 161.4;Basal squamous epithelial cells: 71.7;Granulosa cells: 77.6;Melanocytes: 60.5;Pancreatic endocrine cells: 85.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 100.6;HaCaT: 263.9;HBEC3-KT: 126.9;hTCEpi: 94.3;hTERT-HME1: 72.7;RPTEC TERT1: 116.8"	"Region enhanced"	"Detected in single"		"olfactory bulb: 1.7"	"Low region specificity"	"Detected in all"			"HPA001767, CAB002487"	Enhanced		Supported	"Plasma membrane,Cell Junctions"		NA	NA		510000		"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Plasma membrane"	"Cell Junctions"	"CAB002487: AB_563446, HPA001767: AB_1078376"	"unprognostic (1.55e-1)"	"unprognostic (2.47e-2)"	"unprognostic (1.33e-1)"	"unprognostic (4.38e-3)"	"unprognostic (6.73e-2)"	"unprognostic (1.55e-2)"	"unprognostic (1.85e-2)"	"prognostic unfavorable (8.53e-4)"	"unprognostic (1.22e-1)"	"unprognostic (3.45e-2)"	"prognostic unfavorable (8.43e-4)"	"unprognostic (4.30e-2)"	"unprognostic (2.41e-5)"	"unprognostic (2.11e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.33e-3)"	"unprognostic (8.56e-2)"	3.6	0.2	1.3	3.4	1.5	0.1	8.2	1.9	1.6	9.7	47.1	0.4	0.5	10.0	8.8	26.8	12.0	1.5	0.3	3.5	0.8	6.0	0.0	2.0	2.5	1.2	1.0	32.7	0.6	1.5	4.4	4.5	0.6	13.6	0.7	0.8	12.4	4.6	0.2	25.8	0.7	4.0	1.9	10.9	1.0	1.6	1.1	18.8	1.2	0.0	11.7	3.9	11.2	1.1	100.6	0.2	0.9	0.1	0.1	0.0	8.6	0.0	0.0	0.3	0.1	61.4	36.6	0.0	0.4	0.0	0.2	263.9	2.6	126.9	0.4	0.0	1.2	0.0	0.2	0.0	0.2	0.2	0.5	0.0	94.3	0.1	72.7	0.3	0.0	0.0	0.0	0.2	0.0	48.8	0.1	0.1	5.3	0.9	8.8	0.0	0.0	0.0	116.8	44.5	0.5	0.2	0.8	0.0	50.0	45.6	29.2	0.2	0.0	0.0	0.2	0.0	0.3	0.1	0.2	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.3	1.5	1.9	1.6	3.5	0.8	1.2	1.0	0.6	1.9	1.1	1.1	0.2	16.0	4.6	0.7	0.0	60.8	67.2	161.4	71.7	1.2	6.8	39.2	1.4	0.0	35.9	14.7	2.1	23.4	0.5	0.5	0.0	35.7	0.5	0.9	8.2	1.3	1.2	0.0	6.0	32.1	2.1	3.7	0.0	0.9	1.3	77.6	0.0	0.0	2.8	0.0	9.1	1.5	20.3	0.0	1.9	0.2	0.6	0.7	60.5	0.0	1.0	0.4	1.0	3.0	2.2	85.7	0.1	9.4	1.2	44.5	0.0	0.1	12.6	0.5	0.0	0.6	5.9	0.4	1.0	26.5	30.7	6.3	1.2	0.1	1.5	43.1
CDH4		ENSG00000179242	"Cadherin 4"	P55283	20	61252261-61940617	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 11.0;lymphoid tissue: 3.7;ovary: 6.3;skeletal muscle: 3.8"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 157.0;Excitatory neurons: 54.4;Inhibitory neurons: 70.0;Oligodendrocyte precursor cells: 108.0;Skeletal myocytes: 28.7"	"Group enriched"	"Detected in many"	6	"glioma: 6.9;renal cancer: 3.4;thyroid cancer: 2.8"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 10.8;hTERT-HME1: 14.1;U-2 OS: 19.4;U-251 MG: 35.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015613			Supported	"Plasma membrane"		NA	NA		19000	"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 65: Brain - Ion transport"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 64: Astrocytes - Nervous system maintenance"	"Plasma membrane"		"HPA015613: AB_2732414"	"unprognostic (1.64e-1)"	"unprognostic (1.19e-2)"	"unprognostic (3.39e-4)"	"unprognostic (2.16e-1)"	"unprognostic (2.59e-2)"	"unprognostic (1.08e-1)"	"unprognostic (5.64e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.85e-1)"	"unprognostic (6.72e-2)"	"unprognostic (6.08e-3)"	"unprognostic (1.75e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.64e-2)"	"unprognostic (6.78e-2)"	0.1	1.3	7.3	0.0	4.3	0.1	0.2	0.0	3.4	0.6	0.0	0.3	0.0	0.2	0.0	0.2	0.6	0.1	0.2	3.0	5.0	0.3	0.2	0.3	0.0	1.3	3.0	6.3	0.5	0.1	0.5	0.0	0.4	0.3	0.0	0.7	0.3	0.8	3.8	0.7	0.2	0.0	0.0	3.7	0.2	0.9	11.0	0.2	0.3	0.0	0.0	0.2	0.2	1.1	0.1	1.2	10.8	0.0	0.2	0.7	0.2	3.1	0.0	5.6	0.6	0.3	0.0	0.0	0.3	3.7	3.6	4.1	0.0	6.2	2.2	0.3	0.0	0.0	0.1	0.1	7.1	0.0	0.1	1.1	1.4	1.1	14.1	3.0	1.2	0.4	0.0	0.1	2.1	0.4	0.1	0.1	1.3	0.0	0.1	0.0	0.0	1.6	3.2	0.0	1.0	2.7	0.0	0.1	0.1	1.6	0.0	0.0	0.0	0.0	19.4	0.1	35.2	6.3	0.1	0.1	6.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	7.3	4.3	0.0	3.4	3.0	5.0	1.3	3.0	0.4	0.0	11.0	1.1	0.0	3.2	0.0	157.0	0.0	0.3	0.4	0.0	0.0	1.8	0.4	0.9	1.6	0.0	0.7	0.0	2.1	0.0	0.1	0.1	0.0	1.3	0.9	0.1	0.3	0.2	0.0	0.0	54.4	0.0	0.0	1.0	0.0	0.1	0.0	0.7	0.0	0.0	0.0	16.8	70.0	0.0	0.0	0.0	0.0	0.9	0.6	0.2	0.0	10.3	0.0	19.9	0.0	108.0	24.9	0.2	0.0	0.4	0.0	0.6	0.0	0.1	0.0	1.6	0.0	28.7	0.4	0.1	2.2	0.0	0.3	0.0	0.1	0.4	0.0	0.3
CDH5	"7B4, CD144"	ENSG00000179776	"Cadherin 5"	P33151	16	66366622-66404784	"Cancer-related genes, CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 235.9"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 311.9;Endothelial cells: 206.1;Hepatic stellate cells: 185.6;Late spermatids: 84.6;Syncytiotrophoblasts: 80.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"HUVEC TERT2: 752.5;TIME: 655.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB028366, HPA075875"	Approved		Supported	"Nucleoplasm,Nuclear membrane,Plasma membrane"		NA	NA		1300000000		"Cluster 82: Adipose tissue - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Plasma membrane"	"Nucleoplasm, Nuclear membrane"	"CAB028366: AB_2276033, HPA075875: "	"unprognostic (1.05e-1)"	"unprognostic (8.13e-2)"	"unprognostic (6.11e-2)"	"unprognostic (4.89e-2)"	"unprognostic (4.96e-2)"	"unprognostic (5.50e-3)"	"unprognostic (9.38e-2)"	"unprognostic (5.28e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.46e-1)"	"unprognostic (2.33e-2)"	"unprognostic (2.32e-1)"	"prognostic unfavorable (5.14e-4)"	"unprognostic (9.49e-3)"	"unprognostic (3.01e-2)"	"unprognostic (2.22e-1)"	"unprognostic (3.15e-2)"	84.5	13.8	16.3	14.9	15.9	0.2	71.4	15.1	16.6	16.2	11.3	16.8	7.9	19.9	8.6	12.4	17.1	29.7	84.4	13.8	14.6	19.1	24.0	95.0	13.1	16.7	16.6	8.1	7.7	10.3	7.4	235.9	17.9	11.6	10.2	1.3	12.0	9.1	41.8	16.7	17.0	27.8	15.5	20.4	13.3	10.5	22.6	5.2	37.5	58.9	7.9	22.1	14.2	15.5	0.5	0.6	4.6	0.0	0.0	0.0	47.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	119.8	0.0	0.0	0.7	0.0	0.0	0.0	0.3	0.0	1.0	0.0	0.3	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	752.5	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.7	0.0	0.0	0.0	0.1	0.0	1.4	0.0	0.1	0.1	0.0	15.7	0.0	2.4	0.0	0.1	655.1	0.0	0.9	0.1	0.0	0.0	0.2	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	16.3	15.9	15.1	16.6	13.8	14.6	16.7	16.6	17.9	15.5	22.6	15.5	311.9	0.0	6.2	1.3	0.7	4.1	0.0	0.0	1.8	0.0	1.0	2.7	17.9	5.7	0.6	1.8	0.0	6.6	0.5	0.0	0.0	0.2	33.5	0.5	0.6	206.1	0.0	10.7	0.1	0.0	48.9	7.1	0.0	1.3	3.8	0.0	185.6	1.7	2.3	0.0	0.1	0.0	0.0	35.7	6.3	84.6	6.2	1.2	12.4	28.1	0.1	0.3	0.0	0.5	0.1	0.0	0.0	2.6	2.5	0.1	0.0	0.0	0.0	0.0	0.0	5.0	5.4	10.9	0.3	0.3	3.0	80.7	1.5	3.0	0.1	0.2
CDH6		ENSG00000113361	"Cadherin 6"	P55285	5	31193686-31329146	"Plasma proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 14.8"	"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 48.6;Excitatory neurons: 67.1;Oligodendrocyte precursor cells: 60.8;Pancreatic endocrine cells: 63.8;Proximal tubular cells: 171.1;Sertoli cells: 46.0;Smooth muscle cells: 69.5"	"Group enriched"	"Detected in many"	5	"ovarian cancer: 15.0;renal cancer: 28.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	8	"EFO-21: 477.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA007047, HPA007403, HPA007456, CAB025274"	Enhanced		Supported	"Plasma membrane,Cell Junctions"		NA	NA		9600000		"Cluster 21: Non-specific - Transcription"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Plasma membrane, Cell Junctions"		"CAB025274: , HPA007047: AB_1078374, HPA007403: , HPA007456: AB_1078373"	"unprognostic (3.87e-2)"	"unprognostic (4.69e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.92e-3)"	"unprognostic (1.58e-2)"	"unprognostic (7.61e-3)"	"unprognostic (9.04e-2)"	"unprognostic (2.68e-1)"	"unprognostic (2.74e-2)"	"unprognostic (5.22e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.19e-2)"	"unprognostic (8.29e-3)"	"unprognostic (1.22e-3)"	"unprognostic (2.67e-1)"	"unprognostic (6.22e-2)"	"unprognostic (2.09e-2)"	5.0	1.1	3.2	1.4	9.3	0.2	2.6	2.2	3.7	4.3	0.5	1.3	1.3	2.3	1.8	2.4	6.8	9.2	2.0	2.2	7.4	14.8	0.7	4.5	0.6	4.9	9.5	0.7	0.7	1.1	1.0	3.6	6.0	1.1	0.9	1.5	0.7	1.8	1.2	1.0	1.2	2.6	3.2	0.8	1.0	0.3	9.8	0.4	2.3	1.6	0.7	2.3	1.9	3.9	0.1	1.9	62.2	0.0	0.0	0.0	0.2	1.5	0.1	0.0	0.0	0.2	0.0	0.1	477.1	0.3	0.0	0.0	49.6	0.1	0.0	0.6	0.0	0.1	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.2	17.5	0.1	0.0	0.0	0.5	0.1	0.0	0.0	0.1	9.4	0.0	0.2	0.0	10.9	0.1	14.0	0.0	1.8	0.0	0.0	0.1	0.2	19.3	0.1	0.2	0.0	0.1	1.8	5.9	1.5	0.1	0.4	1.1	0.1	0.1	1.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	3.2	9.3	2.2	3.7	2.2	7.4	4.9	9.5	6.0	3.2	9.8	3.9	5.7	0.0	0.5	7.2	2.4	0.9	0.1	36.5	0.0	10.8	0.1	0.4	3.1	48.6	7.0	11.0	0.0	0.0	0.0	0.0	27.4	37.2	0.2	2.9	0.6	5.3	0.0	0.0	67.1	3.0	0.0	2.9	0.0	2.9	0.0	4.1	0.0	0.1	0.1	0.0	33.6	0.0	0.0	0.0	2.5	0.1	0.3	1.3	0.0	39.4	1.0	0.3	0.0	60.8	5.5	63.8	0.0	0.4	0.0	1.2	0.0	171.1	1.1	0.8	46.0	0.6	69.5	0.0	0.4	0.1	1.0	0.0	1.8	0.2	0.0	0.1
CDIP1	"C16orf5, CDIP, LITAFL"	ENSG00000089486	"Cell death inducing p53 target 1"	Q9H305	16	4510669-4538828	"Predicted intracellular proteins, Predicted membrane proteins"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 90.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Hep G2: 59.4;RPMI-8226: 68.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049352	Approved		Supported	Nucleoplasm,Centrosome		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 35: Non-specific - Unknown function"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 56: Bipolar cells - Visual perception"	Centrosome	Nucleoplasm	"HPA049352: AB_2680724"	"unprognostic (6.38e-3)"	"unprognostic (3.70e-3)"	"unprognostic (2.95e-2)"	"unprognostic (2.50e-3)"	"unprognostic (2.74e-2)"	"unprognostic (2.56e-2)"	"unprognostic (3.48e-1)"	"unprognostic (8.26e-2)"	"unprognostic (3.68e-2)"	"unprognostic (1.03e-2)"	"prognostic favorable (2.14e-5)"	"unprognostic (9.05e-2)"	"prognostic favorable (1.14e-6)"	"unprognostic (1.43e-2)"	"unprognostic (3.51e-2)"	"unprognostic (9.88e-2)"	"unprognostic (4.65e-2)"	19.6	43.2	27.2	5.0	30.0	2.1	18.4	21.2	65.1	26.8	0.0	24.6	14.5	30.0	1.0	22.3	24.6	7.9	57.3	26.6	21.3	49.7	44.1	14.5	5.4	22.3	21.3	34.0	37.9	7.1	65.2	5.3	25.4	25.3	2.5	6.9	14.0	10.9	41.1	17.9	26.0	7.0	15.0	20.1	21.5	28.7	29.3	11.5	24.2	8.4	4.0	20.3	20.1	36.2	10.6	3.6	14.0	3.0	1.7	0.0	0.4	14.9	2.3	11.5	10.6	22.6	2.2	0.7	12.2	10.8	4.6	0.8	12.8	41.9	3.0	27.6	25.8	40.7	12.9	59.4	10.5	20.5	21.0	10.5	44.7	10.2	3.4	3.4	9.6	13.1	1.2	9.1	14.5	1.3	15.0	19.2	19.9	10.6	10.1	50.1	12.8	68.3	3.0	0.5	27.9	13.6	24.2	1.4	16.6	7.2	4.4	13.4	0.8	5.5	16.3	7.7	0.7	27.5	29.1	37.9	0.5	16.7	4.7	4.5	5.8	14.4	11.7	9.0	6.9	6.4	4.1	7.3	5.7	5.7	9.0	6.8	5.0	12.0	17.7	6.6	7.0	5.9	27.2	30.0	21.2	65.1	26.6	21.3	22.3	21.3	25.4	15.0	29.3	36.2	27.1	16.0	7.0	28.7	19.4	29.6	21.5	25.4	38.1	63.5	7.7	14.4	26.5	7.2	9.0	16.5	12.5	1.8	16.3	12.1	52.8	13.0	90.9	1.5	18.7	20.3	9.6	7.2	23.5	9.2	1.6	15.4	7.7	2.9	22.9	11.3	25.7	18.5	19.6	70.7	26.4	6.1	14.2	12.2	11.7	25.4	18.0	17.5	14.2	8.4	7.1	41.4	45.3	9.5	14.7	8.2	13.2	16.6	24.1	13.3	39.6	65.0	0.9	16.1	6.6	8.4	11.3	21.1	27.7	15.2	14.9	6.7	22.9	13.7	6.7	11.5
CDK1	"CDC2, CDC28A"	ENSG00000170312	"Cyclin dependent kinase 1"	P06493	10	60778331-60794852	"Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Transporters"	"Apoptosis, Biological rhythms, Cell cycle, Cell division, Host-virus interaction, Mitosis"	"Host cell receptor for virus entry, Kinase, Receptor, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 53.2;lymphoid tissue: 74.0"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 80.9;Erythroid cells: 209.6;Extravillous trophoblasts: 144.6;Spermatocytes: 110.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"NK-cell: 3.2;T-reg: 3.4"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003387, CAB003799, CAB079974"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	Yes		51000	"Cluster 15: NK-cells - Transcription"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Nucleoplasm, Cytosol"		"CAB003799: AB_344898, CAB079974: , HPA003387: AB_1846356"	"unprognostic (6.34e-2)"	"prognostic favorable (8.81e-4)"	"unprognostic (1.90e-1)"	"unprognostic (6.82e-2)"	"unprognostic (6.67e-2)"	"unprognostic (3.83e-2)"	"prognostic unfavorable (1.10e-6)"	"prognostic unfavorable (7.88e-4)"	"unprognostic (1.30e-2)"	"unprognostic (1.30e-1)"	"prognostic unfavorable (4.15e-6)"	"unprognostic (1.80e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (2.27e-1)"	"unprognostic (2.75e-1)"	"unprognostic (2.13e-1)"	"unprognostic (1.60e-1)"	3.8	1.8	0.9	17.0	1.0	53.2	7.4	0.9	1.5	5.2	0.9	17.6	16.3	7.1	12.2	17.5	3.7	4.3	1.4	0.9	1.0	3.1	3.2	4.7	40.6	1.2	1.2	2.3	0.8	2.5	4.1	19.4	1.1	1.7	20.8	1.3	3.2	5.2	1.4	13.2	14.5	8.0	0.9	9.0	10.1	25.1	1.4	74.0	3.6	2.2	47.5	7.1	6.9	1.0	249.9	93.5	241.1	96.0	15.4	23.6	99.0	183.8	132.7	218.8	209.0	218.9	213.7	226.2	69.6	50.6	79.6	149.9	166.2	106.8	225.8	162.3	121.1	119.4	84.4	128.1	2.8	184.5	117.6	4.7	10.4	142.1	137.0	49.6	133.3	146.2	185.1	270.3	246.9	66.3	234.0	131.1	106.6	149.3	193.1	199.7	224.5	111.3	84.3	81.4	112.7	98.7	123.5	184.9	96.3	130.0	199.9	111.5	55.4	92.8	197.9	99.1	255.8	104.9	180.8	205.6	79.9	203.5	117.6	0.0	0.0	0.0	0.3	0.1	0.2	0.5	0.7	1.3	0.3	0.4	0.2	0.7	0.0	3.2	0.1	0.9	3.4	0.9	0.9	1.0	0.9	1.5	0.9	1.0	1.2	1.2	1.1	0.9	1.4	1.0	7.7	0.0	3.2	0.3	7.1	39.8	5.4	29.9	2.8	1.1	5.3	6.1	0.8	0.0	10.2	18.4	0.0	80.9	3.6	8.9	3.9	0.8	18.7	10.8	6.2	10.5	3.0	209.6	0.4	0.0	144.6	13.3	13.3	9.4	0.0	51.5	7.5	1.3	57.2	0.0	0.2	14.6	30.5	20.5	18.1	10.4	2.1	16.5	1.8	1.9	1.0	1.0	3.1	0.0	0.1	0.4	0.7	0.7	32.1	4.3	2.2	3.0	17.6	0.7	0.0	0.5	24.6	110.0	39.6	33.8	18.6	22.0	10.3	2.1	26.6	10.4
CDK10	PISSLRE	ENSG00000185324	"Cyclin dependent kinase 10"	Q15131	16	89680737-89696354	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Cilium biogenesis/degradation"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007451, HPA059634, HPA067060"	Uncertain		Supported	"Nucleoplasm,Midbody,Midbody ring"		Yes	Yes			"Cluster 27: Non-specific - Gene expression"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	"Midbody, Midbody ring"	"HPA007451: AB_2732400, HPA059634: AB_2684090, HPA067060: AB_2685772"	"unprognostic (7.89e-2)"	"unprognostic (8.08e-2)"	"unprognostic (3.74e-3)"	"unprognostic (9.87e-2)"	"unprognostic (1.76e-1)"	"unprognostic (3.44e-2)"	"unprognostic (4.53e-1)"	"unprognostic (9.06e-2)"	"unprognostic (2.99e-1)"	"unprognostic (2.13e-1)"	"prognostic favorable (2.69e-4)"	"unprognostic (2.58e-2)"	"unprognostic (2.93e-1)"	"unprognostic (3.32e-2)"	"unprognostic (1.79e-1)"	"unprognostic (6.88e-2)"	"prognostic favorable (3.63e-4)"	30.1	38.5	20.2	10.4	20.4	19.5	26.7	20.3	32.8	49.3	22.0	38.2	22.7	25.9	8.7	35.3	36.3	8.6	27.3	21.0	19.5	52.9	77.0	31.0	14.7	18.6	18.7	43.2	49.2	13.5	55.5	12.5	19.6	39.1	11.3	7.6	24.8	7.5	33.8	32.1	36.1	8.2	17.0	37.5	38.5	17.0	18.4	10.8	54.5	4.1	7.0	32.3	36.5	19.1	27.5	17.8	13.9	5.8	5.7	11.0	14.2	22.3	12.6	15.2	4.9	13.1	21.2	23.9	9.8	19.3	9.1	15.5	5.8	30.8	9.3	5.3	14.1	9.7	21.0	1.7	23.4	15.8	17.1	13.3	10.7	9.3	15.3	10.3	27.0	16.1	25.5	3.2	17.7	36.6	19.5	45.0	28.5	29.7	13.1	26.5	19.0	34.1	27.9	21.2	10.1	29.6	28.0	13.0	6.8	15.2	30.3	25.0	24.1	9.1	26.6	10.1	15.4	11.7	6.4	7.5	16.4	25.0	15.5	5.1	14.0	4.2	14.8	19.7	12.8	7.8	13.2	10.7	18.1	9.0	15.1	12.6	1.5	20.4	15.4	12.4	11.6	11.4	20.2	20.4	20.3	32.8	21.0	19.5	18.6	18.7	19.6	17.0	18.4	19.1	28.2	12.8	26.6	35.3	21.2	15.4	24.2	26.9	23.3	17.2	24.5	25.1	6.5	38.6	20.0	27.6	25.0	28.6	26.7	44.8	43.0	28.6	6.1	20.7	21.9	23.0	67.7	15.4	44.5	12.5	19.8	19.6	85.1	16.9	9.5	40.3	21.8	41.1	18.8	18.5	33.3	49.4	26.4	17.4	16.0	8.8	23.9	17.0	19.6	17.8	15.5	8.5	26.8	24.6	20.0	13.6	41.5	12.4	20.8	30.7	58.3	53.7	28.1	32.3	6.6	11.4	16.3	27.3	28.7	22.4	15.5	27.9	22.0	54.8	58.2	22.9
CDK11A	"CDC2L2, CDC2L3, CDK11-p110, CDK11-p46, CDK11-p58, p58GTA, PITSLRE"	ENSG00000008128	"Cyclin dependent kinase 11A"	Q9UQ88	1	1702379-1724357	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Apoptosis, Cell cycle"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 124.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 85.3"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"CAB010467, HPA025061, HPA073626"	Supported		Supported	"Nuclear speckles,Cytosol"		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 2: Immune cells - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 11: Alveolar cells - Smell perception"	"Nuclear speckles"	Cytosol	"CAB010467: AB_631212, HPA025061: AB_1846407, HPA073626: AB_2686619"	"unprognostic (6.25e-2)"	"unprognostic (8.32e-2)"	"unprognostic (1.47e-2)"	"unprognostic (2.74e-1)"	"unprognostic (9.32e-3)"	"unprognostic (3.54e-2)"	"unprognostic (2.25e-3)"	"unprognostic (7.97e-2)"	"prognostic unfavorable (5.06e-4)"	"unprognostic (1.28e-1)"	"unprognostic (5.58e-3)"	"unprognostic (3.07e-2)"	"prognostic unfavorable (1.15e-6)"	"unprognostic (1.97e-1)"	"unprognostic (5.98e-2)"	"unprognostic (1.54e-1)"	"unprognostic (3.70e-2)"	17.7	17.0	14.9	24.8	15.3	41.7	17.7	18.7	16.2	22.2	14.9	25.0	29.3	19.4	8.8	15.7	20.6	9.4	13.5	14.3	15.8	15.5	18.6	27.4	23.3	15.9	14.6	20.3	17.2	9.3	18.5	12.5	15.4	20.3	14.7	13.1	16.8	7.8	26.0	19.8	36.7	8.8	12.9	36.7	20.3	21.6	15.1	17.0	20.0	7.6	13.8	17.8	19.1	16.4	26.6	16.3	18.7	16.9	20.5	14.5	13.4	25.4	14.3	18.7	20.1	21.9	30.1	31.8	15.2	10.0	19.8	27.1	14.3	15.0	14.3	25.4	19.4	28.8	42.6	20.4	13.3	29.6	45.9	17.1	10.7	13.5	12.2	20.3	22.2	21.4	35.7	27.4	11.1	15.5	19.0	33.4	18.1	18.4	16.0	27.7	19.0	18.9	12.3	13.0	17.7	22.6	25.0	36.3	37.9	7.6	20.4	19.4	22.7	24.3	18.5	10.9	17.2	38.0	31.1	35.3	9.8	33.1	7.2	64.1	16.7	22.0	14.5	9.0	12.1	19.3	12.4	10.7	5.6	19.5	12.0	9.9	85.3	12.0	11.6	33.3	10.9	3.5	14.9	15.3	18.7	16.2	14.3	15.8	15.9	14.6	15.4	12.9	15.1	16.4	27.7	51.3	59.0	5.9	33.9	14.0	16.0	12.5	22.2	33.0	11.3	10.4	1.0	14.3	38.3	14.7	27.1	16.2	54.1	28.8	9.8	19.7	37.6	18.0	24.2	26.4	9.1	29.0	5.3	15.3	22.6	16.6	52.5	21.8	84.6	18.9	18.5	15.6	12.2	40.4	5.0	29.1	12.2	12.2	26.9	16.3	35.4	28.5	10.6	2.8	25.6	16.1	44.3	4.5	8.7	25.9	51.0	21.4	42.7	16.3	62.0	11.7	34.5	42.4	13.1	21.3	19.1	124.0	93.7	15.3	14.6	30.5	48.1	16.5	23.0	14.3
CDK13	"CDC2L, CDC2L5, CHED, KIAA1791"	ENSG00000065883	"Cyclin dependent kinase 13"	Q14004	7	39950121-40099580	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Host-virus interaction, mRNA processing, mRNA splicing"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 179.0;Oligodendrocyte precursor cells: 171.9;Oligodendrocytes: 199.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059241	Uncertain		Supported	"Nuclear speckles,Golgi apparatus,Cytosol"		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 34: Non-specific - Transcription"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 52: Non-specific - Transcription"	"Nuclear speckles"	"Golgi apparatus, Cytosol"	"HPA059241: AB_2683956"	"unprognostic (1.99e-1)"	"unprognostic (1.22e-2)"	"unprognostic (2.67e-1)"	"unprognostic (2.72e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.02e-1)"	"unprognostic (4.18e-3)"	"unprognostic (3.42e-2)"	"unprognostic (8.09e-2)"	"unprognostic (1.13e-2)"	"unprognostic (3.77e-2)"	"unprognostic (8.13e-2)"	"unprognostic (8.20e-2)"	"unprognostic (1.21e-1)"	"unprognostic (3.33e-2)"	"unprognostic (3.53e-1)"	"unprognostic (3.53e-2)"	11.4	10.2	8.8	14.6	10.8	28.1	11.1	19.3	9.9	12.8	6.7	11.9	10.5	13.6	14.2	14.7	15.0	12.7	10.4	8.1	10.7	12.7	15.9	12.1	21.7	10.5	8.5	20.1	12.8	17.2	8.0	13.6	8.6	11.2	13.6	19.7	12.9	11.8	11.2	12.0	12.0	12.0	7.2	16.6	12.3	19.0	10.1	19.6	20.6	14.0	20.2	13.4	10.0	14.9	28.4	16.6	28.2	27.0	24.9	24.1	19.3	22.1	23.8	19.8	24.6	17.8	19.1	51.0	12.6	23.4	34.8	33.6	23.4	19.4	29.0	25.3	17.3	22.8	20.0	16.0	23.7	34.8	23.5	14.3	25.5	22.6	30.0	22.6	23.6	23.1	39.0	34.3	20.7	14.7	28.0	24.9	40.8	20.0	19.1	30.5	18.5	20.5	18.5	28.1	20.0	28.8	27.6	59.8	19.9	36.7	24.6	43.0	28.3	27.0	26.0	17.6	30.5	28.3	26.0	41.2	19.8	30.9	35.4	7.8	2.2	4.0	4.1	1.9	2.8	6.4	3.8	3.0	1.3	10.5	3.8	3.9	5.9	4.3	3.1	3.3	3.9	1.3	8.8	10.8	19.3	9.9	8.1	10.7	10.5	8.5	8.6	7.2	10.1	14.9	47.6	44.8	72.0	131.6	49.7	21.4	18.5	15.9	29.0	47.8	36.7	27.7	30.9	25.8	37.1	31.3	70.9	13.7	91.0	23.1	7.9	20.4	13.9	54.3	51.4	30.9	18.7	5.9	179.0	15.4	9.1	31.7	30.1	72.6	17.1	95.5	19.2	23.7	13.2	37.0	166.2	17.6	14.2	23.8	17.4	9.2	26.1	31.6	14.2	145.2	27.9	22.4	53.5	171.9	199.6	28.6	12.9	17.7	50.1	21.8	15.2	12.7	32.8	69.4	6.6	38.5	32.0	36.1	33.4	34.7	26.1	12.2	49.7	56.8	20.1	25.0
CDK14	"PFTAIRE1, PFTK1"	ENSG00000058091	"Cyclin dependent kinase 14"	O94921	7	90466424-91210590	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Wnt signaling pathway"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 545.4;Horizontal cells: 173.3;Inhibitory neurons: 426.8;Oligodendrocyte precursor cells: 320.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	8	"basophil: 9.0;memory B-cell: 8.5;naive B-cell: 4.8;neutrophil: 4.8"	"Group enriched"	"Detected in many"	10	"B-cells: 8.5;granulocytes: 9.0"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 78.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015267	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 6: Brain - Smell perception"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Nucleoplasm, Cytosol"		"HPA015267: AB_1855249"	"prognostic favorable (5.86e-4)"	"unprognostic (3.96e-1)"	"unprognostic (1.91e-2)"	"unprognostic (2.09e-3)"	"unprognostic (1.18e-1)"	"unprognostic (3.45e-1)"	"unprognostic (1.72e-1)"	"unprognostic (4.48e-2)"	"unprognostic (3.60e-2)"	"unprognostic (3.09e-2)"	"unprognostic (2.77e-3)"	"unprognostic (2.91e-2)"	"unprognostic (2.57e-2)"	"prognostic unfavorable (7.79e-4)"	"unprognostic (2.46e-1)"	"unprognostic (2.86e-1)"	"unprognostic (4.39e-3)"	10.1	4.4	9.7	7.8	12.8	7.1	8.6	11.6	31.2	10.1	0.0	5.9	2.7	8.5	3.1	3.1	12.2	12.2	11.9	18.5	7.9	20.7	13.4	9.6	12.4	7.8	17.9	14.5	15.1	3.0	9.2	6.1	7.8	11.2	3.3	17.4	8.3	6.7	4.6	2.5	3.8	7.6	6.4	8.2	8.0	7.9	19.2	5.5	13.3	7.2	12.9	5.7	5.2	20.5	18.0	0.2	35.0	4.5	31.9	32.0	8.0	14.7	14.0	8.8	9.5	0.4	8.6	58.9	1.8	14.6	13.1	5.2	1.8	20.7	16.9	0.1	8.3	0.0	11.2	0.4	14.7	18.3	0.3	22.7	5.3	26.5	9.4	14.7	11.6	0.4	0.3	78.4	18.4	0.1	0.1	7.3	21.8	0.1	9.6	49.3	47.4	50.2	4.6	4.9	7.7	21.9	37.3	0.2	0.7	15.4	4.7	9.2	28.4	37.8	48.5	32.1	23.0	43.1	36.3	41.9	14.6	23.8	37.9	9.0	0.3	0.5	0.0	0.6	0.0	8.5	0.0	0.0	0.8	4.8	0.0	0.0	4.8	0.1	0.5	0.1	0.2	0.5	9.7	12.8	11.6	31.2	18.5	7.9	7.8	17.9	7.8	6.4	19.2	20.5	11.0	19.2	5.1	118.2	37.4	0.8	7.7	6.0	2.2	6.9	7.0	8.9	18.3	12.8	9.1	11.0	0.0	0.2	0.2	0.4	7.9	9.8	53.9	1.7	13.4	2.8	1.8	4.0	545.4	6.7	0.1	16.1	4.1	1.5	0.0	11.2	1.4	11.3	3.7	173.3	426.8	0.3	4.1	3.4	4.9	46.4	15.5	7.0	5.4	66.5	1.7	9.4	0.0	320.7	32.9	13.4	1.3	15.8	78.1	12.8	0.1	22.7	3.9	9.7	0.0	6.3	15.9	5.4	6.6	1.2	1.3	0.0	1.9	6.5	0.3	4.2
CDK16	"FLJ16665, PCTAIRE, PCTAIRE1, PCTGAIRE, PCTK1"	ENSG00000102225	"Cyclin dependent kinase 16"	Q00536	X	47217860-47229997	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Differentiation, Spermatogenesis"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 217.6"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000974, HPA001366, CAB016535"	Approved		Approved	"Plasma membrane,Microtubules,Cytosol"		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 31: Spermatids - Spermatogenesis"	"Microtubules, Cytosol"	"Plasma membrane"	"CAB016535: AB_785112, HPA000974: AB_2666162, HPA001366: AB_1079584"	"unprognostic (2.37e-3)"	"unprognostic (6.93e-2)"	"unprognostic (2.96e-2)"	"unprognostic (1.16e-3)"	"unprognostic (8.80e-2)"	"unprognostic (2.92e-2)"	"prognostic unfavorable (2.02e-6)"	"unprognostic (2.85e-1)"	"unprognostic (5.59e-2)"	"unprognostic (7.62e-3)"	"unprognostic (1.20e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.59e-2)"	"unprognostic (1.83e-1)"	"unprognostic (3.89e-3)"	"unprognostic (2.55e-1)"	48.2	61.3	59.0	30.4	63.6	65.7	38.6	63.8	75.0	37.9	35.7	41.4	34.2	37.5	19.7	60.7	37.6	23.8	113.3	64.3	46.5	62.7	35.0	41.6	24.3	57.2	52.4	45.3	43.1	50.6	41.7	37.9	54.9	37.2	29.6	33.6	43.9	30.4	217.6	41.9	36.3	37.7	39.6	34.0	39.1	55.2	74.3	29.9	50.3	180.4	26.5	34.2	36.8	60.6	177.6	132.5	124.8	185.0	89.5	76.2	124.2	82.4	100.7	122.3	90.5	150.2	83.3	42.1	51.2	148.1	225.7	97.7	134.3	174.7	81.8	50.9	212.6	46.0	193.8	118.8	115.7	48.7	103.0	95.5	109.6	173.8	207.4	101.7	111.0	43.7	69.6	69.7	108.4	153.1	42.7	111.1	97.9	66.3	141.8	44.9	98.8	74.4	91.7	137.7	105.0	79.4	223.2	169.9	86.5	144.4	152.0	59.3	112.9	81.1	131.4	125.4	99.8	54.6	58.2	41.8	71.4	223.0	93.1	2.6	7.8	7.5	3.7	9.3	4.9	3.4	5.0	6.0	9.7	9.8	4.3	4.6	3.2	5.5	8.4	11.3	5.5	6.1	59.0	63.6	63.8	75.0	64.3	46.5	57.2	52.4	54.9	39.6	74.3	60.6	18.8	0.0	6.1	7.2	20.2	32.5	33.0	30.6	33.6	23.5	38.2	26.8	43.3	21.5	22.1	31.3	4.2	25.7	20.1	67.2	54.8	33.7	26.5	41.2	24.5	21.8	28.1	20.6	12.5	37.0	45.2	24.0	46.4	57.7	5.7	27.8	19.2	16.7	25.3	30.3	15.8	34.3	32.6	19.5	30.8	94.8	17.1	23.5	33.8	2.8	12.6	17.1	9.2	3.5	7.8	48.4	46.1	13.2	31.9	48.3	45.1	34.7	17.9	14.6	0.0	19.1	22.6	27.6	17.5	64.2	34.7	26.0	21.5	30.0	48.6	63.3
CDK19	"bA346C16.3, CDC2L6, CDK11, KIAA1028"	ENSG00000155111	"Cyclin dependent kinase 19"	Q9BWU1	6	110609978-110815958	"Enzymes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	"Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 40.8"	"Cell type enhanced"	"Detected in all"		"Late spermatids: 137.1;Oligodendrocyte precursor cells: 154.8;Oligodendrocytes: 476.3"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 23.3"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"neutrophil: 4.6"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007053, HPA007062"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 18: U-2197 - ECM organization"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Cytosol	Nucleoplasm	"HPA007053: AB_1233803, HPA007062: "	"unprognostic (1.66e-2)"	"unprognostic (1.84e-1)"	"unprognostic (3.63e-1)"	"unprognostic (3.00e-3)"	"unprognostic (1.62e-1)"	"unprognostic (2.66e-3)"	"prognostic unfavorable (3.56e-4)"	"unprognostic (1.47e-2)"	"unprognostic (2.96e-2)"	"unprognostic (2.00e-3)"	"unprognostic (3.94e-1)"	"unprognostic (4.04e-1)"	"prognostic unfavorable (4.72e-5)"	"unprognostic (1.75e-1)"	"unprognostic (9.78e-2)"	"unprognostic (6.51e-2)"	"unprognostic (9.50e-3)"	6.2	3.4	22.7	7.2	32.1	11.7	6.4	17.9	29.0	6.6	7.5	6.9	5.3	10.2	3.8	8.2	5.4	8.3	4.4	20.8	19.3	6.4	5.0	6.7	9.4	28.8	24.7	9.8	3.9	6.5	2.3	11.5	22.7	26.7	6.4	8.8	4.4	5.9	3.3	8.5	6.7	7.3	19.4	8.0	7.1	18.5	26.9	13.6	6.1	5.4	9.2	5.3	6.6	40.8	5.7	6.1	21.8	26.4	11.1	15.6	10.8	18.8	19.4	6.7	8.8	7.6	6.4	14.7	6.5	13.2	13.9	3.2	8.0	3.9	15.4	18.2	4.5	26.0	8.8	8.9	6.8	10.5	18.2	10.7	8.6	9.7	14.1	17.0	6.8	12.3	7.6	20.2	14.5	9.7	14.3	15.0	2.0	8.1	4.1	14.8	11.3	5.8	7.8	11.0	10.6	19.8	14.4	11.3	17.0	7.2	3.9	37.1	7.7	14.2	7.6	29.6	11.4	2.1	3.2	12.8	15.6	13.7	14.9	2.1	1.2	0.9	0.4	0.7	0.4	0.6	0.3	0.3	1.0	0.6	0.2	0.3	4.6	0.7	0.4	0.5	0.4	0.3	22.7	32.1	17.9	29.0	20.8	19.3	28.8	24.7	22.7	19.4	26.9	40.8	15.9	3.2	17.8	50.6	19.2	9.8	14.4	6.7	12.0	19.2	14.6	9.4	8.2	18.6	8.7	16.5	16.7	7.0	17.8	27.0	1.9	10.5	102.3	13.7	16.5	13.6	12.6	21.6	85.3	4.7	18.4	12.0	13.7	25.6	7.0	23.0	20.0	12.2	16.4	23.5	51.5	13.5	8.2	33.9	19.9	137.1	10.8	22.1	26.6	62.8	19.6	33.9	22.6	154.8	476.3	7.0	20.0	16.1	5.9	30.0	16.1	7.7	6.9	13.9	6.6	11.2	12.3	56.6	15.8	20.3	16.2	7.9	13.3	10.1	13.8	11.1
CDK2		ENSG00000123374	"Cyclin dependent kinase 2"	P24941	12	55966781-55972789	"Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, DNA damage, DNA repair, Meiosis, Mitosis"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 92.8;Extravillous trophoblasts: 84.7;Melanocytes: 87.2;Syncytiotrophoblasts: 170.7"	"Cancer enhanced"	"Detected in all"		"melanoma: 88.3"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SK-MEL-30: 540.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013115, HPA066915"	Enhanced		Enhanced	Nucleoplasm,Centrosome,Cytosol		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 28: Placenta - Pregnancy"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	Nucleoplasm	"Centrosome, Cytosol"	"CAB013115: AB_2536375, HPA066915: AB_2685748"	"unprognostic (2.36e-2)"	"unprognostic (2.60e-1)"	"unprognostic (3.71e-2)"	"unprognostic (1.83e-2)"	"unprognostic (1.75e-1)"	"prognostic unfavorable (9.94e-4)"	"prognostic unfavorable (8.61e-5)"	"unprognostic (3.48e-2)"	"unprognostic (1.31e-1)"	"unprognostic (4.67e-2)"	"unprognostic (5.38e-3)"	"unprognostic (4.69e-3)"	"prognostic unfavorable (1.46e-10)"	"unprognostic (1.05e-1)"	"unprognostic (1.76e-1)"	"unprognostic (6.16e-2)"	"unprognostic (6.75e-2)"	15.3	9.2	3.5	16.3	3.4	36.0	14.2	3.6	4.9	13.4	6.4	12.5	9.8	13.7	6.3	14.9	13.7	10.8	10.9	3.5	3.8	14.7	16.2	22.9	21.6	4.7	4.0	16.3	10.0	7.9	4.9	47.3	4.1	12.6	14.9	6.5	10.9	14.3	7.0	22.7	12.3	19.5	4.2	14.5	12.2	6.6	4.1	37.2	9.6	8.1	24.8	18.1	12.9	3.9	81.7	39.1	93.6	52.4	19.2	24.9	172.2	98.9	53.5	123.3	114.8	89.4	76.3	77.5	70.9	37.9	46.4	50.8	73.4	44.9	126.8	86.9	68.0	89.0	65.0	34.6	6.3	70.4	61.4	12.6	10.9	83.8	29.1	36.1	63.1	76.8	85.6	68.0	88.3	60.8	149.9	61.7	36.9	55.8	60.7	143.7	86.2	57.1	36.5	77.1	37.4	48.1	114.1	41.7	540.3	54.9	88.9	51.1	34.5	82.9	76.3	65.0	71.0	37.4	46.3	95.5	47.4	51.1	74.2	3.6	2.6	2.2	4.7	2.7	4.6	6.5	2.1	3.5	1.9	3.7	2.0	3.7	1.2	3.4	1.2	7.9	5.4	3.3	3.5	3.4	3.6	4.9	3.5	3.8	4.7	4.0	4.1	4.2	4.1	3.9	17.9	16.0	4.8	1.3	7.3	28.0	23.9	6.2	12.5	0.0	14.5	8.9	3.1	11.5	7.6	1.8	0.0	92.8	7.1	3.7	1.9	11.5	0.6	7.4	6.5	18.2	5.4	14.7	0.1	5.7	84.7	15.7	9.2	13.0	10.8	12.0	10.4	9.1	13.3	1.7	0.1	7.2	6.1	4.7	43.8	0.8	14.9	4.9	87.2	1.9	28.4	4.2	5.2	0.0	0.5	12.3	1.5	4.5	11.8	13.4	2.8	4.5	4.4	3.6	0.0	10.1	11.6	3.1	7.4	14.5	31.4	170.7	9.6	4.8	9.7	19.3
CDK20	"CCRK, p42"	ENSG00000156345	"Cyclin dependent kinase 20"	Q8IZL9	9	87966441-87974753	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Cell cycle, Cell division"	"Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Respiratory ciliated cells: 21.9;Spermatocytes: 30.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"NK-cell: 3.6"	"Group enriched"	"Detected in many"	7	"NK-cells: 3.6;T-cells: 2.3"	"Cell line enhanced"	"Detected in many"		"SCLC-21H: 18.2;THP-1: 29.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA007666, HPA027379, HPA027401"	Enhanced		Supported	Nucleoplasm		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 49: Ciliated cells - Cilium organization"	Nucleoplasm		"HPA007666: AB_10600002, HPA027379: AB_10599939, HPA027401: AB_10601553"	"unprognostic (4.60e-2)"	"unprognostic (6.48e-2)"	"unprognostic (1.69e-2)"	"prognostic favorable (2.59e-4)"	"unprognostic (2.32e-1)"	"unprognostic (4.33e-3)"	"unprognostic (2.81e-4)"	"unprognostic (6.33e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.83e-3)"	"unprognostic (4.04e-2)"	"prognostic favorable (2.12e-5)"	"unprognostic (8.24e-3)"	"unprognostic (5.77e-2)"	"unprognostic (3.83e-2)"	"unprognostic (1.42e-2)"	2.9	14.8	8.8	1.5	9.8	1.0	3.1	5.5	9.5	7.2	11.1	6.4	3.5	5.7	3.8	2.3	13.3	3.5	3.4	10.0	10.6	8.3	3.3	3.0	1.2	6.4	6.8	7.8	6.1	8.4	12.7	1.8	6.9	5.2	2.2	8.4	3.3	5.5	1.0	3.3	4.8	3.6	6.1	1.4	4.4	15.9	10.9	1.3	5.3	1.3	0.5	7.6	3.7	7.1	3.1	3.6	3.2	9.5	2.6	3.5	1.2	2.7	5.4	7.7	6.9	1.1	4.6	0.0	3.7	4.6	13.0	3.7	0.0	2.8	3.2	7.3	3.2	0.0	1.9	0.0	9.2	3.7	4.4	2.6	5.5	12.0	5.1	5.9	0.0	6.7	0.4	0.0	2.2	9.1	2.2	1.2	2.4	7.2	1.1	0.0	0.0	0.1	9.6	2.8	18.2	5.2	2.9	3.9	4.9	1.1	3.9	29.8	0.0	3.4	1.3	0.6	3.0	4.2	4.6	0.0	11.7	2.4	3.5	0.0	0.3	0.2	0.6	0.4	0.3	0.0	1.4	1.0	0.3	0.0	2.3	1.6	0.0	3.6	0.3	0.3	1.5	0.6	8.8	9.8	5.5	9.5	10.0	10.6	6.4	6.8	6.9	6.1	10.9	7.1	0.3	3.2	4.4	5.2	0.2	2.2	2.3	2.2	5.7	6.1	3.0	3.2	2.0	2.8	4.0	1.8	2.1	4.6	0.8	5.8	1.9	5.2	6.3	15.8	6.7	0.8	0.0	0.8	8.3	1.5	2.3	3.4	4.1	5.8	1.3	4.0	0.7	0.8	0.9	8.4	6.7	2.8	4.1	0.0	0.2	4.3	4.4	1.1	0.0	1.0	0.3	5.0	2.1	3.0	2.9	1.4	1.6	6.8	0.3	3.0	7.3	6.3	21.9	15.0	6.6	1.1	3.2	30.2	3.4	0.8	2.3	4.0	1.1	11.6	3.4	1.2
CDK2AP1	"doc-1, DOC1, DORC1, p12DOC-1, ST19"	ENSG00000111328	"Cyclin dependent kinase 2 associated protein 1"	O14519	12	123250112-123272334	"Predicted intracellular proteins"	"Cell cycle"		"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Late spermatids: 131.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"classical monocyte: 44.3;intermediate monocyte: 152.6;myeloid DC: 52.5;non-classical monocyte: 175.4"	"Group enriched"	"Detected in many"	5	"dendritic cells: 52.5;monocytes: 175.4"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB019377, HPA057648, HPA068833"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 25: Spermatids - Spermatogenesis"	Nucleoplasm		"CAB019377: , HPA057648: AB_2683488, HPA068833: AB_2686046"	"unprognostic (1.56e-1)"	"unprognostic (5.94e-2)"	"unprognostic (1.83e-2)"	"unprognostic (3.04e-2)"	"unprognostic (7.77e-2)"	"unprognostic (8.89e-2)"	"unprognostic (4.21e-3)"	"unprognostic (2.86e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.70e-2)"	"unprognostic (3.32e-2)"	"unprognostic (2.22e-1)"	"prognostic unfavorable (5.27e-7)"	"unprognostic (9.32e-2)"	"unprognostic (6.20e-2)"	"unprognostic (5.56e-2)"	"unprognostic (1.18e-1)"	96.1	82.8	239.4	62.7	255.4	70.6	105.0	270.5	285.1	114.8	199.5	111.8	40.1	111.9	127.7	115.1	81.5	87.7	95.1	238.3	272.2	82.2	56.7	78.3	51.0	296.1	256.0	56.0	53.2	72.3	88.8	64.4	288.2	103.5	63.1	43.4	158.8	97.7	91.5	68.1	53.9	120.3	292.7	48.6	84.9	69.1	260.8	86.0	61.4	109.9	56.5	124.9	105.3	288.3	125.7	172.4	451.1	481.5	352.6	443.9	81.8	399.1	369.6	311.1	234.7	131.0	117.5	0.1	174.9	611.4	115.9	111.3	484.0	261.3	256.1	77.6	120.7	66.4	98.0	208.4	192.0	104.9	68.7	282.8	267.0	180.2	116.9	283.4	449.4	151.0	90.6	0.5	594.9	244.3	140.3	170.2	296.1	154.9	129.2	528.7	193.0	54.0	259.7	295.2	416.7	496.5	290.9	141.5	412.0	119.4	272.5	104.3	273.2	286.5	149.1	172.9	267.6	21.0	41.6	116.1	156.6	48.9	640.9	15.9	44.3	21.3	0.5	152.6	1.9	0.9	0.5	0.9	52.5	0.1	0.3	0.5	1.5	1.3	175.4	4.2	0.4	29.7	239.4	255.4	270.5	285.1	238.3	272.2	296.1	256.0	288.2	292.7	260.8	288.3	10.4	28.9	39.7	32.0	3.0	1.3	1.5	8.7	18.2	0.3	6.9	8.8	1.8	8.6	21.7	12.9	0.0	1.6	1.4	12.3	1.9	24.0	30.7	8.0	31.6	14.0	7.7	13.7	12.2	16.7	3.3	13.8	19.9	7.6	19.0	3.2	16.4	6.9	6.0	3.3	5.0	16.7	4.1	26.0	4.9	131.8	13.4	18.8	3.6	14.0	11.4	19.4	1.0	17.1	25.0	24.3	12.5	14.3	2.8	0.4	5.4	3.4	12.5	0.3	0.0	3.2	10.3	1.4	8.1	46.9	2.8	1.4	1.9	1.0	16.2	0.9
CDK4	PSK-J3	ENSG00000135446	"Cyclin dependent kinase 4"	P11802	12	57747727-57756013	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Cancer enriched"	"Detected in all"	5	"glioma: 175.8"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in all"	10	"HBEC3-KT: 2594.8;LHCN-M2: 2819.4;RH-30: 8902.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006024, CAB013116, CAB069405"	Supported		Supported	"Nucleoplasm,Nuclear membrane,Nucleoli,Cytosol"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 39: Non-specific - Basic cellular processes"	Cytosol	"Nucleoplasm, Nuclear membrane, Nucleoli"	"CAB013116: AB_2536376, CAB069405: AB_1613464, HPA006024: AB_2667497"	"unprognostic (8.88e-2)"	"unprognostic (2.53e-1)"	"unprognostic (5.27e-2)"	"unprognostic (9.01e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.10e-1)"	"prognostic unfavorable (2.09e-7)"	"unprognostic (7.39e-2)"	"unprognostic (3.23e-3)"	"unprognostic (2.93e-2)"	"unprognostic (3.19e-2)"	"unprognostic (9.10e-2)"	"prognostic unfavorable (3.15e-5)"	"unprognostic (3.32e-1)"	"unprognostic (1.67e-1)"	"unprognostic (3.64e-1)"	"unprognostic (1.57e-2)"	69.7	87.8	35.0	52.8	37.9	72.0	76.6	37.7	36.9	84.3	35.9	62.6	40.2	97.4	64.2	57.2	69.4	57.1	58.9	33.6	37.1	58.5	51.5	58.0	66.8	37.1	36.9	97.3	70.9	63.5	67.7	52.4	36.8	52.7	63.3	14.5	54.4	54.1	48.2	58.9	47.2	80.4	37.3	51.5	54.8	24.1	37.3	67.6	66.0	52.7	70.6	71.6	60.7	37.6	207.1	235.7	295.7	268.0	253.7	220.7	210.4	116.1	347.9	468.5	385.7	338.2	189.1	297.4	200.2	173.6	293.2	158.0	396.3	2594.8	354.9	150.9	209.0	275.4	149.5	237.9	297.0	309.7	182.5	221.5	180.9	294.2	326.7	326.4	304.8	280.0	301.3	242.7	2819.4	304.9	296.7	256.5	347.0	208.0	249.8	267.3	8902.5	272.1	147.2	320.6	271.2	251.7	205.3	150.2	310.0	195.1	202.8	380.7	146.1	233.6	217.0	265.8	233.1	122.2	206.1	450.8	214.1	291.3	286.9	9.5	46.5	10.3	79.6	65.6	81.8	93.5	70.0	72.5	66.7	90.0	93.0	84.4	4.4	56.6	41.9	84.9	57.0	73.6	35.0	37.9	37.7	36.9	33.6	37.1	37.1	36.9	36.8	37.3	37.3	37.6	47.1	22.4	30.8	7.8	40.0	89.7	78.6	83.4	74.0	15.9	67.2	82.2	0.7	51.5	35.3	47.8	10.4	82.9	26.1	15.9	70.5	93.1	13.5	14.9	77.7	50.8	45.6	98.0	5.2	62.5	134.5	79.4	28.5	22.6	69.1	60.2	39.7	35.8	132.9	18.5	6.7	42.2	40.7	25.1	44.1	8.0	64.0	31.2	53.4	6.5	41.9	51.4	29.9	5.5	8.0	48.3	18.9	63.2	57.8	113.9	14.0	80.9	7.4	17.9	32.9	62.1	61.9	32.1	48.3	74.5	86.1	46.8	32.3	78.8	78.7	49.4
CDK5	PSSALRE	ENSG00000164885	"Cyclin dependent kinase 5"	Q00535	7	151053815-151057897	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Apoptosis, Biological rhythms, Cell cycle, Cell division, Neurogenesis"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Lissencephaly, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 65.8"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB008909, HPA064535"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cell Junctions"		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 65: Brain - Ion transport"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 10: Non-specific - Unknown function"	"Nucleoplasm, Plasma membrane"	"Cell Junctions"	"CAB008909: , HPA064535: AB_2685280"	"unprognostic (1.21e-1)"	"unprognostic (3.23e-2)"	"unprognostic (4.22e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.10e-1)"	"unprognostic (3.48e-1)"	"unprognostic (5.67e-3)"	"unprognostic (1.05e-2)"	"unprognostic (1.22e-1)"	"unprognostic (5.78e-3)"	"unprognostic (6.25e-3)"	"unprognostic (3.35e-1)"	"unprognostic (4.47e-2)"	"unprognostic (1.46e-2)"	"unprognostic (1.77e-1)"	"unprognostic (2.88e-1)"	"unprognostic (1.11e-1)"	6.3	16.8	50.2	9.4	53.2	11.2	8.6	44.9	65.8	8.6	40.0	9.3	10.9	6.7	24.9	10.2	8.2	9.5	9.8	57.5	50.9	13.5	12.5	8.3	9.8	48.6	45.3	4.5	9.5	22.8	14.7	8.6	48.4	8.8	9.9	11.3	9.6	10.2	8.5	9.5	8.6	10.4	43.2	9.4	7.9	4.9	50.1	14.2	10.0	7.2	11.6	8.8	6.0	50.9	31.9	40.8	37.3	59.7	48.8	36.1	17.8	24.4	41.7	47.9	40.3	31.2	31.0	34.7	71.3	31.8	63.5	23.5	67.8	40.6	22.6	24.9	43.3	38.2	32.4	30.7	31.6	29.0	64.4	37.9	28.7	39.0	13.5	62.8	38.8	57.6	36.3	24.0	50.7	68.4	76.4	57.9	39.3	57.2	80.5	38.9	14.8	41.5	46.2	27.9	23.0	97.8	30.9	37.7	43.8	36.0	18.6	25.9	22.7	42.2	10.3	31.2	39.2	52.1	61.4	13.7	66.4	46.5	75.8	18.9	39.4	20.1	13.5	46.2	11.1	13.3	12.8	13.6	44.7	12.8	9.8	11.8	5.7	19.9	36.4	26.9	31.9	23.8	50.2	53.2	44.9	65.8	57.5	50.9	48.6	45.3	48.4	43.2	50.1	50.9	7.6	0.0	6.0	1.6	6.2	3.6	8.2	18.0	6.2	12.1	9.6	10.4	3.1	8.6	14.7	11.0	2.1	26.8	5.4	8.0	39.2	21.4	0.8	14.9	10.9	8.9	9.0	12.2	5.8	18.9	12.3	7.6	9.7	9.3	30.5	23.6	7.9	11.1	41.9	0.0	6.4	8.9	18.3	21.9	6.2	1.3	4.7	16.6	10.6	1.9	19.9	12.6	12.3	1.5	3.7	22.8	15.0	11.3	12.4	4.3	20.2	35.7	14.4	7.1	6.6	4.5	13.1	3.9	11.2	11.4	6.3	9.0	7.3	14.2	9.5	9.0
CDK5R1	"Nck5a, p35, p35nck5a"	ENSG00000176749	"Cyclin dependent kinase 5 regulatory subunit 1"	Q15078	17	32486993-32491253	"Predicted intracellular proteins"	"Biological rhythms"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"brain: 63.5"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 45.9;Early spermatids: 21.2;Excitatory neurons: 36.6;Inhibitory neurons: 31.6;Late spermatids: 18.9"	"Cancer enhanced"	"Detected in many"		"melanoma: 14.6"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"SCLC-21H: 58.1;SH-SY5Y: 15.6;SK-MEL-30: 43.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000252			Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Nucleoplasm, Vesicles"		"HPA000252: AB_2665953"	"unprognostic (1.08e-1)"	"unprognostic (9.13e-2)"	"unprognostic (1.79e-2)"	"unprognostic (3.65e-1)"	"unprognostic (1.97e-1)"	"unprognostic (8.09e-2)"	"unprognostic (2.74e-5)"	"unprognostic (1.81e-2)"	"unprognostic (3.32e-1)"	"unprognostic (2.18e-1)"	"unprognostic (5.90e-2)"	"unprognostic (5.60e-1)"	"unprognostic (6.98e-2)"	"unprognostic (1.60e-1)"	"unprognostic (7.92e-2)"	"unprognostic (8.81e-2)"	"unprognostic (1.03e-1)"	0.8	2.8	37.8	7.1	50.8	5.4	1.2	11.0	63.5	1.5	0.0	0.9	1.4	0.9	0.2	7.5	0.7	0.9	1.1	53.4	21.1	0.8	1.0	0.8	13.9	3.2	10.5	2.6	1.4	0.7	6.9	0.6	4.5	0.6	0.8	10.4	1.1	0.5	2.3	1.9	3.6	0.6	3.5	12.1	1.6	7.2	21.7	4.2	0.5	0.8	14.1	0.8	3.1	34.2	3.9	2.2	9.8	3.1	1.1	1.8	1.1	2.4	1.4	2.9	3.7	5.7	0.9	1.9	2.2	2.0	2.4	1.8	3.8	2.4	3.8	0.7	7.3	0.7	1.1	2.3	0.5	1.3	1.9	1.1	5.8	2.9	2.4	1.1	2.1	6.9	3.9	2.2	6.2	1.6	3.4	1.5	6.2	1.4	2.1	2.9	5.9	7.1	1.4	1.7	58.1	15.6	2.3	1.3	43.8	1.4	2.5	4.4	2.2	4.0	5.9	1.6	6.3	1.1	1.5	1.9	3.4	5.6	9.7	0.0	0.3	0.4	0.8	0.3	0.6	0.2	1.1	0.4	0.0	0.1	1.5	0.9	1.2	0.2	0.1	0.6	0.1	0.6	37.8	50.8	11.0	63.5	53.4	21.1	3.2	10.5	4.5	3.5	21.7	34.2	1.7	0.0	1.5	6.5	13.1	1.5	0.5	1.0	7.4	15.9	3.7	2.3	3.6	0.0	0.8	0.0	45.9	0.6	10.1	0.3	0.0	0.2	21.2	1.1	1.3	1.2	0.0	0.0	36.6	0.6	0.3	1.2	0.5	1.5	0.0	1.6	0.7	0.7	0.9	1.7	31.6	1.4	2.0	3.5	0.5	18.9	0.0	1.3	3.6	2.8	2.0	18.4	10.3	9.5	11.9	1.2	1.2	0.7	0.9	1.2	0.4	1.5	1.0	6.3	0.0	2.9	3.1	6.7	4.3	8.8	1.3	1.1	7.1	1.9	1.1	0.5
CDK5RAP2	"C48, CEP215, FLJ10867, MCPH3"	ENSG00000136861	"CDK5 regulatory subunit associated protein 2"	Q96SN8	9	120388869-120580170	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"		Calmodulin-binding	"Mental retardation, Primary microcephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 148.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 15.7"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035820, HPA035821, HPA046529, CAB079753"	Approved		Enhanced	"Cell Junctions,Centrosome"		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Centrosome	"Cell Junctions"	"CAB079753: AB_2665827, HPA035820: AB_10671939, HPA035821: , HPA046529: AB_2679688"	"unprognostic (7.72e-2)"	"unprognostic (2.04e-2)"	"unprognostic (2.84e-2)"	"unprognostic (4.48e-2)"	"unprognostic (6.63e-2)"	"unprognostic (6.88e-2)"	"unprognostic (6.70e-3)"	"unprognostic (1.31e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.00e-1)"	"unprognostic (7.36e-2)"	"unprognostic (2.26e-2)"	"unprognostic (1.88e-1)"	"unprognostic (4.94e-2)"	"unprognostic (2.36e-1)"	"unprognostic (3.33e-2)"	"unprognostic (7.41e-2)"	10.6	11.7	12.4	9.8	18.0	24.4	14.4	14.1	12.7	14.2	20.6	15.1	5.6	11.5	7.7	12.1	11.9	9.2	17.6	12.5	12.9	8.0	15.7	10.6	15.1	15.4	16.2	17.1	9.5	13.3	12.2	8.6	15.1	13.7	8.6	12.9	22.2	10.5	47.9	16.0	11.0	10.4	13.6	11.5	12.9	20.8	14.9	20.9	11.6	29.6	14.7	12.5	11.1	17.2	19.6	33.8	45.9	27.8	19.3	28.4	24.6	24.6	18.9	27.3	25.4	26.8	25.1	36.3	11.1	24.3	18.7	42.1	36.5	28.3	26.1	29.3	14.7	31.0	62.1	47.7	18.1	38.5	19.9	51.4	18.5	24.3	31.8	20.6	24.1	43.0	29.2	30.6	36.4	44.2	41.8	24.7	42.6	41.5	25.3	40.3	54.5	17.1	19.5	15.4	29.9	34.3	42.9	23.3	28.8	19.7	54.6	26.3	16.1	23.6	25.7	28.0	28.4	22.2	33.4	39.7	24.6	24.4	50.8	15.7	1.7	3.0	3.4	1.7	3.3	5.0	3.2	3.2	1.0	5.8	2.6	2.7	2.4	4.0	4.7	2.2	2.9	1.8	12.4	18.0	14.1	12.7	12.5	12.9	15.4	16.2	15.1	13.6	14.9	17.2	11.6	28.9	39.5	64.9	21.2	7.0	13.5	11.9	13.1	23.7	18.0	17.5	53.8	15.7	19.3	1.8	16.7	13.2	25.8	12.3	7.9	12.6	37.5	24.8	18.1	13.7	8.4	35.3	43.2	14.3	12.7	20.4	10.7	23.7	17.1	41.4	8.6	22.2	10.8	18.5	38.4	12.1	18.3	9.4	8.6	30.6	22.1	25.8	12.4	26.2	13.2	20.4	24.7	66.9	148.7	11.8	8.1	23.3	27.7	9.5	5.6	4.6	35.0	28.9	32.9	43.6	22.3	58.4	36.4	17.8	6.8	7.3	23.1	23.0	11.6	7.7
CDK5RAP3	"C53, FLJ13660, HSF-27, IC53, LZAP, MST016, OK/SW-cl.114"	ENSG00000108465	"CDK5 regulatory subunit associated protein 3"	Q96JB5	17	47967810-47981781	"Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022141, HPA022882, HPA027883"	Supported		Supported	Nucleoli,Vesicles,Cytosol		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 22: Non-specific - Unknown function"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 55: Plasma cells - Humoral immune response"	Cytosol	"Nucleoli, Vesicles"	"HPA022141: AB_1846426, HPA022882: AB_1846428, HPA027883: AB_10602797"	"unprognostic (4.27e-2)"	"unprognostic (1.01e-3)"	"unprognostic (9.95e-3)"	"unprognostic (6.65e-2)"	"unprognostic (5.98e-2)"	"unprognostic (7.19e-3)"	"unprognostic (3.84e-1)"	"unprognostic (4.44e-2)"	"unprognostic (7.55e-2)"	"unprognostic (2.06e-1)"	"unprognostic (2.59e-3)"	"unprognostic (1.92e-2)"	"prognostic unfavorable (3.61e-5)"	"unprognostic (8.35e-3)"	"unprognostic (2.30e-1)"	"unprognostic (9.58e-2)"	"prognostic favorable (7.31e-5)"	45.8	48.2	83.8	42.0	85.7	52.3	48.7	83.7	111.3	58.1	100.4	53.0	54.5	42.4	91.9	52.8	54.2	46.1	39.2	85.5	85.5	60.2	80.6	44.6	51.7	86.4	84.7	69.5	133.6	53.6	93.0	34.3	85.7	62.6	53.8	34.1	77.0	48.5	29.6	43.5	68.5	33.8	83.1	81.4	81.8	83.5	86.6	44.2	73.2	28.1	54.8	48.1	48.3	86.7	72.7	116.5	60.8	114.6	52.6	53.3	112.7	51.4	63.9	52.3	51.0	92.5	72.3	88.7	107.8	55.5	35.2	72.8	41.6	61.4	59.3	127.0	58.1	43.4	157.9	123.8	58.7	50.0	47.5	60.7	51.5	45.9	91.8	64.2	52.8	169.1	49.6	80.8	52.9	140.3	128.3	79.2	38.5	87.4	55.0	74.6	101.4	101.7	52.8	91.3	43.0	104.1	38.3	37.1	51.7	65.3	84.5	65.4	38.9	43.6	38.2	53.1	66.8	106.8	102.9	54.2	54.3	69.1	53.5	20.8	62.6	54.8	33.8	63.8	36.8	40.9	31.4	30.6	50.1	44.7	28.0	31.4	30.5	45.3	67.4	46.0	32.9	41.3	83.8	85.7	83.7	111.3	85.5	85.5	86.4	84.7	85.7	83.1	86.6	86.7	31.3	25.6	62.6	60.7	61.8	33.6	63.3	89.3	50.7	52.0	52.8	40.4	28.4	44.3	84.1	40.5	31.3	68.8	44.9	56.5	50.9	56.8	53.0	35.7	32.9	32.1	61.6	22.9	31.1	67.7	57.4	44.7	147.8	42.5	69.6	68.3	27.5	55.6	61.7	57.2	27.9	70.8	71.2	33.6	40.7	36.3	40.7	44.1	46.2	25.3	47.6	45.1	33.0	25.6	50.6	37.1	60.9	29.7	87.2	49.0	77.2	45.1	85.2	52.6	32.9	34.3	33.2	132.8	45.7	31.0	25.9	61.6	53.0	38.6	56.8	56.6
CDK6	PLSTIRE	ENSG00000105810	"Cyclin dependent kinase 6"	Q00534	7	92604921-92836573	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Differentiation"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Disease variant, FDA approved drug targets, Primary microcephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 41.1"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 215.9;Erythroid cells: 213.5;Late spermatids: 237.0;Oligodendrocytes: 235.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"MOLT-4: 378.4;REH: 173.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA002637, CAB004363"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA		26000	"Cluster 16: MAIT-cells - Unknown function"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 34: Spermatids - Unknown function"	Nucleoplasm	Cytosol	"CAB004363: AB_627242, HPA002637: AB_1846432"	"unprognostic (1.29e-1)"	"unprognostic (5.98e-3)"	"unprognostic (9.07e-2)"	"unprognostic (2.78e-3)"	"unprognostic (2.56e-2)"	"unprognostic (3.24e-2)"	"unprognostic (3.39e-1)"	"unprognostic (2.42e-3)"	"unprognostic (7.19e-2)"	"unprognostic (7.78e-3)"	"prognostic unfavorable (3.86e-6)"	"unprognostic (4.06e-2)"	"unprognostic (4.09e-3)"	"unprognostic (1.09e-1)"	"unprognostic (7.88e-2)"	"unprognostic (1.93e-1)"	"prognostic unfavorable (2.33e-5)"	3.7	7.3	6.7	4.7	7.1	18.1	4.9	5.4	5.1	4.8	2.6	5.9	6.1	3.1	2.1	4.2	2.9	3.6	4.7	4.0	5.0	4.4	5.9	4.1	6.6	6.3	6.7	2.7	6.2	9.9	1.7	17.3	6.3	3.0	7.5	0.5	5.7	4.2	1.0	6.8	7.2	3.2	5.8	4.9	9.1	3.3	9.6	41.1	2.4	2.3	6.2	3.8	4.6	8.8	27.1	11.3	34.9	23.9	10.6	11.5	5.8	27.2	18.4	14.3	13.5	34.7	20.9	21.7	14.4	19.9	8.4	15.8	20.8	42.6	34.4	43.0	10.6	50.8	23.3	34.7	6.3	33.0	2.7	11.5	23.1	17.9	90.8	13.4	5.6	75.1	49.3	55.5	26.7	5.9	378.4	3.8	9.8	37.4	9.1	173.7	112.0	36.4	20.3	0.7	18.1	113.8	3.7	9.8	17.1	26.0	0.6	54.9	19.3	44.1	63.7	18.0	54.2	27.4	0.5	27.6	6.9	112.1	60.8	0.9	0.2	0.6	0.6	0.4	0.9	0.2	0.6	0.8	0.5	0.3	0.7	0.7	0.1	0.7	0.4	0.9	0.3	0.3	6.7	7.1	5.4	5.1	4.0	5.0	6.3	6.7	6.3	5.8	9.6	8.8	38.6	25.6	3.7	2.9	17.7	60.3	23.5	55.0	62.6	0.4	20.7	21.2	18.1	22.8	32.8	22.0	0.0	53.8	30.5	12.1	9.8	37.0	215.9	3.1	29.0	30.7	16.8	213.5	114.7	23.3	5.3	28.5	42.3	6.9	25.3	39.2	11.4	27.0	16.0	0.0	60.3	63.7	28.5	23.0	48.6	237.0	5.0	27.6	19.6	108.7	22.4	0.8	39.1	119.6	235.3	94.7	22.8	3.4	85.3	47.1	20.1	8.2	11.9	0.0	6.6	100.8	32.2	2.7	33.6	36.7	50.4	17.6	42.5	62.8	92.7	27.3
CDK7	"CAK, CAK1, CDKN7, MO15, STK1"	ENSG00000134058	"Cyclin dependent kinase 7"	P50613	5	69234795-69277430	"Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, DNA damage, DNA repair, Transcription, Transcription regulation"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cytotrophoblasts: 121.0;Extravillous trophoblasts: 343.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BEWO: 169.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004364, HPA007932, HPA008453, CAB079975"	Enhanced		Supported	"Nucleoplasm,Nucleoli fibrillar center,Plasma membrane,Cytosol"		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 71: Testis - DNA repair"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 38: Extravillous trophoblasts - Unknown function"	Nucleoplasm	"Nucleoli fibrillar center, Plasma membrane, Cytosol"	"CAB004364: AB_627243, CAB079975: , HPA007932: AB_1078492, HPA008453: "	"unprognostic (3.12e-2)"	"unprognostic (1.23e-1)"	"unprognostic (4.87e-2)"	"unprognostic (4.53e-2)"	"unprognostic (3.29e-2)"	"unprognostic (4.64e-2)"	"unprognostic (2.49e-3)"	"unprognostic (1.64e-2)"	"unprognostic (7.77e-3)"	"unprognostic (1.81e-2)"	"prognostic unfavorable (3.09e-4)"	"unprognostic (3.40e-2)"	"prognostic unfavorable (9.42e-7)"	"unprognostic (2.61e-1)"	"unprognostic (2.38e-1)"	"unprognostic (3.86e-2)"	"unprognostic (1.55e-2)"	13.4	19.8	9.4	9.5	10.2	29.1	14.8	10.9	12.9	17.5	11.5	13.7	13.3	12.1	12.9	37.3	12.5	6.4	12.4	9.5	10.5	18.4	13.6	12.7	4.8	9.7	9.7	11.7	14.1	3.2	18.2	16.2	9.8	13.7	7.4	12.8	18.9	4.8	26.8	25.3	12.2	7.7	9.8	12.6	13.5	30.6	10.0	9.3	13.2	15.0	13.3	16.1	19.9	9.4	42.8	5.9	19.4	30.6	6.4	24.4	169.5	30.9	37.5	46.2	42.9	62.2	64.5	3.7	36.4	36.8	34.2	65.3	10.8	31.3	40.6	9.0	3.1	8.6	21.4	25.9	32.8	17.9	33.8	7.1	61.3	1.8	46.0	24.5	32.5	22.3	16.3	16.1	13.3	33.3	9.4	51.7	20.7	2.8	25.4	12.3	0.7	27.1	42.6	25.4	8.6	17.5	11.6	50.4	42.4	28.1	44.9	39.3	7.4	17.1	27.4	33.1	18.2	14.4	30.4	16.5	31.4	10.2	15.5	27.9	7.9	16.2	5.3	8.9	7.9	10.6	7.8	10.6	7.3	14.5	5.9	6.4	8.2	8.6	4.7	8.9	10.5	6.1	9.4	10.2	10.9	12.9	9.5	10.5	9.7	9.7	9.8	9.8	10.0	9.4	12.2	16.0	13.2	10.7	7.8	57.7	21.4	32.9	15.4	6.4	12.3	14.7	11.3	10.0	20.2	5.5	12.5	121.0	11.7	10.2	15.6	27.8	26.8	33.1	10.7	11.6	3.0	9.9	17.6	21.6	343.6	13.0	9.7	27.2	15.8	7.4	7.1	6.7	24.0	1.7	13.7	12.3	20.3	8.5	6.0	7.9	7.5	8.5	7.2	11.2	11.6	10.4	15.5	8.0	11.9	29.3	16.2	7.2	5.8	28.2	12.3	29.3	42.4	8.7	26.3	10.0	12.5	70.1	18.6	15.9	41.9	64.6	11.4	6.8	13.2	29.8
CDKL2	"KKIAMRE, P56"	ENSG00000138769	"Cyclin dependent kinase like 2"	Q92772	4	75576496-75630716	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 8.3;choroid plexus: 8.6;retina: 9.6;testis: 11.6"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 76.4;Early spermatids: 57.8;Excitatory neurons: 32.8;Inhibitory neurons: 40.9;Oligodendrocytes: 46.4;Spermatocytes: 101.7"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 2.1;HHSteC: 1.9;RPTEC TERT1: 4.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040672			Approved	Nucleoplasm,Centrosome		NA	NA				"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Nucleoplasm, Centrosome"		"HPA040672: AB_10794744"	"unprognostic (2.07e-1)"	"unprognostic (9.96e-2)"	"unprognostic (6.91e-2)"	"unprognostic (3.80e-5)"	"unprognostic (3.43e-2)"	"unprognostic (2.71e-2)"	"unprognostic (1.59e-1)"	"unprognostic (8.14e-3)"	"unprognostic (1.58e-1)"	"unprognostic (1.62e-1)"	"unprognostic (5.85e-2)"	"unprognostic (1.27e-1)"	"prognostic favorable (6.88e-15)"	"unprognostic (5.91e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.64e-1)"	"unprognostic (7.52e-2)"	0.1	1.0	6.3	0.3	6.7	0.0	0.3	4.1	8.3	0.6	8.6	0.7	0.1	0.6	0.9	0.8	1.6	0.4	0.3	6.5	6.1	5.9	0.0	4.7	0.3	6.0	4.8	1.6	0.5	2.5	1.5	0.0	6.5	0.6	0.9	9.6	0.3	0.6	0.0	0.2	0.1	0.4	4.9	0.1	0.6	11.6	5.8	0.0	3.1	0.0	0.6	0.2	0.3	8.3	2.1	0.3	0.1	0.0	0.1	0.1	0.0	0.1	0.8	1.0	0.9	0.1	0.5	0.0	0.3	0.0	1.0	0.2	0.0	0.2	0.9	0.1	1.5	0.0	0.1	0.0	1.9	0.0	0.0	0.6	1.0	0.1	0.3	0.9	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	4.2	0.1	1.1	0.9	0.0	0.0	0.5	1.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.7	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	6.3	6.7	4.1	8.3	6.5	6.1	6.0	4.8	6.5	4.9	5.8	8.3	0.2	25.6	76.4	5.9	0.4	0.1	0.5	0.6	0.6	17.7	0.7	3.0	0.9	1.5	4.7	9.2	4.2	0.1	0.3	3.0	7.9	1.9	57.8	11.6	1.4	0.2	1.8	0.0	32.8	0.2	0.6	1.2	1.1	2.5	1.3	1.0	0.4	0.0	0.1	10.1	40.9	2.3	0.0	0.0	0.4	20.7	1.8	0.5	1.8	3.7	0.0	11.6	0.0	5.5	46.4	0.1	1.0	1.2	0.3	0.2	0.0	29.5	18.6	20.2	0.0	0.4	1.1	101.7	4.1	0.8	0.3	0.3	2.7	0.2	2.7	0.2
CDKL5	"CFAP247, EIEE2, STK9"	ENSG00000008086	"Cyclin dependent kinase like 5"	O76039	X	18425583-18653629	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	"Disease variant, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 216.6;Horizontal cells: 80.8;Inhibitory neurons: 116.1;Oligodendrocytes: 79.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"basophil: 5.7"	"Lineage enriched"	"Detected in single"	11	"granulocytes: 5.7"	"Cell line enhanced"	"Detected in many"		"A549: 10.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002847, CAB011577"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 58: Brain - Synaptic function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Nucleoplasm		"CAB011577: AB_727019, HPA002847: AB_1080107"	"unprognostic (7.01e-2)"	"unprognostic (4.86e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.25e-4)"	"unprognostic (1.17e-1)"	"unprognostic (1.61e-2)"	"unprognostic (1.72e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.07e-1)"	"unprognostic (9.63e-3)"	"unprognostic (2.05e-3)"	"unprognostic (1.66e-1)"	"prognostic favorable (5.54e-4)"	"unprognostic (7.67e-3)"	"unprognostic (1.29e-1)"	"unprognostic (2.67e-3)"	"unprognostic (1.99e-1)"	2.0	1.6	4.9	1.1	6.7	2.5	2.5	0.0	11.7	3.9	0.0	1.9	0.9	2.6	1.9	3.5	1.7	1.8	3.8	6.8	0.0	3.5	1.2	4.6	0.8	0.0	2.5	3.8	2.4	2.4	1.7	3.2	0.0	3.6	1.2	12.2	2.2	2.3	1.7	2.2	0.9	2.5	0.0	1.2	2.4	7.1	5.7	1.7	3.0	2.0	1.1	2.7	3.4	5.4	1.1	10.0	2.6	2.2	2.4	3.6	1.7	1.7	3.0	2.0	2.5	3.3	1.5	1.5	0.3	1.0	4.5	0.5	3.2	1.8	4.3	0.4	1.7	0.1	5.5	2.1	1.1	0.2	0.7	1.7	1.9	5.4	4.9	1.3	1.0	1.6	0.2	1.5	2.7	1.0	0.6	0.8	5.2	0.9	2.3	0.6	3.0	0.1	1.8	7.1	0.5	3.2	2.7	0.9	1.5	4.4	1.3	0.4	6.2	2.5	1.7	5.5	1.3	0.3	0.1	0.3	1.4	0.4	3.0	5.7	0.5	1.1	0.3	0.3	0.1	0.1	0.2	0.1	0.1	0.3	0.3	0.2	2.0	0.2	0.3	0.5	0.1	0.1	4.9	6.7	0.0	11.7	6.8	0.0	0.0	2.5	0.0	0.0	5.7	5.4	9.4	25.6	24.8	37.5	2.8	0.9	10.7	0.7	4.6	19.0	7.9	6.3	12.9	5.7	5.3	7.3	33.3	27.4	3.8	1.3	7.9	7.7	34.3	6.5	8.4	6.3	2.4	2.7	216.6	9.6	3.1	7.4	7.7	7.9	1.3	3.9	6.1	3.4	4.2	80.8	116.1	1.6	2.0	4.4	0.5	55.3	5.9	4.9	0.0	34.7	4.6	23.5	0.0	41.7	79.7	8.2	0.8	5.3	4.3	16.2	0.6	8.9	4.0	20.4	32.9	7.2	8.4	5.8	10.1	4.2	1.3	47.3	2.3	5.7	1.8	22.9
CDKN1A	"CAP20, CDKN1, CIP1, P21, p21CIP1, p21Cip1/Waf1, SDI1, WAF1"	ENSG00000124762	"Cyclin dependent kinase inhibitor 1A"	P38936	6	36676460-36687337	"Cancer-related genes, Human disease related genes, Predicted intracellular proteins"	"Cell cycle"	"Protein kinase inhibitor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"non-classical monocyte: 74.5"	"Group enriched"	"Detected in many"	9	"B-cells: 20.7;dendritic cells: 21.5;monocytes: 74.5"	"Cell line enhanced"	"Detected in many"		"HHSteC: 798.5;HSkMC: 586.5;hTCEpi: 775.8;LHCN-M2: 604.2"	"Region enhanced"	"Detected in all"		"olfactory bulb: 76.0"	"Low region specificity"	"Detected in all"			"CAB000064, HPA005946, CAB069401"	Supported		Supported	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 7: Non-specific - Mitochondria"	"Nucleoplasm, Nuclear bodies"		"CAB000064: , CAB069401: AB_1620493, HPA005946: AB_2667477"	"unprognostic (7.99e-3)"	"unprognostic (4.01e-2)"	"unprognostic (1.58e-1)"	"prognostic favorable (3.14e-5)"	"unprognostic (1.57e-2)"	"unprognostic (2.19e-2)"	"unprognostic (1.39e-2)"	"prognostic unfavorable (7.05e-4)"	"unprognostic (1.30e-1)"	"unprognostic (7.27e-2)"	"unprognostic (2.79e-2)"	"unprognostic (7.55e-3)"	"prognostic favorable (4.95e-5)"	"unprognostic (8.32e-2)"	"unprognostic (6.52e-2)"	"unprognostic (1.12e-1)"	"unprognostic (3.21e-2)"	322.1	98.1	47.0	62.1	48.1	72.7	144.2	47.3	60.9	123.3	85.9	119.0	115.2	74.4	41.0	203.2	213.9	132.6	170.6	47.2	49.5	149.9	173.4	182.2	17.3	63.7	54.6	184.9	130.5	70.1	104.4	44.7	53.4	91.4	108.2	29.2	79.1	29.4	241.6	224.4	130.0	114.3	55.0	34.4	121.3	47.0	50.3	59.7	77.5	26.9	21.8	212.7	142.3	53.6	27.0	108.1	80.1	2.0	273.3	490.3	149.5	435.6	344.8	52.3	203.7	9.6	25.3	18.3	15.5	267.9	48.0	60.2	3.7	477.7	82.4	36.2	22.0	3.0	85.8	137.0	798.5	0.5	127.7	586.5	775.8	476.2	147.1	309.3	275.3	1.4	5.1	120.8	604.2	57.4	3.9	11.3	10.2	112.8	15.5	54.4	67.1	31.9	91.2	201.5	36.7	35.6	101.3	8.4	21.3	185.2	32.7	111.2	155.8	91.5	86.9	6.2	36.4	202.0	42.9	54.5	118.7	9.9	261.0	0.0	22.8	0.5	0.5	52.2	0.8	20.7	1.1	0.6	20.0	16.2	0.3	0.4	4.2	0.7	74.5	21.5	2.9	34.2	47.0	48.1	47.3	60.9	47.2	49.5	63.7	54.6	53.4	55.0	50.3	53.6	571.2	83.3	45.1	1.0	126.9	440.5	340.1	293.1	512.8	0.8	203.9	187.6	151.6	41.5	214.4	68.0	0.0	42.1	56.4	505.3	46.9	217.6	0.9	227.9	57.3	327.1	175.5	5.7	0.5	264.7	52.8	302.4	150.9	199.2	104.4	20.4	71.7	68.9	72.9	0.0	0.4	197.1	156.6	62.0	556.0	3.9	34.5	277.6	218.7	5.6	280.6	58.4	2.1	0.0	0.5	429.9	466.1	16.6	376.4	201.7	383.2	17.2	215.1	3.1	26.3	303.6	471.6	1.2	1.7	620.9	672.0	155.3	106.0	10.7	75.8	478.0
CDKN1B	"KIP1, P27KIP1"	ENSG00000111276	"Cyclin dependent kinase inhibitor 1B"	P46527	12	12715058-12722369	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cell cycle"	"Protein kinase inhibitor"	"Cancer-related genes, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Muller glia cells: 182.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003691, CAB021888, HPA059086"	Approved		Supported	Nucleoplasm,Vesicles		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm	Vesicles	"CAB003691: AB_425362, CAB021888: , HPA059086: AB_2683900"	"unprognostic (5.67e-2)"	"unprognostic (9.76e-2)"	"prognostic favorable (5.15e-4)"	"unprognostic (6.90e-3)"	"unprognostic (5.84e-3)"	"unprognostic (1.03e-2)"	"prognostic unfavorable (3.25e-4)"	"unprognostic (4.04e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.85e-3)"	"unprognostic (9.23e-3)"	"unprognostic (2.96e-1)"	"prognostic unfavorable (8.39e-4)"	"unprognostic (1.23e-1)"	"unprognostic (8.68e-2)"	"unprognostic (2.88e-1)"	"unprognostic (1.15e-1)"	53.4	44.7	53.6	40.1	70.6	68.1	50.2	73.4	81.3	55.3	43.1	43.9	44.5	41.0	24.5	29.1	47.3	24.6	32.9	47.9	58.9	30.2	35.2	38.9	55.3	58.6	58.3	66.1	23.9	34.4	24.4	41.0	61.2	35.9	32.5	55.3	36.3	33.4	81.4	45.4	40.7	24.8	55.1	55.1	30.0	25.8	58.3	71.8	33.7	63.4	39.9	32.0	44.5	91.2	37.1	16.6	94.5	16.6	32.0	18.0	46.1	31.5	53.8	46.0	56.4	47.7	40.4	0.3	12.5	19.6	16.6	34.2	44.9	16.7	41.1	62.4	31.5	28.8	46.5	53.2	42.5	24.5	18.6	19.8	35.3	15.2	44.0	107.8	27.8	54.5	31.5	101.6	16.6	45.9	32.7	35.3	38.0	32.1	16.8	25.2	30.9	63.1	22.5	38.6	35.6	58.4	48.9	34.8	65.8	33.7	18.6	54.6	19.1	22.6	34.9	20.7	33.3	86.1	59.4	33.2	28.2	36.6	22.5	6.2	3.8	8.6	5.9	3.5	6.1	6.8	7.7	7.2	3.6	5.0	8.0	6.1	20.9	7.3	5.5	3.9	12.3	4.0	53.6	70.6	73.4	81.3	47.9	58.9	58.6	58.3	61.2	55.1	58.3	91.2	64.2	44.8	29.3	6.2	126.2	52.6	20.7	21.0	115.5	45.6	39.5	30.1	39.1	21.5	27.1	9.2	27.1	42.9	92.5	32.3	15.6	10.8	70.0	31.2	35.8	51.1	45.7	70.5	8.1	9.3	47.6	39.3	25.5	34.3	31.0	21.3	47.2	30.7	26.8	10.1	13.4	41.4	24.4	55.3	66.0	67.7	55.9	65.1	74.7	23.4	31.6	182.9	60.8	6.0	29.5	10.1	21.3	26.7	121.2	30.3	33.4	16.9	36.4	29.4	92.1	20.2	53.5	7.7	10.8	102.3	52.6	39.0	166.1	20.9	41.9	22.7
CDKN2A	"ARF, CDK4I, CDKN2, CMM2, INK4, INK4a, MLM, MTS1, p14, p14ARF, p16, p16INK4a, p19, p19Arf"	ENSG00000147889	"Cyclin dependent kinase inhibitor 2A"	"P42771, Q8N726"	9	21967752-21995301	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Cell cycle, rRNA processing, Transcription, Transcription regulation, Ubl conjugation pathway"	DNA-binding	"Cancer-related genes, Disease variant, Li-Fraumeni syndrome, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"choroid plexus: 31.7;pituitary gland: 33.7"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 170.1;Club cells: 145.9;Early spermatids: 227.5;Late spermatids: 447.9;Pancreatic endocrine cells: 417.7;Respiratory ciliated cells: 221.9"	"Cancer enhanced"	"Detected in all"		"cervical cancer: 49.9;ovarian cancer: 57.6"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"T-reg: 37.4"	"Group enriched"	"Detected in many"	6	"B-cells: 15.6;T-cells: 37.4"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 289.2;HEK 293: 389.7;HeLa: 311.1;SK-MEL-30: 318.7"					"Low region specificity"	"Detected in some"			"CAB000093, CAB000445, CAB018232, HPA047838"	Enhanced		Supported	Nucleoli		NA	NA		18000	"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	Nucleoli		"CAB000093: AB_442119, CAB000445: , CAB018232: AB_785018, HPA047838: AB_2680174"	"unprognostic (3.41e-2)"	"unprognostic (4.51e-2)"	"unprognostic (3.00e-3)"	"prognostic unfavorable (1.82e-7)"	"unprognostic (5.22e-2)"	"prognostic favorable (5.19e-4)"	"prognostic unfavorable (2.17e-4)"	"unprognostic (1.25e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.56e-2)"	"prognostic unfavorable (5.76e-7)"	"unprognostic (9.41e-2)"	"unprognostic (1.22e-2)"	"unprognostic (3.05e-2)"	"unprognostic (3.55e-1)"	3.7	10.1	7.4	1.7	8.3	1.3	3.1	5.9	8.5	1.1	31.7	1.9	0.8	0.7	1.0	7.4	2.2	0.5	0.7	6.7	6.4	0.5	0.7	2.3	2.1	7.4	5.8	0.8	1.5	2.1	33.7	2.6	7.2	2.1	0.7	0.1	1.6	1.6	0.6	0.9	3.6	0.3	6.2	5.5	3.9	14.8	8.0	2.1	1.3	0.0	2.5	2.4	2.3	9.2	11.8	0.0	1.7	82.2	0.8	0.9	39.1	15.9	0.0	111.7	196.0	19.1	289.2	47.1	167.7	9.5	0.0	36.0	34.3	211.0	91.4	212.2	389.7	0.1	311.1	13.6	8.8	22.4	17.3	21.2	0.0	112.2	61.9	236.3	11.7	0.0	0.1	188.4	105.7	0.8	1.9	0.0	2.6	24.2	185.9	0.2	80.2	166.3	23.4	0.0	195.2	14.0	219.9	36.6	318.7	9.4	42.8	0.7	39.5	0.9	2.6	0.3	0.5	84.7	49.6	177.8	0.2	62.9	1.0	1.5	2.1	0.3	9.9	1.3	14.1	11.1	11.4	17.6	0.3	15.6	0.6	6.7	0.5	0.8	4.2	0.0	37.4	3.6	7.4	8.3	5.9	8.5	6.7	6.4	7.4	5.8	7.2	6.2	8.0	9.2	1.6	0.0	0.0	1.0	11.5	1.8	2.3	170.1	0.0	0.6	6.1	10.4	4.2	0.0	145.9	11.0	0.0	27.9	6.2	8.1	0.0	29.7	227.5	36.4	6.7	2.6	70.9	0.0	1.2	26.4	43.8	7.7	0.0	6.2	4.5	4.6	1.4	0.3	7.6	0.0	3.5	6.3	122.1	10.5	4.2	447.9	3.1	2.9	8.8	7.5	16.2	0.9	5.2	4.5	6.6	417.7	12.1	1.9	38.7	35.4	32.8	0.0	221.9	0.1	0.0	1.1	20.8	7.2	6.2	7.2	0.4	9.2	12.7	11.0	3.8	54.4
CDKN2D	"INK4D, p19"	ENSG00000129355	"Cyclin dependent kinase inhibitor 2D"	P55273	19	10566460-10569059	"Predicted intracellular proteins"	"Cell cycle"		"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 283.7"	"Cell type enhanced"	"Detected in all"		"dendritic cells: 146.8;Erythroid cells: 116.6;Macrophages: 105.4;NK-cells: 155.5;Spermatocytes: 126.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HEL: 90.6;MOLT-4: 113.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011201, HPA043546"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	Yes			"Cluster 52: Eosinophils - Transcription"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 51: Myeloid cells - Hemostasis"	Nucleoplasm	Cytosol	"CAB011201: AB_261049, HPA043546: AB_2678545"	"unprognostic (3.08e-1)"	"prognostic favorable (1.02e-4)"	"unprognostic (3.57e-2)"	"unprognostic (1.49e-2)"	"unprognostic (3.29e-2)"	"unprognostic (1.37e-2)"	"prognostic unfavorable (4.82e-4)"	"unprognostic (2.08e-1)"	"unprognostic (1.08e-2)"	"unprognostic (6.55e-2)"	"unprognostic (3.28e-1)"	"unprognostic (1.50e-1)"	"unprognostic (3.27e-3)"	"unprognostic (9.90e-2)"	"unprognostic (4.52e-1)"	"unprognostic (4.43e-2)"	"unprognostic (1.40e-1)"	13.7	9.8	61.0	13.3	64.9	283.7	9.5	43.9	86.9	9.4	37.3	14.2	6.3	7.0	3.1	14.3	11.0	6.4	18.8	64.8	59.7	11.3	7.1	30.8	23.9	53.8	51.5	7.1	5.8	3.3	15.7	8.2	59.9	8.0	5.6	16.3	7.3	4.1	19.7	18.1	14.5	7.8	46.1	42.4	9.4	38.6	57.6	78.0	6.2	15.9	16.1	11.2	12.9	57.4	30.8	4.8	15.1	10.0	8.0	12.2	3.8	19.8	23.2	21.4	18.8	6.1	7.3	8.5	6.4	21.1	21.6	6.4	5.2	5.1	7.7	34.3	12.6	90.6	5.8	10.2	9.2	9.2	70.2	5.1	16.2	11.0	8.2	17.7	6.1	52.6	3.8	72.3	21.5	4.3	113.9	48.3	3.0	23.4	22.7	18.4	14.7	5.1	9.7	2.6	21.3	11.2	14.0	10.4	15.2	2.8	9.4	24.0	4.7	25.2	12.9	42.1	30.1	44.9	16.5	15.8	26.7	15.5	18.4	143.5	17.7	79.7	30.2	23.2	24.2	56.7	24.9	34.1	17.4	50.0	23.3	27.4	139.9	41.1	35.6	51.0	22.5	31.8	61.0	64.9	43.9	86.9	64.8	59.7	53.8	51.5	59.9	46.1	57.6	57.4	35.2	6.4	7.0	4.6	65.2	23.2	13.7	17.1	38.7	32.4	11.1	15.2	9.2	5.7	8.2	5.5	12.5	4.8	146.8	11.8	9.8	7.7	21.2	26.9	10.2	29.3	7.2	116.6	18.5	4.9	8.4	11.0	3.6	16.7	21.0	4.8	26.7	3.8	10.4	47.1	14.8	6.4	36.7	42.2	47.7	13.7	7.2	105.4	30.2	1.9	46.4	22.2	155.5	1.0	8.2	14.2	9.4	6.0	9.2	11.4	5.0	5.1	10.9	37.1	19.7	8.3	25.8	126.0	83.7	38.6	33.1	4.9	63.4	4.5	6.9	23.8
CDT1	"DUP, RIS2"	ENSG00000167513	"Chromatin licensing and DNA replication factor 1"	Q9H211	16	88803789-88809258	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cell cycle, Cell division, DNA replication, Mitosis"		"Disease variant, Dwarfism, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"bone marrow: 38.5"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 51.4;Erythroid cells: 71.3;Extravillous trophoblasts: 92.0;Spermatogonia: 37.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"NB-4: 149.4"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			HPA017224	Approved		Supported	"Nucleoplasm,Nuclear bodies"		NA	Yes			"Cluster 52: Eosinophils - Transcription"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 24: NB-4 - Immune response"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	"Nuclear bodies"	"HPA017224: AB_1846468"	"unprognostic (1.33e-1)"	"unprognostic (2.04e-2)"	"unprognostic (7.32e-2)"	"unprognostic (2.67e-1)"	"unprognostic (4.34e-1)"	"unprognostic (1.98e-1)"	"prognostic unfavorable (2.12e-6)"	"unprognostic (3.44e-3)"	"unprognostic (2.81e-2)"	"unprognostic (4.59e-2)"	"unprognostic (1.21e-1)"	"unprognostic (9.34e-2)"	"prognostic unfavorable (2.69e-6)"	"unprognostic (7.72e-3)"	"unprognostic (5.79e-2)"	"unprognostic (2.80e-2)"	"unprognostic (8.54e-2)"	0.7	0.8	0.8	3.8	1.2	38.5	0.7	2.5	1.3	1.7	0.0	3.3	4.1	0.5	0.2	6.7	0.5	0.2	0.5	0.8	2.3	0.7	1.0	1.3	4.8	2.2	1.1	0.4	0.6	1.3	2.1	2.8	1.9	0.7	1.6	0.4	1.1	0.2	0.1	3.6	3.9	0.6	0.7	3.1	2.4	3.5	1.1	8.7	0.6	0.0	3.3	0.5	2.3	1.0	33.6	34.5	16.5	25.3	0.7	3.4	64.2	24.1	6.6	19.4	12.0	79.3	33.8	51.4	24.2	5.5	12.7	46.0	21.6	17.7	6.2	18.2	92.1	51.8	28.8	59.9	0.3	28.8	21.5	1.8	1.4	19.8	4.4	1.6	5.9	60.9	80.8	18.4	7.6	90.6	109.3	149.4	41.8	12.2	31.6	120.3	22.9	42.4	4.3	23.8	36.6	26.2	44.4	13.1	16.9	7.4	39.0	55.9	5.9	24.6	42.6	37.2	35.4	61.4	55.7	73.6	19.3	71.9	31.6	0.2	0.1	0.9	0.3	0.0	0.0	0.1	0.1	0.2	0.3	0.2	0.1	0.1	0.7	0.4	0.1	0.1	0.7	0.2	0.8	1.2	2.5	1.3	0.8	2.3	2.2	1.1	1.9	0.7	1.1	1.0	0.4	0.0	1.1	0.7	4.9	11.2	4.3	1.4	7.4	0.7	5.4	7.5	2.2	1.5	1.7	1.8	0.0	51.4	2.2	12.7	1.9	1.1	0.4	1.4	1.4	2.2	2.4	71.3	0.2	0.0	92.0	5.2	9.2	2.2	0.0	29.0	0.4	1.0	19.5	0.0	0.8	16.1	4.1	5.6	5.5	1.2	0.3	2.8	1.8	0.0	1.9	1.5	4.1	0.0	0.6	0.6	2.3	0.4	23.1	2.2	2.0	1.6	2.1	1.9	0.0	2.1	3.4	6.6	37.1	10.8	7.1	24.8	5.4	5.7	30.1	4.4
CDYL	"CDYL1, DKFZP586C1622"	ENSG00000153046	"Chromodomain Y like"	Q9Y232	6	4706159-4955551	"Predicted intracellular proteins"	"Differentiation, Spermatogenesis, Transcription, Transcription regulation"	"Lyase, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"plasmacytoid DC: 6.8"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035578	Enhanced		Supported	"Nuclear speckles"		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 52: Non-specific - Ribosome"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 65: Plasmacytoid DCs - Unknown function"	"Nuclear speckles"		"HPA035578: AB_2674685"	"unprognostic (1.25e-1)"	"unprognostic (8.99e-2)"	"unprognostic (6.03e-2)"	"unprognostic (2.38e-3)"	"prognostic favorable (1.53e-4)"	"unprognostic (1.92e-1)"	"prognostic unfavorable (2.20e-4)"	"unprognostic (2.62e-2)"	"prognostic unfavorable (7.52e-4)"	"unprognostic (2.06e-1)"	"unprognostic (2.05e-2)"	"unprognostic (2.09e-1)"	"unprognostic (5.21e-3)"	"unprognostic (1.90e-1)"	"unprognostic (1.65e-1)"	"unprognostic (2.60e-2)"	"unprognostic (3.94e-1)"	14.0	6.0	6.9	10.2	6.8	20.0	11.5	5.0	6.7	15.0	4.9	13.0	7.0	15.2	10.5	16.8	10.6	8.4	10.4	6.0	6.4	7.2	5.6	8.9	12.1	6.6	6.2	9.9	7.5	12.4	5.1	18.2	6.0	7.6	13.2	6.7	9.0	11.9	19.5	17.8	9.0	14.5	5.6	9.6	9.2	9.0	6.7	9.3	9.7	12.7	12.9	15.6	13.0	6.9	23.7	22.1	30.1	25.5	23.3	15.9	34.4	23.1	17.9	21.3	22.9	18.0	17.2	5.3	22.1	17.6	33.3	19.8	24.2	28.2	24.9	16.4	20.2	20.9	21.0	16.4	28.5	27.9	21.7	12.5	49.8	25.0	37.5	12.9	20.6	19.2	37.9	16.2	10.8	22.9	14.8	25.9	32.6	17.9	21.3	19.0	26.2	43.7	14.7	20.5	25.5	15.4	28.5	24.9	36.9	86.5	15.0	26.3	28.1	25.2	21.6	18.5	26.8	33.7	57.8	18.4	8.3	17.7	28.1	5.3	1.3	0.6	1.5	0.6	1.1	1.0	1.1	1.2	1.6	1.1	0.7	1.1	0.4	1.6	0.8	6.8	0.1	1.3	6.9	6.8	5.0	6.7	6.0	6.4	6.6	6.2	6.0	5.6	6.7	6.9	32.7	19.2	9.4	28.7	18.4	37.3	23.9	11.9	10.8	16.7	31.2	35.8	18.8	14.3	12.0	14.7	22.9	12.9	64.5	44.7	15.6	10.8	62.8	26.9	43.2	22.9	32.3	41.5	52.3	10.4	22.0	18.7	6.1	60.3	5.7	24.3	18.9	11.7	10.5	45.4	41.5	26.6	6.1	17.3	57.9	74.9	5.9	28.1	8.8	101.2	22.7	25.4	19.6	54.3	64.1	16.8	41.8	8.2	22.3	30.1	4.6	10.7	12.1	25.7	6.6	29.7	20.9	10.4	25.3	9.8	41.9	63.8	17.5	10.9	22.6	56.9
CEACAM5	"CD66e, CEA"	ENSG00000105388	"CEA cell adhesion molecule 5"	P06731	19	41708585-41730433	"Cancer-related genes, CD markers, Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Cell adhesion"		"Cancer-related genes, Oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"intestine: 981.2"	"Group enriched"	"Detected in some"	4	"Distal enterocytes: 1389.2;Intestinal goblet cells: 395.0;Paneth cells: 777.3"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 1007.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"OE19: 56.9"									"CAB000021, CAB000022, HPA011041, HPA019758"	Enhanced		Supported	"Plasma membrane"	"Intracellular and membrane"	NA	NA		23000000		"Cluster 37: Intestine - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Plasma membrane"		"CAB000021: , CAB000022: AB_2335697, HPA011041: AB_1078481, HPA019758: AB_1846326"	"unprognostic (1.54e-2)"	"unprognostic (7.59e-2)"	"unprognostic (5.49e-3)"	"unprognostic (1.80e-1)"		"unprognostic (1.38e-2)"		"unprognostic (2.22e-1)"	"unprognostic (3.49e-1)"	"unprognostic (2.11e-1)"	"unprognostic (2.19e-2)"	"unprognostic (2.89e-1)"	"unprognostic (8.67e-9)"	"unprognostic (2.92e-1)"	"unprognostic (2.71e-2)"	"unprognostic (6.31e-2)"	"unprognostic (1.85e-1)"	3.2	0.1	0.0	185.6	0.0	0.2	4.0	0.3	0.1	38.5	0.2	981.2	22.7	1.3	0.2	232.0	0.8	0.8	0.1	0.1	0.0	0.9	0.2	30.2	0.1	0.1	0.0	0.1	0.3	0.0	0.3	0.0	0.0	0.5	942.7	0.0	29.2	3.3	0.1	3.5	61.4	28.7	0.0	0.1	163.2	0.3	0.1	0.2	1.0	0.0	36.9	10.4	71.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1.7	0.0	0.1	0.0	0.0	13.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.2	0.0	0.3	56.9	1.1	0.2	0.0	0.0	0.0	0.4	0.6	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.3	0.0	0.3	0.2	0.0	0.0	0.1	0.1	0.1	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	32.1	4.1	0.0	2.7	0.0	1.0	12.3	0.0	0.0	0.1	0.0	0.4	0.0	34.8	0.0	0.0	0.0	0.0	1389.2	0.0	3.4	0.4	0.0	0.0	0.2	65.7	0.0	0.1	0.9	0.0	0.4	22.4	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.1	395.0	4.1	0.0	0.4	0.0	0.0	0.0	5.4	0.0	0.0	0.0	0.0	0.0	0.1	21.3	777.3	0.0	0.1	16.5	10.2	0.0	4.5	0.0	0.0	0.1	0.4	0.8	0.5	1.9	0.0	0.0	1.2	0.0	192.3	124.4
CEACAM7	"CEA, CGM2"	ENSG00000007306	"CEA cell adhesion molecule 7"	Q14002	19	41673303-41706976	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"intestine: 651.8"	"Group enriched"	"Detected in some"	9	"Distal enterocytes: 1454.0;Paneth cells: 731.2"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 66.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA069621, HPA073910"	Enhanced		Supported	"Plasma membrane,Cytosol"	"Intracellular and membrane"	NA	NA				"Cluster 37: Intestine - Unknown function"		"Cluster 53: Intestinal epithelial cells - Unknown function"	"Plasma membrane"	Cytosol	"HPA069621: AB_2686162, HPA073910: "	"unprognostic (5.24e-2)"	"unprognostic (2.72e-1)"	"unprognostic (1.64e-2)"	"unprognostic (6.03e-2)"		"unprognostic (2.07e-2)"		"unprognostic (4.30e-2)"			"unprognostic (3.61e-2)"	"unprognostic (1.74e-1)"		"unprognostic (4.66e-2)"	"unprognostic (1.86e-1)"		"unprognostic (3.14e-1)"	0.6	0.0	0.0	71.4	0.0	0.1	2.9	0.0	0.0	13.3	0.0	595.8	0.5	0.3	0.0	52.6	0.6	39.4	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.4	651.8	0.0	4.0	0.8	0.1	1.4	0.7	5.7	0.0	0.2	2.0	0.1	0.0	0.0	0.0	0.0	12.0	23.4	39.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.4	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.2	0.0	0.2	0.9	0.0	0.0	0.1	0.0	0.1	0.0	2.8	0.0	0.0	0.0	0.0	1454.0	0.0	116.6	0.1	0.0	0.0	0.5	8.4	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.0	0.0	0.0	0.0	0.1	1.0	731.2	0.0	0.0	1.4	0.0	0.0	2.6	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.1	0.0	38.4	30.3
CEBPA	"C/EBP-alpha, CEBP"	ENSG00000245848	"CCAAT enhancer binding protein alpha"	P49715	19	33299934-33302534	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Host-virus interaction, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 98.7;liver: 194.7;skin 1: 118.7"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 91.6;Hepatocytes: 106.5;Hofbauer cells: 87.0;Suprabasal keratinocytes: 171.8;Syncytiotrophoblasts: 212.3"	"Cancer enhanced"	"Detected in all"		"liver cancer: 70.6"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"basophil: 16.0;classical monocyte: 7.1;intermediate monocyte: 12.3;myeloid DC: 5.1;non-classical monocyte: 15.7"	"Group enriched"	"Detected in many"	15	"dendritic cells: 5.1;granulocytes: 16.0;monocytes: 15.7"	"Cell line enhanced"	"Detected in many"		"BEWO: 196.9;Hep G2: 110.9;NB-4: 114.1;THP-1: 407.7;U-937: 130.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA052734, HPA065037, HPA067937"	Approved		Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 85: Liver - Metabolism"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm	Vesicles	"HPA052734: AB_2681931, HPA065037: AB_2685410, HPA067937: AB_2685927"	"unprognostic (1.80e-1)"	"unprognostic (7.62e-3)"	"unprognostic (2.09e-3)"	"unprognostic (2.21e-2)"	"unprognostic (3.38e-1)"	"unprognostic (3.99e-2)"	"unprognostic (1.94e-1)"	"unprognostic (2.43e-3)"	"unprognostic (5.95e-2)"	"unprognostic (3.96e-2)"	"unprognostic (3.09e-1)"	"unprognostic (9.45e-2)"	"unprognostic (8.02e-3)"	"unprognostic (2.19e-1)"	"unprognostic (1.98e-1)"	"unprognostic (2.49e-2)"	"unprognostic (2.72e-2)"	98.7	2.9	16.2	5.7	17.9	22.6	67.7	18.3	26.9	8.7	10.4	21.0	21.2	2.9	0.8	20.9	4.3	3.0	2.8	15.7	18.8	3.6	194.7	25.5	9.1	27.4	22.4	1.3	9.7	26.8	2.6	16.0	21.3	8.8	11.5	0.6	9.8	3.4	19.1	118.7	20.8	2.5	25.7	7.7	12.5	1.0	24.5	4.1	6.5	4.5	6.3	8.7	14.8	34.8	2.5	5.1	0.1	7.1	55.8	0.0	196.9	0.1	1.5	0.1	0.0	24.8	0.1	0.0	3.0	0.0	1.1	9.4	5.8	0.6	0.0	35.8	7.2	0.1	0.1	110.9	0.9	36.6	42.1	2.2	25.4	0.0	0.2	0.0	0.0	2.8	2.4	0.0	0.0	12.7	0.2	114.1	5.0	61.8	2.7	0.0	0.4	1.1	0.2	17.7	0.4	1.7	0.7	0.5	0.8	6.2	13.7	407.7	0.1	0.1	0.8	0.1	0.9	0.4	0.0	0.2	0.0	130.9	0.0	16.0	7.1	0.0	0.8	12.3	0.7	0.0	0.1	0.5	5.1	0.1	0.2	0.4	2.5	0.0	15.7	0.2	0.0	2.1	16.2	17.9	18.3	26.9	15.7	18.8	27.4	22.4	21.3	25.7	24.5	34.8	5.4	16.0	37.8	0.0	2.8	37.3	20.8	3.3	22.2	0.7	6.2	12.2	0.4	57.2	5.1	0.0	0.0	40.3	14.4	91.6	3.9	0.5	0.0	0.8	0.8	4.9	4.2	5.7	1.9	5.8	44.3	9.5	12.8	1.3	1.3	0.0	2.2	106.5	87.0	0.0	0.3	24.8	4.1	35.0	27.4	0.2	3.1	42.9	5.4	17.8	28.2	8.4	6.2	1.0	0.4	1.9	30.6	1.5	2.0	15.1	42.5	4.9	5.1	0.5	0.0	4.1	3.1	0.2	0.7	29.7	171.8	212.3	5.0	0.3	51.5	12.2
CEBPE	CRP1	ENSG00000092067	"CCAAT enhancer binding protein epsilon"	Q15744	14	23117306-23119255	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	15	"bone marrow: 51.8"	"Cell type enhanced"	"Detected in some"		"Hofbauer cells: 6.6;Kupffer cells: 1.4;Macrophages: 2.3;monocytes: 2.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in many"	218	"eosinophil: 750.4"	"Lineage enriched"	"Detected in many"	250	"granulocytes: 750.4"	"Group enriched"	"Detected in some"	4	"HL-60: 233.8;NB-4: 122.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA002928, CAB005113"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 24: NB-4 - Immune response"	"Cluster 4: Macrophages - Innate immune response"	Nucleoplasm	"Plasma membrane, Cytosol"	"CAB005113: AB_631240, HPA002928: AB_1078494"	"unprognostic (1.33e-2)"	"unprognostic (4.76e-2)"	"unprognostic (4.19e-2)"	"unprognostic (2.04e-1)"	"unprognostic (5.01e-2)"	"unprognostic (1.66e-3)"	"unprognostic (2.84e-1)"	"unprognostic (1.49e-2)"	"unprognostic (3.33e-2)"	"unprognostic (5.69e-2)"	"unprognostic (9.03e-2)"	"unprognostic (2.22e-1)"	"unprognostic (3.80e-3)"	"unprognostic (1.42e-1)"	"unprognostic (1.12e-2)"	"unprognostic (2.57e-2)"	"unprognostic (8.19e-2)"	0.1	0.0	0.1	1.6	0.1	51.8	0.0	0.0	0.2	0.0	0.0	0.2	2.4	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.5	0.4	0.1	0.1	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.2	0.0	0.0	0.0	0.2	0.1	3.2	0.3	0.1	3.4	0.8	0.0	0.3	0.5	0.0	0.0	0.1	0.3	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	233.8	39.6	0.0	0.0	0.0	0.0	0.0	0.0	9.1	0.0	0.0	0.0	0.0	0.9	122.5	0.0	0.0	0.0	10.4	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	18.3	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.2	0.0	26.3	0.0	0.5	3.0	750.4	0.0	0.6	0.1	0.5	1.0	0.4	1.5	0.5	1.8	1.5	3.4	0.0	0.3	1.5	0.0	1.8	0.1	0.1	0.0	0.2	0.0	0.1	0.1	0.1	0.2	0.1	0.3	0.1	0.0	0.0	0.0	0.0	0.9	0.0	0.1	0.0	0.0	0.0	0.3	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	6.6	0.0	0.0	0.0	0.0	1.4	0.6	0.1	0.0	2.3	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.6	0.1	0.0	0.0
CEBPG	"GPE1BP, IG/EBP-1"	ENSG00000153879	"CCAAT enhancer binding protein gamma"	P53567	19	33373685-33382686	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA012024	Enhanced		Supported	Nucleoplasm		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm		"HPA012024: AB_1846503"	"unprognostic (5.56e-2)"	"unprognostic (1.35e-1)"	"unprognostic (3.29e-3)"	"prognostic unfavorable (7.97e-5)"	"unprognostic (8.12e-2)"	"unprognostic (2.35e-2)"	"unprognostic (2.13e-1)"	"unprognostic (5.42e-2)"	"unprognostic (1.19e-2)"	"unprognostic (2.10e-2)"	"unprognostic (1.29e-1)"	"unprognostic (2.74e-2)"	"prognostic unfavorable (7.23e-4)"	"unprognostic (1.16e-1)"	"unprognostic (5.25e-2)"	"unprognostic (8.87e-2)"	"unprognostic (2.01e-2)"	19.1	8.8	16.0	14.2	16.9	15.4	15.1	17.6	23.8	11.0	12.4	30.2	34.1	12.0	9.1	20.1	11.9	11.4	14.8	15.6	19.3	12.9	34.6	16.0	12.4	17.0	17.6	5.3	28.3	15.1	11.0	16.8	17.6	12.0	28.8	17.3	13.5	9.4	47.4	27.7	35.3	14.6	18.7	9.7	18.8	12.5	19.0	14.1	25.7	44.2	13.8	16.3	14.2	18.4	33.4	29.7	30.9	31.0	14.8	21.6	41.8	24.8	22.1	21.9	26.4	35.3	14.4	54.0	19.1	11.8	26.2	16.6	54.8	25.0	37.5	91.7	23.3	29.1	15.6	34.5	49.3	49.1	31.0	28.6	121.0	27.7	86.7	11.1	27.7	45.1	39.3	49.7	17.9	20.4	33.0	25.7	17.5	94.2	18.2	35.1	21.0	22.5	12.4	19.9	61.1	37.2	25.8	26.7	61.3	22.6	22.7	96.8	26.7	22.2	26.3	23.8	39.6	28.4	27.0	32.4	23.4	53.2	31.4	7.5	9.7	4.4	3.6	11.8	4.3	4.6	4.9	5.6	10.3	3.7	5.2	5.0	0.8	3.0	19.1	3.2	6.0	5.6	16.0	16.9	17.6	23.8	15.6	19.3	17.0	17.6	17.6	18.7	19.0	18.4	61.3	19.2	13.2	2.6	30.5	124.3	95.8	51.5	67.7	11.3	32.8	31.9	15.1	48.6	29.6	14.7	8.4	42.6	27.6	160.5	19.6	37.0	90.3	43.2	14.9	50.4	35.3	22.3	11.7	54.1	71.5	26.1	34.1	26.6	26.0	9.5	31.4	66.2	45.6	3.3	8.3	81.8	34.6	35.4	65.1	74.5	6.8	34.4	28.4	10.3	63.9	27.7	28.8	6.0	3.9	75.8	107.7	9.1	30.5	70.2	115.7	30.4	49.4	12.9	6.6	24.7	31.5	76.4	45.2	57.8	155.7	74.8	29.4	5.1	67.8	120.4
CEBPZ	"CBF2, CTF2"	ENSG00000115816	"CCAAT enhancer binding protein zeta"	Q03701	2	37201612-37231596	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 282.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052065	Uncertain		Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	Vesicles	Nucleoplasm	"HPA052065: AB_2681715"	"unprognostic (1.64e-2)"	"unprognostic (1.20e-1)"	"unprognostic (3.00e-3)"	"prognostic unfavorable (5.07e-4)"	"unprognostic (2.88e-1)"	"unprognostic (1.72e-2)"	"prognostic unfavorable (2.94e-5)"	"unprognostic (8.84e-2)"	"unprognostic (3.85e-3)"	"unprognostic (2.66e-1)"	"prognostic unfavorable (8.13e-4)"	"unprognostic (2.65e-2)"	"unprognostic (5.36e-2)"	"unprognostic (4.19e-2)"	"unprognostic (8.76e-2)"	"unprognostic (2.05e-1)"	"unprognostic (8.01e-2)"	21.1	27.8	10.3	18.9	11.5	31.3	26.2	15.8	12.8	17.9	11.9	19.5	17.4	20.1	19.9	20.5	17.2	16.7	15.3	9.8	11.8	25.3	27.1	19.3	24.6	10.9	11.0	23.9	20.6	22.3	10.2	23.0	11.4	19.7	20.0	24.4	16.3	15.6	36.3	17.9	18.1	16.9	10.8	19.9	17.4	38.4	11.1	24.0	22.4	24.4	24.4	26.6	12.6	14.2	61.2	46.6	46.9	26.1	45.2	48.6	39.9	57.0	39.2	47.2	50.5	74.5	45.1	111.5	49.4	33.8	64.4	51.0	122.8	58.5	60.2	71.8	53.9	104.0	47.5	60.9	35.8	105.7	44.9	37.3	56.4	62.8	63.4	31.1	43.3	27.8	114.8	49.8	48.6	31.8	61.5	82.4	153.3	81.0	43.2	48.6	76.3	84.3	45.3	56.9	49.9	80.7	47.5	57.6	65.5	67.6	41.8	45.9	35.5	45.8	52.3	41.3	79.1	55.5	62.0	88.1	40.8	95.6	51.2	34.8	16.8	16.3	23.8	21.7	30.0	29.6	24.7	23.4	17.6	30.0	31.1	26.1	6.1	26.1	22.3	25.6	21.4	14.6	10.3	11.5	15.8	12.8	9.8	11.8	10.9	11.0	11.4	10.8	11.1	14.2	73.4	86.6	82.9	15.0	91.6	107.1	109.2	64.4	83.1	45.5	50.4	54.1	34.4	47.1	81.9	49.7	43.8	54.7	93.4	36.7	107.6	56.1	282.1	56.0	87.2	60.5	44.2	66.7	15.6	62.5	37.4	67.4	52.5	67.5	73.4	44.7	43.9	76.4	35.1	43.7	19.3	56.6	44.7	37.0	36.1	43.3	60.9	44.6	21.4	15.0	54.1	57.1	63.8	18.6	21.4	54.9	30.2	50.8	67.7	79.0	30.2	89.1	54.2	95.5	52.6	94.3	68.3	186.7	99.3	56.8	101.2	45.0	87.7	62.1	64.2	80.9
CELF2	"BRUNOL3, CUGBP2, Etr-3, NAPOR-2"	ENSG00000048740	"CUGBP Elav-like family member 2"	O95319	10	10798397-11336675	"Predicted intracellular proteins"	"mRNA processing"	"Repressor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 78.9"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 558.0;Excitatory neurons: 1676.4;Inhibitory neurons: 576.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEL: 200.2;HMC-1: 186.2;REH: 86.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016395, HPA035813"	Enhanced		Supported	"Nucleoplasm,Vesicles,Midbody ring"		Yes	No			"Cluster 5: Granulocytes - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Nucleoplasm	"Vesicles, Midbody ring"	"CAB016395: AB_2086271, HPA035813: AB_2674797"	"unprognostic (1.62e-2)"	"unprognostic (1.52e-2)"	"unprognostic (1.90e-2)"	"unprognostic (3.55e-2)"	"unprognostic (9.00e-2)"	"prognostic favorable (7.61e-4)"	"unprognostic (1.57e-1)"	"unprognostic (3.77e-2)"	"unprognostic (4.20e-2)"	"unprognostic (5.22e-2)"	"unprognostic (2.60e-3)"	"unprognostic (2.83e-2)"	"unprognostic (2.14e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.84e-1)"	"unprognostic (2.31e-2)"	"unprognostic (1.45e-1)"	39.6	5.7	33.7	30.7	42.7	78.9	17.7	0.2	42.0	14.2	0.0	16.5	9.2	15.0	5.0	21.4	13.3	17.2	37.5	42.5	7.2	3.0	4.3	28.2	42.4	0.9	13.9	46.8	4.4	3.5	6.5	8.6	0.4	14.1	17.9	35.4	9.6	12.2	17.6	8.6	23.4	23.2	8.6	31.1	10.3	7.6	23.7	60.7	8.5	15.0	29.4	16.2	8.0	21.0	0.1	0.0	47.6	0.0	7.4	2.7	5.3	7.0	0.2	1.1	0.2	0.1	0.0	0.1	5.3	6.1	0.0	0.1	6.8	0.2	0.4	40.4	11.9	200.2	0.7	0.0	1.7	58.0	186.2	3.0	0.3	0.4	0.0	0.7	6.7	70.6	9.3	80.7	59.6	0.0	71.9	42.0	19.3	0.0	0.0	86.7	50.8	18.0	3.4	0.0	7.1	0.5	0.1	0.2	51.1	15.2	0.0	39.0	0.1	8.9	2.5	29.9	0.1	30.7	30.1	9.3	2.9	68.8	21.6	68.0	43.2	90.8	54.8	57.5	69.2	48.1	54.1	60.5	53.4	51.0	56.1	52.7	115.1	73.5	67.8	37.9	60.9	63.5	33.7	42.7	0.2	42.0	42.5	7.2	0.9	13.9	0.4	8.6	23.7	21.0	20.4	160.3	147.3	558.0	165.6	19.9	3.4	5.8	12.5	68.2	18.8	13.7	122.7	5.7	22.4	12.9	102.2	1.1	233.5	11.8	15.6	1.6	135.9	5.3	11.3	34.7	59.3	45.2	1676.4	2.1	0.9	106.0	11.2	17.0	128.5	0.7	13.2	5.1	90.0	134.6	576.9	37.5	24.4	261.4	134.3	110.3	111.6	192.9	115.6	376.6	263.6	90.5	256.4	324.7	21.6	1.5	16.9	89.5	124.3	10.1	2.4	1.0	5.8	99.2	52.6	117.6	33.7	4.1	11.5	5.7	14.5	1.9	232.5	8.5	23.8	2.4
CELF4	BRUNOL4	ENSG00000101489	"CUGBP Elav-like family member 4"	Q9BZC1	18	37243040-37565827	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Activator, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"brain: 122.2"	"Group enriched"	"Detected in many"	4	"Bipolar cells: 126.4;Excitatory neurons: 197.7;Horizontal cells: 294.4;Inhibitory neurons: 197.5"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	10	"SCLC-21H: 46.7;SH-SY5Y: 11.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA013322, HPA037986"	Enhanced		Supported	Nucleoplasm		NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 62: Horizontal cells - Visual perception"	Nucleoplasm		"HPA013322: , HPA037986: AB_10673035"	"unprognostic (7.87e-3)"	"unprognostic (2.31e-2)"	"unprognostic (4.31e-3)"	"unprognostic (3.42e-7)"	"unprognostic (2.95e-2)"	"unprognostic (2.95e-2)"	"unprognostic (3.72e-3)"	"unprognostic (2.06e-1)"	"unprognostic (2.74e-1)"	"unprognostic (2.87e-3)"	"unprognostic (1.92e-2)"	"unprognostic (1.00e-2)"	"unprognostic (3.49e-1)"	"unprognostic (1.69e-2)"	"unprognostic (2.48e-1)"	"unprognostic (8.32e-3)"	"unprognostic (6.13e-2)"	0.6	11.5	102.9	1.1	104.8	0.3	0.4	59.5	122.2	0.3	11.1	1.9	0.8	0.4	0.6	0.5	0.4	1.2	1.0	96.4	81.2	1.5	0.3	0.6	0.8	58.3	69.7	1.3	3.9	0.3	28.4	0.8	71.4	0.8	0.4	21.4	1.7	0.2	11.0	1.3	1.2	0.5	34.6	1.1	1.7	3.6	57.4	0.0	1.5	0.2	0.1	0.2	0.5	94.4	0.1	0.1	0.7	0.6	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.5	0.3	1.0	0.0	0.2	0.6	0.1	0.0	0.0	0.8	0.4	0.0	1.8	0.4	0.0	0.0	0.2	0.1	0.1	0.0	0.1	0.0	0.1	0.4	0.1	0.8	0.0	0.3	0.1	0.5	1.7	0.0	0.3	0.1	0.0	2.1	0.0	0.1	46.7	11.7	1.1	0.3	0.1	0.3	0.2	0.1	0.0	1.4	0.7	0.3	0.2	2.9	0.5	0.1	0.2	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	102.9	104.8	59.5	122.2	96.4	81.2	58.3	69.7	71.4	34.6	57.4	94.4	0.2	0.0	0.0	22.5	0.8	0.4	1.4	0.9	0.0	126.4	0.4	0.5	1.9	0.0	0.3	0.0	41.7	0.3	0.1	0.2	0.0	0.4	46.9	0.7	0.9	4.1	12.7	0.0	197.7	1.1	0.3	1.2	2.0	1.2	0.0	1.8	0.7	0.0	8.6	294.4	197.5	2.5	6.1	0.0	0.0	22.6	0.6	0.3	0.0	14.0	0.0	7.3	0.0	19.1	12.3	2.6	0.2	5.3	0.0	2.7	4.4	6.7	0.3	22.0	0.0	4.3	8.2	12.6	7.6	0.0	0.6	0.3	0.3	1.5	3.5	1.2
CENPA	"CenH3, CENP-A"	ENSG00000115163	"Centromere protein A"	P49450	2	26764289-26801067	"Predicted intracellular proteins"	"Cell cycle, Cell division, Host-virus interaction, Mitosis"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 13.3"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 45.0;Extravillous trophoblasts: 33.2;Granulosa cells: 24.2;Plasma cells: 17.8;Spermatogonia: 28.6"	"Cancer enhanced"	"Detected in many"		"testis cancer: 24.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"CAB008371, HPA073086"	Enhanced		Supported	Nucleoplasm		NA	Yes				"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"CAB008371: AB_591074, HPA073086: AB_2686569"	"unprognostic (3.94e-2)"	"unprognostic (1.38e-1)"	"unprognostic (2.29e-2)"	"prognostic unfavorable (2.38e-4)"	"unprognostic (1.13e-1)"	"unprognostic (2.89e-2)"	"prognostic unfavorable (2.88e-8)"	"prognostic unfavorable (3.70e-4)"	"unprognostic (1.69e-3)"	"unprognostic (7.80e-2)"	"prognostic unfavorable (1.30e-4)"	"unprognostic (4.21e-3)"	"unprognostic (0.00e+0)"	"unprognostic (5.74e-2)"	"unprognostic (1.33e-1)"	"unprognostic (7.68e-2)"	"unprognostic (2.07e-1)"	0.2	0.3	0.0	4.0	0.0	3.7	0.4	0.1	0.1	0.5	0.0	2.9	4.1	0.7	0.0	3.7	0.1	0.1	0.2	0.0	0.0	0.1	0.2	0.4	7.3	0.0	0.0	0.1	0.1	0.0	0.0	1.5	0.0	0.1	2.6	0.0	0.6	0.0	0.0	3.6	2.9	0.9	0.0	2.0	1.6	2.2	0.1	13.3	0.1	0.0	8.4	0.7	1.1	0.0	86.4	21.0	34.9	19.3	2.4	4.5	24.3	26.2	22.2	37.3	31.5	15.4	30.0	25.7	16.2	10.4	45.7	25.6	28.9	15.3	37.7	77.3	25.6	44.0	11.0	28.6	0.8	26.7	49.0	0.4	1.6	16.1	24.4	6.7	22.1	33.7	36.7	58.5	32.5	30.1	39.0	42.2	26.6	35.3	34.3	45.4	53.6	30.8	17.5	5.5	27.5	26.7	25.7	32.7	23.6	12.9	18.2	27.2	12.6	23.9	54.2	27.9	46.4	51.5	53.5	107.3	11.1	54.7	46.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.0	0.0	0.0	0.0	5.2	6.2	0.7	1.9	1.8	0.0	2.0	2.5	2.7	0.0	0.5	0.0	0.0	15.3	1.0	2.3	0.0	0.5	0.6	1.6	1.6	1.5	4.2	45.0	0.1	0.2	33.2	4.9	2.6	3.0	0.0	24.2	3.9	0.6	15.7	0.0	0.1	6.6	0.0	2.9	2.8	0.1	0.9	4.4	1.8	0.0	0.0	0.0	1.0	0.0	0.0	0.1	1.4	0.0	17.8	2.1	0.8	0.2	0.1	0.0	0.0	0.6	3.9	16.1	28.6	12.5	5.3	3.4	3.4	1.5	11.1	2.0
CENPC	"CENP-C, CENPC1, hcp-4, MIF2"	ENSG00000145241	"Centromere protein C"	Q03188	4	67468762-67545503	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049740, HPA058252"			Supported	"Nucleoplasm,Nuclear bodies,Kinetochore,Midbody"		Yes	Yes			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 21: Non-specific - Transcription"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 24: Non-specific - Transcription regulation"	"Nuclear bodies, Kinetochore"	"Nucleoplasm, Midbody"	"HPA049740: , HPA058252: AB_2683654"	"unprognostic (4.35e-1)"	"unprognostic (6.41e-3)"	"unprognostic (4.31e-3)"	"unprognostic (7.85e-2)"	"unprognostic (6.31e-2)"	"unprognostic (3.85e-3)"	"unprognostic (6.40e-2)"	"prognostic favorable (9.67e-4)"	"unprognostic (3.22e-2)"	"unprognostic (7.13e-2)"	"unprognostic (8.35e-2)"	"unprognostic (4.32e-2)"	"prognostic favorable (5.63e-4)"	"unprognostic (2.40e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.92e-3)"	1.5	1.6	2.5	1.0	3.2	3.6	3.3	5.6	2.6	2.8	0.2	2.0	1.1	3.1	2.3	1.5	2.9	1.1	1.5	2.2	2.0	2.0	1.4	1.5	1.8	1.3	1.8	5.6	3.8	1.5	2.5	1.3	1.7	2.9	1.2	2.7	2.0	1.6	1.1	2.3	1.8	1.5	1.3	2.0	2.1	1.7	1.7	2.0	3.1	1.1	1.5	2.0	2.3	2.8	0.4	0.5	1.6	0.9	1.9	1.1	0.9	0.6	0.5	0.7	0.5	0.7	1.3	2.7	0.8	0.8	0.2	0.8	2.2	0.9	1.2	0.8	0.4	2.1	0.9	0.9	0.6	3.9	0.8	1.4	0.3	0.5	1.3	1.2	0.4	1.8	3.0	1.6	1.1	0.7	5.3	3.5	1.8	0.8	0.3	2.4	4.0	0.9	1.0	0.8	2.8	1.3	1.2	2.5	0.7	1.6	0.7	1.3	0.4	1.0	0.5	0.7	0.5	1.3	0.5	2.7	1.1	2.2	0.6	0.5	0.2	0.5	0.7	0.4	0.3	0.8	0.8	0.9	0.2	1.1	1.2	0.9	0.2	0.5	0.2	0.4	0.4	0.2	2.5	3.2	5.6	2.6	2.2	2.0	1.3	1.8	1.7	1.3	1.7	2.8	53.1	32.1	35.5	38.8	68.4	15.2	25.3	17.7	35.9	53.7	26.0	32.3	24.3	18.6	31.6	16.5	14.6	20.2	75.0	17.7	11.7	13.5	4.1	21.0	39.0	33.7	13.1	31.7	58.5	16.7	12.9	41.3	35.7	25.1	26.6	39.8	23.2	14.1	12.8	52.2	57.0	18.4	18.3	16.7	7.9	5.5	34.8	26.7	16.0	31.9	27.4	31.6	60.8	46.3	74.6	14.6	13.0	25.6	89.1	15.3	24.2	20.4	27.2	29.0	19.7	54.1	34.2	47.2	44.4	34.7	9.2	18.3	69.8	43.3	16.4	23.9
CENPE	"KIF10, PPP1R61"	ENSG00000138778	"Centromere protein E"	Q02224	4	103105349-103198445	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	"Developmental protein, Motor protein"	"Disease variant, Primary microcephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 10.0;lymphoid tissue: 9.2"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 75.1;Extravillous trophoblasts: 28.4;Granulosa cells: 32.0;Spermatocytes: 75.3;Spermatogonia: 51.0"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in some"		"basophil: 2.9"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA011110, HPA042294"	Enhanced		Enhanced	"Microtubules,Cytokinetic bridge,Mitotic spindle"		Yes	Yes			"Cluster 46: Basophils - DNA binding"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Microtubules	"Cytokinetic bridge, Mitotic spindle"	"HPA011110: , HPA042294: AB_10797386"	"unprognostic (1.62e-1)"	"unprognostic (1.03e-1)"	"unprognostic (5.64e-3)"	"unprognostic (2.55e-2)"	"unprognostic (1.65e-1)"	"unprognostic (3.44e-2)"	"unprognostic (2.40e-8)"	"unprognostic (2.49e-3)"	"unprognostic (1.59e-2)"	"unprognostic (3.38e-1)"	"unprognostic (4.88e-5)"	"unprognostic (1.15e-2)"	"unprognostic (0.00e+0)"	"unprognostic (9.95e-3)"	"unprognostic (2.49e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.37e-1)"	0.4	0.2	0.4	2.7	0.4	10.0	0.6	0.3	0.5	0.4	0.4	1.8	1.5	0.6	0.0	2.0	0.2	0.8	0.2	0.3	0.6	0.2	0.5	0.8	5.6	0.5	0.5	0.1	0.1	0.3	0.0	1.4	0.9	0.3	2.0	0.4	0.3	0.2	0.0	2.0	1.7	1.1	0.3	1.2	1.1	4.1	0.5	9.2	0.2	0.6	4.9	0.8	0.6	0.5	42.6	11.8	42.2	20.5	2.7	6.2	8.4	36.7	18.2	26.9	17.9	19.6	22.2	28.6	9.2	13.7	19.2	18.2	30.3	15.1	42.2	35.9	11.3	33.5	26.8	13.6	0.4	39.9	18.6	1.8	1.1	21.7	18.0	6.0	22.9	25.2	34.4	32.5	34.8	15.6	31.5	18.9	13.8	17.0	17.9	20.9	38.5	9.3	8.0	8.4	19.3	11.5	32.9	22.9	9.0	16.0	12.9	13.9	26.1	25.8	27.2	27.2	38.6	15.9	28.6	28.8	14.2	21.7	27.8	2.9	0.0	0.3	0.0	0.2	0.0	0.2	0.2	0.1	0.1	0.0	0.0	0.1	0.0	0.3	1.5	0.2	0.6	0.0	0.4	0.4	0.3	0.5	0.3	0.6	0.5	0.5	0.9	0.3	0.5	0.5	1.4	3.2	2.2	1.0	6.6	3.6	1.5	2.9	0.0	7.6	1.8	2.7	1.9	0.0	1.3	0.0	8.4	12.7	3.9	4.7	0.0	0.5	7.7	3.5	5.7	4.2	1.2	75.1	2.0	0.0	28.4	6.5	4.6	6.9	7.0	32.0	4.2	0.9	14.1	0.0	1.9	4.3	4.1	10.4	5.7	3.5	0.9	9.6	0.0	0.0	6.0	1.3	2.1	0.5	3.1	1.8	1.4	2.6	16.0	1.4	0.8	0.3	0.3	2.6	0.0	5.7	7.4	75.3	51.0	8.3	2.8	3.6	6.6	7.0	11.6	1.9
CENPF	hcp-1	ENSG00000117724	"Centromere protein F"	P49454	1	214603195-214664571	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Differentiation, DNA synthesis, Mitosis, Myogenesis"	"Developmental protein"	"Cancer-related genes, Ciliopathy, Primary ciliary dyskinesia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 28.8;lymphoid tissue: 33.0"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 84.4;Erythroid cells: 268.7;Extravillous trophoblasts: 78.8;Granulosa cells: 165.8;Spermatocytes: 107.5;Spermatogonia: 107.1"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in single"			"HPA052382, HPA064308, CAB070134"	Enhanced		Supported	Nucleoplasm		Yes	Yes				"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"CAB070134: AB_2229328, HPA052382: AB_2681808, HPA064308: AB_2732711"	"unprognostic (2.80e-1)"	"unprognostic (2.16e-1)"	"unprognostic (2.65e-1)"	"unprognostic (5.30e-2)"	"unprognostic (1.73e-1)"	"unprognostic (2.40e-2)"	"prognostic unfavorable (2.29e-5)"	"unprognostic (1.13e-2)"	"unprognostic (2.58e-3)"	"unprognostic (1.11e-1)"	"prognostic unfavorable (1.39e-4)"	"unprognostic (1.58e-1)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (3.92e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.89e-2)"	"unprognostic (4.12e-1)"	0.8	1.1	0.1	4.4	0.1	28.8	1.8	0.0	0.3	1.3	0.5	5.8	6.1	1.8	0.1	8.6	0.6	0.7	0.4	0.3	0.0	0.4	0.9	0.9	8.5	0.3	0.5	0.7	0.3	0.2	0.1	3.1	0.3	0.5	5.7	1.0	1.4	0.1	0.2	6.2	4.3	2.5	0.2	2.4	2.6	10.5	0.5	33.0	0.4	0.6	10.0	1.4	2.6	0.3	123.7	68.4	144.3	75.8	5.4	7.2	56.3	74.6	30.3	43.9	42.8	54.6	74.1	116.3	43.1	41.7	39.8	74.7	89.9	49.2	74.1	102.6	56.6	96.0	111.4	78.6	0.8	137.0	50.5	2.7	3.8	63.3	72.3	12.7	46.9	52.6	88.4	68.0	79.4	47.0	81.5	54.3	127.9	36.8	30.0	85.7	203.7	38.6	43.2	30.3	67.4	91.2	100.7	66.2	38.9	76.2	79.1	51.9	61.7	78.9	92.2	66.2	155.9	51.6	60.7	108.7	34.4	96.7	71.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.3	0.1	0.0	0.1	0.0	0.0	0.3	0.0	0.1	0.1	0.0	0.3	0.3	0.0	0.3	0.5	0.3	0.2	0.5	0.3	3.0	0.0	3.1	0.0	11.5	9.3	2.8	11.2	3.4	4.7	10.0	6.7	1.9	1.5	9.9	0.0	0.0	53.3	10.8	19.1	0.0	2.0	84.4	30.1	19.3	12.4	0.0	268.7	1.3	0.4	78.8	19.0	32.1	25.2	1.3	165.8	8.9	2.6	32.2	1.7	0.8	20.1	14.2	16.6	6.6	19.8	1.2	16.2	1.8	1.0	0.7	1.4	5.2	0.0	0.1	0.5	1.1	3.0	25.9	2.3	2.1	0.1	16.7	3.1	0.0	8.3	23.9	107.5	107.1	44.6	5.5	5.1	23.3	11.7	41.3	3.7
CENPH		ENSG00000153044	"Centromere protein H"	Q9H3R5	5	69189574-69210357	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 33.8;testis: 29.7"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 74.5;Spermatocytes: 222.7;Spermatogonia: 222.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			HPA036494	Approved		Supported	"Nucleoplasm,Nucleoli rim,Mitotic chromosome"		Yes	No			"Cluster 15: NK-cells - Transcription"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Nucleoplasm, Nucleoli rim"	"Mitotic chromosome"	"HPA036494: AB_10673354"	"unprognostic (1.49e-1)"	"prognostic favorable (6.86e-4)"	"unprognostic (1.73e-2)"	"unprognostic (3.16e-2)"	"unprognostic (2.32e-1)"	"unprognostic (3.87e-2)"	"prognostic unfavorable (5.22e-5)"	"unprognostic (6.14e-3)"	"unprognostic (6.85e-2)"	"prognostic favorable (2.50e-4)"	"unprognostic (4.21e-2)"	"unprognostic (8.80e-2)"	"prognostic unfavorable (5.11e-15)"	"unprognostic (1.17e-1)"	"unprognostic (3.94e-1)"	"unprognostic (2.58e-1)"	"unprognostic (2.20e-1)"	4.2	2.0	1.4	7.5	1.7	33.8	7.7	1.7	2.0	3.9	1.0	7.4	6.5	4.5	2.1	7.5	4.0	1.8	4.0	1.5	1.6	1.6	3.6	2.8	17.7	1.6	1.5	3.9	1.5	2.0	1.4	5.2	1.6	3.3	8.1	2.5	2.9	2.3	4.0	9.2	5.9	3.7	1.4	5.2	3.7	29.7	1.6	18.5	2.5	4.0	18.8	3.8	4.4	2.2	64.6	19.4	88.6	70.2	5.8	18.3	48.0	31.2	32.6	66.9	71.8	26.5	79.6	138.9	36.6	18.1	39.1	47.0	59.0	70.4	85.1	42.7	41.4	32.7	32.5	26.4	2.0	47.1	32.1	7.1	14.6	43.6	47.7	18.9	23.2	73.7	58.7	53.3	52.2	35.6	152.4	67.3	78.1	20.7	17.0	93.2	118.2	108.2	21.1	22.9	61.6	81.9	34.6	22.8	27.5	47.7	31.9	31.4	11.4	33.4	56.1	44.5	78.7	65.5	106.3	111.8	51.1	94.2	64.7	1.0	2.0	3.0	4.7	3.5	7.7	13.3	7.9	6.0	3.1	14.1	9.9	8.6	0.4	8.6	4.2	6.7	9.7	4.8	1.4	1.7	1.7	2.0	1.5	1.6	1.6	1.5	1.6	1.4	1.6	2.2	4.8	0.0	2.6	1.0	18.3	36.7	17.7	17.4	9.6	3.4	10.8	11.7	3.3	4.3	7.1	0.0	0.0	37.4	9.2	5.1	0.0	12.3	26.5	5.5	5.1	6.9	1.2	74.5	1.3	9.1	49.0	7.4	2.6	4.8	5.1	22.4	4.6	1.1	17.0	0.0	1.1	9.5	12.2	7.5	18.2	22.5	3.7	6.3	8.8	1.0	4.3	7.3	6.2	1.0	0.9	7.0	2.5	4.9	14.4	6.9	1.4	3.4	10.8	3.5	19.7	6.4	9.3	222.7	222.8	12.1	19.2	10.0	12.0	6.9	15.9	15.2
CENPI	"CENP-I, FSHPRH1, LRPR1, Mis6"	ENSG00000102384	"Centromere protein I"	Q92674	X	101098218-101163681	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 6.8;lymphoid tissue: 7.1"	"Cell type enhanced"	"Detected in some"		"Erythroid cells: 4.8;Excitatory neurons: 2.9;Extravillous trophoblasts: 4.7;Granulosa cells: 3.2;Oligodendrocytes: 3.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA061297			Supported	"Nuclear bodies,Cytosol"		NA	Yes			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 12: Non-specific - Cell cycle regulation"	"Nuclear bodies"	Cytosol	"HPA061297: AB_2684471"	"unprognostic (3.10e-3)"	"unprognostic (9.71e-2)"	"unprognostic (1.86e-2)"	"unprognostic (3.51e-3)"	"unprognostic (1.24e-1)"	"unprognostic (2.46e-2)"	"unprognostic (5.78e-6)"	"unprognostic (2.96e-2)"	"unprognostic (7.71e-3)"	"unprognostic (3.62e-3)"	"unprognostic (1.20e-3)"	"unprognostic (4.51e-2)"	"unprognostic (2.50e-13)"	"unprognostic (1.25e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.42e-1)"	1.1	0.6	0.9	3.1	1.0	6.8	1.2	2.0	1.0	1.0	0.5	2.7	2.8	1.8	1.4	2.6	0.6	1.4	0.5	1.1	1.1	0.4	0.8	1.0	5.4	1.4	0.6	2.3	0.9	0.2	0.0	2.5	1.4	1.2	3.5	1.8	0.5	0.6	0.2	3.2	2.3	2.7	0.1	1.6	1.5	1.2	1.0	7.1	0.8	0.6	6.3	1.4	0.8	2.9	44.9	30.3	36.6	28.1	4.6	8.2	16.4	47.5	25.2	47.1	94.5	40.9	28.0	32.7	16.5	18.8	72.5	25.7	54.2	25.3	65.4	20.6	13.8	20.2	43.5	15.6	0.5	26.8	21.2	3.3	2.2	62.5	7.7	13.5	40.7	23.3	14.5	58.3	46.1	31.5	26.7	9.8	28.3	21.2	36.8	24.7	53.0	21.0	11.8	26.4	23.4	12.3	58.1	16.3	9.6	33.0	16.2	8.6	16.7	44.0	36.6	41.2	38.3	9.1	23.3	36.5	17.3	35.2	34.7	0.7	0.5	0.6	0.4	0.7	0.3	0.6	0.4	0.6	0.2	0.4	0.4	0.4	1.1	0.7	0.7	0.7	0.8	0.3	0.9	1.0	2.0	1.0	1.1	1.1	1.4	0.6	1.4	0.1	1.0	2.9	0.5	0.0	0.0	2.3	0.9	0.3	0.1	0.6	0.0	0.5	0.4	0.3	0.4	0.0	0.7	0.0	0.0	1.9	0.5	0.8	0.0	0.2	0.2	0.4	0.8	0.5	0.0	4.8	2.9	0.0	4.7	0.6	0.0	0.6	0.0	3.2	0.7	0.2	1.4	0.0	2.3	0.7	0.0	0.6	0.8	0.0	0.3	0.3	0.0	1.0	0.6	0.5	0.0	1.5	3.3	0.1	0.0	0.0	0.7	0.2	0.1	0.0	0.1	0.3	0.0	0.7	1.0	0.3	0.9	1.4	0.1	0.3	0.4	0.8	1.4	0.2
CENPJ	"BM032, CPAP, LAP, LIP1, MCPH6, Sas-4, SASS4, SCKL4"	ENSG00000151849	"Centromere protein J"	Q9HC77	13	24882279-24922889	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Disease variant, Dwarfism, Mental retardation, Primary microcephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 16.3"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 135.8;Spermatocytes: 63.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HEL: 34.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA076638			Supported	Centrosome		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 36: HEL - Hemostasis"	"Cluster 29: Early spermatids - Spermatogenesis"	Centrosome		"HPA076638: "	"unprognostic (2.69e-1)"	"unprognostic (3.17e-1)"	"unprognostic (2.68e-1)"	"unprognostic (1.01e-2)"	"unprognostic (9.39e-2)"	"unprognostic (1.17e-2)"	"unprognostic (2.15e-5)"	"unprognostic (7.41e-2)"	"unprognostic (1.50e-2)"	"unprognostic (9.83e-2)"	"unprognostic (2.44e-1)"	"unprognostic (3.48e-2)"	"prognostic unfavorable (1.75e-5)"	"unprognostic (7.36e-2)"	"unprognostic (5.51e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.13e-1)"	2.6	1.3	1.3	2.4	1.7	4.4	3.3	4.2	3.3	3.7	0.2	3.5	4.2	4.1	2.3	2.2	3.5	1.6	1.6	1.4	1.2	1.2	1.5	2.4	5.0	1.5	1.3	3.5	1.1	0.9	0.7	3.7	1.7	2.4	4.3	1.8	1.5	1.7	2.2	5.0	3.6	3.9	1.0	2.5	2.1	16.3	1.6	3.5	11.0	1.6	4.1	3.3	2.4	1.6	4.5	3.9	14.9	16.4	2.4	3.5	9.0	11.5	5.5	5.5	5.1	8.0	8.3	8.9	3.5	3.1	4.4	12.9	11.4	6.8	11.2	7.9	7.2	34.0	13.1	6.7	0.9	15.3	10.2	1.0	2.5	5.1	4.1	3.1	5.9	7.3	8.3	13.5	8.8	7.7	8.4	23.8	10.2	13.3	5.9	11.3	10.0	4.4	3.1	7.6	8.5	7.5	5.3	6.9	4.8	12.1	2.9	9.4	4.3	8.8	5.6	12.9	7.2	4.9	8.3	8.4	4.3	11.6	10.8	0.0	0.0	0.5	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.1	0.0	1.3	1.7	4.2	3.3	1.4	1.2	1.5	1.3	1.7	1.0	1.6	1.6	7.5	3.2	10.5	6.2	6.7	2.0	4.3	5.8	5.7	8.0	3.8	5.2	6.9	1.5	9.1	3.7	4.2	8.5	7.0	10.8	0.0	2.6	135.8	7.0	13.6	6.3	0.0	17.9	20.1	2.9	14.9	8.4	2.6	13.2	5.1	21.3	2.2	1.4	4.3	3.3	18.4	3.7	2.0	1.6	3.5	24.7	6.5	5.9	0.0	8.4	6.6	3.4	4.1	16.6	13.8	1.9	6.9	5.7	12.6	2.3	8.2	1.1	6.1	2.3	6.6	8.6	10.3	63.5	36.3	5.4	1.3	2.9	6.1	5.2	5.6	2.3
CENPN	"BM039, C16orf60, FLJ13607, FLJ22660"	ENSG00000166451	"Centromere protein N"	Q96H22	16	81006552-81033114	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 37.4"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 64.2;Extravillous trophoblasts: 91.1;Spermatocytes: 52.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA052870			Supported	Nucleoplasm		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"HPA052870: AB_2681978"	"unprognostic (1.23e-2)"	"unprognostic (2.40e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.76e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.76e-2)"	"unprognostic (3.69e-3)"	"prognostic unfavorable (6.49e-4)"	"unprognostic (1.90e-1)"	"unprognostic (2.36e-3)"	"prognostic unfavorable (1.46e-5)"	"unprognostic (3.02e-2)"	"prognostic unfavorable (4.86e-4)"	"unprognostic (2.34e-2)"	"unprognostic (7.42e-2)"	"unprognostic (1.41e-2)"	"unprognostic (7.99e-2)"	5.1	5.0	3.2	7.9	4.0	37.4	3.6	3.1	4.9	2.8	2.1	8.0	7.8	2.3	3.1	7.5	1.6	3.1	5.7	3.3	3.1	5.4	9.0	3.3	11.0	3.8	4.0	1.5	5.2	8.6	1.6	8.9	3.4	18.7	7.6	1.4	2.5	2.7	4.5	3.8	6.4	6.4	2.7	4.3	5.2	11.2	3.9	18.1	2.8	2.6	12.0	6.0	2.8	5.8	86.2	81.0	64.9	58.4	16.9	15.1	82.6	97.5	59.3	137.0	59.6	150.8	64.6	48.1	52.4	48.9	62.7	69.9	53.1	61.5	172.9	29.3	47.9	43.0	63.3	100.9	9.6	64.6	80.4	14.0	6.6	123.3	40.8	18.0	62.6	59.1	83.6	65.9	66.9	160.1	78.0	79.6	69.7	37.2	45.4	90.9	64.5	51.3	22.5	58.6	43.2	38.9	140.3	31.8	40.1	38.9	76.2	34.0	38.5	97.7	101.1	66.8	96.8	46.4	112.1	186.8	45.8	43.7	85.8	0.9	1.4	2.4	2.1	2.8	2.0	1.6	2.7	1.5	6.6	5.9	1.3	1.5	1.7	3.6	3.1	2.2	7.9	2.0	3.2	4.0	3.1	4.9	3.3	3.1	3.8	4.0	3.4	2.7	3.9	5.8	2.8	0.0	4.8	1.0	10.2	24.0	15.7	9.6	14.8	1.0	6.0	7.0	4.8	5.7	5.8	3.7	0.0	47.1	10.0	7.4	0.0	5.7	41.8	4.5	3.8	5.8	1.2	64.2	1.9	6.5	91.1	9.7	11.7	6.4	6.3	13.2	6.8	6.3	27.2	0.0	1.1	12.8	12.2	9.7	20.2	40.9	2.8	10.4	7.2	1.0	4.4	0.8	0.0	0.5	6.1	5.1	4.0	3.4	34.7	13.6	5.1	8.8	1.8	0.4	0.0	7.1	10.0	52.3	39.1	32.7	16.3	27.2	10.9	6.3	22.0	16.6
CENPO	"CENP-O, MGC11266"	ENSG00000138092	"Centromere protein O"	Q9BU64	2	24793136-24822376	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Erythroid cells: 11.2;Extravillous trophoblasts: 11.5;Spermatocytes: 11.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA046189			Supported	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	"Nuclear bodies"	"HPA046189: AB_2679579"	"unprognostic (1.67e-2)"	"unprognostic (2.42e-1)"	"unprognostic (1.98e-2)"	"prognostic unfavorable (3.54e-4)"	"unprognostic (1.79e-1)"	"unprognostic (7.48e-3)"	"prognostic unfavorable (1.73e-6)"	"unprognostic (5.56e-2)"	"unprognostic (4.02e-1)"	"unprognostic (4.81e-2)"	"unprognostic (5.93e-2)"	"unprognostic (1.63e-2)"	"prognostic unfavorable (5.71e-13)"	"unprognostic (4.23e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.96e-1)"	5.2	4.0	3.5	3.5	3.3	9.2	4.6	2.9	4.1	4.0	2.3	3.3	3.2	3.1	0.8	4.5	3.0	1.5	2.8	3.7	3.5	2.9	2.6	3.6	4.9	3.7	3.4	4.5	1.9	1.6	3.6	3.2	3.5	3.1	3.7	1.4	2.5	1.1	3.0	3.8	3.9	2.2	3.2	4.3	2.7	8.3	3.8	11.4	3.4	2.0	5.8	2.5	3.7	3.1	31.1	36.4	40.7	21.7	4.8	7.3	22.7	36.8	21.7	51.0	38.7	46.2	15.5	21.4	4.2	22.8	29.8	16.3	40.6	14.0	34.1	28.1	21.1	34.3	23.9	31.0	2.4	28.7	24.4	3.6	2.5	51.5	11.4	9.3	24.0	25.4	40.3	23.8	31.8	21.8	39.2	20.6	29.3	21.0	22.8	31.0	53.4	11.5	12.9	18.6	27.0	29.3	22.1	16.9	7.9	18.5	16.3	11.8	15.4	46.9	42.8	15.9	41.6	14.5	20.1	42.8	14.5	27.5	36.4	0.0	0.3	0.0	1.0	0.2	0.4	0.4	0.4	0.5	0.4	0.3	0.3	0.7	0.1	0.7	0.3	1.1	0.7	0.3	3.5	3.3	2.9	4.1	3.7	3.5	3.7	3.4	3.5	3.2	3.8	3.1	0.7	3.2	2.2	4.2	1.5	1.1	0.7	1.3	2.2	0.9	1.9	1.4	6.5	0.0	1.2	3.7	0.0	3.9	1.9	3.0	1.9	1.5	3.9	1.5	2.2	2.0	0.0	11.2	5.3	1.3	11.5	2.4	6.6	1.5	1.3	6.5	1.8	0.9	4.9	1.7	4.9	1.6	0.0	1.6	1.1	9.6	0.3	1.1	1.8	3.7	1.2	1.6	1.0	2.0	2.5	1.1	0.5	1.2	8.6	0.5	1.8	1.7	0.7	0.7	0.0	1.1	3.3	11.7	9.5	3.3	1.4	2.9	1.4	2.8	2.7	0.9
CENPP	"CENP-P, RP11-19J3.3"	ENSG00000188312	"Centromere protein P"	Q6IPU0	9	92325953-92620529	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skin 1: 21.4"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 63.3;Excitatory neurons: 73.4;Inhibitory neurons: 70.5;Microglial cells: 94.6;Oligodendrocytes: 74.5;Suprabasal keratinocytes: 100.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021787, HPA058945"	Uncertain		Supported	Nucleoplasm,Nucleoli		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 28: Keratinocytes - Keratinization"	Nucleoplasm	Nucleoli	"HPA021787: AB_1846524, HPA058945: AB_2683860"	"unprognostic (5.48e-2)"	"prognostic favorable (3.91e-4)"	"unprognostic (1.20e-1)"	"unprognostic (2.43e-3)"	"unprognostic (2.64e-2)"	"prognostic favorable (3.65e-4)"	"unprognostic (4.88e-5)"	"unprognostic (8.06e-2)"	"unprognostic (3.51e-3)"	"unprognostic (1.49e-1)"	"unprognostic (1.32e-1)"	"unprognostic (6.68e-3)"	"unprognostic (9.20e-8)"	"unprognostic (1.27e-2)"	"unprognostic (5.12e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.04e-1)"	3.4	3.0	1.7	3.5	2.1	12.3	3.0	5.6	2.1	3.8	0.8	2.4	2.8	2.9	0.7	4.4	2.0	2.8	2.8	2.0	1.5	2.0	1.8	1.9	5.6	1.7	1.4	2.2	2.1	2.4	1.8	3.1	2.0	2.3	2.7	2.4	2.2	1.5	9.0	21.4	1.9	3.0	1.0	2.7	1.8	4.5	1.8	7.1	1.4	4.5	6.4	2.3	4.0	1.8	14.2	8.7	12.0	8.8	4.9	5.3	11.7	14.6	8.2	17.9	14.3	4.0	7.9	18.5	6.7	4.7	16.5	16.8	11.6	8.0	16.6	26.3	15.1	18.6	7.2	5.7	2.6	38.2	17.0	5.8	4.5	17.3	11.1	2.5	9.2	17.5	20.8	25.2	13.8	9.0	53.4	11.6	10.1	26.6	17.9	17.9	20.3	20.0	2.7	14.1	27.8	9.6	16.8	10.5	5.4	8.7	5.6	11.4	4.4	17.4	8.7	26.6	21.2	16.7	21.6	23.9	19.5	18.9	16.1	1.8	1.8	2.6	2.6	6.4	4.7	4.6	3.0	2.3	2.3	3.6	2.7	2.7	0.5	3.5	3.3	3.0	3.5	2.0	1.7	2.1	5.6	2.1	2.0	1.5	1.7	1.4	2.0	1.0	1.8	1.8	3.7	0.0	0.5	17.3	4.5	63.3	4.0	4.5	5.2	6.2	4.0	2.7	2.1	2.8	1.3	0.0	8.4	6.2	3.3	1.6	1.9	1.7	17.5	2.4	4.2	4.4	1.2	11.2	73.4	2.3	9.2	5.8	5.6	2.3	0.0	6.4	2.5	0.9	17.1	1.7	70.5	1.5	0.0	2.1	11.7	4.7	4.4	4.0	14.2	94.6	0.5	2.8	1.0	38.2	74.5	1.1	0.4	4.9	11.9	2.8	0.4	1.8	0.3	7.8	6.6	20.8	9.2	30.2	16.2	9.8	100.9	3.8	3.6	4.4	2.6	2.7
CENPT	"C16orf56, CENP-T, FLJ13111"	ENSG00000102901	"Centromere protein T"	Q96BT3	16	67828157-67847811	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	DNA-binding	Dwarfism	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 89.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041220, HPA058036"	Approved		Supported	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	"Nuclear bodies"	Nucleoplasm	"HPA041220: AB_2677367, HPA058036: AB_2683585"	"unprognostic (9.84e-2)"	"unprognostic (2.86e-2)"	"unprognostic (3.04e-2)"	"unprognostic (8.77e-2)"	"unprognostic (3.14e-2)"	"unprognostic (6.66e-3)"	"unprognostic (1.18e-2)"	"unprognostic (2.81e-1)"	"unprognostic (8.04e-2)"	"unprognostic (3.15e-2)"	"prognostic favorable (2.96e-4)"	"unprognostic (6.64e-3)"	"prognostic unfavorable (1.57e-7)"	"unprognostic (1.85e-1)"	"unprognostic (1.47e-1)"	"unprognostic (9.23e-2)"	"unprognostic (9.74e-3)"	7.0	5.6	7.2	3.1	7.1	5.3	6.4	7.4	10.0	7.9	5.7	8.1	2.4	7.0	1.4	6.6	7.3	1.8	8.0	7.4	7.8	6.3	5.3	6.3	3.6	7.5	7.3	7.7	9.6	4.9	4.3	4.2	7.6	6.5	2.0	0.8	5.8	4.3	8.2	24.8	6.3	4.7	6.8	5.5	7.4	19.6	7.3	4.4	5.1	5.6	2.3	7.3	6.9	7.2	7.6	7.4	10.0	10.2	8.1	7.8	14.7	29.5	13.6	30.2	24.1	7.9	5.6	3.3	7.1	19.8	5.3	12.4	7.5	13.2	10.3	5.3	9.5	1.2	3.2	11.3	5.1	0.6	6.9	8.5	7.7	20.7	4.4	4.4	12.3	8.1	19.3	3.6	14.5	11.9	9.8	10.7	13.5	5.9	7.1	13.4	4.5	17.6	11.2	3.1	3.9	6.8	22.2	4.6	5.8	6.3	6.1	10.0	9.7	4.3	7.4	6.6	7.0	7.0	5.8	19.4	3.3	6.1	7.4	1.4	7.2	6.3	6.5	6.6	7.0	4.9	6.0	8.2	6.0	6.1	5.3	7.0	3.4	5.4	4.3	6.0	8.5	5.1	7.2	7.1	7.4	10.0	7.4	7.8	7.5	7.3	7.6	6.8	7.3	7.2	21.0	16.0	11.3	10.4	17.4	21.0	20.2	24.4	12.5	24.9	20.3	19.3	8.2	14.3	17.2	20.2	8.4	31.5	25.4	27.5	5.9	19.0	52.2	8.8	17.8	19.7	13.1	30.3	16.9	14.2	25.0	23.0	34.1	11.2	8.2	20.9	17.5	9.4	15.2	25.2	12.3	11.3	24.4	8.5	17.8	47.9	24.2	17.9	17.8	7.5	9.8	13.7	21.6	12.1	8.4	19.7	17.8	22.2	26.9	11.1	16.3	10.3	12.2	10.5	26.3	19.9	25.1	89.8	33.5	12.8	19.5	30.1	22.6	24.3	13.7	13.6
CENPU	"CENP-50, CENP-U, KLIP1, MLF1IP, PBIP1"	ENSG00000151725	"Centromere protein U"	Q71F23	4	184694085-184734130	"Predicted intracellular proteins"	"Host-virus interaction, Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 62.6;testis: 29.5"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 489.7;Late spermatids: 900.3;Spermatocytes: 490.2;Spermatogonia: 215.1"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"basophil: 20.7;eosinophil: 14.2"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 20.7"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 157.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA022048			Supported	"Nucleoplasm,Centriolar satellite"		NA	Yes			"Cluster 2: Granulocytes - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 25: Spermatids - Spermatogenesis"	"Nucleoplasm, Centriolar satellite"		"HPA022048: AB_1853985"	"unprognostic (1.47e-1)"	"unprognostic (9.88e-2)"	"unprognostic (5.02e-2)"	"unprognostic (2.37e-1)"	"unprognostic (9.45e-2)"	"unprognostic (4.97e-2)"	"unprognostic (4.39e-3)"	"prognostic unfavorable (7.51e-4)"	"unprognostic (1.67e-3)"	"unprognostic (3.34e-2)"	"prognostic unfavorable (2.09e-4)"	"unprognostic (7.27e-2)"	"prognostic unfavorable (1.11e-9)"	"unprognostic (2.19e-2)"	"unprognostic (7.40e-3)"	"unprognostic (4.46e-2)"	"unprognostic (2.74e-1)"	1.5	1.1	0.1	5.4	0.3	62.6	5.7	0.6	0.3	2.4	0.1	7.8	5.1	1.5	0.7	10.5	0.9	1.1	1.5	0.2	0.2	0.7	3.7	1.7	16.2	0.2	0.2	0.6	1.0	1.4	0.2	4.8	0.6	1.3	8.0	1.5	2.7	0.4	0.9	15.3	5.4	2.7	0.2	2.3	3.7	29.5	0.4	12.8	1.3	0.1	13.6	2.1	3.9	0.5	57.8	17.1	67.9	35.8	4.3	6.4	37.6	40.8	19.4	32.2	21.2	24.8	32.1	45.9	3.8	18.7	20.2	23.0	52.4	33.2	30.6	23.4	23.0	50.4	17.5	12.6	0.7	71.1	29.3	2.7	2.1	33.3	8.4	9.4	32.1	53.9	44.1	157.3	51.1	38.2	111.4	53.0	33.8	12.7	21.5	74.5	24.3	15.6	17.1	26.7	52.0	49.0	31.4	39.4	23.9	25.0	44.1	50.2	20.9	23.8	31.3	23.5	39.7	26.5	29.5	37.6	37.2	55.4	94.5	20.7	0.7	14.2	0.5	2.0	0.4	0.9	0.7	0.8	0.4	0.9	0.6	0.8	0.1	3.5	2.8	1.9	2.5	0.6	0.1	0.3	0.6	0.3	0.2	0.2	0.2	0.2	0.6	0.2	0.4	0.5	1.4	9.6	3.2	0.3	6.5	13.9	6.0	11.5	3.4	0.9	11.5	7.9	2.3	4.3	8.7	1.8	0.0	31.5	5.4	8.9	3.9	4.8	489.7	9.5	4.0	3.8	0.0	115.7	0.4	2.5	48.4	7.3	9.2	6.6	8.9	27.1	1.1	0.9	21.6	0.0	0.4	10.0	10.2	5.1	7.3	900.3	9.0	15.3	0.0	1.0	5.3	0.2	4.1	0.5	1.9	3.0	1.0	6.8	28.3	2.6	0.9	0.7	5.6	1.4	19.7	2.0	7.2	490.2	215.1	29.1	21.5	7.5	6.3	4.4	18.1	11.6
CENPW	"C6orf173, CUG2"	ENSG00000203760	"Centromere protein W"	Q5EE01	6	126340115-126348875	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 50.6;testis: 39.5"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 329.7;Extravillous trophoblasts: 155.9;Spermatocytes: 148.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			HPA067285			Supported	Nucleoplasm		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"HPA067285: AB_2685818"	"unprognostic (3.51e-3)"	"unprognostic (2.35e-1)"	"unprognostic (3.26e-3)"	"unprognostic (9.61e-3)"	"unprognostic (3.78e-1)"	"unprognostic (9.80e-3)"	"prognostic unfavorable (1.21e-5)"	"unprognostic (1.11e-2)"	"unprognostic (2.82e-2)"	"unprognostic (9.07e-2)"	"unprognostic (5.86e-3)"	"unprognostic (1.08e-1)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (1.07e-1)"	"unprognostic (1.85e-1)"	"unprognostic (2.30e-1)"	"unprognostic (1.22e-1)"	8.2	4.3	2.5	12.8	2.3	50.6	6.6	2.0	3.5	14.4	1.4	15.0	8.3	21.6	7.0	23.1	9.2	5.4	1.7	4.2	2.0	3.4	3.6	4.9	15.5	1.9	2.0	4.1	2.1	2.8	2.5	7.8	1.7	6.3	17.5	1.6	8.5	4.4	3.0	8.3	10.8	16.1	1.9	6.8	6.3	39.5	2.0	27.4	2.5	1.9	20.5	6.6	10.9	2.4	73.4	49.0	94.7	82.9	10.3	10.4	81.2	60.0	43.6	81.3	98.3	148.0	50.1	86.8	48.8	38.3	128.7	88.0	78.0	94.3	114.6	94.0	140.2	84.7	141.4	166.3	3.4	123.8	59.1	6.4	10.0	69.1	51.2	23.1	88.3	116.8	144.1	56.5	69.6	119.3	103.1	204.4	60.5	64.0	74.3	107.7	63.2	62.6	38.0	33.0	99.1	44.0	50.8	46.5	67.4	76.9	43.7	119.5	48.0	76.6	78.3	104.6	163.7	36.9	72.7	156.8	45.9	147.0	92.8	3.2	16.9	2.3	2.0	20.3	0.6	6.0	4.4	4.3	15.9	3.5	3.4	2.7	2.9	6.9	14.1	18.9	12.0	5.9	2.5	2.3	2.0	3.5	4.2	2.0	1.9	2.0	1.7	1.9	2.0	2.4	2.5	0.0	2.6	1.0	18.6	38.0	13.4	54.3	6.2	1.3	10.3	18.7	0.3	11.5	29.4	1.8	2.1	52.2	6.1	23.5	5.9	16.6	329.7	18.0	26.5	11.0	7.8	75.1	23.7	17.9	155.9	25.1	17.3	12.7	13.4	31.4	10.8	6.0	63.6	3.3	22.0	27.1	42.7	15.6	40.1	39.3	19.3	19.3	8.8	1.0	12.6	3.1	3.1	1.0	2.4	17.2	10.6	9.1	38.6	24.7	18.1	1.6	7.0	1.4	0.0	6.4	18.1	148.3	83.8	60.9	29.0	21.2	8.6	11.4	51.7	35.8
CEP128	"C14orf145, C14orf61"	ENSG00000100629	"Centrosomal protein 128"	Q6ZU80	14	80476983-80959517	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"lymphoid tissue: 24.9"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 40.1;Microglial cells: 46.9;Oligodendrocyte precursor cells: 37.7;Oligodendrocytes: 71.0;Plasma cells: 81.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"T-reg: 7.8"	"Group enriched"	"Detected in many"	4	"dendritic cells: 6.8;T-cells: 7.8"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 59.9;MOLT-4: 55.7;U-266/70: 110.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001116, HPA018498, HPA077688"	Uncertain		Supported	Centrosome		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 63: T-cells - Adaptive immune response"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 55: Plasma cells - Humoral immune response"	Centrosome		"HPA001116: AB_1078323, HPA018498: AB_1845560, HPA077688: "	"unprognostic (6.13e-3)"	"unprognostic (5.82e-2)"	"unprognostic (1.65e-2)"	"unprognostic (3.49e-2)"	"unprognostic (4.32e-2)"	"unprognostic (5.93e-2)"	"unprognostic (2.64e-2)"	"unprognostic (1.66e-1)"	"unprognostic (3.89e-1)"	"unprognostic (1.87e-1)"	"unprognostic (3.42e-1)"	"unprognostic (1.94e-2)"	"unprognostic (2.60e-3)"	"unprognostic (1.21e-1)"	"unprognostic (3.37e-1)"	"unprognostic (2.45e-1)"	"unprognostic (1.48e-1)"	2.0	0.8	1.4	2.5	2.5	6.2	3.8	4.1	1.5	1.2	1.1	2.0	1.4	2.0	0.6	1.7	2.5	1.0	1.2	1.1	1.3	0.9	0.9	1.4	4.7	2.1	1.4	1.5	0.6	1.7	0.9	1.0	1.7	1.2	1.7	1.6	1.7	1.0	1.8	2.4	1.0	1.9	1.4	2.4	1.7	5.2	1.1	24.9	1.7	0.9	5.2	2.2	1.3	3.0	14.8	7.9	6.8	5.6	1.6	2.6	3.6	15.5	4.8	9.5	9.3	5.3	8.4	34.5	2.8	4.8	6.2	7.8	7.4	4.9	18.0	19.5	4.7	6.7	9.8	2.7	0.8	6.6	8.6	0.6	1.2	13.6	7.3	1.8	7.3	17.0	8.5	59.9	9.1	9.4	55.7	3.7	5.3	4.0	9.4	9.8	16.8	26.7	2.0	7.7	8.6	4.1	13.1	5.4	2.8	6.5	6.0	5.1	6.7	20.5	11.2	5.7	16.4	110.1	4.8	15.2	5.8	9.1	7.3	0.0	0.6	1.3	2.2	0.2	1.7	1.6	2.3	1.6	2.0	0.6	2.0	0.9	0.1	0.9	0.4	6.8	7.8	0.7	1.4	2.5	4.1	1.5	1.1	1.3	2.1	1.4	1.7	1.4	1.1	3.0	2.3	3.2	2.8	40.1	7.5	4.0	2.6	1.1	1.2	6.6	3.2	3.0	3.8	2.8	5.7	3.7	2.1	2.4	12.7	0.6	0.0	1.6	8.5	14.8	3.2	2.7	1.2	7.4	27.3	1.2	9.0	3.5	3.1	2.8	2.5	7.8	3.3	0.3	2.5	6.7	25.5	1.0	2.0	0.0	4.6	5.1	1.5	4.8	3.6	46.9	10.3	4.8	1.0	37.7	71.0	1.2	0.3	1.5	81.1	0.9	0.1	0.5	17.2	13.8	6.6	6.6	2.5	16.7	3.8	4.1	1.7	2.3	8.8	2.3	1.5	1.6
CEP131	"AZ1, AZI1, KIAA1118"	ENSG00000141577	"Centrosomal protein 131"	Q9UPN4	17	81189593-81222999	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cilium biogenesis/degradation, Differentiation, Spermatogenesis, Transport"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Spermatogonia: 20.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024019	Approved		Supported	"Microtubules,Cytokinetic bridge,Centriolar satellite"		Yes	No			"Cluster 14: Monocytes - Unknown function"	"Cluster 71: Testis - DNA repair"	"Cluster 20: HeLa - Mitochondria"	"Cluster 43: Cardiomyocytes - Nuclear processes"	Microtubules	"Cytokinetic bridge, Centriolar satellite"	"HPA024019: AB_1845227"	"unprognostic (1.56e-2)"	"unprognostic (1.09e-2)"	"unprognostic (2.41e-1)"	"unprognostic (2.31e-1)"	"unprognostic (2.80e-1)"	"unprognostic (3.26e-2)"	"prognostic unfavorable (9.68e-5)"	"unprognostic (3.43e-1)"	"unprognostic (7.62e-2)"	"unprognostic (2.43e-1)"	"unprognostic (1.33e-3)"	"unprognostic (7.04e-2)"	"unprognostic (8.82e-3)"	"unprognostic (1.36e-2)"	"unprognostic (8.48e-2)"	"unprognostic (2.66e-1)"	"unprognostic (7.32e-3)"	9.1	8.6	6.7	5.2	6.4	10.2	10.3	7.8	10.0	14.7	7.5	9.8	4.6	11.4	0.9	9.1	11.5	2.0	16.8	6.5	5.8	11.7	6.8	10.7	7.9	6.8	6.2	12.8	10.1	2.2	15.4	4.1	6.2	12.0	0.8	1.8	9.3	2.1	11.1	10.5	10.3	1.6	5.7	19.0	9.9	28.2	6.7	3.5	10.3	2.0	2.2	10.4	10.7	6.8	21.1	20.0	10.6	19.4	1.7	2.7	33.6	14.4	2.5	10.3	7.9	23.8	10.5	14.8	8.0	3.5	6.3	14.9	3.1	7.0	2.5	6.2	26.8	14.3	32.7	41.3	2.9	12.5	30.6	2.3	4.6	7.5	2.1	3.3	7.3	15.6	10.6	8.5	2.7	23.5	29.0	24.3	9.5	6.1	17.7	29.0	12.1	6.1	3.9	18.4	24.2	27.2	18.5	11.4	18.0	3.9	17.2	12.3	10.0	18.6	32.1	16.7	19.2	22.0	4.0	11.3	9.6	10.7	13.5	2.1	0.8	0.5	1.2	2.3	0.3	2.9	0.7	1.1	1.8	1.7	1.1	0.8	1.3	1.0	4.6	2.0	0.1	0.8	6.7	6.4	7.8	10.0	6.5	5.8	6.8	6.2	6.2	5.7	6.7	6.8	6.5	0.0	4.4	5.5	6.6	0.0	3.4	0.0	3.4	5.8	3.3	4.4	13.4	2.8	1.3	3.7	6.2	8.7	4.8	5.6	0.0	4.5	14.0	8.4	3.5	6.0	6.7	5.7	2.1	3.7	7.2	6.9	6.6	2.8	15.9	9.3	2.5	1.7	5.2	5.0	2.9	5.1	0.0	1.9	0.0	17.9	9.6	3.6	0.0	1.0	1.3	6.0	7.2	2.5	2.8	5.2	0.8	3.0	4.4	1.2	1.8	1.4	3.6	6.9	0.0	4.3	5.7	14.7	20.5	3.7	0.0	6.0	3.5	8.4	7.9	2.7
CEP152	"KIAA0912, MCPH9, SCKL5"	ENSG00000103995	"Centrosomal protein 152"	O94986	15	48712928-48811146	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cilium biogenesis/degradation"		"Disease variant, Dwarfism, Mental retardation, Primary microcephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 16.3"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 192.5;Late spermatids: 49.5;Syncytiotrophoblasts: 46.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA039408	Approved		Supported	Nucleoplasm,Centrosome		NA	Yes			"Cluster 42: Non-specific - Transcription"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 29: Early spermatids - Spermatogenesis"	Centrosome	Nucleoplasm	"HPA039408: AB_10795288"	"unprognostic (3.64e-1)"	"unprognostic (1.91e-1)"	"unprognostic (2.61e-1)"	"unprognostic (4.08e-2)"	"unprognostic (2.09e-1)"	"unprognostic (3.87e-4)"	"unprognostic (4.78e-2)"	"unprognostic (8.02e-3)"	"unprognostic (1.04e-2)"	"unprognostic (5.82e-2)"	"unprognostic (4.70e-3)"	"unprognostic (3.47e-2)"	"unprognostic (6.24e-3)"	"unprognostic (5.29e-2)"	"unprognostic (3.55e-1)"	"unprognostic (4.60e-2)"	"unprognostic (1.25e-1)"	2.2	1.3	1.2	3.5	1.4	16.3	1.9	2.0	1.9	1.9	2.6	2.3	2.9	1.4	0.9	2.6	1.9	1.8	2.1	1.0	0.9	2.2	1.0	2.2	4.3	1.2	1.2	2.5	2.9	1.3	0.9	4.7	1.4	1.7	3.1	1.9	2.4	0.9	1.0	3.0	2.9	1.9	0.7	2.4	2.3	9.8	1.8	5.6	2.9	0.6	3.7	1.4	2.3	1.8	8.0	6.1	12.2	15.0	2.1	3.9	7.9	13.9	5.6	10.0	12.3	13.2	6.8	18.6	5.9	4.0	14.1	18.6	13.6	5.0	14.5	16.5	8.3	30.1	34.6	7.2	1.4	25.6	13.4	1.4	3.9	11.1	6.6	3.9	7.5	19.2	18.4	21.6	8.6	4.5	18.6	23.8	7.7	9.5	6.1	22.7	16.4	22.9	3.6	7.5	14.6	9.8	10.7	8.9	4.2	13.3	6.7	12.3	6.2	24.4	12.9	18.9	15.6	9.2	10.8	21.4	7.8	36.2	17.6	2.1	1.0	1.9	0.8	1.4	0.7	0.9	0.9	0.9	0.8	1.7	1.0	1.0	1.8	1.2	1.5	1.5	1.0	0.5	1.2	1.4	2.0	1.9	1.0	0.9	1.2	1.2	1.4	0.7	1.8	1.8	3.9	6.4	2.8	22.2	9.3	3.8	4.1	2.8	4.0	1.5	2.9	3.6	3.9	4.3	1.8	3.7	2.1	31.5	6.8	7.8	0.0	4.7	192.5	6.4	5.3	6.7	3.6	29.9	14.7	6.7	8.5	9.0	7.1	5.0	8.2	20.9	6.1	3.3	7.6	0.0	8.4	8.2	4.1	7.2	6.4	49.5	23.9	8.6	1.8	16.9	6.9	2.9	10.3	6.0	7.0	7.9	3.5	27.1	15.9	3.2	9.1	1.7	8.4	3.6	6.6	6.5	5.4	24.4	10.3	7.0	3.4	46.9	9.9	3.4	10.1	4.1
CEP162	"C6orf84, KIAA1009, QN1"	ENSG00000135315	"Centrosomal protein 162"	Q5TB80	6	84124241-84227643	"Plasma proteins, Predicted intracellular proteins"	"Cilium biogenesis/degradation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 141.3;Oligodendrocytes: 64.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030170, HPA030171, HPA030172, HPA030173"	Supported		Approved	"Nucleoplasm,Centriolar satellite,Cytosol"		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 49: Ciliated cells - Cilium organization"	"Nucleoplasm, Centriolar satellite, Cytosol"		"HPA030170: AB_10611113, HPA030171: AB_10601567, HPA030172: AB_10602414, HPA030173: AB_10602206"	"unprognostic (1.75e-1)"	"unprognostic (1.46e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.26e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.63e-3)"	"unprognostic (2.95e-4)"	"unprognostic (1.03e-1)"	"unprognostic (6.73e-2)"	"unprognostic (1.21e-3)"	"unprognostic (1.57e-3)"	"unprognostic (3.98e-2)"	"unprognostic (2.87e-3)"	"unprognostic (3.27e-2)"	"unprognostic (6.32e-2)"	"unprognostic (3.58e-1)"	"unprognostic (1.44e-3)"	2.0	1.5	1.1	2.3	1.9	2.4	2.6	1.8	1.6	2.4	3.2	1.9	1.2	3.7	2.2	1.8	3.7	2.8	1.6	0.8	1.3	2.5	1.4	2.7	2.2	1.4	1.6	4.1	2.1	4.2	1.2	2.5	1.5	2.4	2.6	2.8	1.9	2.3	1.0	2.3	1.7	2.6	1.3	2.3	2.7	8.6	1.6	3.9	3.5	1.6	2.3	2.1	1.4	3.0	2.5	1.1	7.1	7.8	4.2	6.1	4.6	2.8	2.7	3.9	4.6	3.2	3.4	2.7	2.6	2.2	6.7	3.8	4.2	2.6	6.2	7.0	2.8	5.0	5.1	2.4	2.1	5.5	4.6	2.9	1.9	3.9	1.5	5.0	4.4	3.7	10.2	3.1	2.8	1.3	1.4	3.3	4.8	1.7	1.6	7.6	9.3	1.5	2.9	2.3	4.6	5.7	2.0	1.1	2.1	5.1	2.5	3.7	3.5	3.8	3.4	3.4	3.1	2.3	3.3	1.6	2.4	2.9	4.8	0.0	0.2	0.3	0.4	0.2	0.5	0.5	0.3	0.3	0.1	0.3	0.2	0.4	0.5	0.0	0.2	0.4	0.0	0.2	1.1	1.9	1.8	1.6	0.8	1.3	1.4	1.6	1.5	1.3	1.6	3.0	13.6	32.1	17.6	42.7	9.6	0.0	6.7	0.0	4.6	5.9	6.1	7.1	11.2	4.3	6.8	9.2	12.5	6.5	7.0	7.0	5.9	12.6	141.3	43.2	18.3	11.3	11.4	10.8	35.0	7.1	5.9	13.3	8.6	11.3	18.3	18.0	7.9	4.2	5.5	28.6	29.2	4.7	0.0	7.9	0.0	57.9	11.8	9.9	0.0	36.5	7.6	9.2	6.2	54.3	64.0	6.8	12.7	12.0	3.7	2.5	5.6	6.8	39.4	14.3	13.1	13.8	10.9	58.7	20.0	3.6	0.0	3.8	8.5	13.4	5.0	4.1
CEP164	"KIAA1052, NPHP15"	ENSG00000110274	"Centrosomal protein 164"	Q9UPV0	11	117314557-117413266	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cell cycle, Cell division, Cilium biogenesis/degradation, DNA damage, DNA repair, Mitosis"		"Ciliopathy, Disease variant, Nephronophthisis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 454.5;Early spermatids: 241.0;Late spermatids: 291.7;Rod photoreceptor cells: 268.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037605, HPA037606"	Uncertain		Supported	Nucleoplasm,Centrosome		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 9: Photoreceptor cells - Phototransduction"	"Nucleoplasm, Centrosome"		"HPA037605: AB_10672908, HPA037606: AB_10672498"	"unprognostic (1.92e-1)"	"unprognostic (8.99e-2)"	"unprognostic (7.98e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.00e-1)"	"prognostic unfavorable (2.40e-5)"	"unprognostic (1.82e-1)"	"unprognostic (3.14e-2)"	"unprognostic (1.90e-1)"	"prognostic favorable (5.93e-4)"	"unprognostic (6.54e-2)"	"prognostic unfavorable (2.89e-5)"	"unprognostic (1.30e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.13e-1)"	"unprognostic (7.93e-2)"	7.0	5.8	6.7	9.7	8.2	7.3	6.8	10.8	8.0	10.5	11.5	7.3	4.2	10.8	8.1	8.6	11.4	8.4	4.3	5.5	7.9	5.1	7.3	6.7	7.6	8.2	7.5	11.9	26.3	5.6	11.1	4.6	8.1	6.9	5.1	26.0	5.7	5.8	3.1	8.0	6.2	10.3	4.9	8.5	5.8	23.9	9.2	7.7	8.4	1.3	8.5	7.1	7.5	14.0	13.2	18.0	13.0	25.9	12.8	21.7	4.2	25.6	14.3	18.0	17.5	22.4	20.8	25.9	18.1	15.9	17.7	17.1	14.6	15.0	15.3	25.8	12.0	7.8	18.9	7.1	18.9	11.3	16.8	15.2	12.6	27.3	26.5	16.1	23.6	12.6	21.7	16.4	14.4	11.2	10.6	10.2	9.2	8.5	19.4	14.0	15.5	10.1	7.9	11.3	15.1	21.8	20.3	12.2	14.4	14.4	16.9	13.2	25.7	21.3	13.2	20.7	23.8	5.8	7.7	15.2	10.3	12.6	14.5	96.2	34.3	23.4	35.4	30.9	22.9	38.8	44.3	40.4	13.9	41.0	41.4	32.6	82.5	29.6	42.0	49.4	52.6	10.8	6.7	8.2	10.8	8.0	5.5	7.9	8.2	7.5	8.1	4.9	9.2	14.0	21.0	6.4	13.1	28.1	15.4	7.6	10.3	13.2	10.8	97.7	14.5	23.6	5.8	15.7	10.3	11.0	454.5	4.5	14.3	9.0	1.9	11.1	241.0	26.5	30.3	18.3	15.5	8.0	19.0	14.7	6.8	17.2	17.9	14.7	19.6	17.6	13.2	9.0	12.9	74.0	26.3	10.2	10.2	11.7	11.4	291.7	23.9	14.5	5.4	8.4	21.2	23.4	15.5	21.6	28.7	11.7	5.8	17.0	11.0	9.8	5.4	6.2	31.6	268.7	0.0	30.3	21.4	37.6	17.2	11.4	8.1	2.2	16.4	45.0	11.9	5.6
CEP170	"FAM68A, KAB, KIAA0470"	ENSG00000143702	"Centrosomal protein 170"	Q5SW79	1	243124428-243255348	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"bone marrow: 52.6;brain: 66.3;testis: 89.8"	"Group enriched"	"Detected in many"	10	"Early spermatids: 1490.6;Late spermatids: 4804.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"WM-115: 120.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042151, HPA045597, HPA045787"	Uncertain		Supported	Centrosome,Cytosol		NA	No		21000	"Cluster 14: Monocytes - Unknown function"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 31: Spermatids - Spermatogenesis"	Centrosome	Cytosol	"HPA042151: AB_2677876, HPA045597: AB_2732522, HPA045787: AB_2679453"	"unprognostic (2.97e-1)"	"unprognostic (2.49e-3)"	"unprognostic (8.84e-2)"	"unprognostic (1.04e-2)"	"unprognostic (1.48e-1)"	"unprognostic (7.60e-2)"	"unprognostic (6.83e-5)"	"unprognostic (8.05e-2)"	"unprognostic (9.88e-3)"	"unprognostic (7.09e-2)"	"unprognostic (3.52e-2)"	"unprognostic (6.65e-2)"	"prognostic unfavorable (1.30e-9)"	"unprognostic (2.21e-2)"	"unprognostic (2.17e-1)"	"unprognostic (6.49e-3)"	"unprognostic (9.62e-3)"	8.0	5.0	9.5	8.5	24.1	52.6	5.9	27.7	15.5	6.2	0.0	5.5	3.1	7.2	3.6	4.8	5.2	8.1	7.5	9.7	17.8	2.7	6.3	8.6	6.5	32.3	19.9	8.9	2.1	2.1	4.3	8.2	29.1	4.0	3.0	10.9	3.7	4.1	10.2	3.7	4.4	6.2	27.3	6.7	3.4	89.8	24.6	10.8	12.4	5.8	6.3	6.5	4.4	66.3	17.9	21.7	28.6	23.2	17.8	30.3	9.4	58.3	19.3	23.3	18.6	13.6	14.4	17.0	33.8	33.8	8.5	8.2	23.1	17.6	23.7	36.8	24.9	18.5	21.5	5.8	12.1	28.7	26.4	25.8	4.8	81.3	36.0	51.2	54.3	8.4	43.3	12.4	21.6	4.0	14.8	13.1	47.2	2.7	53.6	31.7	33.6	5.3	5.2	3.1	47.7	79.1	28.0	1.5	19.4	19.0	6.1	26.8	109.7	50.7	21.8	33.9	51.4	16.9	22.4	29.9	31.3	22.3	120.1	4.3	8.7	8.1	1.8	10.6	2.8	3.4	3.7	1.6	9.2	9.4	4.6	2.7	12.8	3.3	11.9	5.9	3.1	2.5	9.5	24.1	27.7	15.5	9.7	17.8	32.3	19.9	29.1	27.3	24.6	66.3	33.4	19.2	19.8	90.4	46.4	15.2	4.8	11.2	26.2	40.2	8.7	12.1	22.2	8.6	9.6	12.9	6.2	3.8	10.9	0.7	0.0	19.5	1490.6	25.3	40.1	43.4	10.8	16.4	115.9	6.9	7.5	37.3	5.6	12.8	23.4	31.3	22.5	7.3	35.9	45.4	124.6	2.4	4.1	38.9	85.0	4804.7	44.1	70.9	23.2	141.5	36.9	11.9	4.1	147.2	299.7	27.4	1.2	35.3	22.3	2.5	1.0	2.8	24.0	19.3	26.3	41.2	34.4	73.5	29.4	16.9	11.5	1.9	13.6	29.1	1.6	3.1
CEP19	"C3orf34, MGC14126"	ENSG00000174007	"Centrosomal protein 19"	Q96LK0	3	196706277-196712250	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cilium biogenesis/degradation"		Obesity	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 54.8;Spermatocytes: 66.3;Spermatogonia: 39.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	8	"basophil: 51.5;eosinophil: 59.0;neutrophil: 144.2"	"Lineage enriched"	"Detected in all"	13	"granulocytes: 144.2"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047614, HPA071138"	Enhanced		Supported	Centrosome		NA	NA			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 20: Retina & Lymphoid tissues - Unknown function"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 66: Spermatocytes - Spermatogenesis"	Centrosome		"HPA047614: AB_2680103, HPA071138: AB_2686348"	"unprognostic (3.00e-1)"	"unprognostic (5.45e-2)"	"unprognostic (5.11e-2)"	"unprognostic (9.31e-2)"	"unprognostic (5.51e-3)"	"unprognostic (4.66e-2)"	"unprognostic (3.56e-4)"	"unprognostic (1.16e-1)"	"unprognostic (1.33e-2)"	"unprognostic (2.10e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.02e-1)"	"unprognostic (2.36e-2)"	"unprognostic (1.91e-1)"	"unprognostic (3.06e-2)"	"unprognostic (2.01e-1)"	"unprognostic (2.33e-2)"	1.6	2.6	5.1	3.1	5.3	1.2	1.1	4.7	6.3	1.7	5.7	1.4	0.9	1.6	3.0	1.5	4.1	1.9	1.4	5.4	5.9	2.6	1.1	1.6	2.9	5.2	5.3	1.8	0.7	3.4	3.8	2.0	5.1	1.6	1.0	6.6	1.2	2.1	0.6	1.6	1.2	1.4	5.0	3.4	0.9	9.9	5.8	7.6	2.2	1.8	3.5	1.8	1.5	5.5	6.0	4.1	5.6	3.5	12.6	9.6	1.6	4.8	9.0	5.1	6.6	2.1	3.9	4.4	13.3	2.4	11.1	2.6	3.8	1.1	5.9	6.2	3.8	6.8	2.0	0.6	5.0	3.1	8.3	4.4	5.5	6.6	1.8	9.3	2.0	5.4	3.8	5.4	5.2	3.1	7.8	5.6	2.9	2.6	6.9	9.0	3.4	2.9	5.4	0.5	5.6	4.0	6.4	0.8	7.6	4.7	5.0	5.9	1.7	5.8	1.3	9.1	3.2	16.2	16.6	9.1	8.4	7.9	5.8	51.5	4.0	59.0	5.4	3.2	6.0	3.8	8.0	7.3	2.6	4.4	10.3	6.6	144.2	7.3	3.7	11.0	4.8	3.9	5.1	5.3	4.7	6.3	5.4	5.9	5.2	5.3	5.1	5.0	5.8	5.5	2.6	0.0	2.0	3.6	4.5	2.0	1.3	2.2	5.2	5.8	2.7	3.0	2.0	2.8	2.1	1.8	0.0	1.8	5.1	0.6	5.9	2.0	54.8	14.8	5.2	3.7	0.0	1.3	8.4	0.8	1.5	3.4	0.0	1.3	1.3	5.0	5.0	0.3	3.1	5.0	6.6	0.4	4.1	2.2	4.7	6.3	6.5	2.4	0.0	1.0	15.3	9.5	14.4	1.5	1.4	0.8	0.0	5.3	7.1	0.8	0.1	4.9	21.4	8.3	0.0	2.9	2.2	66.3	39.6	2.1	0.9	0.4	3.9	8.8	0.4	0.5
CEP192	"FLJ10352, KIAA1569, PPP1R62"	ENSG00000101639	"Centrosomal protein 192"	Q8TEP8	18	12991362-13125052	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 67.6;Excitatory neurons: 94.4;Inhibitory neurons: 91.3;Oligodendrocyte precursor cells: 76.9;Oligodendrocytes: 90.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039392, HPA040503"	Uncertain		Supported	Centrosome,Cytosol		Yes	No			"Cluster 14: Monocytes - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 21: OE19 - Mitochondria"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Centrosome, Cytosol"		"HPA039392: AB_10697549, HPA040503: AB_10670919"	"unprognostic (6.94e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.23e-1)"	"unprognostic (5.89e-2)"	"unprognostic (1.64e-1)"	"unprognostic (2.04e-2)"	"unprognostic (1.13e-3)"	"unprognostic (6.87e-3)"	"unprognostic (5.83e-3)"	"unprognostic (2.20e-2)"	"unprognostic (9.00e-2)"	"unprognostic (6.61e-2)"	"unprognostic (1.28e-1)"	"unprognostic (7.89e-2)"	"unprognostic (2.39e-1)"	"unprognostic (4.54e-2)"	"unprognostic (1.66e-3)"	2.9	2.2	5.0	4.6	7.6	10.8	4.9	9.8	5.2	4.7	0.0	4.5	4.0	6.4	3.9	3.7	4.9	5.7	3.6	4.1	2.4	2.8	2.9	4.4	6.9	4.1	4.7	9.9	4.6	4.7	2.5	4.6	3.6	4.0	5.4	6.8	4.1	3.5	1.8	3.5	4.7	4.6	3.4	5.2	4.7	9.3	5.0	11.6	5.5	3.9	5.6	4.1	2.5	9.7	13.5	7.2	19.1	10.1	8.1	12.6	6.1	9.2	12.1	14.3	15.1	9.9	5.8	15.2	6.1	9.4	10.4	6.4	16.7	8.8	16.8	6.0	6.0	13.8	11.3	5.2	4.3	22.2	10.2	8.8	3.2	12.0	10.9	8.2	11.9	10.7	19.3	9.9	11.3	6.8	19.2	9.6	6.1	24.9	4.4	16.3	14.9	7.9	4.9	13.6	13.9	7.8	14.7	7.2	4.4	9.0	5.8	11.3	12.1	11.2	26.2	12.9	12.8	6.6	10.1	17.0	7.2	9.9	11.0	0.4	0.6	0.5	0.9	0.4	0.7	0.5	0.6	0.6	0.3	1.3	0.6	1.0	0.6	0.2	1.7	0.5	0.5	0.3	5.0	7.6	9.8	5.2	4.1	2.4	4.1	4.7	3.6	3.4	5.0	9.7	13.3	9.6	12.8	67.6	11.4	1.9	3.9	4.3	5.2	13.1	6.4	5.8	28.7	4.3	9.3	7.3	22.9	5.3	13.7	7.6	0.0	4.7	23.3	11.0	11.8	8.5	0.0	18.7	94.4	3.6	3.3	10.5	15.8	12.1	2.5	40.9	8.2	6.5	4.6	11.8	91.3	8.7	4.1	10.1	3.9	14.2	10.2	10.1	1.8	62.8	15.3	6.5	14.4	76.9	90.6	4.8	5.7	13.9	15.0	5.5	4.5	1.2	8.0	17.8	26.3	11.3	8.1	33.5	24.0	8.5	3.1	1.9	12.3	60.6	8.0	7.6
CEP20	"C16orf63, DKFZp686N1651, FLJ31153, FOPNL, FOR20, PHSECRG2"	ENSG00000133393	"Centrosomal protein 20"	Q96NB1	16	15865719-15888625	"Predicted intracellular proteins"	"Cilium biogenesis/degradation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Adipocytes: 11.2;Cardiomyocytes: 28.2;Cytotrophoblasts: 40.4;Extravillous trophoblasts: 27.1;Hofbauer cells: 21.1;Syncytiotrophoblasts: 29.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040599	Supported		Supported	Centrosome		NA	NA			"Cluster 42: Non-specific - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 24: Non-specific - Transcription regulation"	Centrosome		"HPA040599: AB_10794036"	"unprognostic (1.10e-1)"	"unprognostic (6.29e-2)"	"unprognostic (1.16e-3)"	"unprognostic (7.16e-2)"	"unprognostic (2.45e-1)"	"unprognostic (3.77e-2)"	"unprognostic (2.23e-2)"	"unprognostic (6.01e-2)"	"unprognostic (1.72e-1)"	"unprognostic (4.92e-1)"	"unprognostic (4.35e-2)"	"unprognostic (4.78e-1)"	"unprognostic (6.14e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.48e-2)"	"unprognostic (1.71e-1)"	"unprognostic (5.45e-3)"	16.5	19.1	7.7	12.7	7.7	14.1	19.1	8.0	16.5	17.2	8.9	14.9	13.0	13.8	1.3	27.6	15.0	13.9	16.9	7.6	9.5	17.4	19.0	13.6	24.2	8.0	8.0	18.7	18.2	8.5	14.3	9.8	8.3	15.5	13.8	10.5	14.2	11.1	45.7	17.4	12.4	8.0	8.1	13.4	15.3	31.5	8.4	15.8	32.5	5.8	15.8	17.5	17.3	8.3	43.1	45.6	16.0	3.6	35.4	43.2	2.5	23.7	26.7	23.6	27.6	24.4	6.1	31.1	30.2	6.9	43.9	33.5	39.8	3.7	49.4	33.2	29.5	4.5	10.2	12.0	29.7	9.3	34.3	4.0	53.4	5.8	36.8	7.4	39.9	70.8	85.0	5.6	7.1	33.2	28.0	34.7	38.8	29.8	3.8	6.9	37.3	4.1	3.6	13.1	14.4	1.4	2.1	30.6	51.1	33.0	4.5	5.5	14.0	4.9	3.7	47.4	83.5	11.3	38.2	53.1	42.6	72.0	36.4	38.1	14.4	7.3	12.6	15.0	16.8	15.9	15.4	15.4	16.1	15.9	16.1	14.7	4.2	19.2	13.3	18.3	16.7	14.7	7.7	7.7	8.0	16.5	7.6	9.5	8.0	8.0	8.3	8.1	8.4	8.3	11.2	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	28.2	0.0	0.0	0.0	0.0	40.4	8.2	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	27.1	7.8	0.0	0.0	0.0	0.0	0.0	0.0	21.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	29.0	1.3	0.0	0.0	0.0
CEP250	"C-NAP1, CEP2"	ENSG00000126001	"Centrosomal protein 250"	Q9BV73	20	35455164-35519280	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cilium biogenesis/degradation"		"Cone-rod dystrophy, Deafness, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA064875			Supported	Centrosome		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	Centrosome		"HPA064875: AB_2685379"	"unprognostic (6.35e-2)"	"unprognostic (2.94e-1)"	"unprognostic (2.31e-1)"	"unprognostic (1.21e-3)"	"unprognostic (1.99e-1)"	"unprognostic (1.94e-1)"	"prognostic unfavorable (1.77e-7)"	"unprognostic (1.60e-1)"	"unprognostic (7.81e-2)"	"unprognostic (3.47e-2)"	"prognostic favorable (9.27e-6)"	"unprognostic (1.42e-1)"	"prognostic unfavorable (1.97e-6)"	"unprognostic (1.30e-1)"	"unprognostic (6.40e-2)"	"unprognostic (2.90e-3)"	"unprognostic (4.57e-2)"	7.2	8.4	12.8	13.5	12.8	22.6	6.4	12.7	11.9	11.3	11.3	10.6	6.9	10.5	8.9	10.4	11.8	7.5	6.8	11.6	13.4	6.2	6.7	7.1	23.3	11.6	12.5	14.2	7.3	12.7	12.2	6.5	11.1	12.2	8.3	15.7	10.1	8.7	9.4	13.3	11.2	9.7	9.8	20.2	8.3	18.8	14.9	16.3	8.7	6.9	14.3	9.8	10.4	11.6	33.9	38.2	18.5	34.6	27.6	24.8	27.4	16.5	18.4	25.8	20.3	51.2	27.0	36.4	21.5	23.7	80.4	36.6	20.0	50.7	28.7	6.9	8.2	68.1	31.0	49.0	16.7	33.7	36.6	17.7	30.0	43.7	61.9	29.3	27.0	38.3	23.7	33.8	44.2	17.4	41.5	34.0	12.4	18.0	43.1	23.6	53.6	10.1	24.7	38.4	24.9	27.7	45.6	30.3	21.5	14.9	21.3	29.3	43.7	113.5	29.3	42.4	23.8	11.7	13.6	33.9	63.1	22.4	19.9	20.2	2.0	5.2	10.5	2.5	6.5	5.7	4.4	8.5	4.1	6.7	5.3	6.0	0.8	7.4	1.7	14.1	5.1	4.6	12.8	12.8	12.7	11.9	11.6	13.4	11.6	12.5	11.1	9.8	14.9	11.6	3.4	6.4	7.2	7.5	14.6	1.7	6.2	3.6	8.6	21.7	4.5	5.3	13.0	5.7	12.7	9.2	12.5	11.6	15.7	7.0	5.9	5.5	11.7	16.2	8.0	4.8	3.0	19.5	13.6	2.0	6.4	7.6	11.7	9.7	5.1	11.8	7.1	3.8	9.1	16.8	17.6	5.4	2.0	9.0	2.7	20.0	4.4	7.7	1.8	5.6	4.2	8.3	20.6	5.0	5.1	5.1	3.6	3.8	18.7	5.2	5.1	2.2	19.5	28.7	0.0	9.9	6.7	24.1	14.8	10.6	2.7	3.0	15.9	5.5	6.6	3.8
CEP290	"3H11Ag, BBS14, CT87, FLJ13615, JBTS5, KIAA0373, LCA10, MKS4, NPHP6, POC3, rd16, SLSN6"	ENSG00000198707	"Centrosomal protein 290"	O15078	12	88049016-88142099	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cilium biogenesis/degradation, Protein transport, Transport"	Activator	"Bardet-Biedl syndrome, Ciliopathy, Disease variant, Joubert syndrome, Leber congenital amaurosis, Meckel syndrome, Mental retardation, Nephronophthisis, Obesity, Senior-Loken syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Rod photoreceptor cells: 150.5;Spermatocytes: 143.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB029995, HPA043918, HPA064397"	Approved		Supported	Centrosome		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 71: Testis - DNA repair"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 46: Photoreceptor cells - Phototransduction"	Centrosome		"CAB029995: , HPA043918: AB_2678730, HPA064397: AB_2685255"	"unprognostic (7.42e-2)"	"unprognostic (4.02e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.19e-1)"	"unprognostic (3.26e-1)"	"unprognostic (8.90e-2)"	"unprognostic (1.45e-4)"	"unprognostic (2.06e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.94e-2)"	"unprognostic (7.25e-2)"	"prognostic unfavorable (3.21e-6)"	"unprognostic (2.26e-1)"	"unprognostic (1.77e-1)"	"unprognostic (2.44e-2)"	"unprognostic (3.84e-3)"	5.2	5.1	2.7	4.0	3.4	2.8	5.0	3.1	3.8	7.9	1.9	6.3	1.5	6.4	2.7	2.4	8.0	2.6	4.5	2.8	2.9	7.1	3.6	5.0	3.6	2.8	3.0	12.3	4.6	9.0	8.4	3.3	3.0	6.8	2.6	7.2	3.5	2.1	2.9	3.7	4.6	2.9	2.7	4.5	4.8	8.6	2.9	4.3	7.3	1.2	2.6	6.0	4.9	4.3	8.3	4.9	9.8	2.0	4.2	16.1	3.8	8.2	6.6	5.8	5.0	7.3	3.3	7.6	3.6	6.1	9.1	6.4	2.7	5.2	9.1	4.2	4.7	7.5	4.5	4.7	7.6	10.0	3.4	8.3	3.3	12.5	10.4	11.3	11.3	6.5	15.4	1.4	11.0	3.8	5.7	6.2	2.5	1.3	8.5	4.5	11.6	5.1	4.9	6.1	4.7	8.3	5.0	2.5	6.4	7.6	11.3	3.3	10.0	9.5	5.5	8.1	10.7	6.0	10.4	8.2	3.5	3.7	3.9	0.0	0.0	0.1	0.6	0.1	0.8	0.2	0.7	0.5	0.0	0.3	0.7	0.5	0.0	0.5	0.2	0.6	0.5	0.0	2.7	3.4	3.1	3.8	2.8	2.9	2.8	3.0	3.0	2.7	2.9	4.3	29.0	86.6	32.1	56.2	22.5	6.4	16.9	17.5	17.1	65.9	15.1	16.5	50.0	25.8	35.2	29.5	102.2	13.0	28.6	8.4	7.9	26.0	70.6	89.0	57.0	24.6	4.9	12.4	91.8	13.1	8.8	26.1	14.3	32.1	19.0	56.2	13.9	5.7	13.9	65.6	93.7	17.4	34.6	6.3	7.4	29.4	28.6	13.5	14.2	30.9	11.4	35.0	33.0	67.3	100.4	19.0	6.5	37.6	22.5	9.2	6.9	11.0	81.8	150.5	32.9	42.5	32.2	143.9	53.5	6.4	5.5	5.6	23.7	46.1	15.8	9.4
CEP43	"FGFR1OP, FOP"	ENSG00000213066	"Centrosomal protein 43"	O95684	6	166999317-167094789	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Cilium biogenesis/degradation"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 12.3;Cytotrophoblasts: 14.2;Extravillous trophoblasts: 16.2;Hofbauer cells: 10.3;Syncytiotrophoblasts: 6.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA071876	Approved		Supported	Centrosome		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 45: Intestine - Brush border"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 24: Non-specific - Transcription regulation"	Centrosome		"HPA071876: AB_2686467"	"unprognostic (9.14e-2)"	"unprognostic (2.24e-1)"	"unprognostic (3.98e-2)"	"unprognostic (2.39e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.69e-2)"	"unprognostic (9.59e-2)"	"unprognostic (1.00e-1)"	"unprognostic (6.95e-2)"	"unprognostic (8.83e-2)"	"unprognostic (1.08e-3)"	"unprognostic (4.06e-2)"	"prognostic unfavorable (7.32e-4)"	"unprognostic (1.29e-2)"	"unprognostic (2.49e-1)"	"unprognostic (3.15e-1)"	"unprognostic (2.09e-3)"	6.9	14.8	8.8	12.6	8.3	16.7	14.3	8.3	10.0	13.5	9.2	12.4	15.9	14.9	16.9	9.0	27.0	11.2	8.9	8.1	8.3	17.4	36.3	7.3	14.8	8.7	11.4	13.0	11.3	10.5	14.1	8.4	9.4	9.4	16.9	25.4	8.8	9.1	8.5	11.6	15.8	10.4	7.7	11.1	11.3	58.4	8.4	15.7	15.5	10.4	17.7	9.2	9.3	9.4	26.1	14.3	35.3	24.2	20.3	15.1	42.7	33.0	21.9	26.4	25.3	53.1	21.6	31.0	18.3	20.2	70.3	24.0	31.4	23.3	49.3	19.5	27.0	21.4	26.7	58.2	10.8	38.4	21.6	8.4	16.8	54.2	25.2	16.4	18.5	34.5	70.9	25.8	34.2	24.0	31.1	55.8	30.2	50.0	10.9	35.3	23.9	25.7	27.8	13.8	26.2	26.2	26.9	28.6	11.7	24.6	23.5	46.7	12.2	26.1	43.7	31.6	42.1	21.8	32.3	31.4	29.4	35.4	32.7	0.4	6.5	23.5	5.1	6.1	7.6	12.1	5.8	4.8	10.7	8.4	3.4	5.5	38.8	6.3	6.7	16.4	11.7	4.9	8.8	8.3	8.3	10.0	8.1	8.3	8.7	11.4	9.4	7.7	8.4	9.4	3.3	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.3	0.0	0.0	0.0	0.0	14.2	3.8	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	16.2	2.1	0.0	0.0	0.0	0.0	0.0	0.0	10.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	6.3	1.3	0.0	0.0	0.0
CEP55	"C10orf3, CT111, FLJ10540"	ENSG00000138180	"Centrosomal protein 55"	Q53EZ4	10	93496612-93529092	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	"Developmental protein"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 27.4;testis: 21.7"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 29.4;Extravillous trophoblasts: 17.1;Granulosa cells: 19.8;Spermatocytes: 77.3;Spermatogonia: 17.3"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	8	"T-reg: 1.3"	"Lineage enriched"	"Detected in single"	14	"T-cells: 1.3"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in single"			HPA023430	Approved		Approved	"Plasma membrane,Midbody,Centriolar satellite"		Yes	Yes			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Plasma membrane, Centriolar satellite"	Midbody	"HPA023430: AB_10960212"	"unprognostic (9.85e-2)"	"unprognostic (1.12e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.29e-1)"	"unprognostic (5.15e-2)"	"unprognostic (4.26e-2)"	"prognostic unfavorable (3.20e-9)"	"prognostic unfavorable (1.45e-4)"	"unprognostic (1.50e-1)"	"unprognostic (1.05e-1)"	"prognostic unfavorable (2.66e-5)"	"unprognostic (3.99e-2)"	"prognostic unfavorable (0.00e+0)"	"prognostic favorable (3.15e-4)"	"unprognostic (7.86e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.63e-1)"	1.3	0.6	0.0	7.6	0.0	5.0	1.4	0.0	0.2	1.7	0.0	7.0	6.7	1.4	0.1	7.3	0.4	1.4	0.3	0.0	0.1	0.3	0.6	1.3	14.7	0.1	0.3	0.2	0.2	0.2	0.3	3.5	0.2	0.3	8.8	0.0	1.2	0.3	0.1	4.5	6.3	5.2	0.0	2.4	4.6	21.7	0.4	27.4	0.5	0.2	15.5	3.1	2.3	0.1	208.5	81.5	53.0	67.7	5.8	12.0	29.6	112.4	78.2	103.5	106.4	87.2	108.6	55.4	48.2	72.8	69.6	115.4	64.8	54.8	123.4	167.2	33.7	21.0	49.2	29.9	0.6	36.3	46.3	2.8	3.8	110.6	133.5	30.7	97.1	89.9	19.3	101.8	118.5	48.3	96.3	54.8	20.9	64.2	58.8	41.3	86.9	30.3	47.1	25.5	21.7	30.7	86.3	26.3	64.9	40.1	68.9	36.4	61.4	65.3	90.6	90.5	186.7	45.1	66.1	66.8	51.0	134.8	59.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.3	0.2	0.0	0.4	0.1	0.2	0.0	1.3	0.0	2.7	3.6	0.9	1.9	0.0	0.0	1.8	2.0	0.4	2.8	0.2	0.0	0.0	7.7	0.9	3.3	0.0	0.6	29.4	1.7	2.0	1.5	0.0	2.5	0.5	0.2	17.1	2.3	8.2	3.6	0.0	19.8	2.2	0.3	12.9	0.0	0.3	4.5	4.1	7.0	5.1	8.2	0.3	5.1	0.0	0.0	0.0	0.0	2.1	0.0	0.1	0.3	0.0	0.4	14.8	1.1	0.4	0.0	0.2	0.0	0.0	0.5	4.5	77.3	17.3	16.1	1.3	1.5	4.3	1.6	7.9	1.7
CEP57	"KIAA0092, Translokin, TSP57"	ENSG00000166037	"Centrosomal protein 57"	Q86XR8	11	95789965-95832693	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"Early spermatids: 462.9;Late spermatids: 372.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			HPA018315	Approved		Approved	Microtubules,Cytosol	"Intracellular and membrane"	NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 34: Non-specific - Transcription"	"Cluster 24: NB-4 - Immune response"	"Cluster 34: Spermatids - Unknown function"	Microtubules	Cytosol	"HPA018315: AB_1846537"	"unprognostic (1.64e-1)"	"unprognostic (2.30e-1)"	"unprognostic (1.45e-2)"	"unprognostic (2.66e-1)"	"prognostic favorable (7.24e-4)"	"unprognostic (1.69e-1)"	"unprognostic (2.25e-2)"	"unprognostic (8.10e-2)"	"unprognostic (9.04e-3)"	"unprognostic (7.93e-2)"	"unprognostic (2.38e-3)"	"unprognostic (7.81e-2)"	"unprognostic (1.06e-1)"	"unprognostic (4.31e-2)"	"unprognostic (1.35e-1)"	"unprognostic (6.69e-3)"	"unprognostic (3.25e-1)"	16.6	14.0	10.6	19.2	11.4	29.0	21.6	15.0	13.3	19.0	12.6	17.7	32.4	21.8	19.8	15.0	17.7	27.3	15.6	10.4	11.2	15.7	44.6	16.9	30.1	12.2	11.2	31.2	22.8	12.2	14.9	16.1	10.8	16.2	18.6	25.9	14.1	17.3	12.8	17.8	21.9	15.5	10.9	20.5	17.8	27.9	11.7	34.2	22.7	14.3	30.6	14.0	15.1	12.4	26.7	13.1	42.0	32.7	19.4	38.6	34.4	29.8	48.6	41.4	46.1	47.5	55.1	47.1	39.6	22.4	24.2	43.8	34.7	29.5	43.8	38.1	21.8	66.4	36.9	38.4	33.9	67.0	37.2	25.9	42.5	43.2	80.4	39.3	33.4	49.6	43.8	25.3	33.8	13.1	74.7	89.1	23.3	30.2	29.2	43.8	53.2	40.7	34.8	27.8	21.5	28.9	36.1	34.4	38.3	29.7	35.1	44.0	17.2	35.2	28.3	52.0	28.2	16.9	38.1	51.7	14.6	74.4	31.0	19.0	11.8	24.3	19.5	14.4	25.9	23.6	25.7	22.7	15.6	21.7	24.8	23.5	11.6	26.0	13.2	21.1	33.7	17.5	10.6	11.4	15.0	13.3	10.4	11.2	12.2	11.2	10.8	10.9	11.7	12.4	43.7	54.5	51.1	35.9	58.5	36.3	30.6	35.7	51.2	72.3	30.6	42.7	41.3	85.8	41.7	29.5	35.5	44.1	42.8	16.2	54.8	34.2	462.9	52.2	33.0	38.2	28.8	88.1	68.0	25.7	50.8	41.1	18.3	33.0	27.3	58.4	30.7	71.5	33.1	57.2	78.3	34.0	16.2	35.0	37.3	372.7	33.8	33.2	17.8	27.2	37.6	29.6	44.3	57.8	60.9	26.2	23.9	35.7	57.8	28.8	45.2	40.2	52.6	59.0	65.7	34.4	37.8	75.8	46.1	42.0	32.0	38.4	59.1	53.0	47.2	27.6
CEP68	KIAA0582	ENSG00000011523	"Centrosomal protein 68"	Q76N32	2	65056366-65087004	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Adipocytes: 72.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040493, HPA040620"	Enhanced		Supported	"Nucleoplasm,Centriolar satellite"		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Nucleoplasm, Centriolar satellite"		"HPA040493: AB_10673411, HPA040620: AB_10794144"	"unprognostic (7.99e-2)"	"unprognostic (6.15e-2)"	"unprognostic (5.09e-2)"	"unprognostic (4.90e-3)"	"unprognostic (1.31e-2)"	"unprognostic (1.75e-2)"	"unprognostic (4.84e-3)"	"unprognostic (8.25e-3)"	"unprognostic (9.94e-2)"	"unprognostic (5.09e-2)"	"unprognostic (9.22e-2)"	"unprognostic (1.77e-1)"	"prognostic favorable (3.93e-4)"	"unprognostic (2.25e-1)"	"unprognostic (2.50e-1)"	"unprognostic (8.45e-2)"	"unprognostic (1.71e-1)"	15.9	5.8	11.2	6.9	11.3	4.6	14.1	13.8	11.6	15.3	8.5	12.1	5.5	16.9	6.1	9.8	13.7	10.1	13.9	12.3	9.5	7.1	2.6	7.8	10.0	10.5	9.2	21.6	9.1	9.9	5.9	10.2	10.9	11.0	7.0	7.4	10.7	12.3	26.7	11.8	7.5	14.3	8.1	9.2	8.1	6.0	10.1	10.6	9.6	27.7	8.5	10.3	10.5	11.0	3.9	6.9	13.2	9.7	11.6	13.0	24.2	3.7	6.5	5.6	4.9	5.4	3.4	6.6	4.5	6.7	5.7	5.3	8.7	5.6	5.8	8.0	7.5	9.0	2.5	6.5	3.2	5.1	6.1	12.3	7.8	5.1	7.1	9.8	16.1	13.5	8.4	20.7	7.1	4.5	8.6	9.4	13.3	7.1	5.5	8.9	15.9	7.8	5.0	5.1	23.1	15.7	7.3	5.3	7.9	8.0	3.1	3.3	6.4	5.2	7.1	8.2	3.7	22.4	6.5	15.3	2.8	3.9	6.4	0.9	1.3	0.3	2.3	2.5	2.6	2.6	5.4	4.3	3.5	3.6	8.3	5.2	1.1	4.4	5.0	7.2	4.4	2.5	11.2	11.3	13.8	11.6	12.3	9.5	10.5	9.2	10.9	8.1	10.1	11.0	72.0	28.9	10.9	17.9	13.2	7.1	14.2	15.5	22.2	26.7	11.8	13.6	16.7	8.6	15.5	9.2	25.0	15.4	15.4	3.6	9.8	10.3	3.7	11.2	22.2	47.1	13.1	7.2	28.8	21.4	7.5	17.8	9.2	19.8	6.3	24.9	28.5	6.9	9.4	23.5	31.6	5.8	8.2	7.2	14.4	6.2	37.9	18.9	7.2	22.5	18.4	15.5	8.2	22.6	21.2	8.9	4.3	27.1	6.9	8.9	2.8	9.0	15.0	21.3	32.9	30.5	18.5	11.6	23.9	10.1	5.8	34.1	16.1	9.9	11.2	7.3
CEP70	"BITE, FLJ13036"	ENSG00000114107	"Centrosomal protein 70"	Q8NHQ1	3	138494344-138594538	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 222.5;Late spermatids: 299.3;Spermatocytes: 163.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	9	"gdT-cell: 2.8;MAIT T-cell: 3.3;memory B-cell: 1.7;memory CD4 T-cell: 2.1;memory CD8 T-cell: 2.3;naive B-cell: 1.4;naive CD4 T-cell: 4.1;naive CD8 T-cell: 4.0;NK-cell: 2.3;T-reg: 1.3"	"Group enriched"	"Detected in many"	10	"B-cells: 1.7;NK-cells: 2.3;T-cells: 4.1"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036941, HPA036942"	Enhanced		Approved	Nucleoplasm,Centrosome,Cytosol		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 45: Intestine - Brush border"	"Cluster 6: T47d - Mammary gland"	"Cluster 44: Endometrium - Transcription"	"Nucleoplasm, Cytosol"	Centrosome	"HPA036941: AB_10670567, HPA036942: AB_10670957"	"unprognostic (1.61e-1)"	"prognostic favorable (2.93e-4)"	"unprognostic (2.27e-2)"	"unprognostic (3.59e-2)"	"unprognostic (3.31e-2)"	"unprognostic (3.44e-2)"	"unprognostic (1.95e-2)"	"unprognostic (9.92e-3)"	"unprognostic (9.04e-2)"	"unprognostic (4.25e-2)"	"unprognostic (5.01e-3)"	"prognostic unfavorable (9.60e-5)"	"unprognostic (8.90e-3)"	"unprognostic (8.07e-3)"	"unprognostic (1.46e-1)"	"unprognostic (8.71e-3)"	"unprognostic (6.43e-2)"	7.5	12.0	20.1	6.3	20.9	5.9	13.3	24.1	22.3	30.6	16.2	17.6	56.2	20.9	21.6	12.0	30.6	13.1	15.8	18.1	25.4	21.4	29.4	14.7	5.5	22.1	21.8	18.5	24.1	21.8	15.6	3.9	21.8	21.0	18.1	35.8	8.7	21.7	18.0	6.8	19.0	11.7	20.5	6.1	13.1	69.0	23.9	42.4	39.2	20.8	6.9	12.1	11.7	22.7	53.7	11.1	25.3	30.8	15.2	16.9	23.5	10.4	19.4	14.0	20.5	15.5	27.9	12.5	24.0	19.2	53.1	23.0	23.2	20.6	31.1	22.2	15.3	35.7	26.0	20.1	24.2	1.6	12.5	92.3	11.7	10.6	26.2	37.0	20.5	40.1	26.6	40.5	23.1	20.1	38.4	2.1	15.0	13.9	24.6	41.7	32.9	32.3	26.9	23.8	30.7	19.8	54.5	12.7	60.8	28.4	64.3	17.7	12.1	10.3	19.0	21.3	12.9	37.2	22.1	42.6	22.9	3.3	35.7	0.2	0.0	0.1	2.8	0.1	3.3	1.7	2.1	2.3	0.0	1.4	4.1	4.0	0.2	2.3	0.0	0.1	1.3	1.2	20.1	20.9	24.1	22.3	18.1	25.4	22.1	21.8	21.8	20.5	23.9	22.7	7.0	32.1	69.3	44.1	4.8	9.7	46.3	14.0	22.2	15.8	11.8	9.8	34.3	22.8	27.4	20.2	35.5	8.1	4.6	10.5	72.4	24.9	222.5	114.0	14.9	7.7	15.6	13.7	51.8	17.6	4.4	11.8	16.3	52.6	20.8	21.9	6.1	14.7	2.4	21.9	48.5	11.1	8.2	0.3	3.0	299.3	9.9	2.3	10.6	19.7	0.6	26.4	2.1	60.8	30.5	12.7	8.1	12.8	9.2	29.5	3.3	21.1	34.5	31.1	6.6	17.5	12.4	163.6	9.5	18.6	8.1	9.6	8.9	9.5	23.9	28.6
CEP72	"FLJ10565, KIAA1519"	ENSG00000112877	"Centrosomal protein 72"	Q9P209	5	612340-667168	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 7.3"	"Cell type enriched"	"Detected in many"	4	"Melanocytes: 135.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"NK-cell: 4.5"	"Group enriched"	"Detected in many"	4	"B-cells: 1.6;NK-cells: 4.5;T-cells: 1.7"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 46.0;HeLa: 40.0"	"Region enriched"	"Detected in many"	8	"cerebellum: 14.1"	"Not detected"	"Not detected"			"HPA058235, HPA074879"	Approved		Approved	Nucleoplasm,Centrosome,Mitochondria		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 20: HeLa - Mitochondria"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	Centrosome	"Nucleoplasm, Mitochondria"	"HPA058235: AB_2683649, HPA074879: AB_2686720"	"unprognostic (2.06e-1)"	"unprognostic (3.15e-2)"	"unprognostic (1.50e-1)"	"prognostic unfavorable (2.90e-4)"	"unprognostic (8.50e-2)"	"unprognostic (9.74e-2)"	"unprognostic (2.94e-3)"	"unprognostic (3.20e-1)"	"unprognostic (1.58e-2)"	"unprognostic (1.29e-1)"	"unprognostic (3.38e-2)"	"unprognostic (4.38e-3)"	"unprognostic (1.81e-3)"	"unprognostic (3.60e-2)"	"unprognostic (2.93e-1)"	"unprognostic (4.68e-2)"	"unprognostic (1.24e-2)"	1.1	0.9	1.3	1.9	1.2	3.1	1.4	1.5	1.3	1.6	0.8	1.2	1.4	1.3	1.0	2.2	1.6	1.5	0.9	1.4	0.6	1.4	2.1	1.4	2.7	0.7	0.8	2.8	1.9	1.2	1.5	0.7	0.8	1.3	0.8	1.1	1.7	0.8	0.7	2.4	1.6	0.9	0.6	1.8	1.8	7.3	0.9	3.0	1.8	0.6	1.4	1.2	1.7	1.8	7.5	11.9	10.6	15.0	0.9	1.0	19.1	3.2	1.4	7.1	6.2	10.8	11.2	8.8	8.2	1.4	13.2	7.1	7.5	5.4	2.8	46.0	11.8	9.7	40.0	4.3	1.3	11.3	6.3	1.1	2.3	6.1	4.1	1.4	2.8	17.0	10.1	10.1	3.5	5.7	17.1	9.8	7.0	6.4	11.1	12.8	6.1	12.2	2.3	5.8	8.1	6.2	23.3	7.6	2.0	3.3	7.6	8.7	0.9	6.8	9.9	6.5	4.6	6.3	6.4	8.8	4.2	15.7	7.3	0.0	0.3	0.3	1.3	0.1	1.7	1.4	1.1	1.2	0.1	1.6	1.6	1.6	0.0	4.5	0.6	0.4	1.5	0.8	1.3	1.2	1.5	1.3	1.4	0.6	0.7	0.8	0.8	0.6	0.9	1.8	0.7	3.2	1.5	1.3	2.9	5.7	0.9	2.4	0.6	2.5	1.1	1.8	2.2	2.8	1.0	0.0	0.0	1.2	1.1	1.1	0.0	2.5	4.0	2.4	1.5	1.1	0.0	4.2	2.5	0.9	5.1	1.0	3.6	1.9	0.0	3.8	0.4	1.7	1.4	3.3	1.3	0.7	4.1	0.8	2.9	2.2	1.2	0.7	135.2	1.0	1.4	0.9	2.1	2.0	3.9	2.3	0.5	2.6	4.7	1.1	0.1	0.5	3.4	2.0	0.0	1.3	1.1	30.7	10.1	2.8	3.7	1.6	1.9	0.9	1.3	2.5
CEP85	"CCDC21, DKFZP434L0117"	ENSG00000130695	"Centrosomal protein 85"	Q6P2H3	1	26234200-26278808	"Predicted intracellular proteins"	"Chromosome partition"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 132.9;tongue: 65.9"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 29.0;Oligodendrocytes: 28.8;Spermatocytes: 40.9;Spermatogonia: 34.2;Syncytiotrophoblasts: 41.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"eosinophil: 19.2"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028252	Approved		Approved	"Nucleoli,Golgi apparatus,Centrosome,Cytosol"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 33: Striated muscle - Muscle contraction"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	"Nucleoli, Golgi apparatus"	"Centrosome, Cytosol"	"HPA028252: AB_1846142"	"unprognostic (1.08e-1)"	"unprognostic (2.59e-2)"	"unprognostic (1.74e-2)"	"unprognostic (4.16e-2)"	"unprognostic (2.66e-1)"	"unprognostic (5.30e-3)"	"prognostic unfavorable (4.39e-6)"	"unprognostic (3.72e-2)"	"unprognostic (5.30e-2)"	"unprognostic (8.24e-2)"	"unprognostic (9.18e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.29e-1)"	"unprognostic (7.33e-3)"	"unprognostic (5.41e-2)"	"unprognostic (1.02e-2)"	"unprognostic (2.60e-2)"	2.8	3.5	3.9	5.3	8.3	20.8	3.8	5.6	6.7	4.1	3.7	5.4	3.4	3.2	3.2	8.6	2.7	2.7	25.5	4.3	5.9	6.0	5.8	4.7	6.9	7.1	6.8	3.3	5.0	8.8	6.1	3.2	8.9	2.9	6.0	14.1	5.3	2.4	132.9	9.8	5.2	3.7	3.7	6.3	4.7	31.1	7.1	13.6	7.8	65.9	7.8	3.2	6.2	14.3	29.6	12.5	30.2	22.6	7.3	8.9	52.5	18.8	11.5	31.9	28.5	17.4	28.2	34.3	20.1	9.2	14.6	25.5	41.0	14.4	29.9	23.5	20.9	49.7	31.9	19.4	6.6	46.2	43.8	3.8	13.7	24.9	16.4	12.8	14.5	47.7	57.4	39.9	19.2	9.8	38.7	35.2	23.0	17.4	20.8	39.8	31.3	29.7	10.4	5.5	41.4	16.7	24.5	19.8	15.7	21.5	14.5	26.4	14.3	17.1	26.7	19.3	24.7	30.0	48.4	38.9	9.8	65.2	27.5	5.0	6.4	19.2	3.5	6.1	2.8	2.6	2.6	2.7	4.9	1.8	2.2	3.5	0.6	2.3	7.4	2.1	3.6	3.6	3.9	8.3	5.6	6.7	4.3	5.9	7.1	6.8	8.9	3.7	7.1	14.3	1.0	0.0	2.2	3.6	2.7	6.9	4.0	2.5	6.2	11.2	3.7	2.9	29.0	1.5	3.7	5.5	12.5	3.4	5.1	6.9	7.9	1.7	1.0	3.4	2.3	2.0	1.8	16.8	12.8	1.3	3.9	2.3	3.6	4.9	2.5	9.1	1.4	3.1	4.8	0.0	9.9	3.7	2.0	5.0	3.7	2.9	1.5	4.3	1.8	4.7	4.0	1.8	2.1	3.0	28.8	2.7	3.4	0.4	4.4	2.5	2.3	1.1	2.0	11.1	0.0	2.4	2.3	40.9	34.2	8.6	6.1	41.7	3.4	2.3	4.5	4.5
CEP89	"CCDC123, FLJ14640"	ENSG00000121289	"Centrosomal protein 89"	Q96ST8	19	32875925-32971991	"Disease related genes, Predicted intracellular proteins"	"Cilium biogenesis/degradation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039382, HPA040056"			Supported	"Plasma membrane,Cytosol"	"Intracellular and membrane"	NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 49: Ciliated cells - Cilium organization"	Cytosol	"Plasma membrane"	"HPA039382: AB_2676479, HPA040056: AB_10671048"	"unprognostic (4.23e-2)"	"unprognostic (7.50e-3)"	"unprognostic (1.97e-1)"	"unprognostic (1.53e-3)"	"unprognostic (1.30e-1)"	"unprognostic (1.08e-1)"	"prognostic unfavorable (8.78e-5)"	"unprognostic (1.12e-1)"	"unprognostic (4.55e-2)"	"unprognostic (3.04e-2)"	"unprognostic (1.80e-2)"	"unprognostic (4.00e-2)"	"unprognostic (1.74e-1)"	"unprognostic (4.48e-2)"	"unprognostic (6.53e-2)"	"unprognostic (3.03e-1)"	"unprognostic (2.47e-2)"	6.0	6.0	6.3	5.3	6.7	4.7	6.4	7.7	6.4	9.1	7.7	8.9	4.0	9.8	6.7	6.3	8.9	5.1	6.2	6.6	6.9	8.6	3.3	5.7	6.0	5.8	5.6	10.1	6.1	7.0	9.3	5.3	4.7	12.5	4.4	7.4	6.7	5.9	5.9	6.6	6.7	6.9	4.0	6.4	6.2	4.2	7.3	6.2	7.5	4.3	4.3	8.0	6.8	6.0	19.1	25.7	17.1	14.7	9.1	11.0	9.9	14.7	9.8	25.5	19.4	9.3	11.2	7.6	7.8	15.1	14.4	10.5	16.9	11.9	17.6	20.2	10.4	5.9	18.5	8.9	7.2	8.3	5.7	13.3	16.2	24.1	16.2	10.4	19.5	10.4	9.2	11.0	12.3	14.2	9.4	6.4	7.3	10.4	8.0	10.4	9.2	6.6	11.9	10.3	24.1	17.7	15.1	10.3	8.8	10.3	7.7	6.7	12.6	18.4	16.1	16.0	15.3	5.3	9.1	7.0	15.8	7.8	14.0	12.8	3.1	1.6	2.7	4.6	4.9	3.3	2.9	2.4	1.8	5.7	2.8	3.3	3.7	2.1	2.4	3.7	3.4	1.7	6.3	6.7	7.7	6.4	6.6	6.9	5.8	5.6	4.7	4.0	7.3	6.0	12.7	28.9	16.0	17.3	9.5	5.1	11.5	14.5	8.0	16.3	11.7	11.8	17.5	10.0	19.0	20.2	18.8	9.3	9.6	8.0	11.7	19.1	15.1	49.2	24.9	14.8	9.7	13.3	17.2	16.6	11.2	17.7	10.7	17.3	17.1	21.1	14.6	5.6	11.8	20.2	13.6	9.7	8.2	5.3	5.1	8.5	16.1	8.9	5.4	14.0	9.8	9.6	10.3	9.5	15.9	15.1	5.2	12.8	5.4	6.7	9.9	16.3	48.3	38.6	0.0	17.5	16.1	20.3	13.8	7.5	4.5	4.2	9.0	12.7	8.6	6.6
CEP95	"CCDC45, DKFZp667E1824"	ENSG00000258890	"Centrosomal protein 95"	Q96GE4	17	64506865-64542461	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA052426, HPA052428, HPA061371"	Approved		Uncertain	"Centriolar satellite,Cytosol"		NA	No			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 46: Photoreceptor cells - Phototransduction"	Cytosol	"Centriolar satellite"	"HPA052426: AB_2681827, HPA052428: AB_2681829, HPA061371: AB_2684495"	"unprognostic (1.28e-2)"	"unprognostic (9.12e-2)"	"unprognostic (3.66e-3)"	"unprognostic (4.09e-2)"	"unprognostic (3.30e-2)"	"prognostic favorable (5.78e-4)"	"prognostic unfavorable (2.52e-5)"	"unprognostic (6.57e-3)"	"unprognostic (7.88e-3)"	"unprognostic (1.54e-1)"	"unprognostic (1.64e-2)"	"unprognostic (3.57e-3)"	"prognostic unfavorable (5.76e-5)"	"unprognostic (3.48e-1)"	"unprognostic (1.84e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.79e-3)"	8.4	6.4	8.1	11.7	10.2	42.5	17.5	20.5	10.8	12.8	15.4	11.7	13.5	23.4	15.9	9.4	16.6	13.0	8.5	8.5	8.6	10.4	11.3	11.3	20.1	10.4	10.7	25.6	14.4	10.4	6.3	9.5	10.7	14.6	14.6	40.4	9.6	11.7	9.5	23.1	11.8	12.5	8.9	14.0	13.9	19.0	8.3	18.9	21.3	6.9	16.4	9.7	7.9	16.2	18.5	10.7	26.3	22.8	8.6	15.4	23.7	9.6	10.9	12.8	16.9	14.4	11.3	28.7	6.1	13.3	13.2	25.3	21.2	15.9	24.9	7.3	15.6	27.2	28.2	30.8	21.1	28.9	15.3	18.9	19.8	14.2	30.7	18.5	10.9	29.1	31.5	21.5	12.5	21.4	40.3	23.4	14.8	20.9	14.2	31.6	46.1	21.0	16.5	28.4	14.9	28.0	11.8	22.0	30.2	39.1	20.2	25.0	12.7	27.6	23.9	11.5	13.1	23.6	18.5	31.4	11.6	21.5	19.0	0.6	2.7	2.1	2.9	2.9	7.1	3.5	3.6	4.3	3.0	3.7	5.9	4.0	0.9	2.0	2.8	2.9	3.2	1.8	8.1	10.2	20.5	10.8	8.5	8.6	10.4	10.7	10.7	8.9	8.3	16.2	14.9	41.7	26.3	44.7	29.4	16.2	25.6	14.3	40.5	29.9	17.9	20.2	17.6	14.3	29.4	3.7	45.9	9.4	25.1	18.1	7.9	18.6	58.0	45.9	28.9	13.8	7.7	26.5	47.5	11.8	10.8	23.5	18.8	44.8	29.7	31.9	13.2	8.9	8.5	18.5	56.2	13.8	8.2	10.3	12.8	18.5	20.8	16.6	12.4	23.4	15.2	21.3	15.5	42.7	46.7	14.1	10.4	21.4	21.1	15.4	20.2	6.8	53.1	84.8	13.1	41.3	21.6	38.8	27.5	28.4	20.3	6.6	23.7	23.8	19.7	21.9
CERS2	"FLJ10243, LASS2, SP260"	ENSG00000143418	"Ceramide synthase 2"	Q96G23	1	150960583-150975003	"Enzymes, Metabolic proteins, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 732.2"	"Cell type enhanced"	"Detected in all"		"Hepatocytes: 200.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027262, HPA078737"	Approved		Supported	"Nuclear membrane,Endoplasmic reticulum"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 15: Liver - Metabolism"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 2: Hepatocytes - Metabolism"	"Nuclear membrane, Endoplasmic reticulum"		"HPA027262: AB_1852717, HPA078737: "	"unprognostic (1.01e-1)"	"unprognostic (2.70e-3)"	"unprognostic (3.72e-2)"	"unprognostic (1.29e-2)"	"unprognostic (8.23e-2)"	"unprognostic (2.03e-2)"	"unprognostic (7.05e-2)"	"unprognostic (1.60e-1)"	"unprognostic (2.34e-1)"	"unprognostic (4.05e-2)"	"unprognostic (8.17e-3)"	"unprognostic (1.11e-1)"	"unprognostic (2.63e-2)"	"unprognostic (1.56e-1)"	"unprognostic (7.21e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.85e-1)"	95.0	307.2	126.3	53.1	171.3	80.1	100.1	170.2	165.7	96.8	141.7	81.5	94.5	79.9	89.6	46.2	94.1	97.1	71.8	125.5	144.8	261.4	732.2	135.0	56.4	201.5	168.5	104.4	129.3	159.4	84.7	113.8	192.1	83.2	88.6	38.1	61.5	82.7	37.5	46.9	102.8	99.2	158.7	65.1	128.0	49.8	157.2	67.5	161.4	57.3	69.9	91.0	70.7	223.7	154.3	175.8	138.1	277.9	395.1	237.1	100.8	153.1	217.9	278.1	189.1	188.4	248.5	137.7	244.3	242.4	174.6	165.5	195.5	160.7	247.6	194.0	157.7	193.4	107.5	219.3	277.6	216.4	218.5	214.0	197.9	254.3	315.6	341.4	174.3	189.8	210.4	281.0	363.4	255.6	134.2	135.7	200.9	499.4	299.6	160.0	95.4	208.4	311.5	127.2	121.7	185.8	169.6	278.7	183.8	172.1	335.6	296.5	145.4	196.4	93.6	180.1	267.9	189.5	229.0	841.7	222.4	91.0	200.7	212.1	80.2	136.0	76.9	43.7	93.6	34.6	70.3	78.8	69.5	31.9	60.6	60.1	86.5	63.4	32.8	70.1	86.7	88.5	126.3	171.3	170.2	165.7	125.5	144.8	201.5	168.5	192.1	158.7	157.2	223.7	46.3	67.3	67.9	8.8	23.1	24.1	38.2	37.0	18.2	7.5	52.8	27.6	2.8	120.1	23.2	53.3	4.2	77.8	40.2	60.7	13.7	104.6	7.5	24.9	39.9	47.9	24.6	24.8	5.5	92.8	42.4	44.2	16.3	29.7	36.8	33.0	38.9	200.5	55.9	3.3	5.9	29.3	30.5	45.2	35.2	7.9	56.2	54.5	37.4	5.6	39.4	26.5	26.8	7.5	51.3	103.7	32.4	40.3	29.2	52.4	98.8	81.7	21.2	9.9	39.5	37.2	33.8	13.8	6.8	13.9	15.6	54.2	34.3	39.0	29.1	34.2
CERS3	"LASS3, MGC27091"	ENSG00000154227	"Ceramide synthase 3"	Q8IU89	15	100400395-100544995	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism"	Transferase	Ichthyosis	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"esophagus: 55.1;skin 1: 64.0;vagina: 30.3"	"Group enriched"	"Detected in some"	5	"Basal keratinocytes: 18.9;Basal squamous epithelial cells: 39.3;Early spermatids: 23.5;Late spermatids: 17.5;Spermatocytes: 28.2;Squamous epithelial cells: 48.3;Suprabasal keratinocytes: 50.2"	"Cancer enhanced"	"Detected in some"		"head and neck cancer: 14.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	6	"hTCEpi: 65.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA006092, HPA024356"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 61: Squamous epithelial cells - Keratinization"	Nucleoplasm		"HPA006092: AB_1079236, HPA024356: AB_1852721"	"unprognostic (5.01e-3)"	"unprognostic (3.43e-2)"	"unprognostic (6.47e-4)"	"unprognostic (2.35e-2)"	"unprognostic (5.58e-2)"	"unprognostic (1.68e-1)"	"unprognostic (6.84e-3)"	"unprognostic (3.23e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.31e-5)"	"unprognostic (2.65e-1)"	"unprognostic (4.74e-4)"	"unprognostic (1.83e-1)"	"unprognostic (4.33e-2)"	"unprognostic (1.78e-1)"	"unprognostic (4.05e-3)"	0.1	0.0	0.1	0.0	0.2	0.2	3.3	0.3	0.2	15.1	0.0	0.0	0.0	0.0	0.5	55.1	0.7	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.4	0.0	0.1	0.6	0.0	0.1	8.4	0.1	0.6	64.0	0.1	0.0	0.0	0.1	0.1	18.3	0.2	0.4	0.1	0.0	16.0	0.3	30.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.4	0.0	10.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	65.4	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.2	0.3	0.2	0.1	0.0	0.1	0.1	0.1	0.0	0.2	0.1	0.1	0.0	0.0	1.3	0.0	18.9	5.0	3.9	39.3	0.4	0.1	0.3	0.5	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	23.5	0.2	0.0	0.2	0.0	0.0	1.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.2	0.0	0.0	0.0	2.1	17.5	0.6	0.1	0.0	0.0	0.0	0.2	0.0	2.0	1.4	0.1	0.0	0.0	0.0	1.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	28.2	0.7	48.3	50.2	0.0	0.1	0.0	0.0	6.0
CERS4	"FLJ12089, LASS4, Trh1"	ENSG00000090661	"Ceramide synthase 4"	Q9HA82	19	8206736-8262421	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Hepatocytes: 71.3;Muller glia cells: 150.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Hep G2: 55.1;NB-4: 99.8;U-937: 61.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB033734, HPA054729"	Uncertain		Supported	Nucleoplasm,Vesicles		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 22: Non-specific - Unknown function"	"Cluster 24: NB-4 - Immune response"	"Cluster 5: Muller glia cells - Visual perception"	"Nucleoplasm, Vesicles"		"CAB033734: AB_2132977, HPA054729: "	"unprognostic (5.96e-2)"	"prognostic favorable (2.71e-4)"	"unprognostic (2.46e-2)"	"unprognostic (2.82e-2)"	"unprognostic (1.30e-1)"	"prognostic favorable (7.83e-4)"	"unprognostic (1.74e-1)"	"prognostic favorable (3.45e-5)"	"unprognostic (1.48e-2)"	"unprognostic (3.32e-1)"	"prognostic favorable (8.05e-4)"	"unprognostic (1.77e-1)"	"prognostic favorable (9.63e-5)"	"unprognostic (6.08e-3)"	"unprognostic (2.69e-2)"	"unprognostic (2.91e-2)"	"unprognostic (8.08e-3)"	13.6	13.0	31.8	10.0	38.9	3.4	31.1	26.6	37.1	35.9	18.7	17.7	6.3	21.5	61.5	64.3	21.3	11.2	14.8	35.3	25.2	27.8	57.7	19.4	19.9	36.9	30.5	22.0	89.1	29.0	22.2	1.9	30.8	32.9	3.9	36.9	55.0	17.6	3.1	47.7	15.2	12.0	26.8	17.7	26.8	11.5	30.7	13.1	51.9	5.3	20.4	18.4	32.7	44.0	0.4	2.1	2.1	25.0	0.8	0.2	1.7	3.1	8.4	3.7	1.7	19.5	1.7	40.0	27.4	0.0	9.6	13.6	16.4	0.4	1.7	35.5	12.4	7.6	0.1	55.1	31.6	0.0	21.3	12.3	20.7	8.8	18.9	10.5	0.3	17.7	5.9	1.2	0.0	0.8	2.6	99.8	25.4	0.2	8.7	49.1	0.8	3.0	6.3	0.0	9.3	12.2	4.3	0.7	14.5	16.7	18.8	8.8	0.2	2.9	7.8	18.6	0.1	24.5	21.1	32.0	0.1	61.9	2.8	12.3	7.1	27.4	7.5	3.9	5.7	19.8	4.3	4.6	4.1	17.7	3.9	3.8	22.4	22.4	2.4	3.9	5.5	5.8	31.8	38.9	26.6	37.1	35.3	25.2	36.9	30.5	30.8	26.8	30.7	44.0	3.2	6.4	10.7	27.1	31.2	18.0	13.2	12.0	15.4	24.5	47.0	28.8	4.1	22.8	22.2	1.8	18.8	3.4	17.2	0.2	7.9	20.0	1.7	7.9	11.2	8.6	23.9	4.0	38.3	30.5	0.9	15.7	3.1	7.6	12.7	14.4	8.2	71.3	16.4	11.8	24.4	1.3	8.2	7.1	7.2	7.3	14.3	6.7	26.6	16.9	19.6	150.3	27.8	47.7	48.1	9.4	2.5	16.1	12.4	40.6	0.4	44.6	27.8	29.5	6.6	6.9	13.8	1.0	1.6	20.6	25.9	2.9	15.7	2.7	2.5	11.9
CES1	"CEH, CES1A1, CES1A2, CES2, HMSE, HMSE1, SES1"	ENSG00000198848	"Carboxylesterase 1"	P23141	16	55802851-55833337	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Serine esterase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"liver: 2517.1"	"Group enriched"	"Detected in many"	7	"Cholangiocytes: 613.4;Hepatocytes: 2420.8"	"Cancer enriched"	"Detected in all"	6	"liver cancer: 711.4"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	16	"classical monocyte: 109.6;myeloid DC: 114.5"	"Group enriched"	"Detected in many"	22	"dendritic cells: 114.5;monocytes: 109.6"	"Group enriched"	"Detected in some"	5	"Hep G2: 700.9;THP-1: 688.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA012023, HPA046717"	Enhanced		Supported	"Endoplasmic reticulum"	"Intracellular and membrane"	No	NA		40000000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 60: Liver - Hemostasis & Lipid metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 2: Hepatocytes - Metabolism"	"Endoplasmic reticulum"		"HPA012023: AB_1846554, HPA046717: AB_2679770"	"unprognostic (1.04e-2)"	"unprognostic (9.85e-2)"	"unprognostic (2.94e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.55e-3)"	"unprognostic (7.46e-3)"	"unprognostic (1.51e-1)"	"unprognostic (1.42e-1)"	"unprognostic (3.51e-1)"	"unprognostic (5.74e-2)"	"unprognostic (4.62e-2)"	"unprognostic (3.29e-2)"	"unprognostic (1.91e-2)"	"unprognostic (5.32e-2)"	"unprognostic (1.92e-1)"	"unprognostic (2.87e-1)"	"prognostic unfavorable (9.92e-4)"	94.9	14.1	0.9	3.2	1.2	27.0	43.6	0.8	1.8	26.6	3.7	82.3	24.0	60.4	7.5	41.1	54.6	272.9	66.1	1.0	1.4	6.7	2517.1	167.8	1.8	2.3	1.2	20.3	8.8	0.7	3.7	8.5	1.5	39.2	12.3	2.9	41.4	36.4	5.2	14.0	27.4	40.4	1.0	41.0	56.1	7.8	1.1	2.5	9.9	9.4	1.0	57.7	17.7	1.1	0.7	4.4	0.0	0.0	90.8	0.6	3.1	0.3	0.0	0.0	0.0	43.5	0.0	0.0	19.4	0.0	1.4	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.9	700.9	0.0	1.3	0.1	0.2	0.3	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	40.8	0.1	0.6	0.0	0.0	1.5	6.7	0.0	0.5	0.0	0.1	3.2	0.1	1.1	0.9	0.0	688.0	0.1	0.0	0.4	0.2	0.5	2.2	0.1	1.0	0.0	151.7	0.0	0.0	109.6	0.5	4.5	6.1	1.5	1.1	0.7	5.0	114.5	1.2	0.7	1.1	0.6	0.3	1.6	6.8	0.4	58.0	0.9	1.2	0.8	1.8	1.0	1.4	2.3	1.2	1.5	1.0	1.1	1.1	2.0	16.0	67.6	0.0	11.3	16.7	5.3	6.8	1.2	0.0	1.2	8.1	0.8	613.4	31.5	16.5	0.0	0.5	12.2	0.1	0.0	15.4	79.6	1.0	10.6	8.9	37.5	177.7	0.0	18.7	2.2	57.4	1.1	0.2	6.3	0.0	66.0	2420.8	18.1	0.0	0.0	12.2	4.1	107.3	26.7	197.8	18.6	58.7	39.2	1.0	39.6	10.4	7.2	0.0	0.0	0.9	1.3	98.9	1.8	1.5	0.6	0.9	169.0	0.9	0.0	9.8	9.8	1.0	2.3	20.6	11.6	0.8	16.9	0.9	0.7	2.6
CES2	"CE-2, CES2A1, iCE"	ENSG00000172831	"Carboxylesterase 2"	O00748	16	66934444-66945096	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Hydrolase, Serine esterase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 703.3;liver: 345.7"	"Cell type enhanced"	"Detected in all"		"Distal enterocytes: 794.4;Hepatocytes: 518.5;Paneth cells: 519.2;Proximal enterocytes: 2529.8;Undifferentiated cells: 499.5"	"Cancer enhanced"	"Detected in all"		"liver cancer: 104.4"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Not detected"	"Not detected"							"HPA018897, HPA074629"	Enhanced		Approved	"Endoplasmic reticulum,Golgi apparatus,Cytosol"	"Intracellular and membrane"	NA	NA		6400000	"Cluster 44: Non-specific - Transcription"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 45: Enterocytes - Digestion"	"Golgi apparatus"	"Endoplasmic reticulum, Cytosol"	"HPA018897: AB_1846558, HPA074629: "	"unprognostic (8.15e-3)"	"unprognostic (1.82e-2)"	"unprognostic (1.32e-1)"	"unprognostic (2.67e-3)"	"unprognostic (2.74e-2)"	"unprognostic (1.38e-1)"	"unprognostic (5.80e-2)"	"unprognostic (1.31e-1)"	"unprognostic (6.93e-2)"	"unprognostic (7.99e-2)"	"unprognostic (1.73e-3)"	"unprognostic (2.66e-2)"	"prognostic favorable (1.50e-5)"	"unprognostic (8.01e-2)"	"unprognostic (1.53e-1)"	"unprognostic (4.14e-2)"	"unprognostic (1.38e-1)"	18.8	38.1	21.2	18.1	20.6	6.3	13.5	24.1	23.0	22.0	25.6	191.2	703.3	14.6	14.4	132.7	17.9	19.5	51.4	22.1	20.6	96.5	345.7	15.6	11.9	20.8	20.8	17.0	14.4	38.0	15.7	10.1	20.6	16.7	178.8	16.2	32.9	15.0	33.8	32.7	576.5	19.7	20.0	12.4	41.6	9.3	20.9	13.1	27.9	14.3	20.8	13.7	33.5	20.5	11.6	16.6	18.4	25.9	19.5	17.9	14.5	15.9	25.8	17.6	22.1	17.3	23.5	15.7	14.3	20.9	13.3	35.4	14.2	39.8	15.3	10.7	18.9	14.4	9.6	44.2	26.3	21.6	26.3	25.4	82.5	26.0	46.7	24.6	14.1	11.3	22.2	10.9	35.7	9.1	17.7	21.4	10.8	16.3	18.8	20.9	19.1	19.8	60.7	18.6	11.6	16.0	50.9	12.6	14.5	8.1	21.0	26.5	17.5	22.4	12.6	15.3	11.1	23.3	24.0	18.4	36.7	17.3	17.4	4.1	5.4	1.6	5.1	3.8	4.5	3.0	4.1	5.8	4.5	3.1	4.8	4.5	1.6	4.3	4.1	4.3	3.2	3.1	21.2	20.6	24.1	23.0	22.1	20.6	20.8	20.8	20.6	20.0	20.9	20.5	13.2	32.1	24.6	8.8	18.8	19.5	13.5	32.8	39.3	31.2	12.4	18.3	33.6	115.8	19.8	53.3	20.9	16.1	12.9	794.4	37.2	24.6	2.1	26.9	15.0	14.1	24.1	7.8	7.0	33.8	5.7	15.3	60.6	33.7	27.3	80.7	28.5	518.5	19.6	28.6	9.7	196.0	18.3	37.0	9.6	2.3	18.6	15.3	10.6	10.3	19.5	19.0	21.6	8.0	5.9	51.8	519.2	18.0	8.5	19.1	2529.8	176.0	85.4	24.2	32.9	19.5	15.2	47.2	19.7	116.1	20.5	13.5	13.0	22.1	499.5	16.7
CETN3	CEN3	ENSG00000153140	"Centrin 3"	O15182	5	90392257-90409766	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, mRNA transport, Protein transport, Translocation, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 130.4"	"Cell type enriched"	"Detected in all"	4	"Spermatocytes: 469.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035608, HPA063704"	Enhanced		Supported	Centrosome		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 21: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	Centrosome		"HPA035608: AB_10601098, HPA063704: AB_2685097"	"unprognostic (2.08e-1)"	"unprognostic (7.31e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.86e-1)"	"unprognostic (2.53e-1)"	"unprognostic (1.58e-2)"	"prognostic unfavorable (2.22e-4)"	"unprognostic (1.27e-1)"	"unprognostic (2.18e-2)"	"unprognostic (8.77e-2)"	"unprognostic (5.03e-1)"	"unprognostic (5.64e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.21e-1)"	"unprognostic (1.53e-1)"	"unprognostic (5.21e-2)"	"unprognostic (2.35e-1)"	17.4	21.6	18.5	14.7	20.6	7.6	24.0	19.3	26.3	20.6	19.0	16.9	9.7	20.0	21.8	13.5	22.7	10.3	22.1	18.3	20.0	19.8	13.5	13.4	19.1	21.2	19.6	31.0	9.3	24.4	16.8	19.3	21.2	19.0	19.6	35.3	15.1	14.7	14.4	15.4	10.6	13.9	19.3	15.1	12.9	130.4	19.8	20.6	15.2	14.1	21.0	11.3	11.7	27.1	38.4	18.7	66.2	13.4	38.8	49.2	39.5	41.2	25.4	39.7	47.1	25.5	45.3	71.7	40.4	20.2	76.9	26.2	58.5	57.4	63.5	59.6	27.2	36.4	26.9	32.6	27.3	26.9	22.2	32.7	36.6	29.4	49.1	42.5	24.1	56.8	47.2	30.9	44.3	26.5	46.2	42.6	23.2	14.0	42.6	40.6	45.7	37.0	35.1	14.5	36.0	37.2	40.2	19.9	31.7	59.1	37.7	36.6	28.0	22.6	32.7	32.0	55.7	28.6	55.5	63.6	26.9	60.5	23.3	19.7	9.9	14.8	12.9	13.1	13.7	27.3	14.3	14.6	11.3	21.8	20.4	16.3	1.2	17.3	16.6	30.6	13.3	6.9	18.5	20.6	19.3	26.3	18.3	20.0	21.2	19.6	21.2	19.3	19.8	27.1	19.5	19.2	38.7	13.4	17.8	14.3	34.3	70.3	22.2	19.3	23.5	25.7	53.0	27.1	37.5	36.8	18.8	69.4	13.4	11.9	95.9	21.8	20.2	41.4	26.6	22.4	24.0	54.1	8.4	10.0	69.5	33.0	6.1	24.4	6.3	19.6	48.5	42.2	26.0	21.9	12.6	21.2	48.8	19.2	5.1	38.5	44.1	10.3	19.6	8.4	19.6	84.0	17.5	15.1	34.1	12.8	21.4	32.4	8.4	16.5	8.5	46.2	75.9	24.4	59.2	14.2	23.8	469.5	66.3	19.6	15.8	41.7	15.0	17.2	24.8	21.6
CFAP20	"C16orf80, fSAP23, GTL3"	ENSG00000070761	"Cilia and flagella associated protein 20"	Q9Y6A4	16	58113592-58129381	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 336.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018195	Uncertain		Supported	Nucleoplasm		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 14: REH - Unknown function"	"Cluster 29: Early spermatids - Spermatogenesis"	Nucleoplasm		"HPA018195: AB_1850408"	"unprognostic (9.96e-2)"	"unprognostic (5.44e-2)"	"unprognostic (3.80e-1)"	"unprognostic (7.45e-2)"	"unprognostic (2.27e-1)"	"unprognostic (7.14e-3)"	"unprognostic (9.55e-2)"	"unprognostic (2.20e-1)"	"unprognostic (7.12e-2)"	"unprognostic (3.87e-1)"	"unprognostic (2.86e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.15e-2)"	"unprognostic (9.72e-2)"	"unprognostic (9.71e-2)"	"unprognostic (7.58e-3)"	"unprognostic (1.47e-1)"	20.3	23.8	34.9	15.6	36.9	26.0	20.9	35.2	37.9	20.7	33.8	16.8	17.3	20.1	23.1	18.9	36.2	18.0	43.1	35.5	38.2	20.6	33.8	20.5	25.5	33.3	35.0	31.3	14.6	34.7	30.9	30.2	35.1	18.6	16.1	28.5	17.5	17.8	12.1	20.8	16.6	17.5	37.8	18.1	16.4	30.8	35.8	39.3	26.5	20.0	21.9	18.1	17.8	38.1	58.1	45.6	75.5	40.9	27.6	22.0	59.2	53.7	37.4	83.3	53.7	73.3	61.4	60.1	75.5	36.4	37.8	58.0	70.7	53.3	82.2	34.5	75.0	34.1	25.3	97.7	32.1	51.7	64.9	24.9	36.3	53.1	47.9	31.8	51.6	92.5	57.2	28.0	66.3	43.7	147.4	104.2	69.5	39.7	91.6	141.5	94.3	56.7	46.8	35.6	68.7	61.2	95.7	36.9	54.0	51.8	32.0	63.3	36.1	51.0	67.0	56.3	62.1	33.7	33.5	115.1	33.3	53.5	70.0	88.6	29.6	52.9	46.4	30.2	45.5	55.0	48.1	49.6	33.9	49.7	64.0	54.3	24.8	66.6	31.1	56.8	94.9	52.5	34.9	36.9	35.2	37.9	35.5	38.2	33.3	35.0	35.1	37.8	35.8	38.1	70.9	12.8	20.3	10.4	21.8	0.0	38.5	0.0	60.3	28.7	28.7	50.9	51.7	30.0	16.1	20.2	33.3	101.9	29.3	7.4	56.7	36.7	336.7	60.1	29.2	58.7	24.3	19.1	7.3	16.5	75.3	40.8	18.8	22.0	12.6	22.5	30.4	35.7	35.1	18.5	7.7	19.6	0.0	11.4	0.0	137.7	33.8	17.4	0.0	3.7	17.4	32.3	23.7	16.6	21.0	22.6	17.2	31.2	19.1	30.8	23.5	34.7	33.5	38.8	19.7	60.9	30.3	109.7	30.3	35.6	0.0	65.9	31.6	38.5	17.2	19.5
CFAP410	"A2, C21orf2, LRRC76, YF5"	ENSG00000160226	"Cilia and flagella associated protein 410"	O43822	21	44328944-44339402	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"	"Cilium biogenesis/degradation, DNA damage"		"Ciliopathy, Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Cytotrophoblasts: 30.8;Extravillous trophoblasts: 15.7;Hofbauer cells: 35.5;Syncytiotrophoblasts: 32.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030283, HPA030284, CAB034126, CAB034128"	Supported		Supported	Vesicles,Mitochondria,Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 24: Non-specific - Transcription regulation"	Mitochondria	"Vesicles, Cytosol"	"CAB034126: AB_1564257, CAB034128: AB_1564259, HPA030283: , HPA030284: AB_10602700"	"unprognostic (1.84e-1)"	"unprognostic (1.56e-1)"	"unprognostic (3.14e-2)"	"unprognostic (1.29e-2)"	"unprognostic (2.11e-3)"	"unprognostic (1.36e-1)"	"unprognostic (6.58e-2)"	"unprognostic (1.13e-2)"	"unprognostic (9.73e-2)"	"unprognostic (2.77e-1)"	"prognostic favorable (1.32e-4)"	"unprognostic (1.49e-1)"	"prognostic favorable (4.08e-4)"	"unprognostic (2.98e-1)"	"unprognostic (2.79e-1)"	"unprognostic (1.32e-2)"	"unprognostic (1.06e-1)"	19.8	22.2	14.5	5.1	14.6	11.4	19.5	13.8	18.6	22.9	12.7	21.1	6.5	23.4	2.3	12.5	26.3	3.8	19.9	14.9	14.5	26.0	26.8	18.5	6.6	16.5	16.8	22.3	24.0	7.5	34.4	3.3	14.5	26.3	1.4	10.0	18.6	5.0	16.1	17.9	19.2	2.4	13.9	20.9	20.7	30.9	18.5	4.2	32.8	4.9	2.3	19.2	14.8	16.2	12.9	5.2	4.9	6.3	3.2	2.0	19.3	6.4	3.7	2.5	1.3	9.4	3.7	9.1	12.5	2.2	5.1	6.0	0.9	1.2	0.6	14.2	12.9	9.5	4.3	11.2	4.1	10.2	9.8	2.9	2.2	1.0	2.2	4.4	1.6	6.7	11.6	15.1	1.6	15.5	11.2	25.0	12.2	6.4	7.8	28.6	6.3	20.3	2.9	18.0	12.9	12.2	8.9	2.1	11.0	2.9	9.3	22.0	7.5	5.4	6.9	5.8	4.9	25.1	14.2	6.4	13.2	20.4	9.9	1.7	10.2	1.6	9.4	12.6	11.3	16.6	10.0	13.2	10.5	11.6	11.3	11.1	1.3	17.3	9.5	31.3	6.1	7.6	14.5	14.6	13.8	18.6	14.9	14.5	16.5	16.8	14.5	13.9	18.5	16.2	5.5	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	30.8	6.9	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	15.7	7.4	0.0	0.0	0.0	0.0	0.0	0.0	35.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	32.7	1.1	0.0	0.0	0.0
CFL1	CFL	ENSG00000172757	"Cofilin 1"	P23528	11	65823022-65862026	"Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction"	Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB013086, CAB033687, CAB037077, HPA053761"	Approved		Supported	Cytosol		NA	NA		290000000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	Cytosol		"CAB013086: AB_2533565, CAB033687: AB_1121774, CAB037077: AB_1078547, HPA053761: AB_2682251"	"unprognostic (1.14e-1)"	"unprognostic (2.37e-2)"	"unprognostic (7.69e-3)"	"unprognostic (4.32e-3)"	"unprognostic (3.14e-2)"	"unprognostic (2.09e-2)"	"prognostic unfavorable (1.73e-5)"	"unprognostic (1.59e-3)"	"unprognostic (2.52e-1)"	"unprognostic (5.88e-3)"	"unprognostic (6.57e-3)"	"unprognostic (2.09e-1)"	"unprognostic (6.19e-3)"	"unprognostic (1.72e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.49e-1)"	"unprognostic (2.06e-1)"	609.5	435.4	578.8	932.7	598.8	1322.1	514.5	590.1	661.2	451.5	475.3	1145.1	1169.2	713.1	343.2	706.0	481.5	413.6	501.9	637.3	599.8	612.5	471.0	683.4	987.6	626.4	571.5	344.7	264.6	301.8	340.6	479.2	622.1	440.6	990.3	208.9	453.1	457.6	261.9	503.1	1120.7	847.3	608.3	775.2	633.8	267.4	632.2	939.6	370.9	230.6	1100.5	682.9	471.2	695.4	2284.3	1783.6	1908.5	1529.8	1142.6	1157.0	1031.6	2309.7	1942.4	2457.5	1460.7	1012.4	1815.2	1700.8	1755.3	2925.7	1780.5	1623.2	1389.2	2103.8	1824.9	1869.0	718.2	2185.8	1271.2	1162.1	1222.6	1890.2	2854.6	1339.3	1412.4	2166.7	1108.0	1494.0	2663.1	1099.4	1037.6	1648.5	2635.7	2133.0	2739.4	2965.4	2095.8	1985.4	1432.7	2050.3	941.1	2181.9	1847.8	1468.6	952.7	2106.6	1250.6	1733.6	1682.2	1053.4	2104.1	1427.8	2330.5	2087.3	1603.5	2672.6	2194.0	1193.1	2065.2	2251.0	2146.2	1161.7	2004.4	1690.2	2720.0	2973.1	2534.0	2955.4	1964.6	1561.4	1992.5	2296.2	3343.8	1527.0	1459.3	1905.2	2946.2	1961.1	3255.3	2558.6	2696.1	6842.2	578.8	598.8	590.1	661.2	637.3	599.8	626.4	571.5	622.1	608.3	632.2	695.4	805.5	246.8	223.0	24.5	890.8	1349.3	1253.3	1197.1	598.8	198.5	655.2	646.0	74.8	459.0	595.7	520.5	58.4	1239.8	1439.8	2052.9	892.1	2114.0	459.4	376.6	648.1	918.4	779.0	557.7	38.8	1965.0	2470.6	579.0	642.8	603.3	598.2	527.4	698.2	436.3	2911.0	203.6	30.3	1448.8	891.1	1185.5	1706.6	373.2	352.2	1474.2	985.4	38.4	2903.8	478.3	2075.2	22.6	62.0	3082.4	1894.7	502.9	639.1	991.2	2279.4	1246.5	295.5	118.0	420.7	448.2	1184.3	177.4	412.8	703.8	1267.4	1732.4	1276.2	621.7	1315.3	1383.3
CFLAR	"c-FLIP, CASH, CASP8AP1, Casper, cFLIP, CLARP, FLAME, FLIP, I-FLICE, MRIT"	ENSG00000003402	"CASP8 and FADD like apoptosis regulator"	O15519	2	201116154-201176687	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	"Apoptosis, Host-virus interaction"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Langerhans cells: 609.9;Urothelial cells: 521.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in all"	4	"neutrophil: 392.6"	"Lineage enriched"	"Detected in all"	6	"granulocytes: 392.6"	"Cell line enhanced"	"Detected in all"		"U-266/70: 214.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019044, CAB022157, CAB025216"	Uncertain		Supported	"Nucleoplasm,Nuclear bodies,Plasma membrane,Cytosol"		NA	Yes			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 41: Macrophages - Immune response"	"Nucleoplasm, Plasma membrane, Cytosol"	"Nuclear bodies"	"CAB022157: , CAB025216: , HPA019044: AB_10696204"	"unprognostic (4.61e-2)"	"unprognostic (5.32e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.95e-2)"	"prognostic favorable (2.79e-4)"	"unprognostic (7.46e-2)"	"unprognostic (9.01e-2)"	"unprognostic (1.76e-1)"	"unprognostic (6.12e-2)"	"unprognostic (3.08e-2)"	"unprognostic (4.91e-2)"	"unprognostic (2.90e-2)"	"unprognostic (7.83e-2)"	"unprognostic (9.13e-2)"	"unprognostic (6.84e-2)"	"unprognostic (2.24e-2)"	122.4	50.6	38.8	103.9	40.9	247.6	83.1	54.1	47.4	57.0	75.6	86.0	59.2	57.9	60.6	68.0	66.6	71.6	184.8	39.4	32.7	57.5	59.2	174.6	91.1	46.5	40.5	38.3	40.7	31.8	29.4	94.0	42.1	65.6	56.4	12.4	58.0	63.2	222.8	51.0	64.8	58.8	36.6	98.1	56.5	25.3	51.9	54.1	78.8	89.2	107.3	78.7	61.7	46.1	21.5	42.9	30.0	17.9	92.3	71.0	37.5	53.6	92.1	34.3	41.6	50.4	78.4	5.8	49.6	62.5	41.6	15.5	9.8	40.3	53.9	160.7	29.9	32.3	38.4	82.2	63.6	24.2	102.2	76.8	39.6	58.2	50.3	41.7	176.7	7.3	110.8	131.2	63.1	17.9	11.3	96.3	10.2	17.2	32.7	11.7	7.2	46.5	42.5	44.0	6.6	11.8	35.7	31.2	43.2	19.6	22.1	44.8	193.6	71.0	29.5	26.7	26.1	214.6	76.2	35.9	50.6	19.5	36.3	91.8	60.3	70.3	54.4	61.8	48.4	25.6	46.5	52.1	33.4	20.9	29.5	38.3	392.6	45.2	68.5	23.0	60.7	42.0	38.8	40.9	54.1	47.4	39.4	32.7	46.5	40.5	42.1	36.6	51.9	46.1	191.3	451.9	234.9	30.3	126.4	54.8	229.6	164.9	29.0	10.9	38.9	30.0	205.8	102.9	206.7	69.9	31.3	77.2	166.2	132.5	74.3	148.8	83.3	202.8	75.0	261.0	95.1	59.1	6.9	72.5	34.8	89.5	73.4	219.2	81.6	93.4	201.0	97.5	68.6	13.5	16.8	76.8	40.7	123.2	609.9	44.8	51.9	278.0	97.8	146.1	247.0	23.4	276.0	29.7	56.8	166.4	155.6	49.7	317.8	386.0	116.7	101.5	276.1	30.7	39.5	113.2	77.9	14.4	12.2	33.2	86.1	70.1	168.3	56.1	50.9	521.3
CGAS	"C6orf150, MB21D1"	ENSG00000164430	"Cyclic GMP-AMP synthase"	Q8N884	6	73413515-73452297	"Enzymes, Predicted intracellular proteins"	"Antiviral defense, DNA damage, DNA repair, Host-virus interaction, Immunity, Innate immunity"	"DNA-binding, Nucleotidyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 14.0"	"Cell type enhanced"	"Detected in some"		"Adipocytes: 10.2;dendritic cells: 12.0;Glandular and luminal cells: 12.5;Hofbauer cells: 12.4;Macrophages: 10.0;monocytes: 27.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 37.1;RH-30: 43.8;RPMI-8226: 45.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA031700, HPA031702"	Enhanced		Supported	Nucleoplasm		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm		"HPA031700: AB_10601693, HPA031702: AB_2673999"	"unprognostic (2.49e-1)"	"unprognostic (2.36e-1)"	"unprognostic (4.61e-2)"	"unprognostic (4.95e-2)"	"unprognostic (2.49e-2)"	"unprognostic (1.81e-1)"	"unprognostic (4.84e-3)"	"unprognostic (1.01e-2)"	"unprognostic (9.80e-2)"	"unprognostic (4.25e-2)"	"unprognostic (2.20e-2)"	"unprognostic (2.77e-1)"	"prognostic unfavorable (2.27e-7)"	"unprognostic (1.93e-3)"	"unprognostic (1.17e-2)"	"unprognostic (1.86e-1)"	"unprognostic (2.78e-1)"	2.9	1.1	1.7	6.4	2.1	14.0	1.7	2.2	3.0	2.4	1.7	1.9	2.7	1.9	0.6	2.3	1.8	2.6	1.5	1.9	2.0	1.1	0.8	3.5	7.4	2.6	2.2	1.2	1.2	0.6	0.6	3.1	2.6	1.9	1.8	0.2	1.8	1.8	0.5	1.1	2.5	2.0	2.4	5.2	2.3	1.0	3.0	2.3	1.6	0.9	4.7	4.3	2.1	3.4	19.9	5.8	0.1	0.2	1.2	2.7	0.1	10.1	3.7	11.3	12.6	20.7	14.2	0.2	20.9	4.3	6.3	10.1	9.8	0.2	12.0	31.9	0.0	16.9	8.2	0.1	4.0	12.3	11.5	1.6	3.2	11.8	0.1	0.0	3.5	0.1	0.0	37.1	8.7	8.0	0.0	27.1	6.2	2.4	11.2	23.4	43.8	45.2	0.0	7.3	0.3	0.1	17.3	0.4	10.2	0.2	0.0	33.9	5.0	0.0	9.1	8.5	0.2	8.1	19.8	0.2	0.1	17.5	11.4	26.3	12.7	19.0	6.0	17.5	4.7	8.4	7.9	5.9	7.5	6.7	1.8	3.4	8.5	4.2	11.6	17.6	8.0	6.0	1.7	2.1	2.2	3.0	1.9	2.0	2.6	2.2	2.6	2.4	3.0	3.4	10.2	3.2	4.8	0.0	4.7	0.0	0.0	0.0	0.0	0.0	2.6	1.8	0.0	0.0	0.6	0.0	0.0	0.2	12.0	0.0	0.0	2.0	0.0	8.4	8.5	6.0	0.0	0.0	0.0	3.9	0.7	2.3	0.0	12.5	5.1	1.0	0.0	0.0	12.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.0	0.0	0.0	27.4	0.0	0.0	0.0	0.0	5.9	0.0	0.0	3.0	0.0	0.0	0.2	2.9	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.3	8.0	0.7	0.0	0.0
CGN	KIAA1319	ENSG00000143375	Cingulin	Q9P2M7	1	151510510-151538692	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 56.4"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 118.6;Distal enterocytes: 173.2;Paneth cells: 108.7;Proximal enterocytes: 88.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"CACO-2: 91.4;CAPAN-2: 59.1;OE19: 58.6;RT4: 44.0"	"Low region specificity"	"Detected in many"							"CAB017193, HPA027586, HPA027587, HPA027657"	Enhanced		Supported	"Plasma membrane,Cell Junctions"		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Plasma membrane, Cell Junctions"		"CAB017193: , HPA027586: AB_10600208, HPA027587: AB_10601884, HPA027657: AB_10611527"	"unprognostic (1.57e-1)"	"unprognostic (4.30e-2)"	"unprognostic (1.12e-1)"	"unprognostic (8.74e-3)"	"unprognostic (1.02e-1)"	"unprognostic (3.01e-1)"	"unprognostic (1.98e-1)"	"unprognostic (8.38e-2)"	"unprognostic (4.61e-1)"	"unprognostic (2.11e-2)"	"unprognostic (2.96e-3)"	"unprognostic (7.10e-2)"	"prognostic favorable (5.84e-10)"	"unprognostic (2.66e-1)"	"unprognostic (3.00e-1)"	"unprognostic (8.28e-2)"	"unprognostic (2.10e-2)"	5.8	1.1	1.9	6.0	3.3	0.4	9.0	8.5	3.3	4.9	6.5	37.2	52.7	1.4	1.5	8.6	13.2	13.6	0.6	2.0	3.7	12.2	32.1	27.3	0.4	5.5	3.0	2.0	24.2	32.1	3.7	1.6	5.6	10.1	25.1	3.7	21.1	7.0	0.2	17.9	56.4	1.5	1.7	0.4	30.4	6.6	3.4	0.7	4.9	0.1	2.3	8.3	6.2	6.7	28.9	3.2	2.7	4.6	0.0	0.0	35.4	0.1	0.1	0.8	0.9	91.4	59.1	1.3	9.4	0.0	4.9	27.0	8.6	5.0	0.6	17.3	6.0	2.4	1.3	1.8	0.0	0.4	3.6	0.0	1.0	1.3	0.7	0.0	0.3	7.8	1.2	8.1	0.0	26.8	5.0	0.6	22.9	58.6	2.5	5.4	2.8	4.3	17.9	44.0	8.9	4.4	1.8	27.1	1.0	10.3	33.5	0.3	0.5	0.3	8.3	0.5	1.2	7.7	8.4	5.2	0.3	3.3	2.4	0.2	0.1	0.0	0.5	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.2	0.4	0.2	0.1	0.1	0.1	0.0	1.9	3.3	8.5	3.3	2.0	3.7	5.5	3.0	5.6	1.7	3.4	6.7	0.1	118.6	33.3	2.3	0.2	0.3	3.3	5.9	0.6	4.3	14.9	9.1	0.7	24.3	22.4	3.7	0.0	3.5	0.5	173.2	0.0	21.5	0.3	13.8	2.1	0.6	10.3	2.7	0.8	25.4	0.3	2.3	54.6	27.3	0.0	0.5	0.0	29.6	0.3	0.0	10.4	32.7	8.2	0.0	0.4	1.2	0.6	0.5	3.6	0.0	2.1	13.5	0.0	3.5	11.7	49.5	108.7	0.7	0.5	11.9	88.7	3.0	46.8	1.5	0.0	0.1	1.0	1.5	6.9	4.2	1.8	0.4	0.6	1.8	27.2	18.3
CGNL1	"FLJ14957, JACOP, KIAA1749, PCING"	ENSG00000128849	"Cingulin like 1"	Q0VF96	15	57375967-57550717	"Disease related genes, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 68.3"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 87.2;Astrocytes: 79.7;Hepatic stellate cells: 58.5;Hepatocytes: 65.5;Microglial cells: 156.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 52.7;SuSa: 37.6;TIME: 32.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013500, HPA056911, HPA069214"	Enhanced		Supported	"Nuclear bodies,Cell Junctions"		No	No				"Cluster 15: Liver - Metabolism"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 11: Alveolar cells - Smell perception"	"Cell Junctions"	"Nuclear bodies"	"CAB013500: , HPA056911: AB_2683274, HPA069214: AB_2686102"	"unprognostic (1.04e-2)"	"unprognostic (2.42e-1)"	"unprognostic (1.52e-2)"	"prognostic favorable (3.55e-4)"	"unprognostic (3.22e-1)"	"unprognostic (1.51e-3)"	"prognostic favorable (5.58e-4)"	"unprognostic (4.32e-2)"	"unprognostic (2.34e-1)"	"unprognostic (4.86e-2)"	"unprognostic (4.05e-2)"	"unprognostic (1.91e-2)"	"prognostic favorable (1.37e-6)"	"unprognostic (2.26e-2)"	"unprognostic (3.39e-1)"	"unprognostic (1.88e-3)"	"unprognostic (1.18e-2)"	5.0	11.5	23.6	1.5	23.0	0.0	19.8	19.8	18.5	32.0	47.2	3.2	1.2	17.8	4.4	11.0	8.9	2.8	20.1	18.6	24.2	68.3	36.0	21.0	1.1	28.9	28.2	5.8	18.6	9.6	4.1	28.8	27.7	28.7	2.3	12.3	32.3	16.2	0.7	11.5	2.5	10.8	20.0	0.4	15.5	6.6	29.9	4.6	19.8	1.9	3.2	8.9	20.2	15.7	0.0	1.3	13.1	0.0	0.0	0.0	0.2	0.2	2.9	1.1	2.4	8.4	0.1	0.0	11.4	1.7	1.9	0.0	6.2	0.1	1.8	0.1	1.0	0.1	0.1	5.7	0.2	0.1	0.0	0.4	0.4	1.3	0.0	4.4	52.7	0.5	0.0	0.0	2.1	2.4	0.0	0.2	6.5	3.7	0.6	0.1	6.6	0.3	4.4	0.0	0.3	0.7	0.0	5.1	0.0	37.6	0.5	0.6	32.5	0.0	3.3	0.1	1.9	0.0	0.0	0.0	0.2	6.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.6	23.0	19.8	18.5	18.6	24.2	28.9	28.2	27.7	20.0	29.9	15.7	3.9	51.3	87.2	79.7	0.2	4.6	13.4	5.1	4.6	0.4	27.4	27.1	21.0	10.0	11.7	22.0	0.0	1.0	1.6	0.9	41.1	9.9	3.0	11.0	9.4	21.8	13.1	2.7	0.7	13.2	1.0	17.1	11.2	11.8	1.3	3.5	58.5	65.5	0.3	0.0	1.9	3.7	18.3	1.6	4.9	18.1	19.9	0.9	7.2	156.4	0.6	43.7	0.0	11.1	1.5	4.3	1.2	27.8	0.0	18.6	0.2	39.4	2.2	1.4	0.0	6.6	2.3	0.6	0.6	0.8	2.4	1.4	1.2	0.6	2.2	7.0
CGRRF1	"CGR19, RNF197"	ENSG00000100532	"Cell growth regulator with ring finger domain 1"	Q99675	14	54509812-54539292	"Predicted intracellular proteins, Predicted membrane proteins"	"Cell cycle, Growth arrest"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 145.4;Spermatocytes: 112.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002930	Uncertain		Supported	Nucleoplasm,Vesicles		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm	Vesicles	"HPA002930: AB_1078507"	"unprognostic (1.81e-1)"	"unprognostic (3.76e-1)"	"unprognostic (5.61e-2)"	"unprognostic (4.38e-1)"	"unprognostic (1.01e-1)"	"unprognostic (3.21e-1)"	"prognostic unfavorable (6.84e-4)"	"unprognostic (2.25e-1)"	"unprognostic (5.58e-2)"	"unprognostic (2.63e-1)"	"unprognostic (7.29e-2)"	"unprognostic (2.64e-3)"	"prognostic favorable (2.57e-8)"	"unprognostic (2.94e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.74e-1)"	9.9	9.2	20.5	3.9	21.1	7.9	11.9	22.2	25.8	9.6	21.2	11.7	5.3	11.0	13.8	5.9	11.2	5.9	12.3	20.2	21.2	14.5	7.8	7.5	6.0	21.2	21.4	10.0	13.1	12.8	12.7	7.0	21.2	11.3	6.9	13.6	8.5	10.9	19.3	4.2	8.5	8.6	22.1	8.5	9.7	22.3	20.9	5.6	12.7	12.5	5.3	10.1	7.5	22.3	10.4	8.6	9.7	8.6	16.7	10.6	7.3	9.5	10.2	14.6	15.2	8.7	11.7	5.9	11.9	8.2	15.8	9.1	10.8	8.4	18.5	11.9	8.7	8.3	1.7	10.6	20.1	4.6	4.4	10.9	16.7	11.0	18.1	9.6	10.6	9.3	3.3	7.6	13.6	19.0	4.9	7.2	6.0	9.5	15.3	10.8	12.3	2.9	11.8	13.3	6.4	6.3	8.3	3.9	16.1	8.7	11.3	4.2	9.3	18.2	14.3	7.2	8.7	5.0	6.4	8.5	10.0	5.6	12.0	61.9	12.4	22.6	19.1	15.4	18.7	18.2	19.9	20.2	10.4	19.4	20.0	18.6	12.5	20.3	19.0	9.0	22.3	19.7	20.5	21.1	22.2	25.8	20.2	21.2	21.2	21.4	21.2	22.1	20.9	22.3	20.3	9.6	11.5	21.5	22.6	7.6	17.4	26.7	16.5	18.6	18.3	18.7	22.1	14.3	17.3	16.5	10.4	14.7	21.8	17.5	23.5	21.6	145.4	13.7	15.1	20.3	10.7	4.2	14.2	16.9	11.5	22.3	5.6	13.1	29.2	12.7	18.9	10.6	17.0	11.8	13.8	9.1	28.5	14.8	10.3	41.5	16.8	24.8	16.0	12.2	15.5	29.4	16.5	17.1	24.3	17.7	13.1	22.6	11.5	16.8	15.6	27.3	22.6	15.9	19.7	17.0	25.0	112.2	36.0	10.0	3.4	12.0	24.0	12.3	11.0	14.0
CHAF1A	"CAF-1, CAF1, CAF1B, CAF1P150, MGC71229, P150"	ENSG00000167670	"Chromatin assembly factor 1 subunit A"	Q13111	19	4402640-4445018	"Predicted intracellular proteins"	"Cell cycle, DNA damage, DNA repair, DNA replication"	Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 31.4"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 50.3;Spermatocytes: 94.3;Spermatogonia: 103.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"plasmacytoid DC: 15.7"	"Group enriched"	"Detected in many"	4	"dendritic cells: 15.7;granulocytes: 4.7"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			CAB015186	Enhanced		Supported	Nucleoplasm,Cytosol		NA	Yes			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	Cytosol	"CAB015186: AB_628065"	"unprognostic (1.91e-1)"	"prognostic favorable (8.22e-5)"	"unprognostic (2.49e-1)"	"unprognostic (4.71e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.89e-3)"	"unprognostic (5.30e-3)"	"unprognostic (8.78e-2)"	"unprognostic (2.06e-2)"	"unprognostic (2.12e-2)"	"unprognostic (2.46e-2)"	"unprognostic (1.16e-1)"	"unprognostic (8.54e-2)"	"prognostic favorable (4.15e-6)"	"unprognostic (1.71e-1)"	"unprognostic (2.11e-3)"	"unprognostic (4.03e-2)"	4.9	4.4	3.5	9.7	3.0	31.4	4.8	5.6	6.6	4.7	1.3	6.9	6.5	3.9	2.0	10.2	4.0	2.7	3.9	3.7	3.0	2.4	4.1	4.0	13.4	3.4	3.1	3.7	3.9	3.3	3.7	6.2	3.0	5.8	6.6	3.4	5.5	3.0	12.2	10.8	6.7	4.1	2.4	6.9	5.1	14.5	3.1	16.3	2.9	4.1	10.5	4.7	5.6	4.1	65.8	44.0	71.8	45.3	7.0	8.5	36.7	61.2	24.8	50.5	56.7	53.5	22.8	100.4	24.7	19.6	28.6	50.3	61.6	41.5	59.8	58.1	67.2	62.9	69.4	42.7	3.5	73.7	48.8	4.8	8.6	41.5	17.7	9.4	24.0	54.9	76.8	88.0	31.3	37.8	119.2	40.7	80.1	33.5	35.6	87.2	56.8	57.2	13.1	76.7	50.6	39.2	41.6	29.1	24.5	45.2	25.7	53.9	17.5	41.3	35.9	71.1	74.9	43.7	71.0	96.3	34.7	92.8	49.9	3.8	2.3	4.7	0.5	2.3	0.4	1.6	0.6	0.1	2.1	1.0	0.5	0.4	1.2	1.2	0.4	15.7	0.9	0.9	3.5	3.0	5.6	6.6	3.7	3.0	3.4	3.1	3.0	2.4	3.1	4.1	2.3	0.0	3.9	2.0	12.5	9.7	4.6	3.5	6.2	12.1	5.1	3.6	5.7	1.5	2.6	5.5	2.1	25.3	17.3	13.9	1.9	8.5	6.7	5.3	4.2	4.6	1.8	50.3	4.1	6.7	37.9	6.1	10.7	6.5	2.5	19.3	3.3	4.8	12.1	1.7	3.6	10.7	0.0	4.8	21.4	6.7	3.1	11.8	1.8	1.9	11.5	5.2	5.2	2.5	2.9	6.8	1.7	3.8	32.5	4.1	4.6	1.8	5.0	8.4	32.9	5.7	5.5	94.3	103.8	18.7	14.9	14.6	7.7	9.4	14.6	5.9
CHAF1B	"CAF-1, CAF1, CAF1A, CAF1P60, MPHOSPH7, MPP7"	ENSG00000159259	"Chromatin assembly factor 1 subunit B"	Q13112	21	36385392-36419015	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, DNA damage, DNA repair, DNA replication, Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 15.6"	"Cell type enhanced"	"Detected in many"		"Spermatocytes: 14.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"HPA021679, CAB033604"	Enhanced		Supported	Nucleoplasm		NA	Yes			"Cluster 35: T-regs - Unknown function"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"CAB033604: AB_2229411, HPA021679: AB_1846621"	"unprognostic (2.28e-2)"	"prognostic favorable (5.44e-5)"	"prognostic favorable (7.92e-4)"	"unprognostic (1.43e-1)"	"unprognostic (3.28e-3)"	"unprognostic (1.12e-2)"	"prognostic unfavorable (6.14e-6)"	"unprognostic (2.14e-2)"	"unprognostic (1.89e-2)"	"unprognostic (1.13e-2)"	"unprognostic (2.84e-2)"	"unprognostic (6.27e-2)"	"unprognostic (7.66e-6)"	"unprognostic (5.89e-2)"	"unprognostic (5.00e-3)"	"unprognostic (9.12e-2)"	"unprognostic (1.36e-1)"	1.3	0.6	1.5	2.4	1.2	6.9	2.6	2.2	1.5	1.3	0.3	1.9	1.6	1.7	1.5	2.5	1.3	0.9	0.6	1.6	0.7	1.3	0.7	1.0	3.0	0.6	0.4	1.4	3.3	1.6	1.0	1.1	0.7	1.6	2.1	1.7	3.0	0.9	15.6	2.7	1.9	1.5	0.1	1.3	1.2	4.2	0.8	4.1	0.9	1.8	3.5	1.0	1.5	1.0	25.5	15.0	25.3	14.4	1.9	5.0	13.8	17.6	10.1	21.4	22.2	17.1	13.3	19.9	7.6	9.2	21.7	8.2	26.3	11.7	17.2	20.2	20.5	30.9	15.5	12.2	1.3	19.8	14.4	3.1	2.8	20.0	8.6	4.1	10.2	24.1	27.3	18.0	11.0	17.7	31.0	11.5	17.6	23.0	10.8	45.0	13.6	11.4	7.5	12.4	15.2	12.6	27.0	20.3	9.8	10.1	15.9	13.4	6.3	17.2	8.5	15.4	20.8	13.1	26.0	23.1	11.0	21.5	22.3	1.5	0.2	0.3	1.4	0.1	1.2	1.0	1.0	1.0	0.3	1.1	0.6	1.0	1.2	1.7	0.2	0.4	2.2	0.7	1.5	1.2	2.2	1.5	1.6	0.7	0.6	0.4	0.7	0.1	0.8	1.0	1.3	0.0	2.7	2.0	1.8	2.8	6.2	3.7	5.2	1.6	2.8	3.4	1.3	2.8	3.4	3.7	0.0	7.6	2.5	1.7	0.0	7.3	9.1	2.5	1.2	2.5	0.0	10.7	4.4	2.2	9.7	2.6	4.1	2.4	2.5	9.4	1.4	0.5	4.5	1.7	3.1	2.3	10.2	0.9	1.6	6.7	0.6	1.2	5.4	1.9	1.5	1.5	5.2	1.0	2.5	2.2	0.2	0.0	4.4	4.6	0.4	0.3	3.1	2.6	6.6	3.4	2.5	14.4	11.8	7.4	2.4	2.5	2.4	0.5	4.7	3.4
CHCHD1	"C10orf34, FLJ25854"	ENSG00000172586	"Coiled-coil-helix-coiled-coil-helix domain containing 1"	Q96BP2	10	73782047-73783652	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"PC-3: 561.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039046	Approved		Supported	"Nucleoplasm,Nucleoli fibrillar center,Mitochondria"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoplasm, Mitochondria"	"Nucleoli fibrillar center"	"HPA039046: AB_10673234"	"unprognostic (4.97e-2)"	"unprognostic (1.90e-3)"	"unprognostic (2.96e-1)"	"unprognostic (1.31e-3)"	"unprognostic (1.80e-1)"	"unprognostic (9.85e-2)"	"unprognostic (1.75e-2)"	"unprognostic (3.33e-1)"	"unprognostic (1.35e-1)"	"unprognostic (2.24e-2)"	"unprognostic (4.53e-1)"	"unprognostic (1.91e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.54e-1)"	"unprognostic (5.58e-2)"	"prognostic favorable (5.42e-4)"	30.1	53.2	38.7	29.3	39.1	26.7	34.4	40.0	45.1	25.4	41.9	38.1	40.0	25.9	52.0	49.8	25.6	18.5	52.9	38.9	39.6	55.9	54.7	25.6	36.4	38.8	38.5	24.1	31.3	42.8	31.0	29.2	39.2	36.7	29.0	21.9	45.6	21.9	64.2	29.9	35.1	19.1	39.3	40.3	37.6	24.8	39.4	34.6	31.9	50.6	30.8	27.7	30.1	40.1	115.8	87.6	70.8	98.3	57.0	56.6	71.1	58.3	70.7	59.8	80.0	78.6	99.3	56.9	63.3	52.9	60.1	77.9	69.8	79.8	46.9	87.6	132.4	42.7	73.2	119.6	68.6	65.8	65.7	52.3	96.3	51.5	33.0	87.4	83.9	78.8	67.0	61.7	78.3	117.3	82.1	146.5	66.3	109.6	561.7	77.3	53.9	72.6	97.5	63.0	34.2	67.4	36.0	246.2	127.3	56.8	138.0	92.5	47.2	35.7	79.7	60.2	102.4	61.5	70.7	91.2	83.4	133.7	28.5	44.2	51.3	32.5	36.1	54.9	43.9	62.6	43.7	43.5	52.5	50.8	36.1	36.9	21.2	36.6	45.6	75.1	65.2	35.8	38.7	39.1	40.0	45.1	38.9	39.6	38.8	38.5	39.2	39.3	39.4	40.1	45.0	41.7	48.4	5.2	50.7	35.1	34.4	117.2	29.0	27.0	68.7	74.4	77.3	47.1	84.4	60.7	22.9	151.6	49.3	112.1	199.6	80.8	73.3	99.0	64.1	44.5	61.8	61.2	8.6	88.3	166.3	38.2	41.8	75.8	29.8	63.9	51.4	132.5	139.7	20.2	8.0	106.2	122.1	61.2	35.6	16.3	56.5	52.7	40.9	5.6	82.5	76.8	51.5	5.5	9.6	96.4	96.4	55.3	53.3	55.3	101.0	243.3	99.0	35.3	52.6	36.1	52.4	70.1	48.7	71.2	43.5	128.1	41.6	83.9	98.4	54.9
CHCHD10	"C22orf16, MIX17A, N27C7-4"	ENSG00000250479	"Coiled-coil-helix-coiled-coil-helix domain containing 10"	Q8WYQ3	22	23765834-23767972	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Amyotrophic lateral sclerosis, Disease variant, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 1622.6;skeletal muscle: 1220.9"	"Cell type enhanced"	"Detected in all"		"Distal enterocytes: 1264.7;Distal tubular cells: 2498.5;Hepatocytes: 1879.9;Proximal enterocytes: 1501.3;Proximal tubular cells: 1437.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003440	Enhanced		Supported	Mitochondria		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 21: OE19 - Mitochondria"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"HPA003440: AB_1078348"	"unprognostic (3.88e-2)"	"unprognostic (2.36e-3)"	"unprognostic (8.90e-2)"	"unprognostic (9.80e-2)"	"unprognostic (7.68e-2)"	"unprognostic (5.97e-3)"	"unprognostic (1.59e-1)"	"unprognostic (1.85e-1)"	"unprognostic (2.23e-2)"	"unprognostic (2.40e-1)"	"unprognostic (1.61e-1)"	"unprognostic (5.13e-2)"	"prognostic favorable (2.15e-7)"	"unprognostic (5.19e-3)"	"unprognostic (2.06e-1)"	"unprognostic (5.68e-3)"	"unprognostic (2.62e-3)"	216.5	136.5	181.6	30.3	188.3	12.5	144.5	183.0	248.9	77.3	262.6	261.2	92.6	35.5	32.4	147.3	43.1	10.9	1622.6	176.6	190.5	409.5	789.7	56.9	28.6	182.2	182.2	29.0	118.0	220.0	112.3	11.9	187.6	106.4	76.2	63.1	148.3	50.5	1220.9	71.8	159.0	17.9	169.5	100.3	160.2	27.8	204.8	14.0	224.7	660.7	34.5	110.2	89.1	179.3	33.1	66.4	19.7	85.9	42.1	27.7	41.9	11.9	22.8	23.5	28.4	124.1	35.1	113.5	30.7	41.2	12.9	99.8	109.2	34.1	20.5	35.9	140.6	22.5	48.8	117.1	73.8	63.6	108.2	53.3	91.9	35.6	9.3	4.9	29.0	17.2	47.7	48.0	20.6	121.8	21.8	48.2	16.9	194.9	183.5	90.0	4.0	209.0	112.7	55.3	41.3	23.8	13.9	145.7	149.7	36.6	54.9	47.0	15.3	1.0	1.1	18.3	0.2	28.8	11.1	62.5	20.5	54.9	11.2	0.2	4.1	11.2	3.0	9.1	1.9	11.7	3.2	4.0	1.8	10.6	4.9	3.5	0.0	0.8	8.2	7.3	4.3	1.2	181.6	188.3	183.0	248.9	176.6	190.5	182.2	182.2	187.6	169.5	204.8	179.3	88.7	12.8	10.5	36.2	294.8	48.2	415.4	28.2	144.5	136.2	156.9	238.2	503.8	268.8	20.5	419.3	114.7	42.5	104.7	1264.7	2498.5	88.1	27.0	76.6	229.8	47.4	310.5	74.3	38.5	54.5	255.7	67.8	300.7	94.3	84.0	171.9	78.1	1879.9	647.5	99.3	37.6	860.9	26.4	262.1	127.5	18.0	48.7	243.1	373.5	15.9	107.8	188.5	25.7	17.1	17.4	45.9	890.1	29.3	297.3	192.4	1501.3	1437.4	10.0	287.8	124.9	254.0	200.4	32.3	43.4	459.3	43.9	105.2	123.0	216.0	952.4	470.1
CHCHD2	"C7orf17, MIX17B, MNRR1"	ENSG00000106153	"Coiled-coil-helix-coiled-coil-helix domain containing 2"	Q9Y6H1	7	56101573-56106476	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	Transcription	Activator	"Neurodegeneration, Parkinson disease, Parkinsonism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"A-431: 3195.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027407, HPA052510"	Approved		Supported	Mitochondria		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 24: NB-4 - Immune response"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"HPA027407: AB_10959659, HPA052510: AB_2681856"	"unprognostic (8.68e-3)"	"unprognostic (2.79e-1)"	"unprognostic (8.48e-2)"	"unprognostic (2.32e-1)"	"unprognostic (3.90e-2)"	"prognostic unfavorable (1.90e-5)"	"prognostic unfavorable (9.41e-5)"	"unprognostic (4.38e-2)"	"unprognostic (3.61e-1)"	"unprognostic (2.30e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.79e-2)"	"unprognostic (2.60e-2)"	"unprognostic (4.01e-2)"	"unprognostic (1.79e-1)"	"unprognostic (2.09e-1)"	"unprognostic (2.40e-2)"	250.6	665.5	321.4	167.4	331.8	426.3	253.9	361.8	358.5	220.7	351.0	257.6	252.0	219.0	252.4	269.6	210.6	132.1	412.4	325.3	352.7	349.4	316.7	213.8	205.0	340.1	341.5	246.3	315.9	322.9	272.3	151.8	343.2	237.2	191.7	226.2	281.2	196.7	791.4	233.3	243.9	150.5	354.6	223.3	287.6	120.7	352.2	267.7	208.2	591.3	200.2	217.8	214.2	367.9	3195.8	553.5	351.8	732.5	275.9	379.3	261.7	456.7	436.2	584.6	561.3	513.0	517.4	932.1	589.1	285.1	741.3	527.6	456.5	507.4	469.6	609.1	831.5	549.2	422.0	738.9	510.5	745.9	844.8	339.1	571.9	438.0	532.4	312.3	444.1	800.3	1182.9	546.7	486.4	449.9	1007.2	2306.5	760.6	867.3	872.6	668.3	343.3	1539.3	532.5	417.0	671.5	834.3	360.6	874.7	597.1	239.4	1002.5	1046.8	354.2	354.2	823.5	1473.9	683.6	497.1	785.4	1698.9	555.3	802.0	448.0	354.1	509.1	400.6	362.1	458.7	377.4	461.2	387.4	387.2	575.8	435.0	344.9	354.9	268.0	400.9	467.1	785.2	550.9	1066.7	321.4	331.8	361.8	358.5	325.3	352.7	340.1	341.5	343.2	354.6	352.2	367.9	465.1	256.4	284.0	44.4	521.9	717.5	956.6	1072.0	387.0	348.7	758.3	929.8	160.8	513.3	612.1	413.8	62.6	955.1	577.6	807.9	1860.7	1034.0	167.2	593.3	396.0	446.5	541.2	666.1	26.7	1325.1	1259.9	514.7	393.0	622.8	394.3	458.8	377.0	727.2	969.6	492.9	35.6	973.0	752.7	483.5	701.2	213.4	614.2	496.2	763.1	28.1	806.5	769.6	593.2	19.6	43.2	1190.3	974.5	505.9	803.3	1321.7	1138.5	1558.4	559.1	353.7	427.3	620.2	583.8	520.4	574.2	680.8	719.3	1228.8	492.5	633.1	929.0	1464.2
CHCHD3	"FLJ20420, Mic19, MICOS19, MINOS3, PPP1R22"	ENSG00000106554	"Coiled-coil-helix-coiled-coil-helix domain containing 3"	Q9NX63	7	132784870-133082090	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"heart muscle: 125.6;skeletal muscle: 351.7;tongue: 243.0"	"Cell type enhanced"	"Detected in all"		"Inhibitory neurons: 210.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042935	Enhanced		Supported	Mitochondria		NA	NA		13000	"Cluster 27: Non-specific - Gene expression"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Mitochondria		"HPA042935: AB_10794538"	"unprognostic (1.53e-1)"	"unprognostic (2.50e-1)"	"unprognostic (4.15e-2)"	"unprognostic (3.00e-3)"	"unprognostic (5.69e-2)"	"unprognostic (4.75e-3)"	"prognostic unfavorable (3.25e-4)"	"unprognostic (1.39e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.69e-3)"	"unprognostic (2.04e-1)"	"prognostic favorable (1.15e-4)"	"unprognostic (4.98e-2)"	"unprognostic (1.20e-1)"	"unprognostic (2.57e-1)"	"unprognostic (8.03e-2)"	40.4	33.3	18.0	29.0	19.4	51.5	32.8	21.7	25.4	25.5	22.2	45.5	56.7	28.0	19.2	28.3	25.5	22.5	125.6	20.1	19.3	54.8	32.1	26.4	30.3	19.6	19.0	27.2	26.6	59.7	17.2	30.2	19.2	25.4	49.7	40.3	24.3	28.6	351.7	20.8	42.2	37.1	17.7	21.9	31.6	16.8	18.2	42.5	35.6	243.0	29.8	31.8	23.0	21.5	102.0	103.8	99.7	138.9	70.6	64.9	60.2	97.0	90.3	106.7	117.4	121.0	108.9	83.1	37.6	61.1	237.1	69.1	117.0	82.7	148.7	113.4	111.8	85.9	101.9	70.7	139.3	194.7	62.1	59.0	55.8	146.9	151.7	53.2	75.9	107.6	186.1	74.2	100.1	134.3	284.0	169.9	165.1	160.3	117.2	140.6	146.2	119.8	103.9	83.1	127.4	158.8	80.5	62.4	186.7	67.6	52.5	116.2	63.5	101.8	44.3	162.0	176.7	71.3	100.4	206.6	161.1	163.9	146.6	42.3	43.7	33.2	30.5	62.8	28.9	38.5	27.6	29.6	57.9	23.2	23.9	26.9	6.4	45.2	52.1	49.5	41.9	34.0	18.0	19.4	21.7	25.4	20.1	19.3	19.6	19.0	19.2	17.7	18.2	21.5	32.0	25.6	26.2	103.8	36.5	34.9	28.7	56.9	31.9	26.5	29.0	25.7	138.8	38.6	36.2	14.7	22.9	69.7	29.0	40.4	125.2	61.5	99.6	27.8	33.6	34.3	35.9	64.3	201.3	60.7	79.5	38.9	32.6	22.4	34.2	34.6	17.2	20.7	78.4	15.2	210.5	48.9	30.5	27.3	44.4	103.4	31.4	38.3	37.4	100.2	49.7	34.2	37.0	161.4	143.5	50.1	31.0	35.3	46.5	44.4	50.7	88.8	29.6	27.0	32.9	43.4	53.5	20.9	29.2	37.0	40.3	68.4	34.0	55.8	73.1	42.6
CHCHD4	"FLJ31709, MIA40, TIMM40"	ENSG00000163528	"Coiled-coil-helix-coiled-coil-helix domain containing 4"	Q8N4Q1	3	14112077-14124870	"Predicted intracellular proteins"	"Protein transport, Translocation, Transport"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 84.1;Proximal tubular cells: 62.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA034688, HPA063727"	Uncertain		Supported	Mitochondria		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"HPA034688: AB_10696361, HPA063727: AB_2685103"	"unprognostic (3.89e-3)"	"unprognostic (8.82e-2)"	"unprognostic (1.50e-2)"	"unprognostic (7.34e-2)"	"unprognostic (1.11e-2)"	"unprognostic (9.12e-2)"	"unprognostic (2.63e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.82e-1)"	"unprognostic (5.55e-2)"	"unprognostic (3.59e-2)"	"unprognostic (1.43e-1)"	"prognostic favorable (8.63e-5)"	"unprognostic (1.53e-1)"	"unprognostic (2.34e-1)"	"unprognostic (9.65e-2)"	"unprognostic (7.85e-3)"	12.2	14.0	12.3	8.6	12.9	3.3	11.5	12.8	16.4	9.8	13.3	19.5	14.6	8.9	10.1	12.4	9.6	5.8	25.8	12.4	14.4	20.9	18.8	7.6	8.9	13.0	13.8	10.4	11.1	22.9	9.6	8.5	13.0	10.8	15.5	11.4	10.1	11.8	34.1	10.3	11.5	8.8	12.5	10.3	13.6	8.7	12.7	9.4	9.6	29.0	12.7	15.1	9.9	13.3	19.1	39.2	19.8	19.8	16.9	18.9	57.5	20.3	18.7	24.4	21.4	23.3	15.3	40.9	19.4	15.5	24.7	15.3	41.5	41.8	29.8	25.7	41.6	47.9	28.5	31.3	28.2	32.5	19.9	16.6	43.5	40.0	63.5	17.3	27.7	32.4	50.6	35.6	26.3	40.7	41.0	19.6	30.6	59.5	52.1	29.3	19.9	87.5	27.8	20.7	16.3	20.1	22.6	72.2	30.1	17.0	34.6	32.8	10.0	22.3	16.2	27.8	37.4	19.8	56.1	40.6	21.9	49.5	16.6	12.0	15.6	10.7	7.8	24.0	14.0	15.0	13.2	12.1	25.7	22.0	16.8	11.5	6.9	21.8	24.8	10.5	16.3	11.6	12.3	12.9	12.8	16.4	12.4	14.4	13.0	13.8	13.0	12.5	12.7	13.3	6.7	16.0	8.6	2.9	10.6	9.4	14.5	17.9	13.1	7.9	13.3	11.4	24.5	11.5	8.8	9.2	0.0	21.6	3.5	12.2	84.1	18.8	2.6	6.7	8.3	9.0	4.9	20.8	3.2	13.4	22.3	8.9	5.6	5.4	10.8	7.6	3.9	20.4	21.0	5.0	3.8	13.3	16.2	10.0	6.6	5.3	11.5	9.7	8.8	1.9	11.4	9.9	15.5	2.5	3.5	13.1	10.0	10.1	13.2	25.3	22.4	62.2	5.9	7.2	6.6	9.9	11.8	24.7	40.4	20.8	11.8	13.0	7.3	12.0	17.9	11.6
CHCHD6	"CHCM1, MGC13016, Mic25, MICOS25, PPP1R23"	ENSG00000159685	"Coiled-coil-helix-coiled-coil-helix domain containing 6"	Q9BRQ6	3	126704240-126960420	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 53.0"	"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 178.2;Late spermatids: 106.6;Melanocytes: 172.5;Spermatocytes: 119.7"	"Cancer enriched"	"Detected in all"	4	"melanoma: 34.6"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047673, HPA051975"	Approved		Supported	Mitochondria		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 43: Testis - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 4: Macrophages - Innate immune response"	Mitochondria		"HPA047673: AB_10961761, HPA051975: AB_2681679"	"unprognostic (3.94e-2)"	"prognostic favorable (7.46e-4)"	"unprognostic (6.20e-2)"	"unprognostic (1.91e-2)"	"unprognostic (2.60e-1)"	"unprognostic (1.16e-1)"	"unprognostic (6.83e-3)"	"unprognostic (1.87e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.31e-1)"	"unprognostic (6.79e-2)"	"unprognostic (2.08e-1)"	"prognostic favorable (6.76e-4)"	"unprognostic (6.47e-2)"	"unprognostic (2.27e-1)"	"unprognostic (2.79e-1)"	"unprognostic (3.11e-3)"	9.4	12.8	22.2	3.8	24.7	4.2	10.8	17.7	34.3	13.1	16.4	11.6	3.9	11.5	5.0	10.9	13.7	5.0	11.9	35.0	22.7	14.4	7.4	10.7	3.9	19.0	21.6	17.7	14.8	15.6	16.5	4.1	21.0	10.5	3.0	8.3	14.1	7.8	4.7	16.3	6.2	5.4	18.4	6.9	11.7	53.0	21.4	4.9	13.0	3.2	2.9	11.1	11.5	22.1	37.1	21.1	18.4	44.7	6.4	9.8	10.5	14.1	9.5	16.0	15.5	29.3	15.8	16.3	31.8	8.5	17.5	21.3	13.9	38.3	7.9	4.5	37.7	13.5	15.8	29.0	19.0	29.2	8.5	9.9	22.9	7.8	16.3	13.1	10.6	28.4	12.2	9.4	14.2	27.7	43.2	29.1	22.3	20.9	23.7	22.8	28.0	38.9	14.3	15.8	33.6	21.0	14.5	24.3	45.4	9.0	14.2	10.8	9.7	17.9	22.2	24.5	14.6	12.0	5.9	20.4	20.1	9.6	17.0	0.0	2.4	2.1	6.8	4.1	8.8	8.4	9.9	8.4	6.8	11.6	9.4	11.2	0.0	7.7	3.7	4.8	10.0	4.6	22.2	24.7	17.7	34.3	35.0	22.7	19.0	21.6	21.0	18.4	21.4	22.1	8.9	19.2	12.5	20.5	7.1	29.6	21.7	35.5	9.6	15.4	20.0	31.5	18.5	8.6	24.0	14.7	18.8	40.8	3.4	6.4	58.7	22.7	99.0	18.6	8.8	7.3	7.7	8.2	48.1	24.2	12.1	14.8	9.7	5.8	14.0	45.6	6.8	7.2	178.2	20.2	45.1	10.8	28.5	10.1	15.6	106.6	15.8	33.0	172.5	12.2	2.7	20.2	2.1	22.6	22.0	18.9	9.0	22.2	7.1	29.6	2.6	27.9	56.1	16.1	0.0	10.9	17.9	119.7	51.4	16.0	30.1	15.5	8.2	14.1	13.3	21.1
CHD1L	ALC1	ENSG00000131778	"Chromodomain helicase DNA binding protein 1 like"	Q86WJ1	1	147242654-147295765	"Enzymes, Predicted intracellular proteins"	"DNA damage, DNA repair"	"Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 80.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027789, HPA028670"	Enhanced		Supported	Nucleoplasm		NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Nucleoplasm		"HPA027789: AB_10601099, HPA028670: AB_10601257"	"unprognostic (1.07e-1)"	"unprognostic (3.93e-2)"	"unprognostic (1.97e-1)"	"unprognostic (3.49e-1)"	"unprognostic (1.78e-1)"	"unprognostic (2.58e-2)"	"prognostic unfavorable (3.07e-4)"	"unprognostic (1.86e-2)"	"unprognostic (7.83e-2)"	"unprognostic (1.39e-2)"	"unprognostic (4.97e-2)"	"unprognostic (8.21e-2)"	"prognostic unfavorable (1.31e-9)"	"unprognostic (5.51e-2)"	"unprognostic (3.52e-1)"	"unprognostic (2.74e-2)"	"unprognostic (1.16e-1)"	14.4	14.9	19.2	11.9	20.4	17.1	14.6	20.0	28.0	14.6	17.8	16.4	14.4	19.1	9.4	12.7	17.3	6.7	10.8	18.6	18.9	16.5	33.7	17.5	13.1	19.7	19.6	10.9	13.1	19.8	20.1	9.4	19.3	16.4	15.1	4.9	11.6	8.9	12.8	14.4	19.3	16.1	20.3	27.1	15.8	19.5	20.0	14.9	10.6	11.2	11.1	13.1	11.7	20.9	40.0	34.0	28.0	21.2	25.1	21.4	29.6	38.7	31.4	30.4	29.1	30.6	29.2	49.9	15.4	33.9	21.9	37.7	31.2	35.3	30.6	53.6	40.6	43.8	27.5	87.0	31.5	58.9	24.0	25.6	15.1	30.2	31.1	27.9	34.1	51.5	56.0	19.8	44.3	42.2	39.8	43.1	46.9	80.0	47.4	48.8	35.1	41.1	32.2	30.7	16.6	36.4	32.4	39.2	30.8	46.3	21.7	99.3	34.5	19.2	33.2	18.2	49.0	14.9	22.4	37.9	46.7	19.6	33.3	11.3	8.7	3.2	8.7	7.9	8.1	11.7	7.4	6.6	20.3	14.2	6.9	7.9	0.4	10.0	9.2	17.5	5.4	8.2	19.2	20.4	20.0	28.0	18.6	18.9	19.7	19.6	19.3	20.3	20.0	20.9	7.7	12.8	15.6	45.7	27.1	11.5	10.0	8.8	15.9	7.2	12.5	8.5	6.5	11.5	16.4	5.5	6.2	21.7	17.1	15.4	21.5	10.0	21.2	6.4	12.5	11.1	9.0	43.7	48.3	8.2	19.1	12.6	21.4	9.8	21.5	25.1	5.3	33.7	21.8	1.7	40.8	16.7	16.2	16.1	20.7	25.6	7.2	25.5	16.0	36.5	15.9	14.5	12.3	60.8	80.7	10.3	14.4	11.3	14.4	10.8	13.0	12.9	16.1	9.3	6.6	11.9	12.5	38.3	27.4	20.9	10.4	11.8	13.4	18.8	19.7	9.1
CHD3	"Mi-2a, Mi2-ALPHA, ZFH"	ENSG00000170004	"Chromodomain helicase DNA binding protein 3"	Q12873	17	7884796-7912760	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding, Helicase, Hydrolase"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043368, HPA076524"	Supported		Supported	"Nucleoplasm,Nucleoli,Centriolar satellite"		No	No			"Cluster 27: Non-specific - Gene expression"	"Cluster 51: Non-specific - Unknown function"	"Cluster 20: HeLa - Mitochondria"	"Cluster 44: Endometrium - Transcription"	"Nucleoplasm, Nucleoli"	"Centriolar satellite"	"HPA043368: AB_2678448, HPA076524: AB_2686804"	"unprognostic (1.77e-2)"	"unprognostic (8.01e-2)"	"prognostic unfavorable (2.43e-4)"	"prognostic favorable (7.68e-5)"	"unprognostic (1.53e-1)"	"unprognostic (8.11e-3)"	"unprognostic (2.54e-1)"	"unprognostic (1.11e-1)"	"unprognostic (2.83e-2)"	"unprognostic (5.25e-3)"	"prognostic favorable (8.36e-4)"	"unprognostic (9.11e-2)"	"unprognostic (8.31e-2)"	"unprognostic (3.98e-2)"	"unprognostic (1.50e-1)"	"unprognostic (8.90e-3)"	"unprognostic (2.20e-3)"	28.2	29.3	19.9	35.0	27.9	42.7	28.4	0.0	39.9	71.6	0.0	55.3	16.7	63.9	31.2	35.1	56.8	27.8	21.2	35.8	7.0	38.3	5.7	32.4	41.3	4.9	2.4	60.0	34.8	44.7	47.7	16.6	1.1	68.7	22.1	19.0	40.3	38.0	8.0	32.7	34.6	45.0	3.1	31.5	36.3	20.9	8.0	58.2	44.9	9.1	36.7	41.2	42.8	21.4	44.9	108.7	61.6	81.2	72.2	60.9	32.8	51.7	66.1	40.8	43.5	21.1	36.7	122.8	38.3	73.0	34.0	59.6	117.7	52.5	53.0	65.5	67.2	62.7	148.5	2.7	38.3	17.8	112.1	79.2	27.5	55.4	36.9	108.7	76.9	54.1	41.5	2.0	38.8	42.6	48.2	19.6	9.8	45.3	40.3	137.8	82.1	19.3	40.0	107.7	41.9	56.3	126.4	47.9	24.6	16.9	55.7	27.1	99.7	89.4	68.8	22.3	72.5	8.8	1.6	68.3	46.1	47.4	77.6	1.7	2.6	3.3	4.1	1.4	3.6	1.1	4.2	4.0	1.3	1.2	4.6	3.1	2.8	3.2	3.2	3.0	2.5	2.5	19.9	27.9	0.0	39.9	35.8	7.0	4.9	2.4	1.1	3.1	8.0	21.4	20.9	32.1	63.2	10.4	19.6	36.6	47.6	21.1	65.4	60.7	43.8	34.2	14.3	17.2	35.2	80.9	8.4	16.8	57.3	39.8	17.6	22.9	11.3	48.6	51.9	29.4	56.8	19.1	20.6	23.4	20.5	39.9	31.1	70.7	39.9	59.7	22.9	2.7	9.0	45.4	25.2	17.0	12.2	24.7	34.7	18.5	44.4	26.7	8.8	6.5	43.7	12.4	59.8	12.1	2.5	20.9	10.8	57.2	17.4	55.5	10.9	9.7	24.8	17.3	26.3	31.8	43.5	25.5	46.8	52.8	20.5	16.4	62.9	52.0	30.3	60.3
CHD5		ENSG00000116254	"Chromodomain helicase DNA binding protein 5"	Q8TDI0	1	6101787-6180321	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Differentiation, Neurogenesis, Spermatogenesis, Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding, Helicase, Hydrolase"	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"brain: 59.0;pituitary gland: 57.3;testis: 31.8"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 84.3;Early spermatids: 217.8;Excitatory neurons: 80.4;Horizontal cells: 225.4;Inhibitory neurons: 56.2;Late spermatids: 113.2;Rod photoreceptor cells: 49.9"	"Cancer enhanced"	"Detected in single"		"glioma: 0.7"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"SCLC-21H: 12.9;U-2 OS: 5.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015809			Supported	"Nucleoplasm,Nuclear speckles,Cytosol"		NA	NA				"Cluster 78: Testis - Spermatogenesis"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 62: Horizontal cells - Visual perception"	"Nucleoplasm, Nuclear speckles"	Cytosol	"HPA015809: "	"unprognostic (5.03e-4)"	"unprognostic (1.89e-1)"	"unprognostic (2.47e-3)"	"unprognostic (9.40e-6)"	"unprognostic (1.91e-2)"	"unprognostic (2.98e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.97e-2)"	"unprognostic (1.95e-2)"	"unprognostic (6.64e-4)"	"unprognostic (1.34e-1)"	"unprognostic (1.34e-4)"	"unprognostic (1.16e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.98e-1)"	0.2	4.1	31.8	0.2	40.1	0.0	0.1	0.0	59.0	0.4	0.0	1.1	0.2	0.4	0.0	0.3	0.4	0.1	0.4	34.3	13.6	2.4	0.1	0.3	0.0	3.9	11.1	0.5	0.4	0.9	57.3	0.0	4.4	0.9	0.2	7.9	0.2	2.2	0.2	0.3	0.4	0.1	0.9	0.1	1.0	31.8	10.2	0.3	0.1	0.0	0.0	0.7	0.6	31.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.6	0.0	0.1	0.1	0.1	0.0	0.0	0.1	0.1	2.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.2	1.2	0.0	0.1	0.2	1.1	0.0	0.0	0.0	0.0	12.9	0.2	0.1	0.0	0.0	0.0	2.3	0.0	0.0	0.1	5.7	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	31.8	40.1	0.0	59.0	34.3	13.6	3.9	11.1	4.4	0.9	10.2	31.1	0.0	0.0	0.0	5.5	0.1	0.1	0.1	0.0	0.0	84.3	0.1	0.3	2.1	0.0	0.0	3.7	12.5	0.0	0.1	0.2	0.0	0.0	217.8	0.0	0.2	0.6	0.0	0.0	80.4	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	225.4	56.2	0.0	0.0	0.0	0.3	113.2	0.9	0.1	0.0	2.8	0.0	2.0	0.0	4.5	3.7	0.3	0.0	0.4	0.0	0.2	0.0	0.1	0.0	49.9	0.0	0.2	0.5	4.5	17.8	0.0	0.4	0.0	0.1	0.1	0.0	0.0
CHD6	"CHD5, dJ620E11.1, FLJ22369, KIAA1335, RIGB"	ENSG00000124177	"Chromodomain helicase DNA binding protein 6"	Q8TD26	20	41402083-41618384	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Host-virus interaction, Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding, Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015543			Supported	Nucleoplasm		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 21: Non-specific - Transcription"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA015543: "	"unprognostic (5.13e-3)"	"unprognostic (1.85e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.27e-1)"	"unprognostic (6.66e-2)"	"unprognostic (1.36e-1)"	"unprognostic (4.72e-3)"	"prognostic favorable (3.42e-4)"	"unprognostic (1.17e-1)"	"unprognostic (3.17e-1)"	"unprognostic (4.75e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.12e-3)"	"unprognostic (6.66e-2)"	"unprognostic (3.41e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.14e-2)"	7.2	7.7	10.2	6.9	11.4	13.5	12.4	17.5	13.0	9.5	6.0	7.1	4.0	12.7	12.4	6.1	10.0	7.2	8.0	8.5	13.1	7.2	6.8	7.5	8.4	11.7	10.9	16.2	8.1	16.2	7.9	8.4	14.2	12.2	6.1	15.7	8.4	9.3	5.5	8.7	6.1	8.9	7.3	8.2	7.4	7.1	11.0	17.2	13.6	7.8	8.2	8.1	8.8	12.9	8.4	9.8	20.6	9.2	11.5	11.7	13.3	7.2	14.8	12.6	15.2	13.5	6.7	10.0	12.7	12.4	14.2	12.2	12.9	12.4	14.3	3.2	6.3	13.7	9.1	13.2	6.5	10.9	6.6	11.8	11.3	9.2	10.1	13.5	11.0	13.7	11.0	10.4	9.9	23.3	17.3	11.8	6.8	5.2	16.5	13.2	24.2	7.1	7.9	19.3	18.6	12.8	22.1	5.8	14.2	14.9	9.9	8.1	12.7	19.8	9.6	10.0	6.3	9.9	8.6	12.8	8.7	5.2	6.2	20.2	6.0	7.5	8.1	6.1	8.2	8.5	7.0	6.9	5.2	10.6	9.4	8.0	0.9	10.2	10.0	11.4	6.0	2.4	10.2	11.4	17.5	13.0	8.5	13.1	11.7	10.9	14.2	7.3	11.0	12.9	42.2	48.1	30.8	148.2	42.8	18.1	38.6	30.3	37.0	140.4	39.5	34.7	56.6	30.0	34.4	22.0	93.8	34.2	53.3	14.5	21.5	24.4	14.5	50.3	65.3	36.5	60.6	19.6	143.2	15.8	28.2	33.8	19.9	76.0	21.5	65.1	34.2	21.1	16.5	151.4	179.0	35.9	42.7	27.7	44.7	20.3	49.7	27.5	17.8	87.1	40.8	62.2	39.1	182.9	160.6	15.4	16.0	45.5	32.3	30.3	4.1	13.9	35.6	133.8	19.7	71.0	44.4	20.6	61.9	21.8	17.2	32.7	45.5	40.4	24.5	32.9
CHD7	"CRG, FLJ20357, FLJ20361, KIAA1416"	ENSG00000171316	"Chromodomain helicase DNA binding protein 7"	Q9P2D1	8	60678740-60868028	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"rRNA processing, Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding, Helicase, Hydrolase"	"Cancer-related genes, Disease variant, Hypogonadotropic hypogonadism, Kallmann syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 71.5"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 241.8;Oligodendrocyte precursor cells: 298.6;Oligodendrocytes: 255.7;Rod photoreceptor cells: 198.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	15	"B-cells: 14.9;granulocytes: 17.6;T-cells: 6.6"	"Cell line enhanced"	"Detected in many"		"AF22: 51.5;SCLC-21H: 46.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053075			Supported	Nucleoplasm,Nucleoli		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 12: NES - Nervous system development"	"Cluster 9: Photoreceptor cells - Phototransduction"	Nucleoplasm	Nucleoli	"HPA053075: AB_2682035"	"unprognostic (3.77e-2)"	"unprognostic (3.28e-3)"	"unprognostic (3.17e-2)"	"prognostic unfavorable (5.34e-5)"	"unprognostic (9.59e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.86e-3)"	"unprognostic (3.41e-2)"	"unprognostic (3.06e-1)"	"unprognostic (2.73e-1)"	"unprognostic (2.46e-1)"	"unprognostic (1.33e-1)"	"unprognostic (9.09e-2)"	"unprognostic (9.21e-2)"	"unprognostic (1.75e-1)"	"unprognostic (8.20e-2)"	"unprognostic (2.17e-1)"	3.6	1.9	10.3	3.9	17.2	22.1	3.5	71.5	11.0	2.0	2.5	4.6	4.6	2.2	2.2	4.9	2.3	1.9	3.8	9.4	11.5	3.8	3.2	4.6	5.8	19.7	17.2	1.0	4.4	5.3	6.1	4.3	18.8	2.7	4.0	23.7	3.9	1.7	10.4	5.2	6.4	1.7	11.4	5.6	3.5	2.9	15.6	2.6	4.1	4.1	5.7	3.4	3.2	17.7	8.0	4.0	51.5	9.2	0.1	0.0	16.2	0.4	0.1	1.8	1.6	10.0	7.3	15.5	0.9	0.1	2.3	4.8	26.7	7.9	1.6	5.9	14.3	36.5	7.0	13.2	2.1	11.1	6.5	1.0	5.9	0.0	8.5	3.1	7.7	12.5	2.7	13.4	1.2	8.3	17.5	12.7	35.4	8.1	1.8	36.0	12.1	5.0	4.1	9.1	46.9	23.2	1.4	5.9	14.9	18.0	10.5	10.5	9.0	0.5	8.3	0.5	4.3	14.2	8.7	23.7	3.0	1.2	13.4	14.9	0.4	17.6	3.2	0.2	4.1	10.1	3.6	1.1	0.1	14.9	6.6	2.4	9.3	0.0	0.8	0.8	0.3	0.6	10.3	17.2	71.5	11.0	9.4	11.5	19.7	17.2	18.8	11.4	15.6	17.7	35.9	32.1	17.5	68.6	64.3	30.3	35.9	10.8	9.6	36.3	16.6	14.6	35.8	27.1	20.7	16.5	241.8	8.2	17.4	31.8	1.9	17.7	15.9	34.0	4.1	40.5	87.3	3.8	6.8	11.3	8.6	6.4	28.5	37.6	41.0	39.8	21.4	12.6	14.9	70.7	17.8	39.9	32.6	10.8	10.4	8.9	0.9	13.6	21.4	118.0	13.9	121.3	15.5	298.6	255.7	16.9	27.4	0.4	29.1	42.9	17.4	5.4	20.4	198.5	0.0	49.7	9.8	8.0	12.9	25.5	32.4	6.2	21.4	3.0	34.1	35.8
CHD9	"BC022889, FLJ12178, KIAA0308"	ENSG00000177200	"Chromodomain helicase DNA binding protein 9"	Q3L8U1	16	53055033-53329150	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding, Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cone photoreceptor cells: 502.5;Rod photoreceptor cells: 766.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042053, HPA049420, HPA066155"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 14: REH - Unknown function"	"Cluster 46: Photoreceptor cells - Phototransduction"	Nucleoplasm	Cytosol	"HPA042053: AB_2677823, HPA049420: AB_2680758, HPA066155: "	"unprognostic (3.57e-2)"	"unprognostic (3.73e-2)"	"unprognostic (3.44e-3)"	"unprognostic (2.42e-1)"	"unprognostic (4.34e-2)"	"unprognostic (4.35e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.68e-1)"	"unprognostic (7.75e-3)"	"unprognostic (2.87e-2)"	"unprognostic (3.39e-1)"	"unprognostic (2.35e-2)"	"prognostic favorable (1.84e-4)"	"unprognostic (4.96e-2)"	"unprognostic (1.74e-1)"	"unprognostic (5.09e-2)"	"unprognostic (2.87e-1)"	7.4	6.6	13.6	6.0	19.3	21.7	11.5	31.1	9.4	10.1	2.1	8.1	5.4	9.7	6.2	7.7	9.0	8.1	7.1	6.4	17.1	11.1	6.9	7.0	6.9	13.3	17.1	12.7	6.4	10.2	5.0	8.7	16.9	8.4	7.8	28.9	8.5	8.7	7.2	6.3	5.7	7.9	10.1	7.7	9.6	4.9	14.2	9.9	12.2	12.8	6.7	7.1	6.2	17.6	10.4	12.0	25.0	20.8	20.0	28.6	4.4	18.0	13.8	9.9	4.3	6.8	9.1	14.0	11.3	16.8	6.9	12.5	14.0	10.4	14.0	5.0	10.2	18.4	12.0	4.6	13.5	25.3	15.8	19.9	9.5	15.2	18.3	12.9	14.7	8.3	22.2	4.5	13.0	4.2	13.1	5.9	9.6	3.1	8.7	46.2	28.8	5.8	6.4	9.7	10.4	11.7	16.6	5.4	12.3	9.7	6.0	12.0	28.3	18.1	8.9	6.6	12.0	13.1	9.7	21.9	13.2	11.3	17.9	102.0	25.5	27.5	15.7	21.9	24.5	38.9	10.7	17.6	16.2	46.6	8.5	12.0	8.6	38.3	39.4	126.7	6.1	5.4	13.6	19.3	31.1	9.4	6.4	17.1	13.3	17.1	16.9	10.1	14.2	17.6	146.3	70.5	74.7	426.4	111.5	57.2	123.4	107.7	96.8	318.9	81.3	89.9	39.0	55.8	81.5	90.1	502.5	17.4	112.1	80.8	46.9	60.4	16.4	71.8	109.3	97.5	87.6	67.7	272.9	36.7	31.2	117.2	109.1	69.9	96.7	121.8	107.4	66.4	69.0	220.4	297.3	89.7	69.2	67.8	50.7	19.1	108.4	88.6	67.6	319.5	89.3	153.3	98.9	462.4	312.0	39.0	100.5	123.4	70.3	98.2	76.1	60.8	72.3	766.6	59.2	157.2	106.1	105.7	50.9	75.4	75.0	24.9	60.5	89.3	72.1	83.4
CHEK1	CHK1	ENSG00000149554	"Checkpoint kinase 1"	O14757	11	125625665-125676255	"Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, DNA damage, DNA repair"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 25.7;lymphoid tissue: 20.7;seminal vesicle: 29.8"	"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 32.9;Erythroid cells: 34.5;Extravillous trophoblasts: 35.6;Spermatocytes: 48.9;Spermatogonia: 49.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Immune cell enhanced"	"Detected in some"		"T-reg: 6.2"	"Group enriched"	"Detected in many"	5	"granulocytes: 1.7;T-cells: 6.2"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			HPA044364			Supported	Nucleoplasm,Vesicles		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	Vesicles	"HPA044364: AB_2678913"	"unprognostic (6.74e-2)"	"unprognostic (3.63e-1)"	"prognostic favorable (3.62e-4)"	"unprognostic (5.54e-2)"	"unprognostic (2.17e-1)"	"unprognostic (1.03e-1)"	"prognostic unfavorable (3.70e-6)"	"unprognostic (3.95e-3)"	"unprognostic (1.26e-3)"	"unprognostic (2.54e-2)"	"prognostic unfavorable (3.10e-6)"	"unprognostic (1.75e-1)"	"prognostic unfavorable (1.04e-8)"	"unprognostic (2.89e-2)"	"unprognostic (2.64e-1)"	"unprognostic (8.16e-2)"	"unprognostic (1.33e-1)"	1.6	1.3	0.7	8.2	1.0	25.7	2.6	0.6	1.3	1.7	0.5	7.9	6.8	1.7	6.7	4.1	1.1	1.7	0.9	0.7	0.9	2.2	2.1	1.3	14.9	0.7	0.8	1.8	2.0	13.2	1.7	4.8	0.8	1.6	8.7	0.7	1.5	29.8	0.6	3.6	7.3	3.4	0.6	2.2	2.6	8.9	1.2	20.7	1.0	1.3	13.9	3.3	2.1	0.8	48.5	37.0	81.1	47.4	13.5	28.9	35.7	61.1	28.7	41.6	40.1	88.0	100.3	120.7	63.5	24.9	53.7	52.6	54.2	33.2	50.1	81.4	24.8	224.2	27.2	44.7	4.3	121.1	39.6	15.7	6.0	47.6	36.0	19.9	44.7	84.1	117.3	102.7	51.4	23.8	181.3	65.0	86.1	77.1	33.2	104.7	74.4	67.2	37.9	63.2	50.5	53.6	45.2	35.4	15.2	57.3	93.9	40.6	28.4	51.0	47.3	29.6	60.8	21.9	45.4	187.5	20.5	86.6	67.6	1.7	0.2	0.0	0.4	0.1	0.2	0.7	1.6	0.4	0.6	0.3	0.4	0.3	1.1	0.3	0.1	0.7	6.2	0.4	0.7	1.0	0.6	1.3	0.7	0.9	0.7	0.8	0.8	0.6	1.2	0.8	1.1	3.2	0.5	1.6	5.5	6.2	3.9	5.8	5.2	1.7	3.9	6.0	4.6	32.9	4.1	7.3	0.0	17.3	6.0	4.5	3.9	3.4	7.8	5.5	8.0	3.5	1.8	34.5	3.3	1.1	35.6	5.3	6.1	9.9	0.0	21.1	3.6	1.2	11.1	0.0	2.5	9.2	2.0	0.0	5.2	3.1	1.5	3.2	0.0	2.8	3.2	2.8	3.1	1.5	1.6	2.9	3.9	1.2	17.7	3.1	8.0	9.4	2.5	1.7	0.0	3.1	7.8	48.9	49.8	9.5	4.8	7.8	5.1	4.8	16.7	3.0
CHEK2	"bA444G7, CDS1, CHK2, HuCds1, PP1425, RAD53"	ENSG00000183765	"Checkpoint kinase 2"	O96017	22	28687743-28742422	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Apoptosis, Cell cycle, Cell division, DNA damage, DNA repair, Mitosis, Transcription, Transcription regulation"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Disease variant, Li-Fraumeni syndrome, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Spermatogonia: 31.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA001878, CAB002030"	Enhanced		Supported	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	"Golgi apparatus"	"CAB002030: AB_563660, HPA001878: AB_1078514"	"unprognostic (1.54e-1)"	"unprognostic (2.20e-1)"	"unprognostic (5.83e-2)"	"unprognostic (2.93e-2)"	"unprognostic (2.42e-1)"	"unprognostic (3.83e-2)"	"unprognostic (1.49e-3)"	"unprognostic (5.08e-3)"	"unprognostic (3.33e-3)"	"unprognostic (9.62e-3)"	"unprognostic (1.28e-2)"	"unprognostic (3.13e-1)"	"prognostic unfavorable (7.80e-9)"	"unprognostic (2.38e-2)"	"unprognostic (1.78e-1)"	"unprognostic (7.27e-2)"	"unprognostic (6.79e-3)"	4.5	6.2	2.4	8.8	2.5	15.4	5.8	2.4	3.7	5.0	2.8	8.8	6.3	4.1	7.3	7.2	3.7	4.7	4.2	2.3	2.8	4.5	6.3	4.4	12.1	2.6	2.6	8.2	2.3	1.3	2.7	7.8	2.8	4.1	10.9	0.4	3.2	3.8	1.3	6.7	7.0	4.8	2.6	6.7	4.1	8.5	2.8	9.4	3.3	1.1	12.0	6.8	5.0	2.9	30.7	9.7	31.1	32.4	10.1	42.7	18.7	15.2	19.9	18.7	27.8	29.1	21.8	36.3	13.0	11.5	21.6	32.1	42.7	29.0	25.0	24.6	31.2	45.3	25.5	46.2	9.4	33.4	38.0	18.6	13.5	25.0	23.0	14.1	25.4	29.4	30.5	33.9	19.8	39.2	24.6	61.5	40.6	41.3	21.6	52.6	18.2	42.7	17.1	11.2	17.8	9.7	16.7	31.4	17.4	22.8	22.6	32.2	7.8	17.1	19.4	14.3	9.1	21.8	28.3	65.4	17.1	34.9	21.0	9.9	4.0	1.2	1.1	8.1	2.4	11.9	2.1	2.1	8.2	7.8	4.0	2.6	0.6	3.4	4.1	6.1	2.8	3.6	2.4	2.5	2.4	3.7	2.3	2.8	2.6	2.6	2.8	2.6	2.8	2.9	2.3	9.6	4.8	2.9	5.5	6.4	5.3	8.3	8.6	1.1	3.2	3.9	1.8	0.0	5.0	1.8	0.0	15.4	1.1	3.8	0.0	1.8	7.0	2.9	10.1	3.0	1.2	11.2	2.9	1.4	13.6	12.4	5.1	7.0	3.8	7.4	2.5	1.3	9.7	0.0	1.2	5.3	8.2	2.4	8.5	1.2	6.2	5.1	1.8	2.8	3.9	0.8	6.2	0.0	1.0	1.0	4.7	4.5	11.4	2.7	3.0	3.9	2.9	1.1	0.0	10.2	3.0	6.7	31.2	8.3	2.3	3.4	3.3	5.7	10.0	4.5
CHGA		ENSG00000100604	"Chromogranin A"	P10645	14	92923150-92935285	"Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted intracellular proteins"		"Antibiotic, Antimicrobial, Fungicide"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"parathyroid gland: 6568.4"	"Cell type enriched"	"Detected in many"	7	"Enteroendocrine cells: 6553.1"	"Cancer enhanced"	"Detected in many"		"pancreatic cancer: 114.8"	"Group enriched"	"Detected in many"	16	"cerebral cortex: 326.0;white matter: 124.4"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	151	"SCLC-21H: 489.5;SH-SY5Y: 1339.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000023, HPA017369, CAB040544, CAB055506, CAB058688"	Enhanced		Supported	Vesicles	"Intracellular and membrane"	NA	NA	295000000	100000000		"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 17: Intestinal endocrine cells - Hormone signaling"	Vesicles		"CAB000023: , CAB040544: , CAB055506: AB_2081135, CAB058688: AB_2665574, HPA017369: AB_1846698"	"prognostic favorable (7.85e-5)"	"unprognostic (4.89e-2)"	"unprognostic (5.96e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.43e-2)"	"unprognostic (5.95e-2)"	"prognostic unfavorable (2.40e-4)"	"unprognostic (1.74e-1)"	"unprognostic (2.23e-1)"	"unprognostic (4.56e-2)"	"prognostic favorable (4.07e-4)"	"unprognostic (1.85e-1)"	"unprognostic (8.81e-13)"	"unprognostic (1.07e-2)"	"unprognostic (1.77e-1)"	"unprognostic (9.17e-2)"	"prognostic unfavorable (3.99e-4)"	14.5	1248.5	8.6	9.4	11.4	0.2	0.3	0.0	326.0	8.3	0.0	92.0	242.7	0.4	0.3	1.0	1.1	0.2	0.2	4.4	1.7	1.0	0.4	1.6	0.1	14.4	0.0	0.2	102.5	6568.4	446.2	0.0	4.1	12.2	105.2	11.0	0.2	0.3	0.1	0.6	179.9	0.9	0.0	0.1	364.5	77.7	4.3	0.6	24.6	0.0	0.0	1.3	1.2	124.4	0.0	0.5	2.4	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	6.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.8	2.7	0.0	0.0	0.2	0.0	1.4	0.0	0.0	489.5	1339.4	0.0	0.4	0.1	0.0	0.1	0.1	0.0	0.0	4.2	0.3	0.4	0.0	0.0	0.8	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.6	11.4	0.0	326.0	4.4	1.7	14.4	0.0	4.1	0.0	4.3	124.4	0.1	0.0	0.0	11.1	1.0	0.9	0.4	0.0	0.0	17.3	0.2	0.3	2.9	0.0	0.0	0.0	29.2	0.3	0.0	9.8	0.0	0.1	1.3	6.0	2.3	0.8	6553.1	0.0	59.5	0.4	0.1	4.1	195.7	0.5	0.0	0.5	0.0	0.0	1.5	16.8	37.7	820.4	14.2	0.0	0.0	7.9	39.7	0.1	7.2	15.9	2.0	3.7	0.0	10.6	12.8	46.5	137.8	137.3	0.0	6.6	36.7	0.0	0.0	16.2	0.0	0.0	0.2	4.7	2.2	0.0	0.0	0.3	0.2	0.4	25.9	5.1
CHM	"DXS540, REP-1, TCD"	ENSG00000188419	"CHM Rab escort protein"	P24386	X	85861180-86047561	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Sensory transduction, Vision"	"GTPase activation"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Inhibitory neurons: 94.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003231, CAB016171"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 18: U-2197 - ECM organization"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm	Cytosol	"CAB016171: AB_2229397, HPA003231: AB_1078518"	"unprognostic (6.50e-3)"	"unprognostic (1.80e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.74e-2)"	"unprognostic (2.82e-1)"	"unprognostic (4.40e-1)"	"unprognostic (6.20e-3)"	"unprognostic (1.38e-1)"	"unprognostic (1.18e-1)"	"unprognostic (3.03e-1)"	"unprognostic (2.20e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.97e-3)"	"unprognostic (4.18e-2)"	"unprognostic (6.15e-2)"	"unprognostic (2.44e-1)"	"unprognostic (7.60e-3)"	9.3	11.1	2.7	7.3	3.4	2.4	7.7	2.7	4.4	9.3	3.6	6.1	4.6	8.8	4.6	6.7	11.0	7.2	7.2	3.9	2.5	12.1	7.7	7.0	7.1	2.9	2.2	7.8	5.9	14.2	3.8	9.5	3.0	7.6	6.4	9.3	5.6	7.1	6.4	4.2	4.7	8.7	1.3	8.1	7.3	4.6	2.9	8.5	10.9	10.5	6.3	7.6	3.5	3.2	16.8	10.9	10.9	7.2	17.4	18.4	6.9	19.3	16.2	13.2	14.4	8.8	15.0	5.7	24.3	14.0	46.1	9.4	23.9	10.9	22.5	10.9	11.4	3.4	14.6	8.4	13.8	14.3	23.8	14.1	10.1	21.4	26.9	14.6	22.9	9.4	11.9	19.0	20.7	4.8	8.8	5.2	16.2	11.6	17.5	9.0	19.5	8.8	12.2	9.5	9.6	14.8	23.3	7.1	18.3	14.9	6.0	6.7	16.4	16.7	11.0	59.0	9.7	7.2	27.7	7.9	18.0	11.9	14.9	2.2	1.9	0.9	1.6	2.3	1.5	1.8	1.3	1.7	1.5	2.1	1.7	1.8	1.0	1.6	1.9	1.4	1.7	1.2	2.7	3.4	2.7	4.4	3.9	2.5	2.9	2.2	3.0	1.3	2.9	3.2	34.5	3.2	11.0	33.6	22.3	6.9	17.6	18.9	15.9	35.2	14.2	10.3	11.9	15.7	15.9	16.5	8.4	9.6	26.5	10.2	19.6	16.3	0.7	13.8	29.5	22.2	18.7	12.6	82.5	12.4	9.6	21.6	15.3	18.4	16.5	18.2	14.6	12.5	15.5	23.5	94.7	11.8	10.2	23.0	9.1	2.1	15.5	21.4	5.4	52.5	19.6	27.5	18.6	78.4	76.5	15.7	11.4	12.4	17.3	18.9	7.5	35.2	17.7	20.9	46.0	28.0	27.8	3.7	12.2	12.8	7.4	18.3	22.1	28.7	9.4	15.6
CHML	REP-2	ENSG00000203668	"CHM like Rab escort protein"	P26374	1	241628851-241640369	"Predicted intracellular proteins, Predicted membrane proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 48.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in single"		"basophil: 1.1"	"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029627, HPA029628, HPA062967"	Supported		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 34: Non-specific - Transcription"	"Cluster 9: U-2 OS - Unknown function"	"Cluster 65: Plasmacytoid DCs - Unknown function"	"Nucleoplasm, Cytosol"		"HPA029627: AB_2756314, HPA029628: AB_10603784, HPA062967: AB_2797269"	"unprognostic (1.63e-1)"	"unprognostic (6.84e-2)"	"unprognostic (3.57e-1)"	"unprognostic (8.00e-2)"	"unprognostic (2.46e-1)"	"unprognostic (5.66e-2)"	"prognostic unfavorable (9.23e-5)"	"unprognostic (1.90e-2)"	"unprognostic (3.37e-2)"	"unprognostic (8.01e-3)"	"unprognostic (3.02e-3)"	"unprognostic (3.68e-2)"	"unprognostic (2.22e-2)"	"unprognostic (3.60e-1)"	"unprognostic (1.14e-1)"	"unprognostic (2.03e-3)"	"unprognostic (1.09e-1)"	2.7	1.8	0.7	3.5	1.5	7.5	3.6	0.0	3.6	3.1	0.0	3.0	2.2	4.2	2.7	3.3	2.8	3.2	3.0	1.5	0.2	2.9	2.4	3.8	3.7	0.1	1.0	7.4	2.0	4.1	1.5	11.4	0.0	1.9	3.4	3.3	2.3	1.5	2.6	3.2	2.8	3.2	0.0	3.9	3.1	6.1	1.7	6.4	4.4	3.4	3.0	2.1	2.3	1.5	31.3	9.5	14.6	11.7	4.3	12.8	28.4	12.1	6.0	10.3	7.0	17.5	5.6	8.6	18.1	8.1	8.4	6.3	20.6	13.1	19.0	16.5	19.2	11.3	39.4	12.3	8.7	27.2	14.0	10.7	5.8	13.6	14.0	7.2	8.2	22.7	31.0	10.2	12.3	12.2	18.1	18.1	19.4	11.8	30.6	27.3	18.0	28.8	10.4	19.2	18.6	30.6	15.2	11.5	13.3	14.2	13.5	17.4	16.7	20.9	40.8	10.6	23.3	11.9	31.2	9.0	20.3	16.0	33.0	1.1	0.2	0.1	0.1	0.3	0.1	0.3	0.0	0.0	0.2	0.3	0.3	0.2	0.0	0.1	0.2	0.7	0.0	0.0	0.7	1.5	0.0	3.6	1.5	0.2	0.1	1.0	0.0	0.0	1.7	1.5	14.0	48.1	7.0	0.0	17.2	8.5	6.1	3.8	3.4	3.6	9.9	11.7	19.6	4.3	7.9	0.0	0.0	23.5	26.4	6.2	5.9	14.8	12.3	14.4	15.1	8.1	6.7	10.3	0.0	21.3	26.7	6.5	6.6	34.8	3.8	21.3	4.2	2.1	7.1	5.0	0.0	4.2	6.1	17.6	31.0	30.9	10.5	34.7	17.8	0.0	18.6	3.1	4.1	0.0	0.0	22.5	4.3	18.0	5.8	3.9	4.3	2.2	2.0	4.7	13.1	11.4	20.7	9.0	12.6	7.6	7.2	20.1	5.8	9.9	5.0	4.3
CHMP1A	"CHMP1, KIAA0047, PCOLN3, PRSM1, Vps46A"	ENSG00000131165	"Charged multivesicular body protein 1A"	Q9HD42	16	89640816-89657738	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cell cycle, Cell division, Protein transport, Transcription, Transcription regulation, Transport"	Repressor	Neurodegeneration	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA006776			Supported	Nucleoplasm,Centrosome,Cytosol		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Nucleoplasm, Centrosome, Cytosol"		"HPA006776: AB_1078520"	"unprognostic (7.12e-2)"	"unprognostic (1.64e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.41e-2)"	"unprognostic (7.29e-2)"	"unprognostic (8.03e-3)"	"unprognostic (1.28e-3)"	"unprognostic (3.92e-3)"	"unprognostic (2.42e-1)"	"unprognostic (3.53e-1)"	"unprognostic (2.21e-1)"	"unprognostic (2.56e-1)"	"unprognostic (7.98e-3)"	"unprognostic (1.59e-2)"	"unprognostic (4.19e-2)"	"unprognostic (3.24e-1)"	"unprognostic (1.73e-1)"	30.3	31.2	46.3	21.1	44.5	31.4	29.4	41.2	53.4	34.3	36.9	42.7	37.8	35.8	17.0	65.4	31.6	24.8	33.1	46.8	42.7	36.6	30.6	28.7	27.5	45.3	44.3	25.0	25.7	30.4	24.8	24.7	44.0	33.5	23.0	5.4	31.8	22.1	50.0	48.7	42.5	22.4	44.3	31.6	34.0	37.3	45.7	30.5	28.3	25.9	24.3	35.6	36.9	44.2	70.5	66.3	29.5	46.2	42.2	38.2	75.3	53.0	54.3	79.3	38.7	97.1	111.5	37.7	53.2	70.1	52.9	88.3	52.6	69.7	36.7	34.2	82.7	31.0	23.4	108.5	57.8	23.0	31.7	54.7	75.6	74.6	33.8	42.7	41.2	46.2	69.9	18.2	45.6	141.4	55.1	88.3	58.1	78.6	63.5	60.1	58.3	39.8	60.4	43.0	52.7	70.8	103.5	34.3	38.1	27.5	117.6	48.5	63.1	52.7	61.6	65.3	45.8	52.1	59.1	51.1	88.1	54.9	62.5	66.7	51.6	108.9	54.4	62.7	42.0	36.3	43.6	50.1	44.2	33.4	27.5	33.4	86.0	49.8	82.3	49.4	58.5	64.1	46.3	44.5	41.2	53.4	46.8	42.7	45.3	44.3	44.0	44.3	45.7	44.2	31.1	32.1	23.6	17.3	27.5	23.8	24.5	28.8	13.1	24.6	33.9	27.6	16.8	28.6	26.6	31.3	8.4	57.7	43.2	147.3	37.2	55.3	56.4	27.2	26.3	28.3	44.3	16.2	8.8	59.5	74.4	26.9	36.2	35.0	27.9	33.0	23.2	31.1	47.6	43.7	7.9	57.7	30.5	30.4	23.8	125.5	20.5	28.3	23.2	11.2	62.8	36.3	43.3	11.1	9.5	84.7	121.6	24.0	14.8	31.7	109.6	40.9	22.4	20.5	26.3	17.1	27.1	45.4	33.3	26.3	32.5	66.2	28.6	28.8	58.2	36.5
CHMP1B	"C18orf2, CHMP1.5, Vps46B"	ENSG00000255112	"Charged multivesicular body protein 1B"	Q7LBR1	18	11851413-11854444	"Predicted intracellular proteins"	"Cell cycle, Cell division, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	6	"skeletal muscle: 361.4"	"Cell type enhanced"	"Detected in many"		"Suprabasal keratinocytes: 514.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA061997, HPA062896"	Supported		Approved	Nucleoplasm,Midbody		Yes	No			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 33: Striated muscle - Muscle contraction"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 41: Macrophages - Immune response"	Midbody	Nucleoplasm	"HPA061997: AB_2684653, HPA062896: AB_2684898"	"unprognostic (6.73e-2)"	"unprognostic (5.35e-2)"	"unprognostic (1.09e-2)"	"unprognostic (6.74e-3)"	"unprognostic (1.80e-1)"	"unprognostic (1.35e-3)"	"unprognostic (1.44e-1)"	"unprognostic (8.44e-3)"	"unprognostic (1.90e-1)"	"unprognostic (9.44e-3)"	"unprognostic (2.37e-3)"	"unprognostic (9.20e-2)"	"prognostic favorable (7.37e-8)"	"unprognostic (1.88e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.53e-2)"	"unprognostic (1.92e-1)"	43.3	35.7	24.5	36.2	25.9	61.2	29.0	19.6	25.4	25.6	30.0	39.1	38.7	28.3	26.2	39.1	24.8	39.3	40.7	25.9	25.6	33.1	31.1	29.7	29.9	21.9	23.2	29.6	24.8	39.9	29.3	27.8	22.6	27.8	37.5	17.6	29.5	35.0	361.4	40.4	48.8	23.6	20.3	30.2	30.5	14.0	24.0	46.0	52.2	53.2	24.8	49.5	23.8	23.6	30.0	28.8	36.5	31.1	46.9	32.7	52.9	31.4	52.6	21.0	27.9	37.5	29.4	18.5	45.9	34.2	35.0	25.0	16.8	43.7	18.5	17.2	20.8	13.5	43.6	31.1	34.6	51.7	22.3	47.7	92.5	23.5	53.9	46.8	30.7	41.6	23.1	23.4	33.3	37.3	36.1	39.6	15.3	94.9	14.3	18.4	18.8	32.1	56.5	40.5	35.5	35.5	53.1	24.7	50.5	33.9	20.2	47.2	45.2	46.7	24.5	37.3	34.0	27.8	34.3	23.5	43.3	23.8	22.7	32.5	38.8	66.7	15.4	35.7	14.3	14.7	14.3	18.5	30.2	14.7	17.6	16.4	77.9	18.3	36.6	26.7	21.5	29.2	24.5	25.9	19.6	25.4	25.9	25.6	21.9	23.2	22.6	20.3	24.0	23.6	71.2	67.3	47.0	0.0	152.9	419.6	141.8	291.8	216.9	30.5	71.3	59.4	21.7	52.9	157.7	132.4	8.4	135.9	171.0	281.4	60.7	123.0	80.4	146.6	110.2	69.9	143.8	40.4	0.0	80.3	144.4	99.3	70.8	298.3	149.9	38.4	52.8	44.1	118.0	28.6	0.0	104.6	111.9	139.9	440.8	42.6	37.9	354.5	158.3	0.0	102.1	32.2	78.2	0.0	0.0	134.0	393.7	37.2	21.8	93.9	179.2	139.1	84.8	16.8	78.9	61.2	94.5	16.0	21.1	177.1	514.7	253.2	135.5	43.9	96.8	252.2
CHMP5	"C9orf83, CGI-34, HSPC177, SNF7DC2, Vps60"	ENSG00000086065	"Charged multivesicular body protein 5"	Q9NZZ3	9	33264879-33282070	"Plasma proteins, Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB033874, HPA042883, HPA056437"	Enhanced		Supported	Microtubules,Midbody,Cytosol		Yes	No		22000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 24: NB-4 - Immune response"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Microtubules, Cytosol"	Midbody	"CAB033874: AB_10608611, HPA042883: AB_2678212, HPA056437: AB_2683133"	"unprognostic (1.10e-1)"	"unprognostic (1.10e-1)"	"unprognostic (9.08e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.32e-1)"	"unprognostic (4.56e-2)"	"unprognostic (3.87e-2)"	"unprognostic (2.18e-2)"	"unprognostic (4.71e-2)"	"unprognostic (2.14e-3)"	"unprognostic (7.94e-2)"	"unprognostic (2.66e-1)"	"prognostic favorable (2.87e-7)"	"unprognostic (2.22e-1)"	"unprognostic (9.59e-2)"	"unprognostic (1.73e-1)"	"unprognostic (7.31e-2)"	54.6	54.6	48.3	36.7	49.2	30.5	49.6	50.4	63.8	56.4	50.0	55.7	55.2	41.3	48.1	64.6	43.8	42.1	50.8	49.0	50.3	77.8	56.3	53.5	41.6	50.4	49.7	42.9	32.7	63.9	49.7	63.8	50.7	54.8	55.9	53.8	43.7	39.4	48.2	47.0	59.2	33.9	52.7	43.5	54.6	36.2	49.4	44.9	55.8	44.3	38.1	49.7	56.5	56.9	92.2	66.5	67.0	43.5	99.0	89.0	61.9	90.1	99.7	138.3	152.6	50.9	56.9	49.0	96.3	84.3	95.9	39.2	70.5	72.8	111.1	102.5	49.3	41.5	129.7	55.8	85.9	53.4	78.8	95.6	131.3	93.6	86.4	114.5	73.3	68.3	44.9	63.6	110.5	41.3	56.1	164.1	61.8	70.1	80.6	34.0	59.2	32.9	115.2	48.7	32.7	83.6	91.0	53.4	87.2	77.8	54.2	82.7	74.4	69.5	73.0	60.2	80.8	42.3	87.6	57.0	100.5	36.0	45.6	98.6	50.3	106.3	25.3	56.5	27.6	31.0	33.7	33.8	46.5	26.4	30.6	29.4	129.4	47.4	67.3	71.2	43.4	51.3	48.3	49.2	50.4	63.8	49.0	50.3	50.4	49.7	50.7	52.7	49.4	56.9	182.7	89.8	59.0	14.0	52.9	188.1	156.2	372.5	71.7	63.7	85.2	75.1	64.7	94.4	228.6	110.3	27.1	172.0	77.4	241.0	285.7	141.7	245.2	228.0	90.6	133.8	80.2	90.1	19.6	86.1	186.1	104.4	56.1	167.0	58.4	66.5	97.5	70.5	154.9	26.9	19.0	137.9	246.2	100.9	103.2	35.9	93.2	95.3	117.4	15.0	166.3	156.2	38.1	14.6	26.8	151.9	247.9	104.6	45.2	182.4	226.3	355.2	328.9	68.2	85.5	97.0	130.0	99.5	68.7	70.1	236.3	259.0	68.5	71.4	78.5	246.0
CHMP7	MGC29816	ENSG00000147457	"Charged multivesicular body protein 7"	Q8WUX9	8	23243637-23262000	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 32.8"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Group enriched"	"Detected in all"	10	"B-cells: 35.7;T-cells: 76.3"	"Cell line enhanced"	"Detected in all"		"Daudi: 39.7;U-698: 47.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036119	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 57: B-cells - Immune response"	Nucleoplasm	Cytosol	"HPA036119: AB_10673000"	"unprognostic (2.94e-3)"	"unprognostic (1.64e-1)"	"unprognostic (7.59e-3)"	"unprognostic (4.51e-2)"	"unprognostic (2.47e-1)"	"unprognostic (2.83e-3)"	"unprognostic (9.00e-2)"	"unprognostic (1.84e-1)"	"unprognostic (6.44e-2)"	"unprognostic (2.74e-1)"	"unprognostic (1.39e-1)"	"unprognostic (8.98e-3)"	"unprognostic (1.88e-2)"	"unprognostic (6.80e-3)"	"unprognostic (2.06e-1)"	"unprognostic (7.54e-2)"	"unprognostic (2.30e-1)"	4.6	5.9	2.3	19.5	2.4	9.8	4.5	3.6	3.2	5.1	1.4	6.0	4.0	6.2	1.4	4.8	4.9	3.4	3.9	2.3	2.9	3.4	3.5	4.7	32.8	3.4	2.0	4.4	2.7	2.7	3.6	2.1	3.5	4.1	3.4	2.2	5.2	3.6	7.0	4.6	14.7	2.6	1.9	16.9	5.8	4.8	2.9	31.0	4.4	3.9	27.7	5.6	4.7	4.8	6.2	8.6	4.6	7.8	4.2	4.0	5.2	5.0	3.6	7.2	6.1	9.6	4.8	39.7	6.0	3.7	6.9	5.9	4.3	6.3	2.9	10.6	7.4	8.4	11.5	4.9	3.6	2.4	11.4	3.4	4.2	7.0	1.9	4.1	6.0	16.7	9.3	5.6	4.2	6.0	7.3	9.3	7.1	5.9	6.5	2.8	3.7	5.5	3.7	8.0	5.6	5.5	3.9	5.9	2.3	2.5	6.2	4.5	6.7	8.9	5.7	6.7	4.0	15.1	8.5	47.2	6.6	6.6	6.6	1.2	4.8	5.0	6.3	4.8	12.7	35.7	41.3	19.0	3.7	35.6	76.3	45.2	4.3	5.4	3.5	3.0	46.8	32.7	2.3	2.4	3.6	3.2	2.3	2.9	3.4	2.0	3.5	1.9	2.9	4.8	8.6	6.4	7.9	7.2	48.6	13.6	15.8	12.1	12.5	11.9	11.3	10.9	13.2	11.5	11.8	14.7	4.2	15.8	12.7	16.9	19.6	19.7	43.5	5.5	11.3	12.1	13.8	8.6	9.3	15.8	18.8	11.1	11.7	10.2	12.0	13.1	6.4	7.0	15.9	13.5	11.4	13.1	14.2	7.5	7.7	13.7	9.9	13.1	16.0	1.9	17.3	20.6	21.6	3.5	9.5	20.5	12.4	10.5	24.0	15.9	16.0	18.8	7.1	10.6	6.6	10.1	13.1	15.7	16.8	9.2	10.7	20.7	25.7	10.1	10.8	19.6
CHP2		ENSG00000166869	"Calcineurin like EF-hand protein 2"	O43745	16	23755026-23758935	"Cancer-related genes, Predicted intracellular proteins"	"Protein transport, Transport"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	16	"intestine: 305.0;skin 1: 149.7"	"Group enriched"	"Detected in some"	5	"Distal enterocytes: 345.0;Paneth cells: 274.0;Proximal enterocytes: 654.2;Undifferentiated cells: 205.4"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 10.4"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"hTERT-HME1: 7.3;hTERT-RPE1: 10.2;NB-4: 8.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA055198, CAB072806"	Approved		Supported	Nucleoplasm,Nucleoli,Cytosol		NA	NA				"Cluster 56: Intestine - Transmembrane transport"	"Cluster 24: NB-4 - Immune response"	"Cluster 45: Enterocytes - Digestion"	Nucleoplasm	"Nucleoli, Cytosol"	"CAB072806: , HPA055198: "	"unprognostic (4.82e-1)"	"unprognostic (3.40e-1)"	"unprognostic (4.93e-2)"	"unprognostic (1.01e-2)"	"unprognostic (8.85e-2)"	"unprognostic (3.54e-1)"		"unprognostic (4.54e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.38e-1)"	"unprognostic (5.31e-2)"	"unprognostic (4.70e-2)"	"unprognostic (1.44e-5)"	"unprognostic (2.21e-1)"	"unprognostic (5.97e-2)"	"unprognostic (7.84e-2)"	"unprognostic (9.01e-2)"	0.4	0.2	1.1	3.8	1.1	2.2	4.3	3.6	1.3	14.0	0.0	146.7	305.0	0.9	1.1	0.6	0.9	0.4	0.4	0.7	1.6	4.1	0.7	0.6	0.8	0.5	0.1	0.4	0.5	0.1	0.0	1.4	0.9	3.8	147.4	1.3	0.8	4.5	1.2	149.7	250.5	6.5	0.1	0.3	1.1	7.3	0.9	0.5	0.6	0.2	0.4	9.0	4.2	2.9	1.0	2.2	0.5	0.6	1.2	1.3	1.2	2.9	1.1	0.3	1.0	0.5	2.3	0.4	0.9	2.5	1.2	1.4	0.4	2.9	0.6	0.7	0.2	0.5	4.1	1.6	1.7	0.3	0.7	0.9	0.8	2.5	7.3	10.2	1.1	0.3	1.2	1.0	1.2	0.1	0.1	8.7	0.3	0.5	2.1	0.2	0.1	1.4	1.1	0.7	0.6	0.7	0.8	0.2	0.0	0.6	0.2	0.2	1.3	0.5	0.6	0.7	0.1	0.4	0.1	0.2	0.0	0.5	0.5	0.1	0.1	0.0	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.2	0.1	0.1	0.4	0.0	0.1	0.1	0.0	0.0	1.1	1.1	3.6	1.3	0.7	1.6	0.5	0.1	0.9	0.1	0.9	2.9	0.0	0.0	0.0	0.0	0.0	10.3	8.7	6.1	0.0	0.0	0.0	0.1	0.1	0.0	24.4	1.8	0.0	0.9	0.0	345.0	0.0	0.0	0.6	1.3	0.5	0.2	9.1	0.0	0.0	0.0	4.1	0.2	0.0	3.6	4.5	0.7	0.0	0.0	0.1	0.0	0.0	70.0	12.2	0.0	1.6	0.5	0.0	0.2	1.8	0.0	0.0	0.0	0.0	0.0	0.6	0.0	274.0	0.0	0.0	2.5	654.2	12.9	4.4	0.0	0.0	0.0	0.3	0.0	0.2	0.0	67.5	0.7	0.2	0.2	205.4	29.9
CHPF	"CHSY2, CSS2"	ENSG00000123989	"Chondroitin polymerizing factor"	Q8IZ52	2	219538948-219543809	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 163.7;Extravillous trophoblasts: 182.7;Syncytiotrophoblasts: 310.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"plasmacytoid DC: 9.5"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035123	Approved		Supported	Vesicles,Centrosome,Cytosol	"Intracellular and membrane"	NA	NA		570000	"Cluster 52: Eosinophils - Transcription"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 55: Plasma cells - Humoral immune response"	Cytosol	"Vesicles, Centrosome"	"HPA035123: AB_10602799"	"unprognostic (1.13e-3)"	"prognostic unfavorable (1.57e-4)"	"unprognostic (3.65e-3)"	"unprognostic (2.55e-3)"	"unprognostic (1.86e-3)"	"prognostic unfavorable (1.68e-4)"	"unprognostic (1.37e-1)"	"unprognostic (6.59e-3)"	"unprognostic (7.74e-2)"	"unprognostic (1.19e-2)"	"unprognostic (1.18e-1)"	"unprognostic (6.79e-2)"	"unprognostic (1.64e-1)"	"unprognostic (6.55e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.17e-1)"	"prognostic unfavorable (2.96e-4)"	29.9	45.7	26.9	12.5	24.9	1.7	22.3	25.8	34.2	59.1	36.7	21.9	26.7	55.9	13.7	27.3	30.2	24.2	134.8	38.4	31.2	41.1	97.8	42.8	6.5	34.0	30.4	127.4	138.9	24.6	128.3	40.6	32.1	58.6	4.7	8.5	56.1	25.6	16.3	26.2	23.2	12.6	27.4	16.6	40.9	97.5	33.2	3.6	52.8	3.9	4.5	34.3	30.0	34.0	67.5	13.0	9.6	81.0	36.0	55.8	109.7	66.4	55.4	18.5	16.8	36.8	57.5	20.7	139.0	64.6	63.3	84.1	6.3	40.3	2.9	32.3	22.5	7.4	18.0	161.9	49.8	6.6	42.1	75.0	69.2	18.8	17.9	66.7	0.1	7.1	47.2	49.6	17.7	105.5	1.0	17.6	39.8	22.8	50.6	0.1	30.4	41.6	22.4	29.7	23.4	36.0	32.1	30.7	94.3	17.9	10.5	22.6	1.6	67.9	37.1	81.9	35.2	58.9	19.9	9.7	62.1	6.7	70.4	1.7	0.0	6.5	1.9	0.1	2.4	1.0	1.5	1.3	0.0	0.1	1.7	0.6	0.0	1.9	0.0	9.5	1.2	0.7	26.9	24.9	25.8	34.2	38.4	31.2	34.0	30.4	32.1	27.4	33.2	34.0	2.1	0.0	15.2	16.0	16.5	14.5	23.2	52.8	17.1	14.6	40.0	29.6	30.5	22.8	31.2	75.4	10.4	163.7	21.7	15.9	9.8	58.1	4.1	14.0	22.2	2.9	43.0	3.2	4.3	80.4	182.7	56.0	25.5	42.4	10.2	27.4	4.2	64.0	18.5	43.7	9.2	57.8	36.7	2.4	9.1	7.1	24.8	2.3	67.6	5.6	1.8	56.8	9.2	5.5	3.7	65.6	32.7	63.2	123.6	42.3	60.7	20.6	14.6	11.5	26.3	19.3	27.1	11.9	6.3	14.2	11.1	310.3	9.7	46.3	14.3	33.0
CHPT1	CPT1	ENSG00000111666	"Choline phosphotransferase 1"	Q8WUD6	12	101696947-101744140	"Enzymes, Metabolic proteins, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 344.4;Late spermatids: 650.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"basophil: 36.9;eosinophil: 14.6"	"Lineage enriched"	"Detected in all"	8	"granulocytes: 36.9"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA067643	Approved		Supported	Vesicles		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 22: Epithelial cell types - Mixed function"	Vesicles		"HPA067643: "	"unprognostic (1.59e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.91e-1)"	"unprognostic (9.48e-2)"	"unprognostic (3.15e-1)"	"unprognostic (9.17e-2)"	"unprognostic (5.79e-2)"	"unprognostic (4.83e-2)"	"unprognostic (1.12e-1)"	"unprognostic (4.70e-1)"	"unprognostic (5.27e-2)"	"unprognostic (1.16e-2)"	"unprognostic (1.52e-2)"	"unprognostic (3.35e-1)"	"unprognostic (1.72e-1)"	"prognostic favorable (7.41e-4)"	"unprognostic (1.79e-1)"	39.8	47.7	48.6	17.7	49.1	62.0	102.9	43.8	65.6	50.5	41.9	49.4	88.1	19.2	56.1	24.9	33.4	40.2	91.3	46.1	47.3	73.5	157.4	38.4	20.0	50.0	51.2	18.7	25.0	92.4	12.4	22.8	44.9	35.0	48.9	4.8	130.0	50.0	27.8	28.0	75.7	18.8	50.0	23.5	56.0	28.1	54.4	9.0	38.0	28.3	21.2	32.4	26.2	48.9	11.3	51.2	13.7	29.3	106.6	35.7	38.9	40.2	46.2	39.7	25.5	19.3	7.7	17.3	22.1	55.1	54.3	16.9	83.8	14.2	37.3	26.2	70.1	69.7	25.7	112.6	59.4	34.8	13.5	33.6	4.1	18.0	32.7	59.0	20.0	36.4	102.8	43.1	39.4	27.6	20.8	118.5	36.2	53.8	67.4	15.9	26.8	12.4	17.9	43.4	13.8	10.4	37.2	52.3	103.2	21.4	53.8	23.6	14.7	36.1	18.7	28.5	39.9	24.3	7.9	21.2	28.4	39.7	53.4	36.9	2.2	14.6	0.6	1.7	0.6	4.4	1.2	0.9	2.9	2.6	0.4	0.6	3.1	4.6	2.2	3.7	0.6	0.5	48.6	49.1	43.8	65.6	46.1	47.3	50.0	51.2	44.9	50.0	54.4	48.9	27.1	48.1	27.6	159.6	135.1	37.5	313.3	4.2	21.6	19.3	243.8	76.7	45.3	102.9	13.1	64.4	29.2	123.9	32.6	61.7	70.5	8.1	344.4	17.1	50.2	22.5	21.1	168.6	95.8	13.8	56.1	75.4	69.8	21.0	10.8	15.3	31.1	189.7	56.4	35.3	95.6	53.4	2.0	102.9	55.7	650.9	85.4	81.2	145.9	36.5	27.0	68.1	5.2	65.9	10.2	9.6	113.3	89.1	55.4	172.1	174.1	183.7	4.3	16.0	19.7	88.2	37.8	193.8	43.2	43.1	43.2	60.3	41.3	3.4	90.7	291.6
CHRM3		ENSG00000133019	"Cholinergic receptor muscarinic 3"	P20309	1	239386565-239915452	"Disease related genes, FDA approved drug targets, G-protein coupled receptors, Human disease related genes, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 11.8;salivary gland: 17.5"	"Group enriched"	"Detected in many"	28	"Excitatory neurons: 802.9;Inhibitory neurons: 624.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"RPMI-8226: 17.2;SH-SY5Y: 53.5;U-266/70: 21.7;U-266/84: 16.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA024106, HPA048036"	Approved		Supported	"Plasma membrane"		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 22: Non-specific - Unknown function"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Plasma membrane"		"HPA024106: AB_1854211, HPA048036: AB_2680238"	"unprognostic (1.63e-1)"	"unprognostic (4.82e-2)"	"unprognostic (1.05e-1)"	"unprognostic (4.11e-3)"	"unprognostic (3.48e-3)"	"unprognostic (5.81e-2)"	"unprognostic (2.30e-3)"	"unprognostic (5.18e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.27e-1)"	"unprognostic (6.29e-2)"	"unprognostic (6.44e-2)"	"unprognostic (5.34e-4)"	"unprognostic (3.04e-2)"	"unprognostic (2.67e-1)"	"unprognostic (1.02e-1)"	"unprognostic (4.88e-2)"	0.3	0.4	4.6	0.8	7.3	0.2	0.8	0.0	11.8	0.4	0.0	7.0	1.4	1.9	0.4	7.5	0.8	0.7	0.4	7.5	0.0	1.1	0.4	1.1	0.1	0.0	0.0	4.8	10.6	0.5	0.5	0.8	0.0	1.1	2.8	1.7	17.5	3.0	0.0	1.3	1.5	4.1	0.0	0.7	5.0	2.5	4.1	0.1	2.0	0.1	0.1	7.0	0.4	2.9	0.0	0.1	0.4	0.4	0.0	0.0	0.9	0.6	0.1	0.3	0.1	0.0	0.0	0.0	2.1	0.0	0.0	5.8	0.6	3.8	2.7	0.0	3.7	0.6	0.4	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.8	0.0	0.0	1.1	9.1	0.9	1.4	0.0	0.0	4.6	4.6	9.1	0.0	1.1	17.2	0.7	0.8	0.1	53.5	0.0	0.1	0.1	4.0	1.8	0.0	0.3	2.3	0.8	0.1	0.5	21.7	16.3	0.0	0.5	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.1	0.0	0.0	0.0	4.6	7.3	0.0	11.8	7.5	0.0	0.0	0.0	0.0	0.0	4.1	2.9	6.1	0.0	3.7	6.2	0.0	0.0	2.1	0.0	0.6	19.0	4.6	3.2	1.2	0.0	0.8	0.0	0.0	3.2	0.3	11.0	1.9	0.4	19.6	0.1	0.1	3.0	3.5	4.6	802.9	17.3	0.7	3.9	11.7	0.2	1.3	7.5	4.2	0.3	0.5	0.0	624.0	6.0	0.0	0.0	0.0	3.9	0.0	0.2	7.2	22.5	0.0	0.3	0.0	8.5	11.2	2.6	25.3	0.4	0.2	2.5	2.2	1.4	1.6	0.6	0.0	0.2	1.1	12.9	3.0	0.2	0.0	0.5	0.1	0.8	15.5	0.2
CHRNA1	CHRNA	ENSG00000138435	"Cholinergic receptor nicotinic alpha 1 subunit"	P02708	2	174747592-174787935	"Disease related genes, Human disease related genes, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel, Ligand-gated ion channel, Receptor"	"Congenital myasthenic syndrome, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"skeletal muscle: 170.1"	"Cell type enriched"	"Detected in some"	48	"Skeletal myocytes: 193.5"	"Cancer enhanced"	"Detected in many"		"glioma: 5.8"	"Group enriched"	"Detected in some"	13	"cerebral cortex: 12.8;hippocampal formation: 5.5"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	19	"LHCN-M2: 445.4;RH-30: 360.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA071554	Enhanced		Supported	"Plasma membrane"		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 33: Striated muscle - Muscle contraction"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 50: Fibroblasts - ECM organization"	"Plasma membrane"		"HPA071554: AB_2686416"	"unprognostic (1.49e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.22e-3)"	"unprognostic (2.28e-2)"	"unprognostic (2.96e-1)"	"unprognostic (8.55e-3)"	"unprognostic (5.34e-2)"	"unprognostic (5.29e-3)"	"unprognostic (9.59e-2)"	"unprognostic (9.64e-2)"	"unprognostic (9.66e-2)"	"unprognostic (6.37e-2)"	"unprognostic (4.18e-4)"	"unprognostic (2.04e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.86e-1)"	"unprognostic (7.18e-2)"	0.2	0.0	0.2	0.2	0.4	0.0	0.5	0.1	12.8	0.6	0.2	1.5	0.2	0.0	0.2	0.6	0.0	0.0	0.3	5.5	0.2	0.0	0.2	0.6	0.8	0.5	0.2	0.0	0.0	0.0	3.3	0.2	0.5	2.0	0.9	0.0	3.2	0.0	170.1	0.5	0.0	0.0	0.3	0.0	0.0	0.4	0.3	1.1	0.0	20.4	1.2	0.0	0.0	0.7	0.0	0.0	0.4	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	21.5	0.0	0.2	0.0	0.0	1.4	0.0	0.1	0.2	445.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	360.2	0.0	0.0	0.3	2.9	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.8	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.2	0.4	0.1	12.8	5.5	0.2	0.5	0.2	0.5	0.3	0.3	0.7	0.1	0.0	0.0	0.0	2.8	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.3	4.0	0.0	0.0	1.7	0.0	0.0	0.3	0.0	0.0	0.5	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.0	0.1	0.5	0.0	0.6	0.4	1.7	0.3	0.4	1.8	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	193.5	0.3	0.1	0.2	0.0	0.0	0.0	1.8	0.0	0.2	0.0
CHRNA2		ENSG00000120903	"Cholinergic receptor nicotinic alpha 2 subunit"	Q15822	8	27459756-27479883	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Ion transport, Transport"	"Ion channel, Ligand-gated ion channel, Receptor"	"Disease variant, Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	14	"brain: 72.1;prostate: 29.0"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 6.5;Inhibitory neurons: 14.8;Prostatic glandular cells: 2.4;Theca cells: 3.4"	"Cancer enriched"	"Detected in single"	421	"prostate cancer: 30.2"	"Region enhanced"	"Detected in many"		"thalamus: 72.1"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			HPA048348			Supported	"Nucleoplasm,Plasma membrane,Cytokinetic bridge"		Yes	NA				"Cluster 73: Brain - Neuropeptide signaling"		"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Plasma membrane"	"Nucleoplasm, Cytokinetic bridge"	"HPA048348: "	"unprognostic (1.10e-2)"	"unprognostic (1.47e-1)"			"unprognostic (2.23e-2)"	"unprognostic (3.19e-1)"	"unprognostic (6.19e-2)"	"unprognostic (6.29e-3)"			"unprognostic (1.19e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.91e-1)"	"unprognostic (7.60e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.47e-1)"		0.0	0.5	15.8	0.2	5.5	0.9	1.4	38.1	2.9	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.7	8.0	0.0	0.0	0.2	0.1	15.7	21.5	0.0	0.2	0.0	0.3	0.0	3.5	29.0	0.0	3.7	0.0	0.0	0.1	0.2	0.2	0.0	2.3	0.1	0.0	0.0	72.1	2.9	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	15.8	5.5	38.1	2.9	0.7	8.0	15.7	21.5	3.5	2.3	72.1	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.5	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.3	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0
CHRNA3		ENSG00000080644	"Cholinergic receptor nicotinic alpha 3 subunit"	P32297	15	78593052-78621295	"Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Ion transport, Transport"	"Ion channel, Ligand-gated ion channel, Receptor"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"adrenal gland: 39.3;lymphoid tissue: 65.8;retina: 53.5"	"Cell type enriched"	"Detected in some"	19	"Cone photoreceptor cells: 164.7"	"Cancer enhanced"	"Detected in some"		"testis cancer: 1.6"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"SH-SY5Y: 356.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA029430	Enhanced		Supported	"Nuclear speckles,Plasma membrane"		NA	NA				"Cluster 20: Retina & Lymphoid tissues - Unknown function"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 9: Photoreceptor cells - Phototransduction"	"Plasma membrane"	"Nuclear speckles"	"HPA029430: AB_10603785"	"unprognostic (2.28e-1)"	"unprognostic (3.45e-1)"	"unprognostic (2.58e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.12e-1)"	"unprognostic (9.16e-3)"	"unprognostic (1.97e-1)"	"unprognostic (4.28e-2)"	"unprognostic (7.20e-2)"	"unprognostic (3.12e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.86e-4)"	"unprognostic (2.65e-3)"	"unprognostic (2.76e-1)"	"unprognostic (1.53e-1)"	"unprognostic (4.48e-1)"	0.3	39.3	4.4	5.1	2.0	0.0	0.1	6.3	1.0	1.0	0.3	8.1	1.5	0.5	0.0	0.1	0.0	0.3	0.4	0.7	2.3	0.0	0.0	0.2	0.3	3.1	6.4	0.1	0.2	0.0	1.1	0.1	10.0	0.2	4.0	53.5	0.1	0.0	0.1	0.7	3.0	3.7	0.3	0.1	2.8	1.0	9.2	65.8	0.2	0.0	0.8	0.2	0.7	1.0	0.1	0.3	0.7	0.6	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.1	0.2	0.1	0.2	0.0	1.5	0.0	8.8	0.0	0.0	0.3	1.4	0.5	0.4	0.1	0.0	0.1	4.0	0.0	0.3	0.0	0.0	0.0	0.0	22.6	0.2	0.0	0.0	0.3	7.1	0.0	1.6	0.1	0.2	0.4	0.3	0.1	0.0	0.4	67.7	356.1	0.3	0.1	0.1	0.5	0.4	0.0	0.0	0.1	1.7	0.1	0.4	0.2	0.7	0.1	0.1	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.4	2.0	6.3	1.0	0.7	2.3	3.1	6.4	10.0	0.3	9.2	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.8	0.0	0.0	0.8	0.0	0.0	0.0	164.7	0.0	0.0	0.2	1.9	0.0	3.7	0.1	1.2	0.4	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.2	1.7	0.4	3.6	0.0	0.0	0.0	3.5	0.0	0.2	0.0	0.0	0.0	3.3	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.6	0.0	0.1	0.1	0.3	2.1	0.0	0.0	0.0	0.0	2.6	0.1	0.1
CHRNA5		ENSG00000169684	"Cholinergic receptor nicotinic alpha 5 subunit"	P30532	15	78565520-78595269	"Predicted intracellular proteins, Predicted membrane proteins"	"Ion transport, Transport"	"Ion channel, Ligand-gated ion channel, Receptor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 13.0;Extravillous trophoblasts: 11.5;Intestinal goblet cells: 9.8;Spermatocytes: 12.4;Spermatogonia: 28.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			HPA054381	Approved		Approved	"Plasma membrane,Focal adhesion sites"		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	"Focal adhesion sites"	"Plasma membrane"	"HPA054381: AB_2682468"	"unprognostic (2.66e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.32e-2)"	"unprognostic (3.20e-3)"	"unprognostic (6.66e-2)"	"unprognostic (1.29e-3)"	"unprognostic (7.03e-5)"	"prognostic unfavorable (3.64e-5)"	"unprognostic (1.34e-2)"	"unprognostic (1.31e-2)"	"unprognostic (4.52e-2)"	"unprognostic (8.97e-2)"	"unprognostic (6.50e-11)"	"unprognostic (4.37e-1)"	"unprognostic (5.39e-1)"	"unprognostic (5.44e-2)"	"unprognostic (2.22e-1)"	0.8	2.0	1.9	1.9	1.8	0.5	1.5	2.7	3.0	1.0	2.0	4.0	4.8	1.3	1.1	1.6	0.5	4.4	1.3	1.7	1.8	0.3	0.3	0.5	0.7	1.7	2.2	0.7	1.9	0.3	0.2	1.1	2.4	1.9	4.2	2.5	0.7	0.4	3.9	0.6	2.4	2.1	1.6	0.3	2.8	3.1	2.4	0.7	0.3	0.5	1.1	1.8	1.1	2.7	16.5	41.8	22.4	12.5	2.7	1.9	9.1	12.0	5.8	13.0	23.4	16.1	76.7	9.8	28.6	2.6	34.7	14.3	43.5	17.6	13.2	20.1	51.9	18.3	29.5	16.2	1.4	12.4	24.7	0.7	3.1	3.5	4.7	4.8	24.5	13.6	18.2	12.5	8.3	36.1	15.9	4.3	18.2	32.4	11.5	20.1	25.8	9.9	15.7	39.2	37.7	55.0	28.6	27.5	14.1	12.7	61.2	3.2	5.3	17.6	21.0	13.0	38.0	14.3	63.4	11.3	10.6	19.8	16.5	1.0	0.4	0.7	0.1	0.4	0.1	0.0	0.1	0.1	0.2	0.1	0.3	0.3	0.7	0.3	0.4	0.2	0.0	0.1	1.9	1.8	2.7	3.0	1.7	1.8	1.7	2.2	2.4	1.6	2.4	2.7	0.9	0.0	0.0	0.3	1.4	3.2	13.0	0.5	8.6	7.6	1.2	2.9	1.2	2.8	0.2	0.0	0.0	2.6	0.4	1.2	0.0	0.3	1.2	0.5	0.6	2.0	3.5	0.8	1.0	2.0	11.5	1.0	0.5	0.6	0.0	1.5	0.0	0.3	1.0	5.0	1.1	9.8	0.0	0.0	2.3	2.6	0.3	0.8	1.8	0.0	0.2	0.4	1.0	0.5	0.9	0.7	0.1	0.4	0.9	6.7	0.1	0.4	0.1	0.7	0.0	1.3	1.6	12.4	28.8	2.9	1.6	1.0	2.0	0.2	2.1	3.2
CHRNB4		ENSG00000117971	"Cholinergic receptor nicotinic beta 4 subunit"	P30926	15	78624111-78727754	"FDA approved drug targets, Predicted membrane proteins"	"Ion transport, Transport"	"Ion channel, Ligand-gated ion channel, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 3.0;retina: 2.7;testis: 5.8"	"Group enriched"	"Detected in some"	11	"Early spermatids: 44.1;Late spermatids: 54.9"	"Cancer enhanced"	"Detected in some"		"testis cancer: 2.0"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	16	"SCLC-21H: 30.9;SH-SY5Y: 40.7"	"Group enriched"	"Detected in some"	5	"olfactory bulb: 5.3;pons and medulla: 1.4;thalamus: 4.2"					HPA059484			Approved	"Endoplasmic reticulum,Cell Junctions"		NA	NA				"Cluster 77: Retina - Visual perception"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 34: Spermatids - Unknown function"	"Endoplasmic reticulum"	"Cell Junctions"	"HPA059484: "	"unprognostic (4.74e-2)"	"unprognostic (4.54e-1)"	"unprognostic (1.26e-2)"	"unprognostic (8.77e-5)"	"unprognostic (8.15e-2)"	"unprognostic (6.43e-3)"	"unprognostic (1.10e-1)"	"unprognostic (2.30e-2)"	"unprognostic (1.09e-1)"	"unprognostic (3.19e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.45e-4)"	"unprognostic (7.00e-3)"	"unprognostic (2.58e-1)"	"unprognostic (8.50e-2)"	"unprognostic (7.76e-2)"	0.0	2.4	0.2	0.6	0.1	0.3	0.0	0.1	0.2	0.2	0.2	1.1	0.0	0.3	0.3	0.6	0.0	0.0	0.0	0.2	0.5	0.2	0.0	0.0	0.5	0.7	1.8	0.1	0.0	0.2	0.4	0.0	1.4	0.0	0.4	2.7	0.1	0.0	0.3	0.1	0.3	0.4	0.0	0.4	0.3	5.8	0.2	3.0	0.1	0.0	0.4	0.0	0.2	0.3	0.3	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.7	0.1	0.1	0.0	0.0	0.0	0.1	0.2	0.0	0.3	0.0	0.6	0.4	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	30.9	40.7	0.2	0.5	0.1	0.3	0.1	0.1	0.0	0.2	0.5	0.0	0.0	2.1	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.2	0.2	0.5	0.7	1.8	1.4	0.0	0.2	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	2.1	0.1	0.0	0.0	0.0	0.0	44.1	0.3	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	54.9	0.0	0.0	0.0	0.0	0.6	0.4	0.0	0.5	0.1	0.2	0.0	0.4	0.0	0.0	0.3	0.4	0.1	0.1	0.0	0.0	0.0	1.6	2.0	0.0	0.0	0.0	0.0	4.5	0.0	0.1
CHRND	ACHRD	ENSG00000135902	"Cholinergic receptor nicotinic delta subunit"	Q07001	2	232525993-232536667	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel, Ligand-gated ion channel, Receptor"	"Congenital myasthenic syndrome, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	9	"skeletal muscle: 57.6"	"Group enriched"	"Detected in some"	10	"Muller glia cells: 4.0;Skeletal myocytes: 4.4"	"Cancer enriched"	"Detected in single"	7	"head and neck cancer: 1.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	49	"RH-30: 99.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA056404, HPA065404"			Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA				"Cluster 33: Striated muscle - Muscle contraction"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 37: Myocytes - Muscle contraction"	"Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA056404: AB_2732603, HPA065404: AB_2732734"				"unprognostic (1.69e-2)"	"unprognostic (7.93e-2)"	"unprognostic (3.28e-3)"	"unprognostic (7.75e-3)"	"unprognostic (6.04e-2)"	"unprognostic (1.10e-1)"	"unprognostic (7.25e-2)"	"unprognostic (1.90e-1)"		"unprognostic (4.97e-8)"	"unprognostic (7.52e-2)"	"unprognostic (2.86e-1)"	"unprognostic (2.46e-1)"		0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	6.3	0.7	0.0	57.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.0	6.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	99.4	0.0	0.0	0.0	0.8	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.2	0.0	0.2	0.1	0.2	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0
CHST2	C6ST	ENSG00000175040	"Carbohydrate sulfotransferase 2"	Q9Y4C5	3	143119771-143124014	"Metabolic proteins, Predicted membrane proteins"	"Carbohydrate metabolism, Inflammatory response"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 48.4"	"Cell type enhanced"	"Detected in many"		"Muller glia cells: 114.4;NK-cells: 233.8;Plasma cells: 79.3;Sertoli cells: 92.1;Theca cells: 58.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"intermediate monocyte: 4.3;NK-cell: 4.9;non-classical monocyte: 11.4"	"Group enriched"	"Detected in many"	5	"monocytes: 11.4;NK-cells: 4.9"	"Cell line enhanced"	"Detected in many"		"ASC diff: 57.7;ASC TERT1: 58.8;HEL: 48.2;HHSteC: 118.4;HMC-1: 55.4;HSkMC: 62.3;U-266/70: 52.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA013620			Supported	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 5: Muller glia cells - Visual perception"	"Golgi apparatus"	"Nucleoplasm, Cytosol"	"HPA013620: AB_2668861"	"unprognostic (1.55e-2)"	"unprognostic (2.20e-1)"	"unprognostic (7.64e-3)"	"unprognostic (2.75e-1)"	"unprognostic (8.97e-3)"	"unprognostic (2.83e-1)"	"unprognostic (2.70e-2)"	"unprognostic (2.06e-1)"	"unprognostic (2.76e-1)"	"unprognostic (4.11e-2)"	"unprognostic (8.96e-3)"	"unprognostic (9.15e-2)"	"unprognostic (1.31e-2)"	"unprognostic (7.57e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.58e-3)"	"unprognostic (1.34e-1)"	7.7	2.7	17.8	8.1	13.7	16.8	6.3	16.7	14.6	5.7	6.0	3.0	2.1	8.4	1.4	1.1	2.1	1.7	5.6	9.7	13.4	8.4	1.3	7.5	7.7	31.0	18.4	4.9	1.3	0.9	6.9	10.3	28.1	7.4	1.1	11.0	2.7	9.9	1.6	4.4	7.5	3.7	21.4	18.2	3.4	1.7	28.7	14.5	6.7	0.8	5.4	7.1	7.6	48.4	0.0	0.3	3.1	2.6	57.7	58.8	0.2	3.3	9.5	2.3	2.1	0.0	0.0	0.6	2.0	2.3	3.1	0.1	2.3	8.2	1.2	0.8	1.5	48.2	0.1	0.0	118.4	1.2	55.4	62.3	9.7	3.1	10.1	3.6	3.6	7.2	5.5	2.9	15.4	0.0	9.1	12.2	16.5	0.0	8.0	0.5	1.0	0.1	1.7	2.2	3.7	0.0	0.7	0.0	5.6	2.9	0.0	1.9	12.3	7.0	4.1	9.5	13.9	52.4	0.8	3.3	13.8	9.3	37.4	0.7	0.5	0.7	0.3	4.3	0.0	1.1	0.1	0.2	1.6	0.8	0.6	0.5	0.3	4.9	11.4	0.1	0.5	0.9	17.8	13.7	16.7	14.6	9.7	13.4	31.0	18.4	28.1	21.4	28.7	48.4	11.3	0.0	0.0	3.6	17.7	2.4	7.3	2.5	0.0	25.0	2.8	2.7	1.4	0.0	1.8	3.7	2.1	0.6	41.9	0.0	0.0	0.4	0.2	5.7	29.8	9.4	0.0	39.1	6.8	0.2	0.6	14.4	2.0	6.5	11.4	12.5	3.6	0.4	2.8	1.7	8.1	0.0	0.0	10.3	32.2	1.3	12.8	20.2	17.8	1.0	13.6	114.4	233.8	2.5	6.1	5.9	0.0	2.2	79.3	13.1	0.0	0.0	0.1	23.8	92.1	0.8	20.2	0.0	2.2	0.1	0.6	1.0	9.8	58.1	1.3	14.8
CHTF18	"C16orf41, C321D2.4, CHL12, Ctf18"	ENSG00000127586	"Chromosome transmission fidelity factor 18"	Q8WVB6	16	788046-800737	"Predicted intracellular proteins"	"Cell cycle, DNA replication"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 11.7"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 23.1;Extravillous trophoblasts: 19.6;Granulosa cells: 22.0;Spermatogonia: 21.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Immune cell enhanced"	"Detected in some"		"basophil: 2.5"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BEWO: 48.3"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"HPA040976, HPA056209"			Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 71: Testis - DNA repair"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	Cytosol	"HPA040976: AB_2677232, HPA056209: AB_2683066"	"unprognostic (3.83e-2)"	"unprognostic (4.97e-2)"	"unprognostic (4.25e-2)"	"unprognostic (9.35e-2)"	"unprognostic (4.59e-2)"	"unprognostic (3.02e-3)"	"unprognostic (1.80e-3)"	"unprognostic (3.02e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.19e-1)"	"unprognostic (4.00e-2)"	"unprognostic (1.44e-2)"	"prognostic unfavorable (1.43e-8)"	"unprognostic (2.07e-2)"	"unprognostic (1.55e-1)"	"unprognostic (9.89e-2)"	"prognostic favorable (2.78e-4)"	2.7	2.2	0.7	1.1	0.5	6.8	3.2	0.7	1.5	4.3	0.0	3.3	1.9	3.2	0.0	5.1	3.2	0.6	1.8	0.7	0.4	2.6	2.4	2.8	1.4	0.5	0.3	4.8	2.8	0.1	2.5	1.2	0.5	3.4	0.3	0.3	2.7	0.6	2.0	4.0	4.0	0.3	0.1	5.7	3.0	11.7	0.5	1.8	3.1	0.3	0.3	3.1	3.7	0.4	14.4	7.0	5.5	4.5	0.5	0.4	48.3	8.9	2.4	4.4	3.0	12.5	10.8	16.1	8.9	1.5	2.3	15.7	1.2	6.8	0.0	9.2	20.1	7.1	8.6	6.4	0.0	4.4	13.4	0.2	0.8	4.2	2.2	0.6	3.7	16.4	10.9	5.2	1.1	27.7	17.4	16.6	7.2	3.3	8.3	31.1	14.0	21.2	1.5	4.1	7.2	9.2	6.4	14.1	4.8	0.6	10.3	10.8	2.4	6.5	23.5	11.8	12.2	12.3	4.3	9.1	2.0	6.5	11.5	2.5	0.2	0.0	0.7	1.0	0.4	0.1	0.3	0.6	0.4	0.2	0.4	0.1	0.1	0.7	0.6	0.2	0.4	0.2	0.7	0.5	0.7	1.5	0.7	0.4	0.5	0.3	0.5	0.1	0.5	0.4	4.3	3.2	4.2	2.6	3.5	5.4	3.3	2.7	5.7	23.1	4.1	5.5	4.6	0.0	3.0	1.8	2.1	15.2	4.3	7.1	1.9	2.9	1.2	4.2	4.9	2.4	6.6	14.3	2.3	3.9	19.6	3.9	10.2	8.8	4.5	22.0	3.3	2.4	6.4	6.7	1.8	5.3	0.0	2.6	5.8	1.3	1.8	2.9	0.0	2.8	0.3	2.4	2.1	1.5	2.8	1.8	1.0	1.5	5.7	1.4	0.9	1.0	2.5	7.0	0.0	3.2	3.5	13.6	21.2	4.5	2.0	8.6	3.4	5.0	7.4	3.2
CHUK	"IkBKA, IKK-alpha, IKK1, IKKA, NFKBIKA, TCF16"	ENSG00000213341	"Component of inhibitor of nuclear factor kappa B kinase complex"	O15111	10	100188300-100229596	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001402, CAB004240, CAB018564"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm	Cytosol	"CAB004240: AB_627784, CAB018564: AB_649197, HPA001402: AB_1079125"	"unprognostic (8.61e-3)"	"unprognostic (1.70e-1)"	"unprognostic (3.74e-2)"	"unprognostic (3.01e-1)"	"unprognostic (3.02e-2)"	"unprognostic (5.93e-2)"	"unprognostic (4.02e-2)"	"unprognostic (2.09e-1)"	"unprognostic (8.58e-2)"	"unprognostic (8.39e-2)"	"unprognostic (6.73e-2)"	"unprognostic (1.49e-1)"	"prognostic favorable (1.27e-4)"	"unprognostic (2.48e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.88e-3)"	"unprognostic (2.22e-1)"	13.5	10.3	6.6	11.7	7.6	19.6	10.8	7.1	8.3	8.4	8.3	11.9	12.8	8.8	9.1	9.7	7.5	9.0	6.8	6.4	9.2	21.0	17.0	10.2	12.7	7.3	7.5	5.6	11.5	14.0	6.5	10.5	7.6	9.6	13.3	8.0	8.8	9.0	14.2	6.9	10.8	11.8	7.7	9.9	11.2	8.3	8.7	14.3	11.1	11.7	12.6	13.6	6.4	8.7	27.7	22.9	23.0	34.4	21.6	19.3	17.6	34.3	33.5	31.3	38.0	25.9	15.9	37.2	19.7	23.5	21.8	26.7	38.7	18.2	34.9	39.8	33.5	24.7	18.0	28.7	18.4	46.2	34.8	15.5	19.1	36.2	35.0	21.8	22.7	30.1	28.5	29.9	34.6	16.7	36.9	28.4	15.0	21.8	16.5	23.7	25.5	17.0	19.9	17.6	13.7	20.3	18.6	14.2	30.9	18.0	28.5	27.8	23.9	19.6	21.9	21.5	39.7	34.9	33.7	35.7	21.3	36.9	15.8	1.0	1.2	2.1	0.9	1.9	1.5	1.6	1.1	1.6	1.4	1.0	1.3	1.5	2.8	1.8	1.3	0.8	1.2	0.5	6.6	7.6	7.1	8.3	6.4	9.2	7.3	7.5	7.6	7.7	8.7	8.7	11.4	12.8	11.5	17.9	10.8	19.8	7.1	5.1	8.0	6.3	7.3	4.8	9.2	7.2	5.9	5.5	2.1	6.5	14.1	12.2	11.7	7.1	7.6	8.9	8.6	8.4	6.0	12.0	22.7	11.8	7.8	6.5	7.7	12.7	8.2	6.2	7.1	14.4	10.6	13.5	21.3	8.0	8.2	16.9	12.7	8.0	6.2	11.7	7.2	19.7	15.6	4.5	9.2	20.6	27.7	10.4	6.0	6.0	18.5	9.6	9.5	20.0	6.4	5.0	19.7	7.8	12.0	16.4	12.9	13.2	19.0	13.8	11.1	10.1	6.6	10.6
CIAO2A	"CIA2A, FAM96A, FLJ22875"	ENSG00000166797	"Cytosolic iron-sulfur assembly component 2A"	Q9H5X1	15	64072565-64093857	"Predicted intracellular proteins"	"Chromosome partition"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 262.4"	"Group enriched"	"Detected in some"	9	"Cardiomyocytes: 74.8;Cytotrophoblasts: 116.5;Extravillous trophoblasts: 100.6;Hofbauer cells: 218.2;Syncytiotrophoblasts: 88.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040459, HPA063729"	Approved		Enhanced	Nucleoplasm,Cytosol	"Intracellular and membrane"	No	No			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 32: U-937 - Innate immune response"	"Cluster 24: Non-specific - Transcription regulation"	"Nucleoplasm, Cytosol"		"HPA040459: AB_10796456, HPA063729: AB_2685105"	"unprognostic (1.15e-1)"	"unprognostic (8.49e-2)"	"unprognostic (6.59e-2)"	"unprognostic (3.58e-1)"	"unprognostic (1.30e-1)"	"unprognostic (8.07e-2)"	"unprognostic (4.06e-3)"	"unprognostic (5.02e-2)"	"unprognostic (7.16e-2)"	"unprognostic (5.87e-2)"	"unprognostic (1.04e-1)"	"unprognostic (6.48e-3)"	"unprognostic (8.06e-3)"	"unprognostic (1.81e-1)"	"unprognostic (2.58e-1)"	"unprognostic (2.11e-2)"	"unprognostic (1.50e-2)"	27.8	68.6	23.1	53.6	26.0	70.7	48.5	25.7	26.7	31.5	39.1	82.8	107.9	22.6	41.1	30.1	32.1	43.0	78.0	22.0	24.6	81.3	262.4	43.4	105.3	26.1	24.0	20.6	59.8	75.5	24.6	65.5	26.6	39.1	68.4	24.7	44.0	26.8	125.5	19.4	86.8	23.8	26.4	52.8	68.8	20.7	26.9	60.3	80.2	97.4	66.9	46.3	20.3	32.0	114.6	168.6	104.3	71.7	91.7	110.7	61.2	92.7	105.4	120.2	133.5	157.7	172.9	186.9	157.4	56.2	155.7	118.3	197.9	90.2	95.4	171.3	124.2	156.2	137.7	161.2	70.7	240.5	123.1	90.8	87.2	76.7	67.6	84.5	130.1	118.5	222.3	148.8	89.5	197.8	100.1	202.8	144.6	148.9	96.3	154.5	139.8	410.4	154.3	127.0	112.2	87.5	76.8	150.9	180.6	113.9	120.6	243.6	83.0	98.2	129.4	104.7	193.6	144.4	353.8	186.4	109.5	429.3	96.9	122.4	255.8	117.0	67.3	254.1	83.0	346.0	94.8	88.1	231.6	345.5	75.5	74.4	132.0	86.9	228.3	386.5	146.1	269.0	23.1	26.0	25.7	26.7	22.0	24.6	26.1	24.0	26.6	26.4	26.9	32.0	10.0	0.0	0.0	0.0	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	74.8	0.0	0.0	0.0	0.0	116.5	10.0	0.0	0.0	0.0	0.0	0.0	0.0	5.7	0.0	0.0	0.0	0.0	100.6	13.2	0.0	0.0	0.0	0.0	0.0	0.0	218.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.3	0.0	0.0	0.0	0.0	88.8	2.0	0.0	0.0	0.0
CIAO2B	"CGI-128, CIA2B, FAM96B, MIP18"	ENSG00000166595	"Cytosolic iron-sulfur assembly component 2B"	Q9Y3D0	16	66932065-66934423	"Predicted intracellular proteins"	"Chromosome partition"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 143.6;Cytotrophoblasts: 204.8;Extravillous trophoblasts: 190.4;Hofbauer cells: 201.5;Syncytiotrophoblasts: 248.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041501, HPA041736"	Supported		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 24: Non-specific - Transcription regulation"	"Nucleoplasm, Cytosol"		"HPA041501: AB_10795123, HPA041736: AB_10793932"	"unprognostic (2.49e-1)"	"unprognostic (3.79e-2)"	"unprognostic (8.06e-2)"	"unprognostic (5.42e-3)"	"unprognostic (3.93e-2)"	"unprognostic (4.91e-2)"	"unprognostic (4.98e-2)"	"unprognostic (8.49e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.83e-2)"	"unprognostic (1.18e-1)"	"unprognostic (8.96e-2)"	"unprognostic (5.10e-2)"	"unprognostic (1.50e-1)"	"unprognostic (9.84e-2)"	"unprognostic (6.48e-2)"	"unprognostic (1.12e-2)"	92.2	131.3	151.9	59.2	162.7	49.1	78.5	168.2	176.4	89.4	148.5	94.0	63.3	76.8	62.5	156.3	84.2	57.8	215.0	152.9	158.5	158.4	152.9	92.4	83.6	159.3	156.5	90.1	69.9	115.1	112.3	66.0	159.1	80.5	59.8	32.7	69.5	48.8	347.5	60.8	80.3	52.8	160.6	81.8	82.9	76.9	156.7	69.9	87.0	119.6	63.3	86.5	82.6	169.1	131.6	291.8	96.8	122.1	119.9	112.7	118.2	117.3	130.7	175.7	219.5	309.5	147.8	118.4	148.6	139.4	151.1	169.7	140.0	141.7	125.1	148.9	198.1	72.3	83.6	368.3	227.1	107.8	275.1	112.2	135.5	208.4	180.8	133.2	120.8	206.9	124.1	76.7	144.9	252.6	184.6	258.8	129.7	112.5	351.2	155.5	103.3	228.6	264.9	117.0	170.0	190.0	251.4	67.2	186.4	74.4	74.5	176.7	103.6	130.9	156.2	74.5	165.9	167.0	146.7	311.7	231.9	111.3	174.4	209.5	190.1	202.2	169.9	222.3	167.9	226.6	180.2	186.1	216.7	189.7	142.8	159.1	94.9	185.8	241.3	389.8	270.1	207.5	151.9	162.7	168.2	176.4	152.9	158.5	159.3	156.5	159.1	160.6	156.7	169.1	56.8	0.0	0.0	0.0	12.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	143.6	0.0	0.0	0.0	0.0	204.8	53.1	0.0	0.0	0.0	0.0	0.0	0.0	18.3	0.0	0.0	0.0	0.0	190.4	38.9	0.0	0.0	0.0	0.0	0.0	0.0	201.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.9	0.0	0.0	0.0	0.0	248.6	10.9	0.0	0.0	0.0
CIAPIN1	"Anamorsin, CIAE2"	ENSG00000005194	"Cytokine induced apoptosis inhibitor 1"	Q6FI81	16	57428187-57447420	"Predicted intracellular proteins"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 259.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041350, HPA042182"	Enhanced		Supported	Nucleoplasm,Mitochondria		No	No		21000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	Mitochondria	Nucleoplasm	"HPA041350: AB_10796665, HPA042182: AB_10794646"	"unprognostic (1.78e-2)"	"unprognostic (9.62e-2)"	"unprognostic (6.44e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.73e-2)"	"prognostic unfavorable (4.35e-4)"	"unprognostic (1.41e-3)"	"unprognostic (8.15e-3)"	"unprognostic (1.99e-1)"	"unprognostic (2.48e-2)"	"unprognostic (4.70e-3)"	"unprognostic (1.62e-1)"	"prognostic favorable (4.42e-4)"	"unprognostic (5.61e-2)"	"unprognostic (3.86e-2)"	"unprognostic (8.90e-3)"	"unprognostic (1.16e-1)"	19.1	32.8	22.1	19.7	22.3	20.6	18.9	23.2	26.8	16.3	26.3	29.4	21.3	16.3	15.5	30.2	16.1	16.6	38.7	22.5	23.8	30.8	27.3	19.9	24.2	24.3	23.2	12.9	19.6	37.4	17.7	31.6	23.8	18.0	25.9	20.9	19.7	16.3	41.3	28.3	20.9	22.0	20.7	21.6	22.3	68.0	25.1	31.0	18.4	38.4	34.3	24.3	20.2	21.8	51.8	77.8	80.4	61.4	46.5	31.8	67.5	52.7	51.2	102.6	48.1	87.6	40.3	55.0	75.8	46.9	32.4	95.9	113.2	82.2	86.5	32.7	68.2	71.4	63.6	91.6	74.6	88.2	67.7	48.8	88.7	74.9	94.5	40.5	101.9	69.3	101.4	30.7	60.9	51.5	81.1	71.1	100.8	60.3	114.8	146.0	93.6	112.7	69.6	57.7	68.7	85.8	126.4	86.2	56.6	64.6	61.7	76.5	63.2	42.3	52.1	42.4	64.7	76.8	113.4	175.0	51.1	78.9	68.0	53.6	80.5	54.2	74.2	79.2	68.1	65.7	60.8	78.4	94.6	72.6	128.5	115.1	19.8	91.1	64.7	79.8	74.5	153.8	22.1	22.3	23.2	26.8	22.5	23.8	24.3	23.2	23.8	20.7	25.1	21.8	25.3	16.0	22.0	7.8	16.0	14.3	13.9	59.4	8.6	29.2	17.5	18.3	36.1	20.0	28.4	22.0	10.4	90.4	21.8	17.0	39.2	55.4	19.3	14.4	19.1	28.5	18.6	21.9	15.7	51.8	50.0	19.2	19.4	15.1	10.8	28.1	17.9	20.3	40.0	23.5	16.4	17.8	52.9	13.9	13.2	33.6	14.0	17.4	24.9	7.5	42.9	27.9	23.7	11.1	10.6	54.6	23.9	20.7	14.4	23.2	25.5	37.4	14.1	17.8	39.5	11.8	21.3	259.9	69.8	23.2	15.9	106.2	19.3	43.4	28.0	15.2
CIB1	"CIB, KIP, SIP2-28"	ENSG00000185043	"Calcium and integrin binding 1"	Q99828	15	90229975-90234047	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	"Angiogenesis, Apoptosis, Cell adhesion, Cell cycle, Cell division, Differentiation, Spermatogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 1385.8;Respiratory ciliated cells: 1103.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012991, HPA042413, HPA048825"	Approved		Supported	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 25: Spermatids - Spermatogenesis"	"Nucleoplasm, Plasma membrane"		"CAB012991: AB_2533205, HPA042413: AB_2732498, HPA048825: AB_2680533"	"unprognostic (1.20e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.73e-2)"	"prognostic favorable (2.26e-5)"	"unprognostic (7.56e-2)"	"unprognostic (5.51e-2)"	"unprognostic (1.21e-2)"	"unprognostic (8.29e-3)"	"unprognostic (1.77e-1)"	"unprognostic (4.09e-2)"	"unprognostic (5.25e-3)"	"unprognostic (2.44e-1)"	"unprognostic (1.29e-3)"	"unprognostic (1.85e-1)"	"unprognostic (6.31e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.68e-2)"	65.6	163.6	65.4	79.7	69.2	205.5	67.4	67.8	76.5	93.8	96.7	147.9	130.1	44.6	88.1	127.3	146.6	77.4	101.9	62.7	68.8	220.1	195.7	86.7	97.0	70.1	70.3	43.9	214.1	98.3	93.0	38.0	68.7	127.6	138.1	29.1	116.6	72.7	58.8	40.4	128.5	45.3	69.3	117.0	99.3	113.8	69.2	64.4	89.1	42.3	120.9	93.7	68.3	69.3	119.5	261.4	23.8	83.7	98.7	102.7	38.9	123.8	107.2	99.6	87.2	104.7	207.4	34.7	129.7	144.0	125.7	124.2	48.0	141.8	54.0	81.9	114.2	77.5	182.3	175.9	96.2	155.2	71.4	72.2	84.9	91.9	64.6	113.7	129.1	83.7	105.8	53.5	76.4	233.3	118.4	179.4	36.7	223.9	134.0	66.1	62.8	139.7	256.1	199.4	18.7	22.8	168.7	136.5	135.7	41.5	105.3	93.3	81.7	109.6	77.0	132.0	153.2	73.0	122.0	40.3	176.1	174.9	47.8	168.9	201.8	271.3	226.9	248.9	188.0	476.4	269.9	249.4	224.4	418.0	221.5	218.0	118.2	205.7	230.0	149.7	245.8	399.6	65.4	69.2	67.8	76.5	62.7	68.8	70.1	70.3	68.7	69.3	69.2	69.3	77.4	89.8	104.2	14.7	203.7	85.7	253.6	520.1	84.8	12.0	152.0	118.5	86.9	128.7	469.1	183.9	10.4	106.7	198.7	670.9	453.9	372.1	380.8	480.8	101.3	83.9	97.1	62.3	7.7	662.9	117.6	96.5	149.9	222.8	138.8	66.9	79.6	230.1	209.0	3.3	6.6	379.5	463.9	102.5	148.0	1385.8	105.3	180.5	128.1	4.7	187.5	138.4	184.4	5.0	12.2	620.2	794.2	92.6	88.8	699.6	661.4	668.6	1103.6	25.5	39.5	62.3	140.4	160.3	69.0	218.1	67.3	66.1	227.5	91.8	315.5	577.8
CIC	KIAA0306	ENSG00000079432	"Capicua transcriptional repressor"	Q96RK0	19	42268537-42295797	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"	"Cancer-related genes, Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB026388, HPA044341, HPA064725"	Approved		Supported	Nucleoplasm,Vesicles		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 71: Testis - DNA repair"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 62: Horizontal cells - Visual perception"	Nucleoplasm	Vesicles	"CAB026388: , HPA044341: AB_2678901, HPA064725: AB_2685335"	"unprognostic (2.02e-2)"	"unprognostic (4.08e-1)"	"unprognostic (1.41e-2)"	"unprognostic (3.54e-3)"	"unprognostic (3.67e-1)"	"unprognostic (4.17e-3)"	"unprognostic (1.49e-1)"	"unprognostic (2.06e-1)"	"unprognostic (4.87e-1)"	"unprognostic (1.85e-2)"	"unprognostic (1.72e-3)"	"unprognostic (3.10e-1)"	"unprognostic (4.23e-2)"	"unprognostic (1.00e-1)"	"unprognostic (2.38e-1)"	"unprognostic (1.88e-2)"	"unprognostic (1.56e-1)"	41.9	41.5	43.3	23.4	36.1	31.8	42.7	40.7	47.4	53.8	2.3	45.6	15.6	62.3	8.7	34.3	49.1	16.1	35.4	36.3	27.7	41.7	44.6	40.8	24.2	39.5	27.8	70.1	39.4	12.2	58.7	12.6	35.7	40.5	5.8	13.5	35.4	18.7	45.2	47.2	36.9	16.0	17.4	46.9	38.6	74.6	29.4	21.0	44.3	15.3	13.5	39.6	37.5	32.5	31.8	56.7	26.4	34.4	16.6	30.7	10.7	22.8	22.5	22.9	20.9	18.5	21.4	26.7	20.8	21.8	19.6	16.6	14.6	38.9	7.6	61.9	19.6	22.2	44.7	23.0	20.1	11.8	50.9	36.7	25.5	24.4	15.5	24.8	19.2	15.9	21.8	52.5	13.3	31.9	25.1	25.6	16.2	12.6	5.8	21.5	21.2	14.3	20.5	25.3	33.6	27.1	23.7	15.7	21.6	8.3	18.3	25.8	27.5	52.0	43.7	15.9	33.2	41.0	29.8	18.1	37.9	19.4	32.6	0.0	0.5	0.1	0.7	0.8	0.5	0.5	0.3	0.5	0.5	0.6	0.2	0.4	1.1	0.2	0.6	0.6	0.1	0.6	43.3	36.1	40.7	47.4	36.3	27.7	39.5	27.8	35.7	17.4	29.4	32.5	27.8	0.0	3.0	15.7	13.7	25.9	12.8	16.2	27.9	38.3	20.7	16.9	7.8	21.5	7.1	9.2	20.9	6.9	9.1	14.2	3.9	13.4	5.1	14.6	14.9	20.3	14.8	8.4	8.0	15.3	5.1	11.2	17.9	22.3	12.0	11.1	13.9	19.2	11.9	42.1	9.0	10.1	10.2	18.0	23.6	3.3	21.8	15.3	24.9	7.5	13.0	18.4	8.2	4.0	10.3	16.9	11.2	18.0	10.4	11.3	10.6	6.2	8.0	18.8	26.3	19.9	17.6	19.4	20.2	16.5	19.5	13.0	13.2	14.2	10.6	11.9
CILK1	"ICK, KIAA0936, LCK2, MGC46090, MRK"	ENSG00000112144	"Ciliogenesis associated kinase 1"	Q9UPZ9	6	53001279-53061824	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Cilium biogenesis/degradation"	"Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase"	"Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 11.0;Cytotrophoblasts: 20.6;Extravillous trophoblasts: 33.9;Syncytiotrophoblasts: 58.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000791, HPA001113"	Approved		Supported	"Nucleoli fibrillar center"		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 24: Non-specific - Transcription regulation"	"Nucleoli fibrillar center"		"HPA000791: AB_2732392, HPA001113: AB_1851385"	"unprognostic (1.75e-2)"	"unprognostic (1.02e-1)"	"unprognostic (5.47e-2)"	"unprognostic (2.95e-1)"	"unprognostic (2.32e-1)"	"unprognostic (1.00e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.82e-2)"	"unprognostic (1.17e-3)"	"unprognostic (5.11e-2)"	"unprognostic (1.18e-1)"	"unprognostic (8.28e-2)"	"unprognostic (8.12e-3)"	"unprognostic (1.21e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.26e-1)"	7.9	17.9	10.2	4.9	11.0	2.7	10.7	8.4	9.7	8.9	5.1	8.7	9.8	8.0	5.5	8.6	7.4	6.9	8.5	6.8	7.8	4.5	7.5	6.3	5.2	9.4	11.6	9.5	5.0	7.3	1.7	12.1	8.8	9.9	10.7	17.4	17.9	7.3	4.0	8.7	10.4	7.4	8.8	5.6	12.9	4.5	14.9	10.1	6.3	5.0	6.2	6.5	5.8	12.8	7.8	2.9	14.6	10.0	8.9	14.0	17.0	6.9	12.4	10.8	12.3	4.1	2.4	5.7	4.0	21.0	3.5	5.0	17.6	7.1	14.2	19.9	7.0	4.2	3.3	22.3	4.5	5.2	5.4	12.5	7.6	4.6	5.3	7.7	10.2	12.1	8.1	22.6	24.9	6.7	5.6	6.4	5.6	27.0	6.3	8.8	6.5	7.5	4.5	5.6	23.6	10.6	6.7	16.3	9.6	14.2	9.5	10.9	8.5	17.2	8.0	6.5	17.1	6.3	4.8	2.2	3.5	5.0	8.5	2.8	1.0	2.2	1.7	0.8	1.5	1.2	1.2	1.4	1.0	1.5	1.4	1.2	0.5	1.1	0.9	1.4	1.7	0.8	10.2	11.0	8.4	9.7	6.8	7.8	9.4	11.6	8.8	8.8	14.9	12.8	6.3	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.0	0.0	0.0	0.0	0.0	20.6	5.7	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	33.9	5.3	0.0	0.0	0.0	0.0	0.0	0.0	6.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.2	0.0	0.0	0.0	0.0	58.1	0.8	0.0	0.0	0.0
CIP2A	KIAA1524	ENSG00000163507	"Cellular inhibitor of PP2A"	Q8TCG1	3	108549864-108589644	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 7.5;lymphoid tissue: 6.9"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 9.6;Cytotrophoblasts: 8.0;Exocrine glandular cells: 7.3;Extravillous trophoblasts: 12.9;Granulosa cells: 25.3;Hofbauer cells: 8.1"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039570	Approved		Supported	"Plasma membrane,Cytosol"		NA	Yes				"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Cytosol	"Plasma membrane"	"HPA039570: AB_10796329"	"unprognostic (2.02e-1)"	"unprognostic (1.54e-2)"	"unprognostic (2.31e-3)"	"prognostic unfavorable (6.24e-5)"	"unprognostic (3.10e-2)"	"unprognostic (1.07e-2)"	"unprognostic (1.91e-7)"	"unprognostic (2.80e-3)"	"unprognostic (2.53e-3)"	"unprognostic (1.24e-1)"	"prognostic unfavorable (9.18e-4)"	"unprognostic (6.85e-2)"	"prognostic unfavorable (1.42e-4)"	"unprognostic (9.11e-3)"	"unprognostic (3.73e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.25e-1)"	1.1	1.1	0.3	3.4	0.6	7.5	1.4	0.9	0.8	0.9	0.1	1.9	1.2	1.8	0.6	1.7	0.9	1.2	0.7	0.6	0.5	1.0	0.7	1.4	6.7	0.2	0.9	1.9	0.4	0.6	0.7	2.1	0.2	1.8	2.7	2.6	0.6	0.8	0.6	1.2	1.7	1.5	0.0	2.3	1.2	5.7	0.1	6.9	1.2	0.7	5.2	2.0	0.9	0.4	42.2	12.2	33.9	21.8	1.4	3.2	13.8	31.1	14.7	36.2	41.9	15.0	18.5	27.6	10.4	11.4	27.7	20.9	11.7	11.0	65.8	8.8	11.3	33.9	17.4	11.3	0.5	21.8	23.2	1.4	2.3	28.4	11.5	5.9	16.3	12.7	21.1	44.5	36.1	8.7	26.7	19.2	35.0	15.8	20.8	30.1	31.2	15.3	11.0	11.5	16.4	21.6	22.9	9.0	12.7	19.7	15.3	15.6	12.2	37.0	41.7	11.3	38.3	10.2	12.1	46.1	16.4	23.2	38.6	0.1	0.0	0.1	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.2	0.1	0.2	0.0	0.0	0.2	0.0	0.1	0.0	0.3	0.6	0.9	0.8	0.6	0.5	0.2	0.9	0.2	0.0	0.1	0.4	1.2	9.6	1.1	0.0	2.3	0.0	0.0	0.0	0.0	0.0	1.9	1.3	0.0	0.0	2.5	3.7	0.0	8.0	1.8	0.0	1.9	2.8	0.0	2.5	2.8	2.6	0.0	0.0	0.0	7.3	12.9	3.0	0.0	2.7	3.8	25.3	0.0	0.0	8.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	3.1	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.4	0.0	0.0	2.4	1.5	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	1.4	1.7	5.4	0.0	0.0
CIPC	KIAA1737	ENSG00000198894	"CLOCK interacting pacemaker"	Q9C0C6	14	77098126-77117287	"Predicted intracellular proteins"	"Biological rhythms, Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 132.1"	"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 58.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000644			Supported	Nucleoplasm,Nucleoli,Cytosol		NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Nucleoplasm, Cytosol"	Nucleoli	"HPA000644: AB_1079206"	"unprognostic (3.93e-2)"	"unprognostic (6.71e-2)"	"unprognostic (2.62e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.85e-1)"	"unprognostic (2.41e-1)"	"unprognostic (6.67e-3)"	"unprognostic (3.73e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.31e-2)"	"unprognostic (3.20e-1)"	"prognostic favorable (1.77e-10)"	"unprognostic (2.28e-1)"	"unprognostic (2.32e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.21e-1)"	13.2	9.6	41.3	8.4	53.0	4.2	15.8	48.0	41.1	16.8	24.7	26.8	10.3	14.6	13.5	22.1	30.4	9.0	39.8	46.5	44.1	14.2	15.4	11.1	8.4	47.5	48.2	9.1	9.7	29.5	13.5	9.0	43.9	25.5	19.9	41.2	20.5	24.8	132.1	15.4	11.4	16.5	42.3	9.1	11.4	11.7	53.3	10.3	20.4	82.4	10.1	17.2	15.5	49.6	9.4	12.6	25.4	16.8	10.1	8.0	15.4	6.0	9.4	10.9	9.8	10.3	19.4	23.3	5.9	9.7	9.6	14.3	23.7	9.4	14.3	12.3	6.4	14.9	9.8	9.5	9.7	8.4	10.7	9.4	17.9	10.6	6.5	14.1	12.7	19.2	14.0	8.8	8.1	21.4	20.2	10.2	10.6	21.3	10.9	20.2	11.3	14.0	11.0	16.1	35.9	13.4	11.0	17.4	14.9	10.7	27.2	8.6	14.9	7.0	15.1	10.0	7.6	8.4	7.1	11.1	13.2	7.1	14.8	4.3	4.5	1.6	2.6	5.1	4.1	7.9	3.6	2.7	5.4	7.1	3.8	2.8	5.5	5.5	3.8	2.0	4.1	3.6	41.3	53.0	48.0	41.1	46.5	44.1	47.5	48.2	43.9	42.3	53.3	49.6	8.5	16.0	18.4	33.6	4.7	9.1	8.2	5.3	12.5	29.3	18.3	12.6	49.9	8.6	12.6	11.0	58.4	7.4	5.5	43.5	9.8	4.2	11.0	39.8	9.2	7.0	17.4	6.5	16.4	5.6	5.0	5.6	9.2	20.3	1.3	5.8	7.1	29.5	15.2	11.8	20.2	14.8	30.5	16.0	6.6	15.8	4.1	7.2	8.8	9.4	5.8	22.8	2.1	21.1	58.7	5.1	12.4	14.3	4.2	8.3	18.1	6.0	30.5	36.4	13.1	7.9	9.3	19.9	9.1	10.4	9.8	13.5	3.1	7.1	13.7	7.1
CIR1	CIR	ENSG00000138433	"Corepressor interacting with RBPJ, CIR1"	Q86X95	2	174348022-174395712	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing, Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 187.8"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 187.8"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015784, HPA061442"	Approved		Supported	"Nuclear speckles"		NA	NA			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Nuclear speckles"		"HPA015784: AB_1846782, HPA061442: AB_2732664"	"unprognostic (3.17e-3)"	"unprognostic (4.07e-2)"	"unprognostic (1.65e-1)"	"prognostic unfavorable (9.56e-4)"	"unprognostic (2.40e-1)"	"unprognostic (1.56e-1)"	"prognostic unfavorable (2.52e-4)"	"unprognostic (1.00e-2)"	"unprognostic (4.39e-2)"	"prognostic favorable (9.80e-4)"	"unprognostic (1.27e-1)"	"unprognostic (3.66e-2)"	"prognostic unfavorable (1.04e-7)"	"unprognostic (2.23e-1)"	"unprognostic (1.48e-1)"	"unprognostic (8.10e-3)"	"prognostic favorable (2.04e-5)"	26.7	23.8	36.3	23.4	38.1	67.3	35.9	38.5	61.1	26.6	39.5	27.7	25.8	27.4	43.5	20.3	28.3	23.4	28.7	36.0	37.3	25.9	27.5	26.7	31.1	36.8	37.0	33.7	24.9	27.4	25.1	29.8	36.6	26.2	26.3	23.6	24.9	26.0	30.7	30.5	26.7	20.7	35.9	35.0	25.5	31.4	36.3	32.3	29.0	25.2	29.5	24.0	24.2	40.1	20.4	11.4	26.5	21.2	36.3	50.4	39.2	32.9	46.5	32.3	39.5	21.5	30.7	14.1	30.3	32.4	28.3	24.0	22.1	23.4	38.6	26.1	29.1	29.4	17.8	34.9	35.1	35.2	26.0	41.7	41.9	35.5	26.5	55.6	32.4	24.9	30.7	30.8	31.0	19.5	44.1	55.6	24.5	33.2	31.6	24.7	38.1	42.2	38.4	32.1	30.7	36.1	22.7	28.7	52.9	45.7	21.6	51.6	33.6	26.1	19.0	24.9	17.3	34.6	31.4	5.2	37.4	18.2	23.3	71.0	33.8	55.9	28.4	31.7	28.4	41.2	32.2	30.5	21.4	40.5	33.4	30.9	187.8	45.3	33.9	39.5	37.2	28.3	36.3	38.1	38.5	61.1	36.0	37.3	36.8	37.0	36.6	35.9	36.3	40.1	82.0	118.6	79.8	30.0	80.8	28.6	52.2	118.6	39.3	51.7	40.6	66.8	61.4	61.5	101.2	42.3	31.3	72.7	116.5	69.1	119.3	67.3	201.5	192.2	79.7	58.7	51.4	102.5	30.4	78.7	58.1	69.9	30.1	79.6	81.6	59.1	75.7	58.6	63.8	45.4	33.7	81.9	85.5	93.0	30.3	43.4	107.2	75.3	33.8	22.5	108.2	85.7	111.2	30.2	37.3	57.7	79.8	82.4	49.1	37.5	91.6	114.0	202.3	56.2	72.3	71.4	72.1	219.5	54.7	25.4	32.0	116.0	80.5	62.6	53.5	45.7
CIRBP	CIRP	ENSG00000099622	"Cold inducible RNA binding protein"	Q14011	19	1259384-1274880	"Plasma proteins, Predicted intracellular proteins"	"Stress response"	"Activator, Repressor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA060537			Supported	Nucleoplasm		NA	NA		240000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 51: Non-specific - Unknown function"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm		"HPA060537: AB_2684314"	"unprognostic (2.77e-3)"	"prognostic favorable (3.63e-4)"	"unprognostic (9.80e-2)"	"prognostic favorable (1.36e-4)"	"unprognostic (3.95e-2)"	"unprognostic (2.94e-2)"	"unprognostic (3.38e-3)"	"prognostic favorable (2.50e-4)"	"unprognostic (6.43e-2)"	"unprognostic (2.29e-2)"	"prognostic favorable (2.69e-4)"	"unprognostic (1.82e-1)"	"prognostic favorable (3.65e-7)"	"unprognostic (1.04e-1)"	"unprognostic (5.76e-1)"	"unprognostic (2.23e-2)"	"unprognostic (1.49e-2)"	356.6	367.9	176.0	205.7	176.2	377.9	409.6	177.9	277.1	443.1	147.3	400.6	196.5	471.8	429.7	219.6	496.9	279.3	368.6	162.7	181.6	296.3	200.9	300.9	350.4	167.5	166.0	853.0	614.8	490.8	496.2	230.8	164.4	377.1	227.1	383.9	367.5	418.1	485.7	402.7	304.0	313.3	169.2	332.7	405.2	183.8	193.3	327.9	420.1	304.3	383.8	344.7	307.8	186.5	285.8	60.4	434.3	220.1	188.0	209.3	112.3	307.3	428.7	235.1	209.9	112.7	108.1	570.7	162.3	318.6	27.9	133.5	182.5	277.5	181.2	255.4	52.3	340.6	68.2	145.9	684.8	532.0	237.9	518.9	244.6	152.3	659.7	324.3	215.0	282.6	228.3	445.6	247.2	202.9	274.7	144.4	172.3	162.4	100.2	337.3	347.2	280.3	267.5	237.3	204.1	369.3	323.9	145.6	251.3	140.9	304.6	148.3	264.6	174.5	105.3	415.1	271.0	581.3	689.3	463.7	148.9	216.4	229.7	208.5	88.3	205.5	212.3	153.5	217.7	248.7	190.0	193.5	97.0	268.0	213.2	205.0	147.4	229.4	237.0	272.5	244.6	196.3	176.0	176.2	177.9	277.1	162.7	181.6	167.5	166.0	164.4	169.2	193.3	186.5	341.8	205.1	384.3	169.8	541.8	586.6	641.5	585.8	541.8	758.0	682.4	586.5	258.0	427.5	304.2	298.0	329.4	601.9	504.0	175.5	972.4	386.0	78.8	243.9	292.1	388.3	434.2	244.4	51.8	484.2	271.0	493.6	236.0	241.0	404.2	400.6	436.2	149.6	314.4	684.8	69.2	315.5	514.7	372.1	559.7	199.3	649.9	301.0	734.6	60.9	490.2	1307.9	563.4	90.0	157.2	348.7	281.7	499.5	477.5	434.5	399.6	635.6	295.8	712.7	374.7	956.8	488.0	228.5	504.5	327.6	556.8	737.4	482.5	586.9	270.5	378.6
CISD1	"C10orf70, MDS029, mitoNEET, ZCD1"	ENSG00000122873	"CDGSH iron sulfur domain 1"	Q9NZ45	10	58269162-58289586	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"parathyroid gland: 82.3"	"Cell type enhanced"	"Detected in all"		"Distal tubular cells: 716.1;Proximal enterocytes: 539.1;Proximal tubular cells: 726.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA074383	Supported		Supported	Mitochondria		NA	NA		13000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"HPA074383: AB_2686684"	"prognostic unfavorable (1.11e-4)"	"unprognostic (8.60e-3)"	"unprognostic (1.07e-1)"	"unprognostic (4.10e-3)"	"unprognostic (2.41e-2)"	"unprognostic (3.22e-2)"	"prognostic unfavorable (4.15e-4)"	"unprognostic (1.87e-2)"	"unprognostic (2.35e-1)"	"unprognostic (7.78e-2)"	"unprognostic (1.33e-2)"	"unprognostic (7.23e-2)"	"unprognostic (1.34e-3)"	"unprognostic (4.19e-2)"	"unprognostic (7.20e-2)"	"unprognostic (8.07e-2)"	"prognostic unfavorable (6.69e-4)"	5.2	10.1	10.0	6.3	9.8	0.9	5.9	10.4	13.6	6.6	11.8	9.7	22.7	5.6	3.4	11.2	6.1	7.2	43.0	10.1	12.7	26.4	16.6	4.3	6.1	10.1	9.9	6.8	5.3	82.3	5.8	5.5	11.2	7.6	8.8	8.2	9.9	7.1	46.4	8.4	21.8	8.0	9.5	4.6	7.2	2.8	9.6	6.5	10.1	49.9	5.9	7.8	3.0	8.9	20.5	10.2	8.0	14.6	10.5	11.6	4.7	16.9	19.2	16.4	22.5	24.1	18.8	36.1	13.9	17.5	9.6	12.9	21.7	15.1	14.7	16.2	29.4	9.5	16.4	19.6	11.9	17.0	7.1	14.6	12.1	15.7	23.9	13.9	19.5	17.9	21.2	16.5	11.6	6.8	14.6	18.2	8.5	15.5	31.4	11.0	29.3	19.0	22.1	7.1	25.0	9.0	12.9	34.1	12.4	7.0	22.7	9.0	19.3	7.1	12.8	20.5	20.4	16.6	29.0	27.2	18.9	16.6	7.0	0.0	4.5	0.2	4.3	3.4	5.3	6.3	4.9	5.0	7.6	5.4	5.7	5.7	2.3	5.4	2.3	5.0	6.8	4.2	10.0	9.8	10.4	13.6	10.1	12.7	10.1	9.9	11.2	9.5	9.6	8.9	31.4	60.9	45.7	27.4	33.0	128.7	87.3	309.4	78.0	84.6	46.4	61.1	321.6	97.2	180.2	134.3	43.8	174.8	22.7	71.1	716.1	98.0	240.9	42.8	30.4	61.6	225.4	24.8	47.2	82.1	78.5	52.7	38.2	43.8	34.3	23.0	63.9	249.6	68.6	42.1	53.1	141.9	272.6	37.0	37.9	366.1	42.3	31.0	183.2	21.5	34.0	47.2	44.3	36.7	30.9	83.2	121.9	40.3	31.7	109.1	539.1	726.8	138.6	56.3	32.9	50.1	55.6	159.4	65.6	94.9	114.2	72.7	26.2	65.0	147.3	69.4
CISD2	"ERIS, Miner1, NAF-1, WFS2, ZCD2"	ENSG00000145354	"CDGSH iron sulfur domain 2"	Q8N5K1	4	102868974-102892807	"Disease related genes, Human disease related genes, Predicted membrane proteins"	Autophagy		"Deafness, Diabetes mellitus"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 46.0"	"Cell type enhanced"	"Detected in all"		"Erythroid cells: 256.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015914	Approved		Supported	"Endoplasmic reticulum"		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 6: Erythroid cells - Oxygen transport"	"Endoplasmic reticulum"		"HPA015914: AB_1846794"	"unprognostic (1.65e-1)"	"unprognostic (1.45e-1)"	"unprognostic (6.54e-3)"	"unprognostic (8.02e-2)"	"unprognostic (2.78e-2)"	"unprognostic (3.56e-2)"	"unprognostic (1.17e-3)"	"unprognostic (3.48e-3)"	"unprognostic (9.12e-3)"	"unprognostic (2.04e-1)"	"unprognostic (2.54e-1)"	"unprognostic (2.86e-1)"	"unprognostic (1.47e-1)"	"unprognostic (4.66e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.34e-1)"	11.2	19.1	2.4	5.5	2.7	6.0	9.0	3.9	3.2	9.5	4.1	11.5	1.7	9.5	5.3	12.5	8.8	4.3	10.5	2.6	3.2	17.9	46.0	10.7	5.5	2.9	2.9	8.9	20.0	5.4	12.8	3.1	3.0	9.5	3.8	6.1	12.0	1.9	7.4	9.7	10.9	3.0	2.7	14.7	11.4	6.5	3.0	4.0	13.6	1.7	3.5	9.8	10.1	4.0	16.8	5.5	5.8	7.2	14.2	15.2	3.7	12.6	4.6	5.4	8.2	6.5	27.7	12.1	10.9	12.2	12.9	8.1	28.2	10.1	24.8	10.7	4.2	10.5	3.6	6.7	10.1	18.7	16.1	5.9	15.1	23.0	17.8	5.2	9.8	6.7	22.7	21.3	14.7	4.6	16.5	5.4	11.2	5.7	4.0	6.7	5.9	22.2	13.6	5.3	13.4	7.8	7.5	12.8	12.8	6.6	8.5	4.0	4.4	15.8	17.8	21.3	7.8	16.3	23.5	24.2	11.2	5.7	12.6	4.6	2.8	5.8	2.6	2.7	2.7	2.5	2.6	2.7	2.7	2.1	1.7	2.2	2.0	4.4	3.1	3.5	3.5	2.3	2.4	2.7	3.9	3.2	2.6	3.2	2.9	2.9	3.0	2.7	3.0	4.0	24.2	25.6	26.1	10.1	65.3	85.7	45.3	131.0	60.3	33.5	61.2	51.3	27.8	58.6	70.4	77.3	20.9	74.2	52.7	52.9	72.4	101.8	12.2	39.9	41.8	35.8	43.0	256.8	17.5	77.2	131.0	39.6	39.8	48.3	57.8	24.2	26.0	159.9	110.9	30.3	22.1	94.2	146.5	93.5	128.9	6.9	23.9	66.4	69.4	12.2	78.4	36.9	45.3	17.6	25.9	74.3	88.5	33.8	194.3	63.7	82.7	203.9	63.1	33.1	32.9	22.1	41.6	41.7	36.7	56.4	90.1	56.8	54.0	33.4	68.6	53.9
CITED1	MSG1	ENSG00000125931	"Cbp/p300 interacting transactivator with Glu/Asp rich carboxy-terminal domain 1"	Q99966	X	72301638-72307187	"Predicted intracellular proteins"	"Apoptosis, Differentiation, Transcription, Transcription regulation"	"Activator, Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"epididymis: 1473.6"	"Cell type enhanced"	"Detected in many"		"Breast glandular cells: 87.4;Breast myoepithelial cells: 47.6;Granulosa cells: 31.0;Late spermatids: 58.4;Paneth cells: 33.8"	"Cancer enriched"	"Detected in many"	6	"thyroid cancer: 134.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in many"	4	"SK-MEL-30: 244.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049051	Supported		Supported	Nucleoplasm,Cytosol		NA	NA				"Cluster 68: Epididymis - Unknown function"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 35: Glandular cells - Unknown function"	Nucleoplasm	Cytosol	"HPA049051: AB_2680612"	"unprognostic (7.04e-2)"	"unprognostic (3.39e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.79e-3)"	"unprognostic (8.81e-2)"	"unprognostic (5.67e-4)"	"unprognostic (3.40e-1)"	"unprognostic (9.55e-2)"	"unprognostic (4.60e-3)"	"unprognostic (4.38e-2)"	"unprognostic (6.33e-3)"	"unprognostic (1.18e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.62e-1)"	"prognostic favorable (6.10e-4)"	"prognostic favorable (3.95e-4)"	"unprognostic (2.99e-2)"	2.3	5.1	13.0	0.3	6.9	0.2	23.1	5.1	12.2	5.9	3.4	1.0	0.7	3.6	1473.6	0.3	1.5	0.0	0.7	6.7	56.2	5.1	0.4	0.6	0.3	8.5	8.8	1.5	1.5	0.0	209.9	0.0	24.5	11.2	0.2	4.5	0.8	3.0	0.4	0.6	1.0	8.1	4.3	0.4	1.0	199.9	30.6	0.2	8.0	0.4	0.1	0.5	1.0	6.2	0.4	0.3	2.2	57.1	2.5	0.0	2.1	0.0	0.5	0.4	0.3	0.1	0.6	0.0	0.2	0.0	0.6	0.0	20.5	1.4	0.1	6.1	8.0	0.9	0.4	0.0	0.0	0.2	10.4	1.1	0.8	0.5	1.0	0.2	0.2	0.2	2.5	0.0	0.4	0.8	0.2	4.4	3.3	0.0	3.6	0.1	3.6	3.2	0.1	0.4	25.8	12.5	0.4	5.1	244.4	0.2	1.4	1.0	0.0	0.2	1.9	0.4	0.8	0.2	0.5	0.2	0.5	0.4	5.3	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.0	6.9	5.1	12.2	6.7	56.2	8.5	8.8	24.5	4.3	30.6	6.2	2.2	0.0	0.0	0.0	0.0	0.1	1.0	0.4	0.0	5.6	87.4	47.6	0.4	1.5	0.1	3.7	6.2	0.1	0.3	0.3	0.0	0.1	20.4	0.5	0.8	1.0	1.2	0.0	0.7	0.8	0.1	0.7	0.0	0.3	0.0	31.0	0.4	0.1	0.1	0.0	1.5	0.2	0.0	0.0	0.7	58.4	7.5	0.8	3.6	1.9	0.1	1.7	0.0	0.0	0.1	0.4	33.8	3.0	0.0	19.3	0.7	0.3	0.0	3.8	13.1	1.2	3.2	12.6	6.8	0.0	0.0	0.0	0.1	0.5	0.5	1.0
CITED2	MRG1	ENSG00000164442	"Cbp/p300 interacting transactivator with Glu/Asp rich carboxy-terminal domain 2"	Q99967	6	139371807-139374648	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Differentiation, Stress response, Transcription, Transcription regulation"	"Activator, Developmental protein, Repressor"	"Atrial septal defect, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Extravillous trophoblasts: 685.3;Plasma cells: 619.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in all"		"eosinophil: 27.7"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ: 618.3;fHDF/TERT166: 1070.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016157, CAB069879"	Supported		Supported	Nucleoplasm		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 55: Plasma cells - Humoral immune response"	Nucleoplasm		"CAB016157: AB_668099, CAB069879: AB_10003446"	"unprognostic (7.42e-2)"	"unprognostic (2.06e-2)"	"unprognostic (1.56e-2)"	"unprognostic (8.34e-2)"	"unprognostic (4.03e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.87e-2)"	"unprognostic (1.13e-1)"	"unprognostic (4.05e-2)"	"unprognostic (1.11e-2)"	"unprognostic (3.61e-3)"	"unprognostic (1.00e-2)"	"prognostic favorable (3.40e-4)"	"prognostic unfavorable (3.33e-4)"	"unprognostic (1.08e-1)"	"unprognostic (1.65e-1)"	"unprognostic (2.03e-1)"	177.7	107.4	3.8	49.8	2.2	313.6	117.5	29.3	24.0	60.5	5.4	88.0	36.7	188.0	38.7	75.5	207.7	32.6	70.9	1.9	9.3	70.7	203.4	134.0	37.9	8.5	6.5	270.3	74.7	179.0	17.7	104.1	8.3	44.2	42.5	36.4	120.5	42.8	107.6	131.7	65.3	81.9	0.9	136.5	69.5	22.0	19.4	25.1	227.7	24.9	30.4	37.9	64.0	0.7	23.7	13.7	46.7	138.2	191.8	203.7	175.6	618.3	456.0	274.7	255.7	122.5	35.2	17.0	88.5	1070.3	58.5	28.0	14.2	14.5	192.4	467.0	45.8	346.9	76.0	10.1	157.1	103.1	36.5	164.6	64.4	121.3	91.4	177.9	51.2	10.1	132.9	80.1	359.2	51.0	17.5	128.3	43.8	15.0	21.2	24.7	34.2	152.3	131.7	52.5	51.8	0.8	45.2	167.6	21.2	106.8	72.3	348.3	283.6	219.9	69.5	66.4	35.0	23.4	22.6	26.3	68.0	86.9	15.8	3.1	8.2	27.7	3.4	4.6	5.0	1.2	5.4	4.9	3.6	3.1	4.7	2.4	4.0	3.0	6.6	1.6	3.6	3.3	3.8	2.2	29.3	24.0	1.9	9.3	8.5	6.5	8.3	0.9	19.4	0.7	157.1	115.4	272.8	3.6	138.8	35.8	111.5	12.7	347.8	30.6	164.4	180.0	114.1	80.1	36.5	103.0	12.5	173.1	156.5	159.6	185.9	20.5	1.5	122.6	131.7	68.9	99.7	274.3	6.9	14.9	685.3	200.3	121.8	262.3	46.9	133.9	61.1	65.5	372.6	30.3	22.2	111.6	20.3	124.4	67.7	7.7	99.4	188.9	83.6	9.4	44.2	51.9	55.6	1.0	1.3	23.1	97.7	60.9	619.4	46.6	88.8	121.0	27.4	52.5	98.6	107.9	179.1	1.8	20.8	200.8	33.8	269.3	291.8	272.9	112.6	38.4
CKAP2L	"FLJ40629, radmis"	ENSG00000169607	"Cytoskeleton associated protein 2 like"	Q8IYA6	2	112736349-112764664	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"bone marrow: 13.1;lymphoid tissue: 12.1;testis: 4.5"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 25.2;Granulosa cells: 12.5;Spermatocytes: 33.0;Spermatogonia: 35.7"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA039407, HPA040057, HPA070737"	Uncertain		Supported	"Microtubules,Mitotic spindle,Cytosol"		Yes	Yes				"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Microtubules, Mitotic spindle"	Cytosol	"HPA039407: AB_10794091, HPA040057: AB_10794871, HPA070737: AB_2686303"	"unprognostic (2.29e-1)"	"unprognostic (1.54e-1)"	"unprognostic (4.69e-3)"	"unprognostic (1.42e-3)"	"unprognostic (1.69e-1)"	"unprognostic (5.59e-2)"	"unprognostic (5.75e-5)"	"prognostic unfavorable (7.63e-4)"	"unprognostic (2.49e-3)"	"unprognostic (1.91e-1)"	"unprognostic (9.57e-6)"	"unprognostic (2.42e-1)"	"unprognostic (0.00e+0)"	"unprognostic (7.37e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.30e-1)"	"unprognostic (4.49e-2)"	0.4	0.1	0.2	2.6	0.2	13.1	0.4	0.4	0.3	0.4	0.0	1.6	1.5	0.3	0.1	2.3	0.1	0.3	0.0	0.2	0.1	0.1	0.3	0.3	5.0	0.0	0.1	0.0	0.0	0.0	0.0	1.8	0.0	0.1	2.2	0.2	0.3	0.0	0.0	1.5	1.1	1.1	0.0	0.9	1.0	4.5	0.2	12.1	0.2	0.0	5.2	0.8	0.6	0.2	47.9	9.6	35.4	16.2	2.0	3.3	7.2	38.5	32.2	37.9	36.1	8.7	13.3	32.0	15.5	15.1	48.3	18.0	20.4	19.6	64.1	44.8	8.9	53.6	12.7	7.7	0.1	25.2	30.9	0.9	1.9	47.4	27.2	10.1	17.5	22.8	14.3	44.9	31.2	6.9	31.0	10.6	15.4	20.0	29.5	22.3	37.0	8.4	6.9	18.7	19.7	12.7	15.2	12.8	13.3	13.2	12.4	11.8	12.9	42.7	33.7	34.5	28.5	9.9	20.1	26.6	18.5	18.1	69.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.2	0.0	0.2	0.2	0.4	0.3	0.2	0.1	0.0	0.1	0.0	0.0	0.2	0.2	0.1	3.2	0.6	0.0	1.2	3.3	2.1	2.7	0.6	0.0	0.5	0.8	0.5	1.5	0.4	0.0	0.0	11.1	1.3	1.3	0.0	0.4	2.4	1.1	1.6	1.1	0.0	25.2	0.3	0.4	10.6	2.0	1.5	2.1	0.0	12.5	2.9	0.1	6.6	0.0	0.2	3.1	2.0	1.9	1.4	2.1	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.2	0.1	0.0	5.6	1.1	0.1	0.1	0.4	0.0	0.0	0.4	2.8	33.0	35.7	9.5	1.7	1.0	2.5	0.7	3.8	1.1
CKAP5	"ch-TOG, KIAA0097, TOG, TOGp"	ENSG00000175216	"Cytoskeleton associated protein 5"	Q14008	11	46743048-46846308	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 119.7;Spermatocytes: 107.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039377, HPA040375"	Supported		Approved	"Nucleoli,Nucleoli rim,Plasma membrane,Centrosome"		NA	Yes		360000	"Cluster 27: Non-specific - Gene expression"	"Cluster 21: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Plasma membrane, Centrosome"	"Nucleoli, Nucleoli rim"	"HPA039377: AB_10805477, HPA040375: AB_10794739"	"unprognostic (8.00e-2)"	"unprognostic (7.35e-2)"	"unprognostic (2.35e-1)"	"unprognostic (4.12e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.08e-2)"	"prognostic unfavorable (1.03e-6)"	"unprognostic (6.09e-2)"	"unprognostic (1.12e-2)"	"unprognostic (2.21e-2)"	"unprognostic (4.30e-3)"	"unprognostic (3.77e-2)"	"unprognostic (2.03e-1)"	"unprognostic (2.71e-1)"	"unprognostic (1.12e-1)"	"unprognostic (3.48e-1)"	"unprognostic (4.69e-2)"	12.8	30.7	15.9	15.1	19.5	25.9	14.9	30.8	24.3	11.7	5.2	18.5	12.6	15.7	12.2	13.0	11.5	12.2	21.3	21.4	18.0	11.5	45.5	10.4	18.4	21.0	17.4	27.8	9.0	21.2	12.5	17.3	22.9	15.9	17.2	57.0	9.1	13.2	37.8	13.7	12.3	19.3	17.5	11.9	16.1	33.0	20.2	36.4	9.6	28.8	18.5	13.5	10.8	24.6	104.7	95.8	212.6	90.8	48.7	73.0	48.3	117.1	69.4	107.8	114.6	76.8	33.3	104.5	41.0	76.0	117.0	116.2	144.0	62.7	134.3	102.0	107.6	176.6	80.2	78.4	35.0	139.6	76.7	37.0	34.0	60.3	125.6	56.1	79.3	97.9	129.5	103.8	89.2	71.2	127.9	39.2	114.7	78.8	73.0	131.2	210.0	98.3	34.7	63.3	96.8	83.9	149.8	56.9	57.3	88.9	103.9	39.1	64.0	106.2	92.9	180.8	176.2	59.2	137.3	158.6	66.5	64.9	105.9	4.6	4.2	4.6	6.1	6.2	5.9	6.5	4.5	6.9	6.1	6.2	5.4	5.8	0.7	8.6	6.2	3.9	5.6	3.1	15.9	19.5	30.8	24.3	21.4	18.0	21.0	17.4	22.9	17.5	20.2	24.6	13.4	25.6	23.6	32.3	17.4	8.5	11.0	17.9	16.5	19.3	11.6	12.3	65.2	12.8	18.8	9.2	37.5	19.4	11.2	13.3	9.8	12.2	119.7	19.7	21.0	16.5	12.1	32.6	61.9	7.8	15.0	27.8	29.0	18.8	37.9	55.5	11.7	8.1	18.7	13.5	63.1	16.9	16.2	17.6	5.6	50.7	19.6	19.6	7.2	30.9	16.5	16.2	16.5	32.6	51.7	13.7	15.2	29.0	26.4	14.2	9.1	9.3	30.7	25.6	19.7	18.0	21.4	107.4	59.3	24.3	11.6	11.5	16.1	83.3	19.8	9.7
CKB	CKBB	ENSG00000166165	"Creatine kinase B"	P12277	14	103519667-103522833	"Cancer-related genes, Candidate cardiovascular disease genes, Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Kinase, Transferase"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 694.7;intestine: 653.4"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 2767.4;Distal enterocytes: 4691.8;Distal tubular cells: 2281.3;Horizontal cells: 5042.4;Muller glia cells: 3639.8;Rod photoreceptor cells: 3789.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	10	"non-classical monocyte: 290.8"	"Lineage enriched"	"Detected in many"	18	"monocytes: 290.8"	"Cell line enhanced"	"Detected in many"		"CACO-2: 455.8;HEK 293: 1399.8;SCLC-21H: 792.2;SH-SY5Y: 352.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001254, CAB047313"	Enhanced		Supported	Cytosol		No	No		38000000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Cytosol		"CAB047313: , HPA001254: AB_1078528"	"unprognostic (9.97e-2)"	"unprognostic (1.33e-3)"	"unprognostic (4.25e-3)"	"unprognostic (1.10e-1)"	"unprognostic (7.63e-2)"	"unprognostic (3.62e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.30e-1)"	"unprognostic (4.24e-1)"	"unprognostic (4.60e-2)"	"unprognostic (2.68e-3)"	"unprognostic (9.89e-3)"	"prognostic favorable (4.02e-8)"	"unprognostic (2.62e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.67e-2)"	"unprognostic (2.13e-1)"	90.7	60.0	471.6	25.8	627.0	3.2	47.2	641.1	694.7	105.2	192.7	653.4	36.0	222.6	16.0	54.5	197.9	17.9	269.8	428.7	482.3	161.0	9.0	60.3	4.0	427.5	440.4	58.8	27.7	108.2	74.0	4.7	345.1	301.8	151.9	471.3	37.9	208.3	80.0	76.5	120.8	113.8	434.5	6.8	479.9	97.6	596.2	2.8	87.9	47.1	5.1	298.4	101.6	383.6	2.4	54.5	321.1	14.7	4.4	2.3	6.3	37.5	0.3	2.4	1.4	455.8	7.3	0.4	36.9	29.1	9.9	70.2	109.9	1.5	0.2	9.6	1399.8	111.0	242.1	165.4	16.6	0.7	87.9	14.7	0.6	3.9	0.8	3.3	0.0	5.1	198.7	3.7	4.8	20.0	2.3	3.9	109.1	48.3	213.6	13.9	6.8	275.9	65.9	2.5	792.2	352.2	65.3	10.6	25.2	21.6	21.1	40.9	2.2	1.5	56.3	4.7	147.3	21.1	2.7	7.2	6.4	2.1	14.1	2.4	0.5	14.6	0.3	28.5	0.4	0.0	0.2	0.1	16.4	0.2	0.1	0.5	1.0	0.2	290.8	0.0	0.7	6.0	471.6	627.0	641.1	694.7	428.7	482.3	427.5	440.4	345.1	434.5	596.2	383.6	14.8	195.5	103.5	515.8	13.5	153.7	296.2	257.6	56.3	2767.4	41.5	48.9	553.5	145.8	117.9	114.0	1909.9	4.4	3.4	4691.8	2281.3	127.6	445.8	773.2	205.7	60.8	467.1	9.9	178.0	42.5	11.7	96.6	359.4	408.5	28.6	476.1	74.6	9.2	8.2	5042.4	147.0	726.0	187.2	2.8	44.9	147.4	304.1	39.8	181.5	88.1	74.2	3639.8	0.0	93.5	161.2	131.4	1996.9	1089.3	6.6	279.8	9.5	118.0	456.1	3789.9	59.2	15.4	222.6	127.3	97.4	22.1	175.2	41.6	19.1	12.2	755.6	220.1
CLASP2	KIAA0627	ENSG00000163539	"Cytoplasmic linker associated protein 2"	O75122	3	33496245-33718356	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 176.6;retina: 126.4"	"Cell type enhanced"	"Detected in all"		"Astrocytes: 294.5;Excitatory neurons: 514.2;Inhibitory neurons: 526.3;Oligodendrocyte precursor cells: 739.9;Oligodendrocytes: 1315.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA067071			Supported	"Golgi apparatus,Cytosol"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Golgi apparatus"	Cytosol	"HPA067071: AB_2685775"	"unprognostic (1.97e-1)"	"unprognostic (2.05e-1)"	"unprognostic (7.24e-3)"	"unprognostic (5.46e-2)"	"unprognostic (3.16e-2)"	"unprognostic (1.33e-2)"	"unprognostic (1.27e-2)"	"unprognostic (4.51e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.36e-2)"	"unprognostic (2.60e-3)"	"unprognostic (3.25e-2)"	"prognostic favorable (1.48e-6)"	"unprognostic (1.23e-1)"	"unprognostic (2.55e-1)"	"unprognostic (1.07e-2)"	"unprognostic (5.72e-2)"	14.0	25.1	43.4	12.1	84.1	12.3	15.8	100.7	79.1	21.4	0.0	16.9	9.9	20.5	11.3	17.9	16.0	17.7	40.4	44.8	57.5	18.1	10.8	15.3	15.4	69.0	49.9	27.3	11.5	17.7	33.3	15.6	85.9	16.6	13.1	126.4	8.8	20.7	64.9	13.0	11.0	19.4	67.8	14.5	11.2	11.8	60.0	16.1	14.1	63.4	15.9	14.5	11.5	176.6	13.5	29.4	32.9	27.8	20.9	20.4	23.6	24.8	23.2	28.5	30.6	17.2	13.8	44.4	14.1	19.6	18.3	11.5	43.0	19.7	34.4	36.0	30.5	43.7	24.6	15.4	9.9	43.6	35.8	12.7	19.3	30.9	29.2	16.5	28.0	27.0	43.3	24.8	31.1	7.6	32.5	18.6	24.5	13.5	18.4	34.5	30.9	24.1	17.9	15.2	27.4	46.4	28.7	22.1	24.7	26.5	20.9	38.1	27.0	22.3	19.4	16.9	27.7	17.3	34.6	36.5	20.2	29.6	28.8	3.7	4.6	2.6	3.3	4.5	5.1	6.1	2.9	3.2	6.5	3.7	3.9	3.6	0.9	9.1	7.0	6.1	3.5	4.8	43.4	84.1	100.7	79.1	44.8	57.5	69.0	49.9	85.9	67.8	60.0	176.6	19.7	6.4	11.7	294.5	29.9	21.0	8.6	8.8	18.8	103.3	26.0	13.8	37.4	15.7	12.7	14.7	156.4	12.3	36.2	9.9	1.9	6.4	2.8	20.8	15.6	16.1	14.4	12.2	514.2	7.0	8.1	19.2	26.5	27.9	12.0	17.8	16.1	13.9	15.0	92.5	526.3	8.8	8.2	32.3	26.6	2.9	14.3	26.0	16.0	128.4	19.5	32.0	22.6	739.9	1315.9	8.0	5.6	13.5	28.8	12.3	6.1	12.2	13.8	120.6	6.6	34.2	22.9	11.1	14.4	19.3	30.7	12.9	25.6	15.5	11.2	8.8
CLASRP	"CLASP, SFRS16, SWAP2"	ENSG00000104859	"CLK4 associating serine/arginine rich protein"	Q8N2M8	19	45039045-45070956	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA060469, HPA062455"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 71: Testis - DNA repair"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	Nucleoplasm		"HPA060469: AB_2684289, HPA062455: AB_2684770"	"unprognostic (2.99e-2)"	"unprognostic (2.68e-1)"	"prognostic unfavorable (9.77e-4)"	"unprognostic (9.03e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.76e-3)"	"unprognostic (1.58e-2)"	"unprognostic (2.62e-1)"	"unprognostic (8.52e-2)"	"unprognostic (4.01e-2)"	"unprognostic (1.76e-3)"	"unprognostic (3.48e-2)"	"prognostic unfavorable (1.69e-8)"	"unprognostic (2.19e-1)"	"unprognostic (1.74e-2)"	"unprognostic (3.36e-1)"	"prognostic favorable (1.02e-5)"	12.0	8.7	6.3	6.4	7.5	19.5	12.3	6.3	11.2	12.7	3.9	12.7	6.9	12.5	2.6	14.0	13.8	2.8	9.0	6.4	7.0	9.8	11.1	12.0	7.5	9.1	8.6	15.6	15.6	4.6	13.4	4.1	9.2	13.2	3.2	2.6	11.1	4.3	12.3	15.2	13.3	4.0	7.7	14.1	13.4	14.6	8.5	6.2	13.1	3.1	5.4	11.3	12.5	11.7	18.5	25.8	10.4	7.7	3.3	5.1	23.0	15.7	5.8	11.6	11.7	12.2	17.1	28.7	11.7	6.1	4.6	19.9	15.7	11.7	5.1	14.5	23.8	17.0	15.0	15.3	7.6	11.4	22.4	6.5	6.4	7.9	13.9	5.6	8.0	19.0	27.6	15.9	4.1	18.6	30.9	38.2	14.4	11.9	14.8	24.4	11.6	22.0	7.9	18.2	12.0	18.6	12.6	11.9	12.3	5.6	15.2	24.9	12.3	11.5	14.4	9.7	24.0	23.1	20.0	25.3	8.0	18.4	9.6	0.4	2.2	3.7	2.3	1.7	2.0	4.0	1.4	2.4	2.0	3.4	1.9	1.7	5.5	1.8	2.0	3.2	1.1	1.4	6.3	7.5	6.3	11.2	6.4	7.0	9.1	8.6	9.2	7.7	8.5	11.7	16.1	3.2	3.2	28.1	39.0	23.3	25.5	19.5	46.1	25.3	22.7	16.9	4.7	18.6	10.9	16.5	16.7	24.3	24.7	31.7	5.9	12.2	19.2	12.2	16.0	14.6	9.6	17.5	25.2	15.1	32.9	16.9	67.2	18.7	12.7	22.9	15.4	15.0	17.4	20.2	21.5	27.1	14.2	18.5	21.7	10.2	21.8	21.2	3.6	18.7	19.6	19.7	15.5	13.0	65.1	15.0	40.0	17.7	35.0	25.2	30.6	7.0	8.5	29.6	32.9	21.1	18.5	76.7	33.9	29.8	21.6	36.3	20.9	17.6	25.6	21.6
CLCA2	CLCRG2	ENSG00000137975	"Chloride channel accessory 2"	Q9UQC9	1	86424171-86456553	"Predicted membrane proteins"	"Cell adhesion, Ion transport, Transport"	"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"esophagus: 117.5;skin 1: 88.7;vagina: 53.1"	"Cell type enhanced"	"Detected in some"		"Basal keratinocytes: 47.4;Basal respiratory cells: 57.5;Basal squamous epithelial cells: 39.9;Club cells: 37.1;Early spermatids: 30.2;Squamous epithelial cells: 167.1;Suprabasal keratinocytes: 54.8;Urothelial cells: 52.9"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 146.1"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"hTCEpi: 210.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA047192	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cell Junctions"	"Intracellular and membrane"	NA	NA		96000		"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 61: Squamous epithelial cells - Keratinization"	"Plasma membrane, Cell Junctions"	Nucleoplasm	"HPA047192: AB_2679977"	"unprognostic (1.04e-2)"	"unprognostic (1.58e-1)"	"unprognostic (3.96e-3)"	"unprognostic (6.99e-2)"	"unprognostic (6.33e-2)"	"unprognostic (1.40e-1)"		"unprognostic (6.15e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.26e-1)"	"unprognostic (2.73e-1)"	"unprognostic (9.99e-3)"	"unprognostic (1.97e-8)"	"unprognostic (3.88e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.72e-1)"	0.8	0.1	0.2	0.1	0.6	0.0	4.6	0.4	0.5	22.8	0.1	0.6	0.2	0.0	0.5	117.5	0.2	0.1	0.0	0.2	0.3	0.0	0.0	0.3	0.0	0.4	0.3	0.0	0.0	0.0	0.1	0.7	0.4	2.4	0.7	0.0	13.2	0.2	0.2	88.7	0.8	0.0	0.4	0.0	0.1	0.6	0.3	1.0	0.0	0.0	26.0	21.2	53.1	1.0	0.0	0.0	0.0	0.0	0.6	3.0	38.9	1.7	2.7	0.3	1.0	0.0	0.0	0.0	0.0	0.0	0.1	9.7	0.0	33.8	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.4	210.8	1.0	10.1	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.5	0.0	0.0	0.9	0.7	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.6	0.4	0.5	0.2	0.3	0.4	0.3	0.4	0.4	0.3	1.0	0.0	0.0	0.0	0.7	0.0	47.4	13.1	57.5	39.9	0.0	7.7	2.8	0.4	0.0	37.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	30.2	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	5.3	4.1	0.0	3.1	4.5	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.1	0.0	2.5	2.1	0.3	0.0	8.0	0.0	0.0	0.0	0.6	0.2	0.0	167.1	54.8	0.1	0.5	0.0	0.1	52.9
CLCC1	MCLC	ENSG00000121940	"Chloride channel CLIC like 1"	Q96S66	1	108927361-108963504	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Chloride channel, Ion channel"	"Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA009087, HPA013210"	Enhanced		Supported	"Endoplasmic reticulum"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Endoplasmic reticulum"		"HPA009087: AB_1078532, HPA013210: AB_1846895"	"unprognostic (2.95e-1)"	"unprognostic (1.09e-1)"	"prognostic favorable (1.33e-5)"	"unprognostic (4.32e-2)"	"unprognostic (2.55e-1)"	"unprognostic (1.48e-1)"	"unprognostic (2.40e-2)"	"unprognostic (1.45e-1)"	"unprognostic (5.30e-2)"	"unprognostic (9.23e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.36e-1)"	"unprognostic (7.50e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.04e-1)"	"unprognostic (4.68e-3)"	"unprognostic (9.65e-2)"	14.6	16.5	10.1	11.4	14.3	6.1	16.3	10.6	11.7	17.0	7.8	15.4	13.2	17.0	24.3	9.9	15.1	14.0	18.3	10.7	11.5	11.0	22.2	13.0	10.5	12.8	10.9	18.6	24.8	21.3	18.3	17.7	12.1	20.2	13.2	11.8	22.3	20.0	27.2	10.3	12.7	14.9	11.0	11.5	16.1	7.6	11.8	5.2	21.9	24.8	10.8	15.2	13.4	16.0	44.2	22.3	25.1	45.8	36.7	33.9	35.6	43.8	34.2	30.1	34.2	22.6	21.0	10.8	43.7	33.3	18.5	17.1	23.9	16.1	39.4	38.0	23.2	30.4	24.7	23.5	28.9	28.7	28.2	25.2	21.9	33.2	25.7	28.3	27.1	12.1	38.6	47.7	22.1	18.9	2.3	10.1	21.5	16.6	19.8	24.5	13.1	31.2	24.3	30.5	15.9	22.7	46.9	49.6	38.9	18.9	15.9	19.7	26.7	38.3	27.7	35.1	38.4	32.1	33.3	17.1	44.7	21.8	82.5	4.1	5.6	6.1	5.6	8.4	6.1	6.1	4.5	4.4	5.6	3.2	4.9	4.5	1.4	4.7	12.4	6.4	6.8	4.4	10.1	14.3	10.6	11.7	10.7	11.5	12.8	10.9	12.1	11.0	11.8	16.0	13.3	25.6	20.9	26.8	11.8	3.7	14.0	11.7	1.8	12.3	11.8	9.1	5.9	20.0	18.0	11.0	29.2	28.7	9.0	7.1	0.0	18.6	6.7	8.1	21.3	10.9	3.6	5.9	25.0	21.1	12.8	19.5	10.7	13.5	12.0	16.3	9.7	22.3	13.1	21.9	30.3	9.0	16.2	6.7	5.1	2.8	19.9	9.3	8.8	14.0	12.0	11.4	3.1	35.7	39.3	17.7	3.8	18.8	17.7	17.7	7.2	5.0	14.9	18.9	19.7	18.6	10.7	5.5	5.4	6.4	6.3	18.5	8.4	12.5	9.8	9.9
CLCN3	"ClC-3, CLC3"	ENSG00000109572	"Chloride voltage-gated channel 3"	P51790	4	169612633-169723673	"Predicted intracellular proteins, Predicted membrane proteins"	"Antiport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044723	Approved		Supported	Vesicles		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 77: Retina - Visual perception"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 51: Myeloid cells - Hemostasis"	Vesicles		"HPA044723: AB_10959733"	"unprognostic (1.92e-1)"	"unprognostic (3.92e-2)"	"unprognostic (1.95e-3)"	"unprognostic (1.38e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.99e-1)"	"unprognostic (2.25e-1)"	"unprognostic (3.32e-1)"	"unprognostic (1.79e-1)"	"unprognostic (5.40e-2)"	"unprognostic (1.30e-1)"	"prognostic favorable (1.10e-4)"	"unprognostic (2.49e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.45e-1)"	"unprognostic (6.38e-3)"	21.1	34.5	20.1	20.6	28.7	12.3	31.9	29.1	30.2	23.9	20.5	47.5	30.1	18.7	29.4	40.7	26.4	38.0	35.3	22.8	30.5	36.4	25.7	21.2	17.3	32.3	41.0	23.1	41.0	37.2	18.2	24.1	32.1	32.7	52.6	78.3	78.0	21.8	24.7	29.1	29.8	17.8	32.3	16.7	41.2	33.3	26.5	21.0	37.0	22.1	24.5	37.4	17.1	42.0	32.6	33.2	48.7	62.1	96.1	80.8	24.0	42.9	53.5	28.3	34.3	23.7	72.2	40.0	26.1	35.9	32.7	27.2	61.2	26.6	46.9	35.9	24.4	33.8	50.6	27.3	65.8	41.0	54.2	56.6	59.7	50.5	49.5	117.4	51.7	55.2	85.1	88.0	49.7	11.8	56.2	9.4	20.0	56.2	22.4	25.0	21.5	31.6	58.1	66.6	51.9	51.5	38.4	40.9	66.9	39.3	27.9	19.2	43.5	22.5	25.3	36.5	33.7	39.3	64.3	35.5	67.6	15.4	60.8	3.8	4.1	2.9	5.0	4.8	6.5	5.0	3.7	4.7	5.7	3.8	5.7	5.2	2.9	4.5	4.0	7.1	4.7	4.7	20.1	28.7	29.1	30.2	22.8	30.5	32.3	41.0	32.1	32.3	26.5	42.0	35.5	32.1	26.2	58.8	30.7	11.3	25.7	21.5	20.5	90.3	54.6	27.9	66.5	42.9	25.3	62.5	131.3	23.8	23.1	118.3	7.9	37.2	88.1	46.9	35.9	35.2	66.9	83.1	102.4	44.3	18.7	29.5	51.5	51.8	113.0	32.3	38.6	39.3	18.6	60.6	126.1	64.2	20.3	32.9	9.8	67.4	24.5	47.8	32.0	44.0	17.1	136.7	28.8	139.7	141.5	31.9	55.3	21.1	21.4	45.3	37.1	17.9	67.8	115.1	6.6	34.6	21.5	17.2	15.5	42.8	26.1	71.1	21.0	67.0	65.4	34.0
CLCN5	"ClC-5, CLC5, DENTS, hCIC-K2, hClC-K2, NPHL1, NPHL2, XLRH, XRN"	ENSG00000171365	"Chloride voltage-gated channel 5"	P51795	X	49922596-50099235	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Antiport, Ion transport, Transport"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"epididymis: 23.7;kidney: 46.2;liver: 16.9"	"Cell type enriched"	"Detected in many"	4	"Skeletal myocytes: 214.4"	"Cancer enhanced"	"Detected in all"		"renal cancer: 9.0"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"myeloid DC: 2.6;plasmacytoid DC: 2.8"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in all"	4	"CACO-2: 49.0;RH-30: 66.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000401, HPA003213"	Uncertain		Supported	"Golgi apparatus,Plasma membrane,Cytosol"		NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 50: Fibroblasts - ECM organization"	"Golgi apparatus, Plasma membrane"	Cytosol	"HPA000401: AB_1078531, HPA003213: AB_2666843"	"unprognostic (3.33e-2)"	"unprognostic (6.15e-2)"	"unprognostic (3.13e-1)"	"unprognostic (1.57e-1)"	"unprognostic (7.59e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.54e-1)"	"unprognostic (8.08e-3)"	"unprognostic (1.60e-1)"	"unprognostic (5.21e-2)"	"prognostic favorable (5.20e-4)"	"unprognostic (3.59e-2)"	"prognostic favorable (2.05e-8)"	"unprognostic (7.87e-3)"	"unprognostic (1.07e-1)"	"unprognostic (1.25e-1)"	"unprognostic (3.60e-2)"	2.1	2.5	1.7	1.7	1.9	1.5	1.6	3.8	1.6	1.8	2.5	2.4	4.9	4.0	23.7	2.4	3.0	3.9	1.3	1.5	2.9	46.2	16.9	2.8	1.3	3.2	3.2	7.0	2.1	1.4	2.3	5.8	3.7	1.7	2.8	3.4	2.5	1.0	4.0	4.8	3.8	2.9	2.5	1.8	2.9	2.1	2.7	1.1	2.2	2.8	1.2	1.4	2.0	2.3	2.9	5.4	4.2	5.5	12.8	7.5	7.9	2.8	1.2	1.6	1.9	49.0	3.0	3.5	1.2	2.5	9.7	2.8	9.9	1.7	2.2	1.1	7.5	3.3	2.7	12.8	7.2	4.1	5.7	4.9	1.6	3.7	5.9	1.2	5.8	4.0	4.3	4.7	5.3	3.2	1.6	1.4	5.7	7.4	2.4	1.9	66.0	5.2	6.0	5.5	7.2	5.2	3.3	3.0	5.1	14.1	3.0	2.1	3.8	1.6	3.7	12.7	1.4	3.6	11.9	7.3	2.8	6.6	8.5	0.0	0.9	0.0	0.1	0.9	0.1	0.1	0.2	0.2	2.6	0.1	0.0	0.0	0.2	0.1	0.1	2.8	0.0	0.3	1.7	1.9	3.8	1.6	1.5	2.9	3.2	3.2	3.7	2.5	2.7	2.3	4.3	9.6	8.4	20.5	2.1	7.1	1.8	1.6	5.2	27.4	1.8	1.4	1.9	2.8	2.3	12.9	2.1	6.2	17.7	11.3	11.7	4.1	2.0	8.0	10.0	5.5	0.0	3.4	11.5	3.5	2.6	7.9	8.6	22.8	2.5	0.8	1.4	35.2	11.1	8.4	15.6	6.6	4.1	17.6	19.8	0.6	5.3	10.9	3.6	46.9	10.1	2.7	2.1	20.6	9.6	7.7	7.3	13.2	2.2	4.0	20.4	38.8	4.2	4.3	0.0	214.4	4.8	0.9	2.3	8.1	9.5	5.1	1.9	9.3	7.0	4.8
CLDN11	"OSP, OTM"	ENSG00000013297	"Claudin 11"	O75508	3	170418868-170454733	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 130.1;ovary: 95.4;testis: 116.9"	"Cell type enhanced"	"Detected in many"		"Fibroblasts: 56.4;Leydig cells: 105.3;Oligodendrocytes: 394.5;Peritubular cells: 67.7"	"Cancer enhanced"	"Detected in many"		"glioma: 11.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 141.3;ASC TERT1: 174.2;EFO-21: 91.8;HUVEC TERT2: 162.2;TIME: 252.1"	"Region enriched"	"Detected in all"	5	"white matter: 2084.8"					"CAB009789, HPA013166, HPA013657"	Enhanced		Supported	"Lipid droplets,Cell Junctions"		NA	NA				"Cluster 21: Non-specific - Transcription"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 33: Fibroblasts - ECM organization"	"Cell Junctions"	"Lipid droplets"	"CAB009789: AB_639330, HPA013166: AB_1854821, HPA013657: "	"prognostic favorable (6.31e-4)"	"unprognostic (3.18e-1)"	"unprognostic (2.32e-2)"	"unprognostic (5.28e-4)"	"unprognostic (3.45e-2)"	"unprognostic (4.60e-1)"	"unprognostic (5.25e-2)"	"unprognostic (5.40e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.03e-1)"	"unprognostic (5.48e-2)"	"unprognostic (8.70e-11)"	"unprognostic (2.50e-3)"	"unprognostic (1.93e-1)"	"unprognostic (6.68e-3)"	"unprognostic (2.29e-1)"	29.9	5.4	18.8	0.0	51.7	0.0	15.3	48.7	36.5	6.7	4.4	7.6	0.1	8.1	1.5	5.1	18.0	8.7	7.8	22.7	34.6	6.4	2.2	4.8	0.2	130.1	44.2	95.4	0.8	0.0	20.9	1.2	88.6	11.2	0.3	0.2	5.2	1.0	1.5	6.5	6.6	0.4	52.5	1.2	3.1	116.9	47.4	0.0	1.8	0.7	0.1	13.2	13.2	94.6	0.0	0.0	0.1	0.0	141.3	174.2	0.0	1.2	8.5	11.0	19.6	0.0	19.2	0.0	91.8	14.2	0.0	0.0	0.0	0.0	21.9	0.0	0.0	0.0	0.0	10.6	42.8	0.0	0.0	61.0	0.0	60.9	0.0	0.4	162.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.9	0.0	4.6	0.0	0.0	0.0	0.0	0.0	9.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	252.1	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.8	51.7	48.7	36.5	22.7	34.6	130.1	44.2	88.6	52.5	47.4	94.6	16.4	0.0	0.6	2.3	0.4	14.4	15.6	1.0	0.0	0.5	5.7	27.7	1.4	1.5	0.1	1.8	0.0	0.9	0.8	0.3	0.0	0.1	8.3	0.5	0.2	37.3	0.0	2.7	1.5	0.0	1.6	56.4	0.0	0.6	0.0	27.2	49.2	1.1	0.9	0.0	2.8	0.0	0.0	1.2	23.8	24.3	105.3	1.1	14.2	24.4	0.0	0.4	0.0	3.5	394.5	0.7	0.0	67.7	0.0	15.4	0.2	0.2	0.2	0.1	0.0	2.9	6.6	11.6	4.1	1.0	10.2	0.8	0.6	1.6	0.1	2.0
CLDN2		ENSG00000165376	"Claudin 2"	P57739	X	106900164-106930861	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"choroid plexus: 114.7;gallbladder: 101.6;kidney: 165.2;seminal vesicle: 90.1"	"Cell type enhanced"	"Detected in some"		"Ductal cells: 77.5;Exocrine glandular cells: 49.1;Hepatocytes: 25.9;Pancreatic endocrine cells: 30.9;Proximal enterocytes: 32.9;Proximal tubular cells: 153.1"	"Group enriched"	"Detected in many"	5	"colorectal cancer: 53.3;liver cancer: 24.6;pancreatic cancer: 48.5;renal cancer: 87.2;stomach cancer: 30.5"	"Region enriched"	"Detected in some"	5	"hippocampal formation: 8.4"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	6	"OE19: 296.4"	"Group enriched"	"Detected in many"	4	"basal ganglia: 4.5;hippocampal formation: 9.5;pons and medulla: 10.3;thalamus: 8.9"	"Region enhanced"	"Detected in some"		"medulla oblongata: 1.7"	"CAB002609, HPA051548"	Enhanced		Supported	"Nucleoplasm,Cell Junctions"		NA	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 21: OE19 - Mitochondria"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Nucleoplasm, Cell Junctions"		"CAB002609: , HPA051548: AB_2681530"	"unprognostic (2.31e-1)"	"unprognostic (2.62e-1)"	"unprognostic (3.99e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.30e-2)"	"unprognostic (1.42e-2)"	"unprognostic (6.07e-2)"	"unprognostic (7.47e-3)"	"unprognostic (2.24e-1)"	"unprognostic (8.67e-2)"	"unprognostic (8.83e-2)"	"unprognostic (8.15e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.12e-1)"	"prognostic favorable (1.70e-4)"	"unprognostic (9.76e-2)"	0.7	3.0	0.1	2.2	0.1	0.1	0.6	1.6	0.5	0.0	114.7	2.1	21.0	0.1	33.7	0.1	0.3	101.6	0.0	8.4	0.0	165.2	44.2	1.3	0.0	0.2	0.2	0.0	13.2	0.0	0.2	0.0	0.1	1.2	4.5	0.7	0.1	90.1	0.2	0.3	24.5	0.2	0.0	0.0	7.7	0.0	1.3	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.2	27.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	22.1	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	296.4	0.2	0.0	0.0	0.1	46.4	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.1	0.1	0.1	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	1.6	0.5	8.4	0.0	0.2	0.2	0.1	0.0	1.3	0.1	0.0	0.0	0.0	0.0	2.5	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.3	14.3	0.0	1.8	0.0	0.0	0.0	0.3	15.6	77.5	0.1	0.0	0.0	0.0	0.0	0.0	0.4	49.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	25.9	0.0	0.0	0.3	2.7	0.0	0.8	0.0	1.4	0.0	0.7	0.0	0.0	1.6	1.6	0.0	1.0	0.2	30.9	3.6	0.0	0.0	0.0	32.9	153.1	0.0	0.3	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.9	0.0	14.2	0.0
CLDN3	"C7orf1, CPE-R2, CPETR2, HRVP1, RVP1"	ENSG00000165215	"Claudin 3"	O15551	7	73768997-73770270	"Cancer-related genes, Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"			"Cancer-related genes, Williams-Beuren syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 263.1;thyroid gland: 116.3"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 1839.9;Endometrial ciliated cells: 1221.7;Glandular and luminal cells: 1555.7;Intestinal goblet cells: 1471.3;Paneth cells: 2326.0;Proximal enterocytes: 3162.1;Undifferentiated cells: 1266.0"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 529.2"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"MCF7: 230.7;PC-3: 47.6;RPMI-8226: 40.5;SCLC-21H: 58.0;T-47d: 105.4"	"Region enhanced"	"Detected in single"		"basal ganglia: 1.5"	"Region enhanced"	"Detected in many"		"midbrain: 9.7"	HPA014361	Enhanced		Supported	"Cell Junctions"		NA	NA				"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 44: Endometrium - Transcription"	"Cell Junctions"		"HPA014361: AB_2668982"	"unprognostic (1.84e-1)"	"unprognostic (4.83e-2)"	"unprognostic (2.05e-1)"	"unprognostic (5.27e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.31e-1)"	"unprognostic (2.79e-2)"	"unprognostic (8.26e-2)"	"unprognostic (3.11e-1)"	"unprognostic (1.46e-1)"	"unprognostic (2.28e-3)"	"unprognostic (1.42e-1)"	"prognostic favorable (3.39e-5)"	"unprognostic (1.46e-2)"	"unprognostic (1.87e-1)"	"unprognostic (5.18e-2)"	"unprognostic (6.72e-2)"	0.7	0.2	0.2	7.8	0.3	0.2	26.7	4.2	0.3	12.3	37.6	263.1	54.4	7.5	1.4	1.3	29.6	2.2	0.1	1.1	1.2	46.5	40.4	10.7	0.2	1.3	1.9	0.5	96.6	1.5	27.7	1.0	0.6	58.3	17.5	0.4	72.9	8.3	0.1	9.6	169.5	0.8	0.5	0.2	1.4	0.7	0.9	1.0	116.3	0.0	1.2	1.5	0.2	0.2	2.5	3.6	0.0	0.4	0.0	0.0	17.8	0.0	0.0	0.0	0.0	4.2	35.7	0.0	9.9	0.0	0.0	1.0	0.4	0.0	0.0	0.1	4.9	0.0	0.8	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	230.7	0.4	1.2	2.1	9.1	47.6	0.1	0.0	40.5	2.1	0.2	58.0	0.7	0.0	33.6	0.0	0.2	105.4	0.0	0.2	0.2	0.6	0.9	0.1	0.2	0.6	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	4.2	0.3	1.1	1.2	1.3	1.9	0.6	0.5	0.9	0.2	1.6	38.5	37.8	0.0	13.2	0.1	60.3	43.7	0.0	0.7	289.9	182.5	0.6	287.4	86.3	126.9	4.2	63.9	5.1	1839.9	9.8	297.5	0.0	1221.7	130.5	10.3	606.1	5.3	0.0	19.1	17.7	4.1	16.8	1555.7	28.0	1.5	0.4	40.5	5.1	0.0	0.0	1471.3	116.0	0.3	0.0	0.3	2.5	9.9	10.6	0.0	2.0	11.8	0.0	0.0	0.0	36.7	2326.0	0.0	4.4	433.2	3162.1	58.6	498.4	10.6	0.0	0.0	20.3	0.1	0.3	2.7	0.0	72.4	17.5	0.0	1266.0	607.3
CLDN4	"CPE-R, CPETR, CPETR1, hCPE-R, WBSCR8"	ENSG00000189143	"Claudin 4"	O14493	7	73799542-73832690	"Cancer-related genes, Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Chloride channel, Ion channel"	"Cancer-related genes, Williams-Beuren syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 305.0;urinary bladder: 303.5"	"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 3149.1;Glandular and luminal cells: 2298.8;Paneth cells: 2081.0;Prostatic glandular cells: 2184.8;Urothelial cells: 8033.4"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in single"		"midbrain: 1.5"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A-431: 358.1;BEWO: 395.0;CAPAN-2: 761.4;MCF7: 400.2;OE19: 402.0;PC-3: 495.0;RT4: 340.2;SK-BR-3: 636.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			CAB002610	Enhanced		Supported	"Plasma membrane"		NA	NA				"Cluster 37: Intestine - Unknown function"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 22: Epithelial cell types - Mixed function"	"Plasma membrane"		"CAB002610: "	"unprognostic (1.14e-1)"	"unprognostic (2.79e-2)"	"unprognostic (2.25e-1)"	"unprognostic (1.23e-2)"	"unprognostic (1.56e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.60e-2)"	"unprognostic (7.09e-2)"	"unprognostic (3.07e-1)"	"prognostic unfavorable (3.28e-4)"	"unprognostic (2.16e-3)"	"unprognostic (5.11e-1)"	"prognostic favorable (3.46e-10)"	"unprognostic (5.77e-2)"	"unprognostic (1.37e-1)"	"unprognostic (9.38e-2)"	"unprognostic (4.63e-2)"	2.6	0.4	0.1	23.0	0.0	0.2	69.0	0.8	0.3	61.2	4.8	256.3	126.9	26.7	24.4	305.0	75.8	48.9	0.4	0.2	0.0	116.2	4.8	64.0	1.0	0.4	1.5	1.2	116.2	51.9	13.1	36.3	0.3	82.2	123.3	0.3	204.6	39.1	0.5	180.8	190.6	7.3	0.0	0.7	13.3	0.6	0.2	10.7	111.7	0.3	37.5	303.5	105.7	0.0	358.1	4.4	0.0	1.5	0.0	0.4	395.0	3.3	0.2	0.3	0.4	184.9	761.4	0.6	28.0	0.1	2.6	193.3	0.0	0.5	0.4	0.7	0.4	0.2	20.3	127.0	0.1	0.1	0.9	0.0	1.9	0.1	0.4	0.3	0.0	0.2	0.3	0.7	0.0	400.2	0.7	1.9	0.7	402.0	495.0	0.5	6.9	7.6	92.4	340.2	79.5	1.7	0.4	636.8	0.8	21.6	250.9	0.9	0.5	0.9	13.7	3.1	3.5	0.9	0.7	0.7	0.6	0.4	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.8	0.3	0.2	0.0	0.4	1.5	0.3	0.0	0.2	0.0	5.1	275.7	230.2	0.0	12.2	16.2	3149.1	641.6	31.3	0.4	1255.2	548.4	0.8	287.4	954.3	218.8	0.0	771.7	18.7	1985.0	13.7	1026.1	0.0	1201.7	231.0	41.3	675.5	0.0	0.2	447.1	739.7	27.0	94.8	2298.8	27.3	0.2	0.4	0.5	76.3	0.0	0.1	1266.9	905.3	0.6	8.6	0.0	2.5	29.3	14.2	0.0	15.6	0.8	0.0	0.0	0.0	950.2	2081.0	0.0	2.5	2184.8	1906.1	21.6	635.6	0.0	0.0	0.1	68.2	0.0	0.2	1068.1	54.0	956.1	40.7	0.1	965.1	8033.4
CLDN7	"CEPTRL2, CPETRL2, Hs.84359"	ENSG00000181885	"Claudin 7"	O95471	17	7259903-7263983	"Cancer-related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 341.3;intestine: 341.0"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 1391.1;Pancreatic endocrine cells: 822.1;Paneth cells: 1276.4;Proximal enterocytes: 1390.9;Urothelial cells: 975.8"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"BEWO: 84.1;CACO-2: 90.2;CAPAN-2: 173.2;HaCaT: 364.9;MCF7: 129.8;OE19: 139.6;SK-BR-3: 150.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB013063, HPA014703, HPA073662"	Enhanced		Approved	"Vesicles,Cell Junctions"		NA	NA			"Cluster 22: NK-cells - Unknown function"	"Cluster 37: Intestine - Unknown function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Vesicles	"Cell Junctions"	"CAB013063: , HPA014703: AB_1846873, HPA073662: "	"unprognostic (5.47e-2)"	"unprognostic (2.22e-1)"	"unprognostic (4.12e-2)"	"unprognostic (2.90e-1)"	"unprognostic (1.05e-1)"	"unprognostic (8.67e-2)"	"unprognostic (3.41e-2)"	"unprognostic (1.98e-2)"	"unprognostic (5.64e-3)"	"unprognostic (8.34e-2)"	"unprognostic (4.89e-3)"	"unprognostic (1.62e-2)"	"prognostic favorable (8.96e-11)"	"prognostic favorable (4.09e-4)"	"unprognostic (1.87e-1)"	"prognostic favorable (1.85e-4)"	"unprognostic (1.62e-1)"	6.7	8.0	0.4	17.6	0.4	0.2	31.2	0.5	0.6	47.3	0.4	341.0	146.7	4.8	43.9	341.3	41.3	27.4	2.7	0.4	0.4	123.8	40.2	61.8	0.8	0.6	0.5	1.5	108.5	49.0	31.1	14.2	0.6	44.5	128.6	1.1	169.2	30.0	1.5	13.1	248.9	6.2	0.5	5.7	5.2	1.9	0.6	2.4	76.7	0.0	21.2	40.5	96.3	0.9	10.8	1.1	0.2	0.3	0.0	0.6	84.1	0.3	0.3	0.0	0.0	90.2	173.2	0.1	3.2	0.4	0.4	364.9	0.1	11.2	0.0	0.1	1.9	0.1	2.4	0.0	6.5	0.1	0.8	1.5	17.3	0.0	0.6	0.0	8.1	0.1	1.0	0.3	0.1	129.8	0.1	1.2	0.6	139.6	3.4	0.2	0.0	2.5	0.1	0.0	20.4	0.4	1.1	150.2	0.0	6.6	55.0	1.3	16.8	0.2	0.6	0.7	0.2	0.1	0.3	0.1	1.2	0.0	0.3	0.0	0.3	0.0	0.5	0.8	1.3	0.1	0.3	0.8	0.4	0.9	0.9	1.7	0.0	0.7	0.0	0.0	0.3	0.5	0.4	0.4	0.5	0.6	0.4	0.4	0.6	0.5	0.6	0.5	0.6	0.9	4.4	112.2	55.6	0.0	7.4	2.0	295.4	316.3	66.6	0.7	200.4	102.4	0.6	240.2	550.3	321.8	8.4	281.3	3.1	1391.1	39.2	787.5	0.1	210.1	26.6	9.0	326.8	4.0	0.0	790.0	342.7	5.2	15.3	225.5	5.7	0.1	3.6	41.2	33.7	0.0	0.0	741.7	362.2	4.1	6.4	0.2	1.2	11.0	24.9	1.9	11.0	1.6	0.0	0.0	0.0	822.1	1276.4	0.0	0.5	406.5	1390.9	78.6	498.5	6.7	0.0	0.2	38.6	0.4	3.5	366.1	2.6	588.9	10.2	1.0	691.9	975.8
CLDN9		ENSG00000213937	"Claudin 9"	O95484	16	3012923-3014505	"Predicted membrane proteins"	"Host-virus interaction"	"Host cell receptor for virus entry, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 10.8;pituitary gland: 25.2"	"Cell type enhanced"	"Detected in some"		"Cholangiocytes: 15.7;Ductal cells: 9.5;Endometrial ciliated cells: 8.6;Pancreatic endocrine cells: 8.1;Respiratory ciliated cells: 18.1"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 10.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 4.7;CAPAN-2: 7.3;MCF7: 24.2;SCLC-21H: 20.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA076613			Supported	"Vesicles,Cell Junctions"		NA	NA				"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 49: Ciliated cells - Cilium organization"	"Cell Junctions"	Vesicles	"HPA076613: AB_2686808"	"unprognostic (7.93e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.43e-2)"	"prognostic unfavorable (2.24e-6)"	"unprognostic (4.91e-2)"	"unprognostic (6.04e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.75e-1)"	"unprognostic (1.64e-2)"	"unprognostic (5.06e-2)"	"unprognostic (8.97e-3)"	"unprognostic (4.51e-2)"	"unprognostic (2.89e-2)"	"prognostic unfavorable (4.67e-4)"	"unprognostic (1.29e-1)"	"unprognostic (7.71e-3)"	"unprognostic (5.55e-2)"	0.3	0.2	3.3	0.2	4.4	2.7	0.2	10.8	5.6	0.3	2.4	0.5	0.7	0.0	0.0	0.1	1.2	0.2	1.7	3.3	3.6	1.5	5.2	1.2	0.0	5.3	4.0	0.0	6.4	1.4	25.2	0.1	5.6	0.3	0.0	1.9	0.6	0.0	1.2	0.2	0.5	0.0	3.7	2.3	0.5	0.3	4.1	0.3	0.4	0.1	0.0	0.2	0.1	5.2	4.7	0.2	0.0	2.4	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.4	7.3	0.0	0.1	0.0	0.1	0.8	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.5	0.0	0.0	0.2	0.0	0.0	24.2	0.0	2.0	0.1	0.3	0.2	0.0	0.0	0.2	0.2	0.1	20.8	0.0	0.6	0.9	0.0	0.0	0.2	0.2	0.1	0.0	0.0	0.3	0.0	0.3	0.2	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	4.4	10.8	5.6	3.3	3.6	5.3	4.0	5.6	3.7	4.1	5.2	0.0	0.0	0.0	0.0	0.0	0.1	2.6	1.4	0.0	1.3	1.1	0.4	0.3	15.7	2.3	0.0	0.0	0.3	0.0	0.6	0.0	9.5	0.1	8.6	0.3	0.1	1.8	0.0	0.8	1.7	0.9	0.1	0.0	2.7	0.0	0.0	0.4	0.3	0.1	0.0	0.4	0.4	2.0	0.0	0.5	0.0	0.0	0.2	0.0	0.0	0.2	0.2	0.0	0.0	3.4	8.1	1.5	0.0	0.0	1.2	0.4	0.1	18.1	0.7	0.0	0.0	0.6	0.1	0.2	0.0	0.4	1.1	0.1	0.0	0.6	1.8
CLEC14A	C14orf27	ENSG00000176435	"C-type lectin domain containing 14A"	Q86T13	14	38254000-38256093	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	13	"Adipocytes: 396.6;Endothelial cells: 272.8;Hepatic stellate cells: 567.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"fHDF/TERT166: 83.7;HUVEC TERT2: 451.8;TIME: 158.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039468, HPA048119"	Uncertain		Supported	"Endoplasmic reticulum,Golgi apparatus"		NA	NA		4100000		"Cluster 82: Adipose tissue - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Endoplasmic reticulum, Golgi apparatus"		"HPA039468: AB_2676524, HPA048119: AB_2680270"	"unprognostic (4.02e-1)"	"unprognostic (4.26e-2)"	"unprognostic (4.20e-3)"	"unprognostic (9.44e-2)"	"unprognostic (1.35e-1)"	"prognostic favorable (4.13e-6)"	"unprognostic (2.55e-3)"	"unprognostic (2.69e-1)"	"unprognostic (1.67e-1)"	"unprognostic (6.90e-2)"	"unprognostic (5.41e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.63e-2)"	"unprognostic (1.75e-2)"	"unprognostic (1.55e-1)"	"unprognostic (4.97e-2)"	"unprognostic (5.28e-2)"	67.1	9.5	13.6	7.9	13.4	0.1	50.6	13.8	15.2	24.8	10.9	15.2	10.1	31.2	7.6	11.1	22.6	19.0	65.1	11.5	13.3	15.9	9.4	55.5	6.6	15.0	13.9	9.5	7.8	10.5	6.1	25.0	15.4	14.5	7.2	0.8	13.6	9.8	33.2	15.8	18.8	19.8	13.1	16.7	13.8	3.5	14.9	4.6	31.4	43.3	4.2	19.2	16.8	15.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	83.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	27.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	451.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	158.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.6	13.4	13.8	15.2	11.5	13.3	15.0	13.9	15.4	13.1	14.9	15.6	396.6	0.0	3.2	0.0	0.9	3.4	0.2	0.0	1.8	0.1	1.5	2.5	6.4	1.5	0.6	0.0	0.0	0.1	0.2	0.0	0.0	0.1	1.1	0.2	0.5	272.8	0.0	0.0	0.4	0.2	0.1	31.0	0.0	0.3	1.3	0.1	567.2	2.1	0.4	0.0	0.2	0.0	0.0	6.4	3.1	1.0	0.6	1.1	5.4	15.0	0.0	0.2	0.0	4.0	2.9	0.0	0.0	0.4	1.4	0.2	0.0	0.0	0.0	0.5	0.0	14.1	7.5	1.6	0.9	0.9	3.1	0.1	1.3	6.7	0.0	0.3
CLEC5A	"CLECSF5, MDL-1"	ENSG00000258227	"C-type lectin domain containing 5A"	Q9NY25	7	141927357-141947007	"Predicted intracellular proteins, Predicted membrane proteins"	"Host-virus interaction, Immunity, Innate immunity"	"Host cell receptor for virus entry, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"bone marrow: 41.3"	"Group enriched"	"Detected in some"	6	"Hofbauer cells: 18.0;Langerhans cells: 67.5;Macrophages: 58.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	8	"classical monocyte: 9.1"	"Lineage enriched"	"Detected in many"	8	"monocytes: 9.1"	"Group enriched"	"Detected in some"	23	"HL-60: 40.9;U-937: 157.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA054137			Supported	"Plasma membrane,Cytosol"		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 32: U-937 - Innate immune response"	"Cluster 4: Macrophages - Innate immune response"	"Plasma membrane, Cytosol"		"HPA054137: AB_2732582"	"unprognostic (6.89e-2)"	"unprognostic (1.07e-1)"	"unprognostic (5.01e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.69e-2)"	"unprognostic (4.56e-2)"	"unprognostic (1.33e-5)"	"unprognostic (4.57e-1)"	"unprognostic (2.59e-1)"	"prognostic unfavorable (2.21e-4)"	"unprognostic (6.58e-3)"	"unprognostic (1.06e-1)"	"unprognostic (1.73e-2)"	"unprognostic (3.00e-2)"	"unprognostic (2.82e-1)"	"unprognostic (7.23e-2)"	"unprognostic (1.64e-1)"	1.1	1.8	1.1	7.3	1.2	41.3	0.6	1.3	2.6	0.7	2.1	0.2	0.1	0.3	0.0	1.2	0.5	1.8	0.5	1.0	3.3	0.5	1.8	4.0	0.1	2.2	3.3	0.3	1.3	1.2	0.5	0.9	2.2	0.4	0.3	1.0	1.2	0.5	0.0	2.6	0.0	1.3	1.6	1.1	0.2	0.5	4.9	0.6	0.7	0.0	0.1	2.3	0.6	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	40.9	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	157.3	0.0	0.0	9.1	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	1.1	0.0	0.0	0.2	0.0	1.8	1.1	1.2	1.3	2.6	1.0	3.3	2.2	3.3	2.2	1.6	4.9	2.4	0.1	0.0	4.8	0.7	0.6	1.9	0.0	0.0	0.0	0.2	0.1	0.1	0.3	1.5	5.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.2	0.0	0.1	3.5	0.0	0.0	0.1	0.0	0.2	0.8	0.0	0.0	2.5	0.0	0.0	0.0	18.0	0.0	0.2	0.0	0.0	4.7	67.5	0.7	0.0	58.1	1.8	7.5	6.4	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.0	2.9	0.4	0.0	0.0	0.2	0.0	0.1	0.0	1.4	0.3	0.4	0.0	0.0	0.0
CLECL1	DCAL1	ENSG00000184293	"C-type lectin like 1"	Q8IZS7	12	9715860-9733299	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Group enriched"	"Detected in many"	5	"intestine: 9.9;lymphoid tissue: 31.1"	"Group enriched"	"Detected in some"	4	"B-cells: 87.0;dendritic cells: 24.0;Hofbauer cells: 22.2;Kupffer cells: 82.3;Langerhans cells: 64.6;Macrophages: 23.9;monocytes: 55.9;Plasma cells: 42.0"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"memory B-cell: 120.9"	"Lineage enriched"	"Detected in many"	5	"B-cells: 120.9"	"Group enriched"	"Detected in some"	5	"HEL: 49.7;Karpas-707: 66.2;U-698: 173.0;U-937: 95.6"					"Low region specificity"	"Detected in many"			HPA063928			Supported	"Plasma membrane,Centriolar satellite"		NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 57: B-cells - Immune response"	"Plasma membrane, Centriolar satellite"		"HPA063928: "	"unprognostic (2.18e-2)"	"unprognostic (2.35e-3)"	"unprognostic (2.20e-3)"	"unprognostic (1.90e-3)"	"unprognostic (3.66e-1)"	"unprognostic (1.90e-3)"	"unprognostic (2.83e-1)"	"unprognostic (7.55e-4)"	"unprognostic (5.10e-2)"	"unprognostic (2.82e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.20e-1)"	"unprognostic (3.91e-5)"	"unprognostic (3.31e-1)"	"unprognostic (2.45e-1)"	"unprognostic (6.10e-2)"	"unprognostic (7.39e-2)"	1.0	1.6	0.6	9.9	0.9	1.9	2.0	1.4	0.9	0.9	1.3	3.0	2.7	0.9	0.0	0.7	0.8	2.5	0.4	0.6	0.9	0.7	2.1	2.1	24.8	1.8	1.1	0.5	0.2	0.3	0.3	0.7	1.4	0.7	4.3	0.1	1.3	0.5	0.1	0.4	9.9	1.8	1.2	16.2	4.5	0.9	1.1	5.2	0.6	0.2	31.1	3.0	0.3	1.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	11.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	49.7	0.0	0.0	0.0	18.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	66.2	0.0	0.1	0.0	9.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.5	0.0	0.0	0.5	0.0	0.1	0.2	1.2	173.0	0.0	95.6	0.0	2.4	7.9	0.4	4.5	14.4	0.1	120.9	3.9	9.7	18.7	54.3	0.2	1.4	0.3	0.3	15.5	25.4	0.2	5.2	0.6	0.9	1.4	0.9	0.6	0.9	1.8	1.1	1.4	1.2	1.1	1.6	0.3	0.0	0.0	0.0	87.0	2.0	0.1	0.0	0.0	0.0	0.3	0.5	0.0	0.0	1.8	0.0	0.0	0.1	24.0	0.1	0.0	0.0	1.0	0.1	0.1	0.3	0.0	4.4	0.0	0.2	0.1	0.6	0.0	0.1	5.1	0.0	0.4	0.4	22.2	0.0	0.0	0.2	0.0	82.3	64.6	1.4	0.3	23.9	12.4	1.0	55.9	0.0	1.0	0.0	0.0	0.0	0.0	0.0	42.0	0.0	0.0	0.4	0.0	0.0	6.6	0.1	0.1	0.0	0.2	0.1	1.8	0.3	11.2	0.0	0.0	0.1
CLGN		ENSG00000153132	Calmegin	O14967	4	140388453-140427661	"Predicted intracellular proteins, Predicted membrane proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 59.5;testis: 113.6"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 313.3;Early spermatids: 162.4;Endometrial ciliated cells: 93.4;Muller glia cells: 176.4;Spermatocytes: 465.5"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 19.1"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 53.0;MOLT-4: 47.8;U-251 MG: 73.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB020709, HPA048761, HPA058627"	Enhanced		Supported	"Endoplasmic reticulum"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 43: Testis - Unknown function"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Endoplasmic reticulum"		"CAB020709: , HPA048761: AB_2680514, HPA058627: AB_2683782"	"unprognostic (6.74e-2)"	"unprognostic (8.28e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.08e-1)"	"unprognostic (2.30e-2)"	"unprognostic (2.56e-1)"	"unprognostic (3.73e-3)"	"unprognostic (6.14e-2)"	"unprognostic (4.80e-2)"	"unprognostic (3.11e-1)"	"unprognostic (5.38e-3)"	"unprognostic (2.29e-2)"	"unprognostic (2.45e-3)"	"unprognostic (3.00e-3)"	"unprognostic (1.29e-1)"	"unprognostic (2.59e-1)"	"unprognostic (1.01e-1)"	0.4	6.6	0.9	1.0	0.7	2.4	2.7	3.8	1.6	0.9	2.0	2.6	0.5	1.6	0.6	1.2	13.7	0.4	59.5	0.9	2.6	0.4	3.2	0.5	0.7	2.7	1.9	0.3	2.2	0.6	11.2	0.2	2.6	22.5	1.3	17.2	1.0	0.7	0.4	0.2	1.3	1.5	1.2	0.2	2.0	113.6	2.3	2.4	2.7	1.6	1.2	0.6	0.1	0.9	0.2	10.2	10.3	6.9	4.0	21.1	2.4	0.1	9.4	10.0	18.6	0.3	0.9	0.0	27.8	0.9	8.4	0.2	7.5	0.1	16.2	0.4	9.0	3.0	9.8	7.4	41.4	38.9	0.6	2.2	39.2	1.0	0.9	53.0	0.2	9.6	2.0	0.0	0.0	0.5	47.8	0.5	12.0	0.2	28.1	31.5	0.0	0.4	0.0	0.3	16.8	29.8	6.5	4.1	1.8	3.8	1.9	5.6	0.0	27.4	4.7	9.7	73.6	14.4	31.7	19.9	43.4	1.6	2.9	0.9	0.2	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.7	3.8	1.6	0.9	2.6	2.7	1.9	2.6	1.2	2.3	0.9	0.8	0.0	2.2	0.3	0.1	0.0	0.9	8.5	1.2	9.2	3.3	1.8	313.3	0.0	6.4	0.0	4.2	0.5	0.0	0.5	0.0	1.2	162.4	93.4	1.3	11.9	5.3	8.6	7.2	4.2	0.1	10.2	0.0	11.3	0.0	10.1	0.7	3.7	0.1	25.2	6.7	0.4	30.5	0.0	0.0	60.2	5.0	0.7	1.8	0.0	0.1	176.4	0.0	6.6	0.6	0.9	3.9	4.5	0.1	33.8	0.2	0.1	24.6	16.3	0.0	0.6	2.0	465.5	23.9	2.8	0.1	0.3	0.7	0.2	0.8	1.3
CLIC1	"CLCNL1, G6, NCC27, p64CLCP"	ENSG00000213719	"Chloride intracellular channel 1"	O00299	6	31730581-31739763	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transporters"	"Ion transport, Transport"	"Chloride channel, Ion channel, Voltage-gated channel"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB020825, CAB040557"	Enhanced		Supported	Cytosol		NA	NA		22000000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 72: Non-specific - Transcription"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	Cytosol		"CAB020825: , CAB040557: "	"unprognostic (7.26e-2)"	"unprognostic (9.32e-2)"	"unprognostic (2.78e-3)"	"unprognostic (7.29e-2)"	"unprognostic (6.93e-2)"	"unprognostic (2.73e-2)"	"prognostic unfavorable (8.90e-7)"	"unprognostic (2.58e-2)"	"unprognostic (8.51e-2)"	"unprognostic (8.71e-3)"	"unprognostic (1.19e-3)"	"unprognostic (1.34e-1)"	"prognostic unfavorable (8.11e-5)"	"unprognostic (4.51e-2)"	"unprognostic (2.89e-1)"	"unprognostic (1.35e-2)"	"unprognostic (7.31e-2)"	292.8	156.5	6.9	43.4	6.8	64.0	256.7	7.1	11.0	222.2	8.7	291.6	37.0	197.9	20.9	395.9	190.5	43.7	183.7	6.7	10.2	318.5	102.6	330.4	44.1	9.4	7.7	149.8	148.1	20.1	111.5	45.5	8.9	217.0	64.0	2.6	251.3	22.3	47.3	324.8	231.6	32.7	8.9	332.6	247.8	41.0	9.6	35.2	180.8	11.1	58.1	257.7	246.8	8.9	119.5	54.1	87.0	45.6	56.6	118.6	43.3	52.8	105.4	92.6	77.9	125.2	87.2	48.7	73.6	186.0	116.9	70.2	65.8	154.9	124.4	38.9	34.4	93.0	43.4	109.3	73.0	164.3	125.9	74.3	80.5	157.0	148.4	101.7	157.9	44.6	109.4	149.5	181.0	79.2	77.2	213.2	7.7	128.9	78.4	13.5	47.5	115.3	210.2	73.0	16.5	19.5	43.1	49.1	71.5	60.4	33.7	228.3	105.0	128.6	91.2	39.0	166.8	48.3	98.3	66.0	62.4	122.0	136.6	244.3	179.4	239.3	165.6	194.3	135.8	186.1	98.0	155.5	143.8	150.3	30.5	92.3	341.1	176.3	174.3	80.5	149.2	414.2	6.9	6.8	7.1	11.0	6.7	10.2	9.4	7.7	8.9	8.9	9.6	8.9	514.8	70.5	67.0	0.7	382.5	960.8	589.1	869.7	331.2	0.4	274.3	300.5	18.6	296.0	457.7	237.3	0.0	545.5	472.2	730.7	602.6	1096.2	31.8	271.1	212.7	490.1	381.4	208.6	0.0	1008.9	912.5	296.6	370.5	301.3	554.1	431.2	300.9	54.2	1047.6	0.0	0.0	665.6	516.8	533.7	1529.8	17.3	233.9	685.7	524.7	13.1	426.4	86.8	706.5	0.5	0.0	1470.4	997.1	188.1	420.2	851.1	707.7	572.1	473.6	6.9	203.8	136.1	554.0	28.7	16.2	464.1	928.0	572.7	522.2	283.3	675.0	1005.9
CLIC2	"CLCNL2, XAP121"	ENSG00000155962	"Chloride intracellular channel 2"	O15247	X	155276211-155334657	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	"Ion transport, Transport"	"Chloride channel, Ion channel, Voltage-gated channel"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 51.2;Alveolar cells type 1: 89.8;Alveolar cells type 2: 54.9;Endothelial cells: 60.4;Erythroid cells: 70.7;Kupffer cells: 73.5;Langerhans cells: 135.0;monocytes: 71.4"	"Cancer enhanced"	"Detected in all"		"thyroid cancer: 18.7"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"intermediate monocyte: 18.6;myeloid DC: 47.9;non-classical monocyte: 14.2"	"Group enriched"	"Detected in many"	16	"dendritic cells: 47.9;monocytes: 18.6"	"Group enriched"	"Detected in some"	5	"HDLM-2: 103.3;K-562: 60.4;Karpas-707: 53.4;RPMI-8226: 92.2"					"Low region specificity"	"Detected in all"			"HPA047381, HPA060101"	Uncertain		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA		150000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 64: Macrophages - Immune response"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 41: Macrophages - Immune response"	"Plasma membrane, Cytosol"	Nucleoplasm	"HPA047381: AB_2680022, HPA060101: AB_2684204"	"unprognostic (3.27e-2)"	"unprognostic (5.21e-3)"	"unprognostic (9.70e-2)"	"unprognostic (7.25e-2)"	"unprognostic (9.71e-2)"	"unprognostic (3.78e-2)"	"unprognostic (1.46e-1)"	"unprognostic (4.07e-2)"	"unprognostic (2.95e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.97e-1)"	"unprognostic (3.31e-1)"	"prognostic unfavorable (1.74e-5)"	"unprognostic (1.97e-2)"	"unprognostic (2.97e-2)"	"unprognostic (6.63e-2)"	"unprognostic (1.54e-1)"	23.1	7.1	6.9	16.7	7.8	9.8	16.7	6.9	18.1	20.1	7.6	10.9	8.7	22.6	7.8	9.4	12.5	19.0	14.6	7.1	7.0	5.8	12.8	30.6	30.2	7.7	6.9	21.6	3.5	4.6	4.5	9.3	7.4	4.6	13.6	2.4	6.2	6.3	4.4	6.1	10.3	17.7	7.7	50.1	8.5	3.2	8.5	14.5	31.8	14.3	25.6	15.9	10.7	7.8	0.7	0.0	1.0	0.9	1.0	4.7	0.0	0.2	2.8	0.0	0.4	0.0	0.2	0.1	0.4	0.0	0.2	0.1	0.3	0.0	0.0	103.3	0.5	16.4	0.3	0.0	0.0	0.4	0.6	1.4	0.0	0.0	0.1	0.5	0.1	0.5	60.4	53.4	0.3	0.2	0.1	1.3	0.2	0.1	0.4	0.4	0.0	92.2	0.2	0.2	0.7	0.9	0.0	0.1	0.4	0.2	0.0	1.0	0.0	5.3	1.6	2.0	0.9	3.3	4.6	0.0	2.7	2.6	1.7	0.0	3.5	0.2	0.0	18.6	0.3	0.0	0.1	0.1	47.9	0.0	0.0	0.0	1.4	2.0	14.2	5.2	0.0	2.1	6.9	7.8	6.9	18.1	7.1	7.0	7.7	6.9	7.4	7.7	8.5	7.8	51.2	89.8	54.9	3.9	1.1	13.3	0.8	0.2	2.2	1.2	0.7	1.3	3.2	0.0	5.8	0.0	0.0	0.1	0.2	0.1	0.0	0.1	0.1	0.5	11.3	60.4	1.2	70.7	8.6	0.2	0.1	25.6	0.5	0.4	3.8	0.5	27.1	1.2	4.7	0.0	7.0	0.6	0.0	73.5	135.0	1.1	13.7	34.5	17.8	8.4	71.4	0.2	0.0	3.0	2.4	0.1	0.0	9.4	2.0	0.5	0.0	0.6	1.5	0.3	6.6	2.5	4.6	0.3	0.3	0.4	13.8	0.0	2.6	5.2	0.1	1.9
CLIC3		ENSG00000169583	"Chloride intracellular channel 3"	O95833	9	136994608-136996568	"Plasma proteins, Predicted intracellular proteins, Transporters"	"Ion transport, Transport"	"Chloride channel, Ion channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 317.0;skin 1: 122.0;thyroid gland: 109.6;vagina: 132.2"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 811.8;dendritic cells: 456.0;Extravillous trophoblasts: 1219.2;NK-cells: 541.7;Syncytiotrophoblasts: 2039.4"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 130.8"	"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in many"	9	"plasmacytoid DC: 2635.7"	"Lineage enriched"	"Detected in all"	9	"dendritic cells: 2635.7"	"Cell line enhanced"	"Detected in many"		"BEWO: 350.3;MCF7: 168.1;SK-BR-3: 65.0;T-47d: 147.2;TIME: 118.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA005963	Enhanced		Supported	"Nuclear bodies"		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	"Nuclear bodies"		"HPA005963: AB_1078536"	"unprognostic (4.30e-2)"	"unprognostic (2.53e-1)"	"unprognostic (3.54e-1)"	"unprognostic (1.55e-2)"	"unprognostic (5.42e-3)"	"unprognostic (1.85e-1)"	"unprognostic (6.79e-2)"	"unprognostic (5.82e-3)"	"unprognostic (1.39e-1)"	"unprognostic (3.26e-3)"	"unprognostic (7.73e-3)"	"unprognostic (1.15e-1)"	"prognostic unfavorable (1.12e-4)"	"unprognostic (1.95e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.08e-1)"	"prognostic unfavorable (7.74e-4)"	8.6	0.6	0.9	1.3	1.0	4.0	2.6	1.3	1.6	75.0	1.4	1.3	0.3	1.8	4.6	317.0	1.7	0.8	8.6	0.7	1.0	1.0	1.0	38.6	4.1	1.3	0.9	0.6	0.6	0.2	2.4	41.6	1.0	3.0	0.2	0.0	37.7	1.1	1.0	122.0	1.7	0.3	0.8	6.9	7.5	0.7	1.0	7.6	109.6	1.2	20.5	2.1	132.2	1.2	28.8	0.0	0.0	0.0	0.5	1.4	350.3	2.7	1.5	1.0	0.4	3.7	14.0	0.1	22.5	24.3	0.1	12.5	0.0	1.2	0.0	0.0	0.2	0.0	20.7	4.5	3.9	0.0	0.0	1.0	0.2	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	168.1	0.1	0.2	0.1	58.4	5.8	0.0	0.5	0.0	0.0	0.0	0.8	0.0	45.9	65.0	0.0	0.0	147.2	0.0	118.4	0.0	4.1	2.5	0.1	0.0	0.0	0.1	0.5	0.0	0.0	2.9	0.8	2.6	232.3	2.1	99.3	2.6	32.0	143.8	9.4	5.5	6.9	120.4	10.3	283.2	2.3	2635.7	11.5	168.3	0.9	1.0	1.3	1.6	0.7	1.0	1.3	0.9	1.0	0.8	1.0	1.2	11.5	214.7	42.0	0.0	11.6	3.8	3.6	86.6	8.0	0.0	7.3	20.6	3.2	2.8	95.2	1.8	0.0	811.8	456.0	25.2	9.8	1.8	1.7	16.7	2.3	13.4	4.9	5.3	0.0	6.4	1219.2	27.0	22.4	14.4	1.3	1.8	3.6	1.1	91.6	0.0	0.0	5.6	4.1	2.2	5.9	7.8	125.6	8.5	10.6	1.9	4.9	0.0	541.7	0.0	0.0	84.6	10.4	41.8	23.7	4.5	0.7	0.4	12.0	0.0	0.0	0.2	4.4	0.0	1.0	70.2	19.5	2039.4	78.4	1.0	5.2	18.1
CLIC4	"CLIC4L, DKFZP566G223, H1, huH1, P64H1"	ENSG00000169504	"Chloride intracellular channel 4"	Q9Y696	1	24745382-24844321	"Predicted intracellular proteins, Transporters"	"Ion transport, Transport"	"Chloride channel, Ion channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Proximal tubular cells: 346.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"memory B-cell: 13.4;naive B-cell: 11.9"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008019, HPA060804"	Enhanced		Supported	"Plasma membrane,Centrosome"		NA	NA		5800000	"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 48: Smooth muscle cells - ECM organization"	"Plasma membrane, Centrosome"		"HPA008019: AB_1846946, HPA060804: AB_2684370"	"unprognostic (7.35e-3)"	"prognostic unfavorable (8.31e-4)"	"unprognostic (5.54e-2)"	"unprognostic (7.60e-2)"	"unprognostic (2.92e-2)"	"unprognostic (9.48e-2)"	"unprognostic (6.78e-3)"	"unprognostic (1.63e-2)"	"unprognostic (5.50e-2)"	"unprognostic (4.03e-3)"	"unprognostic (1.98e-2)"	"unprognostic (7.01e-2)"	"prognostic favorable (1.48e-5)"	"unprognostic (2.75e-3)"	"unprognostic (2.17e-1)"	"unprognostic (1.22e-2)"	"unprognostic (3.82e-3)"	154.0	58.6	51.8	97.7	70.2	32.3	88.1	61.8	82.7	165.4	39.4	136.3	32.4	201.5	84.6	119.3	103.0	106.5	197.2	50.8	66.5	256.8	72.3	114.6	51.0	73.6	68.0	46.0	49.7	29.3	14.1	120.6	67.0	112.8	66.8	53.1	49.4	152.8	30.7	33.6	54.2	280.4	62.4	43.1	80.0	34.2	88.9	59.6	47.6	53.2	56.4	156.1	73.4	91.4	219.3	25.3	222.7	176.8	299.1	645.6	116.7	561.0	571.4	253.9	304.2	48.3	114.1	129.8	320.1	799.2	77.0	76.8	155.0	151.5	635.7	33.3	64.9	50.0	60.8	88.3	417.3	17.5	6.3	299.3	256.8	363.0	365.1	417.3	427.0	76.0	40.4	138.2	739.0	38.4	34.8	28.5	212.6	50.4	101.8	83.5	247.3	51.5	260.0	58.4	38.9	101.3	144.7	68.4	453.7	228.3	60.0	116.1	601.0	452.2	168.8	199.4	230.1	75.4	111.7	108.6	333.8	151.1	140.5	0.8	5.4	2.5	0.4	4.4	0.0	13.4	0.3	0.2	5.6	11.9	0.1	0.2	1.2	0.0	4.0	1.7	0.0	3.5	51.8	70.2	61.8	82.7	50.8	66.5	73.6	68.0	67.0	62.4	88.9	91.4	178.7	16.0	30.5	24.8	50.8	61.6	50.4	79.8	37.0	3.7	49.9	33.0	172.5	21.5	35.2	14.7	10.4	71.5	2.2	18.1	41.1	39.2	44.9	20.9	103.0	177.1	9.6	40.8	1.5	43.1	211.4	120.5	21.4	53.6	40.0	10.2	88.5	34.4	39.3	1.7	4.2	22.6	20.3	28.2	100.2	27.3	28.6	52.6	129.9	75.9	50.8	13.0	4.1	41.7	196.9	54.7	10.6	87.6	171.2	114.5	0.1	346.1	16.7	26.5	46.0	87.9	162.5	44.0	29.1	29.3	52.0	177.0	8.1	46.5	2.6	49.1
CLIC5	DFNB102	ENSG00000112782	"Chloride intracellular channel 5"	Q9NZA1	6	45880827-46080348	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	"Hearing, Ion transport, Sensory transduction, Transport, Vision"	"Chloride channel, Ion channel, Voltage-gated channel"	"Deafness, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 102.7;skeletal muscle: 289.7;tongue: 98.3"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 509.6;Cardiomyocytes: 285.7;Distal enterocytes: 164.2;Late spermatids: 93.8;Proximal enterocytes: 126.0"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 11.6"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"MAIT T-cell: 5.1"	"Lineage enriched"	"Detected in single"	17	"T-cells: 5.1"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 13.5;EFO-21: 9.2;HDLM-2: 4.7;REH: 11.9;U-266/70: 12.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA074371			Supported	"Nuclear speckles,Plasma membrane"		NA	NA		400000	"Cluster 16: MAIT-cells - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Plasma membrane"	"Nuclear speckles"	"HPA074371: "	"unprognostic (4.95e-2)"	"unprognostic (1.59e-2)"	"unprognostic (8.84e-2)"	"unprognostic (5.05e-2)"	"unprognostic (2.44e-1)"	"unprognostic (6.73e-2)"	"unprognostic (3.37e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.79e-1)"	"unprognostic (6.46e-2)"	"unprognostic (5.50e-2)"	"unprognostic (3.65e-1)"	"unprognostic (6.77e-3)"	"unprognostic (1.22e-1)"	"unprognostic (1.99e-1)"	"unprognostic (8.26e-2)"	"unprognostic (1.01e-1)"	18.9	1.5	3.2	4.3	4.4	0.2	6.5	1.5	2.9	19.0	0.5	28.6	20.9	2.1	0.9	2.9	4.5	3.0	102.7	2.1	5.0	54.7	0.3	70.8	1.7	2.1	3.8	0.5	1.1	1.7	3.0	16.5	2.2	2.6	25.8	16.9	2.7	1.4	289.7	1.2	36.6	2.3	1.8	44.5	1.6	1.4	5.5	1.0	7.3	98.3	1.9	2.0	2.6	1.9	0.9	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.6	13.5	0.0	9.2	0.0	0.0	0.3	0.0	0.1	0.0	4.7	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.8	0.0	0.0	0.0	0.1	0.4	1.6	0.0	11.9	0.3	0.1	0.1	0.4	0.1	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.4	0.1	0.0	12.8	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	1.5	0.0	5.1	0.1	2.0	1.3	0.0	0.0	0.3	0.2	0.0	0.3	0.0	0.0	1.0	0.5	3.2	4.4	1.5	2.9	2.1	5.0	2.1	3.8	2.2	1.8	5.5	1.9	59.6	509.6	30.0	4.6	1.4	0.1	0.1	0.0	1.2	0.3	0.5	0.4	285.7	5.7	26.9	14.7	0.0	0.2	0.7	164.2	0.0	1.7	52.9	4.6	0.5	29.8	13.1	0.4	8.6	0.2	0.1	7.9	0.5	5.7	1.3	0.0	0.7	0.0	0.0	0.0	5.4	23.5	0.0	0.0	0.0	93.8	0.9	0.7	0.0	34.7	0.6	53.8	0.0	0.5	2.9	2.9	51.1	0.7	3.4	3.2	126.0	2.9	11.4	1.8	0.0	6.1	4.3	1.0	0.1	0.1	0.1	2.2	5.8	0.1	13.5	4.3
CLINT1	"CLINT, ENTH, EPNR, KIAA0171"	ENSG00000113282	"Clathrin interactor 1"	Q14677	5	157785743-157859145	"Plasma proteins, Predicted intracellular proteins, Transporters"	Endocytosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in all"	4	"basophil: 749.5"	"Lineage enriched"	"Detected in all"	10	"granulocytes: 749.5"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043280, HPA056947"	Supported		Supported	Nucleoplasm,Vesicles		NA	NA		540000	"Cluster 46: Basophils - DNA binding"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 22: Epithelial cell types - Mixed function"	Vesicles	Nucleoplasm	"HPA043280: AB_10793944, HPA056947: AB_2683283"	"unprognostic (1.92e-2)"	"unprognostic (6.93e-2)"	"prognostic favorable (2.95e-4)"	"unprognostic (7.23e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.79e-1)"	"unprognostic (2.53e-1)"	"unprognostic (8.13e-2)"	"unprognostic (1.05e-1)"	"unprognostic (3.19e-2)"	"unprognostic (4.89e-3)"	"unprognostic (1.04e-1)"	"prognostic favorable (8.88e-5)"	"unprognostic (1.91e-1)"	"unprognostic (1.66e-1)"	"prognostic unfavorable (6.77e-4)"	"unprognostic (3.56e-1)"	28.6	34.4	10.3	42.8	11.9	101.1	31.4	10.6	14.8	36.4	17.7	53.9	68.3	26.4	54.2	72.0	37.8	61.4	34.2	11.8	12.7	70.4	89.5	36.3	49.4	11.8	11.9	26.9	49.3	113.2	17.8	47.1	11.4	29.5	53.4	16.0	50.8	42.4	53.1	39.7	55.7	31.9	11.0	31.0	69.2	20.3	12.4	50.7	56.0	41.0	73.8	64.5	38.8	11.4	65.6	91.7	64.3	59.8	86.3	71.0	91.6	89.7	87.5	83.4	115.9	128.7	100.0	121.3	100.3	82.6	112.0	95.8	87.1	100.4	120.7	57.9	70.4	80.6	80.4	65.2	85.5	112.9	105.6	52.5	75.6	94.7	105.6	53.6	80.0	69.6	70.6	66.1	69.9	56.7	88.7	60.5	67.8	63.6	93.9	78.8	96.9	103.0	84.8	115.4	56.6	62.1	64.5	111.7	87.4	81.2	76.4	78.0	83.7	74.6	56.3	69.5	89.4	76.1	77.9	154.4	61.0	126.2	67.5	749.5	46.5	179.7	43.6	49.2	75.2	47.5	41.4	43.7	62.7	46.2	35.9	38.8	17.6	58.6	53.4	48.5	66.2	53.1	10.3	11.9	10.6	14.8	11.8	12.7	11.8	11.9	11.4	11.0	12.4	11.4	68.6	60.9	132.9	25.1	76.0	57.1	83.7	69.4	80.2	21.6	74.4	44.2	103.9	105.8	137.8	68.0	8.4	45.1	73.8	73.5	95.9	93.4	4.1	116.5	82.4	52.8	54.5	54.9	31.9	64.0	71.9	71.8	119.3	141.9	84.7	40.2	21.0	86.8	30.5	11.8	29.0	78.9	38.7	42.9	87.8	5.6	47.2	73.0	35.6	28.1	94.1	25.5	73.2	39.2	31.4	53.7	62.6	28.6	158.3	92.5	50.3	94.5	148.5	19.0	39.5	67.2	61.9	44.2	40.2	156.3	78.3	68.3	65.5	82.0	99.0	271.5
CLIP1	"CLIP, CLIP-170, CLIP170, CYLN1, RSN"	ENSG00000130779	"CAP-Gly domain containing linker protein 1"	P30622	12	122271432-122422669	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	Transport		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"tongue: 169.1"	"Cell type enhanced"	"Detected in all"		"Syncytiotrophoblasts: 479.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004399, HPA026678"	Approved		Supported	"Microtubule ends,Cytosol"		NA	NA		16000	"Cluster 7: Monocytes - Unknown function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 20: HeLa - Mitochondria"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	"Microtubule ends, Cytosol"		"CAB004399: AB_671001, HPA026678: AB_1846954"	"unprognostic (1.18e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.72e-1)"	"unprognostic (4.91e-2)"	"unprognostic (6.28e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.20e-1)"	"unprognostic (4.73e-2)"	"unprognostic (2.51e-1)"	"unprognostic (7.62e-2)"	"unprognostic (2.31e-2)"	"unprognostic (8.97e-2)"	"unprognostic (3.26e-2)"	"unprognostic (5.50e-2)"	"unprognostic (2.63e-1)"	"unprognostic (3.37e-1)"	"unprognostic (2.52e-3)"	29.6	36.7	22.5	27.8	23.5	18.0	23.2	63.0	24.4	22.8	18.3	34.1	16.9	26.2	18.0	70.8	17.0	22.3	43.1	24.4	24.0	29.7	46.2	28.1	18.4	19.0	22.5	13.1	26.8	90.1	16.4	38.9	17.7	32.5	20.6	26.9	25.2	44.4	165.4	41.3	19.7	42.4	15.7	17.3	19.6	24.8	23.3	13.9	69.5	169.1	25.2	48.3	29.8	24.3	54.2	63.5	46.0	39.1	34.8	51.7	79.4	76.3	69.2	49.2	30.0	31.7	24.4	24.2	49.8	95.7	66.9	65.6	29.7	31.2	57.9	95.0	17.0	7.7	40.2	36.3	68.6	27.8	41.5	32.1	103.3	57.0	87.6	70.3	49.2	20.2	29.4	15.0	47.7	34.6	17.4	8.7	16.7	25.7	53.2	14.7	31.5	11.6	45.5	61.9	16.1	10.7	162.9	39.5	64.0	44.9	31.4	15.9	98.2	36.8	40.1	84.3	49.3	17.0	14.4	14.1	63.0	14.0	25.6	3.3	6.5	4.0	6.6	10.6	5.1	4.9	6.1	5.9	5.6	3.0	4.5	3.2	17.1	4.7	9.4	3.2	6.3	4.1	22.5	23.5	63.0	24.4	24.4	24.0	19.0	22.5	17.7	15.7	23.3	24.3	50.2	134.6	129.9	116.2	32.4	67.2	162.6	42.4	23.9	69.6	50.0	30.1	142.2	50.1	106.5	44.1	43.8	129.7	34.5	38.0	7.9	69.0	156.9	101.2	53.1	57.3	13.9	11.3	115.3	65.5	32.9	69.1	26.0	115.0	72.7	41.3	46.4	48.3	38.3	132.9	107.7	22.3	42.7	41.8	48.5	82.9	35.8	57.0	55.2	45.0	54.2	34.8	46.4	45.2	40.7	95.6	28.5	62.1	33.0	134.4	26.4	13.2	146.5	41.8	72.3	114.6	68.4	22.0	27.4	40.3	143.3	479.4	48.5	39.6	23.0	223.9
CLK1		ENSG00000013441	"CDC like kinase 1"	P49759	2	200853009-200864744	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB033141, HPA062405"	Approved		Supported	"Nucleoplasm,Nuclear membrane"		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 22: Epithelial cell types - Mixed function"	"Nucleoplasm, Nuclear membrane"		"CAB033141: AB_1121713, HPA062405: AB_2684753"	"unprognostic (9.79e-2)"	"unprognostic (2.05e-1)"	"unprognostic (2.15e-2)"	"unprognostic (1.63e-1)"	"unprognostic (9.19e-2)"	"unprognostic (4.50e-3)"	"unprognostic (1.52e-1)"	"unprognostic (2.77e-3)"	"unprognostic (1.78e-2)"	"unprognostic (2.09e-2)"	"unprognostic (1.09e-2)"	"unprognostic (5.63e-3)"	"unprognostic (2.03e-3)"	"unprognostic (9.66e-2)"	"unprognostic (2.30e-1)"	"unprognostic (1.18e-1)"	"prognostic favorable (2.28e-4)"	89.6	82.7	132.9	25.4	137.1	178.0	72.2	140.9	201.6	118.5	136.2	78.3	20.8	65.8	51.1	58.5	85.5	56.5	83.9	133.9	137.7	83.3	84.4	90.3	55.9	138.1	133.4	140.3	63.6	29.0	82.3	64.8	138.6	109.7	24.2	133.8	68.9	49.6	80.4	62.5	51.6	30.9	135.2	113.0	53.2	28.1	134.1	76.0	92.5	71.4	42.0	77.8	112.8	176.0	17.9	13.5	22.6	6.5	24.4	26.1	17.1	19.2	26.8	19.3	25.5	24.6	11.8	5.5	13.1	11.4	11.1	19.7	27.9	8.8	38.2	27.3	24.0	18.1	35.9	30.7	14.7	19.5	31.1	12.3	39.9	23.4	41.8	20.6	11.4	9.5	23.3	77.1	27.0	12.3	23.0	58.4	13.9	11.4	29.8	24.8	25.7	31.8	13.0	11.2	22.0	17.8	16.4	6.1	32.7	12.9	5.3	13.2	19.5	21.4	14.8	21.5	22.0	46.8	20.9	13.7	14.2	15.4	14.9	40.0	7.2	18.6	14.5	5.0	17.3	17.4	15.7	15.8	4.8	11.7	15.6	12.9	16.9	9.5	6.0	11.1	17.2	10.4	132.9	137.1	140.9	201.6	133.9	137.7	138.1	133.4	138.6	135.2	134.1	176.0	122.1	44.8	85.4	112.0	164.2	168.8	263.0	73.6	114.4	59.0	112.9	97.0	96.6	41.5	87.1	27.6	100.1	46.7	213.5	110.9	19.6	31.4	2.3	111.2	108.8	113.6	134.3	87.5	51.7	26.9	56.6	142.5	81.1	173.6	136.9	77.9	82.1	43.3	58.5	52.2	53.6	124.2	50.8	100.5	285.8	9.4	92.9	192.3	154.7	62.8	56.2	54.6	76.2	58.3	169.0	32.0	117.7	75.6	169.0	133.3	88.2	14.9	70.1	99.6	111.7	97.8	128.4	33.1	27.7	117.0	151.7	90.3	261.2	43.0	88.6	184.2
CLK2		ENSG00000176444	"CDC like kinase 2"	P49760	1	155262868-155278491	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055366, HPA059507"	Approved		Enhanced	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 43: Cardiomyocytes - Nuclear processes"	Nucleoplasm	"Nuclear bodies"	"HPA055366: AB_2682795, HPA059507: AB_2684044"	"unprognostic (2.00e-2)"	"unprognostic (1.35e-2)"	"prognostic unfavorable (3.77e-4)"	"unprognostic (2.84e-2)"	"unprognostic (3.16e-1)"	"unprognostic (1.75e-1)"	"prognostic unfavorable (2.82e-4)"	"unprognostic (2.38e-1)"	"unprognostic (2.36e-1)"	"unprognostic (1.36e-2)"	"unprognostic (7.66e-2)"	"unprognostic (3.84e-2)"	"prognostic unfavorable (2.95e-9)"	"unprognostic (1.70e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.11e-1)"	"prognostic favorable (5.43e-4)"	23.7	25.6	11.6	10.7	11.9	11.4	24.4	14.2	14.4	39.2	14.1	24.1	11.7	29.8	12.7	22.6	28.7	9.6	18.5	11.7	12.7	26.8	29.0	22.0	19.6	12.3	11.7	33.9	23.9	14.0	31.4	13.8	12.4	33.1	8.7	9.4	23.3	11.2	16.2	27.5	24.0	10.9	11.7	40.1	20.8	16.2	12.4	18.6	33.2	8.5	15.9	28.1	29.9	13.2	10.8	10.5	29.8	11.4	17.3	9.1	22.5	8.1	12.3	8.2	7.8	13.1	8.7	23.3	9.7	6.6	4.0	17.0	16.8	13.5	6.3	11.4	17.7	20.4	12.9	15.4	14.6	26.8	20.5	7.6	10.7	11.3	20.3	19.0	13.6	16.9	29.6	15.4	10.5	22.2	12.1	11.3	21.2	27.2	17.6	17.7	21.6	28.0	17.9	25.8	11.8	25.1	4.5	10.9	9.9	21.4	15.9	24.9	9.3	4.3	12.1	9.1	9.1	31.6	28.6	22.9	9.9	19.1	5.9	0.5	0.8	1.9	0.8	0.4	1.6	1.2	1.5	0.8	0.9	0.9	1.6	1.6	0.8	0.5	0.4	0.8	0.9	0.6	11.6	11.9	14.2	14.4	11.7	12.7	12.3	11.7	12.4	11.7	12.4	13.2	9.2	16.0	24.3	9.8	13.7	4.6	5.7	4.2	17.6	5.7	7.8	7.5	14.9	12.8	12.6	7.3	4.2	8.0	7.1	5.4	0.0	6.5	6.5	6.9	15.2	11.1	6.7	8.4	8.3	4.4	8.0	11.3	25.0	9.5	10.1	12.1	7.5	8.4	6.9	5.0	6.8	9.1	2.0	11.4	4.5	6.6	7.8	10.4	3.6	9.4	9.5	5.4	8.2	9.5	8.0	4.9	4.8	3.0	17.1	5.7	5.1	3.2	5.1	7.2	6.6	6.4	12.6	8.6	4.3	14.3	4.5	12.4	11.0	7.4	7.2	5.1
CLK3		ENSG00000179335	"CDC like kinase 3"	P49761	15	74598500-74645414	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046817	Approved		Supported	"Nucleoplasm,Intermediate filaments"		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm	"Intermediate filaments"	"HPA046817: AB_10964124"	"unprognostic (4.10e-2)"	"unprognostic (8.43e-2)"	"prognostic unfavorable (2.05e-6)"	"unprognostic (1.91e-3)"	"unprognostic (7.91e-2)"	"unprognostic (5.76e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.30e-2)"	"unprognostic (1.95e-1)"	"unprognostic (2.54e-1)"	"unprognostic (8.14e-3)"	"prognostic unfavorable (5.92e-4)"	"unprognostic (1.35e-2)"	"unprognostic (2.24e-1)"	"unprognostic (9.73e-2)"	"unprognostic (2.48e-1)"	"unprognostic (2.25e-2)"	35.9	28.7	30.3	26.5	31.8	112.4	34.6	36.4	35.9	36.7	32.8	36.6	28.9	32.3	25.9	38.6	31.3	32.7	28.3	30.2	31.2	30.0	29.4	34.0	37.7	32.8	31.6	38.4	33.9	35.3	32.3	31.6	32.5	31.9	21.8	33.1	36.1	29.7	50.7	41.7	33.7	26.2	29.5	41.7	35.1	44.4	32.2	55.8	32.3	52.1	30.3	37.8	33.8	35.4	56.7	35.1	45.5	25.6	57.2	43.4	35.8	37.7	59.2	52.7	64.3	47.9	36.4	51.2	27.2	33.9	73.5	39.0	85.4	36.3	34.3	73.2	46.9	63.0	52.0	33.6	90.7	17.2	46.6	54.8	71.0	69.4	57.4	64.0	58.6	51.0	31.3	36.2	31.1	39.9	50.9	57.3	29.1	55.7	24.6	40.7	21.8	33.7	41.1	40.3	25.5	29.9	30.2	33.0	34.3	34.7	31.4	33.8	27.3	31.0	23.7	19.7	50.2	59.0	51.8	42.2	27.2	82.4	40.1	74.2	65.5	90.0	68.9	74.1	68.2	71.0	73.6	71.9	61.3	78.8	74.4	70.9	115.9	90.7	97.7	69.5	87.7	85.9	30.3	31.8	36.4	35.9	30.2	31.2	32.8	31.6	32.5	29.5	32.2	35.4	29.8	6.4	38.4	14.0	34.1	44.9	44.9	41.6	26.2	35.5	22.8	15.9	18.6	28.6	35.1	12.9	56.3	27.7	41.8	46.7	31.3	34.2	83.6	25.8	19.9	28.6	29.3	31.5	6.6	24.2	46.2	24.5	37.8	41.5	21.5	27.4	21.4	13.4	27.5	28.6	7.9	34.7	42.7	23.3	34.4	19.8	27.7	28.4	28.4	6.5	29.5	18.0	29.9	7.1	9.6	30.8	52.0	20.3	26.6	38.9	35.5	18.6	23.4	42.6	13.1	20.4	35.8	45.4	21.4	21.0	41.9	58.6	40.1	20.4	28.1	63.5
CLN6	"FLJ20561, HsT18960, nclf"	ENSG00000128973	"CLN6 transmembrane ER protein"	Q9NWW5	15	68206992-68257211	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"			"Disease variant, Neurodegeneration, Neuronal ceroid lipofuscinosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Bipolar cells: 181.8;Hofbauer cells: 88.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA066046, HPA066759"	Approved		Approved	"Nucleoli,Endoplasmic reticulum,Vesicles"		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 20: HeLa - Mitochondria"	"Cluster 56: Bipolar cells - Visual perception"	"Endoplasmic reticulum"	"Nucleoli, Vesicles"	"HPA066046: AB_2685604, HPA066759: "	"unprognostic (1.01e-1)"	"unprognostic (1.54e-3)"	"unprognostic (7.01e-2)"	"unprognostic (3.58e-2)"	"unprognostic (2.71e-2)"	"unprognostic (3.08e-1)"	"unprognostic (2.24e-2)"	"unprognostic (5.07e-2)"	"unprognostic (2.40e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.85e-1)"	"prognostic favorable (4.87e-4)"	"unprognostic (1.22e-2)"	"unprognostic (2.22e-1)"	"unprognostic (2.49e-1)"	"unprognostic (6.78e-2)"	11.6	17.6	12.7	14.8	13.0	29.9	11.5	13.3	14.9	11.0	13.2	17.5	14.6	9.8	6.8	16.9	9.8	9.6	9.3	12.1	12.6	20.0	22.7	13.2	16.2	13.3	13.1	6.8	19.1	10.4	10.1	11.6	13.8	12.4	14.9	11.8	14.8	9.2	17.0	14.7	14.6	10.4	12.8	20.7	13.3	10.9	13.0	11.6	12.9	7.3	16.7	10.7	9.6	14.5	38.2	93.1	23.9	33.9	14.5	11.8	57.1	35.3	17.0	42.8	34.9	72.1	60.5	57.6	17.2	21.4	31.7	69.5	69.8	34.5	17.0	38.5	82.3	84.3	66.1	54.3	29.7	95.6	58.1	20.8	11.4	34.7	23.7	9.0	29.1	33.1	56.9	116.0	33.6	103.8	44.0	69.4	57.1	67.3	38.3	42.1	71.8	80.6	36.2	97.0	48.2	20.0	39.5	61.7	34.3	18.0	33.1	95.5	19.3	48.1	55.7	35.8	127.2	81.3	97.3	47.4	30.0	115.4	47.6	0.0	8.8	0.6	3.0	13.0	4.0	2.9	2.2	4.3	5.2	2.3	2.8	1.3	10.5	2.0	16.1	4.4	2.3	3.5	12.7	13.0	13.3	14.9	12.1	12.6	13.3	13.1	13.8	12.8	13.0	14.5	1.4	9.6	6.9	7.2	13.4	20.1	22.0	13.9	14.8	181.8	2.0	1.9	27.4	10.0	9.6	5.5	16.7	42.8	7.1	22.7	0.0	3.3	0.4	1.0	4.8	9.7	15.1	32.8	8.9	1.8	58.4	9.1	8.2	1.4	8.9	5.6	11.0	21.9	88.4	21.9	8.1	20.5	16.2	24.2	14.0	1.4	9.0	11.3	19.6	8.4	12.9	16.9	11.3	5.0	10.2	3.6	26.0	8.2	33.4	23.7	15.6	2.1	3.3	32.7	6.6	7.5	5.6	1.0	19.5	21.1	14.1	21.8	9.5	5.3	35.6	16.3
CLNS1A	"CLCI, ICln"	ENSG00000074201	"Chloride nucleotide-sensitive channel 1A"	P54105	11	77514936-77637794	"Predicted intracellular proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017840, HPA031707, HPA031708, HPA032045"	Approved		Supported	Nucleoplasm,Microtubules,Cytosol		No	No		17000	"Cluster 27: Non-specific - Gene expression"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 32: Non-specific - Translation"	Cytosol	"Nucleoplasm, Microtubules"	"CAB017840: , HPA031707: AB_2674002, HPA031708: AB_2674003, HPA032045: AB_2674123"	"unprognostic (1.30e-1)"	"unprognostic (3.26e-1)"	"unprognostic (5.16e-2)"	"unprognostic (1.30e-2)"	"unprognostic (5.12e-3)"	"unprognostic (5.09e-2)"	"unprognostic (9.63e-2)"	"unprognostic (5.56e-2)"	"unprognostic (2.06e-3)"	"unprognostic (5.56e-2)"	"unprognostic (1.33e-3)"	"unprognostic (1.52e-1)"	"prognostic unfavorable (5.07e-4)"	"unprognostic (2.05e-1)"	"unprognostic (9.19e-2)"	"unprognostic (5.99e-3)"	"unprognostic (1.17e-1)"	53.1	88.7	86.1	63.1	91.8	72.3	79.9	89.3	92.7	62.2	82.0	72.7	49.7	63.5	99.6	85.3	74.8	53.2	76.4	79.9	94.1	59.6	105.6	45.7	99.5	88.0	86.6	103.3	90.0	60.2	54.0	65.6	89.8	61.2	77.5	97.0	58.2	57.5	98.4	54.0	53.6	56.8	90.5	61.9	65.7	45.7	87.9	102.8	79.0	100.7	105.4	74.6	61.0	94.8	138.4	134.7	216.6	160.7	157.1	224.8	86.8	119.1	181.3	189.0	168.9	326.5	190.0	308.6	194.5	144.6	148.1	162.8	263.0	245.6	227.2	178.6	160.1	301.9	161.7	188.8	132.5	451.8	134.1	182.9	278.9	165.9	311.7	185.5	217.4	187.1	404.8	91.9	186.6	205.0	299.2	364.5	205.7	458.8	243.9	161.5	419.8	332.7	136.7	191.9	219.0	250.1	158.2	177.7	112.1	155.2	241.8	195.8	144.4	138.7	171.2	274.4	116.8	184.3	276.6	330.1	55.0	166.9	114.4	48.1	100.6	39.1	61.1	107.1	68.9	96.5	76.1	66.3	138.7	99.5	91.1	77.8	7.1	101.2	93.6	85.3	72.8	105.7	86.1	91.8	89.3	92.7	79.9	94.1	88.0	86.6	89.8	90.5	87.9	94.8	47.9	16.0	20.3	14.7	91.6	82.7	107.0	248.2	116.7	67.2	75.4	78.6	71.6	71.4	102.6	58.8	50.1	132.9	70.0	27.4	84.1	76.4	17.0	45.1	57.4	53.1	31.8	123.6	21.7	87.5	145.9	72.5	43.8	34.5	78.0	117.0	57.5	62.2	91.1	58.9	24.3	65.3	87.5	108.7	99.3	13.6	87.7	74.9	76.5	10.3	153.8	221.9	57.7	17.6	24.9	65.4	54.3	68.4	64.8	108.2	79.3	97.6	71.6	60.3	52.6	61.8	54.5	116.0	109.4	128.0	86.1	80.6	69.2	126.7	112.5	103.9
CLP1	"hClp1, HEAB"	ENSG00000172409	"Cleavage factor polyribonucleotide kinase subunit 1"	Q92989	11	57648188-57661865	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"mRNA processing, tRNA processing"	"Kinase, Transferase"	"Disease variant, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 32.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA057770	Supported		Supported	Nucleoplasm		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 29: Early spermatids - Spermatogenesis"	Nucleoplasm		"HPA057770: AB_2683523"	"unprognostic (1.33e-1)"	"unprognostic (7.90e-2)"	"unprognostic (1.11e-3)"	"unprognostic (2.13e-2)"	"unprognostic (4.90e-2)"	"unprognostic (3.58e-1)"	"unprognostic (1.93e-3)"	"unprognostic (1.16e-1)"	"unprognostic (3.01e-1)"	"unprognostic (1.66e-2)"	"unprognostic (8.82e-2)"	"unprognostic (7.58e-2)"	"unprognostic (8.31e-3)"	"unprognostic (3.71e-2)"	"unprognostic (1.75e-1)"	"unprognostic (8.78e-2)"	"unprognostic (3.07e-1)"	8.9	7.4	3.1	10.1	3.6	26.1	9.2	3.9	4.4	7.1	4.4	9.0	8.7	7.7	7.6	9.2	7.3	5.9	6.5	3.3	3.3	8.0	10.1	7.3	10.8	3.3	3.1	6.8	7.4	6.8	4.4	9.2	3.7	5.6	8.6	3.2	6.7	7.1	8.2	9.0	8.4	8.9	3.4	10.0	8.1	8.4	3.3	11.2	7.2	9.3	13.1	8.6	5.0	3.7	21.2	22.2	21.0	21.6	22.3	14.4	19.7	21.4	23.2	30.1	25.8	21.4	18.4	35.1	24.3	18.9	24.2	25.9	29.2	34.5	34.2	24.3	18.0	19.4	13.5	21.7	17.7	28.5	22.2	17.4	24.0	26.9	18.6	11.9	27.7	17.4	30.4	11.9	24.9	14.8	21.8	32.9	31.8	24.3	22.2	21.7	32.1	37.5	16.5	15.0	11.1	22.3	19.1	17.2	28.7	21.7	32.7	23.2	20.0	16.0	21.7	27.7	15.9	18.6	26.4	39.3	17.3	16.3	17.3	31.2	19.0	20.0	15.9	16.4	18.9	15.6	14.1	16.4	19.0	14.3	16.4	14.9	21.7	13.6	15.9	10.8	16.2	12.3	3.1	3.6	3.9	4.4	3.3	3.3	3.3	3.1	3.7	3.4	3.3	3.7	6.1	9.6	5.1	1.0	8.5	19.4	10.7	13.4	16.5	4.3	6.0	6.2	2.4	7.2	10.5	0.0	6.2	16.5	12.7	4.8	9.8	12.9	32.5	6.7	5.7	7.3	2.4	12.2	1.9	11.7	13.9	7.4	3.1	7.1	8.2	4.9	4.2	3.5	11.0	5.0	1.8	3.2	8.2	6.0	6.9	4.1	5.6	5.8	8.8	1.0	15.0	3.3	7.2	2.5	1.4	9.8	4.7	8.6	5.9	4.7	6.2	10.1	6.4	3.1	6.6	10.4	6.9	9.4	12.0	9.3	14.5	13.5	9.7	6.5	4.6	7.8
CLPP		ENSG00000125656	"Caseinolytic mitochondrial matrix peptidase proteolytic subunit"	Q16740	19	6361531-6370242	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"		"Hydrolase, Protease, Serine protease"	"Deafness, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 229.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA010649	Supported		Supported	Mitochondria		NA	NA		8500	"Cluster 20: T-cells - T-cell receptor"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 10: Non-specific - Unknown function"	Mitochondria		"HPA010649: AB_1078538"	"unprognostic (2.28e-1)"	"unprognostic (7.14e-2)"	"unprognostic (2.82e-1)"	"unprognostic (4.34e-2)"	"unprognostic (2.17e-2)"	"unprognostic (1.15e-2)"	"unprognostic (6.17e-3)"	"unprognostic (7.43e-2)"	"unprognostic (2.76e-1)"	"unprognostic (1.31e-1)"	"prognostic favorable (6.50e-4)"	"unprognostic (1.21e-1)"	"unprognostic (5.65e-2)"	"unprognostic (6.97e-2)"	"unprognostic (1.83e-1)"	"unprognostic (1.03e-1)"	"unprognostic (5.86e-3)"	48.6	65.8	52.0	41.5	51.5	42.9	45.1	52.2	63.8	39.1	58.0	46.6	47.4	41.1	17.8	56.1	40.1	20.8	78.0	50.9	52.7	60.5	90.7	39.7	47.7	52.8	52.4	38.5	53.6	36.6	44.5	25.4	49.5	41.0	22.9	15.6	48.3	31.2	146.8	47.5	43.6	25.1	51.8	45.6	55.6	45.2	54.5	45.2	36.1	59.3	35.6	44.6	37.9	53.9	146.7	98.2	61.2	113.9	38.7	54.8	62.4	76.9	59.5	112.2	102.5	87.2	48.9	124.1	122.8	61.3	61.1	83.1	63.5	109.1	38.5	133.8	189.3	95.8	82.2	122.9	106.6	90.7	129.8	73.4	74.4	78.9	82.9	69.7	113.9	188.5	97.5	174.5	72.3	192.8	153.1	104.5	93.2	100.6	207.8	108.6	73.2	206.2	81.2	79.4	99.3	95.9	48.9	123.8	133.0	36.7	67.3	130.6	76.9	70.5	69.7	180.7	156.0	235.4	225.3	137.2	103.5	132.9	117.3	29.4	82.6	47.8	112.0	79.6	133.5	119.5	159.4	139.6	102.4	131.5	138.4	137.4	62.1	126.5	55.5	155.5	207.2	162.6	52.0	51.5	52.2	63.8	50.9	52.7	52.8	52.4	49.5	51.8	54.5	53.9	39.6	22.4	35.2	8.1	45.9	44.9	59.5	90.8	38.1	31.0	47.6	57.9	45.8	55.8	46.2	44.1	12.5	72.2	43.7	56.0	144.8	88.8	105.5	27.6	43.1	51.6	35.3	54.9	5.4	96.6	113.6	42.4	36.2	35.0	26.0	63.1	61.8	89.6	81.3	21.9	7.5	50.9	54.9	38.9	35.0	229.8	42.6	38.7	55.2	4.7	70.6	46.6	46.4	4.5	9.5	101.9	67.7	43.2	82.4	89.5	110.9	189.0	44.5	24.6	13.1	30.0	79.9	67.7	48.1	56.5	37.1	57.7	65.3	95.1	65.4	65.4
CLPX		ENSG00000166855	"Caseinolytic mitochondrial matrix peptidase chaperone subunit X"	O76031	15	65148219-65185342	"Disease related genes, Predicted intracellular proteins"		Chaperone	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 242.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040262, HPA048199"	Approved		Supported	Nucleoplasm,Mitochondria,Cytosol	"Intracellular and membrane"	NA	NA		65000	"Cluster 49: Eosinophils - Unknown function"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 25: Spermatids - Spermatogenesis"	Mitochondria	"Nucleoplasm, Cytosol"	"HPA040262: AB_10793961, HPA048199: AB_2680312"	"unprognostic (2.78e-1)"	"unprognostic (6.58e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.69e-2)"	"unprognostic (2.00e-2)"	"unprognostic (3.06e-1)"	"unprognostic (1.18e-3)"	"unprognostic (2.64e-1)"	"unprognostic (3.99e-2)"	"unprognostic (1.29e-1)"	"unprognostic (2.53e-2)"	"unprognostic (6.99e-2)"	"prognostic favorable (1.93e-9)"	"unprognostic (1.76e-1)"	"unprognostic (2.64e-1)"	"unprognostic (5.95e-2)"	"unprognostic (3.50e-2)"	7.9	10.8	9.2	6.1	9.7	8.0	9.3	9.5	11.0	7.6	7.4	9.2	8.8	7.8	8.6	13.3	7.9	6.3	14.1	7.8	8.3	12.2	32.9	6.5	9.1	9.8	8.9	9.4	9.4	11.9	4.6	9.8	8.5	8.0	8.0	10.1	7.6	6.0	26.8	14.7	7.4	7.1	8.8	8.4	9.2	9.1	9.4	10.6	9.8	24.0	9.9	7.9	8.9	10.1	8.1	13.7	11.7	14.8	12.2	15.5	12.5	9.2	10.2	9.8	10.3	13.7	11.1	25.0	7.5	12.3	7.3	16.9	43.2	12.1	10.5	9.9	7.9	18.9	12.8	17.4	17.3	24.4	10.5	18.6	16.2	9.0	17.1	11.3	12.6	13.3	17.6	8.6	11.7	10.3	11.6	21.4	13.1	16.0	6.1	22.4	13.9	26.1	18.6	18.5	10.1	8.1	12.4	19.3	13.8	15.3	8.9	20.3	11.2	9.8	8.7	8.0	8.7	9.2	15.0	13.0	9.6	30.4	7.8	2.2	4.1	6.5	4.3	3.5	3.9	4.4	3.7	3.2	3.9	3.9	5.0	4.0	6.4	4.7	3.3	5.9	3.5	2.7	9.2	9.7	9.5	11.0	7.8	8.3	9.8	8.9	8.5	8.8	9.4	10.1	16.4	35.3	35.5	15.3	23.6	19.2	18.8	20.9	18.8	32.3	17.0	15.6	69.9	27.1	29.5	33.1	14.6	41.0	28.5	16.7	21.5	36.8	104.5	24.4	28.7	21.0	10.3	56.8	15.6	31.6	29.2	25.5	33.6	27.5	16.4	37.8	21.0	90.1	22.6	32.0	15.2	20.3	28.5	28.3	16.6	242.3	28.9	20.3	17.8	16.9	34.1	25.9	20.6	12.5	23.9	29.0	18.2	29.7	30.8	24.9	23.1	33.8	27.7	27.2	26.3	23.1	30.1	45.0	30.6	29.1	30.1	89.2	24.4	59.0	24.3	25.5
CLSPN		ENSG00000092853	Claspin	Q9HAW4	1	35720218-35769978	"Predicted intracellular proteins"	"Cell cycle, DNA damage, DNA repair"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 11.3;lymphoid tissue: 7.9;retina: 6.8;testis: 5.7"	"Cell type enhanced"	"Detected in many"		"Rod photoreceptor cells: 101.0;Spermatocytes: 281.1;Spermatogonia: 263.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Region enriched"	"Detected in some"	6	"basal ganglia: 7.8"	"Low region specificity"	"Detected in many"			"HPA026305, HPA026312"			Enhanced	"Nucleoplasm,Golgi apparatus"		Yes	Yes			"Cluster 17: Basophils - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	"Nucleoplasm, Golgi apparatus"		"HPA026305: AB_2671833, HPA026312: AB_2671837"	"unprognostic (4.75e-2)"	"unprognostic (1.01e-1)"	"unprognostic (9.64e-3)"	"unprognostic (3.54e-2)"	"unprognostic (6.82e-2)"	"unprognostic (1.62e-2)"	"unprognostic (1.18e-6)"	"unprognostic (3.99e-3)"	"unprognostic (2.08e-3)"	"unprognostic (1.63e-2)"	"unprognostic (8.71e-6)"	"unprognostic (3.23e-2)"	"unprognostic (7.61e-6)"	"prognostic favorable (4.92e-4)"	"unprognostic (5.12e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.29e-1)"	0.5	0.2	0.7	3.2	0.6	11.3	0.5	0.6	1.4	0.2	0.4	1.4	1.0	0.4	0.7	0.9	0.2	0.3	0.1	1.3	0.3	0.2	0.5	0.4	4.9	0.4	0.4	0.1	0.1	0.2	0.0	1.5	0.6	0.2	2.0	6.8	0.2	0.1	0.6	1.2	1.0	0.9	0.2	1.3	0.9	5.7	0.6	7.9	0.2	0.0	5.2	0.6	0.4	0.9	22.0	17.5	37.8	19.9	2.6	4.8	14.1	43.6	12.0	31.0	41.3	27.9	19.6	45.7	13.9	11.8	22.7	21.4	37.1	14.9	48.1	31.6	16.8	64.5	38.1	12.6	0.1	54.0	36.8	1.0	0.6	53.8	3.7	3.7	16.9	27.1	44.2	30.8	30.3	14.1	56.9	13.1	36.0	14.9	12.2	36.0	57.0	13.8	6.4	35.3	14.0	16.2	37.7	11.6	7.4	25.6	10.0	21.1	12.5	44.6	33.8	27.6	49.3	11.1	29.1	47.1	14.1	37.4	37.0	1.1	0.3	0.3	0.3	0.2	0.1	0.1	0.2	0.2	0.2	0.3	0.1	0.2	1.0	0.5	0.2	0.2	0.3	0.3	0.7	0.6	0.6	1.4	1.3	0.3	0.4	0.4	0.6	0.2	0.6	0.9	2.6	0.0	0.5	0.3	6.5	5.6	5.7	4.4	1.2	9.4	2.9	3.8	1.4	2.8	2.7	0.0	12.5	19.7	4.6	12.8	0.0	1.6	7.9	1.0	3.6	3.6	1.2	55.6	1.6	0.6	41.1	5.2	4.6	3.3	1.3	12.0	2.2	0.4	16.9	1.7	1.5	9.4	2.0	3.0	8.2	6.1	2.5	5.8	3.6	0.0	9.1	9.4	4.1	0.0	0.6	1.4	9.5	0.4	32.5	1.8	0.4	0.2	0.0	101.0	6.6	5.3	8.7	281.1	263.3	5.8	2.0	10.4	7.2	1.2	12.0	3.9
CLTB	Lcb	ENSG00000175416	"Clathrin light chain B"	P09497	5	176392501-176416539	"Plasma proteins, Predicted intracellular proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Pancreatic endocrine cells: 1839.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HBEC3-KT: 704.2;MCF7: 641.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003692, HPA036458"	Approved		Supported	"Vesicles,Plasma membrane,Cytosol"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	Vesicles	"Plasma membrane, Cytosol"	"CAB003692: AB_425372, HPA036458: AB_2675136"	"unprognostic (1.09e-1)"	"unprognostic (1.73e-1)"	"unprognostic (4.51e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.34e-2)"	"unprognostic (1.60e-1)"	"unprognostic (3.54e-3)"	"unprognostic (1.83e-2)"	"unprognostic (1.74e-2)"	"unprognostic (1.93e-1)"	"unprognostic (7.42e-3)"	"unprognostic (1.25e-1)"	"prognostic unfavorable (7.89e-5)"	"unprognostic (3.55e-1)"	"unprognostic (7.50e-2)"	"unprognostic (8.59e-2)"	"unprognostic (1.60e-2)"	102.9	133.6	125.8	50.1	125.1	40.6	82.9	117.8	176.7	180.4	125.3	133.9	92.3	85.9	23.2	473.7	82.4	34.1	320.8	130.8	129.6	90.4	82.5	96.5	32.9	136.9	122.8	107.2	68.2	70.1	112.8	57.5	138.1	88.1	45.5	37.9	128.6	44.4	322.5	453.1	99.7	41.2	114.5	68.7	123.3	38.9	127.9	43.7	69.5	120.8	58.5	106.2	300.8	133.6	229.1	107.6	29.9	128.2	65.7	49.2	244.4	286.3	110.9	178.6	127.0	140.3	103.9	49.6	165.0	130.2	71.8	213.3	51.4	704.2	69.7	341.7	95.3	33.6	163.3	87.7	102.9	53.2	85.6	52.6	241.5	98.1	114.7	36.0	84.7	39.2	65.2	123.4	100.3	641.9	84.5	81.1	24.4	189.5	158.2	91.3	52.9	165.2	95.6	92.0	127.7	43.7	136.6	148.0	103.6	34.7	61.4	101.9	185.2	64.0	96.3	117.5	165.1	96.5	73.3	68.5	51.4	112.7	74.4	6.6	19.7	61.7	13.6	15.8	7.0	5.9	11.9	13.2	20.0	10.1	10.0	10.0	36.6	15.0	20.8	16.1	24.9	8.1	125.8	125.1	117.8	176.7	130.8	129.6	136.9	122.8	138.1	114.5	127.9	133.6	113.7	57.7	19.8	8.5	54.7	634.0	238.7	155.7	180.4	310.5	105.5	124.6	208.5	72.9	93.4	82.8	64.6	141.1	82.3	794.5	135.0	324.7	9.5	58.4	72.7	102.2	151.8	43.6	25.4	453.1	586.9	136.7	193.2	85.2	48.2	40.8	70.3	96.3	111.9	336.5	24.1	348.5	114.0	80.7	226.1	13.7	122.1	88.4	220.5	6.5	85.7	136.1	107.1	8.0	15.2	1839.9	786.9	129.8	76.4	391.4	545.7	269.7	49.6	64.3	78.9	79.6	161.4	15.9	29.1	415.6	803.0	386.5	81.3	151.2	289.7	436.0
CLTC	"CLTCL2, Hc"	ENSG00000141367	"Clathrin heavy chain"	Q00610	17	59619689-59696956	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Autophagy, Cell cycle, Cell division, Mitosis"		"Cancer-related genes, Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010389, CAB011571, CAB017155, HPA059143"	Approved		Enhanced	"Vesicles,Endosomes,Lysosomes,Mitotic spindle,Cytosol"		Yes	No		14000000	"Cluster 27: Non-specific - Gene expression"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 10: Non-specific - Unknown function"	"Vesicles, Endosomes, Lysosomes"	"Mitotic spindle, Cytosol"	"CAB010389: AB_2083184, CAB011571: AB_2083165, CAB017155: , HPA059143: AB_2683924"	"unprognostic (1.56e-1)"	"prognostic unfavorable (7.35e-4)"	"prognostic favorable (7.65e-4)"	"unprognostic (1.03e-1)"	"unprognostic (2.62e-1)"	"unprognostic (5.23e-3)"	"prognostic unfavorable (5.54e-4)"	"unprognostic (1.11e-1)"	"unprognostic (6.43e-2)"	"unprognostic (1.09e-1)"	"unprognostic (3.34e-2)"	"unprognostic (2.69e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.18e-1)"	"unprognostic (9.22e-2)"	"unprognostic (1.10e-1)"	"prognostic unfavorable (2.02e-4)"	105.4	95.2	42.1	89.7	54.9	96.3	81.6	67.3	103.9	92.3	36.7	121.7	74.1	83.1	126.4	82.1	67.8	88.9	90.7	60.7	65.1	125.5	117.7	82.1	75.5	95.5	52.4	73.2	56.8	186.8	51.6	139.6	95.2	97.8	128.3	163.6	68.6	104.2	88.4	81.3	73.3	121.0	43.8	78.8	91.2	71.3	68.2	76.0	114.1	83.9	86.8	101.1	51.6	55.0	293.3	426.1	207.6	207.0	345.8	280.5	240.0	305.7	321.7	268.2	278.9	264.7	175.2	200.6	340.1	436.4	296.9	186.2	313.6	255.1	356.2	214.4	166.8	328.2	248.8	414.0	262.3	228.5	182.3	266.9	154.6	408.0	262.3	211.4	302.0	99.9	334.4	280.4	429.1	511.1	135.6	65.1	179.6	263.3	248.2	118.7	343.6	244.9	297.5	404.1	184.1	216.7	188.3	122.9	180.4	270.5	290.3	142.3	385.6	492.4	287.9	237.0	317.8	213.3	320.3	181.4	357.7	151.6	305.3	16.6	33.1	21.3	17.5	36.3	21.7	13.7	16.1	19.2	36.5	12.9	13.4	15.0	19.9	18.9	32.5	22.8	22.1	23.3	42.1	54.9	67.3	103.9	60.7	65.1	95.5	52.4	95.2	43.8	68.2	55.0	62.6	99.3	107.9	80.3	46.3	63.9	44.4	75.6	28.5	91.9	58.5	34.7	77.9	71.4	103.3	77.3	60.5	109.1	60.7	184.0	27.4	76.2	23.3	95.5	95.6	79.7	120.6	115.9	137.7	97.7	47.7	84.5	99.4	106.1	68.4	75.5	120.7	185.4	182.5	85.8	135.9	120.7	77.3	195.0	93.2	77.2	74.0	128.3	53.4	79.6	102.8	53.9	38.1	73.4	124.2	106.2	76.1	93.6	83.0	86.3	102.7	132.4	128.0	65.2	78.9	66.0	82.8	52.7	38.0	60.5	79.3	107.9	45.9	81.3	127.8	91.6
CLU	"APOJ, CLI, CLU1, CLU2, KUB1, SGP-2, SP-40, TRPM-2"	ENSG00000120885	Clusterin	P10909	8	27596917-27614700	"Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Apoptosis, Complement pathway, Immunity, Innate immunity"	Chaperone	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 10230.8;liver: 9779.1"	"Group enriched"	"Detected in all"	4	"Cholangiocytes: 2586.5;Collecting duct cells: 3525.7;Hepatocytes: 4230.2;Muller glia cells: 8522.6"	"Cancer enhanced"	"Detected in all"		"glioma: 1485.6"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	10	"basophil: 767.1"	"Lineage enriched"	"Detected in all"	33	"granulocytes: 767.1"	"Cell line enhanced"	"Detected in all"		"HeLa: 3644.3;SK-BR-3: 3500.4;T-47d: 2562.4;U-2 OS: 2225.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000572, CAB016253, HPA075983"	Enhanced		Supported	Cytosol	"Secreted to blood"	NA	NA	169000000000	29000000000	"Cluster 38: Basophils - Unknown function"	"Cluster 68: Epididymis - Unknown function"	"Cluster 20: HeLa - Mitochondria"	"Cluster 5: Muller glia cells - Visual perception"	Cytosol		"CAB016253: AB_673562, HPA000572: AB_1078539, HPA075983: "	"unprognostic (1.10e-2)"	"unprognostic (1.81e-2)"	"unprognostic (1.14e-3)"	"unprognostic (2.74e-2)"	"unprognostic (5.59e-2)"	"unprognostic (4.13e-2)"	"unprognostic (1.76e-2)"	"unprognostic (2.37e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.87e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.80e-2)"	"unprognostic (2.33e-2)"	"unprognostic (1.72e-1)"	"prognostic favorable (7.66e-5)"	"unprognostic (5.29e-2)"	1438.7	3809.7	6730.2	897.0	6536.5	53.2	1423.8	6992.3	8050.5	1389.4	6057.7	1407.9	323.9	1152.5	9148.8	768.6	3543.7	2863.5	617.7	6660.5	8149.9	1170.5	9779.1	827.8	2309.4	10230.8	8450.9	756.7	2246.3	1689.2	827.2	131.2	8001.8	986.4	276.1	3274.6	1453.0	5466.4	114.1	281.9	662.7	1439.9	8813.6	295.4	1081.6	2709.4	7385.0	388.1	2406.8	267.7	2343.1	1777.4	741.0	9752.3	13.0	1673.1	73.2	86.4	401.4	546.1	230.7	297.8	584.8	77.3	40.1	323.4	265.5	6.6	1159.9	267.1	926.6	561.2	318.4	48.1	50.3	1268.7	306.4	741.8	3644.3	403.7	348.8	19.2	1891.2	923.4	189.1	334.0	95.5	719.5	1028.1	10.6	10.1	842.2	27.5	288.4	5.7	56.5	603.3	505.3	197.6	6.5	276.1	236.3	763.0	1220.2	66.7	41.7	412.3	3500.4	18.1	349.1	2562.4	10.3	153.2	24.0	2225.3	131.8	101.9	108.1	419.0	16.1	1808.8	122.4	10.3	767.1	18.4	8.9	19.8	6.2	7.4	0.7	23.1	21.3	6.2	1.6	2.8	7.0	79.8	9.3	1.1	11.8	6.5	1073.6	6730.2	6536.5	6992.3	8050.5	6660.5	8149.9	10230.8	8450.9	8001.8	8813.6	7385.0	9752.3	255.3	32.1	91.8	720.5	16.1	81.3	944.6	134.1	118.9	74.3	475.3	480.4	86.1	2586.5	514.0	3525.7	77.2	116.3	15.2	23.6	41.1	488.3	311.3	196.9	31.1	442.0	9.5	92.4	73.4	620.7	22.7	614.8	226.8	185.6	803.0	31.4	1037.7	4230.2	12.6	30.3	81.0	30.9	28.5	180.5	88.9	789.3	114.3	244.6	206.3	69.3	25.1	8522.6	11.3	61.3	54.3	174.8	15.0	57.2	11.6	200.5	9.9	459.2	709.1	221.4	13.1	334.4	157.7	189.8	20.3	58.8	55.3	85.6	58.7	288.9	49.3	353.7
CLUAP1	"CFAP22, FAP22, FLJ13297, IFT38, KIAA0643"	ENSG00000103351	"Clusterin associated protein 1"	Q96AJ1	16	3500976-3539048	"Predicted intracellular proteins"	"Cilium biogenesis/degradation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 215.5;Endometrial ciliated cells: 119.2;Respiratory ciliated cells: 181.3;Rod photoreceptor cells: 116.8;Spermatocytes: 150.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036976, HPA044191"	Uncertain		Supported	Nucleoplasm,Vesicles		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 49: Ciliated cells - Cilium organization"	Nucleoplasm	Vesicles	"HPA036976: AB_10602209, HPA044191: AB_2678852"	"unprognostic (1.78e-1)"	"unprognostic (9.28e-3)"	"unprognostic (1.21e-1)"	"prognostic favorable (3.01e-4)"	"unprognostic (1.57e-1)"	"unprognostic (3.67e-1)"	"unprognostic (4.53e-2)"	"unprognostic (3.63e-2)"	"unprognostic (2.04e-1)"	"unprognostic (8.44e-2)"	"unprognostic (3.13e-1)"	"unprognostic (6.94e-3)"	"unprognostic (5.11e-3)"	"unprognostic (8.43e-2)"	"unprognostic (2.07e-1)"	"unprognostic (8.94e-3)"	"unprognostic (1.12e-2)"	9.7	10.7	11.1	5.9	12.6	3.9	14.7	14.2	14.5	21.1	17.8	11.0	4.2	24.2	16.0	11.1	31.8	10.6	11.4	11.2	11.6	18.6	7.7	12.1	7.4	10.4	12.7	24.6	12.2	31.4	11.7	10.6	9.1	17.0	9.8	28.9	9.1	19.9	9.9	5.6	5.4	20.2	9.8	6.6	9.0	40.0	12.0	12.4	22.0	11.6	6.0	10.8	7.8	10.4	15.7	18.3	20.8	28.9	31.4	32.0	11.0	19.9	26.7	31.4	23.7	5.1	31.3	8.2	16.5	33.7	18.8	16.8	14.7	23.6	26.2	6.6	13.1	6.9	10.3	10.5	36.7	12.5	7.2	21.1	25.4	29.1	29.4	33.1	17.2	16.4	21.7	1.0	23.6	19.3	12.0	14.0	21.5	6.6	11.1	25.9	14.3	15.7	45.7	4.9	23.2	19.8	11.6	8.8	14.3	16.0	18.7	28.8	11.5	20.8	13.8	17.1	15.0	12.8	10.9	2.2	8.0	7.3	15.3	6.2	3.6	1.2	6.2	4.2	12.1	7.3	17.8	10.8	6.8	6.1	26.9	18.4	1.3	9.0	2.4	6.6	10.3	5.8	11.1	12.6	14.2	14.5	11.2	11.6	10.4	12.7	9.1	9.8	12.0	10.4	14.5	22.4	20.5	17.0	3.5	5.6	12.3	29.1	14.8	41.0	13.4	13.8	11.7	11.5	30.6	14.7	108.4	20.7	7.5	3.3	43.0	24.3	215.5	119.2	49.7	12.4	17.5	4.6	23.6	8.0	7.7	21.9	6.6	26.4	5.1	28.1	13.6	9.2	10.4	38.7	26.3	7.9	18.3	4.9	5.7	63.4	31.4	5.0	3.6	5.6	18.1	40.7	12.3	11.1	10.3	8.6	5.3	33.1	3.5	9.4	5.3	34.6	181.3	116.8	6.6	24.7	22.7	150.0	58.4	6.4	4.1	9.3	12.1	36.7	9.0	6.5
CLUH	"CLU1, KIAA0664"	ENSG00000132361	"Clustered mitochondria homolog"	O75153	17	2689386-2712663	"Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Hepatocytes: 122.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"CACO-2: 266.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031505, HPA044346"	Uncertain		Supported	"Nuclear bodies,Vesicles"		NA	NA		5500	"Cluster 7: Monocytes - Unknown function"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Vesicles	"Nuclear bodies"	"HPA031505: AB_2673912, HPA044346: AB_10962153"	"unprognostic (3.48e-2)"	"unprognostic (3.97e-2)"	"unprognostic (9.02e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.15e-2)"	"unprognostic (2.85e-2)"	"unprognostic (2.84e-2)"	"unprognostic (1.84e-1)"	"unprognostic (2.69e-2)"	"unprognostic (5.64e-2)"	"unprognostic (5.11e-2)"	"prognostic favorable (1.92e-5)"	"unprognostic (4.99e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.92e-2)"	"unprognostic (6.26e-2)"	30.8	56.7	13.8	18.1	12.7	14.3	28.5	16.3	18.3	19.8	19.7	45.9	46.6	21.3	1.9	67.7	19.2	15.4	80.8	14.5	11.2	50.6	135.0	19.6	14.6	14.6	13.2	17.0	50.4	15.6	20.3	9.0	15.3	24.7	13.2	7.2	32.1	11.8	127.8	47.5	34.2	8.5	9.3	25.2	35.1	25.2	17.3	6.4	25.2	52.9	11.1	29.6	29.2	11.2	69.5	131.9	8.9	33.3	20.2	14.1	99.9	34.9	13.0	41.9	31.0	266.2	30.0	122.6	41.5	19.4	26.9	127.6	45.3	52.9	14.7	43.6	86.4	68.0	112.2	93.9	17.1	53.7	44.1	22.6	29.7	48.9	24.7	9.4	20.5	43.3	81.8	42.2	11.7	79.8	69.6	58.0	28.2	35.8	67.8	104.7	37.0	70.8	26.0	117.3	43.9	32.6	40.0	129.4	44.4	6.6	72.7	31.3	33.7	33.7	44.9	92.2	80.5	18.2	22.9	49.7	35.4	73.2	41.6	0.0	2.2	0.0	1.7	3.1	1.3	2.2	1.0	0.9	2.4	2.2	2.3	2.1	0.2	0.6	2.0	2.7	1.5	0.9	13.8	12.7	16.3	18.3	14.5	11.2	14.6	13.2	15.3	9.3	17.3	11.2	5.8	6.4	20.9	20.9	6.5	30.5	12.0	11.7	16.5	18.5	23.5	22.7	42.1	41.5	16.7	18.4	22.9	9.7	7.6	47.8	11.7	18.4	1.8	12.7	10.8	8.5	25.8	22.1	9.9	18.3	8.2	6.8	22.4	24.6	1.3	18.1	6.8	122.1	13.1	8.4	11.4	38.8	14.2	10.3	6.3	4.0	5.0	7.9	21.4	4.7	7.4	6.5	2.1	7.5	6.2	19.6	21.2	6.0	11.7	22.9	39.2	35.1	14.1	17.1	6.6	12.3	11.3	8.6	17.5	42.4	35.5	8.2	7.2	43.3	68.3	22.5
CMA1		ENSG00000092009	"Chymase 1"	P23946	14	24505353-24508265	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"breast: 18.5"	"Cell type enriched"	"Detected in some"	28	"granulocytes: 53.8"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB000363, HPA052634"	Enhanced		Supported	"Cytosol,Cytoplasmic bodies"	"Secreted to blood"	NA	NA	3000000		"Cluster 35: T-regs - Unknown function"	"Cluster 46: Fibroblasts - ECM organization"		"Cluster 60: Granulocytes - Receptor signaling"	"Cytoplasmic bodies"	Cytosol	"CAB000363: AB_2083616, HPA052634: AB_2681892"	"unprognostic (1.37e-1)"	"unprognostic (2.27e-3)"	"unprognostic (2.04e-1)"			"unprognostic (7.07e-3)"	"unprognostic (1.48e-2)"	"unprognostic (1.19e-1)"	"unprognostic (5.79e-2)"	"unprognostic (2.21e-1)"	"unprognostic (8.91e-3)"	"unprognostic (4.19e-3)"	"unprognostic (1.29e-4)"	"unprognostic (2.52e-3)"	"unprognostic (7.78e-2)"	"unprognostic (7.37e-2)"	"unprognostic (4.98e-3)"	9.0	0.0	0.2	3.7	0.1	0.2	18.5	0.0	0.2	4.6	0.3	8.7	0.6	3.1	4.3	10.2	0.9	7.3	1.6	0.1	0.2	0.2	0.5	1.5	1.8	0.5	0.3	0.1	1.6	0.6	0.2	0.1	0.3	1.0	8.3	0.0	4.7	1.3	0.9	9.0	5.8	2.2	0.3	0.2	1.5	0.9	0.2	3.0	0.4	3.0	2.4	11.1	0.9	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.2	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.5	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.1	0.0	0.2	0.1	0.2	0.5	0.3	0.3	0.3	0.2	0.2	0.0	0.0	1.9	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	53.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.1	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.4	0.0	0.7	0.0	0.1	0.0
CMAS		ENSG00000111726	"Cytidine monophosphate N-acetylneuraminic acid synthetase"	Q8NFW8	12	22046218-22065674	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Nucleotidyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Syncytiotrophoblasts: 532.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039905	Supported		Uncertain	Nucleoli,Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 45: Intestine - Brush border"	"Cluster 36: HEL - Hemostasis"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	Cytosol	Nucleoli	"HPA039905: AB_10795237"	"unprognostic (5.54e-2)"	"unprognostic (4.10e-2)"	"unprognostic (4.25e-1)"	"unprognostic (5.39e-3)"	"unprognostic (1.94e-2)"	"unprognostic (3.99e-2)"	"unprognostic (2.30e-2)"	"unprognostic (4.17e-3)"	"unprognostic (1.53e-2)"	"unprognostic (1.01e-1)"	"unprognostic (4.44e-1)"	"unprognostic (7.53e-2)"	"prognostic unfavorable (7.19e-4)"	"unprognostic (2.27e-1)"	"unprognostic (1.91e-2)"	"unprognostic (3.65e-1)"	"unprognostic (2.03e-1)"	19.7	57.0	46.6	23.2	51.1	47.9	32.9	40.3	57.8	29.2	35.8	77.8	66.2	23.5	69.0	71.6	21.8	24.4	42.6	51.2	57.3	28.9	72.2	18.1	24.2	43.8	57.1	25.3	42.5	79.4	30.0	34.0	57.1	36.7	71.9	24.8	32.6	26.7	44.0	29.3	63.6	27.7	41.8	20.1	29.7	69.9	49.0	19.8	23.8	41.1	26.1	24.2	40.3	44.0	63.4	50.2	59.5	29.3	47.0	57.5	88.8	43.2	46.2	45.0	47.2	114.1	72.0	56.5	41.3	37.3	83.9	50.9	35.8	60.1	60.7	75.0	45.4	169.1	38.8	57.2	43.2	45.4	85.5	38.5	56.4	58.1	86.3	61.5	61.3	58.7	108.8	28.1	80.9	83.8	52.0	105.3	147.5	69.4	69.5	36.2	63.6	53.7	56.0	67.8	23.8	42.0	34.2	59.6	51.9	120.2	82.3	62.0	45.5	51.2	42.4	46.2	81.1	19.4	26.0	74.9	83.6	34.6	54.3	22.7	27.3	32.1	20.4	29.7	26.1	19.0	26.9	27.0	31.5	18.2	24.2	24.6	2.8	36.9	27.4	20.2	33.8	25.5	46.6	51.1	40.3	57.8	51.2	57.3	43.8	57.1	57.1	41.8	49.0	44.0	21.5	12.8	17.5	12.4	19.2	29.2	76.8	117.2	14.8	38.3	31.9	21.2	72.7	41.5	102.3	23.9	4.2	175.2	17.8	158.1	76.3	56.6	12.4	17.2	19.6	36.8	41.6	153.9	38.7	83.6	141.3	41.7	21.9	20.0	22.8	28.2	34.2	63.6	66.2	35.3	29.2	118.2	93.6	29.8	22.0	19.0	25.4	32.5	44.4	8.4	45.3	33.4	26.8	16.6	25.5	79.7	156.2	27.8	16.7	112.3	133.6	87.0	82.5	20.4	19.7	30.4	42.3	112.2	97.1	52.3	44.5	532.6	24.6	63.0	90.8	190.6
CMC2	"C16orf61, DC13, MGC45036"	ENSG00000103121	"C-X9-C motif containing 2"	Q9NRP2	16	80966448-81020270	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 263.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA006871, CAB026396"	Approved		Supported	Mitochondria		NA	Yes			"Cluster 15: NK-cells - Transcription"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"CAB026396: , HPA006871: AB_1845581"	"unprognostic (2.43e-1)"	"unprognostic (3.63e-2)"	"unprognostic (1.70e-1)"	"unprognostic (3.52e-2)"	"unprognostic (1.50e-1)"	"unprognostic (3.01e-3)"	"unprognostic (2.48e-2)"	"unprognostic (6.36e-2)"	"unprognostic (9.20e-2)"	"unprognostic (3.84e-3)"	"unprognostic (3.48e-2)"	"unprognostic (4.57e-3)"	"prognostic favorable (2.64e-5)"	"unprognostic (1.08e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.68e-1)"	22.1	24.6	47.6	14.0	50.0	45.2	17.0	49.0	60.2	17.2	41.2	22.7	19.1	12.4	16.6	20.4	11.6	17.0	68.4	48.4	50.7	43.5	44.0	24.3	22.4	47.6	47.6	13.7	27.3	30.4	26.1	16.3	47.5	34.9	16.9	16.1	14.8	12.4	54.0	15.3	20.3	15.0	48.3	21.7	27.2	47.0	51.2	30.1	16.2	33.9	17.1	20.7	17.0	54.2	74.8	103.1	76.1	43.7	25.1	25.0	44.9	73.4	33.1	64.0	32.9	71.7	49.9	33.5	53.3	35.8	62.9	52.6	52.5	42.8	84.9	50.9	63.3	51.9	68.4	78.6	40.6	43.5	85.4	21.8	23.8	77.7	43.5	29.2	57.1	83.1	124.2	43.5	63.3	140.1	68.1	138.4	45.2	59.7	62.0	84.2	41.2	43.8	50.4	35.9	64.1	37.1	110.6	39.8	87.3	39.4	78.7	39.2	32.8	57.9	82.0	56.6	75.3	45.4	107.6	193.8	44.6	55.3	69.1	33.2	28.0	37.3	28.8	29.6	27.5	39.1	36.5	30.1	31.6	34.9	25.3	29.2	12.0	44.6	34.2	45.3	64.4	18.0	47.6	50.0	49.0	60.2	48.4	50.7	47.6	47.6	47.5	48.3	51.2	54.2	41.2	35.3	38.8	48.0	54.9	97.6	75.5	53.9	48.9	31.9	48.0	50.7	204.7	42.9	36.5	47.8	54.2	44.8	78.9	29.5	158.5	34.4	95.4	44.2	33.7	36.0	38.3	55.5	88.6	38.0	62.8	45.0	42.8	45.2	95.5	37.3	25.4	86.0	51.4	30.3	62.2	42.9	59.0	70.5	84.1	168.3	24.5	59.7	65.8	14.0	33.8	29.3	51.5	48.7	74.0	39.0	31.9	29.3	83.5	69.1	48.5	166.1	31.4	16.7	59.2	33.3	47.0	263.5	121.5	65.0	102.1	38.0	84.7	55.3	44.8	74.4
CMC4	"MTCP1, MTCP1NB, p8, P8MTCP1"	ENSG00000182712	"C-X9-C motif containing 4"	P56277	X	155061622-155071136	"Disease related genes, Predicted intracellular proteins"			Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-698: 113.5"	"Low region specificity"	"Detected in all"							HPA045866	Approved		Supported	Mitochondria		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 11: Alveolar cells - Smell perception"	Mitochondria		"HPA045866: AB_10964642"										"unprognostic (4.54e-3)"				"unprognostic (7.31e-2)"				14.5	11.5	15.1	9.3	17.0	8.2	12.2	17.5	17.7	13.3	14.8	17.0	12.5	12.4	16.7	11.2	11.8	10.6	52.6	14.3	16.6	15.1	23.3	8.4	15.0	18.0	16.5	15.2	32.7	12.7	11.8	8.2	17.0	12.8	7.0	7.3	18.9	12.6	31.8	10.8	10.1	7.9	16.6	9.7	11.8	8.0	16.0	6.8	14.1	24.5	8.4	12.4	11.6	17.9	63.7	16.6	9.5	19.8	24.5	23.6	14.2	12.0	17.5	16.7	28.3	10.2	11.1	40.7	30.8	13.9	48.0	20.5	11.8	16.2	10.8	45.5	30.7	6.2	10.2	13.5	25.2	12.8	9.3	22.8	24.9	16.7	20.2	15.9	13.3	25.3	6.2	15.2	17.1	23.5	17.2	23.8	5.6	25.3	42.5	14.6	20.9	28.5	18.3	4.2	19.0	14.4	16.0	17.9	20.3	10.9	13.3	8.1	17.3	26.1	16.9	16.4	16.8	62.9	67.3	113.5	23.7	29.5	16.9	2.0	12.9	22.2	14.8	7.5	15.3	19.1	11.9	14.3	19.6	18.6	3.5	9.5	1.2	23.1	3.0	3.8	15.1	8.3	15.1	17.0	17.5	17.7	14.3	16.6	18.0	16.5	17.0	16.6	16.0	17.9	3.9	0.0	4.1	3.3	1.9	0.8	1.1	2.6	2.8	1.0	3.4	5.0	0.0	1.5	6.0	0.0	0.0	1.0	3.9	0.9	3.9	1.5	0.1	2.4	2.7	1.8	1.8	7.8	1.6	0.5	1.0	2.8	2.0	1.4	5.1	2.5	2.2	4.7	1.0	0.0	2.3	0.8	0.0	1.3	2.6	1.4	3.7	1.9	1.8	1.9	1.0	1.4	2.1	2.5	4.6	0.7	1.2	1.9	4.0	0.5	2.0	4.1	4.8	0.3	0.0	1.2	2.0	1.4	0.8	4.2	2.4	1.2	2.9	1.2	1.6	0.7
CMIP		ENSG00000153815	"C-Maf inducing protein"	Q8IY22	16	81444808-81711762	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"basophil: 3.0;neutrophil: 2.4"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in all"		"HMC-1: 180.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054424, HPA066710"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA		83000	"Cluster 17: Basophils - Unknown function"	"Cluster 65: Brain - Ion transport"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 51: Myeloid cells - Hemostasis"	"Nucleoplasm, Cytosol"		"HPA054424: AB_2682484, HPA066710: AB_2685708"	"unprognostic (6.84e-2)"	"unprognostic (1.99e-1)"	"unprognostic (2.89e-2)"	"unprognostic (3.76e-1)"	"unprognostic (3.02e-2)"	"unprognostic (9.83e-3)"	"unprognostic (2.28e-2)"	"prognostic unfavorable (9.47e-7)"	"unprognostic (1.60e-1)"	"unprognostic (1.64e-1)"	"unprognostic (3.10e-2)"	"unprognostic (6.04e-2)"	"unprognostic (4.12e-2)"	"unprognostic (3.42e-2)"	"unprognostic (9.08e-2)"	"prognostic unfavorable (1.05e-4)"	"unprognostic (1.59e-1)"	27.9	22.1	45.2	32.1	46.2	26.1	23.2	12.6	50.1	30.7	0.0	26.5	40.4	18.8	6.1	35.8	23.0	25.6	13.0	48.8	51.1	20.7	13.5	26.3	22.2	29.9	34.8	22.8	19.3	7.8	55.6	28.4	46.1	17.7	23.1	10.8	20.1	15.0	4.7	34.3	49.9	22.5	19.9	22.5	33.3	17.2	52.7	20.1	15.6	5.3	18.2	31.2	32.8	34.4	40.9	133.5	25.9	13.3	13.4	10.7	52.7	28.9	19.5	17.9	7.9	45.5	81.5	18.2	24.2	24.1	23.9	40.6	16.9	96.2	17.0	11.6	12.3	87.4	24.4	80.0	13.3	27.2	180.8	10.5	39.9	33.1	42.5	27.1	50.0	31.7	77.6	15.3	11.1	40.9	47.7	33.8	20.6	39.5	28.1	84.9	8.5	17.8	22.6	39.7	135.0	27.1	67.4	24.7	8.6	25.9	19.1	35.7	34.6	28.5	30.6	27.7	26.8	19.2	15.9	78.0	33.6	31.5	11.7	3.0	0.7	1.0	0.4	0.5	0.2	0.0	0.1	0.1	0.2	0.3	0.0	0.2	2.4	0.2	0.1	0.2	0.1	0.4	45.2	46.2	12.6	50.1	48.8	51.1	29.9	34.8	46.1	19.9	52.7	34.4	81.5	12.8	16.6	59.4	31.7	107.3	66.6	43.8	48.9	15.6	21.5	21.1	7.8	47.1	27.7	14.7	0.0	46.5	71.2	58.0	7.9	22.3	70.0	51.1	9.2	77.3	72.1	17.9	119.1	23.8	106.6	25.7	35.7	45.4	45.1	29.8	70.6	31.6	32.0	25.2	95.2	128.0	40.7	69.4	115.9	100.8	47.5	95.5	12.4	100.2	68.2	8.0	37.0	69.9	52.9	65.5	30.9	143.3	35.2	69.6	47.3	49.6	57.6	3.4	13.1	8.0	24.1	5.0	15.4	51.8	143.5	88.7	42.8	6.4	39.1	111.7
CMPK1	"CMPK, UMP-CMPK"	ENSG00000162368	"Cytidine/uridine monophosphate kinase 1"	P30085	1	47333797-47378839	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Pyrimidine biosynthesis"	"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA053730, HPA058604"	Approved		Supported	Nucleoplasm	"Intracellular and membrane"	NA	NA		1400000	"Cluster 34: Basophils - Unknown function"	"Cluster 37: Intestine - Unknown function"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 27: Mucus-secreting cells - Mucin production"	Nucleoplasm		"HPA053730: AB_2682244, HPA058604: AB_2683773"	"unprognostic (2.16e-2)"	"unprognostic (1.16e-1)"	"unprognostic (9.39e-3)"	"unprognostic (1.18e-1)"	"unprognostic (1.09e-3)"	"unprognostic (1.50e-2)"	"unprognostic (1.59e-2)"	"unprognostic (9.88e-2)"	"unprognostic (5.80e-2)"	"unprognostic (2.90e-2)"	"unprognostic (1.71e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.28e-2)"	"unprognostic (2.58e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.02e-3)"	"unprognostic (7.36e-2)"	88.2	45.2	47.0	64.2	50.6	53.1	102.2	51.9	73.1	74.8	49.8	134.1	163.9	44.2	42.2	108.2	35.2	88.5	63.3	44.5	56.9	78.7	217.2	63.8	71.8	52.6	52.4	38.1	90.9	57.7	32.9	48.8	54.2	95.0	141.0	29.2	157.4	50.7	71.1	65.1	152.5	56.0	52.6	58.0	109.0	17.5	52.3	61.7	92.0	73.9	87.9	80.6	63.8	55.3	124.9	68.4	86.6	77.9	154.6	179.3	122.5	216.4	129.8	128.6	129.9	61.3	84.1	183.4	108.6	147.9	120.5	82.7	64.8	112.1	174.9	279.5	52.7	142.9	91.0	106.7	100.8	206.2	100.2	101.2	132.7	107.5	119.7	121.1	135.2	67.4	137.3	143.5	169.8	45.9	168.2	96.8	55.1	162.9	93.6	103.4	149.8	138.5	126.5	134.9	78.3	41.3	155.0	177.7	128.9	113.7	44.2	121.0	127.7	159.6	92.7	154.5	180.8	103.8	154.3	124.4	126.3	125.3	111.7	43.3	12.8	24.2	16.1	14.0	20.7	13.6	18.0	20.0	13.5	14.3	16.9	16.4	5.3	19.4	17.0	11.4	20.9	15.6	47.0	50.6	51.9	73.1	44.5	56.9	52.6	52.4	54.2	52.6	52.3	55.3	101.7	70.5	54.4	14.4	148.1	175.5	125.3	88.9	102.4	34.2	167.8	67.7	48.9	147.3	87.0	75.4	16.7	82.3	117.9	280.0	174.1	186.8	1.6	56.2	63.3	83.8	117.5	126.0	28.5	181.6	133.0	91.2	125.4	98.2	94.0	39.7	88.5	235.9	75.9	43.7	30.2	326.6	91.6	122.0	265.0	5.0	59.4	107.1	254.3	31.9	100.5	66.9	124.6	20.6	25.0	146.8	168.6	70.0	119.8	203.5	234.6	254.5	112.3	31.1	85.5	75.9	95.8	14.0	29.8	167.0	195.1	118.3	160.5	49.0	240.2	250.8
CMPK2	"NDK, TYKi, UMP-CMPK2"	ENSG00000134326	"Cytidine/uridine monophosphate kinase 2"	Q5EBM0	2	6840570-6866635	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Pyrimidine biosynthesis"	"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 10.6;salivary gland: 8.5"	"Cell type enriched"	"Detected in many"	4	"Erythroid cells: 86.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"eosinophil: 4.9"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+ SV40 Large T+: 12.8;BJ hTERT+ SV40 Large T+ RasG12V: 11.9;HEL: 20.3;MOLT-4: 11.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041430	Approved		Supported	Nucleoplasm,Mitochondria		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 36: HEL - Hemostasis"	"Cluster 6: Erythroid cells - Oxygen transport"	Mitochondria	Nucleoplasm	"HPA041430: AB_10796674"	"unprognostic (2.37e-1)"	"unprognostic (6.07e-2)"	"unprognostic (5.71e-2)"	"prognostic unfavorable (4.71e-4)"	"unprognostic (1.82e-1)"	"unprognostic (5.08e-2)"	"unprognostic (3.80e-2)"	"unprognostic (8.93e-2)"	"unprognostic (6.63e-2)"	"unprognostic (4.54e-3)"	"unprognostic (7.39e-3)"	"unprognostic (1.43e-1)"	"unprognostic (1.09e-3)"	"unprognostic (1.28e-1)"	"unprognostic (1.77e-2)"	"unprognostic (7.69e-2)"	"unprognostic (4.32e-2)"	2.1	1.4	1.7	1.4	2.8	6.4	1.8	0.7	1.8	1.4	1.7	1.3	1.6	0.9	0.3	0.7	0.7	0.8	2.1	1.2	1.9	1.1	0.9	2.8	1.3	6.0	3.0	0.4	1.3	0.9	1.1	1.6	3.2	0.7	0.6	0.1	8.5	0.7	1.1	0.4	2.2	0.9	10.6	3.5	2.9	2.0	2.0	1.9	1.2	1.6	0.7	0.9	0.6	1.5	0.3	0.0	0.1	0.0	0.0	0.0	2.5	0.0	0.2	12.8	11.9	0.0	1.4	3.1	0.8	0.0	3.3	0.2	0.0	0.0	0.0	0.3	0.2	20.3	0.0	0.0	0.0	0.6	1.8	0.1	0.0	0.2	0.0	0.0	0.0	2.0	5.8	0.1	0.0	0.1	11.8	3.6	0.3	0.0	1.0	3.6	0.0	0.0	0.0	0.4	0.4	0.5	0.2	0.0	1.9	0.0	0.0	1.3	0.0	0.0	0.2	0.0	0.0	3.3	0.4	0.0	0.0	3.6	0.8	3.1	1.6	4.9	0.3	3.9	0.2	1.1	0.2	0.2	1.1	0.1	0.2	0.3	1.1	0.5	2.0	0.1	0.4	0.7	1.7	2.8	0.7	1.8	1.2	1.9	6.0	3.0	3.2	10.6	2.0	1.5	20.8	3.2	7.5	0.0	1.9	0.4	0.9	0.5	0.0	1.5	1.7	1.3	1.6	0.0	0.5	1.8	0.0	3.0	3.4	10.0	1.9	2.6	4.0	5.4	0.8	11.7	7.2	86.3	1.9	6.6	2.9	2.7	11.2	1.0	2.5	1.7	7.1	1.4	19.5	0.0	2.5	2.5	0.0	12.3	2.8	1.6	1.5	11.3	0.0	9.4	11.9	5.3	3.1	1.5	0.2	6.2	8.4	5.7	2.1	1.0	8.4	0.7	4.1	0.2	0.0	2.2	2.0	2.7	4.4	0.7	0.4	0.8	4.5	1.6	1.6	2.0
CNDP2	"CN2, CPGL, FLJ10830, HsT2298, PEPA"	ENSG00000133313	"Carnosine dipeptidase 2"	Q96KP4	18	74495816-74523454	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Carboxypeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Glandular and luminal cells: 334.7;Proximal enterocytes: 629.1;Proximal tubular cells: 487.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Karpas-707: 458.7;RPMI-8226: 616.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB026196, HPA036898, HPA036899"	Enhanced		Enhanced	Nucleoplasm,Cytosol		NA	NA		2600000	"Cluster 27: Non-specific - Gene expression"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Nucleoplasm, Cytosol"		"CAB026196: , HPA036898: AB_2675370, HPA036899: AB_2675371"	"unprognostic (2.81e-2)"	"unprognostic (9.96e-2)"	"unprognostic (3.28e-1)"	"unprognostic (1.19e-3)"	"unprognostic (2.57e-2)"	"unprognostic (5.06e-2)"	"unprognostic (2.84e-2)"	"unprognostic (5.35e-2)"	"unprognostic (1.49e-1)"	"unprognostic (9.31e-2)"	"unprognostic (1.56e-3)"	"unprognostic (1.15e-1)"	"prognostic favorable (3.50e-6)"	"unprognostic (2.37e-3)"	"unprognostic (4.65e-3)"	"unprognostic (1.51e-1)"	"unprognostic (1.34e-1)"	54.8	40.7	125.3	75.0	147.0	25.1	60.4	139.4	156.9	136.8	113.0	83.6	190.1	44.2	122.8	78.4	140.8	94.4	63.7	123.7	133.2	327.3	261.1	82.3	86.3	143.1	137.4	34.4	100.7	58.5	48.0	75.4	144.7	122.5	79.5	42.1	57.4	101.7	26.6	47.0	255.0	37.9	140.4	137.0	103.5	20.9	143.9	52.5	159.1	22.4	82.2	94.5	47.4	157.6	64.6	85.0	60.5	57.4	72.2	42.5	252.3	66.0	61.7	88.3	87.4	49.6	67.1	80.3	81.4	72.1	69.0	95.0	92.7	124.9	62.7	121.3	36.7	80.2	42.1	79.6	104.6	158.7	119.3	64.5	93.9	76.4	136.6	50.1	78.3	94.6	86.3	458.7	59.1	71.6	84.9	75.6	91.0	42.4	50.3	91.3	69.4	616.6	346.1	264.1	65.3	34.2	51.6	360.2	91.6	143.0	151.5	64.0	82.5	93.9	79.5	21.2	45.2	85.5	380.6	108.1	63.6	113.8	80.2	37.1	115.4	49.0	77.6	166.3	84.4	102.4	61.6	72.2	185.1	110.5	65.5	72.4	15.9	124.6	174.1	161.3	94.5	135.7	125.3	147.0	139.4	156.9	123.7	133.2	143.1	137.4	144.7	140.4	143.9	157.6	39.2	73.7	62.7	16.6	55.7	9.2	40.3	48.6	12.5	33.6	76.5	36.4	26.9	77.2	56.8	119.5	16.7	157.9	47.8	99.0	187.9	168.1	3.3	187.7	49.7	49.6	65.3	23.3	8.8	154.7	130.9	23.5	63.7	334.7	12.0	34.0	40.0	119.8	216.3	43.7	10.8	82.9	75.3	122.9	24.9	4.1	18.6	79.0	17.8	13.1	90.8	86.6	55.6	15.6	51.7	108.9	103.5	16.6	44.4	65.2	629.1	487.6	73.3	31.6	13.1	15.2	22.3	8.3	7.2	27.1	9.7	109.0	38.2	32.8	99.8	53.8
CNEP1R1	"C16orf69, FLJ38101, NEP1-R1, TMEM188"	ENSG00000205423	"CTD nuclear envelope phosphatase 1 regulatory subunit 1"	Q8N9A8	16	50024410-50037088	"Predicted membrane proteins"	"Lipid metabolism"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042815, HPA077906"	Uncertain		Supported	Cytosol		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 14: REH - Unknown function"	"Cluster 41: Macrophages - Immune response"	Cytosol		"HPA042815: AB_10794765, HPA077906: AB_2686868"	"unprognostic (4.11e-2)"	"unprognostic (2.45e-1)"	"unprognostic (2.79e-2)"	"unprognostic (1.18e-2)"	"unprognostic (2.00e-2)"	"unprognostic (6.33e-2)"	"unprognostic (1.43e-3)"	"unprognostic (1.80e-1)"	"unprognostic (3.42e-2)"	"unprognostic (8.53e-2)"	"unprognostic (3.86e-2)"	"unprognostic (1.21e-2)"	"unprognostic (3.37e-3)"	"unprognostic (5.09e-2)"	"unprognostic (2.09e-1)"	"unprognostic (3.81e-2)"	"unprognostic (6.78e-2)"	9.6	8.4	6.4	14.4	7.3	23.8	7.9	8.0	7.1	8.4	5.9	9.4	8.9	9.2	12.9	12.0	7.6	10.7	9.0	6.7	6.6	7.1	10.6	9.5	14.3	6.6	5.9	9.8	7.1	8.6	8.4	15.6	6.6	8.3	13.4	9.6	8.3	8.2	10.1	11.6	9.2	11.0	6.7	13.4	9.8	18.0	6.7	9.5	5.4	7.3	15.3	10.0	9.0	7.9	11.2	10.2	12.4	13.9	23.5	23.1	17.4	22.5	17.1	21.4	12.5	11.0	15.3	12.4	16.3	18.7	14.6	17.0	10.0	10.9	27.1	9.1	11.7	6.1	6.7	17.8	16.7	8.1	18.1	17.0	18.2	13.9	10.8	16.6	14.8	15.5	7.6	6.9	27.4	3.4	16.0	21.0	9.0	4.9	13.8	19.3	16.4	12.8	15.9	7.4	9.3	11.1	21.3	8.5	9.0	10.7	7.4	10.0	19.3	20.7	15.9	19.7	8.0	11.4	11.3	14.5	12.0	8.1	17.4	16.6	21.0	16.3	16.0	29.2	15.1	9.4	12.4	11.9	17.5	8.7	12.4	14.5	51.0	12.7	36.4	6.9	13.4	14.5	6.4	7.3	8.0	7.1	6.7	6.6	6.6	5.9	6.6	6.7	6.7	7.9	8.2	3.2	7.8	8.8	10.1	10.6	3.4	6.5	5.7	5.8	5.9	3.9	11.4	8.6	6.9	7.3	4.2	17.7	10.6	7.7	3.9	5.2	4.6	5.9	8.6	8.6	4.8	7.8	13.7	5.4	25.1	9.7	8.6	6.8	12.7	5.6	10.0	6.9	14.8	6.7	13.2	3.7	2.0	20.0	20.8	3.9	5.9	18.2	16.0	6.5	15.4	12.2	12.3	8.5	12.5	5.8	6.4	7.9	7.7	4.2	5.0	5.5	4.5	10.0	6.6	9.4	8.4	26.4	18.8	5.5	9.8	14.4	13.3	5.7	5.6	3.8
CNGB1	"CNCG2, CNCG3L, CNGB1B, GAR1, GARP, RCNC2, RCNCb, RP45"	ENSG00000070729	"Cyclic nucleotide gated channel subunit beta 1"	Q14028	16	57882340-57971128	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Olfaction, Sensory transduction, Transport, Vision"	"Ion channel, Ligand-gated ion channel"	"Disease variant, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	17	"retina: 600.2"	"Group enriched"	"Detected in some"	8	"Cone photoreceptor cells: 331.5;Rod photoreceptor cells: 1111.1"	"Cancer enriched"	"Detected in single"	6	"head and neck cancer: 2.6"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 1.5;RPMI-8226: 1.8;SCLC-21H: 5.0;SiHa: 2.9;SK-BR-3: 1.4"	"Region enhanced"	"Detected in some"		"hypothalamus: 4.5"					"HPA039159, HPA060355"			Approved	Vesicles,Cytosol		No	NA				"Cluster 77: Retina - Visual perception"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 46: Photoreceptor cells - Phototransduction"	Cytosol	Vesicles	"HPA039159: AB_10795579, HPA060355: "	"unprognostic (5.52e-3)"	"unprognostic (4.51e-3)"	"unprognostic (1.06e-1)"	"unprognostic (2.73e-3)"	"unprognostic (6.20e-2)"	"unprognostic (1.76e-1)"	"unprognostic (8.56e-4)"	"unprognostic (3.08e-1)"	"unprognostic (9.84e-2)"	"unprognostic (2.83e-1)"	"unprognostic (2.14e-4)"	"unprognostic (5.42e-2)"	"unprognostic (1.01e-3)"	"unprognostic (5.20e-2)"	"unprognostic (1.88e-1)"	"unprognostic (4.57e-2)"	"unprognostic (9.07e-2)"	0.1	2.5	15.5	1.1	13.2	0.2	0.0	0.0	20.4	0.0	0.0	0.6	0.1	0.0	0.2	0.0	0.1	0.3	0.0	24.5	24.8	0.0	0.1	0.1	0.2	2.8	3.2	0.0	0.5	0.0	0.2	0.4	4.4	0.0	0.4	600.2	0.0	0.1	0.0	0.2	0.6	0.1	2.4	0.1	0.0	0.4	36.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.6	0.0	0.0	0.0	0.0	1.1	0.1	0.0	0.0	0.0	0.0	0.1	0.1	1.5	0.0	0.5	0.0	0.0	1.3	0.0	0.1	0.0	0.3	0.9	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.1	0.1	0.0	0.1	0.0	0.0	1.8	0.0	0.6	5.0	0.0	2.9	1.4	0.0	0.0	0.0	0.0	0.4	0.1	0.2	0.2	0.0	0.1	0.3	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	15.5	13.2	0.0	20.4	24.5	24.8	2.8	3.2	4.4	2.4	36.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.5	0.4	0.0	61.6	0.3	0.0	1.1	0.0	0.1	0.0	331.5	6.9	0.0	0.0	0.0	0.4	1.6	0.9	0.1	4.2	0.0	0.0	3.2	0.4	0.9	0.2	0.0	1.3	0.0	0.0	0.0	0.0	0.4	25.2	0.4	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.0	0.0	0.0	89.5	0.0	1.0	0.1	0.2	1.1	0.0	0.0	0.2	0.0	0.3	0.0	1111.1	0.0	0.1	0.2	0.5	0.7	0.0	0.0	1.4	0.1	0.1	0.0	0.2
CNKSR3	"FLJ31349, MAGI1"	ENSG00000153721	"CNKSR family member 3"	Q6P9H4	6	154387515-154510685	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Endometrial ciliated cells: 109.6;Glandular and luminal cells: 155.4;Oligodendrocytes: 142.3;Skeletal myocytes: 211.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"CACO-2: 21.1"									"CAB037133, HPA049651"	Approved		Supported	Mitochondria,Cytosol		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 22: Non-specific - Unknown function"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 44: Endometrium - Transcription"	Cytosol	Mitochondria	"CAB037133: AB_477217, HPA049651: AB_2680841"	"unprognostic (3.07e-1)"	"unprognostic (3.25e-2)"	"unprognostic (1.57e-1)"	"unprognostic (2.34e-1)"	"unprognostic (5.62e-2)"	"unprognostic (1.25e-2)"	"unprognostic (1.37e-1)"	"unprognostic (5.78e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.40e-1)"	"unprognostic (4.67e-3)"	"unprognostic (4.90e-2)"	"prognostic favorable (6.00e-4)"	"unprognostic (4.23e-2)"	"unprognostic (8.79e-2)"	"unprognostic (1.57e-3)"	"unprognostic (3.38e-1)"	3.7	1.1	6.4	1.9	7.6	0.9	3.2	4.8	5.5	4.0	15.0	6.5	5.8	7.6	1.9	13.3	4.1	4.9	6.4	3.6	4.2	7.7	9.7	3.7	1.4	7.8	8.3	6.1	18.9	0.7	2.3	5.6	7.2	3.3	3.4	2.6	5.7	4.8	1.1	3.9	6.4	6.6	5.3	4.5	4.0	4.4	12.7	2.1	2.1	1.4	2.5	4.3	5.3	13.3	0.4	4.9	3.3	6.8	5.8	4.1	0.4	6.0	3.5	10.2	8.3	21.1	0.5	0.1	6.4	6.6	3.4	2.1	9.5	0.7	5.3	0.0	6.3	15.4	1.0	12.1	2.5	0.0	2.7	6.1	3.2	3.9	4.1	1.6	3.2	1.3	2.2	0.1	2.8	1.2	0.1	0.2	2.3	4.1	6.2	4.6	5.9	8.0	11.7	3.1	2.0	12.6	2.8	1.5	1.3	1.4	0.0	1.3	3.7	0.9	3.0	7.7	4.0	0.1	0.0	0.2	0.2	0.3	4.4	0.6	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.1	0.7	0.1	0.1	0.2	0.0	0.0	6.4	7.6	4.8	5.5	3.6	4.2	7.8	8.3	7.2	5.3	12.7	13.3	24.7	12.8	38.4	9.4	0.9	26.5	15.4	7.8	12.5	2.0	11.0	8.3	33.8	30.0	20.2	25.8	0.0	9.2	0.4	31.0	9.8	20.3	42.5	109.6	14.7	66.8	43.2	15.6	23.8	12.3	1.1	12.9	9.2	155.4	5.7	10.8	61.8	65.9	1.7	0.0	1.5	18.4	10.2	7.1	22.5	23.6	5.9	3.5	32.0	24.4	0.8	22.8	0.0	54.8	142.3	7.3	18.5	10.5	0.5	18.7	43.6	31.8	11.7	2.5	0.0	211.8	8.0	1.2	6.3	29.4	23.9	21.5	2.6	14.8	14.1	10.0
CNNM4	"ACDP4, KIAA1592"	ENSG00000158158	"Cyclin and CBS domain divalent metal cation transport mediator 4"	Q6P4Q7	2	96760902-96811874	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Biomineralization, Ion transport, Sensory transduction, Transport, Vision"		"Amelogenesis imperfecta, Cone-rod dystrophy, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"retina: 38.8"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 112.6;Distal enterocytes: 103.4;Rod photoreceptor cells: 51.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in all"		"SK-BR-3: 45.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017732	Enhanced		Uncertain	"Plasma membrane,Actin filaments"		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Actin filaments"	"Plasma membrane"	"HPA017732: AB_1847395"	"unprognostic (1.98e-3)"	"unprognostic (8.95e-3)"	"unprognostic (1.11e-1)"	"prognostic unfavorable (9.14e-4)"	"unprognostic (3.42e-2)"	"unprognostic (5.28e-2)"	"unprognostic (1.54e-3)"	"unprognostic (3.36e-2)"	"unprognostic (2.17e-1)"	"prognostic unfavorable (8.75e-4)"	"unprognostic (4.75e-3)"	"unprognostic (3.72e-1)"	"unprognostic (8.14e-2)"	"unprognostic (3.13e-1)"	"unprognostic (3.44e-2)"	"unprognostic (1.15e-2)"	"unprognostic (1.06e-1)"	2.8	3.6	5.0	6.1	6.8	4.9	7.0	11.2	5.4	5.8	2.8	32.4	6.2	4.0	4.7	7.1	10.4	4.4	12.5	4.9	4.4	6.8	4.4	8.0	4.6	4.1	4.5	5.1	7.4	6.3	9.1	5.8	4.2	5.7	34.3	38.8	6.8	5.1	24.8	7.2	11.3	4.7	3.5	5.3	12.8	7.9	4.5	3.5	9.5	13.1	4.9	5.5	6.4	5.7	11.1	7.2	5.7	10.5	5.8	3.9	15.6	4.8	6.8	6.9	9.3	13.2	11.8	8.1	13.5	5.0	9.5	14.1	14.9	8.1	6.3	16.3	11.7	6.4	4.8	7.2	8.1	3.1	6.2	3.8	10.0	11.0	6.6	4.6	3.8	8.0	3.3	22.3	3.6	15.7	6.6	4.5	7.5	20.5	9.8	9.7	2.6	9.3	6.9	8.6	26.7	8.0	9.1	45.7	6.8	15.9	22.3	5.3	3.4	4.0	8.9	8.8	5.4	7.7	6.6	4.0	5.9	6.1	7.2	1.2	0.4	0.1	0.8	0.4	0.2	0.9	0.4	0.4	0.6	0.5	0.2	0.5	0.2	0.2	0.7	0.4	0.2	0.3	5.0	6.8	11.2	5.4	4.9	4.4	4.1	4.5	4.2	3.5	4.5	5.7	4.5	38.5	7.7	12.4	6.4	5.7	4.9	4.0	4.6	43.1	14.7	11.2	14.1	4.3	11.6	7.3	112.6	5.4	6.1	103.4	0.0	3.2	4.9	14.3	4.4	4.0	10.1	0.8	9.8	4.2	1.7	3.2	12.2	16.1	1.3	5.9	2.2	3.3	3.3	33.7	8.3	26.4	6.1	5.4	4.8	1.6	0.9	5.9	0.0	8.4	2.3	8.3	2.1	11.1	14.6	5.2	21.3	1.2	4.5	4.1	22.3	1.2	10.6	51.5	0.0	4.6	4.3	4.6	2.5	7.3	4.1	6.7	5.4	6.7	26.5	6.1
CNOT1	"AD-005, CDC39, KIAA1007, NOT1, NOT1H"	ENSG00000125107	"CCR4-NOT transcription complex subunit 1"	A5YKK6	16	58519951-58629885	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"RNA-mediated gene silencing, Transcription, Transcription regulation, Translation regulation"	"Developmental protein, Repressor"	"Autism spectrum disorder, Disease variant, Holoprosencephaly, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046577, HPA049664"	Approved		Supported	Cytosol		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 24: Non-specific - Transcription regulation"	Cytosol		"HPA046577: AB_2679706, HPA049664: AB_2680844"	"unprognostic (1.30e-2)"	"unprognostic (6.86e-2)"	"unprognostic (9.25e-3)"	"unprognostic (1.66e-1)"	"unprognostic (2.39e-2)"	"unprognostic (7.11e-2)"	"unprognostic (3.58e-2)"	"unprognostic (2.19e-1)"	"unprognostic (6.43e-2)"	"unprognostic (6.99e-2)"	"unprognostic (1.83e-2)"	"unprognostic (6.63e-2)"	"unprognostic (1.33e-3)"	"unprognostic (2.31e-1)"	"unprognostic (1.12e-1)"	"unprognostic (5.53e-2)"	"unprognostic (1.52e-1)"	29.8	35.2	8.4	46.9	10.7	45.6	36.3	17.4	11.5	34.7	33.5	60.1	55.0	31.8	27.6	73.1	38.9	28.3	26.3	8.6	9.4	39.8	36.0	33.3	58.1	11.5	10.5	39.2	41.1	59.7	21.2	35.1	11.3	31.2	57.3	32.4	38.8	30.6	52.4	43.1	52.3	33.7	8.9	42.9	42.1	108.2	10.6	76.4	42.4	44.1	69.5	49.1	38.6	15.2	128.8	148.2	110.0	88.1	52.1	66.2	127.6	99.6	85.8	111.4	82.0	167.6	75.3	194.0	47.4	75.8	65.5	122.3	177.9	101.0	149.2	72.5	98.8	150.4	121.8	193.7	70.8	235.8	162.4	64.0	67.5	129.7	151.5	66.9	87.7	107.2	181.0	55.3	76.4	52.0	182.6	61.2	114.4	84.9	127.2	229.0	189.5	122.7	62.4	180.0	90.9	58.6	336.0	113.5	56.0	100.5	67.9	121.3	100.9	81.3	80.0	62.2	88.7	124.7	138.2	390.3	85.5	99.4	76.9	18.3	12.1	13.4	13.8	15.6	18.2	14.7	12.9	14.0	14.6	13.8	12.1	12.6	18.6	15.4	22.5	7.3	15.4	11.5	8.4	10.7	17.4	11.5	8.6	9.4	11.5	10.5	11.3	8.9	10.6	15.2	44.4	16.0	42.9	33.0	57.8	47.4	32.6	42.9	25.6	28.2	33.9	27.9	23.8	37.1	45.2	23.9	29.2	33.7	86.3	64.5	9.8	29.8	107.7	57.6	48.0	31.3	36.1	45.0	31.7	47.0	29.9	30.7	35.2	78.2	32.2	45.9	23.9	42.3	35.7	40.4	35.6	54.2	24.4	51.5	39.5	38.6	24.8	46.4	19.6	42.2	50.0	20.0	34.0	42.3	54.9	42.5	34.9	32.4	59.8	43.6	60.1	22.9	51.6	24.3	32.9	38.7	30.4	136.6	64.3	56.0	47.0	37.9	52.1	27.9	64.5	61.2
CNOT6L	"Ccr4b, DKFZp434K098"	ENSG00000138767	"CCR4-NOT transcription complex subunit 6 like"	Q96LI5	4	77713387-77819615	"Enzymes, Predicted intracellular proteins"	"mRNA processing, RNA-mediated gene silencing, Transcription, Transcription regulation, Translation regulation"	"Exonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"dendritic cells: 366.6;T-cells: 240.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042688	Uncertain		Supported	Cytosol		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 24: Non-specific - Transcription regulation"	Cytosol		"HPA042688: AB_10794384"	"unprognostic (3.91e-1)"	"unprognostic (1.95e-2)"	"unprognostic (7.91e-3)"	"unprognostic (4.10e-2)"	"unprognostic (2.56e-1)"	"unprognostic (3.72e-2)"	"unprognostic (8.79e-2)"	"unprognostic (1.09e-1)"	"unprognostic (5.06e-2)"	"unprognostic (6.86e-2)"	"unprognostic (3.55e-2)"	"unprognostic (1.50e-1)"	"prognostic favorable (1.69e-4)"	"unprognostic (4.51e-2)"	"unprognostic (7.95e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.91e-3)"	11.8	9.5	6.9	22.4	7.7	29.5	13.4	14.4	8.1	12.4	6.1	12.9	13.1	11.1	9.8	16.6	11.6	14.0	6.1	6.4	10.1	13.2	19.6	11.6	36.1	7.5	7.7	13.6	19.9	17.8	6.0	22.5	7.1	11.7	15.5	12.9	12.6	12.2	7.2	13.7	13.6	14.5	8.2	23.6	14.7	11.2	11.5	49.5	14.4	8.6	38.5	15.7	8.4	9.0	17.0	9.6	12.5	9.1	14.7	13.6	13.1	13.1	17.8	11.9	15.9	3.5	18.3	26.5	15.4	18.9	8.6	10.9	17.5	18.7	14.9	28.4	10.0	25.4	9.8	10.3	9.1	24.0	22.9	8.1	22.7	12.1	24.3	10.9	38.2	21.2	22.7	38.0	13.9	9.0	52.3	14.0	6.2	13.4	3.2	12.4	38.4	21.5	12.5	13.5	16.0	7.2	23.3	20.1	7.9	15.4	6.8	13.7	35.6	10.9	11.5	19.9	7.3	48.1	21.0	35.1	12.3	11.9	8.6	21.4	4.4	10.6	9.4	7.0	9.9	5.5	7.2	7.7	4.4	7.2	6.7	8.2	6.9	8.2	10.3	6.4	6.4	4.1	6.9	7.7	14.4	8.1	6.4	10.1	7.5	7.7	7.1	8.2	11.5	9.0	93.0	22.4	21.0	34.3	101.1	57.9	13.3	15.9	59.2	39.5	30.5	20.8	16.7	31.5	24.0	36.8	39.6	31.1	366.6	16.9	60.7	8.2	4.7	30.1	24.6	54.0	26.3	31.5	74.8	12.4	8.6	25.1	26.5	46.2	38.0	22.1	45.3	32.6	17.1	32.0	70.7	29.8	14.2	41.0	50.1	3.7	18.6	50.0	24.9	105.9	39.2	19.3	128.8	68.9	60.7	11.0	16.1	12.8	178.5	33.9	28.4	26.3	17.0	43.5	32.9	26.6	29.2	49.4	39.9	44.7	66.1	24.4	240.0	37.9	24.1	26.7
CNOT7	CAF1	ENSG00000198791	"CCR4-NOT transcription complex subunit 7"	Q9UIV1	8	17224966-17246878	"Enzymes, Predicted intracellular proteins"	"RNA-mediated gene silencing, Transcription, Transcription regulation, Translation regulation"	"Exonuclease, Hydrolase, Nuclease, Repressor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA069543			Supported	"Nuclear bodies"		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 46: Photoreceptor cells - Phototransduction"	"Nuclear bodies"		"HPA069543: AB_2686148"	"unprognostic (1.55e-1)"	"unprognostic (4.49e-2)"	"prognostic favorable (4.99e-4)"	"unprognostic (4.61e-2)"	"unprognostic (8.45e-2)"	"unprognostic (3.10e-2)"	"unprognostic (1.44e-3)"	"unprognostic (4.54e-2)"	"unprognostic (6.83e-2)"	"unprognostic (4.09e-3)"	"unprognostic (2.51e-1)"	"unprognostic (1.74e-1)"	"unprognostic (3.49e-2)"	"unprognostic (1.72e-1)"	"unprognostic (4.51e-1)"	"unprognostic (2.24e-1)"	"unprognostic (2.52e-1)"	31.9	32.7	21.6	39.8	25.4	51.0	42.1	35.0	30.7	28.0	20.5	43.0	38.3	39.5	45.1	43.7	36.3	35.7	38.2	24.2	26.8	50.8	48.8	33.0	52.2	19.7	23.3	42.1	36.0	62.6	26.2	43.1	20.3	32.7	43.8	78.0	38.5	29.5	78.9	27.8	38.4	36.6	21.5	39.0	32.0	52.0	24.4	80.2	60.0	72.2	64.9	45.0	20.4	24.0	77.3	93.6	138.1	103.1	57.0	59.6	95.3	97.6	82.5	110.4	97.5	110.2	60.4	106.1	103.9	85.9	177.5	60.3	147.0	122.9	160.2	44.1	71.0	139.9	68.6	119.9	73.2	95.3	82.8	57.3	99.7	94.3	100.3	102.0	133.7	138.2	119.1	114.9	112.9	60.2	234.7	88.2	152.6	144.4	72.0	126.1	102.7	79.9	95.6	167.6	173.6	115.9	68.6	60.3	114.4	112.9	72.5	79.2	90.8	82.0	116.5	92.4	110.8	59.3	208.2	189.5	76.9	88.7	82.8	138.0	93.9	109.5	80.2	116.6	95.3	133.3	109.7	95.7	113.5	135.3	136.6	110.0	84.5	106.5	105.1	101.3	134.8	130.1	21.6	25.4	35.0	30.7	24.2	26.8	19.7	23.3	20.3	21.5	24.4	24.0	46.9	32.1	40.3	15.0	100.4	90.9	65.2	82.5	100.7	114.9	77.1	64.0	58.2	61.5	48.2	62.5	93.8	88.4	74.5	31.0	97.8	79.0	86.5	50.7	37.1	56.8	94.1	60.5	39.1	72.5	115.1	45.9	40.2	53.5	44.9	72.2	69.3	67.2	69.7	25.2	32.1	69.6	81.4	73.5	58.7	33.9	40.7	59.4	26.6	28.1	83.7	68.5	76.2	23.1	34.8	79.3	58.1	40.6	84.0	93.8	52.6	113.9	56.6	219.2	78.9	51.6	56.2	95.9	100.7	90.7	86.0	85.5	77.6	55.3	70.5	84.3
CNP		ENSG00000173786	"2',3'-cyclic nucleotide 3' phosphodiesterase"	P09543	17	41966763-41977740	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	7	"brain: 1395.7"	"Cell type enriched"	"Detected in all"	4	"Oligodendrocytes: 555.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"plasmacytoid DC: 149.4"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Region enriched"	"Detected in all"	4	"white matter: 1789.4"	"Low region specificity"	"Detected in all"			"CAB002672, HPA023266, HPA023278, HPA023280, HPA023338"	Enhanced	Supported	Supported	"Plasma membrane"		NA	NA		46000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Plasma membrane"		"CAB002672: , HPA023266: AB_1847058, HPA023278: AB_1847060, HPA023280: AB_1847061, HPA023338: AB_1847062"	"unprognostic (2.17e-1)"	"unprognostic (4.48e-2)"	"unprognostic (3.85e-3)"	"unprognostic (1.41e-1)"	"unprognostic (3.09e-1)"	"unprognostic (9.71e-2)"	"unprognostic (2.58e-3)"	"unprognostic (2.08e-1)"	"unprognostic (2.23e-1)"	"unprognostic (1.62e-1)"	"unprognostic (5.76e-3)"	"unprognostic (1.87e-1)"	"unprognostic (2.99e-3)"	"unprognostic (1.60e-1)"	"unprognostic (1.55e-1)"	"unprognostic (8.86e-2)"	"unprognostic (1.10e-3)"	34.4	33.5	493.1	31.2	889.6	23.4	29.6	715.5	681.5	41.7	193.5	56.9	21.4	33.5	36.7	63.4	28.9	32.6	25.3	505.1	577.0	58.1	44.8	21.7	35.7	839.4	761.8	32.2	27.8	23.7	28.1	23.5	793.8	41.5	18.4	20.5	47.2	37.2	26.3	34.3	31.4	30.3	644.6	25.8	29.8	16.7	791.1	31.2	24.7	22.2	35.1	37.3	40.5	1395.7	56.9	92.4	85.8	106.6	71.7	67.2	38.5	70.1	102.5	171.1	191.5	73.0	49.6	59.0	54.3	88.5	88.1	95.0	58.3	44.6	59.0	59.7	76.8	56.7	59.3	127.7	76.9	56.7	49.6	111.0	31.5	94.1	22.8	61.9	79.4	58.0	42.4	46.4	60.6	35.1	148.5	50.9	20.7	29.8	66.5	91.4	126.7	58.7	45.7	55.7	50.9	69.5	85.7	127.0	155.5	41.6	57.2	82.3	80.2	66.6	73.7	92.3	81.9	53.4	66.6	47.5	66.1	42.9	266.4	18.7	38.2	23.4	21.5	40.7	17.2	28.0	18.8	17.4	33.8	19.2	16.6	19.6	7.7	23.5	34.0	149.4	22.4	33.0	493.1	889.6	715.5	681.5	505.1	577.0	839.4	761.8	793.8	644.6	791.1	1395.7	26.6	16.0	12.7	14.4	19.0	16.7	17.5	10.4	16.5	22.0	29.5	24.0	13.0	20.0	19.5	35.0	6.2	30.6	53.2	39.9	125.2	46.3	1.3	19.1	27.1	24.8	19.7	25.2	6.8	41.7	50.2	27.7	17.9	21.3	9.5	20.2	20.3	32.3	39.8	50.5	9.5	16.2	18.3	17.0	14.5	4.0	38.8	20.3	55.2	14.0	25.0	84.7	23.7	45.2	555.6	35.5	19.0	36.1	27.8	21.7	19.0	80.5	12.8	25.4	32.9	36.6	29.4	5.1	16.0	30.9	18.9	13.0	16.9	33.3	20.6	17.4
CNR1	"CANN6, CB-R, CB1, CB1A, CB1K5, CNR"	ENSG00000118432	"Cannabinoid receptor 1"	P21554	6	88139864-88166359	"Disease related genes, FDA approved drug targets, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets, Obesity"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 23.0;brain: 25.1"	"Cell type enhanced"	"Detected in some"		"Excitatory neurons: 44.6;Inhibitory neurons: 200.3;Sertoli cells: 98.6"	"Cancer enriched"	"Detected in many"	13	"glioma: 12.5"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"ASC diff: 81.4;HSkMC: 53.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042256, HPA069945"	Enhanced	Supported	Supported	"Plasma membrane,Actin filaments"		NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Plasma membrane"	"Actin filaments"	"HPA042256: AB_2677917, HPA069945: "	"unprognostic (1.28e-1)"	"unprognostic (7.04e-2)"	"unprognostic (4.61e-2)"	"unprognostic (4.08e-3)"	"unprognostic (1.21e-1)"	"unprognostic (1.07e-3)"	"unprognostic (1.37e-1)"	"unprognostic (2.07e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.16e-2)"	"unprognostic (2.74e-2)"	"unprognostic (2.68e-1)"	"unprognostic (1.70e-1)"	"unprognostic (5.59e-3)"	"unprognostic (2.68e-3)"	"unprognostic (5.88e-2)"	"unprognostic (7.00e-2)"	23.0	5.4	10.4	3.5	25.1	0.7	16.9	7.5	22.8	5.7	0.0	12.3	1.1	6.9	2.6	2.4	11.2	2.0	1.0	19.5	11.8	0.9	0.1	4.0	4.4	9.9	1.1	3.8	1.5	0.5	20.7	3.1	0.5	2.9	2.9	1.5	2.6	2.1	2.4	3.8	10.5	3.6	0.0	1.7	4.3	1.2	18.0	1.3	5.1	1.2	6.6	4.1	5.1	3.0	0.0	0.1	3.8	0.0	81.4	9.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	6.0	0.0	0.0	0.0	0.2	1.9	2.9	0.0	5.3	0.0	0.0	53.8	0.0	0.0	0.1	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.4	0.5	0.0	6.8	0.0	1.7	0.1	0.0	0.0	0.0	0.3	0.0	1.4	4.9	0.0	0.0	0.1	0.0	0.0	1.6	7.1	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	10.4	25.1	7.5	22.8	19.5	11.8	9.9	1.1	0.5	0.0	18.0	3.0	3.4	0.0	10.4	3.6	7.1	0.6	0.5	0.0	0.0	1.7	0.1	0.4	0.9	1.5	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.2	0.0	0.4	3.8	0.0	0.0	44.6	0.0	0.0	0.9	1.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	200.3	0.0	0.0	0.3	0.8	0.0	1.5	0.2	0.0	5.6	0.0	0.0	0.0	9.0	3.2	0.0	0.1	0.4	4.2	0.0	0.0	0.0	0.0	0.2	98.6	6.4	12.4	0.0	0.5	0.2	0.1	0.1	0.5	0.0	0.0	0.8
CNST	"C1orf71, FLJ32001, PPP1R64"	ENSG00000162852	"Consortin, connexin sorting protein"	Q6PJW8	1	246566444-246668595	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007225, HPA007226"	Approved		Supported	Vesicles		NA	NA		480000	"Cluster 37: B-cells - Transcription"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 44: Endometrium - Transcription"	Vesicles		"HPA007225: AB_1848869, HPA007226: AB_2667782"	"unprognostic (1.55e-2)"	"unprognostic (9.75e-2)"	"unprognostic (3.33e-2)"	"unprognostic (9.76e-2)"	"unprognostic (2.78e-1)"	"unprognostic (4.28e-2)"	"unprognostic (3.72e-2)"	"unprognostic (7.28e-3)"	"unprognostic (1.01e-1)"	"unprognostic (1.93e-1)"	"unprognostic (3.52e-2)"	"unprognostic (3.47e-2)"	"unprognostic (2.73e-3)"	"unprognostic (6.17e-2)"	"unprognostic (2.63e-1)"	"unprognostic (8.77e-3)"	"unprognostic (2.26e-1)"	13.1	19.2	8.8	10.5	9.7	23.5	10.9	14.4	16.1	9.0	17.1	13.7	10.2	9.0	8.1	16.7	8.8	8.7	8.9	10.3	11.1	8.6	23.5	9.9	16.7	6.9	7.8	10.5	10.2	11.3	7.5	9.3	8.4	8.1	12.0	16.8	7.2	7.3	31.8	10.1	13.2	10.1	5.6	10.4	8.4	12.9	7.6	14.3	13.9	39.0	13.4	11.3	8.8	9.5	8.4	11.0	7.9	7.0	12.8	14.7	16.0	26.9	26.5	26.7	20.2	10.5	10.9	24.6	11.7	26.9	7.9	8.6	12.3	9.2	36.2	13.8	4.2	28.9	10.4	8.0	18.4	14.5	53.5	14.0	8.7	25.9	27.4	13.2	8.4	13.0	37.3	10.5	15.3	6.1	15.9	6.7	25.9	11.7	9.5	15.5	14.2	20.1	10.1	24.4	18.0	21.6	11.5	6.7	34.0	9.2	12.3	12.6	12.0	33.0	7.9	13.8	18.5	31.8	43.8	25.0	8.1	21.2	32.5	47.1	8.1	23.9	14.4	8.8	16.1	35.6	24.8	13.6	8.1	35.7	31.1	16.9	10.7	15.1	22.2	11.7	33.2	15.9	8.8	9.7	14.4	16.1	10.3	11.1	6.9	7.8	8.4	5.6	7.6	9.5	41.3	12.8	17.2	21.2	46.0	24.9	21.5	6.7	27.3	31.5	10.2	7.5	14.3	12.8	17.7	3.7	14.6	4.0	18.2	46.9	7.9	6.9	44.7	43.7	17.2	29.0	15.0	25.2	58.5	6.0	6.2	22.5	16.3	68.3	40.4	8.1	30.0	22.1	10.0	16.8	54.1	19.3	10.2	12.5	12.2	41.6	9.6	32.9	14.2	22.5	10.1	14.9	18.6	43.2	35.7	8.8	31.4	7.9	26.4	16.4	42.7	5.9	23.4	24.4	13.1	20.6	29.2	16.7	13.1	20.6	26.9	9.3	31.7	8.3	14.3	23.3
CNTLN	"bA340N12.1, C9orf101, C9orf39, FLJ20276"	ENSG00000044459	Centlein	Q9NXG0	9	17134982-17503923	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Microglial cells: 91.8;Spermatocytes: 84.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"non-classical monocyte: 3.9"	"Lineage enriched"	"Detected in single"	5	"monocytes: 3.9"	"Cell line enhanced"	"Detected in many"		"HEL: 35.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007201, HPA036728, HPA036729"	Uncertain		Approved	Nucleoplasm,Centrosome,Cytosol		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 36: HEL - Hemostasis"	"Cluster 52: Non-specific - Transcription"	Centrosome	"Nucleoplasm, Cytosol"	"HPA007201: AB_2667775, HPA036728: AB_10670847, HPA036729: AB_10670240"	"unprognostic (1.97e-2)"	"unprognostic (2.81e-3)"	"unprognostic (1.81e-1)"	"unprognostic (2.48e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.60e-1)"	"unprognostic (7.71e-2)"	"unprognostic (1.68e-1)"	"unprognostic (7.71e-3)"	"unprognostic (5.07e-3)"	"unprognostic (1.06e-1)"	"unprognostic (6.65e-2)"	"unprognostic (2.47e-1)"	"unprognostic (5.38e-2)"	"unprognostic (3.35e-2)"	"unprognostic (1.37e-1)"	"unprognostic (5.80e-2)"	4.4	2.4	2.3	2.1	2.4	7.3	3.5	7.7	2.2	5.0	3.3	4.5	1.2	7.1	2.4	2.7	4.3	4.2	2.3	1.7	2.6	2.4	10.5	2.8	2.7	2.7	3.1	8.8	1.7	4.4	2.2	3.6	3.0	2.7	2.2	2.1	1.6	3.2	1.6	1.9	2.2	4.5	2.6	3.9	1.9	5.2	2.5	2.8	3.1	2.5	1.6	3.5	3.5	2.8	8.3	5.6	12.1	6.8	5.8	13.6	0.4	9.5	6.3	7.0	9.5	0.4	2.7	6.0	1.5	6.6	7.5	0.3	14.1	3.9	10.9	0.3	4.9	35.5	11.7	2.0	6.4	4.9	7.4	8.6	2.0	5.8	5.7	6.5	10.0	2.2	1.3	1.1	11.3	0.6	4.0	7.8	9.4	1.4	10.3	5.8	11.2	3.0	4.1	2.0	7.6	7.9	11.6	0.2	3.0	4.8	2.3	12.3	7.5	9.5	3.7	10.4	8.3	4.7	6.1	0.1	4.4	6.1	4.4	0.2	1.3	0.0	0.0	1.6	0.0	0.1	0.1	0.0	0.7	0.1	0.0	0.0	0.1	0.5	3.9	0.7	0.1	0.2	2.3	2.4	7.7	2.2	1.7	2.6	2.7	3.1	3.0	2.6	2.5	2.8	32.0	6.4	17.6	59.7	1.6	8.8	13.7	6.1	13.1	12.3	3.6	5.8	13.4	7.2	3.4	9.2	0.0	2.5	1.1	2.4	5.9	10.1	16.3	23.4	30.7	24.9	2.4	17.1	20.3	12.0	5.2	29.2	4.1	17.0	7.6	42.4	20.0	38.8	18.4	20.2	37.2	5.9	4.1	40.3	11.6	8.8	45.7	24.0	8.8	91.8	31.0	21.4	1.0	70.4	29.6	4.0	0.8	30.9	1.8	3.8	5.3	8.5	6.7	8.1	13.1	34.2	21.3	84.3	48.9	5.3	5.5	1.0	1.7	31.6	5.5	6.3
CNTNAP5	"caspr5, FLJ31966"	ENSG00000155052	"Contactin associated protein family member 5"	Q8WYK1	2	124025287-124915287	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"brain: 7.9"	"Group enriched"	"Detected in some"	49	"Excitatory neurons: 554.6;Inhibitory neurons: 906.4;Oligodendrocyte precursor cells: 760.0"	"Cancer enhanced"	"Detected in single"		"renal cancer: 0.6"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 1.2;SH-SY5Y: 2.6"					"Low region specificity"	"Detected in all"			"HPA069095, HPA069356"			Supported	"Nucleoplasm,Nucleoli fibrillar center,Vesicles"		NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Nucleoli fibrillar center"	"Nucleoplasm, Vesicles"	"HPA069095: AB_2686083, HPA069356: AB_2686127"				"unprognostic (6.32e-3)"	"unprognostic (6.38e-2)"	"unprognostic (1.23e-1)"		"unprognostic (2.25e-1)"	"unprognostic (1.68e-1)"	"unprognostic (7.53e-2)"	"unprognostic (6.20e-2)"	"unprognostic (3.11e-2)"	"unprognostic (2.62e-6)"	"unprognostic (3.65e-3)"	"unprognostic (5.32e-2)"		"unprognostic (9.58e-2)"	0.0	0.5	2.4	0.0	0.6	0.0	0.0	0.0	7.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	4.3	5.1	0.1	0.0	0.0	0.0	6.8	6.3	0.0	0.1	0.0	0.0	0.0	7.3	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.2	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.6	0.0	7.9	4.3	5.1	6.8	6.3	7.3	0.0	7.2	0.8	0.0	0.0	0.0	11.1	0.0	0.0	0.0	0.0	0.0	14.9	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.4	0.0	0.0	0.1	0.0	0.0	554.6	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.7	906.4	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	9.4	0.0	1.0	0.0	760.0	11.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.9	0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1
CNTRL	"CEP1, CEP110"	ENSG00000119397	Centriolin	Q7Z7A1	9	121074753-121177610	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 28.0;testis: 35.3"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 131.7;Spermatocytes: 385.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HL-60: 81.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020468, HPA020480, HPA051583"	Approved		Approved	"Centriolar satellite,Centrosome,Cytosol"		NA	Yes			"Cluster 6: Non-specific - Transcription"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 32: U-937 - Innate immune response"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Centrosome, Cytosol"	"Centriolar satellite"	"HPA020468: AB_2670455, HPA020480: AB_2670457, HPA051583: AB_2681542"	"unprognostic (4.33e-3)"	"unprognostic (2.89e-3)"	"unprognostic (2.09e-2)"	"unprognostic (7.97e-2)"	"unprognostic (1.17e-2)"	"prognostic favorable (9.21e-5)"	"unprognostic (1.05e-2)"	"unprognostic (3.22e-3)"	"unprognostic (3.74e-3)"	"unprognostic (2.02e-1)"	"unprognostic (1.78e-2)"	"unprognostic (5.47e-2)"	"unprognostic (3.60e-3)"	"unprognostic (9.83e-3)"	"unprognostic (2.43e-1)"	"unprognostic (3.57e-2)"	"unprognostic (1.13e-2)"	5.3	3.7	2.5	13.8	3.6	28.0	5.0	4.0	3.2	4.4	6.9	4.6	4.0	6.7	2.7	4.1	7.8	5.4	2.8	2.1	3.3	2.8	4.1	6.7	23.3	5.4	5.5	7.5	3.9	2.8	3.1	6.3	4.1	4.5	5.6	7.5	3.6	3.8	1.1	4.9	5.2	4.9	3.7	12.6	7.8	35.3	3.4	23.9	4.8	1.8	21.7	6.5	2.8	5.3	12.6	8.3	22.5	16.4	3.3	4.9	4.2	8.4	6.2	6.6	5.6	4.7	13.2	55.7	3.3	6.3	11.8	25.2	7.6	5.2	10.4	34.3	5.5	29.4	15.2	6.1	4.5	81.0	34.1	3.1	3.8	6.9	16.5	2.8	14.6	22.7	19.2	31.0	6.5	7.9	31.2	21.5	8.1	16.0	6.6	30.1	33.4	17.4	3.1	5.7	8.5	12.9	28.4	5.2	6.3	3.9	11.0	36.0	10.3	6.7	11.6	10.8	15.8	22.0	25.6	37.8	5.6	32.2	16.1	16.2	7.0	17.0	7.2	4.3	5.5	11.7	7.5	5.5	3.7	11.9	9.0	6.4	2.7	5.0	6.5	10.6	11.5	2.8	2.5	3.6	4.0	3.2	2.1	3.3	5.4	5.5	4.1	3.7	3.4	5.3	19.8	28.9	32.8	34.9	78.7	3.3	13.8	6.8	9.1	33.5	7.4	12.2	8.9	10.0	29.5	3.7	37.5	2.7	58.2	2.7	3.9	5.1	131.7	61.8	12.3	14.8	8.4	33.2	35.4	6.0	3.0	15.1	14.8	10.9	53.0	20.6	14.6	3.9	27.2	30.3	43.8	8.4	4.1	33.9	16.5	44.3	13.7	50.7	8.8	52.5	55.2	8.2	49.4	37.2	53.1	6.3	4.5	12.0	39.1	4.3	2.2	1.4	114.6	59.6	39.5	33.8	14.5	385.0	114.1	10.9	5.7	0.8	57.0	13.1	6.4	6.2
CNTROB	"LIP8, PP1221"	ENSG00000170037	"Centrobin, centriole duplication and spindle assembly protein"	Q8N137	17	7932101-7949920	"Predicted intracellular proteins"	"Cell cycle, Cell division"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Spermatocytes: 44.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023319, HPA023320, HPA023321, HPA023325"	Approved		Supported	Centrosome,Cytosol		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 71: Testis - DNA repair"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	Centrosome	Cytosol	"HPA023319: AB_1852886, HPA023320: AB_1852888, HPA023321: AB_1852890, HPA023325: AB_1852892"	"unprognostic (5.73e-2)"	"unprognostic (1.07e-2)"	"unprognostic (1.98e-1)"	"unprognostic (5.26e-2)"	"unprognostic (4.21e-2)"	"unprognostic (1.03e-2)"	"prognostic unfavorable (9.88e-4)"	"unprognostic (1.04e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.07e-1)"	"unprognostic (3.47e-3)"	"unprognostic (1.48e-2)"	"unprognostic (8.63e-2)"	"unprognostic (4.47e-2)"	"unprognostic (1.54e-1)"	"unprognostic (4.79e-1)"	"unprognostic (2.16e-2)"	18.2	14.6	17.1	13.5	17.7	32.2	17.3	17.9	20.7	26.6	16.2	24.0	10.7	38.0	18.1	20.0	20.1	12.8	15.1	17.8	19.0	18.6	18.1	28.7	15.2	17.8	18.0	20.8	16.8	19.8	18.0	12.0	17.7	19.5	18.9	17.9	16.4	12.5	12.6	26.2	17.2	25.5	16.3	19.0	16.7	65.5	18.7	29.2	19.6	9.8	17.7	18.7	19.5	19.0	51.1	31.0	48.7	25.5	19.1	26.7	15.0	43.9	40.5	59.8	44.0	26.5	18.0	50.2	22.4	38.5	26.9	41.2	36.8	29.9	64.9	50.6	27.4	33.6	58.6	21.5	28.6	31.9	52.8	24.2	21.1	42.0	41.7	28.5	36.6	53.0	24.6	25.9	40.8	15.9	49.5	29.6	10.4	18.5	25.6	51.9	32.6	20.2	26.5	16.1	16.2	29.4	34.3	17.8	14.8	25.2	24.6	20.0	33.2	32.8	27.6	45.2	61.0	38.7	27.1	35.1	28.4	39.6	47.2	6.4	1.8	0.7	1.8	2.5	1.7	1.4	1.4	2.4	1.3	0.9	0.9	1.6	0.2	2.5	1.1	5.3	2.0	2.1	17.1	17.7	17.9	20.7	17.8	19.0	17.8	18.0	17.7	16.3	18.7	19.0	4.2	6.4	19.6	6.5	4.2	7.9	7.5	5.2	4.6	6.6	6.7	6.5	3.4	7.2	6.9	12.9	8.4	4.4	7.4	5.9	1.9	5.8	3.1	5.8	18.0	5.4	3.0	14.1	3.8	6.9	4.7	6.4	6.6	5.4	18.4	10.9	5.7	3.5	6.5	3.3	5.5	7.0	2.0	6.7	9.1	4.8	5.3	9.2	3.6	5.6	1.9	6.4	6.2	4.5	4.3	6.6	3.1	7.9	7.5	5.5	4.4	3.5	5.7	6.2	0.0	5.8	5.4	44.4	8.1	9.0	8.7	2.5	5.7	5.5	8.4	4.5
COA1	"C7orf44, FLJ10803, MITRAC15"	ENSG00000106603	"Cytochrome c oxidase assembly factor 1 homolog"	Q9GZY4	7	43608456-43729717	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA011944	Approved		Supported	Mitochondria		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"HPA011944: AB_1848671"	"unprognostic (1.16e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.22e-1)"	"unprognostic (2.32e-1)"	"unprognostic (1.42e-1)"	"unprognostic (2.85e-3)"	"prognostic unfavorable (7.84e-5)"	"unprognostic (2.21e-1)"	"unprognostic (4.42e-2)"	"unprognostic (2.22e-2)"	"unprognostic (5.22e-2)"	"unprognostic (6.74e-2)"	"unprognostic (1.52e-1)"	"unprognostic (3.52e-1)"	"unprognostic (1.02e-2)"	"unprognostic (2.56e-2)"	"unprognostic (5.39e-2)"	17.1	17.1	20.8	17.2	21.2	23.8	16.0	22.0	25.9	7.7	22.3	12.7	12.9	9.4	14.3	17.0	10.5	12.3	59.2	20.6	21.9	28.3	16.6	13.6	31.5	20.8	20.9	6.9	28.4	25.7	6.4	12.9	21.4	8.5	16.3	23.5	16.4	8.4	74.5	5.6	11.8	10.4	21.0	15.5	17.2	10.9	21.1	27.2	16.5	78.2	35.2	16.3	8.2	21.5	35.4	93.4	75.6	75.2	21.8	24.4	50.7	47.5	82.7	64.5	66.7	71.9	78.8	67.0	79.7	29.9	135.8	50.4	88.9	74.7	81.1	60.4	81.3	83.5	48.8	67.3	35.9	65.7	35.6	20.2	47.1	47.0	69.1	69.0	59.8	79.3	144.1	56.4	52.7	48.6	97.2	164.2	47.9	73.4	66.8	58.2	69.5	125.0	80.3	39.2	46.5	83.0	48.6	89.1	32.5	108.7	66.9	43.6	44.9	31.7	69.2	31.5	69.7	133.7	117.8	122.9	90.4	82.4	86.4	2.0	23.6	21.3	18.7	27.7	13.4	31.8	17.1	18.9	27.6	33.0	23.4	30.2	32.8	30.3	24.1	24.4	18.7	23.3	20.8	21.2	22.0	25.9	20.6	21.9	20.8	20.9	21.4	21.0	21.1	21.5	30.0	28.9	38.8	52.9	52.1	13.0	65.3	41.2	38.1	46.1	39.9	43.6	59.0	30.0	34.4	35.0	45.9	33.7	42.9	14.0	117.4	55.3	7.3	39.0	27.8	33.8	27.6	84.4	76.1	42.9	47.9	27.6	29.0	28.6	26.0	40.9	20.7	26.7	58.6	33.7	88.1	22.3	54.9	38.0	19.6	9.6	29.5	32.0	37.4	70.3	45.5	37.3	57.7	100.5	71.7	41.0	15.9	19.5	51.3	59.4	39.8	124.7	30.9	56.3	13.1	35.0	27.4	97.4	85.7	48.9	16.8	17.9	47.1	40.4	26.9	55.2
COA5	"C2orf64, FLJ27524, MGC52110, Pet191"	ENSG00000183513	"Cytochrome c oxidase assembly factor 5"	Q86WW8	2	98599314-98608515	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal tubular cells: 180.0;Proximal tubular cells: 175.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA057768	Uncertain		Supported	Mitochondria		No	No			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"HPA057768: AB_2683521"	"unprognostic (1.00e-1)"	"unprognostic (4.19e-2)"	"unprognostic (3.85e-2)"	"unprognostic (1.67e-3)"	"unprognostic (2.61e-2)"	"unprognostic (7.11e-2)"	"unprognostic (4.69e-2)"	"prognostic favorable (2.65e-4)"	"unprognostic (1.32e-3)"	"unprognostic (3.71e-3)"	"unprognostic (8.00e-3)"	"unprognostic (3.08e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.29e-1)"	"unprognostic (4.93e-2)"	"unprognostic (2.50e-1)"	"prognostic favorable (1.00e-5)"	14.9	20.9	39.7	10.4	40.9	9.7	18.5	46.0	46.0	19.0	35.6	21.4	14.7	18.5	29.8	11.7	19.2	11.0	21.2	40.1	40.4	26.6	22.8	12.9	16.3	40.7	40.8	21.2	15.6	22.0	23.5	13.4	40.6	19.8	14.4	38.4	15.1	17.6	28.5	16.8	17.7	12.4	40.3	19.4	17.8	12.9	42.6	17.3	22.5	22.0	15.5	18.1	14.1	44.1	18.5	7.9	24.4	17.5	28.1	22.6	20.4	10.6	8.5	11.4	11.8	16.3	15.1	9.6	18.4	8.7	21.7	13.1	21.2	11.5	13.8	24.5	18.5	13.3	15.2	26.0	20.4	13.1	11.6	22.7	23.6	8.1	10.5	19.7	12.0	26.6	18.6	10.8	12.4	14.6	17.2	22.9	16.9	19.8	16.7	10.4	17.2	21.1	24.8	9.9	18.4	23.1	9.1	11.3	27.6	27.4	13.9	26.4	11.1	17.2	15.3	10.4	9.0	17.6	25.0	12.0	21.0	28.0	14.5	20.2	24.9	29.4	23.9	23.5	20.3	23.6	21.0	22.5	24.0	25.3	25.5	25.5	28.0	20.1	25.8	31.2	31.1	22.9	39.7	40.9	46.0	46.0	40.1	40.4	40.7	40.8	40.6	40.3	42.6	44.1	39.5	16.0	28.7	10.4	27.3	10.5	26.3	46.5	28.5	25.5	45.5	62.6	66.6	37.1	32.6	47.8	6.2	36.9	34.8	26.3	180.0	43.4	28.0	52.8	30.4	30.6	27.0	29.4	12.0	24.5	38.8	29.8	21.9	35.6	26.6	33.3	31.8	63.6	52.8	21.9	12.4	37.2	59.0	38.1	12.5	14.9	32.6	30.5	28.4	4.7	41.3	51.4	54.6	8.5	19.1	30.8	29.6	35.0	24.0	34.4	46.1	175.0	49.2	32.0	13.1	23.5	29.7	118.4	33.8	32.5	11.6	32.7	23.5	46.1	33.2	33.6
COA6	C1orf31	ENSG00000168275	"Cytochrome c oxidase assembly factor 6"	Q5JTJ3	1	234373456-234385080	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028588	Approved		Supported	Nucleoplasm,Mitochondria		NA	NA		13000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria	Nucleoplasm	"HPA028588: AB_10601123"	"unprognostic (6.26e-2)"	"unprognostic (1.92e-1)"	"unprognostic (3.05e-1)"	"unprognostic (1.01e-1)"	"unprognostic (7.87e-2)"	"unprognostic (1.20e-3)"	"unprognostic (4.04e-3)"	"unprognostic (4.89e-2)"	"unprognostic (2.79e-2)"	"unprognostic (6.25e-3)"	"unprognostic (9.24e-2)"	"unprognostic (2.36e-1)"	"prognostic unfavorable (1.12e-5)"	"unprognostic (2.38e-1)"	"unprognostic (5.24e-2)"	"unprognostic (2.19e-1)"	"prognostic favorable (7.12e-4)"	23.5	34.2	38.2	21.6	44.0	17.1	21.1	35.7	45.1	15.2	37.0	30.4	44.8	15.1	32.2	31.9	15.3	16.2	41.0	39.7	36.4	44.8	36.7	15.3	30.9	35.5	35.9	15.9	25.8	26.4	16.4	14.2	37.6	22.6	25.6	16.3	24.3	13.2	101.4	16.1	31.2	14.0	36.2	21.2	27.7	9.0	36.2	25.8	17.2	60.9	21.2	21.8	19.4	39.1	69.6	87.2	31.0	35.2	31.7	62.3	98.2	49.9	29.7	51.0	47.8	67.6	90.2	68.4	90.0	28.6	95.7	86.6	48.6	61.4	40.5	86.0	207.1	30.9	92.8	181.4	121.9	77.0	57.6	41.4	80.8	67.2	51.6	44.5	63.9	75.0	153.4	60.2	56.2	37.1	73.7	148.0	76.2	155.5	41.0	43.0	37.1	135.6	65.0	64.6	55.0	39.9	48.5	84.7	162.1	19.7	75.2	130.0	48.9	60.2	50.2	81.7	151.7	71.2	149.8	86.0	46.2	120.3	110.3	59.4	70.3	23.2	40.0	68.2	39.0	65.4	63.3	49.7	76.3	43.4	65.0	49.2	18.8	44.9	59.0	52.2	85.9	48.6	38.2	44.0	35.7	45.1	39.7	36.4	35.5	35.9	37.6	36.2	36.2	39.1	31.2	9.6	24.0	5.9	29.6	57.2	50.2	80.7	34.1	13.6	35.6	57.0	88.1	30.0	51.1	47.8	4.2	50.8	21.1	61.4	103.7	55.2	4.2	63.3	32.9	27.8	22.2	33.7	19.0	69.4	79.2	31.0	31.1	40.9	22.2	35.4	26.7	52.4	84.3	11.8	13.6	64.2	52.9	37.7	32.3	4.9	26.1	39.6	30.2	5.6	45.5	28.1	28.8	9.0	5.9	62.7	42.0	28.2	24.3	77.0	83.4	131.3	64.0	17.8	19.7	22.8	31.9	23.7	26.9	57.9	58.7	43.6	30.6	63.5	72.4	81.8
COCH	"COCH-5B2, DFNA31, DFNA9"	ENSG00000100473	Cochlin	O43405	14	30874514-30895065	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins, Transporters"	Hearing		"Deafness, Disease variant, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"pancreas: 502.0"	"Cell type enhanced"	"Detected in many"		"Exocrine glandular cells: 63.0;Horizontal cells: 84.1"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in all"		"basal ganglia: 71.3"	"Group enriched"	"Detected in some"	12	"memory B-cell: 38.3;naive B-cell: 17.7"	"Lineage enriched"	"Detected in many"	17	"B-cells: 38.3"	"Cell line enhanced"	"Detected in many"		"HEK 293: 95.7;Hep G2: 63.8;K-562: 129.1;NB-4: 105.5;SCLC-21H: 111.8"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"basal ganglia: 50.8"	HPA065086			Supported	Vesicles	"Secreted in other tissues"	NA	NA		160000	"Cluster 19: B-cells - Humoral immune response"	"Cluster 25: Pancreas - Digestion"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 48: Smooth muscle cells - ECM organization"	Vesicles		"HPA065086: "	"unprognostic (8.36e-3)"	"unprognostic (2.51e-2)"	"unprognostic (8.61e-2)"	"unprognostic (1.64e-2)"	"unprognostic (6.48e-2)"	"unprognostic (6.53e-2)"	"unprognostic (9.61e-2)"	"unprognostic (4.03e-1)"	"unprognostic (2.11e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.27e-2)"	"unprognostic (2.91e-3)"	"unprognostic (5.42e-3)"	"unprognostic (3.92e-2)"	"unprognostic (2.80e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.72e-1)"	3.2	3.7	7.3	2.8	71.3	4.0	3.4	1.4	20.9	17.4	19.0	3.2	0.8	0.6	2.2	0.9	6.2	2.9	1.9	5.6	8.0	5.2	0.5	0.6	11.0	2.9	7.9	0.8	502.0	3.4	10.1	1.9	3.7	48.3	2.2	12.1	3.6	73.4	1.3	15.2	2.6	1.1	6.2	2.6	1.7	5.2	12.5	1.3	1.3	5.0	7.7	2.0	23.0	1.7	0.0	35.3	3.1	0.0	0.6	0.1	21.8	0.2	0.0	6.4	17.1	20.9	1.2	0.4	1.7	0.0	1.3	0.1	22.2	0.0	10.6	0.0	95.7	18.1	7.6	63.8	0.0	1.8	7.3	1.3	0.0	0.6	0.0	0.0	0.3	39.9	129.1	5.1	1.6	0.8	9.2	105.5	11.9	0.1	3.7	26.7	0.0	0.9	1.1	3.4	111.8	30.4	2.6	0.6	0.2	12.1	0.0	48.7	0.9	0.0	0.0	0.3	0.1	5.7	15.8	11.2	0.0	0.0	4.7	0.0	0.6	0.0	0.0	0.0	0.0	38.3	0.3	0.0	0.1	17.7	0.0	0.1	0.2	0.0	0.0	0.0	2.2	1.0	7.3	71.3	1.4	20.9	5.6	8.0	2.9	7.9	3.7	6.2	12.5	1.7	2.0	0.0	0.5	3.6	13.4	19.1	2.3	0.3	0.0	2.7	7.9	1.5	0.8	2.8	0.9	0.0	4.2	6.5	1.3	0.6	1.9	0.5	1.5	2.2	0.8	3.1	17.0	7.4	14.3	63.0	14.3	22.0	1.1	1.0	1.3	1.8	5.0	5.0	3.8	84.1	24.2	0.3	6.1	5.0	25.2	2.0	1.5	2.4	19.6	7.5	2.8	14.5	0.0	6.0	16.5	3.7	4.3	6.0	10.0	3.5	0.2	11.7	0.5	4.0	0.0	2.8	9.0	22.1	20.3	0.1	13.5	6.6	3.3	0.1	0.6	1.7
COG3	SEC34	ENSG00000136152	"Component of oligomeric golgi complex 3"	Q96JB2	13	45464898-45536701	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040353, HPA054470"	Approved		Supported	"Nucleoplasm,Golgi apparatus,Plasma membrane,Cytosol"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 21: OE19 - Mitochondria"	"Cluster 27: Mucus-secreting cells - Mucin production"	"Golgi apparatus, Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA040353: AB_10794027, HPA054470: AB_2732585"	"unprognostic (1.75e-1)"	"unprognostic (3.03e-3)"	"unprognostic (1.75e-1)"	"unprognostic (4.04e-3)"	"unprognostic (9.69e-2)"	"unprognostic (2.86e-2)"	"unprognostic (2.18e-2)"	"unprognostic (4.46e-2)"	"unprognostic (2.51e-2)"	"prognostic unfavorable (9.53e-4)"	"unprognostic (5.82e-2)"	"unprognostic (1.21e-2)"	"unprognostic (4.49e-2)"	"unprognostic (7.06e-3)"	"unprognostic (1.13e-1)"	"unprognostic (8.25e-2)"	"unprognostic (1.71e-1)"	11.2	15.0	7.5	9.3	7.7	11.8	15.6	10.5	9.3	15.2	10.5	16.2	12.6	13.0	16.8	12.4	12.2	9.5	11.8	7.4	7.2	12.3	29.5	10.4	10.7	7.0	7.0	15.1	20.8	12.3	14.9	13.0	7.0	18.7	18.9	10.0	18.0	12.4	11.4	13.2	13.2	12.1	6.8	12.4	14.7	9.7	7.5	12.2	17.0	9.7	10.9	12.7	13.1	9.4	8.3	7.4	13.9	12.6	17.9	20.4	13.2	13.5	19.1	15.4	12.8	10.8	14.9	11.3	5.9	16.2	11.4	17.7	11.6	13.7	23.3	8.9	9.3	12.7	9.2	19.2	22.1	18.8	11.7	15.4	20.3	10.3	36.1	18.6	15.2	11.0	8.3	6.8	18.7	12.9	10.5	17.6	11.4	41.5	8.7	12.1	8.1	10.6	14.4	13.4	6.9	12.5	8.7	17.1	18.2	13.1	11.7	19.3	14.4	7.4	5.7	13.9	8.7	9.4	5.4	11.7	14.2	9.4	13.5	3.5	1.9	3.6	3.4	2.2	3.6	2.2	2.6	2.9	1.4	2.3	2.9	2.7	1.7	2.5	1.3	3.4	3.0	1.7	7.5	7.7	10.5	9.3	7.4	7.2	7.0	7.0	7.0	6.8	7.5	9.4	15.8	9.6	31.4	23.2	18.9	15.8	15.2	13.1	14.2	9.7	22.0	17.9	19.7	24.3	19.8	12.9	14.6	14.2	35.5	32.5	15.6	11.6	24.1	15.0	20.1	16.7	22.2	11.4	39.3	37.9	18.8	14.3	26.0	30.8	17.1	22.4	18.9	72.8	10.8	10.1	34.7	54.5	6.1	20.9	9.0	9.0	14.0	13.3	10.6	22.5	13.2	7.6	15.5	34.2	36.9	22.7	32.8	13.5	31.3	26.6	29.4	17.3	11.7	11.2	6.6	12.8	11.7	12.7	8.9	17.7	16.1	32.8	21.2	21.7	24.4	37.3
COG7		ENSG00000168434	"Component of oligomeric golgi complex 7"	P83436	16	23388493-23453189	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Protein transport, Transport"		"Congenital disorder of glycosylation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040758, HPA041824, HPA064645"	Uncertain		Supported	"Golgi apparatus"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 49: Ciliated cells - Cilium organization"	"Golgi apparatus"		"HPA040758: AB_2677120, HPA041824: , HPA064645: AB_2685311"	"unprognostic (1.72e-1)"	"unprognostic (1.02e-2)"	"unprognostic (8.21e-2)"	"prognostic favorable (6.95e-4)"	"unprognostic (3.71e-1)"	"unprognostic (2.15e-1)"	"unprognostic (5.95e-2)"	"unprognostic (2.70e-2)"	"unprognostic (3.10e-1)"	"unprognostic (4.15e-1)"	"unprognostic (6.07e-3)"	"unprognostic (1.58e-1)"	"prognostic favorable (3.14e-4)"	"unprognostic (3.77e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.14e-1)"	8.7	13.1	9.2	7.2	8.7	9.8	10.3	7.5	10.0	14.9	16.7	13.2	8.3	10.9	11.2	12.1	15.0	8.4	10.0	8.6	8.6	12.7	9.5	10.0	6.8	8.8	9.4	13.4	10.2	16.3	23.8	7.5	9.1	16.2	11.8	13.8	13.4	10.4	9.8	12.2	10.5	8.6	7.4	9.8	12.7	10.0	8.8	8.1	14.6	6.4	7.2	11.4	12.2	10.7	10.2	19.5	11.9	13.5	10.4	16.9	10.8	11.2	14.1	12.9	12.9	8.3	17.6	4.8	11.6	17.8	8.2	15.2	10.8	13.8	9.8	15.7	16.3	5.0	15.3	22.2	11.0	13.9	14.2	11.0	11.0	9.9	10.4	16.0	15.2	15.7	12.2	13.6	10.5	29.9	9.3	10.2	10.7	15.7	9.3	18.7	10.3	17.3	14.0	10.0	7.2	9.2	12.6	14.2	9.7	8.9	21.0	17.8	10.7	14.3	7.5	13.4	8.2	12.4	14.1	6.5	19.1	8.1	14.0	8.4	6.7	7.3	6.0	7.7	7.6	3.9	5.5	5.7	8.0	4.6	5.6	8.5	1.6	5.6	10.0	5.7	7.0	4.9	9.2	8.7	7.5	10.0	8.6	8.6	8.8	9.4	9.1	7.4	8.8	10.7	8.0	25.6	16.9	30.3	6.2	6.6	10.1	13.7	10.2	10.1	12.0	12.2	7.2	8.6	19.9	12.9	31.3	12.5	5.5	19.4	1.9	12.0	5.0	24.4	10.8	7.7	19.2	10.8	39.7	13.8	7.6	9.8	27.5	14.2	8.2	13.1	6.1	6.0	6.4	11.8	39.8	19.3	8.2	4.0	2.3	3.6	9.9	7.7	8.8	19.7	4.4	9.2	5.2	45.8	40.6	12.9	11.3	12.4	7.2	9.3	11.6	8.7	39.1	22.4	13.1	10.1	8.6	16.5	13.3	9.1	5.4	11.8	8.9	7.2	15.9	10.7
COG8	"DOR1, FLJ22315"	ENSG00000213380	"Component of oligomeric golgi complex 8"	Q96MW5	16	69320140-69339583	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Protein transport, Transport"		"Congenital disorder of glycosylation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041406, HPA049429"	Approved		Supported	"Golgi apparatus"		No	No			"Cluster 41: Basophils - Cellular respiration"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 50: Fibroblasts - ECM organization"	"Golgi apparatus"		"HPA041406: AB_2677459, HPA049429: AB_2680763"	"unprognostic (4.02e-2)"	"unprognostic (6.46e-2)"	"unprognostic (2.90e-1)"	"unprognostic (1.19e-2)"	"unprognostic (2.77e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.23e-1)"	"unprognostic (4.35e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.02e-1)"	"prognostic favorable (3.12e-5)"	"unprognostic (3.10e-1)"	"prognostic favorable (2.47e-7)"	"unprognostic (4.73e-2)"	"unprognostic (2.58e-1)"	"unprognostic (7.83e-2)"	"unprognostic (1.35e-2)"	9.9	14.5	19.7	8.5	23.2	6.5	11.1	23.2	24.4	9.8	24.0	10.5	10.5	10.8	14.1	9.9	13.9	7.7	11.2	19.4	19.7	13.4	15.0	10.2	11.3	21.1	20.6	13.7	14.2	19.9	12.0	7.9	21.2	10.3	9.9	7.7	13.8	10.6	18.1	16.3	10.0	10.5	20.3	10.9	11.2	20.3	20.9	12.2	13.0	15.8	11.3	9.4	7.7	28.1	13.2	28.5	18.2	26.7	30.1	21.0	19.4	16.9	18.6	23.0	18.7	26.2	19.8	23.7	18.1	23.0	12.4	24.9	29.5	24.3	19.8	11.9	26.4	17.0	19.9	35.0	21.3	21.1	14.8	25.2	23.5	25.2	14.7	22.2	22.6	20.4	35.4	5.7	16.7	38.3	19.4	31.3	32.2	17.8	20.5	35.6	12.6	33.3	23.6	11.1	26.0	31.1	37.5	15.0	17.5	18.4	35.4	17.8	20.5	16.8	14.4	15.8	14.1	31.3	27.1	36.8	17.3	18.8	19.2	41.4	19.6	20.6	17.8	19.0	19.6	13.3	19.2	18.2	18.6	19.0	17.4	16.7	15.6	22.2	17.6	10.7	19.6	16.8	19.7	23.2	23.2	24.4	19.4	19.7	21.1	20.6	21.2	20.3	20.9	28.1	3.2	9.6	9.7	1.3	9.4	4.2	10.4	5.8	5.2	18.9	7.3	6.7	0.0	24.3	10.6	11.0	18.8	15.0	5.0	12.6	1.9	7.6	17.4	6.1	6.4	7.2	12.7	5.5	1.9	8.0	9.1	7.4	7.1	4.6	7.0	9.0	15.7	28.5	9.5	11.8	2.0	11.7	20.3	7.9	3.3	4.8	12.8	3.1	5.4	1.0	8.4	12.1	10.3	2.0	2.6	5.4	9.5	15.8	9.0	9.6	19.3	15.3	10.2	19.9	13.1	15.5	6.2	9.9	13.6	7.2	4.1	9.2	8.3	5.4	16.7	7.2
COIL	"CLN80, p80-coilin"	ENSG00000121058	Coilin	P38432	17	56938199-56961050	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"testis: 98.5"	"Cell type enhanced"	"Detected in all"		"Early spermatids: 249.2;Late spermatids: 591.1;Spermatocytes: 142.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017524, HPA027885, HPA057480, CAB069400"	Enhanced		Supported	"Nucleoplasm,Nucleoli,Nuclear bodies"		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 31: Spermatids - Spermatogenesis"	"Nucleoplasm, Nuclear bodies"	Nucleoli	"CAB017524: AB_1121780, CAB069400: , HPA027885: AB_2672421, HPA057480: "	"unprognostic (1.01e-2)"	"unprognostic (3.05e-1)"	"prognostic favorable (1.77e-4)"	"unprognostic (1.90e-2)"	"unprognostic (3.19e-2)"	"unprognostic (4.13e-3)"	"prognostic unfavorable (1.28e-4)"	"unprognostic (1.64e-1)"	"unprognostic (4.07e-3)"	"unprognostic (3.00e-3)"	"unprognostic (2.50e-2)"	"unprognostic (2.25e-2)"	"unprognostic (1.28e-3)"	"unprognostic (2.50e-1)"	"unprognostic (2.92e-1)"	"unprognostic (3.36e-2)"	"unprognostic (7.71e-2)"	7.7	7.2	6.6	8.8	6.8	19.9	12.2	9.7	8.9	9.2	7.3	9.2	10.2	10.4	11.6	9.7	9.8	7.1	8.0	6.6	7.0	8.7	13.0	7.6	12.8	6.7	6.7	11.9	8.7	12.3	6.2	13.0	7.4	9.3	10.6	12.6	9.8	7.7	11.5	9.8	10.0	8.5	6.8	10.3	9.2	98.5	6.6	13.2	12.1	9.1	13.5	9.3	8.7	8.1	25.0	18.6	37.4	14.5	12.5	14.9	25.8	17.5	16.4	26.1	27.7	25.6	21.0	29.9	34.6	14.0	19.5	14.1	25.6	20.2	37.1	36.1	32.3	48.7	17.4	29.2	13.5	41.5	28.5	13.9	24.7	19.7	21.1	15.5	22.6	17.4	42.9	24.3	24.8	31.6	32.9	26.3	22.0	27.4	18.4	15.5	45.9	23.9	18.1	24.7	31.6	31.2	11.7	11.5	30.1	21.5	41.8	40.0	16.0	30.2	22.7	14.8	23.0	35.6	47.7	34.5	15.8	22.7	18.8	22.3	13.3	17.5	15.5	12.6	17.5	27.6	17.0	16.6	13.5	25.0	19.5	18.9	8.1	16.0	17.2	16.4	18.6	10.1	6.6	6.8	9.7	8.9	6.6	7.0	6.7	6.7	7.4	6.8	6.6	8.1	21.3	12.8	21.0	6.8	26.5	18.7	39.5	34.0	21.1	35.9	21.6	22.5	14.1	22.8	28.3	14.7	37.5	42.2	26.2	12.5	13.7	30.1	249.2	22.7	23.1	26.6	23.9	17.5	8.8	27.7	32.3	23.5	18.3	19.9	22.2	20.3	22.5	23.9	22.7	25.2	10.9	16.5	16.2	16.5	10.4	591.1	42.3	12.3	3.6	10.3	19.6	28.5	34.0	9.5	13.3	23.5	17.3	30.5	15.1	32.2	16.6	23.0	22.0	52.4	13.1	24.9	21.9	142.2	46.8	20.3	22.7	29.1	23.3	17.1	20.8	29.0
COL17A1	"BP180, BPAG2"	ENSG00000065618	"Collagen type XVII alpha 1 chain"	Q9UMD9	10	104031286-104085880	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"			"Cancer-related genes, Disease variant, Epidermolysis bullosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"skin 1: 580.3"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 585.7;Basal respiratory cells: 136.0;Basal squamous epithelial cells: 299.9;Distal enterocytes: 211.5;Proximal enterocytes: 108.5;Suprabasal keratinocytes: 139.4"	"Cancer enriched"	"Detected in many"	5	"head and neck cancer: 227.4"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 204.3;HaCaT: 463.8;HBEC3-KT: 745.8;hTCEpi: 914.1;hTERT-HME1: 783.7"	"Region enriched"	"Detected in single"	4	"cerebellum: 1.0"	"Low region specificity"	"Detected in many"			"HPA043673, HPA052963"	Enhanced		Supported	"Golgi apparatus,Plasma membrane"	"Secreted to extracellular matrix"	NA	NA		32000	"Cluster 1: Neutrophils - Mixed function"	"Cluster 31: Skin - Epidermis development"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Plasma membrane"	"Golgi apparatus"	"HPA043673: AB_10960893, HPA052963: AB_2681999"	"prognostic favorable (1.38e-4)"	"unprognostic (1.33e-1)"	"unprognostic (4.01e-1)"	"unprognostic (1.01e-1)"	"unprognostic (9.65e-2)"	"unprognostic (3.75e-1)"	"unprognostic (2.13e-1)"	"unprognostic (6.82e-3)"	"unprognostic (1.63e-1)"	"unprognostic (7.85e-3)"	"prognostic unfavorable (1.86e-4)"	"unprognostic (2.12e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.23e-1)"	"unprognostic (3.75e-2)"	"unprognostic (8.35e-2)"	1.5	0.4	0.8	6.6	1.1	12.2	37.3	1.0	1.4	50.1	0.6	37.4	10.7	0.6	6.6	116.6	1.1	0.3	0.5	0.5	0.6	0.3	0.3	0.9	0.1	0.6	0.7	0.2	0.4	0.0	1.2	35.4	0.6	17.9	27.3	0.0	82.2	9.6	0.5	580.3	37.2	1.0	0.5	2.3	19.8	25.4	0.6	42.7	5.1	0.0	19.8	9.9	102.0	0.8	26.3	0.4	1.5	0.2	0.1	0.0	80.6	0.5	0.3	0.1	0.2	0.3	204.3	0.0	5.1	0.3	3.9	463.8	0.7	745.8	0.7	0.0	0.7	0.0	0.3	0.2	0.1	0.0	0.4	0.7	914.1	0.5	783.7	0.2	3.5	0.1	0.1	0.9	0.0	0.0	0.0	0.3	1.7	5.1	2.6	0.0	0.0	0.3	35.9	26.4	0.2	0.3	0.0	0.2	0.9	4.0	0.2	0.0	1.5	0.5	5.0	0.3	5.5	0.1	0.0	0.0	1.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.8	1.1	1.0	1.4	0.5	0.6	0.6	0.7	0.6	0.5	0.6	0.8	1.0	0.0	1.1	0.7	0.3	585.7	17.7	136.0	299.9	0.6	1.7	85.5	1.1	0.0	16.5	0.0	0.0	10.2	0.3	211.5	0.0	0.8	14.2	23.7	2.3	3.7	2.4	0.0	0.1	0.9	18.9	2.4	23.0	8.1	0.0	0.1	0.0	0.0	1.3	0.0	0.2	5.7	6.1	0.0	28.9	3.6	0.3	0.7	33.8	0.0	0.0	0.4	0.0	0.0	0.4	78.8	35.7	0.7	1.4	16.6	108.5	0.1	5.9	0.4	0.0	0.4	3.0	22.7	1.5	31.9	139.4	5.6	1.3	0.1	21.6	10.7
COL1A2	OI4	ENSG00000164692	"Collagen type I alpha 2 chain"	P08123	7	94394895-94431227	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins"			"Cancer-related genes, Disease variant, Dwarfism, Ehlers-Danlos syndrome, Osteogenesis imperfecta"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"cervix: 1831.7;gallbladder: 1378.0;smooth muscle: 1416.9"	"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 774.5;Fibroblasts: 2148.2;Glandular and luminal cells: 592.2;Leydig cells: 991.9;Peritubular cells: 501.0;Smooth muscle cells: 770.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 3899.2;ASC TERT1: 4637.0;BJ: 3995.6;BJ hTERT+: 2901.2;fHDF/TERT166: 13615.1;HSkMC: 4058.4"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"spinal cord: 133.7"	"CAB032650, HPA059738"	Approved		Supported	"Endoplasmic reticulum"	"Secreted to extracellular matrix"	NA	NA		27000000		"Cluster 46: Fibroblasts - ECM organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 33: Fibroblasts - ECM organization"	"Endoplasmic reticulum"		"CAB032650: AB_2082039, HPA059738: AB_2684116"	"unprognostic (1.20e-1)"	"unprognostic (6.34e-2)"	"unprognostic (1.32e-1)"	"unprognostic (3.40e-2)"	"unprognostic (2.86e-2)"	"unprognostic (2.81e-1)"	"unprognostic (5.15e-2)"	"unprognostic (7.38e-3)"	"unprognostic (2.01e-2)"	"unprognostic (1.40e-2)"	"unprognostic (5.83e-2)"	"unprognostic (2.15e-1)"	"prognostic unfavorable (1.51e-9)"	"unprognostic (1.35e-2)"	"unprognostic (5.25e-2)"	"unprognostic (1.15e-1)"	"unprognostic (3.31e-3)"	514.8	52.4	6.8	266.2	9.3	2.0	314.5	7.1	17.4	1831.7	18.1	175.7	61.1	411.2	61.6	263.2	206.6	1378.0	275.4	6.0	6.8	40.8	27.4	229.5	91.6	8.7	6.7	297.2	57.1	32.5	33.5	624.6	7.9	196.2	141.8	1.6	60.2	232.3	51.6	424.6	103.2	1416.9	8.8	69.3	89.1	136.6	15.6	32.8	86.4	102.1	60.1	805.6	295.2	8.2	0.1	0.0	22.8	1488.5	3899.2	4637.0	1.3	3995.6	2901.2	642.6	850.5	0.0	2.8	0.3	2.7	13615.1	0.0	0.6	2.2	1.5	160.9	0.1	0.2	0.1	0.0	0.0	1018.6	1.1	0.5	4058.4	0.1	507.9	2.4	0.3	0.5	0.0	0.3	0.3	551.0	0.0	0.6	1.5	2.5	0.0	6.3	0.5	0.8	0.8	0.1	0.0	12.9	1.4	0.3	1.0	0.1	296.0	2.1	0.1	15.9	1626.3	0.8	1022.7	115.5	1.2	0.1	0.4	408.6	0.5	9.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.8	9.3	7.1	17.4	6.0	6.8	8.7	6.7	7.9	8.8	15.6	8.2	112.9	3.2	12.9	1.0	0.8	223.1	0.7	9.3	4.6	0.2	7.2	8.6	21.7	0.0	3.3	1.8	0.0	31.5	2.5	0.0	0.0	3.0	8.4	183.2	774.5	57.2	0.0	0.0	0.0	0.2	31.7	2148.2	26.5	592.2	10.1	16.4	258.8	1.9	116.9	0.0	0.1	0.0	0.0	1.0	394.5	45.1	991.9	16.7	238.3	97.4	2.6	3.2	0.0	0.0	0.2	5.2	0.0	501.0	4.5	1.0	0.0	0.5	0.8	0.4	302.4	249.9	770.7	9.9	4.5	6.2	187.4	70.7	30.6	214.8	0.0	0.8
COL21A1		ENSG00000124749	"Collagen type XXI alpha 1 chain"	Q96P44	6	56056590-56394094	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix: 24.1;placenta: 28.3"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 66.6;Cardiomyocytes: 36.9;Extravillous trophoblasts: 75.3;Inhibitory neurons: 63.3;Respiratory ciliated cells: 51.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"ASC TERT1: 23.4;BEWO: 7.6;HSkMC: 24.0;SuSa: 11.1"					"Low region specificity"	"Detected in all"			HPA031212			Supported	Cytosol	"Secreted to extracellular matrix"	NA	NA		290000		"Cluster 46: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 33: Fibroblasts - ECM organization"	Cytosol		"HPA031212: AB_10599941"	"unprognostic (1.69e-1)"	"unprognostic (4.53e-2)"	"unprognostic (1.58e-1)"	"unprognostic (2.56e-1)"	"unprognostic (1.21e-1)"	"unprognostic (9.32e-3)"	"unprognostic (6.84e-2)"	"unprognostic (9.04e-3)"	"unprognostic (1.54e-3)"	"unprognostic (2.17e-1)"	"unprognostic (5.29e-2)"	"unprognostic (3.10e-1)"	"unprognostic (1.26e-3)"	"unprognostic (3.27e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.27e-3)"	2.6	1.4	2.6	0.6	3.2	0.0	1.4	3.3	1.9	24.1	11.4	7.8	0.5	12.4	2.8	2.4	7.4	3.8	4.2	2.4	5.6	1.1	1.2	7.6	0.5	2.7	6.3	3.7	1.9	0.6	1.9	28.3	3.1	3.5	2.0	0.0	5.0	10.7	1.3	6.6	1.3	7.9	1.5	0.5	2.7	2.7	4.0	0.7	1.0	6.6	0.5	6.1	6.0	2.7	0.0	3.4	0.2	0.0	1.3	23.4	7.6	0.0	1.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	3.2	0.1	0.0	24.0	0.9	0.0	0.3	0.5	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.1	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	11.1	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	3.2	3.3	1.9	2.4	5.6	2.7	6.3	3.1	1.5	4.0	2.7	6.4	0.0	1.5	66.6	0.0	5.9	2.2	2.8	2.2	0.0	0.3	0.4	36.9	0.0	8.2	0.0	0.0	27.5	0.1	0.0	0.0	0.0	7.4	24.8	10.6	6.6	0.0	0.0	16.0	0.0	75.3	28.2	0.5	1.2	0.0	0.2	2.9	0.0	6.1	0.0	63.3	0.0	16.2	0.3	3.0	1.7	15.2	0.3	5.4	0.0	0.0	0.0	0.0	3.5	1.6	0.0	0.0	12.4	0.0	0.1	0.1	0.1	51.3	0.0	0.0	7.3	15.0	1.2	2.5	1.0	4.1	23.3	0.4	2.1	0.2	1.3
COL22A1		ENSG00000169436	"Collagen type XXII alpha 1 chain"	Q8NFW1	8	138588235-138914041	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"pituitary gland: 44.0"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 39.6;Excitatory neurons: 13.0;Late spermatids: 33.7;Muller glia cells: 25.5"	"Cancer enhanced"	"Detected in many"		"testis cancer: 9.1"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 29.5;RT4: 12.2;SCLC-21H: 8.1;U-2 OS: 6.8"					"Low region specificity"	"Detected in many"			HPA024830	Enhanced		Supported	"Endoplasmic reticulum,Vesicles"	"Secreted to extracellular matrix"	NA	NA				"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 5: Muller glia cells - Visual perception"	Vesicles	"Endoplasmic reticulum"	"HPA024830: AB_1847102"	"unprognostic (1.06e-1)"	"unprognostic (1.31e-1)"	"unprognostic (2.88e-2)"	"unprognostic (4.19e-6)"	"prognostic unfavorable (4.15e-4)"	"unprognostic (1.05e-2)"	"unprognostic (5.57e-3)"	"prognostic unfavorable (2.13e-6)"	"unprognostic (2.01e-1)"	"unprognostic (9.24e-2)"	"unprognostic (5.74e-2)"	"unprognostic (3.62e-2)"	"unprognostic (3.66e-15)"	"unprognostic (2.38e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.28e-2)"	"unprognostic (1.09e-1)"	0.1	7.6	0.6	0.6	1.0	0.0	0.0	2.9	0.5	0.8	0.4	1.0	0.3	1.9	0.2	0.1	0.4	0.3	0.2	0.3	1.4	1.9	0.0	0.0	0.5	2.9	1.2	0.2	0.1	1.4	44.0	0.0	0.6	3.0	0.1	5.2	0.9	2.4	0.7	0.0	0.4	1.6	4.3	0.2	2.2	1.1	2.0	2.1	0.2	1.1	1.2	0.9	0.4	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	29.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	12.2	8.1	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	6.8	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	1.0	2.9	0.5	0.3	1.4	2.9	1.2	0.6	4.3	2.0	2.3	0.0	0.0	0.0	0.3	0.0	0.0	3.7	2.5	0.0	0.3	0.2	0.3	1.7	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	4.4	39.6	0.1	0.2	0.8	0.0	0.0	13.0	0.2	0.0	0.2	0.0	0.6	0.0	0.6	0.0	0.0	5.9	0.0	0.8	0.0	8.2	0.0	0.0	33.7	0.3	0.3	0.0	1.0	0.6	25.5	0.0	0.5	0.3	3.0	0.0	0.0	0.0	4.8	0.0	0.1	0.2	1.6	0.0	0.1	0.3	2.1	1.7	0.0	0.0	0.0	0.0	0.0	0.1	1.9
COL4A2	"DKFZp686I14213, FLJ22259"	ENSG00000134871	"Collagen type IV alpha 2 chain"	P08572	13	110305812-110513209	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	Angiogenesis		"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 474.0"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 313.6;Endometrial stromal cells: 308.3;Endothelial cells: 278.2;Extravillous trophoblasts: 512.9;Granulosa cells: 223.8;Sertoli cells: 374.7;Smooth muscle cells: 338.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"EFO-21: 1041.3;WM-115: 428.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010751, HPA029118, HPA069337"	Enhanced		Supported	Vesicles	"Secreted to extracellular matrix"	NA	NA		2700000		"Cluster 82: Adipose tissue - ECM organization"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 48: Smooth muscle cells - ECM organization"	Vesicles		"CAB010751: AB_476828, HPA029118: , HPA069337: "	"unprognostic (2.43e-1)"	"unprognostic (4.13e-3)"	"unprognostic (8.04e-2)"	"unprognostic (6.03e-3)"	"unprognostic (2.20e-1)"	"unprognostic (2.64e-2)"	"unprognostic (3.45e-2)"	"unprognostic (1.15e-2)"	"unprognostic (3.50e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.65e-1)"	"prognostic unfavorable (3.49e-5)"	"unprognostic (1.33e-2)"	"unprognostic (1.57e-2)"	"unprognostic (6.95e-2)"	"prognostic unfavorable (9.25e-4)"	240.5	51.2	15.1	103.5	2.3	0.6	153.5	1.7	5.9	111.6	3.4	282.0	29.5	219.4	10.4	51.8	122.9	84.2	113.0	19.3	1.8	71.7	19.1	181.7	22.8	4.3	7.8	51.9	32.6	25.6	17.5	474.0	6.0	121.3	18.9	2.8	35.0	95.8	44.7	45.2	84.1	226.8	2.6	121.5	96.4	15.7	11.5	7.9	74.9	21.5	7.1	186.2	74.4	2.9	88.9	45.7	218.7	0.6	213.7	99.0	312.8	307.9	97.4	167.3	76.1	2.5	0.7	0.6	1041.3	60.0	75.0	85.4	0.1	82.4	27.3	28.1	46.3	0.2	76.6	0.7	150.5	0.5	1.0	42.8	4.5	114.8	71.2	193.5	158.5	0.0	1.3	0.9	25.4	0.3	0.3	12.1	34.2	0.8	11.7	0.6	87.8	0.4	125.6	0.0	6.4	35.4	0.3	0.9	81.2	84.7	0.6	6.7	327.7	94.9	237.9	2.3	161.9	0.6	3.0	7.4	5.8	0.4	428.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.1	2.3	1.7	5.9	19.3	1.8	4.3	7.8	6.0	2.6	11.5	2.9	313.6	83.3	5.8	17.9	2.9	9.6	8.0	16.3	1.8	2.4	7.0	56.8	31.8	20.0	1.8	53.3	0.0	77.4	0.1	10.0	1.9	39.0	1.7	19.4	308.3	278.2	0.0	8.0	17.7	4.4	512.9	159.1	5.6	50.1	1.3	223.8	102.1	1.8	30.9	0.0	44.0	7.0	2.0	3.3	13.3	3.4	60.6	3.8	39.2	46.9	2.0	7.3	0.0	5.5	1.1	2.8	1.4	176.0	1.5	12.3	23.9	32.7	2.1	0.3	374.7	64.7	338.9	0.9	8.5	0.7	7.0	67.2	3.6	49.4	5.4	2.4
COL8A1	"C3orf7, MGC9568"	ENSG00000144810	"Collagen type VIII alpha 1 chain"	P27658	3	99638475-99799226	"Plasma proteins, Predicted secreted proteins"	"Angiogenesis, Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 246.8;Fibroblasts: 53.3;Hepatic stellate cells: 102.8;Smooth muscle cells: 51.6"	"Cancer enhanced"	"Detected in all"		"thyroid cancer: 34.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 1098.3;hTERT-RPE1: 431.9;LHCN-M2: 313.0;TIME: 471.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA053107	Enhanced		Supported	Vesicles	"Secreted to extracellular matrix"	NA	NA				"Cluster 46: Fibroblasts - ECM organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	Vesicles		"HPA053107: AB_2682046"	"unprognostic (3.13e-2)"	"unprognostic (2.92e-2)"	"unprognostic (2.27e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.07e-3)"	"unprognostic (2.49e-1)"	"unprognostic (2.31e-2)"	"unprognostic (4.83e-2)"	"unprognostic (2.62e-2)"	"unprognostic (4.79e-2)"	"unprognostic (3.58e-2)"	"unprognostic (3.71e-1)"	"prognostic unfavorable (9.39e-8)"	"unprognostic (2.98e-3)"	"unprognostic (1.72e-1)"	"unprognostic (1.38e-2)"	"unprognostic (1.32e-3)"	33.0	7.0	1.7	5.8	2.9	0.0	5.7	1.8	2.6	3.8	4.4	12.4	1.0	5.2	2.7	11.1	9.1	10.8	39.1	1.3	3.0	5.9	0.9	32.8	0.9	3.1	3.9	9.2	1.2	17.9	11.3	4.2	3.4	12.7	6.9	0.5	7.0	12.0	2.3	3.2	3.7	31.5	2.7	1.0	5.3	0.5	2.6	0.4	27.5	7.8	0.5	25.0	5.4	2.5	0.1	0.4	3.0	0.3	142.2	236.4	0.2	68.5	45.7	69.6	138.6	0.0	0.3	0.1	5.9	1098.3	1.9	0.1	0.4	88.2	157.8	0.1	0.2	0.1	7.9	0.0	26.8	0.0	0.1	142.8	3.2	52.6	82.9	431.9	129.4	0.0	0.1	0.2	313.0	0.0	0.0	0.0	2.6	0.0	0.9	0.0	0.0	0.0	144.3	0.0	0.0	0.0	0.0	0.0	0.0	20.8	0.1	0.2	471.5	31.0	24.1	1.6	34.2	0.1	0.0	0.1	58.4	0.0	241.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	2.9	1.8	2.6	1.3	3.0	3.1	3.9	3.4	2.7	2.6	2.5	4.4	246.8	22.1	0.0	0.4	0.8	0.5	2.8	14.8	0.4	1.8	5.2	4.9	4.3	3.9	9.2	0.0	0.1	0.9	0.0	0.0	0.1	1.3	0.2	2.6	14.1	0.0	0.0	1.9	0.0	0.3	53.3	2.0	0.3	5.1	0.2	102.8	0.8	0.1	0.0	0.7	0.0	0.0	1.9	2.3	1.0	2.1	0.8	1.8	4.7	0.2	0.7	2.1	9.0	0.6	0.1	0.0	9.4	0.5	0.2	0.0	1.6	1.0	0.6	0.0	1.9	51.6	0.3	0.3	1.0	0.6	0.4	0.9	0.1	0.0	0.5
COMMD1	"C2orf5, MGC27155, MURR1"	ENSG00000173163	"Copper metabolism domain containing 1"	Q8N668	2	61888724-62147247	"Predicted intracellular proteins"	"Protein transport, Transcription, Transcription regulation, Transport, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034633, HPA049223"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 24: NB-4 - Immune response"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm	Cytosol	"HPA034633: AB_10601800, HPA049223: AB_2680680"	"unprognostic (6.08e-2)"	"unprognostic (2.34e-2)"	"unprognostic (2.83e-1)"	"unprognostic (1.43e-2)"	"unprognostic (2.30e-1)"	"unprognostic (1.22e-2)"	"unprognostic (5.58e-2)"	"unprognostic (1.07e-1)"	"unprognostic (4.93e-1)"	"unprognostic (3.41e-2)"	"unprognostic (2.26e-1)"	"unprognostic (2.07e-1)"	"unprognostic (2.32e-1)"	"unprognostic (6.71e-2)"	"unprognostic (1.27e-1)"	"unprognostic (5.51e-2)"	"unprognostic (2.77e-1)"	20.8	26.4	22.2	21.9	23.4	20.4	27.0	25.2	33.0	23.0	22.9	18.6	22.6	20.0	30.1	24.8	20.9	20.2	54.7	23.5	22.9	31.2	35.9	18.7	23.5	22.1	22.1	21.3	24.1	24.4	14.8	26.5	22.6	22.2	22.6	20.1	33.5	20.2	35.2	22.2	14.9	29.9	22.4	20.6	19.2	24.4	22.2	20.7	28.1	38.1	25.5	23.9	19.8	24.1	23.2	29.1	32.0	25.4	41.2	41.2	27.4	27.2	45.6	53.7	37.9	50.1	20.4	40.4	22.3	50.8	45.8	17.6	18.0	33.1	55.8	43.9	21.1	31.5	16.3	56.0	35.1	49.6	23.8	34.6	37.7	26.1	30.8	39.2	54.6	23.2	19.6	64.3	56.7	43.6	38.6	87.4	27.9	19.0	39.0	27.1	42.4	46.7	49.3	25.0	19.5	21.7	30.7	50.9	28.6	31.8	32.4	21.4	25.9	48.1	41.5	30.2	42.4	26.6	22.9	48.6	26.5	42.8	42.8	62.4	96.2	48.4	63.0	86.5	63.4	91.8	71.5	72.0	117.3	84.7	68.1	73.8	8.1	91.1	78.4	109.5	88.8	110.8	22.2	23.4	25.2	33.0	23.5	22.9	22.1	22.1	22.6	22.4	22.2	24.1	53.0	35.3	33.8	56.8	38.2	54.4	73.8	98.7	47.8	35.4	47.0	72.4	176.7	41.5	57.3	35.0	10.4	127.3	37.3	27.4	129.1	71.5	195.6	50.6	52.1	53.2	21.6	43.1	91.9	65.1	75.5	67.6	32.1	47.2	57.7	60.4	52.5	72.4	101.7	28.6	78.4	29.8	63.1	36.0	81.3	163.5	41.3	46.3	83.6	71.2	118.6	45.3	30.9	89.5	109.7	57.1	37.1	49.7	71.5	48.9	49.0	192.3	49.1	33.2	32.9	57.6	97.2	124.5	58.7	49.6	61.7	147.2	38.6	81.6	30.1	64.0
COMMD10	PTD002	ENSG00000145781	"COMM domain containing 10"	Q9Y6G5	5	116085016-116412762	"Predicted intracellular proteins"	"Transcription, Transcription regulation, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Microglial cells: 184.6;Oligodendrocyte precursor cells: 142.7;Oligodendrocytes: 236.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045441, HPA054156"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm		"HPA045441: AB_10961905, HPA054156: "	"unprognostic (1.14e-1)"	"unprognostic (2.15e-2)"	"unprognostic (5.38e-2)"	"unprognostic (5.72e-2)"	"unprognostic (1.79e-1)"	"unprognostic (5.72e-3)"	"unprognostic (2.12e-2)"	"unprognostic (1.51e-1)"	"unprognostic (3.02e-2)"	"unprognostic (2.64e-1)"	"unprognostic (2.07e-1)"	"unprognostic (3.14e-1)"	"unprognostic (1.84e-3)"	"prognostic unfavorable (2.99e-4)"	"unprognostic (9.47e-2)"	"prognostic unfavorable (6.93e-4)"	"unprognostic (1.59e-1)"	19.4	24.1	12.5	14.2	12.4	14.9	23.1	12.8	15.9	19.2	14.4	17.0	13.0	16.7	32.2	15.6	12.9	17.3	31.3	11.7	13.3	35.4	24.6	13.9	22.1	12.8	13.2	13.9	24.1	25.4	14.3	19.6	13.4	20.7	20.1	17.1	30.7	17.0	14.3	9.6	13.8	19.6	13.5	18.6	16.3	8.1	13.2	16.3	27.4	17.5	20.3	18.0	13.6	14.7	34.7	36.7	37.5	20.0	27.3	37.1	40.2	26.5	30.0	37.5	31.0	29.2	43.7	17.9	29.0	37.9	75.0	18.6	20.8	42.6	56.9	49.3	14.6	22.1	10.7	22.9	30.8	17.5	37.1	23.7	28.7	22.4	29.2	31.1	37.9	25.2	13.6	12.1	50.2	24.2	32.9	41.9	32.7	26.8	16.9	30.9	40.1	51.2	54.7	21.8	20.2	26.0	31.3	30.5	39.7	28.1	34.6	64.1	20.9	31.5	38.5	15.3	46.0	11.9	16.3	45.8	32.1	63.2	36.5	13.6	24.6	18.3	9.9	29.7	13.7	16.2	12.9	12.8	32.7	11.3	12.5	13.0	4.7	22.7	31.0	24.9	15.3	18.9	12.5	12.4	12.8	15.9	11.7	13.3	12.8	13.2	13.4	13.5	13.2	14.7	25.7	9.6	20.0	97.3	36.7	22.2	30.4	54.0	17.6	15.7	28.1	18.3	48.9	11.5	29.5	23.9	6.2	44.9	16.9	11.5	92.0	26.2	1.9	15.8	22.2	24.0	10.7	18.5	84.8	15.1	53.4	25.0	27.0	22.8	46.3	22.5	26.4	15.1	48.7	16.8	90.5	25.1	46.8	28.7	38.4	3.7	21.1	33.1	32.0	184.6	27.1	30.2	15.5	142.7	236.7	17.1	17.2	20.3	30.6	33.1	17.3	101.3	10.4	20.9	0.0	13.4	22.4	8.7	15.6	20.5	25.1	49.5	28.4	36.3	25.5	32.0
COMMD4	FLJ20452	ENSG00000140365	"COMM domain containing 4"	Q9H0A8	15	75336020-75343224	"Predicted intracellular proteins"	"Transcription, Transcription regulation, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039935, HPA066957"	Uncertain		Supported	"Vesicles,Plasma membrane,Cytosol"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 43: Testis - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Cytosol	"Vesicles, Plasma membrane"	"HPA039935: , HPA066957: AB_2685754"	"unprognostic (7.77e-2)"	"unprognostic (3.07e-3)"	"unprognostic (1.03e-1)"	"unprognostic (6.57e-3)"	"unprognostic (1.32e-1)"	"unprognostic (1.89e-1)"	"unprognostic (1.49e-1)"	"unprognostic (2.60e-1)"	"unprognostic (9.11e-2)"	"unprognostic (1.78e-3)"	"unprognostic (2.01e-1)"	"unprognostic (2.65e-1)"	"unprognostic (1.39e-3)"	"unprognostic (2.51e-1)"	"unprognostic (2.27e-1)"	"unprognostic (1.96e-1)"	"unprognostic (5.07e-2)"	36.2	72.3	38.8	33.5	39.4	52.9	36.8	40.5	50.4	31.1	43.7	41.6	48.3	30.3	30.2	39.9	34.6	37.3	38.9	36.9	39.7	54.6	51.0	34.6	44.7	39.5	38.1	24.4	33.8	48.9	33.9	31.2	38.6	34.2	33.8	13.4	43.4	34.0	30.3	35.0	42.2	24.7	40.8	41.3	42.5	81.2	42.4	53.3	38.8	15.3	36.7	33.6	31.8	42.0	138.2	222.5	97.5	124.8	42.3	64.9	98.5	98.8	106.2	191.2	196.6	133.8	184.0	88.8	100.2	79.5	168.8	144.8	175.2	116.5	82.7	70.1	242.4	104.8	169.8	151.0	76.4	79.4	111.0	74.3	63.6	116.2	21.9	48.4	96.5	103.6	108.2	128.1	147.1	179.7	71.0	117.4	140.9	75.2	127.9	127.5	137.4	127.8	98.6	127.8	79.2	114.8	131.2	105.1	169.8	63.8	164.7	160.9	78.6	135.3	119.2	125.8	184.8	93.4	218.7	101.4	138.9	181.9	125.4	27.0	44.1	40.7	84.7	61.8	52.8	47.5	51.7	63.2	50.0	46.4	31.9	47.4	9.5	76.8	55.6	70.6	87.6	39.4	38.8	39.4	40.5	50.4	36.9	39.7	39.5	38.1	38.6	40.8	42.4	42.0	43.7	28.9	52.4	15.0	26.2	27.0	44.8	58.5	28.5	40.7	44.3	50.3	18.7	38.6	46.2	35.0	31.3	80.9	34.8	59.6	58.7	72.6	12.2	37.1	44.9	42.7	30.5	60.8	9.0	78.7	107.0	43.4	33.1	45.7	41.8	91.1	37.5	41.9	127.5	16.8	8.8	72.8	44.7	35.8	27.0	17.6	49.0	41.3	37.4	11.2	28.5	78.1	53.5	7.1	17.6	72.4	61.7	34.3	43.0	26.6	71.2	98.1	39.8	49.4	46.0	36.1	59.3	152.9	63.5	34.3	30.7	50.8	32.2	53.4	58.7	48.7
COMMD5	"FLJ13008, HCaRG, HT002"	ENSG00000170619	"COMM domain containing 5"	Q9GZQ3	8	144841042-144853736	"Predicted intracellular proteins"	"Transcription, Transcription regulation, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046905			Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 35: Non-specific - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 41: Macrophages - Immune response"	"Nucleoplasm, Cytosol"		"HPA046905: AB_2732535"	"unprognostic (2.95e-2)"	"unprognostic (7.62e-2)"	"unprognostic (2.63e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.36e-1)"	"unprognostic (9.13e-2)"	"unprognostic (5.05e-3)"	"unprognostic (6.82e-2)"	"unprognostic (3.24e-1)"	"unprognostic (9.35e-2)"	"unprognostic (2.25e-1)"	"unprognostic (7.97e-3)"	"unprognostic (1.25e-2)"	"unprognostic (8.58e-2)"	"unprognostic (3.43e-1)"	"unprognostic (2.02e-1)"	"unprognostic (7.73e-3)"	17.0	22.9	16.6	11.9	17.0	21.2	15.7	18.1	19.7	14.9	15.6	15.6	12.1	16.1	9.7	20.1	14.2	11.3	18.9	16.2	16.3	18.7	23.2	15.1	16.2	18.1	16.9	12.8	16.7	14.5	17.7	11.0	17.5	16.4	6.8	3.8	15.5	10.7	18.2	16.8	14.9	8.8	17.3	21.9	16.4	11.2	17.2	11.3	16.4	11.4	10.6	15.9	14.3	18.7	32.8	38.3	17.9	24.2	21.8	17.4	16.0	18.5	19.7	30.9	24.2	23.0	25.1	22.3	40.4	22.6	17.9	21.7	22.5	30.6	13.2	29.6	31.7	47.1	35.3	38.8	28.8	16.0	39.6	23.1	27.6	21.2	15.7	15.0	24.2	7.9	34.2	39.8	25.2	59.4	14.6	16.8	27.1	45.6	75.3	18.8	20.4	34.8	30.2	28.3	41.6	36.6	30.9	18.5	27.4	11.9	36.3	29.7	22.4	23.1	45.9	33.3	36.8	16.6	19.2	21.3	32.5	29.7	30.5	66.1	84.3	76.6	55.8	72.4	49.8	60.7	42.4	54.9	74.2	54.1	41.6	46.7	52.3	69.2	47.0	26.8	71.2	70.1	16.6	17.0	18.1	19.7	16.2	16.3	18.1	16.9	17.5	17.3	17.2	18.7	27.8	12.8	15.0	8.5	27.5	27.8	20.4	46.4	11.4	12.3	22.8	23.9	10.9	21.5	25.0	16.5	12.5	35.8	39.0	26.4	39.2	46.4	3.5	19.6	16.4	27.6	19.9	14.1	6.2	40.1	23.8	22.7	13.7	18.6	24.8	15.6	25.7	19.0	70.0	11.8	7.7	16.8	34.6	31.4	27.6	2.5	18.6	34.2	26.6	5.6	37.2	22.3	38.1	6.6	9.5	50.0	18.4	23.3	20.3	42.7	29.8	44.6	28.2	15.2	13.1	16.0	24.6	12.1	17.2	18.4	30.0	33.1	27.0	28.7	18.9	28.5
COMMD8	FLJ20502	ENSG00000169019	"COMM domain containing 8"	Q9NX08	4	47450787-47463702	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Proximal tubular cells: 231.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035887	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Nucleoplasm, Cytosol"		"HPA035887: AB_10600702"	"unprognostic (9.04e-2)"	"unprognostic (1.40e-1)"	"unprognostic (8.55e-3)"	"unprognostic (5.13e-2)"	"unprognostic (2.51e-1)"	"unprognostic (1.74e-2)"	"prognostic unfavorable (1.40e-4)"	"unprognostic (1.07e-2)"	"unprognostic (4.24e-2)"	"unprognostic (3.47e-2)"	"unprognostic (1.78e-1)"	"unprognostic (3.78e-2)"	"prognostic favorable (2.71e-5)"	"unprognostic (1.06e-1)"	"unprognostic (2.10e-1)"	"unprognostic (7.76e-2)"	"unprognostic (7.13e-2)"	13.4	15.5	9.7	20.3	9.8	21.4	13.6	10.0	14.6	11.8	13.0	17.7	18.4	10.4	22.6	24.1	11.3	13.7	27.2	9.5	12.2	45.3	12.7	13.5	30.4	9.9	10.3	10.2	10.4	26.8	13.4	19.0	10.0	10.6	18.1	13.5	8.4	10.0	8.8	17.5	19.0	15.0	10.4	18.1	14.3	24.1	10.3	21.6	21.3	12.6	25.4	16.8	11.8	10.3	32.6	17.6	15.2	7.8	31.6	44.8	21.1	47.8	31.5	30.7	41.5	29.9	37.4	51.7	39.0	45.3	69.4	17.0	49.4	39.1	55.0	30.8	22.1	29.8	17.7	23.2	43.0	73.6	36.8	38.7	51.6	29.2	32.3	28.5	39.5	33.7	22.5	20.6	75.8	18.1	44.1	59.4	10.4	21.8	22.8	21.8	34.7	11.2	88.1	26.3	29.8	15.2	19.9	16.1	39.6	26.5	29.5	48.0	32.7	43.6	41.8	39.2	57.9	21.6	27.6	42.1	47.3	95.2	32.2	114.3	58.2	68.9	44.6	80.4	48.1	48.1	40.5	44.9	74.0	43.4	37.5	43.2	29.0	57.4	89.4	34.3	51.2	71.4	9.7	9.8	10.0	14.6	9.5	12.2	9.9	10.3	10.0	10.4	10.3	10.3	31.3	22.4	16.5	3.3	41.6	22.6	11.4	60.5	21.6	18.2	12.8	16.6	46.1	18.6	32.6	29.5	4.2	86.6	39.1	20.9	107.6	42.8	68.4	43.0	21.6	26.7	21.0	14.5	5.5	46.3	116.3	28.6	16.8	19.2	33.0	11.3	22.5	12.7	90.9	6.7	7.3	19.4	42.7	54.4	42.1	18.9	54.3	50.7	12.4	4.7	82.0	37.2	72.1	2.5	5.3	25.1	23.8	40.6	22.9	8.6	28.0	231.8	57.4	23.8	19.7	16.9	29.9	141.5	59.0	37.3	30.0	105.8	53.9	36.9	28.8	10.2
COMMD9	"FLJ31106, HSPC166"	ENSG00000110442	"COMM domain containing 9"	Q9P000	11	36269284-36289449	"Predicted intracellular proteins"	"Ion transport, Sodium transport, Transcription, Transcription regulation, Transport, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Hofbauer cells: 105.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA009142	Uncertain		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 18: U-2197 - ECM organization"	"Cluster 4: Macrophages - Innate immune response"	Nucleoplasm	"Golgi apparatus, Cytosol"	"HPA009142: AB_1847105"	"unprognostic (1.56e-2)"	"unprognostic (4.75e-3)"	"unprognostic (7.57e-2)"	"unprognostic (4.40e-3)"	"unprognostic (1.91e-1)"	"unprognostic (2.12e-1)"	"unprognostic (1.16e-3)"	"unprognostic (2.62e-1)"	"unprognostic (6.15e-2)"	"prognostic favorable (8.54e-4)"	"unprognostic (4.94e-2)"	"unprognostic (2.40e-1)"	"unprognostic (6.08e-3)"	"unprognostic (7.24e-2)"	"unprognostic (1.71e-1)"	"unprognostic (7.31e-3)"	"unprognostic (1.88e-1)"	26.8	32.1	33.8	21.8	34.1	50.8	24.3	35.1	36.7	17.2	29.6	19.6	21.1	14.1	25.1	24.9	20.3	20.5	31.1	33.8	33.8	38.7	36.6	26.8	26.0	34.2	34.4	19.4	26.4	27.4	23.2	24.8	33.9	14.0	24.2	20.3	21.9	13.3	64.2	27.1	20.2	21.9	36.9	26.8	19.7	14.9	36.0	30.6	25.1	61.7	32.0	20.6	16.6	39.1	28.8	33.4	36.1	38.2	54.5	37.8	20.0	33.6	42.6	74.7	69.8	27.3	23.9	33.0	32.5	67.1	57.5	41.4	64.0	45.2	69.6	39.9	75.2	18.2	57.6	48.0	51.0	71.6	52.3	48.0	49.5	40.9	25.0	38.5	62.2	43.3	45.7	34.7	59.4	36.9	47.9	49.6	38.5	55.6	70.3	52.1	81.7	38.9	78.6	26.6	44.1	49.2	47.9	47.1	43.6	29.2	102.7	27.0	41.9	45.0	34.4	107.9	49.8	24.3	53.2	37.2	51.8	66.4	44.0	85.6	376.6	173.7	91.4	359.0	86.8	130.7	87.5	88.4	383.6	138.3	99.8	83.4	42.7	94.8	300.9	145.8	114.5	315.2	33.8	34.1	35.1	36.7	33.8	33.8	34.2	34.4	33.9	36.9	36.0	39.1	26.9	22.4	29.4	2.6	27.0	15.3	12.7	37.4	13.1	16.6	25.6	38.7	29.9	12.8	20.2	18.4	10.4	43.2	28.3	16.9	78.2	70.1	9.5	13.2	20.3	22.8	25.7	23.1	9.4	46.4	52.9	21.2	11.7	17.0	19.0	25.6	15.4	17.1	105.1	5.0	8.7	20.4	34.6	59.5	35.6	28.9	17.7	57.5	24.9	1.9	61.3	36.3	33.0	4.5	8.8	46.5	17.7	11.7	10.4	4.9	30.3	62.5	8.5	22.9	13.1	12.3	22.8	32.8	33.3	19.6	21.6	24.9	19.2	28.4	24.6	12.0
COPB1	COPB	ENSG00000129083	"COPI coat complex subunit beta 1"	P53618	11	14443440-14500027	"Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"ER-Golgi transport, Host-virus interaction, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012338, HPA043954, HPA064403"	Supported		Enhanced	"Golgi apparatus,Vesicles,Cytosol"		NA	NA		330000	"Cluster 44: Non-specific - Transcription"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 10: Non-specific - Unknown function"	"Golgi apparatus, Vesicles, Cytosol"		"CAB012338: AB_726922, HPA043954: AB_2678746, HPA064403: AB_2685258"	"unprognostic (2.35e-1)"	"unprognostic (1.02e-3)"	"unprognostic (1.36e-2)"	"unprognostic (4.76e-2)"	"unprognostic (3.48e-1)"	"prognostic unfavorable (6.91e-4)"	"prognostic unfavorable (5.63e-7)"	"unprognostic (4.69e-3)"	"unprognostic (3.42e-2)"	"unprognostic (3.60e-1)"	"prognostic unfavorable (8.04e-4)"	"unprognostic (8.94e-2)"	"unprognostic (1.78e-2)"	"unprognostic (3.02e-2)"	"unprognostic (8.00e-2)"	"unprognostic (3.87e-1)"	"unprognostic (1.69e-2)"	48.1	47.1	19.9	55.0	21.8	79.8	62.6	26.2	25.3	64.9	44.7	59.8	57.7	52.6	69.3	46.7	49.2	54.9	43.7	20.1	23.6	65.3	73.6	49.9	59.1	24.2	21.8	49.1	59.2	67.6	48.4	69.2	23.7	66.9	67.1	39.3	67.5	53.8	33.1	36.6	58.8	61.1	23.5	46.3	59.7	46.8	23.0	68.1	81.0	38.1	64.5	60.4	40.0	27.6	134.9	113.6	118.6	89.4	193.1	221.3	95.9	199.2	206.5	173.1	202.0	89.1	203.5	130.1	87.1	252.9	164.6	144.7	134.6	133.3	212.1	122.7	114.0	138.3	74.3	135.8	171.3	128.9	134.4	156.3	172.4	116.0	217.8	158.9	183.7	71.6	104.5	103.8	221.1	101.6	117.2	78.7	61.7	163.3	123.1	94.9	163.1	89.0	156.1	123.3	75.6	81.2	154.2	123.2	104.8	135.5	112.3	110.1	189.5	166.2	85.4	181.3	110.1	55.2	100.5	143.8	125.1	79.2	158.6	52.8	38.7	43.5	45.7	47.8	55.7	38.4	38.1	47.6	52.3	32.0	37.8	39.8	31.2	44.6	49.8	31.1	44.8	43.2	19.9	21.8	26.2	25.3	20.1	23.6	24.2	21.8	23.7	23.5	23.0	27.6	55.6	109.0	63.2	29.0	64.3	38.9	59.7	82.6	52.3	28.4	43.0	27.9	31.3	35.8	107.8	44.1	27.1	65.4	71.2	55.9	41.1	77.1	17.2	72.6	81.4	55.5	43.8	50.9	36.9	81.7	69.6	70.5	63.2	72.5	65.2	50.7	51.4	58.1	60.9	18.5	39.1	87.5	61.1	50.7	43.5	10.7	51.0	61.5	21.4	35.6	70.1	34.0	44.3	32.6	49.6	93.6	37.5	55.3	107.4	54.3	60.6	57.3	131.9	29.5	52.6	60.8	78.7	87.5	64.3	48.7	35.8	117.0	77.0	49.3	51.5	60.7
COPG1	COPG	ENSG00000181789	"COPI coat complex subunit gamma 1"	Q9Y678	3	129249606-129277773	"Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"ER-Golgi transport, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037866, HPA037867, HPA045712"	Supported		Supported	"Nucleoplasm,Golgi apparatus,Cytosol"		No	No		57000	"Cluster 18: Basophils - Vesicular transport"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 27: Mucus-secreting cells - Mucin production"	"Golgi apparatus"	"Nucleoplasm, Cytosol"	"HPA037866: AB_2675710, HPA037867: AB_10697085, HPA045712: AB_2679428"	"unprognostic (8.86e-2)"	"unprognostic (2.22e-2)"	"unprognostic (4.22e-3)"	"unprognostic (1.15e-1)"	"unprognostic (1.81e-1)"	"unprognostic (9.17e-2)"	"prognostic unfavorable (1.22e-6)"	"unprognostic (6.66e-3)"	"unprognostic (1.05e-1)"	"unprognostic (5.64e-2)"	"unprognostic (8.90e-3)"	"unprognostic (3.29e-1)"	"unprognostic (1.23e-3)"	"unprognostic (2.10e-1)"	"unprognostic (3.20e-1)"	"unprognostic (2.99e-1)"	"unprognostic (1.60e-1)"	84.7	111.0	66.6	59.0	68.2	59.4	79.8	69.5	80.7	100.4	93.0	107.6	86.7	75.5	157.4	86.8	70.0	53.8	95.5	70.3	73.7	82.7	149.5	84.4	54.8	74.3	71.5	77.9	162.4	96.3	139.0	81.9	77.4	107.7	109.8	33.4	130.7	72.7	75.7	74.4	86.7	72.2	66.4	81.9	114.0	46.5	73.2	53.5	83.3	43.2	67.1	67.2	72.2	73.2	167.8	83.2	119.1	104.0	272.8	219.0	126.9	266.3	251.8	179.5	225.2	153.9	101.2	91.1	150.8	380.7	145.6	98.4	99.5	157.2	193.6	112.0	41.4	151.9	103.2	252.6	247.9	116.4	156.4	230.9	135.6	143.8	235.0	196.1	164.3	68.9	54.2	213.6	219.2	253.4	68.7	117.7	71.3	243.6	100.9	73.3	111.8	178.3	227.3	136.7	74.1	86.1	204.2	150.3	255.9	129.8	167.1	167.6	223.9	96.9	91.7	207.2	104.2	165.7	86.1	158.9	236.4	86.9	190.0	79.1	49.9	37.2	44.1	59.2	53.6	24.9	39.8	43.9	57.0	26.9	30.0	36.2	37.2	57.0	57.3	52.2	43.8	56.2	66.6	68.2	69.5	80.7	70.3	73.7	74.3	71.5	77.4	66.4	73.2	73.2	16.6	16.0	31.5	7.8	19.2	8.8	16.9	35.4	12.0	9.2	18.9	8.6	23.3	17.2	34.6	27.6	4.2	55.6	19.7	77.0	43.0	44.5	10.4	26.2	27.7	22.8	38.6	22.9	14.1	46.5	63.1	32.5	53.0	36.9	15.2	28.6	28.9	56.5	39.0	5.0	14.8	75.1	22.4	31.2	14.8	4.7	41.0	21.6	23.2	7.5	36.5	12.7	18.6	4.5	11.8	40.8	44.6	31.2	68.4	24.4	64.5	39.5	32.6	7.1	19.7	20.2	33.3	24.3	17.0	16.4	10.2	72.2	19.4	27.7	44.6	20.6
COPRS	"C17orf79, COPR5, HSA272196, TTP1"	ENSG00000172301	"Coordinator of PRMT5 and differentiation stimulator"	Q9NQ92	17	31851871-31859291	"Predicted intracellular proteins"	"Myogenesis, Transcription, Transcription regulation"	"Chromatin regulator"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 253.2;Late spermatids: 288.9;Spermatocytes: 575.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA052552	Approved		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 68: Epididymis - Unknown function"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm	"Plasma membrane, Cytosol"	"HPA052552: AB_2681868"	"unprognostic (1.65e-2)"	"unprognostic (4.88e-2)"	"unprognostic (2.46e-1)"	"unprognostic (4.01e-3)"	"unprognostic (3.12e-2)"	"unprognostic (1.12e-2)"	"prognostic unfavorable (3.69e-4)"	"unprognostic (6.88e-2)"	"unprognostic (3.10e-1)"	"unprognostic (4.44e-2)"	"unprognostic (5.28e-3)"	"unprognostic (1.01e-2)"	"unprognostic (1.19e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.48e-1)"	"unprognostic (3.11e-2)"	51.1	46.5	127.4	20.1	130.0	14.2	49.8	124.6	172.8	42.8	129.5	99.0	16.0	43.4	117.6	26.4	51.7	32.0	66.1	128.7	136.2	55.8	68.1	33.9	21.0	123.6	126.7	51.7	41.9	49.0	67.4	19.7	128.8	60.2	27.4	56.0	35.4	46.3	53.5	30.3	31.1	44.4	123.3	25.1	51.6	241.4	131.2	13.2	63.2	53.3	27.8	57.1	33.3	124.1	101.5	132.9	64.4	66.6	104.3	99.5	45.2	109.7	140.3	125.8	127.8	83.4	27.0	53.0	58.8	135.1	245.0	58.5	116.0	67.6	142.3	18.7	153.8	15.4	79.7	99.5	105.5	53.2	43.4	64.2	87.4	169.3	92.4	135.7	68.6	75.2	75.0	46.9	139.6	89.9	79.6	170.7	49.1	65.2	62.8	61.8	120.8	104.4	74.5	62.8	58.4	44.2	65.9	32.6	107.1	56.1	104.4	57.9	37.0	327.8	85.9	116.6	156.3	76.2	77.2	58.3	170.8	50.1	44.9	1.8	2.0	0.0	0.6	2.0	1.6	1.9	0.5	0.1	2.6	3.6	0.3	0.3	0.6	0.0	0.9	1.0	0.8	0.3	127.4	130.0	124.6	172.8	128.7	136.2	123.6	126.7	128.8	123.3	131.2	124.1	54.2	22.4	8.3	13.7	20.9	34.4	69.0	15.3	29.6	43.1	79.2	88.4	78.9	68.6	13.4	86.5	10.4	31.9	10.7	12.1	225.0	99.6	253.2	142.2	38.5	53.5	19.7	18.7	14.6	80.8	54.9	65.7	14.3	40.5	3.8	39.9	62.4	95.4	87.6	26.9	14.8	15.9	40.7	30.3	34.7	288.9	62.4	36.5	58.7	7.5	47.9	136.3	9.2	3.5	9.2	70.7	8.4	65.1	27.4	127.4	6.4	212.0	55.8	43.0	19.7	46.9	63.5	575.6	63.8	21.4	31.7	27.4	11.2	49.6	21.3	39.6
COPS2	"ALIEN, CSN2, TRIP15"	ENSG00000166200	"COP9 signalosome subunit 2"	P61201	15	49106068-49155661	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016867, HPA018271, HPA061071"	Approved		Supported	"Vesicles,Cytokinetic bridge"		Yes	No		190000	"Cluster 27: Non-specific - Gene expression"	"Cluster 59: Non-specific - Translation"	"Cluster 18: U-2197 - ECM organization"	"Cluster 10: Non-specific - Unknown function"	Vesicles	"Cytokinetic bridge"	"HPA016867: AB_1858336, HPA018271: AB_1858335, HPA061071: AB_2684424"	"unprognostic (3.47e-1)"	"unprognostic (2.28e-2)"	"unprognostic (1.66e-1)"	"unprognostic (7.20e-2)"	"unprognostic (1.86e-1)"	"unprognostic (7.84e-3)"	"unprognostic (1.04e-1)"	"unprognostic (6.77e-2)"	"unprognostic (2.49e-2)"	"unprognostic (6.09e-2)"	"unprognostic (3.86e-3)"	"unprognostic (1.42e-1)"	"unprognostic (4.35e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.97e-1)"	"unprognostic (5.62e-2)"	"unprognostic (1.10e-3)"	61.7	43.4	24.8	34.4	28.5	124.5	67.0	35.0	36.8	61.9	25.3	43.2	43.3	58.4	44.0	63.2	43.2	53.7	61.5	26.1	30.4	60.8	57.6	35.0	45.5	30.9	27.7	76.7	54.0	65.7	26.4	45.0	32.8	45.2	41.6	32.2	40.0	47.0	92.6	35.5	37.2	56.5	35.2	32.0	36.4	51.0	27.5	49.6	61.8	112.1	48.8	59.0	35.3	41.7	92.0	53.1	111.6	94.4	134.2	189.9	76.7	157.3	149.8	135.4	123.5	113.0	49.1	151.1	105.2	152.2	108.7	131.9	160.3	130.9	148.0	103.3	64.5	141.0	105.4	91.7	102.6	134.7	70.7	161.2	104.3	110.4	193.3	149.3	144.0	82.5	184.4	78.8	149.3	49.5	72.3	67.3	72.6	128.4	68.9	78.2	105.2	227.7	143.5	136.5	108.4	78.6	90.7	96.4	127.8	129.4	95.6	133.3	93.4	132.1	71.0	249.6	167.9	71.0	196.3	191.0	123.4	215.1	109.4	11.7	17.9	12.2	13.1	23.5	24.4	14.6	19.7	19.2	21.0	13.9	24.8	16.2	7.4	16.6	22.9	13.3	28.4	16.0	24.8	28.5	35.0	36.8	26.1	30.4	30.9	27.7	32.8	35.2	27.5	41.7	72.8	76.9	56.1	14.4	50.0	87.1	57.1	90.8	80.8	23.2	47.6	59.3	104.3	27.1	69.8	23.9	10.4	56.1	48.2	18.5	54.8	40.3	28.2	56.7	91.6	53.6	20.8	50.1	35.2	29.9	71.0	79.6	36.2	94.0	52.6	39.3	46.1	32.5	43.9	33.7	36.1	25.1	32.6	47.5	44.9	21.6	55.3	46.1	35.6	19.7	49.3	24.8	27.8	21.6	48.7	35.9	21.6	53.4	63.5	53.0	41.0	84.8	47.4	19.7	19.7	74.6	109.0	93.1	43.3	63.2	98.9	131.9	54.0	58.6	34.6	64.4
COPS3	"CSN3, SGN3"	ENSG00000141030	"COP9 signalosome subunit 3"	Q9UNS2	17	17246616-17281273	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 262.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021997, HPA050557"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA		38000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	Cytosol	"HPA021997: AB_1847152, HPA050557: AB_2681176"	"unprognostic (3.35e-2)"	"unprognostic (3.98e-3)"	"unprognostic (1.84e-2)"	"unprognostic (6.29e-2)"	"unprognostic (6.39e-2)"	"unprognostic (1.33e-1)"	"unprognostic (2.56e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.91e-3)"	"unprognostic (2.11e-2)"	"unprognostic (6.37e-3)"	"prognostic unfavorable (1.56e-4)"	"prognostic unfavorable (8.65e-5)"	"unprognostic (2.04e-1)"	"unprognostic (2.48e-1)"	"unprognostic (2.40e-1)"	"unprognostic (3.03e-3)"	30.8	29.1	27.6	29.5	29.0	110.1	28.3	29.9	39.9	27.2	24.7	34.5	24.7	26.3	23.8	41.6	24.0	17.2	59.0	29.8	31.8	23.5	29.1	23.0	37.3	30.8	29.7	23.5	44.3	36.4	39.9	29.0	30.7	25.0	29.8	25.4	30.1	25.8	156.7	33.9	24.9	29.1	29.3	26.7	32.5	76.3	28.4	51.2	24.0	100.7	40.9	29.7	29.0	31.1	141.8	128.8	96.0	86.3	46.2	63.8	58.2	102.6	62.6	150.6	119.3	209.7	50.9	196.9	82.5	83.4	67.5	100.8	138.9	104.2	175.3	76.0	182.1	137.6	90.8	87.0	76.4	120.3	146.1	58.0	77.1	104.3	102.1	43.1	90.0	108.2	114.3	70.4	97.0	137.8	217.4	142.9	90.9	156.3	80.4	163.9	178.9	102.5	61.0	55.2	79.7	63.9	94.0	44.9	83.8	286.9	64.6	76.1	63.2	89.7	101.0	164.7	184.5	54.9	74.5	106.0	81.8	113.2	93.4	37.4	43.0	44.0	35.4	51.3	40.7	35.4	40.0	41.3	60.8	39.1	40.4	37.9	55.6	46.0	52.4	30.8	47.7	56.9	27.6	29.0	29.9	39.9	29.8	31.8	30.8	29.7	30.7	29.3	28.4	31.1	32.0	32.1	19.1	11.1	52.7	54.2	43.3	69.0	33.0	23.2	31.1	27.8	50.5	34.3	38.6	14.7	14.6	95.1	52.2	17.1	33.2	52.8	136.1	27.4	30.1	33.3	37.6	117.0	13.6	51.2	84.5	37.5	21.4	33.5	40.0	26.7	22.9	23.1	67.0	25.2	16.3	37.3	44.7	36.4	52.3	79.2	39.7	43.6	35.6	11.2	60.0	41.3	53.5	13.6	16.0	33.4	18.6	38.0	65.6	43.0	27.4	36.6	25.5	38.0	19.7	52.5	49.9	262.3	109.8	50.1	47.6	104.4	51.3	43.9	43.3	36.5
COPS4	CSN4	ENSG00000138663	"COP9 signalosome subunit 4"	Q9BT78	4	83034447-83075818	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036894, HPA042828"	Approved		Supported	"Nuclear speckles"		NA	NA		100000	"Cluster 44: Non-specific - Transcription"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Nuclear speckles"		"HPA036894: AB_10670929, HPA042828: AB_2678191"	"unprognostic (1.82e-3)"	"unprognostic (1.01e-2)"	"prognostic favorable (4.14e-4)"	"unprognostic (7.97e-3)"	"unprognostic (1.39e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.73e-2)"	"unprognostic (1.57e-1)"	"unprognostic (8.96e-2)"	"unprognostic (3.26e-1)"	"unprognostic (3.10e-2)"	"unprognostic (9.21e-2)"	"prognostic favorable (5.21e-6)"	"unprognostic (5.84e-2)"	"unprognostic (3.07e-1)"	"unprognostic (1.72e-1)"	"unprognostic (2.80e-1)"	25.6	38.6	28.4	22.0	30.7	41.0	32.0	26.9	33.5	31.7	26.0	27.4	23.1	30.8	28.8	30.5	26.0	22.5	59.7	30.6	35.0	38.8	29.2	22.2	29.9	28.4	29.9	31.9	24.6	43.7	39.2	30.2	32.0	30.3	25.1	45.6	23.7	30.5	104.8	26.7	22.0	33.3	28.7	22.5	22.4	45.0	30.8	36.2	38.4	84.1	32.7	31.8	23.5	28.9	51.7	30.4	64.1	59.0	56.0	71.7	34.8	67.2	85.7	74.8	66.0	43.7	51.8	86.9	57.3	140.5	41.3	37.7	80.6	68.9	101.1	55.6	56.9	50.4	43.5	42.1	46.3	86.8	135.6	54.4	47.0	55.8	47.8	56.2	101.1	53.5	65.2	48.0	91.9	43.4	105.0	63.6	35.3	81.1	40.6	74.0	48.8	48.1	59.8	47.2	67.7	39.6	45.0	69.4	43.5	43.8	52.7	46.4	66.7	52.2	55.1	39.7	48.6	49.8	32.7	96.8	50.3	55.2	52.8	91.4	37.0	55.2	43.0	50.4	53.9	39.7	47.1	49.7	45.3	38.9	44.7	48.1	8.2	54.6	59.8	29.0	47.6	52.3	28.4	30.7	26.9	33.5	30.6	35.0	28.4	29.9	32.0	28.7	30.8	28.9	25.6	12.8	20.1	21.9	34.1	42.8	42.2	94.5	23.3	38.7	20.1	23.4	81.3	20.0	51.5	20.2	31.3	82.5	36.5	14.5	90.1	42.4	130.6	24.9	27.6	31.9	31.2	26.5	34.7	33.2	62.7	39.9	15.3	21.3	34.2	38.2	20.0	22.4	49.0	26.9	32.9	22.0	67.1	29.2	29.2	38.3	30.7	27.2	33.8	18.7	37.8	62.5	37.0	28.6	32.9	28.2	22.1	42.9	28.6	20.5	22.6	75.7	37.9	44.6	32.9	34.1	42.5	121.2	50.2	29.7	35.2	95.0	32.8	53.3	26.3	34.3
COPS6	"CSN6, MOV34-34KD"	ENSG00000168090	"COP9 signalosome subunit 6"	Q7L5N1	7	100088969-100092187	"Enzymes, Predicted intracellular proteins"	"Host-virus interaction"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044315	Approved		Supported	Nucleoplasm	"Intracellular and membrane"	NA	NA		110000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"HPA044315: AB_10959750"	"unprognostic (1.48e-2)"	"unprognostic (2.43e-2)"	"unprognostic (6.56e-3)"	"unprognostic (1.38e-1)"	"unprognostic (5.84e-2)"	"unprognostic (2.09e-2)"	"unprognostic (3.62e-3)"	"unprognostic (2.93e-2)"	"unprognostic (2.00e-1)"	"unprognostic (2.45e-2)"	"unprognostic (4.96e-2)"	"unprognostic (1.25e-1)"	"prognostic unfavorable (6.72e-4)"	"unprognostic (1.20e-1)"	"unprognostic (3.58e-2)"	"unprognostic (8.57e-2)"	"unprognostic (8.77e-2)"	71.3	85.5	98.5	48.7	103.0	51.8	68.6	102.5	102.0	87.1	99.5	101.3	44.1	86.5	84.0	90.6	78.1	52.9	112.9	101.9	100.7	70.8	71.6	56.5	50.3	99.3	98.4	74.8	60.2	100.8	79.2	64.0	100.4	68.8	57.8	61.4	65.0	74.2	147.3	61.8	58.4	78.5	101.7	63.1	78.4	57.4	98.7	63.1	61.5	152.8	60.6	90.5	74.7	105.0	167.6	233.4	136.2	163.5	116.1	138.4	86.6	147.7	223.5	239.7	174.9	191.9	153.8	114.4	186.1	242.2	267.3	124.1	155.1	247.9	240.4	114.9	242.6	98.2	215.9	149.3	243.3	112.1	97.6	137.5	161.4	259.2	273.9	159.5	333.0	172.7	142.7	160.5	286.4	413.7	251.6	164.8	124.0	241.3	273.2	117.6	226.6	275.4	193.6	153.8	213.4	158.6	152.7	298.5	114.1	176.4	123.7	109.2	177.9	231.3	211.1	280.5	264.8	118.1	140.2	235.3	175.5	150.0	350.6	231.8	187.8	168.2	178.8	206.6	180.7	168.0	176.8	170.9	211.3	170.3	137.4	153.6	73.5	163.5	194.6	157.8	225.8	146.6	98.5	103.0	102.5	102.0	101.9	100.7	99.3	98.4	100.4	101.7	98.7	105.0	87.8	51.3	44.2	24.8	73.4	110.6	118.1	208.1	70.0	108.3	62.8	76.3	166.3	88.6	117.2	86.5	52.1	197.3	84.2	55.1	211.3	138.3	76.5	61.6	103.4	94.9	75.3	69.0	20.9	113.5	133.7	116.0	52.5	48.3	90.7	100.5	90.3	63.2	128.8	95.9	21.0	67.4	158.7	69.6	82.5	197.1	127.7	55.1	156.5	13.1	101.4	147.0	115.4	17.6	24.0	115.1	64.7	125.3	84.3	95.0	84.2	214.2	117.9	127.1	98.6	76.3	261.5	80.5	100.2	81.2	100.3	137.9	82.7	137.9	87.1	96.1
COPS7A	CSN7A	ENSG00000111652	"COP9 signalosome subunit 7A"	Q9UBW8	12	6724014-6731875	"Predicted intracellular proteins"	"Host-virus interaction"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026915	Supported		Supported	Nucleoplasm,Cytosol		NA	NA		54000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 47: Cytotrophoblasts - Unknown function"	Nucleoplasm	Cytosol	"HPA026915: AB_1847156"	"unprognostic (3.50e-1)"	"unprognostic (1.33e-2)"	"unprognostic (3.95e-3)"	"unprognostic (3.26e-1)"	"unprognostic (2.85e-2)"	"unprognostic (1.96e-3)"	"unprognostic (3.91e-2)"	"unprognostic (4.26e-2)"	"unprognostic (1.76e-1)"	"unprognostic (8.24e-3)"	"unprognostic (1.46e-1)"	"unprognostic (1.34e-2)"	"unprognostic (3.61e-3)"	"unprognostic (1.95e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.26e-1)"	"unprognostic (2.27e-1)"	45.0	52.8	69.2	32.9	69.1	19.7	36.1	69.7	71.7	34.1	66.0	44.5	29.9	39.2	46.7	55.2	44.7	32.7	79.1	71.9	70.9	48.3	53.3	34.7	29.9	72.0	72.0	34.8	40.3	71.9	51.1	42.7	71.4	42.8	30.1	46.8	44.5	40.2	103.6	39.2	29.0	43.1	67.3	33.3	41.2	24.0	77.1	22.8	45.8	98.1	30.4	45.8	38.5	67.4	73.3	78.8	34.0	33.3	96.3	114.0	84.9	93.2	107.8	87.6	86.7	54.3	95.0	47.1	37.1	111.2	49.9	55.9	45.7	86.6	75.5	70.3	57.8	47.0	50.1	63.9	84.6	47.1	28.3	106.7	80.6	97.5	183.4	100.1	61.8	29.2	33.3	18.1	116.0	58.7	29.5	30.3	92.9	91.4	64.1	18.8	71.9	47.2	69.0	69.0	19.4	47.2	58.4	67.5	97.2	79.5	29.9	68.0	70.1	90.8	48.4	82.3	85.6	21.0	24.7	38.4	150.6	60.0	104.7	85.9	56.4	86.1	36.3	73.2	35.8	26.2	30.7	32.2	65.3	36.0	30.2	29.8	43.7	31.0	58.9	41.3	30.9	49.9	69.2	69.1	69.7	71.7	71.9	70.9	72.0	72.0	71.4	67.3	77.1	67.4	23.7	16.0	17.5	17.0	14.7	13.9	31.4	39.8	25.0	37.0	29.1	27.6	36.7	22.8	28.0	23.9	6.2	72.6	11.7	15.7	66.5	47.8	4.3	21.4	28.0	23.4	12.6	17.0	13.0	49.7	58.2	34.8	13.7	22.9	16.5	13.0	22.9	26.3	63.2	30.3	15.3	18.6	69.2	24.2	14.4	6.5	23.0	26.1	12.4	5.6	50.0	51.4	13.4	11.1	11.9	49.8	18.6	25.6	16.2	34.3	22.3	47.3	23.8	23.8	39.5	21.7	33.2	16.9	40.6	39.2	13.9	59.1	12.6	40.6	17.1	30.7
COPS7B	CSN7B	ENSG00000144524	"COP9 signalosome subunit 7B"	Q9H9Q2	2	231781671-231809254	"Predicted intracellular proteins"	"Host-virus interaction"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034675, HPA034676"	Uncertain		Supported	Nucleoplasm		NA	NA		44000	"Cluster 27: Non-specific - Gene expression"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	Nucleoplasm		"HPA034675: AB_10696360, HPA034676: AB_2674274"	"unprognostic (3.21e-1)"	"unprognostic (1.59e-1)"	"unprognostic (6.25e-3)"	"unprognostic (3.59e-3)"	"unprognostic (3.50e-1)"	"unprognostic (4.77e-2)"	"prognostic unfavorable (8.37e-6)"	"unprognostic (1.19e-1)"	"unprognostic (4.81e-2)"	"unprognostic (1.89e-1)"	"unprognostic (5.77e-2)"	"unprognostic (1.98e-1)"	"prognostic unfavorable (1.50e-6)"	"unprognostic (2.37e-2)"	"unprognostic (1.39e-1)"	"unprognostic (6.64e-2)"	"unprognostic (1.55e-3)"	10.8	15.6	16.5	11.3	17.6	11.7	11.3	16.3	26.3	16.7	14.3	15.1	6.9	14.2	10.6	12.7	15.1	8.1	10.8	17.0	16.4	11.9	14.6	11.6	17.8	16.0	17.4	13.8	11.5	19.8	15.5	15.0	17.3	14.9	15.1	9.4	14.1	14.9	13.6	17.0	13.3	16.7	16.2	17.5	15.9	20.5	16.8	22.9	13.9	12.8	22.3	13.9	13.8	18.4	24.8	20.9	31.7	33.5	22.1	27.8	33.9	19.8	18.6	31.5	37.3	35.9	26.6	23.4	21.2	24.3	38.1	19.5	45.6	36.1	46.8	40.3	42.3	46.2	17.9	51.4	23.8	49.1	25.0	19.4	36.2	35.2	25.8	28.6	36.4	58.2	51.7	18.6	30.2	31.8	49.7	40.0	48.5	24.8	22.0	54.6	38.8	25.6	24.2	21.1	34.2	28.5	18.6	15.8	35.4	44.9	20.1	39.6	23.6	22.9	22.1	26.8	27.7	29.9	26.9	65.0	22.0	34.2	23.4	12.6	8.4	4.6	12.3	9.9	12.1	13.3	9.6	11.4	12.5	13.3	13.1	9.4	1.8	15.8	13.7	9.8	10.5	11.5	16.5	17.6	16.3	26.3	17.0	16.4	16.0	17.4	17.3	16.2	16.8	18.4	10.6	16.0	11.3	28.1	17.1	12.4	12.2	24.0	18.2	13.8	16.7	16.5	6.7	10.0	15.2	16.5	10.4	24.2	19.7	8.6	13.7	14.1	54.6	10.7	10.1	11.1	23.3	7.6	14.8	9.3	20.5	12.3	9.7	9.0	5.7	18.1	14.6	7.9	15.1	13.5	14.3	15.7	18.3	12.7	9.7	14.9	18.0	10.1	12.4	14.0	18.6	9.5	35.0	18.1	17.8	13.7	9.5	20.3	13.5	12.5	10.4	9.9	11.4	18.3	13.1	8.3	13.5	43.3	61.4	16.5	8.1	17.8	16.5	21.1	14.3	12.1
COPS8	"COP9, CSN8, MGC1297, SGN8"	ENSG00000198612	"COP9 signalosome subunit 8"	Q99627	2	237085882-237100474	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"hTERT-HME1: 451.5;U-138 MG: 536.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036485	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA		110000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 33: Fibroblasts - ECM organization"	Nucleoplasm	Cytosol	"HPA036485: AB_10670720"	"unprognostic (8.61e-2)"	"unprognostic (1.20e-1)"	"unprognostic (8.74e-2)"	"unprognostic (1.07e-3)"	"unprognostic (1.20e-1)"	"unprognostic (3.54e-3)"	"prognostic unfavorable (4.70e-5)"	"unprognostic (1.34e-2)"	"unprognostic (8.03e-2)"	"unprognostic (2.04e-1)"	"unprognostic (6.85e-2)"	"unprognostic (2.70e-1)"	"unprognostic (2.41e-2)"	"unprognostic (7.36e-3)"	"unprognostic (2.30e-1)"	"unprognostic (1.40e-1)"	"unprognostic (8.82e-2)"	51.2	47.8	58.1	36.0	62.8	41.2	42.0	61.2	67.3	42.8	54.9	36.3	17.0	44.1	38.1	26.8	37.4	42.4	83.7	64.5	76.1	51.9	34.4	29.4	32.5	59.4	59.4	48.2	22.6	64.1	37.5	43.7	62.4	34.1	24.7	91.8	27.7	35.9	172.9	30.4	23.8	54.1	62.2	24.1	30.3	47.2	64.0	48.7	37.2	118.1	32.9	52.0	32.5	63.2	58.9	48.6	103.5	51.8	289.5	226.1	69.2	100.7	99.0	100.3	110.7	31.9	57.9	39.9	37.6	110.0	159.5	43.3	102.4	136.1	138.8	94.9	66.2	58.0	57.5	113.8	199.4	76.3	33.3	376.9	153.0	101.2	451.5	124.6	119.4	84.7	81.9	37.4	320.9	55.7	94.7	77.7	91.7	63.0	70.2	71.7	123.3	79.9	124.7	46.4	50.8	87.3	60.3	51.2	155.4	82.4	59.5	61.4	127.4	536.9	91.1	106.1	110.7	71.1	64.0	127.9	167.4	46.0	138.7	59.1	45.2	56.1	57.1	53.3	70.9	68.3	60.4	65.8	55.7	56.9	58.3	60.7	14.1	72.2	58.0	40.2	70.7	70.5	58.1	62.8	61.2	67.3	64.5	76.1	59.4	59.4	62.4	62.2	64.0	63.2	46.8	32.1	24.4	13.1	38.5	75.5	50.0	97.1	39.9	55.2	32.3	26.8	114.2	31.5	44.4	33.1	27.1	61.6	32.5	12.5	142.8	65.1	34.7	45.0	41.2	52.2	21.0	39.6	20.6	40.8	79.3	85.7	23.0	28.7	42.6	38.9	38.9	23.5	61.0	35.3	20.1	16.5	95.6	29.6	59.3	21.1	72.7	24.2	126.3	11.2	44.6	98.2	39.1	15.1	20.6	52.6	16.7	75.6	44.4	44.9	22.6	96.9	55.3	63.0	59.2	44.7	69.8	98.1	116.1	33.6	64.5	44.5	44.5	50.0	21.0	41.8
COQ4	CGI-92	ENSG00000167113	"Coenzyme Q4"	Q9Y3A0	9	128322544-128334072	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Ubiquinone biosynthesis"		"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Proximal tubular cells: 202.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021406, HPA042945"	Supported		Supported	Mitochondria		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 49: Ciliated cells - Cilium organization"	Mitochondria		"HPA021406: AB_2670691, HPA042945: AB_10961047"	"unprognostic (9.15e-2)"	"prognostic favorable (2.97e-5)"	"unprognostic (2.29e-1)"	"prognostic favorable (4.93e-6)"	"unprognostic (1.60e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.04e-1)"	"unprognostic (7.51e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.31e-3)"	"unprognostic (2.89e-2)"	"prognostic favorable (5.76e-6)"	"unprognostic (6.21e-3)"	"unprognostic (1.98e-1)"	"unprognostic (1.42e-1)"	"unprognostic (5.14e-3)"	23.9	52.9	33.9	21.7	35.3	19.7	28.2	32.9	43.6	31.8	43.1	35.9	76.7	24.9	19.4	62.1	51.8	21.5	39.6	34.8	37.8	62.9	63.8	25.0	24.4	33.4	33.9	30.5	64.1	45.5	53.4	17.6	33.2	41.2	23.7	22.3	47.1	28.3	31.8	56.4	54.1	15.4	32.3	27.5	39.5	22.6	34.3	20.3	51.2	22.6	22.9	31.1	34.1	36.0	36.6	54.4	31.5	36.6	22.4	31.2	58.2	31.7	20.6	40.1	28.0	48.4	46.5	48.6	28.1	24.2	31.6	99.9	27.0	38.0	14.6	25.1	50.5	18.1	112.9	52.9	38.9	51.5	27.0	37.4	45.2	33.6	36.6	21.9	32.4	40.8	121.1	31.5	26.0	106.2	60.5	38.0	37.0	75.1	60.7	60.7	45.2	91.0	49.0	36.9	58.8	40.1	64.7	71.5	41.4	13.8	92.2	18.0	43.3	38.0	35.1	56.9	43.9	53.4	50.4	38.5	47.4	25.0	28.1	22.6	31.1	19.0	44.1	36.4	39.8	39.9	39.4	44.1	39.6	34.4	31.1	38.2	3.8	35.5	37.2	63.7	34.5	29.9	33.9	35.3	32.9	43.6	34.8	37.8	33.4	33.9	33.2	32.3	34.3	36.0	21.3	22.4	29.0	25.8	31.9	28.8	47.1	75.1	47.3	29.9	60.2	65.9	43.0	42.9	48.9	57.0	27.1	90.3	36.5	70.3	142.8	56.4	15.3	139.7	39.8	25.4	31.8	36.0	23.9	63.4	47.5	32.1	35.7	42.2	36.8	37.1	30.0	77.4	49.8	30.3	26.3	65.6	57.0	26.7	23.9	27.4	30.1	24.0	40.9	8.4	27.2	37.4	27.8	17.1	28.8	46.1	66.2	30.9	60.8	32.8	185.3	202.4	161.9	53.3	26.3	27.9	33.4	47.2	31.6	79.4	50.0	47.2	32.3	69.3	85.5	58.0
COQ5	MGC4767	ENSG00000110871	"Coenzyme Q5, methyltransferase"	Q5HYK3	12	120503279-120534434	"Enzymes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"	"Ubiquinone biosynthesis"	"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049487	Approved		Uncertain	Nucleoli,Mitochondria		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoli	Mitochondria	"HPA049487: AB_2680789"	"unprognostic (1.46e-1)"	"unprognostic (1.99e-2)"	"unprognostic (1.32e-1)"	"unprognostic (6.30e-3)"	"unprognostic (2.00e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.88e-1)"	"unprognostic (1.60e-1)"	"unprognostic (2.01e-2)"	"unprognostic (6.20e-2)"	"unprognostic (1.62e-1)"	"unprognostic (8.37e-2)"	"unprognostic (3.79e-2)"	"unprognostic (2.02e-1)"	"unprognostic (7.73e-2)"	"unprognostic (2.00e-2)"	"unprognostic (3.88e-2)"	22.7	29.9	22.3	15.9	25.3	11.3	24.1	24.5	29.0	19.7	26.7	24.7	23.4	17.9	23.0	20.4	22.2	14.4	40.7	22.1	23.4	38.9	60.7	15.4	23.3	24.9	24.2	20.5	20.6	21.6	18.1	23.3	24.8	18.9	24.7	26.3	22.4	15.8	98.5	17.6	20.0	18.2	22.8	21.1	19.3	24.7	24.3	22.3	25.7	69.2	23.4	17.2	17.6	29.5	35.7	56.1	49.2	14.2	63.5	48.5	33.7	42.3	27.6	42.5	26.9	22.5	29.2	35.6	48.8	44.7	29.9	37.7	44.2	47.2	43.3	45.4	26.3	47.4	35.0	37.8	51.8	52.2	28.7	46.8	50.2	40.0	46.1	66.0	38.0	67.5	47.4	25.3	49.7	46.9	30.3	60.0	43.2	25.4	43.2	55.9	49.8	52.0	55.2	26.7	37.0	29.8	30.7	15.5	58.3	51.2	77.8	42.6	37.9	29.1	33.4	21.8	28.5	53.9	48.5	40.5	33.3	48.9	35.8	28.6	44.3	32.3	39.7	44.9	39.0	45.6	42.4	43.2	61.0	52.7	56.8	45.5	9.3	60.6	43.5	40.3	57.2	54.4	22.3	25.3	24.5	29.0	22.1	23.4	24.9	24.2	24.8	22.8	24.3	29.5	14.4	12.8	12.8	7.2	15.5	7.8	11.5	33.5	10.8	12.6	17.5	15.2	30.5	18.6	18.1	14.7	14.6	73.0	12.9	16.1	46.9	32.3	59.8	17.8	12.1	15.4	15.0	17.5	5.7	20.0	45.6	16.5	11.7	11.3	17.2	24.0	15.4	42.4	46.3	5.0	7.8	17.0	22.4	12.8	10.1	23.1	16.4	13.6	23.2	3.7	29.0	18.0	23.7	6.6	17.5	11.0	23.9	18.8	11.0	11.2	35.8	66.7	22.4	15.6	6.6	16.3	14.4	34.7	14.8	14.3	8.9	58.3	15.0	32.8	28.1	10.9
COQ8A	"ADCK3, CABC1, COQ8, SCAR9"	ENSG00000163050	"Coenzyme Q8A"	Q8NI60	1	226940286-226987544	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"Ubiquinone biosynthesis"	"Kinase, Transferase"	"Disease variant, Neurodegeneration, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"skeletal muscle: 1165.1;tongue: 484.7"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 21.9;Collecting duct cells: 33.1;Ductal cells: 21.2;Exocrine glandular cells: 32.7;Proximal tubular cells: 24.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEK 293: 82.0;RPMI-8226: 78.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA061662			Supported	Mitochondria		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 33: Striated muscle - Muscle contraction"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 7: Non-specific - Mitochondria"	Mitochondria		"HPA061662: AB_2684578"	"unprognostic (6.37e-3)"	"unprognostic (2.09e-2)"	"unprognostic (2.29e-1)"	"unprognostic (9.06e-2)"	"unprognostic (8.94e-2)"	"unprognostic (2.49e-1)"	"unprognostic (4.42e-2)"	"unprognostic (3.50e-3)"	"unprognostic (1.81e-1)"	"unprognostic (4.02e-1)"	"unprognostic (4.15e-3)"	"unprognostic (8.67e-2)"	"unprognostic (2.40e-2)"	"unprognostic (9.24e-2)"	"unprognostic (2.82e-1)"	"unprognostic (8.88e-2)"	"unprognostic (2.62e-1)"	63.9	123.8	7.1	10.3	8.0	26.1	35.8	17.3	8.1	16.5	16.1	30.8	29.9	15.9	0.5	32.2	24.6	19.7	123.5	7.1	5.6	14.4	35.7	9.6	12.7	8.9	5.4	34.1	93.8	6.4	5.3	6.5	9.8	18.5	6.4	1.3	32.7	11.7	1165.1	25.1	18.5	7.2	5.9	14.4	52.8	6.7	5.9	8.6	9.4	484.7	4.3	40.8	13.4	11.5	8.0	14.4	3.3	10.3	11.4	7.3	57.7	3.6	2.9	5.2	6.9	23.0	12.8	24.5	17.9	2.4	2.6	9.2	6.9	8.2	0.8	25.5	82.0	16.7	11.2	38.8	2.5	25.8	9.3	14.2	12.2	4.0	5.4	4.9	2.5	24.7	29.4	19.4	0.7	11.0	15.2	37.3	15.5	62.8	29.5	14.9	17.1	78.6	1.6	5.9	59.9	24.2	7.3	28.7	20.6	3.4	15.1	34.8	2.5	5.9	5.3	8.2	13.3	43.0	40.5	13.1	5.3	29.3	6.0	47.7	23.5	68.4	15.8	17.1	15.3	22.2	15.8	14.6	18.6	26.8	21.5	17.0	43.1	21.2	13.6	8.1	21.5	26.0	7.1	8.0	17.3	8.1	7.1	5.6	8.9	5.4	9.8	5.9	5.9	11.5	11.4	3.2	21.9	0.0	5.8	0.0	0.0	0.0	0.0	0.0	18.1	17.1	0.0	0.0	4.3	33.1	0.0	12.2	10.2	0.0	15.6	21.2	0.0	12.3	8.9	5.4	0.0	0.0	0.0	32.7	10.0	6.3	0.0	9.6	13.9	9.8	0.0	0.0	14.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.2	0.0	0.0	11.4	0.0	0.0	0.0	0.0	10.8	0.0	0.0	3.2	0.0	0.0	24.8	2.2	0.0	0.0	0.0	4.4	0.0	0.0	0.0	0.0	7.7	5.2	16.0	0.0	0.0
CORO1B	coronin-2	ENSG00000172725	"Coronin 1B"	Q9BR76	11	67435510-67443821	"Plasma proteins, Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal enterocytes: 301.4;Paneth cells: 324.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"non-classical monocyte: 221.8"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017616, HPA040113, HPA070456"	Enhanced		Supported	"Plasma membrane,Cytosol"		NA	NA		960000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 4: Stomach - Digestion"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Plasma membrane, Cytosol"		"CAB017616: AB_2087018, HPA040113: AB_2676850, HPA070456: AB_2686268"	"unprognostic (1.94e-1)"	"unprognostic (2.40e-1)"	"unprognostic (3.21e-1)"	"prognostic favorable (1.65e-4)"	"unprognostic (1.02e-1)"	"unprognostic (8.23e-3)"	"unprognostic (1.49e-3)"	"unprognostic (7.22e-2)"	"unprognostic (1.86e-1)"	"unprognostic (4.86e-2)"	"unprognostic (1.48e-1)"	"unprognostic (3.88e-2)"	"unprognostic (8.58e-3)"	"unprognostic (1.85e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.21e-2)"	"unprognostic (6.64e-3)"	54.4	56.4	20.2	29.7	23.8	20.3	53.4	23.4	27.0	55.7	21.1	70.2	62.9	72.8	14.6	80.2	54.2	44.1	26.1	19.4	22.7	48.2	47.2	53.7	41.9	28.0	23.6	42.7	52.5	24.6	35.1	31.2	25.1	71.0	34.5	6.6	73.2	39.6	13.0	42.4	62.3	36.7	24.2	66.0	77.1	13.9	25.1	21.1	55.8	9.9	18.4	58.3	53.5	26.3	80.9	81.4	37.5	76.0	94.1	81.3	56.6	58.5	118.0	94.2	70.8	134.1	116.0	6.4	111.3	80.8	95.8	67.9	41.9	74.9	16.8	19.4	40.7	54.9	47.3	57.9	148.1	2.3	120.8	110.6	66.3	80.1	37.2	59.7	120.7	49.4	42.7	9.2	54.2	238.4	14.4	11.2	47.7	198.2	73.4	11.2	41.0	14.9	62.6	104.3	40.7	50.8	52.4	139.6	181.6	26.0	178.5	63.0	92.2	63.4	47.4	87.4	35.2	1.6	3.3	14.6	103.4	8.2	66.4	57.3	102.8	8.0	10.9	212.9	8.3	20.0	37.6	14.6	79.0	11.0	21.2	11.4	47.8	11.9	221.8	60.8	55.2	57.8	20.2	23.8	23.4	27.0	19.4	22.7	28.0	23.6	25.1	24.2	25.1	26.3	58.7	3.2	2.2	4.6	53.4	27.9	60.1	90.8	40.9	13.0	53.8	39.0	1.6	50.1	66.4	47.8	8.4	87.8	39.2	301.4	60.7	111.4	8.9	43.6	32.9	52.0	99.0	19.8	1.8	105.0	229.8	35.8	111.1	64.8	28.0	46.7	47.8	22.4	251.8	15.2	2.4	188.6	81.4	138.6	66.4	5.0	39.4	96.3	71.2	10.3	195.3	30.0	41.2	4.5	6.8	136.9	324.9	34.6	64.3	55.6	263.5	84.0	41.2	14.6	52.6	22.1	55.1	8.1	6.6	47.6	31.0	150.5	100.3	54.8	128.0	74.5
CORO7-PAM16		ENSG00000103426	"CORO7-PAM16 readthrough"		16	4340251-4420494	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"Alveolar cells type 2: 1.1;Club cells: 2.5;Oligodendrocytes: 2.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA041657, HPA053586, HPA062721"	Uncertain		Approved	Nucleoplasm,Microtubules,Mitochondria		NA	NA						"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Nucleoplasm, Mitochondria"	Microtubules	"HPA041657: AB_10796351, HPA053586: AB_2682201, HPA062721: AB_2684849"	"unprognostic (2.95e-2)"	"unprognostic (2.46e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.46e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.24e-2)"	"unprognostic (2.11e-4)"	"unprognostic (4.39e-2)"	"unprognostic (9.83e-3)"	"unprognostic (1.20e-1)"	"unprognostic (8.75e-3)"	"unprognostic (1.05e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.79e-2)"	"unprognostic (2.59e-2)"	"unprognostic (2.19e-1)"	"unprognostic (3.85e-1)"	0.1	0.0	0.1	0.0	0.2	0.2	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.1	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.1	0.2	0.2	0.2	0.2	0.1	0.3	0.2	0.2	0.3	0.2	0.5	0.1	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
COTL1	CLP	ENSG00000103187	"Coactosin like F-actin binding protein 1"	Q14019	16	84565596-84618078	"Plasma proteins, Predicted intracellular proteins"		"Actin-binding, Chaperone"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 273.2;lymphoid tissue: 374.3"	"Cell type enhanced"	"Detected in all"		"Extravillous trophoblasts: 1402.6;Hofbauer cells: 595.3;Kupffer cells: 1015.5;Langerhans cells: 1146.3;Macrophages: 1046.2;monocytes: 949.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"classical monocyte: 2441.1;eosinophil: 3418.8;intermediate monocyte: 4072.1;myeloid DC: 2395.7;neutrophil: 1758.0;non-classical monocyte: 4579.3"	"Group enriched"	"Detected in all"	5	"dendritic cells: 2395.7;granulocytes: 3418.8;monocytes: 4579.3"	"Cell line enhanced"	"Detected in all"		"WM-115: 1271.3"	"Low region specificity"	"Detected in all"							"HPA008918, CAB062328"	Enhanced		Supported	Cytosol		NA	NA		10000000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	Cytosol		"CAB062328: AB_2084785, HPA008918: AB_2668176"	"unprognostic (2.93e-2)"	"unprognostic (1.11e-1)"	"unprognostic (3.27e-2)"	"unprognostic (2.38e-1)"	"unprognostic (3.21e-3)"	"unprognostic (8.95e-2)"	"unprognostic (2.43e-1)"	"unprognostic (1.14e-1)"	"unprognostic (7.70e-2)"	"unprognostic (5.99e-2)"	"unprognostic (5.43e-3)"	"unprognostic (1.47e-2)"	"prognostic unfavorable (5.51e-4)"	"unprognostic (1.26e-1)"	"unprognostic (5.48e-2)"	"unprognostic (7.73e-2)"	"unprognostic (3.35e-3)"	87.8	36.8	65.8	296.0	82.1	273.2	54.2	80.6	67.4	31.7	57.7	68.7	90.4	46.7	12.1	32.4	49.5	75.2	25.1	68.8	82.8	140.5	44.6	110.6	374.3	87.5	80.5	24.1	30.3	32.4	47.4	78.0	86.6	44.5	66.0	44.4	24.9	28.5	10.9	20.4	104.8	66.6	78.0	330.5	126.5	20.5	101.5	88.6	38.0	12.2	263.5	118.4	28.3	86.4	546.3	445.0	994.2	1058.1	111.5	305.0	299.5	462.0	295.8	355.8	136.6	609.1	818.7	149.6	137.6	349.7	211.7	266.8	61.3	364.1	355.1	1.1	77.9	281.9	87.7	162.7	314.0	320.1	1069.3	245.6	57.6	344.2	305.0	222.2	172.2	326.4	26.5	60.5	215.3	88.3	99.1	191.7	123.1	178.5	448.8	10.4	33.7	9.3	529.2	227.5	156.7	7.9	430.7	101.9	238.8	116.9	77.1	256.7	445.9	509.0	290.2	165.8	341.4	11.5	58.1	123.7	397.7	154.1	1271.3	740.1	2441.1	3418.8	69.9	4072.1	92.5	546.6	441.0	417.2	2395.7	279.2	192.6	229.6	1758.0	667.2	4579.3	123.7	685.2	2954.6	65.8	82.1	80.6	67.4	68.8	82.8	87.5	80.5	86.6	78.0	101.5	86.4	44.0	3.2	12.2	20.5	331.8	63.5	116.5	7.5	27.3	10.4	22.2	32.9	5.1	17.2	6.2	77.3	244.0	136.4	104.5	47.0	39.2	73.0	6.8	17.6	74.5	94.4	145.6	78.4	6.8	34.5	1402.6	59.9	181.0	29.8	141.8	126.0	189.2	6.6	595.3	25.2	14.1	77.8	2.0	1015.5	1146.3	10.8	8.1	1046.2	96.0	39.4	949.1	31.5	74.2	27.6	2.1	108.2	19.8	16.1	130.1	165.3	52.8	305.3	4.5	43.2	6.6	15.4	75.7	5.1	39.5	9.2	38.2	172.8	354.9	11.9	140.2	179.6
COX10		ENSG00000006695	"Cytochrome c oxidase assembly factor heme A:farnesyltransferase COX10"	Q12887	17	14069490-14231736	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Heme biosynthesis"	Transferase	"Disease variant, Leigh syndrome, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 44.5;tongue: 44.3"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 88.2;Late spermatids: 81.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA032005, HPA032006"	Supported		Supported	Nucleoli,Mitochondria,Cytosol		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 12: NES - Nervous system development"	"Cluster 25: Spermatids - Spermatogenesis"	Mitochondria	"Nucleoli, Cytosol"	"HPA032005: AB_10603560, HPA032006: AB_10670554"	"unprognostic (6.17e-2)"	"unprognostic (3.14e-1)"	"unprognostic (1.41e-2)"	"unprognostic (4.35e-2)"	"unprognostic (1.86e-1)"	"unprognostic (2.03e-1)"	"unprognostic (1.31e-1)"	"unprognostic (7.40e-2)"	"unprognostic (6.27e-3)"	"unprognostic (1.07e-1)"	"unprognostic (9.46e-3)"	"unprognostic (6.46e-2)"	"prognostic favorable (4.32e-6)"	"prognostic favorable (8.73e-4)"	"unprognostic (8.82e-2)"	"unprognostic (1.02e-2)"	"unprognostic (8.71e-2)"	7.1	7.5	3.1	5.4	2.9	10.4	6.0	4.1	4.4	5.8	4.3	12.5	12.5	5.2	4.4	10.9	5.6	4.2	27.9	3.3	3.9	11.6	10.6	4.4	5.8	3.8	3.5	4.5	9.9	9.6	3.3	7.0	3.5	5.6	12.3	5.6	7.2	5.5	44.5	7.4	10.1	7.2	3.0	4.8	9.3	21.1	4.0	5.4	6.2	44.3	7.5	8.5	6.6	3.6	10.1	19.7	7.7	11.9	7.7	5.6	19.5	12.3	8.4	21.9	14.6	16.3	6.6	23.5	9.8	13.0	6.8	20.2	16.6	16.3	17.3	13.1	15.7	14.5	12.4	20.0	14.2	15.5	12.3	9.8	19.5	14.0	17.6	7.9	11.4	15.8	20.4	8.2	9.5	13.1	13.5	10.5	12.8	37.6	9.5	10.3	28.8	18.5	15.2	20.1	5.2	9.8	12.0	18.5	16.5	36.1	9.6	9.2	9.9	8.9	8.0	9.9	15.8	10.1	15.6	11.2	14.9	15.7	11.9	3.8	11.3	4.4	9.8	16.1	10.6	13.2	11.3	10.5	14.9	9.2	11.9	11.5	1.2	10.0	13.9	4.6	20.1	11.0	3.1	2.9	4.1	4.4	3.3	3.9	3.8	3.5	3.5	3.0	4.0	3.6	5.9	0.0	14.7	25.8	9.6	9.7	9.5	9.8	14.2	7.5	8.7	7.4	88.2	5.7	7.3	11.0	10.4	19.7	5.7	13.8	41.1	9.1	41.1	9.6	9.6	7.8	12.6	13.3	33.5	8.7	17.5	8.8	16.3	9.4	5.1	7.5	3.9	9.6	10.8	0.0	43.0	16.4	8.2	4.4	4.7	81.0	2.1	6.7	5.4	22.5	6.3	4.6	8.2	34.7	26.9	8.8	11.4	6.8	12.5	8.7	26.6	17.8	5.8	12.2	0.0	5.2	12.5	22.8	19.2	19.4	10.4	16.1	8.6	6.6	18.9	13.7
COX14	"C12orf62, MGC14288"	ENSG00000178449	"Cytochrome c oxidase assembly factor COX14"	Q96I36	12	50112082-50120457	"Disease related genes, Human disease related genes, Predicted membrane proteins"			"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Proximal tubular cells: 835.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA044618, HPA062014"	Approved		Supported	Mitochondria		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"HPA044618: AB_10960419, HPA062014: AB_2684657"	"unprognostic (5.71e-2)"	"unprognostic (1.86e-2)"	"unprognostic (1.43e-1)"	"unprognostic (4.04e-1)"	"unprognostic (1.87e-2)"	"unprognostic (3.66e-2)"	"unprognostic (2.20e-2)"	"unprognostic (4.20e-3)"	"prognostic unfavorable (7.90e-4)"	"unprognostic (7.02e-2)"	"unprognostic (1.52e-2)"	"unprognostic (6.34e-2)"	"unprognostic (7.09e-3)"	"unprognostic (3.24e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.84e-2)"	"unprognostic (3.07e-3)"	124.0	106.4	96.3	47.1	101.4	66.2	105.6	110.3	129.7	63.6	120.1	92.4	83.4	46.2	130.5	68.5	54.9	62.9	238.6	94.5	105.5	143.8	145.4	62.3	74.5	102.6	99.8	52.8	62.0	127.8	88.0	54.7	102.9	67.0	77.5	60.6	84.9	80.7	247.6	49.8	84.0	58.7	102.9	66.9	76.5	32.6	104.0	54.9	87.3	276.7	62.0	74.2	47.3	110.2	78.4	168.3	32.8	79.4	169.4	105.7	60.5	61.1	92.7	98.8	89.5	156.7	109.1	69.9	171.9	78.3	82.6	79.0	57.2	87.5	91.7	78.7	236.6	154.3	140.4	139.2	65.1	112.1	133.7	123.8	129.9	67.1	76.7	100.5	96.2	83.1	70.2	153.4	109.1	193.3	93.7	170.3	51.5	116.4	211.3	77.6	52.4	176.8	155.0	149.1	91.0	51.4	92.4	177.5	195.6	72.6	115.1	103.6	75.2	55.0	58.1	92.3	50.1	106.3	199.0	93.5	77.9	105.0	30.9	258.8	197.8	172.7	146.1	194.5	155.6	213.7	186.9	167.0	190.0	188.0	176.7	173.7	67.0	153.1	178.2	247.2	224.8	214.8	96.3	101.4	110.3	129.7	94.5	105.5	102.6	99.8	102.9	102.9	104.0	110.2	91.5	60.9	120.6	11.1	108.8	124.9	91.2	212.9	87.0	68.2	169.2	192.5	524.4	161.5	138.7	222.5	22.9	191.9	111.1	320.9	565.4	131.4	7.1	117.5	58.7	99.2	156.0	69.2	13.1	170.1	122.6	90.3	81.6	88.1	65.4	64.0	88.9	397.9	219.6	47.1	16.3	214.7	187.2	152.3	110.4	22.9	129.2	117.7	149.4	6.5	181.2	111.0	111.2	7.1	22.3	116.8	262.4	109.4	93.0	129.5	492.6	835.5	157.5	67.4	105.2	51.5	130.8	51.1	56.0	121.6	159.3	127.5	112.2	115.4	227.4	118.6
COX15	CEMCOX2	ENSG00000014919	"Cytochrome c oxidase assembly homolog COX15"	Q7KZN9	10	99710868-99732127	"Disease related genes, Human disease related genes, Predicted membrane proteins"			"Disease variant, Leigh syndrome, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037727, HPA037728, HPA066096"	Uncertain		Supported	Nucleoplasm,Mitochondria		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria	Nucleoplasm	"HPA037727: AB_10672391, HPA037728: AB_10672463, HPA066096: AB_2685616"	"unprognostic (9.74e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.99e-1)"	"unprognostic (6.55e-3)"	"unprognostic (1.50e-2)"	"unprognostic (1.34e-1)"	"unprognostic (5.36e-2)"	"unprognostic (2.96e-1)"	"unprognostic (6.84e-2)"	"unprognostic (1.76e-1)"	"unprognostic (3.40e-2)"	"unprognostic (8.34e-2)"	"prognostic favorable (9.21e-6)"	"unprognostic (2.08e-2)"	"unprognostic (2.21e-2)"	"unprognostic (1.86e-2)"	"unprognostic (3.40e-2)"	15.0	31.2	12.9	9.7	13.3	6.6	13.8	12.9	16.4	16.7	14.3	17.1	12.6	15.6	14.2	18.8	15.2	10.4	21.3	12.7	12.7	21.1	23.4	11.4	13.7	12.4	12.9	19.0	16.2	14.6	16.2	10.8	13.0	14.5	16.0	15.3	14.2	11.0	34.5	14.7	15.6	10.9	12.7	17.8	16.2	12.0	13.6	13.4	13.6	27.2	16.1	19.6	15.0	14.1	22.7	50.3	19.6	42.9	28.4	22.4	15.9	16.9	22.1	25.0	23.9	37.6	30.2	42.8	26.6	15.4	15.6	32.1	44.2	25.7	26.5	19.2	21.0	25.1	23.5	39.6	30.0	33.5	22.3	23.3	23.9	27.7	40.9	36.6	26.3	36.1	27.3	29.6	24.2	24.8	24.7	27.6	21.0	22.1	22.0	30.2	29.5	27.9	24.8	16.6	16.7	26.4	29.9	16.6	29.5	15.7	61.2	13.2	22.1	12.4	17.1	18.7	25.6	25.2	36.2	28.5	22.7	53.2	10.7	19.6	12.8	12.4	7.4	15.2	8.8	12.7	8.6	8.4	13.9	11.3	8.6	8.9	7.9	8.7	18.5	5.7	9.9	9.7	12.9	13.3	12.9	16.4	12.7	12.7	12.4	12.9	13.0	12.7	13.6	14.1	11.4	22.4	8.4	32.0	14.1	6.1	10.3	13.2	12.0	14.7	14.2	11.2	25.2	14.3	15.9	14.7	10.4	23.7	9.0	16.5	29.4	17.6	1.9	14.0	15.4	10.8	17.5	9.4	18.7	15.8	20.7	9.6	11.7	14.6	2.5	21.5	7.9	27.2	17.4	13.5	23.7	13.4	6.1	27.4	8.6	1.9	10.5	14.7	12.4	12.2	18.5	13.4	13.4	16.6	26.1	13.2	11.9	10.1	9.0	7.5	16.5	24.5	27.7	15.5	0.0	11.0	9.4	10.1	9.5	12.2	9.2	22.7	10.3	35.8	16.6	9.3
COX16	"C14orf112, HSPC203"	ENSG00000133983	"Cytochrome c oxidase assembly factor COX16"	Q9P0S2	14	70325081-70416984	"Predicted intracellular proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 302.9;Ionocytes: 187.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA062659	Uncertain		Supported	Mitochondria		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 59: Non-specific - Translation"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Mitochondria		"HPA062659: AB_2684823"	"unprognostic (5.44e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.68e-1)"	"unprognostic (1.21e-2)"	"unprognostic (3.63e-1)"	"unprognostic (6.37e-3)"	"unprognostic (1.80e-2)"	"unprognostic (8.22e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.73e-2)"	"unprognostic (6.80e-2)"	"unprognostic (7.44e-2)"	"prognostic favorable (1.03e-12)"	"unprognostic (4.08e-1)"	"unprognostic (1.73e-1)"	"unprognostic (3.97e-1)"	"unprognostic (1.72e-1)"	19.4	27.1	20.2	18.2	19.9	22.8	27.8	20.4	29.2	16.5	22.9	26.6	30.2	12.8	27.1	17.1	17.3	19.4	24.4	20.1	20.7	29.3	40.5	16.7	21.7	21.0	20.1	17.2	43.5	26.9	12.7	14.3	20.5	20.7	22.1	24.3	21.9	13.7	84.0	17.5	26.7	10.5	20.2	18.9	33.4	17.7	20.2	20.8	23.3	44.5	19.0	19.3	12.6	22.5	100.2	31.2	65.9	56.0	26.7	36.0	48.3	55.0	37.1	38.9	34.7	19.2	93.5	26.2	36.6	33.8	33.5	41.8	27.6	35.5	48.9	18.9	27.5	36.9	31.3	22.1	16.1	35.9	48.7	36.1	25.1	24.0	23.0	41.5	34.2	69.2	20.8	54.6	39.0	49.6	85.4	43.8	68.3	83.3	44.5	57.6	53.2	37.0	46.2	49.0	57.8	46.0	46.2	102.4	53.9	42.2	87.4	69.1	42.5	50.2	111.6	55.4	40.6	57.6	38.9	48.2	75.4	19.1	61.1	48.6	33.8	8.0	24.2	38.0	29.2	45.7	34.5	29.1	36.3	39.8	32.3	34.8	2.5	45.6	38.3	55.7	43.6	44.0	20.2	19.9	20.4	29.2	20.1	20.7	21.0	20.1	20.5	20.2	20.2	22.5	22.0	51.3	53.9	0.0	45.0	84.4	9.4	302.9	70.6	8.2	29.7	18.8	7.1	32.9	162.2	23.9	2.1	14.8	22.9	23.8	52.8	47.1	2.7	43.6	21.3	28.5	31.2	46.0	0.0	64.8	20.2	36.0	99.4	62.1	33.5	7.4	31.8	57.7	18.2	1.7	0.0	35.8	187.2	34.6	89.3	4.6	18.3	40.0	96.0	0.0	26.3	25.2	25.7	0.0	0.0	59.1	27.0	15.8	99.3	11.2	42.5	48.6	137.1	10.0	6.6	13.6	27.5	15.4	21.0	125.7	100.7	10.9	39.8	7.3	39.4	14.4
COX17		ENSG00000138495	"Cytochrome c oxidase copper chaperone COX17"	Q14061	3	119654513-119677454	"Cancer-related genes, Predicted intracellular proteins"		Chaperone	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA042226, HPA048158"	Supported		Supported	Mitochondria		NA	NA		220000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	Mitochondria		"HPA042226: AB_2677911, HPA048158: AB_2680292"	"unprognostic (1.98e-2)"	"unprognostic (3.49e-2)"	"unprognostic (1.96e-2)"	"unprognostic (8.29e-2)"	"unprognostic (2.88e-2)"	"unprognostic (6.63e-3)"	"unprognostic (3.49e-2)"	"unprognostic (2.90e-1)"	"unprognostic (1.36e-1)"	"unprognostic (7.11e-3)"	"unprognostic (2.12e-1)"	"unprognostic (4.45e-2)"	"unprognostic (1.33e-2)"	"unprognostic (2.15e-2)"	"unprognostic (1.65e-1)"	"unprognostic (9.19e-2)"	"unprognostic (2.64e-2)"	81.6	178.5	106.5	77.1	111.2	113.3	68.8	117.5	122.4	50.3	149.2	90.2	90.2	41.2	114.1	55.9	47.3	59.4	279.9	105.5	123.6	94.7	172.7	62.3	110.4	115.8	115.3	31.5	102.0	412.1	119.2	63.9	115.7	78.6	78.7	120.6	80.8	90.7	401.4	43.3	88.5	62.9	112.5	64.9	107.5	44.4	113.0	106.6	94.4	363.9	89.8	75.9	35.7	118.6	219.6	257.0	122.7	33.3	53.4	53.1	45.7	130.5	84.2	127.3	133.4	226.4	157.7	164.6	158.0	72.1	174.8	84.0	138.5	154.9	74.9	205.5	155.9	145.0	195.3	180.1	63.1	205.0	246.7	56.6	142.7	77.9	106.0	82.2	87.9	200.8	122.4	370.7	155.4	410.2	212.8	283.5	133.8	212.2	413.3	88.3	82.3	273.7	203.2	141.0	210.5	86.4	153.1	137.1	189.7	76.9	180.5	313.0	66.6	91.3	144.9	59.8	168.4	257.5	348.9	361.1	129.0	157.8	164.2	591.4	241.1	630.6	218.1	357.5	208.1	378.3	241.7	230.3	252.8	320.4	189.1	187.0	174.4	213.6	487.3	538.7	352.6	260.1	106.5	111.2	117.5	122.4	105.5	123.6	115.8	115.3	115.7	112.5	113.0	118.6	194.5	157.0	167.1	5.2	161.5	94.1	132.8	267.9	46.7	108.9	153.8	147.2	622.8	238.8	202.4	498.4	43.8	137.4	116.7	385.3	716.1	264.0	115.0	282.4	64.3	164.7	214.2	162.9	3.8	413.7	193.9	99.3	150.3	178.8	309.3	70.2	116.0	779.8	216.1	75.7	5.6	327.8	427.2	181.8	281.2	39.9	91.0	190.8	277.5	11.2	345.7	178.8	137.0	8.5	8.8	459.7	512.8	136.9	176.5	198.2	434.6	786.2	280.2	174.4	184.1	112.9	171.6	286.0	159.2	85.4	125.4	211.0	129.0	49.6	151.1	199.0
COX19	MGC104475	ENSG00000240230	"Cytochrome c oxidase assembly factor COX19"	Q49B96	7	898778-975549	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021226	Approved		Supported	Cytosol		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 52: Non-specific - Transcription"	Cytosol		"HPA021226: AB_1847176"	"unprognostic (1.83e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.05e-2)"	"unprognostic (3.76e-2)"	"unprognostic (5.22e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.13e-2)"	"unprognostic (1.61e-1)"	"unprognostic (3.96e-1)"	"unprognostic (5.60e-2)"	"unprognostic (4.79e-2)"	"unprognostic (3.36e-2)"	"unprognostic (2.37e-3)"	"unprognostic (2.49e-2)"	"unprognostic (1.64e-1)"	"unprognostic (2.74e-1)"	"unprognostic (9.14e-3)"	4.5	12.3	4.0	3.2	4.7	6.7	4.4	6.3	4.8	5.4	2.2	6.8	5.3	4.8	2.2	5.8	6.8	2.0	5.2	4.0	4.3	6.2	5.9	4.9	4.4	4.8	4.2	5.5	7.5	6.4	5.9	2.7	5.0	6.2	3.5	2.9	6.0	2.8	7.5	8.0	7.4	2.4	3.6	7.6	5.9	4.0	4.4	3.7	5.6	4.9	3.5	5.0	4.8	6.9	13.9	3.7	4.1	5.2	3.1	4.4	7.8	6.1	4.4	5.2	4.3	9.6	7.6	6.8	2.0	3.7	8.2	9.1	4.3	4.2	4.1	2.1	7.2	3.0	4.5	7.1	9.8	7.3	6.8	5.1	9.7	4.0	9.2	5.8	3.3	6.9	9.0	5.7	3.4	9.0	3.1	8.6	10.6	16.3	8.6	7.4	0.9	3.3	4.6	6.0	5.4	5.4	3.5	14.4	12.0	6.7	7.2	17.1	4.2	5.2	7.6	6.0	9.5	7.1	5.2	6.6	4.6	10.4	8.7	9.4	5.2	8.3	5.8	5.1	5.9	6.6	6.1	5.2	4.5	6.1	7.5	7.2	5.0	5.4	5.5	7.9	5.9	4.4	4.0	4.7	6.3	4.8	4.0	4.3	4.8	4.2	5.0	3.6	4.4	6.9	25.4	12.8	21.4	6.2	35.4	24.6	35.9	37.7	19.4	19.3	21.7	19.2	14.2	31.5	24.1	31.3	12.5	27.8	49.7	29.9	15.6	34.9	7.4	58.4	23.8	23.5	44.9	17.2	13.1	34.0	41.8	19.0	17.3	49.3	34.9	28.1	25.0	31.0	26.1	15.2	13.3	32.6	36.7	24.9	28.5	2.7	19.6	29.4	21.4	13.1	46.6	33.3	64.9	6.6	22.7	49.6	31.7	14.3	20.8	36.8	37.7	25.8	36.2	27.0	6.6	18.7	23.2	19.2	32.7	21.4	25.7	41.9	39.5	30.9	32.2	45.3
COX4I1	"COX4, COX4-1"	ENSG00000131143	"Cytochrome c oxidase subunit 4I1"	P13073	16	85798633-85807068	"Disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		Oxidoreductase	"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002485, CAB004080"	Supported		Supported	Mitochondria		NA	NA		55000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"CAB004080: AB_2085427, HPA002485: AB_1078559"	"unprognostic (4.73e-2)"	"unprognostic (9.14e-3)"	"unprognostic (2.65e-1)"	"unprognostic (6.18e-3)"	"unprognostic (2.47e-1)"	"unprognostic (4.52e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.46e-1)"	"unprognostic (5.97e-2)"	"unprognostic (7.82e-3)"	"unprognostic (3.32e-2)"	"unprognostic (2.29e-1)"	"prognostic favorable (2.56e-8)"	"unprognostic (4.23e-2)"	"unprognostic (4.06e-1)"	"unprognostic (1.01e-1)"	"unprognostic (2.38e-2)"	473.1	393.5	874.4	232.5	881.4	583.2	437.1	896.5	971.9	373.1	882.6	690.5	585.9	301.8	478.8	597.2	355.8	246.9	2047.0	869.5	909.5	632.7	611.2	318.6	412.8	896.4	891.1	366.2	490.4	900.7	362.1	256.7	908.6	377.1	707.7	261.2	421.2	312.3	1333.3	552.5	529.5	301.4	877.2	405.9	650.3	191.1	922.9	479.9	361.5	2063.3	538.7	422.6	420.9	881.0	433.7	677.7	460.2	616.8	823.6	761.2	785.7	379.6	771.2	702.3	346.7	1170.2	636.6	698.6	454.2	610.5	389.9	855.1	657.2	765.3	622.2	238.7	678.1	392.9	554.8	1093.8	741.9	362.9	282.0	893.1	1162.8	579.2	786.0	739.1	746.4	563.6	672.3	280.4	602.5	1510.6	730.9	1116.7	623.0	954.1	796.3	816.9	287.5	616.7	1066.7	840.2	543.2	441.1	807.4	513.2	656.2	489.6	753.2	996.6	529.9	355.5	409.5	330.7	419.0	561.4	562.5	1646.3	542.4	702.2	410.6	633.9	1373.2	805.2	700.3	1199.6	868.1	1302.9	930.5	833.2	1480.8	1231.2	1169.3	968.8	513.9	840.6	1089.3	1105.6	1106.1	2815.9	874.4	881.4	896.5	971.9	869.5	909.5	896.4	891.1	908.6	877.2	922.9	881.0	552.0	275.7	398.1	45.1	925.3	1129.4	1242.3	2031.6	1121.8	280.2	1365.2	1553.2	3479.9	1086.6	942.3	632.7	131.3	1223.1	714.3	1863.5	2752.8	1091.1	539.4	480.5	468.0	629.7	1009.6	524.6	44.0	1316.2	1094.7	591.2	813.0	575.6	521.4	554.3	660.7	1314.7	1602.3	212.0	51.7	1782.5	1125.0	1488.5	1376.5	1155.4	498.9	1010.5	1145.5	35.6	1451.7	562.9	785.8	35.7	65.5	1463.7	1950.7	357.7	726.2	1370.7	3811.3	2936.3	545.4	349.9	355.0	481.8	678.0	358.6	321.7	1721.9	1361.7	1481.9	816.5	1020.3	2147.9	1941.7
COX6A1	COX6A	ENSG00000111775	"Cytochrome c oxidase subunit 6A1"	P12074	12	120438090-120440737	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted membrane proteins"		Oxidoreductase	"Charcot-Marie-Tooth disease, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA062394	Approved		Supported	Mitochondria		NA	NA		85000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 45: Intestine - Brush border"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"HPA062394: AB_2684749"	"unprognostic (1.18e-1)"	"unprognostic (1.03e-2)"	"unprognostic (5.10e-2)"	"unprognostic (6.16e-2)"	"unprognostic (1.47e-1)"	"unprognostic (8.78e-2)"	"unprognostic (3.33e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.13e-2)"	"unprognostic (3.22e-2)"	"unprognostic (2.82e-1)"	"prognostic favorable (6.50e-7)"	"unprognostic (2.53e-1)"	"unprognostic (1.31e-1)"	"unprognostic (5.48e-2)"	"unprognostic (2.63e-2)"	353.0	396.5	1004.7	203.3	1040.0	368.0	321.3	1052.0	1305.8	265.4	959.8	597.1	611.5	248.1	273.9	582.2	248.6	231.3	263.9	1030.7	1086.0	664.3	707.1	269.0	273.3	1062.6	1045.6	207.4	373.0	986.0	344.2	193.5	1075.6	282.7	443.1	392.4	373.3	244.3	59.7	372.2	481.2	230.4	995.3	262.3	493.9	224.4	1086.7	327.9	316.1	88.5	255.3	319.6	348.8	1046.6	532.7	1142.5	627.4	653.5	475.4	403.9	755.8	327.1	447.7	585.1	497.2	1388.3	528.9	1115.9	955.5	477.1	442.6	865.0	624.6	737.3	382.3	663.5	1314.3	596.5	594.9	1036.8	434.6	661.9	405.9	487.3	895.5	531.3	632.3	477.0	505.0	801.0	602.9	337.1	494.2	1528.7	965.1	1667.1	566.1	1034.6	1627.5	644.7	414.7	1044.5	945.3	1302.6	822.4	708.6	595.6	589.9	803.5	347.1	1051.4	742.9	373.0	355.0	431.9	370.9	466.8	513.0	791.3	897.5	558.7	643.2	484.9	225.6	347.3	316.4	258.9	353.6	278.9	377.1	305.3	287.3	486.9	296.9	279.3	287.3	297.9	253.7	374.0	516.7	460.6	534.3	1004.7	1040.0	1052.0	1305.8	1030.7	1086.0	1062.6	1045.6	1075.6	995.3	1086.7	1046.6	346.4	397.4	312.4	41.1	355.0	383.3	526.3	1145.7	508.2	238.3	411.3	426.7	124.4	543.3	683.0	774.3	577.6	774.8	289.0	1306.7	1481.1	659.4	207.3	487.3	239.6	311.2	515.7	348.0	26.3	661.9	701.5	304.0	437.3	425.9	272.2	263.9	266.0	971.0	779.3	146.4	38.1	861.7	980.6	376.6	426.0	136.4	302.0	377.7	524.7	19.7	583.9	440.8	332.7	23.6	56.9	726.1	1417.1	265.5	565.2	506.1	1857.6	1701.6	718.9	414.2	341.8	259.0	508.6	455.8	373.7	1155.8	388.0	927.2	341.0	399.5	1049.7	778.9
COX6B1	"COX6B, COXG"	ENSG00000126267	"Cytochrome c oxidase subunit 6B1"	P14854	19	35648323-35658782	"Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"			"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"tongue: 2453.4"	"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 2710.8;Distal tubular cells: 2985.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004192	Supported		Supported	Mitochondria		NA	NA		150000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 21: OE19 - Mitochondria"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"HPA004192: AB_1847180"	"unprognostic (5.12e-2)"	"unprognostic (1.86e-2)"	"unprognostic (3.81e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.62e-2)"	"unprognostic (1.32e-1)"	"unprognostic (2.18e-1)"	"unprognostic (6.16e-2)"	"unprognostic (3.52e-1)"	"unprognostic (4.80e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.88e-1)"	"prognostic favorable (5.42e-4)"	"unprognostic (2.10e-2)"	"unprognostic (6.98e-2)"	"unprognostic (5.74e-2)"	"unprognostic (5.48e-3)"	322.3	211.6	733.9	206.6	741.0	465.2	371.1	780.8	935.9	291.0	758.1	598.9	427.0	197.2	633.9	410.0	329.7	245.8	1284.7	749.3	761.3	519.5	582.3	201.7	316.0	768.3	740.1	241.1	292.4	850.2	169.9	222.3	757.0	249.2	690.0	276.5	356.6	328.6	1467.0	264.7	351.3	342.8	735.4	193.3	336.8	107.0	759.7	426.3	270.5	2453.4	510.5	402.2	205.1	747.2	480.3	1219.5	479.2	649.4	665.5	701.3	455.3	383.4	641.0	684.8	686.4	1018.3	478.0	555.8	663.1	656.6	413.4	341.7	836.5	700.6	683.5	632.0	570.1	929.4	626.6	1014.1	521.1	835.0	454.9	800.2	906.5	619.5	361.1	606.3	690.4	577.8	616.9	783.0	714.9	1019.4	589.2	626.8	357.0	2445.6	811.5	502.1	525.9	930.4	1567.1	1035.9	434.4	484.5	615.9	1049.3	393.4	568.5	419.6	892.9	365.9	363.8	398.0	382.3	605.6	450.5	683.3	776.7	470.9	695.0	472.7	1138.1	1099.7	998.5	628.9	1228.5	607.0	1150.2	854.9	732.8	1140.2	956.3	839.9	744.3	1115.9	672.8	1178.4	1176.1	1138.3	2058.8	733.9	741.0	780.8	935.9	749.3	761.3	768.3	740.1	757.0	735.4	759.7	747.2	324.6	243.6	227.3	27.4	409.4	427.1	436.6	1071.1	373.3	143.5	498.4	615.2	2710.8	664.8	529.6	698.9	64.6	623.0	361.5	1496.0	2985.6	711.7	328.0	427.4	293.2	312.6	625.7	436.5	21.2	808.9	735.5	360.9	484.2	397.2	280.8	277.9	338.8	1270.7	1041.1	89.2	27.9	1277.1	736.5	800.2	705.9	942.4	327.7	582.7	748.8	18.7	807.7	351.1	435.6	16.1	31.6	863.0	1445.3	273.1	523.2	548.7	2291.0	2228.5	445.5	193.3	263.0	293.8	454.2	175.7	186.6	784.8	565.6	670.7	373.1	229.1	1277.5	717.0
COX6C		ENSG00000164919	"Cytochrome c oxidase subunit 6C"	P09669	8	99873200-99893707	"Metabolic proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA014295, CAB016244"	Enhanced		Supported	Mitochondria		NA	NA		210000	"Cluster 44: Non-specific - Transcription"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"CAB016244: AB_2085703, HPA014295: AB_2668966"	"unprognostic (4.91e-2)"	"unprognostic (2.90e-2)"	"unprognostic (6.90e-2)"	"unprognostic (3.37e-2)"	"unprognostic (1.58e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.63e-1)"	"unprognostic (2.07e-2)"	"unprognostic (1.29e-1)"	"unprognostic (3.51e-1)"	"unprognostic (3.70e-1)"	"unprognostic (8.86e-2)"	"unprognostic (3.47e-3)"	"unprognostic (1.10e-1)"	"unprognostic (5.31e-2)"	"unprognostic (1.07e-1)"	"unprognostic (6.99e-3)"	134.0	147.5	180.8	52.9	183.9	152.6	125.7	186.1	291.0	166.4	190.2	268.1	334.8	194.0	175.6	197.3	189.5	20.4	781.6	191.8	195.6	254.9	328.5	108.4	71.1	186.0	188.4	161.9	107.3	101.7	159.5	89.9	189.2	162.6	110.4	147.0	108.1	58.1	666.1	121.4	172.3	42.7	182.4	122.9	180.0	170.8	192.7	44.8	129.1	554.1	51.5	188.7	148.6	188.9	137.6	57.8	63.8	251.3	140.0	100.5	103.1	44.5	42.7	30.1	34.3	54.7	284.5	326.8	320.1	70.1	47.7	176.4	36.4	363.3	51.0	60.5	89.1	684.6	66.9	160.4	88.9	319.3	201.9	95.1	475.3	26.0	56.4	129.2	45.1	103.8	49.8	571.1	51.6	134.2	337.9	289.6	117.9	205.5	127.7	381.0	21.2	320.6	453.4	713.3	191.8	115.2	30.9	654.2	351.5	65.0	461.7	201.1	40.1	220.4	286.0	235.8	63.8	140.7	126.3	209.6	310.2	128.2	200.8	345.8	134.7	114.1	177.8	210.5	189.0	209.7	270.6	193.5	212.9	189.8	319.7	294.9	16.6	187.7	266.5	301.9	272.7	252.9	180.8	183.9	186.1	291.0	191.8	195.6	186.0	188.4	189.2	182.4	192.7	188.9	527.8	403.8	485.1	29.7	382.1	490.8	493.5	1431.9	279.4	217.6	561.3	642.7	2146.4	491.8	731.2	605.1	102.2	978.9	416.1	1263.2	2226.5	673.6	834.3	579.3	778.7	436.9	807.5	400.2	27.6	849.4	853.9	502.0	440.4	551.9	362.5	219.3	384.1	1855.5	1066.5	156.5	33.5	1221.3	1027.4	451.1	539.5	266.5	664.8	440.8	732.8	23.4	778.0	545.0	449.0	22.6	32.1	808.6	1338.7	587.5	412.2	448.4	2173.5	1791.0	702.9	282.0	493.0	367.1	555.9	1180.5	505.2	666.4	640.6	1784.9	452.1	428.0	1246.7	715.5
CPEB1	"CPEB, FLJ13203"	ENSG00000214575	"Cytoplasmic polyadenylation element binding protein 1"	Q9BZB8	15	82543201-82648861	"Predicted intracellular proteins"	"mRNA processing, Translation regulation"	"Activator, Repressor, Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 33.6;testis: 32.4"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 70.0;Inhibitory neurons: 44.3;Oligodendrocytes: 196.5;Spermatocytes: 34.1;Spermatogonia: 62.3"	"Cancer enriched"	"Detected in some"	6	"testis cancer: 14.0"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"naive CD8 T-cell: 1.0"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"SK-MEL-30: 37.9;U-2197: 106.0;U-87 MG: 39.1"									HPA040396			Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 21: Non-specific - Transcription"	"Cluster 18: U-2197 - ECM organization"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Nucleoplasm, Cytosol"		"HPA040396: AB_2676960"	"unprognostic (3.97e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.44e-2)"	"unprognostic (1.77e-3)"	"unprognostic (1.17e-1)"	"unprognostic (2.36e-1)"	"unprognostic (1.98e-1)"	"unprognostic (7.74e-2)"	"unprognostic (3.90e-2)"	"unprognostic (2.07e-2)"	"unprognostic (1.35e-2)"	"unprognostic (7.51e-3)"	"unprognostic (1.97e-3)"	"unprognostic (9.50e-3)"	"unprognostic (8.17e-2)"	"unprognostic (2.05e-2)"	"unprognostic (5.37e-4)"	2.8	5.0	10.4	1.3	18.6	0.2	2.5	20.3	18.6	9.3	4.5	6.8	1.2	4.2	7.9	3.6	8.3	4.0	2.9	12.7	17.0	1.2	0.2	1.6	0.5	21.3	21.7	14.3	1.3	0.8	21.8	0.3	24.0	2.3	2.4	4.5	1.5	3.7	2.4	1.9	2.5	3.4	15.0	0.6	2.5	32.4	20.4	0.4	2.3	10.5	0.5	7.7	6.1	33.6	0.1	3.6	0.3	0.4	2.6	0.2	0.1	2.8	0.3	1.8	1.4	0.2	0.1	0.0	6.3	1.1	19.5	0.1	5.1	0.0	0.4	0.0	4.2	0.1	0.1	0.1	1.8	0.1	2.3	1.4	0.0	3.5	0.0	0.2	0.0	7.6	8.9	0.2	1.3	0.2	0.6	0.1	8.2	0.1	1.0	0.0	0.2	0.1	0.0	0.1	10.5	2.4	9.2	0.5	37.9	11.2	0.1	1.1	0.1	18.9	7.5	106.0	6.0	5.3	14.3	1.4	39.1	0.0	8.2	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.1	0.5	0.0	0.1	0.3	1.0	0.0	0.0	0.0	0.0	0.0	0.1	10.4	18.6	20.3	18.6	12.7	17.0	21.3	21.7	24.0	15.0	20.4	33.6	0.3	0.0	0.0	19.6	0.1	0.8	0.3	0.0	0.0	11.5	0.6	0.3	1.9	0.0	0.0	0.0	10.4	0.0	0.1	0.1	0.0	0.1	12.6	0.5	1.4	0.2	0.0	0.0	70.0	0.0	0.0	5.9	0.5	0.1	1.3	0.3	0.4	0.0	0.3	11.8	44.3	0.0	0.0	0.0	0.8	20.0	4.1	0.4	5.4	10.3	0.1	5.2	0.0	10.1	196.5	0.1	0.0	2.2	0.2	0.5	0.0	0.4	2.2	4.3	6.6	1.9	1.8	34.1	62.3	0.0	0.6	0.1	0.4	0.0	0.0	0.1
CPNE1	CPN1	ENSG00000214078	"Copine 1"	Q99829	20	35626031-35664956	"Plasma proteins, Predicted intracellular proteins"	"Differentiation, Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA065876, HPA072634"	Approved		Supported	"Nucleoplasm,Nuclear membrane"		NA	NA		300000	"Cluster 48: NK-cells - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Nucleoplasm, Nuclear membrane"		"HPA065876: , HPA072634: AB_2686541"	"unprognostic (5.94e-2)"	"unprognostic (9.43e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.99e-3)"	"unprognostic (7.49e-2)"	"unprognostic (1.05e-2)"	"unprognostic (1.58e-3)"	"unprognostic (1.20e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.67e-1)"	"unprognostic (2.47e-1)"	"unprognostic (6.06e-2)"	"prognostic unfavorable (2.74e-10)"	"unprognostic (3.10e-1)"	"unprognostic (8.85e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.35e-1)"	61.0	47.9	15.5	50.5	15.2	70.9	58.5	14.5	17.5	68.7	17.0	65.4	32.5	74.1	58.5	58.7	62.4	48.3	38.4	15.2	15.8	44.1	38.7	59.6	52.3	16.9	14.6	64.7	48.4	38.6	52.1	69.8	15.4	52.3	47.4	17.7	51.6	41.9	43.7	63.4	62.9	70.3	14.5	78.3	51.0	25.5	14.9	82.8	60.2	33.6	81.8	64.4	59.8	19.6	264.1	202.5	112.0	47.3	14.3	18.6	85.4	123.9	219.8	295.0	192.1	590.5	111.2	181.6	115.8	185.3	251.6	98.1	88.1	233.7	182.8	34.7	65.7	459.1	149.9	440.5	131.9	151.5	61.9	121.6	235.8	118.1	139.0	178.9	188.1	183.9	61.4	90.3	144.0	142.9	226.0	201.9	27.8	264.2	187.6	159.1	334.0	125.4	119.9	183.9	78.9	87.9	277.2	129.6	188.1	31.1	134.3	148.8	123.6	306.6	56.4	101.3	131.6	61.5	66.9	126.9	222.7	81.8	69.6	53.6	102.9	180.5	119.3	100.5	164.8	120.8	115.2	112.5	143.7	113.8	111.3	113.6	140.4	206.7	98.8	78.0	153.7	164.5	15.5	15.2	14.5	17.5	15.2	15.8	16.9	14.6	15.4	14.5	14.9	19.6	47.0	19.2	37.3	33.6	55.2	55.1	71.8	82.3	44.9	34.6	40.2	46.0	15.7	32.9	56.5	25.8	20.9	125.1	73.4	26.8	25.4	72.7	39.6	23.3	44.1	53.2	33.6	42.5	37.2	37.8	76.7	56.2	25.0	28.3	48.2	59.9	34.6	23.3	62.4	21.9	33.7	30.8	81.4	43.0	79.6	9.6	54.7	45.5	48.0	30.0	85.0	24.8	62.8	32.6	39.4	44.2	34.0	61.7	60.2	78.6	38.2	34.8	33.9	18.1	46.0	47.0	55.0	13.1	22.9	41.4	49.0	106.3	77.0	65.9	41.2	71.7
CPNE3		ENSG00000085719	"Copine 3"	O75131	8	86514435-86561498	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SK-BR-3: 249.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029552	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA		71000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 41: Macrophages - Immune response"	"Nucleoplasm, Cytosol"		"HPA029552: AB_10600703"	"unprognostic (5.63e-3)"	"unprognostic (1.47e-1)"	"unprognostic (2.95e-2)"	"unprognostic (4.22e-3)"	"unprognostic (9.92e-2)"	"unprognostic (6.58e-2)"	"unprognostic (8.40e-2)"	"unprognostic (4.76e-2)"	"unprognostic (3.50e-1)"	"unprognostic (1.19e-1)"	"unprognostic (8.64e-3)"	"unprognostic (2.77e-1)"	"prognostic favorable (5.07e-4)"	"unprognostic (1.15e-1)"	"unprognostic (4.33e-1)"	"unprognostic (1.65e-3)"	"unprognostic (1.13e-2)"	35.4	29.3	14.6	22.4	17.4	76.6	42.3	23.0	15.0	40.7	24.3	35.0	32.1	33.2	21.4	73.6	32.0	30.1	52.4	15.5	19.2	51.5	46.2	33.8	39.5	15.3	17.6	39.2	29.7	52.1	11.8	25.5	17.3	41.2	34.2	18.2	37.1	29.9	17.5	36.3	30.8	31.7	16.4	28.4	30.1	8.3	16.2	38.5	60.9	26.4	46.5	34.9	25.5	21.8	135.1	46.8	30.9	40.9	116.9	92.1	24.6	63.3	93.3	51.9	58.2	30.4	44.5	36.7	40.6	77.6	31.6	101.2	68.7	67.5	92.5	39.5	52.1	6.0	27.2	34.7	41.0	2.3	1.5	63.0	71.2	57.6	76.0	83.1	64.6	17.6	33.2	68.4	65.0	51.6	65.9	1.8	10.5	110.6	64.4	30.7	28.9	174.4	67.4	92.2	66.2	51.5	55.4	249.3	39.6	35.7	95.0	10.3	69.3	44.5	44.1	61.3	49.4	47.0	63.3	9.9	66.0	12.6	42.9	28.6	32.6	54.3	33.2	38.1	26.2	26.4	27.5	23.8	63.1	26.9	23.8	26.1	46.5	27.6	52.5	62.2	20.9	32.0	14.6	17.4	23.0	15.0	15.5	19.2	15.3	17.6	17.3	16.4	16.2	21.8	84.1	137.8	103.9	23.2	52.0	81.8	110.6	111.8	96.2	16.2	80.2	73.9	120.2	75.8	89.3	69.9	14.6	73.0	85.4	49.4	99.7	77.9	1.6	66.9	73.5	66.3	50.2	28.4	37.0	83.7	55.1	92.6	48.9	83.5	8.2	44.7	66.4	103.9	50.4	45.4	39.9	55.3	81.4	71.0	93.8	4.5	85.7	64.0	53.4	13.1	75.0	75.6	36.0	58.3	24.5	59.3	51.7	87.6	49.4	112.5	53.3	126.1	78.8	17.4	59.2	102.1	77.4	3.2	8.8	183.2	91.1	78.0	55.2	71.4	75.1	91.8
CPOX	"CPO, CPX, HCP"	ENSG00000080819	"Coproporphyrinogen oxidase"	P36551	3	98579446-98593648	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins"	"Heme biosynthesis, Porphyrin biosynthesis"	Oxidoreductase	"Disease variant, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Erythroid cells: 352.8;Extravillous trophoblasts: 75.9;Oligodendrocytes: 99.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in all"		"HEL: 166.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015736, HPA054448"			Supported	Mitochondria		No	No		170000	"Cluster 26: Non-specific - Mitochondria"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 36: HEL - Hemostasis"	"Cluster 6: Erythroid cells - Oxygen transport"	Mitochondria		"HPA015736: AB_1847194, HPA054448: AB_2682490"	"unprognostic (2.14e-1)"	"unprognostic (1.04e-1)"	"unprognostic (4.07e-2)"	"unprognostic (6.09e-2)"	"unprognostic (2.71e-1)"	"unprognostic (2.34e-2)"	"unprognostic (8.58e-3)"	"unprognostic (7.14e-2)"	"unprognostic (2.53e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.10e-2)"	"unprognostic (1.86e-2)"	"prognostic unfavorable (1.04e-5)"	"unprognostic (1.62e-1)"	"unprognostic (2.67e-2)"	"unprognostic (2.15e-2)"	"unprognostic (2.57e-1)"	8.1	10.0	19.7	11.4	28.2	44.1	7.2	24.0	31.7	9.1	13.5	10.0	21.2	10.1	7.2	16.1	7.4	8.1	8.6	19.5	22.4	6.5	35.3	7.5	12.3	30.8	24.9	10.7	7.2	9.5	5.4	18.0	29.8	8.4	12.0	4.5	7.6	7.9	11.2	13.1	15.2	9.0	24.5	9.5	9.4	4.7	25.1	12.8	7.1	9.8	12.3	8.1	10.9	41.8	47.9	22.9	19.9	35.4	36.5	26.9	56.6	30.0	21.7	30.7	34.7	38.2	14.7	5.0	33.1	16.2	33.6	34.1	24.9	32.8	51.9	15.4	21.6	166.4	12.9	49.9	18.5	35.7	37.8	21.2	27.0	29.0	12.0	35.9	29.6	20.2	32.2	20.9	29.1	14.8	36.2	30.4	23.4	26.6	41.0	25.4	45.0	22.1	26.2	19.8	13.1	13.0	32.0	10.9	96.2	22.1	16.7	22.5	24.9	45.1	44.0	26.1	22.4	31.6	26.8	26.7	44.6	38.3	33.7	0.0	0.6	0.0	0.3	0.3	0.7	0.5	0.6	0.8	0.5	0.5	0.2	0.8	0.0	0.6	0.2	0.3	0.3	0.2	19.7	28.2	24.0	31.7	19.5	22.4	30.8	24.9	29.8	24.5	25.1	41.8	6.4	3.2	8.7	9.1	5.6	7.4	3.9	7.3	11.4	4.3	6.0	4.6	8.0	7.2	4.2	3.7	8.4	23.9	6.5	7.9	1.9	3.7	0.1	5.2	8.6	7.4	8.4	352.8	17.7	1.7	75.9	9.4	10.2	5.0	1.3	7.0	11.7	36.4	12.7	0.0	12.3	9.1	4.1	11.3	10.0	0.2	7.5	11.4	12.4	11.2	12.7	5.8	3.1	13.0	99.1	3.2	4.1	7.9	10.4	5.2	9.4	6.3	5.0	5.0	13.1	6.4	7.2	0.3	6.1	12.2	10.2	10.7	12.7	9.7	9.9	4.2
CPPED1	"CSTP1, FLJ11151"	ENSG00000103381	"Calcineurin like phosphoesterase domain containing 1"	Q9BRF8	16	12659799-12803887	"Enzymes, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cytotrophoblasts: 105.2;monocytes: 127.4;Syncytiotrophoblasts: 131.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 674.2"	"Group enriched"	"Detected in all"	28	"dendritic cells: 168.5;granulocytes: 674.2;monocytes: 320.8"	"Cell line enhanced"	"Detected in many"		"Hep G2: 144.2;HMC-1: 129.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040938, HPA041970"	Uncertain		Supported	"Plasma membrane,Cytosol"		No	No		470000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 64: Macrophages - Immune response"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	Cytosol	"Plasma membrane"	"HPA040938: AB_10673443, HPA041970: AB_2677774"	"prognostic unfavorable (9.72e-4)"	"unprognostic (1.70e-1)"	"unprognostic (2.04e-3)"	"unprognostic (1.05e-2)"	"unprognostic (1.13e-3)"	"unprognostic (3.86e-2)"	"unprognostic (1.35e-1)"	"unprognostic (8.67e-2)"	"unprognostic (1.23e-1)"	"unprognostic (3.26e-2)"	"unprognostic (6.26e-2)"	"unprognostic (3.64e-1)"	"prognostic favorable (1.62e-9)"	"unprognostic (5.05e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.48e-3)"	"unprognostic (2.40e-2)"	12.5	9.4	9.1	19.3	14.1	14.0	8.2	13.0	11.4	11.0	7.3	13.3	21.3	7.9	5.1	25.2	7.1	11.2	10.1	8.3	13.3	33.7	34.4	13.7	11.7	14.0	13.1	7.6	4.8	3.9	4.1	18.5	14.4	11.1	14.8	3.7	13.1	8.6	8.2	6.5	21.4	12.9	11.3	29.8	8.7	15.5	12.2	9.2	13.2	9.6	16.6	11.5	8.8	17.3	5.0	29.7	3.3	7.7	12.0	25.3	0.5	54.1	14.5	28.4	23.1	14.5	15.2	7.3	54.6	39.6	12.5	0.4	0.0	13.5	29.3	17.0	8.2	62.5	4.2	144.2	7.4	0.1	129.9	25.4	3.0	2.5	20.2	0.1	43.1	9.9	22.1	4.3	70.4	6.3	5.6	29.1	8.7	2.4	4.2	11.9	18.8	15.6	43.0	9.4	15.3	10.0	0.2	48.5	20.0	15.3	10.5	13.7	65.0	40.6	8.5	0.2	0.1	0.1	1.0	11.6	9.1	31.7	8.8	57.1	224.0	146.1	9.1	320.0	7.8	10.8	7.6	10.0	168.5	8.4	2.4	5.7	674.2	13.5	320.8	41.1	13.8	129.7	9.1	14.1	13.0	11.4	8.3	13.3	14.0	13.1	14.4	11.3	12.2	17.3	12.3	9.6	16.7	8.1	8.7	4.6	3.4	4.9	4.6	3.3	4.7	4.7	10.7	10.0	11.4	14.7	8.4	105.2	18.5	9.2	60.7	43.1	3.6	5.3	13.5	16.7	6.0	31.7	13.1	12.8	15.6	12.6	4.1	9.4	54.4	8.1	7.5	45.8	47.1	10.1	10.2	9.3	6.1	80.3	30.7	4.1	15.5	59.0	7.2	30.0	127.4	13.5	8.2	21.1	70.9	31.9	18.3	24.0	4.4	3.2	40.6	66.0	13.4	6.1	26.3	17.6	11.9	2.5	9.9	14.8	4.5	131.9	8.3	13.6	15.4	1.7
CPQ	"LDP, PGCP"	ENSG00000104324	"Carboxypeptidase Q"	Q9Y646	8	96645242-97149654	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Carboxypeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"thyroid gland: 225.9"	"Cell type enhanced"	"Detected in all"		"Astrocytes: 150.2;Oligodendrocytes: 299.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 250.5"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 116.1;ASC TERT1: 131.4;hTERT-RPE1: 108.2;Karpas-707: 97.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023235, HPA024490"	Enhanced		Supported	"Golgi apparatus,Vesicles"	"Secreted to blood"	NA	NA		51000000	"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Golgi apparatus, Vesicles"		"HPA023235: AB_1855257, HPA024490: AB_1855258"	"unprognostic (4.04e-2)"	"unprognostic (5.46e-2)"	"unprognostic (4.45e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.51e-3)"	"unprognostic (3.98e-3)"	"unprognostic (5.24e-2)"	"unprognostic (2.92e-2)"	"unprognostic (2.67e-2)"	"unprognostic (9.19e-2)"	"unprognostic (2.38e-3)"	"unprognostic (6.16e-3)"	"prognostic favorable (5.40e-5)"	"unprognostic (6.74e-3)"	"unprognostic (8.71e-2)"	"unprognostic (3.21e-2)"	"unprognostic (1.75e-1)"	46.2	35.9	22.6	25.4	33.9	31.8	34.7	28.0	26.7	75.1	20.6	39.6	29.3	46.0	36.2	25.9	39.8	57.8	51.8	21.6	27.0	80.5	70.0	32.3	22.8	32.6	27.5	87.4	46.7	60.7	25.6	39.2	33.2	40.2	33.1	16.8	32.8	54.2	13.3	20.6	35.0	64.7	25.9	31.3	32.1	13.9	30.3	8.2	225.9	33.2	17.0	46.3	38.6	38.6	0.6	2.1	2.1	0.1	116.1	131.4	0.5	35.3	55.6	12.8	26.5	2.0	0.9	0.4	27.2	59.0	15.7	1.0	2.4	2.8	12.0	31.4	4.4	28.4	1.5	17.7	25.6	4.9	37.0	69.6	6.5	15.0	3.7	108.2	6.0	0.1	27.1	97.0	29.4	1.2	0.5	14.1	2.5	0.2	5.2	4.3	0.0	0.6	26.7	13.2	2.4	0.3	10.2	0.4	28.2	25.8	12.3	28.6	21.3	51.9	4.9	0.8	11.5	7.9	0.9	0.3	32.2	21.6	33.5	32.0	71.3	45.1	27.3	49.6	27.6	5.4	20.3	24.0	51.8	7.4	17.6	24.6	250.5	25.9	47.5	14.8	22.2	40.6	22.6	33.9	28.0	26.7	21.6	27.0	32.6	27.5	33.2	25.9	30.3	38.6	46.6	12.8	12.5	150.2	11.7	19.4	25.7	21.3	9.6	12.7	12.1	27.9	27.2	42.9	13.9	47.8	29.2	12.1	40.8	9.3	17.6	22.7	5.0	6.6	43.3	27.1	13.8	7.2	24.0	10.7	1.8	123.8	10.7	8.6	38.0	43.1	51.0	48.3	54.0	10.1	31.3	7.9	24.4	56.0	44.9	9.0	72.4	39.4	78.2	131.2	33.7	43.4	39.1	44.7	299.6	11.7	9.5	73.0	11.9	12.4	42.4	56.0	9.7	16.3	52.6	71.1	67.8	5.6	3.4	2.8	13.1	6.0	23.8	38.6	12.2	13.5
CPS1		ENSG00000021826	"Carbamoyl-phosphate synthase 1"	P31327	2	210477682-210679107	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Urea cycle"	"Allosteric enzyme, Ligase"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"liver: 1063.2"	"Cell type enriched"	"Detected in many"	19	"Hepatocytes: 2075.1"	"Cancer enriched"	"Detected in many"	8	"liver cancer: 136.1"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HeLa: 347.6;SiHa: 65.1;SK-BR-3: 98.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB003781, HPA021400"	Enhanced		Supported	"Nucleoli,Nucleoli rim"		NA	NA		8300000		"Cluster 85: Liver - Metabolism"	"Cluster 20: HeLa - Mitochondria"	"Cluster 2: Hepatocytes - Metabolism"	"Nucleoli, Nucleoli rim"		"CAB003781: , HPA021400: AB_1847197"	"unprognostic (1.67e-2)"	"unprognostic (3.72e-2)"	"unprognostic (4.02e-2)"	"unprognostic (7.21e-7)"	"unprognostic (3.81e-2)"	"unprognostic (2.52e-1)"	"prognostic favorable (6.93e-5)"	"unprognostic (1.23e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.35e-2)"	"unprognostic (5.38e-2)"	"unprognostic (1.94e-3)"	"unprognostic (2.38e-4)"	"unprognostic (5.90e-2)"	"unprognostic (1.13e-1)"	"unprognostic (3.14e-2)"	"unprognostic (3.74e-2)"	2.5	0.4	1.0	0.4	10.0	0.1	1.5	4.9	1.7	0.9	0.1	0.8	211.8	1.6	2.8	1.5	0.9	1.6	1.2	0.7	2.3	1.9	1063.2	1.0	0.3	6.9	8.7	2.9	0.8	0.1	0.9	2.5	6.0	0.8	0.4	0.3	0.5	0.8	0.6	1.4	123.4	2.1	3.4	1.2	0.6	6.0	5.8	0.3	1.7	0.5	0.2	0.6	0.7	6.3	0.9	9.7	14.0	11.7	11.6	16.5	18.0	6.1	6.4	6.3	9.2	1.8	0.0	2.7	0.4	5.3	9.6	3.0	0.5	10.8	15.9	0.0	4.5	10.0	347.6	15.2	2.8	4.0	0.0	9.2	6.2	12.8	13.0	18.7	0.4	4.2	10.3	0.8	10.4	2.8	0.3	0.7	6.3	0.0	1.8	0.7	14.6	1.6	13.2	0.2	0.5	1.1	65.1	98.9	8.1	20.0	0.1	1.6	7.7	17.5	5.8	5.9	13.0	0.0	0.7	0.0	12.5	11.6	11.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	10.0	4.9	1.7	0.7	2.3	6.9	8.7	6.0	3.4	5.8	6.3	0.4	12.8	8.4	6.2	3.6	2.2	0.6	0.9	1.2	1.4	1.3	1.5	1.1	15.7	3.9	1.8	8.4	0.4	0.4	0.1	0.0	0.2	35.5	1.0	2.1	2.0	0.0	18.7	12.1	0.2	0.4	2.6	0.0	1.6	3.8	0.3	16.8	2075.1	0.2	0.0	6.2	13.5	0.0	27.2	2.9	6.5	2.5	0.8	1.8	3.7	0.2	0.7	0.0	3.0	8.8	0.0	2.5	1.2	0.1	1.1	105.6	1.0	1.3	2.3	0.0	1.8	2.3	0.6	1.8	1.5	1.8	20.8	1.8	3.5	41.2	0.4
CPSF4	"CPSF30, NAR"	ENSG00000160917	"Cleavage and polyadenylation specific factor 4"	O95639	7	99438922-99457373	"Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, mRNA processing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cytotrophoblasts: 55.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049094, HPA066470"	Uncertain		Supported	Nucleoplasm,Vesicles		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 47: Cytotrophoblasts - Unknown function"	Nucleoplasm	Vesicles	"HPA049094: AB_2680626, HPA066470: AB_2685672"	"unprognostic (4.03e-3)"	"unprognostic (1.36e-1)"	"unprognostic (1.86e-1)"	"unprognostic (1.90e-2)"	"unprognostic (2.54e-2)"	"unprognostic (1.44e-1)"	"prognostic unfavorable (5.87e-4)"	"unprognostic (5.84e-2)"	"unprognostic (2.28e-2)"	"unprognostic (3.15e-1)"	"unprognostic (3.73e-3)"	"unprognostic (3.36e-2)"	"prognostic unfavorable (1.68e-4)"	"unprognostic (2.47e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.37e-1)"	"unprognostic (4.23e-2)"	20.4	19.0	31.4	13.8	30.8	20.1	19.2	29.9	35.1	18.7	23.6	16.7	14.0	16.8	11.7	20.4	15.7	11.3	17.4	30.1	30.4	17.3	20.2	15.4	23.7	35.5	31.6	18.8	29.9	8.3	18.4	16.7	32.1	19.1	10.7	7.2	19.8	12.3	36.1	20.4	16.1	11.1	30.4	22.0	20.0	32.0	32.3	16.1	13.9	18.0	19.9	16.0	17.4	30.4	40.0	33.9	55.4	44.9	22.4	25.5	66.8	25.8	31.5	38.8	50.5	56.0	52.0	56.4	34.2	25.2	48.2	34.0	39.1	40.5	35.4	41.9	41.6	27.0	41.4	54.4	117.2	49.4	33.3	46.8	34.0	40.7	60.4	28.1	35.8	40.1	70.8	64.8	36.2	95.6	99.6	88.9	51.3	53.0	47.7	40.8	37.0	66.8	24.2	36.1	43.3	50.6	29.4	60.9	61.6	58.2	25.3	51.8	20.0	36.5	50.1	64.3	50.0	59.9	68.6	83.3	28.1	48.1	44.1	1.2	3.4	2.6	3.3	3.0	4.4	8.2	5.0	6.1	4.1	8.4	6.3	5.6	1.3	4.4	2.1	5.4	8.2	3.0	31.4	30.8	29.9	35.1	30.1	30.4	35.5	31.6	32.1	30.4	32.3	30.4	11.6	6.4	8.9	6.2	11.2	8.8	16.4	10.6	9.6	4.6	11.9	10.3	10.4	14.3	8.6	1.8	10.4	55.9	17.7	8.7	15.6	15.6	3.0	4.9	9.3	11.0	7.7	15.6	10.7	17.1	33.1	12.7	5.1	5.3	12.7	27.0	8.2	8.2	21.5	6.7	14.7	10.6	14.2	10.1	13.5	7.8	27.4	8.7	8.8	5.6	18.5	10.7	14.4	6.0	8.1	13.9	6.0	17.3	14.7	28.6	10.1	20.2	4.3	6.9	19.7	23.7	16.4	20.9	19.8	9.3	9.2	45.4	10.7	25.1	12.6	14.9
CPSF7	"CFIM59, FLJ12529"	ENSG00000149532	"Cleavage and polyadenylation specific factor 7"	Q8N684	11	61402641-61430031	"Predicted intracellular proteins"	"mRNA processing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041094	Supported		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	Nucleoplasm	Cytosol	"HPA041094: AB_10794187"	"unprognostic (6.87e-3)"	"unprognostic (8.31e-2)"	"unprognostic (1.94e-1)"	"unprognostic (4.79e-3)"	"unprognostic (1.07e-1)"	"unprognostic (9.41e-3)"	"prognostic unfavorable (9.83e-4)"	"unprognostic (5.35e-2)"	"unprognostic (2.07e-3)"	"unprognostic (7.95e-2)"	"unprognostic (2.59e-1)"	"unprognostic (3.74e-2)"	"unprognostic (3.90e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.38e-1)"	"unprognostic (6.18e-2)"	43.2	44.1	39.1	36.0	40.7	55.0	44.2	40.0	48.4	55.2	39.8	48.9	32.0	54.8	44.1	46.6	55.1	27.3	39.5	37.9	41.3	44.2	62.8	38.0	43.3	38.1	41.0	55.6	49.2	35.0	79.1	37.8	39.1	47.3	34.3	40.7	41.4	34.7	68.0	52.3	49.0	43.7	33.9	57.4	47.3	42.0	39.3	57.8	58.9	48.1	43.7	47.4	45.7	44.3	72.5	71.0	98.0	78.2	52.0	45.8	68.7	58.9	56.2	76.7	58.4	83.7	60.6	107.7	61.4	63.6	65.0	87.4	94.7	67.4	93.1	71.8	48.4	90.9	95.8	68.0	52.5	111.4	77.9	48.7	54.3	81.3	118.4	46.7	52.8	69.1	111.2	67.1	56.2	87.7	110.5	90.9	96.2	50.5	55.6	102.8	77.1	88.9	57.8	87.9	66.3	67.6	78.2	68.4	74.3	59.7	94.4	47.6	53.2	84.4	71.6	79.0	61.4	92.0	116.5	122.4	49.3	53.2	63.0	15.1	5.6	7.1	8.1	6.0	8.7	6.9	6.4	8.4	7.6	6.5	7.0	7.2	9.8	6.7	4.6	6.4	4.8	5.7	39.1	40.7	40.0	48.4	37.9	41.3	38.1	41.0	39.1	33.9	39.3	44.3	23.3	35.3	21.2	56.8	29.0	23.2	18.4	15.5	26.7	21.4	26.1	24.9	11.4	11.5	16.0	16.5	39.6	26.7	29.4	22.6	17.6	15.7	41.8	17.1	21.7	22.6	22.2	20.0	29.8	13.8	17.5	20.7	22.4	21.3	23.5	26.6	22.9	27.2	19.6	32.0	31.0	21.9	16.2	31.0	19.0	29.1	27.4	23.4	3.6	37.5	39.7	24.2	22.6	31.7	39.8	19.5	13.6	25.2	28.6	25.0	22.3	14.3	19.9	21.7	39.5	28.8	22.6	37.5	27.1	25.0	26.3	27.5	22.1	17.7	23.0	23.0
CPT1A	"CPT1, CPT1-L, L-CPT1"	ENSG00000110090	"Carnitine palmitoyltransferase 1A"	P50416	11	68754620-68844410	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Fatty acid metabolism, Lipid metabolism, Transport"	"Acyltransferase, Transferase"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 110.0;Hepatocytes: 108.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008835	Supported		Supported	Mitochondria		NA	NA		45000	"Cluster 2: Granulocytes - Unknown function"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Mitochondria		"HPA008835: AB_1078563"	"prognostic unfavorable (3.84e-4)"	"unprognostic (1.38e-3)"	"unprognostic (3.04e-3)"	"unprognostic (2.46e-2)"	"unprognostic (1.45e-1)"	"unprognostic (7.25e-2)"	"unprognostic (2.17e-1)"	"unprognostic (4.99e-2)"	"unprognostic (2.72e-1)"	"unprognostic (1.47e-2)"	"unprognostic (2.92e-2)"	"unprognostic (2.34e-1)"	"prognostic favorable (2.67e-7)"	"unprognostic (9.76e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.49e-1)"	"unprognostic (2.46e-3)"	24.3	27.7	16.0	22.3	18.4	38.9	22.7	20.2	17.3	20.4	32.0	67.4	70.7	25.1	7.3	22.0	25.4	27.7	25.4	14.7	17.7	38.4	67.9	25.3	15.9	20.6	22.0	18.3	23.6	27.6	14.3	18.4	19.3	20.3	44.6	22.6	26.0	21.9	9.9	17.0	71.3	34.9	15.9	27.4	35.6	13.5	22.1	14.0	15.4	14.3	12.3	18.7	18.0	13.9	29.4	50.9	7.3	48.6	31.2	28.0	2.1	22.9	18.8	17.7	3.6	2.0	96.0	0.1	82.2	60.4	62.2	93.5	63.9	13.6	5.3	46.8	6.3	71.5	52.3	24.0	46.4	41.9	82.6	29.2	6.6	35.5	21.4	24.1	63.5	28.2	7.6	56.8	16.5	83.6	34.4	73.7	0.8	149.7	53.2	94.7	1.2	127.1	41.7	71.7	1.0	31.8	63.0	119.9	20.2	4.8	107.4	40.0	64.5	38.3	0.9	77.7	33.5	43.9	60.1	29.2	40.3	30.3	42.8	8.2	6.6	9.5	7.3	7.7	4.2	1.9	4.4	4.4	4.4	2.0	2.7	5.5	3.2	4.9	6.7	10.4	2.8	2.7	16.0	18.4	20.2	17.3	14.7	17.7	20.6	22.0	19.3	15.9	22.1	13.9	44.4	38.5	28.8	35.6	13.5	9.4	11.0	9.0	28.5	4.8	9.6	7.6	25.5	22.8	18.0	23.9	64.6	15.9	39.3	110.0	19.6	13.8	14.7	33.2	22.6	30.4	16.2	30.9	5.6	9.5	3.9	16.6	31.1	56.7	29.7	23.0	40.7	108.3	15.7	1.7	5.7	48.9	10.2	39.1	11.5	43.9	9.6	24.6	0.0	28.1	31.4	12.7	23.7	7.1	1.7	8.5	43.4	32.0	28.6	9.6	83.4	11.8	23.8	43.0	39.5	18.3	21.1	14.5	10.0	14.8	7.7	7.8	24.0	17.3	67.4	9.2
CPT2	"CPT1, CPTASE"	ENSG00000157184	"Carnitine palmitoyltransferase 2"	P23786	1	53196792-53214197	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism, Transport"	"Acyltransferase, Transferase"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 91.2"	"Cell type enhanced"	"Detected in all"		"Cytotrophoblasts: 85.1;Hepatocytes: 88.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028201, HPA028202, HPA028214"	Enhanced		Approved	Nucleoplasm,Nucleoli,Mitochondria		Yes	No			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Nucleoplasm, Mitochondria"	Nucleoli	"HPA028201: AB_10599177, HPA028202: AB_10599942, HPA028214: AB_10601958"	"unprognostic (2.43e-1)"	"unprognostic (2.27e-1)"	"prognostic favorable (5.27e-4)"	"unprognostic (6.48e-2)"	"unprognostic (1.88e-1)"	"unprognostic (9.34e-2)"	"unprognostic (6.48e-2)"	"unprognostic (1.75e-2)"	"unprognostic (2.86e-1)"	"unprognostic (1.67e-1)"	"unprognostic (3.00e-2)"	"unprognostic (8.97e-2)"	"prognostic favorable (1.46e-12)"	"unprognostic (4.00e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.79e-2)"	"unprognostic (2.95e-2)"	12.9	14.3	6.6	9.4	8.2	5.4	13.6	7.9	7.3	10.3	16.8	35.4	32.4	6.8	10.5	14.2	10.5	9.5	19.5	6.1	7.1	35.1	91.2	11.5	10.6	8.1	7.5	10.2	21.7	27.3	6.7	18.0	8.0	12.2	32.8	7.1	14.6	11.7	17.3	6.7	24.9	11.4	7.7	8.7	18.4	12.9	9.0	10.2	12.5	33.1	13.2	11.1	4.5	8.9	16.0	8.3	17.2	17.8	14.6	11.3	17.5	9.8	13.2	17.5	17.5	8.6	14.5	28.9	14.6	9.2	20.1	19.1	35.1	25.1	15.1	17.0	16.0	21.8	9.9	6.4	25.9	15.9	19.5	23.0	23.2	13.8	11.1	18.6	15.4	26.5	20.9	9.9	13.1	12.8	10.7	13.0	29.8	38.4	20.0	13.2	16.2	34.4	22.9	22.0	25.3	14.4	22.1	30.3	39.7	36.6	32.3	32.2	8.7	8.4	6.1	16.5	8.5	26.3	19.8	16.2	11.6	20.6	12.4	5.6	14.1	14.6	7.2	20.0	8.1	5.3	6.3	8.4	17.9	7.4	10.5	7.2	5.3	6.9	20.5	8.9	9.9	10.3	6.6	8.2	7.9	7.3	6.1	7.1	8.1	7.5	8.0	7.7	9.0	8.9	5.0	12.8	24.1	4.2	7.8	1.8	5.2	20.5	5.2	6.0	7.5	7.0	18.1	15.7	11.4	11.0	14.6	85.1	4.5	49.3	25.4	12.9	1.1	10.9	8.1	5.9	14.5	9.4	1.5	10.5	20.3	7.2	18.3	10.3	2.5	12.7	8.9	88.8	26.3	15.2	2.0	26.6	16.2	15.1	7.2	2.8	6.8	10.5	7.2	1.9	20.2	11.6	6.2	2.5	4.5	10.5	25.6	5.3	9.1	4.9	38.6	41.0	7.6	11.0	6.6	7.5	8.4	49.9	31.3	13.8	2.6	54.6	6.9	25.6	29.5	5.7
CRABP2	CRABP-II	ENSG00000143320	"Cellular retinoic acid binding protein 2"	P29373	1	156699606-156705816	"Predicted intracellular proteins"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 1189.7;vagina: 604.9"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 485.4;Breast glandular cells: 224.2;Club cells: 266.7;Squamous epithelial cells: 714.0;Urothelial cells: 506.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 1592.5;MCF7: 625.9;T-47d: 1201.3"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"spinal cord: 36.0"	HPA004135	Supported		Supported	Nucleoplasm,Cytosol		NA	NA		76000	"Cluster 32: T-cells - Unknown function"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 6: T47d - Mammary gland"	"Cluster 61: Squamous epithelial cells - Keratinization"	Cytosol	Nucleoplasm	"HPA004135: AB_1846516"	"unprognostic (1.17e-2)"	"unprognostic (9.30e-2)"	"unprognostic (3.07e-2)"	"prognostic unfavorable (2.11e-5)"	"unprognostic (1.75e-2)"	"unprognostic (1.08e-1)"	"unprognostic (9.96e-2)"	"unprognostic (1.88e-1)"	"unprognostic (6.45e-2)"	"unprognostic (7.79e-2)"	"unprognostic (7.23e-3)"	"unprognostic (7.16e-2)"	"prognostic unfavorable (3.19e-13)"	"unprognostic (3.05e-3)"	"unprognostic (1.34e-1)"	"unprognostic (3.86e-2)"	"unprognostic (2.25e-2)"	22.2	8.0	9.6	4.8	11.5	5.7	104.5	10.5	18.8	273.7	29.4	13.3	0.9	76.3	4.7	1189.7	83.1	18.2	5.5	10.7	12.8	12.0	2.3	6.4	3.9	8.0	8.2	6.2	3.4	55.1	43.5	40.5	7.8	34.8	4.8	4.5	93.5	57.1	5.0	179.0	3.9	57.0	7.4	7.9	5.6	5.3	12.0	15.5	14.5	1.8	76.2	81.2	604.9	10.1	103.4	5.4	115.3	1.6	147.1	218.0	0.4	215.4	1592.5	17.3	21.3	184.9	369.8	1.6	103.1	234.0	2.2	131.2	28.1	0.8	5.1	2.9	8.1	0.1	13.5	1.6	29.0	0.3	2.5	69.3	10.6	25.4	0.5	13.8	0.7	2.0	1.0	2.2	1.9	625.9	1.7	1.9	136.5	12.3	57.3	1.7	0.8	3.4	2.3	4.0	280.7	20.2	3.0	366.2	1.5	214.9	1201.3	0.7	0.2	4.2	63.1	35.5	13.4	9.8	23.8	1.3	28.6	1.6	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	9.6	11.5	10.5	18.8	10.7	12.8	8.0	8.2	7.8	7.4	12.0	10.1	7.0	0.0	2.6	1.3	1.8	65.0	131.2	485.4	104.2	1.8	224.2	96.8	0.7	1.5	266.7	16.5	2.1	53.9	4.9	0.9	0.0	12.6	2.2	18.0	51.9	10.3	0.0	0.0	3.1	5.2	6.2	168.4	1.1	29.3	0.0	0.5	6.4	0.2	10.0	0.0	1.8	0.9	40.7	0.0	55.4	1.0	19.9	3.9	62.2	0.0	0.0	1.0	0.0	1.5	0.3	18.1	0.2	37.6	0.2	194.9	0.1	0.3	28.2	0.6	0.0	4.3	40.0	2.0	6.1	714.0	190.7	18.1	7.6	4.8	1.7	506.4
CRB3	MGC17303	ENSG00000130545	"Crumbs cell polarity complex component 3"	Q9BUF7	19	6463777-6467221	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 54.5"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 160.9;Pancreatic endocrine cells: 149.9;Paneth cells: 177.3;Suprabasal keratinocytes: 139.5;Urothelial cells: 243.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Immune cell enhanced"	"Detected in many"		"naive CD4 T-cell: 9.2"	"Group enriched"	"Detected in many"	20	"B-cells: 3.1;T-cells: 9.2"	"Cell line enhanced"	"Detected in some"		"A-431: 57.9;BEWO: 35.1;CACO-2: 38.1;HaCaT: 36.9;hTCEpi: 27.8;OE19: 33.1;SK-BR-3: 29.5;T-47d: 25.8"	"Low region specificity"	"Detected in many"							HPA013835	Enhanced		Supported	"Cell Junctions"		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Cell Junctions"		"HPA013835: AB_1847214"	"unprognostic (3.25e-1)"	"unprognostic (4.41e-2)"	"unprognostic (9.69e-2)"	"prognostic favorable (4.54e-4)"	"unprognostic (1.24e-1)"	"unprognostic (1.95e-2)"	"unprognostic (2.81e-1)"	"unprognostic (1.03e-2)"	"unprognostic (1.86e-1)"	"unprognostic (2.57e-2)"	"unprognostic (4.98e-2)"	"unprognostic (1.11e-1)"	"prognostic favorable (0.00e+0)"	"unprognostic (8.42e-3)"	"unprognostic (1.96e-1)"	"unprognostic (1.12e-2)"	"prognostic favorable (8.06e-5)"	0.8	0.4	0.3	4.0	0.7	0.3	5.1	1.2	0.5	9.3	6.1	26.9	36.9	2.2	4.6	54.5	8.2	8.2	0.3	0.3	0.2	34.1	32.5	19.0	0.9	0.4	0.2	0.4	44.0	20.7	15.9	3.5	0.5	9.1	10.5	0.4	24.8	8.9	0.1	41.9	30.6	0.5	0.1	0.8	31.1	0.4	0.2	0.8	16.2	0.0	5.4	6.4	17.6	0.5	57.9	7.0	0.0	0.2	0.0	0.1	35.1	0.0	0.0	0.0	0.0	38.1	23.8	0.3	22.1	0.0	0.3	36.9	0.4	12.5	0.0	0.0	0.4	0.1	0.2	21.5	0.0	0.1	0.1	0.0	27.8	0.0	0.0	0.0	0.1	0.5	0.1	0.5	0.0	15.1	0.2	0.4	1.3	33.1	0.0	0.0	0.0	0.7	16.5	24.0	0.0	0.1	0.2	29.5	0.1	1.7	25.8	0.2	0.0	0.1	0.4	0.2	0.1	0.7	0.3	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	1.3	3.1	4.6	2.2	0.0	1.0	9.2	3.6	0.3	0.0	0.0	0.0	3.4	1.9	0.3	0.7	1.2	0.5	0.3	0.2	0.4	0.2	0.5	0.1	0.2	0.5	0.2	35.3	38.0	0.0	2.2	72.1	64.6	81.3	21.1	0.0	43.6	19.9	0.3	71.4	64.0	31.3	0.0	28.1	0.9	160.9	46.9	113.0	0.0	43.8	4.0	1.8	16.8	3.2	0.1	101.5	9.8	2.0	34.7	58.3	1.3	0.1	0.4	31.8	2.5	0.0	0.0	60.2	63.1	1.0	6.2	0.0	0.0	1.3	7.2	0.0	2.7	0.9	0.0	0.0	0.1	149.9	177.3	0.0	3.1	94.4	86.8	44.5	36.3	0.5	0.0	0.0	4.2	1.1	0.4	45.0	139.5	56.2	3.2	0.2	52.0	243.6
CREB3	"Luman, LZIP, sLZIP"	ENSG00000107175	"CAMP responsive element binding protein 3"	O43889	9	35732598-35736999	"Predicted membrane proteins, Transcription factors"	"Chemotaxis, Host-virus interaction, Transcription, Transcription regulation, Unfolded protein response"	"Activator, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 173.7;Late spermatids: 413.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030978			Supported	Cytosol		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 35: Non-specific - Unknown function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 25: Spermatids - Spermatogenesis"	Cytosol		"HPA030978: AB_2673683"	"unprognostic (1.73e-3)"	"unprognostic (9.72e-2)"	"unprognostic (9.32e-2)"	"unprognostic (5.62e-3)"	"unprognostic (3.61e-1)"	"unprognostic (3.86e-2)"	"prognostic unfavorable (5.57e-4)"	"unprognostic (4.29e-2)"	"unprognostic (4.63e-2)"	"prognostic favorable (5.40e-4)"	"unprognostic (1.13e-1)"	"unprognostic (1.65e-1)"	"prognostic favorable (3.77e-5)"	"unprognostic (1.48e-1)"	"unprognostic (1.61e-1)"	"unprognostic (2.54e-1)"	"unprognostic (1.29e-1)"	26.8	45.5	41.4	16.5	42.2	7.6	26.6	38.9	47.1	29.1	37.5	38.9	14.5	34.1	37.4	16.3	28.6	20.8	27.7	39.8	43.6	29.4	26.4	24.9	14.4	43.0	43.0	26.1	32.6	29.9	38.3	20.6	43.4	37.0	23.1	23.4	31.9	38.6	24.1	18.1	22.6	35.7	41.6	20.3	36.1	44.7	42.4	16.1	26.6	20.0	19.2	32.1	21.4	40.3	39.2	35.6	36.9	30.0	77.5	48.8	22.6	64.1	111.6	69.8	73.1	45.8	19.4	10.5	28.5	108.0	87.8	15.7	25.0	52.7	53.7	37.9	14.5	8.7	44.1	24.8	97.3	16.0	19.2	42.8	45.2	72.0	73.4	66.8	42.6	19.1	11.9	24.7	81.7	22.3	22.3	8.5	19.5	30.9	39.1	18.3	15.3	15.1	69.5	25.2	15.3	21.3	22.6	23.6	17.1	34.6	39.1	7.1	46.4	52.0	27.1	35.6	44.2	12.2	13.2	15.1	55.1	7.4	55.6	24.6	33.5	11.6	26.1	32.8	31.2	28.4	26.1	29.9	37.8	20.0	20.2	18.1	12.8	28.2	29.0	31.4	27.1	28.0	41.4	42.2	38.9	47.1	39.8	43.6	43.0	43.0	43.4	41.6	42.4	40.3	24.4	28.9	17.8	3.9	27.0	35.8	55.4	62.9	20.5	29.2	35.5	27.9	13.2	30.0	43.5	16.5	12.5	49.0	29.5	50.0	33.2	89.0	173.7	26.3	19.4	33.0	26.4	3.8	4.6	70.3	54.9	34.9	25.0	25.9	32.3	20.6	25.7	23.7	35.9	5.0	5.6	67.6	32.6	16.8	59.3	413.5	30.1	22.5	49.8	1.9	42.4	50.6	38.1	3.0	5.4	72.4	42.1	42.2	53.1	65.5	71.3	62.2	56.0	18.5	32.9	22.2	47.9	73.3	32.7	11.9	22.7	61.0	24.2	22.6	29.0	46.8
CREB3L2	"BBF2H7, TCAG_1951439"	ENSG00000182158	"CAMP responsive element binding protein 3 like 2"	Q70SY1	7	137874979-138002086	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transcription factors"	"Transcription, Transcription regulation, Unfolded protein response"	"Activator, Developmental protein, DNA-binding"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Plasma cells: 141.1;Syncytiotrophoblasts: 144.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015068, HPA015534"	Enhanced		Supported	"Nucleoplasm,Endoplasmic reticulum"		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 65: Plasmacytoid DCs - Unknown function"	"Nucleoplasm, Endoplasmic reticulum"		"HPA015068: AB_1847224, HPA015534: AB_2669210"	"unprognostic (8.50e-2)"	"unprognostic (3.70e-2)"	"unprognostic (2.77e-1)"	"unprognostic (1.50e-3)"	"unprognostic (9.88e-2)"	"unprognostic (9.09e-2)"	"unprognostic (5.17e-2)"	"unprognostic (4.50e-1)"	"unprognostic (4.77e-1)"	"unprognostic (8.93e-2)"	"unprognostic (9.48e-2)"	"unprognostic (9.65e-2)"	"unprognostic (2.42e-1)"	"unprognostic (3.08e-3)"	"unprognostic (7.65e-2)"	"unprognostic (2.59e-2)"	"unprognostic (1.32e-2)"	20.7	29.7	8.3	18.5	13.9	23.8	22.8	8.3	12.2	30.3	46.5	22.4	22.3	33.9	26.8	15.0	22.6	15.0	25.9	8.1	9.6	19.6	12.5	19.3	12.8	13.2	10.8	29.0	30.1	59.5	25.1	39.4	12.1	21.6	17.6	5.0	28.7	23.2	6.1	8.7	22.9	29.2	9.6	13.0	17.4	9.0	16.1	10.0	65.3	9.4	20.4	19.5	19.9	17.3	13.1	19.9	37.6	0.6	62.9	61.7	28.1	65.1	104.0	44.4	44.7	27.5	11.7	2.6	16.8	71.1	24.1	6.9	21.9	47.1	86.9	19.1	10.8	83.4	26.7	67.6	41.4	25.3	115.5	25.4	29.2	56.0	65.3	45.5	59.7	6.5	43.8	37.4	52.9	23.5	8.0	31.6	13.6	17.9	13.7	17.5	19.8	22.1	35.3	13.2	9.4	22.3	21.1	54.0	29.1	21.7	7.9	18.9	63.1	59.5	8.7	72.3	24.2	43.9	16.2	16.9	70.9	71.3	135.0	10.4	5.5	6.0	7.3	3.0	9.8	3.9	5.4	8.2	5.7	3.9	2.0	3.4	2.0	7.2	1.6	11.9	12.5	3.2	8.3	13.9	8.3	12.2	8.1	9.6	13.2	10.8	12.1	9.6	16.1	17.3	30.6	6.4	25.9	18.6	27.3	12.2	9.7	18.9	8.0	12.0	32.0	25.4	17.5	21.5	34.9	23.9	10.4	62.6	39.5	24.7	13.7	10.2	56.3	18.1	86.6	31.6	15.7	12.0	7.5	17.6	93.0	49.6	16.3	42.4	49.4	27.8	29.6	24.3	56.3	15.2	10.6	21.0	20.3	34.9	25.6	18.7	61.8	30.7	26.6	63.7	21.4	5.4	40.2	55.8	48.0	14.4	18.2	103.0	141.1	35.1	66.2	7.9	22.4	12.3	39.5	62.3	50.2	3.4	7.4	9.5	7.1	144.5	26.6	11.1	17.0	44.0
CREBBP	"CBP, KAT3A, RSTS, RTS"	ENSG00000005339	"CREB binding protein"	Q92793	16	3725054-3880713	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Biological rhythms, Host-virus interaction, Transcription, Transcription regulation"	"Activator, Acyltransferase, Transferase"	"Cancer-related genes, Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004212, HPA055861"	Supported		Supported	"Nucleoplasm,Nuclear bodies"		No	No			"Cluster 1: Neutrophils - Mixed function"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm	"Nuclear bodies"	"CAB004212: AB_626817, HPA055861: AB_2682948"	"unprognostic (1.17e-1)"	"unprognostic (8.51e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.49e-1)"	"unprognostic (5.09e-2)"	"unprognostic (9.59e-3)"	"unprognostic (6.98e-2)"	"unprognostic (8.96e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.84e-1)"	"prognostic favorable (6.24e-5)"	"unprognostic (1.47e-1)"	"unprognostic (1.74e-1)"	"unprognostic (3.97e-2)"	"unprognostic (8.23e-2)"	17.4	10.6	5.8	17.1	5.2	52.9	16.8	25.4	11.5	20.9	3.7	18.8	12.5	26.5	12.4	16.5	22.4	16.6	14.4	5.9	3.1	12.0	14.3	15.9	17.6	8.9	6.8	37.3	29.7	18.5	11.3	16.9	2.9	16.1	14.1	13.8	17.2	16.2	29.6	21.0	16.4	19.6	0.4	21.0	16.3	33.2	7.9	29.1	23.3	28.9	20.7	16.6	16.5	6.4	12.3	31.0	39.3	17.4	23.5	23.1	20.4	17.4	28.9	29.2	28.2	28.2	22.4	33.7	20.1	33.3	18.7	23.2	45.7	14.2	32.9	57.5	18.5	26.6	29.2	17.9	26.0	26.9	36.5	20.7	14.2	32.5	38.9	18.0	22.3	17.0	30.9	44.8	16.0	42.0	17.9	13.0	32.3	11.7	12.7	83.4	31.1	26.1	11.2	16.2	32.6	21.5	29.5	28.7	16.8	25.3	25.6	25.9	34.7	35.5	35.2	18.4	16.0	20.8	24.3	63.7	7.2	15.8	25.6	1.9	1.1	0.9	1.7	1.5	0.8	3.7	0.8	1.3	0.7	2.1	0.8	1.1	6.7	1.4	2.9	1.5	0.8	0.9	5.8	5.2	25.4	11.5	5.9	3.1	8.9	6.8	2.9	0.4	7.9	6.4	48.1	44.8	51.6	91.1	38.3	56.2	31.0	16.0	27.3	34.2	34.4	25.7	41.2	40.0	28.0	11.0	25.0	17.4	50.1	31.2	5.9	20.9	43.0	37.2	56.4	35.7	15.0	33.4	88.7	20.3	11.3	39.5	32.1	63.5	30.4	53.1	32.5	29.5	20.9	28.6	89.8	25.3	18.3	44.0	42.8	80.2	56.5	49.0	17.8	87.1	52.5	34.5	43.3	111.6	101.2	27.5	19.5	51.1	35.6	39.8	25.2	10.9	28.2	17.6	46.0	75.8	44.9	35.1	42.2	34.6	58.8	30.8	44.2	36.2	24.6	44.2
CREBRF	"C5orf41, LRF"	ENSG00000164463	"CREB3 regulatory factor"	Q8IUR6	5	173056352-173139284	"Predicted intracellular proteins"	"Stress response, Transcription, Transcription regulation, Transport, Unfolded protein response"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 68.1"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 21.8"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015329			Supported	Nucleoplasm		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm		"HPA015329: AB_2669192"	"unprognostic (8.00e-2)"	"unprognostic (2.47e-2)"	"unprognostic (1.30e-1)"	"unprognostic (3.14e-2)"	"unprognostic (5.41e-2)"	"unprognostic (1.85e-3)"	"unprognostic (1.35e-1)"	"unprognostic (6.03e-3)"	"unprognostic (1.78e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.17e-2)"	"unprognostic (4.69e-2)"	"prognostic favorable (3.20e-7)"	"unprognostic (1.40e-2)"	"unprognostic (1.81e-1)"	"unprognostic (2.52e-1)"	"prognostic favorable (9.30e-4)"	12.9	10.8	9.6	10.4	12.6	68.1	11.1	14.6	11.6	12.2	11.6	9.9	8.4	11.6	11.3	8.7	8.7	9.8	11.2	8.1	12.3	14.5	10.8	11.8	13.2	12.0	11.6	19.0	7.9	15.9	5.8	12.7	12.2	10.0	8.5	11.2	8.8	11.6	8.4	12.1	9.5	10.4	11.0	15.2	8.3	13.4	10.7	12.4	23.2	11.9	10.4	10.3	9.3	14.6	1.2	2.8	2.6	4.1	11.7	15.6	6.1	3.7	18.0	3.4	6.5	3.8	6.3	2.3	8.7	3.8	6.3	1.5	1.2	2.9	4.8	8.4	2.5	1.8	1.9	1.2	9.0	1.4	10.0	9.5	7.3	3.7	9.2	8.3	4.2	2.9	1.6	11.7	4.0	2.3	2.2	2.0	0.8	1.9	1.4	2.1	1.8	3.6	4.8	2.5	2.0	3.0	3.7	1.6	13.6	5.5	1.7	2.6	6.9	5.2	1.7	3.5	1.0	13.0	11.7	4.0	3.8	2.5	1.8	5.6	2.7	6.1	3.6	2.4	3.3	2.9	3.6	3.1	1.4	5.6	4.4	3.6	21.8	1.5	3.3	3.1	3.6	1.8	9.6	12.6	14.6	11.6	8.1	12.3	12.0	11.6	12.2	11.0	10.7	14.6	103.6	51.3	48.4	33.6	95.9	79.2	26.0	19.7	105.3	50.1	68.3	48.1	61.4	44.3	25.9	38.6	68.8	11.6	104.1	50.8	15.6	17.4	5.3	68.9	51.1	66.3	76.7	70.7	57.3	15.7	11.1	67.5	21.4	154.0	48.1	75.2	64.6	39.5	20.4	112.7	64.2	30.3	32.6	96.2	57.7	8.4	51.9	76.7	65.8	70.3	81.7	33.1	55.6	40.2	65.3	17.4	31.8	54.9	78.9	67.6	42.4	23.2	34.8	65.0	59.2	89.8	65.6	74.8	48.0	42.7	92.9	37.4	83.5	26.2	20.5	40.9
CREM	hCREM-2	ENSG00000095794	"CAMP responsive element modulator"	Q03060	10	35126791-35212958	"Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Differentiation, Spermatogenesis, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 216.6"	"Cell type enhanced"	"Detected in all"		"dendritic cells: 819.1;Early spermatids: 2013.6;Langerhans cells: 1094.0;Late spermatids: 814.3;T-cells: 612.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HDLM-2: 103.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001818, CAB018352"	Enhanced		Supported	Nucleoplasm,Vesicles		NA	NA			"Cluster 13: T-cells - Unknown function"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm	Vesicles	"CAB018352: AB_673599, HPA001818: AB_1078566"	"unprognostic (1.78e-1)"	"unprognostic (6.26e-3)"	"unprognostic (7.09e-2)"	"unprognostic (2.51e-2)"	"unprognostic (6.22e-3)"	"unprognostic (9.27e-3)"	"unprognostic (1.16e-1)"	"unprognostic (2.41e-2)"	"unprognostic (1.32e-1)"	"unprognostic (7.66e-3)"	"unprognostic (8.98e-2)"	"unprognostic (3.42e-1)"	"prognostic unfavorable (1.23e-5)"	"unprognostic (4.44e-2)"	"unprognostic (4.19e-1)"	"unprognostic (1.66e-2)"	"unprognostic (1.52e-1)"	54.9	137.4	31.9	51.0	34.3	22.0	27.1	31.3	39.2	26.4	38.6	24.5	8.9	30.3	11.4	17.6	29.2	44.5	50.5	33.6	42.9	58.8	60.5	30.5	17.6	36.7	35.5	60.6	16.0	24.5	59.5	100.3	36.0	32.0	13.6	23.5	13.4	23.3	30.0	9.0	15.9	24.5	34.1	25.3	20.7	216.6	35.8	29.3	22.3	31.3	16.9	60.5	19.1	33.5	24.8	39.0	32.3	33.2	22.2	23.0	32.2	31.8	24.8	19.6	27.0	4.6	10.2	42.0	30.2	18.7	21.2	5.6	28.0	20.8	28.5	103.8	20.6	14.9	25.7	18.6	26.5	3.6	15.2	20.4	25.9	38.3	11.7	17.2	55.3	31.1	44.3	16.9	30.4	20.0	26.1	10.8	9.6	9.2	88.6	16.0	16.9	7.8	34.8	9.7	7.5	20.4	15.1	13.1	88.7	36.5	7.2	11.0	74.0	14.9	19.1	41.4	21.3	7.4	10.9	14.6	35.6	33.1	13.0	5.3	3.5	11.5	11.5	5.5	14.6	7.0	12.6	10.4	4.1	6.8	9.0	10.4	9.7	10.2	4.2	12.4	16.2	8.5	31.9	34.3	31.3	39.2	33.6	42.9	36.7	35.5	36.0	34.1	35.8	33.5	98.7	19.2	47.9	42.7	301.8	143.4	58.0	30.9	18.8	18.3	32.1	32.4	62.3	20.0	33.2	165.5	6.2	98.7	819.1	16.8	97.8	40.6	2013.6	32.6	27.6	118.7	69.0	5.7	50.1	44.4	109.1	140.6	29.0	44.2	347.7	14.5	17.9	37.6	120.6	10.1	34.3	17.9	32.6	61.4	1094.0	814.3	26.1	286.1	247.3	30.0	187.4	39.0	65.9	113.1	34.9	30.6	19.7	32.7	109.4	49.5	15.3	64.2	46.1	19.5	46.0	45.5	232.8	464.7	156.8	15.9	108.4	230.0	612.4	46.4	13.6	52.7
CRHR2	"CRF-RB, CRF2, HM-CRF"	ENSG00000106113	"Corticotropin releasing hormone receptor 2"	Q13324	7	30651942-30700129	"G-protein coupled receptors, Predicted membrane proteins, Predicted secreted proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 6.0;choroid plexus: 21.7"	"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 3.0;Excitatory neurons: 8.2;Horizontal cells: 13.5;Inhibitory neurons: 4.9;Smooth muscle cells: 2.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"basal ganglia: 8.1"	"Low region specificity"	"Detected in many"			HPA073345			Supported	"Plasma membrane"	"Secreted - unknown location"	NA	NA				"Cluster 88: Choroid plexus - Transmembrane transport"		"Cluster 62: Horizontal cells - Visual perception"	"Plasma membrane"		"HPA073345: "	"unprognostic (7.14e-2)"	"unprognostic (4.20e-1)"	"unprognostic (1.68e-1)"	"unprognostic (1.24e-3)"	"unprognostic (5.69e-2)"	"unprognostic (8.58e-2)"	"unprognostic (6.00e-2)"	"unprognostic (1.86e-4)"	"unprognostic (2.01e-1)"	"unprognostic (3.07e-1)"	"unprognostic (5.90e-4)"	"unprognostic (4.02e-2)"	"unprognostic (8.29e-4)"	"unprognostic (3.73e-3)"	"unprognostic (2.84e-3)"	"unprognostic (1.81e-1)"	"unprognostic (3.84e-1)"	0.6	0.0	1.5	0.0	1.0	0.0	0.6	0.4	6.0	0.3	21.7	0.2	0.3	0.3	0.0	0.2	0.5	0.1	2.1	2.3	1.0	0.8	0.0	0.1	0.0	1.4	1.0	0.4	1.7	0.1	4.2	0.0	0.4	0.2	0.1	2.5	0.3	1.3	1.2	0.2	0.3	0.1	0.4	0.0	0.2	0.8	2.8	0.0	0.7	2.2	0.0	0.3	0.2	2.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	1.0	0.4	6.0	2.3	1.0	1.4	1.0	0.4	0.4	2.8	2.4	0.3	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.1	0.0	0.0	8.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.5	4.9	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	1.0	0.0	0.1	0.0	0.5	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	2.3	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CRLF3	"CREME9, CYTOR4"	ENSG00000176390	"Cytokine receptor like factor 3"	Q8IUI8	17	30769388-30824692	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 35.5"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007596	Enhanced		Approved	"Plasma membrane,Cytosol"		NA	NA		210000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 63: NK-cells & T-cells - Immune response"	"Plasma membrane, Cytosol"		"HPA007596: AB_1847241"	"unprognostic (1.02e-1)"	"unprognostic (9.79e-2)"	"unprognostic (7.12e-2)"	"unprognostic (9.65e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.55e-1)"	"unprognostic (2.52e-2)"	"unprognostic (9.22e-2)"	"unprognostic (1.00e-2)"	"unprognostic (3.10e-2)"	"unprognostic (5.81e-3)"	"unprognostic (1.41e-1)"	"prognostic unfavorable (1.31e-7)"	"unprognostic (3.35e-1)"	"unprognostic (2.40e-2)"	"unprognostic (1.84e-1)"	"unprognostic (6.51e-2)"	7.5	4.9	3.5	21.5	3.2	20.6	7.0	10.5	4.4	7.6	0.2	7.8	6.1	5.3	2.8	12.8	4.9	7.5	4.3	4.5	2.7	4.2	5.4	9.1	35.5	1.8	1.9	4.3	4.4	7.9	4.7	12.6	2.4	4.7	7.9	9.5	5.9	3.8	3.8	11.1	9.7	6.5	1.3	23.4	6.6	10.3	3.7	33.4	4.3	4.4	32.7	11.0	8.0	3.0	11.3	12.2	7.5	15.6	13.4	10.3	11.1	10.4	10.1	19.8	20.6	13.5	7.4	36.8	15.2	13.0	19.3	19.2	12.8	8.6	23.6	17.6	23.3	15.7	9.9	10.3	7.4	21.0	11.2	6.1	11.8	16.0	13.4	7.4	19.4	32.9	40.1	37.6	12.6	6.8	46.6	21.8	14.9	18.7	7.4	20.0	24.2	22.2	13.1	9.4	5.3	12.5	10.6	16.1	11.6	15.6	12.5	10.3	10.4	11.4	13.9	18.5	25.8	15.7	14.2	24.9	10.9	16.6	12.9	53.7	57.9	139.9	37.0	59.5	39.3	46.7	52.2	42.4	43.0	46.8	99.9	75.6	117.3	40.3	72.1	22.0	63.7	84.5	3.5	3.2	10.5	4.4	4.5	2.7	1.8	1.9	2.4	1.3	3.7	3.0	10.4	0.0	12.5	17.6	50.9	22.6	8.0	5.4	16.5	17.9	7.0	4.3	4.5	2.8	4.6	7.3	14.6	18.7	36.2	9.2	5.9	5.1	13.5	6.1	8.4	10.6	3.6	46.9	54.8	5.3	17.6	7.7	13.3	9.1	22.8	5.5	8.9	4.2	16.8	6.7	56.5	3.9	8.2	26.1	25.0	21.3	6.5	26.7	5.4	42.2	39.9	4.7	47.4	38.7	38.0	9.1	3.4	4.1	25.7	8.4	2.6	5.3	8.9	25.2	13.1	9.2	7.5	27.5	27.3	11.4	27.8	45.8	47.1	5.3	4.2	7.8
CRMP1	"DPYSL1, DRP-1"	ENSG00000072832	"Collapsin response mediator protein 1"	Q14194	4	5748084-5893086	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 59.7;pituitary gland: 67.3;retina: 57.6"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 148.9;Excitatory neurons: 40.8;Horizontal cells: 210.3;Inhibitory neurons: 44.5;Muller glia cells: 78.4"	"Cancer enhanced"	"Detected in all"		"glioma: 37.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 81.0;HAP1: 117.2;NTERA-2: 84.3;REH: 229.4;RH-30: 129.6;SCLC-21H: 167.2;SH-SY5Y: 105.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035640, CAB037313"	Approved		Supported	Centrosome,Cytosol		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 58: Brain - Synaptic function"	"Cluster 14: REH - Unknown function"	"Cluster 62: Horizontal cells - Visual perception"	Centrosome	Cytosol	"CAB037313: AB_1078571, HPA035640: AB_10670838"	"unprognostic (1.56e-1)"	"unprognostic (7.22e-2)"	"unprognostic (5.14e-2)"	"unprognostic (8.08e-3)"	"unprognostic (2.80e-1)"	"unprognostic (2.22e-1)"	"unprognostic (1.84e-2)"	"unprognostic (1.20e-1)"	"unprognostic (2.79e-1)"	"unprognostic (9.71e-2)"	"prognostic favorable (4.54e-4)"	"unprognostic (2.26e-1)"	"unprognostic (8.52e-3)"	"unprognostic (1.21e-2)"	"unprognostic (2.95e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.60e-3)"	1.8	9.8	53.0	2.7	55.9	0.1	0.9	45.0	58.0	9.6	10.7	4.4	1.3	21.9	0.1	2.7	4.9	5.1	2.8	59.7	57.9	2.1	0.3	5.7	1.9	31.0	35.2	7.9	5.7	0.7	67.3	5.4	41.0	3.2	1.6	57.6	2.7	3.1	0.5	3.7	2.9	14.5	30.8	1.1	3.7	3.0	47.1	1.2	2.4	1.1	1.0	2.6	2.9	38.2	1.3	2.7	81.0	2.8	0.1	0.0	0.4	3.2	0.0	0.0	0.0	0.0	0.0	0.0	11.3	0.0	27.2	1.9	117.2	0.0	0.0	2.2	0.9	0.0	4.0	0.6	1.4	0.1	0.7	1.0	0.0	0.0	0.0	11.1	0.0	0.0	0.0	0.3	1.3	0.0	0.4	0.0	84.3	0.0	2.6	229.4	129.6	20.2	0.0	0.2	167.2	105.8	0.0	0.6	1.4	54.2	0.8	0.1	6.8	3.8	27.3	2.3	2.6	14.8	2.2	0.1	9.8	0.9	69.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	53.0	55.9	45.0	58.0	59.7	57.9	31.0	35.2	41.0	30.8	47.1	38.2	1.0	0.0	1.1	23.8	0.0	0.4	0.0	1.5	0.0	148.9	0.0	0.0	1.5	0.0	0.0	0.0	18.8	0.1	0.0	0.0	0.0	0.1	2.2	0.4	13.6	6.3	2.4	1.3	40.8	0.0	0.2	3.5	3.1	0.5	0.0	2.4	0.0	0.0	0.5	210.3	44.5	0.0	0.0	0.0	0.0	5.5	0.6	0.2	1.8	6.5	0.0	78.4	0.0	33.2	2.9	0.4	0.0	0.4	0.0	0.4	0.0	0.0	0.0	22.8	6.6	0.4	6.2	1.0	12.4	1.1	0.1	0.3	0.2	1.5	0.0	0.1
CROCC	"ROLT, rootletin"	ENSG00000058453	"Ciliary rootlet coiled-coil, rootletin"	Q5TZA2	1	16740273-16972964	"Predicted intracellular proteins"	"Cell cycle, Cilium biogenesis/degradation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Rod photoreceptor cells: 109.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021191, HPA021762"	Enhanced		Supported	"Plasma membrane,Centrosome"		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 46: Photoreceptor cells - Phototransduction"	"Plasma membrane, Centrosome"		"HPA021191: AB_1856395, HPA021762: AB_1856396"	"unprognostic (9.07e-3)"	"unprognostic (9.03e-2)"	"unprognostic (6.04e-2)"	"prognostic favorable (8.34e-5)"	"unprognostic (3.27e-1)"	"unprognostic (1.25e-3)"	"unprognostic (1.42e-3)"	"prognostic favorable (7.92e-4)"	"unprognostic (2.05e-1)"	"unprognostic (7.75e-2)"	"unprognostic (3.36e-3)"	"unprognostic (5.75e-2)"	"prognostic unfavorable (7.97e-4)"	"unprognostic (1.58e-1)"	"unprognostic (9.83e-2)"	"unprognostic (6.05e-2)"	"unprognostic (1.76e-3)"	7.6	7.6	5.2	2.3	5.5	1.6	8.0	10.1	7.2	13.5	29.0	10.2	1.7	10.4	0.7	10.0	22.7	1.4	6.2	5.8	6.2	8.3	3.3	8.4	2.4	9.5	11.5	13.3	10.7	1.7	10.2	1.3	6.1	10.4	0.4	11.3	7.6	1.8	6.2	14.3	7.9	1.1	6.2	10.2	8.9	5.3	6.6	2.8	8.1	1.2	0.7	9.2	11.4	6.9	4.1	1.7	3.1	3.1	2.1	1.9	1.2	2.9	0.9	0.9	1.0	0.2	1.8	10.9	2.7	1.3	0.3	4.9	0.7	2.2	0.1	0.9	5.6	5.0	6.1	0.8	3.7	0.3	4.9	1.7	5.0	0.9	0.8	1.7	1.5	7.7	0.7	2.7	0.3	3.5	3.4	1.2	11.1	0.9	2.6	3.1	4.1	3.8	0.7	1.1	9.4	10.2	3.1	2.0	9.7	0.9	4.1	1.4	4.3	2.6	3.4	6.8	2.3	4.7	3.7	2.2	2.6	0.7	3.3	0.0	0.0	0.3	0.3	0.1	0.5	0.1	0.2	0.2	0.0	0.3	0.2	0.1	0.0	0.3	0.0	0.1	0.3	0.1	5.2	5.5	10.1	7.2	5.8	6.2	9.5	11.5	6.1	6.2	6.6	6.9	9.0	0.0	4.6	14.0	5.4	6.2	4.1	4.4	17.1	26.3	7.9	7.7	5.8	5.7	4.1	5.5	27.1	1.3	8.2	2.3	0.0	4.7	5.5	35.2	6.3	7.1	3.6	2.5	27.9	2.3	6.5	11.3	6.1	5.9	1.3	28.2	6.4	1.8	2.4	3.3	24.0	4.3	4.1	1.6	5.3	2.6	19.3	3.4	5.4	11.2	3.1	11.7	12.3	13.0	19.9	2.4	1.9	12.8	2.1	2.0	0.8	1.5	34.0	109.7	0.0	12.8	9.4	1.2	12.8	13.1	5.1	1.1	8.0	3.5	2.7	2.2
CRP	PTX1	ENSG00000132693	"C-reactive protein"	P02741	1	159712289-159714589	"Cancer-related genes, Candidate cardiovascular disease genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Acute phase"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	79	"liver: 9388.5"	"Group enriched"	"Detected in some"	16	"Ductal cells: 1087.7;Hepatocytes: 4142.7"	"Cancer enriched"	"Detected in some"	13	"liver cancer: 1010.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 6.3;HDLM-2: 6.3;U-2 OS: 4.5;U-266/84: 11.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB005036, HPA027367, HPA027396"	Supported		Approved	"Nucleoplasm,Vesicles,Intermediate filaments"	"Secreted to blood"	NA	NA	2920000000	5200000000		"Cluster 62: Liver - Hemostasis"	"Cluster 16: U-266 - Nucleosome"	"Cluster 15: Hepatocytes - Hemostasis"	"Nucleoplasm, Vesicles"	"Intermediate filaments"	"CAB005036: AB_562362, HPA027367: AB_1847216, HPA027396: AB_1847217"	"unprognostic (3.74e-1)"	"unprognostic (5.31e-2)"				"unprognostic (2.97e-2)"	"unprognostic (1.27e-1)"	"unprognostic (3.57e-2)"			"unprognostic (1.33e-2)"	"unprognostic (3.13e-1)"	"prognostic unfavorable (4.17e-10)"	"unprognostic (3.39e-2)"	"unprognostic (3.48e-1)"	"unprognostic (5.60e-2)"	"unprognostic (6.61e-2)"	3.4	0.7	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.8	0.0	0.3	0.0	3.1	0.0	0.5	0.4	111.7	0.7	0.0	0.0	0.7	9388.5	0.5	0.1	0.0	0.0	0.4	118.5	0.0	0.3	0.1	0.0	0.6	0.0	0.0	0.4	0.0	0.3	0.6	0.5	0.0	0.0	6.1	0.4	0.4	0.0	0.0	0.3	0.0	0.0	0.5	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.3	0.0	0.0	0.2	0.0	0.0	0.0	6.3	0.0	0.3	0.0	0.0	0.0	0.2	0.1	0.8	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.1	0.8	0.0	11.7	1.6	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	118.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1087.7	1.4	0.0	0.1	6.3	0.0	163.2	0.0	63.2	0.0	0.0	0.0	0.2	0.0	0.0	89.6	4142.7	0.1	0.0	0.0	0.0	0.0	98.8	0.3	0.7	0.0	0.0	0.0	0.0	9.8	0.0	0.0	0.0	0.0	60.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	3.5	0.1	0.0	0.0	0.0	0.0	6.8	0.0	0.0	0.0
CRTC1	"FLJ14027, KIAA0616, MECT1, TORC1"	ENSG00000105662	"CREB regulated transcription coactivator 1"	Q6UUV9	19	18683678-18782333	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Biological rhythms, Host-virus interaction, Transcription, Transcription regulation"	Activator	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 37.4;Horizontal cells: 43.7"	"Low cancer specificity"	"Detected in all"			"Group enriched"	"Detected in many"	203	"amygdala: 14.2;basal ganglia: 11.4;cerebellum: 27.1;cerebral cortex: 24.3;hippocampal formation: 24.5"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022035, HPA063619"	Enhanced		Supported	"Nucleoplasm,Nuclear bodies,Plasma membrane,Cytosol"		NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 62: Horizontal cells - Visual perception"	"Nucleoplasm, Nuclear bodies"	"Plasma membrane, Cytosol"	"HPA022035: AB_1847255, HPA063619: "	"unprognostic (5.95e-3)"	"unprognostic (2.57e-1)"	"unprognostic (9.94e-2)"	"unprognostic (8.62e-3)"	"unprognostic (9.07e-2)"	"unprognostic (1.57e-2)"	"unprognostic (1.04e-1)"	"unprognostic (5.57e-2)"	"unprognostic (2.27e-1)"	"unprognostic (6.68e-2)"	"prognostic favorable (1.80e-5)"	"unprognostic (3.37e-2)"	"prognostic favorable (3.83e-5)"	"unprognostic (6.83e-3)"	"unprognostic (1.02e-1)"	"unprognostic (2.51e-2)"	"unprognostic (2.03e-2)"	8.8	11.3	14.2	5.2	11.4	2.1	8.2	27.1	24.3	11.3	0.0	8.9	4.0	9.3	3.4	5.2	10.3	3.2	10.5	24.5	0.0	12.8	10.4	7.9	4.1	0.0	0.0	9.4	9.8	4.7	23.7	3.9	0.0	11.6	1.5	4.4	7.3	5.1	14.4	7.4	8.5	2.5	0.0	9.6	9.9	11.3	0.0	3.6	14.4	3.6	2.2	9.7	7.4	0.0	5.2	7.9	6.7	10.7	6.3	4.5	18.6	5.4	3.6	5.3	4.8	5.1	6.6	7.1	11.6	5.2	3.9	5.5	2.1	3.5	1.3	3.1	15.1	6.0	7.8	9.3	5.5	8.3	16.3	7.8	2.9	4.4	1.3	6.8	3.1	7.2	4.8	6.3	3.0	15.2	5.7	10.0	8.8	2.7	13.1	8.7	2.9	8.1	3.2	8.0	12.1	10.7	6.0	5.8	7.0	2.2	6.6	5.2	5.4	6.0	9.1	10.8	6.4	4.4	3.6	4.6	6.9	8.6	4.6	0.3	0.6	0.4	0.4	0.2	0.3	0.5	0.5	0.6	0.7	0.7	0.5	0.3	0.2	0.3	0.4	0.8	0.4	0.4	14.2	11.4	27.1	24.3	24.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.9	0.0	5.3	31.0	6.9	2.7	8.9	7.8	5.7	29.1	5.8	6.1	17.7	10.0	3.5	18.4	27.1	9.7	7.9	6.8	11.7	4.6	1.1	9.6	14.0	5.6	19.2	3.6	37.4	6.0	2.7	7.5	8.6	9.8	2.5	14.7	3.9	4.7	8.8	43.7	26.7	7.1	12.2	6.0	4.0	3.2	9.3	6.3	3.6	10.3	5.5	9.1	8.2	12.1	20.2	3.5	9.6	4.9	2.0	3.0	6.1	5.0	4.8	14.7	0.0	14.2	6.6	2.9	8.8	2.4	2.0	10.4	5.1	8.3	5.2	3.6
CRY1	PHLL1	ENSG00000008405	"Cryptochrome circadian regulator 1"	Q16526	12	106991364-107093549	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Biological rhythms, Sensory transduction, Transcription, Transcription regulation"	"Photoreceptor protein, Receptor, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 108.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB018762	Approved		Supported	"Nucleoplasm,Nuclear membrane,Microtubules"		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 44: Endometrium - Transcription"	"Nucleoplasm, Nuclear membrane, Microtubules"		"CAB018762: AB_2083970"	"unprognostic (1.21e-3)"	"unprognostic (4.74e-2)"	"unprognostic (6.50e-2)"	"unprognostic (9.03e-2)"	"unprognostic (1.79e-1)"	"unprognostic (2.84e-1)"	"unprognostic (3.48e-2)"	"unprognostic (3.61e-1)"	"unprognostic (4.29e-3)"	"unprognostic (1.34e-2)"	"unprognostic (6.85e-3)"	"unprognostic (2.06e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.82e-2)"	"unprognostic (5.08e-1)"	"unprognostic (1.85e-1)"	"unprognostic (2.25e-1)"	13.3	12.4	8.5	7.6	9.8	12.4	11.2	16.2	10.9	11.1	16.7	12.6	11.5	14.2	6.4	11.0	16.4	16.7	11.7	8.4	9.0	13.7	13.6	19.3	5.8	9.8	10.1	9.0	13.5	8.8	8.4	12.1	9.9	11.3	8.6	21.3	9.0	11.5	10.9	9.0	12.7	16.8	9.7	8.7	16.2	37.3	9.9	19.0	17.0	11.0	6.7	15.6	8.6	12.5	17.3	16.9	20.6	23.0	14.6	9.1	36.9	17.9	19.1	36.0	24.2	19.9	10.1	0.0	11.1	16.7	22.7	11.6	26.8	9.3	39.6	17.3	16.6	16.9	15.3	13.8	18.6	17.3	14.2	8.6	9.6	26.4	24.9	17.8	30.5	31.4	19.3	14.6	22.7	12.1	39.2	19.7	25.1	16.5	24.6	34.5	52.3	6.1	25.3	20.2	37.1	19.2	33.6	22.1	10.9	20.0	15.6	9.6	13.5	20.9	22.2	14.6	16.2	26.6	26.6	7.8	10.2	16.3	17.5	12.0	3.2	5.8	12.8	4.7	16.1	1.9	9.6	8.2	4.3	1.9	8.9	8.8	1.4	6.4	8.9	2.8	13.5	5.7	8.5	9.8	16.2	10.9	8.4	9.0	9.8	10.1	9.9	9.7	9.9	12.5	16.3	16.0	16.2	20.5	9.7	69.2	47.9	4.3	55.2	16.8	30.4	14.7	11.1	11.5	6.1	11.0	20.9	8.3	29.1	12.7	17.6	11.4	12.8	27.3	19.3	20.1	19.6	11.2	22.4	16.3	13.4	24.5	45.9	33.2	5.1	6.2	12.1	20.2	6.3	26.9	38.4	9.7	6.1	7.3	21.0	4.8	11.5	8.8	16.0	13.1	16.3	22.8	19.6	35.2	32.8	21.5	7.0	17.3	15.3	29.7	7.7	16.1	18.7	13.7	6.6	24.3	19.2	108.0	32.4	24.3	59.5	15.1	29.7	5.7	6.8	27.0
CRY2		ENSG00000121671	"Cryptochrome circadian regulator 2"	Q49AN0	11	45847118-45883248	"Predicted intracellular proteins"	"Biological rhythms, Sensory transduction, Transcription, Transcription regulation"	"Photoreceptor protein, Receptor, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Bipolar cells: 141.9;Horizontal cells: 101.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037577	Supported		Supported	"Nuclear speckles,Cytosol"	"Intracellular and membrane"	NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 62: Horizontal cells - Visual perception"	"Nuclear speckles"	Cytosol	"HPA037577: AB_10672497"	"unprognostic (1.67e-1)"	"unprognostic (9.35e-2)"	"prognostic unfavorable (1.67e-4)"	"unprognostic (1.31e-2)"	"unprognostic (9.16e-2)"	"unprognostic (3.09e-2)"	"prognostic favorable (6.82e-5)"	"unprognostic (1.48e-3)"	"unprognostic (1.67e-1)"	"unprognostic (5.07e-2)"	"prognostic favorable (4.39e-4)"	"unprognostic (1.01e-1)"	"prognostic favorable (6.44e-15)"	"unprognostic (8.13e-3)"	"unprognostic (1.89e-1)"	"unprognostic (4.24e-2)"	"unprognostic (2.24e-1)"	31.8	22.3	33.3	8.9	35.3	29.4	27.1	36.4	36.9	24.4	22.8	26.5	10.8	23.3	16.9	15.9	29.1	17.4	60.0	36.6	29.3	22.5	62.7	22.9	10.4	27.4	31.5	38.7	34.7	22.4	30.8	13.5	28.5	25.3	9.9	52.8	21.7	22.1	96.7	50.4	16.7	17.1	28.8	14.0	24.6	34.4	35.2	12.6	34.0	64.8	10.3	26.0	18.4	31.4	1.4	4.2	6.3	7.5	16.7	8.4	13.8	5.0	8.9	6.2	4.5	6.8	3.3	9.8	3.8	10.5	5.9	8.5	6.0	5.2	4.3	9.8	5.5	6.4	8.2	9.4	6.4	8.0	8.5	9.9	7.5	4.8	7.6	7.0	4.4	7.5	12.7	16.2	5.6	5.3	6.8	9.4	17.1	17.8	5.0	11.5	9.1	4.6	4.5	7.8	10.1	3.8	8.3	7.5	4.5	8.0	10.0	5.5	5.5	8.7	5.3	13.5	3.6	15.0	10.8	7.9	5.3	3.5	5.3	4.1	3.5	5.4	5.7	4.8	4.7	5.0	5.5	6.1	3.6	4.6	6.6	6.9	1.8	7.5	8.0	2.6	4.9	5.3	33.3	35.3	36.4	36.9	36.6	29.3	27.4	31.5	28.5	28.8	35.2	31.4	11.7	12.8	18.2	48.0	12.6	17.0	9.7	5.1	8.0	141.9	10.6	8.6	34.7	14.3	11.6	7.3	27.1	8.0	10.0	17.2	29.4	5.4	24.2	28.1	7.5	9.2	7.1	3.0	30.3	4.7	5.6	19.8	12.8	15.4	14.7	10.8	8.6	47.3	3.6	101.0	26.0	7.4	6.1	8.5	12.5	8.7	31.4	7.2	16.0	10.3	6.2	34.4	10.3	13.0	13.6	6.0	6.0	39.9	8.5	11.6	10.5	11.6	23.8	27.5	19.7	14.5	14.6	29.1	15.0	4.4	17.5	9.3	9.1	8.4	6.0	9.8
CRYAA	"CRYA1, HSPB4"	ENSG00000160202	"Crystallin alpha A"	P02489	21	43169008-43172805	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Sensory transduction, Vision"	"Chaperone, Eye lens protein"	"Cataract, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	11	"kidney: 85.6;retina: 55.5"	"Cell type enriched"	"Detected in single"	5	"Muller glia cells: 2.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	148	"Hep G2: 38.0"	"Region enhanced"	"Detected in some"		"hippocampal formation: 3.9"					"HPA037737, HPA038430"	Supported		Approved	Nucleoplasm,Cytosol		NA	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 5: Muller glia cells - Visual perception"	Cytosol	Nucleoplasm	"HPA037737: AB_2675639, HPA038430: AB_2732478"							"unprognostic (3.68e-3)"											0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.2	0.5	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	85.6	6.6	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	55.5	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.3	0.6	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	38.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.2	0.5	0.3	0.2	0.2	0.1	0.2	0.2	0.3	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CRYM	DFNA40	ENSG00000103316	"Crystallin mu"	Q14894	16	21238874-21303083	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase	"Deafness, Disease variant, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 78.7;heart muscle: 175.3"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 126.0;Ionocytes: 114.0;Muller glia cells: 640.7;Proximal tubular cells: 190.1"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 14.6"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	21	"plasmacytoid DC: 82.0"	"Lineage enriched"	"Detected in many"	21	"dendritic cells: 82.0"	"Cell line enriched"	"Detected in some"	4	"RPTEC TERT1: 100.3"	"Group enriched"	"Detected in all"	11	"amygdala: 124.0;basal ganglia: 275.1;cerebral cortex: 124.7;hippocampal formation: 324.3;white matter: 128.4"	"Low region specificity"	"Detected in all"			"HPA019086, HPA030619"	Enhanced		Supported	Cytosol		NA	NA		150000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 5: Muller glia cells - Visual perception"	Cytosol		"HPA019086: AB_1847260, HPA030619: AB_2673551"	"unprognostic (1.32e-1)"	"unprognostic (2.93e-3)"	"unprognostic (8.96e-2)"	"unprognostic (1.44e-1)"	"unprognostic (2.13e-1)"	"unprognostic (4.62e-2)"	"unprognostic (2.88e-1)"	"unprognostic (5.75e-3)"	"unprognostic (2.81e-1)"	"unprognostic (7.37e-2)"	"unprognostic (2.05e-2)"	"unprognostic (5.95e-2)"	"unprognostic (2.11e-3)"	"unprognostic (7.79e-3)"	"unprognostic (2.49e-2)"	"unprognostic (1.87e-3)"	"unprognostic (1.31e-1)"	1.9	0.8	37.4	0.9	78.7	1.0	2.7	40.6	62.2	3.7	13.6	6.9	1.6	1.0	0.2	7.6	1.1	7.0	175.3	54.0	31.6	64.4	14.2	8.5	1.1	13.9	19.8	0.3	1.8	8.9	55.6	0.4	15.6	35.4	8.4	54.7	20.6	0.2	13.4	4.1	2.6	0.3	14.1	0.3	1.3	5.1	20.5	0.3	0.4	0.9	3.8	21.8	3.6	31.3	0.2	4.0	0.0	0.0	0.2	0.4	0.7	0.0	2.1	0.1	0.2	0.2	0.2	0.3	1.0	0.0	1.8	0.6	5.4	0.0	0.0	0.0	0.8	23.2	0.1	2.3	0.0	0.1	2.2	0.8	0.0	0.8	1.0	0.0	0.0	0.5	0.0	0.4	0.7	0.3	0.0	0.9	9.7	1.6	0.1	0.1	0.0	0.5	100.3	0.1	3.7	5.2	0.2	0.1	2.6	4.8	0.1	0.0	0.0	0.5	0.7	6.8	0.0	0.2	0.0	0.5	16.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	2.2	0.0	0.0	0.1	3.9	0.0	0.0	0.3	0.0	0.0	82.0	0.0	1.2	37.4	78.7	40.6	62.2	54.0	31.6	13.9	19.8	15.6	14.1	20.5	31.3	0.3	0.0	20.1	5.2	4.1	2.3	25.4	16.3	0.0	6.3	0.4	11.7	126.0	2.8	56.1	14.7	4.2	0.0	11.4	7.1	17.6	0.1	19.7	3.2	1.5	3.0	13.1	4.8	43.8	0.0	0.0	7.1	6.1	7.7	1.3	1.3	0.4	8.3	0.1	1.7	5.9	20.6	114.0	1.6	0.7	12.4	0.0	1.5	33.8	10.3	0.7	640.7	0.0	7.1	6.6	0.4	2.8	0.0	0.3	19.0	7.5	190.1	19.9	26.2	0.0	0.2	4.3	6.7	7.3	0.2	1.3	0.1	1.1	0.1	8.2	68.0
CRYZ		ENSG00000116791	"Crystallin zeta"	Q08257	1	74705482-74733408	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Oxidoreductase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 331.0;liver: 282.9"	"Cell type enhanced"	"Detected in many"		"Collecting duct cells: 160.0;Distal tubular cells: 226.9;Hepatocytes: 200.6;Proximal tubular cells: 526.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RPTEC TERT1: 439.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021921, HPA023290"	Approved		Supported	Cytosol		NA	NA		6400000	"Cluster 44: Non-specific - Transcription"	"Cluster 81: Kidney & Liver - Metabolism"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Cytosol		"HPA021921: AB_1847262, HPA023290: AB_1847263"	"unprognostic (3.64e-2)"	"unprognostic (3.38e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.27e-2)"	"unprognostic (5.32e-3)"	"unprognostic (5.79e-2)"	"unprognostic (6.29e-2)"	"unprognostic (1.04e-1)"	"unprognostic (4.56e-2)"	"unprognostic (1.06e-1)"	"unprognostic (6.38e-3)"	"unprognostic (2.19e-1)"	"unprognostic (1.35e-3)"	"unprognostic (3.12e-1)"	"unprognostic (7.50e-2)"	"unprognostic (2.94e-1)"	"unprognostic (7.32e-2)"	19.8	34.2	19.2	12.9	19.8	2.2	39.0	19.3	36.0	54.6	54.2	21.4	51.2	40.8	120.6	29.0	50.0	68.9	45.6	21.6	23.3	331.0	282.9	32.4	24.4	21.3	24.9	31.6	64.6	52.9	17.0	16.8	24.4	38.8	22.0	15.3	25.0	56.9	25.1	22.2	44.0	40.1	21.1	19.4	25.1	9.2	24.5	33.9	44.5	23.0	23.8	40.8	21.7	24.9	12.1	112.2	57.6	16.3	64.4	70.2	38.6	36.5	57.1	51.8	57.4	88.9	46.1	64.9	62.0	71.3	92.2	31.0	47.2	46.0	83.6	75.2	19.2	27.0	32.2	179.0	33.8	23.1	52.6	33.1	40.0	82.8	15.1	49.1	43.7	35.9	85.9	22.8	109.2	27.0	42.3	38.6	43.1	93.6	72.6	26.8	53.6	23.7	439.4	36.0	15.9	27.9	8.5	60.1	41.2	64.3	54.0	7.7	21.9	12.3	30.7	38.8	55.7	16.2	33.3	32.1	99.4	9.0	35.6	13.1	9.4	1.9	32.1	15.1	26.2	32.8	31.6	30.3	17.1	26.5	27.4	29.5	1.5	30.3	17.9	14.4	42.3	18.8	19.2	19.8	19.3	36.0	21.6	23.3	21.3	24.9	24.4	21.1	24.5	24.9	6.9	28.9	22.6	4.9	20.4	17.8	28.0	32.4	24.5	4.0	16.8	16.8	32.3	84.4	15.7	160.0	2.1	13.5	8.6	6.6	226.9	53.8	0.2	54.8	7.8	8.0	6.7	8.4	4.5	32.4	18.1	20.7	20.9	27.0	14.5	7.8	12.8	200.6	18.5	0.0	4.4	12.0	8.2	15.7	13.7	2.1	20.8	11.4	10.6	4.7	7.1	7.7	11.3	7.1	9.1	31.2	14.5	20.7	20.5	10.2	79.1	526.6	17.3	2.9	0.0	10.6	16.2	1.7	7.4	19.7	21.2	7.3	16.9	13.8	16.2	17.0
CSF1	"M-CSF, MCSF, MGC31930"	ENSG00000184371	"Colony stimulating factor 1"	P09603	1	109910242-109930992	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins"	"Immunity, Inflammatory response, Innate immunity"	"Cytokine, Growth factor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Fibroblasts: 58.9;granulocytes: 113.5;Hepatic stellate cells: 53.2;Sertoli cells: 59.2;Skeletal myocytes: 94.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	13	"basophil: 13.2;eosinophil: 22.3"	"Lineage enriched"	"Detected in many"	16	"granulocytes: 22.3"	"Cell line enhanced"	"Detected in many"		"ASC diff: 220.0;BJ hTERT+: 149.5;GAMG: 142.1;HHSteC: 338.7;HSkMC: 216.4;hTERT-RPE1: 153.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA076624			Supported	"Nuclear bodies,Plasma membrane"	"Secreted to blood"	NA	NA	270000	22000000	"Cluster 52: Eosinophils - Transcription"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Plasma membrane"	"Nuclear bodies"	"HPA076624: AB_2686810"	"unprognostic (2.35e-3)"	"unprognostic (2.14e-1)"	"unprognostic (7.36e-2)"	"unprognostic (4.19e-1)"	"unprognostic (3.60e-1)"	"unprognostic (1.64e-2)"	"prognostic unfavorable (4.25e-5)"	"unprognostic (1.04e-1)"	"unprognostic (1.75e-2)"	"unprognostic (2.18e-1)"	"unprognostic (1.72e-1)"	"unprognostic (5.10e-2)"	"prognostic unfavorable (1.00e-11)"	"unprognostic (2.03e-1)"	"unprognostic (1.88e-2)"	"unprognostic (4.01e-1)"	"unprognostic (3.16e-2)"	67.4	37.5	27.5	24.5	32.9	18.4	46.4	36.9	25.8	25.0	32.9	26.8	13.3	21.1	5.2	15.6	28.5	31.9	29.0	24.5	30.9	17.3	16.4	47.6	28.2	42.3	32.6	22.1	17.5	10.5	8.7	41.2	36.1	21.4	16.2	1.5	18.9	16.6	11.4	19.4	26.7	17.6	36.0	48.0	22.0	3.7	32.2	13.5	22.2	11.3	12.2	42.0	29.6	46.5	9.3	29.3	14.7	5.7	220.0	138.3	5.7	36.0	149.5	25.9	23.9	1.3	4.5	0.2	47.0	80.1	142.1	6.8	5.7	11.0	9.4	99.5	5.3	10.9	17.3	10.3	338.7	0.0	13.7	216.4	3.2	57.5	33.0	153.1	5.4	2.8	2.9	5.5	31.2	0.5	0.3	1.8	5.3	2.4	3.1	1.0	8.4	0.9	10.9	7.9	0.5	1.6	9.7	2.6	12.6	16.7	2.3	1.0	19.2	27.8	10.5	123.7	22.1	2.8	1.1	0.3	70.7	0.1	106.6	13.2	0.0	22.3	0.3	0.0	0.6	0.0	0.9	0.6	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	1.3	0.2	27.5	32.9	36.9	25.8	24.5	30.9	42.3	32.6	36.1	36.0	32.2	46.5	30.6	9.6	35.5	11.8	2.3	7.4	5.1	7.9	13.1	0.3	10.0	9.3	3.2	14.3	5.3	3.7	0.0	0.8	2.0	0.6	0.0	40.4	0.4	20.6	9.3	21.6	7.8	11.1	0.3	2.3	0.5	58.9	4.6	24.8	113.5	0.3	53.2	3.0	9.2	0.0	1.0	0.8	0.0	3.5	13.1	0.3	25.1	8.2	10.6	28.1	1.6	1.8	0.0	3.0	17.5	9.3	1.6	8.6	1.9	8.0	1.2	0.9	1.1	0.2	59.2	94.4	37.1	0.6	0.7	5.6	5.5	0.8	20.9	0.7	1.0	2.6
CSF1R	"C-FMS, CD115, CSFR, FMS"	ENSG00000182578	"Colony stimulating factor 1 receptor"	P07333	5	150053291-150113372	"Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins"	"Immunity, Inflammatory response, Innate immunity"	"Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease variant, FDA approved drug targets, Neurodegeneration, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 113.3;placenta: 103.3"	"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 103.2;Hofbauer cells: 340.4;Kupffer cells: 291.2;Langerhans cells: 73.4;Macrophages: 196.3;Microglial cells: 134.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"intermediate monocyte: 444.6;non-classical monocyte: 646.9"	"Lineage enriched"	"Detected in many"	5	"monocytes: 646.9"	"Group enriched"	"Detected in some"	4	"BEWO: 123.0;SK-BR-3: 47.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB008970, HPA012323"	Uncertain		Supported	"Vesicles,Plasma membrane"	"Intracellular and membrane"	NA	NA		1600000000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 64: Macrophages - Immune response"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 4: Macrophages - Innate immune response"	"Vesicles, Plasma membrane"		"CAB008970: , HPA012323: AB_1848977"	"unprognostic (3.82e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.86e-3)"	"unprognostic (9.83e-2)"	"unprognostic (1.20e-1)"	"unprognostic (7.33e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.45e-1)"	"unprognostic (9.37e-2)"	"unprognostic (1.11e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.65e-1)"	"prognostic unfavorable (1.08e-4)"	"unprognostic (3.67e-2)"	"prognostic unfavorable (4.92e-4)"	"unprognostic (1.72e-2)"	"unprognostic (4.61e-2)"	51.3	31.0	19.6	75.1	17.1	5.6	19.3	20.2	21.4	21.6	19.3	21.9	24.3	12.1	5.8	21.0	17.2	40.6	16.6	19.8	33.8	7.1	27.5	36.6	54.4	41.4	35.5	12.7	9.9	11.8	5.7	103.3	40.1	9.1	21.5	1.5	10.1	20.8	3.2	13.4	37.3	41.9	36.6	113.3	21.0	7.0	40.6	14.3	6.0	11.8	21.7	42.6	3.8	67.6	4.5	0.2	0.0	0.0	1.9	0.4	123.0	0.2	0.2	0.0	0.0	3.8	0.0	5.9	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.1	0.1	0.1	0.2	1.1	3.0	0.0	6.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	6.1	0.1	0.0	0.0	0.0	1.9	0.6	0.0	0.0	0.2	0.2	0.0	47.8	0.0	1.9	0.0	20.7	0.0	0.8	0.2	0.1	3.3	0.0	0.3	0.1	6.6	2.6	0.0	3.0	138.4	4.0	0.6	444.6	0.6	0.3	0.2	0.4	139.0	0.2	0.3	0.2	21.6	0.2	646.9	11.1	0.5	132.7	19.6	17.1	20.2	21.4	19.8	33.8	41.4	35.5	40.1	36.6	40.6	67.6	2.0	0.0	3.8	0.0	4.3	2.8	0.0	0.0	1.2	0.0	0.5	2.3	3.1	4.3	0.0	0.0	0.0	6.2	2.8	0.0	0.0	0.0	4.8	0.0	0.1	10.5	0.0	2.5	0.4	0.0	103.2	2.2	1.5	0.2	2.5	8.3	2.9	1.5	340.4	0.0	0.5	0.3	0.0	291.2	73.4	5.4	1.8	196.3	3.6	134.9	39.4	0.0	1.0	1.5	0.3	0.1	1.7	0.0	1.0	0.0	0.0	0.1	0.7	0.5	13.1	1.2	2.0	2.2	0.2	0.4	1.3	26.4	1.3	2.2	0.2	0.0
CSNK1D	"CKID, CKIdelta, HCKID"	ENSG00000141551	"Casein kinase 1 delta"	P48730	17	82239023-82273731	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Biological rhythms, Wnt signaling pathway"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"Early spermatids: 312.5;Late spermatids: 775.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB015410	Approved		Approved	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 72: Non-specific - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 25: Spermatids - Spermatogenesis"	"Nucleoli fibrillar center"	Nucleoplasm	"CAB015410: AB_831049"	"unprognostic (1.07e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.31e-1)"	"prognostic unfavorable (7.04e-4)"	"unprognostic (2.38e-2)"	"unprognostic (3.43e-2)"	"prognostic unfavorable (2.38e-6)"	"unprognostic (8.05e-2)"	"unprognostic (1.09e-1)"	"unprognostic (5.00e-2)"	"prognostic favorable (9.62e-5)"	"unprognostic (2.23e-3)"	"prognostic unfavorable (8.34e-4)"	"unprognostic (3.54e-1)"	"unprognostic (2.52e-1)"	"unprognostic (5.52e-3)"	"unprognostic (4.74e-2)"	46.7	57.0	36.9	28.9	36.9	25.9	42.3	34.4	37.9	45.3	30.3	57.1	35.1	56.6	26.7	50.8	45.3	24.8	42.4	39.0	40.2	45.5	40.9	45.3	30.8	37.2	37.6	43.1	47.5	43.1	54.2	30.2	36.3	51.8	20.0	15.1	48.6	36.8	88.9	36.4	50.9	29.0	36.3	56.3	49.3	60.7	42.6	34.0	44.7	38.7	22.8	49.0	37.0	32.9	60.3	70.9	39.5	54.7	50.8	53.9	77.7	85.1	54.4	61.0	56.8	58.6	49.4	55.0	66.3	62.5	64.8	57.1	37.4	88.3	48.9	47.0	90.5	68.5	53.4	63.7	146.9	56.9	50.4	81.9	61.5	41.6	61.3	76.0	90.0	39.5	78.5	28.4	58.5	70.6	73.7	59.3	42.2	71.3	108.6	62.6	48.7	49.7	64.8	93.4	48.5	87.4	100.4	85.5	97.7	54.3	61.5	73.0	95.6	86.9	77.3	76.2	67.0	61.0	32.1	58.4	69.5	48.1	64.7	8.8	20.8	27.4	12.3	21.3	11.8	11.1	9.6	12.1	20.1	9.0	8.1	8.7	50.4	15.3	20.3	9.6	9.2	15.4	36.9	36.9	34.4	37.9	39.0	40.2	37.2	37.6	36.3	36.3	42.6	32.9	65.8	48.1	54.3	36.6	81.1	56.6	116.0	58.3	52.9	46.5	59.8	51.2	19.7	31.5	65.7	42.3	27.1	61.8	101.0	105.2	33.2	71.6	312.5	69.6	54.0	54.2	46.2	32.4	24.4	69.6	95.2	42.8	87.1	93.2	60.1	45.3	42.5	33.6	65.3	95.9	21.2	62.8	67.1	51.5	83.8	775.6	30.1	75.7	28.4	24.4	65.8	28.7	79.3	24.6	21.2	87.7	83.2	40.3	80.9	90.8	94.3	43.8	66.6	54.4	39.5	78.6	57.5	55.1	29.6	44.2	48.3	126.6	87.6	46.7	56.7	118.6
CSNK1G1	CK1gamma1	ENSG00000169118	"Casein kinase 1 gamma 1"	Q9HCP0	15	64165525-64356173	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Wnt signaling pathway"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 35.0"	"Cell type enhanced"	"Detected in all"		"Early spermatids: 130.6;Late spermatids: 261.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018209			Supported	Cytosol		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 25: Spermatids - Spermatogenesis"	Cytosol		"HPA018209: AB_1847278"	"unprognostic (9.10e-2)"	"unprognostic (8.09e-2)"	"unprognostic (1.20e-1)"	"unprognostic (2.65e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.64e-1)"	"unprognostic (7.90e-3)"	"unprognostic (3.07e-1)"	"unprognostic (1.61e-2)"	"unprognostic (2.02e-1)"	"unprognostic (8.63e-2)"	"unprognostic (3.75e-2)"	"unprognostic (7.51e-2)"	"unprognostic (8.16e-3)"	"unprognostic (1.31e-1)"	"unprognostic (2.59e-2)"	"unprognostic (2.41e-1)"	4.0	3.4	6.1	6.1	6.9	9.0	6.0	6.4	7.7	5.4	6.3	5.0	3.9	4.5	6.7	7.9	7.3	4.0	2.9	10.4	7.1	5.3	2.9	5.3	5.9	2.8	4.3	5.2	4.1	6.3	4.7	4.9	2.6	3.7	5.4	14.5	3.6	4.4	4.1	6.6	3.8	5.3	3.6	5.9	4.3	35.0	6.8	9.3	7.9	3.3	6.8	5.5	4.6	4.9	6.8	14.2	10.0	13.2	8.3	11.4	8.9	8.3	8.5	13.8	12.5	11.5	13.2	10.8	4.3	13.3	14.2	15.4	26.7	16.5	16.1	20.6	6.8	10.1	11.2	8.0	9.8	18.9	11.4	10.3	21.7	14.0	20.0	11.9	15.4	10.6	12.3	10.4	12.8	9.4	9.7	5.8	9.4	8.9	7.4	16.1	12.5	8.6	11.2	26.8	16.2	9.9	11.1	6.5	9.5	16.4	11.4	7.4	16.8	12.6	14.9	9.8	10.5	12.3	26.0	8.8	11.6	13.5	7.9	0.4	1.9	3.1	2.8	2.8	4.0	1.8	2.5	2.1	1.4	1.8	2.4	2.3	4.5	2.8	2.3	2.1	2.2	1.3	6.1	6.9	6.4	7.7	10.4	7.1	2.8	4.3	2.6	3.6	6.8	4.9	10.9	28.9	11.3	35.6	12.9	11.6	10.5	13.7	19.9	47.1	11.6	7.9	7.3	11.5	12.7	5.5	68.8	6.9	12.6	12.2	1.9	9.6	130.6	37.4	17.9	12.2	22.8	7.8	69.4	7.0	9.0	10.3	15.3	24.6	3.8	15.8	10.4	4.4	10.4	10.1	49.8	10.5	6.1	9.7	10.0	261.1	6.2	14.1	7.2	40.3	13.5	7.9	5.2	40.2	41.3	12.0	7.5	10.1	14.3	11.1	8.2	9.7	23.3	29.3	6.6	14.4	11.8	31.9	19.8	26.7	15.6	4.1	13.2	7.9	10.4	13.2
CSNK2A1	"Cka1, Cka2"	ENSG00000101266	"Casein kinase 2 alpha 1"	P68400	20	472498-543835	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Apoptosis, Biological rhythms, Cell cycle, Transcription, Transcription regulation, Wnt signaling pathway"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB020680, HPA059206, HPA061698, CAB069395"	Supported		Supported	Nucleoplasm		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"CAB020680: , CAB069395: AB_1611912, HPA059206: AB_2683948, HPA061698: AB_2732667"	"unprognostic (1.19e-1)"	"unprognostic (1.44e-1)"	"unprognostic (5.44e-2)"	"unprognostic (8.28e-3)"	"unprognostic (3.62e-2)"	"unprognostic (2.04e-2)"	"prognostic unfavorable (4.11e-6)"	"unprognostic (4.08e-2)"	"unprognostic (3.89e-1)"	"unprognostic (6.88e-2)"	"unprognostic (1.94e-2)"	"unprognostic (1.16e-1)"	"unprognostic (8.58e-2)"	"unprognostic (1.50e-1)"	"unprognostic (4.47e-1)"	"unprognostic (9.53e-2)"	"unprognostic (7.37e-2)"	36.1	32.6	20.9	38.6	23.2	34.0	35.9	28.2	29.6	36.5	29.3	48.3	39.1	35.8	26.6	50.0	39.9	31.3	54.0	25.7	21.0	41.0	31.8	31.6	41.2	20.6	21.1	41.5	46.9	59.1	21.2	42.4	21.1	35.8	40.7	32.9	41.1	37.7	110.5	34.2	40.5	39.1	18.8	30.2	49.5	65.2	22.3	51.6	39.6	86.4	46.6	47.4	28.5	27.3	209.5	170.4	152.9	96.0	61.1	103.8	103.5	117.9	116.1	125.8	139.5	178.5	120.0	179.1	74.2	90.1	179.1	147.8	162.1	167.4	187.2	62.6	57.7	247.3	44.7	177.7	102.5	228.1	51.3	99.5	173.3	105.8	316.0	122.2	139.5	146.4	248.9	112.6	123.8	64.2	262.0	73.7	227.4	173.4	97.6	149.8	140.5	140.9	112.9	128.5	163.9	132.3	97.2	184.0	174.8	120.7	120.4	83.9	142.7	136.0	118.4	90.0	178.5	120.6	311.8	174.1	65.8	119.5	138.6	40.5	23.8	28.7	18.2	32.3	22.4	23.0	18.0	17.6	31.5	22.5	17.9	17.4	14.9	25.1	33.5	25.7	20.4	20.8	20.9	23.2	28.2	29.6	25.7	21.0	20.6	21.1	21.1	18.8	22.3	27.3	50.7	64.1	84.6	51.9	46.1	41.0	40.0	43.8	45.5	49.4	42.1	36.1	59.4	41.5	75.8	44.1	31.3	42.2	50.5	43.5	41.1	68.5	135.5	67.6	77.0	44.5	35.2	59.3	65.6	50.6	54.4	46.3	40.2	75.7	63.8	108.6	27.1	31.1	33.2	60.6	69.3	41.8	46.8	39.2	30.3	140.0	41.0	45.3	14.2	51.5	61.7	38.6	37.0	73.9	73.6	66.6	34.4	36.9	49.6	57.2	43.2	68.8	65.5	27.8	52.6	43.6	56.8	94.2	68.7	52.3	50.2	61.4	38.9	81.2	40.6	59.4
CSPP1	"CSPP, CSPP-L, FLJ22490, JBTS21"	ENSG00000104218	"Centrosome and spindle pole associated protein 1"	Q1MSJ5	8	67062417-67196778	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Ciliopathy, Joubert syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 165.8;Endometrial ciliated cells: 177.6;Respiratory ciliated cells: 202.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA056174			Supported	"Centriolar satellite,Centrosome"		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 49: Ciliated cells - Cilium organization"	"Centriolar satellite, Centrosome"		"HPA056174: "	"unprognostic (1.44e-1)"	"unprognostic (8.23e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.06e-1)"	"unprognostic (4.70e-1)"	"unprognostic (2.59e-2)"	"unprognostic (5.24e-3)"	"unprognostic (3.89e-2)"	"unprognostic (7.85e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.30e-1)"	"unprognostic (3.61e-2)"	"unprognostic (9.29e-2)"	"unprognostic (3.40e-1)"	"unprognostic (9.46e-2)"	"prognostic unfavorable (2.98e-4)"	"unprognostic (2.93e-1)"	4.1	2.9	0.8	1.5	0.7	0.8	4.4	1.5	1.3	5.4	1.4	4.1	2.2	4.3	1.8	3.4	8.4	3.1	3.7	0.6	0.6	5.5	5.4	5.8	1.4	1.0	1.1	5.6	6.0	4.3	3.3	6.0	0.9	3.6	2.8	2.1	3.6	1.6	13.5	3.6	4.0	2.6	0.7	3.3	4.4	12.8	1.2	3.9	4.6	2.8	2.0	4.1	4.1	1.0	5.7	4.9	4.6	5.9	5.3	5.6	4.9	4.9	6.3	6.5	6.9	4.6	6.6	6.5	1.1	3.3	6.9	4.4	11.4	3.4	9.1	3.6	7.2	9.3	2.3	2.9	4.5	7.7	4.0	4.4	2.9	4.2	8.2	3.9	4.1	7.9	16.1	3.0	5.9	2.1	19.1	3.2	6.1	14.8	4.9	10.4	6.9	5.4	4.9	2.6	3.0	3.0	3.1	5.9	4.7	6.3	10.8	4.4	4.1	4.7	4.7	2.1	4.2	4.6	3.2	8.6	3.6	6.1	5.6	0.6	0.1	0.2	0.5	1.0	0.6	0.5	0.4	0.5	0.4	0.8	0.8	0.3	0.0	0.3	0.3	0.4	1.0	0.3	0.8	0.7	1.5	1.3	0.6	0.6	1.0	1.1	0.9	0.7	1.2	1.0	20.9	25.6	11.8	63.3	15.0	21.2	11.1	7.6	16.5	20.5	19.4	18.7	39.8	31.5	32.4	7.3	73.0	21.8	23.6	9.6	3.9	14.8	165.8	177.6	29.1	16.6	11.4	16.6	117.5	9.7	13.7	20.2	11.2	27.7	26.0	36.8	12.1	9.3	7.4	21.9	116.1	9.6	8.2	7.2	9.4	91.0	21.5	12.5	7.2	61.8	12.9	13.6	17.5	89.0	98.1	9.8	5.3	19.5	19.4	11.0	10.8	23.0	202.3	133.2	26.3	31.7	20.4	121.6	60.1	15.3	16.2	18.5	15.9	14.6	13.6	6.9
CSRP3	"CLP, CMD1M, MLP"	ENSG00000129170	"Cysteine and glycine rich protein 3"	P50461	11	19182030-19210571	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Differentiation, Myogenesis, Transcription, Transcription regulation"	"Actin-binding, Developmental protein"	"Cardiomyopathy, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"heart muscle: 2613.3;skeletal muscle: 1649.3;tongue: 579.0"	"Cell type enriched"	"Detected in some"	35	"Cardiomyocytes: 3433.6"	"Cancer enriched"	"Detected in some"	6	"head and neck cancer: 18.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"HSkMC: 1.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA042581	Enhanced		Uncertain	Nucleoplasm,Cytosol		NA	NA		250000		"Cluster 38: Heart - Muscle contraction"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 54: Cardiomyocytes - Muscle contraction"	Cytosol	Nucleoplasm	"HPA042581: AB_2678061"				"unprognostic (1.62e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.55e-2)"				"unprognostic (4.72e-2)"				"unprognostic (5.99e-2)"	"unprognostic (1.08e-1)"			0.3	0.2	0.3	0.0	0.1	0.1	2.8	0.5	0.3	0.0	0.0	0.2	0.0	0.1	0.0	39.6	0.0	0.5	2613.3	0.1	0.2	0.2	0.2	1.2	1.2	0.2	0.1	0.5	2.6	0.0	0.1	0.1	0.2	32.8	0.0	0.0	24.8	0.0	1649.3	0.4	0.2	0.0	0.1	0.0	0.2	0.2	0.2	0.1	0.7	579.0	0.2	0.1	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.8	0.2	0.2	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.5	0.3	0.1	0.2	0.2	0.1	0.2	0.1	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	3433.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	28.8	0.0	0.0	0.3	6.0	0.0	79.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	95.5	32.7	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0
CST3		ENSG00000101439	"Cystatin C"	P01034	20	23626706-23638473	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins"		"Protease inhibitor, Thiol protease inhibitor"	"Age-related macular degeneration, Amyloidosis, Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 4217.6"	"Cell type enriched"	"Detected in all"	4	"Langerhans cells: 18746.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	7	"classical monocyte: 4967.5;intermediate monocyte: 6424.5;myeloid DC: 7959.0;non-classical monocyte: 4297.7;plasmacytoid DC: 4427.4"	"Group enriched"	"Detected in all"	9	"dendritic cells: 7959.0;monocytes: 6424.5"	"Cell line enhanced"	"Detected in many"		"ASC diff: 1733.4;ASC TERT1: 1179.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000118, HPA013143"	Enhanced		Supported	"Golgi apparatus,Vesicles"	"Secreted to blood"	NA	NA	1040000000	2800000000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 41: Macrophages - Immune response"	"Golgi apparatus, Vesicles"		"CAB000118: , HPA013143: AB_1847417"	"unprognostic (3.89e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.45e-1)"	"prognostic favorable (1.83e-4)"	"unprognostic (8.53e-2)"	"unprognostic (4.06e-2)"	"unprognostic (2.10e-2)"	"unprognostic (2.18e-2)"	"unprognostic (3.46e-2)"	"unprognostic (3.72e-1)"	"unprognostic (2.29e-3)"	"unprognostic (3.51e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.97e-1)"	"unprognostic (5.01e-2)"	"prognostic favorable (8.77e-4)"	1046.2	707.6	3041.2	262.3	3117.9	170.8	900.3	2823.3	4217.6	587.8	3094.8	788.7	389.6	708.3	875.9	557.1	802.7	583.0	1275.3	2976.3	2707.6	517.4	833.6	595.8	463.5	3258.4	3096.2	575.8	944.1	320.0	670.1	165.9	2939.3	773.9	416.9	46.9	2008.0	441.5	749.0	497.1	800.3	367.6	3028.1	723.7	979.9	761.3	3302.7	418.9	658.8	517.4	208.1	703.0	618.4	2883.1	155.2	328.2	75.4	175.8	1733.4	1179.8	145.3	261.4	350.7	170.3	137.7	625.1	219.7	0.8	241.0	345.2	221.3	496.2	69.6	499.9	51.9	0.9	253.5	157.6	61.1	1082.9	621.2	7.5	251.0	919.0	415.9	226.6	241.5	352.5	268.5	18.5	147.6	4.0	239.5	234.4	1.5	162.2	103.5	461.9	752.2	5.7	96.4	215.2	708.0	328.3	84.7	98.2	191.1	54.6	343.3	107.7	156.5	548.2	702.0	163.4	119.0	231.6	97.7	157.1	6.2	1.8	138.0	339.5	184.0	48.1	4967.5	33.2	66.9	6424.5	25.5	23.1	18.3	45.8	7959.0	13.6	16.9	31.1	809.3	191.4	4297.7	4427.4	13.6	4250.8	3041.2	3117.9	2823.3	4217.6	2976.3	2707.6	3258.4	3096.2	2939.3	3028.1	3302.7	2883.1	662.4	115.4	168.8	849.5	93.8	942.9	571.1	568.2	213.9	152.4	660.2	512.1	240.7	1361.2	514.5	641.9	29.2	476.8	603.3	1889.9	414.8	489.9	46.2	441.1	795.0	728.2	882.1	252.1	4.5	783.6	308.7	3026.2	981.7	631.0	359.9	687.0	491.9	2563.0	1816.7	48.8	11.2	1360.6	691.7	4301.1	18746.6	184.3	2132.6	4542.6	1563.5	87.1	2025.6	248.7	99.9	263.9	6.0	1458.5	2342.1	1790.4	67.9	786.0	4301.1	1098.6	364.4	36.3	2195.7	1417.0	846.2	125.5	400.6	461.5	822.0	469.0	117.4	208.1	1039.4	1079.7
CSTB	"CST6, EPM1, PME, STFB"	ENSG00000160213	"Cystatin B"	P04080	21	43772511-43776330	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"		"Protease inhibitor, Thiol protease inhibitor"	"Cancer-related genes, Disease variant, Epilepsy, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	8	"esophagus: 11304.7"	"Cell type enhanced"	"Detected in all"		"Basal respiratory cells: 5910.7;Club cells: 4352.8;Hofbauer cells: 2827.7;Squamous epithelial cells: 4910.2;Urothelial cells: 3198.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RT4: 2798.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017380, CAB047320, HPA058557"	Enhanced		Supported	Nucleoli,Cytosol		NA	NA		8700000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Cytosol	Nucleoli	"CAB047320: , HPA017380: AB_1847414, HPA058557: AB_2683755"	"unprognostic (1.69e-1)"	"unprognostic (3.35e-1)"	"unprognostic (2.09e-1)"	"unprognostic (3.05e-2)"	"unprognostic (3.05e-2)"	"unprognostic (5.92e-2)"	"prognostic unfavorable (6.66e-5)"	"unprognostic (1.90e-1)"	"unprognostic (1.32e-1)"	"unprognostic (2.14e-1)"	"unprognostic (1.27e-2)"	"unprognostic (1.79e-1)"	"prognostic unfavorable (2.10e-4)"	"unprognostic (3.63e-1)"	"unprognostic (4.88e-1)"	"unprognostic (4.24e-2)"	"unprognostic (1.24e-1)"	224.3	165.6	254.1	141.6	253.6	73.8	161.9	255.4	314.6	585.8	275.2	243.8	122.9	90.1	175.0	11304.7	154.1	150.7	192.2	252.8	263.0	144.7	189.4	290.1	176.4	258.4	257.8	136.1	116.2	154.4	70.1	132.1	259.6	137.3	194.7	78.9	738.3	138.6	100.1	256.9	135.6	110.4	257.5	125.8	249.9	71.7	262.8	268.2	147.9	197.4	1484.9	611.8	1001.9	262.9	1573.6	495.5	146.3	188.1	874.5	742.6	379.6	310.1	431.0	230.7	230.6	401.6	868.6	123.0	245.8	570.1	1814.0	260.5	384.4	405.7	153.5	529.0	388.4	332.4	385.3	473.8	753.0	85.5	267.1	754.5	439.6	621.2	314.7	389.3	331.2	111.8	276.9	681.1	359.7	431.4	100.1	267.6	336.0	1052.6	791.5	169.7	80.5	1472.0	669.1	2798.2	141.8	121.6	420.2	229.2	928.8	75.7	210.4	214.0	426.3	347.7	162.7	305.5	211.8	148.5	347.4	251.1	1432.5	430.2	242.3	390.1	505.5	313.1	242.9	840.3	224.5	198.5	315.4	255.4	766.1	172.7	221.0	217.6	445.6	152.4	1322.9	93.4	406.9	475.2	254.1	253.6	255.4	314.6	252.8	263.0	258.4	257.8	259.6	257.5	262.8	262.9	210.1	176.3	298.4	43.4	140.5	385.3	460.6	5910.7	191.2	69.8	317.8	345.1	105.7	268.8	4352.8	415.6	35.5	310.4	126.5	803.9	538.1	588.4	10.4	388.8	205.1	307.8	239.3	61.4	17.0	488.2	1199.4	238.6	297.7	458.8	228.2	131.5	250.6	464.5	2827.7	67.3	18.4	308.6	1462.8	483.4	1256.2	40.8	381.1	806.9	471.4	24.4	915.9	160.6	255.4	11.1	32.4	810.9	735.6	330.2	167.7	674.3	524.9	469.9	1997.3	72.9	118.3	86.5	320.0	33.7	111.7	4910.2	596.0	402.5	202.8	170.9	367.2	3198.3
CTC1	"AAF132, C17orf68, FLJ22170"	ENSG00000178971	"CST telomere replication complex component 1"	Q2NKJ3	17	8224815-8248056	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		DNA-binding	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 37.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052436			Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 29: Plasmacytoid DCs - Unknown function"	"Cluster 51: Non-specific - Unknown function"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm	Cytosol	"HPA052436: "	"unprognostic (6.47e-2)"	"unprognostic (1.06e-2)"	"unprognostic (6.16e-3)"	"unprognostic (2.81e-3)"	"unprognostic (1.33e-1)"	"unprognostic (2.20e-3)"	"unprognostic (3.96e-1)"	"unprognostic (2.07e-2)"	"unprognostic (3.00e-1)"	"unprognostic (5.66e-2)"	"prognostic favorable (6.49e-5)"	"unprognostic (2.89e-3)"	"unprognostic (3.24e-1)"	"unprognostic (5.76e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.77e-2)"	"unprognostic (1.66e-2)"	13.8	11.8	13.4	14.7	14.1	18.5	15.9	19.7	18.8	17.6	13.2	16.9	8.0	13.5	10.7	11.1	17.2	6.9	11.7	13.4	13.4	16.6	18.3	18.5	24.1	13.2	13.3	19.9	18.2	10.4	21.4	6.1	13.3	16.6	10.4	22.2	12.4	9.0	7.0	14.1	25.0	9.3	12.2	37.2	15.8	10.8	13.7	31.2	18.0	5.7	21.4	14.8	13.4	14.6	3.0	6.6	5.9	5.5	18.1	4.3	7.2	3.4	3.8	4.8	3.2	5.0	8.8	10.8	3.4	5.9	3.5	10.0	7.0	5.2	3.0	8.0	6.8	5.3	7.2	6.5	3.0	1.7	16.1	4.4	5.5	6.3	8.6	9.5	8.7	15.4	5.1	3.6	3.4	3.9	18.6	7.3	4.8	9.7	1.6	8.7	2.3	6.9	12.4	7.1	5.2	5.9	6.7	8.6	6.0	10.9	5.3	5.0	11.6	1.5	3.6	3.6	4.0	7.4	4.7	7.1	2.9	6.5	4.5	2.0	0.7	1.2	2.0	0.9	2.0	2.2	2.0	1.9	0.7	2.6	2.8	2.5	2.5	1.3	1.2	2.2	1.8	1.0	13.4	14.1	19.7	18.8	13.4	13.4	13.2	13.3	13.3	12.2	13.7	14.6	6.3	0.0	11.1	8.5	16.7	1.9	3.0	1.0	3.4	7.7	6.2	4.1	3.4	7.2	3.0	5.5	37.5	6.4	12.0	4.6	1.9	3.6	3.7	3.6	2.6	6.4	6.7	1.7	10.2	3.8	3.9	3.8	5.6	5.5	6.3	4.0	5.7	8.1	3.9	1.7	10.3	5.8	2.0	8.2	1.0	6.2	4.4	3.5	0.0	3.7	5.6	2.5	6.2	9.0	6.6	4.4	9.4	2.2	9.6	4.1	4.5	2.2	3.0	17.3	0.0	3.1	4.1	4.7	4.2	3.9	2.0	11.1	10.3	2.1	3.5	3.4
CTCF	"CFAP108, FAP108"	ENSG00000102974	"CCCTC-binding factor"	P49711	16	67562467-67639177	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Chromosome partition, Transcription, Transcription regulation"	"Activator, Chromatin regulator, DNA-binding, Repressor"	"Cancer-related genes, Disease variant, Mental retardation, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004122, CAB062550, CAB068181, CAB068182"	Supported		Supported	Nucleoplasm		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 63: T-cells - Adaptive immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"CAB062550: AB_2665624, CAB068181: AB_2665625, CAB068182: AB_2665626, HPA004122: AB_2667139"	"unprognostic (2.70e-1)"	"unprognostic (4.21e-2)"	"unprognostic (3.41e-2)"	"unprognostic (4.70e-2)"	"unprognostic (4.41e-2)"	"unprognostic (2.70e-1)"	"prognostic unfavorable (4.21e-4)"	"unprognostic (1.71e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.36e-2)"	"unprognostic (1.99e-2)"	"prognostic favorable (4.06e-4)"	"unprognostic (3.47e-1)"	"unprognostic (5.99e-2)"	"unprognostic (4.58e-2)"	"unprognostic (1.11e-2)"	17.3	14.5	10.6	20.6	12.2	34.6	17.5	17.4	12.7	21.3	7.4	18.9	15.9	20.8	13.8	20.2	19.9	14.6	15.9	10.7	11.9	18.4	18.7	16.4	29.0	10.3	10.2	22.3	18.4	28.3	12.9	20.4	10.3	17.2	21.6	18.4	17.1	17.7	30.5	23.3	19.4	20.3	9.0	22.7	18.3	10.5	10.2	69.6	19.3	28.4	35.4	19.7	20.0	16.2	34.6	51.2	66.9	26.7	29.9	25.5	54.2	32.4	33.6	45.9	43.5	42.3	34.5	106.6	26.0	27.7	26.2	43.8	65.3	35.7	51.5	38.5	44.0	63.9	28.5	49.3	20.4	73.7	59.7	20.8	42.5	34.6	38.2	27.5	35.5	83.1	57.7	43.3	38.6	66.7	156.8	27.4	58.3	38.7	34.5	113.5	54.9	58.7	28.2	48.7	57.0	40.0	57.3	33.2	27.9	35.2	41.0	45.3	33.8	39.3	41.3	30.5	35.7	38.6	52.6	151.2	23.1	43.1	43.1	6.8	2.3	3.4	4.3	2.4	4.1	5.5	4.8	3.5	2.1	7.4	3.8	4.4	6.8	3.5	4.8	5.6	3.9	1.4	10.6	12.2	17.4	12.7	10.7	11.9	10.3	10.2	10.3	9.0	10.2	16.2	38.0	22.4	29.8	19.9	50.4	22.3	24.3	11.4	35.3	35.5	35.6	33.9	32.6	27.1	28.1	23.9	8.4	27.4	54.0	29.2	19.6	31.3	2.1	29.8	43.9	37.3	31.2	52.6	23.0	33.6	33.7	29.9	27.0	40.2	19.6	39.1	23.9	24.0	24.0	45.4	24.2	26.4	16.2	26.7	12.6	3.6	24.8	31.1	12.4	32.8	29.2	32.3	49.4	17.1	32.8	32.5	16.5	28.6	62.6	35.6	18.8	24.5	16.7	27.6	19.7	38.6	41.4	18.4	27.3	38.8	24.7	29.6	47.9	32.6	23.8	30.0
CTDP1	FCP1	ENSG00000060069	"CTD phosphatase subunit 1"	Q9Y5B0	18	79679803-79754510	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	"Hydrolase, Protein phosphatase"	"Cataract, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"Early spermatids: 113.1;Late spermatids: 123.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"eosinophil: 3.2"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB032641, HPA040394, HPA070389"	Approved		Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 71: Testis - DNA repair"	"Cluster 24: NB-4 - Immune response"	"Cluster 65: Plasmacytoid DCs - Unknown function"	Nucleoplasm	Vesicles	"CAB032641: AB_2261235, HPA040394: AB_10794029, HPA070389: AB_2732155"	"unprognostic (1.71e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.37e-1)"	"prognostic favorable (6.43e-4)"	"unprognostic (2.64e-2)"	"unprognostic (7.99e-2)"	"unprognostic (3.47e-3)"	"unprognostic (1.83e-1)"	"unprognostic (2.54e-1)"	"unprognostic (1.15e-1)"	"unprognostic (5.21e-3)"	"unprognostic (1.99e-2)"	"prognostic favorable (5.51e-5)"	"unprognostic (5.16e-2)"	"unprognostic (8.58e-2)"	"unprognostic (2.85e-2)"	"unprognostic (4.74e-2)"	9.3	7.4	3.8	7.2	3.9	13.7	8.9	3.3	4.2	7.8	4.1	11.1	7.2	10.4	1.4	10.7	8.1	4.0	7.2	3.3	3.3	7.9	9.5	9.3	8.7	5.3	4.2	5.0	9.0	3.3	6.9	4.2	4.0	8.2	3.1	1.5	9.5	3.9	11.9	20.5	10.9	3.1	3.3	13.5	9.9	22.2	4.0	6.5	8.0	3.1	3.7	9.6	8.6	4.4	13.4	14.0	7.7	11.0	6.0	5.0	25.9	9.6	6.1	7.6	7.5	9.4	8.0	17.2	4.2	5.6	9.1	16.4	6.6	8.8	3.1	16.9	12.4	8.5	6.6	12.9	8.7	37.6	20.5	8.4	8.3	8.1	3.8	4.6	9.2	12.2	11.2	8.1	3.0	11.5	25.4	29.5	12.7	4.2	19.1	20.7	10.1	20.0	5.6	13.1	12.0	12.4	10.2	9.8	13.9	5.8	8.0	21.7	12.9	12.9	19.4	5.3	9.7	7.4	27.6	16.1	11.0	18.8	9.3	0.0	0.4	3.2	0.5	0.4	0.4	0.2	0.4	0.8	0.6	0.1	0.5	0.3	1.0	1.1	0.4	0.1	0.1	0.2	3.8	3.9	3.3	4.2	3.3	3.3	5.3	4.2	4.0	3.3	4.0	4.4	7.4	0.0	4.1	3.6	9.2	8.5	5.0	4.0	11.4	9.5	7.7	6.5	3.8	4.3	4.5	3.7	14.6	8.8	24.2	20.0	1.9	5.4	113.1	18.6	8.0	7.5	6.0	13.5	7.7	7.2	8.0	4.8	19.9	24.0	7.0	7.8	6.4	5.7	8.8	23.5	6.6	16.6	6.1	7.5	9.5	123.2	7.8	13.8	7.2	6.5	6.5	6.5	19.6	3.0	8.9	10.2	14.9	10.5	15.2	11.8	10.0	6.8	9.6	14.8	0.0	5.9	7.4	18.0	10.5	10.5	10.1	19.0	18.3	8.0	11.7	12.6
CTDSP1	"NLIIF, SCP1"	ENSG00000144579	"CTD small phosphatase 1"	Q9GZU7	2	218398256-218405941	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"NK-cells: 184.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA062654			Supported	Nucleoplasm		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 63: NK-cells & T-cells - Immune response"	Nucleoplasm		"HPA062654: AB_2684819"	"unprognostic (1.97e-2)"	"unprognostic (4.02e-2)"	"unprognostic (1.67e-3)"	"unprognostic (2.62e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.82e-2)"	"unprognostic (3.90e-2)"	"unprognostic (8.69e-2)"	"unprognostic (2.98e-1)"	"unprognostic (6.38e-2)"	"unprognostic (3.70e-1)"	"unprognostic (1.79e-1)"	"unprognostic (2.58e-1)"	"unprognostic (6.67e-2)"	"unprognostic (2.62e-1)"	"unprognostic (7.01e-2)"	"unprognostic (1.57e-1)"	84.5	55.4	42.1	43.0	47.8	53.1	76.5	41.6	42.2	82.4	40.6	72.2	56.7	80.2	31.9	71.8	74.3	46.7	79.4	36.8	38.8	83.2	118.6	74.5	49.2	55.6	47.0	82.3	79.1	56.9	28.4	77.7	44.6	104.6	44.7	8.7	65.3	57.2	60.0	71.4	75.9	48.4	45.3	92.7	88.3	16.9	45.5	48.0	78.9	53.7	45.4	82.6	70.4	43.2	29.8	37.8	21.8	71.9	58.1	53.8	80.0	38.9	56.2	37.2	32.0	49.7	72.7	18.0	33.0	69.8	25.3	59.1	32.4	47.2	19.0	63.8	25.5	68.3	48.6	67.0	69.4	42.9	89.3	61.5	56.7	28.3	31.7	58.3	55.5	27.5	56.5	62.6	39.9	84.0	37.5	122.1	15.5	47.6	37.8	51.4	30.8	39.2	47.7	36.6	14.5	36.4	34.4	72.9	38.6	27.4	40.8	101.1	48.5	58.7	35.0	45.4	17.4	40.1	28.1	42.6	52.3	39.7	33.2	54.2	30.4	74.1	24.3	24.7	15.5	7.8	14.7	15.8	15.9	7.2	9.3	12.4	56.4	17.3	26.3	5.4	13.8	21.2	42.1	47.8	41.6	42.2	36.8	38.8	55.6	47.0	44.6	45.3	45.5	43.2	65.0	44.8	40.0	15.0	43.0	27.3	29.1	24.7	37.5	14.6	34.8	34.5	35.1	58.6	23.7	31.3	2.1	42.7	70.5	95.0	33.2	36.6	1.9	15.1	35.1	43.4	21.7	52.6	0.7	42.7	43.3	44.7	45.3	27.7	18.3	23.0	67.5	57.3	39.3	6.7	1.0	53.5	12.2	83.2	28.1	4.6	59.4	59.9	33.8	14.0	56.9	55.6	184.4	13.0	12.9	38.5	43.1	44.0	35.7	39.8	85.1	51.1	10.0	28.0	26.3	36.0	44.8	1.7	8.7	37.8	20.3	54.3	55.1	29.4	41.5	30.2
CTIF	KIAA0427	ENSG00000134030	"Cap binding complex dependent translation initiation factor"	O43310	18	48539031-48863217	"Predicted intracellular proteins, Transporters"	"Nonsense-mediated mRNA decay, Translation regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 94.7;Excitatory neurons: 76.4;Inhibitory neurons: 80.6;Oligodendrocyte precursor cells: 75.9;Oligodendrocytes: 59.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016865, HPA024801"	Uncertain		Supported	Cytosol		NA	NA				"Cluster 35: Non-specific - Unknown function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 52: Non-specific - Transcription"	Cytosol		"HPA016865: AB_1852311, HPA024801: AB_1852312"	"unprognostic (5.84e-2)"	"unprognostic (5.86e-2)"	"unprognostic (2.27e-2)"	"unprognostic (1.23e-2)"	"unprognostic (2.06e-1)"	"unprognostic (2.57e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.44e-1)"	"unprognostic (8.86e-2)"	"unprognostic (1.95e-3)"	"unprognostic (2.77e-3)"	"unprognostic (1.35e-1)"	"prognostic favorable (3.18e-4)"	"unprognostic (1.95e-1)"	"unprognostic (1.99e-1)"	"unprognostic (2.34e-3)"	"unprognostic (7.33e-3)"	35.3	20.0	15.7	3.3	13.9	2.0	24.3	10.7	23.2	14.0	0.0	26.0	2.5	21.5	2.6	11.4	16.3	7.5	24.8	16.0	15.5	11.1	24.8	14.3	1.3	20.7	17.4	28.0	9.8	4.6	12.4	4.3	23.3	13.9	1.6	7.4	11.0	5.4	15.8	14.0	9.9	7.0	9.1	6.7	19.6	7.3	19.0	1.4	10.7	4.3	1.0	26.1	12.6	16.7	3.2	3.4	4.5	5.8	11.3	6.0	2.5	15.9	13.2	12.4	11.2	3.5	1.9	0.0	3.5	22.0	5.2	6.7	3.3	9.0	5.3	0.0	2.7	1.4	7.9	8.4	21.6	2.6	4.5	8.4	14.5	7.8	13.8	8.9	8.9	4.1	4.0	9.8	8.0	1.7	0.9	2.0	2.2	3.4	2.8	1.6	5.2	4.2	3.7	4.3	9.6	9.7	5.6	6.0	4.5	3.8	3.8	3.1	18.1	11.4	10.5	3.4	2.9	3.3	4.2	0.0	10.1	1.6	5.1	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.7	13.9	10.7	23.2	16.0	15.5	20.7	17.4	23.3	9.1	19.0	16.7	7.3	35.3	3.7	94.7	1.9	3.3	2.1	3.5	2.8	25.6	11.2	8.4	16.0	5.7	5.6	7.3	16.7	1.9	0.8	4.6	7.9	5.1	11.1	1.7	7.7	8.5	3.5	0.4	76.4	4.8	2.8	13.1	7.1	3.6	4.5	19.5	7.5	23.0	4.2	11.8	80.6	3.5	4.1	6.4	2.7	19.3	25.1	5.0	3.6	30.0	1.5	3.6	3.1	75.9	59.7	5.7	2.7	50.8	4.8	3.0	5.9	5.8	4.7	8.8	6.6	8.8	9.4	2.3	1.8	3.5	2.3	1.2	0.7	34.7	3.3	3.3
CTNS	"CTNS-LSB, PQLC4, SLC66A4"	ENSG00000040531	"Cystinosin, lysosomal cystine transporter"	O60931	17	3636459-3663103	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Melanin biosynthesis, Protein transport, Symport, Transport"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 35.5;Late spermatids: 29.3;Theca cells: 30.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"dendritic cells: 34.3;granulocytes: 27.9;monocytes: 10.4"	"Cell line enhanced"	"Detected in all"		"HDLM-2: 144.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046947			Supported	"Vesicles,Intermediate filaments"		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 43: Testis - Unknown function"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 4: Macrophages - Innate immune response"	"Vesicles, Intermediate filaments"		"HPA046947: AB_2679872"	"unprognostic (1.64e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.21e-1)"	"unprognostic (8.25e-2)"	"unprognostic (8.39e-2)"	"prognostic favorable (7.33e-4)"	"unprognostic (1.28e-2)"	"unprognostic (8.02e-2)"	"unprognostic (1.94e-1)"	"unprognostic (6.62e-3)"	"prognostic favorable (6.39e-5)"	"unprognostic (8.40e-2)"	"unprognostic (2.25e-1)"	"unprognostic (1.80e-1)"	"unprognostic (5.64e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.52e-1)"	10.3	19.5	9.5	10.0	17.0	10.2	9.6	13.5	12.1	20.3	12.1	8.3	12.2	11.3	6.4	8.7	10.3	13.1	10.5	10.8	10.3	15.2	15.9	11.6	10.0	16.5	16.8	12.1	27.0	13.6	9.6	12.9	18.0	10.8	7.2	6.8	12.0	11.6	15.3	19.2	11.0	8.6	10.9	12.1	15.0	24.8	13.2	8.8	9.2	7.4	9.5	9.1	9.4	28.0	17.6	37.0	22.6	18.2	34.5	16.9	13.0	19.6	28.8	21.1	26.0	21.0	16.0	10.2	17.8	11.6	55.9	40.1	19.8	12.1	12.6	144.3	33.7	10.8	32.2	19.3	46.5	8.0	81.3	23.8	14.2	20.2	15.4	28.1	22.2	18.7	12.6	15.9	16.6	15.1	7.8	7.9	9.8	12.2	16.8	16.4	9.3	23.0	15.3	16.2	3.9	17.2	19.2	24.4	20.3	19.0	17.1	7.7	24.2	17.2	11.6	40.3	13.3	12.4	20.0	4.2	28.1	7.8	11.8	27.9	10.4	21.8	3.0	6.9	4.9	5.8	4.0	5.7	9.7	4.9	4.5	5.5	3.1	5.2	7.1	34.3	4.3	7.3	9.5	17.0	13.5	12.1	10.8	10.3	16.5	16.8	18.0	10.9	13.2	28.0	4.4	3.2	2.2	6.5	4.8	1.7	3.5	2.5	4.0	1.6	6.3	5.0	5.2	5.7	2.7	12.9	10.4	6.1	5.2	3.6	0.0	6.7	35.5	5.7	4.4	5.3	2.4	4.0	3.4	6.4	7.1	6.0	7.7	4.3	8.2	6.7	9.3	7.6	25.2	5.0	3.4	2.5	4.1	7.2	5.9	29.3	9.6	12.1	5.4	3.7	10.0	6.5	3.1	5.5	11.1	6.4	3.3	12.8	4.5	6.5	3.2	9.5	7.0	3.9	6.6	3.7	3.5	19.7	8.7	2.9	2.4	8.5	3.3	30.9	1.8	3.2
CTSB		ENSG00000164733	"Cathepsin B"	P07858	8	11842524-11869533	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"		"Hydrolase, Protease, Thiol protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Hofbauer cells: 2744.5;Kupffer cells: 1774.9;Macrophages: 1224.3"	"Cancer enriched"	"Detected in all"	5	"thyroid cancer: 1446.9"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"basophil: 390.6;classical monocyte: 610.1;intermediate monocyte: 467.3;myeloid DC: 287.4;non-classical monocyte: 307.6;plasmacytoid DC: 410.1"	"Group enriched"	"Detected in all"	6	"dendritic cells: 410.1;granulocytes: 390.6;monocytes: 610.1"	"Cell line enhanced"	"Detected in all"		"BJ hTERT+: 1607.5;fHDF/TERT166: 1436.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000457, HPA018156, HPA048998"	Enhanced		Supported	Nucleoli,Vesicles	"Secreted to blood"	NA	NA		100000000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 72: Non-specific - Transcription"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 4: Macrophages - Innate immune response"	Vesicles	Nucleoli	"CAB000457: , HPA018156: AB_1846069, HPA048998: "	"unprognostic (5.74e-2)"	"unprognostic (4.32e-2)"	"unprognostic (1.38e-2)"	"unprognostic (2.17e-2)"	"unprognostic (2.98e-3)"	"unprognostic (5.96e-2)"	"unprognostic (1.36e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.82e-2)"	"unprognostic (1.06e-1)"	"unprognostic (7.61e-2)"	"unprognostic (8.30e-2)"	"unprognostic (2.85e-1)"	"unprognostic (7.39e-2)"	"unprognostic (4.12e-2)"	"prognostic favorable (5.76e-4)"	"prognostic unfavorable (9.02e-4)"	443.9	304.5	65.6	399.7	71.2	87.0	249.0	65.9	77.2	583.2	101.0	312.4	120.8	379.2	116.9	421.6	368.4	230.6	447.0	64.7	95.5	420.6	497.2	428.9	289.6	100.4	90.8	169.1	135.4	79.6	156.8	253.2	107.4	255.5	159.3	33.6	437.3	156.6	237.4	184.7	260.2	316.1	91.9	521.1	194.3	33.2	204.5	60.9	1150.7	99.3	104.0	431.9	477.8	159.2	66.6	283.4	4.0	94.9	657.3	754.5	128.3	885.0	1607.5	258.4	299.5	10.3	294.4	1.5	32.2	1436.1	419.3	279.5	65.3	157.1	195.6	25.9	52.6	58.8	10.0	397.1	479.2	7.7	73.7	296.4	532.2	327.2	427.3	611.5	33.4	20.2	81.7	260.7	194.6	62.5	6.5	23.1	16.3	839.7	91.3	33.6	39.3	202.7	2.6	121.1	4.9	68.6	165.1	68.6	514.6	110.1	97.8	68.7	922.4	766.5	111.9	129.9	259.3	182.7	178.5	4.8	432.5	22.9	249.4	390.6	610.1	90.6	26.3	467.3	35.4	44.1	79.0	31.5	287.4	38.8	48.3	21.5	97.8	31.3	307.6	410.1	78.7	703.7	65.6	71.2	65.9	77.2	64.7	95.5	100.4	90.8	107.4	91.9	204.5	159.2	87.7	109.0	171.4	17.6	54.8	54.7	441.6	563.2	54.7	55.2	94.1	74.5	320.1	165.8	331.7	114.0	41.7	279.4	122.4	147.9	27.4	294.6	15.6	105.8	240.1	163.0	154.7	210.2	36.2	238.2	341.7	155.0	44.4	183.5	179.4	105.9	204.2	239.5	2744.5	58.9	42.8	94.2	158.7	1774.9	436.5	18.5	76.4	1224.3	161.9	70.3	373.1	117.4	24.7	19.1	12.9	363.9	154.0	92.9	47.3	295.5	198.6	351.8	180.8	40.0	39.5	39.4	149.9	10.8	21.0	160.3	40.5	649.6	56.0	32.1	139.6	321.4
CTSC	"DPP1, PALS, PLS"	ENSG00000109861	"Cathepsin C"	P53634	11	88265069-88359684	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Protease, Thiol protease"	"Disease variant, Palmoplantar keratoderma"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 900.7;Club cells: 471.8;Hofbauer cells: 1100.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"BJ hTERT+: 1078.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB025364, HPA066610, HPA068434"	Enhanced		Supported	Vesicles	"Intracellular and membrane"	No	No		19000000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 19: Lung - Lung function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Vesicles		"CAB025364: , HPA066610: AB_2685694, HPA068434: AB_2685989"	"unprognostic (4.05e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.10e-1)"	"unprognostic (3.70e-2)"	"unprognostic (1.45e-2)"	"prognostic unfavorable (9.30e-5)"	"unprognostic (1.62e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.56e-2)"	"unprognostic (3.11e-2)"	"unprognostic (3.35e-1)"	"prognostic favorable (4.80e-4)"	"unprognostic (2.93e-1)"	"unprognostic (4.35e-2)"	"unprognostic (8.10e-2)"	"unprognostic (4.07e-2)"	173.2	60.7	9.9	185.1	9.6	71.7	63.4	11.1	24.9	77.9	14.2	143.1	121.0	43.9	28.5	63.3	54.0	182.0	38.5	9.5	10.1	234.7	82.0	272.6	243.7	14.0	11.9	22.1	52.2	42.4	39.3	253.3	13.3	26.0	191.5	3.7	131.6	28.9	18.8	29.6	128.8	88.9	11.5	197.2	73.6	22.8	19.5	63.7	43.6	31.9	140.6	176.3	43.3	21.3	80.3	75.9	27.6	69.9	103.7	286.1	218.4	626.5	1078.4	372.8	270.3	194.7	361.3	117.3	278.9	365.2	84.3	133.6	50.4	269.2	341.9	204.7	82.8	144.5	188.0	233.5	140.2	188.9	108.7	419.1	198.8	284.5	697.4	302.1	377.6	122.3	155.3	145.4	54.8	14.8	89.1	295.1	172.2	551.5	244.9	113.6	30.7	227.0	451.3	106.6	8.8	66.8	81.2	114.9	80.6	185.4	27.9	152.7	149.3	23.5	190.5	156.8	364.6	61.9	81.0	122.9	56.8	435.8	122.4	85.5	203.8	309.7	230.1	415.6	194.9	47.2	99.6	198.2	209.9	26.3	49.5	115.3	215.0	200.5	582.9	425.0	162.7	243.3	9.9	9.6	11.1	24.9	9.5	10.1	14.0	11.9	13.3	11.5	19.5	21.3	78.6	22.4	88.1	0.3	40.8	30.1	7.3	900.7	33.6	1.5	15.9	14.6	4.4	52.9	471.8	40.5	0.0	414.1	330.6	37.9	29.4	29.8	1.6	13.4	135.6	94.8	11.4	29.7	3.0	90.6	159.2	114.4	39.8	21.2	75.3	25.5	26.4	15.8	1100.6	0.0	8.2	19.4	158.7	344.7	200.7	7.9	198.5	391.7	48.0	61.8	185.4	0.5	299.7	13.6	0.4	44.8	72.3	25.6	78.5	8.5	20.2	166.4	93.7	0.8	59.2	4.4	150.8	3.0	11.1	43.3	27.1	227.3	170.6	286.7	44.9	16.1
CTSF	"CATSF, CLN13"	ENSG00000174080	"Cathepsin F"	Q9UBX1	11	66563464-66568879	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Hydrolase, Protease, Thiol protease"	"Disease variant, Neurodegeneration, Neuronal ceroid lipofuscinosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Late spermatids: 320.9;Muller glia cells: 196.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"SiHa: 23.1;SK-MEL-30: 59.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002141, HPA031431"	Approved		Supported	"Endoplasmic reticulum,Vesicles,Plasma membrane"	"Intracellular and membrane"	NA	NA		5800000	"Cluster 15: NK-cells - Transcription"	"Cluster 35: Non-specific - Unknown function"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 5: Muller glia cells - Visual perception"	Vesicles	"Endoplasmic reticulum, Plasma membrane"	"CAB002141: AB_563471, HPA031431: "	"unprognostic (1.52e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.03e-1)"	"unprognostic (7.22e-3)"	"unprognostic (2.25e-2)"	"unprognostic (6.72e-2)"	"unprognostic (2.67e-2)"	"unprognostic (2.76e-2)"	"unprognostic (3.69e-1)"	"unprognostic (4.14e-1)"	"unprognostic (1.69e-2)"	"unprognostic (9.12e-2)"	"prognostic favorable (8.92e-7)"	"unprognostic (1.36e-2)"	"unprognostic (1.28e-1)"	"unprognostic (3.89e-1)"	"unprognostic (2.42e-1)"	57.8	70.0	68.1	0.8	76.3	0.3	62.2	74.5	74.0	78.8	90.2	76.7	3.0	89.2	21.9	15.6	70.8	10.0	100.2	63.2	74.2	46.9	66.0	32.9	3.6	75.0	70.3	99.1	31.7	20.0	43.3	3.8	68.4	53.5	3.5	26.2	55.7	17.1	91.9	44.4	29.5	12.2	77.2	25.0	54.3	109.7	71.0	3.0	40.6	27.6	3.0	56.6	58.7	86.6	0.0	17.0	3.1	5.4	14.2	8.6	3.4	13.0	11.4	6.3	2.3	0.0	2.2	0.0	21.3	10.4	0.0	1.2	6.8	2.6	4.8	3.7	0.0	0.5	7.0	0.0	9.9	0.3	4.4	22.3	9.1	0.8	1.6	13.7	3.8	2.0	5.4	1.6	5.2	4.6	0.1	1.7	0.9	3.7	9.7	0.0	0.0	1.5	7.1	0.3	4.3	6.9	23.1	0.3	59.5	0.3	7.4	0.6	3.3	1.8	2.9	1.5	1.2	21.2	0.2	0.0	2.2	0.0	2.9	0.0	0.4	0.3	3.9	0.6	4.1	1.5	3.5	4.6	0.6	1.4	6.4	4.1	0.1	4.6	0.2	0.9	1.3	2.2	68.1	76.3	74.5	74.0	63.2	74.2	75.0	70.3	68.4	77.2	71.0	86.6	36.6	12.8	15.6	31.3	5.9	39.8	62.4	8.5	37.5	107.9	45.3	80.6	57.9	41.5	7.4	36.8	41.7	31.6	9.6	0.6	15.6	13.1	163.3	1.7	22.8	27.2	12.0	11.4	26.5	7.5	9.5	118.1	8.2	5.3	9.5	52.1	56.0	67.8	14.9	134.6	31.3	3.1	18.3	21.5	32.8	320.9	145.7	13.1	156.5	12.2	3.1	196.6	17.5	21.6	29.4	5.9	3.2	121.9	12.9	50.5	1.3	44.7	3.3	77.9	78.9	62.0	45.9	169.6	43.3	3.6	25.3	23.7	9.5	30.7	4.3	32.9
CTSH	"ACC-4, ACC-5, ACC4, ACC5, CPSB"	ENSG00000103811	"Cathepsin H"	P09668	15	78921058-78949574	"Cancer-related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Protease, Thiol protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lung: 349.6"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 1569.9;Proximal tubular cells: 523.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"classical monocyte: 208.5;intermediate monocyte: 137.7;memory B-cell: 83.3;myeloid DC: 183.6;naive B-cell: 56.0;non-classical monocyte: 94.8"	"Group enriched"	"Detected in all"	5	"B-cells: 83.3;dendritic cells: 183.6;monocytes: 208.5"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 306.4;HaCaT: 228.2;HDLM-2: 183.0;OE19: 197.4;RT4: 362.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000458, HPA003524"	Enhanced		Supported	"Vesicles,Cytosol,Cytoplasmic bodies"	"Intracellular and membrane"	NA	NA		8700000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 11: Alveolar cells - Smell perception"	"Vesicles, Cytosol, Cytoplasmic bodies"		"CAB000458: , HPA003524: AB_1846075"	"unprognostic (6.47e-2)"	"unprognostic (4.65e-3)"	"unprognostic (1.05e-1)"	"prognostic favorable (6.90e-4)"	"unprognostic (4.37e-2)"	"unprognostic (1.93e-1)"	"unprognostic (7.18e-2)"	"unprognostic (3.30e-3)"	"unprognostic (2.22e-1)"	"unprognostic (5.96e-2)"	"unprognostic (4.10e-2)"	"unprognostic (3.89e-2)"	"unprognostic (6.63e-3)"	"unprognostic (3.83e-1)"	"unprognostic (4.42e-2)"	"unprognostic (2.70e-3)"	"unprognostic (1.79e-3)"	34.3	36.4	29.4	100.6	30.2	36.9	48.8	29.9	47.1	112.8	31.4	32.5	77.8	46.7	26.8	37.9	57.6	104.6	51.3	29.6	32.9	238.2	89.5	349.6	191.8	30.8	31.4	30.0	75.5	77.6	10.1	25.7	31.5	59.7	27.3	4.7	63.0	70.7	16.3	48.4	56.7	43.1	30.7	51.8	93.9	10.1	32.7	51.8	27.7	37.7	131.3	202.2	30.6	32.4	122.0	10.0	1.2	30.5	5.4	0.5	20.3	8.6	3.0	13.9	7.0	17.6	306.4	34.6	12.6	0.0	13.5	228.2	5.2	52.6	10.1	183.0	0.4	3.0	1.3	38.4	12.1	0.4	7.1	5.6	10.7	0.2	0.0	59.4	1.0	5.9	76.0	0.0	17.9	2.8	32.6	87.8	8.9	197.4	4.9	0.3	0.4	5.9	49.9	362.1	2.6	5.2	41.5	27.8	75.4	10.1	12.5	48.0	16.4	0.2	6.2	0.0	5.3	0.8	92.4	19.5	0.1	89.2	12.3	0.0	208.5	2.0	7.6	137.7	29.7	83.3	20.5	7.4	183.6	56.0	1.8	3.8	8.7	3.2	94.8	22.9	18.3	147.5	29.4	30.2	29.9	47.1	29.6	32.9	30.8	31.4	31.5	30.7	32.7	32.4	169.8	237.2	1569.9	59.1	127.4	24.2	280.7	363.9	30.1	1.3	45.5	41.7	26.2	358.9	258.7	367.8	4.2	19.8	8.1	9.1	84.1	225.0	25.3	67.0	86.0	124.5	9.1	3.0	2.2	142.0	39.6	53.8	106.0	42.8	32.8	2.7	14.3	115.5	256.7	0.0	2.9	18.6	101.7	177.8	259.6	22.6	73.0	350.4	80.0	15.9	360.9	22.6	5.2	1.5	1.1	84.6	16.0	6.0	155.8	112.0	153.0	523.2	261.6	6.6	19.7	4.5	22.3	12.3	56.4	41.6	18.6	23.4	29.4	17.8	40.1	340.4
CTSK	"CTSO, CTSO2, PKND, PYCD"	ENSG00000143387	"Cathepsin K"	P43235	1	150794880-150809577	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Protease, Thiol protease"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"cervix: 420.6"	"Cell type enhanced"	"Detected in many"		"Fibroblasts: 372.4;Langerhans cells: 123.6;Leydig cells: 119.0;Melanocytes: 97.8;Peritubular cells: 149.7;Theca cells: 80.9"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	6	"cerebral cortex: 18.1"	"Immune cell enhanced"	"Detected in some"		"classical monocyte: 1.8"	"Lineage enriched"	"Detected in single"	4	"monocytes: 1.8"	"Group enriched"	"Detected in many"	9	"ASC diff: 2284.0;ASC TERT1: 813.2;BJ hTERT+: 1949.1"	"Low region specificity"	"Detected in all"							HPA050346			Supported	Vesicles	"Intracellular and membrane"	NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	Vesicles		"HPA050346: AB_2681101"	"unprognostic (1.48e-1)"	"unprognostic (9.29e-2)"	"unprognostic (1.21e-1)"	"unprognostic (7.61e-3)"	"unprognostic (5.08e-2)"	"unprognostic (6.57e-2)"	"unprognostic (1.02e-1)"	"unprognostic (6.60e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.49e-1)"	"unprognostic (3.54e-2)"	"prognostic unfavorable (7.12e-5)"	"unprognostic (6.07e-3)"	"unprognostic (2.98e-2)"	"unprognostic (5.93e-3)"	"unprognostic (6.41e-2)"	224.1	12.5	2.7	33.1	2.8	3.1	227.7	2.9	18.1	420.6	16.4	68.6	13.8	334.0	44.9	46.0	74.0	299.2	35.8	2.7	2.6	12.7	9.0	36.4	42.1	2.7	2.7	78.4	10.6	6.1	14.6	18.9	2.6	34.1	61.8	6.9	53.3	38.0	15.7	219.8	63.8	141.6	2.8	20.2	41.7	15.1	2.7	12.3	34.7	46.3	48.7	210.5	176.2	2.9	0.7	0.3	1.4	0.8	2284.0	813.2	1.0	55.2	1949.1	3.3	8.3	0.3	0.3	0.4	0.6	129.8	0.0	0.6	0.3	0.4	1.2	0.4	0.4	1.4	0.5	0.0	11.0	0.2	1.3	156.5	1.7	50.5	0.7	137.6	4.2	0.6	0.4	1.4	1.5	1.4	0.0	3.0	10.2	1.0	0.0	0.2	0.1	0.1	3.2	0.1	0.6	2.9	0.4	0.0	29.3	3.9	1.0	1.5	1.0	0.7	0.5	0.6	0.6	2.3	1.7	3.6	184.1	0.0	9.9	0.0	1.8	0.2	0.0	1.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.3	0.2	0.4	0.6	2.7	2.8	2.9	18.1	2.7	2.6	2.7	2.7	2.6	2.8	2.7	2.9	17.9	3.2	4.6	2.6	1.1	68.8	0.5	1.6	2.2	12.1	3.7	9.5	2.0	1.5	3.9	3.7	4.2	1.3	2.8	1.5	0.0	1.0	0.9	2.5	59.0	10.2	1.2	0.8	5.0	0.2	2.5	372.4	11.2	3.8	0.0	77.5	14.6	0.5	21.4	3.3	7.7	1.6	8.2	4.6	123.6	4.4	119.0	8.7	97.8	7.5	4.9	2.7	3.1	7.1	2.5	1.4	1.4	149.7	0.8	1.0	1.4	0.1	2.2	7.7	13.1	4.5	33.9	1.4	1.0	2.6	59.1	1.0	5.4	80.9	1.0	0.7
CTSL	"CTSL1, FLJ31037"	ENSG00000135047	"Cathepsin L"	P07711	9	87724051-87731469	"Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Protease, Thiol protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 563.6"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 1081.6;Extravillous trophoblasts: 1012.3;Hepatic stellate cells: 580.4;Hofbauer cells: 1105.7;Macrophages: 537.2;Syncytiotrophoblasts: 1543.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	10	"intermediate monocyte: 128.1;non-classical monocyte: 195.2"	"Lineage enriched"	"Detected in many"	12	"monocytes: 195.2"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 2305.0;HSkMC: 1061.0"					"Low region specificity"	"Detected in all"			"CAB000459, HPA070413"	Enhanced		Approved	"Golgi apparatus,Vesicles"	"Intracellular and membrane"	NA	NA		17000000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 4: Macrophages - Innate immune response"	"Golgi apparatus, Vesicles"		"CAB000459: AB_2292484, HPA070413: "	"unprognostic (1.05e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.24e-2)"	"unprognostic (1.53e-1)"	"prognostic unfavorable (3.73e-4)"	"unprognostic (1.19e-3)"	"unprognostic (8.12e-3)"	"prognostic unfavorable (5.15e-5)"	"unprognostic (2.09e-1)"	"unprognostic (3.15e-1)"	"unprognostic (6.80e-2)"	"unprognostic (3.21e-1)"	"prognostic favorable (4.34e-4)"	"unprognostic (5.64e-3)"	"unprognostic (2.26e-2)"	"unprognostic (1.72e-1)"	"unprognostic (7.11e-3)"	232.4	86.6	49.2	136.0	55.4	84.8	110.0	52.9	67.5	69.5	67.9	110.3	39.7	108.1	81.6	33.3	108.4	85.0	112.5	47.0	52.3	207.3	333.5	154.9	101.1	54.4	54.0	96.4	61.9	151.1	69.5	563.6	57.5	68.2	58.8	32.3	77.6	91.7	71.9	39.8	57.1	125.2	52.4	124.4	71.4	80.1	112.2	33.0	76.1	79.8	49.4	209.8	48.0	59.6	88.1	423.0	32.6	55.3	514.0	2305.0	198.4	267.2	781.8	232.2	300.6	43.0	86.3	0.0	128.9	355.4	754.0	67.5	49.8	86.0	198.4	1.9	37.8	18.1	111.2	105.1	352.6	0.1	51.4	1061.0	138.9	373.7	134.9	186.6	194.9	0.0	162.5	0.7	326.6	115.6	0.5	9.9	67.7	128.6	77.5	21.6	21.5	0.6	158.6	39.0	42.8	50.6	62.1	133.5	312.3	177.9	14.5	97.9	296.9	190.8	104.7	750.6	125.9	18.5	84.1	0.9	692.6	0.2	67.9	0.3	13.5	0.6	0.3	128.1	0.0	0.0	6.6	0.1	7.9	0.1	16.7	1.3	0.5	0.2	195.2	0.3	1.7	10.1	49.2	55.4	52.9	67.5	47.0	52.3	54.4	54.0	57.5	52.4	112.2	59.6	86.1	41.7	52.9	15.3	11.2	37.7	82.1	58.0	15.4	43.8	12.2	33.4	96.8	87.2	46.4	75.4	18.8	1081.6	0.3	16.3	27.4	91.8	5.3	48.1	119.9	110.0	11.5	251.2	18.6	93.4	1012.3	261.7	10.2	27.6	29.7	63.6	580.4	122.6	1105.7	13.5	24.0	8.5	20.3	206.9	105.4	17.4	156.9	537.2	64.0	14.0	16.2	79.5	0.0	17.6	31.7	67.2	5.6	187.3	1.9	34.5	8.0	138.3	67.3	45.4	92.1	176.9	136.3	207.4	60.5	6.8	34.0	1543.6	10.8	30.8	11.7	44.8
CTSZ	CTSX	ENSG00000101160	"Cathepsin Z"	Q9UBR2	20	58985686-59008238	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 1078.9;Langerhans cells: 983.5;Macrophages: 652.3;monocytes: 723.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 542.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB025114, HPA049876, HPA053504"	Supported		Supported	Vesicles	"Intracellular and membrane"	NA	NA		88000000	"Cluster 49: Eosinophils - Unknown function"	"Cluster 64: Macrophages - Immune response"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 41: Macrophages - Immune response"	Vesicles		"CAB025114: , HPA049876: AB_2680927, HPA053504: AB_2682172"	"unprognostic (7.30e-2)"	"unprognostic (3.98e-2)"	"unprognostic (4.07e-2)"	"unprognostic (1.11e-3)"	"unprognostic (8.25e-3)"	"unprognostic (1.15e-1)"	"unprognostic (4.12e-2)"	"unprognostic (6.59e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.33e-1)"	"unprognostic (5.33e-2)"	"prognostic unfavorable (5.72e-5)"	"unprognostic (1.96e-1)"	"unprognostic (6.92e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.04e-1)"	178.1	117.8	18.9	208.8	21.8	99.8	137.0	20.5	32.0	92.1	59.6	173.8	215.4	87.3	13.4	53.1	88.9	89.4	152.6	15.3	33.9	125.6	356.4	233.3	271.5	31.6	23.5	71.0	89.4	91.8	112.5	118.7	27.9	87.8	77.1	4.1	181.0	66.3	58.7	58.5	226.0	97.9	26.2	234.4	88.2	24.6	47.2	57.1	122.3	54.6	91.3	146.3	69.0	45.4	205.4	139.8	1.1	1.1	114.2	124.2	106.5	291.0	225.4	187.4	152.3	231.6	324.6	96.5	213.9	542.1	0.5	160.1	51.4	257.5	30.2	362.1	13.6	80.3	169.0	0.8	137.3	9.0	331.0	130.9	127.8	83.1	62.4	34.8	281.3	1.1	74.0	48.7	90.0	1.1	1.3	70.6	11.5	43.5	158.2	2.9	0.4	135.7	86.3	25.5	2.7	1.7	222.4	258.4	0.8	19.5	131.9	148.4	420.5	1.4	161.8	209.0	2.0	253.7	172.0	18.2	2.8	207.9	0.4	1.2	1.5	1.6	0.6	1.4	0.4	1.1	0.6	0.4	1.1	1.4	0.7	0.8	1.6	0.5	2.9	1.8	0.3	0.7	18.9	21.8	20.5	32.0	15.3	33.9	31.6	23.5	27.9	26.2	47.2	45.4	132.1	16.0	5.3	5.9	119.8	50.3	64.5	33.8	24.5	6.7	67.4	99.6	21.7	62.9	14.1	71.7	0.0	38.2	104.8	303.6	23.5	176.0	3.5	52.9	47.7	82.2	27.1	63.3	5.3	42.4	104.8	71.5	19.4	71.3	10.8	68.4	62.8	363.0	1078.9	11.8	3.0	56.6	26.4	334.0	983.5	6.0	13.1	652.3	101.4	23.4	723.6	58.6	21.6	2.5	2.5	82.6	217.5	13.9	96.3	50.6	339.8	90.0	18.8	5.0	46.0	67.5	74.5	3.7	4.8	14.5	41.5	41.3	33.4	3.3	99.7	52.7
CTTN	EMS1	ENSG00000085733	Cortactin	Q14247	11	70398404-70436584	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	Endocytosis		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"basophil: 1.2;neutrophil: 2.1"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 2.1"	"Cell line enhanced"	"Detected in many"		"A-431: 450.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011235, HPA057242"	Supported		Supported	"Golgi apparatus,Vesicles,Plasma membrane,Cytosol"		NA	NA		11000000	"Cluster 34: Basophils - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	"Plasma membrane, Cytosol"	"Golgi apparatus, Vesicles"	"CAB011235: , HPA057242: AB_2683379"	"unprognostic (6.34e-2)"	"unprognostic (2.65e-2)"	"unprognostic (2.05e-1)"	"unprognostic (3.13e-2)"	"unprognostic (5.81e-2)"	"prognostic unfavorable (2.19e-6)"	"prognostic unfavorable (4.45e-4)"	"unprognostic (6.10e-2)"	"unprognostic (2.39e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.25e-3)"	"unprognostic (1.20e-1)"	"unprognostic (1.50e-2)"	"unprognostic (6.97e-2)"	"unprognostic (2.79e-1)"	"unprognostic (3.72e-3)"	"unprognostic (1.94e-1)"	91.7	142.5	28.3	15.6	30.0	4.9	82.9	29.7	32.3	112.3	28.5	84.9	28.4	117.8	18.7	131.6	85.0	35.1	106.9	27.7	28.2	109.6	66.9	74.8	9.0	33.2	30.8	112.9	79.5	18.1	94.1	23.9	30.9	101.6	23.8	8.4	92.9	27.0	65.7	104.4	70.9	31.8	29.5	53.3	92.2	62.0	30.3	8.7	89.5	14.5	12.7	88.1	101.2	32.5	450.2	97.2	32.0	37.2	53.2	81.9	52.5	93.8	92.5	80.7	63.4	129.5	110.3	17.5	90.6	121.1	86.3	97.3	38.6	98.7	58.7	35.5	39.1	1.7	73.6	61.1	113.9	0.4	22.6	116.6	68.0	89.4	50.2	84.4	68.8	0.5	51.3	3.3	80.9	122.9	0.9	6.4	35.0	163.4	58.6	0.2	39.3	14.3	90.5	143.7	26.3	44.9	68.3	93.2	158.0	57.2	75.8	1.9	86.8	70.8	45.3	111.2	63.6	7.4	5.2	1.0	141.1	0.4	98.9	1.2	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.2	0.0	2.1	0.0	0.1	0.4	0.0	6.8	28.3	30.0	29.7	32.3	27.7	28.2	33.2	30.8	30.9	29.5	30.3	32.5	95.3	44.8	51.8	61.7	4.0	151.9	102.8	85.8	46.1	39.4	81.0	57.9	64.1	80.1	95.4	134.3	18.8	83.8	1.6	224.4	64.6	146.5	12.4	86.4	84.8	89.9	74.4	18.9	93.4	221.5	95.6	89.1	76.0	116.1	6.3	117.7	78.9	44.1	10.4	38.7	65.4	123.8	57.0	8.9	34.1	26.1	103.2	38.6	122.7	28.1	5.9	42.5	0.0	40.2	145.8	260.6	177.8	98.9	3.1	153.5	108.4	164.3	89.4	32.5	59.2	61.0	87.5	32.0	47.0	76.7	174.9	106.3	5.4	91.4	111.9	258.1
CTU2	"C16orf84, NCS2"	ENSG00000174177	"Cytosolic thiouridylase subunit 2"	Q2VPK5	16	88706483-88715396	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"tRNA processing"		"Primary microcephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041135, HPA041894"	Uncertain		Supported	Mitochondria		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 35: Non-specific - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"HPA041135: AB_10794543, HPA041894: AB_10796463"	"unprognostic (4.19e-1)"	"unprognostic (3.62e-2)"	"unprognostic (5.19e-2)"	"unprognostic (5.77e-2)"	"unprognostic (3.00e-2)"	"unprognostic (5.96e-2)"	"prognostic unfavorable (5.68e-4)"	"unprognostic (4.83e-2)"	"unprognostic (1.56e-1)"	"unprognostic (4.43e-2)"	"unprognostic (1.19e-3)"	"unprognostic (2.90e-2)"	"unprognostic (1.25e-2)"	"unprognostic (3.03e-2)"	"unprognostic (5.83e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.74e-1)"	9.7	9.6	8.8	5.0	8.7	6.2	8.8	7.9	13.8	10.2	6.5	9.9	4.2	11.6	2.0	8.7	9.5	3.5	11.8	9.1	7.5	9.7	12.5	7.9	6.1	9.6	8.1	10.5	11.3	3.6	11.3	3.2	8.5	8.8	1.6	1.4	8.0	3.7	19.1	8.7	7.6	3.4	7.5	9.4	9.6	10.9	8.2	4.0	10.3	5.4	3.4	9.9	8.1	10.5	14.9	22.9	8.8	19.4	7.3	7.5	21.8	15.2	11.4	16.6	8.1	27.2	14.0	21.7	19.8	9.8	7.8	14.7	14.8	14.9	4.5	6.8	44.6	14.9	9.8	27.8	12.4	15.1	10.8	8.5	10.8	13.1	13.9	6.0	14.1	13.1	56.5	6.3	6.3	40.0	42.0	34.9	13.7	12.9	36.9	33.0	6.6	23.4	5.8	5.8	29.0	14.0	24.2	4.6	9.7	5.3	13.8	15.6	15.9	17.5	22.1	19.2	16.8	19.4	10.5	61.7	15.1	32.1	19.6	1.1	5.5	0.0	7.3	6.9	6.0	5.5	6.6	7.3	6.8	5.8	6.4	5.5	0.4	7.5	6.0	6.4	4.1	4.2	8.8	8.7	7.9	13.8	9.1	7.5	9.6	8.1	8.5	7.5	8.2	10.5	6.5	0.0	4.4	2.3	10.0	13.8	12.2	7.8	5.2	12.5	7.3	7.2	2.5	10.0	7.8	1.8	6.2	11.0	15.7	8.4	11.7	8.8	12.1	4.0	7.1	6.6	5.4	3.8	2.9	13.6	16.2	8.6	11.2	4.9	0.0	9.9	3.6	6.7	9.9	13.5	2.3	7.1	4.1	1.9	4.0	7.0	8.1	6.7	5.4	1.0	5.0	4.4	7.2	0.5	2.7	8.9	8.2	9.8	15.5	17.2	9.6	7.8	4.7	8.7	0.0	8.9	11.1	25.6	25.7	6.5	10.7	8.1	9.5	10.8	10.5	8.9
CU639417.1		ENSG00000274559	"Histone H2B type F-S-like"		21	5972924-5973383	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Low tissue specificity"	"Detected in single"			"Cell type enhanced"	"Detected in some"		"Enteroendocrine cells: 1.8;Intestinal goblet cells: 1.4;Paneth cells: 2.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HMC-1: 1.2;T-47d: 2.2;U-2 OS: 1.6;U-266/70: 1.2;U-266/84: 2.2"									"HPA042205, HPA043013, HPA048671"	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 16: U-266 - Nucleosome"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm	Cytosol	"HPA042205: AB_2677900, HPA043013: AB_2678269, HPA048671: AB_2680488"										"unprognostic (3.37e-2)"				"unprognostic (2.63e-1)"				0.5	0.3	0.1	0.0	0.0	0.1	0.4	0.0	0.1	0.6	0.0	0.4	0.1	0.5	0.5	0.6	0.3	1.3	0.4	0.0	0.1	0.7	0.9	0.5	0.7	0.0	0.0	0.3	0.5	0.0	0.2	0.0	0.1	0.5	0.0	0.0	0.3	0.0	0.1	0.4	0.4	0.0	0.0	0.6	0.4	0.5	0.0	0.0	0.4	0.0	0.0	0.4	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.1	0.0	0.4	0.2	0.4	0.0	0.0	0.4	0.4	0.0	0.2	0.6	0.0	0.5	0.3	0.0	0.0	0.7	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.1	0.2	0.0	0.1	0.0	1.1	0.3	0.0	0.4	0.1	0.0	0.4	0.1	0.0	2.2	0.0	0.0	0.0	1.6	0.1	0.2	1.2	2.2	0.2	0.3	0.4	0.4	0.6	0.1	0.8	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.5	0.0	0.0	0.6	0.1	0.3	0.3	0.2	0.2	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0
CUL1		ENSG00000055130	"Cullin 1"	Q13616	7	148697914-148801110	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, Ubl conjugation pathway"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"Early spermatids: 466.3;Late spermatids: 567.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002676, HPA064584"	Supported		Supported	Nucleoplasm,Nucleoli		NA	NA		220000	"Cluster 27: Non-specific - Gene expression"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 25: Spermatids - Spermatogenesis"	Nucleoplasm	Nucleoli	"CAB002676: , HPA064584: AB_2685294"	"unprognostic (3.59e-2)"	"unprognostic (1.23e-1)"	"unprognostic (5.23e-1)"	"unprognostic (1.19e-1)"	"unprognostic (5.06e-3)"	"unprognostic (9.45e-2)"	"unprognostic (1.41e-2)"	"unprognostic (8.23e-2)"	"unprognostic (2.40e-2)"	"unprognostic (3.65e-2)"	"unprognostic (3.40e-2)"	"unprognostic (2.84e-2)"	"unprognostic (2.18e-2)"	"unprognostic (3.88e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.40e-1)"	"unprognostic (7.24e-3)"	33.2	27.3	19.6	29.4	20.9	15.5	30.2	20.4	26.5	28.1	22.2	38.9	23.0	29.8	28.8	30.6	29.4	23.2	35.9	22.1	23.0	21.6	45.1	26.3	39.0	20.4	21.2	30.9	20.6	36.3	25.6	32.7	20.4	27.3	24.5	52.1	26.1	30.1	88.8	28.8	27.3	32.2	21.8	30.0	29.7	95.1	21.3	30.3	27.4	74.6	35.6	34.9	26.6	21.7	79.9	61.6	59.5	93.6	46.6	51.6	72.8	64.8	77.7	65.8	61.4	64.5	53.9	109.6	49.5	65.9	104.4	52.5	87.0	59.9	76.4	72.8	71.9	65.2	39.6	64.5	50.5	74.8	58.9	40.0	58.5	45.9	46.0	59.9	71.3	52.8	100.8	78.2	72.2	76.4	64.1	81.0	111.6	68.6	58.8	78.7	52.3	106.3	54.2	55.4	83.3	61.0	74.5	92.3	51.4	69.9	29.0	57.5	56.6	44.1	15.4	87.7	75.8	70.4	54.2	96.7	94.3	82.5	66.2	15.5	17.0	14.1	16.5	18.3	21.8	17.3	18.9	21.2	26.6	15.0	22.4	18.5	1.4	27.9	18.5	6.7	18.5	20.0	19.6	20.9	20.4	26.5	22.1	23.0	20.4	21.2	20.4	21.8	21.3	21.7	24.0	35.3	40.9	41.4	26.0	27.9	31.1	19.5	22.2	33.4	13.8	17.5	29.2	12.8	32.2	9.2	29.2	66.6	19.1	12.0	17.6	28.1	466.3	20.4	23.4	25.1	15.6	23.1	76.3	26.2	77.1	29.9	19.4	21.9	23.4	31.6	18.5	41.5	29.8	21.9	89.5	19.7	22.4	18.5	16.8	567.7	21.8	25.7	28.4	60.9	51.7	32.7	37.0	52.8	74.3	28.5	15.0	30.5	25.3	29.8	11.7	13.5	33.6	48.9	32.9	30.3	38.9	59.6	34.0	20.6	25.4	73.2	26.5	24.1	18.8	21.7
CUTC	CGI-32	ENSG00000119929	"CutC copper transporter"	Q9NTM9	10	99702558-99756134	"Predicted intracellular proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	7	"skeletal muscle: 385.5;tongue: 204.2"	"Cell type enriched"	"Detected in all"	4	"Spermatocytes: 163.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038619, HPA058231"	Enhanced		Enhanced	Nucleoplasm,Nucleoli,Cytosol		No	No			"Cluster 5: Granulocytes - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 32: U-937 - Innate immune response"	"Cluster 50: Fibroblasts - ECM organization"	"Nucleoplasm, Cytosol"	Nucleoli	"HPA038619: AB_10672649, HPA058231: "	"unprognostic (1.25e-2)"	"unprognostic (5.92e-2)"	"unprognostic (2.70e-1)"	"unprognostic (8.66e-2)"	"unprognostic (7.39e-2)"	"unprognostic (1.39e-1)"	"unprognostic (3.55e-3)"	"unprognostic (8.67e-2)"	"unprognostic (5.36e-2)"	"unprognostic (1.81e-1)"	"unprognostic (5.87e-2)"	"unprognostic (2.06e-1)"	"prognostic unfavorable (3.81e-7)"	"unprognostic (1.00e-1)"	"unprognostic (3.42e-2)"	"unprognostic (2.41e-1)"	"unprognostic (3.97e-1)"	38.7	15.5	19.3	14.6	21.9	23.6	27.3	20.8	25.9	17.3	17.3	19.4	11.1	14.7	11.0	16.0	17.1	12.1	41.7	18.7	20.7	13.5	30.2	15.1	22.3	21.0	20.6	12.6	14.2	8.6	7.8	11.3	21.3	16.1	15.9	28.3	16.9	11.2	385.5	18.6	20.9	14.4	20.1	28.6	18.6	43.4	20.3	23.9	13.2	204.2	19.7	43.8	16.7	25.0	27.4	57.7	19.9	60.7	71.8	32.8	10.8	22.0	28.0	21.6	24.2	26.7	20.5	98.9	19.1	37.5	10.6	22.9	40.8	36.6	23.9	29.5	39.0	32.9	26.1	42.7	33.2	61.5	15.5	34.0	22.3	34.5	71.1	26.8	37.8	56.2	29.6	21.4	16.4	19.4	55.7	63.2	20.0	27.7	21.4	37.5	23.3	38.3	22.8	11.2	6.5	14.8	10.1	15.9	28.9	27.1	25.3	34.7	21.2	9.0	12.2	9.9	29.5	34.7	48.5	69.6	29.4	130.0	8.2	70.6	42.6	111.7	56.9	35.2	60.0	73.4	53.9	54.9	47.1	66.5	74.4	57.2	68.6	63.1	46.0	54.2	57.0	45.3	19.3	21.9	20.8	25.9	18.7	20.7	21.0	20.6	21.3	20.1	20.3	25.0	26.3	9.6	12.5	15.3	32.8	12.1	14.7	23.1	5.7	18.7	12.6	15.2	40.6	14.3	14.9	5.5	8.4	18.6	23.2	4.6	21.5	16.9	12.6	11.4	12.0	19.8	12.1	28.2	8.5	17.4	13.5	32.8	10.7	8.3	30.4	14.4	27.5	23.4	20.9	11.8	9.0	7.4	12.2	17.0	11.7	10.8	13.1	16.6	30.2	7.5	28.0	25.9	21.6	8.0	26.9	10.5	7.4	16.1	27.2	16.1	19.2	34.8	21.5	33.0	19.7	27.1	15.5	163.3	36.7	14.3	10.9	13.5	25.6	36.3	9.6	11.6
CUX1	"CASP, CDP, CDP/Cut, CDP/Cux, CDP1, Clox, CUT, CUTL1, CUX, Cux/CDP, GOLIM6"	ENSG00000257923	"Cut like homeobox 1"	"P39880, Q13948"	7	101815904-102283958	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transcription factors"	"Transcription, Transcription regulation, Transport"	"Developmental protein, DNA-binding, Repressor"	"Cancer-related genes, Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"non-classical monocyte: 35.0"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003277, HPA003317"	Approved		Supported	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 36: Stromal cells - Cell proliferation"	"Nucleoplasm, Golgi apparatus"		"HPA003277: AB_10601804, HPA003317: AB_2666891"	"unprognostic (5.86e-2)"	"unprognostic (5.39e-3)"	"unprognostic (9.62e-3)"	"unprognostic (1.73e-1)"	"prognostic unfavorable (7.51e-4)"	"unprognostic (5.85e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.89e-3)"	"unprognostic (2.20e-1)"	"unprognostic (2.50e-1)"	"prognostic favorable (5.72e-7)"	"unprognostic (1.12e-1)"	"unprognostic (8.85e-2)"	"unprognostic (1.97e-2)"	"unprognostic (2.97e-1)"	30.5	18.0	23.8	24.8	33.6	33.4	17.9	54.0	48.2	35.5	28.0	40.5	33.7	60.9	16.9	32.6	35.3	31.7	82.8	21.5	23.3	40.0	23.2	33.1	19.4	30.8	27.5	46.9	63.3	46.0	24.6	23.1	27.4	30.7	25.3	19.2	36.1	23.2	45.5	24.0	37.3	40.8	26.2	16.9	35.3	9.6	29.3	34.7	49.4	38.8	20.6	32.4	24.8	30.5	41.8	44.0	30.3	37.7	24.1	49.3	18.4	41.1	43.0	17.0	10.9	26.2	26.2	53.6	64.2	40.8	31.3	33.4	19.4	32.9	10.1	25.9	21.8	18.8	32.8	22.2	63.7	24.7	9.9	34.6	65.9	13.1	29.5	48.7	22.3	34.0	44.5	44.2	16.3	85.9	80.8	30.1	12.3	64.0	45.4	52.6	25.1	64.4	27.6	46.5	27.7	82.6	35.8	88.4	35.4	25.1	17.4	29.0	33.5	71.2	47.8	54.4	23.7	28.8	14.5	114.7	65.8	22.3	50.8	3.3	13.9	2.3	3.1	13.4	3.0	2.9	2.3	3.1	10.8	2.4	2.2	3.1	7.0	4.5	35.0	18.2	2.2	8.4	23.8	33.6	54.0	48.2	21.5	23.3	30.8	27.5	27.4	26.2	29.3	30.5	33.7	99.3	60.5	78.4	35.3	26.3	30.9	30.9	33.6	67.2	23.9	17.1	110.5	31.5	40.3	40.5	68.8	54.6	59.6	69.2	9.8	34.4	9.5	50.6	165.2	42.1	42.5	50.0	129.0	24.0	55.5	51.8	62.2	85.0	12.0	97.8	37.5	36.1	32.8	53.8	116.2	48.7	38.7	70.2	42.5	9.4	41.3	75.4	17.8	139.6	65.2	47.7	32.0	96.0	117.5	34.1	50.2	60.9	46.0	55.5	42.9	64.5	37.9	57.3	26.3	105.2	56.6	13.5	14.4	39.9	43.3	88.0	25.7	34.7	46.0	43.8
CWC22	"EIF4GL, fSAPb, KIAA1604, NCM"	ENSG00000163510	"CWC22 spliceosome associated protein homolog"	Q9HCG8	2	179944876-180007297	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036748	Approved		Supported	"Nuclear speckles,Cytosol"		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 50: Fibroblasts - ECM organization"	"Nuclear speckles"	Cytosol	"HPA036748: AB_10669913"	"unprognostic (1.90e-1)"	"unprognostic (7.10e-2)"	"unprognostic (7.30e-2)"	"unprognostic (6.14e-2)"	"unprognostic (4.96e-2)"	"unprognostic (4.33e-2)"	"prognostic unfavorable (7.42e-4)"	"unprognostic (3.15e-1)"	"unprognostic (1.31e-2)"	"unprognostic (3.30e-2)"	"unprognostic (3.84e-2)"	"unprognostic (4.80e-2)"	"prognostic unfavorable (7.76e-5)"	"unprognostic (1.74e-1)"	"unprognostic (3.03e-2)"	"unprognostic (1.41e-1)"	"unprognostic (9.44e-3)"	12.7	10.2	7.1	13.1	7.8	16.0	15.0	13.5	10.1	14.1	7.1	11.9	10.1	16.9	10.4	12.5	12.0	12.1	10.1	7.6	7.2	13.4	16.8	11.5	18.5	6.4	6.9	19.3	9.2	13.5	8.2	14.5	7.0	12.5	11.8	12.4	10.2	10.9	13.6	11.0	10.4	13.9	7.1	14.7	11.0	9.0	7.0	21.8	16.0	14.5	18.2	14.1	12.1	8.9	19.1	11.2	31.6	21.1	22.7	26.7	24.1	24.5	28.7	29.4	28.7	25.9	23.1	36.7	21.6	17.9	25.6	20.5	30.4	23.1	44.2	33.0	26.2	49.1	15.1	35.4	22.0	69.6	26.2	17.5	27.1	37.4	49.8	19.3	22.3	25.2	54.6	21.9	19.7	18.9	36.5	34.7	48.8	22.5	18.3	32.8	38.9	27.7	20.2	23.5	21.6	28.8	20.3	15.9	28.5	33.8	11.8	42.2	19.0	25.1	21.2	16.8	25.7	19.2	21.5	44.3	22.6	27.2	26.1	49.7	13.3	31.4	16.1	16.7	16.3	17.4	17.3	19.5	13.9	14.5	21.1	16.7	22.0	16.0	13.3	8.6	16.5	11.5	7.1	7.8	13.5	10.1	7.6	7.2	6.4	6.9	7.0	7.1	7.0	8.9	38.0	19.2	33.8	20.5	38.0	19.1	29.2	16.9	22.2	19.5	12.9	19.8	26.6	22.8	27.0	11.0	25.0	18.3	36.5	11.8	9.8	23.4	1.6	24.2	31.9	27.2	15.6	14.9	35.8	19.1	17.5	32.5	19.9	25.1	27.3	24.7	16.8	12.8	13.7	13.5	28.4	16.4	14.2	20.6	12.1	2.4	23.3	24.2	3.6	15.0	31.6	17.3	30.9	35.2	35.1	18.7	17.6	18.4	20.8	16.8	15.7	20.3	34.4	19.1	46.0	40.3	25.1	22.8	21.3	14.1	18.6	24.8	32.5	18.6	15.6	19.5
CX3CL1	"ABCD-3, C3Xkine, CXC3, CXC3C, NTN, SCYD1"	ENSG00000006210	"C-X3-C motif chemokine ligand 1"	P78423	16	57372477-57385044	"Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"	"Cell adhesion, Chemotaxis, Host-virus interaction, Inflammatory response"	Cytokine		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"breast: 104.8"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 115.4;Basal prostatic cells: 50.8;Basal respiratory cells: 51.8;Breast glandular cells: 62.3;Breast myoepithelial cells: 51.1;Club cells: 54.8;Endothelial cells: 50.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"EFO-21: 30.1;HDLM-2: 86.0;Hep G2: 63.8;RPTEC TERT1: 36.5;SK-BR-3: 21.5"	"Low region specificity"	"Detected in all"							"CAB026192, HPA040361"	Approved		Supported	"Plasma membrane"	"Secreted to blood"	NA	NA	1870000	370000		"Cluster 82: Adipose tissue - ECM organization"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Plasma membrane"		"CAB026192: , HPA040361: AB_10796453"	"unprognostic (6.89e-3)"	"prognostic favorable (9.46e-4)"	"unprognostic (1.52e-2)"	"unprognostic (3.20e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.82e-1)"	"unprognostic (7.12e-2)"	"unprognostic (2.08e-3)"	"unprognostic (4.49e-2)"	"unprognostic (3.70e-1)"	"unprognostic (2.59e-2)"	"unprognostic (2.06e-2)"	"prognostic favorable (8.52e-7)"	"unprognostic (5.19e-2)"	"unprognostic (2.72e-1)"	"unprognostic (1.11e-2)"	"unprognostic (9.33e-2)"	68.3	4.8	36.4	5.7	39.5	0.1	104.8	11.9	44.8	17.6	19.8	14.3	5.1	13.7	8.7	14.4	18.2	21.0	43.0	46.9	26.4	41.9	14.9	98.8	8.5	25.1	24.8	8.3	13.1	7.1	11.2	3.9	23.6	42.2	5.4	4.3	70.8	45.3	15.0	27.3	12.8	10.6	21.8	1.4	14.5	5.7	30.5	5.2	29.7	19.2	6.2	33.0	17.3	31.2	0.0	0.8	8.0	6.8	0.3	0.1	2.0	0.1	0.0	0.0	0.1	3.1	0.0	0.0	30.1	0.1	4.3	0.3	0.0	0.1	0.0	86.0	0.4	0.0	0.0	63.8	0.9	0.0	0.1	0.9	0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.4	2.8	0.1	0.0	0.1	1.1	0.2	36.5	0.2	0.2	7.1	0.0	21.5	1.9	5.1	0.1	0.2	0.1	0.3	4.7	0.2	2.1	0.1	0.0	0.0	0.1	0.0	1.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	36.4	39.5	11.9	44.8	46.9	26.4	25.1	24.8	23.6	21.8	30.5	31.2	115.4	3.2	4.6	3.3	1.2	4.5	50.8	51.8	31.9	9.8	62.3	51.1	8.3	21.5	54.8	3.7	4.2	0.0	0.8	0.5	0.0	35.1	0.4	12.9	3.3	50.7	1.8	0.0	28.1	1.8	0.1	9.0	0.5	27.3	1.3	0.2	6.1	11.7	0.0	5.0	20.5	0.3	20.3	0.8	4.7	0.5	4.7	0.6	0.0	16.9	0.6	0.8	0.0	13.0	3.2	4.3	0.6	27.8	0.0	29.7	0.2	11.8	28.8	2.2	13.1	2.8	15.7	0.1	0.1	10.3	2.6	0.3	0.8	0.3	1.0	32.6
CXXC5	"HSPC195, RINF, WID"	ENSG00000171604	"CXXC finger protein 5"	Q7LFL8	5	139647299-139683882	"Predicted intracellular proteins"	Transcription	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal tubular cells: 317.0;Early spermatids: 714.2;Horizontal cells: 541.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	7	"MAIT T-cell: 30.0;memory B-cell: 85.1;naive B-cell: 96.7;NK-cell: 71.9;plasmacytoid DC: 59.0"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SK-BR-3: 210.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036508, HPA058148"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 29: Early spermatids - Spermatogenesis"	Nucleoplasm	Cytosol	"HPA036508: AB_10673620, HPA058148: AB_2683621"	"unprognostic (3.08e-2)"	"unprognostic (9.03e-2)"	"prognostic favorable (2.40e-4)"	"prognostic unfavorable (4.10e-7)"	"unprognostic (2.91e-1)"	"unprognostic (2.05e-1)"	"unprognostic (1.11e-3)"	"unprognostic (2.28e-2)"	"unprognostic (2.12e-1)"	"unprognostic (2.72e-1)"	"unprognostic (2.26e-1)"	"unprognostic (2.79e-2)"	"unprognostic (2.63e-2)"	"unprognostic (8.02e-2)"	"unprognostic (1.44e-1)"	"unprognostic (7.26e-2)"	"unprognostic (1.57e-1)"	26.5	20.6	48.9	17.6	65.6	46.9	21.5	103.6	64.5	29.2	36.4	17.5	10.8	15.1	30.0	25.6	29.8	20.1	30.4	56.2	48.2	70.7	88.1	16.1	30.2	91.5	65.1	5.0	61.2	28.0	43.6	15.9	84.0	15.3	11.6	38.7	53.9	18.3	80.1	24.8	22.5	9.1	66.5	34.5	21.0	51.8	61.4	34.3	22.5	21.5	24.7	14.8	23.9	106.4	36.5	30.1	32.6	12.3	44.5	60.6	12.7	23.3	35.3	9.9	19.5	66.8	36.0	47.4	101.0	62.5	59.7	40.5	6.7	17.9	4.7	5.2	11.5	70.5	25.8	47.0	19.2	16.0	1.8	21.8	4.0	16.7	4.8	95.6	2.7	1.5	67.8	7.6	72.6	94.7	17.2	51.1	39.4	39.2	8.5	30.8	66.5	73.5	75.3	26.0	103.0	106.3	8.3	210.6	18.0	71.2	115.5	74.2	14.6	80.2	15.6	38.8	21.4	27.3	62.4	89.9	121.2	5.3	45.6	1.1	6.6	0.6	9.7	1.4	30.0	85.1	0.9	6.8	5.5	96.7	0.5	2.6	1.8	71.9	0.6	59.0	1.4	10.7	48.9	65.6	103.6	64.5	56.2	48.2	91.5	65.1	84.0	66.5	61.4	106.4	22.9	48.1	18.8	24.5	120.4	26.3	14.8	41.9	8.6	232.0	41.0	67.8	49.3	105.8	32.5	147.1	25.0	2.9	90.2	18.6	317.0	125.1	714.2	47.1	53.9	43.6	18.6	52.2	18.7	144.9	23.9	47.8	24.5	53.7	21.5	41.9	36.0	131.8	38.4	541.8	8.7	50.7	61.1	35.6	92.1	200.3	39.1	32.2	60.5	15.0	40.9	220.5	195.7	16.6	44.3	93.9	17.5	30.5	114.1	34.1	22.6	200.0	38.6	49.1	13.1	150.9	48.5	14.2	13.9	15.7	20.9	37.6	21.1	25.1	27.0	21.4
CYB5R3	DIA1	ENSG00000100243	"Cytochrome b5 reductase 3"	P00387	22	42617840-42649392	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Cholesterol biosynthesis, Cholesterol metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism"	Oxidoreductase	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"ASC diff: 830.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001566	Approved		Supported	"Endoplasmic reticulum"		NA	NA		1500000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 48: Smooth muscle cells - ECM organization"	"Endoplasmic reticulum"		"HPA001566: AB_1078601"	"unprognostic (4.73e-2)"	"unprognostic (2.93e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.89e-1)"	"unprognostic (3.05e-1)"	"unprognostic (1.04e-2)"	"prognostic unfavorable (2.13e-5)"	"unprognostic (2.45e-1)"	"unprognostic (8.22e-3)"	"unprognostic (3.01e-1)"	"unprognostic (2.72e-2)"	"unprognostic (6.76e-2)"	"unprognostic (3.33e-3)"	"unprognostic (1.31e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.92e-1)"	"unprognostic (5.24e-2)"	404.4	310.5	147.1	87.4	152.9	82.7	272.2	145.7	189.9	237.3	115.0	192.4	94.8	248.4	58.8	152.4	174.0	139.5	374.3	138.7	163.9	182.9	279.4	201.3	76.3	194.7	174.2	218.3	89.1	62.0	137.4	107.8	169.9	181.4	74.9	27.3	149.8	239.3	203.0	233.6	138.1	200.2	154.8	101.4	182.0	142.7	156.7	54.0	157.8	140.5	72.3	216.7	210.0	160.2	125.5	78.6	126.6	78.6	830.9	654.7	74.4	359.2	330.0	262.2	232.4	104.0	95.6	58.8	156.6	668.8	113.8	112.4	85.3	178.0	133.7	63.9	187.3	83.6	127.3	202.4	211.0	118.4	149.5	397.4	138.1	188.9	124.5	190.8	220.0	74.0	73.5	296.3	361.9	137.9	116.8	108.4	51.0	129.2	142.7	84.9	153.8	131.3	202.0	90.6	56.1	73.2	118.6	113.2	134.0	92.6	90.6	112.0	340.9	282.0	175.3	192.3	137.9	78.3	91.2	72.4	328.8	67.8	237.9	126.3	104.0	300.3	75.9	135.3	76.6	110.1	72.8	83.9	154.0	102.7	50.8	54.0	53.8	63.5	176.7	140.8	95.0	86.4	147.1	152.9	145.7	189.9	138.7	163.9	194.7	174.2	169.9	154.8	156.7	160.2	238.5	86.6	62.2	17.0	51.7	110.1	95.5	184.8	27.3	16.7	52.3	73.2	106.4	105.8	100.9	60.7	4.2	110.0	37.0	90.5	49.0	216.4	4.8	51.4	82.9	161.5	83.7	113.9	12.3	107.0	199.3	183.4	38.2	65.4	62.8	57.8	180.2	230.4	108.3	16.8	16.1	45.8	142.4	50.6	112.0	17.0	253.9	67.7	176.1	25.3	112.5	91.0	33.0	7.1	26.4	156.8	85.6	280.6	36.7	82.3	116.9	110.8	53.3	18.4	190.7	62.5	202.5	23.8	45.5	57.5	112.7	117.9	43.0	233.1	55.2	96.4
CYBRD1	"CYB561A2, DCYTB, FLJ23462, FRRS3"	ENSG00000071967	"Cytochrome b reductase 1"	Q53TN4	2	171522247-171558129	"Enzymes, Metabolic proteins, Predicted membrane proteins, Transporters"	"Electron transport, Transport"	"Oxidoreductase, Translocase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 221.2;Fibroblasts: 243.4;Leydig cells: 202.0;Peritubular cells: 221.5;Proximal enterocytes: 689.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"classical monocyte: 17.4;intermediate monocyte: 17.7;myeloid DC: 16.8;neutrophil: 9.8;non-classical monocyte: 13.7"	"Group enriched"	"Detected in many"	4	"dendritic cells: 16.8;granulocytes: 9.8;monocytes: 17.7"	"Cell line enhanced"	"Detected in many"		"ASC diff: 1064.0;ASC TERT1: 453.8;BJ hTERT+: 408.2;HSkMC: 327.3;hTERT-RPE1: 276.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA014757	Approved		Supported	"Plasma membrane"		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 45: Enterocytes - Digestion"	"Plasma membrane"		"HPA014757: AB_1847374"	"unprognostic (1.35e-1)"	"unprognostic (1.57e-1)"	"unprognostic (2.89e-2)"	"unprognostic (4.87e-2)"	"unprognostic (2.97e-2)"	"unprognostic (3.11e-2)"	"unprognostic (2.86e-1)"	"unprognostic (5.44e-3)"	"unprognostic (8.90e-3)"	"unprognostic (3.57e-3)"	"unprognostic (1.74e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.02e-3)"	"unprognostic (1.93e-2)"	"unprognostic (8.48e-2)"	"unprognostic (2.77e-2)"	"unprognostic (1.51e-2)"	166.7	97.5	32.6	24.4	38.8	18.3	148.7	33.9	34.1	140.0	32.6	68.7	197.7	100.2	49.7	70.6	88.2	153.7	128.6	28.2	45.9	32.0	21.7	129.9	33.8	45.2	38.7	180.9	21.6	12.0	26.1	38.1	40.5	70.6	39.0	22.2	63.7	76.7	23.3	85.0	233.4	87.9	35.6	30.6	53.3	23.8	35.9	27.9	231.0	82.8	30.1	84.3	90.4	43.0	24.8	18.1	10.1	19.2	1064.0	453.8	1.3	88.3	408.2	45.0	56.4	1.1	33.8	0.0	14.8	214.2	46.2	12.2	8.4	7.2	53.2	18.9	2.2	20.7	26.1	0.4	222.7	22.0	1.9	327.3	68.8	70.5	13.7	276.3	29.6	12.4	7.0	0.2	128.3	0.0	7.1	20.4	5.1	0.0	4.6	2.5	125.3	1.5	7.0	1.4	1.3	4.7	104.2	0.2	56.5	3.6	35.8	13.5	59.5	101.0	14.4	96.1	38.3	0.3	0.4	0.2	49.5	18.3	55.6	0.0	17.4	0.8	1.6	17.7	0.3	0.0	0.3	0.2	16.8	0.0	0.0	0.0	9.8	3.6	13.7	0.7	0.0	7.5	32.6	38.8	33.9	34.1	28.2	45.9	45.2	38.7	40.5	35.6	35.9	43.0	37.6	221.2	109.0	45.1	0.9	121.2	47.3	20.3	38.7	0.0	54.7	48.0	18.4	37.1	34.7	25.8	0.0	1.9	3.4	16.1	0.0	1.0	1.5	4.2	35.6	33.9	0.0	85.0	0.9	6.4	2.3	243.4	13.3	8.3	2.5	1.6	73.5	2.4	48.5	0.0	1.5	22.2	2.0	60.7	92.0	6.1	202.0	28.4	44.4	36.5	29.3	27.9	4.1	12.1	54.2	1.8	16.2	221.5	2.2	22.5	689.4	0.3	6.9	1.5	19.7	89.6	49.9	1.2	1.2	7.0	60.1	1.4	5.9	2.8	27.6	18.2
CYFIP2	PIR121	ENSG00000055163	"Cytoplasmic FMR1 interacting protein 2"	Q96F07	5	157266079-157395595	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Apoptosis, Cell adhesion"		"Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 112.2;kidney: 139.9"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 133.5;Collecting duct cells: 158.2;Distal tubular cells: 174.1;Excitatory neurons: 117.7;Inhibitory neurons: 147.5;Oligodendrocyte precursor cells: 120.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 202.4;JURKAT: 145.2;MOLT-4: 204.8;U-266/70: 153.6;U-698: 142.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB055519, HPA068106, HPA071459"	Uncertain		Approved	"Endoplasmic reticulum,Plasma membrane,Cytosol"		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 59: Non-specific - Transcription"	"Endoplasmic reticulum"	"Plasma membrane, Cytosol"	"CAB055519: , HPA068106: AB_2685955, HPA071459: AB_2686400"	"unprognostic (1.02e-2)"	"unprognostic (1.30e-1)"	"unprognostic (7.07e-2)"	"prognostic unfavorable (2.42e-6)"	"unprognostic (3.76e-1)"	"unprognostic (4.58e-2)"	"unprognostic (1.14e-1)"	"unprognostic (6.91e-3)"	"unprognostic (3.97e-2)"	"unprognostic (5.25e-2)"	"prognostic favorable (1.18e-4)"	"unprognostic (3.81e-2)"	"prognostic favorable (3.21e-12)"	"unprognostic (2.90e-1)"	"unprognostic (1.38e-1)"	"unprognostic (3.03e-1)"	"unprognostic (2.49e-2)"	3.2	12.3	61.0	30.8	54.4	55.5	2.8	23.6	103.8	3.1	16.3	8.9	6.3	6.6	25.1	3.8	9.2	8.8	10.4	112.2	25.6	139.9	18.3	12.2	57.1	8.4	33.4	4.8	7.1	64.9	40.1	9.3	6.6	5.8	9.8	35.4	4.0	5.0	7.0	2.8	17.5	5.6	0.0	35.0	20.9	5.3	67.7	85.9	9.9	1.7	55.3	8.3	2.3	37.7	0.3	31.8	47.3	28.8	1.1	1.3	81.5	6.1	9.6	2.5	6.8	6.2	0.6	202.4	14.5	3.4	7.4	0.4	38.0	27.1	5.8	48.8	60.8	28.4	42.3	24.9	4.1	29.1	71.8	5.4	10.9	8.1	0.5	18.8	8.8	145.2	0.4	81.1	7.0	7.7	204.8	5.5	22.3	0.5	8.5	50.6	1.4	102.3	24.5	30.2	70.5	27.4	0.6	28.3	4.6	46.8	19.9	0.8	11.3	2.0	21.4	7.1	5.4	153.6	40.2	142.8	21.4	33.5	11.8	64.8	12.6	90.1	85.9	57.4	61.0	35.8	60.6	75.7	17.8	35.9	63.2	73.2	41.0	53.9	133.7	43.9	53.5	78.0	61.0	54.4	23.6	103.8	112.2	25.6	8.4	33.4	6.6	0.0	67.7	37.7	1.8	3.2	26.9	133.5	76.6	1.1	2.2	2.8	3.4	62.0	3.5	3.4	17.9	8.6	7.4	158.2	16.7	37.2	78.8	6.0	174.1	9.7	15.3	2.8	1.8	2.6	14.4	11.6	117.7	1.6	43.0	3.6	6.1	6.2	2.5	23.1	5.7	30.8	5.3	90.9	147.5	5.6	4.1	6.5	11.4	24.2	1.8	15.7	7.2	23.4	20.3	14.0	101.0	120.6	33.8	1.9	9.9	6.8	41.1	1.3	5.4	55.0	4.7	35.2	0.0	12.2	11.0	3.2	13.1	0.8	1.4	21.1	88.8	2.1	9.1	1.7
CYGB	"HGB, STAP"	ENSG00000161544	Cytoglobin	Q8WWM9	17	76527356-76551175	"Predicted intracellular proteins, Transporters"	"Oxygen transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 104.4"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 94.3;Fibroblasts: 87.6;Leydig cells: 95.7;Melanocytes: 78.2;Sertoli cells: 92.1;Smooth muscle cells: 95.6"	"Cancer enhanced"	"Detected in all"		"melanoma: 34.6"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"naive B-cell: 2.2"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 79.6;Hep G2: 61.7;HHSteC: 120.7;HSkMC: 95.4;SH-SY5Y: 129.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017757, HPA061642"	Approved	Approved	Supported	"Nuclear speckles,Cytosol"		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 50: Fibroblasts - ECM organization"	"Nuclear speckles"	Cytosol	"HPA017757: AB_1847410, HPA061642: AB_2684573"	"unprognostic (6.96e-2)"	"unprognostic (1.39e-1)"	"unprognostic (3.97e-2)"	"prognostic favorable (2.55e-5)"	"prognostic unfavorable (1.85e-4)"	"unprognostic (3.36e-2)"	"unprognostic (3.31e-3)"	"unprognostic (2.01e-1)"	"unprognostic (7.83e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.08e-2)"	"unprognostic (4.14e-2)"	"prognostic unfavorable (2.13e-4)"	"unprognostic (3.34e-2)"	"unprognostic (1.11e-2)"	"unprognostic (2.49e-2)"	"unprognostic (7.76e-2)"	79.6	20.8	10.1	12.0	10.7	1.7	55.1	20.6	13.6	27.7	14.1	27.1	21.1	19.6	4.6	12.8	20.4	13.2	104.4	9.5	15.8	12.4	19.0	27.8	7.2	17.5	26.0	13.8	12.8	11.7	10.9	8.9	26.8	29.9	9.3	77.6	14.2	11.0	19.3	19.5	26.6	5.9	10.1	12.2	22.9	5.3	14.3	5.3	50.1	9.6	2.6	50.7	25.6	9.8	0.2	1.1	1.8	0.4	79.6	23.1	26.1	0.7	2.0	0.3	0.9	0.0	0.3	0.2	24.1	2.4	0.3	0.7	0.1	33.7	0.1	0.1	0.2	0.4	0.4	61.7	120.7	0.0	0.0	95.4	7.2	2.5	2.5	0.4	0.3	0.8	0.3	0.1	1.2	0.8	0.2	0.4	0.3	0.0	1.4	0.5	0.3	0.2	0.4	0.1	0.6	129.8	0.1	0.0	2.7	5.9	0.2	0.6	0.2	3.1	1.6	0.3	0.0	1.2	0.3	0.3	0.2	0.3	9.9	0.0	0.1	0.1	0.2	0.1	0.1	1.6	0.1	0.0	0.1	2.2	0.2	0.5	0.9	1.0	0.0	0.0	0.2	0.2	10.1	10.7	20.6	13.6	9.5	15.8	17.5	26.0	26.8	10.1	14.3	9.8	94.3	3.2	2.0	2.0	3.5	10.8	1.3	17.3	3.4	38.5	1.4	5.7	6.1	0.0	6.7	0.0	0.0	1.4	1.9	0.1	0.0	0.8	0.7	2.9	4.2	23.1	0.0	0.0	2.4	0.2	0.6	87.6	1.5	0.7	0.0	0.2	2.2	1.2	0.4	8.4	12.3	0.0	0.0	0.0	13.3	2.5	95.7	2.6	78.2	3.7	0.0	22.1	0.0	1.0	1.0	0.1	0.0	23.3	0.6	0.8	0.0	0.2	21.1	12.9	92.1	21.8	95.6	1.6	1.4	0.7	6.7	2.9	2.6	9.2	0.0	1.0
CYLD	"CYLD1, KIAA0849, USPL2"	ENSG00000083799	"CYLD lysine 63 deubiquitinase"	Q9NQC7	16	50742050-50801935	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, Immunity, Innate immunity, Ubl conjugation pathway, Wnt signaling pathway"	"Hydrolase, Protease, Thiol protease"	"Cancer-related genes, Disease variant, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 94.3"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HDLM-2: 136.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011713, HPA050095"	Approved		Supported	"Nucleoplasm,Centriolar satellite"		Yes	No			"Cluster 10: Basophils - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 24: Non-specific - Transcription regulation"	"Centriolar satellite"	Nucleoplasm	"CAB011713: AB_731794, HPA050095: AB_2681013"	"unprognostic (9.83e-2)"	"unprognostic (1.17e-2)"	"unprognostic (5.01e-2)"	"unprognostic (2.83e-2)"	"unprognostic (3.84e-1)"	"unprognostic (5.06e-2)"	"unprognostic (3.87e-2)"	"unprognostic (3.24e-2)"	"unprognostic (9.46e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.18e-2)"	"unprognostic (2.32e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.07e-1)"	"unprognostic (3.43e-2)"	"unprognostic (6.83e-2)"	"unprognostic (8.42e-2)"	14.3	22.0	23.9	38.8	23.5	94.3	13.6	17.9	18.2	13.0	22.3	16.3	16.1	15.1	12.1	23.3	11.0	20.5	20.1	17.3	23.3	14.2	21.0	21.5	53.4	21.3	27.8	15.4	15.2	23.0	15.4	15.4	23.6	16.3	19.3	22.0	18.9	16.0	34.3	15.2	16.2	16.8	21.6	39.0	19.9	38.3	32.7	35.6	24.9	20.5	48.4	24.1	12.9	24.2	26.9	8.3	9.4	10.6	14.3	21.0	8.7	39.1	56.7	39.9	23.4	6.9	12.5	30.7	13.7	38.3	43.4	10.3	11.3	23.7	58.7	136.6	16.6	15.5	15.3	5.8	29.1	15.4	69.5	23.0	18.6	48.1	50.1	37.7	16.3	21.3	6.6	26.1	56.4	4.0	14.4	22.3	10.1	8.5	13.3	13.4	18.8	29.4	12.9	9.1	12.0	9.2	33.1	11.2	9.8	14.3	11.0	18.9	18.6	67.2	15.4	23.4	15.9	68.0	68.4	33.2	49.3	16.7	14.7	64.6	15.2	38.3	18.1	17.7	21.8	17.2	27.1	24.5	18.3	11.1	24.4	19.4	32.3	25.7	18.8	11.0	37.3	19.5	23.9	23.5	17.9	18.2	17.3	23.3	21.3	27.8	23.6	21.6	32.7	24.2	28.8	44.8	31.8	31.6	87.7	120.1	59.5	32.2	40.9	89.2	35.5	26.0	34.4	21.5	32.9	18.4	93.8	6.8	84.1	28.3	5.9	20.0	48.2	22.5	24.9	36.0	31.1	26.1	51.9	19.1	4.4	37.3	22.4	47.1	80.5	21.4	27.8	25.5	21.5	67.3	54.7	10.7	30.5	40.0	127.6	31.3	25.4	66.4	74.7	57.1	63.7	23.3	70.0	51.8	119.2	18.0	22.4	21.1	79.7	66.4	15.4	13.9	23.3	48.3	6.6	54.2	30.5	59.2	15.2	64.3	155.6	4.1	119.5	21.3	14.8	66.7
CYP2S1		ENSG00000167600	"Cytochrome P450 family 2 subfamily S member 1"	Q96SQ9	19	41193210-41207539	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Fatty acid metabolism, Lipid metabolism"	"Isomerase, Lyase, Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	8	"intestine: 101.3;stomach 1: 120.4"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 31.0;Gastric mucus-secreting cells: 110.6;Intestinal goblet cells: 29.2;Langerhans cells: 73.0;Proximal enterocytes: 50.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	9	"classical monocyte: 24.7;myeloid DC: 84.4"	"Group enriched"	"Detected in many"	131	"dendritic cells: 84.4;monocytes: 24.7"	"Cell line enhanced"	"Detected in many"		"A549: 99.4;CACO-2: 49.8;HaCaT: 50.3;NTERA-2: 69.6;OE19: 158.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049227, HPA069248"	Approved		Supported	"Endoplasmic reticulum"		NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 9: Intestine - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 41: Macrophages - Immune response"	"Endoplasmic reticulum"		"HPA049227: AB_2680681, HPA069248: AB_2732128"	"unprognostic (1.49e-2)"	"unprognostic (7.45e-2)"	"unprognostic (2.45e-2)"	"unprognostic (6.03e-2)"	"unprognostic (3.93e-2)"	"unprognostic (7.46e-2)"	"unprognostic (1.27e-2)"	"unprognostic (4.85e-2)"	"unprognostic (2.18e-1)"	"unprognostic (1.54e-2)"	"unprognostic (6.25e-3)"	"unprognostic (1.25e-1)"	"prognostic unfavorable (1.60e-6)"	"unprognostic (1.06e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.02e-1)"	"unprognostic (7.66e-2)"	1.8	1.1	1.4	6.7	1.4	1.8	0.9	3.1	1.5	2.7	1.2	26.7	101.3	0.5	0.2	14.5	6.3	5.5	0.5	1.3	4.1	1.1	1.4	7.1	1.7	6.3	10.0	0.3	0.6	0.7	1.2	1.6	6.1	1.3	18.6	0.2	5.0	0.9	0.2	3.7	65.3	1.7	2.2	6.1	120.4	0.8	3.6	3.2	0.6	0.2	13.2	3.6	4.0	2.5	3.8	99.4	0.0	0.1	0.0	0.0	4.5	0.6	0.8	1.0	0.2	49.8	13.6	0.2	10.4	0.7	0.1	50.3	16.6	25.0	0.4	0.0	0.3	12.9	5.1	19.1	19.4	0.0	0.4	0.8	1.4	1.4	0.8	0.2	0.8	4.3	5.8	0.2	0.0	2.0	0.3	0.2	69.6	158.6	12.5	0.2	0.0	0.9	1.5	20.4	0.1	0.6	9.1	0.0	0.0	27.8	12.2	4.7	10.6	0.1	4.0	1.7	0.0	0.5	0.0	0.0	0.5	2.1	0.1	0.0	24.7	0.0	0.0	5.9	0.4	0.0	0.0	0.1	84.4	0.0	0.0	0.0	0.2	0.1	3.7	3.2	0.0	11.4	1.4	1.4	3.1	1.5	1.3	4.1	6.3	10.0	6.1	2.2	3.6	2.5	0.3	0.0	6.9	1.0	0.7	2.5	2.0	18.2	23.3	0.0	0.1	0.3	1.2	0.0	7.6	1.8	0.0	24.9	0.1	31.0	0.0	0.7	0.3	7.4	0.3	0.4	0.0	0.0	0.4	1.0	1.1	0.8	110.6	0.3	1.3	0.1	0.4	0.0	14.5	0.0	0.5	29.2	0.0	5.7	73.0	0.0	0.0	16.0	0.0	1.0	7.2	0.0	0.0	0.5	0.1	23.7	22.3	0.0	0.4	0.5	50.7	0.2	10.8	0.0	0.0	0.3	0.9	0.1	0.4	4.0	2.8	10.3	0.3	0.0	14.1	0.5
CYP4B1		ENSG00000142973	"Cytochrome P450 family 4 subfamily B member 1"	P13584	1	46757838-46819413	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 242.2"	"Group enriched"	"Detected in many"	4	"Alveolar cells type 1: 1227.5;Club cells: 405.1;Respiratory ciliated cells: 763.9"	"Cancer enhanced"	"Detected in many"		"urothelial cancer: 56.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	8	"RT4: 286.7"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			HPA004331	Approved		Supported	Vesicles		NA	NA				"Cluster 82: Adipose tissue - ECM organization"	"Cluster 15: RT4 - Unknown function"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Vesicles		"HPA004331: AB_1078616"	"unprognostic (2.29e-2)"	"prognostic favorable (5.99e-4)"	"unprognostic (7.01e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.28e-1)"	"unprognostic (8.31e-2)"	"unprognostic (1.16e-2)"	"unprognostic (1.98e-2)"	"unprognostic (2.65e-1)"	"unprognostic (2.59e-1)"	"unprognostic (6.12e-2)"	"unprognostic (5.46e-2)"	"unprognostic (7.33e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.22e-3)"	"unprognostic (6.69e-3)"	81.8	4.9	0.3	0.0	0.3	0.0	62.0	0.2	0.6	13.4	1.2	14.6	1.3	9.5	1.7	44.0	48.0	0.5	40.2	0.2	0.3	2.4	0.1	242.2	0.5	0.3	0.3	1.7	3.4	0.7	9.3	1.2	0.3	22.7	0.7	0.0	16.6	15.8	24.0	42.7	15.2	0.1	0.3	0.4	11.5	0.5	0.4	3.1	22.3	24.6	15.2	81.7	30.5	0.3	0.0	0.0	0.0	0.0	20.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	16.5	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	35.6	0.0	0.1	0.0	0.3	0.0	0.2	0.0	0.1	0.0	0.0	0.0	286.7	0.1	0.0	0.0	11.4	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.2	0.6	0.2	0.3	0.3	0.3	0.3	0.3	0.4	0.3	60.8	1227.5	89.3	0.0	0.0	0.5	139.6	111.5	36.5	0.0	2.0	1.5	6.4	1.5	405.1	0.0	0.0	1.2	0.0	0.0	0.0	0.0	1.7	93.8	12.5	23.5	0.0	0.0	0.1	0.0	0.2	47.9	1.1	8.5	6.3	0.0	1.4	0.0	0.6	0.0	0.1	0.0	48.8	0.0	0.3	0.9	0.6	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	6.9	0.0	1.1	763.9	0.0	0.0	3.0	23.3	0.1	0.1	71.4	4.1	0.8	1.8	0.0	0.0	163.0
CYTH2	"ARNO, CTS18.1, cytohesin-2, PSCD2, PSCD2L, Sec7p-L, Sec7p-like"	ENSG00000105443	"Cytohesin 2"	Q99418	19	48469208-48482314	"Plasma proteins, Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 285.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB014872, HPA060662"	Uncertain		Supported	"Golgi apparatus,Plasma membrane,Cytosol"		NA	NA			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 12: NES - Nervous system development"	"Cluster 10: Non-specific - Unknown function"	Cytosol	"Golgi apparatus, Plasma membrane"	"CAB014872: , HPA060662: AB_2732652"	"unprognostic (2.28e-1)"	"unprognostic (1.27e-1)"	"unprognostic (7.60e-3)"	"unprognostic (1.72e-1)"	"unprognostic (4.97e-2)"	"unprognostic (4.10e-2)"	"prognostic unfavorable (1.19e-4)"	"unprognostic (1.66e-1)"	"unprognostic (2.83e-2)"	"unprognostic (3.70e-1)"	"unprognostic (1.85e-1)"	"unprognostic (2.33e-2)"	"unprognostic (9.19e-2)"	"unprognostic (3.14e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.24e-1)"	"prognostic favorable (3.21e-4)"	8.1	12.1	17.2	11.4	17.8	8.1	14.2	20.3	19.0	15.9	15.4	9.3	21.5	10.7	13.6	15.3	7.6	23.2	7.4	16.2	17.1	21.0	7.2	11.2	8.2	18.1	19.1	7.5	16.6	19.6	14.8	16.3	17.4	15.0	8.3	39.0	22.6	9.1	3.6	15.1	21.3	8.2	15.3	10.6	17.5	35.6	21.2	14.9	52.5	5.7	8.8	10.9	10.6	21.2	24.7	36.8	107.9	24.7	16.2	13.9	19.6	18.9	17.3	19.9	18.7	20.1	32.9	16.1	19.2	16.6	16.5	30.4	21.1	23.1	12.5	24.6	28.1	22.5	52.6	22.0	14.6	14.0	29.7	18.0	38.5	24.6	15.9	90.2	26.0	23.4	22.9	55.0	26.6	20.0	23.9	102.5	11.8	22.1	14.9	29.6	15.9	11.2	34.2	52.1	31.9	30.9	20.7	57.6	16.8	34.0	27.1	18.8	28.3	42.6	21.3	10.3	27.8	54.1	30.8	10.8	15.5	27.1	30.7	2.8	2.7	2.3	2.6	2.1	1.8	2.6	3.2	3.7	2.4	1.8	2.8	2.0	7.2	1.4	2.7	3.9	3.6	2.1	17.2	17.8	20.3	19.0	16.2	17.1	18.1	19.1	17.4	15.3	21.2	21.2	48.5	28.9	33.5	15.0	18.7	45.9	115.0	81.1	26.7	35.6	47.6	28.7	11.5	55.8	63.2	40.5	25.0	51.2	42.6	35.0	35.2	82.7	285.9	85.3	26.5	56.0	26.0	4.6	5.7	93.6	47.0	33.5	55.0	56.3	17.7	32.5	50.3	8.3	43.7	21.9	6.8	29.3	67.1	27.9	39.7	163.0	37.3	34.9	35.6	9.4	52.0	42.6	22.6	4.5	12.0	136.6	36.2	36.9	23.2	77.1	57.9	53.3	80.6	59.5	52.6	42.9	70.9	63.5	53.2	23.2	47.5	142.7	33.2	26.0	25.4	139.2
CYTH3	"ARNO3, cytohesin-3, GRP1, PSCD3"	ENSG00000008256	"Cytohesin 3"	O43739	7	6161776-6272644	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 66.5;Inhibitory neurons: 96.5;Microglial cells: 57.1"	"Cancer enriched"	"Detected in all"	5	"melanoma: 47.0"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"MAIT T-cell: 2.5"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"WM-115: 102.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA013979	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 50: Fibroblasts - ECM organization"	Cytosol	Nucleoplasm	"HPA013979: AB_1855799"	"unprognostic (6.58e-2)"	"unprognostic (1.37e-2)"	"unprognostic (1.65e-2)"	"unprognostic (5.75e-3)"	"unprognostic (1.27e-3)"	"unprognostic (1.27e-2)"	"unprognostic (2.32e-2)"	"unprognostic (2.63e-1)"	"unprognostic (8.94e-2)"	"unprognostic (1.81e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.54e-2)"	"unprognostic (1.73e-2)"	"unprognostic (2.20e-1)"	"unprognostic (4.41e-2)"	"prognostic unfavorable (2.63e-5)"	28.8	9.5	16.9	5.4	17.7	7.7	26.5	16.3	20.9	16.4	11.8	18.3	16.5	17.5	6.6	14.0	15.6	11.8	28.5	18.5	15.3	14.2	4.1	19.7	5.4	14.4	15.5	13.9	7.5	11.5	9.8	31.7	15.4	10.2	6.9	5.7	11.9	8.6	15.2	21.6	16.7	12.1	14.2	10.9	13.9	18.6	16.6	5.8	27.7	19.7	4.7	13.8	15.9	17.5	64.7	16.1	15.0	10.4	68.4	80.0	21.2	37.4	32.3	36.1	34.2	25.0	31.3	8.7	22.1	75.5	46.4	59.5	10.4	27.1	23.8	0.6	14.8	2.4	19.8	3.2	32.4	2.7	4.0	57.0	12.1	19.3	27.6	16.2	6.4	12.6	10.3	1.4	26.7	10.6	2.2	11.5	10.4	8.6	21.5	11.5	40.0	5.0	28.0	7.7	9.6	18.4	23.2	79.7	67.0	12.7	4.8	18.1	23.3	24.6	64.4	26.9	23.2	2.9	1.1	9.1	7.9	6.9	102.8	0.3	0.2	0.0	0.9	0.0	2.5	0.1	0.4	1.0	0.1	0.2	0.0	0.6	0.1	1.5	0.2	0.8	0.3	0.2	16.9	17.7	16.3	20.9	18.5	15.3	14.4	15.5	15.4	14.2	16.6	17.5	40.1	16.0	5.8	14.7	3.1	15.2	2.1	1.8	4.0	6.5	9.2	7.5	17.4	2.8	3.2	3.7	8.4	15.4	8.7	9.7	5.9	4.1	14.1	9.4	10.2	14.6	3.0	2.1	66.5	2.8	9.1	24.0	8.2	15.9	12.7	15.8	18.5	1.4	11.9	15.2	96.5	5.5	4.1	4.1	10.9	16.7	16.4	5.9	32.0	57.1	1.9	10.8	3.1	23.1	10.8	10.0	5.4	13.2	4.4	3.9	14.6	1.4	3.7	2.0	39.5	6.1	39.2	24.3	11.2	7.0	11.4	15.2	10.2	10.9	7.1	2.1
CYTH4	"CYT4, cytohesin-4, PSCD4"	ENSG00000100055	"Cytohesin 4"	Q9UIA0	22	37282027-37315341	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 58.3;lymphoid tissue: 67.3"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 117.5;granulocytes: 57.0;Hofbauer cells: 76.8;Kupffer cells: 71.5;Langerhans cells: 87.5;Macrophages: 55.0;NK-cells: 120.5;T-cells: 43.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"HL-60: 34.1;HMC-1: 141.1;THP-1: 95.2;U-266/70: 28.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004065, HPA071573"	Approved		Supported	"Plasma membrane,Cytokinetic bridge,Centriolar satellite,Cytosol"		Yes	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 2: Immune cells - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Plasma membrane"	"Cytokinetic bridge, Centriolar satellite, Cytosol"	"HPA004065: , HPA071573: AB_2686418"	"unprognostic (4.30e-3)"	"unprognostic (1.65e-2)"	"unprognostic (3.03e-2)"	"unprognostic (9.28e-3)"	"unprognostic (9.25e-2)"	"unprognostic (1.69e-2)"	"unprognostic (1.50e-1)"	"unprognostic (5.84e-2)"	"unprognostic (3.30e-3)"	"unprognostic (1.23e-1)"	"unprognostic (3.31e-2)"	"unprognostic (8.42e-2)"	"prognostic unfavorable (2.41e-8)"	"unprognostic (3.70e-2)"	"unprognostic (1.92e-2)"	"unprognostic (5.56e-2)"	"unprognostic (2.07e-1)"	21.5	8.8	4.9	67.3	4.5	58.3	5.1	4.4	8.5	5.3	6.0	10.7	8.5	4.4	1.6	6.1	4.8	16.4	5.6	4.7	5.6	4.1	5.7	18.9	57.0	8.8	7.4	3.4	2.5	2.1	2.9	28.0	7.8	3.6	10.0	0.3	7.3	4.3	2.2	2.2	15.2	12.9	6.7	59.2	11.5	2.7	9.7	25.6	3.0	5.1	40.3	23.2	2.5	9.1	0.6	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.8	9.3	0.3	0.0	2.5	0.1	0.0	0.6	0.0	5.3	0.0	9.8	0.0	0.0	0.0	34.1	141.1	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	23.2	0.0	0.0	0.5	13.5	0.0	0.1	1.0	1.3	0.2	19.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	95.2	0.3	0.0	0.1	0.1	0.0	28.4	4.0	4.5	18.5	11.5	0.2	15.8	62.6	87.5	55.4	102.5	39.0	30.3	30.5	44.8	47.5	31.8	30.0	38.3	199.1	45.0	129.4	113.8	30.7	76.2	4.9	4.5	4.4	8.5	4.7	5.6	8.8	7.4	7.8	6.7	9.7	9.1	1.1	3.2	8.4	0.0	37.0	2.4	0.8	0.0	0.6	0.1	0.7	1.5	2.0	0.0	1.8	0.0	0.0	0.5	117.5	0.1	0.0	0.0	0.4	0.1	0.2	2.5	0.0	2.5	0.2	0.2	0.6	1.9	2.0	0.1	57.0	0.0	2.2	1.1	76.8	0.0	0.2	0.2	0.0	71.5	87.5	0.9	0.6	55.0	7.2	24.4	42.7	0.0	120.5	0.5	0.0	0.8	0.0	0.0	25.1	0.3	0.0	0.8	0.0	0.1	0.0	0.9	1.0	0.0	0.2	0.3	2.3	1.0	43.9	0.0	0.2	0.5
CYTL1	"C17, C4orf4"	ENSG00000170891	"Cytokine like 1"	Q9NRR1	4	5014586-5019458	"Plasma proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 46.0"	"Cell type enhanced"	"Detected in some"		"Adipocytes: 14.1;Endothelial cells: 32.0;Erythroid cells: 86.6;Fibroblasts: 16.8;Hofbauer cells: 15.5;Microglial cells: 23.4"	"Group enriched"	"Detected in many"	5	"glioma: 21.0;melanoma: 20.4"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	11	"NK-cell: 27.0"	"Lineage enriched"	"Detected in many"	11	"NK-cells: 27.0"	"Cell line enhanced"	"Detected in some"		"HEL: 194.1;HUVEC TERT2: 152.3;NB-4: 382.2;WM-115: 89.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA067201			Supported	"Nuclear membrane,Endoplasmic reticulum"	"Secreted in other tissues"	NA	NA		270000	"Cluster 40: NK-cells - Unknown function"	"Cluster 28: Placenta - Pregnancy"	"Cluster 24: NB-4 - Immune response"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Nuclear membrane, Endoplasmic reticulum"		"HPA067201: AB_2732760"	"unprognostic (2.35e-2)"	"unprognostic (9.01e-3)"	"unprognostic (3.56e-1)"	"unprognostic (3.76e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.71e-1)"	"unprognostic (2.09e-2)"	"unprognostic (1.44e-1)"	"unprognostic (7.10e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.54e-1)"	"unprognostic (4.78e-2)"	"prognostic unfavorable (7.43e-4)"	"prognostic unfavorable (3.00e-5)"	"unprognostic (2.18e-1)"	"unprognostic (3.07e-2)"	"prognostic unfavorable (1.25e-4)"	5.8	1.9	2.1	1.8	2.5	13.9	6.9	2.8	3.9	12.9	3.1	5.5	0.6	9.5	1.3	4.8	7.9	4.6	1.5	2.6	2.7	1.0	0.3	4.9	4.5	4.2	3.0	1.7	1.2	1.2	1.6	46.0	3.9	10.8	1.4	0.2	4.3	14.4	0.5	3.2	2.4	4.0	3.3	1.2	4.7	0.3	3.4	4.5	5.8	0.2	4.9	12.0	7.3	4.8	0.1	0.0	0.1	0.0	0.3	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	194.1	0.1	0.0	0.9	0.0	0.0	5.0	0.0	2.7	0.0	0.0	152.3	0.0	0.0	7.5	0.0	0.0	0.0	382.2	0.7	0.0	0.0	5.7	7.7	0.2	0.0	0.0	0.1	8.8	0.3	0.0	24.5	0.2	0.0	0.0	52.7	0.0	34.6	0.1	0.0	1.0	0.2	0.4	0.0	4.8	89.6	2.5	1.2	0.0	0.0	0.4	0.0	0.0	0.0	0.7	0.3	0.0	0.0	0.7	0.1	27.0	0.0	0.4	0.0	0.9	2.1	2.5	2.8	3.9	2.6	2.7	4.2	3.0	3.9	3.3	3.4	4.8	14.1	0.0	0.5	0.0	1.2	2.8	0.1	0.0	0.0	0.0	0.3	0.6	0.0	0.0	0.0	0.0	0.0	0.4	2.3	0.0	0.0	0.2	0.4	0.3	0.3	32.0	0.0	86.6	0.0	0.0	0.4	16.8	0.0	0.3	8.9	0.2	0.7	0.0	15.5	0.0	0.0	0.0	0.0	0.8	2.9	0.0	0.0	4.7	8.8	23.4	0.6	0.0	3.1	0.5	0.0	0.0	0.0	0.0	1.0	0.6	0.0	0.0	0.0	0.0	0.0	2.3	0.8	0.1	0.0	0.3	1.6	0.5	0.5	8.6	0.0	0.6
D2HGDH	"D2HGD, FLJ42195, MGC25181"	ENSG00000180902	"D-2-hydroxyglutarate dehydrogenase"	Q8N465	2	241734602-241768816	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		Oxidoreductase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"memory B-cell: 2.5"	"Group enriched"	"Detected in many"	4	"B-cells: 2.5;T-cells: 1.0"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA056216, HPA060548"	Uncertain		Supported	Mitochondria	"Intracellular and membrane"	NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 59: Non-specific - Translation"	"Cluster 15: RT4 - Unknown function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Mitochondria		"HPA056216: AB_2683070, HPA060548: AB_2732650"	"unprognostic (2.85e-1)"	"unprognostic (3.35e-2)"	"unprognostic (6.98e-3)"	"unprognostic (7.88e-2)"	"unprognostic (2.42e-1)"	"prognostic favorable (9.11e-4)"	"unprognostic (2.49e-3)"	"unprognostic (1.67e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.65e-2)"	"unprognostic (7.82e-3)"	"unprognostic (1.21e-1)"	"unprognostic (7.63e-2)"	"unprognostic (1.48e-2)"	"unprognostic (1.50e-1)"	"unprognostic (9.60e-2)"	"unprognostic (3.05e-2)"	11.5	17.7	6.9	11.2	8.0	18.6	7.6	6.2	7.3	10.5	14.9	16.6	11.4	11.8	13.0	15.0	16.1	14.1	11.4	6.6	6.1	15.9	19.1	10.6	12.0	8.4	6.9	14.8	16.6	15.2	10.5	8.9	6.6	14.6	14.6	3.2	18.7	14.9	33.8	39.4	14.9	9.3	6.1	15.1	14.7	4.9	7.3	7.4	18.0	23.7	11.5	8.9	9.6	8.6	10.2	10.5	6.2	9.6	14.7	7.9	21.5	9.7	12.2	9.6	7.7	11.8	21.9	8.3	4.4	9.7	11.0	23.2	5.9	7.8	4.0	8.8	5.7	15.9	11.3	20.5	8.2	19.0	12.1	14.1	13.7	7.6	7.3	18.5	9.5	13.1	20.7	5.3	8.6	16.8	16.0	19.7	3.0	13.8	20.8	19.5	6.9	16.2	17.6	36.7	20.4	7.2	9.4	23.8	6.6	4.1	14.7	6.7	4.1	14.9	5.6	7.9	5.8	9.9	1.9	13.4	10.3	20.8	10.0	0.0	0.2	0.0	0.2	0.2	0.4	2.5	0.1	1.0	0.4	0.1	0.6	0.2	0.0	0.0	0.3	0.1	0.8	0.1	6.9	8.0	6.2	7.3	6.6	6.1	8.4	6.9	6.6	6.1	7.3	8.6	10.4	9.6	14.3	33.3	10.4	19.8	23.5	13.7	25.6	14.3	22.8	22.7	10.6	25.8	16.3	18.4	14.6	44.0	13.0	40.9	23.5	10.5	3.6	12.5	13.2	9.7	31.8	6.9	7.1	8.7	15.9	15.7	23.0	19.2	5.7	28.0	13.2	46.0	18.2	11.8	9.9	56.4	14.2	10.8	7.5	4.8	16.8	12.6	3.6	15.9	5.3	37.4	8.2	28.6	12.8	6.7	32.0	18.0	15.0	19.3	26.4	31.4	13.9	12.0	6.6	14.0	11.7	2.1	7.0	25.7	14.8	22.6	14.0	27.0	49.9	22.2
DAAM2	KIAA0381	ENSG00000146122	"Dishevelled associated activator of morphogenesis 2"	Q86T65	6	39792298-39904877	"Predicted intracellular proteins"	"Wnt signaling pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 245.9"	"Group enriched"	"Detected in many"	5	"Astrocytes: 275.6;Oligodendrocytes: 449.8;Sertoli cells: 151.2"	"Group enriched"	"Detected in all"	5	"glioma: 15.0;melanoma: 21.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HSkMC: 54.9;JURKAT: 30.4;LHCN-M2: 55.8;SK-MEL-30: 68.7;WM-115: 26.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051300, HPA054630"	Approved		Supported	Nucleoplasm,Vesicles,Cytosol		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 70: Brain - Nervous system development"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Nucleoplasm	"Vesicles, Cytosol"	"HPA051300: AB_2681430, HPA054630: AB_2682549"	"unprognostic (7.53e-2)"	"unprognostic (6.02e-3)"	"unprognostic (4.49e-2)"	"unprognostic (7.93e-2)"	"unprognostic (8.24e-2)"	"unprognostic (4.28e-2)"	"unprognostic (2.43e-2)"	"unprognostic (1.05e-3)"	"unprognostic (1.33e-1)"	"unprognostic (5.89e-2)"	"unprognostic (2.17e-1)"	"unprognostic (5.24e-2)"	"prognostic unfavorable (2.79e-4)"	"unprognostic (2.67e-2)"	"unprognostic (8.54e-2)"	"unprognostic (7.94e-2)"	"unprognostic (8.54e-4)"	33.7	22.5	179.4	9.0	229.4	1.8	23.3	175.8	159.3	15.7	65.1	18.9	9.8	14.0	10.4	36.6	18.5	7.4	13.5	144.0	170.5	9.3	4.8	12.4	3.6	234.8	195.8	10.0	7.5	4.1	5.1	12.2	205.0	11.0	8.7	1.6	7.6	21.7	38.3	8.5	20.9	18.3	194.3	40.2	18.9	12.3	187.7	2.5	13.1	38.1	2.3	9.9	11.3	245.9	0.1	0.0	5.8	0.1	12.2	0.3	0.2	9.8	13.1	2.2	1.2	0.9	0.0	0.1	0.5	14.7	4.5	0.1	0.0	0.0	0.8	0.0	2.4	0.0	0.0	0.1	8.8	0.0	0.1	54.9	0.0	0.3	0.0	15.6	0.0	30.4	0.0	0.1	55.8	0.2	1.5	0.1	1.6	3.1	0.1	0.0	10.0	8.1	0.0	0.0	2.0	2.3	0.0	0.7	68.7	11.7	0.0	0.1	0.6	20.8	6.0	0.2	0.3	0.0	0.0	0.0	0.2	0.0	26.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	179.4	229.4	175.8	159.3	144.0	170.5	234.8	195.8	205.0	194.3	187.7	245.9	11.2	9.6	12.2	275.6	0.1	1.8	0.9	0.0	0.0	1.3	1.5	1.5	2.5	1.5	3.8	0.0	0.0	0.5	0.1	0.0	0.0	0.5	3.8	1.2	10.4	9.0	0.0	2.7	1.4	3.3	0.5	11.8	0.5	2.3	0.0	1.9	2.5	1.2	0.2	0.0	5.8	0.0	0.0	31.5	2.4	6.4	23.6	6.2	8.8	21.5	0.0	5.8	1.0	8.5	449.8	0.3	0.0	22.2	0.0	0.8	0.0	0.1	1.5	1.6	151.2	12.7	48.8	1.0	1.9	0.4	1.1	0.3	0.7	55.9	0.0	1.2
DACH1	DACH	ENSG00000276644	"Dachshund family transcription factor 1"	Q9UI36	13	71437966-71867204	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 88.5;Excitatory neurons: 77.0;Horizontal cells: 87.5;Late spermatids: 103.7;Microglial cells: 143.4;Muller glia cells: 143.8;Spermatocytes: 58.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	15	"basophil: 4.2;eosinophil: 8.4;NK-cell: 4.2;plasmacytoid DC: 6.4"	"Group enriched"	"Detected in many"	33	"dendritic cells: 6.4;granulocytes: 8.4;NK-cells: 4.2"	"Cell line enhanced"	"Detected in some"		"AF22: 14.2;HAP1: 22.5;HEK 293: 16.8;HL-60: 37.9;NB-4: 16.7;SCLC-21H: 36.9;SH-SY5Y: 29.5;THP-1: 26.9"	"Region enriched"	"Detected in all"	5	"basal ganglia: 38.8"	"Region enriched"	"Detected in all"	5	"basal ganglia: 34.2"	"HPA012672, HPA012938, HPA073222"	Approved		Supported	"Nucleoplasm,Nuclear speckles"		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Nucleoplasm, Nuclear speckles"		"HPA012672: AB_1847466, HPA012938: , HPA073222: "	"unprognostic (3.16e-1)"	"unprognostic (5.26e-2)"	"unprognostic (1.41e-2)"	"unprognostic (2.36e-1)"	"unprognostic (4.21e-2)"	"unprognostic (5.63e-2)"	"unprognostic (2.22e-2)"	"unprognostic (8.08e-3)"	"unprognostic (2.12e-2)"	"unprognostic (2.50e-1)"	"unprognostic (3.04e-3)"	"unprognostic (4.37e-1)"	"unprognostic (2.18e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.19e-1)"	"unprognostic (1.24e-1)"	"unprognostic (5.17e-2)"	4.4	11.1	2.3	1.2	14.0	6.0	4.0	1.6	2.9	9.7	0.3	3.1	5.2	3.8	1.3	0.9	2.8	7.2	2.2	1.0	4.6	8.9	2.0	5.9	0.5	7.0	9.3	0.5	1.9	6.6	3.5	6.9	5.9	7.0	3.3	16.7	2.0	2.3	1.9	1.8	6.7	2.0	2.6	5.4	1.9	6.3	4.3	3.5	0.2	1.2	0.4	2.0	2.7	2.4	0.0	0.0	14.2	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	22.5	0.0	0.0	0.0	16.8	0.2	0.0	0.0	0.4	37.9	0.0	0.0	0.0	0.0	0.0	0.0	6.3	0.0	0.0	0.0	0.0	0.0	0.9	16.7	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	36.9	29.5	0.0	0.0	0.0	0.1	0.9	26.9	0.0	0.4	0.3	0.0	0.8	0.0	0.0	0.0	1.0	0.0	0.2	4.2	0.1	8.4	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	4.2	0.0	6.4	0.0	0.1	2.3	14.0	1.6	2.9	1.0	4.6	7.0	9.3	5.9	2.6	4.3	2.4	36.4	0.0	0.6	15.7	0.5	1.7	3.6	0.0	0.0	15.4	19.4	9.3	2.1	1.5	0.0	7.3	4.2	0.0	12.5	0.9	5.9	1.0	88.5	5.0	4.7	34.2	34.1	2.5	77.0	0.0	0.0	4.6	1.1	3.2	5.1	0.3	2.9	0.0	0.2	87.5	28.2	21.4	0.0	1.2	1.2	103.7	3.4	2.5	0.0	143.4	1.1	143.8	0.0	6.6	3.9	0.6	0.3	1.9	0.0	5.8	3.5	6.9	0.7	6.9	13.1	1.5	4.3	58.8	10.2	0.2	1.3	0.0	1.0	1.3	12.6	2.7
DACT1	"DAPPER, DAPPER1, FRODO, HDPR1, THYEX3"	ENSG00000165617	"Dishevelled binding antagonist of beta catenin 1"	Q9NYF0	14	58633967-58648321	"Disease related genes, Predicted intracellular proteins"	"Neurogenesis, Wnt signaling pathway"	"Developmental protein"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 56.0;Late spermatids: 17.9;Peritubular cells: 27.8;Smooth muscle cells: 15.7"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"cerebellum: 17.4"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"SK-MEL-30: 13.5;SuSa: 17.2;U-138 MG: 31.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA003016, HPA074619"	Enhanced		Supported	Nucleoplasm		NA	NA				"Cluster 89: Fibroblasts - ECM organization"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	Nucleoplasm		"HPA003016: AB_1078623, HPA074619: "	"unprognostic (2.47e-2)"	"unprognostic (2.72e-2)"	"unprognostic (1.79e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.03e-2)"	"unprognostic (3.55e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.17e-2)"	"unprognostic (4.79e-2)"	"unprognostic (1.93e-1)"	"unprognostic (5.42e-2)"	"unprognostic (6.54e-2)"	"unprognostic (4.16e-2)"	"unprognostic (1.64e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.37e-3)"	"unprognostic (1.89e-3)"	8.6	7.9	5.2	4.1	4.2	1.5	6.5	17.4	3.3	12.0	0.6	6.3	5.9	7.6	5.8	2.9	5.9	24.9	8.0	3.6	2.5	5.5	2.7	9.3	4.1	1.6	3.2	24.4	2.3	8.0	3.8	12.1	2.0	11.8	6.7	2.0	3.5	13.1	2.4	2.7	3.9	8.9	2.0	7.2	6.9	9.8	2.4	3.6	10.7	4.4	2.3	14.0	6.6	3.4	0.0	0.0	4.0	0.1	4.5	5.0	0.1	2.3	2.9	2.4	2.1	0.3	0.2	0.0	0.1	6.9	4.0	3.6	11.5	0.0	1.3	2.7	2.4	0.0	0.1	0.0	8.2	0.0	1.3	5.9	0.3	9.0	0.0	9.0	0.1	0.8	0.0	0.0	1.6	0.0	0.9	0.1	3.8	0.2	0.9	4.9	5.6	0.0	0.0	0.0	0.1	0.0	6.5	0.0	13.5	17.2	0.0	0.4	0.0	31.7	10.8	0.5	8.5	4.4	1.8	0.0	3.4	1.4	8.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	5.2	4.2	17.4	3.3	3.6	2.5	1.6	3.2	2.0	2.0	2.4	3.4	1.1	0.0	0.0	0.3	1.0	0.8	1.2	0.0	1.2	0.4	0.3	1.5	3.9	7.2	0.0	1.8	0.0	0.2	0.2	0.3	0.0	1.7	56.0	0.4	9.3	1.4	0.0	0.0	2.7	2.3	0.8	11.7	2.0	0.3	0.0	2.3	4.2	0.0	1.2	0.0	4.0	1.0	0.0	2.9	2.1	17.9	12.2	0.6	1.8	6.5	0.0	4.5	0.0	1.5	0.8	3.1	0.0	27.8	0.6	0.4	0.0	1.0	0.0	0.5	0.0	2.9	15.7	12.6	8.6	0.3	1.3	0.1	0.5	3.6	0.5	0.4
DAG1	"156DAG, A3a, AGRNR, DAG"	ENSG00000173402	"Dystroglycan 1"	Q14118	3	49468703-49535618	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Host-virus interaction"	"Host cell receptor for virus entry, Receptor"	"Congenital muscular dystrophy, Disease variant, Dystroglycanopathy, Limb-girdle muscular dystrophy, Lissencephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Granulosa cells: 207.9;Skeletal myocytes: 326.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"BEWO: 280.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB001960, CAB016353, HPA070563"	Enhanced		Supported	"Nucleoplasm,Vesicles,Plasma membrane"	"Intracellular and membrane"	NA	NA		84000000	"Cluster 14: Monocytes - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 40: Granulosa cells - Unknown function"	"Vesicles, Plasma membrane"	Nucleoplasm	"CAB001960: , CAB016353: AB_627292, HPA070563: "	"unprognostic (1.58e-1)"	"unprognostic (5.14e-1)"	"unprognostic (6.71e-3)"	"unprognostic (3.32e-1)"	"unprognostic (7.39e-2)"	"unprognostic (9.91e-2)"	"unprognostic (1.67e-1)"	"unprognostic (3.27e-2)"	"unprognostic (8.18e-2)"	"unprognostic (3.91e-2)"	"unprognostic (5.70e-3)"	"unprognostic (1.10e-1)"	"prognostic favorable (2.59e-4)"	"unprognostic (9.22e-2)"	"unprognostic (1.99e-2)"	"unprognostic (7.43e-2)"	"unprognostic (1.57e-2)"	25.2	22.0	31.5	17.9	32.6	5.4	26.6	30.7	30.7	26.2	25.5	38.8	24.0	32.1	16.2	28.3	31.8	26.4	68.9	30.1	28.9	28.1	43.0	31.8	9.4	33.3	31.4	24.6	51.4	44.3	18.6	77.0	28.6	29.5	30.6	9.8	31.8	37.9	93.8	28.5	24.0	45.9	30.2	12.6	32.0	26.9	34.1	10.5	25.5	95.7	14.3	27.8	22.0	31.2	92.3	92.4	61.9	152.3	80.3	38.8	280.9	63.9	93.7	108.0	69.0	74.2	96.0	13.0	62.2	103.2	87.6	168.4	55.6	81.2	67.2	12.7	18.6	9.6	84.3	87.2	35.5	11.2	17.4	33.3	72.5	100.3	33.3	96.7	97.1	15.3	14.5	9.8	31.2	75.5	10.1	8.1	66.4	110.0	31.2	5.5	60.5	22.3	82.5	126.4	21.8	45.2	74.8	206.0	105.5	170.3	171.6	22.8	51.8	39.1	63.9	76.0	91.4	11.0	24.2	8.1	50.4	12.6	245.9	2.3	1.2	0.7	1.1	1.3	1.2	1.2	0.9	0.9	0.7	1.0	1.0	1.0	2.2	1.1	2.5	1.3	0.7	1.4	31.5	32.6	30.7	30.7	30.1	28.9	33.3	31.4	28.6	30.2	34.1	31.2	19.0	54.5	18.4	32.0	4.0	14.3	8.0	31.7	17.1	7.4	36.1	46.4	56.6	30.0	20.6	35.0	4.2	116.4	5.8	37.3	1.9	32.4	30.0	30.2	17.3	20.9	33.0	14.3	15.6	79.6	118.4	26.1	37.8	37.9	7.0	207.9	16.8	59.9	21.2	3.3	16.5	29.7	14.2	8.6	7.0	20.0	21.5	6.3	33.8	9.4	5.6	27.1	5.2	19.6	10.7	57.2	21.4	36.9	5.1	14.4	18.9	7.6	23.2	8.7	46.0	326.1	36.2	7.1	19.9	19.0	17.0	95.9	5.9	10.0	29.2	10.2
DAGLB	"DAGLBETA, KCCR13L"	ENSG00000164535	"Diacylglycerol lipase beta"	Q8NCG7	7	6409126-6484190	"Enzymes, Metabolic proteins, Predicted membrane proteins"	"Lipid degradation, Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA069377			Supported	"Nucleoplasm,Plasma membrane"		No	No			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 44: Endometrium - Transcription"	"Plasma membrane"	Nucleoplasm	"HPA069377: AB_2686132"	"unprognostic (2.39e-1)"	"unprognostic (4.61e-2)"	"unprognostic (2.13e-3)"	"unprognostic (1.42e-1)"	"unprognostic (9.04e-3)"	"unprognostic (3.68e-2)"	"unprognostic (1.78e-3)"	"unprognostic (2.36e-1)"	"unprognostic (2.22e-1)"	"prognostic unfavorable (7.18e-5)"	"unprognostic (1.25e-1)"	"unprognostic (1.24e-1)"	"prognostic unfavorable (1.54e-4)"	"unprognostic (2.18e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.93e-1)"	"unprognostic (1.81e-2)"	7.3	15.6	9.9	6.7	9.9	15.0	6.6	7.3	11.1	7.0	5.9	6.7	7.6	5.8	3.6	8.0	5.9	6.4	5.6	11.2	8.8	4.9	7.9	9.3	7.4	9.7	7.7	7.9	6.9	7.0	4.3	8.7	8.0	5.3	5.0	3.4	7.7	4.5	13.3	12.4	7.6	5.8	8.4	8.5	7.1	5.5	8.1	8.1	7.5	7.0	6.7	5.8	7.3	10.7	21.6	23.9	10.9	14.3	16.1	12.5	8.4	29.8	21.3	26.6	28.7	13.6	24.4	12.3	12.5	15.4	64.8	32.4	17.8	16.7	15.2	5.8	11.7	6.6	26.9	9.4	17.3	18.8	10.1	11.3	27.2	17.9	17.5	10.7	11.7	15.6	18.2	6.1	15.9	16.2	6.7	26.9	39.6	11.3	18.5	57.4	12.7	25.5	16.8	8.1	13.5	8.4	17.7	26.7	5.3	17.2	19.0	34.7	14.4	22.4	41.9	28.1	13.9	6.2	11.2	10.4	11.3	28.9	28.2	10.8	22.8	22.0	6.2	21.3	5.5	8.2	4.8	4.1	28.6	4.7	11.4	6.7	10.2	3.9	19.5	5.0	4.3	12.2	9.9	9.9	7.3	11.1	11.2	8.8	9.7	7.7	8.0	8.4	8.1	10.7	6.5	9.6	12.6	5.9	7.9	16.8	3.6	6.2	12.0	4.5	5.7	5.7	3.1	4.3	5.0	5.5	2.1	5.1	4.8	12.2	0.0	7.0	0.4	10.3	6.8	9.0	2.4	13.3	13.8	6.2	8.9	5.4	19.4	19.9	3.8	5.5	8.9	8.0	17.2	0.0	9.2	5.8	6.1	16.1	17.4	1.7	6.2	16.3	5.4	26.2	15.8	1.4	7.2	2.5	6.5	12.2	8.0	2.2	5.0	5.7	10.6	1.6	3.8	4.3	0.0	4.0	5.0	8.5	7.1	9.4	13.4	12.4	6.7	7.4	7.6	4.3
DAPK2	"DRP-1, MGC119312"	ENSG00000035664	"Death associated protein kinase 2"	Q9UIK4	15	63907036-64072033	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	Apoptosis	"Calmodulin-binding, Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 50.2;thyroid gland: 41.9"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 86.6;Late spermatids: 112.5;Oligodendrocytes: 99.9;Proximal enterocytes: 64.0"	"Cancer enriched"	"Detected in many"	15	"thyroid cancer: 30.3"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	14	"basophil: 94.3;eosinophil: 213.0;neutrophil: 65.9"	"Lineage enriched"	"Detected in many"	25	"granulocytes: 213.0"	"Cell line enhanced"	"Detected in many"		"ASC diff: 10.6;HaCaT: 9.2;HMC-1: 18.3;MCF7: 9.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA071581			Supported	"Golgi apparatus,Vesicles"		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 59: Non-specific - Translation"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 31: Spermatids - Spermatogenesis"	"Golgi apparatus, Vesicles"		"HPA071581: AB_2686421"	"unprognostic (3.20e-2)"	"unprognostic (4.07e-2)"	"unprognostic (4.23e-2)"	"unprognostic (1.95e-3)"	"unprognostic (2.88e-2)"	"unprognostic (1.30e-2)"	"unprognostic (2.32e-1)"	"prognostic favorable (5.63e-4)"	"unprognostic (1.04e-1)"	"unprognostic (3.18e-1)"	"unprognostic (9.21e-2)"	"unprognostic (8.51e-2)"	"unprognostic (4.77e-7)"	"unprognostic (5.98e-2)"	"unprognostic (1.45e-1)"	"unprognostic (3.20e-3)"	"unprognostic (9.07e-2)"	12.5	2.2	5.9	2.7	7.6	15.9	8.8	5.9	8.1	6.7	4.3	9.8	20.6	1.6	0.2	3.3	1.7	1.5	28.0	5.5	6.7	4.5	2.0	20.0	3.1	6.2	6.8	0.9	2.7	0.9	1.6	0.4	6.6	5.1	6.6	0.4	7.5	3.6	50.2	8.1	21.3	1.7	6.0	7.8	9.9	3.1	6.6	1.5	41.9	19.6	2.6	2.4	9.5	9.5	3.1	2.3	6.1	1.5	10.6	0.5	0.0	2.1	6.7	1.1	1.2	1.0	1.6	0.2	0.7	6.7	3.7	9.2	3.8	0.1	0.6	0.2	0.2	1.3	4.5	0.1	0.1	0.1	18.3	1.1	7.9	0.4	0.2	7.0	0.7	0.1	0.4	0.1	0.7	9.7	0.0	0.4	0.7	3.1	2.2	2.9	0.0	0.3	0.0	3.2	0.4	0.3	0.4	1.2	0.0	1.5	5.2	0.4	0.4	0.9	1.0	1.4	1.8	0.6	0.2	0.0	0.0	3.0	0.3	94.3	0.2	213.0	2.1	0.1	0.9	1.3	0.6	2.2	0.2	0.4	0.0	1.4	65.9	2.7	0.1	8.6	0.1	1.3	5.9	7.6	5.9	8.1	5.5	6.7	6.2	6.8	6.6	6.0	6.6	9.5	24.9	86.6	22.3	5.2	4.8	11.6	7.0	8.7	0.6	0.1	9.4	7.4	46.2	1.5	14.6	0.0	0.0	0.1	22.6	45.2	1.9	9.1	25.3	3.0	1.6	6.4	8.4	0.8	15.9	35.6	0.2	8.7	16.3	7.8	15.2	1.3	5.7	1.3	0.4	5.0	2.1	17.0	6.1	1.3	0.8	112.5	3.1	3.2	0.0	15.0	0.3	2.1	2.1	11.1	99.9	9.4	30.6	5.7	0.4	12.0	64.0	0.3	2.8	0.3	13.1	7.6	4.5	2.6	4.9	0.5	4.1	0.1	14.9	1.9	19.6	14.0
DAPK3	"ZIP, ZIPK"	ENSG00000167657	"Death associated protein kinase 3"	O43293	19	3958453-3971123	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Apoptosis, Transcription, Transcription regulation, Translation regulation"	"Activator, Chromatin regulator, Kinase, Serine/threonine-protein kinase, Transferase"	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028569	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 1: Pancreatic cells - Digestion"	Cytosol	Nucleoplasm	"HPA028569: AB_10794319"	"unprognostic (5.72e-2)"	"unprognostic (3.28e-2)"	"unprognostic (3.34e-3)"	"prognostic favorable (2.01e-5)"	"unprognostic (1.83e-1)"	"unprognostic (2.37e-1)"	"unprognostic (7.72e-3)"	"unprognostic (2.16e-1)"	"unprognostic (2.46e-2)"	"unprognostic (4.95e-2)"	"unprognostic (1.84e-3)"	"unprognostic (7.64e-2)"	"prognostic unfavorable (6.49e-4)"	"unprognostic (9.92e-2)"	"unprognostic (1.41e-1)"	"unprognostic (5.48e-2)"	"unprognostic (2.14e-1)"	49.9	25.4	15.0	29.0	15.2	18.9	47.2	14.3	27.9	58.3	18.9	92.2	30.9	85.0	8.2	37.0	55.4	36.0	106.2	16.8	13.9	27.6	30.4	72.5	21.2	16.2	15.4	48.4	36.4	19.0	38.5	31.9	18.8	53.3	11.0	9.0	41.3	39.3	113.6	51.2	44.4	36.6	11.9	29.6	61.4	42.6	17.4	15.4	31.0	21.1	11.3	59.5	45.3	17.3	79.2	61.1	37.5	47.6	27.5	30.9	57.8	106.0	84.5	84.7	55.5	113.4	23.3	43.4	50.8	93.8	59.6	61.7	36.9	60.3	30.7	64.0	61.2	17.5	76.7	65.9	87.2	42.7	63.1	70.6	73.6	77.0	44.0	50.8	71.2	29.2	56.3	73.2	52.5	51.0	42.4	31.9	58.5	31.8	48.6	52.5	55.3	40.5	51.0	60.9	59.1	41.1	71.4	84.9	61.1	43.8	61.4	33.1	134.8	108.3	49.3	98.1	134.5	81.1	72.4	50.7	86.3	44.0	59.0	32.5	18.0	32.5	23.0	20.3	16.7	15.9	17.8	21.6	16.2	16.6	13.1	12.9	29.8	24.3	14.3	18.6	23.6	14.6	15.0	15.2	14.3	27.9	16.8	13.9	16.2	15.4	18.8	11.9	17.4	17.3	24.1	25.6	10.5	6.5	17.0	100.7	99.7	84.1	27.9	15.2	23.9	15.6	29.2	24.3	35.0	11.0	2.1	50.5	14.5	69.2	17.6	90.3	40.3	27.9	28.2	38.3	27.4	7.0	9.6	88.2	79.1	27.8	40.8	37.5	20.3	24.8	21.4	7.9	22.9	11.8	7.1	48.2	48.8	13.6	22.8	23.6	22.7	16.6	37.4	8.4	25.7	12.8	30.9	6.0	6.7	117.7	49.9	22.6	13.3	46.1	59.6	14.3	18.8	10.7	32.9	19.9	53.0	34.6	15.7	24.4	71.7	93.2	15.1	26.2	29.7	46.3
DARS2	"FLJ10514, mtAspRS"	ENSG00000117593	"Aspartyl-tRNA synthetase 2, mitochondrial"	Q6PI48	1	173824653-173858808	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026506, HPA026528"	Enhanced		Supported	Nucleoplasm,Mitochondria		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Mitochondria	Nucleoplasm	"HPA026506: AB_1847482, HPA026528: AB_1847483"	"unprognostic (3.14e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.06e-1)"	"unprognostic (8.85e-3)"	"unprognostic (1.33e-1)"	"unprognostic (1.14e-2)"	"unprognostic (1.05e-3)"	"unprognostic (4.10e-3)"	"unprognostic (2.20e-1)"	"unprognostic (1.42e-1)"	"unprognostic (6.17e-2)"	"unprognostic (1.15e-1)"	"prognostic favorable (1.74e-4)"	"unprognostic (3.30e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.13e-1)"	"unprognostic (4.73e-3)"	8.8	9.8	3.1	7.6	3.5	5.4	7.5	3.7	4.3	7.1	11.5	14.6	8.7	4.3	4.7	6.4	5.2	4.8	8.4	3.1	3.8	19.9	13.5	5.7	9.2	3.3	3.6	4.4	5.7	15.5	2.9	7.6	3.4	5.3	15.4	5.2	5.2	5.0	5.6	3.4	10.4	5.6	3.5	6.2	9.3	6.2	3.9	10.6	7.6	13.5	12.0	6.7	4.1	3.7	74.8	50.5	26.3	18.7	24.0	34.2	38.6	32.3	30.0	49.2	37.0	47.5	68.2	41.6	45.2	27.2	31.3	77.5	86.6	56.5	66.7	48.6	41.5	35.2	22.7	31.8	24.0	30.9	30.8	23.2	25.3	50.9	44.5	15.4	49.8	30.5	74.7	31.0	39.6	19.9	38.8	16.1	60.2	83.0	63.2	44.3	40.6	78.2	43.7	24.9	40.4	34.2	36.3	79.6	51.3	47.0	84.5	39.7	21.2	22.9	35.3	32.6	52.5	21.7	60.4	46.3	13.3	33.3	51.5	3.9	4.4	3.3	3.8	7.0	5.4	6.0	3.4	3.2	6.4	4.4	3.8	2.6	0.2	3.5	5.0	2.5	3.9	3.5	3.1	3.5	3.7	4.3	3.1	3.8	3.3	3.6	3.4	3.5	3.9	3.7	3.7	3.2	3.1	7.2	5.7	1.8	4.1	3.1	6.2	2.3	3.3	2.5	12.6	4.3	4.2	5.5	0.0	9.7	3.1	4.8	7.9	3.9	2.5	3.9	4.9	4.5	4.2	9.4	5.3	2.7	16.0	3.9	7.1	4.5	5.7	4.5	1.8	5.4	10.3	3.3	6.5	5.2	0.0	4.4	2.2	1.5	3.1	5.1	1.8	8.4	5.6	2.9	3.1	4.0	5.1	3.8	1.9	1.5	7.1	2.6	5.9	7.1	3.0	2.7	0.0	6.2	4.0	8.9	7.1	8.0	1.6	4.2	4.4	9.2	7.2	2.9
DAZAP2	KIAA0058	ENSG00000183283	"DAZ associated protein 2"	Q15038	12	51238724-51271362	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045940			Supported	"Nuclear speckles"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 59: Non-specific - Transcription"	"Nuclear speckles"		"HPA045940: AB_2679506"	"unprognostic (1.00e-2)"	"unprognostic (3.13e-2)"	"unprognostic (7.35e-2)"	"unprognostic (3.44e-2)"	"unprognostic (1.00e-1)"	"unprognostic (5.47e-2)"	"unprognostic (4.75e-3)"	"unprognostic (8.43e-2)"	"unprognostic (4.75e-2)"	"unprognostic (3.30e-1)"	"unprognostic (5.80e-2)"	"unprognostic (1.42e-1)"	"prognostic favorable (3.94e-9)"	"unprognostic (1.79e-1)"	"unprognostic (2.40e-1)"	"unprognostic (3.04e-1)"	"unprognostic (5.84e-3)"	136.4	115.7	112.2	187.5	125.3	613.5	154.0	136.6	124.4	150.5	109.8	206.2	194.9	131.6	122.5	129.9	180.5	168.0	202.1	105.1	125.9	251.4	198.4	193.2	220.6	132.7	119.8	114.1	116.5	227.3	30.7	79.5	134.4	152.8	215.5	75.2	140.7	171.8	113.5	121.4	200.5	148.4	129.8	224.3	174.3	52.7	116.5	213.2	209.8	106.7	241.5	190.3	76.3	151.5	159.8	209.0	95.4	92.2	201.1	171.5	57.6	104.6	208.9	187.7	162.8	155.9	239.0	153.2	262.2	209.9	130.0	147.8	134.2	178.4	189.2	167.3	160.2	227.1	129.7	91.0	216.4	265.5	350.2	220.5	252.1	175.3	147.2	207.2	234.8	118.8	141.6	303.1	155.4	252.6	219.8	145.6	19.6	109.2	58.7	123.2	144.7	165.3	244.9	260.2	103.3	101.0	159.3	137.9	121.3	56.7	190.5	382.7	195.7	111.1	102.4	136.9	132.6	231.5	237.5	158.6	161.2	175.0	66.9	2018.1	2144.1	3354.3	1055.9	1770.0	979.3	1090.7	962.8	1037.9	1354.1	1068.7	1063.1	918.3	3499.5	1045.4	1727.1	875.9	1420.3	4885.3	112.2	125.3	136.6	124.4	105.1	125.9	132.7	119.8	134.4	129.8	116.5	151.5	116.7	144.2	205.1	19.6	271.9	113.8	201.2	144.6	167.9	50.6	127.7	88.5	114.3	165.8	127.9	235.4	58.4	55.8	167.4	337.2	266.1	158.6	28.1	115.1	87.2	138.3	126.3	155.6	16.8	194.7	53.5	108.0	171.8	142.1	182.2	72.2	157.1	177.1	209.4	67.3	16.8	230.6	140.4	444.4	214.2	85.6	117.4	282.0	135.2	19.7	324.4	88.7	221.4	15.6	43.9	198.0	275.8	95.5	169.5	179.9	233.3	292.7	155.9	55.2	46.0	63.2	130.4	39.4	35.4	153.5	133.3	124.9	249.6	72.8	182.4	268.7
DBF4	"ASK, chif, DBF4A, ZDBF1"	ENSG00000006634	"DBF4 zinc finger"	Q9UBU7	7	87876216-87909553	"Predicted intracellular proteins"	"Cell cycle, DNA replication"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	20	"testis: 15.1"	"Group enriched"	"Detected in all"	4	"Early spermatids: 468.6;Spermatocytes: 569.4"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in single"		"basophil: 1.0"	"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA042923			Supported	"Nucleoplasm,Nuclear bodies"		Yes	Yes			"Cluster 10: Basophils - Unknown function"	"Cluster 74: Testis - Spermatogenesis"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Nucleoplasm, Nuclear bodies"		"HPA042923: AB_2678222"	"unprognostic (2.48e-1)"	"unprognostic (8.32e-2)"	"unprognostic (1.15e-2)"	"unprognostic (4.86e-3)"	"unprognostic (2.81e-2)"	"unprognostic (3.63e-1)"	"prognostic unfavorable (4.45e-6)"	"unprognostic (1.05e-1)"	"prognostic unfavorable (6.86e-4)"	"unprognostic (1.46e-3)"	"unprognostic (1.05e-3)"	"unprognostic (2.78e-3)"	"prognostic unfavorable (6.42e-7)"	"unprognostic (1.98e-2)"	"unprognostic (2.40e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.30e-1)"	0.1	0.2	0.2	0.2	0.4	0.6	0.2	0.7	0.4	0.2	0.1	0.2	0.2	0.2	0.3	0.1	0.1	0.4	0.1	0.2	0.1	0.2	0.2	0.1	0.5	0.2	0.2	0.2	0.1	0.1	0.0	0.1	0.2	0.2	0.2	0.2	0.1	0.1	0.1	0.2	0.3	0.0	0.1	0.3	0.2	15.1	0.2	0.6	0.3	0.0	0.5	0.1	0.1	0.3	0.9	0.8	2.0	2.5	0.4	0.4	0.5	1.0	0.2	1.0	2.1	1.4	0.6	2.1	0.6	0.6	1.7	0.9	2.2	0.5	1.0	1.6	1.3	1.3	1.0	0.4	0.1	1.7	1.0	0.4	0.6	1.2	1.0	0.3	0.9	1.9	1.2	4.2	1.4	1.7	2.8	2.0	2.0	2.1	1.9	0.7	3.1	2.5	0.8	0.1	3.0	1.8	1.2	2.2	1.0	1.6	0.9	1.6	0.1	1.2	1.4	3.1	2.0	2.3	5.2	2.1	0.8	3.1	2.5	1.0	0.1	0.1	0.3	0.0	0.1	0.2	0.2	0.1	0.0	0.2	0.2	0.3	0.2	0.2	0.0	0.2	0.4	0.1	0.2	0.4	0.7	0.4	0.2	0.1	0.2	0.2	0.2	0.1	0.2	0.3	13.3	3.2	12.6	5.5	38.4	15.6	16.4	10.7	12.0	6.6	13.0	16.8	3.7	2.8	7.7	9.2	12.5	19.6	59.2	9.7	3.9	8.3	468.6	12.1	23.6	11.1	14.9	40.8	14.7	14.7	36.4	12.4	14.3	17.7	31.0	19.4	6.4	6.5	16.1	3.3	9.1	20.6	16.2	9.1	15.5	116.0	15.5	20.8	12.4	2.8	11.0	2.1	24.7	6.0	6.7	14.1	8.5	9.4	48.9	18.4	4.2	5.8	10.2	16.6	13.1	9.7	11.4	569.4	74.6	20.5	12.6	9.6	44.4	13.5	22.3	11.7
DBF4B	"ASKL1, chifb, DRF1, FLJ13087, ZDBF1B"	ENSG00000161692	"DBF4 zinc finger B"	Q8NFT6	17	44708608-44752264	"Predicted intracellular proteins"	"Cell cycle"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Bipolar cells: 30.0;Horizontal cells: 30.3;Oligodendrocytes: 30.9;Spermatocytes: 35.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			"HPA048465, HPA077959"	Approved		Supported	Nucleoplasm,Vesicles		NA	Yes			"Cluster 52: Eosinophils - Transcription"	"Cluster 68: Epididymis - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	Nucleoplasm	Vesicles	"HPA048465: AB_2680405, HPA077959: "	"unprognostic (2.44e-1)"	"unprognostic (1.26e-1)"	"unprognostic (6.37e-2)"	"unprognostic (2.15e-3)"	"unprognostic (1.62e-1)"	"unprognostic (6.13e-2)"	"unprognostic (1.53e-4)"	"unprognostic (7.61e-2)"	"unprognostic (1.54e-2)"	"unprognostic (4.08e-2)"	"unprognostic (8.43e-3)"	"unprognostic (1.83e-1)"	"unprognostic (4.23e-6)"	"unprognostic (1.50e-1)"	"unprognostic (3.36e-1)"	"unprognostic (2.57e-1)"	"unprognostic (1.39e-1)"	0.9	0.7	1.1	1.2	1.1	2.0	1.3	1.2	1.8	1.5	0.5	1.9	0.6	1.9	3.5	1.4	1.8	0.7	0.8	1.1	1.0	1.6	0.6	0.8	1.5	1.1	1.0	1.7	0.9	0.8	1.7	0.9	1.1	2.3	1.2	2.9	1.1	1.3	0.6	2.0	1.5	1.5	0.8	1.6	1.3	5.1	1.2	1.9	2.7	0.4	1.3	1.6	1.3	1.2	3.7	7.7	5.7	4.2	0.5	1.1	4.9	3.9	1.7	8.1	7.9	3.3	3.1	5.5	2.1	1.3	7.2	3.6	5.0	1.7	9.3	9.2	8.2	7.0	6.2	4.3	0.2	4.8	5.9	0.5	0.6	4.4	1.4	1.8	4.1	9.3	8.9	5.6	4.4	4.0	7.1	2.9	2.5	7.7	4.0	6.2	6.6	2.3	1.8	2.2	3.1	3.4	3.8	1.2	2.9	6.1	3.9	3.1	1.8	2.8	5.2	3.6	7.2	2.6	3.5	7.2	2.1	4.1	4.3	0.0	0.1	0.4	0.0	0.3	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.2	0.1	0.1	0.1	1.1	1.1	1.2	1.8	1.1	1.0	1.1	1.0	1.1	0.8	1.2	1.2	2.1	0.0	1.1	15.0	4.0	0.6	2.6	1.2	1.2	30.0	1.5	1.3	1.1	0.0	2.1	5.5	12.5	4.2	5.8	0.6	0.0	0.3	8.1	2.0	2.2	2.8	4.2	5.5	11.4	0.8	1.4	2.3	1.5	1.1	3.8	9.6	3.3	0.3	1.4	30.3	11.0	0.3	0.0	1.3	3.1	7.4	1.2	2.5	5.4	5.6	1.4	7.2	2.1	7.5	30.9	0.2	0.2	3.0	3.4	2.0	0.7	0.5	1.9	15.7	0.0	4.5	2.0	35.7	16.5	1.9	0.1	1.4	1.4	5.3	1.1	2.3
DBN1	D0S117E	ENSG00000113758	"Drebrin 1"	Q16643	5	177456608-177474401	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Differentiation, Neurogenesis"	"Actin-binding, Developmental protein"	"Alzheimer disease, Amyloidosis, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Ductal cells: 87.1;Pancreatic endocrine cells: 64.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	7	"dendritic cells: 5.8;granulocytes: 9.4;T-cells: 14.0"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051452, HPA056940"	Enhanced	Supported	Supported	"Plasma membrane,Actin filaments"		NA	NA		2000000	"Cluster 16: MAIT-cells - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 12: NES - Nervous system development"	"Cluster 50: Fibroblasts - ECM organization"	"Plasma membrane, Actin filaments"		"HPA051452: AB_2681489, HPA056940: AB_2683279"	"unprognostic (3.81e-2)"	"unprognostic (6.60e-3)"	"unprognostic (2.88e-2)"	"unprognostic (7.57e-3)"	"unprognostic (9.32e-2)"	"unprognostic (5.68e-2)"	"unprognostic (2.01e-3)"	"unprognostic (4.29e-2)"	"unprognostic (1.73e-2)"	"unprognostic (7.92e-2)"	"unprognostic (2.94e-2)"	"unprognostic (3.64e-1)"	"prognostic favorable (8.28e-4)"	"unprognostic (1.53e-1)"	"unprognostic (4.56e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.76e-3)"	59.4	9.3	44.8	17.6	52.5	6.4	36.5	19.3	71.7	59.7	18.6	67.6	9.5	84.4	10.2	30.9	44.7	24.4	39.7	70.1	45.4	52.0	4.0	24.7	9.0	33.8	25.4	34.8	16.9	17.1	45.8	7.1	32.3	29.7	5.9	5.5	33.1	23.9	27.6	36.6	25.0	28.6	24.0	14.2	47.4	27.0	39.7	14.6	33.4	9.0	4.4	61.0	33.1	35.5	17.4	56.1	182.0	319.1	42.4	66.2	56.5	198.6	50.3	113.4	94.5	193.9	59.0	0.3	139.5	155.1	39.0	27.0	80.9	144.0	53.6	5.2	70.4	111.6	72.9	82.0	149.3	43.0	20.5	87.1	37.1	127.3	38.0	113.3	189.4	131.4	54.0	26.0	84.2	25.1	115.1	63.8	264.1	5.7	123.4	338.1	197.2	34.5	85.3	23.7	213.7	289.8	67.0	28.8	111.5	58.4	78.7	42.6	298.6	126.7	169.3	28.2	94.9	6.3	3.1	177.5	53.2	40.5	80.5	9.4	1.4	1.1	10.3	0.8	14.0	0.3	0.3	7.2	1.8	0.4	0.4	5.2	3.2	0.3	0.8	5.8	0.2	2.2	44.8	52.5	19.3	71.7	70.1	45.4	33.8	25.4	32.3	24.0	39.7	35.5	44.2	3.2	1.5	8.1	1.2	10.3	13.7	24.6	9.1	7.0	7.6	9.1	5.1	2.8	11.1	9.2	4.2	1.0	4.5	1.4	1.9	87.1	16.9	8.4	44.0	43.2	40.7	4.8	15.7	43.4	2.8	56.1	11.7	18.4	10.8	49.4	20.7	0.0	1.7	42.1	13.0	2.4	40.7	1.8	8.9	41.6	50.1	6.1	8.8	2.8	2.4	13.4	1.0	5.0	1.0	64.5	0.6	41.0	4.0	16.9	0.6	6.3	5.2	4.5	19.7	10.8	43.4	6.5	26.7	20.1	7.2	0.8	10.4	8.1	3.9	7.5
DBNL	"ABP1, HIP-55, SH3P7"	ENSG00000136279	"Drebrin like"	Q9UJU6	7	44044640-44069456	"Plasma proteins, Predicted intracellular proteins"	"Adaptive immunity, Endocytosis, Immunity, Transport"	Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"monocytes: 338.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020265, HPA027735"	Enhanced		Supported	"Vesicles,Plasma membrane"		NA	NA		3500000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 3: Monocytes - Immune response regulation"	"Vesicles, Plasma membrane"		"HPA020265: AB_1850723, HPA027735: AB_10603790"	"unprognostic (9.57e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.04e-2)"	"unprognostic (5.63e-2)"	"prognostic unfavorable (2.12e-5)"	"unprognostic (2.25e-1)"	"unprognostic (6.18e-3)"	"unprognostic (1.83e-1)"	"unprognostic (5.88e-2)"	"unprognostic (8.92e-2)"	"unprognostic (5.76e-3)"	"unprognostic (5.92e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.79e-1)"	"unprognostic (2.10e-1)"	"unprognostic (1.46e-1)"	"unprognostic (9.51e-2)"	58.1	51.6	44.2	62.8	45.1	76.6	51.3	41.7	50.4	72.4	39.9	54.6	34.7	56.0	20.2	189.0	47.8	47.2	49.2	45.8	45.2	50.7	51.1	57.8	99.6	46.2	44.8	38.0	44.3	38.4	47.8	34.9	48.4	57.0	30.6	9.4	57.5	38.0	34.3	59.9	64.7	44.8	44.3	119.5	54.7	20.8	44.6	64.8	47.6	16.4	89.1	60.3	92.0	43.4	57.6	89.1	60.5	56.6	77.0	49.7	46.0	95.9	93.6	111.5	91.5	90.0	82.5	132.3	70.0	126.1	133.6	101.9	35.6	130.6	40.7	70.6	38.9	51.9	73.8	52.4	78.5	75.8	70.3	46.6	53.3	107.1	35.2	71.5	74.1	83.9	63.8	49.3	105.5	91.5	136.5	85.3	43.1	72.9	73.0	69.4	48.1	64.5	69.8	90.5	65.6	89.8	69.6	121.5	24.4	43.8	94.0	99.4	121.1	82.7	75.5	49.5	113.6	102.7	49.4	81.2	78.3	83.2	183.8	263.3	377.1	295.0	190.3	422.7	148.3	253.9	138.0	155.0	362.5	261.7	136.5	145.1	357.4	192.4	437.9	376.6	183.1	558.8	44.2	45.1	41.7	50.4	45.8	45.2	46.2	44.8	48.4	44.3	44.6	43.4	49.9	44.8	36.2	10.7	105.4	17.6	34.1	62.9	19.4	33.0	26.7	24.0	30.6	25.8	42.2	31.3	35.5	78.9	101.6	58.5	45.0	87.0	10.3	30.7	39.3	44.8	37.8	45.8	7.4	73.2	146.4	39.3	54.6	50.7	65.9	42.3	32.5	22.5	176.0	40.4	6.7	50.0	38.7	129.6	48.6	10.6	37.0	113.4	55.2	7.5	338.3	42.5	112.3	5.5	11.4	105.9	74.0	33.8	50.2	31.5	49.0	33.6	21.6	38.6	6.6	29.0	54.6	24.4	12.8	64.4	26.7	87.3	69.5	51.9	44.0	51.1
DBT	"BCKAD-E2, BCKDH-E2, BCOADC-E2"	ENSG00000137992	"Dihydrolipoamide branched chain transacylase E2"	P11182	1	100186919-100249834	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Acyltransferase, Transferase"	"Disease variant, Maple syrup urine disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 65.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026481, HPA026485, HPA026533"	Enhanced		Supported	Mitochondria		NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 81: Kidney & Liver - Metabolism"	"Cluster 6: T47d - Mammary gland"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"HPA026481: AB_1847504, HPA026485: AB_1847505, HPA026533: AB_1847506"	"unprognostic (1.23e-1)"	"unprognostic (1.23e-1)"	"unprognostic (3.67e-2)"	"unprognostic (5.29e-2)"	"unprognostic (1.92e-2)"	"unprognostic (1.63e-1)"	"unprognostic (3.88e-2)"	"unprognostic (1.65e-2)"	"unprognostic (6.01e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.37e-2)"	"unprognostic (2.90e-1)"	"prognostic favorable (8.79e-12)"	"unprognostic (1.63e-1)"	"unprognostic (3.77e-1)"	"unprognostic (9.67e-2)"	"unprognostic (9.92e-2)"	11.1	13.6	4.4	5.9	5.2	4.6	11.8	4.3	4.9	11.3	3.7	9.2	8.0	8.2	6.0	12.8	11.1	6.3	25.9	4.2	5.0	30.3	43.4	7.4	7.5	5.6	4.6	11.1	15.4	19.4	2.3	10.0	4.5	15.9	10.2	5.9	12.8	11.2	13.4	7.4	7.1	8.0	4.6	6.1	17.3	4.7	5.2	9.9	17.2	19.2	8.9	9.4	4.0	7.1	18.5	8.2	9.5	17.4	23.9	17.6	20.6	13.1	12.3	13.9	15.6	17.7	7.4	17.1	18.3	9.3	8.1	18.7	20.3	17.7	16.8	18.2	11.5	12.1	16.3	9.5	18.0	16.1	6.1	18.2	18.1	10.6	17.9	11.4	12.4	17.9	20.9	19.2	11.1	4.9	14.4	4.1	18.6	14.8	18.4	14.1	30.3	14.2	15.3	15.9	15.8	8.7	27.5	25.4	23.7	16.7	20.9	11.9	10.8	12.1	7.6	15.9	11.0	12.7	14.1	9.1	13.8	10.7	5.3	2.1	1.2	0.8	2.2	1.5	2.4	1.9	2.0	1.9	1.2	2.1	1.8	1.9	1.1	2.0	1.4	1.3	1.5	1.1	4.4	5.2	4.3	4.9	4.2	5.0	5.6	4.6	4.5	4.6	5.2	7.1	9.6	22.4	36.4	29.0	9.6	6.8	6.5	9.8	13.6	22.2	11.9	8.5	65.9	18.6	11.3	12.9	39.6	19.8	10.9	11.4	50.9	10.0	0.8	18.5	20.5	11.7	9.1	8.2	24.0	8.5	11.6	11.3	15.8	15.4	2.5	19.6	15.4	53.2	8.7	15.2	25.2	12.0	14.2	8.8	5.0	1.7	15.2	7.3	3.6	3.7	10.3	14.5	12.3	22.1	26.1	6.4	6.0	21.1	7.1	9.4	9.9	32.1	18.0	22.4	6.6	15.0	12.9	2.8	6.1	18.7	7.2	8.2	9.7	17.3	15.1	5.5
DCAF1	"KIAA0800, MGC102804, VPRBP"	ENSG00000145041	"DDB1 and CUL4 associated factor 1"	Q9Y4B6	3	51395867-51500002	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, Transcription, Transcription regulation, Ubl conjugation pathway"	"Chromatin regulator, Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 53.4"	"Cell type enhanced"	"Detected in many"		"Glandular and luminal cells: 17.9;Granulosa cells: 13.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036142, HPA052445, HPA053203"	Approved		Supported	"Nucleoplasm,Nucleoli fibrillar center"		No	No			"Cluster 27: Non-specific - Gene expression"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm	"Nucleoli fibrillar center"	"HPA036142: AB_10669666, HPA052445: AB_2681835, HPA053203: AB_2682080"	"unprognostic (7.51e-2)"	"unprognostic (3.19e-1)"	"unprognostic (3.71e-3)"	"unprognostic (1.26e-1)"	"unprognostic (5.15e-2)"	"unprognostic (9.75e-2)"	"unprognostic (2.58e-2)"	"unprognostic (1.24e-1)"	"unprognostic (8.75e-2)"	"unprognostic (2.15e-1)"	"unprognostic (2.89e-2)"	"unprognostic (2.21e-2)"	"prognostic favorable (7.45e-5)"	"unprognostic (5.49e-2)"	"unprognostic (5.00e-1)"	"unprognostic (6.81e-2)"	"unprognostic (1.64e-1)"	11.4	11.3	7.6	11.7	8.8	15.9	11.2	11.2	9.4	9.4	9.8	11.0	7.9	10.3	9.4	10.6	8.9	7.4	9.5	7.8	9.3	11.0	11.5	10.0	14.8	8.4	8.8	10.3	10.4	18.9	8.6	10.3	8.6	9.7	10.9	19.7	11.3	9.6	27.9	13.5	11.4	9.2	8.0	11.3	10.3	53.4	8.5	18.6	14.6	16.1	15.9	11.2	10.0	9.0	19.9	23.9	22.8	20.7	20.1	15.9	21.6	21.8	16.2	23.1	22.5	26.4	18.8	48.1	11.7	17.2	35.3	17.1	43.3	19.5	29.6	33.7	21.5	41.2	32.4	22.8	14.7	54.4	28.7	10.6	22.2	29.8	21.6	15.0	18.2	26.1	24.5	30.3	18.3	20.3	41.8	22.0	24.0	23.5	26.0	17.5	24.4	32.0	18.0	30.5	11.8	21.0	24.1	22.0	13.2	16.7	15.0	22.8	22.9	18.8	25.1	31.4	33.9	20.5	29.7	48.2	21.9	36.6	15.7	2.5	3.0	2.4	6.5	3.3	7.4	5.1	5.6	5.6	4.8	4.9	6.0	5.1	0.7	5.8	5.0	3.8	6.7	4.9	7.6	8.8	11.2	9.4	7.8	9.3	8.4	8.8	8.6	8.0	8.5	9.0	11.1	3.2	10.6	0.0	3.6	0.0	0.0	0.0	0.0	0.0	11.3	9.4	0.0	0.0	6.8	3.7	0.0	7.6	9.7	0.0	1.9	7.0	0.0	11.2	10.3	5.6	0.0	0.0	0.0	6.7	5.7	3.0	0.0	17.9	6.3	13.1	0.0	0.0	7.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.9	0.0	0.0	2.6	0.0	0.0	0.0	0.0	7.5	0.0	0.0	2.8	0.0	0.0	6.1	5.1	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	10.5	5.0	7.4	0.0	0.0
DCAF13	"DKFZP564O0463, Gm83, HSPC064, Sof1, WDSOF1"	ENSG00000164934	"DDB1 and CUL4 associated factor 13"	Q9NV06	8	103414714-103443453	"Predicted intracellular proteins"	"Ribosome biogenesis, rRNA processing, Ubl conjugation pathway"	Ribonucleoprotein		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044504	Uncertain		Supported	"Nucleoplasm,Nucleoli,Cell Junctions,Centrosome,Cytosol"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 21: OE19 - Mitochondria"	"Cluster 10: Non-specific - Unknown function"	"Nucleoplasm, Nucleoli"	"Cell Junctions, Centrosome, Cytosol"	"HPA044504: AB_2678963"	"prognostic unfavorable (4.06e-4)"	"unprognostic (4.39e-2)"	"unprognostic (1.70e-1)"	"unprognostic (4.46e-3)"	"unprognostic (3.57e-2)"	"unprognostic (7.86e-3)"	"prognostic unfavorable (8.05e-6)"	"unprognostic (5.92e-3)"	"unprognostic (1.97e-1)"	"unprognostic (1.27e-2)"	"unprognostic (5.54e-3)"	"unprognostic (2.31e-2)"	"prognostic unfavorable (2.85e-4)"	"unprognostic (1.53e-1)"	"unprognostic (1.55e-1)"	"unprognostic (6.42e-2)"	"unprognostic (8.63e-2)"	16.7	19.2	10.3	22.9	11.0	15.2	23.9	11.3	15.6	17.7	12.8	20.7	16.1	16.2	19.1	21.3	18.0	12.7	16.2	10.9	11.1	32.4	20.7	12.9	24.7	10.8	13.7	13.6	18.5	20.0	15.6	18.7	11.4	14.7	21.4	13.8	14.3	12.8	18.8	15.7	14.5	18.2	11.3	14.3	15.6	32.2	10.4	24.7	18.1	16.0	30.5	33.6	14.6	11.9	96.5	84.2	76.9	79.0	54.7	62.7	57.6	70.1	53.2	64.4	65.9	83.1	90.9	132.2	116.1	73.3	64.0	69.9	105.8	89.0	124.1	127.7	74.9	183.0	48.0	95.9	62.2	76.1	75.7	51.8	59.9	95.9	157.5	40.3	91.4	89.6	125.3	56.7	99.9	78.0	144.9	79.3	118.0	268.9	129.6	92.6	93.3	136.4	95.3	78.6	97.6	92.3	43.5	67.3	83.1	67.4	103.9	51.2	60.6	65.3	105.3	85.5	94.7	61.7	116.5	188.0	88.0	162.8	85.7	19.6	37.6	22.1	35.5	46.5	48.8	60.8	37.5	38.2	54.4	50.8	37.0	38.2	4.2	52.8	35.2	28.3	58.0	44.9	10.3	11.0	11.3	15.6	10.9	11.1	10.8	13.7	11.4	11.3	10.4	11.9	40.0	16.0	17.0	9.1	39.7	79.5	76.6	92.4	38.1	19.6	21.6	24.9	20.8	12.8	53.8	33.1	25.0	57.9	34.8	11.0	39.2	55.0	54.6	26.9	35.4	39.9	14.5	22.1	9.5	48.4	75.0	37.4	17.9	24.7	40.6	49.3	17.5	16.9	42.7	16.8	9.0	17.5	69.2	14.8	23.9	16.7	24.2	22.9	26.6	11.2	28.5	28.8	27.8	16.1	20.0	43.6	12.3	17.7	30.3	51.1	24.3	79.1	36.0	23.7	13.1	50.2	48.0	102.0	86.3	37.1	77.0	33.9	33.1	41.7	28.1	56.9
DCAF17	"C2orf37, FLJ13096"	ENSG00000115827	"DDB1 and CUL4 associated factor 17"	Q5H9S7	2	171434217-171485052	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Ubl conjugation pathway"		"Deafness, Diabetes mellitus, Hypotrichosis, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Oligodendrocytes: 56.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA053339, HPA055040"	Uncertain		Supported	Nucleoplasm		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA053339: AB_2682119, HPA055040: AB_2682680"	"unprognostic (1.60e-2)"	"unprognostic (1.21e-1)"	"unprognostic (4.05e-1)"	"unprognostic (1.03e-2)"	"unprognostic (1.60e-1)"	"unprognostic (5.98e-2)"	"unprognostic (5.60e-2)"	"unprognostic (2.67e-2)"	"unprognostic (2.30e-3)"	"unprognostic (2.08e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.12e-2)"	"unprognostic (1.41e-1)"	"unprognostic (4.27e-1)"	"prognostic unfavorable (7.10e-4)"	"unprognostic (2.79e-2)"	3.9	4.5	5.2	5.4	6.6	3.4	6.4	6.6	6.1	6.1	4.3	5.6	4.5	6.2	6.3	4.4	4.6	3.8	3.5	5.1	5.7	5.6	4.5	3.8	7.2	5.5	5.2	7.1	5.0	6.0	3.8	5.3	5.8	5.0	4.6	13.9	4.3	4.5	3.9	7.2	4.7	4.6	5.5	6.4	4.4	5.7	6.9	7.8	10.2	4.3	6.0	5.6	5.4	10.6	8.5	6.9	8.9	10.6	11.0	11.7	13.6	7.3	7.5	7.3	6.8	8.3	5.5	24.4	5.4	9.1	5.5	8.2	9.1	9.0	9.9	11.4	6.2	11.3	6.2	15.0	11.2	16.2	7.9	9.2	11.6	9.3	20.7	8.6	8.0	7.6	17.9	8.2	10.1	5.2	17.9	14.9	13.2	6.2	4.3	13.4	11.7	13.4	6.2	7.6	7.8	11.3	6.9	5.8	7.4	8.3	4.5	8.3	9.6	8.4	7.6	4.8	6.4	12.4	18.3	20.5	8.9	8.2	8.8	1.1	1.3	0.5	2.3	1.5	3.4	1.3	1.8	1.7	1.0	1.8	2.0	2.5	0.0	1.1	1.3	0.8	1.8	1.6	5.2	6.6	6.6	6.1	5.1	5.7	5.5	5.2	5.8	5.5	6.9	10.6	5.8	0.0	7.5	17.9	8.9	4.7	4.7	4.2	8.6	10.1	7.8	6.0	5.0	7.2	3.1	7.3	12.5	6.5	6.0	4.4	9.8	4.8	2.2	6.2	10.7	5.2	10.2	6.9	18.0	3.9	5.7	5.8	8.2	4.9	3.8	8.2	2.5	7.7	5.6	8.4	23.5	4.5	6.1	8.4	4.6	3.6	6.2	5.0	3.6	15.0	4.4	8.8	5.2	24.6	56.5	6.6	2.0	6.0	6.4	6.3	5.5	6.2	6.1	15.2	0.0	6.7	7.2	13.5	17.1	8.7	5.1	5.6	7.5	9.0	4.3	5.0
DCAF6	"IQWD1, PC326"	ENSG00000143164	"DDB1 and CUL4 associated factor 6"	Q58WW2	1	167935783-168075843	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"skeletal muscle: 641.3;tongue: 470.8"	"Cell type enhanced"	"Detected in all"		"Early spermatids: 438.6;Excitatory neurons: 243.8;Late spermatids: 700.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054305			Supported	"Nucleoplasm,Focal adhesion sites"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Nucleoplasm, Focal adhesion sites"		"HPA054305: AB_2682444"	"unprognostic (1.54e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.42e-1)"	"unprognostic (2.31e-1)"	"unprognostic (2.20e-1)"	"unprognostic (1.19e-1)"	"unprognostic (5.42e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.12e-1)"	"unprognostic (1.74e-1)"	"unprognostic (3.20e-2)"	"unprognostic (9.21e-2)"	"unprognostic (7.06e-2)"	"unprognostic (6.00e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.49e-1)"	29.1	45.9	12.8	16.2	17.5	24.6	29.3	9.3	22.4	32.9	22.1	36.8	21.7	24.7	19.5	29.7	25.6	27.5	129.9	20.5	7.0	28.6	95.1	25.4	17.7	5.6	8.8	25.3	20.9	34.5	19.9	27.3	5.8	35.4	29.3	21.3	28.8	25.3	641.3	21.9	21.5	33.8	5.7	18.5	28.2	82.6	12.3	24.4	23.5	470.8	21.4	28.1	20.1	14.0	64.8	30.0	16.4	27.0	52.7	74.3	57.4	64.9	95.3	44.5	65.7	50.4	53.1	52.8	36.9	83.3	21.4	47.4	25.8	47.9	62.4	30.2	27.6	56.5	42.8	36.4	42.4	25.7	26.1	53.2	47.4	42.3	35.0	67.4	49.1	16.9	64.8	42.9	66.3	14.8	28.9	23.3	10.6	36.0	33.1	21.9	34.0	41.7	110.6	30.9	24.2	19.2	51.8	47.0	36.6	33.9	80.8	31.3	70.3	44.6	27.5	44.0	27.3	45.4	39.3	41.3	59.9	21.6	18.6	5.4	5.5	10.4	4.9	7.5	5.2	4.8	3.9	4.3	6.0	3.3	3.5	4.6	5.7	3.7	12.0	3.6	4.8	4.0	12.8	17.5	9.3	22.4	20.5	7.0	5.6	8.8	5.8	5.7	12.3	14.0	22.9	57.7	43.3	81.3	22.5	57.9	30.5	32.1	33.0	14.7	26.7	19.3	216.3	48.6	43.4	25.8	22.9	75.7	19.7	28.1	17.6	33.0	438.6	39.3	24.1	25.3	21.1	111.9	243.8	19.3	32.4	42.7	39.3	35.5	19.6	73.0	23.6	95.4	19.6	5.0	90.0	27.9	26.4	44.0	38.3	700.1	57.5	23.6	37.4	70.3	113.0	15.9	18.6	108.6	71.0	21.2	26.7	48.5	31.1	35.6	35.7	34.9	52.3	18.4	32.9	29.1	30.6	108.3	64.1	34.6	39.8	81.3	22.2	81.5	33.0	29.0
DCAF7	"HAN11, SWAN-1, WDR68"	ENSG00000136485	"DDB1 and CUL4 associated factor 7"	P61962	17	63550477-63594279	"Predicted intracellular proteins"	"Ubl conjugation pathway"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022948, HPA022962"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	Cytosol	"HPA022948: AB_1858820, HPA022962: AB_1858821"	"unprognostic (7.75e-2)"	"unprognostic (3.31e-1)"	"unprognostic (1.37e-3)"	"unprognostic (3.78e-2)"	"unprognostic (1.03e-1)"	"unprognostic (7.24e-2)"	"prognostic unfavorable (2.42e-4)"	"unprognostic (1.86e-1)"	"unprognostic (2.28e-2)"	"unprognostic (3.06e-2)"	"unprognostic (9.79e-2)"	"unprognostic (3.38e-2)"	"prognostic favorable (3.49e-4)"	"unprognostic (2.40e-2)"	"unprognostic (1.97e-1)"	"unprognostic (9.95e-2)"	"unprognostic (4.18e-2)"	12.4	13.6	23.3	22.6	23.1	9.0	15.5	20.1	21.0	19.8	17.8	23.9	25.9	16.7	18.8	17.5	19.3	16.7	18.1	22.2	23.0	26.5	14.3	21.6	29.1	22.7	22.7	16.5	18.4	37.4	12.4	26.7	22.8	21.9	25.7	29.9	18.1	23.3	13.3	14.0	25.0	18.9	24.9	25.4	20.8	14.8	23.6	37.2	22.1	15.3	32.4	22.3	12.8	23.2	33.2	46.4	79.6	51.0	26.9	22.2	20.9	32.6	28.7	35.3	29.7	34.2	35.2	61.2	25.7	32.7	36.9	34.7	67.0	45.8	45.0	23.7	42.7	79.9	29.3	40.3	27.7	89.7	44.4	18.6	29.7	20.6	46.8	42.5	55.8	50.9	85.7	27.8	45.3	40.9	97.7	43.0	25.9	57.5	61.7	77.1	94.5	34.9	51.4	49.7	76.4	141.0	29.4	56.2	38.9	70.0	41.5	72.1	59.3	58.0	26.4	29.6	54.4	28.9	39.6	32.2	33.0	57.1	35.2	10.9	11.3	12.6	11.2	13.1	9.0	8.1	7.7	8.7	10.6	8.3	6.9	7.5	4.7	8.9	16.2	7.8	5.9	8.6	23.3	23.1	20.1	21.0	22.2	23.0	22.7	22.7	22.8	24.9	23.6	23.2	28.5	44.8	45.9	30.3	57.4	31.4	30.5	49.8	46.7	55.4	29.3	25.1	30.8	38.6	38.1	68.0	77.2	51.7	49.0	47.2	23.5	50.1	95.5	30.5	38.0	43.1	72.0	62.6	42.3	45.2	47.7	33.8	31.1	30.1	60.2	67.1	48.9	40.2	55.4	65.6	41.1	49.0	52.9	64.3	45.2	27.6	35.1	61.9	26.6	43.1	72.9	53.1	69.0	36.2	40.5	55.0	41.2	38.0	45.0	45.3	67.7	52.0	43.7	54.0	59.2	23.2	35.8	96.5	35.0	51.6	34.8	21.6	53.1	49.8	57.2	47.6
DCDC2	"DCDC2A, DFNB66, KIAA1154, NPHP19, RU2"	ENSG00000146038	"Doublecortin domain containing 2"	Q9UHG0	6	24171755-24358059	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cilium biogenesis/degradation, Neurogenesis"		"Ciliopathy, Deafness, Disease variant, Nephronophthisis, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"choroid plexus: 15.1;kidney: 23.2;pancreas: 26.2"	"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 62.9;Collecting duct cells: 79.1;Distal tubular cells: 56.7;Ductal cells: 135.9;Endometrial ciliated cells: 160.3;Glandular and luminal cells: 102.4;Proximal tubular cells: 54.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CACO-2: 71.8;EFO-21: 48.3;Hep G2: 82.3;RPTEC TERT1: 254.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA031582, HPA031583, HPA031584"	Enhanced		Supported	"Microtubules,Mitotic spindle,Centriolar satellite,Cytosol"		Yes	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 44: Endometrium - Transcription"	Cytosol	"Microtubules, Mitotic spindle, Centriolar satellite"	"HPA031582: AB_10600901, HPA031583: AB_2673944, HPA031584: AB_2673945"	"unprognostic (8.65e-2)"	"unprognostic (2.07e-2)"	"unprognostic (1.66e-1)"	"unprognostic (6.70e-2)"	"unprognostic (1.08e-2)"	"unprognostic (3.22e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.45e-1)"	"unprognostic (2.90e-1)"	"unprognostic (7.87e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.67e-2)"	"unprognostic (5.22e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.12e-2)"	"unprognostic (2.99e-2)"	0.0	1.3	0.8	0.0	1.2	0.1	4.4	0.3	0.8	1.6	15.1	0.7	0.6	4.4	5.3	0.0	7.6	3.9	0.0	0.8	1.0	23.2	2.2	3.4	0.0	2.2	2.7	0.2	26.2	8.2	1.2	0.6	1.7	1.2	0.6	1.4	0.4	2.3	0.3	0.1	0.1	0.1	2.0	0.1	1.8	3.7	1.1	0.1	8.2	0.2	0.0	0.4	0.0	1.6	0.0	8.8	0.5	0.1	0.0	0.0	0.2	0.0	0.1	0.0	0.0	71.8	0.2	0.0	48.3	0.0	0.1	0.0	0.0	0.1	0.1	0.0	8.2	0.0	0.0	82.3	0.0	0.0	0.0	0.0	0.0	9.7	0.0	1.4	0.0	0.2	0.1	0.0	0.3	10.8	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	254.5	0.3	5.2	0.5	0.0	1.3	0.0	0.2	12.3	0.0	0.0	0.0	0.8	0.0	0.0	0.1	0.0	0.5	0.5	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.8	1.2	0.3	0.8	0.8	1.0	2.2	2.7	1.7	2.0	1.1	1.6	0.2	19.2	14.4	3.9	1.4	0.1	0.6	0.3	0.0	0.0	20.3	11.7	0.3	62.9	6.1	79.1	0.0	0.4	0.0	1.2	56.7	135.9	40.1	160.3	5.3	0.4	3.6	0.0	11.3	8.4	0.0	1.3	3.6	102.4	0.0	4.1	0.0	1.0	0.5	0.0	8.3	2.9	0.0	0.0	0.0	14.6	0.3	1.0	0.0	1.0	2.0	2.3	0.0	1.0	0.5	27.9	4.1	0.4	0.0	1.3	0.0	54.3	37.1	0.1	0.0	0.0	2.4	32.3	2.6	0.0	0.1	0.1	1.1	5.6	2.7	0.9
DCK		ENSG00000156136	"Deoxycytidine kinase"	P27707	4	70992538-71030914	"Enzymes, FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Transferase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 105.8"	"Cell type enhanced"	"Detected in many"		"B-cells: 105.7;Erythroid cells: 284.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Daudi: 232.9;U-698: 191.8"	"Low region specificity"	"Detected in all"							"HPA059609, HPA062773"	Enhanced		Supported	Nucleoplasm		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 6: Erythroid cells - Oxygen transport"	Nucleoplasm		"HPA059609: AB_2684082, HPA062773: AB_2684865"	"unprognostic (9.16e-2)"	"unprognostic (2.44e-1)"	"unprognostic (5.24e-3)"	"unprognostic (4.77e-2)"	"unprognostic (3.95e-1)"	"unprognostic (6.45e-2)"	"prognostic unfavorable (6.90e-7)"	"unprognostic (3.04e-2)"	"unprognostic (7.19e-2)"	"unprognostic (8.28e-2)"	"unprognostic (4.51e-1)"	"unprognostic (1.33e-1)"	"unprognostic (3.37e-2)"	"unprognostic (4.47e-2)"	"unprognostic (6.82e-2)"	"unprognostic (1.33e-1)"	"unprognostic (2.27e-2)"	11.1	15.2	10.1	36.3	11.2	43.9	12.5	9.7	13.6	9.9	11.0	15.7	13.7	13.4	7.2	14.6	9.8	12.4	10.4	10.7	10.7	9.8	9.2	13.4	92.9	10.9	10.4	10.6	8.3	8.8	3.5	15.3	10.8	10.2	18.9	17.1	7.7	7.1	9.5	14.7	15.9	13.9	11.4	32.3	14.2	9.0	9.7	105.8	15.7	12.1	79.6	14.2	6.1	13.4	25.8	17.2	38.5	23.9	12.4	20.4	21.0	65.3	25.6	53.3	43.6	11.3	56.1	232.9	24.7	28.3	31.0	14.8	34.6	21.4	71.0	43.5	16.2	46.6	18.6	20.5	11.8	95.8	58.5	11.2	25.5	32.2	19.5	26.0	31.0	64.4	19.0	93.2	62.0	15.5	126.6	39.5	17.2	45.6	15.6	96.0	74.0	18.6	26.6	18.8	35.1	31.8	24.9	49.6	29.7	17.4	22.3	54.3	22.0	60.1	41.8	47.6	37.1	31.7	21.2	191.8	40.7	60.0	45.0	25.6	17.2	28.9	24.2	20.5	32.0	44.5	33.0	30.6	23.8	41.1	34.2	34.2	8.1	34.4	21.0	63.6	41.2	45.1	10.1	11.2	9.7	13.6	10.7	10.7	10.9	10.4	10.8	11.4	9.7	13.4	16.4	0.0	8.6	6.8	105.7	43.0	10.1	11.9	27.9	16.1	10.4	5.2	6.5	7.2	7.5	12.9	6.2	11.9	97.7	10.4	29.4	19.2	0.7	5.9	7.0	16.3	21.0	284.8	17.1	6.2	19.3	11.0	8.6	7.4	22.9	7.5	22.9	7.2	38.2	18.5	21.0	16.4	22.4	63.2	74.5	2.3	8.4	56.0	46.2	18.7	61.4	15.8	84.5	8.0	11.1	10.5	8.0	10.1	24.6	11.6	7.1	10.0	4.7	10.7	6.6	9.3	15.9	52.0	33.9	28.0	43.3	4.5	62.4	4.8	16.5	8.4
DCLRE1A	"hSNM1, KIAA0086, PSO2, SNM1"	ENSG00000198924	"DNA cross-link repair 1A"	Q6PJP8	10	113834725-113854383	"Predicted intracellular proteins"	"Cell cycle, Cell division, DNA damage, DNA repair, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036907	Approved		Supported	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 51: Myeloid cells - Hemostasis"	Nucleoplasm	"Nucleoli fibrillar center"	"HPA036907: AB_10673626"	"unprognostic (1.22e-1)"	"unprognostic (7.55e-2)"	"unprognostic (4.84e-2)"	"unprognostic (3.82e-2)"	"unprognostic (1.09e-2)"	"unprognostic (1.30e-2)"	"prognostic unfavorable (5.74e-5)"	"unprognostic (1.04e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.01e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.12e-1)"	"unprognostic (3.40e-2)"	"unprognostic (4.05e-2)"	"unprognostic (2.85e-1)"	"unprognostic (3.07e-1)"	"unprognostic (6.34e-2)"	2.1	3.8	3.9	3.9	4.2	4.6	5.2	4.2	5.5	4.0	4.1	4.3	4.1	2.9	5.5	3.3	4.1	2.8	4.4	4.2	4.3	6.0	9.8	3.6	5.3	3.8	3.9	5.3	7.4	8.4	2.9	4.2	4.0	5.9	5.2	8.0	5.0	4.0	3.6	3.7	4.0	3.2	3.8	4.0	5.2	4.7	4.1	5.0	5.1	3.3	5.3	3.2	1.9	4.1	15.8	13.0	19.3	19.7	2.5	4.2	11.0	9.4	9.5	12.5	14.3	10.2	21.1	12.2	10.4	4.8	9.7	12.9	18.6	8.2	16.1	24.2	16.0	20.7	8.0	13.1	8.2	21.9	18.8	2.8	9.8	10.5	18.5	8.3	7.7	16.3	24.1	12.9	7.1	9.4	10.6	8.8	9.4	12.5	6.9	6.1	23.0	8.0	8.3	7.3	8.4	13.9	5.4	9.2	13.8	13.2	11.0	10.5	6.8	7.2	14.1	9.8	15.6	14.9	18.2	18.6	10.7	31.5	10.5	1.3	0.3	0.7	2.8	0.2	1.8	0.6	1.2	1.9	1.1	0.3	0.8	1.4	0.1	1.0	0.5	0.4	3.2	1.2	3.9	4.2	4.2	5.5	4.2	4.3	3.8	3.9	4.0	3.8	4.1	4.1	0.9	6.4	4.1	4.9	1.3	0.6	0.6	2.8	0.6	4.2	2.9	1.9	9.6	5.7	3.6	1.8	0.0	3.0	2.0	2.2	7.9	1.9	0.7	2.9	1.8	1.6	3.5	6.5	4.9	1.1	1.8	2.5	1.5	2.0	1.3	3.6	1.8	7.7	3.2	6.7	4.7	2.5	4.1	3.8	0.6	0.5	1.5	10.3	0.0	2.8	3.6	3.9	2.1	8.0	4.1	1.6	2.3	1.5	3.0	1.3	1.6	3.7	5.1	3.9	0.0	1.7	1.2	6.0	5.4	2.5	0.6	0.7	3.1	2.4	3.4	0.7
DCLRE1B	"APOLLO, FLJ12810, FLJ13998, SNM1B"	ENSG00000118655	"DNA cross-link repair 1B"	Q9H816	1	113905213-113914086	"Disease related genes, Predicted intracellular proteins"	"DNA damage, DNA repair"	"Exonuclease, Hydrolase, Nuclease"	"Dyskeratosis congenita"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Erythroid cells: 23.6;Sertoli cells: 26.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"MCF7: 57.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA064934			Supported	"Nucleoplasm,Nuclear bodies"		NA	Yes			"Cluster 15: NK-cells - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 51: Myeloid cells - Hemostasis"	"Nucleoplasm, Nuclear bodies"		"HPA064934: AB_2685387"	"unprognostic (1.21e-1)"	"unprognostic (3.38e-2)"	"unprognostic (4.47e-3)"	"unprognostic (4.92e-3)"	"unprognostic (1.89e-1)"	"unprognostic (1.02e-2)"	"prognostic unfavorable (4.50e-5)"	"unprognostic (1.31e-2)"	"unprognostic (9.67e-3)"	"unprognostic (2.73e-2)"	"prognostic unfavorable (6.70e-4)"	"unprognostic (1.15e-1)"	"prognostic unfavorable (5.03e-7)"	"unprognostic (1.24e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.25e-1)"	"unprognostic (5.08e-2)"	3.5	1.2	2.5	3.7	2.7	6.0	2.9	4.5	2.8	2.5	2.1	2.8	1.7	2.4	1.6	3.0	2.7	2.2	1.3	2.4	2.7	1.6	1.7	3.2	4.1	2.5	2.7	3.0	0.9	1.1	0.7	3.5	2.5	1.7	3.0	1.2	1.2	1.9	0.8	2.6	1.9	3.3	2.5	4.0	1.6	2.4	2.8	4.8	2.0	1.0	3.9	2.2	1.6	3.3	14.1	5.5	9.9	10.5	7.9	5.4	5.7	11.1	7.4	14.2	15.3	6.0	3.9	14.3	6.8	7.8	6.4	6.4	13.7	11.2	19.6	12.0	10.1	12.4	7.8	5.9	1.5	14.1	12.1	6.2	4.4	18.5	10.6	3.9	7.9	16.5	17.5	11.8	16.7	57.8	21.7	11.5	7.7	5.5	12.6	17.2	30.4	6.5	5.6	6.1	8.7	8.0	12.0	9.2	7.7	7.8	6.1	14.9	4.8	18.6	19.6	31.3	15.8	5.2	5.6	16.0	15.7	13.8	32.9	1.9	4.5	1.3	2.3	3.7	2.5	0.9	2.6	2.2	2.6	1.4	1.7	2.2	0.2	5.8	2.1	1.0	1.8	2.5	2.5	2.7	4.5	2.8	2.4	2.7	2.5	2.7	2.5	2.5	2.8	3.3	3.0	3.2	2.0	0.3	2.8	3.6	1.2	1.7	8.0	3.0	2.6	2.0	1.2	1.5	0.8	0.0	2.1	4.6	4.0	1.0	1.9	4.4	1.3	4.1	2.3	3.4	3.0	23.6	0.8	2.7	9.8	3.4	0.5	2.4	1.3	5.6	2.2	1.6	9.7	1.7	0.9	3.1	2.0	8.5	12.8	0.6	1.8	10.5	0.0	1.0	13.5	0.9	2.1	0.0	1.1	3.7	0.5	2.2	5.0	1.5	0.3	1.7	3.1	1.4	26.3	2.1	5.5	7.9	11.4	6.2	2.7	1.4	4.4	3.0	4.2	1.0
DCLRE1C	"A-SCID, ARTEMIS, FLJ11360, SCIDA, SNM1C"	ENSG00000152457	"DNA cross-link repair 1C"	Q96SD1	10	14897359-14954432	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Adaptive immunity, DNA damage, DNA recombination, DNA repair, Immunity"	"Endonuclease, Exonuclease, Hydrolase, Nuclease"	"Disease variant, SCID"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cone photoreceptor cells: 62.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA069295			Supported	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	"Golgi apparatus"	"HPA069295: AB_2686112"	"unprognostic (8.42e-2)"	"unprognostic (1.69e-2)"	"unprognostic (2.66e-2)"	"unprognostic (2.40e-2)"	"unprognostic (1.36e-2)"	"prognostic favorable (1.30e-4)"	"unprognostic (8.02e-4)"	"unprognostic (1.23e-1)"	"unprognostic (1.24e-1)"	"prognostic favorable (7.98e-4)"	"unprognostic (1.91e-1)"	"unprognostic (4.20e-2)"	"prognostic unfavorable (9.03e-8)"	"unprognostic (2.43e-2)"	"unprognostic (2.32e-1)"	"unprognostic (2.51e-1)"	"unprognostic (5.45e-3)"	4.2	3.3	2.2	8.0	3.2	14.0	6.1	5.7	3.4	4.5	3.7	4.3	5.2	4.4	3.8	7.1	3.7	4.0	2.3	2.2	2.2	3.5	2.6	4.9	14.1	2.8	2.7	4.5	3.1	3.8	2.2	4.4	3.1	4.0	5.2	4.9	4.5	3.7	3.0	6.9	5.4	3.9	2.5	10.4	5.9	1.9	2.9	12.3	5.5	2.7	12.8	5.4	5.1	3.7	16.2	7.8	6.9	13.8	6.4	8.2	6.6	9.7	5.3	13.0	13.5	8.9	13.4	21.7	3.8	7.6	9.2	13.7	7.6	5.1	10.9	13.4	8.0	16.7	8.9	6.0	5.1	10.0	18.4	6.6	4.8	12.7	5.3	8.2	7.4	13.9	10.5	17.4	8.6	7.4	14.9	9.9	4.7	14.4	3.5	17.2	9.2	12.1	6.5	6.0	3.6	6.9	10.7	10.2	27.5	5.3	12.8	18.5	6.0	8.3	11.6	17.1	10.8	9.9	19.1	21.5	8.1	10.5	11.8	27.4	13.9	20.0	12.1	18.9	14.5	25.1	14.1	15.0	20.9	28.1	12.2	13.2	13.2	11.0	17.5	22.4	11.9	8.9	2.2	3.2	5.7	3.4	2.2	2.2	2.8	2.7	3.1	2.5	2.9	3.7	6.6	3.2	6.9	17.9	27.6	17.3	20.8	10.9	5.7	24.8	7.8	4.3	4.4	11.5	26.1	14.7	62.6	15.1	21.8	10.9	3.9	9.9	26.8	8.5	8.6	8.2	6.7	22.7	12.4	11.1	21.9	10.2	7.1	13.1	6.3	14.1	10.4	1.9	10.2	32.0	10.6	7.3	10.2	19.8	20.6	2.3	12.5	13.3	19.6	16.9	21.8	10.4	35.0	12.5	11.9	14.9	15.5	11.3	13.4	21.5	12.3	2.7	22.3	47.9	19.7	18.1	11.9	13.9	18.5	7.3	21.2	5.1	14.8	12.4	8.6	41.4
DCP1A	"HSA275986, SMAD4IP1, SMIF"	ENSG00000272886	"Decapping mRNA 1A"	Q9NPI6	3	53283429-53347586	"Plasma proteins, Predicted intracellular proteins, Transporters"	"Nonsense-mediated mRNA decay"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA013202	Approved		Supported	"Cytoplasmic bodies"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 22: Epithelial cell types - Mixed function"	"Cytoplasmic bodies"		"HPA013202: AB_1857287"	"unprognostic (2.10e-1)"	"unprognostic (7.61e-2)"	"prognostic favorable (9.01e-4)"	"unprognostic (9.79e-3)"	"unprognostic (7.68e-2)"	"unprognostic (4.44e-2)"	"prognostic unfavorable (3.25e-5)"	"unprognostic (2.90e-1)"	"unprognostic (1.42e-1)"	"unprognostic (3.24e-2)"	"unprognostic (1.86e-1)"	"unprognostic (8.37e-2)"	"unprognostic (7.33e-3)"	"unprognostic (9.14e-2)"	"unprognostic (3.40e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.95e-1)"	9.3	8.2	4.3	8.7	4.9	29.9	8.9	11.3	6.8	8.5	5.5	8.5	6.1	11.7	5.8	7.9	9.1	8.2	8.0	4.6	4.9	6.0	6.4	7.7	10.3	4.6	4.6	14.9	6.3	10.3	6.3	10.2	4.8	7.9	8.4	8.6	6.1	6.9	9.5	7.4	7.3	10.4	4.1	9.2	6.8	8.2	5.2	14.2	8.7	9.5	9.8	9.0	7.0	6.3	8.3	8.3	19.4	15.8	13.1	13.5	26.3	9.5	12.5	20.5	19.0	24.7	14.5	18.9	3.7	12.0	12.3	6.8	25.3	9.7	17.8	16.9	11.3	18.5	11.8	12.9	11.4	23.0	24.6	10.7	9.4	18.5	15.0	12.6	15.1	13.2	16.4	20.2	10.1	5.0	30.6	11.2	13.1	8.6	12.1	14.0	12.9	13.2	8.6	18.2	10.1	16.7	16.3	10.7	14.3	14.4	7.0	17.8	16.3	9.8	14.1	10.3	14.5	12.9	11.9	21.9	12.0	12.8	17.8	46.9	25.0	43.0	41.0	25.5	50.4	38.9	41.4	47.8	27.1	48.7	49.6	46.8	26.0	54.3	52.3	31.4	30.9	38.5	4.3	4.9	11.3	6.8	4.6	4.9	4.6	4.6	4.8	4.1	5.2	6.3	28.6	28.9	30.7	26.4	43.6	57.5	48.5	32.4	48.9	27.5	32.7	25.5	26.4	15.7	24.7	7.3	47.9	41.1	34.5	25.5	3.9	29.2	10.8	21.5	33.4	33.5	51.8	20.2	43.4	35.1	52.3	33.6	18.3	34.0	36.8	34.8	24.7	13.2	19.9	28.6	40.5	27.6	24.4	27.6	48.9	26.3	24.8	29.2	10.6	20.6	35.2	18.3	30.9	40.7	44.2	45.0	19.6	25.9	31.8	48.4	22.3	13.5	14.2	30.3	13.1	39.2	32.5	12.8	19.1	27.4	41.2	64.0	39.1	27.7	27.9	62.1
DCP1B	FLJ31638	ENSG00000151065	"Decapping mRNA 1B"	Q8IZD4	12	1946053-2004535	"Predicted intracellular proteins, Predicted membrane proteins"	"Nonsense-mediated mRNA decay"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 36.2;Early spermatids: 55.2;Oligodendrocyte precursor cells: 37.7;Oligodendrocytes: 35.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Lineage enriched"	"Detected in all"	5	"T-cells: 27.3"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039709	Approved		Supported	Vesicles,Cytosol		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 71: Testis - DNA repair"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 64: Astrocytes - Nervous system maintenance"	"Vesicles, Cytosol"		"HPA039709: AB_10672901"	"unprognostic (9.60e-2)"	"unprognostic (7.19e-3)"	"unprognostic (4.37e-3)"	"unprognostic (2.13e-1)"	"unprognostic (7.00e-2)"	"unprognostic (1.08e-1)"	"unprognostic (8.94e-2)"	"unprognostic (3.26e-1)"	"unprognostic (3.13e-1)"	"unprognostic (1.53e-2)"	"unprognostic (5.87e-2)"	"unprognostic (1.83e-1)"	"unprognostic (1.08e-2)"	"unprognostic (3.98e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.84e-2)"	"unprognostic (7.42e-2)"	9.2	16.4	3.4	3.4	3.4	1.6	8.8	3.0	3.6	15.0	3.9	26.2	3.0	21.9	5.8	6.6	13.8	4.0	4.5	3.2	3.6	7.9	10.0	7.9	4.8	2.9	3.0	13.1	9.0	5.5	13.6	3.7	2.9	14.4	5.0	5.0	7.7	6.7	10.5	8.1	10.2	9.2	2.9	9.2	11.9	20.7	3.5	6.7	9.4	5.1	4.6	18.2	10.9	3.1	0.1	3.8	6.9	5.3	8.5	10.7	11.5	4.7	9.2	5.8	7.1	0.6	6.0	9.4	1.6	6.9	5.0	0.0	4.6	5.0	5.1	15.8	5.0	3.9	3.0	5.6	11.3	5.6	4.5	8.1	8.1	5.2	4.5	12.0	9.6	7.2	2.5	3.7	7.1	4.5	7.8	4.6	15.0	3.4	1.4	4.6	3.3	1.7	6.8	0.0	1.0	5.0	4.0	3.3	3.4	15.4	3.4	5.1	5.7	2.8	10.0	6.4	4.9	3.1	2.5	6.5	6.6	3.8	7.1	5.3	2.9	0.3	10.0	4.2	12.5	5.1	10.3	9.8	5.4	4.9	7.8	10.2	0.5	5.9	5.0	2.6	27.3	5.5	3.4	3.4	3.0	3.6	3.2	3.6	2.9	3.0	2.9	2.9	3.5	3.1	4.9	6.4	4.6	36.2	6.4	0.9	4.1	7.5	5.2	6.4	4.0	5.0	2.5	1.5	5.7	7.3	10.4	6.5	5.1	4.0	13.7	7.3	55.2	6.6	8.7	5.8	2.4	3.0	24.3	4.2	4.8	7.6	8.2	2.8	5.7	12.2	3.3	5.9	5.7	6.7	28.9	4.6	14.2	3.5	0.9	19.8	5.6	3.7	1.8	17.8	6.5	4.1	2.1	37.7	35.3	4.9	5.8	9.4	5.8	3.0	8.1	7.2	5.2	7.0	0.0	3.7	7.1	23.6	10.2	4.5	2.4	2.9	8.6	10.3	5.1	2.9
DCP2	NUDT20	ENSG00000172795	"Decapping mRNA 2"	Q8IU60	5	112976702-113022195	"Enzymes, Predicted intracellular proteins"	"Nonsense-mediated mRNA decay"	"Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011677, HPA057676"	Approved		Approved	"Nucleoplasm,Cell Junctions,Cytoplasmic bodies"		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	"Nucleoplasm, Cytoplasmic bodies"	"Cell Junctions"	"CAB011677: AB_731858, HPA057676: AB_2683500"	"unprognostic (2.76e-1)"	"unprognostic (3.27e-1)"	"unprognostic (2.79e-1)"	"unprognostic (3.09e-1)"	"unprognostic (1.28e-1)"	"unprognostic (3.86e-3)"	"prognostic unfavorable (4.84e-4)"	"unprognostic (1.87e-1)"	"unprognostic (3.64e-2)"	"unprognostic (6.26e-2)"	"unprognostic (1.15e-1)"	"unprognostic (9.30e-2)"	"prognostic unfavorable (2.66e-5)"	"unprognostic (8.39e-2)"	"unprognostic (2.84e-1)"	"unprognostic (3.25e-2)"	"unprognostic (5.75e-2)"	4.6	4.0	5.9	8.1	6.0	14.0	6.9	9.8	5.7	6.0	6.6	3.9	3.7	4.3	3.4	4.1	4.7	3.5	3.4	5.9	7.2	4.8	4.7	6.9	12.6	5.5	4.9	6.7	3.3	3.1	3.7	12.1	5.8	4.4	4.1	7.4	5.3	3.5	4.8	5.8	5.1	3.3	4.5	10.2	4.0	3.8	8.5	17.9	3.7	3.9	12.3	4.4	5.2	5.1	6.4	5.6	24.1	19.0	4.5	5.3	37.0	6.7	4.3	7.2	9.8	25.0	13.1	32.2	8.5	3.2	5.6	7.9	27.6	7.1	8.8	9.0	11.0	29.5	4.6	9.9	5.4	20.1	15.3	4.8	5.3	8.4	9.0	6.9	12.5	24.8	22.7	12.0	6.1	8.1	29.6	19.6	20.8	4.0	2.9	27.0	22.7	12.2	10.5	15.4	5.6	11.4	8.3	8.8	11.3	24.1	25.3	24.4	7.7	7.8	13.9	4.4	8.8	8.8	19.8	23.6	4.7	26.0	6.3	14.0	4.9	3.7	3.0	6.1	4.2	3.8	3.7	3.0	5.1	2.5	3.4	3.7	9.4	3.5	7.3	2.9	4.3	2.6	5.9	6.0	9.8	5.7	5.9	7.2	5.5	4.9	5.8	4.5	8.5	5.1	30.0	19.2	16.8	16.0	50.7	27.8	19.9	22.3	31.9	24.7	43.5	26.4	12.4	8.6	24.1	20.2	79.2	66.7	65.0	11.6	19.6	11.2	24.3	21.7	38.1	28.9	16.2	41.9	25.5	11.8	49.6	25.7	17.3	25.7	19.6	66.7	28.5	7.0	31.7	28.6	34.1	8.9	20.3	78.1	41.5	53.8	19.0	57.4	26.6	56.2	90.7	36.9	35.0	26.7	28.8	17.3	10.6	10.9	27.1	33.3	13.8	14.4	22.7	34.6	6.6	16.5	32.3	36.6	29.5	20.0	26.6	64.4	50.1	52.0	13.1	48.8
DCPS	"HINT-5, HINT5, HSL1, HSPC015"	ENSG00000110063	"Decapping enzyme, scavenger"	Q96C86	11	126304060-126350005	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	Hydrolase	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 50.7"	"Cell type enhanced"	"Detected in many"		"Plasma cells: 101.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"plasmacytoid DC: 46.6"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"OE19: 79.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039632, HPA058597"	Supported		Supported	Nucleoplasm,Cytosol		NA	NA		1200000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 21: OE19 - Mitochondria"	"Cluster 55: Plasma cells - Humoral immune response"	Nucleoplasm	Cytosol	"HPA039632: AB_10794200, HPA058597: AB_2683770"	"unprognostic (1.45e-1)"	"unprognostic (5.48e-3)"	"unprognostic (1.76e-1)"	"unprognostic (3.55e-2)"	"unprognostic (5.22e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.96e-1)"	"unprognostic (2.90e-1)"	"unprognostic (5.57e-2)"	"unprognostic (1.91e-2)"	"unprognostic (4.83e-2)"	"unprognostic (5.00e-2)"	"unprognostic (5.25e-2)"	"unprognostic (2.24e-2)"	"unprognostic (8.04e-2)"	"unprognostic (7.67e-2)"	"unprognostic (3.40e-2)"	8.3	11.4	2.8	7.4	4.0	12.1	8.5	5.0	4.5	10.9	8.1	10.1	4.7	11.0	4.1	11.3	8.6	16.0	9.9	3.9	3.2	13.5	50.7	9.0	12.1	3.3	3.4	9.2	12.1	3.5	8.2	4.0	2.9	8.1	5.9	6.3	12.0	5.3	14.6	11.3	9.4	5.5	2.7	17.3	8.7	6.1	3.6	8.9	7.5	5.8	9.6	13.3	9.2	3.4	13.9	8.5	10.2	19.8	7.9	11.2	8.9	6.5	10.3	11.5	10.8	17.5	29.1	19.5	28.0	12.2	7.5	16.2	14.4	24.4	5.9	35.8	7.1	27.1	9.9	14.7	18.8	33.3	25.4	12.5	14.0	16.0	17.6	5.9	14.1	17.0	11.6	34.8	11.2	21.6	21.1	41.5	8.0	79.8	28.7	13.7	13.8	40.6	11.4	15.1	16.1	11.0	20.3	21.1	15.8	6.3	33.8	22.1	9.3	18.7	7.3	8.9	13.7	13.4	14.6	20.0	6.0	51.0	46.7	4.2	10.5	4.3	9.3	15.2	7.8	13.0	8.5	9.7	16.6	8.6	6.4	6.7	1.3	8.9	15.3	46.6	15.4	8.9	2.8	4.0	5.0	4.5	3.9	3.2	3.3	3.4	2.9	2.7	3.6	3.4	14.2	12.8	11.2	6.2	31.2	6.9	16.4	38.7	8.0	6.7	12.2	17.1	5.0	47.1	18.8	42.3	0.0	39.9	35.3	6.4	56.7	19.7	8.1	11.1	12.1	12.4	7.3	14.5	5.8	29.2	43.8	15.9	11.2	23.2	17.1	9.8	8.6	31.4	29.2	3.3	6.0	12.0	28.5	14.1	11.7	2.2	17.1	16.8	17.8	2.8	15.3	10.1	22.6	2.5	4.6	17.1	14.9	18.4	101.1	8.7	6.1	15.0	15.7	9.4	19.7	10.8	14.6	14.8	24.9	18.3	8.9	27.1	24.3	16.2	14.4	24.0
DCT	TYRP2	ENSG00000080166	"Dopachrome tautomerase"	P40126	13	94436811-94479682	"Enzymes, Metabolic proteins, Predicted membrane proteins"	"Melanin biosynthesis"	Isomerase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	35	"skin 1: 107.4"	"Cell type enriched"	"Detected in some"	23	"Melanocytes: 3552.1"	"Cancer enriched"	"Detected in some"	215	"melanoma: 155.5"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	272	"SK-MEL-30: 257.0"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA010742, HPA010743, HPA010800, CAB017634"	Enhanced		Supported	"Vesicles,Plasma membrane"		NA	NA				"Cluster 61: Skin - Cornification"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 48: Smooth muscle cells - ECM organization"	"Plasma membrane"	Vesicles	"CAB017634: AB_1130818, HPA010742: , HPA010743: AB_1847519, HPA010800: AB_1847520"	"unprognostic (5.99e-2)"	"unprognostic (1.67e-2)"	"unprognostic (1.54e-2)"	"unprognostic (3.17e-2)"	"unprognostic (2.45e-2)"	"unprognostic (3.35e-2)"	"unprognostic (2.15e-2)"	"unprognostic (2.81e-2)"	"unprognostic (6.07e-2)"	"unprognostic (1.81e-1)"	"unprognostic (3.64e-3)"	"unprognostic (1.06e-2)"	"unprognostic (6.18e-5)"	"unprognostic (6.97e-2)"	"unprognostic (9.87e-2)"	"unprognostic (1.22e-3)"	"unprognostic (2.42e-1)"	0.4	0.4	0.6	0.0	1.0	0.1	3.0	0.4	0.7	0.2	0.2	0.3	0.0	0.3	0.9	0.0	0.9	0.1	0.1	0.6	0.6	0.2	0.2	0.1	0.0	0.6	0.6	0.4	0.4	0.0	1.6	0.0	0.5	0.3	0.0	0.9	1.5	0.3	0.4	107.4	0.1	0.1	0.6	0.1	0.1	0.6	0.6	0.5	0.2	0.1	0.0	0.2	0.3	0.5	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.9	0.0	0.0	0.0	257.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.2	0.3	0.2	0.6	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	1.0	0.4	0.7	0.6	0.6	0.6	0.6	0.5	0.6	0.6	0.5	0.0	0.0	0.0	23.5	0.0	152.3	0.1	0.0	0.0	1.0	0.3	0.5	0.9	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	15.1	0.5	0.1	1.2	0.0	0.0	16.1	0.2	0.0	1.4	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	14.4	0.0	0.0	0.0	25.5	23.8	0.9	0.0	3552.1	1.9	0.0	3.5	0.0	6.6	2.4	0.0	0.0	0.7	0.0	0.0	0.0	0.2	0.2	0.3	0.0	0.5	1.0	0.5	0.8	0.0	33.4	0.0	0.9	0.1	0.0	0.0
DCTN1		ENSG00000204843	"Dynactin subunit 1"	Q14203	2	74361154-74392087	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, Transport"		"Amyotrophic lateral sclerosis, Cancer-related genes, Neurodegeneration, Neuropathy, Parkinsonism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009108, HPA034635, HPA071875"	Approved		Supported	"Microtubules,Cytokinetic bridge,Mitotic spindle"		Yes	No		250000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Microtubules	"Cytokinetic bridge, Mitotic spindle"	"CAB009108: AB_2090601, HPA034635: AB_2674256, HPA071875: "	"unprognostic (1.14e-1)"	"unprognostic (7.19e-2)"	"unprognostic (1.33e-3)"	"unprognostic (4.08e-2)"	"unprognostic (1.20e-1)"	"unprognostic (2.67e-1)"	"unprognostic (4.61e-3)"	"unprognostic (2.11e-2)"	"unprognostic (2.79e-1)"	"unprognostic (3.73e-3)"	"unprognostic (1.87e-1)"	"unprognostic (2.26e-1)"	"prognostic favorable (2.34e-7)"	"unprognostic (5.41e-2)"	"unprognostic (3.11e-1)"	"unprognostic (7.86e-3)"	"unprognostic (1.12e-3)"	43.3	40.0	90.5	27.0	94.7	23.7	37.4	76.4	113.2	44.3	20.8	51.3	22.2	51.4	17.0	42.6	38.7	28.2	82.6	99.9	80.1	27.6	18.2	36.0	22.8	110.9	85.1	39.2	28.6	118.0	61.2	32.6	112.6	30.0	25.5	43.5	56.3	38.0	87.6	44.2	32.2	49.9	76.0	26.5	39.5	51.3	101.9	34.7	31.3	63.4	24.6	47.6	39.0	116.2	65.0	74.7	68.4	71.9	122.5	90.7	55.2	102.0	105.2	127.0	89.9	99.9	48.6	88.8	40.8	213.0	70.1	63.5	84.3	129.5	96.1	111.2	85.0	92.5	55.6	84.7	94.4	50.7	109.3	109.6	62.0	138.3	82.3	86.9	110.3	79.4	40.3	61.4	97.3	55.6	92.8	52.5	74.0	78.6	78.3	82.3	120.1	63.8	70.2	39.6	83.3	74.1	57.1	67.7	60.6	59.0	43.5	36.5	84.3	115.0	82.7	50.0	77.2	37.8	32.7	78.9	107.6	81.4	82.5	8.3	11.3	12.7	14.4	13.0	11.7	10.1	8.2	10.8	11.2	6.8	5.6	6.3	9.2	9.2	15.6	8.8	7.7	16.5	90.5	94.7	76.4	113.2	99.9	80.1	110.9	85.1	112.6	76.0	101.9	116.2	28.6	32.1	25.4	9.8	23.2	10.1	10.3	19.1	25.6	27.2	19.6	17.8	56.4	18.6	20.0	29.5	25.0	29.8	19.4	41.0	19.6	22.5	7.3	21.5	32.8	26.6	16.7	27.3	28.4	19.9	27.1	25.1	49.5	27.8	29.2	30.8	29.6	19.9	28.8	90.9	26.7	31.8	24.4	21.0	11.3	9.3	44.7	21.2	16.0	8.4	27.3	14.9	23.7	12.1	29.7	26.6	33.6	51.9	24.7	9.6	34.2	19.6	19.4	45.5	19.7	28.3	30.0	40.6	38.5	29.0	11.8	25.2	20.0	33.9	24.9	10.7
DCTN2	"DCTN-50, RBP50"	ENSG00000175203	"Dynactin subunit 2"	Q13561	12	57529633-57547224	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039715, HPA040040"	Enhanced		Supported	Centrosome,Cytosol		NA	NA		630000	"Cluster 34: Basophils - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 31: Spermatids - Spermatogenesis"	Centrosome	Cytosol	"HPA039715: AB_10795154, HPA040040: AB_10794870"	"unprognostic (1.70e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.54e-1)"	"unprognostic (6.88e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.85e-1)"	"prognostic unfavorable (1.38e-7)"	"unprognostic (1.14e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.71e-1)"	"unprognostic (4.26e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.08e-2)"	"unprognostic (9.50e-3)"	"unprognostic (2.09e-1)"	"unprognostic (1.52e-3)"	"unprognostic (3.41e-3)"	85.7	99.7	76.3	40.7	80.5	44.6	76.7	88.6	86.1	91.3	62.5	104.6	44.6	98.3	61.8	120.2	71.9	43.6	102.3	81.4	87.9	84.9	50.7	71.7	43.3	91.1	85.1	75.8	116.0	78.2	75.7	52.4	95.5	66.4	73.5	61.3	82.9	65.4	155.2	103.7	75.9	93.3	82.1	64.2	94.9	51.9	82.7	61.4	69.9	102.7	71.4	79.6	89.8	89.9	94.9	109.4	129.1	90.3	194.7	200.0	69.4	104.7	191.7	205.0	149.6	87.2	79.0	95.5	114.1	172.5	83.8	70.8	106.0	136.4	162.0	108.7	119.1	84.8	48.4	69.9	139.3	58.7	60.0	186.3	213.8	131.5	225.1	245.6	201.9	102.0	127.7	126.6	189.5	107.4	89.3	71.8	62.4	56.2	124.0	77.2	101.0	91.4	158.1	92.3	173.2	125.8	98.3	85.2	96.7	104.0	138.5	54.4	153.5	110.6	95.6	69.1	66.7	94.6	91.6	93.8	106.4	73.8	121.2	47.9	48.5	43.7	38.0	54.2	39.3	32.9	37.9	38.0	49.2	30.3	28.1	34.3	22.5	35.1	50.3	37.5	45.5	62.8	76.3	80.5	88.6	86.1	81.4	87.9	91.1	85.1	95.5	82.1	82.7	89.9	82.6	48.1	30.2	20.2	47.5	64.9	87.2	105.1	58.6	84.3	64.7	76.7	70.9	65.8	60.0	35.0	31.3	118.2	53.5	83.4	80.3	162.7	105.5	42.9	58.6	74.0	49.1	53.6	27.9	227.5	122.1	73.6	80.5	52.4	36.2	70.8	69.9	31.7	102.6	72.3	32.6	70.3	83.4	51.8	54.2	265.5	77.9	52.8	76.5	15.0	153.5	141.9	57.7	23.1	28.2	200.4	85.5	73.0	60.9	85.3	121.1	115.8	40.9	67.8	92.1	59.4	107.6	122.7	37.1	93.6	68.5	163.4	52.6	92.3	94.5	89.5
DCTN6	WS-3	ENSG00000104671	"Dynactin subunit 6"	O00399	8	30156319-30183639	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024049, HPA024558"	Approved		Supported	"Nucleoli,Plasma membrane,Cytosol"		NA	Yes			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoli, Cytosol"	"Plasma membrane"	"HPA024049: AB_1847524, HPA024558: AB_1847525"	"unprognostic (1.28e-1)"	"unprognostic (8.32e-3)"	"unprognostic (1.65e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.69e-1)"	"unprognostic (7.50e-2)"	"prognostic unfavorable (5.51e-4)"	"unprognostic (1.26e-1)"	"unprognostic (7.84e-2)"	"unprognostic (1.08e-2)"	"unprognostic (2.38e-2)"	"unprognostic (9.26e-2)"	"prognostic favorable (5.42e-4)"	"unprognostic (1.06e-1)"	"unprognostic (3.10e-1)"	"unprognostic (7.54e-2)"	"unprognostic (1.43e-1)"	50.6	54.1	48.0	26.6	51.1	43.7	53.0	51.8	74.1	32.3	42.3	37.5	23.8	38.2	43.5	34.3	30.1	32.8	75.6	50.4	54.8	54.2	46.7	34.0	28.3	50.8	49.8	41.5	32.0	72.8	29.7	53.6	51.1	34.7	36.2	42.4	33.6	36.7	36.6	29.0	26.1	42.6	52.9	27.6	31.9	21.9	50.5	37.8	54.6	43.5	31.2	45.8	31.6	58.6	53.6	51.9	64.4	33.8	59.3	80.7	42.1	72.8	87.0	70.4	74.9	33.6	35.8	41.0	76.0	78.8	64.9	39.6	46.1	64.2	83.8	32.4	34.3	57.8	40.9	54.5	45.8	33.6	47.4	68.2	90.4	51.2	54.8	61.5	65.2	58.0	66.4	44.3	77.0	41.7	62.4	53.0	51.6	93.8	32.0	32.4	48.7	35.3	104.6	54.1	105.4	60.0	42.7	53.0	77.9	32.4	50.4	48.3	60.8	37.4	128.9	31.9	52.4	18.1	22.2	51.8	69.7	38.1	68.1	16.7	13.5	5.0	8.1	15.8	9.1	7.1	7.5	9.8	15.9	5.3	9.5	11.4	3.7	11.2	15.9	20.8	8.1	6.8	48.0	51.1	51.8	74.1	50.4	54.8	50.8	49.8	51.1	52.9	50.5	58.6	61.3	25.6	39.7	19.9	34.9	57.2	91.3	127.1	25.6	36.4	45.4	43.2	83.4	47.1	85.3	44.1	14.6	88.5	48.9	28.1	123.3	94.5	18.0	32.5	37.2	58.7	40.8	28.2	19.0	84.5	87.7	56.6	25.0	39.6	46.9	44.0	45.7	42.7	71.4	26.9	17.3	31.6	91.6	43.9	54.8	12.5	80.8	43.2	69.4	15.0	58.4	63.3	17.5	17.6	21.3	91.1	43.1	75.2	32.3	48.8	36.3	147.1	71.6	40.3	52.6	63.1	66.0	44.2	47.3	38.0	63.5	203.6	59.8	49.5	33.0	95.0
DCTPP1	"CDA03, MGC5627, RS21C6, XTP3TPA"	ENSG00000179958	"DCTP pyrophosphatase 1"	Q9H773	16	30423615-30430030	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002832	Uncertain		Supported	Nucleoplasm,Cytosol		NA	Yes		61000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Nucleoplasm, Cytosol"		"HPA002832: AB_1080615"	"prognostic unfavorable (1.64e-5)"	"unprognostic (1.61e-1)"	"unprognostic (1.99e-3)"	"unprognostic (1.17e-2)"	"unprognostic (1.36e-1)"	"unprognostic (4.09e-2)"	"prognostic unfavorable (6.28e-4)"	"unprognostic (2.23e-1)"	"unprognostic (1.07e-1)"	"unprognostic (4.35e-2)"	"unprognostic (2.43e-2)"	"unprognostic (3.65e-2)"	"prognostic favorable (9.71e-9)"	"unprognostic (1.10e-3)"	"unprognostic (8.78e-3)"	"unprognostic (1.10e-2)"	"unprognostic (2.53e-1)"	21.0	21.4	17.6	27.4	18.4	22.2	30.5	18.7	22.5	18.6	18.9	56.4	32.0	18.6	20.0	28.3	28.1	19.5	31.1	18.4	19.5	39.7	21.8	16.2	35.5	18.1	17.6	14.0	24.9	32.1	10.3	16.0	19.0	21.8	58.4	12.2	25.5	19.3	44.7	25.1	27.7	20.5	18.4	27.8	24.3	9.1	18.1	24.5	20.1	36.9	35.7	27.0	19.1	19.4	124.7	149.8	66.8	85.8	18.4	24.1	61.9	58.4	35.1	87.4	87.9	114.7	103.4	168.1	119.1	36.8	54.9	95.9	141.4	115.1	103.5	89.2	221.0	98.3	61.5	150.3	24.1	177.0	144.2	28.6	64.8	96.4	55.6	25.4	88.7	88.2	125.8	57.4	61.5	217.8	210.0	189.9	88.8	124.2	119.2	293.1	74.8	218.1	98.9	80.2	141.4	80.4	39.0	137.7	55.3	41.5	118.4	73.9	45.9	66.0	59.1	85.8	107.2	36.9	118.4	217.5	43.8	145.7	79.6	70.6	36.7	38.1	54.0	70.0	75.8	146.7	68.4	61.4	86.7	128.7	60.9	59.0	4.6	76.1	79.2	94.6	76.4	81.0	17.6	18.4	18.7	22.5	18.4	19.5	18.1	17.6	19.0	18.4	18.1	19.4	34.0	19.2	15.2	0.7	38.2	90.2	53.3	92.5	33.6	23.3	45.8	48.9	34.8	51.5	37.9	44.1	8.4	103.2	22.7	130.3	127.2	135.6	13.4	32.6	29.9	47.4	38.5	29.6	2.6	124.8	101.0	28.3	27.5	66.5	31.1	40.2	31.1	23.2	76.9	15.2	2.7	142.3	73.2	21.0	49.1	45.1	19.6	26.9	48.0	1.0	73.2	25.0	23.7	2.5	4.4	89.0	115.8	19.9	24.1	86.9	68.8	76.7	27.8	21.4	19.7	23.7	40.0	3.3	44.8	39.4	80.3	27.8	28.3	53.8	168.5	45.7
DCUN1D4	KIAA0276	ENSG00000109184	"Defective in cullin neddylation 1 domain containing 4"	Q92564	4	51843000-51916837	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Late spermatids: 111.9;Oligodendrocytes: 131.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036483, HPA036484"	Uncertain		Supported	Nucleoplasm,Vesicles		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 15: Liver - Metabolism"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 25: Spermatids - Spermatogenesis"	Vesicles	Nucleoplasm	"HPA036483: AB_10670719, HPA036484: AB_10671843"	"unprognostic (3.16e-2)"	"unprognostic (2.65e-1)"	"unprognostic (2.77e-3)"	"unprognostic (1.41e-1)"	"unprognostic (5.61e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.80e-2)"	"unprognostic (1.37e-1)"	"unprognostic (8.47e-3)"	"unprognostic (1.61e-3)"	"unprognostic (3.88e-3)"	"unprognostic (1.83e-2)"	"unprognostic (2.93e-3)"	"unprognostic (2.14e-1)"	"unprognostic (5.25e-2)"	"unprognostic (1.10e-3)"	"unprognostic (1.40e-1)"	14.0	17.8	14.5	7.3	14.1	2.8	9.8	14.4	20.3	13.3	8.1	15.0	5.9	13.6	11.5	10.4	12.7	11.4	12.1	13.4	17.3	14.9	28.9	9.1	7.5	16.0	16.2	16.0	9.1	9.5	15.7	6.9	17.2	12.0	8.5	15.7	13.4	16.9	11.8	7.7	9.7	17.3	14.2	9.4	13.3	17.0	18.9	6.5	13.2	11.4	6.1	16.9	10.9	16.4	10.6	18.9	25.5	36.7	25.6	27.5	9.8	31.1	23.2	18.0	15.9	11.8	12.1	8.1	20.1	35.2	23.5	11.2	31.0	19.8	27.8	4.9	9.5	13.8	14.9	28.7	54.9	20.4	17.9	25.1	23.7	19.6	17.9	27.0	19.2	7.4	15.6	5.9	35.3	15.2	24.1	13.6	14.5	21.1	15.1	11.4	12.2	4.4	23.1	12.4	14.4	15.6	13.1	17.8	28.9	13.9	18.4	12.3	28.8	24.0	19.7	19.7	25.7	11.1	18.1	7.3	16.6	18.8	14.4	6.8	3.6	8.8	5.7	3.3	8.5	3.6	6.4	6.5	2.5	2.4	6.0	6.8	1.4	3.7	2.4	1.5	3.2	4.4	14.5	14.1	14.4	20.3	13.4	17.3	16.0	16.2	17.2	14.2	18.9	16.4	13.1	6.4	14.1	86.2	9.7	37.2	19.2	16.5	16.5	23.3	18.1	11.7	40.6	14.3	13.2	16.5	16.7	5.0	9.8	14.9	13.7	10.6	76.3	10.7	16.1	17.9	6.7	11.8	90.9	12.2	8.5	23.1	21.9	10.0	13.3	18.9	17.2	35.8	8.2	30.3	88.6	7.2	12.2	7.3	18.4	111.9	14.9	7.2	32.0	51.5	5.3	14.9	15.5	69.4	131.4	13.3	10.9	25.9	6.3	17.2	8.9	24.1	18.1	17.8	0.0	13.4	20.8	24.6	25.5	17.3	33.2	3.4	11.1	12.4	8.9	15.0
DDAH2	G6A	ENSG00000213722	"Dimethylarginine dimethylaminohydrolase 2"	O95865	6	31727038-31730617	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 386.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"MCF7: 63.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012389, HPA012509"	Uncertain		Supported	Mitochondria		NA	NA		1500000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Mitochondria		"HPA012389: , HPA012509: AB_1847533"	"unprognostic (2.29e-2)"	"unprognostic (1.38e-1)"	"unprognostic (4.49e-2)"	"unprognostic (2.39e-1)"	"unprognostic (1.44e-1)"	"unprognostic (7.67e-2)"	"unprognostic (1.50e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.62e-1)"	"unprognostic (8.78e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.02e-1)"	"unprognostic (9.42e-2)"	"unprognostic (2.32e-1)"	"unprognostic (2.24e-2)"	"unprognostic (2.72e-2)"	96.5	17.2	26.6	12.0	24.7	10.8	81.2	24.2	44.7	131.5	26.1	72.2	4.4	94.4	8.7	39.0	80.5	44.0	63.2	23.9	33.5	67.1	32.1	62.3	20.6	31.8	28.2	67.7	16.5	17.5	26.0	18.3	28.1	65.2	7.7	5.8	58.2	27.0	13.4	67.7	38.9	11.9	32.0	49.4	35.4	13.4	27.4	9.6	65.1	4.5	7.8	61.0	91.0	30.9	2.0	20.1	0.7	28.5	17.0	26.6	3.8	0.0	10.6	10.9	7.3	40.4	6.7	0.4	24.4	26.5	0.9	2.4	0.5	9.7	1.9	0.0	14.2	1.9	7.8	22.4	18.2	0.3	1.5	18.8	1.2	12.2	0.9	3.7	33.3	14.1	0.4	11.1	4.8	63.0	1.5	27.5	4.1	4.3	12.2	0.2	0.9	10.5	21.6	0.5	1.5	5.7	0.0	4.7	27.4	2.9	37.7	7.8	0.1	16.9	24.7	11.2	0.0	4.1	12.8	3.3	11.3	5.9	4.3	141.3	15.4	135.0	14.8	37.4	5.8	49.7	4.0	5.3	26.8	39.6	2.7	3.4	27.8	29.2	44.9	93.9	4.1	11.4	26.6	24.7	24.2	44.7	23.9	33.5	31.8	28.2	28.1	32.0	27.4	30.9	102.3	28.9	14.7	10.4	76.8	66.9	88.7	49.6	56.3	4.5	132.8	96.0	39.5	62.9	36.9	82.8	29.2	15.5	84.4	386.3	178.1	148.2	83.1	62.6	94.2	101.2	150.0	20.4	0.3	32.3	37.3	154.1	33.1	75.0	113.3	121.7	94.9	31.9	223.2	0.0	0.3	71.5	109.9	139.7	301.2	23.6	180.5	95.7	103.2	14.0	64.2	120.9	40.2	4.5	2.7	85.1	299.5	153.1	24.5	95.2	61.5	165.8	50.5	25.7	105.2	122.7	153.0	4.1	12.5	35.8	59.2	18.1	41.1	21.3	104.6	67.0
DDB2	"DDBB, FLJ34321, UV-DDB2, XPE"	ENSG00000134574	"Damage specific DNA binding protein 2"	Q92466	11	47214465-47239217	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins"	"DNA damage, DNA repair, Ubl conjugation pathway"	DNA-binding	"Cancer-related genes, Disease variant, Xeroderma pigmentosum"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 75.1;monocytes: 135.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB025912, HPA058406"	Enhanced		Supported	"Nucleoplasm,Cell Junctions"		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 31: Skin - Epidermis development"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 3: Monocytes - Immune response regulation"	"Nucleoplasm, Cell Junctions"		"CAB025912: , HPA058406: AB_2683708"	"prognostic favorable (7.29e-4)"	"prognostic favorable (1.58e-4)"	"unprognostic (1.49e-1)"	"prognostic favorable (1.20e-4)"	"unprognostic (4.29e-2)"	"unprognostic (2.04e-2)"	"unprognostic (2.96e-2)"	"unprognostic (6.18e-2)"	"unprognostic (2.25e-1)"	"unprognostic (3.58e-3)"	"unprognostic (3.53e-1)"	"unprognostic (1.94e-1)"	"unprognostic (4.57e-3)"	"unprognostic (1.21e-2)"	"unprognostic (4.25e-2)"	"unprognostic (9.82e-3)"	"unprognostic (1.07e-1)"	13.2	22.5	2.6	8.2	3.2	11.6	13.5	3.4	3.6	12.5	3.4	12.8	7.6	12.7	11.7	24.8	17.6	12.5	6.8	2.5	2.4	4.4	27.0	12.2	14.7	3.4	2.7	11.6	14.4	4.8	4.7	6.8	3.5	9.7	14.9	2.3	14.4	11.7	6.2	46.7	10.2	13.9	2.7	11.3	9.5	4.5	3.2	23.5	5.5	6.9	17.0	11.2	14.1	3.6	23.7	62.3	25.9	19.3	16.6	32.7	29.9	26.0	58.8	32.0	37.1	10.1	14.1	56.6	5.3	23.2	23.6	40.8	14.6	51.8	15.7	14.5	27.5	13.3	55.7	46.7	15.8	15.9	34.4	43.4	58.0	15.9	35.2	10.2	94.2	14.7	3.5	27.0	52.7	44.4	60.4	7.7	8.4	31.1	22.3	30.3	5.6	30.6	13.5	22.7	13.2	16.7	31.2	8.7	8.1	30.8	56.1	5.5	41.2	96.8	44.1	21.3	12.6	27.6	22.4	12.5	37.0	20.2	35.9	9.8	12.8	20.2	19.3	18.4	18.8	18.3	20.1	18.8	10.4	14.5	14.8	15.7	3.7	14.1	15.8	0.3	47.7	15.9	2.6	3.2	3.4	3.6	2.5	2.4	3.4	2.7	3.5	2.7	3.2	3.6	13.8	16.0	22.2	7.8	25.1	38.9	39.7	28.1	75.1	5.0	18.0	25.8	7.8	11.5	16.3	5.5	10.4	3.6	21.3	11.1	9.8	12.5	1.5	5.2	8.1	19.5	7.7	19.1	6.6	13.8	9.0	16.0	18.3	9.5	22.8	31.2	15.0	16.6	17.5	1.7	1.4	12.6	16.2	17.5	12.8	2.1	19.0	16.8	19.6	24.4	135.5	9.6	35.0	1.0	10.6	19.9	9.8	10.5	34.1	8.9	15.7	7.7	13.9	12.8	0.0	12.1	14.0	3.1	8.6	34.5	30.3	1.5	34.3	25.4	16.5	26.5
DDHD2	"KIAA0725, SAMWD1, SPG54"	ENSG00000085788	"DDHD domain containing 2"	O94830	8	38225218-38275558	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Lipid degradation, Lipid metabolism"	Hydrolase	"Disease variant, Hereditary spastic paraplegia, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB015202, HPA023143, HPA023147"	Supported		Supported	"Centriolar satellite,Cytosol"		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 52: Non-specific - Transcription"	Cytosol	"Centriolar satellite"	"CAB015202: , HPA023143: AB_1847534, HPA023147: AB_1847535"	"unprognostic (1.49e-3)"	"unprognostic (2.40e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.64e-1)"	"prognostic favorable (7.72e-4)"	"unprognostic (4.54e-2)"	"unprognostic (1.79e-2)"	"unprognostic (1.87e-1)"	"unprognostic (2.63e-2)"	"unprognostic (1.04e-1)"	"unprognostic (4.49e-2)"	"unprognostic (3.01e-3)"	"unprognostic (3.21e-2)"	"unprognostic (2.46e-1)"	"unprognostic (7.88e-2)"	"unprognostic (1.49e-1)"	28.9	18.1	27.3	14.4	32.1	14.9	19.4	33.8	39.7	22.0	23.5	20.1	19.6	20.9	23.3	20.9	19.1	17.5	27.7	30.1	29.3	21.6	12.1	16.9	19.8	32.1	27.7	28.9	22.2	21.1	18.3	15.2	35.1	22.6	16.7	31.7	18.3	29.3	32.0	16.8	22.2	18.2	30.7	17.2	15.0	22.7	32.4	19.5	18.7	35.8	22.3	17.6	17.7	38.8	57.7	26.1	58.3	28.3	21.8	30.6	18.4	18.1	33.0	42.5	38.4	30.8	22.6	22.8	24.1	32.8	26.3	22.7	33.9	34.1	64.9	19.8	22.6	83.0	36.0	29.9	19.6	9.6	12.8	16.0	26.4	26.4	26.8	27.0	51.5	31.2	59.6	24.5	27.3	12.3	66.6	14.7	13.2	9.5	15.1	34.0	50.1	16.5	22.5	34.8	21.2	32.0	44.4	21.9	22.2	18.2	26.3	26.1	46.6	24.8	31.1	24.3	28.4	25.7	25.8	54.0	39.5	18.4	35.3	2.5	3.9	4.7	10.6	4.9	11.8	9.8	9.6	11.9	6.5	15.2	10.2	7.5	0.3	16.5	3.5	3.8	15.6	7.3	27.3	32.1	33.8	39.7	30.1	29.3	32.1	27.7	35.1	30.7	32.4	38.8	15.4	22.4	7.0	20.5	17.3	13.8	10.6	8.2	14.2	27.9	12.7	7.4	23.9	8.6	8.4	20.2	18.8	12.1	16.2	7.2	23.5	11.6	4.5	9.7	13.4	13.8	15.7	25.2	51.3	11.0	11.5	13.6	12.8	12.4	21.0	22.8	12.5	5.5	7.4	53.8	51.2	9.3	6.1	8.4	11.2	10.8	20.2	7.7	19.6	21.5	13.0	19.9	16.5	35.7	46.9	16.2	6.2	20.7	24.0	10.2	23.8	10.0	5.4	5.9	6.6	17.6	13.6	30.9	35.3	8.7	10.7	6.4	17.9	13.4	8.9	7.7
DDIT3	"CHOP, CHOP10, GADD153"	ENSG00000175197	"DNA damage inducible transcript 3"	P35638	12	57516588-57521737	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Apoptosis, Cell cycle, Growth arrest, Stress response, Transcription, Transcription regulation, Unfolded protein response, Wnt signaling pathway"	"Activator, DNA-binding, Repressor"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 170.7"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HHSteC: 784.2;hTERT-HME1: 399.9;SK-MEL-30: 409.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA058416, HPA068416"	Uncertain		Supported	Nucleoplasm		No	No			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm		"HPA058416: AB_2683712, HPA068416: AB_2685985"	"unprognostic (1.12e-1)"	"unprognostic (5.33e-2)"	"unprognostic (2.20e-3)"	"unprognostic (4.92e-2)"	"unprognostic (7.86e-3)"	"unprognostic (2.28e-1)"	"prognostic unfavorable (6.55e-4)"	"unprognostic (8.55e-2)"	"unprognostic (1.26e-3)"	"unprognostic (9.40e-3)"	"unprognostic (4.92e-2)"	"unprognostic (4.16e-2)"	"unprognostic (3.52e-2)"	"unprognostic (3.70e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.56e-1)"	"unprognostic (6.76e-2)"	65.3	66.2	90.6	16.1	97.8	196.5	64.3	97.4	145.5	51.0	92.9	52.0	20.7	39.1	109.3	31.6	41.2	32.1	85.1	89.0	99.2	106.4	81.7	55.4	18.8	95.9	98.4	57.4	37.3	80.5	81.4	37.6	97.1	45.5	26.6	123.1	43.3	25.8	44.8	48.7	28.0	29.2	95.5	34.2	44.4	40.9	106.4	17.8	182.1	55.4	17.5	56.2	49.5	129.5	17.8	16.1	10.1	34.5	90.7	61.0	53.8	48.2	106.0	70.1	65.4	57.2	45.7	25.3	46.9	14.3	186.7	21.4	38.5	7.3	72.2	21.0	15.5	19.9	19.9	42.3	784.2	31.8	29.3	175.7	152.7	118.6	399.9	81.7	16.9	26.5	86.4	94.0	31.2	10.8	21.1	41.5	19.7	37.3	37.5	11.8	220.7	22.3	25.0	22.3	20.9	15.3	14.2	16.2	409.0	37.2	34.4	82.8	9.9	47.5	20.2	45.4	42.0	164.4	60.3	26.8	57.4	29.1	85.8	121.1	17.9	48.8	25.1	16.6	22.7	48.3	17.9	23.6	12.8	44.8	34.1	31.1	170.7	35.6	19.4	15.9	23.8	18.0	90.6	97.8	97.4	145.5	89.0	99.2	95.9	98.4	97.1	95.5	106.4	129.5	237.9	19.2	55.1	17.0	96.6	56.3	176.5	93.1	177.0	114.9	86.3	265.7	177.9	37.1	56.7	22.0	91.8	42.3	101.8	265.7	115.4	43.3	9.5	111.3	39.4	62.3	230.7	12.8	9.6	16.0	17.5	115.7	74.5	82.4	204.0	26.3	27.5	20.1	45.7	55.5	14.5	218.4	101.7	30.4	81.6	6.3	28.0	81.5	88.9	6.5	8.2	156.1	17.5	14.1	23.0	33.0	300.0	38.0	43.2	115.1	61.7	61.6	38.1	160.0	13.1	56.9	122.2	77.7	15.6	91.5	45.7	107.8	89.7	37.2	127.2	65.1
DDIT4	"Dig2, FLJ20500, REDD-1, REDD1, RTP801"	ENSG00000168209	"DNA damage inducible transcript 4"	Q9NX09	10	72273919-72276036	"Predicted intracellular proteins"	"Antiviral defense, Apoptosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Plasma cells: 776.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HBEC3-KT: 657.6;hTCEpi: 2252.5;hTERT-HME1: 877.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034507, HPA034508"	Approved		Supported	Cytosol		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 50: Non-specific - Ribosome"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 22: Epithelial cell types - Mixed function"	Cytosol		"HPA034507: AB_2674199, HPA034508: AB_10601206"	"unprognostic (2.84e-3)"	"unprognostic (1.05e-3)"	"unprognostic (1.06e-1)"	"unprognostic (2.59e-1)"	"unprognostic (7.91e-3)"	"prognostic unfavorable (5.42e-4)"	"unprognostic (7.65e-2)"	"unprognostic (1.62e-3)"	"unprognostic (2.90e-1)"	"unprognostic (4.96e-3)"	"prognostic unfavorable (2.78e-4)"	"unprognostic (9.72e-2)"	"prognostic unfavorable (2.54e-6)"	"unprognostic (8.52e-2)"	"unprognostic (1.12e-1)"	"unprognostic (5.92e-2)"	"unprognostic (1.66e-1)"	313.5	280.9	88.9	83.7	89.3	123.7	287.3	92.5	106.4	415.9	103.4	93.5	20.8	98.6	12.6	425.0	118.6	47.8	237.2	82.4	87.7	179.9	337.1	197.8	90.1	102.9	92.0	741.5	675.4	94.4	169.5	51.8	90.0	171.1	13.3	86.7	224.9	68.3	278.1	231.6	111.7	25.4	88.0	166.3	121.2	32.0	95.8	102.5	105.1	60.0	114.3	315.3	597.5	98.2	139.2	95.2	20.0	179.3	124.0	74.3	52.1	40.3	45.6	13.5	56.7	11.1	280.5	14.3	113.7	6.5	19.1	143.0	28.9	657.6	33.7	213.9	35.8	15.1	115.4	74.0	501.2	47.7	57.7	291.1	2252.5	59.2	877.9	127.1	60.1	33.9	135.3	347.2	51.5	58.7	28.5	62.1	4.2	67.6	22.2	15.2	22.4	265.7	115.9	30.9	33.2	46.2	98.3	152.0	583.9	43.0	20.9	104.4	118.7	4.6	35.4	8.7	22.3	234.3	135.1	42.3	252.9	99.9	29.8	68.8	7.6	51.1	236.4	14.5	249.6	97.4	163.8	141.3	40.3	122.4	274.5	213.7	17.1	408.1	13.0	197.4	136.9	215.0	88.9	89.3	92.5	106.4	82.4	87.7	102.9	92.0	90.0	88.0	95.8	98.2	366.5	12.8	27.1	136.1	290.6	228.5	383.5	534.1	290.8	87.8	129.8	112.5	16.1	77.2	226.6	60.7	79.2	9.9	680.2	109.2	60.7	310.7	3.1	46.4	101.8	177.9	75.1	129.0	2.1	165.3	141.1	203.8	116.2	69.2	415.0	30.8	249.1	83.8	89.7	30.3	3.8	105.6	173.0	102.4	485.9	7.0	88.3	280.5	396.6	5.6	38.9	682.8	249.3	7.1	5.5	131.5	177.7	128.2	776.1	143.5	41.6	19.3	100.6	143.3	72.3	124.2	338.3	2.1	5.7	519.6	251.5	19.0	537.4	126.0	70.6	359.6
DDN	KIAA0749	ENSG00000181418	Dendrin	O94850	12	48995149-48999375	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	12	"brain: 165.7;skeletal muscle: 297.1"	"Group enriched"	"Detected in some"	4	"Collecting duct cells: 3.7;Excitatory neurons: 5.9;Inhibitory neurons: 2.5"	"Cancer enhanced"	"Detected in some"		"glioma: 2.2;head and neck cancer: 2.6"	"Group enriched"	"Detected in many"	31	"amygdala: 142.5;basal ganglia: 115.5;cerebral cortex: 165.7;hippocampal formation: 126.2;white matter: 54.2"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HAP1: 12.0;NB-4: 7.0;RPMI-8226: 23.3;SCLC-21H: 11.8"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	14	"amygdala: 165.3;basal ganglia: 212.8;cerebral cortex: 178.3;hippocampal formation: 171.2;olfactory bulb: 62.7"	HPA060952	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA				"Cluster 47: Non-specific - Unknown function"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Nucleoplasm	Cytosol	"HPA060952: AB_2684396"	"unprognostic (2.80e-2)"	"unprognostic (3.19e-3)"	"unprognostic (4.56e-2)"	"unprognostic (8.10e-3)"	"unprognostic (1.63e-1)"	"unprognostic (1.79e-3)"	"unprognostic (6.20e-5)"	"unprognostic (8.61e-4)"	"unprognostic (2.12e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.48e-1)"	"unprognostic (5.08e-2)"	"unprognostic (1.37e-6)"	"unprognostic (1.72e-2)"	"unprognostic (5.49e-2)"	"unprognostic (1.61e-2)"	"unprognostic (1.53e-2)"	0.1	0.1	142.5	0.2	115.5	1.0	0.1	0.0	165.7	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.7	126.2	0.0	19.5	0.1	0.1	0.2	0.0	0.2	0.0	0.1	0.1	1.3	0.0	0.0	1.4	0.0	0.3	1.6	0.0	297.1	0.3	0.1	0.0	0.0	0.3	0.3	0.2	3.9	0.0	0.1	9.2	0.2	0.0	0.1	54.2	0.4	0.4	0.2	0.7	0.0	0.0	0.1	0.1	0.1	0.1	0.2	5.2	0.5	0.0	0.2	0.1	0.0	1.8	12.0	0.0	0.1	0.6	5.4	2.7	0.6	1.2	0.0	6.5	0.3	0.0	0.1	0.1	0.0	0.1	0.1	0.4	0.0	4.0	0.2	0.2	6.3	7.0	0.1	0.9	1.6	5.7	0.3	23.3	0.0	0.1	11.8	1.1	0.2	0.6	0.3	0.1	0.3	0.9	0.1	0.3	0.5	0.3	0.0	1.4	2.8	5.5	0.3	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	142.5	115.5	0.0	165.7	126.2	0.0	0.0	0.2	0.0	0.0	3.9	54.2	0.4	0.0	0.0	0.7	0.0	0.0	0.1	0.0	0.6	0.0	0.3	0.4	0.6	0.0	0.0	3.7	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.2	0.2	0.2	0.0	0.8	5.9	0.2	0.0	0.1	0.0	0.1	0.0	0.1	0.7	0.0	0.2	0.0	2.5	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	1.0	0.0	0.0	0.0	0.5	0.6	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.2	0.3	0.2	0.4	0.1	0.1	0.0	0.1	0.0
DDOST	"GATD6, KIAA0115, OST, OST48, WBP1"	ENSG00000244038	"Dolichyl-diphosphooligosaccharide--protein glycosyltransferase non-catalytic subunit"	P39656	1	20651767-20661544	"Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"			"Congenital disorder of glycosylation, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cytotrophoblasts: 350.7;Syncytiotrophoblasts: 349.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009746, HPA046841, HPA052867"	Supported		Supported	"Endoplasmic reticulum"		NA	NA		120000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 55: Plasma cells - Humoral immune response"	"Endoplasmic reticulum"		"CAB009746: AB_2092075, HPA046841: AB_2679834, HPA052867: AB_2681977"	"unprognostic (8.57e-3)"	"unprognostic (1.35e-2)"	"unprognostic (1.57e-2)"	"prognostic favorable (5.99e-4)"	"unprognostic (1.62e-1)"	"prognostic unfavorable (4.88e-4)"	"prognostic unfavorable (2.64e-5)"	"unprognostic (1.33e-1)"	"unprognostic (5.51e-3)"	"unprognostic (2.70e-2)"	"unprognostic (3.59e-2)"	"unprognostic (3.72e-1)"	"prognostic unfavorable (9.05e-7)"	"unprognostic (1.07e-1)"	"unprognostic (2.98e-1)"	"unprognostic (1.69e-2)"	"unprognostic (1.07e-1)"	98.1	132.7	44.6	108.5	46.4	191.4	111.9	44.9	46.3	130.7	64.1	161.4	119.4	115.8	224.5	113.2	137.4	98.2	123.4	47.2	53.7	100.6	137.2	104.4	104.6	48.1	45.3	139.5	259.8	112.7	119.1	183.3	46.9	99.8	165.7	42.1	151.7	130.4	80.0	87.3	108.4	122.8	46.1	113.1	139.0	83.4	52.4	84.0	185.6	66.4	121.6	119.3	92.8	51.4	366.0	206.7	178.8	533.9	347.4	359.8	376.6	286.1	545.9	435.5	445.3	278.9	678.8	275.8	501.8	447.0	238.7	292.7	250.4	334.3	321.3	257.0	256.3	235.7	138.5	375.0	513.2	377.5	618.8	371.6	370.2	365.2	439.5	522.8	504.1	180.5	116.3	445.0	266.5	251.1	179.6	308.2	196.5	529.8	214.2	164.5	238.6	492.2	358.7	150.4	133.0	238.3	294.0	299.1	413.5	257.1	237.8	566.8	260.2	249.7	279.6	435.1	274.6	586.1	677.5	195.6	409.4	489.4	342.0	272.0	268.3	257.3	255.6	284.2	270.3	230.4	218.1	239.9	389.7	207.8	203.1	209.6	63.8	266.1	251.4	320.1	256.0	490.6	44.6	46.4	44.9	46.3	47.2	53.7	48.1	45.3	46.9	46.1	52.4	51.4	62.0	35.3	72.3	7.5	93.6	50.2	95.8	200.6	47.3	18.3	70.0	62.5	22.1	77.2	120.0	35.0	29.2	350.7	92.9	52.5	39.2	162.5	29.9	44.7	71.9	65.2	71.8	49.6	10.9	148.3	270.0	102.8	74.5	71.6	79.1	113.2	55.3	74.4	140.8	16.8	9.4	152.6	79.3	66.8	78.8	13.9	74.6	74.5	85.4	6.5	96.4	54.1	87.6	15.6	10.7	93.5	89.7	60.9	320.5	68.9	69.1	54.3	78.9	24.6	46.0	42.5	103.3	136.0	171.3	55.1	53.6	349.7	78.5	122.9	133.7	84.3
DDR2	"NTRKR3, TKT, TYRO10"	ENSG00000162733	"Discoidin domain receptor tyrosine kinase 2"	Q16832	1	162631373-162787405	"Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	Osteogenesis	"Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease variant, Dwarfism, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 89.8;Fibroblasts: 116.5;Leydig cells: 63.0;Peritubular cells: 88.4;Skeletal myocytes: 98.2;Smooth muscle cells: 78.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 233.3;ASC TERT1: 214.4;BJ hTERT+: 163.4;fHDF/TERT166: 137.6;HSkMC: 157.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA070112			Approved	"Plasma membrane,Actin filaments"		Yes	No		770000		"Cluster 57: Non-specific - Angiogenesis"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Plasma membrane, Actin filaments"		"HPA070112: AB_2686229"	"unprognostic (4.12e-2)"	"unprognostic (2.73e-1)"	"unprognostic (6.97e-3)"	"unprognostic (4.52e-2)"	"unprognostic (1.17e-1)"	"unprognostic (8.16e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.19e-1)"	"unprognostic (6.62e-2)"	"unprognostic (2.24e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.15e-1)"	"prognostic unfavorable (1.73e-7)"	"unprognostic (1.56e-3)"	"unprognostic (8.26e-3)"	"unprognostic (7.57e-2)"	"unprognostic (4.10e-3)"	59.8	64.3	13.2	15.8	11.3	0.3	25.2	10.4	9.2	33.7	51.5	54.7	5.8	26.2	13.2	18.1	22.4	23.8	24.1	12.6	24.5	6.4	5.4	14.5	9.1	37.0	22.1	37.4	3.7	2.5	5.4	10.6	31.7	17.3	14.1	5.1	9.8	29.2	4.9	9.7	17.6	42.8	17.8	5.8	20.4	3.9	21.0	3.3	12.9	19.3	6.9	23.2	23.6	25.2	0.3	0.0	0.2	63.2	233.3	214.4	1.0	92.2	163.4	41.5	56.8	0.0	0.2	0.0	0.1	137.6	8.9	0.1	0.3	0.4	54.0	42.9	0.3	0.0	0.4	0.1	103.9	0.2	0.2	157.0	0.4	73.1	2.2	65.8	46.0	0.4	0.6	16.8	36.9	0.1	0.0	0.3	0.4	0.1	0.3	0.1	24.1	0.7	0.2	0.2	0.3	35.4	0.2	0.1	2.9	3.6	0.2	0.3	2.1	58.5	13.8	29.1	12.6	2.6	4.0	0.1	56.3	0.1	62.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.2	11.3	10.4	9.2	12.6	24.5	37.0	22.1	31.7	17.8	21.0	25.2	23.4	3.2	2.3	53.2	2.5	12.6	3.9	0.8	1.2	3.0	6.0	15.6	31.3	1.5	1.1	0.0	0.0	0.5	1.7	3.2	0.0	0.4	8.9	5.0	89.8	22.3	1.2	0.0	13.1	1.8	0.5	116.5	2.6	8.2	1.3	16.7	30.0	3.5	1.2	0.0	26.2	1.0	0.0	1.9	19.3	7.1	63.0	3.1	23.2	29.0	0.0	16.5	2.1	6.0	5.6	1.8	4.4	88.4	5.6	5.9	1.2	2.1	2.4	3.0	39.5	98.2	78.3	1.0	0.9	2.0	8.7	1.0	2.5	34.2	0.8	4.2
DDRGK1	"C20orf116, dJ1187M17.3, UFBP1"	ENSG00000198171	"DDRGK domain containing 1"	Q96HY6	20	3190350-3204685	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Ubl conjugation pathway"		Dwarfism	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA013373, HPA013705"	Approved		Supported	"Nucleoli,Endoplasmic reticulum"		NA	NA		24000	"Cluster 26: Non-specific - Mitochondria"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 10: Non-specific - Unknown function"	"Endoplasmic reticulum"	Nucleoli	"HPA013373: AB_2091955, HPA013705: AB_2668872"	"unprognostic (2.99e-1)"	"unprognostic (1.55e-1)"	"unprognostic (3.42e-2)"	"unprognostic (1.60e-1)"	"unprognostic (6.54e-3)"	"unprognostic (2.14e-1)"	"unprognostic (1.19e-2)"	"unprognostic (1.63e-1)"	"unprognostic (4.10e-3)"	"unprognostic (8.16e-2)"	"unprognostic (5.44e-3)"	"unprognostic (7.29e-2)"	"prognostic favorable (2.01e-5)"	"unprognostic (6.80e-3)"	"unprognostic (1.43e-2)"	"unprognostic (2.48e-2)"	"unprognostic (6.90e-2)"	44.6	89.1	43.2	23.8	44.6	24.8	45.5	38.9	65.7	50.8	36.7	43.3	43.4	43.5	20.0	46.0	49.0	22.4	38.4	42.3	36.8	51.2	77.9	51.6	23.6	39.7	38.8	48.9	84.1	54.7	36.6	25.9	39.5	45.7	19.2	43.2	61.7	32.2	58.2	53.0	44.9	19.9	33.5	36.3	63.0	34.8	37.5	18.6	51.3	14.1	17.0	43.5	44.6	48.4	108.5	133.3	32.3	60.6	71.7	27.2	46.6	67.2	31.9	40.6	44.1	105.7	76.7	64.3	53.6	37.5	77.9	118.2	33.5	100.6	14.8	44.0	62.8	54.4	45.6	186.1	97.9	62.1	56.6	42.8	96.2	77.8	55.2	44.8	37.5	45.3	77.0	74.8	26.4	59.2	42.9	115.5	40.1	73.6	60.8	55.9	28.7	98.6	66.7	99.8	71.4	44.1	69.2	192.7	65.6	19.2	82.0	37.6	57.2	64.9	28.8	46.3	104.2	55.8	67.7	27.3	18.0	51.6	38.9	23.1	36.9	45.6	33.3	25.3	32.7	26.9	35.0	35.6	36.8	26.3	30.8	30.5	9.5	24.6	23.2	57.3	36.2	25.9	43.2	44.6	38.9	65.7	42.3	36.8	39.7	38.8	39.5	33.5	37.5	48.4	57.3	44.8	53.9	19.9	35.1	26.3	68.8	119.0	44.3	47.9	77.1	72.3	31.3	91.5	114.3	69.9	64.6	127.5	50.9	105.8	19.6	147.0	42.2	54.8	42.6	54.1	53.4	26.5	28.6	178.8	65.1	49.3	54.0	79.0	27.3	34.8	50.0	125.6	119.3	52.2	13.9	72.2	154.6	60.9	36.0	21.1	55.9	54.2	39.2	7.5	67.8	73.7	64.9	6.0	28.4	145.0	125.3	68.8	60.5	75.7	216.3	80.5	81.6	108.3	65.7	39.1	115.6	38.7	23.6	64.0	38.8	146.0	44.7	70.0	92.7	75.0
DDX1	DBP-RB	ENSG00000079785	"DEAD-box helicase 1"	Q92499	2	15591178-15634346	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Antiviral defense, Host-virus interaction, Immunity, Innate immunity, mRNA processing, Transcription, Transcription regulation, tRNA processing"	"Activator, DNA-binding, Exonuclease, Helicase, Hydrolase, Nuclease, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 362.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012280, HPA034502, HPA034503"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA		86000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm	Cytosol	"CAB012280: , HPA034502: AB_10794321, HPA034503: AB_10795025"	"unprognostic (9.94e-2)"	"unprognostic (2.95e-2)"	"unprognostic (3.07e-2)"	"unprognostic (8.36e-3)"	"unprognostic (9.28e-3)"	"unprognostic (1.56e-2)"	"prognostic unfavorable (9.09e-9)"	"unprognostic (2.55e-1)"	"unprognostic (2.05e-1)"	"unprognostic (4.81e-3)"	"unprognostic (3.89e-2)"	"unprognostic (2.03e-1)"	"prognostic favorable (9.69e-4)"	"unprognostic (3.80e-1)"	"unprognostic (1.34e-1)"	"unprognostic (4.94e-2)"	"unprognostic (1.20e-3)"	52.8	53.4	32.6	39.0	33.5	37.8	61.7	36.1	44.2	49.9	39.6	54.3	45.0	45.4	48.0	56.5	42.4	31.7	97.6	33.8	37.1	76.7	62.0	38.9	35.3	36.8	32.6	45.7	59.0	89.5	46.7	50.9	36.0	44.6	58.0	55.5	52.9	47.8	157.9	50.3	46.0	56.5	34.7	33.8	50.5	42.5	35.3	47.0	62.3	134.2	46.8	48.4	41.0	36.3	84.1	127.1	172.3	126.2	148.1	125.5	193.3	176.8	142.6	165.1	135.9	203.0	80.7	221.8	80.4	202.8	120.9	118.8	245.5	166.8	170.7	94.6	154.3	244.5	150.6	241.8	110.2	204.5	102.3	101.2	105.9	140.6	129.6	100.8	151.0	98.4	253.4	61.8	161.9	112.2	110.3	126.7	221.0	205.6	104.4	125.0	276.8	152.6	178.9	161.9	136.6	169.3	124.3	118.0	154.8	123.2	83.6	77.5	133.7	132.1	139.8	84.2	197.2	84.5	169.3	296.2	120.5	153.7	128.4	32.4	34.5	20.3	31.0	42.0	33.2	28.6	35.8	37.0	38.8	30.5	39.9	35.8	3.0	38.5	42.0	30.1	38.1	34.1	32.6	33.5	36.1	44.2	33.8	37.1	36.8	32.6	36.0	34.7	35.3	36.3	41.3	80.1	57.6	25.8	34.9	40.3	57.2	96.4	31.9	58.9	50.3	41.5	362.7	67.2	78.6	90.1	52.1	112.1	29.0	43.7	142.8	112.3	23.1	49.2	69.6	57.2	52.1	64.2	52.1	120.3	108.5	67.0	28.5	51.2	57.0	49.3	47.5	123.0	53.4	45.4	48.6	69.8	83.4	30.3	19.7	19.5	72.7	28.1	49.8	29.0	41.2	60.1	55.6	45.8	49.0	107.2	52.4	78.2	32.8	31.3	74.5	170.2	80.6	75.9	59.2	51.3	94.6	174.0	76.8	30.0	42.3	80.2	30.7	73.5	74.1	36.6
DDX11	"CHL1, CHLR1, KRG2, WABS"	ENSG00000013573	"DEAD/H-box helicase 11"	Q96FC9	12	31073860-31104799	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair, DNA replication, Host-virus interaction, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding, Helicase, Hydrolase, RNA-binding"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Rod photoreceptor cells: 25.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA065197	Supported		Supported	Nucleoplasm,Nucleoli		No	Yes			"Cluster 27: Non-specific - Gene expression"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	Nucleoli	"HPA065197: AB_2685430"	"unprognostic (6.10e-2)"	"unprognostic (1.48e-2)"	"unprognostic (1.02e-1)"	"unprognostic (5.09e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.79e-3)"	"prognostic unfavorable (2.40e-4)"	"unprognostic (4.87e-2)"	"unprognostic (3.89e-3)"	"unprognostic (3.53e-1)"	"unprognostic (5.66e-2)"	"unprognostic (1.25e-1)"	"prognostic unfavorable (5.23e-8)"	"unprognostic (1.89e-2)"	"unprognostic (3.64e-2)"	"unprognostic (1.02e-1)"	"unprognostic (8.03e-3)"	5.9	6.4	6.0	10.2	6.8	29.2	7.2	6.9	7.3	10.7	7.1	9.6	8.0	7.5	4.3	9.5	8.0	5.9	5.3	6.0	6.1	9.2	9.3	6.1	13.2	6.9	6.4	11.0	17.5	5.8	9.4	5.4	6.9	10.0	10.1	6.6	8.6	5.3	10.6	16.7	13.4	3.6	6.1	13.8	9.6	8.8	6.7	24.0	8.0	6.6	11.1	6.9	9.8	6.9	36.5	35.0	42.2	34.5	5.8	11.0	58.7	21.8	10.4	25.2	28.5	44.1	58.6	49.2	23.9	10.8	23.6	35.0	31.7	28.9	21.3	43.4	66.6	47.4	71.0	25.4	2.1	37.4	35.0	11.9	13.0	32.6	24.8	16.9	12.6	55.2	26.6	103.3	17.6	30.9	64.5	60.7	84.0	39.9	19.5	55.0	53.3	66.2	13.3	38.5	30.2	21.7	23.4	33.2	10.4	65.0	27.3	25.5	8.2	22.0	42.1	42.2	40.0	39.4	29.6	95.3	24.6	32.5	20.3	0.0	1.3	0.8	2.0	1.2	1.5	2.5	1.9	1.5	1.5	2.6	2.0	2.6	0.5	2.2	4.4	2.4	2.0	1.3	6.0	6.8	6.9	7.3	6.0	6.1	6.9	6.4	6.9	6.1	6.7	6.9	10.1	3.2	9.5	1.6	9.0	6.0	4.0	6.0	2.2	9.4	8.3	7.1	2.5	4.3	6.0	0.0	14.6	7.6	8.8	7.8	0.0	2.0	1.7	5.5	8.9	5.4	0.0	15.3	2.5	3.3	7.5	5.7	9.7	7.4	5.7	15.6	6.1	7.7	5.2	8.4	3.6	6.5	10.2	4.1	5.4	1.3	7.2	4.4	7.2	3.7	3.5	2.7	4.1	1.5	1.7	3.2	2.7	4.5	17.2	6.0	2.3	1.4	6.7	25.8	0.0	4.9	4.8	5.3	18.0	5.5	6.5	2.6	8.4	4.1	9.5	5.1
DDX17	P72	ENSG00000100201	"DEAD-box helicase 17"	Q92841	22	38483438-38507660	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Antiviral defense, Immunity, mRNA processing, mRNA splicing, RNA-mediated gene silencing, rRNA processing, Transcription, Transcription regulation"	"Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB024908, HPA063142"	Supported		Supported	"Nuclear speckles"	"Intracellular and membrane"	NA	NA		420000	"Cluster 1: Neutrophils - Mixed function"	"Cluster 51: Non-specific - Unknown function"	"Cluster 12: NES - Nervous system development"	"Cluster 52: Non-specific - Transcription"	"Nuclear speckles"		"CAB024908: , HPA063142: AB_2684949"	"unprognostic (1.46e-2)"	"unprognostic (5.99e-3)"	"unprognostic (4.24e-3)"	"unprognostic (6.67e-2)"	"unprognostic (1.06e-2)"	"unprognostic (1.02e-2)"	"unprognostic (1.36e-2)"	"prognostic favorable (6.06e-4)"	"unprognostic (1.17e-1)"	"unprognostic (5.51e-1)"	"unprognostic (2.52e-2)"	"unprognostic (2.73e-2)"	"unprognostic (1.89e-2)"	"unprognostic (2.19e-2)"	"unprognostic (1.76e-1)"	"unprognostic (4.31e-2)"	"unprognostic (3.19e-3)"	181.2	172.4	142.0	124.3	160.1	74.5	198.5	150.9	178.4	248.7	174.8	233.8	107.8	216.1	255.3	150.4	248.1	121.1	168.7	143.5	152.1	247.2	152.8	202.2	186.4	152.8	149.4	298.8	214.0	144.7	309.9	158.8	155.3	234.4	114.2	342.0	188.4	123.3	184.8	197.0	227.2	119.7	146.8	293.0	192.1	91.1	148.2	215.2	300.0	106.6	158.2	204.4	201.5	196.5	122.0	79.9	237.6	141.8	148.2	166.0	120.7	104.3	85.9	118.3	121.2	89.0	100.5	225.8	65.8	119.5	82.9	133.2	212.5	127.9	145.9	202.5	142.1	140.4	175.8	133.5	153.4	192.9	170.8	122.3	183.7	86.8	142.9	211.7	153.3	109.6	139.7	255.3	116.0	75.6	128.7	164.0	148.0	172.1	51.6	218.0	122.9	137.1	141.2	132.6	134.1	75.3	155.0	125.9	161.2	180.5	110.0	148.4	140.8	125.7	77.6	80.0	79.3	203.7	130.3	183.4	156.7	123.1	154.2	6.7	8.1	9.5	7.6	7.9	8.9	9.0	7.1	7.3	7.0	7.2	5.7	6.8	16.6	5.1	8.7	10.5	9.1	6.0	142.0	160.1	150.9	178.4	143.5	152.1	152.8	149.4	155.3	146.8	148.2	196.5	252.6	214.7	325.5	483.8	241.9	223.6	206.1	129.3	158.2	448.3	300.7	195.3	147.2	180.1	223.5	283.3	352.3	127.6	297.5	172.8	33.2	111.7	44.4	280.0	293.4	250.4	236.1	177.1	198.9	90.2	99.9	207.5	216.1	234.2	200.7	505.3	233.8	205.3	113.9	321.4	242.1	191.6	146.5	200.6	194.8	49.1	323.7	197.7	154.7	253.9	235.1	223.4	304.9	334.3	553.3	104.7	153.1	278.7	213.1	193.5	154.8	89.8	270.8	559.4	289.3	260.5	213.6	136.4	74.2	120.4	279.9	139.4	218.6	293.7	147.0	255.3
DDX20	"DP103, GEMIN3"	ENSG00000064703	"DEAD-box helicase 20"	Q9UHI6	1	111754832-111775602	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"DNA-binding, Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"testis: 52.8"	"Group enriched"	"Detected in all"	5	"Early spermatids: 738.2;Late spermatids: 718.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005516, CAB015427"	Enhanced		Supported	"Nucleoplasm,Nuclear bodies,Cytosol"	"Intracellular and membrane"	NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 83: Testis - Spermatogenesis"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 34: Spermatids - Unknown function"	"Nucleoplasm, Nuclear bodies"	Cytosol	"CAB015427: AB_629518, HPA005516: AB_1849612"	"unprognostic (3.71e-2)"	"unprognostic (5.25e-2)"	"prognostic favorable (9.85e-5)"	"unprognostic (8.73e-2)"	"unprognostic (2.51e-2)"	"unprognostic (7.09e-2)"	"prognostic unfavorable (6.35e-6)"	"unprognostic (1.17e-1)"	"unprognostic (5.87e-2)"	"unprognostic (7.46e-3)"	"unprognostic (4.21e-1)"	"unprognostic (5.22e-2)"	"unprognostic (1.05e-3)"	"unprognostic (2.60e-2)"	"unprognostic (2.01e-1)"	"unprognostic (4.23e-1)"	"unprognostic (1.30e-2)"	4.6	3.6	0.8	1.3	0.7	2.3	4.3	0.4	0.9	4.2	0.3	3.9	0.5	4.8	0.9	3.3	4.5	1.6	3.6	0.8	0.7	3.0	2.6	3.2	3.0	0.7	0.8	4.3	3.6	2.5	1.9	2.4	0.5	3.0	1.9	0.8	3.3	2.5	8.8	3.6	4.3	2.8	0.5	4.8	3.8	52.8	0.6	3.7	3.2	1.8	4.2	4.0	3.3	1.3	7.0	3.8	7.1	7.3	4.7	5.0	7.0	3.3	9.1	16.3	18.6	5.8	4.5	17.7	5.2	6.4	3.9	5.8	13.5	9.4	18.2	7.3	9.2	7.4	3.2	3.0	4.6	8.4	6.1	3.0	10.4	9.2	12.2	2.4	12.8	7.2	10.8	5.9	12.0	6.5	11.8	0.9	14.1	5.2	8.5	11.3	12.7	5.3	4.8	5.2	11.7	9.5	6.7	7.0	12.7	5.7	7.0	8.5	3.5	7.9	8.2	13.2	8.6	1.2	5.3	12.3	7.5	8.1	18.5	14.9	6.2	6.0	8.2	5.6	10.7	9.3	9.1	8.4	6.8	9.1	10.6	8.6	3.4	9.1	6.6	3.5	10.0	6.9	0.8	0.7	0.4	0.9	0.8	0.7	0.7	0.8	0.5	0.5	0.6	1.3	8.5	12.8	9.4	6.8	13.0	10.8	9.7	6.0	9.6	14.3	6.5	6.6	7.7	5.7	10.0	5.5	2.1	10.2	9.4	2.9	3.9	9.5	738.2	8.1	12.0	9.3	4.2	5.9	7.4	6.9	7.5	6.9	5.1	5.4	7.6	12.3	5.7	5.9	9.3	6.7	7.7	5.8	8.2	7.2	7.0	718.9	16.4	7.3	1.8	3.7	7.5	6.9	6.2	3.0	3.6	6.3	2.3	13.2	9.0	5.2	3.0	7.6	11.8	10.4	6.6	9.7	11.7	121.7	26.3	7.0	7.2	5.1	11.1	14.0	6.6	5.5
DDX23	"prp28, PRPF28, SNRNP100, U5-100K"	ENSG00000174243	"DEAD-box helicase 23"	Q9BUQ8	12	48829756-48852842	"Enzymes, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038680, HPA039037"	Approved		Supported	Nucleoplasm,Nucleoli		NA	NA		21000	"Cluster 2: Granulocytes - Unknown function"	"Cluster 52: Non-specific - Ribosome"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 63: NK-cells & T-cells - Immune response"	"Nucleoplasm, Nucleoli"		"HPA038680: AB_10795401, HPA039037: AB_2676317"	"unprognostic (1.32e-3)"	"unprognostic (8.90e-2)"	"unprognostic (8.92e-2)"	"unprognostic (7.12e-2)"	"unprognostic (5.34e-2)"	"unprognostic (1.47e-1)"	"prognostic unfavorable (3.03e-5)"	"unprognostic (3.54e-2)"	"unprognostic (5.68e-2)"	"unprognostic (2.19e-2)"	"unprognostic (1.69e-1)"	"unprognostic (8.34e-2)"	"unprognostic (5.94e-2)"	"unprognostic (9.78e-2)"	"unprognostic (6.88e-2)"	"unprognostic (2.59e-2)"	"unprognostic (1.44e-1)"	33.2	30.7	28.7	36.9	30.8	26.5	33.1	29.7	29.6	35.3	33.1	39.3	33.5	35.1	25.0	37.5	35.4	25.4	30.1	28.0	29.9	33.0	43.0	33.8	46.6	30.7	29.9	40.6	36.7	34.5	28.4	33.7	29.7	36.1	37.6	27.8	37.3	29.7	54.4	39.2	41.2	34.0	30.1	47.6	38.3	26.7	30.8	63.3	32.9	35.8	48.1	36.1	34.7	30.4	74.0	165.1	76.6	81.5	74.7	51.4	81.3	89.1	68.1	98.9	62.5	162.0	95.7	92.5	95.6	74.4	93.3	64.9	168.1	81.1	84.0	146.1	89.2	122.7	139.0	73.8	40.3	125.3	106.9	49.9	71.7	105.1	62.6	67.6	82.4	80.4	165.6	80.3	72.9	102.1	119.8	118.2	114.4	104.0	77.4	125.9	90.7	73.5	58.3	101.9	94.1	54.9	89.4	101.0	38.4	78.0	99.0	113.7	74.5	74.4	54.1	37.2	71.8	60.1	89.8	109.5	63.3	86.8	41.8	20.9	11.8	21.9	19.3	13.6	19.6	12.6	14.1	17.5	11.3	10.5	13.5	16.6	12.2	12.8	9.8	11.9	14.3	12.0	28.7	30.8	29.7	29.6	28.0	29.9	30.7	29.9	29.7	30.1	30.8	30.4	22.7	25.6	36.5	11.8	25.5	12.9	13.7	12.7	25.6	17.5	18.6	19.4	20.0	22.8	25.8	12.9	25.0	25.9	30.7	33.0	15.6	25.9	14.4	24.4	25.2	27.2	13.9	21.7	6.9	38.9	29.1	19.2	25.5	26.6	18.3	29.8	17.9	18.7	19.1	15.2	8.7	26.6	16.2	13.2	10.3	6.3	24.5	16.5	14.2	9.4	25.5	26.2	35.0	7.5	8.4	33.9	32.3	22.2	32.0	26.7	24.3	12.5	34.4	26.1	19.7	20.8	20.0	43.8	33.1	24.4	15.2	26.5	28.6	21.1	27.3	21.6
DDX25	GRTH	ENSG00000109832	"DEAD-box helicase 25"	Q9UHL0	11	125903348-125943702	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Differentiation, mRNA transport, Spermatogenesis, Translation regulation, Transport"	"Developmental protein, Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"testis: 91.4"	"Group enriched"	"Detected in some"	4	"Early spermatids: 332.1;Spermatocytes: 266.3"	"Cancer enhanced"	"Detected in some"		"glioma: 1.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"JURKAT: 16.1;NTERA-2: 10.8;SCLC-21H: 8.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020137	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm	Cytosol	"HPA020137: AB_1847552"	"unprognostic (5.78e-3)"	"unprognostic (9.75e-3)"	"unprognostic (7.93e-2)"	"unprognostic (5.09e-3)"	"unprognostic (1.11e-2)"	"unprognostic (1.78e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.91e-3)"	"unprognostic (6.24e-5)"	"unprognostic (2.57e-1)"	"unprognostic (2.44e-3)"	"unprognostic (3.89e-1)"	"unprognostic (3.44e-3)"	"unprognostic (1.44e-1)"	"unprognostic (1.76e-1)"	"unprognostic (9.72e-2)"	"unprognostic (1.69e-1)"	0.4	2.7	15.0	0.1	16.1	0.3	0.3	12.4	17.0	0.3	4.0	0.4	0.4	0.3	0.2	0.1	0.6	0.1	0.0	14.3	16.7	2.6	0.3	0.2	0.1	8.7	10.4	0.6	1.4	1.7	14.9	0.2	10.6	0.2	0.1	21.8	0.2	0.4	0.1	1.1	0.1	0.0	7.6	0.3	0.4	91.4	15.0	0.6	4.7	0.1	0.1	0.0	0.2	13.5	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.7	0.0	0.2	0.1	1.2	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	16.1	0.0	0.2	0.0	0.5	1.7	0.0	10.8	0.5	0.0	0.4	0.0	0.0	0.0	0.1	8.7	1.9	0.1	0.0	1.7	1.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.6	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.4	0.2	0.0	0.1	0.0	0.0	15.0	16.1	12.4	17.0	14.3	16.7	8.7	10.4	10.6	7.6	15.0	13.5	0.2	0.0	0.5	16.0	0.5	0.1	0.8	0.0	2.2	18.0	0.1	0.8	1.1	0.0	0.0	0.0	16.7	0.1	0.0	0.0	3.9	0.3	332.1	0.2	0.0	1.0	0.0	0.0	18.0	0.2	0.2	0.4	0.0	0.1	0.0	2.3	0.4	0.5	0.1	16.8	23.1	0.0	0.0	0.0	0.3	66.0	3.7	0.4	0.0	1.9	0.0	20.2	0.0	15.6	3.1	0.1	0.0	4.9	0.0	0.5	0.0	2.7	0.0	16.6	0.0	0.2	0.3	266.3	28.6	0.4	0.0	0.0	0.1	4.0	0.0	0.2
DDX28	"FLJ11282, MDDX28"	ENSG00000182810	"DEAD-box helicase 28"	Q9NUL7	16	68020916-68023232	"Enzymes, Predicted intracellular proteins"	"Ribosome biogenesis"	"Helicase, Hydrolase, RNA-binding, rRNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Syncytiotrophoblasts: 99.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041911, HPA053585"	Approved		Supported	Nucleoli,Mitochondria,Cytosol		No	No			"Cluster 27: Non-specific - Gene expression"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	"Mitochondria, Cytosol"	Nucleoli	"HPA041911: AB_10794161, HPA053585: AB_2682200"	"unprognostic (8.11e-2)"	"unprognostic (1.18e-1)"	"unprognostic (6.10e-3)"	"unprognostic (8.03e-2)"	"unprognostic (1.58e-1)"	"unprognostic (8.69e-2)"	"unprognostic (8.46e-2)"	"unprognostic (9.58e-2)"	"unprognostic (2.19e-1)"	"unprognostic (7.63e-2)"	"unprognostic (8.14e-3)"	"unprognostic (8.53e-2)"	"prognostic favorable (2.07e-10)"	"unprognostic (1.58e-2)"	"unprognostic (6.21e-2)"	"unprognostic (2.23e-1)"	"unprognostic (2.47e-1)"	5.8	10.0	3.9	4.8	4.1	16.8	5.6	4.0	4.3	3.9	4.0	5.7	3.9	6.0	5.1	8.2	5.0	2.8	8.3	4.1	4.7	6.4	8.7	4.3	7.7	4.0	3.9	5.5	5.6	7.0	3.6	4.7	4.3	3.5	4.3	1.6	5.0	3.5	15.4	9.7	7.0	3.7	4.0	9.0	6.3	9.7	4.1	5.6	4.0	7.7	6.4	5.5	4.3	4.1	10.2	14.7	7.1	8.5	9.5	5.3	16.5	6.9	9.8	16.4	11.6	14.4	15.5	37.6	10.2	8.3	9.0	17.9	10.1	16.1	9.6	5.1	16.7	13.6	7.4	14.9	12.8	21.7	14.1	10.3	17.2	13.5	12.4	5.7	9.2	24.9	24.5	5.7	7.4	22.4	22.9	30.0	17.2	10.2	10.7	22.1	6.6	40.3	11.6	11.4	14.8	9.9	27.6	7.8	15.3	8.0	14.9	23.1	7.0	7.3	6.3	10.6	11.2	12.8	16.9	36.7	9.0	16.4	10.1	24.0	22.3	27.4	17.0	22.4	18.7	14.3	15.6	18.5	20.8	19.0	24.2	18.2	7.2	21.5	23.4	10.2	16.0	20.8	3.9	4.1	4.0	4.3	4.1	4.7	4.0	3.9	4.3	4.0	4.1	4.1	4.4	6.4	6.8	0.7	10.9	9.2	14.2	11.7	8.0	5.6	4.8	4.3	4.1	8.6	8.3	3.7	0.0	27.9	4.0	2.9	13.7	12.0	6.6	5.4	4.4	5.7	4.8	9.5	0.9	9.7	12.5	4.4	5.1	5.4	3.8	8.0	6.8	11.6	17.1	3.3	1.0	3.5	6.1	8.5	3.1	4.0	5.0	6.8	7.2	0.0	13.3	7.5	25.7	0.5	1.4	7.4	4.2	3.4	4.2	5.7	2.0	19.7	5.3	4.3	13.1	4.4	9.4	22.7	14.1	6.7	10.7	99.9	7.6	12.5	6.1	8.8
DDX31	"FLJ13633, FLJ14578, FLJ23349, PPP1R25"	ENSG00000125485	"DEAD-box helicase 31"	Q9H8H2	9	132592997-132670401	"Enzymes, Predicted intracellular proteins"		"Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Oligodendrocyte precursor cells: 26.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020891			Supported	"Nucleoli,Golgi apparatus,Vesicles"		NA	NA			"Cluster 22: NK-cells - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 68: Oligodendrocytes - Mixed function"	Nucleoli	"Golgi apparatus, Vesicles"	"HPA020891: "	"unprognostic (5.71e-2)"	"unprognostic (1.76e-2)"	"unprognostic (2.56e-1)"	"unprognostic (7.91e-2)"	"unprognostic (5.79e-2)"	"unprognostic (9.94e-2)"	"prognostic unfavorable (1.68e-7)"	"unprognostic (1.34e-1)"	"unprognostic (2.02e-2)"	"unprognostic (1.66e-1)"	"unprognostic (3.90e-2)"	"unprognostic (9.57e-3)"	"unprognostic (4.57e-3)"	"unprognostic (2.24e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.03e-1)"	3.9	3.8	3.3	5.3	3.9	4.2	6.3	8.8	3.2	4.8	4.0	3.9	3.1	4.5	5.0	5.7	5.2	3.6	3.3	2.8	3.7	6.0	5.5	4.5	6.6	5.1	3.8	9.9	5.8	5.4	4.2	3.5	5.7	5.4	4.7	3.2	8.2	4.3	6.1	8.4	4.2	4.2	2.9	4.8	4.0	6.0	3.6	5.5	13.8	4.2	7.2	5.2	4.9	4.7	12.4	22.2	10.8	14.4	12.4	11.1	20.4	12.9	12.2	19.2	14.5	24.9	24.1	29.9	11.2	11.7	20.8	33.5	32.8	14.6	15.4	18.4	12.3	16.4	19.5	13.1	14.9	29.7	12.8	9.9	19.5	19.7	27.5	7.5	12.7	22.1	30.6	11.4	16.1	26.3	20.6	15.9	26.2	35.4	22.2	21.4	19.3	34.6	17.5	11.4	18.8	13.5	23.4	20.2	18.0	12.2	42.8	8.4	11.1	32.5	15.0	18.7	19.8	5.5	18.8	23.5	12.0	18.2	25.2	0.0	1.1	1.2	3.1	1.6	2.4	2.1	2.9	2.4	2.5	2.7	3.6	2.7	0.2	2.0	1.1	1.6	2.0	1.7	3.3	3.9	8.8	3.2	2.8	3.7	5.1	3.8	5.7	2.9	3.6	4.7	3.3	6.4	6.0	16.6	7.2	5.6	4.5	3.0	9.1	4.3	5.9	8.1	4.4	0.0	10.2	7.3	4.2	5.7	4.7	3.6	1.9	6.2	4.1	3.9	6.6	3.6	24.6	1.7	9.7	5.4	6.8	4.4	4.1	4.6	1.3	6.1	2.9	4.1	5.2	1.7	13.9	5.8	6.1	2.9	1.8	3.0	18.0	2.9	1.8	5.6	4.5	1.7	8.2	26.7	17.1	5.9	1.2	13.2	5.7	5.8	0.7	7.1	5.7	3.7	0.0	4.1	3.4	14.0	13.7	8.8	6.3	3.0	5.0	5.7	6.1	3.5
DDX3Y	DBY	ENSG00000067048	"DEAD-box helicase 3 Y-linked"	O15523	Y	12904108-12920478	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"DNA-binding, Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 96.0"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 275.5;Late spermatids: 575.3"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in all"	6	"cerebral cortex: 31.8"	"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 153.7;HEL: 156.8;U-266/84: 133.1;U-698: 112.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001648, HPA005631, HPA059583"	Enhanced	Supported	Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 25: Spermatids - Spermatogenesis"	Cytosol	Nucleoplasm	"HPA001648: AB_1078635, HPA005631: AB_1078633, HPA059583: "			"unprognostic (3.89e-2)"		"unprognostic (1.70e-1)"	"prognostic favorable (4.70e-5)"	"unprognostic (6.50e-2)"	"unprognostic (4.74e-2)"	"unprognostic (2.22e-2)"		"unprognostic (4.17e-2)"	"unprognostic (3.37e-2)"	"unprognostic (9.61e-2)"	"unprognostic (2.58e-3)"	"unprognostic (1.74e-1)"	"unprognostic (2.66e-2)"	"unprognostic (7.87e-2)"	29.0	26.1	2.8	15.2	2.9	96.0	20.7	5.5	31.8	0.0	6.6	25.8	12.0	0.0	26.8	18.5	0.0	18.7	19.1	2.7	5.5	23.7	22.0	27.4	9.6	2.8	3.3	0.1	14.8	12.4	25.1	22.1	3.2	33.6	24.0	23.6	18.5	31.3	19.9	20.2	25.9	0.0	2.3	26.5	19.8	70.1	3.8	0.0	22.0	28.1	23.6	22.0	0.0	4.6	0.7	28.3	0.0	0.0	0.0	0.0	20.0	69.3	49.9	35.9	44.0	0.2	0.0	153.7	0.1	69.5	0.0	0.0	0.0	0.0	63.2	38.8	0.0	156.8	0.0	46.5	34.2	0.1	0.1	37.4	43.4	0.0	0.0	0.0	0.0	15.2	0.2	0.1	43.1	0.2	61.8	0.2	27.1	0.0	0.0	0.0	18.0	28.2	38.2	41.5	44.5	0.1	0.1	0.2	51.4	43.5	0.0	36.5	49.1	55.0	0.3	0.1	45.8	78.7	133.1	112.8	6.9	0.1	0.0	1.5	3.8	3.2	4.4	3.9	4.0	3.2	3.3	3.7	4.9	2.7	3.9	3.5	3.5	3.4	2.4	1.4	3.0	3.2	2.8	2.9	5.5	31.8	2.7	5.5	2.8	3.3	3.2	2.3	3.8	4.6	0.1	48.1	75.8	10.1	58.0	94.1	92.7	37.5	89.4	53.8	0.0	0.0	26.0	10.0	41.2	9.2	41.7	38.3	13.3	5.6	5.9	13.9	275.5	0.0	0.0	56.5	16.0	24.6	19.7	0.2	18.9	63.4	56.1	0.0	92.9	0.0	42.1	9.1	20.1	42.1	15.7	9.3	10.2	64.1	127.5	575.3	38.8	58.2	26.6	5.6	27.8	53.7	26.8	4.0	5.7	5.0	8.8	39.5	54.7	70.8	10.5	13.9	101.2	49.3	19.7	56.2	39.2	67.2	70.1	43.8	80.4	37.8	66.2	0.0	8.1	75.0
DDX41	"ABS, MGC8828"	ENSG00000183258	"DEAD-box helicase 41"	Q9UJV9	5	177511577-177516961	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Helicase, Hydrolase, RNA-binding"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017911, HPA048803"	Supported		Supported	Nucleoplasm,Nucleoli		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 59: Non-specific - Translation"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm	Nucleoli	"HPA017911: AB_1847558, HPA048803: AB_2680527"	"unprognostic (2.52e-1)"	"unprognostic (1.51e-1)"	"unprognostic (7.57e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.34e-1)"	"unprognostic (2.61e-2)"	"unprognostic (4.21e-3)"	"unprognostic (2.60e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.25e-1)"	"unprognostic (2.89e-2)"	"unprognostic (4.47e-2)"	"prognostic unfavorable (2.21e-6)"	"unprognostic (1.41e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.23e-1)"	"unprognostic (1.75e-1)"	26.5	29.0	15.1	28.7	16.1	22.3	25.4	13.1	21.9	26.1	13.7	26.5	24.8	25.2	16.8	33.7	30.6	18.3	18.9	17.8	14.2	26.8	27.1	24.5	24.7	15.8	13.7	28.6	23.5	31.2	18.0	22.8	16.0	22.3	19.3	14.6	28.7	19.1	43.4	35.0	28.7	20.1	12.8	26.7	26.7	17.9	16.2	24.3	29.0	20.3	25.0	24.8	27.6	16.4	62.1	71.4	42.4	44.9	43.4	45.2	125.1	58.4	35.1	47.1	36.1	107.7	61.3	67.2	83.3	57.6	67.6	47.8	57.2	128.5	33.2	175.4	68.0	90.5	70.8	66.5	52.5	89.3	82.3	48.7	47.0	45.3	59.0	43.5	53.4	68.1	72.3	50.0	55.6	135.5	80.6	45.9	62.0	59.0	61.3	72.7	48.1	86.2	50.5	78.8	45.0	41.9	64.6	83.2	56.5	27.1	54.6	110.2	51.3	74.4	42.8	43.6	87.6	49.6	75.9	120.1	81.3	100.1	47.0	14.3	31.4	22.3	18.3	28.5	23.5	17.0	18.3	16.8	27.2	14.4	14.6	18.8	9.2	25.8	31.4	11.2	18.8	25.6	15.1	16.1	13.1	21.9	17.8	14.2	15.8	13.7	16.0	12.8	16.2	16.4	17.0	25.6	17.8	7.8	20.6	21.0	22.9	37.9	18.2	16.9	17.5	16.5	9.0	25.8	24.3	9.2	2.1	46.6	22.9	22.9	41.1	42.1	11.2	16.1	16.5	22.3	11.4	25.2	6.0	39.6	63.2	17.6	17.3	19.2	29.8	21.3	16.1	18.0	48.8	8.4	6.4	27.0	18.3	23.5	15.4	22.9	14.9	22.2	12.4	4.7	34.6	23.9	20.6	5.0	3.9	33.5	23.9	21.1	23.2	19.0	29.5	40.1	20.5	10.3	13.1	14.5	29.0	24.5	26.7	26.2	20.3	37.5	19.0	25.6	31.0	22.7
DDX46	"FLJ25329, KIAA0801, Prp5, PRPF5"	ENSG00000145833	"DEAD-box helicase 46"	Q7L014	5	134758771-134855133	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036554, HPA057501"	Supported		Supported	"Nucleoli fibrillar center,Nuclear speckles"		NA	NA		13000	"Cluster 6: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	"Nuclear speckles"	"Nucleoli fibrillar center"	"HPA036554: AB_10673621, HPA057501: AB_2683449"	"unprognostic (1.88e-1)"	"unprognostic (1.21e-1)"	"prognostic favorable (9.01e-6)"	"unprognostic (7.00e-2)"	"unprognostic (3.37e-2)"	"unprognostic (1.71e-2)"	"unprognostic (2.04e-3)"	"unprognostic (1.07e-1)"	"unprognostic (1.60e-2)"	"unprognostic (5.05e-2)"	"unprognostic (9.21e-2)"	"unprognostic (6.02e-2)"	"unprognostic (9.70e-3)"	"unprognostic (4.36e-2)"	"unprognostic (4.35e-2)"	"unprognostic (1.64e-2)"	"unprognostic (4.50e-2)"	16.5	14.6	7.6	23.9	8.8	23.1	17.7	16.1	10.8	16.3	11.4	17.3	17.0	19.8	12.3	17.5	15.0	13.4	13.4	6.8	11.2	18.8	17.7	15.8	25.6	10.0	8.4	18.5	20.8	18.4	11.1	15.7	9.2	15.5	20.7	18.0	16.8	12.1	35.2	19.4	18.7	17.6	5.4	20.6	20.0	16.3	10.0	32.1	18.7	22.9	26.6	18.2	15.6	10.3	87.1	78.0	54.4	71.1	20.8	23.2	75.0	56.8	43.7	58.8	65.6	119.2	61.7	108.9	47.7	38.3	62.3	52.5	80.9	54.2	68.7	73.8	73.3	131.0	84.7	48.5	18.0	120.5	67.8	21.0	28.9	62.1	34.8	24.9	47.3	85.9	113.6	45.3	44.1	41.5	104.2	46.9	75.2	50.1	34.8	89.7	142.0	54.8	32.0	73.9	64.2	61.3	79.4	37.2	42.7	63.0	58.3	68.0	59.0	61.8	43.2	47.9	114.0	35.6	103.2	140.2	42.8	112.0	40.0	55.6	31.9	48.2	30.7	29.2	28.0	38.1	30.4	31.3	25.3	43.4	30.9	31.5	55.9	32.3	27.5	38.5	29.7	17.8	7.6	8.8	16.1	10.8	6.8	11.2	10.0	8.4	9.2	5.4	10.0	10.3	102.4	76.9	131.5	35.9	123.6	113.8	121.5	102.7	68.9	131.5	80.6	79.4	69.3	64.3	94.9	103.0	83.4	133.7	142.3	91.3	56.7	100.5	53.4	111.4	155.8	104.7	92.2	90.6	38.7	107.9	160.4	85.1	69.3	115.9	101.2	122.3	76.8	113.1	94.4	121.1	41.2	112.4	63.1	119.3	113.2	26.7	111.9	103.4	56.9	21.5	178.5	79.9	194.7	28.1	57.6	130.7	62.6	113.2	134.7	139.5	79.2	84.1	74.5	176.0	98.6	114.9	115.2	246.3	275.7	81.0	137.0	157.2	131.8	114.5	112.7	144.1
DDX47	"DKFZp564O176, FLJ30012, HQ0256, RRP3"	ENSG00000213782	"DEAD-box helicase 47"	Q9H0S4	12	12813316-12829981	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Apoptosis, mRNA processing, mRNA splicing, rRNA processing"	"Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Ductal cells: 22.6;Exocrine glandular cells: 17.8;Pancreatic endocrine cells: 19.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014855	Approved		Supported	Nucleoli		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 59: Non-specific - Transcription"	Nucleoli		"HPA014855: AB_1847567"	"unprognostic (3.14e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.75e-2)"	"unprognostic (2.38e-1)"	"unprognostic (4.91e-2)"	"unprognostic (5.84e-4)"	"unprognostic (1.96e-1)"	"unprognostic (1.11e-2)"	"unprognostic (1.13e-3)"	"unprognostic (2.79e-1)"	"unprognostic (3.49e-3)"	"unprognostic (6.55e-9)"	"unprognostic (1.68e-1)"	"unprognostic (1.27e-1)"	"unprognostic (3.24e-1)"	"unprognostic (8.20e-6)"	28.8	24.1	23.2	22.7	23.7	41.2	32.1	24.6	30.8	27.8	24.5	29.3	18.2	30.8	22.3	29.1	29.8	19.9	23.0	22.6	24.0	32.1	37.8	24.8	32.7	23.8	23.6	35.6	30.8	36.5	17.5	28.9	24.1	26.4	26.3	16.9	24.5	29.0	44.6	30.5	21.7	33.4	24.4	23.4	29.3	23.1	23.2	35.5	33.3	41.7	39.8	47.6	25.5	25.2	161.7	68.3	65.6	53.7	63.1	61.7	111.8	67.8	77.0	141.0	131.0	104.1	101.0	82.4	25.9	92.2	87.4	102.6	95.2	78.0	157.7	117.2	68.1	75.5	45.3	59.7	53.5	87.0	46.5	60.0	72.4	84.0	68.8	110.7	110.4	63.9	74.3	18.2	78.3	57.7	71.0	60.1	288.7	74.4	41.4	77.7	127.2	50.0	86.5	114.2	28.6	72.5	82.3	52.1	69.2	161.4	21.4	64.9	49.9	56.5	136.5	36.8	103.4	25.2	49.1	148.1	60.2	44.9	66.8	10.5	32.9	8.4	46.6	43.8	55.5	48.0	40.9	43.2	56.8	44.9	53.0	51.5	3.8	40.6	44.4	33.3	43.4	35.8	23.2	23.7	24.6	30.8	22.6	24.0	23.8	23.6	24.1	24.4	23.2	25.2	5.1	3.2	8.2	9.1	8.4	2.2	2.7	2.4	14.2	0.6	1.4	1.0	0.1	0.0	8.5	0.0	0.0	1.7	2.3	3.2	1.9	22.6	0.1	3.0	4.1	4.3	4.8	3.4	8.2	17.8	1.9	3.2	4.6	5.7	12.0	0.9	1.1	0.9	0.9	0.0	9.4	4.2	2.0	1.0	1.6	0.4	0.6	2.5	0.0	12.2	9.7	0.9	2.1	8.0	12.6	19.0	4.2	0.4	12.3	1.9	2.8	1.1	6.3	1.6	6.6	1.6	3.4	0.7	0.7	9.0	1.8	1.4	6.2	0.6	6.5	2.8
DDX5	"G17P1, HLR1, p68"	ENSG00000108654	"DEAD-box helicase 5"	P17844	17	64498254-64508199	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Biological rhythms, mRNA processing, mRNA splicing, Transcription, Transcription regulation"	"Helicase, Hydrolase, RNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005868, HPA020043, HPA071154"	Supported		Supported	Nucleoplasm,Nucleoli		No	No		310000	"Cluster 18: Basophils - Vesicular transport"	"Cluster 34: Non-specific - Transcription"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 52: Non-specific - Transcription"	"Nucleoplasm, Nucleoli"		"CAB005868: AB_446484, HPA020043: AB_1847572, HPA071154: "	"unprognostic (6.64e-2)"	"unprognostic (6.98e-2)"	"prognostic favorable (2.12e-4)"	"unprognostic (8.94e-2)"	"unprognostic (5.08e-2)"	"unprognostic (9.85e-2)"	"unprognostic (5.80e-2)"	"unprognostic (1.61e-2)"	"unprognostic (3.17e-2)"	"unprognostic (4.71e-2)"	"unprognostic (3.03e-3)"	"unprognostic (1.44e-1)"	"unprognostic (4.00e-1)"	"unprognostic (2.08e-1)"	"unprognostic (2.37e-1)"	"unprognostic (2.17e-1)"	"unprognostic (9.28e-3)"	202.9	124.0	75.2	75.7	80.0	219.5	163.4	93.4	91.3	190.4	122.8	176.8	36.1	181.7	61.9	136.9	181.2	186.4	109.8	83.6	83.8	113.6	157.5	185.9	124.7	85.5	79.7	134.2	83.3	177.7	118.9	119.4	79.0	122.8	157.7	211.7	112.0	144.8	165.7	130.6	116.3	274.6	65.4	127.5	137.1	88.7	83.2	272.5	172.8	107.5	157.5	228.2	128.9	100.2	204.7	85.5	353.1	144.4	316.2	316.7	134.1	221.4	349.8	306.9	300.3	98.2	105.3	299.7	102.0	364.8	238.1	87.1	361.6	291.5	428.2	107.7	76.0	211.2	84.5	81.6	216.6	383.9	186.3	301.4	306.8	270.2	264.1	241.5	362.2	303.6	174.3	247.3	284.0	108.7	520.4	44.8	159.5	294.5	32.0	310.1	286.7	239.1	201.8	145.6	151.0	305.7	181.5	167.6	284.0	326.5	138.5	132.1	158.2	123.0	146.3	170.0	207.3	112.2	283.9	622.0	166.6	140.5	184.2	232.6	160.6	170.0	117.2	143.3	149.8	111.5	105.4	125.4	148.5	106.3	107.6	109.4	86.6	112.2	197.1	85.5	135.9	319.9	75.2	80.0	93.4	91.3	83.6	83.8	85.5	79.7	79.0	65.4	83.2	100.2	990.8	535.2	690.9	200.8	909.4	879.5	1536.4	837.0	618.1	403.5	433.3	393.7	249.6	346.0	855.7	369.6	335.7	439.9	1284.6	521.5	334.6	476.2	603.0	1021.9	987.2	767.7	664.1	309.7	187.9	419.2	371.3	733.5	452.1	1288.8	874.3	647.9	528.7	254.3	445.8	420.6	165.7	475.9	801.5	577.8	629.4	136.9	415.4	833.2	432.2	280.1	800.2	587.1	777.5	291.6	325.7	464.2	598.6	437.8	661.5	537.7	552.6	287.5	737.9	550.4	493.0	1437.7	961.5	407.6	399.1	466.4	746.0	887.3	1043.4	745.0	424.7	1056.4
DDX52	ROK1	ENSG00000278053	"DExD-box helicase 52"	Q9Y2R4	17	37609739-37643446	"Enzymes, Predicted intracellular proteins"		"Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 245.1;Glandular and luminal cells: 360.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA056173	Uncertain		Supported	Nucleoplasm,Nucleoli		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 44: Endometrium - Transcription"	"Nucleoplasm, Nucleoli"		"HPA056173: AB_2683056"	"unprognostic (1.05e-2)"	"unprognostic (1.85e-1)"	"prognostic favorable (9.41e-4)"	"unprognostic (4.26e-2)"	"unprognostic (9.96e-3)"	"unprognostic (6.77e-2)"	"prognostic unfavorable (2.44e-6)"	"unprognostic (5.10e-2)"	"unprognostic (2.94e-2)"	"unprognostic (2.79e-1)"	"unprognostic (7.50e-2)"	"unprognostic (2.43e-1)"	"unprognostic (2.36e-1)"	"unprognostic (6.95e-2)"	"unprognostic (5.58e-1)"	"unprognostic (1.26e-2)"	"unprognostic (1.28e-1)"	1.8	2.5	1.6	1.0	1.6	4.2	1.7	2.3	2.0	2.0	2.1	2.2	2.0	2.2	3.9	3.1	1.6	1.8	1.8	1.6	1.7	2.6	2.8	1.8	2.1	1.7	1.6	1.5	2.9	2.2	1.4	1.7	1.9	1.7	2.2	2.1	1.9	1.7	2.5	2.8	3.3	1.8	1.4	2.0	2.4	1.8	1.7	1.5	1.3	1.8	2.1	2.4	1.9	2.2	4.7	10.2	1.0	9.4	5.2	4.6	4.0	6.3	5.4	8.1	7.7	6.6	1.7	2.8	4.2	4.3	1.5	4.4	10.5	7.2	11.0	6.5	12.8	5.9	6.6	4.6	5.1	7.8	3.1	4.5	7.6	5.5	6.3	4.1	9.4	2.7	0.9	1.7	4.7	1.6	11.9	4.3	5.4	2.6	0.8	7.3	8.4	4.9	9.9	5.8	6.6	5.5	7.5	1.8	5.2	5.0	3.3	6.1	6.7	6.6	4.2	3.6	7.3	2.2	3.8	4.9	5.3	4.6	5.2	0.9	0.5	0.7	0.8	0.7	0.6	0.6	0.8	0.6	0.4	0.6	0.7	0.9	0.4	0.8	0.4	1.2	0.5	0.2	1.6	1.6	2.3	2.0	1.6	1.7	1.7	1.6	1.9	1.4	1.7	2.2	28.5	41.7	19.7	17.3	29.4	34.5	33.9	41.2	26.2	34.0	25.4	22.7	33.3	18.6	41.4	27.6	33.3	35.4	47.4	28.7	35.2	76.6	245.1	105.8	77.7	32.3	26.3	42.7	19.4	52.3	31.1	28.1	29.6	360.4	27.3	40.8	28.5	37.2	26.1	47.1	19.3	30.1	34.6	25.8	12.6	97.8	24.5	24.1	17.8	19.7	53.8	26.0	33.0	29.7	23.0	56.8	20.5	24.0	25.4	35.8	35.7	40.2	32.0	36.0	26.3	26.7	34.1	29.6	56.0	33.4	33.2	25.0	30.3	43.7	46.8	49.5
DDX53	"CAGE, CT26"	ENSG00000184735	"DEAD-box helicase 53"	Q86TM3	X	22999960-23003589	"Enzymes, Predicted intracellular proteins"		"Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	38	"brain: 2.1;testis: 5.4"	"Cell type enriched"	"Detected in some"	5	"Early spermatids: 62.6"	"Cancer enriched"	"Detected in single"	4	"testis cancer: 0.7"	"Region enriched"	"Detected in single"	7	"cerebellum: 2.1"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"GAMG: 3.2;K-562: 4.6;RPMI-8226: 2.4;U-2197: 1.4;U-266/84: 10.5"									HPA003186			Supported	Nucleoplasm,Nucleoli,Cytosol		NA	NA				"Cluster 78: Testis - Spermatogenesis"	"Cluster 16: U-266 - Nucleosome"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	Nucleoplasm	"Nucleoli, Cytosol"	"HPA003186: AB_1078637"														"unprognostic (5.76e-1)"	"unprognostic (1.12e-1)"			0.0	0.0	0.2	0.0	0.2	0.0	0.0	2.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.4	0.0	0.3	10.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	2.1	0.2	0.0	0.1	0.1	0.3	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	62.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	11.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	10.9	9.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0
DDX55	KIAA1595	ENSG00000111364	"DEAD-box helicase 55"	Q8NHQ9	12	123602077-123620943	"Enzymes, Predicted intracellular proteins"		"Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 74.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039962, HPA044101"	Approved		Enhanced	Nucleoplasm,Nucleoli,Cytosol		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 24: NB-4 - Immune response"	"Cluster 34: Spermatids - Unknown function"	"Nucleoplasm, Nucleoli"	Cytosol	"HPA039962: AB_2676774, HPA044101: AB_2678810"	"unprognostic (1.14e-1)"	"unprognostic (2.30e-2)"	"unprognostic (2.29e-1)"	"unprognostic (3.71e-3)"	"unprognostic (1.92e-1)"	"unprognostic (2.31e-1)"	"prognostic unfavorable (2.11e-9)"	"unprognostic (1.60e-1)"	"unprognostic (4.49e-2)"	"unprognostic (7.39e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.67e-3)"	"prognostic unfavorable (8.97e-12)"	"unprognostic (9.15e-3)"	"unprognostic (2.94e-1)"	"unprognostic (3.47e-2)"	"unprognostic (1.23e-3)"	11.0	10.3	11.1	10.4	11.1	20.3	11.1	13.2	19.5	12.1	11.2	9.7	7.6	9.6	7.7	11.1	12.2	5.6	6.9	10.7	11.4	12.3	14.7	8.4	13.8	11.5	10.8	13.1	15.4	6.5	11.3	7.7	11.6	11.4	8.8	12.6	9.5	6.3	6.4	13.6	10.8	7.1	9.9	14.9	9.7	9.6	11.3	10.3	9.1	3.4	10.7	10.7	11.1	12.9	20.5	28.4	21.4	21.7	18.0	14.2	32.2	24.8	9.1	21.6	14.8	32.5	14.6	30.2	19.3	10.9	19.5	24.4	32.8	18.4	25.1	22.8	29.7	40.8	34.0	24.3	13.7	50.7	30.7	12.0	19.2	25.7	29.5	16.7	15.8	23.9	42.3	15.5	15.5	21.1	50.0	68.2	33.3	23.6	27.9	37.1	22.7	19.7	15.2	34.8	25.3	21.0	20.2	25.9	35.0	17.7	46.2	32.4	16.3	18.6	24.5	30.6	31.2	28.4	37.4	54.2	17.7	35.8	32.4	3.4	9.1	7.8	11.4	10.6	12.4	13.9	11.1	12.3	7.7	10.7	14.9	13.9	5.2	13.3	6.4	13.2	9.9	8.6	11.1	11.1	13.2	19.5	10.7	11.4	11.5	10.8	11.6	9.9	11.3	12.9	13.3	22.4	13.9	15.7	14.2	11.0	13.4	13.9	9.6	20.2	9.6	14.9	2.5	8.6	11.7	7.3	22.9	13.8	26.3	5.9	7.9	12.2	45.1	9.0	18.4	12.0	7.2	19.6	13.4	12.0	17.4	12.0	11.2	7.2	25.3	16.4	7.1	9.4	14.3	15.2	16.5	15.9	10.2	7.1	7.4	74.8	17.1	9.0	7.2	12.2	9.9	16.1	15.5	6.6	14.3	13.3	7.6	14.7	13.8	13.3	5.9	6.3	12.3	28.1	6.6	10.5	14.1	21.9	18.6	12.5	16.9	7.7	14.2	14.0	10.2	11.0
DDX56	NOH61	ENSG00000136271	"DEAD-box helicase 56"	Q9NY93	7	44565804-44575051	"Enzymes, Predicted intracellular proteins"	"Ribosome biogenesis, rRNA processing"	"Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019749, CAB037320"	Uncertain		Supported	"Nucleoli,Mitotic chromosome"		Yes	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoli	"Mitotic chromosome"	"CAB037320: , HPA019749: AB_1847579"	"unprognostic (3.28e-1)"	"unprognostic (1.05e-1)"	"unprognostic (5.00e-2)"	"unprognostic (1.93e-1)"	"unprognostic (6.08e-3)"	"unprognostic (2.12e-3)"	"prognostic unfavorable (1.38e-5)"	"unprognostic (5.17e-2)"	"unprognostic (2.76e-1)"	"unprognostic (7.07e-2)"	"unprognostic (1.00e-2)"	"unprognostic (6.01e-3)"	"prognostic unfavorable (8.41e-7)"	"unprognostic (2.60e-1)"	"unprognostic (2.88e-2)"	"unprognostic (1.50e-1)"	"unprognostic (4.90e-2)"	21.3	21.8	24.8	21.5	25.6	16.6	17.1	25.5	29.0	19.2	25.3	18.6	20.8	15.4	17.3	25.9	27.2	15.8	20.3	25.1	25.3	16.2	30.1	15.7	29.4	25.6	25.2	22.1	28.2	27.1	7.9	20.1	25.7	18.2	15.7	7.3	24.6	20.2	27.4	32.2	16.4	21.2	25.2	19.5	20.8	10.4	25.2	24.5	23.5	21.5	27.1	28.4	7.3	26.0	69.5	118.8	32.0	70.0	36.6	40.3	62.3	60.9	43.7	107.6	83.9	139.2	90.7	109.8	65.0	59.4	143.5	111.4	70.9	97.5	38.5	45.9	99.2	64.3	90.9	86.1	59.9	77.0	66.4	57.9	78.8	105.8	82.2	35.5	62.0	55.8	150.2	42.8	78.3	103.7	67.3	104.4	108.8	127.8	103.6	70.7	54.3	76.7	69.8	65.4	68.8	90.6	64.2	199.4	58.9	21.3	120.6	105.5	52.4	71.0	86.0	52.6	155.1	88.7	135.0	167.1	75.2	115.1	146.1	36.3	50.8	21.1	37.6	66.3	47.7	48.3	40.9	41.6	63.8	55.0	49.2	38.7	3.6	63.2	67.7	34.8	44.9	59.7	24.8	25.6	25.5	29.0	25.1	25.3	25.6	25.2	25.7	25.2	25.2	26.0	21.5	16.0	29.0	13.1	22.8	17.1	23.9	45.1	21.1	26.6	18.4	14.7	12.3	11.5	40.3	22.0	14.6	57.0	19.1	29.0	27.4	39.4	41.4	21.0	21.1	26.4	18.5	35.8	6.1	32.3	48.5	24.6	30.5	20.6	28.5	35.3	16.8	30.1	35.4	6.7	8.0	24.9	38.7	13.2	17.5	37.5	21.1	17.9	14.2	3.7	28.8	22.4	23.7	6.6	6.2	37.5	18.8	19.9	18.2	24.8	37.2	63.0	31.8	26.9	13.1	22.4	25.1	36.2	25.6	30.1	19.9	47.2	23.6	40.3	36.8	21.3
DDX58	"DKFZp434J1111, FLJ13599, RIG-1, RIG-I, RIG1"	ENSG00000107201	"DExD/H-box helicase 58"	O95786	9	32455302-32526208	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"Antiviral defense, Host-virus interaction, Immunity, Innate immunity"	"Helicase, Hydrolase, RNA-binding"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 41.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"neutrophil: 1.3"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in many"	4	"BJ hTERT+ SV40 Large T+: 79.0;BJ hTERT+ SV40 Large T+ RasG12V: 76.0;GAMG: 22.8"									"CAB012643, HPA047193, HPA073217"	Approved		Supported	"Plasma membrane,Cytosol"		No	No			"Cluster 1: Neutrophils - Mixed function"	"Cluster 16: Immune cells - Immune response"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Plasma membrane, Cytosol"		"CAB012643: , HPA047193: AB_2679978, HPA073217: "	"unprognostic (1.10e-1)"	"unprognostic (4.65e-2)"	"unprognostic (6.56e-2)"	"prognostic unfavorable (5.46e-4)"	"unprognostic (2.45e-1)"	"unprognostic (2.37e-1)"	"unprognostic (8.15e-2)"	"unprognostic (4.57e-2)"	"unprognostic (2.82e-1)"	"unprognostic (6.48e-3)"	"unprognostic (1.00e-2)"	"unprognostic (3.35e-1)"	"prognostic unfavorable (4.66e-4)"	"unprognostic (2.22e-2)"	"unprognostic (3.68e-2)"	"unprognostic (1.05e-2)"	"unprognostic (1.26e-1)"	6.3	4.9	3.5	7.5	2.9	1.3	6.0	3.0	4.3	7.1	3.1	6.3	2.9	5.6	4.7	6.4	4.4	6.0	4.1	2.7	3.6	5.5	6.3	7.1	7.4	5.2	3.7	4.6	5.7	2.5	5.2	5.7	4.0	4.2	5.3	2.3	10.0	3.5	4.8	7.8	7.1	5.7	6.5	9.2	4.8	2.8	3.6	15.6	4.3	1.7	5.2	5.1	5.3	2.9	4.3	2.4	2.5	2.2	7.5	6.4	2.7	2.1	14.6	79.0	76.0	2.4	1.4	0.4	2.7	2.7	22.8	2.8	2.3	1.3	11.4	7.4	0.9	1.1	2.4	3.5	5.0	1.4	4.5	4.9	1.3	6.9	1.3	4.2	14.3	1.5	1.8	1.0	6.6	0.6	3.8	12.4	1.8	0.6	2.0	2.4	3.1	0.0	11.6	0.6	2.0	0.3	1.7	1.7	12.6	1.7	3.5	0.9	13.4	1.5	0.9	1.7	1.1	0.0	0.3	0.9	2.6	3.3	2.1	0.0	0.1	0.3	0.2	0.1	0.3	0.2	0.3	0.0	0.0	0.2	0.2	0.2	1.3	0.4	0.2	0.0	0.2	0.0	3.5	2.9	3.0	4.3	2.7	3.6	5.2	3.7	4.0	6.5	3.6	2.9	41.7	22.4	8.8	20.5	13.9	4.2	5.1	7.2	13.6	4.1	5.8	5.1	5.1	5.7	6.7	1.8	2.1	5.6	13.9	13.8	0.0	19.5	2.7	12.9	8.7	23.6	3.0	5.7	10.4	12.2	7.6	13.9	21.9	20.3	5.1	16.8	9.3	6.7	5.6	6.7	13.2	4.6	4.1	7.3	4.6	0.4	6.5	11.6	0.0	39.4	12.3	6.4	21.6	31.2	17.5	16.2	7.7	6.0	9.1	4.9	16.9	7.2	7.3	2.5	6.6	16.8	13.1	0.5	2.3	10.9	5.4	2.5	17.8	10.4	2.6	5.3
DDX6	"HLR2, RCK, Rck/p54"	ENSG00000110367	"DEAD-box helicase 6"	P26196	11	118747763-118791164	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Helicase, Hydrolase, RNA-binding"	"Cancer-related genes, Disease variant, Mental retardation, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004668, HPA024201, HPA026644"	Approved		Supported	"Cytosol,Cytoplasmic bodies"		NA	NA		19000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 34: Non-specific - Transcription"	"Cluster 36: HEL - Hemostasis"	"Cluster 24: Non-specific - Transcription regulation"	"Cytoplasmic bodies"	Cytosol	"CAB004668: AB_436960, HPA024201: AB_10603562, HPA026644: AB_1847582"	"unprognostic (1.26e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.89e-1)"	"unprognostic (3.40e-2)"	"unprognostic (4.12e-2)"	"unprognostic (5.82e-2)"	"prognostic unfavorable (6.56e-4)"	"unprognostic (3.43e-1)"	"unprognostic (1.48e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.00e-1)"	"unprognostic (7.76e-2)"	"unprognostic (1.98e-1)"	"unprognostic (4.91e-3)"	"unprognostic (1.88e-1)"	"unprognostic (9.58e-2)"	"unprognostic (4.55e-2)"	31.5	28.4	29.1	34.9	36.0	69.0	34.9	50.7	31.9	33.2	12.7	30.0	23.7	30.5	30.5	33.1	29.1	23.6	37.2	31.5	35.4	30.6	34.2	27.3	49.0	28.4	29.3	48.8	30.7	28.3	17.3	31.6	25.2	32.9	27.9	48.7	32.4	29.2	43.2	27.2	26.2	30.6	29.9	45.4	29.9	28.8	37.1	54.9	37.5	41.9	60.9	30.0	21.9	36.6	33.9	50.4	73.6	71.7	64.0	64.8	47.2	45.6	62.0	43.0	40.4	72.1	50.9	77.6	47.1	78.8	44.3	53.2	88.8	69.1	69.0	62.7	17.4	154.5	30.8	57.1	42.0	110.9	55.8	67.1	49.5	63.5	100.8	54.8	69.1	53.2	72.5	110.4	59.2	96.8	81.0	52.1	53.3	50.1	33.6	89.3	59.2	60.1	50.1	92.7	48.7	63.9	84.7	67.2	28.5	56.2	79.2	44.2	81.2	67.2	38.4	39.8	47.6	34.1	47.8	91.7	26.8	52.2	59.2	13.8	4.8	13.2	10.2	6.2	12.3	12.1	10.0	10.8	5.1	12.0	12.2	11.0	19.0	8.3	12.4	7.1	9.9	6.8	29.1	36.0	50.7	31.9	31.5	35.4	28.4	29.3	25.2	29.9	37.1	36.6	84.6	60.9	57.9	37.9	140.1	30.2	75.2	31.3	69.4	82.2	49.8	43.2	116.9	42.9	41.4	44.1	50.1	38.4	184.0	58.6	31.3	32.2	4.2	77.3	81.5	64.6	85.7	88.2	57.3	35.5	36.5	55.6	42.3	91.7	52.5	54.2	61.8	41.5	38.3	62.2	60.9	59.8	42.7	66.9	44.3	10.5	54.0	70.1	33.8	68.4	75.9	90.0	119.4	50.3	80.9	51.2	57.0	45.1	106.0	49.8	57.2	41.3	35.9	91.3	39.5	92.6	69.7	71.1	76.8	73.4	30.5	76.5	130.2	48.8	53.1	78.2
DDX60	FLJ20035	ENSG00000137628	"DExD/H-box helicase 60"	Q8IY21	4	168216291-168318883	"Enzymes, Predicted intracellular proteins"	"Antiviral defense, Immunity, Innate immunity"	"Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"stomach 1: 40.8"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 57.6;Gastric mucus-secreting cells: 90.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+: 27.4;BJ hTERT+ SV40 Large T+ RasG12V: 26.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			HPA046952	Approved		Supported	"Intermediate filaments,Cytosol"		No	No			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 4: Stomach - Digestion"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Cytosol	"Intermediate filaments"	"HPA046952: AB_10963572"	"unprognostic (4.05e-2)"	"unprognostic (2.87e-1)"	"unprognostic (7.22e-3)"	"unprognostic (7.71e-2)"	"unprognostic (2.30e-1)"	"unprognostic (2.65e-2)"	"unprognostic (1.50e-2)"	"unprognostic (3.15e-2)"	"unprognostic (3.06e-1)"	"unprognostic (8.69e-3)"	"prognostic unfavorable (3.35e-4)"	"unprognostic (1.65e-1)"	"unprognostic (4.03e-2)"	"unprognostic (2.48e-1)"	"unprognostic (3.02e-1)"	"unprognostic (3.20e-2)"	"unprognostic (2.44e-1)"	8.2	6.0	2.3	9.8	2.6	5.6	7.2	2.0	2.4	9.6	2.6	17.4	13.3	7.7	4.8	3.5	7.1	9.7	5.9	1.9	2.4	6.7	9.4	11.4	9.8	4.8	2.3	11.0	4.0	6.4	4.0	11.5	2.9	6.0	15.7	3.3	21.3	5.8	2.4	6.5	12.3	6.1	5.1	17.4	40.8	3.4	3.2	15.4	6.3	3.5	6.8	6.8	5.6	3.1	8.3	1.1	4.2	1.4	2.9	10.4	5.3	2.3	14.9	27.4	26.1	0.0	20.2	0.0	1.4	3.1	12.6	6.6	0.5	4.1	8.7	6.1	0.3	12.9	7.3	0.0	9.9	3.8	3.3	7.2	1.7	6.7	1.2	7.1	10.1	4.8	0.0	2.0	3.4	0.3	6.2	2.5	0.4	0.4	2.1	5.1	1.5	0.0	5.3	4.6	0.8	0.7	5.4	1.3	18.8	0.3	1.0	5.1	8.9	2.1	1.5	0.9	2.0	1.6	0.3	0.0	6.6	6.1	6.1	1.6	1.2	1.2	4.2	2.5	4.8	1.4	3.2	4.1	1.1	1.4	3.3	3.7	0.6	3.7	3.0	0.0	3.0	1.8	2.3	2.6	2.0	2.4	1.9	2.4	4.8	2.3	2.9	5.1	3.2	3.1	32.4	35.3	6.5	14.0	12.2	4.2	4.8	6.2	5.7	0.8	3.9	3.2	8.6	11.5	11.5	12.9	0.0	7.6	13.4	57.6	5.9	8.2	3.3	11.8	10.5	22.8	3.0	8.4	0.7	6.8	10.4	11.6	90.2	10.2	27.3	16.2	14.3	4.0	6.2	0.0	1.3	22.4	2.0	4.1	2.8	2.2	8.1	13.5	3.6	25.3	9.3	7.4	17.5	27.6	1.3	12.0	14.9	9.4	3.1	4.1	11.0	4.2	15.3	2.9	6.6	10.0	9.0	1.1	1.0	2.2	2.7	2.9	17.2	18.4	6.0	3.7
DEAF1	"NUDR, SPN, ZMYND5"	ENSG00000177030	"DEAF1 transcription factor"	O75398	11	644233-706715	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Neurogenesis, Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Disease variant, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 67.1"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"HEK 293: 108.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030302	Approved		Supported	"Nucleoplasm,Nucleoli fibrillar center"	"Intracellular and membrane"	NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 30: Mammary glandular cells - Lactation"	Nucleoplasm	"Nucleoli fibrillar center"	"HPA030302: AB_2673421"	"unprognostic (1.32e-2)"	"unprognostic (3.32e-2)"	"unprognostic (3.58e-3)"	"unprognostic (5.90e-2)"	"prognostic unfavorable (9.70e-4)"	"unprognostic (1.54e-2)"	"prognostic unfavorable (1.75e-4)"	"unprognostic (2.42e-2)"	"unprognostic (2.65e-1)"	"unprognostic (2.48e-1)"	"unprognostic (2.61e-3)"	"unprognostic (2.43e-1)"	"unprognostic (2.39e-2)"	"unprognostic (2.79e-1)"	"unprognostic (3.03e-1)"	"unprognostic (1.20e-1)"	"unprognostic (5.15e-2)"	10.9	19.7	51.5	6.5	50.6	9.2	12.5	30.6	67.1	13.2	15.3	12.1	7.8	13.3	10.0	19.8	14.6	9.4	11.0	60.8	32.5	15.4	8.0	9.1	8.7	32.4	36.0	12.4	16.2	11.3	16.9	6.9	32.9	14.6	4.1	4.5	21.4	7.2	16.6	17.5	10.1	8.0	24.5	11.1	20.0	15.0	40.2	9.7	25.3	13.9	6.3	10.7	12.8	45.9	14.1	13.6	22.9	13.1	18.4	22.8	13.5	14.1	18.2	28.3	20.6	9.7	18.6	5.4	14.8	14.0	9.0	14.4	18.1	12.9	4.3	24.2	108.1	13.5	8.5	13.0	32.8	28.0	22.3	20.4	18.1	5.1	15.4	20.1	22.4	15.5	29.0	28.8	11.3	10.9	11.7	31.9	49.9	20.3	24.0	28.1	6.8	24.2	21.9	3.0	27.3	31.8	10.4	18.2	12.9	5.8	8.4	9.7	26.6	10.5	4.7	4.5	13.7	24.5	9.3	10.2	13.4	21.2	22.9	0.0	2.0	2.3	1.6	1.3	1.7	0.6	3.4	1.7	2.8	0.4	3.9	2.0	0.8	2.0	1.2	0.1	1.4	1.1	51.5	50.6	30.6	67.1	60.8	32.5	32.4	36.0	32.9	24.5	40.2	45.9	20.1	0.0	3.9	12.7	8.7	13.3	27.1	11.8	11.4	20.0	35.8	25.7	8.2	18.6	8.0	35.0	10.4	14.9	12.3	10.0	52.8	19.5	3.6	19.6	15.0	19.3	10.9	25.0	33.8	11.1	6.4	20.1	10.7	26.2	0.0	40.1	10.8	12.4	10.0	60.6	35.2	9.3	12.2	12.9	10.2	6.5	19.9	11.2	17.8	17.8	13.7	39.9	7.2	19.1	17.4	15.4	10.6	30.1	9.0	36.0	16.9	34.2	10.0	19.9	13.1	11.4	16.8	7.5	22.1	17.3	15.5	15.5	12.4	42.2	9.1	32.4
DECR1	"DECR, SDR18C1"	ENSG00000104325	"2,4-dienoyl-CoA reductase 1"	Q16698	8	90001405-90053633	"Disease related genes, Enzymes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 290.1;liver: 272.3"	"Cell type enhanced"	"Detected in all"		"Distal tubular cells: 399.2;Proximal tubular cells: 485.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SK-BR-3: 81.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023160, HPA023162, HPA023238"	Enhanced		Supported	Mitochondria,Cytosol		No	No		120000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria	Cytosol	"HPA023160: AB_1847585, HPA023162: AB_1847586, HPA023238: AB_1847587"	"prognostic unfavorable (1.49e-4)"	"unprognostic (5.76e-3)"	"unprognostic (8.37e-3)"	"unprognostic (6.13e-3)"	"unprognostic (2.01e-1)"	"unprognostic (4.45e-2)"	"unprognostic (1.68e-2)"	"unprognostic (8.23e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.55e-1)"	"unprognostic (9.12e-2)"	"unprognostic (1.42e-1)"	"prognostic favorable (1.79e-7)"	"unprognostic (1.40e-1)"	"unprognostic (1.73e-2)"	"unprognostic (1.16e-1)"	"prognostic favorable (6.06e-4)"	60.2	136.8	12.4	9.6	14.4	24.9	54.4	12.5	14.4	29.4	22.2	65.0	20.2	28.0	14.9	52.6	26.1	7.4	290.1	12.7	13.2	103.5	272.3	34.2	15.0	12.2	13.1	35.5	44.4	13.2	32.6	5.9	12.1	28.6	18.8	8.0	42.8	6.5	121.8	43.3	61.0	9.1	12.5	47.1	44.5	52.3	15.4	10.2	33.0	34.4	13.9	31.1	35.8	12.8	13.1	7.9	19.6	16.1	8.0	17.3	5.2	13.2	12.9	5.9	8.2	2.8	13.4	7.7	5.3	15.1	4.1	6.8	7.7	11.1	11.0	12.6	1.2	18.4	13.6	14.5	11.6	8.7	4.4	12.0	7.0	7.6	10.7	10.1	17.4	16.5	21.3	15.5	20.7	16.3	12.5	7.6	1.5	9.1	24.9	7.4	5.8	13.4	23.4	43.9	1.3	10.6	13.0	81.1	7.7	1.1	10.7	7.4	20.1	11.4	6.2	12.9	6.0	10.5	7.5	12.8	8.6	12.0	10.8	3.9	9.1	6.2	7.1	10.2	7.9	7.4	6.9	8.6	8.8	4.6	8.1	7.8	15.2	3.9	9.3	3.9	9.6	5.8	12.4	14.4	12.5	14.4	12.7	13.2	12.2	13.1	12.1	12.5	15.4	12.8	66.1	76.9	59.4	72.5	52.9	41.3	70.6	180.2	35.3	11.4	51.1	57.4	268.3	82.9	96.4	71.7	2.1	50.2	57.6	119.0	399.2	137.8	165.3	68.2	65.5	60.0	104.8	77.4	27.2	92.5	49.0	60.2	61.2	40.6	50.0	81.3	47.8	244.8	115.1	32.0	55.9	105.9	116.0	95.2	82.7	52.6	85.4	85.1	85.4	29.0	107.1	52.5	74.2	66.9	35.0	87.5	111.6	51.6	67.8	30.3	250.3	485.2	69.0	7.6	72.3	54.5	61.7	157.5	24.6	68.6	41.1	41.0	64.4	135.1	139.6	86.8
DEDD	"CASP8IP1, DEDD1, DEFT, FLDED1, KE05"	ENSG00000158796	"Death effector domain containing"	O75618	1	161120974-161132688	"Predicted intracellular proteins"	"Apoptosis, Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA064486, HPA065101, HPA073628"	Approved		Approved	Nucleoplasm,Nucleoli,Cytosol		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 59: Non-specific - Translation"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 59: Non-specific - Transcription"	"Nucleoplasm, Nucleoli"	Cytosol	"HPA064486: , HPA065101: , HPA073628: AB_2732230"	"unprognostic (2.24e-1)"	"unprognostic (2.38e-1)"	"unprognostic (4.81e-2)"	"unprognostic (5.09e-2)"	"unprognostic (4.20e-3)"	"unprognostic (5.94e-2)"	"prognostic unfavorable (8.48e-4)"	"unprognostic (2.52e-1)"	"unprognostic (8.70e-2)"	"unprognostic (7.66e-3)"	"unprognostic (2.33e-2)"	"unprognostic (1.47e-2)"	"prognostic unfavorable (4.98e-7)"	"unprognostic (1.53e-1)"	"unprognostic (1.34e-1)"	"unprognostic (4.06e-2)"	"unprognostic (1.43e-2)"	34.4	21.4	20.6	19.4	22.0	29.8	29.0	21.9	20.8	26.1	18.8	30.5	20.8	24.7	14.9	25.8	26.5	21.2	24.3	20.2	20.4	21.6	24.3	28.6	21.2	21.3	20.7	28.0	21.2	18.2	17.9	22.1	20.7	23.0	13.7	23.9	20.7	15.8	56.7	29.2	23.5	21.0	20.7	27.8	22.4	28.0	21.5	22.5	24.2	34.9	18.3	26.8	25.1	22.6	24.7	24.0	27.7	24.3	21.0	22.2	19.1	20.7	29.3	23.5	26.1	16.7	41.5	26.2	20.4	31.2	17.2	22.0	21.2	32.5	15.1	26.3	23.1	24.5	30.2	22.7	37.0	17.3	35.5	26.8	34.2	25.3	40.1	31.2	38.5	35.6	21.3	38.3	27.8	38.8	42.4	18.9	46.5	49.1	24.5	34.1	19.1	35.0	23.8	29.6	29.3	44.2	21.1	55.1	37.0	29.9	33.0	34.8	27.3	25.6	27.2	30.0	30.6	52.2	35.6	46.9	30.6	18.5	18.6	64.0	36.9	52.8	27.8	34.6	23.7	24.0	27.4	27.9	33.3	22.7	30.6	25.1	41.2	27.7	38.0	29.2	38.4	31.4	20.6	22.0	21.9	20.8	20.2	20.4	21.3	20.7	20.7	20.7	21.5	22.6	27.8	25.6	9.3	8.5	16.7	25.2	13.9	11.5	14.2	6.8	10.5	8.0	10.6	18.6	10.1	9.2	6.2	19.6	16.2	12.9	23.5	13.6	42.6	9.5	8.3	22.3	11.3	13.7	4.8	19.3	19.6	13.3	15.8	11.3	16.5	7.7	21.0	10.7	14.8	13.5	5.1	8.1	2.0	19.8	27.2	43.5	11.8	16.2	14.2	4.7	20.9	6.7	8.2	5.0	10.8	15.6	13.2	9.8	24.2	10.2	12.5	13.7	7.4	13.2	6.6	12.0	16.5	23.5	18.4	22.2	24.9	27.0	15.0	5.7	9.7	17.4
DEGS1	"DEGS-1, Des-1, DES1, FADS7, MLD"	ENSG00000143753	"Delta 4-desaturase, sphingolipid 1"	O15121	1	224175756-224193441	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism"	Oxidoreductase	"Disease variant, Leukodystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"skin 1: 535.6"	"Cell type enhanced"	"Detected in all"		"Basal keratinocytes: 246.0;Cytotrophoblasts: 281.8;Suprabasal keratinocytes: 320.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA076422			Supported	Mitochondria		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 61: Skin - Cornification"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 47: Cytotrophoblasts - Unknown function"	Mitochondria		"HPA076422: AB_2686799"	"unprognostic (2.34e-2)"	"unprognostic (6.91e-2)"	"unprognostic (2.48e-2)"	"prognostic unfavorable (7.74e-5)"	"unprognostic (1.50e-1)"	"unprognostic (2.74e-1)"	"prognostic unfavorable (4.29e-5)"	"unprognostic (7.70e-2)"	"unprognostic (2.31e-1)"	"unprognostic (3.20e-1)"	"unprognostic (3.63e-1)"	"unprognostic (1.27e-1)"	"prognostic unfavorable (6.83e-7)"	"unprognostic (2.87e-1)"	"unprognostic (1.61e-1)"	"unprognostic (3.86e-2)"	"prognostic unfavorable (2.53e-4)"	60.3	31.0	30.3	44.9	33.1	69.5	61.9	35.0	36.2	53.4	42.5	50.8	47.0	44.5	29.5	48.6	34.4	40.5	43.8	31.3	35.6	38.1	35.7	49.1	48.0	36.6	35.2	27.1	22.5	31.5	34.8	128.7	35.9	83.2	27.2	20.8	38.7	58.6	20.9	535.6	33.4	70.9	37.9	38.7	38.6	22.7	34.0	34.2	52.3	23.3	50.9	48.4	72.7	44.5	72.8	50.7	65.2	49.5	275.7	181.1	51.2	201.1	223.8	137.5	164.2	47.1	55.2	58.0	252.4	181.0	82.4	76.3	76.5	67.9	153.0	84.2	141.5	41.7	51.1	29.2	167.9	84.2	86.1	177.4	153.6	125.5	69.9	143.0	140.4	31.4	62.8	61.8	181.2	27.5	43.2	46.9	83.3	40.0	76.1	38.8	92.4	37.5	181.1	19.8	42.3	69.8	106.6	169.4	110.4	118.8	57.1	123.4	125.7	133.4	41.4	153.1	197.5	44.5	55.3	52.8	141.9	41.7	154.2	104.6	61.4	120.3	30.9	67.8	59.8	58.2	52.7	43.3	104.4	74.3	40.7	37.0	67.7	43.9	48.7	34.9	59.0	52.8	30.3	33.1	35.0	36.2	31.3	35.6	36.6	35.2	35.9	37.9	34.0	44.5	71.7	83.3	29.3	13.4	69.9	246.0	44.0	33.6	89.4	31.2	40.7	38.4	20.8	10.0	19.8	11.0	14.6	281.8	40.5	4.0	13.7	34.9	27.9	54.0	90.2	66.7	14.9	18.7	17.4	43.3	48.3	77.7	21.4	146.1	106.5	21.3	55.6	20.8	93.0	18.5	20.4	6.2	34.6	57.8	90.5	13.6	63.0	72.8	69.4	20.6	57.1	26.0	10.3	25.6	32.1	29.5	5.9	79.4	50.1	44.2	20.1	29.7	20.1	18.4	105.2	42.7	89.1	84.3	44.0	50.4	320.4	198.9	58.9	43.7	6.6	13.7
DEK	D6S231E	ENSG00000124795	"DEK proto-oncogene"	P35659	6	18223860-18264548	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"		"Chromatin regulator, DNA-binding"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB015226, HPA054505, HPA057799"	Supported		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 42: Non-specific - Transcription"	"Cluster 9: Intestine - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	Cytosol	"CAB015226: , HPA054505: AB_2682508, HPA057799: AB_2683530"	"unprognostic (6.35e-2)"	"unprognostic (6.11e-2)"	"unprognostic (5.04e-3)"	"unprognostic (1.40e-2)"	"unprognostic (3.66e-1)"	"unprognostic (5.02e-3)"	"prognostic unfavorable (9.65e-4)"	"unprognostic (1.76e-1)"	"unprognostic (1.48e-2)"	"unprognostic (1.61e-3)"	"unprognostic (6.49e-3)"	"unprognostic (1.12e-2)"	"prognostic unfavorable (3.45e-4)"	"unprognostic (1.59e-1)"	"unprognostic (1.68e-1)"	"unprognostic (2.31e-1)"	"unprognostic (3.78e-1)"	50.8	43.0	17.3	82.4	20.1	158.6	63.1	29.6	25.4	48.1	19.8	74.8	76.9	74.2	29.9	65.4	45.6	49.0	61.0	17.3	18.3	46.0	68.0	53.2	125.5	19.5	20.4	61.4	40.3	43.3	19.3	67.7	20.8	56.2	74.2	46.3	37.3	56.1	116.0	49.8	86.8	63.9	18.2	63.8	58.7	22.1	19.5	116.8	102.3	73.4	112.8	59.3	43.0	26.1	450.1	118.6	330.9	276.6	68.9	118.4	184.2	347.4	210.9	338.9	457.1	190.7	165.5	504.2	390.2	181.8	269.1	251.1	260.7	196.2	591.3	346.5	221.3	305.7	179.9	260.0	70.3	499.2	238.2	58.2	98.1	238.2	198.2	164.7	170.9	188.1	392.9	0.6	236.5	156.2	380.3	222.1	208.6	177.4	131.8	471.7	459.7	299.8	184.2	239.6	196.1	183.8	328.9	290.5	224.6	218.4	277.8	212.7	168.7	382.7	220.0	223.9	474.1	32.4	77.0	540.3	95.0	251.3	380.8	116.2	78.2	41.8	69.6	74.9	83.1	66.3	72.5	78.0	72.9	56.1	55.6	55.7	93.4	70.9	92.9	49.0	75.2	67.8	17.3	20.1	29.6	25.4	17.3	18.3	19.5	20.4	20.8	18.2	19.5	26.1	149.7	121.8	130.8	16.3	126.2	271.2	189.8	128.8	146.3	70.3	143.3	161.3	218.8	161.5	112.0	79.1	81.3	284.2	174.5	156.7	82.2	172.0	17.4	118.8	157.7	156.6	88.5	448.8	10.4	173.1	235.4	159.6	85.1	170.6	111.2	195.1	105.7	125.1	190.9	26.9	18.6	188.1	67.1	185.3	300.7	26.2	189.5	219.1	101.4	31.9	263.3	136.2	212.1	26.2	37.1	136.9	117.3	191.5	44.0	252.9	140.0	129.5	89.0	138.8	210.4	189.1	197.0	87.2	220.7	169.9	233.6	108.6	189.1	138.6	232.5	209.2
DENND1A	"FAM31A, FLJ21129, KIAA1608"	ENSG00000119522	"DENN domain containing 1A"	Q8TEH3	9	123379654-123930152	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Protein transport, Transport"	"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"Astrocytes: 258.9;Excitatory neurons: 188.2;Inhibitory neurons: 175.8;Late spermatids: 88.5;Microglial cells: 178.0;Oligodendrocyte precursor cells: 165.4;Oligodendrocytes: 145.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	9	"dendritic cells: 12.1;granulocytes: 20.4;monocytes: 21.1"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020481			Approved	Vesicles,Cytosol		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 64: Astrocytes - Nervous system maintenance"	"Vesicles, Cytosol"		"HPA020481: AB_2092106"	"unprognostic (1.35e-1)"	"unprognostic (3.96e-2)"	"unprognostic (2.00e-1)"	"unprognostic (4.25e-2)"	"unprognostic (1.62e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.34e-1)"	"unprognostic (3.19e-3)"	"unprognostic (2.14e-2)"	"unprognostic (2.14e-2)"	"unprognostic (2.48e-3)"	"unprognostic (5.63e-2)"	"prognostic favorable (4.11e-5)"	"unprognostic (1.25e-1)"	"unprognostic (1.51e-1)"	"unprognostic (9.66e-2)"	"unprognostic (4.31e-2)"	8.5	8.3	8.2	10.3	8.3	27.0	7.1	2.7	10.3	7.9	6.8	10.6	11.3	8.3	4.6	7.7	8.7	7.2	7.3	8.1	6.2	11.4	10.8	6.9	9.0	5.6	6.0	7.9	6.2	11.9	10.2	11.3	4.9	7.7	9.6	10.3	6.1	7.6	8.4	6.9	12.6	9.9	4.8	14.2	6.9	9.5	6.4	7.1	10.8	4.8	6.2	7.6	6.5	5.7	29.0	16.7	14.7	28.0	9.8	15.3	68.3	27.4	41.0	22.9	19.6	23.0	12.5	23.1	5.5	22.3	30.1	15.9	12.6	19.9	22.2	9.8	9.7	10.9	39.1	17.1	13.2	13.2	7.0	14.2	17.6	18.9	32.2	8.0	20.6	21.8	30.3	17.2	18.7	16.5	15.8	19.1	29.4	33.1	25.2	24.3	14.4	19.5	11.4	10.1	31.1	25.3	22.1	14.4	16.9	9.6	19.8	32.8	9.7	24.5	9.4	28.9	14.6	26.0	21.7	16.0	20.6	25.9	16.5	20.4	21.1	4.3	1.8	14.6	0.9	1.7	1.3	0.8	12.1	1.8	0.8	1.0	12.8	0.8	12.8	1.9	0.6	5.3	8.2	8.3	2.7	10.3	8.1	6.2	5.6	6.0	4.9	4.8	6.4	5.7	6.4	0.0	1.5	258.9	10.0	5.1	2.6	2.5	1.8	16.1	4.8	4.3	7.7	7.2	1.7	16.5	16.7	10.0	6.8	25.3	5.9	4.3	35.1	5.0	8.2	10.5	12.0	20.2	188.2	5.1	32.2	7.6	20.9	3.9	4.5	8.8	7.5	14.5	18.0	32.0	175.8	7.6	2.0	21.4	8.2	88.5	14.6	18.7	3.6	178.0	18.7	11.6	5.2	165.4	145.2	6.1	9.5	11.3	13.1	5.3	18.3	16.0	2.9	13.1	0.0	6.7	5.9	3.8	1.4	3.8	2.8	8.8	5.3	4.5	7.8	3.9
DENND1B	"C1orf218, FAM31B, FLJ20054, MGC27044"	ENSG00000213047	"DENN domain containing 1B"	Q6P3S1	1	197504748-197775696	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Protein transport, Transport"	"Guanine-nucleotide releasing factor"	Asthma	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 101.3;Inhibitory neurons: 138.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 19.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042586	Uncertain		Supported	"Nuclear speckles,Cytosol"		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Cytosol	"Nuclear speckles"	"HPA042586: AB_2678064"	"unprognostic (8.79e-2)"	"unprognostic (1.58e-1)"	"unprognostic (4.25e-2)"	"unprognostic (1.20e-1)"	"unprognostic (2.39e-1)"	"unprognostic (7.13e-3)"	"unprognostic (2.69e-1)"	"unprognostic (9.54e-2)"	"unprognostic (7.79e-3)"	"unprognostic (3.99e-2)"	"unprognostic (3.13e-2)"	"unprognostic (5.36e-2)"	"unprognostic (6.11e-2)"	"unprognostic (5.61e-3)"	"unprognostic (1.96e-1)"	"unprognostic (1.52e-1)"	"unprognostic (2.35e-2)"	2.0	2.7	2.4	3.8	8.3	5.6	5.7	3.9	3.0	3.1	1.5	6.0	5.7	2.1	4.0	4.4	2.0	3.4	5.8	2.1	4.4	5.6	5.0	4.3	6.5	2.9	5.3	4.0	5.8	5.9	2.5	1.5	3.6	3.8	5.7	5.9	4.5	3.2	3.9	1.9	6.9	1.9	1.9	4.3	4.8	2.2	4.5	6.6	6.0	5.9	6.5	4.0	2.8	2.6	7.2	1.8	2.0	3.4	0.9	5.0	3.0	5.4	3.7	3.3	2.0	1.9	4.5	13.0	2.7	8.3	1.9	3.6	3.2	3.9	2.9	10.0	3.4	4.7	3.7	0.9	2.7	15.5	5.6	1.7	5.2	1.3	3.6	10.0	1.4	7.4	3.6	19.6	3.3	1.3	8.3	7.9	0.7	1.8	1.7	5.1	1.7	10.3	7.9	6.6	3.4	5.3	8.3	5.5	1.5	3.1	2.3	13.4	4.0	0.4	3.1	0.2	3.2	9.8	0.0	6.4	3.4	6.2	6.2	2.3	0.1	1.1	0.9	0.3	0.4	1.2	0.6	1.4	0.7	0.3	0.3	0.6	0.4	2.7	0.3	0.9	1.8	0.3	2.4	8.3	3.9	3.0	2.1	4.4	2.9	5.3	3.6	1.9	4.5	2.6	9.1	41.7	16.2	46.4	24.1	8.4	23.6	9.2	12.0	18.3	28.9	11.9	28.3	15.7	17.3	14.7	25.0	10.4	22.1	65.5	17.6	9.7	26.8	7.9	5.7	6.5	14.4	8.0	101.3	23.1	9.7	10.9	20.9	17.1	64.7	12.8	9.3	15.3	18.9	5.0	138.5	27.4	4.1	18.9	82.4	26.8	23.9	30.0	16.0	42.2	15.8	8.6	28.8	75.4	5.8	22.5	54.5	13.2	50.7	21.9	59.9	16.4	9.6	14.0	0.0	13.9	6.3	8.1	13.9	22.9	12.1	7.4	42.5	5.7	27.9	53.5
DENND2D	"FLJ22457, RP5-1180E21.2"	ENSG00000162777	"DENN domain containing 2D"	Q9H6A0	1	111185969-111204535	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 93.8"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 71.2;NK-cells: 232.8;T-cells: 83.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in all"	5	"gdT-cell: 236.8;MAIT T-cell: 204.4;memory CD4 T-cell: 172.0;memory CD8 T-cell: 243.8;naive CD4 T-cell: 265.5;naive CD8 T-cell: 256.8;NK-cell: 278.3;T-reg: 79.5"	"Group enriched"	"Detected in all"	6	"NK-cells: 278.3;T-cells: 265.5"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 61.2;MOLT-4: 154.0;SK-BR-3: 96.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA043630, HPA048642"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Nucleoplasm, Cytosol"		"HPA043630: AB_2678589, HPA048642: AB_2680474"	"unprognostic (1.72e-3)"	"prognostic favorable (1.67e-4)"	"unprognostic (2.60e-2)"	"unprognostic (7.01e-2)"	"unprognostic (1.91e-2)"	"prognostic favorable (2.70e-4)"	"unprognostic (5.09e-2)"	"unprognostic (8.10e-2)"	"unprognostic (1.35e-1)"	"unprognostic (4.66e-3)"	"unprognostic (3.09e-2)"	"unprognostic (1.02e-1)"	"unprognostic (9.61e-2)"	"unprognostic (3.80e-3)"	"unprognostic (5.45e-2)"	"unprognostic (2.75e-2)"	"prognostic favorable (8.66e-5)"	9.1	13.0	0.8	39.3	0.7	11.8	12.0	0.7	1.3	10.9	3.7	19.2	19.2	3.5	9.6	25.2	18.6	10.8	1.8	0.5	1.0	14.3	12.1	16.5	93.8	1.8	1.1	6.5	7.8	33.4	9.8	9.0	1.3	7.6	19.7	0.3	19.0	7.6	0.6	14.2	22.5	3.3	1.6	40.1	26.8	9.7	2.7	41.6	11.4	2.2	79.5	29.2	11.6	2.7	32.6	1.4	0.1	0.0	7.3	3.0	0.3	1.9	0.1	3.4	0.8	9.9	14.8	34.4	11.0	4.9	0.2	10.2	0.1	1.7	3.3	61.2	0.0	10.1	2.4	0.0	11.3	0.1	10.1	8.9	7.0	1.0	0.0	10.2	0.3	11.1	0.2	10.3	1.0	27.8	154.0	0.9	0.0	40.8	4.4	4.0	0.0	46.0	10.9	33.6	11.2	0.0	11.4	96.5	3.6	0.2	30.3	32.0	0.0	0.0	0.1	0.0	0.2	9.5	4.1	25.8	0.0	27.1	0.2	5.3	21.0	15.0	236.8	15.5	204.4	42.6	172.0	243.8	19.7	46.3	265.5	256.8	20.7	278.3	11.9	15.1	79.5	197.5	0.8	0.7	0.7	1.3	0.5	1.0	1.8	1.1	1.3	1.6	2.7	2.7	2.1	6.4	16.8	0.3	24.7	5.0	17.9	24.1	9.6	0.1	14.9	8.6	1.2	8.6	23.8	20.2	0.0	1.7	71.2	22.8	19.6	38.0	35.4	8.9	1.4	3.7	6.0	8.2	0.2	15.9	3.1	3.7	25.5	11.3	17.7	4.6	7.5	5.3	57.1	0.0	0.2	34.6	14.2	32.4	2.5	49.2	1.2	17.2	7.2	1.9	11.9	0.0	232.8	0.0	0.1	12.7	18.2	0.4	12.3	35.4	20.4	28.7	20.7	0.4	0.0	1.2	1.8	25.4	0.7	17.7	4.0	11.5	83.2	10.2	21.0	31.3
DENND4B	KIAA0476	ENSG00000198837	"DENN domain containing 4B"	O75064	1	153929501-153946718	"Predicted intracellular proteins, Predicted membrane proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040188, HPA071133"	Approved		Supported	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 2: Immune cells - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 57: B-cells - Immune response"	"Nucleoplasm, Golgi apparatus"		"HPA040188: AB_10671168, HPA071133: AB_2732173"	"unprognostic (1.75e-1)"	"unprognostic (4.75e-2)"	"unprognostic (1.59e-2)"	"unprognostic (9.42e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.45e-3)"	"prognostic unfavorable (4.14e-4)"	"unprognostic (1.58e-1)"	"unprognostic (1.73e-1)"	"unprognostic (6.03e-2)"	"prognostic favorable (3.18e-5)"	"unprognostic (2.21e-1)"	"prognostic unfavorable (9.27e-9)"	"unprognostic (4.24e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.48e-2)"	"unprognostic (1.56e-3)"	18.2	13.4	10.9	24.3	11.1	37.1	15.7	2.3	19.1	17.1	0.0	15.6	9.5	16.3	3.4	10.2	16.2	10.0	21.3	10.2	6.5	13.8	11.4	24.2	30.1	12.0	7.8	19.6	15.5	7.7	13.1	10.3	13.0	13.0	6.0	9.5	11.7	7.0	49.2	11.0	22.0	8.9	3.1	41.0	12.9	7.6	9.8	14.6	15.2	29.5	17.3	15.1	12.9	10.0	12.0	22.7	17.1	17.3	10.0	9.7	17.8	11.5	12.4	17.8	16.6	13.8	13.4	29.9	19.1	7.8	13.5	20.9	15.5	10.6	8.0	27.5	14.0	26.5	26.1	13.3	13.9	28.0	51.5	8.8	18.3	16.6	17.8	14.8	12.8	32.3	28.7	16.4	10.3	24.6	34.2	25.7	23.8	14.1	21.8	36.2	11.5	17.3	8.5	17.6	20.3	24.9	12.1	28.4	16.7	17.0	20.6	68.0	13.5	19.2	18.5	16.1	18.7	49.3	37.7	39.5	13.2	21.7	23.5	1.5	1.6	0.4	1.1	2.4	1.4	1.0	0.9	0.7	1.4	0.9	0.4	1.0	1.5	0.7	1.9	1.9	0.7	1.5	10.9	11.1	2.3	19.1	10.2	6.5	12.0	7.8	13.0	3.1	9.8	10.0	14.7	9.6	10.3	18.6	20.3	4.7	3.7	4.6	1.2	22.3	7.1	6.9	22.9	8.6	5.7	7.3	6.2	4.6	31.9	4.8	5.9	5.2	1.2	4.0	8.0	11.8	4.9	9.5	21.8	6.5	4.7	7.2	13.7	7.4	17.2	12.5	10.8	9.2	18.0	35.3	23.6	4.6	2.0	30.2	11.7	1.9	7.5	31.1	5.4	18.7	22.5	5.8	30.9	19.1	27.9	6.1	4.8	7.9	7.1	6.8	7.6	2.7	4.4	17.8	6.6	7.9	6.0	6.4	8.1	5.7	3.4	3.4	17.0	9.2	7.1	5.2
DENND4C	"bA513M16.3, C9orf55, C9orf55B, FLJ20686, RAB10GEF"	ENSG00000137145	"DENN domain containing 4C"	Q5VZ89	9	19230435-19374281	"Predicted intracellular proteins, Predicted membrane proteins"	"Protein transport, Transport"	"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Microglial cells: 120.9;Oligodendrocyte precursor cells: 107.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014917, HPA015096"	Approved		Supported	"Golgi apparatus,Vesicles,Cytosol"		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 31: Skin - Epidermis development"	"Cluster 36: HEL - Hemostasis"	"Cluster 59: Non-specific - Transcription"	"Golgi apparatus, Vesicles, Cytosol"		"HPA014917: AB_2261659, HPA015096: AB_1845831"	"unprognostic (4.57e-2)"	"unprognostic (1.73e-2)"	"unprognostic (6.81e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.87e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.43e-2)"	"unprognostic (3.38e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.02e-1)"	"unprognostic (3.20e-2)"	"unprognostic (2.39e-1)"	"prognostic favorable (3.51e-5)"	"unprognostic (3.27e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.29e-1)"	21.7	11.9	5.9	9.2	7.0	10.6	21.7	14.1	6.3	17.2	8.0	17.4	25.1	17.2	14.3	14.5	16.4	13.8	14.5	5.3	5.6	13.9	15.2	18.0	11.8	5.9	5.7	21.4	12.9	19.0	8.7	19.6	5.7	16.1	19.8	11.8	15.1	13.4	10.6	29.6	22.4	14.6	5.8	12.7	19.8	11.2	7.2	17.7	17.3	12.4	11.2	16.6	16.0	6.6	17.7	17.5	11.7	15.3	26.6	28.5	21.4	10.0	14.9	10.2	13.7	8.4	11.6	7.5	8.3	13.6	11.8	9.4	13.7	9.4	12.0	47.2	7.8	34.4	18.5	10.4	13.4	8.3	18.8	11.7	18.7	9.0	15.5	21.6	20.2	9.9	9.4	8.5	13.1	7.4	13.8	18.8	9.0	24.7	8.5	12.6	6.6	10.9	29.2	34.1	10.9	8.5	8.4	20.1	7.4	11.0	12.1	11.3	18.5	8.9	5.2	10.0	10.5	5.8	14.9	4.0	7.7	7.6	5.2	8.3	1.6	1.9	5.4	0.8	7.0	1.7	4.6	5.5	3.1	2.3	4.3	5.0	0.9	6.4	0.9	3.2	3.8	2.4	5.9	7.0	14.1	6.3	5.3	5.6	5.9	5.7	5.7	5.8	7.2	6.6	28.6	9.6	11.5	85.8	21.3	51.2	16.7	18.0	65.4	20.9	16.0	11.0	12.4	14.3	21.6	16.5	60.5	29.4	22.6	26.6	1.9	9.8	7.7	12.7	15.5	22.9	19.8	9.7	78.6	12.5	13.5	24.0	47.4	20.4	27.1	24.8	51.0	11.5	19.0	23.5	87.2	22.6	24.4	23.9	22.0	5.2	18.6	32.2	21.4	120.9	8.5	13.6	27.8	107.1	69.1	12.1	20.9	20.3	14.1	19.4	26.4	4.9	21.6	16.3	0.0	19.5	16.2	3.3	6.8	30.9	49.3	16.1	28.2	12.0	23.3	23.2
DENND6A	"AFI1A, FAM116A, FLJ34969"	ENSG00000174839	"DENN domain containing 6A"	Q8IWF6	3	57625454-57693077	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 66.9;Inhibitory neurons: 65.4;Oligodendrocytes: 74.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	5	"basophil: 18.7"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 18.7"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA062618, HPA069725, HPA071711"	Approved		Supported	Vesicles		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 52: Non-specific - Transcription"	Vesicles		"HPA062618: AB_2684809, HPA069725: AB_2686184, HPA071711: AB_2686435"	"unprognostic (6.20e-2)"	"unprognostic (3.86e-2)"	"prognostic favorable (9.21e-4)"	"unprognostic (1.76e-1)"	"unprognostic (7.75e-2)"	"unprognostic (3.17e-1)"	"prognostic unfavorable (6.36e-4)"	"unprognostic (7.16e-2)"	"unprognostic (1.17e-2)"	"unprognostic (2.28e-3)"	"unprognostic (5.97e-3)"	"unprognostic (1.12e-1)"	"prognostic favorable (7.77e-6)"	"unprognostic (3.06e-1)"	"unprognostic (1.63e-1)"	"unprognostic (3.61e-3)"	"unprognostic (2.94e-1)"	11.6	7.3	3.4	8.8	4.6	12.6	12.9	12.9	7.1	11.8	3.8	10.7	7.1	12.7	9.9	11.4	10.3	8.3	8.0	3.0	5.5	8.9	7.7	10.5	12.6	4.2	4.8	20.9	5.3	11.4	6.6	11.8	5.3	9.9	9.2	10.0	8.4	11.7	7.1	8.6	9.2	11.3	4.7	12.9	9.7	8.0	4.7	11.8	14.0	9.8	10.5	10.7	10.5	8.4	16.8	13.5	18.0	11.0	9.4	10.6	10.2	8.6	11.0	10.5	8.2	8.7	18.4	19.9	3.6	8.9	9.2	8.8	14.4	18.2	8.9	5.1	12.9	15.7	15.1	6.7	9.0	12.1	8.9	11.3	13.0	7.2	18.7	10.6	15.2	21.1	10.8	21.1	7.6	7.3	26.2	14.9	10.2	10.6	9.3	10.9	10.7	14.8	12.8	28.1	6.1	22.0	17.1	13.9	12.5	7.7	9.1	14.7	16.7	12.7	6.8	13.6	22.8	15.7	22.2	20.7	14.8	19.9	18.9	18.7	1.0	1.4	2.4	1.1	2.9	0.8	2.3	2.4	1.3	1.2	3.4	2.6	1.5	1.9	1.4	1.0	1.3	1.0	3.4	4.6	12.9	7.1	3.0	5.5	4.2	4.8	5.3	4.7	4.7	8.4	28.8	19.2	8.2	31.3	14.5	12.9	11.8	10.6	12.0	16.2	9.9	9.1	20.8	11.5	10.0	5.5	8.4	6.4	21.4	5.7	3.9	8.1	22.2	10.1	25.6	16.0	3.0	16.2	66.9	10.9	4.4	15.7	10.2	17.1	2.5	24.1	20.7	11.1	11.1	10.1	65.4	5.5	12.2	34.3	9.9	11.3	11.8	16.8	3.6	47.8	16.8	10.2	20.6	42.3	74.3	18.9	3.5	14.3	9.5	8.4	6.5	8.9	8.0	14.5	6.6	19.2	18.3	13.3	5.0	14.1	10.7	2.3	19.6	16.7	6.1	13.0
DEPDC1	"DEP.8, DEPDC1A, FLJ20354, SDP35"	ENSG00000024526	"DEP domain containing 1"	Q5TB30	1	68474152-68497221	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"GTPase activation, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 5.0;lymphoid tissue: 8.1;testis: 8.1"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 44.9;Erythroid cells: 31.8;Extravillous trophoblasts: 35.2;Late spermatids: 73.0;Spermatocytes: 86.8"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			CAB017845	Approved		Supported	"Nucleoplasm,Nucleoli fibrillar center"		NA	Yes			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	"Nucleoli fibrillar center"	"CAB017845: "	"unprognostic (2.73e-1)"	"unprognostic (7.40e-2)"	"prognostic favorable (8.70e-5)"	"unprognostic (1.23e-3)"	"unprognostic (3.06e-1)"	"unprognostic (7.73e-3)"	"unprognostic (4.37e-6)"	"unprognostic (3.39e-3)"	"unprognostic (1.57e-3)"	"unprognostic (8.59e-2)"	"unprognostic (9.04e-6)"	"unprognostic (2.18e-1)"	"unprognostic (0.00e+0)"	"unprognostic (2.39e-2)"	"unprognostic (2.27e-1)"	"unprognostic (2.83e-2)"	"unprognostic (1.11e-1)"	0.3	0.1	0.0	2.6	0.0	5.0	0.6	0.0	0.1	0.4	0.0	2.9	2.5	0.5	0.1	2.4	0.1	0.5	0.1	0.1	0.0	0.0	0.4	0.2	4.8	0.0	0.1	0.0	0.0	0.2	0.0	3.2	0.1	2.1	3.5	0.0	0.3	0.1	0.0	1.6	2.4	1.5	0.0	0.6	1.2	8.1	0.2	8.1	0.3	0.2	4.8	0.9	0.7	0.2	47.2	21.5	40.0	18.5	2.5	5.6	31.3	58.9	26.9	49.1	42.1	17.9	19.3	0.0	42.8	24.4	78.6	30.8	58.6	30.7	82.4	41.2	38.2	38.3	35.9	10.5	0.6	33.4	0.0	2.1	1.6	56.3	31.2	10.0	36.0	16.5	26.6	36.1	88.3	10.7	0.1	12.5	34.6	19.5	28.9	0.0	118.7	15.3	19.8	12.7	44.8	20.7	59.0	24.9	30.3	25.6	22.5	16.6	21.3	31.5	35.5	56.0	69.2	22.5	52.2	0.5	29.7	11.4	65.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.2	0.2	0.4	0.0	0.0	0.3	2.0	3.3	0.8	3.3	1.2	0.4	1.3	1.8	0.8	0.0	0.5	1.8	0.0	20.6	0.4	2.1	0.0	0.2	44.9	4.0	1.6	1.6	0.0	31.8	0.5	0.0	35.2	4.4	8.2	2.0	0.0	17.5	2.2	1.2	8.6	0.0	2.2	5.3	4.1	3.5	1.0	73.0	0.3	1.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.3	0.4	6.9	2.2	0.5	0.1	0.9	0.2	0.0	0.6	4.0	86.8	19.6	12.2	1.3	2.9	1.6	0.5	8.8	1.7
DEPP1	"C10orf10, DEPP, FIG, Fseg"	ENSG00000165507	"DEPP1 autophagy regulator"	Q9NTK1	10	44970981-44978809	"Predicted intracellular proteins"	Autophagy			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adipose tissue: 889.5;breast: 697.2"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 192.0;Ductal cells: 146.3;Exocrine glandular cells: 113.0;Glandular and luminal cells: 87.1;Syncytiotrophoblasts: 300.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"plasmacytoid DC: 1.0"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"ASC diff: 143.2;HDLM-2: 106.7;HHSteC: 258.2;HSkMC: 201.6;HUVEC TERT2: 165.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB013687, HPA037818, HPA037819"	Uncertain		Supported	Vesicles,Mitochondria	"Intracellular and membrane"	NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	Mitochondria	Vesicles	"CAB013687: , HPA037818: , HPA037819: AB_2675685"	"unprognostic (3.99e-2)"	"unprognostic (4.69e-2)"	"unprognostic (5.57e-2)"	"unprognostic (3.55e-1)"	"unprognostic (1.88e-2)"	"unprognostic (5.66e-3)"	"unprognostic (1.28e-1)"	"unprognostic (1.21e-1)"	"unprognostic (4.25e-1)"	"unprognostic (5.53e-2)"	"unprognostic (1.15e-1)"	"unprognostic (8.89e-2)"	"prognostic unfavorable (2.29e-6)"	"unprognostic (2.30e-3)"	"unprognostic (2.13e-1)"	"unprognostic (5.42e-2)"	"unprognostic (3.74e-1)"	889.5	48.4	62.3	19.4	71.4	4.5	697.2	59.5	71.8	153.0	50.3	145.7	16.7	168.5	16.5	65.7	334.2	68.5	260.6	55.5	71.9	95.4	131.6	508.6	63.0	175.9	72.3	297.8	349.7	23.0	85.2	76.5	93.4	82.6	12.0	28.2	119.7	22.8	165.8	165.0	94.8	68.8	101.6	32.8	104.6	19.3	87.4	25.2	200.5	52.2	47.6	177.6	139.1	90.6	30.2	0.2	0.5	0.4	143.2	69.5	7.4	0.2	10.2	0.4	1.8	1.1	11.2	0.0	1.6	13.5	7.1	1.2	1.2	9.1	0.7	106.7	4.0	0.1	0.1	11.0	258.2	0.1	0.1	201.6	0.4	0.1	1.4	24.9	165.0	0.0	0.2	63.2	0.6	0.0	0.1	1.7	0.2	0.6	0.9	5.1	1.7	25.7	0.5	10.9	5.6	0.3	0.0	1.3	5.8	17.0	0.2	7.0	1.6	7.8	5.6	0.5	7.3	1.7	2.8	0.4	44.2	2.6	4.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	1.0	0.0	0.4	62.3	71.4	59.5	71.8	55.5	71.9	175.9	72.3	93.4	101.6	87.4	90.6	192.0	0.0	24.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	47.0	27.8	0.0	0.0	6.2	31.3	0.0	53.8	1.4	0.0	37.2	146.3	0.0	61.3	33.2	60.0	0.0	0.0	0.0	113.0	14.7	79.3	0.0	87.1	0.0	8.4	0.0	0.0	25.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	22.7	0.0	0.0	0.0	0.0	65.0	0.0	0.0	0.5	0.0	0.0	25.5	5.8	0.0	0.0	0.0	38.5	0.0	0.0	0.0	0.0	300.2	1.8	0.8	0.0	0.0
DERA	"CGI-26, DEOC"	ENSG00000023697	"Deoxyribose-phosphate aldolase"	Q9Y315	12	15911302-16037381	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Lyase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 104.6"	"Cell type enhanced"	"Detected in all"		"Proximal tubular cells: 152.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA055897			Supported	Nucleoplasm		NA	NA		320000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Nucleoplasm		"HPA055897: AB_2682963"	"unprognostic (3.05e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.06e-2)"	"unprognostic (7.26e-2)"	"unprognostic (8.12e-2)"	"unprognostic (7.74e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.47e-2)"	"unprognostic (2.76e-1)"	"unprognostic (1.87e-1)"	"prognostic unfavorable (1.32e-4)"	"unprognostic (2.13e-1)"	"unprognostic (1.09e-1)"	"unprognostic (8.74e-2)"	"unprognostic (2.17e-2)"	"prognostic favorable (3.64e-5)"	"unprognostic (3.66e-2)"	21.1	16.3	13.7	17.3	16.0	17.6	21.1	15.8	17.1	16.7	21.5	39.9	41.1	16.2	27.0	30.4	15.0	20.3	18.1	13.4	16.0	74.1	104.6	25.0	20.3	16.5	14.8	6.8	27.2	15.6	12.1	20.7	16.4	13.5	42.1	28.1	17.9	14.1	27.8	25.3	54.0	20.4	15.4	17.0	21.7	9.7	15.2	19.8	27.9	29.6	22.7	18.3	18.2	17.1	63.6	51.4	40.0	36.6	27.1	60.3	80.6	36.6	35.2	48.7	63.2	63.9	118.1	44.3	31.3	47.2	44.1	43.8	43.4	47.6	84.7	71.3	25.6	37.6	24.1	60.6	38.7	40.7	25.2	40.8	54.9	40.9	81.0	42.2	71.6	36.2	5.3	13.1	92.1	24.1	30.6	34.5	86.8	37.3	25.6	45.8	85.5	26.8	125.0	23.2	29.5	49.9	69.3	23.4	75.4	158.2	124.5	50.6	66.3	53.6	33.5	24.4	39.0	13.6	21.4	76.9	66.6	41.1	39.6	15.2	58.4	36.2	16.6	68.4	18.2	29.4	17.7	17.7	74.9	29.9	19.3	15.5	15.8	46.0	76.4	40.4	38.1	41.9	13.7	16.0	15.8	17.1	13.4	16.0	16.5	14.8	16.4	15.4	15.2	17.1	37.2	44.8	28.4	20.2	19.4	29.3	31.6	55.3	21.6	4.8	22.4	18.8	13.5	27.1	43.1	12.9	14.6	65.7	22.1	51.6	109.5	64.3	55.8	27.8	32.3	28.3	26.5	28.2	8.6	59.3	69.9	23.9	14.3	52.9	8.8	30.6	36.4	52.2	61.0	3.3	5.9	44.7	54.9	46.7	26.4	6.7	24.5	44.8	72.9	30.9	47.4	29.8	14.4	28.6	18.9	74.6	49.6	30.5	30.7	19.1	140.0	152.3	27.3	29.9	6.6	17.4	27.5	8.5	16.7	35.5	25.9	71.3	13.9	49.0	42.9	34.0
DERL1	"DER-1, DER1, derlin-1, FLJ13784, MGC3067, PRO2577"	ENSG00000136986	"Derlin 1"	Q9BUN8	8	123013170-123042302	"Plasma proteins, Predicted membrane proteins, Transporters"	"Host-virus interaction, Protein transport, Transport, Unfolded protein response"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Plasma cells: 225.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SK-BR-3: 825.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016562, CAB037269"	Supported		Supported	"Endoplasmic reticulum"		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 55: Plasma cells - Humoral immune response"	"Endoplasmic reticulum"		"CAB037269: AB_609868, HPA016562: AB_1847611"	"prognostic unfavorable (2.43e-4)"	"unprognostic (4.30e-2)"	"unprognostic (2.21e-1)"	"prognostic unfavorable (5.66e-5)"	"unprognostic (9.48e-2)"	"unprognostic (4.21e-3)"	"unprognostic (2.76e-1)"	"unprognostic (1.28e-3)"	"unprognostic (4.42e-2)"	"unprognostic (5.38e-2)"	"unprognostic (1.41e-3)"	"unprognostic (4.35e-1)"	"prognostic unfavorable (1.58e-4)"	"unprognostic (1.88e-3)"	"unprognostic (2.51e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.31e-1)"	69.1	47.6	15.2	53.7	16.4	104.1	34.1	20.2	18.2	26.6	26.6	50.0	47.9	29.4	31.4	35.4	29.4	32.9	41.3	17.9	18.3	30.8	77.5	37.1	48.7	15.7	16.4	38.1	31.6	26.9	23.0	28.0	15.7	27.0	42.8	29.6	29.6	28.7	73.3	23.6	47.0	34.4	16.7	40.0	38.5	32.1	18.0	27.2	42.4	49.1	55.5	41.8	22.5	19.5	130.8	93.9	55.7	72.6	98.3	72.8	47.1	108.9	72.1	68.7	85.1	59.7	126.9	150.7	129.8	87.4	81.2	107.0	51.8	69.3	97.4	174.9	57.6	157.2	62.9	51.6	89.2	62.2	111.0	66.9	87.8	76.0	89.8	62.5	62.8	60.6	95.9	193.7	78.7	254.8	68.5	39.4	42.1	166.4	82.5	68.3	46.2	252.1	182.2	92.1	60.5	89.8	109.9	825.1	68.6	59.6	97.3	55.4	74.2	82.2	154.1	74.1	102.1	239.5	444.6	136.5	135.4	76.4	79.4	73.1	60.7	72.6	89.3	75.7	93.0	69.8	59.5	74.0	49.5	56.1	41.0	64.0	42.1	77.8	77.9	56.6	80.0	83.3	15.2	16.4	20.2	18.2	17.9	18.3	15.7	16.4	15.7	16.7	18.0	19.5	38.6	32.1	25.9	12.4	78.3	42.3	41.8	57.3	26.7	22.6	38.3	21.3	28.1	17.2	44.8	29.5	20.9	41.0	67.6	43.3	9.8	87.7	85.5	18.9	32.3	39.2	30.5	41.0	11.5	75.4	71.4	43.8	26.5	31.2	42.6	24.0	39.3	75.9	68.0	18.5	12.8	62.2	42.7	49.4	44.2	19.9	24.5	45.6	60.5	14.0	47.6	25.5	59.8	17.6	19.1	68.4	40.6	25.6	225.0	63.7	56.6	28.0	31.3	25.6	46.0	32.7	77.6	75.4	40.3	41.0	50.7	78.0	69.8	34.8	37.5	64.4
DERL2	"CGI-101, derlin-2, F-LAN-1, F-LANa, FLANa"	ENSG00000072849	"Derlin 2"	Q9GZP9	17	5471254-5486811	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Host-virus interaction, Unfolded protein response"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 259.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB037287, HPA048957, HPA056551"	Enhanced		Supported	"Endoplasmic reticulum"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Endoplasmic reticulum"		"CAB037287: AB_1078641, HPA048957: AB_2680570, HPA056551: AB_2683171"	"unprognostic (2.54e-1)"	"unprognostic (5.30e-2)"	"unprognostic (5.83e-2)"	"prognostic favorable (7.26e-4)"	"unprognostic (1.51e-2)"	"unprognostic (4.70e-2)"	"unprognostic (1.36e-1)"	"unprognostic (2.63e-1)"	"unprognostic (2.17e-1)"	"unprognostic (1.12e-3)"	"unprognostic (1.73e-3)"	"unprognostic (5.23e-2)"	"prognostic unfavorable (6.49e-4)"	"unprognostic (1.91e-1)"	"unprognostic (1.82e-1)"	"unprognostic (3.73e-1)"	"unprognostic (2.91e-2)"	14.5	18.8	5.7	16.4	6.0	33.9	12.9	6.3	7.6	13.1	7.0	12.9	14.9	12.8	29.6	15.3	14.0	17.3	10.2	5.4	6.2	14.0	28.0	11.3	18.2	6.4	6.4	12.8	28.5	14.7	12.1	13.4	6.6	14.0	12.3	8.1	28.3	11.4	10.6	10.1	17.5	12.4	6.2	15.1	15.5	24.4	6.1	10.8	24.6	4.9	15.4	14.9	11.1	7.6	32.0	40.4	18.8	31.7	31.5	23.6	24.0	44.5	36.1	30.0	36.4	27.8	27.9	22.0	39.2	28.5	33.6	35.0	13.2	25.7	29.9	29.3	27.6	10.8	25.8	30.0	43.4	8.1	25.2	22.0	21.0	40.6	34.9	26.4	31.4	22.4	12.0	37.5	40.9	16.5	17.3	12.3	18.2	20.7	16.0	20.8	26.6	16.3	32.5	16.2	7.9	23.2	27.1	18.5	47.6	20.6	24.8	11.8	23.9	35.4	23.9	21.8	43.3	26.0	31.4	20.0	37.0	20.1	28.4	71.9	62.6	77.0	64.6	70.4	67.2	66.5	61.2	68.7	48.2	65.5	48.3	59.3	59.9	60.4	56.4	69.2	81.0	117.5	5.7	6.0	6.3	7.6	5.4	6.2	6.4	6.4	6.6	6.2	6.1	7.6	36.1	12.8	23.9	12.4	46.4	34.3	50.5	157.7	27.9	17.7	48.4	48.5	31.3	35.8	82.7	44.1	22.9	70.6	70.5	28.1	15.6	79.9	259.2	32.5	41.7	35.7	18.5	35.3	8.1	89.7	103.6	51.3	22.4	41.6	49.4	38.8	30.4	57.5	74.5	11.8	9.0	37.2	89.5	33.6	44.8	63.4	43.8	37.8	46.2	6.5	64.7	35.1	48.4	6.6	16.2	86.7	25.2	35.3	119.9	68.7	37.1	50.4	55.6	24.8	59.2	33.9	54.3	126.4	45.4	26.2	31.1	96.2	47.7	45.8	30.4	62.8
DES	"CMD1I, CSM1, CSM2"	ENSG00000175084	Desmin	P17661	2	219418377-219426734	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"		"Muscle protein"	"Cancer-related genes, Cardiomyopathy, Desmin-related myopathy, Disease variant, Limb-girdle muscular dystrophy, Myofibrillar myopathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 13020.7;intestine: 8627.2;skeletal muscle: 16532.0"	"Cell type enriched"	"Detected in many"	5	"Cardiomyocytes: 2531.9"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 562.1;stomach cancer: 400.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HSkMC: 70.2;LHCN-M2: 145.3;NB-4: 39.5;RH-30: 333.1"	"Low region specificity"	"Detected in many"			"Region enriched"	"Detected in many"	5	"midbrain: 29.5"	"CAB000034, HPA018803"	Enhanced		Supported	"Intermediate filaments"		NA	NA		1600000	"Cluster 7: Monocytes - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 54: Cardiomyocytes - Muscle contraction"	"Intermediate filaments"		"CAB000034: , HPA018803: AB_1847616"	"unprognostic (1.75e-1)"	"unprognostic (1.95e-3)"	"unprognostic (3.43e-2)"	"unprognostic (8.76e-2)"	"unprognostic (7.75e-3)"	"unprognostic (6.61e-3)"	"unprognostic (1.55e-1)"	"unprognostic (2.72e-2)"	"unprognostic (4.67e-1)"	"unprognostic (3.84e-2)"	"unprognostic (2.57e-1)"	"unprognostic (7.43e-2)"	"prognostic unfavorable (5.08e-4)"	"unprognostic (3.49e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.22e-1)"	"unprognostic (9.25e-3)"	235.3	57.1	2.1	436.2	4.9	1.1	51.2	2.1	9.6	504.3	5.0	8627.2	291.3	3015.2	86.0	1481.2	1085.0	452.1	13020.7	2.4	2.5	37.6	15.5	173.9	7.2	3.4	2.5	171.8	14.6	0.5	8.4	52.7	2.4	2218.8	245.6	0.0	255.3	2253.1	16532.0	152.4	1343.5	2557.5	2.1	25.2	1965.6	16.1	2.6	3.2	66.2	5753.8	1.2	4761.8	669.4	2.4	0.0	0.0	0.1	0.0	0.0	2.2	5.3	0.2	0.0	0.1	0.1	0.5	0.0	0.0	9.5	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.2	17.0	0.1	1.3	70.2	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	145.3	0.0	0.0	39.5	0.5	0.0	0.0	0.0	333.1	2.1	0.0	0.0	0.2	1.2	0.0	0.0	0.0	9.2	0.0	5.0	0.0	0.0	0.1	1.7	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.7	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	2.1	4.9	2.1	9.6	2.4	2.5	3.4	2.5	2.4	2.1	2.6	2.4	0.4	0.0	0.0	0.0	0.0	4.1	2.7	0.0	0.0	0.0	0.1	0.0	2531.9	1.5	0.0	0.0	0.0	1.9	0.0	0.4	0.0	0.0	90.6	0.5	6.7	22.7	0.0	0.0	0.1	0.0	5.2	104.6	0.0	0.1	0.0	0.0	1.8	0.0	5.6	0.0	0.0	0.9	0.0	0.0	10.7	71.6	28.9	2.8	12.4	0.0	0.6	0.0	0.0	0.5	0.0	0.5	0.0	50.4	0.0	8.7	0.0	0.1	0.0	0.0	46.0	497.8	210.5	5.0	5.1	0.1	9.8	8.5	2.4	0.0	0.2	2.9
DFFA	"DFF-45, DFF1, DFF45, ICAD"	ENSG00000160049	"DNA fragmentation factor subunit alpha"	O00273	1	10456522-10472529	"Plasma proteins, Predicted intracellular proteins"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002679, HPA018859, HPA019938, HPA025230"	Supported		Supported	"Plasma membrane,Cytosol"		NA	NA		8700	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Plasma membrane, Cytosol"		"CAB002679: , HPA018859: AB_1847622, HPA019938: AB_1847625, HPA025230: AB_1847623"	"unprognostic (1.23e-1)"	"unprognostic (2.63e-1)"	"unprognostic (1.06e-1)"	"unprognostic (3.59e-2)"	"unprognostic (1.57e-2)"	"unprognostic (1.81e-1)"	"prognostic unfavorable (9.46e-4)"	"unprognostic (1.55e-1)"	"unprognostic (9.24e-3)"	"unprognostic (3.57e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.91e-1)"	"prognostic favorable (1.57e-9)"	"unprognostic (1.21e-2)"	"unprognostic (3.46e-2)"	"unprognostic (3.89e-2)"	"unprognostic (1.88e-1)"	13.3	12.6	15.0	12.0	18.0	6.5	12.6	19.7	16.5	11.1	14.2	11.3	12.1	11.7	9.8	16.7	13.0	10.8	12.1	14.9	17.2	16.8	13.2	11.3	12.4	17.4	18.7	15.3	11.4	18.0	9.2	20.1	17.5	11.8	12.2	12.2	10.9	12.3	12.3	10.9	11.1	16.1	16.1	10.7	12.1	9.8	18.3	13.3	12.3	13.9	16.2	14.4	10.1	18.3	37.8	36.8	31.0	35.4	25.7	24.3	15.1	52.5	33.6	53.4	39.6	88.4	48.4	79.9	33.1	44.5	29.7	30.3	60.5	62.2	53.7	31.9	41.8	39.9	37.6	35.8	41.8	49.3	25.4	30.5	30.6	84.4	67.4	29.1	41.3	39.3	72.6	17.6	38.4	48.0	48.8	22.2	27.2	28.3	42.4	41.3	37.1	40.1	48.5	28.6	36.5	35.6	48.9	42.1	58.0	26.6	27.0	17.0	43.4	24.9	34.0	46.4	35.0	21.6	32.5	114.3	26.5	45.7	38.5	1.8	11.2	8.6	15.2	9.1	11.7	16.6	10.3	13.5	10.6	15.8	10.7	13.0	1.4	17.5	12.3	12.4	16.2	10.5	15.0	18.0	19.7	16.5	14.9	17.2	17.4	18.7	17.5	16.1	18.3	18.3	26.9	44.8	34.3	3.3	23.5	34.4	39.0	43.8	30.1	21.1	20.5	25.0	23.7	32.9	36.6	18.4	108.4	91.1	22.8	12.6	37.2	46.5	32.0	22.4	31.6	34.0	34.2	15.6	6.5	39.1	64.9	25.1	20.9	23.8	24.7	35.6	31.4	31.0	41.8	20.2	8.3	17.3	28.5	22.9	13.8	73.2	30.1	17.0	10.6	3.7	37.4	23.3	28.8	5.0	6.9	49.1	10.6	32.4	19.3	48.1	25.0	57.8	26.0	34.0	19.7	29.9	26.9	35.7	28.4	32.0	40.6	66.4	18.5	43.9	27.9	38.9
DFFB	"CAD, CPAN, DFF-40, DFF40"	ENSG00000169598	"DNA fragmentation factor subunit beta"	O76075	1	3857267-3885429	"Predicted intracellular proteins"	Apoptosis	"Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 4.6"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 45.9;Extravillous trophoblasts: 29.5;Oligodendrocytes: 22.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004328, HPA052904"	Approved		Supported	Nucleoplasm,Nucleoli		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 38: Extravillous trophoblasts - Unknown function"	Nucleoli	Nucleoplasm	"CAB004328: AB_626776, HPA052904: AB_2681985"	"unprognostic (2.98e-1)"	"unprognostic (5.09e-2)"	"unprognostic (4.37e-2)"	"unprognostic (1.52e-3)"	"unprognostic (6.12e-2)"	"unprognostic (1.83e-2)"	"unprognostic (1.38e-2)"	"unprognostic (1.28e-3)"	"unprognostic (2.66e-2)"	"unprognostic (1.79e-1)"	"unprognostic (7.82e-3)"	"unprognostic (4.07e-1)"	"unprognostic (1.90e-2)"	"unprognostic (9.86e-3)"	"unprognostic (3.39e-1)"	"unprognostic (2.27e-1)"	"prognostic favorable (6.29e-5)"	1.3	1.1	0.6	1.2	0.7	1.0	1.1	0.5	0.9	1.7	0.0	1.5	4.6	1.6	0.0	0.8	1.3	1.4	0.7	0.7	0.5	0.7	0.4	1.0	1.6	1.5	0.9	1.7	2.4	0.5	0.6	1.3	0.7	0.8	0.8	0.2	1.3	0.7	0.5	0.6	2.0	0.4	0.4	1.9	1.2	0.4	0.6	1.2	0.8	0.5	0.9	1.4	1.0	1.5	3.2	3.3	2.0	4.7	0.6	1.6	1.1	2.7	1.2	4.1	2.8	2.6	2.8	2.6	2.2	0.5	0.8	1.7	0.7	3.2	0.2	9.0	9.7	10.7	1.2	3.2	3.3	8.7	7.9	0.4	0.8	2.4	1.9	0.8	4.1	7.5	7.4	1.6	0.1	1.8	6.1	4.8	2.2	3.9	7.4	4.9	1.2	4.4	1.3	0.6	3.3	5.1	2.3	6.5	10.7	0.0	1.1	3.8	4.1	1.5	1.1	6.5	2.5	2.9	4.6	5.4	1.2	9.0	2.0	3.6	3.7	5.0	3.4	3.8	2.0	2.1	2.5	3.1	5.1	1.0	2.1	3.2	1.2	2.3	7.4	0.0	4.7	2.9	0.6	0.7	0.5	0.9	0.7	0.5	1.5	0.9	0.7	0.4	0.6	1.5	3.3	3.2	4.6	4.2	3.0	0.6	1.0	1.4	1.8	5.5	1.9	2.7	1.3	2.8	1.7	1.8	45.9	3.5	7.3	1.6	1.9	1.9	1.4	3.3	4.6	3.1	2.4	2.5	17.0	1.6	29.5	3.2	1.5	2.5	0.0	4.6	2.5	1.8	2.9	15.2	18.0	4.2	0.0	5.4	1.4	1.2	1.2	3.7	0.0	8.4	2.5	3.9	15.5	5.5	22.7	1.8	1.5	4.9	3.1	0.6	5.0	2.4	1.1	17.9	0.0	1.7	3.2	1.7	2.5	1.7	0.3	1.4	6.0	3.3	4.4	0.7
DGCR8	"C22orf12, DGCRK6, Gy1, pasha"	ENSG00000128191	"DGCR8 microprocessor complex subunit"	Q8WYQ5	22	20080232-20111877	"Plasma proteins, Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 61.3;Rod photoreceptor cells: 60.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"K-562: 78.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA076916, HPA079351"	Approved		Supported	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	"Nuclear bodies, Cytosol"	"HPA076916: , HPA079351: "	"unprognostic (2.57e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.81e-1)"	"unprognostic (8.34e-2)"	"unprognostic (2.75e-3)"	"prognostic unfavorable (1.08e-4)"	"unprognostic (2.34e-1)"	"unprognostic (5.72e-3)"	"unprognostic (2.83e-1)"	"unprognostic (1.09e-3)"	"unprognostic (2.62e-2)"	"prognostic unfavorable (5.67e-4)"	"unprognostic (1.02e-2)"	"unprognostic (4.20e-1)"	"unprognostic (4.68e-2)"	"unprognostic (2.26e-2)"	5.2	4.4	5.3	6.1	5.2	7.7	4.8	9.4	5.6	6.8	5.0	7.0	5.0	8.5	3.6	7.1	6.9	4.7	5.2	5.3	4.6	4.7	4.5	5.3	6.3	5.1	5.1	8.4	6.2	6.4	5.2	11.6	5.6	5.5	5.0	6.5	7.2	5.6	14.8	7.5	6.7	6.0	4.7	5.9	6.1	15.2	5.3	9.5	6.0	9.3	5.9	6.8	5.7	6.2	22.7	15.7	20.1	11.9	7.7	12.4	25.5	21.3	12.6	14.1	9.9	17.0	11.3	20.1	11.6	20.0	9.4	21.4	18.4	17.8	12.2	19.7	27.4	21.7	17.4	14.0	20.3	40.7	17.5	10.0	21.6	14.8	10.7	12.9	12.6	12.1	78.7	14.1	16.5	14.6	24.7	12.1	19.4	16.5	11.8	29.0	21.2	6.8	8.5	20.9	22.3	14.3	19.4	11.3	13.0	12.0	10.9	17.2	18.8	20.5	17.1	13.0	21.9	7.8	11.5	19.9	15.3	18.2	20.3	0.0	1.1	0.6	2.0	0.9	1.5	0.7	0.9	2.1	1.3	0.6	0.9	1.2	0.2	1.6	3.6	1.5	1.2	1.5	5.3	5.2	9.4	5.6	5.3	4.6	5.1	5.1	5.6	4.7	5.3	6.2	8.1	6.4	7.9	11.8	6.0	9.6	5.2	6.8	10.2	37.1	9.1	8.0	4.2	11.5	7.3	5.5	39.6	13.6	6.9	9.6	0.0	6.1	61.3	5.5	8.3	10.2	7.3	10.3	12.4	10.2	11.2	7.3	12.8	7.3	3.8	19.2	9.7	14.4	5.3	43.7	12.7	10.3	4.1	8.4	6.5	39.2	18.3	5.0	5.4	6.5	7.2	10.9	11.3	9.5	14.0	10.9	5.8	10.5	9.3	8.6	6.2	3.4	8.1	60.7	6.6	9.7	8.1	25.2	17.5	10.4	9.2	13.5	9.3	15.1	9.7	5.6
DGKD	"DGKdelta, KIAA0145"	ENSG00000077044	"Diacylglycerol kinase delta"	Q16760	2	233354494-233472104	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Endocytosis, Protein transport, Transport"	"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 30.4"	"Cell type enhanced"	"Detected in many"		"Gastric mucus-secreting cells: 143.2;Inhibitory neurons: 137.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 17.3;HeLa: 21.8;U-698: 22.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027530, HPA049101"	Approved		Supported	Cytosol		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 59: Non-specific - Translation"	"Cluster 20: HeLa - Mitochondria"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Cytosol		"HPA027530: AB_2672320, HPA049101: AB_2680630"	"unprognostic (1.84e-1)"	"unprognostic (2.19e-2)"	"unprognostic (7.76e-3)"	"unprognostic (1.92e-2)"	"unprognostic (5.69e-2)"	"unprognostic (6.24e-2)"	"prognostic unfavorable (1.69e-5)"	"unprognostic (2.25e-1)"	"unprognostic (1.17e-3)"	"unprognostic (6.03e-2)"	"unprognostic (5.76e-2)"	"unprognostic (1.00e-1)"	"prognostic unfavorable (4.07e-8)"	"unprognostic (1.78e-1)"	"unprognostic (7.18e-2)"	"unprognostic (1.22e-1)"	"unprognostic (5.94e-3)"	5.2	3.4	4.3	1.9	5.5	12.0	5.9	20.5	6.2	4.5	3.2	9.0	1.6	5.9	1.6	2.2	5.7	1.0	7.6	5.8	4.0	2.5	3.6	10.6	4.3	6.5	3.9	8.9	2.7	0.4	3.7	2.9	7.4	5.7	2.3	5.4	5.9	0.5	30.4	3.0	12.9	0.7	4.1	11.4	25.2	9.6	4.4	1.0	8.3	0.9	4.5	5.3	2.6	8.8	1.7	8.5	2.1	1.5	1.5	1.4	3.0	2.4	1.0	0.6	0.5	9.7	1.9	10.3	1.1	2.4	4.5	2.0	2.4	1.0	3.2	17.3	11.3	4.7	21.8	5.8	0.9	11.7	7.2	2.3	2.2	1.1	2.1	1.8	0.8	2.1	7.8	1.8	1.6	3.1	9.2	3.3	1.6	2.8	6.9	14.5	5.7	1.6	0.9	3.3	2.1	2.2	1.4	2.3	1.0	1.8	0.6	5.2	1.0	1.2	3.0	1.2	1.7	7.1	6.2	22.7	0.8	5.6	0.6	1.7	1.6	5.6	2.1	0.6	1.1	4.8	0.5	1.5	0.4	5.0	1.7	2.4	1.2	0.6	1.0	0.4	0.2	1.7	4.3	5.5	20.5	6.2	5.8	4.0	6.5	3.9	7.4	4.1	4.4	8.8	18.9	32.1	46.2	27.1	61.1	8.9	6.4	5.6	4.6	33.8	19.6	11.6	21.0	0.0	13.8	0.0	62.6	14.6	62.0	40.6	0.0	3.6	14.9	23.4	12.5	19.1	2.4	5.0	11.1	4.4	1.2	9.7	143.2	38.1	5.7	13.1	4.6	7.0	6.8	8.4	137.9	32.8	8.2	10.4	13.8	38.7	6.5	28.7	8.8	11.2	17.5	13.9	49.4	43.2	81.5	26.0	13.5	4.5	34.7	17.6	29.6	2.6	4.8	44.3	19.7	49.4	21.2	14.4	29.3	4.5	3.7	2.5	32.5	7.6	20.1	9.9
DGKE	"DAGK6, DGK"	ENSG00000153933	"Diacylglycerol kinase epsilon"	P52429	17	56834107-56869567	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Kinase, Transferase"	"Disease variant, Hemolytic uremic syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"retina: 34.5"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 181.1;Cone photoreceptor cells: 189.7;Inhibitory neurons: 90.0;Rod photoreceptor cells: 165.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 84.8;MOLT-4: 30.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017167	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 56: Bipolar cells - Visual perception"	"Nucleoplasm, Cytosol"		"HPA017167: AB_1847638"	"unprognostic (1.19e-2)"	"unprognostic (2.11e-2)"	"unprognostic (2.69e-1)"	"prognostic favorable (3.92e-5)"	"unprognostic (4.20e-2)"	"unprognostic (4.87e-2)"	"unprognostic (3.37e-1)"	"unprognostic (4.27e-2)"	"unprognostic (1.19e-3)"	"unprognostic (4.75e-2)"	"unprognostic (6.07e-3)"	"unprognostic (2.68e-1)"	"unprognostic (2.55e-2)"	"unprognostic (1.99e-1)"	"unprognostic (2.17e-1)"	"unprognostic (1.26e-1)"	"unprognostic (3.69e-3)"	4.1	2.2	5.4	4.5	6.9	3.1	3.0	9.4	7.4	4.9	7.7	4.9	2.6	6.5	4.2	2.6	4.8	4.6	2.9	5.8	8.1	2.6	2.8	5.2	5.0	3.3	4.7	3.5	3.9	4.1	6.2	2.7	3.4	4.1	3.3	34.5	2.5	3.3	1.2	1.9	4.4	4.3	2.7	6.9	3.7	6.5	6.9	9.8	4.0	2.2	4.3	3.8	4.2	5.8	3.5	3.3	3.0	0.3	0.6	1.0	1.4	5.8	4.7	3.9	4.5	7.7	4.2	5.1	7.0	3.1	1.9	4.2	7.2	3.2	7.8	16.5	9.5	6.6	8.9	5.1	3.3	12.7	8.9	1.9	4.0	4.1	8.0	3.6	5.4	14.7	5.5	84.8	4.8	5.1	30.3	7.1	2.3	4.6	10.0	9.4	12.4	12.2	3.9	7.6	4.7	3.2	4.7	2.5	0.2	1.9	5.3	6.0	5.0	1.1	5.4	1.7	0.9	11.3	25.3	3.4	3.3	7.3	0.3	0.1	0.2	0.0	1.0	0.1	0.7	0.9	0.6	0.7	0.2	0.3	0.7	0.9	0.3	0.7	0.2	0.8	1.7	0.3	5.4	6.9	9.4	7.4	5.8	8.1	3.3	4.7	3.4	2.7	6.9	5.8	51.2	3.2	6.0	10.4	11.3	8.9	13.5	3.1	21.6	181.1	5.0	6.3	6.3	10.0	4.0	16.5	189.7	6.6	16.3	5.6	0.0	7.4	18.3	9.0	9.9	30.6	11.3	2.1	66.0	4.7	3.0	6.9	9.7	19.3	0.0	13.1	29.3	4.0	2.2	8.4	90.0	7.7	8.2	5.0	9.3	9.2	4.4	7.4	3.6	32.8	6.3	18.6	14.4	32.6	14.4	6.0	6.4	5.3	15.1	21.3	1.9	0.1	2.8	165.4	6.6	11.8	10.7	28.5	20.7	9.7	6.7	3.4	18.9	5.7	5.8	13.4
DGKG	DAGK3	ENSG00000058866	"Diacylglycerol kinase gamma"	P49619	3	186105668-186362234	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 28.2"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 223.0;Excitatory neurons: 111.0;Inhibitory neurons: 63.5;Oligodendrocyte precursor cells: 334.8"	"Cancer enhanced"	"Detected in some"		"glioma: 2.8"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"classical monocyte: 2.1;eosinophil: 1.2;intermediate monocyte: 1.2;myeloid DC: 1.5;neutrophil: 2.6;non-classical monocyte: 1.5"	"Group enriched"	"Detected in many"	7	"dendritic cells: 1.5;granulocytes: 2.6;monocytes: 2.1"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 23.9;HL-60: 7.7;U-266/84: 9.4;U-87 MG: 14.3;U-937: 7.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036577	Approved		Supported	"Vesicles,Plasma membrane"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 6: Brain - Smell perception"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Vesicles, Plasma membrane"		"HPA036577: AB_10672358"	"unprognostic (2.23e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.56e-2)"	"unprognostic (3.24e-5)"	"unprognostic (2.70e-1)"	"unprognostic (6.09e-4)"	"unprognostic (1.21e-3)"	"unprognostic (3.80e-2)"	"unprognostic (5.88e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.94e-1)"	"unprognostic (5.09e-2)"	"unprognostic (8.05e-7)"	"unprognostic (3.47e-3)"	"unprognostic (7.19e-2)"	"unprognostic (1.41e-1)"	"unprognostic (9.16e-3)"	1.6	4.2	14.2	0.8	17.4	9.3	1.1	28.2	11.9	2.2	0.0	3.2	1.4	1.2	8.0	4.6	4.1	0.9	9.1	20.4	3.6	1.3	0.8	3.8	0.9	20.1	6.5	1.2	0.5	5.7	6.0	7.8	20.8	1.3	0.8	1.7	0.8	1.8	1.8	0.8	1.7	2.4	0.6	0.9	2.1	0.3	9.6	0.5	1.8	1.0	0.8	3.4	1.7	13.2	3.2	4.8	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	2.7	0.0	3.3	0.2	0.0	0.0	0.0	23.9	0.0	3.2	0.0	3.5	0.0	7.7	0.3	0.0	0.0	1.4	0.0	0.1	0.0	0.6	0.0	0.4	0.4	0.1	0.1	2.6	0.4	0.0	1.4	1.7	0.0	2.6	0.0	0.0	0.6	0.0	0.9	0.0	2.0	0.0	0.1	4.9	0.0	0.0	0.8	2.4	2.9	0.0	9.4	0.0	14.3	7.0	2.6	0.0	2.1	1.2	0.0	1.2	0.0	0.3	0.0	0.0	1.5	0.1	0.0	0.0	2.6	0.0	1.5	0.2	0.0	0.7	14.2	17.4	28.2	11.9	20.4	3.6	20.1	6.5	20.8	0.6	9.6	13.2	0.1	0.0	1.7	223.0	3.1	0.4	0.2	0.0	0.6	0.1	0.1	0.4	19.4	1.5	0.0	1.8	0.0	0.1	0.0	0.0	0.0	1.4	2.6	0.3	0.1	5.0	0.0	0.4	111.0	1.2	0.0	0.5	0.5	0.1	0.0	0.3	22.1	0.0	2.1	1.7	63.5	0.1	0.0	3.2	1.4	4.2	1.8	3.4	0.0	12.2	5.2	6.8	0.0	334.8	7.8	1.0	0.1	0.4	0.2	0.4	0.1	0.9	0.0	0.1	13.1	1.8	14.5	0.0	0.2	0.4	0.4	0.1	0.1	0.9	0.1	0.4
DGKH	DGKeta	ENSG00000102780	"Diacylglycerol kinase eta"	Q86XP1	13	42040036-42256578	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 25.8"	"Cell type enhanced"	"Detected in all"		"Prostatic glandular cells: 137.8;Urothelial cells: 147.3"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"basal ganglia: 25.8"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039533, HPA040355, HPA061538"	Uncertain		Supported	"Vesicles,Plasma membrane"		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 15: RT4 - Unknown function"	"Cluster 44: Endometrium - Transcription"	"Plasma membrane"	Vesicles	"HPA039533: AB_10795145, HPA040355: AB_10796452, HPA061538: "	"unprognostic (2.80e-1)"	"unprognostic (7.03e-2)"	"unprognostic (1.30e-1)"	"unprognostic (5.69e-2)"	"unprognostic (1.55e-3)"	"unprognostic (7.62e-2)"	"unprognostic (1.04e-2)"	"unprognostic (9.60e-2)"	"unprognostic (7.00e-3)"	"unprognostic (4.37e-2)"	"unprognostic (1.86e-1)"	"unprognostic (2.41e-1)"	"unprognostic (3.43e-3)"	"unprognostic (1.03e-1)"	"unprognostic (1.67e-1)"	"unprognostic (4.93e-2)"	"unprognostic (1.43e-2)"	3.7	1.3	4.5	2.0	25.8	1.3	3.5	8.7	5.4	4.4	0.0	3.7	1.5	6.4	6.9	4.1	4.3	2.5	3.0	7.3	4.4	3.3	1.0	7.8	2.2	0.0	7.4	2.8	1.0	0.7	2.6	4.5	0.4	2.8	3.3	2.6	3.0	2.1	1.5	3.2	2.7	4.0	0.2	1.7	2.6	2.3	9.7	2.7	2.5	2.2	1.3	5.3	4.6	2.8	5.6	6.6	4.3	3.6	1.9	4.2	0.5	3.4	2.7	2.2	2.8	0.6	4.7	4.3	4.1	3.7	8.3	11.8	3.8	7.7	3.3	3.4	12.4	7.6	3.6	0.4	2.4	3.3	2.0	1.6	7.7	4.3	17.0	3.4	9.9	5.3	3.0	2.9	3.8	5.1	3.4	1.7	1.9	5.2	4.3	5.0	3.8	2.9	7.4	16.7	2.5	2.6	3.1	4.0	3.0	1.8	3.4	8.9	9.8	4.1	3.8	4.5	4.7	1.5	1.5	4.8	2.4	2.9	3.1	0.6	0.3	0.1	0.2	0.2	0.2	0.1	0.4	0.4	0.0	0.2	0.2	0.4	0.9	0.1	0.1	0.3	0.3	0.1	4.5	25.8	8.7	5.4	7.3	4.4	0.0	7.4	0.4	0.2	9.7	2.8	64.8	22.4	20.1	8.8	1.9	61.7	58.1	61.1	15.9	44.5	13.6	8.9	8.5	24.3	44.7	11.0	4.2	3.7	2.2	29.0	1.9	11.3	25.9	64.1	26.0	50.8	47.4	2.7	85.4	7.2	2.2	17.5	15.3	46.2	7.6	5.7	23.2	3.2	6.8	1.7	60.2	18.7	14.2	5.6	43.1	20.1	3.4	8.0	8.8	56.2	8.6	18.8	1.0	54.3	11.0	27.6	19.2	9.1	6.2	137.8	13.1	8.4	91.8	2.6	26.3	16.2	54.1	3.8	3.8	19.7	33.1	2.9	13.0	11.5	22.0	147.3
DGKZ	"DAGK5, DAGK6, DGK-ZETA, hDGKzeta"	ENSG00000149091	"Diacylglycerol kinase zeta"	Q13574	11	46332905-46380554	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 146.2"	"Cell type enhanced"	"Detected in all"		"NK-cells: 129.8"	"Low cancer specificity"	"Detected in all"			"Group enriched"	"Detected in many"	27	"amygdala: 46.5;basal ganglia: 75.1;cerebral cortex: 146.2;hippocampal formation: 133.8;white matter: 51.0"	"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051336	Enhanced	Supported	Supported	"Nuclear speckles"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 63: NK-cells & T-cells - Immune response"	"Nuclear speckles"		"HPA051336: AB_2681448"	"unprognostic (2.85e-2)"	"unprognostic (3.90e-2)"	"unprognostic (2.39e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.40e-1)"	"unprognostic (4.12e-2)"	"unprognostic (3.08e-3)"	"unprognostic (1.31e-1)"	"unprognostic (1.03e-2)"	"unprognostic (2.49e-2)"	"unprognostic (3.66e-3)"	"unprognostic (8.18e-2)"	"prognostic unfavorable (4.74e-5)"	"unprognostic (1.48e-3)"	"unprognostic (7.75e-2)"	"unprognostic (3.61e-2)"	"unprognostic (7.84e-3)"	20.7	14.2	46.5	21.6	75.1	54.6	19.4	3.3	146.2	16.5	0.0	20.3	36.4	16.8	4.0	19.5	15.3	11.1	46.5	133.8	0.0	18.3	10.5	18.3	39.9	0.0	0.0	12.4	31.5	10.0	58.7	14.1	0.0	18.6	6.6	2.5	43.4	10.7	95.7	22.3	41.2	9.1	0.0	36.1	22.2	15.4	1.4	34.0	12.5	25.1	17.1	18.2	15.3	51.0	38.1	33.2	22.1	33.2	11.5	12.8	102.1	29.0	21.5	30.0	26.3	39.8	17.1	48.4	20.5	30.1	33.0	43.3	26.7	42.0	10.6	48.8	62.5	31.7	25.2	29.5	20.5	60.5	61.2	17.3	19.3	16.5	22.2	15.3	33.4	39.3	45.1	29.1	21.5	99.8	58.6	94.3	64.3	54.5	50.3	69.0	38.2	20.6	9.1	36.6	150.3	25.6	33.2	109.6	23.0	13.8	78.8	75.2	37.9	39.2	42.4	62.6	52.9	19.1	23.4	40.3	53.8	54.0	37.2	12.4	13.5	6.0	6.8	5.6	4.1	0.3	4.3	5.9	12.0	0.8	4.3	4.6	9.5	7.6	6.4	5.7	4.4	10.5	46.5	75.1	3.3	146.2	133.8	0.0	0.0	0.0	0.0	0.0	1.4	51.0	46.0	3.2	6.6	44.7	16.4	13.3	22.3	16.3	14.2	27.6	24.6	19.8	24.4	8.6	8.7	9.2	20.9	14.6	95.8	37.7	9.8	13.2	6.1	9.9	15.2	34.2	51.5	23.4	114.0	47.8	105.1	12.4	34.1	14.1	21.0	25.7	56.7	7.1	51.2	16.8	45.0	26.3	22.4	46.1	26.9	11.4	13.1	34.0	12.4	31.9	50.6	6.4	129.8	8.5	24.7	33.5	41.0	8.2	25.3	16.6	97.0	20.2	8.2	9.9	32.9	17.8	16.8	7.0	12.2	12.3	9.2	27.4	71.8	19.4	29.9	17.2
DGLUCY	"C14orf159, FLJ39975"	ENSG00000133943	"D-glutamate cyclase"	Q7Z3D6	14	91060333-91225632	"Enzymes, Predicted intracellular proteins"		Lyase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"tongue: 163.6"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 28.9;Collecting duct cells: 29.5;Cytotrophoblasts: 30.9;Endometrial ciliated cells: 29.4;Granulosa cells: 49.8;Hofbauer cells: 31.7;Theca cells: 35.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 200.5"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							"HPA041423, HPA052932"	Approved		Supported	Cytosol		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 40: Granulosa cells - Unknown function"	Cytosol		"HPA041423: AB_10795540, HPA052932: AB_2681991"	"unprognostic (5.02e-2)"	"unprognostic (1.01e-2)"	"unprognostic (1.56e-1)"	"prognostic favorable (4.28e-4)"	"unprognostic (1.28e-1)"	"unprognostic (2.26e-1)"	"unprognostic (3.58e-2)"	"prognostic favorable (9.48e-5)"	"unprognostic (3.56e-1)"	"prognostic favorable (7.28e-4)"	"unprognostic (2.30e-1)"	"unprognostic (1.74e-1)"	"prognostic favorable (3.77e-15)"	"unprognostic (1.50e-1)"	"unprognostic (9.51e-2)"	"unprognostic (2.75e-2)"	"unprognostic (2.57e-3)"	23.9	32.2	38.5	21.4	46.0	21.7	16.7	53.5	49.2	25.0	76.1	33.5	25.1	26.0	17.2	28.4	38.6	22.6	122.3	36.6	39.8	35.6	24.9	25.0	21.6	45.5	51.3	22.9	16.8	47.9	21.5	16.6	42.1	22.8	30.4	8.3	32.2	34.1	143.0	25.6	23.7	32.0	38.0	33.6	38.1	19.0	45.4	27.3	30.1	163.6	19.9	31.9	20.2	45.2	6.2	16.4	8.0	20.1	32.8	30.6	21.0	6.6	17.7	19.3	19.6	10.9	46.7	41.3	46.0	18.8	24.9	18.0	23.0	24.7	7.9	22.8	9.5	27.7	9.1	13.8	47.8	28.5	38.2	47.5	10.5	10.6	4.0	25.3	34.6	22.8	14.0	54.4	18.4	1.4	22.7	27.0	16.4	0.8	1.4	38.2	15.7	30.9	32.7	25.9	22.4	11.2	10.4	17.8	7.3	8.4	32.0	24.5	24.7	5.7	4.8	17.1	5.9	30.9	23.8	14.0	29.6	36.8	3.8	67.5	48.8	30.8	30.1	69.4	30.3	34.0	19.3	24.5	72.9	22.4	15.9	20.0	200.5	21.0	60.7	22.0	45.2	29.0	38.5	46.0	53.5	49.2	36.6	39.8	45.5	51.3	42.1	38.0	45.4	45.2	19.2	28.9	16.4	0.0	4.3	0.0	0.0	0.0	0.0	0.0	11.5	13.2	0.0	0.0	5.6	29.5	0.0	30.9	12.5	0.0	21.5	17.6	0.0	29.4	14.8	6.2	0.0	0.0	0.0	5.8	15.8	7.4	0.0	25.0	7.6	49.8	0.0	0.0	31.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.2	0.0	0.0	7.2	0.0	0.0	0.0	0.0	6.3	0.0	0.0	2.7	0.0	0.0	17.0	5.1	0.0	0.0	0.0	5.8	0.0	0.0	0.0	0.0	16.8	8.7	35.6	0.0	0.0
DHCR7	SLOS	ENSG00000172893	"7-dehydrocholesterol reductase"	Q9UBM7	11	71428193-71452868	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins"	"Cholesterol biosynthesis, Cholesterol metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism"	Oxidoreductase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 161.1"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 77.9;Granulosa cells: 81.3;Hepatocytes: 156.1;Theca cells: 103.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044280	Approved		Supported	"Endoplasmic reticulum"		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 15: Liver - Metabolism"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 15: Hepatocytes - Hemostasis"	"Endoplasmic reticulum"		"HPA044280: AB_10794893"	"unprognostic (1.76e-1)"	"unprognostic (1.50e-3)"	"unprognostic (1.32e-2)"	"unprognostic (7.16e-3)"	"unprognostic (2.69e-1)"	"unprognostic (2.18e-3)"	"unprognostic (8.57e-3)"	"unprognostic (3.02e-2)"	"unprognostic (4.91e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.08e-2)"	"unprognostic (5.45e-2)"	"prognostic favorable (6.93e-7)"	"unprognostic (1.73e-1)"	"unprognostic (1.01e-1)"	"unprognostic (8.15e-2)"	"prognostic unfavorable (5.67e-4)"	23.7	97.2	28.1	13.0	35.4	46.7	36.3	42.4	37.0	16.2	15.6	21.1	48.1	10.6	59.2	42.2	12.5	8.9	28.8	28.8	35.8	16.3	161.1	21.8	6.0	55.3	38.8	54.4	16.6	24.4	18.4	8.3	55.8	21.6	14.4	8.7	27.8	7.1	13.6	68.2	19.3	9.9	34.4	9.6	19.1	31.0	38.0	4.7	11.9	13.2	9.4	7.9	22.7	58.9	126.4	112.3	106.7	118.9	49.0	75.8	33.7	50.9	134.1	43.1	114.5	419.8	401.5	87.1	79.0	48.6	376.2	235.9	128.8	276.7	44.5	33.5	98.7	33.4	89.3	183.1	127.8	63.7	15.6	89.2	122.1	159.3	108.4	34.6	63.8	112.7	159.6	180.7	43.2	341.1	52.4	72.6	154.1	124.9	67.4	46.9	150.6	377.3	162.3	187.3	144.7	53.9	48.4	157.6	113.9	51.4	153.2	34.5	60.4	11.5	62.4	3.7	61.5	59.3	78.7	95.8	33.8	110.9	48.9	5.6	2.1	1.9	10.5	1.4	12.6	6.5	8.9	9.8	2.8	5.4	11.0	13.0	1.1	5.8	1.5	7.1	6.0	6.9	28.1	35.4	42.4	37.0	28.8	35.8	55.3	38.8	55.8	34.4	38.0	58.9	7.1	3.2	19.1	7.2	7.1	0.8	10.1	77.9	3.4	8.4	21.8	14.9	13.1	15.7	39.2	22.0	12.5	15.5	11.9	9.9	7.9	36.9	0.1	3.9	1.5	11.8	9.5	5.2	3.2	49.9	27.6	12.8	11.7	9.3	0.0	81.3	7.9	156.1	11.9	0.0	4.5	12.3	54.9	3.8	3.3	1.7	8.4	5.6	5.4	1.0	5.8	21.2	4.1	5.0	14.7	26.7	11.5	4.9	10.0	16.5	8.9	3.8	7.6	8.7	13.1	3.9	9.0	0.5	7.0	11.9	1.1	54.2	13.8	103.6	15.0	9.5
DHRS2	"HEP27, SDR25C1"	ENSG00000100867	"Dehydrogenase/reductase 2"	Q13268	14	23630115-23645639	"Metabolic proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"breast: 336.3;urinary bladder: 392.6"	"Cell type enhanced"	"Detected in some"		"Extravillous trophoblasts: 15.1;Syncytiotrophoblasts: 24.8;Theca cells: 12.6;Urothelial cells: 30.6"	"Cancer enriched"	"Detected in many"	6	"urothelial cancer: 141.4"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"Hep G2: 719.8;RT4: 828.1;SK-BR-3: 4047.2;U-2 OS: 1286.3"	"Region enriched"	"Detected in single"	4	"cerebellum: 2.4"					"HPA053915, HPA069551"	Enhanced		Supported	Nucleoplasm,Mitochondria		No	NA				"Cluster 46: Fibroblasts - ECM organization"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	Mitochondria	Nucleoplasm	"HPA053915: AB_2682307, HPA069551: AB_2686150"	"unprognostic (3.07e-1)"	"unprognostic (4.91e-2)"	"unprognostic (3.44e-2)"	"prognostic unfavorable (3.23e-4)"	"unprognostic (9.97e-2)"	"unprognostic (5.03e-3)"	"unprognostic (5.62e-2)"	"unprognostic (1.86e-1)"	"unprognostic (4.08e-1)"	"unprognostic (6.91e-2)"	"unprognostic (6.66e-2)"	"unprognostic (4.59e-2)"	"prognostic unfavorable (3.75e-5)"	"unprognostic (1.83e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.76e-1)"	"prognostic favorable (6.45e-4)"	1.2	1.6	0.3	0.1	0.2	0.0	336.3	0.2	0.4	1.9	0.2	0.2	0.0	0.2	0.4	0.1	0.3	0.0	0.0	0.4	1.2	1.6	23.6	0.2	0.0	0.4	1.2	25.5	10.3	2.1	2.5	3.2	1.7	3.3	0.4	0.4	97.7	3.1	0.0	3.4	0.1	0.2	0.3	19.0	4.7	3.4	1.1	0.0	0.1	0.0	0.0	392.6	13.6	0.3	1.2	2.2	0.2	199.9	0.3	0.3	3.1	0.3	0.2	6.4	0.1	14.4	1.1	0.8	1.9	0.3	10.4	2.0	0.7	1.2	1.4	289.5	21.6	2.8	1.0	719.8	0.0	4.3	25.1	1.7	0.2	2.5	1.7	0.0	0.1	0.4	1.8	0.7	1.4	8.0	2.5	0.3	1.1	6.9	31.7	2.6	6.3	2.7	0.0	828.1	3.5	5.0	5.9	4047.2	4.9	0.7	3.9	1.0	0.0	2.4	1286.3	7.7	4.3	2.0	0.6	11.3	1.7	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.2	0.4	0.4	1.2	0.4	1.2	1.7	0.3	1.1	0.3	0.1	0.0	0.0	0.0	0.4	0.0	2.1	0.2	0.0	0.8	7.4	1.3	0.4	0.0	0.0	0.0	0.0	7.9	0.1	0.1	7.9	0.1	5.0	0.1	0.0	0.2	3.5	0.0	0.1	0.2	15.1	3.5	0.0	0.0	0.0	1.4	0.0	4.9	1.7	0.0	0.1	0.2	0.0	0.3	0.8	3.7	0.0	0.1	0.0	0.0	0.6	0.4	0.0	0.0	0.0	4.8	0.2	1.2	0.0	0.3	0.0	0.2	0.0	1.2	6.6	0.0	0.7	0.3	7.4	0.0	0.1	24.8	0.2	12.6	0.7	30.6
DHTKD1	"CMT2Q, DKFZP762M115, KIAA1630, MGC3090"	ENSG00000181192	"Dehydrogenase E1 and transketolase domain containing 1"	Q96HY7	10	12068954-12123221	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	Glycolysis	Oxidoreductase	"Charcot-Marie-Tooth disease, Disease variant, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 129.5"	"Cell type enhanced"	"Detected in all"		"Hepatocytes: 227.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"T-47d: 102.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037949, HPA037950, HPA066098"	Enhanced		Supported	Mitochondria		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 6: T47d - Mammary gland"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Mitochondria		"HPA037949: AB_2675752, HPA037950: AB_10673650, HPA066098: AB_2685617"	"unprognostic (3.76e-2)"	"unprognostic (8.08e-3)"	"unprognostic (2.24e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.34e-1)"	"unprognostic (3.04e-3)"	"unprognostic (3.83e-3)"	"unprognostic (5.01e-2)"	"unprognostic (5.34e-2)"	"unprognostic (3.02e-3)"	"unprognostic (3.46e-1)"	"unprognostic (1.56e-1)"	"prognostic favorable (3.43e-4)"	"unprognostic (2.12e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.74e-2)"	"unprognostic (2.88e-3)"	10.7	8.4	8.1	6.8	10.4	3.8	8.4	12.6	8.5	8.8	11.9	10.1	7.6	6.2	6.8	7.5	6.1	5.3	13.2	7.6	8.5	42.7	129.5	5.4	8.5	9.5	8.6	10.0	18.0	12.7	5.6	7.7	9.5	12.9	10.8	7.5	13.1	5.7	18.7	5.6	6.9	5.7	8.8	7.8	10.9	4.7	9.1	10.5	11.6	23.1	9.7	6.3	6.1	11.4	27.0	20.4	29.8	23.8	18.2	10.8	35.9	13.3	8.6	23.4	20.6	13.1	15.7	19.3	4.3	8.4	10.8	37.4	31.6	10.4	26.6	10.9	14.2	10.6	7.7	10.1	17.8	4.2	3.8	13.3	7.9	13.7	5.5	9.2	13.0	23.1	16.7	15.1	6.3	52.3	14.4	7.7	16.7	24.9	4.7	24.3	9.7	16.5	15.2	6.4	7.7	34.9	26.3	46.3	15.4	31.7	102.2	15.2	5.8	7.5	5.4	15.8	9.9	13.4	10.3	12.6	9.7	7.4	12.8	23.8	6.8	15.4	4.2	9.2	4.5	13.0	3.2	2.7	11.9	9.9	3.1	4.1	19.4	14.3	17.0	17.3	5.7	4.9	8.1	10.4	12.6	8.5	7.6	8.5	9.5	8.6	9.5	8.8	9.1	11.4	6.9	12.8	38.8	21.5	21.3	5.2	6.7	5.3	10.2	13.3	13.7	8.3	31.1	28.6	7.8	16.5	10.4	35.4	23.2	14.6	19.6	10.9	3.5	8.8	17.3	8.1	11.3	21.9	12.8	11.1	25.1	8.1	21.9	20.8	8.8	45.2	11.0	227.4	10.3	26.9	17.3	18.0	4.1	15.3	10.1	4.2	12.5	13.5	5.4	17.8	13.4	10.4	8.2	15.6	20.5	12.4	9.6	12.0	22.6	9.6	9.4	62.5	5.2	19.2	13.1	10.6	7.4	6.7	3.8	16.2	6.0	13.5	8.4	21.8	16.6	7.8
DHX16	"DBP2, DDX16, Prp2, PRPF2"	ENSG00000204560	"DEAH-box helicase 16"	O60231	6	30653119-30673006	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Helicase, Hydrolase"	"Disease variant, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 92.7;Spermatocytes: 86.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051455	Supported		Supported	Nucleoplasm		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 71: Testis - DNA repair"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm		"HPA051455: AB_2681491"	"unprognostic (7.04e-2)"	"unprognostic (1.37e-1)"	"unprognostic (7.29e-2)"	"unprognostic (7.46e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.94e-1)"	"unprognostic (4.36e-3)"	"unprognostic (1.13e-1)"	"unprognostic (2.66e-2)"	"unprognostic (3.11e-1)"	"unprognostic (8.58e-2)"	"unprognostic (1.24e-2)"	"unprognostic (9.77e-3)"	"unprognostic (4.42e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.64e-1)"	"unprognostic (8.73e-3)"	24.3	28.2	5.4	13.8	6.3	11.3	26.0	6.3	6.8	27.7	8.3	29.5	18.8	25.5	8.6	27.2	26.6	11.3	26.6	5.3	6.0	34.9	36.5	25.4	18.1	6.3	5.9	26.2	35.0	16.0	28.6	10.5	6.4	30.1	10.3	14.4	32.0	12.8	45.0	28.8	37.5	12.5	5.2	40.3	28.3	46.8	6.6	17.1	38.2	17.6	12.7	24.8	26.8	6.4	31.9	17.9	20.3	38.7	26.8	15.7	27.0	33.0	30.7	47.6	44.3	35.8	15.9	25.5	24.2	31.1	39.6	34.0	47.0	24.1	35.5	35.4	15.5	27.2	25.5	17.9	21.4	65.9	40.4	17.6	22.7	47.3	30.1	16.5	16.9	36.9	44.4	29.3	26.7	29.0	22.4	20.8	21.4	20.9	12.1	38.5	17.4	28.2	18.4	24.0	27.9	19.7	30.8	37.4	32.0	20.3	29.5	24.7	11.8	31.2	21.3	27.4	46.3	29.9	49.9	20.2	15.7	36.8	40.4	10.5	11.2	18.6	7.4	14.7	9.5	7.7	9.1	7.9	11.1	5.9	7.4	5.8	11.4	14.8	16.4	9.8	7.4	7.5	5.4	6.3	6.3	6.8	5.3	6.0	6.3	5.9	6.4	5.2	6.6	6.4	13.0	22.4	20.9	4.6	16.9	10.8	11.7	11.3	16.5	13.9	10.0	9.9	14.6	10.0	20.2	5.5	39.6	19.2	14.4	18.3	9.8	15.7	92.7	25.2	18.0	11.8	6.0	14.9	4.3	18.6	20.1	11.6	26.5	15.8	42.3	11.1	8.6	9.7	13.9	5.0	4.1	14.6	8.2	12.6	12.8	49.3	14.3	14.4	5.4	5.6	20.3	11.6	15.5	2.5	5.2	22.9	23.1	12.4	22.1	9.3	18.0	9.8	31.4	51.1	19.7	16.2	19.2	86.9	32.6	14.7	10.7	19.2	19.5	11.4	12.8	9.5
DHX30	"DDX30, FLJ11214, KIAA0890"	ENSG00000132153	"DExH-box helicase 30"	Q7L2E3	3	47802909-47850195	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"Ribosome biogenesis"	"Helicase, Hydrolase, RNA-binding"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA034806	Supported		Supported	Mitochondria,Cytosol		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 43: Testis - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	Mitochondria	Cytosol	"HPA034806: AB_10601364"	"unprognostic (2.00e-1)"	"unprognostic (8.37e-2)"	"unprognostic (3.27e-1)"	"unprognostic (2.14e-2)"	"unprognostic (3.04e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.27e-3)"	"unprognostic (1.14e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.10e-3)"	"unprognostic (1.42e-2)"	"prognostic favorable (1.37e-6)"	"unprognostic (4.12e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.81e-1)"	"unprognostic (2.22e-1)"	22.6	24.6	23.7	17.1	23.3	22.2	22.9	21.4	26.3	26.4	24.8	26.8	16.2	27.6	10.4	23.6	24.8	14.9	28.8	23.5	22.4	26.8	25.2	21.3	20.1	24.0	23.5	27.9	24.1	28.9	32.1	17.5	24.6	26.6	10.9	12.7	21.6	18.2	37.1	27.6	22.3	15.9	20.3	27.3	25.2	54.2	23.8	23.3	24.8	21.0	14.3	25.2	22.8	24.2	21.9	52.3	54.5	56.2	24.6	20.2	35.3	39.0	33.4	65.1	46.5	56.9	42.6	66.4	32.0	37.0	51.2	30.3	73.7	52.1	23.1	49.6	86.1	59.6	76.0	58.6	40.7	56.0	58.3	33.0	33.4	68.1	49.7	28.4	44.0	57.5	82.0	40.6	31.8	57.1	82.2	59.3	60.7	30.2	84.0	44.6	30.6	62.2	32.0	53.6	41.6	61.6	39.6	54.1	31.1	25.0	38.5	58.8	32.2	40.6	51.0	46.7	73.9	56.2	75.3	61.8	42.8	48.3	49.9	14.1	10.7	7.8	16.2	10.6	12.4	10.4	12.4	16.3	13.9	8.7	11.7	12.7	1.6	9.6	11.6	7.9	15.3	14.7	23.7	23.3	21.4	26.3	23.5	22.4	24.0	23.5	24.6	20.3	23.8	24.2	31.1	38.5	46.7	30.7	34.7	18.1	25.7	38.7	39.3	49.0	34.6	35.6	38.1	32.9	34.1	51.5	43.8	41.7	33.1	37.6	66.5	37.8	129.5	59.2	31.7	32.4	40.1	38.5	32.8	36.3	22.8	26.7	42.3	33.2	23.5	40.7	27.5	50.8	35.9	58.9	36.6	25.8	40.7	29.6	17.6	123.8	24.8	24.4	19.6	13.1	32.5	46.3	28.8	22.1	28.7	46.0	41.0	30.1	39.9	28.6	40.5	83.5	49.9	52.8	32.9	27.3	28.6	145.4	50.2	33.5	19.9	29.6	29.7	36.6	38.5	26.3
DHX33	"DDX33, DKFZp762F2011, FLJ21972"	ENSG00000005100	"DEAH-box helicase 33"	Q9H6R0	17	5440917-5468982	"Enzymes, Predicted intracellular proteins"		"Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 81.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA073875	Supported		Supported	Nucleoli		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 29: Early spermatids - Spermatogenesis"	Nucleoli		"HPA073875: AB_2686638"	"unprognostic (4.96e-2)"	"unprognostic (1.35e-1)"	"unprognostic (3.41e-2)"	"unprognostic (2.51e-2)"	"unprognostic (9.24e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.49e-2)"	"unprognostic (6.15e-2)"	"unprognostic (3.11e-2)"	"unprognostic (3.80e-1)"	"unprognostic (2.10e-1)"	"prognostic unfavorable (6.10e-4)"	"unprognostic (1.03e-1)"	"unprognostic (4.66e-1)"	"unprognostic (3.55e-1)"	"unprognostic (4.69e-2)"	"unprognostic (3.37e-2)"	6.2	5.9	5.5	6.3	5.8	4.4	7.0	5.1	6.0	5.4	3.9	5.3	4.8	6.4	4.1	6.2	5.8	4.1	4.5	5.7	4.9	5.2	7.8	4.4	6.0	4.9	5.2	5.6	6.7	7.6	3.9	6.3	4.8	5.4	5.6	6.4	5.6	5.4	8.0	6.9	5.0	5.9	5.0	6.0	5.5	4.5	5.7	5.2	5.1	5.6	5.9	6.5	5.4	5.5	19.0	27.7	17.4	31.1	7.2	14.4	21.6	18.4	11.4	27.6	22.1	17.6	8.1	46.7	12.5	15.1	11.0	22.0	35.4	28.7	35.3	15.0	34.1	18.5	22.4	30.0	14.1	24.9	15.9	12.2	17.3	29.8	40.4	8.3	20.9	22.0	24.9	22.3	15.5	13.4	25.5	13.6	38.5	12.5	14.0	33.5	25.5	25.3	12.8	14.7	15.1	21.7	19.2	16.4	28.0	14.6	12.8	12.9	19.5	19.0	20.2	15.3	39.6	8.3	9.5	23.5	13.6	29.1	27.7	0.2	0.9	0.5	0.5	0.4	0.5	0.7	0.6	0.3	0.4	0.8	0.6	0.6	0.6	0.8	0.3	0.9	0.4	0.2	5.5	5.8	5.1	6.0	5.7	4.9	4.9	5.2	4.8	5.0	5.7	5.5	11.4	12.8	8.6	6.5	8.6	21.0	15.3	8.6	19.9	15.6	18.3	15.7	16.3	17.2	9.9	7.3	20.9	8.3	10.2	8.5	1.9	9.3	81.8	7.6	23.3	16.2	9.1	23.3	14.5	15.3	10.1	13.7	10.7	12.7	3.8	21.0	13.2	28.1	6.3	13.5	15.2	10.9	2.0	16.9	8.7	11.3	7.8	9.9	14.2	6.5	6.8	13.3	9.2	11.6	13.0	12.1	5.1	9.8	10.4	20.9	5.9	5.9	6.1	10.5	0.0	25.1	11.5	10.6	15.7	22.0	19.9	5.1	6.6	19.7	11.9	14.9
DHX36	"DDX36, KIAA1488, MLEL1, RHAU"	ENSG00000174953	"DEAH-box helicase 36"	Q9H2U1	3	154272546-154324487	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Antiviral defense, Differentiation, Immunity, Innate immunity, Transcription, Transcription regulation, Translation regulation, Transport"	"Activator, Developmental protein, DNA-binding, Helicase, Hydrolase, Repressor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 547.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035398, HPA035399"	Approved		Supported	Nucleoplasm,Mitochondria,Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 29: Early spermatids - Spermatogenesis"	Nucleoplasm	"Mitochondria, Cytosol"	"HPA035398: , HPA035399: AB_10670115"	"unprognostic (8.04e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.86e-1)"	"unprognostic (3.50e-3)"	"unprognostic (2.67e-2)"	"unprognostic (3.22e-1)"	"unprognostic (8.80e-3)"	"unprognostic (1.03e-1)"	"unprognostic (7.51e-2)"	"unprognostic (1.26e-1)"	"unprognostic (3.94e-2)"	"unprognostic (3.90e-2)"	"unprognostic (2.72e-1)"	"unprognostic (5.09e-2)"	"unprognostic (5.27e-1)"	"unprognostic (4.96e-2)"	"unprognostic (1.37e-1)"	17.7	14.4	5.6	17.3	8.6	16.3	16.4	8.9	7.3	13.9	6.3	12.0	12.6	18.3	11.6	14.8	14.4	15.5	16.9	5.6	8.1	18.6	20.0	13.7	21.7	7.0	7.5	19.0	16.0	29.1	14.9	19.0	7.2	17.3	13.7	17.0	11.7	16.4	58.9	12.0	12.8	17.1	6.9	15.2	16.0	34.4	6.9	21.7	23.1	31.6	20.5	17.2	11.0	10.0	63.8	42.6	56.6	32.7	26.1	36.3	28.1	40.6	40.5	45.2	53.5	43.7	49.7	61.3	64.0	35.8	41.7	40.1	53.8	34.4	70.6	59.3	35.6	44.5	34.8	25.0	44.2	62.7	37.4	41.3	28.5	48.6	59.1	24.5	39.4	37.3	42.6	34.3	42.2	31.0	52.2	13.7	75.4	33.6	40.5	53.4	47.6	88.8	32.1	44.4	52.7	56.1	42.3	44.4	59.7	38.3	45.5	31.5	44.9	47.1	29.6	44.6	82.1	63.6	43.9	87.5	38.1	32.2	51.1	1.2	1.5	1.8	3.7	1.5	2.3	2.6	3.2	2.5	1.3	3.1	2.9	3.1	0.6	2.6	3.5	3.3	3.1	0.6	5.6	8.6	8.9	7.3	5.6	8.1	7.0	7.5	7.2	6.9	6.9	10.0	95.6	57.7	92.9	45.4	123.6	92.9	146.6	56.6	81.4	152.2	61.8	62.6	60.8	67.2	83.5	60.7	129.3	138.0	179.3	43.8	39.2	71.2	547.0	73.4	147.9	82.0	92.0	68.5	53.5	62.8	69.9	97.6	66.8	104.2	103.8	86.7	72.8	80.5	62.0	154.8	60.2	57.4	73.2	73.7	85.2	335.5	110.6	83.0	53.4	37.5	88.5	86.4	113.3	59.3	55.4	66.5	49.9	121.5	97.6	132.2	40.4	54.4	52.3	128.6	78.9	130.6	88.8	197.4	135.1	65.3	83.1	370.1	152.0	114.2	58.1	128.4
DHX38	"DDX38, hPrp16, KIAA0224, PRP16, PRPF16"	ENSG00000140829	"DEAH-box helicase 38"	Q92620	16	72093613-72112912	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Helicase, Hydrolase"	"Disease variant, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041347, HPA041604"	Uncertain		Supported	Nucleoplasm		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA041347: AB_10796571, HPA041604: AB_2677577"	"unprognostic (2.38e-1)"	"unprognostic (1.89e-1)"	"unprognostic (1.24e-2)"	"unprognostic (3.25e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.01e-1)"	"unprognostic (6.32e-3)"	"unprognostic (8.50e-3)"	"unprognostic (6.97e-2)"	"unprognostic (1.45e-1)"	"unprognostic (7.92e-2)"	"unprognostic (1.28e-3)"	"unprognostic (4.20e-3)"	"unprognostic (2.68e-1)"	"unprognostic (9.46e-2)"	"unprognostic (2.40e-1)"	"unprognostic (2.40e-2)"	25.8	18.7	22.4	22.8	24.4	39.7	23.8	22.2	24.7	25.1	25.9	24.8	19.6	25.5	10.7	24.2	23.8	15.0	27.0	21.5	21.6	19.6	24.0	23.9	27.8	23.2	23.2	30.6	20.2	22.9	19.3	18.6	22.5	20.9	16.1	13.2	21.1	14.4	39.9	27.6	27.3	17.6	22.2	30.4	22.5	21.3	23.5	24.2	22.8	21.4	23.1	23.7	22.9	25.0	38.5	55.0	39.4	21.9	33.4	25.8	51.1	33.6	32.6	49.1	37.8	66.4	37.5	50.5	29.2	50.9	27.0	48.6	46.3	45.8	38.0	25.3	50.0	38.7	48.9	92.5	30.8	46.9	66.7	35.6	41.2	66.1	47.4	25.9	42.9	35.7	58.9	22.9	30.6	112.8	43.9	53.1	49.7	23.9	30.9	55.8	27.1	49.9	24.0	35.6	35.6	38.9	43.8	20.3	24.5	22.5	36.8	38.4	49.4	46.6	40.8	34.8	37.3	56.2	47.6	96.7	43.9	32.1	37.5	7.1	6.2	7.1	11.3	8.3	9.8	8.1	6.8	8.2	6.2	6.0	7.4	7.9	6.4	8.8	5.1	5.5	8.6	5.5	22.4	24.4	22.2	24.7	21.5	21.6	23.2	23.2	22.5	22.2	23.5	25.0	22.5	25.6	34.3	13.7	24.4	12.2	11.0	9.5	20.5	30.7	12.0	13.6	8.6	20.0	22.0	14.7	16.7	15.0	33.3	28.5	0.0	14.5	9.0	19.3	23.0	22.3	30.5	16.8	6.7	20.6	14.3	17.1	28.1	23.6	43.0	24.0	15.0	13.6	14.9	30.3	6.1	24.8	6.1	15.2	13.9	11.0	28.9	20.3	8.8	5.6	16.9	17.9	19.6	8.0	11.1	23.7	17.1	25.2	22.4	12.7	21.1	8.6	19.0	35.3	19.7	25.6	19.1	25.5	17.8	18.5	12.8	20.4	28.2	20.6	23.4	12.6
DHX58	"D11LGP2, LGP2"	ENSG00000108771	"DExH-box helicase 58"	Q96C10	17	42101404-42112714	"Enzymes, Predicted intracellular proteins"	"Antiviral defense, Host-virus interaction, Immunity, Innate immunity"	"Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"monocytes: 39.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+: 45.5;BJ hTERT+ SV40 Large T+ RasG12V: 52.9;SK-MEL-30: 27.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA018670, HPA019570"	Approved		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 64: Macrophages - Immune response"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 3: Monocytes - Immune response regulation"	"Golgi apparatus, Cytosol"	Nucleoplasm	"HPA018670: AB_1847665, HPA019570: AB_1847666"	"prognostic favorable (3.45e-4)"	"unprognostic (1.03e-2)"	"unprognostic (3.56e-3)"	"unprognostic (1.54e-2)"	"unprognostic (2.45e-2)"	"unprognostic (4.82e-2)"	"unprognostic (2.05e-3)"	"unprognostic (5.45e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.15e-1)"	"unprognostic (6.02e-2)"	"unprognostic (3.72e-1)"	"unprognostic (1.27e-2)"	"unprognostic (8.65e-2)"	"unprognostic (8.01e-2)"	"unprognostic (2.31e-1)"	"unprognostic (4.31e-3)"	8.9	11.9	5.5	10.2	6.1	12.3	7.6	4.7	7.4	7.7	4.9	7.0	8.5	7.0	5.9	6.4	11.5	12.1	4.9	4.6	4.8	7.3	14.5	11.8	12.5	6.9	5.4	11.9	6.0	7.2	6.9	7.0	6.2	8.7	5.1	0.6	18.6	8.2	3.7	7.5	8.5	7.3	7.5	18.4	9.3	10.8	5.4	12.5	5.5	4.3	7.4	8.0	5.9	6.7	2.5	0.0	0.1	1.3	11.3	9.9	0.3	3.3	22.4	45.5	52.9	0.3	14.6	0.2	3.4	5.4	10.2	2.0	0.2	3.5	1.7	9.3	0.3	3.9	2.6	0.9	12.6	3.6	8.6	15.9	5.9	4.0	3.9	8.0	5.5	23.5	0.0	12.8	2.5	0.0	21.7	4.5	0.4	0.6	0.0	7.8	0.0	1.2	5.2	8.6	0.4	0.0	1.5	5.9	27.0	0.0	7.9	3.8	2.4	2.3	0.1	0.8	1.1	4.3	3.8	0.2	4.6	3.3	2.6	2.3	7.7	6.9	3.1	9.7	4.8	4.6	4.7	2.9	5.9	3.5	5.1	3.8	3.2	6.8	8.6	2.0	4.4	5.0	5.5	6.1	4.7	7.4	4.6	4.8	6.9	5.4	6.2	7.5	5.4	6.7	9.1	9.6	3.4	6.8	4.8	1.5	3.9	6.2	3.4	1.0	3.5	3.7	1.7	8.6	7.6	7.3	0.0	4.0	4.7	2.3	1.9	7.0	9.0	4.5	2.9	7.0	0.0	0.4	1.9	6.9	4.6	4.1	3.6	4.0	1.3	7.5	3.3	14.0	9.8	0.0	2.4	3.2	4.1	7.0	0.7	12.1	8.7	7.4	3.6	8.4	39.9	2.4	2.1	4.0	1.8	5.7	4.3	9.1	1.3	5.4	3.9	5.7	11.6	0.6	0.0	3.7	3.8	18.1	1.0	2.3	1.6	0.8	6.6	8.2	1.9	2.9
DHX8	"DDX8, Dhr2, HRH1, PRP22, PRPF22"	ENSG00000067596	"DEAH-box helicase 8"	Q14562	17	43483865-43610338	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049285	Approved		Supported	"Nucleoplasm,Nuclear bodies"	"Intracellular and membrane"	NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	"Nuclear bodies"	"HPA049285: AB_2680698"	"unprognostic (2.99e-1)"	"unprognostic (4.42e-2)"	"unprognostic (5.64e-2)"	"unprognostic (9.02e-2)"	"unprognostic (1.25e-1)"	"unprognostic (3.09e-1)"	"unprognostic (1.28e-3)"	"unprognostic (9.43e-2)"	"unprognostic (2.58e-1)"	"unprognostic (3.40e-2)"	"unprognostic (2.26e-2)"	"unprognostic (2.47e-1)"	"unprognostic (1.50e-1)"	"unprognostic (4.04e-1)"	"unprognostic (5.08e-3)"	"unprognostic (2.60e-1)"	"unprognostic (6.28e-2)"	20.4	18.5	25.9	18.0	25.8	55.0	20.5	24.7	36.7	22.4	22.8	21.4	17.3	19.9	26.1	26.9	16.7	16.4	21.8	25.4	24.8	20.3	18.6	20.0	23.7	25.6	25.2	17.0	17.0	27.5	20.8	20.9	25.5	21.6	23.9	16.8	20.8	20.4	22.6	33.7	20.6	23.6	23.4	25.8	19.5	24.3	25.8	35.1	19.0	19.4	29.6	23.0	21.7	25.5	29.2	81.7	43.3	52.4	42.3	42.5	24.0	30.2	62.0	64.9	61.7	37.4	28.1	40.3	27.0	59.4	46.6	38.0	65.9	53.1	74.8	40.8	51.9	33.8	61.2	56.7	35.8	59.8	49.5	21.1	44.1	53.0	58.4	31.4	57.4	52.1	38.8	35.2	51.2	32.0	75.9	52.7	35.5	35.4	31.0	46.2	82.4	40.2	44.3	60.6	37.3	56.0	33.9	18.6	27.3	50.9	44.1	58.3	40.0	50.3	26.9	36.3	45.8	27.5	36.6	44.7	41.2	36.8	41.2	30.2	17.4	20.4	16.0	25.2	14.7	12.2	12.7	15.5	17.0	11.0	10.6	11.5	21.8	11.0	26.1	10.3	12.8	11.4	25.9	25.8	24.7	36.7	25.4	24.8	25.6	25.2	25.5	23.4	25.8	25.5	17.1	6.4	15.0	6.5	18.6	11.9	7.1	12.4	12.0	16.9	16.3	13.0	13.2	7.2	19.2	22.0	18.8	9.1	23.6	13.4	13.7	16.2	19.4	18.3	26.2	17.6	26.7	13.7	10.7	17.7	8.8	14.5	14.8	23.9	14.5	15.3	16.1	14.7	11.1	6.7	10.5	15.3	10.2	14.8	11.5	10.6	12.5	18.4	17.8	14.0	24.8	10.6	21.6	9.5	15.8	21.2	16.0	10.9	20.0	9.4	10.1	12.4	13.7	19.8	19.7	20.3	14.4	27.9	16.8	17.2	13.4	21.2	20.9	11.1	10.8	14.3
DHX9	"DDX9, LKP, RHA"	ENSG00000135829	"DExH-box helicase 9"	Q08211	1	182839347-182887982	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Biological rhythms, DNA replication, Host-virus interaction, Immunity, Inflammatory response, Innate immunity, mRNA processing, mRNA splicing, mRNA transport, RNA-mediated gene silencing, Transcription, Transcription regulation, Transcription termination, Translation regulation, Transport"	"Activator, DNA-binding, Helicase, Hydrolase, RNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011819, HPA028050, HPA055684"	Supported		Supported	Nucleoplasm,Nucleoli		NA	NA		360000	"Cluster 27: Non-specific - Gene expression"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm	Nucleoli	"CAB011819: AB_777725, HPA028050: AB_10603564, HPA055684: AB_2682885"	"unprognostic (8.14e-2)"	"unprognostic (9.32e-2)"	"unprognostic (1.84e-2)"	"unprognostic (4.80e-2)"	"unprognostic (1.58e-1)"	"unprognostic (7.40e-2)"	"prognostic unfavorable (3.17e-4)"	"unprognostic (9.98e-2)"	"prognostic unfavorable (6.04e-4)"	"unprognostic (2.76e-1)"	"unprognostic (2.88e-2)"	"unprognostic (5.53e-2)"	"unprognostic (7.51e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.70e-1)"	"unprognostic (3.17e-1)"	"unprognostic (1.99e-1)"	38.7	30.5	13.6	47.4	15.8	131.4	53.2	19.0	19.7	43.7	17.0	40.2	32.6	49.4	33.0	32.2	45.9	31.1	28.5	13.1	16.0	49.9	36.9	38.6	56.9	15.2	13.6	52.8	30.5	68.2	21.1	44.6	16.3	39.6	47.1	66.5	32.5	44.3	30.3	31.1	36.3	50.8	16.6	40.9	34.5	50.4	14.6	88.7	48.0	37.7	70.2	54.0	30.0	25.5	165.7	158.8	223.0	122.3	113.7	87.8	219.2	143.5	130.3	203.6	137.0	175.8	124.2	264.3	133.7	129.6	121.7	138.8	342.6	155.2	225.7	108.3	169.5	176.4	121.0	119.6	62.5	258.3	115.0	78.6	75.8	200.4	53.4	91.6	161.7	132.9	281.8	91.9	165.1	142.3	263.6	61.1	282.8	173.9	96.8	236.0	208.0	151.0	127.0	187.8	160.0	183.2	203.2	125.0	83.2	186.4	148.4	140.9	127.6	125.3	138.8	128.9	195.9	93.6	167.2	305.0	79.0	137.0	174.5	7.7	21.3	16.1	23.4	22.5	26.2	20.5	19.8	21.1	29.9	16.6	21.6	23.7	8.0	20.0	19.7	14.2	20.1	21.2	13.6	15.8	19.0	19.7	13.1	16.0	15.2	13.6	16.3	16.6	14.6	25.5	43.6	41.7	74.1	59.1	54.5	53.7	61.2	42.7	38.7	59.6	43.3	38.9	43.9	30.0	60.8	51.5	52.1	50.9	70.2	38.6	19.6	49.0	26.8	79.2	67.4	50.7	53.8	74.5	49.4	50.8	47.5	48.0	37.8	109.8	44.9	67.7	36.0	28.0	40.8	28.6	55.5	40.9	30.5	35.4	35.1	45.8	60.3	44.7	30.2	55.3	55.9	42.7	42.2	55.3	70.3	52.3	28.0	47.0	52.4	48.3	35.4	38.0	67.7	77.1	39.5	73.9	54.1	69.9	68.2	51.7	47.2	49.5	59.2	60.9	54.4	55.4
DIAPH2	"DIA, DIA2, POF, POF2"	ENSG00000147202	"Diaphanous related formin 2"	O60879	X	96684663-97604997	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Differentiation, Oogenesis"	"Developmental protein"	"Premature ovarian failure"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 171.0;Late spermatids: 177.8;Microglial cells: 301.7;Oligodendrocyte precursor cells: 281.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005647, CAB015461, CAB068183, CAB068184"	Enhanced		Supported	"Nucleoli,Endoplasmic reticulum,Vesicles"		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 59: Non-specific - Translation"	"Cluster 32: U-937 - Innate immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Endoplasmic reticulum, Vesicles"	Nucleoli	"CAB015461: AB_831223, CAB068183: AB_2665693, CAB068184: AB_2665694, HPA005647: AB_1078657"	"unprognostic (5.75e-2)"	"unprognostic (4.13e-3)"	"unprognostic (1.48e-1)"	"prognostic unfavorable (2.16e-5)"	"unprognostic (1.58e-1)"	"unprognostic (6.48e-2)"	"unprognostic (4.06e-1)"	"unprognostic (1.07e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.43e-2)"	"prognostic unfavorable (2.12e-4)"	"unprognostic (3.39e-2)"	"prognostic unfavorable (3.90e-4)"	"unprognostic (6.44e-2)"	"unprognostic (3.11e-2)"	"unprognostic (6.99e-3)"	"unprognostic (6.08e-3)"	10.7	3.3	3.7	6.4	6.4	17.7	7.0	0.0	4.3	10.6	17.3	8.6	4.3	5.5	3.5	7.7	6.7	5.7	5.4	6.4	3.1	3.1	12.3	8.2	3.8	0.6	0.9	7.7	4.9	7.0	2.0	12.5	1.0	6.1	8.7	3.0	6.6	7.6	12.0	5.3	5.3	7.4	0.2	3.8	7.4	9.4	1.5	6.0	3.9	9.1	3.9	7.4	9.8	1.8	0.0	6.5	3.1	6.3	17.1	28.3	0.0	11.2	11.8	5.9	12.4	5.5	12.3	18.5	8.7	9.7	11.3	0.0	16.6	1.7	7.6	0.5	9.5	0.0	7.4	5.9	14.2	24.3	8.2	14.3	6.0	8.0	24.6	8.0	11.6	13.6	0.0	14.9	11.2	5.3	9.2	10.0	24.4	0.1	9.4	0.0	16.5	0.0	3.4	9.8	0.0	6.3	0.0	3.2	9.0	18.8	2.7	13.2	14.8	12.6	5.8	10.6	7.3	0.2	0.0	15.3	10.7	24.1	7.6	0.0	3.1	3.3	1.1	2.8	0.9	1.7	1.2	1.4	2.3	1.3	0.8	0.7	0.3	0.7	2.5	2.2	0.7	0.6	3.7	6.4	0.0	4.3	6.4	3.1	0.6	0.9	1.0	0.2	1.5	1.8	61.7	32.1	51.1	21.2	18.8	10.8	6.8	11.9	11.4	5.5	9.9	8.1	20.2	15.7	15.0	20.2	0.0	65.2	21.5	36.6	7.9	18.6	80.5	51.2	46.2	31.2	24.6	6.1	171.0	23.4	16.8	35.2	41.8	41.7	7.6	36.1	8.2	26.1	21.0	0.0	90.0	32.3	4.1	29.6	19.3	177.8	45.1	34.7	8.8	301.7	32.7	13.0	10.3	281.0	41.2	38.4	39.3	20.3	11.6	8.0	11.9	9.4	57.1	13.7	26.3	46.7	32.7	7.5	12.9	17.6	18.3	118.3	19.0	19.0	32.5	6.0
DIAPH3	"AN, AUNA1, DRF3, FLJ34705, NSDAN"	ENSG00000139734	"Diaphanous related formin 3"	Q9NSV4	13	59665583-60163928	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			"Cancer-related genes, Deafness, Neuropathy, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 7.1;testis: 18.9"	"Cell type enriched"	"Detected in many"	5	"Early spermatids: 414.4"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA032151			Supported	"Plasma membrane,Microtubules"		NA	Yes				"Cluster 23: Testis - Cell cycle regulation"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 29: Early spermatids - Spermatogenesis"	"Plasma membrane, Microtubules"		"HPA032151: AB_2674181"	"unprognostic (3.78e-2)"	"unprognostic (1.28e-2)"	"prognostic favorable (9.04e-4)"	"prognostic unfavorable (4.18e-4)"	"unprognostic (2.78e-1)"	"unprognostic (4.69e-2)"	"unprognostic (1.27e-4)"	"prognostic unfavorable (3.72e-4)"	"unprognostic (1.74e-2)"	"unprognostic (2.19e-1)"	"unprognostic (5.22e-5)"	"unprognostic (3.59e-3)"	"unprognostic (5.31e-5)"	"unprognostic (4.30e-2)"	"unprognostic (2.37e-1)"	"unprognostic (4.07e-1)"	"unprognostic (2.74e-3)"	0.4	0.1	0.1	1.7	0.2	7.1	0.8	0.3	0.3	0.3	0.2	1.9	1.9	0.6	0.0	2.1	0.1	0.4	0.1	0.1	0.2	0.8	0.2	1.2	2.4	0.2	0.3	0.1	0.2	0.1	0.0	3.5	0.2	0.1	2.1	0.0	0.5	0.0	0.0	1.3	1.6	2.6	0.1	0.5	1.6	18.9	0.3	5.4	0.1	0.0	2.4	0.6	0.7	0.2	47.7	15.6	15.8	9.1	2.7	7.1	26.9	65.0	28.7	64.2	55.6	41.7	31.4	15.9	5.2	33.4	16.7	31.7	26.0	25.5	96.9	18.0	17.9	22.7	37.6	9.5	4.1	31.2	17.4	2.8	0.6	39.2	26.3	16.3	29.2	14.0	17.8	21.9	61.8	6.9	28.0	10.2	14.7	22.5	8.9	18.8	38.9	12.9	19.9	9.6	8.3	14.3	33.2	22.8	9.5	33.8	16.7	16.8	29.3	40.5	25.9	13.7	54.5	14.7	17.1	24.4	10.9	15.2	31.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.2	0.3	0.3	0.1	0.2	0.2	0.3	0.2	0.1	0.3	0.2	0.6	54.5	3.4	39.8	1.9	3.7	0.8	2.1	2.8	0.0	3.9	1.5	1.0	2.8	1.8	0.0	0.0	21.1	1.1	3.8	5.9	1.3	414.4	2.5	3.5	2.1	0.0	26.7	5.6	4.0	30.7	5.8	9.7	9.3	0.0	78.8	1.8	0.4	6.1	0.0	3.3	2.6	2.0	1.0	1.2	56.0	0.6	1.5	0.0	5.6	0.1	3.5	2.1	19.1	1.8	1.5	0.2	0.0	18.9	0.4	1.1	5.4	0.2	0.0	0.0	0.0	7.9	39.2	17.8	11.6	1.1	7.3	2.2	2.8	5.6	1.5
DICER1	"Dicer, HERNA, K12H4.8-LIKE, KIAA0928, MNG1"	ENSG00000100697	"Dicer 1, ribonuclease III"	Q9UPY3	14	95086228-95158010	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Host-virus interaction, RNA-mediated gene silencing"	"Endonuclease, Helicase, Hydrolase, Nuclease, RNA-binding"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 418.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000694, CAB068185"	Approved		Supported	Cytosol		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	Cytosol		"CAB068185: AB_2665650, HPA000694: AB_1078661"	"unprognostic (2.97e-1)"	"unprognostic (2.70e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.72e-1)"	"unprognostic (6.75e-2)"	"unprognostic (9.62e-2)"	"unprognostic (1.96e-2)"	"unprognostic (7.73e-2)"	"unprognostic (1.21e-1)"	"unprognostic (8.52e-3)"	"unprognostic (5.73e-2)"	"unprognostic (9.22e-2)"	"unprognostic (4.22e-2)"	"unprognostic (9.07e-2)"	"unprognostic (2.58e-1)"	"unprognostic (6.04e-3)"	"unprognostic (3.74e-2)"	15.6	7.9	6.7	14.0	22.5	10.8	15.1	12.3	11.4	13.3	7.4	13.0	7.5	12.7	8.3	15.0	12.4	8.7	9.9	7.2	14.0	10.7	12.8	14.9	11.0	19.1	16.0	14.3	12.6	11.5	10.6	18.7	18.5	12.5	10.9	19.3	12.4	10.1	19.2	13.0	11.6	11.5	11.6	12.1	10.1	13.2	20.3	8.5	14.7	16.2	12.0	12.7	14.5	39.4	18.6	19.4	40.7	12.0	7.2	14.5	26.4	15.5	10.7	11.3	11.1	25.4	12.5	20.9	16.1	16.0	10.4	21.2	31.6	13.9	20.5	35.9	14.6	36.5	10.1	16.0	6.7	22.6	18.0	12.2	10.1	12.3	20.8	8.0	16.1	15.7	15.7	16.6	16.9	21.8	24.1	6.8	9.3	11.0	10.2	16.0	31.9	12.2	8.2	30.9	31.9	16.4	16.2	13.4	15.2	19.2	18.0	12.4	16.4	8.1	14.4	14.0	16.9	18.9	31.7	31.4	8.0	14.5	13.1	1.4	1.1	0.8	0.3	1.4	0.7	0.7	0.6	0.4	0.8	0.7	0.5	0.3	3.9	0.5	3.2	0.4	0.7	0.4	6.7	22.5	12.3	11.4	7.2	14.0	19.1	16.0	18.5	11.6	20.3	39.4	69.4	54.5	53.7	88.8	45.7	27.4	49.5	29.9	40.5	98.2	50.7	29.1	36.4	41.5	47.3	46.0	56.3	46.6	36.9	44.0	5.9	33.4	23.3	37.4	54.2	52.0	46.1	33.4	99.7	23.1	22.8	45.6	33.1	50.1	12.0	35.5	42.1	60.1	48.8	107.7	112.2	29.7	24.4	104.2	24.8	15.5	54.3	82.3	23.2	81.5	84.6	33.5	33.0	109.1	418.6	33.2	28.0	52.6	39.2	62.5	27.1	25.9	38.6	73.8	32.9	64.3	41.9	45.5	56.1	63.0	27.6	25.7	31.7	35.9	33.9	62.1
DIMT1	"DIMT1L, HSA9761"	ENSG00000086189	"DIMT1 rRNA methyltransferase and ribosome maturation factor"	Q9UNQ2	5	62347284-62403943	"Enzymes, Predicted intracellular proteins"	"rRNA processing"	"Methyltransferase, RNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Prostatic glandular cells: 104.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042944	Approved		Supported	"Nucleoplasm,Nucleoli,Nucleoli rim,Cytosol"		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 22: Epithelial cell types - Mixed function"	"Nucleoli, Nucleoli rim"	"Nucleoplasm, Cytosol"	"HPA042944: AB_2678234"	"unprognostic (1.58e-1)"	"unprognostic (2.27e-1)"	"unprognostic (6.02e-3)"	"unprognostic (7.16e-2)"	"unprognostic (8.95e-3)"	"unprognostic (1.73e-2)"	"prognostic unfavorable (6.93e-4)"	"unprognostic (8.88e-2)"	"unprognostic (1.18e-2)"	"unprognostic (1.62e-1)"	"unprognostic (5.31e-2)"	"unprognostic (3.70e-1)"	"prognostic unfavorable (8.90e-12)"	"unprognostic (8.89e-2)"	"unprognostic (2.89e-1)"	"unprognostic (1.49e-1)"	"unprognostic (5.15e-2)"	16.3	13.6	6.5	13.3	6.5	9.1	19.7	6.7	9.6	17.2	6.4	10.9	8.5	14.6	13.9	17.5	14.5	14.2	17.7	6.6	6.8	10.6	15.4	9.8	15.9	6.7	6.7	15.5	19.3	13.3	10.3	17.3	6.7	15.9	12.0	2.9	15.2	16.2	9.7	8.5	8.8	21.0	6.7	13.3	8.5	8.2	6.6	15.0	13.4	12.8	16.8	26.0	11.4	6.7	33.1	19.9	24.2	44.1	37.7	57.4	35.0	57.3	33.7	57.3	55.8	45.1	36.3	61.4	48.4	61.9	45.4	20.2	38.7	35.8	61.3	46.4	34.0	27.2	15.0	33.8	48.1	32.4	34.7	46.7	31.1	54.1	57.3	28.1	46.1	37.0	49.3	27.9	47.3	43.5	50.1	58.6	36.1	18.9	49.7	28.2	33.3	119.2	45.8	29.9	31.5	19.8	38.5	32.2	35.5	19.6	27.0	29.2	40.3	21.0	29.5	33.7	71.2	27.4	46.7	62.6	27.0	61.6	45.1	7.9	5.3	2.7	6.7	9.1	12.7	10.4	11.2	9.1	9.3	6.1	11.6	9.7	0.1	7.7	6.8	12.1	7.8	6.3	6.5	6.5	6.7	9.6	6.6	6.8	6.7	6.7	6.7	6.7	6.6	6.7	25.3	3.2	9.5	6.5	37.8	50.9	90.3	54.8	69.4	6.2	29.9	20.2	35.3	17.2	36.3	14.7	10.4	45.3	21.9	5.0	21.5	28.6	10.1	23.8	28.3	32.0	4.8	20.4	11.1	22.5	48.1	35.6	13.7	23.2	13.3	13.3	17.5	13.4	33.1	0.0	10.5	12.1	32.6	16.4	22.8	4.4	28.9	18.5	28.4	2.8	19.7	7.4	13.4	8.0	12.9	19.8	7.5	20.3	29.3	104.3	4.0	32.5	24.0	4.7	6.6	51.8	49.8	16.5	20.4	58.7	37.8	35.7	31.1	28.6	18.3	76.6
DIO3	TXDI3	ENSG00000197406	"Iodothyronine deiodinase 3"	P55073	14	101561351-101563452	"Enzymes, FDA approved drug targets, Metabolic proteins, Predicted membrane proteins"	"Thyroid hormones biosynthesis"	Oxidoreductase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix: 25.0;placenta: 17.8"	"Cell type enhanced"	"Detected in some"		"Endothelial cells: 7.8;Fibroblasts: 27.9;Leydig cells: 10.8;Muller glia cells: 8.1;Peritubular cells: 7.5;Skeletal myocytes: 16.3;Syncytiotrophoblasts: 28.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	10	"AF22: 54.2"	"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in some"		"amygdala: 4.4;hippocampal formation: 5.6"	HPA073684			Supported	Vesicles		NA	NA				"Cluster 89: Fibroblasts - ECM organization"	"Cluster 12: NES - Nervous system development"	"Cluster 33: Fibroblasts - ECM organization"	Vesicles		"HPA073684: "	"unprognostic (4.52e-3)"	"unprognostic (1.80e-1)"	"unprognostic (3.04e-3)"	"unprognostic (3.48e-1)"	"unprognostic (5.16e-2)"	"unprognostic (1.50e-1)"	"unprognostic (4.24e-2)"	"unprognostic (8.11e-2)"	"unprognostic (2.58e-1)"	"unprognostic (6.24e-2)"	"unprognostic (2.34e-1)"	"unprognostic (2.52e-1)"	"unprognostic (7.46e-5)"	"unprognostic (4.82e-3)"	"unprognostic (2.43e-1)"	"unprognostic (1.11e-4)"	"unprognostic (9.80e-3)"	5.0	0.4	0.5	1.8	1.2	0.0	3.2	0.2	1.2	25.0	0.2	1.7	0.0	6.5	0.6	1.8	6.7	3.0	0.6	0.6	0.2	0.3	3.9	2.6	1.3	1.3	0.3	13.6	1.5	0.0	0.7	17.8	0.3	3.2	0.4	0.7	1.7	2.2	1.6	3.5	1.7	0.9	0.4	0.6	1.6	1.3	3.3	0.2	4.1	3.0	0.1	5.2	15.4	0.4	0.0	0.2	54.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.1	0.6	0.0	0.0	0.1	0.0	0.0	1.0	1.3	0.8	0.0	0.0	5.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	1.2	0.2	1.2	0.6	0.2	1.3	0.3	0.3	0.4	3.3	0.4	0.4	0.0	0.0	0.0	0.0	0.4	0.0	0.2	0.0	0.0	0.1	0.6	0.4	0.0	0.0	0.0	0.0	1.9	0.0	5.9	0.0	0.6	0.3	0.4	4.9	7.8	0.0	0.0	0.1	0.0	2.5	27.9	0.0	0.1	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.5	0.0	0.0	0.7	0.6	10.8	0.1	0.0	0.0	0.6	8.1	0.0	0.0	0.0	0.9	1.1	7.5	0.0	0.8	0.0	0.0	0.0	0.2	0.0	16.3	0.7	0.1	0.2	0.2	0.1	28.3	0.2	0.1	0.3	0.4
DIS3	"dis3p, EXOSC11, KIAA1008, RRP44"	ENSG00000083520	"DIS3 homolog, exosome endoribonuclease and 3'-5' exoribonuclease"	Q9Y2L1	13	72752169-72782096	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"rRNA processing"	"Endonuclease, Exonuclease, Hydrolase, Nuclease, RNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 169.2;Late spermatids: 135.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039281, HPA058762"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 32: U-937 - Innate immune response"	"Cluster 34: Spermatids - Unknown function"	Nucleoplasm	Cytosol	"HPA039281: AB_10795583, HPA058762: AB_2683810"	"unprognostic (1.61e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.18e-1)"	"unprognostic (8.97e-2)"	"unprognostic (8.14e-2)"	"unprognostic (1.51e-2)"	"unprognostic (1.49e-1)"	"unprognostic (2.84e-1)"	"unprognostic (6.38e-2)"	"unprognostic (8.68e-2)"	"unprognostic (1.32e-3)"	"unprognostic (3.35e-3)"	"unprognostic (1.02e-1)"	"unprognostic (2.37e-2)"	"unprognostic (3.69e-2)"	"unprognostic (7.88e-2)"	"unprognostic (1.03e-1)"	13.8	9.9	5.3	12.4	5.7	20.4	15.8	9.1	6.7	11.3	7.1	10.0	8.5	11.2	11.5	12.4	9.9	10.4	11.6	5.2	5.9	12.8	16.6	11.4	17.6	5.2	5.6	13.4	8.9	11.9	8.9	12.0	5.3	12.3	10.9	12.1	9.4	10.5	10.2	11.1	9.9	11.0	5.5	12.2	9.9	21.3	6.3	14.1	15.0	10.4	17.3	14.1	10.8	6.9	29.5	13.4	25.9	21.9	26.9	31.9	17.0	25.5	31.0	25.6	31.1	20.7	23.8	35.6	21.6	26.3	16.2	23.8	35.7	29.4	40.9	29.3	26.3	41.8	27.8	18.7	33.4	71.4	23.2	33.4	20.1	29.0	37.9	25.5	27.8	26.6	28.3	14.4	31.4	10.3	30.5	34.8	24.3	44.7	15.7	24.2	19.7	16.2	25.4	23.2	23.3	30.8	20.9	17.3	25.4	26.8	16.7	32.1	26.1	15.4	12.5	17.5	27.4	27.6	33.2	28.0	42.9	33.2	22.7	8.4	3.6	5.2	4.0	6.3	5.6	4.2	5.0	4.5	4.3	3.7	4.9	4.5	2.1	6.9	5.2	2.7	6.7	3.2	5.3	5.7	9.1	6.7	5.2	5.9	5.2	5.6	5.3	5.5	6.3	6.9	51.6	35.3	37.2	12.4	35.3	25.5	36.5	24.5	18.2	38.8	27.6	26.4	27.6	21.5	40.2	9.2	29.2	23.8	45.0	19.0	23.5	21.7	169.2	26.2	37.6	41.2	30.5	18.7	21.5	20.1	23.5	33.3	19.9	45.6	33.6	26.3	26.7	23.7	14.4	32.0	24.0	17.2	18.3	19.2	13.8	135.5	28.9	21.4	12.4	24.4	38.2	23.6	25.7	17.6	24.2	25.4	8.1	28.2	30.2	27.4	16.3	17.2	35.4	41.6	6.6	58.3	27.0	28.9	37.7	31.4	31.3	22.6	33.7	29.1	21.2	53.9
DIS3L	"DIS3L1, FLJ38088, KIAA1955, MGC4562"	ENSG00000166938	"DIS3 like exosome 3'-5' exoribonuclease"	Q8TF46	15	66293217-66333898	"Predicted intracellular proteins"		"Exonuclease, Hydrolase, Nuclease, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041805	Approved		Supported	"Plasma membrane,Centrosome,Cytosol"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 52: Non-specific - Ribosome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	"Plasma membrane, Cytosol"	Centrosome	"HPA041805: AB_10796783"	"unprognostic (2.57e-1)"	"unprognostic (5.37e-2)"	"unprognostic (1.12e-1)"	"unprognostic (3.99e-2)"	"unprognostic (3.16e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.68e-1)"	"unprognostic (2.94e-2)"	"unprognostic (2.27e-2)"	"unprognostic (1.28e-2)"	"unprognostic (1.59e-3)"	"unprognostic (1.86e-1)"	"unprognostic (3.42e-3)"	"unprognostic (2.66e-1)"	"unprognostic (6.18e-2)"	"unprognostic (9.58e-2)"	"unprognostic (3.40e-1)"	11.0	11.8	7.9	6.2	9.8	7.6	9.3	8.9	8.6	10.3	7.7	11.1	5.1	11.1	9.5	7.5	9.6	5.5	12.7	8.0	9.1	8.3	11.0	5.9	7.6	8.7	9.4	11.1	12.8	15.8	10.0	5.4	9.6	8.7	6.0	11.4	8.9	9.0	23.2	7.4	7.7	8.8	8.8	8.7	9.0	9.8	8.9	7.8	11.0	28.3	7.2	9.6	8.1	12.2	14.0	32.6	10.6	14.1	12.2	16.4	12.4	9.5	11.1	14.3	13.2	17.6	10.1	51.6	10.3	13.4	14.9	23.3	25.7	9.2	9.2	12.0	24.1	26.7	25.1	20.1	9.5	27.7	10.1	6.9	9.7	4.5	14.8	9.7	13.1	17.7	18.6	12.6	14.4	12.3	13.8	17.3	15.4	12.7	20.0	18.3	42.1	30.0	5.7	18.9	17.1	15.7	22.3	7.6	11.4	10.0	10.6	21.8	14.4	18.7	16.8	7.4	18.7	10.1	36.9	24.0	6.4	35.9	7.8	8.5	5.1	4.3	7.6	6.1	10.2	6.5	7.7	10.0	8.5	7.8	8.8	7.3	0.6	11.7	13.2	6.7	8.0	6.7	7.9	9.8	8.9	8.6	8.0	9.1	8.7	9.4	9.6	8.8	8.9	12.2	7.1	6.4	16.2	22.5	14.6	4.2	5.5	4.0	17.1	15.6	9.4	7.6	30.3	15.7	7.1	3.7	4.2	17.0	9.6	5.0	5.9	6.5	7.1	8.3	14.6	10.2	3.0	24.2	11.4	3.5	4.5	12.4	10.7	7.3	16.5	25.1	7.1	19.2	9.6	10.1	17.2	10.6	8.2	12.3	7.8	9.9	19.9	10.1	1.8	13.1	14.4	17.7	12.3	22.6	23.1	3.3	5.1	20.3	18.4	4.8	5.4	9.8	8.1	23.2	19.7	9.5	10.1	28.5	17.2	12.1	5.4	3.7	16.0	16.5	14.0	3.8
DISC1		ENSG00000162946	"DISC1 scaffold protein"	Q9NRI5	1	231626790-232041272	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Neurogenesis, Wnt signaling pathway"	"Developmental protein"	Schizophrenia	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 21.7"	"Cell type enriched"	"Detected in many"	4	"Rod photoreceptor cells: 113.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"THP-1: 11.4;TIME: 8.7;WM-115: 8.8"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA048911			Supported	"Intermediate filaments,Cytosol"		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 46: Photoreceptor cells - Phototransduction"	"Intermediate filaments, Cytosol"		"HPA048911: AB_2732549"	"unprognostic (1.08e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.58e-1)"	"unprognostic (2.98e-1)"	"unprognostic (2.57e-2)"	"unprognostic (3.36e-2)"	"unprognostic (6.69e-3)"	"unprognostic (1.41e-1)"	"unprognostic (9.49e-2)"	"unprognostic (1.71e-1)"	"unprognostic (8.89e-2)"	"unprognostic (9.53e-2)"	"unprognostic (1.31e-4)"	"unprognostic (1.74e-2)"	"unprognostic (2.02e-1)"	"unprognostic (5.94e-2)"	"unprognostic (1.94e-1)"	2.4	1.4	5.3	3.1	5.4	2.6	1.9	3.9	5.6	2.1	2.6	1.5	1.1	1.5	0.5	1.3	1.1	2.6	9.0	4.2	4.9	1.1	1.4	1.7	2.4	6.9	5.8	4.4	0.8	1.1	1.0	7.3	6.9	1.2	1.2	21.7	2.0	0.9	1.4	1.2	1.3	1.4	5.6	2.9	1.0	0.9	7.3	3.1	1.8	1.1	1.7	1.6	1.3	7.7	0.0	0.4	4.0	0.1	0.1	0.3	2.8	1.6	3.6	4.1	3.5	1.4	0.8	0.1	4.8	1.3	1.0	0.0	0.3	0.1	3.7	2.6	1.7	2.2	0.3	4.0	0.5	3.7	5.1	2.2	0.7	1.4	1.2	2.8	3.8	2.7	0.0	1.4	4.6	0.4	1.1	5.6	2.0	0.0	1.5	2.7	1.1	0.4	0.1	0.0	0.7	2.2	1.4	0.0	2.4	1.0	0.0	11.4	8.7	2.1	2.3	1.0	0.9	0.9	0.7	0.0	1.7	5.6	8.8	0.1	0.8	0.0	0.2	0.8	0.1	0.0	0.4	0.0	1.0	0.1	0.4	0.1	0.7	0.2	0.4	0.6	0.1	0.2	5.3	5.4	3.9	5.6	4.2	4.9	6.9	5.8	6.9	5.6	7.3	7.7	6.7	0.0	1.1	0.0	2.1	0.9	0.5	0.7	3.4	23.3	2.0	1.8	7.2	0.0	1.2	3.7	8.4	8.0	2.0	0.5	0.0	0.6	16.6	3.4	2.1	6.7	0.0	2.1	0.0	1.1	0.8	3.0	0.0	4.5	7.0	8.0	10.0	0.0	11.3	0.0	0.0	0.1	0.0	13.0	12.6	23.2	0.9	13.7	3.6	0.0	5.6	2.4	2.1	0.0	0.0	2.0	0.3	1.5	2.1	0.7	0.0	0.2	2.5	113.1	0.0	4.6	2.7	1.4	1.6	0.5	1.1	2.5	5.8	8.1	0.7	0.6
DIXDC1	"Dixin, KIAA1735"	ENSG00000150764	"DIX domain containing 1"	Q155Q3	11	111927144-112022653	"Predicted intracellular proteins"	"Wnt signaling pathway"	"Actin-binding, Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 104.3;Horizontal cells: 121.1;Oligodendrocytes: 140.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	11	"eosinophil: 5.2"	"Lineage enriched"	"Detected in single"	11	"granulocytes: 5.2"	"Cell line enhanced"	"Detected in many"		"hTERT-HME1: 42.7;TIME: 50.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039424, HPA039658, HPA061366"	Approved		Supported	Cytosol		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 9: Photoreceptor cells - Phototransduction"	Cytosol		"HPA039424: AB_2676500, HPA039658: AB_2676611, HPA061366: "	"unprognostic (1.93e-1)"	"unprognostic (2.90e-2)"	"unprognostic (8.93e-3)"	"unprognostic (2.84e-1)"	"unprognostic (2.98e-2)"	"unprognostic (1.44e-1)"	"unprognostic (2.37e-1)"	"unprognostic (1.41e-1)"	"unprognostic (7.23e-2)"	"unprognostic (1.59e-1)"	"unprognostic (7.85e-2)"	"unprognostic (5.11e-2)"	"prognostic favorable (6.89e-5)"	"unprognostic (4.10e-2)"	"unprognostic (2.11e-1)"	"unprognostic (2.52e-2)"	"prognostic unfavorable (4.19e-5)"	17.8	17.7	16.4	8.6	23.2	0.7	15.0	36.8	22.6	18.7	22.8	29.5	5.6	24.8	18.6	12.7	20.4	12.6	23.3	17.0	16.9	11.4	7.0	9.4	2.6	20.1	21.8	15.8	3.8	17.1	7.1	10.8	19.1	23.4	10.0	22.0	7.8	35.8	13.7	5.4	9.1	25.6	18.0	2.9	14.9	19.1	19.7	2.6	10.7	12.3	2.5	25.3	12.0	34.4	0.8	3.7	9.9	18.5	29.9	17.5	2.1	7.7	5.3	2.9	5.2	0.6	2.0	1.6	2.0	21.5	3.4	0.9	4.4	2.4	2.9	6.4	3.7	0.8	5.8	10.3	4.6	5.3	0.7	14.2	19.3	6.3	42.7	21.5	30.6	4.0	5.2	0.6	11.9	0.9	3.3	4.6	5.9	0.8	6.6	1.6	2.9	6.1	12.1	0.3	8.0	16.7	5.7	4.6	2.5	4.3	6.8	2.0	50.4	13.1	5.6	2.4	12.9	1.2	5.5	0.8	7.2	13.5	4.7	0.0	0.1	5.2	0.3	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.4	0.4	0.4	0.0	0.0	0.0	0.0	0.1	16.4	23.2	36.8	22.6	17.0	16.9	20.1	21.8	19.1	18.0	19.7	34.4	12.8	16.0	10.3	40.1	0.4	6.4	16.3	4.1	11.4	22.3	23.7	28.8	35.6	7.2	10.1	18.4	104.3	1.4	0.9	2.6	15.6	6.4	23.1	32.1	48.6	28.1	2.4	2.1	47.7	7.7	5.1	32.8	11.7	11.3	1.3	6.3	62.8	19.3	1.7	121.1	83.8	13.9	6.1	3.4	5.3	17.5	39.7	1.5	12.4	20.6	1.0	30.2	0.0	34.7	140.4	7.0	6.2	36.9	2.0	10.8	2.7	15.4	35.5	69.2	13.1	25.3	31.8	62.3	16.4	3.3	4.1	1.4	2.0	3.5	4.5	3.1
DKC1	"Cbf5, DKC, dyskerin, NAP57, NOLA4, XAP101"	ENSG00000130826	"Dyskerin pseudouridine synthase 1"	O60832	X	154762742-154777689	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Ribosome biogenesis, rRNA processing"	"Isomerase, Ribonucleoprotein, RNA-binding"	"Disease variant, Dyskeratosis congenita"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-698: 707.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000166, HPA000447, HPA001022, CAB033086"	Supported		Supported	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA		34000	"Cluster 27: Non-specific - Gene expression"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoli fibrillar center"	Nucleoplasm	"CAB033086: AB_2091314, HPA000166: AB_1078669, HPA000447: AB_1078667, HPA001022: AB_2666175"	"unprognostic (9.87e-3)"	"unprognostic (1.14e-1)"	"unprognostic (1.49e-1)"	"prognostic unfavorable (2.66e-5)"	"unprognostic (2.86e-1)"	"prognostic unfavorable (2.94e-4)"	"prognostic unfavorable (1.39e-5)"	"unprognostic (7.02e-2)"	"prognostic unfavorable (9.13e-4)"	"unprognostic (2.53e-2)"	"unprognostic (2.35e-2)"	"unprognostic (2.63e-2)"	"prognostic unfavorable (1.46e-9)"	"unprognostic (5.28e-2)"	"unprognostic (1.47e-1)"	"unprognostic (4.04e-1)"	"unprognostic (2.55e-1)"	23.5	20.4	17.1	29.9	18.1	68.8	35.3	18.3	20.5	21.3	18.9	28.5	24.2	23.2	22.3	36.4	24.4	15.3	19.4	17.0	18.4	21.7	22.6	16.5	40.2	17.9	18.2	30.8	32.6	26.5	17.6	23.2	18.8	22.2	34.8	19.8	22.0	18.9	31.2	30.6	21.3	22.8	18.0	25.7	21.5	25.3	18.1	39.4	27.8	23.2	47.8	36.8	23.8	19.7	236.5	129.3	77.4	111.4	47.2	48.2	114.9	87.2	60.5	127.2	118.9	164.3	114.2	447.2	221.3	74.7	119.4	123.5	239.6	144.8	189.3	108.8	132.9	223.4	131.1	143.3	66.9	304.6	131.2	46.3	135.6	141.1	320.8	46.6	89.7	146.2	210.1	108.0	88.0	137.7	201.5	233.7	130.2	234.0	158.8	177.1	174.1	230.3	80.4	132.0	170.0	84.4	77.8	133.3	122.7	75.0	68.1	120.8	70.8	91.4	138.2	119.3	292.6	199.8	290.5	707.7	62.2	316.5	102.0	10.8	25.0	33.1	38.6	30.1	48.8	44.2	31.1	41.6	35.5	31.3	40.7	39.1	7.4	41.2	31.2	25.5	26.5	30.3	17.1	18.1	18.3	20.5	17.0	18.4	17.9	18.2	18.8	18.0	18.1	19.7	21.6	25.6	32.3	5.9	47.6	99.7	76.2	45.4	60.3	31.6	39.2	34.0	32.0	25.8	35.2	25.8	14.6	56.6	34.8	17.7	41.1	62.8	2.7	22.4	39.8	39.7	34.1	84.1	6.4	45.3	74.8	36.4	23.0	24.1	56.8	70.0	13.6	26.0	44.5	23.5	7.1	35.9	54.9	21.6	36.4	7.9	25.7	25.8	49.8	7.5	36.4	34.8	29.9	7.5	7.7	47.3	14.8	28.6	45.1	131.2	9.5	25.6	26.7	28.5	13.1	37.8	42.6	41.0	87.2	69.9	98.3	34.2	35.9	59.6	49.9	57.9
DKK2		ENSG00000155011	"Dickkopf WNT signaling pathway inhibitor 2"	Q9UBU2	4	106921802-107283806	"Predicted intracellular proteins, Predicted secreted proteins"	"Wnt signaling pathway"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix: 15.2"	"Cell type enhanced"	"Detected in some"		"Basal keratinocytes: 7.6;Fibroblasts: 18.7;Hofbauer cells: 16.8;Inhibitory neurons: 32.5;Langerhans cells: 11.8;Suprabasal keratinocytes: 7.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	6	"SH-SY5Y: 22.1"	"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"cerebral cortex: 1.5;midbrain: 5.0;pons: 6.3;thalamus: 5.7"	"CAB009727, HPA052611"	Uncertain		Supported	"Golgi apparatus"	"Secreted in other tissues"	NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 50: Fibroblasts - ECM organization"	"Golgi apparatus"		"CAB009727: AB_2091492, HPA052611: AB_2732576"	"unprognostic (3.14e-3)"	"unprognostic (1.03e-1)"	"unprognostic (2.48e-1)"	"unprognostic (3.21e-2)"	"unprognostic (9.75e-2)"	"unprognostic (3.68e-1)"	"unprognostic (1.04e-3)"	"unprognostic (2.47e-2)"	"unprognostic (5.11e-1)"	"unprognostic (5.21e-2)"	"unprognostic (3.21e-1)"	"unprognostic (3.52e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.42e-1)"	"unprognostic (6.86e-2)"	"unprognostic (3.22e-1)"	"unprognostic (4.58e-2)"	1.4	0.8	0.4	0.4	1.4	0.0	3.0	0.0	1.5	15.2	1.2	1.7	0.0	1.0	0.4	1.2	0.5	0.7	2.2	0.7	0.6	0.2	0.2	5.3	0.7	0.9	4.5	4.4	0.2	0.6	1.5	2.8	0.3	2.3	0.5	0.4	1.3	1.7	1.9	4.7	0.3	0.6	0.2	1.3	0.1	0.1	2.3	1.0	0.9	1.2	3.0	0.2	0.8	0.8	0.0	0.0	3.6	0.0	0.6	0.3	0.0	0.1	0.3	0.3	0.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.1	1.0	0.4	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.3	0.0	0.6	0.0	0.5	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	22.1	0.0	0.0	0.1	0.0	0.0	2.8	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.4	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1.4	0.0	1.5	0.7	0.6	0.9	4.5	0.3	0.2	2.3	0.8	2.6	0.0	0.0	0.3	0.0	7.6	0.0	0.0	0.0	0.0	0.1	0.1	0.6	0.0	0.0	1.8	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	1.1	5.4	0.0	0.0	5.2	0.0	0.2	18.7	0.0	0.1	0.0	0.0	3.3	0.0	16.8	0.0	32.5	0.0	0.0	0.3	11.8	0.0	4.1	0.3	7.2	2.8	0.0	0.0	0.0	0.5	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.9	0.0	0.0	0.0	7.4	0.0	0.8	2.0	0.0	0.0
DKK3	"REIC, RIG"	ENSG00000050165	"Dickkopf WNT signaling pathway inhibitor 3"	Q9UBP4	11	11956207-12009769	"Plasma proteins, Predicted secreted proteins"	"Wnt signaling pathway"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"heart muscle: 1224.0"	"Group enriched"	"Detected in many"	7	"Cardiomyocytes: 884.3;Muller glia cells: 1960.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"MAIT T-cell: 6.2;memory CD8 T-cell: 3.8"	"Lineage enriched"	"Detected in single"	62	"T-cells: 6.2"	"Cell line enhanced"	"Detected in many"		"BJ: 418.9;BJ hTERT+: 643.0;fHDF/TERT166: 614.4;hTERT-RPE1: 370.2;TIME: 349.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011868, CAB024949"	Approved		Supported	"Nuclear bodies,Vesicles,Cytosol"	"Secreted in other tissues"	No	No		18000000	"Cluster 16: MAIT-cells - Unknown function"	"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 5: Muller glia cells - Visual perception"	Vesicles	"Nuclear bodies, Cytosol"	"CAB024949: , HPA011868: AB_1847716"	"unprognostic (4.24e-2)"	"unprognostic (6.40e-2)"	"unprognostic (1.96e-1)"	"unprognostic (7.84e-2)"	"unprognostic (3.06e-3)"	"unprognostic (6.58e-3)"	"unprognostic (1.14e-2)"	"unprognostic (1.58e-1)"	"unprognostic (3.31e-3)"	"unprognostic (5.28e-2)"	"unprognostic (4.51e-2)"	"unprognostic (3.87e-2)"	"prognostic unfavorable (6.31e-5)"	"unprognostic (7.41e-3)"	"unprognostic (1.09e-1)"	"unprognostic (2.97e-2)"	"unprognostic (1.02e-3)"	31.2	79.1	110.7	10.0	183.6	0.2	26.0	12.6	135.2	89.7	104.8	53.2	14.6	47.0	16.7	29.7	23.0	67.0	1224.0	147.7	80.2	17.0	5.6	123.7	8.5	95.1	54.3	38.1	18.2	34.2	38.2	25.0	46.8	59.4	13.0	204.1	30.9	78.1	7.8	29.7	24.6	43.1	83.9	33.2	31.7	30.9	99.9	4.7	16.4	18.8	5.4	40.9	48.3	121.6	1.5	13.1	18.1	0.1	15.3	29.7	0.6	418.9	643.0	182.4	205.5	9.6	3.2	0.0	44.8	614.4	96.8	64.4	1.5	181.9	69.5	0.1	0.5	0.0	1.7	0.0	113.6	0.0	0.3	45.3	60.0	61.9	151.3	370.2	195.3	0.0	0.2	0.4	256.4	0.0	0.1	0.4	8.6	0.0	0.5	0.1	1.2	0.1	62.5	0.6	0.5	53.2	2.0	0.0	0.2	47.9	0.2	0.5	349.7	107.5	82.8	11.2	110.3	0.1	0.0	0.3	18.1	0.0	103.5	0.0	0.0	0.0	0.5	0.0	6.2	0.0	0.6	3.8	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.3	110.7	183.6	12.6	135.2	147.7	80.2	95.1	54.3	46.8	83.9	99.9	121.6	5.8	3.2	3.0	94.3	0.1	45.6	59.5	70.3	93.4	31.6	3.2	103.2	884.3	0.0	12.8	0.0	12.5	0.5	0.4	0.0	0.0	0.8	104.3	0.7	8.4	32.9	1.8	0.0	90.4	0.2	0.8	106.1	7.1	0.6	1.3	17.0	66.8	0.4	20.4	13.5	83.7	0.1	0.0	1.3	12.5	88.5	20.5	1.4	64.0	38.4	0.0	1960.4	0.0	27.6	14.7	1.1	0.1	57.6	1.7	32.8	0.0	0.2	2.9	67.5	190.7	12.7	83.4	1.2	3.2	5.8	14.8	0.8	4.1	0.5	0.3	3.0
DLAT	"DLTA, E2, PDC-E2"	ENSG00000150768	"Dihydrolipoamide S-acetyltransferase"	P10515	11	112025408-112064404	"Citric acid cycle related proteins, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Carbohydrate metabolism, Glucose metabolism, Tricarboxylic acid cycle"	"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"tongue: 89.4"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 100.5;Distal tubular cells: 74.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003782, HPA040786, HPA062766"	Supported		Supported	Mitochondria		NA	NA		44000	"Cluster 44: Non-specific - Transcription"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"CAB003782: , HPA040786: AB_2677136, HPA062766: AB_2684864"	"unprognostic (4.57e-3)"	"unprognostic (1.75e-1)"	"prognostic favorable (6.19e-6)"	"unprognostic (7.68e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.70e-2)"	"prognostic unfavorable (7.49e-5)"	"unprognostic (8.68e-2)"	"unprognostic (5.36e-2)"	"unprognostic (2.93e-1)"	"unprognostic (2.23e-3)"	"unprognostic (6.25e-2)"	"prognostic favorable (1.95e-14)"	"unprognostic (5.82e-2)"	"unprognostic (4.12e-2)"	"unprognostic (2.17e-1)"	"unprognostic (6.15e-2)"	24.7	16.5	7.7	13.3	8.3	7.9	14.5	9.5	9.3	11.0	10.4	24.7	18.3	10.0	13.4	19.5	13.0	8.5	69.4	8.1	11.1	33.8	15.5	11.7	16.1	8.3	8.9	9.5	6.8	31.7	8.5	13.1	9.7	14.5	26.0	10.8	16.8	14.8	75.4	10.3	16.5	13.4	8.2	9.9	14.3	9.9	9.4	12.7	20.2	89.4	18.2	14.2	8.1	8.0	18.7	16.4	28.2	34.4	41.6	30.5	26.5	26.6	18.2	34.8	38.7	52.8	56.7	85.4	46.0	28.7	42.6	41.0	65.7	34.2	38.9	27.3	30.2	51.9	17.9	39.2	29.0	64.9	26.6	36.9	37.7	32.0	35.2	24.2	33.9	41.7	88.4	42.6	41.2	16.6	25.4	66.9	30.3	58.6	35.4	45.4	38.0	93.3	64.4	21.4	51.2	27.8	30.7	93.4	20.5	30.9	67.4	42.9	17.8	29.1	29.1	29.1	33.0	11.1	19.4	127.5	7.7	73.0	22.7	9.1	3.8	3.0	4.3	5.8	5.4	5.6	4.9	5.1	5.8	4.0	5.6	5.1	0.3	4.7	6.1	4.5	5.8	5.0	7.7	8.3	9.5	9.3	8.1	11.1	8.3	8.9	9.7	8.2	9.4	8.0	7.6	12.8	14.5	15.3	13.8	11.2	9.2	18.2	14.2	8.1	9.2	5.8	100.5	15.7	13.2	11.0	0.0	21.2	6.4	26.3	74.3	18.7	3.9	15.8	11.6	9.6	17.3	18.1	18.0	11.4	39.6	11.7	11.7	12.1	3.8	13.5	7.5	15.5	18.7	8.4	24.4	17.8	24.4	8.8	7.5	3.2	6.2	9.5	17.8	9.4	16.7	10.4	4.1	11.1	19.7	14.1	9.2	10.9	19.4	7.0	19.0	37.6	30.3	11.1	0.0	14.2	19.9	25.1	18.3	21.1	9.8	17.4	8.5	26.3	26.7	9.3
DLC1	"ARHGAP7, DLC-1, HP, p122-RhoGAP, STARD12"	ENSG00000164741	"DLC1 Rho GTPase activating protein"	Q96QB1	8	13083361-13604610	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"		"GTPase activation"	"Cancer-related genes, Tumor suppressor"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 250.0;Alveolar cells type 2: 225.9;Excitatory neurons: 208.8;Microglial cells: 317.6;Oligodendrocyte precursor cells: 244.3;Oligodendrocytes: 707.2;Sertoli cells: 223.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	9	"basophil: 4.3;non-classical monocyte: 1.1"	"Group enriched"	"Detected in many"	19	"granulocytes: 4.3;monocytes: 1.1"	"Cell line enhanced"	"Detected in many"		"HBF TERT88: 83.2;U-2197: 98.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017753	Uncertain		Approved	Nucleoplasm,Vesicles,Cytosol		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 18: U-2197 - ECM organization"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Vesicles, Cytosol"	Nucleoplasm	"HPA017753: AB_10600805"	"unprognostic (1.83e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.29e-1)"	"prognostic favorable (1.11e-4)"	"unprognostic (7.47e-2)"	"unprognostic (1.39e-1)"	"unprognostic (3.11e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.12e-1)"	"unprognostic (8.46e-3)"	"unprognostic (6.49e-2)"	"unprognostic (2.02e-2)"	"unprognostic (3.56e-3)"	"unprognostic (2.79e-2)"	"unprognostic (7.33e-2)"	"unprognostic (1.67e-1)"	52.5	10.6	17.8	8.8	28.7	2.6	29.6	21.8	18.2	13.5	4.8	19.6	5.6	16.1	5.3	6.3	14.7	19.1	21.5	22.9	21.3	13.7	20.4	42.9	3.8	27.8	23.5	9.5	9.0	6.1	5.3	24.2	29.0	6.7	6.2	1.5	5.6	4.2	7.2	7.1	11.5	19.1	18.8	16.4	13.6	4.0	22.5	2.1	15.7	10.3	1.8	15.4	11.1	38.0	0.1	0.7	6.6	0.0	69.4	35.5	20.3	39.3	33.7	40.7	48.6	11.5	6.6	0.0	9.7	51.4	39.4	6.6	4.3	7.4	83.2	0.0	7.2	39.5	0.1	21.7	31.8	0.0	13.7	36.6	0.6	62.6	46.7	43.3	46.7	0.1	2.7	0.0	33.6	0.8	0.0	0.0	0.7	1.4	4.7	0.0	0.0	0.0	19.7	24.4	0.0	2.9	0.0	1.1	31.8	27.4	0.0	0.0	61.7	45.5	18.8	98.7	15.3	0.1	0.0	0.0	31.6	0.3	63.4	4.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	17.8	28.7	21.8	18.2	22.9	21.3	27.8	23.5	29.0	18.8	22.5	38.0	171.7	250.0	225.9	177.3	2.3	14.8	2.5	4.8	5.2	0.9	9.3	8.3	37.8	24.3	19.7	3.7	0.0	7.8	0.6	0.4	1.9	3.1	8.4	15.3	36.1	138.4	1.2	25.2	208.8	4.4	2.3	74.2	4.6	27.3	68.2	0.1	193.1	25.7	3.6	13.5	151.8	1.2	0.0	18.6	17.0	4.3	72.4	6.2	24.9	317.6	0.2	1.0	0.0	244.3	707.2	3.0	1.3	36.1	1.9	1.4	6.1	1.9	3.0	1.9	223.5	50.0	138.0	6.2	11.4	1.8	9.2	2.7	3.6	31.1	2.9	1.7
DLD	"DLDH, E3, GCSL, LAD, OGDC-E3"	ENSG00000091140	"Dihydrolipoamide dehydrogenase"	P09622	7	107891162-107931730	"Citric acid cycle related proteins, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"tongue: 357.0"	"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 356.2;Distal tubular cells: 226.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044849	Supported		Approved	Nucleoplasm,Mitochondria		NA	NA		10000000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria	Nucleoplasm	"HPA044849: AB_2679111"	"unprognostic (2.01e-3)"	"unprognostic (2.26e-1)"	"unprognostic (1.27e-2)"	"unprognostic (9.27e-2)"	"unprognostic (5.01e-3)"	"unprognostic (9.27e-2)"	"unprognostic (2.48e-1)"	"unprognostic (2.83e-2)"	"unprognostic (1.19e-1)"	"unprognostic (3.95e-2)"	"unprognostic (9.43e-2)"	"unprognostic (7.35e-2)"	"prognostic favorable (7.58e-9)"	"unprognostic (4.08e-2)"	"unprognostic (1.88e-1)"	"unprognostic (4.45e-3)"	"unprognostic (1.18e-1)"	108.7	98.9	22.7	42.1	23.7	54.0	49.0	27.1	29.1	36.3	35.6	109.0	81.8	45.3	21.2	94.1	34.3	48.5	264.1	23.1	29.5	153.3	112.8	39.3	50.1	27.1	27.4	30.0	49.2	136.7	27.8	43.1	26.6	45.7	99.3	35.0	50.2	50.3	295.0	38.9	71.9	67.7	24.9	38.4	80.5	31.3	25.7	43.2	64.2	357.0	67.5	66.1	32.7	23.4	171.4	134.5	74.8	127.9	104.6	91.4	88.4	96.5	80.8	110.6	86.2	159.5	95.5	165.9	159.6	103.0	177.7	110.9	150.2	135.8	166.1	111.1	88.4	116.9	175.6	116.7	80.3	194.7	116.0	104.8	97.6	116.4	63.4	72.3	134.0	137.0	298.5	119.7	121.8	188.1	161.8	138.9	87.4	206.0	98.2	113.1	117.8	225.9	151.8	250.8	92.3	99.9	156.3	262.1	143.9	149.9	100.5	165.8	87.9	120.7	97.3	238.1	149.4	89.3	187.1	114.6	115.0	204.1	130.2	132.7	63.9	136.0	46.9	81.6	49.4	37.8	46.8	46.8	87.2	38.5	47.9	50.5	39.9	68.1	116.9	29.9	49.0	64.2	22.7	23.7	27.1	29.1	23.1	29.5	27.1	27.4	26.6	24.9	25.7	23.4	26.7	28.9	20.7	14.7	26.3	31.4	42.7	124.7	31.3	47.1	24.0	19.2	356.2	51.5	70.5	79.1	22.9	110.2	27.3	56.1	226.9	69.3	10.2	27.6	26.2	32.2	30.6	53.9	23.9	55.9	62.7	36.3	36.7	28.0	26.6	35.3	26.0	86.8	69.2	21.9	25.3	44.1	114.0	41.0	26.5	7.3	23.3	37.5	37.4	15.9	62.2	36.0	38.1	21.1	16.7	42.6	51.4	42.2	30.7	24.3	60.0	178.9	55.5	45.5	26.3	28.4	44.8	55.2	51.5	48.0	32.4	108.4	29.5	73.7	78.7	39.2
DLEC1	"CFAP81, DLC1, FAP81"	ENSG00000008226	"DLEC1 cilia and flagella associated protein"	Q9Y238	3	38039205-38124025	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Differentiation, Spermatogenesis"		"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"choroid plexus: 14.7;fallopian tube: 27.9;testis: 13.2"	"Group enriched"	"Detected in many"	4	"Endometrial ciliated cells: 45.0;Respiratory ciliated cells: 74.4"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA019077	Enhanced		Supported	Cytosol		NA	NA				"Cluster 42: Ciliated cells - Cilium & Cell projection"		"Cluster 49: Ciliated cells - Cilium organization"	Cytosol		"HPA019077: AB_1847724"	"unprognostic (1.24e-4)"	"unprognostic (3.60e-3)"	"unprognostic (2.11e-1)"	"unprognostic (1.09e-3)"	"unprognostic (2.32e-1)"	"unprognostic (1.76e-3)"	"unprognostic (2.50e-3)"	"unprognostic (8.54e-3)"	"unprognostic (1.37e-1)"	"unprognostic (1.69e-1)"	"unprognostic (9.53e-2)"	"unprognostic (7.62e-2)"	"unprognostic (8.70e-4)"	"unprognostic (1.77e-1)"	"unprognostic (1.45e-1)"	"unprognostic (2.89e-2)"	"unprognostic (1.94e-4)"	1.2	0.3	2.3	0.3	2.1	0.9	0.4	1.6	1.2	3.5	14.7	0.3	0.4	0.5	4.1	0.1	27.9	0.6	0.2	2.5	2.9	0.3	0.1	4.8	0.4	6.6	8.6	0.9	0.1	0.1	9.6	0.1	4.7	0.9	0.4	0.0	0.9	0.5	0.0	0.4	0.4	0.1	5.3	0.5	0.3	13.2	3.2	0.1	1.1	0.0	0.3	0.2	0.1	2.5	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.3	2.1	1.6	1.2	2.5	2.9	6.6	8.6	4.7	5.3	3.2	2.5	0.0	3.2	3.0	2.9	0.4	0.5	0.5	3.0	1.2	1.2	0.4	0.4	0.7	0.0	14.1	0.0	0.0	0.1	0.4	1.2	0.0	0.1	4.5	45.0	1.2	0.6	1.2	0.8	1.1	0.2	0.1	1.3	0.0	1.4	2.5	0.2	0.0	0.3	0.5	0.0	0.9	0.7	6.1	0.6	1.2	6.6	0.9	1.1	0.0	2.8	0.8	0.2	2.1	0.5	0.3	0.1	1.4	0.0	2.8	0.5	0.7	0.5	74.4	0.8	0.0	0.7	1.5	6.7	1.3	1.0	0.3	0.1	1.3	0.4	0.2	0.4
DLG5	"KIAA0583, P-dlg"	ENSG00000151208	"Discs large MAGUK scaffold protein 5"	Q8TDM6	10	77790791-77926755	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 112.5;Glandular and luminal cells: 139.6;Horizontal cells: 186.7;Syncytiotrophoblasts: 171.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"PC-3: 20.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001746			Supported	"Cell Junctions"		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 72: Non-specific - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 44: Endometrium - Transcription"	"Cell Junctions"		"HPA001746: AB_2666418"	"unprognostic (1.36e-1)"	"unprognostic (2.30e-1)"	"unprognostic (1.07e-1)"	"unprognostic (6.48e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.94e-2)"	"prognostic unfavorable (5.38e-4)"	"unprognostic (8.48e-2)"	"unprognostic (6.41e-2)"	"unprognostic (1.68e-2)"	"unprognostic (2.02e-2)"	"unprognostic (2.60e-1)"	"unprognostic (8.00e-2)"	"unprognostic (3.06e-1)"	"unprognostic (5.13e-1)"	"unprognostic (6.00e-2)"	"unprognostic (2.74e-2)"	11.9	51.8	8.3	0.5	8.1	0.2	19.4	7.7	8.5	24.4	9.4	28.6	0.3	25.1	16.3	19.7	17.7	1.1	7.4	8.1	8.6	8.8	4.6	8.6	0.4	17.2	9.6	19.5	11.1	6.1	33.9	2.4	10.2	31.2	1.7	4.2	16.8	2.9	26.3	36.3	12.5	2.2	10.1	4.1	16.4	6.2	8.6	1.2	22.3	0.9	1.4	20.3	22.2	10.3	5.7	0.1	4.5	4.9	6.8	2.9	2.9	6.3	3.7	1.1	1.1	0.0	3.8	0.0	6.0	3.2	1.9	6.0	2.3	3.4	4.2	2.0	7.5	1.1	0.0	7.0	6.5	0.4	1.5	3.3	8.1	0.2	9.8	8.2	0.4	0.1	3.0	0.0	3.4	2.0	0.6	1.8	4.3	7.0	20.0	4.1	1.4	0.3	4.8	0.0	1.5	4.2	2.7	5.7	2.2	6.1	2.3	1.1	1.9	1.2	9.2	1.2	5.7	0.0	0.7	0.5	1.2	1.2	0.6	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	8.3	8.1	7.7	8.5	8.1	8.6	17.2	9.6	10.2	10.1	8.6	10.3	5.2	6.4	5.4	21.2	0.5	29.6	24.2	20.2	12.0	18.3	41.9	28.3	2.8	12.8	13.6	20.2	16.7	112.5	12.1	12.2	0.0	6.7	16.4	55.6	41.7	4.9	2.4	0.0	24.0	5.9	23.6	12.5	8.2	139.6	1.3	49.4	3.3	3.3	13.1	186.7	28.3	10.4	8.2	0.0	3.9	10.2	18.6	1.8	8.8	10.3	0.8	46.4	9.2	19.1	13.6	12.4	7.6	18.4	6.8	25.4	15.2	2.1	34.6	15.3	26.3	24.2	15.1	1.6	7.6	10.8	24.2	171.6	5.5	10.4	10.1	23.5
DLGAP5	"DLG1, DLG7, HURP, KIAA0008"	ENSG00000126787	"DLG associated protein 5"	Q15398	14	55148112-55191608	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"bone marrow: 29.7;lymphoid tissue: 42.0;testis: 17.4"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 92.6;Extravillous trophoblasts: 23.1;Plasma cells: 22.1;Spermatocytes: 68.1;Spermatogonia: 31.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"T-reg: 5.4"	"Lineage enriched"	"Detected in many"	5	"T-cells: 5.4"	"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA005546	Enhanced		Supported	"Centriolar satellite,Cytosol"		Yes	Yes			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Centriolar satellite, Cytosol"		"HPA005546: AB_1078677"	"unprognostic (2.24e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.19e-3)"	"prognostic unfavorable (4.59e-4)"	"unprognostic (1.42e-1)"	"unprognostic (1.66e-2)"	"prognostic unfavorable (1.52e-6)"	"prognostic unfavorable (7.85e-4)"	"unprognostic (6.15e-3)"	"unprognostic (3.55e-1)"	"prognostic unfavorable (9.94e-6)"	"unprognostic (4.69e-2)"	"unprognostic (0.00e+0)"	"unprognostic (1.06e-2)"	"unprognostic (3.64e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.93e-2)"	0.8	0.3	1.4	8.1	0.9	29.7	1.4	0.4	1.8	0.8	0.6	5.5	5.0	1.3	0.1	5.2	0.4	0.8	0.2	1.0	1.7	0.2	0.7	0.7	17.9	0.7	1.0	0.2	0.1	0.2	0.0	4.1	0.8	0.2	6.7	0.1	0.8	0.1	0.1	3.1	4.6	2.7	0.3	2.6	3.0	17.4	1.1	42.0	0.4	0.0	18.7	2.0	1.5	3.8	144.8	56.8	140.6	63.7	3.3	13.4	43.8	80.3	52.7	115.3	109.3	45.9	75.8	82.1	44.2	46.9	47.4	85.6	91.5	64.0	150.5	101.9	45.7	84.4	49.9	39.3	0.4	82.7	49.3	2.8	2.2	54.8	27.0	18.9	129.0	82.5	70.5	79.8	109.3	69.2	105.0	42.7	72.6	63.3	57.3	80.8	137.9	39.0	37.9	45.2	71.7	40.7	84.8	31.7	30.8	60.6	71.6	31.6	49.6	52.4	133.3	50.6	94.6	19.4	44.9	108.9	35.9	59.6	83.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	1.9	1.4	0.3	0.0	0.2	0.1	0.2	1.0	0.0	0.0	5.4	0.7	1.4	0.9	0.4	1.8	1.0	1.7	0.7	1.0	0.8	0.3	1.1	3.8	0.1	0.0	0.5	0.0	4.4	1.1	0.7	3.3	0.0	0.0	1.2	0.9	0.4	0.0	1.3	0.0	0.0	11.6	1.4	3.2	0.0	0.4	19.7	7.2	2.6	2.4	0.0	92.6	0.3	0.0	23.1	4.2	7.7	4.5	0.0	15.8	3.9	0.5	10.5	0.0	0.3	3.6	8.2	4.1	1.6	6.0	0.9	3.7	0.0	0.0	0.0	0.0	1.0	0.0	0.3	0.2	0.2	1.2	22.1	0.6	0.3	0.1	1.3	0.0	6.6	0.0	3.8	68.1	31.7	11.6	0.4	1.9	4.0	0.9	6.9	1.4
DLST	"DLTS, KGD2, OGDC-E2"	ENSG00000119689	"Dihydrolipoamide S-succinyltransferase"	P36957	14	74881891-74903743	"Citric acid cycle related proteins, Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Tricarboxylic acid cycle"	"Acyltransferase, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003010	Supported		Supported	Nucleoplasm,Mitochondria,Cytosol		NA	NA		70000	"Cluster 15: NK-cells - Transcription"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 21: OE19 - Mitochondria"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Nucleoplasm	"Mitochondria, Cytosol"	"HPA003010: AB_1078679"	"unprognostic (1.62e-1)"	"unprognostic (3.01e-1)"	"unprognostic (2.45e-3)"	"unprognostic (6.36e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.21e-2)"	"unprognostic (1.16e-1)"	"unprognostic (5.83e-2)"	"unprognostic (3.03e-1)"	"unprognostic (1.37e-1)"	"unprognostic (2.12e-2)"	"unprognostic (1.18e-1)"	"prognostic favorable (1.13e-12)"	"unprognostic (3.29e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.66e-1)"	"unprognostic (4.55e-3)"	64.5	85.5	33.5	32.3	34.7	75.0	59.6	35.8	34.7	62.1	43.8	63.3	58.7	47.5	43.2	62.9	46.1	36.2	129.0	30.8	35.1	100.4	78.4	48.5	36.9	35.8	34.5	45.8	44.8	78.8	35.4	44.8	34.3	41.3	59.3	37.1	46.5	43.5	144.7	64.3	58.3	52.1	33.6	46.1	57.7	29.3	37.3	42.5	42.9	224.2	45.7	58.0	49.7	32.5	79.1	81.1	63.7	45.4	98.1	110.6	97.5	106.3	107.8	106.8	99.0	80.9	88.1	81.0	44.3	118.1	48.1	87.8	109.0	105.6	112.0	61.5	43.3	68.4	66.3	74.8	101.4	49.5	45.4	114.0	90.5	103.8	126.7	95.5	106.1	36.6	53.4	55.6	110.3	112.0	59.0	69.7	55.0	146.6	79.0	73.8	93.8	46.7	125.8	100.8	75.5	64.1	100.6	129.4	71.3	54.2	121.7	70.5	90.8	63.8	83.2	79.5	74.0	38.7	43.7	73.4	93.9	47.9	68.8	3.0	1.3	2.3	2.1	2.0	1.8	1.6	1.9	1.6	2.1	1.0	1.5	2.2	1.3	3.5	1.8	2.8	2.0	1.5	33.5	34.7	35.8	34.7	30.8	35.1	35.8	34.5	34.3	33.6	37.3	32.5	24.2	6.4	4.8	14.0	22.7	26.4	23.5	19.7	21.6	19.1	25.1	20.4	28.5	21.5	10.1	20.2	31.3	41.0	27.7	41.9	56.7	37.8	7.3	10.9	20.4	19.8	14.8	22.5	21.9	25.7	38.8	25.6	30.5	18.9	21.0	19.4	23.2	43.6	32.1	13.5	24.6	31.8	12.2	20.9	19.0	6.2	18.0	18.8	23.2	13.1	27.1	10.0	20.6	18.6	18.5	44.3	28.0	20.7	20.0	28.2	49.8	73.3	8.7	20.8	26.3	18.3	24.0	12.1	15.3	34.2	28.4	79.5	23.1	19.3	40.5	27.7
DLX1		ENSG00000144355	"Distal-less homeobox 1"	P56177	2	172084740-172089677	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	14	"brain: 18.8"	"Cell type enriched"	"Detected in some"	23	"Inhibitory neurons: 30.4"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 11.1"	"Region enhanced"	"Detected in many"		"hypothalamus: 18.8"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 134.5;U-138 MG: 36.9;WM-115: 42.1"	"Group enriched"	"Detected in many"	5	"basal ganglia: 28.6;olfactory bulb: 82.6"	"Region enriched"	"Detected in many"	4	"olfactory bulb: 48.8"	"HPA007175, HPA045884"	Approved		Supported	Nucleoplasm,Vesicles,Cytosol		NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm	"Vesicles, Cytosol"	"HPA007175: , HPA045884: AB_10960361"	"unprognostic (2.14e-2)"	"unprognostic (5.09e-2)"	"unprognostic (3.92e-2)"	"unprognostic (1.89e-3)"	"unprognostic (1.18e-1)"	"unprognostic (1.18e-1)"	"unprognostic (7.92e-3)"	"unprognostic (8.86e-2)"	"unprognostic (2.80e-2)"	"unprognostic (2.03e-1)"	"unprognostic (5.74e-2)"	"unprognostic (2.04e-1)"	"unprognostic (7.40e-9)"	"unprognostic (2.22e-1)"	"unprognostic (9.19e-2)"	"unprognostic (1.25e-1)"	"unprognostic (5.91e-3)"	0.1	1.3	5.9	0.2	4.8	0.0	0.1	0.0	4.4	0.3	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.2	3.5	18.8	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.2	0.0	0.1	0.0	0.1	0.5	0.2	0.1	0.0	0.0	0.1	0.0	3.5	0.0	1.0	0.1	0.3	0.1	0.2	2.7	2.4	0.6	0.6	134.5	2.0	4.5	0.3	3.2	6.5	7.7	4.1	1.0	0.2	0.0	7.8	7.2	7.5	9.4	7.4	1.2	5.2	0.3	33.3	21.1	14.4	5.7	0.1	7.9	15.9	0.0	2.2	1.9	3.2	5.4	0.0	6.7	12.4	0.0	6.3	8.1	0.1	1.9	0.1	0.0	22.9	0.4	15.8	0.0	0.9	4.5	11.3	0.0	6.1	0.8	17.5	0.4	5.2	9.5	7.1	36.9	0.2	16.4	16.4	0.2	0.0	0.1	15.2	21.4	42.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	5.9	4.8	0.0	4.4	3.5	18.8	0.0	0.2	0.0	0.0	3.5	2.7	0.1	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.3	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	30.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
DLX4	"BP1, DLX7, DLX8, DLX9"	ENSG00000108813	"Distal-less homeobox 4"	Q92988	17	49968970-49974959	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, Transcription factors"		"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"placenta: 3.7;skin 1: 3.0"	"Cell type enriched"	"Detected in some"	4	"Extravillous trophoblasts: 77.1"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BEWO: 22.9;CACO-2: 16.8;GAMG: 15.3;HAP1: 11.2;K-562: 13.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA059933	Uncertain		Supported	Nucleoplasm		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 61: Skin - Cornification"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 38: Extravillous trophoblasts - Unknown function"	Nucleoplasm		"HPA059933: AB_2684169"	"unprognostic (8.12e-2)"	"unprognostic (2.48e-1)"	"unprognostic (1.26e-2)"	"unprognostic (2.29e-3)"	"unprognostic (7.49e-2)"	"unprognostic (2.71e-1)"	"unprognostic (9.35e-3)"	"unprognostic (2.85e-2)"	"unprognostic (8.73e-2)"	"unprognostic (5.93e-2)"	"unprognostic (1.29e-2)"	"unprognostic (4.34e-2)"	"unprognostic (2.88e-13)"	"unprognostic (8.79e-3)"	"unprognostic (2.77e-1)"	"unprognostic (5.00e-2)"	"unprognostic (6.86e-2)"	0.2	0.2	0.2	0.2	0.2	0.2	0.3	0.1	0.6	0.3	0.1	0.2	0.1	0.0	0.2	0.7	0.2	0.0	0.1	0.2	0.1	0.2	0.0	0.6	0.2	0.2	0.8	0.0	0.3	0.2	0.1	3.7	0.5	0.2	0.1	0.0	1.1	0.2	0.0	3.0	0.2	0.0	0.2	0.4	0.1	0.3	0.2	0.1	0.3	0.0	0.5	0.2	0.5	0.2	0.5	1.4	0.0	0.1	0.1	0.0	22.9	0.1	0.1	0.1	0.3	16.8	1.0	0.7	3.3	0.3	15.3	2.3	11.2	0.4	0.1	4.5	5.9	0.4	5.7	1.7	0.0	0.9	3.7	0.0	2.8	0.1	0.0	0.2	0.0	3.5	13.5	0.0	0.0	2.9	0.4	6.0	0.2	3.1	0.0	0.0	5.1	0.6	0.1	0.8	1.9	0.1	0.4	1.9	1.1	3.4	4.1	4.0	0.0	0.0	1.0	0.2	0.0	0.9	0.2	0.0	0.4	3.1	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.2	0.2	0.1	0.6	0.2	0.1	0.2	0.8	0.5	0.2	0.2	0.2	0.0	6.4	0.0	0.0	0.2	2.5	0.4	1.0	2.2	0.0	0.5	0.3	1.9	0.0	0.1	0.0	0.0	12.7	0.1	0.1	0.0	0.3	0.1	1.5	0.1	0.2	0.0	0.0	0.3	0.2	77.1	0.6	0.0	0.1	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.3	0.8	0.0	0.0	0.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.1	1.0	1.1	0.4	0.6	16.8	0.1	0.2	0.2	0.3
DMAP1	"DNMAP1, DNMTAP1, EAF2, FLJ11543, KIAA1425, MEAF2, SWC4"	ENSG00000178028	"DNA methyltransferase 1 associated protein 1"	Q9NPF5	1	44213455-44220681	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Growth regulation, Transcription, Transcription regulation"	"Activator, Chromatin regulator, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028419, CAB033018, HPA069527"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 47: Cytotrophoblasts - Unknown function"	Nucleoplasm	Cytosol	"CAB033018: AB_2230431, HPA028419: AB_2672597, HPA069527: "	"unprognostic (1.91e-3)"	"unprognostic (2.79e-3)"	"unprognostic (4.90e-2)"	"unprognostic (6.52e-2)"	"unprognostic (4.80e-2)"	"unprognostic (1.43e-3)"	"prognostic unfavorable (1.44e-4)"	"unprognostic (1.72e-2)"	"unprognostic (7.32e-2)"	"unprognostic (3.01e-1)"	"unprognostic (1.82e-3)"	"unprognostic (1.86e-2)"	"unprognostic (2.29e-3)"	"unprognostic (1.53e-1)"	"unprognostic (1.33e-1)"	"unprognostic (3.09e-1)"	"unprognostic (2.04e-2)"	19.3	53.8	31.7	13.2	32.3	14.6	20.6	32.4	37.4	22.8	30.1	21.1	13.5	20.3	9.7	18.9	20.0	11.7	26.5	32.6	31.0	26.0	28.7	17.9	16.9	30.9	31.2	26.6	33.9	25.5	25.1	14.6	31.0	24.3	11.7	19.5	21.3	13.2	36.1	21.3	22.0	10.7	30.2	27.6	24.2	25.2	32.0	20.9	23.4	25.2	14.4	21.6	19.5	32.8	21.1	22.2	30.6	16.0	15.5	14.6	35.0	18.3	24.4	43.3	37.2	35.7	25.9	31.5	24.1	29.7	16.9	17.0	27.4	23.6	22.8	25.0	44.3	29.0	41.2	36.2	28.0	28.7	21.2	23.0	25.8	35.8	20.5	27.9	28.3	29.5	20.6	28.2	25.7	24.5	40.4	35.9	43.6	10.8	27.0	40.5	30.8	34.5	23.1	26.2	28.0	23.3	34.4	24.3	35.8	29.1	20.1	32.8	27.5	12.2	36.5	28.5	37.6	33.9	21.8	25.4	23.1	28.2	20.6	45.0	23.1	23.1	30.8	20.9	31.9	27.7	31.2	32.2	24.0	28.3	27.8	27.5	9.9	43.8	17.6	19.2	37.5	24.6	31.7	32.3	32.4	37.4	32.6	31.0	30.9	31.2	31.0	30.2	32.0	32.8	23.4	32.1	23.8	11.1	23.6	19.2	25.9	36.4	19.4	43.0	18.6	22.2	22.8	18.6	24.5	11.0	25.0	72.6	30.9	32.8	29.4	31.9	41.9	15.4	14.1	23.9	54.4	25.7	10.4	41.5	34.4	20.5	28.5	14.8	27.3	38.1	23.6	19.1	32.6	23.5	12.1	32.0	44.7	22.3	12.7	69.2	18.0	15.4	17.8	4.7	26.3	46.3	25.7	9.0	9.6	22.9	38.6	17.7	26.8	9.7	46.9	36.2	26.8	56.1	6.6	23.9	25.1	24.5	47.2	15.7	17.8	52.4	25.5	29.3	29.8	16.3
DMGDH		ENSG00000132837	"Dimethylglycine dehydrogenase"	Q9UI17	5	78997564-79236038	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	18	"kidney: 169.4;liver: 283.8"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 40.6;Hepatocytes: 104.2;Late spermatids: 33.1;Proximal tubular cells: 83.9"	"Group enriched"	"Detected in some"	12	"liver cancer: 15.6;renal cancer: 12.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 3.6;Hep G2: 7.6;hTEC/SVTERT24-B: 2.2;Karpas-707: 2.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA036441, HPA036442, HPA077849"	Enhanced		Supported	Mitochondria		NA	NA		680000		"Cluster 81: Kidney & Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Mitochondria		"HPA036441: AB_2675124, HPA036442: AB_10669792, HPA077849: AB_2686859"	"unprognostic (3.11e-2)"	"unprognostic (3.36e-1)"	"unprognostic (6.70e-2)"	"unprognostic (1.81e-1)"	"unprognostic (3.15e-1)"	"unprognostic (2.52e-3)"	"prognostic favorable (5.32e-5)"	"unprognostic (2.21e-1)"	"unprognostic (3.05e-2)"	"unprognostic (3.19e-2)"	"unprognostic (1.07e-4)"	"unprognostic (1.89e-1)"	"prognostic favorable (1.17e-5)"	"unprognostic (2.03e-2)"	"unprognostic (9.75e-4)"	"unprognostic (1.46e-1)"	"unprognostic (2.26e-1)"	8.4	4.5	1.5	0.3	1.7	0.0	2.2	1.4	1.6	1.4	3.0	1.3	0.2	2.8	12.2	1.4	1.3	2.1	1.9	1.5	2.4	169.4	283.8	0.4	0.2	1.5	1.9	2.2	1.8	0.6	2.9	0.1	2.0	1.8	0.4	1.5	0.4	1.8	2.4	0.6	0.6	1.7	1.4	0.1	1.0	2.3	2.9	0.3	4.8	1.5	0.3	1.2	0.5	1.6	0.0	0.0	0.0	0.3	0.3	0.8	0.3	0.2	3.6	0.8	1.4	0.0	0.0	0.0	0.2	1.1	0.0	0.0	0.0	0.0	1.1	0.2	0.0	0.0	0.0	7.6	1.9	0.0	0.0	1.7	2.1	2.2	1.6	1.5	0.0	0.8	0.0	2.3	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	2.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	1.7	1.4	1.6	1.5	2.4	1.5	1.9	2.0	1.4	2.9	1.6	1.3	0.0	1.1	19.9	2.9	0.1	0.5	1.0	1.8	1.9	1.4	1.8	1.0	2.8	0.8	9.2	2.1	0.3	1.9	0.7	19.6	0.4	40.6	2.6	5.0	1.2	1.2	6.1	5.8	0.7	0.1	2.7	3.6	2.7	0.0	4.1	1.8	104.2	0.1	0.0	1.5	1.2	4.1	1.6	0.4	33.1	2.5	1.7	0.0	4.7	0.2	4.3	3.1	4.5	3.3	0.8	1.4	2.6	4.5	0.9	1.6	83.9	4.7	3.7	0.0	1.7	0.7	4.9	5.3	1.8	0.3	0.3	2.9	4.4	0.9	0.8
DMPK	"DM, DM1, DM1PK, DMK, MDPK, MT-PK"	ENSG00000104936	"DM1 protein kinase"	Q09013	19	45769709-45782552	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	Cataract	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 44.1;Sertoli cells: 59.2;Smooth muscle cells: 34.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"RH-30: 85.1"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in many"		"spinal cord: 8.7"	"HPA007164, HPA008905"	Enhanced		Approved	Vesicles,Cytosol		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 38: Heart - Muscle contraction"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 48: Smooth muscle cells - ECM organization"	Cytosol	Vesicles	"HPA007164: AB_1078687, HPA008905: AB_1078685"	"unprognostic (7.44e-2)"	"unprognostic (2.66e-1)"	"unprognostic (1.76e-3)"	"unprognostic (2.61e-3)"	"unprognostic (1.29e-1)"	"unprognostic (5.46e-2)"	"unprognostic (8.67e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.67e-1)"	"prognostic favorable (9.39e-5)"	"unprognostic (1.93e-1)"	"unprognostic (1.60e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.18e-1)"	"unprognostic (3.03e-2)"	"unprognostic (4.24e-3)"	24.2	68.3	22.1	17.5	24.0	3.0	19.1	22.2	33.1	42.8	25.6	121.5	15.8	92.7	5.3	33.4	61.2	13.9	171.3	21.8	21.6	20.3	8.8	29.8	5.2	24.0	23.8	31.1	34.3	2.9	37.9	8.8	22.3	56.4	4.8	4.1	18.6	37.6	173.6	12.3	34.6	59.9	21.9	17.8	51.7	13.2	23.8	4.2	21.7	143.2	1.3	69.1	34.3	21.3	11.7	16.7	13.5	10.7	13.4	12.9	10.5	26.1	22.2	10.5	8.8	2.2	6.6	2.9	2.8	32.9	9.2	15.1	3.0	1.5	2.2	12.4	16.6	0.8	22.6	1.4	12.6	0.1	5.4	22.8	8.0	6.4	1.7	24.2	3.6	2.1	8.6	8.0	15.4	13.7	1.6	3.8	8.8	4.8	3.3	5.0	85.1	6.4	4.7	11.5	10.2	13.5	13.6	27.6	9.3	4.8	28.6	5.5	8.4	9.2	10.4	8.3	15.0	16.8	11.5	2.9	9.5	1.3	13.1	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.1	24.0	22.2	33.1	21.8	21.6	24.0	23.8	22.3	21.9	23.8	21.3	10.5	0.0	2.2	44.1	3.7	8.0	8.1	3.8	5.7	5.7	9.6	9.9	3.7	4.3	3.2	3.7	8.4	2.7	4.2	4.7	1.9	2.7	1.5	8.7	8.6	7.9	10.1	0.4	16.4	17.3	2.0	8.4	8.2	6.3	0.0	9.7	9.3	1.5	0.8	5.0	12.4	8.2	8.2	1.6	9.8	1.8	7.2	0.8	7.2	10.3	0.4	2.6	5.2	26.7	10.0	5.8	4.5	23.3	3.1	4.0	3.8	31.7	7.1	7.4	59.2	27.6	34.9	7.2	6.4	10.1	6.8	1.6	4.5	5.4	5.1	4.6
DMTF1	"DMP1, DMTF, hDMP1, MRUL"	ENSG00000135164	"Cyclin D binding myb like transcription factor 1"	Q9Y222	7	87152409-87196337	"Predicted intracellular proteins, Transcription factors"	"Cell cycle, Transcription, Transcription regulation"	"Activator, DNA-binding"	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Oligodendrocyte precursor cells: 132.7;Oligodendrocytes: 176.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023846	Supported		Supported	Nucleoplasm		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 21: Non-specific - Transcription"	"Cluster 12: NES - Nervous system development"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA023846: AB_1847779"	"unprognostic (3.86e-2)"	"unprognostic (1.88e-1)"	"unprognostic (9.82e-2)"	"unprognostic (8.54e-2)"	"unprognostic (3.13e-1)"	"unprognostic (2.26e-3)"	"unprognostic (9.77e-3)"	"unprognostic (2.53e-3)"	"unprognostic (6.89e-2)"	"unprognostic (2.56e-3)"	"unprognostic (1.15e-2)"	"unprognostic (1.36e-2)"	"prognostic unfavorable (4.39e-5)"	"unprognostic (6.39e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.09e-3)"	20.2	15.7	17.5	16.2	23.3	28.6	20.6	21.7	22.8	24.4	17.2	23.2	16.8	26.0	37.8	13.6	22.7	15.3	16.0	16.8	20.4	21.5	11.5	21.2	20.2	21.4	19.3	29.0	17.1	16.7	23.4	18.0	20.3	19.5	19.4	36.2	15.9	17.4	12.1	19.5	21.3	19.8	16.5	20.4	15.9	50.0	20.2	21.1	27.5	12.9	18.6	20.1	19.6	30.8	27.7	13.3	58.9	50.5	17.1	28.8	25.6	33.6	13.6	19.2	30.3	12.2	25.8	34.3	23.3	20.7	23.2	15.1	40.2	22.9	37.2	17.8	20.4	24.3	40.4	18.6	16.9	23.2	26.3	26.9	19.0	37.4	37.8	32.3	26.2	35.2	44.2	39.8	32.2	25.4	40.5	29.0	45.9	18.0	23.6	34.6	31.3	21.0	18.7	23.1	40.6	50.5	41.6	17.8	29.6	74.1	25.2	15.0	32.8	35.7	18.1	47.0	30.5	29.6	45.4	59.9	20.6	18.7	32.1	14.6	3.5	7.1	7.4	4.0	6.9	8.4	5.7	5.3	2.9	6.5	6.8	6.2	5.3	5.3	4.2	4.6	7.6	3.1	17.5	23.3	21.7	22.8	16.8	20.4	21.4	19.3	20.3	16.5	20.2	30.8	20.9	22.4	31.7	91.1	38.0	13.0	16.6	8.7	12.5	28.5	11.3	9.4	11.8	17.2	16.4	3.7	37.5	15.0	43.8	20.5	3.9	10.0	24.5	15.3	26.6	20.9	19.7	12.6	82.6	8.2	8.8	21.7	23.0	23.0	37.2	42.9	20.0	9.7	11.0	18.5	88.6	14.1	12.2	19.2	11.7	14.1	23.3	18.7	0.0	81.5	20.7	10.4	30.9	132.7	176.5	9.4	20.4	22.6	33.8	21.6	17.8	5.3	21.6	25.6	32.9	18.0	17.8	51.5	19.5	11.1	12.6	7.7	34.4	16.5	11.1	18.1
DNA2	"DNA2L, KIAA0083"	ENSG00000138346	"DNA replication helicase/nuclease 2"	P51530	10	68414064-68472121	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair, DNA replication"	"DNA-binding, Endonuclease, Helicase, Hydrolase, Multifunctional enzyme, Nuclease"	"Disease variant, Dwarfism, Mental retardation, Primary mitochondrial disease, Progressive external ophthalmoplegia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 8.1"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 33.2;Excitatory neurons: 14.1;Inhibitory neurons: 15.5;Oligodendrocytes: 18.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	5	"NK-cell: 1.8"	"Lineage enriched"	"Detected in single"	5	"NK-cells: 1.8"	"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA037487, HPA057526"	Approved		Supported	Mitochondria		No	Yes			"Cluster 15: NK-cells - Transcription"	"Cluster 20: Retina & Lymphoid tissues - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Mitochondria		"HPA037487: AB_10672493, HPA057526: AB_2683456"	"unprognostic (1.79e-1)"	"unprognostic (1.35e-1)"	"unprognostic (4.37e-3)"	"unprognostic (4.60e-3)"	"unprognostic (1.53e-1)"	"unprognostic (1.86e-2)"	"unprognostic (4.50e-5)"	"unprognostic (3.36e-2)"	"unprognostic (4.70e-2)"	"unprognostic (3.72e-2)"	"unprognostic (1.30e-2)"	"unprognostic (3.29e-4)"	"unprognostic (1.09e-10)"	"unprognostic (3.43e-2)"	"unprognostic (1.98e-1)"	"unprognostic (9.36e-2)"	"unprognostic (1.23e-2)"	1.3	0.9	1.9	2.8	2.1	4.6	1.8	2.5	3.6	1.4	1.0	2.3	2.1	1.1	0.9	1.9	0.9	0.9	1.8	1.8	1.9	2.6	4.2	1.8	5.2	2.3	1.9	1.2	1.6	0.4	1.5	1.6	2.4	1.9	2.8	5.3	1.6	0.4	1.6	1.8	3.2	1.1	1.6	2.1	1.9	2.9	2.1	8.1	1.0	0.9	4.2	1.4	1.4	3.2	25.6	13.0	29.0	20.7	3.2	2.2	20.4	12.4	10.3	17.4	21.2	31.1	16.1	26.1	4.6	3.8	6.7	15.2	16.8	6.5	20.7	16.2	12.6	15.8	8.5	12.3	0.9	27.7	16.4	1.8	2.6	12.3	3.6	4.5	7.9	17.0	23.6	22.8	10.1	9.0	42.8	19.8	20.5	10.9	24.0	33.1	20.0	8.4	7.5	11.7	13.1	15.7	16.9	21.4	4.2	20.1	16.5	11.6	3.4	6.6	20.5	8.5	23.8	11.5	13.9	38.3	5.7	26.1	8.9	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.2	0.1	0.1	0.0	1.8	0.0	0.0	0.1	0.0	1.9	2.1	2.5	3.6	1.8	1.9	2.3	1.9	2.4	1.6	2.1	3.2	1.0	6.4	1.1	4.9	1.3	2.3	0.9	1.7	2.8	2.5	2.3	1.4	10.5	2.8	1.1	1.8	6.2	3.9	2.2	1.7	0.0	0.8	2.2	2.0	1.4	2.0	1.2	33.2	14.1	0.9	4.8	2.0	2.6	2.8	0.0	6.0	0.7	4.6	2.2	0.0	15.5	1.8	0.0	1.3	0.7	3.7	0.6	1.5	0.0	4.7	0.5	0.5	2.1	5.5	18.4	0.7	0.1	0.7	7.4	2.5	2.4	0.6	0.8	4.3	0.0	2.4	1.1	9.1	12.2	4.7	1.7	1.2	1.6	0.7	3.7	1.0
DNAAF2	"C14orf104, CILD10, FLJ10563, KTU, PF13"	ENSG00000165506	"Dynein axonemal assembly factor 2"	Q9NVR5	14	49625174-49635244	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Ciliopathy, Kartagener syndrome, Primary ciliary dyskinesia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002894, HPA004113"	Enhanced		Supported	Cytosol		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 57: B-cells - Immune response"	Cytosol		"HPA002894: AB_1078316, HPA004113: AB_1078315"	"unprognostic (3.88e-2)"	"unprognostic (2.11e-1)"	"unprognostic (7.57e-2)"	"unprognostic (5.85e-2)"	"unprognostic (1.19e-2)"	"unprognostic (1.65e-1)"	"unprognostic (9.50e-2)"	"unprognostic (1.75e-2)"	"unprognostic (2.53e-2)"	"unprognostic (2.47e-1)"	"unprognostic (4.51e-2)"	"unprognostic (2.25e-2)"	"prognostic favorable (6.74e-7)"	"unprognostic (6.72e-2)"	"unprognostic (2.54e-1)"	"unprognostic (5.04e-2)"	"unprognostic (3.44e-2)"	3.8	4.6	3.2	4.4	3.1	3.4	5.7	3.8	3.3	4.3	6.0	5.4	7.6	4.0	4.1	4.4	8.6	3.7	4.3	3.0	3.5	6.8	9.3	3.7	5.5	3.5	4.3	3.5	6.9	3.9	3.4	3.4	3.5	4.0	4.7	4.8	5.5	3.0	5.0	3.2	6.2	3.3	3.6	4.1	5.1	6.3	3.4	4.7	5.3	5.3	4.6	4.6	3.3	3.6	14.2	8.3	18.0	14.1	8.6	9.9	17.1	7.5	8.3	8.2	9.0	8.1	13.4	20.7	11.6	5.0	6.7	15.3	15.0	10.6	10.2	14.6	8.9	10.6	6.2	14.1	6.7	17.3	8.6	6.6	11.3	7.0	9.5	8.4	8.5	11.3	16.0	13.8	8.2	17.7	11.4	17.8	19.6	14.7	15.1	14.0	13.9	7.0	11.7	11.8	27.4	20.4	11.2	12.0	13.8	11.3	13.7	6.9	7.0	7.6	21.7	7.9	9.5	27.5	18.4	17.1	2.9	10.5	8.5	7.8	4.9	6.8	7.4	4.5	8.9	11.6	8.2	9.9	5.7	9.3	7.9	7.8	1.8	12.4	5.8	5.1	8.5	4.8	3.2	3.1	3.8	3.3	3.0	3.5	3.5	4.3	3.5	3.6	3.4	3.6	9.8	3.2	5.6	5.9	38.5	41.0	25.0	38.9	41.5	7.0	21.4	20.3	10.6	15.7	14.6	12.9	0.0	21.6	16.2	13.0	31.3	28.4	25.9	30.3	22.9	17.1	9.6	13.9	6.8	24.0	29.4	17.6	19.4	13.8	12.0	12.2	19.2	26.6	14.0	3.3	8.0	15.3	48.8	9.2	21.1	7.5	18.3	10.2	19.6	2.8	10.5	11.3	19.6	6.6	6.2	25.7	13.0	16.6	43.7	36.2	30.8	37.9	27.2	11.9	6.6	16.0	15.4	22.4	17.9	38.6	44.0	12.4	28.0	30.2	22.8	20.0
DNAAF4	"CILD25, DYX1C1, EKN1, FLJ37882"	ENSG00000256061	"Dynein axonemal assembly factor 4"	Q8WXU2	15	55410525-55508234	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	Neurogenesis		"Ciliopathy, Kartagener syndrome, Primary ciliary dyskinesia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 27.5"	"Cell type enhanced"	"Detected in many"		"Endometrial ciliated cells: 171.5;Proximal tubular cells: 34.4;Respiratory ciliated cells: 102.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"RPTEC TERT1: 17.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051048	Uncertain		Supported	"Plasma membrane,Cytosol"		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 49: Ciliated cells - Cilium organization"	"Plasma membrane, Cytosol"		"HPA051048: AB_2681325"	"unprognostic (5.97e-4)"	"unprognostic (3.60e-2)"	"unprognostic (1.69e-1)"	"unprognostic (7.45e-4)"	"unprognostic (1.74e-1)"	"unprognostic (5.30e-3)"	"unprognostic (4.05e-2)"	"unprognostic (3.08e-2)"	"unprognostic (8.24e-2)"	"unprognostic (2.91e-1)"	"unprognostic (9.47e-2)"	"unprognostic (1.75e-1)"	"unprognostic (5.29e-2)"	"unprognostic (3.85e-2)"	"unprognostic (3.06e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.84e-1)"	1.0	2.0	4.7	1.1	4.7	1.2	3.3	3.6	6.8	2.8	8.4	0.9	0.6	3.7	10.6	1.2	11.1	2.2	1.0	4.8	5.8	5.0	0.5	4.3	1.1	5.1	5.0	2.6	2.1	8.5	3.5	0.7	3.8	2.0	0.9	27.5	1.5	2.0	0.8	1.7	0.8	2.0	3.6	1.3	1.0	11.3	6.7	0.7	8.6	0.5	0.9	1.4	0.7	3.7	7.0	4.8	4.9	10.4	2.0	3.5	1.5	1.0	2.6	3.2	3.6	1.0	2.9	0.6	4.4	2.1	5.2	2.1	1.9	2.7	3.7	2.4	2.5	2.6	3.2	1.7	1.8	5.4	4.2	2.2	5.7	7.6	2.9	5.1	7.2	2.2	0.8	0.3	4.8	2.9	1.3	4.7	2.9	11.0	3.7	1.1	2.3	0.9	17.6	2.3	4.9	10.7	4.3	1.3	6.5	4.2	6.2	1.4	2.5	5.0	2.5	4.4	5.2	2.1	5.4	1.7	8.3	1.3	1.5	0.1	0.7	0.5	0.3	0.5	0.3	1.4	0.5	0.5	0.6	1.3	0.7	0.5	1.4	0.4	0.5	1.9	0.7	0.3	4.7	4.7	3.6	6.8	4.8	5.8	5.1	5.0	3.8	3.6	6.7	3.7	4.1	12.8	15.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	7.9	9.8	0.0	0.0	15.5	12.9	0.0	2.0	0.4	0.0	5.9	13.6	0.0	171.5	9.0	2.8	0.0	0.0	0.0	5.1	1.5	3.4	0.0	13.3	2.5	9.7	0.0	0.0	19.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.4	0.0	0.0	34.4	102.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.5	0.7	7.2	0.0	0.0
DNAH14	"C1orf67, DKFZp781B1548, Dnahc14, HL-18, HL18, MGC27277"	ENSG00000185842	"Dynein axonemal heavy chain 14"	Q0VDD8	1	224896262-225399292	"Predicted intracellular proteins"		"Motor protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 22.1"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 135.0;Excitatory neurons: 65.4;Spermatocytes: 74.5"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"K-562: 48.8"	"Low region specificity"	"Detected in many"							"HPA027718, HPA028545, HPA031379"	Uncertain		Supported	Centrosome		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Centrosome		"HPA027718: AB_10601210, HPA028545: AB_2672665, HPA031379: AB_2673851"	"unprognostic (1.16e-1)"	"unprognostic (1.77e-2)"	"unprognostic (2.95e-1)"	"unprognostic (1.86e-2)"	"unprognostic (5.92e-2)"	"unprognostic (1.09e-3)"	"unprognostic (9.94e-4)"	"unprognostic (4.23e-2)"	"unprognostic (1.56e-2)"	"unprognostic (3.67e-2)"	"unprognostic (2.12e-1)"	"unprognostic (2.51e-1)"	"unprognostic (2.33e-9)"	"unprognostic (6.76e-2)"	"unprognostic (7.39e-2)"	"unprognostic (1.27e-1)"	"unprognostic (6.78e-2)"	1.1	3.2	4.2	0.7	3.5	1.9	3.2	0.9	3.4	1.8	4.4	1.9	1.0	1.9	3.6	1.1	1.6	1.6	1.3	3.4	9.2	5.4	5.7	2.3	0.4	3.8	4.3	3.7	5.6	2.1	6.6	1.5	3.9	3.2	2.3	2.7	1.5	1.4	0.1	0.4	0.6	1.1	2.9	0.4	2.6	22.1	8.8	1.4	4.4	0.2	0.2	1.8	1.1	2.9	19.7	9.9	8.9	9.8	3.5	7.1	21.3	4.0	3.7	7.2	6.3	15.6	21.1	0.0	9.7	4.1	0.0	0.2	13.8	3.8	12.2	0.0	23.0	9.4	7.2	3.4	4.3	19.6	3.1	6.9	8.3	10.0	6.9	7.7	2.4	13.5	48.8	0.0	12.4	5.2	3.6	20.3	25.1	22.1	12.0	0.0	33.8	18.0	6.7	9.0	14.9	16.9	15.4	11.5	32.1	14.8	21.2	16.9	0.4	0.1	14.4	0.3	0.1	20.9	14.1	0.2	0.0	0.0	13.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.8	0.0	0.0	0.2	0.0	4.2	3.5	0.9	3.4	3.4	9.2	3.8	4.3	3.9	2.9	8.8	2.9	2.5	12.8	11.5	2.3	0.6	2.0	14.0	6.0	3.4	28.1	10.1	6.2	6.5	10.0	5.7	20.2	33.3	10.6	1.3	2.1	7.9	11.2	135.0	13.1	13.2	3.4	8.3	6.7	65.4	10.0	12.4	4.5	6.6	12.2	14.0	23.3	1.4	7.7	3.4	28.6	44.0	5.2	4.1	0.0	1.2	45.9	2.8	1.2	3.6	6.5	1.0	8.0	1.0	23.6	8.4	9.4	1.1	3.4	1.2	11.2	0.5	8.4	6.7	3.9	6.6	0.5	2.7	74.5	24.9	2.8	0.9	11.5	1.4	10.1	5.0	7.1
DNAH7	KIAA0944	ENSG00000118997	"Dynein axonemal heavy chain 7"	Q8WXX0	2	195737703-196068837	"Plasma proteins, Predicted intracellular proteins"		"Motor protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 12.9;choroid plexus: 29.8"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 197.2;Cone photoreceptor cells: 70.9;Early spermatids: 59.3;Endometrial ciliated cells: 103.5;Excitatory neurons: 93.0;Respiratory ciliated cells: 139.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"PC-3: 5.9;RPTEC TERT1: 2.8"					"Region enhanced"	"Detected in many"		"midbrain: 4.4"	"HPA034724, HPA044070"	Enhanced		Supported	Cytosol		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 49: Ciliated cells - Cilium organization"	Cytosol		"HPA034724: AB_10670977, HPA044070: AB_2678798"	"unprognostic (1.71e-1)"	"unprognostic (2.81e-2)"	"unprognostic (2.65e-2)"	"unprognostic (1.04e-2)"	"unprognostic (3.56e-1)"	"unprognostic (1.58e-2)"	"unprognostic (6.74e-3)"	"unprognostic (2.24e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.63e-1)"	"unprognostic (2.84e-2)"	"unprognostic (1.71e-1)"	"unprognostic (6.25e-3)"	"unprognostic (2.24e-1)"	"unprognostic (7.76e-2)"	"unprognostic (2.52e-3)"	"unprognostic (3.98e-2)"	0.3	1.0	8.2	0.2	7.9	0.0	0.6	3.6	10.1	2.5	29.8	0.7	0.1	0.8	1.7	0.2	9.8	0.6	0.4	8.0	7.1	3.4	0.3	2.3	0.1	10.2	12.9	0.5	2.6	2.0	7.2	0.1	8.0	1.1	0.5	8.9	0.8	0.9	0.0	0.2	0.7	0.3	7.6	0.1	0.6	10.8	9.0	0.1	3.2	0.0	0.2	0.2	0.3	6.7	0.3	1.3	0.3	0.1	0.7	0.4	0.1	0.1	0.8	0.3	0.3	0.2	1.0	0.0	0.3	0.3	1.0	0.0	0.0	0.2	0.2	0.0	0.8	0.0	1.7	0.4	0.1	0.0	0.1	0.2	0.2	1.1	0.2	1.7	0.0	0.0	0.3	1.8	0.5	1.4	0.0	0.0	0.3	0.7	5.9	0.0	0.3	0.5	2.8	0.2	0.6	1.0	0.3	0.2	0.1	0.1	0.5	0.1	0.0	0.7	0.2	1.1	0.3	1.4	1.4	0.0	1.6	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.0	8.2	7.9	3.6	10.1	8.0	7.1	10.2	12.9	8.0	7.6	9.0	6.7	0.5	0.0	6.1	197.2	0.0	0.9	1.2	3.3	0.0	1.9	2.1	1.3	1.3	0.0	12.3	1.8	70.9	0.0	0.1	4.4	0.0	2.9	59.3	103.5	2.8	1.8	0.0	0.0	93.0	0.7	0.0	1.0	1.5	3.0	0.0	0.8	0.7	0.0	0.1	1.7	25.6	1.0	4.1	0.0	1.2	27.8	0.6	0.4	1.8	13.1	0.0	2.9	0.0	5.5	2.2	0.6	0.2	1.5	0.1	1.8	3.7	2.6	139.5	36.8	0.0	2.1	1.1	28.0	5.7	0.0	1.3	0.1	0.2	0.8	0.7	0.7
DNAJA1	"dj-2, hdj-2, HSJ2, HSPF4, NEDD7"	ENSG00000086061	"DnaJ heat shock protein family (Hsp40) member A1"	P31689	9	33025273-33039907	"Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 438.9"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001306, CAB033665"	Approved		Supported	Microtubules,Cytosol		NA	Yes		160000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 65: Brain - Ion transport"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 7: Non-specific - Mitochondria"	Cytosol	Microtubules	"CAB033665: AB_2094242, HPA001306: AB_1079043"	"unprognostic (3.11e-2)"	"unprognostic (5.05e-2)"	"unprognostic (5.14e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.07e-1)"	"unprognostic (9.80e-2)"	"unprognostic (3.17e-2)"	"unprognostic (2.88e-2)"	"unprognostic (5.58e-2)"	"prognostic favorable (5.39e-4)"	"unprognostic (1.69e-2)"	"unprognostic (1.05e-1)"	"prognostic favorable (3.40e-4)"	"unprognostic (3.27e-1)"	"unprognostic (2.65e-1)"	"unprognostic (1.25e-1)"	"unprognostic (4.70e-2)"	102.6	134.7	143.9	83.9	154.7	148.8	65.8	147.4	438.9	83.7	142.7	61.9	44.5	81.0	80.4	51.7	102.7	83.6	72.9	154.1	159.8	114.6	216.9	94.4	80.6	147.7	152.8	83.5	59.7	105.2	80.7	108.3	160.9	85.8	63.5	78.2	61.0	64.7	47.3	43.8	50.1	87.2	155.3	72.0	67.7	135.0	164.6	95.7	66.0	61.5	89.1	130.7	57.3	174.0	255.6	447.5	353.7	123.6	240.2	155.1	202.4	256.5	205.9	451.2	348.2	299.2	115.0	259.5	191.6	175.4	254.9	113.1	515.7	154.7	386.1	368.2	150.2	208.3	537.3	382.7	115.1	242.5	234.2	96.1	156.1	170.4	53.9	218.4	273.6	110.9	330.5	109.7	262.0	208.6	407.7	530.3	345.3	254.2	308.2	294.7	126.6	132.9	254.1	148.8	223.8	243.5	345.4	220.6	120.0	262.5	103.5	231.5	236.1	160.0	273.1	184.6	346.2	69.9	233.3	271.7	209.9	208.3	140.9	154.1	140.8	160.9	93.3	202.0	111.1	127.5	116.8	105.7	127.8	119.7	119.6	113.4	176.2	117.8	268.3	213.4	110.4	209.9	143.9	154.7	147.4	438.9	154.1	159.8	147.7	152.8	160.9	155.3	164.6	174.0	1110.8	214.7	154.9	7.8	368.7	264.6	942.8	245.3	327.8	209.3	307.8	513.5	187.7	95.8	257.7	82.8	208.5	274.0	619.1	287.9	172.1	247.7	536.4	549.2	348.2	427.8	391.1	198.9	16.2	181.1	341.6	392.8	188.6	526.1	424.7	127.6	133.2	129.6	231.1	121.1	16.7	327.3	213.6	156.0	497.4	222.2	99.1	402.3	284.6	22.5	243.7	150.5	91.6	8.0	22.5	189.8	334.7	94.8	195.8	393.8	134.7	178.1	417.8	161.7	105.2	391.1	476.0	492.7	209.4	238.5	265.4	464.9	678.9	179.2	273.3	636.8
DNAJA3	"hTid-1, TID1"	ENSG00000103423	"DnaJ heat shock protein family (Hsp40) member A3"	Q96EY1	16	4425805-4456775	"Predicted intracellular proteins"	Apoptosis	Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016095, HPA040875, HPA044229"	Approved		Supported	Vesicles,Mitochondria		NA	NA		16000	"Cluster 22: NK-cells - Unknown function"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria	Vesicles	"CAB016095: AB_668801, HPA040875: AB_2677183, HPA044229: AB_2678865"	"unprognostic (5.65e-2)"	"unprognostic (1.34e-1)"	"unprognostic (2.86e-3)"	"unprognostic (2.91e-2)"	"unprognostic (4.17e-1)"	"unprognostic (5.18e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.06e-1)"	"unprognostic (3.16e-3)"	"unprognostic (1.55e-1)"	"unprognostic (3.27e-2)"	"prognostic favorable (1.79e-4)"	"unprognostic (4.17e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.92e-1)"	18.9	44.3	15.7	11.8	16.3	6.4	18.3	17.5	18.7	19.9	15.3	25.2	17.5	18.6	6.8	27.8	18.0	8.1	43.6	16.0	16.8	26.7	65.7	15.8	13.3	16.5	16.1	20.7	26.5	23.9	20.2	12.3	17.2	18.7	12.6	8.7	20.2	12.4	90.5	22.7	21.2	10.4	16.6	19.3	23.9	23.6	17.5	11.5	18.7	48.3	11.9	23.8	20.5	16.8	26.4	53.7	16.1	33.1	20.5	18.8	34.6	34.2	22.9	45.1	36.1	40.2	38.7	50.2	32.9	20.3	31.3	38.4	55.7	39.7	24.8	42.2	35.8	25.4	48.8	40.4	50.8	47.5	24.4	22.6	46.6	40.0	66.1	20.5	20.4	36.7	63.1	39.7	27.8	60.9	39.6	33.8	35.6	48.2	43.2	51.5	27.6	92.7	32.5	28.0	43.7	17.3	38.2	77.6	62.0	13.7	46.7	38.3	22.2	35.8	24.5	80.1	44.4	38.5	56.6	69.7	17.9	45.0	39.8	1.4	5.3	3.2	10.3	8.7	12.4	12.1	9.6	9.8	7.6	10.0	12.9	10.4	0.8	11.1	6.9	5.4	10.8	10.5	15.7	16.3	17.5	18.7	16.0	16.8	16.5	16.1	17.2	16.6	17.5	16.8	10.9	12.8	8.1	11.4	23.7	15.7	18.5	12.6	25.0	23.0	14.8	10.8	36.3	14.3	13.0	25.8	10.4	42.8	8.2	17.9	45.0	21.8	62.6	8.9	13.5	13.3	17.5	18.7	19.4	12.2	34.3	13.6	18.8	10.0	12.7	17.9	8.9	46.1	16.6	23.5	20.4	17.5	16.2	10.1	7.0	30.5	19.3	10.0	21.4	6.5	15.2	18.5	16.5	10.6	15.2	13.9	15.5	22.2	19.9	28.9	21.5	25.9	9.2	23.2	13.1	14.2	14.2	50.5	33.7	23.5	16.9	28.5	17.5	29.8	32.7	16.7
DNAJB1	"Hsp40, HSPF1, RSPH16B, Sis1"	ENSG00000132002	"DnaJ heat shock protein family (Hsp40) member B1"	P25685	19	14514769-14560391	"Cancer-related genes, Predicted intracellular proteins"	"Stress response"	Chaperone	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 1705.1"	"Cell type enhanced"	"Detected in all"		"Langerhans cells: 1392.1"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	5	"cerebral cortex: 1705.1"	"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017450, HPA063247"	Enhanced		Supported	Nucleoplasm		NA	Yes		23000	"Cluster 20: T-cells - T-cell receptor"	"Cluster 65: Brain - Ion transport"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 22: Epithelial cell types - Mixed function"	Nucleoplasm		"CAB017450: AB_10631418, HPA063247: AB_2684971"	"unprognostic (3.75e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.46e-1)"	"unprognostic (2.12e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.74e-2)"	"unprognostic (3.83e-1)"	"unprognostic (1.85e-1)"	"unprognostic (7.91e-3)"	"unprognostic (2.17e-1)"	"prognostic favorable (5.96e-4)"	"unprognostic (2.20e-2)"	"unprognostic (4.44e-2)"	"unprognostic (2.00e-2)"	"unprognostic (6.77e-2)"	206.0	216.1	228.5	40.9	241.7	133.8	62.0	320.9	1705.1	188.1	259.4	86.7	35.2	54.0	40.8	439.9	75.3	183.7	182.8	243.8	240.2	245.0	230.3	286.0	42.0	250.4	251.8	231.9	89.8	66.4	148.4	123.4	285.4	73.9	48.4	81.2	109.7	127.1	51.2	128.5	62.7	54.5	240.6	104.5	149.1	149.4	241.8	107.3	97.2	208.0	76.5	133.6	257.7	323.4	192.5	212.5	80.8	81.7	146.8	114.1	45.6	125.9	99.9	210.4	158.8	126.3	106.7	54.8	135.4	121.0	135.5	144.9	169.1	96.7	150.3	55.0	76.1	86.7	115.0	275.6	94.6	57.9	78.5	61.0	237.5	85.3	73.4	114.7	71.6	35.7	131.2	471.6	123.6	130.5	102.2	60.1	80.4	285.9	228.3	73.7	106.3	121.7	101.8	62.4	67.0	51.1	121.1	233.7	127.1	90.8	60.3	60.6	64.7	156.4	98.0	184.1	264.8	193.5	141.7	65.7	114.4	109.2	151.1	68.8	92.4	116.2	171.6	159.0	184.8	93.7	244.5	214.9	76.0	92.0	281.6	219.9	137.6	125.1	172.2	45.1	270.9	322.6	228.5	241.7	320.9	1705.1	243.8	240.2	250.4	251.8	285.4	240.6	241.8	323.4	750.2	157.0	95.4	32.3	248.7	425.8	1142.1	148.0	719.3	60.9	468.8	476.4	367.1	72.9	118.6	23.9	118.9	135.6	214.2	459.6	41.1	132.8	491.8	374.8	339.3	397.3	407.3	60.0	10.2	162.6	199.3	661.2	408.7	552.8	339.4	100.2	86.7	59.9	158.1	52.2	8.9	420.1	81.4	85.1	1392.1	475.3	63.3	559.3	503.4	23.4	31.3	160.7	25.7	3.0	16.5	123.8	380.7	36.9	697.0	461.1	117.3	59.1	138.0	164.7	26.3	398.9	673.3	290.2	53.4	1186.0	478.9	274.9	948.4	104.8	393.7	606.2
DNAJB11	"EDJ, ERdj3, HEDJ"	ENSG00000090520	"DnaJ heat shock protein family (Hsp40) member B11"	Q9UBS4	3	186567403-186585800	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		Chaperone	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010814, HPA017051"	Supported		Supported	"Endoplasmic reticulum"	"Intracellular and membrane"	NA	NA		100000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 55: Plasma cells - Humoral immune response"	"Endoplasmic reticulum"		"HPA010814: AB_1078691, HPA017051: AB_1847792"	"unprognostic (4.29e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.98e-2)"	"unprognostic (2.24e-2)"	"unprognostic (8.53e-2)"	"unprognostic (1.07e-3)"	"unprognostic (3.86e-2)"	"unprognostic (6.52e-2)"	"unprognostic (7.95e-2)"	"unprognostic (2.14e-3)"	"unprognostic (2.58e-2)"	"unprognostic (1.05e-3)"	"prognostic unfavorable (3.44e-9)"	"unprognostic (1.27e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.33e-1)"	"unprognostic (1.82e-1)"	36.1	26.3	17.3	51.5	18.8	50.1	28.2	20.1	19.8	30.3	21.0	38.9	35.2	31.5	36.7	33.2	28.7	28.1	42.9	17.9	20.1	33.0	81.8	35.8	34.5	21.1	19.8	20.5	62.3	31.7	27.0	46.2	20.2	23.3	37.2	16.1	34.3	23.1	22.9	23.9	38.4	30.9	19.3	41.7	37.8	27.1	20.0	30.7	53.2	15.8	36.5	40.6	26.1	21.6	154.5	60.5	87.5	150.5	69.6	53.1	142.4	166.5	98.5	138.6	145.9	187.0	100.5	109.4	326.7	113.3	199.6	139.1	96.0	88.0	135.6	123.7	81.7	97.8	57.0	128.8	150.8	116.8	149.0	46.6	85.5	78.0	130.6	76.4	116.7	59.0	55.8	263.9	93.6	117.4	77.6	85.7	83.1	211.8	76.3	78.1	96.8	187.8	87.7	66.4	73.3	101.3	108.2	181.4	123.2	103.2	209.3	177.6	89.5	76.6	97.1	100.7	244.5	202.9	159.0	175.8	102.3	141.6	169.8	37.4	37.3	39.8	44.0	45.9	37.2	37.2	22.9	36.5	46.2	21.8	21.8	29.2	17.2	50.2	35.4	84.8	33.9	38.4	17.3	18.8	20.1	19.8	17.9	20.1	21.1	19.8	20.2	19.3	20.0	21.6	42.2	19.2	20.9	12.1	78.1	145.3	212.5	104.3	48.9	22.9	38.3	22.7	152.0	67.2	61.4	14.7	18.8	88.7	75.0	93.5	3.9	109.2	41.5	58.2	44.9	63.6	142.1	37.6	10.8	85.7	173.0	63.3	41.3	77.5	54.7	29.4	61.1	105.0	149.4	23.5	11.6	122.8	67.1	65.3	130.3	10.8	31.4	59.4	103.2	14.0	33.3	48.5	63.8	12.1	24.5	86.9	88.2	25.9	251.1	136.6	74.6	18.9	47.3	28.4	65.7	63.7	61.3	190.6	100.7	51.1	112.2	195.1	61.7	28.4	106.8	155.8
DNAJB12	"DJ10, FLJ20027"	ENSG00000148719	"DnaJ heat shock protein family (Hsp40) member B12"	Q9NXW2	10	72332830-72355149	"Predicted membrane proteins, Transporters"	"Host-virus interaction"	Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 235.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010642, HPA072702"	Approved		Supported	"Nuclear membrane,Endoplasmic reticulum"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 59: Non-specific - Translation"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 31: Spermatids - Spermatogenesis"	"Endoplasmic reticulum"	"Nuclear membrane"	"HPA010642: AB_1078692, HPA072702: "	"unprognostic (3.35e-2)"	"unprognostic (1.07e-1)"	"prognostic unfavorable (4.79e-4)"	"unprognostic (6.01e-3)"	"unprognostic (2.68e-1)"	"prognostic unfavorable (8.17e-4)"	"unprognostic (5.73e-2)"	"unprognostic (5.60e-2)"	"unprognostic (8.85e-3)"	"unprognostic (1.95e-1)"	"unprognostic (1.32e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.71e-1)"	"unprognostic (4.05e-2)"	"unprognostic (4.73e-1)"	"unprognostic (1.16e-2)"	"unprognostic (1.87e-1)"	24.1	29.8	18.3	18.1	19.5	27.6	24.5	20.0	20.4	21.6	19.5	23.3	21.4	24.0	23.4	23.2	20.8	17.5	26.8	19.0	18.1	23.9	28.0	21.1	16.4	20.0	18.8	22.6	26.9	32.9	23.7	20.3	19.1	23.4	14.7	16.6	28.4	17.7	37.5	28.5	20.7	19.0	18.4	24.8	23.9	21.4	18.9	17.3	23.5	23.5	16.0	21.6	20.6	20.0	37.4	38.3	23.4	39.3	30.5	31.1	29.6	36.6	63.8	49.5	45.9	44.7	64.3	27.2	28.8	45.1	31.3	61.4	22.2	33.0	26.9	29.9	29.4	14.7	23.0	29.6	68.5	30.1	54.2	39.6	67.6	44.1	55.8	45.0	35.1	25.6	23.2	40.2	43.3	36.7	26.0	26.3	10.8	29.1	11.1	23.4	17.8	18.9	37.7	21.7	16.1	23.0	20.0	74.0	36.8	12.9	28.2	34.2	39.1	24.6	33.4	28.0	46.7	33.8	27.3	16.0	40.6	32.6	17.1	18.7	29.2	18.7	12.8	31.5	11.4	11.5	12.5	9.6	24.6	11.1	10.3	10.2	36.6	13.9	28.9	16.4	13.8	17.5	18.3	19.5	20.0	20.4	19.0	18.1	20.0	18.8	19.1	18.4	18.9	20.0	30.3	28.9	29.3	10.1	30.1	13.4	30.6	38.6	25.6	33.3	36.1	29.6	23.3	50.1	44.3	23.9	22.9	41.1	37.7	38.1	11.7	34.2	122.2	25.1	26.1	25.3	29.4	31.2	12.7	64.3	41.1	28.6	23.4	29.3	40.0	26.4	21.0	29.6	38.1	30.3	13.0	28.8	12.2	36.0	16.0	235.7	36.4	37.6	10.6	7.5	39.6	33.6	35.0	12.1	15.2	34.9	38.1	35.0	34.2	27.4	62.2	34.4	26.8	35.6	52.6	27.4	34.4	32.4	10.9	28.1	15.5	68.0	22.8	37.0	25.9	35.2
DNAJB6	"LGMD1D, MRJ"	ENSG00000105993	"DnaJ heat shock protein family (Hsp40) member B6"	O75190	7	157335381-157417439	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		Chaperone	"Disease variant, Limb-girdle muscular dystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Suprabasal keratinocytes: 960.5;Urothelial cells: 876.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004670, HPA024258, HPA058593"	Supported		Enhanced	Nucleoplasm,Cytosol		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 22: Epithelial cell types - Mixed function"	Nucleoplasm	Cytosol	"CAB004670: AB_425825, HPA024258: AB_1847795, HPA058593: AB_2683767"	"unprognostic (4.37e-1)"	"unprognostic (1.62e-2)"	"unprognostic (3.22e-2)"	"unprognostic (9.26e-3)"	"unprognostic (6.66e-3)"	"unprognostic (4.68e-2)"	"prognostic unfavorable (1.12e-5)"	"unprognostic (5.71e-2)"	"unprognostic (2.62e-2)"	"unprognostic (1.01e-2)"	"unprognostic (8.41e-2)"	"unprognostic (3.19e-1)"	"unprognostic (6.33e-2)"	"unprognostic (2.24e-1)"	"unprognostic (1.54e-1)"	"unprognostic (6.45e-2)"	"unprognostic (1.52e-1)"	82.7	66.0	112.4	55.9	119.0	183.2	87.0	124.0	219.8	76.0	125.6	103.7	43.5	81.5	109.4	117.0	73.8	50.5	121.0	119.5	122.2	73.3	49.8	69.9	54.8	122.8	122.8	76.6	43.6	57.6	65.2	73.7	123.7	58.1	49.2	87.4	74.8	70.5	328.3	132.7	56.9	73.3	120.3	59.3	62.1	118.2	118.5	81.1	52.6	177.5	68.0	92.7	90.8	139.5	179.8	106.7	127.0	130.9	126.3	113.1	117.6	196.2	159.8	179.1	194.4	146.4	176.0	68.7	359.2	146.9	162.4	111.9	87.3	137.8	275.3	138.3	119.6	123.1	61.7	104.6	116.1	92.4	99.4	100.2	130.7	136.1	64.2	178.9	135.6	72.2	203.8	66.9	232.5	121.7	232.4	181.0	255.7	126.1	141.2	122.7	91.1	96.0	148.9	108.1	76.5	201.2	153.5	119.3	151.2	259.6	87.2	129.8	170.0	113.0	85.4	270.6	172.0	126.1	193.1	80.9	160.1	208.7	146.4	345.1	160.8	201.9	133.8	168.2	135.2	134.8	120.8	138.4	120.2	124.0	152.0	141.7	287.8	148.0	206.3	109.9	159.6	247.0	112.4	119.0	124.0	219.8	119.5	122.2	122.8	122.8	123.7	120.3	118.5	139.5	225.2	48.1	62.7	41.1	150.9	756.7	640.9	632.6	182.7	100.4	281.8	175.9	115.0	62.9	206.8	97.5	81.3	276.9	287.0	143.0	193.7	134.9	105.8	225.6	125.2	178.8	193.5	131.1	49.4	69.4	241.8	159.8	66.8	296.3	212.7	70.5	101.4	46.7	164.7	94.2	56.4	149.8	223.8	133.7	803.5	126.4	151.0	339.2	282.8	60.9	313.6	122.7	173.0	37.2	73.5	138.5	132.4	202.3	132.9	413.2	82.4	196.1	253.8	104.0	98.6	146.0	198.8	319.4	504.8	204.1	960.5	508.1	288.0	111.4	155.1	876.8
DNAJC11	FLJ10737	ENSG00000007923	"DnaJ heat shock protein family (Hsp40) member C11"	Q9NVH1	1	6634168-6701924	"Predicted intracellular proteins, Predicted membrane proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023707, HPA028705"	Uncertain		Supported	Mitochondria		No	No			"Cluster 27: Non-specific - Gene expression"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Mitochondria		"HPA023707: , HPA028705: AB_10603662"	"unprognostic (3.74e-2)"	"unprognostic (3.19e-2)"	"unprognostic (4.06e-2)"	"unprognostic (6.05e-3)"	"unprognostic (9.55e-2)"	"unprognostic (6.65e-2)"	"unprognostic (4.38e-3)"	"unprognostic (6.10e-2)"	"unprognostic (6.34e-2)"	"unprognostic (2.89e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.34e-1)"	"prognostic favorable (2.63e-5)"	"unprognostic (6.30e-2)"	"unprognostic (1.76e-1)"	"unprognostic (9.77e-2)"	"unprognostic (1.04e-1)"	16.9	28.3	15.8	19.1	16.3	14.5	16.3	14.5	20.0	15.2	11.9	28.6	27.2	17.2	12.7	24.2	15.5	12.5	37.2	17.7	15.1	54.5	28.8	13.6	19.0	17.9	16.5	18.7	19.0	24.5	12.7	17.7	18.1	15.4	31.7	16.5	17.1	13.8	44.0	20.3	23.3	17.6	13.5	23.3	21.7	16.5	17.8	15.4	14.6	35.9	18.5	18.6	16.2	17.7	44.5	41.5	47.6	44.3	40.5	28.6	44.7	42.6	36.5	82.7	58.9	51.2	61.7	70.0	41.2	49.2	35.3	58.1	82.9	69.1	72.1	40.0	57.6	71.0	84.1	51.4	40.7	85.4	37.6	42.3	19.0	74.8	48.7	29.2	39.6	52.2	92.6	29.7	42.3	35.5	53.6	45.1	49.9	60.2	71.9	60.0	41.7	50.9	53.0	37.3	64.9	46.0	49.3	98.2	55.4	39.9	39.1	44.6	40.5	48.9	26.1	40.9	51.7	34.5	40.7	91.2	48.1	93.5	25.0	10.2	9.6	3.4	8.7	12.8	8.8	7.5	6.2	9.4	12.1	8.4	6.6	5.2	0.3	10.0	14.4	5.3	7.6	9.2	15.8	16.3	14.5	20.0	17.7	15.1	17.9	16.5	18.1	13.5	17.8	17.7	11.9	9.6	11.8	17.3	9.7	19.6	4.4	9.1	4.6	18.5	8.6	9.8	9.7	2.8	9.7	12.9	29.2	21.4	5.3	33.4	35.2	14.2	14.9	8.6	13.1	9.3	14.6	25.2	28.6	13.7	22.8	10.3	23.0	10.5	5.1	27.4	5.0	14.1	16.7	20.2	35.8	22.9	14.2	8.2	24.2	9.3	8.1	9.6	28.4	18.7	8.4	11.8	6.2	15.6	23.3	11.1	19.6	4.5	13.3	6.5	37.2	32.4	12.0	17.7	6.6	11.8	13.7	17.0	11.6	14.5	18.3	23.8	8.9	24.9	36.4	5.3
DNAJC13	"KIAA0678, RME8"	ENSG00000138246	"DnaJ heat shock protein family (Hsp40) member C13"	O75165	3	132417502-132539032	"Human disease related genes, Predicted membrane proteins"	"Protein transport, Transport"	Chaperone	"Disease variant, Neurodegeneration, Parkinson disease, Parkinsonism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036923, HPA036924"	Approved		Supported	Vesicles,Cytosol		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 52: Non-specific - Ribosome"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 10: Non-specific - Unknown function"	Vesicles	Cytosol	"HPA036923: AB_10672480, HPA036924: AB_2675386"	"unprognostic (3.35e-3)"	"unprognostic (7.47e-2)"	"unprognostic (9.16e-2)"	"unprognostic (1.20e-2)"	"unprognostic (9.71e-2)"	"unprognostic (4.92e-2)"	"prognostic unfavorable (7.49e-4)"	"unprognostic (3.68e-2)"	"unprognostic (3.38e-1)"	"unprognostic (1.92e-1)"	"prognostic unfavorable (8.36e-4)"	"unprognostic (1.92e-1)"	"unprognostic (4.81e-3)"	"unprognostic (2.15e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.34e-2)"	"unprognostic (1.22e-1)"	11.7	9.4	5.9	12.4	6.5	15.5	11.4	6.0	6.3	12.9	8.2	14.4	10.9	13.8	11.7	10.7	9.9	9.9	12.9	5.9	6.9	16.0	9.8	11.3	11.0	7.7	6.9	11.7	6.8	12.6	5.9	15.4	7.1	10.8	14.3	10.7	9.1	12.1	12.5	9.8	10.4	16.7	6.3	12.2	9.7	7.8	7.5	12.0	15.7	14.2	10.6	12.4	10.3	7.8	31.0	18.0	22.2	10.9	54.3	46.7	13.7	32.3	62.5	31.4	33.8	20.4	18.2	15.7	20.5	46.3	41.1	24.1	22.1	24.3	43.5	18.3	6.4	20.6	17.1	13.6	27.6	21.1	18.3	34.2	16.4	28.5	35.1	22.7	44.6	26.0	11.4	25.6	43.7	24.1	16.8	9.1	12.7	26.7	15.8	15.9	16.5	13.0	27.7	32.4	7.9	11.9	31.6	16.7	36.1	19.0	24.7	17.8	40.9	34.7	17.8	33.3	13.9	14.8	15.7	21.5	36.8	13.6	25.2	2.0	2.6	0.4	0.8	2.2	0.7	1.0	0.9	0.7	2.8	0.4	0.6	0.8	0.5	0.7	4.0	1.4	0.4	0.8	5.9	6.5	6.0	6.3	5.9	6.9	7.7	6.9	7.1	6.3	7.5	7.8	16.8	12.8	21.9	45.7	14.4	6.6	7.3	7.3	6.8	10.8	8.9	7.2	47.2	8.6	11.3	12.9	33.3	7.9	13.2	21.5	1.9	9.0	1.7	10.3	31.3	17.1	14.4	12.8	48.7	9.1	7.7	20.2	16.8	18.7	12.0	18.9	13.2	8.5	20.5	67.3	48.7	12.5	0.0	34.2	9.2	3.6	15.2	26.5	28.4	60.0	25.1	13.3	6.2	46.8	64.7	11.7	12.5	21.4	13.9	10.5	17.0	18.7	13.1	11.5	6.6	22.3	19.7	5.3	13.7	15.4	7.5	5.1	10.8	22.5	13.4	11.0
DNAJC2	"MPHOSPH11, MPP11, ZRF1, ZUO1, zuotin"	ENSG00000105821	"DnaJ heat shock protein family (Hsp40) member C2"	Q99543	7	103312289-103344830	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Chaperone, Chromatin regulator"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 248.5;Spermatocytes: 238.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 61.3"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020454	Approved		Supported	Cytosol		NA	Yes			"Cluster 42: Non-specific - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Cytosol		"HPA020454: AB_1859492"	"unprognostic (1.07e-1)"	"unprognostic (1.66e-1)"	"unprognostic (5.53e-2)"	"unprognostic (2.20e-2)"	"unprognostic (1.11e-1)"	"unprognostic (7.71e-2)"	"unprognostic (2.13e-3)"	"unprognostic (2.13e-3)"	"unprognostic (1.63e-2)"	"unprognostic (5.35e-2)"	"unprognostic (2.21e-2)"	"unprognostic (1.27e-2)"	"prognostic unfavorable (1.12e-5)"	"unprognostic (1.11e-1)"	"unprognostic (2.30e-1)"	"unprognostic (3.51e-1)"	"unprognostic (3.28e-1)"	15.7	13.4	10.2	12.2	10.7	42.0	13.4	12.7	19.2	13.1	10.5	11.9	14.7	12.8	9.7	13.8	12.1	9.8	13.5	10.5	10.4	16.4	15.7	11.2	16.8	10.0	10.7	15.7	13.4	9.0	12.6	11.9	10.3	12.3	11.9	8.7	12.6	7.7	32.5	13.6	11.9	7.4	9.3	12.2	12.9	31.3	11.4	12.3	12.7	12.7	13.2	18.8	12.8	11.8	52.7	38.1	21.4	38.7	16.1	22.6	41.6	35.1	25.8	38.5	28.6	52.9	37.2	74.9	53.7	24.4	55.2	35.5	57.5	25.7	58.4	40.6	43.4	55.1	38.7	47.3	28.6	97.9	41.2	19.6	21.9	44.9	39.4	16.2	25.6	27.8	128.3	46.2	32.0	83.8	95.0	102.1	75.9	56.8	57.0	59.7	43.0	70.1	22.8	24.8	40.6	38.7	47.7	66.2	39.7	39.6	28.1	49.8	30.8	37.5	59.9	83.3	68.1	48.9	67.8	146.0	27.3	97.9	47.6	61.3	9.0	9.3	10.9	10.3	12.1	11.7	10.9	11.7	9.4	13.7	12.5	12.5	3.6	16.4	15.3	11.2	12.8	5.9	10.2	10.7	12.7	19.2	10.5	10.4	10.0	10.7	10.3	9.3	11.4	11.8	31.3	25.6	47.0	10.7	46.1	64.6	78.7	37.3	35.3	27.1	26.3	36.6	32.3	22.8	50.2	22.0	41.7	43.7	45.9	31.1	35.2	45.0	248.5	43.8	50.1	39.6	35.3	29.9	24.7	46.0	75.5	41.0	42.8	44.2	53.7	50.1	18.5	30.6	39.6	21.9	17.9	39.0	26.4	24.5	41.3	37.3	39.4	37.8	19.6	13.1	42.9	19.3	44.3	24.1	20.6	50.2	32.9	31.2	36.9	79.2	36.4	31.0	43.4	29.0	39.5	63.7	64.8	238.7	131.9	33.5	62.1	55.4	43.2	58.3	51.9	91.5
DNAJC21	"DNAJA5, GS3, JJJ1"	ENSG00000168724	"DnaJ heat shock protein family (Hsp40) member C21"	Q5F1R6	5	34929559-34958964	"Disease related genes, Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA040789	Approved		Supported	Nucleoli,Cytosol		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 20: HeLa - Mitochondria"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Nucleoli, Cytosol"		"HPA040789: AB_10794147"	"unprognostic (1.37e-1)"	"unprognostic (6.01e-2)"	"unprognostic (1.17e-2)"	"unprognostic (1.26e-1)"	"unprognostic (2.69e-1)"	"unprognostic (1.42e-2)"	"prognostic unfavorable (2.36e-5)"	"unprognostic (1.77e-3)"	"unprognostic (3.04e-2)"	"unprognostic (6.68e-3)"	"unprognostic (5.99e-2)"	"unprognostic (6.02e-2)"	"unprognostic (9.27e-3)"	"unprognostic (1.54e-1)"	"unprognostic (3.26e-1)"	"unprognostic (2.57e-1)"	"unprognostic (6.02e-2)"	18.2	12.7	9.5	13.8	10.9	24.1	16.1	10.0	12.1	22.2	9.9	20.1	15.2	16.3	14.3	20.7	11.4	13.6	32.0	8.3	11.0	23.0	23.0	17.5	18.5	10.7	10.5	11.8	20.0	19.4	8.1	24.5	10.7	18.1	18.5	9.3	15.8	17.5	58.4	15.1	15.8	18.2	10.2	12.6	18.8	61.4	10.6	18.0	18.0	42.3	19.7	20.8	16.7	11.0	36.2	25.3	32.0	41.6	39.1	46.4	57.1	47.4	38.9	37.7	25.2	41.6	42.8	75.9	20.1	44.3	46.6	24.3	37.9	49.0	43.8	45.2	27.8	41.7	90.7	35.2	64.6	60.7	37.7	33.2	44.8	41.6	67.7	26.2	35.3	27.8	65.6	59.7	28.1	30.4	51.3	45.2	22.6	39.8	21.4	45.5	79.2	33.7	37.9	44.9	16.5	17.5	128.1	59.4	40.2	35.2	40.1	64.4	43.4	46.5	44.7	27.8	37.7	40.2	40.0	51.0	37.6	71.8	25.1	2.2	1.5	4.7	1.7	1.2	2.5	3.1	2.5	1.6	2.5	2.0	2.5	2.5	0.4	4.0	2.0	2.3	3.4	1.0	9.5	10.9	10.0	12.1	8.3	11.0	10.7	10.5	10.7	10.2	10.6	11.0	53.5	76.9	111.3	23.8	42.0	37.0	73.9	22.4	33.6	52.6	57.0	56.6	151.1	47.1	36.1	36.8	43.8	51.2	59.1	34.6	88.0	21.5	117.5	49.2	77.8	44.9	18.0	40.0	26.9	30.5	25.7	44.4	32.6	68.4	8.2	42.0	37.5	59.5	24.3	75.7	40.4	36.9	6.1	31.4	32.9	47.7	40.4	38.8	37.4	15.0	50.8	31.2	45.3	20.1	32.1	26.6	27.7	38.0	41.4	85.8	28.2	62.5	22.8	73.0	13.1	57.0	44.0	117.4	50.3	43.4	46.7	65.7	52.7	51.4	41.4	77.1
DNAJC5	"CLN4, DNAJC5A, FLJ00118, FLJ13070"	ENSG00000101152	"DnaJ heat shock protein family (Hsp40) member C5"	Q9H3Z4	20	63895126-63936031	"Disease related genes, Human disease related genes, Predicted membrane proteins"		Chaperone	"Disease variant, Neurodegeneration, Neuronal ceroid lipofuscinosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 123.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012139, HPA012737, HPA013154"	Approved		Supported	"Golgi apparatus,Vesicles,Plasma membrane"		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 31: Spermatids - Spermatogenesis"	"Golgi apparatus, Plasma membrane"	Vesicles	"HPA012139: , HPA012737: AB_1847293, HPA013154: AB_1847292"	"unprognostic (9.96e-3)"	"unprognostic (2.75e-1)"	"unprognostic (3.91e-1)"	"unprognostic (3.61e-2)"	"unprognostic (1.65e-1)"	"unprognostic (3.47e-2)"	"prognostic unfavorable (8.82e-6)"	"unprognostic (3.04e-2)"	"unprognostic (2.73e-1)"	"unprognostic (2.65e-2)"	"unprognostic (1.78e-3)"	"unprognostic (1.51e-1)"	"prognostic favorable (7.70e-6)"	"unprognostic (2.24e-2)"	"unprognostic (3.54e-2)"	"unprognostic (4.28e-3)"	"unprognostic (1.08e-2)"	12.6	22.1	30.8	10.7	33.0	16.9	11.1	10.2	39.1	11.4	2.1	17.6	11.5	12.1	5.7	42.0	11.6	7.4	25.8	36.2	31.0	17.7	12.8	18.0	9.9	27.9	23.9	8.8	22.7	21.2	28.5	8.4	30.4	16.7	6.9	28.1	16.2	11.5	14.5	19.2	17.5	8.6	13.8	22.2	20.8	10.7	26.8	8.4	16.8	9.5	8.5	13.4	16.9	25.7	25.2	23.7	19.8	18.8	19.4	15.9	14.6	28.6	27.4	49.4	23.8	52.7	30.2	9.8	31.6	28.2	22.7	36.4	15.9	53.6	16.0	8.2	11.3	19.3	17.4	25.8	18.1	19.2	43.5	18.0	39.9	22.9	11.7	19.1	24.2	16.5	19.2	8.9	22.6	17.3	21.1	30.9	7.1	21.0	26.5	21.0	10.9	10.7	16.4	22.6	21.4	13.9	30.8	48.7	17.8	11.6	23.5	75.9	43.7	42.6	14.4	20.4	21.5	11.1	5.6	13.6	42.9	25.3	25.4	0.7	3.2	2.6	3.2	3.7	1.8	1.6	1.8	2.7	2.5	1.4	2.5	2.5	3.1	1.5	3.1	3.9	3.1	2.6	30.8	33.0	10.2	39.1	36.2	31.0	27.9	23.9	30.4	13.8	26.8	25.7	12.8	6.4	17.8	19.2	10.4	20.8	18.5	25.5	20.5	60.7	17.4	14.1	31.7	14.3	23.2	23.9	62.6	18.5	19.1	71.7	13.7	20.5	48.9	23.9	8.5	18.7	32.4	10.3	37.1	37.6	18.4	12.4	27.0	23.5	1.3	12.1	23.9	27.8	43.5	79.1	38.8	33.3	14.2	51.0	24.8	123.5	7.2	31.4	14.2	25.3	36.9	27.9	22.6	19.1	26.2	59.0	41.1	12.4	17.3	39.5	62.0	22.9	29.4	47.0	13.1	9.0	13.1	13.5	13.2	28.0	22.9	30.2	15.0	13.3	28.4	64.5
DNAJC7	"TPR2, TTC2"	ENSG00000168259	"DnaJ heat shock protein family (Hsp40) member C7"	Q99615	17	41976421-42021376	"Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023015, HPA052395"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA		22000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	Cytosol	"HPA023015: AB_1847804, HPA052395: AB_2681811"	"unprognostic (3.21e-2)"	"unprognostic (2.00e-2)"	"unprognostic (2.47e-3)"	"unprognostic (8.40e-2)"	"unprognostic (1.16e-1)"	"unprognostic (5.31e-3)"	"prognostic unfavorable (3.35e-4)"	"unprognostic (7.71e-2)"	"unprognostic (2.58e-2)"	"unprognostic (1.90e-2)"	"unprognostic (2.48e-2)"	"unprognostic (8.37e-2)"	"unprognostic (3.37e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.42e-2)"	"unprognostic (2.32e-2)"	"unprognostic (8.93e-3)"	41.7	50.5	122.8	43.5	126.4	40.4	39.6	125.0	204.0	39.5	124.2	46.5	37.3	28.3	50.5	66.7	33.8	26.2	85.3	126.8	128.6	65.4	67.0	38.9	53.4	127.6	127.1	43.0	54.9	54.5	55.2	35.9	127.2	37.4	45.4	49.2	39.2	25.0	99.8	48.2	38.1	27.6	124.1	45.1	49.1	46.0	125.5	56.5	38.2	73.0	67.7	40.7	41.3	128.1	99.2	129.6	130.8	100.1	68.5	106.5	120.0	103.6	98.8	139.7	110.6	143.5	93.9	142.0	118.2	113.2	118.4	140.6	192.3	127.9	169.7	123.6	220.1	102.6	116.0	189.7	100.8	185.0	102.7	92.4	82.3	131.5	104.4	101.5	114.8	122.4	160.7	98.9	122.2	66.5	210.8	155.0	139.4	92.3	87.1	124.0	175.4	123.6	116.9	104.8	117.7	104.7	84.9	243.6	126.1	128.7	139.3	177.8	110.3	80.1	105.0	100.1	163.3	72.0	159.4	122.9	103.0	124.0	97.1	49.7	55.9	35.9	30.9	57.8	35.2	39.6	36.3	36.1	57.7	41.9	33.4	32.6	19.8	49.4	59.8	98.5	43.8	38.8	122.8	126.4	125.0	204.0	126.8	128.6	127.6	127.1	127.2	124.1	125.5	128.1	62.2	35.3	38.3	39.2	87.1	65.4	94.4	107.8	37.5	80.5	46.7	43.4	57.6	61.5	54.0	66.2	135.5	108.6	139.0	81.1	115.4	107.6	108.3	83.7	77.8	71.8	111.4	52.4	33.9	132.5	103.8	50.9	38.7	70.6	57.0	105.5	71.4	56.4	102.4	63.9	37.3	63.4	67.1	102.1	99.6	52.3	67.4	94.6	48.0	34.7	166.5	100.0	121.5	36.7	142.0	125.2	62.1	61.3	79.7	77.4	79.2	155.8	61.7	143.5	46.0	78.9	78.5	104.7	111.9	49.3	68.8	126.8	81.9	127.2	79.1	94.6
DNAJC9	"JDD1, SB73"	ENSG00000213551	"DnaJ heat shock protein family (Hsp40) member C9"	Q8WXX5	10	73183362-73247255	"Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 91.9"	"Cell type enhanced"	"Detected in all"		"Erythroid cells: 173.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035215, HPA035216"	Supported		Supported	"Nucleoplasm,Plasma membrane"		NA	NA		39000	"Cluster 44: Non-specific - Transcription"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	"Plasma membrane"	"HPA035215: AB_10603663, HPA035216: AB_2674522"	"unprognostic (4.18e-2)"	"unprognostic (1.61e-2)"	"unprognostic (7.63e-2)"	"unprognostic (2.67e-3)"	"unprognostic (3.45e-1)"	"unprognostic (6.83e-3)"	"unprognostic (2.43e-3)"	"prognostic unfavorable (3.26e-4)"	"unprognostic (6.20e-2)"	"unprognostic (1.66e-1)"	"unprognostic (3.91e-1)"	"prognostic unfavorable (7.07e-5)"	"unprognostic (5.61e-2)"	"unprognostic (3.08e-3)"	"unprognostic (6.49e-2)"	"unprognostic (3.38e-1)"	"unprognostic (1.56e-1)"	9.2	10.6	17.1	17.6	17.5	91.9	15.4	19.2	21.5	11.2	15.4	16.0	14.6	12.8	12.4	16.9	9.7	6.9	8.6	16.9	17.0	10.0	13.4	9.6	28.2	16.4	16.5	15.3	8.7	10.2	10.6	17.6	16.9	11.4	18.0	25.1	11.3	11.2	11.5	17.7	13.9	11.8	15.7	14.8	12.2	12.4	17.0	35.8	8.4	13.1	32.3	11.5	11.9	17.6	135.0	77.3	93.8	68.4	16.1	19.3	45.7	101.5	59.4	101.1	106.1	130.8	89.4	86.9	33.5	43.6	43.7	83.1	92.9	67.5	118.1	98.5	63.8	188.3	79.4	93.4	14.8	173.1	71.0	14.8	33.2	107.1	93.4	36.4	66.2	112.1	168.3	103.0	81.4	118.4	155.0	124.7	36.3	64.4	215.1	114.2	85.1	47.6	52.9	61.5	44.3	73.4	73.5	114.5	52.9	43.7	62.1	76.8	48.0	65.2	118.3	71.3	168.0	45.0	70.6	141.8	64.8	162.9	45.9	23.9	3.7	29.1	25.5	10.7	29.2	32.8	31.3	28.2	6.5	28.3	30.3	26.9	4.5	24.8	10.9	20.3	36.8	18.0	17.1	17.5	19.2	21.5	16.9	17.0	16.4	16.5	16.9	15.7	17.0	17.6	17.3	9.6	12.3	11.1	39.5	47.7	34.1	31.9	33.0	26.1	21.5	24.8	2.7	17.2	24.8	9.2	8.4	107.8	44.6	18.3	21.5	31.5	80.4	15.9	14.0	20.6	12.0	173.8	11.8	31.4	111.4	17.6	12.2	19.0	42.3	26.0	13.9	9.8	61.9	15.2	12.8	25.6	54.9	10.9	19.6	43.3	14.0	17.4	32.0	6.5	23.0	29.5	32.0	7.5	6.5	44.1	16.7	20.3	49.7	27.6	18.2	16.3	21.9	43.2	26.3	17.7	28.3	28.7	65.4	38.2	43.5	58.0	45.2	19.7	38.0	37.5
DNASE1	DNL1	ENSG00000213918	"Deoxyribonuclease 1"	P24855	16	3611728-3680143	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"	Apoptosis	"Actin-binding, Endonuclease, Hydrolase, Nuclease"	"Systemic lupus erythematosus"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 34.5;kidney: 34.2"	"Cell type enriched"	"Detected in many"	11	"Proximal enterocytes: 715.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA010703	Enhanced		Supported	Vesicles	"Secreted in other tissues"	NA	NA		420000	"Cluster 49: Eosinophils - Unknown function"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 45: Enterocytes - Digestion"	Vesicles		"HPA010703: AB_10600806"	"unprognostic (5.18e-2)"	"unprognostic (1.78e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.74e-1)"	"unprognostic (2.38e-1)"	"unprognostic (1.90e-2)"	"unprognostic (3.73e-2)"	"unprognostic (3.82e-1)"	"unprognostic (3.20e-1)"	"unprognostic (9.91e-2)"	"unprognostic (1.69e-3)"	"unprognostic (5.37e-2)"	"unprognostic (1.37e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.45e-1)"	"prognostic favorable (1.14e-4)"	4.6	5.0	5.1	6.6	5.6	4.3	4.6	13.4	6.4	9.8	6.9	6.1	29.7	5.2	5.0	7.1	6.8	2.7	5.5	5.8	4.9	34.2	5.9	4.9	10.0	6.0	5.2	7.5	23.6	2.7	16.3	4.2	6.6	11.6	5.0	4.4	4.9	2.5	3.7	7.8	34.5	2.7	3.2	9.2	11.2	9.2	5.8	9.4	7.4	1.3	8.7	6.0	8.5	9.7	2.9	6.5	11.4	5.9	3.3	2.8	5.2	4.7	0.8	3.7	5.3	8.0	6.9	12.3	3.6	0.7	7.8	4.8	4.2	1.3	3.9	5.5	6.4	4.4	11.3	5.4	1.7	2.9	9.6	2.3	4.8	5.0	1.2	5.8	2.5	10.3	11.2	5.0	3.2	12.3	6.3	13.6	6.9	8.7	3.6	14.9	5.3	5.7	3.1	2.5	8.1	7.6	3.5	10.5	1.9	5.7	10.4	7.7	3.4	6.8	5.0	4.3	2.5	4.8	7.5	21.4	1.7	5.7	6.6	2.7	1.1	3.2	1.5	0.7	1.0	1.4	1.2	1.3	0.6	2.1	1.3	1.8	5.0	1.0	0.7	1.1	1.4	0.5	5.1	5.6	13.4	6.4	5.8	4.9	6.0	5.2	6.6	3.2	5.8	9.7	4.9	9.6	10.3	27.1	9.1	2.7	8.6	3.1	10.8	27.3	5.5	4.8	6.0	4.3	9.7	16.5	22.9	8.6	9.3	11.8	56.7	5.3	19.3	9.8	10.0	7.7	14.3	7.6	20.5	11.0	4.1	7.4	13.3	8.4	2.5	23.3	7.5	1.8	3.9	25.2	22.0	38.6	20.3	5.0	4.2	52.4	8.4	4.4	1.8	15.9	13.2	8.6	30.9	22.1	20.6	5.3	61.4	7.9	7.2	12.4	715.5	2.4	9.1	17.9	0.0	13.6	6.3	28.5	24.5	5.8	3.8	6.2	12.2	10.4	33.4	6.3
DND1	"MGC34750, RBMS4"	ENSG00000256453	"DND microRNA-mediated repression inhibitor 1"	Q8IYX4	5	140670794-140673576	"Predicted intracellular proteins"		"Developmental protein, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"testis: 12.2"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 11.4;Early spermatids: 42.6;Horizontal cells: 20.2;Spermatogonia: 40.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"U-266/70: 1.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA059723			Approved	Nucleoplasm,Mitochondria		NA	NA				"Cluster 78: Testis - Spermatogenesis"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 29: Early spermatids - Spermatogenesis"	"Nucleoplasm, Mitochondria"		"HPA059723: "																		0.4	0.2	2.5	0.0	2.6	0.2	0.4	2.7	3.3	0.5	2.3	0.4	0.1	0.3	0.2	0.4	0.6	0.0	0.4	2.5	2.6	1.1	1.0	0.6	0.1	2.7	2.7	0.4	0.8	0.4	1.3	0.1	2.6	0.9	0.4	0.0	0.3	0.2	0.7	0.6	0.6	0.2	2.6	1.0	0.3	12.2	2.8	0.6	0.6	0.1	0.6	0.3	0.4	2.7	0.1	0.2	0.3	0.2	0.3	0.1	0.7	0.0	0.3	1.1	1.0	0.3	0.2	0.3	0.1	0.2	0.1	0.3	0.7	0.3	0.4	0.2	0.7	0.1	0.7	0.1	0.4	0.2	0.4	0.2	1.1	0.9	0.5	0.1	0.4	0.3	0.2	0.0	0.4	0.1	0.0	1.1	0.2	0.0	0.7	0.9	0.1	0.1	0.5	0.1	0.5	0.4	0.0	0.0	0.3	0.2	0.1	0.2	0.0	0.3	0.6	0.2	0.0	1.6	0.4	0.1	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	2.6	2.7	3.3	2.5	2.6	2.7	2.7	2.6	2.6	2.8	2.7	0.4	3.2	1.1	3.9	1.3	0.5	0.9	0.8	0.0	11.4	1.1	1.0	0.0	1.5	0.7	3.7	4.2	0.3	0.7	0.5	0.0	0.2	42.6	1.2	1.4	0.9	1.2	2.7	3.6	0.4	0.6	0.7	0.5	1.6	0.0	1.7	1.1	1.9	0.6	20.2	3.5	0.9	0.0	1.3	1.5	7.2	0.6	1.0	0.0	1.0	0.2	2.5	1.0	2.5	3.6	0.4	0.1	0.4	0.6	2.0	0.4	0.1	0.5	6.6	0.0	1.7	0.8	6.2	40.0	1.0	1.0	0.3	1.9	0.4	0.9	1.6
DNLZ	"bA413M3.2, C9orf151, HEP, RP11-413M3.2, TIMM15, ZIM17"	ENSG00000213221	"DNL-type zinc finger"	Q5SXM8	9	136359480-136363744	"Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 9.1;Suprabasal keratinocytes: 9.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 13.4;MCF7: 13.2;REH: 13.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA062738			Supported	Nucleoplasm,Mitochondria		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 72: Non-specific - Transcription"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 59: Non-specific - Transcription"	Mitochondria	Nucleoplasm	"HPA062738: AB_2684857"	"unprognostic (2.81e-1)"	"unprognostic (2.93e-1)"	"unprognostic (8.73e-3)"	"unprognostic (2.05e-2)"	"unprognostic (1.30e-1)"	"unprognostic (9.31e-2)"	"unprognostic (1.93e-2)"	"unprognostic (1.61e-2)"	"unprognostic (7.61e-2)"	"unprognostic (2.30e-1)"	"unprognostic (9.51e-3)"	"unprognostic (4.50e-2)"	"unprognostic (2.56e-2)"	"unprognostic (9.07e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.50e-1)"	"unprognostic (4.90e-2)"	16.4	12.2	2.1	0.9	2.5	0.9	16.4	2.7	3.4	16.0	1.4	16.9	1.1	16.6	0.4	10.0	14.1	0.5	36.5	2.1	2.0	23.0	14.4	12.6	1.0	2.2	2.3	12.1	27.9	0.9	11.4	0.4	2.4	12.5	0.1	0.3	10.1	0.5	23.1	13.8	11.3	0.3	2.0	15.5	13.5	12.0	2.3	0.8	12.5	3.8	0.4	17.3	12.2	2.6	1.7	2.8	0.9	3.3	0.5	0.9	1.8	1.8	1.3	2.3	1.0	3.5	1.9	4.1	9.7	1.8	1.7	3.4	0.6	1.7	0.2	13.4	3.1	1.1	1.3	1.0	1.9	2.2	1.4	1.4	1.7	1.8	1.1	0.6	1.2	2.0	1.7	2.9	1.5	13.2	4.5	2.7	5.2	2.7	7.6	13.4	1.6	5.1	2.9	1.6	4.1	4.7	2.8	1.9	2.9	0.5	2.6	1.4	2.8	4.0	3.5	2.8	4.6	2.7	3.3	3.5	2.6	0.9	3.7	0.7	0.0	0.0	0.4	0.2	0.7	1.3	0.6	0.7	0.1	0.5	0.6	0.6	0.1	0.1	0.1	0.3	0.8	0.0	2.1	2.5	2.7	3.4	2.1	2.0	2.2	2.3	2.4	2.0	2.3	2.6	5.4	0.0	0.0	3.3	6.0	8.4	1.1	0.0	9.1	0.6	4.7	3.9	0.8	0.0	0.7	5.5	0.0	1.0	4.3	1.2	1.9	0.5	0.1	3.0	6.9	3.4	0.0	1.7	2.0	1.1	0.9	3.7	3.6	2.6	0.0	1.0	1.4	1.1	1.0	0.0	2.1	1.2	0.0	0.3	7.5	0.2	1.2	3.0	1.8	1.9	0.6	0.3	2.1	2.5	3.5	0.6	0.3	1.2	7.1	0.6	0.8	3.0	0.1	0.4	0.0	2.5	3.7	1.5	4.8	5.7	9.1	1.1	6.9	1.1	0.9	0.9
DNM1L	"DRP1, DVLP, DYMPLE, HDYNIV, VPS1"	ENSG00000087470	"Dynamin 1 like"	O00429	12	32679200-32745650	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Biological rhythms, Endocytosis, Necrosis"	Hydrolase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB009952, HPA039324"	Approved		Enhanced	Vesicles,Cytosol		NA	NA		2000000	"Cluster 27: Non-specific - Gene expression"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 46: Photoreceptor cells - Phototransduction"	Cytosol	Vesicles	"CAB009952: AB_2093533, HPA039324: AB_2676443"	"unprognostic (2.64e-2)"	"unprognostic (2.94e-1)"	"unprognostic (1.10e-3)"	"unprognostic (1.12e-1)"	"unprognostic (5.09e-1)"	"unprognostic (4.06e-2)"	"prognostic unfavorable (6.27e-6)"	"unprognostic (8.68e-2)"	"unprognostic (2.25e-2)"	"unprognostic (1.04e-2)"	"unprognostic (1.71e-1)"	"unprognostic (2.63e-1)"	"unprognostic (4.06e-1)"	"unprognostic (1.00e-1)"	"unprognostic (8.17e-2)"	"unprognostic (7.48e-2)"	"unprognostic (1.57e-2)"	23.2	23.2	25.3	23.5	27.5	40.0	21.1	27.7	32.3	18.4	15.7	24.0	18.6	23.6	23.9	28.6	19.8	17.5	38.9	28.4	26.1	27.9	14.2	16.7	20.9	22.5	22.0	20.0	13.5	40.5	25.3	23.9	23.6	27.0	22.7	44.9	16.0	28.7	43.8	18.3	16.8	32.0	22.2	18.8	17.3	36.0	21.6	21.4	22.4	57.2	24.8	29.9	18.5	26.6	66.8	62.3	64.3	68.3	51.2	52.7	123.2	72.0	55.4	67.2	61.7	80.6	48.0	87.3	50.0	65.8	66.9	57.8	69.2	80.3	79.3	46.6	57.6	102.3	57.2	48.2	41.7	72.5	50.1	48.6	37.4	70.7	66.1	63.5	81.1	41.4	74.4	37.5	75.3	21.7	29.1	61.7	138.2	41.0	30.8	48.6	125.0	61.5	56.5	79.1	57.1	59.3	76.3	51.8	56.7	129.4	59.7	49.0	74.0	57.3	54.4	135.3	68.2	26.1	75.8	86.3	55.6	47.0	43.5	7.4	10.0	3.2	5.6	15.6	6.9	7.0	6.2	6.1	18.8	6.0	7.3	8.4	1.8	8.1	15.6	5.6	7.3	7.9	25.3	27.5	27.7	32.3	28.4	26.1	22.5	22.0	23.6	22.2	21.6	26.6	42.5	38.5	38.4	82.6	36.0	30.0	34.7	28.0	44.3	80.9	32.5	29.2	82.8	20.0	33.3	25.8	131.3	30.0	53.8	26.7	31.3	34.8	63.9	38.8	55.8	42.0	30.5	28.4	139.4	25.1	63.7	41.0	23.9	59.4	50.7	48.8	26.4	16.0	30.8	126.2	150.0	24.9	34.6	27.5	30.7	78.0	26.8	43.3	14.2	44.0	45.6	59.0	34.0	99.5	121.7	45.7	14.4	30.5	48.5	42.8	11.4	23.3	22.8	164.8	19.7	55.0	55.5	79.3	52.3	39.6	27.6	36.0	42.2	26.0	31.5	36.4
DNMT1	"CXXC9, DNMT, MCMT"	ENSG00000130816	"DNA methyltransferase 1"	P26358	19	10133342-10231286	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Chromatin regulator, DNA-binding, Methyltransferase, Repressor, Transferase"	"Deafness, Disease variant, FDA approved drug targets, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in all"		"Cytotrophoblasts: 388.1;Spermatocytes: 229.6;Syncytiotrophoblasts: 323.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002694, CAB005876"	Enhanced		Supported	Nucleoplasm		NA	Yes			"Cluster 6: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 47: Cytotrophoblasts - Unknown function"	Nucleoplasm		"CAB005876: AB_731983, HPA002694: AB_1847810"	"unprognostic (3.51e-1)"	"unprognostic (1.20e-2)"	"unprognostic (1.26e-2)"	"unprognostic (1.40e-1)"	"unprognostic (3.62e-1)"	"unprognostic (7.59e-3)"	"prognostic unfavorable (1.46e-4)"	"unprognostic (2.90e-1)"	"unprognostic (4.23e-3)"	"unprognostic (1.10e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.11e-2)"	"unprognostic (1.28e-3)"	"unprognostic (7.81e-3)"	"unprognostic (1.73e-1)"	"unprognostic (8.11e-2)"	"unprognostic (1.46e-1)"	7.1	3.9	0.9	16.9	2.9	23.1	7.0	11.7	3.1	9.1	0.0	6.9	6.6	7.3	3.1	7.7	6.5	6.2	4.8	2.1	6.6	3.0	3.9	7.8	26.2	3.8	4.5	5.6	3.6	4.3	4.5	26.0	5.7	4.5	6.8	7.5	5.6	4.6	5.3	7.9	7.9	8.8	0.3	8.1	6.3	12.4	3.3	20.6	6.3	5.0	24.9	7.3	6.4	10.6	77.0	40.6	49.5	45.8	24.6	24.0	138.8	52.4	43.9	77.5	74.9	50.6	40.8	138.3	33.8	30.0	38.6	46.6	68.4	44.2	68.4	57.5	100.9	181.5	39.5	27.1	9.6	91.5	73.4	11.5	9.3	68.5	24.1	18.4	39.9	37.6	75.0	82.8	63.3	37.6	109.2	50.4	87.5	38.3	76.6	117.1	67.9	77.2	21.5	49.3	64.5	41.5	58.2	26.2	16.5	33.6	28.9	42.2	31.8	111.3	42.2	73.0	84.4	49.6	69.5	166.8	35.0	68.5	87.1	20.3	21.2	5.9	29.8	22.0	25.1	14.2	22.8	20.4	19.3	20.0	25.5	20.5	4.6	42.6	13.8	31.9	21.9	12.6	0.9	2.9	11.7	3.1	2.1	6.6	3.8	4.5	5.7	0.3	3.3	10.6	36.4	6.4	26.5	12.7	38.0	29.6	20.7	26.8	21.1	86.7	32.6	29.6	14.6	7.2	28.2	22.0	56.3	388.1	54.4	29.0	13.7	26.0	46.1	48.1	42.0	38.9	15.7	109.6	17.6	14.3	73.2	33.6	33.6	60.3	37.2	43.6	25.0	14.8	76.8	65.6	22.6	25.5	38.7	31.4	47.8	50.8	28.0	57.9	14.2	15.0	52.5	32.2	123.6	14.6	20.1	21.1	11.3	28.6	73.4	16.3	4.5	9.3	42.8	50.2	13.1	22.6	32.8	229.6	145.3	41.6	22.4	323.7	70.4	38.7	43.1	16.6
DNMT3A		ENSG00000119772	"DNA methyltransferase 3 alpha"	Q9Y6K1	2	25227855-25342590	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transcription factors"		"Chromatin regulator, DNA-binding, Methyltransferase, Repressor, Transferase"	"Cancer-related genes, Disease variant, Dwarfism, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cone photoreceptor cells: 127.2;Horizontal cells: 95.9;Rod photoreceptor cells: 143.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"NTERA-2: 59.6;REH: 59.5;SH-SY5Y: 71.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009469, HPA026588"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 9: Photoreceptor cells - Phototransduction"	Nucleoplasm		"CAB009469: AB_2093990, HPA026588: AB_1847812"	"unprognostic (2.38e-1)"	"unprognostic (2.94e-1)"	"unprognostic (5.65e-2)"	"prognostic unfavorable (1.55e-4)"	"unprognostic (8.38e-2)"	"unprognostic (7.27e-2)"	"prognostic unfavorable (1.58e-4)"	"unprognostic (2.24e-1)"	"unprognostic (7.25e-2)"	"unprognostic (2.72e-1)"	"prognostic favorable (1.18e-4)"	"unprognostic (2.35e-2)"	"prognostic unfavorable (2.49e-4)"	"unprognostic (1.43e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.14e-1)"	"unprognostic (2.70e-2)"	5.6	9.0	8.9	9.8	12.6	8.7	6.2	9.3	10.7	9.1	2.4	11.3	6.7	9.3	8.7	6.0	7.5	6.3	5.9	8.8	7.9	11.3	5.3	7.3	11.1	9.0	7.6	13.0	8.3	4.2	11.5	15.7	8.6	7.2	6.6	15.4	6.2	5.9	21.0	4.9	8.9	7.1	5.2	13.4	8.5	5.2	9.4	20.6	6.9	10.2	9.0	7.3	6.2	11.3	1.6	8.1	34.6	8.3	3.8	2.7	45.2	1.9	2.2	4.7	3.8	21.1	13.2	0.0	4.7	4.7	3.5	2.2	3.8	5.2	2.8	5.7	4.3	14.7	12.8	25.4	8.8	2.9	7.6	8.2	2.6	6.0	2.2	9.1	19.5	34.0	18.0	2.9	3.5	20.6	33.7	36.5	59.6	14.3	4.2	59.5	32.5	3.8	2.9	3.4	18.6	71.5	2.7	19.6	6.2	29.5	2.1	16.2	6.8	5.4	4.7	1.0	2.5	5.6	5.1	19.6	2.2	8.4	5.5	2.8	1.0	2.1	2.7	1.7	4.0	1.3	1.7	2.4	1.3	1.6	4.6	3.9	2.5	5.5	2.7	2.3	1.9	1.2	8.9	12.6	9.3	10.7	8.8	7.9	9.0	7.6	8.6	5.2	9.4	11.3	18.5	6.4	13.1	28.1	11.0	5.2	10.2	6.6	5.7	73.3	12.1	9.8	15.8	5.7	9.9	20.2	127.2	40.6	15.3	6.3	5.9	16.9	1.6	13.3	19.1	20.5	13.1	15.8	49.4	9.8	10.7	16.4	9.7	10.7	37.4	37.3	11.0	6.4	23.2	95.9	43.2	11.4	2.0	14.2	3.9	1.9	19.3	13.7	7.2	38.4	7.4	20.6	13.4	36.7	63.4	9.3	9.4	15.4	9.8	12.4	6.2	6.6	7.3	143.5	19.7	15.1	14.3	2.8	14.6	8.1	2.6	32.2	19.6	26.1	12.1	10.2
DNMT3B		ENSG00000088305	"DNA methyltransferase 3 beta"	Q9UBC3	20	32762385-32809356	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Transcription factors"		"Activator, DNA-binding, Methyltransferase, Repressor, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 5.3;Extravillous trophoblasts: 5.2;Horizontal cells: 5.0;Inhibitory neurons: 6.8;Sertoli cells: 6.6"	"Cancer enriched"	"Detected in all"	25	"testis cancer: 111.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BEWO: 245.7;CACO-2: 95.8;HEL: 100.7;K-562: 98.6;NTERA-2: 333.9;SuSa: 174.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA001595, HPA001803, CAB069896"	Enhanced		Supported	Nucleoplasm		NA	Yes				"Cluster 23: Testis - Cell cycle regulation"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm		"CAB069896: AB_2094115, HPA001595: AB_1847814, HPA001803: "	"unprognostic (7.65e-3)"	"unprognostic (3.52e-3)"	"unprognostic (1.17e-1)"	"prognostic unfavorable (5.04e-4)"	"unprognostic (3.42e-1)"	"unprognostic (7.27e-2)"	"unprognostic (4.39e-4)"	"unprognostic (4.18e-3)"	"unprognostic (8.60e-3)"	"unprognostic (8.48e-2)"	"unprognostic (6.79e-2)"	"unprognostic (4.65e-2)"	"prognostic unfavorable (1.87e-7)"	"unprognostic (6.62e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.50e-1)"	"unprognostic (6.55e-2)"	0.8	0.6	1.2	0.8	1.5	3.6	1.3	2.4	1.6	1.3	1.0	0.7	0.8	1.0	3.1	0.8	0.7	0.8	1.0	1.2	1.6	1.7	1.2	0.7	0.9	1.4	1.3	0.8	6.0	1.1	0.6	2.0	1.3	0.8	0.7	3.0	1.2	0.6	0.5	3.8	0.8	0.9	1.0	1.0	0.9	5.8	1.4	3.7	1.7	0.2	0.9	1.3	1.1	1.4	3.9	5.3	27.0	6.2	0.5	2.1	245.7	3.5	2.4	3.6	3.8	95.8	4.3	10.0	9.7	1.7	4.3	2.2	17.6	1.7	3.0	1.2	14.0	100.7	3.3	18.5	0.9	4.6	9.7	2.3	1.9	5.5	1.1	1.8	6.6	6.2	98.6	2.7	1.4	15.7	15.6	86.1	333.9	8.8	3.2	15.4	4.5	2.3	9.1	4.2	8.6	5.7	5.9	8.5	2.5	174.4	5.8	5.5	1.6	5.5	12.3	2.8	2.6	5.9	2.8	3.8	2.6	27.4	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	1.2	1.5	2.4	1.6	1.2	1.6	1.4	1.3	1.3	1.0	1.4	1.4	1.6	0.0	1.5	3.9	0.1	0.9	0.2	0.3	0.6	2.1	1.5	1.3	1.3	0.0	0.8	0.0	2.1	5.3	0.3	0.2	0.0	1.3	0.1	0.8	0.9	1.6	0.0	4.6	1.1	0.6	5.2	1.2	0.5	2.2	0.0	1.3	0.7	0.6	0.8	5.0	6.8	0.3	0.0	0.3	0.3	1.0	0.0	0.7	0.0	1.9	0.1	0.8	0.0	1.5	1.3	1.0	0.1	0.4	1.3	0.3	0.1	1.3	0.1	2.5	6.6	0.3	0.9	0.1	2.6	0.9	1.3	4.8	0.3	0.8	0.6	0.1
DNPEP	"ASPEP, DAP"	ENSG00000123992	"Aspartyl aminopeptidase"	Q9ULA0	2	219372043-219400022	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Aminopeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 364.4;Late spermatids: 462.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036398, HPA044860"	Enhanced		Supported	Cytosol		NA	NA		2700000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 10: Non-specific - Unknown function"	Cytosol		"HPA036398: AB_10970915, HPA044860: AB_10961275"	"unprognostic (3.71e-1)"	"unprognostic (6.45e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.05e-2)"	"unprognostic (1.55e-2)"	"unprognostic (2.75e-1)"	"unprognostic (2.54e-3)"	"unprognostic (3.34e-2)"	"unprognostic (2.44e-1)"	"unprognostic (3.49e-2)"	"unprognostic (1.61e-1)"	"unprognostic (6.13e-2)"	"unprognostic (1.67e-1)"	"unprognostic (5.63e-3)"	"unprognostic (3.49e-1)"	"unprognostic (2.50e-1)"	"unprognostic (1.85e-3)"	25.8	18.9	15.4	25.0	15.8	18.0	23.6	14.8	18.6	24.9	14.7	34.5	56.5	22.4	21.5	25.1	25.1	22.6	39.9	16.2	16.9	22.1	32.0	27.6	23.4	15.8	15.0	30.2	27.2	25.8	13.0	37.1	15.2	22.6	30.8	9.5	26.2	24.4	64.5	31.7	56.2	19.9	16.0	24.7	25.4	58.5	17.4	17.5	15.2	46.4	16.2	29.6	21.6	14.7	47.5	25.8	15.4	45.7	39.7	32.2	122.0	23.0	46.5	59.3	62.5	72.6	61.2	27.2	48.7	49.5	76.0	45.0	18.6	53.6	21.3	56.4	12.5	46.6	25.0	79.8	107.2	38.9	32.2	54.4	55.4	61.8	50.2	37.9	41.2	38.6	53.8	45.3	31.0	103.7	60.8	44.5	25.5	67.7	15.1	77.2	35.7	36.5	33.0	74.0	19.1	26.0	27.1	86.5	34.5	26.9	25.8	43.3	23.5	55.4	46.1	31.4	33.7	49.6	31.8	21.3	80.0	37.7	24.1	8.7	17.2	7.3	16.1	19.7	18.8	13.2	13.2	18.3	20.8	16.2	14.0	18.7	1.6	21.2	17.0	7.2	16.6	14.8	15.4	15.8	14.8	18.6	16.2	16.9	15.8	15.0	15.2	16.0	17.4	14.7	43.1	12.8	18.2	8.8	35.6	38.6	74.1	55.1	52.9	19.3	41.2	36.7	33.6	55.8	27.2	25.8	33.3	90.4	26.7	70.4	49.0	62.9	364.4	16.5	36.5	41.8	48.0	19.8	3.1	66.3	96.9	43.4	29.0	19.6	24.1	39.1	30.4	47.9	51.0	10.1	5.2	110.3	38.7	31.5	26.8	462.0	52.5	26.2	32.0	4.7	53.0	29.8	45.3	3.0	3.3	52.3	75.6	41.0	38.3	113.1	202.6	79.6	16.3	37.6	26.3	31.9	120.0	20.1	20.1	43.4	44.8	66.4	34.1	36.9	70.9	74.6
DNPH1	"C6orf108, dJ330M21.3, rcl"	ENSG00000112667	"2'-deoxynucleoside 5'-phosphate N-hydrolase 1"	O43598	6	43225629-43229481	"Predicted intracellular proteins"	"Nucleotide metabolism"	"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 450.0;Proximal enterocytes: 818.0;Proximal tubular cells: 1091.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"OE19: 547.1;RPMI-8226: 347.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029675, HPA029676"	Enhanced		Approved	Nucleoplasm,Cytosol		No	No		540000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 21: OE19 - Mitochondria"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Nucleoplasm	Cytosol	"HPA029675: AB_10599998, HPA029676: AB_10599424"	"unprognostic (1.12e-2)"	"unprognostic (1.38e-1)"	"unprognostic (4.03e-3)"	"unprognostic (8.24e-3)"	"unprognostic (1.69e-1)"	"unprognostic (3.53e-2)"	"unprognostic (2.61e-1)"	"unprognostic (7.72e-2)"	"unprognostic (2.43e-1)"	"unprognostic (2.33e-3)"	"unprognostic (2.25e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.74e-1)"	"unprognostic (5.52e-2)"	"unprognostic (1.36e-1)"	"unprognostic (2.77e-2)"	"unprognostic (5.10e-2)"	46.1	103.3	42.7	29.1	45.1	23.2	37.2	40.2	66.2	45.2	66.7	68.7	104.0	50.2	8.3	62.3	57.8	13.2	46.5	41.7	45.7	172.4	136.8	31.8	33.0	39.9	42.5	40.3	100.7	75.8	37.2	9.2	41.5	42.0	17.9	6.0	45.8	18.7	89.5	42.2	88.3	11.4	43.2	61.6	57.5	10.2	46.1	17.0	35.8	44.7	18.8	39.1	39.8	42.3	189.4	135.3	20.7	86.2	14.4	44.5	64.1	44.9	16.1	29.8	38.9	55.8	67.2	134.9	69.4	15.3	1.5	95.1	16.2	35.7	8.6	72.4	318.7	63.7	127.4	161.2	34.1	54.3	40.3	28.1	44.3	9.0	26.7	12.0	39.6	96.8	147.1	232.0	24.5	311.8	52.3	135.3	41.5	547.1	81.5	87.0	27.7	347.3	52.1	63.6	79.8	96.2	41.4	108.5	95.7	6.6	149.2	177.9	49.7	22.6	39.2	51.6	90.2	160.7	79.6	109.5	14.3	71.6	36.0	1.2	109.7	4.8	42.4	237.9	78.5	219.8	138.8	74.6	178.2	194.6	122.2	83.8	4.1	42.0	176.6	135.3	269.7	92.3	42.7	45.1	40.2	66.2	41.7	45.7	39.9	42.5	41.5	43.2	46.1	42.3	16.4	28.9	38.2	5.5	73.9	61.3	91.3	147.6	68.3	11.9	138.4	181.0	91.0	163.0	80.9	115.8	2.1	53.4	12.9	164.0	450.0	201.6	0.6	159.5	66.4	30.8	64.8	78.8	4.1	107.2	66.5	60.1	88.7	39.1	33.7	108.4	28.5	231.2	308.3	6.7	4.9	216.6	93.6	75.8	62.3	3.1	67.1	63.4	110.3	1.0	36.7	78.4	10.3	5.5	5.1	157.2	155.3	59.8	81.8	112.6	818.0	1091.6	260.3	23.5	0.0	39.4	57.9	8.9	38.1	131.5	73.6	32.3	44.5	82.2	288.9	101.4
DNTT	TDT	ENSG00000107447	"DNA nucleotidylexotransferase"	P04053	10	96304409-96338564	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Terminal addition"	"Nucleotidyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	12	"lymphoid tissue: 329.1"	"Group enriched"	"Detected in some"	5	"Early spermatids: 11.3;Late spermatids: 6.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in single"		"naive CD4 T-cell: 1.3"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in some"	5	"MOLT-4: 416.0;REH: 1415.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA036532, HPA044194"			Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 63: T-cells - Adaptive immune response"	"Cluster 14: REH - Unknown function"	"Cluster 34: Spermatids - Unknown function"	Nucleoplasm	Cytosol	"HPA036532: , HPA044194: AB_10960525"								"unprognostic (4.24e-1)"					"unprognostic (1.00e-1)"		"unprognostic (2.60e-2)"	"unprognostic (1.86e-2)"		0.0	0.0	0.0	0.2	0.1	27.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.7	0.0	329.1	0.4	0.0	2.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	195.3	0.0	0.0	0.0	0.0	416.0	0.0	0.1	0.0	0.0	1415.1	0.0	0.6	0.0	0.0	0.4	0.0	0.0	2.1	0.0	0.3	0.4	0.0	0.0	0.0	0.4	0.7	0.0	0.2	0.1	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.3	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	6.8	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0
DNTTIP1	"C20orf167, dJ447F3.4, Tdif1"	ENSG00000101457	"Deoxynucleotidyltransferase terminal interacting protein 1"	Q9H147	20	45791954-45811427	"Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 124.8"	"Group enriched"	"Detected in all"	6	"dendritic cells: 43.3;granulocytes: 124.8;monocytes: 50.9"	"Cell line enhanced"	"Detected in all"		"PC-3: 280.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045496			Supported	"Nucleoplasm,Nucleoli,Nucleoli rim,Mitotic chromosome"		Yes	No			"Cluster 52: Eosinophils - Transcription"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 3: Monocytes - Immune response regulation"	"Nucleoli, Nucleoli rim, Mitotic chromosome"	Nucleoplasm	"HPA045496: "	"unprognostic (7.77e-2)"	"unprognostic (2.19e-1)"	"unprognostic (2.07e-1)"	"unprognostic (4.52e-2)"	"unprognostic (2.50e-1)"	"unprognostic (3.05e-2)"	"prognostic unfavorable (1.79e-5)"	"unprognostic (6.29e-2)"	"unprognostic (7.16e-2)"	"unprognostic (1.85e-1)"	"unprognostic (5.81e-3)"	"unprognostic (5.63e-2)"	"prognostic unfavorable (1.90e-6)"	"unprognostic (3.18e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.30e-1)"	19.9	19.4	22.8	24.7	23.2	44.1	20.0	23.3	26.1	21.0	23.9	33.2	17.5	27.2	25.0	19.5	24.7	21.7	27.3	23.1	24.2	19.2	19.3	22.3	23.7	23.2	24.3	20.6	15.8	26.1	20.8	23.1	23.4	22.0	38.7	21.7	19.4	22.8	62.0	28.2	21.0	24.4	23.4	25.3	24.6	30.4	23.8	30.1	19.6	31.0	28.0	34.0	19.3	24.4	79.8	41.6	42.1	40.2	31.7	34.1	43.7	29.2	47.1	92.7	83.4	134.8	126.1	32.8	93.2	42.9	147.1	58.4	37.3	62.8	61.1	18.0	47.2	36.0	45.2	87.2	64.4	70.0	56.7	34.4	58.0	60.8	58.2	42.4	55.1	46.9	33.9	32.6	56.0	107.5	57.9	108.2	28.7	44.8	280.7	46.0	52.3	34.4	47.4	37.9	39.5	35.6	59.7	48.2	65.2	32.7	47.6	111.4	32.6	55.4	41.1	54.0	71.0	35.5	24.8	41.0	120.5	44.8	48.1	16.7	50.9	71.0	4.1	22.0	4.2	12.0	5.5	7.0	43.3	11.1	10.1	4.7	124.8	3.3	13.6	16.6	9.3	13.5	22.8	23.2	23.3	26.1	23.1	24.2	23.2	24.3	23.4	23.4	23.8	24.4	21.2	16.0	22.9	10.1	22.0	25.5	44.8	43.1	22.2	19.8	20.3	23.0	19.9	21.5	37.1	25.8	4.2	60.7	14.3	37.2	50.9	57.6	37.9	35.1	19.4	22.6	22.2	9.7	11.2	75.4	43.0	25.7	26.5	20.6	6.3	26.4	25.0	16.6	70.8	20.2	9.5	92.7	59.0	26.3	34.7	15.7	28.3	32.4	16.0	11.2	68.3	53.1	15.5	7.5	10.6	105.0	50.5	27.1	21.9	38.2	33.3	44.2	48.0	29.7	0.0	20.8	26.5	92.9	35.4	19.4	27.6	57.7	16.3	32.9	34.8	60.7
DOCK10	"KIAA0694, ZIZ3"	ENSG00000135905	"Dedicator of cytokinesis 10"	Q96BY6	2	224765090-225042468	"Plasma proteins, Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 83.1;lymphoid tissue: 32.1"	"Cell type enriched"	"Detected in many"	4	"Oligodendrocytes: 1806.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ: 45.5;GAMG: 73.4;HDLM-2: 52.7;TIME: 48.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA058106	Enhanced	Supported	Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Nucleoplasm, Cytosol"		"HPA058106: AB_2683606"	"unprognostic (6.95e-2)"	"unprognostic (1.41e-2)"	"unprognostic (1.05e-2)"	"unprognostic (2.03e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.55e-3)"	"unprognostic (1.19e-1)"	"unprognostic (6.92e-2)"	"unprognostic (3.44e-2)"	"unprognostic (3.80e-1)"	"unprognostic (3.22e-3)"	"unprognostic (3.39e-1)"	"unprognostic (1.24e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.99e-2)"	"unprognostic (2.54e-1)"	"unprognostic (7.72e-2)"	4.5	8.2	22.6	18.8	49.2	10.2	3.8	33.7	33.4	8.7	9.7	6.3	4.1	3.2	1.1	3.2	2.4	6.3	1.6	28.7	35.1	3.2	5.5	7.6	27.8	45.5	38.4	17.7	1.7	2.0	1.0	2.3	48.9	1.6	6.5	5.7	2.5	1.7	1.2	5.0	12.5	4.3	32.0	29.8	6.7	2.2	37.9	32.1	2.7	0.8	19.9	6.4	4.4	83.1	0.0	21.4	6.7	0.0	8.5	17.9	0.0	45.5	36.8	21.3	15.8	0.0	0.0	0.6	0.1	28.9	73.4	0.5	0.0	0.1	16.9	52.7	0.0	0.6	4.5	0.0	0.3	4.4	2.1	4.3	0.4	31.0	12.0	8.3	21.4	7.0	0.1	42.1	36.4	2.1	8.0	6.1	2.6	0.0	5.0	10.5	9.8	6.2	1.1	0.1	0.4	5.5	0.0	0.0	4.8	1.2	1.4	20.0	48.2	22.8	5.7	10.9	15.6	0.0	0.0	0.0	32.2	29.6	10.1	3.0	3.3	0.2	6.5	9.2	6.6	7.2	10.9	9.1	6.9	4.5	10.5	9.3	0.1	14.3	11.8	2.8	8.4	4.5	22.6	49.2	33.7	33.4	28.7	35.1	45.5	38.4	48.9	32.0	37.9	83.1	3.7	3.2	9.1	4.2	47.1	4.7	0.6	0.3	8.0	7.9	0.8	4.3	1.2	0.0	2.5	5.5	0.0	0.3	39.5	0.8	1.9	0.1	3.2	0.2	2.3	3.2	2.4	5.5	8.0	0.0	0.2	4.9	5.1	0.5	36.7	64.0	2.5	1.4	30.6	97.6	244.2	3.8	0.0	54.2	39.7	2.8	0.6	51.0	8.8	201.4	38.3	1.2	38.1	400.6	1806.0	0.2	0.3	0.0	43.5	0.5	0.2	0.3	2.6	1.8	13.1	2.5	18.9	0.3	1.1	2.1	4.1	0.8	75.1	31.4	2.5	0.7
DOCK4	"FLJ34238, KIAA0716"	ENSG00000128512	"Dedicator of cytokinesis 4"	Q8N1I0	7	111726110-112206407	"Plasma proteins, Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"	Proto-oncogene	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 41.6"	"Group enriched"	"Detected in many"	4	"Astrocytes: 791.0;Excitatory neurons: 422.8;Microglial cells: 1568.3;Oligodendrocyte precursor cells: 434.3;Oligodendrocytes: 815.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	4	"neutrophil: 2.7"	"Lineage enriched"	"Detected in single"	4	"granulocytes: 2.7"	"Cell line enhanced"	"Detected in many"		"hTEC/SVTERT24-B: 43.3;HUVEC TERT2: 75.5;TIME: 69.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA071516			Approved	"Nucleoli,Golgi apparatus,Plasma membrane,Cytosol"		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 65: Brain - Ion transport"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Nucleoli, Plasma membrane"	"Golgi apparatus, Cytosol"	"HPA071516: AB_2686407"	"unprognostic (1.37e-1)"	"unprognostic (4.18e-1)"	"unprognostic (1.53e-1)"	"unprognostic (2.48e-2)"	"unprognostic (7.10e-2)"	"unprognostic (2.03e-2)"	"unprognostic (9.10e-2)"	"unprognostic (2.18e-2)"	"unprognostic (3.03e-2)"	"unprognostic (5.78e-2)"	"unprognostic (7.06e-2)"	"unprognostic (3.66e-1)"	"unprognostic (5.71e-2)"	"unprognostic (1.89e-2)"	"unprognostic (9.48e-2)"	"unprognostic (4.39e-2)"	"unprognostic (2.39e-2)"	7.8	4.4	17.1	6.6	41.6	1.4	4.8	11.4	21.9	5.0	0.0	3.2	1.5	4.6	2.8	2.5	5.2	5.0	4.9	40.6	17.8	4.5	10.0	17.3	2.7	16.5	18.1	8.4	3.2	3.3	3.2	6.9	15.6	4.0	2.8	10.5	3.3	2.5	6.2	2.5	2.4	7.3	14.9	1.8	2.2	2.1	19.2	1.7	3.5	7.3	2.2	3.7	3.5	26.0	0.1	3.5	8.8	7.8	7.2	10.4	5.3	1.0	9.6	1.7	2.8	0.0	0.2	0.8	7.6	2.3	2.0	0.5	1.5	8.8	6.5	2.9	12.9	0.4	5.8	14.3	5.1	1.1	0.4	4.9	1.0	43.3	20.8	3.0	75.5	3.4	0.1	22.6	3.8	1.0	2.0	0.7	5.1	1.5	15.8	0.8	7.0	3.6	6.0	0.5	1.9	7.5	6.2	4.3	5.8	8.2	0.8	0.4	69.0	6.6	3.4	13.7	3.0	1.2	0.5	0.9	0.7	1.8	16.5	0.1	0.3	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.7	0.0	0.1	0.1	0.0	0.1	17.1	41.6	11.4	21.9	40.6	17.8	16.5	18.1	15.6	14.9	19.2	26.0	56.4	48.1	6.8	791.0	1.1	5.2	3.3	7.5	8.6	27.4	3.7	6.3	13.1	2.8	16.7	3.7	22.9	0.3	0.1	2.3	0.0	2.1	3.8	1.3	5.5	47.1	10.9	5.3	422.8	0.4	0.2	21.4	0.5	2.2	2.5	5.0	43.9	17.0	14.6	94.2	177.1	0.7	14.2	16.7	21.0	1.5	5.6	27.4	8.8	1568.3	6.1	5.4	0.0	434.3	815.3	1.2	8.0	8.2	0.2	8.2	0.0	1.8	12.2	11.4	13.1	4.2	5.8	0.6	1.9	2.3	2.7	0.0	0.6	26.2	1.5	1.8
DOCK6	"KIAA1395, ZIR1"	ENSG00000130158	"Dedicator of cytokinesis 6"	Q96HP0	19	11199295-11262524	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 70.3;Cardiomyocytes: 185.4;Endothelial cells: 64.8;Hepatic stellate cells: 55.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 68.2;TIME: 68.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049423, HPA049424"	Approved		Supported	Cytosol		NA	NA				"Cluster 82: Adipose tissue - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 43: Cardiomyocytes - Nuclear processes"	Cytosol		"HPA049423: AB_2680760, HPA049424: AB_2680761"	"unprognostic (2.69e-2)"	"unprognostic (2.27e-1)"	"unprognostic (9.51e-2)"	"unprognostic (3.35e-2)"	"unprognostic (4.72e-3)"	"prognostic favorable (9.09e-4)"	"unprognostic (2.54e-2)"	"unprognostic (4.91e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.65e-2)"	"unprognostic (2.57e-1)"	"unprognostic (7.89e-2)"	"unprognostic (1.25e-3)"	"unprognostic (2.76e-1)"	"unprognostic (1.51e-1)"	"unprognostic (5.41e-2)"	"unprognostic (2.95e-1)"	31.2	9.9	7.4	5.4	6.3	0.4	27.5	4.5	9.7	15.4	3.6	16.8	14.2	14.7	4.6	16.8	11.6	12.0	29.6	4.6	5.1	26.3	13.2	46.3	4.9	7.8	7.1	12.0	14.4	5.4	11.9	15.0	6.9	14.8	6.2	1.8	11.4	7.5	15.1	25.2	15.4	7.1	5.7	14.5	15.8	5.8	11.4	2.1	29.0	9.3	2.6	14.2	16.6	5.6	14.6	8.9	9.9	8.1	7.3	10.5	15.9	4.2	6.9	4.1	6.3	16.9	11.2	0.9	25.4	7.1	3.9	8.3	4.3	22.3	2.5	12.4	7.0	2.8	2.2	12.8	11.8	4.3	13.7	8.1	13.0	7.5	17.0	7.9	68.2	0.3	15.7	0.0	9.1	32.7	0.1	14.7	12.5	13.2	16.6	0.9	6.7	14.0	6.8	20.0	0.6	17.6	4.2	4.2	7.6	6.5	4.9	7.6	68.8	7.5	7.8	17.1	7.6	1.2	0.2	14.1	6.3	3.2	6.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.4	6.3	4.5	9.7	4.6	5.1	7.8	7.1	6.9	5.7	11.4	5.6	70.3	3.2	12.6	6.8	0.9	6.5	6.2	8.5	4.6	1.4	4.3	3.8	185.4	5.7	11.3	25.8	0.0	0.3	0.9	15.6	1.9	5.4	3.5	3.9	8.9	64.8	12.1	0.0	2.9	6.8	1.3	19.6	35.2	7.2	5.1	4.7	55.3	5.6	4.6	0.0	5.9	15.9	8.2	2.5	4.4	1.3	22.4	1.6	3.6	35.6	0.0	4.6	0.0	7.1	3.5	11.9	10.9	9.4	1.9	8.4	11.9	1.9	9.2	2.6	19.7	8.4	30.8	1.5	4.3	7.4	11.5	0.5	1.2	7.8	9.7	9.0
DOCK8	"FLJ00026, FLJ00152, FLJ00346, ZIR8"	ENSG00000107099	"Dedicator of cytokinesis 8"	Q8NF50	9	214854-465259	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"choroid plexus: 45.0;lymphoid tissue: 64.8"	"Cell type enhanced"	"Detected in many"		"Microglial cells: 506.8;monocytes: 134.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 173.6"	"Group enriched"	"Detected in all"	4	"dendritic cells: 53.0;granulocytes: 173.6;monocytes: 84.2"	"Cell line enhanced"	"Detected in many"		"Daudi: 52.9;HL-60: 53.3;MOLT-4: 50.1;NB-4: 83.7;REH: 61.9;RT4: 54.3;THP-1: 158.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA003218, HPA073349"	Enhanced		Approved	Nucleoplasm,Centrosome,Mitochondria,Cytosol		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	Centrosome	"Nucleoplasm, Mitochondria, Cytosol"	"HPA003218: AB_1078695, HPA073349: "	"unprognostic (1.56e-1)"	"unprognostic (5.90e-2)"	"unprognostic (7.75e-2)"	"unprognostic (7.55e-3)"	"unprognostic (3.31e-1)"	"unprognostic (6.28e-3)"	"unprognostic (1.79e-1)"	"unprognostic (8.12e-2)"	"unprognostic (2.72e-2)"	"unprognostic (6.72e-2)"	"unprognostic (1.90e-1)"	"unprognostic (3.89e-2)"	"prognostic favorable (9.21e-6)"	"unprognostic (2.91e-1)"	"unprognostic (3.91e-2)"	"unprognostic (3.91e-1)"	"prognostic favorable (6.89e-6)"	11.0	13.3	4.3	35.7	4.4	42.2	7.3	5.2	3.9	4.3	45.0	7.3	7.3	3.0	2.9	7.2	4.3	14.6	2.0	4.0	5.9	16.5	6.1	19.7	51.1	8.8	7.6	2.0	4.2	7.7	2.6	15.3	9.1	5.1	7.3	4.5	4.6	2.8	1.0	3.0	15.4	6.2	9.3	45.6	9.5	7.5	8.8	64.8	4.9	2.5	49.6	14.8	3.3	12.8	0.0	0.0	0.0	0.0	0.0	0.0	10.0	0.0	0.0	0.0	0.0	1.6	1.4	52.9	3.9	0.0	0.0	2.3	0.8	0.3	0.0	18.2	2.3	0.1	0.0	0.2	0.0	53.3	7.1	0.2	9.3	0.0	0.2	0.0	0.0	0.0	11.8	25.9	0.0	3.2	50.1	83.7	0.2	0.2	0.7	61.9	0.1	21.3	0.2	54.3	0.1	0.0	0.0	0.6	3.6	1.0	1.4	158.0	10.2	0.0	0.4	0.7	0.1	10.3	0.1	0.0	0.1	33.3	0.9	65.1	56.9	73.5	12.2	52.0	10.2	25.2	15.7	13.8	53.0	23.2	11.3	11.1	173.6	24.1	84.2	13.8	15.6	22.6	4.3	4.4	5.2	3.9	4.0	5.9	8.8	7.6	9.1	9.3	8.8	12.8	5.0	9.6	33.5	2.3	112.6	6.4	2.5	1.2	45.5	3.6	12.3	10.8	2.3	18.6	4.9	7.3	77.2	70.9	101.9	1.5	1.9	1.0	33.4	1.9	0.7	9.8	8.4	35.1	1.9	6.5	4.3	5.3	12.8	3.2	24.6	12.7	2.9	2.6	58.4	0.0	4.2	12.9	2.0	115.0	49.4	14.8	3.1	107.7	8.8	506.8	134.3	1.1	74.2	4.5	2.2	1.4	24.9	0.4	94.6	1.5	1.2	12.8	8.0	4.2	13.1	30.2	20.6	22.1	13.3	9.4	3.8	42.7	111.6	1.1	1.3	3.4
DOK1	p62dok	ENSG00000115325	"Docking protein 1"	Q99704	2	74549026-74557551	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"granulocytes: 36.8;Hofbauer cells: 48.6;Macrophages: 31.2;monocytes: 41.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 76.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB004224, HPA048561"	Approved		Supported	Cytosol		NA	NA		80000	"Cluster 14: Monocytes - Unknown function"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 4: Macrophages - Innate immune response"	Cytosol		"CAB004224: AB_627447, HPA048561: AB_2680443"	"unprognostic (2.40e-2)"	"unprognostic (2.07e-2)"	"unprognostic (2.60e-1)"	"prognostic favorable (8.42e-4)"	"unprognostic (9.86e-3)"	"unprognostic (1.28e-1)"	"unprognostic (7.10e-2)"	"prognostic favorable (4.64e-4)"	"unprognostic (7.57e-2)"	"unprognostic (1.85e-2)"	"unprognostic (1.89e-2)"	"unprognostic (3.15e-2)"	"prognostic unfavorable (3.16e-6)"	"unprognostic (8.65e-2)"	"unprognostic (2.40e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.20e-2)"	10.8	3.7	8.8	10.2	8.3	13.7	4.7	8.2	9.0	6.6	7.6	5.2	4.4	4.9	0.7	1.4	6.3	3.2	2.8	7.8	8.7	2.7	1.5	6.6	12.3	10.7	8.7	4.2	3.7	6.3	2.2	4.0	9.2	3.1	3.8	0.9	3.0	4.0	1.1	1.6	5.8	4.8	9.2	11.6	6.7	1.7	9.4	7.6	3.9	1.7	10.1	4.7	2.7	9.0	5.3	2.0	6.0	3.0	13.9	16.8	4.2	12.8	10.0	5.2	8.5	1.6	6.1	3.3	18.0	12.3	11.3	0.7	6.1	2.8	1.9	76.3	5.7	43.1	4.4	0.3	10.0	22.0	41.0	12.5	0.0	28.5	14.7	21.7	6.2	13.8	12.7	9.5	10.5	5.6	15.8	45.7	11.1	10.8	1.6	13.0	12.9	3.5	2.7	4.5	2.0	10.0	2.5	0.7	6.7	1.7	3.3	24.1	11.7	32.7	15.1	15.3	2.9	12.6	9.6	0.1	32.9	35.3	5.5	39.0	52.3	38.9	17.3	51.4	13.9	22.9	14.1	15.4	51.3	26.3	10.3	10.3	52.9	27.4	59.3	10.8	24.3	39.8	8.8	8.3	8.2	9.0	7.8	8.7	10.7	8.7	9.2	9.2	9.4	9.0	6.7	9.6	8.8	2.9	15.0	2.0	1.1	3.7	1.2	0.5	2.2	2.8	1.8	4.3	2.0	5.5	0.0	1.9	13.6	8.7	0.0	11.9	0.3	7.4	5.8	7.2	3.0	12.4	0.1	9.1	4.2	6.5	6.1	5.6	36.8	5.8	9.7	0.6	48.6	1.7	0.5	5.9	2.0	26.3	24.2	1.0	5.0	31.2	3.6	4.7	41.1	9.8	16.5	0.5	0.6	10.2	10.0	6.0	6.3	2.4	8.1	3.9	1.7	0.5	6.6	4.1	8.3	0.5	2.1	0.3	1.6	2.3	13.5	7.0	6.8	1.6
DOK3	FLJ22570	ENSG00000146094	"Docking protein 3"	Q7L591	5	177501904-177511274	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 93.6;lymphoid tissue: 118.4"	"Group enriched"	"Detected in many"	5	"B-cells: 31.6;granulocytes: 18.3;Hofbauer cells: 55.7;Kupffer cells: 51.1;Macrophages: 38.3;monocytes: 45.4;Plasma cells: 38.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 133.6"	"Group enriched"	"Detected in many"	6	"B-cells: 37.2;granulocytes: 133.6;monocytes: 77.6"	"Cell line enhanced"	"Detected in many"		"Daudi: 124.0;HMC-1: 87.5;REH: 148.6;U-698: 122.1;U-937: 88.0"	"Low region specificity"	"Detected in many"							HPA077312	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cytokinetic bridge,Cytosol"		Yes	NA		240000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 2: Immune cells - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	"Plasma membrane"	"Nucleoplasm, Cytokinetic bridge, Cytosol"	"HPA077312: AB_2732339"	"unprognostic (2.21e-2)"	"unprognostic (1.14e-2)"	"unprognostic (2.05e-2)"	"unprognostic (5.74e-3)"	"unprognostic (2.32e-2)"	"unprognostic (1.34e-3)"	"unprognostic (4.17e-2)"	"unprognostic (2.20e-1)"	"unprognostic (8.00e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.21e-2)"	"unprognostic (1.60e-1)"	"prognostic unfavorable (3.82e-11)"	"unprognostic (1.34e-1)"	"unprognostic (7.25e-2)"	"unprognostic (1.55e-1)"	"unprognostic (3.78e-2)"	11.0	6.1	5.2	30.2	6.2	93.6	4.4	6.5	7.9	3.2	6.3	8.2	6.5	3.4	1.7	5.5	7.8	4.3	4.1	6.0	7.0	5.0	6.5	27.1	31.5	11.3	6.8	2.1	4.5	0.8	3.4	7.0	10.5	5.5	3.5	2.1	6.6	2.0	3.6	2.6	28.9	4.5	6.7	118.4	5.9	8.9	9.9	4.3	4.4	4.1	32.3	7.1	4.0	8.1	5.2	7.8	5.4	6.3	3.2	0.4	13.0	4.4	1.1	14.0	12.9	11.0	2.2	124.0	3.2	4.0	6.8	8.9	12.2	7.6	6.9	26.1	14.6	21.3	21.4	2.5	1.0	46.1	87.5	1.6	4.5	16.2	1.6	1.5	1.9	11.4	14.8	50.2	5.1	12.9	2.7	52.5	12.2	1.5	12.9	148.6	9.3	1.2	4.4	5.2	7.4	4.9	2.0	2.1	6.2	4.8	11.7	63.4	2.7	12.3	11.3	6.5	5.4	11.1	15.0	122.1	2.7	88.0	2.2	16.8	62.4	57.0	0.3	61.3	0.6	37.2	0.1	0.3	14.5	19.6	0.1	0.1	133.6	0.5	77.6	1.2	0.0	28.7	5.2	6.2	6.5	7.9	6.0	7.0	11.3	6.8	10.5	6.7	9.9	8.1	1.4	0.0	5.6	1.6	31.6	0.3	0.1	0.4	1.8	0.8	1.0	0.9	0.4	0.0	0.2	0.0	0.0	0.5	0.3	0.2	0.0	0.2	0.0	0.4	0.4	1.9	0.0	6.3	4.1	0.2	0.7	1.2	0.5	0.8	18.3	0.2	7.1	0.8	55.7	0.0	3.5	0.3	0.0	51.1	2.3	0.4	0.6	38.3	1.8	3.7	45.4	0.3	2.1	0.5	0.5	0.0	0.7	1.2	38.3	0.2	0.2	0.1	0.1	0.6	0.0	1.8	0.4	3.0	1.9	0.7	0.3	1.0	2.2	0.3	0.8	0.1
DOK7	"C4orf25, Dok-7, FLJ33718, FLJ39137"	ENSG00000175920	"Docking protein 7"	Q18PE1	4	3463306-3501473	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"			"Congenital myasthenic syndrome, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 41.9;skeletal muscle: 29.5"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 17.1;Enteroendocrine cells: 6.0;Late spermatids: 9.9"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 11.0"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	16	"memory B-cell: 3.4;naive B-cell: 2.3;NK-cell: 1.9"	"Group enriched"	"Detected in many"	16	"B-cells: 3.4;NK-cells: 1.9"	"Cell line enriched"	"Detected in some"	4	"MCF7: 36.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA059449, HPA062780"	Approved		Enhanced	Nucleoplasm,Mitochondria		NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 38: Heart - Muscle contraction"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 54: Cardiomyocytes - Muscle contraction"	Nucleoplasm	Mitochondria	"HPA059449: AB_2684023, HPA062780: AB_2732688"	"prognostic favorable (8.45e-5)"	"unprognostic (2.34e-1)"	"unprognostic (2.08e-2)"	"prognostic favorable (2.19e-4)"	"unprognostic (5.96e-2)"	"unprognostic (6.80e-3)"	"unprognostic (1.05e-2)"	"unprognostic (9.54e-2)"	"unprognostic (1.12e-2)"	"unprognostic (5.75e-2)"	"unprognostic (2.54e-1)"	"unprognostic (8.70e-2)"	"unprognostic (1.24e-4)"	"unprognostic (4.61e-3)"	"unprognostic (5.09e-1)"	"unprognostic (3.16e-2)"	"prognostic favorable (1.28e-4)"	0.1	0.9	1.0	0.2	4.7	0.2	0.4	7.8	2.9	2.1	11.1	0.3	0.1	1.0	1.7	0.3	5.9	0.3	41.9	1.1	0.9	2.7	1.1	1.6	0.7	4.2	1.5	0.3	5.8	0.1	15.7	0.0	4.7	1.8	0.1	0.0	1.9	1.0	29.5	1.6	1.4	0.0	0.2	1.9	2.7	4.8	3.0	0.0	0.7	8.8	0.4	1.2	0.6	0.0	2.7	0.9	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	2.6	0.0	1.2	0.0	0.1	1.3	0.0	4.4	0.0	0.0	0.1	0.0	2.7	0.0	0.0	0.1	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.4	36.2	0.0	1.4	0.3	1.6	0.1	0.0	6.7	0.3	2.3	3.0	0.6	0.1	3.0	0.0	0.0	0.0	8.3	0.1	0.0	0.1	0.3	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.1	0.0	2.3	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.1	1.0	4.7	7.8	2.9	1.1	0.9	4.2	1.5	4.7	0.2	3.0	0.0	0.1	0.0	1.5	1.3	5.3	0.0	3.9	3.7	0.0	0.3	0.7	0.9	17.1	0.0	3.0	5.5	0.0	0.0	0.4	0.5	0.0	2.3	5.8	2.6	0.7	0.1	6.0	2.7	0.4	4.4	0.0	1.4	4.1	2.8	0.0	3.0	0.0	0.1	0.1	0.0	0.9	3.0	2.0	0.0	0.0	9.9	0.9	0.1	0.0	0.0	0.1	0.0	3.1	1.0	0.0	1.8	0.0	0.0	0.0	2.0	0.1	0.3	1.8	0.5	0.0	1.0	0.3	0.2	0.4	0.0	0.0	0.0	0.4	0.1	0.4	1.2
DOLK	"DK1, KIAA1094, TMEM15"	ENSG00000175283	"Dolichol kinase"	Q9UPQ8	9	128945530-128947603	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins"		"Kinase, Transferase"	"Congenital disorder of glycosylation, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Spermatocytes: 33.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA066767, HPA068706"			Supported	Nucleoplasm,Nucleoli,Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	"Nucleoplasm, Nucleoli"	Cytosol	"HPA066767: AB_2732751, HPA068706: AB_2732118"	"unprognostic (6.35e-2)"	"unprognostic (2.69e-1)"	"unprognostic (2.63e-1)"	"unprognostic (1.30e-3)"	"unprognostic (3.55e-1)"	"unprognostic (2.81e-3)"	"unprognostic (8.90e-3)"	"unprognostic (3.26e-1)"	"unprognostic (1.02e-1)"	"unprognostic (3.01e-1)"	"unprognostic (8.83e-3)"	"unprognostic (1.83e-2)"	"prognostic favorable (5.53e-4)"	"unprognostic (3.20e-2)"	"unprognostic (1.06e-1)"	"prognostic favorable (6.88e-5)"	"unprognostic (6.13e-3)"	9.6	14.3	6.6	6.3	6.3	1.5	7.8	6.7	6.7	7.4	8.6	7.5	7.6	9.3	13.5	8.6	8.9	7.9	10.5	6.5	7.1	9.1	10.5	9.1	6.8	6.9	7.6	6.7	14.5	16.8	5.9	9.3	7.3	10.0	6.6	4.4	12.0	10.0	6.7	9.9	7.5	9.4	6.5	8.0	10.6	14.5	7.6	5.1	7.8	7.1	6.6	8.6	5.9	6.8	11.7	42.5	14.8	22.0	42.6	22.2	20.0	23.7	38.1	28.5	21.0	33.7	17.9	6.4	12.3	34.6	40.3	80.3	20.3	29.6	14.7	10.7	17.8	8.0	27.4	24.5	43.0	8.8	13.5	31.1	27.0	30.8	16.8	16.7	28.1	9.1	19.7	10.0	31.3	56.9	7.3	7.3	19.0	33.0	26.0	7.2	19.5	25.1	25.7	17.3	13.5	15.1	31.4	25.6	14.1	13.7	44.8	11.4	23.6	25.6	9.2	32.5	19.8	9.4	25.0	6.4	24.2	8.0	19.9	2.7	15.4	6.9	11.2	15.3	10.1	11.8	9.9	12.3	16.6	12.5	12.8	13.2	2.2	13.0	21.2	9.3	16.8	10.5	6.6	6.3	6.7	6.7	6.5	7.1	6.9	7.6	7.3	6.5	7.6	6.8	8.5	6.4	4.1	2.9	2.6	1.8	3.6	13.9	4.6	9.1	4.4	4.3	3.5	10.0	10.9	7.3	8.4	25.6	3.5	5.2	0.0	15.7	15.1	5.9	7.2	9.2	1.2	3.6	1.2	14.2	16.4	8.1	5.1	3.6	1.3	7.5	16.1	9.2	13.5	5.0	2.2	3.5	12.2	5.2	2.7	3.7	12.2	2.9	3.6	1.9	2.8	10.7	5.2	2.5	1.7	11.1	7.5	6.0	1.5	4.4	7.5	9.0	11.4	7.1	0.0	7.0	15.7	33.8	15.1	3.3	1.3	18.2	2.3	15.8	5.7	2.1
DPEP1		ENSG00000015413	"Dipeptidase 1"	P16444	16	89613308-89638456	"Enzymes, FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins"	"Lipid metabolism"	"Dipeptidase, Hydrolase, Metalloprotease, Protease"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	8	"intestine: 377.4;kidney: 255.9;pancreas: 440.7"	"Cell type enhanced"	"Detected in many"		"Peritubular cells: 1217.5;Proximal enterocytes: 4683.5;Proximal tubular cells: 829.6"	"Cancer enriched"	"Detected in many"	8	"colorectal cancer: 107.4"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CACO-2: 8.5;Hep G2: 33.1;HHSteC: 13.9;U-937: 46.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA009426, HPA012783"	Enhanced		Approved	"Nucleoplasm,Cell Junctions"	"Intracellular and membrane"	NA	NA		370000		"Cluster 29: Non-specific - Vesicular transport"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 45: Enterocytes - Digestion"	"Nucleoplasm, Cell Junctions"		"HPA009426: AB_1847842, HPA012783: AB_1847843"	"unprognostic (3.31e-2)"	"unprognostic (3.86e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.95e-2)"	"unprognostic (1.91e-2)"	"unprognostic (4.93e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.89e-1)"	"unprognostic (3.45e-2)"	"unprognostic (5.18e-1)"	"unprognostic (8.68e-2)"	"unprognostic (1.27e-1)"	"prognostic favorable (6.84e-4)"	"unprognostic (6.12e-3)"	"unprognostic (1.92e-1)"	"unprognostic (5.23e-2)"	"unprognostic (3.93e-2)"	0.6	2.3	0.0	1.8	0.0	0.4	0.5	0.0	0.2	4.1	0.0	1.7	85.5	0.6	0.9	0.3	0.6	3.9	0.3	0.0	0.3	255.9	0.5	0.9	2.8	0.2	1.1	0.8	440.7	0.0	0.5	0.8	0.6	0.5	0.5	0.3	1.2	1.0	0.0	2.2	377.4	0.3	0.3	4.5	1.6	46.5	0.9	0.9	0.8	0.0	0.9	2.2	0.9	0.0	0.0	0.9	0.2	0.0	1.7	0.2	4.4	0.0	0.0	0.0	0.0	8.5	0.2	0.0	3.0	0.0	0.0	0.0	0.2	0.0	0.0	2.2	0.6	0.0	0.0	33.1	13.9	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.3	1.1	1.1	3.4	0.0	0.0	0.0	3.0	0.0	0.1	0.9	0.8	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.1	0.1	1.4	0.0	0.0	0.2	0.1	0.0	46.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.2	1.1	0.6	0.3	0.9	0.0	0.1	3.2	1.8	0.0	9.2	0.5	0.0	0.0	0.0	5.8	1.7	0.0	0.3	0.0	0.6	23.9	0.0	0.2	0.0	2.0	56.7	0.5	13.2	0.2	0.2	7.0	8.9	0.0	0.3	192.1	0.8	8.9	1.1	0.1	1.3	0.7	1.1	0.0	0.5	0.0	0.3	142.3	0.0	0.3	0.3	45.2	289.8	4.8	5.4	0.0	1.0	0.1	0.0	0.0	0.1	27.4	187.4	1217.5	61.2	0.0	4683.5	829.6	0.0	0.2	6.6	0.0	0.7	17.3	2.8	0.0	0.3	0.4	2.5	0.2	151.7	0.0
DPF2	"BAF45d, REQ, ubi-d4"	ENSG00000133884	"Double PHD fingers 2"	Q92785	11	65333852-65354262	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Transcription, Transcription regulation"	"Chromatin regulator"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020880, HPA056786"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	Nucleoplasm		"HPA020880: AB_1847845, HPA056786: AB_2683235"	"unprognostic (2.06e-1)"	"unprognostic (2.13e-1)"	"unprognostic (3.45e-2)"	"unprognostic (2.90e-3)"	"unprognostic (1.40e-2)"	"unprognostic (9.66e-2)"	"prognostic unfavorable (1.71e-4)"	"unprognostic (2.04e-1)"	"unprognostic (3.29e-2)"	"unprognostic (3.07e-1)"	"unprognostic (2.43e-1)"	"unprognostic (1.33e-1)"	"unprognostic (6.93e-2)"	"unprognostic (3.04e-2)"	"unprognostic (3.24e-1)"	"unprognostic (1.26e-2)"	"unprognostic (1.34e-1)"	21.2	21.0	41.3	14.2	45.1	24.7	21.6	43.6	43.3	35.0	35.2	36.1	13.1	37.6	22.8	23.1	31.3	14.7	34.2	39.5	42.2	20.8	16.8	19.5	22.3	43.1	43.7	40.9	20.5	19.7	20.1	17.6	42.8	28.6	13.8	17.6	21.1	25.8	38.6	19.3	24.3	27.8	43.7	29.7	24.2	37.7	43.0	37.6	22.5	29.2	24.5	34.2	24.1	48.7	29.9	36.4	45.9	40.5	39.7	39.8	25.5	25.0	35.1	53.5	38.6	36.0	34.8	39.5	40.8	34.0	46.6	31.2	52.2	31.9	37.7	47.6	23.1	50.4	24.6	37.7	61.1	47.0	36.5	35.0	30.4	48.4	86.6	40.1	43.3	47.0	48.7	51.0	35.2	47.3	60.0	49.3	51.6	31.9	37.4	65.1	29.9	46.8	34.0	24.1	29.9	27.3	32.1	45.7	47.0	29.7	59.0	26.2	25.8	35.2	31.3	38.9	25.9	62.7	78.8	51.1	21.6	30.6	40.4	186.4	75.4	141.1	79.7	70.8	87.0	102.0	76.9	78.4	76.2	109.1	78.6	71.9	161.5	125.8	83.0	70.6	107.3	108.4	41.3	45.1	43.6	43.3	39.5	42.2	43.1	43.7	42.8	43.7	43.0	48.7	19.2	6.4	10.1	14.0	35.7	22.7	21.8	41.7	23.9	42.2	20.1	24.9	12.7	27.1	24.2	33.1	47.9	27.2	42.0	11.5	19.6	21.2	5.2	18.3	29.5	24.2	17.4	32.8	18.5	17.4	22.9	27.2	15.3	18.5	16.5	31.8	24.3	13.3	19.5	30.3	19.9	16.8	32.6	17.5	33.8	12.3	58.7	16.9	19.6	15.0	30.0	22.8	35.0	24.1	32.3	19.3	8.6	53.4	21.6	22.6	23.7	22.0	19.3	50.5	32.9	28.8	32.2	60.2	63.5	15.4	23.2	26.5	30.6	28.7	17.9	19.7
DPH1	"DPH2L, DPH2L1, OVCA1"	ENSG00000108963	"Diphthamide biosynthesis 1"	Q9BZG8	17	2030137-2043898	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"		Transferase	"Disease variant, Dwarfism, Ectodermal dysplasia, Hypotrichosis, Mental retardation, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 19.4;Gastric mucus-secreting cells: 21.4;Plasma cells: 12.0;Squamous epithelial cells: 13.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA069750, HPA073864"	Approved		Approved	"Nucleoplasm,Cell Junctions"		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 72: Non-specific - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm	"Cell Junctions"	"HPA069750: AB_2686188, HPA073864: "	"unprognostic (5.54e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.86e-2)"	"unprognostic (1.50e-2)"	"unprognostic (1.46e-1)"	"unprognostic (2.21e-1)"	"unprognostic (1.10e-1)"	"unprognostic (3.93e-2)"	"unprognostic (2.30e-1)"	"prognostic favorable (1.78e-5)"	"unprognostic (2.74e-3)"	"unprognostic (2.10e-2)"	"unprognostic (1.03e-1)"	"unprognostic (3.40e-1)"	"unprognostic (7.30e-2)"	"unprognostic (1.41e-1)"	24.5	32.3	13.1	6.0	12.8	5.3	22.2	16.8	17.7	29.1	10.7	26.8	8.0	28.8	5.6	19.8	31.0	9.1	19.2	13.7	11.9	28.0	36.3	16.6	7.5	10.3	10.9	26.6	32.0	14.2	59.3	8.5	10.3	36.2	6.2	12.4	23.7	11.0	42.3	29.3	20.8	8.9	10.1	24.3	27.0	20.3	11.7	6.7	28.6	13.7	6.0	24.2	22.3	11.5	15.4	24.9	6.3	16.0	22.2	14.2	18.7	19.3	26.8	29.7	18.7	24.1	11.6	29.0	23.6	52.5	11.2	11.6	20.7	21.1	15.9	9.0	52.4	6.3	10.5	13.1	19.4	8.3	10.2	20.3	20.3	22.7	19.0	20.5	13.9	16.8	23.4	11.2	11.9	18.2	14.7	4.8	6.5	17.3	25.9	16.6	5.7	22.0	13.3	8.0	13.1	15.2	17.4	17.9	17.2	6.9	25.9	6.8	10.1	19.4	10.1	26.2	16.7	10.3	8.3	6.8	20.3	10.8	8.5	0.8	4.5	0.8	8.0	6.1	8.9	8.8	6.5	7.4	7.7	7.2	9.6	6.9	0.3	6.7	4.5	5.5	10.2	5.2	13.1	12.8	16.8	17.7	13.7	11.9	10.3	10.9	10.3	10.1	11.7	11.5	0.9	3.2	9.2	1.3	9.3	0.4	0.9	0.5	19.4	2.1	0.8	0.8	1.5	0.0	2.7	0.0	2.1	1.4	0.9	0.6	0.0	0.5	1.2	1.5	1.2	1.7	0.0	9.0	4.0	0.6	0.9	4.5	21.4	0.8	2.5	1.0	0.7	0.0	0.6	1.7	3.7	0.8	0.0	0.0	0.8	1.5	0.6	3.9	0.0	1.0	0.4	0.9	2.1	1.5	1.4	0.0	0.2	0.4	12.0	0.5	0.5	0.5	3.0	2.8	0.0	1.3	3.2	1.2	0.5	13.0	0.3	1.4	5.4	1.3	0.4	0.6
DPH3	"DELGIP, DELGIP1, DESR1, DPH3A, KTI11, MGC20197, ZCSL2"	ENSG00000154813	"Diphthamide biosynthesis 3"	Q96FX2	3	16257061-16264969	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA035287	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 55: Plasma cells - Humoral immune response"	Nucleoplasm	Cytosol	"HPA035287: AB_10604113"	"unprognostic (2.49e-2)"	"unprognostic (8.80e-2)"	"unprognostic (2.84e-2)"	"unprognostic (3.30e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.59e-1)"	"prognostic unfavorable (2.24e-4)"	"unprognostic (1.22e-1)"	"unprognostic (2.83e-1)"	"unprognostic (5.06e-2)"	"unprognostic (5.83e-2)"	"unprognostic (4.13e-1)"	"unprognostic (5.90e-3)"	"unprognostic (1.82e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.19e-2)"	"unprognostic (6.44e-2)"	14.2	11.9	12.7	9.6	13.5	8.4	10.3	14.3	14.3	10.2	13.6	11.5	10.7	10.0	11.0	9.4	8.9	10.2	13.9	12.2	15.6	13.1	15.3	11.1	8.9	15.4	14.4	6.1	7.8	9.0	8.5	13.2	15.0	9.3	8.7	13.4	5.7	11.1	29.4	4.9	13.3	15.2	14.7	9.1	9.4	8.5	13.6	11.5	12.4	20.1	8.1	12.4	5.8	15.5	10.5	14.6	31.9	18.9	58.9	39.7	24.8	29.9	24.4	28.0	31.3	18.1	5.8	10.0	9.3	37.5	24.0	6.2	29.4	17.7	32.6	50.5	20.4	16.6	11.5	21.0	36.7	24.5	15.6	28.6	23.6	36.0	15.2	17.6	25.5	17.4	26.9	16.4	39.9	14.1	19.0	16.5	25.6	15.9	14.7	12.9	20.7	15.4	24.9	8.0	7.2	20.2	13.8	6.7	35.4	25.6	12.5	23.9	29.9	22.9	15.0	41.7	24.0	12.6	44.5	12.8	33.6	27.2	20.7	27.1	16.7	25.7	11.3	22.8	14.0	10.1	11.9	13.8	15.9	9.9	9.9	11.9	35.5	10.7	21.6	6.2	11.9	12.7	12.7	13.5	14.3	14.3	12.2	15.6	15.4	14.4	15.0	14.7	13.6	15.5	32.3	19.2	22.4	10.1	31.0	51.6	42.9	41.0	29.0	11.6	32.9	34.7	34.9	25.8	32.4	16.5	12.5	47.9	28.1	43.0	41.1	49.5	109.1	27.5	35.3	32.5	17.9	32.0	12.0	57.2	80.6	34.4	30.1	33.3	52.0	11.2	26.7	41.6	101.6	6.7	10.3	22.6	26.4	45.5	61.7	63.3	20.5	46.4	28.4	3.7	71.5	24.8	29.9	6.6	9.2	66.6	32.4	15.8	42.2	42.6	79.1	45.4	33.9	15.1	13.1	33.4	36.7	80.4	40.1	31.3	52.4	80.9	34.5	18.7	19.0	47.1
DPP3		ENSG00000254986	"Dipeptidyl peptidase 3"	Q9NY33	11	66480013-66509657	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Aminopeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Rod photoreceptor cells: 72.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035780, HPA035781"	Approved		Supported	Cytosol		NA	NA		3200000	"Cluster 27: Non-specific - Gene expression"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 46: Photoreceptor cells - Phototransduction"	Cytosol		"HPA035780: AB_2674778, HPA035781: AB_10669529"	"unprognostic (5.74e-2)"	"unprognostic (1.16e-3)"	"unprognostic (2.62e-3)"	"unprognostic (4.77e-2)"	"unprognostic (1.99e-1)"	"unprognostic (5.44e-3)"	"unprognostic (1.67e-3)"	"unprognostic (1.25e-3)"	"unprognostic (1.73e-2)"	"unprognostic (9.87e-2)"	"unprognostic (1.02e-2)"	"unprognostic (3.87e-1)"	"unprognostic (5.85e-2)"	"prognostic favorable (1.34e-4)"	"unprognostic (1.81e-2)"	"unprognostic (3.43e-1)"	"unprognostic (5.66e-2)"	11.6	17.5	8.2	21.4	9.1	20.7	11.2	10.2	10.4	11.0	5.4	30.2	24.8	11.7	7.8	23.5	9.8	14.5	10.3	8.4	8.9	17.1	18.6	14.3	21.8	10.2	8.8	6.8	17.3	11.9	8.7	14.3	10.8	14.4	26.3	15.9	18.8	12.9	26.5	13.6	20.5	16.2	8.6	15.4	19.2	9.8	10.2	18.6	11.7	7.4	23.3	17.3	13.5	9.9	84.1	71.6	32.5	36.3	26.4	28.3	50.4	46.5	61.8	61.4	40.7	90.8	68.4	48.7	154.0	52.9	52.2	73.6	52.1	57.0	39.4	92.5	23.8	63.1	32.1	54.2	40.7	77.6	101.1	40.5	54.5	46.2	22.8	26.5	47.8	50.1	45.1	28.2	56.7	95.3	91.0	78.7	55.5	82.0	43.2	63.1	32.7	79.6	52.6	71.7	61.1	52.2	39.7	45.6	62.5	30.3	70.8	44.7	50.1	36.5	39.4	40.7	46.2	23.3	46.6	56.6	48.5	36.5	45.9	20.7	18.8	21.3	21.4	40.0	13.3	11.5	15.8	17.7	32.3	11.1	9.4	13.9	3.2	30.8	27.9	22.5	29.6	17.7	8.2	9.1	10.2	10.4	8.4	8.9	10.2	8.8	10.8	8.6	10.2	9.9	5.8	16.0	13.2	6.8	11.6	6.0	17.4	34.8	8.6	11.4	7.1	3.8	3.0	10.0	27.0	23.9	10.4	46.9	11.5	41.6	13.7	45.6	24.6	8.7	6.2	10.5	18.6	3.4	3.4	61.3	34.2	7.4	29.0	11.5	1.3	9.9	3.6	14.7	37.4	6.7	4.0	19.5	63.1	7.9	9.0	7.0	2.1	10.8	16.0	3.7	31.3	21.6	18.6	4.5	5.6	40.8	25.2	5.3	15.7	11.0	26.4	28.7	17.3	72.9	13.1	4.4	16.2	8.8	20.7	14.4	6.0	36.0	13.1	20.1	29.5	19.5
DPP8	"DP8, DPRP1, FLJ14920, FLJ20283, MGC26191, MSTP141"	ENSG00000074603	"Dipeptidyl peptidase 8"	Q6V1X1	15	65442463-65517704	"Enzymes, Plasma proteins, Predicted intracellular proteins"	Apoptosis	"Aminopeptidase, Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008706	Approved		Supported	Cytosol		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 16: U-266 - Nucleosome"	"Cluster 66: Spermatocytes - Spermatogenesis"	Cytosol		"HPA008706: AB_1078665"	"unprognostic (3.65e-1)"	"unprognostic (2.38e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.24e-1)"	"unprognostic (8.60e-2)"	"unprognostic (2.98e-1)"	"unprognostic (2.46e-1)"	"unprognostic (2.52e-2)"	"unprognostic (1.81e-1)"	"unprognostic (4.09e-2)"	"unprognostic (3.60e-2)"	"unprognostic (1.99e-2)"	"unprognostic (1.01e-1)"	"unprognostic (7.58e-2)"	"unprognostic (8.56e-2)"	"unprognostic (2.59e-1)"	12.7	10.2	7.0	12.1	8.5	14.9	11.8	9.3	11.3	11.8	5.5	11.4	14.4	11.7	9.7	10.0	8.3	9.7	14.9	8.3	9.2	12.7	7.9	11.1	12.9	7.3	8.3	10.8	7.4	15.2	5.7	11.2	7.2	10.8	12.9	15.4	9.5	11.5	27.5	9.8	13.5	13.1	8.5	14.8	11.0	26.1	9.7	13.8	14.1	30.6	11.3	11.2	8.3	9.7	14.1	24.4	15.7	15.8	17.4	25.2	12.8	22.5	28.4	21.1	20.3	10.6	12.6	25.1	16.3	30.3	14.5	25.9	30.6	17.6	26.0	20.9	17.2	24.2	18.1	10.4	17.9	34.3	23.8	18.6	18.3	17.0	16.0	18.5	23.2	19.2	16.4	24.1	26.5	12.5	17.1	12.0	9.9	15.7	11.1	22.6	27.9	24.7	19.8	32.7	10.5	17.0	14.3	15.8	25.3	15.6	14.4	22.5	28.6	28.2	19.2	12.7	25.5	26.9	42.2	25.8	21.3	32.8	20.4	30.5	11.7	15.1	12.1	11.7	12.6	11.8	10.0	11.2	10.9	12.2	9.5	10.6	20.9	8.2	15.8	8.6	11.3	7.2	7.0	8.5	9.3	11.3	8.3	9.2	7.3	8.3	7.2	8.5	9.7	9.7	39.1	35.3	27.9	65.6	30.0	13.4	15.0	20.4	15.9	24.1	21.1	14.2	43.4	21.5	25.4	14.7	37.5	20.4	35.3	25.8	23.5	22.7	57.4	17.3	19.3	39.5	25.9	17.9	50.1	30.0	15.2	22.3	31.1	17.5	27.8	24.7	46.1	18.2	21.5	28.6	58.6	27.0	16.2	36.0	15.1	59.7	29.2	31.9	23.2	38.4	47.6	32.3	45.3	36.2	57.1	38.4	25.8	29.3	24.7	19.3	24.2	27.5	25.9	28.1	19.7	29.9	22.1	69.3	24.4	21.9	20.2	17.6	28.5	46.5	26.7	23.6
DPP9		ENSG00000142002	"Dipeptidyl peptidase 9"	Q86TI2	19	4675224-4724673	"Enzymes, Predicted intracellular proteins"		"Aminopeptidase, Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HBEC3-KT: 203.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036059	Approved		Supported	Cytosol		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 52: Non-specific - Transcription"	Cytosol		"HPA036059: AB_10671240"	"prognostic favorable (4.96e-4)"	"unprognostic (4.16e-2)"	"unprognostic (2.03e-1)"	"prognostic favorable (6.21e-5)"	"unprognostic (5.67e-2)"	"unprognostic (8.30e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.23e-1)"	"unprognostic (8.85e-2)"	"unprognostic (6.38e-2)"	"unprognostic (1.93e-1)"	"unprognostic (3.39e-2)"	"prognostic unfavorable (3.38e-8)"	"prognostic favorable (7.72e-5)"	"unprognostic (1.55e-1)"	"unprognostic (4.22e-1)"	"unprognostic (1.80e-1)"	19.6	16.2	12.2	24.5	13.8	32.8	19.4	12.9	13.7	20.1	25.0	24.2	20.1	20.3	5.9	24.5	16.3	13.5	32.2	13.2	11.7	16.9	57.2	27.4	24.9	14.8	14.3	17.3	20.6	10.1	12.7	12.9	14.3	18.9	13.8	9.5	17.7	12.8	71.0	23.8	26.3	15.3	12.3	28.4	21.1	9.0	16.1	17.9	16.9	23.0	17.1	23.2	20.2	15.4	77.5	60.4	17.6	27.5	26.2	36.3	31.7	44.3	58.5	73.1	47.4	54.3	58.2	36.5	32.8	57.7	49.1	51.7	35.9	203.9	44.5	47.3	34.8	26.8	33.6	47.2	40.0	47.2	55.8	27.9	46.6	114.4	67.2	62.2	66.8	25.0	37.4	78.3	64.1	21.2	54.2	30.0	36.0	30.4	89.0	34.0	37.4	42.4	38.3	52.5	24.8	22.2	38.2	67.8	29.5	18.1	18.8	38.2	54.5	64.9	28.0	101.6	89.6	54.6	62.3	36.8	63.4	53.7	55.7	10.8	7.1	7.7	10.6	8.3	7.9	8.0	4.7	8.5	7.1	4.8	4.5	7.3	3.7	11.4	6.5	3.3	9.7	7.7	12.2	13.8	12.9	13.7	13.2	11.7	14.8	14.3	14.3	12.3	16.1	15.4	21.8	28.9	25.8	14.4	18.8	7.9	13.6	10.2	10.8	18.6	12.2	12.3	14.6	10.0	11.2	3.7	37.5	11.7	22.7	37.4	3.9	12.4	2.0	12.7	14.6	19.4	12.5	7.6	10.1	12.8	18.3	10.7	36.2	22.8	17.1	13.3	17.2	39.5	19.0	23.5	10.2	21.3	6.1	20.4	17.6	3.9	9.9	22.0	5.4	16.9	42.2	9.0	25.7	7.5	13.7	26.6	28.4	9.4	32.9	15.6	20.1	5.1	9.5	30.8	19.7	21.7	12.4	7.5	6.9	12.4	5.5	15.6	21.2	12.8	20.6	16.7
DPY30	"Cps25, HDPY-30, Saf19"	ENSG00000162961	"Dpy-30 histone methyltransferase complex regulatory subunit"	Q9C005	2	31867809-32039805	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Endometrial ciliated cells: 388.8;Respiratory ciliated cells: 396.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043761	Supported		Supported	"Nucleoplasm,Golgi apparatus"		NA	NA		29000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 68: Epididymis - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 49: Ciliated cells - Cilium organization"	Nucleoplasm	"Golgi apparatus"	"HPA043761: AB_10960501"	"unprognostic (2.76e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.52e-2)"	"unprognostic (1.07e-2)"	"unprognostic (1.64e-1)"	"unprognostic (4.57e-3)"	"unprognostic (4.14e-3)"	"unprognostic (1.91e-1)"	"unprognostic (7.87e-2)"	"unprognostic (1.01e-3)"	"unprognostic (1.45e-2)"	"unprognostic (5.75e-2)"	"prognostic unfavorable (4.26e-4)"	"unprognostic (2.70e-1)"	"unprognostic (6.77e-2)"	"unprognostic (2.79e-2)"	"unprognostic (1.49e-1)"	40.2	75.2	66.9	34.3	68.6	31.4	61.3	72.1	84.4	53.2	73.6	50.9	43.4	38.3	78.3	60.2	90.5	42.4	46.7	68.4	73.6	79.1	84.8	44.1	51.8	71.6	71.5	42.7	48.1	58.3	50.9	43.9	73.6	57.3	46.4	33.3	64.6	47.0	48.8	49.7	44.4	37.4	73.2	36.1	46.8	22.6	69.1	52.3	81.6	45.4	49.3	51.8	50.0	77.5	201.8	136.8	100.8	78.1	86.7	128.8	134.9	102.1	90.8	81.2	79.5	197.2	158.3	123.2	102.2	90.8	148.3	79.9	93.1	118.6	88.1	146.4	149.5	110.8	89.7	225.5	76.5	114.3	66.8	87.4	135.6	87.4	76.9	109.1	130.4	55.1	132.5	85.3	125.6	219.4	128.8	228.9	139.2	184.3	140.5	104.0	118.9	155.7	144.2	137.1	162.5	115.9	101.2	141.1	143.6	118.2	98.3	82.1	100.5	73.9	119.1	69.2	125.4	99.9	161.3	166.2	77.6	123.2	91.7	177.6	101.0	150.8	95.5	99.9	116.5	165.9	133.5	119.4	100.5	135.6	118.1	112.0	117.3	105.8	112.8	91.5	200.3	130.6	66.9	68.6	72.1	84.4	68.4	73.6	71.6	71.5	73.6	73.2	69.1	77.5	65.7	51.3	61.5	10.1	61.7	98.0	107.7	233.5	53.5	17.9	110.5	135.1	71.3	80.1	140.8	103.0	0.0	190.2	41.0	84.2	283.7	114.3	64.5	388.8	59.7	62.9	92.1	55.5	16.0	117.2	252.4	63.1	44.4	107.3	46.9	65.1	63.1	102.7	123.5	21.9	17.7	107.6	175.0	65.4	67.2	18.5	72.4	58.7	65.8	13.1	106.8	50.8	55.6	13.6	26.7	125.7	117.8	88.0	40.6	130.5	138.4	296.7	396.4	26.8	85.5	52.4	108.4	65.7	57.4	72.0	122.6	138.7	67.3	67.7	109.0	127.5
DPYSL2	"CRMP2, DHPRP2, DRP-2, DRP2"	ENSG00000092964	"Dihydropyrimidinase like 2"	Q16555	8	26514031-26658178	"Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Differentiation, Neurogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"brain: 549.9"	"Cell type enhanced"	"Detected in all"		"Adipocytes: 362.9;Oligodendrocytes: 367.2"	"Cancer enhanced"	"Detected in all"		"glioma: 89.3"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"classical monocyte: 65.8;intermediate monocyte: 74.5;myeloid DC: 71.2;non-classical monocyte: 48.8;plasmacytoid DC: 42.2"	"Group enriched"	"Detected in all"	5	"dendritic cells: 71.2;monocytes: 74.5"	"Cell line enhanced"	"Detected in many"		"ASC diff: 263.7;Karpas-707: 279.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002381, CAB018719"	Supported		Supported	"Plasma membrane,Cytosol"		NA	NA		3200000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 70: Brain - Nervous system development"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 50: Fibroblasts - ECM organization"	Cytosol	"Plasma membrane"	"CAB018719: AB_2085366, HPA002381: AB_1847244"	"unprognostic (2.88e-2)"	"unprognostic (1.01e-2)"	"unprognostic (9.51e-2)"	"unprognostic (3.16e-3)"	"unprognostic (8.23e-2)"	"unprognostic (1.68e-2)"	"unprognostic (1.51e-1)"	"unprognostic (9.95e-3)"	"unprognostic (5.48e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.79e-2)"	"unprognostic (4.13e-2)"	"unprognostic (5.58e-2)"	"unprognostic (9.32e-3)"	"unprognostic (1.23e-1)"	"unprognostic (3.27e-2)"	"prognostic unfavorable (5.41e-5)"	60.0	34.8	252.6	22.5	348.0	3.5	48.0	332.4	266.7	25.3	0.0	44.8	10.4	24.9	11.4	18.3	29.6	29.4	58.6	276.1	263.2	21.3	17.6	78.2	17.4	362.4	296.0	40.8	11.0	7.1	22.1	43.7	389.9	19.7	19.0	64.0	18.5	14.9	19.2	25.8	27.6	32.9	257.9	33.6	21.5	11.2	305.0	19.3	22.5	25.8	20.1	35.6	26.9	549.9	22.0	104.1	100.2	53.9	263.7	120.6	9.8	41.9	97.0	39.2	50.6	41.0	31.0	32.7	29.7	131.7	78.8	20.9	106.6	42.0	37.1	74.2	9.2	37.0	36.9	57.9	168.5	8.0	14.5	150.8	59.5	107.1	61.9	125.5	80.0	24.9	1.1	279.1	39.9	13.9	64.3	8.1	78.8	69.9	20.0	84.3	40.3	21.8	66.2	25.0	45.6	95.8	51.0	0.5	28.6	65.7	7.8	14.8	145.0	88.2	34.8	74.3	18.5	39.1	43.3	24.8	127.7	48.1	46.0	1.3	65.8	0.6	9.1	74.5	3.3	8.5	8.1	6.2	71.2	4.4	4.0	5.2	1.7	11.3	48.8	42.2	13.3	30.3	252.6	348.0	332.4	266.7	276.1	263.2	362.4	296.0	389.9	257.9	305.0	549.9	362.9	131.4	71.7	193.9	11.5	40.4	1.0	13.2	2.2	111.4	44.4	58.4	105.0	84.4	19.4	22.0	31.3	15.1	64.8	4.5	3.9	21.4	3.1	41.6	154.3	154.6	60.7	22.3	191.9	2.0	9.1	144.9	6.1	33.6	20.8	33.0	211.3	22.8	51.1	141.3	157.0	87.0	4.1	223.5	192.3	10.6	109.0	111.1	120.9	81.5	163.5	165.2	22.6	102.1	367.2	12.6	6.2	89.5	6.5	1.1	4.7	24.4	10.5	38.6	138.1	51.8	110.6	3.8	17.0	1.6	33.8	4.5	14.8	16.8	12.1	1.2
DR1	"NC2-BETA, NC2B, NCB2"	ENSG00000117505	"Down-regulator of transcription 1"	Q01658	1	93345907-93369493	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA050785, HPA055308"	Enhanced		Supported	Nucleoplasm		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm		"HPA050785: AB_2681237, HPA055308: AB_2682779"	"unprognostic (1.46e-1)"	"unprognostic (9.62e-2)"	"prognostic favorable (4.79e-4)"	"unprognostic (1.03e-2)"	"unprognostic (2.08e-2)"	"unprognostic (1.59e-1)"	"prognostic unfavorable (9.95e-7)"	"unprognostic (8.70e-2)"	"unprognostic (6.71e-2)"	"unprognostic (1.44e-2)"	"prognostic unfavorable (9.11e-4)"	"unprognostic (4.30e-2)"	"prognostic unfavorable (7.23e-4)"	"unprognostic (2.07e-1)"	"unprognostic (2.29e-1)"	"unprognostic (4.97e-1)"	"unprognostic (1.60e-1)"	21.8	18.9	9.8	28.8	9.6	59.1	16.8	12.5	9.3	17.7	23.7	18.2	27.2	21.0	11.1	30.0	14.2	23.1	27.0	8.7	10.8	21.8	20.4	19.6	43.3	9.9	9.8	15.9	18.8	16.9	12.1	32.0	9.5	17.1	16.3	14.1	19.5	14.0	50.4	29.4	22.4	19.2	10.3	27.0	30.2	55.7	10.5	47.7	18.7	42.9	30.8	27.3	22.6	10.5	97.1	29.8	46.8	60.6	42.3	47.9	57.5	76.5	46.6	50.9	54.0	34.9	34.1	101.9	86.4	56.7	69.3	50.1	56.7	53.0	74.6	86.4	53.0	85.8	58.7	38.4	67.3	102.1	60.6	33.7	62.4	71.2	102.2	53.1	45.9	60.0	90.0	95.7	61.0	29.8	97.6	32.1	78.1	33.4	72.1	83.5	103.2	104.0	36.3	58.0	45.3	57.6	65.1	59.7	80.6	42.2	42.2	79.4	72.1	91.5	73.0	90.7	116.0	54.9	65.6	105.5	26.3	80.3	38.2	95.2	46.2	82.1	35.3	52.7	39.2	36.9	38.8	40.4	55.9	31.5	38.6	37.8	62.8	35.5	47.4	45.4	57.1	41.3	9.8	9.6	12.5	9.3	8.7	10.8	9.9	9.8	9.5	10.3	10.5	10.5	36.2	28.9	22.1	10.1	43.5	171.3	38.0	38.7	47.3	32.0	29.1	24.1	33.9	22.8	27.9	36.8	25.0	74.5	84.6	42.8	45.0	31.4	183.1	18.4	33.7	37.5	20.8	59.3	8.4	27.7	73.6	34.3	38.2	24.2	48.9	19.7	29.3	27.6	53.0	50.5	8.7	42.6	10.2	50.8	82.8	106.2	28.3	55.2	44.4	15.0	68.0	16.0	69.0	7.5	10.8	52.9	25.9	26.4	31.9	51.6	29.8	40.7	17.6	25.3	32.9	27.7	42.0	163.2	41.2	69.4	160.5	109.9	59.8	26.2	26.9	79.2
DRD4		ENSG00000069696	"Dopamine receptor D4"	P21917	11	637269-640706	"FDA approved drug targets, G-protein coupled receptors, Human disease related genes, Predicted membrane proteins"	"Biological rhythms"	"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"Bipolar cells: 168.8;Cone photoreceptor cells: 87.6;Rod photoreceptor cells: 206.9"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 3.9"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA062682			Uncertain	"Plasma membrane,Centrosome"		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 71: Testis - DNA repair"		"Cluster 56: Bipolar cells - Visual perception"	"Plasma membrane"	Centrosome	"HPA062682: "	"unprognostic (8.83e-2)"	"unprognostic (2.99e-2)"	"unprognostic (4.98e-4)"	"unprognostic (3.81e-2)"	"unprognostic (7.52e-2)"	"unprognostic (7.89e-3)"	"unprognostic (3.14e-2)"	"unprognostic (2.96e-1)"	"unprognostic (8.45e-2)"	"unprognostic (5.07e-2)"	"unprognostic (3.28e-1)"	"unprognostic (8.59e-2)"	"unprognostic (1.05e-4)"	"unprognostic (1.26e-2)"	"unprognostic (8.21e-2)"	"unprognostic (2.36e-2)"	"unprognostic (1.85e-1)"	0.9	0.8	0.5	0.0	0.6	0.0	0.8	1.3	0.6	2.5	0.1	1.9	0.0	1.6	0.0	1.1	2.5	0.0	1.1	0.4	0.0	1.3	1.5	1.3	0.0	0.6	0.2	3.5	1.5	0.0	4.2	0.0	0.5	2.3	0.0	0.0	0.5	0.0	1.0	1.5	1.1	0.0	0.1	0.6	0.8	2.5	0.3	0.0	1.8	0.0	0.0	1.7	1.7	0.6	0.3	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.5	0.6	1.3	0.6	0.4	0.0	0.6	0.2	0.5	0.1	0.3	0.6	0.5	0.0	0.5	4.2	0.2	0.0	0.3	0.2	0.0	168.8	0.3	0.4	1.7	0.0	0.1	1.8	87.6	0.6	8.6	0.8	0.0	0.1	0.7	0.3	0.4	1.5	0.0	0.0	0.8	0.4	0.3	0.5	2.0	0.7	0.0	1.5	0.0	0.1	0.2	6.7	1.2	1.3	0.0	0.3	0.3	0.2	0.6	0.9	0.0	0.0	0.1	26.0	0.0	0.0	2.6	0.4	0.2	0.7	0.1	1.1	8.3	1.9	0.1	206.9	0.0	0.8	0.6	1.2	2.6	0.8	0.4	0.1	0.1	0.5	1.3	0.3
DRG1	NEDD3	ENSG00000185721	"Developmentally regulated GTP binding protein 1"	Q9Y295	22	31399604-31530634	"Plasma proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 160.2"	"Group enriched"	"Detected in all"	5	"Early spermatids: 798.4;Late spermatids: 651.5;Spermatocytes: 469.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001218	Enhanced		Supported	"Nucleoplasm,Nuclear bodies,Cytosol"		No	No		22000	"Cluster 15: NK-cells - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Nucleoplasm, Nuclear bodies"	Cytosol	"HPA001218: AB_1078704"	"unprognostic (4.94e-1)"	"unprognostic (3.33e-2)"	"unprognostic (1.17e-3)"	"unprognostic (5.26e-2)"	"unprognostic (4.66e-2)"	"unprognostic (3.49e-3)"	"prognostic unfavorable (7.71e-4)"	"unprognostic (3.68e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.32e-3)"	"unprognostic (8.69e-3)"	"unprognostic (1.55e-3)"	"unprognostic (4.80e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.01e-1)"	"unprognostic (3.89e-1)"	"unprognostic (2.25e-1)"	31.4	32.6	22.6	21.4	23.9	32.3	35.1	27.0	31.6	27.3	22.8	24.7	22.6	27.8	38.7	27.4	32.7	19.5	44.6	23.7	24.6	35.9	37.9	20.9	29.2	23.9	23.7	35.0	34.1	38.4	18.6	35.7	25.0	25.0	30.0	30.1	30.5	28.8	100.5	23.7	21.3	34.1	24.5	20.1	24.2	160.2	22.7	40.4	34.5	85.1	38.3	30.8	20.6	26.4	80.3	61.3	73.9	63.3	64.4	75.2	61.5	70.2	81.7	125.7	104.4	100.3	38.3	111.2	38.6	86.9	60.3	64.5	128.5	82.8	134.4	52.0	152.0	71.9	64.9	99.6	91.4	174.2	65.1	65.6	60.9	103.7	152.9	64.6	87.5	61.6	93.9	48.1	97.2	88.0	75.7	88.4	62.1	114.0	65.9	98.7	118.9	97.3	82.1	68.6	80.8	50.4	78.5	79.8	107.2	70.8	59.7	77.2	50.6	57.7	79.3	59.1	81.3	67.2	78.5	108.6	57.0	77.7	77.4	25.0	43.3	46.0	34.3	49.7	39.6	53.6	36.6	43.0	45.2	39.4	40.5	39.8	9.8	46.7	37.5	39.6	50.9	47.0	22.6	23.9	27.0	31.6	23.7	24.6	23.9	23.7	25.0	24.5	22.7	26.4	22.0	19.2	15.4	3.9	29.4	38.6	40.8	77.2	29.6	18.7	27.2	27.2	52.4	35.8	37.6	27.6	25.0	126.4	20.6	22.5	64.6	56.4	798.4	23.7	24.4	34.4	11.4	37.8	10.3	45.4	104.5	33.2	21.4	21.1	33.7	27.1	35.7	36.9	60.4	15.2	11.2	31.0	48.8	31.1	24.0	651.5	35.8	22.9	17.8	7.5	39.2	27.6	33.0	9.5	11.1	42.7	27.0	37.2	27.1	48.7	42.9	60.3	28.7	18.4	59.2	35.4	36.1	469.3	92.1	33.1	32.1	117.1	25.5	26.2	41.0	45.3
DRG2		ENSG00000108591	"Developmentally regulated GTP binding protein 2"	P55039	17	18087892-18107970	"Plasma proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007716	Approved		Supported	Nucleoplasm,Vesicles,Cytosol		No	No			"Cluster 27: Non-specific - Gene expression"	"Cluster 59: Non-specific - Translation"	"Cluster 12: NES - Nervous system development"	"Cluster 39: Non-specific - Basic cellular processes"	"Vesicles, Cytosol"	Nucleoplasm	"HPA007716: AB_1078705"	"unprognostic (7.47e-2)"	"unprognostic (1.29e-1)"	"unprognostic (4.78e-2)"	"prognostic favorable (1.56e-4)"	"unprognostic (1.26e-3)"	"unprognostic (7.86e-2)"	"unprognostic (8.85e-2)"	"unprognostic (5.72e-2)"	"unprognostic (8.49e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.88e-3)"	"prognostic unfavorable (7.34e-4)"	"unprognostic (3.10e-1)"	"unprognostic (2.18e-1)"	"unprognostic (1.49e-1)"	"unprognostic (5.64e-2)"	"unprognostic (1.10e-1)"	19.3	19.1	14.2	12.8	14.8	15.9	19.6	14.8	15.0	21.6	13.6	19.4	14.8	22.3	12.9	21.6	19.8	12.6	19.8	14.9	15.7	18.5	16.6	15.7	18.4	15.2	15.4	22.5	19.6	15.8	17.8	12.3	16.1	20.1	10.0	5.2	17.0	15.2	36.6	20.3	17.4	13.7	15.4	19.8	17.9	8.9	14.9	16.0	18.4	16.5	14.9	20.0	18.3	16.5	37.1	51.1	17.4	17.3	31.1	31.7	33.1	24.8	24.7	40.0	37.0	55.5	21.8	35.5	31.8	29.4	21.2	38.9	28.5	35.1	27.4	32.1	74.2	16.0	26.5	31.5	33.4	14.3	24.2	36.4	30.5	39.1	33.0	22.9	38.5	46.8	27.6	13.7	23.6	42.5	38.7	25.8	12.9	51.4	36.1	41.5	41.8	66.7	24.3	21.6	9.9	28.0	25.2	15.2	31.9	102.8	30.0	21.4	29.2	19.6	18.3	23.0	42.8	15.5	19.4	20.1	27.9	26.2	36.6	17.7	21.1	23.6	24.6	23.3	20.2	14.9	17.8	20.0	24.6	17.7	16.9	18.7	2.8	28.2	30.5	13.8	24.9	19.3	14.2	14.8	14.8	15.0	14.9	15.7	15.2	15.4	16.1	15.4	14.9	16.5	23.8	0.0	12.4	8.5	19.5	16.7	19.9	21.2	11.4	14.9	18.8	23.0	3.9	24.3	13.2	7.3	2.1	37.5	26.3	20.1	29.4	29.4	7.3	12.8	19.3	20.8	21.6	10.1	11.9	27.1	40.8	19.4	17.9	12.9	12.0	32.6	16.4	19.4	32.2	6.7	10.0	19.7	16.2	21.4	12.2	14.2	21.5	18.0	12.4	8.4	23.9	19.6	23.7	4.0	8.0	24.8	16.2	24.5	22.9	17.4	31.4	31.8	9.3	13.4	6.6	22.0	21.7	12.1	13.0	18.2	11.6	39.3	21.9	33.9	24.5	14.4
DROSHA	"Etohi2, HSA242976, RN3, RNASE3L, RNASEN"	ENSG00000113360	"Drosha ribonuclease III"	Q9NRR4	5	31400494-31532196	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	"Ribosome biogenesis, RNA-mediated gene silencing"	"Endonuclease, Hydrolase, Nuclease, RNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Oligodendrocyte precursor cells: 74.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031150			Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 34: Non-specific - Transcription"	"Cluster 20: HeLa - Mitochondria"	"Cluster 68: Oligodendrocytes - Mixed function"	Nucleoplasm	Cytosol	"HPA031150: AB_2673761"	"unprognostic (8.37e-3)"	"unprognostic (1.81e-1)"	"unprognostic (9.56e-2)"	"prognostic unfavorable (6.79e-4)"	"unprognostic (5.40e-2)"	"unprognostic (6.03e-2)"	"prognostic unfavorable (1.39e-4)"	"unprognostic (3.11e-1)"	"unprognostic (4.08e-2)"	"unprognostic (9.08e-2)"	"unprognostic (1.86e-1)"	"unprognostic (5.43e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.74e-1)"	"unprognostic (2.39e-1)"	"unprognostic (6.94e-2)"	"unprognostic (2.32e-2)"	12.3	11.3	2.6	15.9	3.8	11.6	11.5	9.4	8.0	13.3	4.2	13.8	13.6	15.9	20.4	11.4	14.5	11.7	13.0	2.0	8.1	12.3	9.7	10.9	16.0	1.1	2.9	20.5	14.4	15.2	4.5	13.8	2.3	13.6	15.6	27.2	12.5	13.2	22.2	13.5	12.2	13.8	0.2	12.5	13.2	11.1	5.2	24.5	15.5	19.6	17.1	12.2	3.9	4.9	38.7	47.3	51.8	70.8	27.0	32.8	74.2	50.0	24.4	45.6	33.9	50.6	49.0	43.3	55.9	36.9	52.7	33.0	63.5	37.8	50.4	40.9	44.6	52.9	157.8	37.0	24.3	59.2	151.6	25.8	26.0	50.7	24.2	34.6	39.5	45.3	68.9	19.7	40.5	38.5	58.3	44.8	49.1	31.2	37.9	52.2	98.9	31.1	25.7	43.2	26.9	35.6	127.1	51.4	30.0	46.0	47.4	34.1	33.9	43.7	50.3	39.0	48.0	35.8	63.5	47.1	30.3	65.9	42.9	0.9	1.2	1.5	2.2	1.3	2.4	1.8	2.4	2.7	2.5	2.0	2.7	2.0	0.3	2.5	2.5	3.0	2.5	1.6	2.6	3.8	9.4	8.0	2.0	8.1	1.1	2.9	2.3	0.2	5.2	4.9	6.2	12.8	14.3	45.4	7.1	3.6	5.0	7.0	10.8	19.4	7.1	6.0	23.4	5.7	12.8	5.5	0.0	8.5	11.4	12.9	3.9	7.8	3.5	12.3	11.6	9.0	11.4	8.0	43.4	8.1	7.6	12.7	8.6	13.6	9.5	20.4	10.0	7.2	7.8	6.7	45.8	8.5	14.2	6.3	3.0	8.2	10.8	6.0	1.8	34.7	8.4	10.2	9.2	74.9	43.9	9.3	10.2	13.2	8.8	6.1	7.3	5.1	16.8	18.8	6.6	10.4	11.6	7.1	10.9	8.8	3.4	4.9	8.3	13.9	11.7	5.9
DSC2	"CDHF2, DSC3"	ENSG00000134755	"Desmocollin 2"	Q02487	18	31058840-31102522	"Disease related genes, Human disease related genes, Plasma proteins, Predicted membrane proteins"	"Cell adhesion"		"Cardiomyopathy, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 164.0;vagina: 97.4"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 384.0;Paneth cells: 324.8;Squamous epithelial cells: 705.6"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 48.7"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	9	"eosinophil: 28.9;neutrophil: 8.1"	"Lineage enriched"	"Detected in many"	14	"granulocytes: 28.9"	"Cell line enhanced"	"Detected in many"		"BEWO: 37.6;CAPAN-2: 48.3;HaCaT: 71.1;hTCEpi: 76.0;OE19: 60.7;SK-BR-3: 44.4;SuSa: 43.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA011911, HPA012615"	Enhanced		Supported	"Plasma membrane,Cytosol"		NA	NA		24000000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 61: Squamous epithelial cells - Keratinization"	"Plasma membrane"	Cytosol	"HPA011911: AB_1847618, HPA012615: AB_1847619"	"unprognostic (3.28e-2)"	"unprognostic (3.20e-1)"	"unprognostic (2.23e-3)"	"unprognostic (2.56e-2)"	"unprognostic (1.90e-1)"	"unprognostic (3.04e-2)"	"unprognostic (1.30e-2)"	"prognostic unfavorable (5.80e-4)"	"unprognostic (7.66e-2)"	"unprognostic (4.07e-2)"	"unprognostic (1.22e-3)"	"unprognostic (2.10e-1)"	"unprognostic (1.43e-3)"	"unprognostic (1.60e-1)"	"unprognostic (1.75e-1)"	"unprognostic (2.49e-1)"	"prognostic unfavorable (3.01e-4)"	5.5	1.8	1.3	12.7	1.4	0.7	22.2	1.3	1.6	59.2	1.9	50.5	41.6	1.5	5.9	164.0	6.1	3.7	10.6	1.2	2.0	5.9	7.3	7.9	3.7	2.6	1.5	0.6	10.5	27.0	0.5	21.3	2.2	15.8	44.5	1.0	46.8	1.0	0.3	11.9	42.9	4.0	1.8	3.0	43.2	0.8	1.6	6.6	4.0	3.1	62.2	3.6	97.4	2.3	18.1	1.9	2.9	0.0	0.0	0.0	37.6	0.0	0.0	0.0	0.0	9.8	48.3	0.0	0.7	0.0	0.9	71.1	11.8	4.9	0.0	0.0	6.9	27.1	8.4	16.9	0.3	0.2	0.5	0.4	76.0	0.0	7.3	6.1	0.0	0.0	13.4	0.0	0.0	14.7	0.0	1.1	11.3	60.7	17.4	13.2	0.0	0.2	0.1	0.7	0.0	0.1	0.0	44.4	0.0	43.4	12.2	18.1	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	28.9	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.1	0.0	0.1	0.0	0.0	0.4	1.3	1.4	1.3	1.6	1.2	2.0	2.6	1.5	2.2	1.8	1.6	2.3	25.1	28.9	5.6	3.3	1.0	83.7	44.5	16.4	67.7	0.8	75.3	65.7	33.8	32.9	11.1	7.3	0.0	100.8	1.0	384.0	0.0	83.5	0.1	19.1	4.0	6.7	69.4	0.4	3.3	33.2	186.6	5.9	47.4	43.8	0.0	2.7	8.2	16.0	24.8	0.0	1.5	83.1	20.3	48.8	29.3	0.2	0.3	35.3	14.2	4.7	25.2	11.2	0.0	2.0	0.2	155.7	324.8	0.7	0.3	140.6	118.2	9.7	3.8	0.7	0.0	1.2	3.0	0.1	1.3	705.6	55.0	83.9	2.0	0.3	114.0	76.1
DSG2	CDHF5	ENSG00000046604	"Desmoglein 2"	Q14126	18	31498177-31549008	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"		"Cardiomyopathy, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 105.3;parathyroid gland: 157.8"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 404.6;Pancreatic endocrine cells: 254.9;Undifferentiated cells: 216.8"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	13	"basophil: 8.4"	"Lineage enriched"	"Detected in single"	13	"granulocytes: 8.4"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 172.9;HaCaT: 269.2;HBEC3-KT: 201.2;hTERT-HME1: 212.1;OE19: 229.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA004896, CAB025122"	Enhanced		Supported	"Cell Junctions"		NA	NA		140000000	"Cluster 41: Basophils - Cellular respiration"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Cell Junctions"		"CAB025122: , HPA004896: AB_1078643"	"unprognostic (1.56e-3)"	"prognostic unfavorable (8.22e-4)"	"prognostic favorable (7.81e-4)"	"unprognostic (8.77e-3)"	"unprognostic (3.53e-4)"	"prognostic unfavorable (5.63e-4)"	"unprognostic (2.86e-3)"	"prognostic unfavorable (2.43e-4)"	"unprognostic (5.21e-2)"	"unprognostic (1.49e-1)"	"prognostic unfavorable (4.94e-5)"	"unprognostic (3.40e-1)"	"prognostic favorable (3.14e-10)"	"unprognostic (1.76e-1)"	"unprognostic (1.51e-1)"	"unprognostic (3.72e-1)"	"unprognostic (8.57e-3)"	23.6	1.2	0.2	14.6	0.2	0.8	40.2	0.6	0.2	13.0	26.4	105.3	79.1	8.6	10.6	10.2	22.4	31.4	31.4	0.7	0.1	33.8	15.1	15.0	1.6	0.3	0.5	13.6	39.5	157.8	1.6	22.9	0.7	31.5	100.0	0.3	68.6	6.5	1.2	6.7	84.6	7.3	0.0	0.4	77.1	3.7	0.4	24.2	42.2	0.7	4.6	41.6	5.7	0.5	119.2	45.3	4.0	0.1	0.6	7.2	143.0	0.0	0.0	0.3	0.0	31.7	172.9	0.0	64.2	0.0	54.4	269.2	54.7	201.2	0.0	0.2	33.9	0.1	46.7	35.9	20.2	15.2	0.3	9.9	136.7	4.2	212.1	102.4	0.0	34.7	47.8	0.2	0.0	31.5	32.2	2.0	55.4	229.5	23.1	52.8	0.0	76.2	65.8	58.5	23.9	0.2	88.3	61.8	0.3	117.8	44.3	12.7	0.1	0.2	25.0	0.3	29.3	5.7	0.2	0.2	19.8	0.1	25.3	8.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.2	0.2	0.6	0.2	0.7	0.1	0.3	0.5	0.7	0.0	0.4	0.5	120.8	54.5	45.4	0.0	1.3	13.5	79.4	76.2	28.5	0.4	68.9	49.3	57.3	101.5	79.6	12.9	0.0	80.1	4.4	404.6	3.9	105.5	1.0	48.6	9.4	13.1	79.9	9.0	3.3	76.1	116.2	12.0	70.3	82.1	4.5	18.8	2.2	26.4	10.3	1.7	0.3	165.7	79.3	0.8	4.0	2.5	1.5	2.2	17.8	0.0	6.3	5.3	1.0	0.5	0.1	254.9	152.0	0.4	0.3	133.5	145.1	10.0	75.4	0.7	0.0	0.6	8.2	2.7	8.9	23.1	6.0	59.9	2.6	6.6	216.8	179.9
DSN1	"C20orf172, dJ469A13.2, hKNL-3, KNL3, MIS13"	ENSG00000149636	"DSN1 component of MIS12 kinetochore complex"	Q9H410	20	36751791-36773818	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Chromosome partition, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 49.8;Spermatocytes: 115.5;Spermatogonia: 75.1;Syncytiotrophoblasts: 47.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002813, HPA030627"	Enhanced		Supported	"Nucleoplasm,Nucleoli fibrillar center,Nuclear bodies,Kinetochore,Cytosol"		Yes	Yes			"Cluster 6: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	"Nucleoli fibrillar center, Nuclear bodies, Kinetochore, Cytosol"	"HPA002813: AB_1078343, HPA030627: AB_2732460"	"unprognostic (3.60e-2)"	"prognostic favorable (4.49e-4)"	"unprognostic (5.22e-3)"	"unprognostic (1.13e-3)"	"unprognostic (2.00e-1)"	"unprognostic (4.64e-2)"	"prognostic unfavorable (4.16e-5)"	"unprognostic (3.93e-1)"	"unprognostic (9.35e-2)"	"unprognostic (5.51e-2)"	"unprognostic (2.98e-2)"	"unprognostic (7.66e-2)"	"prognostic unfavorable (1.54e-5)"	"unprognostic (6.92e-2)"	"unprognostic (2.53e-1)"	"unprognostic (2.58e-2)"	"unprognostic (2.84e-1)"	5.9	9.9	4.2	7.5	4.2	14.3	8.6	3.9	4.5	5.0	5.2	9.2	6.8	4.4	9.3	7.9	4.1	4.4	5.1	4.3	4.4	4.8	9.1	6.3	12.8	4.0	3.9	4.3	4.3	5.5	3.5	8.8	4.1	6.5	10.8	10.7	5.9	6.3	4.0	8.0	7.8	6.3	3.9	9.6	7.3	23.3	4.1	16.4	5.1	4.8	14.3	4.4	4.7	4.7	36.7	29.1	35.7	29.5	14.0	18.0	24.7	42.9	35.1	63.9	70.2	52.5	44.4	39.3	27.4	23.0	69.1	45.8	33.3	32.7	60.3	18.2	22.7	78.3	26.2	36.1	3.0	46.2	34.0	7.0	9.4	43.7	13.8	10.4	31.5	42.4	30.9	33.7	41.7	25.3	59.2	34.5	16.8	63.3	55.1	46.1	109.4	28.4	16.2	20.5	37.8	16.9	52.9	53.7	25.8	26.3	55.9	30.5	16.4	60.1	35.0	56.9	46.1	27.3	39.1	46.4	49.8	40.8	42.6	53.4	6.4	14.5	7.4	11.0	8.4	14.6	8.1	10.3	7.1	18.4	10.1	9.0	11.9	11.1	10.1	46.9	12.2	6.7	4.2	4.2	3.9	4.5	4.3	4.4	4.0	3.9	4.1	3.9	4.1	4.7	6.5	6.4	4.4	1.6	10.3	5.0	11.4	7.6	3.4	8.0	8.7	7.6	5.4	2.8	8.6	5.5	29.2	49.8	9.8	9.2	7.9	6.8	10.6	5.5	5.9	8.1	2.4	22.1	6.3	6.4	30.4	8.4	20.9	9.4	3.8	21.8	7.9	6.2	14.7	6.7	4.4	13.6	4.1	6.3	4.6	8.0	8.7	6.7	1.8	5.6	7.4	6.0	7.2	3.0	3.6	5.1	5.4	7.5	22.9	7.1	7.7	3.6	8.2	17.5	0.0	5.3	8.2	115.5	75.1	12.3	7.2	47.5	7.7	6.9	13.6	11.0
DSP	"DPI, DPII, KPPS2, PPKS2"	ENSG00000096696	Desmoplakin	P15924	6	7541617-7586714	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			"Cardiomyopathy, Disease variant, Epidermolysis bullosa, Palmoplantar keratoderma"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 460.7;skin 1: 854.8"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 902.0;Cardiomyocytes: 729.7;Squamous epithelial cells: 1657.5;Suprabasal keratinocytes: 2018.0"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 314.1"	"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in single"	13	"naive B-cell: 2.0"	"Lineage enriched"	"Detected in single"	20	"B-cells: 2.0"	"Cell line enhanced"	"Detected in many"		"BEWO: 278.0;HaCaT: 302.6;HBEC3-KT: 217.5;hTCEpi: 666.3;SuSa: 204.1"	"Region enriched"	"Detected in single"	23	"hippocampal formation: 11.6"	"Region enhanced"	"Detected in many"		"spinal cord: 9.5"	"CAB037324, HPA045840, HPA054950"	Enhanced		Supported	"Cell Junctions"		NA	NA		100000000	"Cluster 21: B-cells - Adaptive immune response"	"Cluster 31: Skin - Epidermis development"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 61: Squamous epithelial cells - Keratinization"	"Cell Junctions"		"CAB037324: , HPA045840: AB_2679468, HPA054950: AB_2682645"	"unprognostic (1.65e-1)"	"unprognostic (3.09e-1)"	"unprognostic (6.13e-2)"	"unprognostic (1.05e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.05e-2)"	"unprognostic (3.82e-2)"	"unprognostic (7.03e-3)"	"unprognostic (1.28e-1)"	"unprognostic (2.64e-2)"	"unprognostic (5.02e-2)"	"unprognostic (2.94e-2)"	"prognostic favorable (1.53e-9)"	"unprognostic (2.45e-1)"	"unprognostic (2.88e-1)"	"unprognostic (8.38e-2)"	"prognostic unfavorable (1.82e-4)"	5.2	11.6	4.2	7.0	1.8	0.6	65.8	2.5	3.5	151.0	19.3	46.0	52.0	5.4	27.5	460.7	16.3	7.8	84.9	3.4	0.9	22.4	41.9	6.1	3.7	1.6	2.0	2.0	111.5	54.9	9.0	63.3	1.5	29.9	43.5	21.2	125.1	11.7	3.4	854.8	42.3	2.9	2.4	3.2	48.1	1.5	2.2	37.1	41.5	0.6	78.7	13.1	286.1	0.9	132.2	38.9	0.0	0.1	5.6	8.2	278.0	25.5	21.8	12.4	12.0	110.8	33.5	0.1	35.8	40.9	10.0	302.6	46.1	217.5	2.2	0.1	54.1	0.0	21.5	149.5	0.0	0.6	0.9	1.9	666.3	11.0	121.7	30.0	0.0	0.6	0.2	0.2	22.0	61.4	0.1	1.0	5.6	62.6	19.6	0.1	0.1	32.9	45.3	34.8	12.6	0.3	28.5	59.9	0.2	204.1	71.0	0.3	0.0	4.8	1.2	0.3	0.3	0.1	0.2	0.2	0.2	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.2	1.8	2.5	3.5	3.4	0.9	1.6	2.0	1.5	2.4	2.2	0.9	7.6	51.3	17.0	0.0	7.5	902.0	164.5	157.3	278.3	4.4	184.5	126.4	729.7	97.2	197.5	60.7	14.6	273.0	1.2	357.1	1.9	160.6	1.8	306.5	42.4	46.9	174.6	0.0	0.1	111.9	273.1	51.2	237.0	560.1	3.8	532.2	4.6	186.6	27.5	0.0	0.9	204.7	111.9	1.9	77.8	1.3	0.9	5.9	101.4	3.7	2.6	14.7	0.0	0.0	0.1	167.4	284.2	0.0	5.7	204.0	180.7	12.0	176.6	28.6	0.0	0.4	67.4	1.3	2.7	1657.5	2018.0	385.7	8.1	0.3	247.8	269.9
DTL	"CDT2, DCAF2, L2DTL, RAMP"	ENSG00000143476	"Denticleless E3 ubiquitin protein ligase homolog"	Q9NZJ0	1	212035553-212107400	"Predicted intracellular proteins"	"Biological rhythms, DNA damage, DNA replication, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"bone marrow: 14.6;intestine: 4.7;lymphoid tissue: 14.2;placenta: 3.9;testis: 13.7"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 25.3;Erythroid cells: 36.2;Extravillous trophoblasts: 16.2;Spermatocytes: 53.2;Spermatogonia: 20.8"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in single"		"T-reg: 2.0"	"Lineage enriched"	"Detected in single"	8	"T-cells: 2.0"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA028016, HPA032023, HPA032031"	Supported		Supported	Nucleoplasm,Nucleoli,Cytosol		Yes	Yes			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	"Nucleoli, Cytosol"	"HPA028016: AB_10611958, HPA032023: AB_2674114, HPA032031: AB_2674119"	"unprognostic (7.61e-2)"	"unprognostic (1.01e-3)"	"unprognostic (2.14e-2)"	"unprognostic (3.05e-2)"	"unprognostic (2.19e-1)"	"unprognostic (5.31e-2)"	"prognostic unfavorable (4.41e-5)"	"unprognostic (8.96e-3)"	"unprognostic (2.45e-3)"	"unprognostic (8.83e-3)"	"unprognostic (2.52e-3)"	"unprognostic (2.83e-2)"	"prognostic unfavorable (1.71e-9)"	"unprognostic (5.93e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.96e-2)"	"unprognostic (2.82e-1)"	0.6	0.2	0.0	4.1	0.0	14.6	1.9	0.0	0.1	0.6	0.0	3.3	2.3	1.1	0.1	1.9	0.4	0.4	0.1	0.0	0.0	0.1	1.2	1.4	5.6	0.0	0.1	0.1	0.1	0.5	0.2	3.9	0.0	0.4	4.7	0.0	0.4	0.1	0.1	2.1	3.0	1.9	0.0	2.5	1.3	13.7	0.1	14.2	0.5	0.0	6.4	1.2	0.7	0.0	34.1	28.1	48.0	23.6	2.9	5.8	23.3	41.3	25.5	38.1	56.1	17.6	29.0	25.2	15.4	16.1	25.0	25.8	62.5	34.9	54.7	31.4	30.9	40.7	33.6	21.5	0.1	54.1	25.3	2.5	1.2	62.2	32.4	6.8	17.7	44.7	49.1	51.1	44.4	13.5	75.3	24.3	56.6	25.2	32.9	57.2	84.0	49.2	11.6	22.9	29.6	46.0	39.2	37.5	17.6	47.7	32.0	24.1	9.7	38.2	28.6	40.5	47.8	18.4	30.5	57.7	19.1	35.5	37.8	0.0	0.0	0.0	0.2	0.2	0.0	0.2	0.3	0.5	0.1	0.0	0.0	0.1	0.0	0.2	0.0	0.0	2.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	1.2	0.0	0.0	0.0	2.3	2.3	0.4	1.7	0.0	0.0	1.3	1.3	7.0	1.5	0.9	0.0	0.0	12.8	1.4	1.5	0.0	0.4	25.3	0.4	1.3	5.2	0.0	36.2	0.2	0.0	16.2	2.4	3.1	1.0	0.0	11.4	0.7	0.4	4.7	0.0	0.3	3.3	0.0	0.3	0.8	12.4	1.2	2.2	0.0	1.0	0.2	0.0	0.0	0.0	0.1	0.6	0.4	0.0	12.8	0.2	0.6	0.0	0.1	0.0	0.0	0.2	2.7	53.2	20.8	5.6	1.7	1.5	2.6	1.6	5.2	0.7
DTNA	"D18S892E, DRP3, DTN, DTN-1, DTN-2, DTN-3"	ENSG00000134769	"Dystrobrevin alpha"	Q9Y4J8	18	34493290-34891844	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"			"Cardiomyopathy, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"brain: 461.9;choroid plexus: 120.6;heart muscle: 150.0;skeletal muscle: 166.9;tongue: 209.9"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 1756.1;Excitatory neurons: 506.0;Inhibitory neurons: 650.9;Oligodendrocyte precursor cells: 491.6;Oligodendrocytes: 367.4"	"Cancer enriched"	"Detected in many"	9	"glioma: 28.2"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"MCF7: 37.7;NTERA-2: 42.0;SCLC-21H: 51.9;U-87 MG: 52.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB015196, HPA071177"	Enhanced		Approved	"Nucleoplasm,Cell Junctions,Intermediate filaments"		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 64: Astrocytes - Nervous system maintenance"	"Cell Junctions, Intermediate filaments"	Nucleoplasm	"CAB015196: AB_2261797, HPA071177: "	"unprognostic (1.57e-1)"	"unprognostic (4.57e-2)"	"unprognostic (3.13e-3)"	"unprognostic (7.82e-6)"	"unprognostic (5.03e-1)"	"unprognostic (2.43e-3)"	"unprognostic (2.73e-1)"	"unprognostic (7.42e-2)"	"unprognostic (1.23e-1)"	"unprognostic (6.27e-2)"	"unprognostic (1.35e-4)"	"unprognostic (6.89e-2)"	"prognostic favorable (2.64e-7)"	"unprognostic (6.08e-3)"	"unprognostic (3.93e-2)"	"unprognostic (1.12e-1)"	"unprognostic (7.27e-5)"	11.6	6.6	252.7	5.4	248.2	0.8	9.6	243.3	260.1	5.4	120.6	22.4	3.9	8.1	20.5	22.9	11.7	9.4	150.0	250.1	423.0	2.3	2.2	6.6	2.3	461.9	326.9	7.0	18.1	2.4	10.8	4.1	360.4	23.6	7.6	19.8	11.3	25.3	166.9	2.7	8.4	19.4	308.1	4.8	6.8	6.1	269.2	0.5	12.3	209.9	2.0	32.0	5.2	331.0	0.7	0.5	17.3	0.0	9.5	25.1	2.6	3.2	14.8	0.6	1.7	3.8	0.2	0.1	8.9	1.9	15.3	1.1	2.1	7.5	1.8	0.0	10.7	0.1	0.9	5.7	7.1	0.2	0.2	19.2	1.8	11.9	4.5	14.2	6.7	0.1	2.4	1.9	3.8	37.7	0.1	0.2	42.0	0.6	8.1	0.1	7.7	24.1	0.9	0.3	51.9	6.9	0.0	1.7	4.9	23.8	21.8	6.3	0.5	16.7	9.9	0.3	5.2	1.3	2.0	1.0	52.5	0.0	8.4	1.0	0.7	0.0	0.8	0.0	1.1	0.8	1.5	1.1	3.5	0.7	1.6	1.3	0.3	0.8	0.0	0.1	4.3	1.0	252.7	248.2	243.3	260.1	250.1	423.0	461.9	326.9	360.4	308.1	269.2	331.0	5.1	0.0	1.1	1756.1	0.1	1.5	0.1	0.8	0.0	18.3	22.2	12.3	134.3	27.1	1.4	0.0	6.2	0.1	0.4	0.0	5.9	12.6	3.1	7.0	2.6	6.4	0.0	0.0	506.0	25.1	0.1	5.7	0.0	0.4	0.0	2.3	0.0	0.2	9.0	1.7	650.9	0.1	4.1	4.0	21.5	3.7	5.9	8.0	5.4	105.9	0.9	34.0	0.0	491.6	367.4	8.0	0.0	0.4	0.0	1.8	0.1	2.0	7.1	3.8	13.1	22.7	17.3	0.9	4.8	0.2	1.0	0.0	0.2	0.3	0.2	0.2
DTX1	"hDx-1, RNF140"	ENSG00000135144	"Deltex E3 ubiquitin ligase 1"	Q86Y01	12	113056709-113098028	"Enzymes, Predicted intracellular proteins"	"Notch signaling pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 11.1;lymphoid tissue: 11.8"	"Group enriched"	"Detected in many"	6	"Astrocytes: 48.3;Horizontal cells: 171.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	12	"Daudi: 109.1;REH: 45.1;U-698: 110.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051249, HPA055275"	Approved		Supported	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA				"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 62: Horizontal cells - Visual perception"	"Nucleoplasm, Cytosol"	"Nuclear bodies"	"HPA051249: , HPA055275: AB_2682769"	"unprognostic (2.13e-3)"	"unprognostic (3.20e-3)"	"unprognostic (4.24e-4)"	"unprognostic (2.01e-1)"	"unprognostic (7.48e-3)"	"unprognostic (1.59e-3)"	"unprognostic (2.49e-3)"	"unprognostic (1.81e-1)"	"unprognostic (9.55e-2)"	"unprognostic (6.87e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.58e-1)"	"prognostic unfavorable (3.02e-5)"	"unprognostic (2.41e-2)"	"unprognostic (4.70e-1)"	"unprognostic (1.63e-1)"	"unprognostic (4.78e-3)"	9.0	1.7	6.5	5.7	6.8	2.7	6.4	3.2	5.9	2.4	0.2	0.8	1.3	1.5	0.3	0.9	1.8	0.8	1.2	5.2	11.1	3.5	8.9	0.8	11.1	5.2	8.8	0.4	1.6	0.0	3.3	0.3	5.1	0.8	0.1	2.9	2.6	0.3	0.5	1.0	3.5	0.3	3.7	11.8	0.9	1.9	10.5	0.5	2.2	0.1	6.0	0.5	0.6	2.4	0.2	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	109.1	0.8	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.6	0.0	0.0	0.3	4.6	0.0	2.0	0.2	0.0	45.1	0.2	2.6	0.0	0.0	2.7	7.1	0.4	0.4	2.5	0.0	0.1	0.2	1.2	0.0	4.0	0.0	0.1	0.5	0.2	110.7	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	6.5	6.8	3.2	5.9	5.2	11.1	5.2	8.8	5.1	3.7	10.5	2.4	0.7	0.0	0.0	48.3	8.8	1.0	0.0	0.0	0.0	4.7	0.2	0.6	0.7	0.0	0.0	1.8	8.4	0.0	0.3	0.1	7.9	2.5	0.7	0.7	17.5	1.7	0.0	0.0	10.6	0.0	0.0	4.5	0.5	0.4	7.0	0.0	0.4	12.4	0.8	171.6	13.8	0.1	0.0	0.3	0.6	1.7	7.8	0.2	3.6	2.8	0.0	11.4	2.1	13.0	1.0	0.2	0.1	7.5	2.5	0.0	0.0	0.2	0.0	2.8	0.0	0.4	1.3	0.8	2.4	0.0	0.4	0.0	2.2	0.8	0.0	0.0
DTX2	"KIAA1528, RNF58"	ENSG00000091073	"Deltex E3 ubiquitin ligase 2"	Q86UW9	7	76461676-76505995	"Enzymes, Predicted intracellular proteins"	"Notch signaling pathway, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 54.0"	"Cell type enhanced"	"Detected in all"		"Basal respiratory cells: 87.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"A549: 67.7;CAPAN-2: 110.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042931	Approved		Supported	"Nucleoplasm,Nuclear membrane"		NA	Yes			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 71: Testis - DNA repair"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Nucleoplasm, Nuclear membrane"		"HPA042931: AB_2678227"	"unprognostic (1.72e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.62e-2)"	"unprognostic (1.58e-2)"	"prognostic unfavorable (8.47e-4)"	"unprognostic (2.85e-2)"	"unprognostic (1.28e-3)"	"unprognostic (7.54e-2)"	"unprognostic (4.76e-2)"	"unprognostic (2.28e-2)"	"unprognostic (2.10e-2)"	"unprognostic (6.56e-2)"	"prognostic unfavorable (1.13e-8)"	"unprognostic (2.87e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.19e-2)"	10.0	5.0	5.6	12.3	6.3	5.1	10.3	3.3	10.1	17.4	13.8	15.8	10.2	9.3	1.1	54.0	10.5	9.3	6.8	4.3	5.9	5.4	8.7	10.3	10.9	11.1	8.1	8.1	10.5	8.4	6.7	5.3	8.1	13.7	8.1	4.4	30.4	3.9	12.5	31.0	13.3	4.3	3.8	13.3	14.2	28.1	13.5	9.0	7.9	2.7	10.1	12.1	27.2	12.8	31.8	67.7	9.9	14.7	5.5	5.4	21.2	6.8	5.7	7.2	9.9	19.1	110.9	9.8	4.7	6.8	38.1	23.2	5.3	32.1	4.5	22.1	11.3	5.6	14.4	16.9	7.4	8.2	13.7	9.6	19.1	18.7	10.0	5.6	5.5	17.2	17.3	14.3	8.8	15.3	12.6	28.6	14.4	23.8	10.2	13.8	9.1	17.7	3.4	24.4	3.9	8.2	10.9	18.4	9.3	8.6	18.5	21.6	5.8	40.5	19.0	13.8	27.1	10.7	13.7	11.2	8.8	8.8	21.3	17.7	11.6	17.2	8.6	13.3	6.2	6.6	7.1	8.5	10.1	7.3	7.1	7.9	22.8	4.2	18.8	17.8	11.0	8.4	5.6	6.3	3.3	10.1	4.3	5.9	11.1	8.1	8.1	3.8	13.5	12.8	7.3	6.4	5.0	5.2	13.1	33.9	19.5	87.2	23.3	2.6	7.1	4.8	2.3	4.3	59.2	7.3	8.4	18.5	12.0	39.1	3.9	19.4	33.0	8.1	3.1	5.9	9.1	3.8	5.7	10.8	13.5	6.5	61.2	10.7	3.8	3.2	7.1	4.3	21.6	3.3	5.2	25.6	22.4	11.0	7.7	10.4	5.6	14.5	7.2	19.7	10.0	5.7	8.2	18.1	10.0	23.1	37.9	4.9	13.9	20.0	21.0	3.2	62.8	9.2	6.6	3.0	7.3	11.0	11.0	27.0	35.4	37.6	9.7	1.9	26.1	62.5
DTX3L	"BBAP, RNF143"	ENSG00000163840	"Deltex E3 ubiquitin ligase 3L"	Q8TDB6	3	122564338-122575203	"Enzymes, Predicted intracellular proteins"	"Antiviral defense, DNA damage, DNA repair, Host-virus interaction, Immunity, Innate immunity, Protein transport, Transport, Ubl conjugation pathway"	"Chromatin regulator, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"BJ hTERT+ SV40 Large T+: 91.6;BJ hTERT+ SV40 Large T+ RasG12V: 112.3;GAMG: 87.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA010570	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 64: Macrophages - Immune response"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Nucleoplasm, Cytosol"		"HPA010570: AB_1847877"	"unprognostic (8.15e-2)"	"unprognostic (7.36e-3)"	"unprognostic (5.04e-2)"	"unprognostic (3.74e-3)"	"unprognostic (9.51e-2)"	"unprognostic (9.22e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.11e-2)"	"unprognostic (9.23e-2)"	"unprognostic (1.43e-1)"	"prognostic unfavorable (8.99e-4)"	"unprognostic (2.76e-2)"	"unprognostic (2.33e-2)"	"unprognostic (7.77e-2)"	"unprognostic (9.28e-2)"	"unprognostic (3.33e-2)"	"unprognostic (2.61e-2)"	11.1	9.2	5.5	24.4	6.0	12.8	10.8	5.0	6.4	10.1	4.8	15.5	20.6	12.3	6.5	11.4	11.4	15.3	7.3	4.6	6.1	9.9	32.1	20.8	21.8	11.1	6.6	9.4	17.8	11.1	5.3	16.3	7.4	12.3	16.2	2.6	20.3	8.6	7.8	8.1	18.7	14.8	8.3	26.6	15.9	3.6	8.3	17.4	11.9	9.2	20.9	18.2	8.2	7.2	31.2	9.4	2.6	7.9	12.0	27.6	10.2	7.9	29.3	91.6	112.3	9.2	31.2	3.6	15.1	13.2	87.8	30.5	9.2	12.8	20.1	26.3	3.4	27.1	7.2	9.8	23.7	14.0	20.2	23.8	14.8	13.7	7.8	17.4	17.6	16.9	3.5	18.8	6.9	9.6	34.3	9.9	1.7	9.7	17.2	37.5	21.0	6.0	23.4	19.8	3.8	4.1	16.6	7.4	59.5	1.8	8.5	17.5	21.6	10.4	14.5	1.0	10.2	6.8	4.0	16.4	17.9	17.9	10.9	21.4	11.3	12.0	11.6	18.1	12.5	7.5	9.5	12.4	8.7	7.9	8.4	9.3	28.2	10.5	19.4	0.9	9.9	9.9	5.5	6.0	5.0	6.4	4.6	6.1	11.1	6.6	7.4	8.3	8.3	7.2	31.3	32.1	28.1	3.9	19.7	8.9	10.2	10.4	9.1	0.3	12.9	8.1	5.1	15.7	15.0	7.3	0.0	4.1	15.3	46.3	0.0	23.1	2.5	17.2	26.7	24.1	18.5	16.2	0.0	32.5	15.2	13.3	30.5	27.5	15.8	17.5	25.4	56.7	28.4	0.0	0.3	26.6	10.2	38.6	5.8	1.1	8.4	26.1	5.4	13.1	38.2	5.1	40.2	0.5	1.1	32.4	15.0	9.1	11.8	20.1	24.2	15.1	17.0	0.4	32.9	10.0	10.7	1.8	0.5	12.4	6.0	1.8	19.2	8.3	20.6	20.1
DUSP10	"MKP-5, MKP5"	ENSG00000143507	"Dual specificity phosphatase 10"	Q9Y6W6	1	221701424-221742089	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 32.9"	"Cell type enhanced"	"Detected in many"		"granulocytes: 133.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"NK-cell: 19.7"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HaCaT: 102.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA016758	Approved		Supported	"Nucleoplasm,Golgi apparatus,Cytosol"		No	No			"Cluster 15: NK-cells - Transcription"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm	"Golgi apparatus, Cytosol"	"HPA016758: AB_1847880"	"unprognostic (1.55e-1)"	"unprognostic (2.73e-1)"	"unprognostic (1.44e-1)"	"unprognostic (6.65e-2)"	"unprognostic (3.83e-2)"	"unprognostic (2.85e-3)"	"prognostic favorable (5.42e-4)"	"unprognostic (2.89e-1)"	"unprognostic (3.89e-2)"	"unprognostic (9.68e-2)"	"unprognostic (2.38e-2)"	"unprognostic (1.05e-1)"	"prognostic unfavorable (3.69e-4)"	"unprognostic (4.18e-2)"	"unprognostic (2.57e-1)"	"unprognostic (8.88e-3)"	"unprognostic (1.97e-2)"	3.8	2.4	4.3	5.2	7.4	25.0	6.0	7.7	5.3	4.5	4.7	8.0	1.4	3.6	1.2	6.0	6.4	6.6	2.6	4.5	4.5	1.4	32.9	6.2	9.1	7.1	6.0	1.6	17.0	1.2	1.2	3.8	5.8	2.7	4.1	14.9	6.3	0.9	22.9	6.1	3.9	8.9	3.8	6.1	2.5	3.1	9.0	5.6	4.4	3.6	7.6	6.1	2.7	13.5	15.2	6.4	0.5	0.4	45.4	22.6	0.5	10.1	25.9	16.2	12.5	0.3	4.2	11.6	3.3	26.1	11.9	102.3	2.2	9.8	14.0	30.5	1.2	20.4	3.0	1.8	10.6	9.1	13.3	31.9	7.0	17.6	17.8	7.5	0.6	3.0	2.1	4.0	16.0	0.3	1.8	7.2	1.5	3.2	0.7	1.1	28.5	0.9	5.7	9.1	37.4	3.0	1.3	1.2	43.6	5.6	2.1	5.5	3.6	8.1	2.2	12.6	12.4	6.8	5.1	6.2	12.8	4.1	8.9	8.2	5.5	0.3	4.5	4.6	3.9	0.8	2.9	3.1	7.0	0.9	1.0	1.7	0.5	19.7	1.9	0.2	16.9	2.2	4.3	7.4	7.7	5.3	4.5	4.5	7.1	6.0	5.8	3.8	9.0	13.5	4.9	0.0	1.7	2.6	21.7	50.9	13.5	13.6	25.6	6.0	42.4	18.7	4.7	14.3	19.2	3.7	20.9	2.8	39.0	3.1	0.0	35.9	61.1	57.9	6.6	6.7	43.9	2.5	0.3	9.1	3.7	7.9	4.6	53.7	133.5	0.2	1.8	53.6	22.3	1.7	30.9	17.7	69.2	9.7	46.9	7.1	24.8	26.0	23.2	2.8	14.1	14.3	17.5	17.1	50.5	26.2	0.8	12.8	9.9	11.0	0.4	1.1	18.5	34.2	0.0	33.7	5.3	9.7	3.2	16.7	41.3	3.4	47.0	28.7	3.6	16.5
DUSP11	PIR1	ENSG00000144048	"Dual specificity phosphatase 11"	O75319	2	73762184-73780157	"Metabolic proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021052			Supported	"Nucleoplasm,Nucleoli fibrillar center,Cytokinetic bridge"		Yes	Yes			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Nucleoplasm, Nucleoli fibrillar center"	"Cytokinetic bridge"	"HPA021052: AB_2670577"	"unprognostic (2.45e-3)"	"unprognostic (1.06e-1)"	"unprognostic (2.19e-2)"	"unprognostic (7.87e-3)"	"unprognostic (9.14e-2)"	"unprognostic (5.28e-3)"	"prognostic unfavorable (2.10e-7)"	"unprognostic (7.20e-2)"	"unprognostic (5.43e-2)"	"unprognostic (5.85e-2)"	"unprognostic (8.67e-3)"	"unprognostic (3.84e-2)"	"unprognostic (7.56e-3)"	"unprognostic (1.41e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.47e-3)"	"unprognostic (1.46e-1)"	16.0	13.3	7.9	17.1	7.7	35.2	20.4	13.4	11.2	22.4	7.6	16.0	17.3	21.2	19.3	30.5	39.0	15.9	14.2	8.1	6.9	20.2	17.9	14.3	25.3	6.1	5.7	23.5	11.0	14.7	14.0	20.5	6.1	16.5	17.4	8.3	16.0	14.4	14.3	27.6	15.3	19.6	4.8	19.0	16.3	16.8	6.5	24.8	16.5	17.8	26.1	25.2	22.4	8.3	39.4	16.7	17.6	18.6	31.2	38.7	31.2	28.2	36.7	35.8	36.4	24.2	29.1	50.6	17.7	30.6	32.1	26.7	22.0	56.8	34.3	35.2	22.9	31.2	12.0	37.3	32.7	35.5	28.0	31.6	67.3	32.1	44.1	31.1	40.4	24.2	33.6	28.6	40.2	21.3	34.3	37.6	28.4	36.7	22.7	13.6	47.3	46.0	29.3	32.1	25.9	14.1	26.1	30.6	35.7	21.0	16.4	18.6	23.1	25.4	31.4	29.5	33.7	30.7	26.2	68.1	23.5	35.5	25.3	72.5	42.2	99.5	56.3	39.3	73.5	68.3	65.8	67.4	47.3	65.9	69.4	65.5	65.2	69.8	40.6	35.7	88.6	71.7	7.9	7.7	13.4	11.2	8.1	6.9	6.1	5.7	6.1	4.8	6.5	8.3	26.5	9.6	12.0	7.5	39.5	83.2	55.1	93.0	39.3	11.0	12.9	15.1	8.6	27.1	45.7	12.9	4.2	32.8	34.8	15.5	50.9	29.6	9.1	18.0	15.7	34.6	12.0	21.0	14.9	27.3	42.0	26.5	16.3	13.6	40.7	20.5	52.1	15.3	30.7	5.0	12.7	18.0	36.7	20.2	27.1	7.0	28.9	17.0	23.2	10.3	34.8	9.8	41.2	13.0	13.8	28.2	17.8	25.6	31.8	30.0	22.8	50.4	38.2	16.6	6.6	18.2	23.1	23.8	34.6	42.8	83.0	38.6	39.8	20.7	18.8	60.9
DUSP12	"DUSP1, YVH1"	ENSG00000081721	"Dual specificity phosphatase 12"	Q9UNI6	1	161749758-161757238	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008840	Uncertain		Supported	Nucleoplasm		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"HPA008840: AB_1847884"	"unprognostic (3.51e-2)"	"unprognostic (2.62e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.01e-2)"	"unprognostic (2.11e-1)"	"unprognostic (4.04e-2)"	"prognostic unfavorable (1.99e-5)"	"unprognostic (1.86e-1)"	"unprognostic (1.06e-2)"	"unprognostic (2.25e-3)"	"unprognostic (9.52e-2)"	"unprognostic (2.42e-3)"	"prognostic unfavorable (1.55e-7)"	"unprognostic (1.17e-1)"	"unprognostic (1.84e-1)"	"unprognostic (3.25e-2)"	"unprognostic (2.42e-1)"	13.3	9.6	12.1	9.1	12.5	30.9	14.1	14.3	14.6	13.8	12.1	12.9	7.6	14.3	8.9	10.3	12.5	6.7	9.4	12.0	12.4	14.4	9.4	11.4	13.8	12.2	12.2	13.6	13.6	8.2	9.5	11.2	12.3	11.0	10.5	13.2	10.9	9.5	7.4	10.9	12.4	11.0	12.3	14.1	11.5	6.7	12.0	11.7	12.1	7.3	13.0	13.1	11.5	13.3	32.6	28.2	33.1	21.7	17.2	18.5	30.4	25.9	33.7	39.2	29.9	42.1	28.2	19.9	25.7	31.9	24.4	22.7	26.0	32.0	38.0	25.5	22.0	17.8	27.7	28.4	36.4	38.6	17.1	25.4	34.6	34.1	61.0	22.2	27.6	27.2	31.7	20.9	28.3	30.0	22.7	43.2	52.1	35.2	43.1	32.2	32.0	32.9	22.2	39.3	20.6	43.6	21.9	36.2	44.1	36.2	31.3	43.6	19.3	33.3	30.8	26.3	55.6	35.3	31.0	47.0	20.3	38.1	33.3	32.0	16.9	13.7	18.4	19.5	22.9	19.2	20.8	17.8	22.0	20.0	19.6	21.8	6.8	28.4	12.2	10.0	19.5	12.9	12.1	12.5	14.3	14.6	12.0	12.4	12.2	12.2	12.3	12.3	12.0	13.3	22.9	19.2	12.8	8.1	25.5	13.6	14.4	25.9	25.6	15.9	13.4	16.1	5.0	8.6	15.6	7.3	8.4	21.7	26.4	4.8	21.5	22.2	4.2	7.4	13.7	18.4	11.3	16.2	11.9	24.3	22.7	17.3	11.7	7.2	18.3	18.7	18.5	8.2	20.5	10.1	14.8	9.8	8.2	20.6	16.2	1.2	8.7	15.4	10.6	10.3	22.1	15.8	33.0	12.1	14.4	21.2	6.5	17.7	27.5	17.1	8.6	18.5	7.0	19.6	0.0	13.2	24.5	13.9	12.6	18.2	13.1	17.6	23.5	16.4	12.1	12.0
DUSP16	"KIAA1700, MKP-7, MKP7"	ENSG00000111266	"Dual specificity phosphatase 16"	Q9BY84	12	12473282-12562863	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Granulosa cells: 114.9;Oligodendrocytes: 196.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"T-reg: 3.9"	"Lineage enriched"	"Detected in single"	5	"T-cells: 3.9"	"Cell line enhanced"	"Detected in many"		"NTERA-2: 37.7;RT4: 34.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020326	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 40: Granulosa cells - Unknown function"	Nucleoplasm		"HPA020326: AB_1847890"	"unprognostic (8.05e-2)"	"unprognostic (9.47e-2)"	"unprognostic (1.49e-3)"	"unprognostic (4.14e-2)"	"unprognostic (9.86e-2)"	"prognostic favorable (1.01e-4)"	"unprognostic (1.75e-2)"	"unprognostic (3.52e-2)"	"unprognostic (1.13e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.78e-1)"	"unprognostic (2.82e-1)"	"unprognostic (2.34e-3)"	"unprognostic (6.35e-3)"	"unprognostic (2.42e-1)"	"unprognostic (1.46e-1)"	"unprognostic (5.76e-2)"	9.3	47.8	4.9	7.8	8.3	3.6	15.0	7.7	5.3	12.2	6.3	11.3	13.6	11.3	6.2	12.7	10.5	8.0	7.2	4.8	6.0	7.6	33.3	12.0	6.4	7.3	8.1	10.7	18.8	8.0	12.9	5.5	6.2	19.7	10.9	7.5	14.6	3.4	11.3	11.1	13.1	4.9	5.4	6.8	13.2	7.1	6.7	15.2	8.8	4.7	9.0	10.7	17.0	11.8	4.5	6.5	7.6	4.2	2.8	3.3	13.6	2.6	5.8	6.4	9.1	18.1	8.6	0.4	1.4	2.9	11.3	2.9	14.1	2.4	8.6	14.4	7.0	0.7	6.8	19.2	5.4	1.3	3.0	2.8	6.7	5.1	16.3	6.8	5.0	7.3	4.0	11.8	0.4	8.6	1.7	0.9	37.7	11.1	1.9	2.0	2.6	8.6	3.6	34.3	12.3	11.5	10.6	13.6	6.7	28.2	5.5	2.2	4.5	2.9	8.3	1.8	2.9	8.3	10.6	1.5	3.8	2.9	4.0	0.0	0.0	0.0	0.5	0.0	2.3	0.0	1.6	0.7	0.1	0.0	0.5	0.3	0.8	0.0	0.0	0.0	3.9	0.3	4.9	8.3	7.7	5.3	4.8	6.0	7.3	8.1	6.2	5.4	6.7	11.8	9.6	28.9	55.5	30.3	3.3	2.8	14.9	1.5	3.4	4.8	23.8	13.1	11.5	20.0	9.7	3.7	2.1	10.5	5.6	35.7	0.0	14.3	1.3	15.1	10.2	9.2	49.6	0.0	19.5	24.6	4.1	9.9	11.7	19.9	23.5	114.9	7.5	34.2	5.3	6.7	24.8	10.0	2.0	9.4	1.9	2.3	5.9	5.7	5.4	38.4	2.9	36.8	0.0	56.3	196.3	20.9	25.3	6.8	4.3	34.3	25.4	5.2	10.4	4.8	0.0	11.1	10.3	3.0	5.8	6.2	1.8	30.1	27.9	9.9	18.7	24.5
DUSP18	DUSP20	ENSG00000167065	"Dual specificity phosphatase 18"	Q8NEJ0	22	30652051-30667887	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 123.4;Late spermatids: 344.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034070, HPA051349"	Uncertain		Supported	Nucleoplasm		Yes	No			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 25: Spermatids - Spermatogenesis"	Nucleoplasm		"CAB034070: AB_2094867, HPA051349: AB_2681450"	"unprognostic (1.11e-1)"	"unprognostic (2.34e-2)"	"unprognostic (3.49e-3)"	"unprognostic (4.88e-3)"	"unprognostic (1.88e-1)"	"unprognostic (9.12e-2)"	"unprognostic (3.77e-4)"	"unprognostic (1.83e-1)"	"unprognostic (1.61e-1)"	"unprognostic (3.53e-2)"	"unprognostic (9.62e-2)"	"unprognostic (4.87e-2)"	"unprognostic (1.23e-3)"	"unprognostic (6.55e-2)"	"unprognostic (1.97e-1)"	"unprognostic (4.56e-2)"	"unprognostic (1.02e-1)"	3.3	1.9	3.4	4.5	3.6	3.3	2.8	2.9	5.3	2.4	9.1	5.4	5.0	2.9	4.9	4.1	10.9	4.2	2.0	3.7	4.0	2.2	1.0	5.5	4.7	5.4	7.6	2.4	2.9	3.3	4.2	2.1	4.9	2.1	6.8	5.2	2.5	2.4	1.3	4.8	4.6	3.8	4.8	4.3	4.8	13.9	4.5	4.0	3.3	1.6	3.9	3.3	2.6	6.0	5.4	5.4	2.5	5.8	6.2	11.9	2.3	4.9	5.3	4.7	5.1	3.1	5.3	3.6	3.3	6.0	6.2	3.8	1.3	3.8	5.3	9.8	6.1	1.5	2.2	2.2	2.6	7.4	5.3	3.1	5.4	7.8	3.0	5.3	15.0	4.1	1.7	2.8	5.2	4.8	4.2	1.8	0.8	6.4	3.3	2.8	1.7	1.2	5.6	3.7	6.2	3.7	4.8	1.7	3.5	3.2	4.5	2.2	11.1	9.9	5.4	2.7	2.8	2.1	2.6	1.7	11.4	1.3	5.0	31.4	15.3	29.9	8.6	19.3	6.6	9.7	9.6	7.7	17.2	8.7	6.6	7.5	31.8	7.4	21.4	9.7	13.2	8.4	3.4	3.6	2.9	5.3	3.7	4.0	5.4	7.6	4.9	4.8	4.5	6.0	7.2	19.2	5.4	11.4	7.1	21.4	13.3	6.5	2.2	2.9	4.9	3.4	2.0	10.0	9.6	5.5	45.9	1.2	12.0	10.0	3.9	10.1	123.4	34.5	5.0	10.1	35.5	2.1	8.0	9.4	3.9	6.8	8.6	5.0	7.0	4.4	13.9	1.1	8.1	1.7	4.4	15.4	6.1	15.6	28.5	344.2	8.4	13.2	8.8	13.1	13.9	10.1	9.2	1.5	14.3	9.3	15.4	6.8	3.9	8.8	24.2	4.1	64.6	16.8	6.6	8.6	6.6	63.0	17.2	5.7	21.3	1.0	9.7	3.5	19.0	8.7
DUSP2	PAC-1	ENSG00000158050	"Dual specificity phosphatase 2"	Q05923	2	96143169-96145440	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 129.5"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 919.7;Glandular and luminal cells: 321.1;Langerhans cells: 924.0;Macrophages: 353.9;T-cells: 764.7"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	4	"cerebral cortex: 55.0"	"Immune cell enhanced"	"Detected in all"		"gdT-cell: 199.3"	"Group enriched"	"Detected in all"	10	"NK-cells: 148.1;T-cells: 199.3"	"Cell line enhanced"	"Detected in many"		"Daudi: 30.4;HeLa: 29.7;JURKAT: 27.6;Karpas-707: 33.8;NB-4: 29.1;RT4: 34.2;SCLC-21H: 29.6;U-698: 43.2"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in some"			HPA071920			Supported	"Nucleoplasm,Nuclear membrane"		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 24: Non-specific - Transcription regulation"	"Nuclear membrane"	Nucleoplasm	"HPA071920: AB_2686472"	"unprognostic (2.69e-3)"	"unprognostic (6.70e-3)"	"unprognostic (1.15e-1)"	"unprognostic (5.46e-3)"	"unprognostic (3.32e-2)"	"unprognostic (8.54e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.86e-1)"	"unprognostic (3.66e-2)"	"unprognostic (3.10e-1)"	"unprognostic (6.30e-2)"	"prognostic unfavorable (4.97e-5)"	"unprognostic (1.82e-1)"	"unprognostic (2.41e-1)"	"unprognostic (3.94e-2)"	"unprognostic (1.31e-3)"	17.0	6.0	7.6	18.6	11.6	129.5	5.5	7.5	55.0	8.1	9.2	4.5	1.6	7.0	7.7	6.8	7.6	12.5	19.5	13.4	6.2	12.7	7.5	18.2	47.1	8.0	6.3	7.8	2.3	1.7	35.1	1.3	6.7	17.6	2.0	0.4	3.9	61.5	2.8	26.0	11.8	3.4	6.7	42.0	7.4	3.6	6.9	47.3	6.7	3.7	24.6	39.5	9.0	9.3	3.2	0.0	0.2	0.2	0.4	0.5	4.4	3.7	0.0	5.3	5.1	8.9	0.6	30.4	10.6	4.1	0.0	2.2	7.5	0.0	1.0	0.5	0.0	0.7	29.7	0.0	1.9	12.8	2.6	0.9	2.0	0.9	0.0	0.1	0.0	27.6	0.0	33.8	0.2	5.2	25.5	29.1	6.5	0.8	10.6	0.0	0.4	24.3	0.2	34.2	29.6	1.5	1.4	0.3	5.6	0.0	2.0	14.4	0.1	0.0	7.9	0.0	1.7	2.3	3.9	43.2	0.0	13.9	0.3	2.3	4.3	1.0	199.3	10.5	95.4	17.5	46.7	176.2	10.7	13.9	32.0	99.3	6.1	148.1	9.1	3.0	16.1	40.5	7.6	11.6	7.5	55.0	13.4	6.2	8.0	6.3	6.7	6.7	6.9	9.3	50.8	0.0	7.7	0.7	303.7	96.7	155.0	31.3	70.6	27.8	65.8	72.0	37.8	2.8	12.0	9.2	22.9	0.9	919.7	20.4	1.9	0.9	0.9	115.6	62.7	28.7	87.8	50.5	5.2	1.4	1.7	22.8	86.6	321.1	104.3	7.4	12.8	3.9	80.2	0.0	1.4	37.5	8.2	40.4	924.0	1.4	1.8	353.9	144.1	1.9	3.4	1.5	90.6	1.0	0.5	1.0	2.5	1.9	268.5	70.4	1.6	1.4	2.7	3.6	0.0	14.7	26.6	0.6	4.8	50.4	109.7	1.6	764.7	3.0	51.6	41.1
DUSP23	"DUSP25, FLJ20442"	ENSG00000158716	"Dual specificity phosphatase 23"	Q9BVJ7	1	159780932-159782543	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Exocrine glandular cells: 458.5;Proximal tubular cells: 800.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HSkMC: 142.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028211, HPA045792"	Approved		Supported	Nucleoplasm		NA	NA		22000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 81: Kidney & Liver - Metabolism"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Nucleoplasm		"HPA028211: AB_2672522, HPA045792: AB_10961133"	"unprognostic (1.52e-1)"	"unprognostic (4.12e-1)"	"unprognostic (1.40e-3)"	"unprognostic (3.33e-2)"	"unprognostic (4.36e-2)"	"unprognostic (3.22e-1)"	"prognostic unfavorable (3.06e-4)"	"unprognostic (3.16e-1)"	"unprognostic (4.62e-1)"	"unprognostic (3.33e-3)"	"unprognostic (4.72e-2)"	"unprognostic (3.75e-2)"	"prognostic unfavorable (2.59e-5)"	"unprognostic (8.58e-2)"	"unprognostic (2.84e-2)"	"unprognostic (7.47e-2)"	"unprognostic (1.39e-1)"	75.0	122.4	29.1	15.4	31.5	20.5	99.9	32.0	38.5	57.6	30.0	46.3	26.7	55.0	15.5	82.0	52.3	13.4	36.1	31.8	31.4	199.1	189.3	55.3	10.4	32.0	30.1	35.6	76.8	34.6	20.8	5.9	32.1	55.3	13.9	8.1	152.4	15.3	65.4	61.1	42.9	12.0	32.8	39.2	39.7	18.2	31.3	15.2	58.8	16.6	9.1	45.1	53.6	31.0	39.5	42.2	0.3	0.2	39.5	33.5	0.4	15.8	13.0	18.4	14.3	17.3	44.7	0.1	90.9	17.6	4.2	1.5	10.8	14.5	10.0	9.9	4.6	54.4	14.7	0.0	58.6	33.3	40.4	142.8	38.3	12.1	43.0	13.2	71.0	0.1	25.2	19.4	26.3	72.5	3.5	1.4	71.3	71.6	58.7	0.1	0.0	18.8	22.7	6.9	17.8	39.4	28.6	63.0	78.5	7.3	40.6	51.7	51.7	15.3	0.8	1.9	0.2	13.5	34.8	0.5	25.8	26.5	11.7	111.8	181.7	229.1	97.9	153.4	54.6	60.5	72.7	92.8	261.3	43.7	44.0	65.1	185.6	100.5	105.6	59.2	70.8	112.2	29.1	31.5	32.0	38.5	31.8	31.4	32.0	30.1	32.1	32.8	31.3	31.0	100.4	41.7	58.7	3.3	23.8	74.6	129.2	151.8	100.7	8.5	110.6	112.1	29.5	95.8	122.2	51.5	6.2	16.1	28.4	97.7	262.2	210.7	48.3	47.5	30.8	155.8	35.4	37.5	1.4	458.5	29.2	31.2	32.1	130.9	54.5	66.1	75.0	249.4	170.3	1.7	0.5	124.9	91.6	94.3	72.9	8.4	26.4	92.2	42.7	4.7	58.9	74.8	69.0	1.0	4.4	208.4	112.2	15.8	14.6	121.5	140.4	800.7	54.8	10.0	13.1	16.0	34.9	5.4	19.9	123.2	74.4	5.7	43.6	72.3	109.5	116.1
DUSP26	"DUSP24, MGC1136, NEAP"	ENSG00000133878	"Dual specificity phosphatase 26"	Q9BV47	8	33591330-33600023	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"skeletal muscle: 421.3;tongue: 204.4"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 76.8;Cardiomyocytes: 59.4;Cone photoreceptor cells: 41.7;Enteroendocrine cells: 25.7;Horizontal cells: 25.2;Rod photoreceptor cells: 75.2"	"Cancer enhanced"	"Detected in some"		"glioma: 6.7;pancreatic cancer: 4.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"SCLC-21H: 97.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018221	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 56: Bipolar cells - Visual perception"	Nucleoplasm		"HPA018221: AB_2669813"	"unprognostic (2.77e-4)"	"unprognostic (2.70e-2)"	"unprognostic (2.70e-3)"	"unprognostic (5.47e-3)"	"unprognostic (2.01e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.53e-2)"	"unprognostic (2.81e-1)"	"unprognostic (1.39e-1)"	"unprognostic (4.10e-3)"	"unprognostic (1.78e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.52e-2)"	"unprognostic (1.14e-1)"	"unprognostic (8.15e-2)"	"unprognostic (5.80e-2)"	0.7	27.4	44.2	1.2	45.2	0.2	0.4	47.4	49.6	1.2	18.4	2.8	3.5	1.3	5.6	5.0	3.6	1.2	70.8	45.0	53.0	1.5	0.2	3.3	0.4	39.8	42.1	33.2	3.0	2.0	61.4	0.0	55.2	4.2	1.1	34.1	4.6	0.8	421.3	0.3	2.6	2.7	38.3	0.7	3.9	3.6	44.4	0.8	0.9	204.4	0.8	1.2	1.7	41.1	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.3	0.1	0.1	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	1.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	97.7	23.1	0.0	0.1	0.0	0.0	1.1	0.0	0.0	0.0	0.2	0.1	0.1	3.1	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	44.2	45.2	47.4	49.6	45.0	53.0	39.8	42.1	55.2	38.3	44.4	41.1	0.0	0.0	0.0	1.3	0.9	0.0	0.2	0.0	0.6	76.8	0.0	0.3	59.4	0.0	0.0	0.0	41.7	0.0	0.0	0.0	21.5	0.4	7.8	0.4	0.1	0.8	25.7	0.0	11.3	0.4	0.0	3.5	0.5	0.1	0.0	1.0	0.4	0.0	0.0	25.2	14.7	0.5	0.0	0.0	0.0	5.2	0.0	0.1	1.8	2.8	0.0	22.8	0.0	12.1	12.0	1.1	0.0	6.0	5.3	0.3	0.0	2.5	0.0	75.2	0.0	10.8	5.2	0.2	0.2	0.0	0.0	0.0	0.6	0.7	0.1	0.1
DUSP3	VHR	ENSG00000108861	"Dual specificity phosphatase 3"	P51452	17	43766125-43778977	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 261.9"	"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 274.3;Late spermatids: 160.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Group enriched"	"Detected in all"	9	"dendritic cells: 33.5;granulocytes: 11.0;monocytes: 29.3"	"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA063616			Supported	Nucleoplasm,Cytosol		NA	NA		1300000	"Cluster 14: Monocytes - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 54: Cardiomyocytes - Muscle contraction"	Nucleoplasm	Cytosol	"HPA063616: AB_2685061"	"unprognostic (1.52e-1)"	"unprognostic (3.18e-2)"	"unprognostic (1.10e-1)"	"unprognostic (8.54e-2)"	"unprognostic (1.04e-3)"	"prognostic unfavorable (3.00e-4)"	"unprognostic (4.83e-2)"	"unprognostic (8.98e-2)"	"unprognostic (5.13e-1)"	"unprognostic (6.01e-2)"	"unprognostic (1.78e-1)"	"unprognostic (8.40e-3)"	"prognostic favorable (5.49e-5)"	"unprognostic (2.67e-3)"	"unprognostic (5.45e-2)"	"unprognostic (1.94e-1)"	"unprognostic (1.37e-2)"	39.8	43.2	63.6	21.6	67.1	9.9	32.7	57.2	91.0	32.4	59.6	96.1	27.8	49.2	31.1	48.4	33.6	33.4	194.8	69.0	65.4	72.0	108.1	50.2	14.3	64.2	64.3	18.2	48.6	47.0	33.1	31.4	64.4	57.7	26.0	30.8	31.8	72.9	261.9	24.6	38.7	62.9	58.5	40.7	57.5	24.5	65.6	6.2	30.5	213.7	13.0	63.1	33.6	64.3	32.3	57.1	21.5	23.1	61.1	32.7	18.3	23.8	56.4	54.4	65.1	55.4	21.1	4.9	36.7	44.7	112.4	27.3	33.7	29.3	56.9	11.1	25.6	16.2	25.9	45.4	74.5	2.0	16.1	30.5	51.5	42.0	36.2	59.0	38.5	15.9	14.7	5.4	64.2	23.1	8.5	8.4	9.9	45.5	41.1	10.5	64.5	12.1	75.8	33.3	12.0	21.6	27.9	18.3	71.8	58.8	82.2	44.7	40.4	61.1	41.5	87.9	40.1	28.5	40.4	1.2	72.4	22.6	20.8	11.0	29.3	6.4	1.5	15.0	2.7	2.6	2.4	1.9	33.5	2.4	1.9	1.7	7.0	1.7	20.6	13.8	1.6	11.4	63.6	67.1	57.2	91.0	69.0	65.4	64.2	64.3	64.4	58.5	65.6	64.3	23.1	25.6	21.2	6.5	9.2	22.4	47.6	17.6	10.8	17.2	20.3	21.3	274.3	54.3	17.9	42.3	25.0	16.3	9.5	36.9	41.1	47.8	88.6	18.8	16.6	33.8	36.4	11.6	18.1	58.9	21.8	25.9	42.8	25.0	38.7	6.1	25.4	108.8	86.6	20.2	15.5	19.9	24.4	49.1	52.0	160.5	14.6	47.2	10.6	15.9	53.9	16.8	4.1	8.5	13.8	56.5	32.3	26.4	8.0	46.2	57.7	87.6	21.1	17.3	32.9	24.1	28.4	3.3	5.0	16.0	28.8	45.0	6.3	15.1	18.0	42.6
DUSP4	"HVH2, MKP-2, TYP"	ENSG00000120875	"Dual specificity phosphatase 4"	Q13115	8	29333064-29350684	"Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 32.2;stomach 1: 32.4"	"Cell type enhanced"	"Detected in many"		"Glandular and luminal cells: 155.5;Ionocytes: 126.1;Pancreatic endocrine cells: 195.2"	"Cancer enhanced"	"Detected in all"		"melanoma: 42.9"	"Region enhanced"	"Detected in many"		"hippocampal formation: 20.9"	"Immune cell enriched"	"Detected in single"	9	"T-reg: 6.7"	"Lineage enriched"	"Detected in single"	20	"T-cells: 6.7"	"Cell line enhanced"	"Detected in many"		"A549: 100.0;OE19: 91.7;SK-MEL-30: 157.2;WM-115: 122.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA061967			Supported	Nucleoplasm		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 25: Pancreas - Digestion"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 41: Macrophages - Immune response"	Nucleoplasm		"HPA061967: AB_2684648"	"unprognostic (1.92e-1)"	"unprognostic (5.97e-3)"	"unprognostic (3.24e-1)"	"unprognostic (6.54e-2)"	"unprognostic (2.18e-2)"	"unprognostic (7.66e-3)"	"unprognostic (7.30e-2)"	"unprognostic (7.08e-2)"	"unprognostic (1.83e-2)"	"unprognostic (9.73e-3)"	"unprognostic (9.60e-3)"	"unprognostic (3.15e-2)"	"prognostic unfavorable (4.19e-4)"	"unprognostic (6.88e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.08e-2)"	"unprognostic (6.07e-2)"	15.2	5.2	2.3	5.4	1.4	6.2	23.7	5.0	9.0	6.0	0.4	1.2	1.2	4.5	0.1	2.5	1.9	11.3	2.3	20.9	1.2	2.8	0.7	5.7	2.6	1.6	1.1	0.4	32.2	0.6	5.3	7.5	1.1	5.2	1.4	5.9	16.1	10.1	4.2	5.6	2.0	1.2	0.3	1.0	32.4	2.8	2.9	4.2	1.2	0.9	2.7	13.8	2.8	1.1	38.0	100.0	57.9	2.8	7.2	0.0	4.9	7.7	42.0	22.8	10.1	1.1	18.8	0.0	20.5	3.6	16.0	12.0	0.7	25.7	13.5	1.0	1.9	0.3	3.7	0.7	0.2	0.5	47.3	4.6	16.7	7.1	42.1	49.7	18.9	0.4	0.3	4.5	46.0	42.9	0.1	7.1	10.1	91.7	60.5	1.2	1.9	8.1	52.3	19.7	0.4	32.0	10.8	49.5	157.2	1.1	10.7	1.1	53.3	16.7	0.3	0.0	5.7	11.6	1.4	0.1	50.2	8.9	122.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	6.7	0.0	2.3	1.4	5.0	9.0	20.9	1.2	1.6	1.1	1.1	0.3	2.9	1.1	11.1	0.0	2.8	0.0	33.5	12.1	98.3	27.3	4.0	43.2	80.4	62.2	2.6	51.5	51.1	0.0	12.5	3.2	24.0	1.9	0.0	74.3	7.6	64.7	13.3	16.3	97.8	0.0	3.8	78.6	40.9	9.6	121.8	155.5	6.3	0.0	21.8	0.3	25.0	43.7	8.2	8.5	126.1	4.0	102.8	25.6	0.3	47.4	65.8	0.0	75.6	0.8	0.0	1.5	0.3	195.2	0.0	0.0	31.0	30.9	0.4	0.2	43.6	3.4	13.1	18.9	17.8	1.4	8.2	2.3	11.9	17.8	115.6	0.1	4.6	102.7
DUT	dUTPase	ENSG00000128951	"Deoxyuridine triphosphatase"	P33316	15	48331011-48343373	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Nucleotide metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 508.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054422, HPA060360"	Enhanced		Supported	Nucleoplasm		No	Yes		31000	"Cluster 26: Non-specific - Mitochondria"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 32: U-937 - Innate immune response"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"HPA054422: AB_2682483, HPA060360: AB_2684262"	"unprognostic (1.82e-1)"	"unprognostic (3.49e-2)"	"unprognostic (7.89e-2)"	"unprognostic (5.27e-2)"	"unprognostic (2.20e-1)"	"unprognostic (7.17e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.16e-2)"	"unprognostic (4.42e-3)"	"unprognostic (1.87e-2)"	"unprognostic (4.25e-1)"	"unprognostic (3.54e-2)"	"unprognostic (3.68e-2)"	"unprognostic (4.23e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.09e-2)"	"unprognostic (1.71e-2)"	73.0	65.3	54.7	61.7	58.9	162.9	76.4	57.1	77.2	90.7	60.0	69.5	29.3	76.9	49.7	72.1	77.6	33.6	68.9	53.9	59.6	67.6	53.6	58.1	97.8	58.2	55.5	86.1	53.2	48.3	80.0	45.1	58.3	77.8	47.1	49.1	66.5	48.3	57.9	71.6	66.5	40.4	57.7	82.1	61.5	57.3	57.5	111.4	89.2	53.0	87.8	69.1	78.0	63.5	196.1	60.2	143.9	137.1	98.4	104.0	85.3	202.1	128.1	182.8	224.6	69.8	131.0	539.3	106.0	112.0	149.4	262.1	152.4	138.4	177.6	383.4	157.2	442.2	151.8	96.1	54.8	469.0	202.0	64.4	92.1	123.9	65.0	117.8	123.3	316.6	244.0	297.6	136.5	79.3	422.4	548.7	90.7	197.4	114.5	338.6	313.9	570.0	120.8	130.4	207.2	210.1	150.0	119.6	184.4	145.5	169.6	368.6	103.0	190.1	183.1	228.3	269.7	238.1	534.3	532.5	143.6	789.4	213.4	32.5	50.3	46.8	52.9	53.1	68.7	94.8	94.7	84.6	74.0	90.0	97.4	64.3	30.9	60.5	68.4	85.3	94.3	71.4	54.7	58.9	57.1	77.2	53.9	59.6	58.2	55.5	58.3	57.7	57.5	63.5	153.6	54.5	38.9	39.8	126.8	179.6	212.0	222.4	131.5	48.3	158.0	205.5	120.1	95.8	118.5	104.8	14.6	221.8	103.9	62.8	203.5	94.3	36.8	67.2	123.5	123.0	96.1	418.8	36.5	46.5	286.8	147.9	76.5	86.0	84.4	118.3	101.4	77.6	174.5	82.4	32.1	98.4	105.8	87.7	112.6	31.5	184.8	92.0	154.7	23.4	89.5	106.3	95.8	23.6	45.1	45.4	58.8	177.6	192.3	133.2	27.2	256.4	59.6	40.9	157.8	167.1	154.0	508.7	270.0	206.4	168.5	97.1	124.4	82.3	195.4	181.2
DUX4		ENSG00000260596	"Double homeobox 4"	Q9UBX2	4	190173774-190185942	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Transcription factors, Transporters"	"Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"		"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in single"		"brain: 1.0"	"Group enriched"	"Detected in some"	26	"Early spermatids: 4.9;Late spermatids: 5.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 1.5;U-2 OS: 2.2;U-266/70: 4.7;U-266/84: 6.9;U-698: 1.5"	"Low region specificity"	"Detected in some"							HPA058451			Approved	"Nucleoplasm,Nucleoli,Golgi apparatus,Cytosol"		NA	NA				"Cluster 78: Testis - Spermatogenesis"	"Cluster 16: U-266 - Nucleosome"	"Cluster 34: Spermatids - Unknown function"	"Nucleoplasm, Nucleoli"	"Golgi apparatus, Cytosol"	"HPA058451: AB_2683722"																		0.0	0.1	0.3	0.0	0.5	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.7	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.5	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	2.2	0.4	0.0	4.7	6.9	1.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.5	0.0	1.0	0.5	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
DXO	DOM3Z	ENSG00000204348	"Decapping exoribonuclease"	O77932	6	31969810-31972290	"Predicted intracellular proteins"		"Exonuclease, Hydrolase, Nuclease, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"Early spermatids: 467.9;Late spermatids: 242.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046708	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 43: Testis - Unknown function"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 34: Spermatids - Unknown function"	"Nucleoplasm, Cytosol"	"Plasma membrane"	"HPA046708: AB_2679764"	"unprognostic (4.56e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.80e-1)"	"unprognostic (4.07e-3)"	"unprognostic (1.93e-1)"	"unprognostic (2.00e-3)"	"unprognostic (3.43e-3)"	"unprognostic (4.18e-3)"	"unprognostic (3.10e-2)"	"unprognostic (2.64e-3)"	"prognostic favorable (5.87e-4)"	"unprognostic (4.29e-2)"	"prognostic unfavorable (4.77e-6)"	"unprognostic (9.17e-2)"	"unprognostic (7.24e-2)"	"unprognostic (2.01e-1)"	"unprognostic (2.23e-3)"	6.6	17.8	8.2	3.9	8.1	1.4	6.9	8.2	8.5	10.7	9.6	7.1	4.5	8.1	5.8	5.7	8.5	4.2	9.6	8.1	8.4	12.3	13.0	6.4	4.6	9.3	8.6	13.4	10.8	11.8	13.0	4.4	8.7	10.3	3.9	4.8	6.7	6.0	5.3	4.9	5.8	4.8	8.6	9.7	8.6	31.3	8.3	7.0	11.5	7.1	3.0	7.9	7.4	8.5	12.9	6.3	5.8	23.1	9.5	6.4	6.7	7.5	12.0	16.2	15.5	7.6	5.9	5.2	8.5	16.6	5.2	8.7	10.1	16.8	9.4	9.6	12.9	9.3	15.8	16.4	18.7	0.0	4.6	9.7	16.3	10.5	13.5	9.9	21.3	6.6	8.3	11.9	9.8	14.7	1.5	11.1	4.4	8.4	1.3	4.0	4.1	8.2	21.2	4.5	30.1	17.0	6.6	7.3	16.9	4.1	0.0	14.8	7.0	4.7	12.6	4.6	12.3	9.1	9.4	10.2	4.6	14.4	5.2	0.0	1.9	1.0	2.2	1.6	3.9	2.4	2.3	1.4	4.3	2.1	1.6	2.3	0.3	2.1	1.4	1.3	1.6	1.8	8.2	8.1	8.2	8.5	8.1	8.4	9.3	8.6	8.7	8.6	8.3	8.5	11.2	6.4	9.6	11.8	16.8	8.5	15.3	14.3	19.9	13.3	13.6	11.4	7.1	11.5	10.5	3.7	16.7	14.5	14.1	5.0	19.6	8.4	467.9	9.3	10.6	9.8	16.2	4.4	4.4	12.6	9.5	10.9	15.8	8.7	6.3	12.1	8.6	10.9	6.6	5.0	6.2	9.0	12.2	5.9	4.9	242.8	17.7	6.9	12.4	1.9	4.3	16.0	11.3	7.5	6.6	6.9	10.5	12.4	14.7	10.8	10.6	13.3	8.9	15.6	13.1	7.1	14.3	78.4	16.1	11.8	5.5	20.1	15.4	22.6	8.3	11.5
DYM	"DMC, FLJ20071, SMC"	ENSG00000141627	Dymeclin	Q7RTS9	18	49036387-49461347	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"			"Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"Astrocytes: 113.6;Early spermatids: 353.4;Excitatory neurons: 173.2;Inhibitory neurons: 204.1;Late spermatids: 176.1;Microglial cells: 149.9;Oligodendrocyte precursor cells: 167.9;Oligodendrocytes: 299.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043551, HPA049187"	Approved		Supported	"Golgi apparatus"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 59: Non-specific - Translation"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	"Golgi apparatus"		"HPA043551: AB_2678547, HPA049187: AB_2680668"	"unprognostic (1.88e-2)"	"unprognostic (1.23e-1)"	"unprognostic (3.12e-3)"	"unprognostic (1.33e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.85e-3)"	"unprognostic (1.77e-1)"	"unprognostic (1.72e-1)"	"unprognostic (8.30e-3)"	"unprognostic (2.53e-2)"	"unprognostic (2.58e-2)"	"prognostic favorable (2.76e-5)"	"unprognostic (3.89e-1)"	"unprognostic (1.69e-1)"	"unprognostic (4.26e-3)"	"prognostic unfavorable (5.26e-5)"	17.9	19.2	17.3	14.8	19.6	24.0	23.3	24.9	20.4	24.9	24.4	20.7	15.8	19.8	20.2	25.3	18.6	17.7	21.1	16.7	20.4	21.1	19.7	15.7	17.0	22.8	21.1	29.4	80.7	28.6	9.9	14.6	24.5	20.6	16.8	36.0	36.6	22.0	49.6	18.2	14.1	25.1	19.0	12.7	16.6	44.0	19.1	33.0	32.6	46.0	20.7	23.2	22.3	23.9	32.9	19.8	30.6	47.0	56.9	63.9	24.1	32.2	42.1	37.7	36.8	14.6	20.7	102.1	27.8	60.1	27.9	41.0	48.1	42.1	46.0	38.6	24.7	23.8	16.9	43.4	56.7	83.5	41.5	50.1	49.1	44.1	112.7	63.3	59.0	51.6	25.7	60.5	30.4	35.0	56.5	35.5	9.8	27.1	15.2	29.2	39.2	48.3	34.8	37.2	56.5	36.5	21.9	26.1	30.2	34.5	36.7	29.8	32.6	35.6	16.9	15.5	18.9	67.8	52.7	57.4	19.1	51.6	40.5	20.9	26.9	32.7	20.2	23.4	27.2	17.0	19.3	18.7	29.2	13.9	19.6	15.2	11.9	30.6	20.6	8.4	21.4	21.4	17.3	19.6	24.9	20.4	16.7	20.4	22.8	21.1	24.5	19.0	19.1	23.9	16.0	6.4	6.9	113.6	29.1	11.6	20.4	8.1	29.0	20.1	17.9	15.4	24.5	17.2	8.4	3.7	6.2	19.5	17.4	10.5	13.7	18.1	353.4	11.6	17.2	16.3	16.2	17.9	173.2	20.3	22.2	20.6	17.3	14.8	16.5	23.3	14.3	11.5	16.7	21.9	204.1	15.1	6.1	23.0	15.1	176.1	27.7	20.5	3.6	149.9	19.7	16.1	24.7	167.9	299.4	14.7	11.4	27.1	23.8	25.0	16.1	22.5	13.4	24.9	13.1	22.4	15.4	49.8	16.2	19.4	11.4	35.2	21.6	18.1	16.2	20.2
DYNC1H1	"CMT2O, DHC1, DNCH1, Dnchc1, DNCL, DNECL, HL-3, p22"	ENSG00000197102	"Dynein cytoplasmic 1 heavy chain 1"	Q14204	14	101964573-102056443	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, Transport"	"Motor protein"	"Charcot-Marie-Tooth disease, Disease variant, Mental retardation, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003742, CAB010443"	Enhanced		Supported	Centrosome,Cytosol		NA	NA		490000	"Cluster 11: Basophils - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 20: HeLa - Mitochondria"	"Cluster 52: Non-specific - Transcription"	"Centrosome, Cytosol"		"CAB010443: AB_2093483, HPA003742: AB_1078713"	"unprognostic (2.58e-1)"	"unprognostic (6.77e-2)"	"unprognostic (1.68e-1)"	"unprognostic (4.65e-2)"	"unprognostic (4.66e-2)"	"unprognostic (5.49e-2)"	"prognostic unfavorable (3.03e-7)"	"unprognostic (8.93e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.92e-1)"	"unprognostic (2.38e-1)"	"unprognostic (2.31e-1)"	"prognostic favorable (1.09e-6)"	"unprognostic (1.63e-2)"	"unprognostic (8.73e-2)"	"unprognostic (1.93e-1)"	"unprognostic (4.52e-3)"	22.4	19.3	7.8	4.9	7.2	9.2	18.2	16.1	10.9	17.2	0.0	29.1	3.6	24.6	5.0	18.5	17.5	4.0	29.7	9.2	1.1	12.6	9.4	19.9	4.4	5.2	4.3	21.0	15.8	2.0	20.9	3.0	9.0	14.5	3.1	13.2	19.9	2.9	53.1	27.6	19.2	3.1	0.6	14.2	19.7	13.0	2.1	2.0	17.6	1.2	2.4	23.4	18.0	9.2	3.3	6.6	5.0	4.6	3.0	5.0	3.2	3.0	1.8	5.1	4.5	2.6	4.5	4.2	3.4	5.4	4.9	4.0	8.2	5.3	3.6	3.4	3.5	4.1	15.1	3.3	2.7	3.6	6.4	6.4	6.3	14.1	4.9	3.2	3.9	8.0	3.0	8.9	4.5	4.2	5.6	4.1	5.1	2.1	10.2	4.6	3.3	1.6	5.2	7.6	8.4	2.8	3.2	2.2	3.4	4.9	2.5	1.5	11.5	6.8	4.1	11.5	5.1	4.3	7.6	4.9	9.1	2.9	3.0	1.3	0.6	0.8	0.6	0.4	0.5	0.4	0.4	0.4	0.6	0.5	0.3	0.5	1.2	0.4	0.6	0.6	0.4	0.3	7.8	7.2	16.1	10.9	9.2	1.1	5.2	4.3	9.0	0.6	2.1	9.2	102.1	125.0	84.7	83.9	55.9	52.4	46.4	75.0	51.2	126.4	63.1	55.5	182.9	31.5	89.1	77.3	139.7	49.6	106.3	94.2	13.7	112.6	14.8	123.6	131.0	93.7	71.3	38.1	127.3	81.2	42.9	86.5	86.6	134.6	33.5	117.9	46.1	36.7	40.2	183.4	131.0	68.0	75.3	52.7	123.6	16.8	70.5	90.7	71.2	51.5	99.2	63.3	73.2	51.8	93.3	131.3	73.6	71.5	100.0	47.6	82.6	48.5	90.7	115.4	85.5	81.4	106.1	87.1	72.2	59.2	64.1	37.4	91.3	86.1	64.4	46.5
DYNC1I2	"DIC74, DNCI2"	ENSG00000077380	"Dynein cytoplasmic 1 intermediate chain 2"	Q13409	2	171687409-171750158	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Host-virus interaction, Transport"	"Motor protein"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB033836, HPA040619, HPA053987"	Supported		Supported	"Nucleoli,Endoplasmic reticulum,Microtubules,Cytosol"		NA	NA		82000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 70: Brain - Nervous system development"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 7: Non-specific - Mitochondria"	"Endoplasmic reticulum, Cytosol"	"Nucleoli, Microtubules"	"CAB033836: AB_2093633, HPA040619: AB_2677045, HPA053987: AB_2682334"	"unprognostic (3.01e-2)"	"unprognostic (1.05e-2)"	"unprognostic (1.26e-2)"	"unprognostic (8.15e-2)"	"unprognostic (8.90e-2)"	"unprognostic (1.37e-3)"	"unprognostic (2.51e-3)"	"unprognostic (6.30e-3)"	"unprognostic (1.23e-1)"	"unprognostic (1.89e-2)"	"unprognostic (1.40e-2)"	"unprognostic (4.19e-1)"	"prognostic favorable (8.04e-4)"	"unprognostic (1.76e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.35e-3)"	"unprognostic (6.42e-2)"	65.1	58.5	89.2	44.4	121.1	23.1	65.3	122.6	185.9	62.3	70.4	62.3	54.3	74.5	51.0	68.3	47.1	58.6	65.9	89.2	101.4	80.0	41.3	51.7	38.7	130.5	116.2	71.7	38.7	68.2	29.4	76.2	124.1	59.9	64.7	63.5	46.7	60.3	51.0	48.8	51.0	80.4	104.0	41.4	49.3	55.9	112.9	60.0	56.3	57.7	47.4	72.3	53.3	155.5	87.5	55.0	167.0	61.9	151.2	144.0	94.2	149.2	115.7	122.9	133.7	96.5	84.4	79.2	127.7	178.8	168.0	86.2	132.5	143.5	159.8	30.1	59.7	69.3	65.7	109.6	75.5	80.0	71.7	113.0	133.4	152.3	97.3	171.7	219.1	76.5	112.1	21.3	246.1	54.4	68.9	65.7	77.0	127.0	55.5	68.7	149.8	58.3	163.3	138.0	105.8	116.6	82.7	65.6	90.6	126.0	64.1	77.3	238.3	185.9	91.9	75.2	90.9	26.3	54.0	64.5	126.8	64.2	139.2	209.6	93.9	49.2	50.7	98.0	54.3	77.2	58.1	59.4	68.7	71.1	51.7	49.5	5.8	64.4	100.1	111.8	66.2	39.6	89.2	121.1	122.6	185.9	89.2	101.4	130.5	116.2	124.1	104.0	112.9	155.5	146.2	198.7	60.6	30.3	49.2	50.6	59.2	138.5	19.9	73.1	101.7	87.1	75.4	158.7	124.8	169.2	64.6	101.9	46.3	169.5	131.0	207.6	129.5	118.2	147.3	117.1	84.3	95.2	102.4	161.5	107.5	91.2	42.8	172.6	102.3	69.3	174.9	150.7	101.1	80.8	104.9	140.0	116.0	148.1	39.8	48.0	128.6	75.9	35.6	45.9	156.2	91.3	70.0	35.7	182.4	189.2	126.9	138.0	22.7	44.7	139.2	270.3	108.0	128.9	111.7	61.4	111.0	248.4	95.2	43.2	60.0	115.6	46.7	60.6	123.9	58.5
DYNC1LI1	DNCLI1	ENSG00000144635	"Dynein cytoplasmic 1 light intermediate chain 1"	Q9Y6G9	3	32525974-32570858	"Predicted intracellular proteins"	"Cell cycle, Cell division, Host-virus interaction, Mitosis, Transport"	"Motor protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 192.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035013	Approved		Supported	Centrosome,Cytosol		NA	NA		23000	"Cluster 14: Monocytes - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	"Centrosome, Cytosol"		"HPA035013: AB_10600807"	"unprognostic (1.23e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.78e-2)"	"unprognostic (2.25e-2)"	"unprognostic (1.55e-1)"	"unprognostic (5.38e-2)"	"prognostic unfavorable (9.19e-9)"	"unprognostic (1.07e-1)"	"unprognostic (1.30e-1)"	"unprognostic (7.26e-3)"	"unprognostic (5.02e-2)"	"unprognostic (1.05e-2)"	"unprognostic (2.21e-2)"	"unprognostic (2.14e-2)"	"unprognostic (5.51e-2)"	"unprognostic (4.58e-2)"	"unprognostic (2.27e-2)"	17.9	11.3	16.3	17.8	17.3	37.4	21.3	23.9	23.2	15.3	12.9	15.6	13.6	18.6	12.4	15.7	16.3	16.1	48.6	17.0	20.7	21.2	18.7	19.2	20.4	19.2	17.0	16.6	17.8	21.4	13.6	13.0	22.7	20.6	15.7	39.7	11.8	13.8	46.6	35.0	15.0	22.4	14.8	19.5	14.3	40.8	18.2	22.7	14.5	35.2	20.6	19.9	14.1	17.5	40.1	42.2	64.5	40.7	36.2	42.4	177.7	60.4	82.8	106.4	86.9	45.2	33.7	49.7	39.9	61.5	50.6	20.1	65.4	47.3	100.8	47.7	45.5	66.2	28.9	40.7	44.4	75.6	36.9	34.5	37.1	75.3	58.4	38.8	69.8	55.9	75.8	44.6	57.9	32.0	58.2	33.7	66.8	38.1	56.1	50.7	34.4	51.8	44.2	36.0	27.6	41.1	42.4	52.1	47.0	51.2	43.7	43.9	52.3	58.2	48.9	51.2	61.6	32.0	87.1	80.7	32.7	64.5	46.6	33.1	29.5	26.6	10.3	35.4	11.0	13.0	11.1	11.7	33.0	13.4	7.8	10.3	62.7	16.4	59.0	18.0	13.7	28.9	16.3	17.3	23.9	23.2	17.0	20.7	19.2	17.0	22.7	14.8	18.2	17.5	48.6	25.6	28.3	20.5	49.4	43.0	30.9	40.7	40.5	48.0	30.9	28.8	95.7	11.5	40.2	14.7	18.8	34.9	53.8	14.2	46.9	50.5	102.6	65.8	54.9	39.3	30.9	48.8	43.6	46.5	36.6	37.6	25.0	66.8	17.1	29.2	23.6	28.8	39.4	65.6	55.0	23.0	26.4	35.9	54.2	39.9	26.1	50.7	28.4	28.1	80.0	37.2	34.0	25.6	33.5	56.1	20.0	28.6	28.7	23.4	18.9	61.9	44.3	81.9	46.0	36.7	44.9	192.0	169.5	23.7	50.2	11.1	40.8	39.9	16.8	15.0
DYNC2I1	"CFAP163, DIC6, FAP163, FLJ10300, WDR60"	ENSG00000126870	"Dynein 2 intermediate chain 1"	Q8WVS4	7	158856558-158956747	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cilium biogenesis/degradation"		"Ciliopathy, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"Adipocytes: 45.7;Cardiomyocytes: 83.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020607, HPA021316"	Approved		Supported	Centrosome		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 18: U-2197 - ECM organization"	"Cluster 24: Non-specific - Transcription regulation"	Centrosome		"HPA020607: AB_1858817, HPA021316: AB_2215577"	"unprognostic (1.22e-1)"	"unprognostic (3.17e-2)"	"unprognostic (2.05e-1)"	"unprognostic (9.18e-3)"	"unprognostic (3.07e-2)"	"unprognostic (1.03e-1)"	"unprognostic (5.88e-2)"	"unprognostic (1.94e-1)"	"unprognostic (3.58e-2)"	"unprognostic (4.07e-2)"	"unprognostic (4.13e-2)"	"unprognostic (9.23e-2)"	"unprognostic (3.11e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.89e-1)"	"unprognostic (1.17e-3)"	"unprognostic (1.98e-1)"	13.0	7.4	5.7	5.5	4.0	5.6	9.9	6.5	12.3	9.4	16.3	13.4	9.2	9.1	9.3	6.5	13.6	7.0	15.1	3.9	3.7	8.2	3.7	8.8	5.3	5.5	2.5	9.8	5.9	12.8	9.0	6.8	4.7	6.8	6.1	14.1	8.2	6.3	24.1	7.0	10.2	7.3	0.2	7.5	8.0	40.1	4.7	5.8	10.9	10.0	3.5	9.7	7.7	9.1	15.2	15.0	10.4	25.0	7.9	7.6	4.6	9.4	8.3	7.6	8.2	7.3	13.5	6.0	14.3	5.8	9.3	7.1	4.8	10.1	8.5	6.5	9.6	8.0	10.2	3.3	8.0	9.2	17.8	6.3	7.4	5.9	2.5	17.9	6.3	4.3	24.4	3.3	8.9	8.9	15.4	8.2	9.1	5.7	9.7	13.7	10.7	7.3	12.7	7.7	20.8	14.7	19.1	11.5	11.4	9.0	8.4	5.6	7.8	9.5	3.4	31.2	6.9	8.7	10.2	12.9	26.0	8.8	14.4	49.8	8.6	4.7	13.5	5.7	11.9	21.5	10.5	11.3	5.4	22.7	10.1	10.3	5.3	10.3	5.8	42.6	5.4	2.6	5.7	4.0	6.5	12.3	3.9	3.7	5.5	2.5	4.7	0.2	4.7	9.1	45.7	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	83.5	0.0	0.0	0.0	0.0	15.6	14.0	0.0	0.0	0.0	0.0	0.0	0.0	10.0	0.0	0.0	0.0	0.0	13.7	11.7	0.0	0.0	0.0	0.0	0.0	0.0	8.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.2	0.0	0.0	0.0	0.0	11.5	1.8	0.0	0.0	0.0
DYNC2LI1	"CGI-60, D2LIC, DKFZP564A033, LIC3"	ENSG00000138036	"Dynein cytoplasmic 2 light intermediate chain 1"	Q8TCX1	2	43774039-43810010	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cilium biogenesis/degradation"	"Developmental protein, Motor protein"	"Ciliopathy, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 197.5;Respiratory ciliated cells: 133.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 14.8"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RPTEC TERT1: 110.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA062905	Approved		Supported	Cytosol		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 49: Ciliated cells - Cilium organization"	Cytosol		"HPA062905: AB_2684899"	"unprognostic (3.46e-1)"	"unprognostic (3.25e-1)"	"unprognostic (1.75e-1)"	"unprognostic (2.49e-2)"	"unprognostic (2.89e-2)"	"unprognostic (4.05e-2)"	"unprognostic (1.84e-3)"	"unprognostic (9.85e-2)"	"unprognostic (2.87e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.85e-2)"	"unprognostic (1.91e-1)"	"prognostic favorable (2.73e-5)"	"unprognostic (1.06e-1)"	"unprognostic (1.48e-2)"	"unprognostic (4.32e-2)"	"unprognostic (4.60e-2)"	16.2	23.2	20.2	7.5	21.3	6.8	32.6	16.1	23.6	28.3	34.9	15.4	19.0	35.6	46.6	11.0	53.4	20.7	15.5	20.0	21.9	50.2	13.4	23.4	10.2	20.4	19.3	39.7	16.2	42.2	31.2	13.6	18.7	20.8	17.9	44.0	16.3	20.0	10.2	15.8	16.3	19.8	17.9	11.0	17.1	44.9	21.3	10.8	34.3	8.5	9.7	15.0	13.9	20.6	21.2	12.0	20.5	13.1	32.5	64.5	17.6	11.5	24.8	13.3	12.4	4.0	14.4	12.0	24.8	15.2	17.0	13.8	9.9	16.5	15.4	15.4	21.1	9.4	5.5	15.3	31.3	18.7	14.8	38.3	23.4	26.5	12.1	40.6	18.5	14.1	29.0	5.6	18.7	10.8	9.2	20.6	9.4	27.3	12.0	12.2	19.0	3.8	110.1	18.0	14.0	25.1	13.0	7.1	15.5	19.4	19.7	16.9	13.1	11.6	10.5	14.4	9.8	21.0	12.3	3.0	25.8	4.7	12.6	14.8	2.3	2.1	1.7	3.9	1.8	3.7	2.2	2.4	3.1	2.1	2.7	2.3	0.8	2.6	3.1	1.8	1.4	1.4	20.2	21.3	16.1	23.6	20.0	21.9	20.4	19.3	18.7	17.9	21.3	20.6	11.9	19.2	16.8	58.1	6.4	9.7	18.2	42.9	7.4	21.7	19.3	22.4	13.9	21.5	31.3	53.3	29.2	19.7	2.3	10.2	90.1	21.7	197.5	71.7	42.2	8.1	12.7	5.5	96.8	22.0	9.1	27.8	15.3	24.2	17.7	26.2	14.6	7.3	12.4	16.8	64.9	20.3	50.8	4.5	5.3	39.4	33.2	5.9	23.2	22.5	3.3	29.3	4.1	33.7	43.4	14.5	32.1	33.8	4.7	9.6	52.4	84.1	133.8	36.9	19.7	14.8	14.8	102.1	15.9	9.1	9.1	9.3	4.9	30.1	17.5	12.8
DYRK1B	MIRK	ENSG00000105204	"Dual specificity tyrosine phosphorylation regulated kinase 1B"	Q9Y463	19	39825350-39834201	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase"	"Diabetes mellitus, Obesity"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 131.3;testis: 83.8"	"Group enriched"	"Detected in many"	12	"Early spermatids: 179.4;Late spermatids: 580.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"SH-SY5Y: 14.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028522, HPA028786"	Uncertain		Supported	"Nucleoplasm,Mitotic chromosome"		Yes	No			"Cluster 15: NK-cells - Transcription"	"Cluster 33: Striated muscle - Muscle contraction"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 25: Spermatids - Spermatogenesis"	Nucleoplasm	"Mitotic chromosome"	"HPA028522: AB_2672656, HPA028786: AB_10670831"	"unprognostic (2.22e-2)"	"unprognostic (9.86e-2)"	"unprognostic (4.55e-2)"	"unprognostic (3.45e-3)"	"unprognostic (1.96e-1)"	"unprognostic (1.13e-2)"	"unprognostic (2.25e-1)"	"unprognostic (2.39e-1)"	"unprognostic (6.02e-2)"	"unprognostic (3.67e-2)"	"unprognostic (8.93e-2)"	"unprognostic (4.22e-2)"	"prognostic favorable (8.83e-4)"	"unprognostic (9.73e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.53e-2)"	"unprognostic (3.88e-2)"	9.5	19.6	4.8	2.7	4.8	4.7	10.9	4.1	6.2	12.5	4.8	12.4	5.3	11.9	7.8	11.7	13.8	3.3	20.0	4.7	3.6	16.2	7.5	8.8	4.6	3.5	3.4	11.6	10.3	6.5	31.5	2.7	3.6	13.0	2.1	4.1	14.3	3.3	131.3	14.8	10.2	2.6	1.2	14.0	12.1	83.8	3.6	5.2	16.5	49.9	2.5	11.4	10.5	3.0	0.4	9.3	8.8	6.2	4.9	4.6	0.7	2.9	1.8	2.6	2.3	0.9	3.6	1.4	11.0	3.4	0.1	3.2	1.3	2.0	2.3	5.4	7.8	0.6	5.9	0.9	4.1	0.3	1.9	6.2	1.2	0.8	2.9	8.6	0.6	3.5	1.5	2.0	0.4	4.7	2.1	0.8	2.2	2.7	2.1	1.0	0.2	0.6	5.7	2.2	12.7	14.5	4.5	4.4	0.2	4.6	4.4	0.5	4.5	1.1	2.0	1.0	0.9	3.2	1.1	1.0	7.4	0.9	0.4	0.7	1.6	1.8	3.0	1.7	3.6	2.4	2.0	3.1	1.9	1.6	1.0	1.7	2.5	3.3	1.6	4.5	2.2	1.7	4.8	4.8	4.1	6.2	4.7	3.6	3.5	3.4	3.6	1.2	3.6	3.0	6.0	0.0	0.6	6.2	10.9	3.4	3.8	8.4	10.2	15.2	9.0	6.1	6.1	7.2	3.4	16.5	20.9	2.1	21.7	10.3	9.8	13.1	179.4	15.4	6.7	7.3	20.4	19.8	4.6	4.3	1.7	5.1	7.7	10.1	1.3	11.9	12.1	3.9	5.9	10.1	6.3	9.8	10.2	8.2	3.0	580.2	7.2	4.7	5.4	7.5	5.7	8.3	10.3	5.0	3.2	9.7	9.7	5.3	5.0	4.8	11.5	17.4	10.7	13.0	0.0	11.1	4.8	30.1	13.4	6.1	2.8	1.4	10.8	20.2	7.4	3.6
DYRK2		ENSG00000127334	"Dual specificity tyrosine phosphorylation regulated kinase 2"	Q92630	12	67648338-67665406	"Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Apoptosis, Ubl conjugation pathway"	"Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 133.1;Horizontal cells: 80.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027230, HPA056902"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm	Cytosol	"HPA027230: AB_1847925, HPA056902: AB_2683271"	"unprognostic (5.86e-3)"	"unprognostic (4.18e-1)"	"unprognostic (4.08e-3)"	"unprognostic (2.56e-3)"	"unprognostic (1.18e-2)"	"unprognostic (1.69e-1)"	"unprognostic (3.37e-3)"	"unprognostic (7.83e-2)"	"unprognostic (2.83e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.04e-1)"	"unprognostic (3.47e-1)"	"unprognostic (2.12e-2)"	"unprognostic (2.03e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.35e-1)"	9.9	4.6	2.9	14.2	3.3	14.9	6.3	2.3	6.1	7.8	3.2	25.7	20.4	13.1	6.2	10.7	10.0	14.3	24.4	8.6	2.3	4.7	4.2	9.1	21.6	3.4	2.3	8.7	8.6	4.9	3.0	14.1	2.7	6.5	21.9	14.8	5.4	8.8	39.4	7.5	28.0	13.0	3.1	14.7	20.6	5.0	2.7	24.1	6.9	10.4	14.2	11.9	7.6	3.5	24.5	13.4	19.8	14.4	9.7	13.2	15.8	24.2	15.7	11.6	6.6	17.9	13.2	45.3	29.2	35.3	7.1	27.8	16.0	9.6	12.4	19.6	20.9	7.3	9.5	6.9	3.8	16.8	15.2	11.0	13.3	31.4	24.8	19.6	6.6	18.9	9.2	22.9	15.1	13.9	14.4	8.2	17.2	15.8	21.5	37.9	19.7	20.0	13.6	30.2	26.0	30.7	10.1	13.4	13.9	13.3	9.2	13.9	10.0	18.4	17.3	12.8	19.4	10.9	1.9	24.9	17.6	11.1	19.4	2.0	0.3	4.0	3.2	0.7	2.3	1.8	2.3	4.2	1.2	2.0	1.9	3.7	0.4	4.7	0.9	0.5	2.0	1.1	2.9	3.3	2.3	6.1	8.6	2.3	3.4	2.3	2.7	3.1	2.7	3.5	13.0	9.6	10.2	3.9	14.4	11.3	11.9	6.7	8.6	18.0	7.4	8.1	44.5	20.0	11.2	1.8	22.9	3.5	28.6	133.1	0.0	19.0	0.6	28.0	35.9	12.1	24.6	4.8	11.0	18.2	7.9	18.9	25.0	15.6	5.7	13.3	6.4	6.1	17.0	80.8	11.4	62.0	4.1	15.7	22.5	2.0	11.5	15.5	8.8	13.1	12.0	16.7	42.2	6.0	9.1	17.7	61.3	13.2	9.0	16.1	62.9	11.3	30.3	23.3	13.1	53.5	33.6	2.7	10.1	15.6	16.2	4.5	31.0	17.9	32.3	34.4
DYRK3	"hYAK3-2, RED, REDK"	ENSG00000143479	"Dual specificity tyrosine phosphorylation regulated kinase 3"	O43781	1	206635536-206684419	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	"Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 48.0"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 235.3;Late spermatids: 48.1;Spermatocytes: 108.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"plasmacytoid DC: 2.7"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"hTERT-HME1: 73.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA075041			Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 71: Testis - DNA repair"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm	Cytosol	"HPA075041: AB_2686730"	"unprognostic (6.51e-2)"	"unprognostic (1.24e-2)"	"unprognostic (3.36e-2)"	"unprognostic (2.03e-1)"	"unprognostic (2.81e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.20e-4)"	"unprognostic (2.69e-1)"	"unprognostic (3.91e-1)"	"unprognostic (2.71e-1)"	"unprognostic (2.79e-3)"	"unprognostic (2.52e-1)"	"prognostic unfavorable (9.41e-7)"	"unprognostic (2.38e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.99e-2)"	"unprognostic (7.62e-3)"	7.6	2.4	3.7	4.2	3.8	8.8	5.7	1.7	3.7	5.6	5.6	2.3	1.0	5.3	3.1	2.8	5.7	13.5	8.3	5.1	3.8	3.3	4.1	5.5	1.6	3.8	5.1	4.9	3.9	3.0	6.5	1.2	3.4	2.9	1.4	6.4	4.3	3.0	0.8	1.5	1.7	8.1	2.6	1.3	3.1	48.0	3.8	5.9	8.3	1.9	1.8	7.5	2.8	3.5	5.0	6.7	1.6	9.8	16.7	15.9	0.4	15.4	36.7	15.0	19.6	0.4	2.7	7.6	2.2	20.1	25.8	1.5	8.6	14.1	15.8	0.1	4.8	10.5	8.9	1.7	26.9	7.5	6.8	10.9	8.9	25.6	73.6	15.1	11.8	11.6	20.1	1.4	23.2	2.0	16.9	4.4	13.2	0.5	10.8	41.1	4.9	0.1	4.8	0.4	9.3	6.9	13.6	0.6	20.3	2.0	2.0	1.9	8.1	31.1	11.2	14.8	13.2	5.6	2.2	9.1	17.7	8.3	2.9	0.7	0.0	0.2	0.0	0.1	0.1	0.0	0.2	0.0	0.0	0.1	0.1	0.1	0.5	0.0	0.0	2.7	0.0	0.0	3.7	3.8	1.7	3.7	5.1	3.8	3.8	5.1	3.4	2.6	3.8	3.5	13.9	3.2	8.2	4.2	1.0	6.5	10.7	9.6	3.4	0.2	4.7	3.3	10.8	1.5	4.2	1.8	10.4	0.0	1.5	0.3	0.0	5.1	235.3	12.6	8.0	8.5	2.4	23.6	3.6	2.2	0.1	12.7	1.1	5.9	0.0	3.4	3.9	1.1	1.0	0.0	1.5	0.4	2.0	1.0	4.6	48.1	4.1	2.9	8.8	1.0	1.0	3.4	0.0	2.5	0.3	1.2	1.2	1.9	2.1	3.8	0.2	1.7	10.5	8.2	6.6	10.2	10.4	108.7	6.4	1.3	3.7	0.4	2.4	3.0	0.6	5.3
DYSF	"FER1L1, LGMD2B"	ENSG00000135636	Dysferlin	O75923	2	71453722-71686768	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"			"Disease variant, Limb-girdle muscular dystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 95.3"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 30.5;Endothelial cells: 43.7;Excitatory neurons: 34.7;Hepatic stellate cells: 32.2;Kupffer cells: 27.1;Oligodendrocytes: 62.7;Syncytiotrophoblasts: 66.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in some"	7	"neutrophil: 27.0"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 27.0"	"Group enriched"	"Detected in many"	5	"hTERT-RPE1: 31.9;HUVEC TERT2: 85.5;LHCN-M2: 75.3;RH-30: 78.5;TIME: 58.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB002510, HPA017071, HPA021945"	Enhanced		Supported	"Plasma membrane,Centriolar satellite"		Yes	No			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 59: Non-specific - Translation"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Plasma membrane, Centriolar satellite"		"CAB002510: AB_442097, HPA017071: AB_1847927, HPA021945: AB_1847928"	"unprognostic (1.04e-1)"	"unprognostic (7.66e-3)"	"unprognostic (5.43e-3)"	"unprognostic (1.66e-2)"	"unprognostic (1.65e-1)"	"unprognostic (2.42e-1)"	"unprognostic (4.43e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.70e-1)"	"unprognostic (3.21e-1)"	"unprognostic (2.93e-1)"	"unprognostic (6.43e-2)"	"unprognostic (4.88e-3)"	"unprognostic (1.22e-2)"	"unprognostic (3.18e-2)"	"unprognostic (1.36e-1)"	"unprognostic (5.97e-3)"	10.1	1.7	1.0	11.5	1.1	31.6	4.3	4.1	7.7	1.9	0.7	7.0	2.0	2.3	0.5	7.4	3.2	4.6	16.8	0.2	3.8	3.6	6.5	8.3	3.7	14.8	5.1	1.3	1.5	2.3	1.5	21.1	13.7	3.3	2.5	0.5	1.3	4.8	95.3	1.2	3.1	10.2	2.0	21.4	2.5	1.1	10.2	2.3	4.6	32.3	0.9	6.9	1.8	1.8	1.1	0.0	3.3	3.0	0.0	0.0	6.1	0.1	0.8	2.2	1.5	0.4	1.0	0.0	12.1	0.1	3.4	2.5	0.0	1.2	1.1	0.0	0.0	0.2	0.2	0.0	0.3	0.1	0.0	1.5	0.0	2.3	10.6	31.9	85.5	0.2	8.4	0.0	75.3	0.0	0.0	5.8	8.1	0.0	0.9	0.0	78.5	0.0	2.6	0.2	0.0	0.0	4.1	0.7	0.1	7.9	0.3	0.8	58.1	0.3	3.8	0.2	1.1	0.0	0.0	0.0	0.0	13.3	0.0	0.0	4.1	0.1	0.5	0.7	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.2	27.0	0.4	0.1	0.0	0.0	1.4	1.0	1.1	4.1	7.7	0.2	3.8	14.8	5.1	13.7	2.0	10.2	1.8	30.5	3.2	8.1	1.0	1.0	2.4	0.0	0.1	0.0	1.1	0.3	0.6	24.0	0.0	1.3	0.0	0.0	8.1	0.7	0.1	0.0	0.4	4.8	0.7	1.3	43.7	0.0	2.7	34.7	0.2	3.8	2.2	0.0	9.3	2.5	0.3	32.2	13.4	11.4	0.0	13.0	0.2	0.0	27.1	3.0	6.0	0.6	10.2	0.0	16.9	5.8	0.1	0.0	2.5	62.7	0.1	0.0	0.7	0.1	0.2	0.0	2.1	0.7	0.2	6.6	5.2	5.5	0.6	1.1	0.1	1.6	66.2	1.1	0.9	0.0	0.1
DZIP1	"DZIP, KIAA0996"	ENSG00000134874	"DAZ interacting zinc finger protein 1"	Q86YF9	13	95578202-95644706	"Human disease related genes, Predicted intracellular proteins"	"Differentiation, Spermatogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"Early spermatids: 384.1;Late spermatids: 774.5;Spermatocytes: 222.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054891, HPA057272"	Uncertain		Supported	Nucleoplasm,Centrosome		NA	NA				"Cluster 43: Testis - Unknown function"	"Cluster 12: NES - Nervous system development"	"Cluster 31: Spermatids - Spermatogenesis"	"Nucleoplasm, Centrosome"		"HPA054891: AB_2682631, HPA057272: AB_2683390"	"unprognostic (6.74e-3)"	"unprognostic (7.65e-2)"	"unprognostic (1.94e-1)"	"unprognostic (4.64e-3)"	"unprognostic (4.82e-2)"	"unprognostic (5.52e-3)"	"unprognostic (6.34e-2)"	"unprognostic (2.49e-1)"	"unprognostic (3.34e-2)"	"unprognostic (8.63e-2)"	"unprognostic (1.17e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.36e-2)"	"unprognostic (2.41e-3)"	"unprognostic (1.48e-1)"	"unprognostic (3.64e-2)"	"unprognostic (3.89e-3)"	5.0	3.4	8.6	2.5	8.5	0.1	4.4	6.9	9.4	12.4	5.7	10.7	1.0	12.6	7.2	3.2	12.4	5.1	4.3	7.7	8.7	11.4	1.1	4.6	2.2	7.0	8.1	16.3	9.9	0.4	10.3	2.5	6.1	6.4	1.8	4.0	2.3	6.2	1.3	1.6	4.0	6.1	5.6	1.5	4.7	14.8	11.5	0.8	2.4	2.1	1.7	7.9	7.1	7.1	1.1	4.2	17.5	15.5	14.5	16.2	3.6	11.0	13.2	12.7	15.2	0.2	0.0	0.0	2.5	9.4	5.5	0.0	11.7	3.8	14.8	1.1	9.6	15.6	4.4	11.0	9.2	0.1	0.0	11.7	0.4	4.2	5.8	23.1	9.1	1.1	0.0	0.1	11.4	0.0	0.0	0.0	8.6	0.0	0.4	0.0	10.1	0.0	15.4	1.8	4.2	9.9	8.3	0.0	0.6	22.4	0.0	7.3	1.3	12.3	5.3	1.8	8.8	0.0	0.0	0.0	3.5	0.0	2.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	8.6	8.5	6.9	9.4	7.7	8.7	7.0	8.1	6.1	5.6	11.5	7.1	2.4	0.0	0.0	63.6	0.0	0.6	1.1	3.1	4.6	18.7	0.6	3.4	3.5	2.8	3.9	1.8	4.2	4.5	0.0	0.0	7.9	20.8	384.1	37.2	34.1	2.5	0.0	0.0	86.8	0.2	2.6	19.0	0.5	2.7	0.0	3.1	2.9	0.4	0.7	6.7	95.7	0.0	4.1	0.3	1.5	774.5	38.8	1.2	3.6	19.7	2.0	8.3	0.0	106.6	5.1	0.6	0.0	43.6	0.0	0.8	0.0	24.4	19.4	1.5	19.7	18.2	15.8	222.8	12.6	1.2	1.0	1.8	0.5	20.8	0.0	0.3
DZIP1L	"DZIP2, FLJ32844"	ENSG00000158163	"DAZ interacting zinc finger protein 1 like"	Q8IYY4	3	138061990-138115818	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Ciliopathy, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Endometrial ciliated cells: 58.8;Respiratory ciliated cells: 74.0;Rod photoreceptor cells: 19.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030404	Approved		Supported	"Nucleoplasm,Microtubules,Cytokinetic bridge"		Yes	No			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 49: Ciliated cells - Cilium organization"	Microtubules	"Nucleoplasm, Cytokinetic bridge"	"HPA030404: AB_10601548"	"unprognostic (3.65e-2)"	"unprognostic (8.37e-2)"	"unprognostic (2.87e-2)"	"unprognostic (3.71e-2)"	"unprognostic (8.22e-2)"	"unprognostic (6.50e-2)"	"unprognostic (6.47e-4)"	"unprognostic (1.54e-1)"	"unprognostic (3.21e-2)"	"unprognostic (3.13e-1)"	"unprognostic (3.26e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.51e-2)"	"unprognostic (2.35e-3)"	"unprognostic (2.72e-1)"	"unprognostic (9.98e-2)"	"unprognostic (2.77e-2)"	4.9	1.4	1.7	2.2	2.2	8.8	4.7	5.9	2.1	8.6	15.3	5.0	2.2	8.1	1.9	2.5	12.8	5.7	3.3	2.2	2.3	5.6	1.0	5.7	0.9	5.7	7.4	7.0	6.3	2.7	2.1	2.0	4.2	4.1	1.5	4.6	2.1	3.3	1.0	7.8	2.1	4.6	4.3	2.6	7.2	4.1	2.6	0.4	3.6	0.9	0.7	6.1	5.3	2.2	5.4	3.1	6.1	5.1	3.8	5.1	1.4	8.6	5.1	5.0	6.3	2.0	0.4	0.0	4.3	8.0	7.0	1.7	4.5	2.0	2.4	1.2	4.4	2.4	7.5	0.3	3.1	1.8	4.0	5.4	2.0	5.5	2.6	5.1	2.8	1.4	1.8	0.0	6.9	0.3	0.0	0.8	7.4	0.0	1.1	0.0	7.1	0.0	2.3	8.5	2.1	4.8	8.9	0.0	4.3	3.4	2.3	3.7	2.2	12.3	5.6	6.0	4.5	0.0	0.0	0.1	4.9	2.6	4.8	0.0	0.3	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.7	2.2	5.9	2.1	2.2	2.3	5.7	7.4	4.2	4.3	2.6	2.2	1.4	3.2	2.0	4.2	0.0	3.6	0.6	1.9	7.4	8.6	0.2	2.5	2.9	7.2	7.7	1.8	8.4	0.1	0.0	0.0	5.9	3.8	17.4	58.8	8.5	2.6	0.0	1.3	4.0	1.2	0.1	6.5	7.1	1.1	0.0	7.4	0.0	0.0	1.4	3.3	2.9	0.0	2.0	3.2	2.6	1.8	6.2	3.5	0.0	3.7	0.6	2.7	0.0	2.5	0.2	5.9	0.0	4.1	0.0	0.4	0.0	0.8	74.0	19.4	0.0	7.2	9.8	0.6	2.3	1.7	4.3	0.0	0.5	1.7	0.0	0.1
E2F1	"RBBP3, RBP3"	ENSG00000101412	"E2F transcription factor 1"	Q01094	20	33675477-33686385	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Apoptosis, Cell cycle, Host-virus interaction, Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 34.3"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 25.0;Granulosa cells: 11.4;Spermatogonia: 32.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"non-classical monocyte: 1.0"	"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB000329, HPA008003, CAB019308, HPA029735"	Enhanced		Supported	Nucleoplasm,Centrosome		NA	Yes			"Cluster 22: NK-cells - Unknown function"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Nucleoplasm, Centrosome"		"CAB000329: AB_627476, CAB019308: , HPA008003: AB_1847936, HPA029735: AB_2673176"	"unprognostic (7.46e-2)"	"prognostic favorable (9.22e-6)"	"unprognostic (2.11e-2)"	"prognostic unfavorable (4.33e-5)"	"unprognostic (1.51e-1)"	"unprognostic (1.21e-2)"	"prognostic unfavorable (3.83e-5)"	"unprognostic (1.25e-2)"	"unprognostic (8.23e-2)"	"unprognostic (9.66e-2)"	"prognostic unfavorable (4.18e-4)"	"unprognostic (3.15e-2)"	"prognostic unfavorable (8.99e-5)"	"unprognostic (1.05e-2)"	"unprognostic (7.50e-2)"	"prognostic favorable (1.62e-4)"	"unprognostic (1.91e-1)"	1.8	5.5	7.1	5.6	7.1	34.3	1.6	5.2	9.2	1.8	3.9	3.8	3.2	1.2	0.2	5.7	1.3	0.7	1.4	6.1	5.6	0.9	1.8	3.7	8.7	7.6	6.4	3.5	1.0	1.3	0.6	2.4	6.5	1.9	3.9	0.7	1.9	0.9	1.6	4.7	4.1	2.8	7.0	5.0	3.7	10.4	6.9	10.7	0.8	0.8	6.9	2.4	2.5	8.3	48.1	45.4	52.0	40.5	5.2	3.6	39.3	45.0	21.4	55.9	46.7	81.1	48.0	87.3	44.2	20.2	67.7	35.4	25.3	23.8	24.8	26.4	36.5	71.6	71.9	47.7	0.4	34.0	43.6	2.8	1.4	30.6	5.4	5.7	14.6	54.4	19.3	60.0	34.9	42.3	72.8	71.6	15.6	47.9	64.6	71.4	140.7	36.2	9.6	28.7	76.7	54.1	54.6	37.6	22.7	14.8	47.3	42.4	7.9	65.0	37.7	45.8	64.8	58.1	42.0	72.6	54.1	20.0	39.3	0.0	0.0	0.1	0.0	0.2	0.0	0.5	0.1	0.1	0.0	0.0	0.0	0.3	0.0	0.4	1.0	0.1	0.1	0.1	7.1	7.1	5.2	9.2	6.1	5.6	7.6	6.4	6.5	7.0	6.9	8.3	1.1	0.0	1.1	0.7	3.6	2.9	1.7	0.5	0.0	2.3	3.1	4.3	0.4	0.0	1.4	0.0	0.0	5.0	2.9	2.4	0.0	0.9	1.0	0.3	1.0	1.6	0.0	25.0	1.5	0.2	9.6	3.0	7.7	1.2	0.0	11.4	0.7	0.8	4.4	0.0	0.5	4.6	2.0	0.6	2.1	3.1	2.1	3.1	1.8	1.0	0.1	1.5	1.0	1.0	3.4	0.6	0.5	1.2	9.7	0.5	1.4	0.1	0.2	2.3	0.0	1.0	3.0	7.5	32.9	3.7	1.7	1.8	3.3	1.2	7.0	3.5
E2F3		ENSG00000112242	"E2F transcription factor 3"	O00716	6	20401879-20493714	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Cell cycle, Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 67.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029779, HPA065012"			Supported	"Nucleoplasm,Nuclear speckles,Cytosol"		NA	NA			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 56: Bipolar cells - Visual perception"	"Nucleoplasm, Nuclear speckles"	Cytosol	"HPA029779: AB_2732448, HPA065012: AB_2685403"	"unprognostic (4.10e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.80e-3)"	"unprognostic (2.96e-1)"	"unprognostic (9.14e-2)"	"unprognostic (8.99e-3)"	"unprognostic (9.13e-2)"	"unprognostic (1.10e-1)"	"prognostic favorable (1.69e-4)"	"unprognostic (1.14e-2)"	"unprognostic (5.64e-2)"	"prognostic unfavorable (1.63e-8)"	"unprognostic (1.23e-1)"	"unprognostic (2.16e-1)"	"unprognostic (3.50e-1)"	"unprognostic (5.99e-3)"	6.5	4.9	4.8	9.8	5.2	19.8	4.1	2.8	5.7	3.3	3.0	5.4	5.2	3.6	3.9	4.9	2.5	6.4	5.1	6.4	4.6	5.8	4.4	4.9	11.0	3.7	4.6	1.4	2.1	3.1	1.8	5.6	4.2	3.3	6.3	6.1	2.7	3.1	10.0	2.6	5.7	6.0	3.7	8.4	3.6	3.4	5.5	8.6	8.5	9.3	9.5	8.5	2.7	3.8	14.3	11.6	32.2	35.1	10.9	11.9	22.0	18.9	16.8	18.2	19.9	14.3	8.8	32.3	35.2	18.2	16.9	14.6	37.8	17.4	30.3	12.2	25.3	58.1	20.4	16.3	11.6	38.6	33.0	9.7	12.6	17.7	21.6	18.8	12.7	29.8	65.3	19.4	20.9	15.0	43.6	43.2	24.2	11.0	11.9	46.5	27.8	36.5	21.8	25.1	22.9	42.2	17.3	24.1	26.3	20.0	12.4	23.4	17.2	28.6	17.4	14.2	30.5	12.1	40.1	38.3	7.1	23.2	41.3	5.6	2.3	1.1	1.6	1.6	2.0	0.4	1.0	2.4	2.6	0.4	0.8	1.8	7.2	3.5	1.1	1.1	1.6	1.1	4.8	5.2	2.8	5.7	6.4	4.6	3.7	4.6	4.2	3.7	5.5	3.8	4.8	0.0	2.6	53.8	10.6	9.2	12.3	7.0	7.4	34.1	11.9	7.2	10.6	4.3	10.6	7.3	22.9	8.3	15.0	12.0	9.8	7.6	12.2	3.9	14.1	8.5	12.0	17.2	67.7	6.9	13.8	9.2	12.8	10.6	20.3	32.3	14.6	4.7	17.1	32.0	31.9	11.7	4.1	47.2	17.7	5.7	2.8	28.7	5.4	27.2	23.8	2.9	15.5	37.7	2.9	14.8	10.3	3.0	19.1	22.1	4.5	25.1	2.2	9.0	0.0	9.0	11.5	3.0	4.7	16.5	8.9	3.1	15.3	5.7	13.8	18.4
E2F4	E2F-4	ENSG00000205250	"E2F transcription factor 4"	Q16254	16	67192155-67198918	"Predicted intracellular proteins, Transcription factors"	"Cell cycle, Cilium biogenesis/degradation, Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Erythroid cells: 174.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054128			Supported	Nucleoplasm		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 6: Erythroid cells - Oxygen transport"	Nucleoplasm		"HPA054128: AB_2682392"	"unprognostic (1.74e-1)"	"unprognostic (1.81e-1)"	"unprognostic (4.73e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.76e-1)"	"unprognostic (4.39e-3)"	"unprognostic (1.05e-3)"	"unprognostic (7.50e-3)"	"unprognostic (1.37e-1)"	"unprognostic (3.55e-2)"	"unprognostic (1.06e-1)"	"unprognostic (4.21e-2)"	"unprognostic (3.60e-2)"	"unprognostic (3.04e-2)"	"unprognostic (8.44e-2)"	"unprognostic (5.50e-2)"	"unprognostic (1.17e-1)"	43.5	39.6	27.9	39.7	27.2	98.2	38.3	26.5	31.0	35.3	27.1	43.8	32.1	41.2	22.2	47.4	36.7	23.5	39.6	27.4	29.2	38.2	32.0	38.0	48.5	28.7	27.7	33.1	36.1	29.1	39.2	44.0	28.2	36.5	32.0	9.9	29.8	27.6	50.5	34.0	44.3	31.8	27.9	54.7	40.6	32.9	28.2	42.5	33.6	30.0	43.4	42.0	34.1	27.9	67.3	53.2	44.4	54.3	63.5	54.6	158.6	49.1	72.7	88.5	84.8	94.6	71.5	82.7	58.1	52.3	60.7	95.8	69.2	69.2	57.4	35.2	73.4	55.9	31.9	97.5	76.7	110.9	113.0	64.8	53.9	70.4	77.9	33.2	77.8	62.9	107.1	26.8	47.2	115.0	127.9	90.8	109.1	71.7	47.4	152.7	92.8	109.7	41.8	50.9	53.6	63.9	134.2	49.6	58.2	35.2	50.6	109.7	56.0	62.4	58.9	46.1	78.2	65.6	62.0	215.0	73.3	75.5	60.7	1.2	11.8	10.9	8.4	10.7	7.0	6.1	7.7	9.9	14.6	6.6	6.1	5.5	7.5	8.7	8.1	6.3	3.9	7.7	27.9	27.2	26.5	31.0	27.4	29.2	28.7	27.7	28.2	27.9	28.2	27.9	36.2	12.8	16.5	14.7	31.2	41.6	33.9	18.0	10.8	22.3	20.9	16.3	15.1	22.8	13.4	12.9	4.2	116.1	35.1	26.7	19.6	30.2	50.5	16.0	24.4	36.2	22.8	174.7	13.9	37.2	82.8	25.5	36.7	19.4	27.3	25.4	30.0	10.2	44.7	21.9	12.3	23.6	22.4	23.8	29.0	84.9	27.1	30.1	14.2	11.2	41.5	14.3	55.6	10.6	12.2	35.8	19.3	23.7	39.7	56.8	21.4	13.4	9.5	19.2	46.0	20.0	26.9	37.9	45.3	25.8	45.9	79.8	36.7	31.4	30.2	37.9
E2F5		ENSG00000133740	"E2F transcription factor 5"	Q15329	8	85177154-85217158	"Cancer-related genes, Predicted intracellular proteins, Predicted membrane proteins, Transcription factors"	"Cilium biogenesis/degradation, Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 29.6"	"Cell type enhanced"	"Detected in many"		"B-cells: 23.7;Plasma cells: 29.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	7	"memory B-cell: 13.4;naive B-cell: 8.9"	"Lineage enriched"	"Detected in many"	9	"B-cells: 13.4"	"Cell line enhanced"	"Detected in many"		"AF22: 82.6;Daudi: 158.0;U-698: 77.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055723, HPA065441"			Supported	Nucleoplasm,Nucleoli,Vesicles		NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 57: B-cells - Immune response"	Nucleoplasm	"Nucleoli, Vesicles"	"HPA055723: AB_2682897, HPA065441: "	"unprognostic (8.73e-2)"	"unprognostic (3.45e-1)"	"unprognostic (3.15e-2)"	"unprognostic (1.02e-3)"	"unprognostic (6.73e-3)"	"unprognostic (1.62e-1)"	"unprognostic (3.36e-5)"	"unprognostic (1.23e-1)"	"unprognostic (9.53e-2)"	"unprognostic (1.28e-1)"	"unprognostic (3.18e-1)"	"unprognostic (3.87e-2)"	"prognostic unfavorable (1.89e-6)"	"unprognostic (2.88e-2)"	"unprognostic (3.25e-2)"	"unprognostic (3.64e-1)"	"unprognostic (2.95e-3)"	1.8	3.9	4.8	8.0	5.2	1.7	6.7	4.6	6.5	5.2	5.1	6.6	4.9	4.5	8.1	2.2	8.0	4.3	1.9	5.1	5.8	8.1	3.0	4.1	25.9	5.5	5.2	4.9	4.3	13.2	3.7	5.0	5.0	3.6	7.8	0.9	2.3	3.3	0.4	0.8	3.8	4.1	5.1	6.9	5.5	8.5	5.3	10.7	8.7	0.9	29.6	6.9	0.9	5.5	14.2	15.9	82.6	29.7	1.5	2.2	25.0	2.7	6.9	2.4	7.4	9.6	17.4	158.0	10.3	3.5	28.4	2.6	51.0	4.3	3.0	16.0	20.1	16.4	8.3	22.4	13.4	4.8	0.1	3.3	6.9	3.5	12.0	15.7	2.7	16.5	34.7	1.2	4.6	10.0	15.8	10.8	26.1	28.0	12.9	12.9	3.4	17.9	27.5	10.7	9.8	29.8	1.8	5.8	23.8	32.6	33.5	5.2	0.1	3.7	2.5	4.6	10.5	27.6	20.6	77.1	4.3	4.1	8.0	0.0	0.0	0.0	0.1	0.0	0.0	13.4	0.0	0.0	0.1	8.9	0.2	0.4	0.0	1.4	0.0	1.5	0.6	0.6	4.8	5.2	4.6	6.5	5.1	5.8	5.5	5.2	5.0	5.1	5.3	5.5	1.1	0.0	6.5	3.6	23.7	2.3	3.3	1.3	1.2	0.9	5.6	6.0	1.0	5.7	2.9	5.5	10.4	4.1	5.1	3.3	0.0	3.3	7.6	7.3	5.2	1.5	7.8	1.3	7.7	2.6	1.1	3.0	4.1	7.5	1.3	5.5	0.4	2.4	0.5	0.0	4.6	2.7	2.0	0.8	1.0	3.8	1.5	1.9	3.6	4.7	0.3	5.2	4.1	11.6	4.2	3.0	1.7	1.9	29.6	6.9	0.8	5.8	8.6	1.6	0.0	5.0	4.5	8.1	4.6	2.3	2.8	1.1	2.5	4.6	3.7	2.1
E2F6	E2F-6	ENSG00000169016	"E2F transcription factor 6"	O75461	2	11444375-11466177	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Cell cycle, Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Spermatogonia: 48.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	17	"basophil: 7.8"	"Lineage enriched"	"Detected in single"	17	"granulocytes: 7.8"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA075185			Supported	Nucleoplasm		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	Nucleoplasm		"HPA075185: AB_2732282"	"unprognostic (7.13e-2)"	"unprognostic (2.44e-1)"	"unprognostic (1.57e-1)"	"prognostic unfavorable (7.13e-4)"	"unprognostic (4.18e-1)"	"unprognostic (1.62e-1)"	"prognostic unfavorable (1.20e-5)"	"unprognostic (1.90e-1)"	"unprognostic (3.05e-3)"	"unprognostic (7.58e-2)"	"unprognostic (3.17e-3)"	"unprognostic (3.64e-3)"	"unprognostic (2.08e-3)"	"unprognostic (2.72e-2)"	"unprognostic (1.02e-1)"	"unprognostic (9.01e-2)"	"unprognostic (2.13e-1)"	5.5	5.2	5.0	2.5	5.3	3.8	4.3	5.1	6.2	3.3	5.1	4.5	2.8	5.4	3.9	2.7	4.9	3.1	7.6	4.8	5.8	2.6	2.8	3.0	2.4	5.3	5.4	4.7	4.6	3.4	5.0	3.1	5.1	3.3	2.2	3.5	3.6	3.4	14.6	3.7	3.6	4.4	5.1	3.2	4.9	2.8	5.2	2.5	2.7	11.5	1.9	4.0	3.0	5.2	4.2	5.2	10.7	6.0	4.8	3.9	8.0	4.0	7.1	4.6	4.2	10.3	5.6	8.2	4.5	4.6	9.3	3.1	7.6	5.9	4.8	10.6	11.3	14.9	4.0	12.8	9.4	15.4	14.7	6.7	5.5	5.0	5.9	3.9	4.2	7.1	11.3	15.3	3.7	10.1	8.9	16.9	15.3	5.1	6.7	15.6	12.1	8.4	5.0	3.7	9.2	19.1	4.6	6.7	18.8	4.6	6.2	7.7	3.5	6.6	8.5	4.2	9.0	22.0	17.4	19.9	7.2	14.5	10.3	7.8	0.2	0.1	0.1	0.0	0.4	0.0	0.1	0.2	0.2	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.2	5.0	5.3	5.1	6.2	4.8	5.8	5.3	5.4	5.1	5.1	5.2	5.2	15.7	6.4	4.8	7.2	8.4	24.3	23.6	10.6	13.6	12.4	14.5	9.7	9.0	10.0	8.4	3.7	16.7	17.3	8.5	3.4	7.9	11.7	1.4	11.0	14.1	12.2	6.7	3.4	13.9	11.0	13.9	14.3	13.3	14.0	0.0	13.6	8.6	8.8	12.5	13.5	14.9	4.7	8.2	5.4	11.5	2.6	8.7	11.3	17.8	6.5	7.0	10.1	5.2	3.5	20.8	9.4	3.7	11.3	6.1	21.3	5.3	8.4	4.1	11.8	0.0	22.2	12.3	15.7	48.2	8.2	21.9	22.2	8.4	11.7	6.0	16.7
E2F7		ENSG00000165891	"E2F transcription factor 7"	Q96AV8	12	77021248-77065569	"Predicted intracellular proteins, Transcription factors"	"Cell cycle, DNA damage, Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 5.0;lymphoid tissue: 8.3"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 46.9;Endometrial ciliated cells: 17.2;Late spermatids: 70.2"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in single"		"plasmacytoid DC: 1.7"	"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	9	"midbrain: 5.8;pons: 6.4;thalamus: 11.3"	HPA064866			Supported	"Nuclear speckles"		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 31: Spermatids - Spermatogenesis"	"Nuclear speckles"		"HPA064866: AB_2685374"	"unprognostic (1.21e-1)"	"unprognostic (8.92e-2)"	"unprognostic (7.39e-2)"	"unprognostic (7.27e-2)"	"unprognostic (1.54e-1)"	"unprognostic (3.80e-2)"	"unprognostic (6.14e-5)"	"unprognostic (1.05e-3)"	"unprognostic (1.72e-1)"	"unprognostic (3.57e-2)"	"unprognostic (5.67e-5)"	"unprognostic (1.42e-1)"	"unprognostic (0.00e+0)"	"unprognostic (3.05e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.00e-1)"	"unprognostic (2.51e-1)"	0.2	0.1	0.2	1.1	0.2	5.0	0.2	0.0	0.3	0.3	0.3	0.9	0.7	0.2	0.0	1.4	0.6	0.7	0.2	0.2	0.2	0.1	0.2	0.3	1.5	0.7	0.8	0.1	0.2	0.1	0.5	1.0	0.4	0.2	1.5	0.2	0.2	0.1	0.0	1.1	0.8	0.3	0.6	0.3	0.6	2.9	0.2	8.3	0.1	0.1	1.6	0.6	0.5	0.2	20.1	9.4	25.7	10.1	0.8	2.5	31.1	27.6	29.8	14.2	17.0	12.8	6.6	11.2	5.4	5.5	29.5	15.1	15.5	29.8	27.1	4.4	10.4	9.8	27.3	7.3	5.9	8.5	8.8	0.8	7.7	37.4	22.9	8.3	14.2	19.0	10.4	8.9	29.5	10.1	31.9	0.1	18.1	6.7	21.9	23.0	22.2	6.2	3.5	16.8	16.3	10.7	22.9	7.9	6.5	10.9	12.6	8.7	39.3	53.5	26.8	23.0	36.7	9.5	5.8	7.1	19.3	3.8	34.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.7	0.4	0.0	0.2	0.2	0.0	0.3	0.2	0.2	0.7	0.8	0.4	0.6	0.2	0.2	0.1	0.0	0.5	2.3	0.5	0.3	1.0	1.4	4.6	0.0	0.6	0.9	2.1	0.0	2.2	0.0	0.0	1.8	0.4	1.5	0.0	0.3	46.9	17.2	0.8	1.5	0.0	7.4	0.4	1.1	3.1	0.8	6.1	3.1	4.5	6.3	0.0	0.0	0.9	0.0	0.2	1.2	2.0	0.3	1.2	70.2	0.3	1.3	0.0	3.7	0.0	1.6	0.0	0.5	0.0	12.0	0.1	0.7	6.9	1.7	0.0	0.0	3.1	0.1	0.0	0.0	1.2	1.2	2.1	6.3	0.6	0.3	0.8	0.4	2.1	4.3
E2F8	FLJ23311	ENSG00000129173	"E2F transcription factor 8"	A0AVK6	11	19224063-19241620	"Predicted intracellular proteins, Transcription factors"	"Cell cycle, Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 14.2;lymphoid tissue: 11.8;skeletal muscle: 12.6"	"Cell type enhanced"	"Detected in some"		"Erythroid cells: 34.1;Gastric mucus-secreting cells: 10.2;Plasma cells: 9.7;Squamous epithelial cells: 10.0"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"HPA064882, HPA076614"	Enhanced		Supported	Nucleoplasm,Nucleoli,Cytosol		No	No			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoli	"Nucleoplasm, Cytosol"	"HPA064882: AB_2685381, HPA076614: "	"unprognostic (5.62e-2)"	"unprognostic (5.24e-2)"	"unprognostic (3.17e-2)"	"unprognostic (6.99e-3)"	"unprognostic (2.86e-2)"	"unprognostic (1.66e-2)"	"unprognostic (1.29e-5)"	"unprognostic (1.94e-2)"	"unprognostic (3.90e-3)"	"unprognostic (2.41e-1)"	"unprognostic (7.29e-4)"	"unprognostic (1.16e-2)"	"unprognostic (9.13e-8)"	"unprognostic (1.02e-3)"	"unprognostic (1.37e-1)"	"unprognostic (3.81e-1)"	"unprognostic (4.28e-3)"	0.3	0.1	0.0	2.8	0.0	14.2	0.5	0.1	0.1	1.0	0.0	4.0	3.8	0.4	0.0	4.9	0.9	0.4	2.1	0.0	0.0	0.1	0.3	0.3	7.0	0.1	0.0	0.0	0.0	0.0	0.0	1.2	0.2	0.4	5.1	0.0	0.9	0.2	12.6	3.0	3.0	0.6	0.0	1.3	5.6	1.7	0.0	11.8	0.1	0.4	7.3	1.8	1.3	0.1	23.3	7.2	7.1	9.8	0.4	1.1	31.7	13.0	3.7	15.3	16.4	25.4	7.8	23.5	5.5	4.3	9.0	20.2	17.2	1.6	13.5	15.9	14.9	8.0	4.1	7.1	0.0	12.7	19.2	0.3	0.1	3.1	1.0	0.9	21.0	17.2	17.6	22.1	6.3	11.6	25.8	16.6	6.9	26.3	10.1	26.9	12.8	16.0	6.6	16.8	6.0	7.0	5.5	11.3	1.3	4.0	7.7	13.7	4.2	7.3	9.0	18.3	11.8	7.7	16.2	30.6	9.0	24.4	18.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.3	1.1	0.1	1.3	0.0	0.0	0.3	0.1	3.8	0.0	0.5	0.0	0.0	0.9	0.8	2.5	0.0	0.0	0.4	3.3	0.8	0.8	1.2	34.1	0.1	0.0	1.7	1.0	10.2	3.3	0.0	3.1	0.0	0.0	2.4	0.0	0.0	3.9	0.0	0.0	0.0	0.6	0.0	0.8	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.3	1.2	0.0	9.7	0.1	0.4	0.2	5.6	0.0	0.0	1.5	0.9	4.0	3.1	10.0	0.3	0.3	2.2	0.5	6.3	0.9
EAF1		ENSG00000144597	"ELL associated factor 1"	Q96JC9	3	15427598-15450635	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 57.1"	"Group enriched"	"Detected in all"	6	"Early spermatids: 268.7;Late spermatids: 389.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"BEWO: 137.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA059516, HPA060569, HPA069538"	Supported		Approved	"Nucleoplasm,Nuclear bodies,Vesicles"		NA	No			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 34: Spermatids - Unknown function"	"Nucleoplasm, Nuclear bodies"	Vesicles	"HPA059516: AB_2684048, HPA060569: AB_2684322, HPA069538: AB_2686147"	"unprognostic (1.26e-1)"	"unprognostic (1.61e-2)"	"unprognostic (6.37e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.68e-1)"	"unprognostic (5.47e-2)"	"unprognostic (3.14e-3)"	"prognostic unfavorable (6.87e-4)"	"unprognostic (3.22e-1)"	"unprognostic (3.16e-2)"	"unprognostic (3.22e-1)"	"unprognostic (8.45e-2)"	"unprognostic (2.06e-2)"	"unprognostic (5.17e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.46e-2)"	"unprognostic (1.64e-1)"	12.9	9.0	9.2	10.5	8.9	57.1	9.1	7.2	9.4	7.2	7.7	9.0	10.6	7.9	7.6	9.8	7.0	10.4	5.1	10.3	11.1	11.2	19.0	8.3	10.7	9.6	10.3	5.6	9.8	11.8	8.6	10.2	12.3	10.0	9.9	7.7	6.9	6.8	5.3	10.7	10.0	8.3	7.8	9.8	11.4	7.3	10.6	10.6	10.5	5.8	11.1	11.5	5.8	7.9	10.3	16.6	17.1	17.6	9.8	8.3	137.4	14.7	10.5	16.7	16.3	22.7	11.4	28.7	9.3	10.9	10.9	8.6	22.5	13.2	19.2	23.6	16.2	24.8	14.5	20.8	22.1	23.6	19.2	11.0	22.8	24.3	16.2	12.8	16.8	23.1	26.9	20.6	14.1	21.2	23.6	13.2	30.7	19.3	16.9	21.3	14.2	16.0	14.5	17.8	17.6	30.6	18.2	16.7	17.6	21.9	25.2	18.5	16.6	17.5	12.8	15.6	21.8	27.1	58.3	29.7	17.0	27.7	21.1	8.0	7.1	4.6	11.1	5.4	14.3	4.9	9.1	8.7	4.2	3.6	5.4	8.7	6.5	8.1	6.9	9.8	10.9	4.4	9.2	8.9	7.2	9.4	10.3	11.1	9.6	10.3	12.3	7.8	10.6	7.9	11.5	9.6	17.3	6.8	14.2	46.9	9.1	6.0	14.2	8.1	15.8	7.7	4.8	15.7	9.0	12.9	6.2	8.0	29.1	15.5	9.8	8.6	268.7	10.8	16.0	11.8	34.3	7.8	16.4	8.2	14.6	13.9	16.3	14.1	10.2	9.9	12.1	30.4	15.8	21.9	14.0	12.5	12.2	30.7	31.6	389.5	11.5	37.6	23.2	3.7	19.4	5.5	22.6	5.5	10.7	15.6	10.3	12.0	12.2	16.1	16.0	29.7	8.6	6.4	26.3	13.6	11.0	21.5	11.6	17.7	54.3	35.8	22.0	4.3	12.8	19.9
EAPP	"BM036, C14orf11, FLJ20578"	ENSG00000129518	"E2F associated phosphoprotein"	Q56P03	14	34515938-34539711	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002916	Approved		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 34: Non-specific - Transcription"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 39: Non-specific - Basic cellular processes"	"Golgi apparatus"	"Nucleoplasm, Cytosol"	"HPA002916: AB_1078715"	"unprognostic (8.76e-3)"	"unprognostic (1.27e-3)"	"unprognostic (2.08e-3)"	"unprognostic (1.94e-1)"	"unprognostic (4.59e-2)"	"unprognostic (1.64e-1)"	"unprognostic (2.80e-1)"	"prognostic favorable (9.34e-4)"	"unprognostic (1.81e-1)"	"unprognostic (6.38e-2)"	"unprognostic (2.05e-1)"	"unprognostic (7.80e-2)"	"prognostic favorable (2.23e-6)"	"unprognostic (2.64e-1)"	"unprognostic (2.68e-1)"	"prognostic favorable (2.96e-4)"	"unprognostic (3.24e-2)"	37.3	35.8	26.3	24.6	27.0	89.2	51.0	29.7	35.5	33.3	27.1	50.8	35.7	35.0	44.7	29.0	39.4	28.1	29.0	27.1	28.6	42.4	50.2	29.5	37.2	25.9	26.5	49.7	26.7	54.7	21.6	35.2	26.3	33.7	51.7	37.1	36.4	31.2	37.0	46.9	45.6	29.2	28.1	31.3	29.3	23.5	27.1	49.1	45.5	29.3	37.1	31.1	30.0	30.0	37.7	45.1	41.3	24.4	47.8	48.7	64.1	33.8	51.6	41.5	43.1	21.6	48.6	39.1	46.6	41.5	24.7	34.5	30.8	45.1	48.3	49.1	27.1	28.7	31.6	91.7	65.1	51.5	30.4	56.3	56.7	23.8	60.9	54.6	41.7	54.1	28.9	42.0	39.1	88.0	71.4	41.5	24.3	69.4	50.0	44.8	49.5	39.5	50.2	50.3	33.1	36.5	47.8	45.6	76.4	39.4	79.7	32.3	45.2	21.4	18.1	28.1	22.0	52.8	63.1	41.5	20.1	28.0	27.6	139.9	61.9	134.3	65.3	57.8	79.1	107.7	81.9	75.0	54.9	101.0	82.7	75.8	140.2	100.6	80.9	47.8	124.4	80.0	26.3	27.0	29.7	35.5	27.1	28.6	25.9	26.5	26.3	28.1	27.1	30.0	59.8	22.4	53.3	17.0	78.6	46.4	67.2	145.0	74.6	75.6	60.0	70.1	35.4	60.1	78.8	82.8	31.3	125.3	76.3	91.8	174.1	86.6	20.9	82.0	59.6	57.8	66.0	66.7	20.5	84.5	76.5	67.6	26.5	54.8	73.5	98.7	57.5	109.0	58.8	25.2	21.3	112.8	87.5	50.6	33.9	14.9	89.5	47.5	90.7	16.9	71.3	122.0	87.6	17.6	23.1	59.8	102.5	94.4	46.8	61.4	131.5	164.8	102.0	75.7	72.3	69.9	78.7	103.3	38.3	63.8	66.5	189.4	74.2	101.2	98.0	58.2
EBNA1BP2	"EBP2, NOBP, P40"	ENSG00000117395	"EBNA1 binding protein 2"	Q99848	1	43164175-43270936	"Predicted intracellular proteins"	"Ribosome biogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026512, HPA028277"	Approved		Enhanced	"Nucleoli,Nucleoli rim,Mitotic chromosome"		Yes	No		38000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 85: Liver - Metabolism"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoli, Nucleoli rim"	"Mitotic chromosome"	"HPA026512: AB_1847954, HPA028277: AB_10603664"	"unprognostic (9.30e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.05e-3)"	"unprognostic (2.03e-2)"	"unprognostic (8.59e-2)"	"unprognostic (1.19e-1)"	"prognostic unfavorable (4.22e-4)"	"unprognostic (7.64e-3)"	"unprognostic (2.89e-2)"	"unprognostic (1.24e-3)"	"unprognostic (7.11e-2)"	"unprognostic (1.64e-3)"	"unprognostic (4.10e-3)"	"unprognostic (3.04e-3)"	"unprognostic (1.69e-1)"	"unprognostic (3.22e-2)"	"unprognostic (1.33e-2)"	35.1	38.8	30.3	35.2	31.1	34.3	39.5	28.8	33.5	30.0	32.5	35.4	23.6	35.5	55.7	46.5	43.5	21.7	37.1	31.1	31.0	55.7	126.6	27.7	35.9	29.3	28.5	27.3	36.1	45.6	48.9	33.1	30.0	29.0	36.5	19.6	34.5	31.0	51.9	36.8	24.5	35.0	29.6	24.8	33.4	44.4	31.8	30.5	41.4	28.6	39.8	52.5	34.5	31.1	325.0	180.2	66.0	192.7	52.1	58.3	142.6	219.4	107.8	338.7	210.5	215.2	192.5	211.0	167.9	157.0	157.2	218.2	144.5	200.9	360.5	101.2	146.5	144.8	160.9	188.5	95.7	248.7	106.8	47.6	197.4	248.6	197.3	64.2	185.5	145.2	220.3	67.8	165.1	172.8	190.0	152.0	290.8	209.5	165.0	139.2	150.4	235.5	123.7	135.0	132.0	139.9	127.3	228.6	219.0	105.6	94.5	136.1	147.6	128.7	248.9	211.4	360.7	102.9	219.7	262.7	107.6	258.7	265.2	19.7	45.4	24.9	52.3	54.1	55.2	61.5	52.8	54.5	68.7	68.5	48.3	48.3	3.9	59.6	53.3	65.6	60.5	43.6	30.3	31.1	28.8	33.5	31.1	31.0	29.3	28.5	30.0	29.6	31.8	31.1	38.0	35.3	39.5	5.9	36.9	123.0	91.6	78.0	40.5	26.3	50.6	62.1	32.0	52.9	52.5	31.3	6.2	102.2	23.3	34.0	90.1	144.5	163.5	56.8	47.3	51.0	24.1	45.0	5.6	124.4	135.1	51.5	33.1	31.6	50.7	35.1	27.8	148.3	63.3	15.2	3.8	49.7	48.8	22.5	24.7	94.9	33.2	28.9	55.2	3.7	41.4	55.7	35.0	6.0	4.9	135.3	25.8	38.4	53.1	179.3	29.4	135.9	81.3	29.5	39.5	55.0	68.1	92.6	97.8	54.2	99.4	84.3	26.8	57.8	66.2	95.3
EBP	"CDPX2, CHO2, CPX, CPXD"	ENSG00000147155	"EBP cholestenol delta-isomerase"	Q15125	X	48521799-48528716	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins"	"Cholesterol biosynthesis, Cholesterol metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism"	Isomerase	"Cataract, Disease variant, Dwarfism, Ichthyosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 328.5"	"Cell type enhanced"	"Detected in all"		"Hepatocytes: 674.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA003130	Approved		Supported	"Endoplasmic reticulum"		NA	Yes			"Cluster 44: Non-specific - Transcription"	"Cluster 85: Liver - Metabolism"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 15: Hepatocytes - Hemostasis"	"Endoplasmic reticulum"		"HPA003130: AB_1078717"	"unprognostic (1.90e-1)"	"unprognostic (2.64e-2)"	"unprognostic (2.80e-1)"	"unprognostic (6.27e-2)"	"unprognostic (3.41e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.87e-1)"	"unprognostic (4.72e-2)"	"unprognostic (1.47e-1)"	"unprognostic (5.14e-2)"	"unprognostic (4.04e-2)"	"unprognostic (5.39e-2)"	"unprognostic (4.13e-1)"	"unprognostic (1.36e-1)"	10.2	73.3	16.7	17.1	17.2	48.3	17.4	18.5	17.8	19.4	22.0	50.6	85.5	11.0	17.3	41.3	14.3	10.5	32.5	16.8	18.7	44.0	328.5	24.4	18.8	24.4	16.6	12.7	26.0	44.0	7.2	8.2	24.2	40.6	57.5	10.7	25.0	11.7	9.5	27.8	54.2	14.9	15.8	16.9	31.6	14.2	15.9	28.2	14.4	10.6	32.7	14.1	23.3	16.0	224.5	96.4	107.4	77.0	74.5	39.2	50.5	48.2	43.6	64.3	93.9	169.9	382.7	115.9	35.2	41.3	83.5	230.3	217.5	293.8	49.8	85.8	149.7	50.1	115.2	139.3	57.8	179.2	138.2	51.3	108.6	112.9	86.4	22.5	46.5	98.1	77.6	119.5	50.7	163.7	119.1	199.9	118.2	88.3	199.1	93.8	10.3	363.7	175.6	68.8	110.0	59.6	175.4	122.6	31.2	91.5	122.9	71.1	46.6	33.1	56.2	132.9	63.1	47.5	72.1	107.7	78.7	239.7	40.6	96.1	37.7	97.1	129.4	53.4	104.5	71.5	90.5	116.7	53.5	57.2	76.5	99.7	7.3	63.9	57.2	105.4	103.1	93.6	16.7	17.2	18.5	17.8	16.8	18.7	24.4	16.6	24.2	15.8	15.9	16.0	15.2	32.1	49.8	2.9	38.9	37.1	58.2	245.6	23.3	23.8	57.8	26.2	49.9	77.2	116.6	53.3	8.4	55.9	74.5	140.3	39.2	91.7	10.5	30.5	14.7	26.1	30.0	48.8	7.4	239.1	113.0	21.4	36.2	56.5	40.6	41.2	27.1	674.6	65.0	8.4	10.3	96.8	93.6	30.2	36.0	11.8	13.4	31.9	37.4	4.7	34.8	19.3	101.0	5.0	5.1	156.7	137.3	14.7	54.4	46.4	171.9	99.7	34.8	23.3	13.1	12.5	23.6	8.7	22.7	47.6	45.5	37.5	57.1	128.7	149.1	71.1
EBPL	EBRP	ENSG00000123179	"EBP like"	Q9BY08	13	49660674-49691486	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 99.3"	"Cell type enhanced"	"Detected in all"		"Hepatocytes: 305.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049891	Enhanced		Supported	"Endoplasmic reticulum"		NA	NA			"Cluster 30: Non-specific - Translation"	"Cluster 85: Liver - Metabolism"	"Cluster 21: OE19 - Mitochondria"	"Cluster 32: Non-specific - Translation"	"Endoplasmic reticulum"		"HPA049891: AB_2680937"	"unprognostic (1.49e-1)"	"unprognostic (1.41e-2)"	"unprognostic (4.23e-2)"	"unprognostic (3.06e-2)"	"unprognostic (2.81e-1)"	"unprognostic (8.63e-3)"	"unprognostic (3.91e-2)"	"unprognostic (1.57e-1)"	"unprognostic (6.91e-2)"	"prognostic unfavorable (1.38e-4)"	"unprognostic (1.63e-2)"	"unprognostic (2.67e-2)"	"prognostic unfavorable (7.18e-8)"	"unprognostic (1.11e-2)"	"unprognostic (1.11e-1)"	"unprognostic (3.03e-1)"	"unprognostic (1.95e-2)"	21.9	59.7	6.6	12.1	6.5	20.0	23.2	7.0	8.9	37.0	7.5	24.1	14.2	20.4	6.6	62.3	25.5	11.1	8.7	6.7	7.3	14.8	99.3	19.1	11.0	6.8	6.8	33.3	47.7	10.5	10.3	11.2	6.9	21.3	16.3	4.4	27.9	13.5	5.2	33.7	14.3	13.3	7.8	14.4	27.5	11.0	7.9	10.3	16.1	2.5	11.0	23.8	47.6	8.4	46.7	34.9	21.0	88.5	26.0	66.4	37.5	48.5	33.1	30.9	25.0	66.8	65.1	57.9	21.6	23.7	27.1	93.7	38.3	47.4	45.0	46.4	126.8	43.7	23.4	83.3	75.2	69.4	35.0	77.7	100.4	25.6	68.1	49.9	53.6	61.5	36.7	23.0	40.2	25.0	27.4	124.8	72.4	153.2	78.2	58.5	11.7	89.0	66.4	15.2	19.5	50.1	18.0	62.1	21.6	21.7	54.4	54.0	24.6	23.4	23.2	20.2	40.7	14.9	41.2	46.7	11.2	68.6	21.6	2.4	3.0	0.8	2.4	3.6	6.8	4.3	4.8	5.0	5.0	5.4	7.1	4.1	6.4	4.1	3.9	3.3	3.7	1.4	6.6	6.5	7.0	8.9	6.7	7.3	6.8	6.8	6.9	7.8	7.9	8.4	75.5	35.3	23.1	9.8	46.5	108.6	157.6	17.4	115.5	7.9	139.8	192.1	5.4	104.4	17.4	23.9	8.4	32.3	25.5	26.5	41.1	61.2	13.3	61.5	90.6	76.8	27.8	65.6	8.0	52.1	37.1	56.9	56.6	50.0	17.8	64.9	78.9	305.3	38.5	1.7	11.6	80.1	8.2	45.8	36.5	10.0	94.1	27.4	46.2	8.4	30.9	23.6	36.0	8.0	5.1	41.0	42.0	70.0	79.3	116.6	16.5	62.3	8.5	8.4	19.7	57.7	52.7	26.9	17.2	208.6	154.6	15.2	40.3	194.2	133.6	108.9
ECD	"GCR2, hSGT1"	ENSG00000122882	"Ecdysoneless cell cycle regulator"	O95905	10	73130155-73169055	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing, Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006465	Approved		Supported	Nucleoplasm,Cytosol		Yes	No			"Cluster 14: Monocytes - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 59: Non-specific - Transcription"	"Nucleoplasm, Cytosol"		"HPA006465: AB_2667595"	"unprognostic (2.70e-1)"	"unprognostic (1.94e-1)"	"unprognostic (6.46e-2)"	"unprognostic (2.19e-1)"	"unprognostic (2.75e-2)"	"unprognostic (4.71e-3)"	"prognostic unfavorable (6.87e-4)"	"unprognostic (1.22e-1)"	"unprognostic (3.55e-2)"	"unprognostic (6.61e-2)"	"unprognostic (3.07e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.54e-2)"	"unprognostic (1.05e-1)"	"unprognostic (6.77e-2)"	"unprognostic (7.05e-2)"	"unprognostic (3.84e-2)"	13.8	17.2	8.0	14.6	11.2	31.9	17.9	12.7	10.7	14.8	10.2	13.1	12.1	16.0	16.2	15.2	11.9	15.9	12.8	8.5	7.7	17.4	18.9	12.6	17.7	7.4	7.1	13.9	16.7	22.8	11.3	17.8	7.5	16.5	13.9	17.0	14.4	14.3	13.8	15.3	11.7	14.7	7.2	14.4	13.1	19.2	7.6	21.0	19.0	14.3	18.4	20.0	12.5	12.5	41.0	28.8	32.0	48.1	28.8	28.2	26.3	31.1	48.5	49.9	57.8	52.0	41.4	31.8	29.9	30.5	36.7	33.0	34.6	36.9	50.3	26.1	33.5	39.9	21.2	38.0	43.7	48.3	25.3	31.5	30.9	41.6	51.7	37.9	53.3	29.3	42.1	21.4	47.6	34.8	44.5	28.6	33.0	37.7	81.8	32.1	35.6	17.6	40.4	29.5	13.9	26.5	28.4	62.5	40.3	32.6	36.1	23.0	33.3	21.1	42.8	23.3	36.2	25.2	18.1	54.5	40.1	40.4	18.5	21.0	23.3	26.3	24.7	24.9	26.4	24.3	23.0	24.4	20.3	21.2	29.9	21.5	27.5	32.5	34.7	13.8	24.8	20.3	8.0	11.2	12.7	10.7	8.5	7.7	7.4	7.1	7.5	7.2	7.6	12.5	21.2	28.9	12.1	13.1	22.7	11.0	27.9	16.6	24.5	13.9	11.9	10.3	12.5	8.6	23.0	7.3	25.0	22.7	22.7	9.0	7.9	15.8	39.4	15.3	15.5	17.4	10.8	21.8	17.3	12.2	15.7	15.7	23.4	24.8	19.6	12.2	15.0	8.8	16.6	20.2	16.3	11.8	8.2	12.4	10.1	11.5	15.8	16.0	14.2	9.4	10.8	10.3	14.4	11.6	18.6	14.7	5.7	13.2	16.7	13.1	9.8	12.2	10.5	13.1	6.6	17.8	18.2	32.9	16.0	19.2	10.9	33.2	22.1	11.6	9.2	24.7
ECH1	HPXEL	ENSG00000104823	"Enoyl-CoA hydratase 1"	Q13011	19	38815422-38831841	"Metabolic proteins, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	Isomerase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 749.9;skeletal muscle: 906.9"	"Cell type enhanced"	"Detected in all"		"Cytotrophoblasts: 796.9;Proximal tubular cells: 880.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002907, HPA005835"	Supported	Supported	Supported	Mitochondria		No	No		720000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 47: Cytotrophoblasts - Unknown function"	Mitochondria		"HPA002907: AB_1847964, HPA005835: AB_1847965"	"unprognostic (1.91e-1)"	"unprognostic (3.03e-2)"	"unprognostic (3.64e-2)"	"unprognostic (6.43e-2)"	"unprognostic (5.73e-3)"	"unprognostic (6.90e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.79e-1)"	"unprognostic (2.43e-1)"	"unprognostic (5.86e-2)"	"unprognostic (2.24e-1)"	"unprognostic (3.37e-1)"	"unprognostic (7.01e-2)"	"prognostic unfavorable (2.23e-4)"	"unprognostic (3.54e-1)"	"unprognostic (3.52e-1)"	"unprognostic (1.74e-2)"	216.0	343.0	51.2	47.6	53.7	62.3	194.2	54.1	60.3	124.9	58.6	232.9	93.5	115.3	32.3	168.4	114.0	66.8	749.9	49.3	52.5	271.6	556.1	122.1	67.8	51.8	51.8	107.2	141.4	56.0	77.1	67.1	53.4	99.5	99.9	12.8	138.6	43.3	906.9	149.0	167.4	59.7	50.6	192.3	180.5	100.7	55.0	51.0	117.9	455.1	65.7	142.4	132.4	53.3	64.0	273.8	42.0	68.8	161.0	82.0	61.8	31.7	53.2	26.6	27.1	178.8	124.8	98.6	117.2	72.8	24.1	30.1	70.9	72.9	21.1	345.3	37.7	120.7	76.5	146.1	161.3	131.9	116.9	109.0	186.6	35.1	61.2	52.3	63.4	127.3	58.4	160.8	59.6	120.0	91.8	82.2	27.8	278.8	65.9	101.8	126.2	199.0	168.7	142.6	51.4	67.2	161.0	77.1	86.5	27.3	106.4	288.4	53.7	45.5	39.3	46.5	29.6	121.0	153.2	96.4	71.4	164.9	90.7	316.1	312.9	268.0	253.6	248.2	237.2	368.4	243.5	249.1	308.6	361.3	216.5	242.4	41.6	342.7	212.8	221.5	391.8	541.8	51.2	53.7	54.1	60.3	49.3	52.5	51.8	51.8	53.4	50.6	55.0	53.3	125.4	86.6	104.7	13.1	111.1	82.2	220.0	320.8	80.8	22.4	124.0	143.8	302.7	205.9	203.2	145.3	16.7	796.9	103.4	257.7	510.6	195.4	64.5	95.7	56.9	96.4	189.2	99.9	7.1	90.1	370.6	104.1	112.7	77.0	120.9	177.6	90.7	549.4	277.6	37.0	8.6	298.9	193.3	99.0	85.2	56.7	130.8	97.5	145.9	8.4	205.1	53.0	113.3	7.1	16.0	97.0	257.5	143.0	122.1	100.1	383.0	880.0	182.6	21.4	78.9	88.4	119.7	73.3	51.3	121.6	90.8	580.9	118.6	624.2	350.0	218.1
ECSCR	"ARIA, ECSM2"	ENSG00000249751	"Endothelial cell surface expressed chemotaxis and apoptosis regulator"	Q19T08	5	139448560-139462743	"Predicted membrane proteins"	"Angiogenesis, Apoptosis, Chemotaxis, Differentiation"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in some"	12	"Adipocytes: 235.8;Endothelial cells: 214.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	122	"EFO-21: 172.1;HUVEC TERT2: 443.7;TIME: 330.9"									HPA063337			Supported	"Nucleoplasm,Vesicles,Plasma membrane"		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Vesicles, Plasma membrane"	Nucleoplasm	"HPA063337: AB_2732701"	"unprognostic (5.91e-2)"	"unprognostic (2.37e-2)"	"unprognostic (1.95e-2)"	"unprognostic (2.83e-2)"	"unprognostic (3.69e-2)"	"unprognostic (2.15e-3)"	"unprognostic (3.95e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.29e-2)"	"unprognostic (1.78e-1)"	"unprognostic (2.78e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.83e-3)"	"unprognostic (2.41e-3)"	"unprognostic (1.36e-1)"	"unprognostic (9.90e-2)"	"unprognostic (2.91e-1)"	62.7	12.7	5.5	11.2	5.5	0.2	59.8	5.7	8.5	26.8	5.3	19.4	4.6	29.4	7.4	15.9	33.5	12.1	54.6	5.2	5.9	29.9	6.0	60.1	11.6	6.0	5.9	10.4	6.7	4.7	7.1	33.5	6.3	19.6	8.0	0.8	16.1	7.3	15.1	16.6	20.7	24.4	6.1	23.5	15.2	3.3	6.7	3.5	40.9	17.2	7.2	35.5	26.1	5.9	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.3	0.3	0.0	0.0	172.1	0.3	0.1	0.0	0.0	0.0	0.6	1.0	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.4	0.0	0.0	0.0	0.1	443.7	0.1	0.0	0.0	1.4	0.0	0.0	0.9	2.5	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.4	330.9	0.4	0.4	0.0	1.7	0.0	0.0	0.2	0.0	1.5	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.5	5.5	5.7	8.5	5.2	5.9	6.0	5.9	6.3	6.1	6.7	5.9	235.8	0.0	3.9	0.0	1.0	14.9	0.4	0.0	0.0	0.0	1.9	2.5	0.0	0.0	0.6	0.0	0.0	0.2	1.0	0.0	0.0	0.6	0.0	0.4	0.5	214.9	0.0	0.0	0.1	1.2	0.1	3.1	0.0	0.3	0.0	0.0	0.0	0.0	0.8	0.0	0.1	0.0	0.0	0.0	18.3	0.0	0.0	1.7	10.6	5.6	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	1.5	0.0	0.0	0.7	0.4	0.0	0.0	1.9	0.0	0.0	0.0	13.9	0.3	1.3	0.9	0.0	1.6
ECSIT	SITPEC	ENSG00000130159	"ECSIT signaling integrator"	Q9BQ95	19	11505929-11529172	"Predicted intracellular proteins"	"Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042979	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm	Cytosol	"HPA042979: AB_10964063"	"unprognostic (9.88e-2)"	"unprognostic (3.57e-3)"	"unprognostic (2.93e-1)"	"unprognostic (3.55e-3)"	"unprognostic (2.27e-2)"	"unprognostic (3.35e-2)"	"unprognostic (2.18e-1)"	"unprognostic (1.24e-1)"	"unprognostic (2.92e-1)"	"unprognostic (2.18e-1)"	"unprognostic (1.01e-2)"	"unprognostic (4.08e-2)"	"prognostic favorable (1.48e-9)"	"unprognostic (2.30e-3)"	"unprognostic (1.68e-1)"	"unprognostic (2.06e-1)"	"unprognostic (5.95e-2)"	26.2	38.0	28.5	14.9	28.4	24.7	26.8	32.4	38.5	32.2	29.6	42.2	39.5	29.7	9.4	29.2	28.5	15.0	128.5	28.7	29.3	36.6	51.6	20.8	18.0	30.5	28.2	43.1	56.3	30.6	24.3	9.8	31.6	29.8	18.9	12.9	45.7	16.0	124.7	29.6	28.3	16.5	26.1	21.8	48.9	15.0	30.8	15.6	26.2	130.4	13.3	34.3	27.5	30.0	40.0	35.8	20.4	29.2	30.0	33.6	23.1	21.1	26.4	41.8	33.4	52.6	26.4	58.7	42.0	25.4	38.0	52.1	51.6	42.6	14.6	33.2	42.7	54.5	21.6	48.1	29.7	31.5	42.8	35.9	46.0	35.0	38.1	22.1	31.8	53.7	59.2	56.2	15.6	55.2	53.7	48.6	54.6	51.8	91.4	53.3	22.0	77.1	22.3	24.2	77.3	50.2	24.6	38.7	42.4	9.6	45.9	46.3	16.2	44.4	31.2	64.4	38.5	52.7	106.5	28.7	37.0	46.9	32.2	4.1	32.5	12.0	26.6	41.1	30.8	41.7	28.8	25.1	42.3	39.2	31.9	29.3	6.1	26.1	38.3	23.5	35.4	29.7	28.5	28.4	32.4	38.5	28.7	29.3	30.5	28.2	31.6	26.1	30.8	30.0	19.7	9.6	15.7	13.1	25.2	44.5	61.6	48.3	40.9	23.2	38.7	44.2	74.7	52.9	28.3	20.2	12.5	34.5	18.0	44.3	82.2	42.1	18.0	10.2	16.3	23.4	37.3	31.1	15.3	78.5	45.7	27.5	29.6	9.5	22.9	47.1	27.5	49.4	31.1	18.5	19.4	49.3	16.2	29.6	23.5	52.2	34.5	19.5	28.4	3.7	22.2	30.4	29.9	8.0	9.9	38.4	34.8	32.0	21.0	55.9	70.0	101.5	18.5	30.6	32.9	32.7	36.4	17.6	45.1	37.6	41.9	25.2	20.3	53.7	84.6	56.3
EDC3	"FLJ21128, hYjeF_N2-15q23, LSM16, YJDC, YJEFN2"	ENSG00000179151	"Enhancer of mRNA decapping 3"	Q96F86	15	74630558-74696292	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		RNA-binding	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	7	"Early spermatids: 117.2;Late spermatids: 192.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040650, HPA044206, HPA066137"	Uncertain		Supported	"Cytoplasmic bodies"		NA	NA			"Cluster 22: NK-cells - Unknown function"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 25: Spermatids - Spermatogenesis"	"Cytoplasmic bodies"		"HPA040650: AB_2677061, HPA044206: AB_2678857, HPA066137: AB_2685625"	"unprognostic (4.22e-1)"	"unprognostic (1.85e-1)"	"unprognostic (9.13e-2)"	"unprognostic (1.04e-1)"	"unprognostic (2.55e-1)"	"unprognostic (1.25e-1)"	"prognostic unfavorable (7.80e-5)"	"unprognostic (3.06e-1)"	"unprognostic (2.58e-2)"	"unprognostic (4.45e-2)"	"unprognostic (1.33e-1)"	"unprognostic (3.92e-1)"	"unprognostic (1.19e-1)"	"unprognostic (8.85e-2)"	"unprognostic (2.80e-1)"	"unprognostic (3.81e-1)"	"unprognostic (4.81e-2)"	12.8	8.7	14.3	11.7	15.6	7.9	13.8	18.1	16.6	13.0	15.6	12.4	10.4	15.2	11.0	15.5	16.4	10.2	10.5	14.0	15.3	12.9	11.2	10.5	15.1	15.2	15.0	18.6	10.5	13.4	11.9	12.4	14.9	14.3	13.8	11.8	10.3	10.8	14.8	15.3	12.3	17.0	12.7	12.9	11.5	34.8	15.0	18.5	13.1	11.5	18.1	13.0	10.7	18.6	24.9	20.8	39.0	34.9	24.6	22.5	35.7	26.1	30.5	42.4	40.6	58.9	30.2	39.6	24.1	35.8	39.2	50.6	99.0	40.4	29.5	33.7	54.3	41.0	46.9	30.8	29.4	47.8	24.4	23.0	36.9	36.8	39.0	26.8	38.9	45.7	59.3	30.4	30.5	39.8	32.8	26.7	39.2	34.0	22.9	40.8	42.7	40.0	19.4	42.7	42.5	38.8	38.8	33.5	41.8	51.8	34.6	34.6	24.3	36.7	20.3	22.2	38.4	31.9	65.2	44.3	29.1	46.6	29.5	6.1	5.8	4.6	9.6	5.9	10.3	8.3	6.8	7.9	6.8	6.3	6.9	7.5	1.9	13.7	5.0	6.7	8.5	7.1	14.3	15.6	18.1	16.6	14.0	15.3	15.2	15.0	14.9	12.7	15.0	18.6	10.8	6.4	7.8	21.9	7.2	4.7	5.0	7.6	9.6	9.7	6.8	6.2	6.3	8.6	6.7	7.3	0.0	9.7	8.4	7.0	3.9	11.4	117.2	10.2	7.5	9.6	15.6	7.8	19.5	8.1	12.1	7.9	9.7	9.4	4.5	10.2	8.2	8.2	7.6	5.0	18.0	6.8	8.2	7.1	2.4	192.2	9.0	4.6	8.8	17.8	11.5	5.2	11.3	18.6	19.0	9.5	11.1	6.4	14.0	7.6	6.6	5.8	11.3	6.3	13.1	4.6	6.8	12.8	16.3	7.7	2.8	9.3	7.4	7.6	6.0	8.1
EDC4	"Ge-1, HEDLS, RCD-8"	ENSG00000038358	"Enhancer of mRNA decapping 4"	Q6P2E9	16	67873052-67884499	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 22.4;Alveolar cells type 2: 24.8;Excitatory neurons: 14.2;Gastric mucus-secreting cells: 15.3;Inhibitory neurons: 12.6;Oligodendrocytes: 13.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041164, HPA043038"	Supported		Enhanced	"Nucleoplasm,Cytoplasmic bodies"		NA	NA		9700	"Cluster 27: Non-specific - Gene expression"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	"Cytoplasmic bodies"	Nucleoplasm	"HPA041164: AB_2677339, HPA043038: AB_2678281"	"unprognostic (1.97e-1)"	"unprognostic (1.48e-1)"	"unprognostic (8.53e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.15e-1)"	"prognostic unfavorable (7.61e-4)"	"unprognostic (1.47e-2)"	"unprognostic (2.87e-1)"	"unprognostic (7.93e-2)"	"unprognostic (3.75e-3)"	"unprognostic (1.10e-2)"	"unprognostic (2.44e-2)"	"unprognostic (1.48e-1)"	"unprognostic (3.13e-2)"	"unprognostic (7.69e-3)"	"unprognostic (1.17e-1)"	10.1	11.8	36.3	11.9	36.2	24.4	10.6	36.0	42.2	11.6	34.0	15.5	13.7	12.9	9.6	12.1	13.2	12.1	17.0	34.7	34.8	12.2	10.9	10.8	16.3	34.3	34.5	15.8	18.1	13.6	14.0	10.8	34.4	11.3	11.2	8.5	11.3	10.2	21.9	16.1	14.1	9.7	33.0	13.7	15.8	18.3	34.1	20.6	10.9	11.3	16.0	13.1	10.5	37.0	23.8	33.6	22.0	19.9	19.6	14.8	43.6	21.1	17.8	42.4	33.9	55.2	22.4	38.2	22.6	29.1	17.9	32.4	43.1	17.2	21.3	14.8	54.6	27.2	21.9	29.5	23.7	33.2	29.8	20.3	23.2	42.7	19.8	24.9	32.8	28.3	48.2	7.1	25.4	36.5	44.9	83.6	21.8	15.9	18.4	66.1	26.1	42.3	17.0	17.7	38.5	20.8	56.0	15.9	15.8	17.3	29.4	45.2	21.5	17.7	24.7	16.3	28.6	34.9	22.2	94.7	13.6	39.4	16.3	0.7	5.8	4.2	8.9	6.2	7.9	5.6	7.6	8.4	6.0	4.1	7.5	5.4	2.6	8.3	10.9	4.2	11.2	6.6	36.3	36.2	36.0	42.2	34.7	34.8	34.3	34.5	34.4	33.0	34.1	37.0	0.6	22.4	24.8	8.5	4.8	0.0	0.3	0.2	7.4	1.2	0.3	0.4	1.5	0.0	3.2	0.0	4.2	0.2	1.1	1.6	0.0	0.4	0.0	1.0	1.1	2.1	1.2	8.8	14.2	0.0	0.4	2.6	15.3	1.3	3.8	0.8	1.4	0.2	0.4	0.0	12.6	0.4	0.0	0.3	0.3	0.2	0.3	4.5	0.0	11.2	0.0	0.7	1.0	8.5	13.6	0.3	1.2	0.0	8.3	0.2	2.0	0.1	4.4	1.2	6.6	1.0	0.9	0.2	0.2	8.3	0.1	0.0	5.5	0.8	0.4	0.1
EDF1	"CFAP280, EDF-1"	ENSG00000107223	"Endothelial differentiation related factor 1"	O60869	9	136862119-136866308	"Predicted intracellular proteins"	"Differentiation, Transcription, Transcription regulation"	"Activator, Calmodulin-binding, Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Proximal enterocytes: 2662.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035642	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 22: Non-specific - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 45: Enterocytes - Digestion"	"Nucleoplasm, Cytosol"		"HPA035642: AB_10611959"	"unprognostic (2.07e-1)"	"unprognostic (1.25e-2)"	"unprognostic (3.97e-2)"	"unprognostic (3.58e-3)"	"unprognostic (4.49e-2)"	"unprognostic (2.32e-1)"	"unprognostic (9.05e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.63e-2)"	"unprognostic (4.03e-2)"	"unprognostic (2.65e-2)"	"unprognostic (9.76e-2)"	"unprognostic (1.83e-1)"	"unprognostic (2.08e-2)"	"unprognostic (2.31e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.15e-1)"	305.1	423.1	401.9	234.1	403.4	299.6	315.7	408.4	511.3	359.2	392.1	355.4	494.2	280.8	211.9	462.9	281.6	192.2	519.3	404.5	420.1	430.0	668.7	279.5	273.3	415.5	412.3	394.2	715.5	289.9	395.9	202.8	412.2	430.3	206.9	105.1	497.8	230.7	497.6	407.3	486.4	162.7	401.3	309.8	399.1	179.5	405.5	231.3	396.3	321.6	242.2	286.6	343.4	418.0	496.0	646.9	355.3	361.3	342.6	358.5	693.9	555.9	370.3	438.7	339.8	528.1	335.9	429.6	503.5	484.3	392.3	585.0	277.0	424.5	159.7	467.6	338.4	300.4	784.0	727.5	680.2	518.7	394.9	357.4	533.8	344.9	396.9	408.1	426.7	382.7	443.0	540.6	379.7	1071.4	465.6	818.8	375.6	761.1	548.0	404.2	517.5	875.8	592.2	515.4	450.8	433.3	579.8	807.6	587.1	231.9	781.1	715.8	526.6	477.5	363.8	524.5	528.0	311.5	555.7	366.6	625.8	305.7	448.8	290.4	378.6	327.2	351.6	334.9	388.7	430.9	373.6	364.9	379.2	400.3	328.8	343.7	149.3	396.7	282.8	621.6	471.0	544.4	401.9	403.4	408.4	511.3	404.5	420.1	415.5	412.3	412.2	401.3	405.5	418.0	375.9	227.6	290.8	27.1	357.5	522.1	601.8	717.4	314.1	139.5	530.5	691.1	336.9	480.4	421.8	314.5	39.6	683.0	405.4	1157.4	1154.3	668.1	148.4	266.8	317.2	365.7	443.4	277.0	19.1	1274.9	768.6	332.7	349.7	320.2	291.1	386.5	404.8	822.2	571.2	94.2	20.8	1032.8	376.4	394.7	535.9	292.1	581.6	323.0	526.5	15.9	787.1	352.5	460.3	23.1	39.0	1103.5	1413.9	426.5	409.6	625.2	2662.5	1566.5	314.5	155.6	276.1	389.0	469.0	238.7	237.4	408.3	620.3	1127.5	377.8	364.3	764.7	682.5
EDNRA	"ET-A, ETA-R, hET-AR"	ENSG00000151617	"Endothelin receptor type A"	P25101	4	147480917-147544954	"Disease related genes, FDA approved drug targets, G-protein coupled receptors, Human disease related genes, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"seminal vesicle: 113.9"	"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 117.1;Leydig cells: 43.8;Peritubular cells: 68.1;Sertoli cells: 52.6;Smooth muscle cells: 108.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 9.4;ASC TERT1: 18.2;HHSteC: 9.3;LHCN-M2: 22.7;SH-SY5Y: 16.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA013774, CAB018957"	Uncertain		Approved	"Plasma membrane,Cytosol"		NA	NA				"Cluster 89: Fibroblasts - ECM organization"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 48: Smooth muscle cells - ECM organization"	"Plasma membrane, Cytosol"		"CAB018957: AB_2039838, HPA013774: AB_1847994"	"unprognostic (3.08e-2)"	"unprognostic (6.28e-2)"	"unprognostic (1.78e-1)"	"unprognostic (3.42e-1)"	"unprognostic (1.07e-2)"	"unprognostic (1.39e-1)"	"unprognostic (3.20e-2)"	"unprognostic (7.20e-2)"	"unprognostic (2.75e-3)"	"unprognostic (1.47e-2)"	"unprognostic (1.34e-3)"	"unprognostic (2.88e-1)"	"prognostic unfavorable (1.50e-7)"	"prognostic unfavorable (3.93e-4)"	"unprognostic (6.20e-3)"	"unprognostic (3.11e-2)"	"unprognostic (2.53e-3)"	14.0	5.5	2.1	3.3	2.8	0.0	8.3	2.7	4.2	57.0	2.1	3.2	3.4	44.7	23.3	4.4	18.4	12.7	26.0	2.2	2.2	4.2	3.1	22.7	3.8	2.9	3.1	37.5	1.1	3.4	2.8	12.1	2.9	30.7	3.4	0.3	6.4	113.9	4.0	4.6	2.9	45.1	2.5	8.4	5.4	6.2	2.9	4.9	6.8	5.5	2.6	11.8	24.0	3.0	0.0	1.2	5.2	0.0	9.4	18.2	0.0	2.9	3.8	0.4	0.1	0.2	0.0	0.0	0.0	0.9	0.6	0.0	0.4	0.7	0.2	0.0	1.9	0.0	2.8	0.0	9.3	0.0	0.0	6.9	0.6	0.5	0.0	3.4	0.0	0.0	0.0	1.4	22.7	0.3	0.0	0.1	1.5	0.0	1.1	0.0	0.9	0.1	1.3	1.0	0.0	16.3	0.0	0.0	0.0	3.4	0.0	0.0	0.0	3.6	0.7	0.0	0.0	1.3	0.4	0.0	7.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	2.8	2.7	4.2	2.2	2.2	2.9	3.1	2.9	2.5	2.9	3.0	7.7	3.2	5.3	1.0	0.0	3.1	0.8	1.7	27.3	0.1	0.8	5.2	24.9	0.0	4.5	0.0	0.0	0.2	0.1	0.0	0.0	0.1	2.9	3.4	117.1	8.0	0.0	0.0	5.3	0.0	0.1	15.9	0.0	2.7	0.0	14.3	0.0	0.0	0.6	0.0	22.5	0.0	0.0	0.0	3.9	3.5	43.8	0.8	3.6	9.4	0.0	0.1	0.0	2.0	1.0	0.2	0.0	68.1	0.0	1.4	0.0	0.5	0.0	0.5	52.6	0.6	108.6	0.7	0.7	7.1	2.7	0.1	0.9	0.3	0.0	0.4
EDNRB	"ETB, HSCR, HSCR2"	ENSG00000136160	"Endothelin receptor type B"	P24530	13	77895481-77975529	"Disease related genes, FDA approved drug targets, G-protein coupled receptors, Human disease related genes, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"Albinism, Deafness, Disease variant, FDA approved drug targets, Hirschsprung disease, Waardenburg syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 127.8"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 120.5;Astrocytes: 126.3;Hepatic stellate cells: 112.5;Melanocytes: 110.3;Muller glia cells: 116.2;Sertoli cells: 216.9;Skeletal myocytes: 81.3;Smooth muscle cells: 102.1"	"Cancer enhanced"	"Detected in all"		"melanoma: 127.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 68.0;ASC diff: 50.5;SK-MEL-30: 66.0;U-266/70: 40.7;WM-115: 131.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017842, HPA027546"	Approved		Supported	"Plasma membrane,Cytosol"		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 48: Smooth muscle cells - ECM organization"	"Plasma membrane"	Cytosol	"CAB017842: , HPA027546: AB_2672327"	"unprognostic (7.75e-2)"	"unprognostic (6.73e-2)"	"unprognostic (1.41e-3)"	"unprognostic (2.59e-2)"	"unprognostic (8.37e-2)"	"unprognostic (2.45e-3)"	"unprognostic (4.17e-3)"	"unprognostic (5.43e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.38e-2)"	"unprognostic (3.40e-2)"	"unprognostic (3.01e-2)"	"prognostic favorable (7.20e-5)"	"unprognostic (1.59e-2)"	"unprognostic (3.86e-2)"	"unprognostic (4.58e-2)"	"unprognostic (6.77e-3)"	58.8	41.2	34.7	19.5	50.8	0.9	39.8	44.6	26.1	18.7	6.7	13.0	20.0	13.1	3.7	8.2	14.1	14.9	28.1	27.5	51.6	33.0	50.9	51.2	10.4	76.2	66.0	4.7	11.4	15.3	9.6	127.8	47.9	25.3	13.2	17.9	27.0	6.9	11.3	12.5	21.9	12.9	97.2	16.8	10.6	2.3	64.9	4.0	31.8	18.8	4.7	23.6	15.5	78.7	5.7	0.0	68.0	0.0	50.5	2.0	1.0	0.0	0.1	0.0	0.0	25.9	0.0	0.0	2.6	0.0	0.1	0.2	0.0	0.0	0.0	0.3	0.3	0.3	0.0	0.0	3.5	0.0	0.2	13.2	0.0	0.0	0.0	0.1	0.6	0.0	0.2	0.2	1.7	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.1	0.7	0.1	0.1	0.5	0.1	0.0	66.0	8.9	0.0	0.3	0.3	0.6	0.1	0.0	0.4	40.7	24.9	0.1	1.2	0.0	131.8	0.0	0.4	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	34.7	50.8	44.6	26.1	27.5	51.6	76.2	66.0	47.9	97.2	64.9	78.7	120.5	12.8	51.0	126.3	0.2	14.8	1.0	0.0	1.2	5.8	1.2	2.8	10.8	0.0	2.5	0.0	6.2	14.7	0.3	0.1	0.0	0.0	2.9	2.9	20.7	73.3	0.0	0.0	1.3	0.0	13.9	51.1	1.1	35.9	6.3	2.1	112.5	1.1	13.4	0.0	1.6	0.0	0.0	18.7	10.6	2.2	79.9	5.2	110.3	6.5	0.1	116.2	0.0	48.2	0.9	0.1	0.0	2.6	0.1	2.6	0.0	0.1	1.5	4.4	216.9	81.3	102.1	0.4	2.1	0.2	7.2	5.7	1.6	2.5	0.0	1.5
EEA1	ZFYVE2	ENSG00000102189	"Early endosome antigen 1"	Q15075	12	92770637-92929331	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005861, CAB018782, HPA038158, HPA038159"	Supported		Supported	Vesicles		NA	NA		20000	"Cluster 14: Monocytes - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 50: Fibroblasts - ECM organization"	Vesicles		"CAB005861: AB_2262056, CAB018782: AB_2277714, HPA038158: AB_10966710, HPA038159: AB_10962356"	"unprognostic (5.38e-2)"	"unprognostic (4.60e-1)"	"unprognostic (2.00e-2)"	"unprognostic (5.62e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.81e-2)"	"unprognostic (6.75e-2)"	"unprognostic (6.87e-2)"	"unprognostic (1.31e-1)"	"unprognostic (5.00e-2)"	"unprognostic (2.81e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.68e-3)"	"unprognostic (5.86e-2)"	"unprognostic (2.85e-1)"	"unprognostic (3.89e-2)"	"unprognostic (1.65e-1)"	11.4	6.6	2.8	6.7	3.0	3.7	7.2	6.6	4.3	9.3	0.0	8.2	6.7	8.7	4.1	13.1	4.8	7.3	7.8	2.7	3.8	6.6	9.5	7.1	5.6	5.3	4.3	8.9	6.0	8.1	2.8	9.4	5.5	7.3	7.0	13.7	7.0	5.7	9.6	10.2	6.6	8.4	3.2	7.3	7.0	5.3	3.5	4.1	8.1	10.4	5.5	8.5	6.8	4.4	14.9	4.9	7.2	5.1	30.1	30.1	16.4	28.8	16.6	15.0	10.6	17.1	4.0	15.2	5.1	20.3	21.3	17.5	16.0	8.1	23.0	10.2	7.8	16.2	5.9	15.7	16.7	11.6	7.3	19.7	11.7	16.1	24.0	16.7	25.3	4.2	12.2	5.0	15.7	6.9	8.4	7.9	7.2	6.0	10.5	9.2	18.2	10.1	7.7	20.4	6.0	4.4	21.2	13.7	12.9	9.9	18.2	10.1	34.4	21.0	8.0	16.8	11.2	5.4	10.1	10.2	7.8	10.1	11.6	0.0	0.6	0.2	0.4	0.4	0.4	0.5	0.4	0.4	0.5	0.4	0.8	0.5	0.5	0.2	0.9	0.5	0.1	0.2	2.8	3.0	6.6	4.3	2.7	3.8	5.3	4.3	5.5	3.2	3.5	4.4	58.3	99.3	59.8	60.7	36.4	37.9	57.6	25.2	35.9	53.1	26.5	24.9	93.0	17.2	32.8	25.8	37.5	65.5	39.4	35.7	43.0	59.0	15.1	37.1	85.7	58.9	16.8	14.9	58.5	34.7	45.8	81.1	29.0	53.6	32.9	29.8	31.4	37.4	36.4	183.4	76.2	26.6	14.2	38.6	36.8	9.5	61.8	44.5	48.0	68.4	44.0	60.0	28.8	94.5	102.5	40.4	35.9	68.1	19.8	50.0	26.3	35.3	26.4	68.4	46.0	104.4	71.0	131.1	30.0	91.3	50.3	113.6	29.8	35.5	30.7	78.1
EED	"HEED, WAIT-1"	ENSG00000074266	"Embryonic ectoderm development"	O75530	11	86244753-86278813	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Host-virus interaction, Transcription, Transcription regulation"	"Chromatin regulator, Repressor"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012211, HPA060089, HPA061140"	Supported		Supported	Nucleoplasm		NA	Yes			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 16: Immune cells - Immune response"	"Cluster 21: OE19 - Mitochondria"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm		"CAB012211: AB_2262066, HPA060089: AB_2684201, HPA061140: AB_2684437"	"unprognostic (7.46e-2)"	"unprognostic (4.40e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.02e-2)"	"unprognostic (1.33e-1)"	"unprognostic (3.13e-2)"	"prognostic unfavorable (1.80e-5)"	"unprognostic (2.90e-1)"	"unprognostic (1.32e-2)"	"unprognostic (2.39e-1)"	"unprognostic (2.31e-1)"	"unprognostic (9.19e-3)"	"prognostic unfavorable (1.36e-7)"	"unprognostic (1.67e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.33e-2)"	"prognostic favorable (2.27e-5)"	9.3	9.0	13.2	16.3	13.1	9.2	11.4	15.0	15.8	13.8	13.1	12.1	12.1	11.5	15.2	12.7	10.6	9.3	8.9	12.8	13.5	11.5	11.9	8.5	28.8	12.9	12.8	12.1	10.5	9.1	9.4	14.5	13.1	11.7	11.9	16.4	10.3	10.6	10.5	12.1	11.6	10.2	12.9	14.4	10.9	10.3	13.6	17.8	10.7	11.1	32.1	13.0	12.1	13.9	34.2	37.8	40.9	16.8	22.6	20.2	47.0	49.2	22.6	46.3	46.8	121.0	64.4	79.8	50.6	15.8	44.2	41.4	48.7	26.8	43.2	79.7	22.7	51.4	38.7	36.3	19.8	54.2	33.4	12.4	18.0	46.8	20.1	17.5	20.9	34.7	58.8	16.2	39.0	55.2	51.5	55.4	30.4	107.8	18.4	56.2	49.1	38.8	29.1	55.4	27.5	22.4	63.5	29.6	14.5	29.1	49.2	22.6	19.0	48.1	44.1	70.0	43.2	9.2	32.1	63.9	13.7	46.6	36.8	31.0	9.1	15.0	25.4	15.3	22.1	45.0	33.2	32.0	13.9	47.3	26.4	29.6	3.9	19.3	16.8	9.2	58.6	19.1	13.2	13.1	15.0	15.8	12.8	13.5	12.9	12.8	13.1	12.9	13.6	13.9	15.4	6.4	9.3	28.1	32.7	25.6	11.6	27.5	25.0	26.4	13.3	11.8	9.5	11.5	15.4	7.3	18.8	45.2	31.0	16.1	19.6	14.5	7.7	17.6	17.1	16.6	7.2	15.8	35.0	10.2	36.8	14.8	16.3	15.5	15.9	15.0	13.2	11.4	16.9	32.0	45.6	12.8	12.2	14.5	32.5	3.6	22.7	15.2	19.6	37.5	30.4	11.5	25.7	31.2	38.9	11.9	11.1	17.3	17.6	11.9	11.7	8.6	21.3	18.3	6.6	14.3	24.5	18.7	20.0	16.9	16.8	24.9	31.6	17.5	15.0	20.9
EEF1A1	"EE1A1, EEF1A, EF1A, LENG7"	ENSG00000156508	"Eukaryotic translation elongation factor 1 alpha 1"	P68104	6	73489308-73525587	"Cancer-related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Protein biosynthesis, Transcription, Transcription regulation"	"Elongation factor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051759, HPA053862, HPA056990"	Supported		Supported	Cytosol		NA	NA		82000000	"Cluster 30: Non-specific - Translation"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 32: Non-specific - Translation"	Cytosol		"HPA051759: AB_2681595, HPA053862: AB_2797248, HPA056990: AB_2683302"	"unprognostic (6.47e-2)"	"unprognostic (7.86e-3)"	"unprognostic (2.53e-2)"	"unprognostic (9.64e-2)"	"unprognostic (1.39e-2)"	"unprognostic (1.08e-1)"	"prognostic unfavorable (5.57e-4)"	"unprognostic (3.13e-1)"	"unprognostic (1.61e-1)"	"unprognostic (2.77e-1)"	"unprognostic (1.41e-1)"	"unprognostic (3.47e-1)"	"unprognostic (8.61e-2)"	"unprognostic (1.65e-1)"	"unprognostic (8.00e-2)"	"unprognostic (2.04e-1)"	"unprognostic (7.73e-2)"	7265.1	5743.3	2531.3	4576.8	2717.1	10489.1	10504.6	2524.2	2783.1	7953.2	2902.2	6991.5	4783.5	7397.5	7203.8	6302.2	9034.9	4902.1	4074.6	2309.3	2687.4	7520.3	6459.1	4891.3	8813.5	2792.2	2572.6	12627.2	10370.0	6942.9	3776.4	5545.3	2828.4	5639.5	6936.4	2200.9	8381.0	6045.9	1682.1	7151.8	5076.6	7695.8	2980.6	5912.7	5776.4	1701.2	2687.7	8091.2	8348.4	1938.8	11294.9	6993.4	6470.3	2900.2	5218.1	8235.8	8697.0	13940.8	18183.0	32963.3	7874.7	7061.7	21384.2	10632.9	10044.2	12591.7	8020.5	20786.6	9976.7	13824.2	6089.1	5849.1	11729.0	15249.9	9969.0	3868.8	7099.6	7824.7	6142.2	13619.5	14708.8	15773.6	9201.9	26454.1	27514.4	7357.6	24803.6	17437.1	14783.4	8434.8	15242.2	7357.1	13131.5	8385.7	7184.5	17411.3	10348.2	6259.3	4400.0	14212.5	15389.7	26105.5	12201.5	14719.8	8337.9	8853.1	3931.6	10026.7	17535.8	9067.6	6928.7	24671.0	11535.0	4637.5	6195.9	3343.0	9206.4	7296.2	6913.1	5011.8	4780.9	12625.1	7404.1	2888.1	8472.3	895.8	7474.9	7600.7	14243.9	10580.7	12006.0	10174.3	8618.3	8426.8	13912.6	12049.7	681.7	9555.0	7680.9	6461.2	9278.5	26796.5	2531.3	2717.1	2524.2	2783.1	2309.3	2687.4	2792.2	2572.6	2828.4	2980.6	2687.7	2900.2	4915.6	3169.9	6059.2	107.4	11291.6	9829.9	12187.6	10417.5	11667.5	978.9	10528.4	9476.3	160.6	6258.2	5739.8	2637.3	546.3	9401.2	8653.6	2189.4	10344.0	5796.3	1373.9	4535.2	6754.2	5952.7	3862.8	6396.8	84.5	10404.1	12700.2	5756.1	4472.5	5831.2	3736.3	5732.4	6124.7	3323.0	6415.2	494.6	109.3	6969.3	3289.7	7779.7	8970.1	2325.8	8931.5	6705.0	5112.0	175.2	18016.6	3733.0	8468.7	76.9	162.0	7231.8	5821.6	7213.5	6811.7	11638.2	7494.7	14215.0	2974.6	1469.9	3536.8	7040.7	7075.1	1092.8	703.6	12784.4	10055.1	11086.8	9616.5	6982.9	8574.9	16180.0
EEF1AKMT2	"C10orf138, Efm4, METTL10"	ENSG00000203791	"EEF1A lysine methyltransferase 2"	Q5JPI9	10	124748149-124791887	"Metabolic proteins, Predicted intracellular proteins"		"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 29.1;Distal tubular cells: 66.5;Extravillous trophoblasts: 29.8;Proximal tubular cells: 30.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA050138	Approved		Supported	"Nucleoplasm,Nuclear bodies,Vesicles,Cytosol"		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm	"Nuclear bodies, Vesicles, Cytosol"	"HPA050138: AB_2681030"	"unprognostic (1.64e-3)"	"unprognostic (3.42e-2)"	"unprognostic (1.34e-1)"	"unprognostic (9.75e-2)"	"unprognostic (7.19e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.33e-2)"	"unprognostic (2.29e-3)"	"unprognostic (9.04e-3)"	"unprognostic (9.76e-2)"	"unprognostic (1.85e-1)"	"prognostic unfavorable (4.82e-4)"	"unprognostic (3.90e-2)"	"unprognostic (4.44e-2)"	"unprognostic (1.47e-1)"	"prognostic unfavorable (2.53e-4)"	"unprognostic (9.09e-2)"	4.8	3.8	3.0	2.1	3.3	3.6	5.3	4.8	4.2	4.6	3.0	3.7	1.8	4.0	4.6	4.0	3.8	2.1	4.1	3.1	3.0	4.9	5.2	3.3	2.5	2.8	3.1	5.5	4.4	4.5	4.3	2.7	2.8	4.3	3.8	2.5	5.1	2.8	4.0	5.0	3.5	2.6	2.7	3.5	3.7	5.6	2.8	3.3	5.1	3.3	3.1	3.4	4.2	3.6	12.6	3.3	4.8	8.0	3.1	8.0	3.1	5.8	7.6	7.4	6.5	4.3	7.1	8.4	3.0	4.7	2.5	3.8	6.8	4.2	11.5	7.0	2.5	6.8	4.2	3.9	6.0	10.9	4.1	3.9	3.9	4.1	9.9	6.2	4.7	7.0	7.6	9.3	9.3	3.7	5.2	8.5	5.9	4.6	4.8	2.3	5.7	2.6	4.6	2.7	1.5	3.8	3.7	6.2	8.7	3.3	5.4	8.5	5.8	2.7	2.9	4.5	8.8	4.3	3.7	6.8	4.9	5.7	3.9	0.8	1.0	1.6	1.6	1.1	2.5	1.9	1.6	2.0	1.2	1.3	2.2	1.6	0.1	4.4	0.8	1.5	1.9	1.1	3.0	3.3	4.8	4.2	3.1	3.0	2.8	3.1	2.8	2.7	2.8	3.6	23.2	3.2	11.3	0.0	8.9	0.0	0.0	0.0	0.0	0.0	20.5	22.4	0.0	0.0	2.5	11.0	0.0	29.1	13.4	0.0	66.5	20.0	0.0	11.4	11.8	7.5	0.0	0.0	0.0	20.4	29.8	10.4	0.0	10.5	2.5	17.8	0.0	0.0	18.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.7	0.0	0.0	11.4	0.0	0.0	0.0	0.0	19.8	0.0	0.0	2.8	0.0	0.0	30.5	3.6	0.0	0.0	0.0	8.3	0.0	0.0	0.0	0.0	17.1	7.1	14.7	0.0	0.0
EEF1AKMT3	"DKFZP586D0919, FAM119B, METTL21B"	ENSG00000123427	"EEF1A lysine methyltransferase 3"	Q96AZ1	12	57771492-57782541	"Metabolic proteins, Predicted intracellular proteins"		"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Breast glandular cells: 14.9;Breast myoepithelial cells: 7.6;Exocrine glandular cells: 12.7;monocytes: 8.8;Proximal tubular cells: 16.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in all"	7	"RH-30: 152.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA043020, HPA045492"	Uncertain		Approved	"Nucleoplasm,Mitotic chromosome,Centrosome"		Yes	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 7: Non-specific - Mitochondria"	Centrosome	"Nucleoplasm, Mitotic chromosome"	"HPA043020: AB_2678274, HPA045492: "	"unprognostic (2.00e-1)"	"unprognostic (6.52e-2)"	"unprognostic (7.96e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.53e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.55e-3)"	"unprognostic (1.06e-1)"	"unprognostic (7.34e-3)"	"unprognostic (7.52e-3)"	"unprognostic (1.66e-1)"	"unprognostic (2.32e-1)"	"unprognostic (1.54e-3)"	"unprognostic (5.77e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.34e-2)"	"unprognostic (1.23e-1)"	7.5	6.2	2.5	3.6	2.3	2.6	9.2	4.1	2.7	10.5	2.6	5.6	3.9	9.3	9.6	5.6	8.4	5.4	3.7	2.4	1.8	11.6	6.5	5.3	3.6	2.6	2.4	11.4	21.7	6.4	3.7	4.6	2.7	8.2	4.6	3.7	19.4	8.7	2.9	7.3	3.8	7.6	2.1	4.0	7.2	4.2	2.4	1.9	10.1	3.1	3.1	6.3	7.3	3.1	5.4	11.0	4.6	5.9	12.8	12.0	4.0	5.8	10.9	8.9	9.0	5.6	9.5	3.1	7.4	7.6	7.2	5.2	3.7	3.3	9.3	4.0	5.6	14.9	6.6	9.2	11.3	3.7	6.6	12.6	8.7	9.3	9.8	15.2	9.7	13.2	8.9	22.6	5.4	3.8	4.7	11.0	3.4	4.3	8.0	8.5	152.1	10.0	6.0	5.3	4.4	6.0	10.0	7.5	6.2	4.1	11.9	10.0	9.5	13.7	7.7	5.8	6.4	5.7	2.3	3.8	11.3	15.4	10.0	0.4	3.0	0.1	1.8	1.1	7.8	0.5	3.5	2.2	3.1	0.4	1.7	1.4	0.7	1.5	4.6	1.5	2.2	2.3	2.5	2.3	4.1	2.7	2.4	1.8	2.6	2.4	2.7	2.1	2.4	3.1	3.9	0.0	1.5	0.0	0.2	0.0	0.0	0.0	0.0	0.0	14.9	7.6	0.0	0.0	1.8	1.8	0.0	3.4	1.3	0.0	5.9	5.5	0.0	2.0	6.0	1.9	0.0	0.0	0.0	12.7	4.9	3.4	0.0	2.5	2.5	5.4	0.0	0.0	7.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	8.8	0.0	0.0	0.0	0.0	5.3	0.0	0.0	0.1	0.0	0.0	16.4	1.5	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	1.6	0.5	4.7	0.0	0.0
EEF1D	"EF-1D, FLJ20897"	ENSG00000104529	"Eukaryotic translation elongation factor 1 delta"	P29692	8	143579697-143599541	"Plasma proteins, Predicted intracellular proteins"	"Protein biosynthesis, Transcription, Transcription regulation"	"DNA-binding, Elongation factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045101, HPA051002"	Supported		Supported	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA		1300000	"Cluster 30: Non-specific - Translation"	"Cluster 50: Non-specific - Ribosome"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 32: Non-specific - Translation"	"Nucleoplasm, Nucleoli fibrillar center"		"HPA045101: AB_10963077, HPA051002: AB_2681305"	"unprognostic (9.34e-2)"	"unprognostic (2.37e-2)"	"unprognostic (9.92e-2)"	"unprognostic (1.63e-3)"	"unprognostic (5.25e-2)"	"unprognostic (2.06e-1)"	"prognostic unfavorable (3.82e-4)"	"unprognostic (8.56e-2)"	"unprognostic (3.74e-1)"	"unprognostic (2.98e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.76e-1)"	"prognostic unfavorable (2.58e-5)"	"unprognostic (3.99e-2)"	"unprognostic (2.06e-1)"	"unprognostic (2.67e-2)"	"unprognostic (2.14e-1)"	556.9	600.9	278.8	254.4	299.8	474.5	552.1	276.4	339.0	638.4	302.9	716.0	205.3	497.5	228.5	524.8	523.0	179.7	795.4	267.2	277.0	491.3	582.9	435.3	380.0	303.4	283.3	979.4	1349.3	160.2	328.0	147.2	292.4	609.2	148.3	67.1	577.0	201.9	916.1	615.8	505.9	179.9	281.5	609.6	634.3	288.1	281.7	338.7	504.0	433.0	307.3	538.2	554.0	322.1	454.8	644.8	284.2	246.0	251.0	307.0	314.2	344.2	438.4	536.7	424.0	886.7	420.0	345.5	352.2	386.6	160.4	441.8	295.3	556.0	231.7	274.8	487.6	340.6	1211.8	881.5	373.6	214.1	276.9	594.8	796.6	325.1	367.8	309.6	364.5	282.0	325.2	497.6	309.3	1456.4	838.7	539.7	300.3	580.3	852.3	367.2	204.4	681.0	466.3	757.9	280.0	301.6	300.1	726.3	762.5	174.1	544.3	535.7	285.2	309.9	914.8	465.5	757.5	335.2	142.9	380.2	348.4	431.6	275.3	268.2	535.1	259.6	880.1	503.5	1128.3	1400.1	1110.3	922.6	619.1	1461.9	1365.3	1110.3	408.6	864.7	458.9	874.2	1191.8	2020.0	278.8	299.8	276.4	339.0	267.2	277.0	303.4	283.3	292.4	281.5	281.7	322.1	652.3	163.5	415.9	47.7	1397.8	1846.0	1620.8	1277.4	1438.7	75.7	1568.2	2028.8	3.9	732.0	600.3	342.1	20.9	665.5	942.8	718.8	855.0	751.4	413.0	173.0	441.3	705.7	343.3	639.1	11.3	1793.7	822.0	699.2	520.9	263.8	446.1	931.0	871.7	792.9	799.6	79.1	13.0	971.5	526.9	1361.3	1492.3	1087.1	891.3	823.6	1085.1	17.8	1400.9	502.7	1071.1	15.6	30.2	938.4	799.5	633.1	1098.8	1566.2	998.9	1552.3	241.7	88.9	479.9	1005.6	844.4	34.0	142.2	969.5	1648.6	712.5	1297.8	573.3	870.0	1619.4
EEF1E1	"AIMP3, P18"	ENSG00000124802	"Eukaryotic translation elongation factor 1 epsilon 1"	O43324	6	8073360-8102559	"Predicted intracellular proteins, Predicted membrane proteins"	"Protein biosynthesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 244.3;Late spermatids: 231.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA027901, HPA057866"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA		18000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 34: Spermatids - Unknown function"	"Nucleoplasm, Cytosol"		"HPA027901: AB_10611960, HPA057866: AB_2683547"	"unprognostic (9.39e-3)"	"prognostic favorable (3.16e-4)"	"unprognostic (2.23e-1)"	"unprognostic (2.36e-2)"	"unprognostic (1.42e-2)"	"unprognostic (8.21e-2)"	"prognostic unfavorable (1.55e-7)"	"unprognostic (1.79e-1)"	"unprognostic (5.67e-2)"	"prognostic favorable (3.24e-4)"	"unprognostic (1.13e-1)"	"unprognostic (1.76e-2)"	"unprognostic (1.52e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.97e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.13e-1)"	15.5	29.6	26.6	21.5	26.4	57.8	26.5	33.5	33.4	14.9	24.2	18.4	12.0	19.3	26.3	22.6	15.0	13.6	19.1	27.0	31.5	50.6	20.3	13.8	31.7	30.7	34.6	14.7	28.3	31.3	23.9	17.3	31.6	17.8	20.9	25.4	20.0	18.2	22.8	12.3	12.7	19.2	26.7	16.4	23.0	57.5	30.5	25.9	20.6	24.7	31.2	26.4	13.9	30.0	129.5	67.1	104.8	71.9	35.0	56.5	63.6	105.7	67.0	94.4	97.0	111.8	52.5	140.9	229.3	69.8	169.8	51.9	122.3	123.9	156.8	79.6	160.6	113.9	92.0	196.4	63.9	228.2	79.2	47.4	113.5	117.4	116.2	66.4	136.2	113.8	283.3	35.9	91.2	54.0	98.0	183.2	95.8	123.9	107.8	117.9	61.0	221.0	156.3	98.5	156.7	48.0	45.6	100.5	131.9	141.5	79.7	75.7	70.2	77.0	76.7	70.7	156.3	58.4	290.7	199.3	43.1	95.8	126.0	16.2	22.2	14.2	25.7	31.8	36.8	42.9	34.4	34.8	61.2	46.9	38.1	39.5	2.3	30.7	25.5	26.8	45.8	29.3	26.6	26.4	33.5	33.4	27.0	31.5	30.7	34.6	31.6	26.7	30.5	30.0	31.9	16.0	30.0	0.0	39.7	65.9	61.4	99.1	60.3	34.4	43.1	54.1	23.5	21.5	63.4	60.7	10.4	78.7	23.5	11.8	140.8	67.9	244.3	59.0	31.0	34.1	40.1	43.5	0.0	89.0	76.6	30.8	32.1	71.0	15.8	45.4	24.3	30.0	49.7	30.3	0.0	36.6	75.3	31.1	33.4	231.1	26.4	31.3	42.7	0.0	32.6	44.7	29.9	0.0	0.0	69.0	12.9	23.7	48.0	81.3	7.5	186.7	45.9	21.8	13.1	32.8	38.9	131.2	92.2	59.3	76.1	32.3	34.1	69.9	42.0	44.8
EFHD1	FLJ13612	ENSG00000115468	"EF-hand domain family member D1"	Q9BUP0	2	232606057-232682780	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 414.6"	"Cell type enhanced"	"Detected in many"		"Breast glandular cells: 241.8;Breast myoepithelial cells: 129.0;Distal tubular cells: 393.2;Oligodendrocytes: 173.4;Sertoli cells: 197.2;Smooth muscle cells: 130.9;Syncytiotrophoblasts: 263.9"	"Cancer enriched"	"Detected in all"	5	"breast cancer: 100.8"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"neutrophil: 2.2"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"BEWO: 125.8;RPTEC TERT1: 68.6;SK-BR-3: 301.8;T-47d: 236.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049331, HPA056959"	Enhanced		Supported	"Nucleoli fibrillar center,Golgi apparatus"		No	NA		14000	"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 35: Glandular cells - Unknown function"	"Golgi apparatus"	"Nucleoli fibrillar center"	"HPA049331: AB_2680716, HPA056959: AB_2683288"	"unprognostic (9.51e-3)"	"unprognostic (2.21e-2)"	"unprognostic (4.78e-3)"	"unprognostic (3.25e-1)"	"unprognostic (3.40e-1)"	"unprognostic (9.70e-2)"	"unprognostic (9.02e-2)"	"unprognostic (1.13e-1)"	"unprognostic (3.29e-3)"	"unprognostic (1.21e-1)"	"unprognostic (5.57e-2)"	"unprognostic (9.99e-2)"	"prognostic favorable (2.93e-7)"	"unprognostic (2.00e-2)"	"unprognostic (1.84e-1)"	"unprognostic (2.51e-2)"	"unprognostic (2.29e-3)"	86.3	7.0	199.7	3.7	303.2	0.8	180.7	244.9	261.3	86.9	129.9	16.9	4.4	72.4	33.7	9.6	73.7	12.0	46.0	196.6	217.4	186.2	54.6	15.3	3.9	253.6	258.7	76.5	86.5	10.5	16.5	77.9	261.8	25.6	5.7	9.5	22.2	27.7	35.5	30.9	16.2	20.6	201.4	52.5	17.6	20.1	237.8	3.0	32.7	42.7	2.4	22.0	44.5	414.6	0.0	3.4	5.7	1.4	2.2	0.1	125.8	26.8	2.1	2.3	1.9	0.9	0.6	0.1	2.0	11.6	2.9	0.2	19.0	0.0	0.3	0.5	9.2	0.0	2.4	1.9	0.0	0.1	0.3	1.0	0.4	0.2	0.0	0.4	0.0	5.5	3.9	0.5	0.5	2.3	0.6	0.2	8.4	0.0	0.2	0.6	7.2	0.4	68.6	0.7	0.3	3.2	9.1	301.8	18.3	42.3	236.9	2.6	0.0	0.0	1.8	0.4	0.8	0.2	0.1	0.1	0.3	0.1	13.4	1.0	0.2	0.1	0.2	0.1	0.4	0.3	0.3	0.4	0.1	0.1	0.6	0.6	2.2	0.1	0.1	0.2	0.1	0.1	199.7	303.2	244.9	261.3	196.6	217.4	253.6	258.7	261.8	201.4	237.8	414.6	15.6	0.0	0.0	37.5	1.5	3.6	2.8	1.3	1.2	0.5	241.8	129.0	7.4	1.5	4.6	35.0	0.0	112.0	3.0	0.3	393.2	0.0	9.0	1.1	37.8	16.8	0.0	2.7	2.6	0.0	19.7	41.1	0.0	1.7	0.0	3.2	6.4	89.4	8.7	0.0	5.3	0.1	59.0	1.3	3.0	7.0	44.4	2.1	8.8	18.7	0.0	48.0	0.0	1.5	173.4	0.0	0.0	57.2	0.1	4.6	0.0	116.5	1.9	1.4	197.2	8.7	130.9	17.3	13.6	0.4	3.1	263.9	2.5	1.5	0.3	2.0
EFNB1	"CFNS, Elk-L, EPLG2, LERK2"	ENSG00000090776	"Ephrin B1"	P98172	X	68829021-68842160	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted membrane proteins"	"Differentiation, Neurogenesis"	"Developmental protein"	"Cancer-related genes, Craniosynostosis, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 117.3;Granulosa cells: 134.5;Hepatic stellate cells: 143.5;Suprabasal keratinocytes: 120.5;Theca cells: 116.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"myeloid DC: 3.5"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 97.0;hTCEpi: 74.1;PC-3: 70.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB031489, HPA067188"	Uncertain		Supported	"Plasma membrane"		NA	NA		1300000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 40: Granulosa cells - Unknown function"	"Plasma membrane"		"CAB031489: AB_631414, HPA067188: AB_2685799"	"unprognostic (2.00e-1)"	"unprognostic (1.33e-2)"	"unprognostic (1.77e-2)"	"prognostic unfavorable (3.32e-5)"	"unprognostic (1.04e-1)"	"unprognostic (2.48e-2)"	"unprognostic (8.05e-3)"	"unprognostic (2.15e-1)"	"prognostic unfavorable (8.68e-4)"	"unprognostic (3.94e-2)"	"prognostic unfavorable (4.29e-4)"	"unprognostic (1.29e-1)"	"unprognostic (2.17e-3)"	"unprognostic (2.76e-2)"	"unprognostic (8.03e-2)"	"unprognostic (1.72e-3)"	"unprognostic (1.86e-2)"	47.0	23.7	9.3	8.2	9.5	2.3	41.2	8.7	11.8	27.1	8.7	27.6	19.1	19.4	10.7	32.0	19.6	18.3	32.5	9.1	8.9	44.0	11.6	41.6	4.3	9.4	9.1	14.3	7.6	16.5	10.3	25.4	8.9	19.8	13.2	1.2	11.2	16.2	9.1	52.5	20.6	8.8	9.6	26.1	18.1	6.3	9.7	5.6	19.6	9.5	4.8	25.9	27.9	9.3	10.4	5.3	41.9	15.6	21.7	13.4	21.9	8.7	9.5	3.8	2.8	4.8	19.0	2.5	56.7	3.3	5.0	54.3	40.0	97.0	2.1	4.3	10.2	2.6	2.3	8.5	20.0	1.9	21.3	25.0	74.1	9.4	42.4	3.4	29.3	5.3	2.8	0.2	3.3	8.5	4.2	2.0	29.0	63.5	70.9	18.6	4.4	16.6	15.9	36.1	15.6	7.5	6.7	2.0	2.6	31.7	1.6	3.6	49.7	7.2	8.9	19.6	3.3	0.1	2.3	2.5	3.6	11.3	4.7	0.0	0.6	0.3	0.4	1.7	0.3	0.3	0.4	0.4	3.5	0.2	0.3	0.2	0.1	0.7	1.1	0.5	0.2	0.5	9.3	9.5	8.7	11.8	9.1	8.9	9.4	9.1	8.9	9.6	9.7	9.3	81.1	3.2	1.1	2.6	3.2	117.3	66.2	60.7	93.4	3.3	3.6	11.2	8.2	20.0	12.8	22.0	0.0	11.4	5.9	59.4	0.0	16.4	0.4	2.6	7.6	42.4	8.4	2.7	1.0	15.6	75.9	20.5	21.4	4.5	4.5	134.5	143.5	4.8	12.4	1.7	1.0	27.6	8.2	9.1	23.8	1.3	27.4	8.6	21.4	2.8	5.9	12.5	2.1	0.5	0.6	46.3	52.6	8.2	2.3	40.2	28.6	5.7	2.8	1.3	13.1	8.7	12.5	2.0	3.8	76.2	120.5	11.2	4.7	116.2	29.8	93.6
EFNB2	"EPLG5, Htk-L, HTKL, LERK5, MGC126226, MGC126227, MGC126228"	ENSG00000125266	"Ephrin B2"	P52799	13	106489745-106535662	"Cancer-related genes, Plasma proteins, Predicted membrane proteins"	"Angiogenesis, Differentiation, Host-virus interaction, Neurogenesis"	"Developmental protein, Host cell receptor for virus entry, Receptor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 239.7;Hepatic stellate cells: 187.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 76.5;OE19: 45.5;SH-SY5Y: 42.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008999, CAB009368"	Supported		Supported	Nucleoplasm,Cytosol		NA	NA		940000		"Cluster 46: Fibroblasts - ECM organization"	"Cluster 12: NES - Nervous system development"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm	Cytosol	"CAB009368: AB_2095700, HPA008999: AB_1078721"	"unprognostic (1.70e-1)"	"unprognostic (1.95e-3)"	"unprognostic (1.72e-1)"	"unprognostic (5.22e-3)"	"unprognostic (4.52e-3)"	"prognostic unfavorable (3.11e-6)"	"unprognostic (2.32e-2)"	"prognostic unfavorable (8.43e-4)"	"unprognostic (2.09e-1)"	"unprognostic (1.11e-1)"	"prognostic unfavorable (8.70e-5)"	"unprognostic (1.60e-1)"	"unprognostic (1.09e-2)"	"unprognostic (1.30e-1)"	"unprognostic (3.07e-1)"	"unprognostic (4.62e-2)"	"unprognostic (2.27e-3)"	20.7	6.1	3.8	4.3	5.9	0.2	17.1	1.3	6.2	11.0	0.0	22.1	7.9	10.2	0.7	12.1	8.8	4.2	15.5	5.5	4.9	11.2	4.8	23.4	3.2	0.1	0.1	7.2	3.9	3.2	6.3	15.4	0.3	12.5	9.9	3.2	14.0	10.6	6.5	17.2	14.4	5.5	0.1	7.4	15.0	5.4	1.6	3.6	11.9	8.0	3.2	6.5	14.1	4.3	23.3	1.8	76.5	0.1	0.2	0.7	0.3	10.8	5.4	8.2	4.7	19.1	28.7	0.0	11.0	2.5	0.6	28.4	2.9	10.9	8.9	0.0	24.3	0.1	6.0	0.0	1.5	6.9	0.6	3.5	19.0	0.4	16.1	4.1	10.4	0.2	0.1	0.0	9.1	3.3	0.2	0.1	4.7	45.5	5.0	21.9	3.3	0.1	11.9	2.5	5.8	42.7	3.6	1.7	0.1	21.4	1.0	0.2	9.6	16.3	0.0	0.5	23.8	0.4	0.0	0.0	34.5	0.4	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	5.9	1.3	6.2	5.5	4.9	0.1	0.1	0.3	0.1	1.6	4.3	239.7	6.4	35.7	38.8	4.4	83.2	52.9	15.4	13.1	10.4	39.8	45.3	8.8	5.7	13.2	25.8	0.0	1.4	8.6	114.6	0.0	6.8	0.4	24.7	69.8	106.5	50.6	0.0	49.3	1.4	3.1	15.4	69.3	42.1	17.8	11.8	187.4	1.3	1.1	6.7	29.7	59.8	26.4	5.8	11.9	1.0	0.3	4.0	32.0	48.7	0.0	89.1	0.0	3.5	13.9	46.3	64.3	0.4	1.0	25.1	15.9	0.2	8.7	3.4	0.0	33.1	22.8	0.7	3.3	41.1	86.0	1.9	7.9	6.4	71.5	72.0
EFR3A	KIAA0143	ENSG00000132294	"EFR3 homolog A"	Q14156	8	131904093-132013642	"Predicted intracellular proteins"			"Autism, Autism spectrum disorder"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"retina: 121.6"	"Cell type enhanced"	"Detected in all"		"Bipolar cells: 358.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022859, HPA023092, HPA023402"	Enhanced		Supported	"Plasma membrane,Cytosol"		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 54: Non-specific - Microtubule organization"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 56: Bipolar cells - Visual perception"	"Plasma membrane, Cytosol"		"HPA022859: AB_1848029, HPA023092: AB_2293240, HPA023402: AB_1848031"	"unprognostic (4.79e-2)"	"unprognostic (6.54e-2)"	"unprognostic (6.42e-2)"	"unprognostic (4.37e-3)"	"unprognostic (2.77e-1)"	"unprognostic (3.44e-2)"	"unprognostic (3.04e-1)"	"unprognostic (3.02e-1)"	"unprognostic (1.51e-1)"	"unprognostic (8.11e-2)"	"unprognostic (5.89e-3)"	"unprognostic (5.22e-2)"	"unprognostic (3.46e-1)"	"unprognostic (3.00e-1)"	"unprognostic (3.29e-2)"	"unprognostic (1.29e-1)"	"unprognostic (2.21e-3)"	21.7	20.8	22.7	20.8	28.6	14.5	20.0	36.4	35.7	28.3	13.2	21.2	23.2	23.4	38.0	27.5	24.2	21.8	33.9	29.5	9.3	29.8	44.5	27.8	25.3	52.7	13.6	19.3	18.6	33.6	12.0	20.4	59.0	26.9	18.4	121.6	17.3	29.3	41.6	21.2	23.5	36.1	7.0	23.5	22.8	22.1	16.1	24.3	37.8	49.1	27.9	26.9	14.0	23.9	55.3	49.0	15.0	12.4	59.9	68.8	29.9	38.6	54.0	31.5	41.3	10.8	40.4	33.8	35.5	87.6	41.8	17.9	23.9	52.9	38.3	78.3	13.1	33.7	22.7	22.0	57.5	13.0	34.1	58.6	29.6	31.2	49.0	52.2	40.2	16.4	18.7	44.3	56.5	36.1	36.5	11.9	8.5	47.3	30.4	14.5	29.4	16.1	38.0	34.1	10.0	34.6	76.9	10.8	30.6	39.3	34.4	22.0	56.3	55.6	50.9	27.4	40.9	31.3	28.8	20.9	41.2	31.0	29.0	12.0	16.8	17.4	16.2	23.3	14.5	12.6	13.0	13.3	17.3	11.2	11.6	12.0	10.1	15.5	40.9	4.0	11.3	15.8	22.7	28.6	36.4	35.7	29.5	9.3	52.7	13.6	59.0	7.0	16.1	23.9	32.6	41.7	42.8	90.8	40.7	21.2	25.3	29.5	25.0	358.8	29.9	16.6	57.4	28.6	37.5	51.5	91.8	22.8	34.1	33.5	21.5	28.7	4.5	25.9	35.1	29.1	11.4	13.3	126.8	30.9	22.2	34.4	29.0	20.7	25.9	19.8	25.0	79.9	44.5	26.9	122.6	18.7	26.4	59.4	25.0	8.0	19.9	52.9	8.8	60.0	53.3	42.3	42.2	77.9	55.6	25.5	36.0	44.4	32.6	55.8	39.9	58.4	27.7	107.5	19.7	32.3	41.4	52.9	30.9	39.1	31.4	37.1	37.3	36.8	17.0	36.7
EFR3B	"FLJ37871, KIAA0953"	ENSG00000084710	"EFR3 homolog B"	Q9Y2G0	2	25042076-25159135	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 53.1;skeletal muscle: 20.0"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 127.0;Excitatory neurons: 58.5;Inhibitory neurons: 110.7;Late spermatids: 46.0;Microglial cells: 54.4;Oligodendrocytes: 51.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"basophil: 1.3"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 1.3"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 10.3;BEWO: 12.0;SH-SY5Y: 10.7;SK-BR-3: 18.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038089, HPA071831"	Uncertain		Supported	"Plasma membrane,Actin filaments,Cytosol"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Plasma membrane"	"Actin filaments, Cytosol"	"HPA038089: AB_10672618, HPA071831: "	"unprognostic (9.31e-2)"	"unprognostic (3.92e-1)"	"unprognostic (2.10e-1)"	"unprognostic (2.23e-1)"	"unprognostic (1.90e-1)"	"unprognostic (2.44e-2)"	"unprognostic (1.24e-3)"	"unprognostic (3.82e-1)"	"unprognostic (3.42e-1)"	"unprognostic (1.32e-2)"	"unprognostic (4.49e-6)"	"unprognostic (4.83e-2)"	"unprognostic (4.43e-2)"	"unprognostic (1.89e-1)"	"unprognostic (2.46e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.55e-1)"	0.8	1.6	23.0	0.6	53.1	0.3	0.5	22.4	29.5	0.5	0.0	1.1	0.4	0.7	5.1	0.3	0.6	0.5	4.5	51.7	19.0	1.3	0.2	2.5	0.3	45.3	24.0	0.8	0.4	3.9	9.3	1.7	47.5	0.5	0.6	11.0	0.3	0.8	20.0	0.6	0.5	1.2	9.8	3.4	0.9	2.5	27.7	0.3	3.4	3.8	0.2	0.5	0.4	12.1	0.2	8.3	9.5	10.3	0.5	0.1	12.0	1.0	0.2	0.5	0.1	6.7	0.4	0.1	0.6	1.4	3.3	0.6	7.5	0.0	0.1	1.6	1.8	1.6	0.3	0.6	0.0	0.1	0.8	0.1	0.0	2.3	0.1	0.7	0.3	0.2	0.1	0.4	0.2	0.9	0.2	0.5	1.9	0.1	6.6	0.8	9.1	0.3	0.1	0.3	4.0	10.7	1.2	18.0	5.9	5.3	0.9	0.1	0.5	0.5	2.7	4.1	2.0	0.7	0.9	0.1	7.3	0.1	1.9	1.3	0.1	0.3	0.2	0.0	0.1	0.1	0.1	0.1	0.1	0.2	0.1	0.1	0.4	0.2	0.1	0.1	0.0	0.0	23.0	53.1	22.4	29.5	51.7	19.0	45.3	24.0	47.5	9.8	27.7	12.1	3.1	28.9	1.1	127.0	0.0	0.0	0.8	0.0	0.0	9.9	0.3	1.0	9.7	0.0	0.0	9.2	22.9	0.1	0.1	0.7	0.0	0.3	20.6	1.3	0.3	6.7	3.6	0.0	58.5	0.8	0.2	1.0	0.0	0.3	0.0	1.1	2.9	0.0	0.9	5.0	110.7	0.1	0.0	0.0	0.3	46.0	1.2	0.1	0.0	54.4	0.0	22.0	0.0	19.6	51.2	0.7	0.0	2.6	0.1	0.6	0.5	0.1	0.0	10.7	0.0	1.6	1.4	2.4	2.2	0.0	0.1	0.1	0.1	0.2	0.3	0.4
EGLN2	"HIFPH1, PHD1"	ENSG00000269858	"Egl-9 family hypoxia inducible factor 2"	Q96KS0	19	40798996-40808434	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Dioxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 269.1;Late spermatids: 740.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA056649			Supported	Nucleoplasm		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 25: Spermatids - Spermatogenesis"	Nucleoplasm		"HPA056649: AB_2683203"	"unprognostic (1.11e-2)"	"prognostic favorable (2.88e-4)"	"unprognostic (9.40e-3)"	"unprognostic (6.01e-2)"	"unprognostic (6.03e-2)"	"unprognostic (6.47e-3)"	"unprognostic (1.51e-2)"	"unprognostic (4.74e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.95e-1)"	"prognostic favorable (4.81e-4)"	"unprognostic (7.10e-2)"	"unprognostic (7.48e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.35e-1)"	"unprognostic (9.99e-2)"	"unprognostic (1.38e-3)"	57.6	58.5	99.3	50.0	99.8	52.1	47.6	95.1	140.9	70.0	79.6	65.4	34.3	53.9	31.5	40.2	45.5	39.1	67.8	103.4	96.2	54.2	57.7	74.3	62.4	97.3	99.3	59.0	36.6	27.7	44.5	48.3	97.7	59.9	28.5	16.6	39.2	45.1	40.0	27.4	46.7	40.9	90.5	116.8	47.6	232.1	99.9	41.9	55.8	40.8	44.1	57.9	57.9	98.1	46.5	123.4	55.9	54.4	71.1	51.5	36.5	49.4	41.1	68.9	75.4	102.8	45.7	41.1	41.1	59.3	62.5	29.3	70.8	56.3	36.4	51.7	40.5	54.8	76.4	39.4	76.1	42.7	71.6	63.9	58.5	65.8	37.4	43.3	86.0	44.3	79.3	37.3	73.4	32.9	78.9	70.2	48.7	72.4	42.6	72.7	27.7	27.8	74.0	70.2	51.4	46.9	80.9	62.9	67.2	47.2	83.4	114.0	80.5	85.9	61.7	35.7	59.5	18.7	29.6	75.6	63.0	61.4	65.5	93.2	72.5	190.5	85.8	83.4	91.1	85.2	101.7	90.3	62.6	90.0	105.2	89.6	261.6	61.4	82.3	45.5	100.2	110.5	99.3	99.8	95.1	140.9	103.4	96.2	97.3	99.3	97.7	90.5	99.9	98.1	2.8	22.4	16.8	0.0	43.9	48.8	55.2	33.8	17.6	40.5	3.3	0.8	22.2	31.5	30.7	3.7	14.6	58.1	19.0	83.0	0.0	15.8	269.1	0.9	1.5	49.9	44.9	30.7	0.0	10.1	26.5	27.6	23.9	1.2	17.2	0.8	72.8	33.7	66.7	21.9	0.0	33.9	48.8	39.8	62.4	740.8	63.0	26.3	40.9	0.0	38.5	24.4	60.8	0.0	0.0	14.0	71.0	52.3	8.7	67.6	54.9	1.4	23.0	17.8	39.5	14.6	17.2	159.4	52.5	14.2	38.4	132.6	33.2	2.1	43.7	69.8
EGLN3	"HIFPH3, PHD3"	ENSG00000129521	"Egl-9 family hypoxia inducible factor 3"	Q9H6Z9	14	33924227-34462774	"Enzymes, Predicted intracellular proteins"	"Apoptosis, DNA damage"	"Dioxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 110.3;skin 1: 118.2"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 213.7;Cardiomyocytes: 105.8;Distal enterocytes: 135.5;Extravillous trophoblasts: 115.9;Suprabasal keratinocytes: 231.6"	"Cancer enhanced"	"Detected in all"		"renal cancer: 50.9"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	10	"plasmacytoid DC: 25.5"	"Lineage enriched"	"Detected in many"	14	"dendritic cells: 25.5"	"Cell line enhanced"	"Detected in many"		"RH-30: 44.6;RPTEC TERT1: 38.2;RT4: 122.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA064895			Supported	Cytosol		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 15: RT4 - Unknown function"	"Cluster 65: Plasmacytoid DCs - Unknown function"	Cytosol		"HPA064895: AB_2685384"	"unprognostic (3.58e-2)"	"unprognostic (4.76e-3)"	"unprognostic (1.75e-1)"	"unprognostic (8.87e-2)"	"unprognostic (6.88e-2)"	"unprognostic (1.38e-2)"	"prognostic unfavorable (2.14e-5)"	"unprognostic (1.39e-3)"	"unprognostic (3.44e-2)"	"unprognostic (1.79e-1)"	"unprognostic (2.93e-2)"	"unprognostic (2.90e-1)"	"prognostic unfavorable (2.50e-4)"	"unprognostic (1.37e-1)"	"unprognostic (5.21e-2)"	"unprognostic (4.71e-2)"	"unprognostic (6.30e-2)"	14.6	0.8	32.9	9.4	40.9	0.3	10.0	38.2	37.5	12.3	15.4	25.9	35.7	10.0	4.4	27.0	9.4	13.8	110.3	29.7	38.9	16.3	4.9	8.3	5.7	34.3	37.5	2.1	4.3	0.3	3.4	25.4	32.2	9.1	20.0	15.2	11.2	12.0	20.8	118.2	40.9	11.7	31.9	4.9	37.7	1.1	42.9	4.9	2.8	6.4	9.8	51.3	20.8	36.1	31.1	8.0	0.9	32.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.3	8.2	0.0	10.0	0.1	0.9	0.9	15.0	29.4	0.0	3.1	8.0	8.3	20.5	1.0	0.0	0.0	0.4	4.0	14.5	0.0	0.1	0.0	0.0	2.3	16.9	0.0	0.4	2.7	0.7	0.1	24.3	26.7	2.8	0.0	44.6	11.1	38.2	122.9	6.2	7.0	2.0	11.8	3.2	18.2	12.0	0.1	0.0	0.2	3.2	0.0	1.8	0.4	6.7	0.1	7.2	0.0	0.5	0.0	0.0	1.8	0.1	0.0	0.0	0.0	1.2	0.9	2.6	0.0	0.1	0.1	0.1	1.1	0.0	25.5	0.0	0.9	32.9	40.9	38.2	37.5	29.7	38.9	34.3	37.5	32.2	31.9	42.9	36.1	6.0	0.0	0.6	36.2	1.6	213.7	49.0	56.6	3.4	11.6	16.0	17.0	105.8	4.3	24.8	9.2	2.1	11.4	16.0	135.5	9.8	15.6	1.8	42.3	8.5	25.1	16.2	0.4	1.0	6.9	115.9	16.8	74.9	17.2	1.3	0.1	12.5	0.3	3.1	1.7	4.3	31.6	12.2	1.9	62.8	4.9	2.5	10.8	40.9	0.0	0.9	11.6	0.0	6.6	54.2	46.6	41.9	0.7	0.4	17.4	59.7	20.5	37.2	2.4	0.0	17.7	9.4	1.7	0.3	4.1	231.6	103.0	4.5	1.2	14.1	25.7
EGR2	KROX20	ENSG00000122877	"Early growth response 2"	P11161	10	62811996-62919900	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation, Ubl conjugation pathway"	"Activator, DNA-binding, Transferase"	"Charcot-Marie-Tooth disease, Dejerine-Sottas syndrome, Disease variant, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 59.9;thyroid gland: 136.4"	"Cell type enhanced"	"Detected in many"		"Breast glandular cells: 55.5;Breast myoepithelial cells: 68.1;Enteroendocrine cells: 73.1"	"Cancer enhanced"	"Detected in all"		"thyroid cancer: 19.7"	"Group enriched"	"Detected in many"	5	"cerebral cortex: 10.2;hippocampal formation: 5.2"	"Immune cell enhanced"	"Detected in some"		"intermediate monocyte: 2.5;non-classical monocyte: 2.3"	"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in some"	5	"U-87 MG: 22.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA031165			Supported	Nucleoplasm		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 68: Epididymis - Unknown function"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm		"HPA031165: AB_2673768"	"prognostic favorable (7.30e-5)"	"unprognostic (1.86e-3)"	"unprognostic (1.45e-2)"	"unprognostic (8.72e-2)"	"unprognostic (2.92e-2)"	"unprognostic (1.29e-1)"	"unprognostic (2.70e-1)"	"unprognostic (1.75e-1)"	"unprognostic (9.79e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.47e-3)"	"unprognostic (6.54e-2)"	"unprognostic (1.74e-2)"	"unprognostic (3.46e-1)"	"unprognostic (1.11e-3)"	13.7	10.6	0.4	9.8	1.2	8.2	8.6	1.3	10.2	18.5	2.0	3.3	1.9	6.0	59.9	8.8	4.5	31.9	14.9	5.2	0.2	7.9	5.4	15.2	14.4	0.3	0.3	9.4	4.2	7.0	8.7	3.0	0.7	17.5	3.7	1.4	2.9	1.9	0.9	14.2	4.6	16.8	0.1	4.5	2.3	4.1	0.6	26.4	136.4	9.1	7.1	15.7	1.7	1.5	0.0	0.2	2.5	1.0	1.8	2.4	0.4	0.5	0.2	0.6	0.8	0.0	0.3	0.6	0.0	0.6	0.7	0.3	0.2	0.0	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.6	3.8	0.3	0.6	1.3	0.2	0.8	0.1	0.3	0.2	0.8	0.1	1.2	0.0	1.8	0.2	0.1	1.1	0.1	0.3	0.4	0.0	0.2	0.1	0.3	0.2	0.5	4.2	0.5	0.0	0.5	0.1	0.5	0.4	0.2	0.3	1.3	0.7	0.3	22.5	0.5	0.4	0.0	0.5	0.2	0.1	2.5	0.0	0.4	0.0	0.1	0.5	0.4	0.0	0.1	0.7	0.2	2.3	0.0	0.0	0.4	0.4	1.2	1.3	10.2	5.2	0.2	0.3	0.3	0.7	0.1	0.6	1.5	15.9	0.0	12.6	0.0	14.0	21.3	30.1	36.0	33.0	1.4	55.5	68.1	7.8	0.0	9.4	0.0	0.0	1.1	9.9	9.5	0.0	1.4	8.9	13.9	14.0	16.7	73.1	0.0	1.7	0.6	1.6	30.4	13.3	26.1	20.8	2.3	5.3	2.4	25.2	0.0	0.5	29.4	14.2	28.1	39.5	4.3	1.8	40.5	8.8	0.0	0.8	4.1	0.0	0.0	0.1	1.0	4.4	7.2	6.4	5.5	7.7	0.0	7.1	0.7	6.6	20.7	12.0	0.1	2.0	14.8	12.5	1.1	13.6	5.1	25.8	3.1
EHD1	"FLJ42622, FLJ44618, H-PAST, HPAST1, PAST1"	ENSG00000110047	"EH domain containing 1"	Q9H4M9	11	64851642-64888296	"Plasma proteins, Predicted intracellular proteins"	"Cilium biogenesis/degradation, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 151.6;testis: 159.9"	"Group enriched"	"Detected in all"	10	"Early spermatids: 1033.0;Late spermatids: 1950.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049890, HPA049986, HPA066751, HPA067747"	Approved		Supported	"Plasma membrane"		NA	NA		10000000	"Cluster 49: Eosinophils - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 34: Spermatids - Unknown function"	"Plasma membrane"		"HPA049890: AB_2680936, HPA049986: AB_2680983, HPA066751: AB_2685713, HPA067747: AB_2685896"	"unprognostic (1.51e-1)"	"unprognostic (3.21e-1)"	"unprognostic (6.35e-3)"	"unprognostic (2.43e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.44e-1)"	"prognostic unfavorable (2.81e-5)"	"unprognostic (1.46e-3)"	"unprognostic (9.10e-3)"	"unprognostic (9.44e-2)"	"unprognostic (2.11e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.27e-1)"	"unprognostic (6.37e-2)"	"unprognostic (9.88e-2)"	"unprognostic (2.74e-1)"	"unprognostic (2.59e-2)"	39.7	25.4	21.5	59.7	26.6	151.6	21.8	38.6	32.6	26.2	18.2	32.3	33.8	28.1	8.4	26.0	27.0	25.0	39.3	24.9	26.8	31.2	22.0	44.7	65.6	32.7	28.2	13.6	11.1	8.9	7.0	35.4	29.9	18.8	14.5	3.0	16.6	20.9	32.1	34.4	38.5	28.3	31.0	74.4	29.3	159.9	30.5	28.9	19.3	31.5	50.3	55.3	23.0	33.4	109.4	74.1	26.2	28.9	31.2	50.2	15.4	108.2	97.4	89.5	51.8	96.5	66.2	142.0	37.8	129.9	76.5	86.6	27.3	108.9	34.5	89.5	15.2	94.8	37.1	49.1	36.8	30.9	24.6	22.8	22.9	138.7	43.2	40.6	89.8	27.6	39.6	243.8	68.7	57.8	62.5	51.4	17.5	27.5	95.9	24.8	83.5	49.9	84.5	35.7	18.6	16.6	60.8	109.3	48.6	29.5	149.2	21.8	127.9	39.6	35.4	106.0	52.6	100.2	48.5	112.1	103.3	40.1	22.0	18.0	13.9	99.6	39.0	16.1	39.2	24.0	27.3	33.8	7.2	18.2	16.2	23.1	57.1	25.4	33.7	8.7	31.8	30.7	21.5	26.6	38.6	32.6	24.9	26.8	32.7	28.2	29.9	31.0	30.5	33.4	31.2	76.9	30.3	4.2	46.0	67.3	52.8	39.4	17.6	3.8	28.8	24.8	29.2	18.6	22.9	14.7	2.1	88.6	76.5	75.9	7.9	29.4	1033.0	41.9	24.4	29.3	6.6	19.8	1.7	40.8	24.5	32.4	25.5	54.9	93.8	37.2	10.4	10.9	32.2	5.0	3.5	27.7	12.2	37.4	61.0	1950.6	30.1	79.6	26.6	1.9	34.3	5.9	78.2	2.5	12.2	101.5	47.7	27.1	50.8	28.2	38.9	41.9	16.5	2.8	78.9	47.9	53.5	55.0	27.4	19.9	49.2	137.0	71.7	19.8	22.1	42.7
EHD2	PAST2	ENSG00000024422	"EH domain containing 2"	Q9NZN4	19	47713422-47743134	"Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 161.9;Leydig cells: 99.1;Peritubular cells: 107.2;Sertoli cells: 236.7;Smooth muscle cells: 139.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 312.2;BJ: 238.5;fHDF/TERT166: 258.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047394, HPA049890, HPA049986, HPA066751"	Approved		Supported	"Plasma membrane"		NA	NA		1500000		"Cluster 89: Fibroblasts - ECM organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 48: Smooth muscle cells - ECM organization"	"Plasma membrane"		"HPA047394: AB_2680026, HPA049890: AB_2680936, HPA049986: AB_2680983, HPA066751: AB_2685713"	"unprognostic (1.50e-1)"	"unprognostic (2.11e-2)"	"unprognostic (3.16e-3)"	"unprognostic (1.54e-1)"	"unprognostic (3.33e-2)"	"unprognostic (5.42e-3)"	"unprognostic (3.36e-2)"	"unprognostic (1.33e-2)"	"unprognostic (2.70e-3)"	"prognostic unfavorable (8.75e-4)"	"unprognostic (5.49e-3)"	"unprognostic (9.50e-2)"	"prognostic unfavorable (3.98e-4)"	"unprognostic (6.59e-3)"	"unprognostic (6.48e-2)"	"unprognostic (1.82e-2)"	"unprognostic (3.06e-3)"	195.0	59.9	18.4	32.8	17.6	0.4	133.9	16.5	21.2	110.3	11.9	116.1	14.3	119.9	13.2	53.5	75.4	31.2	85.9	15.9	17.1	24.4	14.4	102.8	9.1	23.3	19.3	68.3	28.2	6.2	12.6	50.3	20.0	62.2	14.7	3.0	34.2	51.1	39.6	54.7	54.5	79.6	17.2	40.3	56.3	11.2	24.1	5.1	49.5	28.2	8.3	112.3	88.8	15.8	62.7	142.7	0.1	1.7	312.2	236.0	0.2	238.5	114.0	86.0	70.0	9.3	31.2	0.0	0.3	258.6	20.3	78.1	1.5	126.5	51.9	0.1	0.8	8.4	78.4	0.7	197.0	0.0	16.6	230.1	109.5	72.5	70.6	113.7	168.4	0.7	26.6	0.2	91.7	11.4	13.3	0.7	1.8	9.2	25.9	1.4	10.0	0.2	69.5	2.9	0.1	0.8	212.5	8.2	6.2	19.1	20.2	4.3	192.6	128.0	27.8	112.5	52.2	0.2	0.2	0.2	119.3	3.3	27.9	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.1	18.4	17.6	16.5	21.2	15.9	17.1	23.3	19.3	20.0	17.2	24.1	15.8	161.9	60.9	20.6	10.7	0.3	20.3	29.4	31.0	12.5	5.5	7.3	10.8	11.6	10.0	22.5	5.5	0.0	1.1	0.8	0.1	0.0	21.2	0.6	3.4	60.5	75.4	0.0	8.6	4.0	14.1	1.6	55.8	5.1	4.5	2.5	24.7	48.9	3.1	1.9	0.0	0.9	0.0	2.0	1.3	8.8	4.3	99.1	1.6	8.8	7.5	0.6	1.8	0.0	3.5	0.3	31.1	0.0	107.2	0.1	28.8	0.0	0.1	5.5	0.8	236.7	24.8	139.4	0.9	3.0	15.8	13.5	1.5	1.5	27.2	0.0	33.4
EHF	"ESE3, ESEJ"	ENSG00000135373	"ETS homologous factor"	Q9NZC4	11	34621093-34663288	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"salivary gland: 287.7"	"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 400.8;Basal respiratory cells: 271.6;Club cells: 323.3;Endometrial ciliated cells: 229.6;Glandular and luminal cells: 281.8;Squamous epithelial cells: 251.1;Urothelial cells: 397.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in single"	11	"myeloid DC: 1.7"	"Lineage enriched"	"Detected in single"	11	"dendritic cells: 1.7"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 138.4;HaCaT: 95.7;HBEC3-KT: 107.6;OE19: 132.9;RT4: 214.8;T-47d: 213.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA050923, HPA060734"	Enhanced		Supported	"Nucleoplasm,Golgi apparatus"	"Intracellular and membrane"	No	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 22: Epithelial cell types - Mixed function"	Nucleoplasm	"Golgi apparatus"	"HPA050923: AB_2681275, HPA060734: AB_2684351"	"unprognostic (1.06e-2)"	"unprognostic (1.06e-1)"	"prognostic favorable (5.81e-4)"	"unprognostic (2.82e-1)"	"unprognostic (5.62e-2)"	"unprognostic (1.22e-3)"	"unprognostic (2.44e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.38e-1)"	"unprognostic (6.79e-2)"	"prognostic unfavorable (6.94e-4)"	"unprognostic (1.29e-1)"	"unprognostic (6.26e-2)"	"unprognostic (3.47e-3)"	"unprognostic (2.24e-1)"	"unprognostic (2.89e-1)"	"unprognostic (7.08e-2)"	0.9	1.1	0.9	14.7	1.7	0.2	199.5	0.9	0.6	120.8	1.3	99.3	42.2	13.9	95.0	200.7	129.6	32.2	0.3	1.1	0.8	25.7	1.3	23.4	1.5	2.6	4.0	0.2	41.1	18.5	0.7	0.1	2.8	82.7	126.3	0.8	287.7	153.4	0.2	53.6	34.1	3.5	2.5	1.2	59.5	0.7	1.3	1.3	2.5	0.0	67.3	50.7	79.2	4.7	46.5	26.8	0.0	0.3	0.0	0.0	0.8	0.0	3.9	0.0	0.2	0.4	138.4	0.1	17.1	0.0	0.2	95.7	0.0	107.6	0.5	0.1	0.2	0.0	1.5	0.2	0.0	0.2	0.0	0.0	41.7	0.3	0.2	0.0	0.0	0.0	0.3	0.0	0.1	2.6	0.1	0.8	0.2	132.9	1.0	0.0	0.1	1.0	20.2	214.8	0.0	0.2	0.5	14.8	0.2	0.0	213.5	0.5	0.0	0.2	1.2	5.1	0.4	0.5	0.2	0.3	0.3	0.2	0.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	1.7	0.9	0.6	1.1	0.8	2.6	4.0	2.8	2.5	1.3	4.7	0.8	48.1	97.2	1.3	0.6	109.6	400.8	271.6	133.1	0.0	123.0	51.9	0.9	60.1	323.3	55.2	0.0	0.1	1.1	62.7	15.6	77.8	14.2	229.6	17.7	4.0	23.3	0.0	0.7	86.5	0.0	3.2	53.5	281.8	1.3	0.0	0.0	0.4	0.1	0.0	0.0	82.8	116.0	0.0	17.7	1.0	0.0	5.1	12.4	0.0	5.6	3.8	0.0	0.0	2.4	104.8	30.2	0.0	1.2	173.1	14.1	0.3	204.6	0.0	0.0	0.0	9.6	0.4	0.1	251.1	170.1	1.4	4.9	0.0	74.5	397.3
EHMT1	"bA188C12.1, EHMT1-IT1, Eu-HMTase1, FLJ12879, FLJ40292, KIAA1876, KMT1D"	ENSG00000181090	"Euchromatic histone lysine methyltransferase 1"	Q9H9B1	9	137618992-137870016	"Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Chromatin regulator, Methyltransferase, Transferase"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 167.0;Plasma cells: 170.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA060022, HPA074729"	Approved		Supported	"Nucleoplasm,Nuclear bodies"		No	No			"Cluster 1: Neutrophils - Mixed function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 55: Plasma cells - Humoral immune response"	"Nucleoplasm, Nuclear bodies"		"HPA060022: AB_2684190, HPA074729: "	"unprognostic (1.18e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.19e-2)"	"prognostic favorable (6.56e-4)"	"unprognostic (1.03e-1)"	"prognostic favorable (8.91e-4)"	"unprognostic (5.87e-2)"	"unprognostic (1.74e-2)"	"unprognostic (4.18e-3)"	"unprognostic (2.34e-1)"	"unprognostic (2.26e-2)"	"unprognostic (7.55e-3)"	"unprognostic (2.01e-2)"	"unprognostic (6.58e-3)"	"unprognostic (4.24e-1)"	"unprognostic (7.12e-3)"	"unprognostic (7.75e-2)"	17.7	18.3	11.0	22.3	12.0	30.5	18.2	16.0	12.3	17.0	13.8	19.3	18.8	21.5	9.7	19.1	18.1	14.0	13.5	8.6	8.3	11.0	14.4	15.8	29.6	10.7	10.2	19.9	14.9	13.8	12.9	15.0	11.1	16.2	13.1	13.7	18.4	13.9	31.4	19.3	19.6	15.1	4.4	25.9	18.2	40.5	12.7	22.9	19.6	15.0	21.2	18.3	16.2	19.9	26.7	52.3	57.4	53.2	23.9	24.6	48.1	34.5	21.4	24.7	20.2	34.7	32.5	81.6	32.7	26.0	29.9	56.2	34.8	37.8	19.2	45.3	24.7	34.4	54.2	22.4	20.9	52.9	39.5	22.6	25.9	29.9	28.9	18.1	41.3	30.1	52.6	27.5	17.9	61.9	62.5	26.3	56.0	42.1	34.8	79.3	49.5	47.2	20.7	47.7	50.6	41.1	65.4	45.4	15.3	40.6	51.1	42.0	39.0	28.9	29.5	44.8	33.2	17.2	52.0	67.0	21.3	27.6	32.0	19.5	16.2	21.2	18.0	14.3	11.3	16.4	15.6	15.6	12.9	23.0	14.9	13.5	28.8	17.3	15.6	23.3	14.2	9.7	11.0	12.0	16.0	12.3	8.6	8.3	10.7	10.2	11.1	4.4	12.7	19.9	34.3	19.2	19.2	130.6	64.9	17.5	23.4	26.9	32.5	39.7	30.5	26.7	31.5	25.8	24.7	22.0	52.1	23.8	36.9	24.4	3.9	24.1	86.8	29.3	44.8	29.9	28.1	31.7	74.4	21.0	21.8	27.6	45.3	40.6	18.9	55.8	18.9	41.7	19.7	50.5	76.4	22.2	10.2	25.8	18.1	167.0	35.8	26.9	12.4	71.2	31.2	19.7	51.5	64.3	104.0	25.4	30.3	37.6	170.6	34.9	20.7	14.3	22.6	46.8	13.1	34.7	28.5	80.4	51.9	35.3	20.2	26.5	38.9	81.3	23.8	28.8
EHMT2	"BAT8, C6orf30, Em:AF134726.3, G9A, KMT1C, NG36/G9a"	ENSG00000204371	"Euchromatic histone lysine methyltransferase 2"	Q96KQ7	6	31879759-31897687	"Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Chromatin regulator, Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HL-60: 13.3;NTERA-2: 19.3;U-266/84: 16.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA050550, HPA060259"	Supported		Supported	"Nucleoplasm,Nuclear speckles"	"Intracellular and membrane"	NA	NA				"Cluster 72: Non-specific - Transcription"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 52: Non-specific - Transcription"	"Nuclear speckles"	Nucleoplasm	"HPA050550: AB_2681170, HPA060259: AB_2684234"	"unprognostic (3.11e-2)"	"unprognostic (2.72e-1)"	"unprognostic (4.39e-2)"	"unprognostic (1.92e-2)"	"unprognostic (5.44e-2)"	"unprognostic (3.51e-2)"	"prognostic unfavorable (1.79e-4)"	"unprognostic (3.55e-2)"	"unprognostic (7.41e-2)"	"unprognostic (1.01e-1)"	"unprognostic (5.89e-2)"	"unprognostic (1.88e-1)"	"unprognostic (9.78e-3)"	"unprognostic (8.72e-2)"	"unprognostic (1.84e-1)"	"unprognostic (2.25e-1)"	"unprognostic (9.03e-2)"	8.6	9.6	0.5	0.3	0.4	1.0	8.7	0.4	0.5	15.1	0.2	12.9	2.4	19.8	1.7	10.1	12.8	0.0	5.7	0.4	0.4	7.1	4.6	7.3	1.0	0.4	0.5	16.1	7.8	0.6	12.8	0.7	0.4	10.3	0.3	0.6	9.5	1.3	5.5	9.3	10.5	1.4	0.4	11.5	9.4	12.6	0.5	1.5	10.3	0.4	1.0	13.1	11.3	0.4	0.0	4.5	7.8	0.0	3.4	1.8	5.0	3.5	2.8	3.9	3.2	0.0	0.0	0.0	7.6	5.7	4.0	0.0	0.0	8.6	1.8	5.4	11.8	0.0	0.0	0.1	0.0	13.3	0.0	4.6	1.4	0.0	0.0	0.0	0.0	7.5	0.0	0.0	0.0	0.0	9.4	0.0	19.3	0.0	0.0	8.8	0.0	0.0	1.5	0.0	0.0	0.0	0.0	2.3	6.5	3.1	0.0	0.0	3.8	4.1	3.1	6.9	0.0	11.0	16.1	3.8	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.5	0.4	0.4	0.5	0.4	0.4	0.4	0.5	0.4	0.4	0.5	0.4	16.9	16.0	12.0	22.9	20.3	8.4	6.3	11.9	26.2	60.6	15.9	17.8	6.6	17.2	18.9	25.8	41.7	24.6	13.4	9.2	7.9	15.7	41.5	10.1	19.1	16.1	22.6	19.3	16.6	12.2	15.0	16.0	13.3	11.8	14.5	33.8	22.1	7.5	16.3	38.7	24.4	16.4	12.2	12.9	7.3	60.0	27.4	12.1	19.6	9.4	19.9	26.8	25.7	20.1	23.9	10.8	9.1	23.0	16.5	6.2	12.5	10.1	10.8	48.2	26.3	16.3	15.0	20.8	33.7	23.5	11.1	5.6	18.3	19.9	19.0	5.2
EI24	"EPG4, PIG8, TP53I8"	ENSG00000149547	"EI24 autophagy associated transmembrane protein"	O14681	11	125569280-125584684	"Cancer-related genes, Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Apoptosis, Autophagy"		"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"parathyroid gland: 461.9"	"Cell type enhanced"	"Detected in all"		"Hepatocytes: 575.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HEL: 760.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047165, HPA051029"	Approved		Supported	"Endoplasmic reticulum,Golgi apparatus,Cytosol"		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 36: HEL - Hemostasis"	"Cluster 2: Hepatocytes - Metabolism"	"Endoplasmic reticulum, Cytosol"	"Golgi apparatus"	"HPA047165: AB_2679965, HPA051029: AB_2681317"	"unprognostic (2.04e-3)"	"unprognostic (2.69e-2)"	"unprognostic (1.25e-2)"	"unprognostic (3.43e-2)"	"unprognostic (1.68e-1)"	"unprognostic (2.78e-2)"	"unprognostic (5.02e-2)"	"unprognostic (6.38e-2)"	"unprognostic (6.74e-2)"	"unprognostic (1.17e-2)"	"prognostic unfavorable (9.28e-4)"	"unprognostic (3.50e-2)"	"unprognostic (1.35e-1)"	"unprognostic (4.58e-2)"	"unprognostic (8.35e-2)"	"unprognostic (2.07e-1)"	"unprognostic (3.01e-1)"	53.4	32.6	61.1	36.2	62.5	23.2	72.6	59.7	72.4	51.3	59.8	77.8	49.6	46.2	57.4	80.8	50.8	46.3	55.7	60.2	61.5	61.0	248.4	45.0	28.4	60.2	62.5	42.4	101.8	461.9	30.6	48.5	60.2	49.6	80.4	39.4	75.3	58.0	119.5	70.2	49.3	62.5	62.4	30.5	59.7	33.1	64.4	35.3	40.5	104.6	42.3	78.9	48.4	61.0	156.6	115.6	129.5	160.5	207.7	155.9	162.4	159.6	116.8	104.3	93.4	178.9	303.4	158.0	264.0	146.5	110.8	176.1	199.0	326.8	135.2	42.0	142.6	760.9	77.2	179.9	154.1	170.9	78.4	147.5	292.7	157.4	230.2	102.8	223.9	85.1	351.1	61.1	149.4	113.8	79.0	96.4	173.6	398.3	139.5	113.9	155.4	132.8	177.0	272.4	120.1	116.9	187.1	215.5	63.4	212.3	436.4	165.7	195.2	133.8	93.3	94.7	128.7	39.7	84.8	200.5	58.5	256.1	182.2	4.3	7.0	5.9	7.2	6.7	7.2	8.4	5.7	9.0	10.9	6.3	8.1	6.7	0.8	6.5	4.9	14.5	9.1	5.3	61.1	62.5	59.7	72.4	60.2	61.5	60.2	62.5	60.2	62.4	64.4	61.0	73.5	32.1	38.3	13.4	34.8	120.6	130.3	132.6	120.1	58.9	148.8	100.6	61.9	124.4	69.5	110.3	37.5	166.9	32.4	66.4	144.8	178.6	31.1	34.4	59.3	87.1	98.4	102.7	25.1	181.8	201.2	80.1	87.7	46.5	27.3	76.2	74.6	575.0	110.5	82.4	24.0	115.3	105.8	49.8	96.1	49.7	71.4	40.9	90.7	11.2	40.9	107.1	50.4	13.0	23.0	182.1	67.6	72.2	79.1	270.0	68.5	122.7	43.9	36.9	46.0	60.8	80.1	95.9	112.3	176.3	181.4	140.1	31.0	71.3	135.7	189.4
EID1	"C15orf3, CRI1, EID-1"	ENSG00000255302	"EP300 interacting inhibitor of differentiation 1"	Q9Y6B2	15	48878134-48880173	"Predicted intracellular proteins"	"Cell cycle, Differentiation, Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							"HPA051122, HPA051123"	Approved		Supported	Nucleoplasm		NA	Yes			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 38: Heart - Muscle contraction"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm		"HPA051122: AB_2681350, HPA051123: AB_2681351"	"unprognostic (1.38e-1)"	"unprognostic (6.69e-2)"	"unprognostic (1.64e-1)"	"unprognostic (3.18e-2)"	"unprognostic (7.81e-2)"	"prognostic unfavorable (9.99e-4)"	"unprognostic (1.10e-1)"	"unprognostic (2.79e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.41e-1)"	"unprognostic (6.75e-3)"	"unprognostic (2.46e-1)"	"unprognostic (3.62e-3)"	"prognostic unfavorable (2.91e-4)"	"unprognostic (2.04e-2)"	"unprognostic (2.13e-1)"	"unprognostic (2.09e-1)"	128.6	206.3	96.9	95.4	103.7	61.0	112.0	98.7	153.6	149.8	107.2	143.9	81.6	161.0	132.1	96.6	134.9	120.9	280.1	103.9	111.3	147.9	125.1	99.5	112.0	102.6	101.7	186.7	102.0	144.8	130.1	93.3	100.5	156.1	71.3	158.4	98.3	147.3	278.8	57.6	79.0	141.8	102.1	115.3	84.2	67.9	104.5	117.2	138.5	227.6	83.9	113.1	81.4	123.2	131.5	109.1	260.9	231.6	239.9	316.9	16.4	337.6	304.5	220.3	294.3	95.0	58.0	174.9	305.3	207.0	155.5	115.4	130.2	130.8	247.9	484.1	127.1	300.6	235.8	4.1	186.0	183.0	132.2	278.1	115.1	146.1	91.9	221.4	262.8	151.2	182.3	162.6	258.5	188.7	134.6	174.1	0.5	98.9	97.4	185.1	302.6	290.6	287.4	142.3	233.8	234.6	210.2	80.2	401.2	212.7	145.0	240.6	262.9	322.4	177.7	305.6	299.3	208.4	616.7	125.1	264.6	410.0	230.0	345.0	311.5	275.5	221.3	285.3	209.2	168.3	249.4	231.8	358.1	183.2	179.6	165.3	40.4	230.0	297.5	354.9	332.4	440.1	96.9	103.7	98.7	153.6	103.9	111.3	102.6	101.7	100.5	102.1	104.5	123.2	327.4	387.8	207.7	31.3	127.5	175.5	139.9	459.5	138.9	345.3	188.5	286.4	480.8	183.0	329.9	261.1	120.9	351.6	168.0	46.0	606.5	386.5	17.5	116.0	324.4	356.8	233.7	219.2	38.0	268.0	151.2	443.4	88.2	116.7	188.0	173.8	339.8	166.2	211.3	238.9	43.5	114.0	301.1	208.1	262.0	49.2	702.4	189.7	487.4	30.9	302.2	844.1	213.1	28.6	80.9	191.0	102.1	651.4	134.3	81.4	91.9	446.5	240.2	329.9	322.1	350.7	379.1	98.6	75.0	125.9	145.6	109.6	180.7	463.2	101.5	96.9
EID2	"CRI2, EID-2, MGC20452"	ENSG00000176396	"EP300 interacting inhibitor of differentiation 2"	Q8N6I1	19	39538707-39540161	"Predicted intracellular proteins"	"Differentiation, Myogenesis, Transcription, Transcription regulation"	"Developmental protein, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 48.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045477	Uncertain		Supported	Nucleoplasm		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 47: Cytotrophoblasts - Unknown function"	Nucleoplasm		"HPA045477: AB_10959785"	"unprognostic (5.91e-2)"	"unprognostic (6.37e-3)"	"prognostic favorable (9.73e-4)"	"unprognostic (5.93e-2)"	"unprognostic (6.50e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.52e-2)"	"unprognostic (6.53e-2)"	"unprognostic (6.02e-2)"	"unprognostic (3.43e-1)"	"unprognostic (6.88e-3)"	"prognostic unfavorable (8.74e-4)"	"unprognostic (1.21e-1)"	"unprognostic (2.79e-2)"	"unprognostic (2.25e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.51e-1)"	10.5	17.9	13.3	8.8	14.5	6.4	8.5	13.3	19.5	7.7	11.9	9.1	6.8	11.0	8.1	9.2	8.4	6.2	10.1	14.3	15.6	12.6	10.8	8.4	9.1	13.8	11.8	8.4	7.8	12.6	13.0	14.3	14.1	9.0	6.6	15.7	7.7	8.0	11.1	7.4	9.0	9.8	12.5	9.5	8.8	9.0	12.8	14.2	8.3	10.4	8.4	7.8	6.5	12.6	25.0	33.4	31.1	21.2	24.7	15.3	4.6	29.3	22.0	22.5	23.2	21.2	7.7	25.4	23.5	20.6	15.1	10.5	29.0	21.3	29.0	24.6	36.5	11.4	19.1	25.5	24.5	19.9	16.1	18.0	13.3	18.7	14.4	17.8	26.6	49.0	18.8	17.2	19.8	16.5	29.0	17.5	17.4	30.1	14.0	26.6	29.7	11.9	28.9	22.8	29.0	20.6	31.8	12.6	21.0	20.9	17.1	12.9	19.2	14.3	51.0	19.1	22.3	26.9	33.8	32.1	13.3	18.5	11.8	0.0	0.4	0.7	0.8	0.5	0.8	0.5	1.0	1.0	0.5	0.5	1.0	1.4	0.1	0.3	0.5	0.5	0.2	0.4	13.3	14.5	13.3	19.5	14.3	15.6	13.8	11.8	14.1	12.5	12.8	12.6	16.4	19.2	9.2	2.6	7.3	10.1	4.5	2.4	6.2	23.9	11.2	15.6	19.1	17.2	4.0	14.7	10.4	48.9	14.0	6.5	1.9	5.2	3.2	18.3	23.3	14.4	7.2	4.2	7.4	5.0	5.3	10.0	5.1	12.4	1.3	14.4	13.2	12.9	10.8	26.9	8.0	5.3	0.0	8.1	6.5	1.3	10.2	7.8	8.8	3.7	7.5	31.1	12.3	5.0	8.6	6.2	7.4	13.2	7.2	5.3	5.9	9.5	5.5	20.7	6.6	9.7	12.7	11.3	8.8	5.2	7.5	19.4	11.3	25.2	7.5	2.6
EID3	"FLJ25832, NSE4B, NSMCE4B"	ENSG00000255150	"EP300 interacting inhibitor of differentiation 3"	Q8N140	12	104303739-104305205	"Predicted intracellular proteins"	"DNA damage, DNA recombination, DNA repair, Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"testis: 61.2"	"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 78.5;Early spermatids: 72.8;Spermatocytes: 306.8"	"Cancer enhanced"	"Detected in many"		"testis cancer: 5.4"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"A549: 9.1;BJ: 8.5;BJ hTERT+: 6.9;BJ hTERT+ SV40 Large T+ RasG12V: 6.8;HeLa: 8.9"	"Not detected"	"Not detected"							HPA059367	Uncertain		Supported	Nucleoplasm,Nucleoli		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 83: Testis - Spermatogenesis"	"Cluster 20: HeLa - Mitochondria"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Nucleoplasm, Nucleoli"		"HPA059367: AB_2683992"	"unprognostic (1.25e-1)"	"unprognostic (5.41e-3)"	"unprognostic (5.82e-2)"	"unprognostic (8.21e-2)"	"prognostic unfavorable (1.14e-4)"	"unprognostic (8.02e-2)"	"unprognostic (5.88e-5)"	"unprognostic (1.06e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.66e-2)"	"unprognostic (5.38e-3)"	"unprognostic (1.18e-1)"	"prognostic unfavorable (5.96e-5)"	"unprognostic (8.70e-2)"	"unprognostic (3.54e-1)"	"unprognostic (2.04e-3)"	"unprognostic (2.87e-2)"	2.8	3.1	1.8	3.5	1.7	5.3	2.4	2.1	2.2	3.2	2.8	3.1	0.8	2.7	2.7	1.8	3.1	2.7	2.0	1.9	2.4	1.8	1.4	3.0	6.2	6.6	3.1	4.1	2.5	1.2	3.7	1.7	2.2	3.3	0.9	6.6	1.4	5.5	0.6	2.7	2.7	2.3	1.6	3.0	2.2	61.2	2.4	3.7	1.5	0.9	3.9	2.4	2.1	2.0	0.3	9.1	0.3	0.9	2.0	2.0	1.7	8.5	6.9	4.0	6.8	0.2	0.5	0.1	0.0	1.9	1.8	0.2	0.3	0.7	5.9	0.5	0.1	1.7	8.9	1.4	2.9	0.1	0.5	2.7	0.0	2.5	0.5	0.4	0.6	0.4	0.1	0.5	2.5	0.1	3.1	1.3	0.4	0.1	1.8	0.2	0.0	0.1	2.2	0.3	0.1	0.0	5.6	0.4	0.2	0.2	0.0	0.0	1.3	0.1	0.3	2.0	0.4	0.4	0.2	0.1	0.2	0.0	0.9	0.0	0.3	0.5	4.4	1.4	4.6	2.3	5.6	5.4	0.2	2.3	7.9	5.0	0.7	6.2	0.9	0.5	7.3	2.2	1.8	1.7	2.1	2.2	1.9	2.4	6.6	3.1	2.2	1.6	2.4	2.0	4.7	0.0	6.0	0.0	5.9	13.4	78.5	5.9	1.8	4.9	2.4	3.9	1.4	2.8	2.7	1.8	27.1	2.4	11.1	2.4	0.0	3.5	72.8	13.8	9.6	14.0	0.0	6.6	0.0	1.3	1.6	12.7	5.1	21.1	1.3	6.1	5.3	3.0	1.9	11.8	0.0	1.2	4.1	4.7	26.8	23.5	8.7	6.8	1.8	0.0	4.0	7.5	6.2	0.0	0.0	4.9	4.5	4.5	4.3	47.6	1.2	1.7	7.5	18.6	6.6	7.6	8.4	306.8	44.3	1.4	7.7	2.5	11.1	15.6	1.0	46.9
EIF1AD	"haponin, MGC11102"	ENSG00000175376	"Eukaryotic translation initiation factor 1A domain containing"	Q8N9N8	11	65996545-66002176	"Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054991, HPA058735"	Uncertain		Approved	Nucleoplasm,Vesicles,Cytosol		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 16: U-266 - Nucleosome"	"Cluster 10: Non-specific - Unknown function"	"Nucleoplasm, Vesicles"	Cytosol	"HPA054991: AB_2682664, HPA058735: AB_2683802"	"unprognostic (1.11e-1)"	"unprognostic (8.83e-2)"	"unprognostic (3.03e-1)"	"prognostic unfavorable (3.59e-5)"	"unprognostic (1.30e-2)"	"unprognostic (5.69e-2)"	"prognostic unfavorable (8.63e-5)"	"unprognostic (1.86e-2)"	"unprognostic (1.17e-1)"	"unprognostic (8.76e-2)"	"unprognostic (1.36e-3)"	"unprognostic (2.31e-1)"	"unprognostic (1.59e-3)"	"unprognostic (7.63e-3)"	"unprognostic (1.40e-1)"	"unprognostic (1.28e-3)"	"unprognostic (3.96e-1)"	15.7	17.7	15.3	19.9	15.8	44.6	16.0	18.7	19.8	13.1	14.4	15.8	15.1	15.9	16.2	21.0	15.3	13.0	17.1	16.4	17.7	15.2	17.3	15.0	23.4	16.1	15.7	20.4	19.2	17.1	16.6	21.1	16.3	13.4	14.7	16.6	16.8	14.9	27.2	23.1	16.9	14.8	14.8	20.0	16.1	19.4	17.3	19.9	13.8	23.3	27.6	17.1	14.5	18.4	51.0	43.9	35.0	35.9	27.6	28.8	32.8	36.4	34.6	44.2	37.7	44.8	47.5	38.2	62.6	41.2	38.0	34.9	42.2	48.8	41.5	35.1	21.7	54.4	52.0	46.4	33.7	50.3	41.8	24.1	41.9	65.3	44.1	31.2	31.0	40.9	81.1	54.4	64.7	68.7	46.6	55.1	25.9	23.3	47.5	50.3	35.9	75.0	25.6	31.8	26.5	31.2	39.3	54.7	41.5	28.1	53.1	31.0	36.5	59.7	39.9	47.8	36.1	66.7	85.5	79.8	42.9	33.8	39.5	52.6	20.5	13.5	17.7	16.6	13.6	19.4	15.0	13.0	21.3	19.0	14.1	13.5	13.1	16.4	21.3	12.7	15.3	13.3	15.3	15.8	18.7	19.8	16.4	17.7	16.1	15.7	16.3	14.8	17.3	18.4	8.2	3.2	5.4	3.3	16.2	37.7	12.2	13.4	12.5	7.2	14.2	9.1	16.2	14.3	7.3	5.5	14.6	16.3	17.7	11.6	15.6	12.7	18.3	9.0	8.3	11.6	2.4	21.0	3.0	13.1	23.0	11.4	7.1	10.5	12.7	31.7	16.4	16.5	24.5	11.8	2.8	11.2	6.1	10.4	29.5	14.3	12.2	14.4	12.4	1.0	17.6	10.5	17.5	5.5	4.5	29.0	15.2	5.7	22.6	13.2	13.8	15.7	10.6	18.5	6.6	9.8	27.0	31.3	23.2	15.7	48.9	25.3	16.2	7.4	10.9	13.2
EIF2AK1	"HRI, KIAA1369"	ENSG00000086232	"Eukaryotic translation initiation factor 2 alpha kinase 1"	Q9BQI3	7	6022247-6059175	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		"Kinase, Protein synthesis inhibitor, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"Cytotrophoblasts: 219.1;Erythroid cells: 422.0;Syncytiotrophoblasts: 371.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016496, CAB022082, HPA061675"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 6: Erythroid cells - Oxygen transport"	Nucleoplasm	Cytosol	"CAB022082: , HPA016496: AB_1848057, HPA061675: AB_2684583"	"unprognostic (7.15e-3)"	"unprognostic (2.00e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.91e-1)"	"unprognostic (6.70e-2)"	"unprognostic (9.69e-3)"	"prognostic unfavorable (6.99e-4)"	"unprognostic (2.36e-1)"	"unprognostic (2.54e-1)"	"unprognostic (1.07e-2)"	"unprognostic (1.48e-1)"	"unprognostic (8.96e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.99e-1)"	"unprognostic (5.45e-2)"	"unprognostic (9.02e-2)"	"unprognostic (1.06e-2)"	27.2	39.4	28.1	27.7	28.9	105.9	35.9	30.6	36.1	29.0	34.9	48.8	37.1	25.0	37.4	30.4	31.0	23.8	33.8	28.1	30.6	43.8	65.1	30.3	35.2	30.5	28.9	29.3	44.3	78.0	25.9	52.3	31.6	35.0	47.3	29.0	46.8	24.2	38.3	33.3	37.2	23.8	29.1	26.6	49.1	19.5	29.8	43.6	39.3	34.4	40.4	27.2	22.4	33.7	144.5	90.5	71.2	108.8	66.4	59.6	92.4	73.0	66.8	64.2	80.8	83.7	96.2	112.5	77.4	81.3	115.5	100.4	93.1	67.1	82.2	69.8	140.3	115.9	91.6	127.3	54.3	100.8	102.0	48.1	82.8	60.7	64.9	67.7	69.4	88.1	189.0	106.8	61.4	146.5	55.6	128.6	88.5	84.6	99.7	120.0	74.6	134.0	82.3	70.3	87.3	156.5	139.3	186.6	63.8	98.6	141.0	122.4	65.9	37.0	134.2	65.3	78.2	106.5	114.8	115.6	73.9	129.8	108.7	11.1	6.9	17.3	8.2	5.5	5.6	12.3	6.5	9.3	6.9	9.5	7.5	6.6	3.7	10.2	6.2	6.0	8.9	4.8	28.1	28.9	30.6	36.1	28.1	30.6	30.5	28.9	31.6	29.1	29.8	33.7	23.1	38.5	43.7	14.4	42.8	23.8	34.9	34.3	41.5	29.7	52.5	34.9	49.6	45.8	37.7	44.1	16.7	219.1	52.5	57.1	66.5	55.0	8.8	59.5	42.3	27.5	38.5	422.0	21.8	44.8	82.1	29.7	64.7	48.1	20.8	44.9	21.0	63.2	53.8	32.0	21.9	68.7	54.9	39.0	29.9	16.1	34.5	65.2	24.9	13.1	62.8	46.4	70.0	19.1	26.9	53.0	47.0	37.6	60.1	43.3	47.5	66.1	48.3	26.5	13.1	32.0	26.0	33.7	34.5	45.5	22.4	371.0	38.0	57.1	52.7	32.3
EIF2B3	"EIF-2B, EIF2Bgamma"	ENSG00000070785	"Eukaryotic translation initiation factor 2B subunit gamma"	Q9NR50	1	44850522-44986722	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Protein biosynthesis"	"Initiation factor"	"Disease variant, Leukodystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024213, HPA024218, HPA024219"	Supported		Supported	Vesicles,Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	"Vesicles, Cytosol"		"HPA024213: AB_1848067, HPA024218: AB_1848068, HPA024219: AB_1848069"	"unprognostic (2.12e-2)"	"unprognostic (7.49e-2)"	"unprognostic (4.37e-3)"	"unprognostic (5.14e-2)"	"unprognostic (1.57e-2)"	"unprognostic (4.45e-2)"	"prognostic unfavorable (1.73e-5)"	"unprognostic (4.55e-2)"	"unprognostic (1.14e-2)"	"unprognostic (7.22e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.36e-1)"	"unprognostic (5.38e-2)"	"unprognostic (6.98e-2)"	"unprognostic (7.80e-2)"	"unprognostic (5.69e-3)"	"unprognostic (2.73e-2)"	23.6	27.2	11.4	11.6	10.9	10.9	21.9	13.2	15.6	18.7	10.1	17.5	8.6	17.0	12.5	17.4	16.3	9.6	40.6	11.2	11.6	15.4	24.7	13.5	14.3	11.9	12.1	18.2	16.9	30.0	15.8	9.7	12.8	15.0	13.4	19.0	25.1	13.7	77.0	17.6	10.7	19.4	11.0	14.9	14.2	19.3	11.2	13.3	12.5	48.0	14.5	17.7	17.1	14.0	35.4	26.9	30.9	25.5	36.3	43.1	36.2	56.1	42.2	56.5	52.9	39.0	20.7	90.6	39.9	43.2	45.0	20.6	65.3	48.6	69.5	32.5	58.1	44.3	29.3	38.4	46.2	71.2	24.3	29.3	25.8	61.0	69.9	26.5	52.8	30.1	106.1	31.6	62.3	23.1	69.7	30.2	42.0	38.8	52.7	54.7	51.3	65.7	28.7	15.7	53.2	20.5	55.1	63.8	37.4	40.7	24.7	32.8	28.3	35.9	42.9	53.4	73.7	31.6	37.9	68.9	27.9	59.5	43.1	1.6	23.4	3.9	18.6	37.2	22.8	14.8	18.3	21.1	37.0	18.9	22.9	23.6	2.1	25.5	33.1	25.3	17.6	21.4	11.4	10.9	13.2	15.6	11.2	11.6	11.9	12.1	12.8	11.0	11.2	14.0	13.9	6.4	22.0	24.8	15.8	13.8	19.0	33.0	10.8	15.1	15.8	16.8	79.2	15.7	24.9	5.5	20.9	25.1	12.1	4.5	29.4	18.9	26.1	17.0	23.0	14.4	3.6	15.3	39.9	15.8	22.6	22.6	13.7	11.5	25.9	21.1	3.9	22.6	24.8	21.9	44.5	7.0	20.3	10.7	11.2	11.3	26.4	15.4	17.8	26.2	30.1	21.7	10.3	29.1	35.7	13.7	6.9	25.2	22.6	17.1	5.7	23.1	34.2	21.8	26.3	19.7	45.4	45.5	23.6	17.1	14.9	14.9	13.5	40.4	9.4	13.9
EIF2D	LGTN	ENSG00000143486	"Eukaryotic translation initiation factor 2D"	P41214	1	206571292-206612465	"Predicted intracellular proteins"	"Protein biosynthesis"	"Initiation factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028220	Approved		Supported	"Nuclear bodies,Cytosol"		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 52: Non-specific - Ribosome"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 32: Non-specific - Translation"	Cytosol	"Nuclear bodies"	"HPA028220: AB_10602022"	"unprognostic (1.67e-2)"	"unprognostic (2.44e-1)"	"unprognostic (3.68e-2)"	"unprognostic (6.46e-3)"	"unprognostic (4.09e-3)"	"unprognostic (2.39e-1)"	"unprognostic (2.20e-3)"	"unprognostic (6.60e-2)"	"unprognostic (1.45e-1)"	"unprognostic (3.93e-1)"	"unprognostic (1.49e-1)"	"unprognostic (3.64e-2)"	"prognostic unfavorable (1.74e-4)"	"unprognostic (3.54e-1)"	"unprognostic (1.97e-1)"	"unprognostic (8.32e-2)"	"unprognostic (2.13e-2)"	32.7	32.5	18.1	18.8	20.4	33.0	43.3	19.0	21.0	37.8	22.0	37.9	21.9	35.5	31.9	32.4	42.7	23.9	25.6	17.5	19.1	31.0	31.3	24.4	32.7	19.9	19.7	60.3	41.3	43.6	23.5	27.4	20.1	30.0	32.6	9.8	47.1	30.1	54.1	34.0	24.3	38.1	19.3	23.4	35.7	18.3	19.6	37.0	35.6	51.7	38.6	31.7	31.8	22.1	63.4	38.3	30.6	26.7	88.2	115.1	37.2	34.9	71.7	61.8	60.4	31.3	53.6	106.7	26.5	71.5	19.7	43.6	50.3	78.8	54.4	35.2	66.2	37.5	44.4	59.5	97.2	68.6	36.9	105.9	103.2	49.1	96.9	78.4	79.4	77.0	88.8	48.5	54.5	49.6	61.8	31.7	25.1	46.9	57.9	49.4	65.5	118.4	63.0	23.2	28.6	26.3	30.7	80.9	76.4	45.5	62.0	52.9	56.1	33.9	34.0	15.9	47.2	44.1	26.3	74.4	45.7	45.7	25.9	15.1	17.6	2.8	19.2	16.7	25.9	32.7	26.4	23.6	28.9	26.9	33.7	24.7	0.4	30.0	25.1	15.3	26.3	17.7	18.1	20.4	19.0	21.0	17.5	19.1	19.9	19.7	20.1	19.3	19.6	22.1	18.1	16.0	17.5	15.0	24.1	14.4	37.6	24.3	23.3	10.6	24.6	22.9	10.1	20.0	19.1	11.0	4.2	40.7	15.2	9.4	25.4	19.9	41.3	18.8	17.5	20.9	4.9	26.9	11.4	20.0	26.6	21.6	17.3	12.6	17.7	24.8	23.6	11.4	22.1	3.3	10.7	14.8	24.4	17.2	11.7	16.1	28.9	12.7	17.8	6.5	23.3	12.0	14.4	14.1	17.6	14.4	15.0	27.4	22.9	23.7	15.2	28.8	17.1	14.3	19.7	23.3	23.3	26.4	10.4	31.5	23.2	25.6	20.6	32.7	27.6	30.5
EIF2S2	"EIF2, EIF2beta, PPP1R67"	ENSG00000125977	"Eukaryotic translation initiation factor 2 subunit beta"	P20042	20	34088309-34112243	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Protein biosynthesis"	"Initiation factor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034415, HPA041262, HPA041332"	Approved		Supported	"Nucleoli,Endoplasmic reticulum"		NA	NA		480000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 59: Non-specific - Translation"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 10: Non-specific - Unknown function"	"Endoplasmic reticulum"	Nucleoli	"CAB034415: AB_2095998, HPA041262: AB_2677381, HPA041332: AB_2677417"	"unprognostic (5.76e-3)"	"unprognostic (7.12e-2)"	"unprognostic (2.66e-2)"	"prognostic unfavorable (8.74e-4)"	"unprognostic (1.02e-1)"	"unprognostic (1.47e-3)"	"prognostic unfavorable (3.23e-5)"	"unprognostic (9.36e-3)"	"unprognostic (2.39e-1)"	"unprognostic (6.55e-3)"	"unprognostic (3.04e-3)"	"unprognostic (1.25e-2)"	"prognostic unfavorable (9.64e-10)"	"unprognostic (2.52e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.12e-2)"	50.7	49.2	40.1	44.0	42.1	45.0	42.3	43.1	54.5	34.8	39.8	45.8	38.3	33.7	37.9	61.2	30.6	32.5	46.2	39.0	41.7	54.0	59.2	46.8	52.8	44.3	41.3	32.0	81.4	35.8	27.7	54.2	43.9	35.0	42.8	23.7	43.5	33.9	100.8	39.0	37.6	40.5	43.6	37.9	50.8	37.1	41.6	46.6	42.4	64.0	56.3	63.1	37.9	48.4	211.9	139.1	103.4	125.5	99.1	149.3	196.6	188.7	180.2	184.1	184.6	493.4	144.5	188.5	135.1	171.9	204.1	194.5	169.7	310.6	222.0	61.0	92.3	373.8	110.0	254.5	254.7	241.9	116.7	153.6	259.1	182.7	270.2	125.8	195.5	273.7	223.6	174.8	153.5	135.8	226.0	201.3	100.6	243.7	251.1	128.2	176.0	176.2	145.5	174.2	104.7	71.3	209.3	125.2	403.7	119.2	189.9	282.4	132.8	208.7	129.0	132.5	179.8	162.4	153.8	195.9	196.5	185.0	155.1	54.2	77.1	64.8	54.7	89.0	68.1	84.8	77.2	77.2	75.8	71.2	72.0	72.8	47.3	74.9	83.8	105.3	96.1	64.0	40.1	42.1	43.1	54.5	39.0	41.7	44.3	41.3	43.9	43.6	41.6	48.4	157.4	169.9	162.1	13.7	167.8	180.5	326.3	384.9	81.4	60.5	171.7	154.6	145.1	223.1	241.7	139.8	31.3	359.2	139.6	145.7	307.2	344.2	314.9	182.9	160.1	199.2	126.7	300.7	17.6	529.2	394.4	128.5	110.6	139.1	144.4	80.1	253.4	497.1	243.0	42.1	17.1	229.6	215.7	223.1	119.3	163.7	126.5	147.0	119.2	16.9	286.8	92.8	126.7	17.1	25.2	519.3	133.8	129.4	182.6	292.7	141.5	335.0	207.7	95.3	111.7	102.6	226.6	446.4	211.6	132.7	174.5	641.7	124.0	220.6	200.4	343.8
EIF3A	"EIF3, eIF3-p170, eIF3-theta, EIF3S10, KIAA0139, TIF32"	ENSG00000107581	"Eukaryotic translation initiation factor 3 subunit A"	Q14152	10	119033670-119080823	"Predicted intracellular proteins"	"Host-virus interaction, Protein biosynthesis"	"Initiation factor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038315, HPA038316"	Enhanced		Supported	Nucleoplasm,Cytosol		Yes	No		110000	"Cluster 27: Non-specific - Gene expression"	"Cluster 59: Non-specific - Translation"	"Cluster 32: U-937 - Innate immune response"	"Cluster 10: Non-specific - Unknown function"	"Nucleoplasm, Cytosol"		"HPA038315: AB_10672588, HPA038316: AB_10673168"	"unprognostic (8.15e-2)"	"unprognostic (2.09e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.22e-1)"	"unprognostic (4.53e-3)"	"unprognostic (3.19e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.16e-1)"	"unprognostic (1.84e-1)"	"unprognostic (9.38e-2)"	"unprognostic (3.84e-3)"	"unprognostic (9.07e-2)"	"unprognostic (5.48e-3)"	"unprognostic (8.07e-2)"	"unprognostic (1.20e-1)"	"unprognostic (9.07e-2)"	"unprognostic (1.89e-2)"	83.0	53.2	27.5	73.7	30.9	120.7	62.5	28.4	31.8	48.8	38.0	62.9	65.8	60.1	34.9	69.3	44.8	50.1	69.0	25.7	33.7	58.1	77.9	49.5	75.1	34.8	30.0	61.7	155.1	70.2	24.4	57.0	35.4	55.5	63.9	31.6	73.3	46.3	178.2	69.9	60.0	62.8	31.6	57.4	72.8	44.8	32.4	78.3	70.3	89.8	74.6	76.4	51.8	32.4	258.5	190.9	154.0	211.6	163.6	235.0	119.4	228.9	235.9	144.0	143.7	181.2	165.5	300.2	83.2	190.3	113.3	252.0	202.5	175.7	203.5	166.1	166.3	258.3	143.6	203.2	186.2	382.3	183.9	204.6	193.0	212.7	362.8	240.7	165.7	119.8	269.7	191.9	188.7	152.5	159.4	179.8	147.8	99.4	96.3	162.1	332.1	143.7	137.0	213.9	71.6	151.3	180.2	166.9	244.9	132.0	107.2	241.1	245.6	138.7	128.0	147.1	335.8	164.9	194.0	286.9	147.2	368.2	97.6	49.0	38.2	23.9	27.4	41.8	31.7	25.6	33.1	25.2	36.1	24.7	22.6	24.7	10.0	26.6	58.1	20.5	50.9	28.3	27.5	30.9	28.4	31.8	25.7	33.7	34.8	30.0	35.4	31.6	32.4	32.4	122.1	233.9	323.8	24.5	147.3	304.2	279.1	129.0	203.7	60.1	155.8	133.7	320.7	111.5	198.5	64.4	62.6	169.1	181.1	130.2	27.4	157.2	199.4	230.3	248.6	145.3	141.2	270.0	32.7	185.4	159.5	152.5	159.0	371.8	145.4	132.6	74.3	184.5	126.3	43.7	34.9	168.2	87.5	200.3	169.0	119.1	108.7	196.5	147.7	29.0	235.9	78.2	135.9	24.6	38.9	192.8	105.4	117.8	258.6	253.6	98.5	58.7	158.3	54.1	59.2	209.7	221.6	158.0	112.9	255.3	363.8	252.3	171.1	145.0	227.7	302.3
EIF3C	"eIF3-p110, EIF3S8"	ENSG00000184110	"Eukaryotic translation initiation factor 3 subunit C"	Q99613	16	28688558-28735727	"Plasma proteins, Predicted intracellular proteins"	"Protein biosynthesis"	"Initiation factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 67.3;Alveolar cells type 2: 101.4;Cardiomyocytes: 157.0;Club cells: 91.1;Respiratory ciliated cells: 168.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"CAB034045, HPA047097, HPA049495, HPA050112"	Supported		Supported	Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 59: Non-specific - Translation"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 49: Ciliated cells - Cilium organization"	Cytosol		"CAB034045: AB_1122487, HPA047097: AB_2679930, HPA049495: AB_2680793, HPA050112: AB_2681020"	"unprognostic (2.42e-1)"	"unprognostic (2.69e-2)"	"unprognostic (2.07e-1)"	"unprognostic (2.18e-1)"	"unprognostic (5.84e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.85e-2)"	"unprognostic (5.75e-2)"	"unprognostic (7.23e-2)"	"unprognostic (1.40e-1)"	"unprognostic (3.90e-2)"	"unprognostic (6.54e-3)"	"unprognostic (3.53e-3)"	"unprognostic (2.25e-1)"	"unprognostic (1.48e-1)"	"unprognostic (6.42e-2)"	"unprognostic (1.10e-3)"	174.0	99.7	86.7	113.5	94.3	149.8	185.7	77.4	92.6	136.9	83.2	189.7	148.6	138.0	51.7	159.7	185.9	86.7	135.3	98.1	89.2	172.8	143.1	104.6	124.8	87.4	91.6	236.4	219.6	227.9	86.8	122.8	92.8	115.2	166.1	94.8	187.6	112.9	360.1	188.3	145.0	149.0	80.2	116.2	124.4	140.8	84.2	91.0	175.7	291.9	189.0	144.8	104.2	89.3	182.1	321.5	419.3	481.5	368.0	453.1	627.7	444.1	380.9	587.7	425.4	620.6	333.9	461.7	556.7	322.2	366.5	214.5	361.4	618.1	650.0	188.4	376.0	518.9	466.8	860.4	471.9	791.3	344.6	521.4	367.4	370.4	582.8	253.6	679.5	439.3	595.7	394.5	314.5	783.0	622.0	299.2	652.8	304.0	491.2	638.8	612.7	447.0	317.8	406.4	379.1	573.2	396.8	531.0	478.0	263.3	551.6	356.6	570.3	372.3	370.1	180.4	299.9	325.8	279.0	860.7	378.7	320.4	398.7	54.5	198.1	90.2	122.0	204.0	140.6	114.3	131.8	129.1	213.2	113.9	127.4	120.5	14.3	163.8	220.5	98.3	147.2	267.3	86.7	94.3	77.4	92.6	98.1	89.2	87.4	91.6	92.8	80.2	84.2	89.3	5.0	67.3	101.4	1.0	9.6	11.9	10.0	3.9	15.4	7.0	5.3	3.0	157.0	5.7	91.1	5.5	41.7	3.7	6.2	4.6	1.9	3.3	2.8	8.7	7.7	16.0	6.0	17.5	1.4	3.5	3.1	33.2	10.2	12.9	39.1	7.3	7.9	4.8	3.1	0.0	1.5	5.9	2.0	5.0	8.4	3.5	6.5	12.6	5.4	5.6	3.9	1.9	2.1	4.5	1.0	4.1	5.2	5.3	21.4	5.7	7.1	5.2	168.1	16.2	0.0	6.9	18.5	3.9	4.6	16.9	13.8	5.6	11.2	6.1	6.3	8.8
EIF3D	"eIF3-p66, eIF3-zeta, EIF3S7"	ENSG00000100353	"Eukaryotic translation initiation factor 3 subunit D"	O15371	22	36510855-36529184	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, Protein biosynthesis"	"Initiation factor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045882, HPA063330, HPA066216"	Approved		Supported	Cytosol		NA	NA		36000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 50: Non-specific - Ribosome"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 10: Non-specific - Unknown function"	Cytosol		"HPA045882: AB_2679482, HPA063330: AB_2684988, HPA066216: AB_2685637"	"unprognostic (4.98e-2)"	"unprognostic (2.22e-1)"	"unprognostic (8.74e-3)"	"unprognostic (6.50e-3)"	"unprognostic (1.39e-2)"	"unprognostic (2.34e-3)"	"prognostic unfavorable (8.10e-5)"	"unprognostic (1.47e-1)"	"unprognostic (2.58e-1)"	"unprognostic (9.98e-2)"	"unprognostic (5.54e-3)"	"unprognostic (3.93e-2)"	"unprognostic (5.49e-2)"	"unprognostic (2.14e-2)"	"unprognostic (1.72e-1)"	"unprognostic (5.22e-2)"	"unprognostic (9.78e-2)"	121.7	84.3	46.1	105.2	48.9	176.9	184.5	48.6	48.2	127.8	59.0	118.7	107.3	121.7	123.7	144.5	158.1	84.6	95.0	46.2	48.0	88.4	88.0	87.5	174.1	51.1	48.6	193.3	228.0	108.1	55.3	109.8	51.3	97.8	135.5	45.6	132.8	102.2	152.1	153.4	100.1	118.7	48.9	138.6	129.3	63.5	50.8	162.6	113.5	93.1	211.8	134.7	116.2	52.2	312.4	171.3	172.2	197.2	237.8	462.3	287.8	235.2	321.2	319.5	313.7	270.7	171.1	395.3	173.4	271.8	202.4	230.9	295.1	374.5	320.7	215.7	313.6	215.4	151.9	209.6	428.2	507.5	214.4	419.6	427.7	357.1	515.0	365.1	347.5	128.0	238.3	195.9	363.6	194.0	180.3	281.0	188.5	484.9	141.6	318.1	278.0	305.0	314.2	214.9	135.9	190.7	153.6	311.3	337.4	180.0	196.7	472.5	243.9	247.9	222.6	188.3	333.6	247.5	171.8	316.9	252.1	318.1	242.7	166.7	383.7	141.3	320.3	353.5	520.4	518.1	461.1	381.1	528.9	509.2	558.2	455.7	95.1	402.3	348.9	303.3	608.7	826.1	46.1	48.9	48.6	48.2	46.2	48.0	51.1	48.6	51.3	48.9	50.8	52.2	115.6	60.9	92.0	13.7	184.7	212.9	287.1	299.1	134.9	37.3	231.9	216.8	67.9	130.1	167.1	46.0	31.3	224.2	151.5	68.2	150.6	191.7	126.3	108.4	95.3	141.7	112.7	101.4	8.5	207.8	240.4	99.4	78.0	88.1	187.3	128.9	126.7	41.0	219.7	25.2	8.7	149.1	109.9	211.0	176.1	46.4	138.5	121.7	129.9	8.4	275.1	75.6	137.0	10.6	12.5	185.6	134.7	108.3	72.5	230.6	176.5	160.1	119.9	46.2	72.3	147.9	260.8	106.0	83.2	140.3	215.8	246.1	159.8	162.2	219.7	288.0
EIF3E	"eIF3-p48, EIF3S6, INT6"	ENSG00000104408	"Eukaryotic translation initiation factor 3 subunit E"	P60228	8	108162787-108443496	"Cancer-related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Protein biosynthesis"	"Initiation factor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023973	Approved		Supported	Cytosol		NA	NA		21000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 50: Non-specific - Ribosome"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 32: Non-specific - Translation"	Cytosol		"HPA023973: AB_1848083"	"unprognostic (8.18e-2)"	"unprognostic (4.28e-2)"	"unprognostic (6.26e-2)"	"unprognostic (1.51e-1)"	"unprognostic (3.52e-3)"	"unprognostic (6.93e-3)"	"unprognostic (2.29e-2)"	"unprognostic (2.57e-2)"	"unprognostic (3.47e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.67e-3)"	"unprognostic (3.63e-1)"	"prognostic unfavorable (3.06e-7)"	"unprognostic (2.46e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.81e-1)"	"unprognostic (2.77e-2)"	269.0	201.4	104.7	94.2	107.2	251.7	418.1	113.6	178.1	360.4	110.9	281.2	93.5	232.5	243.3	256.3	263.0	163.5	187.7	104.6	110.0	178.0	199.1	174.2	231.1	107.7	108.9	449.4	409.1	138.5	157.2	161.1	111.2	204.8	155.7	63.6	214.1	186.4	343.2	230.9	181.7	135.6	107.3	157.6	237.0	83.9	107.6	283.0	183.9	241.1	208.9	248.7	267.2	112.7	339.4	208.1	211.3	193.3	518.2	1098.8	139.9	193.0	430.3	415.4	443.0	238.0	260.1	653.0	213.0	288.6	134.2	187.6	421.1	507.6	502.6	216.1	485.0	595.8	218.6	472.3	357.6	287.5	169.0	813.2	745.9	272.8	678.6	534.7	636.8	405.6	477.5	196.8	469.6	453.7	384.2	898.4	196.2	577.7	403.6	300.6	278.8	436.6	520.0	305.2	223.5	192.2	122.0	78.0	363.2	288.2	263.8	413.7	279.1	131.7	241.7	139.9	201.9	167.4	171.6	426.5	171.6	483.1	149.8	79.5	165.6	32.6	104.0	161.0	197.1	214.7	205.5	148.4	218.7	178.0	301.0	225.9	14.6	166.8	153.1	116.6	202.5	317.3	104.7	107.2	113.6	178.1	104.6	110.0	107.7	108.9	111.2	107.3	107.6	112.7	216.8	134.6	204.6	36.9	565.3	1036.0	1105.8	1174.4	805.3	64.5	569.8	274.2	93.1	317.4	463.5	158.2	54.2	614.4	288.0	101.3	606.5	332.3	377.4	173.8	399.2	365.6	297.5	319.8	36.3	354.3	770.9	366.9	196.7	220.5	378.3	277.1	403.4	212.6	424.2	58.9	36.2	400.5	443.5	662.4	875.2	73.8	454.2	368.7	517.6	37.5	621.8	154.8	268.8	59.8	69.2	272.3	279.1	327.6	251.0	728.2	273.8	799.7	201.7	74.6	190.7	434.6	564.5	276.7	102.8	532.6	1117.1	620.3	488.1	490.0	568.6	914.3
EIF3K	"ARG134, EIF3S12, HSPC029, M9, PLAC-24, PRO1474, PTD001"	ENSG00000178982	"Eukaryotic translation initiation factor 3 subunit K"	Q9UBQ5	19	38619082-38636955	"Predicted intracellular proteins"	"Protein biosynthesis"	"Initiation factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045446, HPA054590"	Uncertain		Supported	Cytosol		No	No			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 59: Non-specific - Translation"	"Cluster 21: OE19 - Mitochondria"	"Cluster 32: Non-specific - Translation"	Cytosol		"HPA045446: AB_10962716, HPA054590: AB_2682534"	"unprognostic (7.07e-3)"	"prognostic favorable (1.31e-4)"	"unprognostic (3.04e-2)"	"unprognostic (2.10e-3)"	"unprognostic (1.67e-2)"	"unprognostic (3.16e-1)"	"unprognostic (2.25e-2)"	"unprognostic (3.17e-1)"	"unprognostic (1.46e-1)"	"unprognostic (7.06e-3)"	"unprognostic (2.92e-2)"	"unprognostic (4.26e-2)"	"prognostic favorable (5.43e-4)"	"unprognostic (1.82e-1)"	"unprognostic (1.00e-1)"	"unprognostic (6.49e-2)"	"unprognostic (3.69e-2)"	233.4	177.9	98.8	83.6	100.4	172.7	228.3	104.9	114.2	214.3	113.1	285.5	142.0	186.6	110.2	286.1	188.4	73.2	591.7	98.9	100.9	313.3	189.0	169.3	142.0	103.2	101.7	214.8	262.2	179.6	173.0	72.0	101.0	172.1	165.7	57.9	197.5	100.4	682.7	290.7	219.1	113.7	102.1	222.5	265.7	66.5	103.7	143.7	168.6	462.4	182.1	218.4	216.6	105.3	135.3	421.3	110.1	175.4	196.5	197.7	134.3	104.2	180.7	220.9	192.5	272.0	118.6	300.2	121.2	174.2	128.7	122.4	221.2	280.8	165.1	145.7	184.6	214.0	134.4	197.2	201.0	345.1	170.7	219.6	252.3	151.4	269.6	118.8	242.3	156.6	217.9	250.8	188.8	215.2	185.3	158.6	103.5	474.4	211.4	222.7	197.0	235.7	225.3	311.0	141.5	139.4	114.8	377.1	174.0	117.3	145.9	260.3	133.9	135.0	134.8	81.3	185.9	246.4	276.3	255.6	114.9	321.6	155.0	154.8	267.8	138.2	182.8	297.8	232.1	252.0	222.3	213.2	359.0	218.0	228.9	204.0	72.4	201.2	305.7	209.4	296.4	441.8	98.8	100.4	104.9	114.2	98.9	100.9	103.2	101.7	101.0	102.1	103.7	105.3	372.1	93.0	166.1	26.4	430.3	395.6	547.4	674.4	345.4	83.6	477.2	755.1	502.5	320.3	331.0	217.0	66.7	422.9	376.3	466.2	1097.6	345.5	160.6	182.0	231.8	309.3	326.1	284.2	23.8	453.2	484.8	267.7	231.9	180.6	248.2	239.0	311.7	278.6	660.9	23.5	25.0	567.7	305.2	640.7	552.1	274.4	265.3	470.7	466.0	10.3	572.6	276.9	415.1	14.6	24.7	330.2	487.2	199.7	386.6	461.9	874.5	974.2	198.3	174.9	203.8	331.4	450.3	109.0	83.4	594.2	457.0	454.1	424.0	319.1	719.5	622.7
EIF4A3	"DDX48, EIF4AIII, Fal1, KIAA0111"	ENSG00000141543	"Eukaryotic translation initiation factor 4A3"	P38919	17	80134369-80147151	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"mRNA processing, mRNA splicing, mRNA transport, Nonsense-mediated mRNA decay, rRNA processing, Translation regulation, Transport"	"Helicase, Hydrolase, RNA-binding"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021878	Supported		Supported	Nucleoplasm		NA	NA		280000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm		"HPA021878: AB_1848090"	"unprognostic (7.24e-2)"	"unprognostic (7.33e-3)"	"prognostic favorable (3.57e-5)"	"unprognostic (1.29e-2)"	"unprognostic (2.95e-1)"	"unprognostic (2.52e-2)"	"prognostic unfavorable (1.68e-5)"	"prognostic unfavorable (1.87e-4)"	"unprognostic (3.71e-1)"	"unprognostic (5.06e-2)"	"unprognostic (4.64e-2)"	"unprognostic (2.64e-2)"	"unprognostic (9.78e-3)"	"unprognostic (5.81e-2)"	"unprognostic (9.20e-2)"	"unprognostic (1.38e-2)"	"unprognostic (2.91e-3)"	65.8	81.4	19.0	49.1	21.1	185.8	44.2	21.5	27.2	51.2	22.8	44.3	38.6	46.6	38.8	81.9	54.7	40.1	38.0	22.3	21.0	45.1	42.6	44.0	67.0	19.9	19.5	66.5	37.0	58.5	41.1	52.9	20.3	38.7	47.5	32.3	42.4	32.6	37.3	64.8	38.9	42.6	22.7	47.6	41.4	42.8	20.0	78.2	37.0	34.9	74.7	83.4	55.1	24.7	237.2	208.9	140.5	103.8	105.5	63.2	114.4	119.3	91.0	177.7	141.4	223.7	110.3	221.4	67.9	112.9	126.4	152.2	194.9	136.2	195.0	71.5	192.3	142.5	159.3	244.3	103.1	253.8	133.4	98.7	68.7	149.5	119.4	71.8	147.2	128.7	189.8	140.2	105.3	178.9	224.8	132.8	145.0	223.8	190.0	168.5	282.7	172.2	85.8	196.5	186.1	100.1	170.9	334.2	151.9	130.1	219.3	166.7	100.5	108.7	138.6	159.9	200.3	104.4	86.2	403.2	88.0	158.7	113.3	126.1	167.0	137.4	101.1	174.6	131.2	142.4	128.2	119.4	200.0	119.8	116.9	115.2	98.7	132.9	143.4	326.0	158.2	232.6	19.0	21.1	21.5	27.2	22.3	21.0	19.9	19.5	20.3	22.7	20.0	24.7	117.9	41.7	48.0	6.8	135.1	283.1	273.4	212.9	107.0	23.3	77.0	109.2	61.5	38.6	107.8	29.5	16.7	140.1	165.7	75.4	64.6	85.6	33.2	132.9	109.2	70.5	60.3	24.4	4.1	115.2	225.1	144.3	149.4	248.2	92.6	42.6	32.2	27.0	108.5	6.7	4.3	83.2	89.5	63.4	255.0	12.1	67.1	199.6	103.2	10.3	67.9	48.6	23.7	5.5	7.6	86.6	83.1	49.7	118.6	96.0	47.9	65.0	61.4	32.5	85.5	109.7	207.8	99.4	123.2	77.6	299.1	261.9	138.4	98.0	77.7	252.5
EIF4E	"EIF4E1, EIF4EL1, EIF4F"	ENSG00000151247	"Eukaryotic translation initiation factor 4E"	P06730	4	98879276-98929133	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, Protein biosynthesis, Translation regulation"	"Initiation factor, RNA-binding"	"Autism, Autism spectrum disorder, Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"Early spermatids: 927.0;Late spermatids: 2284.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004077, CAB016316, HPA068358"	Supported		Supported	"Nucleoplasm,Cytosol,Cytoplasmic bodies"		NA	NA		450000	"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 25: Spermatids - Spermatogenesis"	"Cytosol, Cytoplasmic bodies"	Nucleoplasm	"CAB004077: AB_823488, CAB016316: AB_627502, HPA068358: "	"unprognostic (3.07e-3)"	"unprognostic (1.43e-1)"	"unprognostic (6.53e-3)"	"unprognostic (7.52e-2)"	"unprognostic (1.41e-1)"	"unprognostic (2.43e-3)"	"unprognostic (2.03e-5)"	"unprognostic (6.55e-3)"	"unprognostic (1.09e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.10e-3)"	"unprognostic (5.40e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.31e-2)"	"unprognostic (1.28e-1)"	38.0	37.4	27.4	37.7	28.5	57.4	35.6	32.5	34.6	28.5	20.9	45.1	35.9	30.5	38.0	51.7	31.7	31.3	37.5	27.8	34.3	47.4	43.3	27.0	44.6	29.2	31.1	29.1	27.0	45.1	17.0	35.9	29.2	31.4	52.2	54.0	31.2	30.7	39.2	24.2	34.4	39.4	36.2	31.5	35.8	62.6	31.4	53.2	52.6	48.1	58.0	54.4	29.8	34.3	101.1	85.2	139.8	96.5	73.4	74.2	87.3	184.6	105.3	137.0	100.5	111.0	122.7	194.7	59.4	104.4	94.3	49.0	181.9	124.9	158.9	133.5	56.2	135.6	52.7	105.8	62.6	199.3	104.8	54.5	78.3	104.8	82.9	81.5	108.3	97.6	226.6	95.2	120.0	82.9	189.2	110.6	115.0	189.2	72.2	119.7	94.4	90.0	122.0	85.3	123.3	80.3	85.5	188.4	65.4	93.3	89.9	85.9	86.5	110.0	121.6	96.9	153.7	71.4	185.4	179.4	99.7	102.7	127.1	39.5	34.7	59.3	38.2	42.1	44.4	50.0	43.2	40.2	39.6	43.6	47.3	47.3	26.3	54.3	54.8	33.5	46.5	50.3	27.4	28.5	32.5	34.6	27.8	34.3	29.2	31.1	29.2	36.2	31.4	34.3	45.2	32.1	42.2	29.7	93.1	362.1	227.5	202.2	149.7	87.9	81.6	41.1	27.5	55.8	106.0	60.7	35.5	105.3	56.2	140.5	256.3	88.9	927.0	76.1	84.0	77.8	64.6	192.8	45.2	67.4	150.0	87.1	80.0	119.0	51.4	28.0	40.0	77.1	121.1	85.8	45.0	77.4	227.9	61.9	327.6	2284.9	50.7	122.1	193.9	25.3	69.8	82.0	57.7	35.2	50.9	83.8	107.1	49.2	113.0	191.1	83.2	189.2	76.8	64.7	52.6	78.7	151.7	98.7	87.1	171.2	370.9	119.0	82.2	39.8	97.3	224.3
EIF4EBP1	"4E-BP1, PHAS-I"	ENSG00000187840	"Eukaryotic translation initiation factor 4E binding protein 1"	Q13541	8	38030534-38060365	"Cancer-related genes, Predicted intracellular proteins"	"Translation regulation"	"Protein synthesis inhibitor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 188.9;salivary gland: 164.2"	"Cell type enhanced"	"Detected in many"		"Exocrine glandular cells: 730.0;Pancreatic endocrine cells: 277.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB005032, CAB005039, HPA023501"	Supported		Supported	Nucleoplasm,Cytosol		NA	NA		44000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 50: Non-specific - Ribosome"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 1: Pancreatic cells - Digestion"	"Nucleoplasm, Cytosol"		"CAB005032: AB_562030, CAB005039: AB_562029, HPA023501: AB_1848095"	"unprognostic (1.55e-2)"	"unprognostic (2.45e-1)"	"unprognostic (1.58e-1)"	"prognostic unfavorable (8.86e-4)"	"unprognostic (6.94e-2)"	"unprognostic (2.69e-1)"	"unprognostic (1.94e-2)"	"unprognostic (3.27e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.16e-2)"	"unprognostic (3.18e-3)"	"unprognostic (7.21e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (7.98e-2)"	"unprognostic (3.01e-1)"	"unprognostic (4.57e-2)"	"unprognostic (5.72e-3)"	60.9	12.6	7.7	16.9	8.0	35.0	53.6	8.0	10.9	24.9	12.7	25.3	18.5	19.7	2.2	86.0	21.7	8.9	32.7	8.0	9.8	19.5	63.5	25.0	10.3	9.8	8.5	22.2	188.9	7.8	9.2	28.6	9.8	19.2	15.4	1.5	164.2	17.0	98.1	20.8	23.1	14.4	8.5	23.9	43.8	5.5	10.1	9.6	9.6	27.2	10.4	33.6	26.5	10.8	146.9	113.2	32.4	193.2	41.3	32.3	77.0	130.5	111.9	128.4	203.5	74.8	56.3	46.3	101.5	121.3	77.1	85.1	109.1	197.5	74.8	36.0	190.9	269.6	52.0	104.9	423.6	98.8	60.4	100.0	314.9	142.0	264.1	40.1	208.2	57.7	152.7	221.8	54.8	141.7	95.9	297.8	186.0	112.9	243.7	80.3	80.4	197.4	49.3	22.3	281.6	200.8	26.1	78.8	534.8	20.3	105.8	192.2	105.2	76.1	167.1	179.9	137.8	185.1	121.6	72.1	173.4	213.4	169.1	51.1	416.3	258.3	27.9	336.6	27.3	130.7	32.8	30.9	335.0	103.3	26.2	26.0	39.4	35.0	268.3	242.6	66.0	258.3	7.7	8.0	8.0	10.9	8.0	9.8	9.8	8.5	9.8	8.5	10.1	10.8	23.6	9.6	8.3	1.6	25.2	74.4	42.4	114.8	51.8	3.6	84.8	72.8	41.7	57.2	97.3	20.2	2.1	41.3	27.3	70.1	29.4	226.1	17.0	11.6	39.0	54.6	40.2	79.9	0.8	730.0	224.2	68.6	35.7	12.5	18.4	76.0	65.3	103.4	223.4	0.0	1.3	138.2	79.3	108.6	82.2	106.2	43.5	83.9	72.9	1.9	101.9	19.2	21.6	4.0	0.4	277.9	64.5	19.2	38.7	100.2	19.5	103.1	33.5	2.2	13.1	17.6	85.2	1.9	25.5	209.3	85.4	38.6	19.8	69.3	83.8	58.9
EIF5A	"EIF-5A, EIF5A1, MGC104255, MGC99547"	ENSG00000132507	"Eukaryotic translation initiation factor 5A"	P63241	17	7306999-7312463	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transporters"	"mRNA transport, Protein biosynthesis, Protein transport, Translocation, Transport"	"Elongation factor, RNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB005042, HPA061298, HPA074052"	Approved		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Cytosol	"Nucleoplasm, Plasma membrane"	"CAB005042: AB_562281, HPA061298: AB_2684472, HPA074052: "	"unprognostic (3.72e-1)"	"unprognostic (1.67e-1)"	"unprognostic (8.10e-2)"	"unprognostic (2.80e-1)"	"unprognostic (6.95e-2)"	"unprognostic (1.39e-2)"	"unprognostic (1.06e-2)"	"prognostic unfavorable (9.04e-4)"	"unprognostic (4.10e-1)"	"unprognostic (4.11e-2)"	"unprognostic (1.64e-2)"	"unprognostic (8.25e-2)"	"prognostic unfavorable (1.63e-5)"	"unprognostic (3.53e-1)"	"unprognostic (2.79e-1)"	"unprognostic (6.01e-2)"	"unprognostic (7.65e-2)"	317.2	309.3	82.3	138.3	83.8	221.5	240.7	85.5	99.0	222.7	77.8	247.5	113.0	206.2	85.8	575.9	188.1	73.7	316.1	87.8	89.8	241.7	495.6	244.5	135.0	87.7	86.4	161.2	295.0	79.7	166.7	96.4	93.0	189.1	125.7	47.6	230.9	65.6	572.1	407.8	207.5	106.1	86.5	227.4	226.7	201.7	92.3	122.5	181.6	160.3	154.4	221.3	281.8	88.6	838.2	958.6	275.8	570.6	220.8	270.2	427.1	546.2	360.7	730.1	501.6	583.6	343.3	749.7	350.9	451.4	300.3	572.3	610.0	777.8	665.9	466.2	987.2	477.9	710.1	750.6	388.6	324.0	431.7	302.5	374.9	587.8	736.0	259.1	501.4	232.0	673.8	192.2	527.3	496.2	388.6	523.3	525.8	477.2	498.0	412.0	320.5	732.4	464.6	393.8	340.5	431.8	330.0	469.4	360.8	212.3	327.2	258.4	427.7	567.6	379.5	326.2	896.4	168.8	229.9	443.6	515.1	527.2	642.2	146.8	137.6	102.0	157.4	193.1	187.5	154.5	153.1	137.2	215.9	149.1	139.6	144.6	62.0	195.1	186.5	225.0	156.7	200.3	82.3	83.8	85.5	99.0	87.8	89.8	87.7	86.4	93.0	86.5	92.3	88.6	180.1	54.5	37.9	6.2	241.9	349.0	67.9	226.5	378.5	88.3	258.8	138.7	77.8	125.8	72.7	62.5	14.6	324.3	200.3	316.0	74.3	317.3	153.8	136.4	255.2	176.6	150.6	456.1	6.8	239.8	633.8	199.6	172.8	187.8	138.4	87.3	105.7	236.4	296.8	50.5	7.0	317.4	83.4	133.6	283.1	112.9	100.6	151.9	263.3	4.7	245.0	122.2	216.3	2.0	11.5	322.0	223.7	81.3	386.7	507.1	229.3	127.1	41.3	65.0	92.1	160.7	262.1	200.4	82.6	572.0	313.7	428.4	179.3	290.7	384.7	207.0
EIF5A2		ENSG00000163577	"Eukaryotic translation initiation factor 5A2"	Q9GZV4	3	170888418-170908644	"Predicted intracellular proteins, Transporters"	"mRNA transport, Protein biosynthesis, Protein transport, Translocation, Transport"	"Elongation factor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 28.3"	"Group enriched"	"Detected in many"	12	"Early spermatids: 353.0;Late spermatids: 977.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029090	Approved		Supported	Vesicles		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 18: U-2197 - ECM organization"	"Cluster 34: Spermatids - Unknown function"	Vesicles		"HPA029090: AB_10671359"	"unprognostic (2.41e-1)"	"unprognostic (2.42e-1)"	"unprognostic (4.05e-1)"	"unprognostic (5.75e-2)"	"unprognostic (1.27e-1)"	"prognostic unfavorable (7.42e-4)"	"unprognostic (1.11e-3)"	"unprognostic (1.47e-1)"	"unprognostic (3.72e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.79e-1)"	"unprognostic (2.66e-2)"	"unprognostic (3.45e-2)"	"unprognostic (5.92e-2)"	"unprognostic (1.64e-2)"	"unprognostic (4.29e-3)"	4.1	2.7	1.9	3.1	2.8	4.2	2.9	5.8	6.1	3.1	1.9	3.4	1.7	4.5	1.3	2.9	2.4	3.5	4.0	1.9	5.4	5.0	1.6	2.2	2.8	7.2	4.6	4.4	3.3	3.7	1.8	1.8	8.2	2.6	2.6	2.8	1.9	3.0	1.3	1.9	1.6	7.2	4.1	2.3	9.1	28.3	5.5	4.3	2.2	3.1	3.1	3.5	2.0	7.2	22.7	11.6	4.2	5.9	21.7	14.2	10.0	17.1	22.3	17.4	25.1	23.6	14.4	14.2	30.9	23.4	38.9	7.4	13.4	6.0	21.9	15.8	5.8	6.9	4.6	7.5	14.6	18.2	19.9	16.6	8.7	26.3	21.4	24.2	9.1	3.7	5.8	0.1	28.7	7.6	8.1	7.9	8.1	17.5	7.8	0.0	12.0	0.0	7.3	4.0	3.4	6.4	17.7	4.6	14.4	6.5	10.0	11.9	12.0	21.2	15.0	44.8	38.9	21.6	0.3	33.3	7.2	6.2	15.4	14.9	1.4	1.5	12.4	1.5	8.7	2.2	8.4	11.9	1.0	3.5	5.0	8.3	0.7	8.8	1.4	1.0	11.3	5.0	1.9	2.8	5.8	6.1	1.9	5.4	7.2	4.6	8.2	4.1	5.5	7.2	16.6	0.0	0.5	4.9	4.4	17.1	8.5	7.8	10.8	2.5	2.1	2.7	9.5	0.0	1.8	1.8	0.0	1.2	18.1	1.6	1.9	6.4	353.0	0.9	7.7	12.8	4.9	2.1	7.1	7.5	1.9	11.7	8.6	0.6	2.5	2.6	3.3	2.5	8.9	0.0	8.8	0.8	2.0	3.8	7.2	977.9	12.8	4.5	10.6	3.7	7.9	8.0	28.8	4.0	10.1	19.6	6.1	11.3	3.7	8.2	1.7	21.1	3.4	2.7	46.0	9.6	11.6	54.3	10.0	2.3	21.6	0.7	15.7	2.2	1.8	5.7
EIF6	"b(2)gcn, EIF3A, ITGB4BP, p27BBP"	ENSG00000242372	"Eukaryotic translation initiation factor 6"	P56537	20	35278907-35284985	"Plasma proteins, Predicted intracellular proteins"	"Protein biosynthesis, Ribosome biogenesis"	"Initiation factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Pancreatic endocrine cells: 700.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA040873	Enhanced		Supported	Nucleoplasm		NA	NA		260000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 37: Intestine - Unknown function"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	Nucleoplasm		"HPA040873: AB_2677182"	"unprognostic (9.00e-2)"	"unprognostic (2.65e-1)"	"unprognostic (2.06e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.75e-1)"	"unprognostic (2.24e-1)"	"prognostic unfavorable (7.25e-5)"	"unprognostic (9.94e-3)"	"unprognostic (4.97e-2)"	"unprognostic (1.14e-1)"	"unprognostic (4.55e-3)"	"unprognostic (2.63e-1)"	"unprognostic (3.51e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.17e-1)"	"unprognostic (9.18e-2)"	"unprognostic (8.15e-2)"	66.5	99.4	55.8	61.7	56.9	75.8	87.3	58.2	64.9	91.0	64.4	120.2	142.6	80.3	80.7	242.6	99.1	64.7	51.8	57.6	64.4	129.6	172.4	64.0	75.5	59.9	58.3	67.4	73.7	93.1	56.4	68.2	61.6	76.7	122.8	21.6	88.7	84.2	52.2	169.0	119.4	92.9	58.0	68.8	83.3	71.8	57.9	78.9	64.8	56.9	120.4	146.5	125.6	60.1	338.1	447.4	115.3	137.1	136.9	161.9	148.6	205.5	250.8	431.5	322.3	864.0	306.2	232.1	251.2	258.2	326.7	261.8	234.6	671.8	299.9	60.0	154.8	397.5	188.7	752.0	262.6	225.1	177.1	162.8	430.3	331.3	680.3	185.8	298.1	131.4	253.1	116.6	459.7	325.8	128.2	285.5	151.2	367.4	375.3	173.1	203.9	207.1	590.5	243.6	194.2	178.3	163.4	675.6	266.5	93.3	314.7	177.0	248.2	478.8	211.7	244.0	326.3	135.0	149.4	221.8	243.2	216.7	274.6	420.1	267.8	230.4	166.0	278.1	182.5	261.7	165.1	183.9	318.5	263.4	132.7	158.1	89.6	247.4	316.1	291.0	196.8	353.2	55.8	56.9	58.2	64.9	57.6	64.4	59.9	58.3	61.6	58.0	57.9	60.1	80.8	64.1	54.2	4.9	75.7	281.3	270.0	333.6	95.6	32.6	81.9	102.4	27.8	114.4	201.0	165.5	10.4	237.5	82.5	363.7	197.6	375.8	68.9	92.3	60.1	90.3	105.7	50.9	5.7	378.8	217.7	78.5	73.9	90.2	99.0	62.2	60.7	216.0	176.6	25.2	5.0	150.7	193.3	78.6	169.8	94.5	81.7	89.9	106.7	1.9	226.8	68.3	81.4	2.0	6.2	700.9	468.3	67.0	53.9	213.1	373.0	527.0	116.8	32.2	65.7	70.7	170.7	130.5	77.8	197.3	346.5	256.0	70.0	120.4	215.0	468.0
EIPR1	"EIPR-1, TSSC1"	ENSG00000032389	"EARP complex and GARP complex interacting protein 1"	Q53HC9	2	3188925-3377830	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 48.6;Distal tubular cells: 50.9;Ductal cells: 28.7;Extravillous trophoblasts: 36.9;Hofbauer cells: 34.0;Proximal tubular cells: 41.6;Syncytiotrophoblasts: 26.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031231, HPA031232, HPA031233, HPA031234"	Approved		Supported	"Nucleoplasm,Nucleoli,Intermediate filaments"		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 7: Non-specific - Mitochondria"	"Nucleoplasm, Nucleoli"	"Intermediate filaments"	"HPA031231: AB_10669881, HPA031232: AB_10603222, HPA031233: AB_10670026, HPA031234: AB_2673803"	"unprognostic (2.16e-1)"	"unprognostic (2.22e-1)"	"unprognostic (2.71e-1)"	"unprognostic (1.66e-1)"	"unprognostic (4.27e-2)"	"unprognostic (1.22e-1)"	"prognostic unfavorable (3.67e-7)"	"unprognostic (1.94e-1)"	"unprognostic (1.57e-1)"	"unprognostic (7.83e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.50e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.02e-2)"	"unprognostic (3.43e-1)"	"unprognostic (2.24e-2)"	"unprognostic (3.83e-2)"	8.5	15.2	24.8	13.8	25.6	18.2	9.8	24.3	27.3	9.3	20.5	13.6	12.2	9.9	19.4	19.7	13.2	7.7	11.9	26.0	26.2	17.9	16.5	9.3	19.2	22.2	23.2	6.9	10.5	15.8	27.8	9.1	23.9	9.5	11.8	15.9	11.2	7.8	14.0	13.9	10.6	10.6	22.9	14.6	10.8	11.6	25.1	22.2	22.4	15.2	18.0	10.8	11.1	23.6	25.4	48.2	25.9	28.2	15.7	21.1	56.2	26.8	27.8	32.0	24.2	32.5	32.6	45.3	46.8	28.3	30.1	25.9	20.9	39.3	17.3	35.5	37.5	40.7	28.4	76.2	29.9	40.2	49.9	19.5	35.1	32.2	43.6	17.6	41.9	79.0	45.2	30.9	29.7	48.5	37.6	57.9	29.4	61.5	38.1	43.6	26.6	61.6	39.6	35.7	54.5	62.6	18.5	31.7	30.1	13.8	29.0	36.9	29.9	25.3	13.1	21.2	36.9	34.9	88.0	37.8	30.0	40.8	24.1	22.2	15.2	12.8	19.7	17.9	19.6	16.8	16.1	20.6	27.4	20.6	17.6	18.8	6.5	22.2	16.7	30.3	22.2	18.6	24.8	25.6	24.3	27.3	26.0	26.2	22.2	23.2	23.9	22.9	25.1	23.6	5.6	3.2	9.2	0.0	3.5	0.0	0.0	0.0	0.0	0.0	8.5	7.0	0.0	0.0	6.2	20.2	0.0	48.6	7.0	0.0	50.9	28.7	0.0	14.9	7.5	7.0	0.0	0.0	0.0	16.0	36.9	5.0	0.0	11.5	3.8	13.7	0.0	0.0	34.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.2	0.0	0.0	16.5	0.0	0.0	0.0	0.0	20.7	0.0	0.0	2.3	0.0	0.0	41.6	4.4	0.0	0.0	0.0	4.8	0.0	0.0	0.0	0.0	26.7	5.7	24.5	0.0	0.0
ELAC1	D29	ENSG00000141642	"ElaC ribonuclease Z 1"	Q9H777	18	50967991-50988121	"Enzymes, Predicted intracellular proteins"	"tRNA processing"	"Endonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040867, HPA066483"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm	Cytosol	"HPA040867: AB_10697716, HPA066483: AB_2685675"	"unprognostic (1.05e-2)"	"unprognostic (1.65e-1)"	"unprognostic (6.95e-3)"	"unprognostic (1.75e-2)"	"unprognostic (8.61e-2)"	"unprognostic (5.96e-2)"	"unprognostic (3.25e-1)"	"unprognostic (3.03e-3)"	"unprognostic (5.87e-2)"	"unprognostic (2.82e-3)"	"unprognostic (3.67e-3)"	"unprognostic (6.36e-2)"	"prognostic favorable (8.43e-8)"	"unprognostic (3.54e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.59e-2)"	"unprognostic (3.87e-2)"	5.1	7.2	4.2	5.4	4.4	2.3	6.2	3.9	6.0	5.0	4.8	6.2	5.0	4.4	12.8	4.4	6.4	4.1	3.3	4.4	5.2	8.0	9.9	5.1	6.7	3.8	3.9	5.5	8.7	11.8	5.7	5.6	4.0	6.2	7.0	5.0	6.6	6.1	3.1	4.6	6.5	4.3	3.3	6.9	6.3	7.2	5.2	7.2	10.2	2.8	6.9	4.7	3.4	5.1	9.1	6.1	16.0	13.6	17.5	7.4	6.8	9.8	12.7	9.0	6.3	2.3	7.9	7.0	6.5	9.1	7.2	8.8	5.0	10.3	6.1	15.4	1.3	8.6	2.3	1.6	10.4	22.1	5.8	9.3	8.1	4.8	11.0	7.2	9.5	10.0	8.9	16.9	16.0	4.1	7.8	6.4	8.0	7.6	3.1	8.6	5.6	13.0	10.4	3.8	9.4	10.7	8.2	1.4	15.5	6.6	7.5	16.6	8.4	11.6	6.0	3.4	6.7	15.8	14.4	9.3	10.7	7.3	14.9	5.0	9.6	10.0	15.4	11.5	17.1	18.6	14.7	14.9	15.4	16.8	14.0	18.1	0.9	20.8	11.4	13.0	12.8	10.0	4.2	4.4	3.9	6.0	4.4	5.2	3.8	3.9	4.0	3.3	5.2	5.1	5.9	6.4	6.5	7.2	7.6	2.4	5.6	14.5	4.6	7.3	8.7	10.4	8.6	12.8	8.0	3.7	2.1	23.3	4.0	8.5	19.6	14.6	21.4	8.8	6.3	7.9	10.3	5.5	4.1	13.5	13.3	8.1	3.1	4.8	8.2	11.4	10.0	15.2	15.4	5.0	5.3	8.2	14.2	8.9	2.8	22.8	5.0	6.3	5.4	2.8	10.2	15.8	23.7	7.5	8.4	10.4	9.1	7.2	5.6	8.1	15.9	25.5	11.8	8.2	0.0	8.5	6.4	29.1	12.9	5.6	3.4	18.9	6.8	11.1	10.5	4.9
ELAC2	"FLJ10530, HPC2"	ENSG00000006744	"ElaC ribonuclease Z 2"	Q9BQ52	17	12991612-13018065	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"tRNA processing"	"Endonuclease, Hydrolase, Nuclease"	"Disease variant, Primary mitochondrial disease, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SuSa: 394.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019535	Approved		Supported	Nucleoplasm		NA	NA		9500	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 12: NES - Nervous system development"	"Cluster 47: Cytotrophoblasts - Unknown function"	Nucleoplasm		"HPA019535: AB_1848106"	"unprognostic (4.24e-3)"	"unprognostic (2.26e-1)"	"unprognostic (1.11e-1)"	"prognostic favorable (3.24e-6)"	"unprognostic (8.64e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.65e-1)"	"unprognostic (2.47e-1)"	"unprognostic (2.22e-1)"	"unprognostic (3.98e-1)"	"unprognostic (5.31e-3)"	"unprognostic (3.09e-1)"	"unprognostic (5.31e-3)"	"unprognostic (2.21e-1)"	"unprognostic (1.15e-1)"	"unprognostic (8.09e-2)"	"unprognostic (3.70e-2)"	30.7	35.8	13.7	23.0	14.6	22.7	24.6	14.7	14.3	21.7	18.0	28.7	23.1	24.7	17.1	31.9	25.8	21.1	38.1	13.8	15.0	28.6	32.5	19.8	28.0	16.4	14.6	19.8	23.1	33.8	12.5	23.5	15.3	26.4	32.7	22.5	20.4	33.6	60.2	23.8	21.1	33.6	17.1	28.8	24.8	28.1	13.4	28.4	25.8	35.7	37.6	24.6	18.2	22.1	76.4	102.1	69.8	81.5	53.3	53.9	44.9	75.4	59.6	119.8	79.8	84.3	34.8	127.7	84.9	69.9	45.0	96.6	133.6	80.6	113.5	65.7	163.7	73.0	82.1	54.7	40.7	64.7	99.4	47.3	70.6	88.2	80.5	51.4	88.3	71.5	108.0	34.8	88.7	58.0	112.0	58.3	62.2	132.9	80.7	84.1	122.2	82.2	62.0	59.2	37.5	54.6	97.4	61.0	39.2	394.4	59.1	26.2	82.7	152.3	47.6	57.0	116.3	24.7	51.6	53.3	57.6	64.2	54.6	26.9	31.1	19.2	41.6	41.2	43.4	37.7	39.1	40.7	48.4	34.4	39.7	36.2	4.7	53.5	46.8	30.1	53.4	46.3	13.7	14.6	14.7	14.3	13.8	15.0	16.4	14.6	15.3	17.1	13.4	22.1	11.6	6.4	10.8	6.8	18.0	10.3	10.1	16.7	16.5	11.3	12.5	10.8	28.3	12.8	12.9	16.5	2.1	59.3	15.6	13.2	19.6	27.4	6.4	13.0	13.1	14.1	8.4	24.0	9.8	26.0	32.6	16.6	17.3	14.2	9.5	30.4	11.7	28.4	28.2	11.8	9.2	13.5	24.4	14.2	7.0	5.7	10.5	10.0	14.2	3.7	14.7	16.1	14.4	7.1	10.6	25.9	16.6	21.4	21.6	13.5	15.2	19.5	12.2	14.6	52.6	10.1	14.9	26.4	24.4	22.2	14.5	33.5	15.9	59.0	20.7	8.2
ELAPOR1	"EIG121, KIAA1324, maba1"	ENSG00000116299	"Endosome-lysosome associated apoptosis and autophagy regulator 1"	Q6UXG2	1	109113679-109206781	"Predicted intracellular proteins, Predicted membrane proteins"	Autophagy			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 156.7;salivary gland: 166.1;stomach 1: 88.2"	"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 1.6;dendritic cells: 1.2;Hofbauer cells: 1.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in many"	7	"neutrophil: 65.2"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 65.2"	"Cell line enhanced"	"Detected in some"		"MCF7: 20.8;SCLC-21H: 16.8;SK-BR-3: 17.6;T-47d: 59.1;U-87 MG: 12.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA029869, HPA070749"	Enhanced		Supported	"Plasma membrane"		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 25: Pancreas - Digestion"	"Cluster 6: T47d - Mammary gland"	"Cluster 24: Non-specific - Transcription regulation"	"Plasma membrane"		"HPA029869: AB_10794320, HPA070749: AB_2686304"	"unprognostic (2.10e-1)"	"unprognostic (1.42e-2)"	"unprognostic (1.99e-2)"	"prognostic favorable (2.14e-7)"	"unprognostic (4.18e-3)"	"unprognostic (5.63e-2)"	"unprognostic (1.96e-3)"	"prognostic favorable (5.69e-5)"	"unprognostic (2.79e-2)"	"prognostic favorable (2.16e-4)"	"unprognostic (3.50e-3)"	"unprognostic (1.01e-1)"	"unprognostic (2.22e-16)"	"unprognostic (2.46e-1)"	"unprognostic (1.75e-1)"	"unprognostic (5.64e-2)"	"unprognostic (8.02e-2)"	0.8	3.2	3.6	4.1	4.4	0.5	56.7	0.0	4.9	70.1	0.0	28.3	45.5	12.8	9.7	1.6	23.9	5.6	0.2	4.4	13.2	0.1	0.2	5.1	2.5	0.2	0.1	0.1	156.7	9.2	32.9	0.2	0.7	48.6	27.8	0.4	166.1	0.3	0.0	3.9	35.3	1.1	0.0	0.8	88.2	18.3	10.0	0.8	9.0	0.1	1.9	0.4	0.1	1.7	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.8	0.5	0.2	0.1	0.2	0.0	0.0	0.5	0.6	0.7	1.3	0.1	0.0	0.1	0.0	0.2	0.2	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.1	1.1	1.0	0.0	0.0	0.5	20.8	0.2	0.3	0.5	0.0	0.1	0.1	0.3	1.1	0.1	0.0	16.8	0.4	0.1	17.6	0.0	0.1	59.1	0.0	0.4	0.0	2.1	0.2	0.2	1.3	3.6	0.0	12.4	0.0	0.1	0.0	0.1	0.0	4.6	0.0	7.6	0.4	7.5	3.2	0.0	0.1	3.3	1.5	65.2	0.5	0.0	0.0	9.8	2.2	3.6	4.4	0.0	4.9	4.4	13.2	0.2	0.1	0.7	0.0	10.0	1.7	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.8	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.4	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.4	0.0	0.0	0.0
ELAVL1	"Hua, HUR, MelG"	ENSG00000066044	"ELAV like RNA binding protein 1"	Q15717	19	7958573-8005659	"Plasma proteins, Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 227.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005256, HPA046298"	Approved		Supported	Nucleoplasm,Nucleoli,Cytosol		NA	NA		230000	"Cluster 26: Non-specific - Mitochondria"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 14: REH - Unknown function"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm	"Nucleoli, Cytosol"	"CAB005256: AB_2096342, HPA046298: AB_2679618"	"unprognostic (1.19e-1)"	"unprognostic (9.66e-3)"	"unprognostic (2.46e-2)"	"unprognostic (3.98e-1)"	"unprognostic (1.04e-1)"	"unprognostic (6.37e-3)"	"unprognostic (1.81e-2)"	"unprognostic (8.44e-2)"	"unprognostic (3.75e-2)"	"prognostic favorable (4.93e-4)"	"unprognostic (2.09e-1)"	"unprognostic (1.59e-2)"	"unprognostic (7.23e-2)"	"unprognostic (6.14e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.18e-2)"	"unprognostic (1.65e-2)"	27.5	27.7	14.5	33.1	15.6	27.8	25.0	16.0	15.7	29.4	19.5	27.9	25.2	31.6	25.9	30.0	34.3	22.4	34.0	15.3	15.9	24.8	29.0	24.2	40.2	13.7	15.6	31.8	28.4	37.5	21.4	32.7	13.8	26.9	27.2	19.0	29.6	29.4	37.7	24.9	25.1	35.9	16.2	30.1	24.6	46.1	15.1	52.7	27.9	32.2	44.1	37.4	25.2	16.6	127.5	84.1	137.9	104.5	52.9	52.7	76.5	89.5	78.4	136.9	106.3	122.4	73.2	153.2	125.5	104.0	76.9	86.0	155.2	107.9	114.8	134.9	131.8	135.5	58.9	115.7	77.4	129.9	103.1	65.8	63.6	95.7	57.7	64.8	106.2	115.6	140.7	112.6	95.7	95.8	215.3	103.7	122.1	96.4	101.6	239.0	89.6	100.9	87.5	93.9	98.0	70.8	88.9	89.1	71.7	82.6	101.8	101.4	79.7	127.3	87.3	119.2	161.8	109.8	114.7	161.9	71.3	154.2	112.2	29.9	19.7	37.2	16.4	17.2	17.0	20.8	24.0	26.3	25.0	27.7	21.8	16.6	5.3	33.1	22.1	12.5	20.9	16.3	14.5	15.6	16.0	15.7	15.3	15.9	13.7	15.6	13.8	16.2	15.1	16.6	45.7	25.6	23.1	18.6	56.0	72.4	79.5	29.0	51.2	47.2	54.9	37.2	31.3	30.0	20.7	47.8	56.3	86.8	48.1	32.9	66.5	37.1	227.7	41.6	46.5	52.2	42.0	95.7	20.3	33.8	102.3	53.1	40.2	47.2	21.0	59.5	47.2	89.2	64.2	60.6	21.5	52.9	18.3	57.5	79.2	164.1	50.4	47.3	51.6	23.4	43.9	43.4	57.7	33.7	26.9	35.3	45.7	56.8	88.7	98.2	38.3	65.8	27.3	55.7	52.6	45.5	71.0	164.7	61.2	72.0	71.0	74.8	50.9	44.7	60.2	84.6
ELF1		ENSG00000120690	"E74 like ETS transcription factor 1"	P32519	13	40931924-41061440	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 200.9"	"Cell type enhanced"	"Detected in all"		"T-cells: 365.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HMC-1: 271.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001755, CAB005172"	Enhanced		Supported	Nucleoplasm		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm		"CAB005172: AB_631428, HPA001755: AB_1078732"	"unprognostic (1.21e-1)"	"unprognostic (8.73e-3)"	"unprognostic (4.20e-2)"	"unprognostic (8.45e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.02e-1)"	"unprognostic (3.28e-1)"	"unprognostic (2.11e-2)"	"unprognostic (5.78e-2)"	"unprognostic (3.38e-2)"	"unprognostic (2.17e-1)"	"unprognostic (6.02e-3)"	"unprognostic (2.96e-1)"	"unprognostic (4.11e-2)"	"unprognostic (8.98e-2)"	"unprognostic (3.72e-2)"	64.2	22.5	8.8	64.3	14.5	200.9	45.3	13.8	9.9	45.8	11.1	45.6	53.4	35.3	28.9	52.6	41.1	59.6	29.1	8.9	12.4	31.9	50.4	47.3	95.3	19.7	14.1	34.6	56.1	39.8	9.7	48.6	19.5	35.2	48.3	4.2	35.3	33.9	21.3	38.5	57.8	43.9	13.7	68.3	49.7	15.1	14.9	134.5	54.9	25.9	96.9	61.3	36.5	21.0	35.5	20.5	15.3	15.3	68.6	72.6	57.2	35.9	84.9	48.7	55.1	51.2	90.9	199.7	22.1	60.4	36.5	78.7	2.9	45.4	30.8	44.9	23.7	179.6	16.3	36.5	50.9	103.3	271.2	75.1	78.5	32.9	62.0	32.8	69.2	93.1	45.0	51.7	32.4	32.5	136.6	63.1	12.1	117.7	15.8	179.2	25.1	58.7	49.9	54.8	6.1	21.3	31.0	31.0	62.9	21.2	22.0	132.8	63.8	21.5	12.4	17.7	13.0	23.7	14.8	131.2	29.0	65.0	45.9	265.9	60.4	134.2	70.0	66.1	73.8	63.0	79.3	77.9	58.6	65.1	84.8	75.9	97.4	73.0	98.4	38.9	86.8	80.1	8.8	14.5	13.8	9.9	8.9	12.4	19.7	14.1	19.5	13.7	14.9	21.0	156.8	76.9	68.0	51.6	326.8	108.8	188.2	86.0	90.0	2.8	71.5	37.7	41.3	52.9	86.1	57.0	10.4	35.7	292.0	62.9	19.6	70.2	47.7	121.6	69.5	122.0	58.1	78.8	8.2	69.4	55.8	79.0	64.2	126.0	323.1	8.1	91.4	25.2	97.5	3.3	8.6	57.0	95.6	115.4	206.3	21.9	42.9	244.1	120.9	125.5	123.5	8.1	133.9	52.8	138.7	65.9	54.4	43.2	211.5	150.4	58.7	28.3	84.6	3.7	39.5	52.7	52.8	7.7	11.2	95.6	114.8	53.5	365.3	26.9	56.0	221.9
ELF2	"EU32, NERF, NERF-1A, NERF-1B, NERF-2"	ENSG00000109381	"E74 like ETS transcription factor 2"	Q15723	4	139028112-139177218	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 279.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006057, HPA071166"	Enhanced		Supported	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 41: Macrophages - Immune response"	Nucleoplasm	"Nuclear bodies"	"HPA006057: AB_1078733, HPA071166: AB_2686351"	"unprognostic (7.21e-2)"	"unprognostic (3.84e-2)"	"unprognostic (7.41e-2)"	"unprognostic (3.72e-2)"	"unprognostic (2.29e-1)"	"unprognostic (2.80e-2)"	"unprognostic (1.49e-1)"	"unprognostic (2.43e-2)"	"unprognostic (7.05e-3)"	"unprognostic (1.67e-1)"	"unprognostic (5.73e-2)"	"unprognostic (2.21e-2)"	"unprognostic (2.48e-2)"	"unprognostic (3.65e-1)"	"unprognostic (3.47e-1)"	"unprognostic (1.31e-1)"	"unprognostic (4.97e-3)"	23.7	14.2	12.1	15.2	17.3	47.3	24.5	19.2	16.1	21.8	9.6	24.6	15.0	24.7	18.5	17.3	20.7	17.8	20.1	11.1	15.6	15.5	20.4	19.0	19.9	15.6	14.9	28.2	16.7	20.0	22.6	26.8	15.9	21.5	19.2	30.7	21.4	21.7	36.0	23.2	17.6	23.0	13.2	19.6	17.4	37.4	14.5	32.8	23.0	33.6	21.4	19.2	18.4	20.2	15.9	11.3	27.9	21.4	28.2	31.7	26.9	18.4	31.8	19.6	21.8	22.2	31.2	32.3	18.5	25.7	10.4	16.8	41.2	26.3	20.5	20.2	18.6	28.5	26.4	20.0	20.7	32.1	22.1	31.1	24.8	19.3	23.3	25.7	29.5	18.0	46.8	18.4	17.7	27.8	37.8	28.6	17.0	36.4	13.1	36.0	36.8	30.1	25.1	27.2	28.4	32.6	23.1	28.5	17.6	32.4	19.7	38.5	25.0	18.3	15.9	16.7	12.4	40.8	48.6	28.3	13.5	32.4	17.2	13.3	8.3	14.1	12.0	7.2	13.2	17.5	11.8	10.8	9.9	19.3	14.6	13.5	9.1	12.9	7.9	18.0	9.4	5.3	12.1	17.3	19.2	16.1	11.1	15.6	15.6	14.9	15.9	13.2	14.5	20.2	103.0	48.1	22.5	64.0	57.6	53.2	41.1	36.1	120.1	42.0	50.3	40.4	37.0	40.0	39.1	40.5	75.0	32.6	71.9	31.0	43.0	26.4	26.0	60.0	54.3	67.1	47.3	43.5	73.6	24.2	32.3	63.7	35.7	56.3	34.8	44.0	53.2	46.9	22.2	67.3	75.3	38.1	42.7	52.2	40.1	24.6	52.5	59.5	30.2	98.4	49.2	37.3	77.2	83.9	279.4	24.1	33.5	38.0	51.0	52.6	35.9	23.1	48.2	57.7	39.5	81.4	59.2	59.7	42.0	79.0	47.6	23.7	50.7	33.6	27.7	39.6
ELF4	"ELFR, MEF"	ENSG00000102034	"E74 like ETS transcription factor 4"	Q99607	X	130063955-130110716	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 53.1"	"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 34.3;Granulosa cells: 27.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA058595, HPA060277"	Enhanced		Supported	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 15: RT4 - Unknown function"	"Cluster 40: Granulosa cells - Unknown function"	"Nuclear bodies"	Nucleoplasm	"HPA058595: AB_2683768, HPA060277: AB_2684239"	"unprognostic (1.33e-1)"	"unprognostic (8.51e-2)"	"unprognostic (3.83e-1)"	"unprognostic (2.13e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.80e-1)"	"unprognostic (4.43e-3)"	"unprognostic (7.86e-3)"	"unprognostic (3.50e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.29e-2)"	"unprognostic (3.95e-1)"	"prognostic unfavorable (6.49e-6)"	"unprognostic (1.43e-1)"	"unprognostic (5.46e-2)"	"unprognostic (2.51e-1)"	"prognostic favorable (1.42e-4)"	12.2	3.7	1.8	14.6	1.6	53.1	9.6	2.8	2.0	9.4	2.6	18.1	14.2	10.6	2.0	11.7	12.1	9.3	5.6	1.8	2.4	6.0	2.8	15.9	18.3	2.8	2.4	17.5	2.6	4.8	4.2	23.7	2.4	6.1	17.7	0.6	5.5	4.1	2.0	10.9	17.0	10.6	1.5	18.1	20.3	2.6	2.9	19.6	3.9	3.6	18.0	18.8	9.1	3.1	56.0	20.7	3.7	0.4	9.1	19.3	52.6	25.3	32.1	30.4	33.4	28.7	38.9	28.6	49.5	34.8	42.3	35.2	20.5	30.0	29.9	31.0	16.8	56.7	27.3	13.6	20.2	49.7	69.3	20.4	32.6	49.1	48.0	19.0	30.0	6.5	22.0	7.7	16.5	32.8	8.2	28.2	2.4	28.4	19.4	17.6	6.5	12.2	18.3	63.9	13.6	6.0	22.8	21.9	6.9	19.1	11.0	46.9	27.6	21.2	16.6	39.5	47.7	4.2	1.8	22.6	24.6	44.8	5.0	1.6	4.0	5.8	7.1	7.6	5.6	2.6	4.2	6.1	4.5	2.7	4.2	4.8	6.9	6.5	5.5	2.7	4.8	4.2	1.8	1.6	2.8	2.0	1.8	2.4	2.8	2.4	2.4	1.5	2.9	3.1	10.7	9.6	4.4	0.0	8.0	13.6	8.2	2.9	9.1	0.0	2.1	1.5	0.8	0.0	4.4	0.0	0.0	10.6	12.2	24.1	0.0	2.3	0.1	8.9	3.8	8.4	9.0	7.4	0.2	4.0	34.3	6.4	17.9	17.1	1.3	27.5	6.4	1.0	9.7	0.0	0.3	8.3	2.0	12.2	9.2	0.6	1.8	14.8	3.6	5.6	13.1	0.0	16.5	0.0	1.2	9.1	17.4	1.2	2.0	7.5	11.6	0.3	5.4	0.0	6.6	2.6	2.5	0.0	4.0	6.5	10.4	11.2	9.5	5.2	7.1	18.9
ELK3	"ERP, NET, SAP2"	ENSG00000111145	"ETS transcription factor ELK3"	P41970	12	96194375-96269824	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 170.7;Endothelial cells: 148.0;Hepatic stellate cells: 160.6;Respiratory ciliated cells: 103.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001600	Approved		Supported	Nucleoplasm,Mitochondria		NA	NA			"Cluster 13: T-cells - Unknown function"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Nucleoplasm	Mitochondria	"HPA001600: AB_1078752"	"unprognostic (3.11e-1)"	"unprognostic (8.81e-3)"	"unprognostic (6.38e-2)"	"unprognostic (5.77e-2)"	"unprognostic (7.18e-3)"	"unprognostic (1.12e-1)"	"unprognostic (1.15e-1)"	"unprognostic (5.10e-3)"	"unprognostic (7.39e-2)"	"prognostic unfavorable (4.93e-4)"	"unprognostic (2.29e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.20e-3)"	"unprognostic (2.90e-3)"	"unprognostic (1.61e-1)"	"unprognostic (1.70e-1)"	"unprognostic (2.05e-2)"	37.1	14.4	5.4	34.2	6.1	18.4	28.4	14.4	5.8	28.0	11.7	15.6	9.2	35.2	9.3	38.1	16.9	30.2	23.9	4.7	7.2	14.0	10.8	27.5	38.0	9.1	7.9	10.2	9.0	11.6	5.8	27.0	7.9	13.1	13.9	2.9	15.3	15.3	11.2	12.5	13.5	37.9	7.0	41.8	14.8	8.6	8.3	19.7	21.8	22.2	37.5	29.2	24.5	6.6	50.3	29.5	29.7	15.8	73.7	137.3	7.6	62.3	118.5	48.6	37.3	1.7	36.6	8.0	20.9	70.4	36.4	17.6	3.3	99.8	85.0	21.7	11.4	2.5	12.2	11.2	22.3	24.2	5.7	81.3	18.4	100.4	75.4	98.5	117.8	6.0	6.0	32.3	166.4	7.6	4.8	16.4	36.3	7.1	38.8	39.7	49.8	9.1	41.7	13.0	1.4	31.4	20.5	9.1	32.0	44.7	5.0	13.3	73.2	132.4	52.2	82.5	54.8	61.7	55.0	1.8	47.0	28.2	94.1	7.1	23.5	0.5	11.1	13.0	42.5	23.2	25.7	15.0	17.7	19.0	15.4	11.4	7.4	20.1	12.1	7.1	45.4	12.8	5.4	6.1	14.4	5.8	4.7	7.2	9.1	7.9	7.9	7.0	8.3	6.6	170.7	6.4	22.3	3.9	22.3	32.6	44.6	15.0	10.8	0.7	7.1	8.1	6.6	2.8	39.4	5.5	4.2	1.2	27.5	2.1	5.9	21.8	1.0	49.0	19.7	148.0	1.2	12.4	4.2	15.6	3.9	35.2	3.1	44.0	17.1	1.3	160.6	4.3	24.5	0.0	1.9	3.4	2.0	32.0	39.7	2.5	11.5	31.4	12.4	39.4	23.6	5.8	9.2	5.5	5.3	56.8	3.4	10.5	29.5	45.7	0.5	0.7	103.1	0.6	13.1	27.7	19.9	0.2	12.6	24.4	27.0	1.1	32.6	10.6	3.0	79.0
ELK4	SAP1	ENSG00000158711	"ETS transcription factor ELK4"	P28324	1	205597556-205632011	"Cancer-related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Bipolar cells: 104.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	4	"basophil: 6.6"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 6.6"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028863	Uncertain		Supported	Nucleoplasm		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm		"HPA028863: AB_10602492"	"unprognostic (2.08e-1)"	"unprognostic (2.71e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.59e-1)"	"unprognostic (2.15e-1)"	"prognostic favorable (4.65e-4)"	"unprognostic (2.97e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.19e-1)"	"unprognostic (3.53e-1)"	"unprognostic (1.27e-2)"	"unprognostic (2.64e-1)"	"prognostic unfavorable (2.94e-6)"	"unprognostic (2.21e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.08e-1)"	"unprognostic (5.58e-3)"	9.0	4.9	7.4	11.5	11.0	11.7	8.1	12.2	7.5	8.2	7.0	6.9	6.1	7.7	7.2	8.0	6.7	9.2	7.0	6.0	6.4	7.8	13.2	9.7	17.5	8.5	8.8	6.7	8.1	7.8	5.5	7.9	9.9	26.0	6.8	9.3	8.2	5.7	10.6	13.5	9.6	6.1	9.1	15.8	7.7	7.3	8.5	14.1	6.9	8.7	16.8	9.6	9.3	14.1	14.9	13.2	5.1	13.3	11.9	15.2	12.9	9.8	10.1	7.6	8.9	5.7	14.6	31.3	9.0	12.2	5.7	18.0	10.9	12.0	13.1	35.9	7.7	13.6	22.0	12.2	16.1	25.7	51.8	13.4	14.5	12.0	24.4	14.7	32.3	14.8	12.7	25.6	10.7	20.1	21.3	9.5	8.5	3.4	7.8	15.7	31.2	25.4	10.2	32.0	5.9	7.0	25.2	13.7	17.3	8.9	12.7	8.5	23.5	15.3	17.8	13.7	18.8	19.1	18.9	21.1	13.3	10.3	18.2	6.6	0.4	0.7	0.8	0.5	1.1	0.7	0.9	1.1	0.6	1.1	1.1	1.6	0.2	0.6	0.3	0.8	1.0	0.4	7.4	11.0	12.2	7.5	6.0	6.4	8.5	8.8	9.9	9.1	8.5	14.1	50.7	9.6	16.2	7.2	39.3	39.4	35.3	19.0	9.6	104.8	15.1	11.9	20.8	34.3	17.8	31.3	12.5	15.6	34.0	13.8	3.9	14.7	17.4	37.7	37.4	40.1	13.1	21.4	22.8	17.8	6.2	23.2	18.3	82.5	28.5	12.8	36.4	30.2	10.0	25.2	11.7	18.3	14.2	23.5	39.1	19.5	25.4	22.3	30.2	27.2	22.3	11.2	39.1	17.6	28.0	17.5	9.0	15.4	18.6	71.3	14.4	17.5	24.9	26.9	26.3	28.5	21.4	24.6	11.6	19.2	48.6	18.3	32.6	16.7	17.5	103.1
ELL	"C19orf17, ELL1, Men, PPP1R68"	ENSG00000105656	"Elongation factor for RNA polymerase II"	P55199	19	18442663-18522116	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"		"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 297.2;Late spermatids: 235.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004202, HPA046076"	Uncertain		Supported	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 34: Spermatids - Unknown function"	Nucleoplasm	"Nuclear bodies, Cytosol"	"HPA004202: , HPA046076: AB_2679526"	"unprognostic (9.49e-2)"	"unprognostic (1.38e-1)"	"unprognostic (3.26e-3)"	"unprognostic (2.07e-1)"	"unprognostic (1.64e-1)"	"unprognostic (2.10e-1)"	"unprognostic (8.26e-2)"	"unprognostic (2.71e-1)"	"unprognostic (2.34e-1)"	"unprognostic (3.00e-2)"	"unprognostic (6.28e-3)"	"unprognostic (2.38e-2)"	"unprognostic (1.57e-1)"	"unprognostic (2.07e-1)"	"unprognostic (5.12e-1)"	"unprognostic (2.46e-1)"	"unprognostic (1.06e-1)"	15.1	7.7	4.0	9.0	6.2	29.8	11.8	8.4	7.0	11.2	5.0	10.6	6.5	11.0	2.0	10.3	10.6	5.7	10.5	3.6	4.2	12.6	14.1	16.6	7.6	4.7	4.2	13.0	10.0	4.1	11.3	10.0	3.8	9.9	2.3	1.2	8.3	3.6	20.1	15.3	12.8	3.6	4.0	17.3	10.1	38.5	6.1	6.8	8.2	9.9	4.3	10.5	11.0	3.9	12.7	5.7	3.2	6.8	3.4	4.2	22.7	10.0	8.8	7.5	7.1	7.1	9.8	15.6	11.8	6.7	5.2	8.6	4.7	11.1	3.8	13.3	10.9	9.4	5.9	6.3	5.2	10.3	11.8	8.6	9.3	9.8	7.7	5.6	5.4	8.5	13.5	21.8	4.0	10.3	12.5	11.9	10.6	7.8	16.8	10.9	4.8	17.4	5.3	8.8	5.7	6.4	7.4	12.3	11.0	4.1	6.4	12.4	9.0	8.6	6.6	11.6	9.3	34.8	23.4	11.7	11.4	17.6	12.5	0.3	5.9	4.5	4.5	4.1	7.3	2.9	2.6	3.9	5.0	2.1	1.7	2.7	18.1	2.3	2.1	8.6	3.1	4.1	4.0	6.2	8.4	7.0	3.6	4.2	4.7	4.2	3.8	4.0	6.1	3.9	12.3	6.4	6.1	9.1	16.3	28.0	26.4	11.9	23.3	4.5	19.7	10.7	5.1	11.5	7.2	3.7	4.2	47.5	29.5	15.2	11.7	8.7	297.2	22.9	16.0	11.4	19.7	10.3	9.1	8.0	17.6	17.2	12.8	37.7	11.4	5.1	7.5	15.5	19.3	1.7	11.2	10.1	6.1	12.8	21.7	235.9	6.5	20.4	7.2	9.4	13.8	5.3	4.1	7.1	8.0	10.8	3.7	3.0	53.6	14.2	11.8	7.0	8.4	3.4	19.7	13.0	16.7	18.2	24.7	19.4	30.4	68.7	19.2	5.9	7.1	19.9
ELL2	MRCCAT1	ENSG00000118985	"Elongation factor for RNA polymerase II 2"	O00472	5	95885098-95961851	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Oligodendrocytes: 382.9;Plasma cells: 430.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 7.0"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BJ: 322.3;HDLM-2: 291.4;U-266/84: 216.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA013569			Supported	Nucleoplasm		No	No			"Cluster 10: Basophils - Unknown function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 41: Macrophages - Immune response"	Nucleoplasm		"HPA013569: AB_2668853"	"unprognostic (1.18e-2)"	"unprognostic (1.88e-2)"	"unprognostic (3.41e-2)"	"unprognostic (2.94e-2)"	"unprognostic (1.93e-1)"	"unprognostic (5.82e-2)"	"unprognostic (9.14e-2)"	"unprognostic (3.21e-2)"	"unprognostic (1.29e-1)"	"unprognostic (8.05e-2)"	"unprognostic (9.16e-2)"	"unprognostic (1.70e-1)"	"prognostic unfavorable (1.31e-4)"	"prognostic unfavorable (1.61e-4)"	"unprognostic (6.27e-2)"	"unprognostic (1.37e-2)"	"unprognostic (1.74e-2)"	49.0	19.5	13.5	28.6	32.3	48.3	37.3	22.9	26.8	24.0	6.8	13.5	14.5	9.1	5.7	61.2	16.0	35.6	39.9	18.4	32.0	16.5	86.8	35.8	14.6	51.1	28.5	24.8	94.3	15.6	25.1	25.3	33.7	39.1	13.1	3.7	96.5	23.0	33.5	58.9	14.5	11.4	21.3	18.0	44.3	15.2	41.4	8.1	17.1	10.7	21.8	33.2	35.7	55.8	31.7	12.3	3.8	0.5	45.0	56.1	4.6	322.3	56.2	105.4	89.7	23.7	7.2	1.4	6.7	173.7	24.6	40.0	10.0	103.5	129.3	291.4	7.6	20.5	53.5	52.3	29.0	4.5	33.3	55.1	70.1	64.0	191.4	63.2	17.0	3.8	11.5	120.3	100.6	3.3	0.1	5.6	4.9	5.0	16.8	3.1	19.2	25.3	20.3	30.0	6.4	2.1	118.6	6.2	7.3	15.1	3.6	3.7	35.5	137.6	27.4	32.0	59.4	84.0	216.0	1.5	71.9	2.1	9.4	7.0	0.8	5.7	0.6	1.0	1.0	3.5	0.8	0.9	0.4	1.7	0.6	0.5	1.8	1.6	0.8	0.3	1.1	0.6	13.5	32.3	22.9	26.8	18.4	32.0	51.1	28.5	33.7	21.3	41.4	55.8	30.9	28.9	94.9	28.1	93.2	183.2	137.3	47.1	134.9	0.6	56.0	37.6	31.6	14.3	61.5	18.4	0.0	2.0	98.6	19.4	5.9	24.6	2.5	46.2	32.4	33.4	107.8	25.7	138.6	91.9	14.8	64.4	85.6	88.6	172.4	11.2	18.5	141.1	36.7	0.0	87.5	18.1	12.2	64.4	52.0	4.3	7.8	126.5	46.2	83.4	25.3	1.2	2.1	49.8	382.9	70.8	14.7	7.2	430.1	134.7	12.7	15.8	35.2	0.5	13.1	213.2	76.8	17.2	9.2	185.8	171.5	25.9	72.4	2.4	14.3	88.8
ELL3	FLJ22637	ENSG00000128886	"Elongation factor for RNA polymerase II 3"	Q9HB65	15	43772605-43777315	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 57.7;skin 1: 25.0"	"Cell type enhanced"	"Detected in some"		"Basal squamous epithelial cells: 5.2;Gastric mucus-secreting cells: 4.6;Proximal enterocytes: 6.5;Squamous epithelial cells: 21.0"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"memory B-cell: 10.5;naive B-cell: 15.9"	"Lineage enriched"	"Detected in many"	7	"B-cells: 15.9"	"Cell line enhanced"	"Detected in many"		"Daudi: 73.8;OE19: 28.5;T-47d: 39.0;U-698: 149.9"	"Region enriched"	"Detected in single"	11	"olfactory bulb: 1.9"	"Not detected"	"Not detected"			"HPA028938, HPA073494"	Approved		Supported	"Nucleoplasm,Nucleoli,Mitotic chromosome"		Yes	NA			"Cluster 37: B-cells - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 61: Squamous epithelial cells - Keratinization"	"Nucleoplasm, Nucleoli"	"Mitotic chromosome"	"HPA028938: AB_10795352, HPA073494: "	"unprognostic (2.59e-2)"	"unprognostic (4.41e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.28e-1)"	"unprognostic (3.59e-1)"	"unprognostic (2.30e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.42e-3)"	"unprognostic (1.52e-2)"	"unprognostic (3.89e-1)"	"unprognostic (2.19e-1)"	"unprognostic (3.53e-1)"	"unprognostic (1.87e-1)"	"unprognostic (3.67e-2)"	"unprognostic (8.95e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.24e-2)"	0.5	0.9	1.0	9.7	1.0	0.2	5.2	1.0	1.1	1.6	4.7	8.0	14.1	0.6	1.1	4.5	3.9	0.7	0.5	1.0	1.1	1.4	0.7	1.5	49.7	1.0	1.1	1.7	0.4	1.6	0.5	3.7	1.1	2.0	12.3	0.1	2.2	1.0	0.4	25.0	12.9	1.0	1.0	1.0	1.8	16.2	1.4	1.5	0.7	1.9	57.7	0.7	0.8	1.1	2.1	0.2	0.6	1.1	4.9	1.2	0.4	0.2	1.3	2.8	3.1	0.0	1.3	73.8	0.1	1.2	0.1	13.7	1.3	0.7	1.4	1.6	7.3	0.4	2.6	4.6	1.0	0.1	0.0	1.4	12.3	0.7	0.2	0.2	1.1	0.4	0.2	0.0	0.7	4.0	1.5	1.4	0.1	28.5	2.4	0.8	0.0	0.0	1.8	0.0	9.5	0.0	1.7	21.5	0.0	0.3	39.0	0.2	0.0	0.3	0.0	0.0	0.1	0.0	0.0	149.9	0.0	1.3	0.0	0.0	0.1	0.0	0.0	0.1	0.2	10.5	0.6	0.1	0.0	15.9	1.1	0.2	0.0	0.1	0.0	2.2	0.6	0.6	1.0	1.0	1.0	1.1	1.0	1.1	1.0	1.1	1.1	1.0	1.4	1.1	0.1	0.0	0.0	0.0	2.2	0.4	0.1	0.2	5.2	0.0	0.7	0.5	0.0	0.0	0.2	0.0	0.0	0.1	0.3	1.2	0.0	0.1	1.8	0.4	0.1	0.2	0.0	0.4	0.1	0.7	0.0	0.5	4.6	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.1	2.5	0.0	0.0	0.5	2.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.5	0.0	0.0	0.1	6.5	0.1	3.1	0.0	0.0	0.2	0.4	0.2	0.2	21.0	1.0	0.3	0.1	0.1	2.3	0.2
ELMO2	"CED-12, CED12, ELMO-2, FLJ11656, KIAA1834"	ENSG00000062598	"Engulfment and cell motility 2"	Q96JJ3	20	46366050-46432985	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Apoptosis, Phagocytosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018811	Approved		Supported	Cytosol		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 63: NK-cells & T-cells - Immune response"	Cytosol		"HPA018811: AB_1848126"	"unprognostic (1.19e-2)"	"unprognostic (4.24e-2)"	"unprognostic (2.07e-1)"	"prognostic unfavorable (6.54e-4)"	"unprognostic (3.71e-1)"	"unprognostic (1.73e-1)"	"prognostic unfavorable (4.08e-5)"	"unprognostic (8.81e-2)"	"unprognostic (3.06e-2)"	"unprognostic (1.92e-1)"	"prognostic favorable (6.10e-4)"	"unprognostic (4.53e-1)"	"unprognostic (4.42e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.91e-1)"	"unprognostic (3.99e-2)"	"unprognostic (1.20e-2)"	20.4	25.6	47.9	15.9	50.1	41.0	20.0	50.7	52.7	29.1	39.7	22.3	9.9	24.1	20.7	32.4	21.3	11.6	24.5	59.1	46.1	22.9	18.5	25.3	21.2	48.1	48.4	17.6	28.1	27.6	26.2	16.6	46.5	29.1	11.2	25.7	20.7	26.7	35.2	25.0	20.1	24.1	48.6	35.2	18.9	31.3	51.4	15.8	20.4	23.2	21.2	23.5	29.4	53.5	10.0	29.0	33.7	27.9	57.8	37.0	17.3	22.7	31.1	31.2	30.2	39.5	11.0	12.4	35.5	38.2	52.6	23.2	29.0	33.9	24.1	20.5	12.9	20.2	18.7	29.2	43.5	11.3	41.1	36.5	29.7	33.2	23.4	21.4	25.5	29.8	20.4	40.0	29.4	26.3	22.4	29.1	13.0	18.8	28.1	18.8	32.8	25.0	30.7	22.9	20.3	18.3	32.8	28.7	44.2	31.8	22.2	44.6	29.9	64.0	36.0	26.5	15.0	16.0	25.8	12.6	26.5	17.8	19.9	121.8	25.0	42.1	42.0	47.9	51.7	9.9	37.8	40.6	23.6	13.4	23.9	27.2	26.9	58.2	73.3	32.7	27.2	43.9	47.9	50.1	50.7	52.7	59.1	46.1	48.1	48.4	46.5	48.6	51.4	53.5	5.7	3.2	12.5	33.3	5.3	4.8	5.0	2.3	5.2	9.7	7.3	4.8	10.9	8.6	3.6	1.8	29.2	6.0	14.6	2.3	0.0	4.3	6.3	3.9	6.8	6.4	8.3	4.8	15.2	3.3	5.2	7.3	6.1	6.0	8.8	5.3	5.0	2.9	13.7	11.8	13.9	2.9	16.2	8.2	5.3	5.6	11.1	6.1	7.2	15.0	8.0	15.2	18.6	14.1	31.0	4.7	3.4	12.8	6.4	8.7	2.9	4.7	1.7	8.5	26.3	4.7	12.6	11.0	14.5	5.2	6.7	4.1	11.8	6.3	2.7	3.9
ELOA	"SIII, TCEB3, TCEB3A"	ENSG00000011007	"Elongin A"	Q14241	1	23743155-23762059	"Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 83.9;Ductal cells: 41.3;Syncytiotrophoblasts: 41.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005910	Approved		Approved	"Nuclear speckles,Cytosol"		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 18: U-2197 - ECM organization"	"Cluster 7: Non-specific - Mitochondria"	"Nuclear speckles"	Cytosol	"HPA005910: AB_1080227"	"unprognostic (6.90e-2)"	"unprognostic (5.99e-3)"	"unprognostic (4.08e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.99e-1)"	"unprognostic (3.93e-2)"	"prognostic unfavorable (1.44e-5)"	"unprognostic (1.72e-1)"	"unprognostic (8.84e-3)"	"unprognostic (6.00e-2)"	"unprognostic (4.94e-2)"	"unprognostic (2.14e-2)"	"unprognostic (2.95e-3)"	"unprognostic (2.90e-1)"	"unprognostic (4.27e-2)"	"unprognostic (4.80e-2)"	"unprognostic (4.14e-2)"	25.7	12.7	9.8	18.8	10.8	33.4	16.5	13.0	11.5	15.7	10.4	14.8	12.6	13.3	10.1	23.8	12.9	15.4	15.5	10.1	10.9	14.4	29.6	25.8	17.7	10.9	10.6	16.1	42.4	27.0	11.5	19.2	11.0	14.9	16.5	12.7	17.4	13.3	33.2	20.1	13.9	16.8	9.7	16.2	26.5	18.9	11.1	21.6	21.3	26.4	23.6	24.5	14.6	11.8	52.0	28.3	40.2	34.6	46.2	28.6	25.3	52.4	46.9	76.2	66.1	34.9	44.1	27.0	62.7	53.3	42.8	48.5	83.0	55.2	84.4	77.8	41.1	60.9	42.2	41.1	40.9	64.7	35.3	30.6	43.6	83.3	63.2	28.2	46.4	43.7	91.8	45.3	61.6	39.3	33.5	26.1	46.8	57.7	42.4	49.8	50.9	51.3	35.8	34.8	76.2	42.9	47.7	47.5	58.5	44.3	34.4	23.5	49.5	59.5	52.8	106.9	62.5	46.8	56.4	59.2	52.1	63.2	60.7	28.2	24.6	19.6	16.5	24.9	16.3	23.5	13.8	15.1	22.6	18.5	11.2	14.9	6.5	13.7	24.1	18.4	17.1	17.7	9.8	10.8	13.0	11.5	10.1	10.9	10.9	10.6	11.0	9.7	11.1	11.8	24.1	28.9	83.9	0.0	7.9	0.0	0.0	0.0	0.0	0.0	19.6	16.0	0.0	0.0	18.0	18.4	0.0	28.1	17.5	0.0	5.9	41.3	0.0	15.4	27.4	12.5	0.0	0.0	0.0	32.7	35.7	10.1	0.0	23.3	13.9	21.5	0.0	0.0	28.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.4	0.0	0.0	35.2	0.0	0.0	0.0	0.0	37.9	0.0	0.0	4.9	0.0	0.0	19.0	16.8	0.0	0.0	0.0	12.8	0.0	0.0	0.0	0.0	41.3	9.6	32.5	0.0	0.0
ELOVL1	Ssc1	ENSG00000066322	"ELOVL fatty acid elongase 1"	Q9BW60	1	43363398-43368074	"Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted membrane proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism"	Transferase	"Disease variant, Ichthyosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB033426, HPA056557"	Enhanced		Supported	"Endoplasmic reticulum"		NA	Yes			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 30: Mammary glandular cells - Lactation"	"Endoplasmic reticulum"		"CAB033426: AB_2099896, HPA056557: AB_2683173"	"unprognostic (5.23e-2)"	"prognostic unfavorable (3.63e-5)"	"unprognostic (8.00e-2)"	"unprognostic (8.45e-2)"	"unprognostic (7.60e-2)"	"unprognostic (7.40e-2)"	"prognostic unfavorable (2.79e-7)"	"unprognostic (4.74e-2)"	"unprognostic (1.33e-1)"	"unprognostic (4.37e-1)"	"prognostic unfavorable (8.51e-4)"	"unprognostic (1.83e-1)"	"unprognostic (2.88e-2)"	"unprognostic (1.41e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.73e-1)"	"unprognostic (9.00e-2)"	78.5	54.7	77.2	39.8	115.6	52.9	66.6	121.1	116.9	57.1	61.4	63.9	51.6	46.5	30.6	176.6	38.9	42.4	47.2	76.8	93.2	59.7	45.8	59.6	40.1	152.0	110.1	28.9	55.4	46.2	27.2	51.0	140.7	58.7	48.6	8.4	72.7	48.8	24.1	201.9	55.4	50.8	114.8	57.1	70.6	18.6	107.7	22.2	66.8	28.0	55.7	68.5	86.8	165.7	108.0	119.5	22.6	44.8	148.4	138.2	70.2	125.2	154.5	153.5	122.4	105.9	182.5	73.9	94.3	193.6	130.3	119.4	79.7	152.2	93.2	94.6	53.9	96.6	77.3	77.1	128.2	84.2	98.0	106.2	168.2	180.9	198.4	114.8	155.0	27.7	68.1	54.8	178.5	79.5	19.9	69.5	33.5	136.9	120.2	43.6	59.9	89.7	195.5	128.7	27.4	28.8	73.7	258.4	105.8	66.8	121.2	82.4	132.2	129.7	82.5	161.2	161.3	26.6	31.2	35.4	127.8	85.2	120.1	134.9	189.6	172.7	105.1	180.0	93.4	109.0	98.4	103.2	212.8	94.2	63.5	88.0	133.0	114.7	179.6	148.8	113.8	203.1	77.2	115.6	121.1	116.9	76.8	93.2	152.0	110.1	140.7	114.8	107.7	165.7	44.0	19.2	12.5	7.5	28.1	15.6	25.9	61.1	29.6	5.7	60.3	37.5	4.7	34.3	40.2	40.5	10.4	93.4	36.0	114.0	7.9	91.5	3.4	22.9	26.3	43.6	19.2	67.8	3.8	100.1	127.4	26.1	48.4	45.2	21.0	52.6	24.7	16.7	74.9	3.3	3.4	33.8	46.8	46.3	37.5	4.6	20.2	41.5	12.4	7.5	92.5	13.7	32.0	3.0	66.1	133.3	63.9	25.6	19.0	44.7	66.0	23.3	14.5	9.5	19.7	10.0	39.7	8.4	11.2	70.1	31.0	95.9	31.5	50.8	47.2	49.2
ELP1	"DYS, IKAP, IKBKAP, IKI3, TOT1"	ENSG00000070061	"Elongator complex protein 1"	O95163	9	108866898-108934328	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation, tRNA processing"		"Disease variant, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 12.8;Alveolar cells type 2: 18.8;Collecting duct cells: 14.7;Exocrine glandular cells: 21.1;Theca cells: 24.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	8	"basophil: 36.6"	"Lineage enriched"	"Detected in all"	8	"granulocytes: 36.6"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB021340, HPA049677, HPA050686"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 51: Non-specific - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 7: Non-specific - Mitochondria"	Cytosol	Nucleoplasm	"CAB021340: , HPA049677: AB_2680847, HPA050686: AB_2681216"	"prognostic unfavorable (1.57e-4)"	"unprognostic (8.71e-2)"	"unprognostic (5.13e-2)"	"unprognostic (4.21e-2)"	"unprognostic (6.44e-2)"	"unprognostic (4.49e-2)"	"unprognostic (2.76e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.67e-1)"	"unprognostic (4.02e-2)"	"unprognostic (1.10e-2)"	"unprognostic (2.80e-2)"	"unprognostic (1.77e-3)"	"unprognostic (1.69e-1)"	"unprognostic (1.57e-1)"	"unprognostic (2.27e-2)"	"unprognostic (4.98e-2)"	13.6	39.7	5.8	6.5	6.2	6.5	13.6	6.9	8.1	21.5	8.4	17.5	5.8	17.1	9.5	13.0	19.9	6.7	18.2	5.9	7.8	14.4	18.4	15.2	9.6	6.6	6.5	29.9	17.6	29.3	38.1	6.8	7.9	18.0	8.1	24.8	14.8	8.3	15.7	15.9	15.9	8.9	5.9	18.2	15.5	12.0	6.9	9.5	20.1	11.4	8.8	15.5	18.3	6.3	15.6	26.7	19.7	12.8	21.7	21.1	21.1	23.4	15.1	20.8	16.9	31.5	9.2	31.0	12.0	20.2	27.5	35.7	40.7	29.8	25.8	28.6	26.6	15.2	38.2	63.3	18.6	28.7	13.7	18.7	19.1	34.5	26.7	18.0	20.9	33.6	43.1	17.9	22.9	25.3	21.2	13.6	32.1	41.0	34.4	20.7	31.9	18.3	17.3	16.1	26.6	23.9	27.8	23.3	15.7	22.4	33.3	14.1	15.4	10.4	16.2	26.0	25.1	15.5	47.2	13.8	20.0	20.2	19.1	36.6	1.4	2.8	2.9	2.2	4.4	2.2	3.4	4.6	2.4	1.2	3.1	4.0	0.2	4.5	3.3	1.6	2.6	2.1	5.8	6.2	6.9	8.1	5.9	7.8	6.6	6.5	7.9	5.9	6.9	6.3	7.3	12.8	18.8	0.0	2.9	0.0	0.0	0.0	0.0	0.0	7.7	7.0	0.0	0.0	3.1	14.7	0.0	6.9	5.8	0.0	0.0	5.8	0.0	9.9	10.6	4.7	0.0	0.0	0.0	21.1	6.2	3.8	0.0	9.6	2.5	11.4	0.0	0.0	6.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	7.6	0.0	0.0	2.7	0.0	0.0	6.3	6.6	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	5.6	2.8	24.4	0.0	0.0
ELP2	"FLJ10879, STATIP1, StIP"	ENSG00000134759	"Elongator acetyltransferase complex subunit 2"	Q6IA86	18	36129444-36180557	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation, tRNA processing"		"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002996, CAB020835"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 31: Spermatids - Spermatogenesis"	Cytosol	Nucleoplasm	"CAB020835: , HPA002996: AB_1857552"	"unprognostic (5.51e-2)"	"unprognostic (1.29e-1)"	"prognostic favorable (5.41e-4)"	"unprognostic (6.66e-3)"	"unprognostic (4.33e-2)"	"unprognostic (4.54e-1)"	"unprognostic (2.23e-1)"	"unprognostic (5.89e-2)"	"unprognostic (1.92e-1)"	"unprognostic (6.74e-3)"	"unprognostic (7.31e-3)"	"unprognostic (7.07e-2)"	"unprognostic (8.04e-2)"	"unprognostic (1.91e-1)"	"unprognostic (3.05e-2)"	"unprognostic (1.14e-1)"	"unprognostic (8.97e-2)"	17.7	20.7	12.1	12.3	13.2	13.2	35.3	12.4	11.9	23.5	12.3	19.1	15.2	27.3	31.0	15.9	28.8	20.3	23.6	11.4	14.2	18.9	46.2	16.6	19.9	12.1	12.1	48.6	24.4	24.8	20.7	20.8	12.6	29.4	16.2	21.2	19.1	26.3	32.4	21.5	14.0	22.5	12.2	16.7	16.5	22.2	13.4	23.6	21.8	32.3	23.3	22.5	16.9	16.0	23.7	16.7	30.8	27.8	42.7	63.9	33.9	47.9	69.3	39.6	52.5	17.6	21.5	49.6	32.6	40.4	26.5	32.9	39.7	35.8	55.8	22.6	21.1	19.2	27.4	31.0	46.6	63.0	19.6	52.3	40.2	39.4	63.6	59.5	45.0	33.8	32.9	25.4	42.4	28.4	30.6	27.0	36.7	18.2	12.6	48.7	37.0	34.9	35.7	54.4	24.2	46.3	45.1	17.6	73.0	44.0	22.5	31.2	26.8	35.6	20.5	13.2	24.8	30.4	25.6	46.2	30.0	33.2	31.3	22.0	12.1	10.0	12.6	17.6	17.9	20.0	17.0	15.0	17.6	16.3	21.5	18.9	2.2	22.2	24.8	17.5	18.4	14.0	12.1	13.2	12.4	11.9	11.4	14.2	12.1	12.1	12.6	12.2	13.4	16.0	25.0	48.1	28.8	34.3	46.3	32.9	49.4	33.8	39.9	50.1	42.1	28.6	48.5	22.8	29.2	35.0	43.8	39.5	45.9	10.9	29.4	26.4	55.0	29.9	33.1	29.4	24.7	21.7	61.7	22.2	42.3	39.2	17.3	29.5	36.7	39.9	24.7	75.3	22.8	33.7	60.7	20.3	20.3	28.0	24.8	90.4	43.5	20.8	23.2	34.7	39.1	26.9	41.2	52.3	77.4	18.7	12.1	36.5	34.2	60.9	24.3	19.0	36.5	45.4	6.6	40.8	30.6	40.0	33.2	25.0	36.7	39.8	39.7	28.0	26.9	50.7
ELP4	"C11orf19, PAXNEB"	ENSG00000109911	"Elongator acetyltransferase complex subunit 4"	Q96EB1	11	31509755-31790324	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation, tRNA processing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 37.9"	"Cell type enhanced"	"Detected in all"		"Astrocytes: 153.5;Excitatory neurons: 93.6;Inhibitory neurons: 90.2;Microglial cells: 91.8;Oligodendrocyte precursor cells: 129.2;Oligodendrocytes: 123.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038572, HPA038573"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 21: OE19 - Mitochondria"	"Cluster 64: Astrocytes - Nervous system maintenance"	Nucleoplasm		"HPA038572: AB_2676090, HPA038573: AB_2676091"	"unprognostic (7.25e-2)"	"unprognostic (5.40e-2)"	"unprognostic (7.81e-2)"	"unprognostic (1.61e-2)"	"unprognostic (1.73e-1)"	"unprognostic (3.10e-3)"	"unprognostic (1.67e-2)"	"unprognostic (1.87e-1)"	"unprognostic (6.73e-2)"	"unprognostic (8.13e-2)"	"unprognostic (1.01e-1)"	"unprognostic (5.33e-2)"	"unprognostic (1.09e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.48e-1)"	"unprognostic (8.38e-2)"	"unprognostic (3.63e-2)"	7.1	7.2	14.6	7.4	16.4	8.6	6.8	37.9	19.0	7.4	13.3	9.0	4.6	6.8	8.3	9.7	7.3	7.2	10.2	14.0	13.3	10.2	9.6	7.3	9.7	13.6	14.3	7.5	9.4	8.1	5.4	7.8	14.7	6.7	7.7	12.7	6.9	7.4	8.3	9.6	6.5	7.6	13.6	6.4	6.5	8.3	15.2	15.1	6.6	8.3	8.4	7.8	7.3	18.2	13.2	11.2	12.0	14.4	10.9	14.9	4.6	11.5	12.3	16.7	18.4	10.4	11.5	18.0	9.7	10.3	20.9	23.3	16.5	14.4	18.3	15.1	18.3	5.9	13.2	16.0	11.2	12.6	11.2	14.9	8.7	7.2	19.5	13.2	20.4	22.9	27.4	15.7	10.7	20.3	21.4	14.9	6.9	38.9	13.7	12.8	25.7	12.0	25.6	13.0	13.8	6.4	22.3	13.4	10.0	11.7	25.4	18.2	8.2	15.3	13.5	25.3	15.2	6.1	12.9	22.0	10.8	17.6	13.4	5.9	8.0	8.1	6.7	9.2	8.3	9.1	7.6	7.9	9.3	5.9	8.5	7.4	2.1	7.5	9.5	8.3	10.1	6.6	14.6	16.4	37.9	19.0	14.0	13.3	13.6	14.3	14.7	13.6	15.2	18.2	13.9	12.8	10.5	153.5	11.4	8.3	11.0	20.2	6.8	4.9	7.7	8.5	7.7	5.7	14.5	7.3	4.2	20.2	11.4	4.3	29.4	9.1	18.0	11.0	14.0	7.5	6.7	4.6	93.6	11.3	15.6	10.5	4.1	8.3	10.8	12.8	3.9	5.5	11.5	15.2	90.2	6.0	12.2	5.7	2.4	3.6	5.0	8.5	3.6	91.8	7.7	16.5	8.2	129.2	123.4	6.1	3.9	6.4	14.3	2.9	4.0	33.1	8.6	6.1	6.6	8.3	12.9	23.5	10.2	9.4	8.2	18.9	11.4	11.6	6.4	6.9
ELP5	"C17orf81, DERP6"	ENSG00000170291	"Elongator acetyltransferase complex subunit 5"	Q8TE02	17	7251416-7259940	"Predicted intracellular proteins"	"Transcription, Transcription regulation, tRNA processing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 171.6"	"Group enriched"	"Detected in all"	4	"Early spermatids: 405.3;Late spermatids: 699.6;Spermatocytes: 226.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023279, HPA052411"	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 31: Spermatids - Spermatogenesis"	"Nucleoplasm, Cytosol"		"HPA023279: AB_1847613, HPA052411: "	"unprognostic (3.73e-2)"	"unprognostic (9.21e-3)"	"unprognostic (1.24e-1)"	"unprognostic (2.39e-3)"	"unprognostic (7.72e-2)"	"unprognostic (1.22e-1)"	"unprognostic (7.70e-2)"	"unprognostic (1.53e-1)"	"unprognostic (7.83e-3)"	"unprognostic (1.60e-2)"	"prognostic favorable (2.62e-4)"	"unprognostic (1.36e-1)"	"unprognostic (1.83e-1)"	"unprognostic (8.07e-2)"	"unprognostic (2.71e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.30e-2)"	30.6	47.9	21.1	10.0	22.0	14.1	26.7	22.0	23.8	30.0	22.0	36.4	11.5	31.8	12.8	27.9	28.7	9.3	59.7	21.0	21.8	39.6	57.1	22.7	16.7	21.7	21.6	33.7	28.0	19.9	39.7	10.4	21.6	35.4	10.8	18.9	26.1	11.8	57.3	21.2	31.2	17.8	21.2	35.0	29.0	171.6	21.9	22.9	29.3	77.9	16.9	30.9	24.8	21.6	22.4	61.7	27.3	24.9	46.8	36.8	11.9	19.5	23.1	30.7	28.2	62.0	14.3	44.0	21.1	31.3	53.7	16.4	69.6	46.1	22.0	27.4	98.2	40.7	20.5	57.3	23.2	29.2	15.4	26.2	34.0	21.0	41.1	19.4	26.5	54.9	28.6	11.5	48.4	37.5	74.4	55.4	22.5	23.4	42.5	63.0	30.6	23.9	34.5	20.7	13.3	26.4	38.0	11.5	30.9	27.0	16.3	20.9	30.4	17.6	20.6	34.1	31.7	13.3	19.4	51.8	32.0	28.1	23.3	28.6	30.7	16.1	32.3	37.8	41.0	39.3	28.9	30.1	37.4	39.5	30.2	35.9	5.3	38.7	26.1	45.9	44.7	28.6	21.1	22.0	22.0	23.8	21.0	21.8	21.7	21.6	21.6	21.2	21.9	21.6	30.4	9.6	11.7	10.7	38.3	22.0	47.7	47.8	27.9	21.5	27.8	36.6	64.3	12.8	39.9	46.0	20.9	36.1	45.1	29.7	97.8	38.3	405.3	20.5	28.1	26.5	41.6	14.1	9.4	13.6	78.1	28.6	9.7	21.5	7.0	30.1	18.2	24.2	41.4	28.6	9.7	37.0	57.0	13.5	28.8	699.6	34.2	22.8	21.4	10.3	29.0	32.7	29.9	10.6	10.5	19.3	32.9	33.1	26.7	73.5	46.9	107.0	23.1	33.6	39.5	27.1	35.9	226.4	40.8	21.0	21.7	57.9	29.9	29.0	46.5	51.6
EMC8	"C16orf2, C16orf4, COX4NB, FAM158B, NOC4"	ENSG00000131148	"ER membrane protein complex subunit 8"	O43402	16	85771758-85799608	"Predicted intracellular proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 230.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049476	Approved		Supported	"Endoplasmic reticulum,Golgi apparatus"		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	"Endoplasmic reticulum"	"Golgi apparatus"	"HPA049476: AB_2680784"	"unprognostic (2.69e-1)"	"unprognostic (2.62e-2)"	"unprognostic (4.21e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.88e-1)"	"unprognostic (2.41e-3)"	"prognostic unfavorable (8.49e-4)"	"unprognostic (1.30e-1)"	"unprognostic (2.41e-1)"	"unprognostic (2.67e-3)"	"unprognostic (1.03e-1)"	"unprognostic (6.91e-3)"	"prognostic favorable (6.39e-4)"	"unprognostic (9.06e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.24e-1)"	13.5	12.9	13.9	8.3	14.7	17.4	12.7	14.7	13.6	9.7	13.2	12.5	10.6	12.7	7.2	13.1	9.2	6.3	19.5	13.9	13.9	13.8	12.8	9.3	10.1	14.8	14.3	8.2	10.9	11.0	10.2	9.3	13.8	9.9	8.7	7.1	9.9	8.7	20.8	10.5	10.5	9.3	15.1	10.9	11.7	12.2	14.8	10.3	9.6	12.5	9.5	11.7	9.4	16.0	29.8	34.1	21.3	19.5	22.6	21.6	41.4	28.7	28.4	46.9	20.8	54.7	33.5	25.6	32.5	29.1	21.0	33.3	32.0	30.1	41.5	10.9	45.7	21.1	17.3	50.3	34.2	21.7	13.7	23.8	20.1	35.7	41.5	20.2	27.1	30.9	48.6	9.6	29.2	50.7	34.5	61.4	42.5	27.4	43.3	50.0	17.4	21.8	29.9	20.7	35.9	21.4	52.8	17.1	33.9	18.9	33.9	38.1	23.8	28.1	28.7	24.9	37.1	26.6	27.3	102.8	24.1	41.3	30.2	17.9	18.1	25.6	10.9	19.2	12.7	11.1	11.8	14.8	24.2	15.6	14.7	14.4	7.5	19.2	19.5	17.8	12.3	12.3	13.9	14.7	14.7	13.6	13.9	13.9	14.8	14.3	13.8	15.1	14.8	16.0	60.1	6.4	8.6	10.4	25.0	61.3	30.1	28.9	25.0	33.7	26.7	26.0	19.9	15.7	18.5	25.8	12.5	48.5	25.0	28.8	60.7	46.9	230.2	37.1	28.3	33.6	46.6	21.5	6.1	42.1	60.7	26.2	18.8	40.9	9.5	25.1	23.6	23.3	47.0	15.2	7.8	27.4	26.4	28.0	38.0	55.0	24.8	27.1	28.4	8.4	41.9	27.8	27.8	8.0	12.2	50.0	27.2	31.6	33.3	51.1	29.1	46.5	12.5	18.6	26.3	22.5	28.9	54.2	56.5	33.5	54.6	51.0	22.4	37.0	35.6	41.9
EMG1	"C2F, Grcc2f, NEP1"	ENSG00000126749	"EMG1 N1-specific pseudouridine methyltransferase"	Q92979	12	6970913-6997428	"Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Ribosome biogenesis, rRNA processing"	"Methyltransferase, RNA-binding, rRNA-binding, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039304, HPA039666"	Supported		Supported	"Nucleoplasm,Nucleoli rim,Mitotic chromosome"		Yes	No			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 10: Non-specific - Unknown function"	"Nucleoli rim"	"Nucleoplasm, Mitotic chromosome"	"HPA039304: AB_2676432, HPA039666: AB_10672891"	"unprognostic (1.23e-1)"	"unprognostic (1.17e-1)"	"unprognostic (6.77e-2)"	"unprognostic (1.35e-2)"	"unprognostic (2.11e-2)"	"unprognostic (1.13e-1)"	"prognostic unfavorable (3.69e-4)"	"unprognostic (2.70e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.12e-1)"	"unprognostic (9.03e-2)"	"unprognostic (1.38e-1)"	"prognostic unfavorable (2.83e-6)"	"unprognostic (2.13e-1)"	"unprognostic (2.34e-1)"	"unprognostic (6.75e-2)"	"unprognostic (1.62e-1)"	16.8	18.0	13.0	15.2	14.2	12.6	17.3	14.4	20.2	14.9	15.9	14.0	11.1	14.5	13.6	20.2	16.1	4.6	22.6	13.2	14.1	23.2	22.8	15.9	13.4	14.4	14.2	13.9	13.6	9.4	12.8	8.6	14.5	15.7	9.7	9.3	13.6	6.1	21.2	17.4	14.0	7.4	14.3	18.1	14.6	9.9	14.0	12.3	15.6	12.8	12.8	16.1	14.1	15.3	55.5	53.7	20.5	25.2	15.8	11.5	84.7	40.1	17.9	31.2	21.2	106.4	57.6	55.4	14.7	25.1	56.8	39.8	18.9	46.1	35.2	40.1	30.6	76.8	51.7	99.6	20.3	79.0	47.8	18.5	27.2	45.5	51.8	16.2	13.9	38.6	38.6	12.1	29.8	65.3	41.4	48.3	169.6	45.4	28.0	56.3	41.2	44.0	20.0	68.8	11.9	35.7	42.2	43.9	41.4	57.5	12.0	57.8	29.2	32.4	42.6	26.8	92.9	14.6	17.9	97.7	34.8	33.7	52.8	15.5	44.1	22.3	60.7	66.4	63.3	85.3	63.6	67.6	51.2	88.0	74.4	69.1	6.2	60.9	86.4	55.8	68.1	81.3	13.0	14.2	14.4	20.2	13.2	14.1	14.4	14.2	14.5	14.3	14.0	15.3	30.1	16.0	41.3	1.3	34.0	36.6	92.2	79.1	25.0	14.7	29.0	36.8	0.0	24.3	60.9	42.3	8.4	107.3	22.8	18.1	49.0	75.3	9.6	23.1	24.8	32.3	9.6	16.0	1.3	66.8	121.0	31.8	11.7	22.7	60.9	27.7	23.2	35.9	65.4	16.8	1.4	25.7	71.2	25.0	29.3	15.5	37.9	27.7	28.4	1.9	45.1	24.5	43.3	2.0	2.7	75.7	19.8	25.9	17.3	69.0	25.1	81.1	54.0	16.0	39.5	29.2	86.5	28.9	59.7	28.4	39.9	74.3	30.6	46.4	35.7	75.8
EML4	"C2orf2, ELP120, ROPP120"	ENSG00000143924	"EMAP like 4"	Q9HC35	2	42169353-42332548	"Cancer-related genes, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Hep G2: 186.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036687, HPA036688, HPA065337"	Enhanced		Supported	Microtubules,Cytosol		NA	NA		25000	"Cluster 13: T-cells - Unknown function"	"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 24: Non-specific - Transcription regulation"	Microtubules	Cytosol	"HPA036687: AB_2675251, HPA036688: AB_10671968, HPA065337: AB_2685474"	"unprognostic (1.70e-1)"	"unprognostic (1.38e-1)"	"unprognostic (8.17e-2)"	"unprognostic (3.53e-3)"	"unprognostic (1.79e-2)"	"unprognostic (9.19e-2)"	"unprognostic (8.61e-3)"	"unprognostic (1.61e-2)"	"unprognostic (2.96e-3)"	"unprognostic (6.80e-2)"	"unprognostic (7.44e-2)"	"unprognostic (1.60e-2)"	"unprognostic (1.86e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.13e-2)"	11.2	13.7	1.5	32.4	2.5	41.1	14.1	1.0	1.4	11.7	3.9	23.6	38.8	11.1	4.6	11.1	9.9	19.9	4.6	1.6	1.0	19.4	38.1	24.3	28.3	2.2	1.6	8.9	24.3	13.8	4.3	35.6	1.6	9.7	23.7	10.3	21.0	8.0	2.4	18.3	36.5	14.1	2.0	28.3	20.9	20.4	3.7	14.9	21.5	3.9	30.0	27.3	5.7	2.8	45.1	76.7	43.7	34.9	15.6	25.4	47.7	27.3	21.4	29.7	28.5	80.8	55.1	41.1	18.5	26.9	45.6	22.7	38.0	26.3	51.3	80.8	31.8	37.7	23.5	186.3	19.7	28.8	37.1	27.9	9.8	39.4	26.5	14.4	20.9	14.0	37.9	40.3	32.5	26.4	27.3	7.7	44.8	57.8	21.9	27.8	69.2	24.3	24.2	64.3	42.9	86.3	26.9	27.7	20.8	39.6	14.4	11.4	24.6	30.1	39.9	24.3	24.9	44.9	33.3	34.6	26.3	27.0	21.6	5.6	4.7	9.9	9.0	13.7	19.0	13.9	15.0	14.8	4.1	9.1	12.8	9.6	12.3	11.9	14.6	5.3	22.3	7.6	1.5	2.5	1.0	1.4	1.6	1.0	2.2	1.6	1.6	2.0	3.7	2.8	47.0	60.9	107.3	37.9	137.6	67.3	74.3	60.5	75.1	35.1	53.5	45.7	7.0	51.5	60.9	40.5	47.9	143.0	120.8	57.0	17.6	34.0	33.1	33.4	50.1	50.8	102.3	20.8	54.2	75.4	47.5	55.3	76.0	86.6	48.1	80.7	43.9	61.9	65.6	16.8	60.0	69.3	34.6	40.3	56.6	31.0	23.9	74.8	16.0	119.9	38.4	35.1	47.4	62.8	32.9	38.1	58.9	23.0	139.5	65.4	51.3	41.3	28.6	47.3	6.6	25.0	47.6	46.5	39.4	73.4	79.7	118.9	223.8	42.0	85.0	96.4
EMSY	C11orf30	ENSG00000158636	"EMSY transcriptional repressor, BRCA2 interacting"	Q7Z589	11	76444923-76553025	"Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, Transcription, Transcription regulation"	"Chromatin regulator, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012234, HPA050777"	Supported		Supported	Nucleoplasm		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm		"CAB012234: AB_449325, HPA050777: AB_2681232"	"unprognostic (1.69e-2)"	"unprognostic (8.15e-2)"	"unprognostic (1.51e-3)"	"unprognostic (3.66e-2)"	"unprognostic (2.60e-2)"	"unprognostic (1.54e-2)"	"unprognostic (3.32e-2)"	"unprognostic (3.87e-2)"	"unprognostic (2.01e-2)"	"unprognostic (7.70e-2)"	"unprognostic (8.47e-2)"	"unprognostic (5.37e-2)"	"unprognostic (2.99e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.99e-1)"	"unprognostic (6.64e-2)"	"unprognostic (8.74e-2)"	6.8	5.8	4.6	7.7	7.5	13.1	8.7	15.3	8.6	8.1	6.9	7.6	5.2	10.0	7.6	6.1	8.6	6.4	9.0	4.9	8.0	7.3	5.6	9.0	8.9	6.0	5.9	11.4	8.8	9.8	5.7	12.2	6.7	7.7	8.7	17.8	7.1	7.7	9.3	5.7	6.6	10.1	4.3	7.9	6.6	8.7	6.3	13.3	8.2	12.6	8.4	7.3	7.4	12.3	8.6	11.9	26.8	16.5	9.9	9.8	11.8	13.5	13.3	17.3	18.9	20.3	11.5	11.7	12.7	14.7	14.3	16.8	21.9	13.0	26.6	18.7	8.2	18.2	18.5	8.8	6.3	20.0	15.8	8.9	8.5	19.8	16.3	11.0	15.8	19.6	12.9	20.0	14.1	22.8	26.9	12.0	11.7	26.9	15.6	17.1	49.2	16.4	12.0	10.0	16.7	7.3	19.0	12.8	4.1	16.5	25.9	12.2	11.9	16.2	21.8	42.0	9.6	11.1	12.8	33.1	5.4	12.0	12.1	11.9	3.5	7.5	4.5	3.3	4.3	4.3	4.3	5.5	2.6	4.9	3.9	3.7	7.3	3.6	2.7	4.2	4.7	3.0	4.6	7.5	15.3	8.6	4.9	8.0	6.0	5.9	6.7	4.3	6.3	12.3	14.0	16.0	7.8	0.0	15.1	0.0	7.5	0.0	17.1	19.7	12.1	10.2	0.0	2.8	6.2	12.9	35.5	15.6	14.0	4.8	13.7	6.2	1.8	13.7	14.0	10.7	7.3	13.5	0.0	4.3	7.7	9.2	10.2	10.1	2.5	17.2	12.8	7.3	8.6	15.2	0.0	12.0	0.0	7.9	0.0	2.0	11.5	9.0	0.0	0.0	7.3	8.9	14.4	0.0	0.0	5.9	4.4	12.4	20.1	14.1	8.4	10.1	6.6	22.8	13.1	11.5	10.6	25.8	12.3	15.0	0.0	21.1	13.3	12.3	8.1	11.7
EMX1		ENSG00000135638	"Empty spiracles homeobox 1"	Q04741	2	72916260-72936071	"Predicted intracellular proteins, Transcription factors"		"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"brain: 13.1;kidney: 36.4"	"Cell type enhanced"	"Detected in some"		"Collecting duct cells: 55.2;Excitatory neurons: 13.0;Proximal tubular cells: 35.7"	"Cancer enriched"	"Detected in some"	5	"renal cancer: 3.7"	"Region enriched"	"Detected in some"	10	"cerebral cortex: 13.1"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 2.3;CACO-2: 3.7;HEK 293: 8.3;HMC-1: 1.6;RPTEC TERT1: 1.4;U-2 OS: 1.2"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	17	"amygdala: 2.7;cerebral cortex: 10.5;hippocampal formation: 7.8"	"HPA006230, HPA006421"	Approved		Supported	"Nucleoli,Nucleoli rim,Mitotic chromosome"		Yes	No				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Nucleoli, Nucleoli rim"	"Mitotic chromosome"	"HPA006230: AB_2667542, HPA006421: AB_1078739"	"unprognostic (4.54e-2)"	"unprognostic (5.59e-2)"	"unprognostic (8.71e-2)"	"unprognostic (2.22e-6)"	"unprognostic (4.82e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.94e-1)"	"unprognostic (2.16e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.99e-1)"	"unprognostic (3.07e-1)"	"prognostic favorable (1.54e-6)"	"unprognostic (4.08e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.08e-3)"	"unprognostic (5.02e-2)"	0.2	0.1	0.1	0.0	1.3	0.0	0.0	0.0	13.1	0.0	0.0	0.4	0.8	0.0	0.7	0.1	0.0	0.0	0.0	1.3	0.0	36.4	0.1	0.0	0.0	0.0	0.0	0.0	0.3	5.9	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.3	3.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.0	0.1	0.0	0.0	2.3	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	8.3	0.0	0.0	1.1	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.3	0.0	13.1	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	1.0	0.0	0.0	55.2	0.0	0.1	0.0	1.2	5.9	0.0	0.9	0.0	0.0	0.0	0.0	0.0	13.0	0.4	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.6	0.0	0.0	0.0	1.6	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.9	35.7	0.0	0.0	0.0	0.0	0.0	1.5	5.2	0.0	0.0	0.0	0.1	0.0	0.3	0.0
EN1		ENSG00000163064	"Engrailed homeobox 1"	Q05925	2	118842171-118847648	"Predicted intracellular proteins, Transcription factors"		"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 18.2;skeletal muscle: 13.9;skin 1: 10.4"	"Cell type enhanced"	"Detected in some"		"Breast glandular cells: 5.6;Fibroblasts: 4.8;Melanocytes: 12.4;Skeletal myocytes: 12.0;Smooth muscle cells: 5.4"	"Cancer enhanced"	"Detected in many"		"breast cancer: 5.6"	"Region enriched"	"Detected in many"	6	"midbrain: 18.2"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 16.1;ASC TERT1: 7.2;fHDF/TERT166: 13.3;HSkMC: 13.5;PC-3: 7.8;U-138 MG: 9.9;U-2197: 11.2"	"Region enriched"	"Detected in single"	5	"midbrain: 4.9"	"Region enriched"	"Detected in some"	6	"midbrain: 23.6"	"CAB014884, HPA073141"	Enhanced		Approved	"Nucleoplasm,Nucleoli rim"		NA	NA				"Cluster 80: Striated muscle - Unknown function"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Nucleoli rim"	Nucleoplasm	"CAB014884: , HPA073141: AB_2686573"	"unprognostic (5.20e-2)"	"unprognostic (1.61e-1)"	"unprognostic (5.78e-2)"	"unprognostic (4.84e-7)"	"unprognostic (1.87e-3)"	"unprognostic (1.90e-1)"		"unprognostic (1.95e-3)"	"unprognostic (1.16e-1)"	"unprognostic (2.06e-2)"	"unprognostic (1.19e-2)"	"unprognostic (4.46e-1)"	"unprognostic (3.38e-9)"	"unprognostic (2.15e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.70e-1)"	"unprognostic (9.30e-3)"	3.5	0.2	0.1	0.0	0.1	0.0	1.6	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	1.8	0.7	18.2	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	13.9	10.4	0.0	0.0	0.5	0.0	0.0	0.1	1.4	0.0	0.0	0.6	0.0	0.0	0.0	0.5	4.0	0.2	0.6	0.2	16.1	7.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.3	4.7	0.5	0.6	0.0	0.0	0.0	1.3	0.0	0.7	0.0	0.1	0.0	0.0	13.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.1	0.0	7.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	2.3	0.0	0.0	0.0	9.9	1.0	11.2	1.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	1.6	0.0	0.0	0.5	0.7	18.2	3.2	0.5	1.4	0.5	1.0	0.0	0.0	0.0	0.0	2.3	0.0	0.1	0.0	0.0	5.6	2.8	0.8	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	4.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.1	12.4	0.0	0.0	0.0	0.0	1.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.0	5.4	0.1	0.4	0.0	2.6	0.0	0.2	0.0	0.0	0.0
EN2		ENSG00000164778	"Engrailed homeobox 2"	P19622	7	155458129-155464831	"Disease related genes, Predicted intracellular proteins, Transcription factors"		"Developmental protein, DNA-binding"	"Autism, Autism spectrum disorder"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	21	"brain: 19.2"	"Group enriched"	"Detected in some"	4	"Endometrial ciliated cells: 3.6;Glandular and luminal cells: 8.7"	"Cancer enhanced"	"Detected in many"		"melanoma: 6.3"	"Group enriched"	"Detected in many"	6	"cerebellum: 19.2;midbrain: 8.0"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 41.1;AN3-CA: 15.2;HAP1: 9.0;HEK 293: 25.1;SK-MEL-30: 12.9"	"Region enriched"	"Detected in some"	8	"cerebellum: 27.8"	"Region enriched"	"Detected in some"	5	"cerebellum: 52.3"	"HPA045646, HPA069809"			Supported	"Nucleoplasm,Nucleoli,Nucleoli fibrillar center"		No	No				"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 12: NES - Nervous system development"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm	"Nucleoli, Nucleoli fibrillar center"	"HPA045646: AB_2679404, HPA069809: AB_2686205"	"unprognostic (2.44e-3)"	"unprognostic (1.71e-2)"	"unprognostic (4.89e-2)"	"unprognostic (7.99e-3)"	"prognostic unfavorable (1.74e-6)"	"unprognostic (2.54e-1)"	"unprognostic (8.02e-2)"	"unprognostic (7.00e-2)"	"unprognostic (1.15e-1)"	"unprognostic (9.87e-3)"	"unprognostic (1.07e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.03e-13)"	"unprognostic (4.91e-3)"	"unprognostic (2.72e-1)"	"unprognostic (2.24e-1)"	"unprognostic (5.64e-3)"	0.1	0.1	0.1	0.0	0.2	0.0	0.1	19.2	0.7	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.2	0.4	0.1	0.0	0.0	0.0	0.2	8.0	0.6	0.3	0.5	0.1	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.0	0.3	0.0	0.0	0.8	0.9	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.8	0.7	41.1	15.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	6.1	0.0	1.4	0.0	9.0	0.0	0.0	0.0	25.1	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.3	5.5	0.0	0.0	0.0	0.0	2.0	0.0	3.2	0.0	0.1	0.3	0.0	0.0	3.0	0.0	12.9	0.0	0.0	2.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	19.2	0.7	0.2	0.4	0.2	8.0	2.3	0.3	0.9	2.0	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.8	0.8	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.7	3.6	0.6	0.2	0.0	0.0	0.0	0.2	0.0	0.4	0.0	8.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.9	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.9	0.4	1.5	0.6	0.0	0.1	0.0	0.1	0.3	0.0	0.0
ENG	"CD105, END, HHT1, ORW, ORW1"	ENSG00000106991	Endoglin	P17813	9	127815013-127854658	"Cancer-related genes, Candidate cardiovascular disease genes, CD markers, Disease related genes, Human disease related genes, Plasma proteins, Predicted membrane proteins"	"Angiogenesis, Cell adhesion"		"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 528.7"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 407.5;Endothelial cells: 514.4;Extravillous trophoblasts: 294.4;Hepatic stellate cells: 579.0;Leydig cells: 487.1;Peritubular cells: 1421.8;Syncytiotrophoblasts: 376.4;Theca cells: 308.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"classical monocyte: 19.9;intermediate monocyte: 28.2;myeloid DC: 10.3;NK-cell: 7.6;non-classical monocyte: 22.1"	"Group enriched"	"Detected in many"	4	"dendritic cells: 10.3;monocytes: 28.2;NK-cells: 7.6"	"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 263.8;HUVEC TERT2: 487.4;TIME: 1027.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000096, HPA011862, HPA067440, CAB072873"	Enhanced		Supported	"Nuclear bodies,Plasma membrane"		NA	NA		280000000	"Cluster 7: Monocytes - Unknown function"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Plasma membrane"	"Nuclear bodies"	"CAB000096: AB_563482, CAB072873: AB_2665725, HPA011862: AB_1846217, HPA067440: AB_2685840"	"unprognostic (2.28e-1)"	"unprognostic (1.13e-1)"	"unprognostic (3.87e-2)"	"unprognostic (2.96e-2)"	"unprognostic (1.77e-1)"	"prognostic favorable (6.61e-4)"	"prognostic favorable (5.62e-6)"	"unprognostic (2.15e-1)"	"unprognostic (4.06e-1)"	"unprognostic (3.87e-2)"	"unprognostic (2.20e-2)"	"unprognostic (8.98e-2)"	"prognostic unfavorable (4.26e-4)"	"unprognostic (3.33e-3)"	"unprognostic (7.35e-2)"	"unprognostic (2.84e-1)"	"unprognostic (1.27e-1)"	234.5	92.6	44.4	80.2	41.5	18.8	164.8	45.2	44.5	129.7	50.4	62.4	33.2	111.1	35.1	43.1	122.4	58.7	528.7	36.7	43.1	211.6	60.7	260.7	43.4	50.0	47.1	220.9	47.1	29.7	56.1	93.6	52.8	93.9	17.5	2.1	46.2	73.5	72.3	51.3	76.8	65.7	43.1	226.5	57.6	98.9	59.4	17.3	169.2	54.8	17.7	93.0	95.8	43.6	1.3	1.0	7.1	0.4	117.8	81.0	217.8	147.1	102.0	74.4	43.4	0.5	1.3	1.0	70.2	263.8	56.8	2.4	0.0	23.2	24.5	0.7	0.3	42.3	76.7	4.6	91.7	20.2	0.5	137.6	5.4	97.7	34.9	1.0	487.4	1.4	0.7	1.4	88.1	0.9	0.6	1.8	1.7	0.3	4.2	66.9	12.5	1.4	0.0	0.4	0.8	1.8	78.0	65.3	20.1	4.7	13.8	29.8	1027.5	248.1	13.7	164.7	0.7	5.2	1.2	0.9	67.1	52.0	83.2	0.0	19.9	0.5	1.8	28.2	0.6	0.6	3.0	3.4	10.3	1.4	1.9	3.0	0.5	7.6	22.1	3.8	1.2	8.4	44.4	41.5	45.2	44.5	36.7	43.1	50.0	47.1	52.8	43.1	59.4	43.6	407.5	3.2	16.0	2.0	9.2	12.0	2.3	2.1	2.8	2.8	9.5	9.8	28.4	18.6	2.3	3.7	4.2	30.0	8.6	0.4	0.0	10.2	8.6	7.7	67.9	514.4	2.4	49.2	0.6	1.1	294.4	85.7	3.1	8.1	15.2	0.8	579.0	9.8	132.0	0.0	0.7	1.6	0.0	65.4	29.7	51.4	487.1	56.6	24.9	78.7	36.2	2.0	4.1	1.5	1.1	1.4	0.0	1421.8	2.1	2.0	0.0	0.3	5.1	4.6	72.3	44.0	57.5	4.4	5.2	1.3	8.4	376.4	9.6	308.1	0.5	1.4
ENO2		ENSG00000111674	"Enolase 2"	P09104	12	6913745-6923698	"Cancer-related genes, Candidate cardiovascular disease genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	Glycolysis	Lyase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"retina: 1695.6"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 318.2;Cone photoreceptor cells: 312.8;Horizontal cells: 429.0;Rod photoreceptor cells: 787.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"gdT-cell: 9.9;MAIT T-cell: 11.3;memory B-cell: 6.8;memory CD4 T-cell: 13.1;memory CD8 T-cell: 11.4;naive B-cell: 4.4;naive CD4 T-cell: 8.2;naive CD8 T-cell: 8.6;neutrophil: 7.0;T-reg: 7.5"	"Group enriched"	"Detected in many"	7	"B-cells: 6.8;granulocytes: 7.0;T-cells: 13.1"	"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 537.4;U-87 MG: 398.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000063, HPA068284, HPA068721, CAB073539, CAB079023"	Enhanced	Supported	Supported	"Plasma membrane,Cytosol"		NA	NA		55000000	"Cluster 16: MAIT-cells - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 46: Photoreceptor cells - Phototransduction"	"Plasma membrane, Cytosol"		"CAB000063: AB_2099322, CAB073539: , CAB079023: , HPA068284: , HPA068721: AB_2732119"	"unprognostic (8.96e-2)"	"unprognostic (8.28e-2)"	"prognostic unfavorable (6.96e-4)"	"unprognostic (1.28e-1)"	"unprognostic (7.95e-3)"	"unprognostic (1.39e-2)"	"prognostic unfavorable (5.15e-4)"	"unprognostic (1.48e-1)"	"unprognostic (9.43e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.98e-1)"	"unprognostic (2.02e-2)"	"prognostic unfavorable (7.89e-11)"	"unprognostic (7.61e-2)"	"unprognostic (3.06e-1)"	"unprognostic (8.10e-3)"	"unprognostic (1.24e-1)"	25.6	46.7	280.8	20.0	289.7	9.6	20.2	291.2	400.7	55.9	97.5	74.0	10.2	40.1	12.6	15.3	40.2	17.9	53.7	295.0	289.4	27.8	7.7	33.8	26.3	289.4	189.9	29.7	9.0	43.6	124.4	10.4	282.2	34.9	15.5	1695.6	13.8	34.4	7.4	19.3	37.1	35.0	164.3	26.4	30.4	9.6	259.0	26.7	42.0	6.4	24.4	57.4	44.1	306.2	74.3	45.3	16.2	0.5	23.7	26.0	1.5	56.5	37.3	82.0	125.9	8.6	5.8	103.9	9.5	24.3	108.8	11.0	173.0	15.4	116.1	211.9	16.6	141.0	47.7	60.3	17.4	8.3	161.2	13.0	0.7	61.1	11.5	537.4	17.5	137.9	9.5	1.1	56.3	10.3	66.9	8.8	84.9	31.7	27.2	75.0	13.9	22.9	38.5	9.8	128.3	94.0	14.3	1.0	96.3	76.4	4.5	3.9	20.9	69.4	73.7	95.7	73.0	73.3	79.5	15.4	398.4	0.3	15.2	2.1	0.0	0.2	9.9	0.0	11.3	6.8	13.1	11.4	0.1	4.4	8.2	8.6	7.0	0.4	0.3	1.2	7.5	6.1	280.8	289.7	291.2	400.7	295.0	289.4	289.4	189.9	282.2	164.3	259.0	306.2	3.2	35.3	27.4	54.2	11.2	6.2	2.3	45.2	1.8	318.2	5.2	4.3	16.1	1.5	17.2	12.9	312.8	0.3	7.5	0.3	0.0	17.0	0.5	9.6	2.1	9.9	23.9	7.0	96.2	1.8	1.1	8.3	2.0	2.7	67.2	1.0	5.3	0.2	1.7	429.0	89.4	0.5	18.3	0.6	6.9	0.3	5.6	5.9	12.4	25.3	3.5	146.1	0.0	23.6	31.5	9.3	1.2	9.8	9.2	2.5	0.1	0.2	32.2	787.2	13.1	8.1	20.2	1.5	2.5	1.1	2.3	0.3	17.1	0.3	0.4	2.2
ENO3		ENSG00000108515	"Enolase 3"	P13929	17	4948092-4957131	"Candidate cardiovascular disease genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	Glycolysis	Lyase	"Disease variant, Glycogen storage disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	26	"skeletal muscle: 14758.3;tongue: 10771.0"	"Group enriched"	"Detected in many"	5	"Cardiomyocytes: 582.2;Skeletal myocytes: 248.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HDLM-2: 263.8;HeLa: 120.0;HMC-1: 115.1;RH-30: 170.2;RPMI-8226: 96.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000793, HPA068284, HPA068721"	Enhanced		Supported	"Plasma membrane,Cytosol"		Yes	No		86000000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 37: Myocytes - Muscle contraction"	"Plasma membrane, Cytosol"		"HPA000793: AB_1078742, HPA068284: , HPA068721: AB_2732119"	"unprognostic (7.35e-2)"	"unprognostic (5.25e-2)"	"prognostic unfavorable (7.33e-4)"	"unprognostic (1.57e-1)"	"unprognostic (1.29e-1)"	"unprognostic (5.86e-2)"	"unprognostic (5.68e-2)"	"unprognostic (2.08e-2)"	"unprognostic (8.12e-2)"	"unprognostic (1.42e-1)"	"unprognostic (6.04e-3)"	"unprognostic (2.21e-2)"	"unprognostic (4.63e-2)"	"unprognostic (5.34e-2)"	"unprognostic (3.48e-1)"	"unprognostic (2.15e-1)"	"unprognostic (4.50e-2)"	7.8	5.5	3.8	15.6	3.9	20.4	8.0	7.1	4.3	6.6	5.0	8.0	20.1	7.2	7.1	173.8	7.4	2.6	499.8	3.5	3.7	10.3	108.0	8.6	13.0	4.3	5.0	6.0	5.5	4.0	7.9	6.3	4.6	47.3	3.0	5.0	116.8	3.1	14758.3	8.3	15.6	2.8	4.1	16.9	10.1	9.3	4.3	5.8	10.3	10771.0	4.9	5.6	5.0	4.9	12.0	25.5	11.3	10.7	9.1	2.2	27.6	21.0	2.7	1.5	1.3	12.8	8.1	21.9	25.8	1.9	3.5	15.4	3.8	1.9	1.0	263.8	24.3	21.9	120.0	18.9	3.7	6.8	115.1	14.4	3.8	2.1	4.1	9.8	1.4	24.8	10.2	39.0	4.9	6.6	7.9	26.5	14.8	3.3	10.6	34.6	170.2	96.9	3.1	7.9	7.1	27.1	13.6	11.4	14.7	7.6	10.2	7.0	6.5	12.1	21.3	5.4	16.0	27.6	16.8	18.2	6.7	20.8	12.2	31.4	28.5	50.4	36.8	41.5	24.8	24.5	30.8	34.4	37.6	20.1	20.0	32.2	34.4	34.9	47.6	29.9	43.2	83.6	3.8	3.9	7.1	4.3	3.5	3.7	4.3	5.0	4.6	4.1	4.3	4.9	1.2	0.0	1.8	2.3	2.7	2.0	1.2	2.1	4.0	6.6	3.0	3.0	582.2	0.0	2.2	5.5	4.2	5.4	3.2	2.9	0.0	1.5	1.8	0.9	1.6	7.3	0.0	3.8	0.2	0.8	3.8	17.3	4.6	2.2	8.2	2.4	2.2	56.2	4.5	3.3	0.2	2.2	2.0	3.5	6.7	3.7	0.3	4.3	1.8	0.0	78.3	1.9	4.1	1.0	0.5	1.8	1.9	0.4	2.3	1.2	6.6	9.5	0.3	2.5	6.6	248.4	55.8	7.9	7.5	2.1	1.8	3.3	4.5	1.1	2.6	0.8
ENOX1	"cCNOX, CNOX, FLJ10094, PIG38"	ENSG00000120658	"Ecto-NOX disulfide-thiol exchanger 1"	Q8TC92	13	43213518-43786908	"Predicted intracellular proteins"	"Biological rhythms, Electron transport, Transport"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 14.1"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 173.3;Early spermatids: 190.8;Excitatory neurons: 452.3;Inhibitory neurons: 692.0;Late spermatids: 264.8;Oligodendrocyte precursor cells: 167.9;Oligodendrocytes: 771.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"hTEC/SVTERT24-B: 17.3;RH-30: 24.1;TIME: 17.8;U-2197: 17.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038355	Approved		Supported	"Plasma membrane"	"Intracellular and membrane"	NA	NA				"Cluster 78: Testis - Spermatogenesis"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Plasma membrane"		"HPA038355: AB_10673171"	"unprognostic (9.64e-2)"	"unprognostic (3.38e-3)"	"unprognostic (1.64e-1)"	"unprognostic (1.20e-3)"	"unprognostic (1.06e-1)"	"unprognostic (2.69e-1)"	"unprognostic (2.88e-1)"	"unprognostic (6.72e-3)"	"unprognostic (2.60e-1)"	"unprognostic (2.29e-3)"	"unprognostic (1.32e-1)"	"unprognostic (9.93e-2)"	"unprognostic (1.32e-3)"	"unprognostic (1.07e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.08e-3)"	"unprognostic (1.42e-2)"	3.4	1.0	7.8	2.5	12.5	0.3	1.8	4.6	9.2	3.3	0.4	8.5	0.6	5.0	0.9	1.0	2.7	1.6	4.7	7.7	7.9	3.5	0.4	0.9	2.2	10.0	6.9	6.4	1.3	0.7	1.9	4.4	10.3	3.0	1.5	2.0	0.4	3.7	8.1	0.5	1.4	4.2	7.4	0.7	2.3	9.0	8.9	2.8	0.4	0.7	1.4	3.1	2.1	14.1	0.2	0.3	3.4	0.0	3.4	13.2	0.7	1.6	3.8	5.7	5.4	2.4	0.4	0.0	0.2	5.1	0.6	0.1	0.7	0.4	2.5	4.2	5.6	0.7	4.0	0.1	2.1	0.1	0.9	12.7	1.2	17.3	8.7	0.9	0.4	2.8	0.0	0.8	3.5	0.3	5.9	0.2	3.8	0.1	1.5	0.0	24.1	0.0	3.0	0.7	11.8	4.5	2.1	3.5	0.9	2.6	0.7	0.1	17.8	1.9	0.6	17.9	1.9	0.0	0.1	0.1	8.3	0.0	12.8	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.8	12.5	4.6	9.2	7.7	7.9	10.0	6.9	10.3	7.4	8.9	14.1	1.5	3.2	0.0	173.3	0.0	0.6	1.3	0.0	2.2	4.3	1.2	0.6	3.0	0.0	2.5	0.0	0.0	0.1	0.0	0.1	5.9	0.6	190.8	0.1	1.9	0.4	0.0	0.0	452.3	0.4	0.0	2.5	0.0	0.1	0.0	2.3	0.0	0.0	0.2	1.7	692.0	0.0	0.0	0.0	1.8	264.8	12.2	0.4	0.0	15.0	0.0	0.3	0.0	167.9	771.1	0.1	0.0	4.5	0.0	2.7	0.0	1.1	5.3	0.4	6.6	6.1	5.1	3.8	7.3	0.3	0.3	0.3	0.1	12.3	0.0	0.5
ENOX2	"APK1, COVA1, tNOX"	ENSG00000165675	"Ecto-NOX disulfide-thiol exchanger 2"	Q16206	X	130622325-130903317	"Predicted intracellular proteins"	"Biological rhythms, Electron transport, Growth regulation, Transport"	Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Oligodendrocyte precursor cells: 51.3;Oligodendrocytes: 132.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000514, HPA003027"	Uncertain		Approved	"Plasma membrane,Cytosol"	"Intracellular and membrane"	NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Cytosol	"Plasma membrane"	"HPA000514: AB_1078558, HPA003027: "	"unprognostic (1.34e-2)"	"unprognostic (7.02e-2)"	"unprognostic (9.75e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.94e-1)"	"unprognostic (2.60e-1)"	"unprognostic (4.07e-2)"	"unprognostic (6.07e-2)"	"unprognostic (6.27e-3)"	"unprognostic (5.22e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.44e-1)"	"prognostic favorable (1.09e-5)"	"unprognostic (6.42e-2)"	"unprognostic (4.60e-2)"	"unprognostic (3.02e-1)"	"unprognostic (1.38e-1)"	6.4	7.6	6.4	5.6	9.2	3.3	6.4	5.5	6.9	6.9	5.0	4.9	4.1	8.8	5.4	7.2	7.6	6.6	10.8	6.1	8.0	4.3	5.4	5.1	8.2	7.5	6.7	7.9	3.8	7.8	1.7	5.9	6.4	6.1	5.3	2.8	4.6	8.0	6.7	4.4	4.7	8.2	6.2	7.3	5.6	5.9	7.6	8.6	6.3	8.3	9.5	6.9	3.0	9.2	15.7	12.9	16.2	7.4	15.3	13.2	7.3	12.6	15.3	8.5	5.3	6.0	12.9	11.3	30.1	11.6	11.4	10.9	11.4	13.0	10.7	15.3	12.1	24.6	7.4	6.6	10.6	20.2	16.6	10.7	19.3	10.1	11.3	4.0	12.8	9.9	17.1	8.6	7.0	21.4	13.2	3.7	9.0	20.8	16.0	8.7	10.4	12.9	10.0	10.5	5.5	9.6	12.2	7.2	17.0	6.1	4.6	10.1	10.5	8.3	4.9	13.2	26.4	9.2	4.9	7.6	23.6	19.2	13.8	7.0	11.1	12.9	9.4	14.1	9.6	11.7	10.5	9.7	10.8	11.9	11.2	9.7	1.8	10.8	7.7	5.8	12.4	9.3	6.4	9.2	5.5	6.9	6.1	8.0	7.5	6.7	6.4	6.2	7.6	9.2	11.8	3.2	7.4	15.0	11.5	4.2	6.9	5.1	19.4	4.4	8.1	5.3	13.0	5.7	7.5	3.7	0.0	6.2	7.9	4.9	7.9	8.0	1.0	8.3	13.3	8.6	4.8	11.6	18.7	9.3	5.5	9.7	10.7	5.4	6.3	7.4	7.5	12.3	6.9	3.3	31.2	6.7	14.2	21.3	7.7	2.2	5.6	12.6	8.8	23.4	18.4	4.3	19.6	51.3	132.2	10.1	2.6	6.4	11.9	6.4	4.5	8.4	13.1	8.3	6.6	11.6	9.5	11.4	10.6	13.8	4.8	7.3	11.1	7.6	5.7	5.7
ENTPD6	"CD39L2, dJ738P15.3, IL6ST2, NTPDase-6"	ENSG00000197586	"Ectonucleoside triphosphate diphosphohydrolase 6"	O75354	20	25195693-25228075	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SK-MEL-30: 289.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015491, HPA069555"	Approved		Supported	"Golgi apparatus"	"Secreted to blood"	NA	NA		41000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 22: Non-specific - Unknown function"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Golgi apparatus"		"HPA015491: AB_2669200, HPA069555: AB_2686152"	"unprognostic (3.24e-1)"	"unprognostic (1.27e-2)"	"unprognostic (5.91e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.76e-1)"	"unprognostic (4.44e-1)"	"unprognostic (2.10e-3)"	"unprognostic (7.41e-3)"	"unprognostic (2.74e-3)"	"unprognostic (1.17e-1)"	"unprognostic (2.14e-1)"	"unprognostic (1.03e-1)"	"unprognostic (8.14e-3)"	"unprognostic (1.78e-2)"	"unprognostic (2.74e-1)"	"unprognostic (4.86e-2)"	"unprognostic (4.48e-2)"	24.8	55.4	54.3	22.8	64.0	15.2	27.7	39.7	65.9	22.9	26.5	61.0	60.0	21.8	18.4	25.3	23.2	26.5	75.9	56.0	49.8	40.4	38.9	25.4	16.1	29.6	32.2	36.2	49.6	23.5	60.0	25.2	45.2	55.7	44.9	15.7	71.2	17.2	38.7	19.4	63.0	18.6	25.7	19.8	47.2	36.3	48.5	29.8	28.8	21.9	13.0	24.5	21.8	38.9	78.8	122.8	32.9	64.0	41.0	50.8	70.8	63.0	45.0	54.0	48.3	65.5	60.0	47.6	91.4	60.9	104.7	100.3	40.1	96.2	35.5	29.2	36.2	38.3	18.2	150.4	60.7	52.7	57.3	47.4	53.1	67.7	51.4	39.4	43.7	46.1	51.5	78.8	40.0	75.6	49.2	32.6	20.8	63.9	96.0	27.1	102.9	108.4	67.8	46.3	52.0	26.7	17.7	105.1	289.4	29.6	75.3	43.4	48.6	61.9	63.7	51.6	75.7	50.5	43.8	21.0	44.5	34.1	116.3	0.1	25.2	4.9	18.8	17.0	25.6	8.7	16.5	15.0	26.4	11.0	16.9	15.5	1.1	14.1	7.6	18.5	17.2	22.1	54.3	64.0	39.7	65.9	56.0	49.8	29.6	32.2	45.2	25.7	48.5	38.9	6.4	19.2	28.5	12.4	9.9	9.8	16.2	23.6	6.2	19.2	25.8	21.8	5.8	25.8	14.8	18.4	10.4	63.2	11.0	81.4	9.8	42.5	22.1	10.5	7.6	7.6	34.0	4.2	18.6	40.1	21.7	12.8	52.5	15.4	3.8	65.2	14.3	15.0	26.7	25.2	19.4	57.5	26.4	17.7	17.4	65.2	20.5	17.6	10.6	11.2	16.0	4.2	10.3	13.0	9.2	33.8	59.8	42.2	16.5	27.9	68.4	13.5	10.7	9.1	6.6	6.3	9.6	3.0	8.8	8.6	6.0	59.8	12.0	25.8	72.6	12.1
EP400	"CAGH32, DKFZP434I225, KIAA1498, KIAA1818, P400, TNRC12"	ENSG00000183495	"E1A binding protein p400"	Q96L91	12	131949942-132080460	"Plasma proteins, Predicted intracellular proteins"		"Chromatin regulator, DNA-binding, Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"B-cells: 4.0;dendritic cells: 4.7;T-cells: 1.7"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016704, HPA049013"	Supported		Supported	Nucleoplasm		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	Nucleoplasm		"HPA016704: AB_1854888, HPA049013: AB_2680598"	"unprognostic (2.28e-1)"	"unprognostic (4.04e-1)"	"unprognostic (4.33e-1)"	"unprognostic (8.03e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.60e-1)"	"prognostic unfavorable (2.11e-4)"	"unprognostic (3.10e-1)"	"unprognostic (1.37e-2)"	"unprognostic (4.90e-2)"	"unprognostic (2.05e-2)"	"unprognostic (2.35e-1)"	"unprognostic (1.13e-2)"	"unprognostic (2.33e-1)"	"unprognostic (4.36e-1)"	"unprognostic (2.46e-2)"	"unprognostic (2.24e-1)"	11.9	14.0	18.5	7.6	15.6	12.2	11.9	15.0	18.1	16.8	9.3	15.7	6.0	14.4	13.2	11.4	15.0	5.9	11.6	18.2	14.6	15.4	11.7	11.3	11.4	14.0	12.1	19.5	12.5	9.5	17.4	6.4	13.1	14.3	6.6	18.1	10.3	8.8	19.3	15.4	13.1	7.3	8.7	18.6	11.7	14.6	15.5	11.7	14.3	8.9	8.6	13.1	12.6	16.5	23.5	30.6	28.3	14.2	16.6	16.3	22.3	13.0	9.9	9.8	8.4	18.3	7.1	19.9	11.8	16.2	11.1	17.6	13.7	13.0	13.2	8.3	20.6	28.5	10.8	20.8	13.7	30.9	21.3	14.0	12.1	18.1	16.3	16.7	16.9	12.7	28.3	5.5	14.3	29.6	23.5	42.1	22.6	12.7	26.3	24.6	19.0	8.1	13.3	28.3	22.8	19.2	15.1	10.4	15.0	20.4	17.4	24.1	25.4	15.6	24.3	17.6	18.9	14.1	11.6	19.8	16.2	17.0	16.0	0.7	0.7	0.6	1.1	0.6	1.1	4.0	1.0	0.9	0.6	4.0	1.2	1.7	0.6	0.6	0.6	4.7	0.7	0.6	18.5	15.6	15.0	18.1	18.2	14.6	14.0	12.1	13.1	8.7	15.5	16.5	19.1	3.2	17.9	44.4	27.8	9.9	10.5	11.0	17.1	34.2	14.0	10.5	13.9	7.2	14.3	16.5	39.6	12.6	22.4	13.2	1.9	11.3	12.5	21.3	25.5	18.6	14.4	14.9	59.6	10.4	11.4	17.3	14.8	21.8	6.3	34.1	15.7	12.1	15.0	25.2	56.4	13.8	12.2	14.1	7.6	6.8	16.4	17.9	7.2	24.4	16.7	15.7	29.9	55.8	48.9	15.3	14.0	17.0	24.3	17.8	8.8	4.2	35.9	37.2	19.7	31.2	20.2	62.8	54.3	20.0	13.1	17.8	26.5	26.9	13.5	13.4
EPB41	"4.1R, EL1"	ENSG00000159023	"Erythrocyte membrane protein band 4.1"	P11171	1	28887091-29120046	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Cell cycle, Cell division, Mitosis, Transport"	"Actin-binding, Calmodulin-binding"	"Elliptocytosis, Hereditary hemolytic anemia, Pyropoikilocytosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"retina: 80.0"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 151.6;Cone photoreceptor cells: 137.6;Erythroid cells: 187.1;Rod photoreceptor cells: 171.4"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"cerebellum: 42.2"	"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEL: 136.3;K-562: 136.5"	"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in all"	8	"cerebellum: 105.6"	"HPA028076, HPA028096, HPA028412, HPA028414"	Supported		Supported	"Nuclear bodies,Plasma membrane,Cell Junctions,Cytokinetic bridge,Mitotic spindle,Cytosol"		Yes	No		1100000	"Cluster 1: Neutrophils - Mixed function"	"Cluster 34: Non-specific - Transcription"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 6: Erythroid cells - Oxygen transport"	"Plasma membrane, Cell Junctions"	"Nuclear bodies, Cytokinetic bridge, Mitotic spindle, Cytosol"	"HPA028076: AB_2672476, HPA028096: , HPA028412: AB_2672592, HPA028414: AB_10601366"	"unprognostic (2.16e-1)"	"unprognostic (1.96e-1)"	"unprognostic (8.92e-3)"	"prognostic unfavorable (4.58e-4)"	"unprognostic (5.00e-2)"	"prognostic favorable (5.87e-4)"	"unprognostic (5.01e-3)"	"unprognostic (5.40e-3)"	"unprognostic (2.52e-2)"	"unprognostic (6.65e-2)"	"unprognostic (7.81e-2)"	"unprognostic (1.42e-2)"	"prognostic unfavorable (1.75e-6)"	"unprognostic (2.66e-2)"	"unprognostic (2.42e-1)"	"unprognostic (1.22e-1)"	"unprognostic (6.67e-2)"	11.0	10.2	1.8	21.9	18.3	63.3	14.1	42.2	6.0	14.5	4.9	23.6	17.7	10.2	5.3	16.6	6.3	15.0	9.7	1.2	4.7	12.7	21.7	15.1	37.4	8.2	5.6	16.3	18.8	15.5	4.7	7.2	8.5	15.0	23.1	80.0	19.1	9.1	15.9	15.3	23.3	9.9	3.5	22.9	27.0	10.4	4.7	69.0	15.2	13.8	37.0	15.5	1.9	3.0	27.0	6.9	62.3	29.4	5.2	0.8	19.5	6.9	10.1	8.4	10.5	16.8	31.2	49.1	17.2	9.2	13.5	11.9	78.7	6.6	8.6	86.4	23.8	136.3	19.7	28.6	10.1	45.8	88.2	1.7	18.4	8.2	13.8	19.9	14.1	73.5	136.5	36.2	0.1	8.8	72.3	30.4	62.0	44.1	10.0	110.9	28.2	68.3	7.7	33.3	78.0	60.5	19.7	19.2	43.3	21.7	14.7	18.2	1.2	0.3	13.3	12.9	13.4	52.5	72.4	85.2	12.1	47.8	6.8	33.3	3.2	21.4	12.9	1.1	15.4	17.2	18.3	14.1	4.4	13.6	22.1	12.7	44.2	10.9	1.5	4.4	28.9	15.3	1.8	18.3	42.2	6.0	1.2	4.7	8.2	5.6	8.5	3.5	4.7	3.0	25.3	19.2	71.7	20.2	58.2	10.5	8.6	7.8	15.4	151.6	20.0	12.2	21.5	20.0	16.8	16.5	137.6	2.4	75.3	26.5	17.6	17.1	16.4	11.3	4.1	15.1	41.6	187.1	76.3	18.7	4.2	7.9	29.6	29.1	24.1	24.9	17.5	30.0	7.1	21.9	61.7	29.0	16.2	23.7	9.0	22.7	2.1	32.4	0.0	78.7	29.3	15.7	85.5	7.5	4.8	28.6	20.3	2.2	46.7	12.2	32.8	13.4	15.2	171.4	13.1	2.8	8.5	39.3	55.7	14.9	16.8	4.1	71.6	4.2	33.0	12.6
EPB41L1	"4.1N, KIAA0338"	ENSG00000088367	"Erythrocyte membrane protein band 4.1 like 1"	Q9H4G0	20	36091504-36232799	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		Actin-binding	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 156.4;Inhibitory neurons: 75.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	10	"plasmacytoid DC: 1.0"	"Lineage enriched"	"Detected in single"	10	"dendritic cells: 1.0"	"Cell line enhanced"	"Detected in many"		"A549: 163.5;HaCaT: 237.9;OE19: 192.9;SK-BR-3: 185.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054104, HPA056817"	Enhanced		Supported	"Plasma membrane"		NA	NA		33000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 48: Smooth muscle cells - ECM organization"	"Plasma membrane"		"HPA054104: AB_2682380, HPA056817: AB_2683244"	"unprognostic (2.01e-2)"	"unprognostic (7.77e-2)"	"unprognostic (1.76e-2)"	"prognostic unfavorable (6.46e-5)"	"unprognostic (1.19e-1)"	"unprognostic (2.31e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.56e-2)"	"unprognostic (3.87e-1)"	"unprognostic (5.83e-3)"	"prognostic unfavorable (9.30e-4)"	"unprognostic (1.78e-1)"	"prognostic favorable (4.39e-10)"	"unprognostic (1.25e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.47e-1)"	"unprognostic (2.26e-2)"	55.1	122.1	68.6	8.1	73.8	0.4	25.7	66.0	97.2	37.7	0.0	31.2	13.8	27.9	31.0	46.3	45.3	40.3	21.3	64.7	81.7	64.7	8.9	30.1	4.4	101.5	80.3	41.8	29.3	37.0	21.1	21.8	94.0	26.9	20.9	39.5	56.6	42.6	12.0	14.2	16.7	27.2	53.0	8.1	64.2	18.3	75.0	4.5	24.8	15.4	14.0	40.7	31.7	79.9	53.5	163.5	57.7	21.5	36.8	22.8	53.8	16.8	37.7	35.1	27.9	108.7	93.7	3.0	26.4	52.7	71.7	237.9	26.7	19.6	26.2	0.5	14.9	0.4	52.7	107.6	11.3	0.2	19.4	19.9	9.4	32.9	2.7	44.7	8.6	13.0	2.7	41.5	30.5	34.2	1.8	0.9	21.4	192.9	49.9	2.6	16.0	66.3	30.5	84.6	20.1	24.5	74.9	185.6	6.4	43.9	45.8	2.4	7.3	40.9	43.0	20.8	3.7	50.3	19.0	0.6	71.2	0.2	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	68.6	73.8	66.0	97.2	64.7	81.7	101.5	80.3	94.0	53.0	75.0	79.9	14.5	16.0	22.1	27.7	0.4	2.9	5.0	11.1	30.7	31.9	12.8	9.4	8.5	28.6	16.5	47.8	156.4	1.5	0.8	23.8	19.6	22.2	2.9	10.6	8.7	9.2	15.5	0.0	56.8	10.8	0.5	11.0	50.4	7.5	52.5	13.3	10.0	3.7	6.9	32.0	75.7	6.0	4.1	1.3	2.2	2.7	15.8	6.0	3.6	3.7	0.0	22.7	0.0	24.6	73.1	31.6	15.7	42.2	2.1	5.1	8.0	37.1	21.9	8.7	32.9	6.8	35.1	4.6	7.1	43.2	1.7	1.1	0.8	7.1	13.2	18.0
EPB41L2	"4.1-G, 4.1G"	ENSG00000079819	"Erythrocyte membrane protein band 4.1 like 2"	O43491	6	130839347-131063322	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell cycle, Cell division, Mitosis, Transport"	Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"retina: 368.5"	"Cell type enhanced"	"Detected in many"		"Microglial cells: 433.8;Muller glia cells: 472.5;Rod photoreceptor cells: 1272.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005730, HPA006642"	Supported		Enhanced	"Nucleoplasm,Plasma membrane,Cell Junctions"		NA	NA		54000	"Cluster 7: Monocytes - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 46: Photoreceptor cells - Phototransduction"	"Plasma membrane"	"Nucleoplasm, Cell Junctions"	"HPA005730: AB_1848195, HPA006642: AB_1848194"	"unprognostic (3.18e-2)"	"unprognostic (1.04e-1)"	"unprognostic (8.34e-3)"	"unprognostic (3.40e-3)"	"unprognostic (1.41e-1)"	"unprognostic (5.17e-2)"	"prognostic unfavorable (2.41e-5)"	"unprognostic (1.25e-1)"	"unprognostic (1.23e-1)"	"prognostic unfavorable (2.16e-4)"	"unprognostic (3.24e-1)"	"unprognostic (1.63e-1)"	"unprognostic (5.63e-2)"	"unprognostic (3.64e-2)"	"unprognostic (3.82e-1)"	"unprognostic (3.48e-2)"	"unprognostic (9.19e-2)"	121.0	35.0	57.8	40.9	108.2	10.0	50.1	62.4	90.2	41.4	6.0	59.1	27.5	49.2	24.1	28.6	55.2	39.6	52.5	57.5	58.2	24.3	26.7	58.6	37.7	101.3	65.5	92.6	20.2	14.8	18.0	58.8	102.1	23.6	49.7	368.5	23.3	32.9	38.7	16.0	47.8	43.1	66.8	59.7	26.6	74.5	73.4	30.7	33.7	67.8	26.4	36.0	34.8	120.8	34.0	35.6	78.0	109.5	53.4	85.7	23.9	56.4	72.2	57.9	79.9	67.5	47.7	41.7	102.9	79.6	46.6	17.1	30.6	53.2	114.2	178.4	70.9	74.0	42.5	38.5	31.5	0.1	87.4	42.3	1.1	101.7	38.8	91.8	89.3	62.5	206.1	115.8	37.2	8.5	59.4	13.1	72.6	146.3	38.5	90.9	94.4	4.0	96.5	31.9	8.4	0.3	23.7	0.7	45.4	80.1	12.2	78.3	108.9	66.9	125.0	113.6	172.1	95.6	1.7	38.5	45.8	0.5	103.8	0.1	2.9	0.5	0.9	8.0	0.8	2.5	0.9	1.1	8.2	8.4	1.4	0.6	0.0	1.1	3.2	2.2	2.6	1.2	57.8	108.2	62.4	90.2	57.5	58.2	101.3	65.5	102.1	66.8	73.4	120.8	132.5	6.4	12.0	150.5	17.0	15.4	13.3	5.3	24.5	63.1	10.2	19.9	16.5	21.5	16.0	1.8	225.2	4.4	4.8	54.7	0.0	32.7	332.6	72.3	83.3	92.9	10.2	5.9	300.9	16.6	5.7	120.5	9.7	113.2	44.3	100.3	43.9	5.4	33.5	28.6	144.0	41.9	0.0	166.7	63.3	332.1	73.0	50.8	10.6	433.8	14.0	472.5	2.1	119.1	288.8	57.9	25.0	46.3	10.2	6.2	28.0	10.4	11.2	1272.4	118.3	149.6	89.2	102.8	97.6	12.1	10.2	2.5	9.4	82.8	39.3	7.2
EPC1	Epl1	ENSG00000120616	"Enhancer of polycomb homolog 1"	Q9H2F5	10	32267751-32378798	"Predicted intracellular proteins"	"Growth regulation, Transcription, Transcription regulation"	"Activator, Chromatin regulator"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"bone marrow: 149.7"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028931			Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 24: Non-specific - Transcription regulation"	"Nucleoplasm, Vesicles"		"HPA028931: "	"unprognostic (6.94e-2)"	"unprognostic (3.03e-2)"	"unprognostic (9.93e-2)"	"unprognostic (9.43e-2)"	"unprognostic (5.73e-2)"	"prognostic favorable (6.40e-4)"	"unprognostic (1.80e-2)"	"unprognostic (3.83e-3)"	"unprognostic (7.43e-2)"	"unprognostic (5.55e-2)"	"prognostic favorable (6.02e-4)"	"unprognostic (4.40e-2)"	"unprognostic (1.59e-3)"	"unprognostic (1.03e-1)"	"unprognostic (1.29e-1)"	"unprognostic (2.08e-1)"	"unprognostic (1.18e-3)"	14.4	9.6	12.5	13.9	13.7	149.7	19.4	21.2	14.5	17.5	12.0	15.9	11.5	20.6	15.8	11.1	14.8	12.8	11.9	12.4	12.0	11.9	13.8	14.7	21.5	12.4	12.7	23.4	14.4	14.6	10.3	11.7	13.0	15.0	16.1	19.3	15.0	10.3	22.7	13.8	12.9	16.8	12.5	18.6	13.9	14.4	12.4	31.9	16.8	23.4	17.6	15.2	14.1	16.2	12.0	9.6	21.4	17.9	10.6	14.1	12.4	12.2	6.9	15.6	12.8	10.7	15.1	21.8	8.0	13.6	8.2	12.1	12.1	10.4	10.8	15.9	19.4	18.0	13.5	19.2	11.4	14.1	24.7	12.9	15.8	9.3	7.3	13.9	12.8	18.3	18.8	27.7	12.6	12.9	21.5	10.1	5.3	11.4	8.4	27.7	18.3	11.2	12.1	10.9	18.7	17.8	11.4	8.3	20.1	11.8	8.6	18.7	11.6	9.3	22.7	7.8	10.6	11.3	12.2	35.6	10.0	21.1	8.4	65.8	15.3	36.3	18.9	10.2	16.0	27.4	16.9	15.0	9.1	30.9	17.5	16.1	46.8	13.4	13.2	27.4	21.1	7.7	12.5	13.7	21.2	14.5	12.4	12.0	12.4	12.7	13.0	12.5	12.4	16.2	103.8	41.7	50.9	133.2	166.8	28.6	85.0	54.0	78.6	101.4	69.6	84.3	32.4	52.9	49.2	40.5	68.8	34.9	182.6	55.5	9.8	51.5	11.8	54.1	86.7	70.1	98.6	74.9	108.0	43.6	40.7	71.8	58.1	65.8	85.4	74.9	58.5	35.8	35.2	114.4	106.7	63.9	50.8	55.7	46.8	13.1	94.8	84.4	40.9	134.0	75.4	57.3	148.3	161.9	131.8	49.9	52.3	68.1	139.4	71.6	50.4	20.5	44.1	85.8	98.6	134.9	82.5	77.8	58.3	62.9	24.9	46.1	175.3	56.5	51.0	72.4
EPCAM	"17-1A, 323/A3, CD326, CO-17A, EGP-2, EGP34, EGP40, Ep-CAM, ESA, GA733-2, HEA125, KS1/4, KSA, Ly74, M4S1, MH99, MIC18, MK-1, MOC31, TACST-1, TACSTD1, TROP1"	ENSG00000119888	"Epithelial cell adhesion molecule"	P16422	2	47345158-47387601	"Cancer-related genes, CD markers, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Tumor antigen"	"Cancer-related genes, Disease variant, FDA approved drug targets, Hereditary nonpolyposis colorectal cancer"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 806.0"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 2317.0;Ductal cells: 999.6;Intestinal goblet cells: 1378.2;Paneth cells: 2437.0;Proximal enterocytes: 2681.1;Undifferentiated cells: 1607.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A-431: 538.9;CACO-2: 680.9;CAPAN-2: 944.4;OE19: 911.8;RPTEC TERT1: 398.6"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"CAB003809, HPA026761, CAB030012, CAB055098, HPA067463"	Enhanced		Supported	"Plasma membrane"		NA	NA		22000		"Cluster 9: Intestine - Unknown function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Plasma membrane"		"CAB003809: AB_562285, CAB030012: AB_756075, CAB055098: AB_2335685, HPA026761: AB_1848198, HPA067463: AB_2685846"	"unprognostic (6.79e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.59e-2)"	"unprognostic (1.16e-2)"	"unprognostic (1.61e-1)"	"unprognostic (3.49e-2)"	"unprognostic (2.01e-1)"	"unprognostic (3.61e-2)"	"unprognostic (3.40e-1)"	"prognostic favorable (3.30e-4)"	"unprognostic (5.27e-2)"	"unprognostic (3.28e-2)"	"prognostic favorable (1.04e-6)"	"unprognostic (6.38e-3)"	"unprognostic (1.28e-1)"	"unprognostic (6.45e-3)"	"unprognostic (6.08e-2)"	4.4	12.2	3.1	77.0	4.0	10.2	99.7	1.5	3.1	116.2	1.0	806.0	726.5	33.0	238.9	10.8	114.3	71.1	0.6	3.3	9.2	223.1	3.1	74.7	0.9	2.8	3.2	1.2	125.4	219.5	86.9	1.7	3.4	60.5	751.0	0.6	119.8	52.8	0.1	8.8	769.6	22.2	2.6	1.4	172.4	21.7	10.4	6.4	286.8	0.1	2.8	30.9	4.2	2.6	538.9	5.4	0.4	1.2	0.0	0.0	321.3	0.2	0.0	0.6	0.0	680.9	944.4	0.1	141.5	1.0	0.4	247.3	4.6	62.2	2.0	0.1	56.3	0.3	2.5	261.6	0.1	0.3	0.4	0.0	17.6	0.0	0.0	0.0	0.8	0.0	160.9	0.0	0.3	269.7	0.5	24.0	164.3	911.8	31.4	0.3	0.0	136.9	398.6	231.3	354.0	3.2	4.3	187.7	0.6	132.7	158.3	1.0	0.7	0.3	6.3	2.0	1.1	39.2	0.6	0.8	0.5	0.2	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	3.1	4.0	1.5	3.1	3.3	9.2	2.8	3.2	3.4	2.6	10.4	2.6	3.7	310.9	148.1	1.3	7.0	9.3	227.6	127.4	14.2	0.5	184.7	112.9	2.0	243.1	222.8	448.8	0.0	16.4	2.3	2317.0	76.3	999.6	8.6	434.7	35.3	5.8	498.1	23.1	1.1	402.8	6.5	6.3	150.3	445.3	32.5	11.8	1.4	0.6	2.9	0.0	0.4	1378.2	486.2	0.0	5.2	5.6	20.5	5.6	35.6	0.0	11.5	15.7	0.0	0.5	1.2	617.5	2437.0	18.8	1.8	257.9	2681.1	195.9	219.0	0.7	13.1	0.5	13.7	83.5	130.3	33.3	10.4	6.0	9.4	70.3	1607.7	230.7
EPHA2	ECK	ENSG00000142627	"EPH receptor A2"	P29317	1	16124337-16156069	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted membrane proteins, RAS pathway related proteins"	"Angiogenesis, Apoptosis, Cell adhesion, Differentiation, Host-virus interaction"	"Host cell receptor for virus entry, Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Cataract, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 147.9"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 202.3;Glandular and luminal cells: 182.9;Squamous epithelial cells: 156.3;Suprabasal keratinocytes: 248.3;Urothelial cells: 200.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	94	"plasmacytoid DC: 9.4"	"Lineage enriched"	"Detected in single"	94	"dendritic cells: 9.4"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 201.1;PC-3: 229.0;U-251 MG: 242.1;WM-115: 258.2"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			CAB010464			Supported	"Nuclear speckles,Golgi apparatus,Plasma membrane,Cell Junctions"		NA	Yes		12000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 44: Endometrium - Transcription"	"Plasma membrane, Cell Junctions"	"Nuclear speckles, Golgi apparatus"	"CAB010464: AB_631436"	"unprognostic (9.41e-2)"	"unprognostic (1.67e-1)"	"unprognostic (4.13e-2)"	"unprognostic (1.67e-2)"	"unprognostic (6.22e-2)"	"unprognostic (9.12e-2)"	"unprognostic (5.24e-2)"	"unprognostic (1.29e-3)"	"unprognostic (2.52e-2)"	"unprognostic (7.05e-3)"	"unprognostic (1.52e-3)"	"unprognostic (2.77e-1)"	"unprognostic (2.65e-2)"	"unprognostic (2.08e-1)"	"unprognostic (1.73e-1)"	"unprognostic (4.77e-3)"	"unprognostic (4.40e-2)"	21.4	9.5	3.5	4.8	3.1	0.3	14.6	2.9	3.7	38.2	11.7	12.4	10.0	12.1	1.3	147.9	13.5	28.2	15.8	3.1	3.1	18.7	18.9	17.9	7.6	3.8	3.7	5.8	23.2	3.7	7.4	14.0	3.8	11.2	5.8	6.4	67.7	4.2	4.6	40.3	12.8	3.7	3.6	7.6	15.6	1.8	4.3	3.2	15.2	5.1	11.1	56.1	58.8	3.1	76.9	151.7	41.4	20.1	2.9	3.5	24.3	45.2	63.4	79.9	50.6	63.9	201.1	0.1	189.8	25.9	98.8	30.6	9.9	104.4	27.6	0.4	7.0	0.0	46.7	41.1	51.3	0.1	0.2	4.8	38.1	43.7	95.6	125.0	86.4	0.0	0.3	0.1	51.6	24.3	0.0	0.0	20.0	57.2	229.0	0.1	37.6	0.2	85.1	39.0	0.1	6.4	87.8	21.2	6.1	21.3	3.0	0.9	108.1	28.5	76.7	2.0	242.1	0.0	0.5	0.6	22.0	0.1	258.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.4	0.0	0.0	3.5	3.1	2.9	3.7	3.1	3.1	3.8	3.7	3.8	3.6	4.3	3.1	17.1	54.5	38.4	2.0	1.2	202.3	114.3	110.9	66.0	2.7	39.5	43.9	6.5	44.3	113.4	9.2	4.2	9.7	8.9	96.8	0.0	33.8	5.8	104.5	19.2	26.3	3.0	0.0	0.1	14.2	1.2	5.8	68.3	182.9	5.7	0.4	29.3	23.3	1.9	0.0	0.2	42.0	34.6	1.6	17.0	0.2	3.4	3.7	26.6	4.7	1.1	7.1	0.0	0.0	0.0	104.6	111.7	0.0	0.0	60.8	22.4	1.8	89.8	2.5	32.9	11.6	21.2	0.2	0.8	156.3	248.3	7.5	2.6	0.4	42.9	200.4
EPHA3	"ETK, ETK1, HEK, HEK4, TYRO4"	ENSG00000044524	"EPH receptor A3"	P29320	3	89107621-89482134	"Cancer-related genes, Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"	"Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"prostate: 31.5"	"Group enriched"	"Detected in some"	4	"Excitatory neurons: 70.6;Inhibitory neurons: 106.6;Microglial cells: 103.0;Oligodendrocytes: 48.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"AF22: 197.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB010462, HPA069390"	Approved		Supported	"Nucleoplasm,Nuclear membrane,Plasma membrane,Actin filaments,Cytosol"	"Intracellular and membrane"	NA	NA				"Cluster 46: Fibroblasts - ECM organization"	"Cluster 12: NES - Nervous system development"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Nuclear membrane, Plasma membrane, Cytosol"	"Nucleoplasm, Actin filaments"	"CAB010462: AB_2099218, HPA069390: "	"unprognostic (1.48e-3)"	"unprognostic (2.30e-2)"	"unprognostic (4.95e-2)"	"unprognostic (1.90e-1)"	"unprognostic (2.96e-2)"	"unprognostic (1.47e-2)"	"unprognostic (2.03e-1)"	"unprognostic (9.10e-3)"	"unprognostic (1.24e-3)"	"unprognostic (7.43e-2)"	"unprognostic (1.83e-1)"	"unprognostic (2.23e-1)"	"prognostic unfavorable (3.28e-7)"	"unprognostic (3.63e-2)"	"unprognostic (1.88e-2)"	"unprognostic (4.05e-2)"	"unprognostic (1.20e-2)"	5.4	1.0	2.1	1.8	1.3	0.0	2.3	0.2	3.8	12.3	0.1	3.8	2.3	5.5	0.2	3.2	1.3	18.8	8.2	2.2	0.7	1.3	4.9	2.4	3.6	3.3	0.9	4.1	2.1	1.0	0.9	20.1	4.0	31.5	6.2	8.0	2.2	7.1	0.8	0.7	2.4	7.9	0.8	0.9	2.5	1.0	1.7	1.0	11.0	6.3	3.2	14.3	6.4	2.2	0.0	0.0	197.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.0	0.0	0.0	11.2	0.2	0.7	0.0	2.4	0.0	0.0	11.8	0.0	0.0	1.7	2.0	0.0	3.9	0.0	0.0	0.6	0.0	2.5	0.1	0.3	0.0	2.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.1	0.0	0.1	0.0	0.5	0.1	0.1	36.1	0.1	0.0	0.0	1.7	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	1.3	0.2	3.8	2.2	0.7	3.3	0.9	4.0	0.8	1.7	2.2	2.2	0.0	0.0	5.5	0.0	0.5	0.3	0.0	0.6	6.4	0.0	0.1	2.4	0.0	0.0	0.0	2.1	0.2	0.0	0.0	0.0	0.0	1.8	0.0	0.5	1.8	0.0	0.0	70.6	0.0	0.1	18.1	0.5	0.0	0.0	0.0	1.1	0.0	0.1	20.2	106.6	0.0	0.0	0.0	0.7	1.6	2.1	0.1	0.0	103.0	0.0	4.7	0.0	2.5	48.0	0.0	0.0	8.2	0.0	0.1	0.0	0.0	0.0	18.7	6.6	0.7	19.2	0.1	0.0	0.3	0.3	0.5	0.2	1.3	0.0	0.1
EPHB1	"EPHT2, Hek6"	ENSG00000154928	"EPH receptor B1"	P54762	3	134597801-135260467	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion, Neurogenesis"	"Kinase, Receptor, Transferase, Tyrosine-protein kinase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 40.6"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 198.8;dendritic cells: 53.7;Early spermatids: 42.2;Excitatory neurons: 47.9;Inhibitory neurons: 44.3;Late spermatids: 41.2;Oligodendrocyte precursor cells: 77.9"	"Cancer enriched"	"Detected in many"	6	"glioma: 7.0"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	33	"neutrophil: 24.0;plasmacytoid DC: 23.3"	"Group enriched"	"Detected in many"	33	"dendritic cells: 23.3;granulocytes: 24.0"	"Group enriched"	"Detected in some"	5	"HDLM-2: 63.9;HMC-1: 35.5;RPTEC TERT1: 16.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA067740	Enhanced		Approved	"Endoplasmic reticulum,Plasma membrane,Cytosol"		NA	NA			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 64: Astrocytes - Nervous system maintenance"	"Endoplasmic reticulum, Plasma membrane, Cytosol"		"HPA067740: AB_2685895"	"unprognostic (1.99e-1)"	"unprognostic (3.45e-1)"	"unprognostic (2.52e-1)"	"unprognostic (1.41e-6)"	"unprognostic (6.52e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.07e-1)"	"unprognostic (8.15e-2)"	"unprognostic (9.88e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.04e-1)"	"unprognostic (4.82e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.37e-3)"	"unprognostic (4.88e-4)"	1.0	0.6	4.7	0.8	18.7	0.7	3.2	40.6	12.8	1.8	0.0	3.2	1.4	2.2	0.9	1.9	1.3	1.7	0.3	7.0	5.1	1.3	1.6	0.3	1.9	5.0	14.4	0.7	0.3	0.2	1.0	0.2	5.5	1.7	0.5	4.2	2.2	2.7	4.9	4.8	0.7	0.7	0.9	1.9	0.6	10.8	12.0	0.7	7.0	10.3	1.7	1.5	1.0	4.2	0.0	0.0	8.4	0.1	0.2	0.0	0.0	6.6	0.1	0.3	0.1	0.1	0.0	1.1	1.6	3.4	0.6	0.1	5.5	0.0	1.2	63.9	0.8	4.8	0.0	0.0	0.0	0.0	35.5	0.1	0.0	0.1	0.0	0.3	0.2	0.5	0.0	0.3	4.7	0.2	0.0	0.3	2.4	1.2	0.1	0.0	0.9	0.2	16.5	0.0	1.1	0.2	0.0	0.1	0.0	1.1	0.1	0.7	0.5	1.1	3.4	0.7	7.9	0.1	0.0	0.2	0.3	0.0	0.1	0.1	0.0	0.4	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	24.0	0.0	0.0	23.3	0.0	0.2	4.7	18.7	40.6	12.8	7.0	5.1	5.0	14.4	5.5	0.9	12.0	4.2	1.9	0.0	0.0	198.8	1.0	3.7	0.0	0.0	0.0	1.9	0.8	12.3	1.6	0.0	0.0	0.0	10.4	0.0	53.7	0.0	0.0	0.8	42.2	0.1	0.5	2.8	0.0	0.0	47.9	0.4	0.1	0.4	0.0	0.1	0.0	3.3	0.4	7.0	0.4	0.0	44.3	0.0	0.0	0.0	0.8	41.2	0.6	0.8	1.8	8.4	0.1	16.9	0.0	77.9	5.6	0.9	0.0	0.0	0.0	0.1	0.0	0.1	0.0	1.5	0.0	3.3	0.8	0.5	1.6	0.0	5.8	0.0	0.2	3.0	0.3	0.2
EPHB2	"DRT, EPHT3, ERK, Hek5, Tyro5"	ENSG00000133216	"EPH receptor B2"	P29323	1	22710839-22921500	"Cancer-related genes, Disease related genes, Enzymes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	Neurogenesis	"Developmental protein, Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease variant, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 23.3"	"Cell type enhanced"	"Detected in many"		"Ductal cells: 45.1;Enteroendocrine cells: 48.7;Intestinal goblet cells: 61.1;Oligodendrocytes: 76.3;Pancreatic endocrine cells: 63.7;Undifferentiated cells: 97.2"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 23.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"GAMG: 86.5;HUVEC TERT2: 74.2;TIME: 79.2;U-251 MG: 69.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB013647, HPA071200"	Approved		Supported	"Nucleoplasm,Plasma membrane"	"Intracellular and membrane"	No	No		380000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 9: Intestine - Unknown function"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Plasma membrane"	Nucleoplasm	"CAB013647: , HPA071200: AB_2686360"	"unprognostic (2.47e-2)"	"unprognostic (2.43e-2)"	"prognostic favorable (4.98e-4)"	"prognostic unfavorable (1.05e-5)"	"unprognostic (3.99e-2)"	"unprognostic (8.91e-3)"	"unprognostic (1.23e-1)"	"unprognostic (2.33e-3)"	"unprognostic (1.56e-1)"	"unprognostic (7.73e-2)"	"unprognostic (1.23e-2)"	"unprognostic (2.15e-2)"	"unprognostic (2.16e-4)"	"unprognostic (1.45e-1)"	"unprognostic (8.07e-2)"	"unprognostic (2.58e-1)"	"unprognostic (3.46e-2)"	3.1	1.6	2.1	9.2	3.7	0.5	1.6	4.1	4.2	2.5	0.0	22.6	21.0	1.8	1.9	0.6	4.4	3.7	3.3	2.2	4.3	3.8	0.4	1.8	2.9	5.7	4.5	10.6	3.9	6.1	2.9	4.0	4.8	1.9	23.3	2.9	1.5	3.0	0.2	0.9	21.8	3.3	5.0	2.4	1.7	1.8	5.4	1.2	7.3	0.3	1.7	4.4	1.0	8.2	43.4	17.2	17.2	27.7	1.6	1.5	0.0	10.0	0.5	27.3	5.7	6.3	16.6	0.6	20.2	4.0	86.5	39.6	10.8	52.8	7.7	0.1	4.1	0.0	1.9	0.1	16.5	0.0	4.3	5.3	17.5	48.7	0.3	25.4	74.2	2.4	1.8	0.1	5.7	6.4	1.1	0.3	4.0	49.0	11.2	5.3	18.0	0.8	14.7	4.0	18.0	19.3	17.4	0.7	0.2	1.5	1.1	0.5	79.2	11.5	29.6	29.4	69.5	0.0	0.2	0.1	21.8	0.9	0.5	0.1	0.4	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.1	3.7	4.1	4.2	2.2	4.3	5.7	4.5	4.8	5.0	5.4	8.2	0.4	3.2	0.0	5.5	0.3	0.8	1.7	20.5	0.0	15.4	0.1	0.1	1.3	7.2	8.6	0.0	0.0	0.5	0.1	24.3	0.0	45.1	2.6	1.0	0.8	1.2	48.7	0.0	34.1	8.0	2.8	5.0	1.1	2.4	0.0	0.5	0.4	0.4	9.6	6.7	32.3	61.1	6.1	7.6	1.4	0.8	0.9	7.2	0.0	21.5	0.7	18.4	0.0	5.5	76.3	63.7	12.6	0.7	0.3	2.3	5.5	0.2	1.7	1.8	0.0	0.6	2.1	0.5	3.5	0.0	0.4	1.1	0.3	0.2	97.2	1.1
EPN1		ENSG00000063245	"Epsin 1"	Q9Y6I3	19	55675226-55709858	"Plasma proteins, Predicted intracellular proteins"	Endocytosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Proximal enterocytes: 387.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"HEK 293: 263.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009729, HPA061136, HPA071503"	Approved		Supported	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"		No	No			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 45: Enterocytes - Digestion"	"Plasma membrane, Cytosol"	"Nucleoplasm, Vesicles"	"CAB009729: AB_2277865, HPA061136: AB_2684436, HPA071503: "	"unprognostic (6.93e-2)"	"unprognostic (2.47e-1)"	"unprognostic (5.30e-2)"	"unprognostic (1.32e-1)"	"unprognostic (7.94e-2)"	"unprognostic (8.76e-2)"	"unprognostic (1.23e-2)"	"unprognostic (7.23e-3)"	"unprognostic (1.18e-1)"	"unprognostic (1.28e-1)"	"unprognostic (6.16e-2)"	"unprognostic (4.63e-2)"	"unprognostic (1.05e-2)"	"unprognostic (3.86e-3)"	"unprognostic (1.57e-1)"	"unprognostic (2.78e-3)"	"unprognostic (7.92e-3)"	57.1	75.3	63.1	27.3	61.2	22.1	53.0	30.3	82.2	51.1	14.8	73.1	88.7	47.8	9.2	80.5	48.7	14.3	148.6	65.2	31.5	85.2	137.1	50.5	19.3	37.8	38.5	76.2	104.3	22.3	51.1	17.4	31.1	64.8	16.2	8.9	50.9	20.0	156.1	71.0	80.4	11.0	27.9	72.8	152.6	80.8	40.0	11.6	49.0	35.3	11.2	50.1	54.5	47.1	95.5	128.8	31.5	64.8	35.6	33.8	64.6	69.3	39.0	48.2	48.0	54.1	58.7	58.1	46.1	55.6	42.5	71.5	27.7	52.9	17.4	20.4	263.2	42.8	67.4	65.3	48.9	27.8	39.3	43.9	45.6	41.7	30.1	34.7	46.4	40.7	64.7	48.0	32.2	53.6	44.4	45.2	72.3	71.4	179.6	29.5	42.8	103.2	36.8	55.3	45.2	109.9	64.1	68.8	48.0	21.7	51.6	95.7	78.4	133.0	63.8	48.4	101.3	52.2	50.9	41.7	97.9	55.0	67.5	1.4	1.8	2.3	0.6	2.2	0.4	1.0	0.6	0.6	1.1	0.8	0.6	0.6	2.1	0.3	3.6	1.7	0.9	1.5	63.1	61.2	30.3	82.2	65.2	31.5	37.8	38.5	31.1	27.9	40.0	47.1	62.6	3.2	20.4	9.8	44.2	31.4	29.0	25.9	44.3	33.3	32.7	25.8	15.5	55.8	17.9	44.1	66.7	46.1	28.1	227.7	119.3	57.1	63.2	39.5	37.5	46.1	45.0	35.3	7.8	88.5	80.8	37.2	145.2	45.9	10.8	87.0	83.9	106.1	62.9	28.6	7.8	115.6	22.4	136.5	21.4	169.4	47.5	55.4	23.2	6.5	40.8	33.6	28.8	4.5	8.9	106.5	167.7	53.0	57.7	37.6	387.2	81.8	20.9	41.3	13.1	41.2	34.6	50.2	62.7	46.6	27.4	52.3	26.3	48.2	132.5	39.2
EPN2	"EHB21, KIAA1065"	ENSG00000072134	"Epsin 2"	O95208	17	19215615-19336715	"Predicted intracellular proteins"	Endocytosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	6	"Oligodendrocyte precursor cells: 868.6;Oligodendrocytes: 258.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"basophil: 10.9;eosinophil: 29.0;neutrophil: 9.0"	"Lineage enriched"	"Detected in many"	8	"granulocytes: 29.0"	"Cell line enhanced"	"Detected in many"		"SuSa: 127.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049809, HPA053360"	Approved		Supported	Vesicles		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 12: NES - Nervous system development"	"Cluster 68: Oligodendrocytes - Mixed function"	Vesicles		"HPA049809: AB_2680893, HPA053360: AB_2682126"	"unprognostic (1.38e-2)"	"unprognostic (2.54e-2)"	"unprognostic (2.58e-2)"	"unprognostic (2.09e-1)"	"unprognostic (1.94e-1)"	"unprognostic (8.12e-3)"	"unprognostic (6.73e-3)"	"unprognostic (1.43e-1)"	"unprognostic (8.89e-2)"	"unprognostic (4.58e-3)"	"unprognostic (3.42e-2)"	"unprognostic (1.57e-1)"	"prognostic favorable (9.13e-5)"	"unprognostic (1.32e-1)"	"unprognostic (9.40e-2)"	"unprognostic (2.23e-2)"	"prognostic unfavorable (8.15e-5)"	20.5	13.9	62.1	9.7	64.9	11.5	16.7	50.4	62.8	36.3	32.7	28.3	9.6	29.5	11.5	40.3	26.6	14.6	32.5	62.6	56.2	21.3	9.3	18.6	6.5	61.6	63.6	22.5	14.6	15.3	18.1	21.6	57.5	23.6	9.5	19.1	17.9	23.4	22.4	50.1	13.3	22.5	46.6	14.3	15.9	19.7	63.6	4.7	17.8	17.0	8.4	27.0	33.8	91.6	31.3	30.4	43.9	19.2	22.8	36.3	34.5	29.4	18.9	17.9	15.3	20.2	9.2	4.9	28.2	29.5	16.8	29.0	19.8	22.1	21.9	23.6	21.2	3.2	20.3	9.2	23.7	1.4	13.1	20.5	19.5	28.3	22.7	23.2	38.8	6.6	8.6	3.9	15.8	22.5	1.3	2.1	11.1	41.3	19.8	7.1	18.8	8.1	21.0	8.6	13.0	28.8	20.9	13.9	14.7	127.9	21.0	4.0	35.6	19.7	22.3	30.9	12.9	6.7	4.3	3.9	54.0	0.5	31.1	10.9	1.3	29.0	1.6	0.8	1.2	3.0	1.1	1.3	0.5	3.4	1.3	1.2	9.0	0.7	1.0	0.6	1.0	0.7	62.1	64.9	50.4	62.8	62.6	56.2	61.6	63.6	57.5	46.6	63.6	91.6	60.0	54.5	29.3	74.4	13.7	24.1	36.6	21.2	43.9	68.3	32.8	33.4	44.5	25.8	25.0	38.6	47.9	27.6	3.3	7.2	27.4	22.5	36.8	69.2	35.0	42.5	6.0	13.5	51.3	8.4	39.8	36.1	15.8	40.6	14.0	37.3	15.0	10.4	8.4	35.3	45.0	16.8	10.2	5.1	6.2	72.7	46.6	5.9	5.4	54.4	1.6	38.3	2.1	868.6	258.3	23.3	14.9	39.5	14.4	32.0	7.0	14.2	43.2	82.3	26.3	50.5	63.7	45.8	38.3	63.9	48.9	21.9	7.4	35.0	7.8	40.1
EPN3	"FLJ20778, MGC129899"	ENSG00000049283	"Epsin 3"	Q9H201	17	50532682-50543750	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 35.9;stomach 1: 37.3"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 77.9;Distal enterocytes: 27.6;Gastric mucus-secreting cells: 44.9;Intestinal goblet cells: 24.9;Squamous epithelial cells: 30.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HaCaT: 28.6;HBEC3-KT: 40.3;MCF7: 66.4;OE19: 62.8;RT4: 50.2;SK-BR-3: 25.8;T-47d: 57.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA055546, HPA063224"	Approved		Supported	Nucleoplasm,Vesicles		NA	NA				"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 6: T47d - Mammary gland"	"Cluster 47: Cytotrophoblasts - Unknown function"	Vesicles	Nucleoplasm	"HPA055546: AB_2682844, HPA063224: AB_2684964"	"unprognostic (1.91e-2)"	"unprognostic (1.99e-2)"	"unprognostic (2.41e-1)"	"unprognostic (2.91e-2)"	"unprognostic (1.25e-3)"	"unprognostic (2.06e-1)"	"unprognostic (5.70e-3)"	"unprognostic (7.62e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.20e-1)"	"unprognostic (6.66e-3)"	"unprognostic (1.00e-2)"	"prognostic favorable (1.53e-5)"	"unprognostic (1.45e-1)"	"unprognostic (1.16e-1)"	"unprognostic (4.90e-1)"	"unprognostic (3.52e-3)"	0.2	8.9	2.3	0.8	1.3	0.6	2.3	6.4	6.0	6.5	1.2	7.1	6.8	0.4	3.2	35.9	7.5	5.9	7.1	0.7	2.1	6.0	0.1	0.3	0.0	11.5	5.4	13.5	23.0	21.2	0.8	4.2	13.6	9.9	4.4	0.2	11.1	5.6	0.1	30.5	3.2	0.1	0.5	0.0	37.3	2.8	13.4	3.2	1.1	0.0	3.7	5.5	12.9	1.8	20.5	0.3	0.0	0.2	0.0	0.0	5.3	0.0	0.0	0.0	0.0	14.7	12.1	0.0	0.2	0.0	0.1	28.6	0.0	40.3	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.1	0.2	0.1	21.8	0.1	3.0	0.0	0.0	0.1	0.0	0.0	0.0	66.4	0.3	0.0	0.0	62.8	0.4	0.0	0.0	0.1	0.2	50.2	0.4	0.0	0.0	25.8	0.0	0.4	57.4	0.2	1.5	0.3	0.4	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	1.3	6.4	6.0	0.7	2.1	11.5	5.4	13.6	0.5	13.4	1.8	0.2	0.0	0.0	0.0	0.4	2.3	4.4	4.1	10.8	2.9	6.5	3.4	5.4	8.6	8.3	18.4	0.0	77.9	0.0	27.6	5.9	9.2	1.0	3.8	0.6	0.4	3.6	0.0	1.0	11.5	7.4	0.8	44.9	5.5	0.0	3.1	0.0	0.0	5.9	0.0	1.7	24.9	2.0	0.0	0.0	2.1	2.8	0.5	0.0	1.0	0.6	0.6	0.0	0.0	0.0	3.4	10.3	0.0	1.3	4.9	2.1	0.3	4.3	0.9	0.0	0.0	0.8	0.0	0.5	30.0	5.5	10.7	0.2	12.4	19.3	7.8
EPOP	"C17orf96, LOC100170841, PRR28"	ENSG00000273604	"Elongin BC and polycomb repressive complex 2 associated protein"	A6NHQ4	17	38671703-38674957	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 10.4;testis: 10.0"	"Cell type enhanced"	"Detected in some"		"Breast glandular cells: 19.3;Breast myoepithelial cells: 13.6;Glandular and luminal cells: 6.4;Syncytiotrophoblasts: 13.1"	"Low cancer specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"amygdala: 4.5;basal ganglia: 8.8;cerebral cortex: 10.4;hippocampal formation: 7.7;white matter: 5.4"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 47.9;Hep G2: 57.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA055190, HPA056555"	Enhanced		Supported	"Nucleoplasm,Cytosol,Cytoplasmic bodies"		NA	NA				"Cluster 78: Testis - Spermatogenesis"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 35: Glandular cells - Unknown function"	Nucleoplasm	"Cytosol, Cytoplasmic bodies"	"HPA055190: AB_2682731, HPA056555: AB_2683172"	"unprognostic (9.08e-2)"	"unprognostic (3.71e-1)"	"unprognostic (5.79e-2)"	"unprognostic (6.75e-3)"	"unprognostic (1.83e-1)"	"unprognostic (1.84e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.11e-1)"	"unprognostic (2.17e-2)"	"unprognostic (2.63e-2)"	"unprognostic (1.78e-10)"	"unprognostic (8.97e-2)"	"unprognostic (2.51e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.01e-2)"	1.6	2.2	4.5	1.7	8.8	0.5	1.1	0.9	10.4	0.9	0.5	0.8	0.3	1.2	0.8	1.9	1.1	0.9	1.2	7.7	0.9	1.6	3.8	1.1	2.7	1.4	1.7	0.8	3.7	4.8	0.8	1.3	1.6	1.4	0.4	2.2	0.8	0.9	0.6	3.3	0.9	0.7	1.3	1.1	1.3	10.0	1.7	1.5	0.6	0.3	3.5	2.9	0.7	5.4	9.2	10.8	6.8	47.9	1.5	0.4	11.7	1.9	0.7	2.1	3.3	10.8	3.3	17.1	11.6	1.2	6.1	7.3	22.6	4.6	3.7	18.2	17.1	3.8	1.5	57.3	3.1	2.1	9.0	1.0	8.0	2.3	4.6	4.4	1.6	18.8	12.0	25.9	1.4	14.4	15.8	5.1	1.5	6.0	9.6	37.3	3.9	37.8	1.3	2.4	10.4	15.8	6.0	7.8	2.1	11.0	11.4	7.2	2.7	2.0	2.0	2.2	1.8	13.5	16.1	21.7	3.9	25.4	7.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	8.8	0.9	10.4	7.7	0.9	1.4	1.7	1.6	1.3	1.7	5.4	4.4	0.0	1.1	0.0	1.0	0.0	0.0	0.0	0.0	0.0	19.3	13.6	0.0	0.0	1.3	1.8	0.0	1.7	3.5	0.0	0.0	4.2	0.0	3.4	4.8	1.8	0.0	0.0	0.0	4.0	1.5	1.0	0.0	6.4	0.0	1.6	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	2.6	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	13.1	0.6	0.8	0.0	0.0
EPOR		ENSG00000187266	"Erythropoietin receptor"	P19235	19	11377207-11384342	"Cancer-related genes, Disease related genes, FDA approved drug targets, Human disease related genes, Predicted membrane proteins"		Receptor	"Cancer-related genes, Congenital erythrocytosis, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Erythroid cells: 114.7;Hepatic stellate cells: 66.8;Hofbauer cells: 42.4"	"Cancer enhanced"	"Detected in all"		"thyroid cancer: 20.5"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA077654			Supported	"Nuclear speckles,Plasma membrane"	"Intracellular and membrane"	NA	Yes			"Cluster 14: Monocytes - Unknown function"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 6: Erythroid cells - Oxygen transport"	"Plasma membrane"	"Nuclear speckles"	"HPA077654: "	"unprognostic (9.13e-2)"	"unprognostic (7.14e-2)"	"unprognostic (1.45e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.88e-1)"	"unprognostic (1.11e-1)"	"unprognostic (3.70e-1)"	"unprognostic (1.50e-2)"	"unprognostic (5.60e-2)"	"unprognostic (9.00e-2)"	"prognostic favorable (3.17e-5)"	"unprognostic (6.37e-3)"	"unprognostic (1.59e-2)"	"unprognostic (2.08e-1)"	"unprognostic (2.00e-1)"	"unprognostic (7.48e-2)"	"unprognostic (1.01e-3)"	6.5	17.5	6.0	1.4	6.3	22.4	5.0	6.7	8.2	7.1	7.7	2.7	1.4	3.3	13.6	1.3	6.7	2.3	9.7	6.3	6.0	21.6	10.7	6.4	2.2	6.1	6.1	3.1	11.8	23.2	8.2	8.0	6.4	4.6	1.7	3.3	3.3	7.3	2.3	1.6	2.3	1.8	6.0	11.9	7.8	1.8	6.2	1.7	30.2	1.5	1.6	3.1	3.7	6.3	3.7	1.2	3.6	4.2	5.3	3.4	2.1	2.2	7.0	3.6	4.5	1.3	1.4	2.5	4.0	4.1	5.0	0.9	2.8	1.4	4.1	2.1	1.6	14.3	1.3	2.1	3.8	2.9	5.5	2.4	0.5	4.8	3.3	8.5	8.5	5.3	12.5	12.0	4.1	3.3	2.7	3.5	1.9	2.0	9.6	7.2	6.3	5.6	3.4	1.9	1.4	11.0	1.5	2.0	6.4	3.7	3.6	4.9	3.5	1.9	2.6	6.6	2.1	6.0	4.7	2.8	10.5	2.9	2.1	9.3	3.7	3.0	1.7	4.6	3.6	2.0	3.4	2.5	2.1	1.2	3.7	2.2	10.2	0.8	7.3	0.1	3.3	2.4	6.0	6.3	6.7	8.2	6.3	6.0	6.1	6.1	6.4	6.0	6.2	6.3	6.1	19.2	18.8	24.8	11.5	2.3	4.0	2.0	2.8	3.8	3.6	6.1	6.5	5.7	3.1	20.2	0.0	2.2	5.2	1.3	3.9	2.2	0.8	9.9	6.8	13.5	8.4	114.7	2.2	3.3	12.2	9.8	15.3	13.9	26.6	1.2	66.8	3.5	42.4	1.7	3.0	3.5	2.0	17.0	4.0	0.6	2.8	15.4	8.8	7.5	4.6	7.9	11.3	1.0	1.6	3.1	0.4	4.1	3.8	1.8	0.2	1.0	2.9	2.5	19.7	3.8	18.5	5.1	7.7	1.6	1.0	3.0	9.6	2.6	1.8	1.2
EPS8L1	"DRC3, FLJ20258, MGC23164, MGC4642"	ENSG00000131037	"EPS8 like 1"	Q8TE68	19	55072020-55087923	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 124.3;skin 1: 59.7"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 104.1;Gastric mucus-secreting cells: 108.1;Paneth cells: 110.2;Syncytiotrophoblasts: 428.0;Urothelial cells: 189.4"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in some"		"eosinophil: 2.3"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"A-431: 17.6;BEWO: 58.8;SK-BR-3: 19.6;T-47d: 28.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041851, HPA043545"	Uncertain		Supported	Cytosol		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Cytosol		"HPA041851: AB_2677706, HPA043545: AB_2678544"	"unprognostic (1.91e-1)"	"unprognostic (2.06e-1)"	"prognostic unfavorable (4.44e-4)"	"unprognostic (7.18e-2)"	"unprognostic (9.33e-2)"	"unprognostic (2.54e-2)"	"unprognostic (4.61e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.62e-1)"	"unprognostic (9.43e-2)"	"unprognostic (5.84e-3)"	"unprognostic (2.65e-2)"	"unprognostic (3.85e-3)"	"unprognostic (5.04e-3)"	"unprognostic (3.02e-1)"	"unprognostic (5.41e-3)"	"unprognostic (2.63e-1)"	4.5	0.2	0.0	0.9	0.1	0.1	4.0	0.0	0.1	24.0	0.0	3.5	2.3	1.5	0.0	124.3	14.8	0.9	0.6	0.1	0.0	25.1	0.7	3.9	0.0	0.1	0.1	0.5	5.6	2.1	2.1	5.4	0.1	9.2	0.6	0.0	20.4	2.5	0.5	59.7	2.0	0.0	0.0	0.6	27.0	0.6	0.2	0.1	17.4	0.0	1.6	2.7	37.1	0.2	17.6	0.7	0.6	0.4	0.0	0.0	58.8	1.5	0.1	0.0	0.1	7.6	13.7	0.3	3.4	0.0	0.1	9.7	0.4	2.1	0.0	0.3	1.6	1.3	0.6	0.5	0.2	2.6	10.8	0.0	3.6	0.0	0.0	0.0	0.0	1.2	6.2	0.1	0.0	8.0	0.9	2.6	0.8	12.7	0.0	0.1	0.0	5.4	2.7	3.6	0.2	3.8	1.0	19.6	0.8	0.6	28.9	3.2	1.3	0.0	0.7	0.0	0.0	2.4	3.1	1.6	3.3	0.9	2.0	1.1	0.2	2.3	0.3	0.0	0.3	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.8	0.0	1.4	0.3	0.2	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.2	0.2	4.0	9.6	6.1	0.3	0.8	2.0	28.4	39.5	8.6	0.0	16.3	15.1	2.6	8.6	92.2	31.3	0.0	55.1	4.0	104.1	13.7	20.4	1.6	29.1	6.3	10.7	3.0	0.0	0.1	10.2	26.8	4.7	108.1	41.7	10.2	5.4	10.0	0.1	8.9	0.0	0.1	39.0	24.4	1.9	3.4	4.5	1.2	2.6	21.4	0.0	5.2	0.2	6.2	0.0	0.1	94.5	110.2	0.7	1.0	48.7	12.7	1.1	53.6	0.6	26.3	0.5	21.6	1.6	3.6	6.6	4.0	428.0	2.8	0.3	22.1	189.4
EPS8L2	"FLJ21935, FLJ22171, MGC3088"	ENSG00000177106	"EPS8 like 2"	Q9H6S3	11	694438-727727	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Deafness, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 188.5"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 211.4;Paneth cells: 175.3;Proximal enterocytes: 235.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	8	"plasmacytoid DC: 3.1"	"Lineage enriched"	"Detected in single"	8	"dendritic cells: 3.1"	"Cell line enhanced"	"Detected in many"		"A-431: 234.3;BEWO: 220.8;CAPAN-2: 206.6;SK-BR-3: 257.5"	"Low region specificity"	"Detected in many"			"Region enriched"	"Detected in single"	10	"cerebellum: 9.2"	HPA041143	Approved		Supported	Cytosol		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 37: Intestine - Unknown function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Cytosol		"HPA041143: AB_10794985"	"unprognostic (1.39e-2)"	"unprognostic (1.07e-1)"	"unprognostic (7.58e-2)"	"unprognostic (3.40e-2)"	"prognostic unfavorable (2.31e-4)"	"unprognostic (6.87e-2)"	"unprognostic (3.27e-2)"	"unprognostic (1.33e-1)"	"unprognostic (4.82e-2)"	"unprognostic (4.26e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.92e-1)"	"unprognostic (3.25e-2)"	"unprognostic (2.51e-2)"	"unprognostic (4.19e-1)"	"unprognostic (2.79e-1)"	"unprognostic (5.03e-2)"	7.8	11.2	5.2	5.7	4.8	0.0	27.0	8.9	5.5	49.4	4.9	42.7	100.8	11.4	3.5	188.5	19.2	13.3	4.3	4.5	6.8	98.4	101.7	32.4	0.7	10.9	9.2	11.8	43.7	3.8	11.5	17.7	6.2	29.3	15.5	1.0	94.6	15.2	1.3	76.3	105.0	2.9	7.1	1.4	48.1	3.2	7.1	2.0	70.2	0.4	10.9	17.5	80.1	6.5	234.3	68.6	0.2	1.6	2.7	14.4	220.8	20.1	20.3	29.2	12.5	51.4	206.6	0.4	81.6	21.4	5.4	122.4	0.6	117.8	6.4	0.6	5.4	0.0	27.7	94.7	16.3	0.3	0.4	8.1	77.8	8.0	18.7	12.3	0.2	0.1	1.8	1.1	3.2	72.1	0.5	1.3	2.7	71.5	24.0	0.5	0.8	1.8	103.8	55.2	0.8	0.8	75.9	257.5	0.5	14.3	94.9	0.2	1.5	11.2	27.3	7.2	1.6	0.9	1.0	0.8	6.1	0.6	0.9	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	3.1	0.0	0.1	5.2	4.8	8.9	5.5	4.5	6.8	10.9	9.2	6.2	7.1	7.1	6.5	1.8	141.1	51.8	3.9	11.2	19.8	26.2	48.8	51.8	0.6	39.1	37.0	4.5	57.2	62.4	90.1	0.0	47.9	21.6	211.4	27.4	55.2	1.0	47.3	7.1	4.7	43.8	1.3	3.1	80.0	33.4	11.5	131.0	60.8	7.0	0.4	0.7	59.4	4.7	0.0	3.8	76.8	32.6	2.1	7.8	2.3	18.0	2.7	14.2	2.8	3.1	10.0	16.5	2.0	0.7	83.2	175.3	11.7	7.6	33.6	235.9	108.2	60.9	1.5	0.0	0.9	7.5	1.1	4.8	74.9	24.4	92.5	18.6	0.9	77.2	32.1
ERBB2	"CD340, HER-2, HER2, NEU, NGL"	ENSG00000141736	"Erb-b2 receptor tyrosine kinase 2"	P04626	17	39687914-39730426	"Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Transcription, Transcription regulation"	"Activator, Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Collecting duct cells: 136.1;Distal enterocytes: 111.0;Proximal enterocytes: 121.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"gdT-cell: 5.0"	"Lineage enriched"	"Detected in many"	4	"T-cells: 5.0"	"Group enriched"	"Detected in many"	41	"OE19: 6565.0;SK-BR-3: 3115.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB000043, HPA001060, HPA001338, HPA001383, CAB020416, CAB062555"	Enhanced		Enhanced	"Plasma membrane,Cytosol"		NA	NA		980000	"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 21: OE19 - Mitochondria"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Plasma membrane"	Cytosol	"CAB000043: AB_2335701, CAB020416: AB_442047, CAB062555: AB_2665610, HPA001060: AB_2666185, HPA001338: AB_2666279, HPA001383: AB_1078500"	"unprognostic (1.97e-1)"	"unprognostic (6.60e-3)"	"unprognostic (6.21e-2)"	"prognostic unfavorable (8.99e-8)"	"unprognostic (2.96e-2)"	"unprognostic (1.40e-2)"	"unprognostic (1.97e-2)"	"unprognostic (9.04e-2)"	"unprognostic (1.79e-2)"	"unprognostic (1.20e-3)"	"prognostic unfavorable (9.17e-4)"	"unprognostic (3.92e-1)"	"prognostic favorable (2.41e-14)"	"unprognostic (9.29e-2)"	"unprognostic (1.40e-1)"	"unprognostic (3.75e-2)"	"unprognostic (1.96e-1)"	13.0	5.4	16.1	12.1	20.5	1.6	56.0	14.3	13.1	37.6	23.3	68.2	63.6	25.2	26.6	102.4	64.2	31.0	57.0	13.3	16.0	73.5	31.1	36.2	4.8	22.4	22.7	23.9	37.6	81.7	17.3	27.0	17.1	55.6	48.5	8.1	68.7	50.5	20.7	91.0	67.3	25.0	18.5	6.9	49.7	11.7	15.4	7.4	56.5	15.0	28.0	40.0	52.9	16.4	38.7	45.7	50.4	31.7	59.3	41.2	67.7	27.2	44.9	58.6	48.9	34.4	102.7	2.9	54.6	62.7	31.5	117.6	2.8	61.2	26.9	5.2	38.6	1.8	36.0	56.3	35.3	0.9	1.0	41.0	56.6	36.2	21.9	56.2	24.4	1.9	6.2	2.4	43.3	59.4	7.1	3.0	90.7	6565.0	11.7	3.9	20.5	5.4	58.9	118.9	9.4	2.6	51.5	3115.9	16.9	62.2	88.1	2.2	2.9	30.2	37.7	37.7	17.6	5.3	3.3	3.6	3.0	0.9	98.5	1.1	0.2	0.4	5.0	0.1	0.3	0.6	0.2	1.4	0.2	0.6	0.5	1.4	1.2	0.4	0.1	0.1	0.2	1.7	16.1	20.5	14.3	13.1	13.3	16.0	22.4	22.7	17.1	18.5	15.4	16.4	3.9	41.7	40.1	12.7	2.2	14.0	19.0	37.1	17.6	4.6	62.7	34.9	20.7	32.9	43.8	136.1	12.5	12.0	5.1	111.0	7.9	30.9	0.3	48.7	13.9	6.1	15.6	1.3	0.9	25.5	84.8	15.7	53.5	61.3	0.0	20.3	11.7	10.7	4.0	6.7	1.0	47.5	42.7	2.2	3.1	1.0	18.3	1.7	10.6	1.0	1.2	24.1	26.8	2.0	1.0	32.5	54.8	23.0	1.1	34.9	121.7	19.5	42.0	5.8	0.0	13.1	12.7	6.8	5.7	43.5	18.9	22.7	2.8	4.4	75.4	31.3
ERBB3	"HER3, LCCS2"	ENSG00000065361	"Erb-b2 receptor tyrosine kinase 3"	P21860	12	56076799-56103505	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"		"Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 254.3;Oligodendrocytes: 187.0;Paneth cells: 184.6;Proximal enterocytes: 240.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"basophil: 2.4;neutrophil: 1.0"	"Lineage enriched"	"Detected in single"	6	"granulocytes: 2.4"	"Cell line enhanced"	"Detected in many"		"Hep G2: 116.4;OE19: 119.1;RT4: 89.7;SK-BR-3: 106.5;SK-MEL-30: 149.5;T-47d: 122.2;WM-115: 153.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB025331, HPA045396, HPA070524"	Approved		Supported	"Plasma membrane,Actin filaments"	"Secreted - unknown location"	NA	NA		450000	"Cluster 17: Basophils - Unknown function"	"Cluster 45: Intestine - Brush border"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Plasma membrane"	"Actin filaments"	"CAB025331: , HPA045396: AB_2679312, HPA070524: "	"unprognostic (2.97e-1)"	"unprognostic (2.71e-2)"	"unprognostic (1.91e-1)"	"unprognostic (8.97e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.07e-3)"	"unprognostic (2.31e-3)"	"unprognostic (2.66e-2)"	"unprognostic (9.89e-2)"	"unprognostic (4.30e-2)"	"unprognostic (4.76e-3)"	"unprognostic (5.77e-2)"	"unprognostic (1.06e-2)"	"unprognostic (4.56e-2)"	"unprognostic (1.57e-1)"	"unprognostic (6.72e-3)"	"unprognostic (2.07e-2)"	2.4	2.6	34.4	8.0	69.2	0.9	56.5	45.9	62.0	20.9	10.9	62.9	88.5	5.5	12.3	82.0	12.1	30.6	9.0	39.2	43.1	36.2	98.6	29.3	0.6	59.4	54.4	1.6	57.0	23.8	2.4	13.0	54.7	37.8	64.1	1.3	83.0	18.2	2.4	75.7	82.5	3.8	36.2	0.6	74.7	2.3	55.9	1.0	9.4	1.7	12.5	21.8	44.2	104.9	39.8	2.1	3.2	1.4	0.2	0.1	63.2	3.9	7.2	4.5	4.1	20.4	70.4	0.2	0.8	1.0	0.6	32.2	5.0	7.7	2.3	0.7	3.0	0.1	1.1	116.4	0.1	0.1	0.5	1.3	9.3	0.7	0.3	0.7	0.1	0.8	2.6	1.0	0.4	71.6	0.4	1.3	10.4	119.1	1.9	0.4	7.4	2.1	7.9	89.7	3.3	1.3	2.6	106.5	149.5	9.1	122.2	0.7	0.3	0.5	4.0	1.9	0.5	0.9	0.6	0.6	0.4	0.3	153.4	2.4	0.1	0.3	0.2	0.1	0.1	0.1	0.2	0.1	0.1	0.2	0.2	0.4	1.0	0.4	0.2	0.2	0.3	0.1	34.4	69.2	45.9	62.0	39.2	43.1	59.4	54.4	54.7	36.2	55.9	104.9	0.8	118.6	81.0	1.0	1.5	18.2	15.3	21.6	19.4	1.5	106.4	47.8	1.9	171.6	74.6	35.0	2.1	52.6	2.0	254.3	1.9	60.1	1.3	36.1	10.9	2.7	93.1	2.7	0.7	88.1	84.6	4.5	96.4	95.9	1.3	0.7	5.0	112.0	6.1	0.0	2.0	145.2	40.7	1.9	3.7	0.5	1.5	1.5	55.2	1.0	1.7	7.7	0.0	49.8	187.0	94.8	184.6	0.0	0.3	103.3	240.2	30.0	54.8	1.1	6.6	4.5	3.4	9.5	13.4	87.7	36.9	100.6	2.5	0.1	136.9	135.4
ERBIN	"ERBB2IP, LAP2"	ENSG00000112851	"Erbb2 interacting protein"	Q96RT1	5	65926556-66082546	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 119.1"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 70.5;dendritic cells: 61.3;Endometrial ciliated cells: 62.3;Glandular and luminal cells: 101.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA048606, HPA059863"	Approved		Supported	"Nuclear speckles,Plasma membrane"		NA	NA		39000	"Cluster 38: Basophils - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 7: Non-specific - Mitochondria"	"Nuclear speckles, Plasma membrane"		"HPA048606: AB_2680461, HPA059863: AB_2684146"	"unprognostic (4.34e-1)"	"unprognostic (5.56e-2)"	"unprognostic (9.88e-2)"	"unprognostic (2.15e-2)"	"unprognostic (2.04e-1)"	"unprognostic (4.23e-3)"	"unprognostic (1.74e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.46e-2)"	"unprognostic (6.52e-2)"	"unprognostic (5.45e-3)"	"unprognostic (7.98e-2)"	"unprognostic (5.62e-3)"	"unprognostic (7.21e-3)"	"unprognostic (3.08e-1)"	"unprognostic (6.86e-2)"	"unprognostic (7.81e-2)"	15.7	14.5	65.2	29.5	109.6	30.0	24.7	64.2	67.6	23.2	19.0	27.8	24.5	22.6	27.0	20.1	20.0	28.4	16.9	56.2	91.6	29.5	33.3	21.5	40.6	91.3	88.0	20.0	18.8	22.6	8.3	16.4	106.0	26.4	26.3	28.1	21.8	20.2	19.8	32.8	44.1	19.7	64.4	31.4	40.3	27.5	86.6	48.7	29.9	20.7	39.0	28.5	13.0	119.1	97.8	32.2	41.5	49.6	30.0	36.0	31.5	61.5	62.6	85.3	94.3	31.5	113.8	82.2	58.8	95.3	67.2	31.7	26.5	45.1	149.4	36.3	12.0	28.3	41.3	24.7	39.5	22.0	26.3	39.4	29.2	47.2	67.5	50.0	32.1	37.1	29.4	54.6	58.1	33.5	59.0	25.1	10.1	9.7	9.5	53.7	33.0	45.8	49.9	65.6	20.0	18.7	65.0	21.7	46.4	30.9	38.4	53.8	29.8	48.3	85.9	29.8	80.8	47.2	31.7	69.8	31.6	35.9	28.1	13.1	4.1	5.5	5.2	5.8	4.8	4.7	3.9	4.6	3.5	3.7	4.5	4.8	9.2	3.9	5.1	2.2	3.8	2.8	65.2	109.6	64.2	67.6	56.2	91.6	91.3	88.0	106.0	64.4	86.6	119.1	53.0	70.5	57.5	0.0	13.2	0.0	0.0	0.0	0.0	0.0	39.4	24.8	0.0	0.0	31.6	53.3	0.0	6.5	61.3	0.0	11.7	26.7	0.0	62.3	50.0	26.1	0.0	0.0	0.0	24.9	11.2	16.2	0.0	101.9	27.8	47.8	0.0	0.0	40.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	28.4	0.0	0.0	5.7	0.0	0.0	0.0	0.0	50.3	0.0	0.0	13.3	0.0	0.0	41.7	24.0	0.0	0.0	0.0	17.1	0.0	0.0	0.0	0.0	8.9	20.0	51.4	0.0	0.0
ERC1	"CAST2, ELKS, KIAA1081, MGC12974, RAB6IP2"	ENSG00000082805	"ELKS/RAB6-interacting/CAST family member 1"	Q8IUD2	12	990509-1495933	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Protein transport, Transport"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 292.3;Horizontal cells: 185.1;Inhibitory neurons: 487.0;Microglial cells: 213.6;Oligodendrocyte precursor cells: 230.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019513, HPA019523, HPA024130"	Approved		Supported	"Vesicles,Plasma membrane,Cytosol"		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 21: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Cytosol	"Vesicles, Plasma membrane"	"HPA019513: AB_1856012, HPA019523: AB_1856013, HPA024130: AB_1856014"	"unprognostic (2.41e-1)"	"unprognostic (4.00e-2)"	"unprognostic (2.14e-1)"	"unprognostic (5.70e-2)"	"unprognostic (2.81e-1)"	"unprognostic (1.32e-1)"	"unprognostic (5.50e-2)"	"unprognostic (8.49e-2)"	"unprognostic (2.53e-1)"	"unprognostic (3.26e-2)"	"unprognostic (1.04e-1)"	"unprognostic (6.79e-2)"	"unprognostic (3.75e-3)"	"unprognostic (4.19e-2)"	"unprognostic (3.01e-1)"	"unprognostic (7.37e-2)"	"prognostic unfavorable (7.01e-4)"	10.4	9.7	12.2	6.8	14.4	7.3	8.0	38.1	12.8	8.9	8.0	11.8	3.5	9.0	4.8	11.8	8.2	7.5	13.9	15.2	18.5	9.2	6.5	7.3	4.8	13.7	14.8	10.5	7.6	15.4	8.1	11.8	13.7	9.5	6.2	7.0	8.4	12.1	9.4	9.4	5.8	12.9	11.9	5.8	7.2	7.5	17.7	7.9	13.4	9.0	5.3	13.4	9.0	12.6	8.2	20.1	10.3	7.1	27.8	22.2	14.2	25.0	20.0	17.0	15.3	17.7	10.0	12.5	3.4	33.2	16.8	13.3	22.1	19.7	23.1	25.9	11.6	30.3	20.1	9.3	21.1	16.1	6.9	18.7	17.0	30.0	55.6	20.7	22.3	7.9	9.6	23.9	12.9	9.2	5.2	3.5	16.8	8.1	9.7	9.9	38.9	3.8	16.9	14.2	6.3	12.3	38.8	9.3	13.9	37.6	9.3	7.0	39.6	29.6	29.0	21.6	24.0	6.4	13.1	18.1	19.2	9.4	12.9	1.5	3.1	2.3	1.7	1.2	2.4	12.7	2.7	2.7	2.7	5.6	3.8	2.7	2.4	1.4	4.8	3.4	2.8	0.7	12.2	14.4	38.1	12.8	15.2	18.5	13.7	14.8	13.7	11.9	17.7	12.6	36.9	25.6	25.1	155.4	21.2	21.0	25.6	9.4	29.0	39.2	13.2	14.1	56.4	17.2	17.4	20.2	47.9	34.1	12.6	12.7	1.9	20.3	34.3	31.2	43.4	34.6	30.0	7.6	292.3	13.4	18.0	32.3	23.9	53.9	14.5	59.2	24.3	17.3	12.4	185.1	487.0	11.9	2.0	12.6	16.5	35.2	24.8	17.0	14.2	213.6	18.4	34.8	6.2	230.7	171.1	18.5	10.3	30.9	39.1	30.8	6.1	4.1	13.2	33.4	19.7	35.5	33.1	18.5	28.8	33.8	27.4	78.7	15.8	18.7	10.3	29.4
ERCC2	"EM9, MAG, MGC102762, MGC126218, MGC126219, XPD"	ENSG00000104884	"ERCC excision repair 2, TFIIH core complex helicase subunit"	P18074	19	45349837-45370918	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"Chromosome partition, DNA damage, DNA repair, Host-virus interaction, Transcription, Transcription regulation"	"DNA-binding, Helicase, Hydrolase"	"Cancer-related genes, Cataract, Cockayne syndrome, Deafness, Disease variant, Dwarfism, Ichthyosis, Xeroderma pigmentosum"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Granulosa cells: 34.1;Spermatocytes: 30.5;Theca cells: 29.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005375, HPA038057, HPA069266"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 43: Testis - Unknown function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 40: Granulosa cells - Unknown function"	Nucleoplasm	Cytosol	"CAB005375: AB_2100152, HPA038057: AB_2675810, HPA069266: AB_2686104"	"unprognostic (1.10e-1)"	"unprognostic (5.48e-1)"	"unprognostic (5.08e-2)"	"unprognostic (9.92e-3)"	"unprognostic (1.35e-1)"	"unprognostic (1.23e-2)"	"unprognostic (1.67e-3)"	"unprognostic (1.46e-1)"	"unprognostic (3.41e-1)"	"unprognostic (1.06e-1)"	"prognostic favorable (3.26e-4)"	"unprognostic (3.36e-2)"	"unprognostic (2.44e-3)"	"unprognostic (1.94e-1)"	"unprognostic (5.47e-1)"	"unprognostic (8.99e-2)"	"unprognostic (3.45e-2)"	6.8	13.0	10.5	6.9	10.3	4.8	6.5	8.4	11.7	7.5	8.4	7.5	4.9	9.7	3.2	6.3	8.0	4.1	7.0	10.8	9.3	7.6	9.0	5.8	5.8	10.6	9.9	7.8	7.7	7.7	9.7	4.5	9.6	6.7	4.0	3.1	7.3	6.7	11.7	7.2	6.6	6.9	8.1	8.1	7.5	13.9	10.1	5.3	8.4	6.3	5.2	7.5	5.9	8.9	28.0	13.3	27.1	38.4	16.3	19.4	15.2	38.8	27.4	50.2	40.2	32.6	18.6	10.0	21.6	39.9	19.1	14.0	19.1	32.9	18.5	24.4	31.8	16.9	26.8	35.4	33.3	27.1	28.4	22.4	5.6	55.8	31.9	28.2	29.1	28.8	41.8	10.9	34.8	14.7	16.1	17.9	12.7	27.2	24.6	30.3	19.4	8.3	14.0	24.9	15.8	17.1	34.2	23.9	13.6	20.6	22.8	35.4	37.9	46.4	25.3	19.9	88.0	24.9	15.8	14.2	13.8	16.4	21.2	0.0	17.2	6.5	9.1	18.0	11.9	9.1	8.9	8.9	21.8	6.5	8.2	8.7	0.5	15.6	14.9	10.4	9.8	12.1	10.5	10.3	8.4	11.7	10.8	9.3	10.6	9.9	9.6	8.1	10.1	8.9	4.2	6.4	3.4	6.2	5.8	6.2	5.5	8.6	4.6	0.0	6.1	4.3	6.7	8.6	8.7	5.5	0.0	10.5	4.1	5.9	13.7	10.7	4.7	3.3	4.5	5.5	7.2	5.5	2.9	8.2	12.1	6.8	6.1	3.8	0.0	34.1	7.9	12.3	11.5	0.0	3.1	8.5	4.1	8.2	4.2	2.8	6.5	6.3	3.6	1.0	4.2	0.0	5.2	5.0	1.4	8.1	3.1	7.9	7.5	4.2	4.1	13.0	7.5	0.0	0.0	3.5	9.9	30.5	13.1	5.1	5.7	4.8	4.7	29.1	8.8	3.2
ERCC4	"FANCQ, RAD1, XPF"	ENSG00000175595	"ERCC excision repair 4, endonuclease catalytic subunit"	Q92889	16	13920154-13952348	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair"	"DNA-binding, Endonuclease, Hydrolase, Nuclease"	"Cancer-related genes, Cockayne syndrome, Disease variant, Dwarfism, Fanconi anemia, Xeroderma pigmentosum"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 18.5"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 140.7;Late spermatids: 117.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000156, HPA045828"	Approved		Supported	"Nucleoplasm,Nuclear bodies,Plasma membrane"		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 29: Early spermatids - Spermatogenesis"	"Nucleoplasm, Nuclear bodies"	"Plasma membrane"	"CAB000156: , HPA045828: AB_2679463"	"unprognostic (2.05e-1)"	"unprognostic (1.52e-1)"	"unprognostic (2.12e-3)"	"unprognostic (9.41e-2)"	"unprognostic (3.35e-1)"	"unprognostic (1.40e-2)"	"unprognostic (1.64e-2)"	"unprognostic (2.26e-1)"	"unprognostic (3.59e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.18e-1)"	"unprognostic (8.49e-2)"	"unprognostic (5.26e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.15e-1)"	"unprognostic (6.30e-2)"	"unprognostic (5.88e-4)"	2.7	3.9	4.7	3.3	5.2	2.5	2.8	6.7	5.4	3.3	4.3	1.9	1.7	3.3	2.8	2.9	3.5	3.0	3.6	4.3	4.9	2.9	3.2	2.7	3.3	5.1	4.8	4.3	2.7	3.9	1.6	2.6	4.9	3.6	2.2	4.1	2.8	2.9	18.5	3.0	1.9	3.6	4.4	3.7	2.6	5.5	5.4	4.2	4.4	3.3	2.9	2.6	1.5	6.8	4.7	5.5	5.3	7.5	8.7	8.1	4.0	6.1	6.4	5.4	6.8	2.1	4.5	7.8	8.6	5.4	4.8	5.8	8.0	4.1	8.3	10.7	4.7	3.8	6.7	5.2	7.9	5.2	4.2	6.1	5.7	7.1	6.0	5.3	7.2	4.6	6.1	8.8	7.6	3.9	7.0	3.4	3.9	2.4	3.1	7.8	10.8	9.7	3.3	3.2	4.3	5.1	7.5	6.0	5.8	4.2	7.5	3.9	7.9	7.8	5.7	7.0	5.4	7.9	9.9	5.2	7.6	6.2	8.1	4.9	2.3	2.3	2.6	2.7	2.9	2.5	2.4	2.0	2.3	3.1	2.4	2.6	2.7	3.6	2.4	3.2	2.5	1.1	4.7	5.2	6.7	5.4	4.3	4.9	5.1	4.8	4.9	4.4	5.4	6.8	14.0	19.2	13.5	16.6	11.3	4.8	6.1	18.3	10.2	0.0	10.0	9.5	8.6	14.3	12.7	5.5	0.0	17.3	9.7	3.3	9.8	11.6	140.7	18.6	19.0	13.5	9.6	12.0	20.4	8.4	6.2	13.0	5.1	7.4	1.3	17.8	17.2	17.7	11.7	0.0	21.2	4.8	10.2	13.6	6.5	117.9	14.9	11.4	10.6	8.4	14.4	0.0	17.5	12.1	20.1	9.9	1.7	21.1	14.4	10.2	4.4	13.3	26.1	0.0	26.3	17.3	12.2	49.4	28.9	9.2	5.5	12.3	11.8	18.0	6.0	4.7
ERCC5	"ERCM2, XPGC"	ENSG00000134899	"ERCC excision repair 5, endonuclease"	P28715	13	102845831-102875995	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair"	"DNA-binding, Endonuclease, Hydrolase, Nuclease"	"Cancer-related genes, Cockayne syndrome, Deafness, Disease variant, Dwarfism, Xeroderma pigmentosum"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 60.7;Gastric mucus-secreting cells: 44.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA045845, HPA050374"	Supported		Supported	Nucleoplasm		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 9: Intestine - Unknown function"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 58: T-cells - T-cell receptor"	Nucleoplasm		"HPA045845: AB_2679471, HPA050374: AB_2681106"	"unprognostic (1.28e-3)"	"unprognostic (1.32e-3)"	"unprognostic (1.86e-2)"	"unprognostic (9.28e-3)"	"unprognostic (6.19e-2)"	"unprognostic (8.73e-2)"	"unprognostic (1.23e-1)"	"unprognostic (8.72e-2)"	"unprognostic (2.52e-1)"	"unprognostic (2.55e-1)"	"unprognostic (7.77e-3)"	"unprognostic (5.76e-3)"	"prognostic unfavorable (2.96e-6)"	"unprognostic (3.56e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.67e-1)"	"prognostic favorable (6.82e-4)"	14.1	11.1	7.8	10.9	8.6	16.3	14.5	8.9	11.8	12.2	10.5	14.5	20.1	9.2	13.4	10.7	9.7	10.8	9.8	8.1	8.2	12.6	21.8	12.8	15.2	8.5	8.2	12.5	11.3	12.3	3.7	11.3	8.5	11.7	14.3	12.6	10.5	10.8	9.5	13.2	17.1	9.6	8.0	15.2	16.3	7.0	8.4	21.3	13.5	10.8	16.5	11.2	3.9	8.4	21.5	10.5	15.4	7.4	34.4	30.5	8.9	24.5	31.1	13.6	16.7	10.8	37.9	19.3	10.4	23.4	9.4	23.8	14.3	19.6	10.1	19.4	9.7	16.6	23.7	13.3	15.9	50.9	26.3	26.1	19.2	15.7	25.6	19.6	23.1	23.4	9.5	16.5	23.9	8.0	18.7	23.5	7.7	30.2	9.9	14.9	10.9	17.9	19.3	15.7	9.0	14.1	12.6	25.0	8.8	13.6	13.9	43.4	21.4	7.5	5.5	3.7	13.1	16.1	5.0	9.4	41.3	20.7	10.9	19.2	11.9	20.4	16.2	15.0	14.6	8.9	17.1	19.8	14.3	8.8	18.4	18.2	3.5	20.5	21.1	7.4	20.7	17.7	7.8	8.6	8.9	11.8	8.1	8.2	8.5	8.2	8.5	8.0	8.4	8.4	2.2	3.2	9.5	0.0	22.2	7.1	4.7	11.5	16.5	0.0	2.0	2.0	28.6	14.3	14.0	0.0	0.0	9.6	7.3	17.6	0.0	1.6	60.7	2.4	4.8	8.6	4.9	24.8	0.0	1.2	7.5	11.0	44.9	2.1	19.0	1.7	13.2	21.2	10.5	0.0	0.0	22.3	10.2	17.2	6.5	28.3	22.1	14.0	7.2	0.0	12.6	0.0	19.6	0.0	0.0	1.7	16.7	15.8	21.5	4.0	26.6	1.5	11.4	0.0	19.7	10.6	6.7	11.6	6.3	19.1	7.0	5.7	31.3	1.7	18.2	5.0
ERCC6L2	"C9orf102, FLJ37706, HEBO, RAD26L"	ENSG00000182150	"ERCC excision repair 6 like 2"	Q5T890	9	95871264-96121154	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"DNA damage, DNA repair"	"DNA-binding, Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 105.8;Excitatory neurons: 90.1;Inhibitory neurons: 88.5;Oligodendrocyte precursor cells: 130.7;Oligodendrocytes: 117.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA021259, HPA021260, HPA021271, HPA022422"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 29: Plasmacytoid DCs - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 68: Oligodendrocytes - Mixed function"	"Nucleoplasm, Cytosol"		"HPA021259: AB_1859542, HPA021260: AB_1859544, HPA021271: AB_1859543, HPA022422: "	"unprognostic (6.70e-2)"	"unprognostic (2.40e-1)"	"unprognostic (2.68e-1)"	"unprognostic (1.28e-1)"	"unprognostic (8.30e-2)"	"unprognostic (3.62e-2)"	"unprognostic (4.64e-2)"	"unprognostic (3.92e-1)"	"unprognostic (9.21e-2)"	"unprognostic (3.21e-2)"	"unprognostic (5.09e-2)"	"unprognostic (1.32e-1)"	"prognostic favorable (8.70e-5)"	"unprognostic (3.63e-1)"	"unprognostic (2.32e-1)"	"unprognostic (1.07e-1)"	"unprognostic (7.39e-2)"	3.2	3.8	3.3	2.6	4.6	5.1	4.1	5.8	4.2	4.4	3.6	4.0	2.6	4.7	3.5	3.2	3.2	3.4	2.9	4.3	3.8	3.8	3.6	3.2	4.4	3.3	3.4	5.0	2.9	5.5	2.1	3.8	4.1	4.3	3.5	5.4	2.8	4.1	3.7	3.0	2.7	4.2	3.0	4.7	4.2	4.5	3.4	6.8	5.5	3.8	3.9	3.4	2.7	6.9	5.4	8.5	8.3	9.0	5.2	4.3	3.7	5.9	7.8	8.1	5.9	8.9	4.4	6.6	2.6	9.5	10.5	8.0	12.0	5.0	8.6	3.9	3.8	8.2	7.5	5.4	4.8	9.4	6.0	5.2	2.9	8.2	6.0	3.4	6.0	7.9	8.2	3.7	4.5	6.4	8.2	4.9	6.0	6.1	5.1	6.3	14.5	2.7	5.3	5.7	7.7	6.0	5.8	4.3	4.1	4.9	5.6	4.0	7.6	8.1	6.7	9.3	6.8	3.0	4.0	3.6	6.5	5.8	7.0	1.2	1.9	2.0	3.7	1.7	4.8	2.6	4.2	3.9	2.0	4.3	5.1	5.1	1.5	2.7	3.0	5.4	3.2	1.1	3.3	4.6	5.8	4.2	4.3	3.8	3.3	3.4	4.1	3.0	3.4	6.9	20.2	16.0	16.2	105.8	13.8	5.0	12.6	7.2	12.5	0.0	6.6	6.2	18.8	8.6	13.5	0.0	0.0	6.3	18.3	7.5	0.0	8.8	7.8	9.0	32.4	12.9	4.9	12.4	90.1	8.2	3.5	19.3	11.7	11.3	15.2	24.9	8.6	6.6	6.3	0.0	88.5	8.4	6.1	11.1	3.8	3.8	26.8	10.8	3.6	62.8	13.7	0.0	12.3	130.7	117.9	8.3	4.5	27.8	13.5	9.7	7.2	4.0	15.5	0.0	19.7	26.1	19.9	17.0	11.1	12.2	4.4	4.8	15.7	45.9	6.4	9.5
ERG	"erg-3, p55"	ENSG00000157554	"ETS transcription factor ERG"	P11308	21	38380027-38661780	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 94.4;Endothelial cells: 105.5;Hepatic stellate cells: 69.9;Microglial cells: 88.1"	"Cancer enriched"	"Detected in all"	4	"prostate cancer: 18.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"HUVEC TERT2: 138.3;MOLT-4: 47.7;REH: 151.5;TIME: 113.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB018377, HPA046598"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA				"Cluster 82: Adipose tissue - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Nucleoplasm	Cytosol	"CAB018377: AB_675518, HPA046598: AB_2679715"	"unprognostic (2.14e-1)"	"prognostic unfavorable (6.18e-6)"	"unprognostic (6.44e-3)"	"unprognostic (8.64e-3)"	"unprognostic (5.65e-2)"	"unprognostic (1.91e-1)"	"unprognostic (9.03e-4)"	"unprognostic (4.30e-2)"	"unprognostic (2.63e-2)"	"unprognostic (1.29e-1)"	"unprognostic (3.42e-2)"	"unprognostic (2.89e-1)"	"prognostic unfavorable (3.94e-4)"	"unprognostic (4.31e-3)"	"unprognostic (3.88e-2)"	"unprognostic (2.64e-2)"	"unprognostic (5.63e-3)"	24.6	4.1	5.1	7.1	5.5	7.6	20.0	5.0	5.5	10.0	3.0	5.4	3.4	11.6	1.9	5.2	9.1	12.0	12.4	4.5	5.1	12.8	6.1	19.6	7.5	5.9	5.4	4.4	4.9	2.4	2.4	24.3	6.2	7.1	3.4	0.5	3.7	4.3	7.9	4.9	6.5	12.0	4.7	26.6	4.6	1.5	7.0	4.1	10.0	9.9	3.7	9.2	6.9	5.4	0.0	0.0	1.5	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.6	0.0	0.0	0.2	22.3	0.0	0.1	0.9	0.0	0.0	138.3	0.1	0.0	0.0	0.0	1.0	47.7	0.0	0.5	0.0	0.0	151.5	0.0	0.0	0.0	0.1	0.1	0.0	1.1	0.2	0.0	0.0	0.0	0.0	113.4	0.7	2.2	0.5	0.0	0.0	0.0	0.0	0.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	5.1	5.5	5.0	5.5	4.5	5.1	5.9	5.4	6.2	4.7	7.0	5.4	94.4	0.0	3.9	0.3	0.7	3.4	1.7	0.6	3.4	0.0	0.6	4.3	3.8	4.3	1.3	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.7	0.7	0.4	105.5	0.0	13.5	13.3	0.0	0.0	5.7	0.0	2.1	24.0	4.4	69.9	1.3	0.3	0.0	1.7	0.4	0.0	5.9	3.4	2.1	0.9	0.9	3.6	88.1	0.2	0.0	0.0	7.1	1.4	0.0	0.0	0.0	1.5	1.4	0.0	0.0	0.0	0.1	0.0	2.4	3.7	0.3	1.4	0.5	3.4	0.0	0.6	0.5	0.3	0.6
ERGIC1	"ERGIC-32, ERGIC32, KIAA1181, NET24"	ENSG00000113719	"Endoplasmic reticulum-golgi intermediate compartment 1"	Q969X5	5	172834251-172952683	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"ER-Golgi transport, Transport"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Hepatocytes: 247.8;Intestinal goblet cells: 202.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018666, HPA018900"	Enhanced		Enhanced	Nucleoplasm,Vesicles		NA	NA			"Cluster 22: NK-cells - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 27: Mucus-secreting cells - Mucin production"	"Nucleoplasm, Vesicles"		"HPA018666: AB_1848241, HPA018900: AB_1848242"	"unprognostic (8.86e-2)"	"unprognostic (3.50e-2)"	"unprognostic (3.44e-2)"	"unprognostic (5.71e-2)"	"unprognostic (7.96e-2)"	"unprognostic (2.46e-2)"	"unprognostic (9.53e-3)"	"unprognostic (7.02e-3)"	"unprognostic (2.06e-1)"	"unprognostic (6.25e-2)"	"unprognostic (1.77e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.74e-2)"	"unprognostic (1.67e-1)"	"unprognostic (3.86e-2)"	"unprognostic (9.28e-2)"	"unprognostic (3.22e-2)"	67.3	147.8	33.4	49.1	31.2	44.9	60.3	47.4	35.4	127.2	26.7	97.7	79.5	67.4	75.3	55.0	72.4	50.2	60.9	35.8	31.8	66.1	193.2	77.8	40.8	41.4	36.4	56.9	80.6	50.7	48.5	47.9	38.1	146.8	102.7	21.6	97.6	69.8	92.3	46.7	79.4	64.1	33.0	69.2	107.1	25.3	41.3	83.1	75.2	91.9	55.0	58.3	54.3	34.0	120.2	112.8	95.0	211.6	353.3	262.0	51.9	239.5	179.3	105.5	97.4	159.5	120.4	114.8	166.9	406.4	181.7	43.2	68.5	316.8	123.3	92.0	67.5	70.7	156.1	86.1	258.9	33.3	21.6	223.8	128.6	155.8	143.8	173.8	171.0	117.8	42.6	156.8	177.1	150.4	96.5	57.6	56.0	283.7	101.4	327.4	62.9	358.5	245.2	68.6	52.9	96.0	82.7	234.7	120.6	91.1	98.0	37.4	132.4	171.3	69.1	165.9	99.2	246.8	294.0	47.5	236.9	78.3	76.2	3.7	7.5	19.2	3.1	10.5	5.2	9.3	1.6	2.1	6.1	6.2	1.0	2.3	30.6	14.3	14.3	3.1	1.0	5.1	33.4	31.2	47.4	35.4	35.8	31.8	41.4	36.4	38.1	33.0	41.3	34.0	41.9	57.7	29.5	22.9	62.0	22.8	32.1	22.7	14.8	37.2	51.2	35.1	32.9	68.6	29.4	49.7	16.7	20.7	44.3	83.6	21.5	101.9	11.5	36.2	48.0	33.5	26.0	25.9	35.4	60.8	90.3	47.2	49.5	77.9	23.5	64.4	37.5	247.8	41.1	21.9	41.8	202.9	36.7	77.0	105.2	33.8	65.0	54.8	7.2	30.0	91.1	39.0	36.0	47.7	30.6	86.9	59.3	58.3	96.2	74.2	95.0	38.5	28.4	12.6	39.5	56.1	41.1	1.9	10.5	27.2	26.9	9.0	25.1	103.5	73.3	47.8
ERGIC2	"Erv41, PTX1"	ENSG00000087502	"ERGIC and golgi 2"	Q96RQ1	12	29337352-29381189	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"ER-Golgi transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 383.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049695	Approved		Supported	"Nucleoli rim,Golgi apparatus,Vesicles"		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 18: U-2197 - ECM organization"	"Cluster 29: Early spermatids - Spermatogenesis"	"Golgi apparatus, Vesicles"	"Nucleoli rim"	"HPA049695: AB_2680855"	"unprognostic (1.62e-2)"	"unprognostic (3.50e-2)"	"unprognostic (5.53e-2)"	"unprognostic (3.56e-1)"	"unprognostic (1.45e-1)"	"unprognostic (5.19e-3)"	"prognostic unfavorable (8.06e-6)"	"unprognostic (3.70e-2)"	"unprognostic (2.32e-2)"	"prognostic favorable (8.18e-4)"	"prognostic unfavorable (7.02e-6)"	"unprognostic (2.67e-1)"	"prognostic unfavorable (3.76e-6)"	"unprognostic (6.02e-2)"	"unprognostic (2.08e-1)"	"unprognostic (3.19e-2)"	"unprognostic (2.64e-1)"	38.5	32.5	22.7	37.8	24.6	10.5	46.0	25.1	29.0	34.4	20.8	37.1	34.4	34.4	50.1	46.0	24.2	33.1	52.4	22.6	25.9	30.6	47.6	26.3	33.8	24.9	23.9	26.9	40.2	47.2	20.7	53.1	24.3	39.5	33.7	29.4	49.2	34.5	33.8	19.2	34.9	39.3	25.4	26.7	32.6	57.8	24.4	35.0	45.1	47.0	43.6	50.1	22.1	34.4	96.7	87.0	69.1	46.8	94.8	111.5	170.1	153.1	123.4	92.7	98.3	115.7	157.6	51.3	149.1	120.7	168.7	98.7	66.0	98.3	146.4	112.6	69.4	84.0	114.6	68.3	55.7	121.2	70.0	79.1	75.9	115.8	116.7	169.3	71.8	69.8	70.5	144.6	122.6	52.3	60.3	126.2	98.9	101.3	235.0	54.9	189.9	107.6	75.5	140.1	26.5	43.2	77.2	86.5	91.5	145.9	168.0	96.7	81.8	124.1	108.1	169.1	167.6	106.4	145.5	106.0	103.7	87.3	105.3	92.3	50.2	70.6	84.7	79.9	102.9	83.2	107.6	101.2	55.1	71.0	106.6	90.3	181.1	72.1	101.1	120.9	130.8	90.1	22.7	24.6	25.1	29.0	22.6	25.9	24.9	23.9	24.3	25.4	24.4	34.4	54.6	28.9	28.6	20.9	74.3	57.9	68.9	144.1	39.9	54.8	57.2	55.1	61.7	38.6	99.0	53.3	54.2	119.2	60.8	19.4	49.0	72.7	383.0	48.7	66.5	43.7	41.8	44.8	39.2	62.8	120.6	73.0	25.5	54.6	55.8	44.2	34.6	50.2	56.4	48.8	37.8	33.5	87.5	25.5	40.2	51.9	52.5	37.1	62.2	14.0	41.6	69.5	52.5	32.2	48.3	58.1	20.5	59.8	154.0	85.7	32.4	49.5	64.6	60.0	32.9	58.5	105.7	75.0	36.3	49.4	66.3	156.2	68.0	54.0	34.7	78.8
ERI2	"EXOD1, KIAA1504, MGC16943, ZGRF5"	ENSG00000196678	"ERI1 exoribonuclease family member 2"	A8K979	16	20780193-20900349	"Predicted intracellular proteins"		"Exonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Spermatocytes: 39.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	5	"basophil: 13.8"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 13.8"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035384, HPA035385"	Uncertain		Supported	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 12: Non-specific - Cell cycle regulation"	"Nucleoplasm, Golgi apparatus"		"HPA035384: AB_10602316, HPA035385: AB_2674600"	"unprognostic (1.25e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.01e-3)"	"unprognostic (4.36e-2)"	"unprognostic (8.64e-2)"	"unprognostic (2.78e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.55e-1)"	"unprognostic (5.99e-2)"	"unprognostic (3.04e-2)"	"unprognostic (2.07e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.56e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.45e-1)"	"unprognostic (1.05e-2)"	"unprognostic (9.28e-3)"	4.7	6.8	4.3	3.7	4.9	6.4	9.2	4.4	5.5	3.9	4.8	7.4	8.1	4.1	7.6	6.7	5.7	4.5	4.4	4.1	4.4	6.5	12.1	4.7	3.8	4.9	4.4	4.5	7.4	14.0	5.0	5.4	4.9	7.5	10.2	4.2	5.1	4.8	5.1	7.1	7.8	4.6	4.6	3.6	8.4	13.1	4.7	7.5	6.2	3.7	4.4	4.5	4.7	5.7	17.1	7.9	21.6	9.5	6.5	8.3	13.0	13.3	7.9	11.8	14.9	10.2	17.0	4.8	14.6	7.3	8.2	12.7	21.8	13.7	21.8	15.3	11.4	11.5	9.7	17.6	6.0	22.3	9.0	7.5	16.7	15.9	13.2	6.3	7.2	0.0	37.1	13.5	20.0	15.3	3.2	19.8	13.4	17.5	4.5	25.5	17.7	10.5	11.0	13.4	11.0	13.5	8.5	16.0	10.3	11.4	33.7	24.7	5.5	12.5	7.0	12.2	17.9	8.3	13.4	2.9	11.9	17.9	17.6	13.8	1.8	1.7	0.4	1.3	0.3	0.5	0.4	0.4	1.9	0.0	0.3	0.2	0.1	0.5	2.6	0.6	0.8	0.4	4.3	4.9	4.4	5.5	4.1	4.4	4.9	4.4	4.9	4.6	4.7	5.7	4.0	16.0	6.7	18.3	1.0	5.0	5.3	5.6	8.0	5.3	11.3	5.8	7.3	5.7	8.5	9.2	0.0	8.3	0.9	8.0	9.8	4.1	22.5	6.9	5.5	3.0	0.0	22.7	10.4	5.2	9.1	4.3	9.7	6.0	0.0	7.1	2.9	10.9	8.4	3.3	10.6	9.6	6.1	8.2	4.1	14.7	6.2	5.8	1.8	5.6	6.7	5.0	3.1	10.6	20.3	4.7	6.6	5.3	2.8	4.5	7.5	6.8	12.6	3.5	0.0	5.6	3.5	39.3	20.0	9.7	3.7	3.7	2.5	4.5	8.5	5.7
ERLIN1	"C10orf69, Erlin-1, KE04, SPFH1, SPG62"	ENSG00000107566	"ER lipid raft associated 1"	O75477	10	100150094-100186033	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	"Cholesterol metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism"		"Disease variant, Hereditary spastic paraplegia, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 114.1"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 77.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA011252	Enhanced		Supported	"Endoplasmic reticulum"	"Intracellular and membrane"	NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 85: Liver - Metabolism"	"Cluster 32: U-937 - Innate immune response"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Endoplasmic reticulum"		"HPA011252: AB_1853965"	"unprognostic (3.22e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.57e-1)"	"unprognostic (6.98e-3)"	"unprognostic (2.69e-1)"	"unprognostic (1.70e-2)"	"unprognostic (2.30e-1)"	"prognostic unfavorable (7.63e-4)"	"unprognostic (1.26e-1)"	"unprognostic (9.68e-2)"	"unprognostic (1.99e-3)"	"unprognostic (9.09e-2)"	"unprognostic (1.32e-3)"	"unprognostic (6.10e-3)"	"unprognostic (1.76e-1)"	"unprognostic (2.97e-1)"	"unprognostic (1.93e-1)"	29.4	14.2	8.6	21.4	10.5	76.2	21.4	9.5	10.1	27.5	10.3	37.0	40.4	21.8	17.6	32.8	31.6	16.3	11.0	9.6	9.4	27.2	114.1	19.1	14.5	8.6	8.2	30.4	19.2	19.4	5.4	42.2	9.0	17.7	38.2	10.8	15.1	16.4	8.6	22.5	30.2	22.4	8.8	16.6	36.8	28.0	9.0	15.6	26.2	13.6	21.2	28.6	19.1	9.7	97.4	95.3	46.9	86.3	113.5	107.9	96.8	148.7	138.3	120.2	137.5	64.0	109.9	42.6	59.7	139.9	100.5	98.5	42.6	90.0	164.1	26.1	38.8	36.7	38.5	83.5	47.6	128.4	39.4	62.6	53.6	105.8	129.2	114.9	90.1	43.5	36.8	25.2	130.2	40.7	33.5	65.9	33.8	66.2	40.4	28.3	77.2	31.6	53.9	37.6	19.1	31.1	85.6	23.6	56.0	53.8	59.3	109.0	101.7	118.7	92.4	72.4	160.8	19.6	35.2	57.1	105.6	204.8	60.6	8.1	20.4	24.4	10.5	15.1	9.3	7.4	7.9	8.6	16.3	6.7	8.1	10.9	15.0	9.9	11.9	4.1	5.6	9.7	8.6	10.5	9.5	10.1	9.6	9.4	8.6	8.2	9.0	8.8	9.0	9.7	28.2	0.0	11.5	5.2	6.4	15.8	11.3	16.1	12.5	4.6	13.4	12.3	4.8	5.7	14.6	14.7	6.2	20.6	6.4	31.5	0.0	9.9	28.9	16.3	19.5	18.8	13.2	19.1	16.2	10.9	62.7	17.1	20.4	20.9	8.2	19.7	13.6	77.6	14.3	3.3	14.8	27.5	0.0	14.4	7.2	12.9	15.2	12.9	10.6	12.2	13.3	5.9	6.2	15.6	21.0	9.5	19.8	7.9	4.7	12.7	25.6	12.6	30.2	6.2	0.0	14.3	11.8	50.9	15.4	20.6	20.3	24.8	6.6	19.6	27.6	15.6
ERLIN2	"C8orf2, Erlin-2, NET32, SPFH2, SPG18"	ENSG00000147475	"ER lipid raft associated 2"	O94905	8	37736601-37758422	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	"Cholesterol metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism"		"Hereditary spastic paraplegia, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002025, CAB014894"	Supported		Supported	"Endoplasmic reticulum"	"Intracellular and membrane"	NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 44: Endometrium - Transcription"	"Endoplasmic reticulum"		"CAB014894: , HPA002025: AB_1080077"	"unprognostic (5.82e-3)"	"unprognostic (2.45e-1)"	"prognostic favorable (5.16e-4)"	"unprognostic (1.08e-2)"	"prognostic unfavorable (4.51e-4)"	"unprognostic (3.39e-2)"	"unprognostic (1.89e-1)"	"unprognostic (3.77e-2)"	"unprognostic (6.67e-2)"	"unprognostic (4.21e-2)"	"unprognostic (1.88e-2)"	"unprognostic (1.78e-3)"	"prognostic favorable (6.67e-6)"	"unprognostic (4.78e-2)"	"unprognostic (2.83e-1)"	"unprognostic (3.43e-1)"	"unprognostic (2.33e-1)"	20.3	17.8	15.7	14.6	17.3	14.4	25.0	16.5	16.8	20.0	27.2	24.2	17.7	21.2	32.3	17.9	30.1	19.8	17.8	14.2	16.3	40.4	40.8	15.5	11.5	18.0	18.5	30.8	26.2	41.4	8.3	21.2	17.7	25.4	25.0	21.6	29.4	23.8	18.9	15.3	23.6	19.5	17.9	14.6	24.9	17.0	15.6	14.7	46.5	14.1	12.6	16.8	10.3	18.6	39.0	38.5	43.0	31.4	47.3	33.9	47.2	59.1	51.9	31.8	33.2	20.1	50.8	18.9	95.8	63.4	30.3	41.4	31.2	48.4	46.8	11.2	24.2	27.8	22.7	22.7	31.5	17.8	34.1	43.3	49.1	46.3	48.1	39.6	30.7	17.2	51.1	17.7	47.4	18.3	25.8	14.7	45.9	53.8	17.7	17.9	29.9	15.2	42.8	41.9	7.7	20.7	39.3	12.6	35.6	50.1	62.0	27.1	31.1	30.9	26.4	56.8	31.1	24.3	41.0	24.2	55.0	28.4	40.7	1.3	6.5	13.4	4.4	7.0	3.6	4.5	2.7	3.5	5.4	2.3	4.1	3.8	6.1	2.5	9.6	7.6	5.5	3.1	15.7	17.3	16.5	16.8	14.2	16.3	18.0	18.5	17.7	17.9	15.6	18.6	14.7	12.8	14.3	21.5	7.1	9.7	10.0	18.5	13.1	25.2	24.9	20.7	30.2	25.8	22.8	33.1	20.9	17.9	6.0	19.0	9.8	23.8	21.3	31.3	18.5	13.6	11.4	8.0	3.7	22.1	27.0	18.8	17.3	27.8	3.8	14.4	17.5	41.0	20.6	16.8	6.4	24.3	20.3	23.9	6.6	16.8	11.8	16.1	14.2	7.5	12.3	23.5	5.2	11.6	16.7	18.8	17.4	17.7	16.8	15.2	25.4	19.8	47.6	18.7	19.7	19.1	14.8	47.4	18.5	21.9	7.4	15.7	7.1	12.9	25.4	12.8
ERMAP	"BTN5, RD, SC"	ENSG00000164010	"Erythroblast membrane associated protein (Scianna blood group)"	Q96PL5	1	42817122-42844991	"Blood group antigen proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Blood group antigen"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Erythroid cells: 81.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HEL: 38.3"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"HPA042573, HPA054672"	Uncertain		Approved	"Golgi apparatus,Cytosol"		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 6: Erythroid cells - Oxygen transport"	"Golgi apparatus"	Cytosol	"HPA042573: AB_10794282, HPA054672: "	"unprognostic (9.46e-2)"	"unprognostic (4.47e-2)"	"unprognostic (2.56e-3)"	"unprognostic (1.15e-1)"	"unprognostic (6.09e-2)"	"unprognostic (2.11e-3)"	"unprognostic (2.82e-1)"	"unprognostic (7.48e-2)"	"unprognostic (2.71e-3)"	"unprognostic (6.46e-2)"	"unprognostic (1.68e-1)"	"unprognostic (2.06e-1)"	"unprognostic (1.02e-2)"	"unprognostic (8.28e-2)"	"unprognostic (4.81e-2)"	"unprognostic (1.48e-1)"	"unprognostic (9.48e-2)"	8.0	9.2	3.9	4.7	4.2	30.5	8.3	3.8	4.6	8.6	4.8	7.3	6.5	6.0	15.8	7.2	10.1	7.5	4.3	3.8	5.0	7.1	13.2	7.2	4.9	5.0	4.5	5.5	9.5	8.4	5.8	5.9	4.4	7.8	8.1	4.3	8.6	6.2	2.3	9.3	6.1	6.3	4.4	5.2	7.8	4.1	4.8	5.3	13.0	3.6	5.4	5.5	3.9	5.0	5.2	7.1	2.1	7.0	7.7	22.4	2.0	10.5	17.8	9.3	9.3	2.9	9.6	4.6	3.5	11.2	4.4	6.5	2.4	3.2	8.3	7.8	8.2	38.3	5.2	2.3	9.5	5.2	18.8	13.7	11.8	4.3	9.9	16.8	6.1	5.6	26.4	4.7	8.6	3.6	2.3	1.6	5.1	3.3	3.8	2.6	2.8	4.3	8.0	8.1	4.7	3.2	9.0	3.3	4.0	3.7	6.6	19.6	9.6	6.9	3.9	5.9	4.8	1.8	4.4	2.0	5.6	5.8	4.4	0.0	4.3	2.1	1.2	4.5	0.6	1.3	1.2	0.9	5.1	0.7	1.0	1.0	1.3	2.2	3.0	1.0	3.2	1.9	3.9	4.2	3.8	4.6	3.8	5.0	5.0	4.5	4.4	4.4	4.8	5.0	2.4	12.8	10.9	9.8	2.9	3.8	2.9	3.2	6.2	1.8	6.6	6.3	2.2	4.3	6.2	3.7	22.9	3.1	4.4	4.8	1.9	3.6	4.3	4.7	6.2	3.3	5.4	81.7	5.5	7.2	1.6	3.6	6.1	5.6	2.5	10.4	3.6	12.9	7.8	11.8	2.2	4.4	0.0	11.7	2.9	25.7	2.8	7.4	5.4	14.0	7.1	4.8	1.0	9.5	10.6	4.8	3.9	4.1	2.1	2.9	3.5	4.0	6.5	4.5	0.0	4.7	2.6	0.1	0.7	5.7	3.8	2.9	2.3	7.4	5.5	2.3
ERN2	IRE1b	ENSG00000134398	"Endoplasmic reticulum to nucleus signaling 2"	Q76MJ5	16	23690310-23713226	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Apoptosis, Transcription, Transcription regulation"	"Hydrolase, Kinase, Multifunctional enzyme, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"cervix: 19.5;gallbladder: 17.0;intestine: 28.9;salivary gland: 22.9;stomach 1: 51.9"	"Cell type enhanced"	"Detected in some"		"Club cells: 38.4;Distal enterocytes: 80.2;Gastric mucus-secreting cells: 193.7;Intestinal goblet cells: 143.9;Paneth cells: 37.2;Undifferentiated cells: 70.9"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 17.0;pancreatic cancer: 19.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	6	"OE19: 43.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA076875	Approved		Approved	"Endoplasmic reticulum,Cytosol"	"Intracellular and membrane"	NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 37: Intestine - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 27: Mucus-secreting cells - Mucin production"	"Endoplasmic reticulum, Cytosol"		"HPA076875: "	"unprognostic (1.06e-1)"	"unprognostic (5.20e-2)"	"unprognostic (3.45e-1)"	"unprognostic (2.98e-2)"	"unprognostic (3.83e-2)"	"unprognostic (1.13e-2)"	"unprognostic (7.67e-4)"	"unprognostic (1.31e-1)"	"unprognostic (1.16e-1)"	"unprognostic (4.93e-2)"	"unprognostic (7.34e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.14e-9)"	"unprognostic (1.48e-1)"	"unprognostic (2.14e-1)"	"unprognostic (1.06e-1)"	"unprognostic (3.13e-3)"	0.1	0.4	0.1	3.0	0.1	0.0	0.1	0.6	0.4	19.5	0.2	28.9	12.9	0.0	0.0	0.9	0.4	17.0	0.0	0.1	0.2	0.1	0.0	0.8	0.0	0.2	0.1	0.0	0.9	0.0	0.2	0.0	0.2	3.5	23.0	0.0	22.9	0.1	0.0	0.2	12.4	0.9	0.0	0.0	51.9	0.1	0.1	0.0	0.0	0.0	0.0	4.6	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	6.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	43.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.2	0.0	0.1	0.0	0.0	0.1	0.1	0.6	0.4	0.1	0.2	0.2	0.1	0.2	0.0	0.1	0.4	0.0	0.0	1.1	0.0	0.8	0.0	1.5	6.8	0.0	0.0	0.0	0.0	0.5	20.0	38.4	0.0	0.0	0.5	0.0	80.2	0.0	2.3	0.1	0.5	0.2	0.1	10.8	0.0	0.2	1.9	0.0	0.1	193.7	1.6	4.5	0.1	0.0	0.0	0.1	0.0	0.1	143.9	6.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.0	0.1	33.1	37.2	0.0	0.5	1.3	6.1	0.1	16.9	0.0	0.0	1.7	1.6	0.0	0.2	0.0	0.0	0.1	0.4	0.0	70.9	11.1
ERRFI1	"GENE-33, MIG-6, RALT"	ENSG00000116285	"ERBB receptor feedback inhibitor 1"	Q9UJM3	1	8004404-8026309	"Predicted intracellular proteins"			"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 743.8;pancreas: 678.8"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 1242.3;Basal prostatic cells: 1428.1;Hepatocytes: 722.3;Suprabasal keratinocytes: 732.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	5	"non-classical monocyte: 2.0"	"Lineage enriched"	"Detected in single"	5	"monocytes: 2.0"	"Cell line enhanced"	"Detected in many"		"HHSteC: 558.4;LHCN-M2: 442.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA076543			Supported	Cytosol		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 22: Epithelial cell types - Mixed function"	Cytosol		"HPA076543: "	"unprognostic (2.13e-3)"	"unprognostic (1.01e-2)"	"unprognostic (2.34e-1)"	"unprognostic (1.71e-2)"	"unprognostic (2.50e-3)"	"unprognostic (1.66e-3)"	"unprognostic (2.27e-2)"	"unprognostic (1.05e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.47e-1)"	"unprognostic (4.50e-2)"	"unprognostic (2.10e-1)"	"unprognostic (1.19e-3)"	"unprognostic (1.11e-3)"	"unprognostic (1.18e-1)"	"unprognostic (2.34e-1)"	"unprognostic (8.03e-3)"	143.6	41.7	13.8	31.0	15.3	1.8	127.6	33.0	20.5	87.0	42.2	61.5	33.3	78.1	18.3	51.2	75.8	131.1	53.3	16.7	20.3	157.3	743.8	82.8	17.6	31.9	16.7	148.5	678.8	88.0	112.1	125.6	17.4	53.1	23.4	36.3	76.1	26.0	225.9	124.6	47.2	88.5	28.6	9.5	125.0	16.5	18.7	18.4	113.4	30.2	12.5	86.9	75.5	20.9	86.1	49.7	20.8	28.2	192.6	143.0	215.7	81.9	23.8	15.0	17.5	22.2	218.9	1.4	47.9	27.6	102.5	18.2	5.8	144.7	68.2	2.6	16.1	1.3	15.1	260.1	558.4	0.9	3.3	195.8	142.7	49.4	118.7	208.4	38.3	3.6	6.1	0.7	442.5	36.8	0.3	5.5	50.0	66.3	121.7	7.4	233.8	1.4	69.3	27.0	14.3	8.5	16.2	36.5	26.0	145.6	25.4	2.0	54.4	57.7	33.9	49.0	116.6	1.3	1.1	1.5	222.0	3.8	54.4	0.0	0.1	0.0	0.4	0.0	0.0	0.1	0.4	0.4	0.0	0.1	0.3	0.4	0.0	0.0	2.0	0.1	0.2	0.0	13.8	15.3	33.0	20.5	16.7	20.3	31.9	16.7	17.4	28.6	18.7	20.9	93.0	221.2	108.7	22.5	9.2	1242.3	1428.1	228.6	249.8	9.8	186.3	115.9	52.1	177.3	198.7	27.6	14.6	87.6	25.7	161.9	31.3	99.1	24.0	209.6	74.4	29.8	109.5	21.5	18.4	111.2	51.0	130.1	56.6	336.3	14.5	3.9	32.5	722.3	10.0	3.3	16.5	70.2	59.0	11.7	95.0	63.9	51.9	17.9	71.2	8.4	0.6	40.0	3.1	13.0	30.9	144.9	127.2	38.4	6.6	382.2	78.1	131.1	86.3	9.9	6.6	113.9	93.3	21.1	21.8	152.6	732.9	259.0	33.5	4.9	82.7	543.4
ESPL1	"ESP1, KIAA0165, SEPA"	ENSG00000135476	"Extra spindle pole bodies like 1, separase"	Q14674	12	53268299-53293638	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Chromosome partition"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 8.5;esophagus: 15.4;lymphoid tissue: 10.7"	"Cell type enhanced"	"Detected in many"		"Ionocytes: 22.4;Proximal enterocytes: 22.6;Squamous epithelial cells: 7.4"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB012185, HPA073188"	Approved		Supported	Nucleoplasm,Vesicles		NA	Yes			"Cluster 39: Non-specific - mRNA processing"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 45: Enterocytes - Digestion"	Nucleoplasm	Vesicles	"CAB012185: AB_304056, HPA073188: "	"unprognostic (1.57e-1)"	"unprognostic (3.56e-2)"	"unprognostic (3.84e-2)"	"prognostic unfavorable (5.32e-5)"	"unprognostic (2.91e-1)"	"unprognostic (1.11e-1)"	"prognostic unfavorable (2.01e-5)"	"prognostic unfavorable (7.14e-4)"	"unprognostic (1.59e-2)"	"unprognostic (2.48e-1)"	"unprognostic (4.17e-3)"	"unprognostic (1.18e-2)"	"unprognostic (7.42e-13)"	"prognostic favorable (7.10e-4)"	"unprognostic (2.39e-1)"	"unprognostic (7.41e-2)"	"unprognostic (1.42e-1)"	0.4	0.2	0.0	2.4	0.0	8.5	0.5	0.0	0.0	3.5	0.0	1.5	3.9	0.2	0.0	15.4	0.2	0.4	0.1	0.0	0.0	0.9	0.6	0.4	4.4	0.0	0.0	0.1	0.1	0.0	0.0	1.1	0.0	0.1	1.4	0.0	2.0	0.1	0.0	2.6	4.3	0.7	0.0	1.0	0.9	6.2	0.1	10.7	0.1	0.0	4.9	0.6	5.9	0.0	27.8	23.6	27.6	21.1	0.6	1.9	17.5	15.9	8.6	28.8	19.2	15.8	22.7	49.9	9.5	6.8	17.4	20.2	32.6	9.9	14.3	13.7	32.8	30.6	24.1	11.1	0.1	19.5	25.2	0.6	0.6	15.5	7.6	2.8	15.4	22.2	42.6	41.0	9.1	29.2	30.6	16.4	22.5	14.5	12.9	29.3	30.2	21.4	4.2	11.6	18.9	15.8	11.9	20.4	10.1	13.0	36.9	12.7	8.2	14.5	27.2	11.9	25.5	32.5	29.7	31.9	8.2	19.0	27.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.5	0.0	0.0	0.3	0.6	0.9	0.3	0.5	0.6	0.0	1.0	1.3	0.9	0.0	0.4	3.7	0.0	1.9	0.6	2.7	0.0	0.2	0.8	0.2	0.8	1.0	3.5	1.3	0.7	0.0	2.3	1.1	3.6	0.7	0.0	4.4	0.7	6.8	2.6	0.0	0.4	2.7	22.4	0.6	2.1	1.2	0.0	1.3	0.0	1.0	0.0	0.0	0.0	0.0	0.5	1.5	1.3	0.4	2.1	0.4	22.6	6.6	0.2	0.0	0.0	0.4	0.9	5.5	4.1	7.4	0.6	0.3	0.4	0.1	2.8	0.4
ESR2	"ER-beta, Erb, NR3A2"	ENSG00000140009	"Estrogen receptor 2"	Q92731	14	64084232-64338112	"Cancer-related genes, Disease related genes, FDA approved drug targets, Human disease related genes, Nuclear receptors, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Receptor"	"Cancer-related genes, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 6.1"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 61.4;Granulosa cells: 26.6;Late spermatids: 93.7;Rod photoreceptor cells: 35.6;Spermatocytes: 28.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"Karpas-707: 4.2;U-266/70: 9.8;U-698: 16.4"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"cerebellum: 6.1"	"HPA068406, CAB079300"	Enhanced		Supported	Nucleoplasm,Vesicles		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 71: Testis - DNA repair"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 40: Granulosa cells - Unknown function"	Nucleoplasm	Vesicles	"CAB079300: , HPA068406: "	"unprognostic (7.63e-3)"	"unprognostic (2.28e-3)"	"unprognostic (8.27e-3)"	"unprognostic (5.41e-2)"	"unprognostic (2.91e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.80e-1)"	"unprognostic (4.38e-2)"	"unprognostic (1.95e-1)"	"unprognostic (8.75e-2)"	"unprognostic (2.57e-2)"	"unprognostic (1.65e-1)"	"unprognostic (3.03e-5)"	"unprognostic (1.57e-1)"	"unprognostic (1.66e-1)"	"unprognostic (4.21e-2)"	"unprognostic (5.89e-2)"	1.5	6.1	1.2	1.2	0.6	1.0	0.9	3.0	0.8	1.4	3.5	0.9	1.0	1.2	0.4	0.7	1.0	0.5	0.6	0.5	0.9	1.5	0.7	0.6	2.1	0.7	0.6	5.4	2.1	0.1	0.8	0.2	1.0	1.5	1.0	2.0	0.8	0.2	1.4	1.0	1.3	0.3	0.3	1.8	1.0	5.7	1.7	2.5	0.6	0.2	1.6	1.1	0.6	0.9	0.8	0.4	0.7	0.6	0.0	0.1	1.5	0.2	0.0	0.1	0.1	0.3	0.9	3.1	0.1	0.1	0.4	1.0	0.8	0.0	0.1	0.7	0.4	0.3	1.0	0.1	0.1	0.1	0.3	0.0	0.0	0.1	0.2	0.2	0.3	1.1	0.5	4.2	0.2	0.8	0.5	0.2	0.7	0.6	0.4	0.5	0.4	0.3	0.1	1.3	2.2	0.6	0.4	0.2	1.1	0.4	0.7	0.1	0.5	0.4	1.0	0.2	0.1	9.8	3.1	16.4	0.2	0.1	0.8	0.3	0.1	0.5	0.3	0.2	0.2	0.5	0.2	0.4	0.0	0.7	0.4	0.3	0.6	0.2	0.3	1.1	0.2	0.1	1.2	0.6	3.0	0.8	0.5	0.9	0.7	0.6	1.0	0.3	1.7	0.9	0.9	6.4	0.0	6.8	5.5	0.3	2.2	0.4	2.8	1.6	0.3	0.1	0.9	4.3	0.9	0.0	6.2	0.7	5.2	0.1	0.0	0.3	61.4	3.5	0.9	3.0	0.0	0.4	12.4	0.7	0.5	2.2	0.0	4.9	1.3	26.6	1.1	0.1	0.1	0.0	17.9	0.8	0.0	0.0	0.3	93.7	0.9	0.2	1.8	7.5	0.1	0.9	6.2	10.6	7.6	0.5	0.1	1.2	16.6	3.8	0.4	0.1	1.7	35.6	0.0	1.5	1.4	28.0	1.4	0.5	0.1	1.1	3.0	16.4	0.8	1.8
ESRRA	"ERR1, ERRa, ERRalpha, ESRL1, NR3B1"	ENSG00000173153	"Estrogen related receptor alpha"	P11474	11	64305497-64316743	"Nuclear receptors, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 195.3"	"Cell type enhanced"	"Detected in all"		"Distal enterocytes: 159.2;Hepatocytes: 266.3;Proximal enterocytes: 199.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA053785, HPA077297"	Approved		Supported	"Nucleoplasm,Nucleoli fibrillar center,Microtubules,Cytokinetic bridge"		Yes	No			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 2: Hepatocytes - Metabolism"	"Nucleoplasm, Nucleoli fibrillar center, Microtubules"	"Cytokinetic bridge"	"HPA053785: AB_2682260, HPA077297: "	"unprognostic (7.63e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.28e-2)"	"unprognostic (3.08e-1)"	"unprognostic (7.24e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.97e-1)"	"unprognostic (2.98e-1)"	"unprognostic (3.52e-2)"	"unprognostic (2.50e-2)"	"unprognostic (1.03e-1)"	"prognostic favorable (1.34e-7)"	"unprognostic (3.43e-3)"	"unprognostic (3.19e-2)"	"unprognostic (2.38e-2)"	"unprognostic (7.20e-2)"	27.3	35.5	25.5	15.8	29.8	16.3	23.6	36.4	31.4	17.5	33.6	67.6	81.8	15.5	4.7	62.7	14.6	10.2	154.9	23.5	31.6	70.3	91.5	30.9	11.0	30.9	31.7	8.1	56.3	23.9	15.9	15.4	29.8	26.4	22.9	5.1	48.5	12.6	195.3	35.9	65.4	7.1	26.6	32.0	52.4	8.4	37.5	8.4	28.3	88.8	12.4	31.0	28.8	23.7	25.9	40.2	9.8	23.6	13.0	12.7	54.2	25.0	11.9	9.2	9.0	37.4	30.3	34.9	45.1	12.8	23.7	66.0	16.9	33.0	3.5	23.0	21.0	22.9	51.7	30.1	18.0	39.3	55.3	17.4	49.8	20.7	27.0	12.8	12.8	18.1	37.9	18.7	15.3	57.9	19.4	55.9	27.9	30.4	74.4	20.4	19.7	79.6	31.1	52.4	20.6	26.2	12.8	81.2	83.8	5.5	25.8	38.2	28.9	16.6	20.4	47.4	25.6	28.6	25.5	23.6	26.9	38.2	13.4	0.2	2.9	4.8	2.7	5.4	2.6	1.7	2.3	1.9	2.7	2.3	2.3	3.3	5.3	1.8	5.1	2.1	3.6	1.7	25.5	29.8	36.4	31.4	23.5	31.6	30.9	31.7	29.8	26.6	37.5	23.7	20.8	9.6	22.7	21.2	14.7	18.6	41.0	29.7	18.8	28.8	30.9	24.3	9.2	100.1	21.3	20.2	33.3	103.8	20.9	159.2	54.8	51.3	3.4	18.7	17.4	15.3	37.8	19.4	13.6	80.2	61.3	12.4	39.8	20.3	7.6	9.3	35.0	266.3	33.6	33.7	16.6	82.5	28.5	82.7	11.7	1.1	6.5	22.2	17.8	11.2	28.8	20.1	27.8	9.0	6.4	81.1	103.1	12.0	8.2	42.8	199.7	82.2	19.8	20.4	13.1	18.7	21.7	3.5	7.1	26.3	18.5	134.2	14.5	22.2	113.7	65.0
ESRRB	"DFNB35, ERR2, ERRb, ERRbeta, ESRL2, NR3B2"	ENSG00000119715	"Estrogen related receptor beta"	O95718	14	76310712-76501837	"Disease related genes, Human disease related genes, Nuclear receptors, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Receptor"	"Deafness, Disease variant, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"retina: 36.5"	"Cell type enhanced"	"Detected in some"		"Distal tubular cells: 13.7;Early spermatids: 14.1;Horizontal cells: 55.5;Late spermatids: 37.6;Rod photoreceptor cells: 40.3"	"Cancer enhanced"	"Detected in single"		"testis cancer: 0.6"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HMC-1: 1.3;K-562: 5.0;U-266/70: 2.3"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA074772			Supported	Nucleoplasm,Cytosol		NA	NA				"Cluster 77: Retina - Visual perception"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 46: Photoreceptor cells - Phototransduction"	Nucleoplasm	Cytosol	"HPA074772: "	"unprognostic (1.12e-1)"	"unprognostic (1.34e-2)"	"unprognostic (6.28e-2)"	"unprognostic (3.92e-5)"	"unprognostic (5.18e-2)"	"unprognostic (3.15e-2)"	"unprognostic (2.14e-1)"	"unprognostic (1.48e-1)"	"unprognostic (2.28e-2)"	"unprognostic (2.24e-2)"	"unprognostic (2.16e-2)"	"unprognostic (4.11e-2)"	"unprognostic (2.68e-1)"	"unprognostic (3.46e-1)"	"unprognostic (1.89e-1)"	"unprognostic (2.12e-4)"	"unprognostic (4.40e-2)"	0.0	0.0	0.4	0.0	0.4	0.0	0.3	0.4	0.4	0.0	1.2	0.0	0.0	0.0	0.2	0.0	0.1	0.0	4.9	0.3	0.6	6.6	0.0	0.0	0.0	1.5	1.2	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.0	36.5	0.0	0.0	6.5	0.0	0.0	0.0	0.6	0.1	2.4	1.2	0.9	0.1	0.0	1.6	0.0	0.0	0.0	0.8	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.7	0.2	0.0	0.0	0.0	0.3	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	5.0	0.2	0.0	0.6	0.0	0.2	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.4	0.0	0.0	0.5	0.0	0.4	0.0	0.2	2.3	0.7	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.4	0.4	0.4	0.3	0.6	1.5	1.2	0.7	0.6	0.9	0.8	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	2.4	1.0	0.4	5.8	0.0	0.0	0.0	2.1	0.0	0.0	0.0	13.7	0.0	14.1	0.0	0.0	0.8	0.0	0.0	1.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	55.5	2.0	0.0	0.0	0.0	0.0	37.6	0.0	0.1	0.0	3.7	0.0	4.6	0.0	1.5	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	40.3	0.0	0.1	0.8	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ESX1	"ESX1L, ESXR1"	ENSG00000123576	"ESX homeobox 1"	Q8N693	X	104250038-104254933	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	69	"testis: 8.9"	"Cell type enriched"	"Detected in some"	25	"Spermatogonia: 98.0"	"Cancer enriched"	"Detected in single"	5	"testis cancer: 0.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	11	"TIME: 24.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA051992, HPA073330"	Enhanced		Supported	"Nuclear speckles"		NA	NA				"Cluster 36: Testis - Spermatogenesis"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	"Nuclear speckles"		"HPA051992: AB_2681684, HPA073330: "															"unprognostic (1.87e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	24.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	98.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1
ESYT1	"FAM62A, KIAA0747, MBC2"	ENSG00000139641	"Extended synaptotagmin 1"	Q9BSJ8	12	56118250-56144674	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016858, HPA076926"	Approved		Supported	"Endoplasmic reticulum"		NA	NA		720000	"Cluster 2: Granulocytes - Unknown function"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Endoplasmic reticulum"		"HPA016858: AB_1848404, HPA076926: AB_2686819"	"unprognostic (5.02e-2)"	"unprognostic (3.62e-2)"	"unprognostic (6.26e-3)"	"unprognostic (1.87e-1)"	"unprognostic (3.28e-2)"	"unprognostic (8.44e-2)"	"unprognostic (5.41e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.39e-2)"	"unprognostic (1.77e-1)"	"unprognostic (6.85e-3)"	"unprognostic (1.29e-1)"	"prognostic favorable (3.86e-4)"	"unprognostic (3.04e-2)"	"unprognostic (8.43e-3)"	"unprognostic (1.52e-2)"	"unprognostic (3.98e-2)"	107.9	39.3	15.2	38.5	14.4	18.7	72.7	18.5	18.9	36.6	19.8	45.9	17.2	53.4	22.2	29.2	47.1	27.8	24.5	13.5	23.0	26.8	46.7	45.0	45.9	34.2	21.7	38.8	39.5	40.7	11.7	38.7	36.2	30.5	36.2	8.9	28.0	47.2	54.2	26.1	30.7	74.4	22.5	37.2	29.3	12.1	23.6	36.6	27.8	33.3	49.8	44.7	32.3	24.0	107.0	78.1	62.2	158.2	90.8	67.3	53.4	117.4	129.3	136.2	94.4	72.4	114.3	40.8	92.2	201.3	50.7	118.7	73.7	120.4	121.6	58.8	54.2	244.7	56.0	58.5	125.9	193.2	371.6	76.7	125.5	147.1	81.3	145.3	117.8	39.2	153.6	263.9	124.4	81.2	70.4	116.4	78.9	44.6	102.5	105.4	85.0	107.3	113.7	89.0	52.4	54.8	174.1	52.9	80.5	71.3	111.1	128.4	154.5	104.8	94.7	59.7	85.7	62.3	99.0	58.7	97.3	79.6	111.7	423.2	37.4	423.0	127.2	69.4	157.2	62.4	129.4	129.5	87.2	48.2	102.3	120.2	9.3	84.2	85.6	29.7	139.6	177.8	15.2	14.4	18.5	18.9	13.5	23.0	34.2	21.7	36.2	22.5	23.6	24.0	44.4	9.6	9.3	4.6	25.9	16.3	19.8	23.5	14.2	5.5	20.5	21.3	8.2	14.3	12.9	31.3	10.4	31.9	22.3	6.1	0.0	36.8	2.0	20.5	15.1	28.2	25.2	17.9	10.2	26.8	18.1	17.6	9.2	19.3	62.7	24.7	27.1	37.8	46.4	0.0	7.1	12.0	22.4	21.3	24.8	2.1	17.4	22.9	35.6	6.5	50.6	5.7	60.8	2.0	4.1	26.2	3.5	25.2	18.5	19.9	2.2	4.4	10.7	5.9	52.6	14.3	22.0	3.9	2.9	18.0	11.9	37.9	40.3	12.5	10.8	12.7
ESYT2	"CHR2SYT, FAM62B, KIAA1228"	ENSG00000117868	"Extended synaptotagmin 2"	A0FGR8	7	158730995-158830253	"Plasma proteins, Predicted membrane proteins, Transporters"	"Endocytosis, Lipid transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Microglial cells: 185.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002132, HPA070823"	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA		24000	"Cluster 48: NK-cells - Unknown function"	"Cluster 52: Non-specific - Ribosome"	"Cluster 18: U-2197 - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Plasma membrane, Cytosol"		"HPA002132: AB_1078807, HPA070823: "	"unprognostic (2.30e-1)"	"unprognostic (1.06e-2)"	"unprognostic (2.72e-2)"	"unprognostic (2.84e-2)"	"unprognostic (5.72e-2)"	"unprognostic (5.43e-2)"	"unprognostic (9.01e-2)"	"unprognostic (9.94e-2)"	"unprognostic (1.72e-1)"	"unprognostic (8.71e-3)"	"prognostic unfavorable (5.73e-4)"	"unprognostic (2.13e-1)"	"unprognostic (7.54e-2)"	"unprognostic (6.70e-2)"	"unprognostic (4.58e-2)"	"unprognostic (3.70e-3)"	"prognostic unfavorable (2.81e-5)"	53.9	37.0	24.0	25.6	25.0	34.8	33.9	21.8	28.7	30.8	22.7	38.4	22.3	36.1	30.1	45.0	34.4	32.2	35.1	27.7	25.3	27.2	24.5	33.4	27.5	22.1	24.6	48.1	29.2	30.9	20.6	43.3	24.6	25.3	30.3	14.2	32.1	30.5	44.9	31.0	27.6	38.7	21.7	21.4	25.5	15.8	30.7	37.0	39.3	41.8	25.4	35.8	29.3	19.4	92.9	57.8	19.5	19.8	62.2	72.6	55.3	47.5	48.9	36.7	40.6	29.7	106.1	27.5	52.2	86.2	66.6	46.0	27.8	50.2	35.1	31.5	28.3	26.2	44.0	32.2	64.1	95.0	55.8	53.4	51.8	41.8	55.2	73.1	44.8	81.9	56.4	97.8	61.9	71.7	96.0	66.7	29.2	53.9	56.7	82.4	37.0	38.8	58.6	38.4	46.8	30.2	151.6	109.7	66.7	43.4	37.7	96.3	69.3	40.3	18.8	178.7	60.5	68.6	17.3	27.5	102.4	93.8	121.5	1.7	1.4	1.2	6.1	1.8	3.4	1.1	5.1	4.3	2.8	0.6	4.6	5.5	0.9	5.4	1.2	1.8	4.2	2.3	24.0	25.0	21.8	28.7	27.7	25.3	22.1	24.6	24.6	21.7	30.7	19.4	65.7	38.5	32.4	55.5	18.1	46.1	12.9	22.6	19.4	15.0	32.6	21.6	30.8	21.5	33.7	47.8	16.7	31.6	54.0	41.0	3.9	15.3	18.0	60.6	17.8	48.5	21.1	17.7	137.1	20.0	26.1	44.2	15.8	47.0	12.6	36.8	23.2	20.9	20.2	13.5	119.3	31.2	24.4	20.2	83.6	5.3	35.1	27.7	51.6	185.5	21.9	12.1	43.3	67.3	61.4	29.9	14.1	54.5	36.2	23.2	28.0	8.7	61.8	10.8	32.9	42.6	60.4	10.6	10.2	22.0	51.7	40.8	43.4	19.5	26.0	25.8
ETAA1	ETAA16	ENSG00000143971	"ETAA1 activator of ATR kinase"	Q9NY74	2	67397322-67412089	"Predicted intracellular proteins"	"DNA damage, DNA repair"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035048, HPA035049"	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 51: Non-specific - Unknown function"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm	Cytosol	"HPA035048: AB_10670300, HPA035049: AB_2674430"	"unprognostic (1.23e-1)"	"unprognostic (2.56e-1)"	"unprognostic (5.79e-2)"	"unprognostic (2.10e-1)"	"unprognostic (1.30e-1)"	"unprognostic (3.39e-2)"	"unprognostic (6.47e-2)"	"unprognostic (5.53e-2)"	"unprognostic (1.12e-2)"	"unprognostic (8.33e-2)"	"unprognostic (9.89e-2)"	"unprognostic (1.87e-1)"	"unprognostic (8.52e-3)"	"unprognostic (9.85e-2)"	"unprognostic (7.88e-2)"	"unprognostic (5.01e-2)"	"unprognostic (1.14e-2)"	4.7	11.1	2.7	4.3	3.1	3.9	7.1	4.0	3.3	6.7	3.9	5.0	3.6	6.9	6.2	5.9	6.6	4.3	3.9	2.4	2.7	6.1	5.3	5.4	6.5	2.9	2.8	7.3	8.2	6.1	3.3	4.2	2.9	5.0	4.4	5.7	6.2	3.9	3.5	6.2	5.5	5.1	2.7	5.5	5.2	4.6	2.8	6.3	6.3	3.1	5.0	5.1	6.6	3.5	7.9	5.9	10.2	9.0	7.6	10.4	8.0	8.2	10.8	8.7	8.3	4.8	9.3	14.8	4.4	6.8	12.1	9.5	8.9	10.0	12.3	8.6	6.8	8.1	14.7	7.1	7.2	8.3	7.4	8.3	13.8	6.4	9.7	13.7	13.8	11.8	6.8	6.1	12.0	3.5	12.3	9.0	10.3	12.7	6.3	8.6	16.0	6.8	10.5	5.1	8.5	16.7	8.4	7.6	8.0	9.9	6.6	4.0	9.6	11.6	8.9	5.6	9.8	6.8	6.5	11.6	10.9	8.6	9.0	1.3	1.1	0.9	2.2	1.8	2.4	3.5	2.0	1.3	1.4	3.6	2.7	2.4	0.1	2.0	2.6	2.0	3.2	1.3	2.7	3.1	4.0	3.3	2.4	2.7	2.9	2.8	2.9	2.7	2.8	3.5	7.7	22.4	21.0	10.4	7.6	2.4	7.9	8.3	6.8	5.1	8.8	8.4	10.1	15.7	9.1	12.9	0.0	6.6	9.1	3.5	11.7	17.8	0.6	15.0	15.0	7.8	10.7	13.7	6.3	18.4	6.3	10.9	6.6	11.1	6.3	15.4	10.4	8.9	4.8	5.0	6.6	7.1	2.0	5.1	1.5	1.9	12.2	4.8	1.8	2.8	9.4	6.5	15.5	15.1	13.6	20.4	4.7	13.2	7.0	8.0	5.9	15.0	16.6	4.6	0.0	8.9	7.3	12.7	8.2	7.9	2.6	2.1	7.2	14.1	7.0	6.1
ETV4	"E1A-F, E1AF, PEA3"	ENSG00000175832	"ETS variant transcription factor 4"	P43268	17	43527844-43579620	"Cancer-related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 23.3;Cholangiocytes: 17.2;Distal tubular cells: 17.6;Enteroendocrine cells: 14.9;Extravillous trophoblasts: 19.8;Syncytiotrophoblasts: 14.9"	"Cancer enhanced"	"Detected in all"		"testis cancer: 80.8"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 177.7;Hep G2: 173.0;SK-MEL-30: 197.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA005768	Approved		Supported	"Nucleoli rim,Mitotic chromosome"		Yes	No				"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 38: Extravillous trophoblasts - Unknown function"	"Nucleoli rim"	"Mitotic chromosome"	"HPA005768: AB_1848294"	"unprognostic (2.32e-1)"	"unprognostic (7.33e-2)"	"unprognostic (2.14e-1)"	"unprognostic (2.51e-1)"	"unprognostic (1.97e-2)"	"unprognostic (3.14e-3)"	"prognostic unfavorable (2.48e-4)"	"unprognostic (1.58e-2)"	"unprognostic (5.34e-2)"	"unprognostic (8.13e-2)"	"unprognostic (7.05e-2)"	"unprognostic (3.01e-1)"	"unprognostic (7.79e-2)"	"unprognostic (2.03e-1)"	"unprognostic (7.08e-2)"	"prognostic favorable (7.60e-4)"	"unprognostic (1.69e-1)"	0.5	2.4	1.2	1.0	1.6	0.0	7.0	0.8	2.2	3.6	0.0	2.0	6.1	2.4	1.0	9.2	2.5	6.4	3.1	1.3	0.8	5.4	1.2	2.2	0.6	1.0	0.9	0.4	7.8	7.9	14.7	5.2	1.4	4.5	1.7	3.0	4.6	3.6	1.3	6.4	4.2	1.4	0.3	0.4	3.8	1.2	0.7	0.3	6.9	2.5	4.8	2.1	5.3	0.9	24.5	67.0	80.4	177.7	3.1	20.1	17.9	7.9	21.1	14.9	15.2	38.1	33.9	0.1	4.3	4.1	36.6	43.6	2.7	40.2	13.2	0.8	0.5	2.3	10.7	173.0	4.3	47.0	20.9	3.6	1.4	56.8	35.0	16.8	32.1	0.3	48.9	0.1	31.0	9.8	0.2	82.9	116.9	123.1	110.9	99.8	9.8	58.9	33.0	17.3	0.1	71.4	2.1	4.5	197.0	43.8	0.8	13.9	15.1	10.6	52.0	15.7	22.1	7.3	47.8	0.1	18.9	8.9	63.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.2	1.6	0.8	2.2	1.3	0.8	1.0	0.9	1.4	0.3	0.7	0.9	0.2	0.0	0.0	1.3	0.0	1.9	2.5	3.6	23.3	3.2	10.4	12.3	1.1	17.2	2.4	0.0	0.0	2.3	0.1	1.1	17.6	6.5	3.1	0.7	0.3	1.5	14.9	0.0	1.6	1.0	19.8	1.9	3.1	1.6	0.0	0.2	0.7	0.0	0.8	0.0	1.0	4.0	2.0	0.3	0.3	6.0	0.3	0.2	3.6	1.0	0.0	10.9	0.0	1.0	0.0	3.7	3.3	0.4	0.0	0.9	1.9	0.1	1.0	0.3	0.0	2.1	1.7	0.0	1.3	3.6	1.1	14.9	0.3	0.1	7.7	4.3
ETV7	"TEL-2, TEL2"	ENSG00000010030	"ETS variant transcription factor 7"	Q9Y603	6	36354091-36387800	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 16.0;skin 1: 15.4"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 19.2;Cytotrophoblasts: 28.8;Exocrine glandular cells: 23.8;Proximal enterocytes: 21.5;Spermatogonia: 26.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 18.9;T-reg: 16.3"	"Group enriched"	"Detected in many"	4	"granulocytes: 18.9;monocytes: 5.7;T-cells: 16.3"	"Cell line enhanced"	"Detected in some"		"BEWO: 27.1;BJ hTERT+ SV40 Large T+: 14.7;BJ hTERT+ SV40 Large T+ RasG12V: 27.8;HDLM-2: 59.7"					"Low region specificity"	"Detected in all"			HPA029033	Uncertain		Supported	Nucleoplasm		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 31: Skin - Epidermis development"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 47: Cytotrophoblasts - Unknown function"	Nucleoplasm		"HPA029033: AB_10601375"	"unprognostic (1.67e-2)"	"prognostic favorable (5.16e-4)"	"unprognostic (9.48e-2)"	"unprognostic (1.57e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.62e-3)"	"unprognostic (9.08e-2)"	"unprognostic (4.11e-2)"	"unprognostic (2.08e-2)"	"prognostic favorable (5.32e-4)"	"unprognostic (6.81e-3)"	"unprognostic (1.11e-1)"	"unprognostic (1.69e-3)"	"unprognostic (5.54e-2)"	"unprognostic (4.93e-1)"	"unprognostic (1.27e-2)"	"prognostic favorable (2.95e-6)"	1.9	2.1	1.5	6.9	1.5	0.9	2.1	1.0	1.7	2.1	1.4	3.3	16.0	1.0	1.3	3.6	2.2	3.4	0.4	1.5	1.4	2.3	2.9	4.9	5.3	2.2	1.2	1.5	1.6	2.2	3.8	3.6	2.1	2.9	2.6	0.4	8.6	1.5	0.2	15.4	12.7	1.0	2.1	3.1	6.2	1.1	1.4	4.0	1.2	0.3	3.9	5.5	2.5	1.4	3.2	0.0	0.2	0.1	0.0	0.2	27.1	0.0	9.2	14.7	27.8	0.5	6.2	0.1	0.7	0.2	2.3	3.3	0.4	1.7	0.7	59.7	0.5	0.5	0.0	0.0	1.8	0.0	0.3	1.2	2.4	0.7	0.2	0.0	0.4	0.0	0.1	0.2	0.3	0.1	0.2	0.3	0.2	0.3	0.1	6.1	0.1	0.2	0.2	1.1	0.8	0.0	0.6	2.1	0.5	0.0	3.1	0.6	0.2	0.3	0.7	0.3	0.1	0.1	0.1	0.2	0.0	2.7	0.4	0.0	3.7	0.3	1.6	5.7	3.9	3.3	5.4	2.2	0.9	2.4	1.0	1.4	18.9	0.6	1.9	0.0	16.3	2.5	1.5	1.5	1.0	1.7	1.5	1.4	2.2	1.2	2.1	2.1	1.4	1.4	1.4	19.2	14.8	0.3	1.2	2.0	2.2	8.0	6.2	0.2	2.5	2.7	0.5	7.2	7.1	0.0	0.0	28.8	0.7	6.6	0.0	12.4	0.4	0.4	1.4	1.1	3.6	0.0	0.5	23.8	6.6	2.7	8.2	0.7	2.5	1.7	0.0	0.4	2.9	0.0	0.3	6.5	6.1	1.3	1.6	0.5	1.5	1.0	3.6	0.0	6.5	3.1	1.0	0.0	0.3	13.4	7.8	1.2	5.6	4.8	21.5	1.3	3.0	0.6	0.0	1.0	5.5	0.9	26.8	6.4	3.7	8.5	3.6	0.7	7.6	4.8
EVA1A	"FAM176A, FLJ13391, TMEM166"	ENSG00000115363	"Eva-1 homolog A, regulator of programmed cell death"	Q9H8M9	2	75469302-75569722	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Apoptosis, Autophagy"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"liver: 191.6"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 41.7;Cytotrophoblasts: 43.3;Hepatocytes: 78.1;Proximal tubular cells: 77.3;Syncytiotrophoblasts: 124.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 85.7;U-138 MG: 110.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008055	Approved		Supported	"Vesicles,Plasma membrane"		NA	Yes				"Cluster 85: Liver - Metabolism"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Vesicles	"Plasma membrane"	"HPA008055: AB_1080308"	"unprognostic (2.72e-1)"	"unprognostic (2.61e-2)"	"unprognostic (4.14e-3)"	"unprognostic (1.01e-1)"	"unprognostic (1.36e-2)"	"unprognostic (3.60e-2)"	"unprognostic (5.02e-2)"	"unprognostic (1.77e-2)"	"unprognostic (1.77e-1)"	"prognostic favorable (5.67e-4)"	"unprognostic (7.33e-2)"	"unprognostic (1.22e-1)"	"prognostic favorable (5.80e-4)"	"unprognostic (8.19e-2)"	"unprognostic (4.37e-2)"	"unprognostic (2.43e-2)"	"unprognostic (9.07e-2)"	1.1	0.5	0.2	1.1	0.9	0.1	3.4	0.6	0.5	9.8	0.2	0.7	1.7	2.8	9.6	0.4	3.7	1.2	1.6	0.2	0.3	20.0	191.6	20.7	0.4	1.1	0.5	0.5	23.8	7.6	1.1	17.3	0.9	0.9	0.7	0.5	8.9	2.2	1.2	2.7	1.8	2.0	0.7	10.8	0.6	2.9	0.8	5.1	1.8	1.6	0.3	0.8	0.8	0.8	1.0	14.5	1.5	0.4	3.1	21.2	1.4	68.0	45.3	59.2	30.1	0.5	1.2	0.1	6.3	85.7	54.2	9.4	1.7	14.4	36.8	0.0	1.1	0.0	2.5	45.7	2.2	0.0	0.1	15.0	8.3	73.2	33.3	59.0	37.2	0.0	0.0	0.0	46.1	0.0	0.1	0.0	3.3	0.2	23.5	7.9	0.1	0.0	32.5	0.5	0.9	1.6	6.2	0.4	53.7	2.2	0.2	0.3	31.0	110.3	46.3	2.0	71.9	0.7	0.1	0.3	62.5	0.0	59.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.9	0.6	0.5	0.2	0.3	1.1	0.5	0.9	0.7	0.8	0.8	6.1	41.7	35.4	1.0	0.9	2.8	13.7	14.3	3.4	1.2	11.7	12.3	0.3	1.5	23.0	11.0	0.0	43.3	0.4	0.1	27.4	30.5	12.2	13.3	1.4	4.8	1.8	0.0	1.1	16.1	25.9	4.7	0.0	11.4	0.0	0.0	2.2	78.1	3.5	0.0	0.9	1.1	4.1	0.8	1.2	9.4	0.3	0.6	28.4	2.8	0.1	0.0	0.0	1.5	0.9	9.7	0.0	0.7	0.0	12.3	0.5	77.3	1.7	0.1	0.0	2.2	9.0	2.2	0.9	1.1	0.9	124.8	1.1	0.0	1.6	10.5
EVPL	EVPK	ENSG00000167880	Envoplakin	Q92817	17	76004502-76027306	"Predicted intracellular proteins"	Keratinization			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 281.2;skin 1: 147.4;vagina: 101.9"	"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 26.7;Squamous epithelial cells: 94.1;Suprabasal keratinocytes: 25.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HaCaT: 59.8;MCF7: 40.4;RT4: 87.8;SK-BR-3: 43.2;T-47d: 54.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB002220, HPA053969"	Enhanced		Supported	"Intermediate filaments,Cytosol"		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 15: RT4 - Unknown function"	"Cluster 61: Squamous epithelial cells - Keratinization"	"Intermediate filaments"	Cytosol	"CAB002220: AB_563701, HPA053969: AB_2682326"	"unprognostic (2.10e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.41e-1)"	"unprognostic (4.21e-1)"	"unprognostic (1.05e-2)"	"unprognostic (1.87e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.44e-1)"	"unprognostic (7.40e-3)"	"unprognostic (2.64e-1)"	"unprognostic (2.40e-2)"	"unprognostic (2.31e-1)"	"unprognostic (3.47e-1)"	"unprognostic (7.93e-2)"	"unprognostic (3.09e-2)"	1.3	0.3	0.6	1.0	0.6	2.5	2.6	1.1	1.0	47.5	0.8	8.9	11.0	1.5	1.7	281.2	2.1	1.7	0.2	0.6	0.3	17.0	0.3	9.4	0.6	2.8	1.3	0.3	4.0	3.4	1.5	0.3	2.8	8.0	1.5	0.6	42.3	1.8	1.4	147.4	9.1	1.0	0.5	0.3	5.2	0.8	0.6	0.4	10.7	0.1	7.9	12.7	101.9	1.5	28.1	23.4	0.0	0.3	0.2	0.0	9.6	0.2	0.0	0.0	0.0	2.6	16.7	0.0	0.1	0.0	0.0	59.8	0.1	7.8	0.1	0.1	0.2	0.7	19.4	17.4	0.0	0.2	4.2	0.2	12.3	0.2	0.0	0.0	0.0	3.7	0.1	1.1	0.0	40.4	1.0	3.6	0.1	11.9	10.5	11.5	0.1	0.4	16.7	87.8	1.1	0.0	11.4	43.2	0.0	0.2	54.1	0.8	0.0	0.0	0.1	0.2	0.1	0.1	0.2	0.1	0.1	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.3	0.0	0.2	0.1	0.0	0.6	0.6	1.1	1.0	0.6	0.3	2.8	1.3	2.8	0.5	0.6	1.5	0.2	19.2	19.5	0.0	0.0	11.7	4.7	10.5	26.7	0.3	5.1	2.9	3.7	4.3	16.5	5.5	0.0	0.2	0.2	10.8	1.9	4.4	0.0	4.3	0.6	0.3	20.4	1.3	0.3	0.5	0.2	0.5	12.8	8.9	12.6	0.2	0.0	0.0	0.0	0.0	0.1	5.7	2.0	0.6	2.1	0.1	0.9	0.2	1.8	0.0	0.1	0.0	0.0	0.0	0.1	8.4	7.4	1.9	1.2	4.6	19.3	3.4	13.1	0.1	0.0	0.7	0.7	0.1	1.2	94.1	25.9	0.0	0.4	0.4	15.5	12.9
EXD2	"C14orf114, EXDL2, FLJ10738"	ENSG00000081177	"Exonuclease 3'-5' domain containing 2"	Q9NVH0	14	69191511-69244020	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"DNA damage, DNA repair"	"Exonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Spermatocytes: 36.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002906, HPA005848"	Uncertain		Approved	"Intermediate filaments,Mitochondria"		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 6: T47d - Mammary gland"	"Cluster 66: Spermatocytes - Spermatogenesis"	Mitochondria	"Intermediate filaments"	"HPA002906: AB_1078767, HPA005848: AB_1078768"	"unprognostic (3.36e-2)"	"unprognostic (1.61e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.63e-1)"	"unprognostic (2.85e-1)"	"prognostic unfavorable (8.47e-4)"	"unprognostic (9.91e-2)"	"unprognostic (8.03e-2)"	"unprognostic (2.46e-1)"	"unprognostic (4.64e-2)"	"unprognostic (8.97e-2)"	"prognostic favorable (2.08e-9)"	"unprognostic (1.16e-1)"	"unprognostic (3.06e-2)"	"unprognostic (8.75e-2)"	"unprognostic (2.14e-2)"	8.0	6.9	16.0	5.0	17.2	2.5	9.7	16.7	18.8	13.6	15.0	9.5	6.8	9.6	12.1	10.4	13.1	8.1	8.7	15.8	15.7	10.4	5.9	8.6	4.2	17.3	16.4	11.0	18.1	16.0	10.0	7.5	17.4	10.2	9.2	13.0	15.4	10.5	11.0	6.6	6.5	10.1	17.1	5.8	9.7	19.9	16.2	7.2	11.5	9.7	4.5	8.4	7.4	18.9	29.6	13.6	10.3	15.3	6.2	7.4	13.0	14.4	12.1	13.1	17.3	11.6	20.3	0.0	10.4	15.1	8.0	16.4	11.5	14.5	14.7	7.4	13.7	8.6	5.2	6.8	24.2	6.4	7.9	15.1	23.5	13.4	8.7	8.1	18.9	7.4	5.5	11.0	12.7	14.8	3.6	9.6	11.2	15.8	13.5	0.0	9.9	10.4	19.5	10.8	20.0	17.8	10.8	22.2	10.6	11.0	29.8	5.5	15.0	12.2	8.5	9.9	7.5	8.3	12.0	0.1	0.1	6.9	9.3	12.2	2.5	2.2	2.2	1.4	4.2	2.9	2.3	2.3	5.4	1.5	2.8	4.1	0.3	2.9	1.4	4.2	1.8	2.3	16.0	17.2	16.7	18.8	15.8	15.7	17.3	16.4	17.4	17.1	16.2	18.9	7.2	12.8	10.9	15.7	4.3	3.2	4.9	6.2	14.2	9.9	9.9	7.2	12.1	7.2	9.0	0.0	8.4	8.5	2.5	4.7	5.9	10.7	3.2	7.7	8.4	6.0	6.1	7.8	27.4	8.8	4.4	6.5	8.2	11.1	1.3	9.6	10.8	5.4	6.8	10.1	22.6	8.4	8.2	6.3	2.2	2.3	6.2	3.3	3.6	11.2	6.8	7.5	2.1	21.6	19.1	8.8	6.2	12.0	5.6	5.6	3.6	4.8	11.0	9.3	0.0	7.2	7.4	36.1	8.1	12.6	4.3	2.9	2.6	6.1	7.9	4.3
EXO5	"C1orf176, DEM1, FLJ21144"	ENSG00000164002	"Exonuclease 5"	Q9H790	1	40508741-40516556	"Predicted intracellular proteins"	"DNA damage, DNA repair"	"DNA-binding, Exonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"THP-1: 150.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028429			Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	Cytosol	"HPA028429: AB_2092105"	"unprognostic (9.44e-2)"	"unprognostic (7.36e-2)"	"unprognostic (3.69e-2)"	"unprognostic (6.65e-2)"	"unprognostic (1.66e-1)"	"unprognostic (3.23e-2)"	"prognostic unfavorable (9.16e-6)"	"unprognostic (4.65e-2)"	"unprognostic (2.24e-3)"	"unprognostic (1.91e-3)"	"unprognostic (4.78e-2)"	"prognostic unfavorable (2.93e-4)"	"unprognostic (9.95e-3)"	"unprognostic (4.36e-2)"	"unprognostic (4.13e-1)"	"unprognostic (9.85e-3)"	"unprognostic (2.53e-1)"	4.7	4.5	2.2	5.7	3.3	4.7	5.5	3.8	2.8	4.9	2.3	5.0	4.4	6.1	5.2	4.4	5.1	4.2	4.0	2.5	2.2	5.0	6.4	5.3	8.4	1.9	2.1	4.4	4.2	4.1	3.4	5.1	1.9	5.3	5.0	4.5	4.6	5.5	4.2	5.2	5.5	7.6	2.0	7.0	4.1	3.9	3.1	10.8	4.4	2.4	10.9	4.8	4.1	2.4	14.6	5.2	12.5	21.0	8.3	7.5	8.7	19.4	4.9	17.1	20.5	9.3	17.3	19.6	11.7	12.4	19.4	17.8	12.3	12.9	20.4	6.6	8.0	17.1	24.8	13.0	10.2	0.1	16.4	7.8	8.0	23.6	8.7	5.0	10.9	13.7	20.0	0.1	24.6	6.1	27.4	13.4	19.0	2.4	2.0	20.7	42.6	7.7	8.6	22.3	15.1	13.4	25.0	8.9	15.9	19.1	12.5	150.1	12.3	11.7	35.1	26.5	19.1	5.6	18.7	0.1	1.7	5.3	23.8	8.8	5.9	15.0	12.6	8.7	10.4	10.8	8.7	9.1	7.0	8.4	10.5	10.2	10.5	8.1	6.6	5.8	12.9	6.5	2.2	3.3	3.8	2.8	2.5	2.2	1.9	2.1	1.9	2.0	3.1	2.4	2.4	0.0	1.7	1.6	3.4	0.9	0.9	5.0	1.8	3.3	2.2	2.7	1.1	7.2	3.1	7.3	4.2	5.0	5.3	2.3	0.0	4.8	1.2	1.0	2.4	3.2	1.2	3.0	3.1	2.4	4.6	2.6	1.1	1.5	5.7	5.8	2.2	3.6	5.2	3.3	2.1	2.2	4.1	2.5	2.4	1.3	3.4	2.0	1.8	3.7	4.8	4.8	4.1	1.5	1.9	2.9	1.9	1.9	3.1	1.0	2.4	2.3	2.5	2.9	6.6	3.2	2.9	6.1	6.3	1.9	1.0	1.9	2.9	3.1	3.0	0.3
EXOC6	"DKFZp761I2124, EXOC6A, FLJ1125, MGC33397, SEC15L, SEC15L1, Sec15p"	ENSG00000138190	"Exocyst complex component 6"	Q8TAG9	10	92826831-93059493	"Plasma proteins, Predicted intracellular proteins, Transporters"	"Exocytosis, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"retina: 164.2"	"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 181.7;Microglial cells: 146.1;Oligodendrocyte precursor cells: 157.3;Rod photoreceptor cells: 177.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 30.6"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 113.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036285, HPA059111"	Approved		Supported	Nucleoplasm,Vesicles		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 77: Retina - Visual perception"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 46: Photoreceptor cells - Phototransduction"	Vesicles	Nucleoplasm	"HPA036285: AB_10673617, HPA059111: AB_2683907"	"unprognostic (1.41e-1)"	"unprognostic (1.39e-3)"	"unprognostic (5.20e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.16e-3)"	"unprognostic (7.21e-3)"	"unprognostic (3.84e-1)"	"unprognostic (2.70e-1)"	"unprognostic (1.66e-1)"	"unprognostic (8.13e-2)"	"prognostic favorable (4.66e-4)"	"unprognostic (2.12e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.42e-1)"	"unprognostic (6.41e-2)"	8.7	14.4	5.9	8.2	7.5	12.9	8.0	7.7	8.6	6.5	8.0	9.6	8.1	6.1	5.7	4.2	5.8	10.1	7.1	8.2	6.0	6.4	10.1	10.7	9.5	3.4	2.4	3.9	10.0	6.3	6.1	37.4	3.7	8.6	10.2	164.2	5.6	4.3	31.8	5.0	9.5	7.7	3.3	9.1	7.0	9.9	6.1	8.5	28.4	19.7	8.2	10.1	3.5	7.1	19.8	24.3	25.7	16.8	1.3	1.6	9.1	9.0	24.9	8.1	9.7	9.1	16.5	22.5	19.0	4.3	6.6	12.3	20.8	5.7	10.1	20.1	20.9	35.1	8.3	11.7	9.6	36.4	30.6	2.2	3.0	7.2	4.8	14.6	113.8	14.6	29.2	14.5	4.0	10.7	15.3	23.2	3.5	40.2	7.0	22.5	11.2	11.6	17.4	13.2	8.5	11.9	9.2	9.2	11.8	6.4	18.2	18.8	22.4	0.6	8.2	7.5	14.7	10.8	12.4	18.1	2.8	41.6	9.3	6.2	4.9	15.2	3.0	3.9	3.0	6.7	3.4	2.8	5.1	6.6	2.7	3.2	30.6	2.8	3.9	11.1	3.3	2.4	5.9	7.5	7.7	8.6	8.2	6.0	3.4	2.4	3.7	3.3	6.1	7.1	28.3	16.0	16.7	33.6	27.6	3.3	10.7	8.6	3.4	40.2	9.8	6.5	12.0	20.0	15.0	16.5	39.6	22.9	24.1	14.3	5.9	28.3	5.4	8.8	3.0	53.1	25.6	39.2	181.7	15.4	7.8	7.8	13.7	16.5	10.8	24.3	77.1	14.2	21.4	23.5	100.3	16.6	14.2	18.2	12.5	12.6	4.4	18.9	5.4	146.1	22.8	27.1	19.6	157.3	84.7	14.1	10.3	14.7	13.8	14.1	10.8	8.4	10.0	177.8	13.1	13.6	9.0	25.0	25.5	4.9	4.8	20.5	18.4	29.8	11.9	15.8
EXOG	"ENDOGL1, ENDOGL2, ENGL, ENGL-a, ENGL-b"	ENSG00000157036	"Exo/endonuclease G"	Q9Y2C4	3	38496127-38542161	"Predicted intracellular proteins"		"Endonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"NK-cells: 59.8;Rod photoreceptor cells: 78.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012531, HPA071050"	Enhanced		Supported	Mitochondria	"Intracellular and membrane"	NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 52: Non-specific - Transcription"	Mitochondria		"HPA012531: AB_2732403, HPA071050: "	"unprognostic (2.88e-1)"	"unprognostic (5.81e-3)"	"unprognostic (3.55e-3)"	"unprognostic (2.77e-1)"	"unprognostic (8.32e-3)"	"unprognostic (8.90e-3)"	"unprognostic (4.78e-4)"	"unprognostic (3.59e-2)"	"unprognostic (3.99e-2)"	"unprognostic (3.10e-2)"	"prognostic favorable (1.92e-5)"	"prognostic unfavorable (4.90e-4)"	"unprognostic (6.51e-2)"	"unprognostic (1.64e-2)"	"unprognostic (4.79e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.78e-2)"	3.9	5.1	5.5	4.0	5.4	3.9	3.4	7.9	7.0	5.2	3.4	4.9	2.0	4.7	3.5	2.6	3.8	3.5	12.9	5.9	5.1	3.7	3.4	3.8	6.0	5.1	5.7	3.9	3.9	3.3	5.6	2.9	4.5	4.8	3.2	5.3	3.2	3.6	3.2	1.9	4.4	4.5	4.1	5.5	3.6	3.9	5.9	5.0	4.5	3.2	4.7	4.4	3.5	6.4	4.3	7.6	8.7	7.6	5.7	8.4	3.5	13.9	8.7	11.6	12.9	6.8	4.3	15.1	3.5	5.5	3.3	4.3	11.0	4.7	9.8	17.5	10.2	11.4	12.7	7.6	7.0	12.7	9.5	6.4	5.2	10.3	5.4	5.5	16.2	8.6	5.2	9.9	18.2	2.9	8.6	4.2	8.3	3.7	9.8	5.8	4.6	6.7	6.0	5.5	4.0	2.0	8.5	2.1	3.8	3.9	2.9	6.1	13.3	9.5	7.2	10.8	11.2	5.7	10.3	13.3	7.4	10.9	7.1	0.9	10.0	4.5	26.6	9.8	23.8	60.3	25.8	26.4	7.2	47.1	25.9	25.2	0.6	27.8	11.6	14.4	12.9	5.5	5.5	5.4	7.9	7.0	5.9	5.1	5.1	5.7	4.5	4.1	5.9	6.4	9.8	6.4	4.5	15.3	24.9	2.9	6.5	13.4	8.0	49.9	4.4	3.7	33.0	7.2	5.8	11.0	56.3	12.3	23.8	5.4	0.0	8.5	3.7	3.2	9.7	12.9	16.9	13.7	23.5	5.3	2.1	10.8	4.6	3.6	1.3	14.0	9.7	5.7	7.0	40.4	29.1	7.5	10.2	8.3	6.2	3.7	27.1	6.0	12.4	15.0	16.0	13.0	59.8	31.7	23.5	6.4	7.4	17.7	19.1	5.5	4.3	4.0	8.0	78.3	13.1	11.6	9.5	36.5	28.0	4.6	1.0	1.9	22.9	14.0	9.7	6.3
EXOSC10	"p2, p3, p4, PM-Scl, PM/Scl-100, PMSCL2, RRP6, Rrp6p"	ENSG00000171824	"Exosome component 10"	Q01780	1	11066618-11099869	"Predicted intracellular proteins"	"Nonsense-mediated mRNA decay, rRNA processing"	"Exonuclease, Hydrolase, Nuclease, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028470, HPA028484, CAB037141"	Supported		Supported	"Nucleoplasm,Nucleoli,Nucleoli rim,Cytosol"		No	No			"Cluster 27: Non-specific - Gene expression"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	"Nucleoli, Nucleoli rim"	"Nucleoplasm, Cytosol"	"CAB037141: AB_532315, HPA028470: AB_10599180, HPA028484: AB_10611250"	"unprognostic (1.23e-2)"	"unprognostic (3.46e-2)"	"unprognostic (1.85e-2)"	"unprognostic (1.62e-1)"	"unprognostic (6.88e-2)"	"unprognostic (6.37e-2)"	"prognostic unfavorable (2.49e-6)"	"unprognostic (3.36e-1)"	"unprognostic (4.66e-2)"	"unprognostic (2.52e-1)"	"unprognostic (5.49e-2)"	"unprognostic (2.52e-2)"	"unprognostic (7.68e-3)"	"unprognostic (3.43e-1)"	"unprognostic (9.03e-2)"	"prognostic favorable (5.27e-4)"	"unprognostic (1.33e-1)"	31.8	21.4	18.3	25.9	18.4	39.4	30.8	23.1	22.2	32.5	14.7	27.6	20.7	28.7	23.9	27.3	26.4	19.2	20.3	17.7	15.9	21.8	20.0	24.3	31.1	17.2	15.2	35.8	24.0	25.2	26.1	26.1	16.6	25.3	27.6	35.4	25.4	21.0	33.3	37.0	26.1	27.5	13.7	27.4	26.1	23.4	17.9	32.7	23.3	22.6	34.2	24.6	28.4	19.1	66.4	41.5	84.9	33.0	44.3	48.7	48.5	63.8	46.8	109.8	99.1	61.6	94.1	66.3	40.3	61.0	48.8	64.2	95.0	71.2	100.1	74.9	95.0	96.5	80.5	63.2	43.4	79.5	73.7	38.4	60.2	108.1	63.1	40.9	69.4	58.0	103.2	59.3	61.4	37.4	78.5	73.1	56.5	50.3	49.1	79.8	72.2	58.1	64.8	33.3	54.5	53.3	68.8	58.9	77.0	59.4	51.5	72.1	63.6	58.2	60.4	53.0	76.2	35.7	60.0	130.0	59.4	116.2	71.5	57.7	32.0	26.6	36.2	41.5	43.0	36.4	37.7	36.7	37.9	36.5	31.9	35.4	6.2	49.3	51.2	19.3	39.4	43.3	18.3	18.4	23.1	22.2	17.7	15.9	17.2	15.2	16.6	13.7	17.9	19.1	18.4	28.9	18.3	17.0	26.1	13.3	14.3	19.8	26.2	14.9	11.0	23.6	6.4	12.8	29.2	5.5	47.9	26.5	18.8	16.4	9.8	25.0	16.4	14.3	21.0	20.1	9.0	28.0	20.3	31.9	34.3	17.2	31.1	19.2	20.2	26.2	13.9	11.1	24.7	21.9	24.3	16.5	22.4	15.1	14.1	7.1	29.5	18.7	12.4	9.4	24.0	6.1	28.8	30.2	15.2	30.2	9.4	23.0	26.8	8.5	12.7	8.8	27.3	34.8	13.1	18.4	17.6	21.9	20.8	28.7	13.4	22.7	21.2	19.7	20.1	10.0
EXOSC2	"hRrp4p, p7, RRP4, Rrp4p"	ENSG00000130713	"Exosome component 2"	Q13868	9	130693721-130704894	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"rRNA processing"	RNA-binding	"Deafness, Disease variant, Dwarfism, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021756, HPA021790"	Approved		Supported	Nucleoplasm,Nucleoli		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 52: Non-specific - Ribosome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Nucleoplasm, Nucleoli"		"HPA021756: AB_2670809, HPA021790: AB_1848320"	"unprognostic (8.19e-2)"	"unprognostic (1.93e-2)"	"unprognostic (1.09e-1)"	"prognostic unfavorable (4.36e-4)"	"unprognostic (1.22e-1)"	"unprognostic (1.95e-2)"	"prognostic unfavorable (1.39e-5)"	"unprognostic (8.33e-3)"	"unprognostic (4.82e-2)"	"unprognostic (1.48e-1)"	"unprognostic (8.55e-2)"	"unprognostic (1.20e-3)"	"unprognostic (4.73e-2)"	"unprognostic (6.57e-2)"	"unprognostic (3.01e-1)"	"unprognostic (5.05e-2)"	"unprognostic (1.41e-1)"	9.1	8.2	8.6	13.8	8.7	9.9	12.6	8.9	11.1	8.9	8.6	10.3	7.7	12.8	6.8	10.0	12.8	5.6	8.8	8.9	8.9	9.7	13.0	6.7	13.0	8.5	8.6	14.8	9.9	11.5	3.2	9.2	8.4	9.3	11.9	10.6	7.1	9.0	15.0	8.4	8.3	12.9	8.9	8.3	8.2	4.1	8.6	14.6	8.4	12.0	15.8	10.1	8.6	9.3	39.9	79.7	46.6	41.2	16.8	18.9	34.0	58.6	28.1	57.4	44.1	64.4	33.7	79.0	31.2	31.8	62.9	71.0	75.8	58.8	62.9	46.9	36.7	63.1	75.2	45.3	31.3	96.7	39.9	24.0	21.7	80.8	94.1	21.1	41.6	52.3	70.1	33.1	41.0	70.3	68.2	27.3	57.8	109.3	51.0	52.3	85.8	85.5	27.5	36.4	28.6	31.8	68.3	51.4	31.1	32.8	53.5	34.1	25.5	56.1	43.5	50.2	83.3	16.8	71.4	117.2	40.0	55.0	44.7	1.7	7.3	6.0	10.0	8.3	10.6	11.6	10.2	8.9	10.4	10.0	11.1	9.4	1.6	16.5	5.7	7.1	10.1	7.7	8.6	8.7	8.9	11.1	8.9	8.9	8.5	8.6	8.4	8.9	8.6	9.3	7.6	6.4	20.5	3.6	13.5	10.6	12.6	7.7	8.0	12.4	6.1	8.3	8.7	4.3	5.7	3.7	6.2	19.1	10.6	6.0	5.9	13.4	1.4	3.8	11.4	8.0	1.2	23.5	5.3	11.3	22.8	9.8	5.1	4.5	12.7	14.0	7.1	10.7	12.8	5.0	5.2	7.9	4.1	2.5	5.7	1.7	8.4	7.8	7.2	1.9	5.4	14.7	13.4	4.5	4.0	8.3	2.7	7.9	13.7	14.2	5.0	10.4	6.7	15.0	6.6	11.7	10.2	5.8	10.9	10.6	8.4	8.3	10.1	11.9	10.0	8.1
EXOSC3	"CGI-102, hRrp-40, hRrp40p, p10, RRP40, Rrp40p"	ENSG00000107371	"Exosome component 3"	Q9NQT5	9	37759234-37832117	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"rRNA processing"	RNA-binding	"Disease variant, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Spermatocytes: 132.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020485	Supported		Supported	Nucleoplasm		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm		"HPA020485: AB_10960685"	"unprognostic (7.07e-2)"	"unprognostic (4.51e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.13e-1)"	"unprognostic (3.69e-1)"	"unprognostic (4.95e-2)"	"prognostic unfavorable (7.01e-5)"	"unprognostic (3.06e-1)"	"prognostic unfavorable (7.39e-4)"	"unprognostic (1.71e-3)"	"unprognostic (5.38e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.20e-2)"	"unprognostic (9.25e-3)"	"unprognostic (2.07e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.04e-1)"	9.9	12.3	5.4	9.7	5.7	6.5	9.1	8.7	6.3	10.4	5.6	9.1	7.2	9.7	4.3	14.4	8.8	4.1	7.8	5.4	5.4	10.5	10.1	7.5	11.1	4.9	5.4	10.3	7.9	6.9	8.5	6.6	5.0	9.4	6.2	5.2	9.3	6.5	11.4	8.2	8.9	5.1	5.7	10.8	8.9	21.6	5.5	12.9	8.4	5.3	11.8	10.2	11.5	7.1	69.2	46.8	25.1	32.5	16.5	13.4	33.7	38.5	15.0	31.7	29.6	63.0	11.1	52.3	29.0	14.3	36.2	26.2	28.3	27.3	35.7	75.1	46.9	43.4	57.5	59.3	19.4	66.7	38.5	9.1	13.5	24.0	15.2	10.2	17.0	38.1	108.7	24.7	22.8	40.9	59.3	53.1	69.6	61.7	53.9	53.9	31.2	29.2	17.9	22.0	36.8	36.4	21.9	18.0	26.3	19.8	23.7	48.0	19.7	25.4	47.1	32.0	62.2	16.5	45.4	70.7	25.7	51.2	28.9	34.1	44.4	36.8	35.6	53.9	45.7	53.1	42.9	47.8	42.4	49.1	43.0	41.3	27.8	40.2	49.3	50.4	51.2	55.6	5.4	5.7	8.7	6.3	5.4	5.4	4.9	5.4	5.0	5.7	5.5	7.1	14.7	22.4	19.9	3.3	25.8	54.2	32.7	47.2	8.6	7.4	17.1	19.3	7.8	22.8	24.0	7.3	0.0	58.0	22.6	13.5	33.2	40.6	74.3	19.2	20.1	14.6	10.7	29.5	4.3	34.9	76.7	20.9	8.6	13.2	29.2	23.7	12.8	13.1	45.4	6.7	4.1	14.9	22.4	19.9	17.9	16.4	16.8	17.6	19.6	1.9	26.3	11.2	20.6	2.5	5.9	34.9	17.7	13.2	19.9	27.6	15.7	32.7	21.9	7.5	26.3	17.6	30.6	132.4	53.1	20.0	54.1	31.5	19.6	28.9	20.2	27.2
EXOSC4	"FLJ20591, hRrp41p, p12A, RRP41, RRP41A, Rrp41p, SKI6, Ski6p"	ENSG00000178896	"Exosome component 4"	Q9NPD3	8	144078648-144080648	"Plasma proteins, Predicted intracellular proteins"	"rRNA processing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 94.9"	"Group enriched"	"Detected in many"	4	"Early spermatids: 320.6;Late spermatids: 856.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"PC-3: 430.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024792, HPA065103"	Approved		Supported	Nucleoplasm,Vesicles,Cytosol		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 71: Testis - DNA repair"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 31: Spermatids - Spermatogenesis"	"Nucleoplasm, Cytosol"	Vesicles	"HPA024792: AB_1848325, HPA065103: "	"unprognostic (2.32e-1)"	"unprognostic (1.55e-2)"	"unprognostic (3.06e-1)"	"unprognostic (3.53e-2)"	"unprognostic (1.33e-1)"	"unprognostic (2.29e-2)"	"unprognostic (6.58e-3)"	"unprognostic (1.26e-1)"	"unprognostic (8.36e-2)"	"prognostic favorable (2.23e-4)"	"unprognostic (4.32e-2)"	"unprognostic (1.41e-1)"	"unprognostic (2.30e-2)"	"unprognostic (5.18e-2)"	"unprognostic (1.23e-1)"	"unprognostic (2.71e-1)"	"unprognostic (5.11e-2)"	19.3	31.2	15.1	11.4	16.5	14.9	16.9	16.0	23.4	13.1	16.1	18.8	15.4	17.0	5.0	27.5	16.1	7.2	23.7	15.6	15.0	23.6	35.0	16.0	12.1	16.8	14.9	12.3	18.8	10.3	17.6	9.2	15.5	18.8	5.7	3.5	26.6	12.5	21.2	22.1	15.2	6.1	15.4	23.8	24.0	94.9	15.8	10.1	13.9	8.2	6.6	17.4	15.2	15.9	51.8	104.8	18.1	44.2	15.6	11.7	51.8	39.9	15.2	28.9	28.9	73.4	33.4	28.9	54.6	15.5	21.0	40.4	33.8	40.5	8.3	42.5	117.8	42.7	77.9	83.3	25.9	31.4	48.6	16.9	40.9	33.2	26.2	11.4	14.8	32.0	68.8	19.8	23.8	177.8	51.4	62.0	47.6	51.2	430.6	21.7	30.2	74.8	27.7	48.3	57.6	75.4	46.6	59.7	95.4	9.3	68.1	49.0	15.2	29.9	66.3	73.6	68.1	52.4	67.8	37.5	43.1	50.8	47.7	61.5	78.3	34.1	37.4	76.6	38.7	59.7	29.3	37.4	75.0	60.2	37.7	36.2	22.9	45.6	43.0	97.4	36.1	49.5	15.1	16.5	16.0	23.4	15.6	15.0	16.8	14.9	15.5	15.4	15.8	15.9	16.3	9.6	21.3	2.9	17.8	94.4	45.2	58.6	45.5	10.0	40.7	41.4	22.3	24.3	31.9	27.6	8.4	48.2	17.2	46.6	123.3	50.6	320.6	23.8	28.3	25.5	25.9	24.6	3.2	46.3	44.2	24.7	25.0	18.8	14.0	21.0	19.2	54.9	44.7	6.7	3.3	35.6	48.8	29.8	40.7	856.7	18.6	29.9	35.6	0.0	45.7	23.5	14.4	3.0	3.6	61.7	52.4	21.1	32.5	55.5	41.0	102.5	31.7	8.2	13.1	14.7	43.5	97.0	34.7	48.1	87.9	48.2	12.8	37.8	47.1	48.7
EXOSC7	"EAP1, hRrp42p, KIAA0116, p8, RRP42, Rrp42p"	ENSG00000075914	"Exosome component 7"	Q15024	3	44975241-45036066	"Predicted intracellular proteins"	"rRNA processing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036182, HPA057980"	Approved		Supported	"Nuclear speckles"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 59: Non-specific - Translation"	"Cluster 24: NB-4 - Immune response"	"Cluster 10: Non-specific - Unknown function"	"Nuclear speckles"		"HPA036182: AB_10673346, HPA057980: AB_2683571"	"unprognostic (1.69e-2)"	"unprognostic (3.92e-3)"	"unprognostic (1.84e-3)"	"unprognostic (4.97e-2)"	"unprognostic (3.00e-3)"	"unprognostic (2.16e-1)"	"unprognostic (2.34e-3)"	"unprognostic (2.21e-2)"	"unprognostic (2.96e-1)"	"unprognostic (7.85e-2)"	"unprognostic (1.20e-1)"	"unprognostic (7.67e-3)"	"prognostic favorable (2.69e-4)"	"unprognostic (4.33e-1)"	"unprognostic (7.30e-2)"	"unprognostic (2.94e-1)"	"unprognostic (1.20e-1)"	17.5	44.1	9.5	12.5	9.5	17.2	18.4	10.0	10.4	23.5	10.7	15.3	11.6	20.4	7.0	27.2	17.0	9.1	27.0	9.5	10.9	22.2	18.1	15.0	19.6	10.4	9.8	19.0	18.6	20.1	17.3	15.4	10.1	15.9	10.8	5.9	17.5	15.9	43.8	44.6	13.2	11.2	9.7	15.3	20.0	23.2	10.5	20.2	19.9	36.4	16.8	22.7	22.2	9.8	61.5	55.7	44.9	37.3	45.9	50.0	40.5	26.2	42.2	56.0	57.7	93.3	47.8	77.4	40.3	45.6	42.6	33.9	55.9	72.2	46.0	52.3	49.2	67.5	64.5	91.5	88.7	95.3	26.5	44.1	45.6	61.2	123.6	36.5	54.8	84.9	107.4	37.8	40.3	63.2	68.6	167.9	54.3	55.2	78.4	33.8	41.7	117.7	51.0	85.5	20.9	31.4	37.0	31.6	39.7	38.4	46.7	77.9	39.3	28.8	43.0	48.3	71.7	47.1	47.5	92.6	42.4	131.6	26.2	6.8	41.3	7.6	38.8	41.5	43.6	71.3	44.6	40.2	66.0	59.7	51.8	41.4	2.1	58.3	31.5	40.2	47.7	45.4	9.5	9.5	10.0	10.4	9.5	10.9	10.4	9.8	10.1	9.7	10.5	9.8	25.0	35.3	30.1	16.0	23.2	61.8	68.8	97.2	47.3	29.5	23.9	43.2	39.0	21.5	46.5	35.0	18.8	67.8	22.1	8.6	135.0	51.7	3.9	23.7	34.8	24.0	13.1	19.6	19.9	46.7	62.4	32.7	23.0	21.7	15.2	33.0	18.2	28.6	46.5	20.2	22.5	19.3	79.3	14.2	22.6	8.3	47.8	17.4	26.6	8.4	20.6	37.6	33.0	10.6	14.0	41.7	10.3	41.0	19.4	74.8	17.7	47.4	34.3	23.4	13.1	25.7	53.9	53.7	66.3	35.5	74.2	63.1	26.2	52.2	24.3	56.3
EXOSC8	"bA421P11.3, CIP3, EAP2, OIP2, p9, RRP43, Rrp43p"	ENSG00000120699	"Exosome component 8"	Q96B26	13	36998816-37009614	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"rRNA processing"	RNA-binding	"Disease variant, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 163.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034240, HPA039702, HPA043942, HPA075230"	Uncertain		Supported	"Nucleoli fibrillar center,Mitotic chromosome,Vesicles"		Yes	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 32: U-937 - Innate immune response"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Nucleoli fibrillar center, Mitotic chromosome, Vesicles"		"CAB034240: AB_2101977, HPA039702: AB_2676634, HPA043942: AB_2678742, HPA075230: "	"unprognostic (8.67e-2)"	"unprognostic (9.39e-2)"	"unprognostic (5.77e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.58e-2)"	"unprognostic (1.24e-2)"	"unprognostic (1.02e-1)"	"unprognostic (4.01e-2)"	"unprognostic (3.24e-3)"	"unprognostic (2.45e-2)"	"unprognostic (2.35e-2)"	"unprognostic (7.32e-3)"	"prognostic unfavorable (8.39e-7)"	"unprognostic (9.58e-3)"	"unprognostic (7.42e-2)"	"unprognostic (1.10e-1)"	"unprognostic (4.51e-1)"	15.0	14.2	16.6	19.1	17.6	27.5	18.8	17.9	24.3	16.8	16.6	17.0	12.6	14.2	14.4	18.2	16.8	8.4	19.4	16.9	17.8	17.9	19.8	13.5	21.2	17.5	17.1	16.4	13.9	11.6	10.8	15.6	18.1	14.2	19.0	15.3	11.3	13.2	24.2	16.6	14.0	16.6	17.3	17.5	15.3	27.8	17.0	31.5	12.3	24.8	25.1	16.2	14.7	19.7	47.5	33.5	97.7	66.4	28.4	30.1	73.8	68.9	48.8	93.2	74.2	72.7	93.6	65.1	29.8	38.2	91.4	64.7	92.7	67.1	111.5	96.3	73.9	174.8	34.2	87.4	37.0	148.3	58.9	17.4	51.3	62.6	100.2	24.1	72.8	93.6	86.6	41.3	66.4	59.1	78.6	116.6	101.4	113.2	44.0	48.5	98.6	53.5	51.1	30.8	23.8	46.1	38.1	44.5	65.3	51.1	35.4	117.6	37.2	35.5	49.1	42.9	95.5	23.3	29.4	135.7	56.0	104.1	66.8	28.9	29.8	23.5	42.8	39.6	44.8	66.0	54.1	50.5	33.9	57.2	67.1	62.7	6.0	46.2	41.7	54.8	54.6	52.4	16.6	17.6	17.9	24.3	16.9	17.8	17.5	17.1	18.1	17.3	17.0	19.7	43.5	32.1	38.9	15.7	40.1	36.1	51.6	109.6	25.0	20.8	25.0	50.0	50.2	18.6	69.5	11.0	8.4	86.8	46.8	13.1	56.7	58.1	115.7	21.5	31.4	39.4	13.2	57.9	7.0	52.1	92.3	41.8	19.4	20.6	103.6	46.2	18.5	17.4	46.8	28.6	8.6	19.1	79.3	13.6	34.2	54.6	40.7	26.0	26.6	10.3	32.6	27.1	35.0	17.1	22.0	36.1	16.4	36.5	38.8	29.0	18.0	26.6	53.4	32.0	26.3	38.8	52.1	163.3	85.9	29.0	36.2	67.0	38.7	42.7	30.2	37.7
EXOSC9	"p5, p6, PM/Scl-75, PMSCL1, RRP45, Rrp45p"	ENSG00000123737	"Exosome component 9"	Q06265	4	121801318-121817021	"Disease related genes, Predicted intracellular proteins"	"rRNA processing"	RNA-binding	"Disease variant, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 154.0;Spermatocytes: 170.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041838, HPA048257, CAB070171"	Approved		Enhanced	Nucleoplasm,Nucleoli		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoli	Nucleoplasm	"CAB070171: AB_11026964, HPA041838: AB_10794492, HPA048257: AB_2680331"	"unprognostic (7.36e-2)"	"unprognostic (1.22e-2)"	"unprognostic (2.81e-2)"	"unprognostic (2.23e-1)"	"unprognostic (2.78e-1)"	"unprognostic (3.36e-2)"	"prognostic unfavorable (1.04e-4)"	"unprognostic (7.89e-2)"	"unprognostic (3.73e-2)"	"unprognostic (1.66e-2)"	"unprognostic (9.25e-2)"	"unprognostic (9.85e-3)"	"prognostic unfavorable (6.49e-4)"	"unprognostic (3.28e-2)"	"unprognostic (6.66e-2)"	"unprognostic (1.68e-1)"	"unprognostic (7.21e-2)"	14.7	14.3	9.2	16.7	9.9	37.9	14.4	10.5	15.3	11.9	8.4	11.7	9.3	12.9	14.4	12.3	12.9	8.1	15.7	9.4	9.9	11.8	16.0	13.6	25.8	9.3	9.2	12.9	11.2	14.7	11.0	14.1	9.3	10.4	12.6	9.9	11.9	9.3	21.6	13.9	12.0	10.2	9.0	15.8	11.7	43.4	9.2	32.8	10.1	18.6	21.1	14.8	11.9	10.4	66.3	29.9	76.7	44.4	10.7	20.6	39.2	83.7	45.4	114.6	84.5	32.5	53.2	113.9	20.1	50.5	35.7	23.2	83.1	38.1	95.6	51.1	39.9	56.8	43.4	43.0	26.0	98.5	51.1	16.1	20.1	77.8	20.3	23.7	56.0	72.6	102.2	42.3	110.0	38.9	154.6	78.6	42.7	25.2	34.7	80.6	134.4	52.4	41.4	21.0	51.3	53.7	28.8	45.5	52.3	38.9	38.2	64.2	35.2	50.4	76.5	44.4	80.9	63.0	49.7	132.5	52.4	67.8	34.2	15.8	14.5	23.4	17.6	21.1	18.5	20.7	20.9	25.4	17.9	22.4	22.1	22.6	3.8	14.4	21.3	15.9	24.9	14.0	9.2	9.9	10.5	15.3	9.4	9.9	9.3	9.2	9.3	9.0	9.2	10.4	20.4	44.8	19.1	4.9	20.8	12.7	15.5	31.7	18.8	10.7	6.7	10.7	13.2	17.2	25.4	3.7	10.4	31.4	21.5	5.7	1.9	23.7	154.0	10.9	15.6	17.6	6.0	27.0	10.4	30.5	31.3	15.8	7.7	11.8	31.0	25.4	10.0	5.5	24.5	16.8	8.8	9.8	28.5	11.9	10.1	21.8	13.1	16.3	8.8	11.2	22.2	15.3	16.5	6.6	10.9	20.2	9.2	10.9	22.9	8.4	6.5	8.5	16.8	17.7	6.6	23.4	21.8	170.4	62.8	14.1	14.8	10.9	26.2	16.5	11.6	12.1
EXT2	SOTV	ENSG00000151348	"Exostosin glycosyltransferase 2"	Q93063	11	44095673-44251962	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted membrane proteins"		"Glycosyltransferase, Transferase"	"Cancer-related genes, Disease variant, Epilepsy, Hereditary multiple exostoses, Mental retardation, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA078409			Supported	"Golgi apparatus"		NA	NA		39000000	"Cluster 27: Non-specific - Gene expression"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 33: Fibroblasts - ECM organization"	"Golgi apparatus"		"HPA078409: AB_2686884"	"unprognostic (5.87e-2)"	"unprognostic (3.05e-3)"	"unprognostic (3.48e-2)"	"unprognostic (3.94e-1)"	"unprognostic (1.42e-1)"	"prognostic unfavorable (2.50e-4)"	"unprognostic (1.77e-3)"	"unprognostic (2.22e-2)"	"unprognostic (1.97e-1)"	"unprognostic (2.05e-1)"	"unprognostic (1.74e-3)"	"unprognostic (3.70e-2)"	"prognostic unfavorable (5.36e-6)"	"unprognostic (7.07e-3)"	"unprognostic (2.97e-1)"	"unprognostic (3.85e-1)"	"unprognostic (1.36e-2)"	33.5	22.8	14.4	22.1	15.4	11.2	29.3	15.4	16.3	36.1	17.5	29.1	26.5	43.1	33.3	20.1	33.7	28.1	27.3	15.6	18.1	26.5	26.9	27.9	16.0	15.5	16.0	33.5	26.5	28.9	20.1	61.9	15.5	29.8	28.7	20.9	26.7	30.2	16.2	25.8	31.0	49.3	14.7	21.6	23.8	21.6	19.4	15.2	27.6	18.4	17.3	29.7	28.5	16.1	57.9	71.6	38.3	121.5	170.4	124.2	60.8	181.1	198.0	93.1	125.1	51.2	36.5	40.4	82.1	188.8	98.5	90.0	41.0	114.0	110.0	83.2	71.5	38.4	33.7	39.7	67.5	37.5	76.6	97.7	73.4	56.3	86.6	108.8	132.7	34.8	50.0	63.9	68.4	40.3	25.9	22.3	43.8	67.1	70.9	32.3	116.1	21.1	53.9	49.1	30.9	35.5	118.1	41.4	28.1	67.0	69.8	37.2	137.8	127.4	90.6	133.1	111.4	33.4	46.0	30.4	84.7	27.9	140.0	15.2	17.5	19.4	20.9	17.7	23.5	9.0	16.5	19.3	21.3	8.8	15.4	15.2	3.4	26.3	12.8	7.4	14.2	15.5	14.4	15.4	15.4	16.3	15.6	18.1	15.5	16.0	15.5	14.7	19.4	16.1	24.5	16.0	10.6	41.4	8.7	15.2	17.3	22.0	10.8	11.5	11.0	11.4	10.2	8.6	13.5	12.9	14.6	34.3	10.6	21.1	5.9	33.5	43.2	7.9	17.1	19.2	1.8	6.7	64.3	23.7	37.0	32.3	7.7	11.5	6.3	22.7	22.9	18.3	18.3	13.5	63.3	12.9	12.2	10.8	7.2	23.0	27.4	10.4	5.4	28.1	10.2	17.4	7.2	50.3	51.8	24.0	14.9	28.6	7.0	23.6	31.6	8.2	8.1	15.0	19.7	15.8	20.7	51.2	24.4	10.2	12.6	35.3	9.2	12.2	15.0	15.3
EYA1	BOR	ENSG00000104313	"EYA transcriptional coactivator and phosphatase 1"	Q99502	8	71197433-71592025	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair, Transcription, Transcription regulation"	"Activator, Chromatin regulator, Developmental protein, Hydrolase, Protein phosphatase"	"Deafness, Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"choroid plexus: 18.7;parathyroid gland: 23.7"	"Cell type enriched"	"Detected in some"	11	"Astrocytes: 214.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 27.6;RH-30: 21.3;RPMI-8226: 9.5;SH-SY5Y: 51.4"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"cerebellum: 20.7"	HPA028917			Supported	"Nucleoplasm,Nuclear bodies"		NA	NA				"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 64: Astrocytes - Nervous system maintenance"	"Nucleoplasm, Nuclear bodies"		"HPA028917: AB_2672826"	"unprognostic (3.74e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.72e-3)"	"unprognostic (5.95e-2)"	"unprognostic (9.17e-2)"	"unprognostic (2.91e-4)"	"unprognostic (1.98e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.81e-1)"	"unprognostic (9.72e-2)"	"unprognostic (1.13e-1)"	"unprognostic (4.22e-12)"	"unprognostic (1.06e-2)"	"unprognostic (1.84e-1)"	"unprognostic (3.81e-4)"	"unprognostic (1.25e-2)"	0.6	0.6	2.8	0.1	7.8	0.0	0.2	0.5	2.1	5.1	18.7	0.1	0.1	0.1	0.1	0.4	2.0	0.3	4.5	1.3	2.5	0.1	0.0	0.4	0.0	2.1	4.9	0.2	0.0	23.7	10.8	0.0	2.3	12.0	0.2	0.4	0.8	4.0	2.8	0.0	0.2	0.2	0.0	0.1	0.8	0.8	4.6	11.7	0.6	2.5	0.1	2.6	4.3	0.6	0.2	0.0	6.4	27.6	0.0	0.0	0.0	0.2	2.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.9	1.6	0.0	0.0	4.7	0.0	2.2	0.0	0.0	0.5	0.0	6.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.0	1.0	0.0	0.0	0.0	2.0	0.0	1.5	0.0	21.3	9.5	0.0	0.0	2.2	51.4	0.0	0.0	1.6	5.9	0.0	0.1	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	6.3	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	7.8	0.5	2.1	1.3	2.5	2.1	4.9	2.3	0.0	4.6	0.6	0.2	0.0	0.0	214.5	0.0	0.1	0.0	6.4	0.6	0.1	0.0	0.1	8.8	0.0	7.5	0.0	0.0	0.8	0.0	0.0	0.0	0.0	4.4	3.1	0.1	0.2	0.0	0.0	1.3	0.0	0.5	1.3	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	13.5	0.0	2.0	0.0	0.0	6.4	0.3	0.0	0.0	11.2	0.0	0.1	0.0	18.6	0.6	0.0	0.0	0.4	0.0	0.1	0.0	0.3	10.5	0.2	0.0	0.2	0.5	0.8	1.0	1.1	0.1	0.5	0.0	1.4	0.0	0.1
EYA2	EAB1	ENSG00000064655	"EYA transcriptional coactivator and phosphatase 2"	O00167	20	46894624-47188844	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, Transcription, Transcription regulation"	"Activator, Chromatin regulator, Developmental protein, Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix: 55.6"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 153.8;Basal prostatic cells: 47.5;Basal respiratory cells: 50.4;Endometrial ciliated cells: 43.7;Glandular and luminal cells: 53.8;Oligodendrocyte precursor cells: 48.7"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 69.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HBEC3-KT: 40.1;SCLC-21H: 58.3;U-266/70: 110.9;U-266/84: 139.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA027024, HPA059291"	Uncertain		Supported	Cytosol		NA	NA				"Cluster 57: Non-specific - Angiogenesis"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 64: Astrocytes - Nervous system maintenance"	Cytosol		"HPA027024: AB_1848334, HPA059291: AB_2683967"	"unprognostic (1.08e-1)"	"unprognostic (5.71e-3)"	"unprognostic (4.03e-1)"	"prognostic favorable (4.30e-5)"	"unprognostic (3.32e-2)"	"unprognostic (1.72e-1)"	"unprognostic (4.94e-3)"	"unprognostic (1.10e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.21e-1)"	"unprognostic (2.54e-1)"	"unprognostic (2.65e-1)"	"unprognostic (7.06e-2)"	"unprognostic (2.15e-1)"	"unprognostic (2.78e-1)"	"unprognostic (4.17e-3)"	"unprognostic (1.56e-1)"	12.0	1.5	12.3	2.4	14.1	0.0	11.0	15.6	12.3	55.6	11.2	9.3	0.3	17.2	3.7	34.2	34.0	1.8	5.0	10.7	11.8	4.7	2.1	2.2	0.8	14.6	14.4	0.7	1.9	9.4	5.3	6.3	13.7	23.6	3.1	1.2	31.2	9.3	2.5	5.3	1.1	1.8	11.8	0.6	8.9	5.6	13.4	18.8	14.6	3.4	6.6	4.9	16.5	11.0	0.2	4.4	0.2	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	1.7	2.5	1.9	0.3	40.1	0.0	0.0	8.1	0.0	0.1	0.0	0.0	0.1	0.3	2.1	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.3	7.7	0.1	0.0	0.6	0.1	0.0	0.1	0.8	0.5	0.0	0.0	58.3	0.0	0.0	24.8	0.0	3.0	5.3	0.2	0.0	0.0	4.5	0.3	8.8	110.9	139.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.3	14.1	15.6	12.3	10.7	11.8	14.6	14.4	13.7	11.8	13.4	11.0	0.4	0.0	0.0	153.8	0.9	0.6	47.5	50.4	14.8	0.4	7.8	7.6	0.5	2.8	33.0	0.0	6.2	27.7	0.0	2.5	0.0	0.9	0.2	43.7	3.9	0.6	1.2	0.0	1.5	0.0	3.0	4.8	9.2	53.8	1.3	9.8	0.4	3.3	7.4	0.0	5.1	0.6	34.6	0.0	0.4	0.3	0.0	1.1	3.6	13.1	2.6	0.0	0.0	48.7	1.0	1.1	1.7	0.7	3.4	10.9	0.0	6.3	22.2	0.4	0.0	0.3	2.8	0.2	7.4	16.0	0.3	10.8	0.6	4.2	3.6	34.6
EYA3	DKFZp686C132	ENSG00000158161	"EYA transcriptional coactivator and phosphatase 3"	Q99504	1	27970344-28088637	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, Transcription, Transcription regulation"	"Activator, Chromatin regulator, Developmental protein, Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 80.2;Oligodendrocytes: 80.5;Spermatocytes: 98.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA052432, HPA062889"	Uncertain		Supported	Nucleoplasm		Yes	No			"Cluster 49: Eosinophils - Unknown function"	"Cluster 20: Retina & Lymphoid tissues - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	Nucleoplasm		"HPA052432: AB_2681831, HPA062889: AB_2684895"	"unprognostic (3.57e-1)"	"unprognostic (2.61e-1)"	"unprognostic (2.85e-1)"	"unprognostic (8.74e-2)"	"unprognostic (1.39e-1)"	"prognostic favorable (5.11e-4)"	"unprognostic (1.39e-3)"	"unprognostic (2.21e-1)"	"unprognostic (4.81e-2)"	"unprognostic (1.00e-1)"	"unprognostic (9.13e-2)"	"unprognostic (8.98e-2)"	"prognostic favorable (3.15e-6)"	"unprognostic (5.17e-2)"	"unprognostic (2.79e-1)"	"unprognostic (7.60e-2)"	"unprognostic (6.11e-2)"	4.7	4.8	7.4	8.2	7.0	5.2	7.1	8.8	7.9	7.4	9.6	5.7	5.9	6.1	6.4	9.9	6.2	4.3	6.4	6.5	7.6	11.6	6.0	5.9	9.4	7.1	7.1	6.4	6.5	8.3	7.6	7.7	7.2	6.1	6.2	10.5	5.6	5.4	7.1	9.0	6.3	5.5	6.4	7.2	5.5	11.4	7.6	9.4	9.3	8.3	14.4	7.1	6.1	7.9	16.3	6.6	13.1	9.7	14.9	11.6	7.3	11.8	11.0	13.2	12.9	6.4	9.5	25.5	12.3	7.8	4.9	15.3	24.4	9.5	15.6	13.4	13.5	28.2	14.4	11.6	8.8	27.9	25.2	7.0	8.3	14.6	9.7	11.3	17.0	9.0	26.9	9.6	11.9	7.0	18.0	18.5	27.5	12.6	8.6	13.2	24.9	16.8	15.3	8.8	14.9	8.2	12.6	7.6	11.0	10.5	6.2	7.3	16.6	15.9	8.4	15.1	9.4	13.9	15.2	22.0	11.5	26.7	7.0	5.7	6.8	7.3	7.5	6.9	6.7	5.2	5.8	5.4	8.3	4.6	4.9	5.6	6.4	7.1	6.1	5.1	5.4	1.9	7.4	7.0	8.8	7.9	6.5	7.6	7.1	7.1	7.2	6.4	7.6	7.9	12.6	9.6	10.8	46.4	17.5	17.8	11.3	10.0	9.6	18.3	12.0	7.1	9.2	12.8	7.9	25.8	16.7	13.0	10.6	8.2	15.6	13.5	80.2	13.6	13.2	12.9	20.4	9.9	66.0	8.9	14.4	11.6	16.8	15.3	12.0	15.8	14.6	8.7	9.7	18.5	58.8	9.1	12.2	13.3	46.1	39.1	10.2	14.6	12.4	39.4	12.9	8.1	10.3	45.2	80.5	14.5	10.9	6.0	13.7	12.0	13.8	18.0	5.7	20.6	13.1	11.1	8.4	98.7	50.6	10.7	22.9	10.9	15.8	9.6	10.5	11.7
EZH1	"KIAA0388, KMT6B"	ENSG00000108799	"Enhancer of zeste 1 polycomb repressive complex 2 subunit"	Q92800	17	42700275-42745049	"Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, Methyltransferase, Repressor, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"retina: 133.4"	"Cell type enhanced"	"Detected in many"		"Rod photoreceptor cells: 258.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"ASC diff: 48.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005478, HPA077684"	Supported		Supported	Nucleoplasm		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 54: Non-specific - Microtubule organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 46: Photoreceptor cells - Phototransduction"	Nucleoplasm		"HPA005478: AB_1848340, HPA077684: AB_2732356"	"unprognostic (1.01e-1)"	"unprognostic (6.02e-2)"	"unprognostic (2.19e-2)"	"unprognostic (8.57e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.84e-3)"	"unprognostic (1.76e-2)"	"unprognostic (1.18e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.55e-3)"	"unprognostic (5.22e-3)"	"unprognostic (4.11e-3)"	"unprognostic (1.48e-2)"	"unprognostic (4.60e-2)"	"unprognostic (3.29e-1)"	"unprognostic (5.39e-2)"	"unprognostic (4.74e-2)"	39.6	18.1	35.0	14.4	37.4	15.2	34.1	42.4	41.5	41.5	29.4	31.6	13.0	31.1	26.5	21.6	35.6	12.8	31.8	33.9	33.9	28.6	13.4	25.7	20.5	37.7	36.5	47.8	18.3	25.5	26.3	12.5	40.2	26.0	15.4	133.4	20.2	23.8	43.8	26.1	30.6	20.4	32.3	37.8	20.7	12.0	35.8	22.9	28.4	33.2	20.4	29.2	31.4	41.5	8.9	9.3	12.4	8.5	48.4	29.1	10.4	14.0	12.7	11.4	11.6	4.4	10.8	13.4	8.6	15.0	11.2	19.8	8.1	9.2	16.3	15.0	14.5	4.7	19.7	5.4	16.6	10.2	10.8	16.7	16.6	8.6	20.8	20.0	9.4	13.4	12.5	18.5	10.2	3.7	16.6	12.9	3.4	8.2	4.7	10.7	12.4	14.5	11.7	9.3	8.4	6.8	7.8	3.8	9.5	17.5	13.2	6.5	9.8	12.2	5.0	14.4	8.9	19.3	10.4	8.0	8.8	10.4	6.4	14.2	5.2	7.8	6.0	5.4	8.2	5.8	5.3	6.1	2.0	6.3	7.7	5.8	19.7	5.8	3.6	6.3	6.4	2.6	35.0	37.4	42.4	41.5	33.9	33.9	37.7	36.5	40.2	32.3	35.8	41.5	34.2	9.6	20.8	41.1	23.6	5.2	14.2	6.6	8.6	71.7	8.7	13.1	39.3	20.0	14.1	12.9	66.7	7.9	24.6	9.3	9.8	11.2	0.7	21.8	23.2	20.7	13.1	36.4	36.8	7.5	3.2	25.3	8.6	25.5	20.3	19.4	15.4	7.8	9.0	47.1	34.0	4.9	12.2	17.1	7.2	2.8	31.1	14.7	1.8	15.0	24.1	30.8	33.0	20.6	58.9	12.1	7.7	34.3	15.9	9.1	12.9	10.7	28.0	258.1	52.6	32.7	24.1	10.7	10.6	6.6	6.1	10.8	21.8	26.2	7.4	9.6
EZH2	"ENX-1, EZH1, KMT6, KMT6A"	ENSG00000106462	"Enhancer of zeste 2 polycomb repressive complex 2 subunit"	Q15910	7	148807383-148884321	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Biological rhythms, Transcription, Transcription regulation"	"Chromatin regulator, Methyltransferase, Repressor, Transferase"	"Cancer-related genes, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 47.9;lymphoid tissue: 43.0;testis: 27.8"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 109.3;Spermatocytes: 142.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009589, HPA029131"	Enhanced		Supported	Nucleoplasm		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"CAB009589: , HPA029131: AB_2672920"	"unprognostic (2.42e-1)"	"unprognostic (3.95e-3)"	"unprognostic (1.57e-1)"	"unprognostic (3.30e-3)"	"unprognostic (1.33e-1)"	"unprognostic (3.85e-3)"	"prognostic unfavorable (2.11e-6)"	"unprognostic (2.21e-2)"	"prognostic unfavorable (1.96e-4)"	"unprognostic (2.32e-3)"	"unprognostic (1.58e-3)"	"unprognostic (1.69e-3)"	"prognostic unfavorable (8.18e-12)"	"prognostic favorable (6.97e-4)"	"unprognostic (1.83e-1)"	"unprognostic (2.12e-1)"	"unprognostic (6.67e-2)"	1.5	1.5	1.1	10.1	1.1	47.9	2.7	2.0	1.3	2.7	1.5	7.0	6.4	2.0	1.2	10.8	1.1	1.9	1.2	1.1	1.1	2.1	3.3	2.3	22.1	1.2	1.2	1.6	3.7	1.3	0.5	4.8	1.2	1.3	8.2	3.3	2.8	0.2	2.9	10.7	6.9	2.8	1.0	5.6	4.0	27.8	1.5	43.0	1.3	1.9	21.1	3.5	3.8	1.2	65.6	30.1	99.7	66.9	3.1	5.1	54.6	49.7	19.9	39.9	40.2	45.6	73.2	114.3	23.5	18.7	36.3	39.0	52.1	17.1	50.6	164.9	51.8	48.9	38.4	35.5	8.0	110.1	38.5	4.3	9.6	29.9	15.9	12.1	24.0	108.9	105.9	73.6	36.2	74.0	215.7	91.7	79.6	57.0	39.9	131.3	56.0	70.9	18.6	31.0	95.1	60.3	62.3	46.8	16.5	25.3	34.3	46.7	14.8	42.4	19.8	85.2	90.4	65.7	76.6	115.3	38.6	74.2	84.9	0.4	1.7	1.1	1.2	1.2	0.9	1.1	2.6	2.2	3.8	0.6	1.4	0.9	0.1	7.2	3.6	0.8	8.3	1.2	1.1	1.1	2.0	1.3	1.1	1.1	1.2	1.2	1.2	1.0	1.5	1.2	14.4	0.0	6.7	1.3	14.5	26.5	6.7	6.3	10.2	6.0	15.1	12.2	6.1	2.8	7.1	7.3	35.5	28.8	35.9	14.7	3.9	9.5	109.3	16.3	17.0	9.4	9.0	57.0	6.2	8.5	32.2	9.9	15.8	24.2	21.6	45.9	3.3	2.2	11.9	15.2	9.2	20.5	6.1	9.0	33.6	27.7	3.1	19.1	14.2	14.0	14.9	2.6	12.3	16.6	7.0	12.4	10.5	0.7	37.4	4.8	6.8	1.2	9.7	21.3	6.6	13.8	24.1	142.2	58.2	35.8	29.0	30.5	25.7	4.7	22.1	5.9
F11R	"CD321, JAM-1, JAM-A, JAM1, JAMA, JCAM, PAM-1"	ENSG00000158769	"F11 receptor"	Q9Y624	1	160995211-161021343	"CD markers, Plasma proteins, Predicted membrane proteins"	"Host-virus interaction"	"Host cell receptor for virus entry, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 253.2;Urothelial cells: 242.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"eosinophil: 165.5;neutrophil: 113.4"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 165.5"	"Cell line enhanced"	"Detected in many"		"HaCaT: 205.4;OE19: 202.4;SuSa: 232.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004671, HPA043616, HPA061700"	Enhanced		Supported	"Cell Junctions,Microtubules"		NA	NA		1900000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 37: Intestine - Unknown function"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 22: Epithelial cell types - Mixed function"	Microtubules	"Cell Junctions"	"CAB004671: AB_425964, HPA043616: , HPA061700: AB_2684589"	"unprognostic (1.60e-2)"	"unprognostic (5.78e-3)"	"unprognostic (1.78e-3)"	"unprognostic (2.24e-1)"	"unprognostic (4.99e-2)"	"unprognostic (4.89e-2)"	"unprognostic (2.28e-1)"	"unprognostic (2.55e-1)"	"unprognostic (6.35e-2)"	"unprognostic (1.98e-3)"	"unprognostic (1.87e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.78e-1)"	"unprognostic (2.50e-1)"	"unprognostic (1.59e-1)"	"unprognostic (9.72e-3)"	"unprognostic (5.01e-2)"	21.1	24.5	6.6	20.8	6.3	21.3	26.8	6.0	8.2	24.2	9.6	52.6	55.9	11.9	21.1	85.5	33.1	28.7	12.8	6.3	6.5	40.4	73.6	67.1	13.2	7.8	7.5	14.0	41.7	36.3	18.8	50.7	7.5	28.7	51.7	2.2	49.4	21.2	6.1	48.2	64.0	9.0	7.2	21.5	52.6	13.0	8.6	16.5	39.2	6.3	32.0	52.2	44.1	7.1	122.9	15.5	4.7	1.4	3.3	0.2	95.5	0.6	0.1	4.0	4.1	113.5	155.9	8.9	78.6	0.2	22.6	205.4	25.3	105.2	6.4	6.9	17.8	25.8	6.2	52.3	4.8	24.2	72.6	1.4	132.5	0.6	32.7	24.1	98.6	18.8	35.6	2.5	0.6	53.5	7.6	13.6	80.1	202.4	21.9	11.3	0.0	39.2	67.2	94.4	34.3	8.8	29.2	123.4	26.2	232.8	132.6	41.7	58.8	0.3	3.0	0.4	1.2	28.2	59.3	3.1	18.0	23.4	7.5	34.6	31.0	165.5	12.6	16.3	6.7	4.7	11.7	8.0	24.6	2.9	11.1	8.8	113.4	8.2	13.0	18.7	5.7	25.1	6.6	6.3	6.0	8.2	6.3	6.5	7.8	7.5	7.5	7.2	8.6	7.1	27.7	253.2	137.2	0.0	9.8	35.2	119.7	86.2	64.3	0.9	35.0	15.5	3.3	67.2	136.2	77.3	2.1	78.6	10.2	154.9	7.9	76.8	7.2	120.8	13.9	41.5	62.2	10.3	2.7	71.0	176.2	9.1	66.8	150.9	18.3	13.7	34.2	68.8	31.0	0.0	1.1	71.5	46.8	14.4	25.5	2.1	2.1	24.7	8.8	7.5	48.7	1.5	13.4	3.0	0.4	91.4	114.1	0.7	10.8	135.3	82.5	12.6	178.8	2.4	0.0	5.1	6.2	13.4	2.9	102.3	50.6	63.1	12.3	8.1	50.7	242.0
F2RL3	PAR4	ENSG00000127533	"F2R like thrombin or trypsin receptor 3"	Q96RI0	19	16888999-16892606	"G-protein coupled receptors, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Blood coagulation, Hemostasis"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 19.0;lung: 33.4;thyroid gland: 19.2"	"Cell type enriched"	"Detected in some"	4	"Adipocytes: 110.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	7	"HEL: 30.7;HMC-1: 11.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA031401, HPA042340"			Supported	"Plasma membrane"		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 36: HEL - Hemostasis"	"Cluster 51: Myeloid cells - Hemostasis"	"Plasma membrane"		"HPA031401: , HPA042340: "	"unprognostic (6.17e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.64e-2)"	"unprognostic (3.83e-1)"	"unprognostic (3.27e-1)"	"unprognostic (8.31e-3)"	"unprognostic (2.97e-1)"	"unprognostic (3.28e-2)"	"unprognostic (6.52e-2)"	"unprognostic (2.60e-1)"	"unprognostic (6.30e-2)"	"unprognostic (3.00e-3)"	"prognostic favorable (6.25e-4)"	"unprognostic (2.37e-2)"	"unprognostic (1.43e-1)"	"unprognostic (3.53e-1)"	"unprognostic (2.11e-2)"	19.0	2.6	0.7	1.5	0.7	1.3	18.0	1.9	0.7	1.1	1.2	4.3	1.5	1.6	1.6	1.5	1.5	2.8	5.6	0.6	0.7	9.8	0.5	33.4	2.3	0.5	0.6	0.8	9.3	1.1	2.7	1.0	0.5	1.4	1.3	1.2	1.2	0.5	3.2	3.1	4.9	1.0	0.0	1.3	5.0	1.7	1.2	0.4	19.2	0.6	0.9	1.9	1.2	1.3	0.3	0.3	0.8	0.4	0.1	0.2	0.9	0.4	0.1	0.2	0.2	0.5	0.8	0.6	0.6	0.3	0.3	0.6	0.2	0.3	0.3	0.4	0.4	30.7	1.3	0.5	0.2	0.3	11.6	0.0	0.1	0.3	0.2	0.4	0.9	0.6	2.5	1.1	0.2	0.5	0.4	2.9	0.4	0.4	0.3	0.3	0.2	1.0	0.3	0.6	0.5	0.3	0.3	0.2	0.1	0.7	0.6	2.0	1.2	0.6	0.6	0.4	0.3	0.5	0.4	0.6	0.3	0.5	0.4	3.3	0.9	0.7	0.9	0.4	0.8	1.6	1.0	0.8	0.3	1.8	1.4	1.3	2.2	1.8	0.6	1.7	0.8	1.4	0.7	0.7	1.9	0.7	0.6	0.7	0.5	0.6	0.5	0.0	1.2	1.3	110.4	0.0	1.1	0.0	0.3	0.4	0.3	0.3	0.0	0.0	0.3	0.3	0.7	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.0	0.9	27.5	0.0	0.8	0.0	0.5	0.0	2.7	0.0	0.2	7.0	0.3	1.4	0.0	0.3	0.0	0.0	0.0	0.0	0.3	1.0	0.4	0.0	9.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	2.0	0.6	0.0	0.1	0.0	0.0	0.0	0.7	0.3	0.0	0.0	0.1	0.4	0.5	0.1	0.3	0.2	0.3
FAAP100	"C17orf70, FLJ22175"	ENSG00000185504	"FA core complex associated protein 100"	Q0VG06	17	81539885-81553961	"Predicted intracellular proteins"	"DNA damage, DNA repair"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023954, HPA024626, HPA026532"	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 72: Non-specific - Transcription"	"Cluster 24: NB-4 - Immune response"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm	Cytosol	"HPA023954: AB_1845601, HPA024626: AB_1845602, HPA026532: AB_1845603"	"unprognostic (5.25e-2)"	"unprognostic (5.40e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.03e-2)"	"unprognostic (2.91e-1)"	"unprognostic (1.85e-2)"	"unprognostic (4.87e-3)"	"unprognostic (1.30e-1)"	"unprognostic (1.16e-1)"	"unprognostic (3.49e-2)"	"unprognostic (1.05e-3)"	"unprognostic (6.91e-2)"	"prognostic unfavorable (1.00e-7)"	"unprognostic (1.14e-1)"	"unprognostic (1.45e-1)"	"unprognostic (9.85e-2)"	"unprognostic (4.24e-1)"	14.7	16.8	6.7	13.8	7.0	10.1	15.9	14.7	9.5	18.6	6.8	15.8	12.0	17.3	3.1	16.2	18.8	9.5	16.3	6.7	6.4	21.2	22.7	16.0	15.9	8.1	6.5	19.5	26.6	7.8	22.4	7.2	6.3	20.7	4.9	3.7	14.6	7.8	13.2	16.1	18.8	6.9	5.1	38.1	15.5	13.3	7.3	8.8	24.1	6.0	7.3	17.9	15.5	8.8	11.7	21.3	9.4	26.8	11.0	11.5	14.6	11.2	5.9	14.3	8.9	14.5	14.0	21.0	8.6	15.5	13.8	15.0	4.9	14.5	3.3	6.1	13.9	13.5	23.3	20.0	11.6	15.4	16.0	14.0	10.7	10.4	11.7	17.6	27.0	22.0	20.7	16.5	7.0	23.0	24.4	25.8	11.3	13.6	7.7	22.1	9.4	19.3	10.4	21.1	20.5	17.1	8.5	24.4	10.4	9.7	26.2	20.7	22.8	30.6	18.8	8.3	18.9	18.3	1.5	10.7	8.0	9.9	14.3	0.0	3.0	1.2	2.4	2.8	1.9	3.0	1.6	1.6	2.9	2.0	1.5	1.2	0.4	2.4	1.4	3.2	1.6	2.2	6.7	7.0	14.7	9.5	6.7	6.4	8.1	6.5	6.3	5.1	7.3	8.8	11.4	3.2	7.5	0.0	7.5	0.0	3.5	0.0	4.6	10.3	9.8	10.9	8.9	10.0	2.5	14.7	4.2	6.1	8.5	7.1	3.9	8.2	1.9	4.5	7.3	7.5	7.3	11.8	0.0	6.9	4.8	8.3	15.8	6.8	0.0	14.9	6.8	11.7	8.4	6.7	0.0	6.2	0.0	14.1	0.0	3.0	5.0	7.0	0.0	0.0	8.9	6.2	4.1	0.0	0.0	8.9	4.4	5.3	6.6	5.3	12.7	6.8	1.5	4.9	0.0	7.4	6.4	7.3	7.5	9.5	0.0	3.1	6.2	10.7	7.3	3.6
FAAP20	"C1orf86, FLJ31031"	ENSG00000162585	"FA core complex associated protein 20"	Q6NZ36	1	2184461-2212720	"Predicted intracellular proteins"	"DNA damage, DNA repair"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Late spermatids: 337.5;Proximal tubular cells: 290.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038829	Uncertain		Supported	"Nucleoplasm,Nuclear bodies,Cell Junctions"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 72: Non-specific - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm	"Nuclear bodies, Cell Junctions"	"HPA038829: AB_10673476"	"unprognostic (1.36e-2)"	"unprognostic (2.86e-2)"	"unprognostic (2.69e-3)"	"unprognostic (1.65e-1)"	"unprognostic (2.64e-1)"	"unprognostic (6.11e-2)"	"prognostic unfavorable (4.57e-4)"	"unprognostic (2.81e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.80e-1)"	"prognostic favorable (2.88e-4)"	"unprognostic (1.59e-1)"	"unprognostic (1.96e-3)"	"unprognostic (1.36e-1)"	"unprognostic (1.67e-1)"	"unprognostic (4.93e-2)"	"unprognostic (8.55e-2)"	39.3	57.5	18.1	3.2	18.9	5.6	41.2	20.8	28.0	52.5	20.5	48.5	4.6	50.0	1.3	38.8	37.8	1.5	50.0	14.5	19.6	64.8	52.1	37.9	3.6	24.6	18.9	45.3	38.7	5.1	75.5	3.2	19.6	61.1	1.8	3.7	30.7	7.1	26.4	42.7	31.8	1.8	20.2	45.0	47.3	54.8	26.9	2.9	52.9	4.0	3.1	43.7	40.7	18.9	27.7	4.4	5.8	7.3	3.6	4.7	34.8	30.4	11.0	9.6	12.9	6.7	18.0	31.7	43.7	4.8	9.0	13.5	4.2	4.6	4.9	68.3	61.0	26.5	6.8	14.4	13.5	18.7	24.8	8.1	9.8	5.8	6.3	5.9	11.9	24.6	37.1	7.6	6.7	11.6	27.0	57.6	20.8	5.4	55.6	36.0	18.1	30.7	4.6	4.5	47.4	63.5	19.8	8.6	58.5	5.3	8.5	7.5	25.6	15.1	35.8	18.7	17.4	68.9	39.9	48.2	28.0	11.4	6.4	9.8	16.4	63.4	18.4	16.9	18.1	28.3	16.5	19.8	17.0	25.7	22.2	18.6	20.6	10.8	15.6	42.4	16.2	10.6	18.1	18.9	20.8	28.0	14.5	19.6	24.6	18.9	19.6	20.2	26.9	18.9	71.7	6.4	11.9	0.0	82.3	0.0	97.7	0.0	79.6	29.1	120.9	138.2	22.1	62.9	6.8	97.5	4.2	119.7	83.6	14.5	170.2	128.5	102.7	44.3	77.2	62.1	43.7	36.8	0.0	110.8	144.1	65.3	64.7	49.9	7.6	74.8	84.6	94.5	134.0	15.2	0.0	56.0	0.0	110.8	0.0	337.5	86.0	82.3	0.0	0.0	178.9	84.7	91.6	0.0	0.0	141.1	40.8	82.8	60.9	152.8	56.2	290.1	8.0	29.5	65.7	63.3	68.8	101.5	38.3	88.4	0.0	89.8	62.4	102.5	42.2	113.2
FAAP24	"C19orf40, FLJ46828, MGC32020"	ENSG00000131944	"FA core complex associated protein 24"	Q9BTP7	19	32972209-32978229	"Predicted intracellular proteins"	"DNA damage, DNA repair"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 14.6;Spermatocytes: 22.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041168	Uncertain		Supported	Nucleoplasm,Vesicles		NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 51: Non-specific - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	Vesicles	"HPA041168: AB_10960496"	"unprognostic (1.18e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.34e-1)"	"prognostic unfavorable (4.38e-4)"	"unprognostic (6.52e-2)"	"unprognostic (2.73e-1)"	"unprognostic (2.58e-3)"	"unprognostic (3.76e-2)"	"unprognostic (1.88e-2)"	"unprognostic (3.98e-2)"	"unprognostic (2.82e-3)"	"unprognostic (3.54e-2)"	"prognostic unfavorable (4.00e-7)"	"unprognostic (4.37e-3)"	"unprognostic (5.30e-1)"	"unprognostic (2.31e-3)"	"unprognostic (2.15e-1)"	1.7	1.4	0.8	2.6	0.7	3.5	1.8	1.2	1.1	1.0	1.1	1.7	1.8	1.3	2.4	1.8	1.4	2.3	0.7	0.8	0.6	1.2	1.4	1.4	3.1	1.4	0.6	2.5	0.9	0.4	0.8	1.6	1.0	4.8	2.5	0.5	1.2	1.1	0.5	2.8	2.2	1.5	0.4	2.4	1.4	6.2	0.9	2.6	1.8	0.2	3.5	1.5	1.2	2.2	6.0	15.0	5.7	9.3	3.2	6.3	4.9	7.7	8.2	14.5	18.8	10.3	9.7	7.0	11.2	3.2	11.4	4.2	11.7	5.9	11.5	19.4	5.4	15.3	5.8	7.6	1.7	5.2	7.5	3.5	3.5	9.0	5.3	2.3	5.9	11.2	8.2	7.1	11.1	6.7	11.6	7.1	2.6	8.7	6.7	10.2	5.1	3.9	2.9	3.6	5.9	4.9	8.7	9.9	6.1	6.2	6.6	13.7	3.5	14.2	6.6	6.2	7.2	5.5	12.4	9.6	10.1	11.9	9.6	15.3	5.7	8.8	3.2	6.9	3.8	6.4	4.0	4.9	3.6	6.2	3.6	5.2	13.9	7.1	7.8	6.9	5.6	3.2	0.8	0.7	1.2	1.1	0.8	0.6	1.4	0.6	1.0	0.4	0.9	2.2	1.7	3.2	1.1	0.0	3.0	0.0	3.3	0.0	1.8	1.5	3.9	3.6	0.5	2.8	1.3	3.7	2.1	11.1	6.5	1.2	1.9	1.6	7.2	4.4	3.0	2.1	1.2	7.4	0.0	8.0	14.6	3.1	0.5	6.3	1.3	7.1	3.6	0.4	8.2	5.0	0.0	2.4	0.0	5.1	0.0	12.3	3.4	3.5	0.0	0.0	7.0	0.6	2.1	0.0	0.0	4.2	2.4	3.4	2.6	3.2	3.5	1.0	0.0	1.0	0.0	2.7	2.2	22.6	8.3	2.7	0.0	5.1	2.5	5.8	2.7	2.6
FABP1	L-FABP	ENSG00000163586	"Fatty acid binding protein 1"	P07148	2	88122982-88128062	"Cancer-related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	Transport		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	13	"intestine: 5501.2;liver: 13065.3"	"Cell type enhanced"	"Detected in some"		"Distal enterocytes: 12424.2;Hepatocytes: 7459.2;Paneth cells: 3975.2;Proximal enterocytes: 15929.5"	"Group enriched"	"Detected in many"	14	"colorectal cancer: 175.1;liver cancer: 437.4"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"CACO-2: 122.1;Hep G2: 393.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB002305, HPA028275"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA		45000000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 45: Enterocytes - Digestion"	"Nucleoplasm, Cytosol"		"CAB002305: AB_563728, HPA028275: AB_10600909"			"unprognostic (1.91e-1)"		"unprognostic (7.91e-3)"		"unprognostic (5.47e-2)"			"unprognostic (1.96e-1)"	"unprognostic (2.03e-2)"		"unprognostic (2.35e-1)"	"unprognostic (7.99e-2)"	"unprognostic (8.92e-2)"	"unprognostic (2.29e-1)"		6.7	0.8	0.6	160.2	0.6	0.0	10.7	0.5	1.8	0.7	0.4	5501.2	4751.8	13.0	0.0	2.6	3.9	0.5	0.8	0.6	0.7	727.6	13065.3	0.9	3.7	0.6	0.5	0.9	1.0	0.3	0.8	0.7	0.5	2.6	3416.4	0.1	0.5	8.4	0.9	0.5	4727.6	230.4	0.5	2.8	15.8	1.1	0.6	0.1	0.5	0.4	0.1	0.6	0.8	0.7	0.0	0.0	0.0	0.0	0.0	0.0	33.3	0.0	0.0	0.0	0.0	122.1	0.0	1.4	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	2.2	0.0	393.9	0.0	7.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.1	33.0	0.5	0.0	0.0	0.3	6.4	37.4	0.0	0.5	3.6	24.7	2.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.1	11.8	0.7	0.4	0.1	2.5	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.6	0.6	0.5	1.8	0.6	0.7	0.6	0.5	0.5	0.5	0.6	0.7	0.0	0.0	0.0	0.3	42.6	0.0	0.0	0.0	0.0	0.0	0.1	0.3	1.3	120.1	0.0	60.7	0.0	0.2	0.0	12424.2	156.5	0.0	0.0	0.0	0.0	7.5	261.9	149.7	0.1	0.0	1.2	0.1	2.6	0.0	129.2	0.0	105.3	7459.2	1.5	0.0	0.1	1061.1	0.0	166.0	0.0	0.0	0.0	8.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	3975.2	0.0	0.0	0.1	15929.5	2014.4	0.0	0.0	0.0	0.0	0.1	0.1	1.5	0.0	0.0	1.4	29.3	0.0	1708.4	0.0
FABP5	"E-FABP, KFABP, PA-FABP"	ENSG00000164687	"Fatty acid binding protein 5"	Q01469	8	81280536-81284777	"Cancer-related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Transporters"	Transport		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 3691.0;vagina: 2600.3"	"Cell type enhanced"	"Detected in all"		"Adipocytes: 2511.2;Alveolar cells type 2: 1891.0;Hofbauer cells: 2385.2;Squamous epithelial cells: 9211.0"	"Group enriched"	"Detected in all"	4	"cervical cancer: 268.3;head and neck cancer: 288.8;urothelial cancer: 73.7"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 1167.2;MOLT-4: 1213.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017831, CAB040577, HPA051895"	Enhanced		Supported	"Plasma membrane,Cytosol"	"Intracellular and membrane"	NA	NA		14000000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 61: Squamous epithelial cells - Keratinization"	Cytosol	"Plasma membrane"	"CAB017831: , CAB040577: , HPA051895: AB_2681654"	"unprognostic (8.76e-2)"	"unprognostic (7.28e-2)"	"unprognostic (1.54e-2)"	"unprognostic (9.04e-2)"	"unprognostic (1.33e-3)"	"unprognostic (1.37e-1)"	"unprognostic (1.95e-3)"	"unprognostic (4.03e-3)"	"unprognostic (2.71e-1)"	"unprognostic (3.13e-1)"	"unprognostic (6.16e-2)"	"unprognostic (3.57e-2)"	"prognostic unfavorable (4.69e-10)"	"unprognostic (1.99e-1)"	"unprognostic (3.72e-1)"	"unprognostic (1.61e-1)"	"unprognostic (6.60e-2)"	379.8	15.5	107.9	137.8	112.9	111.8	241.8	112.3	146.5	1340.4	307.4	256.7	83.3	62.7	4.8	3691.0	22.4	87.7	343.4	116.6	130.7	34.0	27.5	272.5	191.4	162.8	120.5	12.1	73.1	443.0	32.7	338.8	155.7	22.9	210.6	33.3	514.9	17.1	119.1	692.7	122.3	52.4	133.1	127.4	181.2	45.1	118.2	137.6	74.9	306.1	292.9	362.3	2600.3	138.9	76.9	215.9	133.1	0.3	615.7	59.0	0.3	158.0	8.9	123.2	153.3	2.2	100.3	1167.2	86.7	38.3	1.1	69.2	328.9	254.8	103.7	597.6	603.2	449.0	136.2	345.0	54.2	421.6	107.9	45.0	507.0	146.8	306.1	121.3	708.9	328.6	125.9	124.1	73.7	69.3	1213.7	199.9	170.5	785.1	732.1	526.0	0.4	127.7	198.9	951.4	514.4	190.7	74.1	24.7	61.0	230.2	1.2	201.6	97.0	0.1	331.3	1.6	1.4	155.6	70.1	902.2	52.2	396.8	184.9	8.1	14.3	0.9	6.1	16.6	9.3	17.2	6.9	13.7	55.9	10.4	3.1	11.9	5.2	22.3	5.5	54.8	9.8	13.4	107.9	112.9	112.3	146.5	116.6	130.7	162.8	120.5	155.7	133.1	118.2	138.9	2511.2	288.4	1891.0	30.7	93.0	121.0	90.0	881.2	727.3	23.7	22.3	48.6	5.7	2.8	649.8	22.0	45.9	28.0	97.5	420.3	3.9	35.4	29.5	55.7	579.5	662.2	197.2	74.4	7.7	23.8	272.4	140.6	278.8	29.6	55.8	70.1	35.3	1.4	2385.2	21.9	10.9	216.3	175.0	182.2	764.3	46.0	6.2	405.5	206.3	4.7	697.1	273.0	15.5	6.0	16.3	43.3	561.0	5.3	132.9	71.3	10.4	2.3	115.7	43.5	361.6	140.0	336.8	179.4	182.5	9211.0	168.6	27.0	102.3	68.8	419.2	232.6
FABP7	"B-FABP, BLBP"	ENSG00000164434	"Fatty acid binding protein 7"	O15540	6	122779716-122784074	"Metabolic proteins, Predicted intracellular proteins"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 366.1;choroid plexus: 164.8;retina: 175.3;tongue: 199.3"	"Cell type enriched"	"Detected in some"	6	"Muller glia cells: 1407.3"	"Group enriched"	"Detected in many"	6	"glioma: 139.3;renal cancer: 51.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"AF22: 105.5;U-251 MG: 28.8;WM-115: 63.7"	"Region enriched"	"Detected in all"	5	"olfactory bulb: 1195.2"	"Low region specificity"	"Detected in all"			"CAB025488, HPA028825, CAB058697"	Enhanced		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 58: Brain - Synaptic function"	"Cluster 12: NES - Nervous system development"	"Cluster 5: Muller glia cells - Visual perception"	Nucleoplasm	"Golgi apparatus, Cytosol"	"CAB025488: , CAB058697: AB_2665600, HPA028825: AB_10602130"	"prognostic favorable (2.49e-4)"	"unprognostic (1.56e-2)"		"unprognostic (2.53e-3)"	"unprognostic (5.80e-2)"	"unprognostic (2.29e-1)"		"unprognostic (1.14e-1)"	"unprognostic (7.11e-2)"		"unprognostic (2.09e-2)"	"unprognostic (3.42e-2)"	"prognostic unfavorable (1.65e-6)"	"unprognostic (9.83e-2)"	"unprognostic (1.30e-2)"	"unprognostic (2.50e-1)"	"unprognostic (8.66e-2)"	1.9	0.4	184.8	0.1	210.5	0.3	38.0	228.1	366.1	1.2	164.8	0.7	0.1	0.1	0.2	0.8	0.1	0.1	0.3	198.7	176.2	0.8	0.3	0.0	0.1	188.0	175.5	0.1	0.1	0.0	8.0	0.4	171.2	0.3	0.1	175.3	8.8	3.9	8.8	41.8	0.1	0.0	170.8	0.0	0.4	0.2	174.0	1.8	0.0	199.3	0.1	0.2	0.4	182.9	0.0	0.1	105.5	0.0	0.0	0.0	3.8	0.0	0.9	0.0	0.0	0.2	0.1	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	1.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	8.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	1.0	0.1	0.2	0.1	0.2	0.0	0.1	28.8	0.0	0.0	0.0	1.2	0.1	63.7	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	184.8	210.5	228.1	366.1	198.7	176.2	188.0	175.5	171.2	170.8	174.0	182.9	0.1	0.0	0.0	14.0	0.0	12.2	0.3	0.0	0.0	11.6	44.5	38.9	1.3	0.0	0.0	0.0	12.5	4.8	0.4	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	2.9	0.0	228.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	2.9	5.0	1.1	0.0	0.0	0.0	1.4	0.0	0.0	0.1	30.2	0.0	0.0	1407.3	0.0	41.7	0.5	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.0	48.0	0.0	0.5	0.3	0.0	0.3	0.0	18.9	7.1	0.3	0.0	0.0	0.0
FADD	"GIG3, MORT1"	ENSG00000168040	"Fas associated via death domain"	Q13158	11	70203296-70207390	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Apoptosis, Host-virus interaction, Immunity, Innate immunity"		"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 75.0;Ductal cells: 55.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"A-431: 331.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA001464, CAB010209"	Supported		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 34: Non-specific - Transcription"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Nucleoplasm, Cytosol"		"CAB010209: AB_2100622, HPA001464: AB_1848348"	"unprognostic (2.08e-1)"	"prognostic unfavorable (6.35e-4)"	"unprognostic (6.91e-2)"	"unprognostic (9.51e-2)"	"unprognostic (3.89e-1)"	"prognostic unfavorable (8.22e-5)"	"unprognostic (7.25e-3)"	"prognostic unfavorable (2.21e-5)"	"unprognostic (1.16e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.45e-3)"	"unprognostic (2.78e-3)"	"unprognostic (1.29e-1)"	"unprognostic (2.04e-2)"	"unprognostic (2.07e-1)"	"prognostic favorable (3.45e-4)"	"unprognostic (7.29e-2)"	9.8	13.8	10.6	14.0	10.5	8.8	13.6	10.9	10.1	13.1	10.6	14.8	14.1	12.6	17.6	14.3	13.2	12.1	8.4	9.9	10.8	14.2	16.0	10.6	16.9	12.6	10.8	12.5	8.2	9.1	6.4	15.3	11.6	9.2	12.8	4.0	11.3	13.4	10.9	12.5	13.9	10.3	11.2	13.2	14.8	5.7	11.4	20.3	11.3	9.0	16.9	11.4	9.2	11.3	331.2	54.7	26.6	24.3	31.6	25.4	23.8	55.3	43.6	47.5	31.6	47.1	52.3	48.7	51.9	37.1	44.8	47.7	26.3	49.3	36.8	45.7	28.8	22.3	30.6	24.3	28.5	28.0	28.4	25.4	34.5	51.4	64.7	38.1	45.3	26.7	37.0	24.4	42.1	48.5	34.4	49.5	42.1	75.1	89.1	26.3	64.3	47.0	46.8	24.1	23.5	22.3	41.0	38.0	117.1	30.3	41.3	30.7	51.0	36.6	35.7	56.7	53.9	33.8	27.8	28.6	53.2	28.0	52.6	37.1	36.2	28.2	41.7	38.4	47.5	38.7	44.1	48.9	37.1	33.9	44.6	40.7	88.6	37.7	45.3	33.7	45.7	36.1	10.6	10.5	10.9	10.1	9.9	10.8	12.6	10.8	11.6	11.2	11.4	11.3	7.8	0.0	5.3	0.7	12.1	11.9	14.8	18.1	6.2	6.8	14.0	15.7	0.1	14.3	7.7	18.4	0.0	75.0	9.3	22.9	21.5	55.9	0.7	7.3	11.7	15.6	2.4	19.8	1.4	34.7	37.3	10.0	12.8	10.6	1.3	13.8	14.6	8.5	31.2	3.3	1.6	14.3	0.0	11.0	8.8	2.4	13.4	10.8	32.0	2.8	20.9	10.0	18.6	0.5	1.4	49.0	15.3	16.6	9.6	11.8	24.5	33.7	5.4	4.1	0.0	5.2	14.5	10.4	14.2	14.4	10.5	30.8	13.3	18.9	17.4	14.4
FAF1	"CGI-03, hFAF1, HFAF1s, UBXD12, UBXN3A"	ENSG00000185104	"Fas associated factor 1"	Q9UNN5	1	50437028-50960267	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	Apoptosis		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Astrocytes: 202.4;Excitatory neurons: 296.7;Inhibitory neurons: 278.9;Microglial cells: 177.1;Oligodendrocyte precursor cells: 269.9;Oligodendrocytes: 424.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018253, CAB072814"	Approved		Supported	Nucleoplasm		NA	NA		12000	"Cluster 26: Non-specific - Mitochondria"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Nucleoplasm		"CAB072814: , HPA018253: AB_1848351"	"unprognostic (1.52e-1)"	"unprognostic (1.25e-2)"	"unprognostic (6.49e-3)"	"unprognostic (4.69e-2)"	"unprognostic (6.35e-2)"	"unprognostic (1.19e-2)"	"prognostic unfavorable (1.87e-5)"	"unprognostic (2.51e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.82e-1)"	"unprognostic (9.52e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.17e-1)"	"unprognostic (9.00e-2)"	"unprognostic (2.01e-3)"	"unprognostic (6.42e-3)"	18.2	16.8	21.0	9.2	22.0	21.0	18.5	21.8	27.5	18.9	18.7	23.7	12.4	18.2	11.7	23.1	15.7	8.7	34.9	22.3	22.1	21.5	23.6	14.9	13.1	21.5	21.5	19.9	26.2	23.2	20.6	10.6	22.0	18.5	12.7	19.6	18.1	16.3	67.9	28.1	16.4	13.4	21.8	14.0	18.2	47.8	21.2	22.2	18.3	37.6	14.1	21.4	18.7	25.9	37.4	27.1	23.1	39.3	22.4	21.1	33.9	35.5	32.1	53.9	48.8	30.4	26.0	59.9	25.7	30.5	47.5	27.2	37.3	33.1	45.9	40.1	33.5	49.9	33.5	31.6	36.4	54.3	28.5	19.8	29.4	57.0	69.4	27.8	29.5	44.5	58.9	0.2	28.1	15.0	56.6	43.0	30.6	49.3	19.2	52.1	50.7	0.0	54.9	33.1	0.3	28.6	32.3	64.9	56.4	32.0	20.4	64.1	18.2	30.4	37.3	37.8	0.2	45.1	50.6	69.3	0.0	77.6	35.7	1.1	2.1	4.9	4.0	2.7	5.5	2.5	3.6	4.0	3.6	4.2	4.3	2.8	0.7	4.3	3.5	2.9	6.1	1.6	21.0	22.0	21.8	27.5	22.3	22.1	21.5	21.5	22.0	21.8	21.2	25.9	17.9	6.4	18.2	202.4	26.9	21.4	38.5	27.8	33.6	19.9	16.9	16.9	43.9	11.5	27.2	16.5	27.1	14.2	18.0	13.1	29.4	8.8	75.1	15.1	15.6	14.2	11.4	44.6	296.7	11.6	28.2	16.0	29.0	16.9	5.7	19.2	10.4	18.2	11.4	16.8	278.9	17.8	6.1	13.6	18.0	117.2	11.1	15.4	16.0	177.1	8.9	20.0	15.5	269.9	424.4	8.5	9.7	10.9	35.4	18.3	20.0	28.3	32.7	33.0	6.6	26.2	20.3	36.9	15.6	37.9	28.1	15.3	27.9	19.6	21.6	34.1
FAF2	"ETEA, KIAA0887, UBXD8, UBXN3B"	ENSG00000113194	"Fas associated factor family member 2"	Q96CS3	5	176447628-176510074	"Predicted intracellular proteins, Predicted membrane proteins"	"Unfolded protein response"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA065968, HPA071246, HPA073828"	Approved		Enhanced	"Endoplasmic reticulum,Lipid droplets"		NA	NA		12000	"Cluster 27: Non-specific - Gene expression"	"Cluster 34: Non-specific - Transcription"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 55: Plasma cells - Humoral immune response"	"Lipid droplets"	"Endoplasmic reticulum"	"HPA065968: AB_2685589, HPA071246: AB_2732176, HPA073828: AB_2686636"	"unprognostic (6.25e-3)"	"unprognostic (9.61e-2)"	"unprognostic (3.52e-3)"	"unprognostic (1.02e-3)"	"unprognostic (4.74e-2)"	"unprognostic (4.47e-2)"	"prognostic unfavorable (1.79e-4)"	"prognostic unfavorable (1.38e-4)"	"unprognostic (6.02e-2)"	"unprognostic (2.68e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.88e-1)"	"unprognostic (2.74e-3)"	"unprognostic (9.03e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.56e-3)"	"unprognostic (1.48e-1)"	15.5	19.7	13.5	15.0	14.1	21.7	17.5	15.0	17.0	16.9	18.1	16.8	15.0	18.6	17.5	16.7	17.3	14.6	11.4	14.0	14.9	14.7	21.0	15.4	16.3	13.5	14.4	20.0	16.2	24.9	14.7	16.7	14.6	18.2	19.2	22.6	16.4	14.7	11.6	19.4	14.7	18.8	13.3	14.9	14.5	21.0	14.7	23.1	19.5	12.8	18.7	18.0	13.1	13.5	36.9	41.1	39.9	44.4	55.4	43.9	54.6	47.2	53.8	52.7	56.6	53.9	64.9	32.1	52.0	50.2	95.6	55.5	57.8	119.6	72.3	128.7	31.8	21.1	40.7	26.4	56.3	46.2	26.4	58.1	51.6	64.5	53.2	34.0	44.3	35.8	30.7	42.6	50.8	61.2	40.6	24.2	32.4	39.8	34.4	39.5	34.7	35.9	44.7	48.0	35.3	37.7	57.5	49.4	52.9	34.1	58.1	36.2	49.9	71.9	38.8	40.1	63.8	36.2	41.6	41.2	45.4	32.5	64.2	9.0	6.8	4.7	6.8	5.6	8.3	4.9	5.6	7.3	8.0	4.8	7.1	6.4	5.6	9.2	12.1	5.3	9.8	5.7	13.5	14.1	15.0	17.0	14.0	14.9	13.5	14.4	14.6	13.3	14.7	13.5	26.4	28.9	54.5	26.8	19.6	5.4	34.4	49.7	16.5	46.3	18.6	18.7	13.4	15.7	44.9	18.4	45.9	34.8	19.2	17.6	11.7	34.0	12.1	24.6	41.0	29.0	19.9	17.5	29.0	37.2	40.8	32.6	23.4	27.6	32.2	32.6	28.2	24.3	22.5	15.2	34.2	15.1	34.6	16.1	8.0	5.6	30.4	17.9	12.4	14.0	23.3	39.6	26.8	31.7	36.1	59.1	12.0	31.2	22.0	32.3	17.3	9.3	41.3	29.9	26.3	36.3	36.6	59.8	51.3	16.6	8.5	57.9	18.4	43.2	17.1	29.0
FAM107A	"DRR1, TU3A"	ENSG00000168309	"Family with sequence similarity 107 member A"	O95990	3	58564117-58627610	"Predicted intracellular proteins"	"Cell cycle, Growth regulation, Stress response"	Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	12	"brain: 1923.8;choroid plexus: 1389.1"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 196.3;Astrocytes: 81.9;Endothelial cells: 121.3;Hepatic stellate cells: 150.6;Muller glia cells: 125.0"	"Cancer enriched"	"Detected in many"	6	"glioma: 110.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"ASC diff: 20.7;HUVEC TERT2: 64.9"	"Low region specificity"	"Detected in all"							HPA055888	Enhanced		Supported	"Nuclear speckles"		NA	NA				"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Nuclear speckles"		"HPA055888: AB_2682957"	"unprognostic (1.20e-2)"	"unprognostic (1.19e-3)"	"unprognostic (1.47e-2)"	"prognostic unfavorable (3.56e-4)"	"unprognostic (3.11e-1)"	"unprognostic (7.80e-3)"	"prognostic favorable (3.38e-4)"	"unprognostic (1.92e-1)"	"unprognostic (1.64e-1)"	"unprognostic (5.73e-2)"	"unprognostic (7.82e-3)"	"unprognostic (2.22e-2)"	"unprognostic (1.33e-2)"	"unprognostic (1.33e-2)"	"unprognostic (2.82e-1)"	"unprognostic (1.92e-1)"	"unprognostic (7.95e-3)"	73.2	7.5	1824.7	8.3	1801.2	0.3	58.6	1490.8	1923.8	34.5	1389.1	36.9	5.4	36.3	53.3	29.2	87.0	16.0	140.4	1745.7	1736.7	45.0	5.5	93.2	3.1	1611.9	1644.5	11.8	23.3	5.9	109.6	29.4	1613.0	80.5	16.0	85.1	40.6	38.0	26.3	23.3	45.2	42.5	1564.5	25.7	37.7	5.7	1698.7	43.9	51.4	32.8	8.6	68.9	41.6	1770.4	0.0	0.0	0.9	0.0	20.7	1.3	0.3	0.1	0.0	0.1	0.2	0.0	0.1	0.1	5.8	0.0	0.2	0.4	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.4	1.4	0.0	0.1	0.1	0.3	64.9	0.0	0.0	0.9	0.0	0.0	0.0	0.3	0.4	0.0	0.1	0.2	0.1	0.2	0.1	0.0	0.2	0.2	0.0	0.1	0.0	0.2	0.2	0.0	3.6	0.3	0.2	0.2	0.1	0.1	0.0	0.1	1.0	0.1	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1824.7	1801.2	1490.8	1923.8	1745.7	1736.7	1611.9	1644.5	1613.0	1564.5	1698.7	1770.4	196.3	6.4	5.5	81.9	0.5	2.2	50.8	0.3	2.2	5.2	2.3	1.3	26.5	4.3	3.2	38.6	52.1	0.1	0.4	0.0	9.8	1.1	14.5	23.2	2.4	121.3	3.6	2.7	1.4	0.2	0.0	18.4	0.0	39.3	1.3	5.9	150.6	1.6	0.0	3.3	5.3	0.0	0.0	2.2	3.7	32.4	32.9	1.9	5.4	14.0	0.0	125.0	0.0	2.0	0.6	0.3	0.0	11.7	1.3	7.3	0.2	4.5	2.3	50.2	6.6	6.6	10.4	0.7	0.4	0.4	2.7	0.0	1.0	0.5	0.0	2.2
FAM107B	"C10orf45, FLJ45505, HITS, MGC11034"	ENSG00000065809	"Family with sequence similarity 107 member B"	Q9H098	10	14518557-14774897	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Oligodendrocytes: 526.5;Proximal tubular cells: 359.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"granulocytes: 63.8;NK-cells: 53.8;T-cells: 106.2"	"Cell line enhanced"	"Detected in all"		"Daudi: 373.0;HDLM-2: 449.6;Karpas-707: 309.6;THP-1: 294.4"	"Low region specificity"	"Detected in all"							"HPA039661, HPA058814, HPA073195"	Approved		Supported	"Nucleoplasm,Golgi apparatus"		NA	NA		15000	"Cluster 20: T-cells - T-cell receptor"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm	"Golgi apparatus"	"HPA039661: AB_10794751, HPA058814: AB_2683825, HPA073195: AB_2732221"	"unprognostic (1.24e-1)"	"unprognostic (1.91e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.80e-2)"	"unprognostic (8.90e-2)"	"unprognostic (1.09e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.36e-1)"	"unprognostic (6.82e-2)"	"unprognostic (5.60e-2)"	"unprognostic (4.63e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.80e-1)"	"unprognostic (6.93e-2)"	"unprognostic (7.01e-2)"	"unprognostic (3.53e-2)"	48.4	44.7	82.3	90.2	150.8	171.5	44.3	112.4	112.5	42.2	90.8	64.2	32.7	48.2	11.4	22.8	20.6	66.1	11.1	84.2	102.1	119.6	147.3	64.8	152.3	136.8	125.9	7.3	70.6	70.0	21.3	22.2	130.7	27.6	42.5	15.2	68.6	113.7	3.5	22.2	55.9	31.4	95.5	50.6	122.8	37.3	118.7	48.0	12.6	9.3	134.0	66.7	17.1	223.6	60.8	129.1	50.3	3.4	7.6	1.7	21.3	59.7	85.8	35.9	25.6	79.9	49.9	373.0	52.8	27.5	13.4	18.6	16.1	36.4	63.5	449.6	13.9	10.3	55.6	95.0	26.7	136.6	23.3	4.2	28.0	14.9	7.2	42.4	154.6	72.5	1.1	309.6	28.2	15.6	33.6	39.5	12.5	72.7	28.2	240.8	39.1	140.2	81.9	39.0	18.7	53.5	23.6	12.4	39.0	44.7	46.0	294.4	50.8	37.0	31.2	118.3	20.3	136.2	131.7	241.3	6.5	117.5	10.1	52.3	6.0	63.8	100.2	7.1	97.7	12.4	79.4	85.0	5.2	12.6	105.7	106.2	25.2	53.8	14.9	3.5	78.0	74.8	82.3	150.8	112.4	112.5	84.2	102.1	136.8	125.9	130.7	95.5	118.7	223.6	12.8	105.8	44.4	7.2	203.6	89.7	147.1	25.4	16.5	4.8	94.6	30.4	4.1	134.4	52.5	286.9	2.1	18.1	194.7	65.9	223.0	44.3	27.0	234.9	98.7	37.8	14.3	22.7	1.6	106.8	38.2	49.7	175.3	268.2	119.2	32.7	72.8	177.4	37.1	201.9	7.3	110.5	36.7	53.9	120.9	53.2	2.5	110.7	51.6	15.0	68.8	13.6	198.8	11.1	526.5	90.3	44.3	4.9	176.6	139.6	25.9	359.9	85.3	15.0	0.0	5.4	64.6	56.2	35.7	8.3	82.3	62.5	237.7	3.8	39.9	240.2
FAM110A	"bA371L19.3, C20orf55"	ENSG00000125898	"Family with sequence similarity 110 member A"	Q9BQ89	20	833715-857463	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skin 1: 71.2"	"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 71.7;Extravillous trophoblasts: 138.2;Langerhans cells: 74.2;Macrophages: 70.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	6	"basophil: 543.5;eosinophil: 163.4;intermediate monocyte: 160.6;non-classical monocyte: 248.6"	"Group enriched"	"Detected in all"	9	"granulocytes: 543.5;monocytes: 248.6"	"Cell line enhanced"	"Detected in all"		"SK-BR-3: 84.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB034110, HPA069240"	Uncertain		Uncertain	Nucleoplasm,Vesicles,Cytosol		Yes	Yes			"Cluster 10: Basophils - Unknown function"	"Cluster 31: Skin - Epidermis development"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 51: Myeloid cells - Hemostasis"	"Nucleoplasm, Vesicles"	Cytosol	"CAB034110: AB_1562838, HPA069240: AB_2686103"	"unprognostic (6.33e-2)"	"unprognostic (2.53e-2)"	"unprognostic (1.57e-2)"	"unprognostic (3.43e-2)"	"unprognostic (1.81e-1)"	"unprognostic (3.37e-2)"	"unprognostic (4.90e-3)"	"unprognostic (5.55e-2)"	"unprognostic (6.01e-2)"	"unprognostic (4.78e-2)"	"unprognostic (2.35e-2)"	"unprognostic (2.47e-1)"	"prognostic unfavorable (4.42e-4)"	"unprognostic (9.64e-3)"	"unprognostic (1.17e-2)"	"unprognostic (6.42e-3)"	"unprognostic (4.21e-3)"	4.2	5.5	4.2	5.9	5.2	8.8	9.0	3.1	3.6	10.1	3.9	5.5	10.0	2.5	4.7	39.3	2.5	2.3	4.0	2.8	3.4	8.8	3.6	12.3	6.7	5.5	5.3	2.8	5.5	11.0	7.9	6.6	5.6	19.3	3.2	1.2	18.4	3.6	4.0	71.2	9.7	1.1	3.3	23.4	6.1	3.7	6.6	6.9	7.6	0.6	7.8	9.2	18.4	3.6	27.7	7.3	4.1	7.6	4.4	1.9	27.8	8.5	4.7	5.3	4.7	16.0	16.9	8.9	3.7	5.3	7.6	43.7	3.3	22.2	4.4	7.3	2.3	18.6	4.9	4.2	2.0	5.1	6.3	1.2	27.1	7.3	7.1	1.6	3.6	8.1	10.2	21.5	4.9	16.4	14.3	13.8	5.3	17.7	12.3	14.1	7.0	11.7	4.1	19.6	7.7	9.1	7.4	84.0	3.8	1.7	34.9	7.5	4.8	12.6	9.1	11.5	9.6	7.8	7.3	3.8	2.0	13.2	9.2	543.5	28.3	163.4	13.2	160.6	11.7	7.0	23.7	27.2	36.2	11.7	28.1	27.9	15.3	6.9	248.6	3.9	43.0	24.2	4.2	5.2	3.1	3.6	2.8	3.4	5.5	5.3	5.6	3.3	6.6	3.6	3.5	0.0	7.0	0.0	18.5	32.6	17.0	31.6	71.7	0.3	26.7	20.1	2.9	7.2	15.7	11.0	0.0	41.5	24.3	5.1	1.9	10.1	9.9	3.0	1.7	8.0	10.8	16.2	0.5	6.0	138.2	3.6	5.1	5.2	51.5	1.4	17.2	0.7	20.0	5.0	0.4	8.8	16.2	36.7	74.2	24.3	3.4	70.0	7.2	1.9	29.9	0.3	25.7	0.5	0.1	13.4	7.8	1.9	3.5	20.9	16.1	2.4	7.4	2.6	6.6	1.1	4.3	3.4	4.9	57.7	36.8	31.3	26.1	14.2	10.4	24.6
FAM110B	"C8orf72, MGC39325"	ENSG00000169122	"Family with sequence similarity 110 member B"	Q8TC76	8	57994509-58204279	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"Inhibitory neurons: 195.6;Oligodendrocyte precursor cells: 253.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"eosinophil: 13.4;intermediate monocyte: 3.5;non-classical monocyte: 6.8"	"Group enriched"	"Detected in many"	11	"granulocytes: 13.4;monocytes: 6.8"	"Cell line enhanced"	"Detected in many"		"RPTEC TERT1: 12.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008318, HPA011781"	Uncertain		Supported	Mitochondria,Cytosol		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Mitochondria, Cytosol"		"HPA008318: AB_1853892, HPA011781: AB_1853891"	"unprognostic (2.07e-1)"	"unprognostic (6.91e-2)"	"unprognostic (2.27e-1)"	"prognostic unfavorable (3.88e-8)"	"unprognostic (4.09e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.29e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.02e-1)"	"unprognostic (8.72e-2)"	"prognostic favorable (1.44e-4)"	"unprognostic (1.06e-2)"	"prognostic favorable (4.31e-8)"	"unprognostic (2.23e-3)"	"unprognostic (1.97e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.15e-4)"	6.6	1.3	14.1	1.9	11.5	2.2	5.2	18.1	12.0	7.9	8.1	6.6	0.8	5.7	2.2	1.3	5.0	2.7	15.7	15.2	18.1	5.6	5.6	3.8	0.7	11.7	11.2	5.3	1.6	10.9	3.8	2.7	14.0	5.3	1.4	4.0	5.8	6.7	12.0	2.8	3.2	6.0	8.2	20.5	4.6	6.1	11.9	0.7	6.1	6.0	0.7	6.3	4.9	7.4	0.0	1.1	3.9	0.1	1.7	0.6	1.5	7.5	8.6	5.1	2.3	0.0	0.1	0.0	1.4	5.3	4.6	0.0	3.5	0.0	3.9	0.0	3.6	0.7	1.1	4.5	5.8	1.0	0.2	6.1	1.4	0.2	3.2	0.6	0.0	1.7	0.0	0.1	3.9	0.1	0.0	2.7	3.7	5.3	1.6	0.0	4.3	0.0	12.8	0.8	3.7	4.1	0.0	0.5	0.2	4.5	3.4	0.4	0.0	3.6	2.3	0.0	2.6	1.6	0.0	0.0	1.7	0.0	4.3	0.0	1.4	13.4	0.0	3.5	0.0	0.2	0.0	0.0	0.9	0.0	0.0	0.2	0.5	0.0	6.8	0.0	0.1	0.7	14.1	11.5	18.1	12.0	15.2	18.1	11.7	11.2	14.0	8.2	11.9	7.4	4.2	0.0	5.5	39.2	0.5	9.8	22.8	0.2	3.4	10.6	8.9	6.6	27.7	1.5	0.9	23.9	2.1	1.7	0.1	0.1	7.9	8.7	5.8	1.0	10.9	7.5	7.2	0.0	37.5	2.9	21.9	28.1	9.2	2.5	4.5	5.4	14.6	8.0	4.9	6.7	195.6	0.2	4.1	8.7	10.2	2.2	9.9	6.6	16.0	43.1	1.3	20.1	0.0	253.8	9.2	1.7	0.1	14.7	0.2	17.4	0.0	8.8	0.7	6.6	32.9	38.1	19.8	1.2	2.5	1.0	4.1	1.5	1.0	0.5	0.0	6.7
FAM124B	FLJ22746	ENSG00000124019	"Family with sequence similarity 124 member B"	Q9H5Z6	2	224378698-224402107	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 8.5"	"Group enriched"	"Detected in some"	4	"Adipocytes: 13.8;Endothelial cells: 10.8;Erythroid cells: 9.4;granulocytes: 4.5"	"Cancer enriched"	"Detected in many"	10	"testis cancer: 7.3"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 29.5;eosinophil: 17.2"	"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	7	"HUVEC TERT2: 103.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA070240	Approved		Approved	Nucleoplasm,Mitochondria		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 28: Placenta - Pregnancy"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Nucleoplasm	Mitochondria	"HPA070240: AB_2686238"	"unprognostic (2.01e-1)"	"unprognostic (1.83e-1)"	"unprognostic (6.87e-3)"	"unprognostic (2.49e-1)"	"unprognostic (7.10e-2)"	"unprognostic (1.72e-2)"	"unprognostic (1.28e-2)"	"unprognostic (5.78e-2)"	"unprognostic (3.19e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.57e-1)"	"unprognostic (3.36e-1)"	"unprognostic (7.61e-3)"	"unprognostic (1.36e-2)"	"unprognostic (4.30e-1)"	"unprognostic (2.25e-1)"	"unprognostic (5.80e-3)"	5.2	0.5	1.4	1.1	1.2	4.7	4.3	1.4	1.7	1.5	0.9	0.9	1.0	1.6	0.3	1.4	1.2	1.2	1.8	1.3	1.6	0.6	1.9	2.3	0.7	1.8	1.7	0.4	0.4	2.4	0.2	8.5	1.5	0.5	1.0	0.2	0.8	0.5	1.2	1.8	1.0	2.3	1.6	0.5	0.6	0.3	1.7	1.1	1.0	4.6	0.7	1.5	1.4	1.1	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	5.5	0.1	0.0	0.0	0.0	15.0	0.0	0.1	0.0	0.0	0.0	103.4	0.0	4.8	0.2	0.0	0.1	0.0	0.1	6.1	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.7	7.5	0.2	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	29.5	3.0	17.2	0.2	2.3	0.0	0.0	0.7	0.0	7.9	0.0	0.0	0.0	0.1	5.4	0.8	0.0	2.5	1.1	1.4	1.2	1.4	1.7	1.3	1.6	1.8	1.7	1.5	1.6	1.7	1.1	13.8	0.0	0.0	0.0	0.1	0.8	0.0	0.0	0.0	0.3	0.1	0.1	0.5	0.0	0.0	0.0	0.0	0.4	0.7	0.0	0.0	0.0	1.2	0.3	0.2	10.8	0.0	9.4	0.2	0.0	0.1	0.4	0.0	0.8	4.5	0.0	2.2	0.4	0.4	0.0	0.2	0.0	0.0	0.9	0.6	0.0	0.0	0.7	0.0	1.0	0.5	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.3	0.0	0.1	0.1	0.0	0.1	1.1	0.1	0.0	0.0
FAM126A	"DRCTNNB1A, HCC, HYCC1, hyccin"	ENSG00000122591	"Family with sequence similarity 126 member A"	Q9BYI3	7	22889371-23014130	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Cataract, Disease variant, Leukodystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Oligodendrocytes: 133.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042873	Approved		Supported	"Plasma membrane,Cytosol"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Plasma membrane, Cytosol"		"HPA042873: AB_2678207"	"unprognostic (7.94e-2)"	"unprognostic (2.53e-2)"	"unprognostic (1.58e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.96e-1)"	"unprognostic (7.38e-2)"	"unprognostic (3.54e-4)"	"unprognostic (1.35e-1)"	"unprognostic (9.76e-3)"	"unprognostic (1.30e-2)"	"unprognostic (7.23e-2)"	"unprognostic (6.19e-2)"	"prognostic unfavorable (6.04e-7)"	"prognostic unfavorable (5.99e-4)"	"unprognostic (1.87e-1)"	"unprognostic (2.40e-2)"	"prognostic unfavorable (9.03e-4)"	14.9	4.7	5.0	8.5	6.9	4.2	12.2	4.4	6.5	9.7	7.9	9.7	9.4	8.7	1.4	12.2	6.7	11.4	10.5	12.1	4.5	4.7	8.5	13.7	11.5	5.0	5.9	6.6	6.2	2.3	5.0	14.8	5.4	5.9	4.4	4.9	6.8	4.8	25.0	4.9	6.9	11.5	4.5	11.8	4.6	12.0	6.3	4.2	6.6	15.3	9.2	9.4	11.2	7.8	22.4	12.4	63.6	22.3	61.3	100.9	10.6	103.0	101.8	41.6	63.9	19.8	10.6	13.3	15.9	82.6	87.2	7.7	44.3	14.7	72.6	6.6	22.4	14.7	18.1	13.0	48.0	19.3	15.7	41.1	9.2	85.0	61.3	83.4	42.5	7.5	30.4	58.6	77.5	7.9	10.8	24.2	63.0	0.1	22.9	15.7	63.5	9.5	13.1	11.2	10.4	0.1	38.1	0.4	19.2	52.5	8.2	20.4	51.0	150.0	18.3	71.8	37.4	67.2	30.6	60.9	91.1	12.5	112.6	4.7	2.9	13.7	1.4	7.8	1.3	6.4	2.6	1.3	3.9	7.4	0.9	1.5	0.3	2.1	9.8	1.6	4.0	2.5	5.0	6.9	4.4	6.5	12.1	4.5	5.0	5.9	5.4	4.5	6.3	7.8	27.8	3.2	15.1	19.6	29.1	25.5	5.1	8.3	15.9	60.3	5.4	32.4	21.9	2.8	4.2	3.7	2.1	11.8	28.8	0.5	0.0	6.8	49.0	12.5	22.4	31.4	7.7	19.8	13.6	4.8	15.5	42.9	2.6	11.3	8.2	8.6	26.0	17.7	15.2	16.8	13.6	3.0	2.0	25.1	55.2	22.4	20.2	31.5	35.6	47.8	24.0	6.8	11.3	23.6	133.2	3.6	1.4	19.5	26.4	4.7	8.3	5.7	2.4	4.6	19.7	24.0	31.7	72.2	11.1	35.0	24.0	6.0	20.6	12.2	4.7	6.5
FAM126B	"HYCC2, MGC39518"	ENSG00000155744	"Family with sequence similarity 126 member B"	Q8IXS8	2	200973718-201071671	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cone photoreceptor cells: 164.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in all"	4	"neutrophil: 25.7"	"Lineage enriched"	"Detected in all"	6	"granulocytes: 25.7"	"Cell line enhanced"	"Detected in all"		"U-266/84: 58.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036166, HPA036167, HPA067307"	Uncertain		Supported	"Nucleoplasm,Cell Junctions"		NA	NA			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 34: Non-specific - Transcription"	"Cluster 16: U-266 - Nucleosome"	"Cluster 52: Non-specific - Transcription"	"Cell Junctions"	Nucleoplasm	"HPA036166: AB_10696651, HPA036167: AB_2674982, HPA067307: AB_2685821"	"unprognostic (7.47e-3)"	"unprognostic (5.54e-2)"	"unprognostic (2.52e-1)"	"unprognostic (9.08e-2)"	"unprognostic (8.96e-2)"	"unprognostic (3.01e-3)"	"unprognostic (1.11e-2)"	"unprognostic (2.61e-3)"	"unprognostic (1.34e-1)"	"unprognostic (1.48e-2)"	"unprognostic (1.79e-2)"	"unprognostic (1.90e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.44e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.10e-2)"	7.8	4.5	4.7	6.3	5.2	17.4	4.8	15.9	8.1	4.0	2.3	7.2	6.8	3.9	4.0	8.2	3.2	4.3	3.4	6.5	3.1	7.8	7.4	5.4	5.9	3.3	3.2	3.8	4.9	4.9	3.8	5.0	3.3	3.7	6.4	10.4	4.3	2.7	3.0	7.1	6.6	3.9	0.6	6.8	7.5	4.5	5.2	5.9	6.9	3.6	6.1	3.8	4.4	6.1	5.4	2.8	3.9	4.2	4.0	5.3	8.2	5.0	3.0	4.0	3.7	7.2	6.2	4.9	4.8	5.1	3.7	6.5	8.1	3.1	6.0	7.1	4.9	14.3	7.6	6.7	3.3	17.6	11.9	2.3	3.9	5.5	3.3	3.1	3.9	5.2	13.4	17.6	4.1	3.3	10.5	11.4	2.8	3.5	4.7	6.1	5.9	4.6	3.7	5.9	7.7	3.8	5.3	6.0	4.7	5.1	4.2	7.7	7.9	7.5	5.3	3.7	4.6	13.1	58.8	10.5	4.3	6.7	5.4	2.6	1.8	6.3	3.8	2.4	4.0	2.6	3.2	3.0	1.6	2.7	3.1	3.7	25.7	3.1	2.7	1.1	2.4	1.9	4.7	5.2	15.9	8.1	6.5	3.1	3.3	3.2	3.3	0.6	5.2	6.1	21.5	28.9	23.9	45.1	29.3	52.6	10.7	17.0	23.3	52.9	16.3	9.4	17.2	27.1	20.4	20.2	164.7	16.6	38.3	59.1	17.6	10.6	9.1	12.7	16.4	22.7	37.1	23.1	113.4	10.5	10.1	15.9	24.5	16.2	24.7	19.9	35.3	21.0	12.0	26.9	98.3	23.4	22.4	33.9	51.6	6.6	31.7	21.1	30.2	45.0	41.5	20.3	73.2	57.8	64.6	21.3	31.1	25.6	34.0	13.2	47.3	16.4	23.1	42.7	19.7	14.8	15.9	32.8	22.9	31.6	74.2	17.4	35.6	15.3	22.0	19.6
FAM162A	"C3orf28, E2IG5"	ENSG00000114023	"Family with sequence similarity 162 member A"	Q96A26	3	122384176-122412334	"Predicted membrane proteins"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Basal respiratory cells: 625.3;Distal tubular cells: 540.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035856, HPA075611"	Approved		Supported	Mitochondria		NA	NA		19000	"Cluster 27: Non-specific - Gene expression"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 21: OE19 - Mitochondria"	"Cluster 10: Non-specific - Unknown function"	Mitochondria		"HPA035856: AB_10611965, HPA075611: "	"unprognostic (1.17e-2)"	"unprognostic (1.42e-1)"	"unprognostic (5.64e-2)"	"unprognostic (1.10e-1)"	"unprognostic (3.99e-1)"	"unprognostic (7.84e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.15e-1)"	"unprognostic (5.91e-3)"	"unprognostic (8.74e-2)"	"unprognostic (1.95e-2)"	"unprognostic (7.91e-3)"	"unprognostic (4.75e-2)"	"unprognostic (2.69e-1)"	"unprognostic (1.06e-1)"	"unprognostic (4.10e-2)"	"prognostic favorable (3.93e-4)"	49.0	105.7	54.8	31.3	60.2	39.9	43.9	57.3	82.2	84.5	57.1	145.9	56.1	49.5	59.4	207.6	49.7	46.2	174.2	57.1	58.5	107.6	200.3	32.0	32.9	55.9	57.2	84.3	133.9	116.6	51.0	17.6	55.6	74.6	149.0	83.5	59.8	49.2	141.0	89.8	56.3	44.6	56.6	31.7	93.2	43.6	58.8	34.7	44.1	142.6	42.7	76.9	131.5	55.6	132.0	27.7	40.4	75.6	72.1	66.4	20.7	52.9	46.8	49.0	123.9	69.4	58.7	142.1	89.2	18.2	40.3	89.8	73.5	128.1	130.0	74.0	55.1	115.6	44.0	125.8	47.4	114.0	39.6	77.3	65.5	46.7	97.9	164.3	66.0	137.7	79.2	55.6	71.1	52.0	116.9	137.9	59.5	294.9	144.4	69.5	57.8	186.9	144.3	314.9	60.1	48.1	39.4	92.4	114.3	59.9	57.9	55.7	47.0	48.4	34.6	28.7	55.6	108.8	39.9	144.8	143.3	109.7	22.8	9.9	25.8	75.7	58.3	68.2	86.9	75.3	79.5	74.0	84.6	68.1	85.1	88.6	8.5	50.6	75.9	70.4	80.4	38.8	54.8	60.2	57.3	82.2	57.1	58.5	55.9	57.2	55.6	56.6	58.8	55.6	55.7	28.9	46.0	41.1	68.2	128.1	155.3	625.3	82.0	31.5	80.6	109.5	338.4	84.4	188.6	130.6	47.9	51.4	47.9	477.5	540.0	148.2	102.5	82.0	30.1	49.8	106.9	47.7	33.0	177.6	47.8	78.7	84.6	79.2	85.7	59.3	44.6	280.4	92.7	38.7	30.4	374.3	240.1	66.7	108.9	33.1	134.5	61.2	104.9	7.5	108.9	79.7	45.3	22.1	21.6	141.6	313.2	148.6	61.2	121.4	186.2	466.2	95.5	29.9	105.2	83.2	315.3	146.4	68.3	315.1	132.8	47.2	66.0	121.1	358.4	210.9
FAM172A	"C5orf21, DKFZP564D172, Toupee"	ENSG00000113391	"Family with sequence similarity 172 member A"	Q8WUF8	5	93617725-94111699	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"Astrocytes: 174.3;Excitatory neurons: 259.9;Inhibitory neurons: 297.7;Microglial cells: 227.7;Oligodendrocyte precursor cells: 264.9;Oligodendrocytes: 343.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012299, HPA045505"	Approved		Supported	Nucleoplasm,Cytosol	"Intracellular and membrane"	NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 21: Non-specific - Transcription"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Nucleoplasm	Cytosol	"HPA012299: AB_1845724, HPA045505: AB_2679354"	"unprognostic (1.12e-2)"	"unprognostic (2.17e-1)"	"unprognostic (3.10e-2)"	"unprognostic (7.78e-2)"	"unprognostic (2.03e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.98e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.57e-2)"	"unprognostic (2.52e-3)"	"unprognostic (1.91e-1)"	"prognostic unfavorable (4.43e-4)"	"unprognostic (1.38e-1)"	"unprognostic (6.56e-2)"	"unprognostic (1.72e-2)"	"unprognostic (1.03e-2)"	13.6	9.7	10.2	8.1	10.7	7.6	12.9	12.8	11.1	12.7	7.3	8.4	7.5	12.7	10.0	11.6	12.2	9.4	9.3	10.2	11.0	12.3	5.3	9.1	9.2	10.4	9.7	15.0	9.6	12.4	7.1	8.3	10.2	12.4	8.1	14.8	10.9	14.3	3.0	7.7	8.9	11.5	10.6	9.8	8.8	5.6	10.4	9.8	15.5	6.7	9.0	9.4	7.4	11.4	7.5	8.8	20.4	23.1	24.0	29.3	10.7	16.4	12.1	6.7	6.5	6.0	10.1	10.7	11.6	18.7	11.8	6.3	6.3	22.2	15.4	7.4	7.7	14.2	17.0	3.6	10.0	11.5	15.8	25.3	12.2	6.2	11.8	23.7	15.0	10.1	3.0	3.3	27.3	8.3	9.3	8.1	3.1	13.8	7.0	10.3	21.7	10.3	10.1	14.5	17.5	32.1	12.4	5.0	11.6	12.8	12.8	12.9	14.8	15.6	14.1	10.3	18.7	13.4	20.8	11.9	24.0	11.9	29.1	12.4	4.0	5.4	8.2	5.4	8.4	6.7	6.1	6.2	5.3	6.3	6.8	6.9	9.3	9.7	4.1	5.0	6.9	4.8	10.2	10.7	12.8	11.1	10.2	11.0	10.4	9.7	10.2	10.6	10.4	11.4	27.8	54.5	26.4	174.3	40.0	12.2	25.0	26.4	23.3	49.5	31.4	28.2	21.5	22.8	23.4	11.0	31.3	13.0	47.4	14.3	60.7	19.9	47.7	29.2	34.9	25.4	16.9	10.3	259.9	21.2	13.7	32.6	21.9	21.9	25.3	22.7	21.8	14.9	11.3	42.1	297.7	13.9	22.4	21.3	12.1	34.2	38.5	18.0	21.4	227.7	27.9	37.4	58.7	264.9	343.8	20.1	14.7	36.5	17.3	19.7	27.7	35.2	47.5	54.5	13.1	39.5	30.7	22.4	26.1	25.8	10.1	10.9	37.4	30.7	16.4	24.4
FAM184A	"C6orf60, FLJ13942"	ENSG00000111879	"Family with sequence similarity 184 member A"	Q8NB25	6	118959763-119149387	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 43.3;choroid plexus: 30.5"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 103.0;Astrocytes: 261.2;Oligodendrocyte precursor cells: 88.4;Syncytiotrophoblasts: 266.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 11.8;HEK 293: 11.1;Hep G2: 7.9;JURKAT: 11.6;K-562: 10.4;SCLC-21H: 8.5;SH-SY5Y: 8.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034571, HPA034572, HPA041955"	Uncertain		Supported	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	"Golgi apparatus"	"Nucleoplasm, Cytosol"	"HPA034571: AB_10602498, HPA034572: AB_2674228, HPA041955: AB_2677768"	"unprognostic (1.21e-1)"	"unprognostic (4.11e-3)"	"unprognostic (6.95e-2)"	"unprognostic (3.40e-3)"	"unprognostic (6.80e-2)"	"unprognostic (1.64e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.18e-4)"	"unprognostic (2.59e-1)"	"unprognostic (3.19e-1)"	"unprognostic (5.16e-4)"	"unprognostic (8.38e-3)"	"unprognostic (4.02e-2)"	"unprognostic (9.11e-3)"	"unprognostic (8.16e-3)"	"unprognostic (5.70e-2)"	"unprognostic (2.32e-1)"	3.1	1.6	33.3	1.3	36.3	0.2	4.7	37.3	43.3	3.6	30.5	3.5	3.0	2.5	3.0	1.4	3.2	1.8	2.5	34.3	33.0	6.7	6.3	9.9	3.5	31.9	32.4	4.5	3.2	4.8	11.0	23.0	32.4	3.9	0.9	16.3	3.3	2.8	0.9	1.7	1.6	1.6	29.1	0.6	1.7	16.9	32.6	0.6	7.0	2.2	3.5	2.4	2.1	34.5	0.1	0.3	11.8	0.9	0.3	0.3	0.0	0.6	0.4	0.5	0.9	2.0	1.1	0.9	0.0	0.2	5.3	0.0	3.4	0.0	0.2	1.3	11.1	0.1	0.9	7.9	0.2	0.0	0.6	0.4	0.1	0.1	0.0	0.3	0.0	11.6	10.4	0.7	0.3	0.3	0.4	0.1	6.0	0.6	1.3	0.0	0.1	0.0	0.1	0.1	8.5	8.0	0.7	0.6	1.8	2.2	2.1	1.4	0.3	0.8	0.5	0.2	2.9	4.9	3.3	0.3	1.5	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.3	0.0	33.3	36.3	37.3	43.3	34.3	33.0	31.9	32.4	32.4	29.1	32.6	34.5	21.0	48.1	103.0	261.2	0.7	2.4	5.9	0.4	11.4	35.2	3.8	8.8	6.4	2.8	17.7	3.7	29.2	61.4	0.6	0.4	17.6	1.0	22.9	2.0	2.0	5.3	6.0	0.4	66.9	1.1	18.9	11.8	1.5	0.8	6.3	8.9	1.8	4.0	5.6	13.5	55.5	0.6	0.0	0.3	1.8	9.2	3.7	1.0	0.0	34.7	0.0	11.1	0.0	88.4	20.6	0.3	1.2	7.2	2.7	1.6	0.4	3.1	37.3	28.4	6.6	45.2	4.1	61.8	16.0	4.2	3.4	266.4	5.8	1.4	0.7	2.0
FAM189B	"C1orf2, cote1"	ENSG00000160767	"Family with sequence similarity 189 member B"	P81408	1	155247205-155255483	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Horizontal cells: 40.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006659, HPA050674"	Uncertain		Supported	Nucleoplasm		NA	NA				"Cluster 72: Non-specific - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 62: Horizontal cells - Visual perception"	Nucleoplasm		"HPA006659: AB_1078339, HPA050674: AB_2681213"	"unprognostic (1.56e-2)"	"prognostic unfavorable (4.98e-4)"	"unprognostic (1.44e-2)"	"prognostic unfavorable (9.59e-5)"	"unprognostic (1.46e-2)"	"unprognostic (4.86e-3)"	"prognostic unfavorable (3.43e-4)"	"unprognostic (2.70e-2)"	"unprognostic (3.49e-2)"	"unprognostic (2.73e-1)"	"unprognostic (5.15e-2)"	"unprognostic (1.64e-1)"	"prognostic unfavorable (3.43e-7)"	"unprognostic (4.16e-2)"	"unprognostic (5.28e-2)"	"unprognostic (1.41e-3)"	"unprognostic (3.25e-2)"	12.1	14.5	7.3	3.6	5.1	1.7	11.1	6.8	14.9	13.5	0.2	22.0	5.3	17.1	0.6	17.5	12.3	1.9	11.3	5.9	4.6	11.3	8.6	10.6	2.2	12.5	4.8	12.0	9.2	4.5	14.0	3.2	15.7	13.9	1.3	1.4	11.1	4.1	28.4	13.5	11.4	3.3	5.9	8.9	15.6	13.1	14.9	1.4	9.8	5.7	1.4	21.1	14.1	6.3	22.4	18.9	9.2	31.1	9.6	14.8	4.2	20.9	10.5	10.9	9.8	21.5	13.6	21.9	27.0	11.2	7.8	21.2	12.1	16.7	2.4	27.5	39.6	17.3	12.3	11.0	16.4	4.7	18.4	16.5	10.3	10.5	6.4	11.4	15.3	14.7	13.3	7.2	8.8	14.0	19.9	8.3	20.6	13.0	39.2	21.3	14.5	24.7	7.2	8.9	19.9	30.1	8.9	25.5	23.8	4.9	27.5	16.7	17.4	14.5	18.3	15.4	21.7	16.1	17.4	10.5	17.1	9.0	12.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	7.3	5.1	6.8	14.9	5.9	4.6	12.5	4.8	15.7	5.9	14.9	6.3	10.1	3.2	2.2	7.5	6.1	6.0	12.8	10.0	17.6	18.0	10.8	9.7	12.2	8.6	5.3	12.9	18.8	12.9	3.9	8.0	1.9	13.7	3.7	4.8	9.2	13.3	6.7	9.2	14.8	10.5	15.1	9.2	8.2	8.0	5.7	13.9	13.6	7.5	8.0	40.4	14.5	10.2	12.2	11.2	4.7	8.0	9.6	6.0	7.2	4.7	6.0	7.5	8.2	8.0	8.5	11.9	5.2	9.1	4.3	19.2	12.3	5.9	6.0	19.3	0.0	8.5	9.6	23.2	13.6	13.3	8.2	14.4	4.3	12.6	9.6	12.6
FAM207A	"C21orf70, PRED56"	ENSG00000160256	"Family with sequence similarity 207 member A"	Q9NSI2	21	44940012-44976989	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034178, HPA036354, HPA036559"	Approved		Supported	Nucleoplasm,Nucleoli		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 36: HEL - Hemostasis"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoli	Nucleoplasm	"CAB034178: AB_1564323, HPA036354: AB_10672242, HPA036559: "	"unprognostic (1.83e-1)"	"unprognostic (9.07e-2)"	"unprognostic (4.99e-3)"	"unprognostic (1.05e-2)"	"unprognostic (1.37e-2)"	"unprognostic (1.14e-3)"	"prognostic unfavorable (7.04e-4)"	"unprognostic (3.23e-2)"	"unprognostic (4.31e-2)"	"unprognostic (1.93e-2)"	"unprognostic (1.84e-2)"	"unprognostic (7.94e-2)"	"prognostic unfavorable (7.80e-4)"	"unprognostic (1.81e-1)"	"unprognostic (2.56e-1)"	"unprognostic (4.12e-1)"	"unprognostic (5.77e-2)"	19.8	20.9	9.8	11.3	11.0	12.6	17.6	13.9	16.1	14.3	5.7	22.3	11.1	15.1	2.1	17.9	14.5	2.2	53.6	10.6	9.8	20.3	31.1	13.0	9.3	11.1	10.8	11.6	21.5	6.0	9.4	5.3	10.7	14.2	3.7	6.1	15.7	5.7	43.3	18.5	14.3	4.8	7.7	23.8	20.2	27.3	12.3	9.4	10.5	14.4	6.5	21.4	13.4	10.0	48.4	51.9	17.2	22.2	8.3	11.4	40.9	32.4	8.7	24.4	19.6	88.1	14.8	49.0	68.7	11.5	35.5	31.8	23.9	35.5	9.7	35.9	72.8	144.6	36.4	75.2	33.1	47.7	18.1	19.9	20.4	22.0	19.2	10.5	26.7	41.6	83.9	33.5	18.6	86.7	45.2	74.3	58.2	36.0	72.1	44.0	18.4	85.7	23.5	19.0	84.0	35.7	43.0	50.7	51.4	12.2	35.4	33.8	35.2	20.4	42.3	27.5	70.8	70.0	65.5	47.6	16.3	81.1	29.1	3.1	4.0	4.1	1.8	4.1	1.8	7.7	3.2	4.3	3.8	5.0	3.5	3.5	2.4	4.4	4.7	8.9	4.0	2.3	9.8	11.0	13.9	16.1	10.6	9.8	11.1	10.8	10.7	7.7	12.3	10.0	13.8	0.0	7.5	5.5	25.6	19.2	31.7	35.3	27.9	22.7	41.4	57.7	22.6	34.3	22.7	18.4	4.2	36.9	28.8	60.0	46.9	68.1	14.8	30.6	30.1	23.3	26.4	29.2	3.2	63.5	70.7	23.3	16.8	20.9	10.2	48.6	26.4	56.3	68.4	6.7	3.8	34.3	12.2	33.3	18.4	38.5	14.6	24.9	24.9	1.0	51.7	36.9	41.2	6.0	2.9	59.3	34.8	12.8	29.4	77.9	84.1	90.2	15.2	18.3	32.9	17.7	36.2	82.0	42.0	35.1	21.0	30.8	19.5	70.7	44.3	39.9
FAM20B	"GXK1, KIAA0475"	ENSG00000116199	"FAM20B glycosaminoglycan xylosylkinase"	O75063	1	179025804-179076567	"Metabolic proteins, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007409	Approved		Supported	"Nucleoplasm,Golgi apparatus"		NA	NA		14000000	"Cluster 21: B-cells - Adaptive immune response"	"Cluster 38: Heart - Muscle contraction"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 6: Erythroid cells - Oxygen transport"	"Golgi apparatus"	Nucleoplasm	"HPA007409: AB_10601649"	"unprognostic (7.58e-2)"	"unprognostic (1.12e-1)"	"unprognostic (4.97e-2)"	"unprognostic (6.23e-3)"	"unprognostic (3.29e-1)"	"unprognostic (3.07e-1)"	"unprognostic (4.76e-2)"	"unprognostic (7.70e-3)"	"unprognostic (7.85e-2)"	"unprognostic (3.93e-2)"	"unprognostic (5.36e-2)"	"unprognostic (1.58e-1)"	"unprognostic (3.76e-1)"	"unprognostic (2.03e-1)"	"unprognostic (1.76e-1)"	"unprognostic (3.67e-2)"	"unprognostic (3.74e-1)"	20.9	22.4	15.0	11.2	17.2	11.7	15.9	12.7	17.1	16.1	7.7	22.2	9.9	18.0	15.4	17.6	15.4	13.6	23.4	18.0	17.2	17.3	16.5	16.3	11.3	14.0	14.6	19.9	11.4	21.4	14.4	17.0	14.5	16.5	14.4	28.7	11.8	19.4	19.6	12.8	11.5	19.4	13.5	12.4	13.6	8.0	15.3	11.5	17.9	25.6	10.8	16.2	12.3	14.7	41.4	37.1	28.2	30.0	49.1	51.4	31.2	33.7	38.3	23.2	20.7	18.7	40.1	21.3	43.2	59.7	19.1	29.3	29.0	24.8	33.8	27.3	19.5	67.9	34.8	23.9	24.5	45.5	41.1	30.1	26.5	31.7	24.5	35.4	29.0	29.2	77.0	30.2	37.5	23.1	19.9	16.4	37.1	46.2	7.9	24.1	29.7	28.4	19.5	46.1	37.5	91.8	35.5	39.7	34.5	39.8	34.4	32.8	30.8	36.7	32.2	51.1	46.0	24.5	48.5	18.2	36.5	21.7	37.3	0.9	0.6	0.2	1.3	0.6	1.3	1.4	0.7	1.1	0.8	1.5	1.1	1.0	0.6	1.6	0.8	1.2	1.0	0.5	15.0	17.2	12.7	17.1	18.0	17.2	14.0	14.6	14.5	13.5	15.3	14.7	16.8	6.4	11.4	16.0	7.5	15.6	12.6	8.9	4.6	15.7	12.2	9.3	40.1	12.8	9.0	18.4	25.0	9.0	9.0	10.6	3.9	8.8	5.2	8.8	17.8	13.8	14.4	43.3	28.3	13.0	7.7	14.6	9.2	14.5	17.1	20.2	9.3	14.2	7.6	38.7	32.0	7.9	10.2	11.6	8.1	5.1	17.7	9.6	16.0	19.7	14.1	9.0	2.1	17.6	32.5	13.7	3.8	21.4	6.2	19.7	5.0	5.9	8.8	21.0	13.1	20.0	17.7	17.6	13.8	9.6	12.9	7.5	8.0	24.1	8.5	24.7
FAM32A	"DKFZP586O0120, OTAG-12"	ENSG00000105058	"Family with sequence similarity 32 member A"	Q9Y421	19	16185380-16192046	"Predicted intracellular proteins"	"Apoptosis, Cell cycle"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051712	Approved		Supported	Nucleoplasm,Nucleoli		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Nucleoplasm, Nucleoli"		"HPA051712: AB_2681582"	"unprognostic (3.20e-2)"	"unprognostic (1.44e-3)"	"unprognostic (1.25e-1)"	"unprognostic (1.16e-3)"	"unprognostic (1.23e-2)"	"unprognostic (2.75e-1)"	"unprognostic (3.31e-2)"	"unprognostic (1.37e-2)"	"unprognostic (3.86e-3)"	"unprognostic (1.18e-3)"	"unprognostic (1.56e-1)"	"unprognostic (9.31e-2)"	"unprognostic (3.23e-2)"	"unprognostic (4.27e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.60e-2)"	"unprognostic (6.49e-3)"	64.5	69.9	64.9	48.2	66.4	94.6	57.1	60.5	69.3	44.6	57.3	68.8	78.2	57.2	49.5	69.6	45.3	53.8	54.8	66.2	62.1	60.7	95.3	51.4	60.9	62.9	63.1	43.3	52.8	54.0	37.8	61.4	63.5	50.0	57.8	28.1	56.3	47.4	50.8	73.3	74.9	52.9	60.1	67.7	68.9	30.6	65.8	64.1	48.6	49.1	59.5	63.4	49.8	64.3	102.8	76.7	118.3	76.8	137.1	104.7	111.8	97.1	109.8	117.5	128.3	106.1	120.4	67.6	165.2	126.4	84.4	76.8	122.4	106.2	102.6	89.6	134.2	125.5	66.2	95.6	110.4	159.4	141.0	121.6	109.4	94.5	86.2	103.8	128.4	137.2	100.2	96.6	117.6	136.0	124.4	165.9	170.6	168.9	187.7	129.3	81.9	111.6	129.6	100.6	101.6	154.3	82.3	77.2	107.8	84.5	65.5	179.5	120.5	90.8	53.9	167.4	123.5	114.5	204.5	107.8	132.0	191.7	80.2	278.1	266.5	547.9	127.5	339.2	136.3	152.9	122.0	140.3	228.8	159.1	146.2	160.5	220.6	161.5	390.0	157.5	185.6	343.3	64.9	66.4	60.5	69.3	66.2	62.1	62.9	63.1	63.5	60.1	65.8	64.3	59.2	44.8	46.2	3.3	54.7	46.7	32.4	61.7	40.9	26.8	56.5	51.9	36.8	55.8	45.6	36.8	20.9	100.9	65.3	119.8	92.0	102.1	17.9	39.5	56.5	58.7	67.8	49.6	6.2	103.5	108.2	52.5	40.2	53.3	62.7	55.0	45.7	99.8	86.5	42.1	6.9	63.8	34.6	75.5	45.8	40.7	38.8	57.2	58.7	6.5	93.4	56.4	84.5	7.1	7.1	136.4	157.3	52.3	49.1	49.6	120.1	85.5	37.8	24.5	26.3	27.9	61.0	26.5	44.3	47.7	53.3	105.8	53.5	56.0	59.6	54.8
FAM83D	"C20orf129, CHICA, dJ616B8.3"	ENSG00000101447	"Family with sequence similarity 83 member D"	Q9H4H8	20	38926312-38953106	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"		Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 84.7;intestine: 83.1;smooth muscle: 95.3"	"Group enriched"	"Detected in many"	4	"Basal squamous epithelial cells: 44.9;Erythroid cells: 72.6;Extravillous trophoblasts: 67.5;Squamous epithelial cells: 71.7;Syncytiotrophoblasts: 152.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	7	"B-cells: 1.1;NK-cells: 1.1;T-cells: 2.0"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA049333, HPA060854"			Supported	"Microtubules,Cytokinetic bridge,Mitotic spindle,Cytosol"		Yes	Yes			"Cluster 26: Non-specific - Mitochondria"	"Cluster 37: Intestine - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 61: Squamous epithelial cells - Keratinization"	"Mitotic spindle"	"Microtubules, Cytokinetic bridge, Cytosol"	"HPA049333: AB_2680717, HPA060854: "	"unprognostic (7.90e-3)"	"unprognostic (4.34e-2)"	"unprognostic (6.41e-2)"	"prognostic unfavorable (1.49e-4)"	"unprognostic (1.95e-1)"	"unprognostic (1.01e-1)"	"prognostic unfavorable (5.44e-6)"	"prognostic unfavorable (9.69e-4)"	"unprognostic (2.21e-2)"	"unprognostic (1.12e-1)"	"prognostic unfavorable (4.73e-5)"	"unprognostic (3.52e-2)"	"prognostic unfavorable (1.81e-14)"	"unprognostic (2.57e-3)"	"unprognostic (5.74e-2)"	"unprognostic (2.82e-1)"	"unprognostic (4.87e-2)"	1.6	1.8	0.8	7.2	1.6	23.3	1.1	0.9	1.4	4.1	0.2	83.1	8.4	1.0	1.6	84.7	1.0	13.6	1.0	0.9	0.5	5.7	3.7	5.2	4.5	0.5	0.4	0.5	0.4	0.2	0.4	3.4	0.5	16.2	8.6	0.2	7.8	1.7	0.2	10.2	34.7	95.3	0.5	1.9	44.9	5.0	0.5	6.6	1.0	0.2	12.2	27.0	17.1	0.9	112.2	67.3	52.0	44.0	5.8	6.5	93.6	49.3	30.2	94.7	57.4	103.4	49.7	28.3	47.6	32.1	73.4	93.1	71.8	83.9	87.9	9.4	28.6	32.6	50.7	75.2	4.7	14.6	16.5	3.3	4.2	54.6	31.4	11.4	52.7	12.3	29.6	39.5	54.4	59.7	22.7	21.3	43.2	64.4	85.1	21.8	96.0	15.6	27.6	28.0	24.3	40.2	143.0	117.4	20.6	48.1	73.6	14.9	25.4	62.4	76.4	71.6	110.1	12.0	19.6	29.0	28.1	21.2	46.7	0.0	0.0	0.0	0.2	0.1	0.9	0.6	1.0	1.1	0.0	1.1	1.1	1.4	0.0	1.1	0.1	0.0	2.0	0.5	0.8	1.6	0.9	1.4	0.9	0.5	0.5	0.4	0.5	0.5	0.5	0.9	3.9	0.0	1.3	0.3	2.3	2.3	5.8	7.0	44.9	0.0	2.8	9.0	0.8	1.5	18.0	0.0	0.0	17.3	6.3	6.5	0.0	0.1	0.5	1.1	1.6	2.2	1.8	72.6	3.7	0.0	67.5	2.7	18.3	2.1	0.0	8.2	1.8	5.7	4.8	0.0	1.2	6.0	4.1	1.6	0.5	0.6	0.3	2.6	0.0	0.0	0.0	0.0	0.0	0.5	0.5	0.1	6.0	0.0	12.5	1.6	1.7	8.3	4.5	0.0	19.7	0.3	4.0	15.7	18.3	71.7	1.8	152.6	5.2	0.3	10.2	4.1
FAM83G	"FLJ41564, PAWS1"	ENSG00000188522	"Family with sequence similarity 83 member G"	A6ND36	17	18968789-19004764	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 51.3;skin 1: 67.3"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 77.8;Basal squamous epithelial cells: 39.3;Distal enterocytes: 46.5;Squamous epithelial cells: 55.3;Suprabasal keratinocytes: 68.5"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 22.2"	"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in single"		"basophil: 1.1"	"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA023369, HPA023940"	Enhanced		Approved	Cytosol		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 31: Skin - Epidermis development"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 61: Squamous epithelial cells - Keratinization"	Cytosol		"HPA023369: AB_1848415, HPA023940: AB_1848416"	"unprognostic (2.12e-2)"	"unprognostic (5.90e-2)"	"unprognostic (1.17e-1)"	"unprognostic (9.48e-2)"	"unprognostic (1.42e-3)"	"unprognostic (2.04e-2)"	"prognostic unfavorable (8.29e-4)"	"unprognostic (1.07e-3)"	"unprognostic (1.14e-1)"	"unprognostic (2.03e-2)"	"unprognostic (1.17e-1)"	"unprognostic (3.51e-2)"	"unprognostic (5.65e-2)"	"prognostic favorable (7.58e-6)"	"unprognostic (9.68e-2)"	"unprognostic (5.13e-2)"	"unprognostic (3.74e-2)"	2.3	2.2	0.8	2.9	0.8	1.4	2.8	0.8	1.2	10.8	2.1	8.2	10.8	2.5	0.9	51.3	1.6	6.4	17.2	0.8	1.9	7.1	21.7	3.2	3.0	1.6	1.4	1.4	9.5	6.4	4.3	0.7	2.7	3.5	5.3	0.2	10.9	2.2	6.9	67.3	11.3	1.5	0.9	2.0	9.8	1.0	1.4	3.7	5.6	0.8	5.7	2.5	17.0	0.7	24.7	22.4	0.2	0.0	0.7	2.0	35.9	25.2	11.0	21.0	15.7	28.7	8.8	16.1	15.1	16.7	17.1	28.6	3.6	21.1	9.6	13.2	8.1	0.4	11.2	15.9	15.3	2.9	7.9	2.8	38.9	13.6	22.3	7.9	7.6	2.5	7.7	0.5	6.0	15.0	0.7	6.0	11.0	34.1	0.1	0.1	0.0	7.8	10.1	6.2	11.2	0.0	8.7	5.3	1.5	29.1	9.2	3.6	14.2	12.9	21.6	6.1	29.8	2.2	4.0	4.1	10.1	0.1	8.6	1.1	0.0	0.0	0.7	0.0	0.3	0.3	0.4	0.2	0.0	0.3	0.3	0.0	0.0	0.0	0.2	0.0	0.5	0.2	0.8	0.8	0.8	1.2	0.8	1.9	1.6	1.4	2.7	0.9	1.4	0.7	0.6	3.2	2.2	0.0	2.5	77.8	12.2	9.9	39.3	0.2	7.1	2.9	5.1	11.5	6.3	7.3	0.0	0.4	0.7	46.5	0.0	15.8	0.1	2.4	1.0	1.9	7.1	2.7	0.1	10.0	9.7	2.6	17.3	5.0	8.9	3.5	1.1	20.9	1.2	0.0	0.1	17.7	8.2	0.3	7.8	1.9	0.0	1.0	5.4	0.0	1.0	0.2	3.1	0.5	0.0	24.3	22.8	0.0	3.0	13.2	15.3	4.4	2.5	0.4	0.0	1.3	2.0	0.1	1.0	55.3	68.5	1.9	2.6	0.0	17.1	9.1
FAM98B	FLJ38426	ENSG00000171262	"Family with sequence similarity 98 member B"	Q52LJ0	15	38454127-38487710	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008320, HPA008502"	Enhanced		Supported	Nucleoplasm,Vesicles		NA	NA		20000	"Cluster 40: NK-cells - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	"Nucleoplasm, Vesicles"		"HPA008320: AB_1848419, HPA008502: AB_1848420"	"unprognostic (1.05e-2)"	"unprognostic (3.13e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.00e-2)"	"unprognostic (1.54e-2)"	"unprognostic (3.09e-2)"	"unprognostic (9.25e-3)"	"unprognostic (1.74e-1)"	"unprognostic (4.69e-2)"	"unprognostic (2.18e-1)"	"unprognostic (3.15e-1)"	"unprognostic (3.15e-2)"	"unprognostic (1.51e-2)"	"unprognostic (2.26e-1)"	"unprognostic (4.36e-2)"	"unprognostic (1.94e-1)"	"unprognostic (1.13e-1)"	12.7	11.4	9.5	12.8	10.2	9.8	12.9	16.4	12.6	9.7	7.2	15.4	9.6	13.3	9.0	9.0	8.1	7.0	12.4	10.8	10.9	13.1	7.8	8.1	13.8	9.4	9.7	11.2	6.1	19.3	6.4	12.0	10.0	12.1	11.6	19.8	6.3	10.0	13.8	8.8	10.0	9.5	10.1	11.2	9.5	8.5	9.6	28.6	11.7	16.3	13.3	11.9	7.0	12.6	30.7	16.2	77.7	40.0	14.1	25.7	37.9	38.6	28.2	37.4	37.5	35.8	14.4	21.1	41.4	32.2	37.9	31.8	47.4	39.5	52.2	21.8	25.7	62.6	33.9	27.8	20.4	59.8	34.6	23.9	24.1	33.3	38.5	27.4	38.9	45.7	45.6	25.7	36.0	13.8	50.7	31.8	42.0	34.8	22.3	53.3	42.0	17.7	32.8	39.9	47.8	48.9	42.5	27.0	19.8	34.6	33.0	36.6	32.7	42.1	51.5	28.2	44.0	47.6	46.1	78.3	23.1	38.9	44.8	2.3	0.5	1.4	2.8	0.4	2.4	1.6	2.8	2.3	0.6	1.9	3.4	2.6	0.4	2.2	0.6	1.4	1.9	0.4	9.5	10.2	16.4	12.6	10.8	10.9	9.4	9.7	10.0	10.1	9.6	12.6	17.9	16.0	21.4	16.3	16.8	14.7	12.7	14.1	14.2	36.8	15.2	11.6	48.9	12.8	18.1	16.5	16.7	30.6	16.4	11.0	7.9	16.4	3.4	19.1	21.5	16.9	12.6	16.6	22.5	19.8	22.4	16.6	16.8	17.0	13.3	18.4	16.8	13.1	12.6	20.2	20.5	22.6	12.2	15.8	12.2	2.5	12.5	10.9	5.4	18.7	21.4	18.5	21.6	12.1	23.8	14.3	9.8	17.0	18.2	12.4	11.1	12.7	18.8	27.9	6.6	21.5	16.2	27.2	17.1	19.7	14.8	21.5	15.3	14.7	19.3	14.1
FAN1	"KIAA1018, MTMR15"	ENSG00000198690	"FANCD2 and FANCI associated nuclease 1"	Q9Y2M0	15	30890559-30943108	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"DNA damage, DNA repair"	"Endonuclease, Exonuclease, Hydrolase, Nuclease"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Oligodendrocytes: 44.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048198			Supported	"Nucleoplasm,Cytokinetic bridge,Cytosol"		Yes	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Nucleoplasm	"Cytokinetic bridge, Cytosol"	"HPA048198: AB_2680311"	"unprognostic (7.18e-3)"	"unprognostic (5.63e-2)"	"unprognostic (1.96e-1)"	"unprognostic (3.30e-2)"	"unprognostic (6.99e-2)"	"unprognostic (2.86e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.19e-1)"	"unprognostic (5.94e-2)"	"unprognostic (3.53e-2)"	"unprognostic (3.53e-2)"	"unprognostic (9.67e-2)"	"prognostic favorable (1.42e-6)"	"unprognostic (3.73e-1)"	"unprognostic (1.19e-1)"	"unprognostic (8.93e-3)"	"unprognostic (1.29e-1)"	6.2	8.5	9.3	0.9	9.5	0.5	6.7	9.4	9.7	10.1	9.3	10.7	0.9	9.2	6.6	6.5	9.0	1.2	8.8	8.9	9.5	9.5	9.6	5.5	0.8	9.7	9.8	11.8	12.7	5.9	11.4	3.0	10.0	11.5	2.0	2.7	9.8	1.4	18.7	10.8	7.3	2.4	9.5	6.8	8.6	8.9	9.9	4.4	10.0	7.3	0.7	9.3	9.7	10.0	5.2	9.9	3.6	1.9	12.4	9.3	0.8	4.4	2.1	4.7	5.0	4.5	1.7	0.6	7.6	3.6	7.4	9.2	4.7	9.4	5.0	4.2	1.4	1.3	5.5	1.9	4.8	1.2	1.9	2.8	7.3	3.0	7.3	7.2	3.4	5.7	4.7	6.1	4.7	0.6	8.6	3.1	2.2	11.5	2.8	7.0	12.0	2.3	6.7	2.3	4.5	4.6	9.2	5.6	3.0	8.8	4.4	3.3	3.3	9.4	3.0	5.0	3.4	7.4	8.7	1.1	4.1	1.9	1.1	0.0	0.1	0.0	1.4	0.3	2.0	1.2	1.2	0.7	0.9	1.5	1.8	1.1	0.0	1.8	4.3	1.1	1.4	0.7	9.3	9.5	9.4	9.7	8.9	9.5	9.7	9.8	10.0	9.5	9.9	10.0	9.1	16.0	8.4	21.2	5.4	4.1	5.8	4.9	9.6	17.0	11.2	9.8	17.0	0.0	10.7	9.2	20.9	6.5	3.5	7.6	9.8	4.5	11.9	10.2	12.9	8.8	7.8	6.9	23.7	2.9	2.2	8.4	8.6	9.0	8.8	15.5	6.8	13.4	3.7	26.9	25.5	11.0	8.2	5.4	2.5	7.1	10.5	3.9	5.4	15.0	3.4	14.9	7.2	13.6	44.2	3.6	6.4	6.8	7.0	6.0	4.2	8.0	13.6	23.5	6.6	9.4	7.6	20.9	16.4	7.2	2.4	4.1	5.3	9.2	10.3	3.7
FANCA	"FA-H, FAA, FACA, FAH, FANCH"	ENSG00000187741	"FA complementation group A"	O15360	16	89737549-89816657	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"DNA damage, DNA repair"		"Cancer-related genes, Disease variant, Fanconi anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 20.2;testis: 21.6"	"Cell type enhanced"	"Detected in many"		"Spermatocytes: 44.1;Spermatogonia: 38.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA063236			Supported	Nucleoplasm		NA	Yes			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"HPA063236: AB_2684966"	"unprognostic (5.99e-2)"	"unprognostic (5.68e-2)"	"unprognostic (2.36e-1)"	"unprognostic (5.12e-2)"	"unprognostic (1.87e-1)"	"unprognostic (7.11e-2)"	"unprognostic (1.45e-4)"	"unprognostic (9.21e-2)"	"unprognostic (1.58e-2)"	"unprognostic (2.05e-1)"	"unprognostic (4.82e-3)"	"unprognostic (8.48e-4)"	"unprognostic (7.82e-10)"	"unprognostic (3.67e-2)"	"unprognostic (2.05e-1)"	"unprognostic (2.94e-1)"	"unprognostic (1.62e-1)"	1.4	1.9	1.7	6.7	1.9	20.2	1.9	2.4	3.3	2.1	1.5	5.5	5.2	1.2	0.8	6.6	2.0	1.2	1.6	1.8	1.2	2.9	6.1	3.4	12.5	1.4	1.1	1.4	1.9	1.4	1.9	4.1	1.5	1.7	6.2	1.0	2.1	0.6	0.7	5.2	5.6	2.1	1.1	6.7	3.6	21.6	1.5	8.1	1.7	0.6	13.5	2.2	2.7	1.9	23.2	34.8	40.8	35.7	2.6	5.2	31.2	28.2	15.3	46.5	19.5	30.6	37.3	56.2	12.9	9.8	15.5	34.7	27.7	21.1	48.8	13.4	46.5	16.6	49.1	63.4	1.7	17.1	17.5	1.7	2.2	37.8	12.0	6.6	14.9	28.0	40.9	16.9	24.6	53.6	34.6	73.7	26.5	31.5	21.3	61.4	32.8	10.3	11.8	21.5	36.3	19.7	41.9	12.3	5.4	23.3	22.4	30.4	11.1	37.0	38.9	20.9	30.0	15.1	19.0	56.3	17.5	37.8	36.1	2.5	7.4	9.9	4.2	8.5	3.0	7.0	2.4	3.7	6.2	4.6	0.6	2.6	9.4	8.2	9.2	0.4	9.2	4.2	1.7	1.9	2.4	3.3	1.8	1.2	1.4	1.1	1.5	1.1	1.5	1.9	1.5	0.0	1.1	0.7	9.6	3.4	1.6	2.6	0.0	8.1	3.0	2.0	2.9	0.0	3.5	16.5	10.4	16.0	12.3	5.1	1.9	2.0	5.9	2.8	3.5	2.1	1.8	20.8	10.0	1.6	9.9	3.3	9.2	3.4	2.5	19.0	5.3	4.7	8.8	3.3	5.7	8.1	2.0	4.1	3.1	4.1	1.5	6.8	0.0	1.0	3.0	1.1	21.6	3.0	1.7	1.9	1.7	0.0	21.1	1.3	6.6	10.4	6.4	7.7	0.0	2.7	3.5	44.1	38.5	3.8	1.8	25.3	9.3	6.8	11.4	2.6
FANCC	"FA3, FAC, FACC"	ENSG00000158169	"FA complementation group C"	Q00597	9	95099054-95426796	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair"		"Cancer-related genes, Disease variant, Fanconi anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 24.6"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 178.6;Hepatocytes: 42.6;Late spermatids: 87.8;Microglial cells: 49.6;Oligodendrocytes: 48.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	7	"basophil: 8.8"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 8.8"	"Cell line enhanced"	"Detected in all"		"RH-30: 47.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017793, HPA030771"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 29: Early spermatids - Spermatogenesis"	Nucleoplasm		"CAB017793: , HPA030771: AB_2673604"	"unprognostic (1.48e-2)"	"unprognostic (4.33e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.63e-1)"	"unprognostic (2.14e-1)"	"unprognostic (1.32e-2)"	"unprognostic (3.41e-3)"	"unprognostic (1.26e-2)"	"unprognostic (7.45e-3)"	"unprognostic (1.37e-1)"	"unprognostic (8.00e-3)"	"unprognostic (3.19e-2)"	"prognostic favorable (6.03e-6)"	"unprognostic (2.35e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.49e-1)"	"unprognostic (5.71e-2)"	2.6	1.7	1.7	3.1	2.4	3.3	3.4	8.9	2.7	4.1	1.7	4.0	5.5	3.2	1.1	3.5	2.8	3.7	2.7	1.8	2.3	6.8	24.6	4.0	2.7	3.9	2.3	2.3	4.4	1.5	3.5	3.1	3.2	3.5	4.3	2.4	3.0	1.5	3.6	5.9	6.2	2.1	1.7	2.3	3.6	9.5	2.4	4.2	3.1	1.2	2.6	3.0	3.2	3.9	21.5	14.6	18.7	16.9	2.0	5.4	11.7	8.1	5.7	14.1	13.9	16.2	9.3	12.7	6.4	7.2	10.6	25.5	21.1	8.5	8.4	12.9	10.1	9.8	16.6	9.6	2.7	11.6	11.3	4.9	3.8	11.1	5.4	3.9	8.4	10.1	14.9	5.7	10.3	17.1	9.7	5.8	9.6	23.2	8.9	17.3	47.1	7.0	6.4	6.8	26.2	13.1	18.9	7.4	4.2	8.2	6.9	8.6	4.0	13.0	17.1	14.5	14.1	5.9	12.0	6.8	6.6	9.8	15.9	8.8	0.3	0.0	0.9	0.6	0.9	0.6	0.4	0.9	0.3	0.6	0.7	0.7	0.1	0.1	1.3	0.9	0.4	0.5	1.7	2.4	8.9	2.7	1.8	2.3	3.9	2.3	3.2	1.7	2.4	3.9	3.0	3.2	2.2	9.4	2.2	2.5	2.7	1.2	2.8	6.1	3.5	3.7	1.9	5.7	2.3	0.0	4.2	3.0	2.7	3.3	1.9	4.4	178.6	3.5	5.5	4.3	0.0	3.0	22.1	4.1	5.0	3.3	2.0	4.7	5.7	3.9	5.0	42.6	2.0	10.1	13.8	4.0	0.0	3.5	1.3	87.8	6.5	1.6	1.8	49.6	2.8	2.1	1.0	32.2	48.9	3.1	1.0	2.2	4.4	3.0	5.6	8.9	1.0	4.5	0.0	4.1	2.3	19.4	13.2	4.0	2.7	2.3	2.1	4.5	4.7	2.5
FANCD2	"FA-D2, FACD, FAD, FANCD"	ENSG00000144554	"FA complementation group D2"	Q9BXW9	3	10026414-10101932	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cell cycle, DNA damage, DNA repair"		"Cancer-related genes, Disease variant, Fanconi anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 17.8"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 25.2;Spermatocytes: 62.5;Spermatogonia: 30.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BEWO: 120.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB016117, HPA063742"	Approved		Supported	"Nucleoplasm,Nucleoli,Nuclear bodies,Cytosol"		No	No			"Cluster 46: Basophils - DNA binding"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	"Nucleoli, Nuclear bodies, Cytosol"	"CAB016117: AB_2278211, HPA063742: AB_2685110"	"unprognostic (3.25e-2)"	"unprognostic (1.09e-1)"	"unprognostic (6.21e-2)"	"unprognostic (1.12e-2)"	"unprognostic (2.92e-1)"	"unprognostic (3.36e-2)"	"unprognostic (1.08e-5)"	"unprognostic (2.96e-2)"	"unprognostic (1.59e-3)"	"prognostic unfavorable (5.00e-5)"	"unprognostic (1.23e-2)"	"unprognostic (9.14e-2)"	"unprognostic (4.41e-10)"	"unprognostic (9.11e-3)"	"unprognostic (3.99e-1)"	"unprognostic (7.76e-2)"	"unprognostic (2.89e-2)"	1.1	0.7	2.7	7.7	2.1	17.8	3.4	1.6	5.3	1.5	1.1	4.0	3.2	2.0	0.7	2.5	2.6	2.0	0.5	3.4	1.6	0.9	1.1	1.9	12.2	3.9	1.4	3.6	0.8	0.8	0.5	4.7	3.0	1.9	6.4	3.1	4.9	1.0	4.8	4.5	4.0	2.0	2.4	6.4	3.5	11.8	2.3	9.8	1.9	0.4	13.0	2.3	1.3	5.1	24.1	25.4	46.5	13.2	2.4	3.5	120.7	22.0	9.8	31.3	25.4	18.8	23.0	46.7	9.8	7.0	25.1	20.2	48.8	16.7	31.0	22.6	33.0	63.6	39.6	17.9	0.4	48.1	37.9	1.2	2.6	34.1	18.4	4.2	18.4	39.3	39.6	51.6	23.1	27.2	40.6	17.9	56.1	18.1	17.6	43.4	37.7	32.5	10.3	26.7	13.0	25.3	26.4	20.1	8.3	33.5	31.0	29.4	10.6	24.6	28.4	15.1	31.5	21.7	46.4	77.2	14.1	47.7	43.2	2.7	0.6	1.9	0.6	0.5	0.6	2.4	0.9	0.5	0.4	3.2	1.1	0.9	1.5	1.0	1.4	1.8	1.5	0.5	2.7	2.1	1.6	5.3	3.4	1.6	3.9	1.4	3.0	2.4	2.3	5.1	0.7	0.0	0.5	0.7	12.5	4.6	3.5	2.9	2.8	3.1	4.5	2.7	2.0	1.5	1.9	1.8	10.4	12.7	5.6	3.1	0.0	1.9	5.9	2.6	1.5	2.1	1.2	25.2	3.0	3.5	15.2	2.6	2.0	3.4	1.3	11.8	3.3	1.5	5.7	0.0	2.6	3.2	6.1	3.8	7.0	8.0	2.1	3.7	3.6	1.9	4.9	0.6	1.0	1.5	2.4	1.8	3.6	1.5	8.1	2.2	0.5	0.7	2.0	5.6	19.7	2.6	2.1	62.5	30.2	4.1	2.7	7.0	5.2	1.6	7.6	3.1
FANCE	"FACE, FAE"	ENSG00000112039	"FA complementation group E"	Q9HB96	6	35452338-35467102	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair"		"Cancer-related genes, Disease variant, Fanconi anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 22.1;Extravillous trophoblasts: 104.8;Syncytiotrophoblasts: 46.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB014893	Enhanced		Supported	Nucleoplasm		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 31: Skin - Epidermis development"	"Cluster 32: U-937 - Innate immune response"	"Cluster 38: Extravillous trophoblasts - Unknown function"	Nucleoplasm		"CAB014893: "	"unprognostic (2.66e-1)"	"unprognostic (8.01e-3)"	"unprognostic (7.73e-2)"	"prognostic unfavorable (6.25e-4)"	"unprognostic (1.99e-1)"	"unprognostic (2.80e-3)"	"prognostic unfavorable (2.08e-9)"	"unprognostic (8.90e-2)"	"unprognostic (5.70e-3)"	"unprognostic (8.41e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.91e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.70e-1)"	"unprognostic (3.05e-1)"	"unprognostic (2.44e-2)"	"unprognostic (5.14e-2)"	4.6	1.5	2.6	3.2	2.5	5.8	5.0	2.8	3.1	7.1	2.0	3.1	2.1	3.7	3.4	8.6	4.8	1.5	3.3	2.3	2.9	2.1	1.3	4.1	4.5	2.7	2.6	7.8	3.5	4.0	3.1	9.3	2.6	3.8	3.0	1.8	4.3	2.7	11.0	13.8	3.5	3.1	2.4	3.8	3.4	8.7	2.7	2.6	3.0	3.1	5.7	4.0	7.7	2.7	9.9	4.2	12.8	27.6	9.2	15.9	34.6	11.4	9.6	14.8	12.1	11.1	5.3	33.0	7.5	6.7	11.2	7.2	13.7	9.8	13.9	11.0	11.9	23.8	11.7	6.8	4.8	12.6	8.2	10.1	28.6	17.7	27.7	3.9	8.7	12.6	21.3	11.6	12.2	11.4	5.8	16.6	4.7	10.6	7.0	18.8	12.3	12.1	3.1	10.0	12.1	11.4	6.4	9.1	10.0	11.9	8.8	43.7	5.6	16.7	14.5	10.9	18.1	7.4	29.3	11.6	3.9	24.3	16.8	0.0	0.2	0.2	0.4	0.1	0.7	0.1	0.6	0.9	0.1	0.5	0.3	0.3	0.0	0.5	0.1	0.4	0.3	0.2	2.6	2.5	2.8	3.1	2.3	2.9	2.7	2.6	2.6	2.4	2.7	2.7	7.0	6.4	0.0	1.0	2.4	8.8	4.1	4.7	1.8	1.1	2.0	2.8	2.7	0.0	1.6	0.0	0.0	22.1	2.0	1.6	0.0	1.7	0.3	1.9	2.4	3.7	1.2	2.5	0.4	0.8	104.8	2.8	1.1	3.4	0.0	5.2	1.4	0.7	6.0	0.0	0.9	3.6	0.0	0.8	1.3	0.6	1.5	1.4	1.8	2.8	0.5	1.9	1.0	0.5	1.0	1.1	0.4	0.7	3.1	5.8	1.1	0.3	0.1	2.0	0.0	4.0	3.4	8.2	13.2	4.6	7.1	46.7	2.2	3.4	4.4	3.5
FANCF	FAF	ENSG00000183161	"FA complementation group F"	Q9NPI8	11	22622533-22625823	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins"	"DNA damage, DNA repair"		"Cancer-related genes, Fanconi anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"Distal tubular cells: 45.0;Early spermatids: 168.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008899			Supported	Nucleoplasm		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	Nucleoplasm		"HPA008899: "	"unprognostic (1.16e-2)"	"unprognostic (4.10e-2)"	"unprognostic (2.33e-2)"	"unprognostic (1.37e-2)"	"unprognostic (4.55e-2)"	"unprognostic (8.84e-2)"	"prognostic unfavorable (2.27e-4)"	"unprognostic (4.29e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.74e-3)"	"unprognostic (3.95e-1)"	"unprognostic (1.67e-1)"	"unprognostic (2.29e-1)"	"unprognostic (3.73e-2)"	"unprognostic (1.81e-1)"	"unprognostic (9.14e-2)"	"unprognostic (7.64e-3)"	2.1	3.8	3.8	5.6	3.8	2.8	5.2	4.1	3.9	4.9	6.1	5.6	7.9	3.9	8.5	2.8	8.9	3.2	3.6	3.5	4.2	5.0	4.2	3.4	8.2	4.2	4.3	6.1	8.1	4.9	3.7	3.0	3.9	4.6	5.9	5.1	6.1	4.8	1.2	5.1	7.6	2.5	4.1	6.3	7.1	4.9	4.6	9.3	5.6	1.1	7.7	3.5	2.1	4.5	2.3	6.7	8.6	9.5	4.5	5.4	3.5	4.3	5.3	5.0	5.5	4.3	3.5	11.3	1.2	4.5	8.9	9.6	7.2	7.5	2.5	18.5	3.3	4.3	2.7	7.0	5.2	8.0	4.6	5.2	14.1	1.7	7.7	8.5	8.1	15.9	10.9	13.8	3.2	7.0	20.4	7.5	9.8	19.2	8.4	17.0	4.1	12.8	9.7	8.7	32.0	15.1	2.4	7.7	7.8	9.2	15.5	7.1	5.7	5.0	5.1	9.3	6.4	8.0	11.0	3.4	8.1	3.2	11.8	12.3	7.6	16.8	15.3	8.1	18.0	16.1	14.3	14.9	9.2	20.9	19.3	16.2	1.1	15.0	8.7	13.5	10.7	10.6	3.8	3.8	4.1	3.9	3.5	4.2	4.2	4.3	3.9	4.1	4.6	4.5	4.7	3.2	2.2	2.3	13.9	3.3	6.2	8.8	6.8	15.2	7.1	6.0	5.7	18.6	6.3	3.7	10.4	11.6	15.3	10.2	45.0	18.8	168.1	14.1	6.8	6.3	3.5	8.0	2.6	18.7	7.5	5.4	10.7	6.8	2.5	9.6	6.4	10.7	6.9	16.8	3.3	16.5	10.2	6.9	2.6	25.5	9.6	6.7	5.4	5.6	11.3	13.1	22.6	0.5	6.2	10.7	10.3	9.8	7.1	5.6	13.2	22.5	24.4	18.0	6.6	3.2	5.3	23.1	16.7	10.1	2.3	2.3	11.2	11.1	15.8	2.4
FANCG	"FAG, XRCC9"	ENSG00000221829	"FA complementation group G"	O15287	9	35073835-35079942	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins"	"DNA damage, DNA repair"		"Cancer-related genes, Disease variant, Fanconi anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 20.6;Spermatogonia: 20.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB008105, HPA045335"	Approved		Approved	"Nucleoli,Plasma membrane,Cytosol"		NA	Yes			"Cluster 41: Basophils - Cellular respiration"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Plasma membrane, Cytosol"	Nucleoli	"CAB008105: AB_2231542, HPA045335: AB_2679292"	"unprognostic (9.41e-2)"	"unprognostic (2.62e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.09e-1)"	"unprognostic (5.83e-3)"	"prognostic unfavorable (2.02e-4)"	"unprognostic (8.92e-2)"	"unprognostic (1.42e-2)"	"unprognostic (2.27e-3)"	"unprognostic (9.01e-2)"	"unprognostic (5.62e-2)"	"prognostic unfavorable (2.38e-7)"	"unprognostic (1.14e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.24e-1)"	"unprognostic (2.10e-1)"	3.4	3.1	2.8	5.1	2.8	12.4	4.5	3.6	3.8	5.1	2.1	4.3	4.9	4.2	2.3	5.9	5.8	3.3	1.9	2.7	2.7	3.9	2.9	3.3	7.7	2.8	2.7	6.2	6.3	4.7	3.0	4.5	2.7	3.9	4.0	2.4	4.3	4.1	2.3	6.5	4.6	4.5	2.5	5.5	4.1	6.4	2.7	12.2	4.0	1.7	6.9	3.5	4.6	3.4	34.7	40.7	30.4	28.3	6.4	10.2	25.0	23.6	16.3	44.9	42.5	20.1	21.2	33.4	15.8	7.7	33.1	20.5	25.3	22.0	17.6	38.7	14.8	24.5	45.5	13.2	1.8	24.5	26.9	8.1	4.1	39.5	18.2	8.0	23.8	40.7	15.7	44.3	23.5	31.5	43.2	34.5	32.5	26.4	30.1	43.8	35.2	23.1	10.9	14.6	14.4	26.1	15.7	22.3	8.3	13.4	28.4	17.2	13.4	21.0	42.8	28.3	33.1	12.4	24.0	20.6	19.2	18.5	30.1	10.5	0.7	6.7	6.1	2.2	5.3	5.6	4.8	4.6	1.9	5.4	3.6	3.8	1.1	7.8	2.0	4.2	8.2	3.1	2.8	2.8	3.6	3.8	2.7	2.7	2.8	2.7	2.7	2.5	2.7	3.4	3.2	3.2	4.6	6.8	4.9	4.5	6.1	3.9	10.2	4.7	5.9	5.0	1.5	2.8	3.3	3.7	4.2	15.0	4.1	3.0	3.9	4.9	0.4	2.3	3.8	4.4	1.8	11.6	3.0	2.3	20.6	5.1	1.5	3.6	14.0	10.3	4.2	1.1	7.7	5.0	3.3	4.1	2.0	1.3	4.7	0.6	3.4	2.3	3.6	1.0	2.8	4.0	3.1	0.5	4.1	1.9	2.4	4.1	14.1	4.4	3.5	2.3	1.3	3.1	0.0	3.0	3.9	14.7	20.7	8.5	2.6	6.6	4.9	2.8	6.7	5.2
FANCM	"FAAP250, KIAA1596"	ENSG00000187790	"FA complementation group M"	Q8IYD8	14	45135930-45200890	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair"	"DNA-binding, Helicase, Hydrolase"	"Disease variant, Premature ovarian failure"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"Early spermatids: 65.5;Late spermatids: 206.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA055144			Supported	Nucleoplasm		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 25: Spermatids - Spermatogenesis"	Nucleoplasm		"HPA055144: AB_2682715"	"unprognostic (8.40e-2)"	"unprognostic (6.70e-2)"	"unprognostic (3.99e-2)"	"unprognostic (4.32e-2)"	"unprognostic (2.15e-1)"	"unprognostic (2.31e-3)"	"unprognostic (2.66e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.57e-2)"	"unprognostic (8.52e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.23e-2)"	"unprognostic (7.55e-2)"	"unprognostic (2.90e-1)"	"unprognostic (1.71e-1)"	"unprognostic (8.94e-2)"	"unprognostic (1.13e-2)"	1.9	1.6	0.8	2.2	1.6	5.6	2.8	1.9	2.2	2.0	0.3	1.6	1.3	2.4	2.2	1.9	1.6	1.8	1.3	1.0	0.9	1.8	1.5	1.7	3.3	1.0	0.8	2.9	1.1	1.5	0.8	1.9	1.2	1.6	1.8	2.8	1.4	1.9	1.6	2.6	1.2	1.9	0.7	2.3	1.4	7.6	1.1	4.1	1.5	2.3	2.6	1.5	1.5	1.2	8.2	7.0	8.1	7.5	6.4	3.5	6.5	10.3	4.1	8.1	10.1	11.3	6.2	10.6	5.8	2.6	4.5	10.6	9.5	4.4	11.0	7.6	5.4	5.1	7.8	6.4	1.1	13.0	6.1	2.2	1.6	8.1	5.1	1.8	7.1	6.6	9.1	8.9	6.9	8.1	9.5	9.2	3.2	6.3	11.6	9.0	12.7	4.5	3.4	5.8	7.3	1.9	9.4	7.6	4.0	5.1	8.0	6.0	5.6	11.8	11.0	10.6	8.1	4.4	8.7	10.3	2.3	7.9	7.0	6.6	0.7	2.5	2.0	2.0	1.1	4.3	1.3	0.7	0.6	2.0	2.0	1.7	1.0	1.1	0.9	1.7	1.0	0.6	0.8	1.6	1.9	2.2	1.0	0.9	1.0	0.8	1.2	0.7	1.1	1.2	6.5	0.0	3.1	9.8	8.3	2.7	1.1	1.9	4.6	6.3	3.9	2.4	8.3	1.5	3.1	1.8	2.1	7.6	5.6	1.7	0.0	2.2	65.5	3.5	5.8	5.1	0.0	12.8	21.0	2.7	3.5	4.6	5.1	3.0	1.3	9.4	5.7	1.7	3.5	3.3	15.6	1.6	4.1	3.8	2.9	206.1	9.0	4.0	3.6	18.7	5.9	4.8	3.1	20.1	22.7	2.4	0.8	5.3	8.4	0.8	1.5	1.9	1.1	6.9	6.6	4.7	6.0	26.5	14.0	4.4	1.8	2.3	5.6	9.5	3.2	0.7
FANK1		ENSG00000203780	"Fibronectin type III and ankyrin repeat domains 1"	Q8TC84	10	125896564-126009592	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"choroid plexus: 34.2;fallopian tube: 35.1;testis: 56.5"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 603.8;Late spermatids: 603.0;Respiratory ciliated cells: 222.2;Spermatocytes: 126.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	16	"T-reg: 61.2"	"Lineage enriched"	"Detected in single"	612	"T-cells: 61.2"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 19.3;hTCEpi: 9.8;hTERT-RPE1: 13.0;RPTEC TERT1: 13.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA038413			Supported	Nucleoplasm		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 31: Spermatids - Spermatogenesis"	Nucleoplasm		"HPA038413: AB_10697249"	"unprognostic (4.25e-2)"	"unprognostic (4.63e-2)"	"unprognostic (1.80e-1)"	"prognostic favorable (3.83e-4)"	"unprognostic (1.17e-3)"	"unprognostic (4.02e-2)"	"unprognostic (6.29e-2)"	"unprognostic (1.44e-1)"	"unprognostic (3.12e-3)"	"unprognostic (5.72e-2)"	"unprognostic (2.09e-1)"	"unprognostic (3.42e-2)"	"unprognostic (9.53e-3)"	"unprognostic (2.84e-2)"	"unprognostic (1.17e-2)"	"unprognostic (1.10e-2)"	"unprognostic (1.44e-1)"	0.9	3.6	5.1	0.7	5.2	1.0	4.6	3.7	3.5	3.3	34.2	3.1	2.3	2.4	12.0	3.6	35.1	2.1	0.8	6.2	6.9	5.8	0.2	5.7	0.5	15.6	18.8	5.5	4.2	4.5	7.4	1.3	10.5	2.2	4.6	15.8	2.4	3.0	0.2	5.7	2.1	1.4	10.7	0.3	5.3	56.5	6.7	1.6	8.3	0.5	1.3	2.3	2.5	5.9	7.2	2.4	0.6	4.0	3.0	3.0	4.5	2.7	1.9	0.7	0.6	0.1	19.3	0.0	0.5	2.0	1.0	9.3	0.0	3.4	0.5	0.2	0.1	0.0	1.0	0.0	1.1	0.4	0.6	0.9	9.8	2.7	0.9	13.0	1.0	0.0	0.4	0.0	1.1	6.1	0.0	1.4	0.4	6.5	0.2	0.0	0.3	0.6	13.6	2.0	0.5	2.0	2.2	4.5	0.5	7.4	0.7	0.3	0.9	1.3	2.2	1.8	0.1	0.0	0.3	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	3.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	61.2	0.2	5.1	5.2	3.7	3.5	6.2	6.9	15.6	18.8	10.5	10.7	6.7	5.9	0.9	12.8	6.3	18.9	0.2	5.1	3.4	18.6	1.2	1.5	7.2	5.7	0.8	1.5	26.6	12.9	33.3	2.6	0.0	5.2	13.7	12.3	603.8	94.9	3.1	1.7	0.0	0.4	15.9	8.9	5.9	2.2	2.0	6.0	3.8	16.5	1.1	0.0	1.0	3.3	14.1	12.4	12.2	0.3	2.3	603.0	3.7	1.1	1.8	2.8	0.2	6.3	0.0	3.0	2.7	11.1	6.9	4.5	0.2	3.2	1.5	11.1	222.2	10.0	0.0	0.8	6.1	126.7	15.5	1.3	3.4	5.1	2.4	12.2	3.6	3.6
FAR1	"FLJ22728, MLSTD2, SDR10E1"	ENSG00000197601	"Fatty acyl-CoA reductase 1"	Q8WVX9	11	13668668-13732346	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism"	Oxidoreductase	"Cataract, Disease variant, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 437.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017322	Approved		Supported	Peroxisomes		NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 15: RT4 - Unknown function"	"Cluster 25: Spermatids - Spermatogenesis"	Peroxisomes		"HPA017322: AB_1848424"	"unprognostic (3.96e-2)"	"unprognostic (1.92e-1)"	"prognostic favorable (2.27e-4)"	"unprognostic (1.38e-1)"	"unprognostic (1.34e-1)"	"unprognostic (4.62e-2)"	"unprognostic (3.66e-1)"	"unprognostic (3.30e-1)"	"unprognostic (2.79e-1)"	"unprognostic (3.60e-2)"	"unprognostic (2.59e-2)"	"unprognostic (1.84e-2)"	"unprognostic (2.97e-2)"	"unprognostic (2.52e-1)"	"unprognostic (2.22e-1)"	"unprognostic (2.22e-1)"	"unprognostic (2.37e-3)"	21.1	16.2	19.3	23.0	36.0	74.9	20.6	34.3	31.5	23.8	24.5	32.9	38.7	24.7	24.9	50.9	17.7	13.7	20.0	22.6	29.7	14.0	5.0	20.2	20.5	48.4	29.9	19.9	21.3	29.1	15.6	24.6	44.1	20.5	37.6	32.6	18.2	15.4	15.2	12.2	21.1	30.7	37.3	20.5	62.0	20.8	32.1	16.5	19.8	18.6	23.9	28.4	30.0	94.8	79.5	50.6	49.1	38.4	45.9	52.6	26.7	69.2	27.6	50.0	52.7	53.5	66.4	100.9	30.2	55.5	74.3	84.3	73.2	69.9	76.1	30.0	59.4	43.4	44.8	0.2	44.1	87.9	33.7	40.2	70.3	36.2	107.7	36.9	49.6	50.2	68.9	29.3	41.5	39.9	65.5	26.3	25.8	100.1	72.6	56.9	62.6	28.4	48.4	126.4	37.7	27.3	65.5	61.6	34.4	56.2	37.8	54.1	62.1	68.5	58.2	63.7	58.4	16.4	59.6	84.7	43.4	26.4	42.4	10.4	24.9	28.0	7.7	21.3	5.4	3.5	3.7	6.6	28.5	5.5	3.3	5.5	38.9	9.1	18.2	4.4	5.3	7.7	19.3	36.0	34.3	31.5	22.6	29.7	48.4	29.9	44.1	37.3	32.1	94.8	38.6	35.3	21.1	80.0	24.2	32.2	24.2	21.5	41.5	46.0	27.6	20.3	24.1	5.7	26.2	22.0	41.7	25.7	40.2	59.8	5.9	12.8	100.8	21.1	36.5	31.4	36.0	38.5	146.0	25.9	18.5	26.8	114.7	26.2	38.7	23.3	29.6	2.5	33.9	47.1	113.5	28.8	26.4	53.5	57.0	181.3	26.8	48.8	35.6	71.2	54.8	20.6	20.6	93.5	437.2	29.3	43.4	25.6	36.1	30.8	23.3	8.7	18.7	50.4	26.3	29.3	29.3	41.6	32.3	116.9	19.9	9.9	25.8	17.0	47.7	42.0
FARSB	"FARSLB, FRSB, PheHB"	ENSG00000116120	"Phenylalanyl-tRNA synthetase subunit beta"	Q9NSD9	2	222566899-222656092	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase"	"Disease variant, Mental retardation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036677, HPA036678, HPA061398"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA		28000	"Cluster 27: Non-specific - Gene expression"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm	Cytosol	"HPA036677: AB_2675242, HPA036678: AB_10673504, HPA061398: AB_2684504"	"unprognostic (9.95e-3)"	"unprognostic (1.86e-3)"	"unprognostic (7.02e-2)"	"unprognostic (7.42e-3)"	"unprognostic (1.90e-1)"	"unprognostic (1.15e-1)"	"prognostic unfavorable (6.45e-10)"	"unprognostic (8.89e-3)"	"unprognostic (4.51e-2)"	"unprognostic (3.63e-2)"	"unprognostic (5.25e-3)"	"unprognostic (6.25e-2)"	"prognostic unfavorable (3.21e-5)"	"unprognostic (1.36e-1)"	"unprognostic (4.38e-2)"	"unprognostic (2.10e-1)"	"prognostic unfavorable (1.25e-4)"	12.8	10.9	9.5	7.6	10.0	8.0	12.8	10.4	11.3	13.1	6.5	14.7	9.1	13.5	6.5	20.7	11.9	3.9	16.7	10.2	10.7	11.8	14.1	9.4	7.4	9.6	9.4	14.3	15.6	8.0	13.2	5.0	10.8	11.2	11.1	10.0	10.4	6.1	31.9	14.9	10.8	8.1	8.4	9.7	13.9	13.5	9.9	7.7	9.7	13.2	8.3	13.1	13.7	9.4	31.1	17.8	20.7	27.2	18.0	26.3	31.0	31.0	19.2	29.4	23.9	45.3	16.6	15.3	22.7	22.6	24.7	25.8	39.7	34.7	43.0	22.8	20.7	35.1	18.9	28.8	27.9	51.9	14.0	17.6	27.0	33.9	51.2	10.5	28.3	26.4	53.5	30.3	36.1	28.9	31.2	29.2	26.6	37.0	22.0	30.2	49.4	49.8	24.5	19.9	33.4	11.2	12.9	22.4	27.6	24.7	20.9	21.3	15.8	25.5	21.1	37.8	38.5	14.8	15.5	54.5	20.8	34.0	27.2	0.5	7.6	1.2	9.6	9.4	14.3	15.1	12.8	11.9	14.4	12.7	16.4	14.2	0.9	17.4	11.3	7.2	12.5	13.7	9.5	10.0	10.4	11.3	10.2	10.7	9.6	9.4	10.8	8.4	9.9	9.4	10.2	6.4	6.4	21.2	25.2	12.4	19.5	32.7	19.4	17.9	16.3	18.0	28.6	5.7	18.5	22.0	4.2	37.0	7.5	18.1	35.2	24.7	57.5	17.3	15.8	13.3	20.9	24.2	50.2	30.4	43.3	18.0	32.6	18.6	5.1	21.8	7.5	17.8	27.4	3.3	56.7	19.9	20.3	10.1	9.7	73.1	15.2	11.8	7.2	26.2	11.3	13.2	15.5	38.7	38.2	22.8	11.3	19.9	27.3	18.1	9.9	31.0	16.8	19.5	6.6	17.6	34.4	67.4	33.7	28.8	14.2	22.2	16.9	24.3	45.8	14.3
FAS	"APO-1, APT1, CD95, FAS1, TNFRSF6"	ENSG00000026103	"Fas cell surface death receptor"	P25445	10	88990531-89017059	"Cancer-related genes, Candidate cardiovascular disease genes, CD markers, Disease related genes, Human disease related genes, Metabolic proteins, Predicted membrane proteins, Predicted secreted proteins"	Apoptosis	"Calmodulin-binding, Receptor"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 109.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 114.7"	"Group enriched"	"Detected in all"	5	"granulocytes: 114.7;T-cells: 96.2"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 83.4;Karpas-707: 109.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027444	Uncertain		Supported	"Nuclear bodies,Plasma membrane,Cytosol"	"Secreted to blood"	NA	NA	11900000	420000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 85: Liver - Metabolism"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 24: Non-specific - Transcription regulation"	"Plasma membrane"	"Nuclear bodies, Cytosol"	"HPA027444: AB_10601378"	"unprognostic (6.84e-2)"	"unprognostic (2.88e-3)"	"unprognostic (8.38e-3)"	"unprognostic (1.94e-1)"	"unprognostic (2.35e-2)"	"unprognostic (9.56e-2)"	"unprognostic (7.00e-2)"	"unprognostic (2.05e-1)"	"unprognostic (3.01e-1)"	"unprognostic (7.70e-2)"	"unprognostic (1.26e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.52e-3)"	"unprognostic (2.10e-1)"	"unprognostic (2.32e-2)"	"unprognostic (4.95e-3)"	"unprognostic (1.65e-1)"	14.1	26.3	3.6	17.0	3.6	20.8	10.9	2.9	4.7	12.7	2.8	16.4	7.0	12.8	10.3	10.8	14.8	15.7	7.5	3.6	3.7	7.2	23.3	21.7	18.9	4.6	3.1	20.1	3.7	2.7	3.7	10.4	4.0	8.9	23.3	3.3	6.5	9.3	2.3	9.4	9.2	15.0	3.5	11.2	4.4	2.6	3.9	14.4	7.3	2.6	15.6	12.9	10.2	4.3	22.7	8.2	5.4	13.9	37.0	51.3	0.0	51.8	50.2	1.7	9.1	0.1	23.4	4.7	19.0	52.1	9.6	4.0	1.0	44.8	3.2	83.4	8.7	0.4	5.2	14.7	31.6	3.4	1.6	69.2	38.7	31.4	66.0	24.5	4.7	17.8	0.0	109.0	44.0	1.4	6.4	3.4	0.6	0.2	1.8	1.4	0.5	5.0	60.7	7.3	0.4	0.2	7.7	0.0	0.8	7.0	13.9	1.0	9.5	15.8	9.0	15.2	12.3	45.3	5.3	0.4	11.8	10.2	4.5	43.1	9.4	30.9	9.9	12.3	13.8	7.5	27.6	19.6	11.5	4.0	3.1	10.0	114.7	3.1	22.1	0.2	96.2	12.8	3.6	3.6	2.9	4.7	3.6	3.7	4.6	3.1	4.0	3.5	3.9	4.3	10.3	57.7	13.8	40.1	12.8	45.9	109.7	53.1	39.9	0.0	5.5	9.5	3.5	12.8	27.5	9.2	0.0	0.4	16.3	24.9	0.0	6.3	11.3	9.2	22.3	8.9	8.4	9.5	8.8	4.3	0.2	35.4	8.6	15.5	3.8	4.9	2.2	19.3	5.5	1.7	2.8	14.4	8.2	7.0	31.7	4.9	19.0	17.7	12.4	17.8	20.9	14.5	10.3	8.0	0.7	6.5	8.7	13.9	32.2	46.0	15.6	14.4	26.3	0.7	6.6	26.8	29.1	11.3	1.1	28.5	43.9	0.4	48.4	11.8	24.4	30.0
FASTK	FAST	ENSG00000164896	"Fas activated serine/threonine kinase"	Q14296	7	151076593-151080866	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	Apoptosis	"Kinase, RNA-binding, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031621, CAB032539"	Approved		Supported	"Nuclear speckles,Mitochondria"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria	"Nuclear speckles"	"CAB032539: AB_2101115, HPA031621: AB_10611966"	"unprognostic (7.67e-2)"	"unprognostic (6.41e-3)"	"prognostic unfavorable (4.73e-4)"	"unprognostic (2.60e-1)"	"unprognostic (1.75e-3)"	"unprognostic (2.03e-3)"	"unprognostic (1.14e-3)"	"unprognostic (1.01e-1)"	"unprognostic (1.24e-1)"	"unprognostic (4.66e-2)"	"prognostic favorable (3.99e-4)"	"unprognostic (3.49e-2)"	"unprognostic (2.79e-2)"	"unprognostic (4.12e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.09e-1)"	"unprognostic (8.17e-2)"	23.4	36.5	35.5	13.4	33.8	8.2	21.7	32.3	50.6	23.5	30.1	31.5	26.2	23.3	11.9	39.5	21.1	14.5	66.9	34.8	32.9	34.9	58.0	18.8	14.4	34.2	33.9	24.6	28.1	31.0	41.2	9.4	34.5	34.1	11.8	7.9	27.8	18.8	122.6	28.2	25.0	11.8	33.1	24.8	29.0	21.8	35.7	14.7	26.9	95.3	10.5	26.7	25.1	34.3	39.3	45.0	13.9	34.9	50.4	22.4	22.8	29.9	40.1	25.3	29.7	31.5	34.9	9.2	41.0	40.9	46.9	24.1	13.5	36.4	6.1	26.9	23.8	11.4	12.7	27.8	62.7	9.0	25.2	29.8	51.8	29.4	21.5	20.9	30.0	22.4	17.0	20.2	29.2	80.4	20.4	23.5	24.6	47.8	50.8	13.2	17.4	30.4	34.2	27.8	16.4	18.2	40.3	62.5	43.0	11.5	34.4	31.2	24.0	32.7	7.5	31.7	28.0	50.5	33.0	6.5	66.2	19.0	39.8	18.0	31.5	30.1	22.3	32.5	23.4	19.5	23.4	23.4	28.4	21.6	25.5	21.9	6.8	20.4	32.5	38.2	28.3	21.9	35.5	33.8	32.3	50.6	34.8	32.9	34.2	33.9	34.5	33.1	35.7	34.3	21.2	0.0	7.0	17.9	34.3	24.6	37.8	68.8	23.3	42.9	31.7	26.9	18.9	30.0	43.6	25.8	25.0	49.2	38.2	59.2	86.1	49.4	10.0	22.5	21.3	22.9	44.9	28.2	12.7	47.6	26.8	33.8	54.6	24.8	38.8	38.6	23.6	37.1	43.3	37.0	13.6	54.9	59.0	26.3	22.5	20.2	36.4	25.8	94.3	7.5	35.3	54.7	44.3	9.5	10.7	38.6	40.0	34.3	46.1	27.7	86.6	66.3	24.9	51.1	13.1	33.7	35.0	58.5	70.7	36.0	25.3	60.5	34.8	50.1	61.2	35.0
FASTKD2	KIAA0971	ENSG00000118246	"FAST kinase domains 2"	Q9NYY8	2	206765357-206796189	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Ribosome biogenesis"	"RNA-binding, rRNA-binding"	"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA067191			Supported	Mitochondria		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"HPA067191: AB_2685801"	"unprognostic (1.19e-1)"	"unprognostic (2.45e-1)"	"unprognostic (3.50e-3)"	"unprognostic (1.36e-3)"	"unprognostic (7.40e-2)"	"unprognostic (2.69e-3)"	"prognostic unfavorable (8.29e-4)"	"unprognostic (1.69e-2)"	"unprognostic (2.98e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.38e-3)"	"unprognostic (1.48e-1)"	"unprognostic (6.32e-2)"	"unprognostic (4.87e-2)"	"unprognostic (7.18e-2)"	"unprognostic (1.03e-3)"	"unprognostic (3.57e-2)"	14.4	14.0	5.2	12.4	5.9	11.4	17.3	4.8	6.2	12.8	7.5	15.0	14.9	15.8	8.8	15.9	12.9	11.5	24.9	5.7	5.3	17.4	27.2	11.8	14.3	5.8	4.5	15.7	11.6	18.4	6.9	13.0	6.5	13.3	17.0	11.2	11.2	11.1	31.5	11.8	12.5	15.7	4.4	11.2	13.3	12.0	4.9	13.1	17.8	36.6	17.2	20.4	9.6	4.8	30.2	27.0	24.7	28.1	27.2	32.7	46.2	34.3	29.0	57.3	32.4	48.3	32.0	37.4	37.5	35.5	66.7	40.0	30.7	47.4	50.4	11.7	19.8	29.4	25.6	46.6	33.1	64.3	26.5	35.2	48.8	43.8	47.2	29.1	39.3	27.2	56.4	18.6	42.8	25.3	27.3	27.4	44.0	28.2	51.2	23.7	38.1	38.8	39.4	49.7	36.0	22.9	26.6	44.7	41.3	36.8	20.9	33.4	30.8	35.0	31.5	24.4	36.3	18.5	32.9	48.0	40.6	29.2	29.5	9.6	21.4	5.2	19.2	21.4	21.5	20.1	21.3	20.2	31.0	17.3	28.0	25.2	1.4	31.2	16.5	14.6	18.7	20.5	5.2	5.9	4.8	6.2	5.7	5.3	5.8	4.5	6.5	4.4	4.9	4.8	17.8	28.9	11.4	19.6	20.3	23.7	33.7	28.8	32.5	18.9	11.1	12.2	23.2	7.2	22.8	12.9	22.9	28.2	15.1	6.7	9.8	19.2	30.9	14.5	23.1	14.6	7.3	11.6	41.9	15.1	22.4	21.2	27.5	14.9	5.1	17.5	9.3	17.6	14.8	6.7	40.3	10.5	12.2	7.9	9.4	8.0	9.6	10.8	5.4	25.3	12.9	9.3	8.2	26.2	23.2	12.1	8.2	13.9	20.0	13.7	8.8	12.7	15.9	22.8	13.1	19.3	17.4	37.5	12.8	24.5	21.5	25.7	18.4	18.6	13.1	22.6
FASTKD3	"FLJ23274, MGC5297"	ENSG00000124279	"FAST kinase domains 3"	Q14CZ7	5	7859159-7869037	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA068525, HPA074462"	Approved		Supported	Nucleoplasm,Mitochondria		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 20: HeLa - Mitochondria"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoplasm, Mitochondria"		"HPA068525: AB_2685999, HPA074462: AB_2686692"	"unprognostic (5.27e-2)"	"unprognostic (1.28e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.61e-2)"	"unprognostic (1.20e-1)"	"unprognostic (5.41e-3)"	"prognostic unfavorable (1.87e-5)"	"unprognostic (6.66e-3)"	"unprognostic (4.56e-3)"	"unprognostic (3.19e-2)"	"unprognostic (1.61e-2)"	"unprognostic (5.82e-3)"	"unprognostic (5.68e-3)"	"unprognostic (1.58e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.19e-1)"	"prognostic favorable (8.53e-4)"	3.5	5.4	2.5	3.8	2.6	4.4	6.2	2.4	3.4	4.0	3.2	5.6	5.3	3.3	4.0	3.1	3.1	3.2	3.2	2.4	2.5	9.1	6.7	3.6	5.5	2.4	2.4	4.5	3.0	5.8	2.8	3.3	2.6	4.2	6.6	3.5	3.3	3.4	5.7	4.7	5.9	3.9	2.5	4.6	4.8	2.7	2.2	5.2	4.1	4.3	6.5	3.4	2.6	3.0	10.5	9.0	8.5	11.1	5.2	6.6	16.8	8.5	7.2	13.0	9.9	13.6	10.8	36.0	16.6	9.3	16.5	10.8	21.5	12.0	18.7	9.9	11.1	12.6	28.7	10.7	7.2	21.0	9.8	7.7	5.0	12.3	7.3	5.8	7.2	14.1	17.5	6.1	10.0	7.6	14.2	12.2	7.8	10.9	12.7	16.0	10.4	8.3	10.8	11.1	5.9	5.6	25.9	11.1	12.6	7.7	10.0	9.5	4.8	12.8	13.2	13.6	14.3	7.0	7.2	22.9	8.7	18.9	10.8	2.9	4.2	5.9	4.6	5.7	6.1	7.7	6.6	4.8	5.2	5.7	7.2	6.8	0.2	4.2	4.7	3.0	8.1	3.6	2.5	2.6	2.4	3.4	2.4	2.5	2.4	2.4	2.6	2.5	2.2	3.0	5.3	16.0	5.9	3.9	5.7	2.5	2.3	11.6	1.8	3.3	5.4	4.7	5.0	5.7	5.1	0.0	0.0	7.8	8.8	6.5	5.9	9.1	0.4	3.1	5.4	5.3	7.2	4.6	5.6	11.8	7.1	4.8	4.1	3.3	3.8	4.2	6.4	9.7	8.4	5.0	4.9	6.5	12.2	7.0	5.1	1.1	5.3	5.2	1.8	0.0	12.1	3.5	10.3	2.0	5.9	11.6	4.4	4.5	4.9	3.0	12.4	21.3	6.5	5.3	0.0	3.5	4.0	4.0	6.0	6.6	5.5	4.2	6.8	8.0	7.7	2.1
FBF1	"ALB, FBF-1, FLJ00103, KIAA1863"	ENSG00000188878	"Fas binding factor 1"	Q8TES7	17	75909574-75941140	"Predicted intracellular proteins"	"Cilium biogenesis/degradation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 32.3"	"Cell type enhanced"	"Detected in many"		"Late spermatids: 43.1;Spermatocytes: 27.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023677			Supported	Centrosome		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 43: Testis - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 25: Spermatids - Spermatogenesis"	Centrosome		"HPA023677: AB_1848440"	"unprognostic (7.40e-3)"	"unprognostic (9.90e-3)"	"unprognostic (6.62e-2)"	"unprognostic (1.38e-3)"	"unprognostic (3.14e-3)"	"unprognostic (7.88e-4)"	"unprognostic (5.76e-4)"	"unprognostic (6.67e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.24e-3)"	"unprognostic (6.31e-5)"	"unprognostic (6.76e-2)"	"unprognostic (1.08e-9)"	"unprognostic (1.75e-1)"	"unprognostic (1.88e-1)"	"unprognostic (3.59e-1)"	"unprognostic (1.77e-1)"	3.7	6.8	7.8	3.6	9.9	5.2	3.9	7.6	8.3	6.1	6.3	4.9	2.7	4.6	7.9	8.7	6.2	3.1	3.7	7.9	6.9	5.9	2.6	4.2	4.2	8.8	8.9	6.0	4.4	4.2	13.0	2.0	7.9	9.6	1.9	4.2	5.7	4.5	3.3	13.0	4.4	1.7	8.0	5.6	4.0	32.3	9.8	4.4	18.8	1.3	2.7	5.1	8.7	9.5	11.2	14.6	4.3	8.0	3.9	2.7	11.7	6.3	1.2	4.3	3.1	3.7	6.3	5.4	4.0	3.0	6.1	6.9	2.5	4.5	3.1	3.1	4.8	4.9	9.9	2.8	1.9	1.6	7.4	2.7	5.3	7.1	4.7	2.2	3.3	19.2	9.1	6.2	2.9	12.5	14.1	5.5	3.6	3.4	6.2	11.1	7.0	4.8	2.2	1.8	4.9	4.5	9.0	6.7	3.5	3.2	18.7	3.9	2.0	9.3	7.4	4.9	5.8	10.6	2.9	2.3	5.9	3.6	9.2	0.1	0.1	0.1	0.3	0.3	0.1	0.1	0.2	0.4	0.0	0.0	0.3	0.3	0.0	0.2	0.1	0.4	0.5	0.1	7.8	9.9	7.6	8.3	7.9	6.9	8.8	8.9	7.9	8.0	9.8	9.5	2.4	0.0	2.6	9.1	3.7	3.1	4.9	3.1	12.0	5.4	3.9	3.9	1.6	0.0	7.0	3.7	10.4	6.4	4.4	2.8	3.9	1.3	15.7	8.1	4.4	2.3	1.2	3.4	8.0	0.7	2.1	4.1	6.1	3.9	2.5	7.6	0.0	0.0	2.2	5.0	8.9	2.5	0.0	0.0	2.1	43.1	6.5	1.5	3.6	1.9	1.2	2.7	8.2	3.5	5.7	0.7	1.7	6.0	3.2	2.3	6.2	1.4	9.4	8.0	0.0	4.7	3.2	27.1	9.1	5.2	2.6	3.6	5.9	4.3	3.0	2.4
FBL	"FIB, FLRN, Nop1, RNU3IP1"	ENSG00000105202	Fibrillarin	P22087	19	39834458-39846379	"Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"rRNA processing"	"Methyltransferase, Ribonucleoprotein, RNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 747.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB001514, HPA049546, HPA077724"	Supported		Supported	"Nucleoli fibrillar center"		NA	NA		79000	"Cluster 30: Non-specific - Translation"	"Cluster 50: Non-specific - Ribosome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 34: Spermatids - Unknown function"	"Nucleoli fibrillar center"		"CAB001514: AB_367009, HPA049546: AB_2680811, HPA077724: "	"prognostic favorable (1.65e-4)"	"unprognostic (1.71e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.32e-2)"	"unprognostic (4.23e-3)"	"unprognostic (1.42e-1)"	"prognostic unfavorable (1.32e-4)"	"unprognostic (5.56e-2)"	"unprognostic (1.92e-1)"	"unprognostic (4.09e-3)"	"unprognostic (4.69e-2)"	"unprognostic (8.81e-2)"	"prognostic unfavorable (4.52e-6)"	"unprognostic (4.04e-2)"	"unprognostic (5.94e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.97e-1)"	130.3	86.7	30.0	66.3	31.0	124.9	147.8	28.4	34.0	186.5	28.8	112.1	52.2	136.9	61.2	191.5	145.3	32.8	72.8	27.5	28.4	93.3	73.4	88.2	99.2	30.6	29.4	255.1	155.9	50.1	66.0	42.9	30.2	109.9	85.6	23.3	110.5	48.2	127.6	221.8	113.4	67.3	30.0	130.8	104.8	77.2	31.1	103.0	89.5	57.2	157.3	125.6	156.2	31.5	248.5	510.6	208.0	237.2	82.6	140.5	125.0	137.5	122.8	237.6	225.9	301.8	142.8	555.9	125.9	119.7	72.0	98.3	308.2	295.4	290.8	101.2	405.3	225.2	181.9	276.8	106.5	528.3	169.1	114.2	105.9	190.3	395.0	107.4	184.2	239.5	361.8	228.0	133.2	340.3	468.9	232.7	206.4	353.8	156.1	256.3	209.7	282.5	131.4	282.1	280.2	163.2	133.5	210.9	87.7	116.2	107.1	190.6	99.8	112.3	177.2	156.8	324.8	155.5	176.1	374.1	113.4	341.6	105.2	2.7	41.8	6.4	70.6	36.3	101.7	83.5	73.9	70.3	74.8	84.5	100.6	97.3	3.2	92.5	40.5	78.1	58.3	71.6	30.0	31.0	28.4	34.0	27.5	28.4	30.6	29.4	30.2	30.0	31.1	31.5	45.9	32.1	48.1	2.3	166.6	350.3	323.8	150.2	200.9	18.8	168.3	177.3	37.5	105.8	77.4	40.5	25.0	130.7	118.9	88.5	74.3	108.8	361.1	43.4	97.9	105.4	92.8	129.3	2.7	190.9	283.2	84.2	65.7	53.7	95.9	139.0	105.7	54.1	104.8	15.2	2.6	170.0	46.8	104.3	169.8	747.7	118.1	66.5	97.8	2.8	135.8	33.3	151.4	1.0	4.1	94.5	95.6	78.6	102.8	266.6	59.1	78.7	43.7	24.9	72.3	193.9	122.8	41.7	83.4	201.8	330.7	121.6	123.3	157.3	265.3	240.1
FBLL1	LOC345630	ENSG00000188573	"Fibrillarin like 1"	A6NHQ2	5	168529305-168530634	"Metabolic proteins, Predicted intracellular proteins"	"rRNA processing"	"Methyltransferase, Ribonucleoprotein, RNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"brain: 35.4;pituitary gland: 15.5"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 8.5;Cone photoreceptor cells: 6.2;Enteroendocrine cells: 6.7;Horizontal cells: 6.7;Inhibitory neurons: 6.6;Sertoli cells: 6.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"SCLC-21H: 24.2;SH-SY5Y: 20.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049546, HPA077724"	Uncertain		Supported	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 62: Horizontal cells - Visual perception"	"Nucleoli fibrillar center"	Nucleoplasm	"HPA049546: AB_2680811, HPA077724: "	"unprognostic (2.75e-3)"	"unprognostic (2.37e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.91e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.87e-2)"	"unprognostic (1.43e-1)"	"unprognostic (4.41e-2)"	"unprognostic (2.45e-1)"	"unprognostic (3.80e-3)"	"unprognostic (9.69e-2)"	"unprognostic (6.55e-3)"	"unprognostic (3.15e-1)"	"unprognostic (6.18e-2)"	"unprognostic (8.32e-2)"	"unprognostic (1.22e-1)"	0.2	3.0	22.0	0.1	21.0	0.0	0.6	12.8	35.4	0.5	4.6	0.9	0.4	0.2	0.0	0.2	0.4	0.2	0.3	20.4	32.2	0.6	0.7	0.1	0.0	22.7	21.0	0.7	0.9	0.4	15.5	0.2	26.1	1.0	0.1	1.4	0.9	0.3	0.1	0.5	0.5	0.2	11.4	0.2	0.5	5.9	23.1	0.0	0.2	0.0	0.0	0.3	0.3	20.1	0.0	0.5	1.8	0.3	0.1	0.0	0.9	0.2	0.0	0.0	0.1	0.2	0.1	0.0	0.1	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.9	0.0	0.1	0.1	0.5	0.0	1.3	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	24.2	20.2	2.1	0.0	1.2	0.0	0.0	1.5	0.0	0.0	1.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.0	21.0	12.8	35.4	20.4	32.2	22.7	21.0	26.1	11.4	23.1	20.1	0.0	0.0	0.0	2.0	0.0	0.1	0.1	0.0	0.6	8.5	1.4	1.8	1.2	0.0	0.0	0.0	6.2	0.1	0.0	0.0	0.0	0.4	1.7	0.9	1.4	0.2	6.7	0.0	4.3	0.2	0.1	0.8	0.0	2.4	0.0	1.6	0.0	0.0	0.1	6.7	6.6	0.4	0.0	0.0	0.0	2.3	0.0	0.1	3.6	1.0	0.0	0.7	0.0	3.0	1.1	0.2	0.0	0.0	0.0	0.3	1.0	0.4	0.0	2.8	6.6	0.2	0.4	3.1	0.4	0.2	0.1	0.0	0.1	1.2	0.3	0.0
FBLN2		ENSG00000163520	"Fibulin 2"	P98095	3	13549125-13638422	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 292.8"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 92.7;Endometrial stromal cells: 84.4;Fibroblasts: 458.4;Leydig cells: 170.9;Peritubular cells: 227.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"myeloid DC: 6.7;naive CD8 T-cell: 3.7"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 384.0;fHDF/TERT166: 264.3;HMC-1: 311.6;HSkMC: 221.9;U-2197: 139.2"	"Group enriched"	"Detected in many"	4	"olfactory bulb: 12.4;white matter: 3.1"	"Low region specificity"	"Detected in all"			"HPA001934, CAB018622"	Enhanced		Supported	"Plasma membrane"	"Secreted to extracellular matrix"	NA	NA		35000000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Plasma membrane"		"CAB018622: AB_2294196, HPA001934: AB_1078827"	"unprognostic (1.19e-1)"	"unprognostic (7.76e-2)"	"unprognostic (3.21e-1)"	"prognostic unfavorable (9.48e-4)"	"unprognostic (2.82e-2)"	"unprognostic (1.05e-1)"	"prognostic favorable (3.17e-4)"	"unprognostic (8.02e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.70e-2)"	"unprognostic (2.57e-1)"	"unprognostic (4.66e-2)"	"unprognostic (2.13e-2)"	"unprognostic (1.89e-2)"	"unprognostic (2.82e-2)"	"unprognostic (2.61e-2)"	"unprognostic (1.41e-1)"	157.3	7.6	5.9	12.7	7.7	1.0	97.3	5.2	9.0	63.4	6.4	32.7	6.2	31.1	3.2	42.4	26.8	46.2	292.8	7.0	4.9	8.7	3.7	29.2	8.4	5.3	5.3	5.8	8.6	3.0	2.3	80.3	4.8	29.1	11.8	0.6	39.4	8.8	47.7	72.5	19.8	14.7	4.1	6.0	22.3	46.7	6.9	14.2	63.7	48.9	5.6	79.6	56.7	4.4	0.0	1.4	50.9	0.0	384.0	51.7	23.8	124.9	98.2	122.4	80.4	8.1	0.3	0.0	5.9	264.3	0.2	0.2	0.0	0.5	22.9	0.1	0.1	100.7	1.9	0.0	26.0	0.2	311.6	221.9	2.0	19.3	0.0	0.2	0.0	8.6	0.8	0.9	0.6	0.3	5.2	0.6	12.2	0.0	0.7	0.2	0.0	0.5	0.9	0.1	3.0	2.4	0.5	90.3	0.1	13.6	0.2	0.3	0.1	0.1	0.1	139.2	0.1	0.2	0.0	0.0	1.1	0.2	0.5	0.0	0.0	0.0	0.0	0.0	0.1	1.1	0.0	0.2	6.7	1.3	0.0	3.7	0.0	0.2	0.0	0.5	0.0	0.9	5.9	7.7	5.2	9.0	7.0	4.9	5.3	5.3	4.8	4.1	6.9	4.4	92.7	0.0	1.5	1.6	3.6	30.8	0.8	10.5	2.2	0.0	1.7	1.9	8.8	0.0	12.3	7.3	2.1	7.8	1.9	0.1	0.0	0.0	3.8	2.9	84.4	43.8	0.0	1.7	0.6	0.2	4.8	458.4	6.1	2.7	23.6	0.6	47.8	0.4	3.6	0.0	0.6	0.0	0.0	1.9	49.8	12.1	170.9	4.5	39.2	26.2	0.3	1.2	0.0	30.7	0.3	0.3	0.0	227.2	1.6	1.2	2.7	0.1	1.4	0.4	13.1	29.7	26.4	3.4	13.5	2.0	28.8	6.2	5.3	0.2	0.0	1.1
FBP2		ENSG00000130957	"Fructose-bisphosphatase 2"	O00757	9	94558720-94593824	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Carbohydrate metabolism, Gluconeogenesis"	"Allosteric enzyme, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	8	"skeletal muscle: 753.6;tongue: 385.3"	"Group enriched"	"Detected in some"	7	"Gastric mucus-secreting cells: 11.2;Skeletal myocytes: 8.7;Spermatogonia: 8.5"	"Cancer enhanced"	"Detected in some"		"stomach cancer: 1.2"	"Region enriched"	"Detected in some"	4	"hippocampal formation: 6.1"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 3.9;CACO-2: 2.1;HMC-1: 2.2;MCF7: 3.0;OE19: 2.9;PC-3: 2.0;SiHa: 2.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA012513, HPA077371"	Enhanced		Approved	"Plasma membrane,Cytosol"		NA	NA		960000		"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 37: Myocytes - Muscle contraction"	"Plasma membrane, Cytosol"		"HPA012513: AB_1848446, HPA077371: "	"unprognostic (3.88e-2)"	"unprognostic (3.54e-4)"	"unprognostic (2.38e-1)"	"unprognostic (6.03e-2)"		"unprognostic (2.21e-1)"	"unprognostic (1.54e-2)"	"unprognostic (9.40e-4)"	"unprognostic (3.95e-3)"	"unprognostic (5.11e-2)"	"unprognostic (2.39e-2)"	"unprognostic (4.69e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.36e-2)"	"unprognostic (2.03e-1)"		"unprognostic (1.48e-4)"	0.1	0.9	0.1	0.1	0.0	0.0	0.2	1.2	0.1	0.0	69.2	0.3	5.3	0.0	0.0	8.1	0.0	0.1	0.2	6.1	0.0	0.2	0.2	0.4	0.4	0.7	0.3	0.0	4.3	49.7	0.0	0.1	0.1	1.2	0.0	0.0	4.2	3.3	753.6	0.2	0.9	0.0	0.9	0.0	36.1	1.4	1.4	0.2	0.3	385.3	0.9	0.3	0.0	0.0	0.3	1.3	0.0	1.4	0.0	0.0	3.9	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.1	0.0	1.2	1.1	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	3.0	0.0	0.0	0.0	2.9	2.0	0.0	0.0	0.0	0.0	1.4	0.3	0.0	2.8	0.6	0.0	0.1	0.2	0.1	0.0	0.0	1.2	1.2	0.0	0.0	0.0	0.6	0.1	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.2	0.1	6.1	0.0	0.7	0.3	0.1	0.9	1.4	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.1	0.0	0.1	0.0	0.0	0.5	1.3	0.0	0.0	11.2	0.0	0.0	0.0	1.1	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.7	0.1	0.2	8.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0
FBXL17	"DKFZP434C1715, Fbl17, Fbx13, FBXO13"	ENSG00000145743	"F-box and leucine rich repeat protein 17"	Q9UF56	5	107859035-108382098	"Predicted intracellular proteins, Predicted membrane proteins"	"Neurogenesis, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"Astrocytes: 270.0;Excitatory neurons: 568.2;Inhibitory neurons: 578.0;Microglial cells: 205.2;Oligodendrocyte precursor cells: 302.6;Oligodendrocytes: 256.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036410, HPA036411"	Uncertain		Supported	Nucleoplasm		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm		"HPA036410: AB_2675109, HPA036411: AB_10669603"	"unprognostic (8.15e-2)"	"unprognostic (3.77e-2)"	"unprognostic (2.18e-2)"	"unprognostic (1.21e-1)"	"unprognostic (4.58e-2)"	"unprognostic (2.72e-2)"	"unprognostic (2.08e-2)"	"unprognostic (2.65e-1)"	"unprognostic (6.67e-2)"	"unprognostic (3.08e-2)"	"unprognostic (5.98e-2)"	"unprognostic (6.30e-2)"	"prognostic favorable (4.60e-8)"	"unprognostic (1.86e-1)"	"unprognostic (3.34e-1)"	"prognostic unfavorable (3.27e-4)"	"unprognostic (3.35e-2)"	15.4	13.8	11.8	7.8	13.1	5.9	10.4	7.5	15.3	10.8	3.8	10.1	10.6	9.9	8.9	12.0	9.0	9.1	27.0	12.4	12.5	16.9	14.2	8.9	8.5	9.0	12.2	9.3	10.0	26.0	5.7	5.9	9.0	11.8	10.4	25.6	9.8	13.7	55.8	8.7	10.9	11.7	10.5	10.7	10.1	8.6	11.8	10.1	24.6	41.7	10.7	8.5	4.5	10.3	8.7	8.5	9.6	17.7	15.8	16.4	6.4	10.4	23.3	8.4	11.3	1.7	17.9	9.7	16.0	16.9	13.0	3.8	7.7	11.9	13.0	9.8	6.9	9.2	9.0	4.2	8.2	6.2	10.1	11.8	17.4	7.8	5.7	16.3	10.1	3.9	1.3	12.2	18.5	6.5	5.4	7.9	1.3	6.7	7.9	7.6	12.8	12.7	11.7	11.9	8.2	14.0	13.6	11.9	13.4	6.6	9.4	14.6	11.0	18.9	5.9	5.9	13.6	9.5	14.3	7.0	16.7	9.4	12.6	0.1	0.1	0.8	0.4	0.2	0.4	0.2	0.4	0.4	0.2	0.3	0.4	0.3	0.3	0.2	0.1	0.4	0.2	0.1	11.8	13.1	7.5	15.3	12.4	12.5	9.0	12.2	9.0	10.5	11.8	10.3	13.2	19.2	14.5	270.0	13.9	16.8	7.4	7.5	6.8	37.2	18.6	10.2	38.3	17.2	8.3	29.5	56.3	4.8	12.8	22.8	17.6	7.3	5.6	8.5	9.7	12.3	29.9	5.7	568.2	13.1	6.5	12.1	12.2	10.7	16.5	12.2	21.0	21.4	8.4	30.3	578.0	21.7	2.0	21.0	14.1	5.4	14.0	9.9	16.0	205.2	13.1	20.8	12.3	302.6	256.1	13.3	16.0	16.6	10.7	8.6	14.4	15.0	6.1	50.4	0.0	16.6	9.8	9.5	3.9	10.6	24.6	4.5	12.6	13.8	16.6	8.8
FBXL2	"FBL2, FBL3"	ENSG00000153558	"F-box and leucine rich repeat protein 2"	Q9UKC9	3	33277025-33403662	"Predicted intracellular proteins"	"Host-virus interaction, Ubl conjugation pathway"	Calmodulin-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 48.8;Excitatory neurons: 125.0;Inhibitory neurons: 92.8;Late spermatids: 50.7;Oligodendrocyte precursor cells: 55.8;Oligodendrocytes: 49.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 5.7;LHCN-M2: 6.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003240, HPA061783"	Approved		Approved	"Nucleoplasm,Nucleoli,Plasma membrane"		NA	NA				"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Plasma membrane"	"Nucleoplasm, Nucleoli"	"HPA003240: , HPA061783: AB_2684605"	"unprognostic (5.73e-2)"	"unprognostic (4.47e-2)"	"unprognostic (7.92e-2)"	"unprognostic (7.21e-2)"	"unprognostic (3.68e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.10e-2)"	"unprognostic (2.09e-1)"	"unprognostic (3.16e-1)"	"unprognostic (2.00e-1)"	"unprognostic (4.31e-2)"	"unprognostic (1.06e-1)"	"prognostic favorable (3.35e-4)"	"unprognostic (3.30e-3)"	"unprognostic (9.72e-2)"	"unprognostic (4.28e-2)"	"unprognostic (5.90e-2)"	0.9	1.3	3.6	0.4	3.8	0.3	1.0	2.2	4.0	1.1	4.2	1.1	0.7	1.0	2.1	0.4	1.5	0.6	0.9	3.5	3.7	1.4	0.2	1.2	0.3	2.9	2.6	1.4	1.1	2.7	2.7	1.4	3.0	1.0	0.2	4.2	0.8	1.6	0.2	0.6	0.5	0.8	1.6	0.5	0.8	1.1	3.3	0.2	2.3	0.0	0.2	0.8	0.9	2.7	2.7	0.7	1.0	1.0	1.5	2.4	0.4	2.0	1.6	1.8	2.6	0.5	3.1	0.1	0.6	1.3	0.8	0.5	0.9	2.1	1.2	0.2	1.1	0.4	2.3	0.5	1.8	0.2	0.4	0.9	1.6	1.1	0.8	5.7	3.3	1.9	0.5	0.2	6.2	0.2	0.5	0.3	0.7	0.3	0.6	0.1	0.6	0.1	4.6	0.7	1.1	1.1	0.9	0.5	0.8	1.7	1.3	0.7	2.5	0.8	0.7	0.6	1.1	0.2	0.1	0.1	0.8	0.2	0.6	0.3	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.1	0.3	0.1	0.1	0.1	0.0	0.0	3.6	3.8	2.2	4.0	3.5	3.7	2.9	2.6	3.0	1.6	3.3	2.7	2.7	3.2	7.3	22.2	1.0	1.1	7.6	5.6	1.8	15.3	3.0	3.7	2.4	2.8	4.8	5.5	25.0	0.5	0.4	0.1	3.9	3.9	48.8	18.8	3.6	3.8	0.0	0.0	125.0	0.4	1.5	5.0	5.6	6.2	0.0	6.2	2.2	0.1	0.5	18.5	92.8	0.3	8.2	0.8	2.4	50.7	1.5	0.5	1.8	22.5	0.1	6.6	0.0	55.8	49.6	4.2	0.1	4.1	0.3	4.2	0.2	3.2	16.5	17.7	6.6	3.6	3.9	21.3	8.6	0.7	1.1	0.7	1.5	3.5	0.1	3.8
FBXL4	"FBL4, FBL5"	ENSG00000112234	"F-box and leucine rich repeat protein 4"	Q9UKA2	6	98868535-98948006	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Ubl conjugation pathway"		"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocyte precursor cells: 97.0;Oligodendrocytes: 94.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029140, CAB033362"	Approved		Supported	"Nuclear speckles"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 68: Oligodendrocytes - Mixed function"	"Nuclear speckles"		"CAB033362: AB_2103974, HPA029140: AB_10611967"	"unprognostic (1.24e-1)"	"unprognostic (5.10e-2)"	"unprognostic (1.10e-2)"	"unprognostic (1.42e-1)"	"unprognostic (3.34e-2)"	"unprognostic (1.66e-1)"	"unprognostic (2.03e-1)"	"unprognostic (3.10e-1)"	"unprognostic (2.79e-1)"	"unprognostic (2.68e-1)"	"unprognostic (4.53e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.05e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.65e-1)"	"unprognostic (2.62e-1)"	5.8	8.0	5.9	5.3	8.4	5.1	7.7	7.6	5.5	7.0	5.5	6.2	5.9	6.9	11.2	5.3	7.7	6.6	5.9	4.6	7.1	13.1	15.7	5.9	6.1	8.0	8.3	8.2	9.4	12.7	4.8	6.8	8.4	8.0	6.9	5.1	9.9	6.6	9.4	5.7	5.8	6.2	7.2	5.3	7.4	4.1	7.4	9.0	12.2	7.2	6.4	5.7	5.3	11.0	5.7	9.0	7.6	10.2	12.5	22.8	8.2	12.7	10.7	7.3	10.3	4.1	10.7	13.1	11.5	10.6	12.8	8.1	8.8	9.2	11.1	21.4	7.2	9.3	6.2	9.4	9.7	11.5	8.9	13.0	16.4	6.6	18.4	20.4	9.5	10.2	12.6	10.1	13.4	5.6	4.3	5.5	4.0	7.5	5.5	14.6	5.2	10.7	13.9	8.2	9.5	7.7	6.7	8.9	12.2	9.2	6.6	8.2	13.3	8.4	3.7	11.9	9.3	3.4	3.4	5.5	10.5	10.4	10.2	18.4	4.7	13.0	4.6	4.5	6.1	7.1	4.6	4.6	3.8	5.7	5.9	5.6	5.9	4.3	6.0	2.5	6.1	3.9	5.9	8.4	7.6	5.5	4.6	7.1	8.0	8.3	8.4	7.2	7.4	11.0	12.2	19.2	11.9	42.7	14.2	9.7	8.2	9.0	12.0	14.9	9.1	8.3	16.2	5.7	8.8	36.8	22.9	10.1	9.5	9.8	19.6	9.7	5.4	10.6	14.5	10.8	7.2	20.2	46.9	11.0	10.7	13.7	14.3	7.9	8.9	20.8	11.4	19.4	8.9	10.1	58.3	13.7	8.2	12.3	6.4	2.1	19.0	11.8	5.4	41.2	14.9	10.6	12.3	97.0	94.4	7.5	9.8	12.8	8.8	13.9	12.5	11.8	11.3	13.3	13.1	12.7	10.0	4.1	6.4	12.4	8.5	9.9	9.3	16.9	10.4	8.2
FBXO11	"FBX11, UBR6"	ENSG00000138081	"F-box protein 11"	Q86XK2	2	47789316-47906498	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"		"Cancer-related genes, Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002690			Supported	Nucleoplasm,Nucleoli		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 21: Non-specific - Transcription"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 44: Endometrium - Transcription"	"Nucleoplasm, Nucleoli"		"HPA002690: AB_1848448"	"unprognostic (1.18e-1)"	"unprognostic (8.65e-3)"	"unprognostic (3.93e-2)"	"unprognostic (2.05e-2)"	"unprognostic (7.92e-2)"	"unprognostic (1.42e-1)"	"unprognostic (3.85e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.55e-2)"	"unprognostic (9.82e-2)"	"unprognostic (5.77e-2)"	"unprognostic (2.33e-2)"	"unprognostic (3.21e-2)"	"unprognostic (1.55e-1)"	"unprognostic (3.71e-1)"	"unprognostic (2.19e-1)"	"unprognostic (3.20e-2)"	27.9	19.6	24.5	19.1	25.9	32.2	20.9	32.7	28.7	21.1	21.0	19.7	16.8	33.1	24.8	18.7	22.2	20.9	22.8	26.5	25.6	21.7	26.8	22.5	25.7	22.8	23.1	34.4	19.6	30.2	17.5	23.0	24.0	22.7	20.1	33.3	16.5	20.4	28.3	19.1	17.3	29.7	22.9	24.2	19.1	41.0	25.9	22.5	26.1	28.7	27.7	22.1	16.9	25.2	52.8	26.9	62.9	53.9	42.6	40.2	37.2	36.0	48.6	32.6	31.9	22.9	25.9	32.8	45.4	50.2	40.5	25.6	42.5	37.1	47.9	22.3	21.5	31.6	21.3	36.6	41.0	33.5	32.1	39.3	41.7	28.8	48.2	51.9	42.1	16.6	31.3	33.9	40.4	25.5	31.7	32.8	38.2	34.7	26.2	40.9	58.3	25.5	47.1	42.5	44.1	52.3	34.2	31.5	54.6	46.4	14.7	27.9	46.4	40.2	37.2	27.5	40.0	28.9	16.5	60.9	27.4	30.8	42.1	4.3	1.1	2.1	1.5	1.2	1.6	2.1	1.4	1.7	1.4	1.5	2.6	1.7	2.6	2.2	1.1	2.0	1.6	1.1	24.5	25.9	32.7	28.7	26.5	25.6	22.8	23.1	24.0	22.9	25.9	25.2	40.6	16.0	39.0	100.9	34.1	67.0	44.4	22.0	24.5	45.1	22.3	15.1	11.0	15.7	24.9	18.4	33.3	19.6	37.8	24.7	11.7	17.2	34.4	38.6	40.3	39.4	23.9	17.1	151.4	15.2	16.0	37.0	23.4	48.6	29.1	37.3	33.2	20.0	25.5	55.5	134.8	17.1	24.4	40.1	81.4	40.4	30.1	51.8	35.6	137.7	30.9	30.2	25.7	138.7	143.8	25.8	17.1	39.9	36.3	44.3	17.3	14.6	37.4	42.5	19.7	42.3	34.6	86.6	50.7	24.2	59.0	36.0	35.6	33.4	19.5	65.1
FBXO28	"CENP-30, Fbx28, FLJ10766, KIAA0483"	ENSG00000143756	"F-box protein 28"	Q9NVF7	1	224114111-224162047	"Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003289	Approved		Supported	"Nucleoplasm,Focal adhesion sites"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 22: Epithelial cell types - Mixed function"	Nucleoplasm	"Focal adhesion sites"	"HPA003289: AB_2666879"	"unprognostic (4.91e-2)"	"unprognostic (5.57e-2)"	"unprognostic (1.78e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.33e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.12e-1)"	"unprognostic (8.25e-2)"	"unprognostic (2.03e-1)"	"unprognostic (7.09e-2)"	"unprognostic (5.09e-3)"	"unprognostic (2.60e-1)"	"unprognostic (1.98e-3)"	"unprognostic (9.46e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.41e-1)"	"unprognostic (2.61e-1)"	10.9	7.5	6.5	8.3	7.3	8.9	12.3	8.8	10.5	10.9	7.4	10.3	8.5	10.0	7.9	12.4	8.2	9.5	8.1	7.6	9.1	13.6	17.4	8.9	10.5	8.5	7.4	11.3	7.6	13.7	4.4	9.0	8.8	10.0	10.6	8.3	7.9	8.5	12.5	21.1	7.7	9.8	8.0	8.9	8.5	7.8	7.8	10.9	9.8	14.2	10.6	11.5	9.0	8.9	24.6	10.6	16.2	17.4	16.6	19.0	26.7	24.3	19.7	16.0	15.2	14.9	18.7	11.8	24.4	22.3	10.3	20.9	24.2	23.4	27.4	17.0	27.0	15.0	12.8	10.7	20.7	28.3	18.8	18.6	27.7	23.2	41.9	18.8	27.1	15.0	24.8	16.4	29.1	8.1	14.9	14.4	38.6	32.3	22.8	15.7	23.1	22.3	30.2	16.1	26.2	28.1	25.1	38.0	27.4	16.9	20.2	28.2	31.2	19.8	15.0	25.0	46.1	17.8	22.3	18.0	24.5	13.7	39.3	7.4	6.5	11.8	5.8	6.0	7.2	8.9	5.9	6.8	7.8	9.0	5.9	6.6	4.2	8.6	6.9	3.5	8.8	4.6	6.5	7.3	8.8	10.5	7.6	9.1	8.5	7.4	8.8	8.0	7.8	8.9	15.0	6.4	10.6	22.5	16.8	34.3	25.5	11.3	9.6	20.5	14.7	11.7	11.4	7.2	13.5	11.0	22.9	14.2	12.3	17.2	9.8	13.2	30.3	15.9	13.0	16.4	18.5	17.4	48.8	11.5	13.1	12.7	7.1	22.9	14.0	12.6	14.3	23.4	13.9	18.5	43.8	12.7	14.2	17.7	16.3	14.8	13.1	16.8	28.4	34.7	16.4	12.6	7.2	45.8	43.7	17.7	12.2	13.2	15.4	21.5	12.0	22.8	11.5	18.6	13.1	14.9	12.7	24.7	26.8	17.2	39.1	23.0	18.9	10.9	14.6	30.7
FBXO38	"Fbx38, FLJ13962, MOKA, SP329"	ENSG00000145868	"F-box protein 38"	Q6PIJ6	5	148383935-148442836	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Adaptive immunity, Immunity, Ubl conjugation pathway"		"Disease variant, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034821, HPA041444"	Approved		Supported	"Nucleoplasm,Plasma membrane,Cytokinetic bridge,Cytosol"		Yes	No			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 59: Non-specific - Transcription"	"Nucleoplasm, Plasma membrane"	"Cytokinetic bridge, Cytosol"	"HPA034821: AB_10669897, HPA041444: AB_2677484"	"unprognostic (7.72e-2)"	"unprognostic (5.75e-3)"	"unprognostic (1.95e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.21e-1)"	"unprognostic (2.70e-2)"	"unprognostic (7.06e-2)"	"unprognostic (5.43e-3)"	"unprognostic (1.45e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.03e-1)"	"unprognostic (6.29e-2)"	"unprognostic (2.21e-3)"	"unprognostic (1.31e-3)"	"unprognostic (1.83e-1)"	"unprognostic (1.64e-1)"	"unprognostic (4.70e-3)"	12.8	11.5	7.3	12.9	8.4	9.8	13.9	8.1	9.9	14.1	8.2	12.5	9.6	12.5	11.1	10.5	10.0	11.5	17.4	7.0	7.7	12.9	18.0	14.5	14.6	8.0	7.6	12.3	9.5	18.5	10.2	13.8	8.0	14.6	13.0	11.0	11.5	12.0	18.7	12.2	11.6	12.3	7.5	14.4	12.5	12.4	7.8	20.2	12.2	16.8	15.6	13.8	11.2	9.9	12.6	13.2	20.1	14.7	22.1	24.6	10.4	16.1	30.7	22.4	30.5	19.6	15.1	18.2	15.5	26.2	23.6	17.2	21.2	20.3	26.8	20.1	13.6	10.8	19.0	13.3	21.9	29.6	17.0	24.0	17.1	21.6	21.1	24.0	30.7	16.6	12.2	19.1	22.3	5.1	18.8	13.8	9.4	13.9	19.8	16.6	29.3	18.4	21.7	14.5	17.9	17.3	21.4	14.2	21.2	17.1	15.0	21.2	20.2	20.4	7.3	10.8	18.2	23.3	25.1	15.3	20.3	16.6	15.8	15.1	6.1	9.1	5.0	8.0	5.5	4.9	4.7	5.0	7.5	3.8	4.8	6.2	11.2	7.7	15.2	3.7	7.4	4.9	7.3	8.4	8.1	9.9	7.0	7.7	8.0	7.6	8.0	7.5	7.8	9.9	10.6	16.0	45.7	25.1	13.8	3.3	5.5	7.4	7.4	10.3	8.5	6.7	18.7	11.5	10.6	11.0	10.4	7.5	13.4	11.3	5.9	8.8	11.2	8.9	9.9	10.8	9.6	7.2	40.2	6.7	6.8	11.8	14.8	10.4	15.8	9.6	11.4	16.9	12.6	13.5	37.4	10.1	6.1	24.9	6.4	2.9	9.0	17.8	3.6	38.4	12.3	5.9	12.3	33.2	44.4	9.9	8.9	18.4	11.0	8.6	9.3	9.3	16.4	9.0	0.0	6.9	7.8	20.6	8.6	9.2	3.8	12.3	12.1	11.2	9.0	8.7
FBXO5	"EMI1, FBX5, Fbxo31"	ENSG00000112029	"F-box protein 5"	Q9UKT4	6	152970519-152983579	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"bone marrow: 44.1;lymphoid tissue: 27.3"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 36.0;Extravillous trophoblasts: 30.5;Spermatocytes: 32.3;Spermatogonia: 26.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB008106, HPA029048"	Approved		Supported	Nucleoplasm		NA	Yes			"Cluster 27: Non-specific - Gene expression"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"CAB008106: AB_828450, HPA029048: AB_10602132"	"unprognostic (1.22e-2)"	"unprognostic (7.21e-2)"	"unprognostic (4.61e-3)"	"unprognostic (1.24e-2)"	"unprognostic (5.92e-2)"	"unprognostic (2.94e-2)"	"unprognostic (2.43e-8)"	"unprognostic (2.46e-2)"	"unprognostic (1.55e-2)"	"unprognostic (7.32e-2)"	"unprognostic (2.89e-1)"	"unprognostic (5.86e-2)"	"unprognostic (1.25e-9)"	"prognostic favorable (8.65e-4)"	"unprognostic (1.20e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.51e-1)"	3.1	3.1	1.5	7.3	1.6	44.1	4.5	2.6	2.1	4.0	1.9	5.0	4.6	5.3	4.5	3.7	3.0	2.6	1.8	1.4	1.7	3.1	4.4	3.4	14.9	1.6	1.6	4.1	3.0	2.3	2.1	6.3	1.7	3.0	5.1	3.3	2.7	2.9	0.9	4.3	4.3	5.0	1.6	5.5	4.6	3.9	1.8	27.3	4.4	2.6	14.6	4.0	3.0	2.0	33.7	17.2	70.8	48.1	5.3	10.8	22.6	79.9	35.5	58.7	65.6	35.6	19.8	81.6	23.9	21.3	39.7	31.4	56.4	26.7	70.0	44.2	50.6	82.3	24.1	38.7	10.2	74.4	48.6	7.7	4.9	39.8	30.9	14.3	27.3	42.3	88.2	74.5	53.9	25.7	85.2	47.6	41.5	25.8	25.0	71.0	56.8	52.8	20.8	18.0	46.1	47.9	56.6	30.2	15.6	24.7	21.8	68.7	20.6	43.9	57.4	51.1	94.8	24.9	29.5	120.4	31.9	54.3	54.2	0.0	1.9	0.0	2.8	2.5	4.0	5.1	4.7	5.2	3.7	5.0	4.6	4.8	0.0	7.1	3.2	4.3	6.6	2.5	1.5	1.6	2.6	2.1	1.4	1.7	1.6	1.6	1.7	1.6	1.8	2.0	6.0	0.0	1.1	1.3	9.8	9.9	3.7	4.0	7.4	3.2	5.7	5.2	1.8	2.8	3.9	1.8	6.2	15.2	13.5	2.6	3.9	3.0	0.4	2.3	10.5	5.7	4.8	36.0	1.0	1.6	30.5	9.1	7.7	4.0	2.5	16.6	5.0	1.9	7.9	1.7	0.9	6.1	2.0	3.2	6.1	0.1	4.4	5.3	1.8	1.9	4.2	4.1	9.2	1.5	2.1	1.5	0.5	6.0	24.7	3.6	1.5	3.6	1.9	3.6	13.1	8.6	8.9	32.3	26.1	10.2	5.3	5.9	7.9	8.0	6.3	2.0
FBXO7	"Fbx, FBX7, PARK15"	ENSG00000100225	"F-box protein 7"	Q9Y3I1	22	32474676-32498829	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Ubl conjugation pathway"		"Disease variant, Neurodegeneration, Parkinson disease, Parkinsonism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 279.9"	"Cell type enhanced"	"Detected in all"		"Erythroid cells: 680.9;Late spermatids: 620.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA032113, HPA032114, CAB034296"	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA		550000	"Cluster 2: Granulocytes - Unknown function"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 6: Erythroid cells - Oxygen transport"	"Nucleoplasm, Cytosol"		"CAB034296: AB_2102563, HPA032113: AB_2674156, HPA032114: AB_10696202"	"unprognostic (3.99e-2)"	"unprognostic (1.53e-1)"	"prognostic favorable (1.08e-5)"	"unprognostic (1.36e-1)"	"unprognostic (2.82e-1)"	"unprognostic (2.11e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.45e-2)"	"unprognostic (2.28e-1)"	"unprognostic (2.53e-1)"	"prognostic favorable (2.66e-10)"	"unprognostic (3.33e-2)"	"unprognostic (1.65e-1)"	"unprognostic (7.02e-2)"	"unprognostic (1.79e-3)"	51.6	61.7	70.3	35.9	86.8	279.9	52.9	79.9	86.5	53.5	72.3	53.5	47.7	49.2	68.7	40.1	66.6	43.9	38.5	68.3	76.2	106.5	128.4	59.6	54.6	85.0	83.8	62.7	41.0	75.9	50.6	71.5	84.1	42.6	53.8	40.1	43.1	53.5	31.0	50.6	48.4	57.1	79.0	65.6	48.4	99.5	79.8	77.9	134.2	48.3	61.8	54.8	44.0	97.8	72.1	52.1	69.3	77.1	105.8	99.5	45.9	64.3	119.6	102.7	121.9	54.4	51.1	71.2	49.6	114.6	87.8	47.6	103.3	84.7	105.1	111.8	80.9	99.1	54.4	83.7	126.8	126.2	82.8	83.8	134.1	90.6	69.2	93.4	112.2	53.1	77.5	88.0	112.7	57.7	65.3	81.2	26.7	102.3	36.1	64.1	72.2	84.0	118.2	81.0	96.6	63.1	81.3	62.4	235.2	98.3	34.0	67.2	76.0	50.6	69.4	48.4	49.5	62.1	69.3	67.6	97.4	65.6	212.3	251.5	59.9	132.1	83.3	70.6	101.5	70.2	75.9	84.9	82.2	63.6	65.6	72.6	22.4	98.3	74.9	55.8	101.3	90.4	70.3	86.8	79.9	86.5	68.3	76.2	85.0	83.8	84.1	79.0	79.8	97.8	48.8	41.7	25.3	37.9	60.4	46.3	69.4	72.7	48.9	26.0	46.5	32.3	16.1	65.8	48.1	49.7	18.8	90.2	73.6	43.4	97.8	75.3	303.3	41.3	37.8	53.1	67.6	680.9	27.6	77.4	108.9	47.9	40.2	47.2	55.8	63.6	53.9	88.6	71.9	33.7	26.7	42.7	65.1	64.8	53.2	620.8	45.1	55.0	119.2	28.1	125.2	54.1	72.1	101.0	170.6	77.2	58.0	48.9	62.7	68.3	72.2	152.9	34.2	38.1	46.0	35.3	46.2	149.4	136.9	42.3	43.3	71.6	62.3	41.8	47.2	83.7
FBXW7	"AGO, CDC4, FBW7, FBX30, FBXW6, FLJ11071, SEL-10, SEL10"	ENSG00000109670	"F-box and WD repeat domain containing 7"	Q969H0	4	152320544-152536092	"Cancer-related genes, Predicted intracellular proteins"	"Biological rhythms, Host-virus interaction, Ubl conjugation pathway"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 66.9"	"Cell type enhanced"	"Detected in all"		"Basal keratinocytes: 201.8;Excitatory neurons: 529.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 23.5"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-266/70: 79.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013793, CAB029987"	Supported		Supported	Nucleoplasm,Vesicles		NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Nucleoplasm, Vesicles"		"CAB013793: AB_2533451, CAB029987: AB_2246842"	"unprognostic (3.32e-1)"	"unprognostic (9.02e-2)"	"unprognostic (1.84e-2)"	"unprognostic (3.08e-2)"	"unprognostic (3.87e-1)"	"unprognostic (1.36e-3)"	"unprognostic (4.37e-1)"	"unprognostic (1.94e-1)"	"unprognostic (8.28e-2)"	"unprognostic (3.29e-1)"	"unprognostic (5.32e-3)"	"unprognostic (3.19e-2)"	"prognostic unfavorable (1.52e-4)"	"unprognostic (3.38e-2)"	"unprognostic (1.41e-1)"	"unprognostic (5.49e-3)"	"unprognostic (2.17e-3)"	14.2	9.5	37.9	15.0	43.1	19.8	14.2	54.3	66.9	8.7	6.7	9.5	7.8	8.6	24.3	14.3	15.6	9.2	24.7	48.2	23.0	6.7	11.2	11.4	16.1	17.1	20.9	9.1	12.8	7.8	9.2	9.4	18.1	7.8	10.3	18.0	11.8	7.5	26.0	63.1	10.4	9.1	11.8	16.2	13.0	22.8	29.4	14.7	10.3	19.7	20.3	11.9	10.7	47.4	9.8	8.0	19.1	14.2	12.2	9.4	16.2	13.4	12.9	8.5	8.1	15.7	12.0	24.7	3.9	13.7	6.5	5.2	16.9	30.9	12.1	16.2	8.0	11.9	10.7	10.9	12.7	29.2	10.6	14.8	45.7	15.2	24.4	8.4	15.2	20.5	19.2	25.7	10.8	13.7	34.9	10.6	9.7	8.0	6.1	32.2	8.0	5.3	9.8	17.0	12.7	10.2	8.5	11.3	7.5	21.6	6.4	12.6	15.6	11.3	12.6	5.4	8.2	79.0	47.5	24.4	9.4	9.2	8.3	23.5	2.7	1.6	4.0	3.0	2.7	2.8	3.1	2.7	1.6	1.8	3.4	2.5	4.8	7.1	2.2	2.1	2.9	1.3	37.9	43.1	54.3	66.9	48.2	23.0	17.1	20.9	18.1	11.8	29.4	47.4	29.5	9.6	22.9	80.0	48.1	201.8	36.5	29.9	120.1	74.9	32.1	30.9	61.8	12.8	15.1	9.2	31.3	10.9	54.7	22.2	3.9	14.3	17.4	37.7	37.3	36.1	14.5	30.1	529.6	13.5	39.9	27.2	21.4	61.6	15.8	19.1	17.9	18.3	10.5	11.8	186.5	16.4	32.6	18.8	47.0	10.2	15.2	33.7	28.4	172.4	28.0	37.0	35.0	102.5	99.8	18.7	18.2	11.3	174.5	36.3	8.9	7.5	11.9	41.4	13.1	33.2	25.5	74.1	87.2	57.0	174.9	31.2	46.2	18.7	14.9	70.5
FBXW8	"FBW6, FBW8, FBX29, FBXO29"	ENSG00000174989	"F-box and WD repeat domain containing 8"	Q8N3Y1	12	116910950-117031148	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 53.5;Excitatory neurons: 40.6;Inhibitory neurons: 38.9;Late spermatids: 84.1;Oligodendrocyte precursor cells: 38.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038850, HPA038851"	Supported		Supported	Cytosol		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 34: Spermatids - Unknown function"	Cytosol		"HPA038850: AB_2676238, HPA038851: AB_10673479"	"unprognostic (2.63e-2)"	"unprognostic (1.13e-1)"	"unprognostic (9.03e-2)"	"unprognostic (1.48e-2)"	"unprognostic (1.08e-1)"	"unprognostic (9.97e-2)"	"unprognostic (3.35e-2)"	"unprognostic (2.17e-1)"	"unprognostic (2.39e-2)"	"unprognostic (4.30e-2)"	"unprognostic (1.32e-1)"	"unprognostic (8.02e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.34e-1)"	"unprognostic (6.20e-2)"	"unprognostic (6.34e-2)"	"unprognostic (2.55e-1)"	5.3	4.9	2.5	4.7	9.5	3.5	5.9	1.5	3.0	5.8	10.1	4.9	3.6	6.5	3.9	5.3	6.3	4.1	4.7	4.1	3.0	4.0	4.0	4.5	5.6	2.9	2.3	8.6	7.1	8.5	8.2	7.6	1.9	4.8	4.9	4.4	6.6	5.2	5.3	5.8	4.3	5.8	1.3	4.1	5.9	4.9	3.7	5.5	9.4	3.4	6.6	5.2	5.0	2.6	8.6	15.5	13.4	10.8	12.1	16.9	8.8	16.0	16.6	11.8	11.4	4.9	5.9	13.0	5.9	21.1	6.3	9.1	10.1	6.3	9.5	20.6	7.3	6.3	7.1	5.0	20.7	8.1	4.7	17.6	5.4	11.0	24.7	16.7	13.2	11.7	8.2	6.0	10.7	22.3	6.4	5.5	15.7	3.9	9.4	10.0	6.1	11.2	9.5	14.6	12.0	33.4	11.5	4.1	7.9	11.3	15.2	7.1	16.7	10.4	4.3	10.8	5.0	19.0	12.6	12.2	14.2	4.9	17.2	0.2	0.8	2.0	1.4	0.8	1.3	2.4	0.8	0.9	1.1	1.9	0.5	0.8	0.0	3.9	1.0	1.1	1.2	0.7	2.5	9.5	1.5	3.0	4.1	3.0	2.9	2.3	1.9	1.3	3.7	2.6	3.2	0.0	6.4	21.9	5.4	1.9	3.0	1.4	5.2	9.1	3.5	4.2	3.1	4.3	5.6	1.8	25.0	9.4	5.5	1.4	1.9	4.2	53.5	4.1	6.6	3.6	9.1	3.8	40.6	4.5	6.5	5.4	8.6	3.6	2.5	11.1	0.7	3.0	4.3	1.7	38.9	4.2	0.0	3.5	0.8	84.1	9.3	2.6	0.0	33.7	2.3	3.1	5.2	38.2	28.3	2.4	3.3	5.3	7.7	5.4	1.0	2.2	4.7	15.2	0.0	7.2	4.2	4.6	6.7	3.5	1.4	6.7	4.5	11.6	3.7	3.2
FCAR	CD89	ENSG00000186431	"Fc fragment of IgA receptor"	P24071	19	54874235-54891420	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"		"IgA-binding protein, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 26.1;lung: 10.5;lymphoid tissue: 13.5"	"Group enriched"	"Detected in some"	6	"Kupffer cells: 12.8;Macrophages: 18.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"classical monocyte: 1.2;neutrophil: 4.0"	"Group enriched"	"Detected in many"	27	"granulocytes: 4.0;monocytes: 1.2"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			HPA014050	Approved		Supported	"Plasma membrane"	"Intracellular and membrane"	NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 40: Neutrophils - Inflammatory response"		"Cluster 19: Monocytes & Neutrophils - Innate immune response"	"Plasma membrane"		"HPA014050: AB_1846338"	"unprognostic (1.46e-1)"	"unprognostic (5.74e-2)"	"unprognostic (1.30e-1)"	"unprognostic (4.71e-3)"	"unprognostic (3.46e-1)"	"unprognostic (2.02e-1)"	"unprognostic (7.99e-2)"	"unprognostic (1.54e-2)"	"unprognostic (1.59e-2)"	"unprognostic (4.70e-2)"	"unprognostic (1.41e-2)"	"unprognostic (7.05e-2)"	"unprognostic (4.19e-6)"	"unprognostic (9.23e-2)"	"unprognostic (8.10e-3)"	"unprognostic (8.04e-3)"	"unprognostic (9.81e-2)"	4.5	0.3	0.0	1.0	0.0	26.1	0.7	0.0	0.3	0.2	0.0	0.6	0.0	0.2	0.0	0.3	3.4	0.0	1.5	0.0	0.0	0.5	1.7	10.5	0.0	0.1	0.0	0.3	0.2	0.0	0.3	0.0	0.1	0.3	0.0	0.0	0.4	0.0	0.4	0.1	0.4	0.1	0.0	13.5	0.8	0.1	0.0	0.0	0.5	0.1	0.0	0.6	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.3	0.1	0.3	0.0	0.0	0.2	0.0	0.0	1.6	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.3	0.0	0.0	0.4	0.0	0.0	1.3	0.0	0.0	0.0	1.1	0.0	0.2	0.0	0.0	12.8	0.3	0.0	0.0	18.0	0.0	1.0	2.4	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.3	0.0	0.0	0.7	0.5	0.0	0.3	0.3	0.1	0.0	0.0	0.3	0.1	0.3	0.0	0.0	0.1
FCGR1A	"CD64, CD64A"	ENSG00000150337	"Fc fragment of IgG receptor Ia"	P12314	1	149782671-149791675	"CD markers, FDA approved drug targets, Predicted membrane proteins"	"Immunity, Innate immunity"	"IgG-binding protein, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 93.3;lymphoid tissue: 41.3"	"Cell type enhanced"	"Detected in some"		"Hofbauer cells: 283.3;Kupffer cells: 140.9;Late spermatids: 64.9;Macrophages: 94.9"	"Cancer enriched"	"Detected in many"	4	"glioma: 10.3"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	7	"classical monocyte: 131.5;intermediate monocyte: 54.7;myeloid DC: 35.6;neutrophil: 93.4"	"Group enriched"	"Detected in many"	53	"dendritic cells: 35.6;granulocytes: 93.4;monocytes: 131.5"	"Cell line enriched"	"Detected in some"	5	"THP-1: 191.6"					"Low region specificity"	"Detected in all"			HPA026910			Uncertain	"Golgi apparatus,Vesicles,Plasma membrane"		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 68: Epididymis - Unknown function"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 4: Macrophages - Innate immune response"	Vesicles	"Golgi apparatus, Plasma membrane"	"HPA026910: "	"unprognostic (5.27e-2)"	"unprognostic (2.89e-2)"	"unprognostic (2.34e-2)"	"unprognostic (7.97e-2)"	"unprognostic (8.44e-3)"	"unprognostic (1.73e-1)"	"unprognostic (7.69e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.88e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.98e-2)"	"unprognostic (6.18e-2)"	"prognostic unfavorable (4.83e-8)"	"unprognostic (1.28e-1)"	"unprognostic (4.51e-2)"	"unprognostic (9.99e-2)"	"unprognostic (9.03e-2)"	12.2	7.2	8.4	41.3	8.9	17.9	3.6	8.8	12.8	4.2	8.4	2.3	1.1	1.6	93.3	1.7	1.8	8.2	2.2	8.6	9.4	2.8	4.2	28.6	14.4	14.6	10.6	2.3	4.3	2.7	2.5	32.6	13.0	1.6	2.1	2.3	1.9	2.4	0.3	0.4	1.3	19.1	13.2	12.5	2.1	3.7	12.2	1.4	1.4	0.8	0.8	14.7	0.8	18.9	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	13.3	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	41.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.1	1.0	0.0	0.0	0.1	0.3	191.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	24.4	0.0	2.0	131.5	1.6	0.0	54.7	0.7	1.6	0.0	0.3	35.6	0.0	0.0	0.1	93.4	0.0	11.8	0.9	0.3	48.5	8.4	8.9	8.8	12.8	8.6	9.4	14.6	10.6	13.0	13.2	12.2	18.9	0.3	0.0	3.1	0.0	0.8	0.1	0.0	0.0	0.6	1.5	0.2	0.8	1.7	1.5	1.3	0.0	2.1	2.7	0.0	0.0	0.0	0.0	30.8	0.1	0.1	9.3	0.0	2.7	0.1	0.0	1.3	1.0	0.0	0.1	0.0	0.2	1.8	0.5	283.3	0.0	0.1	0.0	0.0	140.9	6.0	64.9	0.3	94.9	0.0	7.5	34.7	0.3	0.0	0.5	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.2	0.7	1.3	6.6	0.2	0.3	0.6	0.4	0.1	0.0	4.1	0.6	0.1	0.1	0.0
FCGR1B	CD64b	ENSG00000198019	"Fc fragment of IgG receptor Ib"	Q92637	1	121087345-121097161	"FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Immunity"	"IgG-binding protein, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 51.5;lymphoid tissue: 18.9"	"Cell type enhanced"	"Detected in some"		"Hofbauer cells: 86.5;Kupffer cells: 51.5;Late spermatids: 14.6;Macrophages: 36.6;monocytes: 16.4;Sertoli cells: 19.7"	"Cancer enriched"	"Detected in single"	4	"glioma: 1.6"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"classical monocyte: 31.2;neutrophil: 36.3"	"Group enriched"	"Detected in many"	4	"granulocytes: 36.3;monocytes: 31.2"	"Group enriched"	"Detected in some"	6	"NB-4: 19.8;THP-1: 73.9"									HPA026910			Uncertain	"Golgi apparatus,Vesicles,Plasma membrane"	"Intracellular and membrane"	NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 68: Epididymis - Unknown function"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	Vesicles	"Golgi apparatus, Plasma membrane"	"HPA026910: "	"unprognostic (3.21e-2)"	"unprognostic (4.35e-2)"	"unprognostic (1.13e-2)"	"unprognostic (2.84e-1)"	"unprognostic (1.85e-1)"	"unprognostic (9.60e-2)"	"unprognostic (1.56e-2)"	"unprognostic (6.42e-2)"	"unprognostic (3.10e-2)"	"unprognostic (8.17e-2)"	"unprognostic (1.91e-1)"	"unprognostic (3.65e-1)"	"unprognostic (3.24e-10)"	"unprognostic (8.99e-2)"	"unprognostic (2.85e-2)"	"unprognostic (7.86e-3)"	"unprognostic (8.93e-2)"	5.0	3.0	4.4	18.9	4.5	6.6	1.8	4.5	7.8	1.0	3.7	0.7	0.5	0.7	51.5	0.7	0.8	1.9	1.1	4.6	4.7	1.4	1.7	6.8	2.2	6.1	5.7	0.6	2.6	0.7	1.0	11.0	6.2	0.8	0.8	0.8	0.9	0.6	0.4	0.2	0.7	5.8	6.0	7.2	0.9	0.7	6.2	0.4	2.1	0.1	0.3	4.0	0.4	6.4	0.3	0.0	0.0	0.0	0.0	0.0	0.9	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	5.9	7.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.0	0.0	19.8	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.8	0.1	0.0	0.3	1.0	73.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.5	0.0	0.0	31.2	0.6	0.0	19.0	0.0	0.0	0.0	0.0	7.9	0.0	0.0	0.0	36.3	0.0	12.4	0.3	0.0	8.8	4.4	4.5	4.5	7.8	4.6	4.7	6.1	5.7	6.2	6.0	6.2	6.4	0.4	0.0	2.0	0.0	0.7	0.0	0.0	0.0	0.0	0.6	0.1	0.6	2.2	0.0	0.6	0.0	2.1	0.8	0.1	0.1	0.0	0.0	7.7	0.2	0.2	2.0	0.0	0.8	0.0	0.0	0.3	1.1	0.0	0.0	0.0	0.4	0.4	0.3	86.5	3.3	0.1	0.0	0.0	51.5	4.1	14.6	1.2	36.6	0.0	11.2	16.4	0.1	1.0	0.5	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.4	19.7	0.6	0.1	0.5	0.2	0.0	0.0	0.4	0.1	0.0	0.0	0.1
FCGR2A	"CD32, CD32A, CDw32, FCG2, FCGR2, FCGR2A1, IGFR2"	ENSG00000143226	"Fc fragment of IgG receptor IIa"	P12318	1	161505430-161524013	"CD markers, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	Immunity	"IgG-binding protein, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 101.7;placenta: 107.3"	"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 178.2;Kupffer cells: 159.1;Langerhans cells: 336.6;Macrophages: 305.0;monocytes: 97.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	6	"neutrophil: 2322.4"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 2322.4"	"Cell line enhanced"	"Detected in some"		"HEL: 29.4;HMC-1: 56.2;K-562: 17.9;NB-4: 15.8;THP-1: 61.9;U-937: 26.7"									"HPA010718, HPA010776, HPA014730"	Enhanced		Supported	"Golgi apparatus,Plasma membrane"		NA	NA		46000000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 19: Lung - Lung function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 4: Macrophages - Innate immune response"	"Plasma membrane"	"Golgi apparatus"	"HPA010718: AB_1078463, HPA010776: , HPA014730: AB_2669074"	"unprognostic (2.57e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.48e-2)"	"unprognostic (4.12e-2)"	"unprognostic (5.89e-2)"	"unprognostic (6.17e-2)"	"unprognostic (1.24e-2)"	"unprognostic (1.17e-1)"	"unprognostic (7.63e-2)"	"unprognostic (1.17e-3)"	"unprognostic (2.43e-2)"	"unprognostic (2.91e-1)"	"prognostic unfavorable (6.49e-7)"	"unprognostic (8.85e-3)"	"unprognostic (6.47e-3)"	"unprognostic (1.54e-1)"	"unprognostic (3.42e-2)"	68.0	24.8	7.3	101.7	6.6	48.6	13.3	8.0	12.1	18.1	13.9	16.0	8.1	7.3	4.3	11.7	14.6	36.8	11.5	6.5	11.5	12.7	12.3	77.5	16.1	15.1	11.4	7.2	12.7	8.5	7.6	107.3	13.3	6.1	21.0	2.3	9.9	9.6	2.6	3.5	10.8	40.9	11.9	61.8	10.1	4.4	13.8	9.8	6.4	10.2	7.7	68.3	5.2	21.8	0.0	0.0	0.0	2.4	0.0	0.3	0.0	0.0	0.5	0.0	0.1	0.0	0.0	2.3	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	29.4	0.3	0.0	0.7	8.6	56.2	0.5	0.0	0.0	0.0	0.7	0.1	0.0	17.9	0.5	0.0	0.0	0.4	15.8	0.0	0.0	1.1	0.2	1.2	8.1	0.0	0.0	0.1	0.0	0.0	0.0	4.6	0.0	0.0	61.9	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.7	0.4	26.7	6.6	2.4	358.3	421.8	0.7	268.4	1.0	3.2	0.5	0.4	89.9	1.7	0.4	0.7	2322.4	0.4	232.7	3.8	0.9	170.3	7.3	6.6	8.0	12.1	6.5	11.5	15.1	11.4	13.3	11.9	13.8	21.8	2.3	22.4	49.1	0.0	8.6	8.7	0.9	0.3	1.2	0.4	1.1	3.8	1.8	2.8	12.1	0.0	0.0	1.0	3.4	0.1	9.8	0.2	38.2	0.1	0.8	15.6	0.0	3.0	0.1	0.6	1.6	8.9	1.1	0.1	30.4	0.1	3.9	2.1	178.2	0.0	0.1	0.0	0.0	159.1	336.6	66.5	1.5	305.0	17.8	12.2	97.3	0.5	7.2	1.0	0.6	0.5	0.0	0.0	4.6	0.3	0.0	9.6	3.7	0.2	6.6	1.5	6.0	0.4	0.6	0.8	7.7	1.6	4.8	0.2	0.1	0.4
FCHSD2	"KIAA0769, SH3MD3"	ENSG00000137478	"FCH and double SH3 domains 2"	O94868	11	72836745-73142318	"Predicted intracellular proteins"	"Endocytosis, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Inhibitory neurons: 219.6;Microglial cells: 387.8;Oligodendrocyte precursor cells: 471.0;Oligodendrocytes: 198.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RPMI-8226: 164.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038545, HPA038546"	Uncertain		Approved	"Nuclear speckles,Plasma membrane,Actin filaments,Focal adhesion sites"		Yes	No			"Cluster 10: Basophils - Unknown function"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 68: Oligodendrocytes - Mixed function"	"Plasma membrane, Actin filaments"	"Nuclear speckles, Focal adhesion sites"	"HPA038545: AB_2676074, HPA038546: AB_10673013"	"unprognostic (1.80e-2)"	"unprognostic (1.50e-2)"	"prognostic favorable (1.71e-4)"	"unprognostic (1.63e-1)"	"unprognostic (3.14e-2)"	"unprognostic (2.62e-3)"	"unprognostic (1.41e-2)"	"unprognostic (2.62e-1)"	"unprognostic (1.27e-2)"	"unprognostic (2.56e-1)"	"unprognostic (3.69e-2)"	"unprognostic (6.16e-2)"	"unprognostic (2.89e-3)"	"unprognostic (2.02e-1)"	"unprognostic (4.70e-1)"	"unprognostic (2.92e-1)"	"unprognostic (1.23e-1)"	22.2	19.2	43.3	33.4	47.9	28.6	16.8	31.5	38.7	14.9	34.6	14.5	8.9	16.0	6.9	11.7	13.8	22.6	25.5	37.0	44.5	13.0	17.6	23.9	45.2	36.6	36.4	32.3	10.4	9.9	8.1	31.2	35.4	11.6	14.4	19.6	9.3	13.8	8.8	9.0	17.7	17.2	32.5	42.3	13.1	22.6	41.3	28.5	14.9	14.7	46.1	21.6	11.7	45.0	14.2	12.3	26.0	31.3	9.8	23.9	21.8	26.7	50.6	14.8	12.0	9.6	21.0	76.3	31.3	31.0	15.6	20.0	15.3	14.1	21.0	27.2	7.0	64.2	14.3	33.4	25.7	30.6	7.6	14.6	15.6	15.1	17.7	33.4	35.7	26.7	13.7	49.6	19.5	16.1	36.4	54.7	5.5	15.6	13.8	56.4	39.8	164.1	24.8	21.4	13.1	16.9	9.6	16.2	31.9	12.2	12.4	23.7	47.9	45.9	18.5	32.9	7.5	46.8	29.4	71.2	8.4	51.4	13.8	18.3	8.4	18.7	2.8	5.1	1.9	22.2	2.8	3.2	8.1	26.9	3.2	4.1	19.9	2.0	3.0	32.3	3.2	3.6	43.3	47.9	31.5	38.7	37.0	44.5	36.6	36.4	35.4	32.5	41.3	45.0	47.3	9.6	14.0	114.9	76.7	8.5	5.2	3.6	9.1	13.5	5.9	4.7	16.0	8.6	6.1	3.7	25.0	12.4	39.4	1.9	1.9	4.1	6.2	6.6	8.3	30.2	4.8	19.4	79.4	6.2	9.2	9.4	7.7	5.4	2.5	33.6	46.1	11.3	19.9	10.1	219.6	7.7	4.1	30.8	29.9	10.0	10.8	32.8	5.4	387.8	20.6	10.6	5.2	471.0	198.1	5.3	5.7	16.6	70.1	3.8	1.8	3.5	3.9	17.0	6.6	13.0	26.1	9.6	13.0	7.1	5.8	12.0	14.9	6.0	3.7	4.8
FCRLB	"FCRL2, FCRLM2, FCRLY, FLJ31052, FREB-2"	ENSG00000162746	"Fc receptor like B"	Q6BAA4	1	161721563-161728143	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in single"		"lymphoid tissue: 1.8"	"Cell type enhanced"	"Detected in many"		"Hepatic stellate cells: 7.5;NK-cells: 11.3;Proximal tubular cells: 14.7"	"Cancer enhanced"	"Detected in many"		"urothelial cancer: 7.8"	"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in many"		"basophil: 6.4"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 4.8;Daudi: 6.0;fHDF/TERT166: 8.8;HMC-1: 7.4;PC-3: 4.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			CAB026139	Uncertain		Supported	Cytosol	"Intracellular and membrane"	NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Cytosol		"CAB026139: "	"unprognostic (1.87e-1)"	"unprognostic (1.20e-4)"	"unprognostic (5.77e-3)"	"unprognostic (7.49e-3)"	"unprognostic (1.73e-3)"	"unprognostic (2.95e-1)"	"unprognostic (2.98e-2)"	"unprognostic (1.18e-3)"	"unprognostic (1.89e-1)"	"unprognostic (3.59e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.22e-2)"	"unprognostic (2.25e-3)"	"unprognostic (1.27e-1)"	"unprognostic (9.92e-3)"	"unprognostic (3.14e-2)"	0.2	0.1	0.5	0.7	0.4	0.0	0.1	0.5	0.7	0.1	0.2	0.1	0.1	0.0	0.0	0.1	0.2	0.0	0.1	0.5	0.4	0.7	0.3	0.1	0.9	0.5	0.5	0.1	0.2	0.1	0.0	0.1	0.6	0.1	0.1	0.1	0.3	0.9	0.0	0.2	0.1	0.0	0.4	0.3	0.1	0.1	0.4	0.0	0.1	0.0	1.8	0.2	0.1	0.6	0.6	0.1	0.0	0.3	0.4	0.6	0.0	3.7	4.8	1.2	1.2	0.1	0.1	6.0	0.2	8.8	0.2	0.0	0.2	0.3	3.1	0.1	0.3	0.2	0.1	0.1	0.2	0.0	7.4	1.1	0.0	2.1	0.1	0.3	1.1	0.0	0.3	0.3	0.1	0.3	0.0	2.1	0.1	0.0	4.4	0.0	0.4	0.2	0.1	0.2	0.0	0.0	0.0	0.1	1.9	0.2	0.0	0.0	0.6	1.3	0.6	1.3	0.7	0.0	0.0	2.3	2.5	0.4	0.6	6.4	0.1	1.8	1.8	0.0	0.6	3.4	1.1	1.0	0.4	4.7	0.5	0.8	1.0	3.7	0.2	0.0	0.0	0.5	0.5	0.4	0.5	0.7	0.5	0.4	0.5	0.5	0.6	0.4	0.4	0.6	2.8	0.0	0.0	0.3	2.9	1.1	1.1	1.0	0.6	0.2	1.5	1.5	1.5	0.0	1.2	3.7	0.0	2.1	3.9	0.1	5.9	1.3	0.1	0.3	1.3	2.3	1.2	5.3	0.9	1.1	5.6	1.1	0.0	0.4	0.0	1.2	7.5	1.2	1.4	0.0	1.2	0.0	0.0	1.9	1.2	0.2	0.0	3.4	1.8	0.0	0.7	3.4	11.3	0.0	0.3	1.0	0.1	0.4	3.0	0.6	0.0	14.7	0.7	0.7	0.0	0.2	1.6	2.7	1.4	1.3	0.4	0.8	2.4	2.2	0.0	1.1
FDFT1	SQS	ENSG00000079459	"Farnesyl-diphosphate farnesyltransferase 1"	P37268	8	11795573-11839304	"Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Cholesterol biosynthesis, Cholesterol metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism"	"Multifunctional enzyme, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Basal respiratory cells: 479.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"Daudi: 133.1;RPMI-8226: 361.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008874	Approved		Supported	"Endoplasmic reticulum"		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 72: Non-specific - Transcription"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Endoplasmic reticulum"		"HPA008874: AB_1078844"	"unprognostic (2.33e-1)"	"unprognostic (2.60e-1)"	"prognostic favorable (4.92e-5)"	"unprognostic (1.29e-2)"	"unprognostic (1.46e-2)"	"unprognostic (1.71e-1)"	"unprognostic (8.10e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.39e-1)"	"unprognostic (2.45e-1)"	"unprognostic (2.31e-3)"	"unprognostic (2.57e-1)"	"prognostic favorable (6.59e-9)"	"unprognostic (2.28e-1)"	"unprognostic (4.06e-2)"	"unprognostic (3.86e-1)"	"unprognostic (2.06e-1)"	69.1	126.7	8.2	6.7	14.9	15.0	69.5	13.1	11.6	93.3	7.4	113.4	6.7	80.2	2.9	165.7	59.4	3.2	62.9	10.0	11.7	71.3	118.3	88.0	6.0	29.9	14.1	66.9	58.6	2.0	51.2	4.2	23.1	64.5	5.8	5.4	141.7	3.1	160.3	129.0	92.2	4.9	15.4	50.4	113.2	118.7	15.3	3.2	45.9	6.9	4.5	70.4	107.8	31.9	19.1	8.1	28.8	19.4	3.8	5.7	10.9	19.2	10.6	7.4	8.6	8.1	14.1	133.1	3.9	3.2	34.6	17.8	10.6	24.7	8.2	13.1	17.2	9.6	11.1	21.7	7.4	5.5	13.0	11.2	6.0	13.2	4.7	5.3	2.1	24.5	12.1	60.0	4.6	11.1	16.7	12.9	27.1	9.0	5.3	14.9	11.3	361.0	11.9	61.5	9.6	11.2	4.3	11.2	35.9	12.3	11.6	6.8	11.3	5.1	21.6	3.1	5.8	17.0	30.2	26.3	7.5	18.7	19.7	52.1	19.5	25.5	23.1	23.6	20.7	60.5	25.3	24.5	29.1	45.6	25.7	23.3	22.3	26.7	15.1	27.9	45.7	43.9	8.2	14.9	13.1	11.6	10.0	11.7	29.9	14.1	23.1	15.4	15.3	31.9	31.1	54.5	164.1	67.6	78.0	52.5	94.0	479.6	87.6	17.7	79.6	49.8	78.5	101.5	325.8	79.1	14.6	266.2	49.4	134.8	88.0	165.6	294.4	55.0	20.9	45.2	79.1	113.2	29.3	284.4	153.3	37.1	64.2	68.1	57.0	86.2	22.1	221.8	94.1	11.8	25.6	117.4	284.8	41.9	32.2	228.8	77.0	54.3	101.4	38.4	97.1	61.9	55.6	30.2	95.6	163.6	108.4	53.4	50.0	101.3	87.0	74.9	142.6	21.0	52.6	13.8	74.4	215.5	76.1	112.5	88.8	175.0	55.7	131.4	100.4	167.2
FEM1A		ENSG00000141965	"Fem-1 homolog A"	Q9BSK4	19	4791734-4801273	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	11	"skeletal muscle: 273.6;tongue: 121.2"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016565, HPA063622"			Supported	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 33: Striated muscle - Muscle contraction"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 37: Myocytes - Muscle contraction"	"Nucleoplasm, Golgi apparatus"	Cytosol	"HPA016565: AB_1848489, HPA063622: AB_2685063"	"unprognostic (4.62e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.66e-1)"	"unprognostic (6.75e-2)"	"unprognostic (3.60e-1)"	"unprognostic (2.42e-3)"	"unprognostic (2.04e-1)"	"unprognostic (6.74e-2)"	"unprognostic (1.25e-2)"	"unprognostic (9.21e-2)"	"unprognostic (2.28e-3)"	"unprognostic (6.25e-2)"	"unprognostic (6.18e-5)"	"unprognostic (3.72e-3)"	"unprognostic (1.25e-1)"	"unprognostic (1.91e-1)"	"unprognostic (4.70e-2)"	4.3	3.7	8.0	4.0	7.8	7.5	4.4	8.1	8.0	3.2	6.8	3.8	3.7	3.0	3.6	8.4	3.4	2.7	17.8	8.2	6.1	3.8	4.4	4.2	4.7	7.9	7.5	3.5	8.5	9.6	0.9	4.2	7.3	4.9	3.3	3.0	5.9	3.3	273.6	8.5	3.3	3.9	7.1	4.3	3.9	2.4	7.8	4.8	3.5	121.2	4.6	4.1	1.0	8.5	9.2	6.2	5.7	12.4	6.2	3.6	8.3	5.4	4.4	8.5	6.0	9.7	4.1	10.4	5.4	6.7	4.6	9.3	10.1	8.9	5.5	12.4	11.6	10.1	4.9	7.4	9.4	17.0	12.4	5.3	13.6	6.6	9.4	4.0	6.2	13.9	15.1	19.3	5.9	9.3	14.3	6.2	17.7	5.7	15.0	13.1	7.4	11.0	7.7	11.6	18.5	13.1	7.1	13.2	10.4	4.3	10.2	14.5	8.7	7.7	5.6	12.1	14.4	22.3	20.0	8.8	7.9	12.1	11.1	4.7	2.8	2.8	2.5	3.2	2.1	1.9	2.0	2.3	2.6	2.5	1.7	2.0	2.4	2.6	3.0	2.6	1.5	1.8	8.0	7.8	8.1	8.0	8.2	6.1	7.9	7.5	7.3	7.1	7.8	8.5	7.9	25.6	32.8	1.6	16.6	20.1	14.9	7.7	12.5	16.8	20.8	16.4	6.5	18.6	15.5	1.8	16.7	21.2	16.1	16.7	13.7	10.3	5.3	8.7	11.6	12.3	13.1	28.6	2.7	11.8	13.8	9.2	6.1	19.1	22.8	7.5	15.4	18.7	12.3	11.8	3.2	15.5	4.1	15.4	8.7	3.5	9.0	13.1	3.6	2.8	17.2	12.1	32.0	2.5	2.3	12.4	9.4	8.2	9.9	15.5	10.9	10.1	11.3	19.8	6.6	27.1	9.3	12.7	6.2	18.3	29.5	27.1	14.3	16.8	18.0	17.7
FEM1B		ENSG00000169018	"Fem-1 homolog B"	Q9UK73	15	68277745-68295862	"Predicted intracellular proteins"	"Apoptosis, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"Early spermatids: 835.0;Late spermatids: 289.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041920, HPA042192"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 29: Early spermatids - Spermatogenesis"	Nucleoplasm	Cytosol	"HPA041920: AB_10796788, HPA042192: AB_10796574"	"unprognostic (1.50e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.87e-2)"	"unprognostic (6.29e-2)"	"unprognostic (1.83e-1)"	"unprognostic (3.27e-1)"	"unprognostic (9.91e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.72e-1)"	"unprognostic (6.84e-2)"	"unprognostic (1.89e-2)"	"unprognostic (3.49e-3)"	"unprognostic (1.35e-1)"	"unprognostic (2.89e-2)"	"unprognostic (4.67e-2)"	17.3	13.6	15.1	16.2	16.8	60.1	23.7	21.3	18.7	18.0	6.9	17.5	15.4	26.8	14.6	24.6	15.3	14.9	19.8	17.3	14.7	13.7	20.1	16.4	15.8	12.9	12.5	20.0	11.6	18.0	9.0	18.9	16.2	18.6	16.4	22.6	12.7	20.8	49.3	23.3	16.6	30.2	13.8	17.2	12.9	71.7	14.3	18.9	17.1	27.4	18.6	22.0	16.1	23.1	17.3	31.2	31.7	29.9	27.8	25.6	21.1	24.1	25.1	24.5	22.3	21.1	22.7	39.8	17.1	33.2	17.6	61.6	66.5	30.7	20.3	19.1	26.3	43.7	36.8	13.4	24.1	35.8	26.1	23.8	64.9	29.6	71.3	34.9	19.5	19.9	37.3	47.2	20.9	20.1	26.0	18.2	32.2	13.9	10.0	37.1	35.5	51.6	15.5	62.1	42.2	26.6	25.0	25.6	67.4	39.8	23.1	33.0	25.6	42.2	37.1	14.8	22.3	30.7	71.2	42.4	24.1	38.3	25.6	0.0	3.1	2.0	3.0	4.2	2.8	2.0	2.9	3.2	2.4	2.3	3.5	2.7	2.3	3.7	3.6	1.7	1.6	2.0	15.1	16.8	21.3	18.7	17.3	14.7	12.9	12.5	16.2	13.8	14.3	23.1	25.2	22.4	35.4	12.7	16.9	98.7	56.3	32.1	48.3	31.5	29.2	25.7	51.6	21.5	23.7	18.4	12.5	17.1	20.8	25.8	0.0	23.4	835.0	21.7	34.3	24.4	19.9	21.4	33.4	12.0	12.7	26.5	15.3	25.6	14.5	26.9	16.1	30.9	31.8	38.7	29.4	23.2	12.2	27.3	33.4	289.6	24.5	24.9	40.9	30.0	22.4	17.6	10.3	17.6	33.5	20.8	17.9	27.8	14.9	37.0	22.2	13.3	29.4	13.1	26.3	26.7	31.3	25.2	8.9	49.5	111.2	16.8	17.2	23.6	20.3	59.3
FER	"PPP1R74, TYK3"	ENSG00000151422	"FER tyrosine kinase"	P16591	5	108747841-109196841	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Kinase, Transferase, Tyrosine-protein kinase"	Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in all"	6	"Alveolar cells type 1: 80.1;Astrocytes: 207.3;Early spermatids: 158.1;Excitatory neurons: 266.3;granulocytes: 95.5;Inhibitory neurons: 313.8;Late spermatids: 182.4;Microglial cells: 227.7;Oligodendrocyte precursor cells: 284.0;Oligodendrocytes: 216.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in many"	5	"RPMI-8226: 91.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007641, CAB022464"	Approved		Supported	Cytosol		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 21: Non-specific - Transcription"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Cytosol		"CAB022464: , HPA007641: AB_1078845"	"unprognostic (1.72e-1)"	"unprognostic (1.66e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.46e-3)"	"unprognostic (4.72e-2)"	"unprognostic (5.65e-2)"	"unprognostic (6.81e-2)"	"unprognostic (7.39e-2)"	"unprognostic (1.05e-1)"	"unprognostic (8.36e-3)"	"unprognostic (7.36e-2)"	"unprognostic (8.05e-2)"	"prognostic favorable (5.55e-4)"	"unprognostic (3.83e-3)"	"unprognostic (3.22e-1)"	"unprognostic (1.03e-1)"	"unprognostic (3.99e-3)"	4.2	3.7	3.4	3.0	3.2	1.6	3.6	2.8	3.4	3.8	0.6	3.9	1.7	3.7	2.9	4.2	3.0	3.3	3.0	3.1	3.9	3.5	2.3	3.7	1.4	3.6	3.7	4.6	1.9	9.4	2.5	4.2	3.8	3.0	2.4	5.7	2.5	3.9	1.3	4.5	2.0	4.9	4.1	2.7	2.2	6.7	3.1	2.8	6.4	2.0	2.0	3.5	3.2	5.0	9.8	3.4	11.0	18.0	6.6	10.1	7.2	11.4	11.0	6.5	7.6	19.0	5.5	15.3	6.9	13.8	8.4	6.3	6.2	14.4	14.7	6.5	8.4	9.8	14.5	7.0	4.4	5.6	8.2	6.2	7.9	15.8	17.5	6.4	9.8	14.6	12.9	11.1	8.4	2.7	4.4	1.7	1.6	0.9	7.0	3.3	10.7	91.7	6.4	3.3	3.8	5.6	18.6	1.0	11.4	7.0	4.4	2.4	14.7	12.5	10.2	6.5	9.0	9.4	14.9	5.9	7.4	1.9	6.0	8.9	3.7	4.6	1.2	2.5	2.1	10.3	0.7	1.4	2.3	3.4	1.2	1.5	0.3	1.1	2.0	4.5	1.7	0.9	3.4	3.2	2.8	3.4	3.1	3.9	3.6	3.7	3.8	4.1	3.1	5.0	23.8	80.1	28.3	207.3	9.5	29.2	15.8	9.5	25.6	17.6	6.6	8.5	21.9	10.0	21.8	14.7	18.8	3.9	7.5	4.9	1.9	13.6	158.1	13.1	17.2	19.7	8.4	10.7	266.3	6.0	10.7	31.4	16.8	12.6	95.5	21.8	18.9	2.3	8.2	18.5	313.8	4.5	8.2	9.5	13.4	182.4	19.3	14.1	14.2	227.7	12.0	10.5	4.1	284.0	216.0	9.1	4.7	17.7	13.7	12.1	1.7	6.9	27.9	16.3	6.6	30.7	23.8	7.7	11.5	13.2	17.6	3.1	10.4	10.2	4.1	6.9
FERMT2	"KIND2, mig-2, PLEKHC1, UNC112B"	ENSG00000073712	"Fermitin family member 2"	Q96AC1	14	52857268-52952435	"Predicted intracellular proteins"	"Cell adhesion, Cell shape, Wnt signaling pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040505, HPA072965"	Uncertain		Supported	"Nucleoplasm,Focal adhesion sites,Cytosol"		NA	NA		230000	"Cluster 16: MAIT-cells - Unknown function"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 48: Smooth muscle cells - ECM organization"	"Focal adhesion sites"	"Nucleoplasm, Cytosol"	"HPA040505: AB_10673300, HPA072965: "	"unprognostic (4.38e-2)"	"unprognostic (4.25e-2)"	"unprognostic (8.00e-3)"	"unprognostic (2.42e-2)"	"unprognostic (2.51e-2)"	"unprognostic (4.89e-3)"	"unprognostic (2.50e-2)"	"unprognostic (1.92e-1)"	"unprognostic (4.21e-2)"	"unprognostic (1.07e-1)"	"unprognostic (3.58e-1)"	"unprognostic (1.99e-1)"	"unprognostic (3.87e-2)"	"unprognostic (3.96e-3)"	"unprognostic (7.69e-2)"	"unprognostic (3.14e-1)"	"unprognostic (1.73e-3)"	148.4	21.2	28.7	38.8	31.6	0.5	57.6	29.0	37.3	44.7	18.0	104.3	13.1	105.1	26.3	46.8	55.7	65.7	66.9	31.0	27.4	55.4	108.3	47.9	15.3	35.7	29.1	43.6	20.6	18.4	13.1	116.5	33.5	69.1	33.3	29.5	22.6	117.9	48.8	13.4	29.3	155.6	30.6	37.6	46.4	15.5	27.6	6.9	35.9	69.6	6.6	77.7	29.1	38.1	22.8	18.9	101.6	46.8	163.7	133.7	84.6	148.4	95.2	172.3	107.9	34.1	17.6	0.1	49.4	153.1	33.8	9.6	80.1	11.1	128.3	0.2	22.6	31.9	83.1	40.3	209.6	0.4	12.6	129.4	23.5	95.3	125.4	78.5	91.2	16.8	0.6	153.4	131.7	28.0	7.7	0.5	64.3	0.2	51.3	3.9	103.8	0.4	60.9	20.6	6.2	130.5	157.8	35.0	37.7	103.3	30.1	1.1	115.2	134.5	92.4	108.2	56.0	22.6	29.4	0.6	30.9	0.2	33.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	28.7	31.6	29.0	37.3	31.0	27.4	35.7	29.1	33.5	30.6	27.6	38.1	152.7	76.9	42.0	116.5	1.0	18.6	150.6	15.5	13.6	39.5	33.8	41.4	65.8	24.3	25.6	40.5	37.5	74.8	2.3	0.2	31.3	48.5	68.2	20.1	141.7	110.4	0.0	2.7	13.7	33.2	178.1	103.9	3.6	40.2	58.3	31.6	110.3	82.3	10.4	15.2	16.1	0.5	4.1	8.9	19.5	27.9	74.9	4.4	46.2	29.0	4.8	52.3	1.0	41.2	92.0	27.6	0.1	174.9	4.5	40.0	0.0	44.7	10.1	56.0	151.2	83.4	174.1	4.1	16.2	2.2	8.1	102.6	7.9	12.3	0.4	37.0
FEV	Pet-1	ENSG00000163497	"FEV transcription factor, ETS family member"	Q99581	2	218981087-218985184	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	16	"brain: 70.8"	"Cell type enriched"	"Detected in some"	32	"Enteroendocrine cells: 744.9"	"Group enriched"	"Detected in some"	10	"pancreatic cancer: 3.0;prostate cancer: 9.9;stomach cancer: 2.4"	"Group enriched"	"Detected in many"	7	"midbrain: 70.8;pons: 20.1"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"HMC-1: 35.5;SH-SY5Y: 43.8"	"Region enhanced"	"Detected in single"		"midbrain: 1.9"	"Group enriched"	"Detected in some"	5	"midbrain: 4.8;pons: 2.7"	HPA067679		Supported	Supported	"Nuclear speckles"		NA	NA				"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 17: Intestinal endocrine cells - Hormone signaling"	"Nuclear speckles"		"HPA067679: AB_2685884"			"unprognostic (4.58e-1)"		"unprognostic (1.60e-1)"					"unprognostic (7.21e-2)"	"prognostic favorable (4.85e-4)"	"unprognostic (2.87e-1)"	"unprognostic (3.96e-1)"	"unprognostic (1.52e-1)"	"unprognostic (2.15e-1)"			0.1	2.3	0.0	0.0	1.7	0.0	0.0	0.0	0.6	0.0	0.0	1.2	4.3	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.1	0.1	0.0	0.0	0.0	6.2	70.8	0.0	1.3	0.0	2.6	0.0	20.1	2.2	1.8	0.4	0.0	0.0	0.0	0.0	2.1	0.0	0.1	0.0	3.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.1	0.0	0.0	0.0	0.0	35.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	5.1	43.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.6	0.6	0.1	6.2	70.8	20.1	0.1	0.3	0.2	0.2	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	1.2	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.1	744.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	22.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.5	0.0	0.2	6.0	0.0	0.0	3.4	1.2	0.0	0.0	0.8	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.4	0.1
FEZF1	ZNF312B	ENSG00000128610	"FEZ family zinc finger 1"	A0PJY2	7	122301303-122310691	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Developmental protein, DNA-binding, Repressor"	"Disease variant, Hypogonadotropic hypogonadism, Kallmann syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	28	"brain: 126.1"	"Group enriched"	"Detected in some"	5	"Bipolar cells: 5.1;Spermatocytes: 5.5"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in many"	5	"thalamus: 126.1"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	10	"NTERA-2: 152.1;SCLC-21H: 66.0"	"Region enriched"	"Detected in some"	11	"hypothalamus: 11.7"	"Region enriched"	"Detected in single"	14	"hypothalamus: 7.4"	"HPA064639, HPA073693"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA				"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm	Cytosol	"HPA064639: AB_2685308, HPA073693: AB_2686626"		"unprognostic (8.48e-2)"	"unprognostic (3.41e-2)"	"unprognostic (3.64e-1)"	"unprognostic (3.43e-2)"	"unprognostic (4.17e-1)"	"unprognostic (4.10e-2)"	"unprognostic (2.64e-3)"			"unprognostic (2.54e-1)"	"unprognostic (1.34e-1)"		"unprognostic (2.96e-2)"	"unprognostic (2.55e-1)"		"unprognostic (1.48e-2)"	0.1	0.0	2.9	0.0	3.1	0.0	0.0	0.2	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	24.8	0.0	0.0	0.0	0.0	0.3	2.6	0.0	0.0	0.0	3.0	0.0	0.5	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	4.5	126.1	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	11.1	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.7	0.0	0.0	0.0	0.0	152.1	3.8	2.7	0.0	0.0	0.0	0.0	0.2	66.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	7.2	0.3	0.0	0.1	2.0	0.0	0.0	0.9	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	3.1	0.2	1.8	0.6	24.8	0.3	2.6	0.5	0.2	126.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.1	0.1	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	5.5	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0
FFAR1	"FFA1R, GPR40"	ENSG00000126266	"Free fatty acid receptor 1"	O14842	19	35351552-35353862	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"bone marrow: 2.8;brain: 4.8;ovary: 2.5;pancreas: 4.4"	"Cell type enhanced"	"Detected in some"		"Enteroendocrine cells: 1.8;granulocytes: 1.3;Granulosa cells: 1.4"	"Cancer enriched"	"Detected in single"	13	"pancreatic cancer: 2.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"U-698: 1.6"	"Not detected"	"Not detected"							HPA048933			Supported	"Plasma membrane"		NA	NA				"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 57: B-cells - Immune response"	"Plasma membrane"		"HPA048933: "	"unprognostic (9.49e-2)"				"unprognostic (2.08e-1)"			"unprognostic (1.59e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.03e-1)"	"unprognostic (4.51e-2)"		"unprognostic (1.03e-2)"	"unprognostic (4.46e-2)"	"unprognostic (6.19e-2)"	"unprognostic (9.56e-3)"		0.0	0.0	1.5	0.1	2.1	2.8	0.0	1.4	1.9	0.0	0.8	0.0	0.3	0.0	0.0	0.0	0.6	0.0	0.0	1.3	1.5	0.0	0.0	0.1	0.4	2.1	1.6	2.5	4.4	0.0	0.1	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	1.3	0.3	0.6	0.2	1.9	0.0	0.0	0.0	0.1	0.0	0.0	4.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.5	2.1	1.4	1.9	1.3	1.5	2.1	1.6	2.1	1.3	1.9	4.8	0.1	0.0	0.5	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.1	0.4	0.0	0.0	1.3	1.4	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0
FGD5	"FLJ00274, FLJ39957, ZFYVE23"	ENSG00000154783	"FYVE, RhoGEF and PH domain containing 5"	Q6ZNL6	3	14810853-14934571	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 51.3;Endothelial cells: 44.7;Hepatic stellate cells: 55.6;Microglial cells: 25.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"HUVEC TERT2: 94.9;TIME: 81.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014436, HPA014536, HPA019191"	Uncertain		Supported	"Plasma membrane"		NA	NA				"Cluster 82: Adipose tissue - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Plasma membrane"		"HPA014436: , HPA014536: AB_1848518, HPA019191: AB_1848519"	"unprognostic (2.57e-1)"	"unprognostic (7.33e-2)"	"unprognostic (1.03e-1)"	"unprognostic (3.28e-2)"	"unprognostic (2.02e-2)"	"unprognostic (1.03e-3)"	"unprognostic (1.08e-1)"	"unprognostic (4.10e-2)"	"unprognostic (6.34e-2)"	"unprognostic (5.53e-2)"	"unprognostic (1.46e-1)"	"unprognostic (9.39e-2)"	"unprognostic (6.84e-3)"	"unprognostic (1.71e-2)"	"unprognostic (3.46e-1)"	"unprognostic (1.32e-2)"	"prognostic favorable (7.50e-4)"	19.8	4.4	4.8	5.6	4.3	0.3	15.0	4.1	4.9	10.4	3.4	5.3	9.2	11.3	2.3	5.7	8.5	11.9	11.5	3.0	2.9	10.1	3.1	20.6	4.2	4.5	11.5	5.3	2.2	3.5	3.2	17.7	4.8	5.3	4.6	0.2	3.7	4.4	6.8	5.4	7.0	11.4	3.2	25.0	4.6	4.3	6.7	2.0	7.5	13.4	3.6	7.7	5.6	3.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	94.9	0.1	0.0	0.0	0.0	0.0	0.4	0.2	5.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	6.6	0.4	0.0	81.1	0.0	6.6	21.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.8	4.3	4.1	4.9	3.0	2.9	4.5	11.5	4.8	3.2	6.7	3.0	51.3	0.0	4.6	0.0	0.9	3.1	0.2	0.0	1.2	0.1	1.3	1.9	4.4	1.5	0.6	0.0	0.0	0.3	0.4	0.1	1.9	0.2	7.3	0.4	5.3	44.7	0.0	5.3	3.4	0.2	0.1	11.3	1.1	0.3	0.0	0.0	55.6	1.3	10.5	0.0	8.6	0.2	0.0	2.2	5.9	9.9	11.5	3.3	1.8	25.3	0.0	0.0	1.0	0.5	0.3	4.8	2.5	4.5	0.0	0.3	1.0	7.0	0.0	0.2	0.0	4.9	2.4	0.2	3.6	0.1	1.8	0.5	0.7	2.3	0.5	0.2
FGF1	"AFGF, ECGF, ECGF-beta, ECGFA, ECGFB, FGF-alpha, FGFA, GLIO703, HBGF1"	ENSG00000113578	"Fibroblast growth factor 1"	P05230	5	142592178-142698070	"Cancer-related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted secreted proteins, RAS pathway related proteins"	"Angiogenesis, Differentiation"	"Developmental protein, Growth factor, Heparin-binding, Mitogen"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 295.2;choroid plexus: 125.8"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 75.1;Cardiomyocytes: 62.4;Muller glia cells: 69.4;Oligodendrocytes: 119.8"	"Cancer enriched"	"Detected in many"	12	"glioma: 33.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ: 44.6;BJ hTERT+: 33.0;BJ hTERT+ SV40 Large T+: 35.9;BJ hTERT+ SV40 Large T+ RasG12V: 45.0;HBF TERT88: 64.3;hTEC/SVTERT24-B: 45.4;LHCN-M2: 30.6;U-2 OS: 33.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003265, CAB017519"	Enhanced		Supported	Nucleoplasm	"Secreted in other tissues"	NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 5: Muller glia cells - Visual perception"	Nucleoplasm		"CAB017519: AB_629473, HPA003265: AB_1848522"	"unprognostic (1.25e-2)"	"unprognostic (2.43e-1)"	"unprognostic (1.06e-1)"	"unprognostic (3.41e-3)"	"unprognostic (2.55e-2)"	"unprognostic (3.52e-1)"	"unprognostic (2.77e-1)"	"unprognostic (2.39e-1)"	"unprognostic (3.63e-1)"	"unprognostic (1.57e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.54e-1)"	"prognostic favorable (2.59e-5)"	"unprognostic (3.72e-4)"	"unprognostic (2.49e-1)"	"prognostic favorable (3.45e-5)"	"unprognostic (3.01e-4)"	17.9	3.3	206.3	1.6	259.3	1.1	12.5	213.9	295.2	1.3	125.8	2.4	1.0	3.1	7.9	2.0	1.7	2.5	50.2	183.5	245.5	66.5	1.7	2.8	1.2	236.2	237.7	0.9	0.8	4.3	6.5	2.1	259.9	1.8	1.3	18.8	7.3	2.3	2.2	1.7	1.2	2.5	225.4	6.9	0.8	2.0	244.3	1.5	5.6	7.8	2.0	1.2	1.0	272.8	5.6	0.3	0.3	1.5	1.1	3.3	1.8	44.6	33.0	35.9	45.0	0.2	0.2	1.3	3.1	15.4	2.1	0.7	0.0	3.5	64.3	0.2	0.0	0.0	0.8	0.4	0.6	0.0	0.4	1.6	1.1	45.4	2.7	9.7	0.0	0.2	0.0	1.6	30.6	0.7	0.1	0.9	1.4	0.1	1.4	0.2	1.5	0.6	1.5	0.2	1.1	2.3	0.1	0.9	0.6	8.0	0.0	0.2	1.1	5.8	33.0	0.8	21.3	0.8	0.4	0.3	8.2	0.3	1.6	0.0	0.0	0.4	0.4	0.0	0.3	0.0	0.1	0.1	0.0	0.2	0.1	0.3	0.3	0.0	0.1	0.2	0.1	0.0	206.3	259.3	213.9	295.2	183.5	245.5	236.2	237.7	259.9	225.4	244.3	272.8	1.4	0.0	0.0	75.1	0.1	0.4	5.0	5.7	7.4	3.5	1.2	25.4	62.4	0.0	2.1	20.2	16.7	1.1	0.1	0.0	0.0	1.1	0.4	0.0	0.7	4.8	0.0	0.0	13.0	0.0	0.5	4.7	0.0	0.2	0.0	0.0	1.1	0.0	0.1	0.0	14.6	0.0	12.2	0.0	0.0	1.4	0.0	0.2	3.6	29.0	0.0	69.4	0.0	15.1	119.8	0.6	0.0	0.4	0.0	5.3	0.0	0.3	0.1	11.6	6.6	0.5	23.4	0.1	0.1	0.6	0.0	0.8	0.4	0.0	0.0	0.7
FGF13	"FGF2, FHF2, FLJ30672, LINC00889"	ENSG00000129682	"Fibroblast growth factor 13"	Q92913	X	138614727-139222777	"Predicted intracellular proteins"	Neurogenesis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 50.0;parathyroid gland: 49.5;skeletal muscle: 67.3;tongue: 52.3"	"Cell type enriched"	"Detected in many"	6	"Inhibitory neurons: 432.5"	"Cancer enhanced"	"Detected in some"		"prostate cancer: 2.0"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"neutrophil: 3.7"	"Lineage enriched"	"Detected in single"	9	"granulocytes: 3.7"	"Cell line enhanced"	"Detected in many"		"AF22: 43.0;fHDF/TERT166: 38.1;HAP1: 39.8;RPMI-8226: 34.4;U-2197: 69.3;WM-115: 37.5"					"Low region specificity"	"Detected in all"			HPA002809			Supported	Cytosol		NA	NA			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 18: U-2197 - ECM organization"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Cytosol		"HPA002809: AB_1078855"	"unprognostic (3.23e-1)"	"unprognostic (3.13e-2)"	"unprognostic (5.42e-2)"	"unprognostic (1.42e-2)"	"unprognostic (1.87e-1)"	"unprognostic (2.87e-3)"	"unprognostic (9.92e-3)"	"unprognostic (2.97e-3)"	"unprognostic (4.92e-2)"	"unprognostic (5.90e-3)"	"unprognostic (5.22e-3)"	"unprognostic (6.79e-2)"	"unprognostic (4.96e-4)"	"unprognostic (4.36e-3)"	"unprognostic (1.22e-1)"	"unprognostic (2.27e-1)"	"unprognostic (7.48e-2)"	18.5	2.6	17.8	2.9	18.9	4.1	6.6	4.0	30.2	11.3	4.9	7.0	4.0	10.7	3.4	6.6	3.6	6.1	1.9	39.4	20.7	7.4	1.8	2.3	5.3	12.4	15.2	8.8	1.1	49.5	4.2	13.3	50.0	17.6	4.8	11.3	11.2	4.9	67.3	1.8	4.7	6.6	11.3	6.2	5.3	4.1	21.9	0.9	5.2	52.3	2.2	6.0	4.3	14.6	0.1	0.5	43.0	0.1	0.1	0.0	0.3	0.1	0.0	0.0	0.0	0.1	0.2	0.3	0.7	38.1	0.3	2.7	39.8	0.1	0.0	0.3	11.1	0.2	0.3	1.6	1.5	0.3	0.5	0.6	1.0	0.1	0.0	0.2	0.0	2.5	1.8	12.4	4.4	0.3	0.1	0.3	4.4	0.1	14.3	6.6	2.8	34.4	6.3	0.2	0.1	0.2	0.0	0.3	26.8	21.0	0.1	0.2	0.8	1.3	1.8	69.3	19.1	16.2	9.8	0.1	15.3	12.8	37.5	1.6	0.2	0.8	0.0	0.1	0.0	0.2	0.1	0.0	0.0	0.1	0.1	0.0	3.7	0.1	0.2	0.4	0.1	0.0	17.8	18.9	4.0	30.2	39.4	20.7	12.4	15.2	50.0	11.3	21.9	14.6	9.7	0.0	0.0	12.7	0.1	0.4	3.0	0.3	2.8	3.6	18.3	4.1	2.6	10.0	3.0	7.3	0.0	0.2	0.0	0.5	17.6	4.2	0.0	7.7	5.0	3.6	2.4	0.0	43.5	5.8	0.3	6.1	3.1	20.5	0.0	1.4	1.4	0.1	29.3	0.0	432.5	0.8	6.1	3.7	1.4	1.4	26.1	0.6	1.8	62.8	0.6	44.8	0.0	14.1	2.4	3.8	6.7	24.5	0.1	16.9	0.0	2.9	1.8	4.2	32.9	18.0	13.7	0.0	3.7	0.1	0.9	0.1	0.3	0.8	0.3	1.0
FGF2	FGFB	ENSG00000138685	"Fibroblast growth factor 2"	P09038	4	122826708-122898236	"Cancer-related genes, Candidate cardiovascular disease genes, FDA approved drug targets, Predicted intracellular proteins, Predicted secreted proteins, RAS pathway related proteins, Transporters"	"Angiogenesis, Differentiation"	"Developmental protein, Growth factor, Heparin-binding, Mitogen"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 33.7;Astrocytes: 111.0;Endometrial stromal cells: 40.6;Fibroblasts: 77.1;Oligodendrocyte precursor cells: 42.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ: 243.8;BJ hTERT+: 148.4;fHDF/TERT166: 278.2;hTERT-HME1: 147.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000125, HPA065502"	Enhanced		Supported	"Nucleoplasm,Nuclear bodies"	"Secreted in other tissues"	NA	NA	92500			"Cluster 57: Non-specific - Angiogenesis"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 36: Stromal cells - Cell proliferation"	"Nucleoplasm, Nuclear bodies"		"CAB000125: , HPA065502: "	"unprognostic (1.53e-2)"	"unprognostic (3.12e-1)"	"unprognostic (1.08e-1)"	"unprognostic (7.42e-2)"	"unprognostic (2.10e-1)"	"unprognostic (3.33e-1)"	"unprognostic (6.98e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.82e-1)"	"unprognostic (1.79e-1)"	"prognostic unfavorable (9.85e-4)"	"unprognostic (3.37e-1)"	"unprognostic (4.61e-3)"	"unprognostic (2.36e-1)"	"unprognostic (1.81e-1)"	"unprognostic (4.45e-2)"	"unprognostic (3.45e-3)"	24.3	2.6	14.8	5.3	16.1	0.1	9.5	12.2	14.7	8.7	14.2	14.1	1.7	14.2	4.5	4.7	8.0	7.1	5.0	12.2	18.8	4.0	2.0	8.3	1.8	18.6	20.5	12.6	1.5	4.7	3.2	6.4	15.6	7.6	4.0	3.4	3.5	8.7	1.4	1.9	3.7	12.6	16.8	1.1	6.2	1.9	18.3	1.6	2.4	4.8	1.8	14.8	6.1	13.3	4.7	14.1	7.8	30.5	18.8	31.1	0.0	243.8	148.4	104.3	60.2	0.2	0.4	0.0	20.5	278.2	81.8	0.7	8.1	0.5	104.3	12.3	3.3	0.0	28.7	0.2	55.3	1.4	0.1	16.8	1.7	103.6	147.6	52.0	11.8	0.0	6.9	8.4	27.4	0.1	0.1	0.2	21.6	0.1	5.4	0.0	3.9	0.1	33.0	0.0	4.4	4.0	48.4	0.1	2.0	44.7	0.1	0.5	10.6	85.7	12.2	32.0	20.0	8.6	10.3	0.0	24.7	0.1	9.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.8	16.1	12.2	14.7	12.2	18.8	18.6	20.5	15.6	16.8	18.3	13.3	33.7	6.4	0.0	111.0	0.3	1.7	1.6	0.8	2.8	4.6	4.5	8.9	4.7	0.0	1.3	7.3	0.0	2.7	0.4	0.0	3.9	8.2	10.9	1.5	40.6	11.5	1.8	0.4	1.8	1.0	0.1	77.1	0.0	1.6	0.0	5.7	17.2	1.3	0.5	0.0	6.6	0.0	0.0	0.0	2.4	3.8	9.9	1.7	5.4	15.9	0.6	9.3	0.0	42.3	5.8	11.0	0.0	8.2	1.6	16.0	0.0	0.6	0.0	2.0	0.0	15.2	14.2	4.7	1.1	0.3	1.3	4.8	0.5	0.1	0.0	2.0
FGF5		ENSG00000138675	"Fibroblast growth factor 5"	P12034	4	80266599-80336680	"Disease related genes, Human disease related genes, Predicted secreted proteins, RAS pathway related proteins"		"Growth factor, Mitogen"	"Disease variant, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 11.7;gallbladder: 3.4"	"Cell type enhanced"	"Detected in some"		"Distal tubular cells: 1.9;Excitatory neurons: 9.4;Microglial cells: 1.9;Proximal tubular cells: 4.1"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"cerebellum: 11.7"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ: 64.1;BJ hTERT+: 120.0;fHDF/TERT166: 88.0;HBF TERT88: 88.0;LHCN-M2: 81.1;U-138 MG: 109.5;U-251 MG: 55.0"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"CAB010313, HPA042442"			Supported	"Nucleoplasm,Nucleoli fibrillar center,Cytosol"	"Secreted in brain"	NA	NA				"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Nucleoli fibrillar center"	"Nucleoplasm, Cytosol"	"CAB010313: AB_2102677, HPA042442: AB_2678001"	"unprognostic (6.44e-2)"	"unprognostic (6.24e-3)"	"unprognostic (8.49e-4)"	"unprognostic (1.10e-1)"	"unprognostic (2.91e-1)"	"unprognostic (2.80e-3)"		"unprognostic (6.87e-4)"	"unprognostic (2.53e-1)"	"unprognostic (1.69e-1)"	"unprognostic (3.57e-3)"	"unprognostic (1.17e-2)"	"unprognostic (3.33e-16)"	"unprognostic (3.02e-3)"	"unprognostic (3.14e-1)"		"unprognostic (2.83e-2)"	0.0	0.0	0.2	0.6	0.0	0.1	0.0	11.7	1.2	0.0	0.0	1.4	0.1	0.1	0.0	0.1	0.0	3.4	0.1	0.6	0.0	0.8	0.0	0.0	0.0	2.7	0.2	0.1	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	1.1	1.0	0.0	0.0	0.2	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.1	0.0	0.1	6.1	21.8	0.0	64.1	120.0	16.5	12.2	0.0	0.1	0.0	0.0	88.0	1.2	0.1	0.1	22.5	88.0	0.0	1.1	0.2	0.1	0.0	1.7	0.6	0.0	6.3	0.0	48.6	23.0	27.9	5.7	0.0	0.0	0.2	81.1	0.0	0.1	0.3	0.1	0.0	2.1	0.2	0.2	0.0	0.2	0.0	0.6	0.2	0.0	0.0	0.8	0.0	0.0	0.2	20.9	109.5	4.6	5.4	55.0	0.0	0.0	0.1	6.3	0.0	2.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	11.7	1.2	0.6	0.0	2.7	0.2	3.0	0.0	0.5	0.5	0.0	0.0	1.1	0.3	0.0	0.0	0.8	1.2	0.0	0.0	0.0	0.0	0.3	0.0	0.8	0.0	0.0	0.0	0.0	0.0	1.9	0.3	0.6	0.0	0.1	0.0	0.0	0.0	9.4	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	1.9	0.0	0.0	0.0	0.5	0.1	0.3	0.0	0.0	0.0	0.1	0.0	4.1	0.1	0.0	0.0	0.0	1.3	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1
FGFR2	"BEK, CD332, CEK3, CFD1, ECT1, JWS, K-SAM, KGFR, TK14, TK25"	ENSG00000066468	"Fibroblast growth factor receptor 2"	P21802	10	121478332-121598458	"Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins"	Apoptosis	"Heparin-binding, Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Craniosynostosis, Disease variant, Ectodermal dysplasia, FDA approved drug targets, Lacrimo-auriculo-dento-digital syndrome, Mental retardation, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 273.8;choroid plexus: 198.1"	"Group enriched"	"Detected in many"	5	"Astrocytes: 228.2;Cholangiocytes: 213.1;Oligodendrocytes: 562.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	24	"basophil: 13.2;eosinophil: 3.8"	"Lineage enriched"	"Detected in single"	58	"granulocytes: 13.2"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 189.0;BEWO: 60.9;CACO-2: 49.6;HaCaT: 55.6;HAP1: 63.7;NTERA-2: 57.8;T-47d: 49.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010886, HPA035305"	Uncertain		Supported	"Nucleoplasm,Vesicles,Cell Junctions"	"Secreted - unknown location"	NA	NA		1200000	"Cluster 34: Basophils - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Cell Junctions"	"Nucleoplasm, Vesicles"	"CAB010886: AB_259379, HPA035305: AB_10672862"	"unprognostic (5.53e-2)"	"prognostic favorable (8.79e-4)"	"unprognostic (1.08e-1)"	"unprognostic (5.23e-2)"	"unprognostic (1.73e-1)"	"prognostic favorable (9.32e-4)"	"unprognostic (1.53e-1)"	"unprognostic (4.96e-3)"	"unprognostic (1.74e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.07e-1)"	"unprognostic (3.74e-2)"	"unprognostic (1.01e-1)"	"unprognostic (6.11e-2)"	"unprognostic (2.54e-1)"	"unprognostic (6.93e-2)"	"unprognostic (2.25e-1)"	5.7	21.3	103.9	8.2	186.8	0.3	22.9	178.9	198.9	19.7	198.1	44.8	10.4	54.6	15.3	25.2	29.6	31.3	5.6	109.9	124.7	26.3	41.0	30.9	2.9	250.9	185.9	18.0	31.0	61.0	6.8	15.7	220.5	27.4	21.2	1.2	59.1	54.6	0.5	109.3	12.2	43.6	165.5	0.8	22.5	7.6	148.0	10.1	54.6	0.2	9.1	16.6	27.4	273.8	7.2	0.4	30.2	189.0	0.1	0.0	60.9	0.4	0.0	0.0	0.0	49.6	1.1	0.1	12.5	2.8	0.1	55.6	63.7	13.0	0.0	0.1	12.7	0.0	0.2	1.2	1.5	0.2	11.7	0.1	26.2	0.0	0.6	0.0	0.0	0.3	0.2	0.2	0.0	11.7	0.2	0.1	57.8	8.7	0.0	0.1	0.0	7.5	18.0	15.8	0.5	0.5	0.4	33.4	0.0	36.6	49.3	0.0	0.1	0.3	8.5	0.2	0.7	0.1	0.1	0.0	0.3	0.0	0.5	13.2	0.0	3.8	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	103.9	186.8	178.9	198.9	109.9	124.7	250.9	185.9	220.5	165.5	148.0	273.8	1.4	19.2	36.0	228.2	0.6	40.1	34.3	18.4	58.6	0.2	8.7	25.4	9.1	213.1	38.4	36.8	0.0	16.5	0.3	7.3	0.0	7.4	4.1	28.1	4.4	1.0	2.4	2.7	14.8	0.2	3.0	9.0	13.3	53.1	0.0	0.1	1.8	5.0	2.3	0.0	31.2	40.8	10.2	0.6	4.4	9.6	1.2	1.1	5.4	10.3	0.6	2.0	1.0	6.0	562.5	0.7	3.0	6.0	0.1	15.0	1.8	13.6	15.3	0.2	0.0	1.6	2.6	0.7	9.9	18.7	27.7	4.0	1.5	0.4	3.8	31.4
FGFR3	"ACH, CD333, CEK2, JTK4"	ENSG00000068078	"Fibroblast growth factor receptor 3"	P22607	4	1793293-1808872	"Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins"	Apoptosis	"Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Craniosynostosis, Deafness, Disease variant, Dwarfism, Ectodermal dysplasia, FDA approved drug targets, Lacrimo-auriculo-dento-digital syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 148.3;esophagus: 139.7;skin 1: 271.5"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 410.4;Basal keratinocytes: 103.8;Cholangiocytes: 91.5;Suprabasal keratinocytes: 88.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"CACO-2: 48.2;HaCaT: 34.9;Hep G2: 80.6;NTERA-2: 36.1;RT4: 64.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004231, HPA067204"	Enhanced		Supported	"Endoplasmic reticulum"	"Secreted - unknown location"	NA	NA		2500000		"Cluster 27: Brain & Skin - Unknown function"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 64: Astrocytes - Nervous system maintenance"	"Endoplasmic reticulum"		"CAB004231: AB_627596, HPA067204: AB_2685804"	"unprognostic (1.34e-1)"	"unprognostic (5.29e-3)"	"unprognostic (1.49e-1)"	"prognostic unfavorable (3.77e-4)"	"unprognostic (5.90e-2)"	"unprognostic (1.24e-3)"	"unprognostic (7.22e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.99e-1)"	"unprognostic (2.17e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.88e-2)"	"unprognostic (1.30e-1)"	"unprognostic (9.11e-3)"	"unprognostic (1.98e-1)"	"unprognostic (4.74e-2)"	"unprognostic (1.97e-1)"	1.6	1.6	118.0	1.5	140.6	1.4	5.5	115.6	104.0	23.7	37.4	12.2	19.5	1.5	2.8	139.7	2.2	7.9	4.8	100.8	107.6	39.3	40.7	7.4	0.4	144.7	129.2	0.5	76.4	0.2	16.1	9.3	109.8	13.8	5.2	0.2	20.2	15.0	1.3	271.5	14.7	0.4	108.9	4.0	7.8	17.6	148.3	1.7	1.5	0.9	11.1	23.1	60.9	81.2	0.0	3.8	19.5	5.6	0.0	0.3	22.1	2.4	0.3	0.8	0.4	48.2	1.0	0.0	17.8	0.7	0.7	34.9	5.5	0.3	0.3	0.2	19.3	14.2	3.9	80.6	0.1	0.0	0.6	0.0	10.9	0.2	0.1	0.1	0.1	2.3	16.7	0.1	0.0	23.9	0.8	0.5	36.1	19.5	0.1	1.2	1.0	0.3	2.8	64.1	5.7	1.6	1.9	4.0	0.0	22.2	20.4	2.5	1.0	0.0	2.1	0.5	1.6	0.1	0.0	0.0	0.2	1.7	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	118.0	140.6	115.6	104.0	100.8	107.6	144.7	129.2	109.8	108.9	148.3	81.2	2.2	0.0	32.5	410.4	1.1	103.8	4.1	29.8	23.9	0.0	4.8	1.5	3.1	91.5	37.6	14.7	0.0	0.5	1.6	36.1	0.0	5.0	7.9	3.0	1.7	3.4	4.2	0.0	0.5	0.7	12.0	3.2	3.6	4.0	0.0	0.1	16.1	30.4	0.6	0.0	1.3	20.7	4.1	1.2	6.5	1.3	0.6	0.6	12.4	14.0	0.6	0.1	0.0	34.2	2.2	0.4	18.0	0.4	0.0	4.2	21.2	9.9	9.8	0.6	0.0	0.7	2.9	0.4	25.9	55.0	88.7	0.8	0.7	0.1	17.0	12.8
FGFRL1		ENSG00000127418	"Fibroblast growth factor receptor like 1"	Q8N441	4	1009936-1026898	"Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 34.0;Granulosa cells: 30.9;Hepatocytes: 37.5;Muller glia cells: 94.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"intermediate monocyte: 1.1;non-classical monocyte: 1.2"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"U-251 MG: 99.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB026019, HPA068828"	Approved		Supported	Vesicles		No	No			"Cluster 7: Monocytes - Unknown function"	"Cluster 22: Non-specific - Unknown function"	"Cluster 20: HeLa - Mitochondria"	"Cluster 5: Muller glia cells - Visual perception"	Vesicles		"CAB026019: , HPA068828: AB_2686043"	"unprognostic (1.30e-2)"	"unprognostic (2.54e-2)"	"unprognostic (6.27e-2)"	"unprognostic (2.80e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.62e-2)"	"unprognostic (9.79e-2)"	"unprognostic (4.87e-3)"	"unprognostic (8.46e-2)"	"unprognostic (2.01e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.36e-3)"	"unprognostic (1.49e-1)"	"unprognostic (7.80e-2)"	"unprognostic (1.06e-2)"	"unprognostic (1.96e-2)"	38.1	56.0	40.8	5.0	43.3	7.6	24.1	40.6	49.5	15.7	29.8	10.2	7.3	9.9	3.4	5.5	36.0	9.3	19.8	39.2	33.5	25.4	52.8	15.1	3.1	49.9	45.8	25.4	71.6	16.1	21.6	3.0	46.5	12.4	4.9	10.5	37.6	2.7	20.6	10.7	13.5	4.0	42.2	9.1	27.2	5.5	47.9	1.4	67.1	9.6	2.2	11.2	8.0	42.1	23.2	31.6	11.3	34.3	11.9	12.3	2.9	40.4	6.2	12.9	8.4	23.1	47.9	2.6	49.3	63.3	58.3	5.8	21.8	14.1	11.8	8.3	21.0	0.3	41.2	61.5	24.0	13.7	5.6	25.7	11.7	22.4	9.5	48.4	12.5	9.3	25.3	8.9	7.9	30.8	16.0	37.7	14.2	39.7	83.8	24.7	16.3	16.7	22.6	3.6	1.2	2.2	38.1	0.8	15.2	13.4	22.5	11.9	26.1	68.8	27.2	35.2	99.8	8.9	12.9	3.8	18.1	15.6	22.8	0.6	0.0	0.0	0.2	1.1	0.0	0.1	0.4	0.0	0.1	0.0	0.0	0.1	0.0	0.0	1.2	0.0	0.0	0.1	40.8	43.3	40.6	49.5	39.2	33.5	49.9	45.8	46.5	42.2	47.9	42.1	3.8	3.2	4.1	34.0	2.8	6.5	3.7	5.4	2.2	5.4	13.2	6.1	8.5	11.5	6.9	7.3	0.0	1.6	4.1	4.4	0.0	9.6	0.2	6.0	4.2	2.6	1.8	4.8	3.2	10.2	26.6	5.1	6.6	13.5	1.3	30.9	5.3	37.5	3.2	0.0	2.8	11.0	0.0	1.6	2.5	1.2	4.4	3.4	7.2	1.9	1.3	94.0	1.0	5.0	5.4	19.9	2.7	3.4	2.2	11.4	2.9	7.6	7.0	5.6	0.0	3.3	5.1	0.4	4.2	1.2	4.7	1.5	4.2	17.5	3.6	8.8
FHL1	"bA535K18.1, FHL1B, FLH1A, KYO-T, MGC111107, SLIM1, XMPMA"	ENSG00000022267	"Four and a half LIM domains 1"	Q13642	X	136146702-136211359	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	Differentiation	"Developmental protein"	"Disease variant, Emery-Dreifuss muscular dystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	7	"skeletal muscle: 11467.1;tongue: 9770.8"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 1145.1;Early spermatids: 373.8;Late spermatids: 1206.9"	"Cancer enhanced"	"Detected in all"		"renal cancer: 88.1"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"NK-cell: 36.1"	"Group enriched"	"Detected in many"	4	"dendritic cells: 19.4;NK-cells: 36.1;T-cells: 18.2"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 303.7;fHDF/TERT166: 258.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001040, HPA001391, CAB020817"	Enhanced		Supported	"Plasma membrane,Cytosol"		NA	NA		12000000	"Cluster 48: NK-cells - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 54: Cardiomyocytes - Muscle contraction"	Cytosol	"Plasma membrane"	"CAB020817: , HPA001040: AB_1848541, HPA001391: AB_1848542"	"unprognostic (2.16e-1)"	"unprognostic (5.13e-2)"	"unprognostic (1.33e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.61e-3)"	"unprognostic (1.76e-2)"	"unprognostic (2.51e-2)"	"unprognostic (9.34e-2)"	"unprognostic (7.12e-3)"	"unprognostic (1.20e-1)"	"unprognostic (2.21e-3)"	"unprognostic (1.72e-1)"	"unprognostic (6.17e-3)"	"unprognostic (4.04e-2)"	"unprognostic (7.52e-2)"	"unprognostic (2.05e-3)"	"prognostic unfavorable (2.11e-4)"	938.4	65.8	120.8	75.5	117.2	11.7	441.8	95.9	126.3	315.5	85.8	672.0	83.2	464.6	107.7	538.1	281.6	127.6	1462.3	130.8	144.9	45.2	43.1	285.6	41.7	103.9	125.4	102.8	39.4	196.5	92.9	106.6	115.9	408.8	161.4	76.2	161.3	541.1	11467.1	101.3	235.5	486.5	114.8	43.0	368.4	60.2	130.1	25.1	310.1	9770.8	32.1	469.6	253.1	102.9	0.4	44.3	60.7	57.8	127.2	52.3	1.5	183.7	303.7	34.8	81.3	0.3	12.7	0.7	55.8	258.8	95.0	0.5	119.2	148.0	28.2	0.4	136.7	0.7	34.4	0.0	121.6	0.3	26.8	96.6	24.4	41.2	128.7	14.1	36.6	34.5	0.1	26.0	81.9	2.5	26.1	1.6	19.1	0.2	52.2	69.8	2.6	38.2	1.1	0.1	43.5	63.8	6.6	0.2	12.4	24.1	0.3	2.4	102.5	150.2	71.0	5.9	44.7	6.8	16.0	1.1	11.9	1.4	18.2	0.1	0.7	0.0	5.2	0.1	13.8	5.8	18.2	7.2	3.1	3.6	12.0	4.0	1.2	36.1	0.0	19.4	2.2	11.1	120.8	117.2	95.9	126.3	130.8	144.9	103.9	125.4	115.9	114.8	130.1	102.9	203.0	48.1	11.7	32.0	8.1	56.5	26.9	15.1	14.2	36.2	1.4	8.3	1145.1	0.0	4.9	11.0	8.4	0.6	8.6	0.5	1.9	3.0	373.8	4.3	32.3	61.1	13.8	17.9	70.2	0.2	1.1	236.0	2.0	2.0	15.8	41.0	113.6	6.1	4.3	99.3	55.6	0.8	0.0	5.1	47.0	1206.9	123.9	35.6	32.0	16.9	7.4	209.6	2.1	35.2	8.2	0.6	7.6	152.4	15.5	20.1	0.6	11.6	4.8	19.4	105.2	248.1	235.7	7.4	88.6	2.7	44.8	2.7	15.5	9.6	2.0	2.6
FHOD1	FHOS	ENSG00000135723	"Formin homology 2 domain containing 1"	Q9Y613	16	67229387-67247481	"Plasma proteins, Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 88.1;skeletal muscle: 127.0"	"Cell type enhanced"	"Detected in many"		"granulocytes: 40.6;Theca cells: 40.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in all"		"HMC-1: 112.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA024468	Approved		Supported	Cytosol		NA	NA		1300000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 59: Non-specific - Translation"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 52: Non-specific - Transcription"	Cytosol		"HPA024468: AB_1848568"	"unprognostic (6.53e-3)"	"prognostic unfavorable (9.57e-4)"	"unprognostic (5.42e-2)"	"unprognostic (2.14e-3)"	"unprognostic (1.11e-1)"	"unprognostic (2.18e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.81e-1)"	"unprognostic (2.03e-1)"	"unprognostic (1.50e-1)"	"unprognostic (4.62e-2)"	"unprognostic (4.27e-2)"	"prognostic unfavorable (1.90e-8)"	"unprognostic (1.72e-1)"	"unprognostic (1.56e-1)"	"unprognostic (3.14e-3)"	"unprognostic (4.70e-2)"	16.9	16.9	3.6	9.6	3.5	6.2	13.2	3.5	4.0	9.6	4.6	9.3	5.9	8.5	1.6	4.5	7.9	5.5	10.4	3.4	3.3	10.5	3.3	26.6	8.5	4.1	4.0	14.7	7.7	3.7	5.4	8.9	3.9	8.8	4.2	0.3	8.4	3.9	127.0	6.2	9.7	5.8	4.0	88.1	7.2	5.0	4.8	4.1	16.8	29.8	5.9	7.4	6.7	3.8	12.0	31.6	11.8	9.8	46.1	27.9	39.2	24.9	19.8	27.2	26.3	22.3	15.7	14.1	17.5	18.0	8.8	14.7	13.5	20.0	13.5	11.3	21.7	63.1	13.9	24.5	12.2	26.3	112.1	34.8	2.6	42.2	4.1	24.3	43.0	19.9	32.9	9.3	17.6	41.0	18.1	48.3	17.6	11.0	10.0	20.3	25.9	33.8	8.7	4.9	3.7	19.2	38.2	22.4	22.5	11.7	23.8	21.1	51.6	37.4	22.0	24.0	20.3	29.9	32.0	20.7	76.1	24.7	34.7	0.3	0.7	0.1	0.2	0.2	0.3	0.0	0.3	0.2	0.4	0.1	0.1	0.1	0.5	0.3	0.2	0.2	0.3	0.6	3.6	3.5	3.5	4.0	3.4	3.3	4.1	4.0	3.9	4.0	4.8	3.8	18.0	12.8	21.6	4.6	7.2	5.7	1.8	2.0	3.4	1.8	11.5	8.0	13.8	10.0	5.9	5.5	8.4	8.7	11.4	16.9	0.0	3.6	1.1	3.5	8.1	22.3	9.1	8.6	2.5	5.9	4.7	10.9	5.6	4.7	40.6	12.0	25.0	0.8	17.1	1.7	2.2	13.1	2.0	20.3	19.7	1.1	10.5	19.8	3.6	17.8	18.9	2.9	10.3	2.0	0.6	7.4	6.1	10.9	7.1	3.1	6.3	1.4	3.9	1.2	26.3	4.2	15.7	19.0	12.3	5.6	3.7	1.9	13.3	40.3	13.8	1.7
FIBP	FGFIBP	ENSG00000172500	"FGF1 intracellular binding protein"	O43427	11	65883740-65888531	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 608.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA011729	Approved		Supported	"Nuclear speckles"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 25: Spermatids - Spermatogenesis"	"Nuclear speckles"		"HPA011729: AB_1848579"	"unprognostic (1.70e-1)"	"unprognostic (6.06e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.35e-1)"	"unprognostic (1.37e-1)"	"unprognostic (4.49e-2)"	"prognostic unfavorable (1.74e-4)"	"unprognostic (2.23e-1)"	"unprognostic (2.95e-1)"	"unprognostic (3.10e-3)"	"unprognostic (2.13e-1)"	"unprognostic (1.29e-1)"	"unprognostic (5.50e-2)"	"unprognostic (2.39e-1)"	"unprognostic (3.18e-1)"	"unprognostic (1.83e-2)"	"unprognostic (4.89e-2)"	34.1	48.4	48.0	26.8	49.0	32.2	33.0	48.0	55.1	31.1	41.8	30.8	30.4	35.9	29.4	35.6	37.2	22.3	56.8	51.0	50.5	48.3	37.1	31.6	35.6	53.3	47.6	28.6	39.0	32.8	31.2	25.1	54.3	30.6	27.3	19.8	27.9	24.6	53.6	45.7	35.3	30.9	46.6	43.3	37.7	64.9	49.9	40.3	35.9	56.1	42.9	29.7	28.3	47.8	61.0	86.9	48.3	118.6	72.8	91.2	35.9	54.8	110.9	74.3	62.0	36.1	83.1	79.7	98.2	124.1	35.9	65.2	48.5	121.0	48.1	93.7	62.2	77.3	84.1	54.7	99.8	100.7	64.4	73.8	68.3	54.1	114.4	60.0	93.7	61.5	27.4	139.4	98.9	198.2	78.9	88.0	47.8	61.5	130.7	104.9	45.6	196.3	88.5	79.6	87.8	80.4	60.3	110.6	110.5	32.5	113.0	58.1	86.3	79.7	66.4	130.9	40.3	73.8	87.6	48.4	101.1	73.6	30.7	123.5	121.2	98.9	71.1	136.9	74.4	100.7	67.2	64.9	164.7	83.1	52.7	57.0	20.4	101.1	150.0	84.1	100.6	109.4	48.0	49.0	48.0	55.1	51.0	50.5	53.3	47.6	54.3	46.6	49.9	47.8	55.8	12.8	28.0	4.9	57.0	47.3	51.7	105.7	38.7	47.7	66.9	85.6	44.7	42.9	55.7	44.1	31.3	79.4	41.1	61.6	93.9	114.2	176.7	45.3	59.8	52.6	93.5	39.1	7.1	149.3	125.7	50.3	37.2	39.6	67.2	68.6	45.3	36.5	115.0	42.1	7.3	49.2	57.0	75.3	75.9	608.0	36.1	67.9	51.6	3.7	129.3	47.1	101.0	3.5	5.6	98.9	68.8	39.5	60.1	56.1	185.8	150.1	54.9	52.8	19.7	39.2	77.2	100.5	84.0	51.5	52.1	71.8	54.6	79.6	58.8	61.5
FIG4	"ALS11, CMT4J, dJ249I4.1, hSac3, KIAA0274, SAC3"	ENSG00000112367	"FIG4 phosphoinositide 5-phosphatase"	Q92562	6	109690609-109878098	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		Hydrolase	"Amyotrophic lateral sclerosis, Charcot-Marie-Tooth disease, Disease variant, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 49.5;Oligodendrocyte precursor cells: 46.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017823, HPA068859"	Approved		Supported	"Vesicles,Lipid droplets"		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Vesicles, Lipid droplets"		"CAB017823: , HPA068859: AB_2686049"	"prognostic unfavorable (5.91e-4)"	"unprognostic (4.12e-2)"	"prognostic favorable (8.42e-4)"	"unprognostic (3.17e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.16e-1)"	"prognostic unfavorable (4.73e-4)"	"unprognostic (7.06e-2)"	"unprognostic (2.69e-1)"	"unprognostic (8.67e-2)"	"unprognostic (3.44e-3)"	"unprognostic (4.22e-2)"	"prognostic favorable (8.19e-4)"	"unprognostic (1.48e-1)"	"unprognostic (2.02e-1)"	"unprognostic (5.45e-2)"	"unprognostic (2.00e-2)"	9.3	10.2	5.5	7.1	7.2	5.6	8.1	5.9	7.7	8.2	12.9	10.1	5.0	8.5	7.8	9.4	7.2	7.6	7.7	6.0	8.8	9.5	6.1	13.4	10.1	6.4	7.3	8.2	7.5	17.4	11.9	8.8	8.9	7.7	9.5	10.8	10.7	7.8	10.6	7.6	9.1	10.3	5.6	13.8	8.7	8.2	6.1	12.3	9.3	8.3	10.1	9.2	8.4	7.0	8.3	8.4	11.7	14.9	11.8	17.2	7.8	9.9	14.1	8.3	23.2	4.6	7.2	23.2	5.8	18.9	14.9	5.2	12.6	8.5	20.7	13.3	16.5	10.9	5.9	5.5	11.4	9.5	10.0	8.8	9.9	12.8	10.6	22.8	18.3	13.9	6.8	8.8	12.7	6.8	12.0	8.4	5.9	12.0	4.7	7.9	6.1	7.3	13.3	18.4	12.8	11.7	7.1	10.7	21.1	15.6	6.0	23.1	11.2	4.2	3.8	5.4	9.5	3.4	2.6	7.9	27.3	8.5	4.6	15.4	24.9	14.2	8.8	24.5	7.7	18.9	6.3	8.5	19.2	21.2	7.5	7.5	7.4	10.0	15.2	8.1	9.4	11.7	5.5	7.2	5.9	7.7	6.0	8.8	6.4	7.3	8.9	5.6	6.1	7.0	4.9	16.0	9.0	24.5	15.7	4.6	7.1	7.3	5.2	8.8	5.4	3.3	6.7	2.8	6.9	9.2	2.1	13.4	9.5	7.0	5.9	9.8	18.0	7.5	5.3	5.2	10.2	3.0	49.5	11.4	7.0	6.0	8.2	7.9	8.8	8.6	7.1	4.1	23.3	1.7	32.4	8.6	8.2	19.2	6.8	17.7	3.4	17.3	8.8	29.0	16.4	8.5	11.3	46.8	37.4	7.6	6.3	6.8	6.5	4.0	6.3	8.2	9.1	7.6	0.0	5.1	6.6	5.5	12.1	8.3	4.4	12.3	9.3	5.6	6.4	8.9
FILIP1	"FILIP, KIAA1275"	ENSG00000118407	"Filamin A interacting protein 1"	Q7Z7B0	6	75291859-75493800	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 53.8;skeletal muscle: 35.8;tongue: 48.9"	"Cell type enriched"	"Detected in many"	4	"Cardiomyocytes: 582.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 6.9;HUVEC TERT2: 1.7;RPTEC TERT1: 1.9;U-266/70: 6.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA053564	Enhanced		Approved	"Plasma membrane,Actin filaments"		No	NA				"Cluster 38: Heart - Muscle contraction"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 54: Cardiomyocytes - Muscle contraction"	"Plasma membrane, Actin filaments"		"HPA053564: AB_2682192"	"unprognostic (4.90e-2)"	"unprognostic (3.77e-2)"	"unprognostic (9.77e-3)"	"unprognostic (3.83e-1)"	"unprognostic (1.52e-1)"	"unprognostic (4.98e-1)"	"unprognostic (2.27e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.06e-1)"	"unprognostic (5.17e-3)"	"unprognostic (3.29e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.30e-3)"	"unprognostic (3.97e-3)"	"unprognostic (2.34e-1)"	"unprognostic (4.65e-2)"	"unprognostic (7.66e-3)"	6.8	1.5	1.5	2.9	1.8	0.2	2.4	0.1	2.5	1.8	0.7	11.7	1.8	8.5	0.9	9.5	4.8	5.7	53.8	4.1	0.5	1.8	3.2	7.6	1.2	0.2	0.5	1.3	1.4	12.4	1.4	5.1	0.3	3.9	3.3	0.4	1.2	3.4	35.8	0.6	2.6	13.2	0.5	0.3	3.2	2.1	0.8	1.1	2.3	48.9	0.9	10.9	1.6	1.5	0.0	1.3	0.2	0.1	0.0	0.2	0.1	0.2	0.0	0.0	0.0	0.0	0.1	0.1	6.9	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.2	0.1	0.2	0.0	0.0	0.1	0.1	0.9	0.0	0.1	0.0	0.0	1.7	0.2	0.0	0.2	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	1.9	0.4	0.1	0.1	0.0	0.1	0.0	1.5	0.0	0.2	0.0	0.0	0.0	0.0	0.0	6.9	0.7	0.0	0.0	0.3	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.2	0.0	0.1	0.1	0.0	0.0	1.5	1.8	0.1	2.5	4.1	0.5	0.2	0.5	0.3	0.5	0.8	1.5	82.1	128.2	82.6	5.9	0.5	0.6	0.5	2.8	0.0	3.5	0.5	0.8	582.5	0.0	9.1	0.0	0.0	0.8	0.5	0.1	1.9	0.1	54.2	18.2	1.7	45.9	0.0	2.7	9.7	0.4	0.3	60.3	0.0	19.2	1.3	1.7	72.1	0.7	1.3	0.0	12.8	0.1	8.2	1.9	1.2	17.6	2.5	1.8	1.8	5.6	0.0	2.5	1.0	6.0	10.0	0.0	0.0	4.5	0.0	0.8	0.4	0.1	62.4	3.5	92.1	70.2	114.2	7.1	7.9	0.7	0.9	0.8	1.8	11.9	0.1	0.4
FIS1	"CGI-135, H_NH0132A01.6, TTC11"	ENSG00000214253	"Fission, mitochondrial 1"	Q9Y3D6	7	101239458-101252316	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Proximal tubular cells: 891.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA017430	Approved		Supported	Mitochondria		NA	NA		140000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"HPA017430: AB_1848608"	"unprognostic (1.45e-2)"	"unprognostic (8.20e-2)"	"unprognostic (4.31e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.48e-2)"	"unprognostic (1.63e-1)"	"unprognostic (7.73e-2)"	"unprognostic (6.54e-2)"	"unprognostic (5.33e-2)"	"unprognostic (2.93e-1)"	"unprognostic (1.36e-3)"	"unprognostic (3.47e-2)"	"prognostic favorable (1.08e-7)"	"unprognostic (1.29e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.42e-1)"	205.8	227.6	202.4	60.0	231.0	110.2	195.2	234.0	230.7	149.5	194.5	211.0	83.0	168.1	100.5	155.9	166.0	70.9	382.2	198.4	213.5	250.5	294.9	140.4	73.2	238.9	222.7	152.3	208.7	201.1	209.3	75.4	237.8	160.3	69.5	34.8	142.4	90.0	475.6	174.3	137.3	83.7	223.9	163.0	194.4	145.5	217.6	84.0	178.9	284.2	63.8	163.2	141.1	256.0	110.1	124.3	94.7	133.6	103.6	136.6	63.5	118.1	139.0	103.2	88.3	81.7	173.2	107.4	145.7	159.4	98.1	64.0	65.8	184.5	56.8	87.9	101.0	49.8	154.7	100.6	124.5	93.1	75.0	131.9	172.5	73.4	111.5	117.2	185.6	60.3	109.0	142.9	155.0	445.1	145.1	160.4	100.8	221.2	123.0	70.7	53.4	235.8	155.1	107.5	120.6	141.9	57.0	261.5	83.0	81.3	88.0	101.5	159.6	120.6	76.6	127.9	125.3	122.2	98.6	61.6	111.7	103.0	159.0	153.9	137.7	135.9	122.3	141.7	126.4	152.7	115.5	115.9	149.6	152.8	115.0	120.5	104.5	126.3	131.6	123.2	155.6	207.9	202.4	231.0	234.0	230.7	198.4	213.5	238.9	222.7	237.8	223.9	217.6	256.0	301.0	102.5	119.1	16.0	127.5	104.9	158.6	158.4	114.4	48.2	220.5	309.2	349.4	207.3	114.8	229.9	16.7	259.8	120.7	334.5	561.5	263.5	208.5	145.4	120.7	205.8	219.4	423.7	13.6	293.4	309.2	166.7	110.1	126.4	136.3	132.4	182.0	384.9	297.0	35.3	13.2	317.9	128.1	170.9	133.5	730.3	193.9	136.0	218.7	15.0	214.1	281.5	171.9	6.6	83.1	232.2	460.4	179.0	184.8	221.0	603.6	891.2	130.9	59.6	98.6	161.1	233.3	188.0	201.2	192.7	135.7	324.1	127.5	247.4	277.5	192.5
FKBP3	"FKBP-25, FKBP25"	ENSG00000100442	"FKBP prolyl isomerase 3"	Q00688	14	45115599-45135319	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Isomerase, Rotamase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 424.4;tongue: 372.0"	"Cell type enhanced"	"Detected in all"		"Late spermatids: 377.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000864, CAB012232, CAB012520"	Supported		Supported	Cytosol		NA	NA		1300000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 10: Non-specific - Unknown function"	Cytosol		"CAB012232: , CAB012520: AB_873554, HPA000864: AB_1078873"	"unprognostic (7.77e-2)"	"unprognostic (1.47e-1)"	"unprognostic (3.18e-1)"	"unprognostic (9.72e-2)"	"unprognostic (1.25e-1)"	"unprognostic (9.82e-3)"	"unprognostic (3.58e-3)"	"unprognostic (2.28e-1)"	"unprognostic (5.04e-3)"	"unprognostic (1.22e-3)"	"unprognostic (7.47e-2)"	"unprognostic (6.92e-3)"	"unprognostic (1.00e-1)"	"unprognostic (3.07e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.00e-2)"	"unprognostic (1.47e-1)"	40.9	46.8	100.3	35.8	102.3	38.4	50.0	110.1	122.1	38.1	91.8	49.4	44.7	31.4	64.8	54.7	31.4	29.8	109.5	101.9	100.6	66.5	69.7	27.6	53.7	100.7	99.3	35.3	32.8	55.5	56.6	46.9	100.1	57.7	49.1	82.3	37.1	37.9	424.4	38.3	47.8	39.2	99.8	39.9	38.0	52.9	101.4	59.6	40.1	372.0	57.7	43.3	38.6	105.8	161.0	175.3	249.0	132.4	109.0	117.8	98.3	96.2	110.3	149.3	163.5	154.8	134.1	85.1	98.9	110.0	84.1	130.0	188.4	124.8	211.7	123.7	111.0	69.8	138.8	202.6	107.1	122.2	72.8	112.0	127.5	87.2	80.1	136.8	198.0	131.9	102.9	62.1	179.9	196.9	197.5	163.0	126.7	178.3	164.5	187.0	183.7	102.9	242.2	183.7	151.2	59.2	154.8	94.5	156.0	186.4	222.6	89.9	128.7	113.0	195.6	59.9	75.1	104.0	198.8	132.5	68.3	83.0	108.1	23.4	22.4	22.1	18.7	27.3	22.8	29.7	25.0	25.7	33.3	21.8	23.4	26.7	3.6	24.2	29.4	43.0	30.8	20.2	100.3	102.3	110.1	122.1	101.9	100.6	100.7	99.3	100.1	99.8	101.4	105.8	48.3	41.7	46.6	25.8	45.3	47.8	94.4	205.5	45.5	79.3	39.9	46.7	202.5	48.6	101.4	93.8	10.4	320.9	51.2	56.4	252.4	131.1	212.7	55.0	83.3	58.5	56.1	50.9	49.7	73.0	135.4	70.0	36.7	68.1	53.7	75.6	38.2	91.1	131.1	40.4	44.5	71.2	124.1	39.9	43.0	377.4	80.8	53.7	69.4	17.8	110.7	80.7	50.4	21.1	34.3	88.4	53.7	97.8	58.0	76.4	91.8	220.1	73.5	67.4	105.2	71.3	118.5	154.0	111.2	65.0	47.9	165.0	48.8	84.1	96.1	77.6
FKBP8	"FKBP38, FKBPr38"	ENSG00000105701	"FKBP prolyl isomerase 8"	Q14318	19	18531751-18544077	"Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Apoptosis, Host-virus interaction"	"Isomerase, Rotamase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Erythroid cells: 719.1;Late spermatids: 1236.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"eosinophil: 93.4;neutrophil: 78.0"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 93.4"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB025346, HPA045177"	Supported		Supported	"Endoplasmic reticulum,Mitochondria,Cytosol"		NA	NA		10000	"Cluster 52: Eosinophils - Transcription"	"Cluster 43: Testis - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 25: Spermatids - Spermatogenesis"	Mitochondria	"Endoplasmic reticulum, Cytosol"	"CAB025346: , HPA045177: AB_2679244"	"unprognostic (1.61e-1)"	"unprognostic (1.33e-1)"	"prognostic unfavorable (1.24e-4)"	"unprognostic (8.93e-2)"	"unprognostic (2.73e-1)"	"unprognostic (9.22e-2)"	"unprognostic (2.54e-2)"	"unprognostic (2.26e-1)"	"unprognostic (2.10e-2)"	"unprognostic (1.49e-1)"	"prognostic favorable (7.76e-4)"	"unprognostic (8.51e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.97e-1)"	"unprognostic (6.89e-2)"	"unprognostic (1.12e-2)"	"unprognostic (2.32e-1)"	206.9	161.5	426.8	79.8	423.7	272.9	197.3	359.7	645.5	235.3	332.7	311.1	85.5	188.6	59.0	238.3	198.1	85.5	244.3	427.4	395.7	194.8	233.7	187.6	97.9	427.6	405.1	263.6	167.2	109.1	312.3	91.2	406.1	249.4	33.6	51.4	200.0	115.3	202.7	185.9	159.2	62.5	381.7	193.6	189.3	378.4	423.4	86.2	205.9	105.5	52.7	228.3	222.4	437.8	196.3	139.0	106.0	201.7	106.2	165.6	266.8	155.0	163.1	116.5	160.2	133.3	259.1	111.6	245.0	191.7	77.7	104.4	65.0	216.5	31.4	136.6	316.5	105.3	175.4	162.3	183.3	105.5	220.6	217.3	204.8	104.0	65.4	216.1	121.9	213.2	222.4	254.8	102.1	329.1	190.4	313.1	216.3	174.6	200.2	197.8	88.4	387.3	154.9	126.6	117.1	213.2	108.8	87.7	197.5	77.8	104.5	299.4	143.2	143.2	130.3	282.1	120.0	194.6	118.2	130.8	321.5	166.7	130.8	18.1	14.7	93.4	14.2	15.5	13.3	10.2	14.6	16.3	11.1	9.8	11.1	12.6	78.0	8.8	19.0	11.3	15.8	30.1	426.8	423.7	359.7	645.5	427.4	395.7	427.6	405.1	406.1	381.7	423.4	437.8	115.9	9.6	1.1	35.3	115.1	95.3	164.1	118.4	68.3	64.8	110.9	107.4	2.0	115.8	58.0	101.2	14.6	246.4	107.0	287.7	248.4	178.4	412.3	65.6	59.2	92.3	205.9	719.1	32.0	126.9	234.8	126.5	80.5	64.6	52.8	125.0	99.6	66.4	237.3	99.3	33.2	156.8	126.1	184.1	145.0	1236.4	203.8	152.1	202.7	8.4	221.9	149.0	183.4	12.5	32.8	166.9	283.4	165.5	127.2	139.4	339.3	290.4	51.9	56.4	98.6	95.7	129.9	193.5	212.4	96.5	117.9	312.9	145.0	121.7	158.3	158.0
FLAD1	"FAD1, PP591"	ENSG00000160688	"Flavin adenine dinucleotide synthetase 1"	Q8NFF5	1	154983338-154993111	"Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		"Nucleotidyltransferase, Transferase"	"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028476, HPA028486, HPA028563"	Approved		Supported	"Plasma membrane,Cytosol"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 25: Spermatids - Spermatogenesis"	"Plasma membrane, Cytosol"		"HPA028476: AB_10599974, HPA028486: AB_10600206, HPA028563: AB_10602286"	"unprognostic (2.64e-1)"	"unprognostic (2.60e-1)"	"unprognostic (2.72e-1)"	"unprognostic (3.84e-2)"	"unprognostic (7.34e-2)"	"unprognostic (1.45e-1)"	"prognostic unfavorable (3.04e-4)"	"unprognostic (1.31e-1)"	"unprognostic (2.32e-1)"	"unprognostic (8.08e-2)"	"unprognostic (6.51e-2)"	"unprognostic (9.74e-2)"	"prognostic unfavorable (2.55e-6)"	"unprognostic (1.67e-2)"	"unprognostic (5.06e-2)"	"unprognostic (5.50e-2)"	"unprognostic (1.17e-2)"	21.9	21.1	19.2	17.0	20.5	14.2	23.5	20.2	20.7	20.4	19.7	22.8	20.1	19.8	20.5	26.1	19.1	11.8	28.7	20.1	19.5	21.7	32.8	17.7	22.8	20.2	20.3	15.5	18.9	18.0	15.1	14.3	20.6	24.3	18.9	9.8	21.0	13.7	34.1	32.9	24.9	17.7	19.6	30.1	22.0	19.0	20.6	16.0	22.5	32.0	23.0	22.6	21.1	21.0	33.4	52.4	32.8	56.1	27.9	20.5	62.1	24.7	20.5	35.2	30.2	46.9	40.1	38.5	48.8	23.0	18.3	42.6	63.4	51.3	23.0	40.6	47.5	31.4	42.8	33.7	38.1	46.0	39.1	29.5	65.9	40.2	42.8	17.0	41.5	40.4	51.4	30.3	30.2	71.8	31.9	32.0	71.7	72.2	53.8	52.8	16.2	88.7	33.9	45.8	54.9	75.6	38.7	86.2	50.0	63.0	74.0	68.6	26.4	21.9	30.1	28.6	39.6	47.5	63.7	66.9	26.4	36.8	36.1	29.8	35.3	23.7	34.5	33.0	38.9	39.0	31.9	33.8	37.7	34.2	29.1	28.9	7.8	26.1	41.4	38.3	37.9	37.6	19.2	20.5	20.2	20.7	20.1	19.5	20.2	20.3	20.6	19.6	20.6	21.0	12.2	9.6	10.6	9.8	19.3	26.5	18.1	37.1	23.3	15.7	16.4	15.9	39.4	20.0	22.6	25.8	6.2	42.5	16.9	22.1	31.3	24.4	25.3	15.4	12.0	14.1	12.0	19.0	8.2	28.2	42.6	12.1	25.0	12.6	8.8	21.2	11.7	27.0	27.6	15.2	6.3	20.8	28.5	18.1	11.1	77.6	10.2	14.8	14.2	5.6	34.7	23.3	32.0	4.5	8.2	25.4	14.9	9.8	18.3	26.1	30.3	32.9	19.3	17.2	6.6	9.7	18.3	22.9	20.6	25.7	27.6	36.0	20.2	23.1	25.4	20.0
FLCN	"BHD, DENND8B, MGC17998, MGC23445"	ENSG00000154803	Folliculin	Q8NFG4	17	17212212-17237188	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins"		"GTPase activation"	"Cancer-related genes, Disease variant, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cone photoreceptor cells: 79.2;Erythroid cells: 81.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB015158, HPA028760"	Supported		Supported	"Plasma membrane,Cytosol"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 72: Non-specific - Transcription"	"Cluster 18: U-2197 - ECM organization"	"Cluster 6: Erythroid cells - Oxygen transport"	Cytosol	"Plasma membrane"	"CAB015158: AB_2231645, HPA028760: AB_10601323"	"unprognostic (1.99e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.53e-2)"	"unprognostic (1.74e-1)"	"unprognostic (3.85e-2)"	"unprognostic (3.69e-1)"	"unprognostic (3.73e-2)"	"unprognostic (1.32e-1)"	"unprognostic (3.58e-2)"	"unprognostic (3.90e-1)"	"prognostic favorable (4.49e-4)"	"unprognostic (6.45e-3)"	"unprognostic (2.55e-3)"	"unprognostic (1.92e-1)"	"unprognostic (9.71e-2)"	"unprognostic (2.62e-2)"	"unprognostic (1.65e-1)"	21.8	19.0	19.0	10.7	25.9	17.7	18.9	27.3	31.6	42.5	18.3	43.7	23.3	37.0	14.5	13.8	25.2	17.0	29.2	31.9	14.0	15.3	28.9	26.8	12.4	21.3	15.2	35.3	15.2	13.1	28.6	13.1	22.0	27.1	10.2	7.2	16.4	13.7	42.7	19.3	26.8	14.5	14.0	29.2	22.4	21.0	19.3	8.6	23.8	18.4	8.0	28.2	25.5	28.3	12.0	30.4	11.5	14.9	36.4	20.6	15.8	11.8	19.1	18.0	24.3	24.3	10.4	6.3	13.8	14.0	40.2	14.4	14.0	7.3	9.3	10.9	12.2	12.4	9.1	13.9	33.6	4.9	33.5	30.3	24.0	27.6	20.8	16.4	14.8	9.2	17.7	16.4	17.6	17.5	8.3	8.4	11.2	17.8	8.1	16.9	52.7	7.3	11.0	14.1	13.6	8.8	11.6	7.5	19.3	70.7	11.1	8.8	15.7	40.6	16.6	56.5	14.1	7.7	7.4	5.7	26.0	10.8	16.6	2.4	2.8	1.6	1.6	3.7	2.2	3.6	1.9	1.4	1.4	3.2	2.1	1.9	6.0	2.8	1.4	1.4	2.9	1.8	19.0	25.9	27.3	31.6	31.9	14.0	21.3	15.2	22.0	14.0	19.3	28.3	8.4	25.6	12.6	17.0	9.2	18.4	12.7	5.7	2.8	20.7	13.2	6.5	23.7	14.3	6.2	7.3	79.2	10.9	5.3	25.0	1.9	12.3	14.5	16.8	11.3	12.5	25.7	81.7	31.3	8.3	7.4	20.6	9.7	15.2	1.3	10.3	27.8	24.1	16.6	47.1	23.7	11.0	16.2	21.6	19.2	20.4	28.0	13.2	10.6	18.7	12.2	13.3	6.2	17.1	32.4	9.8	15.6	20.3	4.4	11.6	36.8	6.1	9.1	18.5	19.7	24.8	11.1	6.3	10.8	5.3	18.2	33.8	10.0	16.3	12.6	13.0
FLI1	"EWSR2, SIC-1"	ENSG00000151702	"Fli-1 proto-oncogene, ETS transcription factor"	Q01543	11	128686535-128813267	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes, Disease variant, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 35.8"	"Cell type enhanced"	"Detected in many"		"B-cells: 65.7;Endothelial cells: 84.2;Hepatic stellate cells: 64.6;Kupffer cells: 86.4;Microglial cells: 231.4;monocytes: 68.4;NK-cells: 93.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEL: 113.9;HUVEC TERT2: 60.5;REH: 49.8;TIME: 63.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA065030, HPA073099"	Approved		Supported	"Nucleoplasm,Nuclear bodies"		Yes	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 2: Immune cells - Immune response"	"Cluster 36: HEL - Hemostasis"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Nucleoplasm, Nuclear bodies"		"HPA065030: , HPA073099: AB_2686572"	"unprognostic (1.38e-2)"	"unprognostic (7.46e-2)"	"unprognostic (6.16e-2)"	"unprognostic (3.74e-2)"	"unprognostic (6.22e-2)"	"unprognostic (4.26e-3)"	"unprognostic (1.33e-1)"	"unprognostic (8.32e-3)"	"unprognostic (2.97e-1)"	"unprognostic (9.91e-2)"	"unprognostic (1.60e-2)"	"unprognostic (1.42e-1)"	"prognostic unfavorable (4.60e-4)"	"unprognostic (4.79e-2)"	"unprognostic (2.07e-2)"	"unprognostic (2.62e-1)"	"unprognostic (4.79e-2)"	10.2	1.9	3.7	10.9	2.3	12.2	6.0	2.1	2.8	5.7	1.2	3.7	3.2	4.6	1.1	2.8	2.7	6.1	6.2	1.8	2.9	2.1	2.8	10.8	12.3	4.7	2.7	1.2	1.7	3.5	0.7	12.5	4.3	1.9	2.9	0.5	2.2	2.2	2.8	1.7	4.0	5.9	3.5	35.8	4.3	0.9	3.9	17.2	2.9	6.6	10.4	6.7	1.9	2.8	0.2	0.0	5.6	0.0	0.8	1.0	0.1	3.3	9.2	3.8	3.1	0.0	0.0	18.5	31.7	11.1	1.1	0.1	0.8	13.5	4.1	9.0	0.2	113.9	0.5	0.0	6.0	13.7	14.6	0.8	1.1	7.7	17.3	11.1	60.5	25.6	0.0	23.3	0.8	0.0	13.3	8.1	1.8	0.0	3.1	49.8	0.1	19.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	5.0	0.0	20.4	63.0	0.7	0.0	0.2	3.5	7.3	16.4	16.6	0.1	31.8	5.2	34.5	15.5	24.5	10.1	15.3	11.9	6.8	8.9	8.2	19.1	6.0	3.7	8.2	11.8	12.3	19.1	3.3	11.1	20.1	3.7	2.3	2.1	2.8	1.8	2.9	4.7	2.7	4.3	3.5	3.9	2.8	53.4	6.4	5.3	0.3	65.7	5.1	0.3	1.7	2.2	0.0	0.7	1.3	5.5	5.7	0.1	1.8	0.0	0.4	43.1	0.0	0.0	0.0	0.5	0.4	0.6	84.2	0.0	23.4	0.3	0.0	0.4	5.9	2.0	0.3	22.8	0.0	64.6	1.3	43.2	0.0	1.5	0.1	0.0	86.4	24.7	0.5	1.8	60.3	7.2	231.4	68.4	0.1	93.7	4.0	0.7	0.0	0.0	0.7	56.9	0.3	0.0	0.4	0.8	0.4	6.6	2.1	3.1	0.2	0.1	0.6	4.1	0.3	52.8	0.9	0.2	0.4
FLNB	"ABP-278, FH1, FLN1L, LRS1, TABP, TAP"	ENSG00000136068	"Filamin B"	O75369	3	58008400-58172251	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Differentiation, Myogenesis"	"Actin-binding, Developmental protein"	"Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 344.9;Pancreatic endocrine cells: 385.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"plasmacytoid DC: 17.9"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"TIME: 523.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004747, HPA004886, CAB019322"	Enhanced		Supported	"Golgi apparatus,Plasma membrane,Actin filaments,Cytosol"		NA	NA		20000000	"Cluster 41: Basophils - Cellular respiration"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Plasma membrane"	"Golgi apparatus, Actin filaments, Cytosol"	"CAB019322: , HPA004747: AB_1848599, HPA004886: AB_1848600"	"unprognostic (1.29e-2)"	"unprognostic (1.08e-2)"	"unprognostic (5.97e-2)"	"unprognostic (6.86e-2)"	"unprognostic (1.26e-1)"	"unprognostic (2.05e-1)"	"unprognostic (6.52e-2)"	"unprognostic (1.72e-1)"	"unprognostic (9.61e-2)"	"unprognostic (5.02e-3)"	"prognostic unfavorable (8.45e-5)"	"unprognostic (9.23e-2)"	"prognostic favorable (3.45e-6)"	"unprognostic (4.38e-2)"	"unprognostic (1.36e-1)"	"unprognostic (6.65e-3)"	"unprognostic (2.33e-1)"	74.6	63.1	42.8	22.3	51.3	7.4	90.4	50.9	52.4	45.5	57.1	122.2	52.8	75.5	120.3	57.7	75.9	19.6	47.2	40.1	41.6	96.7	71.5	49.9	24.4	54.4	52.3	68.9	83.2	59.9	38.1	48.0	52.6	124.4	74.4	10.2	64.0	51.4	16.3	91.3	92.7	36.2	48.1	55.3	70.2	30.4	50.0	74.8	91.1	17.8	23.8	114.7	58.6	58.3	134.4	225.0	22.3	32.9	14.8	25.0	385.7	49.0	39.3	106.6	108.4	227.1	223.1	21.9	18.1	172.9	172.8	215.9	42.1	311.5	103.0	121.6	20.8	18.4	192.7	110.5	107.8	16.2	63.1	40.2	132.1	148.5	448.3	125.2	365.4	94.7	30.9	6.6	67.0	29.2	49.3	38.5	34.5	146.6	192.1	21.6	5.8	18.7	143.8	224.6	24.7	23.1	247.3	132.6	27.4	160.9	110.3	44.6	523.3	27.8	84.5	334.1	175.6	4.8	1.7	17.0	102.2	29.2	29.9	10.1	0.3	5.0	0.5	0.8	2.7	4.1	1.7	0.8	1.4	1.6	5.1	3.8	0.2	7.3	1.5	17.9	2.0	1.5	42.8	51.3	50.9	52.4	40.1	41.6	54.4	52.3	52.6	48.1	50.0	58.3	133.7	51.3	30.2	3.9	11.0	50.6	42.9	73.2	29.0	3.3	86.6	43.4	10.0	57.2	62.0	47.8	39.6	28.7	36.8	344.9	0.0	93.8	15.6	103.6	24.4	92.9	49.2	10.3	34.1	67.1	207.1	28.8	88.7	133.8	24.7	34.4	151.3	52.0	14.6	1.7	34.3	82.8	38.7	11.3	12.2	22.4	16.1	11.1	5.4	22.5	11.6	9.1	2.1	25.1	40.9	385.7	161.0	27.8	3.4	115.2	157.3	6.5	76.1	10.6	0.0	4.4	25.9	4.4	6.9	46.4	51.7	49.8	9.9	84.6	93.0	88.4
FLNC	"ABP-280, ABPL, FLN2"	ENSG00000128591	"Filamin C"	Q14315	7	128830406-128859274	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"		Actin-binding	"Cardiomyopathy, Disease variant, Myofibrillar myopathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 635.2;skeletal muscle: 1384.8;tongue: 442.6"	"Cell type enriched"	"Detected in many"	26	"Cardiomyocytes: 1892.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ: 393.6;fHDF/TERT166: 180.2;hTEC/SVTERT24-B: 190.6;U-2 OS: 163.5"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA006135, HPA071007"	Enhanced		Supported	"Plasma membrane,Cytosol"		NA	NA		26000000		"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 54: Cardiomyocytes - Muscle contraction"	"Plasma membrane, Cytosol"		"HPA006135: AB_1848602, HPA071007: "	"unprognostic (1.25e-1)"	"unprognostic (7.38e-2)"	"unprognostic (4.47e-2)"	"unprognostic (1.40e-2)"	"prognostic unfavorable (2.80e-4)"	"unprognostic (1.64e-3)"	"unprognostic (4.42e-3)"	"prognostic unfavorable (2.17e-5)"	"unprognostic (1.03e-3)"	"unprognostic (2.35e-2)"	"unprognostic (1.35e-3)"	"unprognostic (6.37e-2)"	"prognostic unfavorable (5.69e-4)"	"unprognostic (5.68e-3)"	"unprognostic (1.15e-1)"	"unprognostic (1.52e-3)"	"prognostic unfavorable (3.73e-5)"	13.1	3.4	5.8	25.9	11.5	0.0	5.9	11.5	9.9	16.9	3.0	215.4	9.4	96.6	4.6	40.3	35.4	13.8	635.2	5.9	16.7	2.8	1.1	12.5	0.6	52.1	11.1	9.4	2.1	3.2	1.6	2.4	29.9	71.1	9.8	0.5	16.5	100.7	1384.8	8.9	40.3	114.4	51.7	0.7	65.6	2.2	19.1	0.3	4.3	442.6	0.2	162.7	21.3	49.8	0.1	0.8	4.2	0.1	34.4	41.2	4.1	393.6	73.6	109.2	52.3	124.0	1.0	0.1	64.7	180.2	44.9	0.1	23.7	0.9	64.4	0.2	13.1	0.1	20.2	0.1	43.2	0.0	0.2	78.0	0.1	190.6	0.1	44.2	69.0	0.3	49.0	0.2	75.8	0.0	0.0	1.5	64.5	0.1	22.6	0.1	127.5	1.0	0.1	0.0	2.1	7.0	0.7	0.1	0.3	88.0	0.4	1.6	144.6	38.2	163.5	10.1	0.2	0.1	0.0	0.3	129.0	0.1	5.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.8	11.5	11.5	9.9	5.9	16.7	52.1	11.1	29.9	51.7	19.1	49.8	3.6	3.2	0.5	0.7	0.0	3.7	0.3	0.1	1.2	0.6	0.3	1.3	1892.3	0.0	1.9	1.8	0.0	0.4	0.2	0.5	0.0	0.7	0.4	1.8	5.0	31.4	0.0	0.0	0.2	0.2	3.0	31.6	0.0	2.9	0.0	0.6	1.8	0.0	0.9	0.0	1.1	0.3	0.0	0.0	6.9	0.9	5.3	0.5	5.4	0.0	0.0	0.1	0.0	0.0	5.8	2.6	0.1	10.5	1.2	2.7	0.0	1.1	0.0	0.2	0.0	71.8	38.1	0.3	1.0	0.2	4.5	1.9	1.0	0.1	0.2	1.0
FLOT1		ENSG00000137312	"Flotillin 1"	O75955	6	30727709-30742732	"Plasma proteins, Predicted intracellular proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 314.3"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"GAMG: 423.3;hTERT-RPE1: 242.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001393, CAB007766"	Enhanced		Approved	"Golgi apparatus,Vesicles,Plasma membrane"		NA	NA		160000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 72: Non-specific - Transcription"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Golgi apparatus"	"Vesicles, Plasma membrane"	"CAB007766: AB_562116, HPA001393: AB_1078892"	"unprognostic (2.68e-1)"	"unprognostic (2.23e-1)"	"prognostic unfavorable (5.78e-4)"	"unprognostic (1.78e-2)"	"unprognostic (2.21e-1)"	"unprognostic (3.41e-3)"	"unprognostic (2.68e-3)"	"unprognostic (1.86e-1)"	"unprognostic (2.65e-1)"	"prognostic favorable (3.06e-4)"	"unprognostic (1.81e-2)"	"unprognostic (9.36e-2)"	"prognostic unfavorable (1.49e-4)"	"unprognostic (6.43e-3)"	"unprognostic (3.92e-1)"	"unprognostic (1.61e-2)"	"unprognostic (2.46e-2)"	141.7	239.5	49.3	27.9	54.6	41.7	129.8	49.4	60.9	111.1	56.8	150.3	28.7	108.9	8.4	81.8	95.8	23.1	234.5	55.1	57.9	146.1	127.3	136.8	22.1	50.9	51.5	84.1	88.5	41.4	102.5	35.0	57.4	109.6	17.7	6.3	99.1	45.8	190.0	51.7	87.1	33.0	45.8	129.6	96.9	65.0	53.6	24.9	111.7	83.1	17.0	134.5	96.9	48.8	54.3	18.3	46.4	62.0	49.1	71.0	1.3	59.7	67.5	82.8	79.3	19.4	30.0	13.0	29.0	101.3	423.3	41.8	35.0	20.1	28.6	36.1	1.3	41.1	17.5	19.1	119.2	12.2	67.0	75.4	30.6	40.9	71.3	242.7	65.9	37.9	21.7	52.7	77.9	22.9	38.0	14.5	15.1	29.4	15.7	20.2	48.4	38.0	30.3	13.0	16.4	17.2	33.7	28.7	164.6	30.4	43.8	10.1	44.0	199.5	37.6	20.6	120.6	18.6	19.7	28.8	26.2	42.6	122.7	179.3	76.9	132.0	35.0	38.9	24.1	28.0	21.3	30.4	58.9	23.0	23.7	27.4	314.3	79.9	26.3	59.2	3.9	58.3	49.3	54.6	49.4	60.9	55.1	57.9	50.9	51.5	57.4	45.8	53.6	48.8	175.4	89.8	77.0	26.1	38.1	28.7	111.5	44.9	80.2	14.7	72.1	73.4	90.6	62.9	59.2	84.6	6.2	82.2	57.7	103.2	123.3	77.6	60.2	73.9	50.1	141.6	68.8	41.7	41.3	85.9	70.7	67.6	55.5	75.2	143.3	41.4	154.9	59.7	130.6	20.2	40.2	66.6	57.0	61.3	84.9	144.1	61.8	89.4	71.2	28.1	99.2	64.7	68.0	27.2	22.7	65.7	112.0	38.0	60.4	69.5	89.0	172.1	80.7	18.1	52.6	58.1	65.9	80.2	26.7	63.7	26.9	61.6	51.2	29.1	83.2	99.4
FLOT2	"ECS-1, ECS1, ESA, ESA1, M17S1"	ENSG00000132589	"Flotillin 2"	Q14254	17	28879335-28897733	"Plasma proteins, Predicted intracellular proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001396, CAB004395, HPA071038"	Supported		Supported	"Vesicles,Plasma membrane"		NA	NA		170000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Plasma membrane"	Vesicles	"CAB004395: AB_627618, HPA001396: AB_1078894, HPA071038: "	"unprognostic (6.04e-2)"	"unprognostic (8.76e-3)"	"unprognostic (3.01e-1)"	"unprognostic (8.92e-2)"	"unprognostic (4.15e-3)"	"unprognostic (2.17e-2)"	"unprognostic (4.36e-3)"	"unprognostic (2.12e-1)"	"unprognostic (5.21e-2)"	"unprognostic (1.20e-1)"	"unprognostic (9.98e-2)"	"unprognostic (2.80e-1)"	"unprognostic (4.12e-3)"	"unprognostic (2.64e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.11e-3)"	"unprognostic (2.20e-2)"	60.2	46.4	38.4	56.8	38.6	97.1	56.2	28.1	47.6	42.8	45.2	58.9	21.0	39.1	21.2	69.3	46.8	27.0	63.5	41.1	42.5	71.4	98.4	59.5	68.2	45.9	37.1	37.7	38.8	30.0	22.3	58.4	41.3	67.8	27.2	20.3	61.7	51.6	51.6	38.2	53.0	35.3	37.5	122.7	44.6	10.4	47.1	47.8	39.6	44.1	63.6	78.8	49.6	36.1	55.5	90.8	69.6	60.2	33.6	44.2	76.6	42.5	57.9	60.9	71.3	96.0	45.7	76.9	79.3	47.6	42.0	63.3	76.5	69.7	25.9	245.5	91.4	92.7	80.5	70.3	43.6	76.8	15.2	53.3	53.6	49.3	66.9	64.1	97.4	21.8	89.0	65.6	28.9	83.5	21.2	54.0	61.4	48.6	24.6	32.6	70.6	189.3	92.0	166.9	61.9	103.3	99.8	69.6	77.5	66.7	72.3	136.3	81.5	21.4	38.2	35.2	65.0	36.5	68.2	39.5	59.9	72.3	40.7	171.9	106.0	213.2	98.8	96.6	72.6	98.5	74.6	84.5	144.3	118.1	55.3	69.0	415.2	78.5	110.2	38.8	97.6	143.2	38.4	38.6	28.1	47.6	41.1	42.5	45.9	37.1	41.3	37.5	47.1	36.1	34.2	22.4	21.9	12.7	46.8	12.6	27.1	20.6	29.6	6.9	24.9	30.1	32.9	22.8	16.5	20.2	10.4	96.6	20.5	29.0	15.6	39.3	13.0	25.8	13.2	37.0	25.8	49.2	17.0	31.1	68.9	14.8	23.0	27.6	6.3	15.6	48.9	45.1	44.4	5.0	19.2	25.9	10.2	43.3	22.6	42.3	10.8	31.1	8.8	22.5	75.2	10.7	35.0	16.1	11.0	32.2	16.5	8.6	27.8	14.8	14.8	26.7	19.1	12.4	19.7	7.1	13.4	1.6	6.9	42.4	9.2	37.1	32.5	4.2	32.0	26.7
FLRT3		ENSG00000125848	"Fibronectin leucine rich transmembrane protein 3"	Q9NZU0	20	14322985-14337614	"Disease related genes, Human disease related genes, Predicted membrane proteins"	"Cell adhesion"	"Developmental protein"	"Disease variant, Hypogonadotropic hypogonadism, Kallmann syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 23.2"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 218.0;Alveolar cells type 2: 156.5;Basal prostatic cells: 168.3;Club cells: 73.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 27.5;hTCEpi: 51.3;RPTEC TERT1: 17.3;WM-115: 62.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA056033	Enhanced		Supported	"Plasma membrane,Cell Junctions,Cytosol"	"Intracellular and membrane"	NA	NA		1100000		"Cluster 7: Kidney - Transmembrane transport"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 11: Alveolar cells - Smell perception"	"Plasma membrane"	"Cell Junctions, Cytosol"	"HPA056033: AB_2683016"	"unprognostic (2.14e-1)"	"unprognostic (2.57e-1)"	"unprognostic (2.98e-1)"	"unprognostic (1.14e-3)"	"unprognostic (2.30e-1)"	"unprognostic (6.00e-2)"	"unprognostic (1.63e-1)"	"prognostic unfavorable (9.85e-5)"	"unprognostic (1.24e-1)"	"unprognostic (1.81e-1)"	"prognostic unfavorable (1.54e-4)"	"unprognostic (3.05e-1)"	"prognostic favorable (1.49e-7)"	"unprognostic (1.54e-2)"	"unprognostic (2.48e-1)"	"unprognostic (3.07e-3)"	"unprognostic (3.65e-1)"	5.0	3.7	2.3	0.8	3.0	0.0	2.3	6.4	5.3	3.2	0.9	1.6	11.8	2.3	3.1	1.6	2.4	5.0	0.6	5.3	1.3	23.2	7.0	17.7	0.1	0.0	1.3	10.6	1.2	8.2	1.0	1.8	0.8	8.2	0.8	1.6	1.2	14.0	2.0	6.3	2.3	1.4	0.6	0.7	9.7	1.2	2.3	7.3	5.2	0.7	0.3	7.9	2.1	1.8	0.0	12.2	27.5	0.0	0.0	0.0	0.0	2.7	0.8	0.1	0.0	15.3	5.6	0.0	0.9	0.6	0.0	8.0	0.0	8.3	0.1	0.0	1.8	0.0	0.4	0.3	2.4	0.0	0.0	4.6	51.3	0.0	9.7	0.0	0.1	0.2	0.0	0.2	5.3	0.4	3.7	0.0	8.9	6.2	0.1	0.1	0.2	0.0	17.3	3.6	0.5	5.7	0.0	0.0	9.2	15.5	0.5	0.0	0.0	0.0	1.8	0.1	0.7	0.0	0.0	0.0	0.2	0.0	62.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	3.0	6.4	5.3	5.3	1.3	0.0	1.3	0.8	0.6	2.3	1.8	0.3	218.0	156.5	2.3	0.5	8.7	168.3	26.1	55.8	23.9	4.4	6.5	1.2	24.3	73.1	22.0	6.2	0.5	0.0	2.2	13.7	23.6	0.2	0.7	1.7	1.9	11.3	0.0	27.2	14.9	0.0	8.7	37.8	0.7	5.1	5.0	2.9	8.5	0.2	6.7	39.3	2.5	2.0	0.3	0.7	0.5	3.7	1.3	5.4	1.9	1.6	0.6	0.0	26.2	3.9	10.0	3.0	0.4	0.1	24.9	3.5	49.2	13.4	3.3	0.0	25.0	1.8	0.0	0.1	5.9	16.6	0.0	0.8	1.4	1.5	18.3
FLT1	"FLT, VEGFR1"	ENSG00000102755	"Fms related receptor tyrosine kinase 1"	P17948	13	28300346-28495145	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins"	"Angiogenesis, Chemotaxis, Differentiation"	"Developmental protein, Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	7	"placenta: 432.4"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 411.6;Endothelial cells: 263.1;Extravillous trophoblasts: 815.4;Hepatic stellate cells: 234.9;Microglial cells: 433.8;Syncytiotrophoblasts: 1127.1"	"Cancer enhanced"	"Detected in all"		"renal cancer: 28.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ: 71.8;BJ hTERT+: 57.2;HMC-1: 349.2;HUVEC TERT2: 64.9;WM-115: 127.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011740, HPA014290, CAB068189, CAB068190"	Enhanced		Supported	"Plasma membrane,Actin filaments"	"Secreted to blood"	NA	NA	876000	87000	"Cluster 21: B-cells - Adaptive immune response"	"Cluster 28: Placenta - Pregnancy"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	"Plasma membrane"	"Actin filaments"	"CAB068189: AB_2665636, CAB068190: AB_2665637, HPA011740: AB_1858737, HPA014290: AB_1858738"	"unprognostic (3.33e-2)"	"unprognostic (3.52e-3)"	"unprognostic (1.13e-3)"	"unprognostic (5.02e-2)"	"unprognostic (3.65e-1)"	"unprognostic (5.03e-2)"	"unprognostic (8.25e-2)"	"unprognostic (2.27e-3)"	"unprognostic (9.91e-2)"	"unprognostic (6.61e-2)"	"unprognostic (2.33e-1)"	"unprognostic (1.57e-1)"	"prognostic unfavorable (2.19e-4)"	"unprognostic (4.20e-2)"	"unprognostic (6.00e-2)"	"unprognostic (1.57e-1)"	"unprognostic (6.32e-2)"	47.6	9.6	37.6	9.1	36.2	1.1	31.2	37.0	43.0	16.4	24.6	9.4	7.5	17.2	3.7	5.9	11.7	16.6	46.0	33.3	39.8	34.9	18.2	25.8	5.3	44.6	40.0	4.4	12.7	30.5	9.0	432.4	50.1	13.9	6.1	52.5	7.0	11.0	19.9	5.9	9.3	17.4	33.4	18.6	10.9	17.4	59.6	3.6	48.9	38.8	5.7	14.0	9.5	38.7	0.1	0.0	0.0	0.6	0.6	0.9	0.3	71.8	57.2	25.8	14.9	0.0	0.2	0.1	0.1	9.6	0.0	0.3	6.7	0.0	45.4	0.0	2.0	0.2	0.1	0.0	0.1	0.0	349.2	0.6	0.0	0.1	1.0	0.1	64.9	6.1	1.7	0.3	0.0	0.3	4.5	3.7	37.5	0.0	0.1	2.9	0.0	0.1	0.1	0.1	8.1	0.6	0.0	0.1	0.2	44.4	0.3	0.2	6.3	0.2	1.2	0.1	0.1	2.1	1.0	0.2	0.4	0.3	127.8	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.8	0.1	0.1	0.5	0.0	0.0	0.1	0.0	0.0	37.6	36.2	37.0	43.0	33.3	39.8	44.6	40.0	50.1	33.4	59.6	38.7	411.6	0.0	6.0	2.0	4.7	4.1	0.7	0.2	3.4	17.8	1.2	1.5	26.5	2.8	2.9	0.0	4.2	197.2	1.4	0.1	1.9	0.6	157.2	0.5	1.5	263.1	0.0	0.0	0.9	0.0	815.4	32.1	0.5	2.1	1.3	0.1	234.9	6.9	30.8	1.7	14.5	0.0	0.0	12.5	23.6	173.8	18.6	15.3	0.0	433.8	0.0	153.2	0.0	9.5	2.0	0.0	0.0	48.5	4.1	1.3	0.0	0.1	1.8	9.7	92.1	11.4	30.1	14.6	4.6	1.0	4.8	1127.1	2.8	1.5	0.0	1.1
FLT4	"PCL, VEGFR-3, VEGFR3"	ENSG00000037280	"Fms related receptor tyrosine kinase 4"	P35916	5	180601506-180649624	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins"	Angiogenesis	"Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in some"	7	"Adipocytes: 27.4;Endothelial cells: 27.1;Extravillous trophoblasts: 37.1;Hepatic stellate cells: 64.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	4	"MAIT T-cell: 3.8"	"Lineage enriched"	"Detected in single"	31	"T-cells: 3.8"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 10.1;BEWO: 12.4;HEK 293: 15.6;HL-60: 9.5;HUVEC TERT2: 9.9;JURKAT: 12.3;T-47d: 14.6;TIME: 15.7"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"CAB000099, HPA046519, HPA067906, HPA074389"	Approved		Supported	"Nuclear speckles,Plasma membrane,Cell Junctions"	"Secreted to blood"	NA	NA	20000000	290000000	"Cluster 16: MAIT-cells - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 6: T47d - Mammary gland"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Nuclear speckles, Plasma membrane"	"Cell Junctions"	"CAB000099: , HPA046519: AB_2732527, HPA067906: AB_2732775, HPA074389: "	"unprognostic (7.35e-2)"	"unprognostic (1.63e-1)"	"unprognostic (9.45e-3)"	"unprognostic (3.81e-1)"	"unprognostic (9.26e-2)"	"unprognostic (3.20e-3)"	"unprognostic (1.13e-2)"	"unprognostic (1.80e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.70e-1)"	"unprognostic (2.13e-2)"	"unprognostic (3.69e-1)"	"unprognostic (1.88e-2)"	"unprognostic (9.41e-3)"	"unprognostic (1.83e-1)"	"unprognostic (8.26e-2)"	"unprognostic (1.32e-1)"	17.2	11.3	3.5	4.7	4.6	0.8	14.7	2.6	3.4	9.0	2.6	4.9	2.8	8.0	3.0	4.4	9.8	3.8	9.7	5.1	2.6	20.1	6.2	16.9	5.5	3.4	3.0	4.5	2.0	2.3	7.8	6.4	3.6	5.6	1.3	0.3	2.0	2.5	4.7	4.0	7.2	4.1	2.8	17.6	3.5	3.1	4.2	1.0	25.7	4.1	1.4	5.6	5.5	2.7	0.1	2.5	3.2	10.1	0.0	0.0	12.4	0.3	0.1	0.0	0.0	0.4	0.3	0.3	0.9	0.1	0.6	0.4	3.4	0.2	0.3	0.1	15.6	1.2	0.5	0.5	0.1	9.5	0.3	0.2	0.1	0.2	0.4	0.3	9.9	12.3	0.4	0.4	2.1	5.6	0.1	0.5	7.0	0.3	0.6	8.2	0.1	0.1	0.1	0.3	0.3	1.1	0.1	0.2	0.1	3.1	14.6	0.3	15.7	0.2	6.9	0.2	0.1	0.2	0.1	0.1	0.1	0.2	0.1	0.1	0.0	0.0	0.5	0.0	3.8	0.0	0.2	0.8	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	3.5	4.6	2.6	3.4	5.1	2.6	3.4	3.0	3.6	2.8	4.2	2.7	27.4	0.0	1.7	0.7	0.7	0.9	0.2	0.0	1.2	0.2	1.4	1.4	4.5	0.0	0.6	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.4	0.1	0.1	27.1	0.0	0.0	0.2	0.0	37.1	0.8	0.0	0.1	2.5	2.4	64.6	0.6	1.2	0.0	0.1	0.0	0.0	3.3	0.8	0.7	0.3	0.6	0.0	3.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.8	0.0	0.2	0.0	0.7	0.7	0.1	5.2	0.1	1.1	1.0	1.8	0.2	0.0	0.1
FMN1	"DKFZP686C2281, FLJ45135, FMN, LD, MGC125288, MGC125289"	ENSG00000248905	"Formin 1"	Q68DA7	15	32765544-33194714	"Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 16.9;retina: 30.0"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 117.0;Cone photoreceptor cells: 221.0;Excitatory neurons: 439.4;Inhibitory neurons: 340.0"	"Cancer enriched"	"Detected in many"	9	"melanoma: 14.5"	"Region enriched"	"Detected in some"	7	"cerebral cortex: 16.9"	"Immune cell enhanced"	"Detected in single"		"basophil: 1.3"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 21.4;RH-30: 26.9;SK-MEL-30: 28.7;T-47d: 24.8;U-138 MG: 17.2;U-2197: 17.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005465, HPA046786"	Supported		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 77: Retina - Visual perception"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm	Cytosol	"HPA005465: AB_1859515, HPA046786: AB_10963545"	"unprognostic (1.57e-1)"	"unprognostic (5.92e-3)"	"unprognostic (1.96e-1)"	"unprognostic (2.10e-3)"	"unprognostic (3.67e-2)"	"unprognostic (3.00e-2)"	"unprognostic (1.56e-2)"	"unprognostic (2.84e-2)"	"unprognostic (3.44e-1)"	"unprognostic (3.31e-2)"	"unprognostic (7.41e-3)"	"unprognostic (3.53e-1)"	"unprognostic (4.89e-2)"	"unprognostic (2.89e-2)"	"unprognostic (3.73e-1)"	"unprognostic (4.32e-1)"	"unprognostic (7.61e-2)"	1.8	0.8	0.0	2.4	0.0	1.2	3.0	0.0	16.9	5.3	0.0	5.7	1.3	1.0	0.7	2.0	3.1	2.4	0.9	0.0	0.0	2.8	0.5	3.4	0.9	2.3	0.0	0.2	1.2	1.4	3.7	3.7	0.0	1.8	4.4	30.0	4.2	1.2	0.7	4.2	1.8	2.2	0.0	1.0	7.9	10.2	1.7	3.8	2.5	0.5	0.6	1.3	3.6	0.0	3.8	4.0	0.8	0.4	0.1	0.4	4.9	5.4	4.1	1.5	4.0	0.6	5.0	0.6	1.8	6.1	3.4	3.7	0.1	3.7	3.9	0.0	0.2	3.1	0.8	0.4	0.2	0.0	0.2	1.5	0.2	7.9	0.1	3.1	0.0	0.1	0.0	21.4	8.8	3.9	0.1	0.0	1.1	7.0	0.3	0.6	26.9	4.9	1.8	1.5	0.3	0.9	0.0	3.3	28.7	0.9	24.8	0.0	4.9	17.2	2.7	17.9	1.6	0.0	0.0	0.9	7.3	0.2	10.1	1.3	0.2	0.0	0.1	0.0	0.2	0.0	0.2	0.2	0.5	0.2	0.1	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	16.9	0.0	0.0	2.3	0.0	0.0	0.0	1.7	0.0	0.4	41.7	46.9	10.1	1.6	3.7	3.2	2.0	3.4	117.0	7.7	5.1	3.1	14.3	17.3	0.0	221.0	12.0	5.4	13.3	11.7	5.7	16.5	17.4	2.4	2.7	9.0	0.4	439.4	1.8	5.9	2.6	97.9	7.0	24.0	1.8	0.0	0.4	10.9	47.1	340.0	16.8	16.2	28.0	3.9	12.8	0.9	29.6	33.8	64.6	5.8	6.9	0.0	8.0	61.9	11.4	11.4	0.7	2.2	4.5	4.0	1.6	29.4	102.4	0.0	13.0	1.0	18.4	16.0	7.3	3.4	18.3	5.0	0.1	9.9	5.7
FMNL3	"DKFZp762B245, MGC45819, WBP3"	ENSG00000161791	"Formin like 3"	Q8IVF7	12	49636499-49708165	"Predicted intracellular proteins"	Angiogenesis	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 35.8;Cone photoreceptor cells: 39.6;dendritic cells: 48.6;Microglial cells: 119.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"plasmacytoid DC: 5.1"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"TIME: 47.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002552, HPA023201"	Uncertain		Supported	"Golgi apparatus,Vesicles,Plasma membrane,Cytosol"		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Golgi apparatus, Vesicles, Plasma membrane"	Cytosol	"HPA002552: AB_1078862, HPA023201: AB_1848575"	"unprognostic (2.97e-1)"	"unprognostic (2.77e-3)"	"unprognostic (4.97e-3)"	"unprognostic (7.19e-2)"	"unprognostic (5.42e-2)"	"unprognostic (2.33e-3)"	"unprognostic (5.37e-3)"	"unprognostic (1.52e-2)"	"unprognostic (2.83e-1)"	"unprognostic (1.54e-1)"	"unprognostic (6.67e-2)"	"unprognostic (2.79e-1)"	"prognostic unfavorable (3.58e-5)"	"unprognostic (1.04e-1)"	"unprognostic (2.31e-1)"	"unprognostic (2.03e-1)"	"unprognostic (2.69e-2)"	12.2	5.7	13.7	20.5	13.2	5.2	10.6	13.0	11.2	9.6	3.0	8.0	5.7	11.2	19.2	4.5	6.9	11.1	12.6	11.0	12.6	9.3	2.7	17.4	23.5	21.7	14.6	16.1	3.2	3.6	4.1	14.0	18.2	6.0	5.6	2.7	4.6	4.4	5.6	4.4	10.2	11.5	17.7	13.4	6.6	10.1	20.4	20.1	13.4	6.7	28.3	8.6	6.3	20.4	8.6	2.5	18.4	6.1	5.0	20.1	0.2	10.4	21.0	13.8	12.1	9.7	2.3	18.2	19.5	12.4	15.2	0.4	9.5	4.3	12.6	16.2	3.6	20.1	2.9	0.5	8.8	4.0	25.1	12.7	0.7	21.7	9.1	41.2	37.1	9.0	4.6	13.0	20.5	6.3	16.6	6.0	6.0	0.9	5.5	7.9	23.0	2.8	13.1	1.3	3.0	8.6	6.0	0.8	11.8	9.3	1.5	5.9	47.2	34.2	11.8	0.6	18.2	6.7	0.4	9.8	21.3	12.4	14.7	3.0	0.1	0.8	0.8	0.4	0.4	0.2	0.3	0.5	0.2	1.1	0.4	0.5	0.0	0.6	0.3	5.1	0.1	0.5	13.7	13.2	13.0	11.2	11.0	12.6	21.7	14.6	18.2	17.7	20.4	20.4	35.8	3.2	3.4	6.8	17.5	1.7	0.7	0.4	2.2	11.3	1.3	2.3	3.3	0.0	1.4	1.8	39.6	2.1	48.6	0.1	0.0	0.3	2.0	0.7	2.6	29.7	0.0	1.7	16.0	0.6	0.8	7.1	1.5	2.0	27.8	5.4	15.7	0.8	11.1	3.3	6.5	0.8	0.0	6.9	9.0	4.6	3.7	17.7	5.4	119.0	22.9	0.5	16.5	27.6	5.5	0.8	0.1	6.4	1.8	0.8	0.0	0.2	0.2	2.0	13.1	15.5	10.3	5.9	7.5	0.4	1.4	2.5	13.6	2.6	0.1	0.4
FMO5		ENSG00000131781	"Flavin containing dimethylaniline monoxygenase 5"	P49326	1	147175351-147243050	"Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Monooxygenase, Oxidoreductase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"liver: 683.3"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 64.2;Cholangiocytes: 133.0;Hepatocytes: 265.4;Proximal enterocytes: 108.8;Proximal tubular cells: 69.2"	"Cancer enriched"	"Detected in many"	7	"liver cancer: 43.0"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in some"	4	"Hep G2: 41.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA012373	Enhanced		Supported	"Endoplasmic reticulum,Cytosol"		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 85: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 2: Hepatocytes - Metabolism"	"Endoplasmic reticulum, Cytosol"		"HPA012373: AB_1848975"	"unprognostic (2.70e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.06e-2)"	"unprognostic (1.39e-1)"	"unprognostic (3.96e-2)"	"unprognostic (2.43e-2)"	"unprognostic (2.94e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.85e-2)"	"unprognostic (2.93e-1)"	"unprognostic (1.13e-1)"	"prognostic favorable (1.34e-6)"	"unprognostic (3.77e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.85e-1)"	"unprognostic (4.11e-2)"	3.1	5.7	2.0	5.1	2.9	2.0	46.1	3.9	2.8	7.8	0.5	41.3	71.3	2.8	6.9	1.2	3.6	15.8	3.1	2.1	2.4	51.5	683.3	27.1	4.0	4.2	2.9	4.1	48.1	68.3	6.7	2.4	4.8	9.7	46.6	0.9	32.7	4.0	0.8	11.6	73.9	3.5	3.2	4.0	120.1	5.2	3.1	1.1	2.0	1.4	2.5	3.9	1.5	5.6	0.1	1.1	0.6	0.1	2.8	0.8	0.9	0.7	0.5	0.3	0.8	0.7	2.4	0.4	0.8	0.8	0.2	0.4	0.0	0.0	0.0	1.4	0.2	1.6	0.1	41.7	0.9	1.4	9.0	1.3	0.2	0.4	0.0	0.4	0.6	0.2	0.1	0.1	1.5	1.4	0.2	0.7	2.8	5.3	0.8	0.4	0.5	0.4	3.4	0.6	0.5	0.3	0.9	2.8	1.3	1.3	2.1	10.4	1.1	0.0	0.3	0.9	0.0	0.3	0.0	0.3	1.1	0.5	0.3	7.0	12.9	4.1	2.0	5.9	0.3	4.7	0.5	0.6	5.4	8.5	0.3	1.3	1.3	1.2	1.8	2.5	1.6	3.9	2.0	2.9	3.9	2.8	2.1	2.4	4.2	2.9	4.8	3.2	3.1	5.6	2.8	9.6	64.2	11.1	6.4	1.7	3.9	0.9	1.8	2.0	17.5	6.7	1.9	133.0	10.4	14.7	0.0	1.5	1.7	60.8	7.9	7.5	7.7	2.5	1.8	2.7	6.7	4.8	8.2	5.9	1.1	2.9	24.5	6.1	5.7	9.8	5.0	265.4	4.0	3.3	6.4	34.4	4.1	10.0	2.3	4.5	2.8	4.6	28.4	10.3	5.3	0.2	4.1	10.1	17.5	7.0	29.0	1.5	0.4	5.6	108.8	69.2	18.1	1.3	0.0	2.2	1.0	5.9	0.9	1.3	1.6	1.4	2.6	6.6	20.7	6.4
FNBP1	"FBP17, KIAA0554"	ENSG00000187239	"Formin binding protein 1"	Q96RU3	9	129887187-130043194	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	Endocytosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 317.7;Langerhans cells: 402.9;monocytes: 433.2;Oligodendrocytes: 522.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HDLM-2: 137.7;JURKAT: 143.2;MOLT-4: 140.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019635, HPA019691, HPA022119, HPA067742"	Enhanced		Supported	"Vesicles,Plasma membrane"		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 41: Macrophages - Immune response"	"Plasma membrane"	Vesicles	"HPA019635: AB_2732423, HPA019691: AB_2670231, HPA022119: AB_2670897, HPA067742: "	"unprognostic (2.86e-1)"	"unprognostic (2.59e-3)"	"unprognostic (1.22e-2)"	"unprognostic (2.10e-1)"	"unprognostic (3.20e-1)"	"unprognostic (1.43e-2)"	"unprognostic (6.30e-3)"	"unprognostic (9.10e-2)"	"unprognostic (2.90e-1)"	"unprognostic (6.17e-2)"	"unprognostic (9.26e-2)"	"unprognostic (2.65e-1)"	"prognostic unfavorable (8.45e-5)"	"unprognostic (6.84e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.10e-1)"	"unprognostic (1.21e-1)"	21.8	11.9	51.2	57.8	73.7	40.6	16.4	77.4	53.4	32.5	22.2	107.3	15.0	50.0	17.0	39.4	34.8	27.8	15.1	47.0	62.5	16.4	18.4	25.4	78.1	67.6	69.1	22.1	8.1	10.7	17.7	16.3	65.8	41.4	29.6	12.6	16.3	44.1	24.1	25.9	37.6	46.8	55.9	60.9	29.6	17.3	69.9	111.0	33.4	13.2	74.3	68.4	26.8	86.6	42.5	19.3	34.9	40.8	21.0	25.8	29.5	23.7	20.2	17.6	14.7	20.3	16.2	82.9	20.4	44.5	20.8	20.7	33.0	21.6	17.6	137.7	9.8	22.8	22.8	13.8	35.8	62.3	75.1	18.7	9.3	32.6	19.5	25.6	26.1	143.2	5.4	1.1	16.4	34.0	140.1	60.8	27.5	5.7	32.6	31.9	28.3	24.1	22.1	23.0	5.5	17.6	43.3	42.9	16.5	33.3	30.0	28.3	31.9	16.6	20.7	30.5	15.0	16.4	64.4	3.8	20.0	42.2	25.2	13.2	5.1	9.6	10.8	5.6	9.3	12.7	9.7	10.3	5.8	7.7	8.9	8.6	9.3	6.0	6.5	6.9	10.9	4.5	51.2	73.7	77.4	53.4	47.0	62.5	67.6	69.1	65.8	55.9	69.9	86.6	27.2	35.3	25.2	317.7	180.4	33.1	21.3	12.8	21.6	20.2	42.5	24.6	14.8	15.7	29.8	22.0	52.1	18.6	217.2	28.3	19.6	22.6	1.7	46.2	38.8	38.3	18.1	31.3	65.6	17.3	24.5	38.8	26.5	78.7	80.4	9.2	71.0	18.4	43.6	28.6	107.8	8.7	20.3	221.2	402.9	5.5	46.6	131.1	76.5	95.5	433.2	42.8	223.5	69.4	522.1	21.8	19.8	51.6	147.9	67.8	0.2	15.0	42.3	29.5	59.2	19.9	41.0	26.5	45.4	26.7	41.1	63.9	233.7	7.1	16.2	42.3
FNBP1L	"C1orf39, FLJ20275, TOCA1"	ENSG00000137942	"Formin binding protein 1 like"	Q5T0N5	1	93448118-93554661	"Predicted intracellular proteins"	"Autophagy, Endocytosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	5	"basophil: 7.3"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 7.3"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA065273	Approved		Supported	Cytosol		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 12: NES - Nervous system development"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Cytosol		"HPA065273: AB_2685452"	"unprognostic (1.83e-1)"	"unprognostic (4.28e-2)"	"unprognostic (2.57e-3)"	"unprognostic (8.46e-2)"	"unprognostic (7.68e-2)"	"unprognostic (8.65e-2)"	"prognostic unfavorable (8.92e-4)"	"unprognostic (5.89e-2)"	"unprognostic (1.74e-1)"	"unprognostic (6.35e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.37e-1)"	"prognostic favorable (4.72e-7)"	"unprognostic (3.59e-2)"	"unprognostic (5.64e-2)"	"unprognostic (2.74e-2)"	"unprognostic (1.78e-1)"	28.3	7.8	13.6	5.4	25.8	2.1	33.0	13.6	13.8	18.0	13.8	17.3	20.6	16.8	18.6	8.9	13.4	14.5	20.0	12.0	15.4	36.1	13.3	16.8	3.1	14.6	19.1	13.9	17.3	20.8	10.5	17.2	14.2	15.6	17.5	12.4	43.1	11.5	17.4	12.7	20.2	12.3	15.9	2.8	23.7	15.0	14.4	6.5	31.8	21.4	4.0	14.9	13.2	12.7	29.7	16.2	83.4	46.8	17.6	12.4	92.8	14.6	9.9	10.8	15.0	19.9	9.2	0.1	29.4	14.3	29.0	14.9	20.3	16.7	15.4	18.5	15.2	15.8	23.5	29.9	8.8	2.8	0.3	23.0	27.2	10.2	14.8	28.2	52.1	18.1	6.2	0.1	25.8	13.8	11.6	1.2	63.7	50.5	16.4	24.4	63.7	7.8	47.5	44.6	32.6	47.0	45.4	88.0	25.8	97.3	33.5	4.0	52.1	25.2	31.7	0.6	10.2	9.1	7.5	0.2	2.5	0.4	17.5	7.3	0.1	0.7	0.0	0.0	0.0	0.3	0.3	0.0	0.3	0.4	0.0	0.2	0.0	0.0	0.0	1.5	0.2	0.1	13.6	25.8	13.6	13.8	12.0	15.4	14.6	19.1	14.2	15.9	14.4	12.7	130.0	109.0	42.1	48.0	4.3	26.5	61.5	27.5	18.2	13.3	62.9	59.1	42.6	40.0	60.9	62.5	4.2	37.6	2.2	35.4	56.7	77.9	12.1	61.1	30.0	49.8	67.0	36.6	41.0	48.4	35.7	20.5	50.0	91.7	16.4	19.6	25.0	21.0	11.8	69.0	110.8	33.0	14.2	4.7	22.7	19.7	8.1	10.6	39.2	80.6	7.1	18.8	0.0	55.3	4.2	55.8	34.5	3.8	1.0	56.0	43.6	50.8	53.8	10.0	26.3	5.9	49.9	23.4	37.2	22.0	25.7	17.1	4.1	10.2	38.4	75.6
FNIP2	"FNIPL, KIAA1450, MAPO1"	ENSG00000052795	"Folliculin interacting protein 2"	Q9P278	4	158769026-158908050	"Predicted intracellular proteins"	"DNA damage"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Langerhans cells: 288.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"intermediate monocyte: 3.3;myeloid DC: 2.1;non-classical monocyte: 7.2"	"Group enriched"	"Detected in many"	7	"dendritic cells: 2.1;monocytes: 7.2"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 179.0;U-266/70: 57.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042779, HPA052758, HPA072420"	Approved		Supported	"Centriolar satellite,Cytosol"		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 41: Macrophages - Immune response"	Cytosol	"Centriolar satellite"	"HPA042779: AB_10794386, HPA052758: , HPA072420: AB_2732200"	"unprognostic (3.38e-2)"	"unprognostic (2.26e-1)"	"unprognostic (2.06e-2)"	"unprognostic (4.02e-1)"	"unprognostic (1.46e-1)"	"unprognostic (3.56e-1)"	"unprognostic (1.56e-1)"	"unprognostic (2.18e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.80e-1)"	"unprognostic (7.93e-2)"	"unprognostic (1.77e-1)"	"prognostic favorable (3.96e-11)"	"unprognostic (1.84e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.67e-1)"	"unprognostic (7.10e-2)"	26.3	7.7	6.7	10.1	13.2	8.9	12.1	6.5	12.8	12.7	4.4	21.8	7.4	11.1	9.3	14.5	8.0	20.4	25.3	12.3	8.3	47.8	58.3	24.9	7.7	10.3	10.1	10.7	19.4	15.9	3.2	30.1	8.8	10.8	22.3	8.8	13.9	11.3	11.4	10.1	9.3	17.9	7.3	13.3	22.8	10.0	22.5	7.2	18.5	20.0	5.5	13.6	5.2	18.6	4.0	4.5	19.2	10.1	14.1	8.9	21.0	8.6	9.1	8.7	9.8	5.3	4.0	0.2	2.1	31.2	10.7	3.7	18.4	8.9	10.5	179.0	6.6	18.7	2.5	7.3	8.8	7.9	36.0	6.5	7.3	5.9	7.7	12.8	9.9	9.8	11.4	0.8	14.6	1.3	18.4	1.0	6.1	12.7	4.6	10.8	9.5	5.1	7.0	10.2	12.3	10.9	4.7	3.2	19.5	6.1	4.0	4.3	12.5	14.0	8.7	9.6	6.5	57.3	26.0	3.8	13.9	9.5	10.0	0.4	0.7	0.2	0.5	3.3	0.3	0.0	0.3	0.2	2.1	0.0	0.2	0.6	0.1	0.6	7.2	0.4	0.1	0.4	6.7	13.2	6.5	12.8	12.3	8.3	10.3	10.1	8.8	7.3	22.5	18.6	93.7	19.2	129.2	20.9	6.5	35.6	30.9	7.2	14.2	17.7	18.4	16.4	55.4	58.6	23.2	40.5	54.2	13.1	17.8	80.9	23.5	38.5	17.6	51.6	13.8	78.1	62.4	25.4	109.0	79.9	7.4	35.1	30.1	82.0	27.9	15.7	95.3	114.7	65.4	10.1	95.5	44.9	8.2	90.6	288.0	9.9	13.4	101.5	40.9	64.6	28.4	4.9	11.3	56.8	151.8	80.5	77.2	9.8	5.4	55.7	11.1	72.9	15.3	27.9	52.6	72.3	34.0	25.8	22.8	13.6	36.8	8.2	13.0	10.4	46.8	41.2
FOS	"AP-1, c-fos"	ENSG00000170345	"Fos proto-oncogene, AP-1 transcription factor subunit"	P01100	14	75278826-75282230	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"		DNA-binding	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	6	"neutrophil: 504.8"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 504.8"	"Cell line enhanced"	"Detected in many"		"hTCEpi: 453.1;OE19: 170.9"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"cerebellum: 80.9;spinal cord: 235.3"	HPA018531	Approved		Supported	Nucleoplasm		Yes	No			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 50: Fibroblasts - ECM organization"	Nucleoplasm		"HPA018531: AB_1846576"	"unprognostic (1.18e-2)"	"unprognostic (8.70e-2)"	"unprognostic (1.61e-1)"	"unprognostic (3.80e-1)"	"unprognostic (3.08e-2)"	"unprognostic (4.82e-2)"	"unprognostic (2.09e-1)"	"unprognostic (3.30e-1)"	"unprognostic (9.55e-3)"	"unprognostic (4.20e-3)"	"unprognostic (1.04e-1)"	"prognostic favorable (7.81e-4)"	"unprognostic (3.20e-2)"	"unprognostic (1.52e-2)"	"unprognostic (3.22e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.66e-2)"	1136.1	735.7	62.9	576.0	87.2	2270.6	477.4	184.8	113.1	700.5	111.5	479.5	235.3	410.4	58.4	1250.8	1777.3	1160.0	513.1	58.9	190.7	266.1	308.8	486.9	449.9	145.1	84.0	1188.7	298.4	264.7	452.3	417.4	92.0	791.1	627.4	233.3	555.6	462.3	99.1	1645.4	584.5	964.3	100.6	178.0	525.6	87.2	104.4	424.2	1007.6	1014.2	26.8	946.5	346.6	121.7	2.2	1.4	7.1	10.4	59.9	18.3	42.1	6.4	2.4	4.5	3.2	4.4	12.6	0.6	1.8	43.5	42.6	3.0	3.6	74.7	1.1	1.2	1.1	1.0	21.9	1.9	27.6	2.6	42.8	44.3	453.1	3.9	27.4	6.2	2.7	9.2	2.0	19.7	1.2	26.1	0.9	12.9	7.4	170.9	2.5	2.0	1.4	23.8	18.8	20.4	52.4	3.6	9.8	85.9	39.8	21.8	1.4	9.2	6.3	0.4	5.7	3.7	2.0	52.4	61.2	9.6	2.9	8.0	5.7	38.3	81.0	89.5	0.3	20.1	0.4	0.3	0.2	0.7	69.6	0.2	0.2	0.1	504.8	4.6	2.5	1.5	0.4	27.7	62.9	87.2	184.8	113.1	58.9	190.7	145.1	84.0	92.0	100.6	104.4	121.7	3911.0	1102.6	1859.4	137.1	1015.9	859.7	1644.7	1577.5	4336.7	106.1	3184.1	2874.6	1027.6	1416.9	752.7	191.3	129.3	1506.7	1323.5	1648.6	17.6	690.9	17.4	1834.4	3720.3	1624.0	1628.0	290.5	4.9	528.1	2694.6	4146.8	2049.5	3656.5	1630.6	751.3	1317.2	207.2	1693.8	35.3	3.0	1967.2	793.5	2600.2	1540.4	53.5	943.8	2910.7	855.6	58.1	269.5	1119.5	10.3	6.0	1.8	383.5	1507.8	178.3	1256.1	1115.7	1675.1	20.0	354.4	406.9	1209.6	3390.9	2705.7	10.0	10.5	2438.0	1092.4	2283.3	1497.0	417.4	1366.2	298.4
FOSB	"AP-1, DKFZp686C0818, G0S3, GOS3, GOSB, MGC42291"	ENSG00000125740	"FosB proto-oncogene, AP-1 transcription factor subunit"	P53539	19	45467995-45475179	"Predicted intracellular proteins, Transcription factors"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Breast glandular cells: 1627.1;Skeletal myocytes: 2234.0"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in many"		"cerebral cortex: 45.6"	"Immune cell enhanced"	"Detected in some"		"neutrophil: 4.5"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"GAMG: 11.4;HMC-1: 13.3;hTCEpi: 8.1;Karpas-707: 6.8;SK-BR-3: 9.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB010267, HPA054663"	Approved		Supported	Nucleoplasm,Vesicles		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm	Vesicles	"CAB010267: AB_640583, HPA054663: AB_2682562"	"unprognostic (7.22e-2)"	"unprognostic (9.74e-2)"	"unprognostic (2.91e-1)"	"unprognostic (3.04e-1)"	"unprognostic (1.08e-2)"	"unprognostic (2.50e-1)"	"unprognostic (1.30e-3)"	"unprognostic (9.43e-2)"	"unprognostic (2.04e-2)"	"unprognostic (2.99e-2)"	"unprognostic (2.50e-1)"	"unprognostic (1.40e-1)"	"unprognostic (3.51e-2)"	"unprognostic (4.99e-3)"	"unprognostic (8.72e-2)"	"unprognostic (4.45e-2)"	"unprognostic (4.04e-2)"	394.7	121.6	2.1	118.4	5.5	433.8	91.7	35.7	45.6	150.3	4.8	37.6	24.8	46.6	3.9	187.7	404.1	347.1	48.9	11.1	7.8	34.7	85.5	113.5	67.7	1.5	1.6	274.4	126.3	46.2	27.3	57.8	1.5	118.5	78.4	10.7	76.8	29.6	3.3	267.8	63.1	353.7	0.8	21.8	104.4	8.8	1.2	152.2	316.0	81.3	1.6	213.9	11.0	3.8	0.4	0.6	0.1	0.3	1.2	0.3	1.8	2.3	1.0	0.7	0.7	0.5	1.0	2.0	0.4	1.5	11.4	0.8	0.5	1.6	0.5	0.3	0.7	0.6	0.8	0.4	0.8	1.1	13.3	0.5	8.1	1.7	1.9	0.4	0.9	2.3	0.8	6.8	0.2	0.2	0.2	1.2	0.4	1.0	0.4	0.5	0.1	1.4	0.6	1.3	3.1	0.4	1.4	9.6	1.2	1.9	0.5	0.8	0.1	0.5	0.6	1.1	0.7	5.1	0.8	0.5	1.1	0.8	1.3	0.9	1.2	1.0	0.2	0.1	0.4	0.0	0.2	0.1	1.0	0.1	0.0	0.0	4.5	0.1	0.0	0.0	0.1	0.1	2.1	5.5	35.7	45.6	11.1	7.8	1.5	1.6	1.5	0.8	1.2	3.8	1048.7	685.9	761.3	2.6	445.7	380.5	533.4	162.4	865.6	50.6	1627.1	1523.2	177.8	370.3	174.4	11.0	135.5	237.5	359.6	551.1	1.9	145.5	10.1	667.9	1204.4	442.6	877.0	68.6	1.3	74.2	301.9	788.2	911.3	1541.3	830.4	239.3	393.7	77.9	210.3	8.4	0.3	898.4	42.7	345.2	353.4	11.3	240.2	797.3	172.5	1.0	16.3	186.1	1.0	0.0	0.3	111.6	457.3	59.5	503.4	307.3	417.8	2.7	111.5	217.6	302.4	2234.0	608.8	3.3	4.5	476.3	380.9	396.9	481.8	174.2	616.5	208.5
FOSL1	fra-1	ENSG00000175592	"FOS like 1, AP-1 transcription factor subunit"	P15407	11	65892049-65900573	"Cancer-related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Transcription factors"		DNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 56.4;urinary bladder: 84.3"	"Group enriched"	"Detected in many"	4	"Basal keratinocytes: 338.0;Basal prostatic cells: 398.5;Basal squamous epithelial cells: 281.1;Prostatic glandular cells: 196.9;Squamous epithelial cells: 210.4;Suprabasal keratinocytes: 339.5;Urothelial cells: 456.4"	"Cancer enhanced"	"Detected in all"		"head and neck cancer: 51.2"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	4	"myeloid DC: 3.4"	"Lineage enriched"	"Detected in single"	4	"dendritic cells: 3.4"	"Cell line enhanced"	"Detected in many"		"PC-3: 829.4;U-2197: 520.1;WM-115: 1123.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"CAB004396, HPA030728"	Enhanced		Supported	Nucleoplasm		NA	Yes			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 22: Epithelial cell types - Mixed function"	Nucleoplasm		"CAB004396: AB_627632, HPA030728: "	"unprognostic (2.88e-2)"	"unprognostic (1.56e-1)"	"unprognostic (9.46e-2)"	"unprognostic (1.33e-1)"	"prognostic unfavorable (1.80e-4)"	"prognostic unfavorable (2.05e-4)"	"unprognostic (2.70e-1)"	"prognostic unfavorable (1.95e-4)"	"unprognostic (1.12e-1)"	"unprognostic (2.11e-1)"	"prognostic unfavorable (9.26e-5)"	"unprognostic (7.85e-2)"	"prognostic unfavorable (6.40e-6)"	"unprognostic (2.23e-1)"	"unprognostic (1.53e-1)"	"unprognostic (2.28e-1)"	"unprognostic (2.82e-2)"	56.4	11.2	1.2	7.7	1.3	26.8	10.5	2.2	4.3	6.0	1.0	7.4	1.0	3.5	0.1	48.9	8.5	29.6	11.9	1.6	1.7	12.6	5.6	16.7	0.3	1.9	1.4	1.7	12.9	0.5	4.8	2.7	2.1	6.4	1.9	0.6	11.0	0.8	4.1	25.2	5.5	4.7	1.0	1.7	21.0	0.9	1.9	2.7	5.3	0.3	2.1	84.3	13.8	1.0	324.3	43.8	5.4	20.4	45.7	44.4	45.0	288.5	257.2	239.7	131.7	14.2	252.6	0.5	65.1	199.7	379.6	60.6	19.6	227.4	210.8	9.7	0.7	20.6	4.5	34.9	57.0	13.3	6.9	18.8	23.1	191.1	297.1	117.9	80.4	0.2	48.8	1.7	320.9	12.3	0.3	26.5	21.5	27.0	829.4	1.5	25.7	1.3	116.7	20.4	0.4	0.5	18.2	0.8	229.0	13.0	1.0	12.1	200.6	282.5	62.7	520.1	423.8	0.3	1.4	0.9	389.7	4.9	1123.6	0.0	0.8	0.0	0.1	0.5	0.0	0.0	0.2	0.1	3.4	0.0	0.2	0.0	0.5	0.0	0.3	0.4	0.0	0.5	1.2	1.3	2.2	4.3	1.6	1.7	1.9	1.4	2.1	1.0	1.9	1.0	15.2	6.4	4.4	0.3	2.0	338.0	398.5	56.2	281.1	0.0	27.6	12.2	1.0	4.3	26.2	0.0	0.0	1.3	4.3	11.8	0.0	25.1	0.3	24.4	12.2	30.1	11.3	0.8	0.1	3.5	4.3	45.8	74.9	56.3	9.5	0.3	6.1	0.4	1.9	0.0	0.1	6.8	10.2	1.0	46.6	0.0	0.3	15.5	44.4	1.0	1.1	0.1	0.0	0.5	0.2	39.0	11.1	0.0	6.2	196.9	1.2	0.2	10.7	0.0	0.0	32.4	26.1	0.4	0.7	210.4	339.5	17.6	6.8	0.1	4.2	456.4
FOXA1	HNF3A	ENSG00000129514	"Forkhead box A1"	P55317	14	37589552-37596059	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Chromatin regulator, Developmental protein, DNA-binding, Repressor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"prostate: 74.7;stomach 1: 28.0"	"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 113.8;Basal squamous epithelial cells: 76.8;Breast glandular cells: 87.9;Enteroendocrine cells: 84.6;Prostatic glandular cells: 89.8;Respiratory ciliated cells: 66.7;Urothelial cells: 154.5"	"Group enriched"	"Detected in many"	5	"breast cancer: 80.0;prostate cancer: 127.0"	"Region enriched"	"Detected in single"	5	"midbrain: 3.5"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"Hep G2: 48.9;MCF7: 105.3;PC-3: 69.5;RT4: 96.7;SK-BR-3: 97.0;T-47d: 135.9"	"Region enhanced"	"Detected in some"		"midbrain: 1.1"	"Region enriched"	"Detected in single"	6	"midbrain: 5.4"	"CAB011595, HPA050505"	Enhanced		Supported	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA				"Cluster 37: Intestine - Unknown function"	"Cluster 6: T47d - Mammary gland"	"Cluster 35: Glandular cells - Unknown function"	Nucleoplasm	"Nucleoli fibrillar center"	"CAB011595: AB_2104842, HPA050505: AB_2681148"	"unprognostic (1.61e-1)"	"unprognostic (8.80e-2)"	"unprognostic (1.12e-1)"	"unprognostic (4.65e-1)"	"unprognostic (2.58e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.71e-1)"	"unprognostic (3.01e-1)"	"unprognostic (1.54e-2)"	"unprognostic (6.30e-2)"	"unprognostic (0.00e+0)"	"unprognostic (3.67e-1)"	"unprognostic (2.58e-1)"	"unprognostic (1.69e-2)"	"prognostic favorable (1.00e-4)"	0.2	0.1	0.0	1.6	0.0	0.0	22.3	0.0	0.0	1.5	0.0	12.4	8.4	0.1	0.6	11.9	2.4	2.3	0.0	0.0	0.3	0.1	26.9	7.5	0.0	0.1	3.5	0.0	0.5	0.0	0.7	0.0	0.2	74.7	10.4	0.0	19.3	0.3	0.0	1.3	4.8	0.2	0.2	0.0	28.0	0.4	0.7	0.0	0.0	0.0	2.3	20.5	4.4	0.0	4.9	4.4	0.0	2.8	0.0	0.0	0.5	0.0	0.4	0.0	0.0	21.3	2.7	0.0	1.4	0.0	0.1	23.4	13.2	3.3	0.1	0.0	23.4	0.0	4.1	48.9	0.0	0.0	0.2	0.0	0.7	0.0	0.4	1.9	0.0	0.4	0.9	0.0	0.0	105.3	0.1	0.3	0.0	32.0	69.5	0.0	1.1	0.4	9.9	96.7	11.8	0.0	4.8	97.0	0.0	0.0	135.9	0.4	0.0	0.9	0.1	0.4	3.2	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	3.5	0.2	0.2	0.7	0.0	0.3	28.9	43.5	0.0	0.1	1.0	113.8	47.8	76.8	0.0	87.9	34.8	1.3	30.0	52.3	3.7	0.0	0.0	0.5	27.5	0.0	1.5	0.4	2.7	0.2	1.2	84.6	0.0	0.0	2.4	0.0	1.0	35.7	4.4	2.5	0.0	1.1	31.7	0.0	0.0	0.0	34.9	42.7	0.9	0.3	0.9	0.0	0.7	3.6	0.0	1.0	0.0	0.0	0.0	0.0	4.3	27.2	0.0	1.2	89.8	4.9	0.0	66.7	0.0	0.0	0.0	2.3	0.9	1.2	62.9	0.1	0.0	1.4	0.1	27.9	154.5
FOXA2	HNF3B	ENSG00000125798	"Forkhead box A2"	Q9Y261	20	22580998-22585455	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Chromatin regulator, Developmental protein, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"liver: 36.2;pancreas: 26.6;stomach 1: 31.1"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 96.1;Alveolar cells type 2: 78.0;Cholangiocytes: 47.1;Exocrine glandular cells: 37.0;Gastric mucus-secreting cells: 37.8;Hepatocytes: 63.7;Intestinal goblet cells: 87.2"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in single"	5	"midbrain: 2.5"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 17.5;HBEC3-KT: 19.3;Hep G2: 28.8;hTERT-HME1: 12.6;OE19: 22.7;PC-3: 24.7;SCLC-21H: 42.7"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	9	"midbrain: 3.9"	"CAB001388, HPA066846"	Enhanced		Supported	"Nucleoplasm,Cell Junctions"		NA	NA				"Cluster 29: Non-specific - Vesicular transport"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 27: Mucus-secreting cells - Mucin production"	"Nucleoplasm, Cell Junctions"		"CAB001388: AB_2262810, HPA066846: AB_2685736"		"unprognostic (1.19e-1)"	"unprognostic (1.99e-1)"	"prognostic favorable (7.57e-6)"	"unprognostic (6.82e-2)"	"unprognostic (1.50e-6)"	"unprognostic (1.38e-1)"	"unprognostic (8.17e-2)"		"prognostic favorable (6.28e-4)"	"prognostic favorable (2.34e-4)"	"unprognostic (3.18e-1)"	"unprognostic (2.55e-15)"	"unprognostic (2.50e-2)"	"unprognostic (1.68e-1)"	"unprognostic (7.12e-2)"	"unprognostic (3.93e-3)"	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	14.2	0.0	7.3	3.7	2.1	0.0	0.1	4.3	4.0	0.0	0.0	0.0	0.2	36.2	13.7	0.0	0.0	2.5	0.0	26.6	0.0	0.0	0.0	0.0	0.3	9.5	0.0	0.0	0.0	0.0	0.0	2.8	0.1	0.0	0.0	31.1	0.4	0.5	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	17.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.0	0.6	0.0	0.3	0.0	0.1	0.0	0.0	19.3	0.0	0.0	1.2	0.0	0.0	28.8	0.0	0.0	0.0	0.0	10.3	0.0	12.6	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	22.7	24.7	0.0	0.0	0.0	0.8	0.0	42.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	5.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.5	0.0	0.0	96.1	78.0	0.0	0.1	0.0	0.8	0.5	0.0	0.0	0.1	0.3	0.3	47.1	12.5	0.0	0.0	0.0	0.0	21.7	0.0	25.6	0.1	30.8	2.6	0.1	28.1	0.0	0.0	37.0	0.0	0.3	37.8	27.1	4.5	0.0	0.7	63.7	0.0	0.0	0.0	87.2	6.1	1.0	0.0	0.1	0.0	0.3	0.0	0.0	0.6	0.0	0.0	0.0	0.0	24.4	6.8	0.0	0.2	1.0	1.0	0.0	10.0	0.0	0.0	0.0	0.2	4.1	0.2	0.0	0.0	0.0	1.0	0.0	28.7	0.1
FOXC1	"ARA, FKHL7, FREAC3, IGDA, IHG1, IRID1"	ENSG00000054598	"Forkhead box C1"	Q12948	6	1609915-1613897	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Angiogenesis, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding, Repressor"	"Deafness, Disease variant, Peters anomaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"salivary gland: 154.4"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 93.7;Breast myoepithelial cells: 59.4;Endothelial cells: 64.7;Hepatic stellate cells: 65.7;Urothelial cells: 64.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 92.4;HEK 293: 91.8;RPTEC TERT1: 35.9"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"spinal cord: 18.0"	HPA040670			Supported	Nucleoplasm,Cytosol		NA	NA				"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Nucleoplasm	Cytosol	"HPA040670: AB_10673412"	"unprognostic (2.65e-2)"	"unprognostic (1.15e-2)"	"prognostic unfavorable (3.53e-4)"	"unprognostic (3.22e-2)"	"unprognostic (3.22e-2)"	"unprognostic (1.24e-1)"	"unprognostic (3.30e-2)"	"unprognostic (1.54e-2)"	"unprognostic (4.04e-3)"	"unprognostic (1.58e-1)"	"unprognostic (2.33e-3)"	"unprognostic (9.55e-2)"	"unprognostic (1.11e-2)"	"unprognostic (6.48e-2)"	"unprognostic (2.04e-1)"	"unprognostic (3.83e-3)"	"unprognostic (3.74e-1)"	12.3	6.0	7.7	1.2	8.3	0.6	9.0	7.1	9.3	6.3	11.0	1.7	0.9	3.7	1.7	4.8	5.0	7.5	14.0	6.0	6.5	19.9	1.2	3.3	1.7	9.0	7.4	4.7	3.6	1.6	9.5	4.1	8.7	8.6	0.9	0.3	154.4	6.4	2.4	11.1	1.6	2.3	7.1	0.4	1.7	2.0	9.2	8.3	5.6	2.9	2.2	9.4	5.6	7.1	18.0	2.0	0.6	92.4	4.2	4.6	2.9	8.9	10.3	5.4	4.3	6.7	3.7	0.0	10.0	5.2	3.9	19.9	8.8	6.5	4.5	5.7	91.8	3.7	5.3	3.3	2.8	1.4	6.0	15.6	8.7	7.3	8.3	2.8	7.9	0.6	2.7	0.1	2.3	3.8	0.0	2.0	0.3	8.9	7.6	0.0	3.7	0.5	35.9	13.3	3.4	8.0	10.9	0.1	6.4	4.5	2.6	1.5	2.0	11.5	7.1	5.9	9.6	0.4	0.8	0.0	3.2	4.5	10.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	7.7	8.3	7.1	9.3	6.0	6.5	9.0	7.4	8.7	7.1	9.2	7.1	93.7	0.0	0.6	0.0	0.4	17.7	31.9	26.3	13.6	0.0	42.2	59.4	7.1	0.0	23.6	11.0	0.0	5.3	1.9	0.9	1.9	3.9	0.6	8.6	1.1	64.7	0.0	0.0	0.0	17.1	0.6	21.2	1.5	3.8	0.0	0.7	65.7	0.4	1.3	0.0	0.0	1.5	8.2	1.3	5.5	1.4	16.1	2.7	1.8	23.4	0.0	0.3	0.0	0.5	0.1	16.2	0.1	28.2	0.1	9.5	0.0	7.4	34.9	0.0	0.0	19.2	40.4	0.7	3.1	11.2	6.5	0.8	1.1	4.4	0.6	64.9
FOXC2	"FKHL14, MFH-1"	ENSG00000176692	"Forkhead box C2"	Q99958	16	86566829-86569728	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 5.6"	"Group enriched"	"Detected in some"	4	"Peritubular cells: 30.9;Sertoli cells: 19.7;Smooth muscle cells: 33.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"hTEC/SVTERT24-B: 25.2;HUVEC TERT2: 19.5;LHCN-M2: 31.2;TIME: 36.0;U-138 MG: 18.4;U-2197: 31.5;U-87 MG: 24.0"	"Low region specificity"	"Detected in many"			"Region enriched"	"Detected in many"	6	"spinal cord: 42.7"	HPA056302			Supported	"Nucleoplasm,Nuclear bodies"		NA	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 48: Smooth muscle cells - ECM organization"	"Nucleoplasm, Nuclear bodies"		"HPA056302: AB_2683093"	"unprognostic (3.17e-2)"	"unprognostic (1.76e-3)"	"unprognostic (4.87e-2)"	"unprognostic (4.32e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.60e-2)"	"unprognostic (4.49e-2)"	"unprognostic (1.15e-2)"	"unprognostic (4.71e-2)"	"unprognostic (8.88e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.73e-1)"	"prognostic unfavorable (3.57e-7)"	"unprognostic (1.12e-2)"	"unprognostic (3.47e-2)"	"unprognostic (2.43e-1)"	"unprognostic (1.84e-4)"	2.4	1.5	0.5	0.3	1.1	0.0	1.8	0.9	1.6	2.2	3.2	0.5	0.1	0.8	0.6	0.5	2.0	1.3	5.6	0.4	0.4	5.4	0.1	2.1	0.4	0.5	0.5	1.1	0.2	0.1	2.4	0.1	0.5	1.0	0.1	0.1	2.4	0.6	0.7	0.8	0.4	0.4	0.7	0.0	0.4	1.9	0.7	0.1	2.0	0.5	0.1	0.8	1.5	0.3	0.0	0.0	0.0	0.0	5.8	7.8	0.0	11.3	14.3	8.0	1.5	0.0	0.0	0.0	1.5	1.4	11.2	0.0	0.2	3.3	7.0	0.0	0.6	0.0	7.9	0.0	2.7	0.0	0.0	1.3	3.4	25.2	7.9	14.5	19.5	0.0	0.0	0.0	31.2	0.0	0.0	0.0	0.0	0.5	0.1	0.0	1.7	0.0	0.1	0.1	0.0	0.0	1.8	0.0	0.0	5.9	0.0	0.0	36.0	18.4	0.0	31.5	0.0	0.0	0.0	0.0	24.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	1.1	0.9	1.6	0.4	0.4	0.5	0.5	0.5	0.7	0.7	0.3	1.5	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	1.0	0.8	2.1	0.0	0.0	1.8	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.2	0.0	5.7	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.5	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	1.6	1.5	0.1	1.8	1.0	0.0	0.2	0.0	0.0	0.0	0.5	0.0	30.9	1.2	0.8	0.0	0.0	0.0	0.1	19.7	0.6	33.2	0.2	5.0	0.5	0.0	0.0	0.0	0.0	0.1	1.4
FOXI1	"FKHL10, FREAC6"	ENSG00000168269	"Forkhead box I1"	Q12951	5	170105897-170109734	"Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"kidney: 44.0;salivary gland: 11.4"	"Cell type enriched"	"Detected in some"	4	"Ionocytes: 132.2"	"Group enriched"	"Detected in many"	7	"breast cancer: 5.8;renal cancer: 23.1"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	16	"eosinophil: 1.5"	"Lineage enriched"	"Detected in single"	16	"granulocytes: 1.5"	"Group enriched"	"Detected in some"	5	"MCF7: 1.4;SuSa: 2.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA071469	Enhanced		Supported	Nucleoli,Vesicles		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 12: NES - Nervous system development"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoli	Vesicles	"HPA071469: AB_2686403"	"unprognostic (3.06e-1)"	"unprognostic (1.24e-1)"	"unprognostic (2.09e-1)"	"unprognostic (2.48e-2)"		"unprognostic (8.06e-2)"		"unprognostic (7.47e-2)"		"unprognostic (2.73e-1)"	"unprognostic (1.52e-2)"	"unprognostic (9.71e-3)"	"unprognostic (4.88e-3)"	"unprognostic (6.20e-2)"	"unprognostic (1.34e-2)"		"unprognostic (2.22e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	7.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	44.0	0.0	0.0	0.0	0.6	0.0	0.0	0.3	0.5	0.1	0.0	0.1	3.0	0.0	0.0	11.4	1.5	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	1.5	0.2	0.0	0.0	7.6	6.5	0.3	0.0	0.3	1.8	0.0	0.0	0.1	0.0	27.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	132.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	1.0	0.2	0.0	0.0	0.0
FOXJ2	FHX	ENSG00000065970	"Forkhead box J2"	Q9P0K8	12	8032716-8055517	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Meiosis, Spermatogenesis, Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008723	Approved		Supported	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 52: Non-specific - Ribosome"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 41: Macrophages - Immune response"	Nucleoplasm	"Nucleoli fibrillar center"	"HPA008723: AB_1078903"	"unprognostic (1.68e-1)"	"unprognostic (2.70e-1)"	"unprognostic (1.22e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.37e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.60e-1)"	"unprognostic (9.65e-2)"	"unprognostic (3.08e-1)"	"unprognostic (2.74e-3)"	"unprognostic (3.40e-1)"	"unprognostic (1.46e-1)"	"prognostic unfavorable (4.63e-4)"	"unprognostic (9.01e-2)"	"unprognostic (2.48e-2)"	"unprognostic (2.30e-2)"	"unprognostic (2.02e-2)"	13.8	8.3	6.6	8.7	6.7	15.5	12.3	14.3	11.9	15.5	4.6	14.8	7.3	17.7	8.0	8.8	14.4	8.1	14.7	6.7	6.6	7.3	5.9	12.1	8.3	6.3	6.2	16.8	10.0	15.4	8.5	11.0	6.1	10.6	7.7	9.3	9.5	12.8	25.2	17.5	10.1	14.7	5.1	10.8	11.3	5.8	6.2	10.7	9.9	20.6	9.1	13.5	12.3	7.0	12.4	10.3	11.1	14.0	12.6	13.8	24.3	17.5	17.8	16.7	12.4	14.8	13.3	0.2	3.2	21.3	15.4	13.2	10.0	11.7	17.8	21.6	6.8	16.4	11.8	5.1	15.8	7.4	43.9	12.2	17.2	21.7	31.5	17.4	12.1	13.0	12.2	8.0	13.7	9.6	10.5	6.6	12.6	18.4	6.8	11.2	17.2	6.0	7.0	8.2	4.6	6.3	22.0	15.1	7.6	23.1	3.5	8.8	11.0	20.3	24.8	14.5	10.7	6.4	6.8	8.1	13.1	5.9	12.3	2.5	1.4	2.2	1.5	1.1	1.9	0.8	1.5	1.7	1.8	1.5	1.7	1.5	2.7	2.8	1.5	1.7	1.2	1.2	6.6	6.7	14.3	11.9	6.7	6.6	6.3	6.2	6.1	5.1	6.2	7.0	14.1	16.0	13.1	6.2	9.1	18.9	4.5	5.5	14.8	10.7	10.4	9.1	19.9	12.8	4.0	0.0	8.4	5.5	7.7	7.1	0.0	5.9	0.4	4.0	14.0	12.8	4.9	13.7	6.1	7.5	3.1	12.0	7.7	7.2	3.8	16.1	18.9	9.5	10.1	8.4	6.4	8.4	4.1	13.2	23.0	0.9	10.5	13.9	7.2	6.5	14.2	4.0	11.3	3.0	5.7	10.3	4.4	17.0	6.7	9.8	5.0	2.4	2.9	7.5	19.7	9.9	8.4	1.4	6.4	14.2	21.5	6.2	12.3	8.1	7.4	5.3
FOXK1	IMAGE:5164497	ENSG00000164916	"Forkhead box K1"	P85037	7	4682295-4771442	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Host-virus interaction, Myogenesis, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 113.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017998, HPA018864"	Enhanced		Supported	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 35: Non-specific - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 25: Spermatids - Spermatogenesis"	Nucleoplasm	"Nucleoli fibrillar center"	"HPA017998: AB_1849077, HPA018864: AB_1849079"	"unprognostic (3.05e-2)"	"unprognostic (5.01e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.55e-2)"	"unprognostic (3.51e-1)"	"unprognostic (3.03e-1)"	"prognostic unfavorable (2.54e-6)"	"unprognostic (2.34e-2)"	"unprognostic (2.62e-2)"	"unprognostic (1.73e-3)"	"unprognostic (2.66e-3)"	"unprognostic (4.96e-2)"	"unprognostic (3.79e-3)"	"unprognostic (1.08e-1)"	"unprognostic (1.50e-1)"	"unprognostic (4.34e-2)"	"unprognostic (3.72e-1)"	6.3	11.3	6.9	4.2	7.1	9.5	5.7	1.4	8.9	7.1	0.0	9.8	3.0	9.1	2.1	7.5	7.6	2.3	7.5	9.2	5.2	6.0	4.8	8.6	4.0	9.2	6.6	7.7	6.5	2.7	12.5	3.0	7.6	5.9	2.6	3.6	4.6	4.0	11.0	9.7	5.8	4.8	5.9	6.3	6.3	9.2	8.7	4.0	4.9	4.8	3.4	6.9	7.4	7.5	11.8	14.8	9.4	18.6	9.0	6.8	11.6	5.3	4.6	3.7	4.2	14.8	13.0	19.9	6.0	8.5	11.9	18.9	10.2	12.9	3.7	5.8	6.3	9.4	16.1	8.4	8.8	11.7	10.3	13.0	7.1	8.9	12.3	6.0	7.2	7.5	20.5	4.3	4.5	13.5	4.5	20.9	14.1	4.8	7.4	16.7	9.4	12.7	5.4	17.2	8.4	10.6	8.0	17.2	6.2	7.2	9.6	15.4	22.4	6.4	20.1	10.0	11.4	11.9	10.5	12.9	8.6	13.4	10.3	0.9	0.9	0.4	1.7	1.6	2.5	1.2	1.7	1.7	1.1	1.1	1.8	1.8	0.5	1.6	1.6	0.9	0.9	1.4	6.9	7.1	1.4	8.9	9.2	5.2	9.2	6.6	7.6	5.9	8.7	7.5	15.7	32.1	17.5	25.5	16.8	33.4	15.2	31.9	12.0	18.0	15.7	15.2	12.9	8.6	14.4	14.7	22.9	13.6	26.0	11.4	5.9	10.6	44.7	17.8	20.4	17.2	13.1	3.6	42.0	15.2	4.0	18.6	9.7	25.1	7.6	29.5	16.1	11.6	10.6	23.5	35.2	11.3	12.2	17.5	17.9	113.2	19.3	11.4	16.0	30.9	21.4	10.3	54.6	25.1	58.2	19.7	9.6	28.6	6.0	29.1	8.1	15.5	14.7	13.9	19.7	17.6	25.3	19.1	20.4	15.3	50.0	4.0	19.3	17.9	17.9	21.5
FOXK2	"ILF, ILF1"	ENSG00000141568	"Forkhead box K2"	Q01167	17	82519713-82644662	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027523, HPA073491"	Approved		Supported	Nucleoplasm,Vesicles,Mitochondria		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm	"Vesicles, Mitochondria"	"HPA027523: AB_10601013, HPA073491: "	"unprognostic (2.39e-1)"	"unprognostic (8.28e-2)"	"unprognostic (2.05e-1)"	"unprognostic (9.52e-2)"	"unprognostic (3.11e-1)"	"unprognostic (1.43e-1)"	"prognostic unfavorable (1.24e-6)"	"unprognostic (3.35e-2)"	"unprognostic (2.25e-1)"	"unprognostic (5.19e-2)"	"unprognostic (2.18e-2)"	"unprognostic (2.26e-1)"	"unprognostic (3.80e-3)"	"unprognostic (2.24e-2)"	"unprognostic (4.89e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.52e-2)"	14.0	24.0	10.7	12.6	13.2	8.0	12.1	14.7	16.3	14.2	1.2	18.1	9.3	19.7	9.8	20.2	13.2	10.0	17.1	12.4	10.5	12.7	13.1	14.2	12.5	5.8	7.1	14.7	15.4	20.0	17.7	15.7	6.3	13.3	9.4	11.6	12.1	12.5	43.0	18.8	12.1	16.4	3.0	11.6	14.7	28.1	9.4	18.4	15.4	28.4	11.9	15.5	13.4	12.7	48.4	50.4	46.3	50.9	26.2	28.5	31.0	27.6	31.6	47.4	47.9	49.1	30.1	40.7	19.6	34.4	52.3	27.6	49.7	32.0	44.4	28.3	47.9	42.3	32.7	49.4	41.0	47.3	27.2	27.2	57.2	50.4	56.8	29.2	48.9	43.7	57.7	40.7	26.3	28.8	81.8	30.4	26.5	39.7	38.2	53.0	39.4	34.2	21.7	40.1	76.2	56.1	27.4	69.0	65.1	48.8	48.7	54.3	38.3	62.2	43.2	42.2	56.6	46.7	45.1	53.5	33.4	39.0	33.4	1.5	1.0	1.2	1.4	0.7	1.1	1.5	1.1	1.4	1.2	1.0	0.8	0.9	0.1	1.6	0.9	2.0	1.3	0.6	10.7	13.2	14.7	16.3	12.4	10.5	5.8	7.1	6.3	3.0	9.4	12.7	21.5	51.3	27.1	23.5	11.5	37.2	8.0	10.6	10.2	19.2	17.7	15.7	19.5	7.2	16.2	14.7	12.5	11.9	19.3	15.6	3.9	8.7	15.6	19.4	22.4	14.9	10.9	7.8	44.6	10.7	8.8	13.2	14.3	26.7	2.5	22.1	10.8	13.4	20.0	47.1	39.6	12.6	8.2	17.3	22.0	24.1	9.3	19.2	12.4	20.6	13.9	12.3	6.2	33.2	49.1	11.4	12.4	13.2	13.3	13.6	12.2	7.1	13.9	16.7	0.0	19.8	16.6	15.0	10.3	17.0	43.0	9.7	11.6	30.6	13.0	10.7
FOXL2	"BPES, BPES1"	ENSG00000183770	"Forkhead box L2"	P58012	3	138944224-138947137	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	DNA-binding	"Cancer-related genes, Disease variant, Premature ovarian failure"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"cervix: 12.8;ovary: 44.8;parathyroid gland: 12.5"	"Cell type enriched"	"Detected in some"	4	"Granulosa cells: 208.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 4.9;fHDF/TERT166: 5.6;HEL: 8.1;hTCEpi: 7.1;K-562: 8.4;SiHa: 5.6;THP-1: 5.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA069613	Enhanced		Supported	Nucleoplasm		NA	NA				"Cluster 89: Fibroblasts - ECM organization"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 40: Granulosa cells - Unknown function"	Nucleoplasm		"HPA069613: AB_2686160"	"unprognostic (1.46e-1)"	"unprognostic (3.28e-2)"		"unprognostic (4.76e-3)"	"unprognostic (2.05e-1)"	"unprognostic (5.16e-4)"		"unprognostic (3.55e-2)"	"unprognostic (2.35e-3)"	"unprognostic (5.08e-2)"	"unprognostic (3.79e-2)"	"unprognostic (2.19e-1)"	"unprognostic (9.63e-8)"	"unprognostic (2.16e-2)"	"unprognostic (4.65e-1)"	"unprognostic (2.90e-2)"	"unprognostic (1.61e-2)"	0.0	2.6	1.0	0.0	0.8	0.0	0.0	0.6	0.8	12.8	0.3	0.0	0.0	7.3	0.4	0.0	11.9	0.0	0.0	0.6	0.6	0.0	0.0	0.0	0.0	0.8	0.8	44.8	0.1	12.5	10.0	0.1	0.8	0.1	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.8	0.8	0.0	0.0	0.7	1.2	0.0	0.0	0.1	0.0	0.0	2.1	0.7	4.9	1.8	0.2	3.4	0.0	0.0	1.4	0.1	0.0	0.4	0.0	0.0	0.3	0.0	2.2	5.6	0.2	1.1	0.0	0.0	0.1	0.0	0.0	8.1	0.9	0.0	0.0	0.1	0.0	0.0	7.1	0.0	0.0	1.1	0.0	0.0	8.4	0.0	2.7	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.4	1.6	0.0	0.0	5.6	0.0	0.0	0.3	0.0	5.9	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.8	0.6	0.8	0.6	0.6	0.8	0.8	0.8	0.8	1.2	0.7	0.2	0.0	0.0	0.0	0.1	0.5	0.1	0.1	0.0	0.0	0.0	0.1	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.5	41.8	1.6	0.0	0.0	0.0	0.2	0.3	20.9	0.0	1.0	0.0	208.9	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	6.2	1.8	1.4	0.0	1.0	0.0	0.3	48.4	0.0	0.0
FOXM1	"FKHL16, HFH-11, HNF-3, INS-1, MPHOSPH2, MPP2, TGT3, trident"	ENSG00000111206	"Forkhead box M1"	Q08050	12	2857680-2877174	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Cell cycle, DNA damage, DNA repair, Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 25.0;lymphoid tissue: 32.2;testis: 21.4"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 22.4;Erythroid cells: 18.7;Extravillous trophoblasts: 18.2;Late spermatids: 25.5;Plasma cells: 19.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			CAB017832	Uncertain		Supported	"Nucleoplasm,Nucleoli,Nucleoli rim,Cytosol"		NA	Yes				"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Nucleoplasm, Nucleoli, Nucleoli rim"	Cytosol	"CAB017832: "	"unprognostic (3.18e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.22e-2)"	"unprognostic (1.09e-2)"	"unprognostic (4.30e-2)"	"unprognostic (3.75e-2)"	"prognostic unfavorable (1.95e-6)"	"prognostic unfavorable (2.92e-4)"	"unprognostic (1.01e-2)"	"unprognostic (3.25e-2)"	"prognostic unfavorable (3.03e-5)"	"unprognostic (6.09e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (2.80e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.94e-1)"	1.9	1.1	0.4	9.4	0.5	25.0	1.8	0.8	0.8	1.7	0.2	10.5	9.7	1.7	0.2	11.1	0.8	1.5	0.5	0.8	0.3	0.7	1.2	1.8	11.3	0.4	0.9	0.3	0.4	0.4	0.1	6.1	0.6	0.7	12.5	1.1	1.9	0.8	0.6	6.4	8.8	7.5	0.1	3.1	5.2	21.4	1.0	32.2	0.9	0.3	15.2	3.0	3.2	0.6	133.0	129.5	101.3	92.2	14.2	19.0	129.2	84.0	80.4	165.2	147.2	166.9	114.8	84.5	17.7	119.8	188.5	100.2	153.1	76.1	160.0	159.8	80.3	94.7	121.6	71.6	2.0	79.2	75.0	9.9	8.3	154.4	106.1	39.1	117.8	96.8	55.6	184.9	130.5	122.6	108.3	36.8	225.6	136.1	95.4	77.3	149.8	44.1	38.1	82.7	56.3	89.1	106.7	90.4	46.6	189.4	87.1	87.8	48.0	134.3	200.5	160.4	300.4	24.7	44.3	122.1	63.1	74.3	147.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.4	0.5	0.8	0.8	0.8	0.3	0.4	0.9	0.6	0.1	1.0	0.6	0.1	0.0	1.3	0.7	2.4	2.9	1.3	1.0	1.2	2.0	1.7	1.3	0.5	1.5	0.8	1.8	4.2	7.1	0.8	6.6	1.9	0.2	22.4	1.2	2.1	2.5	0.0	18.7	1.1	0.0	18.2	3.2	10.2	2.4	0.0	15.4	3.6	0.8	9.1	5.0	0.6	7.5	2.0	4.2	1.2	25.5	0.9	2.4	0.0	0.0	1.1	0.6	1.0	0.5	1.0	0.3	0.3	0.7	19.9	1.0	1.4	0.4	0.2	4.0	0.0	1.2	3.0	15.0	9.9	10.2	1.4	1.9	3.3	0.9	12.9	1.9
FOXN2	HTLF	ENSG00000170802	"Forkhead box N2"	P32314	2	48314637-48379295	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 54.0;brain: 53.3"	"Cell type enhanced"	"Detected in many"		"Oligodendrocyte precursor cells: 152.3;Oligodendrocytes: 282.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003485	Supported		Supported	Nucleoplasm,Vesicles		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Nucleoplasm	Vesicles	"HPA003485: AB_1078905"	"unprognostic (5.38e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.86e-2)"	"unprognostic (2.65e-3)"	"prognostic favorable (3.85e-4)"	"unprognostic (4.00e-1)"	"unprognostic (2.32e-2)"	"unprognostic (1.52e-1)"	"unprognostic (8.95e-2)"	"unprognostic (2.59e-1)"	"unprognostic (5.15e-3)"	"unprognostic (4.14e-2)"	"prognostic unfavorable (2.81e-5)"	"unprognostic (2.24e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.34e-2)"	"unprognostic (1.12e-2)"	17.9	5.5	13.3	15.4	30.3	54.0	8.0	25.3	19.0	7.7	4.2	7.7	8.3	6.7	4.2	9.3	5.5	9.7	8.6	13.9	16.3	6.6	19.8	9.5	19.4	24.1	21.0	5.9	8.9	9.5	3.0	13.4	21.9	5.0	8.0	3.4	5.5	4.2	4.8	3.6	10.3	9.8	20.0	18.1	7.9	6.3	19.2	14.9	6.9	6.4	17.1	10.6	3.9	53.3	13.1	19.5	22.2	19.6	17.2	12.7	24.3	14.4	15.8	11.9	13.2	17.3	15.9	28.4	18.7	17.0	14.5	16.2	13.7	16.5	17.2	22.3	11.7	56.1	13.3	17.4	30.0	30.9	42.1	11.4	6.9	12.9	22.3	9.6	12.8	11.6	26.6	32.7	19.5	10.1	34.4	20.3	16.8	9.8	10.2	17.0	46.5	23.2	10.2	16.5	12.4	12.6	6.9	13.2	24.9	7.5	5.7	18.0	15.0	16.0	16.1	15.2	15.2	17.8	14.2	40.5	13.9	27.5	22.2	120.9	32.4	129.6	24.0	26.2	27.4	21.2	23.1	22.4	33.6	20.6	17.2	17.7	40.8	25.7	36.4	20.8	28.8	17.2	13.3	30.3	25.3	19.0	13.9	16.3	24.1	21.0	21.9	20.0	19.2	53.3	22.1	0.0	7.4	66.6	31.3	15.6	27.5	10.0	15.4	6.7	5.4	5.6	11.1	14.3	6.1	1.8	0.0	6.7	28.3	7.0	5.9	6.0	4.8	8.9	17.2	21.8	2.4	22.5	28.1	5.4	32.1	13.3	14.3	13.3	22.8	1.2	20.7	19.7	17.9	13.5	25.2	8.0	8.2	39.5	47.3	4.7	12.2	44.4	12.4	35.6	44.1	7.8	26.8	152.3	282.0	11.0	7.1	11.3	31.0	35.2	11.3	4.8	3.3	3.6	6.6	17.8	27.4	22.7	13.1	11.9	21.2	16.6	38.3	2.8	8.9	35.9
FOXO1	"FKH1, FKHR, FOXO1A"	ENSG00000150907	"Forkhead box O1"	Q12778	13	40555667-40666641	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Apoptosis, Autophagy, Differentiation, Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 91.0"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 177.3;Endometrial stromal cells: 161.0;Granulosa cells: 177.9;Oligodendrocytes: 131.5;Skeletal myocytes: 131.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 40.4;Daudi: 45.3;HSkMC: 53.6;U-698: 57.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001252, CAB022326"	Approved	Approved	Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 30: Non-specific - Translation"	"Cluster 59: Non-specific - Translation"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 40: Granulosa cells - Unknown function"	"Nucleoplasm, Cytosol"		"CAB022326: , HPA001252: AB_1078906"	"unprognostic (4.72e-2)"	"unprognostic (1.81e-1)"	"unprognostic (8.54e-2)"	"unprognostic (4.35e-1)"	"unprognostic (2.42e-1)"	"unprognostic (2.52e-1)"	"prognostic favorable (3.74e-4)"	"unprognostic (6.35e-2)"	"unprognostic (1.60e-1)"	"unprognostic (8.65e-3)"	"unprognostic (1.71e-1)"	"unprognostic (1.31e-1)"	"prognostic favorable (1.33e-5)"	"unprognostic (1.93e-1)"	"unprognostic (5.44e-1)"	"unprognostic (9.09e-2)"	"unprognostic (9.63e-2)"	43.2	9.7	11.2	13.1	16.1	13.8	27.6	10.0	10.9	19.1	16.7	13.8	5.0	39.1	6.5	13.0	25.7	14.5	13.9	9.1	11.8	11.8	38.5	16.8	23.8	14.1	12.7	65.6	16.5	5.3	7.6	11.2	12.7	10.1	9.6	3.9	9.8	10.1	91.0	18.0	10.9	27.0	10.5	15.7	9.5	8.9	11.3	11.6	19.0	22.2	24.0	13.4	17.4	14.3	0.7	1.7	12.4	0.3	40.4	7.9	11.8	1.8	2.5	0.5	0.3	3.7	3.0	45.3	8.1	1.2	1.9	10.7	9.8	5.3	0.7	20.9	10.1	0.0	1.4	10.1	19.1	0.4	1.2	53.6	35.5	0.2	6.7	2.5	31.7	3.3	0.9	14.0	3.1	1.6	0.1	0.6	18.0	6.2	3.1	32.4	14.3	3.6	22.9	5.8	2.6	0.6	1.6	8.5	1.8	14.1	1.5	1.1	18.6	0.3	2.3	0.1	1.1	7.9	3.3	57.8	1.2	2.1	5.7	0.9	0.6	0.5	1.3	0.8	1.8	3.7	3.6	2.2	0.4	5.8	5.5	4.3	2.5	1.4	1.4	0.0	5.1	1.0	11.2	16.1	10.0	10.9	9.1	11.8	14.1	12.7	12.7	10.5	11.3	14.3	57.9	0.0	4.4	177.3	29.3	29.3	19.1	13.0	27.9	3.7	12.9	17.3	11.5	10.0	9.9	9.2	12.5	0.5	22.9	27.5	0.0	11.1	7.2	55.4	161.0	50.2	52.2	3.2	7.4	18.0	3.8	40.8	18.8	118.8	1.3	177.9	84.3	47.9	6.5	5.0	23.0	21.0	8.2	14.6	26.9	4.0	18.6	18.6	12.4	117.1	18.4	5.5	8.2	47.3	131.5	19.5	16.3	13.2	32.9	10.1	7.7	8.8	9.2	9.8	6.6	131.7	31.3	6.4	14.6	25.3	26.7	0.8	40.3	64.0	12.5	13.0
FOXO4	"AFX1, MLLT7"	ENSG00000184481	"Forkhead box O4"	P98177	X	71095851-71103532	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, RAS pathway related proteins, Transcription factors"	"Cell cycle, Differentiation, Myogenesis, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 116.5"	"Group enriched"	"Detected in many"	5	"Cytotrophoblasts: 260.7;Syncytiotrophoblasts: 307.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in many"	6	"BEWO: 159.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039560, HPA040232"	Enhanced		Supported	"Nuclear speckles,Cytosol"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Nuclear speckles"	Cytosol	"HPA039560: AB_2676572, HPA040232: AB_2676894"	"unprognostic (4.64e-2)"	"unprognostic (2.94e-2)"	"unprognostic (2.19e-1)"	"unprognostic (2.49e-1)"	"unprognostic (4.79e-2)"	"prognostic favorable (4.61e-4)"	"unprognostic (1.09e-1)"	"unprognostic (3.20e-2)"	"unprognostic (1.58e-1)"	"unprognostic (7.18e-2)"	"unprognostic (2.13e-2)"	"unprognostic (8.16e-2)"	"prognostic favorable (3.46e-4)"	"unprognostic (2.45e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.75e-3)"	15.8	33.6	73.9	6.5	80.6	22.0	13.9	58.9	68.7	12.9	43.1	22.1	11.0	17.1	16.4	12.0	17.6	9.4	18.2	58.3	61.8	9.4	7.2	10.0	7.1	71.7	70.5	23.2	12.7	16.0	7.0	116.5	65.3	14.3	8.0	7.5	16.7	19.2	67.3	15.1	14.3	8.2	62.3	13.9	13.5	17.3	68.8	14.5	10.9	49.4	6.4	17.2	13.2	81.6	4.6	1.2	3.4	4.9	7.9	5.7	159.1	3.4	3.9	1.8	4.5	3.3	6.5	5.9	4.7	4.5	1.9	2.1	8.8	4.2	2.2	6.0	13.7	8.5	27.3	5.0	4.8	4.9	6.9	5.1	9.7	1.7	1.1	7.9	4.7	8.4	17.5	12.5	0.8	0.9	8.6	8.0	16.9	11.5	5.6	5.7	8.5	10.1	3.0	2.6	2.8	7.3	7.1	1.1	8.3	24.7	1.9	3.1	4.3	1.1	2.3	8.3	0.8	7.7	4.3	1.0	4.3	13.6	1.3	0.0	0.1	1.0	0.2	0.1	0.0	0.2	0.1	0.2	0.0	0.2	0.1	0.4	0.9	0.2	0.1	0.0	0.3	0.3	73.9	80.6	58.9	68.7	58.3	61.8	71.7	70.5	65.3	62.3	68.8	81.6	10.1	0.0	2.7	0.3	3.8	5.4	3.9	0.6	9.1	1.3	8.2	7.7	6.6	5.7	1.5	9.2	4.2	260.7	6.5	20.6	1.9	2.7	0.3	3.2	2.8	6.1	6.1	17.7	0.8	3.0	24.3	4.0	5.1	3.1	2.5	3.1	5.0	2.9	22.3	1.7	0.8	12.2	0.0	7.1	5.2	1.4	6.8	4.4	3.6	1.0	2.6	4.4	4.1	1.0	2.2	3.1	8.6	15.4	7.3	2.5	17.1	4.4	1.5	0.8	6.6	4.0	3.8	0.6	0.4	6.0	3.4	307.8	7.0	48.3	7.4	3.8
FOXP1	"12CC4, hFKH1B, HSPC215, QRF1"	ENSG00000114861	"Forkhead box P1"	Q9H334	3	70954708-71583989	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"	"Cancer-related genes, Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in many"		"basal ganglia: 41.1"	"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"hTEC/SVTERT24-B: 95.0"					"Low region specificity"	"Detected in all"			"HPA003876, CAB011501"	Supported		Supported	Nucleoplasm		NA	NA			"Cluster 30: Non-specific - Translation"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Nucleoplasm		"CAB011501: AB_732428, HPA003876: AB_1078907"	"unprognostic (2.31e-1)"	"unprognostic (4.35e-3)"	"unprognostic (2.09e-2)"	"unprognostic (3.54e-2)"	"unprognostic (2.69e-1)"	"unprognostic (2.81e-3)"	"unprognostic (1.68e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.23e-1)"	"unprognostic (2.03e-1)"	"unprognostic (4.38e-3)"	"unprognostic (3.40e-1)"	"unprognostic (6.14e-2)"	"unprognostic (1.05e-1)"	"unprognostic (8.65e-2)"	"unprognostic (1.27e-1)"	"unprognostic (6.05e-2)"	16.5	3.8	5.0	20.3	41.1	38.5	14.5	0.3	12.5	11.2	9.9	28.7	12.2	15.3	6.5	23.0	14.3	21.0	12.7	7.8	0.0	7.0	13.0	22.9	22.2	3.1	6.7	32.4	16.8	6.5	9.1	13.7	0.9	21.2	23.4	2.6	29.7	9.6	8.2	10.9	15.3	22.7	0.1	17.8	20.6	14.4	6.6	26.3	14.5	11.1	25.4	21.6	14.2	8.1	9.6	8.0	16.8	13.2	8.4	21.3	8.2	26.3	30.9	22.0	17.4	51.9	11.2	31.1	4.3	12.9	17.6	6.9	31.0	22.8	40.3	7.8	11.7	13.0	17.0	52.7	20.5	25.7	31.6	21.7	10.3	95.0	42.1	18.3	36.6	15.4	13.6	36.7	10.8	42.6	11.9	9.3	19.7	7.2	39.9	38.0	30.7	4.7	18.8	30.1	14.5	27.6	32.6	7.7	1.9	15.9	5.6	21.9	47.7	34.9	14.3	48.9	42.2	9.0	7.1	41.8	22.5	35.7	7.5	46.9	15.3	15.2	18.3	13.1	19.4	58.1	38.7	22.6	13.0	62.2	60.8	40.0	27.0	22.2	25.3	21.7	35.9	28.8	5.0	41.1	0.3	12.5	7.8	0.0	3.1	6.7	0.9	0.1	6.6	8.1	158.8	73.7	121.3	130.9	266.5	183.0	170.6	58.2	176.4	30.3	98.5	115.1	42.1	148.7	72.0	33.1	18.8	47.2	122.9	118.1	31.3	79.0	156.0	116.3	48.2	184.9	271.6	111.5	391.0	95.1	12.6	90.4	95.8	128.0	219.8	117.7	184.9	72.3	49.5	6.7	139.9	231.2	154.6	117.6	209.0	89.6	42.0	101.3	37.4	414.1	120.3	15.5	116.4	184.5	286.4	124.8	102.8	24.8	66.0	178.8	91.7	19.4	83.7	42.8	92.1	102.9	119.4	13.7	33.6	111.5	101.4	52.4	168.1	33.1	157.2	146.3
FOXP3	"AIID, DIETER, IPEX, JM2, PIDX, SCURFIN, XPID"	ENSG00000049768	"Forkhead box P3"	Q9BZS1	X	49250438-49270477	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"	"Diabetes mellitus, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 7.2;lymphoid tissue: 7.4"	"Cell type enhanced"	"Detected in some"		"granulocytes: 1.3;Hepatocytes: 1.4;Horizontal cells: 3.3;Melanocytes: 1.8;T-cells: 5.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Immune cell enriched"	"Detected in some"	11	"T-reg: 53.3"	"Lineage enriched"	"Detected in single"	394	"T-cells: 53.3"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 2.9;MCF7: 5.2;SiHa: 4.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB026301, HPA045943"	Enhanced		Supported	Nucleoplasm		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 16: Immune cells - Immune response"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm		"CAB026301: , HPA045943: AB_2679508"	"unprognostic (2.46e-2)"	"prognostic favorable (1.91e-4)"	"unprognostic (4.95e-3)"	"prognostic favorable (7.02e-4)"	"unprognostic (2.55e-4)"	"prognostic favorable (4.90e-4)"	"unprognostic (2.42e-2)"	"unprognostic (3.46e-1)"	"unprognostic (1.04e-2)"	"unprognostic (1.99e-3)"	"unprognostic (8.77e-3)"	"unprognostic (1.94e-1)"	"unprognostic (2.73e-14)"	"unprognostic (5.93e-2)"	"unprognostic (4.55e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.39e-1)"	0.2	0.2	0.9	7.4	0.7	1.3	0.7	1.5	0.8	0.4	0.0	0.6	0.7	0.2	7.2	1.2	0.2	1.6	0.2	0.8	0.6	0.3	2.4	0.9	6.1	0.7	0.7	0.4	0.2	0.4	0.5	0.1	0.8	0.6	0.7	0.7	1.1	0.8	0.3	2.3	1.9	0.3	0.5	2.4	1.6	1.3	0.8	7.2	0.6	0.1	5.2	2.8	0.3	0.7	0.1	0.3	0.2	0.9	0.1	0.0	1.1	0.2	0.2	0.1	0.4	0.8	0.2	0.6	0.3	0.5	0.6	0.3	0.8	0.0	0.1	2.9	0.5	0.2	0.3	0.2	0.4	0.3	0.4	0.1	0.8	0.9	1.7	0.0	0.0	0.9	0.9	0.7	0.0	5.2	0.1	0.3	0.8	0.1	0.7	0.4	0.3	0.2	0.2	0.2	0.6	0.5	4.7	0.5	2.0	0.5	1.5	0.8	0.8	0.3	1.4	0.5	0.1	0.4	1.1	0.4	0.2	0.8	0.7	0.0	0.0	0.0	0.0	0.1	0.2	0.0	4.7	0.2	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	53.3	1.3	0.9	0.7	1.5	0.8	0.8	0.6	0.7	0.7	0.8	0.5	0.8	0.7	0.1	0.0	0.6	0.3	0.4	0.5	0.0	0.0	0.0	0.2	0.3	0.3	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.1	1.3	0.1	0.0	1.4	0.1	3.3	0.2	0.0	0.0	0.0	0.6	0.0	0.0	0.3	1.8	0.0	0.2	0.2	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.8	0.9	0.0	0.4	0.0	5.3	0.2	0.0	0.0
FOXQ1	HFH1	ENSG00000164379	"Forkhead box Q1"	Q9C009	6	1312098-1314758	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"stomach 1: 107.2;urinary bladder: 53.5"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 60.4;Basal respiratory cells: 24.9;Collecting duct cells: 40.5;Gastric mucus-secreting cells: 67.2;Suprabasal keratinocytes: 45.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CACO-2: 39.0;HaCaT: 44.7;Hep G2: 93.8;OE19: 117.1;RT4: 38.2"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA059700			Supported	Nucleoplasm		Yes	NA				"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 61: Squamous epithelial cells - Keratinization"	Nucleoplasm		"HPA059700: AB_2684107"	"unprognostic (2.04e-3)"	"unprognostic (3.44e-1)"	"unprognostic (1.10e-1)"	"unprognostic (7.18e-2)"	"unprognostic (1.50e-3)"	"unprognostic (2.15e-1)"	"unprognostic (3.26e-2)"	"unprognostic (1.15e-3)"	"unprognostic (1.04e-2)"	"unprognostic (1.06e-1)"	"unprognostic (7.65e-3)"	"prognostic favorable (6.68e-4)"	"unprognostic (1.49e-2)"	"unprognostic (3.16e-3)"	"unprognostic (2.82e-1)"	"unprognostic (3.93e-2)"	"unprognostic (1.96e-2)"	0.3	0.0	6.9	0.2	5.2	0.0	1.4	7.1	7.1	6.7	3.8	0.8	10.4	0.9	0.3	11.3	3.9	5.4	0.0	4.7	5.1	9.8	6.4	4.0	0.0	5.6	6.0	0.0	6.5	0.1	2.5	1.1	6.0	8.9	0.4	0.1	30.4	1.1	0.2	25.7	0.6	0.0	5.3	0.0	107.2	0.2	7.5	0.6	3.6	0.6	8.0	53.5	16.9	4.7	16.0	1.4	0.0	0.0	0.0	0.0	0.0	0.7	13.5	0.1	0.1	39.0	22.6	0.0	0.7	0.0	0.1	44.7	0.0	1.7	0.0	0.0	1.1	0.0	8.2	93.8	0.0	0.0	2.4	0.0	16.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	117.1	0.8	0.0	0.0	0.0	0.4	38.2	0.3	0.0	3.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	15.5	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.9	5.2	7.1	7.1	4.7	5.1	5.6	6.0	6.0	5.3	7.5	4.7	0.3	16.0	10.6	0.0	0.0	60.4	3.2	24.9	6.8	0.0	5.3	5.1	0.8	0.0	16.8	40.5	0.0	0.0	0.0	0.0	1.9	3.0	0.0	5.2	3.0	0.4	0.0	0.0	1.2	13.4	0.0	1.4	67.2	14.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	4.1	0.0	2.9	0.0	0.0	0.7	1.8	15.9	0.0	0.0	0.0	0.0	0.5	11.8	0.0	0.0	0.2	0.6	0.0	6.2	5.0	0.0	0.0	0.0	1.6	0.0	0.0	22.2	45.5	0.0	0.3	0.0	0.0	3.9
FOXR2	"FOXN6, MGC21658"	ENSG00000189299	"Forkhead box R2"	Q6PJQ5	X	55623400-55626192	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	11	"testis: 1.3"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in single"		"testis cancer: 0.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	110	"NTERA-2: 10.8;SH-SY5Y: 9.9;U-266/70: 6.2;U-266/84: 16.8"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"HPA034487, HPA057358"	Uncertain		Supported	Nucleoplasm		NA	NA				"Cluster 83: Testis - Spermatogenesis"	"Cluster 16: U-266 - Nucleosome"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	Nucleoplasm		"HPA034487: AB_10795354, HPA057358: AB_2683418"															"unprognostic (3.81e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.2	16.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0
FOXRED1	H17	ENSG00000110074	"FAD dependent oxidoreductase domain containing 1"	Q96CU9	11	126269055-126278131	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Electron transport, Respiratory chain, Transport"	Oxidoreductase	"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039620, HPA046192"	Uncertain		Supported	Mitochondria		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 6: T47d - Mammary gland"	"Cluster 12: Non-specific - Cell cycle regulation"	Mitochondria		"HPA039620: AB_2676602, HPA046192: AB_2679580"	"prognostic unfavorable (7.36e-4)"	"unprognostic (4.62e-2)"	"unprognostic (2.71e-1)"	"unprognostic (3.47e-3)"	"unprognostic (1.76e-1)"	"unprognostic (1.84e-1)"	"unprognostic (9.59e-2)"	"unprognostic (1.43e-1)"	"unprognostic (8.14e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.20e-2)"	"unprognostic (1.59e-1)"	"prognostic favorable (2.01e-6)"	"unprognostic (1.57e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.00e-1)"	"unprognostic (1.94e-1)"	8.1	13.8	13.6	5.9	14.6	12.1	7.6	15.3	16.6	5.8	17.1	12.0	10.4	6.7	6.4	9.2	7.5	5.6	21.2	15.0	14.7	14.7	37.4	5.3	10.4	15.3	14.3	4.8	7.8	9.7	8.1	7.1	15.3	6.9	12.9	3.7	7.3	6.8	17.8	7.5	8.6	7.9	14.7	11.1	10.9	8.7	15.8	11.5	6.1	29.4	10.6	7.1	6.0	14.8	23.5	26.6	19.5	24.3	14.2	6.8	26.1	11.6	14.9	22.1	22.1	40.0	24.1	38.2	32.3	9.8	28.7	38.5	51.7	31.5	13.8	20.4	14.3	79.7	16.7	48.2	18.8	19.7	16.4	6.3	12.1	14.9	26.5	6.0	24.7	40.2	46.6	20.6	18.7	32.7	23.1	35.3	16.0	61.8	45.2	37.0	34.1	45.2	20.5	11.9	25.0	21.5	23.8	35.7	13.1	12.2	85.9	33.4	9.0	13.1	10.7	23.8	19.4	12.2	19.0	31.9	16.2	66.5	18.7	1.6	10.1	5.9	6.7	13.4	7.0	7.1	5.3	8.9	12.1	6.2	7.4	6.7	2.0	9.9	9.9	16.8	7.6	8.1	13.6	14.6	15.3	16.6	15.0	14.7	15.3	14.3	15.3	14.7	15.8	14.8	6.1	9.6	11.5	19.6	13.5	3.6	6.2	14.9	8.0	24.8	7.3	7.0	21.7	10.0	10.7	3.7	27.1	27.7	12.2	12.6	7.9	13.6	4.2	7.4	8.7	7.6	13.1	14.9	24.7	13.8	24.1	9.8	17.9	7.8	9.5	17.8	10.0	28.2	20.4	13.5	27.1	12.6	8.2	7.1	5.1	7.2	5.6	8.0	8.8	4.7	7.1	18.6	9.2	14.1	16.1	10.7	5.9	11.3	24.4	4.6	8.9	21.0	6.7	32.2	6.6	8.9	9.6	24.5	24.0	11.0	5.7	21.1	8.9	25.0	14.9	4.8
FP565260.1		ENSG00000275464	"Periodic tryptophan protein 2 homolog"		21	5130871-5154658	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Alveolar cells type 2: 9.1;Ductal cells: 9.3;Exocrine glandular cells: 8.0;granulocytes: 5.1;Hofbauer cells: 6.3;Pancreatic endocrine cells: 8.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEL: 102.4"									HPA024573	Uncertain		Approved	Nucleoli,Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 2: Immune cells - Immune response"	"Cluster 36: HEL - Hemostasis"	"Cluster 1: Pancreatic cells - Digestion"	Nucleoli	Cytosol	"HPA024573: AB_1855963"	"unprognostic (3.37e-3)"	"unprognostic (4.09e-2)"	"unprognostic (4.43e-1)"	"unprognostic (9.66e-3)"	"unprognostic (2.58e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.16e-3)"	"unprognostic (1.34e-1)"	"unprognostic (2.30e-3)"	"unprognostic (8.40e-3)"	"unprognostic (5.16e-2)"	"unprognostic (1.07e-2)"	"unprognostic (9.34e-3)"	"unprognostic (1.74e-2)"	"unprognostic (5.76e-2)"	"unprognostic (5.96e-2)"	"unprognostic (1.11e-1)"	9.2	9.2	6.4	9.9	8.8	12.1	7.4	7.2	8.0	5.9	4.9	8.5	9.1	6.8	1.7	8.3	7.8	7.3	7.5	7.1	6.8	9.0	6.8	7.1	13.4	7.6	7.2	6.7	7.7	6.5	6.0	7.9	9.1	6.5	8.4	3.5	6.7	4.7	10.1	8.6	8.2	7.3	6.8	11.5	7.6	7.1	7.2	6.7	6.6	3.2	5.3	11.4	7.1	13.7	32.0	24.0	15.4	24.2	6.6	5.0	9.1	0.2	0.0	0.1	0.1	0.4	20.1	0.3	14.1	10.5	20.8	21.0	42.9	19.0	0.0	7.4	15.1	102.4	12.4	11.9	10.4	47.6	29.1	17.8	22.5	25.5	20.1	5.0	20.1	16.5	56.8	11.6	6.6	28.4	34.4	33.1	60.4	36.5	29.3	54.0	14.2	28.8	13.5	25.3	16.6	27.3	25.5	38.4	14.9	4.2	31.5	24.9	10.2	12.0	29.7	0.3	32.9	13.9	16.0	63.5	20.4	62.3	16.7	3.3	7.3	6.9	18.5	12.6	21.2	11.0	11.3	13.5	8.7	11.2	11.1	15.2	4.1	9.9	18.2	5.5	8.5	11.6	6.4	8.8	7.2	8.0	7.1	6.8	7.6	7.2	9.1	6.8	7.2	13.7	0.9	0.0	9.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	2.5	1.9	0.0	0.0	2.5	0.0	0.0	2.7	1.1	0.8	0.0	9.3	0.0	0.8	1.1	0.9	0.0	0.0	0.0	8.0	1.4	0.9	0.0	0.9	5.1	0.6	0.0	0.0	6.3	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	3.1	0.0	0.0	0.0	0.0	8.7	0.0	0.0	0.0	0.0	0.0	0.9	0.7	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	2.3	1.2	0.4	0.9	0.0
FRK	"GTK, PTK5, RAK"	ENSG00000111816	"Fyn related Src family tyrosine kinase"	P42685	6	115931149-116060891	"Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Kinase, Transferase, Tyrosine-protein kinase"	"FDA approved drug targets, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"choroid plexus: 13.7"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 89.4;Oligodendrocytes: 97.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"OE19: 18.3;RT4: 7.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB025217, HPA030479, HPA072590"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 21: OE19 - Mitochondria"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm	Cytosol	"CAB025217: , HPA030479: AB_2732457, HPA072590: "	"unprognostic (7.70e-3)"	"unprognostic (1.99e-2)"	"unprognostic (1.11e-1)"	"unprognostic (4.68e-3)"	"unprognostic (1.96e-1)"	"unprognostic (3.49e-2)"	"unprognostic (2.09e-1)"	"unprognostic (1.58e-1)"	"unprognostic (4.23e-2)"	"unprognostic (5.82e-3)"	"unprognostic (1.45e-1)"	"unprognostic (7.54e-2)"	"prognostic favorable (9.66e-7)"	"unprognostic (1.52e-2)"	"unprognostic (1.34e-1)"	"unprognostic (2.02e-2)"	"unprognostic (1.10e-1)"	0.8	1.1	1.3	1.2	2.1	1.5	2.4	5.8	5.0	1.8	13.7	4.6	6.2	1.0	2.5	2.9	2.6	2.6	1.8	1.8	0.0	9.0	6.8	1.8	0.7	0.3	0.1	0.9	2.8	1.0	0.4	0.8	1.0	2.2	4.8	2.9	4.0	2.4	2.2	1.9	6.3	0.8	0.2	0.9	4.9	1.9	1.1	1.2	1.0	0.8	1.6	2.1	1.0	5.7	2.5	4.0	0.5	0.9	0.2	0.2	0.6	0.5	0.1	0.0	0.1	3.1	3.8	0.9	3.5	0.5	0.5	5.8	0.2	1.1	0.1	3.3	0.3	1.3	3.3	2.7	0.2	0.9	0.7	0.2	1.5	0.3	0.4	0.4	0.2	0.6	0.6	2.3	1.0	1.3	0.7	0.5	1.0	18.3	0.7	1.1	3.3	1.2	4.8	7.6	0.7	0.8	0.7	5.1	0.5	0.9	1.5	0.7	0.8	1.0	1.0	0.7	0.5	3.6	2.7	1.6	1.1	0.6	0.6	0.9	0.2	0.2	0.4	0.1	0.5	0.2	0.3	0.4	0.1	0.4	0.2	0.3	0.8	0.3	0.2	0.3	0.2	0.0	1.3	2.1	5.8	5.0	1.8	0.0	0.3	0.1	1.0	0.2	1.1	5.7	0.4	0.0	10.3	10.4	0.5	2.7	20.8	23.3	6.8	0.6	7.3	2.9	9.2	11.5	22.6	23.9	0.0	4.4	0.1	34.9	11.7	20.3	89.4	28.1	1.7	0.7	19.8	0.0	12.2	16.4	4.3	3.5	29.0	30.4	3.8	0.2	1.4	21.9	0.9	6.7	7.7	14.5	34.6	0.6	0.4	38.1	0.6	0.6	0.0	1.0	1.0	0.2	0.0	2.5	97.8	21.9	23.3	1.2	0.5	23.4	49.3	28.4	36.6	0.3	13.1	9.9	16.2	4.6	1.0	16.4	3.1	0.8	1.0	2.3	19.1	46.2
FRMD7	"FLJ43346, NYS, NYS1"	ENSG00000165694	"FERM domain containing 7"	Q6ZUT3	X	132076990-132128020	"Cancer-related genes, Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	Neurogenesis		"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"endometrium 1: 2.9;kidney: 2.7;smooth muscle: 2.2"	"Cell type enriched"	"Detected in single"	19	"Distal tubular cells: 9.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"U-87 MG: 1.5"	"Region enriched"	"Detected in many"	28	"olfactory bulb: 65.7"	"Region enriched"	"Detected in single"	86	"olfactory bulb: 21.3"	HPA000886	Uncertain		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA				"Cluster 1: Thyroid gland - Transcription"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 39: Non-specific - Basic cellular processes"	"Plasma membrane, Cytosol"	Nucleoplasm	"HPA000886: AB_1079269"	"unprognostic (3.08e-2)"	"unprognostic (1.27e-1)"			"unprognostic (1.36e-1)"	"unprognostic (3.07e-1)"	"unprognostic (4.02e-2)"	"unprognostic (1.64e-2)"	"unprognostic (2.28e-1)"	"unprognostic (2.18e-2)"	"unprognostic (3.84e-1)"	"unprognostic (3.54e-2)"			"unprognostic (3.00e-1)"			0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.2	0.0	0.0	0.0	2.9	0.5	0.0	0.5	0.0	0.1	0.1	0.1	2.7	0.4	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.5	0.1	0.2	0.0	2.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.1	0.1	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	9.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
FRMD8	"FKSG44, FLJ90369, iTAP"	ENSG00000126391	"FERM domain containing 8"	Q9BZ67	11	65386621-65413525	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Suprabasal keratinocytes: 83.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"WM-115: 129.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002861	Approved		Approved	"Nucleoplasm,Plasma membrane,Centriolar satellite,Cytosol"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 71: Testis - DNA repair"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 28: Keratinocytes - Keratinization"	"Plasma membrane, Centriolar satellite"	"Nucleoplasm, Cytosol"	"HPA002861: AB_1078878"	"unprognostic (1.54e-1)"	"unprognostic (4.07e-1)"	"unprognostic (6.28e-2)"	"unprognostic (1.73e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.17e-1)"	"prognostic unfavorable (9.94e-5)"	"unprognostic (9.12e-3)"	"unprognostic (1.51e-2)"	"unprognostic (6.36e-3)"	"unprognostic (1.90e-2)"	"unprognostic (6.41e-3)"	"unprognostic (4.19e-3)"	"unprognostic (1.47e-2)"	"unprognostic (7.36e-3)"	"unprognostic (3.34e-1)"	"unprognostic (2.91e-2)"	19.8	17.5	9.6	11.8	11.0	13.0	19.7	12.2	14.5	20.8	9.1	15.0	11.7	14.6	5.3	37.3	15.8	11.6	17.1	13.1	7.9	19.7	13.4	23.5	15.6	12.9	11.3	12.2	23.0	4.0	11.6	10.4	11.4	15.8	6.7	1.7	18.0	6.5	14.8	34.0	23.8	6.6	9.5	40.8	13.4	18.0	11.5	11.1	17.8	5.1	13.6	14.6	26.4	16.2	17.8	22.1	8.7	20.4	23.0	12.0	15.6	20.1	18.1	16.7	12.7	21.2	28.5	21.9	41.9	27.6	11.6	30.3	11.3	16.9	7.0	38.8	10.6	29.9	21.5	11.7	12.4	16.9	44.8	14.9	13.2	15.7	8.2	8.9	26.6	23.2	25.5	23.5	18.3	23.9	26.6	24.6	10.2	13.0	28.7	33.7	16.6	25.2	13.5	21.8	18.9	14.0	15.0	60.1	47.7	7.7	22.0	13.7	23.6	18.4	19.7	26.1	12.3	41.0	22.5	20.4	16.0	10.7	129.8	1.1	12.4	17.7	13.1	13.2	14.1	12.5	9.6	16.7	11.3	9.6	8.8	9.8	23.0	8.2	19.6	13.4	10.8	12.3	9.6	11.0	12.2	14.5	13.1	7.9	12.9	11.3	11.4	9.5	11.5	16.2	30.3	3.2	5.8	2.0	20.5	54.3	22.5	17.7	6.2	5.4	15.4	12.6	7.4	12.8	13.8	12.9	0.0	6.4	25.8	29.3	7.9	21.0	22.3	20.1	12.1	24.8	13.1	24.0	13.4	29.1	15.5	13.0	10.7	23.1	14.0	27.3	37.5	11.0	16.0	5.0	4.9	20.5	8.2	20.2	68.7	4.6	6.2	18.7	19.6	10.3	21.6	4.3	18.6	5.0	10.3	33.8	14.0	7.2	11.9	28.1	32.8	4.6	14.3	4.5	6.6	11.4	14.4	5.3	9.6	24.9	83.5	11.4	21.9	35.2	14.6	35.7
FSBP		ENSG00000265817	"Fibrinogen silencer binding protein"	O95073	8	94378377-94436952	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 12.0"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 3.2;Endometrial ciliated cells: 15.3;Glandular and luminal cells: 6.2;Rod photoreceptor cells: 2.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA025059, HPA026509"	Approved		Supported	Nucleoplasm		NA	NA				"Cluster 77: Retina - Visual perception"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm		"HPA025059: AB_2671718, HPA026509: AB_10602307"																		0.7	1.0	1.2	0.5	1.5	1.4	1.4	1.6	1.7	1.7	3.7	0.6	0.6	1.5	2.6	1.1	1.6	0.9	1.3	0.9	1.2	1.0	1.2	0.7	0.9	1.2	2.3	2.7	1.0	1.1	1.6	0.9	1.0	1.9	0.7	12.0	1.1	2.1	1.3	1.5	0.7	0.8	1.3	0.8	1.4	1.8	1.8	1.2	1.1	0.6	0.8	1.5	1.1	1.3	3.7	1.7	7.6	3.8	1.1	1.3	1.3	1.4	1.4	1.5	1.3	1.9	1.9	2.6	4.1	1.1	1.2	0.9	4.7	2.4	2.6	2.6	1.8	2.9	1.4	1.6	3.3	1.9	0.8	2.4	0.5	2.1	6.4	2.5	2.4	9.0	4.5	4.4	1.4	2.4	6.6	2.3	4.9	1.4	1.1	1.4	4.4	2.5	4.0	5.1	2.5	3.0	0.9	0.3	4.6	5.9	2.5	0.7	2.1	3.0	1.3	1.6	1.5	1.3	1.9	1.3	1.8	2.8	3.4	0.1	0.0	0.0	0.1	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.4	0.2	0.1	0.1	0.0	0.0	0.0	0.0	1.2	1.5	1.6	1.7	0.9	1.2	1.2	2.3	1.0	1.3	1.8	1.3	0.6	3.2	0.0	0.0	0.0	0.0	0.0	0.2	0.6	1.1	0.2	0.3	0.0	0.0	0.6	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	15.3	1.8	0.2	0.0	0.0	0.0	0.0	0.0	0.5	2.0	6.2	0.0	1.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.4	0.0	0.0	0.2	0.0	0.0	0.9	0.0	0.0	0.5	0.9	0.0	0.0
FSCN1	"FLJ38511, p55, SNL"	ENSG00000075618	"Fascin actin-bundling protein 1"	Q16658	7	5592816-5606655	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"		Actin-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Granulosa cells: 256.5;Hofbauer cells: 274.2;monocytes: 1028.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"myeloid DC: 2.1"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"BEWO: 600.3;Hep G2: 464.9;K-562: 533.6;NB-4: 600.9;PC-3: 508.2;SH-SY5Y: 482.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000121, HPA005723, CAB035991, HPA050654"	Enhanced		Supported	"Plasma membrane,Cytosol"		NA	Yes		4300000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 24: NB-4 - Immune response"	"Cluster 3: Monocytes - Immune response regulation"	Cytosol	"Plasma membrane"	"CAB000121: AB_2278596, CAB035991: , HPA005723: AB_1849159, HPA050654: AB_2681203"	"unprognostic (1.91e-1)"	"unprognostic (2.03e-2)"	"unprognostic (3.12e-2)"	"unprognostic (5.00e-3)"	"unprognostic (1.18e-1)"	"prognostic unfavorable (5.76e-4)"	"unprognostic (2.16e-3)"	"prognostic unfavorable (2.28e-4)"	"unprognostic (6.31e-2)"	"unprognostic (1.25e-1)"	"unprognostic (3.27e-3)"	"unprognostic (1.54e-1)"	"prognostic unfavorable (8.15e-7)"	"unprognostic (1.21e-2)"	"unprognostic (8.57e-2)"	"unprognostic (1.05e-2)"	"unprognostic (6.93e-3)"	27.5	39.7	41.5	31.1	62.2	8.3	24.9	26.3	57.2	33.7	10.7	12.1	4.4	19.7	0.7	69.4	15.6	7.6	15.8	39.4	28.2	17.3	8.3	27.6	14.5	49.4	42.7	47.7	5.5	2.3	20.2	27.9	22.8	10.3	1.7	3.4	23.8	2.4	7.3	56.3	12.6	5.7	20.9	55.6	9.3	42.5	79.0	9.0	25.6	2.1	8.3	20.4	41.6	77.1	62.3	139.3	91.2	326.3	34.8	65.4	600.3	144.2	62.4	24.2	26.1	98.5	15.6	1.3	172.0	63.5	24.3	231.3	52.2	229.9	2.1	70.6	28.7	4.8	142.0	464.9	18.0	0.2	13.9	40.8	66.6	46.1	37.2	40.4	118.3	0.7	533.6	0.9	31.6	6.9	2.0	600.9	238.4	4.2	508.2	140.0	22.3	2.3	34.9	5.9	73.1	482.4	121.0	2.6	5.3	58.5	3.9	38.4	246.4	167.4	289.3	99.1	151.0	0.9	0.8	0.7	107.8	0.6	317.2	0.0	0.8	0.0	0.0	0.2	0.0	0.1	0.0	0.0	2.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.7	41.5	62.2	26.3	57.2	39.4	28.2	49.4	42.7	22.8	20.9	79.0	77.1	90.0	3.2	4.1	1.6	8.3	181.2	26.7	75.1	189.5	9.4	32.3	44.3	10.4	1.5	13.4	1.8	0.0	6.7	10.8	3.9	0.0	12.8	14.3	8.0	37.8	120.6	42.1	28.0	12.1	5.1	110.8	48.9	10.7	10.1	16.5	256.5	84.6	0.8	274.2	0.0	10.9	5.4	8.2	28.0	136.1	12.3	25.4	27.4	51.6	23.4	1028.2	73.5	0.0	4.5	43.2	15.5	1.1	9.1	4.2	7.5	0.4	0.4	2.9	2.6	0.0	29.7	46.3	5.7	8.0	121.2	147.2	14.6	12.2	8.3	2.6	28.0
FSTL3	"FLRG, FSRP"	ENSG00000070404	"Follistatin like 3"	O95633	19	676392-683392	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Predicted secreted proteins"	"Osteogenesis, Transcription, Transcription regulation"		"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	4	"Extravillous trophoblasts: 3647.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"BEWO: 164.7;hTCEpi: 181.2;SiHa: 341.5;U-2197: 173.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB024899, HPA045378"	Approved		Supported	Nucleoplasm	"Secreted in other tissues"	NA	Yes		7000000	"Cluster 7: Monocytes - Unknown function"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 20: HeLa - Mitochondria"	"Cluster 38: Extravillous trophoblasts - Unknown function"	Nucleoplasm		"CAB024899: , HPA045378: AB_2679300"	"unprognostic (9.86e-3)"	"unprognostic (1.32e-3)"	"prognostic unfavorable (3.01e-4)"	"prognostic unfavorable (3.03e-4)"	"unprognostic (2.19e-3)"	"unprognostic (1.51e-3)"	"unprognostic (8.64e-3)"	"prognostic unfavorable (4.61e-7)"	"unprognostic (9.50e-2)"	"prognostic unfavorable (1.65e-4)"	"unprognostic (3.50e-2)"	"unprognostic (5.91e-2)"	"unprognostic (1.03e-3)"	"unprognostic (7.22e-3)"	"unprognostic (3.07e-1)"	"unprognostic (3.75e-1)"	"unprognostic (5.89e-3)"	82.9	163.3	16.6	24.1	15.3	13.3	62.4	13.3	19.8	75.6	16.0	82.7	7.7	62.0	6.1	22.0	70.2	16.5	124.1	16.4	17.3	55.9	26.2	132.7	5.5	22.6	16.0	63.8	49.3	3.2	28.9	179.4	17.9	74.9	5.9	2.4	21.1	22.1	11.7	32.3	36.5	42.4	16.7	22.6	43.2	75.2	18.1	2.3	37.9	4.9	1.6	70.5	63.1	18.9	9.5	74.0	5.1	3.7	22.3	56.4	164.7	126.1	18.5	30.7	11.3	27.1	14.4	4.1	49.4	84.7	17.6	65.2	4.1	106.4	10.1	7.8	8.7	3.5	110.2	22.4	95.6	6.7	12.0	70.7	181.2	34.0	140.2	79.3	5.5	3.9	8.2	5.3	46.7	33.1	2.4	4.0	6.2	62.0	26.2	7.2	3.4	8.7	43.1	1.7	3.3	5.7	341.5	6.9	4.3	6.4	6.2	3.5	75.5	30.6	106.6	173.4	46.9	8.5	4.4	2.3	4.7	20.0	14.2	0.0	1.9	0.0	0.4	1.8	0.0	0.1	0.6	0.4	0.9	0.3	1.0	0.6	0.0	0.2	1.4	0.3	0.0	0.9	16.6	15.3	13.3	19.8	16.4	17.3	22.6	16.0	17.9	16.7	18.1	18.9	4.6	19.2	1.9	40.5	1.5	14.5	31.0	11.7	1.8	1.3	11.3	7.9	16.7	32.9	4.4	9.2	0.0	53.9	1.0	1.1	7.9	86.1	8.8	6.4	14.8	8.7	1.2	1.7	9.8	64.3	3647.6	59.6	2.0	18.3	0.0	5.7	16.4	1.9	77.1	3.3	8.4	1.0	0.0	3.7	4.8	7.6	61.2	7.4	5.4	2.8	10.6	6.6	1.0	6.0	5.5	306.5	0.2	26.7	1.0	78.0	1.2	17.7	3.1	1.1	46.0	22.4	57.0	4.6	5.6	4.3	7.7	792.0	2.0	3.6	2.5	30.7
FTO	"ALKBH9, KIAA1752, MGC5149"	ENSG00000140718	"FTO alpha-ketoglutarate dependent dioxygenase"	Q9C0B1	16	53701692-54158512	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"		"Dioxygenase, Oxidoreductase, Transferase"	"Disease variant, Obesity"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Astrocytes: 173.3;Excitatory neurons: 226.1;Inhibitory neurons: 240.7;Oligodendrocyte precursor cells: 210.6;Oligodendrocytes: 282.5;Respiratory ciliated cells: 182.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017123, HPA041086, HPA068695"	Enhanced		Supported	Vesicles,Cytosol		No	No		540000	"Cluster 27: Non-specific - Gene expression"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Cytosol	Vesicles	"CAB017123: , HPA041086: AB_2677293, HPA068695: AB_2732117"	"unprognostic (9.74e-2)"	"unprognostic (2.49e-1)"	"unprognostic (9.30e-2)"	"unprognostic (1.24e-2)"	"unprognostic (1.81e-1)"	"unprognostic (2.09e-2)"	"unprognostic (2.95e-2)"	"unprognostic (1.41e-1)"	"unprognostic (8.67e-2)"	"unprognostic (1.02e-1)"	"unprognostic (3.88e-2)"	"unprognostic (6.80e-2)"	"unprognostic (1.44e-1)"	"unprognostic (5.81e-3)"	"unprognostic (1.78e-1)"	"unprognostic (4.30e-3)"	"unprognostic (6.11e-3)"	24.4	33.6	31.8	12.5	36.6	8.2	36.3	30.1	37.7	25.8	31.0	22.2	7.7	26.9	21.4	17.2	25.3	21.6	27.1	35.2	39.5	25.0	17.4	36.8	15.0	29.2	31.3	27.2	20.7	40.6	26.2	20.1	31.9	20.0	14.1	38.4	18.9	23.9	33.1	21.4	12.5	29.9	30.5	16.4	15.0	8.3	33.8	17.0	27.5	23.0	14.8	21.9	18.5	43.9	15.1	26.8	35.0	35.9	67.3	50.4	11.5	35.6	32.2	29.3	8.5	16.8	19.3	34.4	38.2	46.3	16.6	21.7	32.4	34.9	42.5	16.0	25.5	15.5	33.6	31.7	46.2	12.5	17.1	55.9	36.5	26.6	32.5	36.6	44.1	25.1	15.2	8.4	48.1	11.8	28.0	19.2	18.1	15.5	17.5	42.2	52.9	32.3	44.6	12.3	43.0	29.7	40.4	23.6	10.8	33.7	31.1	29.3	42.4	36.4	23.9	19.8	22.1	15.9	13.9	35.0	33.9	22.9	28.7	14.9	17.9	9.7	25.6	22.7	32.4	17.6	24.4	25.9	23.8	17.4	22.5	24.4	2.9	26.4	16.5	9.5	26.6	23.1	31.8	36.6	30.1	37.7	35.2	39.5	29.2	31.3	31.9	30.5	33.8	43.9	15.1	80.1	62.0	173.3	10.3	12.4	10.0	8.6	13.6	22.8	69.1	39.5	22.3	15.7	54.4	7.3	12.5	9.3	10.2	4.8	7.9	9.0	39.1	11.0	18.3	17.4	6.6	9.7	226.1	5.7	7.4	23.1	9.7	9.9	25.9	16.8	11.0	13.8	9.2	16.8	240.7	6.6	10.2	9.0	13.2	69.9	14.3	11.8	10.6	134.0	5.5	19.6	10.3	210.6	282.5	5.5	5.0	15.1	18.7	6.0	4.5	15.8	182.7	14.1	13.1	21.6	16.8	3.5	3.4	11.0	9.1	5.1	12.9	17.8	6.3	7.9
FUCA1		ENSG00000179163	"Alpha-L-fucosidase 1"	P04066	1	23845077-23868290	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Glycosidase, Hydrolase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 181.7;Distal enterocytes: 226.6;Paneth cells: 221.0;Proximal enterocytes: 210.9;Syncytiotrophoblasts: 200.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 165.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046542, HPA056371"	Enhanced		Supported	Vesicles	"Intracellular and membrane"	NA	NA		60000000	"Cluster 14: Monocytes - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 4: Macrophages - Innate immune response"	Vesicles		"HPA046542: AB_2679691, HPA056371: AB_2683108"	"unprognostic (6.94e-3)"	"unprognostic (6.53e-2)"	"unprognostic (2.68e-3)"	"prognostic favorable (2.45e-4)"	"unprognostic (5.64e-3)"	"unprognostic (2.59e-3)"	"unprognostic (1.56e-2)"	"unprognostic (1.79e-3)"	"unprognostic (4.99e-1)"	"unprognostic (2.18e-2)"	"unprognostic (2.05e-1)"	"unprognostic (4.23e-2)"	"prognostic favorable (5.70e-13)"	"unprognostic (3.75e-2)"	"unprognostic (4.35e-2)"	"unprognostic (1.54e-2)"	"unprognostic (2.13e-3)"	34.2	34.4	8.3	49.8	8.2	7.7	26.3	8.3	11.2	54.5	23.8	124.2	90.3	20.7	113.0	17.0	51.1	46.6	20.6	8.3	10.5	78.2	104.8	55.1	168.2	9.5	8.8	23.8	23.9	56.9	17.6	72.6	9.6	50.2	140.7	5.7	40.8	60.4	15.8	14.9	81.3	26.7	9.3	71.8	63.9	27.7	10.8	26.8	70.6	17.7	94.1	74.9	13.2	12.8	15.9	10.6	2.2	31.9	4.2	0.3	11.0	16.6	34.4	17.1	31.6	14.5	165.1	23.9	40.9	21.3	18.8	9.4	15.3	35.4	22.4	16.9	25.6	19.7	9.2	32.7	14.2	2.0	62.7	15.3	19.7	6.2	8.1	55.2	6.9	13.3	9.3	0.5	20.6	17.5	5.0	17.7	5.4	48.1	16.9	26.9	0.2	26.2	63.5	40.5	10.9	10.6	47.9	18.5	26.2	17.9	13.6	7.8	1.8	5.8	9.0	38.9	5.6	28.5	31.0	8.5	14.5	58.9	9.5	54.8	100.4	51.9	27.2	99.9	23.1	23.8	19.5	22.9	44.0	14.1	18.9	22.0	12.8	44.6	91.1	25.4	21.4	64.8	8.3	8.2	8.3	11.2	8.3	10.5	9.5	8.8	9.6	9.3	10.8	12.8	12.9	25.6	28.6	4.2	10.5	3.6	27.4	99.3	6.8	4.4	22.2	10.4	5.6	40.0	77.8	84.6	0.0	181.7	13.9	226.6	15.6	64.1	61.0	31.5	2.8	11.6	10.8	20.6	5.8	50.3	24.2	16.7	33.1	13.3	8.2	11.1	25.7	42.7	156.4	0.0	6.3	44.4	44.7	121.0	13.5	24.4	23.3	85.4	8.8	2.8	29.6	13.0	10.3	4.0	4.7	34.9	221.0	19.5	8.7	23.6	210.9	40.2	53.7	5.0	6.6	16.7	13.2	109.0	24.8	8.5	2.8	200.6	11.2	34.6	79.5	40.3
FURIN	"FUR, PACE, PCSK3, SPC1"	ENSG00000140564	"Furin, paired basic amino acid cleaving enzyme"	P09958	15	90868588-90883564	"Enzymes, Plasma proteins, Predicted membrane proteins"	"Host-virus interaction"	"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 305.6;salivary gland: 220.5"	"Cell type enhanced"	"Detected in many"		"Exocrine glandular cells: 117.5;Hepatocytes: 131.8;Pancreatic endocrine cells: 108.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009499, HPA067869"	Enhanced		Supported	"Nucleoplasm,Golgi apparatus"	"Intracellular and membrane"	NA	NA		130000	"Cluster 10: Basophils - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 1: Pancreatic cells - Digestion"	"Golgi apparatus"	Nucleoplasm	"CAB009499: AB_2105095, HPA067869: "	"unprognostic (2.46e-1)"	"unprognostic (2.73e-2)"	"unprognostic (7.33e-2)"	"unprognostic (2.30e-2)"	"unprognostic (4.11e-3)"	"unprognostic (4.37e-2)"	"unprognostic (8.11e-2)"	"prognostic unfavorable (1.58e-4)"	"unprognostic (2.24e-1)"	"unprognostic (9.92e-3)"	"unprognostic (1.78e-1)"	"unprognostic (1.96e-1)"	"unprognostic (4.52e-3)"	"unprognostic (4.57e-2)"	"unprognostic (4.46e-2)"	"unprognostic (4.27e-3)"	"unprognostic (8.20e-2)"	54.5	24.4	12.8	36.4	10.5	73.8	42.4	10.6	14.5	26.4	11.7	32.8	27.6	32.3	9.8	33.7	30.4	19.4	58.5	14.9	9.0	56.8	305.6	63.2	13.0	12.5	10.8	22.4	108.6	27.3	45.9	40.6	11.3	60.1	12.1	12.9	220.5	17.7	61.3	62.7	35.5	14.3	10.4	51.4	34.0	8.6	15.6	11.8	56.1	25.3	11.2	30.2	33.3	9.3	50.8	31.2	6.8	29.8	49.4	32.1	77.5	64.4	48.1	26.3	18.1	45.4	54.3	1.9	148.8	47.5	46.1	91.5	14.0	32.5	5.4	148.0	35.2	90.9	52.8	57.7	26.2	13.0	141.2	35.6	35.3	29.5	13.2	62.4	84.7	14.6	70.5	8.5	17.8	32.3	5.0	29.2	21.5	44.2	9.3	7.9	26.6	10.9	35.2	39.1	13.1	9.2	54.5	28.5	42.5	31.9	10.7	31.4	125.9	29.4	60.1	43.7	95.5	15.2	93.4	3.4	55.8	40.1	60.7	2.0	0.9	1.5	0.7	0.1	0.2	0.4	0.2	0.3	0.6	0.1	0.0	0.1	0.7	0.4	0.0	0.3	0.0	1.1	12.8	10.5	10.6	14.5	14.9	9.0	12.5	10.8	11.3	10.4	15.6	9.3	44.1	3.2	27.4	4.2	7.3	19.4	10.0	10.4	2.8	12.8	12.0	9.0	16.3	21.5	8.5	22.0	25.0	20.9	26.9	49.5	0.0	47.1	0.5	15.2	9.7	29.4	37.8	26.5	7.9	117.5	16.5	11.4	21.9	32.3	15.8	7.0	23.9	131.8	24.8	8.4	7.5	31.7	10.2	35.3	42.1	1.4	11.1	33.6	16.0	5.6	14.0	13.6	24.7	2.0	4.4	108.3	26.4	10.9	7.2	24.3	28.7	7.8	2.0	28.0	26.3	10.5	18.6	2.8	3.6	8.5	23.0	84.3	19.6	4.7	17.9	16.4
FUS	"ALS6, FUS1, hnRNP-P2, HNRNPP2, TLS"	ENSG00000089280	"FUS RNA binding protein"	P35637	16	31180138-31191605	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"		"DNA-binding, RNA-binding"	"Amyotrophic lateral sclerosis, Cancer-related genes, Disease variant, Neurodegeneration, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008784, CAB033036, CAB058691"	Supported		Supported	Nucleoplasm		NA	NA		480000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm		"CAB033036: AB_2105208, CAB058691: AB_2665583, HPA008784: AB_1849181"	"unprognostic (3.06e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.86e-2)"	"unprognostic (8.68e-2)"	"unprognostic (1.44e-1)"	"unprognostic (8.03e-2)"	"prognostic unfavorable (4.38e-4)"	"unprognostic (2.15e-2)"	"unprognostic (1.00e-1)"	"unprognostic (5.22e-3)"	"unprognostic (1.01e-1)"	"unprognostic (1.01e-3)"	"unprognostic (1.12e-3)"	"unprognostic (1.87e-1)"	"unprognostic (5.27e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.49e-2)"	88.6	47.6	43.6	102.9	48.6	98.9	65.1	50.6	59.2	85.3	27.2	72.5	59.5	102.0	40.9	58.5	99.2	38.8	70.4	46.9	48.6	83.6	54.3	64.8	97.9	44.3	43.0	134.2	57.3	85.0	47.2	58.3	46.9	59.1	62.8	59.4	60.0	70.4	98.6	53.8	62.6	98.1	45.7	69.3	59.4	69.1	44.8	174.1	58.6	86.0	113.2	87.5	63.2	52.1	386.6	337.2	492.6	292.9	128.3	101.7	429.3	504.1	253.1	319.6	238.3	440.7	254.9	579.6	359.3	310.7	349.4	173.0	563.6	421.0	284.3	341.5	304.7	486.6	224.6	445.3	222.7	529.7	348.5	222.4	99.8	437.5	258.9	120.1	295.7	419.6	537.6	204.7	357.0	483.0	446.2	475.5	649.0	307.7	402.0	677.0	535.9	350.1	344.0	265.6	279.1	478.9	344.5	255.7	267.8	314.9	291.8	597.5	276.3	371.5	365.5	242.1	520.5	181.4	350.4	779.0	204.4	364.2	460.9	12.3	38.2	52.8	53.6	67.3	49.9	29.1	36.5	45.9	41.7	35.2	40.3	43.9	35.0	37.3	59.3	50.3	31.0	27.4	43.6	48.6	50.6	59.2	46.9	48.6	44.3	43.0	46.9	45.7	44.8	52.1	414.6	102.5	121.2	58.1	470.7	144.8	345.7	201.0	507.6	272.6	209.8	223.8	102.1	112.9	156.3	104.8	131.3	299.3	488.8	266.8	68.4	183.6	130.8	201.0	366.1	278.4	212.1	188.2	75.4	154.8	398.5	309.0	222.8	309.7	229.7	445.0	174.2	59.1	208.5	201.9	85.9	229.5	132.2	148.4	270.7	51.2	307.3	282.7	165.4	94.6	185.4	230.8	341.9	117.6	122.2	175.7	219.4	215.5	266.6	245.4	205.4	69.7	115.4	266.3	164.3	584.4	344.2	221.0	237.1	443.6	154.3	295.1	518.2	327.9	232.6	281.2
FUT6	"FCT3A, FLJ40754, FT1A, FucT-VI"	ENSG00000156413	"Fucosyltransferase 6"	P51993	19	5830408-5839722	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 79.4;kidney: 36.1;salivary gland: 45.7"	"Cell type enhanced"	"Detected in some"		"Distal enterocytes: 35.6;Intestinal goblet cells: 39.4;Paneth cells: 21.5;Proximal enterocytes: 101.4;Proximal tubular cells: 45.3;Undifferentiated cells: 29.0"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 9.8"	"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in single"		"basophil: 1.3"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in some"	6	"Hep G2: 10.5;RPMI-8226: 4.0"									"HPA043707, HPA046966"	Approved		Supported	"Golgi apparatus"	"Secreted to blood"	NA	NA		51000	"Cluster 10: Basophils - Unknown function"	"Cluster 37: Intestine - Unknown function"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 45: Enterocytes - Digestion"	"Golgi apparatus"		"HPA043707: AB_2678628, HPA046966: AB_2679879"	"unprognostic (3.65e-2)"	"unprognostic (3.00e-3)"	"unprognostic (2.13e-3)"	"unprognostic (2.78e-3)"	"unprognostic (6.35e-2)"	"prognostic favorable (2.12e-4)"	"unprognostic (8.02e-2)"	"unprognostic (6.68e-3)"	"unprognostic (4.01e-2)"	"unprognostic (8.53e-2)"	"unprognostic (2.62e-2)"	"unprognostic (4.94e-2)"	"prognostic favorable (3.17e-8)"	"unprognostic (1.05e-2)"	"unprognostic (1.38e-1)"	"unprognostic (2.40e-1)"	"unprognostic (1.27e-1)"	0.1	0.0	0.1	2.6	0.1	0.4	1.7	0.2	0.1	17.3	0.4	17.3	28.6	0.3	0.0	79.4	0.6	9.3	0.0	0.1	0.1	36.1	12.4	0.2	0.1	0.1	0.1	0.0	3.7	0.0	0.0	0.0	0.1	0.2	11.6	2.0	45.7	2.5	0.0	0.1	27.0	0.4	0.1	0.1	4.8	0.2	0.1	0.0	0.0	0.0	6.7	0.0	26.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.0	0.2	10.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.2	0.0	0.0	0.7	4.0	0.2	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.2	0.0	1.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.6	0.0	0.1	0.0	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.2	0.0	0.5	0.0	0.7	0.0	0.4	3.5	0.0	0.4	3.7	1.9	0.3	18.6	15.7	1.8	0.0	0.2	0.3	35.6	3.9	6.8	0.3	0.6	0.7	0.3	4.9	0.0	0.1	0.4	0.1	0.3	0.0	0.7	0.0	0.2	0.7	5.1	0.1	0.0	0.1	39.4	8.2	0.0	0.8	0.0	0.3	0.4	0.0	0.0	0.0	0.9	0.0	0.5	0.1	2.7	21.5	0.0	0.0	0.2	101.4	45.3	6.4	11.5	0.0	0.3	0.7	1.0	0.6	3.6	0.1	0.0	0.5	0.1	29.0	1.7
FXN	"CyaY, FA, FARR, FRDA, X25"	ENSG00000165060	Frataxin	Q16595	9	69035751-69079076	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Heme biosynthesis, Ion transport, Iron storage, Iron transport, Transport"	Oxidoreductase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Hepatocytes: 69.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022164, HPA068304"	Supported		Supported	Mitochondria,Cytosol		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 55: Plasma cells - Humoral immune response"	Mitochondria	Cytosol	"CAB022164: , HPA068304: AB_2685970"	"unprognostic (3.38e-2)"	"unprognostic (1.54e-1)"	"unprognostic (7.47e-2)"	"unprognostic (2.37e-3)"	"unprognostic (4.08e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.99e-1)"	"unprognostic (4.19e-2)"	"unprognostic (2.53e-1)"	"unprognostic (2.71e-3)"	"unprognostic (1.10e-1)"	"unprognostic (9.06e-2)"	"unprognostic (1.67e-1)"	"unprognostic (4.74e-2)"	10.3	20.1	8.9	7.8	9.2	29.1	10.1	9.7	8.9	9.3	11.7	10.4	7.4	12.1	12.1	9.5	10.2	5.3	27.0	9.0	10.4	12.9	46.3	7.1	9.8	9.8	10.2	17.6	15.1	22.2	8.1	9.1	9.8	10.2	12.3	4.1	11.7	13.6	25.5	5.2	7.7	13.3	9.5	12.6	10.1	10.7	9.9	5.4	10.4	19.8	10.4	12.3	7.9	10.4	27.0	22.1	34.2	17.0	15.7	23.1	34.3	18.6	16.3	28.0	21.2	11.8	16.6	45.9	14.0	19.5	28.8	28.6	41.8	42.6	34.9	53.9	47.5	66.2	14.1	87.2	26.7	48.7	27.7	25.7	33.7	27.8	29.9	9.6	37.7	28.0	50.3	43.9	26.1	25.6	14.0	21.0	47.5	53.1	42.8	32.7	24.0	32.0	32.2	21.5	26.9	12.1	19.2	12.5	20.7	24.3	14.1	14.4	22.7	18.0	32.0	24.1	27.6	11.6	11.4	27.8	8.5	39.7	18.5	8.1	39.9	0.4	48.6	45.4	37.5	36.3	48.0	48.4	42.8	22.7	61.6	59.8	1.9	60.8	36.2	33.2	43.3	49.5	8.9	9.2	9.7	8.9	9.0	10.4	9.8	10.2	9.8	9.5	9.9	10.4	11.0	3.2	11.5	13.1	19.9	9.7	19.8	36.6	14.8	6.8	16.9	20.8	38.2	10.0	10.5	14.7	4.2	39.9	14.9	4.9	21.5	17.5	2.4	11.7	22.5	16.9	7.2	56.1	14.2	14.7	22.3	14.7	14.3	8.7	7.0	15.4	11.0	69.0	33.4	0.0	18.6	15.3	18.3	22.1	16.1	6.3	15.8	13.9	17.8	9.4	18.3	7.6	28.8	6.6	10.8	15.0	3.7	13.2	42.0	17.1	5.8	27.2	7.4	1.6	13.1	10.1	19.8	5.1	32.3	29.8	8.1	14.6	17.1	27.9	17.5	14.1
FXR2	FMR1L2	ENSG00000129245	"FMR1 autosomal homolog 2"	P51116	17	7591230-7614897	"Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 120.9"	"Cell type enhanced"	"Detected in many"		"Horizontal cells: 63.9;Rod photoreceptor cells: 55.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011205, HPA022997"	Supported		Supported	Cytosol		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 62: Horizontal cells - Visual perception"	Cytosol		"CAB011205: AB_476964, HPA022997: AB_1849208"	"unprognostic (9.57e-2)"	"unprognostic (1.23e-1)"	"unprognostic (5.15e-3)"	"unprognostic (2.61e-1)"	"unprognostic (1.62e-1)"	"unprognostic (7.56e-3)"	"unprognostic (1.96e-1)"	"unprognostic (3.50e-3)"	"unprognostic (2.15e-1)"	"unprognostic (2.18e-1)"	"prognostic favorable (3.49e-6)"	"unprognostic (2.79e-1)"	"unprognostic (1.28e-2)"	"unprognostic (2.46e-1)"	"unprognostic (2.64e-1)"	"unprognostic (7.79e-2)"	"unprognostic (7.67e-2)"	19.7	27.9	31.5	11.4	34.3	9.8	17.4	36.5	37.9	21.2	26.9	26.7	13.9	21.7	11.6	20.9	20.1	10.9	66.0	33.2	40.0	22.2	20.6	19.2	14.1	41.1	40.9	20.4	16.2	30.7	33.0	15.5	43.4	21.6	11.5	37.7	19.9	18.2	120.9	22.5	17.4	17.1	33.4	16.8	19.9	27.4	37.2	20.8	17.1	84.4	15.1	23.3	19.4	34.9	36.6	48.3	43.8	45.7	36.7	25.0	33.7	54.2	45.1	77.2	53.2	27.2	11.9	33.8	34.8	37.2	34.1	40.1	58.2	24.8	51.4	39.1	62.4	19.6	42.2	15.9	35.7	0.2	39.8	23.5	35.8	58.8	56.4	43.3	27.1	26.9	35.4	11.6	38.8	18.6	26.9	19.3	26.2	18.9	25.8	37.9	26.6	21.3	28.2	13.0	26.1	47.2	37.3	24.3	37.8	41.3	25.3	14.5	24.3	36.0	22.5	24.0	64.8	19.0	18.6	15.5	41.3	15.8	48.0	2.6	0.8	2.5	0.9	1.0	1.3	0.5	1.5	1.9	1.3	0.9	1.2	1.3	2.1	1.0	0.6	0.9	1.8	0.8	31.5	34.3	36.5	37.9	33.2	40.0	41.1	40.9	43.4	33.4	37.2	34.9	10.3	32.1	17.9	10.7	7.7	11.5	15.4	7.9	2.8	46.9	10.4	8.3	41.7	8.6	9.5	16.5	31.3	15.9	15.1	12.0	1.9	11.6	1.8	11.1	9.2	10.5	9.6	15.6	10.3	9.3	11.5	10.8	10.7	11.0	2.5	12.9	15.0	11.7	9.1	63.9	12.0	10.1	10.2	7.3	9.7	2.7	9.6	7.1	0.0	3.7	7.4	23.3	16.5	8.5	12.4	17.6	12.5	15.4	6.3	15.4	15.5	8.9	7.6	55.8	6.6	14.2	17.7	22.9	28.2	8.7	14.3	17.1	7.6	14.6	7.4	10.3
FYTTD1	"DKFZp761B1514, UIF"	ENSG00000122068	"Forty-two-three domain containing 1"	Q96QD9	3	197737179-197787596	"Predicted intracellular proteins"	"mRNA transport, Transport"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054474, HPA074880"	Enhanced		Supported	"Nuclear speckles"		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 65: Plasmacytoid DCs - Unknown function"	"Nuclear speckles"		"HPA054474: , HPA074880: "	"unprognostic (3.61e-2)"	"unprognostic (6.01e-2)"	"unprognostic (4.88e-2)"	"prognostic unfavorable (3.08e-4)"	"unprognostic (2.33e-2)"	"unprognostic (3.80e-1)"	"unprognostic (3.69e-2)"	"unprognostic (9.57e-3)"	"unprognostic (4.44e-2)"	"unprognostic (1.66e-1)"	"unprognostic (5.04e-3)"	"unprognostic (8.74e-2)"	"unprognostic (8.49e-3)"	"unprognostic (3.40e-2)"	"unprognostic (3.36e-1)"	"unprognostic (3.29e-1)"	"unprognostic (3.15e-1)"	29.7	20.9	12.1	27.1	12.6	39.2	26.6	16.1	14.6	24.8	9.1	19.9	16.7	30.4	19.6	43.9	19.1	24.4	41.3	12.1	14.9	25.7	28.9	23.6	32.4	12.4	13.9	27.5	36.4	28.7	12.6	33.5	13.0	25.1	21.6	33.8	18.2	28.8	92.6	27.1	19.3	34.9	12.8	26.3	18.2	41.1	13.3	34.1	29.6	67.0	37.7	33.6	16.9	14.9	104.5	22.6	43.7	41.7	50.1	55.3	13.4	50.0	50.8	75.4	61.4	35.3	34.8	66.4	177.1	59.3	40.0	36.7	55.5	51.0	79.8	14.5	24.9	99.8	32.9	16.1	48.9	75.1	46.5	40.0	64.6	40.8	58.3	52.1	60.4	36.8	45.9	139.0	67.6	86.9	82.2	18.1	9.6	45.1	41.2	74.9	53.6	47.4	54.8	67.3	82.4	35.7	76.8	60.0	56.4	31.8	141.2	39.1	54.0	38.5	38.1	49.0	53.6	83.5	137.2	79.3	40.8	106.4	40.6	59.2	26.9	26.5	32.4	31.8	40.7	20.0	30.7	35.9	29.9	18.9	33.4	32.2	8.5	64.6	31.0	16.9	30.2	45.7	12.1	12.6	16.1	14.6	12.1	14.9	12.4	13.9	13.0	12.8	13.3	14.9	60.6	35.3	27.2	14.7	78.5	82.3	46.6	24.3	42.7	35.1	47.0	34.4	109.7	25.8	30.1	47.8	31.3	24.4	63.9	19.0	90.1	35.5	21.7	27.3	58.9	55.2	56.4	25.2	23.7	36.1	27.5	53.7	30.1	42.6	66.6	29.4	36.4	50.7	38.0	45.4	19.6	23.7	28.5	48.6	67.8	18.3	32.0	54.8	51.6	22.5	108.6	41.8	82.4	19.6	23.0	34.3	16.5	37.2	65.4	74.5	17.1	51.1	44.6	45.2	39.5	45.8	63.1	96.3	90.7	54.0	91.1	50.1	60.7	51.9	20.0	63.6
FZD1	DKFZp564G072	ENSG00000157240	"Frizzled class receptor 1"	Q9UP38	7	91264433-91271326	"Cancer-related genes, G-protein coupled receptors, Plasma proteins, Predicted membrane proteins, Transporters"	"Wnt signaling pathway"	"Developmental protein, G-protein coupled receptor, Receptor, Transducer"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 44.9;Cholangiocytes: 45.8;Horizontal cells: 141.3;Peritubular cells: 45.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"intermediate monocyte: 2.0;non-classical monocyte: 2.8"	"Lineage enriched"	"Detected in single"	5	"monocytes: 2.8"	"Cell line enhanced"	"Detected in many"		"AF22: 24.8;HSkMC: 32.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB013008	Approved		Supported	"Plasma membrane"		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 62: Horizontal cells - Visual perception"	"Plasma membrane"		"CAB013008: "	"unprognostic (1.46e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.15e-1)"	"unprognostic (3.16e-2)"	"unprognostic (4.51e-3)"	"unprognostic (2.09e-1)"	"unprognostic (5.29e-3)"	"unprognostic (3.70e-2)"	"unprognostic (2.36e-2)"	"unprognostic (5.48e-3)"	"unprognostic (2.14e-1)"	"unprognostic (7.39e-3)"	"prognostic favorable (8.87e-7)"	"unprognostic (1.05e-2)"	"unprognostic (4.16e-2)"	"unprognostic (5.53e-2)"	"unprognostic (4.13e-2)"	5.4	4.4	2.4	2.7	2.5	1.1	10.7	5.8	2.4	9.9	11.1	5.9	5.1	8.6	4.3	5.2	5.5	5.7	12.7	4.7	2.9	9.6	2.5	10.7	1.3	2.5	6.2	10.1	4.7	2.4	3.9	10.0	2.3	10.3	3.7	2.0	9.0	16.4	1.9	10.4	5.1	5.3	2.3	3.2	4.6	1.6	3.4	1.8	20.5	2.4	1.3	6.4	11.2	2.0	0.8	2.5	24.8	2.6	19.8	17.0	4.5	9.2	5.8	3.3	2.3	1.1	4.3	0.0	2.2	5.9	4.2	4.7	3.9	2.0	2.2	0.0	4.9	0.2	4.6	1.3	1.4	4.2	1.0	32.3	3.6	7.6	2.4	12.6	0.7	2.8	1.5	3.6	9.7	6.2	0.8	1.1	6.4	1.3	4.2	5.1	15.3	0.4	5.3	11.8	3.4	6.5	7.0	5.6	1.6	5.7	3.0	3.8	3.8	13.9	10.4	15.0	3.8	3.3	2.5	0.4	15.0	3.5	16.5	0.0	0.6	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.0	2.8	0.0	0.0	0.2	2.4	2.5	5.8	2.4	4.7	2.9	2.5	6.2	2.3	2.3	3.4	2.0	5.7	3.2	1.5	4.6	1.1	4.2	44.9	7.0	10.8	1.6	27.7	29.5	18.5	45.8	4.6	12.9	2.1	3.4	0.6	7.4	0.0	4.3	0.3	12.0	13.1	4.5	3.5	0.8	0.6	2.0	2.2	18.5	2.0	15.7	12.7	1.8	15.4	0.9	3.5	141.3	1.0	3.0	4.1	17.4	16.2	1.1	33.2	14.3	17.8	1.9	4.6	3.0	1.0	1.0	0.2	1.9	4.8	45.1	0.4	11.7	6.0	11.6	2.4	2.9	0.0	6.2	10.3	0.5	3.7	9.1	5.1	2.1	0.6	2.6	4.6	7.3
FZD6	Hfz6	ENSG00000164930	"Frizzled class receptor 6"	O60353	8	103298433-103332866	"Disease related genes, G-protein coupled receptors, Human disease related genes, Potential drug targets, Predicted membrane proteins"	"Wnt signaling pathway"	"Developmental protein, G-protein coupled receptor, Receptor, Transducer"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Glandular and luminal cells: 73.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	4	"NK-cell: 4.0"	"Lineage enriched"	"Detected in single"	4	"NK-cells: 4.0"	"Cell line enhanced"	"Detected in many"		"hTCEpi: 127.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017991	Approved		Supported	"Plasma membrane"		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 31: Skin - Epidermis development"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 44: Endometrium - Transcription"	"Plasma membrane"		"HPA017991: AB_1849138"	"unprognostic (8.22e-3)"	"unprognostic (2.64e-1)"	"unprognostic (4.75e-2)"	"unprognostic (2.57e-1)"	"unprognostic (1.22e-2)"	"unprognostic (6.99e-2)"	"unprognostic (4.01e-2)"	"unprognostic (2.74e-1)"	"unprognostic (2.43e-1)"	"unprognostic (2.66e-1)"	"prognostic unfavorable (1.20e-6)"	"unprognostic (3.62e-2)"	"unprognostic (1.83e-1)"	"unprognostic (2.86e-1)"	"unprognostic (1.32e-1)"	"unprognostic (4.92e-2)"	"unprognostic (7.54e-2)"	11.7	10.6	3.0	4.2	2.8	1.0	15.1	3.1	4.3	14.2	5.7	7.0	5.7	13.0	9.5	18.7	23.5	10.6	9.1	2.9	3.0	14.5	4.0	18.6	5.1	3.8	3.1	5.4	11.2	25.3	9.8	15.1	3.8	12.6	7.0	4.6	11.7	10.3	2.0	24.0	4.6	9.3	3.0	4.0	7.4	3.6	3.3	10.0	22.3	5.6	9.9	21.6	10.2	3.2	59.8	11.0	29.6	0.0	7.9	20.6	17.1	31.0	34.1	27.2	17.6	6.2	47.8	0.0	51.4	29.7	9.1	90.3	16.8	65.7	51.0	13.5	18.0	31.4	12.2	8.5	93.4	0.0	0.0	23.0	127.6	29.4	91.5	67.1	58.2	7.0	3.2	27.0	31.5	25.5	29.8	2.7	6.7	4.7	20.6	2.3	12.3	0.0	59.1	39.5	10.0	7.9	44.8	22.8	59.9	15.8	0.0	11.6	4.1	6.1	32.0	24.9	32.7	6.4	3.7	13.3	18.0	0.0	40.4	0.0	0.0	0.1	0.2	0.0	0.0	0.5	0.8	0.4	0.3	0.5	0.9	0.4	0.0	4.0	0.0	0.1	0.4	0.2	3.0	2.8	3.1	4.3	2.9	3.0	3.8	3.1	3.8	3.0	3.3	3.2	38.3	25.6	22.5	10.1	2.8	46.9	15.9	51.1	42.7	4.1	16.1	12.7	4.8	8.6	35.4	12.9	2.1	22.7	2.1	4.9	0.0	11.7	9.6	51.0	5.8	42.0	5.3	6.7	19.9	8.2	7.1	7.0	14.8	73.6	0.0	11.2	13.9	3.7	2.4	6.7	7.3	7.4	26.4	1.0	5.1	2.9	1.2	1.3	14.2	16.9	0.7	11.8	1.0	8.5	3.6	9.5	3.2	1.5	8.6	13.4	2.8	7.1	53.8	4.8	0.0	1.6	7.7	7.0	0.8	41.9	44.6	14.6	3.0	1.7	5.6	23.2
FZD7	FzE3	ENSG00000155760	"Frizzled class receptor 7"	O75084	2	202033855-202038441	"G-protein coupled receptors, Human disease related genes, Predicted membrane proteins"	"Wnt signaling pathway"	"Developmental protein, G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Breast glandular cells: 30.9;Breast myoepithelial cells: 37.0;Cardiomyocytes: 21.1;Fibroblasts: 23.5;Proximal enterocytes: 21.3"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"cerebellum: 30.2"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ: 42.8;BJ hTERT+: 48.4;CAPAN-2: 62.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA059979, HPA069165, HPA076183"	Approved		Supported	Vesicles		NA	NA				"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 35: Glandular cells - Unknown function"	Vesicles		"HPA059979: , HPA069165: AB_2686096, HPA076183: "	"unprognostic (3.44e-2)"	"unprognostic (6.89e-2)"	"unprognostic (9.30e-3)"	"unprognostic (2.44e-3)"	"unprognostic (4.92e-2)"	"unprognostic (1.02e-1)"	"prognostic unfavorable (7.71e-5)"	"unprognostic (1.40e-1)"	"unprognostic (4.92e-2)"	"unprognostic (8.22e-2)"	"unprognostic (2.73e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.87e-3)"	"unprognostic (8.16e-3)"	"unprognostic (1.43e-1)"	"unprognostic (4.16e-2)"	"unprognostic (2.05e-3)"	10.2	3.0	4.9	5.6	4.7	0.4	15.5	30.2	4.3	13.2	6.3	36.7	6.9	18.4	14.1	9.4	16.8	6.3	14.4	8.8	5.0	8.2	1.2	5.3	3.9	5.2	4.9	25.0	1.7	1.1	9.3	5.7	5.5	19.2	5.5	1.3	21.7	23.5	26.7	10.9	10.8	11.1	4.9	1.9	5.9	2.1	4.5	1.1	5.1	9.5	3.8	27.1	15.3	5.6	10.3	5.2	33.2	10.8	10.6	7.9	14.8	42.8	48.4	11.9	13.9	32.2	62.7	0.1	25.1	26.2	7.9	10.6	6.0	1.3	13.7	5.4	8.6	1.1	2.1	2.7	7.2	2.1	2.1	7.6	1.0	6.4	3.7	9.5	0.0	0.7	2.9	2.6	9.8	4.2	0.0	5.7	36.6	2.0	3.5	4.2	6.4	1.1	1.9	6.1	5.5	12.6	5.4	0.4	6.8	26.7	3.8	2.5	0.1	23.8	8.8	15.0	5.4	2.7	2.2	0.1	4.9	0.5	16.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.9	4.7	30.2	4.3	8.8	5.0	5.2	4.9	5.5	4.9	4.5	5.6	3.5	0.0	8.1	3.6	2.0	10.3	8.3	1.9	14.8	0.0	30.9	37.0	21.1	1.5	0.3	1.8	0.0	0.5	2.0	4.7	1.9	1.6	0.1	1.5	2.0	1.7	1.2	0.0	1.5	0.2	1.1	23.5	2.6	3.6	1.3	7.5	0.7	0.7	1.5	0.0	0.2	9.9	0.0	0.8	5.7	0.5	5.3	2.0	3.6	0.0	0.1	7.5	0.0	0.0	0.1	0.6	2.1	4.9	1.7	6.9	21.3	0.1	0.9	0.6	6.6	13.5	16.3	1.6	2.9	11.4	9.8	0.8	2.5	0.5	7.6	1.8
FZR1	"CDC20C, CDH1, FZR, FZR2, HCDH, HCDH1, KIAA1242"	ENSG00000105325	"Fizzy and cell division cycle 20 related 1"	Q9UM11	19	3506311-3538334	"Predicted intracellular proteins"	"Cell cycle, Cell division, DNA damage, DNA repair, Mitosis, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 104.2;Late spermatids: 208.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043536	Approved		Supported	"Nucleoplasm,Nuclear membrane"		NA	Yes			"Cluster 52: Eosinophils - Transcription"	"Cluster 71: Testis - DNA repair"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 31: Spermatids - Spermatogenesis"	"Nucleoplasm, Nuclear membrane"		"HPA043536: AB_10968058"	"unprognostic (2.78e-1)"	"prognostic favorable (1.75e-4)"	"unprognostic (1.15e-1)"	"prognostic favorable (2.57e-4)"	"unprognostic (1.60e-1)"	"unprognostic (1.36e-2)"	"unprognostic (9.20e-2)"	"unprognostic (1.61e-1)"	"unprognostic (9.70e-2)"	"unprognostic (1.18e-1)"	"unprognostic (4.15e-3)"	"unprognostic (1.41e-2)"	"unprognostic (3.75e-1)"	"unprognostic (5.41e-3)"	"unprognostic (1.75e-1)"	"unprognostic (9.04e-2)"	"unprognostic (1.04e-1)"	14.8	25.2	17.0	9.3	14.0	33.5	16.4	19.1	17.2	21.3	5.2	17.2	21.9	19.3	4.0	23.5	18.2	9.4	13.0	16.7	17.1	18.1	23.5	15.6	11.4	19.2	17.3	22.9	17.3	10.9	34.1	8.9	19.3	19.1	3.7	5.6	19.7	10.5	18.5	26.2	18.4	6.3	12.0	18.8	15.6	52.7	15.8	13.9	24.0	7.5	7.0	16.2	20.9	13.5	44.0	25.7	24.3	22.4	7.5	10.4	18.9	26.7	17.8	31.0	24.2	26.2	21.1	24.3	13.5	19.7	15.0	25.2	13.7	23.4	6.2	32.9	23.5	11.6	19.5	26.2	13.4	20.9	23.8	9.8	13.5	18.8	11.2	11.7	18.4	23.0	21.0	41.1	16.1	22.8	37.5	15.2	20.5	13.6	20.1	28.0	20.6	23.6	15.6	21.6	22.3	25.0	24.1	17.5	13.1	5.5	18.2	19.1	24.9	17.6	21.3	42.9	47.4	42.9	10.8	18.5	24.4	41.5	22.3	1.1	0.7	2.0	1.0	0.7	0.6	1.0	1.0	0.7	0.6	0.8	0.6	0.8	1.3	1.2	0.5	0.5	0.9	0.6	17.0	14.0	19.1	17.2	16.7	17.1	19.2	17.3	19.3	12.0	15.8	13.5	8.1	0.0	5.0	6.5	15.4	17.8	35.8	10.6	6.2	20.7	14.5	11.2	3.4	17.2	8.6	12.9	10.4	21.9	11.0	25.8	5.9	16.5	104.2	14.1	8.2	11.0	21.6	26.5	6.3	14.9	14.2	10.1	26.5	14.3	3.8	20.4	10.0	17.9	16.4	30.3	9.1	18.1	18.3	7.9	11.4	208.2	12.8	11.9	12.4	3.7	18.1	8.5	9.2	6.6	10.4	28.1	17.0	9.4	13.7	20.6	17.4	13.5	10.8	15.6	6.6	7.3	12.9	58.4	15.8	11.9	22.6	45.4	11.9	15.6	16.1	28.3
G2E3	"FLJ20333, KIAA1333, PHF7B"	ENSG00000092140	"G2/M-phase specific E3 ubiquitin protein ligase"	Q7L622	14	30559158-30620064	"Enzymes, Predicted intracellular proteins"	"Apoptosis, Ubl conjugation pathway"	"Developmental protein, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 42.3"	"Group enriched"	"Detected in all"	6	"Early spermatids: 722.5;Late spermatids: 233.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001601	Uncertain		Approved	"Golgi apparatus,Vesicles,Cytosol"		NA	Yes			"Cluster 18: Basophils - Vesicular transport"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 29: Early spermatids - Spermatogenesis"	Cytosol	"Golgi apparatus, Vesicles"	"HPA001601: AB_1079198"	"unprognostic (4.75e-2)"	"unprognostic (6.31e-2)"	"unprognostic (2.27e-2)"	"unprognostic (4.86e-2)"	"unprognostic (9.10e-2)"	"unprognostic (3.99e-2)"	"unprognostic (5.44e-6)"	"unprognostic (1.17e-2)"	"unprognostic (2.81e-2)"	"unprognostic (1.86e-1)"	"unprognostic (3.13e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.23e-1)"	"unprognostic (2.32e-2)"	"unprognostic (2.12e-2)"	4.8	3.2	2.1	6.4	7.0	10.0	6.4	11.6	5.5	6.4	0.7	5.6	5.0	6.3	3.7	6.2	4.8	3.8	4.8	2.4	5.6	4.5	5.2	4.5	9.1	3.1	2.5	6.1	5.2	5.6	2.7	6.3	2.7	5.1	5.3	13.8	4.9	4.6	3.0	5.9	4.9	6.2	1.0	6.3	5.3	42.3	7.0	14.3	6.6	3.9	8.9	4.9	3.9	9.6	37.9	15.6	33.7	16.1	11.2	15.0	30.5	31.9	12.9	20.2	22.9	17.1	20.5	32.9	10.9	18.4	15.9	29.7	36.4	18.8	42.2	25.7	15.7	19.6	17.1	31.0	10.3	34.0	22.5	8.1	7.4	15.1	34.9	18.3	22.9	22.5	21.2	24.2	29.0	21.9	22.6	9.6	31.2	27.5	32.7	21.4	0.0	8.2	10.5	22.3	28.4	19.9	27.7	16.0	7.9	20.5	19.1	12.5	17.3	19.7	21.9	16.9	21.9	14.1	47.7	38.8	5.4	16.6	29.2	20.2	6.5	12.9	7.6	8.5	10.1	9.2	7.4	6.3	5.6	9.9	9.2	7.8	5.9	6.5	11.3	6.8	6.6	4.1	2.1	7.0	11.6	5.5	2.4	5.6	3.1	2.5	2.7	1.0	7.0	9.6	22.6	19.2	9.0	17.9	32.9	21.9	22.5	11.8	26.7	34.9	13.0	10.8	10.0	12.8	13.6	5.5	25.0	17.8	23.0	9.0	9.8	8.9	722.5	13.9	26.6	17.0	13.8	42.7	45.3	7.1	22.7	20.6	14.3	14.1	17.1	23.3	13.2	7.5	14.2	35.3	38.4	14.7	14.2	13.9	12.4	233.9	16.4	16.5	8.8	24.4	16.2	15.5	32.0	41.7	43.1	10.7	9.4	14.3	14.4	22.5	5.6	12.0	10.9	33.4	52.6	18.0	18.6	69.8	42.7	20.7	25.4	10.0	24.9	11.9	12.4	20.6
G3BP1	"G3BP, HDH-VIII"	ENSG00000145907	"G3BP stress granule assembly factor 1"	Q13283	5	151771045-151812911	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Host-virus interaction, Immunity, Innate immunity, Transport"	"DNA-binding, Endonuclease, Helicase, Hydrolase, Nuclease, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004052, CAB037068"	Supported		Supported	Cytosol		NA	NA		280000	"Cluster 13: T-cells - Unknown function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 28: Keratinocytes - Keratinization"	Cytosol		"CAB037068: AB_1840864, HPA004052: AB_1849348"	"unprognostic (1.31e-1)"	"unprognostic (3.94e-2)"	"unprognostic (1.19e-3)"	"unprognostic (1.28e-2)"	"unprognostic (1.05e-1)"	"unprognostic (3.09e-2)"	"unprognostic (1.03e-3)"	"unprognostic (1.83e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.36e-1)"	"unprognostic (2.06e-3)"	"unprognostic (1.23e-2)"	"prognostic unfavorable (3.33e-4)"	"unprognostic (1.97e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.11e-2)"	"unprognostic (3.88e-2)"	52.3	46.8	32.9	60.2	36.1	27.5	54.1	42.8	44.6	42.0	41.0	47.8	34.8	42.5	33.1	54.8	51.0	38.8	51.0	30.7	36.1	57.1	69.0	36.1	78.3	34.5	35.7	62.5	30.4	41.5	16.5	58.2	35.8	41.3	50.6	18.3	31.8	37.3	112.2	43.4	33.9	47.8	35.0	46.7	40.3	65.5	38.6	66.0	42.6	92.1	85.7	66.3	31.9	43.3	204.9	267.0	177.0	96.3	253.2	119.2	232.4	204.1	190.6	290.6	348.6	413.7	310.3	384.7	307.0	188.0	231.6	210.9	319.7	395.6	333.7	122.5	173.8	232.9	201.1	334.8	128.8	281.6	163.9	123.4	186.7	243.7	232.2	98.7	209.7	140.9	191.3	173.3	254.5	179.7	273.9	142.4	231.4	146.0	209.6	254.3	235.1	187.2	163.1	290.5	195.2	132.0	200.8	307.0	319.3	169.2	246.3	174.7	238.2	202.0	239.7	187.3	364.0	104.9	171.3	305.0	132.2	229.6	337.8	132.2	102.3	84.7	189.2	135.4	255.3	168.8	215.6	186.7	141.0	160.0	201.8	193.2	37.8	203.7	134.1	134.7	249.2	287.2	32.9	36.1	42.8	44.6	30.7	36.1	34.5	35.7	35.8	35.0	38.6	43.3	88.9	19.2	41.4	32.7	112.0	239.5	101.3	82.4	148.0	37.1	74.8	60.7	62.3	44.3	66.2	64.4	16.7	94.0	91.7	47.3	78.2	69.6	49.6	80.6	104.4	112.1	50.2	96.1	25.7	53.0	94.6	98.0	70.3	87.2	73.6	73.8	76.8	169.4	78.2	57.2	30.6	59.4	50.8	81.2	195.0	30.1	65.0	73.3	87.2	37.5	83.7	54.3	45.3	29.7	45.3	59.2	42.9	57.2	89.3	160.0	33.5	80.0	74.2	36.6	39.5	111.6	90.7	58.0	89.3	155.6	256.4	67.3	99.6	72.2	78.5	98.0
G6PC3	UGRP	ENSG00000141349	"Glucose-6-phosphatase catalytic subunit 3"	Q9BUM1	17	44070735-44076344	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	Gluconeogenesis	Hydrolase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA067052			Supported	"Endoplasmic reticulum"		NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Endoplasmic reticulum"		"HPA067052: AB_2685771"	"unprognostic (9.13e-2)"	"unprognostic (2.28e-1)"	"unprognostic (3.61e-1)"	"prognostic favorable (1.11e-4)"	"unprognostic (1.88e-3)"	"unprognostic (3.16e-1)"	"prognostic unfavorable (9.61e-4)"	"unprognostic (2.79e-1)"	"unprognostic (2.43e-1)"	"unprognostic (1.15e-2)"	"unprognostic (2.59e-2)"	"unprognostic (1.85e-3)"	"unprognostic (1.87e-3)"	"unprognostic (4.53e-2)"	"unprognostic (3.06e-2)"	"unprognostic (2.35e-1)"	"unprognostic (4.49e-2)"	56.7	97.2	64.8	22.5	67.8	16.0	55.6	70.5	79.3	47.6	88.8	42.1	28.7	55.4	63.9	37.1	45.6	23.9	61.9	65.3	77.5	75.2	26.4	42.9	19.3	74.9	86.9	44.3	56.5	66.7	95.1	25.8	96.1	59.5	18.2	17.1	48.7	40.6	54.3	26.8	39.6	23.0	67.9	45.2	51.4	55.1	72.7	15.2	71.1	26.4	12.0	48.7	37.7	72.4	40.0	231.7	73.7	128.5	77.9	58.3	55.3	45.0	86.9	96.2	64.4	97.1	62.3	88.9	62.8	95.1	65.4	67.4	53.5	92.1	44.5	46.4	86.0	49.3	142.5	182.4	84.1	46.1	59.8	77.3	44.3	93.1	62.3	59.6	79.3	35.9	51.5	109.6	72.5	112.1	22.4	71.4	99.3	48.7	133.5	45.6	48.4	207.5	137.6	93.6	92.7	83.0	49.1	57.4	59.3	82.9	158.6	45.1	87.6	98.8	53.1	26.8	63.5	74.0	56.2	26.1	110.3	38.2	128.9	3.0	33.1	7.9	9.9	43.4	12.1	12.1	8.0	9.1	54.2	13.9	9.7	12.9	1.4	17.5	26.3	74.5	8.5	16.9	64.8	67.8	70.5	79.3	65.3	77.5	74.9	86.9	96.1	67.9	72.7	72.4	22.3	3.2	12.9	5.2	10.4	2.5	17.3	31.8	8.0	10.5	20.7	21.5	6.4	21.5	25.2	40.5	12.5	64.3	17.1	12.4	13.7	59.3	5.0	18.9	22.1	26.0	22.9	9.7	2.8	49.4	41.1	25.0	16.8	20.1	18.3	20.2	18.5	7.1	58.7	5.0	4.5	14.1	24.4	21.6	12.2	6.2	20.2	20.9	14.2	0.0	21.8	30.7	10.3	8.0	5.5	33.6	13.6	23.0	27.2	19.5	20.5	36.0	24.6	8.3	13.1	15.3	21.4	31.5	26.7	14.3	2.6	42.5	7.0	43.9	19.7	17.2
G6PD	G6PD1	ENSG00000160211	"Glucose-6-phosphate dehydrogenase"	P11413	X	154531391-154547572	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Carbohydrate metabolism, Glucose metabolism"	Oxidoreductase	"Cancer-related genes, Disease variant, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 105.9"	"Cell type enhanced"	"Detected in many"		"monocytes: 112.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"eosinophil: 412.7"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 412.7"	"Cell line enhanced"	"Detected in all"		"A549: 2333.8;MCF7: 883.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000247, HPA000834"	Enhanced		Enhanced	"Centriolar satellite,Cytosol"		No	No		2400000	"Cluster 49: Eosinophils - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 3: Monocytes - Immune response regulation"	Cytosol	"Centriolar satellite"	"HPA000247: AB_1078978, HPA000834: AB_1078977"	"unprognostic (1.73e-2)"	"unprognostic (1.53e-3)"	"unprognostic (1.13e-2)"	"unprognostic (1.02e-1)"	"unprognostic (7.78e-2)"	"unprognostic (4.34e-2)"	"prognostic unfavorable (9.45e-13)"	"unprognostic (2.78e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.76e-2)"	"unprognostic (1.09e-1)"	"unprognostic (3.66e-1)"	"unprognostic (2.89e-3)"	"unprognostic (2.83e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.47e-1)"	"unprognostic (7.25e-2)"	40.7	39.1	19.9	30.2	21.8	105.9	31.9	20.5	28.3	20.6	20.0	13.9	13.1	21.6	13.3	54.3	19.3	46.5	14.3	21.3	22.7	12.7	6.5	29.4	28.9	25.4	22.2	24.1	13.0	9.6	27.5	13.7	24.5	12.2	13.1	26.1	21.2	14.4	4.2	21.3	12.4	25.6	19.7	26.9	18.1	54.0	26.1	26.2	45.9	5.1	37.2	33.8	22.4	21.9	168.5	2333.8	49.7	189.7	207.2	281.7	43.5	116.0	341.7	120.0	205.8	111.2	61.9	110.9	174.1	274.3	475.9	146.3	79.3	202.5	60.3	111.4	55.0	116.8	517.2	244.6	401.6	117.8	373.5	136.6	58.5	233.9	49.8	185.6	252.5	79.8	69.6	46.3	218.4	883.9	77.5	93.0	35.3	549.5	172.2	74.9	28.4	120.5	357.1	210.9	49.6	62.0	115.9	444.5	99.9	65.0	67.1	99.4	289.8	73.1	250.0	102.5	181.8	58.2	80.0	189.8	200.6	77.5	150.9	166.1	84.9	412.7	50.3	72.1	32.1	16.0	13.7	36.7	40.1	17.0	16.5	28.2	137.4	69.3	63.5	18.9	18.7	72.8	19.9	21.8	20.5	28.3	21.3	22.7	25.4	22.2	24.5	19.7	26.1	21.9	7.9	0.0	17.0	4.6	21.5	12.5	24.3	46.6	8.6	6.2	14.6	8.6	1.1	14.3	22.9	11.0	18.8	29.6	58.9	25.5	29.4	39.3	10.3	7.7	13.7	13.2	9.5	37.7	2.9	29.3	41.2	19.6	23.4	10.7	37.5	26.1	18.2	1.6	45.6	33.7	2.3	11.5	24.4	58.2	26.0	20.8	26.1	56.6	19.6	5.6	112.3	13.6	83.4	3.5	3.7	31.0	11.4	16.1	21.6	23.9	18.5	18.3	10.9	32.5	6.6	7.5	23.6	10.9	32.8	34.4	13.8	36.3	33.8	11.6	13.5	30.5
GAB2	KIAA0571	ENSG00000033327	"GRB2 associated binding protein 2"	Q9UQC2	11	78215293-78418348	"Predicted intracellular proteins, RAS pathway related proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 97.9"	"Cell type enhanced"	"Detected in many"		"Inhibitory neurons: 147.9;Microglial cells: 204.2;Oligodendrocyte precursor cells: 142.7;Oligodendrocytes: 480.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 13.0;neutrophil: 20.1"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 20.1"	"Cell line enhanced"	"Detected in many"		"SH-SY5Y: 62.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000271, HPA001368, CAB022159"	Enhanced		Supported	"Plasma membrane"		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 70: Brain - Nervous system development"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Plasma membrane"		"CAB022159: , HPA000271: AB_1078925, HPA001368: AB_2666287"	"unprognostic (2.51e-2)"	"unprognostic (1.90e-1)"	"unprognostic (3.56e-3)"	"unprognostic (1.99e-3)"	"unprognostic (1.04e-2)"	"unprognostic (4.69e-2)"	"unprognostic (4.47e-2)"	"unprognostic (1.08e-1)"	"unprognostic (6.54e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.25e-1)"	"unprognostic (1.74e-1)"	"prognostic favorable (9.32e-5)"	"unprognostic (6.95e-2)"	"unprognostic (4.35e-1)"	"unprognostic (3.99e-2)"	"unprognostic (1.67e-2)"	18.5	8.2	69.5	12.9	80.7	39.9	11.6	56.2	65.3	14.8	31.2	9.4	14.4	19.8	3.1	8.9	13.6	9.3	14.5	54.5	68.4	6.7	4.4	20.0	7.0	79.4	70.9	20.0	6.8	6.8	8.8	15.5	74.0	7.0	11.0	3.5	7.1	7.1	6.4	13.3	10.7	17.3	68.0	13.1	8.2	5.7	72.0	21.3	6.6	6.8	5.8	10.6	10.9	97.9	3.7	3.1	8.8	1.0	12.7	5.4	39.1	5.7	6.8	4.0	3.3	23.8	1.9	1.1	24.8	7.9	1.0	5.9	21.2	0.5	5.2	36.3	2.2	14.6	5.9	4.2	6.3	5.6	2.8	6.1	1.9	15.6	2.4	11.8	23.4	4.2	38.8	1.2	6.7	1.5	2.8	13.8	2.8	8.4	4.4	27.4	8.5	0.5	7.3	13.4	7.6	62.1	1.4	2.9	14.4	12.7	13.2	15.5	19.4	1.8	4.5	15.2	1.4	9.8	1.5	0.6	1.5	8.6	16.8	13.0	3.1	0.9	0.0	1.7	0.0	0.7	0.0	0.0	1.0	0.4	0.0	0.0	20.1	0.0	4.9	2.2	0.2	1.0	69.5	80.7	56.2	65.3	54.5	68.4	79.4	70.9	74.0	68.0	72.0	97.9	6.6	3.2	20.7	57.5	8.7	2.0	0.7	0.5	0.6	4.3	3.6	2.7	10.9	1.5	1.1	0.0	0.0	5.0	4.0	9.2	0.0	2.5	7.0	5.5	9.1	7.6	10.7	4.2	80.7	6.4	16.6	6.9	6.6	10.6	5.7	50.4	5.3	0.8	12.1	16.8	147.9	4.0	4.1	29.5	17.5	5.1	8.1	22.8	7.2	204.2	17.5	0.5	1.0	142.7	480.3	8.2	3.3	10.9	4.2	4.3	10.5	0.8	2.6	2.1	13.1	8.3	5.4	3.7	1.7	1.8	2.8	22.2	3.5	3.5	8.9	2.2
GABPB1	"E4TF1-47, GABPB, GABPB2"	ENSG00000104064	"GA binding protein transcription factor subunit beta 1"	Q06547	15	50275389-50355408	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019653, HPA067444"	Supported		Supported	"Nucleoplasm,Cytoplasmic bodies"		NA	Yes			"Cluster 10: Basophils - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 22: Epithelial cell types - Mixed function"	Nucleoplasm	"Cytoplasmic bodies"	"HPA019653: AB_1849370, HPA067444: AB_2685842"	"unprognostic (7.79e-3)"	"unprognostic (2.42e-2)"	"unprognostic (3.84e-1)"	"unprognostic (1.92e-1)"	"unprognostic (9.33e-2)"	"unprognostic (3.99e-2)"	"unprognostic (3.25e-2)"	"unprognostic (5.65e-2)"	"unprognostic (1.86e-2)"	"unprognostic (8.94e-3)"	"unprognostic (1.23e-1)"	"unprognostic (4.54e-3)"	"prognostic unfavorable (2.53e-4)"	"unprognostic (3.18e-2)"	"unprognostic (2.37e-1)"	"unprognostic (1.13e-1)"	"unprognostic (3.93e-3)"	14.1	7.5	5.5	13.6	6.1	34.7	11.5	11.1	7.1	8.5	5.8	9.0	7.6	10.4	9.5	8.0	8.6	9.2	7.1	5.7	5.7	7.4	13.9	9.3	18.8	6.2	5.2	8.2	7.4	9.8	4.7	14.3	6.3	9.6	10.7	8.1	8.5	6.9	7.4	8.2	7.9	10.0	5.3	11.9	8.8	16.1	5.8	24.8	9.6	8.1	20.1	16.8	6.9	9.2	25.4	28.6	41.0	32.0	10.6	14.8	54.7	32.5	25.5	37.6	32.9	48.9	20.3	33.0	19.3	26.9	29.7	40.8	37.2	27.9	47.5	46.1	22.2	39.2	29.3	33.7	25.3	37.9	29.1	19.7	26.8	35.3	45.6	21.0	66.9	35.6	36.6	40.4	25.4	58.1	56.5	34.1	28.2	27.8	19.2	68.6	29.8	31.7	22.9	31.7	38.9	32.0	29.0	27.0	33.4	38.9	23.5	37.1	32.1	34.2	28.3	60.4	58.9	28.6	42.0	57.8	21.1	34.5	35.2	44.5	16.2	32.7	19.8	20.1	26.5	31.6	19.4	21.4	22.4	26.4	17.7	20.5	16.1	27.3	15.7	17.7	27.9	20.2	5.5	6.1	11.1	7.1	5.7	5.7	6.2	5.2	6.3	5.3	5.8	9.2	18.2	9.6	11.2	10.7	80.0	47.2	126.7	15.1	23.9	43.1	10.1	9.4	17.7	24.3	7.2	7.3	35.5	43.2	47.3	11.4	3.9	12.2	79.5	8.3	11.9	38.0	50.4	38.7	13.9	7.6	50.5	33.2	23.9	10.9	47.0	8.6	41.7	30.6	37.0	37.0	12.3	24.9	12.2	73.4	22.3	33.3	57.8	42.2	19.6	15.9	54.0	32.4	120.5	22.1	19.1	14.6	21.6	38.4	58.7	89.3	21.4	8.4	8.7	45.8	26.3	64.0	32.5	28.9	34.0	32.7	35.8	55.4	77.2	6.7	27.8	116.6
GABPB2	MGC29891	ENSG00000143458	"GA binding protein transcription factor subunit beta 2"	Q8TAK5	1	151070578-151125542	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 75.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"U-698: 33.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028471, HPA058483"	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 71: Testis - DNA repair"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	Cytosol	"HPA028471: AB_10602319, HPA058483: AB_2683730"	"unprognostic (1.21e-1)"	"unprognostic (7.03e-3)"	"unprognostic (2.76e-2)"	"unprognostic (9.95e-2)"	"unprognostic (5.50e-2)"	"unprognostic (1.71e-2)"	"unprognostic (2.70e-1)"	"unprognostic (2.11e-2)"	"unprognostic (4.65e-2)"	"unprognostic (7.71e-2)"	"unprognostic (1.98e-2)"	"unprognostic (8.02e-2)"	"unprognostic (1.75e-2)"	"unprognostic (1.61e-2)"	"unprognostic (2.71e-1)"	"unprognostic (2.03e-1)"	"unprognostic (1.90e-3)"	5.5	4.9	4.4	4.2	6.4	7.0	4.5	6.9	5.3	5.8	3.8	5.5	3.5	5.1	3.8	4.9	5.8	3.6	6.4	4.2	4.9	4.8	3.8	4.4	5.5	5.5	5.2	9.3	4.1	5.1	5.8	3.2	5.2	5.3	4.8	5.3	4.3	3.7	5.1	7.2	4.7	3.9	3.9	5.4	4.9	11.7	5.7	9.8	5.4	3.7	5.1	5.7	5.5	7.9	9.2	3.2	2.2	2.7	7.6	11.2	2.9	8.4	5.2	4.7	3.3	0.9	6.7	9.6	3.0	8.0	2.5	7.8	4.8	4.3	6.9	3.6	1.8	2.6	5.3	0.1	5.1	10.6	5.2	6.1	4.9	6.5	9.7	3.7	1.7	10.0	6.6	6.5	5.7	13.1	14.6	1.9	1.0	5.3	3.4	4.3	3.6	4.5	4.0	2.5	3.8	1.6	10.7	3.7	3.1	2.1	9.3	11.2	5.3	1.2	4.0	8.5	6.8	3.5	1.8	33.9	3.8	7.9	5.7	1.5	0.9	0.5	1.4	1.1	0.8	1.0	1.5	1.2	0.8	1.3	1.3	1.4	1.4	0.8	1.8	1.6	0.6	1.0	4.4	6.4	6.9	5.3	4.2	4.9	5.5	5.2	5.2	3.9	5.7	7.9	9.4	9.6	16.8	21.2	10.0	11.5	9.3	9.6	10.2	26.3	8.9	10.3	22.4	17.2	14.8	12.9	25.0	5.8	18.0	12.3	9.8	5.7	36.3	13.5	15.4	11.0	9.6	14.9	18.4	5.8	4.6	16.2	9.7	9.7	7.0	11.7	15.7	7.1	8.2	33.7	25.3	15.6	4.1	13.4	9.7	17.1	22.4	11.3	8.8	15.9	14.3	10.9	33.0	11.6	39.3	5.3	8.5	21.4	8.1	6.9	10.7	4.6	20.8	36.5	6.6	38.5	15.4	75.6	55.7	9.6	10.1	4.5	16.3	15.6	16.8	7.0
GABRG1		ENSG00000163285	"Gamma-aminobutyric acid type A receptor subunit gamma1"	Q8N1C3	4	46035769-46124054	"FDA approved drug targets, Predicted membrane proteins"	"Ion transport, Transport"	"Chloride channel, Ion channel"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"brain: 44.7"	"Cell type enriched"	"Detected in some"	8	"Astrocytes: 135.5"	"Cancer enriched"	"Detected in single"	8	"glioma: 0.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"U-266/70: 1.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035622, HPA058102"	Approved		Supported	"Plasma membrane"		NA	NA				"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 64: Astrocytes - Nervous system maintenance"	"Plasma membrane"		"HPA035622: AB_10603669, HPA058102: "	"unprognostic (2.50e-1)"				"unprognostic (2.20e-1)"		"unprognostic (6.06e-2)"			"unprognostic (1.46e-2)"	"unprognostic (7.39e-4)"		"unprognostic (1.23e-1)"		"unprognostic (1.28e-1)"	"unprognostic (1.99e-1)"		0.1	0.1	21.6	0.0	20.6	0.0	0.0	19.0	27.3	0.0	9.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	19.4	31.7	0.0	0.0	0.0	0.0	24.8	38.0	1.2	0.0	0.0	0.6	0.0	23.9	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	21.1	0.1	0.0	0.2	44.7	0.0	0.1	0.0	0.0	0.0	0.0	23.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.4	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.6	20.6	19.0	27.3	19.4	31.7	24.8	38.0	23.9	21.1	44.7	23.1	0.3	0.0	0.0	135.5	0.0	0.0	0.0	0.0	0.0	5.4	0.0	0.0	0.3	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	8.2	0.0	0.0	0.0	0.0	0.0	5.4	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	12.5	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	11.2	0.0	15.4	0.0	2.5	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	6.6	0.0	1.8	0.1	0.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0
GADD45A	"DDIT1, GADD45"	ENSG00000116717	"Growth arrest and DNA damage inducible alpha"	P24522	1	67685201-67688334	"Cancer-related genes, Predicted intracellular proteins"	"Cell cycle, DNA damage, Growth arrest"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 240.5"	"Cell type enhanced"	"Detected in all"		"Basal keratinocytes: 858.9;Basal prostatic cells: 2807.1;Glandular and luminal cells: 982.6;Urothelial cells: 1740.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"eosinophil: 48.4"	"Group enriched"	"Detected in all"	5	"granulocytes: 48.4;T-cells: 18.6"	"Cell line enhanced"	"Detected in all"		"HHSteC: 365.9;hTERT-HME1: 577.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053420			Supported	"Nuclear speckles"		NA	Yes			"Cluster 2: Granulocytes - Unknown function"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 22: Epithelial cell types - Mixed function"	"Nuclear speckles"		"HPA053420: AB_2682144"	"unprognostic (1.36e-2)"	"unprognostic (3.29e-2)"	"unprognostic (9.58e-2)"	"unprognostic (3.76e-3)"	"unprognostic (5.81e-2)"	"unprognostic (1.36e-2)"	"unprognostic (1.57e-3)"	"unprognostic (2.80e-3)"	"unprognostic (1.42e-1)"	"unprognostic (6.26e-2)"	"unprognostic (3.43e-2)"	"unprognostic (5.21e-2)"	"prognostic favorable (8.06e-6)"	"unprognostic (6.11e-2)"	"unprognostic (2.89e-1)"	"unprognostic (3.43e-3)"	"unprognostic (1.93e-1)"	122.0	15.9	21.0	20.0	24.7	136.2	83.7	19.2	27.5	65.6	22.3	29.6	24.8	69.5	23.3	39.2	42.3	44.2	62.2	20.8	24.0	147.2	164.9	75.0	13.7	34.7	26.8	49.6	20.2	19.5	19.1	22.2	24.6	25.6	21.2	19.0	32.4	36.9	240.5	57.9	32.2	38.3	18.6	26.8	53.2	12.3	25.3	30.7	73.8	26.4	16.8	50.4	44.4	28.7	138.6	9.7	22.3	7.5	44.8	43.9	219.8	239.5	122.6	88.5	96.7	50.8	25.3	61.1	71.4	42.0	206.6	85.3	3.0	219.6	164.5	44.9	23.6	75.7	24.0	51.8	365.9	22.5	7.5	76.7	117.8	107.7	577.7	41.5	61.0	15.2	165.6	109.9	104.5	4.8	7.2	27.3	29.8	19.3	96.3	16.4	177.2	67.9	44.2	110.5	102.7	17.1	51.9	15.2	158.3	79.7	2.6	23.2	61.6	85.7	111.6	89.3	165.7	267.3	54.9	106.8	37.8	11.1	86.3	23.6	5.7	48.4	6.3	2.8	5.3	2.3	4.4	5.3	2.6	1.5	1.2	2.0	8.2	6.5	2.0	4.1	18.6	8.7	21.0	24.7	19.2	27.5	20.8	24.0	34.7	26.8	24.6	18.6	25.3	28.7	402.5	64.1	19.0	6.8	51.2	858.9	2807.1	273.2	225.3	45.1	56.7	100.6	190.5	47.1	155.8	103.0	10.4	24.6	85.1	175.3	236.7	264.4	1.6	410.7	250.6	176.6	131.7	116.2	6.1	253.6	117.8	177.0	87.7	982.6	44.5	18.9	74.6	110.1	18.6	26.9	7.0	99.6	122.1	23.5	290.6	4.0	38.2	94.7	158.3	7.5	273.2	30.3	12.3	6.6	1.0	367.3	202.0	64.7	116.8	786.2	101.4	530.0	135.1	72.8	52.6	136.0	201.6	3.7	18.8	365.2	390.8	17.6	139.5	88.6	70.3	1740.4
GADD45GIP1	"CKBBP2, CKbetaBP2, CRIF1, MGC4667, MGC4758, PLINP-1, Plinp1, PRG6"	ENSG00000179271	"GADD45G interacting protein 1"	Q8TAE8	19	12953119-12957223	"Predicted intracellular proteins, Ribosomal proteins"	"Cell cycle, Host-virus interaction"	"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055205, HPA065048, HPA071910"	Supported		Supported	Nucleoplasm,Mitochondria		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria	Nucleoplasm	"HPA055205: AB_2682736, HPA065048: AB_2685412, HPA071910: "	"unprognostic (5.82e-2)"	"unprognostic (2.62e-2)"	"unprognostic (4.49e-2)"	"unprognostic (2.08e-1)"	"unprognostic (8.14e-3)"	"unprognostic (2.49e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.65e-1)"	"unprognostic (9.67e-2)"	"unprognostic (7.73e-3)"	"unprognostic (1.06e-1)"	"unprognostic (7.09e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.50e-2)"	"unprognostic (1.73e-1)"	32.0	46.3	28.9	14.0	28.8	20.6	29.9	28.7	41.3	32.0	27.2	39.0	12.4	34.4	7.7	41.8	30.7	7.5	75.7	28.4	31.0	42.0	52.2	25.2	13.5	31.1	33.1	28.7	39.0	11.6	34.6	11.0	30.6	37.1	4.8	7.4	28.9	9.5	80.1	31.4	25.4	6.8	28.5	32.5	33.1	22.7	30.4	8.8	30.9	23.1	6.5	36.3	28.4	29.9	68.7	56.9	23.5	33.2	16.1	20.8	32.7	49.4	24.5	48.2	39.5	79.1	27.1	49.1	79.8	29.8	34.7	47.0	28.9	48.2	12.4	32.1	140.5	34.9	78.6	90.2	39.2	58.2	51.3	24.7	38.4	33.6	27.5	25.7	28.3	46.1	53.6	18.8	30.3	100.6	93.2	122.8	65.0	44.0	176.7	68.1	23.7	79.2	38.1	39.9	71.9	65.7	36.8	49.3	60.4	11.6	38.4	54.7	46.4	93.0	32.9	81.7	92.3	73.4	55.1	52.0	64.5	72.7	54.8	13.4	35.6	12.6	33.3	34.6	33.1	102.5	51.3	53.1	43.6	84.1	55.1	40.0	2.1	39.9	29.9	41.4	46.9	29.5	28.9	28.8	28.7	41.3	28.4	31.0	31.1	33.1	30.6	28.5	30.4	29.9	111.9	41.7	51.6	6.5	132.4	145.4	189.2	198.9	83.6	59.9	127.0	141.1	157.0	114.4	123.4	138.0	22.9	321.9	101.5	232.1	401.1	265.8	41.8	166.8	139.9	151.8	139.1	159.3	6.1	381.7	355.8	138.3	88.2	130.6	73.6	158.1	146.7	288.8	245.5	37.0	8.1	205.7	101.7	132.9	228.9	56.0	191.3	106.0	179.7	8.4	253.1	103.9	95.8	7.1	14.7	311.5	138.3	170.4	142.4	247.0	215.9	616.7	160.6	88.8	190.7	141.0	164.4	85.4	129.4	153.3	160.8	204.3	105.6	235.8	258.9	171.0
GAK	DNAJC26	ENSG00000178950	"Cyclin G associated kinase"	O14976	4	849276-932373	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Cell cycle"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 134.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027405, HPA027459, HPA027463"	Approved		Supported	"Golgi apparatus,Vesicles"		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 24: NB-4 - Immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Golgi apparatus"	Vesicles	"HPA027405: AB_10611111, HPA027459: AB_10599948, HPA027463: AB_10601959"	"unprognostic (1.55e-1)"	"unprognostic (1.66e-1)"	"unprognostic (2.46e-1)"	"unprognostic (3.24e-3)"	"unprognostic (1.07e-1)"	"unprognostic (3.50e-3)"	"unprognostic (1.68e-1)"	"unprognostic (7.07e-2)"	"unprognostic (1.39e-2)"	"unprognostic (3.34e-1)"	"unprognostic (3.03e-2)"	"unprognostic (3.33e-3)"	"prognostic favorable (1.70e-6)"	"unprognostic (1.09e-3)"	"unprognostic (1.79e-1)"	"unprognostic (6.26e-2)"	"prognostic favorable (7.41e-4)"	31.9	40.7	21.1	25.9	22.5	35.5	34.0	20.1	29.7	42.7	20.1	56.3	51.2	41.9	8.0	49.7	43.0	17.7	25.4	21.5	17.8	55.0	47.7	46.0	25.6	28.7	19.8	40.5	53.1	22.7	37.1	15.6	22.1	41.8	14.8	9.4	71.0	13.3	31.4	40.4	57.4	9.8	17.7	61.5	54.2	45.8	20.6	21.6	38.5	6.6	12.9	38.7	39.3	20.5	36.0	28.3	16.9	29.0	16.6	14.2	43.6	33.0	19.7	22.3	18.5	35.9	49.8	30.4	20.9	20.1	40.3	29.7	17.7	27.4	10.5	30.7	27.9	35.3	29.5	27.5	31.1	36.2	53.0	20.5	23.2	22.7	11.0	14.2	24.7	35.3	38.4	37.4	15.2	34.7	61.6	92.1	30.4	38.2	46.3	50.2	19.4	27.4	18.2	28.8	29.0	31.3	19.3	24.2	23.3	14.1	39.2	30.7	40.8	30.9	18.0	31.8	45.1	59.5	41.3	33.8	34.9	43.7	29.0	3.0	10.3	12.8	8.8	9.8	7.6	4.9	5.8	6.1	6.5	3.9	3.3	4.8	7.4	4.8	24.6	7.6	5.6	9.4	21.1	22.5	20.1	29.7	21.5	17.8	28.7	19.8	22.1	17.7	20.6	20.5	24.7	25.6	33.2	34.0	33.9	17.0	15.3	17.9	14.8	27.2	25.3	17.7	12.2	18.6	28.2	25.8	64.6	19.0	46.2	131.3	9.8	18.8	99.1	32.2	21.6	26.7	29.4	26.1	25.7	28.0	17.5	19.5	93.8	52.5	18.3	31.2	18.5	31.6	36.6	11.8	23.5	66.5	26.4	35.9	18.4	134.7	25.1	35.5	16.0	59.0	28.8	16.3	35.0	9.0	24.4	37.6	71.1	18.8	26.1	28.4	65.8	31.0	33.8	26.9	19.7	17.9	18.0	32.9	27.4	19.9	22.3	31.1	34.6	41.6	65.0	44.6
GAL	"GAL-GMAP, GALN, GLNN, GMAP"	ENSG00000069482	"Galanin and GMAP prepropeptide"	P22466	11	68683779-68691175	"Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins"		"Hormone, Neuropeptide"	"Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	23	"brain: 645.9;pituitary gland: 885.8"	"Group enriched"	"Detected in many"	4	"Basal prostatic cells: 22.2;Ductal cells: 38.9;Endometrial ciliated cells: 64.2;Endometrial stromal cells: 50.8;Exocrine glandular cells: 52.1;Extravillous trophoblasts: 48.7;Glandular and luminal cells: 26.4;Pancreatic endocrine cells: 39.5;Prostatic glandular cells: 82.5;Urothelial cells: 24.3"	"Cancer enhanced"	"Detected in many"		"testis cancer: 22.2"	"Region enriched"	"Detected in many"	13	"hypothalamus: 645.9"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"CACO-2: 267.2;HEK 293: 119.3;K-562: 139.5;NB-4: 493.5;SH-SY5Y: 189.6"	"Region enhanced"	"Detected in many"		"hypothalamus: 82.6"	"Low region specificity"	"Detected in all"			"HPA049864, CAB079779"	Enhanced	Supported	Supported	"Golgi apparatus,Vesicles"	"Secreted to blood"	NA	NA	60000	200000	"Cluster 7: Monocytes - Unknown function"	"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 24: NB-4 - Immune response"	"Cluster 36: Stromal cells - Cell proliferation"	"Golgi apparatus"	Vesicles	"CAB079779: , HPA049864: AB_2680922"	"unprognostic (8.56e-2)"	"unprognostic (1.45e-2)"	"unprognostic (7.50e-2)"	"prognostic unfavorable (1.22e-4)"	"unprognostic (2.70e-1)"	"unprognostic (2.27e-2)"	"unprognostic (8.07e-3)"	"prognostic unfavorable (8.17e-4)"	"unprognostic (5.98e-2)"	"unprognostic (1.07e-2)"	"unprognostic (8.84e-2)"	"unprognostic (7.42e-2)"	"unprognostic (1.20e-1)"	"unprognostic (8.85e-2)"	"unprognostic (7.88e-2)"	"unprognostic (5.38e-2)"	"unprognostic (3.24e-2)"	3.2	0.9	2.8	14.9	2.1	0.7	4.4	1.1	5.2	1.0	0.8	17.6	1.8	0.2	0.0	0.8	1.0	0.2	1.0	2.2	645.9	1.5	0.3	0.5	0.1	48.5	5.1	0.2	2.1	0.1	885.8	0.3	13.8	4.4	4.0	0.0	0.9	0.2	0.4	33.3	4.1	9.9	0.6	0.3	9.7	1.0	19.5	0.7	0.4	0.0	0.0	0.7	2.9	2.6	0.0	11.0	1.1	0.3	0.0	0.0	24.0	36.7	0.0	0.7	0.0	267.2	9.9	0.0	12.7	1.3	0.4	0.1	0.0	0.2	0.0	0.0	119.3	6.4	74.6	0.0	1.3	3.7	0.0	1.7	4.0	0.0	0.1	0.0	6.3	0.0	139.5	0.0	0.2	77.2	0.0	493.5	60.3	2.9	23.7	0.0	0.1	51.1	0.6	0.0	49.8	189.6	25.8	1.5	0.0	26.8	1.5	57.6	0.0	0.0	0.0	0.3	2.9	0.0	0.0	0.1	0.0	0.4	0.5	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	2.1	1.1	5.2	2.2	645.9	48.5	5.1	13.8	0.6	19.5	2.6	0.6	0.0	0.0	0.0	0.2	2.0	22.2	0.1	0.0	0.0	3.2	5.8	1.4	0.0	0.0	0.0	0.0	0.6	0.1	0.7	0.0	38.9	0.1	64.2	50.8	3.4	1.8	4.2	2.1	52.1	48.7	6.6	2.0	26.4	4.5	0.4	0.0	0.0	2.0	0.0	0.2	1.1	4.1	0.0	1.2	0.2	0.0	0.7	1.8	0.0	0.6	0.0	0.0	0.0	0.3	39.5	0.1	0.0	1.0	82.5	0.0	0.4	0.0	0.0	0.0	1.6	6.7	2.2	10.9	1.1	3.4	1.9	0.8	0.0	1.3	24.3
GALNT2	GalNAc-T2	ENSG00000143641	"Polypeptide N-acetylgalactosaminyltransferase 2"	Q10471	1	230057990-230282122	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"	"Congenital disorder of glycosylation, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Exocrine glandular cells: 133.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"WM-115: 429.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA011222	Supported		Supported	"Golgi apparatus"	"Intracellular and membrane"	NA	NA		13000000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 55: Plasma cells - Humoral immune response"	"Golgi apparatus"		"HPA011222: AB_1849446"	"unprognostic (1.26e-1)"	"prognostic unfavorable (1.22e-6)"	"unprognostic (1.15e-2)"	"unprognostic (1.35e-2)"	"unprognostic (8.70e-3)"	"unprognostic (7.77e-3)"	"unprognostic (1.25e-1)"	"prognostic unfavorable (8.48e-8)"	"unprognostic (2.93e-1)"	"unprognostic (1.93e-1)"	"unprognostic (1.70e-2)"	"unprognostic (9.65e-2)"	"prognostic unfavorable (2.79e-13)"	"unprognostic (3.79e-3)"	"unprognostic (1.49e-1)"	"unprognostic (3.64e-2)"	"unprognostic (1.89e-1)"	32.9	49.6	17.0	34.8	19.9	13.9	21.9	15.2	16.7	24.7	22.0	28.9	19.5	27.1	6.9	21.0	22.4	21.2	27.4	15.8	18.6	18.5	100.1	27.1	14.0	23.0	19.5	39.2	68.1	9.9	13.6	27.6	18.3	21.4	12.4	19.8	22.1	14.3	67.4	14.7	23.6	25.0	15.3	17.4	33.1	19.7	25.1	42.8	19.0	27.4	11.2	33.4	19.5	15.5	79.5	103.7	59.9	71.4	112.4	95.3	122.8	146.3	90.0	58.4	55.6	45.2	146.5	20.0	106.2	77.7	135.9	150.7	39.9	123.0	48.6	200.1	52.0	60.7	217.2	50.9	60.9	23.4	114.8	136.9	59.8	78.0	30.9	127.3	69.2	110.1	77.0	29.6	65.6	21.8	122.3	23.9	82.1	52.8	97.7	134.3	85.5	61.7	57.4	92.9	18.9	70.1	148.4	7.9	91.0	31.7	46.5	43.5	165.3	56.7	107.9	129.5	118.0	97.9	60.3	44.4	146.1	46.3	429.7	1.5	10.7	3.6	4.4	9.3	3.2	3.4	2.6	4.5	7.8	5.8	2.5	5.0	3.2	2.8	10.2	13.2	3.3	7.7	17.0	19.9	15.2	16.7	15.8	18.6	23.0	19.5	18.3	15.3	25.1	15.5	18.6	16.0	21.3	71.5	32.1	15.3	20.0	52.8	20.5	30.8	13.8	10.7	13.6	18.6	30.1	23.9	33.3	7.3	21.7	24.1	5.9	49.7	47.2	18.7	15.4	17.9	16.8	27.6	67.3	133.0	123.4	36.1	21.4	24.5	13.3	20.5	19.6	98.8	24.9	28.6	82.0	18.9	4.1	42.4	9.7	24.6	35.8	28.9	24.9	106.8	44.0	10.9	18.6	72.9	44.6	88.5	21.6	29.3	109.0	23.5	17.9	19.2	23.5	73.5	13.1	33.1	25.4	3.4	14.0	16.6	8.0	16.6	21.2	32.8	17.6	29.9
GALNT3	"GalNAc-T3, HFTC, HHS"	ENSG00000115339	"Polypeptide N-acetylgalactosaminyltransferase 3"	Q14435	2	165747588-165794659	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"stomach 1: 77.3"	"Cell type enhanced"	"Detected in many"		"Intestinal goblet cells: 152.8;Pancreatic endocrine cells: 188.1;Prostatic glandular cells: 155.7;Urothelial cells: 274.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 50.5"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 85.4;HaCaT: 108.3;HBEC3-KT: 69.2;hTCEpi: 88.2;OE19: 201.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA007613	Enhanced		Supported	"Golgi apparatus"		NA	NA		440000	"Cluster 46: Basophils - DNA binding"	"Cluster 37: Intestine - Unknown function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 22: Epithelial cell types - Mixed function"	"Golgi apparatus"		"HPA007613: AB_1078941"	"unprognostic (1.95e-1)"	"prognostic unfavorable (2.08e-4)"	"unprognostic (1.16e-3)"	"unprognostic (2.78e-1)"	"unprognostic (3.22e-2)"	"prognostic unfavorable (4.10e-4)"	"unprognostic (4.13e-2)"	"unprognostic (4.47e-2)"	"unprognostic (2.74e-1)"	"unprognostic (6.44e-2)"	"unprognostic (3.62e-3)"	"unprognostic (1.33e-1)"	"unprognostic (1.14e-2)"	"unprognostic (1.79e-2)"	"unprognostic (3.54e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.57e-1)"	1.5	1.7	1.7	8.4	2.1	54.0	26.0	2.7	1.8	29.3	4.3	48.9	43.5	5.2	9.3	27.4	38.8	32.2	0.6	1.8	3.4	10.9	2.4	14.0	3.7	4.5	5.2	6.8	26.2	6.9	9.8	6.4	3.3	25.2	53.2	3.7	55.3	8.2	0.3	15.3	39.5	2.5	7.0	20.1	77.3	25.8	1.9	3.3	25.4	0.4	12.3	17.3	12.6	5.4	61.5	0.0	0.6	0.2	0.1	2.6	43.0	18.3	7.7	6.6	16.0	32.0	85.4	0.4	0.1	0.0	0.1	108.3	0.0	69.2	13.5	1.3	13.0	0.0	14.9	0.3	0.3	14.5	0.4	0.5	88.2	0.0	30.3	2.1	0.1	2.9	0.0	55.0	5.0	42.7	0.5	5.6	0.1	201.1	7.8	0.2	0.0	1.7	17.8	42.0	6.5	0.1	0.3	49.6	16.8	1.9	21.7	0.9	0.5	0.1	1.0	0.1	0.3	34.4	16.3	1.3	0.2	14.0	0.6	50.5	6.8	32.2	10.2	9.0	7.5	6.6	3.1	5.8	11.4	6.0	1.0	3.4	25.2	10.6	13.8	17.3	5.6	6.2	1.7	2.1	2.7	1.8	1.8	3.4	4.5	5.2	3.3	7.0	1.9	5.4	1.0	12.8	34.4	7.8	13.6	38.0	107.9	36.5	29.6	0.6	45.0	26.8	0.4	35.8	45.9	66.2	0.0	8.5	37.7	68.6	3.9	70.2	127.5	91.8	5.2	2.9	23.4	1.3	10.5	113.2	22.5	2.3	102.4	70.5	45.7	0.7	1.1	0.6	8.2	0.0	5.1	152.8	28.5	1.9	12.4	14.1	2.5	8.3	16.0	1.0	7.5	16.1	15.5	27.6	1.4	188.1	46.5	0.4	29.7	155.7	32.6	3.1	89.3	1.0	6.6	0.6	4.3	71.5	1.1	42.4	41.3	11.2	14.4	1.2	61.8	274.4
GALR1	"GALNR, GALNR1"	ENSG00000166573	"Galanin receptor 1"	P47211	18	77249848-77277900	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"adrenal gland: 1.4;brain: 1.9;pituitary gland: 1.4"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 68.1;Enteroendocrine cells: 17.6;Oligodendrocyte precursor cells: 42.7;Respiratory ciliated cells: 11.7"	"Cancer enriched"	"Detected in single"	6	"glioma: 1.0"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in some"		"hypothalamus: 5.2"	"Low region specificity"	"Detected in many"			HPA074584			Supported	"Plasma membrane"		NA	NA				"Cluster 26: Pituitary gland - Hormone signaling"		"Cluster 23: Spermatids - Flagellum & Golgi organization"	"Plasma membrane"		"HPA074584: "	"unprognostic (1.65e-1)"				"unprognostic (1.56e-2)"	"unprognostic (2.85e-1)"			"unprognostic (3.00e-1)"	"unprognostic (2.11e-1)"	"unprognostic (2.77e-3)"	"unprognostic (1.31e-2)"	"unprognostic (5.34e-3)"	"unprognostic (7.33e-3)"	"unprognostic (9.49e-2)"	"unprognostic (2.18e-1)"		0.1	1.4	0.8	0.1	0.5	0.2	0.1	0.1	0.8	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.7	1.5	0.0	0.2	0.0	0.0	1.1	1.6	0.0	0.0	0.2	1.4	0.0	0.8	0.2	0.1	0.5	0.0	0.2	0.0	0.1	0.2	0.0	1.3	0.0	0.1	0.1	1.9	0.0	0.1	0.0	0.0	0.0	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.8	0.5	0.1	0.8	0.7	1.5	1.1	1.6	0.8	1.3	1.9	0.8	4.2	0.0	3.6	0.0	0.0	0.0	1.1	0.0	0.0	4.2	0.0	0.0	0.6	0.0	0.6	1.8	0.0	0.0	0.0	0.1	0.0	0.0	68.1	0.3	0.1	0.3	17.6	0.0	1.4	0.0	0.0	1.0	0.0	0.3	1.3	0.1	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	8.0	0.0	0.3	0.0	0.0	0.1	0.2	1.0	42.7	0.3	0.0	1.1	0.0	0.0	0.8	0.0	0.1	11.7	0.4	0.0	3.1	0.2	0.1	0.8	0.0	0.0	0.0	0.3	0.0	0.0	1.2
GAN	"GAN1, GIG, KLHL16"	ENSG00000261609	Gigaxonin	Q9H2C0	16	81314944-81390809	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"		"Disease variant, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skin 1: 24.8"	"Cell type enhanced"	"Detected in many"		"Suprabasal keratinocytes: 130.4;Urothelial cells: 188.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BEWO: 10.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011825, HPA049473"	Approved		Supported	Microtubules		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 22: Epithelial cell types - Mixed function"	Microtubules		"CAB011825: AB_732515, HPA049473: AB_2680782"	"unprognostic (1.78e-1)"	"unprognostic (1.55e-1)"	"unprognostic (8.23e-2)"	"unprognostic (2.51e-2)"	"unprognostic (8.37e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.42e-4)"	"unprognostic (1.90e-1)"	"unprognostic (3.86e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.22e-3)"	"unprognostic (5.91e-3)"	"unprognostic (3.12e-3)"	"unprognostic (5.93e-2)"	"unprognostic (9.98e-2)"	"unprognostic (1.46e-2)"	"unprognostic (5.86e-2)"	1.3	0.9	7.3	0.7	5.7	0.7	2.4	6.6	4.7	2.6	1.0	2.3	0.8	1.3	1.1	5.4	1.3	0.6	1.5	6.9	8.8	1.0	1.1	1.7	0.7	9.3	8.6	1.4	1.2	0.8	1.4	0.8	5.5	2.0	1.2	3.2	2.3	0.7	1.5	24.8	1.4	0.9	8.7	0.9	1.8	0.9	8.7	0.9	1.1	1.4	1.3	1.5	4.3	9.2	1.6	2.0	1.5	2.1	1.9	1.0	10.4	1.2	0.7	0.8	0.3	5.1	1.8	2.5	1.4	1.6	0.4	3.1	2.7	1.3	1.8	0.6	1.4	2.2	1.8	4.1	2.0	2.1	2.4	1.1	3.8	1.3	3.5	1.1	1.7	2.1	2.8	1.1	1.1	9.1	1.9	2.9	4.0	2.2	0.6	3.7	1.4	1.0	1.6	5.0	1.5	1.0	4.3	4.2	1.4	3.6	2.9	2.0	2.5	2.3	2.1	0.8	1.9	2.2	2.7	5.8	1.2	2.4	1.7	0.7	0.4	0.2	0.8	0.4	0.7	0.4	0.8	0.6	0.2	0.5	0.7	0.9	0.3	0.9	0.3	0.9	0.6	0.2	7.3	5.7	6.6	4.7	6.9	8.8	9.3	8.6	5.5	8.7	8.7	9.2	12.2	12.8	8.2	69.5	9.9	91.3	66.8	15.0	34.1	28.4	15.4	18.5	12.5	7.2	29.5	5.5	89.6	19.3	17.4	27.5	0.0	9.4	2.3	11.6	19.3	14.7	5.4	12.6	21.2	6.7	15.4	14.1	17.3	14.0	1.3	7.2	12.1	6.7	5.6	23.5	29.5	15.1	10.2	6.8	30.9	4.6	9.6	8.6	37.4	14.0	7.5	14.0	9.2	22.1	18.3	18.6	16.8	12.8	11.0	75.0	14.8	3.8	30.1	43.8	6.6	20.2	17.6	11.9	16.4	67.1	130.4	21.3	16.1	5.3	15.6	188.7
GAPT	"C5orf29, FLJ33641"	ENSG00000175857	"GRB2 binding adaptor protein, transmembrane"	Q8N292	5	58491435-58497090	"Predicted intracellular proteins"	"B-cell activation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"bone marrow: 16.9;lymphoid tissue: 42.7"	"Cell type enhanced"	"Detected in some"		"B-cells: 84.8;dendritic cells: 160.1;granulocytes: 55.0;Macrophages: 43.0;monocytes: 41.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in many"	5	"eosinophil: 1000.3"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 1000.3"	"Cell line enhanced"	"Detected in some"		"HEL: 71.5;HL-60: 41.8;NB-4: 43.3;THP-1: 33.7;U-937: 118.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA011048, HPA011070"	Uncertain		Supported	"Golgi apparatus,Vesicles,Plasma membrane"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 32: U-937 - Innate immune response"	"Cluster 65: Plasmacytoid DCs - Unknown function"	"Plasma membrane"	"Golgi apparatus, Vesicles"	"HPA011048: , HPA011070: AB_1848887"	"unprognostic (9.79e-2)"	"unprognostic (5.67e-3)"	"unprognostic (2.39e-2)"	"unprognostic (3.26e-2)"	"unprognostic (3.36e-2)"	"unprognostic (8.09e-4)"	"unprognostic (4.32e-1)"	"unprognostic (1.23e-3)"	"unprognostic (4.14e-2)"	"unprognostic (9.47e-3)"	"unprognostic (7.28e-2)"	"unprognostic (2.93e-1)"	"unprognostic (3.52e-3)"	"unprognostic (3.74e-2)"	"unprognostic (2.42e-2)"	"unprognostic (2.33e-2)"	"unprognostic (1.40e-2)"	1.7	0.8	0.7	28.5	0.7	16.9	2.3	0.7	1.1	2.7	1.3	2.7	3.7	1.3	1.1	2.1	1.6	5.7	0.7	0.7	1.0	0.8	2.0	4.2	25.3	1.3	1.1	0.4	1.1	1.1	0.6	1.0	1.3	1.8	3.8	0.5	1.9	1.2	0.2	0.8	6.6	4.7	1.0	18.2	3.7	0.7	1.1	6.9	0.6	0.7	42.7	6.0	0.5	1.8	0.2	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	6.2	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	71.5	0.2	0.0	0.0	41.8	12.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.3	0.0	0.0	0.0	43.3	0.0	0.0	0.0	17.7	0.1	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	33.7	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	118.4	0.0	125.5	66.7	1000.3	0.4	46.5	0.5	97.0	0.4	0.4	76.8	97.4	0.3	0.3	82.0	1.4	59.3	205.4	0.3	32.0	0.7	0.7	0.7	1.1	0.7	1.0	1.3	1.1	1.3	1.0	1.1	1.8	0.4	3.2	1.9	0.0	84.8	0.0	0.0	0.0	0.0	0.0	1.0	0.9	0.2	0.0	0.6	0.0	0.0	0.0	160.1	0.0	0.0	0.0	1.6	0.0	0.1	0.9	0.0	8.8	0.0	0.0	0.1	0.4	0.5	0.0	55.0	0.0	0.4	0.0	14.3	0.0	0.0	0.0	0.0	19.4	6.0	0.5	0.0	43.0	0.0	1.9	41.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.1	0.0	0.0	3.5	0.0	0.0	0.0
GAR1	NOLA1	ENSG00000109534	"GAR1 ribonucleoprotein"	Q9NY12	4	109815510-109824740	"Plasma proteins, Predicted intracellular proteins"	"Ribosome biogenesis, rRNA processing"	"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059098	Supported		Approved	"Nucleoplasm,Nucleoli fibrillar center"		NA	Yes			"Cluster 27: Non-specific - Gene expression"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoplasm, Nucleoli fibrillar center"		"HPA059098: AB_2683904"	"unprognostic (9.72e-2)"	"unprognostic (6.94e-2)"	"unprognostic (3.04e-2)"	"unprognostic (4.47e-2)"	"unprognostic (2.40e-1)"	"unprognostic (1.24e-2)"	"prognostic unfavorable (2.64e-5)"	"unprognostic (1.01e-2)"	"unprognostic (1.73e-1)"	"unprognostic (4.17e-3)"	"unprognostic (2.14e-2)"	"unprognostic (2.45e-3)"	"unprognostic (1.17e-1)"	"unprognostic (5.11e-2)"	"unprognostic (1.11e-1)"	"unprognostic (6.49e-2)"	"unprognostic (1.08e-3)"	14.7	16.4	10.0	13.5	10.1	31.7	15.9	9.8	13.0	12.3	10.1	16.0	11.3	13.7	11.4	23.0	13.3	6.4	12.7	10.0	10.3	20.1	16.5	9.6	13.5	10.1	10.1	15.5	14.7	9.3	11.8	11.5	10.3	12.2	15.2	7.1	13.2	8.0	12.2	23.2	13.2	11.7	9.9	15.5	12.9	15.1	10.3	13.8	10.7	6.6	16.0	16.3	13.5	10.6	45.7	65.5	34.3	49.7	19.3	26.8	34.1	47.1	24.1	35.3	30.1	100.6	60.2	103.5	27.5	38.9	39.5	22.2	68.8	47.7	66.5	31.2	68.3	57.7	57.1	113.1	46.6	150.8	35.2	27.0	49.5	48.6	37.6	27.9	44.5	48.1	146.8	34.6	50.0	121.7	78.5	115.4	59.5	78.4	68.7	58.0	57.2	41.2	55.3	79.3	51.2	55.7	26.3	80.6	46.2	29.5	25.1	48.4	39.3	38.5	51.1	27.2	61.4	42.0	70.7	132.2	26.3	69.7	43.2	7.5	4.0	2.9	6.1	6.7	6.5	8.4	5.9	6.2	6.3	7.9	6.7	6.2	0.7	7.3	6.3	6.8	6.8	2.6	10.0	10.1	9.8	13.0	10.0	10.3	10.1	10.1	10.3	9.9	10.3	10.6	25.2	3.2	17.0	4.6	29.0	57.9	40.9	42.7	27.3	11.9	36.3	37.2	13.8	14.3	33.1	16.5	14.6	69.9	23.4	18.5	25.4	49.2	1.3	54.0	39.9	30.9	18.6	62.1	6.6	53.8	65.8	24.7	30.1	36.9	19.0	38.1	18.2	19.6	35.8	5.0	6.3	40.7	10.2	13.3	17.2	4.3	22.1	16.0	17.8	5.6	16.1	39.2	17.5	5.5	7.4	49.5	22.7	18.8	24.7	68.5	14.5	40.4	35.6	9.3	6.6	35.2	27.7	45.0	38.3	40.2	60.0	87.8	24.8	44.6	46.1	40.6
GARS1	"CMT2D, DSMAV, GARS, GlyRS, SMAD1"	ENSG00000106105	"Glycyl-tRNA synthetase 1"	P41250	7	30580533-30634033	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Hydrolase, Ligase, Transferase"	"Charcot-Marie-Tooth disease, Disease variant, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 34.1;Cytotrophoblasts: 47.0;Extravillous trophoblasts: 70.0;Hofbauer cells: 44.3;Syncytiotrophoblasts: 39.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017896, HPA019097"	Enhanced		Supported	Cytosol	"Intracellular and membrane"	NA	NA		560000	"Cluster 44: Non-specific - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 24: Non-specific - Transcription regulation"	Cytosol		"HPA017896: AB_1849478, HPA019097: AB_1849480"	"prognostic unfavorable (1.02e-4)"	"unprognostic (2.46e-2)"	"unprognostic (5.45e-2)"	"prognostic unfavorable (8.48e-4)"	"unprognostic (2.04e-1)"	"unprognostic (1.57e-3)"	"prognostic unfavorable (8.95e-5)"	"unprognostic (7.31e-3)"	"unprognostic (4.76e-1)"	"unprognostic (4.00e-3)"	"unprognostic (1.77e-1)"	"unprognostic (4.45e-2)"	"prognostic unfavorable (1.70e-5)"	"unprognostic (3.92e-1)"	"unprognostic (3.40e-2)"	"unprognostic (6.32e-2)"	"prognostic unfavorable (3.04e-5)"	34.2	31.0	33.3	43.3	36.5	32.0	31.7	34.2	46.2	32.6	49.9	39.8	27.6	29.1	37.3	53.8	23.3	29.9	32.9	38.6	45.7	42.7	46.0	34.0	47.2	38.1	34.7	26.7	78.5	58.1	36.5	39.9	42.0	26.8	48.6	46.9	36.1	29.3	48.1	43.4	26.0	49.8	33.2	22.3	47.4	51.5	43.4	40.7	51.5	45.0	67.3	54.0	29.4	35.2	231.4	119.8	103.4	364.5	191.9	286.8	172.0	332.4	330.5	184.0	369.8	159.5	115.4	375.9	96.2	443.1	281.6	174.5	262.6	230.2	327.7	92.9	82.5	182.6	84.8	141.1	604.0	267.6	149.8	272.5	391.9	265.8	304.9	128.1	241.6	354.1	350.2	465.4	296.7	154.7	216.8	204.3	259.6	222.4	183.4	114.0	90.1	299.0	219.5	109.1	117.9	177.4	88.1	261.5	509.2	182.8	225.3	409.3	208.2	82.2	262.9	164.9	217.9	403.8	390.8	445.9	289.4	398.8	392.9	40.0	27.0	24.1	22.9	35.8	27.4	21.0	26.0	28.8	35.8	16.3	25.2	30.2	5.2	20.9	41.7	18.5	31.9	23.9	33.3	36.5	34.2	46.2	38.6	45.7	38.1	34.7	42.0	33.2	43.4	35.2	10.7	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	34.1	0.0	0.0	0.0	0.0	47.0	10.2	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	70.0	13.6	0.0	0.0	0.0	0.0	0.0	0.0	44.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.0	0.0	0.0	0.0	0.0	39.8	2.0	0.0	0.0	0.0
GASK1A	"C3orf41, DKFZP434B172, FAM198A"	ENSG00000144649	"Golgi associated kinase 1A"	Q9UFP1	3	42979267-43060211	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Cytotrophoblasts: 1.4;Extravillous trophoblasts: 2.6;Fibroblasts: 1.8;Hofbauer cells: 3.9;Syncytiotrophoblasts: 2.7"	"Cancer enhanced"	"Detected in many"		"glioma: 5.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 3.1;RPMI-8226: 3.4;SK-BR-3: 2.6;T-47d: 6.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047726	Approved		Supported	Vesicles	"Secreted - unknown location"	NA	NA		600000		"Cluster 15: Liver - Metabolism"	"Cluster 6: T47d - Mammary gland"	"Cluster 50: Fibroblasts - ECM organization"	Vesicles		"HPA047726: AB_10960554"	"unprognostic (2.16e-3)"	"unprognostic (2.19e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.93e-2)"	"unprognostic (7.48e-2)"	"unprognostic (2.18e-2)"	"unprognostic (1.65e-2)"	"unprognostic (5.79e-2)"	"unprognostic (2.69e-1)"	"unprognostic (6.21e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.57e-4)"	"unprognostic (4.45e-2)"	"unprognostic (2.09e-2)"	"unprognostic (3.49e-2)"	"unprognostic (3.81e-1)"	5.5	2.1	4.9	2.5	6.4	0.0	4.2	6.3	3.8	10.6	4.9	3.4	0.7	9.8	2.2	1.8	11.3	5.3	1.7	4.1	5.9	1.0	13.1	3.1	0.7	8.8	7.7	6.8	2.0	0.1	3.0	2.0	7.6	2.6	1.0	3.9	2.6	2.2	1.4	1.7	2.1	6.0	6.3	0.9	3.4	2.9	10.0	0.6	2.1	0.8	0.3	3.2	3.9	5.2	0.0	0.0	0.0	3.1	0.1	0.0	1.1	0.2	0.3	0.0	0.0	0.1	0.9	0.0	1.0	0.0	1.6	0.0	0.3	0.0	0.0	0.0	1.9	0.7	0.0	0.0	0.6	0.4	1.2	0.8	0.0	0.4	0.7	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.8	0.0	1.9	0.0	0.0	0.0	0.0	3.4	0.0	0.5	0.1	0.3	0.0	2.6	0.0	0.1	6.7	0.9	0.0	0.4	0.6	1.4	0.0	0.2	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	4.9	6.4	6.3	3.8	4.1	5.9	8.8	7.7	7.6	6.3	10.0	5.2	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	1.8	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0
GATA1	"ERYF1, GATA-1, GF1, NF-E1, NFE1"	ENSG00000102145	"GATA binding protein 1"	P15976	X	48786562-48794311	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	30	"bone marrow: 59.9"	"Cell type enriched"	"Detected in some"	4	"Erythroid cells: 165.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in some"	6	"eosinophil: 471.7"	"Lineage enriched"	"Detected in single"	1877	"granulocytes: 471.7"	"Group enriched"	"Detected in some"	9	"HEL: 221.5;HMC-1: 211.9;K-562: 238.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"HPA000232, HPA000233, CAB009195"	Enhanced		Supported	Nucleoplasm		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 6: Erythroid cells - Oxygen transport"	Nucleoplasm		"CAB009195: AB_2232148, HPA000232: AB_1078949, HPA000233: AB_1078951"	"unprognostic (1.93e-1)"	"unprognostic (7.54e-2)"	"unprognostic (8.95e-3)"	"unprognostic (3.84e-3)"	"unprognostic (2.25e-1)"	"unprognostic (3.00e-4)"	"unprognostic (4.87e-2)"	"unprognostic (3.48e-2)"	"unprognostic (4.44e-2)"	"unprognostic (1.95e-2)"	"unprognostic (6.04e-2)"	"unprognostic (7.71e-3)"	"unprognostic (4.13e-2)"	"unprognostic (2.24e-1)"	"unprognostic (2.78e-1)"	"unprognostic (9.10e-2)"	"unprognostic (2.71e-2)"	0.2	0.1	0.0	0.1	0.2	59.9	0.1	0.2	0.1	0.2	0.0	0.2	0.5	0.3	0.0	0.2	0.1	0.6	0.1	0.0	0.2	0.2	0.3	2.0	0.1	0.3	0.2	0.0	0.0	0.0	0.2	1.0	0.2	0.3	0.3	0.4	0.1	0.1	0.0	0.3	0.5	0.3	0.2	2.0	0.5	1.4	0.2	0.1	0.1	0.4	0.0	0.4	0.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	221.5	0.0	0.0	0.0	0.2	211.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	238.9	0.4	0.0	0.0	0.1	26.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.1	83.6	0.2	471.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.9	0.0	0.2	0.0	0.0	4.4	0.0	0.2	0.2	0.1	0.0	0.2	0.3	0.2	0.2	0.2	0.2	0.6	0.0	0.0	1.3	0.7	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	12.5	0.0	0.0	0.0	0.0	165.6	0.1	0.0	0.5	0.3	0.0	0.0	37.9	0.0	1.1	0.0	0.5	0.0	0.0	0.0	0.0	0.6	0.4	31.5	0.0	9.2	0.0	0.0	0.1	0.0	1.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.3	0.1	0.0	0.0	0.1	1.2	0.2	0.0	0.0
GATA2	NFE1B	ENSG00000179348	"GATA binding protein 2"	P23769	3	128479427-128493201	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Phagocytosis, Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 261.6;Glandular and luminal cells: 116.5;granulocytes: 638.7;Syncytiotrophoblasts: 321.4"	"Group enriched"	"Detected in all"	5	"endometrial cancer: 12.7;prostate cancer: 36.7;urothelial cancer: 13.2"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	330	"basophil: 513.2"	"Lineage enriched"	"Detected in single"	4344	"granulocytes: 513.2"	"Cell line enhanced"	"Detected in many"		"BEWO: 281.0;HEL: 360.7;HMC-1: 187.4;SH-SY5Y: 325.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005633, CAB024847"	Enhanced		Supported	Nucleoplasm		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 60: Granulocytes - Receptor signaling"	Nucleoplasm		"CAB024847: , HPA005633: AB_1078954"	"unprognostic (1.71e-1)"	"unprognostic (8.90e-2)"	"unprognostic (1.12e-1)"	"unprognostic (8.61e-2)"	"unprognostic (8.67e-2)"	"unprognostic (4.17e-2)"	"unprognostic (5.96e-3)"	"unprognostic (7.30e-2)"	"unprognostic (3.98e-2)"	"unprognostic (4.12e-2)"	"unprognostic (3.58e-2)"	"unprognostic (3.04e-1)"	"prognostic favorable (2.04e-4)"	"unprognostic (2.50e-1)"	"unprognostic (8.07e-2)"	"unprognostic (2.08e-1)"	"prognostic favorable (5.22e-5)"	16.9	9.8	7.1	2.7	5.3	5.1	12.8	3.6	4.6	32.9	2.1	6.6	4.3	42.7	7.1	4.9	49.7	10.7	19.5	3.9	3.4	20.7	1.3	34.8	2.8	8.2	12.2	4.3	13.7	6.9	9.7	22.5	7.9	54.4	2.9	0.1	4.8	52.2	6.4	9.2	8.5	10.8	4.0	11.4	6.6	2.7	8.8	0.8	7.3	5.2	1.2	33.8	23.9	4.1	24.4	5.9	1.3	15.9	2.0	0.6	281.0	53.8	45.2	18.0	6.5	10.0	10.7	0.5	14.8	31.9	1.5	25.5	14.7	0.0	7.6	0.0	8.3	360.7	42.9	16.0	4.0	36.8	187.4	0.3	0.3	0.7	0.3	2.9	28.6	0.2	96.7	0.5	0.4	9.0	0.1	74.2	1.0	0.2	1.8	0.1	7.0	0.4	0.5	21.5	21.8	325.9	13.6	70.1	2.4	14.4	13.5	15.0	52.0	1.2	0.7	12.7	7.4	0.1	0.0	0.2	0.6	2.5	3.7	513.2	0.0	1.5	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	3.9	7.1	5.3	3.6	4.6	3.9	3.4	8.2	12.2	7.9	4.0	8.8	4.1	69.0	6.4	27.7	0.0	0.9	4.8	25.5	0.0	1.2	0.2	1.5	1.5	5.7	0.0	1.8	75.4	0.0	63.4	2.3	0.5	1.9	0.2	10.1	74.2	43.2	75.4	3.0	62.4	0.0	14.2	261.6	8.8	0.5	116.5	638.7	0.9	57.5	0.2	10.8	0.0	0.0	0.3	0.0	0.3	4.6	6.4	0.6	7.9	8.8	15.9	0.7	0.1	0.0	0.0	0.0	0.9	0.0	0.4	5.4	29.5	0.0	0.2	0.7	0.2	0.0	2.2	11.0	0.6	4.7	0.9	2.4	321.4	14.0	0.2	0.3	10.5
GATA3	HDR	ENSG00000107485	"GATA binding protein 3"	P23771	10	8045378-8075198	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Immunity, Innate immunity, Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes, Deafness, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"parathyroid gland: 109.9;skin 1: 172.9"	"Cell type enhanced"	"Detected in many"		"Breast glandular cells: 267.1;Cytotrophoblasts: 323.5;Extravillous trophoblasts: 746.6;Suprabasal keratinocytes: 198.9;Syncytiotrophoblasts: 1134.9"	"Group enriched"	"Detected in many"	24	"breast cancer: 190.0;urothelial cancer: 87.0"	"Group enriched"	"Detected in many"	5	"midbrain: 28.3;pons: 12.6"	"Group enriched"	"Detected in many"	41	"gdT-cell: 19.9;MAIT T-cell: 26.9;memory CD4 T-cell: 36.7;memory CD8 T-cell: 28.8;naive CD4 T-cell: 19.9;naive CD8 T-cell: 18.3;NK-cell: 36.1;T-reg: 43.6"	"Group enriched"	"Detected in many"	57	"NK-cells: 36.1;T-cells: 43.6"	"Cell line enhanced"	"Detected in many"		"BEWO: 190.2;MCF7: 473.4;RT4: 194.3;SH-SY5Y: 161.2;T-47d: 605.2"	"Region enriched"	"Detected in single"	6	"midbrain: 6.1"	"Group enriched"	"Detected in some"	11	"medulla oblongata: 5.2;midbrain: 14.0;pons: 11.8;thalamus: 13.1"	"CAB016217, HPA029730"	Enhanced		Supported	Nucleoplasm		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 61: Skin - Cornification"	"Cluster 6: T47d - Mammary gland"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	Nucleoplasm		"CAB016217: AB_2108591, HPA029730: AB_10601907"	"unprognostic (1.70e-1)"	"unprognostic (7.23e-2)"	"unprognostic (3.58e-2)"	"unprognostic (2.00e-1)"	"unprognostic (7.03e-3)"	"unprognostic (4.68e-3)"	"unprognostic (4.23e-2)"	"unprognostic (9.65e-2)"	"unprognostic (2.06e-1)"	"unprognostic (2.55e-1)"	"unprognostic (3.83e-1)"	"unprognostic (1.17e-1)"	"prognostic unfavorable (3.13e-4)"	"unprognostic (1.48e-1)"	"unprognostic (5.16e-2)"	"unprognostic (6.31e-2)"	"unprognostic (1.82e-3)"	6.7	6.4	0.9	3.8	0.2	4.1	34.2	0.2	0.2	3.4	0.8	0.7	1.0	0.6	8.6	0.6	0.5	1.2	2.5	0.1	0.6	24.9	1.0	3.4	7.8	3.9	28.3	0.1	0.3	109.9	5.0	32.2	12.6	11.2	0.7	0.0	19.9	24.9	2.1	172.9	2.4	0.3	0.5	7.2	1.5	0.2	4.1	25.0	3.0	1.0	3.8	38.8	10.8	0.2	33.8	8.1	0.0	0.4	0.0	0.0	190.2	0.7	0.0	0.0	0.1	12.4	29.9	0.0	0.1	0.0	0.0	28.9	3.2	0.6	0.1	95.8	10.2	0.2	0.3	0.1	2.1	0.1	0.5	0.0	6.9	0.1	1.8	1.0	15.3	45.8	0.4	0.0	0.1	473.4	54.2	0.5	3.5	6.5	4.5	2.8	2.6	0.8	0.0	194.3	9.8	161.2	0.5	26.8	0.0	34.1	605.2	0.1	0.0	2.4	5.9	1.4	4.3	0.9	0.0	0.0	1.3	0.0	1.7	0.1	0.1	0.0	19.9	0.0	26.9	0.4	36.7	28.8	0.0	0.1	19.9	18.3	0.7	36.1	0.0	0.0	43.6	7.0	0.9	0.2	0.2	0.2	0.1	0.6	3.9	28.3	12.6	0.5	4.1	0.2	14.6	0.0	6.0	0.0	3.4	94.8	69.6	1.6	0.0	0.0	267.1	167.3	1.3	0.0	1.5	178.4	0.0	323.5	49.2	0.0	0.0	0.2	0.2	0.5	0.4	12.6	0.0	2.1	0.0	0.4	746.6	5.3	2.6	0.7	2.5	0.0	6.8	0.6	30.7	0.0	0.0	0.0	0.0	3.5	9.9	0.1	0.0	3.8	8.8	1.0	1.5	0.0	51.5	0.0	0.0	4.1	1.1	0.0	12.2	45.8	0.0	0.6	0.3	0.0	0.0	1.1	2.8	0.0	1.4	1.0	198.9	1134.9	93.4	0.5	0.0	106.1
GATA4		ENSG00000136574	"GATA binding protein 4"	P43694	8	11676959-11760002	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Atrial septal defect, Cardiomyopathy, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"heart muscle: 88.6;ovary: 95.4;pancreas: 53.5"	"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 41.4;Exocrine glandular cells: 33.7;Gastric mucus-secreting cells: 61.2;Granulosa cells: 158.4;Hepatic stellate cells: 57.8;Late spermatids: 37.0;Leydig cells: 41.3;Peritubular cells: 41.3;Theca cells: 80.1"	"Cancer enhanced"	"Detected in many"		"stomach cancer: 21.8;testis cancer: 12.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Hep G2: 19.7;HHSteC: 20.9;OE19: 6.2;SH-SY5Y: 20.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB013125, HPA073899"	Uncertain		Supported	"Nuclear bodies"		NA	NA				"Cluster 29: Non-specific - Vesicular transport"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 40: Granulosa cells - Unknown function"	"Nuclear bodies"		"CAB013125: AB_2533804, HPA073899: AB_2686641"	"unprognostic (2.99e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.36e-1)"	"unprognostic (8.68e-4)"	"unprognostic (2.66e-3)"	"unprognostic (1.71e-1)"	"unprognostic (8.55e-3)"	"unprognostic (1.02e-2)"	"unprognostic (5.47e-2)"	"unprognostic (2.55e-1)"	"unprognostic (2.78e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.67e-8)"	"unprognostic (1.09e-1)"	"unprognostic (1.61e-1)"		"unprognostic (1.29e-2)"	0.2	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	20.2	0.2	0.0	0.0	2.3	4.0	88.6	0.0	0.0	0.0	36.6	0.2	0.0	0.0	0.0	95.4	53.5	0.0	0.1	7.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	9.8	0.0	0.0	0.1	35.2	32.4	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.0	1.2	0.0	0.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.6	0.9	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	19.7	20.9	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	6.2	0.0	0.0	0.2	1.3	0.0	0.0	1.5	20.5	0.0	0.0	0.1	3.9	1.2	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	41.4	1.5	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.2	16.1	0.0	0.1	6.1	0.0	0.0	0.1	33.7	0.2	12.0	61.2	0.0	0.0	158.4	57.8	12.1	0.6	0.0	0.1	0.8	0.0	2.8	0.0	37.0	41.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	14.5	0.0	41.3	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	5.3	2.4	2.2	0.0	0.0	0.8	0.1	80.1	0.9	0.0
GATA6		ENSG00000141448	"GATA binding protein 6"	Q92908	18	22169589-22202528	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Atrial septal defect, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 57.8;ovary: 73.0"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 97.6;Gastric mucus-secreting cells: 100.9;Granulosa cells: 52.9"	"Cancer enhanced"	"Detected in many"		"stomach cancer: 26.0"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	23	"basophil: 4.0"	"Lineage enriched"	"Detected in single"	23	"granulocytes: 4.0"	"Cell line enhanced"	"Detected in many"		"BEWO: 54.8;CACO-2: 69.7;hTERT-RPE1: 25.5;OE19: 37.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB011581, HPA066629"	Approved		Supported	Nucleoplasm		Yes	No			"Cluster 34: Basophils - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm		"CAB011581: AB_732529, HPA066629: AB_2685695"	"unprognostic (1.90e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.11e-1)"	"unprognostic (4.48e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.72e-2)"	"unprognostic (2.16e-1)"	"unprognostic (9.43e-2)"	"unprognostic (4.36e-2)"	"unprognostic (3.47e-1)"	"unprognostic (2.61e-1)"	"unprognostic (8.45e-3)"	"prognostic unfavorable (1.92e-9)"	"unprognostic (8.75e-3)"	"unprognostic (2.07e-1)"	"unprognostic (1.91e-1)"	"unprognostic (2.12e-2)"	22.2	57.8	0.0	2.5	0.2	0.0	3.8	0.0	0.3	4.9	2.8	11.4	22.8	19.8	1.2	0.8	28.9	11.1	43.9	0.1	0.0	3.0	12.6	14.8	1.9	0.1	0.0	73.0	22.7	0.3	0.6	6.5	0.0	5.5	11.0	0.1	0.8	0.7	0.8	1.5	20.7	9.5	0.2	15.0	49.6	6.3	0.1	0.4	5.3	0.6	0.2	23.0	3.2	0.0	10.1	1.4	0.0	0.0	2.1	1.0	54.8	0.3	0.4	0.8	1.0	69.7	3.8	0.0	3.2	1.2	3.4	10.8	0.4	4.5	1.4	0.0	13.6	0.0	4.3	6.1	14.3	0.6	0.6	0.4	8.9	12.1	9.1	25.5	9.5	0.0	0.5	0.0	0.0	1.5	0.0	0.2	0.1	37.6	9.8	0.0	1.1	0.2	0.4	2.8	0.9	0.1	10.7	6.1	3.0	2.7	1.7	0.0	0.7	1.4	1.6	11.4	1.7	0.0	0.0	0.0	6.2	0.3	9.9	4.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.1	0.0	0.1	0.0	0.0	0.2	0.1	0.0	7.3	44.8	30.2	0.0	0.0	0.9	4.0	4.6	1.8	0.0	3.4	2.7	97.6	30.0	6.1	0.0	0.0	0.9	0.9	50.0	0.0	28.4	44.7	6.3	6.3	11.5	26.0	2.7	0.1	19.6	11.2	24.4	100.9	16.6	5.1	52.9	28.5	11.1	1.6	0.0	0.1	45.8	2.0	0.6	0.9	8.8	3.4	0.5	0.0	1.0	0.0	0.0	0.0	0.0	0.2	36.8	27.7	10.1	0.2	4.1	43.3	0.0	3.9	0.0	32.9	0.4	8.6	1.4	1.4	0.9	0.9	1.9	1.3	11.4	47.2	2.9
GATB	"PET112, PET112L"	ENSG00000059691	"Glutamyl-tRNA amidotransferase subunit B"	O75879	4	151670504-151761007	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Protein biosynthesis"	Ligase	"Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	5	"Muller glia cells: 333.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042610	Uncertain		Supported	Mitochondria		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 5: Muller glia cells - Visual perception"	Mitochondria		"HPA042610: AB_10797502"	"unprognostic (2.52e-1)"	"unprognostic (3.33e-1)"	"unprognostic (1.01e-3)"	"unprognostic (5.08e-2)"	"unprognostic (2.31e-1)"	"unprognostic (6.91e-2)"	"unprognostic (2.24e-1)"	"unprognostic (5.77e-2)"	"unprognostic (2.06e-1)"	"unprognostic (6.76e-2)"	"unprognostic (1.37e-1)"	"unprognostic (8.17e-2)"	"prognostic favorable (1.20e-10)"	"unprognostic (1.91e-1)"	"unprognostic (8.39e-2)"	"unprognostic (3.09e-2)"	"unprognostic (2.46e-1)"	11.8	15.6	15.4	5.6	17.5	9.5	8.3	18.0	20.4	6.7	14.9	9.8	5.8	5.5	8.3	10.3	8.7	5.5	33.3	16.3	16.9	21.6	22.2	5.3	7.6	17.4	16.5	11.3	5.3	18.3	5.2	8.6	17.1	5.5	9.6	17.0	7.9	6.4	23.0	9.4	6.4	8.0	17.7	6.5	8.2	8.0	17.2	12.2	7.5	40.3	9.7	6.9	6.1	20.4	14.9	11.6	16.1	15.7	22.9	21.7	13.9	19.3	24.9	33.3	25.8	19.5	23.8	20.2	5.0	20.1	20.3	13.7	34.5	36.6	35.3	11.4	21.1	9.4	15.2	40.7	22.4	19.1	9.0	22.8	23.1	32.0	11.2	19.2	25.1	28.0	36.8	17.1	26.0	16.7	24.1	20.8	16.6	12.4	21.1	20.4	15.5	16.1	30.2	12.3	16.5	18.5	15.8	21.1	23.1	15.4	17.9	13.7	14.1	16.8	9.1	11.7	13.4	20.3	28.2	16.8	23.7	16.9	12.5	0.9	11.6	2.0	4.5	16.9	7.3	11.4	6.1	6.5	20.9	9.9	7.8	7.3	1.1	8.7	12.1	8.1	7.0	10.8	15.4	17.5	18.0	20.4	16.3	16.9	17.4	16.5	17.1	17.7	17.2	20.4	4.3	9.6	4.8	11.4	6.7	0.0	6.0	0.0	5.7	9.8	6.3	7.1	64.8	1.5	3.7	11.0	8.4	23.4	2.9	3.2	27.4	11.2	8.0	6.7	7.3	4.4	2.4	15.6	28.4	7.4	16.6	8.8	6.6	7.1	1.3	12.3	2.5	17.2	17.1	10.1	16.4	4.2	0.0	7.3	0.0	10.6	5.3	7.6	0.0	15.9	10.8	333.3	1.0	14.1	27.5	6.9	4.9	4.5	5.6	3.1	6.3	22.7	1.5	17.1	6.6	6.5	5.9	14.3	14.0	10.6	0.0	13.4	3.6	12.5	7.1	4.5
GATD1	"FLJ34283, PDDC1"	ENSG00000177225	"Glutamine amidotransferase like class 1 domain containing 1"	Q8NB37	11	767220-777488	"Enzymes, Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 44.8;Alveolar cells type 2: 22.1;Collecting duct cells: 22.0;Theca cells: 25.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HEK 293: 120.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008812	Uncertain		Supported	Nucleoplasm	"Secreted to blood"	NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 35: Non-specific - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm		"HPA008812: AB_10962724"	"unprognostic (3.39e-1)"	"unprognostic (2.48e-2)"	"unprognostic (1.31e-1)"	"unprognostic (3.58e-2)"	"unprognostic (2.82e-2)"	"unprognostic (3.03e-2)"	"prognostic unfavorable (3.98e-4)"	"unprognostic (3.50e-2)"	"unprognostic (2.19e-1)"	"unprognostic (5.67e-2)"	"unprognostic (5.23e-3)"	"unprognostic (4.89e-3)"	"prognostic favorable (3.79e-5)"	"unprognostic (2.84e-2)"	"unprognostic (8.40e-2)"	"unprognostic (6.11e-2)"	"unprognostic (6.61e-3)"	15.9	37.5	37.7	11.3	35.8	7.9	16.7	35.1	37.8	22.7	36.6	23.3	15.4	24.9	12.6	23.7	22.7	7.3	16.3	37.4	36.5	24.0	19.3	15.4	11.2	46.4	41.8	25.9	15.9	10.5	30.1	9.2	35.8	23.0	6.5	9.7	17.5	12.2	14.4	21.0	18.2	7.9	38.4	19.6	17.8	18.6	45.3	8.8	22.0	6.5	6.8	19.7	20.4	37.5	41.3	22.3	22.2	23.9	10.2	15.6	20.9	24.2	10.5	22.0	19.3	15.8	62.5	22.1	8.6	16.0	23.2	42.7	16.7	21.6	11.0	28.1	120.5	13.0	38.8	36.0	17.5	25.4	27.8	22.4	23.2	9.3	14.2	19.9	17.1	25.8	34.2	20.0	12.4	11.0	29.3	27.5	21.3	13.4	42.8	31.4	15.1	28.0	19.2	9.1	56.9	22.3	22.9	32.0	16.6	5.7	28.5	16.8	31.3	23.2	17.5	12.7	18.8	23.4	12.9	28.4	35.4	33.9	19.6	1.0	5.2	0.9	2.9	6.6	2.1	2.7	3.0	2.9	6.9	2.3	2.4	1.7	0.5	1.2	2.6	4.0	1.4	2.0	37.7	35.8	35.1	37.8	37.4	36.5	46.4	41.8	35.8	38.4	45.3	37.5	8.7	44.8	22.1	0.0	4.4	0.0	0.0	0.0	0.0	0.0	11.9	10.4	0.0	0.0	7.4	22.0	0.0	13.8	5.2	0.0	5.9	10.3	0.0	11.8	15.2	3.8	0.0	0.0	0.0	7.6	7.9	8.5	0.0	9.6	6.3	19.2	0.0	0.0	13.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.2	0.0	0.0	4.6	0.0	0.0	0.0	0.0	16.6	0.0	0.0	1.3	0.0	0.0	14.7	7.3	0.0	0.0	0.0	5.8	0.0	0.0	0.0	0.0	9.6	3.9	25.8	0.0	0.0
GATM	AGAT	ENSG00000171766	"Glycine amidinotransferase"	P50440	15	45361124-45402327	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Transferase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	12	"kidney: 2099.3;liver: 2804.2;pancreas: 2935.3"	"Group enriched"	"Detected in many"	8	"Hepatocytes: 1495.2;Proximal tubular cells: 3703.0"	"Cancer enhanced"	"Detected in all"		"liver cancer: 135.2"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"memory B-cell: 11.0;myeloid DC: 6.6;naive B-cell: 5.4;plasmacytoid DC: 6.8"	"Group enriched"	"Detected in many"	5	"B-cells: 11.0;dendritic cells: 6.8"	"Group enriched"	"Detected in many"	4	"RH-30: 210.1;RT4: 55.8;U-266/70: 126.3;U-266/84: 165.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026077	Enhanced		Supported	Mitochondria		NA	NA		600000	"Cluster 43: B-cells - Humoral immune response"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Mitochondria		"HPA026077: AB_1849528"	"unprognostic (1.91e-1)"	"unprognostic (1.33e-2)"	"unprognostic (2.77e-2)"	"unprognostic (6.57e-2)"	"unprognostic (9.43e-2)"	"unprognostic (1.67e-2)"	"unprognostic (6.99e-3)"	"unprognostic (1.04e-1)"	"unprognostic (4.51e-2)"	"unprognostic (3.36e-2)"	"unprognostic (1.33e-1)"	"unprognostic (5.67e-2)"	"prognostic favorable (1.38e-4)"	"unprognostic (1.09e-1)"	"unprognostic (4.07e-2)"	"unprognostic (3.60e-2)"	"unprognostic (1.80e-1)"	14.4	21.4	133.9	12.4	138.4	1.8	25.4	152.5	216.5	9.9	94.3	19.6	175.5	8.4	10.5	25.1	11.6	47.7	57.2	131.1	140.9	2099.3	2804.2	7.3	18.4	148.0	135.4	165.2	2935.3	2.7	8.3	74.7	153.4	12.4	11.5	7.5	57.5	15.1	142.5	137.6	110.2	14.5	149.2	33.6	99.2	78.2	140.4	12.6	63.0	46.9	29.7	18.0	15.5	181.2	12.9	6.5	4.4	0.6	0.1	0.2	0.8	0.1	0.1	0.0	0.2	1.4	21.4	34.4	1.0	0.0	5.7	2.2	17.0	0.6	0.4	1.9	0.3	2.8	0.4	0.3	0.8	20.7	2.6	0.8	0.7	0.0	0.4	0.0	0.3	7.8	0.4	0.7	0.2	0.6	2.2	0.6	11.2	31.3	0.0	0.5	210.1	1.5	3.5	55.8	23.5	4.1	6.9	0.4	1.2	2.1	2.9	23.7	0.0	0.0	0.5	0.2	6.3	126.3	165.5	0.8	1.6	0.3	1.0	0.0	1.1	0.3	0.2	1.6	0.0	11.0	0.0	0.2	6.6	5.4	0.0	1.4	0.0	0.1	0.6	6.8	0.0	1.0	133.9	138.4	152.5	216.5	131.1	140.9	148.0	135.4	153.4	149.2	140.4	181.2	2.4	3.2	1.1	67.3	42.3	54.3	14.9	5.2	5.7	8.1	16.9	9.5	35.5	228.8	5.4	71.7	0.0	1.0	0.8	3.1	295.4	58.2	8.8	1.3	0.4	7.3	0.0	29.3	6.8	290.0	1.2	19.8	69.8	2.7	3.8	219.5	23.9	1495.2	89.6	8.4	3.3	3.1	2.0	80.3	80.3	18.3	4.4	50.6	23.2	20.6	3.1	19.1	2.1	57.3	196.3	97.3	3.9	3.4	7.2	6.4	98.4	3703.0	1.9	3.8	6.6	38.4	16.8	22.0	9.7	16.0	133.7	1.8	17.6	4.1	3.4	20.4
GBF1	"ARF1GEF, KIAA0248"	ENSG00000107862	"Golgi brefeldin A resistant guanine nucleotide exchange factor 1"	Q92538	10	102245371-102382899	"Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, Protein transport, Transport"	"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 28.6"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037759, HPA037760"	Uncertain		Supported	"Golgi apparatus"		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 59: Non-specific - Transcription"	"Golgi apparatus"		"HPA037759: AB_10671884, HPA037760: AB_2675651"	"unprognostic (5.97e-2)"	"unprognostic (3.33e-1)"	"unprognostic (2.74e-3)"	"unprognostic (7.02e-2)"	"unprognostic (2.03e-1)"	"unprognostic (6.72e-2)"	"unprognostic (3.78e-2)"	"unprognostic (8.28e-2)"	"unprognostic (1.12e-2)"	"unprognostic (5.34e-3)"	"unprognostic (2.04e-2)"	"unprognostic (6.06e-2)"	"unprognostic (1.87e-1)"	"unprognostic (2.10e-1)"	"unprognostic (2.24e-1)"	"unprognostic (3.02e-1)"	"unprognostic (3.09e-2)"	19.4	21.1	31.5	16.0	31.7	25.0	19.3	28.7	47.2	21.7	34.9	24.6	20.6	23.5	12.7	21.9	19.7	9.8	30.0	32.2	27.7	21.7	23.2	20.5	14.6	28.5	37.3	21.6	25.6	24.4	31.5	11.5	30.6	24.2	13.9	19.2	24.5	15.2	48.1	24.9	25.8	16.4	27.1	21.7	21.2	20.5	29.8	11.8	25.4	30.1	13.8	21.7	20.5	29.1	19.4	49.7	23.3	25.1	62.9	40.7	28.1	37.7	56.0	45.3	48.1	52.7	35.1	21.7	29.7	59.6	33.8	38.6	45.9	52.8	33.8	35.4	36.9	33.3	38.1	44.6	26.4	35.2	46.8	37.3	28.0	60.7	57.5	77.2	45.2	22.5	20.7	53.7	41.8	36.9	24.2	38.9	15.4	29.5	35.6	33.6	72.1	18.8	39.3	30.9	15.0	16.3	30.2	22.3	26.5	33.1	50.4	30.8	60.5	29.1	29.6	37.7	55.6	32.4	36.3	26.5	30.0	36.3	22.1	28.6	4.5	4.3	4.9	5.0	5.9	6.5	3.6	6.5	5.0	3.9	5.7	5.3	4.6	4.6	4.1	4.2	7.4	3.9	31.5	31.7	28.7	47.2	32.2	27.7	28.5	37.3	30.6	27.1	29.8	29.1	12.5	12.8	10.1	56.5	15.5	9.8	5.5	10.6	17.6	24.7	15.7	12.8	17.0	15.7	10.9	12.9	56.3	12.2	15.1	31.4	3.9	12.5	4.9	14.3	18.1	12.3	12.0	13.9	72.1	16.7	16.3	14.6	31.1	15.6	7.6	10.3	8.2	17.6	12.2	52.2	73.0	21.9	12.2	11.0	5.0	4.7	10.2	13.4	12.4	66.5	9.5	11.1	9.2	80.9	71.1	18.6	20.7	11.3	46.0	7.7	27.1	9.0	12.3	41.0	6.6	21.7	12.3	36.0	25.4	20.7	13.1	17.6	16.0	19.1	19.4	6.7
GBP2		ENSG00000162645	"Guanylate binding protein 2"	P32456	1	89106132-89150456	"Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Glandular and luminal cells: 152.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 19.1;EFO-21: 20.3;HDLM-2: 25.9;HUVEC TERT2: 18.1;RT4: 21.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA042682, CAB045975"	Supported		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 72: Non-specific - Transcription"	"Cluster 15: RT4 - Unknown function"	"Cluster 44: Endometrium - Transcription"	"Nucleoplasm, Cytosol"		"CAB045975: AB_10584474, HPA042682: AB_2678113"	"prognostic favorable (7.57e-4)"	"unprognostic (2.92e-2)"	"unprognostic (3.65e-2)"	"unprognostic (3.02e-2)"	"unprognostic (1.34e-1)"	"unprognostic (4.68e-2)"	"unprognostic (2.70e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.53e-1)"	"unprognostic (2.75e-3)"	"prognostic unfavorable (5.73e-5)"	"unprognostic (1.14e-1)"	"prognostic unfavorable (2.14e-10)"	"unprognostic (7.75e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.29e-2)"	"prognostic favorable (1.10e-5)"	66.6	89.2	3.1	31.8	3.2	8.0	64.6	2.8	4.7	80.4	2.5	100.4	15.0	63.4	11.7	41.2	64.4	22.7	21.4	2.5	4.6	27.3	27.7	89.7	26.2	8.8	5.1	60.5	7.5	27.9	13.8	8.1	5.7	54.6	18.4	0.5	34.6	20.6	53.8	55.4	62.0	31.8	3.7	51.1	46.0	9.0	6.4	9.3	21.1	16.5	15.9	83.8	65.4	4.0	5.4	0.1	0.0	0.0	19.1	12.5	1.9	2.1	17.0	2.1	6.8	0.0	5.0	0.0	20.3	14.0	14.8	0.7	0.0	0.1	1.3	25.9	0.0	0.1	3.1	1.3	2.6	0.5	0.9	14.1	0.0	5.1	0.0	9.3	18.1	0.0	0.3	0.4	7.4	0.0	0.0	4.3	0.0	4.6	0.1	0.0	7.5	0.0	3.7	21.6	0.0	0.2	7.4	1.5	0.1	0.5	0.1	1.0	13.9	2.7	0.1	3.1	1.5	14.0	0.0	0.0	6.9	0.1	0.1	19.1	31.4	10.9	34.4	42.8	43.3	4.7	32.4	32.9	11.6	3.4	24.3	25.4	139.4	26.7	77.8	0.6	79.1	32.5	3.1	3.2	2.8	4.7	2.5	4.6	8.8	5.1	5.7	3.7	6.4	4.0	35.4	25.6	34.3	0.7	21.5	46.5	123.5	24.9	18.2	0.2	56.1	30.4	4.1	27.1	27.1	18.4	0.0	40.2	47.7	41.9	0.0	113.9	35.7	59.6	39.7	60.5	10.2	8.2	0.6	73.2	51.2	41.2	18.3	152.4	47.4	2.5	28.2	30.5	33.2	0.0	1.1	15.7	8.2	84.5	29.4	33.3	4.7	81.1	8.8	14.0	60.6	0.5	110.2	1.5	0.1	73.2	25.9	8.6	17.3	80.3	128.3	12.2	27.5	0.2	19.7	81.9	45.2	1.8	4.6	24.9	61.8	57.7	81.8	33.3	15.3	87.0
GBP4	Mpa2	ENSG00000162654	"Guanylate binding protein 4"	Q96PP9	1	89181144-89198942	"Plasma proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 84.4;Endothelial cells: 81.2;Hepatic stellate cells: 92.4;Theca cells: 122.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 12.1;HDLM-2: 9.9;HEL: 13.0;REH: 11.1;RT4: 18.3;U-266/70: 16.0"									"HPA030101, HPA062039"	Enhanced		Supported	"Golgi apparatus,Plasma membrane"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 16: Immune cells - Immune response"	"Cluster 15: RT4 - Unknown function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Golgi apparatus"	"Plasma membrane"	"HPA030101: AB_10601654, HPA062039: "	"unprognostic (1.32e-2)"	"unprognostic (3.89e-3)"	"unprognostic (1.02e-2)"	"unprognostic (1.07e-3)"	"unprognostic (3.22e-1)"	"unprognostic (9.93e-3)"	"unprognostic (5.65e-2)"	"unprognostic (1.09e-1)"	"unprognostic (3.22e-1)"	"prognostic favorable (9.29e-5)"	"unprognostic (1.91e-3)"	"unprognostic (3.38e-1)"	"prognostic unfavorable (1.30e-5)"	"unprognostic (1.22e-1)"	"unprognostic (3.91e-2)"	"unprognostic (2.68e-2)"	"unprognostic (2.02e-3)"	11.3	5.2	4.0	29.5	3.9	6.6	6.7	4.4	4.8	4.2	2.6	6.6	12.4	8.8	4.5	7.2	9.1	8.8	11.0	3.8	4.3	9.8	14.1	31.2	34.3	7.1	3.7	16.4	1.6	6.5	2.7	11.9	7.7	5.8	7.2	3.4	7.1	6.7	7.1	2.1	11.8	7.7	3.9	29.0	11.9	2.9	4.4	10.0	7.8	9.4	11.0	13.1	4.5	3.9	0.8	0.0	0.1	0.3	0.1	0.1	0.6	1.8	7.6	8.0	7.2	0.1	12.1	0.6	1.0	2.3	0.6	0.9	0.0	0.3	0.4	9.9	0.1	13.0	0.4	0.3	1.0	0.2	0.3	0.4	0.0	0.1	0.0	1.2	1.9	0.3	0.4	2.3	0.0	0.2	6.6	0.3	0.4	0.1	0.1	11.1	0.2	0.4	0.1	18.3	0.2	0.5	0.3	0.7	0.3	0.6	0.5	1.4	0.4	0.3	1.6	0.2	0.2	16.0	0.3	0.3	0.3	0.1	2.3	0.6	4.1	0.4	7.1	14.1	6.1	2.5	7.6	7.9	2.2	3.3	5.6	5.2	5.6	13.8	14.5	0.9	9.0	5.5	4.0	3.9	4.4	4.8	3.8	4.3	7.1	3.7	7.7	3.9	4.4	3.9	84.4	32.1	39.3	0.0	28.3	4.6	9.1	20.7	1.8	2.8	3.5	2.4	3.6	8.6	25.3	5.5	8.4	0.9	29.0	5.1	0.0	2.2	1.9	4.8	8.4	81.2	0.0	11.2	0.5	3.3	1.6	22.2	9.2	7.4	21.5	17.9	92.4	6.5	8.3	0.0	2.5	4.3	4.1	29.2	10.9	1.2	3.7	33.7	5.4	15.9	33.8	15.5	36.0	1.0	0.6	36.3	1.9	1.9	7.2	24.4	4.4	1.5	43.3	12.2	0.0	5.3	11.3	2.4	3.4	2.9	3.0	1.5	34.2	122.6	2.4	13.6
GCA	GCL	ENSG00000115271	Grancalcin	P28676	2	162318840-162371595	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"bone marrow: 325.7"	"Cell type enhanced"	"Detected in all"		"Early spermatids: 185.0;Kupffer cells: 183.3;Macrophages: 153.5;monocytes: 228.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"eosinophil: 327.4;neutrophil: 864.2"	"Lineage enriched"	"Detected in all"	7	"granulocytes: 864.2"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035033, HPA035034"	Enhanced		Supported	"Plasma membrane,Cytosol"		NA	NA		1300000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	Cytosol	"Plasma membrane"	"HPA035033: AB_10669854, HPA035034: AB_10669900"	"unprognostic (9.62e-2)"	"unprognostic (9.76e-2)"	"unprognostic (3.33e-1)"	"unprognostic (3.82e-2)"	"unprognostic (2.60e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.33e-3)"	"unprognostic (1.36e-1)"	"unprognostic (8.87e-2)"	"unprognostic (2.49e-2)"	"unprognostic (1.20e-1)"	"unprognostic (9.78e-2)"	"unprognostic (6.56e-2)"	"unprognostic (5.80e-2)"	"unprognostic (3.07e-1)"	"unprognostic (3.06e-2)"	"unprognostic (1.32e-2)"	30.5	13.5	16.4	62.6	23.0	325.7	17.6	20.2	28.8	12.2	11.4	18.0	19.3	9.8	24.6	10.9	16.2	23.0	9.7	15.9	17.7	18.3	15.0	26.5	33.0	25.5	20.7	8.5	16.6	10.4	8.2	25.2	23.6	12.2	19.6	10.6	12.3	9.7	2.7	7.0	18.7	18.8	21.6	70.1	25.1	24.1	19.5	18.4	17.0	14.9	25.4	26.1	5.7	37.3	2.6	4.2	10.7	0.0	2.5	2.2	0.4	4.0	11.1	6.2	11.1	8.7	30.6	3.7	27.0	0.3	14.2	1.6	4.1	12.7	7.7	17.1	16.8	33.5	2.9	17.7	3.0	41.6	9.1	2.8	4.3	5.7	1.2	15.8	0.9	25.9	0.6	12.1	0.5	33.0	0.9	24.2	6.5	22.5	16.4	14.2	2.7	18.5	32.7	18.6	6.9	12.0	5.1	23.3	19.7	12.5	15.8	17.7	0.8	1.6	11.2	17.8	6.2	11.5	23.2	0.6	9.2	15.8	7.7	38.8	132.4	327.4	2.7	78.4	3.5	21.6	4.8	4.8	63.2	21.1	8.1	5.0	864.2	2.5	63.3	17.2	10.2	71.4	16.4	23.0	20.2	28.8	15.9	17.7	25.5	20.7	23.6	21.6	19.5	37.3	28.8	16.0	36.5	10.1	54.5	15.4	28.2	19.6	12.5	10.2	32.6	16.4	4.1	50.1	21.2	33.1	2.1	55.5	17.3	14.4	76.3	49.5	185.0	21.1	9.1	26.4	39.4	36.1	25.9	60.5	20.8	14.4	43.8	24.9	44.9	13.6	48.9	15.0	107.9	11.8	15.4	29.9	32.6	183.3	60.5	32.8	10.8	153.5	16.0	17.8	228.5	21.1	10.3	1.0	98.0	36.5	25.7	6.4	23.4	24.3	18.4	69.7	24.7	4.4	6.6	12.2	18.3	52.6	13.5	15.1	18.2	46.9	16.3	16.7	28.9	21.0
GCAT	KBL	ENSG00000100116	"Glycine C-acetyltransferase"	O75600	22	37807905-37817176	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 140.2"	"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 80.3;Hepatocytes: 66.1;Proximal tubular cells: 163.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020460, HPA063924"	Approved		Supported	"Nucleoplasm,Nuclear speckles,Mitochondria"		Yes	No			"Cluster 20: T-cells - T-cell receptor"	"Cluster 22: Non-specific - Unknown function"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Nucleoplasm	"Nuclear speckles, Mitochondria"	"HPA020460: AB_1849548, HPA063924: "	"unprognostic (1.61e-1)"	"unprognostic (1.80e-2)"	"unprognostic (8.38e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.10e-2)"	"unprognostic (4.17e-2)"	"unprognostic (2.40e-1)"	"unprognostic (1.37e-2)"	"unprognostic (3.56e-2)"	"unprognostic (2.76e-3)"	"unprognostic (1.12e-1)"	"unprognostic (2.51e-1)"	"unprognostic (1.36e-3)"	"unprognostic (8.00e-2)"	"unprognostic (1.97e-1)"	"unprognostic (4.73e-3)"	"unprognostic (3.99e-1)"	6.6	15.7	25.1	3.2	24.8	14.1	6.5	26.2	33.3	6.3	22.5	7.3	4.9	7.8	3.0	17.0	6.0	5.0	43.4	26.1	25.0	13.0	53.3	5.6	2.8	25.9	27.4	9.0	140.2	6.0	9.7	2.7	27.8	22.8	4.9	2.2	13.3	6.8	19.5	8.1	5.4	4.2	24.4	1.5	13.2	10.3	27.9	4.3	16.0	19.1	3.1	7.1	7.0	24.6	18.7	4.7	11.9	68.2	24.0	19.4	8.4	25.9	26.9	19.2	16.3	10.5	2.1	5.8	11.8	11.7	11.3	10.6	11.9	18.3	4.3	2.6	21.9	12.9	15.0	42.5	39.0	23.0	16.4	22.8	10.9	12.7	27.7	6.2	16.0	23.0	33.2	6.6	9.2	16.2	24.3	42.3	5.0	28.8	19.0	25.2	2.5	34.4	24.6	14.3	24.5	16.7	20.0	32.3	13.9	4.2	25.8	11.1	11.8	19.3	10.6	12.9	9.2	21.9	11.5	12.1	13.3	21.1	20.5	0.1	0.6	0.4	0.7	0.7	0.3	0.1	1.6	0.5	1.3	0.0	3.5	1.4	0.3	1.3	0.4	1.3	1.7	1.4	25.1	24.8	26.2	33.3	26.1	25.0	25.9	27.4	27.8	24.4	27.9	24.6	3.5	6.4	15.4	9.8	2.8	7.8	18.5	11.2	12.5	8.9	18.6	17.4	54.6	11.5	9.4	11.0	4.2	15.7	0.7	13.1	80.3	7.2	4.1	9.9	8.1	5.5	2.4	22.7	5.0	10.3	19.6	9.8	15.3	16.7	8.9	17.6	5.0	66.1	4.7	8.4	4.7	32.3	8.2	2.9	1.3	7.7	3.7	2.1	21.4	1.0	1.0	25.1	1.0	6.6	4.1	5.4	8.7	9.8	2.0	19.1	8.6	163.8	6.4	2.2	6.6	4.8	30.1	12.6	33.2	19.6	6.0	27.8	3.0	27.8	24.0	14.4
GCC1	"FLJ22035, GCC1P, GCC88, MGC20706"	ENSG00000179562	"GRIP and coiled-coil domain containing 1"	Q96CN9	7	127580628-127593611	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	9	"Early spermatids: 102.7;Late spermatids: 131.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019369, HPA021323"	Enhanced		Supported	"Golgi apparatus,Plasma membrane,Cytosol"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 31: Spermatids - Spermatogenesis"	"Golgi apparatus"	"Plasma membrane, Cytosol"	"HPA019369: AB_1849552, HPA021323: AB_1849554"	"unprognostic (1.09e-1)"	"unprognostic (4.96e-2)"	"unprognostic (1.83e-1)"	"unprognostic (9.51e-2)"	"unprognostic (1.07e-1)"	"unprognostic (7.20e-2)"	"unprognostic (1.26e-1)"	"unprognostic (2.54e-2)"	"unprognostic (1.83e-1)"	"unprognostic (5.08e-2)"	"unprognostic (4.81e-2)"	"unprognostic (4.50e-3)"	"unprognostic (1.17e-3)"	"unprognostic (4.17e-3)"	"unprognostic (1.22e-1)"	"unprognostic (8.65e-2)"	"unprognostic (9.96e-2)"	6.6	6.6	5.4	7.8	6.3	13.5	9.2	6.4	5.7	7.0	6.2	6.9	6.5	6.1	6.5	7.0	5.9	6.3	4.8	5.2	5.9	6.2	10.6	6.9	8.6	6.3	6.3	8.0	6.9	9.4	4.5	7.5	6.1	7.3	6.2	3.6	8.2	6.7	6.6	7.8	6.5	5.1	6.2	8.3	7.7	11.0	6.1	8.3	7.7	6.7	9.9	7.1	4.7	7.2	15.7	20.8	9.0	19.5	19.7	13.5	12.4	13.4	15.5	13.2	16.5	17.5	10.5	14.4	8.0	12.6	29.7	17.0	13.1	14.7	14.1	20.3	11.9	10.6	11.4	9.2	29.2	18.5	16.9	12.7	39.7	14.1	27.8	12.4	12.6	14.2	17.6	16.1	15.0	15.6	18.0	16.0	18.8	17.2	16.1	12.7	9.8	16.5	11.4	12.0	14.2	20.6	14.4	67.9	27.5	16.1	11.6	13.2	16.4	19.5	6.3	17.0	15.6	43.6	20.6	9.1	19.3	18.6	20.2	5.3	7.1	13.2	7.1	6.9	9.1	6.6	6.4	7.0	6.6	6.3	5.1	5.2	13.1	8.7	8.2	3.8	6.5	8.1	5.4	6.3	6.4	5.7	5.2	5.9	6.3	6.3	6.1	6.2	6.1	7.2	4.8	12.8	7.7	0.0	9.6	10.6	5.0	2.7	12.0	4.1	11.5	6.1	3.6	4.3	3.7	3.7	4.2	7.2	7.3	10.0	5.9	5.1	102.7	4.3	5.5	6.7	7.2	8.2	0.0	6.4	4.6	5.0	8.6	6.8	1.3	5.9	5.0	7.4	5.2	11.8	0.0	8.2	2.0	10.1	8.3	131.7	5.3	7.6	12.4	0.0	6.9	4.9	5.2	0.0	0.0	5.9	6.6	3.8	6.3	5.4	6.0	4.5	2.4	5.9	6.6	5.9	6.5	7.8	4.6	6.3	10.4	10.4	8.8	5.8	5.8	5.4
GCC2	"GCC185, KIAA0336"	ENSG00000135968	"GRIP and coiled-coil domain containing 2"	Q8IWJ2	2	108449191-108509415	"Plasma proteins, Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035849, HPA035850"	Enhanced		Enhanced	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 52: Non-specific - Transcription"	"Golgi apparatus"	Nucleoplasm	"HPA035849: AB_10671941, HPA035850: AB_2674821"	"unprognostic (1.35e-1)"	"unprognostic (1.29e-2)"	"unprognostic (2.45e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.45e-1)"	"prognostic unfavorable (4.24e-4)"	"unprognostic (1.59e-1)"	"unprognostic (3.11e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.06e-1)"	"unprognostic (6.53e-2)"	"unprognostic (6.53e-3)"	"unprognostic (3.99e-1)"	"unprognostic (4.71e-1)"	"unprognostic (9.61e-2)"	"unprognostic (1.64e-2)"	9.0	12.7	3.4	17.6	5.1	25.2	17.4	0.0	5.5	12.5	26.2	19.2	21.7	15.3	41.7	7.5	15.0	21.4	8.4	3.2	3.8	16.6	10.7	14.8	21.5	2.5	4.2	15.5	12.5	15.0	4.1	13.7	2.8	19.6	20.8	17.3	15.2	17.1	2.3	7.9	22.9	9.4	0.9	18.8	26.4	16.6	1.4	18.9	20.5	9.4	16.3	14.1	3.6	6.0	12.5	10.4	12.6	5.5	14.2	22.6	27.4	17.6	26.8	9.2	12.9	18.4	17.2	14.9	22.3	16.0	16.7	10.4	10.0	14.1	15.8	16.9	13.6	18.7	16.3	15.8	12.7	26.4	14.3	29.1	13.3	23.1	16.3	20.0	13.6	13.9	25.3	12.4	17.4	7.1	13.6	18.1	21.9	11.5	12.0	11.7	17.9	16.1	12.2	20.1	13.6	12.5	21.1	16.7	18.7	18.2	8.3	12.8	21.3	13.3	20.2	12.4	6.7	18.0	26.9	18.2	17.2	7.0	9.8	47.3	8.9	25.9	25.5	8.0	25.1	27.0	28.2	27.8	7.3	24.3	38.2	33.5	35.6	14.9	17.6	31.8	23.0	8.2	3.4	5.1	0.0	5.5	3.2	3.8	2.5	4.2	2.8	0.9	1.4	6.0	92.6	150.6	103.3	44.1	125.2	23.8	68.6	54.8	29.6	155.9	60.3	57.5	85.6	75.8	95.7	104.8	139.7	44.2	157.6	152.1	50.9	114.5	73.9	253.3	85.1	68.1	85.6	39.5	104.9	81.6	56.3	74.2	65.7	118.6	82.2	113.9	65.0	36.7	37.0	70.7	73.6	152.6	52.9	49.8	39.3	39.9	71.4	66.0	33.8	62.8	88.5	59.0	134.9	50.8	66.1	116.1	125.2	82.8	108.7	91.7	134.0	63.1	259.7	127.2	52.6	61.4	66.2	163.0	120.7	21.0	17.5	65.0	139.1	138.0	88.3	114.5
GCDH	ACAD5	ENSG00000105607	"Glutaryl-CoA dehydrogenase"	Q92947	19	12891160-12914207	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase	"Disease variant, Glutaricaciduria"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 89.1"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 115.5;Proximal tubular cells: 147.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043252, HPA048492"	Enhanced		Supported	Mitochondria		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 15: Liver - Metabolism"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Mitochondria		"HPA043252: AB_2678390, HPA048492: AB_2680418"	"unprognostic (2.46e-1)"	"unprognostic (1.64e-3)"	"unprognostic (6.79e-3)"	"unprognostic (8.07e-3)"	"unprognostic (8.20e-3)"	"unprognostic (3.14e-2)"	"prognostic favorable (7.28e-5)"	"prognostic favorable (3.35e-4)"	"unprognostic (1.62e-1)"	"unprognostic (3.03e-2)"	"unprognostic (7.50e-3)"	"unprognostic (7.46e-2)"	"prognostic favorable (6.79e-8)"	"unprognostic (7.09e-3)"	"unprognostic (3.42e-1)"	"unprognostic (5.32e-2)"	"unprognostic (1.59e-1)"	16.8	17.8	20.2	11.2	22.4	13.0	15.6	22.1	23.3	10.2	21.8	13.2	11.8	12.6	8.6	14.0	15.2	8.4	29.3	19.2	19.4	24.5	89.1	9.3	16.8	20.7	20.9	16.8	15.5	11.5	10.6	5.4	21.0	13.6	8.5	5.5	20.0	11.5	30.5	10.1	13.0	8.2	19.9	12.8	18.6	4.5	20.9	17.8	11.9	27.1	11.9	14.9	9.9	22.7	22.9	14.1	15.0	27.5	21.4	9.8	13.8	17.2	11.1	21.6	15.7	26.9	10.8	33.0	31.9	10.5	10.8	15.6	20.8	16.4	10.6	28.6	22.8	21.0	24.6	33.1	24.8	43.7	18.8	13.8	19.9	15.3	16.1	8.8	18.1	44.4	51.8	11.4	10.7	28.9	51.7	41.7	16.7	22.0	36.1	48.2	15.3	68.9	12.6	12.1	32.3	18.9	22.8	22.6	16.7	9.6	17.8	29.3	13.3	18.0	12.9	29.9	18.2	59.5	32.2	34.6	11.0	50.7	15.4	13.9	13.9	8.5	18.8	12.1	18.8	18.1	23.2	21.0	24.0	19.5	30.9	23.8	3.1	38.8	9.8	14.7	21.4	20.0	20.2	22.4	22.1	23.3	19.2	19.4	20.7	20.9	21.0	19.9	20.9	22.7	6.0	3.2	5.3	25.5	21.2	7.9	14.5	13.3	11.4	14.2	17.3	10.8	10.0	22.8	8.6	11.0	25.0	16.2	17.2	11.6	52.8	14.0	2.6	7.7	10.0	7.3	15.6	60.4	7.1	11.2	21.5	10.2	12.8	10.9	7.0	19.5	13.6	115.5	21.5	8.4	7.4	13.8	16.2	14.4	5.0	1.8	13.1	9.9	17.8	5.6	20.7	18.6	18.6	14.6	15.1	10.2	9.7	12.8	25.4	11.3	17.4	147.8	7.2	12.3	0.0	13.7	9.8	8.3	7.4	13.4	5.3	16.3	20.9	33.0	20.6	12.1
GCFC2	"C2orf3, DNABF, GCF, TCF9"	ENSG00000005436	"GC-rich sequence DNA-binding factor 2"	P16383	2	75652000-75710985	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA077882	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 25: Spermatids - Spermatogenesis"	Nucleoplasm		"HPA077882: AB_2686864"	"unprognostic (1.98e-1)"	"unprognostic (5.18e-2)"	"unprognostic (1.53e-1)"	"prognostic unfavorable (9.59e-4)"	"unprognostic (5.67e-3)"	"unprognostic (2.75e-1)"	"unprognostic (2.34e-2)"	"unprognostic (3.74e-2)"	"unprognostic (8.80e-2)"	"unprognostic (4.21e-2)"	"unprognostic (1.63e-1)"	"unprognostic (5.71e-2)"	"unprognostic (3.20e-2)"	"unprognostic (8.37e-2)"	"unprognostic (1.04e-2)"	"prognostic unfavorable (3.09e-4)"	"unprognostic (6.07e-2)"	10.7	10.5	13.8	4.2	16.3	7.4	12.1	14.4	17.3	19.2	9.7	9.7	3.7	11.1	11.4	9.6	13.7	4.7	11.3	12.2	14.4	19.0	28.5	7.8	8.8	13.7	14.5	14.3	14.1	7.5	11.2	6.9	13.9	14.0	3.8	11.7	7.8	5.5	29.1	15.8	8.1	6.3	15.1	12.3	9.4	12.0	14.4	7.6	12.1	9.1	6.5	9.0	10.4	17.3	14.4	13.9	9.8	11.6	5.3	6.7	12.7	9.5	7.7	9.7	9.2	16.7	10.3	14.2	13.4	6.5	11.9	5.5	11.9	6.5	13.0	20.9	25.5	10.9	13.6	44.9	8.3	18.8	10.2	7.2	8.2	4.8	14.5	11.0	11.6	17.6	16.5	8.2	9.3	11.3	19.6	31.8	15.5	10.5	15.3	22.8	20.1	34.6	16.3	15.7	18.0	22.6	12.8	14.5	16.2	6.9	10.8	10.6	12.6	9.3	12.2	13.4	19.3	9.5	17.7	10.8	9.2	11.7	20.7	0.6	8.1	3.8	10.4	5.7	11.9	18.2	9.7	12.1	9.4	12.6	14.3	13.2	0.4	5.4	9.6	13.3	11.5	8.9	13.8	16.3	14.4	17.3	12.2	14.4	13.7	14.5	13.9	15.1	14.4	17.3	11.6	16.0	11.2	49.6	15.7	27.8	20.5	14.0	21.6	11.2	14.4	13.5	22.4	17.2	20.2	12.9	0.0	36.7	14.8	7.3	21.5	16.0	31.5	11.4	18.0	15.0	16.2	12.0	60.8	19.0	23.5	21.9	8.2	8.7	13.9	15.6	13.2	24.9	12.5	16.8	51.7	7.5	8.2	13.9	12.0	75.4	16.8	8.8	14.2	20.6	7.1	10.6	16.5	75.9	75.9	13.8	7.8	9.8	11.3	18.0	6.2	19.3	15.1	9.1	13.1	20.2	13.5	15.5	22.7	16.5	24.7	23.7	13.3	17.4	10.6	16.8
GCH1	"DYT14, DYT5, DYT5a, GCH, GTPCH1"	ENSG00000131979	"GTP cyclohydrolase 1"	P30793	14	54842008-54902826	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Tetrahydrobiopterin biosynthesis"	"Allosteric enzyme, Hydrolase"	"Disease variant, Dystonia, Parkinsonism, Phenylketonuria"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 31.4;liver: 36.7"	"Cell type enhanced"	"Detected in many"		"Enteroendocrine cells: 212.5;Hepatocytes: 94.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"non-classical monocyte: 11.1"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BEWO: 23.5;Daudi: 25.0;JURKAT: 23.0;SH-SY5Y: 50.9"	"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"midbrain: 12.7"	HPA028612	Approved		Supported	"Nucleoplasm,Nuclear membrane,Cytosol"		No	No			"Cluster 51: Monocytes - Innate immune response"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 41: Macrophages - Immune response"	Nucleoplasm	"Nuclear membrane, Cytosol"	"HPA028612: AB_10602135"	"unprognostic (3.77e-2)"	"unprognostic (2.67e-3)"	"unprognostic (6.73e-2)"	"unprognostic (2.39e-1)"	"unprognostic (9.26e-2)"	"unprognostic (1.27e-1)"	"unprognostic (7.26e-2)"	"unprognostic (1.75e-1)"	"unprognostic (3.97e-1)"	"prognostic favorable (8.69e-4)"	"prognostic favorable (1.41e-4)"	"unprognostic (1.23e-1)"	"unprognostic (1.96e-2)"	"unprognostic (7.22e-3)"	"unprognostic (1.76e-2)"	"unprognostic (2.23e-1)"	"prognostic favorable (6.67e-4)"	2.4	6.0	2.1	8.1	3.0	31.4	1.8	1.1	2.0	0.4	1.5	2.4	9.4	0.4	0.2	3.5	1.2	0.4	1.9	1.9	4.8	4.6	36.7	4.1	7.0	3.5	16.1	0.5	2.6	0.9	1.8	0.3	8.4	1.5	2.4	0.1	1.7	1.0	0.4	2.2	7.5	1.1	2.4	6.9	2.8	1.2	7.8	3.8	0.8	0.2	2.0	3.3	1.4	2.0	4.7	0.6	1.3	7.1	0.0	0.0	23.5	0.0	2.0	2.4	2.9	1.4	1.0	25.0	6.9	0.2	5.8	4.0	4.9	1.5	0.1	10.9	5.2	0.6	0.3	3.1	8.4	0.0	1.9	0.3	0.7	1.2	0.1	0.0	0.7	23.0	2.8	0.0	0.0	5.0	15.1	0.3	0.4	6.5	8.2	9.6	2.8	0.0	2.9	1.6	11.6	50.9	3.3	2.4	1.6	0.4	2.9	1.5	0.3	0.1	4.0	9.9	3.8	10.5	8.4	7.8	3.1	8.4	0.0	0.0	2.6	0.2	2.8	5.3	2.1	0.7	1.0	1.5	2.8	1.9	2.5	1.3	0.3	1.8	11.1	0.1	2.1	1.2	2.1	3.0	1.1	2.0	1.9	4.8	3.5	16.1	8.4	2.4	7.8	2.0	19.2	3.2	4.8	0.7	33.4	74.6	30.9	23.6	17.6	0.0	19.4	13.2	6.5	4.3	13.6	5.5	2.1	1.9	50.9	21.8	7.9	8.7	0.5	16.8	5.8	19.8	212.5	10.1	3.8	9.4	44.3	15.3	43.8	29.3	0.0	0.3	6.8	94.6	6.1	0.0	5.9	22.7	4.1	28.0	33.3	0.6	0.3	55.8	10.6	15.9	29.5	0.7	29.9	0.5	0.8	11.0	13.6	4.9	14.4	20.5	17.1	48.6	6.9	0.4	0.0	12.5	7.5	2.2	6.7	20.8	76.1	4.2	41.8	11.9	12.2	39.0
GCHFR	"GFRP, HsT16933"	ENSG00000137880	"GTP cyclohydrolase I feedback regulator"	P30047	15	40764068-40767708	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"liver: 350.1"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 787.2;Hofbauer cells: 522.9;Proximal enterocytes: 620.8;Proximal tubular cells: 500.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Hep G2: 120.3;RPTEC TERT1: 146.6;SCLC-21H: 124.6"	"Group enriched"	"Detected in many"	5	"cerebellum: 10.3;midbrain: 11.8;pons and medulla: 9.4"					HPA046258	Enhanced		Supported	Nucleoplasm		NA	NA		170000	"Cluster 48: NK-cells - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 2: Hepatocytes - Metabolism"	Nucleoplasm		"HPA046258: AB_10967205"	"unprognostic (2.50e-1)"	"unprognostic (1.49e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.72e-2)"	"unprognostic (9.89e-3)"	"unprognostic (3.51e-3)"	"unprognostic (1.57e-1)"	"prognostic favorable (5.62e-4)"	"unprognostic (4.63e-2)"	"unprognostic (1.67e-1)"	"unprognostic (3.81e-1)"	"unprognostic (2.31e-1)"	"unprognostic (7.03e-3)"	"unprognostic (9.28e-3)"	"unprognostic (2.91e-2)"	"unprognostic (1.84e-1)"	"unprognostic (2.55e-1)"	37.4	20.1	13.6	8.9	13.3	19.5	34.5	17.4	20.1	16.1	18.5	18.7	38.8	6.5	2.2	57.2	15.8	10.0	10.9	13.1	14.5	73.5	350.1	46.4	24.7	18.2	67.3	19.2	15.3	9.8	12.2	6.6	33.7	19.4	6.9	4.2	22.3	3.2	4.5	31.1	60.7	1.7	13.5	13.0	16.4	3.3	15.9	23.0	12.8	7.4	19.5	12.2	17.6	12.2	0.3	7.7	6.2	33.3	9.5	3.4	16.7	2.2	7.8	3.7	7.4	90.7	49.7	46.0	31.1	1.9	2.4	6.1	16.4	3.1	0.8	36.2	26.2	45.5	65.3	120.3	7.7	29.9	15.2	7.8	3.8	1.6	0.6	2.9	14.4	3.7	23.2	13.2	1.1	17.2	7.9	60.4	16.0	8.2	56.5	64.7	0.5	28.8	146.6	24.2	124.6	1.9	20.1	87.7	10.4	8.1	25.3	30.0	0.0	0.6	1.2	2.2	0.3	0.9	6.0	28.9	4.9	66.3	4.0	18.0	73.3	102.4	76.8	23.6	129.0	48.2	67.1	71.1	48.7	31.2	68.3	44.7	11.7	132.6	22.4	90.4	144.4	109.0	13.6	13.3	17.4	20.1	13.1	14.5	18.2	67.3	33.7	13.5	15.9	12.2	24.3	3.2	54.0	0.3	24.9	14.5	21.6	72.2	8.6	2.5	81.4	48.0	0.1	84.4	87.0	64.4	12.5	161.9	25.9	75.7	76.3	52.5	0.6	46.2	4.9	13.7	60.6	24.4	1.6	32.7	37.0	10.1	16.3	35.7	44.4	12.2	31.4	787.2	522.9	0.0	1.7	74.4	111.9	56.1	18.5	0.5	17.7	71.9	67.6	0.0	29.0	26.1	102.0	0.0	0.4	18.7	161.8	8.6	12.8	25.6	620.8	500.2	58.3	22.4	0.0	4.7	12.4	2.9	12.5	79.7	14.9	36.5	49.2	1.7	125.3	40.8
GCNA	"ACRC, NAAR1"	ENSG00000147174	"Germ cell nuclear acidic peptidase"	Q96QF7	X	71578411-71613583	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 11.0"	"Cell type enhanced"	"Detected in some"		"Collecting duct cells: 3.7;dendritic cells: 6.9;Endometrial ciliated cells: 2.9;Glandular and luminal cells: 7.0;Plasma cells: 3.3;T-cells: 4.7;Theca cells: 4.0"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"											"HPA023476, HPA030870"	Enhanced		Supported	Nucleoplasm		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 20: HeLa - Mitochondria"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm		"HPA023476: AB_1844530, HPA030870: "	"unprognostic (6.01e-2)"	"unprognostic (2.30e-1)"	"unprognostic (1.43e-2)"	"unprognostic (4.37e-3)"	"unprognostic (1.39e-1)"	"unprognostic (2.35e-4)"	"unprognostic (5.84e-2)"	"unprognostic (1.31e-1)"	"unprognostic (3.16e-1)"	"unprognostic (1.68e-1)"	"unprognostic (1.03e-2)"	"unprognostic (2.06e-1)"	"unprognostic (5.07e-10)"	"unprognostic (2.30e-1)"	"unprognostic (5.06e-2)"	"unprognostic (4.74e-1)"	"unprognostic (1.15e-5)"	1.9	4.6	4.1	1.3	4.5	1.3	1.4	5.1	8.1	2.0	3.7	1.5	0.8	1.3	0.9	1.3	1.5	0.7	1.9	4.5	4.7	2.2	2.6	2.4	1.9	4.8	3.8	1.8	2.5	0.2	2.0	0.4	4.4	1.8	0.7	2.2	1.3	0.4	4.2	1.4	2.4	0.7	3.4	4.9	1.8	11.0	4.1	1.1	2.2	1.2	1.0	1.5	1.7	4.8	0.3	0.5	1.1	1.0	2.2	2.0	0.6	1.8	1.0	0.6	1.0	1.0	0.7	2.9	1.4	1.0	0.6	1.4	2.2	0.1	0.9	0.5	1.5	0.6	2.8	0.3	0.6	0.5	2.6	0.8	3.5	0.5	0.5	2.3	0.4	2.2	0.8	1.8	1.3	0.3	0.2	2.1	1.1	1.3	1.3	0.5	0.0	2.1	1.4	0.8	0.6	0.1	0.6	0.3	1.6	1.1	0.2	1.8	0.7	0.7	1.3	0.9	0.5	0.5	1.4	1.1	1.2	1.1	1.1	0.2	0.1	0.0	0.1	0.1	0.3	0.3	0.4	0.8	0.1	0.1	0.2	0.2	0.2	0.3	0.0	0.1	0.8	0.1	4.1	4.5	5.1	8.1	4.5	4.7	4.8	3.8	4.4	3.4	4.1	4.8	1.8	0.0	0.5	0.0	1.3	0.0	0.0	0.0	0.0	0.0	2.0	2.8	0.0	0.0	0.0	3.7	0.0	0.0	6.9	0.0	0.0	0.8	0.0	2.9	1.5	0.5	0.0	0.0	0.0	1.0	0.1	0.9	0.0	7.0	2.5	2.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	3.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.3	4.7	4.0	0.0	0.0
GCNT1	"C2GNT, NACGT2, NAGCT2"	ENSG00000187210	"Glucosaminyl (N-acetyl) transferase 1"	Q02742	9	76419850-76651203	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"intestine: 49.9;parathyroid gland: 84.1;stomach 1: 39.0;thyroid gland: 21.5"	"Cell type enhanced"	"Detected in many"		"Gastric mucus-secreting cells: 93.8;Kupffer cells: 42.2;Proximal enterocytes: 40.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"eosinophil: 21.6"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HHSteC: 46.2;HSkMC: 39.4;U-2197: 33.9"	"Group enriched"	"Detected in all"	6	"cerebellum: 7.6;olfactory bulb: 24.9"	"Low region specificity"	"Detected in all"			"HPA003522, HPA003523, HPA031151"	Uncertain		Supported	"Nuclear speckles"		NA	NA		84000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 18: U-2197 - ECM organization"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Nuclear speckles"		"HPA003522: , HPA003523: , HPA031151: AB_10602904"	"unprognostic (3.14e-1)"	"unprognostic (2.01e-1)"	"unprognostic (2.19e-1)"	"prognostic favorable (8.44e-4)"	"unprognostic (5.53e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.65e-2)"	"unprognostic (3.37e-2)"	"unprognostic (2.40e-1)"	"unprognostic (2.63e-1)"	"unprognostic (1.90e-1)"	"unprognostic (3.06e-1)"	"unprognostic (3.02e-3)"	"unprognostic (4.21e-1)"	"unprognostic (2.00e-1)"	"unprognostic (2.80e-1)"	"prognostic unfavorable (4.96e-4)"	4.0	0.8	1.8	5.0	2.2	5.1	4.6	4.8	1.7	10.6	1.3	8.7	49.9	5.9	0.7	1.8	1.5	2.9	1.2	2.0	0.9	0.9	1.9	4.2	6.7	1.0	1.0	0.7	2.1	84.1	0.9	2.9	1.0	6.3	9.3	0.1	3.8	1.3	0.3	1.1	32.3	4.8	1.0	7.3	39.0	1.6	1.5	3.0	21.5	0.7	4.7	2.2	0.8	1.4	4.7	0.4	0.3	0.1	5.5	26.5	6.7	18.8	8.4	15.0	10.5	4.7	1.1	3.3	1.8	14.1	2.9	4.0	9.5	7.8	16.6	2.3	1.6	8.2	0.4	0.8	46.2	6.0	2.7	39.4	2.0	14.5	15.5	12.2	13.9	4.1	0.0	3.2	15.1	7.1	3.2	9.7	8.8	11.9	1.1	5.3	9.3	1.6	17.5	8.3	2.0	0.0	2.3	2.5	0.1	6.6	0.0	4.1	5.6	9.3	5.9	33.9	8.4	4.7	0.9	0.0	18.7	10.1	2.3	6.1	3.2	21.6	1.5	7.8	0.5	1.9	1.7	1.5	5.8	10.2	0.3	1.1	1.1	5.8	7.3	2.8	2.5	2.1	1.8	2.2	4.8	1.7	2.0	0.9	1.0	1.0	1.0	1.0	1.5	1.4	2.9	0.0	1.7	2.0	8.3	0.9	5.0	34.4	0.6	0.0	8.8	4.2	1.0	0.0	15.6	3.7	0.0	2.1	10.7	16.6	0.0	1.0	20.1	15.1	4.2	5.1	27.6	17.9	11.8	24.3	27.1	3.4	93.8	24.6	10.8	0.6	6.4	0.3	8.1	0.0	1.7	21.3	16.2	42.2	8.5	12.9	0.0	18.6	1.8	15.0	6.7	0.1	8.2	0.5	0.8	12.9	14.5	1.2	2.2	6.8	40.7	1.4	17.0	0.4	0.0	0.9	1.8	1.8	3.3	1.0	0.3	19.0	10.6	0.2	38.4	1.5
GCNT4	"C2GNT3, LINC01336"	ENSG00000176928	"Glucosaminyl (N-acetyl) transferase 4"	Q9P109	5	75025346-75052558	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 24.0;lymphoid tissue: 15.4;stomach 1: 18.5"	"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 32.9;Cytotrophoblasts: 39.6;Glandular and luminal cells: 16.7;Proximal enterocytes: 28.0;Syncytiotrophoblasts: 24.4"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	20	"amygdala: 1.1;basal ganglia: 1.8;cerebral cortex: 3.3;hippocampal formation: 2.1;white matter: 1.4"	"Immune cell enhanced"	"Detected in many"		"basophil: 22.4"	"Group enriched"	"Detected in many"	53	"granulocytes: 22.4;T-cells: 18.2"	"Cell line enriched"	"Detected in some"	5	"RT4: 37.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA037431	Approved		Supported	"Nucleoplasm,Golgi apparatus"		No	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 56: Intestine - Transmembrane transport"	"Cluster 15: RT4 - Unknown function"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Golgi apparatus"	Nucleoplasm	"HPA037431: AB_10670382"	"unprognostic (1.88e-2)"	"unprognostic (5.63e-2)"	"unprognostic (6.05e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.12e-1)"	"unprognostic (4.98e-2)"	"unprognostic (4.11e-3)"	"unprognostic (1.63e-2)"	"unprognostic (3.47e-1)"	"unprognostic (2.20e-2)"	"unprognostic (4.49e-3)"	"unprognostic (6.04e-2)"	"prognostic favorable (1.93e-7)"	"unprognostic (8.39e-2)"	"unprognostic (1.93e-1)"	"unprognostic (6.06e-2)"	"unprognostic (5.82e-2)"	0.9	0.8	1.1	2.9	1.8	0.7	1.3	0.0	3.3	1.4	0.0	1.4	24.0	1.2	1.9	2.2	2.1	5.3	0.4	2.1	0.0	4.1	1.1	1.7	4.4	0.0	0.0	1.0	4.6	9.6	0.2	6.3	0.0	1.7	1.3	0.1	0.5	4.8	1.0	2.1	20.2	2.3	0.0	1.7	18.5	1.6	0.0	15.4	0.5	1.4	3.0	4.1	1.8	1.4	0.3	0.2	1.4	2.3	2.5	0.8	0.1	2.8	7.2	1.5	1.2	3.7	0.2	0.0	0.4	2.2	0.8	1.0	1.4	2.5	0.3	0.0	0.1	1.2	0.3	0.3	1.1	0.0	0.0	0.4	3.9	0.1	0.5	0.0	0.0	2.2	0.0	0.5	0.2	0.0	2.1	0.1	0.6	8.0	0.0	0.0	0.0	3.6	0.3	37.1	0.0	0.1	0.3	0.0	0.1	7.0	0.0	0.0	0.0	0.8	0.2	1.0	0.1	0.0	0.0	0.0	0.5	0.0	0.1	22.4	0.0	0.0	1.2	0.0	5.0	0.0	11.4	3.7	0.0	0.0	11.1	8.1	0.2	0.3	0.2	0.1	18.2	2.3	1.1	1.8	0.0	3.3	2.1	0.0	0.0	0.0	0.0	0.0	0.0	1.4	1.2	3.2	5.0	0.7	0.3	0.6	8.7	0.5	0.0	0.0	0.9	2.3	0.5	32.9	2.7	12.9	0.0	39.6	0.8	4.9	9.8	7.1	0.1	11.9	2.4	1.8	0.0	0.0	1.3	4.4	0.9	2.5	14.8	16.7	7.6	2.0	3.3	0.7	2.3	0.0	0.0	2.7	0.0	0.3	0.0	0.3	4.1	0.2	0.0	0.0	0.7	0.0	0.0	0.0	0.0	5.2	6.9	2.6	0.5	3.0	28.0	0.7	0.6	0.0	6.6	1.6	2.5	0.2	1.7	0.6	0.1	24.4	3.7	0.0	4.4	4.2
GDAP1	"CMT2K, CMT4, CMT4A"	ENSG00000104381	"Ganglioside induced differentiation associated protein 1"	Q8TB36	8	74320613-74518007	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"			"Charcot-Marie-Tooth disease, Disease variant, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 26.0"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 46.9;Cone photoreceptor cells: 47.9;Excitatory neurons: 75.7;Horizontal cells: 47.1;Inhibitory neurons: 67.3;Oligodendrocyte precursor cells: 67.8;Rod photoreceptor cells: 47.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"SH-SY5Y: 38.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014266, HPA024334"	Enhanced		Supported	Mitochondria,Cytosol		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 58: Brain - Synaptic function"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 56: Bipolar cells - Visual perception"	Mitochondria	Cytosol	"HPA014266: AB_1849581, HPA024334: AB_1849583"	"unprognostic (3.19e-2)"	"unprognostic (1.52e-3)"	"unprognostic (2.72e-1)"	"prognostic unfavorable (1.82e-4)"	"unprognostic (3.31e-1)"	"unprognostic (4.36e-2)"	"unprognostic (1.72e-2)"	"prognostic favorable (2.68e-4)"	"unprognostic (3.88e-1)"	"unprognostic (4.17e-1)"	"unprognostic (9.44e-3)"	"unprognostic (2.44e-1)"	"unprognostic (5.40e-2)"	"unprognostic (3.29e-1)"	"unprognostic (6.99e-2)"	"prognostic unfavorable (4.54e-4)"	"unprognostic (2.73e-1)"	2.7	9.6	19.0	3.3	22.5	1.2	4.0	15.2	26.0	2.9	4.9	2.5	2.4	3.9	1.9	4.0	2.8	2.5	2.1	25.3	19.7	4.2	1.5	2.4	3.3	14.5	17.0	6.0	7.4	12.4	20.6	1.2	18.1	4.1	2.4	19.0	2.4	4.1	2.7	1.7	2.3	2.8	12.2	1.9	2.0	4.7	16.7	4.5	6.6	3.1	2.8	3.9	2.6	20.5	3.5	16.8	17.7	4.8	1.2	1.6	1.5	1.8	8.2	8.3	9.5	7.8	5.0	14.8	2.5	1.2	10.6	6.6	12.4	7.0	16.2	19.7	3.6	7.4	8.9	14.0	0.7	7.6	15.8	4.7	2.3	5.3	8.2	0.9	1.1	7.3	3.4	0.3	4.8	5.7	12.6	0.4	20.1	24.5	17.9	8.7	9.2	3.2	2.9	15.3	18.2	38.9	13.1	3.4	9.7	4.9	14.9	2.6	0.0	11.7	6.2	2.9	5.5	9.3	15.7	6.8	7.3	0.3	13.8	0.5	0.9	1.0	0.8	3.1	1.0	1.4	0.8	1.3	0.8	1.3	0.6	0.6	1.8	0.7	5.5	0.2	4.0	0.8	19.0	22.5	15.2	26.0	25.3	19.7	14.5	17.0	18.1	12.2	16.7	20.5	6.4	6.4	5.1	27.1	5.9	1.8	7.4	4.2	6.2	46.9	6.2	6.1	5.9	5.7	3.6	3.7	47.9	0.4	3.9	2.1	9.8	5.2	5.4	15.4	7.0	6.7	20.4	2.1	75.7	5.8	0.3	4.8	3.1	2.8	17.2	2.1	6.4	1.8	4.7	47.1	67.3	1.7	12.2	6.3	2.5	1.3	4.1	4.6	1.8	15.0	2.9	23.5	4.1	67.8	41.9	3.7	1.4	5.7	2.6	2.6	3.6	6.6	4.9	47.7	0.0	8.0	5.5	14.7	13.1	3.7	1.3	0.0	3.1	6.5	1.7	3.8
GDF6	"BMP13, KFS, KFS1, SGM1"	ENSG00000156466	"Growth differentiation factor 6"	Q6KF10	8	96142333-96160806	"Disease related genes, Human disease related genes, Predicted secreted proteins"	Apoptosis	"Cytokine, Developmental protein, Growth factor"	"Disease variant, Dwarfism, Leber congenital amaurosis, Microphthalmia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"placenta: 10.9"	"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 2.3;Distal tubular cells: 1.9;Excitatory neurons: 1.6;Fibroblasts: 3.1;Oligodendrocyte precursor cells: 7.1;Spermatogonia: 2.4"	"Cancer enhanced"	"Detected in some"		"renal cancer: 2.8;thyroid cancer: 2.3"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"hTERT-RPE1: 20.4;LHCN-M2: 33.1;SuSa: 15.9"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	5	"midbrain: 1.2"	HPA045206	Uncertain		Supported	"Nucleoplasm,Nuclear membrane,Vesicles"	"Secreted to blood"	NA	NA				"Cluster 28: Placenta - Pregnancy"	"Cluster 12: NES - Nervous system development"	"Cluster 33: Fibroblasts - ECM organization"	Vesicles	"Nucleoplasm, Nuclear membrane"	"HPA045206: AB_10962508"	"unprognostic (1.13e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.83e-2)"	"unprognostic (9.66e-9)"	"unprognostic (6.49e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.41e-1)"	"unprognostic (3.18e-2)"	"unprognostic (3.80e-3)"	"unprognostic (1.09e-3)"	"unprognostic (5.37e-2)"	"unprognostic (8.13e-3)"	"prognostic unfavorable (2.17e-4)"	"unprognostic (5.88e-4)"	"unprognostic (1.88e-2)"	"unprognostic (2.68e-2)"	"unprognostic (1.71e-1)"	1.3	0.1	0.3	0.9	0.3	0.0	0.4	0.4	0.8	0.2	0.0	0.7	0.3	1.4	0.4	0.4	0.5	2.4	2.8	0.3	0.4	0.2	0.4	0.2	0.1	0.8	0.4	0.1	0.7	0.1	0.1	10.9	1.0	0.3	0.3	0.0	0.0	1.4	0.0	0.0	0.9	1.1	0.4	0.0	0.6	0.6	0.8	0.1	0.6	0.0	0.0	0.8	0.9	0.4	0.0	0.0	0.2	0.0	1.1	0.6	3.9	2.6	0.0	2.3	2.0	0.0	0.0	0.0	0.0	0.2	0.0	1.4	0.0	0.0	3.2	0.0	0.6	0.0	0.0	0.0	3.0	0.0	0.0	0.1	0.0	3.0	0.0	20.4	0.2	0.0	0.0	0.0	33.1	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.9	0.0	0.0	0.0	0.8	0.0	0.3	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.3	0.4	0.8	0.3	0.4	0.8	0.4	1.0	0.4	0.8	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	2.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.6	0.8	0.1	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.8	1.0	2.4	0.0	0.0	0.3	0.1	0.0	0.0	0.1
GEMIN2	SIP1	ENSG00000092208	"Gem nuclear organelle associated protein 2"	O14893	14	39114223-39136973	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 45.8;Late spermatids: 41.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB015426, HPA046570, HPA057114"	Enhanced		Supported	"Nucleoplasm,Nucleoli,Nuclear bodies"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 12: Non-specific - Cell cycle regulation"	"Nucleoplasm, Nuclear bodies"	Nucleoli	"CAB015426: AB_629517, HPA046570: AB_2679703, HPA057114: AB_2683340"	"unprognostic (4.53e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.52e-1)"	"unprognostic (5.07e-3)"	"unprognostic (1.04e-1)"	"unprognostic (3.52e-2)"	"prognostic unfavorable (3.88e-6)"	"unprognostic (8.62e-3)"	"unprognostic (3.05e-2)"	"unprognostic (1.99e-3)"	"unprognostic (3.08e-1)"	"unprognostic (3.03e-1)"	"unprognostic (4.53e-3)"	"unprognostic (1.52e-1)"	"unprognostic (1.58e-1)"	"unprognostic (3.95e-1)"	"unprognostic (6.78e-2)"	6.1	4.3	6.1	4.5	6.3	10.3	7.9	10.2	7.9	5.9	4.6	6.0	6.7	5.4	7.2	5.7	5.9	4.2	7.7	5.7	3.9	6.1	5.6	4.8	8.8	3.6	2.6	5.9	4.7	3.7	4.6	5.6	3.6	4.8	6.1	4.7	4.3	4.5	12.1	6.3	4.7	7.7	1.1	5.2	5.1	8.3	3.4	9.1	5.5	7.9	7.8	6.2	5.5	6.2	23.6	34.5	33.3	23.7	11.3	12.6	17.0	11.5	9.0	30.3	30.0	30.7	27.9	36.0	23.4	9.8	11.0	17.5	45.6	18.7	31.5	17.6	26.7	21.5	18.1	76.8	23.9	32.6	12.8	7.3	17.6	18.8	27.5	8.7	26.6	31.4	25.2	25.6	17.3	48.9	36.3	31.2	23.6	29.7	38.3	32.8	36.4	22.6	17.5	15.6	32.2	6.2	24.5	17.7	12.4	18.4	41.5	14.0	11.2	12.7	20.0	13.3	18.6	26.8	44.2	54.1	6.6	34.0	19.6	10.8	12.0	9.9	13.5	13.1	9.8	15.3	12.3	13.5	16.2	15.8	13.5	14.4	3.1	11.9	11.5	16.1	11.8	9.2	6.1	6.3	10.2	7.9	5.7	3.9	3.6	2.6	3.6	1.1	3.4	6.2	11.6	6.4	3.7	4.9	10.3	8.5	8.1	20.9	8.0	5.9	7.3	12.1	6.0	5.7	11.4	5.5	10.4	12.9	7.0	2.2	11.7	10.8	45.8	11.2	11.3	10.6	3.6	17.2	7.4	6.4	18.9	12.5	2.6	7.5	5.7	11.7	9.7	6.6	11.4	5.0	6.2	7.1	14.2	10.6	7.3	41.1	9.0	6.3	7.2	4.7	9.4	8.1	9.2	4.0	7.4	6.9	2.5	9.8	9.4	8.0	3.1	14.7	15.5	6.9	6.6	8.3	8.1	25.9	15.4	11.3	8.0	3.8	9.1	11.6	9.3	4.8
GEMIN4	"DKFZP434B131, DKFZP434D174, HC56, HCAP1, HHRF-1, p97"	ENSG00000179409	"Gem nuclear organelle associated protein 4"	P57678	17	744421-753999	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 148.3;Late spermatids: 157.2;Spermatocytes: 57.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA065699, HPA067891"	Uncertain		Supported	"Nuclear bodies,Cytosol"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Nuclear bodies, Cytosol"		"HPA065699: AB_2685534, HPA067891: AB_2685918"	"unprognostic (1.85e-1)"	"unprognostic (3.36e-1)"	"unprognostic (1.05e-1)"	"unprognostic (3.92e-2)"	"unprognostic (1.60e-1)"	"unprognostic (7.41e-3)"	"unprognostic (2.00e-2)"	"unprognostic (7.95e-2)"	"unprognostic (1.98e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.89e-2)"	"unprognostic (8.67e-3)"	"unprognostic (4.65e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.61e-1)"	"unprognostic (4.74e-2)"	"unprognostic (8.56e-3)"	12.4	7.7	3.0	8.2	3.0	15.5	12.3	10.5	6.2	13.4	5.9	9.5	8.0	12.1	5.7	14.8	12.3	13.0	11.2	2.9	3.3	4.9	8.6	9.8	13.6	2.3	2.4	15.6	9.7	6.3	5.7	6.6	2.6	14.4	6.3	3.4	11.7	8.2	13.9	38.9	9.8	8.5	2.1	10.0	14.5	48.9	3.1	13.2	15.6	10.1	12.3	11.8	12.4	2.6	44.8	77.8	25.5	38.3	15.8	19.9	31.7	25.0	17.4	44.4	39.1	44.5	23.6	77.9	32.5	21.6	23.6	55.4	48.3	47.0	35.3	29.6	72.3	28.0	40.9	25.1	11.3	30.1	36.8	19.3	23.3	36.5	25.6	15.4	25.3	44.9	39.6	31.7	24.0	31.7	49.8	17.0	24.7	37.4	33.0	53.1	12.1	36.6	18.9	32.5	26.4	21.4	25.7	26.1	11.7	18.2	27.8	21.7	20.2	27.3	24.6	35.6	61.4	5.3	12.4	44.8	23.5	41.9	31.8	1.6	7.0	0.3	7.9	9.6	13.6	11.8	8.6	8.4	9.3	12.3	10.1	10.2	0.9	8.7	11.6	5.2	6.0	10.0	3.0	3.0	10.5	6.2	2.9	3.3	2.3	2.4	2.6	2.1	3.1	2.6	2.9	16.0	6.7	1.3	8.5	20.4	14.3	6.6	9.1	2.9	4.6	4.7	38.4	4.3	8.5	0.0	0.0	8.4	4.4	3.1	3.9	7.5	148.3	2.6	3.9	5.8	1.2	3.0	1.2	6.4	8.3	6.4	7.7	2.9	1.3	11.1	4.6	5.2	5.4	5.0	1.5	7.0	8.2	3.9	5.7	157.2	11.5	2.6	5.4	1.0	4.8	2.4	2.1	0.0	0.5	8.4	1.8	6.8	4.3	7.4	2.3	2.2	4.4	1.4	0.0	6.2	6.4	57.0	11.2	8.7	16.1	4.0	3.2	7.4	8.7	9.8
GEMIN5		ENSG00000082516	"Gem nuclear organelle associated protein 5"	Q8TEQ6	5	154887411-154938211	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing, Protein biosynthesis, Translation regulation"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037392, HPA037393"	Uncertain		Enhanced	"Nuclear bodies,Cytosol"		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 52: Non-specific - Ribosome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	Cytosol	"Nuclear bodies"	"HPA037392: AB_2675453, HPA037393: AB_10672489"	"unprognostic (1.14e-2)"	"unprognostic (2.81e-3)"	"unprognostic (5.41e-3)"	"prognostic unfavorable (6.23e-5)"	"unprognostic (5.44e-2)"	"unprognostic (1.69e-1)"	"prognostic unfavorable (1.78e-4)"	"unprognostic (9.91e-2)"	"unprognostic (8.70e-2)"	"unprognostic (3.61e-2)"	"unprognostic (9.38e-2)"	"unprognostic (5.11e-2)"	"prognostic unfavorable (2.05e-4)"	"unprognostic (1.02e-1)"	"unprognostic (2.54e-1)"	"unprognostic (9.40e-3)"	"unprognostic (5.01e-2)"	8.3	4.4	5.0	5.0	5.9	3.3	8.2	5.4	5.6	5.9	5.0	5.4	3.3	6.2	4.6	5.3	6.1	3.4	6.7	5.1	5.4	4.7	6.0	4.3	6.5	5.2	5.2	8.4	5.5	6.4	4.4	4.8	5.4	5.8	4.6	4.1	4.6	5.9	12.3	7.3	4.0	6.9	5.2	5.6	4.3	6.0	5.4	7.5	5.3	10.2	7.3	6.8	5.0	6.9	17.2	25.0	15.9	37.0	16.8	14.2	20.4	16.4	9.9	28.0	20.6	41.6	15.0	45.0	20.2	15.7	28.8	17.8	47.7	29.8	38.0	9.0	22.3	27.3	15.6	25.2	9.3	48.0	15.2	10.7	13.6	38.9	23.2	10.1	23.2	10.7	43.9	10.7	21.2	23.6	26.0	19.2	22.3	13.4	19.4	33.3	31.2	37.4	11.6	11.6	20.9	14.4	18.9	20.7	13.3	15.7	24.6	11.0	14.2	25.1	18.0	19.1	37.2	10.7	17.5	34.5	10.7	38.8	22.6	0.0	1.9	1.7	2.4	2.3	3.9	3.4	2.2	2.2	2.6	2.7	3.2	3.5	0.1	2.8	2.2	1.9	2.2	2.1	5.0	5.9	5.4	5.6	5.1	5.4	5.2	5.2	5.4	5.2	5.4	6.9	6.7	0.0	6.4	6.8	8.4	10.3	6.7	5.3	10.2	6.3	5.2	5.0	15.0	1.5	12.3	3.7	0.0	4.4	5.0	1.9	0.0	5.7	3.4	4.3	9.5	8.4	1.2	8.8	19.1	4.2	4.4	11.1	5.1	4.8	1.3	15.6	4.6	9.2	4.5	16.8	20.5	3.9	0.0	14.4	2.6	4.1	10.8	4.5	7.2	11.2	6.0	7.0	5.2	15.1	19.3	3.4	1.1	13.2	4.5	7.0	2.6	4.5	2.5	4.3	0.0	11.5	8.6	11.7	16.1	8.2	15.9	2.1	5.6	15.6	4.7	4.9
GEMIN6	FLJ23459	ENSG00000152147	"Gem nuclear organelle associated protein 6"	Q8WXD5	2	38751534-38785002	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 164.5;Spermatocytes: 87.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035726, HPA035727"	Approved		Supported	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	"Nucleoplasm, Nuclear bodies"		"HPA035726: AB_10669528, HPA035727: AB_2674753"	"unprognostic (1.97e-2)"	"unprognostic (3.83e-1)"	"unprognostic (2.32e-1)"	"unprognostic (1.31e-2)"	"unprognostic (1.86e-1)"	"unprognostic (2.10e-2)"	"unprognostic (3.82e-3)"	"unprognostic (3.10e-2)"	"unprognostic (8.13e-2)"	"unprognostic (3.53e-3)"	"unprognostic (2.71e-1)"	"unprognostic (1.20e-1)"	"prognostic unfavorable (2.94e-4)"	"unprognostic (2.47e-1)"	"unprognostic (2.38e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.67e-2)"	6.5	10.1	7.7	7.7	8.2	3.6	8.3	8.2	10.9	6.7	8.2	6.9	9.0	6.5	10.3	7.1	9.0	5.5	6.0	7.7	7.6	12.5	13.8	5.3	10.8	7.7	7.8	9.8	6.8	7.5	6.2	7.4	8.1	5.6	8.5	6.1	6.1	5.2	13.1	5.4	7.8	8.7	7.4	7.9	7.2	19.6	8.0	8.1	6.7	7.0	12.4	7.7	5.8	10.5	38.8	31.2	21.3	24.9	27.3	23.8	36.4	32.4	16.1	28.1	23.3	33.1	18.1	52.8	36.3	16.8	39.4	18.1	33.5	31.6	40.7	45.5	42.3	34.4	17.9	54.4	18.7	29.0	17.2	16.3	22.9	37.6	18.5	19.2	29.9	14.1	35.9	17.9	28.4	27.4	35.1	37.0	36.6	45.4	37.0	24.1	37.6	28.9	25.8	13.4	26.6	41.9	8.3	31.1	25.3	24.7	16.0	9.8	16.4	27.1	34.6	21.4	49.1	36.7	77.4	50.6	21.8	43.0	27.7	3.1	24.3	7.8	19.6	28.6	21.7	32.4	20.3	20.3	24.0	29.5	24.4	25.5	3.6	26.3	26.6	17.7	31.3	22.4	7.7	8.2	8.2	10.9	7.7	7.6	7.7	7.8	8.1	7.4	8.0	10.5	11.8	12.8	24.0	1.0	18.7	8.3	10.3	31.5	7.4	6.9	13.9	21.1	9.1	14.3	22.3	11.0	4.2	29.7	7.5	7.5	29.4	22.2	164.5	28.6	21.3	14.9	1.2	18.5	1.7	17.8	37.8	16.1	16.8	8.3	12.6	19.0	16.8	33.5	26.4	11.8	1.8	10.7	6.1	19.5	15.5	29.0	20.5	15.0	10.6	1.9	23.4	9.2	15.5	1.5	1.2	19.1	11.4	11.3	13.3	10.7	21.2	68.5	32.6	7.9	19.7	10.7	15.7	87.8	18.3	16.1	11.5	7.3	12.5	30.5	17.7	7.7
GEMIN7	FLJ13956	ENSG00000142252	"Gem nuclear organelle associated protein 7"	Q9H840	19	45079195-45091518	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052075			Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 55: Plasma cells - Humoral immune response"	"Nucleoplasm, Cytosol"		"HPA052075: AB_2681718"	"unprognostic (3.32e-1)"	"unprognostic (1.48e-2)"	"unprognostic (3.84e-1)"	"unprognostic (3.17e-2)"	"unprognostic (1.60e-1)"	"unprognostic (7.00e-2)"	"prognostic unfavorable (5.86e-5)"	"unprognostic (7.78e-2)"	"unprognostic (2.17e-1)"	"unprognostic (2.95e-1)"	"unprognostic (1.47e-3)"	"unprognostic (1.20e-1)"	"prognostic unfavorable (9.64e-11)"	"unprognostic (7.01e-2)"	"unprognostic (4.54e-1)"	"unprognostic (1.83e-1)"	"prognostic favorable (8.00e-4)"	16.2	17.0	16.7	15.3	16.4	23.4	15.8	17.8	19.0	15.3	19.3	20.2	21.1	12.5	9.3	29.6	12.7	10.5	21.7	17.1	17.2	22.7	32.3	15.5	26.8	17.4	17.8	9.5	16.7	10.1	21.9	12.7	17.5	18.3	14.2	8.0	19.0	7.2	35.1	23.5	23.9	10.8	16.9	37.1	24.0	6.0	18.0	11.8	12.5	16.4	19.4	18.5	19.2	17.8	48.3	62.6	36.0	44.4	27.0	27.8	27.8	36.2	26.3	54.1	60.0	38.3	30.1	47.8	24.3	31.3	30.0	29.5	52.6	43.0	32.6	38.4	68.6	52.8	29.2	50.4	37.6	42.7	30.3	41.9	34.8	30.3	21.8	27.7	53.4	28.5	56.3	48.7	21.5	71.2	41.2	44.2	33.9	73.2	32.3	48.6	16.6	62.4	41.4	34.9	35.6	24.9	28.3	60.3	32.8	28.9	40.9	44.9	29.1	20.0	38.0	13.1	48.4	50.3	80.6	77.7	32.1	42.7	32.8	32.8	33.5	37.1	70.5	28.2	67.6	67.3	51.1	65.3	47.4	57.8	39.4	51.1	18.3	74.6	20.5	54.1	48.4	46.4	16.7	16.4	17.8	19.0	17.1	17.2	17.4	17.8	17.5	16.9	18.0	17.8	7.5	19.2	12.1	5.2	23.0	18.1	12.4	27.3	8.0	5.8	14.9	14.5	9.9	21.5	18.4	3.7	0.0	37.9	19.3	12.7	21.5	36.7	1.5	5.9	9.7	13.2	13.2	15.3	7.5	33.7	57.2	13.0	27.0	7.5	3.8	7.9	16.4	19.9	34.7	1.7	8.1	19.8	22.4	18.8	15.4	3.1	14.3	14.2	12.4	8.4	63.3	8.0	48.4	10.1	4.1	44.5	19.7	6.4	42.1	15.9	27.8	26.0	5.1	4.6	6.6	7.3	11.9	4.9	8.3	20.0	23.7	25.9	12.4	13.8	25.0	12.1
GEMIN8	"FAM51A1, FLJ20514"	ENSG00000046647	"Gem nuclear organelle associated protein 8"	Q9NWZ8	X	14006726-14029893	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Oligodendrocytes: 44.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028613	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 21: Non-specific - Transcription"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoplasm, Cytosol"		"HPA028613: AB_10602905"	"unprognostic (7.10e-2)"	"unprognostic (1.91e-3)"	"unprognostic (1.83e-1)"	"unprognostic (1.87e-3)"	"unprognostic (2.58e-1)"	"unprognostic (5.42e-2)"	"prognostic unfavorable (7.78e-5)"	"unprognostic (3.87e-3)"	"unprognostic (3.29e-1)"	"unprognostic (2.40e-2)"	"unprognostic (5.52e-2)"	"unprognostic (2.40e-1)"	"unprognostic (4.74e-2)"	"unprognostic (4.23e-2)"	"unprognostic (2.07e-2)"	"unprognostic (7.75e-2)"	"prognostic favorable (7.73e-5)"	15.7	15.0	16.3	10.9	19.1	14.3	21.4	19.4	15.9	19.8	20.9	18.3	8.7	22.3	18.8	15.6	22.1	15.2	15.2	16.0	17.8	17.8	15.7	14.3	16.2	21.2	18.8	28.1	20.4	15.0	21.5	10.5	21.2	15.8	12.4	28.5	23.4	18.2	9.5	16.6	12.3	18.9	20.3	14.7	16.3	6.9	18.2	12.9	20.8	6.0	14.1	15.5	15.7	24.0	12.7	12.7	15.2	3.2	26.9	38.6	7.9	11.8	11.7	10.1	7.5	6.0	20.7	29.3	25.7	10.5	11.1	16.0	10.7	21.3	13.1	14.8	17.1	7.5	8.9	14.2	13.8	18.9	15.3	29.5	32.1	18.0	32.1	30.3	25.2	22.0	13.2	24.6	17.0	16.2	17.2	26.6	15.2	16.5	6.6	26.3	9.7	51.4	15.6	12.9	13.0	37.1	14.6	21.5	13.8	35.7	28.4	16.3	16.6	7.1	4.2	19.7	4.6	16.7	8.7	19.1	16.2	10.5	4.3	1.0	10.1	0.4	13.1	9.9	15.2	17.2	20.5	12.2	18.9	13.3	17.4	13.5	1.2	15.4	10.9	22.1	13.0	11.5	16.3	19.1	19.4	15.9	16.0	17.8	21.2	18.8	21.2	20.3	18.2	24.0	9.5	6.4	8.9	23.2	8.1	7.6	11.7	16.8	13.6	3.4	13.3	15.4	5.2	11.5	15.0	9.2	0.0	15.2	7.2	5.1	19.6	22.7	19.9	20.7	6.7	8.4	3.5	5.5	13.2	11.8	16.0	11.3	9.7	14.8	6.3	8.0	4.6	7.5	10.9	10.1	18.0	11.1	10.2	6.0	6.1	3.4	10.2	5.0	1.8	4.7	7.6	6.7	7.2	16.1	44.0	11.2	7.4	8.6	15.8	6.5	5.5	36.6	15.9	6.4	0.0	11.2	9.4	7.4	5.5	12.9	9.5	8.3	7.2	14.0	12.2	9.4
GET4	"C7orf20, CEE, CGI-20, H_NH1244M04.5, TRC35"	ENSG00000239857	"Guided entry of tail-anchored proteins factor 4"	Q7L5D6	7	876554-896436	"Predicted intracellular proteins"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Gastric mucus-secreting cells: 36.7;Oligodendrocytes: 15.8;Plasma cells: 37.2;Squamous epithelial cells: 23.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019765	Uncertain		Enhanced	"Nucleoplasm,Nucleoli,Mitotic chromosome,Cytosol"		Yes	No			"Cluster 26: Non-specific - Mitochondria"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	"Nucleoplasm, Cytosol"	"Nucleoli, Mitotic chromosome"	"HPA019765: AB_1845750"	"unprognostic (2.80e-2)"	"unprognostic (2.40e-2)"	"unprognostic (2.10e-2)"	"unprognostic (9.66e-4)"	"unprognostic (9.86e-2)"	"unprognostic (8.64e-2)"	"unprognostic (4.10e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.59e-1)"	"unprognostic (6.28e-2)"	"unprognostic (2.43e-1)"	"unprognostic (1.21e-1)"	"unprognostic (7.65e-2)"	"unprognostic (8.18e-2)"	"unprognostic (1.26e-1)"	"unprognostic (5.93e-2)"	"unprognostic (9.47e-2)"	25.0	98.0	28.9	12.5	33.7	31.6	26.8	29.7	37.0	28.1	19.1	33.5	20.8	25.5	21.1	43.7	32.1	11.4	33.1	28.8	31.1	68.8	98.4	25.5	15.8	36.1	33.4	34.3	46.1	13.7	70.7	20.5	36.0	37.8	8.8	16.4	28.8	12.3	56.3	46.9	33.6	7.7	29.1	37.5	41.5	79.0	34.0	14.4	34.3	21.9	10.4	31.3	28.9	45.6	78.8	38.1	25.8	38.4	13.2	9.1	81.7	21.2	14.9	26.5	26.6	103.4	95.1	28.5	21.7	12.4	73.7	48.7	29.3	23.3	11.5	11.6	50.9	15.8	31.5	59.5	29.1	27.1	28.1	13.8	27.6	23.4	15.1	19.9	21.1	32.5	103.6	25.7	15.2	59.7	20.8	65.2	93.3	46.1	56.0	43.0	4.5	30.8	23.8	45.4	46.7	50.5	19.5	71.2	32.2	31.5	54.2	47.8	21.4	19.6	43.6	45.7	29.5	38.5	25.9	37.5	20.1	46.2	50.3	22.3	28.5	32.4	23.9	27.6	23.3	24.3	26.4	24.1	29.4	24.5	25.2	27.0	21.9	27.7	35.3	33.3	26.9	24.8	28.9	33.7	29.7	37.0	28.8	31.1	36.1	33.4	36.0	29.1	34.0	45.6	0.3	0.0	3.1	14.7	10.6	1.0	0.3	0.2	14.8	0.8	1.1	0.9	0.6	0.0	2.2	0.0	4.2	1.1	0.7	2.3	0.0	0.9	4.0	2.0	1.1	1.5	0.0	9.2	9.1	0.7	0.7	3.8	36.7	2.8	1.3	1.2	0.0	0.4	0.6	8.4	9.1	2.8	0.0	0.6	0.8	2.7	0.0	6.1	0.0	4.7	0.5	0.2	0.0	10.1	15.8	0.8	1.0	0.0	37.2	0.4	3.6	1.1	2.1	1.4	0.0	0.8	1.8	0.6	1.1	23.5	1.0	1.6	9.9	0.8	1.7	0.8
GFAP	FLJ45472	ENSG00000131095	"Glial fibrillary acidic protein"	P14136	17	44903159-44916937	"Candidate cardiovascular disease genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			"Disease variant, Leukodystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"brain: 13076.3"	"Cell type enriched"	"Detected in some"	7	"Astrocytes: 381.9"	"Cancer enriched"	"Detected in some"	368	"glioma: 2468.0"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"neutrophil: 6.2"	"Group enriched"	"Detected in many"	5	"granulocytes: 6.2;NK-cells: 1.7"	"Cell line enhanced"	"Detected in many"		"U-87 MG: 6.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000039, HPA056030, HPA063513"	Enhanced	Supported	Supported	"Intermediate filaments"		No	No		170000000	"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 70: Brain - Nervous system development"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 64: Astrocytes - Nervous system maintenance"	"Intermediate filaments"		"CAB000039: AB_10013382, HPA056030: AB_2683015, HPA063513: AB_2685027"	"unprognostic (1.79e-2)"	"unprognostic (2.74e-1)"	"unprognostic (9.83e-2)"	"unprognostic (2.12e-5)"	"unprognostic (4.08e-1)"	"unprognostic (5.09e-1)"	"unprognostic (1.26e-1)"	"unprognostic (6.53e-2)"	"unprognostic (6.57e-3)"	"unprognostic (7.35e-2)"	"unprognostic (5.86e-2)"	"unprognostic (1.24e-1)"	"unprognostic (7.63e-2)"	"unprognostic (2.75e-5)"	"unprognostic (1.49e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.64e-1)"	1.9	1.8	5096.2	2.2	5407.4	14.1	3.5	5902.8	4887.4	1.9	2342.2	1.4	0.4	0.9	1.5	3.7	2.2	1.6	8.2	5059.3	9869.7	2.1	1.7	1.3	1.9	13076.3	9001.4	2.1	1.5	1.6	33.9	0.7	9204.1	1.3	1.0	117.7	1.9	1.0	2.1	2.6	0.7	0.9	10040.2	1.5	1.5	1.4	8068.5	0.4	1.7	0.3	1.1	1.4	0.9	10496.9	1.0	0.7	1.2	2.3	0.0	0.4	0.2	1.0	1.2	1.5	1.2	1.3	1.5	2.2	1.9	0.5	0.9	2.7	1.4	0.4	1.8	3.0	1.1	1.4	2.1	0.9	0.0	0.2	2.2	0.1	0.8	1.0	0.0	1.7	0.0	2.3	0.7	5.3	0.8	1.3	1.9	2.6	1.6	0.1	3.3	0.7	0.7	1.2	0.7	0.6	1.6	1.8	0.1	1.7	0.2	1.0	1.2	1.2	0.7	1.2	0.9	1.1	2.0	0.7	1.6	1.6	6.1	2.0	2.7	1.5	0.8	0.3	0.3	0.6	0.2	0.2	0.2	0.4	0.1	0.5	0.3	0.4	6.2	1.7	0.5	0.5	0.2	0.2	5096.2	5407.4	5902.8	4887.4	5059.3	9869.7	13076.3	9001.4	9204.1	10040.2	8068.5	10496.9	0.0	0.0	0.0	381.9	0.1	0.0	0.1	0.0	0.0	0.8	1.3	0.6	5.2	0.0	0.0	0.0	6.2	0.0	0.1	0.0	0.0	0.3	0.1	0.1	0.1	0.8	0.0	0.0	0.5	0.2	0.0	0.3	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	3.7	0.0	53.5	0.0	10.1	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	4.4	0.0	0.2	0.1	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.1
GFI1B	ZNF163B	ENSG00000165702	"Growth factor independent 1B transcriptional repressor"	Q5VTD9	9	132944000-132991687	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Chromatin regulator, Developmental protein, DNA-binding, Repressor"	Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	18	"bone marrow: 39.0"	"Cell type enriched"	"Detected in some"	4	"Erythroid cells: 99.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	20	"basophil: 195.6;eosinophil: 395.8"	"Lineage enriched"	"Detected in many"	26	"granulocytes: 395.8"	"Group enriched"	"Detected in some"	5	"HEL: 168.9;HMC-1: 104.6;K-562: 53.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB004420, HPA006291"	Enhanced		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 51: Myeloid cells - Hemostasis"	"Nucleoplasm, Plasma membrane"		"CAB004420: AB_2110132, HPA006291: "	"unprognostic (1.79e-2)"	"unprognostic (2.90e-4)"	"unprognostic (6.54e-2)"	"unprognostic (1.76e-1)"	"unprognostic (2.33e-1)"	"unprognostic (1.54e-2)"		"unprognostic (2.53e-3)"	"unprognostic (1.05e-1)"	"unprognostic (2.47e-1)"	"unprognostic (1.54e-1)"	"unprognostic (4.61e-2)"	"unprognostic (3.71e-2)"	"unprognostic (2.17e-1)"	"unprognostic (2.53e-1)"	"unprognostic (1.53e-2)"	"unprognostic (1.41e-1)"	0.0	0.0	0.0	0.3	0.1	39.0	0.0	0.2	0.2	0.0	0.2	0.5	0.9	0.0	0.1	0.1	0.0	0.3	0.2	0.1	0.0	0.0	0.2	1.1	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.5	0.1	0.1	0.3	0.0	0.1	0.1	0.4	0.5	1.0	0.1	0.1	1.8	0.3	2.1	0.1	0.1	0.0	0.0	0.2	0.1	0.0	0.4	0.3	0.1	0.0	0.0	0.1	0.5	0.1	0.0	0.0	0.0	0.0	1.9	0.3	23.8	0.0	0.0	0.0	1.5	0.0	0.6	0.0	0.0	0.0	168.9	0.2	0.1	0.0	0.1	104.6	0.0	1.4	0.0	0.2	0.0	0.0	0.0	53.0	0.2	0.0	0.0	0.1	17.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.5	0.0	1.5	0.0	0.0	0.0	195.6	0.3	395.8	0.1	1.9	0.1	0.1	0.1	0.0	1.9	0.2	0.5	0.1	3.9	0.5	15.1	1.0	0.0	12.5	0.0	0.1	0.2	0.2	0.1	0.0	0.4	0.1	0.1	0.1	0.1	0.4	0.2	0.0	0.6	0.0	0.4	0.0	0.4	0.0	0.0	0.0	0.2	0.0	1.3	0.0	1.8	0.0	0.0	0.1	0.1	0.8	0.0	0.1	3.8	0.0	0.3	0.4	1.2	99.1	0.4	0.0	0.2	0.3	0.0	0.1	14.5	0.4	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.3	0.0	12.9	0.0	15.8	0.0	0.0	0.6	0.0	0.0	0.5	0.2	0.0	24.2	0.0	0.0	0.5	0.3	0.0	0.0	0.0	0.0	0.1	0.2	0.4	0.4	0.0	0.0	0.3	0.2	1.0	0.6	0.1
GFOD2	"FLJ23802, MGC11335"	ENSG00000141098	"Glucose-fructose oxidoreductase domain containing 2"	Q3B7J2	16	67674531-67719339	"Predicted intracellular proteins, Predicted secreted proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 89.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040939, HPA041112"	Uncertain		Supported	Nucleoplasm,Cytosol	"Secreted to blood"	NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 37: Intestine - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 29: Early spermatids - Spermatogenesis"	Nucleoplasm	Cytosol	"HPA040939: AB_10796564, HPA041112: AB_10794541"	"unprognostic (9.80e-2)"	"unprognostic (2.20e-1)"	"unprognostic (2.06e-2)"	"unprognostic (3.16e-3)"	"unprognostic (4.62e-2)"	"unprognostic (1.38e-1)"	"unprognostic (2.93e-2)"	"unprognostic (5.61e-3)"	"unprognostic (1.19e-1)"	"unprognostic (2.22e-2)"	"prognostic favorable (5.95e-4)"	"unprognostic (1.17e-1)"	"prognostic favorable (8.66e-4)"	"unprognostic (1.90e-1)"	"unprognostic (1.76e-1)"	"unprognostic (7.87e-2)"	"unprognostic (9.64e-2)"	12.5	12.2	13.4	6.9	13.8	16.6	12.6	27.4	14.8	17.6	13.4	11.8	11.7	10.8	5.5	33.5	13.0	7.9	7.2	13.0	13.9	12.4	40.8	9.3	8.7	11.3	12.9	6.4	8.9	12.0	13.2	14.7	13.6	10.9	9.3	8.1	12.7	7.3	9.2	16.7	9.2	9.2	8.8	18.5	8.0	11.1	12.6	8.1	10.3	7.1	12.9	10.9	26.3	11.5	15.8	25.1	15.1	31.0	14.9	11.3	18.1	12.7	16.5	23.3	23.9	21.5	13.9	26.6	11.8	14.8	12.6	19.4	15.6	14.9	19.3	16.2	20.1	6.7	14.5	30.4	11.4	11.0	12.5	9.1	16.9	31.0	9.2	11.7	34.5	26.9	14.1	4.9	13.2	33.0	18.2	13.4	20.7	9.4	13.8	28.7	8.9	20.8	14.5	21.5	30.4	18.4	31.6	10.5	9.6	8.7	15.9	7.3	26.4	17.8	18.1	16.3	13.0	13.2	19.8	29.0	11.1	15.8	13.3	0.5	4.8	5.2	4.4	2.9	7.2	6.3	7.7	7.9	4.8	7.0	6.6	5.3	9.0	5.9	3.1	5.4	9.2	3.7	13.4	13.8	27.4	14.8	13.0	13.9	11.3	12.9	13.6	8.8	12.6	11.5	36.1	0.0	8.4	8.5	7.7	22.9	15.8	8.1	15.9	13.7	21.7	12.4	5.3	15.7	10.9	11.0	14.6	10.3	10.6	23.8	5.9	21.1	89.6	22.5	10.9	33.8	43.2	56.6	18.3	11.6	24.1	10.4	3.6	8.7	4.5	12.2	31.1	46.7	6.6	21.9	16.8	17.0	16.2	7.5	10.0	29.9	8.7	4.6	8.8	6.5	5.2	12.0	11.3	8.5	7.3	15.8	14.2	11.3	9.1	12.4	20.6	13.0	24.5	11.0	6.6	11.9	11.4	19.9	14.8	10.1	27.3	22.2	10.3	9.3	18.3	21.3
GFRAL	"bA360D14.1, C6orf144, GRAL, UNQ9356"	ENSG00000187871	"GDNF family receptor alpha like"	Q6UXV0	6	55327469-55402493	"Predicted membrane proteins"		Receptor		"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA047372	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Actin filaments,Focal adhesion sites"		NA	NA						"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Nucleoplasm, Plasma membrane"	"Actin filaments, Focal adhesion sites"	"HPA047372: AB_2680017"															"unprognostic (2.31e-1)"			0.2	0.0	0.2	0.0	0.3	0.0	0.0	0.3	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.3	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.2	0.3	0.3	0.3	0.2	0.1	0.1	0.1	0.1	0.1	0.2	0.2	0.5	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0
GGA1		ENSG00000100083	"Golgi associated, gamma adaptin ear containing, ARF binding protein 1"	Q9UJY5	22	37608725-37633564	"Predicted intracellular proteins, Transporters"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 179.3"	"Cell type enhanced"	"Detected in all"		"Late spermatids: 221.2;Spermatocytes: 193.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA048280, HPA051016"	Supported		Supported	"Nucleoplasm,Golgi apparatus,Vesicles"		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 43: Testis - Unknown function"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Golgi apparatus, Vesicles"	Nucleoplasm	"HPA048280: AB_2680338, HPA051016: AB_2681312"	"unprognostic (1.64e-1)"	"unprognostic (1.42e-2)"	"unprognostic (4.08e-1)"	"unprognostic (9.23e-3)"	"unprognostic (2.00e-1)"	"unprognostic (2.77e-2)"	"prognostic unfavorable (6.29e-4)"	"unprognostic (2.32e-2)"	"unprognostic (2.81e-1)"	"unprognostic (1.32e-1)"	"prognostic favorable (4.86e-4)"	"unprognostic (1.42e-2)"	"unprognostic (1.53e-2)"	"unprognostic (1.14e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.22e-1)"	"unprognostic (1.16e-3)"	25.0	49.3	35.9	23.3	39.7	37.2	27.3	39.0	42.3	38.0	41.0	35.0	24.3	32.1	21.5	41.1	37.4	20.4	29.5	35.3	35.0	42.4	42.1	33.7	29.1	41.1	37.6	46.3	34.5	33.2	52.7	19.1	38.4	40.0	17.8	22.8	34.9	19.6	43.1	35.7	40.7	16.9	36.1	55.6	34.9	179.3	41.2	26.9	44.7	24.6	21.1	31.6	33.5	45.0	37.4	28.3	32.9	31.1	28.0	23.0	35.4	30.8	25.0	27.0	29.6	23.3	21.8	59.9	20.6	22.9	17.0	35.0	29.4	35.6	24.8	51.0	53.6	24.0	52.3	27.3	28.1	56.1	42.6	28.4	31.3	38.9	24.2	45.1	26.5	30.3	48.0	36.8	27.8	37.7	24.8	64.2	26.2	39.2	28.7	28.5	25.8	25.2	28.8	31.0	30.4	54.0	18.7	39.0	48.9	31.3	42.4	42.0	31.0	36.8	35.2	32.1	24.4	81.1	35.3	62.5	39.9	33.6	30.8	8.1	10.7	6.1	18.0	10.2	22.1	8.3	7.2	23.3	6.7	5.0	5.1	16.5	4.5	11.6	7.9	5.8	8.0	11.5	35.9	39.7	39.0	42.3	35.3	35.0	41.1	37.6	38.4	36.1	41.2	45.0	17.9	25.6	38.5	26.8	50.9	24.2	31.1	36.5	21.1	57.6	26.5	20.8	19.2	20.0	34.5	44.1	83.4	38.8	34.7	67.3	5.9	34.9	148.2	27.6	19.8	32.6	32.4	38.3	18.4	20.1	37.4	18.8	44.4	26.5	49.4	33.3	40.7	20.4	77.1	25.2	19.3	40.4	32.6	66.9	40.3	221.2	26.4	50.5	16.0	20.6	47.9	37.0	73.2	16.6	28.7	36.6	51.6	22.6	24.4	24.7	55.4	13.2	46.7	74.1	26.3	26.9	22.1	193.4	50.4	19.7	28.6	56.8	59.6	44.4	42.8	33.6
GGA3	KIAA0154	ENSG00000125447	"Golgi associated, gamma adaptin ear containing, ARF binding protein 3"	Q9NZ52	17	75236599-75262363	"Predicted intracellular proteins, Transporters"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022945, HPA024645"	Approved		Supported	"Golgi apparatus"		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 16: Immune cells - Immune response"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	"Golgi apparatus"		"HPA022945: AB_1849639, HPA024645: AB_2671629"	"unprognostic (9.16e-2)"	"unprognostic (8.89e-2)"	"unprognostic (1.69e-1)"	"prognostic unfavorable (8.26e-4)"	"unprognostic (1.20e-1)"	"unprognostic (4.60e-3)"	"prognostic unfavorable (2.77e-6)"	"unprognostic (6.33e-2)"	"unprognostic (1.42e-1)"	"unprognostic (9.30e-2)"	"unprognostic (4.63e-3)"	"unprognostic (4.90e-3)"	"prognostic unfavorable (3.41e-4)"	"unprognostic (1.27e-1)"	"unprognostic (2.99e-3)"	"unprognostic (1.28e-2)"	"unprognostic (9.68e-3)"	11.7	9.8	9.0	13.0	8.4	15.7	10.8	7.7	11.4	12.3	4.3	12.4	11.5	10.8	9.8	17.0	10.2	11.4	12.8	8.4	6.7	11.1	11.6	13.0	17.5	8.9	7.6	15.3	12.3	9.1	9.0	14.6	7.6	10.1	11.7	6.7	12.3	7.8	22.7	15.7	15.0	11.8	6.8	19.6	13.0	11.5	7.8	12.8	9.9	10.5	19.0	11.6	12.2	9.4	16.9	21.1	19.5	11.9	21.5	17.9	22.8	18.5	13.3	24.9	21.2	24.8	18.4	21.4	8.2	16.4	19.9	10.6	13.8	8.0	25.7	15.1	21.4	34.3	19.2	19.6	10.3	32.5	24.3	14.1	19.7	13.6	23.5	13.2	26.5	16.1	37.8	19.1	17.7	17.4	42.5	9.6	13.8	19.6	14.9	16.9	28.0	14.3	17.1	18.4	14.0	23.9	18.5	33.2	14.9	27.3	25.3	17.4	29.6	25.7	18.7	17.4	19.9	19.8	15.1	27.5	20.8	23.0	17.2	5.1	6.8	2.9	5.5	5.9	5.1	3.9	4.9	4.2	6.4	4.7	4.3	4.6	7.3	8.4	5.8	6.6	5.4	6.0	9.0	8.4	7.7	11.4	8.4	6.7	8.9	7.6	7.6	6.8	7.8	9.4	9.5	35.3	21.0	13.4	15.5	2.5	4.9	5.2	8.0	8.1	8.8	7.6	12.6	4.3	9.6	0.0	10.4	10.3	21.2	14.3	5.9	5.2	27.6	10.5	13.6	10.2	0.0	4.6	20.6	7.0	11.0	7.7	21.9	14.7	10.1	12.4	9.7	10.4	12.5	6.7	20.2	10.0	6.1	19.2	7.1	30.1	9.3	19.4	12.4	16.9	20.3	5.9	10.3	18.1	21.2	11.6	9.1	10.1	11.0	8.2	9.5	3.5	10.2	8.9	0.0	7.7	6.1	8.1	6.9	7.8	5.3	13.0	12.2	7.0	12.8	8.5
GGPS1	GGPPS1	ENSG00000152904	"Geranylgeranyl diphosphate synthase 1"	O95749	1	235327350-235344532	"Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Isoprene biosynthesis"	Transferase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 212.7;Late spermatids: 290.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029472, HPA050727"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 21: Non-specific - Transcription"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 25: Spermatids - Spermatogenesis"	Cytosol	Nucleoplasm	"HPA029472: AB_10696206, HPA050727: "	"unprognostic (7.45e-2)"	"unprognostic (3.18e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.23e-2)"	"unprognostic (1.43e-1)"	"unprognostic (3.10e-3)"	"prognostic unfavorable (6.69e-4)"	"unprognostic (4.50e-2)"	"unprognostic (3.66e-2)"	"unprognostic (3.77e-3)"	"unprognostic (2.66e-2)"	"unprognostic (8.77e-3)"	"unprognostic (1.95e-2)"	"unprognostic (1.99e-1)"	"unprognostic (3.35e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.70e-2)"	24.0	23.5	20.4	17.3	21.4	7.8	34.1	23.0	27.6	24.5	18.5	24.8	21.2	23.3	30.4	22.4	21.2	20.0	23.5	21.1	22.5	27.8	21.7	20.1	21.3	21.8	20.6	23.3	16.4	21.1	17.6	19.2	22.3	29.4	23.9	38.8	31.2	19.7	29.8	20.3	20.6	25.7	22.3	20.5	20.4	48.2	20.9	27.6	27.4	28.9	21.9	23.6	17.0	25.7	41.3	22.3	54.5	41.5	41.7	59.9	20.5	36.2	50.7	23.6	33.1	17.5	64.5	28.1	51.3	40.6	38.1	33.5	29.4	37.8	31.2	28.8	54.4	24.0	19.7	29.9	46.9	30.0	19.7	39.3	66.5	32.2	43.0	41.8	42.5	46.2	58.5	24.7	31.5	24.6	37.0	35.7	46.4	109.9	11.5	22.6	17.3	32.6	66.2	22.4	43.3	59.8	27.3	61.5	54.7	20.1	76.7	46.5	35.9	27.9	20.8	47.6	34.7	42.0	55.8	34.3	35.4	33.3	51.4	43.7	31.0	48.5	31.5	37.3	32.1	38.6	39.5	33.8	30.4	32.8	36.2	33.4	27.8	31.9	54.2	25.2	42.5	36.8	20.4	21.4	23.0	27.6	21.1	22.5	21.8	20.6	22.3	22.3	20.9	25.7	18.3	32.1	34.5	16.3	27.2	39.9	60.4	64.6	27.9	32.1	29.1	22.4	24.5	17.2	39.5	20.2	43.8	30.7	24.1	21.4	72.4	37.5	212.7	16.8	15.1	29.4	17.4	12.0	26.5	28.3	43.7	31.0	14.3	12.9	24.6	16.4	28.9	13.0	26.8	48.8	25.7	26.1	69.2	26.9	49.0	290.7	35.8	24.3	67.6	20.6	36.7	55.4	36.0	15.6	23.2	31.8	23.3	35.0	8.5	65.6	29.3	61.3	30.4	51.2	26.3	26.1	32.5	111.6	50.0	18.7	40.6	47.1	33.0	30.9	22.7	55.9
GHITM	"DERP2, HSPC282, My021, PTD010, TMBIM5"	ENSG00000165678	"Growth hormone inducible transmembrane protein"	Q9H3K2	10	84139509-84153568	"Predicted membrane proteins"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 1114.2;Late spermatids: 2559.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016464, HPA061664"	Approved		Supported	Mitochondria		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"HPA016464: AB_1849656, HPA061664: AB_2684579"	"unprognostic (6.26e-3)"	"unprognostic (1.85e-1)"	"unprognostic (2.75e-2)"	"unprognostic (1.51e-1)"	"unprognostic (4.61e-2)"	"prognostic unfavorable (1.76e-4)"	"unprognostic (5.71e-2)"	"unprognostic (4.56e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.28e-1)"	"unprognostic (8.14e-2)"	"unprognostic (5.71e-2)"	"prognostic favorable (2.32e-10)"	"unprognostic (2.46e-2)"	"unprognostic (2.09e-1)"	"unprognostic (3.56e-2)"	"unprognostic (1.25e-1)"	113.9	179.5	124.3	87.0	133.3	110.6	93.8	138.6	147.7	73.1	150.6	171.2	163.5	76.8	86.1	114.4	71.4	68.9	365.3	136.1	146.1	300.7	271.1	74.1	87.3	136.6	128.1	72.7	77.7	197.3	88.8	70.3	138.5	80.6	166.4	144.3	94.4	84.2	369.3	79.7	137.1	85.7	125.4	73.8	123.1	115.7	137.5	86.5	105.9	456.6	103.3	92.3	76.5	123.1	228.2	230.8	97.1	223.5	162.6	143.3	171.6	153.3	267.4	193.7	180.2	283.1	183.8	178.9	167.7	203.2	170.9	199.9	208.4	200.0	185.9	179.8	157.4	127.7	227.3	281.0	306.5	402.0	200.0	162.7	384.1	200.4	577.8	201.8	169.9	150.5	299.9	324.3	180.4	197.4	143.6	318.9	98.3	184.8	203.2	128.3	89.4	270.5	271.4	179.2	79.4	92.4	154.7	134.1	325.1	111.2	273.7	254.2	145.3	94.0	126.5	138.5	251.1	227.9	265.7	199.9	246.8	364.4	67.1	293.7	284.9	276.5	173.9	304.7	194.2	211.0	178.9	186.0	279.9	177.9	166.6	178.8	223.7	206.7	281.3	145.3	235.3	578.0	124.3	133.3	138.6	147.7	136.1	146.1	136.6	128.1	138.5	125.4	137.5	123.1	94.1	96.1	87.6	23.2	138.0	170.3	185.1	440.9	87.0	135.9	102.2	71.8	689.3	140.2	235.8	158.2	70.9	260.4	134.0	376.0	579.2	295.3	1114.2	58.7	68.6	120.7	125.6	242.9	33.6	232.3	234.9	119.6	107.6	67.1	102.0	79.3	88.5	326.1	267.7	101.0	34.5	206.0	443.5	156.2	169.2	2559.1	110.3	153.0	163.7	16.9	228.3	269.0	114.4	14.6	24.3	223.3	276.3	136.9	167.3	180.1	343.7	802.9	173.4	159.9	144.7	114.5	219.8	263.1	153.2	150.4	170.3	386.0	141.6	158.4	281.4	212.9
GHR	GHBP	ENSG00000112964	"Growth hormone receptor"	P10912	5	42423439-42721878	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted membrane proteins, Predicted secreted proteins"	Endocytosis	Receptor	"Disease variant, Dwarfism, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 84.7;liver: 213.3"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 53.3;Hepatocytes: 141.3;Inhibitory neurons: 115.7;Oligodendrocyte precursor cells: 181.0"	"Group enriched"	"Detected in many"	4	"breast cancer: 2.8;liver cancer: 7.6;prostate cancer: 8.1;renal cancer: 2.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"HSkMC: 21.2;T-47d: 56.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045339, HPA057705"	Enhanced		Supported	"Plasma membrane,Cytosol,Cytoplasmic bodies"	"Secreted to blood"	NA	NA	2200000	24000000		"Cluster 85: Liver - Metabolism"	"Cluster 6: T47d - Mammary gland"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Plasma membrane, Cytosol, Cytoplasmic bodies"		"HPA045339: AB_2679294, HPA057705: AB_2683507"	"unprognostic (2.18e-2)"	"unprognostic (5.45e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.96e-2)"	"unprognostic (3.12e-1)"	"unprognostic (1.57e-1)"	"prognostic favorable (2.73e-6)"	"unprognostic (1.06e-1)"	"unprognostic (3.92e-2)"	"unprognostic (3.73e-2)"	"unprognostic (6.15e-3)"	"unprognostic (2.67e-2)"	"unprognostic (1.67e-3)"	"unprognostic (4.29e-4)"	"unprognostic (7.82e-2)"	"unprognostic (7.33e-4)"	"unprognostic (8.35e-6)"	84.7	5.6	1.8	1.7	2.1	0.2	30.1	1.7	1.7	5.2	2.3	5.8	1.1	4.5	4.6	3.9	5.4	5.2	8.9	1.8	5.6	11.8	213.3	4.0	1.3	1.0	2.0	7.5	2.1	5.5	1.2	4.8	1.4	11.1	5.7	0.4	3.7	4.7	45.7	5.6	4.3	4.0	1.1	4.0	6.1	1.7	3.4	2.3	4.6	11.6	0.9	5.0	5.8	1.4	0.0	0.0	0.6	5.0	3.3	0.7	0.1	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.4	0.0	0.0	0.3	4.3	0.0	0.0	2.6	0.0	0.1	0.0	0.6	0.0	0.0	21.2	7.0	0.0	1.0	0.1	0.1	0.0	0.0	0.0	1.8	0.2	0.0	0.0	0.3	0.0	0.7	0.0	0.3	0.0	0.0	0.6	0.0	0.0	0.3	0.1	3.5	0.6	56.0	0.1	3.0	4.8	2.1	2.6	0.5	0.5	0.0	0.0	0.5	0.0	2.6	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.8	2.1	1.7	1.7	1.8	5.6	1.0	2.0	1.4	1.1	3.4	1.4	17.2	0.0	0.5	14.7	0.4	4.7	4.5	17.8	10.2	0.6	9.7	16.0	18.6	1.5	1.9	1.8	0.0	17.4	0.5	2.8	1.9	0.0	5.1	0.5	9.4	4.8	3.0	5.3	53.3	0.2	2.2	23.8	0.5	0.3	0.0	1.1	6.1	141.3	1.9	0.0	115.7	1.9	0.0	3.0	1.8	2.8	18.6	0.7	1.8	36.5	0.0	0.7	0.0	181.0	3.6	0.2	1.7	12.0	0.0	5.2	0.0	9.6	0.6	0.4	13.1	18.7	15.1	0.7	0.3	2.9	3.7	40.2	0.5	49.4	2.2	0.9
GID8	"bA305P22.1, C20orf11, FLJ20602, TWA1"	ENSG00000101193	"GID complex subunit 8 homolog"	Q9NWU2	20	62938147-62948475	"Predicted intracellular proteins"	"Wnt signaling pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049929, HPA055047"	Approved		Supported	"Nucleoplasm,Cell Junctions"		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	Nucleoplasm	"Cell Junctions"	"HPA049929: AB_2680957, HPA055047: AB_2682682"	"unprognostic (1.35e-1)"	"unprognostic (4.06e-2)"	"unprognostic (5.90e-2)"	"prognostic unfavorable (4.78e-4)"	"unprognostic (1.19e-1)"	"unprognostic (8.25e-2)"	"unprognostic (3.88e-2)"	"unprognostic (4.58e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.83e-1)"	"unprognostic (2.72e-2)"	"unprognostic (1.43e-1)"	"prognostic favorable (3.22e-4)"	"unprognostic (3.97e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.01e-1)"	"unprognostic (6.87e-2)"	12.5	13.3	18.8	13.5	18.3	39.2	17.1	18.7	18.3	19.1	16.7	16.6	13.8	16.3	16.8	41.8	20.1	11.1	14.2	19.2	18.6	17.2	24.7	12.7	20.7	17.8	18.4	26.3	20.4	19.0	15.9	13.0	17.4	16.2	14.3	13.0	17.1	14.8	14.8	30.5	15.5	12.5	18.8	16.9	18.1	13.7	19.2	25.3	18.4	13.2	23.1	15.6	22.5	18.3	39.9	25.0	36.6	33.2	29.5	23.1	35.8	21.8	18.2	61.1	27.5	121.4	37.9	49.9	36.5	28.4	25.1	45.2	33.9	45.3	36.9	13.4	16.6	46.5	32.8	58.6	23.2	54.5	37.7	25.6	49.4	26.4	30.4	22.2	30.1	32.5	36.3	21.0	21.3	56.0	65.3	48.4	37.0	66.1	37.0	51.1	68.8	29.9	22.5	55.4	38.0	31.0	51.5	49.9	32.8	27.0	69.5	51.9	30.6	36.4	45.4	28.8	29.9	21.9	27.0	51.2	24.6	26.2	23.5	5.3	9.5	15.4	9.8	8.3	11.6	7.4	10.4	11.1	8.9	8.2	11.2	12.7	13.5	12.3	7.7	6.7	9.9	8.1	18.8	18.3	18.7	18.3	19.2	18.6	17.8	18.4	17.4	18.8	19.2	18.3	33.5	19.2	27.4	11.4	42.7	51.6	46.9	76.6	50.1	23.1	56.4	53.0	30.9	52.9	46.5	40.5	6.2	101.7	48.6	57.3	41.1	44.7	19.1	46.4	27.4	37.7	45.0	71.1	17.7	40.4	105.1	35.1	27.0	40.1	26.6	24.4	46.4	77.7	51.8	16.8	15.0	50.1	50.8	47.9	46.4	19.4	32.9	42.9	24.9	11.2	62.1	28.3	51.5	11.6	14.4	40.8	39.2	42.2	44.0	68.2	55.7	42.5	38.8	16.5	13.1	34.1	30.7	49.1	57.9	82.1	79.8	156.9	45.8	21.6	52.1	71.7
GIMAP1	"HIMAP1, IAN2, IMAP1, IMAP38"	ENSG00000213203	"GTPase, IMAP family member 1"	Q8WWP7	7	150716606-150724284	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 24.7"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 189.8;Endothelial cells: 109.9;Hepatic stellate cells: 117.8;Kupffer cells: 109.1;monocytes: 74.9;NK-cells: 185.3;T-cells: 97.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"HUVEC TERT2: 14.7;MOLT-4: 9.2;TIME: 3.9"	"Low region specificity"	"Detected in many"							"HPA044887, HPA053441"	Uncertain		Supported	"Endoplasmic reticulum"		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 63: NK-cells & T-cells - Immune response"	"Endoplasmic reticulum"		"HPA044887: AB_10960351, HPA053441: AB_2682152"	"unprognostic (1.60e-2)"	"unprognostic (6.58e-3)"	"unprognostic (8.21e-3)"	"unprognostic (2.54e-3)"	"unprognostic (1.10e-1)"	"unprognostic (2.33e-3)"	"prognostic favorable (1.09e-4)"	"unprognostic (1.66e-2)"	"unprognostic (3.54e-2)"	"unprognostic (3.44e-1)"	"unprognostic (4.60e-3)"	"unprognostic (7.89e-2)"	"unprognostic (1.77e-3)"	"unprognostic (2.18e-1)"	"prognostic unfavorable (6.12e-4)"	"unprognostic (7.49e-2)"	"unprognostic (1.96e-1)"	9.8	2.5	3.0	11.0	3.0	1.0	7.9	2.9	3.5	3.8	3.0	3.7	3.5	4.6	1.1	2.1	4.4	3.2	9.3	2.8	2.9	3.5	2.4	8.9	19.6	3.5	3.2	1.5	1.4	1.5	1.1	7.1	3.4	2.3	2.2	0.1	2.5	2.0	5.4	2.5	6.9	3.8	3.5	24.7	3.3	0.8	3.6	6.6	5.3	7.1	8.4	3.5	3.0	3.2	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	14.7	1.9	0.0	0.0	0.0	0.0	9.2	0.8	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	3.0	32.2	0.1	43.8	29.6	51.1	0.3	47.5	54.2	13.5	0.6	68.2	56.2	2.7	42.6	30.6	0.8	34.0	35.0	3.0	3.0	2.9	3.5	2.8	2.9	3.5	3.2	3.4	3.5	3.6	3.2	189.8	3.2	1.5	0.0	5.1	5.5	0.6	0.0	1.2	0.6	1.9	3.6	5.9	2.8	0.6	0.0	0.0	0.3	51.5	0.1	0.0	0.3	0.3	0.4	0.6	109.9	0.0	10.5	0.0	0.4	0.3	3.7	1.5	0.2	8.2	0.2	117.8	2.0	37.9	0.0	0.0	0.0	0.0	109.1	7.6	1.3	1.5	48.0	8.8	0.0	74.9	0.3	185.3	0.0	0.0	0.1	0.1	0.0	7.6	0.7	0.2	0.5	0.0	1.0	0.0	2.5	3.5	0.3	0.5	0.7	3.1	0.4	97.3	1.0	0.0	0.7
GIMAP1-GIMAP5		ENSG00000281887	"GIMAP1-GIMAP5 readthrough"		7	150716668-150743646	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"			"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 16.4"	"Cell type enhanced"	"Detected in some"		"Endothelial cells: 1.3;Microglial cells: 1.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"monocytes: 37.9;NK-cells: 69.5;T-cells: 101.0"	"Group enriched"	"Detected in some"	6	"HUVEC TERT2: 5.6;JURKAT: 2.3;MOLT-4: 4.5;THP-1: 1.9;TIME: 2.1"									HPA053441			Supported	"Endoplasmic reticulum"		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 64: Macrophages - Immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 11: Alveolar cells - Smell perception"	"Endoplasmic reticulum"		"HPA053441: AB_2682152"																		7.2	1.4	1.6	5.5	1.6	0.5	5.8	1.6	2.5	3.9	1.9	2.9	3.1	4.0	0.0	1.9	5.1	0.4	5.5	1.4	1.8	3.2	1.4	7.5	5.0	2.4	1.7	1.2	0.7	0.1	1.5	1.1	2.0	2.2	0.0	0.0	1.7	0.2	2.5	2.1	4.2	0.5	2.1	16.4	1.8	0.4	2.1	1.3	4.7	1.8	0.0	3.7	2.9	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.6	2.3	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	1.5	37.9	0.0	67.2	32.4	75.1	0.6	73.4	94.4	15.2	0.7	101.0	85.1	4.4	69.5	28.2	1.1	51.5	76.2	1.6	1.6	1.6	2.5	1.4	1.8	2.4	1.7	2.0	2.1	2.1	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0
GIMAP2	"DKFZp586D0824, HIMAP2, IAN12, IMAP2"	ENSG00000106560	"GTPase, IMAP family member 2"	Q9UG22	7	150685697-150693641	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 78.4"	"Cell type enhanced"	"Detected in many"		"Hepatic stellate cells: 45.0;Kupffer cells: 132.3;monocytes: 74.4;NK-cells: 96.8;T-cells: 57.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 62.7;JURKAT: 34.9;MOLT-4: 79.5;REH: 34.0;U-937: 32.4"					"Not detected"	"Not detected"			"HPA013589, HPA014746"	Approved		Supported	"Nucleoplasm,Lipid droplets"		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Lipid droplets"	Nucleoplasm	"HPA013589: AB_1849666, HPA014746: "	"prognostic favorable (3.50e-4)"	"unprognostic (4.73e-2)"	"unprognostic (2.53e-1)"	"unprognostic (3.56e-3)"	"unprognostic (6.60e-2)"	"unprognostic (6.64e-3)"	"unprognostic (4.60e-2)"	"unprognostic (5.97e-2)"	"unprognostic (3.39e-2)"	"unprognostic (3.91e-1)"	"unprognostic (5.52e-2)"	"unprognostic (8.06e-2)"	"prognostic unfavorable (1.29e-4)"	"unprognostic (2.54e-1)"	"unprognostic (1.88e-2)"	"unprognostic (2.56e-2)"	"unprognostic (3.08e-2)"	11.7	6.9	6.7	40.3	6.6	11.6	11.9	7.1	9.7	10.6	6.5	11.8	12.4	10.7	8.9	4.9	8.3	17.0	8.0	6.3	6.9	6.0	17.0	22.0	78.4	9.2	7.4	16.9	2.1	2.7	2.6	19.6	8.5	5.0	15.7	0.5	6.5	6.2	4.2	5.8	19.4	11.4	8.3	62.1	11.9	1.8	7.4	50.2	6.1	12.3	57.4	15.7	5.2	8.7	1.6	0.0	0.0	0.0	0.6	0.6	0.8	0.0	18.1	2.2	5.1	0.0	23.7	4.2	0.4	1.4	9.8	1.0	0.0	1.0	0.2	19.8	0.0	12.8	0.0	0.5	2.8	9.9	12.6	6.8	1.8	1.7	0.1	5.3	62.7	34.9	0.4	4.9	1.0	0.0	79.5	24.9	0.0	0.0	0.0	34.0	0.6	9.7	0.1	5.9	0.0	0.0	0.1	0.1	6.3	0.0	0.9	25.2	14.2	0.9	0.3	0.2	0.1	5.6	5.5	0.0	2.3	32.4	3.4	15.1	83.8	7.3	93.9	118.3	118.3	15.8	122.0	114.8	47.6	15.8	166.7	124.8	40.7	136.2	121.4	5.7	107.6	130.2	6.7	6.6	7.1	9.7	6.3	6.9	9.2	7.4	8.5	8.3	7.4	8.7	15.5	12.8	2.2	1.0	11.8	3.3	1.9	0.6	1.2	0.1	1.7	1.3	1.1	1.5	1.1	0.0	0.0	0.4	22.8	1.5	0.0	1.6	0.0	3.8	3.8	27.8	0.0	13.5	0.1	0.7	0.7	3.4	1.1	1.1	19.7	1.4	45.0	4.2	38.1	0.0	0.2	4.2	6.1	132.3	11.1	0.1	4.1	38.5	1.8	7.5	74.4	0.9	96.8	2.0	0.3	1.0	2.9	0.7	4.0	2.2	8.4	1.2	4.6	0.1	6.6	1.7	1.1	0.1	0.3	0.5	3.1	0.4	57.7	4.8	3.7	2.5
GIMAP4	"FLJ11110, HIMAP4, IAN1, IMAP4"	ENSG00000133574	"GTPase, IMAP family member 4"	Q9NUV9	7	150567369-150573953	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 127.7"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 182.3;Endothelial cells: 195.2;Hepatic stellate cells: 222.0;Kupffer cells: 197.2;Macrophages: 110.0;monocytes: 176.0;NK-cells: 344.0;T-cells: 186.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in some"	26	"HUVEC TERT2: 326.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA019135, HPA019137, HPA027198"	Enhanced		Approved	Vesicles,Cytosol		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 63: NK-cells & T-cells - Immune response"	"Vesicles, Cytosol"		"HPA019135: AB_1849670, HPA019137: AB_1849672, HPA027198: AB_10602599"	"unprognostic (5.03e-2)"	"unprognostic (3.30e-3)"	"unprognostic (4.08e-2)"	"prognostic favorable (7.63e-4)"	"unprognostic (1.72e-1)"	"unprognostic (1.73e-2)"	"unprognostic (7.00e-2)"	"unprognostic (2.40e-2)"	"unprognostic (1.87e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.21e-1)"	"prognostic unfavorable (1.13e-4)"	"unprognostic (1.65e-1)"	"unprognostic (3.32e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.29e-1)"	46.1	18.3	15.0	75.1	15.6	4.2	31.8	16.2	21.2	19.7	16.3	21.2	16.5	23.0	9.6	12.0	18.7	24.6	31.3	14.3	16.0	17.3	29.9	50.8	127.7	19.2	18.0	7.7	6.7	9.6	6.0	48.7	18.0	10.2	22.4	1.5	11.2	13.3	17.5	8.4	25.0	38.3	18.8	115.6	18.0	4.2	16.4	30.5	21.1	48.1	85.1	31.1	11.6	18.7	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	326.4	3.4	0.1	0.3	0.0	0.0	0.4	0.2	0.4	0.0	0.0	12.7	0.1	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	2.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	8.5	370.2	5.2	325.8	390.9	404.2	3.0	408.0	402.8	122.1	1.3	424.3	361.9	339.7	263.4	320.4	5.3	312.1	776.9	15.0	15.6	16.2	21.2	14.3	16.0	19.2	18.0	18.0	18.8	16.4	18.7	182.3	3.2	12.4	0.3	7.3	6.8	0.2	0.0	3.4	0.1	2.2	4.7	9.9	5.7	1.8	11.0	0.0	0.6	82.6	0.0	0.0	0.2	0.6	0.3	0.4	195.2	0.0	9.7	0.5	0.2	0.8	9.0	2.0	0.3	6.3	0.0	222.0	3.7	96.4	0.0	0.1	0.0	0.0	197.2	20.9	1.7	5.0	110.0	10.6	18.7	176.0	0.2	344.0	0.0	0.1	0.1	0.0	0.0	14.7	0.4	0.0	1.9	0.7	0.4	13.1	3.9	7.9	0.0	0.8	1.1	6.1	0.8	186.2	0.8	0.0	0.3
GIMAP7	"IAN7, MGC27027"	ENSG00000179144	"GTPase, IMAP family member 7"	Q8NHV1	7	150514872-150521073	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 170.1"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 265.8;Endothelial cells: 263.3;Hepatic stellate cells: 267.4;Kupffer cells: 156.8;monocytes: 140.8;NK-cells: 632.4;T-cells: 255.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"monocytes: 666.6;NK-cells: 1121.0;T-cells: 2269.3"	"Group enriched"	"Detected in some"	9	"HUVEC TERT2: 92.9;MOLT-4: 78.6"	"Not detected"	"Not detected"							"HPA020266, HPA020268"	Enhanced		Supported	"Golgi apparatus,Vesicles"		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Golgi apparatus, Vesicles"		"HPA020266: AB_1849680, HPA020268: AB_1849682"	"unprognostic (4.85e-3)"	"unprognostic (1.65e-3)"	"unprognostic (6.11e-2)"	"unprognostic (1.32e-2)"	"unprognostic (3.71e-1)"	"prognostic favorable (7.43e-4)"	"prognostic favorable (8.98e-5)"	"unprognostic (6.49e-3)"	"unprognostic (5.24e-2)"	"unprognostic (6.12e-3)"	"unprognostic (2.36e-2)"	"unprognostic (2.81e-1)"	"unprognostic (2.07e-3)"	"unprognostic (2.07e-1)"	"unprognostic (3.14e-2)"	"unprognostic (2.01e-1)"	"unprognostic (8.86e-2)"	49.8	15.0	16.3	73.6	17.4	6.6	37.4	17.1	21.3	19.2	16.0	20.3	21.1	27.8	19.8	12.6	21.5	22.1	40.1	15.5	17.2	20.9	20.4	61.0	170.1	19.0	17.8	7.4	7.6	10.5	5.6	31.5	19.1	10.9	23.3	1.2	13.7	12.0	27.8	9.3	40.1	33.6	17.6	124.3	22.0	4.5	18.0	52.5	28.2	56.1	99.2	29.6	13.0	17.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	92.9	9.4	0.0	0.0	0.0	0.0	78.6	0.1	0.0	0.0	0.0	0.3	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	35.7	656.5	9.6	1184.0	595.9	1164.2	6.5	1762.9	1440.6	286.3	6.5	2269.3	1597.2	52.5	1121.0	666.6	16.3	1076.9	2581.7	16.3	17.4	17.1	21.3	15.5	17.2	19.0	17.8	19.1	17.6	18.0	17.6	265.8	0.0	13.2	0.3	13.1	2.4	0.4	0.0	2.8	0.0	2.8	5.6	14.6	5.7	0.6	1.8	0.0	0.2	125.1	0.2	0.0	0.5	1.3	0.9	0.6	263.3	0.0	17.0	0.0	0.7	0.0	8.0	3.1	0.7	13.9	0.0	267.4	5.3	15.5	0.0	0.0	0.1	0.0	156.8	10.6	2.0	2.5	54.9	1.8	22.5	140.8	0.4	632.4	0.5	0.1	0.4	1.2	0.4	19.3	0.2	0.0	1.7	0.7	0.4	0.0	6.0	9.4	0.2	0.9	1.1	3.3	0.4	255.9	0.9	0.2	0.0
GINS4	"MGC14799, SLD5"	ENSG00000147536	"GINS complex subunit 4"	Q9BRT9	8	41529218-41545030	"Predicted intracellular proteins"	"DNA replication"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 6.2"	"Cell type enhanced"	"Detected in many"		"Granulosa cells: 17.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024663, HPA026580"	Uncertain		Supported	Nucleoplasm,Centrosome		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	Centrosome	"HPA024663: AB_1857224, HPA026580: AB_1857225"	"unprognostic (7.74e-2)"	"unprognostic (3.72e-2)"	"unprognostic (2.25e-3)"	"prognostic unfavorable (2.30e-5)"	"unprognostic (1.70e-1)"	"unprognostic (4.01e-2)"	"unprognostic (1.71e-3)"	"unprognostic (8.01e-3)"	"unprognostic (4.03e-3)"	"unprognostic (1.50e-2)"	"unprognostic (4.34e-4)"	"unprognostic (1.79e-1)"	"unprognostic (3.67e-5)"	"unprognostic (2.40e-3)"	"unprognostic (1.39e-1)"	"unprognostic (4.11e-1)"	"unprognostic (3.22e-1)"	0.8	0.8	0.9	4.0	1.2	5.9	1.8	1.5	1.1	0.9	0.9	2.1	1.6	1.4	0.7	1.7	0.8	1.5	0.7	0.9	0.9	0.6	1.4	0.7	5.1	1.4	1.0	1.1	0.9	0.6	0.2	2.6	1.2	0.7	3.0	0.8	0.8	0.5	0.5	2.1	1.7	1.5	0.5	1.7	1.3	2.9	1.0	6.2	1.3	0.1	6.0	1.2	0.8	2.3	20.3	28.3	39.4	17.9	2.4	3.1	16.4	28.1	16.9	28.8	33.6	26.4	17.3	28.1	11.2	14.3	21.6	15.0	32.1	23.4	41.9	10.4	17.8	40.8	20.6	17.9	0.6	8.9	20.2	1.7	1.1	47.2	10.4	6.6	14.4	33.0	20.3	9.0	20.4	13.8	37.6	10.1	22.0	21.5	15.4	34.4	36.8	11.8	10.3	19.1	12.2	9.5	20.3	8.8	8.1	19.9	22.8	9.9	10.0	19.3	28.9	36.1	28.8	10.6	16.4	33.0	13.8	20.9	48.3	1.5	0.7	0.3	1.5	0.7	0.9	1.2	2.5	1.0	0.3	2.8	1.5	1.0	1.9	1.4	0.3	2.9	3.7	1.0	0.9	1.2	1.5	1.1	0.9	0.9	1.4	1.0	1.2	0.5	1.0	2.3	1.3	0.0	1.1	0.7	6.4	2.8	2.8	2.3	1.2	4.0	2.1	4.3	0.8	0.0	1.3	9.2	2.1	9.1	5.6	3.7	0.0	1.8	0.9	2.0	2.3	1.9	3.5	9.9	0.2	1.8	12.4	3.5	4.1	3.7	1.3	17.5	1.1	0.5	4.8	0.0	0.7	4.0	4.1	1.8	9.4	0.6	1.2	5.7	0.0	0.0	9.6	1.7	3.1	0.0	2.5	2.1	0.3	2.2	9.2	1.2	0.5	0.9	0.3	2.5	0.0	3.6	5.9	9.6	11.8	2.5	1.1	5.9	6.9	9.0	6.0	1.6
GIPC2	"FLJ20075, SEMCAP-2"	ENSG00000137960	"GIPC PDZ domain containing family member 2"	Q8TF65	1	77979542-78138444	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 38.0;kidney: 41.4;lymphoid tissue: 27.9"	"Cell type enhanced"	"Detected in many"		"Proximal enterocytes: 122.1;Proximal tubular cells: 267.7;Undifferentiated cells: 63.8"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC TERT1: 6.1;HaCaT: 6.0;Hep G2: 23.0;HUVEC TERT2: 23.5"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA051212, HPA062684"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA				"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Nucleoplasm	Cytosol	"HPA051212: , HPA062684: AB_2684833"	"unprognostic (1.72e-2)"	"unprognostic (9.37e-2)"	"prognostic favorable (5.49e-4)"	"unprognostic (1.09e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.29e-2)"	"unprognostic (2.01e-1)"	"unprognostic (2.35e-1)"	"unprognostic (7.63e-2)"	"unprognostic (2.22e-1)"	"unprognostic (5.91e-2)"	"unprognostic (1.44e-1)"	"prognostic favorable (2.11e-6)"	"unprognostic (6.55e-2)"	"unprognostic (1.78e-1)"	"unprognostic (4.18e-2)"	"unprognostic (1.29e-1)"	3.9	23.8	0.5	1.7	0.4	0.3	3.0	0.4	0.5	1.8	0.5	15.6	38.0	2.1	0.9	2.1	3.1	5.5	1.5	0.5	0.4	41.4	18.4	2.7	0.8	0.4	0.4	2.4	18.1	2.3	0.9	3.5	0.4	1.7	14.9	0.1	4.2	0.9	1.1	4.7	38.0	2.8	0.4	27.9	6.0	1.0	0.5	0.4	1.0	1.6	0.8	2.0	1.9	0.4	0.0	0.0	0.0	0.1	2.4	6.1	0.0	1.0	0.0	0.5	1.1	5.1	3.3	1.5	0.1	0.5	0.0	6.0	0.0	0.0	3.2	0.2	0.0	0.8	0.0	23.0	1.2	0.0	0.0	1.0	0.1	3.5	0.1	0.0	23.5	0.0	0.0	0.1	2.9	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.1	0.0	0.5	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.4	0.4	0.5	0.5	0.4	0.4	0.4	0.4	0.4	0.5	0.4	33.6	0.0	1.3	2.0	2.0	12.9	2.4	0.9	4.0	0.4	5.2	1.5	3.2	27.1	2.5	9.2	2.1	6.7	0.0	43.7	33.2	11.8	2.5	13.3	0.9	21.6	3.0	0.4	14.7	33.0	3.1	2.9	8.6	7.2	0.0	5.9	22.9	43.3	13.2	0.0	15.2	34.4	0.0	0.8	1.9	1.2	1.2	2.1	0.0	14.0	1.0	0.0	0.0	4.5	8.9	16.5	39.3	0.0	0.0	0.8	122.1	267.7	11.7	0.5	0.0	1.3	1.3	0.6	2.5	7.9	21.7	1.6	1.3	32.4	63.8	6.0
GIT1		ENSG00000108262	"GIT ArfGAP 1"	Q9Y2X7	17	29573475-29594054	"Plasma proteins, Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 122.3"	"Cell type enhanced"	"Detected in all"		"Early spermatids: 97.8;Late spermatids: 99.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004059, HPA004186"	Enhanced		Supported	"Focal adhesion sites,Mitochondria,Cytosol"		NA	NA		36000	"Cluster 15: NK-cells - Transcription"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 34: Spermatids - Unknown function"	"Focal adhesion sites, Cytosol"	Mitochondria	"HPA004059: AB_1078966, HPA004186: AB_1078967"	"unprognostic (3.66e-1)"	"unprognostic (4.46e-2)"	"unprognostic (3.24e-2)"	"unprognostic (6.30e-3)"	"unprognostic (1.46e-1)"	"unprognostic (1.08e-1)"	"prognostic unfavorable (2.54e-6)"	"unprognostic (3.00e-3)"	"unprognostic (2.79e-1)"	"unprognostic (5.23e-2)"	"unprognostic (2.12e-2)"	"unprognostic (3.08e-1)"	"unprognostic (8.48e-2)"	"unprognostic (5.56e-2)"	"unprognostic (7.30e-2)"	"unprognostic (2.10e-1)"	"unprognostic (1.69e-1)"	30.2	13.5	79.4	18.0	89.3	14.4	29.9	29.1	122.3	22.0	14.9	20.5	17.9	20.9	7.6	28.6	22.5	15.5	28.9	101.2	38.0	18.4	7.6	34.8	21.3	42.5	45.3	21.3	21.9	18.0	23.7	21.1	39.7	21.3	10.1	12.1	19.0	14.4	31.9	34.2	20.5	12.9	31.7	22.3	19.1	88.8	51.8	23.1	23.2	18.5	15.2	21.6	23.6	62.1	49.7	80.9	39.1	69.9	30.4	19.1	45.3	23.9	23.4	28.2	25.1	33.1	18.0	37.3	37.3	31.5	50.5	79.5	41.6	61.4	14.4	48.3	49.7	26.9	39.8	29.8	37.0	34.4	21.3	23.4	69.2	32.4	50.5	40.0	53.0	48.6	22.3	31.2	20.5	50.9	109.0	45.7	29.2	49.9	19.2	81.7	52.3	55.6	25.8	26.7	82.0	70.0	33.8	77.2	117.7	27.9	38.0	45.0	66.2	26.7	38.2	59.3	49.0	25.8	39.3	41.5	43.9	29.0	45.9	0.1	1.6	1.4	1.9	2.5	0.9	0.7	1.9	2.1	2.2	0.6	1.6	1.1	0.5	2.4	1.8	1.8	1.3	1.8	79.4	89.3	29.1	122.3	101.2	38.0	42.5	45.3	39.7	31.7	51.8	62.1	54.6	3.2	1.5	21.9	9.5	27.1	6.7	9.2	10.2	15.5	12.6	16.3	8.7	4.3	4.9	5.5	10.4	5.1	17.3	19.2	1.9	7.5	97.8	9.4	16.8	30.8	14.9	1.7	16.8	9.4	8.0	9.7	11.2	10.5	1.3	17.9	22.5	4.0	8.3	11.8	14.1	13.8	8.2	9.5	18.9	99.2	14.3	10.6	8.8	15.9	7.4	13.3	9.2	12.5	16.9	9.5	11.5	10.5	8.7	13.4	17.2	6.1	9.8	10.2	13.1	17.3	9.5	30.5	11.5	14.4	28.1	3.6	12.4	8.6	14.6	8.3
GJA1	"CX43, GJAL, ODD, ODDD, ODOD, SDTY3"	ENSG00000152661	"Gap junction protein alpha 1"	P17302	6	121435595-121449727	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted membrane proteins"			"Cancer-related genes, Cataract, Disease variant, Hypotrichosis, Palmoplantar keratoderma"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 250.0;Astrocytes: 276.2;Basal keratinocytes: 234.9;Cardiomyocytes: 199.7;Endometrial stromal cells: 215.5;Granulosa cells: 494.3;Suprabasal keratinocytes: 378.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 462.7;HUVEC TERT2: 362.3;NTERA-2: 365.8;SuSa: 453.4;U-87 MG: 350.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB010753, HPA035097, HPA047551, HPA069245"	Enhanced	Supported	Supported	"Nucleoplasm,Vesicles,Cell Junctions"		NA	NA				"Cluster 27: Brain & Skin - Unknown function"	"Cluster 12: NES - Nervous system development"	"Cluster 40: Granulosa cells - Unknown function"	"Vesicles, Cell Junctions"	Nucleoplasm	"CAB010753: AB_476857, HPA035097: AB_2674460, HPA047551: AB_2732540, HPA069245: "	"unprognostic (3.37e-2)"	"unprognostic (3.41e-3)"	"unprognostic (2.95e-1)"	"unprognostic (4.18e-2)"	"unprognostic (1.48e-2)"	"unprognostic (1.67e-2)"	"unprognostic (1.27e-1)"	"unprognostic (6.78e-2)"	"unprognostic (2.89e-2)"	"unprognostic (1.56e-1)"	"unprognostic (5.47e-2)"	"unprognostic (1.00e-1)"	"unprognostic (4.88e-2)"	"prognostic unfavorable (4.99e-5)"	"unprognostic (2.39e-1)"	"unprognostic (1.29e-1)"	"unprognostic (3.00e-3)"	121.2	287.6	313.5	24.7	310.2	0.9	60.6	260.1	409.0	261.7	193.1	17.5	18.2	98.7	10.6	74.9	32.7	99.9	168.9	273.6	362.6	21.2	10.6	67.9	21.1	340.3	380.9	43.5	19.4	236.2	31.3	290.2	307.4	83.3	19.7	3.3	35.6	148.0	10.3	388.2	24.7	112.5	335.9	4.2	30.7	36.9	373.3	24.3	169.1	22.1	34.9	116.0	184.9	341.0	0.1	43.5	186.8	0.4	99.7	61.5	0.4	142.5	286.9	46.9	113.7	0.7	0.4	0.0	15.8	55.8	40.2	18.3	5.1	87.4	151.3	0.1	51.6	2.3	15.7	0.0	124.1	0.0	0.4	164.6	92.1	172.5	61.7	462.7	362.3	0.0	0.1	4.3	9.4	8.4	0.1	80.6	365.8	0.1	47.2	0.1	0.0	3.7	188.6	21.0	0.4	2.9	0.0	0.3	0.1	453.4	14.9	0.3	269.5	143.8	39.4	122.8	93.5	0.1	0.1	0.1	350.4	0.1	20.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	313.5	310.2	260.1	409.0	273.6	362.6	340.3	380.9	307.4	335.9	373.3	341.0	152.2	250.0	80.0	276.2	0.1	234.9	133.6	71.1	77.4	0.3	9.5	20.1	199.7	0.0	17.5	1.8	2.1	53.4	0.4	0.0	0.0	76.9	0.5	21.5	215.5	166.6	0.0	0.0	0.3	4.2	7.9	124.4	0.5	51.7	8.8	494.3	33.9	0.1	8.6	0.0	0.6	0.0	4.1	0.9	55.3	1.7	2.5	3.6	44.4	15.0	0.6	0.3	0.0	4.0	1.0	10.8	0.0	4.1	0.1	29.7	0.0	0.1	6.2	0.3	0.0	5.9	80.2	0.9	1.8	68.3	378.2	20.0	4.9	127.1	0.4	52.7
GJB3	"CX31, DFNA2, EKV"	ENSG00000188910	"Gap junction protein beta 3"	O75712	1	34781214-34786369	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"			"Deafness, Disease variant, Non-syndromic deafness, Palmoplantar keratoderma"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"esophagus: 77.8;skin 1: 145.0"	"Group enriched"	"Detected in many"	5	"Basal keratinocytes: 138.4;Basal prostatic cells: 71.9;Basal respiratory cells: 43.6;Pancreatic endocrine cells: 119.8;Prostatic glandular cells: 63.4;Squamous epithelial cells: 91.9;Suprabasal keratinocytes: 170.6;Urothelial cells: 171.0"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 58.5"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 88.8;CAPAN-2: 121.7;HaCaT: 99.4;HBEC3-KT: 84.9;hTCEpi: 136.8;OE19: 54.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA074472			Supported	"Vesicles,Cell Junctions"		NA	NA				"Cluster 31: Skin - Epidermis development"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 22: Epithelial cell types - Mixed function"	"Vesicles, Cell Junctions"		"HPA074472: AB_2686694"	"unprognostic (1.34e-3)"	"unprognostic (2.30e-1)"	"unprognostic (2.84e-2)"	"unprognostic (5.22e-3)"	"unprognostic (3.82e-2)"	"unprognostic (2.00e-2)"	"unprognostic (1.21e-4)"	"prognostic unfavorable (4.56e-4)"	"unprognostic (2.30e-1)"	"unprognostic (1.29e-1)"	"prognostic unfavorable (7.56e-5)"	"unprognostic (4.50e-2)"	"unprognostic (5.74e-3)"	"unprognostic (1.35e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.27e-2)"	"unprognostic (2.46e-2)"	0.3	0.2	1.3	1.7	0.6	0.0	5.5	1.1	1.0	8.9	0.0	4.2	0.2	0.3	2.8	77.8	1.1	7.0	0.1	0.6	0.0	0.5	1.5	0.6	0.5	0.2	0.0	0.1	0.3	0.0	0.1	1.4	0.1	4.0	5.0	0.0	8.9	1.7	0.6	145.0	1.3	0.1	0.0	0.0	5.9	0.8	0.1	0.8	0.2	0.0	12.9	11.9	26.4	0.2	88.8	2.6	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	121.7	0.0	11.6	0.1	0.1	99.4	0.0	84.9	0.0	0.1	0.0	0.3	5.0	0.0	0.0	0.0	0.0	0.0	136.8	0.0	35.0	0.0	0.0	0.0	0.0	0.1	0.0	4.8	0.0	0.0	0.4	54.2	22.3	0.0	0.0	0.0	40.8	33.0	0.0	0.0	13.1	0.9	0.0	0.1	1.0	0.1	0.0	0.1	5.7	0.0	0.4	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.6	1.1	1.0	0.6	0.0	0.2	0.0	0.1	0.0	0.1	0.2	0.0	3.2	0.0	0.0	0.0	138.4	71.9	43.6	16.5	0.0	2.0	1.3	0.4	1.5	15.5	5.5	0.0	0.3	0.0	18.3	0.0	14.6	0.0	4.1	0.4	1.7	1.8	0.0	0.2	7.3	0.2	1.7	3.1	8.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.8	6.1	0.0	12.5	0.0	0.0	0.4	14.2	0.0	0.0	0.0	0.0	0.0	0.0	119.8	8.1	0.0	0.0	63.4	0.5	0.0	10.1	0.0	0.0	0.0	2.1	0.1	0.3	91.9	170.6	0.1	0.5	0.0	19.1	171.0
GJB4	CX30.3	ENSG00000189433	"Gap junction protein beta 4"	Q9NTQ9	1	34759740-34762327	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"			"Disease variant, Palmoplantar keratoderma"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"skin 1: 43.1"	"Group enriched"	"Detected in some"	4	"Basal prostatic cells: 31.1;Pancreatic endocrine cells: 37.0;Urothelial cells: 102.6"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 9.0;HaCaT: 12.2;HBEC3-KT: 8.3;hTCEpi: 5.7;OE19: 4.5;RPTEC TERT1: 4.8;RT4: 5.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA055112, HPA073904"	Enhanced		Supported	"Cell Junctions"		NA	NA				"Cluster 61: Skin - Cornification"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 22: Epithelial cell types - Mixed function"	"Cell Junctions"		"HPA055112: AB_2682699, HPA073904: "	"unprognostic (3.30e-2)"	"prognostic favorable (5.48e-4)"	"unprognostic (1.57e-1)"	"unprognostic (2.70e-2)"	"unprognostic (4.21e-2)"	"unprognostic (2.22e-1)"	"unprognostic (2.16e-2)"	"unprognostic (2.18e-2)"	"unprognostic (5.40e-2)"	"unprognostic (3.65e-1)"	"prognostic unfavorable (3.24e-5)"	"unprognostic (3.73e-2)"	"unprognostic (5.81e-3)"	"unprognostic (1.26e-1)"	"unprognostic (1.67e-1)"	"unprognostic (3.52e-4)"	"unprognostic (5.42e-2)"	0.0	0.0	0.0	0.3	0.1	0.0	2.6	0.0	0.2	0.7	0.0	0.2	0.0	0.0	5.5	2.3	0.2	4.8	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.8	0.3	0.0	0.5	1.0	0.2	43.1	0.1	0.0	0.0	0.0	0.4	0.2	0.0	0.4	0.1	0.0	2.3	7.9	1.4	0.0	9.0	0.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.6	0.0	1.3	0.0	0.1	12.2	0.0	8.3	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	4.8	5.9	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.8	31.1	13.9	1.2	0.0	0.3	0.1	0.1	0.0	5.7	0.0	0.0	0.1	0.1	0.3	0.0	3.7	0.0	0.3	0.0	0.2	1.8	0.0	0.0	0.6	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.3	1.8	0.0	0.0	0.0	0.0	0.0	0.0	37.0	1.3	0.0	0.0	12.9	0.1	0.0	6.8	0.0	0.0	0.0	0.7	0.0	0.0	3.5	6.0	0.3	0.1	0.0	0.4	102.6
GJB6	"CX30, DFNA3, ED2, EDH, HED"	ENSG00000121742	"Gap junction protein beta 6"	O95452	13	20221962-20232365	"Disease related genes, Human disease related genes, Predicted membrane proteins"	Hearing		"Deafness, Disease variant, Ectodermal dysplasia, Non-syndromic deafness, Palmoplantar keratoderma"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 95.6;esophagus: 195.4;vagina: 139.3"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 58.8;Basal keratinocytes: 12.2;Basal respiratory cells: 15.6;Ionocytes: 12.2;Squamous epithelial cells: 31.0"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 145.0"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"T-reg: 2.6"	"Lineage enriched"	"Detected in single"	5	"T-cells: 2.6"	"Cell line enriched"	"Detected in some"	10	"RT4: 186.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014846			Supported	"Cell Junctions"		NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 15: RT4 - Unknown function"	"Cluster 61: Squamous epithelial cells - Keratinization"	"Cell Junctions"		"HPA014846: AB_1847135"	"unprognostic (5.57e-2)"	"unprognostic (1.20e-1)"	"unprognostic (3.90e-4)"	"unprognostic (7.90e-2)"	"unprognostic (2.37e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.83e-1)"	"unprognostic (8.96e-2)"	"unprognostic (9.64e-2)"	"unprognostic (2.82e-2)"	"unprognostic (2.82e-2)"	"unprognostic (3.54e-2)"	"unprognostic (1.14e-11)"	"unprognostic (8.99e-2)"	"unprognostic (1.16e-1)"	"unprognostic (6.35e-3)"	"unprognostic (5.04e-2)"	0.5	0.2	55.8	0.3	59.4	95.6	3.8	73.0	80.9	65.9	36.0	0.0	0.0	0.9	0.2	195.4	0.4	1.3	0.1	50.2	63.5	0.0	0.1	0.3	0.8	60.0	71.8	0.0	0.1	0.0	4.4	0.0	57.5	0.2	0.1	0.0	34.5	0.0	0.1	56.8	0.2	0.0	47.7	0.2	0.3	1.4	76.3	37.6	5.3	0.0	15.4	10.3	139.3	42.7	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	12.1	0.0	0.0	0.0	0.0	4.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	3.0	0.0	0.0	0.0	0.0	0.0	186.3	0.0	0.0	0.0	0.0	0.0	0.6	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.5	1.1	0.6	0.5	0.0	0.0	0.0	2.6	0.2	55.8	59.4	73.0	80.9	50.2	63.5	60.0	71.8	57.5	47.7	76.3	42.7	0.0	0.0	0.0	58.8	0.0	12.2	1.7	15.6	4.0	0.0	0.0	0.1	0.6	0.0	4.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	6.9	5.8	0.4	0.1	0.0	0.0	0.1	0.0	0.1	0.1	0.0	6.6	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	12.2	0.0	0.4	4.6	0.0	0.2	0.0	1.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.6	0.0	0.1	0.2	0.0	0.0	0.0	0.4	0.1	0.3	31.0	3.8	0.0	0.3	0.0	0.0	2.4
GJC2	"CX46.6, CX47, GJA12, SPG44"	ENSG00000198835	"Gap junction protein gamma 2"	Q5T442	1	228149930-228159826	"Disease related genes, Human disease related genes, Predicted membrane proteins"			"Disease variant, Hereditary spastic paraplegia, Leukodystrophy, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"brain: 51.3"	"Group enriched"	"Detected in many"	4	"Cone photoreceptor cells: 12.5;Oligodendrocytes: 26.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 5.4;SCLC-21H: 2.9;TIME: 2.7"	"Region enhanced"	"Detected in all"		"white matter: 105.5"	"Low region specificity"	"Detected in all"			HPA069619			Supported	"Plasma membrane,Cytosol"		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Plasma membrane, Cytosol"		"HPA069619: "	"unprognostic (2.67e-1)"	"unprognostic (1.81e-2)"	"unprognostic (6.42e-2)"	"unprognostic (8.19e-3)"	"unprognostic (4.24e-1)"	"unprognostic (1.57e-1)"	"unprognostic (6.94e-2)"	"unprognostic (2.56e-1)"	"unprognostic (4.99e-2)"	"unprognostic (7.09e-2)"	"unprognostic (7.88e-3)"	"unprognostic (9.67e-2)"	"unprognostic (6.09e-3)"	"unprognostic (2.53e-2)"	"unprognostic (7.36e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.02e-1)"	2.9	0.9	13.6	0.6	31.2	0.2	1.7	39.0	20.2	4.2	5.2	5.8	0.2	4.7	0.9	1.4	5.4	0.7	1.7	13.9	19.5	1.3	0.5	2.9	0.6	43.9	31.6	3.8	0.5	0.7	1.4	0.5	38.1	3.0	0.3	0.5	0.8	1.7	0.8	1.7	1.7	1.8	28.1	1.4	2.4	1.2	27.6	0.4	2.0	0.8	0.3	4.2	3.5	51.3	0.2	0.2	0.1	0.3	0.8	0.4	1.0	0.8	0.2	0.3	0.4	0.5	0.7	0.1	5.4	1.5	0.4	0.5	0.2	0.2	0.1	0.2	0.9	0.2	1.4	1.2	1.4	0.0	0.0	0.2	0.1	0.5	0.3	0.7	0.1	1.0	0.6	0.1	0.2	0.3	1.1	0.3	0.3	0.0	1.1	0.2	0.1	0.0	0.4	0.0	2.9	1.7	0.2	0.0	0.2	0.1	0.1	0.2	2.7	0.7	2.1	2.5	0.9	0.1	0.4	0.1	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	13.6	31.2	39.0	20.2	13.9	19.5	43.9	31.6	38.1	28.1	27.6	51.3	2.8	0.0	0.6	0.7	0.2	3.4	1.3	0.6	1.8	2.6	1.3	0.6	1.8	0.0	0.0	0.0	12.5	0.0	0.4	0.2	0.0	0.1	0.2	1.0	1.1	4.3	0.0	0.0	0.8	0.5	0.0	2.2	0.0	1.6	0.0	0.3	3.6	0.0	0.1	3.3	1.1	0.3	0.0	0.6	3.8	0.0	2.5	1.3	1.8	0.0	0.0	0.3	0.0	0.0	26.9	1.1	0.0	4.1	0.0	0.6	0.0	0.0	0.0	1.0	0.0	0.6	1.8	0.0	0.0	0.5	1.7	0.0	0.8	0.6	0.3	1.0
GLB1	"EBP, ELNR1"	ENSG00000170266	"Galactosidase beta 1"	P16278	3	32996609-33097202	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Glycosidase, Hydrolase"	"Disease variant, Gangliosidosis, Mucopolysaccharidosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"BEWO: 857.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB008382, HPA040610, HPA069503"	Enhanced		Supported	"Golgi apparatus,Vesicles"	"Intracellular and membrane"	NA	NA		2700000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 4: Macrophages - Innate immune response"	Vesicles	"Golgi apparatus"	"CAB008382: AB_590642, HPA040610: AB_2677039, HPA069503: AB_2686142"	"unprognostic (1.51e-2)"	"unprognostic (3.66e-2)"	"unprognostic (5.02e-3)"	"unprognostic (9.66e-3)"	"unprognostic (9.61e-3)"	"unprognostic (1.04e-1)"	"unprognostic (2.31e-3)"	"unprognostic (1.32e-1)"	"unprognostic (2.08e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.06e-1)"	"unprognostic (2.08e-1)"	"prognostic favorable (1.14e-5)"	"unprognostic (3.05e-1)"	"unprognostic (2.33e-1)"	"unprognostic (2.20e-1)"	"unprognostic (5.85e-2)"	22.0	36.1	12.1	27.8	13.0	21.9	20.5	12.5	14.8	33.4	16.0	43.5	43.0	21.9	103.6	15.4	28.2	32.0	15.5	12.5	14.8	46.0	48.2	42.7	25.8	14.3	12.9	21.4	30.8	59.4	18.5	53.8	15.4	23.2	45.6	14.9	25.3	29.3	7.7	15.8	31.0	30.6	12.4	24.4	35.5	13.5	13.5	17.5	52.8	10.8	23.0	31.8	16.2	15.1	37.4	63.6	39.8	48.3	241.9	123.7	857.2	59.1	157.6	73.7	95.1	91.3	86.5	17.9	50.9	120.9	53.9	35.1	38.1	75.5	53.7	104.9	33.0	69.9	35.3	47.4	124.3	50.5	69.9	144.9	70.2	67.0	39.2	144.1	116.5	24.7	64.3	67.0	81.8	44.6	29.6	31.6	26.4	78.0	27.0	24.7	26.4	86.6	78.4	54.4	12.0	40.3	75.0	120.2	74.4	69.3	80.3	130.2	67.7	46.8	32.2	65.2	50.1	53.2	87.9	5.9	99.6	71.2	36.7	43.9	146.2	86.4	29.2	125.8	40.4	37.9	34.3	31.8	166.5	35.6	17.9	21.8	56.6	26.0	92.1	35.1	77.1	91.9	12.1	13.0	12.5	14.8	12.5	14.8	14.3	12.9	15.4	12.4	13.5	15.1	8.7	19.2	25.3	39.2	18.6	6.0	13.6	60.1	10.8	11.3	11.5	7.5	9.1	34.3	43.3	27.6	6.2	100.1	14.1	41.9	27.4	53.5	24.8	18.7	16.0	17.4	16.9	20.6	46.7	35.4	55.3	29.2	26.0	27.1	26.6	20.6	19.6	39.7	79.5	5.0	46.0	23.5	40.7	43.9	13.9	5.0	15.2	41.7	14.2	23.4	64.6	16.5	10.3	27.2	24.2	28.1	43.4	21.1	19.8	9.9	36.2	33.1	31.0	16.2	13.1	12.9	16.3	1.0	6.6	10.1	3.4	49.1	18.7	51.0	32.0	12.1
GLDC	"GCSP, NKH"	ENSG00000178445	"Glycine decarboxylase"	P23378	9	6532467-6645729	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"liver: 173.5"	"Cell type enhanced"	"Detected in many"		"Collecting duct cells: 31.3;Cytotrophoblasts: 79.0;Extravillous trophoblasts: 41.6;Hepatocytes: 120.5;Oligodendrocyte precursor cells: 52.3;Proximal tubular cells: 31.6;Syncytiotrophoblasts: 46.0"	"Cancer enhanced"	"Detected in many"		"testis cancer: 41.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BEWO: 235.7;CACO-2: 58.2;HMC-1: 45.6;RPTEC TERT1: 95.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002318, HPA052887"	Enhanced		Supported	Nucleoplasm,Mitochondria		NA	NA		740000	"Cluster 37: B-cells - Transcription"	"Cluster 15: Liver - Metabolism"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 47: Cytotrophoblasts - Unknown function"	Mitochondria	Nucleoplasm	"HPA002318: AB_1849700, HPA052887: AB_2681980"	"unprognostic (6.73e-2)"	"unprognostic (1.19e-1)"	"unprognostic (6.50e-2)"	"prognostic unfavorable (5.24e-5)"	"unprognostic (1.50e-1)"	"unprognostic (7.87e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.40e-1)"	"unprognostic (1.74e-1)"	"unprognostic (2.47e-2)"	"unprognostic (2.69e-1)"	"prognostic favorable (3.50e-4)"	"unprognostic (1.65e-2)"	"unprognostic (1.27e-1)"	"unprognostic (5.62e-3)"	"unprognostic (1.17e-2)"	0.3	0.3	15.3	1.4	15.5	0.5	0.8	14.7	23.7	0.4	12.9	1.0	0.8	0.4	5.2	3.2	0.7	0.8	0.1	14.8	14.4	38.2	173.5	1.0	1.6	14.0	13.6	0.3	0.1	0.0	4.9	15.2	13.4	0.5	0.4	1.6	1.1	1.0	1.3	4.5	0.8	0.0	13.1	1.2	1.0	3.5	15.8	0.0	5.1	0.1	1.2	1.1	0.1	15.3	0.6	4.9	2.1	25.6	0.2	0.4	235.7	0.1	0.0	0.0	0.1	58.2	0.5	0.3	5.6	0.1	0.7	0.4	0.0	0.7	0.2	1.2	13.4	0.2	0.3	38.3	0.0	0.1	45.6	0.0	0.1	1.8	0.3	1.0	9.0	4.3	0.0	0.5	1.2	1.5	0.9	0.2	27.5	4.6	3.8	1.3	0.0	0.5	95.4	1.0	22.6	11.7	0.0	21.4	0.3	13.9	5.3	0.1	3.0	0.6	0.6	2.6	1.3	1.1	34.4	0.1	0.8	2.4	5.1	0.4	0.1	0.1	0.1	0.0	0.1	0.8	0.1	0.0	0.0	0.1	0.0	0.1	0.4	0.1	0.1	0.1	0.0	0.3	15.3	15.5	14.7	23.7	14.8	14.4	14.0	13.6	13.4	13.1	15.8	15.3	0.2	0.0	0.0	17.6	1.9	0.0	0.0	0.2	1.2	0.4	1.5	0.6	0.7	11.5	0.1	31.3	0.0	79.0	0.2	0.0	5.9	0.0	12.6	5.4	0.5	0.6	0.0	0.0	21.6	0.2	41.6	0.3	0.0	10.7	0.0	1.1	2.2	120.5	7.0	0.0	15.9	0.0	0.0	2.8	0.3	10.8	0.3	0.4	0.0	1.9	0.0	9.6	0.0	52.3	1.8	0.1	0.0	0.0	15.1	0.0	0.0	31.6	0.0	0.4	0.0	1.7	0.8	4.5	5.1	0.4	0.0	46.0	0.8	0.0	0.0	0.1
GLDN	"CLOM, COLM, colmedin, CRG-L2, UNC-122"	ENSG00000186417	Gliomedin	Q6ZMI3	15	51341655-51408005	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins"	"Differentiation, Neurogenesis"	"Developmental protein"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 84.8"	"Cell type enriched"	"Detected in many"	5	"Oligodendrocytes: 510.8"	"Cancer enhanced"	"Detected in many"		"glioma: 4.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HHSteC: 2.7;MCF7: 1.3;SuSa: 1.8;U-266/70: 3.3;U-266/84: 2.9"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA050873, HPA059441"	Uncertain		Supported	"Vesicles,Plasma membrane"	"Secreted to extracellular matrix"	NA	NA		410000		"Cluster 70: Brain - Nervous system development"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Vesicles, Plasma membrane"		"HPA050873: , HPA059441: AB_2684018"	"unprognostic (5.04e-2)"	"unprognostic (2.57e-2)"	"unprognostic (5.15e-5)"	"unprognostic (3.21e-3)"	"unprognostic (2.82e-2)"	"unprognostic (2.33e-1)"	"unprognostic (2.07e-4)"	"unprognostic (2.02e-1)"	"unprognostic (1.22e-1)"	"unprognostic (3.30e-2)"	"unprognostic (3.15e-1)"	"unprognostic (2.14e-2)"	"unprognostic (9.89e-2)"	"unprognostic (1.60e-2)"	"unprognostic (2.20e-1)"	"unprognostic (3.80e-3)"	"unprognostic (1.37e-1)"	18.5	2.3	18.1	1.6	51.1	0.7	9.7	35.0	28.6	1.8	0.0	3.5	0.2	0.5	0.5	0.5	1.2	3.4	5.0	15.5	31.2	0.4	0.1	8.7	0.2	47.6	48.9	0.5	0.5	0.4	0.6	3.9	56.4	2.4	6.4	1.3	1.4	0.7	1.0	5.0	0.6	0.6	26.0	2.9	2.1	0.2	41.7	0.1	0.8	0.9	0.2	1.5	1.5	84.8	0.1	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.7	0.0	0.0	0.0	0.3	0.0	0.5	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	2.7	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.3	0.1	0.0	0.1	0.5	0.8	0.0	0.0	0.0	0.0	1.1	0.2	0.0	0.0	1.0	0.0	1.8	0.0	0.5	0.0	0.0	0.0	0.1	0.0	3.3	2.9	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	18.1	51.1	35.0	28.6	15.5	31.2	47.6	48.9	56.4	26.0	41.7	84.8	40.1	0.0	2.6	2.0	0.0	6.2	0.0	0.3	0.0	9.2	0.2	0.3	8.4	0.0	0.1	0.0	0.0	5.2	0.0	47.0	0.0	0.0	0.0	0.0	0.1	3.7	1.2	0.0	7.4	0.0	0.6	7.9	4.6	0.2	0.0	4.5	0.0	0.2	4.9	0.0	17.2	1.7	0.0	14.9	9.5	0.0	0.3	16.1	3.6	42.2	0.0	0.3	0.0	2.0	510.8	0.1	28.6	0.0	0.0	0.1	0.0	0.1	0.9	0.8	0.0	4.7	9.8	0.1	0.1	0.0	4.0	100.4	0.6	0.4	5.1	1.6
GLE1	"GLE1L, hGLE1, LCCS1"	ENSG00000119392	"GLE1 RNA export mediator"	Q53GS7	9	128504719-128542288	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"mRNA transport, Protein transport, Translocation, Transport"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 77.0;Late spermatids: 58.1;Spermatocytes: 51.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041689, HPA043538, HPA061560"	Supported		Supported	"Nuclear membrane,Nucleoli"		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Nuclear membrane"	Nucleoli	"HPA041689: AB_2677617, HPA043538: AB_2678539, HPA061560: AB_2684560"	"unprognostic (8.74e-3)"	"unprognostic (2.18e-2)"	"unprognostic (1.17e-1)"	"prognostic favorable (7.49e-4)"	"unprognostic (1.75e-1)"	"unprognostic (5.58e-2)"	"unprognostic (7.91e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.91e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.41e-1)"	"unprognostic (7.95e-2)"	"unprognostic (4.00e-2)"	"prognostic favorable (7.04e-4)"	"unprognostic (2.62e-1)"	"unprognostic (1.99e-3)"	"unprognostic (5.64e-2)"	11.6	14.0	9.2	15.7	9.2	15.1	15.7	12.4	11.3	13.0	13.4	17.4	16.2	11.6	10.8	16.4	14.1	7.8	14.9	8.9	8.8	14.1	16.3	12.3	20.4	8.7	9.2	16.2	9.5	17.6	14.1	9.2	8.6	11.8	18.3	16.5	11.1	12.4	22.5	19.1	15.8	12.9	8.4	15.2	12.9	32.0	9.3	25.9	13.3	12.4	22.2	12.8	12.3	8.9	29.6	54.5	26.2	44.9	25.3	25.5	34.6	29.2	24.9	40.2	28.4	36.8	20.1	59.6	23.0	33.0	38.6	101.4	45.9	41.7	34.5	56.9	29.8	30.6	57.8	34.6	28.5	49.9	38.8	18.1	39.7	45.6	48.5	22.3	22.9	54.7	44.7	51.0	46.7	68.6	49.5	35.2	22.2	79.1	46.7	49.8	64.2	79.0	27.3	26.1	30.9	23.1	71.3	42.7	25.9	21.1	78.9	34.9	17.0	42.5	28.1	50.2	41.2	50.9	131.9	45.9	39.9	37.5	46.8	40.0	21.1	24.4	22.1	26.0	18.1	13.4	17.2	20.0	22.1	20.5	15.2	17.7	18.0	27.4	27.5	13.0	22.3	19.8	9.2	9.2	12.4	11.3	8.9	8.8	8.7	9.2	8.6	8.4	9.3	8.9	4.0	9.6	9.0	11.1	11.4	6.5	5.3	10.4	8.6	7.6	8.8	7.6	13.0	5.7	7.2	7.3	8.4	16.1	6.9	13.2	5.9	11.7	77.0	12.2	7.4	3.6	5.4	12.0	14.0	6.2	11.7	7.6	10.2	9.4	9.5	10.9	4.6	14.2	15.7	10.1	15.5	12.7	8.2	15.1	5.7	58.1	10.2	13.5	3.6	10.3	20.0	8.9	15.5	18.1	15.5	8.3	8.0	6.4	13.4	6.1	16.3	13.7	12.6	8.6	13.1	7.7	7.3	51.3	25.5	14.4	6.8	13.3	12.1	7.1	14.1	5.4
GLG1	"CFR-1, ESL-1, MG-160"	ENSG00000090863	"Golgi glycoprotein 1"	Q92896	16	74447427-74607144	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA010815	Supported		Supported	"Golgi apparatus"		NA	NA		2100000	"Cluster 32: T-cells - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 52: Non-specific - Transcription"	"Golgi apparatus"		"HPA010815: AB_2232486"	"unprognostic (3.70e-2)"	"prognostic unfavorable (1.99e-4)"	"unprognostic (7.42e-2)"	"unprognostic (3.30e-2)"	"unprognostic (1.90e-1)"	"unprognostic (5.02e-3)"	"unprognostic (5.13e-3)"	"unprognostic (9.45e-3)"	"unprognostic (8.46e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.29e-1)"	"unprognostic (8.85e-2)"	"prognostic favorable (1.56e-7)"	"unprognostic (3.54e-2)"	"unprognostic (1.24e-2)"	"unprognostic (1.09e-1)"	"prognostic unfavorable (7.97e-4)"	42.7	36.8	25.0	17.4	26.3	9.0	40.3	24.0	25.7	53.3	17.3	44.5	17.3	57.8	22.4	30.9	46.7	20.4	50.5	24.7	27.5	42.6	25.6	38.2	16.3	27.0	29.0	69.0	58.1	34.3	38.9	24.9	25.2	37.5	18.7	20.3	36.1	24.9	53.8	35.2	36.4	29.9	25.0	35.1	36.3	40.6	29.5	20.0	43.1	16.4	18.9	42.3	40.8	30.0	38.4	52.2	44.7	43.3	113.7	113.2	42.8	45.0	64.2	48.6	68.3	34.4	116.0	22.8	59.8	102.9	35.8	71.1	30.1	62.1	80.1	10.3	26.1	17.9	37.8	54.3	70.5	29.3	12.6	68.0	32.8	63.6	66.3	91.3	100.8	54.8	19.0	24.9	44.2	70.0	14.1	26.0	34.7	81.2	20.6	33.9	32.6	59.5	31.6	17.1	15.8	23.3	87.3	24.9	25.0	47.7	28.2	36.5	79.1	46.1	40.9	48.2	30.3	47.4	51.2	41.1	86.3	22.5	46.6	3.2	16.7	13.3	19.1	15.7	19.2	11.6	23.8	20.9	18.5	10.1	28.2	22.6	7.3	15.4	19.9	18.4	21.0	19.0	25.0	26.3	24.0	25.7	24.7	27.5	27.0	29.0	25.2	25.0	29.5	30.0	52.8	64.1	50.7	114.3	46.4	27.1	27.2	33.0	55.8	68.5	35.6	35.6	79.5	77.2	39.7	51.5	146.0	78.0	75.6	33.5	7.9	39.9	39.7	49.2	79.3	62.0	38.6	25.0	133.4	42.5	43.6	101.4	38.7	58.0	3.8	91.0	75.3	40.7	50.1	70.7	155.3	31.9	24.4	68.8	42.1	28.1	96.9	44.4	42.7	62.8	64.8	59.6	111.2	97.5	137.3	40.8	28.8	114.3	100.2	33.6	47.8	44.2	44.3	57.9	92.1	84.6	59.9	89.2	87.9	30.5	21.6	75.2	72.4	72.4	32.9	26.4
GLI2	"HPE9, THP1, THP2"	ENSG00000074047	"GLI family zinc finger 2"	P10070	2	120735623-120992653	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding, Repressor"	"Disease variant, Holoprosencephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ovary: 10.9"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 39.5;Fibroblasts: 10.4;Leydig cells: 25.1;Peritubular cells: 30.9;Skeletal myocytes: 16.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 20.1;hTEC/SVTERT24-B: 13.1;U-2 OS: 17.9;WM-115: 18.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"CAB008558, HPA074275"	Approved		Supported	Nucleoplasm,Nucleoli		No	No				"Cluster 89: Fibroblasts - ECM organization"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 50: Fibroblasts - ECM organization"	"Nucleoplasm, Nucleoli"		"CAB008558: AB_2111910, HPA074275: AB_2686677"	"unprognostic (6.76e-2)"	"unprognostic (2.51e-1)"	"unprognostic (1.05e-1)"	"unprognostic (9.83e-3)"	"unprognostic (4.63e-2)"	"unprognostic (2.04e-1)"	"unprognostic (9.43e-2)"	"unprognostic (1.65e-2)"	"unprognostic (2.19e-3)"	"unprognostic (2.58e-1)"	"unprognostic (9.23e-3)"	"unprognostic (1.81e-2)"	"unprognostic (4.49e-10)"	"unprognostic (1.13e-1)"	"unprognostic (8.88e-2)"	"unprognostic (2.32e-2)"	"unprognostic (1.42e-3)"	1.6	1.0	1.9	0.9	2.2	0.0	1.4	1.4	1.3	4.3	0.6	3.4	0.4	4.7	1.2	0.8	2.8	2.1	2.3	1.1	1.9	1.4	0.4	2.0	0.3	2.1	2.1	10.9	0.3	0.1	1.8	0.8	1.8	2.9	0.6	0.0	1.4	1.1	0.9	2.7	1.6	1.9	1.6	0.8	1.6	2.4	1.8	1.3	1.0	0.4	0.3	3.1	2.4	0.9	0.0	10.3	20.1	5.5	3.2	4.0	0.0	5.8	1.8	2.4	2.4	0.0	0.5	0.0	0.9	5.2	0.9	0.3	4.3	0.2	1.9	0.0	2.1	0.4	6.1	0.2	3.8	0.0	1.2	2.3	0.0	13.1	0.0	2.1	0.2	0.0	0.0	0.0	0.8	0.0	0.0	0.0	10.6	1.6	4.3	0.1	2.2	3.5	0.0	0.0	2.0	2.1	3.8	0.0	0.2	4.3	0.1	0.0	5.1	0.0	17.9	2.5	0.0	0.0	0.1	0.0	7.4	0.0	18.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	2.2	1.4	1.3	1.1	1.9	2.1	2.1	1.8	1.6	1.8	0.9	0.3	0.0	0.0	39.5	0.0	2.0	0.1	0.5	0.6	0.0	0.1	0.9	1.4	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.2	1.1	0.3	6.1	0.5	0.0	0.0	0.7	0.2	0.1	10.4	0.0	1.0	0.0	0.1	0.0	0.0	0.1	0.0	1.7	0.0	0.0	0.0	1.5	2.1	25.1	0.1	0.0	2.8	0.0	0.0	1.0	3.0	0.3	1.0	0.0	30.9	0.1	0.1	0.0	0.0	0.0	0.0	0.0	16.0	3.4	0.1	3.6	0.1	1.7	0.0	0.0	7.9	0.0	0.1
GLI3	"ACLS, GCPS, PAP-A, PAPA, PAPA1, PAPB, PHS, PPDIV"	ENSG00000106571	"GLI family zinc finger 3"	P10071	7	41960949-42264100	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enriched"	"Detected in many"	8	"Astrocytes: 301.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 47.1;WM-115: 34.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA005534	Approved		Supported	Nucleoplasm,Nucleoli,Vesicles		NA	NA				"Cluster 46: Fibroblasts - ECM organization"	"Cluster 12: NES - Nervous system development"	"Cluster 64: Astrocytes - Nervous system maintenance"	Nucleoplasm	"Nucleoli, Vesicles"	"HPA005534: AB_1078973"	"unprognostic (2.53e-1)"	"unprognostic (2.41e-2)"	"unprognostic (7.58e-2)"	"unprognostic (8.22e-3)"	"unprognostic (1.10e-1)"	"unprognostic (1.28e-2)"	"unprognostic (1.01e-1)"	"unprognostic (5.35e-3)"	"unprognostic (2.24e-1)"	"unprognostic (7.38e-2)"	"unprognostic (4.03e-1)"	"unprognostic (3.54e-2)"	"unprognostic (1.48e-5)"	"unprognostic (9.13e-3)"	"unprognostic (5.41e-2)"	"unprognostic (3.21e-3)"	"unprognostic (7.00e-2)"	6.1	1.9	9.2	3.6	8.8	0.1	8.9	1.0	5.4	7.2	0.0	11.6	1.2	11.8	2.7	3.7	8.2	3.8	1.6	6.3	5.5	1.7	0.3	3.4	0.9	1.7	10.4	13.2	0.7	0.5	1.1	11.9	3.0	5.5	2.9	1.8	2.8	8.2	1.1	8.3	3.4	10.7	0.5	1.1	2.6	1.7	14.4	3.0	4.6	2.3	1.7	4.8	7.3	2.3	0.0	0.0	47.1	0.4	16.9	23.6	3.5	3.1	9.0	9.3	12.8	0.0	0.0	0.0	1.7	22.1	22.7	10.1	8.7	8.9	10.8	0.0	7.0	0.0	6.0	0.0	9.0	0.0	0.1	21.0	12.9	10.6	6.8	5.7	10.6	5.4	0.0	0.2	5.6	5.6	0.4	0.0	20.9	0.0	21.2	12.4	0.1	1.4	0.2	6.4	1.5	0.0	6.3	7.0	4.1	23.8	8.0	0.1	11.3	13.6	18.8	16.0	6.0	0.1	0.0	0.0	7.3	0.2	34.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.2	8.8	1.0	5.4	6.3	5.5	1.7	10.4	3.0	0.5	14.4	2.3	2.9	0.0	7.7	301.3	0.2	23.5	7.2	8.5	31.9	1.6	20.5	27.1	1.8	0.0	2.3	1.8	0.0	21.1	0.5	0.0	0.0	0.0	16.6	2.4	12.6	3.4	0.0	0.0	0.8	0.0	13.6	25.9	0.0	4.6	1.3	10.5	3.9	0.0	3.3	0.0	3.6	0.1	6.1	0.3	6.3	5.4	19.3	0.4	8.8	22.5	0.0	13.6	0.0	8.5	0.7	0.1	0.0	3.4	1.2	6.6	0.0	3.8	1.5	1.1	13.1	17.0	12.1	0.3	2.2	7.9	15.5	34.2	0.7	5.2	0.1	5.0
GLIS3	"MGC33662, ZNF515"	ENSG00000107249	"GLIS family zinc finger 3"	Q8NEA6	9	3824127-4348392	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"	"Congenital hypothyroidism, Diabetes mellitus"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 24.2;choroid plexus: 20.5"	"Cell type enriched"	"Detected in many"	7	"Astrocytes: 649.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 21.5;HSkMC: 29.5;RPTEC TERT1: 20.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA056426	Approved		Supported	Nucleoplasm	"Intracellular and membrane"	NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 64: Astrocytes - Nervous system maintenance"	Nucleoplasm		"HPA056426: AB_2683128"	"unprognostic (6.24e-2)"	"unprognostic (2.30e-2)"	"unprognostic (1.54e-1)"	"unprognostic (3.63e-3)"	"unprognostic (4.10e-1)"	"unprognostic (1.88e-1)"	"unprognostic (1.81e-2)"	"unprognostic (7.14e-2)"	"unprognostic (4.66e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.63e-1)"	"unprognostic (1.91e-3)"	"unprognostic (6.88e-3)"	"unprognostic (8.54e-2)"	"unprognostic (1.04e-1)"	"unprognostic (6.35e-2)"	4.3	1.6	5.1	2.1	5.5	0.2	1.9	4.9	4.6	7.8	20.5	2.0	0.7	3.3	2.8	0.5	8.7	6.5	2.9	5.4	10.8	7.8	3.3	3.8	1.1	24.2	18.0	6.6	9.7	2.4	2.4	1.4	11.4	3.3	2.1	1.3	3.1	8.2	1.3	0.8	1.5	2.1	13.7	2.0	1.8	2.8	6.5	0.2	18.6	0.8	0.7	4.0	2.4	13.2	1.0	8.5	2.5	0.0	3.7	9.5	0.4	5.9	21.5	3.1	4.4	1.3	3.4	0.0	4.3	5.5	9.6	0.0	2.0	0.0	6.7	2.5	1.2	0.0	0.4	0.0	11.0	0.9	0.0	29.5	0.0	9.8	1.1	5.8	0.4	0.1	0.0	0.2	2.9	0.4	0.0	1.5	0.2	0.0	0.8	0.0	5.2	0.0	20.8	0.0	0.0	0.0	0.8	0.0	0.0	1.1	0.0	0.0	5.5	3.4	0.9	3.2	13.3	0.0	0.0	0.0	8.1	0.0	3.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	5.1	5.5	4.9	4.6	5.4	10.8	24.2	18.0	11.4	13.7	6.5	13.2	8.1	9.6	24.0	649.7	1.0	1.9	9.3	17.1	0.6	1.0	4.6	1.3	1.6	75.8	34.5	69.9	0.0	3.2	0.3	3.7	0.0	51.0	5.2	79.6	17.5	11.2	43.7	0.0	18.3	22.6	3.2	21.9	4.1	82.3	1.3	1.6	6.8	8.3	2.4	0.0	54.2	1.6	12.2	0.8	4.0	2.4	13.7	3.4	3.6	86.2	2.2	15.6	0.0	26.7	4.1	49.1	3.9	11.3	0.0	16.5	2.4	16.4	35.7	0.4	0.0	34.4	19.0	1.3	7.4	0.6	1.3	4.2	1.2	8.8	6.6	6.1
GLO1	GLOD1	ENSG00000124767	"Glyoxalase I"	Q04760	6	38675925-38703145	"Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Lyase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in all"	4	"HMC-1: 2571.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB040541, CAB040542, HPA059791"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		No	No		1500000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 38: Extravillous trophoblasts - Unknown function"	"Nucleoplasm, Plasma membrane, Cytosol"		"CAB040541: , CAB040542: , HPA059791: AB_2684126"	"unprognostic (4.33e-2)"	"unprognostic (1.09e-1)"	"unprognostic (4.37e-2)"	"unprognostic (1.08e-2)"	"unprognostic (3.96e-3)"	"unprognostic (2.51e-1)"	"prognostic unfavorable (5.21e-4)"	"unprognostic (5.09e-2)"	"unprognostic (2.10e-2)"	"unprognostic (1.28e-2)"	"unprognostic (2.61e-2)"	"unprognostic (8.71e-2)"	"unprognostic (1.20e-2)"	"unprognostic (9.29e-2)"	"unprognostic (1.83e-1)"	"unprognostic (2.54e-1)"	"unprognostic (6.21e-2)"	55.4	62.3	69.4	38.9	74.1	31.6	74.2	74.6	83.4	55.9	77.2	51.8	116.3	57.8	110.9	60.0	72.3	41.4	88.9	72.6	76.2	87.2	157.7	66.6	48.4	73.7	72.8	82.8	42.1	106.1	23.2	64.1	75.1	171.4	52.3	100.3	43.2	62.1	154.2	66.6	67.7	61.8	77.9	48.2	48.5	27.9	72.9	50.0	54.8	128.8	60.3	52.4	51.6	77.1	201.6	92.0	257.4	256.7	119.2	213.9	227.0	171.1	161.4	235.4	243.0	224.4	75.3	222.5	132.2	137.5	280.1	129.5	222.5	221.1	295.8	203.8	343.0	329.4	105.7	211.3	178.5	126.7	2571.5	183.9	133.5	223.7	159.0	153.2	258.5	154.9	264.7	143.6	223.3	170.6	199.5	160.5	185.5	179.2	176.7	171.0	311.1	145.8	217.8	149.9	199.3	201.3	120.6	165.4	329.8	175.9	192.4	628.3	107.6	182.0	167.1	159.8	275.9	112.7	227.0	608.6	66.1	322.7	299.6	23.7	20.7	15.3	35.5	33.4	48.0	51.9	35.3	36.7	39.0	51.4	32.7	34.9	2.7	23.5	26.9	60.4	34.1	33.3	69.4	74.1	74.6	83.4	72.6	76.2	73.7	72.8	75.1	77.9	72.9	77.1	69.2	131.4	174.4	26.1	86.3	64.6	112.6	88.2	37.0	56.1	67.7	55.8	133.2	58.6	84.5	90.1	20.9	102.7	68.3	34.1	248.4	132.1	4.5	76.2	58.8	74.3	36.5	83.5	23.9	73.3	323.0	86.0	53.0	67.5	71.4	78.7	161.0	114.0	78.8	69.0	21.9	39.3	99.7	125.7	72.8	6.5	83.9	70.0	104.9	17.8	92.6	190.3	49.4	25.1	24.8	77.3	36.0	109.9	86.4	178.8	103.2	132.2	80.7	65.5	46.0	62.0	70.9	15.0	16.1	77.2	88.2	73.2	62.4	123.7	63.4	130.2
GLP2R		ENSG00000065325	"Glucagon like peptide 2 receptor"	O95838	17	9822206-9892099	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 12.2;intestine: 13.5;urinary bladder: 11.8"	"Cell type enhanced"	"Detected in some"		"Cone photoreceptor cells: 4.2;Excitatory neurons: 6.4;Leydig cells: 3.1;Rod photoreceptor cells: 23.3"	"Cancer enhanced"	"Detected in single"		"pancreatic cancer: 1.1"	"Group enriched"	"Detected in many"	6	"basal ganglia: 3.0;cerebral cortex: 3.6;hippocampal formation: 3.2;white matter: 1.7"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"HeLa: 78.1"	"Group enriched"	"Detected in some"	5	"cerebral cortex: 2.1;hippocampal formation: 2.4"	"Low region specificity"	"Detected in all"			"CAB022690, HPA049244"	Supported		Supported	"Plasma membrane"		NA	NA				"Cluster 37: Intestine - Unknown function"	"Cluster 20: HeLa - Mitochondria"	"Cluster 46: Photoreceptor cells - Phototransduction"	"Plasma membrane"		"CAB022690: , HPA049244: AB_2680690"	"unprognostic (2.14e-1)"	"unprognostic (2.45e-3)"	"unprognostic (2.66e-3)"	"unprognostic (2.21e-2)"	"unprognostic (3.81e-3)"	"unprognostic (2.09e-1)"	"unprognostic (1.39e-2)"	"unprognostic (5.15e-2)"	"unprognostic (7.63e-2)"	"unprognostic (7.14e-2)"	"unprognostic (2.19e-1)"	"unprognostic (6.16e-3)"	"unprognostic (3.40e-8)"	"unprognostic (9.53e-5)"	"unprognostic (5.51e-2)"	"unprognostic (3.92e-1)"	"unprognostic (6.48e-3)"	8.1	0.3	0.4	0.7	3.0	0.0	0.8	0.0	3.6	6.0	0.0	13.5	9.9	1.2	0.0	0.7	1.6	12.2	0.6	3.2	0.0	0.3	2.7	1.0	0.6	0.0	0.2	0.4	1.6	0.0	0.0	1.1	0.0	0.1	6.0	3.4	0.0	0.1	0.1	0.1	8.2	1.9	0.0	0.1	3.7	0.4	0.0	0.1	0.2	0.2	0.2	11.8	1.5	1.7	0.0	16.6	0.0	0.0	0.8	0.0	0.8	0.0	0.3	0.0	0.1	0.0	0.5	0.0	0.0	0.0	2.3	0.2	0.0	0.0	0.1	0.0	0.0	0.0	78.1	0.6	1.0	0.1	0.0	0.0	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.4	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	3.0	0.0	3.6	3.2	0.0	0.0	0.2	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.6	0.0	0.0	0.0	4.2	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.1	0.0	0.0	6.4	0.0	0.0	1.7	0.0	0.3	0.0	0.0	0.4	0.1	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	3.1	0.1	0.0	0.0	0.0	0.5	0.0	1.5	0.2	0.0	0.0	1.5	0.0	0.0	0.0	0.1	0.0	23.3	0.0	1.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
GLRX	"GRX, GRX1"	ENSG00000173221	Glutaredoxin	P35754	5	95751319-95822726	"Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Electron transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 777.4"	"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 723.9;Extravillous trophoblasts: 751.2;Proximal enterocytes: 968.3;Proximal tubular cells: 1165.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"BJ hTERT+: 569.0;RPTEC TERT1: 462.1;U-87 MG: 441.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB008634, HPA046431, CAB069419"	Approved		Supported	"Plasma membrane,Cytosol"		NA	NA		6300000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Plasma membrane, Cytosol"		"CAB008634: AB_1616672, CAB069419: AB_1616670, HPA046431: AB_2679663"	"unprognostic (1.69e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.94e-2)"	"unprognostic (4.81e-2)"	"unprognostic (2.01e-2)"	"unprognostic (2.22e-2)"	"unprognostic (8.62e-3)"	"unprognostic (9.31e-3)"	"unprognostic (1.99e-2)"	"unprognostic (1.65e-2)"	"unprognostic (2.34e-1)"	"unprognostic (1.82e-1)"	"unprognostic (8.11e-2)"	"unprognostic (2.18e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.61e-1)"	"unprognostic (2.61e-1)"	82.1	101.4	32.5	80.0	34.9	173.7	37.2	46.3	52.4	28.2	29.0	57.2	194.7	12.7	10.1	13.6	17.2	50.8	102.7	47.3	37.1	247.4	143.6	71.9	61.5	52.0	42.1	10.9	10.9	82.4	23.7	102.0	39.8	28.5	47.4	6.9	59.2	25.6	777.4	38.3	170.3	25.7	34.3	64.9	40.2	4.9	43.6	75.6	18.9	55.9	80.4	53.1	20.9	37.9	22.2	97.1	8.4	18.0	211.3	310.4	1.6	326.5	569.0	35.9	62.9	31.2	10.2	86.2	45.7	99.0	83.0	9.7	12.9	156.4	100.5	75.7	24.1	62.8	63.5	248.1	386.6	67.2	182.8	184.4	23.2	219.7	21.3	81.1	75.3	179.3	8.2	51.3	262.3	7.9	121.4	133.0	22.2	3.3	111.6	186.1	66.8	107.9	462.1	16.8	23.6	12.5	85.3	47.8	39.4	22.0	13.0	66.0	78.0	91.9	101.9	74.6	14.4	37.1	202.0	70.4	441.3	170.6	19.7	48.9	727.2	901.6	222.9	483.8	313.6	142.9	205.0	166.7	459.8	107.8	201.4	186.1	783.8	113.4	411.2	166.6	457.7	781.7	32.5	34.9	46.3	52.4	47.3	37.1	52.0	42.1	39.8	34.3	43.6	37.9	77.5	22.4	28.4	3.6	74.1	17.2	62.9	330.5	8.6	2.2	57.9	31.5	154.9	65.8	183.6	93.8	0.0	47.4	130.0	173.8	723.9	60.4	0.3	83.4	49.0	47.1	31.7	63.1	8.7	96.0	751.2	63.1	35.7	118.0	31.6	3.5	46.4	206.9	271.5	0.0	8.0	89.9	65.1	304.9	276.1	2.3	19.0	232.3	69.4	12.2	340.0	7.8	302.8	2.0	2.4	113.5	291.3	13.9	200.2	89.5	968.3	1165.9	124.1	3.9	19.7	22.1	67.0	0.6	1.6	4.1	20.6	285.3	97.7	11.7	85.4	214.6
GLRX5	"C14orf87, GRX5, PR01238"	ENSG00000182512	"Glutaredoxin 5"	Q86SX6	14	95533503-95544724	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 195.0"	"Cell type enhanced"	"Detected in all"		"Distal tubular cells: 518.5;Erythroid cells: 1134.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042465, HPA063716"	Approved		Supported	Mitochondria		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 6: Erythroid cells - Oxygen transport"	Mitochondria		"HPA042465: AB_10794048, HPA063716: AB_2685102"	"unprognostic (2.57e-1)"	"unprognostic (6.76e-2)"	"unprognostic (1.60e-2)"	"unprognostic (2.69e-2)"	"unprognostic (3.72e-2)"	"unprognostic (2.43e-3)"	"unprognostic (1.29e-1)"	"unprognostic (5.41e-2)"	"unprognostic (8.28e-2)"	"prognostic favorable (1.08e-5)"	"unprognostic (1.85e-1)"	"unprognostic (1.02e-1)"	"prognostic favorable (7.83e-10)"	"unprognostic (1.44e-1)"	"unprognostic (3.81e-2)"	"unprognostic (2.66e-2)"	"unprognostic (8.91e-2)"	37.2	52.1	44.1	17.6	44.9	178.8	27.2	43.8	50.2	22.3	46.7	44.8	46.2	19.2	39.0	24.5	23.6	17.5	76.9	46.6	45.8	74.5	105.5	18.3	23.1	43.3	44.5	32.8	31.5	46.3	18.9	37.8	44.3	26.8	37.3	10.1	29.3	29.6	195.0	18.3	33.2	24.4	42.9	20.8	34.2	35.7	46.2	40.3	26.7	168.9	27.0	24.5	15.0	42.9	77.1	92.7	61.4	68.0	74.2	57.5	202.0	54.9	56.1	69.4	69.1	124.8	87.5	111.7	77.4	42.8	39.2	75.5	116.5	79.6	71.5	68.5	94.4	100.3	63.4	202.2	73.5	160.9	96.5	55.4	74.1	49.9	81.1	28.1	76.1	94.4	115.7	88.3	61.2	205.5	133.6	165.9	81.5	89.7	107.8	220.8	184.3	67.8	93.3	89.3	127.9	75.2	54.8	81.3	87.7	59.9	107.7	72.6	55.6	30.5	65.0	77.6	85.7	41.7	57.9	92.0	67.2	99.8	72.2	0.4	2.9	4.8	3.4	4.3	4.9	4.6	4.6	6.0	4.7	5.4	3.7	3.9	1.3	3.9	2.7	9.0	6.2	1.8	44.1	44.9	43.8	50.2	46.6	45.8	43.3	44.5	44.3	42.9	46.2	42.9	78.7	28.9	30.0	7.8	41.1	108.5	58.7	7.5	61.5	38.5	112.8	135.9	150.0	64.3	10.4	95.6	33.3	97.8	66.5	76.3	518.5	15.2	312.0	49.7	61.5	58.9	54.0	1134.9	15.0	15.6	164.9	66.2	46.4	48.3	14.7	110.3	47.2	147.2	58.7	50.5	16.4	72.1	4.1	41.7	58.7	90.2	54.3	50.7	87.2	7.5	21.3	128.1	52.5	12.5	15.2	15.2	39.5	73.7	75.2	108.2	51.8	281.4	9.1	43.0	59.2	61.1	92.7	115.4	79.0	102.2	124.9	53.8	48.8	169.0	88.0	76.6
GLS	"GLS1, KIAA0838"	ENSG00000115419	Glutaminase	O94925	2	190880821-190965552	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		Hydrolase	"Cataract, Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 316.8"	"Cell type enhanced"	"Detected in all"		"Collecting duct cells: 391.8;Excitatory neurons: 427.1;Proximal tubular cells: 539.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"EFO-21: 907.3;RPTEC TERT1: 419.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036223	Enhanced		Supported	Mitochondria	"Intracellular and membrane"	No	No		92000	"Cluster 44: Non-specific - Transcription"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Mitochondria		"HPA036223: AB_10669984"	"unprognostic (7.45e-2)"	"unprognostic (3.42e-2)"	"unprognostic (3.21e-1)"	"prognostic unfavorable (3.45e-4)"	"unprognostic (1.17e-1)"	"unprognostic (2.08e-3)"	"unprognostic (2.51e-3)"	"unprognostic (4.24e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.40e-1)"	"unprognostic (8.01e-2)"	"unprognostic (9.06e-2)"	"unprognostic (5.41e-2)"	"unprognostic (1.62e-1)"	"unprognostic (5.03e-2)"	"unprognostic (2.13e-1)"	"unprognostic (4.12e-1)"	37.0	77.4	38.5	45.7	50.5	28.7	32.0	40.5	74.6	31.0	35.6	32.0	92.2	28.8	26.6	16.8	25.1	41.8	34.7	55.5	35.9	316.8	11.7	55.6	68.0	44.7	19.8	28.9	36.9	62.0	19.9	35.8	52.5	20.8	30.1	81.8	20.4	31.2	15.8	28.5	103.4	36.9	12.0	49.3	18.7	16.2	24.1	41.7	35.7	23.6	57.9	36.5	23.6	44.8	43.6	47.2	32.4	43.1	99.7	68.9	84.0	126.8	95.7	90.6	103.1	58.1	42.1	88.5	907.3	269.3	46.1	55.6	58.0	50.0	131.5	219.8	37.7	147.3	69.1	72.2	90.8	87.2	66.5	62.9	51.0	71.2	48.4	90.1	119.3	36.7	69.3	175.2	203.3	22.8	59.2	83.7	86.9	25.7	76.7	74.2	83.7	77.4	419.2	78.9	44.9	46.8	172.8	37.9	169.2	115.1	14.9	53.0	85.3	129.4	94.5	65.9	156.8	56.2	138.9	122.1	46.7	70.6	105.5	6.4	1.0	1.9	3.7	1.5	6.5	3.4	4.4	4.8	1.6	3.8	4.5	5.5	2.1	2.8	1.1	3.6	4.1	1.1	38.5	50.5	40.5	74.6	55.5	35.9	44.7	19.8	52.5	12.0	24.1	44.8	81.0	189.1	122.5	61.0	89.3	174.5	44.7	15.6	60.9	93.5	51.8	49.5	38.2	35.8	28.4	391.8	210.6	4.4	128.0	100.6	50.9	21.4	6.6	33.7	66.8	68.3	59.2	17.9	427.1	24.5	15.6	66.0	46.4	97.9	36.8	48.2	63.5	4.3	29.1	26.9	270.5	36.7	14.2	31.2	230.0	7.3	28.6	84.3	88.9	143.4	68.4	11.9	55.6	163.3	146.9	29.8	92.9	43.2	118.4	70.1	165.9	539.1	17.0	111.9	19.7	71.6	76.0	11.3	12.9	61.7	162.8	4.0	114.0	97.8	43.6	56.7
GLTP		ENSG00000139433	"Glycolipid transfer protein"	Q9NZD2	12	109850945-109880541	"Metabolic proteins, Predicted intracellular proteins"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 334.1;skin 1: 276.6"	"Cell type enhanced"	"Detected in all"		"Squamous epithelial cells: 266.5;Suprabasal keratinocytes: 479.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA056461, HPA065503"	Approved		Supported	Cytosol		NA	NA		25000	"Cluster 7: Monocytes - Unknown function"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 15: RT4 - Unknown function"	"Cluster 61: Squamous epithelial cells - Keratinization"	Cytosol		"HPA056461: AB_2683138, HPA065503: "	"unprognostic (1.18e-1)"	"prognostic favorable (2.01e-5)"	"unprognostic (7.46e-2)"	"unprognostic (6.22e-3)"	"unprognostic (1.95e-1)"	"unprognostic (3.73e-2)"	"prognostic unfavorable (7.68e-4)"	"unprognostic (6.63e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.47e-1)"	"unprognostic (3.03e-1)"	"unprognostic (4.83e-2)"	"unprognostic (4.46e-2)"	"unprognostic (2.20e-1)"	"prognostic favorable (4.17e-6)"	"unprognostic (3.28e-2)"	19.0	21.7	59.1	17.5	98.8	19.3	27.1	93.6	75.1	94.4	43.1	38.4	14.6	15.9	34.8	334.1	13.6	14.2	21.0	62.3	69.9	53.2	15.1	24.4	19.3	110.3	89.5	18.2	23.8	31.4	12.5	17.8	102.5	29.4	31.8	7.0	84.7	19.1	18.6	276.6	32.1	18.8	84.0	21.5	21.6	16.3	87.3	18.0	23.5	18.1	108.2	33.6	178.0	138.5	39.3	27.9	15.5	16.7	36.2	41.4	11.0	47.4	58.2	36.0	29.7	11.3	14.9	34.5	25.3	57.8	17.5	47.3	24.2	54.9	50.7	35.0	21.5	22.6	15.9	16.5	31.6	24.6	25.5	30.1	68.8	64.6	45.3	53.9	61.3	34.8	10.1	22.5	53.2	52.9	33.6	19.8	28.1	32.0	36.8	29.3	36.4	36.3	20.5	116.1	20.0	19.8	30.1	77.1	26.0	14.1	36.1	8.6	83.2	41.4	21.9	61.5	36.5	30.1	27.7	23.8	83.0	25.1	25.9	42.6	65.7	37.3	51.5	66.0	32.4	23.9	31.0	46.5	48.8	21.5	20.1	35.8	32.9	42.4	57.0	8.0	37.6	40.6	59.1	98.8	93.6	75.1	62.3	69.9	110.3	89.5	102.5	84.0	87.3	138.5	48.1	25.6	60.9	10.4	37.5	145.4	109.1	72.1	88.2	11.4	55.6	44.4	14.6	18.6	62.7	44.1	14.6	86.5	48.3	95.6	199.6	39.0	20.5	30.1	33.3	47.9	32.4	10.1	9.9	56.5	20.0	35.0	28.5	59.1	20.8	19.0	34.2	15.3	34.5	13.5	11.4	39.2	50.8	61.6	84.6	11.7	23.0	55.3	60.5	13.1	61.8	23.4	64.9	21.6	140.1	53.5	40.0	18.0	26.2	80.6	102.3	38.2	25.2	12.3	39.5	23.5	37.3	22.9	20.8	266.5	479.2	210.6	46.3	31.4	59.1	129.0
GLUD1	"GDH, GLUD"	ENSG00000148672	"Glutamate dehydrogenase 1"	P00367	10	87050202-87094843	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 816.4"	"Cell type enhanced"	"Detected in all"		"Astrocytes: 294.1;Hepatocytes: 402.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Hep G2: 555.0"	"Low region specificity"	"Detected in all"							"HPA042492, HPA044839, HPA061369"	Approved		Supported	Mitochondria	"Intracellular and membrane"	NA	NA		23000000	"Cluster 26: Non-specific - Mitochondria"	"Cluster 15: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 41: Macrophages - Immune response"	Mitochondria		"HPA042492: AB_2678024, HPA044839: AB_2679107, HPA061369: AB_2684494"	"unprognostic (1.48e-1)"	"unprognostic (1.26e-2)"	"unprognostic (3.55e-1)"	"unprognostic (1.07e-1)"	"prognostic favorable (3.81e-4)"	"unprognostic (1.31e-1)"	"unprognostic (1.91e-2)"	"unprognostic (5.50e-2)"	"unprognostic (2.06e-1)"	"unprognostic (4.57e-3)"	"prognostic unfavorable (1.76e-5)"	"unprognostic (1.13e-1)"	"prognostic favorable (1.44e-6)"	"unprognostic (2.29e-1)"	"unprognostic (4.23e-2)"	"unprognostic (7.19e-2)"	"unprognostic (4.27e-2)"	70.1	93.0	217.2	44.8	219.0	29.2	96.4	180.4	216.8	50.2	135.8	63.4	80.9	48.1	30.0	77.0	47.4	53.3	75.6	193.3	223.2	249.2	816.4	57.7	42.9	220.9	222.9	71.6	66.2	39.0	37.1	58.8	202.3	110.5	61.5	90.2	55.6	53.2	51.1	84.2	88.6	53.3	223.2	46.4	57.0	22.3	254.6	44.8	68.1	64.4	59.2	68.1	55.6	202.3	127.1	100.3	77.1	131.5	143.0	174.5	84.0	97.7	167.8	92.4	100.5	233.0	120.6	141.5	77.8	143.4	53.0	194.7	101.4	98.5	98.0	102.7	79.8	69.0	55.9	555.0	318.1	163.2	95.5	121.3	181.5	103.2	304.9	140.3	112.0	109.3	70.7	124.0	101.0	92.1	148.1	145.7	88.2	136.9	79.8	110.4	98.3	93.1	267.4	101.8	39.7	73.9	87.8	68.8	126.1	73.9	94.3	112.8	112.4	47.8	42.5	98.2	101.0	73.6	81.4	167.5	115.3	182.8	29.3	9.1	14.2	9.7	8.3	11.1	10.3	9.8	11.2	10.1	15.9	11.3	9.9	8.0	1.2	13.6	16.0	5.9	12.6	6.5	217.2	219.0	180.4	216.8	193.3	223.2	220.9	222.9	202.3	223.2	254.6	202.3	49.3	22.4	23.9	294.1	56.6	106.0	57.5	32.2	105.3	22.5	83.3	38.2	60.2	57.2	47.3	60.7	37.5	95.7	45.6	56.1	156.5	32.5	14.2	37.3	44.0	54.1	39.4	52.6	35.8	33.8	63.8	89.0	86.2	59.7	43.2	33.6	50.7	402.3	69.1	15.2	38.0	49.5	36.7	74.1	184.5	26.0	88.0	81.4	104.9	42.2	50.6	140.0	39.1	48.7	42.9	50.2	38.3	90.7	75.7	103.4	124.2	175.5	21.6	68.9	65.7	41.3	55.9	11.4	8.6	189.5	122.3	47.6	84.6	70.9	49.6	107.3
GLUL	GLNS	ENSG00000135821	"Glutamate-ammonia ligase"	P15104	1	182378098-182392206	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	Angiogenesis	"Ligase, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 1443.6"	"Group enriched"	"Detected in all"	4	"Late spermatids: 8544.2;Muller glia cells: 6247.0"	"Cancer enhanced"	"Detected in all"		"liver cancer: 365.1"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 656.8"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 656.8"	"Cell line enhanced"	"Detected in many"		"ASC diff: 1150.8;ASC TERT1: 807.6;HSkMC: 702.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007316, HPA007571, CAB008636"	Approved		Supported	"Plasma membrane,Mitochondria,Cytosol"		NA	NA		150000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 25: Spermatids - Spermatogenesis"	"Mitochondria, Cytosol"	"Plasma membrane"	"CAB008636: AB_1616669, HPA007316: AB_888438, HPA007571: AB_1078980"	"prognostic favorable (4.81e-4)"	"unprognostic (1.52e-3)"	"unprognostic (3.89e-1)"	"unprognostic (3.32e-1)"	"unprognostic (1.25e-1)"	"unprognostic (9.52e-2)"	"unprognostic (7.58e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.26e-1)"	"unprognostic (8.92e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.38e-2)"	"unprognostic (4.17e-2)"	"unprognostic (2.06e-1)"	"unprognostic (5.55e-2)"	"unprognostic (4.53e-3)"	753.5	76.0	694.3	156.9	746.5	232.9	573.5	717.5	1237.1	161.4	583.2	157.8	24.4	116.7	115.7	218.7	224.3	105.4	129.7	676.6	764.7	65.3	280.7	221.7	75.2	891.0	783.7	303.0	204.7	32.3	70.5	176.6	767.0	103.4	92.5	891.1	233.5	96.0	1443.6	231.4	148.2	124.1	725.0	216.4	648.2	87.1	811.4	97.0	257.4	472.0	103.2	185.5	292.0	810.4	26.4	10.8	117.2	0.2	1150.8	807.6	86.0	44.1	141.7	25.9	23.4	64.1	26.7	22.4	46.3	85.5	23.8	59.3	51.8	309.4	21.5	61.2	143.3	296.5	47.6	124.8	61.1	132.6	227.2	702.1	363.3	32.9	384.6	39.1	52.8	71.7	254.3	13.3	92.6	15.0	208.2	126.5	87.3	36.8	55.0	74.3	31.3	38.6	45.8	114.0	79.7	52.5	12.4	157.3	17.4	93.3	153.1	165.9	39.7	0.9	1.9	0.8	10.1	4.8	3.4	0.4	22.3	73.9	5.0	396.5	153.4	409.4	42.3	145.8	17.6	11.5	29.9	35.5	80.0	17.8	15.3	25.3	656.8	27.2	130.5	43.7	13.0	172.0	694.3	746.5	717.5	1237.1	676.6	764.7	891.0	783.7	767.0	725.0	811.4	810.4	127.8	125.0	173.8	599.4	37.6	134.7	533.8	1190.7	260.0	105.6	166.6	99.1	216.2	171.6	855.3	82.8	52.1	161.7	113.4	118.3	74.3	124.2	1491.3	140.2	150.0	191.5	325.9	319.7	3.4	116.6	65.9	404.4	388.4	124.6	786.3	88.0	152.8	597.1	798.0	43.7	22.0	256.7	451.6	907.2	614.1	8544.2	487.4	687.4	136.9	74.9	112.7	6247.0	42.2	38.2	330.0	108.1	105.3	375.0	38.7	421.0	10.3	46.6	569.9	176.0	92.1	481.5	218.5	48.2	63.6	186.5	128.3	235.3	108.6	53.3	173.3	1420.5
GLYCTK	"HBEBP2, HBEBP4"	ENSG00000168237	"Glycerate kinase"	Q8IVS8	3	52287089-52295257	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		"Kinase, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	11	"liver: 275.1"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 183.0;Proximal enterocytes: 105.2;Proximal tubular cells: 83.0"	"Cancer enriched"	"Detected in all"	6	"liver cancer: 52.7"	"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006913	Approved		Approved	"Golgi apparatus,Cytosol,Rods & Rings"		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 62: Liver - Hemostasis"	"Cluster 21: OE19 - Mitochondria"	"Cluster 2: Hepatocytes - Metabolism"	Cytosol	"Golgi apparatus, Rods & Rings"	"HPA006913: AB_1078993"	"unprognostic (1.51e-2)"	"unprognostic (2.55e-1)"	"unprognostic (1.25e-1)"	"unprognostic (3.46e-2)"	"unprognostic (1.18e-1)"	"prognostic favorable (1.64e-4)"	"unprognostic (2.72e-2)"	"unprognostic (2.84e-2)"	"unprognostic (7.73e-3)"	"unprognostic (1.82e-1)"	"unprognostic (3.36e-3)"	"unprognostic (2.15e-1)"	"unprognostic (3.30e-2)"	"unprognostic (3.42e-1)"	"unprognostic (3.77e-1)"	"unprognostic (3.82e-2)"	"unprognostic (9.00e-3)"	14.8	8.3	1.0	4.5	0.9	6.7	9.3	0.5	1.5	2.9	0.9	11.4	22.4	3.2	0.6	3.8	2.7	2.2	4.4	0.9	1.2	24.9	275.1	4.2	4.6	1.4	0.9	2.4	5.9	2.5	2.9	2.2	1.2	3.7	3.6	0.6	3.1	1.0	3.6	1.9	21.7	1.6	0.4	8.9	8.5	2.3	1.2	2.3	4.1	1.0	3.2	3.3	2.5	1.2	2.9	5.8	3.4	1.2	15.7	2.4	1.8	2.4	2.6	4.6	3.9	12.1	2.4	6.7	1.6	2.7	3.7	1.6	1.7	7.8	0.8	2.0	1.8	9.3	7.5	16.2	1.7	2.8	5.0	2.4	3.5	7.6	3.2	2.1	10.2	5.2	2.4	4.5	3.6	1.9	5.9	2.7	1.5	14.2	4.2	1.9	2.5	11.1	5.8	3.9	1.9	1.9	2.6	1.4	3.0	1.0	3.2	1.7	3.8	3.5	4.1	2.4	6.1	5.1	3.9	5.4	2.7	4.9	2.2	2.2	5.2	6.6	5.6	2.8	2.6	4.4	4.2	4.9	5.6	2.6	3.3	4.3	4.4	3.6	3.5	3.4	6.6	3.7	1.0	0.9	0.5	1.5	0.9	1.2	1.4	0.9	1.2	0.4	1.2	1.2	5.4	6.4	3.2	0.7	8.2	0.4	3.2	4.1	1.8	1.6	2.1	1.4	1.6	18.6	3.0	9.2	0.0	7.9	9.2	18.4	19.6	5.4	0.3	4.4	2.7	8.3	23.4	26.5	0.6	6.2	5.3	2.9	27.0	8.6	1.3	3.4	14.6	183.0	13.2	0.0	0.4	15.8	2.0	16.6	2.4	0.0	1.2	9.1	3.6	1.0	7.7	1.2	9.2	0.5	0.7	4.0	40.6	0.0	13.5	2.8	105.2	83.0	2.4	1.5	0.0	2.7	2.7	1.8	8.3	2.1	1.3	11.1	9.3	7.7	24.9	4.3
GM2A	SAP-3	ENSG00000196743	"GM2 ganglioside activator"	P17900	5	151212150-151270440	"Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Lipid metabolism, Sphingolipid metabolism"	Hydrolase	"Disease variant, Gangliosidosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 224.7;Hofbauer cells: 100.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"B-cells: 30.9;dendritic cells: 39.6;monocytes: 40.4"	"Cell line enhanced"	"Detected in all"		"BEWO: 207.1;HBEC3-KT: 291.8;hTCEpi: 287.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008063	Enhanced		Approved	Vesicles,Cytosol	"Intracellular and membrane"	NA	NA		19000000	"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 38: Extravillous trophoblasts - Unknown function"	"Vesicles, Cytosol"		"HPA008063: AB_1849842"	"unprognostic (4.33e-2)"	"unprognostic (8.97e-3)"	"unprognostic (2.27e-1)"	"unprognostic (3.01e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.70e-1)"	"prognostic unfavorable (1.77e-5)"	"unprognostic (1.22e-1)"	"unprognostic (1.72e-2)"	"unprognostic (1.31e-2)"	"unprognostic (1.50e-2)"	"unprognostic (5.33e-3)"	"unprognostic (9.81e-2)"	"unprognostic (4.24e-2)"	"unprognostic (4.42e-2)"	"unprognostic (3.02e-2)"	"unprognostic (1.65e-1)"	17.4	20.5	29.3	30.0	39.7	20.6	28.0	38.9	31.1	30.8	17.9	19.7	15.8	15.1	30.8	56.2	15.4	23.4	26.2	27.1	34.3	11.4	24.8	39.0	61.4	42.6	37.9	21.3	14.9	28.3	6.6	57.9	44.3	21.1	26.3	11.7	17.0	17.9	7.2	81.8	16.3	20.0	39.0	36.0	15.8	11.6	36.2	72.3	13.0	10.5	77.9	40.3	49.5	46.7	22.3	14.8	15.1	71.7	98.0	48.2	207.1	35.0	75.1	19.0	25.6	30.3	26.1	71.9	35.1	26.9	51.1	60.0	16.7	291.8	27.2	41.4	10.5	11.7	16.8	37.9	23.7	19.1	117.1	65.4	287.0	24.4	16.4	26.0	27.6	85.1	11.4	30.7	30.1	9.6	38.4	18.0	10.2	11.4	32.3	17.7	7.1	46.3	18.4	43.3	3.9	13.4	29.1	133.0	58.3	52.0	30.7	22.5	24.6	46.0	17.6	38.3	10.6	75.2	96.8	187.0	53.1	30.1	19.4	7.6	40.4	2.4	3.7	13.6	2.7	30.9	4.3	3.9	39.6	29.8	6.1	4.8	8.7	4.4	3.4	28.0	5.4	18.6	29.3	39.7	38.9	31.1	27.1	34.3	42.6	37.9	44.3	39.0	36.2	46.7	5.8	16.0	23.0	5.5	25.0	14.9	18.5	63.2	26.7	5.8	5.4	15.5	30.9	0.0	29.7	18.4	2.1	53.6	8.3	4.4	1.9	7.2	0.5	5.7	6.8	7.3	3.6	5.0	2.2	8.1	224.7	10.2	10.7	7.7	69.6	16.3	8.6	24.2	100.8	6.7	2.7	5.4	10.2	55.7	32.5	1.6	8.1	67.8	8.8	2.8	52.5	8.0	7.2	3.5	9.5	6.0	4.7	13.9	28.8	6.7	6.2	5.4	19.9	3.7	0.0	7.9	6.9	1.8	4.2	45.6	23.9	52.5	5.6	6.4	6.7	36.5
GMEB2	"KIAA1269, P79PIF, PIF79"	ENSG00000101216	"Glucocorticoid modulatory element binding protein 2"	Q9UKD1	20	63587602-63627101	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 29.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA009706, HPA067455"	Approved		Enhanced	Nucleoplasm,Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 71: Testis - DNA repair"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm	Cytosol	"HPA009706: AB_1078996, HPA067455: AB_2685845"	"unprognostic (4.55e-1)"	"unprognostic (5.65e-2)"	"unprognostic (3.16e-1)"	"unprognostic (1.38e-3)"	"unprognostic (1.36e-1)"	"unprognostic (4.85e-2)"	"unprognostic (2.77e-3)"	"unprognostic (2.04e-1)"	"unprognostic (5.47e-2)"	"unprognostic (5.43e-2)"	"unprognostic (2.01e-2)"	"unprognostic (2.04e-2)"	"unprognostic (6.86e-3)"	"unprognostic (2.82e-2)"	"unprognostic (3.84e-1)"	"unprognostic (3.46e-1)"	"unprognostic (2.29e-1)"	7.5	8.0	6.2	5.0	5.9	19.3	7.4	6.3	6.7	8.7	5.5	8.5	5.0	9.0	2.5	9.3	10.3	3.1	7.9	6.1	5.3	8.5	9.0	8.2	6.7	6.2	5.8	9.5	9.8	5.6	8.3	3.6	5.6	9.0	2.4	2.1	8.8	3.5	9.2	9.3	9.3	3.3	5.2	10.7	8.2	13.4	6.2	8.1	15.5	3.4	4.4	8.0	7.1	5.6	13.8	8.3	9.9	8.6	4.7	4.3	13.2	9.3	5.9	14.7	7.7	25.9	10.1	10.9	9.5	8.1	10.6	19.2	7.8	13.7	6.5	5.8	8.8	8.5	12.7	12.6	6.4	8.1	13.6	6.2	12.9	9.5	11.8	6.2	6.5	13.6	12.6	7.7	5.1	14.9	19.8	17.8	7.1	16.3	13.1	21.3	10.1	10.1	6.1	12.1	14.8	12.2	17.0	14.8	10.0	4.5	18.1	13.3	8.3	16.0	8.7	9.7	10.4	14.7	12.8	17.2	9.7	7.5	10.7	0.0	0.8	1.4	1.7	1.0	1.5	0.7	1.5	1.5	0.8	1.0	1.6	1.4	1.7	0.8	2.5	1.0	1.1	1.0	6.2	5.9	6.3	6.7	6.1	5.3	6.2	5.8	5.6	5.2	6.2	5.6	5.6	3.2	5.6	9.1	7.3	6.0	11.2	3.8	5.2	5.2	6.4	5.6	3.2	4.3	5.0	3.7	0.0	4.1	6.3	9.3	1.9	4.3	29.3	6.9	5.2	6.8	9.6	2.5	5.3	5.4	6.9	4.2	5.6	10.3	2.5	6.0	4.6	6.6	4.5	8.4	4.2	7.6	2.0	3.5	3.8	6.9	4.1	4.5	1.8	4.7	3.2	2.4	4.1	2.5	4.8	6.1	8.2	5.7	7.8	12.0	5.5	3.5	4.2	5.9	6.6	5.0	4.6	22.2	9.5	5.1	5.4	11.5	8.9	3.5	6.1	12.1
GMNN	Gem	ENSG00000112312	"Geminin DNA replication inhibitor"	O75496	6	24774931-24786099	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cell cycle"	"DNA replication inhibitor"	"Cancer-related genes, Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 231.4"	"Cell type enhanced"	"Detected in all"		"Glandular and luminal cells: 184.8;Paneth cells: 300.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011458, CAB047327, CAB047328, HPA049977, HPA054597"	Enhanced		Supported	Nucleoplasm,Cytosol		Yes	No			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 25: Pancreas - Digestion"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm	Cytosol	"CAB011458: AB_2110946, CAB047327: , CAB047328: , HPA049977: AB_2680978, HPA054597: AB_2682538"	"unprognostic (1.37e-1)"	"unprognostic (3.43e-3)"	"unprognostic (3.91e-3)"	"unprognostic (1.52e-2)"	"unprognostic (1.28e-1)"	"unprognostic (4.37e-2)"	"unprognostic (2.90e-3)"	"unprognostic (8.29e-2)"	"unprognostic (1.23e-3)"	"prognostic favorable (4.13e-4)"	"prognostic unfavorable (9.77e-4)"	"unprognostic (1.33e-2)"	"prognostic unfavorable (7.82e-5)"	"unprognostic (2.25e-1)"	"unprognostic (7.92e-2)"	"unprognostic (3.63e-2)"	"unprognostic (5.90e-3)"	10.1	7.7	16.9	17.2	18.2	68.9	24.2	19.5	23.7	11.1	13.5	41.6	17.8	10.6	5.8	16.6	16.5	7.9	8.0	14.7	20.2	24.6	18.2	8.9	30.4	17.0	20.2	14.6	231.4	8.4	11.1	16.5	17.8	41.5	44.4	16.3	8.7	24.9	7.4	40.3	16.1	12.5	16.4	19.1	22.6	37.4	19.8	37.4	10.8	14.3	23.7	28.4	13.9	15.5	110.9	64.2	159.2	66.2	22.2	23.5	106.0	106.0	55.9	124.4	135.5	125.1	38.8	110.1	131.3	34.4	91.3	63.3	139.4	78.1	133.0	41.2	145.4	151.5	109.3	207.4	20.7	119.1	53.1	19.1	25.1	75.9	29.5	25.8	62.2	84.6	193.9	56.9	88.9	86.3	224.9	128.2	87.3	89.6	50.2	128.9	124.4	141.2	53.5	94.6	127.3	78.3	47.5	77.4	95.2	89.1	81.3	72.0	30.9	75.7	76.8	88.3	182.6	62.8	207.6	210.3	23.1	220.9	111.2	5.5	5.2	17.1	4.4	6.9	5.6	9.2	8.5	6.9	7.6	4.6	6.1	6.9	3.0	5.9	5.0	9.4	15.9	5.6	16.9	18.2	19.5	23.7	14.7	20.2	17.0	20.2	17.8	16.4	19.8	15.5	24.0	6.4	15.6	8.8	17.0	33.0	28.4	57.4	18.8	9.5	51.0	52.5	12.1	18.6	68.1	44.1	2.1	83.2	19.9	72.6	9.8	113.6	94.8	84.8	30.6	18.4	25.9	66.2	3.5	112.3	136.3	17.7	12.2	184.8	13.3	36.4	13.9	17.4	54.0	11.8	5.3	66.3	10.2	10.7	13.2	28.0	9.6	15.2	23.2	5.6	12.6	30.9	6.2	5.5	3.2	31.8	300.5	10.9	41.6	25.6	20.8	20.6	25.2	13.7	19.7	8.0	21.9	158.8	58.8	26.8	63.5	48.7	19.1	30.4	156.5	30.1
GNA12	gep	ENSG00000146535	"G protein subunit alpha 12"	Q03113	7	2728105-2844308	"Human disease related genes, Predicted intracellular proteins"		Transducer		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 53.2"	"Cell type enhanced"	"Detected in many"		"Oligodendrocyte precursor cells: 68.3;Syncytiotrophoblasts: 173.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB010046	Approved		Supported	Cytosol		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 70: Brain - Nervous system development"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 65: Plasmacytoid DCs - Unknown function"	Cytosol		"CAB010046: AB_2263416"	"unprognostic (1.21e-1)"	"unprognostic (1.19e-2)"	"unprognostic (9.28e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.14e-2)"	"unprognostic (1.27e-3)"	"prognostic unfavorable (1.20e-6)"	"unprognostic (1.38e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.36e-2)"	"unprognostic (4.45e-3)"	"unprognostic (7.90e-2)"	"prognostic unfavorable (4.71e-5)"	"unprognostic (1.22e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.72e-1)"	"prognostic unfavorable (2.27e-4)"	17.8	14.9	42.5	11.2	47.1	11.0	12.2	38.4	35.8	12.9	18.3	16.6	5.1	17.0	4.7	7.7	12.9	9.4	17.9	36.1	39.6	8.6	9.3	12.8	12.8	53.2	43.9	18.2	11.9	8.0	12.3	24.4	42.5	9.5	6.1	3.0	8.0	11.4	6.7	5.0	11.3	13.6	46.2	10.6	11.6	10.1	52.6	5.6	6.7	7.3	10.1	16.6	9.2	42.3	35.5	19.1	19.4	29.2	30.4	24.1	53.5	29.1	33.7	30.9	35.3	18.4	24.5	7.5	19.4	34.6	64.7	15.6	13.5	30.1	20.9	89.9	13.5	15.3	9.9	19.6	35.4	2.5	13.1	23.5	16.1	36.3	24.4	31.8	33.3	10.6	17.3	23.0	28.1	16.8	4.1	14.1	27.3	9.1	32.9	26.8	22.4	15.2	11.4	23.8	15.4	22.3	16.4	24.4	12.2	27.6	13.6	20.9	39.5	33.6	39.9	33.2	48.6	16.1	20.3	6.8	36.1	22.5	33.7	1.4	0.5	0.1	0.2	1.3	0.3	1.0	0.5	0.3	0.4	1.7	0.5	0.0	0.1	0.0	0.3	1.8	0.7	0.4	42.5	47.1	38.4	35.8	36.1	39.6	53.2	43.9	42.5	46.2	52.6	42.3	21.8	6.4	11.7	41.8	22.0	7.0	3.8	5.4	0.6	6.0	14.5	10.4	16.3	10.0	6.1	1.8	12.5	63.7	16.6	8.0	3.9	7.9	13.3	9.3	21.8	16.7	7.8	9.5	31.9	10.2	17.0	19.6	10.2	10.8	0.0	13.9	19.2	13.5	25.4	8.4	36.0	5.5	6.1	21.6	63.5	13.6	17.1	25.8	21.4	22.5	21.7	16.1	7.2	68.3	29.9	13.2	4.0	18.8	7.3	8.4	4.7	7.1	5.8	10.7	0.0	16.8	17.3	8.6	9.4	1.2	3.7	173.2	6.2	23.7	5.3	3.2
GNA13	"G13, MGC46138"	ENSG00000120063	"G protein subunit alpha 13"	Q14344	17	65009289-65056740	"Cancer-related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"		Transducer	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 144.5"	"Cell type enriched"	"Detected in all"	4	"Langerhans cells: 537.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA010087	Approved		Supported	Cytosol		NA	NA		320000	"Cluster 7: Monocytes - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 41: Macrophages - Immune response"	Cytosol		"HPA010087: AB_10601478"	"unprognostic (2.55e-1)"	"unprognostic (2.27e-1)"	"unprognostic (1.33e-3)"	"unprognostic (1.23e-3)"	"unprognostic (8.21e-2)"	"unprognostic (7.05e-2)"	"unprognostic (4.22e-3)"	"unprognostic (1.09e-1)"	"unprognostic (7.77e-2)"	"unprognostic (4.66e-1)"	"unprognostic (1.16e-2)"	"unprognostic (1.94e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.59e-1)"	23.7	22.5	21.3	41.5	23.9	144.5	15.8	25.0	22.5	17.6	21.3	27.7	21.0	17.9	10.5	18.2	15.9	26.5	12.6	20.2	26.6	17.6	27.0	27.1	46.8	26.9	21.7	22.6	15.3	15.8	8.3	39.3	30.1	15.1	26.2	17.2	10.4	16.1	36.8	12.1	23.3	22.9	25.4	33.5	18.0	15.4	23.7	49.9	17.9	38.6	44.6	30.5	12.3	35.2	33.3	36.9	32.6	21.6	31.8	29.5	32.2	25.3	28.7	35.0	39.7	20.7	23.0	130.0	16.1	26.6	42.0	22.5	35.0	29.4	51.5	35.4	19.5	69.0	20.7	38.7	45.7	54.2	45.5	23.9	43.8	32.2	42.0	29.1	48.6	33.6	29.7	82.3	36.9	29.3	88.9	18.8	19.4	30.2	25.7	49.0	64.8	47.2	32.0	53.3	24.5	48.8	19.7	34.8	43.8	62.1	40.7	50.0	37.9	58.4	48.8	25.0	33.2	57.3	79.4	151.4	20.1	32.2	30.4	7.3	6.0	7.6	5.6	12.5	5.7	4.5	6.8	6.8	5.2	4.0	3.9	4.4	13.8	6.8	8.5	2.1	9.7	4.0	21.3	23.9	25.0	22.5	20.2	26.6	26.9	21.7	30.1	25.4	23.7	35.2	34.5	12.8	13.0	68.9	80.9	67.8	27.8	13.1	42.1	5.3	21.0	13.0	11.7	18.6	10.1	9.2	4.2	16.6	60.5	82.2	7.9	11.8	4.5	25.3	23.6	35.4	16.8	21.2	20.7	11.6	15.1	24.3	23.9	49.9	30.4	21.9	32.5	13.8	57.4	6.7	27.3	11.6	12.2	57.9	537.6	8.0	11.5	123.8	69.4	44.0	44.1	34.4	29.9	29.1	36.7	13.4	30.7	24.0	45.9	28.3	23.5	16.4	13.8	6.1	32.9	19.2	19.9	6.7	13.6	33.7	65.9	14.0	66.5	15.4	13.7	36.2
GNAI1		ENSG00000127955	"G protein subunit alpha i1"	P63096	7	79768028-80226181	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, Transport"	Transducer	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 220.0;Oligodendrocytes: 410.7;Suprabasal keratinocytes: 214.2;Syncytiotrophoblasts: 183.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	6	"NK-cell: 12.8"	"Lineage enriched"	"Detected in many"	6	"NK-cells: 12.8"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022449, HPA042141"	Approved		Supported	Nucleoplasm,Nucleoli,Centrosome		NA	NA		1600000	"Cluster 48: NK-cells - Unknown function"	"Cluster 31: Skin - Epidermis development"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Centrosome	"Nucleoplasm, Nucleoli"	"CAB022449: , HPA042141: AB_2677870"	"unprognostic (2.29e-1)"	"unprognostic (2.83e-2)"	"unprognostic (2.64e-2)"	"unprognostic (1.54e-1)"	"unprognostic (7.05e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.92e-2)"	"unprognostic (2.08e-2)"	"prognostic unfavorable (5.09e-4)"	"unprognostic (9.78e-2)"	"unprognostic (1.26e-1)"	"unprognostic (4.48e-1)"	"unprognostic (9.41e-3)"	"prognostic unfavorable (6.47e-4)"	"unprognostic (1.12e-1)"	"unprognostic (1.94e-2)"	"unprognostic (1.53e-1)"	47.5	26.2	8.9	2.6	18.8	0.4	34.9	14.9	17.7	18.5	4.4	25.4	4.7	14.8	0.7	19.7	10.9	3.2	9.4	10.8	13.3	36.6	15.2	15.2	2.0	18.8	15.0	17.1	4.5	1.3	10.9	13.6	18.4	8.8	2.6	1.5	10.4	3.0	6.2	47.9	9.9	4.1	15.5	5.9	17.7	13.0	14.2	1.3	14.2	2.9	1.5	24.7	19.9	36.6	2.2	18.6	10.5	0.0	14.5	7.9	9.1	14.3	7.2	5.5	8.7	0.0	3.4	0.0	4.5	9.3	5.1	2.6	7.0	9.5	5.4	0.0	11.9	10.4	12.9	1.2	14.8	1.8	0.0	12.0	19.9	4.1	9.5	4.4	3.5	0.0	0.0	0.1	7.7	0.6	0.0	0.1	6.1	0.2	11.0	8.6	5.2	7.8	15.7	7.0	12.5	9.2	13.5	0.0	10.3	5.4	2.0	0.3	13.0	21.8	15.6	5.1	4.4	0.0	0.0	0.2	6.1	1.2	10.2	1.3	0.4	0.4	0.1	0.4	0.0	0.0	0.1	0.1	1.9	0.1	1.1	0.5	0.3	12.8	1.0	0.2	0.1	0.4	8.9	18.8	14.9	17.7	10.8	13.3	18.8	15.0	18.4	15.5	14.2	36.6	121.1	19.2	13.8	11.4	0.9	220.0	20.6	81.6	35.3	3.9	7.0	7.7	6.7	21.5	42.3	29.5	0.0	83.6	1.3	11.1	88.0	7.2	1.7	23.2	58.5	31.5	19.9	4.2	71.4	3.8	84.6	35.9	4.6	40.3	30.3	43.9	17.5	20.0	10.0	26.9	77.4	7.8	36.7	1.0	28.6	7.0	33.5	3.9	103.2	4.7	2.9	49.1	0.0	53.3	410.7	9.4	6.3	74.4	1.2	17.4	0.9	18.4	36.8	5.0	111.7	10.6	70.8	9.7	45.7	31.9	214.2	183.5	2.9	2.9	10.7	19.2
GNAI2	"GIP, GNAI2B"	ENSG00000114353	"G protein subunit alpha i2"	P04899	3	50226292-50259362	"Human disease related genes, Predicted intracellular proteins"	"Cell cycle, Cell division"	Transducer		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Adipocytes: 656.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007704	Approved		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA		4000000	"Cluster 52: Eosinophils - Transcription"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 7: Non-specific - Mitochondria"	Cytosol	"Nucleoplasm, Plasma membrane"	"HPA007704: AB_1849230"	"prognostic favorable (1.03e-4)"	"unprognostic (3.89e-1)"	"unprognostic (3.35e-2)"	"unprognostic (8.40e-3)"	"unprognostic (2.58e-1)"	"unprognostic (2.32e-2)"	"unprognostic (2.59e-2)"	"unprognostic (3.23e-1)"	"unprognostic (1.08e-3)"	"unprognostic (6.01e-2)"	"unprognostic (7.00e-3)"	"unprognostic (1.12e-1)"	"unprognostic (6.24e-3)"	"unprognostic (1.44e-1)"	"unprognostic (4.30e-2)"	"unprognostic (4.33e-2)"	"unprognostic (1.38e-1)"	210.2	100.3	155.2	217.9	167.3	367.1	152.8	166.3	181.6	146.0	120.2	142.1	69.9	141.7	66.9	124.4	136.9	152.5	157.1	144.3	184.6	79.4	126.5	214.5	251.3	199.8	170.2	147.7	64.1	66.9	99.2	241.8	194.8	103.6	64.3	35.6	71.9	156.9	69.3	87.0	103.0	154.0	173.6	262.1	73.6	69.6	173.3	160.3	101.3	89.4	170.4	169.7	108.4	193.2	128.2	63.0	186.3	197.6	220.7	277.5	35.5	271.1	399.6	354.9	361.1	70.4	173.2	149.1	119.2	567.0	193.4	100.1	132.8	350.3	222.8	331.2	50.9	364.8	158.0	110.2	219.8	329.2	479.8	270.3	152.9	319.1	129.8	289.6	837.8	124.1	26.1	307.1	357.5	155.7	313.6	433.0	109.7	59.0	302.4	185.0	89.8	219.7	232.6	130.9	48.4	86.1	189.5	57.1	124.4	150.4	94.3	346.1	792.3	330.9	187.5	309.2	274.7	199.4	278.3	127.0	373.6	466.9	398.1	16.6	59.3	113.7	33.7	80.9	20.2	28.8	26.8	34.3	57.3	26.1	20.2	25.8	145.2	23.5	74.5	47.2	34.0	27.3	155.2	167.3	166.3	181.6	144.3	184.6	199.8	170.2	194.8	173.6	173.3	193.2	656.8	41.7	32.1	25.1	119.5	56.7	59.7	32.3	45.5	29.0	61.6	83.8	22.9	55.8	26.6	44.1	14.6	79.5	311.4	11.7	5.9	124.3	203.3	57.8	115.7	340.3	92.2	52.1	12.4	60.5	84.4	101.9	21.9	71.8	89.9	150.0	221.3	79.7	336.0	6.7	14.8	24.6	18.3	342.7	291.7	302.0	90.7	386.1	83.6	58.1	356.6	292.6	151.4	26.7	45.4	160.3	40.9	95.5	104.8	46.1	30.3	24.5	24.4	21.9	52.6	85.3	163.1	16.6	22.6	37.6	62.9	116.4	164.9	156.3	20.5	70.1
GNAS	"GNAS1, GNASXL, GPSA, NESP, NESP55, SCG6, SgVI"	ENSG00000087460	"GNAS complex locus"	"O95467, P63092, P84996, Q5JWF2"	20	58839718-58911192	"Cancer-related genes, Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		Transducer	"Cancer-related genes, Cushing syndrome, Disease variant, Dwarfism, Obesity, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Horizontal cells: 1886.1;Late spermatids: 1756.9;Skeletal myocytes: 1998.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010337, HPA018122, HPA027478, HPA028386"	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cytosol"	"Intracellular and membrane"	NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm	"Plasma membrane, Cytosol"	"CAB010337: AB_631538, HPA018122: AB_1849236, HPA027478: AB_10599284, HPA028386: AB_10601983"	"unprognostic (7.48e-2)"	"unprognostic (1.41e-1)"	"unprognostic (3.90e-2)"	"unprognostic (4.77e-2)"	"unprognostic (8.37e-3)"	"unprognostic (2.82e-2)"	"unprognostic (4.53e-3)"	"unprognostic (8.01e-2)"	"unprognostic (4.29e-2)"	"prognostic favorable (8.76e-4)"	"unprognostic (2.07e-2)"	"unprognostic (1.58e-1)"	"prognostic unfavorable (3.49e-4)"	"unprognostic (5.24e-3)"	"unprognostic (1.61e-1)"	"unprognostic (8.25e-2)"	"unprognostic (1.36e-1)"	784.8	1215.3	1564.4	512.6	1524.7	887.4	578.9	1413.1	1768.3	828.5	1373.3	657.1	492.4	611.4	1253.8	883.1	742.9	672.7	1990.6	1557.3	2716.9	625.0	651.1	640.3	769.2	1710.5	1949.4	766.5	1917.7	1799.4	1153.6	884.6	1963.4	577.3	607.3	731.2	2943.9	594.4	2400.4	526.8	527.3	782.4	1598.4	606.6	587.1	357.9	1882.0	854.4	3432.2	2813.1	800.0	687.1	239.3	1483.9	215.6	897.3	1501.9	663.3	2691.8	1822.3	1200.1	1219.1	1635.0	1937.3	1201.8	2480.5	1446.7	911.9	1670.3	2314.3	1305.6	976.1	1499.0	2195.3	1540.9	401.4	784.6	984.9	1651.7	2232.7	1420.7	641.6	483.0	1566.4	1113.6	875.1	1399.1	1561.0	1669.7	1100.6	692.0	1294.6	1319.1	4131.0	1759.5	1452.8	487.9	214.0	894.4	1436.7	1287.3	1589.4	2165.5	1315.8	1818.3	3853.2	2157.6	2117.1	1354.2	1921.8	1570.0	1581.7	1343.3	2210.2	1477.0	688.5	1452.3	1314.0	993.3	1583.2	900.0	473.7	1107.1	217.9	96.7	114.2	68.9	127.3	80.0	103.2	73.4	74.8	129.2	93.6	65.8	82.6	103.4	95.6	150.3	174.9	92.7	100.9	1564.4	1524.7	1413.1	1768.3	1557.3	2716.9	1710.5	1949.4	1963.4	1598.4	1882.0	1483.9	982.6	221.2	258.8	192.0	310.8	130.4	182.0	130.0	205.5	397.8	465.6	684.4	1025.3	237.4	212.2	261.1	56.3	832.6	390.8	357.3	444.1	233.9	734.9	487.7	515.7	518.3	463.1	252.1	232.5	228.9	342.0	380.9	196.3	685.0	138.6	542.3	380.1	256.4	379.1	1886.1	439.7	327.2	181.0	380.4	405.7	1756.9	265.3	437.1	222.3	236.1	204.0	1367.2	137.0	194.5	166.6	339.9	300.0	197.1	309.7	268.1	273.7	153.6	218.0	222.0	210.4	1998.0	560.4	226.0	73.6	240.5	117.8	1211.7	301.8	860.9	304.4	316.5
GNB2		ENSG00000172354	"G protein subunit beta 2"	P62879	7	100673567-100679174	"Predicted intracellular proteins, RAS pathway related proteins, Transporters"		Transducer		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010032, HPA040736"	Approved		Supported	"Plasma membrane"		NA	NA		940000	"Cluster 52: Eosinophils - Transcription"	"Cluster 72: Non-specific - Transcription"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 10: Non-specific - Unknown function"	"Plasma membrane"		"CAB010032: AB_2263466, HPA040736: AB_2677106"	"unprognostic (1.55e-1)"	"unprognostic (5.76e-2)"	"unprognostic (1.01e-3)"	"unprognostic (2.76e-1)"	"unprognostic (1.11e-2)"	"unprognostic (1.94e-1)"	"unprognostic (3.68e-3)"	"unprognostic (3.52e-1)"	"unprognostic (6.58e-2)"	"unprognostic (2.54e-1)"	"unprognostic (9.79e-3)"	"unprognostic (1.70e-1)"	"unprognostic (3.75e-2)"	"unprognostic (1.24e-1)"	"unprognostic (3.19e-1)"	"unprognostic (5.29e-2)"	"unprognostic (2.98e-1)"	198.4	211.0	131.4	128.3	137.3	207.5	188.0	112.3	179.6	209.4	103.8	168.0	103.2	182.4	63.7	328.4	179.8	105.5	175.9	130.2	138.1	186.1	185.8	210.1	107.9	140.3	130.1	175.3	184.8	98.9	203.3	107.4	123.6	183.0	83.6	20.1	190.8	113.6	175.9	295.5	143.5	113.5	126.3	225.9	172.4	92.9	137.6	90.2	144.8	90.2	105.7	165.2	217.7	120.7	358.6	268.6	222.7	272.5	169.8	199.9	194.3	208.4	288.4	294.3	241.7	205.3	333.7	157.7	216.0	311.3	332.2	243.0	177.7	312.6	103.0	216.9	152.1	120.8	198.7	171.3	282.4	157.7	254.5	259.5	291.1	304.2	244.6	237.6	343.6	132.5	228.6	303.3	270.4	980.0	249.5	450.3	173.5	225.1	290.1	234.3	136.3	253.8	235.4	291.3	241.0	380.1	278.0	449.2	201.3	125.3	192.4	192.1	325.8	313.8	346.8	619.2	266.6	88.8	111.9	240.9	237.1	349.7	443.6	27.6	28.6	70.9	17.5	42.7	16.2	13.6	17.9	15.4	28.1	18.1	11.8	12.4	117.2	15.4	35.9	23.8	23.5	12.5	131.4	137.3	112.3	179.6	130.2	138.1	140.3	130.1	123.6	126.3	137.6	120.7	138.1	57.7	97.0	16.0	104.1	151.8	159.3	72.9	148.0	10.4	105.4	106.0	35.0	100.1	55.5	84.6	4.2	172.4	89.4	285.4	162.4	163.7	32.6	133.5	106.8	136.5	180.4	127.7	12.7	218.7	312.1	117.6	135.1	127.2	44.4	97.6	126.0	69.9	264.4	72.3	10.8	211.2	75.3	198.6	198.8	20.1	144.8	193.5	140.5	15.9	160.8	128.2	96.8	5.0	6.9	257.1	285.6	130.1	122.5	226.5	162.3	107.0	68.3	8.5	65.7	62.0	162.2	34.3	69.6	240.7	194.8	293.9	117.8	88.1	192.2	259.5
GNB4		ENSG00000114450	"G protein subunit beta 4"	Q9HAV0	3	179396088-179451476	"Disease related genes, Human disease related genes, Predicted intracellular proteins, RAS pathway related proteins"		Transducer	"Charcot-Marie-Tooth disease, Disease variant, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 81.1;Kupffer cells: 98.1;Macrophages: 66.8;Microglial cells: 91.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 143.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB018383, CAB018737, HPA040736"	Supported		Supported	"Plasma membrane"		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 61: Skin - Cornification"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 4: Macrophages - Innate immune response"	"Plasma membrane"		"CAB018383: AB_631542, CAB018737: AB_640712, HPA040736: AB_2677106"	"unprognostic (2.56e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.01e-1)"	"unprognostic (5.97e-3)"	"unprognostic (2.12e-1)"	"unprognostic (1.44e-2)"	"unprognostic (8.28e-2)"	"unprognostic (1.16e-1)"	"unprognostic (3.44e-1)"	"unprognostic (1.56e-1)"	"unprognostic (2.32e-2)"	"prognostic unfavorable (1.39e-6)"	"unprognostic (1.90e-3)"	"unprognostic (3.13e-2)"	"unprognostic (8.90e-2)"	"unprognostic (2.80e-3)"	14.9	6.3	8.7	21.9	19.2	33.7	12.4	7.3	11.2	11.5	2.9	9.5	5.9	9.2	3.7	21.9	7.0	15.2	13.9	9.6	8.7	5.9	7.8	16.0	17.7	15.5	8.5	5.8	2.8	2.7	3.0	21.8	14.5	4.5	8.6	2.0	4.7	4.0	3.1	34.1	6.4	23.5	14.5	18.1	7.4	4.3	10.9	7.9	6.3	5.7	11.5	13.2	6.8	19.7	33.4	15.4	37.7	0.8	23.8	41.5	44.1	46.7	33.1	54.1	61.3	0.8	3.7	61.6	9.9	54.3	49.7	0.6	36.4	43.1	56.7	143.6	29.2	71.3	54.9	0.7	23.4	62.3	16.2	32.9	6.6	42.4	21.6	12.0	59.3	13.7	18.7	0.8	42.8	1.3	32.8	24.3	18.9	0.2	19.3	61.4	49.2	25.3	34.9	1.9	7.0	20.5	37.5	33.0	61.1	23.0	67.5	26.1	45.3	45.1	27.4	13.6	61.6	0.3	0.9	0.8	24.7	52.8	35.4	5.6	21.3	11.0	0.2	27.8	0.1	6.7	0.4	0.3	24.9	13.6	0.4	0.3	14.5	3.4	23.5	12.8	0.6	8.8	8.7	19.2	7.3	11.2	9.6	8.7	15.5	8.5	14.5	14.5	10.9	19.7	40.0	25.6	12.8	17.9	20.1	18.7	1.8	2.5	13.6	1.7	14.3	12.3	15.6	0.0	12.3	3.7	6.2	13.8	11.5	0.1	3.9	1.1	1.2	15.6	22.9	42.9	0.0	22.9	18.6	1.6	18.7	26.6	3.6	10.8	10.8	16.2	53.2	0.9	81.1	1.7	18.4	0.0	2.0	98.1	17.4	1.4	10.2	66.8	14.2	91.8	59.9	0.8	2.1	11.6	7.7	2.8	0.0	15.8	8.1	2.6	0.2	0.2	11.3	4.0	26.3	9.9	41.8	2.3	16.8	23.4	25.4	4.1	2.9	14.7	0.0	1.3
GNE	"IBM2, Uae1"	ENSG00000159921	"Glucosamine (UDP-N-acetyl)-2-epimerase/N-acetylmannosamine kinase"	Q9Y223	9	36214441-36277042	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Allosteric enzyme, Hydrolase, Kinase, Multifunctional enzyme, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"intestine: 48.4;liver: 90.5;salivary gland: 55.3"	"Cell type enhanced"	"Detected in all"		"Distal enterocytes: 59.3;Hepatocytes: 119.3;Intestinal goblet cells: 88.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"RPTEC TERT1: 107.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007045, HPA027258"	Approved		Supported	Cytosol		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 85: Liver - Metabolism"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 27: Mucus-secreting cells - Mucin production"	Cytosol		"HPA007045: AB_1079003, HPA027258: AB_1849873"	"unprognostic (7.54e-2)"	"unprognostic (1.61e-2)"	"unprognostic (1.07e-3)"	"unprognostic (7.28e-2)"	"unprognostic (7.00e-2)"	"unprognostic (1.85e-2)"	"unprognostic (2.78e-3)"	"unprognostic (5.39e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.70e-2)"	"unprognostic (2.88e-3)"	"unprognostic (4.20e-2)"	"prognostic favorable (9.28e-11)"	"unprognostic (2.90e-1)"	"unprognostic (8.28e-2)"	"unprognostic (2.95e-1)"	"unprognostic (1.72e-2)"	11.9	9.0	5.5	8.7	7.4	15.5	15.8	8.9	6.5	11.3	7.9	34.0	4.3	10.3	3.5	11.6	9.1	7.4	7.7	5.5	7.3	10.0	90.5	6.8	7.3	7.7	7.3	14.8	10.2	6.1	4.8	14.2	8.9	15.3	48.4	8.0	55.3	7.2	7.9	3.8	7.6	11.7	6.6	6.2	4.6	4.8	7.1	6.2	6.9	15.3	9.5	14.2	7.5	10.5	9.9	44.4	20.1	17.1	22.5	22.4	29.9	13.5	17.9	19.5	25.1	10.5	32.6	13.5	14.2	24.2	50.5	3.9	15.3	4.6	21.8	25.1	1.4	11.0	26.0	15.2	15.4	0.2	31.2	14.4	4.6	32.0	30.6	14.3	8.4	20.7	14.4	27.3	19.3	1.8	19.1	6.3	11.8	6.7	23.7	15.5	16.3	3.8	107.7	19.4	16.7	15.2	13.7	5.3	12.6	7.1	4.8	12.0	12.2	12.7	12.9	15.5	12.2	11.7	26.0	7.0	17.0	9.8	18.2	0.2	0.5	0.2	0.7	0.6	0.5	0.6	0.9	0.8	0.4	0.9	1.0	1.2	0.3	0.7	0.8	0.6	0.4	0.6	5.5	7.4	8.9	6.5	5.5	7.3	7.7	7.3	8.9	6.6	7.1	10.5	9.7	9.6	10.0	9.4	7.1	1.9	3.1	6.7	1.8	8.4	8.2	7.5	6.7	10.0	16.9	9.2	6.2	8.6	4.3	59.3	1.9	10.4	3.4	7.2	12.1	6.3	11.5	7.8	12.8	6.0	9.5	8.3	2.6	10.6	10.1	9.1	7.1	119.3	2.9	11.8	15.6	88.1	16.2	7.8	4.4	2.4	10.8	5.4	1.8	5.6	6.1	1.9	2.1	32.2	28.2	5.3	20.3	6.4	7.9	6.9	2.9	2.2	18.8	6.9	13.1	10.0	6.3	1.8	2.7	1.2	1.6	19.8	5.7	2.3	26.8	13.4
GNL1	HSR1	ENSG00000204590	"G protein nucleolar 1 (putative)"	P36915	6	30541377-30557174	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 193.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB033575, HPA043338, HPA050455"	Uncertain		Supported	Vesicles		NA	NA		11000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 71: Testis - DNA repair"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 25: Spermatids - Spermatogenesis"	Vesicles		"CAB033575: AB_2109945, HPA043338: AB_2678437, HPA050455: AB_2681132"	"unprognostic (2.76e-2)"	"unprognostic (3.68e-2)"	"unprognostic (2.21e-1)"	"unprognostic (3.53e-2)"	"unprognostic (3.30e-2)"	"unprognostic (2.75e-1)"	"unprognostic (4.22e-2)"	"unprognostic (8.33e-2)"	"unprognostic (1.03e-1)"	"unprognostic (3.84e-2)"	"unprognostic (3.95e-3)"	"unprognostic (7.32e-2)"	"unprognostic (5.67e-3)"	"unprognostic (4.42e-2)"	"unprognostic (2.10e-1)"	"unprognostic (4.15e-1)"	"unprognostic (1.78e-1)"	22.6	19.6	3.3	3.5	3.5	2.0	21.7	2.0	4.0	30.5	1.7	19.3	0.6	27.3	3.9	17.0	26.2	2.4	15.2	2.3	4.8	21.2	13.1	27.8	2.3	3.3	3.0	37.5	24.3	7.8	23.8	2.8	3.5	19.9	3.4	4.1	16.6	3.9	15.0	23.3	17.4	4.5	2.7	18.7	20.0	38.0	4.7	5.0	23.3	1.6	4.6	21.1	22.9	5.4	10.5	2.2	5.9	16.9	10.9	12.8	0.4	3.2	6.4	2.6	4.0	15.1	6.5	4.8	6.2	10.4	25.8	6.9	15.4	12.7	4.4	1.8	9.0	7.8	7.9	1.4	0.0	1.3	5.0	11.0	9.9	20.4	6.7	0.0	1.1	18.6	14.2	0.3	6.5	2.4	3.8	0.2	3.4	8.4	1.6	7.3	3.6	5.3	8.7	4.5	5.2	4.9	4.2	3.1	1.6	2.0	3.0	4.9	6.2	10.5	3.0	2.0	3.7	7.9	9.3	9.9	0.1	6.6	13.1	0.2	0.2	0.2	0.7	0.2	1.0	0.4	0.8	0.9	0.0	0.3	0.1	0.3	0.2	0.4	0.2	0.1	0.5	0.5	3.3	3.5	2.0	4.0	2.3	4.8	3.3	3.0	3.5	2.7	4.7	5.4	48.2	44.8	41.8	17.3	45.0	59.3	104.0	44.1	56.3	40.6	35.4	40.6	14.3	34.3	28.8	25.8	41.7	72.6	36.3	22.6	23.5	38.4	113.1	30.0	40.2	50.8	46.0	13.3	26.2	35.3	65.5	46.4	27.5	47.5	31.7	40.9	50.7	16.9	28.5	16.8	27.0	25.8	26.4	19.8	32.5	193.5	36.4	24.6	28.4	9.4	14.8	30.9	18.6	11.1	10.8	29.9	22.1	32.0	42.6	56.2	32.4	30.3	20.7	34.6	39.5	47.9	58.1	108.4	51.8	36.1	40.6	160.1	46.0	40.9	27.0	66.7
GNL3	"C77032, E2IG3, MGC800, NS"	ENSG00000163938	"G protein nucleolar 3"	Q9BVP2	3	52681156-52694497	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB020770, HPA036742, HPA036743"	Enhanced		Enhanced	"Nucleoli rim,Nuclear bodies,Mitotic chromosome"		Yes	No		13000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoli rim"	"Nuclear bodies, Mitotic chromosome"	"CAB020770: , HPA036742: AB_2675282, HPA036743: AB_2675283"	"unprognostic (4.40e-1)"	"unprognostic (9.30e-2)"	"unprognostic (4.10e-3)"	"unprognostic (2.21e-1)"	"unprognostic (5.11e-2)"	"unprognostic (1.98e-1)"	"prognostic unfavorable (2.93e-4)"	"unprognostic (1.46e-1)"	"unprognostic (3.29e-3)"	"unprognostic (1.14e-2)"	"unprognostic (1.67e-3)"	"prognostic unfavorable (6.11e-4)"	"prognostic unfavorable (5.69e-5)"	"unprognostic (1.33e-1)"	"unprognostic (9.25e-2)"	"unprognostic (1.03e-3)"	"unprognostic (1.06e-2)"	47.2	47.1	17.1	42.1	17.0	27.4	68.8	18.4	24.4	38.8	18.7	40.0	38.8	33.8	25.6	65.0	28.2	28.0	29.6	17.9	19.4	33.4	50.3	29.7	51.5	17.9	17.7	35.8	60.7	27.1	35.9	36.4	17.8	46.7	46.0	16.0	46.4	26.3	78.2	39.1	29.6	32.2	16.9	34.0	41.0	26.8	17.9	35.9	28.6	42.9	64.9	92.3	41.3	19.1	110.4	79.1	114.4	125.3	105.6	105.1	178.1	133.0	101.5	135.4	100.6	121.3	80.8	255.4	42.2	100.1	104.6	78.2	189.1	125.1	180.5	156.3	134.6	196.8	139.0	189.3	218.1	283.7	138.0	96.1	216.5	147.8	224.1	90.3	107.8	99.7	214.8	136.2	93.8	77.7	170.6	162.1	195.6	153.4	151.2	99.3	93.0	315.0	108.9	153.9	81.4	105.6	82.1	190.5	193.6	101.7	74.7	155.8	86.6	92.8	100.0	139.2	281.7	147.6	252.0	387.0	96.9	203.5	148.4	1.2	15.2	3.3	19.9	16.7	34.1	28.7	26.8	24.1	26.1	23.9	30.4	29.4	1.8	26.1	12.9	40.7	18.8	20.2	17.1	17.0	18.4	24.4	17.9	19.4	17.9	17.7	17.8	16.9	17.9	19.1	34.6	22.4	48.2	5.2	84.3	163.7	146.0	111.9	77.4	19.0	72.6	46.4	51.3	25.8	144.9	12.9	10.4	73.2	78.5	42.8	41.1	105.1	54.4	44.7	76.5	53.4	47.8	51.5	11.6	104.6	117.5	92.9	47.9	53.0	63.1	47.5	23.2	41.9	40.9	21.9	11.1	71.7	67.1	24.2	77.6	28.2	51.9	43.0	78.2	5.6	59.5	17.7	38.1	7.1	9.4	99.9	34.4	34.3	122.3	126.1	19.1	47.2	56.5	14.8	6.6	106.2	79.1	37.9	74.4	59.4	153.7	90.3	63.0	74.5	85.8	135.7
GNL3L	"FLJ10613, GNL3B"	ENSG00000130119	"G protein nucleolar 3 like"	Q9NVN8	X	54530183-54621521	"Predicted intracellular proteins"	"Ribosome biogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036314, HPA036315"	Supported		Supported	Nucleoplasm,Nucleoli,Cytosol		NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 52: Non-specific - Ribosome"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 52: Non-specific - Transcription"	Nucleoli	"Nucleoplasm, Cytosol"	"HPA036314: AB_10669986, HPA036315: AB_2675055"	"unprognostic (9.71e-3)"	"unprognostic (6.58e-2)"	"unprognostic (6.24e-2)"	"unprognostic (1.99e-2)"	"unprognostic (1.13e-2)"	"unprognostic (1.38e-1)"	"unprognostic (2.92e-2)"	"unprognostic (5.46e-2)"	"unprognostic (8.44e-2)"	"unprognostic (9.97e-2)"	"unprognostic (4.91e-3)"	"unprognostic (7.87e-2)"	"unprognostic (8.05e-3)"	"unprognostic (2.99e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.75e-3)"	"unprognostic (1.10e-1)"	4.6	3.6	2.0	7.0	3.6	8.9	4.8	2.6	2.7	4.8	3.1	4.7	3.9	4.7	3.7	5.7	4.7	4.7	7.2	2.7	2.6	4.4	3.9	5.0	7.6	3.1	3.6	3.8	5.0	5.7	2.3	5.6	3.2	3.7	6.1	3.8	4.0	4.4	7.1	5.7	4.7	7.3	2.7	6.9	5.3	2.3	3.4	8.3	8.5	7.8	8.5	6.7	3.5	5.4	20.7	49.1	9.5	20.9	10.2	8.3	15.2	9.8	8.7	13.4	9.9	43.4	16.6	26.9	21.3	18.2	15.1	18.7	34.6	14.9	19.0	15.9	16.4	30.0	34.0	17.2	7.9	42.6	26.0	10.0	7.1	31.0	17.4	5.7	13.4	16.4	19.2	27.0	14.0	36.5	25.5	11.8	29.6	13.0	26.7	27.7	23.9	27.8	10.3	28.8	17.1	8.4	39.7	24.3	11.7	20.9	30.9	11.4	20.0	22.6	22.1	21.8	18.4	19.9	25.7	35.9	12.8	34.6	27.8	23.6	14.4	15.0	16.5	12.8	15.0	15.1	14.8	13.8	11.1	16.0	10.6	11.7	19.2	21.5	15.0	10.2	9.3	12.5	2.0	3.6	2.6	2.7	2.7	2.6	3.1	3.6	3.2	2.7	3.4	5.4	9.2	12.8	18.5	14.4	15.3	1.3	3.6	3.9	9.6	10.2	6.1	3.9	8.5	8.6	11.8	3.7	12.5	7.1	14.1	7.4	3.9	9.4	0.4	8.2	17.2	9.4	3.5	12.0	14.8	8.7	6.4	7.4	10.7	9.6	10.8	10.9	7.1	4.6	4.9	8.4	14.8	4.7	8.2	9.4	4.2	0.0	5.6	9.4	0.0	14.0	12.0	3.4	25.7	16.1	23.2	9.8	3.9	3.0	10.0	4.2	6.8	5.3	7.8	9.3	6.6	8.5	7.1	1.1	7.7	6.6	2.0	5.5	11.9	9.5	7.6	3.6
GNPTAB	"GNPTA, KIAA1208, MGC4170"	ENSG00000111670	"N-acetylglucosamine-1-phosphate transferase subunits alpha and beta"	Q3T906	12	101745499-101830959	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		Transferase	"Cancer-related genes, Disease variant, Mucolipidosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"NK-cells: 192.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014558, HPA042343"	Approved		Supported	"Golgi apparatus"		NA	NA		160000	"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 63: NK-cells & T-cells - Immune response"	"Golgi apparatus"		"HPA014558: AB_2732409, HPA042343: "	"unprognostic (6.72e-2)"	"unprognostic (1.66e-1)"	"unprognostic (8.71e-3)"	"prognostic favorable (8.48e-4)"	"unprognostic (1.39e-1)"	"unprognostic (8.37e-2)"	"unprognostic (2.73e-1)"	"unprognostic (8.57e-2)"	"unprognostic (3.73e-2)"	"unprognostic (1.09e-2)"	"unprognostic (2.28e-2)"	"unprognostic (2.00e-1)"	"unprognostic (6.86e-2)"	"unprognostic (3.44e-1)"	"unprognostic (1.02e-1)"	"unprognostic (5.44e-2)"	"unprognostic (4.98e-2)"	11.9	7.9	18.8	16.2	22.2	23.9	16.4	14.4	20.0	17.4	2.7	29.6	14.2	11.8	6.2	15.6	8.8	14.8	21.5	22.7	10.8	14.5	9.4	27.0	20.6	8.5	11.1	7.2	11.3	23.0	8.4	14.8	9.7	20.1	30.3	13.0	54.3	13.0	16.4	25.1	16.2	15.9	8.9	19.0	21.3	10.4	12.4	34.1	13.9	25.9	17.8	19.3	12.0	13.3	18.2	17.5	6.4	10.9	52.3	24.8	19.6	25.4	52.3	24.7	32.2	13.5	12.4	38.1	17.9	35.1	20.1	23.2	29.8	32.8	38.4	18.1	15.6	16.3	15.4	19.3	9.7	15.0	31.7	19.3	17.7	23.5	13.8	61.4	44.0	30.0	25.9	11.0	23.4	27.8	45.6	21.0	22.0	22.6	12.5	10.6	32.6	51.2	39.5	46.8	13.6	11.2	42.3	29.7	60.7	23.5	30.6	9.8	43.6	23.1	12.5	19.6	14.4	30.0	32.9	21.5	26.4	21.8	14.6	8.6	3.8	4.4	18.8	3.6	6.2	3.0	4.0	10.3	7.1	4.9	5.1	7.9	1.4	17.0	4.6	6.9	3.3	3.7	18.8	22.2	14.4	20.0	22.7	10.8	8.5	11.1	9.7	8.9	12.4	13.3	25.3	60.9	65.0	35.9	42.1	16.8	32.9	16.2	17.1	23.6	25.2	18.9	43.5	18.6	27.8	22.0	25.0	25.7	107.3	68.3	7.9	10.3	0.6	25.3	23.7	21.1	18.0	19.5	84.5	15.1	15.0	18.9	33.1	61.6	122.8	24.6	10.4	9.7	46.7	8.4	83.8	29.6	24.4	46.7	17.6	3.8	17.1	41.2	42.7	30.0	43.5	26.9	192.6	135.2	19.8	15.7	129.3	12.8	63.9	28.1	17.7	13.8	10.0	37.0	0.0	18.6	14.9	12.4	33.0	26.7	14.3	8.8	63.4	30.6	49.7	46.5
GOLGA4	"GCP2, GOLG, golgin-240, p230"	ENSG00000144674	"Golgin A4"	Q13439	3	37243177-37366751	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 683.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035102, HPA040675"	Supported		Supported	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 54: Cardiomyocytes - Muscle contraction"	"Golgi apparatus"	Nucleoplasm	"HPA035102: AB_10601472, HPA040675: "	"unprognostic (9.46e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.18e-2)"	"unprognostic (5.67e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.54e-1)"	"unprognostic (5.61e-2)"	"unprognostic (1.38e-1)"	"unprognostic (5.79e-3)"	"unprognostic (3.90e-2)"	"unprognostic (5.62e-2)"	"unprognostic (8.55e-2)"	"prognostic favorable (3.62e-6)"	"unprognostic (7.16e-2)"	"unprognostic (1.04e-1)"	"unprognostic (3.92e-2)"	"unprognostic (1.33e-1)"	38.6	36.3	18.3	19.5	26.7	21.2	28.8	26.6	22.3	27.6	58.3	28.1	38.8	20.0	23.5	37.3	21.1	19.3	63.7	17.6	20.8	34.5	60.8	25.7	17.0	27.2	24.6	23.4	48.0	33.5	40.6	36.1	27.5	29.6	28.1	56.8	38.4	20.7	118.8	48.2	36.9	19.5	21.8	24.1	38.2	44.3	22.3	17.6	47.2	102.3	19.6	25.0	28.9	29.9	62.6	42.3	21.4	27.1	55.2	47.2	54.4	78.3	65.2	30.2	36.3	36.5	33.9	21.4	19.9	67.1	34.7	35.9	34.4	55.5	62.3	27.4	25.2	28.9	37.9	58.5	55.2	30.9	20.3	25.4	51.8	47.7	92.1	48.8	44.4	15.8	35.9	32.6	49.1	26.8	23.7	13.4	23.4	31.7	39.9	5.4	64.8	22.8	37.4	64.4	13.7	18.1	48.6	51.8	61.4	40.8	76.3	22.4	54.0	30.7	35.6	60.0	56.7	39.8	30.1	18.3	54.4	26.6	36.8	30.7	6.6	15.5	16.2	7.6	14.0	9.9	10.3	11.9	5.5	11.6	10.7	8.1	8.9	15.7	15.2	11.8	7.6	4.3	18.3	26.7	26.6	22.3	17.6	20.8	27.2	24.6	27.5	21.8	22.3	29.9	85.4	237.2	312.9	142.0	98.2	158.3	134.0	70.2	128.1	171.9	97.0	84.1	683.5	84.4	147.4	46.0	358.6	112.7	126.4	154.3	29.4	117.5	240.7	131.6	141.8	102.2	89.6	127.1	154.5	120.2	117.8	128.0	140.2	242.7	62.0	112.9	63.1	147.5	92.0	188.4	168.6	166.2	65.1	73.1	73.9	46.7	119.9	80.3	69.4	107.7	91.9	145.8	132.8	133.7	223.2	136.4	109.1	113.6	150.2	169.7	181.2	64.5	82.4	361.0	85.5	161.8	95.7	435.6	227.2	98.5	175.7	249.6	97.2	125.7	139.3	189.2
GOLGA5	"golgin-84, GOLIM5, ret-II, rfg5"	ENSG00000066455	"Golgin A5"	Q8TBA6	14	92794305-92839947	"Cancer-related genes, Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000992, HPA063876"	Enhanced	Supported	Supported	"Golgi apparatus"		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 21: OE19 - Mitochondria"	"Cluster 55: Plasma cells - Humoral immune response"	"Golgi apparatus"		"HPA000992: AB_1079009, HPA063876: AB_2685140"	"unprognostic (2.06e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.57e-1)"	"unprognostic (2.64e-1)"	"unprognostic (1.73e-1)"	"unprognostic (2.77e-2)"	"unprognostic (1.68e-1)"	"unprognostic (3.15e-1)"	"unprognostic (1.78e-1)"	"unprognostic (5.02e-2)"	"unprognostic (1.15e-2)"	"unprognostic (2.83e-2)"	"unprognostic (7.67e-2)"	"unprognostic (6.44e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.06e-2)"	"unprognostic (2.49e-2)"	26.0	23.3	21.4	18.2	23.7	10.4	33.1	22.4	26.4	32.2	23.9	26.4	23.3	21.9	54.2	25.0	19.2	24.0	21.5	20.8	22.3	25.5	54.3	22.4	18.8	22.6	22.4	20.6	32.2	33.6	23.5	28.2	23.1	31.2	32.5	15.8	32.4	25.8	26.9	23.3	22.9	26.0	22.6	19.1	32.9	34.3	22.1	16.9	33.2	20.0	23.3	24.1	19.6	25.9	32.4	29.4	25.9	23.7	53.1	71.4	44.3	43.9	80.4	41.9	49.2	21.8	43.4	21.0	35.1	70.2	29.2	33.4	23.1	35.9	56.6	25.8	11.2	19.9	14.0	29.3	61.5	23.3	31.8	55.1	63.7	29.5	60.6	46.2	42.0	21.8	17.7	27.3	46.5	60.1	18.1	19.6	16.1	70.2	31.0	13.9	37.9	21.1	42.8	38.9	18.4	26.0	40.0	29.6	45.7	35.7	51.0	25.6	35.0	23.9	15.6	31.3	22.2	33.3	27.6	18.2	54.9	18.2	40.8	10.4	10.0	23.6	10.3	13.0	11.8	9.5	10.4	10.6	9.9	9.5	9.2	8.1	8.8	8.7	11.9	9.1	12.9	6.7	21.4	23.7	22.4	26.4	20.8	22.3	22.6	22.4	23.1	22.6	22.1	25.9	18.7	28.9	26.3	8.8	15.7	7.8	11.2	17.9	16.5	7.5	16.2	11.9	26.8	8.6	19.6	14.7	12.5	23.7	17.2	23.8	29.4	25.3	31.6	17.6	24.6	16.7	22.3	15.8	17.6	32.7	32.0	21.7	33.1	25.7	9.5	29.7	13.9	33.5	15.4	25.2	15.6	31.6	4.1	14.7	10.3	18.5	23.0	14.6	12.4	15.0	18.2	15.6	16.5	14.6	21.9	28.9	12.0	25.2	29.2	19.4	19.9	24.2	18.7	10.7	26.3	18.0	19.3	34.1	37.0	16.5	11.4	50.3	15.9	15.6	16.5	16.5
GOLPH3	"GOPP1, GPP34, MIDAS, Vps74"	ENSG00000113384	"Golgi phosphoprotein 3"	Q9H4A6	5	32124716-32174319	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044564, HPA055841"	Approved		Supported	"Golgi apparatus,Vesicles"		NA	NA		23000	"Cluster 26: Non-specific - Mitochondria"	"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 55: Plasma cells - Humoral immune response"	"Golgi apparatus, Vesicles"		"HPA044564: AB_10795169, HPA055841: AB_2682940"	"unprognostic (1.64e-2)"	"unprognostic (1.66e-1)"	"unprognostic (9.27e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.28e-1)"	"unprognostic (9.34e-2)"	"unprognostic (1.89e-2)"	"unprognostic (8.19e-2)"	"unprognostic (2.95e-2)"	"unprognostic (7.48e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.15e-1)"	"unprognostic (8.56e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.52e-2)"	50.1	38.3	28.5	41.9	29.2	20.8	50.0	29.8	34.5	56.2	32.9	76.6	46.3	41.6	58.7	43.1	41.0	77.7	38.4	26.5	29.6	61.5	110.1	50.7	49.2	30.2	29.5	51.5	62.6	54.9	29.8	68.4	29.9	75.3	60.2	19.8	64.8	50.4	37.3	32.8	49.3	52.3	29.1	39.5	52.9	27.0	29.7	43.9	48.0	57.0	52.4	60.5	41.3	32.3	57.7	37.9	59.9	65.5	111.3	106.1	171.6	77.8	103.3	71.5	67.7	51.9	101.3	51.7	75.0	105.7	69.3	52.8	75.1	54.9	89.7	67.7	44.9	56.9	119.9	99.4	89.4	88.8	64.0	81.3	77.1	70.3	80.1	65.8	57.9	33.6	60.5	121.8	80.4	58.0	57.1	115.3	51.8	78.0	38.5	52.8	86.4	53.8	89.9	72.1	45.6	51.0	180.8	186.9	79.4	75.6	76.4	97.1	56.5	62.7	58.5	49.7	55.6	136.1	179.3	62.5	56.3	125.8	76.4	6.8	8.0	19.2	7.8	10.6	6.8	11.5	8.4	10.1	8.9	16.0	9.9	7.2	7.9	8.5	10.5	6.9	13.2	4.2	28.5	29.2	29.8	34.5	26.5	29.6	30.2	29.5	29.9	29.1	29.7	32.3	33.9	60.9	49.2	26.8	53.3	70.0	44.5	30.0	51.2	13.5	59.6	30.7	31.7	88.6	42.8	44.1	10.4	67.3	52.0	72.6	52.8	58.0	5.2	46.3	35.8	46.2	52.0	50.5	47.9	44.1	111.6	51.7	57.6	71.3	14.5	16.8	59.3	153.6	54.4	13.5	45.8	86.3	40.7	63.7	56.2	16.1	50.7	49.1	44.4	43.1	48.7	20.2	36.0	53.8	60.1	49.7	35.1	57.2	120.0	83.9	59.8	59.8	49.1	10.0	39.5	30.8	52.1	15.4	25.1	68.2	73.6	110.0	45.6	50.4	50.2	80.7
GOLPH3L	GPP34R	ENSG00000143457	"Golgi phosphoprotein 3 like"	Q9H4A5	1	150646230-150697154	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in all"	6	"U-698: 313.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA072016			Supported	"Golgi apparatus,Cytosol"		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 51: Non-specific - Unknown function"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 40: Granulosa cells - Unknown function"	"Golgi apparatus"	Cytosol	"HPA072016: "	"unprognostic (1.21e-1)"	"unprognostic (2.61e-1)"	"unprognostic (3.76e-3)"	"unprognostic (3.24e-1)"	"unprognostic (3.24e-2)"	"unprognostic (1.82e-1)"	"unprognostic (3.18e-2)"	"unprognostic (4.72e-2)"	"unprognostic (5.00e-2)"	"unprognostic (2.64e-1)"	"unprognostic (9.88e-3)"	"unprognostic (2.71e-1)"	"unprognostic (3.36e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.48e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.93e-2)"	10.9	14.3	8.8	11.8	9.3	6.0	20.8	9.3	11.4	21.8	13.5	31.1	17.9	14.7	33.3	30.3	25.3	14.1	10.3	8.7	11.4	18.6	9.6	13.6	12.6	9.3	13.3	21.4	22.8	19.0	11.0	13.0	11.7	15.8	36.4	12.8	23.3	17.6	14.7	18.9	20.1	15.2	9.0	11.0	22.7	14.4	10.9	15.8	25.7	13.5	18.5	21.5	13.5	8.5	25.2	23.0	12.2	7.6	31.8	22.5	21.8	22.6	33.0	23.7	32.9	10.3	45.1	29.3	31.5	14.7	16.1	21.6	20.8	18.5	28.6	21.1	21.5	33.8	13.2	15.2	26.7	27.8	28.2	16.1	31.8	24.2	54.4	26.1	37.5	21.1	27.6	19.6	14.1	25.4	24.2	13.1	25.7	46.1	21.6	16.8	14.5	36.5	30.6	17.5	19.3	18.8	11.6	33.2	18.0	31.4	25.6	32.5	29.3	7.3	13.3	10.2	18.5	23.8	22.9	313.5	22.3	28.3	10.9	7.5	1.6	2.8	9.5	1.6	13.0	10.5	9.9	9.7	8.7	9.8	12.7	9.4	1.4	18.0	3.6	12.6	11.6	5.4	8.8	9.3	9.3	11.4	8.7	11.4	9.3	13.3	11.7	9.0	10.9	8.5	11.7	9.6	10.3	12.1	9.8	12.9	11.3	16.7	9.6	9.0	26.3	14.4	10.4	24.3	22.6	12.9	6.2	22.1	9.7	50.0	25.4	21.6	22.2	27.5	10.3	14.1	21.0	10.9	12.7	36.6	17.9	12.9	17.9	15.6	11.4	48.6	16.1	10.9	12.4	0.0	13.6	46.6	14.2	9.1	7.4	12.7	16.4	7.5	16.0	24.4	13.1	14.9	6.2	11.6	13.5	21.2	34.6	19.9	15.0	27.7	31.6	26.9	51.2	13.3	0.0	10.0	9.5	14.6	4.3	15.7	17.8	30.8	10.4	22.0	36.0	39.6
GOLT1B	"CGI-141, GOT1, YMR292W"	ENSG00000111711	"Golgi transport 1B"	Q9Y3E0	12	21501781-21518408	"Predicted membrane proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055909, HPA066383"	Approved		Supported	Nucleoplasm,Vesicles		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 55: Plasma cells - Humoral immune response"	Vesicles	Nucleoplasm	"HPA055909: AB_2682967, HPA066383: AB_2685667"	"unprognostic (1.22e-2)"	"unprognostic (3.07e-3)"	"unprognostic (1.84e-1)"	"unprognostic (3.65e-1)"	"unprognostic (3.45e-1)"	"unprognostic (5.37e-3)"	"prognostic unfavorable (1.99e-8)"	"unprognostic (2.24e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.76e-1)"	"prognostic unfavorable (2.32e-4)"	"unprognostic (1.36e-1)"	"prognostic unfavorable (4.83e-10)"	"unprognostic (3.13e-1)"	"unprognostic (2.14e-1)"	"unprognostic (6.78e-2)"	"unprognostic (1.04e-1)"	17.5	22.1	12.7	16.9	14.1	25.8	18.5	13.4	18.9	18.0	12.7	13.4	10.6	14.6	15.6	13.6	12.5	13.9	14.8	13.9	15.1	15.5	18.8	17.6	15.0	13.2	14.6	10.9	21.6	11.9	19.0	29.0	13.8	16.1	14.8	14.1	16.1	13.2	15.5	12.9	11.3	17.7	13.9	12.4	14.2	10.6	14.7	11.2	15.9	11.8	14.1	17.8	12.2	16.3	31.2	30.0	28.5	36.5	56.5	83.2	46.1	126.5	48.2	40.4	63.3	45.4	48.1	19.4	29.8	66.6	71.0	30.1	23.4	27.2	69.5	29.4	22.8	29.7	19.6	32.8	61.0	37.0	36.8	44.2	50.1	44.9	85.6	67.7	35.8	24.4	18.6	21.1	59.2	30.7	17.3	62.1	75.7	27.8	23.5	14.0	65.0	39.4	32.2	18.7	7.2	23.1	49.0	20.6	70.4	90.2	28.2	39.4	40.6	46.5	49.5	57.1	67.2	20.3	45.9	51.8	63.6	35.5	64.2	48.0	26.6	20.8	22.1	31.4	26.6	22.7	25.8	24.4	27.0	25.9	23.3	23.8	7.2	21.6	29.4	29.4	28.0	27.6	12.7	14.1	13.4	18.9	13.9	15.1	13.2	14.6	13.8	13.9	14.7	16.3	23.4	9.6	15.6	15.0	38.9	46.7	23.4	42.7	27.3	27.6	20.4	11.2	18.9	22.8	36.8	16.5	10.4	29.0	34.9	13.8	27.4	31.6	3.4	10.9	26.3	28.7	13.1	22.9	70.4	33.4	72.4	45.7	15.3	21.7	21.5	10.3	16.8	23.2	41.0	18.5	49.3	31.7	38.7	23.6	65.1	5.2	17.4	35.4	53.4	14.0	26.0	17.5	18.6	25.1	25.4	38.6	15.4	19.9	75.8	49.0	8.7	21.7	18.2	7.7	13.1	24.6	39.3	23.7	32.4	22.8	63.9	64.0	39.1	9.6	14.6	44.9
GON7	C14orf142	ENSG00000170270	"GON7 subunit of KEOPS complex"	Q9BXV9	14	93202894-93207065	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 68.4;Endometrial ciliated cells: 187.5;Proximal tubular cells: 51.8;Respiratory ciliated cells: 94.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"basophil: 6.2"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051832	Approved		Supported	"Nucleoplasm,Nucleoli rim"		NA	NA		41000	"Cluster 41: Basophils - Cellular respiration"	"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 21: OE19 - Mitochondria"	"Cluster 49: Ciliated cells - Cilium organization"	"Nucleoplasm, Nucleoli rim"		"HPA051832: AB_2681628"	"unprognostic (2.28e-2)"	"unprognostic (1.96e-3)"	"unprognostic (2.79e-2)"	"unprognostic (1.45e-3)"	"unprognostic (3.43e-2)"	"unprognostic (1.51e-1)"	"prognostic unfavorable (1.53e-5)"	"unprognostic (3.40e-3)"	"unprognostic (8.82e-2)"	"unprognostic (1.45e-3)"	"unprognostic (2.47e-3)"	"unprognostic (7.37e-2)"	"prognostic favorable (3.08e-4)"	"unprognostic (2.96e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.67e-1)"	"unprognostic (2.77e-1)"	6.9	13.2	9.0	5.8	8.8	0.4	8.3	8.6	11.5	12.1	15.8	13.9	13.2	5.4	23.3	6.8	35.4	7.2	14.7	9.0	10.1	17.8	12.9	8.8	1.9	9.8	9.4	5.6	10.4	12.6	12.8	5.6	10.2	7.9	12.0	13.4	7.9	5.7	13.4	4.9	10.2	5.2	8.6	8.8	9.1	8.7	9.6	3.7	8.7	12.9	9.9	6.9	5.7	9.1	11.6	9.2	13.3	8.9	9.2	21.4	9.3	11.0	6.2	21.6	17.5	9.1	18.1	4.7	7.2	7.0	12.6	18.2	18.3	9.2	25.1	0.1	0.0	4.6	22.5	22.6	4.7	9.7	19.6	4.1	11.9	15.1	9.7	6.0	13.3	5.5	16.7	1.5	9.3	26.8	11.3	23.4	3.4	49.6	4.3	20.0	12.9	21.4	23.4	12.9	15.8	19.8	8.2	20.4	24.8	11.8	16.8	19.9	13.6	7.6	15.1	16.5	6.2	10.0	29.6	3.1	23.2	10.8	13.2	6.2	0.9	0.4	0.8	1.7	0.1	0.0	0.5	0.6	1.5	0.7	0.2	0.4	0.9	0.3	0.8	0.2	0.8	0.5	9.0	8.8	8.6	11.5	9.0	10.1	9.8	9.4	10.2	8.6	9.6	9.1	17.2	6.4	13.6	0.0	7.2	0.0	0.0	0.0	0.0	0.0	19.7	23.9	0.0	0.0	9.9	14.7	0.0	19.6	12.7	0.0	68.4	27.7	0.0	187.5	15.8	7.3	0.0	0.0	0.0	21.7	18.1	5.8	0.0	27.4	10.1	9.4	0.0	0.0	35.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.0	0.0	0.0	6.7	0.0	0.0	0.0	0.0	17.5	0.0	0.0	1.4	0.0	0.0	51.8	94.7	0.0	0.0	0.0	6.8	0.0	0.0	0.0	0.0	7.7	7.0	21.3	0.0	0.0
GORAB	"FLJ11752, GO, NTKL-BP1, SCYL1BP1"	ENSG00000120370	"Golgin, RAB6 interacting"	Q5T7V8	1	170532131-170553834	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			Dwarfism	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027250, HPA027746"	Approved		Supported	"Nucleoplasm,Nucleoli,Golgi apparatus,Cytosol"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 59: Non-specific - Transcription"	"Golgi apparatus"	"Nucleoplasm, Nucleoli, Cytosol"	"HPA027250: AB_10611253, HPA027746: "	"unprognostic (1.59e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.69e-1)"	"unprognostic (4.75e-3)"	"prognostic favorable (1.39e-4)"	"prognostic unfavorable (5.26e-4)"	"unprognostic (8.48e-3)"	"unprognostic (2.94e-2)"	"unprognostic (2.06e-2)"	"unprognostic (1.43e-1)"	"unprognostic (3.77e-2)"	"prognostic unfavorable (7.83e-12)"	"unprognostic (2.52e-2)"	"unprognostic (2.83e-1)"	"unprognostic (7.71e-2)"	"unprognostic (1.70e-1)"	3.1	5.2	1.6	1.9	1.6	0.6	2.8	1.6	3.1	3.8	1.9	3.6	1.4	3.2	3.5	2.3	2.1	2.1	3.1	1.5	2.3	2.5	4.3	2.5	3.6	1.6	1.8	4.3	3.7	1.9	3.0	3.1	1.7	2.8	3.3	1.3	3.3	2.6	1.1	1.9	2.7	2.0	1.7	3.1	2.1	2.0	2.0	2.8	3.0	2.1	3.0	3.1	3.3	1.8	3.4	3.8	4.5	2.0	9.0	5.8	2.9	4.8	7.5	3.6	4.6	1.9	4.9	5.1	6.1	4.3	2.4	4.0	6.4	2.8	6.0	4.8	1.6	2.5	4.0	2.8	4.9	4.4	3.1	4.4	2.5	4.2	3.9	5.5	3.5	2.3	4.4	2.3	5.3	0.6	5.8	4.0	4.7	6.2	4.0	3.9	3.8	6.0	4.2	1.9	1.4	3.0	3.6	4.8	11.5	3.1	2.7	8.4	4.4	6.8	3.1	2.9	7.2	3.5	4.4	3.8	5.2	4.0	5.4	0.7	3.9	0.0	2.3	4.2	3.9	2.8	4.1	3.5	4.3	2.8	3.6	3.0	0.5	3.8	3.1	2.7	5.3	2.6	1.6	1.6	1.6	3.1	1.5	2.3	1.6	1.8	1.7	1.7	2.0	1.8	8.1	0.0	11.4	8.8	8.9	2.8	4.0	6.5	8.6	4.7	5.2	7.1	9.4	10.0	7.1	5.5	2.1	6.0	6.2	12.8	3.9	12.3	2.3	5.5	10.4	8.3	0.0	3.4	9.3	6.0	7.3	10.5	9.2	6.7	13.9	5.2	5.3	6.6	7.1	5.0	7.7	9.4	8.2	6.9	4.6	3.2	14.0	5.6	3.6	3.7	10.1	4.3	3.1	9.0	7.3	5.7	9.8	6.4	10.3	4.9	4.3	6.0	2.4	7.1	6.6	8.2	9.3	13.1	8.1	5.4	1.6	5.6	6.3	5.1	6.4	3.0
GORASP1	"FLJ23443, GOLPH5, GRASP65, P65"	ENSG00000114745	"Golgi reassembly stacking protein 1"	Q9BQQ3	3	39096599-39107863	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 98.9;Late spermatids: 56.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA056283	Supported		Supported	"Golgi apparatus"		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 34: Spermatids - Unknown function"	"Golgi apparatus"		"HPA056283: AB_2683085"	"unprognostic (1.06e-1)"	"unprognostic (8.31e-2)"	"unprognostic (1.05e-1)"	"prognostic favorable (6.92e-6)"	"unprognostic (2.77e-1)"	"unprognostic (1.98e-2)"	"prognostic unfavorable (5.13e-4)"	"unprognostic (2.13e-2)"	"unprognostic (8.79e-3)"	"unprognostic (1.05e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.73e-3)"	"prognostic favorable (1.91e-6)"	"unprognostic (1.21e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.44e-1)"	"unprognostic (3.24e-3)"	16.9	13.5	35.4	12.8	36.4	11.5	18.6	38.7	35.7	25.2	30.3	23.6	13.6	18.8	16.6	20.0	22.2	15.6	21.3	34.1	35.9	26.9	26.3	19.6	13.4	41.7	36.9	13.3	24.5	22.5	15.4	21.0	38.0	22.1	26.0	20.6	26.2	30.7	16.3	16.4	18.5	24.0	42.0	21.5	19.1	10.5	38.8	11.8	18.4	19.0	17.4	17.9	14.8	46.6	15.6	19.0	18.0	17.8	42.8	28.1	16.6	27.1	31.1	27.5	24.6	11.3	18.4	16.8	15.7	41.4	17.2	24.7	20.7	32.2	19.3	22.4	14.3	23.8	18.7	16.0	19.3	20.0	25.8	22.0	43.8	28.5	28.0	30.6	38.2	6.0	19.8	20.3	26.3	22.6	5.6	18.9	13.1	35.7	23.1	6.0	10.7	23.8	27.4	28.1	7.1	14.0	25.7	51.4	16.1	24.4	33.2	20.7	29.0	15.4	14.3	37.0	15.0	14.1	14.8	4.1	18.3	16.7	23.0	6.5	12.0	7.0	3.3	12.7	4.5	11.7	4.1	3.1	12.8	9.3	4.7	3.4	6.9	2.8	17.2	7.2	6.7	8.0	35.4	36.4	38.7	35.7	34.1	35.9	41.7	36.9	38.0	42.0	38.8	46.6	21.1	3.2	9.8	23.2	8.7	4.1	10.6	6.5	8.0	8.5	12.9	9.7	8.7	12.8	7.2	12.9	0.0	14.0	3.4	21.4	11.7	10.7	98.9	15.5	11.4	13.4	11.4	5.5	7.7	8.7	11.1	8.9	24.5	16.3	1.3	8.8	8.9	11.4	9.5	8.4	9.2	15.3	8.2	7.2	9.8	56.1	7.2	9.5	12.4	9.4	7.0	7.3	0.0	9.0	9.6	11.0	8.0	6.4	5.7	11.4	14.2	6.0	10.7	11.1	0.0	8.8	10.0	10.1	6.8	8.0	5.8	19.8	4.4	6.5	15.1	12.6
GOSR2	"Bos1, GS27"	ENSG00000108433	"Golgi SNAP receptor complex member 2"	O14653	17	46923075-46975524	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Protein transport, Transport"		"Disease variant, Epilepsy, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"Early spermatids: 303.0;Late spermatids: 796.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"CAB017456, HPA048956, HPA054472"	Uncertain		Supported	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 34: Spermatids - Unknown function"	"Nucleoplasm, Golgi apparatus"		"CAB017456: AB_10532285, HPA048956: AB_2680569, HPA054472: AB_2682499"	"unprognostic (3.28e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.49e-2)"	"unprognostic (3.54e-2)"	"unprognostic (1.30e-2)"	"unprognostic (1.35e-1)"	"prognostic unfavorable (3.80e-4)"	"unprognostic (7.43e-2)"	"unprognostic (2.13e-1)"	"unprognostic (2.41e-2)"	"unprognostic (7.23e-3)"	"unprognostic (2.41e-1)"	"unprognostic (2.46e-3)"	"unprognostic (4.50e-1)"	"unprognostic (3.07e-1)"	"unprognostic (2.84e-3)"	"unprognostic (4.29e-2)"	23.2	25.6	28.5	21.7	28.7	16.4	24.8	31.6	37.6	24.8	32.9	22.8	49.8	23.8	31.6	21.5	21.3	18.3	32.5	29.3	29.3	42.2	33.9	23.6	26.4	28.7	29.7	26.1	31.3	35.5	37.1	28.7	29.2	23.1	27.4	25.0	32.5	30.5	43.1	21.9	43.2	29.8	28.1	30.1	23.1	48.3	29.5	27.1	26.6	34.3	31.8	25.2	18.6	30.9	44.6	47.2	33.5	40.3	54.9	39.3	37.8	59.7	58.5	63.5	56.7	60.1	25.7	37.7	33.1	75.4	66.5	30.1	43.4	48.5	77.8	83.0	33.3	56.8	37.4	60.1	60.3	44.9	44.1	40.8	47.1	52.2	73.2	49.0	52.6	43.7	56.5	50.9	46.2	46.8	50.0	24.2	31.1	60.1	65.8	43.5	64.0	44.5	40.7	37.7	28.8	61.5	33.3	19.2	47.9	57.1	55.1	31.3	62.1	60.0	38.8	47.4	58.9	64.6	39.4	60.1	56.1	28.6	67.1	39.5	33.1	29.2	33.9	63.2	31.3	29.8	29.7	27.8	32.7	38.6	29.1	25.4	3.6	31.2	86.0	29.7	38.8	35.2	28.5	28.7	31.6	37.6	29.3	29.3	28.7	29.7	29.2	28.1	29.5	30.9	23.7	25.6	18.7	17.9	22.0	16.6	17.3	16.7	4.6	18.5	21.1	18.0	16.2	15.7	14.5	33.1	6.2	30.2	23.8	15.9	23.5	34.5	303.0	9.1	18.0	25.2	7.2	20.6	24.2	42.7	33.1	18.4	15.3	11.0	14.5	22.7	21.8	22.4	45.1	23.5	26.3	16.8	16.2	22.0	14.7	796.1	16.8	15.0	10.6	21.5	22.0	16.4	14.4	17.1	28.4	58.1	24.2	14.3	23.5	22.1	96.5	90.0	13.7	20.4	0.0	9.3	26.8	33.1	26.7	7.4	16.9	52.7	14.9	18.4	12.6	20.5
GOT1	AST1	ENSG00000120053	"Glutamic-oxaloacetic transaminase 1"	P17174	10	99396870-99430624	"Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Amino-acid biosynthesis"	"Aminotransferase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"heart muscle: 511.1;liver: 369.5;skeletal muscle: 489.9;tongue: 1011.6"	"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 449.0;Distal tubular cells: 240.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA064532, HPA072629"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	Yes		100000000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm	Cytosol	"HPA064532: AB_2685279, HPA072629: AB_2686540"	"unprognostic (6.40e-2)"	"prognostic favorable (6.23e-4)"	"unprognostic (5.99e-2)"	"unprognostic (2.84e-2)"	"unprognostic (2.82e-1)"	"unprognostic (2.96e-2)"	"unprognostic (5.25e-2)"	"unprognostic (1.08e-3)"	"unprognostic (6.67e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.79e-2)"	"unprognostic (1.79e-1)"	"prognostic favorable (3.72e-13)"	"unprognostic (1.93e-2)"	"unprognostic (4.23e-1)"	"unprognostic (6.85e-2)"	"unprognostic (1.00e-1)"	14.7	54.9	67.8	14.7	71.1	8.0	22.7	70.3	119.1	53.1	82.6	50.9	62.0	13.1	25.9	42.7	17.9	49.0	511.1	70.0	77.6	143.1	369.5	15.5	14.1	83.5	55.0	18.1	34.0	142.4	22.5	14.4	83.7	22.7	59.2	106.2	48.6	27.4	489.9	23.9	45.8	21.4	48.4	16.9	58.9	33.6	69.1	17.7	47.7	1011.6	30.3	22.3	21.0	70.1	73.7	40.3	46.0	114.4	35.1	30.7	127.1	58.9	108.7	101.8	109.8	89.9	56.4	71.9	20.4	50.2	89.2	88.6	107.1	78.9	105.8	25.7	46.7	28.1	46.7	114.3	184.9	77.9	44.0	47.3	82.5	86.9	228.4	69.5	49.5	48.6	71.1	106.2	65.4	64.9	42.5	56.5	29.2	118.7	56.1	45.5	44.4	72.8	173.7	37.5	19.6	28.7	44.8	59.3	222.6	66.8	115.7	27.1	23.3	25.4	56.3	28.0	68.7	76.8	99.7	74.3	65.4	40.8	34.1	4.0	8.7	6.8	19.7	25.8	18.4	17.6	21.5	20.7	21.9	21.2	15.6	22.7	0.8	20.5	31.5	36.4	27.6	15.6	67.8	71.1	70.3	119.1	70.0	77.6	83.5	55.0	83.7	48.4	69.1	70.1	10.3	16.0	16.2	26.1	38.8	11.9	41.8	82.7	24.5	95.6	18.8	21.2	449.0	72.9	34.4	73.5	62.6	35.9	10.7	62.1	240.7	51.9	166.7	17.8	9.3	16.7	19.7	39.5	47.4	30.8	18.1	23.5	76.9	21.5	31.8	20.2	17.2	191.8	31.6	75.7	63.3	45.3	54.9	12.4	6.9	24.1	11.1	13.0	49.8	13.1	10.5	36.6	6.2	21.1	37.2	27.6	34.4	14.3	22.4	13.1	97.0	163.3	27.9	76.5	13.1	15.2	20.5	116.7	10.4	40.9	10.4	55.1	14.6	47.0	66.4	42.3
GP6	GPVI	ENSG00000088053	"Glycoprotein VI platelet"	Q9HCN6	19	55013705-55038264	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Blood coagulation, Hemostasis"	Receptor	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"testis: 2.7"	"Cell type enhanced"	"Detected in some"		"Cone photoreceptor cells: 6.2;Early spermatids: 14.3;Excitatory neurons: 9.9;Inhibitory neurons: 10.2;Late spermatids: 8.7;Macrophages: 10.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	13	"HEL: 9.4;K-562: 4.1;U-2 OS: 2.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA047611, HPA066482"	Approved		Supported	"Plasma membrane"	"Intracellular and membrane"	NA	NA		44000000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 71: Testis - DNA repair"	"Cluster 36: HEL - Hemostasis"	"Cluster 51: Myeloid cells - Hemostasis"	"Plasma membrane"		"HPA047611: , HPA066482: AB_2685674"	"unprognostic (3.06e-3)"	"unprognostic (4.58e-2)"	"unprognostic (1.74e-5)"	"unprognostic (1.94e-1)"	"unprognostic (1.20e-1)"	"unprognostic (3.52e-2)"	"unprognostic (7.50e-4)"	"unprognostic (2.81e-1)"	"unprognostic (1.00e-1)"	"unprognostic (4.18e-2)"	"unprognostic (3.04e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.53e-1)"	"unprognostic (2.62e-1)"	"unprognostic (3.32e-2)"	"unprognostic (5.44e-3)"	"unprognostic (2.70e-2)"	0.1	0.0	0.1	0.0	0.1	0.9	0.2	0.7	0.5	0.5	0.0	0.2	0.0	0.2	0.0	1.4	0.4	0.0	0.7	0.1	0.0	0.5	0.2	0.9	0.0	0.0	0.0	0.3	0.2	0.1	0.3	0.1	0.1	0.4	0.0	0.2	0.4	0.1	0.1	1.2	0.1	0.0	0.0	0.9	0.2	2.7	0.0	0.0	0.4	0.0	0.0	0.2	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.4	0.1	0.0	0.1	0.1	0.3	9.4	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.1	4.1	0.1	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.1	0.0	2.5	0.1	0.0	0.1	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	1.2	0.1	0.1	0.7	0.5	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	3.6	0.0	0.0	0.3	0.3	0.0	2.0	0.3	0.4	0.7	1.5	0.3	0.0	6.2	0.1	0.4	0.7	0.0	0.1	14.3	1.4	0.4	1.2	0.0	0.0	9.9	0.4	0.3	0.6	0.0	2.2	1.3	0.8	3.3	0.2	0.1	3.3	10.2	0.0	0.0	0.8	0.2	8.7	0.3	10.3	0.0	1.0	0.3	0.4	2.1	1.5	1.5	0.2	0.1	0.0	0.0	0.4	0.1	0.0	1.9	2.6	0.0	0.4	0.2	1.4	1.2	0.0	0.1	0.5	0.4	0.0	0.3	0.7
GPAA1	"GAA1, hGAA1"	ENSG00000197858	"Glycosylphosphatidylinositol anchor attachment 1"	O43292	8	144082590-144086216	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"GPI-anchor biosynthesis"		"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"PC-3: 275.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA077224	Approved		Approved	"Endoplasmic reticulum,Centrosome,Mitochondria,Cytosol"		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	"Endoplasmic reticulum, Cytosol"	"Centrosome, Mitochondria"	"HPA077224: "	"unprognostic (2.53e-3)"	"unprognostic (1.39e-1)"	"unprognostic (3.06e-2)"	"unprognostic (2.57e-2)"	"unprognostic (2.49e-2)"	"unprognostic (4.05e-2)"	"unprognostic (1.73e-3)"	"unprognostic (2.64e-1)"	"unprognostic (8.92e-2)"	"unprognostic (1.67e-2)"	"unprognostic (2.04e-3)"	"unprognostic (4.72e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.03e-1)"	"unprognostic (3.89e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.73e-2)"	47.0	75.5	35.7	21.2	37.5	48.2	46.7	39.9	43.6	52.2	62.3	46.1	35.8	56.9	18.8	51.7	45.9	25.0	72.1	35.9	35.6	61.9	69.9	42.6	23.4	41.9	37.4	49.9	66.2	47.5	37.2	20.0	40.7	50.9	13.1	11.4	60.5	40.5	71.7	47.1	46.8	18.8	40.1	48.4	55.8	40.9	38.1	18.6	60.1	28.4	12.9	43.0	42.8	47.6	67.3	117.2	26.9	84.7	60.8	51.5	92.8	68.5	66.5	55.8	57.4	49.0	108.9	36.6	94.1	73.9	26.4	82.5	17.9	67.2	8.1	60.4	59.0	58.0	53.1	36.3	58.6	28.5	83.2	56.8	61.6	56.9	39.4	45.0	46.4	61.5	42.1	125.7	54.1	237.6	55.9	26.5	27.2	79.3	275.8	38.1	34.2	176.9	48.4	46.8	45.7	63.2	88.8	112.4	51.1	14.7	73.2	79.3	31.6	51.8	88.6	29.5	77.2	70.0	57.5	24.9	91.2	34.8	72.0	35.7	64.4	59.0	84.2	78.1	57.2	37.4	41.7	66.7	59.6	40.1	40.6	57.7	14.8	69.1	91.9	107.1	40.1	76.7	35.7	37.5	39.9	43.6	35.9	35.6	41.9	37.4	40.7	40.1	38.1	47.6	41.0	38.5	40.0	13.7	46.7	28.8	54.9	84.6	37.0	60.8	74.9	59.9	42.7	55.8	58.0	44.1	64.6	123.4	72.5	100.2	25.4	125.8	5.7	30.8	30.7	37.3	56.9	48.0	12.8	89.9	152.9	57.1	56.6	37.3	64.8	45.1	42.5	74.9	86.6	55.5	14.6	52.6	79.3	53.6	25.6	10.9	40.4	41.2	72.9	6.5	57.4	98.0	98.9	15.6	20.4	76.0	91.0	37.6	85.5	58.0	155.1	90.3	46.8	73.2	59.2	50.8	50.5	194.8	109.9	55.9	22.3	109.3	38.9	66.5	85.3	48.1
GPATCH11	"CCDC75, CENP-Y, CENPY, FLJ38348"	ENSG00000152133	"G-patch domain containing 11"	Q8N954	2	37084451-37099244	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 75.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Karpas-707: 65.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038231, HPA038232"	Enhanced		Supported	Nucleoplasm		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 20: Retina & Lymphoid tissues - Unknown function"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"HPA038231: AB_2675904, HPA038232: AB_10675788"	"unprognostic (1.28e-2)"	"unprognostic (1.58e-1)"	"unprognostic (2.45e-1)"	"unprognostic (1.80e-1)"	"unprognostic (3.88e-2)"	"unprognostic (2.23e-2)"	"unprognostic (4.58e-3)"	"unprognostic (2.40e-2)"	"unprognostic (2.44e-2)"	"unprognostic (4.39e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.26e-1)"	"unprognostic (8.64e-3)"	"unprognostic (4.31e-2)"	"unprognostic (4.44e-2)"	"unprognostic (3.40e-2)"	"unprognostic (7.16e-2)"	23.0	6.3	7.5	7.8	8.5	10.0	6.9	8.8	9.9	7.0	6.0	4.5	4.8	4.8	3.7	5.1	3.7	4.4	5.4	7.7	8.8	5.5	5.7	6.3	12.7	8.3	8.0	5.9	3.0	5.5	3.5	5.7	8.5	4.0	4.9	21.0	3.7	4.1	2.4	5.9	5.0	4.3	8.5	8.0	4.8	11.6	8.0	10.3	6.4	5.4	11.7	5.2	3.1	10.4	12.5	7.4	12.4	9.7	25.7	11.9	13.2	22.1	8.9	13.1	10.7	9.4	5.2	14.4	12.1	8.3	11.4	8.8	14.8	5.3	19.5	24.7	16.1	26.3	9.8	9.6	8.3	31.7	27.5	7.8	9.4	18.0	10.1	8.6	11.6	9.0	25.0	65.8	15.4	6.3	20.6	17.4	5.3	20.5	10.3	16.9	26.4	40.7	5.7	5.3	14.9	13.9	11.6	7.4	11.2	9.9	7.6	14.6	12.9	23.7	13.1	17.4	24.7	25.6	28.2	21.6	16.9	26.2	21.3	5.9	2.4	2.2	4.4	2.0	4.4	8.7	3.2	3.7	3.6	6.8	3.4	3.5	0.8	6.7	0.7	12.2	2.6	1.5	7.5	8.5	8.8	9.9	7.7	8.8	8.3	8.0	8.5	8.5	8.0	10.4	14.7	12.8	8.1	3.9	23.3	4.2	2.7	5.7	7.4	24.3	6.2	7.0	14.1	8.6	5.0	11.0	25.0	8.8	48.7	12.1	11.7	9.3	32.9	12.6	20.0	12.8	3.0	22.1	14.3	14.1	30.5	12.2	8.6	13.9	12.0	8.7	17.9	15.0	13.4	13.5	12.1	9.1	6.1	18.8	15.0	10.5	16.1	21.1	3.6	5.6	12.7	28.9	22.6	10.6	12.5	14.8	4.9	22.2	23.2	1.6	9.7	13.2	11.5	52.7	13.1	13.4	21.7	75.5	43.6	7.8	5.4	3.8	16.8	13.7	6.0	2.0
GPATCH2	"CT110, FLJ10252, GPATC2, Pfa1, PPP1R30"	ENSG00000092978	"G-patch domain containing 2"	Q9NW75	1	217426992-217631090	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cone photoreceptor cells: 171.0;Rod photoreceptor cells: 144.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027181, HPA027322"	Uncertain		Supported	"Nuclear speckles"		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 9: Photoreceptor cells - Phototransduction"	"Nuclear speckles"		"HPA027181: AB_10602601, HPA027322: AB_1848645"	"unprognostic (3.27e-1)"	"unprognostic (2.66e-1)"	"unprognostic (1.29e-1)"	"unprognostic (2.04e-1)"	"unprognostic (3.27e-2)"	"unprognostic (5.13e-2)"	"unprognostic (6.50e-2)"	"unprognostic (1.28e-1)"	"unprognostic (6.24e-3)"	"unprognostic (2.46e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.03e-1)"	"prognostic unfavorable (9.99e-6)"	"unprognostic (3.52e-1)"	"unprognostic (2.50e-2)"	"unprognostic (1.53e-2)"	"unprognostic (5.41e-2)"	4.1	4.2	3.5	4.1	4.0	3.2	7.1	3.0	4.8	5.9	6.3	4.3	4.9	6.5	5.9	5.5	5.0	6.1	3.5	4.3	5.1	5.2	4.9	4.2	5.1	2.9	3.2	4.8	3.9	6.9	4.4	6.3	3.1	6.9	4.6	5.7	3.7	5.3	6.6	4.4	4.8	5.1	3.2	4.8	4.8	6.2	4.5	6.3	6.6	2.9	5.6	6.1	4.1	3.8	8.4	9.4	9.9	7.8	8.6	8.7	8.2	7.7	9.4	10.5	9.9	8.3	10.6	8.9	7.6	6.7	6.5	9.7	11.2	9.1	12.2	6.6	6.4	5.9	7.9	5.3	10.6	9.0	6.7	7.7	13.0	12.3	20.0	9.1	7.3	9.8	14.7	0.1	7.7	7.9	12.2	6.4	18.0	6.7	10.2	5.9	22.7	10.7	7.4	17.9	11.6	16.5	13.7	12.5	10.7	15.5	11.7	8.7	7.5	9.8	6.8	13.9	7.2	9.0	6.8	8.4	7.4	5.9	7.1	4.1	3.1	1.1	2.6	1.9	1.8	2.6	3.0	1.8	3.4	2.8	2.7	2.4	0.4	2.7	2.9	5.0	2.9	1.5	3.5	4.0	3.0	4.8	4.3	5.1	2.9	3.2	3.1	3.2	4.5	3.8	17.5	12.8	15.9	43.8	19.4	15.6	16.1	13.4	14.8	55.4	27.2	27.9	14.4	21.5	15.3	18.4	171.0	20.8	24.5	22.4	13.7	20.4	62.6	41.3	36.4	20.5	20.8	12.0	113.1	18.0	22.2	23.0	19.4	24.0	9.5	32.9	20.7	12.4	15.7	50.5	60.5	21.5	18.3	9.2	9.2	22.8	19.9	16.6	5.4	39.4	17.2	27.7	28.8	46.3	47.1	15.0	17.2	23.0	24.5	17.5	17.9	18.1	22.3	144.2	19.7	36.8	20.2	53.3	23.8	12.9	19.5	21.6	20.0	41.4	23.1	19.0
GPATCH3	"FLJ12455, GPATC3"	ENSG00000198746	"G-patch domain containing 3"	Q96I76	1	26890488-26900467	"Disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"		"Disease variant, Glaucoma"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA032078, HPA054973"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	Nucleoplasm	Cytosol	"HPA032078: AB_10603671, HPA054973: AB_2682656"	"unprognostic (2.93e-2)"	"unprognostic (1.33e-2)"	"unprognostic (7.34e-2)"	"unprognostic (9.63e-2)"	"unprognostic (1.42e-1)"	"unprognostic (9.44e-2)"	"prognostic unfavorable (1.23e-7)"	"unprognostic (4.37e-2)"	"unprognostic (7.75e-2)"	"unprognostic (6.46e-2)"	"prognostic favorable (6.42e-4)"	"unprognostic (3.77e-1)"	"unprognostic (3.22e-3)"	"unprognostic (2.31e-2)"	"unprognostic (3.81e-2)"	"unprognostic (2.59e-1)"	"unprognostic (6.82e-2)"	8.3	11.5	10.9	6.3	12.1	23.2	8.2	11.2	13.0	8.0	9.5	8.6	8.5	8.6	8.9	9.4	6.8	5.7	9.9	10.2	9.9	9.1	12.5	6.7	9.0	10.7	11.0	7.1	8.9	7.9	7.6	8.0	10.2	8.2	6.2	5.4	7.9	6.1	18.1	13.0	9.3	6.4	10.4	11.8	9.9	10.8	11.2	9.3	7.5	12.4	7.5	8.5	7.6	12.9	12.5	9.9	9.4	14.5	8.9	8.5	12.7	9.4	10.9	18.6	16.2	12.1	14.6	11.4	10.3	9.6	9.7	12.6	15.8	17.8	9.9	13.0	18.1	22.5	22.3	25.2	11.9	15.2	14.6	12.5	15.7	18.3	10.1	8.2	12.1	14.9	26.7	15.0	7.8	9.2	13.5	28.2	21.5	14.4	12.2	16.6	13.5	18.0	9.2	6.5	12.2	14.6	18.8	16.0	27.9	10.1	14.3	14.5	12.9	11.8	13.9	16.2	10.7	19.0	27.4	15.2	10.6	21.6	10.6	30.3	17.9	22.3	16.2	14.6	13.1	12.5	13.3	14.2	18.7	11.9	13.6	13.0	7.8	9.8	19.0	14.2	12.6	14.4	10.9	12.1	11.2	13.0	10.2	9.9	10.7	11.0	10.2	10.4	11.2	12.9	5.4	3.2	3.9	1.6	11.7	9.7	4.8	5.6	8.0	6.4	7.0	4.7	4.0	1.5	3.7	0.0	12.5	15.5	10.3	11.6	5.9	10.9	2.2	4.5	4.1	8.1	11.3	6.9	3.5	12.5	10.0	5.3	11.2	6.1	5.7	7.8	8.2	6.2	11.2	5.0	3.0	4.7	6.1	9.4	7.5	1.4	5.3	10.0	8.8	1.9	15.3	6.6	12.3	3.5	3.5	10.6	7.5	7.2	8.3	4.3	10.4	7.4	3.1	5.5	6.6	6.6	5.9	12.5	25.3	8.3	9.8	30.1	11.2	6.6	6.2	4.9
GPBP1	DKFZp761C169	ENSG00000062194	"GC-rich promoter binding protein 1"	Q86WP2	5	57173948-57264679	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Langerhans cells: 622.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037773	Approved		Approved	"Vesicles,Plasma membrane,Cytosol"		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 20: Retina & Lymphoid tissues - Unknown function"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 22: Epithelial cell types - Mixed function"	"Vesicles, Cytosol"	"Plasma membrane"	"HPA037773: AB_10671721"	"unprognostic (1.53e-1)"	"unprognostic (2.23e-2)"	"unprognostic (1.57e-1)"	"unprognostic (3.49e-1)"	"unprognostic (8.30e-2)"	"unprognostic (9.68e-3)"	"unprognostic (1.24e-2)"	"unprognostic (3.19e-2)"	"unprognostic (6.85e-3)"	"unprognostic (3.70e-1)"	"unprognostic (5.93e-2)"	"unprognostic (5.48e-2)"	"unprognostic (3.75e-2)"	"unprognostic (1.65e-1)"	"unprognostic (4.89e-2)"	"unprognostic (2.57e-1)"	"prognostic favorable (4.15e-5)"	39.2	48.6	67.6	37.8	72.0	66.0	55.7	87.7	87.8	46.5	63.6	38.9	31.2	42.6	48.0	36.9	47.0	36.6	39.8	66.0	67.8	48.0	44.0	43.5	57.8	66.2	68.0	65.1	35.7	50.1	41.7	43.3	66.8	42.1	36.9	83.7	42.6	36.5	59.0	38.2	40.3	32.7	68.5	48.1	37.6	75.2	67.3	69.0	51.5	56.5	53.0	43.9	38.0	85.4	56.4	45.3	83.7	70.1	53.8	51.6	75.9	42.9	72.4	68.6	88.4	73.0	63.2	74.2	48.0	44.0	84.9	37.5	71.9	48.6	86.8	41.7	48.1	61.9	49.6	61.5	62.9	45.2	60.8	43.6	74.8	56.1	78.1	65.8	56.7	59.5	62.3	117.6	56.4	72.3	70.3	78.6	51.2	28.2	31.3	75.4	68.5	72.7	53.7	58.7	72.7	56.0	62.1	53.4	69.6	54.3	104.9	75.8	37.3	25.0	50.2	35.1	62.0	90.0	79.6	81.6	40.7	66.7	46.9	93.8	38.2	76.4	59.6	41.0	76.3	71.5	72.1	72.6	43.7	61.9	78.5	73.8	73.2	79.5	45.5	29.8	84.9	68.8	67.6	72.0	87.7	87.8	66.0	67.8	66.2	68.0	66.8	68.5	67.3	85.4	132.9	60.9	88.3	129.3	272.2	227.5	241.1	102.6	206.1	139.8	146.1	87.9	89.0	65.8	121.9	84.6	148.0	99.0	246.9	149.6	99.7	76.5	249.9	246.6	134.0	123.1	107.7	82.7	106.4	55.9	74.3	143.2	115.2	267.8	142.8	119.0	68.2	47.0	56.2	134.6	96.4	103.3	118.0	70.3	622.0	102.4	133.9	162.8	188.5	112.4	160.7	95.7	178.2	168.9	221.6	70.5	176.3	91.4	261.6	246.5	87.9	72.6	154.6	199.0	52.6	129.7	139.9	379.3	279.6	195.6	237.7	161.7	285.2	107.0	102.0	304.1
GPC1	glypican	ENSG00000063660	"Glypican 1"	P35052	2	240435663-240468076	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skin 1: 226.0"	"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 199.8;Syncytiotrophoblasts: 102.7;Urothelial cells: 110.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030571, HPA070449"	Enhanced		Supported	"Plasma membrane,Cytosol"	"Intracellular and membrane"	NA	NA		9500000		"Cluster 31: Skin - Epidermis development"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 38: Extravillous trophoblasts - Unknown function"	"Plasma membrane, Cytosol"		"HPA030571: AB_10602322, HPA070449: "	"unprognostic (1.22e-2)"	"unprognostic (2.53e-2)"	"prognostic unfavorable (5.78e-5)"	"prognostic unfavorable (1.55e-4)"	"unprognostic (1.95e-1)"	"unprognostic (1.83e-3)"	"prognostic unfavorable (2.44e-6)"	"unprognostic (1.00e-2)"	"unprognostic (2.15e-1)"	"unprognostic (5.08e-3)"	"unprognostic (2.28e-1)"	"unprognostic (4.38e-1)"	"unprognostic (1.91e-1)"	"unprognostic (4.40e-2)"	"unprognostic (2.92e-1)"	"unprognostic (1.95e-2)"	"unprognostic (2.12e-2)"	36.8	78.5	42.8	9.0	37.0	0.4	30.7	25.3	64.4	44.5	3.1	36.7	5.8	37.1	9.3	88.4	30.8	8.5	145.2	41.7	28.5	47.6	35.7	21.9	1.4	29.2	30.4	45.1	25.8	9.8	55.7	29.0	26.3	67.8	3.5	5.0	35.2	22.5	134.2	226.0	17.4	16.4	11.3	15.6	23.0	48.7	46.0	9.1	15.7	35.3	6.6	35.1	62.3	24.8	69.0	92.9	21.6	56.7	64.3	61.5	87.3	161.5	78.8	18.3	21.2	33.3	74.9	1.8	21.8	172.0	100.1	186.0	11.7	114.7	3.8	33.3	9.8	0.1	80.7	41.7	92.2	1.6	6.2	54.3	73.4	41.2	21.3	38.1	9.7	3.4	0.4	3.3	47.5	36.0	1.3	0.6	33.7	7.7	20.5	12.3	98.2	16.1	15.0	109.6	21.5	14.4	105.7	91.9	10.1	19.3	29.1	7.0	45.6	97.3	162.3	46.9	67.8	0.7	0.4	0.8	69.4	1.7	111.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	42.8	37.0	25.3	64.4	41.7	28.5	29.2	30.4	26.3	11.3	46.0	24.8	1.2	16.0	6.1	45.7	0.7	45.9	69.6	62.2	56.3	22.4	8.3	18.2	53.2	21.5	34.0	25.8	2.1	73.7	0.3	3.7	7.9	27.8	0.9	6.2	24.7	2.8	0.0	0.0	53.0	10.8	199.8	21.0	1.5	8.9	4.5	49.4	11.0	26.3	9.1	25.2	45.0	7.0	16.2	0.6	7.7	3.8	19.0	1.2	35.6	5.6	1.6	24.9	1.0	18.6	8.9	17.6	0.9	7.5	0.9	67.0	0.5	2.3	30.2	6.4	26.3	33.9	38.2	2.2	9.9	44.8	46.2	102.7	1.9	14.5	3.6	110.5
GPC3	"DGSX, OCI-5, SDYS, SGB, SGBS, SGBS1"	ENSG00000147257	"Glypican 3"	P51654	X	133535745-133985594	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"		"Protease inhibitor"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"placenta: 574.9"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 65.1;Extravillous trophoblasts: 61.0;Fibroblasts: 404.2;Muller glia cells: 88.9;Syncytiotrophoblasts: 148.6"	"Cancer enriched"	"Detected in all"	4	"liver cancer: 269.0"	"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"naive CD4 T-cell: 1.8;naive CD8 T-cell: 1.2"	"Lineage enhanced"	"Detected in single"		"T-cells: 1.8"	"Group enriched"	"Detected in some"	5	"HAP1: 514.3;Hep G2: 1825.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006316			Supported	"Plasma membrane"		NA	NA		27000	"Cluster 32: T-cells - Unknown function"	"Cluster 28: Placenta - Pregnancy"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 33: Fibroblasts - ECM organization"	"Plasma membrane"		"HPA006316: AB_1078994"	"unprognostic (2.06e-1)"	"unprognostic (2.36e-1)"	"unprognostic (9.51e-2)"	"unprognostic (4.17e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.46e-1)"	"unprognostic (6.10e-2)"	"unprognostic (1.17e-2)"	"unprognostic (2.07e-2)"	"unprognostic (3.92e-3)"	"unprognostic (6.06e-2)"	"unprognostic (1.71e-1)"	"unprognostic (3.81e-3)"	"prognostic unfavorable (4.83e-4)"	"unprognostic (1.43e-1)"	"unprognostic (2.21e-1)"	"unprognostic (1.60e-1)"	99.9	22.8	0.5	3.5	1.0	0.0	61.8	0.5	0.3	11.8	0.2	6.5	1.6	9.2	41.1	6.7	13.9	13.7	24.5	0.3	4.0	87.0	5.1	122.9	2.5	1.9	3.1	15.5	21.2	4.1	47.0	574.9	3.0	8.3	4.1	6.2	13.7	9.2	4.5	18.0	5.6	7.3	1.7	3.7	13.6	2.8	2.0	8.0	22.4	28.6	10.9	14.6	9.3	1.0	0.0	0.0	21.8	1.7	0.7	0.1	0.0	0.0	0.0	0.0	0.0	154.0	0.0	0.0	0.1	0.1	0.0	0.0	514.3	0.4	0.0	0.0	22.6	0.0	0.9	1825.2	0.3	0.0	0.5	12.9	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.5	0.1	132.1	0.1	0.0	0.0	0.0	0.1	122.4	6.1	15.3	40.3	0.0	0.0	0.4	233.8	0.5	23.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	1.8	1.2	0.0	0.7	0.0	0.0	0.0	0.1	0.5	1.0	0.5	0.3	0.3	4.0	1.9	3.1	3.0	1.7	2.0	1.0	28.5	0.0	1.7	0.3	1.0	10.5	4.8	17.0	0.0	0.4	5.0	10.4	0.5	1.5	20.0	5.5	0.0	65.1	0.8	0.5	19.6	0.3	0.9	0.2	0.4	1.8	1.8	0.0	2.5	1.6	61.0	404.2	0.5	1.5	0.0	1.0	2.2	0.0	26.7	0.0	2.5	3.1	2.0	0.0	6.1	2.4	10.5	1.0	3.6	23.4	0.0	88.9	0.0	3.5	1.4	1.7	2.6	3.0	0.4	2.7	1.2	40.7	24.3	3.1	0.0	21.7	21.3	6.9	7.1	0.2	4.0	148.6	1.1	7.6	4.1	0.6
GPD2		ENSG00000115159	"Glycerol-3-phosphate dehydrogenase 2"	P43304	2	156435290-156613735	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 151.1;Late spermatids: 95.5;Oligodendrocyte precursor cells: 148.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"classical monocyte: 3.3;eosinophil: 1.7;intermediate monocyte: 1.6;myeloid DC: 2.7;neutrophil: 1.1;non-classical monocyte: 2.3"	"Group enriched"	"Detected in many"	5	"dendritic cells: 2.7;granulocytes: 1.7;monocytes: 3.3"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008012, HPA045506"	Enhanced		Supported	Mitochondria	"Intracellular and membrane"	NA	NA		620000	"Cluster 14: Monocytes - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 20: HeLa - Mitochondria"	"Cluster 68: Oligodendrocytes - Mixed function"	Mitochondria		"HPA008012: AB_1079013, HPA045506: AB_2679355"	"unprognostic (1.30e-1)"	"unprognostic (2.50e-1)"	"unprognostic (1.08e-1)"	"unprognostic (4.79e-3)"	"unprognostic (3.25e-1)"	"unprognostic (2.39e-2)"	"prognostic unfavorable (1.44e-4)"	"unprognostic (1.75e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.86e-1)"	"unprognostic (2.60e-3)"	"unprognostic (6.67e-2)"	"unprognostic (6.02e-3)"	"unprognostic (1.73e-1)"	"unprognostic (1.89e-1)"	"unprognostic (2.41e-1)"	"unprognostic (1.01e-2)"	8.2	5.7	13.3	8.1	17.7	13.4	16.2	15.2	18.6	10.3	6.5	18.6	14.4	6.8	5.2	20.3	18.2	8.9	6.2	19.8	16.3	8.0	3.4	11.4	7.0	13.5	16.2	8.6	6.8	20.5	5.5	6.7	13.1	10.9	18.0	9.6	14.9	7.1	24.7	12.5	15.7	6.1	14.5	8.5	17.4	5.5	18.5	6.1	12.2	14.3	8.6	14.3	9.5	13.6	39.0	27.2	15.3	24.5	32.6	39.6	0.1	48.0	31.2	32.1	38.6	53.9	35.7	8.4	31.9	27.4	13.2	44.5	28.9	44.5	41.4	23.9	9.5	6.0	46.9	0.0	12.0	11.2	12.6	19.5	15.4	55.6	27.1	20.6	24.1	3.7	12.0	1.9	41.7	24.4	0.3	1.0	28.7	15.2	31.0	12.3	9.8	9.2	41.8	50.7	27.3	9.9	45.0	34.4	30.4	25.9	10.9	30.8	22.8	5.7	26.9	26.5	36.5	1.3	0.3	0.4	32.9	3.0	47.1	0.3	3.3	1.7	0.3	1.6	0.5	0.1	0.1	0.4	2.7	0.2	0.3	0.2	1.1	0.4	2.3	0.3	0.5	1.5	13.3	17.7	15.2	18.6	19.8	16.3	13.5	16.2	13.1	14.5	18.5	13.6	12.1	19.2	12.3	151.1	7.8	20.0	23.3	24.9	21.1	5.5	23.4	12.8	13.1	7.2	19.8	22.0	6.2	9.6	6.2	52.1	1.9	9.5	84.8	12.3	6.1	11.3	17.4	6.9	27.9	13.4	15.2	9.2	30.5	23.3	12.7	13.0	10.4	3.4	21.3	5.0	46.9	17.1	10.2	18.6	18.7	95.5	12.2	21.0	24.9	61.8	10.8	4.2	4.1	148.3	48.7	16.2	17.4	7.2	5.6	66.7	16.0	3.9	18.2	11.1	0.0	8.3	12.3	2.6	3.2	41.7	21.5	11.1	7.6	7.0	19.4	77.8
GPHN	KIAA1385	ENSG00000171723	Gephyrin	Q9NQX3	14	66507407-67181803	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Molybdenum cofactor biosynthesis"	"Multifunctional enzyme, Transferase"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 62.4"	"Group enriched"	"Detected in many"	4	"Astrocytes: 493.0;Excitatory neurons: 686.5;Inhibitory neurons: 866.7;Oligodendrocyte precursor cells: 576.1;Oligodendrocytes: 597.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003116, CAB004419, HPA024694"	Enhanced		Approved	Vesicles,Cytosol		NA	NA		6900	"Cluster 16: MAIT-cells - Unknown function"	"Cluster 15: Liver - Metabolism"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Vesicles	Cytosol	"CAB004419: AB_627670, HPA003116: AB_1078963, HPA024694: AB_1849616"	"unprognostic (8.37e-2)"	"unprognostic (2.53e-2)"	"unprognostic (2.42e-1)"	"unprognostic (1.20e-1)"	"unprognostic (5.14e-2)"	"unprognostic (4.89e-3)"	"unprognostic (8.29e-2)"	"unprognostic (1.41e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.23e-1)"	"unprognostic (2.49e-2)"	"unprognostic (8.54e-2)"	"prognostic favorable (5.25e-12)"	"unprognostic (9.81e-2)"	"unprognostic (2.27e-1)"	"unprognostic (7.50e-2)"	"prognostic unfavorable (4.61e-5)"	13.8	11.1	35.5	3.5	36.0	2.6	13.4	48.4	54.1	9.7	20.9	11.8	7.4	9.9	11.6	12.2	11.1	6.2	17.1	36.1	37.6	25.3	62.4	9.3	3.8	32.7	35.3	8.9	23.9	11.7	13.6	3.6	32.3	11.3	10.1	23.1	9.4	6.6	24.5	15.2	9.0	6.2	32.4	6.7	14.7	6.2	34.6	5.8	11.9	13.8	4.3	11.4	10.7	39.5	39.9	8.8	13.7	15.9	14.2	17.5	9.5	11.1	5.7	12.7	12.2	2.8	17.9	0.0	1.8	7.7	5.5	13.1	17.0	19.9	18.9	15.0	14.9	15.8	9.4	22.3	7.8	9.1	15.8	13.3	13.8	2.9	16.0	4.8	11.8	13.8	9.3	14.2	7.1	19.2	11.9	22.2	5.0	28.3	17.0	0.0	32.5	13.2	16.7	7.5	25.8	10.3	10.2	31.6	12.4	3.3	18.5	11.5	6.7	14.1	24.8	11.3	13.0	22.8	9.1	0.3	10.5	0.8	11.2	0.0	0.7	0.3	2.0	1.2	3.2	1.2	2.5	1.7	1.1	1.9	1.7	1.6	0.0	1.3	1.0	1.5	3.0	0.7	35.5	36.0	48.4	54.1	36.1	37.6	32.7	35.3	32.3	32.4	34.6	39.5	11.5	6.4	13.1	493.0	11.8	4.7	9.2	5.8	27.9	34.3	12.4	6.7	12.7	8.6	10.8	1.8	52.1	3.9	3.5	8.6	13.7	4.0	3.8	7.2	13.5	10.7	6.0	7.6	686.5	5.3	2.3	8.7	19.9	13.6	0.0	3.9	15.7	47.6	3.7	43.7	866.7	15.0	8.2	5.8	1.7	5.0	11.1	4.5	1.8	148.0	1.3	8.9	1.0	576.1	597.5	3.1	7.8	5.7	15.1	11.5	7.1	20.1	2.4	34.9	0.0	12.5	11.8	11.8	8.9	26.7	5.8	2.1	7.9	9.0	10.4	6.5
GPI	"AMF, NLK"	ENSG00000105220	"Glucose-6-phosphate isomerase"	P06744	19	34359480-34402413	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Gluconeogenesis, Glycolysis"	"Cytokine, Growth factor, Isomerase"	"Cancer-related genes, Disease variant, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 331.0;Late spermatids: 1127.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB018655, HPA024305, CAB040563, HPA052171"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cytosol"	"Secreted to blood"	No	No		86000000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 34: Spermatids - Unknown function"	"Plasma membrane, Cytosol"	Nucleoplasm	"CAB018655: AB_2112653, CAB040563: , HPA024305: AB_1849922, HPA052171: AB_2681748"	"unprognostic (1.03e-1)"	"unprognostic (8.39e-3)"	"unprognostic (2.39e-2)"	"unprognostic (1.38e-2)"	"unprognostic (4.52e-2)"	"unprognostic (6.45e-3)"	"unprognostic (1.95e-2)"	"unprognostic (8.52e-3)"	"unprognostic (3.18e-1)"	"unprognostic (1.45e-1)"	"unprognostic (4.93e-2)"	"unprognostic (2.75e-1)"	"unprognostic (3.24e-3)"	"unprognostic (2.62e-2)"	"unprognostic (2.43e-1)"	"unprognostic (2.60e-3)"	"unprognostic (2.88e-2)"	196.9	283.2	83.4	74.5	101.9	222.8	129.0	67.7	130.5	95.0	84.8	162.9	113.7	92.4	27.2	197.8	88.8	87.1	407.2	108.5	73.6	196.8	222.6	91.2	66.4	73.5	58.5	97.0	84.2	166.3	147.2	47.5	69.3	94.4	84.3	156.1	105.1	61.0	416.6	120.1	126.5	78.4	34.0	102.2	122.5	95.9	83.2	50.1	100.8	374.6	76.0	147.9	121.5	95.8	572.9	596.1	58.7	433.3	167.5	121.9	134.1	183.4	132.4	206.3	253.7	314.9	169.6	303.5	311.4	177.9	149.1	343.7	337.7	437.0	259.4	461.0	105.1	382.1	252.3	310.8	108.4	517.6	259.3	173.7	136.6	289.0	132.7	273.3	209.3	230.5	210.3	261.8	140.2	319.2	245.5	133.5	158.0	421.3	174.6	242.7	149.1	649.4	254.1	275.4	304.9	185.8	331.9	634.3	131.7	100.5	144.4	161.7	171.9	80.8	185.5	256.7	312.8	535.5	383.7	318.4	287.4	372.3	170.6	188.8	93.2	331.3	80.4	141.2	99.1	59.9	73.7	93.1	101.0	50.5	61.8	72.8	7.4	58.0	180.3	31.6	83.4	123.4	83.4	101.9	67.7	130.5	108.5	73.6	73.5	58.5	69.3	34.0	83.2	95.8	34.2	28.9	40.0	98.9	43.8	25.9	30.1	104.5	42.7	98.8	34.1	27.2	232.5	42.9	51.4	57.0	75.0	44.5	41.6	76.7	115.4	101.7	331.0	35.9	41.2	38.0	63.7	46.7	121.8	66.9	69.2	47.1	109.1	58.0	23.4	36.1	42.8	89.5	89.6	237.2	127.2	75.8	50.8	52.9	40.5	1127.2	37.0	58.1	35.6	17.8	44.4	32.6	23.7	43.7	87.7	77.6	39.4	30.5	77.1	31.5	111.8	103.0	33.1	68.3	19.7	44.3	65.0	7.8	22.3	139.1	32.8	39.3	64.3	74.8	126.9	37.2
GPN1	"ATPBD1A, MBDIN, NTPBP, RPAP4, XAB1"	ENSG00000198522	"GPN-loop GTPase 1"	Q9HCN4	2	27628247-27651511	"Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 86.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036793, HPA036794, CAB037303"	Uncertain		Supported	Nucleoplasm,Mitochondria,Cytosol		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 34: Spermatids - Unknown function"	"Nucleoplasm, Cytosol"	Mitochondria	"CAB037303: AB_477173, HPA036793: AB_2675318, HPA036794: AB_10672230"	"unprognostic (9.42e-2)"	"unprognostic (1.44e-1)"	"unprognostic (5.64e-2)"	"prognostic unfavorable (2.88e-5)"	"unprognostic (2.57e-1)"	"unprognostic (1.63e-3)"	"prognostic unfavorable (1.71e-5)"	"unprognostic (3.50e-2)"	"unprognostic (8.27e-3)"	"unprognostic (8.93e-2)"	"unprognostic (4.05e-3)"	"unprognostic (2.34e-1)"	"unprognostic (1.21e-2)"	"unprognostic (2.51e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.72e-1)"	22.8	22.8	19.3	20.3	19.8	34.1	26.4	19.9	26.1	18.1	19.5	22.7	19.9	19.1	19.9	25.5	21.0	18.6	21.3	19.4	21.6	26.3	24.6	18.6	28.7	22.5	22.6	18.4	22.8	25.9	16.6	26.5	21.8	17.7	25.6	24.9	21.5	16.9	32.4	24.8	19.6	22.4	19.6	22.2	20.6	25.5	21.9	30.1	22.8	27.2	30.3	24.0	19.5	21.2	94.6	53.3	48.8	35.4	44.3	44.8	48.7	52.0	50.5	70.7	52.1	58.0	47.4	58.8	49.2	56.4	65.4	39.5	67.6	63.4	71.5	55.4	47.6	66.8	38.3	70.7	57.3	100.0	33.7	46.7	54.8	72.6	67.1	49.4	75.2	51.5	84.7	53.5	84.1	54.2	60.3	75.1	83.4	70.9	50.7	60.2	144.4	61.0	57.9	53.5	42.9	67.6	57.2	61.5	58.4	44.7	37.1	56.0	62.9	61.5	91.1	30.9	122.7	60.8	71.8	156.9	88.0	85.0	51.8	92.4	61.3	55.1	79.1	71.6	86.0	74.6	72.2	92.0	89.7	68.7	63.8	78.2	9.3	106.1	72.1	46.8	79.2	82.3	19.3	19.8	19.9	26.1	19.4	21.6	22.5	22.6	21.8	19.6	21.9	21.2	17.6	12.8	10.4	2.3	18.7	21.7	21.7	28.2	10.8	9.2	14.8	11.8	11.8	14.3	19.7	14.7	4.2	43.5	28.8	9.5	23.5	46.4	86.3	20.5	14.1	17.3	17.4	18.7	6.6	36.3	46.2	14.3	9.7	21.7	24.7	17.7	17.5	10.2	33.4	11.8	6.6	13.0	20.3	20.1	26.8	76.0	14.9	17.6	23.2	2.8	28.9	15.0	27.8	5.0	5.0	46.3	13.5	10.9	11.2	20.1	16.2	20.8	14.3	10.9	13.1	13.2	19.0	36.6	23.4	13.6	18.6	33.1	31.0	20.2	20.0	18.9
GPR1		ENSG00000183671	"G protein-coupled receptor 1"	P46091	2	206175316-206218047	"G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"choroid plexus: 12.2"	"Group enriched"	"Detected in some"	6	"Extravillous trophoblasts: 12.3;Granulosa cells: 42.1"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 2.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 24.7;HHSteC: 133.9;hTCEpi: 61.8"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA010525	Uncertain		Supported	"Nucleoplasm,Vesicles,Plasma membrane"		NA	NA				"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 40: Granulosa cells - Unknown function"	"Plasma membrane"	"Nucleoplasm, Vesicles"	"HPA010525: AB_1078919"	"unprognostic (5.32e-2)"	"unprognostic (1.20e-1)"	"unprognostic (2.82e-1)"	"unprognostic (2.25e-2)"	"unprognostic (3.27e-5)"	"unprognostic (1.36e-1)"	"unprognostic (4.00e-3)"	"unprognostic (1.49e-2)"	"unprognostic (7.89e-2)"	"unprognostic (9.94e-2)"	"unprognostic (3.42e-3)"	"unprognostic (5.65e-2)"	"unprognostic (4.29e-4)"	"unprognostic (8.48e-4)"	"unprognostic (1.21e-1)"	"unprognostic (2.68e-2)"	"unprognostic (3.06e-3)"	1.5	2.7	0.1	0.2	0.9	0.0	0.7	0.5	0.3	2.6	12.2	0.3	0.1	0.5	0.2	4.5	0.5	1.2	1.6	0.6	0.3	0.4	0.0	0.2	0.8	0.0	0.0	1.3	0.0	0.4	0.2	3.9	0.0	0.2	0.3	0.7	0.9	0.1	0.7	4.8	0.3	1.0	0.0	0.0	0.1	0.9	0.2	0.0	0.3	2.4	0.3	1.0	5.6	0.0	2.2	0.2	1.8	0.0	0.4	7.5	0.6	14.4	24.7	8.8	7.4	0.0	0.0	0.0	0.8	7.3	0.6	0.2	0.7	0.0	2.9	0.0	0.3	0.0	4.2	0.0	133.9	0.0	0.0	5.5	61.8	12.5	20.0	10.2	0.0	0.0	0.0	0.0	17.8	0.0	0.0	0.0	6.9	0.5	1.3	0.0	0.0	0.0	0.0	0.0	0.3	6.1	2.9	0.0	0.0	1.6	0.1	0.0	0.3	10.5	4.8	12.5	1.1	0.0	0.0	0.0	3.8	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.9	0.5	0.3	0.6	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.5	0.6	0.6	0.2	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.8	0.0	12.3	4.5	0.0	0.0	0.0	42.1	0.0	0.0	0.3	0.0	0.6	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	3.3	0.0	0.0	0.3	0.6	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.3	0.0	0.9	1.2	0.0	0.0	0.8	1.0	0.7	0.5	0.0	0.0	0.4
GPR148	PGR6	ENSG00000173302	"G protein-coupled receptor 148"	Q8TDV2	2	130729070-130730336	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA046655, HPA060527"	Uncertain		Supported	"Plasma membrane"		NA	NA							"Plasma membrane"		"HPA046655: , HPA060527: AB_2684307"											"unprognostic (7.16e-4)"				"unprognostic (3.38e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.1	0.0	0.5	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.7	0.0	0.2	0.3	0.1	0.4	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
GPR156	"GABABL, PGR28"	ENSG00000175697	"G protein-coupled receptor 156"	Q8NFN8	3	120164645-120285222	"G-protein coupled receptors, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in some"		"testis: 2.7"	"Group enriched"	"Detected in some"	4	"Astrocytes: 15.0;Early spermatids: 8.3;Late spermatids: 17.9;Oligodendrocyte precursor cells: 13.0"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"fHDF/TERT166: 1.3;PC-3: 1.3;SiHa: 3.5;U-2 OS: 1.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA028642, HPA028644"	Uncertain		Supported	"Plasma membrane"		NA	NA				"Cluster 49: Ciliated cells - Cilium organization"	"Cluster 20: HeLa - Mitochondria"	"Cluster 25: Spermatids - Spermatogenesis"	"Plasma membrane"		"HPA028642: AB_10599711, HPA028644: AB_10600441"	"unprognostic (2.85e-3)"	"unprognostic (1.02e-1)"	"unprognostic (3.53e-3)"	"unprognostic (2.02e-3)"	"unprognostic (1.07e-1)"	"unprognostic (3.79e-1)"	"unprognostic (2.62e-4)"	"unprognostic (2.03e-1)"	"unprognostic (4.54e-4)"	"unprognostic (5.03e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.10e-1)"	"unprognostic (4.03e-5)"	"unprognostic (2.43e-2)"	"unprognostic (3.43e-2)"	"unprognostic (4.91e-3)"	"unprognostic (6.71e-2)"	0.0	0.0	0.3	0.1	0.3	0.0	0.3	0.0	0.2	0.2	0.1	0.0	0.0	0.4	0.0	0.2	1.0	0.1	0.0	0.2	0.1	0.1	0.0	0.1	0.0	0.3	0.3	0.3	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.4	0.7	0.4	0.0	0.0	0.0	0.4	0.3	0.0	0.0	2.7	0.1	0.3	0.0	0.3	0.0	0.2	0.0	0.3	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.3	0.0	0.3	0.5	0.0	0.2	0.0	0.3	1.3	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.8	0.0	0.3	0.1	0.0	0.8	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.4	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.4	0.6	3.5	0.0	0.4	0.1	0.4	0.0	0.1	0.1	1.9	0.0	0.1	0.4	0.2	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.2	0.2	0.1	0.3	0.3	0.1	0.3	0.1	0.3	0.0	0.0	0.0	15.0	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	8.3	0.3	0.2	0.0	0.0	0.0	1.5	0.2	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	17.9	0.0	0.1	0.0	1.0	0.0	1.3	0.0	13.0	2.9	0.1	0.0	0.4	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.3	0.1	0.6	1.4	0.0	0.0	0.1	0.0	0.3	0.0	0.0
GPR160	"GPCR1, GPCR150"	ENSG00000173890	"G protein-coupled receptor 160"	Q9UJ42	3	170037995-170085392	"G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 107.9;parathyroid gland: 216.6"	"Cell type enhanced"	"Detected in many"		"Enteroendocrine cells: 194.8;Proximal enterocytes: 362.1;Proximal tubular cells: 151.4;Rod photoreceptor cells: 153.2;Undifferentiated cells: 199.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"RPMI-8226: 123.9;SK-BR-3: 95.8;THP-1: 197.2;U-266/70: 206.2;U-266/84: 127.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA006970	Approved		Supported	"Plasma membrane"		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Plasma membrane"		"HPA006970: AB_1849275"	"unprognostic (1.70e-1)"	"unprognostic (5.08e-3)"	"unprognostic (2.96e-2)"	"unprognostic (2.39e-3)"	"unprognostic (2.20e-1)"	"unprognostic (3.01e-1)"	"unprognostic (5.21e-2)"	"prognostic favorable (1.21e-4)"	"unprognostic (5.71e-3)"	"unprognostic (1.35e-1)"	"unprognostic (4.35e-2)"	"unprognostic (1.77e-1)"	"prognostic favorable (4.93e-7)"	"unprognostic (1.40e-1)"	"unprognostic (2.25e-1)"	"unprognostic (1.43e-1)"	"prognostic favorable (3.61e-4)"	12.2	1.7	0.7	15.9	1.0	107.9	22.5	1.0	1.6	11.2	0.9	72.0	73.8	5.8	57.9	2.9	5.4	18.6	1.0	0.6	0.7	59.8	4.1	15.0	27.9	1.4	0.9	0.6	18.4	216.6	1.4	4.1	1.1	26.7	72.6	104.7	19.3	6.3	1.3	1.2	98.6	4.4	0.8	25.2	43.0	5.2	0.9	9.5	6.7	2.7	30.4	26.8	1.0	1.2	64.2	1.5	0.3	0.5	0.3	0.4	15.6	0.4	0.5	0.4	1.9	11.7	8.1	29.4	12.9	0.6	4.0	0.7	8.8	0.5	1.0	45.9	17.7	19.1	1.0	24.3	0.2	38.2	24.8	0.2	0.9	2.0	2.3	2.8	1.4	13.7	6.4	73.9	0.4	41.5	2.9	8.4	10.3	39.1	2.4	5.3	1.1	123.9	32.3	86.8	6.1	1.8	0.8	95.8	4.5	8.2	55.9	197.2	1.9	0.2	0.4	7.1	4.8	206.2	127.9	51.4	0.8	40.3	2.8	2.9	1.1	9.3	0.5	0.4	1.0	8.0	1.0	0.4	2.4	12.3	3.0	1.1	11.3	0.4	0.2	3.2	0.3	1.2	0.7	1.0	1.0	1.6	0.6	0.7	1.4	0.9	1.1	0.8	0.9	1.2	35.2	9.6	51.1	0.7	25.9	0.4	3.2	4.1	0.0	9.5	48.5	18.3	1.0	28.6	22.7	62.5	39.6	3.1	11.6	88.9	54.8	10.3	33.7	20.6	4.4	8.7	194.8	0.4	1.5	72.0	21.1	1.0	50.0	54.0	1.3	0.1	20.0	0.9	7.4	15.2	0.6	133.9	18.3	11.7	11.2	36.3	0.6	17.0	28.4	7.5	62.3	16.6	0.0	1.0	0.9	60.3	118.6	0.4	56.8	25.4	362.1	151.4	27.9	153.2	0.0	0.8	1.4	7.4	13.1	0.9	0.9	27.2	4.2	1.2	199.7	35.5
GPR174	FKSG79	ENSG00000147138	"G protein-coupled receptor 174"	Q9BXC1	X	79144688-79175318	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"lymphoid tissue: 16.9"	"Cell type enhanced"	"Detected in some"		"B-cells: 6.6;dendritic cells: 30.6;Plasma cells: 4.2;T-cells: 18.5"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"JURKAT: 42.3;MOLT-4: 75.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA041025, HPA058306"	Enhanced		Supported	"Vesicles,Plasma membrane,Centriolar satellite"		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 7: Non-specific - Mitochondria"	"Plasma membrane"	"Vesicles, Centriolar satellite"	"HPA041025: AB_10794260, HPA058306: "	"unprognostic (6.38e-3)"	"unprognostic (9.87e-3)"	"unprognostic (4.36e-2)"	"unprognostic (1.18e-2)"	"unprognostic (1.84e-1)"	"unprognostic (8.48e-4)"	"unprognostic (7.12e-2)"	"unprognostic (1.05e-2)"	"unprognostic (1.75e-1)"	"unprognostic (2.02e-1)"	"unprognostic (2.46e-1)"	"unprognostic (1.05e-1)"	"unprognostic (6.53e-5)"	"unprognostic (2.27e-1)"	"unprognostic (2.64e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.78e-2)"	0.8	0.4	0.5	6.9	0.3	2.5	0.9	0.6	0.6	0.4	0.3	1.0	2.0	0.5	0.6	0.3	0.3	1.1	0.3	0.4	0.4	0.5	1.0	1.9	15.2	0.7	0.5	0.2	0.1	0.1	0.1	0.2	0.7	0.7	1.6	0.2	1.5	0.1	0.2	0.2	3.6	0.3	0.3	8.1	2.1	0.1	0.4	16.9	0.9	0.1	10.4	1.4	0.6	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.9	0.1	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	42.3	0.0	1.2	0.0	0.0	75.1	0.1	0.0	0.0	0.0	2.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.4	0.0	0.2	0.0	0.0	0.0	6.5	0.0	3.6	3.6	2.0	1.2	2.5	4.8	6.1	0.1	2.6	4.2	4.9	0.3	4.6	5.5	1.0	4.8	1.6	0.5	0.3	0.6	0.6	0.4	0.4	0.7	0.5	0.7	0.3	0.4	0.5	0.7	0.0	2.4	0.0	6.6	0.1	0.0	0.0	0.0	0.0	0.7	0.6	0.0	0.0	0.6	1.8	0.0	0.0	30.6	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.1	0.0	3.1	0.0	0.0	0.0	0.0	0.0	4.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	18.5	0.1	0.0	0.0
GPR20		ENSG00000204882	"G protein-coupled receptor 20"	Q99678	8	141356470-141367286	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in some"			"Cell type enriched"	"Detected in some"	4	"Sertoli cells: 72.3"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	18	"intermediate monocyte: 2.6;non-classical monocyte: 4.3"	"Lineage enriched"	"Detected in single"	22	"monocytes: 4.3"	"Cell line enriched"	"Detected in single"	6	"EFO-21: 4.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA071337			Supported	"Plasma membrane,Cytosol"		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 48: Smooth muscle cells - ECM organization"	"Plasma membrane"	Cytosol	"HPA071337: "	"unprognostic (4.47e-2)"	"unprognostic (2.64e-3)"	"unprognostic (5.18e-2)"	"unprognostic (2.00e-2)"	"unprognostic (7.47e-2)"	"unprognostic (2.28e-1)"	"unprognostic (4.43e-2)"	"unprognostic (5.01e-2)"	"unprognostic (3.54e-1)"	"unprognostic (2.13e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.07e-2)"	"unprognostic (7.41e-2)"	"unprognostic (5.50e-2)"	"unprognostic (6.23e-2)"	"unprognostic (4.07e-1)"	0.8	0.2	0.0	0.2	0.0	0.0	0.6	0.0	0.4	2.0	0.0	1.4	0.4	1.9	0.7	0.6	1.5	0.7	1.1	0.0	0.0	0.6	0.2	1.5	0.0	0.0	0.0	1.2	0.2	0.1	0.2	1.2	0.1	0.9	0.3	0.0	0.2	0.8	0.3	0.4	2.1	1.8	0.0	0.2	1.7	0.1	0.0	0.0	0.5	0.4	0.0	0.7	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.1	0.1	0.4	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.5	0.3	0.0	0.0	0.7	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	1.9	0.0	0.2	1.8	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	72.3	0.3	16.2	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1
GPR37L1	ETBR-LP-2	ENSG00000170075	"G protein-coupled receptor 37 like 1"	O60883	1	202122917-202133592	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"brain: 76.4"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 91.7;Muller glia cells: 59.6;Oligodendrocyte precursor cells: 89.0;Oligodendrocytes: 20.4"	"Cancer enriched"	"Detected in some"	57	"glioma: 36.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"HaCaT: 1.2;MCF7: 1.5;T-47d: 3.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA061629, HPA064454"	Enhanced		Approved	"Nucleoplasm,Vesicles,Plasma membrane,Cell Junctions"		NA	NA				"Cluster 70: Brain - Nervous system development"	"Cluster 6: T47d - Mammary gland"	"Cluster 68: Oligodendrocytes - Mixed function"	"Nucleoplasm, Cell Junctions"	"Vesicles, Plasma membrane"	"HPA061629: , HPA064454: AB_2685268"	"unprognostic (2.12e-2)"	"unprognostic (1.83e-1)"	"unprognostic (2.96e-1)"	"unprognostic (1.61e-3)"	"unprognostic (4.52e-1)"	"unprognostic (8.20e-2)"	"unprognostic (2.26e-4)"	"unprognostic (5.83e-2)"	"unprognostic (3.46e-3)"	"unprognostic (2.07e-1)"	"unprognostic (1.83e-1)"	"unprognostic (3.28e-2)"	"unprognostic (4.86e-3)"	"unprognostic (1.14e-1)"	"unprognostic (4.58e-2)"	"unprognostic (1.18e-3)"	"unprognostic (3.49e-1)"	0.1	0.2	55.2	0.0	71.1	0.2	0.0	60.7	52.2	0.2	10.6	0.9	0.2	0.1	0.1	0.1	0.1	0.0	0.1	48.0	50.7	0.0	0.2	0.0	0.0	66.7	67.0	0.0	0.0	0.0	0.6	0.0	53.7	0.2	0.2	2.8	0.1	0.3	0.1	0.1	0.3	0.1	59.4	0.0	0.2	0.3	76.4	0.0	0.1	0.1	0.0	0.0	0.1	53.1	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.5	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	55.2	71.1	60.7	52.2	48.0	50.7	66.7	67.0	53.7	59.4	76.4	53.1	0.0	0.0	0.0	91.7	0.1	0.4	0.5	0.7	0.0	1.2	0.3	0.3	1.1	1.5	1.7	0.0	4.2	0.1	0.0	4.9	0.0	3.2	4.5	0.9	0.2	0.1	0.0	0.0	0.4	1.2	1.0	0.2	0.0	0.5	0.0	0.0	0.0	0.4	0.0	0.0	0.5	1.1	0.0	0.0	0.0	0.8	0.9	0.1	0.0	2.8	0.0	59.6	0.0	89.0	20.4	2.1	2.7	1.9	0.0	0.8	1.3	0.1	1.1	4.9	0.0	0.5	0.1	0.0	0.1	0.0	0.1	0.7	0.1	0.2	0.7	1.0
GPR50	"H9, Mel1c"	ENSG00000102195	"G protein-coupled receptor 50"	Q13585	X	151176584-151181465	"G-protein coupled receptors, Plasma proteins, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"pituitary gland: 17.1"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"head and neck cancer: 1.4"	"Region enhanced"	"Detected in some"		"hypothalamus: 3.4"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"HEK 293: 5.0;SuSa: 4.0"	"Group enriched"	"Detected in many"	4	"hypothalamus: 14.4;white matter: 5.0"	"Region enriched"	"Detected in single"	10	"hypothalamus: 4.8"	"HPA049862, HPA054678"	Enhanced		Supported	"Nucleoplasm,Plasma membrane"		NA	NA				"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"		"Plasma membrane"	Nucleoplasm	"HPA049862: AB_2680920, HPA054678: AB_2682570"						"unprognostic (8.84e-3)"		"unprognostic (5.59e-2)"							"unprognostic (1.15e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.1	0.6	0.1	0.0	0.0	0.0	17.1	0.4	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	3.4	0.6	0.1	0.5	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
GPRASP1	"GASP, GASP1"	ENSG00000198932	"G protein-coupled receptor associated sorting protein 1"	Q5JY77	X	102651092-102659083	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Bipolar cells: 42.6;Cardiomyocytes: 28.6;Cone photoreceptor cells: 37.5"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 7.7"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+ RasG12V: 4.5;REH: 5.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000161, HPA031061"	Approved		Supported	Cytosol		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 14: REH - Unknown function"	"Cluster 50: Fibroblasts - ECM organization"	Cytosol		"HPA000161: AB_2247872, HPA031061: AB_2673718"	"unprognostic (3.92e-3)"	"unprognostic (1.10e-1)"	"unprognostic (2.07e-4)"	"unprognostic (1.42e-1)"	"unprognostic (3.32e-2)"	"unprognostic (1.71e-3)"	"unprognostic (3.57e-1)"	"unprognostic (2.33e-2)"	"unprognostic (1.58e-1)"	"unprognostic (2.82e-1)"	"prognostic favorable (1.77e-5)"	"unprognostic (3.34e-1)"	"unprognostic (2.48e-1)"	"unprognostic (1.93e-2)"	"unprognostic (1.63e-1)"	"prognostic unfavorable (7.38e-4)"	"unprognostic (1.23e-2)"	8.6	22.6	25.1	5.4	23.9	3.8	9.9	19.8	31.2	32.4	2.7	23.3	2.4	25.5	10.7	4.4	26.7	7.6	17.7	22.8	33.2	10.3	2.9	7.2	9.4	16.6	17.8	53.4	5.6	17.3	43.5	2.9	18.6	20.4	4.5	29.9	8.7	17.7	6.1	5.2	12.4	15.3	12.8	11.3	9.6	5.3	23.6	6.8	26.1	4.2	7.6	18.6	16.9	20.2	0.2	0.5	1.7	1.1	1.7	1.7	1.0	1.8	0.1	2.7	4.5	0.2	0.3	0.0	0.4	3.8	0.3	0.5	0.5	0.1	3.9	0.0	0.2	0.1	0.6	0.5	1.4	0.2	0.2	2.2	0.7	3.3	0.3	0.4	0.2	1.8	0.3	0.1	4.3	0.4	3.7	0.1	1.2	0.3	0.6	5.6	1.7	0.0	0.2	0.4	1.7	2.7	0.6	0.2	0.5	1.4	0.2	0.9	0.5	0.8	1.0	0.5	0.3	0.3	0.5	0.0	0.4	0.2	1.1	0.0	0.0	0.0	0.5	0.0	1.3	0.2	1.1	0.4	0.0	0.7	2.3	2.3	0.0	0.1	0.0	0.3	0.8	0.5	25.1	23.9	19.8	31.2	22.8	33.2	16.6	17.8	18.6	12.8	23.6	20.2	5.1	0.0	3.6	0.0	4.4	3.6	4.1	0.8	1.8	42.6	1.8	3.0	28.6	1.5	3.5	5.5	37.5	0.4	3.5	0.1	0.0	0.2	0.3	0.6	6.5	7.3	6.0	0.4	0.0	0.2	0.2	9.9	1.1	0.7	2.5	13.9	7.1	0.7	0.3	6.7	0.0	0.7	0.0	0.3	2.0	1.7	15.2	1.3	1.8	0.0	0.5	12.9	3.1	0.0	0.0	0.6	0.1	15.4	2.2	3.8	0.4	1.7	1.2	18.8	6.6	16.9	8.5	7.0	2.4	0.4	0.9	0.1	7.3	6.5	0.8	1.6
GPRC5B	RAIG-2	ENSG00000167191	"G protein-coupled receptor class C group 5 member B"	Q9NZH0	16	19856691-19886167	"G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"brain: 490.3"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 197.7;Late spermatids: 269.9;Oligodendrocytes: 171.0"	"Cancer enhanced"	"Detected in all"		"glioma: 52.6"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"naive CD4 T-cell: 2.8"	"Lineage enhanced"	"Detected in single"		"T-cells: 2.8"	"Cell line enhanced"	"Detected in many"		"EFO-21: 92.5;HHSteC: 60.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015247	Enhanced		Supported	Nucleoplasm,Nucleoli,Vesicles		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 34: Spermatids - Unknown function"	Vesicles	"Nucleoplasm, Nucleoli"	"HPA015247: AB_1849323"	"unprognostic (1.26e-1)"	"unprognostic (1.32e-1)"	"prognostic unfavorable (9.27e-5)"	"unprognostic (2.60e-3)"	"unprognostic (3.28e-1)"	"unprognostic (2.46e-1)"	"unprognostic (3.97e-2)"	"unprognostic (5.70e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.26e-2)"	"unprognostic (2.76e-2)"	"unprognostic (1.27e-1)"	"prognostic favorable (6.30e-4)"	"unprognostic (4.73e-2)"	"unprognostic (1.06e-1)"	"unprognostic (4.42e-3)"	"unprognostic (6.78e-3)"	25.3	7.0	249.1	4.4	428.3	0.1	19.6	365.2	263.4	12.8	13.1	8.1	5.7	13.1	14.8	8.1	20.1	15.3	40.7	245.8	278.4	22.4	3.2	5.8	7.8	379.4	327.1	22.6	21.7	45.9	14.1	15.7	333.0	9.6	2.4	17.4	40.1	17.7	72.7	7.5	11.1	7.5	262.7	2.5	41.3	34.0	315.0	3.2	13.8	73.8	3.4	12.8	8.6	490.3	1.2	29.9	29.0	5.2	29.3	2.0	5.3	0.3	7.4	2.9	1.8	28.0	1.0	0.0	92.5	1.0	18.9	1.6	21.6	0.2	1.7	0.2	8.6	0.0	0.1	0.0	60.3	0.0	0.0	2.5	0.0	4.9	0.0	7.9	14.3	0.7	6.6	0.6	6.7	1.5	0.1	0.1	31.8	0.0	15.6	8.9	0.0	0.2	1.1	13.8	22.9	1.9	3.6	1.9	27.2	9.1	0.1	0.6	2.9	0.0	3.5	14.4	0.8	0.4	0.1	0.3	1.4	0.3	1.8	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.7	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.1	0.0	0.0	0.5	249.1	428.3	365.2	263.4	245.8	278.4	379.4	327.1	333.0	262.7	315.0	490.3	71.4	0.0	3.0	75.4	1.2	1.3	5.3	2.6	9.1	30.7	22.5	16.3	15.7	40.0	7.2	31.3	0.0	5.0	0.3	0.2	1.9	65.3	197.7	4.1	20.7	44.8	0.0	0.0	2.4	64.5	1.4	14.8	31.6	13.7	0.0	0.4	9.3	0.2	4.1	0.0	13.5	0.0	38.7	1.6	2.6	269.9	23.9	2.2	16.0	7.5	1.0	24.8	0.0	51.8	171.0	72.8	0.0	26.7	1.3	12.3	0.0	0.3	3.3	6.0	13.1	3.3	13.0	4.9	1.6	2.4	1.7	2.5	0.8	7.0	0.2	1.6
GPRIN1	"GRIN1, KIAA1893"	ENSG00000169258	"G protein regulated inducer of neurite outgrowth 1"	Q7Z2K8	5	176595802-176610156	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 22.1;pituitary gland: 8.1;retina: 6.9"	"Group enriched"	"Detected in some"	4	"Bipolar cells: 12.8;Excitatory neurons: 7.5;Horizontal cells: 21.9;Inhibitory neurons: 8.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 56.5;SCLC-21H: 59.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036478, HPA070892"	Enhanced		Supported	"Vesicles,Plasma membrane"		NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 62: Horizontal cells - Visual perception"	"Plasma membrane"	Vesicles	"HPA036478: AB_2675145, HPA070892: AB_2686321"	"unprognostic (1.70e-1)"	"unprognostic (7.38e-2)"	"unprognostic (4.41e-2)"	"unprognostic (5.66e-2)"	"unprognostic (6.54e-3)"	"unprognostic (3.06e-1)"	"unprognostic (4.76e-6)"	"prognostic unfavorable (6.83e-6)"	"unprognostic (1.11e-1)"	"unprognostic (1.45e-1)"	"unprognostic (2.59e-3)"	"unprognostic (1.56e-3)"	"prognostic unfavorable (2.79e-7)"	"unprognostic (4.24e-3)"	"unprognostic (5.60e-2)"	"unprognostic (2.21e-1)"	"unprognostic (3.32e-3)"	0.5	1.6	16.9	0.8	15.9	0.2	0.3	6.8	19.5	0.3	0.0	1.1	3.8	0.4	0.0	0.8	0.1	0.3	0.4	22.1	15.7	0.6	0.4	0.4	0.8	4.3	3.5	0.0	0.6	0.1	8.1	0.3	5.1	0.2	0.4	6.9	0.3	0.0	0.3	1.0	3.2	0.7	3.3	0.4	0.8	1.5	14.8	0.9	0.2	0.2	1.1	0.3	0.2	6.6	7.5	7.9	9.8	14.1	2.1	4.6	8.3	9.8	5.1	7.5	9.7	9.6	4.8	17.0	19.6	5.3	22.0	6.5	6.3	6.8	6.5	56.5	4.3	0.3	4.1	3.4	0.9	0.4	4.2	2.3	5.1	8.1	1.2	1.5	5.5	3.8	9.1	24.0	6.3	19.7	1.8	0.0	9.9	5.0	15.4	31.7	10.9	10.1	8.4	7.7	59.5	34.1	11.4	3.2	17.7	1.2	7.4	6.5	6.8	13.8	16.0	5.3	14.5	0.4	2.3	4.8	11.9	0.8	15.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.9	15.9	6.8	19.5	22.1	15.7	4.3	3.5	5.1	3.3	14.8	6.6	0.4	0.0	0.0	0.3	0.5	2.4	0.1	0.3	0.6	12.8	0.4	0.3	0.3	0.0	0.1	0.0	0.0	0.1	0.4	0.3	1.9	0.4	0.0	0.5	0.6	1.0	1.8	0.0	7.5	1.8	0.9	0.4	0.0	1.2	0.0	0.3	0.0	0.0	0.9	21.9	8.0	0.3	0.0	0.0	0.3	0.0	0.3	0.2	0.0	1.9	0.1	1.1	1.0	2.5	0.3	1.6	0.1	0.0	0.8	0.2	0.0	0.3	0.4	3.1	0.0	1.5	0.3	0.7	2.7	0.4	1.4	0.1	0.3	0.4	0.2	0.1
GPS2		ENSG00000132522	"G protein pathway suppressor 2"	Q13227	17	7311324-7315564	"Cancer-related genes, Predicted intracellular proteins"	"Host-virus interaction, Transcription, Transcription regulation"	"Activator, Repressor"	"Cancer-related genes, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 279.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA067540	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 59: Non-specific - Translation"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 31: Spermatids - Spermatogenesis"	Nucleoplasm		"HPA067540: AB_2685860"	"unprognostic (1.53e-2)"	"unprognostic (3.43e-1)"	"unprognostic (3.33e-2)"	"unprognostic (1.71e-3)"	"unprognostic (1.55e-1)"	"unprognostic (1.53e-4)"	"unprognostic (1.37e-2)"	"unprognostic (1.33e-1)"	"unprognostic (3.18e-2)"	"unprognostic (2.84e-1)"	"prognostic favorable (7.50e-5)"	"unprognostic (1.37e-2)"	"prognostic unfavorable (3.42e-5)"	"unprognostic (2.09e-1)"	"unprognostic (1.44e-1)"	"unprognostic (6.87e-2)"	"unprognostic (1.28e-3)"	45.4	47.7	30.3	15.5	30.9	26.8	39.7	30.7	37.8	42.1	28.4	47.5	14.6	39.5	14.2	38.0	36.8	13.2	65.8	30.3	30.9	49.8	33.3	34.0	17.2	31.8	30.7	39.5	39.0	24.4	33.8	13.9	31.1	35.3	17.1	12.0	39.4	16.9	154.9	52.0	34.5	15.6	29.5	34.6	40.0	102.7	31.2	21.6	34.6	52.9	20.1	43.9	37.2	31.7	28.1	60.6	24.9	26.4	36.5	20.2	21.2	20.1	26.7	45.2	39.0	39.2	16.1	32.0	15.5	31.1	32.3	42.1	25.4	42.4	31.5	37.9	34.8	30.1	62.2	53.0	26.4	19.1	37.1	19.3	31.2	59.0	17.1	19.5	26.0	29.7	18.8	8.6	43.2	25.8	38.2	21.2	24.6	29.3	22.8	29.5	30.8	34.1	36.4	32.1	23.5	39.5	35.6	23.6	28.9	21.4	23.6	18.6	15.9	23.0	20.5	28.2	48.9	25.0	37.0	21.0	30.3	23.2	38.1	78.3	47.2	82.7	53.5	59.8	49.5	81.6	56.6	58.5	39.5	63.8	51.9	47.8	79.1	41.5	67.7	66.0	81.2	58.1	30.3	30.9	30.7	37.8	30.3	30.9	31.8	30.7	31.1	29.5	31.2	31.7	29.1	12.8	10.8	19.9	36.9	15.8	11.5	11.4	29.0	29.9	19.2	17.8	1.2	17.2	16.6	20.2	66.7	13.5	55.7	52.4	25.4	21.7	100.3	15.0	22.6	18.9	16.8	29.9	15.0	26.8	11.1	14.9	25.5	17.5	19.0	23.4	11.4	10.6	10.3	38.7	12.5	23.2	6.1	14.1	25.0	279.3	21.1	21.1	19.6	13.1	21.6	15.5	41.2	10.6	17.1	19.5	35.9	15.4	42.2	8.4	42.2	25.7	14.6	44.8	19.7	17.4	18.8	37.4	42.9	18.1	16.9	19.6	39.0	17.1	21.8	9.1
GPSM1	"AGS3, DKFZP727I051"	ENSG00000160360	"G protein signaling modulator 1"	Q86YR5	9	136327476-136359605	"Predicted intracellular proteins"	"Differentiation, Neurogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 26.1;Bipolar cells: 37.2;Cone photoreceptor cells: 22.9;Muller glia cells: 36.0;Rod photoreceptor cells: 43.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"REH: 82.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042199, HPA060736"	Approved		Supported	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 14: REH - Unknown function"	"Cluster 5: Muller glia cells - Visual perception"	"Golgi apparatus"	Nucleoplasm	"HPA042199: AB_10959329, HPA060736: "	"unprognostic (1.73e-2)"	"unprognostic (1.35e-1)"	"prognostic unfavorable (6.07e-4)"	"unprognostic (4.07e-3)"	"unprognostic (3.44e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.37e-2)"	"unprognostic (2.03e-2)"	"unprognostic (1.48e-1)"	"unprognostic (5.96e-3)"	"unprognostic (3.37e-2)"	"prognostic unfavorable (3.30e-4)"	"unprognostic (4.66e-2)"	"unprognostic (1.84e-1)"	"unprognostic (6.42e-2)"	"unprognostic (7.48e-2)"	13.0	21.7	32.6	4.2	30.6	4.5	12.4	50.9	44.4	38.7	12.7	18.5	3.3	23.3	7.2	6.0	20.3	4.7	74.9	30.5	26.7	19.6	4.7	35.4	2.1	34.9	29.8	38.1	42.3	3.8	19.7	6.6	28.7	30.6	1.2	18.7	8.6	5.9	2.7	17.0	9.3	4.0	25.1	19.9	17.2	29.4	28.6	2.0	12.4	0.7	1.1	15.1	24.4	28.6	3.9	6.2	14.5	25.4	8.1	14.1	12.1	43.0	17.6	11.8	6.4	12.5	4.1	0.0	17.8	26.0	9.9	2.9	2.3	8.8	2.6	35.1	25.5	5.0	23.4	2.3	34.7	0.3	6.1	23.0	5.8	10.8	6.2	14.5	12.0	5.9	13.5	0.2	7.9	14.2	2.4	4.9	15.5	1.4	22.5	82.3	26.2	12.7	3.2	2.8	35.6	44.4	8.0	1.0	13.7	5.6	17.7	8.6	20.0	21.7	17.5	25.7	8.9	7.6	0.3	0.1	13.0	0.0	21.0	0.0	0.0	0.0	0.1	0.4	0.1	0.0	0.2	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.1	32.6	30.6	50.9	44.4	30.5	26.7	34.9	29.8	28.7	25.1	28.6	28.6	4.7	3.2	3.3	26.1	0.6	4.2	2.3	0.8	0.0	37.2	2.5	5.8	12.4	0.0	0.8	0.0	22.9	0.6	1.6	0.0	11.7	3.3	0.6	2.7	18.1	3.9	1.8	2.5	9.0	1.9	0.8	9.1	0.5	5.5	5.7	14.2	3.6	0.0	1.1	10.1	11.6	0.0	0.0	0.3	2.8	1.3	10.5	1.5	8.8	6.5	0.5	36.0	0.0	9.5	10.4	7.3	0.0	9.4	0.3	10.6	0.0	0.1	0.6	43.0	0.0	5.8	6.0	0.4	3.7	0.1	3.3	0.3	1.1	3.3	0.0	4.0
GPSM2	"DFNB82, LGN, Pins"	ENSG00000121957	"G protein signaling modulator 2"	P81274	1	108875350-108934545	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Cell cycle, Cell division, Mitosis, Transport"		Deafness	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 46.9;tongue: 54.4"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 133.5;Oligodendrocyte precursor cells: 134.7;Oligodendrocytes: 127.4;Syncytiotrophoblasts: 89.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"eosinophil: 3.2;T-reg: 1.8"	"Group enriched"	"Detected in many"	5	"granulocytes: 3.2;T-cells: 1.8"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007327, HPA008408, CAB018962"	Uncertain		Supported	Cytosol		NA	Yes			"Cluster 52: Eosinophils - Transcription"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 68: Oligodendrocytes - Mixed function"	Cytosol		"CAB018962: , HPA007327: AB_1849941, HPA008408: AB_1849939"	"unprognostic (1.97e-1)"	"unprognostic (6.80e-2)"	"prognostic favorable (7.86e-5)"	"unprognostic (1.37e-3)"	"unprognostic (3.18e-2)"	"unprognostic (1.97e-2)"	"unprognostic (8.57e-6)"	"unprognostic (7.12e-2)"	"unprognostic (2.76e-2)"	"unprognostic (3.92e-2)"	"prognostic unfavorable (5.89e-4)"	"unprognostic (7.55e-3)"	"prognostic unfavorable (3.02e-4)"	"unprognostic (6.27e-3)"	"unprognostic (1.00e-1)"	"unprognostic (5.14e-3)"	"unprognostic (6.00e-2)"	5.3	3.5	27.3	4.4	39.5	14.4	7.5	33.8	25.2	12.6	10.8	15.3	9.1	6.8	2.6	34.1	4.2	2.6	4.3	23.3	29.5	2.3	2.9	9.0	6.4	33.9	36.3	3.3	3.6	9.7	3.1	7.7	33.9	5.9	15.2	8.6	10.1	4.7	10.7	37.7	11.5	10.5	32.1	2.7	5.1	11.5	34.1	18.4	3.2	54.4	13.2	6.0	17.7	46.9	135.6	16.2	36.8	27.7	36.4	20.2	30.0	24.2	61.4	29.9	45.4	16.0	31.7	30.5	6.7	33.4	21.0	28.3	25.3	59.1	39.6	30.7	15.8	19.8	34.7	16.5	4.8	28.6	18.5	4.1	113.9	29.4	129.8	9.4	26.9	19.5	14.9	42.3	58.4	37.8	26.1	12.2	8.7	52.1	29.4	20.1	66.7	6.6	24.3	18.6	30.4	26.9	37.0	69.2	26.9	10.3	27.6	24.3	18.0	21.7	36.7	64.8	48.5	18.4	20.9	28.6	34.3	47.4	108.9	0.1	0.3	3.2	0.2	0.3	0.1	0.2	0.2	0.2	0.3	0.4	0.4	0.3	0.3	0.1	0.1	0.1	1.8	0.1	27.3	39.5	33.8	25.2	23.3	29.5	33.9	36.3	33.9	32.1	34.1	46.9	4.6	16.0	3.3	63.0	5.7	62.7	18.8	12.9	47.3	47.7	3.0	3.7	2.5	2.8	12.5	7.3	133.5	46.3	6.7	10.8	11.7	2.5	54.0	5.2	20.6	5.1	9.1	33.9	11.7	1.9	47.7	19.5	8.6	9.2	2.5	14.4	2.9	1.6	9.0	43.7	24.0	14.1	10.2	5.3	11.3	21.3	18.6	4.9	26.6	3.7	5.3	8.0	2.1	134.7	127.4	4.8	7.8	5.3	5.3	5.6	8.4	0.9	9.0	48.1	0.0	43.6	6.9	20.6	28.9	24.0	40.6	89.2	7.1	10.0	18.7	15.5
GPX1		ENSG00000233276	"Glutathione peroxidase 1"	P07203	3	49357176-49358353	"Cancer-related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Oxidoreductase, Peroxidase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 3273.8;Kupffer cells: 3971.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"dendritic cells: 1534.3;granulocytes: 1010.7;monocytes: 1337.0"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011582, HPA044758"	Approved		Supported	Cytosol		NA	NA		3100000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 15: Liver - Metabolism"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 51: Myeloid cells - Hemostasis"	Cytosol		"CAB011582: AB_2112120, HPA044758: AB_2679076"	"unprognostic (1.50e-2)"	"unprognostic (4.34e-3)"	"unprognostic (1.25e-1)"	"prognostic favorable (7.78e-4)"	"unprognostic (1.26e-1)"	"unprognostic (1.83e-1)"	"unprognostic (6.73e-3)"	"unprognostic (5.03e-2)"	"unprognostic (3.40e-2)"	"unprognostic (2.48e-1)"	"unprognostic (5.46e-2)"	"unprognostic (1.53e-1)"	"unprognostic (7.64e-3)"	"unprognostic (9.14e-3)"	"unprognostic (3.16e-2)"	"unprognostic (5.72e-3)"	"unprognostic (7.64e-3)"	321.4	200.0	178.3	151.9	186.6	246.7	151.5	190.2	298.9	90.9	247.3	86.9	122.2	82.2	17.8	134.3	86.5	91.1	95.5	173.1	198.9	152.9	281.6	168.3	174.3	234.0	213.0	61.9	74.4	35.2	85.7	121.2	208.3	107.0	42.7	8.3	113.1	53.9	157.1	70.4	113.6	70.4	218.0	195.9	92.9	31.5	217.6	75.3	82.1	61.7	86.6	116.8	94.9	256.3	322.8	189.2	72.6	95.4	113.5	205.9	225.9	217.7	114.7	151.5	80.1	157.8	229.7	0.6	301.6	139.8	181.7	93.2	98.8	660.3	31.6	200.2	271.6	224.8	190.2	397.4	575.6	161.0	594.4	455.9	267.6	292.4	221.5	190.0	341.5	78.6	0.5	179.3	125.9	0.8	51.2	407.0	441.3	147.4	510.5	190.8	93.8	120.3	258.2	385.6	87.7	178.5	249.5	1.5	287.3	75.7	1.5	559.5	546.5	209.7	236.0	385.8	453.6	1.1	127.9	116.3	390.5	436.3	507.8	1010.7	1337.0	707.6	69.8	483.7	100.9	314.2	127.7	83.7	1093.1	276.8	118.4	116.2	136.4	107.4	275.8	1534.3	233.3	1401.2	178.3	186.6	190.2	298.9	173.1	198.9	234.0	213.0	208.3	218.0	217.6	256.3	0.0	109.0	323.5	6.2	148.1	249.7	432.8	985.0	92.2	32.1	0.0	0.0	0.0	220.2	616.7	0.0	10.4	499.9	491.5	229.5	0.0	0.0	300.7	0.0	0.0	227.8	251.3	364.1	12.8	0.0	830.3	131.0	73.4	0.0	480.6	0.0	585.7	888.1	3273.8	1.7	17.9	285.0	386.6	3971.6	965.7	1102.9	134.5	1305.5	273.9	41.2	828.6	63.4	138.0	8.0	7.6	0.0	179.0	67.0	82.4	481.0	349.9	0.0	490.0	14.6	210.4	150.6	151.8	12.7	169.4	112.1	154.1	278.8	112.2	0.0	367.3	517.0
GRAMD1A	"FLJ90346, KIAA1533"	ENSG00000089351	"GRAM domain containing 1A"	Q96CP6	19	34994784-35026471	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Autophagy, Lipid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"monocytes: 146.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008852, HPA012570"	Approved		Supported	"Plasma membrane,Cytosol"		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 50: Non-specific - Ribosome"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 3: Monocytes - Immune response regulation"	"Plasma membrane"	Cytosol	"HPA008852: AB_1079203, HPA012570: AB_2112577"	"unprognostic (3.09e-2)"	"unprognostic (4.62e-2)"	"unprognostic (8.65e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.87e-1)"	"unprognostic (3.42e-3)"	"unprognostic (5.96e-2)"	"unprognostic (4.54e-1)"	"unprognostic (5.70e-2)"	"unprognostic (1.07e-2)"	"unprognostic (2.91e-1)"	"prognostic unfavorable (7.95e-12)"	"unprognostic (2.04e-1)"	"unprognostic (4.40e-1)"	"unprognostic (2.90e-2)"	"unprognostic (4.36e-2)"	37.9	36.9	17.8	28.0	15.9	23.9	31.1	16.4	24.5	33.2	17.5	30.1	15.1	32.5	5.3	11.6	36.2	16.5	30.3	17.4	18.5	27.4	21.2	58.1	28.8	21.8	20.7	38.4	80.8	17.8	29.2	16.8	21.5	32.6	8.4	5.1	55.6	17.0	47.8	14.5	23.3	18.9	18.2	42.1	35.8	16.6	21.5	18.7	25.4	18.9	12.8	35.7	20.1	17.1	17.3	106.0	21.3	41.5	23.9	27.5	19.6	21.6	27.5	21.8	21.6	39.8	11.9	10.8	41.2	25.2	19.3	9.5	22.2	31.9	8.2	48.9	47.3	24.6	25.5	36.8	48.3	21.7	41.1	46.5	19.9	16.1	26.7	36.6	71.5	54.1	31.8	5.7	16.0	13.2	46.5	23.6	38.6	28.4	12.7	47.1	6.9	10.7	24.8	2.5	30.8	64.4	20.0	12.7	33.7	18.4	19.4	20.6	38.9	34.9	22.3	8.0	29.6	8.8	26.3	22.4	23.5	19.6	27.0	23.1	5.7	5.4	3.5	9.6	7.3	0.6	4.6	2.7	5.1	1.2	3.5	5.4	12.7	5.7	19.9	1.7	4.1	3.8	17.8	15.9	16.4	24.5	17.4	18.5	21.8	20.7	21.5	18.2	21.5	17.1	51.0	22.4	37.3	28.1	23.6	20.8	64.4	15.1	18.2	15.8	22.0	18.7	12.3	0.0	16.1	16.5	16.7	13.1	32.3	3.5	3.9	36.8	1.4	15.3	19.9	63.2	39.4	20.4	8.9	57.8	35.8	25.6	10.7	16.5	9.5	39.5	66.4	5.6	53.8	8.4	12.1	15.0	14.2	39.4	81.6	3.0	25.7	37.7	33.8	15.0	146.0	23.1	19.6	12.5	15.1	41.2	9.6	25.2	40.4	68.6	1.4	15.1	11.5	14.9	13.1	15.4	26.0	1.2	5.7	3.4	15.3	33.1	48.1	50.6	19.7	51.9
GRAMD1B	"KIAA1201, LINC01059"	ENSG00000023171	"GRAM domain containing 1B"	Q3KR37	11	123358428-123627774	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 258.8;choroid plexus: 91.8;retina: 96.7"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 94.7;Cone photoreceptor cells: 114.7;Excitatory neurons: 120.7;Inhibitory neurons: 102.8;Oligodendrocyte precursor cells: 95.0;Rod photoreceptor cells: 92.3;Theca cells: 109.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	4	"plasmacytoid DC: 7.0"	"Lineage enriched"	"Detected in many"	4	"dendritic cells: 7.0"	"Group enriched"	"Detected in many"	4	"A549: 62.4;HDLM-2: 168.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008557, HPA075204"	Approved		Supported	"Endoplasmic reticulum,Vesicles,Plasma membrane"		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 58: Brain - Synaptic function"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 9: Photoreceptor cells - Phototransduction"	"Endoplasmic reticulum, Plasma membrane"	Vesicles	"HPA008557: AB_1079197, HPA075204: "	"unprognostic (1.86e-1)"	"unprognostic (7.18e-3)"	"unprognostic (2.43e-2)"	"unprognostic (2.74e-3)"	"unprognostic (8.15e-2)"	"unprognostic (4.28e-2)"	"unprognostic (2.69e-3)"	"unprognostic (4.12e-3)"	"unprognostic (1.40e-1)"	"unprognostic (2.90e-2)"	"unprognostic (9.60e-2)"	"unprognostic (8.06e-2)"	"prognostic unfavorable (4.30e-7)"	"unprognostic (1.39e-2)"	"unprognostic (6.00e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.69e-1)"	1.8	258.8	22.5	4.3	27.4	18.6	1.1	80.1	52.3	0.9	91.8	1.6	34.6	1.1	9.4	0.6	3.6	12.1	15.0	55.6	19.4	15.5	1.5	2.6	5.4	25.7	20.1	15.2	2.4	0.7	16.6	5.0	24.2	1.1	1.1	96.7	1.9	2.0	3.4	0.5	25.2	1.2	9.4	3.6	11.4	16.8	33.5	6.6	4.9	2.2	3.5	1.2	0.8	26.1	0.1	62.4	3.5	0.1	0.3	0.7	9.5	20.5	14.6	4.1	1.8	2.6	0.4	3.8	10.4	10.1	6.8	0.0	6.2	0.0	4.3	168.5	5.0	0.0	28.3	0.7	0.0	22.1	0.0	1.0	0.1	7.1	0.0	5.2	1.8	1.6	0.0	0.2	3.7	0.5	3.8	7.2	7.6	28.3	23.0	10.8	9.8	6.8	0.2	0.0	20.0	16.3	4.9	0.5	0.1	8.1	0.5	12.0	12.3	23.8	3.2	4.2	1.0	0.0	0.0	0.0	4.6	20.5	1.1	0.0	1.2	0.4	0.4	0.7	0.2	0.0	1.5	1.2	1.7	0.0	0.2	0.2	0.1	1.6	0.7	7.0	0.7	0.5	22.5	27.4	80.1	52.3	55.6	19.4	25.7	20.1	24.2	9.4	33.5	26.1	1.4	0.0	0.5	94.7	0.6	0.0	0.0	0.1	1.2	44.3	1.1	1.0	5.7	21.5	0.2	5.5	114.7	6.9	17.9	0.1	3.9	0.7	9.6	1.6	0.6	1.0	0.0	0.0	120.7	0.4	3.7	1.6	16.3	0.9	0.0	41.9	0.7	0.0	2.6	45.4	102.8	1.8	0.0	3.8	2.6	2.7	0.6	7.5	0.0	37.5	2.5	23.4	0.0	95.0	5.5	3.9	1.3	0.7	2.4	0.1	17.3	8.9	0.4	92.3	0.0	3.0	4.2	3.9	1.9	0.1	0.4	2.5	7.2	109.3	1.5	0.0
GRAP2	"GADS, GRBLG, GrbX, Grf40, Mona"	ENSG00000100351	"GRB2 related adaptor protein 2"	O75791	22	39901084-39973721	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	18	"lymphoid tissue: 184.8"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 32.6;granulocytes: 146.9;Macrophages: 82.0;NK-cells: 59.8;T-cells: 57.1"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	7	"gdT-cell: 51.4;MAIT T-cell: 38.2;memory CD4 T-cell: 37.5;memory CD8 T-cell: 56.2;naive CD4 T-cell: 31.3;naive CD8 T-cell: 58.2;T-reg: 35.0"	"Lineage enriched"	"Detected in many"	9	"T-cells: 58.2"	"Group enriched"	"Detected in some"	4	"HEL: 45.7;JURKAT: 175.8;K-562: 44.8;MOLT-4: 122.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA005788, CAB022073"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA		290000	"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 63: T-cells - Adaptive immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 51: Myeloid cells - Hemostasis"	"Nucleoplasm, Cytosol"	"Plasma membrane"	"CAB022073: , HPA005788: AB_1079021"	"unprognostic (1.96e-4)"	"unprognostic (1.82e-4)"	"unprognostic (4.19e-2)"	"unprognostic (8.91e-4)"	"unprognostic (2.92e-2)"	"unprognostic (5.56e-5)"	"unprognostic (1.27e-2)"	"unprognostic (8.41e-3)"	"unprognostic (4.69e-2)"	"unprognostic (9.29e-2)"	"unprognostic (5.17e-3)"	"unprognostic (2.83e-2)"	"unprognostic (1.75e-3)"	"unprognostic (2.10e-1)"	"unprognostic (2.20e-2)"	"unprognostic (1.34e-1)"	"unprognostic (8.06e-2)"	1.2	0.7	0.2	7.9	0.2	10.3	2.0	0.2	0.3	1.5	0.5	2.2	3.6	0.8	0.5	1.2	0.7	2.6	1.1	0.2	0.3	0.6	1.2	4.4	15.7	0.6	0.3	0.2	0.4	0.1	0.3	0.6	0.5	1.6	2.3	0.3	1.7	0.7	0.4	1.1	4.5	0.9	0.5	9.3	3.8	1.9	0.4	184.8	0.8	0.5	12.9	3.0	1.2	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.8	0.0	45.7	0.0	0.0	0.0	0.0	6.9	0.0	0.1	0.0	0.2	0.3	0.0	175.8	44.8	0.0	0.0	0.0	122.8	0.0	0.1	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.5	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.8	6.3	0.7	0.1	51.4	0.3	38.2	3.1	37.5	56.2	1.2	5.2	31.3	58.2	6.6	5.4	0.3	0.8	35.0	74.9	0.2	0.2	0.2	0.3	0.2	0.3	0.6	0.3	0.5	0.5	0.4	0.7	1.1	0.0	6.7	0.3	8.2	1.7	0.0	0.0	0.0	0.6	1.1	0.8	1.0	2.8	0.0	0.0	0.0	0.0	18.3	0.1	0.0	0.4	4.8	0.3	0.1	0.8	1.2	32.6	1.3	0.2	0.0	0.6	0.0	0.1	146.9	0.2	2.5	2.3	0.2	0.0	1.2	0.6	0.0	1.9	4.6	2.9	0.3	82.0	1.8	1.0	6.8	0.3	59.8	2.5	1.0	0.0	0.3	0.4	6.3	0.4	0.0	0.4	0.0	0.0	0.0	0.5	0.9	4.4	2.1	0.1	1.1	0.1	57.1	0.0	0.1	0.3
GRB10		ENSG00000106070	"Growth factor receptor bound protein 10"	Q13322	7	50590063-50793462	"Cancer-related genes, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 87.6;Early spermatids: 143.0;Late spermatids: 212.6;Oligodendrocytes: 124.7;Rod photoreceptor cells: 81.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	13	"basophil: 10.0;eosinophil: 3.0"	"Lineage enriched"	"Detected in single"	28	"granulocytes: 10.0"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB019423, HPA027502, HPA031818"	Enhanced		Supported	Vesicles		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 54: Non-specific - Microtubule organization"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 9: Photoreceptor cells - Phototransduction"	Vesicles		"CAB019423: AB_2112883, HPA027502: AB_10602325, HPA031818: AB_2674057"	"unprognostic (2.82e-2)"	"unprognostic (1.69e-3)"	"unprognostic (1.25e-2)"	"unprognostic (1.45e-2)"	"unprognostic (3.68e-2)"	"unprognostic (1.60e-1)"	"unprognostic (6.83e-2)"	"unprognostic (5.91e-3)"	"unprognostic (1.67e-2)"	"unprognostic (2.31e-3)"	"unprognostic (4.44e-1)"	"unprognostic (2.07e-1)"	"unprognostic (1.23e-3)"	"unprognostic (1.73e-3)"	"unprognostic (8.16e-3)"	"unprognostic (2.63e-2)"	"unprognostic (8.50e-2)"	27.6	26.0	29.5	6.5	33.6	10.0	25.0	25.2	32.5	18.2	28.5	27.2	17.2	19.8	10.3	9.5	18.8	21.6	34.8	26.5	40.2	29.3	32.1	20.6	6.0	31.5	41.8	14.2	94.3	10.5	24.3	14.7	40.2	20.1	6.4	83.5	16.5	15.0	57.4	9.1	13.3	16.1	21.6	36.8	17.6	18.1	48.2	2.8	27.8	76.0	4.0	31.0	15.9	33.5	0.3	32.5	51.6	21.1	23.5	17.8	27.6	13.1	11.3	24.9	29.7	19.8	0.4	0.7	22.6	16.7	71.0	3.1	53.5	13.9	12.2	0.4	21.6	56.7	32.6	14.4	49.8	36.0	84.1	46.4	21.0	38.6	37.4	23.9	62.7	3.9	109.5	0.6	18.7	4.0	6.4	48.0	56.9	27.2	55.4	16.8	0.0	0.3	16.0	13.1	22.7	0.2	1.6	8.1	68.7	33.0	27.7	71.6	78.7	21.8	29.6	45.4	50.4	2.1	0.7	0.4	68.9	32.2	75.2	10.0	0.1	3.0	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.5	0.0	0.0	0.0	0.0	0.1	29.5	33.6	25.2	32.5	26.5	40.2	31.5	41.8	40.2	21.6	48.2	33.5	46.3	6.4	8.3	3.9	1.2	7.5	5.3	9.4	7.4	12.1	14.8	9.0	13.5	47.1	5.2	5.5	87.6	4.5	0.3	6.9	1.9	18.3	143.0	5.3	12.4	45.2	0.0	19.0	64.8	24.4	16.5	15.4	5.6	9.7	0.0	0.8	53.2	26.8	1.6	5.0	55.0	2.8	6.1	9.7	5.5	212.6	1.8	4.0	7.2	40.3	0.8	21.8	0.0	41.7	124.7	36.4	3.0	0.4	0.6	22.2	11.2	22.2	2.3	81.9	0.0	9.2	10.9	1.9	16.2	1.2	4.3	2.6	1.5	0.9	3.8	7.0
GRB2	NCKAP2	ENSG00000177885	"Growth factor receptor bound protein 2"	P62993	17	75318076-75405709	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"	"Host-virus interaction"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Extravillous trophoblasts: 340.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002589, HPA030749, HPA030750"	Approved		Supported	Nucleoplasm,Nucleoli		NA	NA		400000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 16: Immune cells - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 57: B-cells - Immune response"	Nucleoplasm	Nucleoli	"CAB002589: AB_10693935, HPA030749: AB_2673590, HPA030750: AB_2673591"	"unprognostic (4.83e-3)"	"unprognostic (1.85e-1)"	"unprognostic (1.14e-1)"	"unprognostic (3.42e-3)"	"unprognostic (1.70e-1)"	"unprognostic (2.06e-1)"	"prognostic unfavorable (6.04e-7)"	"unprognostic (1.01e-2)"	"unprognostic (2.73e-1)"	"unprognostic (1.80e-2)"	"unprognostic (1.06e-2)"	"unprognostic (1.89e-2)"	"unprognostic (1.08e-2)"	"unprognostic (8.13e-2)"	"unprognostic (3.40e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.58e-1)"	55.7	58.0	66.1	98.3	64.8	127.1	40.3	56.6	66.1	35.9	49.9	54.7	57.3	46.4	31.5	51.0	39.5	43.2	53.3	71.0	68.7	50.5	54.0	65.5	116.9	64.1	64.8	39.3	35.0	39.8	42.6	64.5	61.5	41.8	52.6	24.1	40.6	45.8	48.8	36.3	60.6	58.9	67.5	92.2	44.6	18.5	68.5	83.1	37.6	39.1	107.3	67.5	36.1	72.3	98.6	87.7	58.9	71.1	64.1	54.5	129.5	91.2	70.5	89.3	87.3	75.8	66.7	128.9	57.9	97.0	77.5	58.5	84.0	76.1	89.8	63.4	76.5	137.2	55.7	111.8	57.3	162.8	259.0	55.2	78.0	112.9	55.8	62.3	128.3	125.3	95.5	88.8	64.9	127.4	160.3	160.5	40.5	98.9	81.3	113.7	123.8	94.9	82.7	75.0	66.6	101.1	83.7	85.4	114.7	102.8	94.4	264.9	83.4	100.0	71.0	81.8	104.9	161.1	127.3	205.5	79.1	125.8	75.3	134.5	136.1	164.9	52.3	160.9	45.0	94.5	48.0	52.2	101.2	96.5	46.8	47.8	273.8	51.5	185.1	71.9	56.5	102.9	66.1	64.8	56.6	66.1	71.0	68.7	64.1	64.8	61.5	67.5	68.5	72.3	73.5	60.9	62.2	18.3	210.5	47.0	45.7	31.0	67.7	35.7	45.6	37.5	59.7	41.5	46.9	16.5	31.3	71.9	137.6	74.4	52.8	64.8	3.0	52.9	56.4	60.9	41.9	55.5	41.5	63.4	340.9	47.2	47.9	57.6	124.4	30.0	41.7	42.3	260.3	35.3	41.1	46.4	22.4	182.0	243.8	5.6	25.1	259.9	46.2	81.5	237.0	47.1	73.2	31.7	41.5	77.2	69.6	41.8	236.3	63.3	60.1	69.9	55.1	46.4	6.6	34.6	50.5	27.4	49.9	76.3	44.8	87.2	109.0	59.7	44.9	92.7
GRB7		ENSG00000141738	"Growth factor receptor bound protein 7"	Q14451	17	39737927-39747291	"Cancer-related genes, Predicted intracellular proteins"		"Repressor, RNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 60.2;kidney: 61.5"	"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 77.1;Basal squamous epithelial cells: 104.7;Prostatic glandular cells: 79.0;Squamous epithelial cells: 124.7;Syncytiotrophoblasts: 98.6;Urothelial cells: 79.7"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in single"	11	"cerebellum: 5.6"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in many"	5	"OE19: 1706.0"	"Region enhanced"	"Detected in many"		"cerebellum: 8.3"	"Low region specificity"	"Detected in many"			"CAB005226, HPA057084, CAB073538"	Approved		Supported	"Plasma membrane,Cytosol"		NA	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 21: OE19 - Mitochondria"	"Cluster 61: Squamous epithelial cells - Keratinization"	"Plasma membrane, Cytosol"		"CAB005226: AB_2113278, CAB073538: , HPA057084: AB_2683330"	"unprognostic (8.46e-2)"	"unprognostic (2.06e-2)"	"unprognostic (1.45e-1)"	"prognostic unfavorable (6.60e-7)"	"unprognostic (7.06e-3)"	"unprognostic (2.09e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.85e-1)"	"unprognostic (2.02e-1)"	"prognostic unfavorable (3.10e-4)"	"prognostic unfavorable (6.90e-4)"	"unprognostic (2.59e-2)"	"prognostic favorable (8.23e-5)"	"unprognostic (1.83e-2)"	"unprognostic (4.77e-2)"	"unprognostic (5.49e-3)"	"unprognostic (4.01e-2)"	5.9	0.1	0.0	0.7	0.4	0.0	14.2	5.6	0.4	13.5	4.5	8.1	11.8	3.3	3.8	60.2	22.3	9.5	1.2	0.2	0.0	61.5	11.1	10.6	0.1	0.0	0.4	1.0	32.7	11.4	6.9	11.9	0.5	14.5	10.0	0.1	25.2	11.6	0.3	39.9	10.8	1.0	0.0	0.5	16.9	1.2	0.1	1.1	6.6	0.1	8.7	7.5	26.2	0.3	12.6	14.4	0.0	0.0	0.0	0.0	19.1	0.0	0.8	0.1	0.5	44.7	24.3	0.0	4.2	0.4	0.9	24.1	0.0	16.1	0.0	0.0	2.1	0.0	6.4	38.5	0.0	0.0	0.0	0.0	15.1	0.2	3.7	2.5	0.1	0.0	0.0	0.0	0.0	11.5	0.2	0.1	4.9	1706.0	3.4	0.1	0.0	18.6	18.5	14.0	9.5	0.1	18.4	370.7	0.1	17.3	14.0	0.0	0.0	0.0	1.1	0.2	0.0	0.2	0.1	1.0	1.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	5.6	0.4	0.2	0.0	0.0	0.4	0.5	0.0	0.1	0.3	0.5	22.4	15.1	0.0	0.9	38.2	77.1	20.0	104.7	0.2	48.2	30.5	2.5	17.2	18.2	22.0	0.0	35.7	0.7	25.6	9.8	35.6	0.0	30.2	5.3	2.6	14.4	0.0	0.3	19.4	27.4	3.1	27.0	41.8	1.3	0.5	0.4	5.1	2.8	0.0	0.0	19.7	40.7	0.0	2.3	0.0	2.8	1.3	5.4	0.0	1.6	0.4	0.0	0.0	0.0	26.7	26.0	1.2	0.3	79.0	28.3	13.8	20.9	0.1	0.0	0.9	2.1	0.4	0.3	124.7	41.9	98.6	1.4	0.0	21.1	79.7
GRHL1	"LBP-32, MGR, TFCP2L2"	ENSG00000134317	"Grainyhead like transcription factor 1"	Q9NZI5	2	9951693-10002277	"Metabolic proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 119.6;skin 1: 87.7;vagina: 66.9"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 62.6;Cytotrophoblasts: 61.9;Extravillous trophoblasts: 80.5;Suprabasal keratinocytes: 132.7;Syncytiotrophoblasts: 184.6;Urothelial cells: 104.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in single"		"eosinophil: 2.2"	"Lineage enriched"	"Detected in single"	8	"granulocytes: 2.2"	"Cell line enhanced"	"Detected in many"		"BEWO: 212.3;RT4: 41.4;SK-BR-3: 112.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA005798, HPA006420"	Enhanced		Supported	Nucleoplasm,Vesicles		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	Nucleoplasm	Vesicles	"HPA005798: AB_1079026, HPA006420: AB_1079025"	"unprognostic (2.26e-3)"	"unprognostic (5.80e-2)"	"unprognostic (8.35e-2)"	"unprognostic (7.33e-3)"	"unprognostic (2.70e-1)"	"unprognostic (2.76e-2)"	"unprognostic (4.43e-3)"	"unprognostic (6.73e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.00e-1)"	"unprognostic (8.83e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.14e-4)"	"unprognostic (3.66e-1)"	"unprognostic (3.40e-1)"	"unprognostic (4.04e-2)"	"unprognostic (2.14e-1)"	4.5	1.3	2.2	1.2	2.3	8.7	39.8	0.8	2.8	31.0	1.0	1.5	1.2	1.0	7.3	119.6	2.2	3.0	2.5	2.7	2.5	4.0	12.2	5.0	1.0	0.8	1.5	0.4	4.2	29.0	3.6	26.7	0.9	11.4	1.0	11.4	44.7	7.3	1.1	87.7	0.7	0.7	0.6	0.8	3.7	3.2	4.3	0.9	2.9	0.4	26.1	13.9	66.9	1.7	10.9	0.2	1.2	3.0	0.4	0.5	212.3	1.0	1.5	0.7	1.2	0.9	7.5	1.4	0.4	0.1	1.5	6.5	13.0	1.4	3.1	3.2	5.9	0.3	2.3	4.3	0.3	0.7	1.2	0.4	5.5	6.0	0.0	0.0	1.1	2.3	2.2	4.1	0.0	14.3	2.2	1.7	0.8	3.5	2.5	0.9	1.0	1.9	1.4	41.4	2.4	1.6	2.0	112.3	2.7	17.4	13.7	0.4	1.2	0.6	2.6	3.3	1.3	2.7	1.7	1.5	0.6	1.7	1.8	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.2	0.0	0.0	0.2	1.7	2.2	2.3	0.8	2.8	2.7	2.5	0.8	1.5	0.9	0.6	4.3	1.7	2.2	3.2	8.1	3.9	1.2	40.0	23.1	10.7	2.8	25.5	37.1	19.9	2.1	1.5	31.1	20.2	62.6	61.9	1.3	1.2	0.0	2.9	6.4	4.5	1.3	4.2	3.5	0.0	14.6	9.1	80.5	5.4	3.1	9.6	10.2	0.4	2.5	7.7	7.7	11.8	6.0	0.8	4.1	1.0	15.7	3.0	0.0	10.6	21.4	1.9	1.0	1.1	0.0	4.0	1.0	5.7	0.1	0.4	1.0	31.5	0.1	2.4	18.6	11.5	0.0	3.0	3.7	9.6	5.1	35.2	132.7	184.6	2.1	0.1	1.2	104.6
GRHL2	"BOM, DFNA28, FLJ13782, TFCP2L3"	ENSG00000083307	"Grainyhead like transcription factor 2"	Q6ISB3	8	101492439-101669726	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Corneal dystrophy, Deafness, Disease variant, Dwarfism, Ectodermal dysplasia, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skin 1: 28.6"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 32.1;Respiratory ciliated cells: 28.8;Squamous epithelial cells: 27.1;Suprabasal keratinocytes: 26.0"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 39.3;CACO-2: 28.0;HaCaT: 46.3;hTCEpi: 35.5;MCF7: 32.7;OE19: 37.9;RT4: 68.9;T-47d: 79.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA004820, HPA062839"	Uncertain		Supported	Nucleoplasm		NA	NA				"Cluster 30: Epididymis - Antimicrobial activity"	"Cluster 15: RT4 - Unknown function"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm		"HPA004820: AB_1857928, HPA062839: AB_2684878"	"prognostic unfavorable (6.43e-4)"	"unprognostic (2.54e-2)"	"unprognostic (4.09e-2)"	"unprognostic (2.95e-2)"	"unprognostic (2.68e-1)"	"unprognostic (4.79e-2)"	"unprognostic (1.90e-1)"	"unprognostic (2.66e-1)"	"unprognostic (1.64e-1)"	"unprognostic (8.59e-2)"	"prognostic unfavorable (6.27e-4)"	"unprognostic (2.61e-2)"	"unprognostic (8.29e-4)"	"unprognostic (4.54e-3)"	"unprognostic (2.64e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.03e-2)"	0.1	0.0	0.0	1.0	0.0	0.0	12.3	0.0	0.3	6.9	0.0	8.0	4.0	1.7	16.1	20.4	8.5	3.3	0.0	0.0	0.0	6.3	0.4	5.6	0.0	0.0	0.0	0.0	11.1	9.3	0.8	6.7	0.0	23.2	9.2	0.0	14.8	7.2	0.0	28.6	4.3	0.4	0.0	0.1	9.8	0.3	0.0	2.9	10.2	0.0	4.6	7.7	10.4	0.0	39.3	0.0	0.0	0.0	0.0	0.0	19.5	0.0	0.0	0.0	0.0	28.0	18.9	0.0	0.0	0.1	0.0	46.3	0.0	22.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	35.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	32.7	0.0	0.3	0.2	37.9	0.0	0.0	0.0	0.1	0.0	68.9	1.9	0.0	0.0	15.0	0.0	4.4	79.7	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	32.1	13.0	0.3	0.0	24.3	10.5	7.6	20.5	0.0	14.4	6.1	0.7	17.2	20.8	11.0	0.0	14.0	0.2	10.3	5.9	7.5	2.4	20.0	1.5	0.8	1.2	0.0	0.8	5.5	7.1	0.8	15.3	20.7	0.0	0.0	0.0	0.0	1.4	0.0	1.3	9.8	2.0	0.0	1.1	9.3	0.0	0.3	1.8	0.0	0.6	0.0	0.0	2.0	0.5	8.8	8.5	0.0	1.3	9.3	5.7	0.1	28.8	0.0	0.0	0.5	1.0	0.1	0.0	27.1	26.0	19.8	0.3	0.1	11.0	6.3
GRIK1	"GluK1, GLUR5"	ENSG00000171189	"Glutamate ionotropic receptor kainate type subunit 1"	P39086	21	29536933-29940033	"FDA approved drug targets, Predicted membrane proteins"	"Ion transport, Transport"	"Ion channel, Ligand-gated ion channel, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	11	"adrenal gland: 12.5;brain: 32.6;retina: 38.2"	"Group enriched"	"Detected in some"	10	"Inhibitory neurons: 2260.1;Oligodendrocyte precursor cells: 862.5"	"Cancer enriched"	"Detected in some"	5	"glioma: 4.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"Daudi: 1.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014623, HPA073879"	Uncertain		Supported	"Vesicles,Plasma membrane"		NA	NA				"Cluster 77: Retina - Visual perception"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Plasma membrane"	Vesicles	"HPA014623: AB_1850305, HPA073879: "	"unprognostic (1.39e-1)"	"unprognostic (6.54e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.04e-2)"	"unprognostic (1.03e-3)"	"unprognostic (1.56e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.12e-3)"	"unprognostic (1.25e-1)"	"unprognostic (8.77e-2)"	"unprognostic (4.89e-3)"	"unprognostic (1.20e-3)"	"unprognostic (1.47e-8)"	"unprognostic (2.09e-1)"	"unprognostic (2.68e-1)"	"unprognostic (1.09e-1)"	"unprognostic (3.15e-3)"	0.2	12.5	7.5	0.2	6.6	0.1	1.8	2.4	6.0	0.8	0.0	0.3	0.0	0.1	2.0	0.3	0.0	0.1	0.0	8.4	12.3	0.0	0.1	0.1	0.1	30.0	11.2	0.3	0.0	0.0	0.2	0.4	32.6	2.4	0.5	38.2	0.0	0.1	0.1	0.8	0.4	0.1	2.6	0.1	0.2	0.5	9.7	0.0	0.0	0.0	0.0	0.4	0.4	2.9	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.3	0.2	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.1	0.2	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.2	0.1	0.1	0.2	0.0	0.0	0.1	0.2	0.0	0.1	0.1	0.4	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	7.5	6.6	2.4	6.0	8.4	12.3	30.0	11.2	32.6	2.6	9.7	2.9	0.1	0.0	0.0	27.4	0.0	0.3	0.0	0.0	0.0	149.8	2.3	0.3	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	5.8	0.1	1.2	0.4	0.0	0.0	29.8	0.0	0.0	0.7	0.0	0.2	0.0	148.8	0.0	0.0	0.1	1.7	2260.1	0.0	0.0	0.0	0.4	13.2	0.3	0.2	3.6	10.3	0.0	2.5	0.0	862.5	8.9	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	4.9	0.0	0.0	5.7	0.0	0.0	0.0	0.1	0.0	0.1	33.8	0.1	0.0
GRIK5	"GluK5, GRIK2, KA2"	ENSG00000105737	"Glutamate ionotropic receptor kainate type subunit 5"	Q16478	19	41998321-42069498	"FDA approved drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel, Ligand-gated ion channel, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 36.5;testis: 32.9"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 17.9;Bipolar cells: 23.0;Excitatory neurons: 32.4;Horizontal cells: 18.5;Inhibitory neurons: 31.1;Oligodendrocyte precursor cells: 31.7;Rod photoreceptor cells: 21.2"	"Group enriched"	"Detected in many"	5	"glioma: 15.4;ovarian cancer: 6.6;thyroid cancer: 6.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEL: 13.7;hTERT-RPE1: 21.2;NTERA-2: 13.1;REH: 37.5;SCLC-21H: 10.3;SH-SY5Y: 22.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA074001			Supported	"Nucleoplasm,Plasma membrane"		NA	NA				"Cluster 78: Testis - Spermatogenesis"	"Cluster 14: REH - Unknown function"	"Cluster 56: Bipolar cells - Visual perception"	"Plasma membrane"	Nucleoplasm	"HPA074001: AB_2732248"	"unprognostic (4.99e-2)"	"unprognostic (3.40e-1)"	"unprognostic (1.30e-3)"	"unprognostic (6.68e-3)"	"unprognostic (4.28e-2)"	"unprognostic (3.86e-1)"	"unprognostic (5.82e-1)"	"unprognostic (2.23e-1)"	"unprognostic (3.89e-2)"	"unprognostic (1.73e-2)"	"prognostic favorable (7.23e-4)"	"unprognostic (8.43e-2)"	"prognostic unfavorable (9.32e-4)"	"unprognostic (6.47e-3)"	"unprognostic (5.77e-2)"	"unprognostic (4.57e-2)"	"unprognostic (6.12e-2)"	1.6	4.0	20.0	1.7	17.3	3.0	1.2	6.2	26.7	5.3	0.1	16.4	0.7	7.3	1.8	1.6	6.8	1.9	4.9	36.5	15.5	7.0	0.3	0.5	0.7	3.6	4.8	3.6	2.7	14.8	18.3	0.0	7.0	6.2	1.0	12.5	0.7	6.5	0.5	0.9	3.4	5.2	3.0	1.3	5.3	32.9	14.6	0.9	11.3	0.7	0.6	5.0	2.7	6.6	0.1	0.2	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.2	0.1	0.0	0.2	0.2	0.0	0.0	0.4	0.3	13.7	0.0	0.0	0.3	0.0	0.0	0.2	0.1	0.1	0.0	21.2	0.0	0.6	0.1	0.6	0.0	0.2	0.2	0.0	13.1	0.1	0.0	37.5	0.0	0.1	5.8	0.1	10.3	22.7	0.1	0.0	0.2	0.6	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.8	0.0	0.1	1.4	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.0	17.3	6.2	26.7	36.5	15.5	3.6	4.8	7.0	3.0	14.6	6.6	0.2	0.0	0.0	17.9	0.1	0.4	0.1	0.0	0.0	23.0	0.2	0.8	3.1	0.0	0.0	1.8	2.1	0.0	0.0	0.1	0.0	0.8	1.6	0.2	0.2	0.4	0.0	0.0	32.4	0.0	0.0	0.6	0.0	0.3	4.5	7.2	0.0	0.0	0.0	18.5	31.1	0.0	0.0	0.0	0.0	2.3	0.9	0.1	0.0	2.8	0.0	9.1	0.0	31.7	0.9	0.1	0.0	0.4	0.0	0.4	0.0	0.0	0.0	21.2	0.0	4.9	1.7	4.2	2.2	0.2	0.4	0.0	0.0	0.0	0.0	0.1
GRK4	"GPRK2L, GPRK4"	ENSG00000125388	"G protein-coupled receptor kinase 4"	P32298	4	2963571-3040760	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 19.3;testis: 42.3"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 123.0;Early spermatids: 357.7;Late spermatids: 500.3;Spermatocytes: 180.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA057023	Approved		Supported	"Plasma membrane,Cytosol"		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 21: Non-specific - Transcription"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 40: Granulosa cells - Unknown function"	Cytosol	"Plasma membrane"	"HPA057023: AB_2683313"	"unprognostic (1.86e-2)"	"unprognostic (2.88e-1)"	"unprognostic (1.03e-1)"	"unprognostic (9.51e-3)"	"unprognostic (3.65e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.21e-1)"	"unprognostic (2.39e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.87e-1)"	"unprognostic (3.90e-4)"	"unprognostic (3.20e-1)"	"unprognostic (1.01e-2)"	"unprognostic (4.74e-2)"	"unprognostic (2.17e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.89e-1)"	2.8	3.3	6.2	1.1	6.2	1.3	2.4	19.3	8.4	3.0	0.3	2.8	1.0	2.7	2.3	1.8	2.1	2.4	4.9	6.5	5.7	2.2	2.0	2.0	1.2	6.0	5.5	3.5	5.4	4.4	6.2	1.6	5.7	2.0	1.4	10.1	2.9	2.1	4.8	2.3	1.4	2.1	3.6	1.4	3.0	42.3	6.4	1.6	3.3	4.4	1.2	2.3	2.2	7.2	2.3	0.8	2.7	7.9	6.3	6.1	1.6	4.3	1.9	2.4	2.1	2.3	0.7	5.1	1.9	7.1	4.8	0.7	3.6	3.6	2.1	3.4	3.4	5.6	3.2	2.6	3.8	2.3	1.9	4.1	5.7	4.3	2.0	2.7	4.7	5.5	5.4	6.6	5.8	2.6	4.8	4.8	2.1	3.3	6.0	6.1	3.4	2.1	2.3	2.9	15.2	4.8	2.7	1.2	4.1	1.9	6.0	3.5	5.5	6.6	1.7	4.5	4.0	6.5	4.0	3.8	3.3	5.0	2.2	2.1	0.3	0.6	0.3	0.7	0.4	0.3	0.2	0.2	0.1	0.3	0.5	0.4	1.1	0.5	0.2	0.7	0.1	0.4	6.2	6.2	19.3	8.4	6.5	5.7	6.0	5.5	5.7	3.6	6.4	7.2	3.9	3.2	7.4	34.6	2.1	11.2	3.2	5.0	7.4	57.1	5.0	5.5	11.4	4.3	5.6	3.7	123.0	2.1	4.7	0.8	13.7	2.7	357.7	4.2	7.2	4.2	10.3	8.6	53.9	3.8	5.3	8.7	5.1	3.8	5.7	75.0	6.1	3.0	3.4	18.5	71.1	2.4	4.1	2.9	4.6	500.3	13.1	3.1	7.2	9.4	3.0	11.4	2.1	48.2	29.3	2.1	0.4	8.2	5.3	1.8	2.0	5.0	1.2	58.2	6.6	8.4	5.7	180.4	22.3	6.5	11.4	3.0	4.0	34.6	1.3	2.4
GRK5	GPRK5	ENSG00000198873	"G protein-coupled receptor kinase 5"	P34947	10	119207571-119459745	"Enzymes, Predicted intracellular proteins"	"Apoptosis, Wnt signaling pathway"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 57.7;Microglial cells: 56.2;Sertoli cells: 59.2;Smooth muscle cells: 46.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 32.1;HUVEC TERT2: 24.9;OE19: 25.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB025579, HPA046838"	Approved		Supported	"Nuclear membrane,Nuclear speckles,Plasma membrane"		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 21: OE19 - Mitochondria"	"Cluster 50: Fibroblasts - ECM organization"	"Nuclear membrane, Nuclear speckles"	"Plasma membrane"	"CAB025579: , HPA046838: AB_2679833"	"unprognostic (1.09e-1)"	"unprognostic (3.47e-1)"	"unprognostic (1.19e-1)"	"unprognostic (6.02e-2)"	"unprognostic (6.56e-2)"	"unprognostic (3.74e-2)"	"unprognostic (4.62e-2)"	"unprognostic (3.69e-1)"	"unprognostic (4.11e-1)"	"unprognostic (1.06e-1)"	"unprognostic (3.70e-1)"	"unprognostic (2.32e-1)"	"prognostic unfavorable (2.38e-7)"	"unprognostic (1.10e-1)"	"unprognostic (3.27e-2)"	"unprognostic (1.55e-2)"	"unprognostic (1.90e-2)"	38.4	18.0	4.2	5.9	5.0	2.7	24.6	5.0	4.6	18.8	3.5	26.3	10.0	21.1	3.5	12.6	19.6	5.7	48.8	4.0	5.1	14.2	12.9	65.6	7.8	3.9	3.6	35.0	4.7	21.3	13.3	8.3	3.9	14.1	4.9	1.0	7.8	4.0	11.9	11.5	25.8	7.3	3.3	37.0	27.5	4.1	4.9	6.2	19.6	9.7	6.8	19.4	18.1	3.5	3.7	2.3	5.4	5.7	11.8	11.0	1.6	7.1	32.1	4.1	2.3	1.7	5.4	3.9	1.6	11.1	7.5	0.9	2.3	7.7	2.7	15.4	2.0	0.7	4.6	7.0	8.2	0.2	2.0	1.5	1.1	8.5	1.2	5.2	24.9	2.4	0.4	3.7	1.5	0.7	3.8	3.5	0.8	25.8	5.2	1.3	0.8	0.9	0.6	1.5	1.8	4.9	2.4	1.1	7.0	3.0	0.1	0.9	7.8	2.3	1.6	14.6	2.8	0.9	4.4	2.4	4.9	4.4	2.4	0.4	1.5	2.9	2.0	1.4	0.1	3.8	3.0	1.6	0.9	4.0	4.5	2.0	2.1	0.1	0.5	0.0	4.0	1.7	4.2	5.0	5.0	4.6	4.0	5.1	3.9	3.6	3.9	3.3	4.9	3.5	32.6	57.7	3.7	3.6	19.7	1.7	0.7	0.5	1.2	3.9	2.3	2.0	19.4	0.0	1.3	3.7	0.0	3.7	13.3	0.4	0.0	1.1	18.7	0.4	5.1	28.4	4.8	0.0	17.7	3.1	15.8	35.7	18.8	1.0	4.5	7.8	24.7	2.2	4.4	1.7	36.5	0.8	6.1	15.5	6.3	4.9	4.4	14.2	7.2	56.2	3.6	0.0	19.6	14.1	5.7	2.4	1.2	4.5	10.2	0.7	4.9	0.6	0.8	0.9	59.2	18.2	46.5	1.3	2.1	0.7	2.4	13.1	14.1	4.6	0.5	0.9
GRN	"CLN11, PCDGF, PGRN"	ENSG00000030582	"Granulin precursor"	P28799	17	44345246-44353106	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		Cytokine	"Neurodegeneration, Neuronal ceroid lipofuscinosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Hofbauer cells: 1420.7;Kupffer cells: 892.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	6	"classical monocyte: 2057.5;intermediate monocyte: 1122.4;myeloid DC: 1534.2;neutrophil: 851.2;non-classical monocyte: 548.1;plasmacytoid DC: 1331.9"	"Group enriched"	"Detected in all"	9	"dendritic cells: 1534.2;granulocytes: 851.2;monocytes: 2057.5"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008763, CAB019394, HPA028747"	Uncertain		Enhanced	Endosomes,Lysosomes	"Secreted to blood"	NA	NA	138000000	110000000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 18: U-2197 - ECM organization"	"Cluster 4: Macrophages - Innate immune response"	Lysosomes	Endosomes	"CAB019394: , HPA008763: AB_1850339, HPA028747: AB_10603767"	"unprognostic (1.84e-1)"	"unprognostic (2.34e-1)"	"unprognostic (8.38e-3)"	"unprognostic (2.82e-1)"	"prognostic unfavorable (8.78e-4)"	"unprognostic (7.41e-2)"	"unprognostic (3.53e-3)"	"unprognostic (3.57e-1)"	"unprognostic (1.63e-1)"	"unprognostic (2.40e-1)"	"unprognostic (2.24e-2)"	"unprognostic (1.52e-1)"	"unprognostic (6.34e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.62e-1)"	158.9	123.2	61.5	160.4	67.2	478.5	120.7	67.7	97.3	156.7	73.9	189.8	130.9	108.3	134.0	534.0	87.1	157.3	153.0	61.0	69.7	167.4	118.9	309.5	183.2	81.0	71.5	73.8	108.9	87.8	84.4	183.2	87.6	111.7	110.3	12.5	262.9	100.6	60.6	189.7	179.0	91.9	71.8	349.8	127.9	59.4	94.3	67.8	127.7	45.9	107.8	150.0	198.3	97.3	119.3	197.5	52.7	159.5	443.2	231.8	181.2	147.3	447.5	231.6	309.8	86.3	294.0	364.0	299.4	217.6	312.9	185.3	68.6	334.5	75.8	55.8	186.8	38.4	93.8	175.2	245.5	61.6	493.6	332.4	450.5	188.1	106.0	391.2	269.8	64.3	75.1	51.3	148.8	183.1	32.8	172.8	44.3	110.5	334.0	97.7	180.8	433.0	248.2	145.9	54.7	74.7	201.0	92.7	360.9	138.0	209.4	229.0	340.7	437.6	104.6	300.5	97.8	116.3	313.9	122.3	268.1	149.6	124.2	215.1	2057.5	176.5	35.1	1122.4	27.8	174.0	37.1	31.1	1534.2	112.2	27.8	26.5	851.2	30.6	548.1	1331.9	55.4	1613.4	61.5	67.2	67.7	97.3	61.0	69.7	81.0	71.5	87.6	71.8	94.3	97.3	113.0	86.6	83.3	12.7	82.8	112.7	151.1	574.2	97.9	23.6	85.7	69.7	90.7	133.0	332.7	218.8	18.8	429.1	195.7	494.8	9.8	447.7	2.1	103.8	83.8	170.9	124.3	38.7	6.8	307.3	324.1	149.4	83.6	372.5	75.5	90.0	207.8	84.7	1420.7	47.1	6.6	214.6	146.5	892.0	360.8	6.8	60.9	699.2	208.1	20.6	501.6	58.9	20.6	11.1	11.8	285.3	581.7	57.2	65.8	70.7	312.1	120.5	70.0	11.8	85.5	45.4	83.3	25.1	72.2	255.5	96.5	640.0	30.8	89.6	274.5	175.6
GRPEL1	"FLJ25609, GrpE, hMGE"	ENSG00000109519	"GrpE like 1, mitochondrial"	Q9HAV7	4	7058895-7068064	"Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036647	Supported		Supported	Mitochondria		NA	NA		23000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 24: NB-4 - Immune response"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"HPA036647: AB_10672359"	"unprognostic (6.13e-3)"	"unprognostic (3.66e-2)"	"unprognostic (1.92e-2)"	"unprognostic (6.31e-2)"	"unprognostic (9.77e-2)"	"unprognostic (2.12e-3)"	"unprognostic (2.17e-1)"	"unprognostic (2.21e-3)"	"unprognostic (1.51e-1)"	"unprognostic (5.53e-2)"	"unprognostic (4.99e-2)"	"unprognostic (3.86e-2)"	"prognostic favorable (2.00e-6)"	"unprognostic (9.61e-2)"	"unprognostic (7.18e-2)"	"unprognostic (2.81e-1)"	"unprognostic (7.30e-2)"	15.4	35.9	12.7	7.7	13.2	24.9	11.2	14.2	16.4	7.2	14.2	10.1	9.0	7.0	8.4	10.9	8.4	7.5	23.1	13.1	13.6	20.7	32.4	7.7	10.2	14.0	13.5	10.4	10.1	13.1	6.9	7.8	14.4	7.9	9.7	12.4	8.6	7.9	26.8	10.7	7.8	8.3	13.8	10.4	11.1	12.8	13.7	7.6	8.9	29.7	11.3	15.2	7.6	14.1	21.7	20.0	11.3	22.3	21.3	17.9	13.9	27.9	22.2	30.8	22.6	35.5	27.5	46.4	18.3	21.4	47.7	21.5	45.0	32.0	35.9	11.2	28.2	49.8	17.6	38.7	24.9	50.7	24.2	17.8	41.4	27.3	32.8	15.7	27.4	30.8	29.7	18.9	36.7	21.9	40.3	62.5	16.9	38.8	65.7	26.6	42.1	19.5	31.0	22.4	31.6	15.3	21.9	21.5	24.3	11.4	19.3	29.2	23.8	20.5	12.7	29.5	49.3	20.3	31.1	31.0	27.9	32.6	16.5	12.0	25.2	41.1	22.8	27.6	31.9	27.3	24.4	25.9	36.3	21.6	30.8	23.9	8.4	26.2	22.7	22.0	26.6	27.2	12.7	13.2	14.2	16.4	13.1	13.6	14.0	13.5	14.4	13.8	13.7	14.1	52.5	25.6	32.1	1.6	40.7	133.4	134.8	68.5	60.9	27.8	44.0	43.6	96.1	34.3	43.1	38.6	10.4	69.3	52.9	35.3	133.1	75.0	60.3	35.0	41.7	51.5	18.5	34.5	4.5	47.7	80.3	46.5	26.0	38.0	58.2	23.2	25.0	109.4	60.3	28.6	5.1	34.1	52.9	29.0	74.7	84.9	28.0	41.7	64.0	2.8	54.0	26.4	17.5	3.0	6.5	91.4	27.6	29.0	27.0	116.5	49.2	203.1	36.2	28.0	0.0	38.1	56.3	51.7	55.0	58.1	125.2	86.1	61.6	92.0	47.0	120.3
GRPR	"BB2, BB2R"	ENSG00000126010	"Gastrin releasing peptide receptor"	P30550	X	16123565-16153518	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	10	"pancreas: 20.3"	"Cell type enriched"	"Detected in single"	15	"Inhibitory neurons: 6.3"	"Cancer enriched"	"Detected in some"	4	"breast cancer: 6.6"	"Region enhanced"	"Detected in some"		"hypothalamus: 1.6"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	10	"PC-3: 29.2;T-47d: 38.2;U-138 MG: 51.5"	"Region enhanced"	"Detected in single"		"hypothalamus: 2.0"	"Low region specificity"	"Detected in all"			HPA069604			Supported	"Plasma membrane"		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 25: Pancreas - Digestion"	"Cluster 6: T47d - Mammary gland"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Plasma membrane"		"HPA069604: AB_2686158"	"unprognostic (3.32e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.72e-1)"	"unprognostic (9.24e-2)"	"unprognostic (2.87e-1)"	"unprognostic (9.17e-2)"	"unprognostic (5.06e-2)"	"unprognostic (2.82e-1)"	"unprognostic (1.01e-1)"	"unprognostic (3.68e-3)"	"unprognostic (2.62e-1)"	"unprognostic (1.57e-1)"	"unprognostic (5.59e-2)"	"unprognostic (2.15e-2)"	"unprognostic (2.56e-1)"	"unprognostic (2.92e-1)"	"unprognostic (2.86e-2)"	0.1	0.1	0.1	0.2	0.2	0.1	1.9	0.0	0.3	0.3	0.1	0.4	0.1	0.5	1.9	0.0	0.1	0.1	0.2	0.2	1.6	0.0	0.0	0.1	0.1	0.3	0.0	0.0	20.3	0.2	0.0	0.1	0.2	0.5	0.3	0.1	0.0	0.1	0.2	0.0	0.1	0.8	1.1	0.1	1.1	0.0	0.0	0.0	0.1	0.2	0.1	0.1	0.0	0.1	0.6	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.7	0.3	0.0	0.9	0.1	4.0	1.6	0.4	0.1	0.0	0.1	1.5	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	1.2	0.5	0.0	0.0	0.0	0.5	0.0	29.2	0.0	0.1	0.1	0.1	0.0	0.8	0.1	0.0	0.1	0.1	1.5	38.2	0.1	0.2	51.5	1.9	0.0	1.6	0.3	0.2	0.2	0.0	0.1	0.8	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.2	0.0	0.3	0.2	1.6	0.3	0.0	0.2	1.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	6.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
GSC		ENSG00000133937	"Goosecoid homeobox"	P56915	14	94768223-94770113	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"		"Developmental protein, DNA-binding"	Dwarfism	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"adipose tissue: 3.8;breast: 6.8"	"Cell type enhanced"	"Detected in some"		"Adipocytes: 3.5;Breast myoepithelial cells: 2.2;Ductal cells: 3.0;Exocrine glandular cells: 2.4;Fibroblasts: 9.2;Langerhans cells: 2.3;Skeletal myocytes: 2.6;Smooth muscle cells: 4.6"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in single"	9	"hypothalamus: 1.4"	"Immune cell enriched"	"Detected in single"	8	"gdT-cell: 3.6"	"Lineage enriched"	"Detected in single"	18	"T-cells: 3.6"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 1.3;HEK 293: 2.0;MCF7: 3.2;REH: 3.3;SH-SY5Y: 3.5;T-47d: 2.5;U-251 MG: 2.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB079923, CAB079924"			Supported	"Nucleoplasm,Nuclear speckles,Actin filaments"		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 14: REH - Unknown function"	"Cluster 50: Fibroblasts - ECM organization"	"Nucleoplasm, Nuclear speckles"	"Actin filaments"	"CAB079923: , CAB079924: "	"unprognostic (2.11e-2)"	"unprognostic (1.04e-1)"	"unprognostic (3.15e-2)"	"unprognostic (5.11e-2)"	"unprognostic (2.49e-1)"	"unprognostic (3.70e-3)"	"unprognostic (1.82e-3)"	"unprognostic (3.87e-2)"	"unprognostic (3.41e-1)"	"unprognostic (2.74e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.28e-1)"	"unprognostic (5.18e-10)"	"unprognostic (4.96e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.16e-1)"	3.8	0.0	0.0	0.0	0.0	0.0	6.8	0.0	0.0	0.1	0.4	0.1	0.1	0.2	0.0	0.1	0.4	0.0	0.5	0.0	1.4	0.1	0.0	0.0	0.3	0.1	0.1	0.1	0.6	0.1	0.4	0.0	0.0	0.7	0.0	0.0	0.9	0.5	1.2	0.8	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.2	1.6	2.2	0.1	0.3	0.2	0.0	0.0	0.2	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.1	0.0	0.3	0.0	0.0	0.3	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	3.2	0.2	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.1	2.5	0.0	0.0	0.0	0.6	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.1	0.0	0.2	0.4	0.0	0.0	0.0	0.4	0.2	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.4	0.1	0.1	0.0	0.0	0.1	0.0	3.5	0.0	0.0	0.0	0.1	0.6	0.3	0.0	0.0	0.0	1.0	2.2	1.1	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	3.0	0.1	0.3	0.1	0.4	0.0	0.0	0.0	2.4	0.0	9.2	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.1	0.0	0.2	0.0	0.0	0.6	0.0	1.0	0.0	0.0	0.7	0.0	0.0	0.5	0.5	0.0	0.0	0.0	0.0	0.0	2.6	4.6	0.0	1.2	0.0	0.9	0.0	0.4	0.0	0.0	0.1
GSDMA	"FLJ39120, GSDM, GSDM1"	ENSG00000167914	"Gasdermin A"	Q96QA5	17	39953263-39977768	"Predicted intracellular proteins, Transporters"	Necrosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	9	"skin 1: 58.9"	"Group enriched"	"Detected in some"	5	"Collecting duct cells: 3.7;Hofbauer cells: 5.0;Kupffer cells: 5.6;Macrophages: 2.6;Suprabasal keratinocytes: 2.7;Theca cells: 2.8"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 7.6"	"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"HBEC3-KT: 4.1;hTCEpi: 2.7;hTERT-HME1: 5.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA023313, HPA064826"	Enhanced		Supported	"Nucleoplasm,Nuclear bodies,Plasma membrane,Cytosol"		NA	NA		44000	"Cluster 16: MAIT-cells - Unknown function"	"Cluster 61: Skin - Cornification"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 4: Macrophages - Innate immune response"	"Plasma membrane, Cytosol"	"Nucleoplasm, Nuclear bodies"	"HPA023313: AB_1850378, HPA064826: AB_2685361"	"unprognostic (1.32e-2)"	"unprognostic (2.01e-1)"	"unprognostic (2.95e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.62e-1)"	"unprognostic (1.97e-1)"	"unprognostic (7.77e-2)"	"unprognostic (1.39e-1)"	"unprognostic (3.24e-1)"	"unprognostic (3.52e-2)"	"unprognostic (2.71e-1)"	"unprognostic (2.90e-2)"	"unprognostic (1.06e-2)"	"unprognostic (9.86e-2)"	"unprognostic (7.45e-2)"	"unprognostic (3.63e-2)"	"unprognostic (3.79e-2)"	3.4	0.7	0.2	0.9	0.2	0.4	3.5	0.4	0.4	0.8	0.2	0.7	0.6	0.4	6.6	3.2	0.3	0.8	0.3	0.3	0.2	0.3	0.3	0.4	0.7	0.4	0.0	0.1	0.3	1.3	0.1	1.6	0.4	0.1	1.2	0.0	0.8	0.0	0.4	58.9	0.5	0.6	0.0	0.2	0.3	0.3	0.4	0.5	0.1	0.1	3.4	1.1	1.5	0.4	0.2	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	4.1	0.0	0.1	0.2	0.5	0.4	0.2	0.0	0.1	0.8	0.0	2.7	0.5	5.4	0.0	0.0	0.0	0.1	1.3	0.0	0.5	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.5	0.1	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.1	0.1	0.4	0.0	0.0	0.1	0.0	0.3	0.2	0.0	0.0	0.9	0.1	0.1	2.2	0.0	2.6	0.0	1.3	0.8	0.1	0.1	0.6	0.9	0.7	0.1	0.1	0.2	0.5	0.5	0.2	0.2	0.4	0.4	0.3	0.2	0.4	0.0	0.4	0.0	0.4	0.4	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.5	0.0	0.0	3.7	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.1	0.2	0.2	0.0	0.0	0.1	0.2	0.1	0.1	0.0	0.0	0.0	0.1	0.7	0.0	5.0	0.0	0.1	0.7	0.0	5.6	0.6	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	2.7	0.0	0.2	2.8	0.0	0.0
GSDMB	"GSDML, PRO2521"	ENSG00000073605	"Gasdermin B"	Q8TAX9	17	39904595-39919854	"Predicted intracellular proteins, Transporters"	"Cytolysis, Necrosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 76.2;liver: 52.8;stomach 1: 47.4"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 45.7;Gastric mucus-secreting cells: 62.2;Intestinal goblet cells: 30.7;Paneth cells: 54.2;Proximal enterocytes: 108.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in many"	8	"SK-BR-3: 458.1"					"Not detected"	"Not detected"			"CAB013681, HPA023925, HPA052407"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 45: Enterocytes - Digestion"	Nucleoplasm	Cytosol	"CAB013681: , HPA023925: AB_1850383, HPA052407: AB_2681819"	"unprognostic (5.78e-2)"	"prognostic favorable (3.41e-5)"	"unprognostic (1.27e-1)"	"unprognostic (5.70e-2)"	"unprognostic (6.85e-2)"	"unprognostic (2.81e-1)"	"unprognostic (1.10e-1)"	"unprognostic (6.44e-2)"	"unprognostic (3.81e-1)"	"unprognostic (8.72e-2)"	"unprognostic (2.34e-2)"	"unprognostic (1.71e-2)"	"prognostic unfavorable (5.13e-11)"	"unprognostic (1.88e-1)"	"unprognostic (1.99e-1)"	"unprognostic (8.91e-2)"	"prognostic favorable (5.91e-9)"	13.5	1.4	12.2	13.1	12.4	5.1	9.3	12.9	22.6	6.0	11.6	45.0	66.9	3.4	5.1	4.8	6.2	12.5	4.8	12.5	11.3	6.0	52.8	7.9	11.0	11.5	11.4	6.3	8.2	0.3	4.0	2.9	11.6	10.9	57.0	5.3	4.6	4.4	1.5	8.3	76.2	5.0	11.2	15.0	47.4	4.3	11.9	10.8	8.9	0.4	8.4	20.1	5.6	13.2	2.0	1.5	2.9	0.8	6.7	4.3	2.6	1.8	1.1	0.6	1.8	1.7	55.2	2.8	2.5	1.7	0.9	7.6	1.6	1.6	4.0	11.7	1.8	1.1	0.8	0.8	2.0	0.3	0.7	2.9	9.2	2.4	3.3	4.6	1.2	9.0	1.3	3.5	0.7	0.6	3.3	6.2	0.8	18.2	2.0	3.1	1.1	4.5	0.2	1.8	1.1	1.4	0.6	458.1	1.9	13.2	2.4	1.9	1.7	2.0	3.0	5.1	1.0	9.9	9.2	2.8	0.7	1.9	0.3	0.0	0.0	0.5	0.2	0.0	0.0	0.2	0.7	0.3	0.0	0.0	0.6	0.1	0.2	0.0	0.0	0.0	0.1	0.0	12.2	12.4	12.9	22.6	12.5	11.3	11.5	11.4	11.6	11.2	11.9	13.2	1.5	3.2	12.0	9.1	3.9	1.9	1.4	4.9	4.0	2.8	3.3	2.9	2.5	8.6	8.1	5.5	4.2	1.6	3.5	45.7	0.0	1.7	5.5	1.5	1.8	1.8	6.1	0.0	20.1	7.8	0.6	1.2	62.2	1.8	1.3	3.0	0.4	8.1	0.3	1.7	9.2	30.7	0.0	1.3	2.0	5.4	1.2	1.1	3.6	3.7	1.5	1.3	2.1	7.1	5.1	8.9	54.2	1.9	5.6	1.4	108.2	0.3	14.1	2.3	0.0	1.4	2.2	0.4	1.4	1.8	3.4	0.3	4.8	3.0	23.7	6.7
GSDMD	"DF5L, FLJ12150, GSDMDC1"	ENSG00000104518	"Gasdermin D"	P57764	8	143553207-143563062	"Predicted intracellular proteins, Transporters"	"Immunity, Inflammatory response, Innate immunity, Necrosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 226.7;Proximal enterocytes: 297.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004656, HPA044487"	Uncertain		Supported	Nucleoplasm	"Intracellular and membrane"	NA	NA		11000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm		"CAB004656: AB_426076, HPA044487: AB_2678957"	"unprognostic (1.11e-2)"	"unprognostic (8.44e-2)"	"unprognostic (6.72e-2)"	"unprognostic (4.00e-2)"	"unprognostic (4.38e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.66e-1)"	"unprognostic (2.65e-1)"	"unprognostic (7.20e-2)"	"unprognostic (6.36e-2)"	"unprognostic (4.66e-2)"	"unprognostic (8.90e-2)"	"prognostic unfavorable (1.43e-4)"	"unprognostic (8.51e-3)"	"unprognostic (1.60e-1)"	"unprognostic (1.96e-1)"	"unprognostic (6.77e-3)"	43.1	36.0	6.5	34.1	6.7	39.4	41.5	6.5	9.0	42.9	11.1	48.4	51.3	36.7	9.1	22.5	41.5	15.7	24.6	6.2	6.4	50.6	88.8	54.8	42.3	7.7	7.2	39.5	35.1	19.2	18.3	16.5	7.2	39.0	13.6	1.0	32.5	15.1	11.0	16.8	60.3	12.4	7.1	120.1	37.9	7.3	7.0	24.4	46.4	6.1	16.1	35.8	31.7	7.1	40.8	18.4	0.3	0.1	13.4	14.7	23.8	13.8	36.4	44.0	47.4	3.1	54.6	14.5	21.9	21.1	19.6	12.5	0.7	31.1	11.1	43.8	2.8	23.2	5.4	22.6	17.8	4.2	1.0	35.5	2.6	16.1	9.4	14.5	34.1	34.2	1.4	49.1	2.3	0.8	87.5	7.1	0.3	27.3	67.6	30.2	1.5	48.7	22.5	39.9	0.5	0.6	44.2	39.8	43.4	5.6	69.7	24.8	13.3	0.2	44.6	3.2	22.1	16.5	22.4	0.4	26.5	19.6	21.8	65.4	44.7	45.9	55.0	73.2	44.8	39.9	48.6	53.7	40.7	31.1	33.8	40.4	46.2	41.1	69.1	29.1	71.1	46.8	6.5	6.7	6.5	9.0	6.2	6.4	7.7	7.2	7.2	7.1	7.0	7.1	91.1	12.8	29.1	6.8	39.8	10.8	47.1	55.7	23.9	0.2	31.6	30.5	12.2	47.1	37.5	31.3	0.0	62.0	54.6	226.7	60.7	68.3	2.2	33.8	20.0	57.0	39.6	14.9	0.1	92.7	98.1	34.0	68.8	27.2	27.3	171.1	75.3	72.3	63.1	0.0	0.1	114.8	30.5	50.1	18.4	7.0	23.6	52.5	17.8	7.5	74.4	28.9	81.4	0.5	0.1	50.2	181.1	22.6	41.1	34.6	297.7	121.8	43.1	1.7	59.2	24.0	34.4	1.4	12.3	13.8	8.9	41.7	61.5	24.2	131.8	45.9
GSDME	"DFNA5, ICERE-1"	ENSG00000105928	"Gasdermin E"	O60443	7	24698355-24757940	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	Necrosis		"Deafness, Non-syndromic deafness, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Cytotrophoblasts: 168.1;Distal tubular cells: 41.1;Extravillous trophoblasts: 26.5;Hofbauer cells: 39.9;Syncytiotrophoblasts: 104.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"memory B-cell: 9.0;myeloid DC: 5.9;naive B-cell: 8.4"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011326, CAB019306"	Approved		Supported	Cytosol		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 47: Cytotrophoblasts - Unknown function"	Cytosol		"CAB019306: , HPA011326: AB_1847629"	"unprognostic (1.08e-1)"	"unprognostic (1.77e-2)"	"unprognostic (6.29e-2)"	"unprognostic (6.36e-3)"	"unprognostic (6.70e-2)"	"unprognostic (1.49e-2)"	"prognostic unfavorable (2.49e-5)"	"unprognostic (4.35e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.35e-1)"	"unprognostic (2.23e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.13e-3)"	"unprognostic (1.48e-3)"	"unprognostic (6.70e-2)"	"unprognostic (1.06e-1)"	"unprognostic (5.90e-2)"	13.5	7.8	16.4	2.9	16.7	0.5	7.6	13.3	18.0	17.3	9.2	6.4	7.7	24.8	15.3	3.6	14.3	8.5	9.7	18.1	15.0	13.3	4.5	4.4	5.8	19.4	18.7	16.9	2.6	7.3	7.0	35.0	16.1	7.5	2.4	6.3	3.1	21.1	7.8	3.0	26.8	15.1	16.5	1.8	3.9	12.9	14.1	5.8	14.5	5.2	3.8	15.0	10.1	26.6	31.4	21.7	9.6	41.2	51.4	28.6	16.4	24.1	63.6	24.5	34.3	22.9	1.1	0.5	20.6	66.4	81.7	20.5	5.8	105.4	42.8	0.1	2.1	0.8	39.3	48.0	43.0	0.1	1.5	31.3	75.3	43.5	103.1	73.0	42.3	13.8	3.0	5.2	55.3	0.4	1.9	0.8	10.2	0.1	15.7	0.2	33.6	0.0	74.5	21.9	0.4	60.0	36.5	0.6	42.3	24.3	2.2	2.8	27.9	23.1	39.7	31.6	29.2	2.4	0.6	15.5	69.8	0.1	5.8	0.0	1.9	0.0	0.0	0.2	0.0	9.0	0.1	0.0	5.9	8.4	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.6	16.4	16.7	13.3	18.0	18.1	15.0	19.4	18.7	16.1	16.5	14.1	26.6	1.0	6.4	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	2.1	3.9	0.0	0.0	0.6	5.5	0.0	168.1	0.0	0.0	41.1	1.9	0.0	0.7	16.9	1.3	0.0	0.0	0.0	0.9	26.5	4.3	0.0	1.0	0.0	4.8	0.0	0.0	39.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.7	0.0	0.0	8.3	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.1	0.0	0.0	8.8	1.5	0.0	0.0	0.0	4.8	0.0	0.0	0.0	0.0	104.7	0.7	0.9	0.0	0.0
GSK3B		ENSG00000082701	"Glycogen synthase kinase 3 beta"	P49841	3	119821321-120094994	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Biological rhythms, Carbohydrate metabolism, Differentiation, Glycogen metabolism, Neurogenesis, Wnt signaling pathway"	"Developmental protein, Kinase, Serine/threonine-protein kinase, Signal transduction inhibitor, Transferase"	"Alzheimer disease, Diabetes mellitus"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 218.7;Inhibitory neurons: 246.3;Microglial cells: 197.7;Oligodendrocyte precursor cells: 241.8;Oligodendrocytes: 202.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016263, HPA028017"	Approved		Supported	Nucleoplasm		No	No			"Cluster 52: Eosinophils - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm		"CAB016263: AB_2279451, HPA028017: AB_10600708"	"unprognostic (1.09e-2)"	"unprognostic (2.62e-1)"	"unprognostic (1.40e-1)"	"unprognostic (2.17e-3)"	"unprognostic (1.15e-1)"	"unprognostic (4.86e-2)"	"prognostic unfavorable (8.20e-5)"	"unprognostic (3.39e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.67e-2)"	"unprognostic (1.05e-3)"	"unprognostic (6.79e-2)"	"prognostic favorable (1.52e-4)"	"unprognostic (2.39e-1)"	"unprognostic (2.58e-1)"	"unprognostic (1.28e-2)"	"unprognostic (1.16e-1)"	11.0	13.6	9.2	11.7	9.5	15.1	11.2	16.6	16.9	10.0	0.0	11.7	12.3	10.3	11.1	13.8	10.1	11.1	18.2	8.2	13.8	12.0	14.8	13.9	10.4	15.2	15.3	9.3	10.7	17.3	7.1	16.3	16.5	10.0	12.4	23.6	13.2	9.3	17.5	16.3	15.3	13.3	4.9	12.9	12.6	23.1	9.6	20.0	15.1	18.0	11.7	12.0	9.5	12.5	59.3	22.7	46.8	25.5	31.9	29.5	50.3	36.6	57.6	28.3	29.3	25.9	23.8	24.1	19.1	43.0	33.8	46.0	22.2	59.1	45.8	15.5	6.6	42.2	18.4	16.6	35.6	31.6	49.9	34.3	39.5	27.0	56.8	27.3	31.5	29.3	13.6	34.6	40.5	25.1	44.0	10.7	25.2	23.3	28.3	16.9	41.0	22.2	25.1	45.3	37.1	22.6	38.5	29.0	44.1	41.1	30.9	27.0	40.0	45.5	55.1	12.7	20.6	31.9	35.2	44.8	29.4	22.0	33.9	1.0	1.8	6.3	0.7	1.6	1.2	0.5	1.0	1.7	1.4	0.7	0.9	0.8	6.6	0.5	2.1	1.1	1.2	0.8	9.2	9.5	16.6	16.9	8.2	13.8	15.2	15.3	16.5	4.9	9.6	12.5	39.3	32.1	26.7	113.6	28.3	50.9	37.8	22.2	46.1	63.2	21.9	17.0	39.7	20.0	21.4	18.4	60.5	27.0	29.0	37.3	11.7	26.9	138.2	25.2	31.6	31.5	26.9	15.4	218.7	32.0	49.3	25.1	46.4	32.5	17.2	18.1	25.0	22.9	21.5	143.0	246.3	22.3	20.3	27.3	29.2	48.1	13.1	33.4	35.6	197.7	35.5	31.6	22.6	241.8	202.5	49.0	23.4	19.9	29.0	28.7	35.8	17.3	16.3	42.4	13.1	24.4	38.2	38.8	29.3	50.8	41.1	43.0	36.4	32.7	25.9	41.6
GSN	DKFZp313L0718	ENSG00000148180	Gelsolin	P06396	9	121207794-121332843	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Cilium biogenesis/degradation"	"Actin capping, Actin-binding"	"Amyloidosis, Cancer-related genes, Corneal dystrophy, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 2486.9"	"Cell type enhanced"	"Detected in all"		"Adipocytes: 1649.5;Fibroblasts: 4145.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"eosinophil: 1135.9"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 1313.9;HaCaT: 533.6"	"Region enriched"	"Detected in all"	4	"white matter: 869.2"	"Low region specificity"	"Detected in all"			"CAB010823, CAB016728, CAB036009, HPA054026"	Supported		Supported	"Actin filaments"	"Secreted to blood"	NA	NA	112000000000	240000000000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Actin filaments"		"CAB010823: , CAB016728: , CAB036009: , HPA054026: AB_2682347"	"unprognostic (3.25e-2)"	"unprognostic (4.44e-3)"	"unprognostic (1.22e-1)"	"unprognostic (3.10e-3)"	"unprognostic (4.23e-2)"	"unprognostic (4.85e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.20e-1)"	"unprognostic (6.54e-2)"	"unprognostic (6.56e-2)"	"unprognostic (3.06e-2)"	"unprognostic (8.01e-3)"	"unprognostic (4.98e-2)"	"unprognostic (1.23e-2)"	"prognostic unfavorable (1.79e-5)"	1892.9	162.5	169.7	109.7	317.4	175.0	1244.6	291.2	213.0	577.4	155.6	867.4	152.0	767.7	108.2	435.1	663.2	226.1	2486.9	163.4	219.8	153.1	40.6	308.7	93.2	380.9	284.6	303.8	140.7	70.9	260.6	79.0	354.7	344.0	204.6	57.8	508.7	400.9	420.4	612.9	384.1	350.0	270.6	136.5	469.7	78.1	279.0	99.7	702.6	687.8	87.3	897.2	655.5	376.1	38.4	60.9	39.0	129.8	1313.9	351.8	26.4	130.9	264.7	30.1	56.5	64.2	130.1	3.0	36.6	182.8	48.5	533.6	3.2	84.3	16.9	6.5	7.6	31.2	57.1	167.5	32.0	7.0	146.0	140.0	84.9	51.7	34.4	83.1	120.4	6.1	10.4	5.3	137.0	81.1	0.4	304.4	12.7	76.2	45.1	8.4	13.1	4.3	156.4	63.4	7.7	10.4	60.9	62.5	197.2	84.6	245.3	158.8	217.4	100.0	33.2	10.4	12.8	1.8	2.0	3.2	105.3	18.2	278.1	302.9	122.0	1135.9	1.9	84.9	0.8	17.6	0.8	1.4	345.3	6.7	0.8	0.7	307.1	217.8	23.7	243.2	4.2	105.4	169.7	317.4	291.2	213.0	163.4	219.8	380.9	284.6	354.7	270.6	279.0	376.1	1649.5	147.4	55.7	82.3	22.7	341.2	278.1	252.7	103.0	7.5	120.8	212.0	272.0	85.8	354.3	121.4	77.2	55.8	74.9	557.7	105.7	258.5	9.9	141.9	163.1	724.8	63.1	17.2	17.1	202.3	94.3	4145.2	322.7	220.6	104.0	31.8	273.5	16.5	492.6	1.7	9.0	762.9	512.7	139.0	798.7	20.2	588.7	273.7	537.2	155.5	487.5	220.6	55.6	33.2	443.1	315.8	590.5	671.8	24.1	91.4	77.4	39.8	583.7	86.5	611.4	362.4	740.4	8.7	13.7	175.9	299.1	84.0	58.7	34.3	52.2	144.7
GSR		ENSG00000104687	"Glutathione-disulfide reductase"	P00390	8	30678066-30727846	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase	"Cancer-related genes, Disease variant, FDA approved drug targets, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 32.3"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001538, CAB008632, HPA064806"	Approved		Supported	Cytosol		NA	NA		81000000	"Cluster 46: Basophils - DNA binding"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 40: Granulosa cells - Unknown function"	Cytosol		"CAB008632: AB_1616690, HPA001538: AB_1078986, HPA064806: "	"unprognostic (1.23e-1)"	"prognostic favorable (3.37e-4)"	"prognostic favorable (4.08e-5)"	"unprognostic (2.89e-3)"	"unprognostic (1.62e-1)"	"unprognostic (3.50e-1)"	"prognostic unfavorable (3.26e-5)"	"unprognostic (3.61e-2)"	"unprognostic (1.01e-1)"	"unprognostic (4.15e-2)"	"unprognostic (2.83e-2)"	"unprognostic (6.92e-3)"	"prognostic favorable (1.80e-4)"	"unprognostic (2.31e-3)"	"unprognostic (2.26e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.29e-1)"	13.6	23.3	12.3	18.7	11.1	25.9	11.0	10.6	11.7	28.5	25.8	42.5	54.3	16.0	21.6	37.3	21.6	30.5	25.4	12.9	12.5	45.3	35.8	17.4	23.6	9.5	14.2	23.1	26.5	82.3	14.8	23.5	12.0	35.3	46.6	12.8	25.8	29.4	28.9	12.8	50.8	17.9	10.7	22.1	41.8	11.6	17.6	26.7	16.9	21.3	24.0	22.5	27.7	11.2	49.4	197.8	35.9	40.1	35.8	38.3	29.1	23.4	46.8	31.8	36.7	66.0	31.3	95.8	94.8	32.0	96.1	59.2	62.3	51.1	33.1	22.6	40.7	104.6	67.0	197.8	88.4	38.6	159.7	72.6	28.5	48.9	20.9	33.5	43.3	57.3	73.2	55.1	67.9	44.1	147.1	32.0	65.4	191.9	31.5	43.8	41.9	59.3	56.0	124.3	28.2	31.8	31.2	87.8	58.8	40.7	37.5	32.6	63.8	21.0	34.7	37.3	35.2	20.2	29.4	70.0	51.9	51.8	62.4	32.3	5.9	15.0	5.0	5.4	8.8	3.6	4.5	5.4	6.0	2.3	2.8	3.7	8.2	3.6	7.9	3.9	4.5	3.1	12.3	11.1	10.6	11.7	12.9	12.5	9.5	14.2	12.0	10.7	17.6	11.2	8.2	3.2	20.8	12.7	13.7	4.2	15.2	9.4	52.3	6.7	6.7	5.0	26.8	30.0	15.0	12.9	16.7	17.0	20.3	61.8	9.8	11.4	8.4	61.4	13.4	9.9	34.1	28.6	18.1	19.8	6.3	10.0	33.1	41.3	6.3	64.3	12.1	43.4	18.2	3.3	27.4	51.7	8.2	40.5	5.8	18.9	7.2	22.1	8.8	11.2	20.6	12.6	17.5	12.5	10.0	15.2	32.0	10.9	15.6	27.5	75.7	19.0	11.7	8.0	6.6	7.0	8.6	1.2	3.4	39.6	5.4	6.4	17.3	17.2	47.5	33.5
GSS		ENSG00000100983	"Glutathione synthetase"	P48637	20	34928432-34956027	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Glutathione biosynthesis"	Ligase	"Disease variant, FDA approved drug targets, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 164.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054508, HPA059315"	Enhanced		Supported	Nucleoplasm		NA	NA		28000000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm		"HPA054508: AB_2682509, HPA059315: AB_2683976"	"unprognostic (5.80e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.14e-1)"	"unprognostic (7.21e-2)"	"unprognostic (3.63e-2)"	"unprognostic (5.68e-2)"	"prognostic unfavorable (7.21e-5)"	"unprognostic (2.90e-2)"	"unprognostic (8.52e-2)"	"unprognostic (3.64e-1)"	"unprognostic (6.49e-2)"	"unprognostic (1.50e-1)"	"prognostic favorable (7.31e-6)"	"unprognostic (3.35e-3)"	"unprognostic (1.96e-1)"	"unprognostic (1.42e-3)"	"unprognostic (1.52e-1)"	18.8	46.9	24.2	17.7	25.6	27.1	23.8	21.4	26.2	21.1	24.6	41.1	30.4	17.4	67.7	43.4	26.9	17.9	24.8	25.4	25.3	42.7	44.8	21.7	15.9	23.7	25.1	14.3	15.7	27.7	26.4	19.8	25.5	34.2	40.6	15.7	28.9	18.6	20.4	34.6	28.4	19.1	22.9	23.7	28.5	23.7	25.9	21.5	23.2	16.9	18.5	22.9	26.1	25.4	63.7	75.7	36.2	51.2	41.4	42.8	51.5	52.9	48.7	81.6	67.1	139.9	75.5	44.8	68.6	54.9	78.7	58.7	53.6	134.8	68.5	20.9	30.4	176.1	46.8	140.1	58.1	44.8	59.5	45.3	141.8	77.0	128.8	36.3	58.4	59.5	87.1	35.7	100.6	70.1	72.5	63.5	21.4	83.2	96.0	64.8	72.7	106.9	117.7	63.9	71.0	41.3	93.6	86.5	70.9	19.7	106.5	40.5	46.7	93.1	52.5	61.7	46.5	35.7	35.9	49.1	79.4	48.6	56.7	17.5	36.2	8.7	30.4	39.2	27.6	12.8	24.0	31.4	43.6	8.7	27.7	23.7	8.4	29.3	36.6	23.9	32.6	29.0	24.2	25.6	21.4	26.2	25.4	25.3	23.7	25.1	25.5	22.9	25.9	25.4	10.6	19.2	10.5	13.4	9.9	26.3	32.5	72.4	38.7	23.0	32.8	20.8	17.1	27.1	38.1	25.8	10.4	79.4	19.1	58.1	25.4	51.6	55.6	14.8	18.2	16.1	23.4	26.9	12.2	47.2	52.5	19.3	37.2	16.4	17.7	80.1	10.0	27.3	59.9	35.3	13.8	50.6	48.8	17.2	17.3	164.1	10.2	26.8	16.0	5.6	31.0	29.6	19.6	10.1	9.9	39.8	40.1	18.4	19.6	21.4	33.8	121.5	18.1	16.9	26.3	12.0	21.0	14.7	18.9	38.1	24.2	49.0	20.6	52.1	77.7	33.0
GSTA1		ENSG00000243955	"Glutathione S-transferase alpha 1"	P08263	6	52791371-52803860	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Isomerase, Oxidoreductase, Peroxidase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 916.5;kidney: 943.1;liver: 2610.5"	"Cell type enhanced"	"Detected in many"		"Exocrine glandular cells: 1652.6;Granulosa cells: 3177.1;Proximal enterocytes: 4294.8;Proximal tubular cells: 3190.6;Theca cells: 4578.2"	"Cancer enriched"	"Detected in many"	4	"liver cancer: 555.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	14	"Hep G2: 263.9"									"HPA004342, HPA048934, HPA053817"	Supported		Supported	Cytosol		NA	NA	27800000			"Cluster 85: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 40: Granulosa cells - Unknown function"	Cytosol		"HPA004342: AB_1078987, HPA048934: AB_2680563, HPA053817: AB_2630367"	"unprognostic (4.84e-3)"	"unprognostic (2.40e-2)"	"unprognostic (3.40e-1)"	"unprognostic (4.78e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.00e-2)"	"prognostic favorable (8.66e-4)"	"unprognostic (5.75e-2)"	"unprognostic (6.90e-3)"	"unprognostic (3.00e-1)"	"unprognostic (8.27e-2)"	"prognostic unfavorable (3.71e-4)"	"unprognostic (1.21e-1)"	"unprognostic (4.26e-3)"	"unprognostic (1.02e-1)"	"unprognostic (2.16e-2)"	0.5	916.5	0.0	2.5	0.0	0.0	4.2	0.0	0.2	2.0	0.0	7.3	672.0	0.4	7.0	5.3	86.1	119.5	0.2	0.0	0.0	943.1	2610.5	12.2	0.5	0.0	0.0	78.9	148.6	0.0	0.2	0.5	0.0	18.7	8.1	0.0	21.5	0.6	0.1	1.2	674.6	0.3	0.0	0.2	135.5	336.8	0.3	0.1	0.1	0.0	11.5	2.2	5.1	0.1	0.0	0.1	0.1	0.0	0.0	0.0	1.1	0.1	0.0	0.0	0.0	19.4	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.5	0.1	263.9	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.1	0.0	0.0	0.4	2.1	0.0	0.2	1.5	2.1	0.3	0.0	0.0	1.1	0.0	0.2	0.5	0.5	0.1	0.6	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	6.4	7.7	0.0	13.5	0.0	5.0	35.7	0.0	0.0	7.0	1.5	0.0	453.2	159.9	73.5	0.0	0.1	0.1	5.8	536.1	71.3	11.8	0.4	0.1	3.1	3.0	45.5	0.0	1652.6	0.2	7.3	116.7	0.5	2.5	3177.1	26.4	1013.9	0.1	0.0	0.0	165.6	42.7	31.5	0.0	43.0	65.6	25.3	0.0	0.0	13.3	0.0	1.0	0.0	0.1	629.1	187.4	4.5	0.2	27.6	4294.8	3190.6	533.5	0.0	0.0	0.0	98.6	36.8	3.4	6.8	0.0	0.5	10.4	4578.2	295.3	58.7
GSTA2	GST2	ENSG00000244067	"Glutathione S-transferase alpha 2"	P09210	6	52750087-52763475	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"kidney: 696.0;liver: 2058.5"	"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 201.6;Distal tubular cells: 213.2;Exocrine glandular cells: 239.6;Pancreatic endocrine cells: 334.7;Proximal enterocytes: 367.0;Proximal tubular cells: 1186.6;Respiratory ciliated cells: 435.5"	"Group enriched"	"Detected in many"	16	"liver cancer: 124.6;renal cancer: 48.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	13	"CACO-2: 25.9;Hep G2: 20.0"									"HPA004342, HPA048934, HPA053817"	Supported		Supported	Cytosol		NA	NA				"Cluster 85: Liver - Metabolism"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Cytosol		"HPA004342: AB_1078987, HPA048934: AB_2680563, HPA053817: AB_2630367"	"unprognostic (1.14e-1)"		"unprognostic (1.20e-1)"	"unprognostic (2.72e-2)"			"unprognostic (1.15e-1)"	"unprognostic (6.43e-3)"		"unprognostic (2.41e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.15e-1)"	"prognostic unfavorable (1.17e-4)"	"unprognostic (4.34e-2)"	"unprognostic (1.91e-1)"		"unprognostic (6.54e-2)"	0.4	4.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.6	149.5	0.0	0.7	0.1	2.5	109.4	0.0	0.0	0.0	696.0	2058.5	4.8	0.1	0.0	0.0	0.2	299.2	0.0	0.0	0.1	0.0	3.8	0.1	0.0	0.5	0.0	0.0	0.0	115.5	0.0	0.0	0.0	11.7	44.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.0	0.0	0.0	25.9	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	1.2	0.0	20.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.2	0.0	1.7	0.0	0.0	0.6	0.4	0.0	0.0	0.0	0.2	0.7	0.0	0.0	0.6	0.0	0.0	0.3	0.6	0.5	0.5	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.4	0.0	1.7	0.0	0.2	1.5	0.0	0.0	0.1	0.1	0.0	201.6	31.1	16.5	0.0	0.0	0.0	0.1	213.2	8.1	6.9	0.0	0.0	0.6	0.0	0.0	0.0	239.6	0.2	0.5	7.7	0.0	0.0	37.2	0.7	124.2	0.1	0.0	0.0	13.7	2.0	2.2	0.0	14.6	1.2	5.1	0.0	0.0	5.2	0.0	0.0	0.0	0.1	334.7	18.8	0.4	0.0	3.9	367.0	1186.6	435.5	0.0	0.0	0.0	1.5	1.9	0.7	0.0	0.0	0.0	2.6	10.4	30.1	1.3
GSTA3		ENSG00000174156	"Glutathione S-transferase alpha 3"	Q16772	6	52896639-52909698	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"adrenal gland: 67.3;fallopian tube: 65.4;placenta: 22.7;skin 1: 26.0"	"Cell type enhanced"	"Detected in some"		"Cytotrophoblasts: 194.9;Syncytiotrophoblasts: 515.3;Theca cells: 91.3"	"Cancer enhanced"	"Detected in some"		"endometrial cancer: 1.5;testis cancer: 1.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"SuSa: 1.4"									"HPA004342, HPA048934, HPA053817"	Approved		Supported	Cytosol		NA	NA				"Cluster 89: Fibroblasts - ECM organization"	"Cluster 12: NES - Nervous system development"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	Cytosol		"HPA004342: AB_1078987, HPA048934: AB_2680563, HPA053817: AB_2630367"	"unprognostic (7.51e-2)"			"unprognostic (7.06e-3)"		"unprognostic (3.10e-1)"	"unprognostic (5.53e-2)"	"unprognostic (4.38e-3)"	"unprognostic (2.86e-3)"	"unprognostic (1.81e-1)"		"unprognostic (1.41e-1)"		"unprognostic (1.93e-1)"	"unprognostic (9.35e-2)"			0.0	67.3	0.0	0.1	0.1	0.0	1.8	0.0	0.0	1.1	0.5	0.0	0.3	0.8	0.8	0.0	65.4	0.0	0.0	0.0	0.2	0.0	0.0	1.4	0.0	0.1	0.5	0.9	0.1	2.9	0.0	22.7	0.0	0.1	0.0	0.0	0.3	0.2	0.0	26.0	0.4	0.1	0.0	0.0	2.4	11.0	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.1	0.5	0.0	0.0	0.3	0.1	0.0	0.0	1.1	0.0	0.0	1.0	0.0	0.9	0.0	0.0	0.4	0.0	0.0	0.0	6.2	0.0	0.0	194.9	0.0	0.0	0.0	0.0	1.3	47.0	0.5	0.5	0.0	0.0	0.0	0.0	7.5	1.1	0.0	0.7	1.3	7.4	0.0	0.4	15.7	0.0	0.0	0.0	2.0	0.0	0.4	2.1	1.5	0.0	24.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.4	24.8	0.0	0.0	0.0	0.8	0.5	0.5	0.0	9.8	515.3	0.1	91.3	0.0	0.0
GSTCD	FLJ13273	ENSG00000138780	"Glutathione S-transferase C-terminal domain containing"	Q8NEC7	4	105708778-105847725	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 120.2;Late spermatids: 52.4;Oligodendrocyte precursor cells: 53.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 5.5"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046160, HPA061782"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 29: Early spermatids - Spermatogenesis"	Nucleoplasm		"HPA046160: AB_10961048, HPA061782: AB_2797265"	"unprognostic (4.10e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.06e-3)"	"unprognostic (4.44e-3)"	"unprognostic (6.44e-2)"	"unprognostic (6.43e-2)"	"unprognostic (1.84e-3)"	"unprognostic (4.30e-2)"	"unprognostic (2.43e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.38e-2)"	"unprognostic (5.46e-2)"	"unprognostic (8.67e-2)"	"unprognostic (8.59e-2)"	"unprognostic (2.68e-1)"	"unprognostic (1.32e-2)"	"unprognostic (7.02e-2)"	2.6	2.4	1.7	3.8	2.1	5.3	5.5	3.8	2.1	3.6	5.7	3.7	2.6	3.6	2.7	5.0	4.3	3.6	2.3	1.6	2.0	4.4	2.5	2.6	4.6	2.0	2.3	2.9	3.2	3.5	2.3	3.7	2.0	3.9	4.0	7.3	2.2	3.5	2.1	3.3	3.0	4.1	1.7	2.8	3.3	10.8	1.9	4.7	5.3	2.7	5.2	2.4	2.2	3.2	11.2	10.0	22.2	19.5	5.8	7.4	16.6	15.5	7.9	18.6	16.6	9.2	21.0	13.2	7.7	6.5	10.8	8.9	25.8	16.0	26.3	19.9	7.2	10.7	9.5	12.6	2.5	20.7	7.4	4.0	8.0	17.2	13.1	7.0	11.6	13.2	22.0	11.7	16.0	9.1	21.9	7.7	12.2	16.4	11.5	14.9	13.1	7.4	20.4	8.0	18.0	8.1	11.9	17.2	6.6	19.5	15.3	8.3	8.8	13.8	14.4	8.6	12.2	4.4	10.1	7.4	8.6	10.4	19.4	0.7	0.8	0.4	0.9	1.1	1.0	1.0	0.8	0.3	1.0	1.1	0.9	1.5	5.5	1.4	1.4	1.3	0.1	0.7	1.7	2.1	3.8	2.1	1.6	2.0	2.0	2.3	2.0	1.7	1.9	3.2	5.8	6.4	3.9	32.7	5.2	2.5	3.6	2.4	2.2	22.3	10.4	4.8	3.3	8.6	1.9	9.2	27.1	6.1	2.6	5.6	3.9	5.8	120.2	7.7	8.1	4.6	4.2	12.8	32.0	5.0	8.1	5.0	6.6	9.9	2.5	9.3	3.6	8.0	7.7	21.9	32.2	4.4	2.0	5.1	3.1	52.4	8.4	4.2	5.4	9.4	4.2	7.3	3.1	53.8	35.4	6.8	1.3	4.5	7.1	3.8	1.7	5.0	2.4	21.4	0.0	5.4	4.9	11.2	7.5	6.4	4.3	3.3	2.9	6.3	6.1	2.0
GSTK1	GST13	ENSG00000197448	"Glutathione S-transferase kappa 1"	Q9Y2Q3	7	143244093-143270854	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 1160.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006311, HPA022904"	Supported		Supported	Peroxisomes		NA	NA		110000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 39: Non-specific - Basic cellular processes"	Peroxisomes		"HPA006311: AB_1849786, HPA022904: AB_1849787"	"prognostic favorable (4.41e-6)"	"unprognostic (2.40e-1)"	"unprognostic (6.53e-2)"	"unprognostic (4.49e-3)"	"unprognostic (2.92e-2)"	"unprognostic (1.15e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.99e-1)"	"unprognostic (1.43e-1)"	"unprognostic (3.76e-3)"	"unprognostic (1.99e-2)"	"unprognostic (7.27e-2)"	"prognostic favorable (2.10e-6)"	"unprognostic (2.66e-2)"	"unprognostic (2.94e-1)"	"unprognostic (9.13e-2)"	"unprognostic (2.15e-2)"	150.9	180.9	77.5	135.9	82.5	187.0	159.1	82.7	89.2	154.5	141.0	217.9	317.2	95.2	110.7	154.0	144.7	140.6	271.7	75.7	82.7	257.2	449.3	125.1	185.0	85.2	84.0	71.1	138.0	308.2	79.7	104.2	85.3	111.4	230.8	26.9	213.0	96.4	238.6	132.6	277.1	106.6	79.8	236.5	163.4	85.1	83.3	96.2	160.1	324.1	183.7	129.5	112.4	88.6	150.7	106.1	14.7	130.1	224.2	319.7	68.8	87.0	148.4	76.3	150.8	64.5	375.2	85.4	120.8	126.7	114.5	222.4	57.5	136.2	66.0	165.0	62.3	69.6	80.9	102.9	154.1	84.7	108.4	290.4	164.3	88.0	62.0	113.1	205.3	109.5	99.3	100.9	207.2	116.2	87.3	152.9	34.7	291.3	158.6	73.9	2.4	169.6	266.1	81.6	59.7	81.4	159.4	256.3	137.4	88.3	123.6	117.0	122.2	41.0	37.7	108.5	75.2	171.0	86.5	20.0	148.5	336.0	86.6	351.1	537.1	210.7	298.5	597.9	289.7	254.5	554.6	386.4	445.2	183.2	281.3	274.6	165.0	188.3	641.7	187.0	800.5	917.1	77.5	82.5	82.7	89.2	75.7	82.7	85.2	84.0	85.3	79.8	83.3	88.6	181.9	70.5	95.6	17.0	134.1	114.2	174.9	244.0	118.4	11.6	181.9	198.2	172.9	211.6	219.5	121.4	12.5	295.3	151.4	301.6	291.6	160.5	561.3	102.7	95.8	117.0	153.6	63.3	25.8	120.3	132.0	96.4	185.5	92.9	145.1	47.4	155.3	322.1	304.2	8.4	28.8	252.8	154.6	288.3	174.1	1160.2	72.7	195.8	151.2	16.9	228.5	85.9	194.7	16.6	14.3	104.5	505.2	50.8	130.0	82.9	670.0	620.2	154.0	15.4	85.5	65.9	121.7	6.9	10.3	166.3	116.4	183.7	250.7	150.7	366.5	218.9
GSTM2	GST4	ENSG00000213366	"Glutathione S-transferase mu 2"	P28161	1	109668022-109709551	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 61.0;Plasma cells: 28.4;Squamous epithelial cells: 27.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 116.0;HSkMC: 115.6"	"Low region specificity"	"Detected in all"							"CAB040547, HPA055972, HPA055973"	Approved		Supported	Vesicles,Cytosol		NA	NA		1200000	"Cluster 26: Non-specific - Mitochondria"	"Cluster 35: Non-specific - Unknown function"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 59: Non-specific - Transcription"	Cytosol	Vesicles	"CAB040547: , HPA055972: AB_2682992, HPA055973: AB_2682993"	"unprognostic (2.51e-3)"	"unprognostic (1.28e-1)"	"unprognostic (2.04e-2)"	"unprognostic (2.57e-2)"	"unprognostic (2.20e-1)"	"unprognostic (5.04e-2)"	"unprognostic (7.31e-2)"	"prognostic favorable (9.70e-5)"	"unprognostic (1.51e-2)"	"unprognostic (7.43e-2)"	"unprognostic (1.80e-3)"	"unprognostic (2.94e-1)"	"unprognostic (1.48e-3)"	"unprognostic (1.07e-2)"	"unprognostic (1.87e-1)"	"unprognostic (2.32e-1)"	"unprognostic (2.14e-1)"	73.7	84.4	92.3	11.9	109.9	10.7	81.2	86.7	104.6	165.9	111.5	115.2	26.3	70.6	43.7	61.6	102.7	22.0	99.7	93.5	104.7	86.8	35.6	45.2	14.3	94.3	97.1	240.9	54.5	53.6	113.7	9.3	91.9	159.0	17.7	25.1	55.2	80.7	218.4	88.2	65.5	34.2	93.9	52.6	88.3	41.9	105.2	15.9	97.9	108.4	12.6	108.3	144.5	90.6	0.0	3.5	37.8	38.9	44.0	116.0	7.2	24.5	42.6	22.1	28.0	6.7	0.0	0.7	25.5	61.1	18.0	0.2	3.1	0.2	28.6	1.5	0.8	14.0	0.4	9.3	29.6	1.1	25.2	115.6	1.0	32.7	0.0	58.5	16.1	11.6	4.2	0.7	48.5	0.3	19.5	24.6	6.7	0.7	32.4	23.8	0.1	0.2	6.6	0.5	8.1	18.7	0.0	1.0	13.0	21.7	38.6	7.0	0.2	24.3	1.2	35.3	1.9	11.9	19.0	1.3	36.7	0.5	0.3	1.8	3.8	29.6	3.1	6.3	3.1	8.8	8.8	3.4	23.0	6.2	34.4	15.1	2.2	18.0	4.1	29.8	9.4	10.8	92.3	109.9	86.7	104.6	93.5	104.7	94.3	97.1	91.9	93.9	105.2	90.6	2.0	0.0	4.8	16.0	4.5	4.8	2.4	0.9	20.5	1.5	4.5	4.3	61.0	2.8	11.5	3.7	0.0	0.5	6.1	0.4	0.0	0.2	1.9	2.8	10.3	5.8	0.0	10.9	1.5	0.0	0.2	19.2	14.8	2.7	2.5	4.4	1.8	0.8	1.5	3.3	2.6	1.3	2.0	0.8	2.3	10.4	15.5	3.4	5.4	11.2	0.7	7.2	8.2	12.5	0.7	0.1	0.0	10.5	28.4	0.8	0.4	1.2	9.9	0.3	6.6	5.6	13.6	0.3	0.8	27.0	2.8	0.5	5.1	4.0	0.7	1.6
GSTP1	"FAEES3, GST3, GSTP"	ENSG00000084207	"Glutathione S-transferase pi 1"	P09211	11	67583742-67586656	"Cancer-related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Transferase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 2087.9"	"Cell type enhanced"	"Detected in all"		"Squamous epithelial cells: 4033.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"hTCEpi: 4998.3;OE19: 7810.3"	"Low region specificity"	"Detected in all"							"HPA019779, HPA019869"	Enhanced		Supported	Mitochondria,Cytosol		No	No		69000000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 61: Squamous epithelial cells - Keratinization"	"Mitochondria, Cytosol"		"HPA019779: AB_1849799, HPA019869: AB_1849801"	"unprognostic (9.81e-2)"	"unprognostic (6.52e-2)"	"unprognostic (7.24e-2)"	"unprognostic (2.72e-2)"	"unprognostic (1.06e-2)"	"unprognostic (1.30e-3)"	"unprognostic (3.27e-1)"	"unprognostic (4.98e-2)"	"unprognostic (1.28e-1)"	"unprognostic (5.16e-3)"	"unprognostic (2.14e-3)"	"unprognostic (9.37e-2)"	"unprognostic (5.72e-2)"	"unprognostic (7.78e-2)"	"unprognostic (2.23e-1)"	"unprognostic (6.72e-3)"	"unprognostic (1.48e-1)"	290.5	276.2	346.8	232.1	370.3	601.3	288.7	358.9	425.7	641.9	695.8	329.6	394.6	331.9	280.3	2087.9	647.5	435.8	367.2	341.4	381.9	567.7	45.1	468.3	321.8	375.7	379.2	306.9	340.9	737.4	320.2	326.9	378.5	291.7	197.1	137.9	541.2	780.4	355.0	731.4	321.7	214.2	367.0	257.2	535.5	45.8	378.1	296.9	579.0	312.5	380.8	526.5	946.2	377.7	1202.5	1599.4	763.7	1198.9	577.8	645.2	705.3	511.3	678.1	761.2	589.3	2956.3	1225.0	3.3	1144.7	813.5	683.7	1707.8	2073.9	2248.5	214.4	848.0	765.3	59.9	1107.6	0.5	852.2	400.3	667.6	807.2	4998.3	609.9	583.3	560.9	1160.2	847.2	1318.2	321.8	605.7	4.3	918.2	1100.6	1475.2	7810.3	681.3	844.8	129.6	3.8	1236.8	3.6	260.6	754.3	719.1	230.9	2394.0	598.2	3.6	656.3	634.5	351.6	883.8	740.6	378.6	200.0	1353.9	447.1	400.0	652.4	747.8	56.0	3145.4	246.6	720.0	2470.8	271.9	509.2	322.4	597.7	3582.7	476.3	267.8	466.5	130.5	1443.8	1608.5	1435.1	363.3	3948.4	346.8	370.3	358.9	425.7	341.4	381.9	375.7	379.2	378.5	367.0	378.1	377.7	466.7	1153.8	872.3	25.5	296.8	865.6	1914.8	3813.8	767.2	170.0	628.7	838.3	297.3	987.9	2763.5	1230.4	33.3	2116.8	372.4	655.0	1805.9	1811.9	4.9	1381.0	589.0	431.4	368.2	166.3	6.8	1444.4	1703.9	710.5	781.9	1020.9	269.9	795.0	382.3	10.5	861.2	70.7	10.1	992.4	1930.7	597.9	1090.3	25.5	572.3	703.5	1531.5	27.2	2166.5	558.5	459.3	17.6	38.4	1412.1	948.9	400.2	591.6	2266.2	844.4	3495.5	3715.4	274.4	361.6	401.3	941.7	4.8	54.9	4033.7	1061.7	1645.5	342.5	527.8	1118.5	3418.6
GSTT2B	GSTT2P	ENSG00000133433	"Glutathione S-transferase theta 2B"	P0CG30	22	23957414-23961195	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"adrenal gland: 81.8;breast: 307.9"	"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 29.4;Hepatocytes: 27.6;Muller glia cells: 20.9;Peritubular cells: 28.6;Skeletal myocytes: 26.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 57.0;HHSteC: 81.9;SK-MEL-30: 60.3;T-47d: 64.8"									HPA000750	Uncertain		Supported	Nucleoplasm,Cytosol		No	No				"Cluster 82: Adipose tissue - ECM organization"	"Cluster 6: T47d - Mammary gland"	"Cluster 33: Fibroblasts - ECM organization"	Cytosol	Nucleoplasm	"HPA000750: AB_1849804"	"prognostic favorable (5.06e-4)"	"unprognostic (5.14e-2)"	"unprognostic (1.90e-1)"	"unprognostic (4.51e-2)"	"unprognostic (7.13e-2)"	"unprognostic (8.41e-3)"	"unprognostic (2.58e-1)"	"unprognostic (7.99e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.76e-2)"	"unprognostic (4.11e-1)"	"unprognostic (1.18e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.48e-2)"	"unprognostic (2.19e-3)"	12.3	81.8	21.6	4.3	21.5	0.0	307.9	21.4	27.0	16.6	19.5	17.2	1.4	15.5	12.0	24.7	16.1	5.5	23.9	20.8	22.7	15.2	39.5	18.5	1.8	22.2	22.2	22.6	26.1	6.4	26.0	4.4	22.2	40.6	1.9	3.8	12.5	10.4	16.4	47.8	8.3	11.8	21.0	10.2	23.8	5.5	24.3	1.8	18.6	41.0	1.6	12.1	14.0	21.1	17.0	0.8	0.0	57.0	1.0	1.1	2.4	8.0	4.7	11.5	11.9	24.8	0.2	0.0	12.9	20.2	29.7	24.5	0.0	25.5	5.2	0.0	2.2	0.9	33.6	4.0	81.9	0.1	9.1	33.4	4.0	33.2	6.7	32.6	9.6	0.0	0.0	0.0	6.9	0.3	0.0	0.0	0.2	0.9	12.5	0.0	42.4	0.1	26.0	0.0	1.1	23.8	8.2	0.2	60.3	0.2	64.8	0.9	32.0	9.9	6.5	1.3	6.4	0.0	0.0	0.1	6.1	0.0	23.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.6	21.5	21.4	27.0	20.8	22.7	22.2	22.2	22.2	21.0	24.3	21.1	8.1	3.2	3.6	1.3	0.9	0.0	8.6	0.0	2.8	3.9	9.4	17.9	0.2	7.2	1.3	0.0	0.0	1.6	0.1	0.0	29.4	7.9	0.6	1.3	11.8	7.1	1.2	5.3	2.4	9.1	3.5	7.6	1.1	2.9	1.3	2.2	18.5	27.6	10.5	0.0	2.1	0.4	0.0	3.8	0.0	1.5	9.9	1.5	0.0	0.0	3.2	20.9	0.0	2.0	0.7	4.2	0.0	28.6	0.7	7.9	0.0	5.7	0.0	2.8	6.6	26.7	9.6	0.4	0.7	0.9	0.0	1.8	0.2	0.4	0.1	3.8
GTF2A1	TFIIA	ENSG00000165417	"General transcription factor IIA subunit 1"	P52655	14	81175452-81221377	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 7.3"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000869	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 29: Early spermatids - Spermatogenesis"	Nucleoplasm	Cytosol	"HPA000869: AB_1080253"	"unprognostic (1.93e-1)"	"unprognostic (1.31e-1)"	"unprognostic (7.98e-3)"	"unprognostic (1.40e-1)"	"unprognostic (1.50e-2)"	"unprognostic (1.20e-1)"	"unprognostic (6.04e-3)"	"unprognostic (1.65e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.85e-1)"	"unprognostic (7.49e-2)"	"unprognostic (2.76e-1)"	"unprognostic (3.87e-2)"	"unprognostic (4.04e-2)"	"unprognostic (2.44e-1)"	"unprognostic (2.11e-1)"	"unprognostic (5.88e-2)"	10.4	10.1	3.0	12.9	4.3	7.4	13.0	12.3	11.1	11.0	0.1	10.1	9.6	12.0	14.7	13.2	8.7	9.9	10.2	4.6	4.3	11.4	14.5	9.0	16.2	2.3	2.8	13.0	9.8	14.5	5.7	13.2	2.7	10.8	11.0	13.5	8.3	9.0	10.7	11.3	9.1	10.4	2.4	12.6	10.6	19.6	3.3	21.1	23.2	15.5	14.7	10.7	7.4	5.3	20.5	20.0	41.0	27.8	22.8	19.0	15.7	25.9	24.7	21.6	19.4	30.0	20.1	33.9	20.5	20.1	15.9	15.5	28.7	18.2	38.0	31.1	9.0	31.4	21.5	17.9	22.5	21.6	30.6	17.9	13.6	29.8	38.4	22.5	22.4	27.1	19.5	44.0	27.9	34.0	54.9	12.5	22.9	15.5	19.8	30.0	36.6	20.8	14.4	41.2	40.2	23.7	59.8	22.8	25.6	19.6	34.6	17.8	29.4	21.9	17.0	30.7	25.9	35.9	42.2	34.5	17.5	24.6	35.8	7.3	0.7	1.3	1.3	0.5	1.0	0.7	1.2	0.7	0.4	0.6	1.0	1.2	1.2	1.0	2.6	1.9	0.7	0.5	3.0	4.3	12.3	11.1	4.6	4.3	2.3	2.8	2.7	2.4	3.3	5.3	27.0	19.2	13.6	25.5	22.3	18.0	8.6	11.9	10.8	24.9	18.4	19.7	26.5	5.7	14.0	23.9	35.5	15.1	21.4	21.2	1.9	12.0	59.4	14.5	26.5	20.7	18.6	32.0	32.9	13.0	14.4	20.0	17.9	18.9	30.4	37.2	16.8	25.9	17.0	40.4	33.4	17.5	10.2	25.2	22.1	8.0	12.8	25.0	10.6	29.0	30.9	22.0	18.6	26.7	26.4	12.4	15.8	13.5	56.2	16.6	13.0	15.0	11.4	15.8	26.3	22.0	23.7	28.6	26.5	23.9	24.4	26.0	21.7	16.2	11.6	12.0
GTF2A2	"HsT18745, TFIIA"	ENSG00000140307	"General transcription factor IIA subunit 2"	P52657	15	59638062-59657541	"Predicted intracellular proteins"	"Host-virus interaction, Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"Early spermatids: 1134.9;Late spermatids: 732.8;Spermatocytes: 1264.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA056239			Supported	Nucleoplasm		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 16: U-266 - Nucleosome"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm		"HPA056239: AB_2683074"	"unprognostic (2.18e-2)"	"unprognostic (3.21e-1)"	"unprognostic (9.37e-2)"	"unprognostic (1.09e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.53e-2)"	"unprognostic (3.06e-2)"	"unprognostic (1.31e-2)"	"unprognostic (7.35e-2)"	"unprognostic (6.29e-2)"	"unprognostic (3.47e-1)"	"unprognostic (7.13e-2)"	"unprognostic (1.58e-1)"	"unprognostic (2.79e-1)"	"unprognostic (2.74e-2)"	"unprognostic (1.47e-1)"	"unprognostic (8.90e-2)"	54.4	56.9	37.6	54.5	39.5	72.0	49.6	42.7	44.0	52.5	38.8	62.8	40.3	48.7	54.6	60.9	46.2	43.6	64.0	38.1	42.7	69.8	49.8	39.7	52.6	41.5	40.1	52.0	43.1	65.4	58.3	43.3	41.0	46.0	51.1	41.9	58.2	34.3	75.1	39.5	42.0	45.4	42.2	43.3	46.3	211.9	38.6	60.0	41.1	55.1	51.8	61.4	65.5	44.1	149.1	206.4	136.8	130.9	83.8	70.5	157.7	164.0	79.8	134.6	133.3	224.4	58.9	136.5	149.5	107.9	197.6	124.3	138.7	100.6	95.4	242.2	112.9	157.4	146.5	143.4	107.5	171.5	134.1	66.0	95.1	112.3	94.9	95.3	87.6	105.6	226.7	136.1	113.6	103.8	112.9	130.8	181.7	49.6	120.0	104.4	142.9	166.5	133.7	172.2	148.0	157.1	152.1	171.5	160.1	180.5	120.7	179.2	121.5	126.4	224.7	142.5	297.7	134.1	426.3	303.8	143.2	284.0	157.2	174.0	129.8	170.3	88.1	140.7	92.4	126.9	103.1	98.9	174.2	100.2	87.4	96.7	70.0	117.5	135.1	201.0	132.7	134.9	37.6	39.5	42.7	44.0	38.1	42.7	41.5	40.1	41.0	42.2	38.6	44.1	109.4	41.7	58.5	17.0	89.8	98.7	184.6	213.0	83.1	51.1	107.3	155.8	120.4	62.9	132.2	64.4	47.9	217.8	99.9	122.4	211.3	148.8	1134.9	129.9	85.8	96.6	82.1	121.4	22.4	148.8	199.7	103.7	51.5	92.4	82.2	87.9	74.6	78.4	148.3	50.5	27.5	100.8	195.3	100.1	107.7	732.8	125.9	101.9	80.0	16.9	158.9	173.8	107.1	24.1	35.4	181.6	104.6	137.3	109.6	210.7	83.5	149.2	129.7	62.2	65.7	102.9	133.7	1264.3	166.3	89.8	106.8	151.9	87.3	120.8	120.5	236.2
GTF2B	TFIIB	ENSG00000137947	"General transcription factor IIB"	Q00403	1	88852633-88891944	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, Transcription, Transcription regulation"	"Acyltransferase, DNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA061626	Supported		Supported	"Nucleoplasm,Nuclear bodies"		No	No			"Cluster 5: Granulocytes - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 7: Non-specific - Mitochondria"	"Nucleoplasm, Nuclear bodies"		"HPA061626: AB_2684570"	"prognostic favorable (4.81e-4)"	"unprognostic (5.21e-2)"	"unprognostic (3.94e-3)"	"unprognostic (1.27e-1)"	"unprognostic (1.66e-1)"	"unprognostic (2.43e-1)"	"unprognostic (1.08e-2)"	"unprognostic (2.65e-2)"	"unprognostic (4.37e-3)"	"unprognostic (3.37e-1)"	"unprognostic (1.37e-2)"	"unprognostic (3.13e-1)"	"unprognostic (1.42e-2)"	"unprognostic (1.10e-2)"	"unprognostic (1.40e-1)"	"unprognostic (4.06e-3)"	"unprognostic (3.74e-2)"	25.3	26.4	14.8	18.8	15.7	62.2	28.3	16.4	24.0	22.9	17.7	22.6	17.9	21.8	30.3	26.3	22.7	23.8	15.7	15.5	16.5	22.9	32.6	22.0	28.9	15.5	15.9	26.3	23.3	22.7	20.3	25.2	15.7	18.1	23.1	17.9	22.9	16.3	23.1	28.3	23.9	20.7	16.2	28.7	23.0	16.3	15.1	40.2	21.2	18.5	31.3	31.5	23.7	17.0	40.0	13.6	34.6	18.8	49.8	34.4	42.9	32.1	39.4	44.1	46.4	17.9	24.3	45.5	37.8	28.0	53.3	22.0	36.8	32.1	38.3	42.8	34.3	48.6	21.2	32.1	31.9	56.8	28.7	30.0	32.1	38.2	21.7	33.4	25.1	41.1	43.1	33.6	47.0	12.6	54.9	46.7	28.8	35.4	29.3	34.4	46.8	34.2	47.0	47.2	26.7	22.4	28.5	35.4	57.8	30.7	15.9	51.1	22.3	19.2	24.0	35.0	38.8	35.1	29.9	62.6	12.8	48.8	16.7	91.2	49.3	82.1	45.9	57.1	53.2	57.8	52.1	50.5	62.5	48.2	62.9	53.9	99.7	54.9	60.4	40.5	70.1	50.9	14.8	15.7	16.4	24.0	15.5	16.5	15.5	15.9	15.7	16.2	15.1	17.0	106.6	6.4	29.7	13.7	114.9	46.3	75.4	63.3	58.6	14.6	39.7	104.9	12.3	21.5	45.6	11.0	2.1	74.0	122.3	39.1	39.2	49.2	22.9	53.9	28.4	30.3	20.3	51.1	22.7	38.6	60.0	53.0	41.8	29.8	48.9	30.2	16.8	17.6	40.5	18.5	21.4	30.5	52.9	32.3	42.5	7.9	36.4	93.4	28.4	22.5	40.3	30.7	33.0	18.1	25.2	49.9	70.5	29.3	74.3	27.8	26.9	47.4	55.2	18.5	13.1	86.6	65.0	24.2	29.0	40.1	50.0	150.1	122.8	34.5	22.7	79.4
GTF2E2	"FE, TF2E2, TFIIE-B"	ENSG00000197265	"General transcription factor IIE subunit 2"	P29084	8	30578318-30658236	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004816, CAB009603, HPA025065"	Approved		Enhanced	Nucleoplasm,Cytosol		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 22: Non-specific - Unknown function"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 22: Epithelial cell types - Mixed function"	Nucleoplasm	Cytosol	"CAB009603: AB_2114537, HPA004816: AB_2667252, HPA025065: AB_10601658"	"unprognostic (4.84e-2)"	"unprognostic (7.38e-3)"	"unprognostic (6.20e-3)"	"unprognostic (9.09e-2)"	"unprognostic (6.30e-2)"	"unprognostic (4.38e-1)"	"unprognostic (6.05e-3)"	"unprognostic (8.69e-2)"	"unprognostic (2.29e-1)"	"unprognostic (4.72e-2)"	"unprognostic (1.57e-2)"	"unprognostic (4.09e-2)"	"prognostic unfavorable (5.82e-7)"	"unprognostic (8.25e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.05e-3)"	"unprognostic (1.24e-1)"	24.5	29.1	14.9	17.8	16.1	9.4	19.9	19.9	19.3	25.1	16.9	20.9	19.5	19.4	17.2	26.4	16.4	13.2	16.2	15.9	17.3	21.4	28.1	17.8	25.9	14.8	15.1	30.3	51.8	15.4	20.1	16.8	15.0	18.7	16.0	11.6	15.9	14.6	13.4	20.6	17.5	18.5	14.7	20.4	24.4	32.7	16.5	22.4	17.4	11.0	26.6	24.1	24.1	15.8	53.7	43.7	29.2	31.2	77.4	68.2	22.0	57.7	52.4	46.5	58.6	26.2	38.2	70.0	48.0	51.9	67.0	37.8	49.1	53.8	61.5	31.8	28.2	34.9	28.9	63.0	75.4	17.1	29.5	50.6	70.7	49.7	50.7	46.3	65.3	51.2	68.7	42.1	74.5	37.3	83.7	42.9	33.1	66.0	51.9	43.2	31.6	35.4	50.9	36.7	22.4	29.1	32.1	21.5	46.5	38.3	20.8	20.9	49.9	30.6	31.4	25.9	39.8	42.6	62.7	77.0	48.2	28.8	41.3	4.3	4.2	6.4	3.6	3.5	4.1	18.8	5.7	7.6	7.3	11.7	5.6	5.5	2.2	9.7	3.7	8.2	7.0	2.8	14.9	16.1	19.9	19.3	15.9	17.3	14.8	15.1	15.0	14.7	16.5	15.8	20.2	0.0	8.4	16.6	48.7	47.9	48.1	44.3	48.3	9.2	19.1	17.5	9.9	17.2	28.2	14.7	10.4	43.0	32.3	26.5	19.6	31.5	96.7	42.2	33.8	22.9	13.2	14.1	30.2	33.1	51.4	30.0	31.1	29.0	11.4	17.7	26.4	27.0	34.1	5.0	30.1	24.2	22.4	21.6	39.3	58.9	39.4	28.4	21.4	13.1	58.8	9.0	46.4	17.1	21.8	43.3	23.4	70.7	35.9	72.7	46.5	48.2	40.0	14.9	26.3	17.5	28.0	74.3	87.9	38.3	46.5	62.1	36.9	26.1	24.5	91.8
GTF2F2	"BTF4, RAP30, TFIIF"	ENSG00000188342	"General transcription factor IIF subunit 2"	P13984	13	45120510-45284893	"Enzymes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"DNA-binding, Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006912	Supported		Supported	Nucleoplasm,Microtubules		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 59: Non-specific - Translation"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm	Microtubules	"HPA006912: AB_1080256"	"unprognostic (3.39e-1)"	"unprognostic (2.65e-2)"	"unprognostic (3.27e-1)"	"unprognostic (1.29e-1)"	"unprognostic (4.51e-2)"	"prognostic unfavorable (1.65e-5)"	"unprognostic (3.67e-2)"	"unprognostic (3.17e-1)"	"unprognostic (3.36e-2)"	"unprognostic (2.53e-3)"	"unprognostic (2.31e-2)"	"unprognostic (4.76e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.09e-1)"	"unprognostic (6.53e-3)"	"unprognostic (3.94e-2)"	"unprognostic (6.44e-3)"	10.9	16.6	12.4	11.0	13.2	18.3	12.9	12.4	14.9	13.5	18.1	18.3	10.4	11.6	15.4	16.5	10.0	8.4	20.0	13.1	13.2	15.0	11.3	9.6	13.4	12.3	13.0	12.1	10.7	14.1	12.9	11.0	12.4	10.7	14.2	9.9	12.2	13.0	25.0	24.9	10.0	12.9	13.5	10.2	11.3	13.3	13.0	14.8	11.4	15.8	14.4	15.5	14.8	15.6	43.2	15.9	29.3	21.8	17.6	25.8	24.3	46.2	30.2	46.1	44.9	26.8	65.7	42.9	25.4	33.9	44.8	46.9	44.3	37.1	66.7	32.6	38.4	50.8	20.7	35.2	28.1	57.0	27.9	21.8	55.9	34.4	57.8	52.0	29.9	32.9	36.6	15.8	125.6	24.2	42.0	65.2	34.8	68.6	38.3	39.0	22.2	24.8	101.4	15.0	15.6	26.0	23.5	22.9	39.8	27.5	18.6	45.9	23.7	38.6	33.1	30.8	79.9	10.0	14.6	42.7	44.9	36.1	41.2	16.2	15.9	29.9	10.3	16.7	12.4	17.3	12.1	12.4	18.8	17.8	13.5	13.5	22.5	18.9	18.9	14.7	14.7	10.1	12.4	13.2	12.4	14.9	13.1	13.2	12.3	13.0	12.4	13.5	13.0	15.6	21.6	41.7	32.1	41.1	36.0	75.1	82.8	80.2	35.9	19.2	27.3	30.2	79.4	10.0	41.6	11.0	4.2	33.0	25.7	29.0	49.0	49.7	93.0	34.9	37.5	27.6	28.2	32.6	23.7	33.6	49.4	28.9	13.7	56.8	39.3	25.6	18.2	21.4	49.1	8.4	35.1	26.4	50.8	27.1	38.2	82.3	24.2	32.0	76.5	36.5	38.2	36.8	27.8	57.8	48.9	48.5	30.3	31.6	30.4	88.3	22.6	42.7	29.4	21.5	6.6	35.6	32.3	68.6	83.9	34.5	72.7	33.8	28.8	33.5	40.7	75.1
GTF2H2	"BTF2, BTF2P44, p44, T-BTF2P44, TFIIH"	ENSG00000145736	"General transcription factor IIH subunit 2"	Q13888	5	71032670-71067689	"Predicted intracellular proteins"	"DNA damage, DNA repair, Host-virus interaction, Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"Daudi: 18.5;RPTEC TERT1: 19.1"									HPA047001			Supported	"Nuclear speckles"		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 72: Non-specific - Transcription"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	"Nuclear speckles"		"HPA047001: AB_2679899"	"unprognostic (7.40e-3)"	"unprognostic (4.71e-1)"	"unprognostic (6.31e-2)"	"unprognostic (2.99e-1)"	"unprognostic (1.62e-1)"	"unprognostic (3.07e-1)"	"unprognostic (1.29e-2)"	"unprognostic (4.69e-2)"	"unprognostic (2.08e-1)"	"unprognostic (2.22e-3)"	"unprognostic (3.74e-1)"	"unprognostic (3.06e-1)"	"unprognostic (3.67e-2)"	"unprognostic (3.93e-2)"	"unprognostic (2.43e-1)"	"unprognostic (1.87e-3)"	"unprognostic (1.62e-1)"	3.1	2.9	0.6	1.1	0.7	1.1	2.8	1.1	1.7	3.9	0.4	4.6	0.2	3.8	2.0	2.6	3.4	1.2	2.7	0.6	0.9	3.6	3.4	2.8	4.8	0.8	0.9	3.4	4.3	1.1	2.6	0.9	1.0	2.3	1.0	1.7	2.8	0.6	3.5	1.9	2.9	5.1	0.6	2.8	2.9	3.7	0.9	1.4	3.5	0.0	0.3	2.6	3.0	1.2	4.8	0.0	4.2	0.0	11.0	12.8	13.9	0.5	0.2	0.3	0.7	12.0	0.4	18.5	8.4	10.2	6.1	3.1	0.6	0.1	0.3	15.0	14.0	8.7	0.2	0.9	12.3	0.4	0.0	0.0	2.7	0.4	0.0	2.4	0.0	0.1	0.2	3.3	0.0	7.3	5.6	6.0	0.1	0.1	0.0	6.6	2.6	11.1	19.1	0.0	0.4	4.6	12.1	1.4	11.5	0.3	7.7	8.0	4.2	5.3	1.1	0.7	8.7	0.2	0.8	4.7	0.1	0.8	10.1	0.2	0.5	0.2	0.6	0.3	0.2	0.5	0.7	0.5	0.3	0.8	0.7	0.5	2.1	0.3	0.3	0.3	0.0	0.3	0.6	0.7	1.1	1.7	0.6	0.9	0.8	0.9	1.0	0.6	0.9	1.2	6.9	16.0	27.0	6.8	17.6	16.6	23.5	17.5	7.4	23.3	14.9	8.1	16.7	28.6	18.7	12.9	39.6	37.3	9.6	8.4	46.9	19.1	5.4	17.0	17.7	12.6	12.0	15.2	10.0	20.5	17.5	14.6	7.1	17.7	6.3	25.5	14.6	12.5	15.0	25.2	10.2	5.9	14.2	15.0	9.9	7.0	24.2	11.0	14.2	4.7	7.9	10.6	9.2	9.0	11.0	16.7	7.5	13.2	14.6	23.7	8.9	22.5	22.7	39.7	26.3	14.1	12.5	60.3	55.9	6.9	12.5	9.6	15.3	15.5	9.1	18.7
GTF2H3	"BTF2, P34, TFIIH"	ENSG00000111358	"General transcription factor IIH subunit 3"	Q13889	12	123633739-123662604	"Predicted intracellular proteins"	"DNA damage, DNA repair, Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004844, HPA053562"	Uncertain		Supported	Nucleoplasm		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 34: Non-specific - Transcription"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm		"HPA004844: AB_2667265, HPA053562: AB_2682191"	"unprognostic (1.07e-1)"	"unprognostic (1.36e-1)"	"unprognostic (6.02e-2)"	"unprognostic (6.13e-3)"	"unprognostic (2.29e-1)"	"unprognostic (7.34e-2)"	"prognostic unfavorable (6.72e-8)"	"unprognostic (1.02e-1)"	"unprognostic (1.22e-3)"	"unprognostic (3.30e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.10e-1)"	"unprognostic (5.68e-3)"	"unprognostic (4.71e-2)"	"unprognostic (1.22e-1)"	"unprognostic (7.49e-2)"	"unprognostic (2.80e-2)"	10.4	9.0	6.1	12.9	6.0	11.2	15.6	5.8	6.9	11.7	5.0	14.0	10.5	12.9	8.9	15.4	15.0	9.7	10.7	5.8	5.2	11.2	14.1	9.7	16.6	5.9	6.3	11.2	5.6	11.7	5.9	12.9	6.4	13.0	16.2	10.1	7.3	11.3	13.8	12.8	10.6	14.2	5.8	10.4	11.7	12.2	6.2	16.0	13.4	11.1	16.1	11.4	8.2	7.1	42.0	21.7	27.6	35.5	33.3	37.1	38.9	31.2	38.2	47.1	31.6	23.2	21.1	48.4	37.4	43.0	18.8	27.8	46.2	56.4	56.2	41.4	32.5	39.7	19.3	33.3	46.8	80.9	25.3	39.7	42.2	38.2	85.9	35.3	34.2	59.4	60.4	15.7	42.9	27.4	40.5	27.2	35.6	29.6	39.9	41.3	42.1	27.4	24.1	40.1	24.8	21.8	41.1	19.8	32.1	30.1	55.4	48.1	22.9	29.3	22.3	45.9	50.7	28.8	42.3	47.6	33.7	40.5	34.3	11.4	4.6	6.0	7.6	6.9	7.6	5.9	6.1	8.1	7.0	5.7	8.7	8.0	0.6	10.7	7.0	5.9	6.7	4.1	6.1	6.0	5.8	6.9	5.8	5.2	5.9	6.3	6.4	5.8	6.2	7.1	20.8	22.4	24.3	23.5	19.2	11.7	12.3	20.9	27.9	16.2	12.6	15.2	7.4	12.8	22.3	12.9	10.4	26.3	13.8	8.4	3.9	12.9	8.6	18.3	24.7	11.1	6.7	21.6	26.6	11.0	23.4	17.1	16.8	16.7	24.1	19.9	12.1	16.9	17.2	16.8	27.8	12.3	6.1	12.3	7.9	4.3	11.8	15.3	1.8	10.3	16.1	21.9	7.2	15.6	23.1	10.8	10.8	11.3	17.1	10.5	6.1	15.8	20.7	13.7	13.1	18.8	15.2	32.6	27.1	25.7	13.2	23.7	14.5	36.2	15.7	10.4
GTF2H4	"P52, TFB2, TFIIH"	ENSG00000213780	"General transcription factor IIH subunit 4"	Q92759	6	30908207-30914106	"Predicted intracellular proteins"	"DNA damage, DNA repair, Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 12.5;Gastric mucus-secreting cells: 9.7;granulocytes: 7.0;Plasma cells: 9.2;Squamous epithelial cells: 13.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							HPA074336			Supported	"Nuclear speckles"		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	"Nuclear speckles"		"HPA074336: AB_2686679"	"unprognostic (7.05e-2)"	"unprognostic (1.79e-1)"	"unprognostic (3.07e-1)"	"unprognostic (4.79e-4)"	"unprognostic (7.42e-2)"	"unprognostic (1.11e-1)"	"unprognostic (5.54e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.84e-1)"	"unprognostic (2.36e-2)"	"unprognostic (5.66e-4)"	"unprognostic (7.74e-3)"	"prognostic unfavorable (4.08e-4)"	"unprognostic (1.22e-1)"	"unprognostic (9.53e-2)"	"unprognostic (6.06e-2)"	"unprognostic (2.07e-2)"	12.6	11.1	5.4	6.6	6.6	4.7	11.4	6.2	7.0	12.8	4.8	12.0	1.8	12.8	1.9	14.4	10.6	2.2	9.3	5.6	6.3	14.6	21.5	10.1	5.6	5.2	5.8	12.2	11.0	6.8	13.4	3.5	4.9	10.5	4.0	1.1	8.6	3.5	13.2	9.7	10.4	1.9	6.0	11.9	12.4	11.9	6.3	8.7	13.5	3.8	3.7	11.7	11.7	8.1	20.5	15.0	15.9	16.5	16.0	11.6	17.7	3.3	5.3	5.8	9.6	14.9	9.1	12.3	8.0	21.1	11.1	16.6	10.7	21.4	10.6	18.6	2.5	10.0	11.5	13.8	10.1	0.0	17.0	18.5	20.5	9.8	0.0	10.3	6.1	9.1	35.2	11.3	11.4	25.0	22.5	16.9	18.5	10.4	6.1	28.5	0.0	11.8	20.7	11.4	9.2	4.5	0.8	11.5	8.8	9.8	16.2	13.7	6.8	15.5	21.5	16.4	28.6	11.1	13.1	9.3	8.9	16.8	7.0	1.8	1.1	0.9	0.8	1.2	0.3	1.3	1.2	1.3	2.5	0.6	1.2	2.2	0.0	1.1	0.6	1.2	2.1	0.3	5.4	6.6	6.2	7.0	5.6	6.3	5.2	5.8	4.9	6.0	6.3	8.1	0.6	0.0	0.0	4.2	4.0	0.4	0.1	0.4	12.5	0.7	1.1	0.8	0.0	1.5	0.1	0.0	2.1	0.4	0.5	0.4	1.9	0.6	0.1	1.1	1.0	1.8	0.0	4.2	4.6	0.6	0.4	1.4	9.7	1.0	7.0	0.8	0.7	1.1	0.3	0.0	3.3	0.0	0.0	1.2	1.2	0.0	0.9	1.5	1.8	1.9	0.3	0.5	0.0	3.5	2.8	0.0	1.2	0.7	9.2	0.1	0.1	0.9	0.8	0.3	0.0	0.4	1.9	1.4	0.4	13.8	1.0	0.3	3.5	0.4	0.6	0.1
GTF2IRD1	"BEN, Cream1, GTF3, MusTRD1, RBAP2, WBSCR11, WBSCR12"	ENSG00000006704	"GTF2I repeat domain containing 1"	Q9UHL9	7	74453790-74602605	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Williams-Beuren syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 68.1"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 48.3;Inhibitory neurons: 42.1;Rod photoreceptor cells: 41.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044254	Approved		Supported	Nucleoplasm,Cytosol		Yes	No				"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 9: Photoreceptor cells - Phototransduction"	Nucleoplasm	Cytosol	"HPA044254: AB_10964747"	"unprognostic (8.92e-2)"	"unprognostic (6.94e-2)"	"unprognostic (1.61e-1)"	"prognostic unfavorable (9.71e-5)"	"unprognostic (2.24e-1)"	"unprognostic (3.35e-2)"	"unprognostic (2.71e-3)"	"unprognostic (3.77e-2)"	"unprognostic (1.84e-2)"	"unprognostic (6.26e-2)"	"unprognostic (4.89e-3)"	"unprognostic (3.31e-1)"	"unprognostic (2.53e-1)"	"unprognostic (8.61e-2)"	"unprognostic (1.08e-1)"	"unprognostic (3.06e-2)"	"unprognostic (2.25e-3)"	6.0	12.6	7.0	3.4	7.0	0.5	6.9	7.2	8.1	16.8	14.0	15.1	7.7	11.3	8.6	26.7	8.8	5.7	11.6	6.0	8.4	18.6	4.6	11.7	1.0	9.2	8.9	10.5	10.0	18.9	27.6	5.8	9.0	13.3	5.6	36.7	17.3	8.2	68.1	22.4	6.7	8.4	6.7	2.0	13.9	5.0	10.1	3.4	17.4	29.7	5.4	15.0	19.8	10.2	21.2	12.9	28.1	30.8	22.2	10.8	0.2	8.8	23.7	17.1	17.7	21.7	30.1	5.4	6.5	18.1	41.7	11.6	22.6	10.2	12.6	0.2	13.0	1.1	43.1	26.1	71.2	0.2	0.7	14.7	42.1	12.0	48.9	39.7	8.9	10.4	15.5	0.1	19.2	26.1	2.7	18.9	22.6	25.7	12.8	28.1	16.4	20.0	32.7	14.6	23.1	30.5	21.7	39.0	19.9	14.2	23.4	21.2	4.6	17.5	16.9	11.4	20.5	1.1	3.4	8.9	6.7	0.3	14.1	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.2	0.1	0.0	0.1	0.0	0.0	7.0	7.0	7.2	8.1	6.0	8.4	9.2	8.9	9.0	6.7	10.1	10.2	0.9	9.6	8.2	48.3	0.1	7.9	9.9	10.5	9.6	30.8	5.6	4.1	10.4	12.8	6.8	9.2	33.3	1.4	1.5	4.5	11.7	7.6	1.6	11.5	8.0	4.1	4.2	0.8	24.6	9.2	1.8	5.6	6.1	17.0	2.5	8.0	2.9	3.1	2.6	21.9	42.1	3.6	8.2	1.2	5.7	0.3	4.1	2.5	7.2	14.0	0.7	5.9	1.0	25.6	24.9	11.6	3.2	5.7	0.0	17.8	3.6	17.4	12.7	41.1	0.0	19.0	5.7	0.1	3.7	18.2	6.7	2.9	1.1	2.4	7.4	15.8
GTF2IRD2	"FLJ37938, GTF2IRD2A"	ENSG00000196275	"GTF2I repeat domain containing 2"	Q86UP8	7	74796144-74851551	"Disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding	"Williams-Beuren syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"SK-BR-3: 59.0"									"HPA056679, HPA056680"			Supported	Nucleoplasm		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 59: Non-specific - Translation"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA056679: AB_2683205, HPA056680: AB_2683206"	"unprognostic (7.91e-5)"	"unprognostic (3.90e-3)"	"unprognostic (1.43e-2)"	"unprognostic (5.35e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.85e-2)"	"unprognostic (5.47e-2)"	"unprognostic (6.80e-3)"	"unprognostic (1.22e-1)"	"unprognostic (6.11e-2)"	"unprognostic (4.43e-5)"	"unprognostic (3.18e-2)"	"unprognostic (8.97e-3)"	"unprognostic (2.58e-1)"	"unprognostic (6.35e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.59e-4)"	11.6	12.7	6.5	4.6	7.5	8.5	12.6	7.3	7.1	16.8	7.6	16.3	5.9	13.0	5.0	9.6	15.5	4.6	18.7	6.5	7.7	13.2	17.4	9.1	5.7	7.3	7.5	19.6	15.3	6.7	13.0	3.8	7.6	15.4	6.5	7.7	11.9	6.8	38.7	9.3	9.7	7.4	6.9	8.9	15.1	7.4	7.4	8.2	13.5	17.8	5.5	14.0	11.3	10.0	16.6	5.4	7.3	10.6	10.2	6.6	5.6	5.6	5.7	6.4	7.3	1.5	13.9	4.3	1.3	9.1	11.0	3.3	0.1	3.4	5.5	2.1	1.3	3.5	8.3	7.9	9.6	5.8	0.7	6.3	5.3	1.8	4.9	8.0	6.6	3.3	10.3	8.8	5.8	14.6	2.3	16.5	11.5	18.2	3.8	4.3	2.6	15.8	15.7	14.6	5.1	16.7	22.8	59.0	13.3	6.3	12.5	11.3	6.0	9.8	2.5	1.7	8.9	6.6	3.0	4.7	8.0	3.9	20.9	12.3	7.1	7.8	3.2	4.1	4.7	18.9	7.2	9.5	7.3	11.6	8.7	5.5	1.0	5.5	3.6	13.0	7.1	7.6	6.5	7.5	7.3	7.1	6.5	7.7	7.3	7.5	7.6	6.9	7.4	10.0	6.7	19.2	27.4	23.5	20.7	3.2	11.7	6.9	15.4	27.4	15.8	13.1	11.7	21.5	15.5	12.9	56.3	7.2	11.2	18.1	3.9	21.4	20.3	15.5	10.6	7.2	27.0	3.8	4.5	28.1	7.4	14.3	17.9	11.1	14.0	32.0	18.5	9.6	4.7	37.0	8.5	19.9	6.1	7.9	4.6	5.2	43.8	6.8	10.6	3.7	11.7	12.4	26.8	14.6	20.5	28.8	18.0	25.9	8.5	12.3	15.0	6.7	22.5	40.7	13.1	29.2	13.2	2.8	2.6	11.2	4.3	6.4	12.0	18.2	21.1	8.0
GTF2IRD2B		ENSG00000174428	"GTF2I repeat domain containing 2B"	Q6EKJ0	7	75092573-75149817	"Disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding	"Williams-Beuren syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"memory B-cell: 14.8"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA056679, HPA056680"			Supported	Nucleoplasm		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 52: Non-specific - Ribosome"	"Cluster 24: NB-4 - Immune response"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm		"HPA056679: AB_2683205, HPA056680: AB_2683206"	"prognostic favorable (3.27e-4)"	"unprognostic (1.32e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.70e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.53e-2)"	"unprognostic (2.19e-2)"	"unprognostic (6.28e-2)"	"unprognostic (1.32e-1)"	"unprognostic (2.86e-1)"	"unprognostic (8.90e-4)"	"unprognostic (1.54e-2)"	"unprognostic (7.21e-3)"	"unprognostic (2.31e-1)"	"unprognostic (3.61e-1)"	"unprognostic (3.18e-3)"	"unprognostic (2.65e-5)"	11.5	9.5	6.2	5.7	10.8	14.0	13.6	7.8	8.8	13.6	10.7	15.1	5.1	16.0	5.5	8.1	17.3	9.4	15.1	6.3	7.1	13.8	15.6	10.7	5.3	9.7	9.5	32.8	17.0	13.8	7.5	7.3	9.1	12.9	9.2	10.8	13.3	12.9	36.0	5.9	7.9	13.5	7.9	8.0	15.4	4.6	11.2	17.2	12.3	28.6	7.9	13.8	8.5	19.8	19.0	7.4	12.4	12.9	9.8	13.4	9.4	9.7	14.5	4.4	11.5	3.5	14.2	11.4	9.4	9.7	17.3	6.3	6.1	6.3	5.3	14.7	5.5	8.4	9.5	7.9	19.0	13.5	12.5	12.4	12.7	3.7	15.5	15.9	6.1	4.1	11.7	24.4	14.4	12.4	9.1	31.6	12.6	16.3	11.5	18.0	3.8	17.6	13.2	13.8	11.5	21.6	20.4	20.9	22.7	3.4	20.8	13.0	10.8	11.4	7.7	10.4	12.8	10.1	6.3	31.4	5.3	12.9	25.6	0.5	1.3	5.0	1.0	1.8	1.5	14.8	1.7	2.2	1.0	6.6	2.9	1.3	1.3	1.1	1.1	1.4	2.6	0.7	6.2	10.8	7.8	8.8	6.3	7.1	9.7	9.5	9.1	7.9	11.2	19.8	4.6	0.0	10.8	20.5	22.1	4.5	4.5	10.3	27.3	7.2	11.9	9.5	21.1	14.3	5.5	7.3	12.5	2.4	8.1	9.1	0.0	12.9	13.5	9.9	7.8	6.1	19.2	8.6	4.1	12.9	2.7	13.2	35.2	5.6	3.8	13.3	11.0	12.0	2.6	13.5	7.2	15.1	10.2	8.1	5.4	4.4	27.4	4.0	21.4	5.6	6.0	6.5	9.2	15.6	27.0	14.8	14.6	17.0	23.4	4.6	10.2	3.4	13.8	13.4	13.1	11.3	10.7	2.5	1.5	22.2	4.3	3.0	13.0	6.0	14.3	3.6
GTF3A	"AP2, TFIIIA"	ENSG00000122034	"General transcription factor IIIA"	Q92664	13	27424619-27435823	"Predicted intracellular proteins, Transcription factors"	"Ribosome biogenesis, Transcription, Transcription regulation"	"DNA-binding, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007990	Supported		Supported	Nucleoplasm		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 52: Non-specific - Ribosome"	"Cluster 24: NB-4 - Immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	Nucleoplasm		"HPA007990: AB_1857960"	"unprognostic (9.88e-3)"	"unprognostic (3.40e-1)"	"unprognostic (2.16e-1)"	"unprognostic (1.36e-1)"	"unprognostic (2.87e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.57e-2)"	"unprognostic (8.64e-2)"	"unprognostic (7.53e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.39e-1)"	"unprognostic (3.41e-1)"	"prognostic unfavorable (3.43e-6)"	"unprognostic (1.98e-1)"	"unprognostic (1.33e-1)"	"unprognostic (3.26e-1)"	"unprognostic (1.41e-1)"	63.5	40.3	51.0	50.3	53.0	85.3	59.3	53.1	63.0	31.9	50.4	41.8	30.3	26.6	57.4	38.3	32.8	33.4	126.7	52.8	51.9	52.5	129.8	33.2	81.2	53.2	53.3	16.0	116.4	34.5	26.9	28.4	52.7	30.7	40.4	10.4	70.4	34.8	89.3	25.0	32.3	38.0	53.0	54.6	46.9	17.4	52.9	111.6	31.2	132.6	89.8	46.0	23.7	56.2	91.2	78.8	65.4	136.8	90.4	98.8	93.3	95.1	86.0	118.3	75.4	118.5	139.4	275.3	65.9	112.6	73.9	64.9	136.6	131.0	165.8	289.2	93.1	229.9	71.6	135.4	102.5	432.3	150.9	81.5	137.9	109.2	142.4	81.8	107.2	246.9	184.2	88.6	140.5	178.3	311.3	467.9	115.8	299.6	210.7	154.8	169.3	254.0	142.5	39.2	158.9	81.5	67.6	101.6	141.7	83.7	73.7	223.6	66.0	62.5	67.1	49.3	99.1	57.0	104.9	275.1	67.1	264.9	117.4	116.8	173.8	162.5	250.2	180.1	335.2	290.5	251.6	271.7	218.4	250.3	192.5	219.6	38.3	243.7	169.5	298.3	345.1	484.4	51.0	53.0	53.1	63.0	52.8	51.9	53.2	53.3	52.7	53.0	52.9	56.2	96.9	44.8	33.0	15.0	183.3	63.2	62.4	109.1	56.3	41.7	107.2	117.6	207.8	91.5	58.3	27.6	29.2	76.3	207.1	20.0	150.6	195.7	33.9	60.1	68.1	76.3	34.8	126.4	28.7	190.6	187.4	75.0	63.2	49.1	75.5	93.0	40.0	146.7	215.5	35.3	25.8	60.6	77.3	156.1	119.3	85.6	63.6	133.9	97.8	15.9	185.3	73.1	236.9	7.1	24.3	153.3	28.9	58.3	248.4	122.7	35.6	207.7	37.9	35.7	85.5	58.3	76.1	34.8	145.1	83.4	64.4	42.1	187.1	89.0	69.8	70.3
GTF3C1	TFIIIC220	ENSG00000077235	"General transcription factor IIIC subunit 1"	Q12789	16	27459555-27549913	"Predicted intracellular proteins, Predicted membrane proteins"	Transcription	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cone photoreceptor cells: 93.8;dendritic cells: 86.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"gdT-cell: 31.9"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051617, HPA075900"	Approved		Approved	Nucleoplasm,Nucleoli		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 72: Non-specific - Transcription"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 63: NK-cells & T-cells - Immune response"	"Nucleoplasm, Nucleoli"		"HPA051617: AB_2681553, HPA075900: "	"unprognostic (6.46e-2)"	"unprognostic (6.86e-3)"	"unprognostic (2.16e-1)"	"unprognostic (5.59e-2)"	"unprognostic (6.65e-2)"	"unprognostic (2.90e-2)"	"prognostic unfavorable (8.73e-4)"	"unprognostic (8.23e-2)"	"unprognostic (9.25e-3)"	"unprognostic (5.32e-2)"	"prognostic favorable (9.56e-4)"	"unprognostic (2.10e-1)"	"prognostic favorable (1.25e-4)"	"unprognostic (2.06e-1)"	"unprognostic (5.67e-2)"	"unprognostic (5.56e-3)"	"unprognostic (8.23e-3)"	18.1	28.8	24.2	9.9	24.4	16.6	16.7	21.5	32.6	31.2	40.5	21.2	8.8	26.7	7.8	65.2	24.6	11.5	38.5	24.6	21.8	25.4	21.7	20.3	12.2	20.4	20.8	24.4	35.3	18.6	47.8	11.0	19.6	40.4	9.7	18.3	24.9	12.6	50.2	51.0	18.5	15.5	17.0	21.3	24.7	26.6	22.2	18.6	34.6	20.8	11.2	19.7	35.1	21.7	27.8	60.1	43.3	50.7	37.8	30.4	24.6	29.5	33.0	40.2	34.0	45.0	25.6	30.5	42.3	36.4	30.6	30.3	55.4	37.6	32.9	13.7	53.1	25.2	49.8	63.8	21.3	29.1	32.2	37.5	28.0	49.5	21.8	26.9	40.2	34.6	31.7	24.2	32.0	67.6	32.5	34.8	58.4	15.1	28.3	59.7	53.4	31.4	25.2	28.7	54.4	36.5	29.8	24.9	18.6	34.4	44.8	21.8	43.2	40.2	24.0	25.6	30.7	25.6	24.8	30.2	16.6	31.7	30.2	2.6	3.4	3.5	31.9	3.2	23.0	3.1	3.6	15.8	4.3	2.2	3.7	10.0	2.5	12.2	3.3	6.6	4.0	6.9	24.2	24.4	21.5	32.6	24.6	21.8	20.4	20.8	19.6	17.0	22.2	21.7	16.9	19.2	23.9	29.7	10.8	18.4	7.3	14.3	23.3	45.5	10.6	11.9	27.4	10.0	17.2	12.9	93.8	7.8	86.2	18.4	5.9	11.8	2.8	40.4	37.3	18.0	30.0	7.2	30.2	11.5	4.3	22.5	19.9	22.3	19.0	26.1	13.9	13.7	10.9	26.9	33.9	17.6	18.3	10.3	7.7	4.5	19.3	12.9	3.6	14.0	10.0	15.0	52.5	17.1	23.4	15.8	9.3	15.8	29.6	13.9	10.2	9.0	30.8	35.1	13.1	16.4	15.1	17.2	18.2	34.8	20.6	4.2	32.7	25.7	12.2	6.7
GTF3C2	"KIAA0011, TFIIIC110"	ENSG00000115207	"General transcription factor IIIC subunit 2"	Q8WUA4	2	27325849-27357034	"Predicted intracellular proteins"	Transcription			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 61.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA008274, HPA035836"	Uncertain		Supported	Nucleoplasm		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 34: Spermatids - Unknown function"	Nucleoplasm		"HPA008274: , HPA035836: AB_10601813"	"unprognostic (1.76e-1)"	"unprognostic (9.64e-2)"	"unprognostic (9.89e-2)"	"prognostic unfavorable (8.25e-5)"	"unprognostic (1.33e-1)"	"unprognostic (4.88e-2)"	"prognostic unfavorable (1.21e-8)"	"unprognostic (1.57e-1)"	"unprognostic (1.77e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.59e-2)"	"unprognostic (7.39e-2)"	"unprognostic (1.86e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.94e-1)"	"unprognostic (7.97e-2)"	"unprognostic (3.00e-1)"	18.7	25.6	19.5	23.2	20.8	23.5	21.1	26.2	27.6	19.0	23.5	25.3	22.4	19.8	23.7	34.5	24.4	15.3	23.2	19.9	20.8	23.3	21.1	19.7	26.6	21.2	18.7	20.7	30.7	33.1	20.0	19.6	20.0	20.1	27.7	25.2	25.2	18.5	28.7	32.2	24.2	23.3	17.2	26.8	24.3	26.0	22.0	30.4	29.4	18.5	33.5	23.2	21.4	28.1	86.2	75.7	62.5	60.6	36.2	35.2	91.2	30.8	41.8	39.8	33.7	56.3	53.7	75.1	54.1	43.0	40.8	50.6	93.2	59.2	38.0	59.5	81.0	63.3	48.5	76.0	33.0	69.7	60.6	44.4	52.3	45.4	58.4	38.0	51.8	50.4	90.1	54.9	38.8	70.4	64.9	50.7	118.2	69.0	47.6	79.1	69.2	83.9	56.8	63.9	58.0	101.5	33.1	78.6	57.7	52.8	42.2	39.3	39.6	48.2	52.4	36.9	58.1	60.2	71.9	169.4	48.1	55.4	53.8	29.6	18.2	14.5	14.3	15.0	15.1	13.3	12.6	15.2	15.6	11.4	12.4	12.2	8.4	13.3	19.2	9.8	8.5	19.7	19.5	20.8	26.2	27.6	19.9	20.8	21.2	18.7	20.0	17.2	22.0	28.1	7.9	19.2	22.1	11.8	17.5	9.8	9.8	11.9	18.2	11.3	13.9	11.6	11.7	14.3	14.9	5.5	22.9	19.3	12.9	22.2	9.8	16.6	54.9	13.6	10.9	10.3	3.5	24.8	17.3	22.8	23.6	10.0	17.3	14.6	18.3	16.2	10.0	11.1	16.1	10.1	16.2	17.6	12.2	18.4	7.6	61.9	9.3	12.1	5.4	16.9	18.3	8.9	12.3	14.1	18.9	21.5	9.0	7.9	18.6	13.0	16.0	11.8	14.8	18.0	6.6	9.7	11.8	9.1	16.4	19.4	12.6	20.0	13.7	11.8	15.1	14.4
GTF3C3	"TFIIIC102, TFiiiC2-102"	ENSG00000119041	"General transcription factor IIIC subunit 3"	Q9Y5Q9	2	196763035-196799725	"Predicted intracellular proteins, Predicted membrane proteins"	Transcription	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA069179			Supported	"Nucleoplasm,Nuclear membrane"		NA	NA			"Cluster 42: Non-specific - Transcription"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 15: RT4 - Unknown function"	"Cluster 52: Non-specific - Transcription"	"Nucleoplasm, Nuclear membrane"		"HPA069179: AB_2686099"	"unprognostic (1.44e-1)"	"unprognostic (2.63e-2)"	"unprognostic (1.89e-1)"	"unprognostic (4.52e-2)"	"unprognostic (5.88e-2)"	"unprognostic (3.64e-2)"	"prognostic unfavorable (1.26e-6)"	"unprognostic (1.92e-1)"	"unprognostic (9.28e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.09e-1)"	"unprognostic (5.62e-2)"	"unprognostic (3.36e-2)"	"unprognostic (2.79e-1)"	"unprognostic (2.72e-1)"	"unprognostic (1.70e-1)"	"unprognostic (3.08e-2)"	11.0	10.9	18.1	9.6	20.4	36.8	19.5	25.1	23.1	10.9	23.8	10.8	10.2	12.2	15.1	11.4	11.9	19.6	10.0	19.8	19.9	9.5	12.9	10.5	18.8	21.7	19.0	13.8	13.1	13.6	9.0	12.5	25.9	10.2	13.1	18.6	9.7	10.0	13.6	20.9	10.8	14.3	17.9	13.8	12.1	13.9	19.5	13.4	15.1	7.3	10.9	11.6	9.4	31.8	14.4	19.2	28.4	22.2	13.1	19.4	28.0	26.2	16.3	24.7	25.0	41.4	23.0	29.8	15.9	15.7	24.1	19.2	24.4	23.3	28.7	35.0	26.6	37.2	59.9	38.6	21.8	32.8	28.9	25.8	21.4	17.8	25.0	21.9	22.6	25.7	45.6	54.6	14.9	34.0	28.6	29.2	16.9	16.9	29.3	24.4	20.7	19.8	17.6	43.2	22.6	20.5	16.7	14.6	17.8	35.9	15.4	21.1	15.0	21.2	15.1	16.7	19.3	26.0	34.4	22.2	21.8	24.4	16.9	8.4	4.7	4.4	3.9	3.1	3.5	4.8	3.5	4.0	2.8	6.8	4.2	4.0	4.4	4.8	5.8	4.3	4.8	2.3	18.1	20.4	25.1	23.1	19.8	19.9	21.7	19.0	25.9	17.9	19.5	31.8	17.4	22.4	16.0	19.2	11.6	4.0	12.2	16.6	10.2	18.1	8.8	8.8	35.8	7.2	21.4	14.7	18.8	15.3	18.1	7.7	13.7	12.4	4.4	18.2	17.4	17.0	12.5	19.1	24.7	12.3	12.6	12.9	11.2	13.3	14.0	24.7	12.8	8.2	13.5	0.0	29.8	10.1	16.2	12.7	5.0	4.6	13.4	11.8	7.2	27.2	22.0	12.5	9.2	23.1	38.5	14.7	6.4	10.9	16.3	8.4	12.9	10.9	37.2	15.6	6.6	10.1	13.6	44.7	24.8	11.6	5.5	15.7	12.2	18.2	11.9	9.4
GTF3C4	"KAT12, TFIIIC90"	ENSG00000125484	"General transcription factor IIIC subunit 4"	Q9UKN8	9	132670035-132694953	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	Transcription	"Acyltransferase, DNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA069369			Supported	Nucleoplasm,Mitochondria		No	No			"Cluster 40: NK-cells - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm	Mitochondria	"HPA069369: AB_2686130"	"unprognostic (7.02e-2)"	"unprognostic (9.01e-2)"	"unprognostic (1.31e-1)"	"unprognostic (4.10e-2)"	"unprognostic (8.20e-2)"	"unprognostic (2.78e-1)"	"unprognostic (3.71e-3)"	"unprognostic (1.69e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.76e-1)"	"unprognostic (4.77e-1)"	"unprognostic (1.92e-2)"	"prognostic favorable (2.99e-4)"	"unprognostic (1.65e-1)"	"unprognostic (1.23e-1)"	"unprognostic (2.35e-1)"	"unprognostic (1.54e-2)"	4.9	4.4	4.3	4.6	5.0	6.9	8.4	9.2	4.3	7.3	3.6	5.3	3.9	6.6	5.5	6.7	6.6	5.2	5.8	4.5	5.2	6.0	5.3	5.7	5.0	3.4	4.8	10.3	6.1	9.4	3.2	6.4	3.7	6.2	5.4	5.5	7.3	5.7	5.8	9.8	3.6	6.2	3.6	4.5	5.8	8.3	5.6	8.1	9.5	8.0	6.6	5.0	3.8	3.8	15.2	21.7	25.8	22.5	12.3	14.4	20.0	15.1	18.4	19.6	14.4	25.4	10.9	22.7	9.8	18.6	18.1	33.8	39.8	23.6	21.1	15.4	19.1	19.0	28.9	10.8	12.8	28.6	12.4	11.4	17.6	20.4	26.1	11.6	16.8	15.1	32.7	11.4	14.0	24.6	17.8	13.3	33.1	22.2	21.4	17.6	31.1	20.6	14.3	12.5	36.3	24.6	25.9	25.8	15.9	15.8	35.4	12.1	17.8	32.9	18.7	15.1	21.6	4.9	12.3	25.1	13.5	17.8	20.7	0.0	0.3	0.2	0.5	0.3	0.4	0.5	0.4	0.6	0.2	0.4	0.5	0.5	0.3	0.5	0.2	0.5	0.4	0.2	4.3	5.0	9.2	4.3	4.5	5.2	3.4	4.8	3.7	3.6	5.6	3.8	9.9	19.2	11.5	2.3	7.8	30.7	6.9	6.9	21.6	15.5	19.1	14.7	14.6	1.5	6.7	3.7	14.6	7.5	9.0	6.6	7.9	8.3	6.5	21.5	26.2	11.6	13.1	8.2	3.2	6.3	7.5	13.0	8.6	17.7	1.3	17.1	10.0	8.6	6.3	20.2	3.1	8.1	10.2	7.6	9.3	3.7	19.0	6.3	3.6	1.9	7.1	11.9	7.2	1.0	2.1	5.8	7.0	19.2	10.7	11.6	3.8	6.6	16.2	16.9	0.0	18.8	10.9	16.7	13.8	22.1	40.1	6.4	8.8	18.2	9.0	6.4
GTF3C6	"bA397G5.3, C6orf51, TFIIIC35"	ENSG00000155115	"General transcription factor IIIC subunit 6"	Q969F1	6	110958706-110967890	"Predicted intracellular proteins"	Transcription	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA056179, HPA061345"	Approved		Supported	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm	"Nuclear bodies"	"HPA056179: AB_2683058, HPA061345: AB_2684485"	"unprognostic (6.98e-2)"	"unprognostic (1.38e-1)"	"unprognostic (2.66e-1)"	"unprognostic (3.04e-1)"	"unprognostic (6.99e-2)"	"unprognostic (2.34e-1)"	"prognostic unfavorable (7.27e-6)"	"unprognostic (2.08e-2)"	"unprognostic (9.79e-3)"	"unprognostic (2.89e-1)"	"unprognostic (5.42e-2)"	"unprognostic (7.75e-2)"	"unprognostic (1.42e-3)"	"unprognostic (9.31e-2)"	"unprognostic (1.69e-1)"	"unprognostic (2.39e-2)"	"unprognostic (1.14e-2)"	53.2	55.0	71.5	53.5	73.6	53.5	47.1	73.7	114.9	42.0	73.4	66.9	52.3	30.8	45.8	44.8	45.2	57.8	86.6	70.8	76.3	76.2	51.3	33.9	55.8	72.4	72.6	28.2	30.8	65.3	37.1	32.5	72.7	94.6	65.4	39.0	38.3	41.6	231.2	31.1	46.7	48.7	72.9	33.6	49.8	61.9	72.3	49.7	40.2	168.0	58.1	61.1	27.5	74.9	85.8	154.0	166.5	155.7	59.9	121.9	145.4	143.8	105.1	131.9	109.2	229.0	74.7	121.1	137.8	132.9	30.4	38.6	141.1	120.0	145.5	175.9	205.3	234.2	145.9	347.5	113.4	360.9	190.8	121.4	103.3	115.2	112.8	89.7	155.2	154.3	281.7	79.4	246.8	166.5	198.6	371.4	169.9	109.6	121.0	183.2	95.6	109.7	221.5	214.7	105.4	148.5	107.0	16.8	133.0	98.6	58.7	244.2	163.0	38.2	112.0	260.5	232.3	51.7	127.2	235.9	39.7	208.1	191.3	112.6	116.9	71.0	104.2	170.7	117.9	164.1	130.0	131.0	158.3	133.7	100.9	118.9	18.5	116.2	141.1	173.4	292.4	167.5	71.5	73.6	73.7	114.9	70.8	76.3	72.4	72.6	72.7	72.9	72.3	74.9	58.0	70.5	47.1	12.7	67.1	30.3	70.9	169.2	34.1	37.6	85.3	90.4	279.1	203.0	99.5	104.8	16.7	94.6	75.0	138.8	305.2	190.4	169.1	119.1	82.0	66.0	109.8	86.9	4.9	293.0	251.1	66.4	47.9	167.8	54.4	71.2	55.6	94.5	284.6	26.9	6.7	98.6	144.5	79.8	50.1	223.9	65.0	104.5	55.2	6.5	172.4	133.2	81.4	7.1	13.4	210.8	125.2	68.4	78.3	126.9	118.9	404.7	74.9	37.0	65.7	63.5	88.1	153.1	105.8	72.5	29.7	90.4	72.3	120.2	121.4	117.8
GTPBP3	"FLJ14700, GTPBG3, MSS1, MTGP1, THDF1"	ENSG00000130299	"GTP binding protein 3, mitochondrial"	Q969Y2	19	17334920-17342731	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"tRNA processing"		"Cardiomyopathy, Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA042158	Approved		Supported	Mitochondria		NA	NA			"Cluster 22: NK-cells - Unknown function"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 32: Non-specific - Translation"	Mitochondria		"HPA042158: AB_10964400"	"unprognostic (1.52e-1)"	"unprognostic (1.08e-2)"	"unprognostic (2.23e-1)"	"unprognostic (3.08e-3)"	"unprognostic (1.34e-1)"	"unprognostic (2.18e-2)"	"prognostic unfavorable (1.86e-4)"	"unprognostic (6.32e-2)"	"unprognostic (1.82e-1)"	"unprognostic (2.70e-2)"	"unprognostic (3.25e-2)"	"prognostic unfavorable (2.81e-4)"	"prognostic unfavorable (1.64e-4)"	"unprognostic (4.94e-3)"	"unprognostic (1.21e-1)"	"unprognostic (2.56e-1)"	"unprognostic (1.79e-1)"	8.0	13.5	6.8	5.1	5.9	4.9	9.1	6.1	7.0	10.6	6.0	8.8	5.5	8.5	1.8	13.1	9.6	2.1	8.7	6.3	7.5	11.3	14.1	7.6	6.5	9.0	7.1	10.2	12.2	5.3	8.8	3.3	9.0	10.5	2.9	4.1	10.2	3.9	9.2	15.1	9.4	2.8	6.2	12.7	9.3	3.0	7.0	3.5	8.8	3.1	4.3	8.9	10.4	6.5	19.7	11.6	10.6	13.8	3.5	3.3	51.2	9.1	3.8	8.2	8.0	16.2	15.6	29.8	22.8	3.4	5.8	17.2	13.5	7.8	6.7	24.9	62.6	17.8	18.4	21.4	4.6	19.3	11.2	3.4	11.2	7.6	9.7	5.7	6.6	20.9	34.6	13.0	4.2	15.7	23.2	17.2	22.4	12.2	51.5	27.4	8.2	28.3	7.6	8.8	24.7	22.0	9.8	14.9	12.9	7.0	13.2	7.9	7.2	12.6	11.3	28.0	16.3	21.9	36.7	35.4	10.0	25.0	9.8	0.4	2.3	0.4	4.8	3.2	4.0	3.0	4.5	4.3	3.6	4.1	4.9	4.6	0.7	5.2	1.7	6.7	3.3	2.8	6.8	5.9	6.1	7.0	6.3	7.5	9.0	7.1	9.0	6.2	7.0	6.5	10.5	3.2	5.3	11.8	10.8	17.1	9.3	11.4	13.6	20.3	14.9	14.9	7.2	4.3	6.1	5.5	31.3	21.4	10.2	5.9	7.9	12.5	0.3	5.2	7.7	9.7	3.0	12.0	6.2	10.9	25.3	9.0	9.2	7.9	2.5	15.7	8.6	9.8	10.1	11.8	9.4	9.7	12.2	5.6	7.7	0.2	11.8	6.2	10.6	2.8	8.6	8.3	12.3	8.0	8.3	10.8	7.5	13.5	18.0	9.7	9.1	7.1	5.9	20.7	6.6	7.2	10.8	2.9	4.6	11.5	17.5	8.3	12.6	15.9	13.2	6.4
GUCY1A1	"GC-SA3, GUC1A3, GUCY1A3"	ENSG00000164116	"Guanylate cyclase 1 soluble subunit alpha 1"	Q02108	4	155666726-155737059	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"cGMP biosynthesis"	Lyase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Adipocytes: 38.4;Alveolar cells type 2: 56.1;Breast glandular cells: 37.4;Breast myoepithelial cells: 24.9;Distal tubular cells: 19.6;Ductal cells: 21.8;Smooth muscle cells: 49.4"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 24.9"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"NK-cell: 8.2;non-classical monocyte: 10.1;plasmacytoid DC: 11.5"	"Group enriched"	"Detected in many"	35	"dendritic cells: 11.5;monocytes: 10.1;NK-cells: 8.2"	"Cell line enhanced"	"Detected in some"		"HAP1: 6.8;HEK 293: 5.5;Karpas-707: 9.7;MOLT-4: 18.5;RPTEC TERT1: 12.1;RT4: 14.2;SH-SY5Y: 8.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010887, HPA056004, HPA058617"	Uncertain		Supported	Nucleoplasm		NA	NA		7100	"Cluster 40: NK-cells - Unknown function"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 48: Smooth muscle cells - ECM organization"	Nucleoplasm		"CAB010887: AB_259901, HPA056004: AB_2683007, HPA058617: AB_2732624"	"unprognostic (4.81e-3)"	"unprognostic (2.60e-1)"	"unprognostic (3.03e-1)"	"unprognostic (2.15e-1)"	"unprognostic (1.99e-2)"	"unprognostic (7.77e-3)"	"unprognostic (1.07e-1)"	"prognostic favorable (2.38e-4)"	"unprognostic (1.85e-3)"	"unprognostic (6.46e-2)"	"unprognostic (3.42e-2)"	"unprognostic (7.16e-2)"	"prognostic unfavorable (7.59e-4)"	"unprognostic (1.60e-2)"	"prognostic unfavorable (3.59e-4)"	"unprognostic (2.27e-1)"	"unprognostic (6.55e-3)"	14.4	7.8	10.1	17.0	24.1	1.2	15.4	2.8	14.0	14.5	0.1	27.1	8.7	16.1	6.2	7.5	9.5	12.6	33.7	12.7	8.0	15.6	8.0	21.0	8.5	5.3	10.0	5.6	13.1	31.4	3.9	25.9	4.5	25.8	10.3	17.0	5.3	13.9	5.1	2.5	9.2	28.9	8.7	14.1	8.6	1.2	10.2	7.5	7.2	18.7	9.2	7.3	6.6	8.5	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	6.8	0.0	0.0	0.0	5.5	1.3	0.0	0.0	0.0	0.0	0.0	0.8	0.1	0.0	0.0	0.1	0.0	3.6	0.0	9.7	0.0	0.0	18.5	0.0	0.0	0.0	0.2	4.1	0.0	3.0	12.1	14.2	2.5	8.7	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.2	0.2	0.0	2.3	0.1	0.0	0.0	0.0	2.5	0.1	0.0	0.0	0.1	8.2	10.1	11.5	0.0	1.0	10.1	24.1	2.8	14.0	12.7	8.0	5.3	10.0	4.5	8.7	10.2	8.5	38.4	9.6	56.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	37.4	24.9	0.0	0.0	6.8	11.0	0.0	0.4	1.7	0.0	19.6	21.8	0.0	5.5	9.7	10.9	0.0	0.0	0.0	2.0	0.3	8.3	0.0	15.2	3.8	3.0	0.0	0.0	4.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	12.9	2.2	0.0	0.0	0.0	49.4	0.0	0.0	0.0	0.0	0.3	0.6	0.1	0.0	0.0
GUSB		ENSG00000169919	"Glucuronidase beta"	P08236	7	65960684-65982215	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Glycosidase, Hydrolase"	"Cancer-related genes, Disease variant, Mucopolysaccharidosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Karpas-707: 213.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036322, HPA036323"	Approved		Supported	Vesicles	"Intracellular and membrane"	NA	NA		330000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 4: Macrophages - Innate immune response"	Vesicles		"HPA036322: AB_10670796, HPA036323: AB_2675059"	"unprognostic (1.54e-2)"	"unprognostic (6.49e-2)"	"unprognostic (1.18e-2)"	"unprognostic (3.50e-1)"	"unprognostic (2.58e-2)"	"unprognostic (4.46e-2)"	"unprognostic (2.89e-1)"	"unprognostic (1.56e-3)"	"unprognostic (1.32e-1)"	"unprognostic (2.32e-1)"	"unprognostic (7.00e-3)"	"unprognostic (1.91e-1)"	"unprognostic (3.34e-2)"	"unprognostic (8.83e-3)"	"unprognostic (1.98e-1)"	"unprognostic (5.06e-1)"	"unprognostic (1.45e-1)"	28.4	18.2	11.0	22.3	12.3	84.2	80.9	12.0	16.1	26.7	14.3	38.2	36.1	26.2	41.8	16.4	24.6	27.6	19.6	10.7	11.5	25.1	104.0	35.7	25.6	13.2	12.2	19.9	33.6	30.3	12.6	48.2	13.2	20.2	41.9	9.7	32.9	21.2	10.9	18.8	29.8	19.1	11.9	34.0	38.1	19.5	13.0	22.7	27.7	14.4	24.0	27.3	15.4	13.5	67.0	26.5	25.2	56.3	80.9	49.1	35.3	21.3	56.8	45.0	42.1	37.0	67.8	30.9	32.3	26.8	24.1	27.5	16.5	25.1	26.8	27.3	34.1	41.5	40.9	27.3	39.7	89.6	67.1	33.4	26.7	26.3	33.3	54.5	39.3	18.0	63.2	213.5	30.5	50.3	34.2	92.0	17.9	103.0	21.0	34.4	55.9	172.4	29.4	42.8	36.2	32.7	55.6	129.1	72.3	29.9	71.1	88.8	28.5	55.3	49.3	21.8	53.6	119.6	151.9	50.0	41.0	116.3	68.3	26.0	80.1	65.7	32.0	103.0	28.4	27.7	24.7	28.4	80.5	22.6	16.8	19.5	13.2	46.6	93.5	34.2	34.5	51.4	11.0	12.3	12.0	16.1	10.7	11.5	13.2	12.2	13.2	11.9	13.0	13.5	53.1	51.3	58.7	10.1	33.0	18.0	32.0	51.9	29.0	12.2	26.1	19.9	12.2	48.6	48.9	29.5	8.4	81.9	32.6	52.2	5.9	41.1	59.1	28.9	26.5	39.7	43.0	47.1	12.3	30.3	61.2	49.5	49.5	49.4	36.8	38.3	37.9	72.7	126.4	16.8	10.6	51.6	30.5	88.1	33.2	46.7	43.2	78.0	39.2	14.0	44.8	28.0	20.6	8.5	14.2	29.4	49.5	28.6	87.5	25.3	50.6	26.8	43.2	20.1	26.3	27.1	26.0	49.6	31.0	16.0	14.8	66.9	32.2	24.4	44.3	29.6
GYPA	"CD235a, GPA, MN, MNS"	ENSG00000170180	"Glycophorin A (MNS blood group)"	P02724	4	144109303-144140751	"Blood group antigen proteins, CD markers, Predicted membrane proteins"	"Host-virus interaction"	"Blood group antigen, Host cell receptor for virus entry, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	38	"bone marrow: 156.3"	"Cell type enriched"	"Detected in some"	350	"Erythroid cells: 1995.6"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	5	"cerebral cortex: 1.7"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	203	"HEL: 149.1;K-562: 37.7"									"CAB002658, HPA014811"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA		15000000		"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 36: HEL - Hemostasis"	"Cluster 6: Erythroid cells - Oxygen transport"	"Nucleoplasm, Plasma membrane, Cytosol"		"CAB002658: , HPA014811: AB_1849827"					"unprognostic (1.60e-1)"								"unprognostic (2.47e-2)"					0.1	0.1	0.1	0.0	0.1	156.3	0.0	0.0	1.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	2.3	0.5	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.1	4.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	2.2	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	149.1	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	37.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	1.7	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.7	0.0	0.0	1.9	0.0	0.7	0.0	0.0	0.0	0.0	1995.6	2.4	0.0	2.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	2.1	0.0	1.7	0.0	0.0	0.9	0.0	0.3	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	5.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.6	0.2	0.0	0.0
GYPC	"CD236, CD236R, Ge, GPC, GYPD"	ENSG00000136732	"Glycophorin C (Gerbich blood group)"	P04921	2	126656133-126696667	"Blood group antigen proteins, CD markers, Predicted membrane proteins"		"Blood group antigen"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 441.0"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 1728.6;Hofbauer cells: 488.7"	"Cancer enhanced"	"Detected in all"		"melanoma: 66.9"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HHSteC: 433.1;K-562: 362.1;SK-MEL-30: 668.4;U-266/70: 363.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008965, CAB009445"	Enhanced		Supported	"Plasma membrane"		NA	NA		970000	"Cluster 20: T-cells - T-cell receptor"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 6: Erythroid cells - Oxygen transport"	"Plasma membrane"		"CAB009445: AB_2116251, HPA008965: AB_1078455"	"unprognostic (1.63e-2)"	"unprognostic (7.14e-3)"	"unprognostic (8.39e-2)"	"unprognostic (3.31e-3)"	"unprognostic (4.19e-2)"	"unprognostic (1.69e-2)"	"unprognostic (8.82e-2)"	"unprognostic (3.52e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.21e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.11e-1)"	"unprognostic (2.05e-2)"	"unprognostic (2.73e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.29e-1)"	"unprognostic (8.00e-3)"	172.3	73.0	17.3	51.5	17.6	441.0	109.2	17.5	30.8	75.7	20.2	89.1	18.2	62.3	20.2	42.3	68.4	56.3	161.9	16.5	20.2	58.4	18.5	101.4	110.5	22.2	18.4	91.5	34.8	9.6	16.9	50.3	22.0	46.5	19.3	10.3	26.4	56.1	212.7	37.0	52.9	55.9	20.6	98.5	41.0	7.3	23.6	59.6	33.3	204.1	75.9	73.0	54.4	24.9	1.3	0.0	152.0	0.2	116.1	100.5	0.2	24.0	186.4	28.9	84.9	0.0	0.2	0.6	0.4	69.6	107.6	0.3	85.7	0.1	9.5	79.7	0.0	279.0	0.0	0.0	433.1	99.0	0.7	237.4	0.0	23.1	0.1	2.3	1.0	190.4	362.1	214.6	70.5	0.0	0.1	148.9	46.7	0.0	0.4	18.1	12.1	0.4	11.8	0.0	0.2	0.0	0.3	0.0	668.4	20.7	0.0	258.5	65.7	107.3	1.0	7.3	1.2	363.9	257.4	0.5	51.4	135.8	99.3	0.8	28.6	2.2	153.1	40.3	172.2	95.8	136.7	186.5	50.0	102.6	190.5	188.3	21.9	81.1	24.7	27.1	179.4	119.0	17.3	17.6	17.5	30.8	16.5	20.2	22.2	18.4	22.0	20.6	23.6	24.9	260.7	6.4	7.7	0.7	152.7	38.0	3.4	17.0	43.3	0.6	14.6	110.5	34.9	84.4	6.0	14.7	2.1	4.9	194.0	0.0	135.0	202.9	1.6	3.6	99.8	157.2	0.0	1728.6	0.4	4.9	6.9	170.5	10.2	2.5	22.9	23.3	229.2	6.2	488.7	0.0	0.5	1.1	0.0	118.0	108.5	4.9	87.3	134.9	305.9	15.0	98.0	5.1	204.9	6.0	0.1	6.0	0.4	69.2	250.9	9.4	0.0	8.1	1.7	2.6	59.2	65.8	88.6	0.2	0.7	41.9	26.6	9.0	228.0	31.8	1.6	2.9
GZF1	"dJ322G13.2, ZBTB23, ZNF336"	ENSG00000125812	"GDNF inducible zinc finger protein 1"	Q9H116	20	23362182-23373062	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"	"Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024520	Uncertain		Supported	Nucleoplasm,Nucleoli		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 32: U-937 - Innate immune response"	"Cluster 7: Non-specific - Mitochondria"	"Nucleoplasm, Nucleoli"		"HPA024520: AB_10963938"	"unprognostic (3.11e-1)"	"unprognostic (3.18e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.26e-1)"	"unprognostic (5.65e-2)"	"prognostic unfavorable (9.81e-7)"	"unprognostic (8.98e-2)"	"unprognostic (2.66e-1)"	"unprognostic (8.70e-2)"	"unprognostic (3.88e-2)"	"unprognostic (1.92e-1)"	"unprognostic (3.97e-2)"	"unprognostic (1.22e-1)"	"unprognostic (2.42e-1)"	"unprognostic (1.13e-3)"	"unprognostic (1.45e-1)"	5.9	18.7	9.6	5.5	10.4	31.5	5.0	11.1	10.9	6.0	9.2	6.5	3.9	6.5	5.3	4.4	6.5	5.5	12.4	9.4	9.8	7.7	6.4	6.0	5.2	10.0	12.8	9.2	5.2	6.7	7.9	6.4	9.9	5.9	4.1	10.5	5.0	6.8	9.4	4.7	4.8	5.7	10.6	5.3	5.4	13.3	11.7	5.5	7.0	8.1	4.4	5.8	4.6	10.4	8.2	14.2	8.9	9.0	10.3	10.0	7.1	9.8	9.0	9.9	9.2	10.9	6.4	16.6	8.5	8.5	19.3	14.3	10.3	13.2	11.2	2.8	6.7	15.4	6.0	14.7	13.4	9.3	9.0	10.1	9.6	10.7	16.3	13.8	6.7	11.4	10.6	25.2	14.3	10.9	14.5	11.6	6.6	11.5	19.3	9.5	21.3	11.6	7.4	8.2	13.7	7.8	8.7	15.4	20.9	7.3	10.2	13.4	8.7	16.0	9.2	12.1	10.6	20.5	9.0	14.4	4.7	41.8	8.8	0.0	1.6	0.8	0.7	0.9	0.5	1.0	1.0	1.0	1.6	0.6	0.9	1.0	1.2	0.5	1.2	1.3	0.3	0.9	9.6	10.4	11.1	10.9	9.4	9.8	10.0	12.8	9.9	10.6	11.7	10.4	9.8	6.4	9.6	5.5	12.6	10.8	3.1	3.8	8.6	12.6	6.0	6.9	19.7	1.5	4.7	3.7	18.8	4.9	8.7	3.9	7.9	3.6	18.9	10.4	9.7	8.4	5.4	4.0	6.6	3.3	3.2	8.3	7.1	17.8	13.9	8.2	2.2	5.2	8.7	6.7	7.6	4.2	4.1	13.2	28.8	27.5	9.3	23.9	1.8	1.0	2.5	10.3	5.2	4.5	5.6	4.0	4.6	8.2	11.6	3.2	2.8	3.8	7.7	13.4	0.0	8.8	11.5	20.7	8.9	7.6	8.4	5.6	7.9	14.0	3.7	1.8
H1-0	"H1.0, H1F0, H1FV"	ENSG00000189060	"H1.0 linker histone"	P07305	22	37805093-37807436	"Plasma proteins, Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 660.5"	"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 51.4;Cytotrophoblasts: 42.9;Extravillous trophoblasts: 125.7;Hofbauer cells: 73.2;Syncytiotrophoblasts: 219.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"dendritic cells: 8.1;granulocytes: 17.1;monocytes: 11.7"	"Cell line enhanced"	"Detected in many"		"OE19: 662.8;U-2 OS: 823.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000843	Supported		Supported	"Nucleoplasm,Nuclear bodies,Golgi apparatus,Actin filaments"		Yes	No		120000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 24: Non-specific - Transcription regulation"	"Nucleoplasm, Nuclear bodies"	"Golgi apparatus, Actin filaments"	"HPA000843: AB_1079062"	"unprognostic (1.29e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.69e-2)"	"unprognostic (1.27e-1)"	"unprognostic (3.31e-3)"	"unprognostic (1.19e-1)"	"unprognostic (2.18e-1)"	"unprognostic (3.85e-1)"	"unprognostic (7.68e-2)"	"unprognostic (1.86e-1)"	"unprognostic (5.95e-3)"	"unprognostic (4.86e-3)"	"prognostic favorable (7.68e-7)"	"unprognostic (3.40e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.37e-3)"	"unprognostic (1.73e-1)"	89.8	53.5	56.6	36.7	55.4	660.5	121.4	72.5	64.1	218.3	42.5	146.2	129.9	168.2	43.5	230.6	119.7	56.3	86.5	55.4	67.1	292.8	179.3	72.4	24.4	58.4	54.2	120.7	125.9	93.2	58.2	80.0	57.7	151.7	120.0	39.9	155.3	40.2	216.2	228.6	137.1	97.7	52.6	36.7	131.2	42.4	58.3	136.2	93.9	93.5	46.6	85.6	194.9	55.8	159.6	67.9	206.0	91.8	53.4	48.4	291.6	126.9	262.3	362.6	512.6	278.1	247.3	0.2	31.1	106.3	84.1	303.8	0.0	87.2	256.0	0.9	15.3	268.2	25.3	187.4	185.8	0.1	0.7	45.4	152.4	182.3	203.2	4.0	97.8	60.4	0.1	0.5	28.5	263.3	45.4	26.5	80.2	662.8	329.9	74.6	122.6	56.1	58.0	42.7	47.3	263.9	349.9	235.4	473.9	91.8	184.2	167.1	65.4	27.4	823.3	122.7	25.9	0.7	18.5	1.2	33.5	95.9	80.3	17.1	9.9	15.7	0.1	11.7	0.1	0.0	1.0	0.2	8.1	0.1	2.8	0.4	5.4	0.1	10.3	7.4	0.2	6.9	56.6	55.4	72.5	64.1	55.4	67.1	58.4	54.2	57.7	52.6	58.3	55.8	19.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	51.4	0.0	0.0	0.0	0.0	42.9	0.2	0.0	0.0	0.0	0.0	0.0	0.0	12.6	0.0	0.0	0.0	0.0	125.7	25.2	0.0	0.0	0.0	0.0	0.0	0.0	73.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.5	0.0	0.0	0.0	0.0	219.7	0.0	0.0	0.0	0.0
H1-1	"H1.1, H1a, H1F1, HIST1H1A"	ENSG00000124610	"H1.1 linker histone, cluster member"	Q02539	6	26017032-26017787	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	7	"brain: 1.0"	"Group enriched"	"Detected in some"	4	"Cardiomyocytes: 3.3;Cytotrophoblasts: 1.2;Extravillous trophoblasts: 4.2;Hofbauer cells: 2.0"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"hypothalamus: 1.0"	"Immune cell enhanced"	"Detected in single"		"T-reg: 1.7"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in single"		"REH: 1.0"	"Not detected"	"Not detected"							"HPA043753, HPA056830"	Enhanced		Supported	Nucleoplasm		NA	Yes			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 65: Brain - Ion transport"	"Cluster 14: REH - Unknown function"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm		"HPA043753: AB_2678654, HPA056830: "		"unprognostic (3.80e-1)"					"unprognostic (1.82e-1)"			"unprognostic (1.15e-1)"				"unprognostic (1.96e-1)"	"unprognostic (1.21e-1)"	"unprognostic (3.05e-1)"		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.8	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.4	0.8	0.1	0.2	0.0	0.5	0.0	0.0	0.0	0.0	0.3	1.7	0.1	0.0	0.0	0.0	0.4	0.2	1.0	0.1	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	1.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	4.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.0	0.0
H1-2	"H1.2, H1c, H1F2, H1s-1, HIST1H1C"	ENSG00000187837	"H1.2 linker histone, cluster member"	P16403	6	26055740-26056470	"Plasma proteins, Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 49.3;Cytotrophoblasts: 42.7;Extravillous trophoblasts: 68.1;Hofbauer cells: 75.5;Syncytiotrophoblasts: 298.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"basophil: 258.6;eosinophil: 458.7;neutrophil: 229.3"	"Lineage enriched"	"Detected in all"	6	"granulocytes: 458.7"	"Cell line enhanced"	"Detected in many"		"K-562: 334.2;SiHa: 311.1;U-2 OS: 601.6;U-266/70: 673.7;U-266/84: 661.8"	"Low region specificity"	"Detected in all"							"CAB011507, HPA055907"	Supported		Supported	"Nucleoplasm,Nucleoli rim"		NA	NA		5500000	"Cluster 2: Granulocytes - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 16: U-266 - Nucleosome"	"Cluster 24: Non-specific - Transcription regulation"	"Nucleoplasm, Nucleoli rim"		"CAB011507: AB_2117984, HPA055907: AB_2682966"	"unprognostic (4.43e-2)"	"unprognostic (1.57e-3)"	"unprognostic (1.31e-2)"	"unprognostic (2.96e-2)"	"unprognostic (5.47e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.07e-1)"	"prognostic unfavorable (1.12e-4)"	"unprognostic (1.45e-1)"	"prognostic unfavorable (1.56e-4)"	"unprognostic (1.85e-1)"	"unprognostic (8.93e-2)"	"unprognostic (3.08e-1)"	"prognostic favorable (8.06e-5)"	72.2	47.6	67.1	27.2	55.3	229.5	71.7	148.8	64.2	116.1	84.5	54.5	33.6	14.6	42.0	70.3	41.3	18.9	154.7	51.1	60.1	236.3	130.0	60.5	31.5	64.6	70.4	89.4	60.5	8.7	15.2	43.8	56.7	132.9	44.2	22.0	39.8	16.4	227.4	65.0	42.8	7.9	57.4	56.6	73.4	26.8	71.4	62.0	59.7	99.1	27.8	29.5	90.6	76.7	39.9	27.5	20.5	21.9	49.9	10.0	0.7	19.5	30.8	87.9	92.6	14.9	28.1	3.1	109.6	25.6	32.8	17.3	6.4	15.0	24.3	38.7	23.4	16.5	27.8	17.5	14.7	7.8	38.4	70.4	19.9	11.5	19.2	27.3	13.8	17.6	334.2	243.3	43.7	17.3	20.8	18.3	11.5	96.3	41.4	10.8	9.5	129.1	52.8	28.1	52.6	17.9	311.1	53.0	22.0	19.1	65.8	12.5	6.8	41.1	601.6	12.5	9.0	673.7	661.8	31.3	29.9	253.6	14.4	258.6	14.3	458.7	19.3	14.2	24.4	57.7	31.9	21.4	30.5	76.8	29.4	23.1	229.3	20.2	18.9	31.6	48.3	22.1	67.1	55.3	148.8	64.2	51.1	60.1	64.6	70.4	56.7	57.4	71.4	76.7	14.9	0.0	0.0	0.0	6.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	49.3	0.0	0.0	0.0	0.0	42.7	29.2	0.0	0.0	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.0	68.1	9.4	0.0	0.0	0.0	0.0	0.0	0.0	75.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.6	0.0	0.0	0.0	0.0	298.4	4.5	0.0	0.0	0.0
H1-4	"H1.4, H1e, H1F4, H1s-4, HIST1H1E"	ENSG00000168298	"H1.4 linker histone, cluster member"	P10412	6	26156329-26157115	"Disease related genes, Predicted intracellular proteins"		DNA-binding	"Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"bone marrow: 52.3;brain: 53.8"	"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 11.2;Cytotrophoblasts: 8.0;dendritic cells: 18.6;Extravillous trophoblasts: 11.3;Hofbauer cells: 7.7;Plasma cells: 6.7;Syncytiotrophoblasts: 7.3"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"cerebellum: 53.8"	"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"RPMI-8226: 10.5;U-266/70: 12.5;U-266/84: 15.1;U-87 MG: 12.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011506, HPA055907"	Supported		Supported	"Nuclear speckles"		NA	Yes		8300000	"Cluster 6: Non-specific - Transcription"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 16: U-266 - Nucleosome"	"Cluster 24: Non-specific - Transcription regulation"	"Nuclear speckles"		"CAB011506: AB_470256, HPA055907: AB_2682966"	"unprognostic (6.96e-2)"	"unprognostic (1.25e-1)"	"unprognostic (3.06e-2)"	"unprognostic (1.86e-1)"	"unprognostic (9.62e-2)"	"unprognostic (1.04e-2)"	"unprognostic (5.78e-3)"	"unprognostic (2.31e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.37e-1)"	"unprognostic (7.72e-13)"	"unprognostic (4.54e-3)"	"unprognostic (3.46e-2)"	"unprognostic (1.30e-3)"	"unprognostic (2.18e-2)"	1.7	0.3	0.4	0.3	2.4	52.3	2.7	53.8	26.5	3.2	7.3	1.7	0.3	0.5	0.3	1.2	0.7	0.4	0.6	2.8	11.7	2.1	1.1	1.2	2.5	11.8	0.0	1.8	1.8	0.3	1.9	0.9	3.2	2.5	0.4	0.0	3.0	0.2	0.4	4.1	2.7	0.1	5.0	1.4	1.4	1.4	5.5	2.7	0.9	0.1	0.5	0.9	2.8	11.4	2.6	0.3	0.5	5.5	0.1	0.0	6.6	0.0	0.4	1.2	0.9	0.1	1.6	1.3	0.7	0.1	0.5	1.2	0.3	0.7	0.5	1.8	1.6	0.9	0.5	0.4	0.1	0.8	1.1	0.1	0.3	0.3	0.6	0.1	0.5	1.4	4.4	7.0	0.2	0.5	8.6	7.8	2.0	0.8	0.8	4.0	1.3	10.5	0.3	0.0	4.0	0.9	3.3	0.8	1.2	0.6	1.1	2.8	0.5	2.5	3.8	1.5	2.6	12.5	15.1	6.1	12.6	2.3	1.2	257.4	43.0	106.3	66.4	42.1	76.6	73.6	52.1	61.6	49.0	119.6	39.4	37.1	60.4	70.7	39.5	48.6	56.9	31.4	0.4	2.4	53.8	26.5	2.8	11.7	11.8	0.0	3.2	5.0	5.5	11.4	3.6	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.2	0.0	0.0	0.0	0.0	8.0	18.6	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	11.3	2.5	0.0	0.0	0.0	0.0	0.0	0.0	7.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	7.3	1.8	0.0	0.0	0.0
H1-5	"H1b, H1F5, H1s-3, HIST1H1B"	ENSG00000184357	"H1.5 linker histone, cluster member"	P16401	6	27866792-27867588	"Plasma proteins, Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"bone marrow: 7.8;brain: 4.6;choroid plexus: 4.1;lymphoid tissue: 2.1"	"Cell type enhanced"	"Detected in some"		"Cytotrophoblasts: 1.5;dendritic cells: 2.2;Extravillous trophoblasts: 4.7;Hofbauer cells: 3.3"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 4.6"	"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"B-cells: 10.3;dendritic cells: 12.1;T-cells: 3.3"	"Cell line enhanced"	"Detected in some"		"MOLT-4: 9.2;NB-4: 4.9;U-698: 3.9"	"Not detected"	"Not detected"							"CAB012241, HPA055907, HPA060331"	Supported		Supported	Nucleoplasm		NA	NA		2300000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm		"CAB012241: , HPA055907: AB_2682966, HPA060331: "	"unprognostic (2.34e-1)"	"unprognostic (3.75e-4)"	"unprognostic (2.12e-2)"	"unprognostic (3.63e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.37e-2)"	"unprognostic (1.91e-2)"	"unprognostic (4.93e-2)"	"unprognostic (1.20e-1)"	"unprognostic (8.47e-2)"	"unprognostic (6.23e-3)"	"unprognostic (5.85e-2)"		"unprognostic (5.68e-4)"	"unprognostic (2.10e-1)"	"unprognostic (9.79e-2)"	"unprognostic (1.35e-1)"	0.1	0.0	1.5	0.2	0.9	7.8	0.1	4.0	1.0	0.0	4.1	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.5	1.2	0.0	0.0	0.1	1.6	1.8	2.3	0.0	0.0	0.0	0.0	0.3	3.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.7	0.0	1.5	0.4	0.1	0.1	3.8	2.1	0.0	0.0	0.3	0.3	0.0	4.6	1.4	0.0	0.5	0.0	0.0	0.0	1.0	0.4	0.3	0.7	0.3	0.4	0.9	1.7	0.2	0.5	0.4	0.5	0.0	0.0	0.0	0.6	0.8	2.2	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.7	0.0	0.0	0.5	1.1	1.7	1.2	0.0	0.2	9.2	4.9	1.4	1.3	0.0	2.7	0.0	0.0	0.2	0.0	1.2	0.6	1.5	0.3	0.0	0.4	0.6	1.6	0.5	0.8	0.1	0.8	0.6	1.8	0.0	3.9	1.2	0.6	0.8	0.0	0.9	0.0	3.1	0.8	1.5	4.6	2.9	3.2	5.1	10.3	1.7	1.9	0.8	1.7	1.1	12.1	3.3	2.1	1.5	0.9	4.0	1.0	0.5	1.2	1.8	2.3	3.0	1.5	3.8	4.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.5	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	4.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.2	0.0	0.0	0.0
H2AC21	HIST2H2AB	ENSG00000184270	"H2A clustered histone 21"	Q8IUE6	1	149887469-149887965	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"brain: 15.3"	"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in some"			"Region enhanced"	"Detected in many"		"cerebellum: 15.3"	"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"MOLT-4: 3.3;NB-4: 1.9;U-266/70: 1.6;U-266/84: 1.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB011483, HPA041189"	Supported		Supported	Nucleoplasm		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 24: NB-4 - Immune response"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm		"CAB011483: AB_732909, HPA041189: AB_2677357"	"unprognostic (6.31e-2)"	"unprognostic (6.63e-2)"	"unprognostic (2.22e-2)"	"unprognostic (2.31e-1)"	"unprognostic (3.09e-1)"	"unprognostic (3.34e-1)"	"unprognostic (2.42e-3)"	"unprognostic (1.99e-1)"	"unprognostic (1.53e-1)"	"unprognostic (2.03e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.69e-1)"		"unprognostic (9.97e-3)"	"unprognostic (5.33e-2)"	"unprognostic (2.00e-2)"	"unprognostic (4.36e-2)"	0.2	0.1	3.3	0.0	4.6	3.4	0.3	15.3	3.0	0.4	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.7	3.0	0.1	0.1	0.2	0.0	0.5	1.3	0.3	0.1	0.0	0.0	0.0	1.0	0.1	0.0	0.0	0.1	0.0	0.2	0.6	0.5	0.0	1.5	0.3	0.1	0.1	2.3	0.3	0.1	0.0	0.0	0.1	0.2	3.7	0.5	0.0	0.2	0.2	0.0	0.0	0.4	0.3	0.0	0.0	0.4	0.0	0.3	0.4	0.2	0.0	0.0	0.4	0.3	0.0	0.0	0.1	0.7	0.2	0.4	0.2	0.0	0.0	0.5	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.4	0.3	0.2	0.0	3.3	1.9	0.4	0.3	0.5	0.7	0.2	0.7	0.0	0.1	0.6	0.4	0.8	0.0	0.1	0.0	0.2	1.4	0.0	0.3	1.2	0.0	0.3	1.6	1.9	0.5	0.6	0.1	0.2	1.5	1.9	0.8	2.2	1.7	2.0	3.7	3.7	3.3	2.1	6.6	2.3	2.5	9.8	3.6	2.0	4.0	2.0	0.5	3.3	4.6	15.3	3.0	1.7	3.0	0.5	1.3	1.0	1.5	2.3	3.7	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
H2AC8	"H2A.1, H2A/a, H2AFA, HIST1H2AE"	ENSG00000277075	"H2A clustered histone 8"	P04908	6	26216975-26217483	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 41.2;breast: 40.7"	"Group enriched"	"Detected in some"	9	"Cytotrophoblasts: 6.5;Extravillous trophoblasts: 5.5;Hofbauer cells: 18.0;Syncytiotrophoblasts: 13.8"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 40.9"	"Group enriched"	"Detected in all"	5	"cerebellum: 41.2;white matter: 17.5"	"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-266/70: 37.0"									"CAB012242, HPA041189"	Supported		Supported	Nucleoplasm		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 50: Non-specific - Ribosome"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm		"CAB012242: AB_470265, HPA041189: AB_2677357"	"unprognostic (4.26e-2)"	"unprognostic (1.55e-2)"	"unprognostic (4.66e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.45e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.48e-2)"	"unprognostic (7.22e-2)"	"unprognostic (1.24e-2)"	"unprognostic (6.99e-2)"	"unprognostic (1.21e-3)"	"unprognostic (1.30e-2)"	"unprognostic (7.64e-2)"	"unprognostic (1.15e-1)"	"unprognostic (2.41e-1)"	"unprognostic (2.20e-1)"	"unprognostic (9.36e-2)"	4.3	2.4	2.1	1.6	5.6	19.3	40.7	41.2	6.0	14.7	4.6	7.9	3.6	1.6	16.7	8.6	7.8	1.8	4.2	5.1	3.7	11.6	5.7	7.9	2.9	2.3	1.1	6.8	1.0	0.4	3.4	1.6	3.7	32.9	2.1	1.5	4.7	1.2	0.2	16.5	4.6	0.6	1.7	9.5	5.2	4.3	3.3	9.4	5.8	0.1	0.8	2.2	17.4	17.5	4.1	0.0	3.0	0.0	4.9	0.9	0.8	1.3	2.0	4.3	2.9	2.0	3.3	0.2	10.8	0.4	3.9	3.4	1.5	2.0	1.7	4.5	3.7	2.7	5.9	2.6	0.9	0.3	4.1	8.4	0.9	1.8	0.2	1.2	2.1	0.8	11.4	2.9	0.4	7.5	9.3	7.9	3.5	14.1	3.7	7.3	2.4	14.7	1.8	2.3	11.9	5.0	10.9	3.7	2.4	2.0	14.9	4.1	0.0	0.2	0.8	1.8	1.8	37.0	0.0	0.0	1.5	5.5	2.7	18.2	2.2	8.2	2.8	2.6	4.1	4.7	3.3	4.6	5.9	6.0	1.7	2.3	10.1	4.5	1.6	17.6	4.4	10.4	2.1	5.6	41.2	6.0	5.1	3.7	2.3	1.1	3.7	1.7	3.3	17.5	0.6	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	6.5	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	5.5	0.4	0.0	0.0	0.0	0.0	0.0	0.0	18.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.8	0.2	0.0	0.0	0.0
H2AX	H2AFX	ENSG00000188486	"H2A.X variant histone"	P16104	11	119093854-119095467	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, DNA damage, DNA recombination, DNA repair, Host-virus interaction, Meiosis"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Adipocytes: 43.7;Cytotrophoblasts: 83.2;dendritic cells: 34.0;Extravillous trophoblasts: 106.6;Hofbauer cells: 45.8;Syncytiotrophoblasts: 64.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012264, HPA041189, HPA051647"	Supported		Supported	"Nucleoplasm,Nuclear speckles"		Yes	Yes			"Cluster 52: Eosinophils - Transcription"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm	"Nuclear speckles"	"CAB012264: AB_297215, HPA041189: AB_2677357, HPA051647: AB_2681563"	"unprognostic (1.44e-1)"	"unprognostic (1.96e-1)"	"unprognostic (6.46e-2)"	"unprognostic (6.41e-2)"	"unprognostic (3.07e-1)"	"unprognostic (3.25e-1)"	"prognostic unfavorable (1.51e-4)"	"unprognostic (2.32e-3)"	"unprognostic (1.93e-1)"	"unprognostic (3.07e-3)"	"unprognostic (6.78e-2)"	"unprognostic (9.31e-2)"	"prognostic unfavorable (5.47e-9)"	"unprognostic (1.21e-3)"	"unprognostic (1.20e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.99e-2)"	13.2	20.7	35.2	12.6	37.8	24.9	8.0	39.0	42.2	13.3	20.6	18.6	13.3	14.0	2.1	43.6	13.1	3.1	13.4	33.7	32.3	17.0	13.9	14.3	16.0	43.9	38.9	18.7	11.6	3.4	24.3	11.0	37.8	15.7	4.3	6.6	11.4	4.7	12.4	18.1	18.8	3.5	38.0	24.0	16.1	15.4	37.8	30.5	10.4	3.6	12.0	11.8	15.7	51.8	132.1	77.9	120.3	72.3	10.9	7.9	126.4	146.0	44.0	80.3	70.4	124.0	55.1	89.7	85.9	34.0	60.5	134.0	57.5	41.7	21.5	133.4	161.0	182.2	20.7	129.8	11.4	90.5	108.9	6.7	9.0	34.2	21.0	13.1	40.7	115.4	149.9	143.1	38.9	335.6	207.8	269.9	87.5	60.0	162.6	200.7	141.6	42.7	37.5	56.3	127.6	152.0	116.0	66.6	20.6	20.6	99.8	68.2	50.9	77.7	204.2	63.8	110.2	38.7	40.8	92.3	17.9	145.2	155.0	3.8	1.3	4.2	1.6	0.6	0.8	0.9	1.7	1.7	1.8	0.8	1.1	1.0	0.6	2.2	0.8	0.8	1.6	1.2	35.2	37.8	39.0	42.2	33.7	32.3	43.9	38.9	37.8	38.0	37.8	51.8	43.7	0.0	0.0	0.0	7.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.2	0.0	0.0	0.0	0.0	83.2	34.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	106.6	9.4	0.0	0.0	0.0	0.0	0.0	0.0	45.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.2	0.0	0.0	0.0	0.0	64.2	7.2	0.0	0.0	0.0
H2AZ1	"H2A.Z, H2AFZ, H2AZ"	ENSG00000164032	"H2A.Z variant histone 1"	P0C0S5	4	99948086-99950355	"Plasma proteins, Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 621.6"	"Cell type enhanced"	"Detected in some"		"Adipocytes: 211.4;Cytotrophoblasts: 625.4;Extravillous trophoblasts: 1438.5;Hofbauer cells: 711.2;Syncytiotrophoblasts: 403.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022549, HPA057236"	Supported		Supported	Nucleoplasm		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm		"CAB022549: , HPA057236: AB_2683377"	"unprognostic (1.21e-2)"	"unprognostic (2.97e-3)"	"unprognostic (1.03e-3)"	"unprognostic (7.60e-2)"	"unprognostic (1.97e-1)"	"unprognostic (8.74e-3)"	"prognostic unfavorable (1.02e-5)"	"unprognostic (2.29e-3)"	"unprognostic (1.98e-1)"	"unprognostic (4.99e-3)"	"unprognostic (9.70e-2)"	"unprognostic (1.05e-2)"	"prognostic unfavorable (2.16e-6)"	"unprognostic (3.02e-1)"	"unprognostic (1.33e-1)"	"unprognostic (6.34e-2)"	"unprognostic (1.52e-1)"	104.6	88.6	104.7	193.5	115.0	621.6	120.9	112.0	156.8	116.8	114.4	206.7	149.4	156.0	99.2	220.9	105.5	110.5	98.8	108.9	113.5	137.5	104.4	137.9	348.0	103.2	105.5	130.2	88.3	79.2	110.5	146.0	106.9	123.6	193.6	123.7	122.5	114.6	127.5	140.1	155.3	207.2	110.6	161.6	155.3	150.3	107.4	545.3	88.9	121.7	385.4	165.3	129.5	113.6	1249.7	864.3	1753.9	911.2	354.8	314.7	581.6	1287.6	930.7	1319.4	1229.9	897.5	1422.2	2205.2	451.5	666.0	862.3	442.9	1558.6	1268.1	1566.7	956.4	1088.7	1130.4	974.2	1029.1	212.4	2028.8	914.6	235.3	549.6	1004.5	561.1	369.3	1322.2	1313.0	1133.0	1293.1	1558.8	1751.0	1710.7	1697.0	1013.0	1402.9	822.1	1443.6	1279.6	928.0	741.0	750.1	1142.6	875.9	796.4	1507.4	1509.1	608.7	772.0	1550.7	686.7	841.6	1589.0	578.0	1674.1	736.1	1208.3	2671.0	939.8	1348.6	1342.7	780.2	689.8	1375.4	351.5	788.5	393.9	493.8	580.9	475.6	590.8	419.7	533.4	437.6	1482.5	453.8	1053.0	379.0	868.9	1555.4	104.7	115.0	112.0	156.8	108.9	113.5	103.2	105.5	106.9	110.6	107.4	113.6	211.4	0.0	0.0	0.0	35.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	130.2	0.0	0.0	0.0	0.0	625.4	147.1	0.0	0.0	0.0	0.0	0.0	0.0	49.0	0.0	0.0	0.0	0.0	1438.5	78.5	0.0	0.0	0.0	0.0	0.0	0.0	711.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	32.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	44.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	54.2	0.0	0.0	0.0	0.0	403.2	39.0	0.0	0.0	0.0
H2BW1	H2BFWT	ENSG00000123569	"H2B.W histone 1"	Q7Z2G1	X	104011147-104013687	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA056289, HPA060383"	Uncertain		Supported	Nucleoplasm		NA	NA							Nucleoplasm		"HPA056289: AB_2683087, HPA060383: "						"unprognostic (5.07e-2)"				"unprognostic (1.55e-1)"					"unprognostic (1.15e-1)"		"unprognostic (1.85e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
H3-3A	"H3.3A, H3F3, H3F3A"	ENSG00000163041	"H3.3 histone A"	P84243	1	226061851-226072019	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins"		DNA-binding	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Adipocytes: 600.6;Cytotrophoblasts: 1411.0;Extravillous trophoblasts: 2181.9;Hofbauer cells: 1487.3;Syncytiotrophoblasts: 1616.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 4487.2"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 4487.2"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB011481, CAB037178, HPA042570"	Supported		Supported	Nucleoplasm		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm		"CAB011481: AB_880446, CAB037178: AB_532248, HPA042570: AB_2678056"	"unprognostic (1.82e-1)"	"unprognostic (1.95e-2)"	"unprognostic (1.00e-1)"	"unprognostic (2.19e-3)"	"unprognostic (2.83e-2)"	"unprognostic (3.74e-1)"	"unprognostic (9.83e-3)"	"unprognostic (4.71e-2)"	"unprognostic (1.77e-3)"	"unprognostic (3.69e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.29e-1)"	"prognostic unfavorable (1.21e-6)"	"unprognostic (3.66e-2)"	"unprognostic (8.03e-3)"	"unprognostic (2.21e-3)"	"unprognostic (6.03e-2)"	409.6	440.4	240.3	662.2	255.8	2033.8	594.8	262.4	343.4	544.2	244.8	708.3	655.2	492.2	721.3	595.8	565.3	487.7	500.1	229.1	252.3	457.9	537.9	438.9	793.5	273.8	247.1	453.0	435.4	499.7	270.0	490.0	274.4	474.8	790.0	271.6	586.9	382.0	337.1	617.2	672.5	468.6	272.4	539.1	547.2	255.9	246.8	1239.6	480.5	435.5	894.6	597.6	409.0	295.7	751.2	417.0	1589.6	910.2	432.9	498.9	1186.2	337.3	416.2	547.8	429.0	446.2	1214.5	715.3	731.0	427.9	273.5	684.4	802.4	631.9	535.0	445.9	1371.0	889.5	569.9	595.2	427.8	901.4	1026.6	465.6	715.8	385.3	502.1	743.0	826.8	915.7	1271.3	1125.2	626.2	433.8	1791.8	1504.6	2163.0	1881.1	815.7	1286.9	1110.4	1871.4	1159.6	784.3	1542.1	2279.8	991.0	1227.4	842.4	882.3	1399.1	2103.7	471.4	397.1	527.2	532.6	1024.0	523.6	643.4	1178.4	380.2	853.2	874.1	869.5	1043.6	1486.1	378.9	830.2	385.9	722.1	405.2	415.8	791.8	661.7	375.0	423.1	4487.2	442.5	945.8	635.2	636.8	1364.8	240.3	255.8	262.4	343.4	229.1	252.3	273.8	247.1	274.4	272.4	246.8	295.7	600.6	0.0	0.0	0.0	202.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	38.2	0.0	0.0	0.0	0.0	1411.0	449.2	0.0	0.0	0.0	0.0	0.0	0.0	109.5	0.0	0.0	0.0	0.0	2181.9	188.0	0.0	0.0	0.0	0.0	0.0	0.0	1487.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	218.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	112.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	70.8	0.0	0.0	0.0	0.0	1616.9	75.3	0.0	0.0	0.0
H3-4	"H3.4, H3/g, H3FT, H3t, HIST3H3"	ENSG00000168148	"H3.4 histone"	Q16695	1	228424845-228425360	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	8	"brain: 1.6;choroid plexus: 1.1;testis: 3.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"CAB001386, CAB003812, HPA042570"	Approved		Supported	Nucleoplasm		NA	NA				"Cluster 78: Testis - Spermatogenesis"			Nucleoplasm		"CAB001386: , CAB003812: AB_365490, HPA042570: AB_2678056"	"unprognostic (4.45e-1)"				"unprognostic (4.66e-2)"			"unprognostic (1.36e-1)"		"unprognostic (3.78e-3)"	"unprognostic (1.75e-2)"		"unprognostic (4.04e-2)"	"unprognostic (1.39e-2)"			"unprognostic (2.26e-2)"	0.0	0.0	0.1	0.0	0.1	0.0	0.0	1.6	0.7	0.2	1.1	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.8	0.2	0.1	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	3.1	0.3	0.0	0.0	0.0	0.0	0.1	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	1.6	0.7	0.1	0.1	0.8	0.2	0.8	0.2	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
H4-16	"HIST4H4, MGC24116"	ENSG00000197837	"H4 histone 16"	P62805	12	14767999-14771131	"Disease related genes, Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 15.9"	"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 1.7;Cytotrophoblasts: 1.0;dendritic cells: 2.6;Hofbauer cells: 1.6;Syncytiotrophoblasts: 1.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	4	"neutrophil: 24.1"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 24.1"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 4.7;HeLa: 3.7"	"Low region specificity"	"Detected in all"							"CAB011503, CAB037279, HPA042201"	Supported		Supported	Nucleoplasm		NA	NA		25000000	"Cluster 1: Neutrophils - Mixed function"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm		"CAB011503: AB_873863, CAB037279: AB_1079064, HPA042201: AB_2677898"	"unprognostic (1.87e-1)"	"unprognostic (6.84e-2)"	"unprognostic (1.70e-2)"	"unprognostic (6.89e-2)"	"unprognostic (2.16e-2)"	"unprognostic (4.86e-2)"	"unprognostic (3.67e-2)"	"unprognostic (9.69e-3)"	"unprognostic (4.54e-2)"	"unprognostic (3.25e-2)"	"unprognostic (5.35e-2)"	"unprognostic (6.62e-3)"	"unprognostic (4.38e-2)"	"unprognostic (1.02e-2)"	"unprognostic (1.33e-3)"	"unprognostic (2.01e-1)"	"unprognostic (1.28e-3)"	0.4	1.0	4.5	1.2	12.0	0.6	0.9	3.8	6.0	2.0	2.9	0.7	1.2	0.8	1.8	2.2	1.5	1.4	0.8	1.9	12.1	0.7	0.4	0.8	1.5	6.4	5.9	1.2	1.2	0.2	0.5	1.7	4.2	4.3	1.2	1.2	1.4	0.9	0.5	1.7	1.0	0.6	5.4	1.9	2.7	1.7	15.9	1.4	1.7	0.0	1.2	0.8	1.1	4.9	1.3	0.5	0.0	1.5	1.6	0.0	0.9	0.8	0.0	0.6	0.5	0.8	4.7	1.2	0.3	0.4	0.0	0.8	0.0	0.6	0.3	1.5	0.6	0.0	3.7	1.2	0.4	0.3	1.1	1.1	0.3	0.1	0.6	0.0	0.0	0.4	0.0	1.5	0.0	0.6	0.3	0.4	1.6	0.4	0.2	1.3	0.0	2.3	0.0	3.4	0.5	0.8	3.1	0.8	0.2	0.3	0.5	0.6	1.0	0.2	2.4	0.6	1.0	1.6	1.1	3.6	1.1	0.0	0.8	0.0	2.5	0.3	2.3	2.4	4.1	5.3	2.7	2.6	2.7	5.7	2.4	2.8	24.1	3.0	1.0	4.6	4.0	1.6	4.5	12.0	3.8	6.0	1.9	12.1	6.4	5.9	4.2	5.4	15.9	4.9	0.8	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	1.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.4	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	1.6	0.4	0.0	0.0	0.0
HABP4	"IHABP4, SERBP1L"	ENSG00000130956	"Hyaluronan binding protein 4"	Q5JVS0	9	96450169-96491336	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing, Transcription, Transcription regulation, Translation regulation"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 73.3"	"Group enriched"	"Detected in many"	10	"Early spermatids: 224.6;Late spermatids: 808.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"B-cells: 1.9;T-cells: 1.6"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055969, HPA062366"	Enhanced		Supported	"Nuclear membrane,Cytosol"		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 25: Spermatids - Spermatogenesis"	"Nuclear membrane"	Cytosol	"HPA055969: AB_2682991, HPA062366: "	"unprognostic (1.67e-1)"	"unprognostic (7.99e-2)"	"unprognostic (2.12e-3)"	"unprognostic (2.40e-1)"	"unprognostic (1.77e-1)"	"unprognostic (5.91e-2)"	"unprognostic (1.36e-2)"	"unprognostic (3.63e-2)"	"unprognostic (3.49e-1)"	"unprognostic (2.42e-2)"	"unprognostic (1.75e-3)"	"unprognostic (1.36e-1)"	"prognostic favorable (1.10e-7)"	"unprognostic (2.25e-1)"	"unprognostic (1.40e-1)"	"unprognostic (4.93e-2)"	"unprognostic (3.62e-2)"	21.9	12.8	62.7	7.0	70.1	1.8	16.8	55.1	73.3	16.1	40.8	19.2	3.0	13.5	7.0	7.6	13.5	8.8	28.1	62.3	63.9	27.0	7.6	10.8	8.3	66.2	65.4	15.6	6.6	12.9	22.6	3.5	66.1	12.5	4.2	16.0	6.2	11.1	16.8	9.5	10.4	9.7	59.5	7.5	12.5	43.9	61.3	4.6	13.7	13.4	5.3	18.4	13.0	68.9	14.8	16.6	20.6	22.3	44.7	37.9	14.6	19.5	21.8	14.5	15.7	24.9	24.0	7.5	9.4	29.4	45.9	10.6	17.4	3.7	11.6	9.0	10.3	2.9	7.8	42.0	22.7	0.7	3.0	15.5	6.7	16.5	13.0	21.9	10.4	8.4	3.4	21.6	26.4	15.2	0.3	4.6	9.6	20.5	15.8	7.6	17.9	0.3	24.8	6.4	13.0	8.8	10.6	6.2	32.5	15.2	4.5	3.2	17.8	19.8	4.6	36.6	16.8	13.2	14.0	3.3	15.9	5.9	29.8	0.0	0.0	0.0	0.5	0.1	0.5	1.9	1.6	1.3	0.0	1.1	1.1	1.1	0.1	0.4	0.3	0.0	1.3	0.2	62.7	70.1	55.1	73.3	62.3	63.9	66.2	65.4	66.1	59.5	61.3	68.9	22.2	0.0	7.4	27.1	5.9	11.5	10.8	0.9	4.0	22.6	3.8	6.9	11.0	14.3	5.5	18.4	0.0	2.5	5.5	0.9	17.6	4.7	224.6	7.3	9.0	14.6	13.1	0.8	47.4	5.8	7.4	13.3	1.5	8.1	1.3	13.0	15.0	6.3	6.6	23.5	33.2	0.9	4.1	1.3	9.3	808.8	13.7	6.0	17.8	10.3	2.7	22.2	3.1	18.6	37.5	6.3	0.0	23.7	5.1	10.0	1.1	43.7	1.8	15.6	6.6	5.8	26.4	26.8	15.4	0.9	8.0	1.4	13.3	3.0	1.3	6.0
HACE1	KIAA1320	ENSG00000085382	"HECT domain and ankyrin repeat containing E3 ubiquitin protein ligase 1"	Q8IYU2	6	104728094-104859919	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, Transcription, Transcription regulation, Ubl conjugation pathway"	Transferase	"Disease variant, Hereditary spastic paraplegia, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 30.6"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 45.9;Excitatory neurons: 118.8;Inhibitory neurons: 84.2;Microglial cells: 45.9;Oligodendrocyte precursor cells: 64.3;Oligodendrocytes: 74.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046071			Supported	"Nuclear bodies,Endoplasmic reticulum"		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 28: Placenta - Pregnancy"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Endoplasmic reticulum"	"Nuclear bodies"	"HPA046071: AB_2679524"	"unprognostic (6.32e-2)"	"unprognostic (3.77e-2)"	"unprognostic (2.93e-2)"	"unprognostic (1.12e-2)"	"unprognostic (3.75e-2)"	"unprognostic (3.75e-3)"	"unprognostic (1.22e-3)"	"unprognostic (4.63e-2)"	"unprognostic (7.41e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.56e-2)"	"unprognostic (2.25e-1)"	"prognostic unfavorable (1.17e-5)"	"unprognostic (1.12e-2)"	"unprognostic (2.06e-1)"	"prognostic unfavorable (7.50e-4)"	"unprognostic (1.75e-1)"	3.7	3.2	2.7	2.2	4.4	2.9	3.1	5.0	4.8	3.9	0.4	2.6	2.1	3.9	1.1	5.3	3.3	3.1	3.3	3.1	2.5	6.2	1.6	3.6	2.2	1.9	2.6	3.8	1.9	7.2	1.5	30.6	2.3	3.7	1.8	11.5	2.9	4.1	2.2	2.5	2.1	4.0	1.4	2.5	2.4	10.4	3.1	3.9	4.5	4.1	2.4	3.3	2.9	5.8	3.9	2.7	11.3	14.3	6.6	8.8	13.3	7.7	11.9	4.8	7.2	2.5	2.3	2.2	3.4	5.9	8.1	2.6	2.8	5.3	10.0	9.1	7.2	7.7	2.5	3.4	6.6	6.8	2.5	5.9	4.7	6.2	5.2	6.3	8.0	9.2	7.6	2.4	9.6	2.8	5.1	4.1	5.0	2.9	2.6	8.0	12.8	0.9	3.8	6.6	6.1	9.1	4.2	4.3	2.3	7.3	2.7	9.2	8.5	3.9	3.2	10.5	7.4	3.5	4.1	7.6	4.0	6.4	7.1	0.0	0.6	0.7	1.2	1.0	1.3	0.9	1.1	1.1	0.6	0.8	1.2	0.9	0.1	0.8	0.5	0.8	0.4	0.5	2.7	4.4	5.0	4.8	3.1	2.5	1.9	2.6	2.3	1.4	3.1	5.8	11.6	3.2	1.1	42.4	5.1	4.7	2.3	2.3	5.2	11.6	5.3	3.7	6.7	1.5	3.9	5.5	45.9	10.6	4.1	1.5	1.9	1.6	6.2	2.7	6.2	12.9	1.8	3.0	118.8	1.5	5.4	7.1	5.6	3.4	1.3	7.1	4.2	2.6	5.7	16.8	84.2	2.0	0.0	4.1	2.4	4.6	6.2	3.5	1.8	45.9	4.3	6.1	8.2	64.3	74.6	1.4	2.9	3.8	3.7	1.6	3.8	5.7	2.6	31.7	6.6	6.4	6.6	13.2	3.5	5.3	4.7	6.3	6.2	2.9	1.9	1.9
HACL1	"2-HPCL, HPCL, PHYH2"	ENSG00000131373	"2-hydroxyacyl-CoA lyase 1"	Q9UJ83	3	15560699-15601852	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	Lyase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in all"	5	"basophil: 117.3"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 117.3"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035496, HPA035497, HPA073760"	Approved		Supported	Nucleoplasm,Vesicles		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Vesicles	Nucleoplasm	"HPA035496: AB_10601328, HPA035497: AB_2674653, HPA073760: AB_2686633"	"unprognostic (6.64e-3)"	"unprognostic (2.82e-2)"	"unprognostic (2.24e-3)"	"unprognostic (3.82e-1)"	"unprognostic (4.08e-2)"	"unprognostic (1.77e-1)"	"unprognostic (2.96e-2)"	"unprognostic (6.31e-2)"	"unprognostic (8.27e-3)"	"unprognostic (5.23e-2)"	"unprognostic (3.30e-2)"	"unprognostic (1.44e-1)"	"prognostic favorable (2.63e-5)"	"unprognostic (6.62e-2)"	"unprognostic (2.66e-1)"	"unprognostic (3.23e-2)"	"unprognostic (9.07e-2)"	14.4	12.0	7.5	8.2	7.8	11.6	14.6	10.4	10.5	9.1	7.9	10.0	56.6	8.3	16.6	7.5	10.8	8.8	11.0	7.6	7.0	26.0	51.8	9.7	14.1	7.4	7.2	7.5	15.2	20.0	7.8	7.8	7.0	10.8	12.0	12.2	9.1	9.1	17.6	10.6	27.7	9.5	7.4	11.4	13.2	26.7	6.8	13.9	20.4	10.6	14.5	10.3	6.4	10.0	15.1	28.6	8.2	30.7	13.4	12.4	82.3	14.2	22.0	26.6	26.3	27.3	14.3	14.6	9.7	18.7	10.5	10.4	18.7	25.3	23.8	13.6	36.4	25.4	17.7	24.7	20.3	30.5	23.1	13.7	16.2	37.9	16.6	8.3	31.4	18.3	24.0	21.2	22.9	28.7	14.0	12.6	19.7	19.7	29.7	14.4	21.5	19.6	26.4	20.2	9.6	12.3	22.4	19.0	25.2	12.8	8.5	25.4	22.5	14.1	14.6	17.4	24.7	27.2	50.9	28.5	27.1	26.4	17.2	117.3	16.0	18.3	14.4	20.1	21.2	15.4	15.5	18.0	16.0	21.2	14.8	16.1	3.4	24.1	24.2	10.2	19.8	13.0	7.5	7.8	10.4	10.5	7.6	7.0	7.4	7.2	7.0	7.4	6.8	10.0	12.4	9.6	17.3	34.9	22.1	10.3	12.0	13.5	20.5	19.3	9.1	10.2	6.4	14.3	15.6	11.0	29.2	27.2	15.7	6.1	13.7	16.0	66.6	12.6	6.0	12.3	9.1	8.2	67.4	25.2	18.0	12.0	11.2	5.4	13.3	12.7	8.9	24.3	13.2	13.5	55.8	7.5	10.2	9.3	8.1	56.8	23.3	8.8	12.4	25.3	19.3	24.8	8.2	40.7	38.8	14.5	11.2	15.4	21.4	9.0	41.9	39.7	29.8	38.3	6.6	9.0	11.2	51.1	24.4	8.6	7.1	18.9	19.4	15.1	10.6	7.9
HADH	"HADH1, HADHSC, SCHAD"	ENSG00000138796	"Hydroxyacyl-CoA dehydrogenase"	Q16836	4	107989714-108035174	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	"Oxidoreductase, Transferase"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"tongue: 280.3"	"Cell type enhanced"	"Detected in all"		"Hepatocytes: 272.4;Proximal enterocytes: 383.0;Proximal tubular cells: 318.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039588, HPA043888"	Enhanced		Supported	Mitochondria		No	Yes		1000000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"HPA039588: AB_10673425, HPA043888: AB_2678716"	"unprognostic (1.73e-1)"	"unprognostic (3.32e-3)"	"unprognostic (3.05e-3)"	"unprognostic (8.86e-3)"	"unprognostic (1.83e-1)"	"unprognostic (6.83e-2)"	"unprognostic (9.26e-3)"	"unprognostic (1.55e-2)"	"unprognostic (9.22e-2)"	"unprognostic (3.24e-2)"	"unprognostic (2.96e-1)"	"unprognostic (1.18e-2)"	"prognostic favorable (0.00e+0)"	"unprognostic (1.67e-1)"	"unprognostic (4.22e-2)"	"unprognostic (5.67e-2)"	"unprognostic (1.88e-2)"	143.0	54.1	23.2	20.9	23.8	27.4	74.9	24.6	26.3	37.9	33.5	101.2	84.4	49.8	24.9	34.2	56.2	24.0	175.6	22.9	27.2	140.2	225.5	22.8	22.2	24.7	26.3	54.3	42.1	40.2	18.0	13.7	26.0	35.4	90.8	10.4	55.9	42.4	249.7	28.0	89.1	72.7	26.0	18.0	60.7	27.9	24.9	76.0	37.7	280.3	28.5	34.1	28.7	28.0	32.2	27.9	64.3	46.2	149.2	48.2	27.0	43.1	68.5	49.6	48.9	21.2	60.9	185.0	23.5	38.8	34.6	42.0	85.5	64.5	55.5	49.6	37.2	39.9	50.5	48.9	24.3	88.2	17.0	50.4	34.1	35.1	32.3	41.4	34.4	127.1	53.1	98.7	57.3	58.9	163.6	36.7	29.0	147.8	30.1	113.5	84.3	89.2	54.5	129.4	73.2	43.1	41.1	161.9	45.6	37.0	77.4	70.8	20.6	35.5	18.9	48.5	26.7	52.1	63.3	80.6	47.0	60.2	27.0	0.0	11.1	11.4	17.2	14.2	22.1	31.4	19.5	20.7	36.8	27.1	22.4	22.2	1.2	36.7	20.1	41.7	17.7	16.3	23.2	23.8	24.6	26.3	22.9	27.2	24.7	26.3	26.0	26.0	24.9	28.0	17.3	28.9	33.8	11.1	25.7	15.6	54.2	65.8	41.5	6.9	46.5	56.1	225.6	52.9	48.1	35.0	4.2	41.0	18.3	164.7	160.4	43.3	196.8	41.4	22.6	17.5	32.4	65.6	15.1	32.2	44.7	28.2	52.5	26.1	10.8	63.9	21.0	272.4	116.5	6.7	18.9	93.3	36.7	37.8	11.8	108.5	46.3	25.3	21.4	12.2	15.3	26.8	8.2	9.5	9.9	23.0	100.8	35.3	32.0	33.9	383.0	318.8	70.8	6.8	39.5	21.7	38.2	22.4	20.3	64.0	18.2	17.0	19.6	66.3	194.2	49.1
HADHB	MTPB	ENSG00000138029	"Hydroxyacyl-CoA dehydrogenase trifunctional multienzyme complex subunit beta"	P55084	2	26243170-26290465	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	"Acyltransferase, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 793.3;skeletal muscle: 950.6;tongue: 1097.1"	"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 1167.5;Distal tubular cells: 520.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037539, HPA037540, HPA066099"	Enhanced		Supported	Mitochondria		No	No		61000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 54: Cardiomyocytes - Muscle contraction"	Mitochondria		"HPA037539: AB_10671374, HPA037540: AB_2675531, HPA066099: AB_2685618"	"unprognostic (5.15e-2)"	"unprognostic (8.72e-2)"	"unprognostic (8.21e-2)"	"unprognostic (8.67e-2)"	"unprognostic (7.70e-2)"	"unprognostic (2.59e-2)"	"unprognostic (7.29e-2)"	"unprognostic (9.70e-2)"	"unprognostic (2.01e-1)"	"unprognostic (2.09e-1)"	"unprognostic (2.03e-1)"	"unprognostic (8.94e-2)"	"prognostic favorable (1.37e-9)"	"unprognostic (2.47e-1)"	"unprognostic (2.50e-1)"	"unprognostic (2.88e-1)"	"unprognostic (9.68e-2)"	127.0	224.7	120.6	51.1	135.4	58.8	91.3	146.4	138.1	65.2	128.0	110.7	224.2	55.9	73.7	101.3	68.8	64.3	793.3	109.0	138.1	231.4	324.8	64.7	54.9	135.9	141.6	78.4	83.7	209.5	48.1	65.6	139.6	77.1	113.2	63.0	104.8	75.0	950.6	74.4	184.4	79.0	141.4	75.8	109.0	67.1	143.3	53.1	90.8	1097.1	62.5	89.2	64.1	152.8	108.2	83.2	56.6	102.2	342.1	190.1	57.9	89.0	134.6	89.0	86.8	100.5	101.7	53.9	60.8	145.3	100.1	82.8	95.2	124.8	109.2	121.1	83.1	123.6	44.9	194.2	145.9	100.6	90.0	183.7	201.6	92.7	149.0	151.0	168.2	81.0	105.2	83.9	189.5	78.0	57.1	190.7	39.8	160.2	89.0	61.7	188.3	103.2	183.3	148.9	27.2	93.7	151.7	169.8	239.5	68.5	105.4	177.9	118.0	83.5	86.9	79.3	65.1	62.6	101.1	94.7	95.5	158.4	84.4	95.7	168.1	66.4	45.2	150.3	57.6	65.5	61.3	56.6	154.2	49.7	55.8	51.3	72.7	88.2	123.3	51.8	94.7	135.6	120.6	135.4	146.4	138.1	109.0	138.1	135.9	141.6	139.6	141.4	143.3	152.8	106.5	48.1	36.5	63.0	48.3	62.1	136.5	183.3	49.5	29.3	49.5	52.3	1167.5	104.4	107.7	97.5	56.3	227.9	42.4	129.5	520.4	124.0	93.4	59.5	49.0	75.2	74.9	85.2	32.7	57.2	75.2	79.5	53.0	60.2	62.8	94.2	69.9	277.6	139.6	13.5	33.0	93.4	114.0	98.1	67.4	99.7	56.5	78.1	88.9	27.2	110.2	65.0	32.0	35.2	47.5	58.4	134.8	62.8	37.1	60.5	376.0	321.1	73.5	80.0	72.3	72.9	80.7	120.4	49.4	53.8	54.7	186.6	45.2	194.0	113.5	110.3
HAO2	"GIG16, HAOX2"	ENSG00000116882	"Hydroxyacid oxidase 2"	Q9NYQ3	1	119368779-119394130	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	16	"kidney: 303.7;liver: 425.6"	"Group enriched"	"Detected in some"	7	"Hepatocytes: 256.8;Proximal tubular cells: 450.1"	"Group enriched"	"Detected in some"	26	"liver cancer: 25.6;renal cancer: 11.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA050355			Uncertain	Vesicles,Cytosol		NA	NA				"Cluster 81: Kidney & Liver - Metabolism"		"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Cytosol	Vesicles	"HPA050355: "	"unprognostic (1.13e-1)"	"unprognostic (1.68e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.00e-1)"	"unprognostic (6.22e-2)"	"unprognostic (5.33e-3)"	"unprognostic (2.80e-2)"	"unprognostic (3.27e-1)"	"unprognostic (3.15e-1)"	"unprognostic (3.17e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.73e-1)"	"prognostic favorable (4.92e-4)"	"unprognostic (9.66e-2)"	"unprognostic (1.79e-1)"	"unprognostic (2.89e-2)"	"unprognostic (5.14e-4)"	0.0	0.6	0.2	0.1	0.6	0.0	0.6	0.1	0.6	0.0	0.0	0.2	0.1	0.0	0.2	0.0	0.0	0.0	0.1	0.2	0.0	303.7	425.6	0.0	0.3	0.2	0.0	0.0	0.1	0.0	0.0	0.3	0.2	0.1	0.1	0.0	0.0	0.0	0.0	4.4	0.1	0.0	0.1	0.4	0.2	0.1	0.3	23.3	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.3	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.6	0.1	0.6	0.2	0.0	0.2	0.0	0.2	0.1	0.3	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	5.7	0.0	11.0	0.0	0.0	0.0	0.0	49.0	0.0	0.0	0.0	0.0	0.6	0.0	13.5	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.1	4.2	256.8	0.1	0.0	0.1	0.0	0.0	6.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	450.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.3	0.1	0.0	0.0
HAP1	"HAP2, hHLP1, HIP5, HLP"	ENSG00000173805	"Huntingtin associated protein 1"	P54257	17	41717742-41734644	"Predicted intracellular proteins"	"Autophagy, Cilium biogenesis/degradation, Exocytosis, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 68.4"	"Cell type enriched"	"Detected in many"	4	"Glandular and luminal cells: 66.5"	"Cancer enhanced"	"Detected in many"		"glioma: 6.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"REH: 96.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA023394, HPA076992"	Enhanced		Supported	Nucleoli,Cytosol		NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 14: REH - Unknown function"	"Cluster 44: Endometrium - Transcription"	Cytosol	Nucleoli	"HPA023394: AB_1850492, HPA076992: AB_2686822"	"unprognostic (2.84e-3)"	"unprognostic (3.74e-3)"	"unprognostic (2.42e-2)"	"unprognostic (2.30e-1)"	"unprognostic (7.53e-2)"	"unprognostic (4.90e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.32e-1)"	"unprognostic (6.11e-2)"	"unprognostic (8.76e-2)"	"prognostic favorable (4.26e-4)"	"unprognostic (1.38e-1)"	"unprognostic (2.46e-2)"	"unprognostic (1.70e-1)"	"unprognostic (3.17e-1)"	"unprognostic (1.99e-2)"	"unprognostic (9.29e-2)"	0.6	1.5	24.8	0.3	18.9	0.1	1.0	14.8	21.6	14.5	10.2	2.1	2.7	3.4	1.6	1.1	2.6	1.5	0.1	18.3	58.8	3.3	0.4	0.9	0.2	26.7	26.4	1.2	1.0	0.0	11.6	1.5	24.5	1.9	0.5	0.8	1.5	1.3	0.2	1.6	1.5	0.6	20.3	3.5	11.0	2.1	68.4	2.8	5.0	0.1	0.2	0.5	1.9	16.8	0.2	3.1	1.4	3.1	0.0	0.0	0.3	0.3	0.1	0.6	0.1	1.9	0.2	0.2	1.1	0.2	0.5	13.1	6.7	0.5	0.0	0.0	3.4	0.0	1.8	0.1	0.3	0.0	0.6	0.0	1.6	0.1	0.7	0.2	0.0	0.0	0.0	0.1	0.0	1.5	0.1	0.2	1.6	18.7	0.8	96.0	0.0	3.7	0.6	1.0	0.4	0.1	0.7	0.4	0.1	1.5	2.4	0.0	0.0	0.0	1.3	0.1	0.1	0.2	0.0	0.0	0.2	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.3	0.2	0.1	0.1	0.1	0.0	24.8	18.9	14.8	21.6	18.3	58.8	26.7	26.4	24.5	20.3	68.4	16.8	1.1	0.0	1.7	3.3	0.3	3.1	7.3	1.0	6.8	1.6	1.6	6.7	3.6	0.0	1.9	0.0	2.1	1.5	0.5	1.1	0.0	0.3	0.5	11.5	7.6	3.2	0.0	0.0	1.0	0.9	0.7	3.4	7.7	66.5	0.0	0.2	1.4	0.8	0.5	0.0	5.4	0.6	4.1	0.6	2.2	0.6	0.3	1.2	0.0	0.0	0.4	0.6	2.1	14.6	0.3	1.5	0.2	0.7	0.3	5.3	0.2	0.2	1.7	1.8	0.0	10.6	2.3	0.1	4.7	8.4	3.1	15.7	0.9	0.1	1.1	3.5
HAPLN1	CRTL1	ENSG00000145681	"Hyaluronan and proteoglycan link protein 1"	P10915	5	83637805-83720855	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"placenta: 75.0"	"Cell type enhanced"	"Detected in some"		"Fibroblasts: 146.7;Granulosa cells: 43.2;Inhibitory neurons: 35.6;Syncytiotrophoblasts: 23.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	33	"PC-3: 152.4;SuSa: 70.1;TIME: 91.8;U-2 OS: 139.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019105, HPA019482, HPA025238"	Enhanced	Approved	Supported	Vesicles	"Secreted to extracellular matrix"	NA	NA				"Cluster 28: Placenta - Pregnancy"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 33: Fibroblasts - ECM organization"	Vesicles		"HPA019105: AB_1850496, HPA019482: AB_1850498, HPA025238: "	"unprognostic (5.74e-4)"	"unprognostic (2.94e-2)"	"unprognostic (6.58e-3)"	"unprognostic (2.30e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.76e-3)"	"unprognostic (6.01e-4)"	"unprognostic (2.52e-2)"	"unprognostic (1.70e-1)"	"unprognostic (9.04e-3)"	"unprognostic (1.31e-1)"	"unprognostic (2.28e-2)"	"prognostic unfavorable (4.81e-9)"	"unprognostic (6.87e-2)"	"unprognostic (2.04e-1)"	"unprognostic (8.62e-2)"	"unprognostic (3.91e-2)"	0.1	0.0	0.3	0.8	0.7	0.0	0.1	1.1	0.9	0.1	0.0	9.0	7.2	0.6	0.3	2.1	0.0	0.8	3.9	0.6	2.7	0.1	0.0	0.5	0.0	0.9	1.0	0.5	0.5	0.2	0.0	75.0	0.6	0.9	11.1	0.1	0.5	0.0	0.0	0.3	10.8	0.5	0.3	0.2	4.8	0.0	0.0	0.0	0.2	0.0	0.0	2.1	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.2	2.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.9	0.2	0.0	3.4	0.0	152.4	0.2	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.3	0.0	70.1	0.1	0.0	91.8	0.0	139.4	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.7	1.1	0.9	0.6	2.7	0.9	1.0	0.6	0.3	0.0	0.3	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	9.2	0.0	0.2	0.0	0.0	0.0	0.1	0.5	6.9	0.0	0.0	0.5	0.0	10.6	146.7	0.0	0.1	0.0	43.2	0.0	0.0	10.6	0.0	35.6	2.6	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	6.6	0.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	23.7	0.1	3.8	0.4	0.0
HARS2	"HARSL, HARSR, HO3"	ENSG00000112855	"Histidyl-tRNA synthetase 2, mitochondrial"	P49590	5	140691430-140699305	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase"	"Deafness, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035941, HPA075303"	Approved		Approved	Mitochondria	"Intracellular and membrane"	NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 59: Non-specific - Translation"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 59: Non-specific - Transcription"	Mitochondria		"HPA035941: AB_10671237, HPA075303: "	"prognostic unfavorable (6.49e-4)"	"unprognostic (3.15e-2)"	"prognostic favorable (6.19e-4)"	"unprognostic (1.79e-2)"	"unprognostic (1.78e-1)"	"unprognostic (8.30e-3)"	"prognostic unfavorable (2.92e-4)"	"unprognostic (7.77e-2)"	"unprognostic (1.88e-1)"	"unprognostic (5.26e-2)"	"unprognostic (1.58e-1)"	"unprognostic (2.68e-2)"	"unprognostic (1.85e-1)"	"unprognostic (5.40e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.49e-1)"	"unprognostic (1.31e-2)"	19.6	24.6	14.0	13.8	14.2	14.4	18.9	13.7	14.2	22.0	16.8	23.5	16.6	19.5	15.0	20.0	18.4	9.8	27.9	14.0	14.2	23.3	19.3	16.0	15.1	14.1	14.0	21.1	15.6	20.8	20.8	14.2	14.4	20.2	22.3	11.5	17.5	13.4	35.0	21.1	20.9	14.0	13.8	26.9	20.4	14.8	14.3	15.2	19.0	28.4	16.1	21.1	20.6	15.7	20.9	46.2	19.6	50.6	21.9	28.6	32.3	26.3	29.8	36.1	31.4	42.7	25.5	26.3	41.3	29.3	35.5	25.9	27.3	49.4	33.2	26.6	22.4	19.1	45.3	28.6	20.9	26.1	27.1	27.0	32.9	35.3	39.7	29.4	26.5	27.4	18.0	24.1	35.6	26.6	25.7	32.1	22.6	15.7	28.9	25.8	19.9	26.8	33.9	48.1	27.0	38.9	38.1	61.0	54.2	28.5	54.0	25.5	32.5	32.4	17.8	18.2	35.2	23.6	37.0	25.2	25.4	29.5	32.9	37.7	13.1	28.6	19.1	18.9	21.1	16.9	18.4	19.2	14.9	14.8	19.0	20.6	15.1	29.3	15.0	12.1	20.1	13.3	14.0	14.2	13.7	14.2	14.0	14.2	14.1	14.0	14.4	13.8	14.3	15.7	8.6	3.2	5.8	2.6	12.3	3.4	3.7	7.8	9.6	5.5	5.9	5.5	20.4	7.2	7.8	5.5	0.0	20.3	6.6	8.5	13.7	14.9	1.1	5.3	8.0	9.7	7.7	9.9	5.5	16.1	18.7	6.3	13.3	6.4	2.5	11.8	9.7	7.2	10.0	0.0	4.8	8.7	18.3	8.2	6.2	2.3	9.3	7.4	3.6	2.8	12.8	8.3	3.1	6.0	6.2	18.3	12.1	10.5	9.6	4.1	7.2	9.0	8.6	5.6	0.0	4.4	7.0	8.9	14.4	9.5	4.0	14.4	8.0	11.2	11.7	4.4
HAS1	HAS	ENSG00000105509	"Hyaluronan synthase 1"	Q92839	19	51713112-51723991	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 49.6;ovary: 20.8"	"Cell type enhanced"	"Detected in some"		"Basal keratinocytes: 26.6;Bipolar cells: 20.3;Cholangiocytes: 38.6;Fibroblasts: 64.2;Suprabasal keratinocytes: 17.8"	"Cancer enhanced"	"Detected in some"		"pancreatic cancer: 2.0"	"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in single"	4	"eosinophil: 2.5"	"Lineage enriched"	"Detected in single"	18	"granulocytes: 2.5"	"Cell line enriched"	"Detected in some"	4	"U-87 MG: 112.6"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA067602	Approved		Supported	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 50: Fibroblasts - ECM organization"	"Plasma membrane"	Nucleoplasm	"HPA067602: AB_2685871"	"unprognostic (3.56e-2)"	"unprognostic (1.19e-1)"	"unprognostic (4.43e-2)"	"unprognostic (5.26e-4)"	"unprognostic (7.17e-3)"	"unprognostic (7.05e-2)"	"unprognostic (1.02e-1)"	"unprognostic (5.49e-4)"	"unprognostic (4.80e-2)"	"unprognostic (1.99e-2)"	"unprognostic (8.43e-2)"	"unprognostic (1.72e-1)"	"unprognostic (2.30e-11)"	"unprognostic (9.12e-4)"	"unprognostic (8.99e-2)"	"unprognostic (3.73e-4)"	"unprognostic (2.43e-2)"	49.6	0.5	1.4	6.3	1.1	3.6	1.3	1.1	1.1	0.1	0.0	2.8	0.1	1.0	0.0	0.8	9.0	5.5	9.2	0.9	2.0	0.5	0.6	3.7	0.0	1.8	0.8	20.8	2.1	0.3	0.9	0.3	0.7	0.2	0.5	0.2	0.2	0.0	0.2	5.4	1.3	0.7	0.3	0.3	1.7	0.3	2.2	0.1	0.7	0.0	0.0	6.3	0.6	1.3	0.0	0.5	0.0	0.0	0.2	0.6	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.7	0.0	0.1	3.2	0.0	27.0	0.0	0.1	0.0	0.0	0.0	0.2	6.8	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.4	0.0	0.3	0.8	0.0	0.0	0.0	0.0	112.6	0.0	0.2	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	1.4	1.1	1.1	1.1	0.9	2.0	1.8	0.8	0.7	0.3	2.2	1.3	1.5	0.0	1.8	0.0	0.2	26.6	0.1	0.8	0.6	20.3	0.0	0.0	1.3	38.6	0.7	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.1	0.5	0.5	0.0	0.0	1.7	0.0	0.2	64.2	2.6	0.0	2.5	0.0	0.0	0.1	0.2	0.0	1.5	0.0	0.0	0.8	9.0	0.2	0.3	8.3	8.8	0.0	0.0	0.2	0.0	0.0	0.9	0.1	0.0	0.4	0.1	0.2	0.0	0.1	0.0	0.5	0.0	3.1	10.6	0.1	0.5	0.4	17.8	0.1	0.3	0.0	0.0	0.2
HASPIN	GSG2	ENSG00000177602	"Histone H3 associated protein kinase"	Q8TF76	17	3723903-3726699	"Enzymes, Predicted intracellular proteins"	"Cell cycle"	"Chromatin regulator, Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 6.0;lymphoid tissue: 5.3;testis: 7.3"	"Cell type enhanced"	"Detected in some"		"Cytotrophoblasts: 1.2;Extravillous trophoblasts: 3.3"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"							"HPA027422, HPA030698"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"HPA027422: AB_10601812, HPA030698: AB_2673575"	"unprognostic (1.15e-2)"	"unprognostic (2.78e-2)"	"unprognostic (7.06e-2)"	"unprognostic (2.14e-2)"	"unprognostic (8.05e-2)"	"unprognostic (2.81e-1)"	"unprognostic (1.01e-4)"	"unprognostic (1.57e-2)"	"unprognostic (6.60e-2)"	"unprognostic (1.77e-1)"	"unprognostic (2.75e-3)"	"unprognostic (3.82e-3)"	"unprognostic (0.00e+0)"	"unprognostic (5.65e-3)"	"unprognostic (3.09e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.73e-1)"	0.2	0.1	0.0	1.8	0.2	6.0	0.4	0.0	0.1	0.2	0.2	1.1	1.5	0.2	0.1	1.3	0.3	0.2	0.1	0.0	0.0	0.1	0.1	1.4	4.2	0.1	0.1	0.1	0.2	0.0	0.0	0.6	0.1	0.3	1.0	0.0	0.4	0.0	0.6	0.7	1.8	0.4	0.0	1.7	0.9	7.3	0.2	5.3	0.3	0.1	5.1	0.3	0.5	0.2	11.3	12.2	11.1	12.5	0.7	1.4	9.3	10.2	7.8	19.7	19.3	9.6	4.6	27.7	5.7	5.7	7.9	18.0	20.1	9.9	18.7	0.1	16.7	13.8	9.9	5.8	0.5	8.1	13.7	0.9	0.8	14.9	9.2	2.4	9.1	21.6	12.4	23.7	10.1	5.9	16.4	4.8	9.8	8.7	8.3	16.8	13.9	7.4	3.0	7.8	4.4	6.5	8.9	6.1	3.5	9.6	6.1	7.5	4.7	8.7	9.9	9.8	18.1	4.5	5.4	13.4	5.1	11.5	10.7	0.1	0.1	0.5	0.0	0.1	0.0	0.1	0.1	0.0	0.2	0.5	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.2	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	1.2	0.2	0.0	0.0	0.1	0.0	0.1	0.1	0.3	0.0	0.0	0.0	0.0	3.3	0.2	0.0	0.2	0.0	0.9	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0
HAT1	KAT1	ENSG00000128708	"Histone acetyltransferase 1"	O14929	2	171922448-171983686	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036788, CAB037191"	Supported		Supported	Nucleoplasm		NA	NA		27000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 52: Non-specific - Ribosome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Nucleoplasm		"CAB037191: AB_477070, HPA036788: AB_10672267"	"unprognostic (1.76e-1)"	"unprognostic (1.01e-2)"	"unprognostic (7.39e-3)"	"unprognostic (8.24e-3)"	"unprognostic (2.76e-1)"	"unprognostic (1.54e-1)"	"prognostic unfavorable (5.72e-5)"	"unprognostic (2.71e-2)"	"unprognostic (9.08e-3)"	"unprognostic (3.69e-2)"	"unprognostic (1.56e-2)"	"unprognostic (1.24e-1)"	"unprognostic (3.23e-2)"	"unprognostic (6.89e-2)"	"unprognostic (1.80e-1)"	"unprognostic (3.97e-2)"	"unprognostic (6.69e-2)"	27.7	27.0	14.3	33.5	15.5	59.8	41.4	15.9	19.2	26.8	15.3	27.7	19.9	24.6	16.7	26.6	24.4	24.6	31.4	13.1	16.2	32.2	30.2	25.7	48.7	15.0	14.6	23.2	30.0	37.9	16.9	30.6	15.5	29.0	30.7	28.8	32.8	24.0	67.7	23.8	21.7	29.3	16.1	27.7	23.6	20.1	15.5	50.7	32.8	50.8	47.5	39.0	19.6	17.3	132.4	61.5	106.6	98.8	55.2	56.8	75.2	133.9	88.9	144.4	149.9	144.3	88.2	147.0	85.0	81.5	122.7	101.3	116.7	109.5	220.5	83.5	115.8	131.1	91.5	131.0	26.7	165.5	77.9	34.2	62.2	191.0	63.6	45.5	92.6	100.4	136.5	93.1	166.5	91.8	131.1	148.3	89.0	158.9	63.9	102.8	134.4	99.4	85.3	130.2	67.8	55.4	112.4	62.4	118.1	81.5	86.4	164.5	47.5	129.8	99.2	109.5	137.1	40.9	100.5	173.8	87.6	117.8	113.8	47.6	35.3	53.7	32.8	42.0	40.6	35.5	34.9	34.0	27.4	30.7	33.9	37.6	40.3	44.6	59.2	14.3	49.2	34.0	14.3	15.5	15.9	19.2	13.1	16.2	15.0	14.6	15.5	16.1	15.5	17.3	55.6	35.3	28.9	13.7	49.7	74.2	117.7	129.7	46.1	24.2	36.4	42.3	49.5	25.8	66.2	27.6	33.3	77.5	43.5	19.0	82.2	45.2	70.3	33.1	32.3	43.2	14.3	103.1	28.6	46.5	83.1	43.7	15.8	28.9	40.6	30.7	28.9	20.1	51.8	28.6	45.3	20.9	111.9	29.5	36.3	14.7	30.7	34.5	32.0	16.9	28.8	53.4	43.3	21.6	28.0	27.8	21.0	36.9	50.8	52.0	18.2	46.0	65.4	42.0	39.5	43.8	51.3	65.7	67.5	28.8	52.7	58.3	49.0	43.9	29.4	64.1
HAUS1	"CCDC5, FLJ40084, HEI-C, HsT1461"	ENSG00000152240	"HAUS augmin like complex subunit 1"	Q96CS2	18	46104378-46128333	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Extravillous trophoblasts: 111.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040601, HPA040652"	Supported		Supported	Centrosome,Cytosol		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Cytosol	Centrosome	"HPA040601: AB_10794743, HPA040652: AB_10793966"	"unprognostic (1.74e-2)"	"unprognostic (1.89e-2)"	"unprognostic (8.13e-3)"	"unprognostic (1.92e-1)"	"unprognostic (2.29e-1)"	"unprognostic (1.47e-1)"	"prognostic unfavorable (2.45e-4)"	"unprognostic (1.39e-1)"	"unprognostic (4.76e-3)"	"prognostic favorable (1.55e-4)"	"unprognostic (3.75e-1)"	"prognostic unfavorable (6.76e-4)"	"unprognostic (5.97e-3)"	"unprognostic (5.40e-2)"	"unprognostic (9.79e-3)"	"unprognostic (3.66e-2)"	"unprognostic (7.96e-2)"	14.3	11.0	7.2	18.4	7.2	37.8	18.9	7.3	10.2	13.7	9.0	18.5	14.3	17.0	38.7	14.5	13.4	16.9	11.8	7.0	7.8	13.0	13.7	12.2	35.6	7.5	7.6	26.4	11.4	14.3	10.7	17.8	7.8	10.4	22.1	9.5	10.5	12.9	7.2	10.1	14.3	16.8	8.0	14.6	13.0	16.2	7.3	41.4	13.3	13.2	39.5	16.2	11.9	8.1	72.8	43.6	157.3	86.9	38.8	59.4	42.5	68.4	65.7	105.5	104.4	43.2	39.5	136.4	40.5	48.3	49.8	74.6	94.0	56.4	115.1	77.7	64.2	99.2	40.7	82.0	32.5	184.2	59.7	28.6	21.6	64.6	33.3	45.6	115.1	91.5	72.4	39.8	94.2	41.9	150.0	87.7	101.1	33.0	24.9	144.6	112.4	98.4	85.4	49.9	74.3	77.2	64.3	22.3	52.9	60.7	33.3	89.0	67.9	62.8	42.1	27.9	73.4	43.5	73.2	130.6	39.9	157.0	74.0	11.1	46.5	36.7	40.3	45.4	45.0	79.4	53.0	48.9	58.3	64.8	38.1	45.0	4.9	55.9	35.8	62.5	99.9	55.4	7.2	7.2	7.3	10.2	7.0	7.8	7.5	7.6	7.8	8.0	7.3	8.1	20.6	12.8	12.2	3.3	26.5	17.5	15.8	47.8	16.5	6.1	16.4	18.7	10.1	15.7	33.0	14.7	4.2	58.7	22.0	11.1	17.6	38.2	7.5	15.9	18.3	29.4	12.1	53.9	4.2	42.3	111.7	25.1	7.1	14.5	29.8	31.3	23.2	6.9	50.9	11.8	4.8	24.1	28.5	33.6	24.7	12.4	22.7	25.8	21.4	4.7	45.8	21.5	37.0	8.0	5.2	31.8	12.4	25.9	21.9	8.1	14.3	24.7	29.3	8.7	19.7	15.9	20.2	50.8	55.8	15.3	15.5	23.7	23.9	20.7	26.8	12.9
HAUS3	"C4orf15, dgt3, IT1, MGC4701"	ENSG00000214367	"HAUS augmin like complex subunit 3"	Q68CZ6	4	2078998-2242276	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040649, HPA048190"	Approved		Uncertain	"Microtubules,Cytokinetic bridge,Mitotic spindle,Mitochondria"		Yes	No			"Cluster 15: NK-cells - Transcription"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 24: Non-specific - Transcription regulation"	Mitochondria	"Microtubules, Cytokinetic bridge, Mitotic spindle"	"HPA040649: AB_2677060, HPA048190: AB_2680308"	"unprognostic (4.22e-2)"	"unprognostic (1.50e-1)"	"unprognostic (6.30e-2)"	"unprognostic (2.87e-1)"	"unprognostic (2.26e-1)"	"unprognostic (2.57e-3)"	"unprognostic (7.63e-3)"	"unprognostic (2.14e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.17e-1)"	"unprognostic (3.81e-3)"	"unprognostic (2.79e-2)"	"unprognostic (2.15e-2)"	"unprognostic (2.79e-1)"	"unprognostic (4.40e-2)"	"prognostic favorable (4.78e-5)"	9.6	8.6	3.5	7.5	3.5	27.5	8.9	9.0	4.6	8.1	1.9	8.3	6.5	7.3	4.9	8.0	7.2	4.2	5.8	3.4	3.2	6.2	7.4	9.0	10.2	3.4	3.4	7.3	10.5	4.0	5.6	6.5	3.3	8.5	5.3	5.8	8.5	4.5	7.4	8.9	9.2	4.7	2.3	12.0	9.0	10.7	3.4	8.6	7.4	4.6	8.3	7.1	7.7	4.3	9.8	4.7	14.2	13.0	5.5	8.5	12.8	14.3	6.0	12.7	10.6	9.5	12.5	18.9	6.5	5.7	14.3	9.3	11.9	7.2	15.9	6.8	6.9	12.5	13.1	7.0	4.5	11.6	11.2	4.3	10.2	11.0	5.8	6.6	10.3	8.8	22.0	21.2	12.5	5.4	19.6	19.5	11.2	8.5	12.3	13.9	12.4	10.4	6.3	6.7	18.4	10.0	10.1	7.6	8.4	10.5	15.7	7.8	8.5	18.1	7.8	11.1	17.0	11.2	10.6	16.9	8.8	16.8	12.0	9.6	4.2	12.2	7.9	5.8	10.1	5.5	8.2	8.9	3.8	9.1	9.5	8.9	4.7	10.7	6.9	6.8	12.0	6.6	3.5	3.5	9.0	4.6	3.4	3.2	3.4	3.4	3.3	2.3	3.4	4.3	15.5	3.2	4.8	0.0	15.8	12.6	5.0	6.4	15.4	11.9	9.3	8.8	5.8	7.2	10.3	3.7	12.5	7.3	24.0	3.9	1.9	7.4	11.8	8.9	11.8	9.4	7.2	23.1	0.0	5.7	11.7	9.6	4.6	8.3	13.3	12.1	6.8	3.7	7.2	25.2	0.0	6.4	12.2	5.4	9.3	6.4	9.9	10.4	12.4	0.0	7.9	6.5	16.5	0.0	0.0	5.3	1.8	8.6	22.5	5.1	5.8	2.6	5.4	12.5	0.0	12.3	17.7	34.4	25.3	10.5	7.7	5.1	26.5	10.1	5.8	3.0
HAUS7	"UCHL5IP, UIP1"	ENSG00000213397	"HAUS augmin like complex subunit 7"	Q99871	X	153447666-153495516	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 45.4;Oligodendrocyte precursor cells: 31.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003614			Approved	"Plasma membrane,Centrosome"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Plasma membrane, Centrosome"		"HPA003614: AB_1080368"	"unprognostic (2.06e-1)"	"prognostic favorable (6.12e-4)"	"unprognostic (3.81e-2)"	"unprognostic (3.21e-2)"	"unprognostic (5.84e-3)"	"unprognostic (5.52e-2)"	"unprognostic (1.75e-2)"	"unprognostic (7.50e-2)"	"unprognostic (1.56e-1)"	"unprognostic (3.39e-1)"	"unprognostic (4.65e-3)"	"unprognostic (6.28e-2)"	"prognostic unfavorable (3.94e-4)"	"unprognostic (1.98e-1)"	"unprognostic (1.15e-1)"	"unprognostic (4.25e-2)"	"unprognostic (1.09e-2)"	19.0	13.0	29.1	9.2	31.3	11.0	16.2	26.3	54.0	42.3	24.3	15.9	7.1	17.8	15.1	11.4	21.3	13.2	23.5	32.3	26.3	25.2	13.6	19.5	14.4	28.3	27.0	16.0	8.2	5.0	11.9	12.3	28.4	22.5	5.8	3.0	12.5	17.9	12.0	44.7	13.3	11.5	26.4	28.5	11.5	12.6	29.0	10.4	19.2	9.2	9.5	17.4	21.7	32.3	28.2	44.9	24.1	51.2	8.9	14.1	37.2	17.8	12.1	30.1	51.4	36.2	17.3	25.5	59.2	18.5	43.1	32.0	39.6	29.4	15.6	23.6	59.6	19.3	33.5	26.9	9.3	26.9	35.5	21.1	7.4	29.5	16.4	13.1	22.4	32.5	21.7	17.6	15.7	68.9	41.7	60.5	15.7	67.5	65.8	36.5	30.2	47.0	10.2	17.3	25.1	20.5	10.3	27.4	9.6	8.9	10.8	20.8	10.7	27.1	42.9	50.8	36.1	24.0	33.7	97.6	11.7	68.9	34.6	14.8	53.2	22.7	32.6	66.7	34.5	44.0	36.1	33.6	46.7	36.5	35.2	32.2	6.7	39.1	62.0	26.0	33.8	34.3	29.1	31.3	26.3	54.0	32.3	26.3	28.3	27.0	28.4	26.4	29.0	32.3	9.4	6.4	8.1	45.4	5.3	7.1	1.6	3.6	1.2	2.1	2.7	3.0	2.5	4.3	2.6	0.0	4.2	12.6	6.0	9.3	5.9	10.4	0.1	1.0	1.8	5.6	2.4	6.6	11.9	8.0	24.6	6.3	3.6	0.7	19.7	1.6	15.4	4.2	12.2	3.3	4.9	13.8	4.1	10.0	6.8	0.5	5.9	5.0	3.6	4.7	13.4	2.0	12.3	31.7	3.5	7.4	7.7	7.5	2.5	3.3	6.9	14.9	3.5	1.9	6.6	1.9	6.5	2.2	6.7	1.3	4.7	9.3	4.9	1.7	14.9	1.5
HAX1	"HAX-1, HCLSBP1, HS1BP1"	ENSG00000143575	"HCLS1 associated protein X-1"	O00165	1	154272589-154275875	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055141, HPA075289"	Approved		Supported	Mitochondria		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"HPA055141: AB_2682714, HPA075289: AB_2686742"	"unprognostic (1.32e-1)"	"unprognostic (2.68e-1)"	"unprognostic (9.50e-2)"	"unprognostic (6.93e-2)"	"unprognostic (2.88e-2)"	"unprognostic (1.73e-2)"	"unprognostic (1.55e-3)"	"unprognostic (2.34e-1)"	"unprognostic (2.20e-1)"	"unprognostic (9.09e-3)"	"unprognostic (3.09e-2)"	"unprognostic (8.91e-2)"	"prognostic unfavorable (1.34e-5)"	"unprognostic (1.52e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.69e-1)"	"unprognostic (3.96e-1)"	58.6	63.0	100.0	43.6	105.5	36.8	74.4	105.2	124.1	60.0	100.6	62.0	48.0	46.2	100.1	53.7	61.7	40.4	168.6	100.5	107.9	76.1	104.0	45.2	58.3	102.1	99.9	72.9	85.5	84.9	88.6	40.5	102.9	55.5	63.3	54.1	85.8	63.8	256.7	48.8	43.2	64.1	105.1	47.1	66.3	69.5	105.0	67.4	69.2	242.7	77.3	58.5	48.9	103.3	115.3	100.7	84.2	178.0	100.3	111.8	132.1	109.8	178.7	227.0	207.5	126.6	125.7	170.9	150.7	188.0	105.9	100.0	190.7	151.3	172.3	171.0	140.8	81.8	76.5	104.4	221.5	172.5	167.0	104.4	274.2	172.8	206.3	82.2	129.7	246.1	166.1	244.8	145.6	260.9	169.9	136.1	88.7	277.4	213.2	121.3	59.7	326.7	115.4	60.8	123.2	121.7	96.4	228.2	326.7	137.5	190.0	454.8	64.5	92.7	122.7	97.7	148.8	284.8	315.9	315.3	139.0	158.4	153.4	266.5	97.6	215.4	113.7	121.9	129.3	136.1	139.2	128.3	118.6	142.2	166.5	132.6	61.1	116.7	150.1	122.8	183.3	163.9	100.0	105.5	105.2	124.1	100.5	107.9	102.1	99.9	102.9	105.1	105.0	103.3	69.9	28.9	37.6	7.2	125.2	74.6	112.2	118.8	60.9	57.0	92.8	123.1	106.9	62.9	71.6	46.0	47.9	84.8	76.1	54.1	181.9	93.3	147.6	41.3	36.6	65.6	57.6	66.0	12.0	106.4	132.1	62.2	36.7	34.0	99.6	80.6	61.4	90.3	98.7	40.4	12.9	67.1	91.6	63.9	79.3	104.6	61.2	66.8	87.2	9.4	128.5	91.1	91.6	7.5	17.1	84.6	63.6	62.1	192.9	92.5	128.7	141.8	59.3	97.5	59.2	58.2	76.0	223.8	112.0	71.0	76.4	88.8	97.7	74.3	71.7	101.7
HBZ	"HBZ-T1, HBZ1"	ENSG00000130656	"Hemoglobin subunit zeta"	P02008	16	142728-154503	"Predicted intracellular proteins"	"Oxygen transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"bone marrow: 3.9;testis: 7.3"	"Group enriched"	"Detected in some"	4	"Erythroid cells: 82.9;Hofbauer cells: 192.0;Late spermatids: 275.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	80	"K-562: 2189.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA063268, HPA064073, HPA071726"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA		80000000		"Cluster 23: Testis - Cell cycle regulation"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 25: Spermatids - Spermatogenesis"	Cytosol	Nucleoplasm	"HPA063268: , HPA064073: , HPA071726: AB_2732184"					"unprognostic (3.56e-1)"				"unprognostic (1.32e-1)"									0.6	0.0	0.5	0.0	0.4	3.9	0.6	0.2	0.8	0.5	0.8	0.1	0.0	0.1	0.0	0.1	0.2	0.0	0.2	0.5	0.3	0.1	0.2	0.5	0.0	0.2	0.1	0.1	0.0	0.0	0.2	0.6	0.2	0.3	0.0	0.0	0.1	0.0	0.1	0.4	0.1	0.0	0.1	0.3	0.1	7.3	0.2	0.0	0.1	0.0	0.0	0.2	0.5	0.4	0.0	0.0	0.0	0.3	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.2	0.1	4.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.9	27.2	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2189.0	0.2	0.0	0.6	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.8	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.4	0.2	0.8	0.5	0.3	0.2	0.1	0.2	0.1	0.2	0.4	0.3	0.0	0.0	1.0	0.0	0.5	0.0	0.0	0.0	0.0	0.2	0.5	0.7	0.0	0.0	0.0	0.0	3.0	0.3	0.0	0.0	0.0	40.0	0.0	0.1	3.7	0.0	82.9	0.5	0.0	42.4	1.8	0.0	0.0	0.0	0.1	0.4	0.0	192.0	0.0	0.3	0.0	0.0	0.3	0.3	275.5	0.6	0.1	0.0	0.0	0.0	1.8	0.0	0.0	0.1	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.7	6.6	1.9	4.8	1.3	1.8	0.0	0.1	10.4	0.1	0.0	0.1	0.0
HCAR2	"GPR109A, HCA2, HM74A, NIACR1, Puma-g, PUMAG"	ENSG00000182782	"Hydroxycarboxylic acid receptor 2"	Q8TDS4	12	122701293-122703357	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins"	Apoptosis	"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 40.8;skin 1: 30.2"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 94.4;Basal prostatic cells: 84.7;Basal respiratory cells: 52.0;Basal squamous epithelial cells: 120.1;Ionocytes: 87.5;Langerhans cells: 124.0;Suprabasal keratinocytes: 106.1"	"Group enriched"	"Detected in many"	8	"cervical cancer: 12.6;head and neck cancer: 16.1;lung cancer: 6.4;urothelial cancer: 9.2"	"Region enriched"	"Detected in some"	5	"cerebral cortex: 5.9"	"Immune cell enriched"	"Detected in many"	5	"neutrophil: 176.7"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 176.7"	"Cell line enriched"	"Detected in some"	6	"HaCaT: 118.4"									HPA028660	Approved		Supported	"Cell Junctions"		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 61: Squamous epithelial cells - Keratinization"	"Cell Junctions"		"HPA028660: AB_10602139"	"unprognostic (5.43e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.77e-1)"	"unprognostic (2.05e-1)"	"unprognostic (6.65e-2)"	"unprognostic (1.33e-1)"	"unprognostic (3.33e-3)"	"unprognostic (7.26e-2)"	"unprognostic (2.17e-1)"	"unprognostic (1.77e-2)"	"unprognostic (7.10e-2)"	"unprognostic (7.33e-2)"	"unprognostic (4.83e-4)"	"unprognostic (5.76e-2)"	"unprognostic (5.07e-2)"	"unprognostic (1.54e-1)"	"unprognostic (4.63e-2)"	22.2	0.3	0.1	9.8	0.2	22.1	7.6	0.1	5.9	8.9	0.2	0.7	0.9	0.2	0.3	40.8	0.7	0.8	0.9	0.3	0.1	3.9	2.9	11.9	0.6	0.1	0.1	0.1	0.2	5.5	0.3	4.5	1.2	3.4	0.3	0.2	14.2	14.7	0.2	30.2	1.0	0.3	0.1	25.9	1.5	2.7	0.2	10.5	0.5	1.9	10.2	6.9	14.0	0.1	4.5	0.4	0.1	0.1	1.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	118.4	0.0	7.3	0.0	0.0	0.1	0.0	0.0	0.0	0.7	0.0	0.3	0.1	3.8	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	1.0	0.0	0.3	0.0	0.0	0.4	0.1	0.0	0.0	0.0	19.5	0.2	0.0	0.4	0.1	0.0	0.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.3	0.0	0.0	38.7	2.5	2.6	0.0	5.3	0.0	0.1	0.0	0.0	1.7	0.0	0.0	0.0	176.7	0.0	23.9	0.0	0.0	1.4	0.1	0.2	0.1	5.9	0.3	0.1	0.1	0.1	1.2	0.1	0.2	0.1	0.4	0.0	4.3	0.0	0.5	94.4	84.7	52.0	120.1	0.5	3.4	1.1	0.1	0.0	40.3	0.0	0.0	1.5	0.0	0.0	0.0	0.0	24.9	0.4	0.2	1.2	0.0	0.0	0.0	0.0	26.3	2.4	0.0	0.3	2.5	0.0	0.0	0.0	3.7	0.0	0.0	0.0	87.5	4.1	124.0	2.7	0.0	17.8	8.8	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	25.3	0.0	0.0	8.5	0.1	0.0	0.1	1.4	0.0	0.1	47.2	106.1	2.6	1.5	0.0	0.0	32.5
HCFC1	"CFF, HCF-1, HCF1, HFC1, MGC70925, MRX3, PPP1R89, VCAF"	ENSG00000172534	"Host cell factor C1"	P51610	X	153947557-153971818	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Host-virus interaction"	"Chromatin regulator"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA078588	Supported		Supported	Nucleoplasm		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 59: Non-specific - Translation"	"Cluster 16: U-266 - Nucleosome"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"HPA078588: "	"unprognostic (2.05e-3)"	"unprognostic (2.92e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.64e-1)"	"unprognostic (5.13e-2)"	"prognostic unfavorable (4.31e-6)"	"unprognostic (1.35e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.74e-1)"	"prognostic favorable (9.62e-5)"	"unprognostic (1.45e-1)"	"unprognostic (1.29e-3)"	"unprognostic (1.99e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.73e-2)"	"unprognostic (2.80e-1)"	18.8	25.5	18.4	15.5	16.9	40.2	17.1	14.9	22.5	21.9	10.3	29.7	11.4	33.6	8.5	25.1	24.3	7.6	23.1	19.7	14.1	22.1	23.8	21.6	19.0	16.6	16.8	25.5	21.1	11.4	33.9	8.7	15.2	23.5	7.0	7.2	19.2	12.8	28.4	18.6	25.3	11.1	13.6	32.8	24.8	17.9	16.8	26.1	21.1	10.5	12.1	23.6	19.8	17.1	45.3	57.7	38.4	48.9	15.8	11.2	56.3	18.2	14.0	21.1	19.1	61.5	29.8	81.6	45.3	23.6	34.6	36.4	41.8	29.7	11.0	43.6	49.2	49.0	47.7	48.8	10.8	60.9	77.8	17.6	19.1	36.8	15.9	12.7	22.7	58.2	69.4	50.2	15.0	63.0	84.6	78.2	50.0	29.4	35.1	97.5	31.6	49.3	16.0	41.4	42.5	46.2	33.7	34.4	19.4	18.4	31.7	54.4	30.2	39.9	49.0	35.0	59.4	79.1	117.0	100.2	32.5	58.6	38.6	0.9	2.1	0.9	3.0	3.1	2.1	2.4	2.4	2.3	2.4	2.4	2.4	3.4	0.4	1.5	2.2	4.2	1.7	2.3	18.4	16.9	14.9	22.5	19.7	14.1	16.6	16.8	15.2	13.6	16.8	17.1	19.1	19.2	17.8	7.5	21.9	16.6	13.4	15.5	20.5	21.0	24.6	18.7	35.9	20.0	13.6	12.9	14.6	16.5	26.8	20.1	3.9	17.4	0.6	16.7	18.4	21.2	19.2	39.9	8.4	16.5	21.3	17.7	19.9	21.6	3.8	25.0	15.7	29.5	21.3	20.2	8.3	23.2	8.2	35.2	13.8	1.8	17.4	26.0	5.4	9.4	28.6	13.6	17.5	8.0	7.2	19.5	13.3	21.8	32.0	25.7	12.6	8.8	13.4	12.4	6.6	21.8	21.2	11.3	25.0	28.9	13.9	15.9	22.8	14.3	23.9	20.5
HCFC2	HCF-2	ENSG00000111727	"Host cell factor C2"	Q9Y5Z7	12	104064531-104106524	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 250.3;Spermatocytes: 130.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006227	Approved		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm	"Plasma membrane, Cytosol"	"HPA006227: AB_1079042"	"unprognostic (4.22e-3)"	"unprognostic (1.22e-1)"	"unprognostic (1.08e-1)"	"unprognostic (7.66e-2)"	"unprognostic (3.15e-2)"	"unprognostic (2.11e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.07e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.43e-2)"	"unprognostic (2.71e-2)"	"unprognostic (4.54e-2)"	"unprognostic (4.23e-3)"	"unprognostic (1.16e-2)"	"unprognostic (2.24e-1)"	"unprognostic (1.19e-2)"	"unprognostic (7.23e-2)"	6.3	6.7	3.8	3.6	5.2	2.7	5.1	4.4	5.4	7.4	2.0	9.2	5.2	7.9	5.0	6.2	5.3	5.7	5.1	3.7	4.2	5.7	7.3	4.7	4.6	4.9	5.0	7.8	6.0	6.7	4.1	6.4	4.8	7.2	4.3	8.0	4.5	9.4	9.7	4.4	5.0	7.2	4.7	5.1	5.2	9.5	4.6	5.2	6.9	11.2	3.7	5.9	6.0	6.6	2.0	2.3	2.3	2.0	12.7	12.5	1.7	9.1	4.1	6.8	3.9	1.1	0.9	2.1	3.1	7.1	2.5	2.2	2.9	1.6	7.3	3.5	2.8	2.1	2.3	1.0	8.5	1.7	3.3	7.8	4.3	4.2	3.5	9.8	5.3	3.1	2.5	4.2	12.3	1.8	3.1	4.0	0.5	1.3	4.7	2.5	7.6	1.3	3.1	1.4	3.3	2.5	4.4	3.2	3.5	1.5	5.0	1.9	8.0	10.7	1.4	5.6	3.1	5.3	1.7	1.8	5.1	2.3	4.4	0.4	0.6	0.9	0.8	1.1	0.9	0.5	0.7	0.9	0.7	0.5	0.8	0.9	0.1	0.8	1.8	0.4	0.9	0.5	3.8	5.2	4.4	5.4	3.7	4.2	4.9	5.0	4.8	4.7	4.6	6.6	19.3	12.8	14.1	18.9	10.0	8.0	6.6	5.4	8.6	19.6	6.1	5.0	12.5	1.5	9.6	5.5	20.9	5.0	8.8	7.4	9.8	6.2	250.3	7.9	18.5	14.4	8.4	7.4	31.8	3.3	5.0	16.0	6.6	6.5	17.1	9.8	15.7	11.5	7.4	23.5	33.9	4.7	8.2	11.4	5.7	59.4	21.8	8.6	7.2	16.9	9.3	13.7	7.2	30.7	45.6	3.1	6.0	27.8	12.2	2.7	7.7	8.6	10.4	22.2	13.1	18.7	17.4	130.9	16.4	8.5	7.2	10.8	11.3	17.9	3.8	3.3
HCK	JTK9	ENSG00000101336	"HCK proto-oncogene, Src family tyrosine kinase"	P08631	20	32052197-32101856	"Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Exocytosis, Host-virus interaction, Immunity, Inflammatory response, Innate immunity, Phagocytosis"	"Kinase, Transferase, Tyrosine-protein kinase"	Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 112.1"	"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 150.7;Kupffer cells: 155.5;Langerhans cells: 89.2;Macrophages: 170.1;Microglial cells: 52.5;monocytes: 222.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	16	"classical monocyte: 575.0;eosinophil: 707.8;intermediate monocyte: 1059.1;myeloid DC: 336.3;neutrophil: 801.3;non-classical monocyte: 1251.7"	"Group enriched"	"Detected in all"	16	"dendritic cells: 336.3;granulocytes: 801.3;monocytes: 1251.7"	"Group enriched"	"Detected in some"	9	"THP-1: 69.3;U-937: 199.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB005195, HPA035534, HPA063768"	Approved		Supported	"Vesicles,Plasma membrane,Cytosol"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 2: Immune cells - Immune response"	"Cluster 32: U-937 - Innate immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	Vesicles	"Plasma membrane, Cytosol"	"CAB005195: AB_631619, HPA035534: , HPA063768: AB_2685118"	"unprognostic (6.22e-2)"	"unprognostic (6.16e-3)"	"unprognostic (2.26e-2)"	"unprognostic (7.98e-2)"	"unprognostic (8.83e-2)"	"unprognostic (5.50e-2)"	"unprognostic (4.09e-2)"	"unprognostic (1.72e-2)"	"unprognostic (4.34e-2)"	"unprognostic (1.59e-1)"	"unprognostic (4.08e-2)"	"unprognostic (1.21e-1)"	"prognostic unfavorable (1.66e-4)"	"unprognostic (4.92e-2)"	"unprognostic (4.42e-2)"	"unprognostic (6.95e-2)"	"unprognostic (1.12e-1)"	24.8	9.2	4.7	100.0	5.0	55.2	6.0	5.5	6.0	5.5	13.7	12.8	15.2	3.1	2.6	6.7	7.6	14.4	4.8	4.7	6.2	4.7	14.1	46.0	38.6	9.9	6.8	2.5	4.5	2.1	3.1	20.9	8.3	4.0	13.6	0.5	5.1	4.7	1.6	5.8	17.8	25.3	8.1	112.1	6.7	2.3	8.4	14.5	2.8	6.9	39.3	32.8	4.1	12.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.9	0.0	0.1	0.1	1.3	0.0	0.0	0.1	0.0	4.3	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	15.6	0.0	0.1	0.1	4.9	0.4	0.0	0.0	0.4	0.2	0.6	0.0	0.0	0.3	0.0	0.5	0.0	0.2	0.7	0.0	69.3	0.0	0.0	0.3	0.0	0.1	1.9	0.3	10.3	0.0	199.6	0.0	6.4	575.0	707.8	1.1	1059.1	1.3	48.4	1.1	1.1	336.3	43.0	1.1	0.9	801.3	11.0	1251.7	30.4	1.2	566.4	4.7	5.0	5.5	6.0	4.7	6.2	9.9	6.8	8.3	8.1	8.4	12.0	0.6	6.4	14.0	0.0	17.1	3.1	4.0	0.2	0.6	0.1	0.4	1.3	2.0	1.5	3.9	7.3	0.0	0.9	12.1	0.2	1.9	0.1	2.5	0.1	0.1	3.7	1.8	1.7	1.2	0.6	0.9	1.3	4.6	0.1	6.3	0.1	1.1	2.3	150.7	0.0	1.0	0.5	22.4	155.5	89.2	0.3	0.0	170.1	1.8	52.5	222.0	0.0	4.1	1.5	0.6	0.0	0.0	0.0	0.7	0.5	0.1	0.3	1.5	0.1	0.0	0.6	0.5	0.2	0.3	0.2	1.1	1.6	3.0	0.2	0.9	3.7
HCLS1	"CTTNL, HS1"	ENSG00000180353	"Hematopoietic cell-specific Lyn substrate 1"	P14317	3	121631399-121660927	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 153.6;lymphoid tissue: 300.3"	"Cell type enhanced"	"Detected in many"		"B-cells: 175.7;Kupffer cells: 666.3;Macrophages: 269.0;monocytes: 245.7;NK-cells: 216.3;T-cells: 181.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 265.6;HMC-1: 362.3;RPMI-8226: 256.5;THP-1: 262.8;U-266/70: 361.6;U-698: 371.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019143	Enhanced		Supported	"Plasma membrane,Cytosol"		NA	NA		870000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 16: Immune cells - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Plasma membrane, Cytosol"		"HPA019143: AB_1850532"	"unprognostic (2.27e-2)"	"unprognostic (1.79e-3)"	"unprognostic (5.38e-3)"	"unprognostic (6.29e-2)"	"unprognostic (1.01e-2)"	"unprognostic (4.02e-3)"	"unprognostic (2.35e-1)"	"unprognostic (4.88e-3)"	"unprognostic (1.70e-2)"	"unprognostic (1.19e-1)"	"unprognostic (6.76e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.03e-3)"	"unprognostic (2.93e-1)"	"unprognostic (3.46e-2)"	"unprognostic (2.60e-2)"	"unprognostic (2.01e-1)"	67.0	32.9	14.6	147.2	14.7	153.6	25.5	15.4	18.7	20.7	15.8	29.2	21.2	13.7	6.4	15.7	21.5	37.8	18.4	14.3	17.0	21.5	39.1	52.7	207.6	21.6	17.5	9.4	11.9	7.7	14.6	51.4	20.8	15.8	31.4	2.3	16.0	11.1	7.3	11.1	68.7	34.6	18.5	300.3	27.1	4.5	18.2	140.3	15.4	18.8	242.8	53.0	13.7	23.0	0.8	0.0	0.2	0.1	20.9	11.5	5.7	4.1	4.0	0.8	1.6	0.1	0.0	265.6	124.6	0.0	0.2	0.3	6.9	9.9	1.1	120.6	0.0	172.6	0.0	0.0	11.6	192.4	362.3	2.2	0.5	0.0	1.5	0.0	153.4	106.2	35.1	235.9	0.0	0.0	137.9	162.9	0.3	0.2	4.5	137.1	0.2	256.5	0.0	68.0	0.3	0.2	0.2	0.4	0.6	0.6	0.1	262.8	203.5	0.0	2.0	0.3	0.9	361.6	118.1	371.5	1.9	181.5	0.2	357.3	713.1	1180.9	405.3	870.4	333.0	345.7	334.2	376.8	636.2	313.1	279.3	326.2	1619.2	280.0	997.1	197.4	494.2	1427.9	14.6	14.7	15.4	18.7	14.3	17.0	21.6	17.5	20.8	18.5	18.2	23.0	23.0	9.6	31.8	1.0	175.7	3.2	1.0	7.8	0.6	0.5	2.7	5.1	2.3	4.3	13.1	0.0	0.0	122.4	139.5	0.8	0.0	0.3	1.1	8.8	1.6	23.3	0.0	50.5	1.4	0.2	60.0	7.0	8.6	3.1	73.4	0.7	27.8	7.7	126.9	0.0	0.7	0.4	4.1	666.3	105.8	1.5	3.4	269.0	19.6	26.2	245.7	0.4	216.3	0.5	0.3	0.2	0.2	1.2	148.6	0.4	0.1	0.9	24.7	0.8	13.1	3.7	6.7	0.6	0.6	1.3	4.4	145.4	181.4	2.4	0.5	2.2
HCST	"DAP10, DKFZP586C1522, KAP10, PIK3AP"	ENSG00000126264	"Hematopoietic cell signal transducer"	Q9UBK5	19	35902529-35904377	"Metabolic proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"bone marrow: 253.7;lymphoid tissue: 115.6"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 993.2;Hofbauer cells: 571.1;Kupffer cells: 396.6;Langerhans cells: 584.5;Macrophages: 392.7;NK-cells: 1687.0;T-cells: 769.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEL: 239.9;HL-60: 139.6;HMC-1: 154.3;THP-1: 177.8;U-937: 272.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB034435, HPA063026"	Enhanced		Supported	"Golgi apparatus,Vesicles,Plasma membrane"		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 32: U-937 - Innate immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Golgi apparatus, Plasma membrane"	Vesicles	"CAB034435: AB_2117803, HPA063026: "	"unprognostic (1.40e-3)"	"unprognostic (3.07e-2)"	"unprognostic (3.04e-2)"	"unprognostic (7.27e-3)"	"unprognostic (1.23e-1)"	"unprognostic (8.23e-3)"	"unprognostic (1.85e-1)"	"unprognostic (2.54e-1)"	"prognostic favorable (6.70e-4)"	"unprognostic (5.97e-2)"	"unprognostic (1.94e-3)"	"unprognostic (1.02e-1)"	"prognostic unfavorable (1.59e-10)"	"unprognostic (3.78e-1)"	"unprognostic (3.25e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.56e-1)"	27.2	9.5	14.0	53.6	13.8	253.7	14.1	13.7	18.5	9.6	16.6	12.7	11.3	8.3	4.7	5.5	9.9	11.5	8.3	13.5	17.0	10.6	14.5	40.3	68.0	18.3	14.7	5.7	6.7	2.5	9.6	24.7	17.6	9.4	8.6	2.2	10.7	8.2	4.2	6.6	28.2	11.2	17.1	115.6	15.4	3.4	18.2	59.6	7.9	3.0	37.8	16.4	8.0	22.2	0.9	0.0	0.3	0.5	1.1	0.0	0.3	1.9	1.1	0.0	0.6	0.8	1.2	26.9	1.7	2.0	0.4	0.9	0.0	0.2	0.0	0.6	0.0	239.9	0.5	0.7	0.9	139.6	154.3	1.6	0.3	0.0	0.0	0.7	0.0	14.8	2.1	33.4	0.4	0.4	16.9	54.7	0.3	0.3	0.7	0.8	0.5	2.0	0.4	0.1	0.9	0.4	1.3	0.7	0.9	0.2	0.5	177.8	0.5	1.4	1.8	0.2	0.2	1.6	1.1	39.5	1.4	272.2	0.3	124.7	725.8	105.8	1583.4	546.1	1172.3	78.6	664.6	1293.3	409.8	51.0	550.6	1108.0	196.1	1290.7	314.4	823.7	629.9	1421.2	14.0	13.8	13.7	18.5	13.5	17.0	18.3	14.7	17.6	17.1	18.2	22.2	12.3	6.4	43.3	0.0	85.3	28.6	1.3	1.7	2.8	0.4	11.4	12.8	1.2	15.7	7.1	9.2	0.0	3.8	993.2	1.8	0.0	2.8	1.3	4.0	2.5	18.3	0.0	84.2	0.1	1.2	4.7	9.5	14.8	5.5	240.4	0.3	21.0	14.3	571.1	1.7	0.1	0.9	2.0	396.6	584.5	3.0	2.1	392.7	44.4	5.6	309.9	0.7	1687.0	0.0	0.1	1.0	1.4	0.0	97.7	0.6	2.0	6.1	5.1	2.2	19.7	4.2	6.2	2.2	4.9	2.7	21.0	6.0	769.9	1.0	2.7	1.2
HDAC2	"KDAC2, RPD3, YAF1"	ENSG00000196591	"Histone deacetylase 2"	Q92769	6	113933028-114011308	"Cancer-related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Biological rhythms, Transcription, Transcription regulation"	"Chromatin regulator, Hydrolase, Repressor"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005054, HPA011727"	Supported		Supported	Nucleoplasm		NA	NA		25000	"Cluster 27: Non-specific - Gene expression"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	Nucleoplasm		"CAB005054: AB_562295, HPA011727: AB_1850540"	"prognostic unfavorable (7.07e-4)"	"unprognostic (1.44e-1)"	"unprognostic (2.67e-1)"	"unprognostic (2.56e-2)"	"unprognostic (2.61e-2)"	"unprognostic (1.89e-2)"	"prognostic unfavorable (5.39e-10)"	"unprognostic (2.03e-1)"	"unprognostic (2.63e-2)"	"unprognostic (9.00e-2)"	"unprognostic (2.01e-1)"	"unprognostic (3.92e-1)"	"unprognostic (1.84e-2)"	"unprognostic (1.96e-1)"	"unprognostic (2.42e-1)"	"unprognostic (9.80e-2)"	"unprognostic (3.51e-1)"	35.9	42.7	26.6	37.4	31.5	63.4	54.8	32.8	40.0	45.2	22.3	48.0	34.4	57.3	53.4	43.3	48.7	34.6	41.1	26.7	34.7	46.3	34.6	33.0	42.6	31.2	29.5	53.4	37.1	45.7	35.9	56.1	31.2	47.0	53.6	37.2	34.3	45.3	48.6	46.1	36.7	54.3	28.8	35.9	40.5	76.7	31.1	68.5	45.6	43.4	52.1	63.2	37.5	37.5	126.7	84.9	387.1	224.3	97.7	110.5	162.6	146.6	119.0	168.5	200.1	226.3	90.1	103.6	119.0	132.5	173.1	96.6	266.0	148.1	281.4	148.9	185.0	249.2	102.1	131.8	129.7	256.1	107.7	90.0	97.6	180.0	167.2	164.4	199.6	179.2	326.4	101.6	282.7	105.5	231.9	229.6	220.0	133.4	116.3	155.0	193.0	95.2	174.4	148.9	258.3	219.1	115.9	107.5	127.7	231.4	78.6	294.0	163.2	107.0	122.9	113.7	246.9	80.6	113.9	244.6	90.9	242.6	185.3	43.5	39.0	42.1	28.0	38.6	37.3	37.0	34.0	30.3	51.0	31.4	41.8	39.1	23.1	39.8	50.2	44.2	36.0	37.2	26.6	31.5	32.8	40.0	26.7	34.7	31.2	29.5	31.2	28.8	31.1	37.5	40.2	57.7	57.8	13.4	51.4	192.1	91.3	152.6	85.4	31.0	61.0	54.6	64.0	25.8	116.4	53.3	4.2	157.7	42.6	43.5	43.0	154.9	86.8	74.3	91.6	73.8	100.5	129.4	29.9	105.0	140.7	76.2	53.5	63.2	55.1	103.9	50.0	31.9	102.0	15.2	26.3	73.4	175.0	64.1	89.8	109.1	83.0	63.3	83.6	26.2	107.7	30.9	33.0	29.1	34.0	133.6	51.3	67.4	56.2	90.0	37.4	71.7	98.7	28.1	39.5	94.7	88.0	199.0	215.5	96.5	193.1	207.7	45.5	53.9	94.6	100.5
HDAC3	"HD3, KDAC3, RPD3, RPD3-2"	ENSG00000171720	"Histone deacetylase 3"	O15379	5	141620876-141636849	"Enzymes, FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins"	"Biological rhythms, Host-virus interaction, Transcription, Transcription regulation"	"Chromatin regulator, Hydrolase, Repressor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005583, HPA052052, CAB072336"	Supported		Supported	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 3: Monocytes - Immune response regulation"	Nucleoplasm	"Golgi apparatus"	"CAB005583: AB_562296, CAB072336: , HPA052052: AB_2681708"	"unprognostic (6.65e-2)"	"unprognostic (1.96e-1)"	"prognostic favorable (3.39e-4)"	"unprognostic (1.17e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.19e-2)"	"unprognostic (3.16e-1)"	"unprognostic (5.56e-2)"	"unprognostic (2.45e-2)"	"prognostic favorable (3.95e-4)"	"unprognostic (1.12e-1)"	"prognostic unfavorable (2.65e-6)"	"unprognostic (1.85e-1)"	"unprognostic (1.63e-2)"	"unprognostic (2.28e-3)"	"unprognostic (2.17e-1)"	24.3	39.8	7.8	22.7	8.4	37.3	25.3	7.8	9.5	25.7	9.9	23.3	18.7	23.5	26.4	34.1	26.5	20.3	24.4	8.7	8.4	24.2	39.6	21.4	32.7	8.2	8.0	26.0	28.4	44.9	18.4	22.4	7.9	20.6	24.5	16.4	25.5	21.9	40.2	40.8	23.5	26.1	8.5	27.8	23.3	15.8	8.5	38.3	24.1	34.1	42.7	26.2	25.8	8.2	59.8	40.2	74.0	109.5	68.5	54.3	47.0	42.6	93.5	94.8	134.8	86.5	49.7	86.4	54.0	56.2	67.3	51.2	72.9	98.8	117.0	74.6	79.0	68.8	33.3	50.4	48.1	83.5	60.1	47.0	63.2	55.3	71.3	49.6	61.9	76.8	67.6	44.7	61.5	55.8	92.1	72.9	63.9	36.8	31.0	65.8	76.2	62.3	49.9	59.7	60.2	49.4	57.0	57.1	71.7	46.2	61.8	52.3	32.1	58.3	36.1	45.8	71.8	36.6	47.8	82.1	48.8	78.6	50.8	41.3	51.7	39.6	34.1	53.8	45.5	47.8	42.5	41.9	107.5	47.5	45.9	38.5	21.5	35.1	46.8	55.1	55.6	43.8	7.8	8.4	7.8	9.5	8.7	8.4	8.2	8.0	7.9	8.5	8.5	8.2	19.1	9.6	13.2	16.6	36.0	44.2	26.8	38.1	37.0	33.2	29.0	25.5	15.9	18.6	19.6	12.9	60.5	55.3	43.8	18.5	21.5	33.4	10.4	10.0	21.0	21.3	18.0	50.7	40.6	35.4	51.6	28.8	19.9	10.2	18.4	33.9	21.4	18.7	38.8	50.5	38.2	19.7	28.5	19.5	44.9	4.2	22.4	31.7	32.0	10.3	51.1	33.3	38.1	22.1	21.9	33.4	16.3	22.2	36.3	28.7	19.5	20.5	10.8	36.5	26.3	18.1	24.7	25.4	27.5	38.1	51.4	61.2	30.3	42.6	25.9	30.3
HDAC4	"BDMR, HA6116, HD4, HDAC-4, HDAC-A, HDACA, KIAA0288"	ENSG00000068024	"Histone deacetylase 4"	P56524	2	239048168-239401654	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, Hydrolase, Repressor"	"Autism spectrum disorder, FDA approved drug targets, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 58.2"	"Group enriched"	"Detected in many"	4	"Astrocytes: 62.0;Early spermatids: 69.9;Excitatory neurons: 118.1;Inhibitory neurons: 84.9;Late spermatids: 59.0;Microglial cells: 38.4;Oligodendrocyte precursor cells: 85.5;Oligodendrocytes: 124.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"basophil: 32.0;neutrophil: 47.7"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 47.7"	"Cell line enhanced"	"Detected in many"		"JURKAT: 49.1;MOLT-4: 48.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA048723, HPA071448"	Approved		Supported	"Nucleoplasm,Nuclear speckles,Cytosol"		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Nuclear speckles"	"Nucleoplasm, Cytosol"	"HPA048723: AB_2680501, HPA071448: "	"unprognostic (1.54e-1)"	"unprognostic (1.76e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.18e-3)"	"unprognostic (2.43e-2)"	"unprognostic (2.39e-3)"	"unprognostic (3.06e-4)"	"unprognostic (1.00e-1)"	"unprognostic (1.24e-1)"	"prognostic unfavorable (6.33e-4)"	"prognostic favorable (1.13e-4)"	"unprognostic (1.40e-1)"	"unprognostic (4.82e-3)"	"unprognostic (2.40e-1)"	"unprognostic (3.26e-2)"	"unprognostic (1.32e-2)"	"unprognostic (6.04e-2)"	4.4	6.3	9.3	5.0	12.0	17.0	3.8	0.6	13.4	7.5	0.1	29.0	2.7	9.1	2.5	8.0	6.7	7.1	5.2	9.0	6.5	3.7	2.4	3.9	3.5	9.9	6.1	7.5	3.7	2.7	6.5	1.5	11.2	5.6	3.4	2.4	3.3	5.9	58.2	5.9	7.2	6.2	2.3	5.6	7.2	9.2	6.7	9.7	4.2	35.6	2.5	10.0	4.5	10.1	3.2	5.8	4.1	6.1	4.5	3.9	5.9	3.0	2.3	2.3	1.7	2.9	7.5	2.0	1.9	3.4	3.6	3.4	4.0	2.0	1.4	12.8	1.8	3.1	5.1	5.8	3.8	5.5	4.6	4.4	2.6	4.6	3.3	2.3	2.4	49.1	3.7	4.5	2.7	4.7	48.1	10.7	4.0	6.0	2.8	7.6	7.2	4.0	5.3	4.4	4.6	6.4	5.3	2.5	16.2	2.6	1.0	17.9	1.9	5.0	0.4	6.8	4.6	3.3	3.2	3.1	6.9	6.9	7.4	32.0	10.2	2.3	1.0	3.3	1.2	0.2	1.1	1.0	1.0	0.1	0.5	0.5	47.7	3.2	1.7	0.6	1.7	1.1	9.3	12.0	0.6	13.4	9.0	6.5	9.9	6.1	11.2	2.3	6.7	10.1	8.6	3.2	7.4	62.0	5.2	7.9	2.9	3.0	8.6	12.2	6.2	4.8	13.3	7.2	2.9	11.0	2.1	1.5	12.8	4.1	0.0	2.8	69.9	7.0	15.1	7.1	6.0	6.1	118.1	2.2	1.7	14.0	7.7	7.4	2.5	6.6	11.7	6.7	3.2	16.8	84.9	5.2	2.0	17.2	10.0	59.0	11.8	10.3	5.4	38.4	14.9	8.6	15.5	85.5	124.0	1.9	1.6	12.4	7.0	6.4	5.0	1.6	2.6	7.1	0.0	18.7	6.5	2.8	3.3	11.1	9.7	1.4	12.2	4.9	6.4	2.7
HDAC5	"FLJ90614, KIAA0600, NY-CO-9"	ENSG00000108840	"Histone deacetylase 5"	Q9UQL6	17	44076746-44123702	"Cancer-related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, Hydrolase, Repressor"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cone photoreceptor cells: 118.9;Syncytiotrophoblasts: 218.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB019400, HPA030991"	Approved		Supported	"Nuclear speckles,Golgi apparatus,Cytosol"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	"Nuclear speckles"	"Golgi apparatus, Cytosol"	"CAB019400: AB_2116626, HPA030991: AB_10795286"	"unprognostic (1.30e-2)"	"prognostic favorable (6.14e-4)"	"unprognostic (6.65e-2)"	"unprognostic (8.06e-2)"	"unprognostic (3.49e-1)"	"unprognostic (3.52e-2)"	"prognostic unfavorable (3.12e-5)"	"unprognostic (8.80e-3)"	"unprognostic (3.80e-2)"	"unprognostic (2.37e-2)"	"unprognostic (4.91e-3)"	"unprognostic (4.30e-1)"	"prognostic favorable (3.30e-5)"	"unprognostic (1.51e-2)"	"unprognostic (3.11e-1)"	"unprognostic (6.00e-2)"	"unprognostic (1.76e-2)"	30.8	24.7	39.3	10.9	33.5	20.7	28.8	48.8	48.5	40.6	3.3	36.3	11.6	33.2	15.5	45.1	34.1	15.9	53.5	40.4	31.6	24.8	17.4	33.6	14.0	37.6	41.1	45.0	22.5	31.5	48.1	22.6	35.1	29.2	7.3	24.3	22.9	15.1	77.5	71.3	22.9	14.8	22.4	26.4	24.0	19.7	40.0	10.4	30.8	28.6	11.6	29.2	37.0	50.3	8.7	5.5	14.9	3.5	28.2	21.7	53.6	22.8	56.1	11.3	18.1	12.3	9.1	13.5	9.0	54.4	16.5	6.9	17.6	9.8	4.7	21.2	28.7	26.3	18.6	28.6	12.2	8.7	35.7	31.2	16.5	12.8	15.8	19.0	9.3	10.6	20.0	26.5	65.5	6.7	14.3	26.2	16.4	6.7	13.0	54.7	41.6	35.4	1.2	3.8	38.6	20.3	6.7	27.6	31.2	21.8	39.3	49.6	5.1	27.8	17.5	6.6	11.7	43.6	39.7	16.2	16.0	10.7	13.4	11.6	9.2	9.7	5.4	13.5	3.8	7.2	4.3	5.4	11.1	7.5	4.5	4.0	20.9	4.5	16.8	9.7	4.1	7.3	39.3	33.5	48.8	48.5	40.4	31.6	37.6	41.1	35.1	22.4	40.0	50.3	24.0	12.8	13.7	11.1	20.4	29.2	32.3	9.0	26.2	87.8	23.8	21.3	27.1	30.0	11.9	20.2	118.9	21.9	19.6	22.4	21.5	17.2	20.2	17.1	10.7	22.1	46.0	9.3	18.9	8.7	53.1	24.1	10.2	25.1	12.6	47.0	24.3	9.3	22.7	82.4	31.0	14.9	6.1	18.5	17.8	10.0	48.4	29.8	14.2	12.2	16.5	18.9	11.3	14.1	26.2	11.5	16.5	43.6	14.2	41.2	21.5	7.3	12.4	60.4	65.7	31.8	40.1	4.2	32.7	28.1	32.8	218.1	17.0	29.9	11.3	25.3
HDAC6	"FLJ16239, HD6, JM21, KIAA0901, PPP1R90"	ENSG00000094631	"Histone deacetylase 6"	Q9UBN7	X	48801377-48824982	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins"	"Autophagy, Transcription, Transcription regulation"	"Actin-binding, Chromatin regulator, Hydrolase, Repressor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 88.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003714, CAB004236, HPA026321"	Supported		Supported	Nucleoplasm		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 43: Testis - Unknown function"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	Nucleoplasm		"CAB004236: AB_627708, HPA003714: AB_1850544, HPA026321: AB_1850546"	"unprognostic (9.53e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.66e-2)"	"unprognostic (2.42e-2)"	"unprognostic (2.82e-2)"	"unprognostic (4.11e-3)"	"unprognostic (2.17e-2)"	"unprognostic (1.16e-1)"	"unprognostic (7.68e-2)"	"unprognostic (2.83e-1)"	"unprognostic (1.16e-3)"	"unprognostic (2.33e-2)"	"unprognostic (6.10e-2)"	"unprognostic (1.47e-1)"	"unprognostic (6.60e-2)"	"unprognostic (2.34e-1)"	"prognostic favorable (3.34e-4)"	21.9	26.0	26.6	14.2	30.7	22.9	23.6	31.1	54.2	29.6	29.8	27.8	17.8	26.8	10.6	24.4	28.2	11.1	26.0	26.7	33.0	57.9	97.3	25.2	15.6	32.6	32.7	32.5	26.3	22.3	45.6	13.8	33.9	24.4	16.1	27.9	21.6	12.2	26.1	21.4	28.0	15.3	28.9	29.4	26.6	53.8	30.6	18.8	27.1	16.1	15.1	23.7	22.8	31.0	31.0	25.7	49.6	19.1	20.2	16.6	33.4	14.4	12.4	27.2	26.2	24.9	25.7	29.9	13.8	17.1	34.6	21.3	30.6	15.5	23.2	27.7	19.1	40.7	32.2	26.0	18.3	19.2	60.4	25.7	25.1	21.5	25.3	24.8	23.5	37.4	45.9	31.9	17.7	10.9	27.0	29.3	18.5	14.2	24.5	23.1	53.5	31.3	15.8	13.3	25.9	25.3	29.5	8.7	17.4	63.4	36.1	17.5	19.1	21.5	26.7	29.3	14.2	29.6	31.3	21.3	21.3	24.0	21.5	0.0	5.1	5.8	4.7	8.3	3.4	3.7	3.3	3.4	7.6	5.3	3.1	2.9	2.5	3.6	11.7	8.3	4.0	4.9	26.6	30.7	31.1	54.2	26.7	33.0	32.6	32.7	33.9	28.9	30.6	31.0	11.4	19.2	25.1	20.9	12.5	7.5	10.2	8.8	6.2	37.6	10.7	10.4	10.6	8.6	17.5	18.4	50.1	11.5	12.6	21.4	19.6	7.9	48.1	10.0	13.0	10.3	14.4	11.4	15.2	7.4	12.3	10.7	21.9	13.2	6.3	22.5	13.6	51.9	11.1	40.4	18.4	15.5	10.2	12.3	9.8	18.4	14.0	13.2	5.4	10.3	12.7	21.9	18.6	17.1	19.0	7.2	13.2	11.3	12.8	7.1	17.8	47.6	12.4	34.0	13.1	15.5	11.1	88.4	41.7	8.6	5.8	9.7	9.7	21.8	16.2	7.2
HDAC7	"DKFZP586J0917, HDAC7A"	ENSG00000061273	"Histone deacetylase 7"	Q8WUI4	12	47782722-47833132	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, Hydrolase, Repressor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Hepatic stellate cells: 101.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	4	"neutrophil: 6.5"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 6.5"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004775			Supported	Cytosol		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Cytosol		"HPA004775: AB_1850548"	"unprognostic (3.83e-1)"	"unprognostic (9.49e-3)"	"unprognostic (1.37e-2)"	"unprognostic (4.46e-2)"	"unprognostic (6.56e-3)"	"unprognostic (2.22e-2)"	"unprognostic (2.50e-3)"	"unprognostic (1.26e-1)"	"prognostic unfavorable (5.16e-4)"	"unprognostic (1.28e-1)"	"unprognostic (2.07e-1)"	"unprognostic (2.38e-2)"	"prognostic unfavorable (8.25e-4)"	"unprognostic (6.24e-2)"	"unprognostic (4.38e-2)"	"unprognostic (9.69e-2)"	"prognostic favorable (4.65e-4)"	52.5	41.8	7.7	28.5	8.1	23.6	45.3	3.2	9.7	46.2	24.6	44.2	8.9	51.4	13.6	23.5	50.3	16.8	31.6	4.1	4.8	29.3	6.0	55.0	27.3	17.2	7.1	44.9	14.5	20.1	20.6	19.5	10.2	34.4	4.8	2.8	30.6	17.1	16.2	40.1	28.6	16.9	3.4	38.4	27.2	7.9	10.7	80.0	39.2	9.4	15.2	44.3	38.5	7.6	41.6	28.1	28.6	46.9	21.9	60.2	25.3	39.4	30.7	28.3	18.8	37.4	38.4	80.5	126.8	37.1	13.9	37.8	6.7	31.4	10.5	38.8	13.6	27.6	29.9	8.6	23.6	9.1	1.2	39.4	10.8	28.6	15.4	51.6	58.6	45.9	29.9	33.4	18.6	18.0	83.2	21.8	39.4	9.1	29.1	64.2	14.7	29.6	12.1	26.9	8.1	18.8	30.6	14.1	14.4	18.4	13.4	12.0	66.6	56.9	61.0	47.6	28.9	70.8	58.8	67.4	23.8	41.9	19.1	0.0	1.4	0.0	0.8	0.5	0.9	0.8	0.7	0.7	0.4	0.5	0.8	0.6	6.5	0.9	0.5	0.3	0.3	1.5	7.7	8.1	3.2	9.7	4.1	4.8	17.2	7.1	10.2	3.4	10.7	7.6	80.6	41.7	32.1	34.9	32.7	13.8	26.8	28.7	8.6	20.3	22.5	17.4	13.4	28.6	28.6	36.8	0.0	4.8	18.6	5.3	1.9	31.6	15.5	26.2	39.4	79.3	7.3	40.4	19.9	23.0	3.5	37.8	25.5	58.4	8.8	20.2	101.7	2.0	15.6	28.6	17.5	9.6	24.4	32.7	14.1	6.9	55.0	13.3	14.2	46.9	20.5	11.7	28.8	10.6	13.6	66.8	7.3	33.1	42.9	69.1	0.6	3.8	31.8	4.0	26.3	18.3	26.9	1.1	3.7	10.3	21.6	2.9	28.2	9.3	8.1	46.8
HDGFL3	"Hdgfrp3, HRP-3"	ENSG00000166503	"HDGF like 3"	Q9Y3E1	15	83112738-83207823	"Predicted intracellular proteins"		"Growth factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 96.9;Breast glandular cells: 34.3;Endometrial ciliated cells: 34.2;Endometrial stromal cells: 48.4;Granulosa cells: 41.4;Theca cells: 48.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"NK-cell: 1.8"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040719	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 21: Non-specific - Transcription"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm		"HPA040719: AB_2677097"	"unprognostic (1.28e-3)"	"unprognostic (1.13e-1)"	"unprognostic (3.52e-2)"	"unprognostic (3.38e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.55e-2)"	"unprognostic (1.91e-2)"	"unprognostic (2.95e-2)"	"unprognostic (2.99e-2)"	"unprognostic (4.68e-2)"	"unprognostic (1.93e-3)"	"unprognostic (3.39e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.06e-2)"	"unprognostic (3.55e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.85e-1)"	6.3	5.9	11.1	2.9	12.0	2.4	5.6	11.6	14.9	5.0	7.2	7.0	1.2	6.0	8.3	3.6	4.7	4.0	5.7	11.8	11.5	4.8	0.8	5.1	2.9	10.5	10.5	5.0	1.7	17.7	6.8	3.0	10.5	4.9	2.6	8.5	2.4	4.6	2.5	2.0	2.9	5.3	11.1	3.4	2.9	9.7	11.8	4.3	6.5	2.5	2.2	5.6	3.8	10.7	7.2	6.2	17.9	9.3	7.4	10.1	5.9	6.7	11.9	7.0	7.3	0.5	13.2	0.1	8.0	1.8	7.5	2.9	19.9	10.3	10.1	33.5	10.2	11.6	3.0	0.1	10.3	0.4	1.8	6.0	8.4	8.0	13.9	10.8	17.0	12.4	9.0	0.3	13.2	7.4	7.1	0.7	13.3	0.0	3.5	0.1	17.4	0.1	10.5	14.6	22.5	17.1	10.1	2.4	8.9	12.9	2.8	1.3	14.7	14.5	10.8	3.0	20.9	2.1	0.8	8.6	6.7	5.5	10.0	0.7	0.3	1.0	0.5	0.1	0.0	0.1	0.1	0.1	0.2	0.2	0.2	0.2	0.8	1.8	0.1	0.2	0.0	0.1	11.1	12.0	11.6	14.9	11.8	11.5	10.5	10.5	10.5	11.1	11.8	10.7	96.9	12.8	17.8	0.0	0.2	0.0	0.0	0.0	0.0	0.0	34.3	27.3	0.0	0.0	10.5	20.2	0.0	0.3	14.1	0.0	15.6	21.1	0.0	34.2	48.4	25.8	0.0	0.0	0.0	22.9	0.6	15.4	0.0	25.6	5.1	41.4	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.0	10.3	0.0	0.0	0.0	0.0	23.6	0.0	0.0	3.1	0.0	0.0	0.3	9.5	0.0	0.0	0.0	20.4	0.0	0.0	0.0	0.0	0.3	3.5	48.1	0.0	0.0
HDLBP	"HBP, VGL"	ENSG00000115677	"High density lipoprotein binding protein"	Q00341	2	241227264-241317061	"Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Cholesterol metabolism, Lipid metabolism, Lipid transport, Steroid metabolism, Sterol metabolism, Transport"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA004189, CAB026457"	Enhanced		Supported	Cytosol		NA	NA		95000	"Cluster 14: Monocytes - Unknown function"	"Cluster 25: Pancreas - Digestion"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 25: Spermatids - Spermatogenesis"	Cytosol		"CAB026457: , HPA004189: AB_1079044"	"unprognostic (2.57e-2)"	"unprognostic (1.13e-2)"	"unprognostic (2.13e-2)"	"unprognostic (1.51e-1)"	"unprognostic (4.46e-1)"	"unprognostic (1.19e-1)"	"prognostic unfavorable (2.58e-5)"	"unprognostic (1.70e-2)"	"unprognostic (1.71e-1)"	"unprognostic (4.45e-2)"	"unprognostic (4.39e-3)"	"unprognostic (3.92e-2)"	"unprognostic (9.48e-3)"	"unprognostic (2.47e-2)"	"unprognostic (1.79e-1)"	"prognostic unfavorable (6.39e-5)"	"prognostic unfavorable (4.12e-4)"	159.7	135.7	54.9	114.0	62.4	105.4	150.9	54.7	55.0	204.1	169.6	181.9	136.2	138.5	180.0	194.2	212.9	156.1	160.3	59.3	55.3	135.1	247.7	112.8	81.2	67.6	65.4	151.4	603.8	164.1	141.6	176.1	62.1	182.0	171.1	66.8	446.8	143.0	367.6	118.6	136.0	171.8	60.2	79.2	231.6	226.5	78.0	74.7	191.3	365.8	111.1	158.6	98.6	76.0	310.0	239.5	237.4	383.7	587.9	715.3	362.6	736.7	719.9	319.7	451.3	233.1	299.2	93.2	88.1	1039.3	334.0	235.2	356.9	465.8	528.2	150.4	236.0	323.0	305.1	535.7	566.7	233.0	251.4	528.8	369.1	466.0	515.9	500.4	448.1	140.9	310.1	120.0	511.9	309.5	120.4	106.1	237.9	290.4	161.2	111.7	511.9	175.5	255.1	380.1	208.4	223.5	332.3	334.5	278.4	304.2	262.6	201.8	585.4	402.1	255.1	551.5	325.3	136.2	130.8	166.5	488.1	161.1	371.8	26.0	39.3	17.4	15.6	41.0	20.3	19.6	17.7	18.8	41.3	12.7	15.5	15.1	22.0	19.2	58.1	26.4	18.1	27.5	54.9	62.4	54.7	55.0	59.3	55.3	67.6	65.4	62.1	60.2	78.0	76.0	53.9	76.9	102.7	38.5	60.6	70.2	117.4	80.4	150.2	41.0	125.3	98.8	220.5	71.4	124.9	75.4	43.8	133.9	34.7	176.2	135.0	106.7	111.0	152.8	178.3	80.8	96.5	72.6	44.5	122.1	166.5	156.3	203.4	168.2	68.4	199.3	86.7	199.3	94.6	69.0	45.9	291.1	30.5	70.3	66.4	398.0	148.8	75.1	56.9	46.9	77.8	53.5	20.6	46.3	58.1	116.5	118.4	174.9	354.7	203.9	136.3	117.9	163.3	40.0	65.7	126.5	117.0	132.1	120.7	192.4	77.6	215.5	50.7	134.0	163.2	156.1
HEATR3	FLJ20718	ENSG00000155393	"HEAT repeat containing 3"	Q7Z4Q2	16	50065970-50107272	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041990, HPA058579"	Uncertain		Enhanced	Nucleoplasm,Cytosol		Yes	No			"Cluster 7: Monocytes - Unknown function"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	Nucleoplasm	Cytosol	"HPA041990: AB_10793940, HPA058579: AB_2683762"	"unprognostic (7.36e-3)"	"unprognostic (2.72e-1)"	"unprognostic (2.01e-3)"	"unprognostic (1.97e-1)"	"unprognostic (1.20e-1)"	"unprognostic (4.80e-3)"	"prognostic unfavorable (4.11e-5)"	"unprognostic (7.68e-2)"	"unprognostic (5.11e-2)"	"unprognostic (8.79e-2)"	"unprognostic (4.96e-2)"	"unprognostic (1.96e-1)"	"prognostic unfavorable (5.16e-6)"	"unprognostic (2.26e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.86e-1)"	"unprognostic (3.17e-2)"	7.1	8.2	3.8	9.0	3.7	5.6	5.3	4.6	4.2	5.1	4.3	7.0	4.9	5.0	4.5	8.0	4.8	4.2	6.4	3.7	3.6	6.7	10.2	6.3	6.6	4.2	3.2	3.3	8.0	4.8	6.5	5.8	3.4	4.9	6.3	4.8	6.0	3.4	12.0	6.3	7.0	5.3	3.2	12.6	6.6	5.8	3.8	4.6	3.7	6.2	6.2	5.1	5.1	3.9	13.0	12.8	11.8	18.6	7.0	9.6	12.6	15.5	10.1	15.0	6.0	15.9	9.4	24.4	10.9	14.7	5.6	15.1	14.1	11.3	17.2	6.1	15.4	12.1	9.0	20.4	10.2	21.1	23.5	7.5	7.8	10.4	6.2	6.6	12.2	12.6	15.5	3.9	14.9	7.8	16.2	26.4	13.8	15.5	13.1	17.6	15.8	19.8	8.4	10.4	15.1	8.0	14.8	18.9	10.0	8.8	8.5	15.4	16.1	12.0	8.0	9.1	11.8	9.8	8.0	21.3	11.7	20.9	12.0	0.5	2.4	0.5	0.9	2.8	1.0	0.6	0.5	1.0	1.7	0.8	0.8	0.9	0.5	0.7	2.6	1.5	0.9	1.0	3.8	3.7	4.6	4.2	3.7	3.6	4.2	3.2	3.4	3.2	3.8	3.9	4.2	3.2	5.8	7.8	4.6	3.2	1.4	1.5	3.4	7.8	3.1	2.0	6.0	2.8	1.8	1.8	16.7	3.5	7.1	3.3	7.9	2.4	10.7	3.7	6.8	4.6	3.5	3.8	21.2	3.1	3.6	4.7	7.7	3.8	1.3	6.5	1.8	9.6	9.4	1.7	16.7	3.2	4.1	22.2	4.7	18.3	3.4	13.9	1.8	7.5	13.3	2.4	3.1	20.1	12.8	2.9	2.5	2.2	7.2	1.9	4.7	4.1	2.8	8.1	0.0	2.5	4.2	5.3	4.8	7.6	1.7	1.0	5.8	6.7	5.8	1.5
HEATR5B	"DKFZp686P15184, KIAA1414"	ENSG00000008869	"HEAT repeat containing 5B"	Q9P2D3	2	36968383-37084372	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 62.3;Inhibitory neurons: 58.9;Oligodendrocyte precursor cells: 57.3;Oligodendrocytes: 69.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042025, HPA055639"	Approved		Approved	"Nuclear speckles,Vesicles,Cytosol"		NA	NA		6800	"Cluster 46: Basophils - DNA binding"	"Cluster 34: Non-specific - Transcription"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 59: Non-specific - Transcription"	"Nuclear speckles, Vesicles, Cytosol"		"HPA042025: AB_10959880, HPA055639: AB_2682870"	"unprognostic (3.11e-2)"	"unprognostic (1.65e-2)"	"unprognostic (4.07e-1)"	"unprognostic (6.05e-2)"	"unprognostic (3.70e-2)"	"unprognostic (7.75e-2)"	"unprognostic (5.95e-2)"	"unprognostic (3.33e-3)"	"unprognostic (8.26e-2)"	"unprognostic (3.08e-2)"	"unprognostic (1.66e-1)"	"unprognostic (8.07e-2)"	"unprognostic (5.80e-3)"	"unprognostic (8.69e-2)"	"unprognostic (4.18e-1)"	"unprognostic (2.72e-1)"	"unprognostic (3.95e-1)"	9.7	8.8	7.1	15.0	7.1	24.3	14.5	11.7	9.8	9.9	4.9	9.9	10.8	9.5	16.9	11.7	8.1	10.7	9.7	7.4	6.4	9.3	9.3	10.8	31.9	5.8	5.2	9.8	18.2	13.4	6.3	10.2	6.4	11.4	13.5	24.3	14.3	7.7	4.9	18.2	11.5	8.3	3.9	19.0	12.3	9.6	7.0	24.7	11.8	9.4	31.2	10.1	8.5	8.1	16.2	8.1	11.7	17.8	11.9	11.7	14.9	10.1	7.4	9.0	9.1	9.6	10.9	34.6	7.1	8.6	11.9	13.4	11.6	8.2	11.7	17.0	12.6	22.6	11.3	13.1	7.4	24.5	28.5	10.8	11.2	13.0	12.3	9.9	15.5	18.3	21.6	29.8	10.9	9.6	21.5	17.4	7.7	16.7	5.6	20.5	11.9	26.3	10.5	13.8	14.3	12.6	10.6	16.7	7.8	11.7	12.0	7.9	17.2	13.5	7.7	9.9	7.9	18.5	16.2	39.0	11.0	14.3	9.0	18.3	5.0	12.3	7.7	2.8	7.1	9.7	8.5	8.7	9.0	14.0	8.7	7.6	5.2	7.5	4.4	11.2	9.7	5.9	7.1	7.1	11.7	9.8	7.4	6.4	5.8	5.2	6.4	3.9	7.0	8.1	12.9	22.4	10.3	35.9	20.8	9.8	4.2	4.7	6.8	13.0	11.9	8.3	20.8	8.6	7.1	5.5	10.4	7.0	24.4	11.3	1.9	4.6	6.3	14.8	10.0	9.5	5.4	18.7	62.3	6.2	6.2	9.4	25.5	11.1	7.0	9.8	11.7	7.8	6.3	16.8	58.9	8.9	6.1	17.0	15.7	2.6	9.0	13.2	7.2	56.2	9.2	6.5	16.5	57.3	69.7	8.8	6.3	6.4	17.6	5.5	12.7	5.4	12.8	16.2	19.7	6.5	10.6	3.6	11.2	11.7	11.6	5.6	14.5	7.7	8.7	4.9
HECW1	"KIAA0322, NEDL1"	ENSG00000002746	"HECT, C2 and WW domain containing E3 ubiquitin protein ligase 1"	Q76N89	7	43112629-43566001	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 16.4;kidney: 7.8"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 135.6;Excitatory neurons: 533.3;Inhibitory neurons: 157.3;Late spermatids: 72.0;Oligodendrocyte precursor cells: 277.9"	"Not detected"	"Not detected"			"Region enriched"	"Detected in many"	4	"cerebral cortex: 16.4"	"Group enriched"	"Detected in some"	4	"basophil: 4.9;neutrophil: 3.3"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 4.9"	"Cell line enhanced"	"Detected in some"		"A549: 3.8;GAMG: 3.7;U-266/70: 12.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007203, HPA007593, HPA007609"	Uncertain		Supported	Cytosol		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 58: Brain - Synaptic function"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Cytosol		"HPA007203: AB_2667776, HPA007593: AB_1852305, HPA007609: AB_2117518"	"unprognostic (1.40e-1)"	"unprognostic (2.85e-3)"	"unprognostic (2.57e-1)"	"unprognostic (4.39e-1)"	"unprognostic (2.43e-2)"	"unprognostic (2.80e-2)"	"unprognostic (8.65e-4)"	"unprognostic (6.93e-2)"	"unprognostic (7.30e-2)"	"unprognostic (7.31e-2)"	"unprognostic (3.43e-2)"	"unprognostic (2.67e-2)"	"unprognostic (1.43e-3)"	"unprognostic (1.64e-2)"	"unprognostic (5.23e-3)"	"unprognostic (1.89e-2)"	"unprognostic (2.42e-2)"	0.1	0.0	1.5	0.2	1.7	0.5	0.2	0.0	16.4	0.1	0.0	0.2	0.0	0.2	0.6	1.0	0.1	1.9	0.0	0.7	0.0	7.8	0.1	0.1	0.4	0.2	0.0	0.3	0.0	0.2	0.0	0.1	0.1	1.3	0.1	2.2	0.4	0.2	0.9	0.6	0.1	0.1	0.0	0.1	0.3	1.8	0.2	0.0	0.5	2.6	0.2	0.3	0.1	3.8	0.0	3.8	0.3	0.5	0.0	0.0	0.0	1.2	2.2	0.1	0.5	0.0	0.0	0.2	2.3	2.2	3.7	0.2	0.0	0.0	0.2	0.1	0.7	0.0	0.3	0.2	0.2	1.1	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.2	0.0	2.3	0.0	0.0	0.0	0.0	1.8	0.1	0.7	0.4	0.0	0.0	0.0	0.0	0.1	0.4	0.4	0.0	0.0	0.2	0.2	0.0	0.0	0.6	0.8	0.9	0.3	12.0	0.4	0.0	2.7	0.3	0.0	4.9	0.8	0.7	0.3	0.5	0.2	0.6	0.3	0.1	0.1	1.0	0.3	0.3	3.3	0.6	0.6	0.9	0.1	0.0	1.5	1.7	0.0	16.4	0.7	0.0	0.2	0.0	0.1	0.0	0.2	3.8	0.0	0.0	0.0	7.8	0.1	0.4	0.3	0.0	0.0	15.4	0.1	0.3	1.4	0.0	0.0	0.0	4.2	0.0	0.0	0.5	0.0	0.0	135.6	1.1	3.6	0.2	0.0	0.0	533.3	0.0	0.1	0.7	0.0	0.7	0.0	0.0	0.4	0.1	0.0	45.4	157.3	0.1	0.0	0.0	1.4	72.0	0.3	0.2	0.0	24.4	0.1	0.6	0.0	277.9	4.8	0.0	1.4	0.4	0.0	0.4	4.3	15.8	0.0	1.9	0.0	0.6	0.4	3.2	3.3	0.3	0.3	0.0	0.6	0.2	0.5	0.3
HELB		ENSG00000127311	"DNA helicase B"	Q8NG08	12	66302493-66343643	"Enzymes, Predicted intracellular proteins"	"DNA damage, DNA repair"	"Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in some"			"Cell type enhanced"	"Detected in many"		"dendritic cells: 32.8;T-cells: 43.5"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"A549: 2.7;HDLM-2: 2.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052461			Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 20: HeLa - Mitochondria"	"Cluster 24: Non-specific - Transcription regulation"	"Nucleoplasm, Plasma membrane"		"HPA052461: "	"unprognostic (1.33e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.97e-1)"	"unprognostic (9.06e-3)"	"unprognostic (8.65e-2)"	"unprognostic (1.34e-2)"	"unprognostic (2.00e-1)"	"unprognostic (5.22e-2)"	"unprognostic (1.20e-1)"	"unprognostic (2.13e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.45e-1)"	"unprognostic (1.39e-6)"	"unprognostic (3.97e-3)"	"unprognostic (9.19e-4)"	"unprognostic (1.93e-1)"	"unprognostic (9.50e-3)"	0.8	0.3	0.1	0.4	0.1	1.0	0.7	0.1	0.3	0.5	0.2	0.7	0.0	0.4	0.0	0.6	0.5	0.1	0.4	0.1	0.1	0.7	1.2	1.1	0.5	0.4	0.2	0.8	0.9	0.1	1.2	0.0	0.3	0.8	0.1	0.1	0.8	0.0	0.2	0.5	1.2	0.1	0.2	1.8	0.8	0.4	0.3	0.4	0.7	0.0	0.3	0.5	0.6	0.4	0.4	2.7	0.2	0.6	0.1	0.1	0.5	0.6	0.1	0.6	1.2	0.6	1.5	1.0	0.9	0.1	0.9	0.8	0.5	0.2	0.3	2.6	0.2	0.8	2.1	0.0	0.0	0.0	0.5	0.0	0.0	0.7	0.1	0.2	0.1	1.3	0.6	1.1	0.4	1.1	0.0	0.2	0.0	1.1	0.5	0.2	1.0	0.2	0.0	0.0	0.1	0.3	1.7	0.2	0.4	0.4	0.3	1.7	0.2	0.2	0.5	0.3	0.5	1.2	1.0	0.5	0.1	0.9	0.4	4.5	0.8	5.8	2.6	0.5	4.2	0.4	4.9	3.9	1.7	0.7	5.1	4.1	0.7	3.5	0.2	0.6	5.6	1.0	0.1	0.1	0.1	0.3	0.1	0.1	0.4	0.2	0.3	0.2	0.3	0.4	14.7	0.0	7.5	1.3	14.0	0.6	2.5	0.6	10.8	3.2	10.3	9.8	4.0	0.0	6.6	0.0	12.5	3.0	32.8	4.3	1.9	1.7	0.5	12.6	11.5	9.9	4.8	6.1	7.7	1.1	2.5	5.7	11.7	20.9	2.5	10.3	4.6	2.8	3.3	13.5	5.2	5.6	2.0	5.5	3.3	0.8	3.4	10.3	3.6	20.6	8.0	2.4	14.4	0.0	16.2	2.4	3.0	0.7	21.7	5.8	5.9	3.2	3.4	6.5	0.0	11.3	8.0	1.2	1.5	5.2	1.7	2.5	43.5	9.2	6.4	1.8
HEPACAM2	FLJ38683	ENSG00000188175	"HEPACAM family member 2"	A8MVW5	7	93188534-93226469	"Predicted membrane proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"intestine: 96.2"	"Group enriched"	"Detected in some"	11	"Enteroendocrine cells: 218.2;Intestinal goblet cells: 387.5;Ionocytes: 349.9;Paneth cells: 318.1"	"Group enriched"	"Detected in many"	5	"colorectal cancer: 8.4;pancreatic cancer: 10.7;renal cancer: 10.6;stomach cancer: 5.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	36	"SCLC-21H: 172.1"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA012381			Supported	"Nucleoplasm,Vesicles,Mitotic spindle"		Yes	NA		210000		"Cluster 9: Intestine - Unknown function"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 27: Mucus-secreting cells - Mucin production"	"Vesicles, Mitotic spindle"	Nucleoplasm	"HPA012381: AB_1853037"	"unprognostic (2.01e-3)"	"unprognostic (6.05e-2)"	"prognostic favorable (9.73e-5)"	"unprognostic (1.33e-2)"	"unprognostic (7.27e-2)"	"unprognostic (2.24e-2)"	"unprognostic (4.48e-2)"	"unprognostic (8.40e-3)"	"unprognostic (7.61e-2)"	"unprognostic (8.68e-2)"	"unprognostic (5.37e-3)"	"unprognostic (4.93e-2)"	"unprognostic (3.64e-3)"	"unprognostic (2.06e-1)"	"unprognostic (4.73e-2)"	"unprognostic (3.82e-1)"	"unprognostic (6.34e-2)"	0.1	0.1	0.0	2.3	0.0	2.5	8.9	0.0	0.1	0.0	0.0	64.3	30.1	0.0	0.5	0.1	0.0	0.2	0.1	0.0	0.0	15.2	0.0	0.1	0.0	0.1	0.1	0.0	4.3	0.4	7.3	0.2	0.0	0.8	96.2	0.0	2.6	1.4	0.0	0.0	48.0	1.5	0.1	0.1	10.1	3.2	0.0	0.1	0.0	0.0	1.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	4.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	3.5	0.2	0.0	0.0	0.4	0.1	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	172.1	0.2	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.2	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.7	0.4	0.3	1.1	0.7	0.0	0.0	15.1	6.6	0.2	0.0	0.9	5.5	0.0	0.0	0.0	17.2	9.8	0.1	2.5	0.0	0.0	0.1	218.2	18.7	0.5	0.0	0.0	0.1	27.5	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.6	387.5	349.9	0.0	0.0	2.4	0.0	0.0	7.2	1.0	0.0	0.0	0.0	0.0	2.2	0.0	318.1	0.0	0.1	0.9	11.5	0.0	0.3	0.0	0.0	0.0	0.1	5.6	1.2	0.0	0.1	0.1	0.1	0.0	19.7	0.3
HERC2	"D15F37S1, jdf2, p528"	ENSG00000128731	"HECT and RLD domain containing E3 ubiquitin protein ligase 2"	O95714	15	28111040-28322179	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"DNA damage, DNA repair, Ubl conjugation pathway"	Transferase	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HEL: 54.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017188, HPA048389, HPA074166"	Approved		Supported	"Plasma membrane,Cytosol"		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 59: Non-specific - Translation"	"Cluster 36: HEL - Hemostasis"	"Cluster 40: Granulosa cells - Unknown function"	Cytosol	"Plasma membrane"	"CAB017188: , HPA048389: AB_2680382, HPA074166: "	"unprognostic (1.59e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.92e-1)"	"unprognostic (6.64e-2)"	"unprognostic (6.62e-2)"	"unprognostic (5.74e-2)"	"unprognostic (9.17e-2)"	"unprognostic (2.08e-1)"	"unprognostic (1.87e-1)"	"unprognostic (4.11e-2)"	"unprognostic (9.40e-3)"	"unprognostic (3.60e-2)"	"prognostic favorable (1.41e-7)"	"unprognostic (7.66e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.34e-2)"	"unprognostic (1.71e-1)"	5.3	5.7	2.5	2.3	2.9	4.0	4.9	1.5	3.1	5.5	3.0	9.3	2.6	7.6	1.7	5.2	6.1	2.2	7.4	2.3	1.1	3.7	3.7	5.1	2.3	2.0	1.8	8.3	6.1	5.4	6.3	2.7	2.7	4.4	2.8	5.3	4.8	2.9	14.2	5.3	6.1	3.7	0.4	4.3	6.3	4.8	2.7	4.4	5.8	9.3	2.4	5.6	5.0	6.2	8.5	16.5	11.2	4.7	9.2	6.9	3.2	6.0	7.1	7.6	7.3	8.6	1.1	8.5	7.2	10.4	11.5	8.5	12.0	5.9	5.6	5.2	7.8	54.0	20.2	2.9	3.5	12.8	4.1	5.7	4.5	9.0	11.2	4.9	10.2	7.0	21.2	3.4	7.3	3.9	2.9	4.3	3.4	6.4	7.1	10.2	16.0	0.7	2.6	18.2	12.3	7.1	14.6	4.1	4.5	5.8	4.8	14.8	15.3	14.0	9.2	5.5	9.1	2.2	3.3	7.7	6.5	5.9	7.6	0.1	0.2	0.1	0.3	0.0	0.1	0.2	0.1	0.1	0.2	0.4	0.2	0.1	0.0	0.1	0.1	0.6	0.2	0.1	2.5	2.9	1.5	3.1	2.3	1.1	2.0	1.8	2.7	0.4	2.7	6.2	56.2	22.4	23.5	68.9	34.3	16.4	15.3	18.1	27.9	107.9	39.1	31.2	66.6	21.5	23.6	64.4	148.0	25.9	28.5	31.8	1.9	28.7	13.0	35.0	55.8	73.3	28.1	67.9	88.9	30.4	15.5	34.3	43.3	29.6	3.8	135.0	38.9	36.7	19.0	122.8	82.9	32.1	16.2	22.3	20.7	15.8	56.2	22.1	69.4	84.3	26.9	41.0	45.3	65.9	89.7	36.6	30.8	52.3	56.6	20.5	31.1	19.8	19.6	142.9	65.7	46.0	43.2	72.5	66.4	38.3	21.0	17.8	30.0	62.7	35.5	11.5
HERC3	KIAA0032	ENSG00000138641	"HECT and RLD domain containing E3 ubiquitin protein ligase 3"	Q15034	4	88592434-88708541	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"retina: 114.1"	"Group enriched"	"Detected in some"	9	"Cardiomyocytes: 23.8;Cytotrophoblasts: 7.0;Extravillous trophoblasts: 17.3;Hofbauer cells: 9.3;Syncytiotrophoblasts: 7.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 48.2;hTERT-HME1: 68.6"									HPA039170	Approved		Supported	Cytosol		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 77: Retina - Visual perception"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 38: Extravillous trophoblasts - Unknown function"	Cytosol		"HPA039170: AB_10673414"	"unprognostic (2.21e-2)"	"unprognostic (1.65e-2)"	"unprognostic (9.28e-3)"	"unprognostic (3.24e-1)"	"unprognostic (6.26e-2)"	"unprognostic (1.88e-2)"	"unprognostic (1.30e-2)"	"unprognostic (1.85e-2)"	"unprognostic (9.77e-2)"	"unprognostic (6.51e-3)"	"unprognostic (3.48e-3)"	"unprognostic (2.58e-2)"	"prognostic favorable (5.65e-7)"	"unprognostic (1.83e-1)"	"unprognostic (3.21e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.16e-2)"	11.6	10.2	10.6	13.3	13.4	24.3	14.0	24.5	12.5	13.3	9.4	11.4	11.6	9.9	9.6	16.5	10.2	12.0	21.9	9.6	9.5	14.9	12.1	13.6	17.1	13.6	9.4	12.0	9.3	21.1	9.4	10.1	14.0	19.5	12.1	114.1	12.1	10.9	19.3	18.2	12.1	13.6	7.8	16.1	12.8	3.2	10.0	16.8	14.5	24.4	15.0	11.0	15.3	16.8	12.2	2.4	2.4	3.8	15.3	23.9	9.0	14.5	24.2	13.0	8.5	2.8	14.8	12.0	7.9	48.2	6.1	5.2	4.4	14.1	13.0	7.2	3.4	8.9	6.3	1.9	7.9	22.6	15.7	13.2	15.4	12.7	68.6	8.9	14.2	7.5	7.8	6.2	29.5	3.8	17.8	6.7	0.4	9.6	3.9	19.7	16.5	4.5	8.3	2.6	3.4	3.2	20.4	10.7	4.6	3.9	1.9	12.2	25.7	16.7	9.6	19.9	10.4	11.5	3.1	7.5	11.5	10.2	6.1	7.8	4.9	7.3	3.8	5.6	4.4	4.3	4.7	4.0	5.4	4.2	7.0	4.4	16.2	2.4	9.2	2.4	8.1	2.9	10.6	13.4	24.5	12.5	9.6	9.5	13.6	9.4	14.0	7.8	10.0	16.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.8	0.0	0.0	0.0	0.0	7.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	17.3	1.2	0.0	0.0	0.0	0.0	0.0	0.0	9.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	7.4	0.0	0.0	0.0	0.0
HERC4	"DKFZP564G092, KIAA1593"	ENSG00000148634	"HECT and RLD domain containing E3 ubiquitin protein ligase 4"	Q5GLZ8	10	67921899-68075301	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Differentiation, Spermatogenesis, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocyte precursor cells: 174.9;Oligodendrocytes: 209.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"BJ: 201.4;fHDF/TERT166: 226.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045453, HPA070301"	Uncertain		Supported	"Nucleoli fibrillar center,Cytosol"		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Cytosol	"Nucleoli fibrillar center"	"HPA045453: AB_10961917, HPA070301: AB_2686247"	"unprognostic (3.66e-2)"	"unprognostic (6.31e-2)"	"unprognostic (1.58e-1)"	"unprognostic (2.30e-1)"	"unprognostic (1.42e-1)"	"unprognostic (4.23e-2)"	"unprognostic (3.51e-2)"	"unprognostic (1.01e-3)"	"unprognostic (3.54e-1)"	"unprognostic (8.57e-2)"	"unprognostic (4.94e-3)"	"unprognostic (2.25e-2)"	"prognostic unfavorable (3.86e-5)"	"unprognostic (1.17e-1)"	"unprognostic (2.40e-1)"	"unprognostic (3.98e-1)"	"unprognostic (2.31e-2)"	13.9	19.6	18.2	14.4	18.9	10.9	14.3	19.5	23.5	15.2	15.3	14.1	13.8	14.9	14.0	14.5	13.4	13.3	13.6	20.6	22.4	13.7	16.6	13.9	21.0	19.4	19.7	15.3	11.1	12.0	14.1	16.5	19.4	12.2	15.9	13.9	11.5	11.4	13.5	13.4	14.6	15.6	18.1	18.2	11.6	14.2	21.1	15.2	13.1	12.3	19.4	16.2	14.3	26.7	75.4	30.4	16.7	28.5	47.5	63.9	15.5	201.4	125.5	75.5	47.6	17.5	35.3	29.7	14.3	226.7	40.6	40.9	21.1	28.9	102.0	17.6	9.2	13.7	51.3	12.2	22.6	17.3	21.3	30.2	33.8	39.3	34.4	89.1	47.5	15.0	14.9	14.3	117.4	35.2	11.3	19.9	9.9	15.8	49.0	15.3	7.6	8.2	32.3	23.7	8.7	9.4	66.1	26.4	26.5	37.6	15.4	20.1	65.0	38.2	17.5	94.7	31.9	8.7	11.2	17.8	67.7	32.3	13.6	10.8	5.0	6.6	3.9	4.1	5.0	3.4	4.1	4.5	5.7	3.4	4.1	4.2	6.7	5.2	4.1	1.6	5.6	3.7	18.2	18.9	19.5	23.5	20.6	22.4	19.4	19.7	19.4	18.1	21.1	26.7	29.8	48.1	29.3	127.0	41.0	50.3	33.7	27.2	26.2	50.1	29.1	16.6	23.0	14.3	24.1	18.4	43.8	29.3	38.7	78.7	7.9	19.5	66.4	44.3	45.4	30.9	22.1	32.4	170.2	12.2	40.8	30.3	34.1	70.9	30.4	31.3	28.5	24.5	23.6	53.8	148.8	29.9	26.4	42.9	23.3	47.4	26.8	30.9	17.8	149.9	36.0	18.9	40.2	174.9	209.2	38.6	52.3	19.2	17.4	42.6	37.8	24.9	25.5	45.8	6.6	33.2	28.1	25.2	12.4	23.4	60.9	15.6	40.9	38.5	21.9	48.5
HERC6	FLJ20637	ENSG00000138642	"HECT and RLD domain containing E3 ubiquitin protein ligase family member 6"	Q8IVU3	4	88378739-88443097	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"BJ hTERT+ SV40 Large T+: 116.1;BJ hTERT+ SV40 Large T+ RasG12V: 85.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035846	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 13: T-cells - Unknown function"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 40: Granulosa cells - Unknown function"	Cytosol	Nucleoplasm	"HPA035846: AB_10673487"	"unprognostic (1.95e-2)"	"unprognostic (2.71e-1)"	"unprognostic (2.23e-2)"	"unprognostic (2.67e-2)"	"unprognostic (8.61e-2)"	"unprognostic (2.98e-2)"	"unprognostic (2.78e-2)"	"unprognostic (3.27e-1)"	"unprognostic (1.49e-1)"	"unprognostic (5.95e-2)"	"unprognostic (1.52e-2)"	"unprognostic (6.22e-2)"	"prognostic favorable (7.14e-5)"	"unprognostic (1.80e-1)"	"unprognostic (2.59e-1)"	"unprognostic (8.43e-3)"	"unprognostic (3.77e-2)"	4.1	5.5	6.5	5.4	7.2	7.9	6.2	5.2	8.8	14.2	4.3	6.1	5.3	8.5	4.2	20.9	9.7	10.7	9.6	7.0	7.6	6.0	4.8	8.1	5.0	8.2	6.6	8.3	5.4	7.1	4.4	5.5	7.3	8.4	6.1	4.4	30.5	5.1	3.0	4.1	5.3	8.0	11.7	8.2	7.2	3.9	6.9	12.3	4.3	4.7	5.3	6.0	11.2	6.8	6.7	4.5	0.3	0.9	0.3	3.8	1.2	0.8	22.1	116.1	85.8	0.4	8.3	0.0	1.5	2.1	18.8	2.5	10.9	5.7	7.6	13.9	2.2	6.3	3.8	0.6	3.7	11.3	4.2	5.2	1.3	9.1	0.3	7.0	3.4	5.2	0.0	1.5	2.6	4.1	5.3	3.6	1.5	6.0	2.2	3.6	0.1	0.5	7.8	8.2	0.3	2.7	8.2	2.7	13.5	5.6	4.8	2.0	1.2	1.6	2.1	0.2	2.1	0.3	0.1	0.0	5.2	2.5	5.4	4.4	3.2	4.7	6.4	3.4	12.8	3.5	8.9	6.3	2.8	3.0	6.9	4.7	1.9	6.0	7.4	0.3	12.5	4.2	6.5	7.2	5.2	8.8	7.0	7.6	8.2	6.6	7.3	11.7	6.9	6.8	11.4	12.8	10.6	14.4	5.8	2.8	5.2	3.3	4.6	18.1	4.9	4.6	13.9	7.2	9.8	5.5	16.7	5.8	5.0	8.3	0.0	7.8	1.3	6.4	3.9	11.5	1.8	4.8	21.5	17.4	1.8	6.6	5.6	5.0	5.7	25.9	5.3	2.2	5.0	1.7	25.8	2.9	4.1	2.2	0.8	1.6	4.4	4.7	5.4	28.1	5.7	3.7	4.1	24.1	2.8	13.3	2.4	5.7	3.8	8.3	6.2	4.1	14.6	1.0	6.6	2.0	3.6	0.8	2.1	18.4	1.1	2.5	8.2	13.3	2.5	8.0
HES1	"bHLHb39, FLJ20408, HES-1, HRY"	ENSG00000114315	"Hes family bHLH transcription factor 1"	Q14469	3	194136148-194138732	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Hepatic stellate cells: 850.6;Muller glia cells: 1146.0;Paneth cells: 1137.2;Undifferentiated cells: 882.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	8	"eosinophil: 15.6"	"Lineage enriched"	"Detected in many"	8	"granulocytes: 15.6"	"Cell line enhanced"	"Detected in many"		"hTCEpi: 94.1;OE19: 95.8;SK-BR-3: 78.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA066929			Supported	Nucleoplasm		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm		"HPA066929: AB_2732753"	"unprognostic (1.79e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.79e-2)"	"unprognostic (4.44e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.46e-1)"	"unprognostic (3.01e-2)"	"unprognostic (1.05e-1)"	"unprognostic (4.64e-1)"	"unprognostic (2.62e-2)"	"unprognostic (2.04e-2)"	"unprognostic (1.40e-2)"	"unprognostic (1.71e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.85e-1)"	"prognostic favorable (2.04e-5)"	64.2	32.2	13.6	7.9	14.9	0.9	87.0	12.5	15.0	66.0	11.8	44.1	31.2	22.5	9.0	127.8	22.4	17.7	65.6	14.7	16.8	87.3	68.7	47.1	7.0	15.3	17.4	25.3	34.8	22.6	42.7	27.5	13.5	90.1	35.7	66.5	79.9	31.5	69.9	184.5	23.9	9.8	13.5	23.4	42.1	12.8	14.5	11.9	93.2	22.4	11.8	59.8	136.6	11.6	9.3	2.6	20.8	27.1	6.1	0.0	5.2	4.3	12.2	0.9	0.5	36.4	26.1	1.3	74.6	1.6	12.6	51.4	3.9	24.2	0.3	7.7	44.0	33.1	3.5	9.4	0.1	0.2	30.1	2.2	94.1	0.8	10.9	14.3	28.6	1.7	16.1	1.2	0.0	43.9	47.5	45.7	19.4	95.8	17.8	0.1	1.5	1.0	28.0	71.2	1.2	1.6	21.0	78.9	38.9	23.6	22.2	2.6	22.3	2.3	21.8	0.3	31.3	0.2	0.1	0.2	1.6	0.1	43.7	0.0	0.0	15.6	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.1	0.0	13.6	14.9	12.5	15.0	14.7	16.8	15.3	17.4	13.5	13.5	14.5	11.6	684.0	25.6	96.0	70.2	54.2	122.9	498.5	736.7	159.4	15.9	352.0	164.1	128.8	517.6	355.1	196.8	16.7	41.1	4.7	696.8	189.8	268.9	2.2	231.9	37.6	401.8	160.1	19.2	1.2	199.1	6.0	274.1	105.0	257.4	303.4	16.1	850.6	163.1	24.4	10.1	0.4	579.7	213.6	95.3	76.2	8.7	58.7	74.6	80.0	5.6	22.8	1146.0	0.0	4.5	0.1	227.1	1137.2	18.8	5.0	231.1	297.5	126.6	190.2	54.9	164.3	76.8	291.7	1.2	13.2	367.8	296.5	209.2	24.1	31.4	882.7	358.1
HEXA		ENSG00000213614	"Hexosaminidase subunit alpha"	P06865	15	72340924-72376420	"Candidate cardiovascular disease genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Glycosidase, Hydrolase"	"Disease variant, Gangliosidosis, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Hofbauer cells: 234.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018082, HPA054583"	Supported		Supported	Vesicles,Cytosol	"Intracellular and membrane"	NA	NA		20000000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 4: Macrophages - Innate immune response"	Vesicles	Cytosol	"HPA018082: , HPA054583: AB_2682531"	"unprognostic (1.51e-2)"	"unprognostic (1.73e-2)"	"unprognostic (3.41e-1)"	"prognostic favorable (5.63e-8)"	"unprognostic (6.58e-2)"	"unprognostic (1.32e-2)"	"unprognostic (1.34e-2)"	"unprognostic (2.82e-2)"	"unprognostic (3.75e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.59e-2)"	"unprognostic (9.98e-2)"	"unprognostic (3.98e-1)"	"unprognostic (7.05e-3)"	"unprognostic (3.02e-2)"	"unprognostic (4.73e-2)"	"unprognostic (8.69e-2)"	49.8	56.1	18.3	37.6	21.1	110.0	58.5	20.4	21.6	73.8	28.5	55.1	49.8	42.6	164.6	24.8	47.8	76.7	54.3	19.9	20.1	90.1	79.4	84.2	54.2	23.0	21.3	39.3	30.6	54.0	26.3	102.0	24.6	45.3	67.0	32.1	45.0	53.3	22.1	21.8	41.2	59.5	21.7	54.7	45.1	35.6	27.0	38.1	76.5	33.2	42.4	71.6	19.7	29.9	39.8	66.4	27.8	53.8	223.6	253.1	39.7	54.8	274.1	115.3	182.8	34.6	282.7	32.9	50.9	110.0	59.9	77.1	74.5	34.6	72.5	26.5	30.0	41.4	60.4	60.9	172.9	99.9	113.1	216.7	101.3	50.4	89.3	210.3	107.4	48.4	65.1	197.6	156.0	33.9	21.7	50.0	16.0	128.9	0.3	22.3	60.6	75.3	129.1	61.6	23.8	26.4	136.5	126.6	307.3	56.1	23.4	123.9	54.1	171.9	70.7	160.1	59.3	104.7	151.8	33.4	62.1	130.4	85.3	24.2	84.6	60.1	43.8	35.7	38.7	41.1	28.8	38.9	98.0	38.0	22.5	33.2	8.1	51.3	13.3	37.3	28.2	63.0	18.3	21.1	20.4	21.6	19.9	20.1	23.0	21.3	24.6	21.7	27.0	29.9	68.9	64.1	62.4	19.9	46.3	22.2	33.3	94.3	19.4	42.4	28.6	30.4	26.9	30.0	68.0	66.2	106.3	150.2	54.2	36.6	60.7	88.3	20.6	27.2	30.2	50.8	47.2	19.1	22.7	38.0	68.0	78.7	42.8	40.6	29.9	49.9	43.5	42.9	234.3	26.9	24.7	46.3	81.4	92.8	75.0	13.7	74.3	118.1	94.3	24.4	60.3	38.4	82.4	20.6	26.7	39.1	74.6	44.8	37.7	33.0	68.5	66.7	37.5	56.9	46.0	24.5	31.7	24.3	32.3	13.5	15.6	157.6	36.7	45.2	50.6	27.5
HEXIM2	FLJ32384	ENSG00000168517	"HEXIM P-TEFb complex subunit 2"	Q96MH2	17	45160700-45170040	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 56.9;testis: 44.6"	"Group enriched"	"Detected in many"	5	"Early spermatids: 150.9;Late spermatids: 274.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Hep G2: 55.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023323, HPA028455"	Enhanced		Supported	"Nucleoplasm,Nuclear speckles"		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 51: Myeloid cells - Hemostasis"	"Nucleoplasm, Nuclear speckles"		"HPA023323: AB_1850651, HPA028455: AB_10602603"	"unprognostic (9.03e-3)"	"unprognostic (2.18e-2)"	"unprognostic (4.01e-2)"	"prognostic favorable (2.53e-4)"	"unprognostic (2.36e-1)"	"unprognostic (6.35e-3)"	"unprognostic (9.70e-2)"	"unprognostic (1.34e-2)"	"unprognostic (1.03e-1)"	"prognostic favorable (9.85e-4)"	"unprognostic (2.34e-3)"	"unprognostic (1.93e-1)"	"unprognostic (1.29e-2)"	"unprognostic (2.32e-3)"	"unprognostic (6.98e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.90e-2)"	4.8	10.1	8.5	5.2	9.0	4.6	4.6	12.2	9.8	4.9	13.4	7.1	10.2	4.7	4.5	4.7	5.6	7.8	6.9	7.2	7.3	10.5	15.1	4.2	7.3	9.1	8.4	6.2	10.8	7.5	7.9	3.4	8.2	6.0	2.7	4.8	11.5	5.7	56.9	6.6	7.6	2.8	8.6	6.4	8.1	44.6	9.0	5.0	8.7	15.1	3.3	5.8	3.9	9.1	9.0	31.7	6.9	15.3	7.5	12.3	13.1	4.9	5.9	7.8	8.6	12.1	23.4	5.6	25.0	3.5	4.0	14.6	6.8	6.0	2.4	12.9	10.9	4.2	33.4	55.1	5.4	3.6	8.9	10.7	5.6	6.8	2.4	15.1	3.9	11.3	4.6	13.4	3.6	15.6	5.7	7.6	7.5	12.5	13.8	7.7	10.4	17.1	9.8	8.8	8.2	7.2	4.4	8.8	20.7	4.8	23.3	6.1	3.8	14.0	7.5	9.4	11.7	20.7	23.9	5.2	11.0	6.6	10.7	8.2	11.7	10.6	4.8	9.4	8.0	10.1	3.5	5.8	10.2	5.5	2.7	5.0	8.2	8.1	3.1	12.9	4.7	12.0	8.5	9.0	12.2	9.8	7.2	7.3	9.1	8.4	8.2	8.6	9.0	9.1	3.1	0.0	1.5	1.6	4.8	2.0	4.0	3.1	5.7	13.1	6.8	7.2	0.3	5.7	2.5	1.8	4.2	11.7	4.1	2.7	19.6	5.5	150.9	4.9	3.0	4.3	4.8	0.8	2.2	1.6	5.4	3.9	3.6	3.4	7.0	8.8	5.3	7.7	7.0	3.3	3.0	6.2	4.1	9.3	3.3	274.9	5.9	16.4	3.6	1.0	4.9	11.6	5.2	1.5	3.1	1.6	3.1	7.2	7.2	2.0	18.3	36.2	1.8	9.9	0.0	5.4	4.6	41.4	13.7	3.3	3.0	6.2	2.1	7.2	6.1	2.5
HEY1	"bHLHb31, CHF-2, CHF2, HERP2, HESR-1, HESR1, HRT-1"	ENSG00000164683	"Hes related family bHLH transcription factor with YRPW motif 1"	Q9Y5J3	8	79762371-79767857	"Cancer-related genes, Predicted intracellular proteins, Transcription factors, Transporters"	"Notch signaling pathway, Transcription, Transcription regulation"	"Developmental protein, DNA-binding, Repressor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 105.2;Endothelial cells: 47.6;Extravillous trophoblasts: 112.6;Skeletal myocytes: 74.5"	"Cancer enhanced"	"Detected in all"		"glioma: 43.1"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	5	"neutrophil: 6.9"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 6.9"	"Cell line enhanced"	"Detected in many"		"HEK 293: 125.7;PC-3: 28.8;SK-MEL-30: 93.3;WM-115: 31.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055599, HPA063472"	Enhanced		Supported	"Nucleoplasm,Nuclear membrane,Cytosol"		NA	NA			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Nucleoplasm	"Nuclear membrane, Cytosol"	"HPA055599: AB_2682858, HPA063472: AB_2685018"	"unprognostic (1.15e-1)"	"unprognostic (5.06e-2)"	"unprognostic (5.13e-3)"	"unprognostic (2.12e-1)"	"unprognostic (1.86e-3)"	"unprognostic (8.47e-2)"	"unprognostic (4.21e-3)"	"unprognostic (9.56e-2)"	"unprognostic (1.72e-1)"	"unprognostic (7.22e-2)"	"unprognostic (1.25e-2)"	"unprognostic (6.71e-3)"	"unprognostic (5.92e-3)"	"unprognostic (5.77e-2)"	"unprognostic (8.53e-2)"	"unprognostic (1.74e-2)"	"unprognostic (1.00e-1)"	21.1	2.2	17.4	2.1	23.0	0.6	19.0	19.4	19.1	7.2	9.6	6.7	1.7	3.5	0.9	2.8	3.9	4.2	23.9	18.4	20.3	2.8	2.8	15.2	2.2	18.1	21.0	2.0	3.4	3.3	18.4	17.8	19.3	6.0	2.6	5.3	10.1	1.7	19.5	4.2	5.8	3.2	19.1	2.4	4.8	3.1	22.8	3.4	6.5	16.2	2.5	9.3	5.2	15.4	1.7	0.1	1.1	9.1	0.8	0.7	22.0	2.1	2.1	0.3	0.3	0.1	0.1	3.3	2.3	1.0	1.0	4.6	4.9	0.1	0.2	0.5	125.7	0.0	4.1	2.1	1.4	0.0	0.7	1.3	3.7	0.1	16.2	0.4	3.4	0.0	9.0	3.6	1.3	0.1	0.0	0.5	0.1	0.3	28.8	0.0	4.6	3.3	0.4	3.9	5.2	14.6	0.1	2.4	93.3	19.6	0.1	0.1	2.0	0.7	2.4	0.0	1.8	3.3	0.7	0.2	3.4	0.0	31.4	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	6.9	0.0	1.3	0.0	0.0	0.0	17.4	23.0	19.4	19.1	18.4	20.3	18.1	21.0	19.3	19.1	22.8	15.4	105.2	0.0	1.8	15.0	0.8	3.2	3.4	27.6	2.8	6.8	8.6	12.2	4.3	0.0	19.5	0.0	0.0	6.8	1.8	5.3	15.6	2.6	4.6	12.6	4.1	47.6	36.8	0.0	7.7	1.2	112.6	5.3	1.5	33.5	10.8	1.9	41.0	0.9	1.8	21.9	8.0	2.0	26.4	0.6	5.7	3.2	0.0	2.3	33.8	20.6	0.0	10.9	0.0	18.6	1.0	0.7	7.5	0.4	0.8	1.7	0.2	0.4	7.7	12.2	0.0	74.5	12.1	0.6	15.4	3.4	3.0	23.4	1.1	1.5	2.5	2.6
HFE	"HFE1, HLA-H"	ENSG00000010704	"Homeostatic iron regulator"	Q30201	6	26087281-26098343	"Disease related genes, Human disease related genes, Predicted membrane proteins"	"Ion transport, Iron transport, Transport"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Kupffer cells: 25.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"A549: 39.2;T-47d: 54.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017276, HPA053470"	Approved		Supported	"Nucleoplasm,Plasma membrane"		No	No			"Cluster 14: Monocytes - Unknown function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 6: T47d - Mammary gland"	"Cluster 4: Macrophages - Innate immune response"	"Plasma membrane"	Nucleoplasm	"HPA017276: AB_1850677, HPA053470: AB_2682163"	"unprognostic (6.96e-2)"	"unprognostic (7.87e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.24e-2)"	"unprognostic (6.07e-3)"	"unprognostic (7.58e-2)"	"unprognostic (4.23e-1)"	"unprognostic (1.77e-1)"	"unprognostic (8.21e-3)"	"unprognostic (1.78e-1)"	"unprognostic (3.31e-3)"	"unprognostic (1.82e-1)"	"unprognostic (1.33e-2)"	"unprognostic (2.12e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.33e-1)"	"unprognostic (3.17e-1)"	9.6	7.9	1.3	5.3	2.1	0.6	7.8	1.4	1.9	6.7	9.3	5.8	5.9	4.9	12.4	4.8	4.5	8.1	3.7	1.5	1.5	6.7	15.4	7.5	3.6	2.4	1.7	7.3	6.3	15.4	1.2	6.1	2.2	6.8	6.9	1.3	6.9	9.6	2.3	2.8	5.0	6.0	1.7	8.6	8.3	1.7	1.9	1.7	9.9	3.0	3.1	7.4	3.2	2.8	17.2	39.2	0.7	18.6	27.3	21.1	0.1	12.2	28.5	15.1	23.6	3.3	34.3	1.8	32.4	20.2	22.9	10.7	0.0	14.2	19.1	4.6	0.2	0.5	8.1	2.6	5.6	0.0	0.7	21.6	4.0	16.7	1.4	13.2	10.4	0.0	0.7	0.4	13.0	7.2	0.1	0.2	0.9	8.1	0.0	2.3	0.0	0.3	12.5	11.5	0.1	0.1	7.3	0.0	10.2	0.3	54.0	1.9	8.2	10.6	1.1	10.7	10.6	0.2	0.4	0.2	15.9	0.2	23.5	1.3	10.7	0.0	1.5	10.4	1.2	3.3	1.6	2.1	4.7	1.3	0.4	1.0	1.9	0.2	9.2	0.3	0.3	3.8	1.3	2.1	1.4	1.9	1.5	1.5	2.4	1.7	2.2	1.7	1.9	2.8	3.9	3.2	5.1	1.0	1.7	1.7	2.6	3.7	6.2	1.0	3.7	2.2	3.2	2.8	6.7	5.5	2.1	1.7	0.5	3.8	0.0	4.1	0.1	1.8	2.3	3.4	1.8	2.7	0.1	3.4	0.8	4.6	8.2	1.5	2.5	3.0	6.8	12.2	11.1	0.0	0.1	4.0	4.1	25.4	7.6	0.2	3.7	7.4	0.0	2.8	3.8	2.9	2.1	0.0	3.3	2.4	0.9	6.0	0.3	2.6	2.9	2.7	5.9	1.7	0.0	5.7	2.4	0.2	1.1	3.4	3.4	1.8	1.0	2.8	3.3	1.9
HFM1	"FLJ36760, FLJ39011, MER3, SEC63D1"	ENSG00000162669	"Helicase for meiosis 1"	A2PYH4	1	91260766-91404856	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	Meiosis	"Helicase, Hydrolase"	"Disease variant, Premature ovarian failure"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"pituitary gland: 9.3;testis: 13.8"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 50.9;Inhibitory neurons: 38.4;Oligodendrocyte precursor cells: 90.5;Spermatocytes: 58.9"	"Cancer enhanced"	"Detected in single"		"testis cancer: 0.9"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 5.2;AN3-CA: 2.8;K-562: 3.0;SH-SY5Y: 2.1;U-266/70: 2.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA035036, HPA035557"			Supported	"Golgi apparatus,Vesicles"		NA	NA				"Cluster 21: Non-specific - Transcription"	"Cluster 12: NES - Nervous system development"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	"Golgi apparatus, Vesicles"		"HPA035036: AB_2797224, HPA035557: AB_10696507"	"unprognostic (1.35e-2)"	"unprognostic (9.39e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.83e-4)"	"unprognostic (2.05e-2)"	"unprognostic (1.52e-1)"	"unprognostic (7.43e-3)"	"unprognostic (1.79e-1)"	"unprognostic (7.75e-2)"	"unprognostic (7.97e-2)"	"unprognostic (1.76e-4)"	"unprognostic (2.81e-2)"	"unprognostic (1.06e-2)"	"unprognostic (2.89e-3)"	"unprognostic (2.78e-2)"	"unprognostic (1.77e-4)"	"unprognostic (9.59e-2)"	0.4	0.3	1.0	0.1	1.0	0.2	0.4	5.1	1.0	0.9	0.0	0.5	0.3	2.3	1.1	0.1	0.8	0.2	0.6	0.7	1.6	0.7	0.1	0.2	0.1	1.7	1.6	3.9	0.7	0.1	9.3	0.5	1.1	0.6	0.3	4.5	0.5	1.1	1.5	0.1	0.2	0.9	1.1	0.4	0.2	13.8	1.6	0.1	1.6	1.1	0.2	0.4	0.3	1.3	0.0	0.1	5.2	2.8	0.0	0.1	0.0	0.3	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	1.0	0.6	0.0	0.0	0.1	0.7	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	3.0	0.0	0.0	0.0	0.3	0.1	1.6	0.0	0.0	0.2	1.0	0.0	0.0	0.0	1.7	2.1	0.0	0.0	0.7	1.4	0.0	0.5	0.0	0.0	0.5	0.5	0.1	2.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	1.0	5.1	1.0	0.7	1.6	1.7	1.6	1.1	1.1	1.6	1.3	0.2	0.0	1.1	50.9	0.0	0.0	0.0	0.0	0.6	3.9	0.1	0.3	3.1	0.0	0.0	0.0	6.2	0.5	0.0	0.0	0.0	0.4	17.8	0.2	1.9	0.4	0.0	2.5	17.6	0.2	0.2	0.6	0.0	0.0	0.0	5.9	0.0	0.0	0.1	0.0	38.4	0.0	0.0	0.0	0.0	5.0	4.1	0.0	0.0	10.3	0.0	2.4	0.0	90.5	9.5	0.1	0.0	2.2	0.0	0.1	0.0	0.0	0.0	6.2	0.0	2.0	1.4	58.9	15.6	0.0	0.0	0.0	0.0	1.8	0.0	0.0
HGS	"Hrs, Vps27, ZFYVE8"	ENSG00000185359	"Hepatocyte growth factor-regulated tyrosine kinase substrate"	O14964	17	81683326-81703138	"Plasma proteins, Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 137.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004872, HPA007728"	Uncertain		Enhanced	Endosomes,Lysosomes,Cytosol		NA	NA		45000	"Cluster 18: Basophils - Vesicular transport"	"Cluster 35: Non-specific - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 44: Endometrium - Transcription"	"Endosomes, Lysosomes"	Cytosol	"HPA004872: AB_1079053, HPA007728: AB_1850681"	"unprognostic (6.52e-2)"	"prognostic unfavorable (4.22e-4)"	"unprognostic (4.29e-1)"	"unprognostic (1.31e-2)"	"unprognostic (4.91e-2)"	"unprognostic (1.04e-1)"	"prognostic unfavorable (5.61e-5)"	"unprognostic (5.54e-3)"	"unprognostic (1.09e-1)"	"unprognostic (9.27e-2)"	"unprognostic (5.30e-2)"	"unprognostic (1.27e-1)"	"prognostic unfavorable (4.31e-7)"	"unprognostic (3.69e-1)"	"unprognostic (2.27e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.45e-1)"	73.3	95.6	101.5	24.8	102.2	54.5	69.7	98.9	127.1	81.4	98.2	75.7	29.3	66.7	32.7	118.8	70.2	27.0	82.1	103.3	99.3	100.8	85.7	80.1	30.6	105.9	103.2	74.4	85.1	28.1	81.7	24.8	104.3	86.3	25.3	15.7	72.4	29.6	93.7	95.2	81.2	28.5	98.1	100.6	84.6	105.9	102.7	35.3	68.5	18.5	24.8	81.1	83.9	104.1	104.2	93.1	47.8	66.6	56.0	59.8	57.3	65.5	86.6	99.6	76.8	72.6	65.0	23.4	47.2	106.4	88.6	63.2	43.7	100.6	45.8	19.7	76.0	58.8	98.8	117.5	92.8	47.1	55.4	78.1	100.9	93.9	121.9	82.7	120.9	44.5	54.8	30.4	92.1	77.9	58.1	71.4	43.8	75.9	88.9	51.3	48.6	41.0	94.5	87.7	54.9	86.1	54.6	114.9	78.3	48.3	82.3	98.6	87.3	119.5	82.4	69.6	123.3	41.6	17.6	21.8	96.9	53.3	89.4	48.8	28.7	38.9	24.5	32.3	16.6	16.4	18.5	19.4	23.5	15.8	14.1	16.0	44.7	27.1	33.6	19.3	22.3	35.9	101.5	102.2	98.9	127.1	103.3	99.3	105.9	103.2	104.3	98.1	102.7	104.1	20.8	25.6	28.7	17.6	22.0	27.9	23.8	27.7	29.6	30.6	27.0	25.9	3.1	17.2	27.6	22.0	35.5	34.0	27.4	60.9	1.9	43.3	72.3	45.6	28.7	26.3	11.4	23.4	14.2	42.6	36.5	21.8	68.8	66.1	23.4	26.3	16.1	20.7	29.5	23.5	12.6	32.4	22.4	22.9	26.6	137.8	28.9	30.3	23.2	15.9	28.1	20.6	25.7	6.6	16.1	68.2	42.7	23.0	27.6	53.9	41.1	14.6	32.3	35.5	13.1	17.8	24.0	36.9	32.5	37.0	30.3	50.2	23.5	22.1	36.2	50.8
HIC2	"HRG22, KIAA1020, ZBTB30, ZNF907"	ENSG00000169635	"HIC ZBTB transcriptional repressor 2"	Q96JB3	22	21417371-21451463	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 39.6;Extravillous trophoblasts: 41.4;Syncytiotrophoblasts: 39.5"	"Cancer enriched"	"Detected in all"	5	"testis cancer: 17.8"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BEWO: 69.2;K-562: 126.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA031884, HPA059399"	Uncertain		Supported	Nucleoplasm		NA	NA				"Cluster 23: Testis - Cell cycle regulation"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 38: Extravillous trophoblasts - Unknown function"	Nucleoplasm		"HPA031884: AB_10602234, HPA059399: AB_2684003"	"unprognostic (2.37e-1)"	"unprognostic (2.73e-1)"	"unprognostic (1.39e-1)"	"prognostic unfavorable (7.42e-5)"	"unprognostic (1.83e-1)"	"unprognostic (3.83e-1)"	"unprognostic (3.62e-2)"	"unprognostic (3.11e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.49e-2)"	"unprognostic (1.21e-4)"	"unprognostic (1.28e-1)"	"unprognostic (4.83e-3)"	"unprognostic (7.34e-3)"	"unprognostic (3.33e-1)"	"unprognostic (3.86e-2)"	"unprognostic (5.64e-2)"	2.2	1.2	2.5	1.4	2.6	3.7	1.5	0.8	2.8	1.7	0.0	2.1	1.3	2.0	0.5	2.6	2.2	0.8	1.5	2.7	0.9	1.7	1.8	1.8	1.5	1.0	0.6	3.4	2.1	1.1	2.6	5.8	0.9	1.2	0.8	1.5	1.4	0.7	1.1	1.5	2.1	0.7	0.2	2.4	2.4	7.4	1.0	1.7	2.4	1.1	0.9	1.1	1.5	1.4	2.2	2.7	14.4	4.3	1.1	0.9	69.2	1.4	0.5	1.4	1.2	27.2	0.8	5.1	1.4	0.9	0.9	5.9	10.2	0.9	0.8	3.4	15.0	6.8	4.0	15.0	1.2	6.0	3.1	1.1	0.5	2.1	0.9	0.7	1.1	2.1	126.9	2.1	0.7	2.1	2.7	6.2	15.3	4.8	2.0	6.7	6.4	0.8	0.7	3.6	4.0	7.0	1.8	2.1	2.6	14.9	1.2	9.0	1.9	2.2	5.4	2.1	1.6	4.2	3.6	5.4	1.8	2.5	1.5	0.0	0.1	0.0	0.0	0.0	0.2	0.2	0.2	0.0	0.0	0.0	0.2	0.1	0.1	0.1	0.2	0.3	0.0	0.0	2.5	2.6	0.8	2.8	2.7	0.9	1.0	0.6	0.9	0.2	1.0	1.4	10.3	3.2	1.1	3.6	7.7	5.5	5.4	2.6	23.9	14.8	4.7	4.2	3.9	7.2	1.7	1.8	14.6	39.6	4.4	10.0	0.0	2.6	14.2	8.3	7.6	6.5	6.1	5.7	11.8	2.6	41.4	6.6	11.2	7.6	1.3	6.4	2.9	3.0	10.3	8.4	7.5	7.4	6.1	3.8	4.3	29.9	5.6	5.6	5.4	1.9	4.5	3.0	2.1	5.0	2.3	2.8	4.6	10.1	10.4	8.1	7.0	1.6	1.5	7.3	6.6	10.7	6.0	12.2	24.5	27.1	4.5	39.5	5.8	2.6	9.3	7.5
HID1	"C17orf28, DMC1, HID-1"	ENSG00000167861	"HID1 domain containing"	Q8IV36	17	74950742-74973166	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 111.2"	"Cell type enhanced"	"Detected in many"		"Gastric mucus-secreting cells: 71.4;Intestinal goblet cells: 89.5;Paneth cells: 87.8;Proximal enterocytes: 107.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"plasmacytoid DC: 2.6"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"MCF7: 115.9;OE19: 99.2;SH-SY5Y: 56.7;SK-BR-3: 172.6;T-47d: 101.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031406	Approved		Supported	"Golgi apparatus,Cytosol"		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 22: Non-specific - Unknown function"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 27: Mucus-secreting cells - Mucin production"	"Golgi apparatus, Cytosol"		"HPA031406: AB_2673866"	"unprognostic (7.41e-2)"	"unprognostic (1.96e-1)"	"unprognostic (2.69e-1)"	"unprognostic (2.22e-3)"	"unprognostic (4.47e-3)"	"unprognostic (6.79e-3)"	"unprognostic (4.00e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.78e-1)"	"unprognostic (3.90e-1)"	"unprognostic (1.54e-3)"	"unprognostic (1.37e-1)"	"prognostic favorable (3.13e-5)"	"unprognostic (1.17e-1)"	"unprognostic (2.83e-1)"	"unprognostic (1.09e-1)"	"prognostic favorable (1.34e-4)"	13.2	5.8	21.7	6.6	26.9	2.0	23.2	41.5	33.3	19.9	2.8	17.9	39.1	11.9	29.1	5.5	19.0	21.6	12.4	22.0	24.3	12.3	4.4	20.4	5.3	27.4	22.7	3.0	111.2	14.4	44.0	20.1	30.3	36.2	17.9	8.7	86.2	20.2	4.6	7.6	27.3	6.3	10.4	16.7	68.7	6.8	25.4	2.8	16.8	5.7	6.3	12.3	7.6	39.1	5.2	11.4	1.3	15.8	0.0	0.0	2.7	0.0	0.6	1.1	1.0	10.6	5.8	0.0	1.0	0.0	1.4	4.9	14.5	1.0	0.8	0.0	11.4	0.1	0.3	10.1	2.7	0.0	1.1	0.2	6.0	0.1	2.4	0.3	26.0	3.8	0.7	4.0	0.0	115.9	0.7	0.2	0.4	99.2	7.1	0.2	0.0	21.8	14.5	44.8	21.1	56.7	0.0	172.6	0.0	3.6	101.2	0.0	0.5	0.1	1.4	0.4	0.0	2.0	0.3	0.1	0.2	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.5	0.6	0.9	0.7	0.0	0.1	1.0	1.1	0.0	0.0	0.0	2.6	0.0	0.4	21.7	26.9	41.5	33.3	22.0	24.3	27.4	22.7	30.3	10.4	25.4	39.1	21.4	0.0	5.5	4.9	4.6	1.5	2.6	3.1	0.6	14.3	20.4	12.3	3.8	4.3	8.6	0.0	0.0	26.3	1.1	16.0	3.9	19.0	0.4	10.2	3.0	19.1	35.3	0.0	16.1	26.9	1.7	1.0	71.4	20.3	0.0	1.1	20.7	0.4	2.5	20.2	15.5	89.5	16.2	0.8	0.4	1.0	0.9	0.7	7.2	6.5	0.6	2.8	0.0	8.0	50.9	22.9	87.8	0.0	22.7	17.8	107.4	0.5	6.5	4.4	0.0	1.5	1.8	0.4	2.1	0.5	0.4	35.0	1.8	0.1	15.6	13.9
HIF1AN	"DKFZp762F1811, FIH1, FLJ20615, FLJ22027"	ENSG00000166135	"Hypoxia inducible factor 1 subunit alpha inhibitor"	Q9NWT6	10	100529072-100559998	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Dioxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 41.6;tongue: 40.8"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA048742, HPA065302, CAB069903"	Supported		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 25: Spermatids - Spermatogenesis"	Nucleoplasm	Cytosol	"CAB069903: AB_10000508, HPA048742: AB_2680507, HPA065302: AB_2685458"	"unprognostic (4.07e-2)"	"unprognostic (7.75e-2)"	"unprognostic (2.35e-2)"	"unprognostic (3.83e-2)"	"unprognostic (1.67e-2)"	"unprognostic (1.21e-1)"	"unprognostic (8.07e-3)"	"unprognostic (8.82e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.41e-3)"	"unprognostic (1.54e-2)"	"unprognostic (3.05e-2)"	"unprognostic (3.01e-2)"	"unprognostic (3.09e-2)"	"unprognostic (9.92e-2)"	"unprognostic (1.41e-1)"	"unprognostic (3.24e-2)"	6.5	8.1	6.9	7.8	6.5	6.2	6.5	6.1	7.3	6.2	5.7	7.5	7.2	7.3	7.2	7.5	6.8	6.3	12.3	6.6	6.0	7.5	5.4	5.7	7.8	6.7	7.5	10.3	8.1	12.1	6.5	6.0	6.5	7.5	6.6	9.8	6.5	8.3	41.6	10.1	7.2	7.4	6.0	6.8	6.5	13.9	7.0	9.3	5.5	40.8	9.6	7.1	5.4	6.5	13.8	14.4	19.0	19.1	28.8	11.9	16.3	14.4	34.4	20.9	24.5	22.3	11.5	14.8	12.8	21.7	15.4	15.9	16.9	13.0	22.6	16.5	10.2	14.2	12.8	17.2	14.9	17.1	17.9	11.7	12.9	20.4	22.2	29.4	11.9	19.5	6.3	8.1	23.9	14.4	18.3	11.2	6.2	11.6	6.9	13.2	23.4	7.2	14.6	18.2	7.2	11.9	12.4	7.6	13.7	15.8	25.7	9.2	10.1	10.6	13.8	10.6	14.7	10.9	11.8	11.1	17.6	13.8	8.1	13.7	7.6	15.3	7.7	10.7	7.7	7.9	8.0	7.3	7.2	6.4	7.6	7.8	8.0	9.1	13.0	2.6	9.8	8.4	6.9	6.5	6.1	7.3	6.6	6.0	6.7	7.5	6.5	6.0	7.0	6.5	7.9	0.0	6.5	11.8	16.7	11.0	11.5	16.4	13.1	17.9	12.3	8.9	40.7	14.3	11.7	11.0	16.7	27.8	16.5	15.5	9.8	17.3	21.5	9.0	11.3	12.1	13.2	16.0	12.2	13.9	17.6	10.9	11.2	8.7	6.3	20.0	8.2	10.9	14.3	25.2	11.2	12.0	8.2	18.5	6.8	49.3	11.1	10.1	3.6	11.2	23.4	15.0	27.8	11.1	12.8	17.7	11.3	12.0	11.2	11.4	20.1	20.5	11.6	23.1	6.6	12.0	16.1	48.2	26.6	11.4	11.6	32.7	14.0	14.8	13.3	10.3
HIF3A	"bHLHe17, IPAS, MOP7, PASD7"	ENSG00000124440	"Hypoxia inducible factor 3 subunit alpha"	Q9Y2N7	19	46297042-46343433	"Predicted intracellular proteins, Transcription factors"	"Angiogenesis, Apoptosis, Stress response, Transcription, Transcription regulation"	"Developmental protein, Repressor"	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 83.5;Astrocytes: 257.9;Endothelial cells: 60.4;Leydig cells: 136.4;Muller glia cells: 79.9;Oligodendrocyte precursor cells: 69.9;Peritubular cells: 103.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"ASC TERT1: 9.3;HHSteC: 19.1;HSkMC: 16.8;TIME: 16.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041141	Approved		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Nucleoplasm, Cytosol"	"Plasma membrane"	"HPA041141: AB_10803997"	"unprognostic (9.20e-2)"	"unprognostic (2.99e-1)"	"unprognostic (5.48e-2)"	"prognostic unfavorable (6.90e-9)"	"unprognostic (4.12e-2)"	"unprognostic (2.35e-2)"	"unprognostic (3.57e-3)"	"unprognostic (1.30e-1)"	"unprognostic (3.32e-2)"	"unprognostic (1.38e-2)"	"unprognostic (3.76e-2)"	"unprognostic (7.07e-2)"	"unprognostic (3.41e-4)"	"unprognostic (1.55e-2)"	"unprognostic (1.61e-1)"	"unprognostic (4.45e-4)"	"unprognostic (5.98e-2)"	34.2	8.8	24.1	1.1	24.7	0.7	24.2	17.5	25.9	32.5	9.4	55.4	1.1	31.1	4.1	10.8	35.8	2.6	55.9	19.5	17.4	7.3	2.7	32.8	1.2	22.2	22.3	34.2	6.5	0.5	22.6	27.4	18.6	22.3	2.0	10.0	7.5	7.1	10.7	10.8	24.8	3.0	16.8	31.8	37.3	5.4	22.5	0.5	13.0	9.7	0.4	55.0	25.1	17.3	0.0	0.0	1.5	0.2	4.3	9.3	0.4	0.0	0.0	0.0	0.0	2.1	0.2	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.0	19.1	0.1	0.5	16.8	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.8	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.4	0.0	0.0	0.0	2.3	0.0	0.1	16.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.7	0.0	0.0	1.1	0.1	0.2	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.2	0.1	0.1	0.7	0.1	0.4	0.7	0.1	0.0	24.1	24.7	17.5	25.9	19.5	17.4	22.2	22.3	18.6	16.8	22.5	17.3	83.5	3.2	1.8	257.9	0.5	1.1	2.2	0.3	0.6	1.5	1.4	0.9	45.7	17.2	0.7	0.0	0.0	0.2	0.3	0.2	1.9	0.0	1.9	2.4	7.0	60.4	1.2	8.0	0.7	0.0	0.4	13.6	1.1	2.3	0.0	3.1	51.0	0.9	0.6	0.0	3.5	1.2	0.0	1.3	2.1	7.4	136.4	0.7	3.6	33.7	0.0	79.9	0.0	69.9	1.2	0.1	8.0	103.4	0.0	1.6	0.5	0.1	0.0	2.5	6.6	5.5	8.4	1.6	3.6	0.2	2.3	0.5	0.4	0.1	2.1	0.7
HIGD1A	"DKFZP564K247, HIG1, RCF1A"	ENSG00000181061	"HIG1 hypoxia inducible domain family member 1A"	Q9Y241	3	42782908-42804490	"Predicted membrane proteins"	"Electron transport, Respiratory chain, Stress response, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal enterocytes: 638.8;Distal tubular cells: 632.0;Paneth cells: 610.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"plasmacytoid DC: 509.4"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043336	Approved		Supported	Nucleoplasm,Mitochondria		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Mitochondria	Nucleoplasm	"HPA043336: AB_10795039"	"unprognostic (6.46e-2)"	"unprognostic (3.72e-3)"	"prognostic favorable (2.12e-4)"	"unprognostic (3.65e-2)"	"unprognostic (8.87e-2)"	"unprognostic (3.53e-1)"	"unprognostic (3.70e-1)"	"unprognostic (8.45e-2)"	"unprognostic (6.14e-2)"	"unprognostic (2.94e-1)"	"unprognostic (1.24e-1)"	"unprognostic (8.94e-2)"	"prognostic favorable (3.99e-8)"	"unprognostic (7.37e-2)"	"unprognostic (3.01e-1)"	"unprognostic (1.52e-1)"	"unprognostic (3.88e-2)"	121.3	130.0	134.6	75.3	140.6	53.8	81.4	151.4	198.8	90.2	135.4	295.2	162.2	65.9	95.2	162.8	62.6	79.3	323.1	139.4	155.1	198.9	343.5	66.5	50.9	148.1	148.8	39.4	60.8	111.4	90.5	64.6	153.5	101.5	300.1	152.7	75.1	96.3	174.2	68.8	134.8	96.2	156.1	48.9	145.9	63.7	145.6	52.8	115.5	316.7	80.0	99.5	120.1	174.0	159.9	67.0	182.9	165.2	420.3	244.3	195.2	205.1	151.0	168.4	165.8	132.8	166.7	95.8	120.5	161.8	114.0	92.9	143.0	203.0	225.6	135.5	145.9	301.0	127.6	257.4	191.8	180.4	131.4	274.0	233.7	129.0	181.4	94.7	159.8	135.1	299.7	110.3	247.3	51.1	96.1	61.1	162.7	133.7	176.5	80.9	138.0	72.1	454.1	361.1	82.7	108.2	187.6	142.0	207.0	182.9	145.0	130.0	166.1	127.4	105.2	341.1	219.1	89.7	184.1	207.2	165.2	185.7	100.6	115.7	66.2	130.5	72.9	115.4	65.8	56.6	71.5	73.6	77.2	43.6	60.3	70.5	70.0	65.6	143.2	509.4	99.4	171.5	134.6	140.6	151.4	198.8	139.4	155.1	148.1	148.8	153.5	156.1	145.6	174.0	50.1	54.5	82.4	32.3	39.7	131.2	153.1	244.8	59.2	35.7	86.4	62.0	351.5	80.1	133.0	138.0	10.4	114.1	99.5	638.8	632.0	113.3	8.4	87.3	41.2	50.8	82.0	126.8	32.8	145.0	202.7	98.1	100.9	63.6	93.3	49.7	59.6	197.9	77.1	28.6	27.3	193.5	343.8	46.9	113.3	13.0	30.7	63.4	176.1	21.5	82.7	232.5	43.3	14.1	32.9	279.4	610.7	52.3	65.5	193.5	122.4	296.4	106.0	41.2	78.9	28.8	119.8	186.1	78.7	94.2	204.6	299.9	50.7	101.5	168.0	254.2
HIGD2A	"MGC2198, RCF1B"	ENSG00000146066	"HIG1 hypoxia inducible domain family member 2A"	Q9BW72	5	176388751-176389761	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Electron transport, Respiratory chain, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA042715	Uncertain		Supported	Mitochondria,Cytosol		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 32: Non-specific - Translation"	Mitochondria	Cytosol	"HPA042715: AB_2678127"	"unprognostic (9.24e-2)"	"unprognostic (6.31e-3)"	"unprognostic (7.96e-2)"	"unprognostic (3.90e-3)"	"unprognostic (1.13e-1)"	"unprognostic (2.94e-2)"	"prognostic unfavorable (9.47e-4)"	"unprognostic (2.39e-1)"	"unprognostic (3.19e-1)"	"unprognostic (1.98e-2)"	"unprognostic (3.11e-3)"	"unprognostic (9.56e-2)"	"unprognostic (2.39e-2)"	"unprognostic (1.45e-1)"	"unprognostic (8.09e-2)"	"unprognostic (1.78e-1)"	"unprognostic (9.65e-2)"	146.1	175.6	143.3	87.0	146.2	133.1	113.5	147.2	175.0	104.7	168.0	199.4	118.9	111.7	51.3	130.0	105.0	80.5	318.7	139.8	146.0	182.7	163.3	95.7	132.9	143.9	142.2	118.7	108.7	204.9	125.1	54.6	141.6	127.9	96.3	45.5	163.2	92.7	422.5	140.8	136.6	68.1	145.3	129.3	148.6	66.0	149.0	110.7	114.0	297.9	92.7	152.3	105.2	145.7	104.9	166.6	99.0	172.6	98.5	186.4	262.2	66.6	109.7	164.7	206.4	176.0	202.2	183.3	149.9	107.1	214.2	127.3	146.2	260.6	65.9	424.0	234.0	92.6	161.7	244.7	137.4	149.7	230.1	238.2	213.2	93.7	113.3	126.3	141.7	146.5	104.0	341.5	124.0	315.9	165.3	178.1	124.8	195.5	181.7	157.1	75.6	324.7	265.5	158.7	107.9	141.5	71.4	295.2	310.5	100.7	173.3	233.7	96.8	118.5	124.7	110.2	142.5	165.2	216.6	158.4	150.5	254.1	77.5	284.2	743.6	219.8	391.2	975.8	389.5	618.1	540.1	452.6	930.0	496.0	488.1	464.2	124.6	308.0	1024.9	616.8	621.8	971.3	143.3	146.2	147.2	175.0	139.8	146.0	143.9	142.2	141.6	145.3	149.0	145.7	100.4	73.7	78.6	0.0	212.5	232.2	332.8	358.0	272.0	60.5	225.5	288.5	145.3	174.5	191.0	182.1	12.5	223.0	184.2	415.6	534.1	204.5	83.9	140.0	120.6	110.9	266.6	90.8	0.0	237.3	185.4	129.1	142.2	124.2	130.0	157.0	120.3	217.0	378.7	65.6	0.0	450.7	219.7	458.8	345.2	56.8	140.1	292.1	257.9	0.0	449.7	138.1	230.7	0.0	0.0	110.0	493.0	85.0	184.2	292.6	313.8	542.8	142.3	47.7	118.3	145.9	138.8	96.7	79.4	301.8	225.0	280.2	223.7	182.1	385.3	532.4
HIGD2B	HIGD2BP	ENSG00000175202	"HIG1 hypoxia inducible domain family member 2B"	Q4VC39	15	72675798-72686182	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"			"Tissue enriched"	"Detected in single"	10	"testis: 3.6"	"Group enriched"	"Detected in some"	10	"Early spermatids: 18.3;Late spermatids: 8.6;Spermatocytes: 20.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA019016, HPA042715"	Uncertain		Supported	Mitochondria,Cytosol		NA	NA				"Cluster 83: Testis - Spermatogenesis"		"Cluster 66: Spermatocytes - Spermatogenesis"	Mitochondria	Cytosol	"HPA019016: AB_1850711, HPA042715: AB_2678127"	"unprognostic (1.22e-1)"	"unprognostic (1.09e-1)"		"unprognostic (2.24e-3)"	"unprognostic (5.09e-2)"	"unprognostic (3.34e-1)"	"unprognostic (2.42e-1)"	"unprognostic (6.88e-2)"	"unprognostic (1.39e-1)"	"unprognostic (6.98e-2)"	"unprognostic (3.90e-1)"	"unprognostic (8.80e-2)"	"unprognostic (6.11e-4)"	"unprognostic (6.95e-2)"	"unprognostic (2.97e-1)"	"unprognostic (1.11e-2)"	"unprognostic (3.18e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.5	0.2	0.1	0.0	0.0	0.1	0.4	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	18.3	0.4	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.3	0.0	8.6	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.4	0.0	0.3	0.0	0.2	0.4	0.0	0.0	0.1	0.0	20.1	1.5	0.0	0.1	0.1	0.1	0.0	0.1	0.2
HILPDA	"C7orf68, FLJ21076, HIG-2, HIG2"	ENSG00000135245	"Hypoxia inducible lipid droplet associated"	Q9Y5L2	7	128455849-128458418	"Predicted membrane proteins"	"Stress response"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 164.3"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 170.8;Club cells: 140.2;Extravillous trophoblasts: 246.8;Ionocytes: 311.3;Syncytiotrophoblasts: 241.1"	"Cancer enhanced"	"Detected in all"		"renal cancer: 72.4"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"eosinophil: 67.8"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SK-BR-3: 116.1"	"Low region specificity"	"Detected in all"							HPA010515	Approved		Supported	"Nucleoplasm,Lipid droplets"	"Intracellular and membrane"	NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Lipid droplets"	Nucleoplasm	"HPA010515: AB_1850710"	"unprognostic (1.10e-2)"	"unprognostic (1.68e-2)"	"unprognostic (1.88e-2)"	"unprognostic (2.27e-1)"	"unprognostic (2.10e-2)"	"unprognostic (2.70e-2)"	"prognostic unfavorable (4.30e-11)"	"unprognostic (9.20e-3)"	"unprognostic (4.07e-3)"	"unprognostic (2.49e-1)"	"unprognostic (4.06e-3)"	"unprognostic (2.15e-2)"	"prognostic unfavorable (2.05e-7)"	"unprognostic (2.23e-2)"	"unprognostic (2.77e-1)"	"unprognostic (1.50e-2)"	"unprognostic (1.27e-1)"	101.1	8.1	14.9	6.9	19.8	20.2	59.9	22.6	18.7	59.1	12.8	23.5	5.7	11.1	7.5	164.3	10.9	8.8	56.9	15.9	18.9	40.2	38.8	50.3	5.9	26.5	26.8	45.5	12.4	4.4	13.8	36.2	22.3	14.8	7.3	43.3	23.6	7.0	6.0	50.6	8.0	8.2	21.1	8.8	19.0	17.1	25.4	7.6	14.5	5.5	7.4	38.3	86.1	21.0	30.0	61.3	34.1	37.6	45.5	16.9	62.5	11.0	13.4	22.6	24.6	15.0	26.5	21.2	8.3	16.5	22.9	19.6	19.4	23.3	28.6	11.3	17.3	12.2	13.9	14.1	10.2	19.8	16.7	28.0	19.7	17.8	11.8	23.0	18.8	32.5	18.2	8.1	22.6	37.2	60.9	36.8	41.2	22.3	26.7	45.5	15.5	31.0	12.5	44.8	32.3	29.1	17.0	116.1	21.8	30.5	95.6	18.4	13.3	28.6	13.9	21.4	13.5	8.2	6.3	25.7	51.7	30.1	25.0	23.4	6.6	67.8	4.5	7.5	6.3	17.6	5.5	5.3	6.8	17.6	5.4	5.3	2.6	13.9	5.9	11.9	4.0	4.1	14.9	19.8	22.6	18.7	15.9	18.9	26.5	26.8	22.3	21.1	25.4	21.0	22.6	9.6	5.5	0.0	9.3	64.2	14.8	170.8	9.1	6.5	11.1	13.8	4.1	2.8	140.2	1.8	18.8	114.3	5.0	10.0	0.0	27.5	0.5	23.6	49.1	30.9	13.1	12.6	0.0	8.9	246.8	44.0	6.6	38.6	18.9	85.6	11.0	3.3	27.6	26.9	0.0	11.2	311.3	4.4	89.2	2.4	30.4	14.8	37.4	0.0	13.7	15.8	3.1	0.0	0.0	35.5	4.5	24.5	6.4	27.1	2.4	9.6	98.9	23.2	6.6	7.0	43.4	7.8	17.3	10.0	52.0	241.1	9.7	16.2	14.9	122.4
HINT1	"HINT, PKCI-1, PRKCNH1"	ENSG00000169567	"Histidine triad nucleotide binding protein 1"	P49773	5	131155383-131224468	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Transcription, Transcription regulation"	Hydrolase	"Disease variant, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Proximal tubular cells: 3537.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044577	Approved		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA		2800000	"Cluster 30: Non-specific - Translation"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 32: Non-specific - Translation"	Cytosol	"Nucleoplasm, Plasma membrane"	"HPA044577: AB_10795618"	"unprognostic (2.00e-1)"	"unprognostic (9.27e-2)"	"unprognostic (2.04e-2)"	"unprognostic (1.03e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.35e-1)"	"unprognostic (8.30e-3)"	"unprognostic (2.48e-1)"	"unprognostic (1.30e-2)"	"unprognostic (6.49e-2)"	"unprognostic (6.50e-3)"	"unprognostic (4.43e-2)"	"unprognostic (4.39e-3)"	"unprognostic (2.08e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.67e-1)"	"unprognostic (3.68e-1)"	132.6	175.0	235.7	139.8	245.1	259.3	172.7	241.6	326.2	117.6	243.8	227.6	176.1	119.6	187.5	181.3	165.6	108.0	167.2	245.9	247.8	256.7	474.2	119.0	206.5	241.6	237.2	121.5	165.5	285.6	152.5	87.5	249.1	155.1	226.5	110.8	172.8	116.4	334.1	170.0	196.3	124.2	242.6	126.9	136.5	80.1	240.8	166.5	177.2	278.4	192.3	152.9	129.7	245.3	437.1	522.7	448.2	877.2	273.1	297.1	441.3	300.3	230.9	235.4	272.1	547.1	516.8	563.3	625.7	329.6	569.1	253.4	315.4	635.3	244.1	500.0	514.6	199.1	814.0	771.9	532.6	349.4	65.4	400.1	618.6	295.8	528.2	533.7	314.1	727.8	313.4	1132.1	338.8	419.9	548.0	945.6	415.6	425.6	362.0	407.9	436.1	988.1	500.6	567.0	563.3	351.9	380.5	243.5	612.0	574.4	291.2	520.8	396.0	351.7	244.0	323.0	684.2	342.3	561.4	578.8	497.8	586.8	346.3	179.8	187.9	85.0	196.3	109.9	298.0	384.9	462.0	294.2	396.9	332.6	416.0	325.5	35.6	269.0	128.0	521.4	362.5	608.6	235.7	245.1	241.6	326.2	245.9	247.8	241.6	237.2	249.1	242.6	240.8	245.3	582.7	282.0	279.1	34.3	718.2	1301.2	1472.2	1928.1	889.5	191.2	1134.3	1831.1	517.0	1028.0	882.2	715.4	45.9	780.9	641.6	1245.1	1663.0	1024.5	783.0	718.9	443.7	501.2	698.1	669.7	53.8	774.3	1632.8	400.2	355.2	753.7	108.2	666.5	436.2	2380.1	887.1	148.0	48.0	947.2	915.5	472.4	906.9	206.3	392.4	447.0	965.8	34.7	1269.4	405.1	488.1	26.7	55.4	894.3	1094.2	418.6	679.7	1998.9	1690.3	3537.5	708.3	194.0	243.3	287.0	730.3	625.5	197.9	1109.1	1146.1	456.8	671.1	464.3	1280.4	1713.2
HIP1	ILWEQ	ENSG00000127946	"Huntingtin interacting protein 1"	O00291	7	75533298-75738962	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Apoptosis, Differentiation, Endocytosis, Transcription, Transcription regulation"	"Actin-binding, Activator"	"Cancer-related genes, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 50.9"	"Cell type enriched"	"Detected in many"	4	"Late spermatids: 1373.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"basophil: 9.5;eosinophil: 6.8;neutrophil: 6.8;NK-cell: 3.0;plasmacytoid DC: 3.3"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"A549: 55.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA013606, CAB015334, CAB016402, HPA017964"	Enhanced		Supported	Vesicles		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 25: Spermatids - Spermatogenesis"	Vesicles		"CAB015334: AB_2117565, CAB016402: AB_627725, HPA013606: AB_1850717, HPA017964: AB_1850719"	"unprognostic (8.23e-2)"	"unprognostic (1.22e-1)"	"unprognostic (2.20e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.59e-1)"	"unprognostic (2.73e-3)"	"unprognostic (1.03e-2)"	"unprognostic (1.11e-2)"	"unprognostic (2.02e-2)"	"unprognostic (2.70e-2)"	"unprognostic (7.98e-2)"	"unprognostic (1.73e-3)"	"unprognostic (9.67e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.00e-2)"	"unprognostic (1.09e-1)"	16.7	7.9	23.6	7.3	38.7	5.4	13.2	29.8	29.0	11.7	14.4	6.1	2.7	9.8	9.2	5.3	12.9	8.3	9.0	22.4	24.9	14.8	9.3	18.5	4.7	34.6	35.4	8.0	3.8	4.2	3.4	19.7	32.0	6.8	4.1	4.6	4.0	11.2	4.2	10.6	5.0	12.2	24.5	11.2	4.8	30.4	34.8	3.1	15.3	8.4	4.5	9.0	7.9	50.9	5.2	55.9	37.1	35.2	15.3	20.8	11.1	9.7	6.3	6.2	4.6	3.2	5.0	3.8	11.2	24.2	21.6	6.3	38.1	8.0	8.3	3.1	7.1	3.0	6.6	5.3	15.2	0.8	14.8	16.0	4.8	20.4	4.2	11.4	26.3	4.2	4.0	3.6	10.1	21.6	2.5	22.2	40.5	0.5	6.6	4.4	15.5	0.3	4.7	20.0	1.8	16.2	9.0	5.6	12.5	32.8	34.6	13.9	9.4	18.0	13.7	6.2	13.6	4.0	0.4	8.9	18.1	8.0	12.4	9.5	0.9	6.8	0.9	0.9	0.7	0.3	0.1	0.7	1.4	0.4	0.1	0.5	6.8	3.0	0.7	3.3	1.4	0.3	23.6	38.7	29.8	29.0	22.4	24.9	34.6	35.4	32.0	24.5	34.8	50.9	54.0	60.9	37.5	43.8	7.8	17.6	6.2	7.1	20.5	12.0	14.8	10.7	14.3	11.5	12.2	27.6	12.5	2.1	27.2	2.2	13.7	14.4	256.9	15.5	24.2	54.3	4.8	7.8	16.3	6.0	10.0	17.1	6.1	25.5	14.0	25.9	36.8	22.5	14.9	23.5	19.0	3.0	6.1	18.5	49.1	1373.3	22.4	24.1	10.6	45.9	9.4	14.3	21.6	336.3	313.7	3.1	7.7	24.8	18.4	4.2	0.3	2.6	1.3	9.4	85.5	25.9	44.8	12.1	5.6	5.6	9.1	0.8	13.5	7.7	3.3	3.5
HIP1R	"FLJ14000, HIP12, HIP3, ILWEQ, KIAA0655"	ENSG00000130787	"Huntingtin interacting protein 1 related"	O75146	12	122834453-122862961	"Cancer-related genes, Predicted intracellular proteins"	Endocytosis	Actin-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 103.4"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 134.5;Oligodendrocyte precursor cells: 168.9;Oligodendrocytes: 117.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"memory B-cell: 9.3;naive B-cell: 10.6"	"Group enriched"	"Detected in many"	8	"B-cells: 10.6;granulocytes: 2.9;T-cells: 3.0"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017187, HPA038135, HPA038136"	Enhanced		Supported	"Vesicles,Plasma membrane,Cytosol"		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 22: Non-specific - Unknown function"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 68: Oligodendrocytes - Mixed function"	"Plasma membrane, Cytosol"	Vesicles	"CAB017187: , HPA038135: AB_2675851, HPA038136: AB_2675852"	"unprognostic (4.52e-1)"	"unprognostic (6.39e-2)"	"unprognostic (7.07e-2)"	"unprognostic (6.55e-3)"	"unprognostic (8.67e-2)"	"unprognostic (1.00e-2)"	"unprognostic (1.02e-2)"	"unprognostic (8.11e-2)"	"unprognostic (6.37e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.39e-2)"	"unprognostic (6.72e-2)"	"prognostic favorable (6.50e-7)"	"unprognostic (2.18e-2)"	"unprognostic (2.84e-1)"	"unprognostic (2.54e-3)"	"prognostic favorable (7.26e-4)"	18.5	24.0	68.6	10.4	95.5	13.3	22.6	78.8	80.3	16.0	33.5	16.3	31.8	9.0	3.8	18.0	9.0	7.7	18.9	68.0	67.8	50.2	25.6	15.4	17.5	87.3	83.8	5.6	50.2	8.9	42.0	4.7	75.6	21.0	4.9	5.5	58.7	10.5	7.2	51.7	36.0	2.2	65.3	20.9	66.7	8.5	85.7	12.6	21.5	4.4	11.7	11.4	19.7	103.4	38.1	10.8	8.0	33.1	2.3	6.1	39.2	5.9	9.5	5.9	4.6	16.8	11.1	36.0	19.0	4.3	8.9	32.4	9.7	21.4	0.5	5.8	14.0	0.8	13.8	17.8	7.1	2.8	24.5	3.8	14.9	8.0	13.4	8.1	40.5	16.5	9.6	2.0	3.4	54.4	17.4	8.8	7.4	32.8	12.8	9.0	10.2	12.5	19.6	45.4	8.1	17.9	7.1	18.0	9.5	4.3	36.6	1.5	32.8	3.7	27.5	11.7	5.7	24.8	14.2	21.8	6.0	6.0	3.1	0.0	0.0	2.9	2.7	0.0	1.5	9.3	1.7	2.1	0.0	10.6	3.0	1.9	0.2	0.7	0.0	0.0	0.4	2.0	68.6	95.5	78.8	80.3	68.0	67.8	87.3	83.8	75.6	65.3	85.7	103.4	57.0	0.0	13.4	134.5	38.0	13.3	16.8	8.4	6.8	16.4	21.2	18.2	4.2	60.1	11.1	60.7	29.2	3.7	18.2	28.4	0.0	40.1	3.1	21.9	4.7	18.2	7.8	1.3	11.2	28.7	13.1	2.3	80.5	37.5	5.7	25.3	19.2	24.4	0.6	18.5	9.7	29.9	22.4	1.2	4.2	2.9	1.5	2.2	10.6	9.4	0.1	12.5	7.2	168.9	117.8	22.7	25.3	1.2	17.2	20.2	47.5	17.9	14.2	16.6	0.0	2.5	4.1	6.5	13.3	11.5	21.0	1.9	15.0	1.3	23.9	28.4
HIPK1	"KIAA0630, MGC26642, MGC33446, MGC33548, Myak, Nbak2"	ENSG00000163349	"Homeodomain interacting protein kinase 1"	Q86Z02	1	113929324-113977869	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Transcription, Transcription regulation"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 142.0"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"MCF7: 176.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA016664	Approved		Supported	Nucleoplasm,Centrosome,Cytosol		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 24: Non-specific - Transcription regulation"	"Nucleoplasm, Cytosol"	Centrosome	"HPA016664: AB_1850725"	"unprognostic (2.98e-1)"	"unprognostic (3.94e-2)"	"unprognostic (4.89e-3)"	"unprognostic (2.52e-2)"	"unprognostic (6.47e-2)"	"unprognostic (9.84e-3)"	"unprognostic (4.64e-3)"	"unprognostic (7.22e-2)"	"unprognostic (7.52e-2)"	"unprognostic (1.45e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.15e-1)"	"unprognostic (8.63e-2)"	"unprognostic (1.84e-1)"	"unprognostic (2.64e-1)"	"unprognostic (1.94e-2)"	"unprognostic (1.99e-2)"	19.8	20.0	24.7	20.2	23.5	142.0	16.8	44.5	20.9	24.4	42.4	19.0	12.7	18.1	17.2	23.1	35.0	22.2	18.0	20.6	32.5	18.2	17.8	23.4	20.9	37.2	39.4	22.8	21.8	21.3	20.5	17.7	29.8	15.4	18.9	56.5	15.2	17.7	25.7	23.4	16.8	18.2	36.9	20.7	17.8	47.1	27.5	57.4	29.8	27.1	20.6	19.7	18.8	25.6	23.4	18.8	25.4	19.5	29.2	15.2	17.1	15.8	19.0	22.2	20.9	21.8	8.8	31.4	21.2	25.3	8.2	15.5	33.1	18.6	31.7	23.0	16.7	45.8	23.7	23.0	24.3	36.7	54.2	16.5	26.5	28.3	28.7	20.8	33.2	54.2	31.8	32.8	32.1	176.4	48.8	21.0	26.2	17.1	15.8	29.1	74.4	10.9	19.8	19.9	11.2	15.0	28.9	30.6	20.5	27.9	17.7	52.3	32.6	21.5	29.0	35.3	24.3	20.1	17.2	26.7	23.7	29.3	50.3	2.1	2.5	5.0	3.0	2.1	3.0	0.9	2.7	2.8	1.7	1.1	2.6	3.3	5.8	2.7	1.6	3.7	2.0	1.5	24.7	23.5	44.5	20.9	20.6	32.5	37.2	39.4	29.8	36.9	27.5	25.6	30.1	54.5	37.2	14.4	26.0	61.4	16.2	16.7	15.4	57.7	29.8	20.2	34.6	22.8	24.5	27.6	70.9	10.7	125.8	38.9	5.9	14.6	95.2	147.9	33.4	28.9	37.2	64.4	27.4	21.0	10.3	24.3	20.9	47.0	46.9	26.3	21.8	37.4	22.2	74.0	33.9	25.4	12.2	49.5	77.7	101.4	22.1	50.2	21.4	31.9	43.1	30.6	36.0	21.1	26.5	18.8	22.4	37.2	43.5	33.7	17.8	16.4	116.4	64.8	26.3	36.5	44.3	49.7	31.5	25.6	80.6	14.2	69.7	21.9	28.3	32.7
HIPK2		ENSG00000064393	"Homeodomain interacting protein kinase 2"	Q9H2X6	7	139561570-139777998	"Enzymes, Metabolic proteins, Plasma proteins, Predicted membrane proteins"	"Apoptosis, DNA damage, Transcription, Transcription regulation"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	10	"brain: 397.5"	"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 463.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	7	"basophil: 27.5"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 27.5"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 120.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007611	Supported		Supported	Nucleoplasm		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Nucleoplasm		"HPA007611: AB_1850730"	"unprognostic (1.35e-3)"	"unprognostic (1.49e-2)"	"unprognostic (1.65e-1)"	"unprognostic (7.65e-2)"	"unprognostic (5.50e-2)"	"unprognostic (9.44e-2)"	"unprognostic (2.76e-1)"	"unprognostic (4.66e-2)"	"unprognostic (1.44e-1)"	"unprognostic (2.76e-2)"	"unprognostic (3.42e-3)"	"unprognostic (4.58e-2)"	"prognostic favorable (9.99e-4)"	"unprognostic (1.38e-1)"	"unprognostic (7.82e-2)"	"unprognostic (3.93e-3)"	"unprognostic (1.03e-2)"	19.8	9.2	253.4	6.9	359.7	15.0	10.3	124.8	187.0	4.3	39.4	6.6	7.4	6.0	4.1	9.2	8.8	4.7	30.3	146.3	235.5	25.5	14.9	10.7	4.1	253.8	268.7	5.5	11.5	11.5	8.9	10.1	192.5	9.3	4.8	27.8	12.1	5.7	23.5	3.0	6.3	3.9	187.4	6.9	14.5	1.9	318.3	6.9	9.3	17.0	4.2	6.0	5.2	397.5	11.7	51.4	23.2	14.3	55.2	39.4	2.7	6.4	6.3	7.0	7.3	3.8	6.3	0.0	14.3	12.1	43.2	0.6	10.7	16.6	17.5	120.9	4.3	53.7	8.7	18.4	31.0	14.9	14.0	60.3	10.5	32.4	47.9	16.5	17.6	10.0	31.7	14.4	54.3	8.9	18.9	10.6	5.9	6.6	34.3	22.1	12.7	1.6	31.5	2.0	14.1	12.9	14.4	0.5	7.0	4.3	7.9	6.0	59.5	24.5	11.6	28.5	31.4	68.7	44.3	10.2	49.4	7.7	13.4	27.5	1.3	3.5	0.2	1.1	0.3	0.6	0.5	0.2	0.6	0.5	1.6	0.5	1.7	0.2	4.1	0.2	0.1	0.7	253.4	359.7	124.8	187.0	146.3	235.5	253.8	268.7	192.5	187.4	318.3	397.5	107.8	16.0	31.2	82.6	45.8	9.3	30.6	24.9	16.5	116.0	65.6	32.6	213.9	55.8	35.6	64.4	152.2	8.8	72.0	38.4	35.2	32.5	3.1	39.1	12.2	80.3	67.2	18.5	17.8	67.0	1.5	28.1	70.8	41.7	44.9	24.3	151.0	145.2	15.7	222.1	36.3	32.2	63.1	119.5	10.9	4.0	13.1	53.2	44.4	49.6	47.6	78.0	95.8	145.3	463.7	63.4	24.6	18.8	97.9	118.9	22.5	75.0	48.7	62.9	46.0	96.6	60.8	2.7	4.8	42.5	9.5	9.6	30.5	20.1	29.3	43.9
HIPK3	"DYRK6, FIST3, PKY, YAK1"	ENSG00000110422	"Homeodomain interacting protein kinase 3"	Q9H422	11	33256672-33357023	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Apoptosis, Transcription, Transcription regulation"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028069	Approved		Supported	"Nuclear bodies,Cytosol"		NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Cytosol	"Nuclear bodies"	"HPA028069: AB_10601815"	"unprognostic (2.41e-3)"	"unprognostic (1.02e-1)"	"unprognostic (4.61e-1)"	"unprognostic (5.74e-2)"	"unprognostic (2.09e-1)"	"unprognostic (1.78e-2)"	"unprognostic (1.63e-1)"	"unprognostic (7.29e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.78e-1)"	"unprognostic (2.18e-1)"	"unprognostic (2.68e-1)"	"unprognostic (3.29e-3)"	"unprognostic (7.89e-3)"	"unprognostic (1.80e-1)"	"unprognostic (1.87e-1)"	"unprognostic (2.48e-2)"	57.8	21.5	29.5	25.3	31.5	23.3	35.1	32.9	23.4	27.6	75.9	30.7	16.7	33.1	24.2	30.9	31.7	30.6	53.7	19.9	42.1	38.2	29.8	26.9	22.8	35.5	36.2	27.2	25.8	46.7	12.8	34.7	27.8	23.3	20.6	22.4	22.9	26.1	69.0	22.3	20.2	39.3	34.2	30.6	22.1	18.9	43.1	25.5	33.7	85.3	24.7	32.3	22.4	33.0	19.3	18.0	13.4	15.1	60.5	37.9	12.9	20.0	23.1	15.9	13.3	19.9	13.8	20.7	16.3	24.4	8.0	24.3	10.2	22.2	22.1	30.8	15.8	21.0	20.3	15.2	25.0	22.9	12.8	35.8	42.8	6.1	17.7	16.5	19.4	14.8	6.4	40.4	26.0	10.1	19.2	15.8	3.4	17.3	11.1	25.4	47.3	19.9	26.4	29.4	2.0	11.3	27.1	30.7	18.7	14.2	34.6	41.2	25.8	24.8	16.9	28.9	14.6	21.7	37.2	21.4	11.9	23.5	23.7	10.6	12.7	6.1	4.0	9.4	5.0	2.8	3.6	4.3	14.0	3.3	3.2	4.0	21.1	4.4	11.1	1.7	4.0	5.0	29.5	31.5	32.9	23.4	19.9	42.1	35.5	36.2	27.8	34.2	43.1	33.0	122.2	12.8	44.7	46.0	29.6	66.5	42.8	21.3	39.3	16.2	35.8	25.8	159.9	37.1	32.9	33.1	18.8	18.6	31.2	32.7	5.9	13.0	21.8	76.5	80.5	96.5	37.1	20.6	44.9	24.9	13.4	59.2	23.0	49.0	14.5	24.3	57.5	53.2	30.7	32.0	48.0	28.4	12.2	102.0	76.0	26.1	42.9	68.1	58.7	73.1	69.1	16.2	25.7	45.8	69.1	21.5	21.1	37.6	24.9	52.6	40.7	35.0	65.4	24.9	52.6	83.4	56.4	10.7	8.1	33.4	75.0	15.5	29.8	12.5	25.2	51.2
HIVEP1	"CIRIP, CRYBP1, MBP-1, PRDII-BF1, Schnurri-1, ZAS1, ZNF40, ZNF40A"	ENSG00000095951	"HIVEP zinc finger 1"	P15822	6	12008762-12164999	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 94.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA050724, HPA067457"	Approved		Supported	"Nucleoplasm,Nuclear bodies,Mitochondria,Cytosol"		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 16: U-266 - Nucleosome"	"Cluster 65: Plasmacytoid DCs - Unknown function"	Nucleoplasm	"Nuclear bodies, Mitochondria, Cytosol"	"HPA050724: AB_2616457, HPA067457: "	"unprognostic (2.55e-1)"	"unprognostic (5.85e-2)"	"unprognostic (1.15e-1)"	"unprognostic (6.03e-2)"	"unprognostic (1.75e-2)"	"unprognostic (5.65e-3)"	"unprognostic (4.83e-2)"	"unprognostic (1.38e-1)"	"unprognostic (2.20e-1)"	"unprognostic (1.85e-1)"	"unprognostic (5.69e-2)"	"unprognostic (1.98e-1)"	"unprognostic (4.40e-2)"	"unprognostic (3.01e-2)"	"unprognostic (2.21e-1)"	"unprognostic (4.49e-2)"	"unprognostic (2.38e-1)"	7.2	2.3	0.8	8.0	3.0	16.7	5.5	0.7	3.0	7.4	6.5	6.4	5.0	5.9	4.5	7.4	6.1	7.3	3.8	2.2	0.8	4.5	11.7	6.3	8.0	1.3	2.8	6.5	6.7	10.5	3.3	4.9	0.5	6.9	6.6	5.8	4.8	5.8	2.8	5.7	5.2	6.2	0.0	6.0	4.9	4.8	1.2	9.1	4.9	6.2	8.3	9.3	3.3	1.6	8.1	5.9	7.5	4.2	5.8	7.3	7.2	6.4	5.5	5.2	5.7	3.8	4.2	6.7	13.6	7.8	12.4	7.6	7.4	9.2	7.1	14.6	4.3	3.1	5.6	3.7	4.7	3.7	2.5	5.1	9.0	10.6	16.3	11.0	15.5	4.6	32.9	7.5	11.5	6.0	5.9	3.3	6.4	2.8	2.7	3.2	9.8	10.7	3.1	8.7	7.1	5.2	15.9	12.8	4.3	16.6	7.6	4.7	25.2	13.0	5.8	12.3	7.4	30.0	27.3	12.0	4.0	4.8	5.5	2.4	1.8	2.1	1.2	2.0	0.9	3.1	2.0	0.8	1.2	4.8	3.4	2.1	11.7	3.3	5.2	9.0	4.4	0.7	0.8	3.0	0.7	3.0	2.2	0.8	1.3	2.8	0.5	0.0	1.2	1.6	40.2	28.9	16.9	74.7	35.6	32.2	25.4	7.4	30.7	20.4	12.3	10.9	10.4	17.2	17.6	7.3	12.5	3.4	18.7	17.5	3.9	5.6	2.5	37.7	16.4	20.3	10.8	6.5	94.6	7.2	1.8	25.2	22.4	51.0	7.6	7.0	6.4	12.3	5.9	21.9	68.3	14.4	4.1	9.6	47.9	1.8	3.7	23.1	19.6	44.0	29.6	13.1	5.2	59.3	25.0	11.5	10.3	4.5	33.6	25.2	6.7	2.5	16.7	9.7	0.0	21.0	17.1	3.9	3.5	18.7	33.4	5.2	18.8	6.6	8.6	23.7
HIVEP2	"HIV-EP2, MBP-2, MIBP1, Schnurri-2, ZAS2, ZNF40B"	ENSG00000010818	"HIVEP zinc finger 2"	P31629	6	142751469-142956698	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding	"Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 326.2;Inhibitory neurons: 223.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 37.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA055954			Supported	Nucleoplasm		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 52: Non-specific - Ribosome"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Nucleoplasm		"HPA055954: "	"unprognostic (1.35e-2)"	"unprognostic (1.61e-2)"	"unprognostic (8.48e-2)"	"unprognostic (2.03e-2)"	"unprognostic (2.55e-1)"	"unprognostic (1.20e-2)"	"unprognostic (7.71e-2)"	"unprognostic (8.44e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.34e-2)"	"unprognostic (1.19e-2)"	"unprognostic (1.93e-1)"	"unprognostic (8.09e-3)"	"unprognostic (1.25e-2)"	"unprognostic (5.32e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.10e-1)"	7.9	6.9	5.2	10.4	7.8	3.1	6.2	10.1	15.6	4.2	0.0	5.4	4.5	6.1	5.0	8.5	11.4	9.8	7.4	9.5	1.3	6.0	5.6	7.9	12.0	1.0	4.9	13.1	10.1	8.3	5.9	7.2	1.2	5.0	4.3	5.7	8.7	5.1	21.0	8.0	6.0	5.5	0.8	8.2	4.9	1.8	5.8	19.0	8.2	13.9	12.1	13.8	5.5	10.5	6.0	1.1	1.4	5.2	11.1	12.3	4.1	8.5	21.8	5.2	6.3	0.4	4.9	9.5	5.2	37.7	9.9	3.8	2.3	17.4	12.7	3.7	2.7	2.6	3.9	2.4	8.4	8.4	0.1	11.4	16.9	21.3	24.3	12.1	2.8	7.5	0.1	8.4	8.9	6.8	11.1	3.6	1.3	1.4	8.5	14.4	9.3	0.8	4.8	10.4	14.0	5.9	11.3	9.2	6.3	2.5	1.7	4.9	3.0	17.5	4.4	14.8	7.5	17.4	3.1	19.8	4.9	6.4	8.3	0.0	0.1	0.0	0.6	0.2	1.4	0.9	1.4	1.2	0.4	0.4	1.4	1.1	0.9	0.7	0.2	0.2	1.2	0.5	5.2	7.8	10.1	15.6	9.5	1.3	1.0	4.9	1.2	0.8	5.8	10.5	22.2	22.4	25.5	65.6	18.4	94.3	45.2	9.1	5.2	15.1	13.7	7.6	18.3	5.7	27.6	7.3	25.0	2.8	22.4	5.1	0.0	12.5	2.1	53.2	29.4	26.5	3.5	4.2	326.2	14.8	1.2	30.5	2.0	101.0	3.8	6.1	8.6	4.5	2.8	30.3	223.0	4.9	16.2	4.4	52.7	1.2	11.8	17.5	24.9	67.5	5.1	2.5	4.1	98.0	75.3	22.8	6.6	15.8	22.1	53.6	5.3	3.3	25.1	2.2	0.0	37.6	25.7	0.6	0.9	11.5	94.6	4.7	29.5	2.6	3.4	56.8
HIVEP3	"FLJ16752, KBP-1, KBP1, KIAA1555, KRC, Schnurri-3, SHN3, ZAS3, ZNF40C"	ENSG00000127124	"HIVEP zinc finger 3"	Q5T1R4	1	41506365-42035925	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 6.6"	"Group enriched"	"Detected in many"	5	"Astrocytes: 83.9;Excitatory neurons: 219.6;Inhibitory neurons: 271.9;Microglial cells: 163.9;Oligodendrocyte precursor cells: 83.9;Oligodendrocytes: 196.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 18.8;hTEC/SVTERT24-B: 9.5;Karpas-707: 11.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005728	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm		"HPA005728: AB_10612117"	"unprognostic (2.87e-3)"	"unprognostic (2.38e-2)"	"unprognostic (4.65e-2)"	"unprognostic (2.56e-1)"	"unprognostic (1.55e-2)"	"unprognostic (6.50e-2)"	"unprognostic (2.70e-3)"	"unprognostic (3.73e-1)"	"unprognostic (1.50e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.41e-1)"	"unprognostic (2.07e-8)"	"unprognostic (1.43e-1)"	"unprognostic (1.38e-2)"	"unprognostic (1.13e-2)"	"unprognostic (3.21e-1)"	1.6	0.6	0.8	2.1	2.1	1.6	1.4	1.4	1.6	0.4	0.0	0.5	0.4	0.4	0.3	1.9	0.5	0.7	0.8	2.0	0.0	1.0	0.3	1.9	1.7	0.7	0.4	0.5	0.8	0.4	2.1	0.6	1.0	1.4	0.5	0.6	1.6	0.3	0.6	4.6	0.6	0.8	0.1	1.1	0.7	0.3	0.5	6.6	1.5	0.4	2.1	1.8	0.5	0.3	1.9	0.6	0.2	1.8	2.2	1.0	0.0	0.9	0.2	2.3	4.0	0.1	0.3	4.0	0.6	1.0	1.5	2.7	0.4	0.4	3.1	18.8	0.5	0.2	0.9	0.0	0.4	0.3	0.3	5.6	0.4	9.5	1.1	0.6	0.5	1.3	0.0	11.0	1.8	1.2	3.0	0.8	0.6	0.6	2.3	2.0	2.9	2.2	1.5	0.4	2.0	0.6	2.6	0.7	0.5	1.1	0.9	3.4	3.4	2.0	2.2	0.6	4.6	3.3	1.4	2.6	8.1	0.2	7.5	0.0	0.5	0.0	0.6	1.1	0.1	0.1	0.2	0.3	0.4	0.4	0.0	0.2	0.0	0.0	1.0	0.1	0.1	0.4	0.8	2.1	1.4	1.6	2.0	0.0	0.7	0.4	1.0	0.1	0.5	0.3	5.9	6.4	10.5	83.9	9.6	23.7	26.5	4.3	17.6	16.4	15.1	11.0	6.9	5.7	8.2	1.8	2.1	0.4	17.6	3.5	1.9	3.1	9.9	1.2	7.7	7.5	3.6	4.4	219.6	2.7	4.4	11.1	1.5	2.8	1.3	0.2	11.4	2.5	6.2	25.2	271.9	1.2	2.0	6.5	17.3	31.9	8.7	15.0	5.4	163.9	9.1	16.0	27.8	83.9	196.0	3.1	0.1	4.1	3.3	15.5	1.9	3.2	1.1	3.5	6.6	23.9	7.4	11.3	8.6	23.7	8.7	0.8	14.5	10.0	0.9	11.1
HK1		ENSG00000156515	"Hexokinase 1"	P19367	10	69269984-69401884	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Glycolysis, Immunity, Inflammatory response, Innate immunity"	"Allosteric enzyme, Kinase, Transferase"	"Cancer-related genes, Charcot-Marie-Tooth disease, Disease variant, Mental retardation, Neurodegeneration, Neuropathy, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"Early spermatids: 374.0;Horizontal cells: 304.5;Late spermatids: 1034.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007043, HPA007044, CAB010052"	Supported		Supported	Mitochondria		NA	NA		560000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 25: Spermatids - Spermatogenesis"	Mitochondria		"CAB010052: AB_627721, HPA007043: AB_1850652, HPA007044: AB_1079049"	"unprognostic (8.80e-2)"	"unprognostic (1.78e-1)"	"unprognostic (2.03e-1)"	"unprognostic (2.00e-3)"	"unprognostic (1.15e-2)"	"prognostic unfavorable (3.39e-6)"	"unprognostic (1.23e-1)"	"unprognostic (1.97e-1)"	"unprognostic (4.29e-2)"	"unprognostic (1.16e-1)"	"unprognostic (3.93e-3)"	"unprognostic (1.12e-1)"	"unprognostic (1.37e-3)"	"unprognostic (7.25e-2)"	"unprognostic (1.40e-2)"	"unprognostic (2.00e-3)"	"unprognostic (3.86e-2)"	47.0	24.4	61.0	45.0	65.7	60.3	40.6	58.0	76.6	54.7	64.2	60.1	13.1	41.3	11.2	129.9	37.0	25.7	150.8	69.1	62.7	49.2	8.5	48.1	34.1	56.7	59.8	19.9	12.3	25.0	44.9	49.3	71.1	52.9	31.9	147.6	67.1	53.1	193.5	102.6	29.2	49.8	40.0	40.3	61.6	77.2	53.5	44.9	71.0	146.7	47.6	74.3	80.9	54.1	101.6	56.6	74.2	71.1	81.0	60.4	47.1	98.3	256.5	128.5	138.0	16.3	11.0	7.3	75.8	165.9	92.9	86.2	69.9	220.0	122.0	67.5	54.5	250.0	58.3	1.1	91.7	5.1	181.2	91.5	125.8	184.5	407.6	160.8	135.4	36.8	424.5	51.3	178.7	167.7	29.7	13.1	113.8	51.7	247.0	44.8	45.0	0.6	88.7	117.4	75.7	88.7	112.6	215.4	65.2	104.3	117.7	16.5	140.4	190.5	86.4	106.5	139.6	61.1	42.8	17.4	247.3	130.4	56.1	68.7	88.8	44.6	41.5	125.2	69.0	33.5	47.9	47.6	81.0	19.9	41.7	33.9	20.9	31.2	135.4	9.1	58.1	110.4	61.0	65.7	58.0	76.6	69.1	62.7	56.7	59.8	71.1	40.0	53.5	54.1	26.1	25.6	32.4	38.2	26.5	48.3	50.5	37.8	43.9	83.9	33.1	21.7	130.6	4.3	34.2	27.6	54.2	70.6	14.6	30.3	13.7	28.6	374.0	32.6	28.0	37.9	18.7	104.8	53.8	30.6	93.3	30.3	41.3	34.5	23.4	72.6	26.7	1.1	49.4	304.5	49.8	28.7	44.7	41.7	21.9	1034.1	15.2	51.3	37.4	29.0	35.3	32.9	20.6	14.1	3.5	54.6	11.1	18.4	19.1	29.1	0.7	1.1	30.7	95.5	19.7	22.2	43.1	5.3	6.2	86.0	51.7	118.9	30.5	28.3	19.3	43.5
HK2		ENSG00000159399	"Hexokinase 2"	P52789	2	74834127-74893359	"Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	Glycolysis	"Allosteric enzyme, Kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"retina: 144.0"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 216.4;Early spermatids: 89.5;Paneth cells: 108.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"eosinophil: 51.7"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"U-87 MG: 172.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA028587, HPA061711"	Enhanced		Supported	Vesicles,Centrosome,Mitochondria,Cytosol		NA	NA		100000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 54: Non-specific - Microtubule organization"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Mitochondria, Cytosol"	"Vesicles, Centrosome"	"HPA028587: AB_10602605, HPA061711: "	"unprognostic (1.28e-1)"	"unprognostic (1.52e-3)"	"unprognostic (3.02e-1)"	"unprognostic (3.63e-2)"	"unprognostic (1.69e-1)"	"unprognostic (7.21e-2)"	"prognostic unfavorable (3.65e-4)"	"unprognostic (2.85e-2)"	"unprognostic (2.57e-1)"	"unprognostic (2.17e-1)"	"unprognostic (4.43e-3)"	"unprognostic (2.24e-2)"	"prognostic unfavorable (1.37e-4)"	"unprognostic (1.20e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.42e-1)"	"unprognostic (7.67e-2)"	58.2	2.7	2.7	14.6	3.9	45.7	16.0	4.8	5.6	7.8	2.7	46.6	2.8	5.1	66.1	19.9	9.7	9.5	7.9	3.5	3.6	1.9	2.7	15.2	5.8	11.1	6.3	14.9	2.9	2.5	1.9	13.1	8.5	4.9	37.3	144.0	14.7	1.1	45.6	14.6	13.0	3.3	5.9	6.9	18.7	32.8	6.0	3.7	14.1	83.7	7.8	27.1	15.9	8.6	55.9	0.4	12.5	45.4	103.3	10.8	46.5	21.3	30.6	23.4	33.4	44.0	9.8	40.7	20.1	9.9	30.2	19.0	57.0	44.7	67.0	11.6	12.5	55.1	12.4	61.0	32.5	80.8	86.3	18.2	47.3	44.5	77.1	26.3	11.3	23.0	49.2	0.2	6.9	39.6	19.8	82.0	45.3	52.4	38.2	31.8	26.2	31.7	14.2	77.2	9.2	44.6	13.5	67.4	27.4	17.8	3.6	12.8	9.4	74.0	13.4	31.2	39.2	27.1	8.2	20.2	172.5	57.9	19.9	16.8	14.0	51.7	0.2	11.0	0.6	1.2	0.8	0.1	11.8	1.3	1.2	1.2	11.2	0.0	7.7	0.3	1.5	4.7	2.7	3.9	4.8	5.6	3.5	3.6	11.1	6.3	8.5	5.9	6.0	8.6	1.6	16.0	45.3	4.9	5.7	51.6	9.5	26.7	5.7	14.8	16.0	5.6	7.2	4.3	24.2	5.5	83.4	2.3	0.6	216.4	0.0	4.6	89.5	5.8	4.1	4.4	39.0	4.2	0.2	4.5	33.5	6.4	14.8	15.0	22.2	27.2	1.4	0.3	15.8	21.9	0.1	37.7	6.1	20.8	35.1	46.0	14.6	22.8	23.2	25.3	18.9	6.3	2.1	0.5	0.7	25.6	108.3	7.9	4.7	34.3	5.4	0.2	15.2	42.1	13.1	19.9	3.3	3.9	4.2	10.7	57.0	8.2	3.6	5.8	51.7	70.0
HLA-A		ENSG00000206503	"Major histocompatibility complex, class I, A"	P04439	6	29941260-29945884	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Adaptive immunity, Host-virus interaction, Immunity, Innate immunity"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Ductal cells: 3747.8;Proximal enterocytes: 5267.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"A-431: 1363.9;fHDF/TERT166: 360.3;HBEC3-KT: 366.7;RPMI-8226: 372.1;U-266/70: 344.6"									CAB078470			Supported	"Golgi apparatus,Plasma membrane"		NA	NA		170000000	"Cluster 49: Eosinophils - Unknown function"	"Cluster 64: Macrophages - Immune response"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 63: NK-cells & T-cells - Immune response"	"Plasma membrane"	"Golgi apparatus"	"CAB078470: AB_10985125"	"unprognostic (1.56e-2)"	"unprognostic (9.14e-2)"	"unprognostic (1.34e-2)"	"prognostic favorable (9.59e-4)"	"unprognostic (3.49e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.12e-1)"	"unprognostic (7.28e-2)"	"unprognostic (3.42e-2)"	"prognostic favorable (6.47e-4)"	"unprognostic (2.96e-1)"	"unprognostic (3.24e-1)"	"unprognostic (1.84e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.32e-2)"	"unprognostic (1.20e-2)"	"unprognostic (1.54e-2)"	635.4	714.2	15.0	34.8	15.5	137.7	566.7	14.7	36.5	504.9	18.0	737.5	278.3	476.1	181.1	366.8	390.3	239.9	473.4	14.6	17.0	687.0	392.0	1007.3	132.0	19.1	15.8	338.8	200.0	18.5	406.5	52.1	16.5	370.9	94.6	9.9	364.1	1.2	246.5	673.3	959.1	14.5	16.8	1413.1	442.2	132.6	18.0	138.9	531.9	14.5	178.3	412.3	466.8	18.3	1363.9	35.0	0.0	0.0	205.9	193.7	1.4	1.4	2.5	2.1	2.3	0.2	0.1	4.0	0.6	360.3	179.1	31.2	0.2	366.7	0.5	3.1	13.5	237.5	9.5	7.4	11.2	0.5	14.4	2.0	0.0	2.5	1.1	0.6	0.2	177.8	0.4	1.4	0.5	0.0	1.1	24.3	2.9	0.2	4.1	27.5	2.5	372.1	246.7	276.5	0.6	12.4	29.3	0.2	11.8	82.8	1.6	30.4	5.8	18.7	0.8	5.8	4.0	344.6	92.6	77.7	0.4	199.9	0.2	321.6	119.0	182.7	164.7	95.5	134.8	96.9	125.4	146.3	18.6	64.3	86.5	119.2	248.7	133.1	109.6	54.6	222.2	191.9	15.0	15.5	14.7	36.5	14.6	17.0	19.1	15.8	16.5	16.8	18.0	18.3	1622.4	371.8	478.6	22.9	1316.2	856.4	886.2	1417.5	228.8	30.8	289.6	188.5	147.4	936.5	952.5	503.9	6.2	18.3	1879.4	2631.8	88.0	3747.8	52.2	239.4	374.0	1717.8	955.2	499.4	3.6	1310.0	18.5	743.5	853.7	556.2	603.0	253.3	1266.2	276.4	1840.9	37.0	19.3	1755.3	1265.4	1575.0	1124.0	95.6	704.6	1419.1	635.0	67.5	3258.0	170.4	3201.9	49.3	16.1	1802.9	2452.4	484.1	1110.7	1026.6	5267.3	294.9	609.6	24.4	558.8	397.3	579.2	197.4	23.8	216.5	947.7	31.7	2234.9	1021.3	1225.4	1262.8
HLA-DMB	"D6S221E, RING7"	ENSG00000242574	"Major histocompatibility complex, class II, DM beta"	P28068	6	32934629-32941028	"Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 78.8;lymphoid tissue: 101.5"	"Group enriched"	"Detected in many"	4	"B-cells: 228.5;dendritic cells: 129.4;Hofbauer cells: 274.8;Kupffer cells: 201.9;Langerhans cells: 472.8;Macrophages: 272.4;monocytes: 187.1;Proximal enterocytes: 284.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in all"	6	"B-cells: 128.8;dendritic cells: 85.3;monocytes: 73.8"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 14.2;Daudi: 27.6;EFO-21: 12.4;U-266/70: 7.8;U-698: 31.9"					"Low region specificity"	"Detected in all"			"HPA012298, HPA077524"	Supported		Supported	Vesicles		NA	NA			"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 64: Macrophages - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 41: Macrophages - Immune response"	Vesicles		"HPA012298: AB_1853927, HPA077524: "	"unprognostic (5.34e-2)"	"unprognostic (1.63e-2)"	"unprognostic (2.45e-2)"	"prognostic favorable (3.89e-5)"	"unprognostic (3.07e-1)"	"unprognostic (7.64e-3)"	"unprognostic (4.00e-1)"	"unprognostic (3.46e-3)"	"unprognostic (6.99e-2)"	"unprognostic (8.76e-2)"	"unprognostic (8.93e-2)"	"unprognostic (2.73e-1)"	"unprognostic (6.82e-3)"	"unprognostic (2.03e-1)"	"unprognostic (4.14e-2)"	"unprognostic (8.35e-2)"	"unprognostic (5.60e-2)"	38.3	35.9	0.1	13.2	0.2	6.9	25.7	0.3	1.0	21.6	0.1	19.9	0.0	14.6	7.4	9.3	14.6	0.1	11.1	0.0	0.6	41.9	7.8	59.9	17.6	0.3	0.4	9.5	9.1	0.0	9.2	0.8	0.2	13.1	14.9	0.5	14.7	0.0	5.3	14.3	78.8	0.0	0.9	101.5	17.6	2.2	0.1	9.9	45.9	0.0	18.8	14.4	10.3	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.2	27.6	12.4	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.9	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	7.8	0.4	31.9	0.0	0.1	0.0	0.5	73.2	16.7	1.2	73.8	2.6	94.0	1.0	2.9	85.0	128.8	0.7	2.4	4.7	16.2	28.1	85.3	6.7	71.4	0.1	0.2	0.3	1.0	0.0	0.6	0.3	0.4	0.2	0.9	0.1	1.1	36.8	9.6	57.0	0.7	228.5	12.0	1.0	5.4	2.2	0.2	2.5	4.7	2.6	5.7	12.7	16.5	0.0	1.7	129.4	3.3	11.7	28.8	0.5	7.5	5.4	37.2	4.2	10.3	0.8	4.4	1.6	3.8	3.1	38.5	15.2	22.7	5.7	0.5	274.8	0.0	0.6	8.5	2.0	201.9	472.8	1.5	3.4	272.4	16.0	27.2	187.1	0.5	21.6	1.0	0.1	2.5	17.8	1.9	3.8	1.3	284.8	7.4	16.8	1.1	6.6	1.6	3.1	0.6	0.7	1.1	10.9	2.7	17.6	0.9	10.3	8.7
HLA-DPA1	HLA-DP1A	ENSG00000231389	"Major histocompatibility complex, class II, DP alpha 1"	P20036	6	33064569-33080775	"Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lung: 319.9;lymphoid tissue: 359.6"	"Cell type enhanced"	"Detected in many"		"B-cells: 1387.3;Kupffer cells: 1794.6;Langerhans cells: 8122.8;Macrophages: 2736.9;monocytes: 2940.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"classical monocyte: 81.8;intermediate monocyte: 187.4;memory B-cell: 150.4;myeloid DC: 296.0;naive B-cell: 136.5;non-classical monocyte: 124.1;plasmacytoid DC: 82.6"	"Group enriched"	"Detected in all"	7	"B-cells: 150.4;dendritic cells: 296.0;monocytes: 187.4"	"Cell line enhanced"	"Detected in many"		"Daudi: 37.2;HDLM-2: 115.9;REH: 30.3;U-698: 26.1"									HPA017967	Enhanced		Supported	Vesicles		NA	NA		240000	"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 64: Macrophages - Immune response"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 41: Macrophages - Immune response"	Vesicles		"HPA017967: AB_1853929"	"unprognostic (8.93e-3)"	"unprognostic (3.15e-2)"	"unprognostic (3.64e-2)"	"unprognostic (9.40e-3)"	"unprognostic (9.07e-2)"	"unprognostic (2.80e-2)"	"unprognostic (5.69e-2)"	"unprognostic (1.82e-2)"	"unprognostic (7.28e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.93e-1)"	"unprognostic (1.80e-1)"	"unprognostic (8.38e-2)"	"unprognostic (1.17e-1)"	"unprognostic (4.69e-2)"	"unprognostic (8.11e-2)"	"unprognostic (1.06e-1)"	180.8	108.0	2.2	33.4	2.0	12.8	138.4	2.7	3.3	76.7	2.5	72.1	20.2	55.3	8.3	43.1	63.0	13.0	62.0	2.0	3.4	99.0	36.8	319.9	51.3	4.9	2.8	24.9	28.6	5.9	58.0	3.4	4.3	64.0	16.1	2.0	59.5	16.2	29.5	66.3	174.4	14.6	4.3	359.6	52.1	13.4	3.1	30.2	76.6	7.3	51.5	58.6	60.0	4.4	0.1	0.0	0.0	0.0	0.8	1.3	1.1	0.4	0.4	0.5	0.0	0.0	4.9	37.2	5.0	0.9	7.1	0.0	0.0	0.0	0.1	115.9	2.5	6.2	0.0	0.0	0.1	0.0	11.6	1.7	0.0	2.2	0.0	0.0	0.6	0.0	0.0	3.3	0.0	0.0	0.1	0.1	0.6	0.0	0.0	30.3	0.0	4.9	0.1	0.0	0.1	0.0	0.0	0.0	2.9	0.0	0.0	1.3	2.6	7.8	0.1	0.1	0.0	5.6	0.9	26.1	12.2	0.2	4.4	2.2	81.8	6.6	21.6	187.4	5.7	150.4	9.6	23.9	296.0	136.5	3.4	15.7	3.0	20.9	124.1	82.6	29.2	136.0	2.2	2.0	2.7	3.3	2.0	3.4	4.9	2.8	4.3	4.3	3.1	4.4	621.8	83.3	404.3	0.3	1387.3	206.7	7.2	12.4	9.1	2.8	41.2	110.4	12.1	64.3	107.3	23.9	0.0	4.2	574.9	10.6	9.8	36.4	2.8	1.2	4.1	337.8	10.2	80.3	0.5	18.8	9.3	53.7	48.4	2.8	64.6	14.3	62.2	7.5	1153.8	5.0	0.9	18.2	12.2	1794.6	8122.8	11.7	18.0	2736.9	302.4	32.8	2940.3	5.1	94.7	0.0	0.1	4.7	5.4	27.4	100.2	10.6	114.0	42.7	129.2	5.0	52.6	14.7	29.8	1.3	4.8	6.0	175.2	6.8	157.8	11.5	28.6	34.4
HLA-DPB1	HLA-DP1B	ENSG00000223865	"Major histocompatibility complex, class II, DP beta 1"	P04440	6	33075990-33089696	"Human disease related genes, Predicted membrane proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 278.7;lymphoid tissue: 409.4"	"Cell type enhanced"	"Detected in many"		"B-cells: 1569.6;Kupffer cells: 2374.2;Langerhans cells: 12627.8;Macrophages: 2453.8;monocytes: 3754.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"myeloid DC: 285.5"	"Group enriched"	"Detected in all"	10	"B-cells: 227.8;dendritic cells: 285.5;monocytes: 137.5"	"Group enriched"	"Detected in some"	6	"HDLM-2: 65.9;REH: 26.5"									"HPA011078, HPA058509"	Enhanced		Approved	"Nucleoplasm,Cell Junctions"		NA	NA		470000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 64: Macrophages - Immune response"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 41: Macrophages - Immune response"	"Cell Junctions"	Nucleoplasm	"HPA011078: AB_1079378, HPA058509: AB_2683737"	"unprognostic (5.44e-3)"	"unprognostic (7.03e-3)"	"unprognostic (9.84e-2)"	"prognostic favorable (3.38e-4)"	"unprognostic (9.43e-2)"	"unprognostic (1.80e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.51e-3)"	"unprognostic (1.77e-2)"	"unprognostic (5.64e-2)"	"unprognostic (1.57e-1)"	"unprognostic (4.34e-1)"	"unprognostic (4.35e-2)"	"unprognostic (1.80e-1)"	"unprognostic (4.17e-2)"	"unprognostic (3.58e-2)"	"unprognostic (1.85e-1)"	151.6	101.3	1.0	42.0	1.0	5.8	112.8	3.3	1.3	68.2	0.9	69.4	12.4	50.2	2.9	43.9	55.7	17.2	51.1	0.8	1.8	96.1	38.6	278.7	66.7	1.8	1.3	26.2	32.4	1.0	51.5	0.8	1.8	70.3	2.5	1.5	57.2	6.4	25.1	72.3	176.5	4.7	2.1	409.4	54.1	12.8	1.0	10.9	69.5	1.3	42.2	49.2	56.5	3.0	0.0	0.0	0.1	0.0	0.0	0.3	3.6	0.0	0.0	0.0	0.0	0.0	0.0	1.3	6.2	0.2	0.0	0.1	0.0	0.0	0.0	65.9	1.9	1.5	0.0	0.0	0.0	0.0	0.5	1.4	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	4.9	0.0	0.0	26.5	0.1	0.3	0.3	0.0	0.9	0.0	0.0	0.3	0.1	0.4	0.0	0.1	1.8	0.1	0.2	0.0	0.0	7.2	0.3	4.4	1.1	0.0	0.0	0.5	59.6	4.0	14.8	137.5	1.8	226.6	5.1	22.2	285.5	227.8	2.3	11.9	1.6	8.2	60.3	77.5	22.7	107.8	1.0	1.0	3.3	1.3	0.8	1.8	1.8	1.3	1.8	2.1	1.0	3.0	354.8	67.3	330.7	1.3	1569.6	300.5	26.0	5.6	19.4	26.9	54.0	123.6	10.3	67.2	62.3	29.5	16.7	4.8	692.9	7.8	3.9	58.3	3.6	2.0	16.3	297.8	9.6	87.9	1.3	15.6	8.1	62.3	48.4	2.7	61.6	13.6	97.1	8.8	1099.4	8.4	1.6	13.0	10.2	2374.2	12627.8	10.1	27.4	2453.8	323.7	20.6	3754.7	43.3	203.9	2.5	0.2	7.4	10.0	21.1	50.9	28.2	154.7	60.2	54.4	21.9	46.0	21.4	47.5	1.3	7.8	6.4	233.3	9.0	200.7	3.9	23.0	51.7
HLA-DQB1	"CELIAC1, HLA-DQB, IDDM1"	ENSG00000179344	"Major histocompatibility complex, class II, DQ beta 1"		6	32659467-32668383	"Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"			"Tissue enhanced"	"Detected in many"		"lung: 179.1;lymphoid tissue: 301.8"	"Cell type enhanced"	"Detected in many"		"B-cells: 995.1;Langerhans cells: 4144.8;Macrophages: 1090.5;monocytes: 1038.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"classical monocyte: 153.5;intermediate monocyte: 142.9;memory B-cell: 159.2;myeloid DC: 386.3;naive B-cell: 169.1;plasmacytoid DC: 116.5"	"Group enriched"	"Detected in all"	6	"B-cells: 169.1;dendritic cells: 386.3;monocytes: 153.5"	"Cell line enriched"	"Detected in some"	6	"HDLM-2: 599.9"									HPA013667	Enhanced		Supported	"Golgi apparatus,Rods & Rings"		NA	NA			"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 16: Immune cells - Immune response"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 41: Macrophages - Immune response"	"Rods & Rings"	"Golgi apparatus"	"HPA013667: AB_1853932"	"unprognostic (8.60e-3)"	"unprognostic (1.91e-2)"	"unprognostic (5.91e-2)"	"unprognostic (9.85e-3)"	"unprognostic (4.48e-1)"	"unprognostic (5.30e-2)"	"unprognostic (4.75e-2)"	"unprognostic (1.06e-2)"	"unprognostic (2.51e-2)"	"unprognostic (1.48e-1)"	"unprognostic (3.48e-2)"	"unprognostic (3.94e-1)"	"unprognostic (1.34e-2)"	"unprognostic (3.13e-1)"	"unprognostic (4.16e-1)"	"unprognostic (2.43e-1)"	"unprognostic (1.40e-1)"	56.6	23.9	2.2	77.8	2.2	40.0	45.3	2.7	3.1	19.9	3.0	45.8	0.2	18.9	126.9	21.3	22.2	43.6	21.6	2.0	3.6	34.3	37.1	179.1	301.8	4.7	3.8	7.4	14.3	10.6	21.3	10.1	2.9	17.1	39.0	1.7	24.2	11.9	9.6	31.8	78.0	11.2	4.6	139.3	128.0	7.0	3.1	108.2	26.3	0.0	122.3	89.9	16.9	5.5	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	93.9	2.2	0.0	0.0	19.2	0.0	19.2	0.0	599.9	13.4	0.0	0.0	0.0	0.0	0.2	7.8	0.0	3.0	0.0	0.0	0.0	0.0	2.9	0.0	1.8	0.0	7.2	0.1	0.9	0.1	0.0	0.0	0.0	0.1	0.2	0.0	1.3	0.0	0.1	1.6	1.1	1.4	0.0	3.3	10.9	0.2	0.0	0.6	0.8	0.4	68.7	2.1	66.0	47.1	0.1	0.0	0.3	153.5	27.9	12.8	142.9	6.6	159.2	6.9	20.0	386.3	169.1	0.4	6.3	11.8	10.4	41.1	116.5	41.1	217.0	2.2	2.2	2.7	3.1	2.0	3.6	4.7	3.8	2.9	4.6	3.1	5.5	162.9	41.7	181.1	0.0	995.1	89.9	8.7	23.1	31.3	5.1	16.8	32.1	3.2	27.1	40.7	18.4	10.4	1.4	188.2	10.3	7.9	38.8	16.5	4.1	1.0	135.3	22.8	37.2	0.2	20.0	3.0	18.8	41.8	5.2	38.5	7.9	25.0	2.3	422.1	0.0	0.8	24.7	12.2	487.3	4144.8	7.5	6.5	1090.5	97.8	8.4	1038.0	1.1	25.7	0.0	0.1	28.3	27.4	9.8	86.9	8.7	417.9	18.5	53.0	2.7	6.6	4.8	9.6	2.7	2.5	18.5	66.3	3.0	84.5	0.9	36.1	49.1
HM13	"dJ324O17.1, H13, IMP1, IMPAS, PSENL3, PSL3, SPP, SPPL1"	ENSG00000101294	"Histocompatibility minor 13"	Q8TCT9	20	31514410-31577923	"Enzymes, Plasma proteins, Predicted membrane proteins"		"Hydrolase, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Hofbauer cells: 324.9;Plasma cells: 400.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045089, HPA056062"	Enhanced		Supported	"Endoplasmic reticulum"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 55: Plasma cells - Humoral immune response"	"Endoplasmic reticulum"		"HPA045089: AB_10962054, HPA056062: AB_2683022"	"unprognostic (8.03e-2)"	"unprognostic (2.11e-2)"	"unprognostic (5.03e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.82e-1)"	"unprognostic (5.87e-3)"	"prognostic unfavorable (1.95e-5)"	"unprognostic (2.66e-2)"	"unprognostic (2.14e-2)"	"unprognostic (2.55e-1)"	"unprognostic (2.30e-1)"	"unprognostic (8.10e-2)"	"prognostic unfavorable (4.64e-12)"	"unprognostic (3.77e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.85e-1)"	"unprognostic (8.17e-2)"	78.6	102.9	10.5	60.9	13.5	61.7	63.4	13.6	15.7	100.0	42.4	54.5	52.6	72.9	111.4	128.6	70.4	46.7	55.9	12.5	17.1	61.4	136.1	83.7	40.7	17.8	17.9	59.2	241.1	68.8	90.0	64.6	17.4	66.0	44.4	20.8	217.7	80.3	44.6	51.6	52.1	49.1	14.2	70.2	92.5	21.9	23.9	30.5	74.7	14.1	54.2	64.9	72.2	20.9	143.8	147.6	56.6	87.7	260.2	163.5	197.6	239.0	221.3	159.7	162.8	287.3	166.8	90.4	312.8	262.7	209.7	253.8	74.9	162.0	97.7	46.2	112.0	201.3	99.7	179.3	287.0	118.1	78.1	152.5	103.5	133.7	182.7	159.0	124.5	56.0	90.2	364.0	148.8	170.3	100.0	84.0	67.8	234.9	248.5	63.6	272.6	436.5	154.4	75.6	76.3	90.4	243.5	234.9	199.2	56.4	182.0	109.5	153.3	243.1	129.8	246.3	136.2	225.5	145.5	71.7	328.7	413.0	219.4	117.7	380.9	190.8	116.7	372.6	159.7	91.9	108.0	112.9	260.8	74.4	70.6	84.1	282.8	117.5	363.7	271.9	104.1	374.1	10.5	13.5	13.6	15.7	12.5	17.1	17.8	17.9	17.4	14.2	23.9	20.9	67.4	51.3	55.4	23.8	78.2	33.4	59.0	127.8	31.3	45.4	65.6	49.1	13.6	71.4	102.2	53.3	123.0	154.0	70.7	115.2	13.7	145.6	15.5	55.0	111.5	60.9	61.5	38.9	40.5	169.7	139.0	93.2	80.0	128.4	42.4	55.5	53.2	86.4	324.9	43.7	39.2	134.5	63.1	81.2	83.1	15.9	60.6	106.1	65.8	28.1	77.4	52.2	53.5	33.7	23.8	144.3	81.2	43.6	400.6	92.4	54.8	51.0	49.3	44.8	32.9	49.2	79.2	26.1	26.4	60.0	35.4	213.6	60.1	97.2	70.8	69.3
HMBOX1	"FLJ21616, HNF1LA, HOT1, PBHNF"	ENSG00000147421	"Homeobox containing 1"	Q6NT76	8	28890395-29064764	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 20.0"	"Cell type enhanced"	"Detected in all"		"Astrocytes: 125.7;Oligodendrocyte precursor cells: 118.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055855, HPA058586, CAB070418"	Approved		Supported	"Nucleoplasm,Nuclear bodies,Cytosol"		Yes	No			"Cluster 14: Monocytes - Unknown function"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	Nucleoplasm	"Nuclear bodies, Cytosol"	"CAB070418: AB_11154826, HPA055855: AB_2682945, HPA058586: AB_2683764"	"unprognostic (2.68e-3)"	"unprognostic (2.30e-3)"	"unprognostic (4.52e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.03e-3)"	"unprognostic (1.20e-1)"	"unprognostic (2.75e-3)"	"unprognostic (1.49e-1)"	"unprognostic (4.25e-2)"	"unprognostic (1.89e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.51e-1)"	"unprognostic (3.84e-2)"	"unprognostic (2.81e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.47e-1)"	4.6	6.7	7.6	5.1	11.9	10.8	4.2	10.6	5.7	3.7	1.7	3.8	3.1	4.4	3.0	3.2	3.7	4.2	4.5	5.3	17.9	4.3	4.2	4.6	5.3	15.0	20.0	6.1	3.3	5.0	1.8	6.8	15.6	2.9	3.9	6.2	3.1	2.5	2.8	4.4	4.3	5.2	10.4	5.7	4.3	7.6	11.6	4.9	6.2	3.7	5.9	3.8	2.4	12.9	6.2	6.8	7.1	8.2	6.5	6.7	6.0	2.6	3.5	4.0	4.3	3.1	3.9	15.1	6.3	4.5	6.0	5.3	14.4	5.3	5.6	5.5	2.4	15.6	13.8	4.2	5.3	5.4	10.2	3.3	7.5	5.3	10.1	4.9	9.1	9.0	22.7	14.4	5.7	3.8	9.9	2.7	5.0	6.6	1.6	8.1	7.1	3.4	2.8	11.5	3.0	9.2	5.1	3.9	5.4	5.9	3.9	4.8	13.0	3.6	16.8	3.9	3.8	4.4	4.8	5.9	4.6	6.5	5.4	3.2	2.4	1.1	1.9	2.6	2.7	3.4	1.9	1.8	2.5	2.6	2.4	2.4	1.4	1.2	4.7	1.9	0.8	1.4	7.6	11.9	10.6	5.7	5.3	17.9	15.0	20.0	15.6	10.4	11.6	12.9	25.5	16.0	18.1	125.7	30.3	16.7	15.8	18.1	15.9	24.4	15.3	10.5	23.6	20.0	14.0	29.5	39.6	12.9	18.7	16.2	15.6	8.3	93.0	15.0	21.2	34.2	17.4	19.6	90.1	14.4	14.1	19.2	11.2	29.4	17.1	36.7	68.6	13.7	10.3	30.3	109.8	12.9	22.4	19.8	36.4	31.5	35.8	20.1	16.0	91.8	21.4	28.3	26.8	118.1	111.8	14.1	11.3	31.6	14.4	21.0	20.4	8.8	14.3	31.6	19.7	34.6	17.3	43.6	15.2	10.1	19.7	19.2	22.8	19.5	14.7	22.6
HMGA1	HMGIY	ENSG00000137309	"High mobility group AT-hook 1"	P17096	6	34236873-34246231	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 275.1"	"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 947.5;Cytotrophoblasts: 894.3;Pancreatic endocrine cells: 1838.5;Prostatic glandular cells: 1483.3;Syncytiotrophoblasts: 822.8;Urothelial cells: 1681.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB032200, HPA065612, HPA068442"	Enhanced		Supported	Nucleoplasm,Nucleoli		NA	NA		72000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	Nucleoplasm	Nucleoli	"CAB032200: AB_2117771, HPA065612: , HPA068442: "	"unprognostic (1.81e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.08e-1)"	"prognostic unfavorable (7.13e-4)"	"unprognostic (1.57e-1)"	"unprognostic (1.20e-3)"	"prognostic unfavorable (1.29e-6)"	"prognostic unfavorable (3.36e-4)"	"unprognostic (8.54e-2)"	"unprognostic (1.84e-2)"	"prognostic unfavorable (8.71e-4)"	"unprognostic (1.55e-1)"	"unprognostic (8.22e-2)"	"unprognostic (4.52e-3)"	"unprognostic (1.19e-1)"	"unprognostic (4.37e-1)"	"unprognostic (2.65e-2)"	28.1	9.0	22.1	79.6	20.9	184.0	27.4	17.8	27.3	93.3	2.6	59.9	118.7	22.8	16.7	275.1	41.0	39.2	35.8	24.1	23.3	89.2	20.0	46.5	139.3	24.3	19.1	4.7	31.9	15.0	15.4	82.4	21.1	27.7	57.2	32.2	69.7	12.6	119.7	141.6	103.6	9.7	15.4	68.7	73.3	80.1	22.9	156.0	31.5	35.1	154.7	100.1	109.6	25.2	1418.7	547.0	274.2	192.9	124.8	916.6	1193.8	556.0	628.8	421.5	233.4	361.3	960.0	658.9	273.1	229.1	264.0	294.7	326.2	991.8	332.3	146.0	228.2	202.6	177.1	488.2	263.7	732.1	227.3	396.1	109.4	765.1	395.8	1083.8	1290.0	369.3	832.0	32.9	596.0	143.0	650.0	898.8	1340.9	697.5	950.3	947.6	6.2	728.0	286.6	128.4	477.0	202.5	59.3	278.3	533.3	430.2	112.2	775.8	1132.1	218.5	691.2	321.3	528.0	260.5	444.5	867.4	461.2	301.7	1115.0	18.7	26.6	35.5	24.4	26.8	32.2	63.5	45.0	39.0	79.6	39.5	52.0	42.9	6.7	20.1	26.5	86.6	55.8	30.7	22.1	20.9	17.8	27.3	24.1	23.3	24.3	19.1	21.1	15.4	22.9	25.2	11.0	28.9	21.7	2.3	117.8	432.3	947.5	181.3	109.8	29.0	88.8	47.4	30.8	28.6	106.1	40.5	4.2	894.3	70.3	173.5	46.9	755.3	7.2	50.5	14.6	113.9	117.0	268.3	5.4	277.5	799.8	72.0	79.5	115.3	66.7	8.3	18.2	12.3	377.2	11.8	5.7	226.4	97.6	74.0	149.9	24.5	5.6	94.3	90.7	1.0	74.3	44.1	33.0	4.5	2.7	1838.5	249.1	2.6	198.2	1483.3	174.5	15.8	21.7	41.9	0.0	18.6	77.7	40.2	417.6	224.7	361.4	822.8	66.6	0.9	364.3	1681.0
HMGA2	"BABL, HMGIC, LIPO"	ENSG00000149948	"High mobility group AT-hook 2"	P52926	12	65824460-65966291	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Cell cycle, Cell division, DNA condensation, Growth regulation, Mitosis, Transcription, Transcription regulation"	DNA-binding	"Cancer-related genes, Disease variant, Dwarfism, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 4.9;testis: 3.8"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 16.0;Early spermatids: 18.4;Glandular and luminal cells: 17.3;Granulosa cells: 29.7;Pancreatic endocrine cells: 19.9;Smooth muscle cells: 33.7"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in single"		"basophil: 1.4"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"AF22: 324.4;hTERT-RPE1: 232.6;SuSa: 216.1"									"CAB017809, HPA039076"	Approved		Supported	"Nucleoplasm,Nucleoli,Nucleoli rim"		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 12: NES - Nervous system development"	"Cluster 10: Non-specific - Unknown function"	"Nucleoplasm, Nucleoli, Nucleoli rim"		"CAB017809: , HPA039076: AB_2676335"	"unprognostic (2.39e-1)"	"unprognostic (6.00e-2)"	"unprognostic (2.08e-1)"	"unprognostic (3.68e-3)"	"unprognostic (5.21e-3)"	"prognostic unfavorable (4.79e-4)"	"unprognostic (4.05e-3)"	"unprognostic (6.17e-3)"	"unprognostic (6.71e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.54e-6)"	"unprognostic (3.33e-2)"	"unprognostic (4.55e-5)"	"unprognostic (4.22e-2)"	"unprognostic (2.53e-1)"	"unprognostic (2.53e-2)"	"prognostic unfavorable (2.86e-4)"	0.4	0.0	0.3	0.3	0.2	4.9	0.2	0.7	0.5	1.1	0.0	2.1	1.3	0.4	0.0	0.3	1.2	0.3	0.1	0.2	0.1	0.2	0.2	0.1	0.1	0.4	0.2	0.6	0.9	0.0	0.4	0.2	0.2	0.0	2.4	0.5	0.1	0.1	1.5	0.4	1.0	0.1	0.1	0.1	1.1	3.8	0.2	0.2	0.6	0.2	0.1	0.1	0.1	0.4	47.9	21.4	324.4	45.8	15.0	82.0	0.1	148.5	68.5	26.0	25.8	28.1	19.8	0.0	92.3	7.0	120.0	20.5	54.2	129.3	123.8	0.2	56.2	0.2	0.7	169.3	8.4	4.7	0.4	62.7	8.0	55.2	98.4	232.6	105.0	0.2	0.1	0.6	149.9	0.2	0.4	27.8	190.3	4.6	89.2	12.7	16.1	0.1	68.9	0.3	0.0	0.0	0.1	0.1	85.0	216.1	0.5	0.7	120.8	89.5	26.9	71.2	45.3	0.2	0.2	0.4	112.0	0.3	21.4	1.4	0.2	0.2	0.1	0.2	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.6	0.3	0.6	0.1	0.0	0.0	0.3	0.2	0.7	0.5	0.2	0.1	0.4	0.2	0.2	0.1	0.2	0.4	0.0	0.0	1.1	5.9	0.2	0.0	3.6	16.0	2.8	0.0	0.1	0.1	1.7	0.0	3.0	0.0	0.0	0.8	0.0	5.0	0.0	2.5	18.4	10.4	0.8	0.6	0.0	7.4	0.8	0.8	0.5	2.3	3.1	17.3	0.0	29.7	0.7	0.0	9.0	0.0	0.9	5.1	4.1	0.0	0.0	9.0	0.3	0.7	0.0	0.0	0.0	0.0	1.0	0.0	0.9	19.9	4.5	0.0	0.4	5.5	4.0	0.3	7.3	0.0	0.0	1.1	33.7	13.5	0.6	0.3	0.1	0.8	0.3	0.3	8.4	1.1
HMGB1	"DKFZp686A04236, HMG1, HMG3, SBP-1"	ENSG00000189403	"High mobility group box 1"	P09429	13	30456704-30617597	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Adaptive immunity, Autophagy, Chemotaxis, DNA damage, DNA recombination, DNA repair, Host-virus interaction, Immunity, Inflammatory response, Innate immunity"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA003506, CAB005873, HPA073663"	Supported		Supported	Nucleoplasm	"Secreted to blood"	NA	NA		2800000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 14: REH - Unknown function"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"CAB005873: AB_444360, HPA003506: AB_1079070, HPA073663: "	"unprognostic (9.56e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.97e-2)"	"unprognostic (1.07e-1)"	"unprognostic (4.44e-2)"	"unprognostic (4.29e-2)"	"unprognostic (3.16e-2)"	"unprognostic (4.33e-2)"	"unprognostic (5.73e-2)"	"unprognostic (1.73e-1)"	"unprognostic (2.64e-2)"	"unprognostic (2.30e-2)"	"unprognostic (4.28e-3)"	"unprognostic (5.22e-3)"	"unprognostic (4.67e-1)"	"unprognostic (9.13e-3)"	"unprognostic (1.97e-2)"	312.0	224.3	266.2	355.1	282.2	1021.3	318.2	267.6	362.4	319.0	227.0	327.8	281.9	363.6	270.1	297.0	265.5	227.0	242.2	250.1	282.9	243.7	360.8	242.2	664.8	281.5	273.3	254.9	189.3	226.1	163.3	252.1	286.2	265.9	381.2	174.8	224.5	280.1	388.5	244.2	309.2	319.5	277.7	284.9	269.0	153.9	269.9	900.3	267.4	364.7	738.9	282.7	274.1	308.2	816.7	617.4	1402.5	1054.0	384.5	380.1	551.4	1012.6	547.9	957.3	643.5	983.6	1328.6	1639.3	515.5	924.0	880.6	886.5	1484.7	817.4	1639.6	869.6	622.4	1727.4	455.4	913.5	210.3	2513.6	1009.8	253.4	426.0	713.3	656.6	497.8	1302.2	1350.8	1167.9	571.7	855.6	1508.3	3224.3	2682.1	1184.3	1424.3	683.7	2673.3	1927.8	965.8	908.1	792.8	1264.0	1139.8	928.6	682.0	541.0	672.3	668.5	1857.9	814.7	637.2	921.8	689.7	1197.1	513.9	714.8	3508.3	261.1	1634.0	1369.3	1036.6	503.7	926.1	467.3	410.9	522.1	582.6	532.3	530.7	520.1	590.7	477.4	459.7	631.7	615.4	411.0	512.5	702.6	1072.0	266.2	282.2	267.6	362.4	250.1	282.9	281.5	273.3	286.2	277.7	269.9	308.2	948.9	458.3	496.6	188.4	920.7	791.1	986.7	942.7	752.4	414.3	471.9	630.0	172.5	561.9	561.3	603.2	131.3	998.9	759.9	408.1	766.9	941.3	113.4	611.2	1040.2	766.0	423.0	1808.9	58.5	967.2	1441.4	676.5	486.3	728.3	546.8	772.2	589.0	749.5	728.8	196.9	47.2	675.6	710.1	549.9	884.4	107.2	720.1	694.2	674.1	81.5	578.7	609.9	879.5	99.5	149.3	1212.3	554.8	666.9	1252.9	811.2	506.7	827.5	418.7	252.8	650.8	588.9	1005.9	549.1	1211.0	1045.8	691.9	465.7	797.9	515.7	839.1	867.9
HMGB2	HMG2	ENSG00000164104	"High mobility group box 2"	P26583	4	173331376-173334432	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Chemotaxis, DNA recombination, Immunity, Inflammatory response, Innate immunity, Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	12	"bone marrow: 2347.2;lymphoid tissue: 939.2"	"Cell type enhanced"	"Detected in all"		"Erythroid cells: 1915.4;Extravillous trophoblasts: 872.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 798.0"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"MOLT-4: 2454.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003506, CAB037206, HPA053314, HPA073663"	Enhanced		Supported	Nucleoplasm,Nucleoli	"Secreted to blood"	NA	Yes		1200000	"Cluster 46: Basophils - DNA binding"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	Nucleoli	"CAB037206: AB_1079071, HPA003506: AB_1079070, HPA053314: AB_2682109, HPA073663: "	"unprognostic (2.82e-1)"	"unprognostic (8.52e-3)"	"unprognostic (2.56e-1)"	"unprognostic (8.37e-2)"	"unprognostic (8.05e-2)"	"unprognostic (1.21e-2)"	"prognostic unfavorable (3.76e-5)"	"unprognostic (2.12e-1)"	"prognostic unfavorable (3.13e-4)"	"unprognostic (4.41e-2)"	"prognostic unfavorable (7.04e-4)"	"unprognostic (9.65e-2)"	"prognostic unfavorable (7.60e-12)"	"unprognostic (1.60e-2)"	"unprognostic (2.83e-2)"	"unprognostic (2.68e-2)"	"unprognostic (1.21e-2)"	90.3	31.0	36.3	146.1	38.4	2347.2	89.1	35.4	49.9	79.0	33.0	117.1	93.2	92.3	47.3	115.6	78.8	43.5	85.8	33.2	38.3	74.3	37.8	83.8	390.4	37.5	36.8	118.9	27.2	18.3	35.4	111.0	38.0	46.9	122.2	134.1	59.8	35.2	72.4	75.1	108.7	65.5	36.3	159.5	66.0	136.0	36.1	939.2	56.4	57.0	388.9	68.2	86.1	40.1	498.2	114.6	976.8	444.4	118.2	118.2	375.1	366.3	271.3	386.7	345.7	329.0	673.6	1645.5	79.2	203.0	207.4	190.3	645.0	196.1	601.0	1004.0	303.4	1823.2	308.8	487.8	115.7	1642.8	683.4	114.7	59.2	194.2	439.1	211.5	402.8	866.1	703.9	2282.4	358.9	409.9	2454.9	1513.7	355.4	289.4	199.3	1226.7	499.7	620.4	227.0	208.8	838.6	759.0	365.5	209.6	166.6	340.8	291.1	1173.2	236.0	175.5	513.6	219.0	554.9	734.8	437.1	1869.4	149.1	1178.4	464.4	798.0	135.9	407.0	94.1	57.6	86.2	72.5	137.8	131.1	112.8	57.6	88.4	85.3	316.7	83.0	49.1	43.2	266.4	107.6	36.3	38.4	35.4	49.9	33.2	38.3	37.5	36.8	38.0	36.3	36.1	40.1	167.0	28.9	64.1	5.9	153.2	158.8	141.5	131.8	75.1	48.9	75.3	107.8	229.0	38.6	78.3	55.2	35.5	472.6	222.9	116.5	142.8	25.9	30.4	71.2	71.7	128.0	74.7	1915.4	2.7	16.1	872.5	121.5	63.2	76.5	110.6	210.5	171.7	26.5	210.1	45.4	4.7	191.2	109.9	295.0	142.9	33.1	105.3	233.9	67.6	6.5	241.9	81.8	132.8	1.0	4.8	11.3	75.2	57.6	268.6	114.2	65.4	51.0	149.8	143.5	78.9	71.7	134.4	493.6	400.9	233.6	134.0	128.7	289.5	42.3	284.7	89.0
HMGB3	"HMG2A, HMG4, MGC90319"	ENSG00000029993	"High mobility group box 3"	O15347	X	150980509-150990771	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Immunity, Innate immunity, Transcription, Transcription regulation"	DNA-binding	Microphthalmia	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 136.6"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 419.1;Extravillous trophoblasts: 820.7;Syncytiotrophoblasts: 1400.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"eosinophil: 11.3"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"HBEC3-KT: 738.7;U-698: 675.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA062583, HPA073663"	Enhanced		Supported	Nucleoplasm,Nucleoli		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 34: Non-specific - Transcription"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	Nucleoplasm	Nucleoli	"HPA062583: AB_2684800, HPA073663: "	"unprognostic (2.85e-3)"	"unprognostic (2.82e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.08e-2)"	"unprognostic (1.16e-1)"	"unprognostic (4.60e-2)"	"unprognostic (2.66e-3)"	"unprognostic (4.54e-3)"	"unprognostic (2.70e-2)"	"prognostic favorable (9.85e-5)"	"unprognostic (6.03e-2)"	"unprognostic (1.96e-2)"	"prognostic favorable (6.15e-4)"	"unprognostic (2.58e-2)"	"unprognostic (9.29e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.11e-1)"	8.9	13.7	10.5	19.7	10.5	85.6	15.6	10.4	20.3	34.0	6.5	43.9	27.1	16.4	44.8	26.1	16.9	9.7	11.3	14.5	13.9	19.6	101.4	15.9	25.2	13.0	11.2	5.9	17.2	85.4	4.2	136.6	11.3	13.9	32.4	3.1	23.8	15.9	53.5	19.2	28.1	13.8	10.2	21.2	16.1	40.1	13.4	65.2	14.3	8.9	35.8	18.7	10.5	9.5	263.5	115.5	351.9	184.2	14.5	42.9	437.4	112.9	73.6	127.9	66.1	91.6	106.0	183.0	354.8	87.5	72.3	123.3	324.4	738.7	143.3	125.6	94.7	159.4	110.2	145.6	21.5	243.9	78.0	33.9	171.6	52.5	131.5	32.7	168.3	110.5	84.5	105.4	154.2	201.9	269.3	186.2	209.2	171.0	138.1	325.4	286.3	103.6	95.2	125.3	252.7	164.4	167.4	177.7	56.0	199.3	157.8	158.5	128.0	53.0	123.9	169.9	253.1	94.9	128.7	675.7	63.1	121.3	109.9	0.0	4.3	11.3	0.4	3.0	0.1	2.7	2.0	2.9	6.1	0.5	0.0	0.2	0.7	0.8	5.0	3.1	5.8	2.5	10.5	10.5	10.4	20.3	14.5	13.9	13.0	11.2	11.3	10.2	13.4	9.5	10.4	38.5	31.2	0.7	15.1	23.7	18.9	158.6	12.5	0.5	24.2	16.0	16.0	8.6	123.5	31.3	2.1	419.1	4.5	32.1	37.2	82.4	232.3	61.9	18.9	19.6	65.7	136.1	1.3	86.5	820.7	17.6	22.4	55.9	8.2	44.2	13.6	84.4	101.0	0.0	3.7	37.0	219.7	20.8	43.7	75.9	3.7	22.1	21.4	2.8	23.6	4.1	1.0	1.5	0.5	91.5	35.7	3.4	47.1	27.5	31.8	66.5	113.3	1.8	0.0	39.8	29.0	22.7	50.2	41.1	20.3	1400.2	10.1	10.4	60.7	18.5
HMGCS1	HMGCS	ENSG00000112972	"3-hydroxy-3-methylglutaryl-CoA synthase 1"	Q01581	5	43287470-43313512	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Cholesterol biosynthesis, Cholesterol metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 390.2"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 511.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"AF22: 797.7;GAMG: 523.5;HBEC3-KT: 467.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB032907, HPA036913, HPA036914"	Approved		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		No	No		470000	"Cluster 44: Non-specific - Transcription"	"Cluster 85: Liver - Metabolism"	"Cluster 12: NES - Nervous system development"	"Cluster 15: Hepatocytes - Hemostasis"	"Nucleoplasm, Cytosol"	"Plasma membrane"	"CAB032907: AB_2118319, HPA036913: AB_2675380, HPA036914: AB_10671751"	"unprognostic (1.31e-1)"	"unprognostic (5.12e-3)"	"unprognostic (6.82e-3)"	"unprognostic (4.59e-2)"	"unprognostic (8.39e-2)"	"unprognostic (2.49e-2)"	"unprognostic (1.03e-1)"	"unprognostic (3.14e-2)"	"unprognostic (1.27e-2)"	"unprognostic (3.13e-1)"	"unprognostic (6.40e-3)"	"unprognostic (9.15e-2)"	"prognostic favorable (3.87e-6)"	"unprognostic (1.09e-1)"	"unprognostic (9.22e-2)"	"unprognostic (3.03e-2)"	"unprognostic (2.37e-2)"	19.2	55.2	25.2	27.2	32.9	15.8	40.1	23.0	38.6	56.4	16.8	50.2	93.6	19.8	36.1	137.5	12.4	23.3	16.1	36.1	44.6	32.8	390.2	51.4	21.5	46.5	34.7	21.6	26.6	31.7	15.0	22.5	47.2	40.5	45.4	34.2	53.2	15.7	17.8	85.9	47.2	19.9	24.7	14.8	43.4	33.2	35.3	19.1	23.6	16.7	31.5	18.3	69.5	30.4	103.4	48.8	797.7	93.0	45.8	178.4	54.1	16.2	63.8	22.8	45.2	86.6	146.6	108.4	35.6	23.3	523.5	80.2	199.7	467.2	24.1	23.5	240.7	40.1	45.3	119.3	71.3	88.0	28.0	98.5	56.2	119.5	47.9	14.0	23.7	98.4	73.1	291.7	19.4	48.9	81.3	111.9	143.1	41.7	25.9	57.5	111.9	121.8	357.7	158.2	68.2	33.0	83.6	41.4	25.9	114.5	63.6	116.7	28.3	17.1	85.7	18.0	15.5	38.8	64.0	148.3	15.0	106.2	15.5	3.3	1.8	1.9	2.4	3.3	2.4	3.8	2.6	3.4	3.5	2.9	2.2	3.1	3.0	3.2	3.6	2.9	2.6	1.6	25.2	32.9	23.0	38.6	36.1	44.6	46.5	34.7	47.2	24.7	35.3	30.4	27.8	67.3	172.6	70.5	44.8	108.3	42.3	93.8	68.3	43.6	46.3	30.0	8.9	47.1	79.2	47.8	52.1	22.3	43.3	211.2	13.7	43.0	9.0	47.1	20.2	31.3	92.1	22.3	44.9	59.8	41.1	32.3	100.4	98.6	58.5	56.6	22.1	511.7	25.5	48.8	42.6	101.9	75.3	21.9	38.2	3.2	12.8	27.5	26.6	15.0	49.1	26.4	14.4	53.3	41.8	50.4	132.3	14.3	38.1	149.2	56.8	21.4	51.1	50.1	0.0	40.1	32.8	20.0	8.7	197.9	236.4	44.5	36.4	129.4	62.9	74.5
HMGN1	"FLJ27265, FLJ31471, HMG14, MGC104230, MGC117425"	ENSG00000205581	"High mobility group nucleosome binding domain 1"	P05114	21	39342315-39349647	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012260, HPA048694"	Supported		Supported	Nucleoplasm		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 46: Photoreceptor cells - Phototransduction"	Nucleoplasm		"CAB012260: AB_304786, HPA048694: AB_2680496"	"unprognostic (4.49e-2)"	"unprognostic (5.52e-2)"	"unprognostic (4.85e-2)"	"unprognostic (6.28e-2)"	"unprognostic (2.20e-1)"	"unprognostic (5.21e-3)"	"unprognostic (8.50e-3)"	"unprognostic (1.32e-1)"	"unprognostic (2.46e-3)"	"unprognostic (5.68e-2)"	"unprognostic (3.02e-2)"	"unprognostic (5.24e-2)"	"prognostic unfavorable (8.74e-7)"	"unprognostic (3.20e-1)"	"unprognostic (3.72e-2)"	"unprognostic (3.84e-2)"	"unprognostic (8.98e-3)"	56.1	73.7	54.1	120.5	52.3	202.4	121.4	52.0	63.7	115.8	54.6	126.0	121.3	78.8	187.6	124.8	100.2	72.9	39.1	53.3	58.7	114.4	100.8	72.5	219.1	57.1	57.5	72.9	92.2	132.1	73.8	111.6	55.7	93.2	136.2	245.5	97.1	75.2	16.2	82.5	133.6	65.3	57.2	100.9	113.2	64.8	56.4	238.7	117.2	26.3	294.9	114.2	73.8	58.5	517.7	135.9	450.3	316.3	74.5	131.1	299.7	266.6	191.8	261.0	233.0	262.6	420.6	1161.6	246.8	223.7	309.8	106.5	317.4	377.9	336.1	459.5	317.7	883.6	225.7	355.8	187.0	768.2	291.3	167.4	349.9	260.2	350.6	222.4	363.6	513.6	680.2	191.6	436.7	686.7	780.2	691.0	798.0	682.3	237.8	853.2	224.7	466.0	469.5	308.3	386.3	362.2	582.8	364.1	356.0	183.1	479.5	807.5	239.6	127.2	128.7	94.0	279.7	235.6	394.8	690.7	179.4	882.9	341.4	103.7	76.4	282.5	138.0	68.9	153.5	228.9	175.2	143.7	216.5	205.8	195.2	172.2	53.8	174.5	67.7	294.9	221.5	231.4	54.1	52.3	52.0	63.7	53.3	58.7	57.1	57.5	55.7	57.2	56.4	58.5	169.9	93.0	139.7	55.2	420.4	278.5	532.0	674.9	233.9	265.1	650.7	412.6	56.1	307.4	349.0	285.1	331.5	599.2	405.1	306.8	737.6	479.9	642.8	304.4	287.3	223.3	345.2	275.6	34.9	350.5	970.7	196.6	221.7	309.2	219.9	277.8	135.7	176.2	533.9	240.6	55.1	442.1	514.7	176.1	389.6	180.6	175.8	279.6	243.7	45.0	415.1	427.8	358.4	96.5	68.8	381.0	307.4	200.1	335.9	684.7	327.8	625.4	226.8	1301.8	32.9	122.0	179.5	81.9	149.1	399.7	313.7	602.1	326.1	289.2	537.1	699.9
HMGN2	HMG17	ENSG00000198830	"High mobility group nucleosomal binding domain 2"	P05204	1	26472440-26476642	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"CAB018371, HPA077364"	Supported		Supported	Nucleoplasm,Nucleoli		NA	NA		640000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 32: U-937 - Innate immune response"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	Nucleoli	"CAB018371: , HPA077364: AB_2686835"	"unprognostic (3.10e-2)"	"unprognostic (6.88e-2)"	"unprognostic (3.10e-3)"	"unprognostic (4.13e-2)"	"unprognostic (4.06e-1)"	"unprognostic (2.27e-2)"	"prognostic unfavorable (1.34e-4)"	"unprognostic (2.36e-1)"	"unprognostic (2.44e-3)"	"unprognostic (2.86e-2)"	"unprognostic (1.05e-3)"	"unprognostic (5.23e-3)"	"prognostic unfavorable (3.92e-4)"	"unprognostic (3.00e-2)"	"unprognostic (2.54e-1)"	"unprognostic (8.21e-2)"	"unprognostic (1.15e-1)"	216.3	225.6	180.2	254.5	187.3	1137.3	234.8	179.6	251.3	328.1	162.5	280.3	176.3	283.8	359.3	291.1	293.4	142.9	192.5	170.6	183.1	259.7	212.9	259.2	436.5	185.1	178.8	394.6	252.5	160.4	328.7	214.9	188.4	281.6	301.1	285.0	217.1	162.8	251.8	242.8	270.0	235.8	188.7	324.3	224.7	160.4	175.8	916.1	306.1	133.5	534.0	245.1	250.7	211.6	1074.5	304.8	1192.5	496.5	112.0	251.6	390.8	517.2	331.2	1089.4	835.7	305.8	1073.1	1107.2	443.1	482.3	338.4	627.8	1564.6	565.6	1001.7	684.2	906.7	1222.2	401.5	360.2	197.7	2793.6	738.7	254.9	303.4	602.1	369.1	245.1	541.7	866.8	964.3	643.0	623.0	690.8	1906.1	1363.3	922.7	1463.0	619.6	1384.3	1598.6	776.5	380.3	278.6	1064.5	641.1	1384.3	498.7	651.4	304.9	759.0	1508.9	322.3	536.9	920.4	977.1	943.6	641.2	899.2	1266.9	338.9	2989.0	1056.9	331.8	530.8	1430.5	279.2	622.3	267.3	532.2	379.7	343.3	531.5	505.6	412.4	337.7	462.4	355.5	690.4	704.7	746.7	1084.6	180.2	187.3	179.6	251.3	170.6	183.1	185.1	178.8	188.4	188.7	175.8	211.6	128.7	342.9	394.4	28.1	459.3	288.6	323.8	383.2	211.1	180.2	353.0	241.3	93.4	221.6	314.8	261.1	141.8	898.7	325.2	227.2	371.7	218.4	204.3	328.9	291.1	190.3	576.9	980.4	14.4	268.7	606.4	435.4	263.5	278.1	383.0	375.0	185.6	147.5	763.0	94.2	22.2	564.5	193.3	434.3	467.9	53.5	185.8	477.5	227.7	15.0	655.6	376.0	399.6	15.1	36.9	93.7	304.4	151.9	669.5	250.4	238.0	320.4	495.6	370.2	124.9	249.0	325.7	306.4	412.0	585.8	213.4	923.4	369.5	351.9	613.2	314.0
HMGN3	TRIP7	ENSG00000118418	"High mobility group nucleosomal binding domain 3"	Q15651	6	79201245-79234738	"Predicted intracellular proteins"		"Chromatin regulator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB018370, HPA027971, HPA063572"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 24: NB-4 - Immune response"	"Cluster 49: Ciliated cells - Cilium organization"	Nucleoplasm	Cytosol	"CAB018370: , HPA027971: AB_1850808, HPA063572: AB_2732703"	"unprognostic (1.02e-1)"	"unprognostic (2.04e-2)"	"unprognostic (5.92e-2)"	"unprognostic (5.26e-2)"	"unprognostic (3.48e-1)"	"unprognostic (3.88e-2)"	"unprognostic (5.24e-2)"	"prognostic favorable (2.76e-4)"	"unprognostic (8.78e-2)"	"unprognostic (5.31e-3)"	"unprognostic (1.47e-3)"	"unprognostic (5.81e-2)"	"prognostic unfavorable (1.02e-7)"	"unprognostic (1.70e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.69e-1)"	"unprognostic (6.43e-3)"	92.4	174.4	132.9	69.5	136.2	72.8	116.1	141.8	190.4	82.2	153.6	100.6	90.4	93.6	168.6	95.1	209.3	82.8	227.2	132.9	135.8	168.4	147.5	111.5	127.1	139.5	135.2	105.5	90.3	116.7	152.0	114.6	140.8	84.7	73.4	164.6	154.3	68.0	151.4	81.1	74.1	76.1	136.6	91.5	106.9	83.2	133.7	112.7	113.2	130.1	109.9	77.1	81.9	145.6	101.7	90.3	309.7	135.0	121.9	99.6	70.1	69.0	73.7	75.6	110.3	508.3	83.9	1.2	124.2	56.5	101.0	63.4	203.6	78.3	74.2	298.7	170.9	355.9	292.3	268.9	78.0	294.9	52.3	121.5	85.4	50.3	27.7	72.9	170.9	74.3	212.3	275.0	123.8	92.9	136.3	564.7	227.8	87.7	224.5	229.7	472.6	103.8	525.3	145.3	126.0	168.5	131.3	149.4	102.4	271.1	85.1	488.6	75.0	20.9	91.7	73.5	155.3	235.3	375.2	1.9	11.8	1.1	103.0	38.3	147.3	13.6	107.8	148.0	95.9	112.9	75.7	92.8	179.2	99.8	88.7	106.8	7.2	142.3	143.9	208.6	90.4	169.3	132.9	136.2	141.8	190.4	132.9	135.8	139.5	135.2	140.8	136.6	133.7	145.6	140.6	96.1	167.9	129.9	110.1	171.1	193.7	516.8	234.5	261.8	301.4	376.3	424.5	231.6	373.7	242.8	75.0	940.6	169.9	35.3	602.6	229.3	72.5	775.8	108.1	166.0	272.9	95.4	115.8	198.6	823.7	165.3	116.2	199.2	109.6	80.9	261.3	256.3	309.7	195.2	105.3	131.1	435.4	186.0	206.5	60.9	187.0	148.4	257.9	58.1	403.3	320.2	198.8	66.9	159.7	107.2	52.4	167.0	211.3	85.3	36.5	852.5	900.3	134.3	144.7	102.4	233.9	26.8	52.0	260.0	149.9	555.3	109.9	232.4	121.5	173.2
HMGN5	NSBP1	ENSG00000198157	"High mobility group nucleosome binding domain 5"	P82970	X	81113699-81201913	"Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 107.4"	"Cell type enhanced"	"Detected in many"		"Proximal tubular cells: 113.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 209.6;Karpas-707: 298.5"	"Low region specificity"	"Detected in all"							"HPA000511, HPA076238"	Approved		Supported	Nucleoplasm,Mitochondria		NA	NA		41000	"Cluster 29: Plasmacytoid DCs - Unknown function"	"Cluster 68: Epididymis - Unknown function"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Nucleoplasm	Mitochondria	"HPA000511: AB_1079505, HPA076238: "	"unprognostic (1.49e-2)"	"unprognostic (1.44e-1)"	"unprognostic (3.72e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.07e-1)"	"unprognostic (3.98e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.96e-1)"	"unprognostic (9.63e-3)"	"prognostic favorable (6.60e-4)"	"unprognostic (2.78e-3)"	"unprognostic (1.16e-1)"	"unprognostic (2.32e-3)"	"unprognostic (3.06e-2)"	"unprognostic (1.07e-1)"	"unprognostic (6.53e-2)"	"unprognostic (1.08e-1)"	13.2	24.6	31.6	6.1	31.8	34.0	14.5	28.8	60.6	12.7	27.7	16.6	23.0	17.2	65.2	14.8	17.5	11.0	10.2	29.3	32.3	27.6	23.0	8.7	5.3	35.3	32.5	20.4	12.7	20.3	29.7	4.8	32.6	15.4	16.3	7.3	13.0	19.4	9.4	12.0	21.5	10.8	32.1	12.9	13.8	107.4	32.7	30.7	17.9	8.7	6.6	12.1	11.6	33.1	1.1	9.6	26.4	130.0	22.2	6.8	5.5	7.4	11.5	2.2	3.2	3.1	49.6	209.6	22.7	3.1	2.1	8.9	158.6	19.2	4.8	123.5	62.9	87.6	97.0	1.6	2.6	147.9	83.1	5.6	4.9	8.1	7.9	7.3	10.4	132.2	118.2	298.5	13.3	4.4	135.2	51.8	117.9	29.5	34.5	5.1	110.1	98.3	32.0	3.5	1.1	3.1	0.9	2.9	9.1	22.6	16.3	34.6	12.2	4.2	33.5	20.4	28.5	20.7	9.4	33.8	12.4	57.5	7.4	1.3	3.1	1.2	7.5	1.6	6.6	3.8	4.4	4.0	5.2	6.0	8.7	7.6	1.4	3.4	2.2	10.0	1.7	2.9	31.6	31.8	28.8	60.6	29.3	32.3	35.3	32.5	32.6	32.1	32.7	33.1	18.1	9.6	16.4	19.9	9.0	15.9	27.6	12.8	17.6	3.5	18.9	17.5	11.1	27.1	16.2	46.0	0.0	0.6	6.4	22.7	68.4	12.8	24.5	44.0	11.0	18.1	17.4	64.8	11.6	18.7	0.4	15.4	16.8	31.1	13.3	39.4	22.1	87.2	15.7	1.7	16.5	34.2	28.5	11.3	10.8	79.7	29.5	10.2	8.8	13.1	2.9	25.8	7.2	25.6	8.5	7.1	19.6	41.0	9.6	15.0	27.4	113.6	55.9	1.7	46.0	13.3	19.6	18.9	8.7	32.8	14.9	0.4	8.3	31.0	45.0	24.4
HNF1A	"HNF1, LFB1, MODY3, TCF1"	ENSG00000135100	"HNF1 homeobox A"		12	120978543-121002512	"Cancer-related genes, Human disease related genes, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"			"Group enriched"	"Detected in some"	4	"intestine: 15.4;kidney: 16.7;liver: 34.7;pancreas: 9.5"	"Cell type enhanced"	"Detected in some"		"Distal enterocytes: 14.5;Hepatocytes: 15.8;Intestinal goblet cells: 9.4;Paneth cells: 14.8;Proximal enterocytes: 33.4;Proximal tubular cells: 16.0;Undifferentiated cells: 10.8"	"Group enriched"	"Detected in many"	4	"colorectal cancer: 4.5;liver cancer: 3.6;pancreatic cancer: 1.4;renal cancer: 3.6;stomach cancer: 4.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"A549: 8.9;CACO-2: 29.4;Hep G2: 32.5;OE19: 15.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"CAB010430, HPA035231"	Enhanced		Supported	Nucleoplasm		NA	NA				"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 45: Enterocytes - Digestion"	Nucleoplasm		"CAB010430: AB_2116746, HPA035231: AB_2674528"	"unprognostic (5.92e-3)"	"unprognostic (8.47e-2)"	"unprognostic (4.12e-3)"	"unprognostic (6.18e-3)"	"unprognostic (3.72e-1)"	"unprognostic (1.27e-2)"	"unprognostic (9.18e-2)"	"unprognostic (9.18e-2)"	"unprognostic (2.99e-1)"	"unprognostic (2.01e-1)"	"unprognostic (9.77e-3)"	"unprognostic (5.21e-2)"	"unprognostic (6.25e-3)"	"unprognostic (5.55e-2)"	"unprognostic (2.48e-1)"		"unprognostic (6.93e-3)"	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.1	0.1	0.2	0.0	5.5	15.4	0.2	0.0	0.1	1.1	0.8	0.0	0.1	0.1	16.7	34.7	0.0	0.0	0.1	0.1	0.0	9.5	0.0	0.0	0.0	0.1	0.0	2.5	0.0	0.0	0.0	0.0	0.2	14.3	0.1	0.0	0.0	4.3	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	8.9	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	29.4	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	32.5	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.4	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.2	0.1	0.5	0.0	0.0	0.6	0.2	0.0	1.2	4.3	0.0	1.8	0.0	0.1	0.4	14.5	0.0	2.6	0.0	1.3	0.2	0.3	4.8	0.0	0.2	5.3	0.1	0.2	4.6	0.5	0.0	0.1	0.4	15.8	0.1	0.0	0.2	9.4	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.7	0.5	0.0	0.5	0.0	3.9	14.8	0.0	0.1	0.5	33.4	16.0	0.0	0.3	0.0	0.8	0.3	0.1	0.3	0.0	0.3	0.0	0.5	0.0	10.8	0.4
HNF1B	"HNF1beta, LFB3, MODY5, TCF2, VHNF1"	ENSG00000275410	"HNF1 homeobox B"	P35680	17	37686431-37745105	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Diabetes mellitus"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 61.1;pancreas: 33.0"	"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 78.6;Collecting duct cells: 57.0;Distal tubular cells: 45.0;Ductal cells: 42.0;Early spermatids: 32.3;Glandular and luminal cells: 41.7;Pancreatic endocrine cells: 31.7;Proximal tubular cells: 38.2"	"Cancer enhanced"	"Detected in many"		"renal cancer: 32.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"RPTEC TERT1: 139.3"	"Region enhanced"	"Detected in single"		"hypothalamus: 2.0"	"Low region specificity"	"Detected in single"			"HPA002083, CAB068192"	Enhanced		Supported	Nucleoplasm,Vesicles		NA	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm	Vesicles	"CAB068192: AB_2665649, HPA002083: AB_1080232"	"unprognostic (2.52e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.63e-2)"	"unprognostic (5.29e-3)"	"unprognostic (5.29e-2)"	"unprognostic (3.00e-2)"	"unprognostic (1.58e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.71e-2)"	"unprognostic (2.33e-1)"	"prognostic favorable (6.00e-4)"	"unprognostic (7.06e-2)"	"unprognostic (2.26e-1)"	"unprognostic (7.49e-2)"	"prognostic favorable (2.51e-6)"	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	2.7	0.0	9.9	6.9	1.5	7.5	0.0	5.7	15.1	0.0	0.0	0.1	61.1	12.9	6.8	0.0	0.0	0.0	0.0	33.0	3.5	0.0	0.0	0.0	2.3	7.1	0.0	0.0	4.4	0.0	0.0	8.6	0.1	0.0	0.0	8.2	3.9	0.1	0.0	0.0	0.0	0.0	3.2	0.1	0.0	0.0	19.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.7	2.2	0.0	28.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.0	0.0	0.0	0.1	139.3	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	9.6	14.1	0.0	0.0	0.0	2.5	0.1	0.0	0.0	0.0	0.0	0.6	78.6	1.9	57.0	0.0	0.0	0.0	15.4	45.0	42.0	32.3	18.5	3.6	0.4	14.4	0.0	0.2	25.4	0.0	0.2	13.7	41.7	5.7	0.0	0.0	5.1	0.1	0.0	0.2	13.5	0.0	0.3	0.0	11.6	0.6	0.4	0.0	0.0	1.0	0.0	0.0	0.0	0.1	31.7	11.4	0.0	0.0	2.6	14.3	38.2	3.7	0.0	0.0	0.0	0.3	3.0	2.5	0.0	0.0	0.0	0.6	0.0	20.4	2.7
HNF4A	"HNF4, MODY, MODY1, NR2A1, TCF14"	ENSG00000101076	"Hepatocyte nuclear factor 4 alpha"	P41235	20	44355700-44434596	"Disease related genes, Human disease related genes, Nuclear receptors, Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Transcription, Transcription regulation"	"Activator, DNA-binding, Receptor, Repressor"	"Diabetes mellitus, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 102.4;kidney: 43.3;liver: 117.1"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 232.6;Hepatocytes: 186.8;Intestinal goblet cells: 69.8;Paneth cells: 120.0;Proximal enterocytes: 153.9;Proximal tubular cells: 170.1;Undifferentiated cells: 136.1"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 48.2;liver cancer: 38.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"CACO-2: 154.4;Hep G2: 114.8;OE19: 42.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA004712, CAB019417"	Enhanced		Supported	Nucleoplasm		NA	NA				"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm		"CAB019417: AB_2295208, HPA004712: AB_1079075"	"unprognostic (2.47e-1)"	"unprognostic (3.08e-1)"	"unprognostic (2.34e-1)"	"unprognostic (2.29e-1)"	"unprognostic (8.54e-2)"	"unprognostic (1.56e-2)"	"unprognostic (6.90e-2)"	"unprognostic (4.79e-3)"	"unprognostic (2.59e-2)"	"unprognostic (3.77e-2)"	"unprognostic (2.45e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.75e-2)"	"unprognostic (8.40e-3)"	"unprognostic (2.12e-1)"		"unprognostic (2.70e-2)"	0.2	0.1	0.1	5.9	0.2	0.1	0.1	0.2	0.2	0.0	8.4	58.6	102.4	0.1	0.0	0.1	1.0	5.9	0.0	0.4	0.0	43.3	117.1	0.1	0.1	0.0	0.0	0.0	25.2	0.0	0.0	0.0	0.0	0.0	44.1	0.1	0.0	0.1	0.2	0.0	82.6	1.8	0.0	0.0	22.6	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	14.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	154.4	6.0	0.1	1.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.9	114.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.2	0.0	42.2	0.0	0.0	0.1	0.7	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.2	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	1.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.4	35.8	0.0	12.9	0.0	0.0	0.0	232.6	15.6	7.8	4.0	2.5	0.1	0.4	35.9	2.7	0.5	22.1	0.0	0.1	38.2	0.1	4.5	0.0	3.6	186.8	0.0	0.0	0.3	69.8	0.0	5.3	0.0	18.7	0.3	1.6	0.0	0.0	1.0	0.0	0.0	0.0	0.1	21.0	120.0	0.4	0.1	0.3	153.9	170.1	0.0	0.0	0.0	0.6	0.2	0.4	0.0	0.0	0.0	0.0	0.7	0.8	136.1	0.2
HNRNPH3	"2H9, HNRPH3"	ENSG00000096746	"Heterogeneous nuclear ribonucleoprotein H3"	P31942	10	68331174-68343193	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing"	"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038264			Supported	Nucleoplasm		NA	NA		650000	"Cluster 49: Eosinophils - Unknown function"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 22: Epithelial cell types - Mixed function"	Nucleoplasm		"HPA038264: AB_10697246"	"unprognostic (1.72e-1)"	"unprognostic (3.04e-1)"	"unprognostic (1.70e-1)"	"unprognostic (2.85e-1)"	"unprognostic (7.25e-2)"	"unprognostic (1.09e-1)"	"prognostic unfavorable (2.30e-5)"	"unprognostic (6.17e-2)"	"unprognostic (8.29e-2)"	"unprognostic (1.75e-1)"	"unprognostic (2.32e-1)"	"unprognostic (9.81e-3)"	"unprognostic (2.75e-3)"	"unprognostic (7.70e-2)"	"unprognostic (3.49e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.06e-3)"	71.8	65.3	80.6	65.7	82.6	101.8	58.8	81.2	96.6	79.4	69.1	74.4	56.4	92.5	44.5	55.1	72.1	44.1	67.2	76.4	82.4	84.2	56.7	63.5	79.1	85.8	83.7	109.7	44.7	54.4	55.0	83.2	87.2	59.9	63.7	81.1	47.7	60.2	92.2	63.2	64.6	68.0	86.4	63.9	59.2	69.1	81.4	98.1	75.1	66.9	78.2	68.6	69.2	87.5	233.2	220.5	343.4	107.6	131.8	81.0	221.6	199.1	104.2	183.2	150.0	379.3	200.7	364.7	106.8	132.5	145.2	151.9	280.2	192.8	280.9	226.4	148.2	282.9	194.1	231.7	115.4	326.9	149.4	53.6	172.7	209.0	368.0	151.0	142.8	191.2	356.8	122.7	205.2	323.6	291.3	350.6	229.2	169.0	258.6	239.6	288.2	119.0	148.3	189.7	155.0	168.5	211.9	144.2	221.7	195.4	153.7	164.5	154.6	170.9	284.8	89.8	273.4	147.6	213.7	368.2	94.1	159.0	135.1	22.7	18.6	37.6	17.0	21.2	18.1	16.2	20.4	20.2	21.6	16.2	25.7	21.6	23.8	22.3	26.0	17.6	20.2	13.4	80.6	82.6	81.2	96.6	76.4	82.4	85.8	83.7	87.2	86.4	81.4	87.5	133.6	102.5	117.3	33.6	111.1	325.8	275.5	99.9	113.3	114.2	83.2	102.6	115.5	64.3	114.5	73.5	95.9	149.6	111.7	71.6	60.7	89.6	29.0	108.2	138.9	125.7	107.7	127.9	39.8	83.8	202.2	143.6	69.3	162.5	141.1	111.5	75.0	39.6	95.5	87.5	41.9	80.2	73.2	69.5	153.2	21.1	96.3	97.1	129.9	50.6	105.7	107.8	75.2	51.8	84.6	76.8	99.7	120.4	97.9	214.3	84.6	72.0	115.2	146.7	131.5	150.0	174.6	277.3	164.5	89.7	266.8	191.8	128.5	90.8	84.4	215.1
HOMER2	"CPD, Cupidin, DFNA68, HOMER-2, HOMER-2A, HOMER-2B, Vesl-2"	ENSG00000103942	"Homer scaffold protein 2"	Q9NSB8	15	82836946-82986153	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	Hearing		"Deafness, Disease variant, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 226.2"	"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 215.9;Endometrial ciliated cells: 184.4;Glandular and luminal cells: 151.9"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 15.2"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"myeloid DC: 1.1"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"HAP1: 52.7;Karpas-707: 92.6;SCLC-21H: 50.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040134, CAB079014"	Uncertain	Supported	Supported	Cytosol		NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 25: Pancreas - Digestion"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 44: Endometrium - Transcription"	Cytosol		"CAB079014: , HPA040134: AB_10795272"	"unprognostic (7.34e-2)"	"unprognostic (3.58e-2)"	"unprognostic (5.75e-4)"	"unprognostic (3.31e-3)"	"unprognostic (4.85e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.04e-2)"	"unprognostic (7.13e-3)"	"unprognostic (2.69e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.02e-1)"	"unprognostic (2.75e-1)"	"unprognostic (8.16e-4)"	"unprognostic (2.30e-1)"	"unprognostic (3.21e-2)"	"unprognostic (1.26e-1)"	"unprognostic (4.45e-3)"	1.5	6.3	6.5	1.1	7.6	4.6	26.9	8.2	12.8	23.1	69.8	3.2	8.5	8.4	33.7	21.2	25.9	12.8	21.9	16.2	7.8	7.2	46.4	5.3	1.3	5.7	4.6	2.6	226.2	5.1	7.7	0.6	5.7	57.7	1.0	6.4	71.2	4.6	108.7	45.0	1.3	1.4	4.1	4.8	55.4	6.1	6.0	3.0	28.9	55.9	3.6	1.3	11.7	8.0	16.6	6.9	7.2	18.9	0.2	0.1	1.1	1.1	0.0	1.7	0.6	1.2	11.5	0.1	8.8	8.4	8.3	9.1	52.7	24.9	1.2	45.1	33.5	10.6	0.4	8.3	0.7	0.4	32.6	1.8	37.4	0.6	2.1	1.9	0.0	20.6	0.4	92.6	7.0	48.4	3.2	1.1	11.4	1.4	5.1	2.2	11.5	5.5	25.3	20.1	50.8	13.1	18.6	14.1	17.6	5.2	17.1	3.5	0.2	17.2	31.7	1.3	15.3	11.8	5.9	1.8	29.0	0.4	6.4	0.1	0.1	0.4	0.0	0.1	0.0	0.2	0.1	0.0	1.1	0.3	0.1	0.0	0.4	0.0	0.0	0.5	0.2	0.3	6.5	7.6	8.2	12.8	16.2	7.8	5.7	4.6	5.7	4.1	6.0	8.0	1.9	16.0	10.1	24.8	3.8	4.6	56.1	7.2	10.2	15.0	39.7	20.4	23.0	215.9	14.6	11.0	18.8	1.1	4.4	0.3	7.9	29.6	1.9	184.4	15.4	12.4	3.0	8.2	24.8	76.5	0.4	3.6	14.3	151.9	0.0	11.9	1.4	59.6	13.3	20.2	35.1	0.4	0.0	3.2	73.9	4.0	1.8	9.2	37.4	7.5	7.9	18.5	1.0	6.6	11.8	25.9	0.1	0.7	4.1	81.5	0.7	12.1	4.0	5.1	0.0	7.8	4.8	5.5	16.6	19.4	6.0	0.7	3.1	4.1	0.4	30.5
HOMER3	HOMER-3	ENSG00000051128	"Homer scaffold protein 3"	Q9NSC5	19	18929201-18941261	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 125.1"	"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 76.4;Muller glia cells: 72.6;Proximal tubular cells: 84.2;Theca cells: 322.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"classical monocyte: 15.0"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"NB-4: 353.6;THP-1: 420.0;U-266/84: 375.4"	"Region enriched"	"Detected in all"	6	"cerebellum: 189.2"	"Low region specificity"	"Detected in all"			"CAB032656, HPA040999, CAB079015"	Enhanced	Supported	Supported	"Plasma membrane,Cytosol,Cytoplasmic bodies"		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 52: Non-specific - Transcription"	Cytosol	"Plasma membrane, Cytoplasmic bodies"	"CAB032656: AB_2120801, CAB079015: , HPA040999: AB_2677242"	"unprognostic (3.41e-2)"	"unprognostic (1.71e-1)"	"prognostic unfavorable (4.24e-5)"	"unprognostic (1.19e-1)"	"unprognostic (2.06e-1)"	"unprognostic (1.11e-1)"	"prognostic unfavorable (4.93e-5)"	"unprognostic (1.07e-1)"	"unprognostic (8.88e-2)"	"unprognostic (5.78e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.10e-2)"	"unprognostic (5.99e-2)"	"unprognostic (3.76e-2)"	"unprognostic (2.33e-1)"	"unprognostic (1.41e-1)"	"unprognostic (4.11e-2)"	33.1	29.6	33.3	9.9	41.9	22.3	26.2	76.9	44.6	31.7	41.1	27.0	7.0	24.6	6.4	15.3	16.7	16.5	25.0	40.4	35.1	52.2	6.1	25.6	7.9	42.3	40.9	20.1	12.4	37.5	8.6	14.7	42.8	21.9	6.0	5.9	27.6	9.4	114.5	35.4	14.4	10.6	39.4	125.1	17.0	9.2	41.6	7.4	49.3	18.6	3.8	29.7	26.0	45.5	112.1	28.5	53.1	44.4	48.3	48.6	26.2	108.1	94.9	106.4	53.4	14.6	41.8	0.9	49.9	122.1	76.1	68.6	18.4	140.4	58.9	4.0	11.0	0.1	9.7	27.5	44.9	21.5	1.7	39.3	89.4	59.0	79.1	113.0	130.3	7.9	3.2	28.6	78.1	30.3	1.9	353.6	27.3	6.1	115.5	55.2	16.2	53.4	38.2	28.3	0.2	44.8	26.6	31.2	78.5	10.2	14.0	420.0	105.3	94.0	42.0	114.5	132.2	274.2	375.4	93.6	148.0	270.6	69.8	0.1	15.0	2.9	0.1	5.3	0.0	2.3	0.8	0.3	1.3	2.7	0.1	0.0	5.8	0.0	1.6	0.2	0.8	4.2	33.3	41.9	76.9	44.6	40.4	35.1	42.3	40.9	42.8	39.4	41.6	45.5	21.7	3.2	0.0	9.4	9.3	11.9	22.4	24.4	6.8	2.2	14.3	22.5	4.1	2.8	8.0	12.9	0.0	1.0	0.6	0.1	11.7	22.9	2.0	4.3	18.7	38.0	1.8	0.4	0.3	13.6	2.4	20.5	0.0	6.3	10.2	34.8	21.8	0.7	76.4	1.7	3.9	0.9	22.4	16.2	7.6	1.7	13.7	32.2	12.4	1.9	8.3	72.6	0.0	1.0	13.4	42.0	0.0	10.9	13.8	25.2	0.0	84.2	3.6	4.1	0.0	14.4	27.8	4.7	6.7	4.2	14.5	1.1	2.5	322.4	0.3	21.4
HOMEZ	KIAA1443	ENSG00000215271	"Homeobox and leucine zipper encoding"	Q8IX15	14	23272422-23299447	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 34.4"	"Group enriched"	"Detected in all"	6	"Early spermatids: 309.7;Late spermatids: 78.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036316, HPA036317"	Enhanced		Supported	Nucleoplasm,Nucleoli		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 15: RT4 - Unknown function"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	"Nucleoplasm, Nucleoli"		"HPA036316: AB_2675056, HPA036317: AB_10669787"	"unprognostic (3.70e-2)"	"unprognostic (7.58e-2)"	"unprognostic (6.36e-2)"	"unprognostic (3.93e-2)"	"unprognostic (9.11e-2)"	"unprognostic (5.23e-2)"	"unprognostic (1.20e-2)"	"unprognostic (1.59e-2)"	"unprognostic (1.37e-1)"	"prognostic favorable (2.41e-5)"	"unprognostic (2.23e-1)"	"unprognostic (1.77e-1)"	"prognostic favorable (1.17e-11)"	"unprognostic (2.62e-1)"	"unprognostic (2.00e-1)"	"prognostic favorable (1.75e-4)"	"unprognostic (3.23e-1)"	6.1	4.9	4.6	4.7	6.2	1.5	6.7	5.9	5.8	6.5	4.0	6.7	7.3	5.3	8.0	9.8	7.0	5.2	7.8	4.8	5.5	9.4	6.2	6.1	4.6	6.8	5.5	9.9	7.8	8.8	3.6	5.7	6.3	6.5	6.2	6.0	7.0	9.6	9.0	7.7	5.0	7.2	4.9	5.6	7.8	34.4	6.7	9.4	7.3	14.9	7.9	10.9	5.7	6.4	7.0	7.2	13.0	12.3	19.8	8.7	14.8	7.2	9.4	6.8	8.7	3.3	14.6	15.2	6.1	7.1	16.0	23.3	17.3	18.0	8.5	8.4	6.6	5.2	6.0	14.1	25.8	7.6	4.4	13.5	17.7	5.4	11.8	15.1	13.1	17.0	15.6	6.0	11.8	16.1	5.9	5.2	5.3	21.3	4.1	9.2	9.7	6.7	12.5	28.5	4.2	5.2	6.9	19.3	7.8	19.7	12.0	8.9	14.6	4.7	2.1	5.9	3.3	25.1	11.3	5.0	2.5	5.5	7.2	2.9	5.0	7.3	3.5	4.5	2.8	2.6	3.0	2.9	4.8	2.3	3.2	3.9	0.8	2.4	3.4	2.9	4.1	2.9	4.6	6.2	5.9	5.8	4.8	5.5	6.8	5.5	6.3	4.9	6.7	6.4	3.7	6.4	7.0	4.6	5.6	2.8	18.4	19.9	9.1	5.8	7.0	5.7	6.9	12.8	14.4	23.9	6.2	6.9	4.6	6.8	13.7	11.0	309.7	4.4	4.2	5.7	3.6	5.0	1.9	10.9	6.6	5.2	13.7	6.9	3.8	8.2	5.3	6.9	8.7	10.1	2.0	9.2	8.2	6.1	5.1	78.9	6.8	5.8	3.6	6.5	15.1	6.9	5.2	3.0	6.8	9.1	5.5	7.5	6.1	16.3	8.6	19.8	12.9	3.7	6.6	4.7	4.7	15.2	5.3	10.1	5.1	9.3	4.2	3.8	7.9	29.1
HOOK2	HK2	ENSG00000095066	"Hook microtubule tethering protein 2"	Q96ED9	19	12763003-12872740	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Proximal enterocytes: 291.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"MCF7: 83.7;RT4: 100.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043519, HPA050351"	Approved		Supported	Vesicles,Cytosol		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 50: Non-specific - Ribosome"	"Cluster 15: RT4 - Unknown function"	"Cluster 45: Enterocytes - Digestion"	"Vesicles, Cytosol"		"HPA043519: AB_2678525, HPA050351: AB_2681102"	"unprognostic (4.26e-1)"	"unprognostic (3.80e-2)"	"unprognostic (2.53e-3)"	"unprognostic (1.16e-1)"	"unprognostic (4.57e-1)"	"unprognostic (1.59e-3)"	"unprognostic (1.76e-1)"	"unprognostic (6.25e-3)"	"unprognostic (3.06e-2)"	"unprognostic (2.52e-2)"	"unprognostic (1.75e-3)"	"prognostic unfavorable (7.59e-5)"	"prognostic favorable (3.28e-4)"	"unprognostic (3.27e-3)"	"unprognostic (5.74e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.91e-2)"	40.0	20.6	15.8	10.3	15.1	4.1	45.8	15.5	21.0	31.4	14.3	35.8	52.0	15.1	46.8	55.5	27.0	20.9	63.3	14.8	15.2	54.9	46.8	24.0	7.1	15.3	14.3	24.9	98.1	38.4	113.8	14.2	15.5	53.1	25.0	13.4	59.3	26.8	70.7	56.2	43.1	10.7	12.7	18.0	41.8	24.7	14.8	7.5	96.2	34.0	13.3	25.1	39.3	15.5	38.5	9.7	11.3	8.0	12.5	11.5	40.5	11.9	5.6	6.5	8.3	33.3	44.2	7.5	20.8	11.5	5.7	48.6	12.0	34.3	6.8	19.7	8.8	7.5	21.1	11.0	5.9	4.2	10.2	14.0	32.4	8.3	13.4	15.0	3.9	14.6	12.6	5.7	13.6	83.7	4.3	7.8	4.8	24.9	10.2	12.1	7.1	18.6	13.4	100.5	28.1	14.5	8.7	25.7	7.3	11.5	35.3	9.1	7.2	12.6	8.5	19.7	4.2	20.6	23.9	4.5	13.4	14.2	9.3	0.2	0.8	0.0	1.4	1.3	0.9	1.7	1.8	0.6	1.3	1.2	3.0	1.9	1.0	1.3	0.8	0.6	0.4	1.1	15.8	15.1	15.5	21.0	14.8	15.2	15.3	14.3	15.5	12.7	14.8	15.5	14.8	19.2	38.0	25.1	34.4	50.5	99.8	135.0	158.8	117.7	84.4	62.9	29.6	75.8	84.5	82.8	100.1	85.0	11.9	137.2	43.0	77.5	9.2	26.2	21.0	18.6	63.0	11.1	28.9	45.4	40.2	24.2	140.2	39.3	12.6	30.7	22.1	24.4	16.6	63.9	43.3	93.9	118.0	11.1	21.6	9.1	27.1	20.4	28.4	6.5	19.7	26.6	10.3	17.1	10.6	46.7	98.0	26.7	30.1	131.6	291.7	45.4	49.3	84.5	13.1	24.5	25.4	73.9	26.1	82.1	65.5	128.1	27.9	42.1	95.6	87.1
HOOK3	HK3	ENSG00000168172	"Hook microtubule tethering protein 3"	Q86VS8	8	42896946-43030535	"Cancer-related genes, Predicted intracellular proteins"	"Protein transport, Transport"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 9.4"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024756	Approved		Supported	"Golgi apparatus,Centriolar satellite,Cytosol"		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 34: Non-specific - Transcription"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 44: Endometrium - Transcription"	"Centriolar satellite"	"Golgi apparatus, Cytosol"	"HPA024756: AB_1850913"	"unprognostic (1.84e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.73e-1)"	"unprognostic (8.61e-3)"	"unprognostic (6.05e-2)"	"unprognostic (1.77e-3)"	"unprognostic (2.36e-1)"	"unprognostic (2.23e-1)"	"unprognostic (1.78e-1)"	"unprognostic (3.97e-2)"	"unprognostic (1.13e-1)"	"unprognostic (4.13e-1)"	"prognostic unfavorable (1.32e-4)"	"unprognostic (1.63e-1)"	"unprognostic (3.78e-1)"	"unprognostic (2.55e-1)"	"unprognostic (7.12e-2)"	9.8	6.2	3.1	7.4	8.7	11.1	8.9	11.9	8.9	8.2	1.5	7.5	7.5	8.3	8.2	10.6	7.0	14.4	4.6	4.0	11.1	6.6	7.3	8.0	6.6	7.6	4.9	6.1	7.6	7.2	4.1	8.6	7.3	12.4	7.7	8.8	9.6	7.1	10.6	8.1	8.9	6.7	4.4	6.6	9.5	11.4	4.9	6.4	21.7	8.2	7.4	9.3	6.0	15.5	11.2	10.9	26.2	14.2	19.0	16.7	10.1	14.0	11.6	11.5	10.7	14.5	12.8	13.9	13.9	18.8	10.9	6.4	22.1	9.5	18.5	9.5	6.4	26.3	9.2	10.2	10.6	2.8	14.9	13.7	6.6	15.4	13.2	15.9	16.7	9.7	14.7	15.9	14.0	2.7	21.7	5.2	9.5	8.8	3.3	12.6	27.3	3.5	8.6	16.5	6.7	10.6	15.9	6.7	7.4	11.4	12.2	9.4	30.2	17.1	13.2	20.9	9.0	15.6	18.6	18.1	14.5	9.9	25.8	9.4	2.0	2.0	1.2	2.0	0.4	0.9	1.1	0.9	2.4	0.9	0.6	0.8	2.2	1.2	1.9	1.4	0.8	1.1	3.1	8.7	11.9	8.9	4.0	11.1	7.6	4.9	7.3	4.4	4.9	15.5	75.3	93.0	60.6	90.1	43.2	68.3	36.2	28.7	43.3	40.1	29.4	22.4	48.2	44.3	43.6	25.8	33.3	43.6	40.6	26.1	27.4	47.1	120.3	60.0	84.0	65.2	65.4	34.5	102.1	32.8	25.9	65.8	33.1	93.8	53.8	37.9	60.3	36.4	38.0	75.7	107.6	26.9	20.3	79.4	96.4	36.3	44.7	82.8	55.2	78.7	118.6	36.3	37.0	119.1	157.8	59.7	27.6	53.8	43.6	43.5	37.3	21.4	35.2	32.2	65.7	63.4	74.6	28.0	21.5	39.8	74.7	113.7	40.9	42.6	16.2	71.1
HORMAD2	"CT46.2, MGC26710"	ENSG00000176635	"HORMA domain containing 2"	Q8N7B1	22	30080464-30177075	"Predicted intracellular proteins"	Meiosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"testis: 22.8"	"Group enriched"	"Detected in some"	7	"Early spermatids: 52.8;Spermatocytes: 133.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA003074, HPA043880"	Enhanced		Supported	Nucleoplasm,Centrosome,Cytosol		NA	NA				"Cluster 83: Testis - Spermatogenesis"		"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	Nucleoplasm	"Centrosome, Cytosol"	"HPA003074: AB_1850916, HPA043880: "					"unprognostic (1.43e-1)"		"unprognostic (6.77e-3)"	"unprognostic (2.33e-1)"		"unprognostic (1.36e-2)"			"unprognostic (8.19e-3)"	"unprognostic (1.96e-1)"	"unprognostic (2.50e-2)"	"unprognostic (2.12e-1)"		0.1	0.0	0.2	0.0	0.3	0.0	0.0	0.3	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.0	2.9	0.0	0.0	0.3	0.3	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	22.8	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.3	0.3	0.2	0.4	0.3	0.3	0.3	0.3	0.3	0.3	0.1	0.0	0.0	3.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	52.8	0.1	0.1	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.7	3.4	0.0	0.0	0.6	0.0	0.0	0.0	0.0	9.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	6.6	0.2	0.0	133.0	12.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0
HOXA10	"HOX1, HOX1H"	ENSG00000253293	"Homeobox A10"	P31260	7	27170592-27180261	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"endometrium 1: 76.8;skeletal muscle: 76.4"	"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 174.0;Enteroendocrine cells: 68.1;Paneth cells: 32.1"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"basophil: 10.7;NK-cell: 13.1"	"Group enriched"	"Detected in many"	5	"granulocytes: 10.7;NK-cells: 13.1"	"Cell line enhanced"	"Detected in many"		"HEK 293: 179.0;THP-1: 96.7;U-937: 100.4"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	190	"spinal cord: 18.9"	"CAB019384, HPA071918"	Approved		Supported	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 36: Stromal cells - Cell proliferation"	Nucleoplasm	"Nuclear bodies"	"CAB019384: , HPA071918: "	"unprognostic (4.98e-2)"	"unprognostic (5.66e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.47e-1)"	"unprognostic (3.01e-2)"	"unprognostic (2.73e-3)"	"unprognostic (2.61e-2)"	"unprognostic (1.41e-2)"	"unprognostic (8.05e-2)"	"unprognostic (2.71e-2)"	"unprognostic (3.83e-3)"	"unprognostic (1.57e-1)"	"unprognostic (7.13e-2)"	"unprognostic (8.46e-3)"	"unprognostic (1.03e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.35e-2)"	13.4	6.8	0.0	6.1	0.0	4.3	6.8	0.0	0.0	40.8	0.0	32.6	0.1	76.8	9.1	0.2	8.3	0.1	0.0	0.0	0.0	13.7	0.1	0.1	2.3	0.0	0.0	0.8	0.0	0.0	0.0	13.4	0.0	26.3	13.2	0.0	0.0	15.4	76.4	6.0	7.9	44.9	0.1	0.2	0.1	0.3	0.0	5.2	0.1	0.0	0.2	20.4	17.2	0.1	20.6	4.3	0.0	59.9	29.3	28.0	0.2	40.1	27.2	18.0	16.8	6.1	17.8	0.0	10.9	31.6	0.0	22.6	15.5	0.0	13.2	9.5	179.0	21.6	15.0	0.5	0.8	9.6	31.4	17.8	0.9	1.5	0.0	0.0	27.5	6.3	0.9	0.0	13.3	0.0	0.0	63.1	0.0	16.6	18.8	1.9	4.0	0.1	34.7	9.6	46.7	0.1	13.8	0.0	0.1	6.4	0.1	96.7	0.0	0.0	16.1	21.1	0.2	0.4	0.1	0.0	0.0	100.4	0.5	10.7	0.1	0.3	2.2	0.0	0.0	0.1	0.0	0.2	1.2	0.3	0.0	0.0	0.0	13.1	0.0	0.4	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	5.5	0.0	0.0	0.0	0.2	3.7	10.0	0.0	0.6	0.0	4.4	4.6	1.6	0.0	0.0	7.3	0.0	0.5	4.5	28.8	19.6	0.0	0.0	3.1	174.0	5.4	68.1	15.5	0.0	0.0	0.4	13.3	0.0	2.9	0.0	0.0	0.0	0.0	0.8	0.0	0.0	25.0	0.0	2.5	4.7	0.0	0.0	2.0	5.4	0.0	0.5	0.0	7.2	0.0	0.0	0.0	32.1	0.4	1.3	18.1	18.8	27.1	0.0	0.0	0.0	13.3	15.7	2.3	4.6	0.5	4.1	0.5	3.1	0.0	25.5	10.1
HOXA11	"HOX1, HOX1I"	ENSG00000005073	"Homeobox A11"	P31270	7	27181157-27185232	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix: 44.8;endometrium 1: 96.7;smooth muscle: 41.2"	"Cell type enriched"	"Detected in some"	19	"Endometrial stromal cells: 116.8"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 32.5;HEK 293: 44.0;THP-1: 34.7;U-937: 43.4"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	36	"spinal cord: 3.5"	"HPA006770, HPA035623"	Enhanced		Supported	Nucleoplasm		NA	NA				"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 32: U-937 - Innate immune response"	"Cluster 36: Stromal cells - Cell proliferation"	Nucleoplasm		"HPA006770: AB_2667672, HPA035623: AB_10601576"	"unprognostic (5.95e-2)"	"unprognostic (9.23e-2)"	"unprognostic (3.07e-2)"	"unprognostic (2.70e-2)"	"unprognostic (6.29e-2)"	"unprognostic (9.78e-2)"	"unprognostic (2.82e-3)"	"unprognostic (4.36e-2)"	"unprognostic (1.61e-2)"	"unprognostic (3.05e-2)"	"unprognostic (2.08e-3)"	"unprognostic (1.73e-2)"	"prognostic unfavorable (2.57e-5)"	"unprognostic (2.17e-2)"	"unprognostic (6.90e-2)"	"unprognostic (2.03e-2)"	"unprognostic (2.56e-1)"	3.5	0.7	0.0	1.4	0.0	0.0	0.4	0.0	0.0	44.8	0.0	23.1	0.0	96.7	0.0	0.0	1.3	0.0	0.0	0.0	0.0	6.1	0.0	0.0	0.3	0.0	0.0	0.6	0.0	0.0	0.0	10.0	0.0	14.7	3.9	0.0	0.1	9.6	7.9	1.5	0.2	41.2	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	17.0	10.4	0.0	4.8	0.3	0.0	13.1	15.2	11.1	0.0	26.8	32.5	18.9	13.8	0.3	1.7	0.0	6.1	23.5	0.1	3.2	16.3	0.0	14.7	1.6	44.0	5.7	11.2	0.7	0.9	12.5	1.7	6.5	0.6	0.1	0.0	0.0	14.1	1.1	0.4	0.0	2.2	0.4	0.0	9.4	0.0	4.4	13.1	0.7	0.0	0.3	9.6	8.1	5.6	0.0	6.7	0.0	2.0	3.6	1.2	34.7	0.0	0.2	12.9	3.2	1.5	0.0	0.0	0.0	0.2	43.4	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.3	2.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	1.8	0.0	0.1	0.3	1.1	5.9	0.0	0.8	4.0	116.8	1.3	5.3	0.0	0.0	0.0	0.1	3.6	0.0	1.7	0.0	0.0	0.0	0.0	0.3	0.0	0.0	2.1	0.0	0.0	0.3	0.0	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	2.8	0.2	0.2	0.0	0.0	0.0	0.9	5.8	1.2	0.1	0.0	0.0	0.0	0.6	0.1	1.1	1.3
HOXA13	"HOX1, HOX1J"	ENSG00000106031	"Homeobox A13"	P31271	7	27193503-27200091	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"cervix: 23.1;placenta: 17.1;prostate: 22.3;seminal vesicle: 23.3"	"Cell type enriched"	"Detected in some"	4	"Distal enterocytes: 41.3"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 10.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HAP1: 26.9;HEK 293: 37.3;PC-3: 18.4;RT4: 42.1;THP-1: 18.2;U-937: 20.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA046098, HPA069061"			Supported	"Nucleoplasm,Mitotic chromosome,Intermediate filaments"		Yes	NA				"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 15: RT4 - Unknown function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm	"Mitotic chromosome, Intermediate filaments"	"HPA046098: AB_2679536, HPA069061: "	"unprognostic (7.20e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.02e-1)"	"unprognostic (8.04e-4)"	"unprognostic (1.06e-3)"	"unprognostic (2.24e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.40e-2)"	"unprognostic (9.22e-3)"	"unprognostic (7.30e-3)"	"unprognostic (8.39e-3)"	"unprognostic (1.54e-1)"	"unprognostic (1.42e-11)"	"unprognostic (2.58e-3)"	"unprognostic (1.38e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.36e-2)"	0.6	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	23.1	0.0	9.9	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.1	0.0	22.3	11.9	0.0	0.0	23.3	2.1	0.3	0.0	0.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	12.1	14.1	0.0	2.2	1.6	0.0	2.5	0.2	0.0	0.1	13.2	14.4	5.1	3.3	2.8	0.2	0.0	1.6	6.2	0.7	0.0	26.9	0.0	4.3	0.0	37.3	1.9	6.9	0.2	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.2	0.1	0.0	8.7	0.0	11.8	18.4	2.7	0.6	0.0	0.1	42.1	0.7	0.0	3.3	0.0	0.3	2.0	0.0	18.2	0.0	0.5	4.5	0.3	0.1	0.0	0.0	0.0	0.0	20.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	41.3	0.0	0.0	0.6	0.1	4.0	1.1	8.4	0.0	0.0	0.0	0.1	2.4	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	8.6	0.0	0.0	0.7	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.0	0.0	0.0	5.5	0.0	0.1	0.0	0.0	0.0	0.1	2.8	0.5	0.0	0.0	0.1	0.1	0.1	0.0	10.3	3.1
HOXA3	"HOX1, HOX1E"	ENSG00000105997	"Homeobox A3"	O43365	7	27106184-27152581	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 27.9;Endometrial stromal cells: 17.9;Intestinal goblet cells: 15.8;Proximal tubular cells: 13.2;Undifferentiated cells: 16.6"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	15	"medulla oblongata: 10.5;pons: 7.8;spinal cord: 9.4;white matter: 7.1"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 38.2;CACO-2: 25.2;CAPAN-2: 66.5;HEK 293: 29.7;WM-115: 35.5"	"Region enriched"	"Detected in single"	30	"pons and medulla: 3.0"	"Region enhanced"	"Detected in some"		"medulla oblongata: 3.9;spinal cord: 3.1"	HPA029157	Uncertain		Supported	Nucleoplasm		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 36: Stromal cells - Cell proliferation"	Nucleoplasm		"HPA029157: AB_10601020"	"unprognostic (1.32e-1)"	"unprognostic (3.71e-2)"	"unprognostic (1.58e-1)"	"unprognostic (3.85e-3)"	"unprognostic (2.94e-2)"	"unprognostic (5.48e-2)"	"unprognostic (2.81e-2)"	"unprognostic (2.05e-2)"	"unprognostic (8.61e-2)"	"unprognostic (6.00e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.09e-2)"	"prognostic unfavorable (2.52e-6)"	"unprognostic (1.03e-1)"	"unprognostic (1.35e-1)"	"unprognostic (3.65e-2)"	"unprognostic (5.82e-2)"	7.1	3.2	0.0	2.3	0.0	0.3	7.3	0.0	0.0	5.3	0.0	12.2	3.9	8.5	6.4	8.2	18.4	2.9	0.6	0.0	0.0	12.9	0.7	6.0	1.4	10.5	0.6	3.0	0.7	3.8	0.0	0.1	7.8	6.5	4.6	0.0	0.2	2.3	7.6	4.9	9.5	3.4	9.4	2.3	6.6	2.8	0.1	1.6	2.2	3.1	0.2	8.9	3.7	7.1	11.9	13.7	0.0	38.2	0.0	0.0	0.0	0.4	0.4	0.1	0.2	25.2	66.5	1.8	18.7	1.0	5.2	15.9	0.7	1.7	0.0	0.5	29.7	0.5	0.4	20.6	1.3	0.7	0.7	2.4	0.1	3.1	3.6	0.0	3.6	1.7	1.3	0.2	1.5	0.6	0.0	1.0	0.0	3.3	8.6	14.1	4.4	0.0	11.4	5.4	5.6	0.0	2.1	0.0	5.8	0.5	1.1	0.8	16.5	0.0	2.0	3.9	3.1	0.0	0.0	0.6	1.2	2.6	35.5	0.4	0.0	0.2	0.1	0.0	0.0	0.1	0.0	0.1	0.3	0.0	0.0	0.0	0.9	0.4	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.5	0.6	7.8	9.4	0.1	7.1	6.2	0.0	0.0	0.0	0.2	1.1	3.8	0.0	27.9	0.0	5.7	6.1	1.0	0.0	0.0	3.7	0.0	0.0	0.7	6.2	5.9	0.1	8.1	2.0	17.9	5.8	4.2	1.7	0.0	0.0	0.0	6.8	0.0	0.5	1.3	0.2	9.3	0.3	0.1	0.0	0.0	15.8	0.0	0.3	0.7	9.1	0.6	1.3	3.6	0.0	0.0	0.0	1.0	0.0	0.0	0.0	7.3	0.0	0.0	2.4	5.5	13.2	0.0	0.0	0.0	2.9	9.2	2.2	1.4	11.8	1.3	0.0	1.2	0.1	16.6	4.5
HOXA4	"HOX1, HOX1D"	ENSG00000197576	"Homeobox A4"	Q00056	7	27128507-27130780	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Adipocytes: 11.6;Basal squamous epithelial cells: 31.9;Distal tubular cells: 15.6;Hepatic stellate cells: 16.8;Proximal tubular cells: 13.1;Squamous epithelial cells: 12.5"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	10	"medulla oblongata: 19.3;pons: 16.1;spinal cord: 15.6;white matter: 14.1"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 29.0;HEK 293: 22.2;REH: 21.0;WM-115: 29.1"	"Region enriched"	"Detected in single"	46	"pons and medulla: 11.3"					HPA060088	Approved		Supported	"Nuclear bodies"		NA	NA				"Cluster 89: Fibroblasts - ECM organization"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 50: Fibroblasts - ECM organization"	"Nuclear bodies"		"HPA060088: AB_2684200"	"unprognostic (3.37e-2)"	"unprognostic (6.27e-3)"	"unprognostic (1.01e-2)"	"prognostic unfavorable (6.37e-4)"	"unprognostic (3.12e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.64e-1)"	"unprognostic (1.32e-1)"	"unprognostic (4.22e-1)"	"unprognostic (1.31e-1)"	"unprognostic (7.39e-2)"	"unprognostic (4.23e-1)"	"unprognostic (5.63e-2)"	"unprognostic (2.65e-2)"	"unprognostic (3.38e-1)"	"unprognostic (3.59e-4)"	"unprognostic (3.93e-2)"	16.2	10.0	0.0	2.1	0.0	0.7	10.5	0.1	0.1	5.5	0.0	13.2	4.9	5.9	13.0	15.3	22.1	3.6	1.9	0.0	0.0	16.3	1.5	14.7	1.3	19.3	1.6	6.8	1.9	25.8	0.0	0.1	16.1	5.9	2.4	0.0	0.6	5.8	18.8	4.9	8.2	4.6	15.6	6.9	13.4	1.6	0.0	1.9	3.7	8.2	0.4	7.7	4.6	14.1	9.5	3.1	0.0	29.0	0.0	0.0	1.9	0.9	0.9	3.0	3.0	5.9	1.9	2.5	0.1	2.8	2.7	4.0	1.1	0.4	2.3	0.1	22.2	0.0	0.9	13.7	3.3	3.3	5.4	3.2	2.4	10.2	0.8	0.0	10.3	0.8	0.0	0.0	10.0	2.5	0.0	11.2	0.0	3.3	7.2	21.0	4.4	0.2	14.6	2.2	1.4	0.0	2.9	0.0	11.2	1.0	0.7	1.7	13.5	0.0	4.6	7.6	0.2	0.0	0.0	1.0	6.1	5.1	29.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	19.3	1.6	16.1	15.6	0.0	14.1	11.6	0.0	0.0	0.0	0.1	0.9	3.1	0.0	31.9	0.0	3.6	7.7	0.4	0.0	0.0	0.0	0.0	0.0	0.4	1.7	15.6	0.0	0.4	0.2	2.6	5.2	3.0	0.8	0.0	0.0	0.9	5.4	0.5	0.1	0.0	0.4	16.8	0.0	0.2	0.0	0.0	0.9	0.0	0.6	0.3	0.4	0.0	0.9	0.0	0.0	0.1	0.0	1.0	0.0	0.0	0.0	0.5	0.7	1.4	0.7	1.0	13.1	0.0	0.0	0.0	8.3	5.8	0.4	3.2	12.5	1.3	0.1	0.8	1.4	2.0	2.5
HOXA6	"HOX1, HOX1B"	ENSG00000106006	"Homeobox A6"	P31267	7	27145396-27150603	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 10.0"	"Cell type enhanced"	"Detected in some"		"Breast myoepithelial cells: 5.2;Distal enterocytes: 7.5;Distal tubular cells: 5.9;Endometrial stromal cells: 14.8;Enteroendocrine cells: 9.0;Smooth muscle cells: 6.2;Undifferentiated cells: 8.0"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"spinal cord: 7.7"	"Immune cell enhanced"	"Detected in single"		"basophil: 3.1"	"Lineage enhanced"	"Detected in single"		"granulocytes: 3.1"	"Group enriched"	"Detected in many"	9	"AN3-CA: 61.7;HEK 293: 84.4"	"Region enriched"	"Detected in single"	34	"pons and medulla: 3.3"					"HPA004203, HPA077900"	Approved		Supported	"Nucleoplasm,Nuclear speckles"		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 68: Epididymis - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 36: Stromal cells - Cell proliferation"	Nucleoplasm	"Nuclear speckles"	"HPA004203: AB_1079079, HPA077900: "	"unprognostic (1.70e-1)"	"unprognostic (6.76e-3)"	"unprognostic (2.70e-2)"	"prognostic unfavorable (1.40e-4)"	"unprognostic (1.06e-1)"	"unprognostic (6.06e-2)"		"unprognostic (9.73e-2)"	"unprognostic (6.32e-2)"	"unprognostic (2.94e-2)"	"unprognostic (7.82e-2)"	"unprognostic (2.17e-1)"	"prognostic favorable (2.03e-4)"	"unprognostic (1.45e-1)"	"unprognostic (2.81e-2)"		"unprognostic (3.93e-1)"	3.0	2.7	0.1	1.4	0.1	0.2	2.4	0.0	0.2	2.5	0.0	6.6	0.2	5.4	3.7	0.3	10.0	0.2	0.0	0.1	0.0	4.5	0.0	2.1	1.1	7.1	0.0	0.2	0.0	0.3	0.0	0.1	1.8	2.5	1.5	0.0	0.1	1.9	1.2	2.9	4.2	1.4	7.7	0.2	1.3	0.0	0.0	0.1	0.2	0.0	0.0	3.0	1.4	5.4	1.2	2.1	0.1	61.7	0.1	0.0	0.2	0.5	0.6	0.4	0.6	1.5	7.2	1.5	2.3	0.5	0.2	2.8	1.5	0.0	0.0	1.9	84.4	1.0	1.2	0.8	0.0	1.3	2.1	4.9	0.1	0.0	0.8	0.1	2.9	2.0	0.4	0.0	0.7	0.8	0.1	0.3	0.1	0.4	2.1	8.4	0.0	0.0	5.9	3.9	6.4	0.0	2.9	0.3	1.3	0.0	0.8	0.8	0.0	0.1	0.9	3.3	2.3	0.0	0.0	1.4	0.0	6.2	6.1	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.2	0.0	0.0	0.1	0.1	0.0	0.2	0.1	0.0	7.1	0.0	1.8	7.7	0.0	5.4	2.1	0.0	0.0	0.0	0.3	0.3	1.6	0.0	0.0	0.0	4.0	5.2	0.0	0.0	0.0	1.8	0.0	0.0	0.5	7.5	5.9	0.0	0.0	0.6	14.8	1.9	9.0	0.0	0.0	0.0	0.0	1.8	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	3.7	0.0	0.0	0.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	3.9	0.0	0.0	1.0	3.4	1.3	0.1	0.0	0.0	3.7	6.2	0.0	0.0	0.3	0.4	0.0	0.4	0.1	8.0	1.4
HOXA7	"HOX1, HOX1A"	ENSG00000122592	"Homeobox A7"	P31268	7	27153716-27157936	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Breast myoepithelial cells: 29.1;Distal tubular cells: 131.0;Early spermatids: 29.4;Proximal tubular cells: 53.4;Spermatocytes: 27.4"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	29	"medulla oblongata: 4.6;pons: 2.1;spinal cord: 8.2;white matter: 5.1"	"Immune cell enriched"	"Detected in single"	6	"NK-cell: 4.7"	"Lineage enriched"	"Detected in single"	6	"NK-cells: 4.7"	"Cell line enhanced"	"Detected in many"		"HAP1: 36.9;RPTEC TERT1: 45.4;SCLC-21H: 36.3"	"Region enriched"	"Detected in single"	12	"pons and medulla: 1.3"	"Region enriched"	"Detected in some"	6	"spinal cord: 21.4"	HPA074048			Supported	"Nucleoplasm,Nuclear membrane"		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm	"Nuclear membrane"	"HPA074048: AB_2686655"	"unprognostic (5.40e-2)"	"unprognostic (2.34e-1)"	"unprognostic (1.45e-1)"	"prognostic unfavorable (7.87e-5)"	"unprognostic (3.30e-1)"	"unprognostic (2.53e-1)"	"unprognostic (3.02e-1)"	"unprognostic (3.24e-2)"	"unprognostic (2.14e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.04e-2)"	"unprognostic (1.14e-1)"	"prognostic favorable (1.15e-5)"	"unprognostic (9.08e-2)"	"unprognostic (8.90e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.25e-1)"	8.2	17.8	0.0	5.9	0.0	0.3	9.4	0.0	0.1	4.2	0.0	13.8	0.2	5.8	17.8	2.8	15.5	0.1	0.0	0.0	0.0	20.1	0.0	2.7	2.1	4.6	0.1	0.8	0.2	0.2	0.0	0.3	2.1	4.9	8.9	0.0	0.0	6.7	16.5	12.0	8.6	3.8	8.2	1.7	3.9	2.4	0.1	2.9	0.5	0.1	0.4	7.3	5.2	5.1	13.6	4.6	0.0	14.1	0.0	0.0	0.8	4.7	8.0	9.6	11.0	7.0	5.1	9.2	12.8	3.7	0.3	9.1	36.9	0.0	5.8	0.0	23.2	0.6	4.8	0.2	0.9	0.8	0.5	7.5	0.4	1.1	12.9	0.0	18.5	15.7	0.0	0.0	3.7	2.4	0.0	2.2	0.5	9.6	1.4	4.8	8.5	0.0	45.4	9.1	36.3	0.1	25.6	0.0	0.1	2.5	0.4	3.7	1.6	0.0	8.6	26.0	4.6	0.0	0.2	0.2	0.0	17.9	0.1	0.0	0.0	0.0	0.8	0.0	0.0	0.1	0.0	0.1	0.5	0.0	0.0	0.0	0.0	4.7	0.0	0.3	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.0	4.6	0.1	2.1	8.2	0.1	5.1	11.0	0.0	0.0	0.0	0.6	9.1	7.2	0.1	12.0	0.0	18.7	29.1	0.4	0.0	0.1	12.9	0.0	1.1	1.3	10.3	131.0	0.0	29.4	0.2	2.1	5.9	16.2	5.5	0.0	0.0	3.9	5.8	0.0	0.0	0.0	0.2	0.4	0.0	0.3	0.0	0.0	12.5	0.0	0.0	1.9	7.2	0.6	0.6	3.6	0.0	0.1	0.0	0.0	0.0	0.0	0.1	8.8	0.0	1.7	5.2	2.3	53.4	0.1	0.0	0.0	10.8	16.1	27.4	4.1	8.6	12.4	0.3	1.0	1.2	16.1	5.3
HOXB1	"HOX2, HOX2I"	ENSG00000120094	"Homeobox B1"	P14653	17	48528526-48531011	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"Early spermatids: 2.2"	"Cancer enriched"	"Detected in single"	15	"testis cancer: 3.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA044576	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA						"Cluster 23: Spermatids - Flagellum & Golgi organization"	Nucleoplasm	Cytosol	"HPA044576: AB_10794501"	"unprognostic (1.80e-2)"	"unprognostic (9.50e-3)"		"unprognostic (8.22e-2)"		"unprognostic (1.22e-1)"		"unprognostic (6.26e-2)"		"unprognostic (2.40e-2)"	"unprognostic (1.03e-1)"			"unprognostic (1.96e-1)"	"unprognostic (6.74e-2)"		"unprognostic (1.45e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.3	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.2
HOXB2	"HOX2, HOX2H"	ENSG00000173917	"Homeobox B2"	P14652	17	48540894-48545109	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 156.5;Endometrial ciliated cells: 69.2;NK-cells: 58.7"	"Low cancer specificity"	"Detected in all"			"Group enriched"	"Detected in many"	13	"medulla oblongata: 14.9;pons: 10.9;spinal cord: 12.1;white matter: 10.7"	"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AF22: 54.5;EFO-21: 52.2;HEK 293: 59.1;HMC-1: 116.8;WM-115: 52.6"	"Region enriched"	"Detected in single"	34	"pons and medulla: 4.4"	"Group enriched"	"Detected in some"	4	"medulla oblongata: 4.9;spinal cord: 7.0"	HPA047857			Supported	Nucleoplasm		NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm		"HPA047857: AB_2680184"	"unprognostic (8.58e-3)"	"unprognostic (4.39e-2)"	"unprognostic (4.13e-2)"	"unprognostic (2.12e-1)"	"prognostic unfavorable (1.99e-4)"	"unprognostic (3.16e-1)"	"unprognostic (2.12e-2)"	"unprognostic (7.72e-2)"	"unprognostic (3.57e-1)"	"unprognostic (1.75e-2)"	"unprognostic (2.60e-1)"	"unprognostic (3.24e-1)"	"unprognostic (3.04e-3)"	"unprognostic (4.12e-1)"	"unprognostic (5.75e-2)"	"unprognostic (5.29e-2)"	"unprognostic (2.89e-1)"	26.7	29.0	0.2	6.6	0.2	3.6	21.7	0.4	0.3	20.8	0.3	44.5	3.5	17.4	42.7	24.0	33.6	5.2	11.7	0.2	0.2	47.5	5.0	15.6	7.2	14.9	0.9	3.4	3.7	19.6	0.4	2.4	10.9	13.7	2.4	0.0	0.8	12.0	9.9	8.9	17.3	5.3	12.1	16.4	16.5	3.4	0.3	4.2	6.7	7.8	2.0	11.1	18.7	10.7	0.3	1.9	54.5	0.1	12.1	14.0	0.2	5.1	0.0	0.1	0.0	0.7	0.4	0.0	52.2	15.3	0.0	0.0	8.2	0.0	0.1	0.2	59.1	21.4	2.7	0.0	21.3	0.0	116.8	8.9	0.0	23.3	9.2	0.5	8.6	0.2	42.3	0.1	31.9	0.1	0.1	0.1	0.0	1.3	0.2	0.0	26.9	0.1	38.9	4.9	0.0	0.0	4.0	0.0	34.3	3.8	28.9	0.0	0.3	0.0	3.5	0.6	0.1	0.0	0.1	0.1	20.8	0.0	52.6	3.9	0.3	0.0	3.0	0.4	1.0	0.2	4.6	3.4	1.5	0.5	6.8	2.9	0.0	1.8	0.3	4.8	6.1	1.0	0.2	0.2	0.4	0.3	0.2	0.2	14.9	0.9	10.9	12.1	0.3	10.7	27.9	3.2	1.1	0.0	4.9	7.0	7.3	0.5	53.5	0.0	18.5	18.7	2.5	0.0	2.0	53.3	0.0	15.9	26.9	1.0	156.5	1.4	0.5	69.2	9.9	21.4	2.4	21.9	0.0	0.2	30.2	19.4	0.0	42.4	21.0	0.0	31.1	0.3	7.6	0.0	0.0	1.6	24.4	10.4	21.2	1.7	0.0	11.4	12.4	2.8	7.5	0.0	58.7	0.0	0.1	0.1	1.7	0.0	3.7	8.8	0.1	26.1	0.9	0.0	0.0	9.6	31.6	7.4	6.6	36.6	5.7	24.9	28.6	0.1	0.9	28.0
HOXB3	"HOX2, HOX2G"	ENSG00000120093	"Homeobox B3"	P14651	17	48548870-48604912	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 70.5"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 26.6;Collecting duct cells: 99.3;Early spermatids: 37.9;Endometrial ciliated cells: 25.6;Glandular and luminal cells: 35.0;Hepatic stellate cells: 25.0"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	19	"medulla oblongata: 28.3;pons: 13.0;spinal cord: 24.5;white matter: 13.6"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 43.9;HEK 293: 47.4;RPTEC TERT1: 35.0;U-251 MG: 38.2"	"Region enriched"	"Detected in single"	39	"pons and medulla: 8.8"	"Group enriched"	"Detected in some"	22	"medulla oblongata: 10.1;pons: 3.9;spinal cord: 12.2"	"CAB009860, HPA064990"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm		"CAB009860: AB_2119262, HPA064990: AB_2685398"	"unprognostic (5.88e-2)"	"unprognostic (1.01e-1)"	"unprognostic (5.61e-2)"	"unprognostic (7.04e-2)"	"unprognostic (8.39e-3)"	"unprognostic (1.72e-1)"	"unprognostic (1.52e-1)"	"unprognostic (2.88e-2)"	"unprognostic (3.09e-2)"	"unprognostic (4.32e-3)"	"unprognostic (8.14e-2)"	"unprognostic (8.27e-2)"	"unprognostic (3.17e-1)"	"unprognostic (7.60e-2)"	"unprognostic (7.85e-2)"	"unprognostic (2.32e-1)"	"prognostic favorable (8.45e-6)"	22.7	11.3	0.2	7.8	0.1	1.8	19.3	0.2	0.2	23.3	0.3	43.6	6.5	13.6	70.5	13.5	38.5	7.6	5.2	0.3	0.1	38.7	4.1	12.6	4.8	28.3	1.0	1.6	4.8	20.0	0.2	4.2	13.0	9.3	11.8	0.0	0.6	25.4	10.6	7.7	27.5	9.4	24.5	15.7	17.7	10.3	0.4	1.3	4.8	8.2	1.2	11.3	10.2	13.6	6.6	13.9	10.1	4.6	8.7	12.1	2.5	0.2	0.0	0.2	0.2	6.2	43.9	3.5	34.0	30.1	4.4	0.3	2.0	0.7	0.1	10.6	47.4	10.9	7.0	0.0	13.4	0.0	27.3	12.3	0.0	13.3	0.7	6.5	13.8	13.2	14.8	0.4	8.4	0.2	0.7	0.3	0.2	14.3	1.3	0.0	7.0	1.4	35.0	6.7	0.0	0.1	1.5	0.0	7.8	7.5	13.9	3.0	15.1	4.5	13.6	2.5	38.2	3.5	4.5	0.4	9.5	0.0	8.6	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.2	0.0	0.3	0.2	0.6	0.2	0.1	0.2	0.1	0.2	0.2	0.3	0.1	28.3	1.0	13.0	24.5	0.4	13.6	26.6	0.0	1.9	0.0	0.5	2.5	3.0	0.0	11.4	0.0	5.9	2.7	1.8	1.5	0.7	99.3	0.0	3.2	2.0	11.4	7.9	0.2	37.9	25.6	4.3	13.6	2.4	0.8	0.0	0.0	0.8	8.1	0.0	35.0	8.8	0.0	25.0	0.4	0.7	0.0	0.0	7.5	0.0	1.6	4.2	12.9	0.3	0.8	5.4	0.0	0.3	0.0	6.2	0.0	0.0	0.4	7.7	0.4	0.4	3.2	7.6	0.9	0.0	0.0	0.0	4.8	6.2	6.1	11.7	13.9	1.4	0.4	2.0	0.0	9.5	7.0
HOXB4	"HOX2, HOX2F"	ENSG00000182742	"Homeobox B4"	P17483	17	48575507-48578350	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 19.6"	"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 28.5;Collecting duct cells: 64.4;Glandular and luminal cells: 25.1;Hepatic stellate cells: 24.3;NK-cells: 38.1"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	30	"medulla oblongata: 11.3;pons: 4.6;spinal cord: 9.1;white matter: 5.8"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"EFO-21: 63.7;HMC-1: 37.5;K-562: 33.7"	"Region enriched"	"Detected in single"	36	"pons and medulla: 3.5"	"Group enriched"	"Detected in some"	13	"medulla oblongata: 3.7;spinal cord: 4.7"	HPA057432	Uncertain		Supported	Nucleoplasm,Centrosome		NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 68: Epididymis - Unknown function"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm	Centrosome	"HPA057432: AB_2683437"	"unprognostic (2.71e-2)"	"unprognostic (3.87e-2)"	"unprognostic (8.97e-3)"	"unprognostic (5.39e-3)"	"unprognostic (1.14e-2)"	"unprognostic (1.66e-1)"	"unprognostic (2.65e-2)"	"unprognostic (1.59e-2)"	"unprognostic (2.14e-1)"	"prognostic unfavorable (2.23e-4)"	"unprognostic (3.22e-2)"	"unprognostic (1.14e-1)"	"unprognostic (3.41e-1)"	"unprognostic (2.10e-1)"	"unprognostic (4.85e-2)"	"unprognostic (9.25e-3)"	"unprognostic (3.41e-3)"	6.9	3.1	0.1	3.7	0.0	0.7	3.5	0.0	0.1	6.8	0.1	9.8	2.6	3.4	19.6	3.4	12.8	3.3	1.0	0.0	0.0	8.7	1.1	4.6	2.3	11.3	0.2	0.3	1.2	4.4	0.0	2.6	4.6	1.0	2.4	0.0	0.3	7.6	2.6	2.5	5.1	4.3	9.1	4.4	4.3	1.2	0.2	1.9	1.0	3.9	1.4	2.9	2.2	5.8	0.3	0.5	0.0	0.2	12.2	9.2	5.2	0.0	0.0	0.8	0.4	6.2	3.1	9.2	63.7	3.3	0.7	0.3	11.8	0.0	0.2	23.3	21.5	21.9	1.6	0.0	12.5	0.0	37.5	10.0	0.0	14.9	0.0	1.2	18.4	14.6	33.7	0.6	15.1	0.0	5.5	0.2	0.0	5.8	0.0	0.0	12.3	4.5	12.5	5.4	0.0	0.0	1.7	0.0	8.7	4.2	0.5	4.3	6.0	0.4	0.5	2.2	0.4	5.0	11.9	2.1	4.3	0.0	5.4	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.7	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	11.3	0.2	4.6	9.1	0.2	5.8	19.9	0.0	0.0	0.0	3.0	3.8	1.3	0.0	28.5	0.0	2.7	1.7	0.9	0.0	0.0	64.4	0.0	23.5	18.4	1.0	11.7	0.2	0.2	18.5	2.7	19.0	0.0	5.0	0.0	0.0	13.1	8.2	0.5	25.1	3.8	0.0	24.3	0.2	4.0	0.0	0.0	2.3	0.0	2.8	4.4	0.2	0.3	2.1	5.4	0.0	1.3	0.0	38.1	0.0	0.0	0.0	1.9	0.0	6.6	0.5	1.0	2.0	0.7	0.0	0.0	5.9	6.4	6.0	23.2	15.5	1.8	6.0	9.9	0.1	1.8	3.1
HOXB5	"HOX2, HOX2A"	ENSG00000120075	"Homeobox B5"	P09067	17	48591257-48593779	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 39.1;kidney: 32.5"	"Cell type enhanced"	"Detected in some"		"Collecting duct cells: 53.3;Distal tubular cells: 25.4;Endometrial ciliated cells: 48.8;Glandular and luminal cells: 46.0"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 28.1"	"Region enhanced"	"Detected in many"		"medulla oblongata: 39.1"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HEK 293: 28.8;HeLa: 8.7;RPTEC TERT1: 21.7"	"Region enriched"	"Detected in single"	230	"pons and medulla: 22.9"	"Group enriched"	"Detected in some"	9	"medulla oblongata: 19.3;spinal cord: 14.3"	"HPA043851, HPA074454"			Supported	"Nucleoplasm,Nucleoli fibrillar center,Cytosol"		NA	NA				"Cluster 68: Epididymis - Unknown function"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm	"Nucleoli fibrillar center, Cytosol"	"HPA043851: AB_2732509, HPA074454: AB_2686690"	"unprognostic (6.50e-2)"	"unprognostic (1.63e-1)"	"unprognostic (4.22e-2)"	"prognostic favorable (6.28e-4)"	"unprognostic (6.48e-3)"	"unprognostic (7.12e-2)"	"unprognostic (8.14e-2)"	"prognostic unfavorable (4.61e-4)"	"unprognostic (2.47e-1)"	"unprognostic (1.47e-3)"	"unprognostic (5.10e-2)"	"unprognostic (9.64e-2)"	"unprognostic (7.61e-3)"	"unprognostic (8.08e-3)"	"unprognostic (1.35e-1)"	"unprognostic (2.86e-2)"	"prognostic favorable (8.59e-5)"	4.8	3.9	0.1	2.5	0.0	0.1	1.8	0.0	0.1	6.2	0.0	16.6	1.7	2.3	18.4	0.2	7.4	0.2	0.1	0.1	0.0	32.5	0.6	5.9	0.1	39.1	0.3	0.2	0.7	1.0	0.0	1.2	10.9	1.1	4.9	0.0	0.0	6.9	0.4	0.8	12.2	1.9	24.8	2.6	4.9	0.8	0.0	0.0	0.5	0.2	0.0	2.8	1.5	9.0	2.6	6.5	0.0	3.2	3.2	3.5	0.0	0.0	0.0	0.0	0.0	0.1	3.5	0.0	6.5	3.7	0.7	0.0	0.3	0.0	0.0	0.0	28.8	1.3	8.7	0.0	5.5	0.0	1.4	1.8	0.0	3.9	0.0	1.1	2.0	0.2	2.1	0.0	4.4	0.0	0.0	0.0	0.0	3.6	2.3	0.0	1.2	0.0	21.7	2.2	0.0	0.0	0.2	0.0	3.3	0.1	0.6	0.0	6.5	0.9	2.6	0.7	0.4	0.0	0.0	0.0	0.2	0.0	4.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	39.1	0.3	10.9	24.8	0.0	9.0	4.9	0.0	1.1	0.0	0.0	0.9	0.2	0.0	1.2	0.0	0.3	0.3	0.4	0.0	0.0	53.3	0.0	0.0	0.1	13.5	25.4	0.0	0.9	48.8	4.1	6.6	4.2	2.7	0.0	0.0	0.0	3.8	1.1	46.0	0.0	0.0	8.2	0.0	0.7	0.0	0.0	11.4	0.0	4.2	0.8	0.5	0.0	0.5	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.5	0.4	0.0	0.1	7.0	0.5	0.0	0.0	0.0	0.2	4.9	8.6	11.0	0.3	0.3	0.0	0.6	0.0	11.3	0.1
HOXB6	"HOX2, HOX2B"	ENSG00000108511	"Homeobox B6"	P17509	17	48595751-48604992	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 40.3;kidney: 60.2"	"Group enriched"	"Detected in many"	4	"Collecting duct cells: 136.1;Distal tubular cells: 113.5;Endometrial ciliated cells: 80.7;Glandular and luminal cells: 56.4"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 32.7"	"Group enriched"	"Detected in some"	17	"medulla oblongata: 12.9;spinal cord: 22.6;white matter: 6.3"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"EFO-21: 28.2;HEK 293: 80.3;RPTEC TERT1: 53.2;TIME: 30.1"	"Region enriched"	"Detected in single"	102	"pons and medulla: 10.1"	"Group enriched"	"Detected in some"	168	"medulla oblongata: 8.1;spinal cord: 25.4"	HPA042063			Supported	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm	"Golgi apparatus"	"HPA042063: AB_10796470"	"unprognostic (5.01e-2)"	"unprognostic (4.48e-2)"	"unprognostic (1.99e-1)"	"prognostic favorable (2.46e-4)"	"unprognostic (1.30e-1)"	"unprognostic (8.80e-3)"	"unprognostic (5.64e-2)"	"unprognostic (2.06e-3)"	"unprognostic (3.97e-2)"	"unprognostic (1.84e-2)"	"unprognostic (6.97e-2)"	"unprognostic (6.64e-2)"	"unprognostic (2.50e-3)"	"unprognostic (2.53e-3)"	"unprognostic (5.76e-2)"	"unprognostic (7.11e-2)"	"unprognostic (4.19e-3)"	10.2	7.4	0.2	4.4	0.1	0.2	4.6	0.3	0.2	18.3	0.0	16.1	1.0	4.3	40.3	0.3	13.4	0.3	0.7	0.1	0.0	60.2	0.8	6.2	0.4	12.9	0.0	0.3	1.2	1.3	0.1	2.6	0.8	2.0	6.1	0.0	0.2	21.1	1.7	1.2	14.0	2.3	22.6	3.0	9.3	1.1	0.1	0.0	0.7	0.5	0.0	3.8	2.2	6.3	5.2	11.9	0.0	6.2	5.3	5.5	0.1	0.0	0.0	0.0	0.0	6.5	7.7	0.0	28.2	14.2	2.0	0.1	1.4	0.4	0.0	0.2	80.3	7.1	23.8	0.0	7.9	0.6	18.0	6.9	0.2	11.4	0.2	4.3	5.4	0.5	4.7	0.1	15.7	0.3	0.0	0.3	0.0	20.0	4.7	0.0	13.1	0.7	53.2	2.6	0.0	0.0	4.4	0.0	8.2	0.1	2.1	2.5	30.1	1.0	6.0	5.0	22.2	0.0	0.0	0.1	0.9	0.0	9.7	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.1	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.3	0.2	0.1	0.0	12.9	0.0	0.8	22.6	0.1	6.3	10.6	0.0	0.0	0.0	0.4	0.8	0.5	0.0	0.0	0.0	0.4	0.5	0.4	0.0	0.0	136.1	0.0	0.2	0.0	18.1	113.5	0.1	1.0	80.7	5.5	10.6	7.7	0.4	0.0	2.0	2.9	3.0	0.0	56.4	0.0	0.0	4.2	0.0	1.7	0.0	0.0	9.0	0.0	18.6	3.1	0.3	0.9	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	20.8	0.0	0.0	0.6	9.5	2.8	0.0	0.0	0.0	0.9	6.4	4.8	6.2	0.0	1.1	0.3	1.2	0.0	11.0	1.2
HOXB7	"HOX2, HOX2C"	ENSG00000260027	"Homeobox B7"	P09629	17	48607232-48633572	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"epididymis: 135.1"	"Cell type enhanced"	"Detected in many"		"Collecting duct cells: 86.5;Distal enterocytes: 131.3;Distal tubular cells: 148.7;Endometrial ciliated cells: 82.9;Glandular and luminal cells: 73.1;Intestinal goblet cells: 77.6;Paneth cells: 67.8;Proximal enterocytes: 140.3;Undifferentiated cells: 63.1"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	8	"medulla oblongata: 5.6;spinal cord: 13.3;white matter: 7.5"	"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"EFO-21: 81.9;OE19: 74.7;RPTEC TERT1: 66.5;SK-MEL-30: 84.3"	"Region enriched"	"Detected in single"	58	"pons and medulla: 5.7"	"Region enriched"	"Detected in some"	7	"spinal cord: 22.2"	HPA049940	Uncertain		Supported	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 30: Epididymis - Antimicrobial activity"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Nucleoplasm, Nuclear bodies"	Cytosol	"HPA049940: AB_2616461"	"unprognostic (6.76e-2)"	"unprognostic (6.76e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.39e-3)"	"unprognostic (1.42e-2)"	"unprognostic (1.69e-2)"	"unprognostic (8.05e-3)"	"unprognostic (9.16e-2)"	"unprognostic (9.91e-2)"	"unprognostic (7.01e-3)"	"unprognostic (7.81e-3)"	"unprognostic (1.17e-2)"	"unprognostic (1.56e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.41e-1)"	"prognostic favorable (2.39e-4)"	13.2	11.0	0.1	3.9	0.1	0.2	12.4	0.0	0.3	21.8	0.1	16.9	1.1	5.2	135.1	0.4	8.7	0.7	0.3	0.1	0.1	30.4	0.4	2.2	2.7	5.6	0.1	0.5	0.8	5.5	0.1	5.8	1.1	2.4	15.9	0.0	0.2	16.9	1.7	3.3	18.1	6.7	13.3	3.0	5.9	1.9	0.3	0.2	0.4	0.2	0.9	7.7	5.5	7.5	48.1	20.6	0.0	0.5	14.2	21.1	0.0	0.0	0.0	0.2	0.8	31.9	0.9	0.9	81.9	19.9	23.9	6.9	0.1	0.0	0.0	22.3	15.1	7.4	15.4	0.0	11.7	0.0	14.8	13.8	6.3	14.2	0.0	3.5	43.8	14.7	8.0	0.3	46.0	12.5	1.0	0.4	0.0	74.7	0.1	0.0	39.2	5.5	66.5	15.8	0.0	0.1	16.0	0.0	84.3	1.1	3.8	4.7	38.1	0.0	24.8	20.5	36.9	2.6	6.3	0.1	0.4	0.0	58.6	0.0	0.0	0.0	1.5	0.0	0.8	0.7	0.2	0.8	0.0	1.4	0.0	0.5	0.0	1.0	0.0	0.7	2.1	0.2	0.1	0.1	0.0	0.3	0.1	0.1	5.6	0.1	1.1	13.3	0.3	7.5	55.4	0.0	0.0	0.0	2.0	5.5	0.9	0.0	0.6	0.0	0.9	1.0	0.3	0.0	0.0	86.5	0.0	6.8	1.6	131.3	148.7	0.1	0.3	82.9	6.3	20.3	36.5	1.3	0.0	1.3	19.3	6.4	0.0	73.1	5.1	0.0	1.4	0.2	11.5	0.0	0.0	77.6	0.0	10.6	5.4	0.2	0.6	2.8	24.9	0.0	1.7	0.0	2.1	0.0	0.0	0.3	67.8	0.0	5.1	0.6	140.3	31.6	0.0	0.0	0.0	3.5	8.9	1.7	20.9	0.2	2.0	1.8	2.6	0.1	63.1	3.5
HOXB8	"HOX2, HOX2D"	ENSG00000120068	"Homeobox B8"	P17481	17	48611377-48615292	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 114.1;epididymis: 48.1;kidney: 37.6"	"Cell type enhanced"	"Detected in some"		"Collecting duct cells: 88.3;Distal tubular cells: 72.4;Endometrial ciliated cells: 21.3;Enteroendocrine cells: 44.1;Glandular and luminal cells: 26.6"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 33.3"	"Region enhanced"	"Detected in many"		"spinal cord: 114.1"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 34.0;HDLM-2: 17.2;HEK 293: 36.9;LHCN-M2: 17.3;RPTEC TERT1: 35.3"	"Region enriched"	"Detected in single"	65	"pons and medulla: 6.5"	"Region enriched"	"Detected in all"	5	"spinal cord: 51.2"	HPA075905			Supported	Nucleoplasm		NA	NA				"Cluster 68: Epididymis - Unknown function"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm		"HPA075905: AB_2686767"	"unprognostic (4.44e-1)"	"unprognostic (2.60e-1)"	"unprognostic (1.01e-1)"	"unprognostic (2.13e-1)"	"unprognostic (1.94e-2)"	"unprognostic (9.07e-5)"	"unprognostic (6.63e-3)"	"unprognostic (1.40e-3)"	"unprognostic (6.00e-2)"	"unprognostic (5.66e-3)"	"unprognostic (2.93e-2)"	"unprognostic (1.14e-2)"	"prognostic favorable (1.30e-7)"	"unprognostic (1.77e-2)"	"unprognostic (6.64e-2)"	"unprognostic (4.57e-2)"	"unprognostic (2.88e-3)"	7.2	7.2	0.1	1.5	0.0	0.0	2.7	0.0	0.0	10.7	0.0	4.7	0.0	2.8	48.1	0.0	1.4	0.0	0.0	0.0	0.0	37.6	0.0	0.4	0.0	36.4	0.0	0.1	0.1	0.8	0.1	0.3	1.8	1.0	1.2	0.0	0.0	20.8	0.4	0.5	7.1	1.5	114.1	0.1	6.6	1.0	0.0	0.0	0.1	0.0	0.0	3.7	0.7	20.8	2.1	5.3	0.0	0.8	0.7	1.0	0.8	0.0	0.0	0.0	0.0	0.3	0.8	0.0	34.0	5.3	0.6	0.0	0.1	0.0	0.0	17.2	36.9	1.0	0.1	0.0	0.3	0.0	5.5	1.1	0.0	0.1	0.0	0.7	2.1	0.2	11.6	0.0	17.3	0.0	0.0	0.4	0.0	11.3	0.0	0.0	3.6	0.1	35.3	1.0	0.0	0.1	0.6	0.0	5.4	0.1	0.4	0.0	8.8	0.0	1.6	0.1	0.7	0.0	0.0	0.0	0.1	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	36.4	0.0	1.8	114.1	0.0	20.8	4.9	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.1	0.4	1.0	0.0	0.0	88.3	0.0	0.0	0.1	1.8	72.4	0.0	0.3	21.3	2.1	2.6	44.1	0.0	0.0	0.0	0.8	0.3	0.0	26.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	4.2	0.0	0.0	0.7	0.8	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.4	0.0	0.2	2.7	8.9	0.0	0.0	0.0	0.1	0.8	2.3	9.2	0.0	0.0	0.0	0.3	0.0	5.0	0.0
HOXB9	"HOX2, HOX2E"	ENSG00000170689	"Homeobox B9"	P17482	17	48621156-48626358	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"epididymis: 87.9;intestine: 26.3;kidney: 22.9"	"Cell type enhanced"	"Detected in some"		"Collecting duct cells: 58.8;Distal enterocytes: 30.4;Distal tubular cells: 39.2;Enteroendocrine cells: 176.7;Intestinal goblet cells: 40.7;Undifferentiated cells: 45.5"	"Group enriched"	"Detected in many"	5	"colorectal cancer: 56.0;endometrial cancer: 26.4"	"Region enhanced"	"Detected in single"		"spinal cord: 2.9"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 339.3;HEK 293: 126.4;HMC-1: 127.7;K-562: 145.7"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	69	"spinal cord: 6.8"	HPA004928			Supported	Nucleoplasm		NA	No				"Cluster 30: Epididymis - Antimicrobial activity"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 17: Intestinal endocrine cells - Hormone signaling"	Nucleoplasm		"HPA004928: "	"unprognostic (2.16e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.57e-1)"	"prognostic unfavorable (4.47e-4)"	"unprognostic (1.38e-4)"	"prognostic unfavorable (6.64e-5)"	"unprognostic (3.15e-2)"	"unprognostic (1.60e-3)"	"unprognostic (6.30e-3)"	"unprognostic (3.41e-2)"	"unprognostic (5.94e-3)"	"unprognostic (1.04e-1)"	"unprognostic (2.28e-3)"	"unprognostic (1.43e-1)"	"unprognostic (5.34e-2)"	"unprognostic (1.85e-1)"	"unprognostic (6.00e-2)"	0.5	1.0	0.0	4.6	0.0	0.0	0.5	0.0	0.0	11.4	0.0	26.3	0.0	0.9	87.9	0.0	0.3	0.0	0.0	0.0	0.0	22.9	0.0	0.0	0.2	0.1	0.0	0.0	0.0	2.2	0.0	0.6	0.0	0.4	22.3	0.0	0.0	15.8	0.1	0.1	13.4	1.3	2.9	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	2.6	0.3	0.7	18.0	5.8	0.0	32.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	12.6	7.0	0.1	34.6	0.9	3.9	0.1	5.5	0.0	0.0	339.3	126.4	59.1	2.3	0.0	2.3	1.1	127.7	0.1	0.2	0.1	3.3	9.8	0.0	2.7	145.7	0.1	5.5	0.3	0.0	0.4	0.0	8.0	5.4	0.3	21.9	1.9	57.1	0.2	0.0	0.0	4.4	0.0	37.4	0.5	0.6	0.3	0.4	0.1	32.1	0.2	10.4	0.2	0.4	0.2	0.1	0.1	6.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.9	0.0	0.7	3.2	0.0	0.0	0.0	0.2	0.1	0.2	0.0	0.0	0.0	0.3	0.1	0.2	0.0	0.0	58.8	0.0	0.0	0.5	30.4	39.2	0.0	0.1	5.5	0.4	3.0	176.7	0.0	0.0	0.0	0.0	0.1	0.0	4.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	40.7	0.0	0.0	0.7	0.3	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	13.3	0.0	0.0	0.3	6.0	0.9	0.0	0.0	0.0	0.0	0.3	0.5	1.2	0.0	0.0	0.0	0.4	0.0	45.5	0.2
HOXC10	HOX3I	ENSG00000180818	"Homeobox C10"	Q9NYD6	12	53985065-53990279	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"skeletal muscle: 113.5"	"Cell type enhanced"	"Detected in some"		"Basal keratinocytes: 21.2;Collecting duct cells: 16.5;Distal tubular cells: 62.6;Proximal tubular cells: 100.4;Skeletal myocytes: 22.4;Suprabasal keratinocytes: 19.2"	"Cancer enhanced"	"Detected in many"		"renal cancer: 20.2"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 291.5;ASC diff: 82.5;ASC TERT1: 75.6;fHDF/TERT166: 67.6;T-47d: 99.4"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	319	"spinal cord: 31.8"	HPA053919	Uncertain		Supported	"Nucleoplasm,Nuclear bodies"		NA	NA				"Cluster 33: Striated muscle - Muscle contraction"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Nuclear bodies"	Nucleoplasm	"HPA053919: AB_2682308"	"unprognostic (1.44e-2)"	"unprognostic (1.09e-1)"	"unprognostic (4.56e-4)"	"unprognostic (1.57e-1)"	"unprognostic (1.59e-3)"	"unprognostic (1.98e-1)"		"unprognostic (1.73e-2)"	"unprognostic (1.23e-1)"	"unprognostic (9.60e-3)"	"unprognostic (3.96e-2)"	"unprognostic (7.37e-3)"	"unprognostic (2.25e-2)"	"unprognostic (3.56e-2)"	"unprognostic (5.07e-2)"	"unprognostic (5.24e-3)"	"unprognostic (1.91e-1)"	13.1	1.1	0.0	0.2	0.0	0.0	1.9	0.0	0.0	0.7	0.0	0.2	0.0	1.5	0.0	0.1	8.8	0.0	0.0	0.0	0.0	22.5	0.0	0.0	1.6	0.0	0.0	1.8	0.0	0.0	0.0	0.5	0.0	0.7	0.0	0.0	0.0	0.5	113.5	16.4	2.1	0.8	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.7	1.2	0.1	0.7	3.3	0.0	291.5	82.5	75.6	0.5	10.1	24.4	13.6	12.6	0.6	0.9	0.5	2.7	67.6	1.9	31.4	4.1	0.0	6.5	15.2	5.6	3.0	36.2	0.0	0.4	0.0	3.7	36.0	0.5	1.0	0.0	0.0	0.1	8.5	2.3	0.0	9.4	1.8	0.1	7.5	0.1	36.4	1.1	0.0	0.4	0.0	30.6	0.0	0.0	3.9	6.9	10.0	15.7	0.4	99.4	2.2	0.0	8.0	10.2	0.2	13.3	1.3	0.2	0.1	0.1	1.7	22.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.9	0.0	0.0	0.0	1.0	21.2	0.0	0.0	0.0	0.0	4.8	7.9	0.3	0.0	0.0	16.5	0.0	0.0	0.1	0.0	62.6	0.0	0.2	0.0	0.8	0.7	0.0	0.0	0.0	0.0	0.0	10.2	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	7.2	0.4	0.6	0.9	14.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	100.4	0.0	0.0	0.0	22.4	5.2	3.6	4.4	0.0	19.2	0.1	0.4	0.0	0.0	0.0
HOXC11	HOX3H	ENSG00000123388	"Homeobox C11"	O43248	12	53973126-53977643	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"skeletal muscle: 1.8;skin 1: 5.0"	"Cell type enhanced"	"Detected in some"		"Basal keratinocytes: 7.5;Distal tubular cells: 1.9;Melanocytes: 3.6;Proximal enterocytes: 3.7;Spermatocytes: 3.5;Suprabasal keratinocytes: 3.8"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 34.7;BJ hTERT+: 17.5;HaCaT: 15.4;HeLa: 12.4;T-47d: 27.4"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	13	"spinal cord: 1.3"	HPA038291	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA				"Cluster 31: Skin - Epidermis development"	"Cluster 6: T47d - Mammary gland"	"Cluster 48: Smooth muscle cells - ECM organization"	Nucleoplasm	Cytosol	"HPA038291: AB_10674552"	"unprognostic (1.50e-3)"	"unprognostic (1.93e-2)"	"unprognostic (1.14e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.93e-3)"	"unprognostic (1.17e-2)"		"unprognostic (6.90e-3)"	"unprognostic (1.32e-2)"	"unprognostic (7.41e-3)"	"unprognostic (4.46e-3)"	"unprognostic (2.25e-1)"	"unprognostic (3.26e-3)"	"unprognostic (3.99e-2)"	"unprognostic (1.06e-1)"		"unprognostic (1.82e-1)"	1.6	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.3	0.4	0.0	0.0	0.4	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.6	1.8	5.0	1.0	0.1	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.0	9.3	1.1	0.0	34.7	3.2	4.9	0.0	5.1	17.5	7.4	5.3	0.3	1.3	0.0	0.3	4.8	0.0	15.4	6.6	0.0	3.3	1.0	0.1	0.2	12.4	0.0	0.0	0.1	0.1	0.9	1.4	0.0	0.4	0.0	0.0	0.3	1.5	0.0	4.8	2.2	0.0	0.1	0.0	10.1	0.1	0.0	0.6	0.0	0.7	1.2	0.0	0.2	3.2	7.8	3.1	0.3	27.4	0.0	0.0	0.0	5.8	0.4	0.3	0.0	0.0	0.0	0.0	0.6	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.5	0.0	0.0	0.0	0.0	0.7	0.3	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.2	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	1.6	0.0	0.3	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.9	0.0	0.0	0.0	1.0	1.0	3.5	0.9	0.0	3.8	0.0	0.1	0.0	0.2	0.0
HOXC4	"HOX3, HOX3E"	ENSG00000198353	"Homeobox C4"	P09017	12	54016931-54056030	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 27.0"	"Cell type enhanced"	"Detected in some"		"Basal squamous epithelial cells: 9.1;Endometrial ciliated cells: 12.3;Granulosa cells: 10.5;Sertoli cells: 6.6;Squamous epithelial cells: 8.2"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 12.4"	"Region enhanced"	"Detected in many"		"medulla oblongata: 16.7;pons: 16.2"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 23.8;HDLM-2: 31.2;HEK 293: 33.0;SH-SY5Y: 27.3"	"Region enriched"	"Detected in single"	24	"pons and medulla: 9.4"	"Group enriched"	"Detected in some"	49	"medulla oblongata: 4.9;pons: 3.7;spinal cord: 6.0"	HPA053910			Supported	Nucleoplasm		NA	NA				"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 40: Granulosa cells - Unknown function"	Nucleoplasm		"HPA053910: AB_2682305"	"unprognostic (2.78e-2)"	"unprognostic (8.51e-2)"	"unprognostic (2.96e-6)"	"unprognostic (3.30e-2)"	"unprognostic (6.27e-2)"	"unprognostic (1.81e-2)"	"unprognostic (1.24e-1)"	"unprognostic (6.63e-3)"	"unprognostic (6.42e-2)"	"unprognostic (1.42e-1)"	"unprognostic (8.83e-3)"	"unprognostic (4.37e-2)"	"unprognostic (7.81e-2)"	"unprognostic (8.43e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.11e-4)"	"unprognostic (9.82e-2)"	8.6	4.5	0.1	2.1	0.1	0.1	5.2	0.1	0.2	1.0	0.1	2.1	1.1	4.7	7.2	8.1	27.0	0.4	0.5	0.2	0.2	13.5	0.1	0.8	3.6	16.7	1.1	11.1	0.3	0.1	0.1	6.3	16.2	1.6	0.2	0.0	0.3	0.9	9.1	6.2	6.8	4.8	6.4	1.8	5.2	3.3	0.3	0.4	1.0	0.0	1.9	0.7	0.8	3.7	5.3	5.1	0.0	23.8	9.4	4.9	0.0	2.4	2.5	2.4	1.7	0.2	4.3	20.5	0.2	18.5	0.1	4.7	0.4	0.6	1.5	31.2	33.0	0.2	2.9	0.0	1.1	2.5	0.7	12.5	2.3	13.7	2.4	0.0	0.3	6.7	1.1	0.0	8.9	0.3	2.8	0.5	0.1	0.9	0.1	6.7	7.2	0.0	10.2	0.0	0.0	27.3	3.8	1.2	13.7	1.1	18.0	1.2	0.0	12.0	6.9	1.0	12.8	5.3	6.0	10.6	0.7	2.3	12.8	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.2	0.2	0.2	16.7	1.1	16.2	6.4	0.3	3.7	1.1	0.0	0.0	0.0	2.5	0.0	0.0	0.0	9.1	0.0	1.4	3.4	0.5	0.0	0.0	0.0	0.0	0.1	3.9	0.0	1.9	0.0	4.1	12.3	0.3	0.1	0.0	0.0	0.0	0.0	0.0	3.3	2.6	0.1	0.0	10.5	0.0	0.0	0.2	0.0	0.0	0.4	0.0	0.8	0.0	2.9	3.1	0.2	0.0	0.0	0.3	0.0	2.1	0.0	0.0	0.1	0.0	1.5	3.7	0.0	0.1	2.9	0.0	0.0	6.6	3.9	3.6	2.7	0.5	8.2	0.0	0.3	1.6	2.7	0.1	0.0
HOXC5	"HOX3, HOX3D"	ENSG00000172789	"Homeobox C5"	Q00444	12	54033050-54035361	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 3.6;fallopian tube: 4.1"	"Cell type enhanced"	"Detected in some"		"Basal squamous epithelial cells: 5.2;Fibroblasts: 2.6;Granulosa cells: 2.5;Leydig cells: 2.5;Peritubular cells: 2.6;Skeletal myocytes: 2.6;Smooth muscle cells: 2.5;Spermatocytes: 3.2;Squamous epithelial cells: 2.2"	"Cancer enhanced"	"Detected in single"		"ovarian cancer: 0.7"	"Group enriched"	"Detected in many"	15	"medulla oblongata: 3.4;pons: 3.6;spinal cord: 1.9;white matter: 1.2"	"Immune cell enhanced"	"Detected in single"		"gdT-cell: 3.0"	"Lineage enriched"	"Detected in single"	31	"T-cells: 3.0"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 7.1;ASC TERT1: 4.8;HSkMC: 4.5;SH-SY5Y: 7.6"	"Region enriched"	"Detected in single"	46	"pons and medulla: 4.6"	"Group enriched"	"Detected in some"	5	"medulla oblongata: 1.5;spinal cord: 2.1"	HPA026794	Uncertain		Supported	"Nucleoplasm,Cell Junctions"		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 68: Epididymis - Unknown function"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 50: Fibroblasts - ECM organization"	Nucleoplasm	"Cell Junctions"	"HPA026794: AB_10612118"	"unprognostic (1.57e-1)"	"unprognostic (7.73e-3)"		"unprognostic (1.70e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.16e-3)"		"unprognostic (2.87e-3)"	"unprognostic (6.89e-2)"	"unprognostic (9.53e-3)"	"unprognostic (1.86e-2)"	"unprognostic (2.69e-2)"	"unprognostic (2.01e-3)"	"unprognostic (1.17e-2)"	"unprognostic (7.53e-3)"	"unprognostic (2.19e-3)"	"unprognostic (1.08e-2)"	1.0	0.9	0.0	0.1	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.2	0.2	0.3	2.7	0.9	4.1	0.1	0.0	0.0	0.0	0.9	0.0	0.1	0.2	3.4	0.1	2.6	0.0	0.0	0.0	0.8	3.6	0.0	0.0	0.0	0.0	0.2	1.2	1.1	0.7	1.5	1.9	0.0	2.1	1.4	0.0	0.0	0.2	0.0	0.0	0.1	0.1	1.2	0.8	1.9	0.0	7.1	4.0	4.8	0.0	0.4	0.3	0.8	0.6	3.0	0.4	0.0	0.5	2.1	0.0	1.1	0.1	0.0	0.3	2.4	2.4	0.0	1.0	0.1	0.1	0.0	0.1	4.5	0.4	3.3	0.4	0.0	0.0	0.0	0.0	0.0	1.5	1.1	0.0	0.1	0.0	1.3	0.2	0.0	0.0	0.0	1.0	0.0	0.0	7.6	0.5	0.2	3.9	0.9	1.4	0.0	0.0	1.2	0.7	2.6	0.2	0.0	0.0	0.0	0.1	0.1	2.8	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.1	3.6	1.9	0.0	1.2	0.5	0.0	0.0	0.0	0.0	0.9	0.0	0.0	5.2	0.0	0.3	0.9	0.1	0.0	0.0	1.8	0.0	0.1	0.8	0.0	1.9	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.1	2.6	0.0	0.0	0.0	2.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	2.5	0.1	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	1.5	0.0	0.0	0.0	2.6	2.5	3.2	1.0	2.2	0.9	0.3	0.1	1.0	0.1	0.0
HOXC6	"HOX3, HOX3C"	ENSG00000197757	"Homeobox C6"	P09630	12	53990624-54030823	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 27.1;ovary: 26.2"	"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 17.6;Fibroblasts: 14.0;Granulosa cells: 13.2;Leydig cells: 22.4;Peritubular cells: 15.1;Skeletal myocytes: 13.5;Spermatocytes: 34.0"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	15	"medulla oblongata: 4.1;pons: 4.3;spinal cord: 3.1;white matter: 1.5"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 94.4;fHDF/TERT166: 47.9;HDLM-2: 80.6"	"Region enriched"	"Detected in single"	14	"pons and medulla: 1.4"	"Region enriched"	"Detected in single"	32	"spinal cord: 9.7"	HPA054981			Supported	Nucleoplasm,Cytosol		No	No				"Cluster 89: Fibroblasts - ECM organization"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 33: Fibroblasts - ECM organization"	Nucleoplasm	Cytosol	"HPA054981: AB_2682662"	"unprognostic (3.54e-2)"	"unprognostic (9.20e-2)"	"unprognostic (1.68e-6)"	"unprognostic (3.92e-2)"	"unprognostic (1.10e-3)"	"unprognostic (5.01e-4)"	"unprognostic (5.52e-3)"	"unprognostic (3.32e-3)"	"unprognostic (2.81e-1)"	"unprognostic (6.26e-2)"	"unprognostic (8.82e-2)"	"unprognostic (3.70e-3)"	"prognostic unfavorable (3.55e-6)"	"unprognostic (8.63e-2)"	"unprognostic (5.76e-2)"	"unprognostic (1.40e-2)"	"unprognostic (4.71e-2)"	18.9	14.8	0.0	1.1	0.0	0.0	13.4	0.0	0.1	1.1	0.0	1.0	0.3	5.3	19.3	2.9	27.1	0.1	0.6	0.0	0.1	17.8	0.0	0.7	4.3	4.1	0.2	26.2	0.4	0.3	0.0	5.7	4.3	1.3	0.2	0.5	0.2	0.5	17.3	13.3	11.4	8.8	3.1	0.2	0.7	3.5	0.1	0.1	1.0	0.0	0.0	1.3	1.5	1.5	6.6	4.5	0.0	94.4	34.1	32.0	1.0	4.9	4.7	7.9	7.1	4.1	7.4	3.0	6.3	47.9	2.3	10.7	3.8	0.5	6.7	80.6	27.3	5.2	14.6	0.0	3.8	0.5	12.0	30.7	5.0	15.7	5.6	0.0	0.3	0.3	3.5	0.0	27.4	1.5	0.0	3.3	0.0	0.8	4.1	0.0	3.6	0.0	24.1	0.2	0.0	11.8	7.3	7.0	21.7	8.2	16.6	1.3	0.0	9.7	21.1	10.7	7.0	0.7	0.9	0.2	3.7	0.8	20.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	4.1	0.2	4.3	3.1	0.1	1.5	3.9	0.0	0.0	0.0	0.3	6.2	0.0	0.0	9.1	0.0	3.2	5.8	0.6	0.0	0.0	3.7	0.0	0.4	0.2	0.0	17.6	0.0	1.6	0.0	0.6	1.1	0.0	0.0	0.0	0.0	3.0	14.0	0.0	0.0	0.0	13.2	0.0	0.0	0.9	0.0	0.0	2.3	0.0	0.0	1.8	1.0	22.4	0.4	12.4	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	15.1	0.1	0.0	0.8	9.6	0.0	2.1	6.6	13.5	11.8	34.0	2.7	5.1	4.0	0.3	0.4	7.4	0.2	0.0
HOXC8	"HOX3, HOX3A"	ENSG00000037965	"Homeobox C8"	P31273	12	54008985-54012769	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 15.4;skeletal muscle: 16.8"	"Cell type enhanced"	"Detected in some"		"Fibroblasts: 12.2;Granulosa cells: 11.0;Melanocytes: 10.6;Peritubular cells: 7.9;Proximal tubular cells: 7.4;Skeletal myocytes: 17.9;Smooth muscle cells: 7.6"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 41.6;ASC TERT1: 27.6;fHDF/TERT166: 49.8;HSkMC: 33.2;LHCN-M2: 38.7"	"Not detected"	"Not detected"			"Region enriched"	"Detected in many"	5	"spinal cord: 10.5"	"HPA028911, CAB037020"	Uncertain		Supported	Nucleoplasm,Microtubules		NA	NA				"Cluster 52: Non-specific - Ribosome"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 33: Fibroblasts - ECM organization"	Nucleoplasm	Microtubules	"CAB037020: AB_1840935, HPA028911: AB_10602236"	"unprognostic (1.03e-1)"	"unprognostic (5.90e-2)"	"unprognostic (6.26e-6)"	"unprognostic (4.89e-2)"	"unprognostic (5.20e-4)"	"unprognostic (5.34e-3)"		"unprognostic (2.43e-3)"	"unprognostic (1.28e-1)"	"unprognostic (3.61e-2)"	"unprognostic (1.45e-2)"	"unprognostic (3.52e-2)"	"prognostic unfavorable (1.47e-5)"	"unprognostic (2.47e-1)"	"unprognostic (1.84e-2)"	"unprognostic (4.68e-2)"	"unprognostic (1.14e-2)"	5.2	5.2	0.0	0.7	0.0	0.0	5.6	0.0	0.0	0.4	0.0	0.4	0.0	0.4	15.4	0.2	7.9	0.0	0.0	0.0	0.0	4.9	0.0	0.1	1.8	0.1	0.0	4.5	0.0	0.0	0.0	2.0	0.0	0.3	0.0	0.3	0.0	0.1	16.8	3.1	5.7	7.6	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.4	0.4	0.0	1.0	2.7	0.0	15.0	41.6	27.6	0.2	2.8	0.1	4.9	3.1	4.4	2.4	0.0	0.3	49.8	0.8	2.0	3.9	1.2	5.4	5.3	5.3	0.9	2.1	0.0	4.9	0.0	5.8	33.2	3.9	15.7	9.0	0.5	0.4	0.8	0.6	0.0	38.7	1.2	0.0	0.4	0.0	0.3	0.7	0.0	0.0	0.0	6.1	0.0	0.0	2.0	5.4	1.0	13.8	3.6	1.6	0.0	0.0	1.0	8.0	6.8	1.7	0.1	0.0	0.0	0.9	0.0	9.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	4.6	0.1	0.0	1.2	0.0	1.5	2.9	0.3	0.0	0.0	1.8	0.0	0.0	0.0	0.2	1.9	0.0	0.1	0.0	0.1	0.8	0.0	0.0	0.0	0.0	0.2	12.2	0.0	0.0	0.0	11.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	3.9	0.2	6.2	0.2	10.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.9	0.0	0.1	0.3	7.4	0.0	1.3	6.6	17.9	7.6	5.6	3.1	0.2	4.3	0.3	0.3	3.2	0.1	0.1
HOXD11	"HOX4, HOX4F"	ENSG00000128713	"Homeobox D11"	P31277	2	176104216-176109754	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"endometrium 1: 7.1;intestine: 3.8;kidney: 4.7;prostate: 3.3;vagina: 4.3"	"Cell type enhanced"	"Detected in some"		"Basal prostatic cells: 26.7;Collecting duct cells: 22.0;Distal enterocytes: 22.8;Endometrial stromal cells: 29.0;Enteroendocrine cells: 20.6;Urothelial cells: 14.0"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEK 293: 21.9;RPTEC TERT1: 2.6;SCLC-21H: 6.1;U-251 MG: 4.4"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	40	"spinal cord: 3.9"	HPA055155			Supported	Nucleoplasm		NA	NA				"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm		"HPA055155: AB_2682719"	"unprognostic (1.99e-1)"	"unprognostic (1.48e-1)"	"unprognostic (2.32e-2)"	"unprognostic (9.05e-2)"	"unprognostic (1.85e-3)"	"unprognostic (2.48e-1)"		"unprognostic (1.93e-2)"	"unprognostic (2.13e-2)"	"unprognostic (6.73e-2)"		"unprognostic (5.00e-2)"	"unprognostic (2.11e-8)"	"unprognostic (2.09e-3)"	"unprognostic (2.49e-2)"		"unprognostic (2.27e-3)"	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	3.1	0.0	3.8	0.0	7.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	4.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	3.3	0.3	0.0	0.0	0.9	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.4	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.4	1.4	0.0	0.0	0.0	0.0	21.9	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.3	6.1	0.3	2.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.2	0.4	26.7	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	22.0	0.0	0.1	0.0	22.8	9.8	0.0	0.0	1.1	29.0	1.7	20.6	0.0	0.0	0.0	0.1	1.7	0.0	0.5	0.0	0.0	0.0	0.0	0.4	0.0	0.0	8.6	0.0	0.0	1.2	0.2	0.9	0.2	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	7.8	1.2	0.0	8.8	0.0	0.3	0.0	0.0	0.0	0.1	2.3	0.1	0.4	0.0	0.9	0.0	0.1	0.0	9.2	14.0
HOXD3	"HOX1D, HOX4, HOX4A"	ENSG00000128652	"Homeobox D3"	P31249	2	176136612-176173102	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"epididymis: 42.1"	"Cell type enhanced"	"Detected in some"		"Adipocytes: 6.6;Collecting duct cells: 9.2;Distal tubular cells: 15.6;Early spermatids: 14.4;Endothelial cells: 6.5;Theca cells: 4.7"	"Cancer enhanced"	"Detected in some"		"ovarian cancer: 1.2"	"Group enriched"	"Detected in many"	8	"medulla oblongata: 8.9;pons: 5.7;spinal cord: 5.7;white matter: 4.9"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 9.7;HSkMC: 11.2;RPTEC TERT1: 12.0;SCLC-21H: 14.5;SH-SY5Y: 10.1"	"Region enriched"	"Detected in single"	35	"pons and medulla: 3.5"	"Group enriched"	"Detected in some"	6	"medulla oblongata: 4.1;pons: 1.1;spinal cord: 3.0"	"HPA051831, HPA063671"			Supported	"Nucleoplasm,Nuclear bodies"		No	NA				"Cluster 68: Epididymis - Unknown function"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 29: Early spermatids - Spermatogenesis"	Nucleoplasm	"Nuclear bodies"	"HPA051831: , HPA063671: AB_2685083"	"unprognostic (1.13e-1)"	"unprognostic (3.28e-1)"	"unprognostic (1.52e-2)"	"unprognostic (6.50e-2)"	"unprognostic (1.31e-1)"	"unprognostic (7.07e-2)"	"unprognostic (1.97e-2)"	"unprognostic (1.54e-2)"	"unprognostic (9.56e-2)"	"unprognostic (5.57e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.56e-1)"	"unprognostic (2.57e-4)"	"unprognostic (1.47e-3)"	"unprognostic (1.55e-1)"	"unprognostic (3.44e-1)"	"unprognostic (7.44e-2)"	3.2	2.3	0.2	0.8	0.4	0.0	2.8	0.4	0.3	3.2	0.1	1.0	0.3	6.9	42.1	0.7	6.8	0.6	0.2	0.2	0.4	7.9	0.0	0.2	0.8	8.9	0.8	5.5	0.2	0.1	0.0	0.1	5.7	1.7	0.6	0.0	0.5	7.1	0.7	0.9	0.8	4.1	5.7	0.7	0.3	1.7	0.4	0.2	0.4	0.0	0.2	1.0	2.0	4.9	0.0	0.0	0.0	0.0	0.4	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.7	1.7	0.2	0.0	0.4	0.0	0.0	0.1	3.6	0.0	0.0	0.1	0.0	0.0	0.0	11.2	0.9	0.0	0.3	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	1.1	0.0	0.0	0.0	12.0	0.9	14.5	10.1	0.2	0.1	4.6	0.2	0.0	0.0	1.0	0.2	0.2	1.5	0.8	0.0	0.2	0.0	0.5	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.4	0.3	0.2	0.4	8.9	0.8	5.7	5.7	0.4	4.9	6.6	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	9.2	0.0	0.0	0.0	0.3	15.6	0.0	14.4	0.1	2.1	6.5	1.2	0.0	0.2	0.0	0.0	0.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.8	3.5	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	2.0	0.0	0.3	4.5	0.0	0.1	0.3	2.9	0.0	0.0	0.0	1.3	1.1	0.8	0.5	0.0	1.3	0.0	0.1	4.7	0.6	0.1
HOXD4	"HOX4, HOX4B"	ENSG00000170166	"Homeobox D4"	P09016	2	176151550-176153226	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"endometrium 1: 24.4;epididymis: 28.0"	"Cell type enhanced"	"Detected in some"		"Adipocytes: 5.5;Collecting duct cells: 16.5;Early spermatids: 3.7;Endothelial cells: 3.6;Leydig cells: 4.7;Proximal tubular cells: 6.5;Sertoli cells: 6.6"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 5.3"	"Group enriched"	"Detected in many"	21	"medulla oblongata: 10.6;pons: 5.6;spinal cord: 8.1;white matter: 7.3"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 16.6;HEK 293: 39.7;RPTEC TERT1: 29.6;SK-MEL-30: 11.0"	"Region enriched"	"Detected in single"	46	"pons and medulla: 4.5"	"Group enriched"	"Detected in some"	4	"medulla oblongata: 6.0;spinal cord: 7.8"	"HPA054383, HPA070349"	Approved		Supported	"Nucleoplasm,Cell Junctions"		NA	NA				"Cluster 68: Epididymis - Unknown function"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Nucleoplasm	"Cell Junctions"	"HPA054383: AB_2682470, HPA070349: AB_2686258"	"unprognostic (9.37e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.03e-3)"	"unprognostic (1.10e-3)"	"unprognostic (9.21e-2)"	"unprognostic (5.17e-3)"	"unprognostic (5.19e-2)"	"unprognostic (6.69e-3)"	"unprognostic (1.66e-1)"	"unprognostic (3.47e-1)"	"unprognostic (1.49e-1)"	"unprognostic (2.50e-1)"	"unprognostic (7.78e-2)"	"unprognostic (1.12e-2)"	"unprognostic (9.93e-2)"	"unprognostic (5.81e-2)"	"unprognostic (1.61e-1)"	6.9	8.3	0.0	1.6	0.0	0.0	7.4	0.0	0.1	7.1	0.0	7.3	1.0	24.4	28.0	1.1	14.3	1.5	0.6	0.0	0.0	18.5	0.0	0.4	1.7	10.6	0.3	15.1	0.6	0.1	0.0	0.4	5.6	2.9	2.0	0.0	0.7	11.1	2.8	2.4	6.2	9.7	8.1	7.2	1.0	3.0	0.0	0.2	1.2	0.5	0.4	2.7	4.0	7.3	0.5	0.3	0.0	0.0	2.0	3.0	0.0	0.2	0.9	0.1	1.1	0.9	0.0	0.0	16.6	3.4	0.7	0.2	2.6	0.0	0.4	0.0	39.7	0.5	0.0	0.0	0.5	0.0	0.1	9.3	2.6	0.0	0.5	0.2	6.2	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	4.4	0.0	0.0	0.0	29.6	4.1	2.5	4.2	0.6	0.0	11.0	0.6	0.0	0.0	5.0	0.5	0.2	2.9	2.1	0.0	0.1	0.0	2.0	0.0	5.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	10.6	0.3	5.6	8.1	0.0	7.3	5.5	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.3	0.1	0.0	0.0	16.5	0.0	0.0	0.0	0.9	0.0	0.0	3.7	0.1	1.1	3.6	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.0	0.0	0.7	2.6	4.7	0.1	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.7	3.0	0.0	0.1	0.3	6.5	0.0	0.0	6.6	0.6	0.9	0.3	0.4	0.0	0.6	0.0	0.1	3.0	1.3	0.0
HOXD9	"HOX4, HOX4C"	ENSG00000128709	"Homeobox D9"	P28356	2	176122719-176124937	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix: 42.2;endometrium 1: 57.8;kidney: 52.1"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 38.4;Collecting duct cells: 23.9;Distal tubular cells: 37.2;Endothelial cells: 39.2;Leydig cells: 34.2;Peritubular cells: 26.7;Sertoli cells: 39.5"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"EFO-21: 11.3;HEK 293: 16.1;RPTEC TERT1: 19.0;SH-SY5Y: 21.7;SK-MEL-30: 13.2;TIME: 16.9"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	80	"spinal cord: 8.0"	HPA068683			Supported	Nucleoplasm,Nucleoli		NA	NA				"Cluster 89: Fibroblasts - ECM organization"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Nucleoplasm, Nucleoli"		"HPA068683: AB_2686018"	"unprognostic (1.89e-1)"	"unprognostic (9.41e-2)"	"prognostic unfavorable (8.25e-4)"	"unprognostic (1.37e-1)"	"unprognostic (1.03e-2)"	"prognostic favorable (9.58e-4)"	"prognostic unfavorable (1.08e-5)"	"unprognostic (6.62e-2)"	"unprognostic (4.58e-2)"	"unprognostic (1.54e-2)"	"unprognostic (2.56e-3)"	"unprognostic (6.71e-2)"	"unprognostic (4.77e-3)"	"unprognostic (8.38e-2)"	"unprognostic (5.94e-2)"	"unprognostic (1.89e-1)"	"unprognostic (9.44e-2)"	11.6	6.4	0.0	1.3	0.0	0.0	13.9	0.0	0.0	42.2	0.0	29.3	0.1	57.8	14.8	3.5	16.1	0.9	0.2	0.0	0.0	52.1	0.1	0.7	2.4	0.5	0.0	11.1	0.3	0.3	0.0	0.5	0.1	32.3	2.9	0.0	1.2	8.0	1.6	5.8	3.0	15.2	0.5	2.4	0.5	5.6	0.1	0.5	1.4	0.2	0.8	6.1	35.3	0.8	0.1	0.0	0.0	0.0	0.5	0.4	0.2	1.6	1.1	1.3	1.1	0.0	0.0	0.0	11.3	1.6	0.8	7.6	0.1	0.0	0.9	0.0	16.1	0.0	0.8	0.0	0.1	0.0	0.0	3.6	0.6	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	4.3	0.0	19.0	7.1	4.3	21.7	5.5	0.0	13.2	1.1	0.0	0.0	16.9	0.0	3.6	5.3	6.0	0.0	0.0	0.0	1.9	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.5	0.1	0.8	38.4	0.0	0.0	0.0	0.4	2.4	1.9	0.0	0.0	0.0	0.8	0.5	0.7	0.0	0.0	23.9	0.0	0.0	1.0	8.5	37.2	0.0	0.2	0.8	10.9	39.2	7.8	0.0	0.0	0.0	0.2	1.8	0.0	0.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	2.6	0.0	0.0	3.0	1.3	34.2	0.2	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	26.7	0.0	1.1	0.0	3.0	0.0	0.0	39.5	1.9	3.3	2.2	1.4	0.1	1.8	0.0	1.1	13.9	3.8	0.8
HP1BP3	HP1-BP74	ENSG00000127483	"Heterochromatin protein 1 binding protein 3"	Q5SSJ5	1	20740266-20787323	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028215, HPA054295"	Supported		Supported	"Nuclear speckles"		NA	Yes		30000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 43: Cardiomyocytes - Nuclear processes"	"Nuclear speckles"		"HPA028215: AB_10601021, HPA054295: AB_2682440"	"unprognostic (3.90e-3)"	"unprognostic (6.83e-2)"	"unprognostic (7.69e-2)"	"unprognostic (3.66e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.25e-3)"	"prognostic unfavorable (2.76e-4)"	"unprognostic (1.97e-1)"	"unprognostic (3.26e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.94e-2)"	"unprognostic (9.50e-2)"	"unprognostic (6.86e-2)"	"unprognostic (1.65e-1)"	"unprognostic (6.30e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.43e-2)"	87.9	78.9	62.2	76.2	75.1	141.7	80.1	69.6	76.5	143.6	62.1	107.9	71.3	116.5	63.0	94.8	96.7	75.3	75.7	64.5	66.6	83.5	66.5	84.1	91.4	68.1	64.4	135.6	74.4	98.1	60.9	85.9	67.5	81.3	88.2	96.4	83.0	74.3	113.9	86.9	93.8	100.3	61.3	89.2	83.1	54.5	68.7	134.5	106.3	78.7	90.3	93.9	114.2	107.6	207.3	106.1	261.6	157.5	152.3	172.8	157.3	230.2	182.4	156.7	163.1	97.6	232.0	208.2	113.4	176.6	108.4	171.9	136.7	125.5	199.8	306.5	124.7	296.2	230.5	85.4	98.1	209.7	181.7	135.1	90.6	159.0	208.5	193.0	160.5	245.1	169.9	251.8	180.1	64.2	323.5	93.0	69.3	152.6	126.3	250.4	255.0	219.2	113.6	66.6	175.0	180.0	279.8	112.9	181.2	132.9	117.3	138.7	196.4	176.2	164.2	180.7	139.2	144.0	194.2	246.7	150.2	213.0	204.0	102.4	55.3	202.6	57.1	45.0	59.7	70.8	61.9	62.1	52.2	58.4	80.4	54.5	66.1	63.3	54.9	59.5	71.6	49.0	62.2	75.1	69.6	76.5	64.5	66.6	68.1	64.4	67.5	61.3	68.7	107.6	129.4	150.6	156.2	96.9	112.1	130.4	137.4	81.6	159.9	117.8	116.6	108.7	161.4	94.4	94.5	104.8	54.2	87.6	144.7	105.6	154.6	87.0	40.8	85.3	184.6	136.8	103.7	214.6	98.3	93.4	70.7	161.9	98.8	128.2	137.8	131.8	129.2	101.0	72.6	80.8	93.7	113.4	83.4	100.7	104.1	22.3	172.7	116.9	113.8	130.2	111.2	119.5	127.7	142.7	189.9	113.0	90.1	162.5	162.0	124.6	91.7	110.7	54.6	97.6	157.8	145.2	148.3	141.3	110.1	201.8	134.5	92.9	151.9	116.2	115.3	118.4
HPDL	"4-HPPD-L, GLOXD1, MGC15668"	ENSG00000186603	"4-hydroxyphenylpyruvate dioxygenase like"	Q96IR7	1	45326895-45328679	"Human disease related genes, Predicted intracellular proteins"		"Dioxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in some"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 29.1;Gastric mucus-secreting cells: 8.2;Undifferentiated cells: 7.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BEWO: 111.7;HL-60: 34.2;NB-4: 42.8;SK-BR-3: 72.5"	"Low region specificity"	"Detected in many"							"HPA031997, HPA057346"			Supported	Nucleoplasm,Mitochondria		No	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 47: Cytotrophoblasts - Unknown function"	Mitochondria	Nucleoplasm	"HPA031997: AB_10602909, HPA057346: AB_2683415"	"prognostic favorable (1.81e-4)"	"unprognostic (1.36e-1)"	"unprognostic (2.46e-1)"	"prognostic unfavorable (1.60e-5)"	"unprognostic (1.02e-2)"	"unprognostic (6.71e-2)"	"unprognostic (3.93e-3)"	"unprognostic (1.25e-1)"	"unprognostic (1.63e-1)"	"prognostic favorable (1.03e-4)"	"unprognostic (1.08e-3)"	"unprognostic (2.52e-2)"	"unprognostic (6.66e-2)"	"unprognostic (1.26e-2)"	"unprognostic (1.00e-1)"	"unprognostic (3.03e-2)"	"unprognostic (1.43e-1)"	0.4	0.2	1.0	1.3	1.3	1.8	0.4	3.1	1.0	1.2	0.0	3.7	2.4	0.6	0.0	2.2	0.6	0.0	0.3	0.9	0.9	0.6	0.1	0.3	1.0	1.3	1.2	0.6	0.3	0.0	0.3	2.1	1.3	0.6	2.8	0.4	1.0	0.2	1.6	0.8	2.5	0.3	0.8	1.8	3.4	0.3	1.3	1.2	0.6	0.6	0.9	0.5	1.1	1.3	0.1	1.1	0.5	0.1	0.1	0.4	111.7	1.5	0.0	2.0	0.4	28.7	7.7	5.8	0.3	1.5	0.0	7.0	0.0	0.4	0.7	0.2	0.3	0.6	13.4	0.0	0.7	34.2	0.9	1.1	0.2	1.2	0.0	0.1	2.2	0.2	0.0	5.2	0.2	14.6	22.1	42.8	0.5	23.0	0.0	6.6	0.1	19.4	0.4	0.4	22.2	1.5	14.6	72.5	11.4	1.6	0.2	6.3	1.0	0.0	0.3	1.3	0.0	0.9	0.6	21.3	0.1	0.1	1.4	0.0	0.0	0.0	0.1	0.0	0.3	0.6	0.1	0.2	0.2	0.0	0.2	0.1	0.0	0.5	0.0	0.0	0.1	0.1	1.0	1.3	3.1	1.0	0.9	0.9	1.3	1.2	1.3	0.8	1.3	1.3	0.1	0.0	0.0	2.9	1.0	0.1	2.3	0.5	1.2	0.2	0.7	1.0	0.4	0.0	0.1	0.0	0.0	29.1	0.3	3.0	3.9	0.4	0.2	0.1	1.5	0.7	1.2	4.2	0.0	0.0	5.8	0.8	8.2	0.2	0.0	0.9	0.4	0.1	2.5	0.0	0.2	3.3	0.0	0.0	0.3	0.0	0.3	0.2	0.0	0.0	0.1	0.0	0.0	0.5	0.0	1.8	1.9	0.0	5.2	2.2	0.4	0.3	0.0	0.4	0.0	0.6	0.8	0.0	1.9	2.1	1.1	5.1	0.4	1.2	7.6	1.5
HPGD	SDR36C1	ENSG00000164120	"15-hydroxyprostaglandin dehydrogenase"	P15428	4	174490175-174523154	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism, Prostaglandin metabolism"	Oxidoreductase	"Cancer-related genes, Disease variant, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"stomach 1: 235.0;urinary bladder: 376.0"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 457.8;Extravillous trophoblasts: 701.7;granulocytes: 864.5;Proximal enterocytes: 500.6;Urothelial cells: 922.8"	"Cancer enhanced"	"Detected in many"		"urothelial cancer: 52.4"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"basophil: 123.7;T-reg: 45.0"	"Group enriched"	"Detected in many"	73	"granulocytes: 123.7;T-cells: 45.0"	"Cell line enhanced"	"Detected in many"		"A549: 157.8;ASC diff: 110.6;HEL: 355.0;OE19: 102.1;RT4: 565.7;SuSa: 121.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004919, HPA005679"	Enhanced		Supported	Nucleoplasm,Cytosol		No	NA		20000	"Cluster 46: Basophils - DNA binding"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 15: RT4 - Unknown function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Cytosol	Nucleoplasm	"HPA004919: AB_1079081, HPA005679: AB_1079080"	"unprognostic (1.23e-3)"	"unprognostic (1.61e-1)"	"unprognostic (5.96e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.09e-2)"	"unprognostic (2.53e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.23e-1)"	"unprognostic (1.08e-1)"	"unprognostic (4.28e-2)"	"unprognostic (3.54e-3)"	"unprognostic (2.34e-2)"	"prognostic favorable (3.20e-4)"	"unprognostic (2.44e-1)"	"unprognostic (2.59e-1)"	"unprognostic (1.37e-4)"	"unprognostic (2.33e-2)"	9.2	16.5	1.0	11.4	0.7	2.7	159.9	0.5	1.2	32.2	8.7	60.9	152.2	45.5	36.5	81.6	13.4	24.9	1.6	1.2	2.8	60.2	210.8	91.0	5.5	1.4	2.0	1.1	2.6	85.3	2.1	99.1	1.0	10.2	57.4	1.0	7.7	4.0	2.5	39.8	117.3	63.7	0.8	10.3	235.0	1.6	2.2	12.2	1.7	3.0	26.6	376.0	83.0	0.7	0.0	157.8	0.0	0.0	110.6	5.4	0.4	0.0	0.0	0.0	0.4	45.1	0.2	0.1	0.0	0.0	0.2	14.2	16.0	0.0	0.0	0.3	2.9	355.0	10.8	0.3	0.0	2.1	0.9	5.6	2.6	0.0	0.1	0.1	0.0	22.6	0.2	0.0	0.0	0.3	1.2	0.3	1.4	102.1	7.4	16.3	0.3	1.3	36.2	565.7	0.9	0.4	0.0	1.3	3.5	121.3	0.1	0.0	0.3	0.0	0.2	0.1	0.0	28.4	0.0	0.1	0.3	0.2	0.0	123.7	0.3	16.6	9.9	0.0	15.6	0.4	5.2	4.5	0.7	0.2	1.6	4.0	1.3	1.1	0.0	0.0	45.0	3.0	1.0	0.7	0.5	1.2	1.2	2.8	1.4	2.0	1.0	0.8	2.2	0.7	3.4	16.0	33.0	0.0	4.3	17.3	80.8	6.9	45.5	3.3	14.5	6.7	0.8	35.8	23.6	22.0	0.0	48.5	38.5	457.8	21.5	7.4	1.4	5.7	5.4	18.2	8.4	17.2	0.8	94.5	701.7	25.3	196.7	36.4	864.5	1.5	13.9	245.7	21.4	0.0	9.7	60.7	0.0	14.8	19.5	0.5	19.9	29.2	76.5	5.6	2.9	0.0	10.3	0.0	4.1	42.4	254.7	0.0	50.2	76.8	500.6	131.1	4.4	0.8	0.0	2.4	3.7	0.5	1.0	53.4	22.4	56.6	42.7	65.0	58.9	922.8
HPGDS	"GSTS, GSTS1, GSTS1-1, H-PGDS, PGD2, PGDS"	ENSG00000163106	"Hematopoietic prostaglandin D synthase"	O60760	4	94298535-94342876	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Prostaglandin biosynthesis, Prostaglandin metabolism"	"Isomerase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 18.7"	"Group enriched"	"Detected in many"	18	"granulocytes: 1056.2;Hofbauer cells: 631.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	28	"basophil: 18.1"	"Lineage enriched"	"Detected in single"	28	"granulocytes: 18.1"	"Group enriched"	"Detected in some"	8	"HEL: 46.2;HMC-1: 13.5"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA024035	Enhanced		Approved	Nucleoplasm,Vesicles,Cytosol		NA	NA		250000	"Cluster 46: Basophils - DNA binding"	"Cluster 19: Lung - Lung function"	"Cluster 36: HEL - Hemostasis"	"Cluster 60: Granulocytes - Receptor signaling"	"Vesicles, Cytosol"	Nucleoplasm	"HPA024035: AB_1855743"	"unprognostic (5.71e-2)"	"unprognostic (5.80e-3)"	"unprognostic (1.17e-1)"	"unprognostic (5.36e-3)"	"unprognostic (2.76e-1)"	"unprognostic (2.38e-4)"	"unprognostic (1.01e-2)"	"unprognostic (4.41e-3)"	"unprognostic (1.35e-1)"	"unprognostic (7.75e-4)"	"unprognostic (1.44e-1)"	"unprognostic (1.14e-1)"	"unprognostic (5.15e-3)"	"unprognostic (4.07e-2)"	"unprognostic (6.48e-2)"	"unprognostic (2.61e-2)"	"unprognostic (6.14e-2)"	3.4	1.9	2.2	1.1	2.1	1.1	4.0	2.3	3.1	3.5	2.1	5.1	5.8	2.4	2.3	2.9	1.4	6.9	1.8	2.3	2.3	1.5	0.8	9.4	0.6	2.7	2.6	0.5	0.5	0.8	0.4	18.7	2.9	2.6	5.3	0.1	1.5	1.3	0.5	3.3	5.6	3.3	2.6	0.3	2.8	0.7	3.1	2.0	0.3	1.7	0.9	4.8	1.2	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	46.2	0.0	0.0	0.0	3.5	13.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.1	0.1	0.3	0.0	0.1	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.1	2.2	2.1	2.3	3.1	2.3	2.3	2.7	2.6	2.9	2.6	3.1	3.5	0.3	12.8	44.7	1.0	0.2	4.1	0.8	0.0	0.6	0.0	0.2	0.8	0.3	0.0	3.7	0.0	0.0	3.6	0.7	0.5	0.0	0.5	0.1	0.2	0.0	2.0	7.1	12.2	0.8	0.0	3.0	3.0	3.6	0.0	1056.2	0.0	0.0	0.0	631.9	0.0	0.6	0.0	0.0	11.4	13.1	0.0	0.3	16.3	3.6	32.8	0.1	0.0	0.0	0.0	0.5	0.1	1.2	0.4	2.1	3.9	0.0	0.0	1.5	0.1	0.0	0.6	0.4	0.0	0.1	0.0	5.4	5.5	20.5	0.3	0.9	0.2
HPRT1	"HGPRT, HPRT"	ENSG00000165704	"Hypoxanthine phosphoribosyltransferase 1"	P00492	X	134460165-134520513	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Purine salvage"	"Glycosyltransferase, Transferase"	"Disease variant, FDA approved drug targets, Gout"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal tubular cells: 226.9;Spermatocytes: 213.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006360, CAB012200"	Enhanced		Supported	Cytosol		NA	NA		9400000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 58: Brain - Synaptic function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	Cytosol		"CAB012200: AB_297217, HPA006360: AB_1079082"	"unprognostic (2.02e-1)"	"unprognostic (2.18e-1)"	"unprognostic (1.46e-1)"	"unprognostic (2.32e-3)"	"unprognostic (8.55e-2)"	"prognostic unfavorable (1.35e-5)"	"unprognostic (1.58e-2)"	"unprognostic (4.77e-3)"	"unprognostic (4.93e-2)"	"unprognostic (2.02e-2)"	"unprognostic (7.05e-2)"	"unprognostic (1.38e-3)"	"unprognostic (6.00e-2)"	"unprognostic (2.12e-1)"	"unprognostic (2.04e-1)"	"unprognostic (2.70e-2)"	"unprognostic (1.51e-1)"	15.6	26.2	37.3	24.3	39.4	54.7	20.4	26.0	63.7	13.6	22.9	25.5	20.4	14.0	62.7	20.3	16.9	14.6	24.5	40.3	47.1	45.5	45.8	14.5	32.1	31.2	32.1	16.8	37.1	21.9	31.5	16.3	34.7	15.4	23.5	74.1	13.5	16.0	22.6	14.8	26.5	17.3	24.6	16.9	32.2	76.1	31.4	31.3	22.1	17.8	30.6	25.4	13.9	31.3	138.0	64.9	18.0	37.2	39.4	56.1	54.1	71.6	68.7	89.5	116.8	58.7	85.5	154.4	158.7	46.7	106.8	82.0	117.4	98.2	153.4	129.2	219.3	84.0	85.0	60.2	38.9	182.9	74.0	41.6	36.1	80.1	126.4	49.5	104.9	90.3	65.5	3.8	71.0	141.0	141.9	157.0	37.0	160.7	171.8	83.8	91.1	158.6	109.6	65.7	113.0	61.6	51.7	41.5	50.1	48.8	35.5	75.2	52.4	60.5	45.6	175.0	181.5	56.5	105.1	0.9	74.6	199.5	33.8	5.8	21.9	20.4	20.8	36.5	30.0	24.0	30.4	27.6	37.9	24.8	24.8	26.9	5.6	39.4	35.5	15.7	57.4	25.3	37.3	39.4	26.0	63.7	40.3	47.1	31.2	32.1	34.7	24.6	31.4	31.3	32.1	19.2	8.2	11.1	39.6	39.6	55.7	75.6	18.8	38.3	26.4	22.0	23.8	30.0	29.9	57.0	4.2	17.9	28.1	16.8	226.9	50.1	11.9	30.1	28.3	39.2	27.5	101.8	55.3	32.3	30.5	29.5	30.1	41.8	34.9	29.0	20.7	22.2	71.2	25.2	43.1	30.4	63.1	60.7	81.7	32.2	40.7	56.2	55.2	10.3	122.5	37.2	26.8	22.1	30.7	36.6	28.2	26.7	30.9	78.1	24.1	30.2	28.9	78.0	52.6	31.6	39.4	213.5	172.6	40.4	38.8	6.0	53.8	30.2	51.3	46.8
HPS5	"AIBP63, BLOC2S2, RU2"	ENSG00000110756	"HPS5 biogenesis of lysosomal organelles complex 2 subunit 2"	Q9UPZ3	11	18278668-18322198	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			"Albinism, Disease variant, Hermansky-Pudlak syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 35.7"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 96.1"	"Cancer enhanced"	"Detected in all"		"melanoma: 19.0"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA077851	Approved		Supported	Cytosol		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 41: Macrophages - Immune response"	Cytosol		"HPA077851: "	"unprognostic (2.25e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.59e-1)"	"unprognostic (9.85e-3)"	"unprognostic (5.89e-1)"	"unprognostic (1.47e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.61e-1)"	"unprognostic (5.20e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.59e-1)"	"prognostic unfavorable (2.05e-4)"	"unprognostic (2.06e-1)"	"unprognostic (1.18e-1)"	"unprognostic (8.67e-2)"	"unprognostic (2.72e-1)"	7.4	8.4	4.4	5.8	5.5	3.7	10.5	4.7	4.5	5.1	5.9	4.8	6.1	5.0	2.8	7.3	5.1	3.9	5.9	4.0	4.6	5.4	35.7	8.6	9.2	5.6	5.0	7.1	6.8	3.6	8.5	7.1	5.9	4.8	3.3	8.9	16.3	3.5	5.5	6.3	8.1	3.9	5.2	9.0	4.6	14.8	5.4	5.9	6.0	3.1	8.3	4.9	5.5	7.4	5.9	8.5	9.0	9.1	11.9	6.6	9.8	15.3	12.6	9.9	10.4	5.3	1.8	14.1	5.8	13.3	12.4	8.3	10.6	10.1	12.1	11.8	7.7	6.9	7.1	6.7	11.2	15.2	12.4	10.6	9.9	6.1	12.9	10.0	8.0	9.0	9.1	8.0	16.1	4.8	8.1	11.0	4.5	6.8	9.3	11.8	12.9	6.0	9.6	5.3	3.0	5.9	19.2	6.8	22.8	8.9	5.1	8.8	5.9	11.3	6.1	14.8	7.1	3.4	12.0	16.1	6.2	7.8	32.4	12.3	3.6	2.9	2.1	5.4	2.6	5.3	2.6	2.2	8.3	4.4	2.5	2.6	1.0	2.8	6.0	3.2	2.6	2.5	4.4	5.5	4.7	4.5	4.0	4.6	5.6	5.0	5.9	5.2	5.4	7.4	17.2	96.1	14.6	13.1	30.8	15.6	14.2	16.2	12.5	17.5	17.4	23.0	18.2	17.2	14.7	7.3	31.3	22.2	16.0	4.7	5.9	5.2	50.9	20.7	11.2	13.4	10.7	11.6	16.7	8.4	10.6	11.8	18.3	30.0	14.5	17.8	7.9	45.1	18.1	10.1	21.0	5.0	12.2	22.7	45.0	18.6	8.4	35.8	28.4	11.2	32.3	16.1	0.0	21.1	24.0	6.2	8.5	13.2	17.4	15.2	27.1	6.5	21.1	26.1	6.6	17.1	13.1	16.2	12.6	19.6	15.3	17.4	17.8	10.5	6.0	21.8
HPSE	"HPA, HPSE1, HSE1"	ENSG00000173083	Heparanase	Q9Y251	4	83292461-83335153	"Enzymes, Metabolic proteins, Predicted secreted proteins"	"Cell adhesion"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 16.4;Kupffer cells: 41.5;Macrophages: 20.2;monocytes: 33.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"classical monocyte: 27.2;neutrophil: 18.5"	"Group enriched"	"Detected in many"	4	"granulocytes: 18.5;monocytes: 27.2"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 39.8;OE19: 40.1;TIME: 25.8"	"Region enhanced"	"Detected in some"		"olfactory bulb: 3.7"	"Low region specificity"	"Detected in all"			"CAB009813, HPA055344"			Supported	Nucleoplasm,Vesicles	"Secreted to extracellular matrix"	No	No		6500000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	Nucleoplasm	Vesicles	"CAB009813: AB_2120854, HPA055344: "	"unprognostic (6.57e-2)"	"unprognostic (1.22e-2)"	"unprognostic (9.13e-2)"	"unprognostic (5.92e-3)"	"unprognostic (1.12e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.24e-2)"	"unprognostic (5.65e-2)"	"unprognostic (7.06e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.50e-1)"	"unprognostic (9.62e-3)"	"unprognostic (3.27e-1)"	"unprognostic (2.78e-1)"	"unprognostic (3.04e-3)"	"unprognostic (4.15e-2)"	"unprognostic (3.70e-3)"	3.4	4.5	0.8	6.6	0.9	2.3	1.0	0.6	1.7	2.4	0.4	5.9	2.1	2.7	0.2	9.9	3.9	2.7	0.8	0.9	0.9	1.6	2.4	3.2	4.5	1.8	1.0	4.5	0.8	5.6	1.2	2.1	1.3	0.6	6.4	0.2	9.7	0.6	0.3	5.3	2.8	1.9	1.8	6.0	2.0	5.7	2.7	2.0	0.7	0.3	3.9	3.0	3.3	3.6	13.5	0.6	0.1	1.7	3.2	0.9	0.1	1.5	8.2	3.6	16.5	0.0	11.0	0.4	2.3	4.2	20.8	12.3	16.8	2.5	6.5	1.4	1.7	4.2	9.0	0.2	1.4	2.5	8.4	1.8	5.1	2.4	15.4	1.4	18.1	2.4	0.1	39.8	1.5	2.8	0.2	0.3	0.7	40.1	2.6	0.0	0.4	0.6	10.2	0.3	9.3	0.0	17.7	9.8	1.4	2.6	1.5	3.8	25.8	1.5	4.6	1.4	1.7	0.5	6.2	0.2	9.9	11.4	2.7	0.4	27.2	0.0	1.4	10.1	1.0	0.2	2.7	1.0	3.0	0.3	1.7	1.6	18.5	2.3	1.5	0.1	5.2	7.9	0.8	0.9	0.6	1.7	0.9	0.9	1.8	1.0	1.3	1.8	2.7	3.6	0.3	6.4	4.4	0.0	0.7	3.4	3.0	3.3	2.8	0.0	0.3	0.5	0.6	0.0	5.6	1.8	0.0	0.5	2.4	10.1	0.0	1.9	0.6	2.3	3.7	1.0	6.6	2.7	0.8	1.3	2.9	1.4	4.1	13.2	0.0	0.4	2.9	0.6	16.4	0.0	3.8	2.8	0.0	41.5	3.0	0.3	0.6	20.2	0.0	7.5	33.9	0.0	3.1	0.0	0.1	1.1	6.7	0.0	0.7	1.7	4.1	0.0	2.8	0.0	0.0	0.1	1.2	0.2	1.0	4.0	3.7	1.5	6.2	1.4	4.6	3.7
HR	"ALUNC, AU"	ENSG00000168453	"HR lysine demethylase and nuclear receptor corepressor"	O43593	8	22114419-22133384	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"DNA-binding, Oxidoreductase"	"Disease variant, Hypotrichosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 20.9;skin 1: 52.7"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 91.4;Cone photoreceptor cells: 33.3;Distal enterocytes: 27.5;Gastric mucus-secreting cells: 26.5;Paneth cells: 31.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A549: 21.2;HaCaT: 81.7;OE19: 39.9;SiHa: 28.8;T-47d: 30.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054888			Supported	Nucleoplasm		NA	NA				"Cluster 27: Brain & Skin - Unknown function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 56: Bipolar cells - Visual perception"	Nucleoplasm		"HPA054888: AB_2682630"	"unprognostic (9.11e-2)"	"unprognostic (2.12e-2)"	"unprognostic (7.32e-2)"	"unprognostic (4.68e-3)"	"unprognostic (6.49e-2)"	"unprognostic (2.80e-1)"	"unprognostic (1.53e-2)"	"unprognostic (2.45e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.75e-1)"	"unprognostic (2.27e-2)"	"unprognostic (8.00e-3)"	"unprognostic (1.81e-1)"	"unprognostic (2.32e-1)"	"unprognostic (2.28e-2)"	2.4	1.0	4.3	1.8	6.7	0.0	2.7	7.8	14.5	3.8	0.0	9.0	4.8	1.6	0.1	20.9	1.1	1.3	2.3	3.1	4.8	0.6	0.4	0.8	0.3	11.3	9.0	0.6	0.5	0.0	2.7	0.1	12.0	3.8	3.2	1.8	5.1	4.2	0.7	52.7	4.7	1.5	2.4	0.5	7.7	5.3	8.8	0.6	4.3	0.9	1.2	3.0	11.7	11.5	1.9	21.2	0.0	0.0	0.2	0.6	0.1	0.1	0.1	0.0	0.0	0.0	2.6	0.0	20.7	1.5	1.0	81.7	0.0	2.0	0.0	0.0	0.0	0.0	17.8	0.1	4.7	0.0	0.1	4.1	12.9	0.0	1.4	1.3	0.0	2.1	0.0	0.2	0.0	12.7	1.5	0.3	0.0	39.9	16.3	1.9	0.0	0.5	0.3	5.7	1.0	4.7	28.8	6.4	6.5	0.3	30.0	0.0	0.0	0.4	17.2	0.0	0.9	0.0	0.0	0.0	0.2	0.0	7.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	6.7	7.8	14.5	3.1	4.8	11.3	9.0	12.0	2.4	8.8	11.5	1.9	0.0	0.0	1.3	0.0	12.0	4.5	4.3	10.8	91.4	4.0	3.9	2.7	0.0	1.4	1.8	33.3	0.1	0.1	27.5	0.0	0.1	0.3	1.6	1.2	0.6	7.8	0.0	8.7	0.7	0.2	2.1	26.5	2.1	0.0	0.3	1.8	0.3	0.0	10.1	3.9	8.1	0.0	0.0	2.1	1.9	3.4	0.1	21.4	0.0	0.0	3.2	0.0	2.0	9.2	0.3	31.2	7.2	0.0	3.0	11.0	0.1	1.3	8.8	0.0	5.8	3.3	0.1	0.3	15.5	17.8	0.8	0.3	0.2	19.5	6.8
HRH1		ENSG00000196639	"Histamine receptor H1"	P35367	3	11137093-11263557	"FDA approved drug targets, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 46.1;Distal enterocytes: 44.9;Glandular and luminal cells: 41.6;Suprabasal keratinocytes: 41.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"hTEC/SVTERT24-B: 30.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029740	Uncertain		Supported	"Plasma membrane,Cytosol"		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 44: Endometrium - Transcription"	"Plasma membrane"	Cytosol	"HPA029740: AB_10601578"	"unprognostic (4.60e-3)"	"unprognostic (3.41e-2)"	"unprognostic (6.37e-3)"	"unprognostic (9.55e-2)"	"unprognostic (3.32e-2)"	"unprognostic (1.07e-2)"	"unprognostic (9.60e-3)"	"unprognostic (4.00e-3)"	"unprognostic (7.54e-2)"	"unprognostic (4.98e-2)"	"prognostic unfavorable (1.27e-5)"	"unprognostic (1.43e-1)"	"unprognostic (1.70e-2)"	"unprognostic (1.66e-1)"	"unprognostic (3.13e-2)"	"unprognostic (7.19e-2)"	"unprognostic (1.20e-1)"	5.7	3.0	5.5	3.1	6.2	0.1	3.4	1.7	6.5	5.0	2.1	8.8	2.7	4.3	4.8	3.3	7.4	7.1	1.5	6.1	5.3	4.2	0.7	4.1	1.2	4.6	2.9	5.9	0.6	0.9	0.5	3.9	3.6	2.4	5.1	0.2	1.8	3.5	0.9	5.1	4.3	5.4	3.2	1.0	1.7	0.8	5.8	1.2	1.2	2.2	1.4	14.3	5.0	4.1	2.6	6.1	0.0	0.0	2.7	28.5	4.2	4.6	15.3	13.3	8.8	1.1	21.8	0.0	13.4	10.6	13.5	17.3	0.0	6.3	17.7	10.1	0.0	1.4	9.7	0.0	8.4	4.5	2.4	10.0	3.7	30.4	10.5	18.4	19.1	0.2	0.0	0.1	5.8	0.0	0.0	1.9	0.0	2.6	5.4	0.4	1.6	0.6	23.2	3.6	0.2	0.0	6.6	4.6	0.0	0.2	0.0	3.5	28.8	14.8	9.4	15.3	23.4	0.0	1.7	0.1	22.5	3.9	13.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.9	0.0	5.5	6.2	1.7	6.5	6.1	5.3	4.6	2.9	3.6	3.2	5.8	4.1	11.5	6.4	1.1	33.3	0.1	46.1	8.9	7.4	6.8	0.0	0.5	0.5	0.5	0.0	19.3	1.8	0.0	0.2	0.0	44.9	0.0	0.6	0.3	20.5	6.9	20.2	3.5	0.0	34.6	0.7	1.0	16.7	8.6	41.6	2.5	28.8	2.5	0.0	27.2	0.0	19.1	15.1	4.1	12.5	12.3	0.2	3.7	9.8	0.0	2.8	0.1	0.0	0.0	2.0	1.1	14.0	21.0	0.0	0.0	6.2	29.1	0.7	5.0	0.2	0.0	6.8	2.8	1.8	3.3	2.2	41.5	0.5	1.0	0.2	15.8	19.3
HSCB	"DNAJC20, HSC20, Jac1"	ENSG00000100209	"HscB mitochondrial iron-sulfur cluster cochaperone"	Q8IWL3	22	28742039-28757515	"Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018447, HPA031518"	Uncertain		Supported	Nucleoplasm,Mitochondria,Cytosol		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoplasm, Mitochondria, Cytosol"		"HPA018447: AB_1853867, HPA031518: AB_2673919"	"unprognostic (8.19e-3)"	"unprognostic (6.48e-2)"	"unprognostic (9.62e-3)"	"prognostic favorable (3.78e-4)"	"unprognostic (3.30e-1)"	"unprognostic (7.02e-2)"	"unprognostic (1.15e-1)"	"unprognostic (2.53e-2)"	"unprognostic (5.83e-2)"	"unprognostic (7.38e-3)"	"unprognostic (4.44e-1)"	"unprognostic (2.81e-1)"	"unprognostic (1.54e-3)"	"unprognostic (2.19e-1)"	"unprognostic (3.39e-1)"	"unprognostic (2.12e-1)"	"prognostic favorable (8.38e-4)"	8.6	15.3	5.1	6.0	4.9	3.2	9.8	5.3	6.9	12.3	4.7	11.1	8.6	8.0	5.1	7.9	9.3	7.1	8.4	4.8	5.1	11.0	22.0	6.2	11.0	5.6	4.8	12.0	12.5	5.3	7.3	4.5	5.7	10.7	4.5	1.0	18.8	6.2	11.6	7.9	7.3	4.6	5.0	9.0	11.5	4.1	5.4	4.3	8.0	8.1	4.9	10.7	9.0	5.8	13.8	8.5	3.4	5.5	6.3	16.0	6.5	9.9	13.8	14.2	8.8	3.8	4.8	15.1	4.6	5.6	3.4	9.5	6.9	6.3	6.9	14.6	27.2	5.3	5.8	10.7	13.4	9.7	7.7	10.9	13.8	8.0	12.6	7.5	11.0	4.2	8.2	13.1	5.7	20.1	4.3	8.9	8.4	15.0	20.9	8.6	10.8	17.2	15.9	3.9	11.8	10.8	5.4	20.5	25.9	2.9	8.6	5.9	6.0	19.3	10.2	18.6	9.2	18.2	15.9	13.5	13.5	7.1	13.2	10.1	7.8	4.1	6.1	15.2	7.3	13.0	6.2	7.2	11.5	9.6	6.6	8.3	0.4	11.1	12.0	6.0	4.9	5.9	5.1	4.9	5.3	6.9	4.8	5.1	5.6	4.8	5.7	5.0	5.4	5.8	21.4	22.4	19.6	14.4	22.8	11.6	22.2	23.3	40.5	5.5	29.4	37.7	7.8	18.6	23.9	20.2	6.2	16.0	16.7	9.0	29.4	25.0	5.5	12.7	23.3	18.4	19.8	12.6	10.0	28.0	13.5	21.4	11.7	21.6	23.4	17.2	20.3	36.3	27.9	5.0	11.2	14.6	16.2	19.0	14.9	4.3	18.6	19.2	14.2	9.4	22.6	17.4	41.2	16.1	14.2	21.2	11.3	11.7	34.1	20.5	20.2	58.1	24.1	8.1	6.6	19.1	21.9	15.1	16.7	19.8	15.6	13.3	15.9	27.1	21.2	17.2
HSD11B1L	"HSD1L, SCDR10, SDR26C2"	ENSG00000167733	"Hydroxysteroid 11-beta dehydrogenase 1 like"	Q7Z5J1	19	5680604-5688523	"Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 58.2"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"SH-SY5Y: 19.0"					"Low region specificity"	"Detected in all"			HPA049078			Supported	Vesicles	"Secreted in brain"	NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 65: Brain - Ion transport"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 49: Ciliated cells - Cilium organization"	Vesicles		"HPA049078: AB_2680622"	"unprognostic (2.34e-2)"	"unprognostic (1.10e-1)"	"unprognostic (4.73e-3)"	"unprognostic (5.26e-2)"	"unprognostic (9.37e-2)"	"prognostic favorable (4.38e-4)"	"unprognostic (4.81e-3)"	"unprognostic (6.63e-3)"	"unprognostic (2.63e-1)"	"unprognostic (2.47e-1)"	"unprognostic (1.18e-3)"	"unprognostic (1.43e-1)"	"unprognostic (3.33e-2)"	"unprognostic (1.75e-1)"	"unprognostic (5.77e-2)"	"unprognostic (4.52e-1)"	"unprognostic (1.73e-2)"	3.9	9.8	46.6	1.3	46.7	2.6	5.1	32.0	58.2	5.5	34.0	8.4	1.6	5.4	5.1	3.7	6.7	3.0	5.9	46.1	41.8	12.4	5.4	4.4	1.4	38.4	36.5	6.7	7.0	7.3	21.2	1.5	37.2	6.1	1.0	6.3	5.8	4.1	10.9	9.3	3.4	1.6	32.9	3.2	6.3	8.1	42.4	1.6	8.6	3.3	1.0	6.0	4.3	39.1	3.6	3.0	11.3	2.1	5.0	5.7	2.2	2.7	4.4	1.1	4.8	1.3	3.3	0.8	5.9	2.2	0.9	1.7	1.4	1.8	1.0	3.2	3.6	2.3	3.0	2.2	3.6	0.9	7.9	5.5	3.9	1.6	1.6	10.4	1.8	5.1	2.4	2.9	4.6	0.3	2.1	2.1	3.0	14.2	4.1	3.6	0.5	3.1	9.5	0.8	3.2	19.0	0.5	1.6	12.8	3.8	2.6	0.7	3.2	2.7	5.0	4.9	2.2	7.6	2.8	0.9	7.7	1.2	2.4	1.5	1.0	0.5	0.6	2.7	0.6	0.5	1.4	1.6	1.0	1.1	1.8	1.7	1.9	0.7	1.8	2.2	0.4	0.9	46.6	46.7	32.0	58.2	46.1	41.8	38.4	36.5	37.2	32.9	42.4	39.1	8.2	0.0	2.6	13.7	2.6	8.2	8.6	12.9	9.6	11.3	23.7	23.1	2.3	10.0	8.6	23.9	14.6	4.7	3.0	4.5	15.6	12.4	9.5	21.8	6.0	6.1	25.7	1.3	24.7	4.7	6.5	8.1	4.6	5.4	10.2	12.4	8.9	4.1	5.1	8.4	20.4	4.6	12.2	2.8	6.0	13.9	7.2	2.4	5.4	1.9	3.1	30.5	1.0	14.1	4.6	4.8	4.3	12.8	0.9	8.4	4.1	33.3	31.2	12.9	0.0	8.1	9.5	10.8	12.7	4.8	10.2	2.9	3.1	16.6	3.7	9.7
HSD17B1	"EDH17B2, EDHB17, HSD17, MGC138140, SDR28C1"	ENSG00000108786	"Hydroxysteroid 17-beta dehydrogenase 1"	P14061	17	42552922-42555214	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	12	"placenta: 82.3"	"Group enriched"	"Detected in many"	4	"Granulosa cells: 1574.2;Syncytiotrophoblasts: 1495.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in many"	8	"BEWO: 399.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA021032, HPA065296"	Enhanced		Supported	Cytosol		NA	NA		19000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 28: Placenta - Pregnancy"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 40: Granulosa cells - Unknown function"	Cytosol		"HPA021032: AB_1844345, HPA065296: AB_2685457"	"unprognostic (1.13e-1)"	"unprognostic (1.40e-2)"	"unprognostic (1.68e-2)"	"unprognostic (9.25e-2)"	"unprognostic (1.73e-1)"	"unprognostic (3.88e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.10e-1)"	"unprognostic (9.35e-2)"	"unprognostic (6.04e-2)"	"unprognostic (2.88e-5)"	"unprognostic (2.17e-1)"	"unprognostic (1.30e-1)"	"unprognostic (2.60e-2)"	"unprognostic (5.09e-1)"	"unprognostic (4.98e-1)"	"unprognostic (1.32e-2)"	4.4	1.9	3.8	1.7	4.2	0.8	3.0	3.9	4.6	3.0	2.7	2.2	2.1	2.1	0.7	6.0	3.2	0.5	2.1	3.8	3.5	2.4	2.0	1.5	1.0	4.8	3.5	6.8	3.0	0.6	2.4	82.3	4.4	2.6	0.1	0.6	3.7	0.5	4.4	6.3	2.1	0.2	3.2	2.0	2.2	3.8	3.9	0.4	2.8	0.0	0.4	1.7	3.1	6.1	7.0	6.0	1.8	20.2	1.0	0.3	399.0	4.3	0.0	0.0	0.0	2.9	2.8	0.1	4.0	0.2	1.8	9.7	0.7	3.9	0.0	7.6	10.7	3.7	3.8	4.3	0.9	2.7	3.9	0.9	13.2	0.5	2.7	1.5	0.1	2.6	5.7	1.2	0.0	4.8	3.2	2.3	0.4	1.4	2.8	3.9	3.0	2.5	0.5	3.4	4.3	5.6	2.4	41.4	4.2	0.9	48.5	1.1	4.3	2.7	5.4	2.4	2.7	7.7	4.6	1.5	1.9	1.9	2.8	1.0	2.2	2.5	1.1	2.4	1.3	1.2	1.4	1.1	1.3	1.4	1.0	1.0	2.2	1.6	1.5	0.9	0.8	2.0	3.8	4.2	3.9	4.6	3.8	3.5	4.8	3.5	4.4	3.2	3.9	6.1	2.3	0.0	2.2	6.5	2.2	3.1	8.0	14.9	6.2	8.3	11.6	10.7	3.0	4.3	5.3	5.5	12.5	333.0	3.3	4.7	23.5	1.7	1.4	3.3	9.3	4.2	4.2	0.8	1.4	5.6	30.4	11.6	1.5	3.8	2.5	1574.2	3.6	6.4	29.7	10.1	1.6	2.7	8.2	0.6	1.2	1.9	1.8	3.6	1.8	1.9	1.0	11.2	2.1	2.0	3.3	2.0	2.0	3.4	1.4	11.6	2.5	20.5	4.2	8.9	0.0	6.7	29.2	0.8	2.7	14.6	7.4	1495.8	2.6	30.0	2.6	10.4
HSD17B11	"17-BETA-HSD11, 17-BETA-HSDXI, DHRS8, PAN1B, RetSDR2, SDR16C2"	ENSG00000198189	"Hydroxysteroid 17-beta dehydrogenase 11"	Q8NBQ5	4	87336515-87391188	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 288.6;liver: 241.6"	"Cell type enhanced"	"Detected in all"		"Paneth cells: 498.6;Proximal enterocytes: 1134.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 768.7"	"Group enriched"	"Detected in all"	4	"granulocytes: 768.7;monocytes: 202.0"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 295.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021608	Enhanced		Supported	"Lipid droplets"	"Intracellular and membrane"	NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 45: Enterocytes - Digestion"	"Lipid droplets"		"HPA021608: AB_1847660"	"unprognostic (4.53e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.35e-2)"	"unprognostic (4.14e-2)"	"unprognostic (9.68e-2)"	"unprognostic (1.92e-1)"	"unprognostic (3.35e-1)"	"unprognostic (3.70e-2)"	"unprognostic (1.78e-1)"	"unprognostic (8.53e-2)"	"unprognostic (1.24e-3)"	"unprognostic (1.83e-1)"	"unprognostic (2.65e-3)"	"unprognostic (5.53e-2)"	"unprognostic (2.13e-2)"	"unprognostic (2.44e-2)"	"unprognostic (1.04e-2)"	56.0	64.1	15.0	33.0	15.7	109.9	45.5	19.7	18.6	44.0	18.8	139.6	216.7	57.5	28.2	21.5	44.2	107.7	21.0	15.6	18.4	75.9	241.6	104.4	41.5	20.1	17.5	60.6	54.5	10.9	13.1	47.2	18.9	25.5	145.8	8.2	14.8	34.2	12.1	14.5	288.6	49.4	19.3	42.7	36.6	10.1	16.7	36.3	19.3	26.3	34.9	41.8	33.5	22.8	1.0	45.4	22.2	56.1	66.5	92.4	31.2	23.4	39.3	16.1	29.9	38.2	295.2	0.0	45.8	26.2	14.8	0.9	65.6	5.2	18.0	72.1	13.8	63.3	22.9	131.0	37.6	114.8	114.0	65.3	1.7	22.5	7.4	51.3	31.5	27.4	67.9	32.7	30.1	1.8	24.0	144.8	37.8	146.7	7.6	63.2	20.4	77.7	45.5	70.0	7.2	69.3	47.5	1.6	87.0	28.2	0.1	112.7	24.9	11.0	47.9	43.1	13.0	15.0	6.6	7.1	20.1	80.6	77.0	591.1	202.0	442.9	62.5	142.7	74.8	57.1	62.6	64.6	108.2	47.6	55.8	64.2	768.7	82.3	125.8	36.8	77.4	171.6	15.0	15.7	19.7	18.6	15.6	18.4	20.1	17.5	18.9	19.3	16.7	22.8	169.0	314.1	179.5	13.4	89.0	28.0	77.0	16.0	10.8	1.8	5.0	6.2	5.3	368.9	83.7	44.1	2.1	30.6	63.1	356.8	25.4	53.9	1.2	9.0	28.1	101.8	93.7	68.8	16.8	58.6	59.7	77.3	28.1	18.8	100.1	34.1	112.5	337.3	129.1	18.5	14.7	180.8	18.3	220.4	176.2	5.1	104.1	139.1	67.6	43.1	197.3	36.3	113.3	16.6	19.0	65.9	498.6	59.5	60.8	39.5	1134.9	173.6	62.2	3.9	72.3	77.9	43.0	2.7	15.4	10.4	21.5	14.9	93.8	65.4	281.0	93.9
HSDL1	SDR12C3	ENSG00000103160	"Hydroxysteroid dehydrogenase like 1"	Q3SXM5	16	84122141-84145192	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Horizontal cells: 45.4;Rod photoreceptor cells: 44.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045745			Supported	"Vesicles,Intermediate filaments,Mitochondria"		No	No			"Cluster 34: Basophils - Unknown function"	"Cluster 21: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 40: Granulosa cells - Unknown function"	Mitochondria	"Vesicles, Intermediate filaments"	"HPA045745: AB_2679440"	"unprognostic (2.16e-1)"	"unprognostic (4.32e-2)"	"unprognostic (2.09e-1)"	"unprognostic (4.80e-3)"	"unprognostic (3.66e-2)"	"unprognostic (1.68e-1)"	"prognostic unfavorable (3.50e-4)"	"unprognostic (1.25e-2)"	"unprognostic (7.43e-2)"	"unprognostic (3.39e-2)"	"unprognostic (6.42e-2)"	"unprognostic (3.66e-1)"	"prognostic favorable (4.20e-7)"	"unprognostic (2.30e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.03e-2)"	"unprognostic (1.14e-2)"	7.5	15.4	14.3	7.1	14.6	4.4	11.9	10.9	13.0	10.6	10.7	7.4	6.2	13.2	10.5	7.8	12.6	7.1	15.7	14.0	18.3	10.8	5.1	9.1	9.0	15.0	14.8	22.0	4.9	15.1	11.9	9.1	18.6	9.8	6.9	34.3	7.3	11.1	20.7	8.0	5.7	10.8	9.5	8.0	6.4	13.2	17.0	14.1	26.8	30.5	9.2	7.3	7.1	10.2	11.1	12.6	57.4	19.8	20.7	14.5	14.6	13.8	13.1	17.0	8.9	14.5	18.8	22.7	24.7	12.4	18.8	7.6	31.1	12.1	26.9	4.9	18.9	10.9	7.9	32.5	21.0	17.1	19.2	11.0	20.0	24.1	15.4	21.9	20.9	30.6	23.0	28.2	34.3	27.3	37.8	17.4	29.5	6.4	13.3	36.7	20.4	8.4	16.6	12.0	27.1	20.2	35.0	5.6	39.0	28.5	34.4	10.2	17.5	19.2	22.9	13.9	11.3	44.1	38.1	36.9	22.8	12.3	18.2	21.2	5.0	11.1	3.8	3.4	5.0	5.0	4.1	4.6	2.8	7.5	5.3	5.6	5.5	4.3	6.3	0.0	5.4	4.4	14.3	14.6	10.9	13.0	14.0	18.3	15.0	14.8	18.6	9.5	17.0	10.2	8.9	12.8	16.4	7.8	8.2	4.8	4.6	6.4	8.6	20.2	10.2	8.3	16.7	1.5	8.6	3.7	14.6	6.9	4.4	3.7	5.9	7.9	38.5	11.4	10.5	7.7	9.5	5.7	12.4	6.7	6.6	7.7	3.6	11.0	1.3	38.6	9.3	4.1	12.2	45.4	15.8	3.7	4.1	6.9	3.5	12.2	5.9	10.4	5.4	11.2	6.1	28.4	5.2	15.6	13.0	6.8	2.5	10.1	10.1	5.2	3.9	8.0	13.7	44.2	0.0	8.0	7.8	35.8	30.1	8.8	7.0	8.8	6.6	12.7	4.5	4.8
HSF1	HSTF1	ENSG00000185122	"Heat shock transcription factor 1"	Q00613	8	144291591-144314720	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"DNA damage, DNA repair, Host-virus interaction, mRNA processing, mRNA transport, Stress response, Transcription, Transcription regulation, Transport"	"Activator, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 248.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004239, HPA008888"	Supported		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 72: Non-specific - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm	Cytosol	"CAB004239: AB_627753, HPA008888: AB_1079088"	"unprognostic (7.08e-2)"	"unprognostic (1.89e-2)"	"unprognostic (6.07e-2)"	"prognostic unfavorable (8.93e-4)"	"unprognostic (1.55e-1)"	"unprognostic (5.63e-2)"	"prognostic unfavorable (4.95e-4)"	"unprognostic (5.69e-3)"	"unprognostic (1.05e-1)"	"unprognostic (4.35e-2)"	"unprognostic (1.40e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.07e-2)"	"unprognostic (2.23e-1)"	"unprognostic (2.13e-1)"	"unprognostic (1.12e-1)"	51.7	55.7	20.0	14.7	19.2	18.0	47.9	18.2	24.0	48.6	17.0	70.6	14.1	51.7	7.4	48.1	52.1	12.4	133.5	18.6	19.1	50.2	46.0	49.5	14.5	22.3	21.4	57.3	68.7	18.7	48.1	17.0	20.2	53.2	10.8	7.6	39.8	17.1	125.1	49.2	39.7	15.3	18.6	42.8	57.8	107.8	21.7	14.7	45.7	32.2	12.6	58.7	46.2	18.0	40.8	53.8	22.9	19.6	37.6	35.0	37.9	29.7	26.6	28.8	25.0	36.3	34.6	46.7	42.5	41.5	28.2	28.9	35.2	42.7	18.3	29.9	40.7	58.4	51.8	50.1	59.1	17.1	43.4	34.2	39.3	40.6	74.2	30.6	39.4	41.9	39.6	27.1	29.4	82.0	58.0	26.2	29.4	52.6	154.2	37.2	19.9	59.2	20.6	40.5	34.3	27.9	45.4	35.9	52.8	23.8	40.5	34.5	40.2	29.5	66.3	46.8	49.5	18.8	15.4	39.9	41.8	31.4	28.8	14.2	23.2	26.3	16.7	24.9	17.2	19.2	17.8	21.1	24.6	17.3	17.1	15.9	9.7	16.3	32.2	12.6	22.9	19.2	20.0	19.2	18.2	24.0	18.6	19.1	22.3	21.4	20.2	18.6	21.7	18.0	46.5	6.4	11.2	8.5	40.4	51.4	73.8	53.8	39.9	67.8	37.0	30.5	46.4	22.8	34.7	29.5	62.6	69.9	38.2	43.3	150.6	39.2	248.7	35.1	20.5	44.4	40.9	120.8	12.1	41.1	80.6	34.7	44.9	34.6	37.5	51.1	40.7	63.8	49.5	69.0	14.7	36.8	42.7	25.7	45.6	106.7	37.3	32.7	33.8	12.2	59.7	24.9	34.0	6.0	12.9	45.3	49.3	42.9	40.4	76.6	63.8	34.9	25.9	33.1	59.2	41.3	39.2	84.4	47.7	36.3	45.5	111.0	39.0	105.9	45.8	76.4
HSF2		ENSG00000025156	"Heat shock transcription factor 2"	Q03933	6	122399551-122433119	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Stress response, Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 97.1;Spermatocytes: 73.8;Spermatogonia: 97.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016067, HPA031455"	Approved		Supported	Nucleoplasm		No	No			"Cluster 32: T-cells - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 12: NES - Nervous system development"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	Nucleoplasm		"CAB016067: AB_627754, HPA031455: AB_10670702"	"unprognostic (1.62e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.55e-1)"	"unprognostic (5.42e-2)"	"unprognostic (2.27e-3)"	"unprognostic (1.45e-1)"	"prognostic unfavorable (1.51e-6)"	"unprognostic (3.40e-3)"	"unprognostic (2.60e-1)"	"unprognostic (2.58e-1)"	"unprognostic (1.25e-3)"	"unprognostic (3.03e-1)"	"prognostic unfavorable (7.65e-4)"	"unprognostic (9.27e-2)"	"unprognostic (5.44e-2)"	"unprognostic (1.89e-1)"	"unprognostic (2.42e-1)"	9.5	15.2	12.2	7.9	12.3	29.6	12.7	15.0	13.5	13.1	15.9	11.6	6.9	14.5	10.3	8.2	11.9	7.5	23.3	11.5	12.6	6.8	5.5	8.8	12.7	10.5	10.9	14.6	6.4	14.0	10.6	8.2	11.3	11.1	6.9	44.5	8.5	12.7	48.6	12.7	9.1	14.0	10.7	9.2	9.4	37.9	13.0	17.9	8.8	64.3	12.5	9.6	9.0	13.1	8.5	8.7	44.5	35.8	19.6	15.6	12.2	14.6	35.5	26.9	41.6	13.0	7.0	32.2	12.4	18.9	30.2	10.5	30.1	14.4	37.4	32.7	36.4	31.8	8.6	27.1	19.9	23.5	15.4	20.0	21.6	22.3	25.2	24.9	16.4	28.8	34.0	15.5	25.6	11.5	38.8	30.9	13.6	12.2	12.3	35.6	18.0	10.3	20.5	9.7	46.5	31.5	15.1	12.5	14.5	32.5	10.8	25.5	10.4	14.3	16.2	16.1	22.6	22.1	22.7	41.4	15.5	15.3	18.9	6.9	3.9	6.1	11.7	4.7	12.6	9.2	11.0	10.3	5.5	7.0	27.9	22.0	0.6	11.0	6.8	3.8	13.2	11.4	12.2	12.3	15.0	13.5	11.5	12.6	10.5	10.9	11.3	10.7	13.0	13.1	10.6	19.2	10.3	17.0	11.9	31.7	11.4	8.1	27.3	21.8	12.1	10.9	36.6	4.3	11.1	0.0	27.1	15.5	14.4	1.9	11.7	7.7	97.1	21.3	14.6	10.3	6.6	16.2	26.6	4.2	7.4	16.2	10.2	9.6	8.8	19.4	6.1	4.9	7.9	21.9	29.4	6.1	24.4	4.8	7.8	21.3	10.2	6.0	19.6	14.0	2.9	15.2	7.2	24.1	23.5	4.8	5.2	9.8	7.9	8.7	3.2	7.5	23.3	34.2	26.3	14.9	12.1	73.8	97.0	16.1	25.7	3.1	20.5	39.6	5.4	6.4
HSF4	CTM	ENSG00000102878	"Heat shock transcription factor 4"	Q9ULV5	16	67164681-67169945	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Stress response, Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"	"Cataract, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 69.2"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 38.5;Excitatory neurons: 30.9;Horizontal cells: 43.7;Inhibitory neurons: 30.0;Leydig cells: 32.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 17.1;T-47d: 12.9;U-266/70: 22.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048584			Supported	"Nuclear speckles"		NA	NA				"Cluster 22: Non-specific - Unknown function"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 62: Horizontal cells - Visual perception"	"Nuclear speckles"		"HPA048584: AB_2680452"	"unprognostic (1.90e-1)"	"unprognostic (3.05e-2)"	"prognostic unfavorable (8.24e-5)"	"unprognostic (9.20e-3)"	"unprognostic (2.61e-1)"	"unprognostic (1.43e-1)"	"unprognostic (8.98e-2)"	"unprognostic (1.36e-1)"	"unprognostic (4.06e-2)"	"unprognostic (2.45e-1)"	"unprognostic (2.85e-2)"	"unprognostic (4.26e-3)"	"prognostic unfavorable (2.19e-6)"	"unprognostic (1.20e-1)"	"unprognostic (1.33e-1)"	"unprognostic (4.48e-2)"	"unprognostic (8.74e-3)"	12.4	23.7	43.6	1.3	44.3	1.8	12.7	44.6	69.2	17.9	39.2	10.1	4.8	12.4	4.8	11.0	21.1	3.6	20.0	44.6	43.7	17.1	20.3	8.7	1.6	45.0	41.9	19.8	35.9	4.3	30.1	3.3	46.4	28.3	1.8	5.6	19.0	1.9	25.9	14.5	6.1	2.1	41.3	6.0	14.4	7.0	43.3	1.1	17.9	4.1	1.1	18.8	10.9	45.8	1.6	1.1	0.0	1.1	0.5	3.0	5.2	0.5	0.6	0.2	0.0	2.4	3.5	0.1	2.5	1.1	0.7	5.9	0.4	0.7	0.2	2.3	2.2	0.6	4.5	3.1	2.3	0.3	4.4	1.3	4.8	0.2	2.5	17.1	0.9	4.0	1.5	5.1	2.3	1.5	0.8	1.8	0.1	3.4	3.2	2.0	1.7	8.7	4.4	2.5	3.5	7.6	4.9	3.0	7.8	2.1	12.9	4.5	0.9	1.6	1.6	6.4	1.5	22.3	3.7	1.5	4.9	1.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	43.6	44.3	44.6	69.2	44.6	43.7	45.0	41.9	46.4	41.3	43.3	45.8	2.6	3.2	7.7	38.5	1.1	3.1	3.4	2.9	4.6	10.8	9.1	7.7	5.3	4.3	2.7	3.7	2.1	1.0	0.7	2.9	0.0	1.0	0.5	4.1	2.8	1.6	1.2	0.0	30.9	1.3	0.6	6.0	14.8	7.0	1.3	2.3	2.9	5.7	21.9	43.7	30.0	3.0	2.0	0.8	2.5	1.8	32.9	4.6	10.6	5.6	1.5	8.8	0.0	4.0	15.2	1.4	3.5	22.2	1.5	4.0	0.4	2.4	4.8	11.4	0.0	5.4	3.2	0.4	2.3	3.6	3.4	0.7	0.9	1.9	2.9	2.0
HSFX1	LW-1	ENSG00000171116	"Heat shock transcription factor family, X-linked 1"	Q9UBD0	X	149774068-149776867	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in some"											"HPA051700, HPA063040"	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA				"Cluster 68: Epididymis - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"		Nucleoplasm	"Plasma membrane, Cytosol"	"HPA051700: AB_2681578, HPA063040: AB_2732695"	"unprognostic (3.50e-2)"	"unprognostic (2.86e-1)"			"unprognostic (2.30e-2)"	"unprognostic (6.32e-2)"		"unprognostic (3.38e-2)"	"unprognostic (3.78e-1)"	"unprognostic (5.03e-2)"	"unprognostic (3.70e-1)"	"unprognostic (3.56e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.68e-2)"	"unprognostic (1.92e-1)"	"unprognostic (2.46e-1)"	"unprognostic (3.10e-1)"	0.8	0.8	1.5	0.3	1.8	0.0	1.1	1.9	2.6	1.7	2.8	1.8	0.5	1.3	3.3	1.2	1.5	0.8	1.9	2.0	1.4	1.0	1.0	0.9	0.4	1.5	1.5	3.1	1.0	0.8	1.2	1.2	2.2	2.0	0.1	0.7	1.3	0.6	1.3	1.2	1.0	0.4	1.0	2.5	1.0	3.4	1.8	0.1	1.5	0.0	0.4	1.4	1.5	1.8	0.0	1.1	0.0	0.4	1.4	0.9	0.2	0.2	0.0	0.2	0.0	0.8	0.7	0.7	1.2	0.1	0.7	0.0	0.6	0.2	0.1	0.1	0.0	0.2	0.5	0.1	0.8	0.1	0.1	0.0	0.0	0.0	0.6	1.1	0.3	0.0	0.0	0.2	0.1	1.3	0.1	0.5	0.3	0.1	0.6	0.3	0.8	0.0	1.0	0.5	0.5	0.2	0.1	0.0	0.2	0.8	0.1	0.2	0.2	0.0	0.6	0.2	0.4	0.2	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	1.5	1.8	1.9	2.6	2.0	1.4	1.5	1.5	2.2	1.0	1.8	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
HSFX2		ENSG00000268738	"Heat shock transcription factor family, X-linked 2"	Q9UBD0	X	149592512-149595314	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"testis: 12.3"	"Cell type enriched"	"Detected in single"	16	"Cardiomyocytes: 1.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 1.1;HEK 293: 1.1;hTCEpi: 1.5;MCF7: 1.4;U-138 MG: 1.5"									"HPA051700, HPA063040"	Supported		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA				"Cluster 78: Testis - Spermatogenesis"	"Cluster 12: NES - Nervous system development"	"Cluster 43: Cardiomyocytes - Nuclear processes"	Nucleoplasm	"Plasma membrane, Cytosol"	"HPA051700: AB_2681578, HPA063040: AB_2732695"					"unprognostic (7.64e-2)"					"unprognostic (6.92e-3)"				"unprognostic (2.00e-1)"				0.3	0.4	0.8	0.2	1.0	0.0	0.6	0.9	2.2	0.5	1.0	0.6	0.5	0.6	0.2	0.4	1.0	0.0	1.2	0.7	0.1	0.5	0.5	0.6	0.1	0.5	0.3	1.0	0.4	1.3	0.4	0.4	0.4	0.9	0.5	1.0	1.0	1.4	0.7	1.2	0.3	0.7	0.0	1.1	0.4	12.3	0.1	0.6	0.5	2.1	0.2	0.3	0.5	0.8	0.5	0.0	1.1	0.6	0.0	0.2	0.0	0.2	0.5	0.2	0.6	0.0	0.0	0.1	0.2	0.3	0.0	1.0	0.0	0.3	0.1	0.0	1.1	0.0	0.4	0.0	0.0	0.1	0.3	0.5	1.5	0.6	0.0	0.2	0.0	0.7	0.0	0.0	0.0	1.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.6	0.3	0.1	0.0	0.0	1.5	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	1.0	0.9	2.2	0.7	0.1	0.5	0.3	0.4	0.0	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
HSFY1	"HSF2L, HSFY"	ENSG00000172468	"Heat shock transcription factor Y-linked 1"	Q96LI6	Y	18546691-18588963	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	11	"testis: 10.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA074968			Supported	Nucleoplasm,Cytosol		NA	NA				"Cluster 78: Testis - Spermatogenesis"		"Cluster 34: Spermatids - Unknown function"	"Nucleoplasm, Cytosol"		"HPA074968: "																		0.0	0.0	0.4	0.0	0.5	0.1	0.0	0.6	0.9	0.0	0.8	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.4	0.6	0.2	0.1	0.0	0.0	0.5	0.5	0.0	0.0	0.0	0.1	0.0	0.6	0.1	0.0	0.2	0.1	0.0	0.2	0.2	0.0	0.0	0.4	0.0	0.0	10.5	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.5	0.6	0.9	0.4	0.6	0.5	0.5	0.6	0.4	0.6	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
HSFY2	FLJ25453	ENSG00000169953	"Heat shock transcription factor Y-linked 2"	Q96LI6	Y	18731440-18773735	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	24	"testis: 21.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA074968			Supported	Nucleoplasm,Cytosol		NA	NA				"Cluster 78: Testis - Spermatogenesis"		"Cluster 29: Early spermatids - Spermatogenesis"	"Nucleoplasm, Cytosol"		"HPA074968: "																		0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.1	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.8	0.0	0.4	0.2	0.2	0.3	0.0	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
HSP90AB1	"HSPC2, HSPCB"	ENSG00000096384	"Heat shock protein 90 alpha family class B member 1"	P08238	6	44246166-44253888	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transporters"	"Stress response"	Chaperone	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Basal prostatic cells: 4755.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005230, HPA055729, HPA072606, HPA074351"	Enhanced		Supported	Cytosol	"Intracellular and membrane"	NA	Yes		63000000	"Cluster 27: Non-specific - Gene expression"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 22: Epithelial cell types - Mixed function"	Cytosol		"CAB005230: AB_2121392, HPA055729: AB_2682899, HPA072606: AB_2732203, HPA074351: AB_2732252"	"unprognostic (6.12e-3)"	"unprognostic (2.96e-3)"	"unprognostic (4.72e-2)"	"unprognostic (9.24e-2)"	"unprognostic (4.20e-1)"	"unprognostic (1.15e-3)"	"unprognostic (1.76e-3)"	"unprognostic (2.74e-1)"	"unprognostic (7.97e-2)"	"prognostic favorable (4.03e-4)"	"unprognostic (1.31e-1)"	"unprognostic (1.60e-1)"	"prognostic unfavorable (9.94e-4)"	"unprognostic (3.02e-1)"	"unprognostic (9.53e-2)"	"unprognostic (2.63e-1)"	"unprognostic (1.06e-1)"	584.8	719.5	647.1	368.9	700.4	466.4	507.6	675.2	1529.5	581.3	651.0	425.3	215.8	594.2	540.1	463.8	708.5	332.5	783.8	699.9	811.5	494.6	396.5	526.9	427.7	707.0	738.2	1204.8	722.9	606.0	574.8	451.9	764.3	471.2	389.8	339.5	410.2	491.9	1379.0	483.7	332.6	526.8	655.1	346.0	538.8	251.6	745.8	362.1	456.8	998.8	571.4	525.0	509.4	818.8	2393.2	1495.7	1298.1	1606.0	871.2	904.4	1355.3	1049.1	1021.8	1898.3	1325.5	2254.5	708.0	3029.2	1106.3	1099.8	1928.1	1349.9	3197.5	1563.4	2326.7	1010.5	1292.5	2359.3	793.9	2978.8	628.9	2386.2	1563.2	842.6	1034.9	1495.5	1277.7	1658.4	1847.6	1533.9	3210.4	1095.1	1309.8	2404.3	2003.1	1432.6	1519.7	4378.9	1129.7	1900.7	1325.9	1658.7	1287.7	1422.1	1891.1	1154.8	816.3	1164.8	1526.2	1751.5	1518.6	1178.2	1169.0	1124.0	1875.7	931.1	2440.0	1255.6	2125.8	5370.7	1221.7	1720.8	1312.1	65.9	231.7	52.8	343.7	341.0	577.8	544.0	380.3	395.0	375.1	473.1	509.3	494.0	27.3	434.9	349.0	232.1	326.8	678.5	647.1	700.4	675.2	1529.5	699.9	811.5	707.0	738.2	764.3	655.1	745.8	818.8	1165.2	897.4	678.2	70.5	906.4	1059.3	4755.7	862.6	1331.1	329.3	938.9	1418.3	1407.0	519.0	942.6	366.0	227.2	1104.3	629.3	538.6	729.8	1011.1	185.5	1385.8	1359.6	1070.6	567.4	775.9	103.5	688.9	1107.1	1247.3	616.2	1444.8	1003.4	761.3	360.5	360.3	807.5	339.9	151.0	578.2	518.8	314.5	1262.5	198.4	686.0	896.7	736.4	76.8	573.3	326.1	200.8	69.9	127.4	811.7	504.8	611.2	725.0	1810.6	361.5	664.8	1219.1	262.1	348.4	1512.7	1437.2	266.1	694.1	1232.8	923.5	1123.3	1265.6	1350.0	739.6	2408.7
HSPA9	"GRP75, HSPA9B, mot-2, mthsp75, PBP74"	ENSG00000113013	"Heat shock protein family A (Hsp70) member 9"	P38646	5	138553756-138575675	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"		Chaperone	"Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000898, CAB005219"	Supported		Supported	Mitochondria		NA	NA		3600000	"Cluster 27: Non-specific - Gene expression"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"CAB005219: AB_647720, HPA000898: AB_1079032"	"prognostic unfavorable (2.93e-4)"	"unprognostic (1.86e-1)"	"prognostic favorable (4.53e-4)"	"unprognostic (3.73e-2)"	"unprognostic (2.33e-1)"	"unprognostic (9.06e-2)"	"unprognostic (2.05e-2)"	"unprognostic (1.10e-1)"	"unprognostic (9.85e-2)"	"unprognostic (2.53e-1)"	"unprognostic (2.74e-1)"	"unprognostic (1.31e-1)"	"unprognostic (8.78e-3)"	"unprognostic (1.02e-1)"	"unprognostic (2.15e-1)"	"unprognostic (3.27e-2)"	"unprognostic (2.29e-1)"	88.6	226.3	10.3	51.5	15.1	98.8	72.4	25.4	26.0	60.3	28.8	80.3	61.2	67.0	33.9	87.8	56.5	38.3	179.5	10.9	19.6	112.1	194.2	62.5	43.6	19.6	20.7	80.0	79.8	169.4	71.4	46.5	23.8	56.4	56.5	48.8	78.9	46.7	288.9	77.5	64.3	44.2	21.6	54.7	91.8	50.1	17.8	44.6	91.3	193.6	55.7	73.8	65.6	29.1	196.0	276.6	111.4	231.0	138.1	94.3	274.7	198.3	196.7	255.4	268.6	579.4	194.4	419.3	263.7	150.8	382.0	158.6	334.0	314.1	298.2	219.7	177.9	230.5	209.0	270.4	360.4	229.0	201.3	142.6	317.7	299.5	494.8	78.7	128.0	167.8	280.4	297.5	134.7	220.6	206.7	82.9	182.5	191.6	173.3	252.1	188.8	302.4	192.8	267.4	150.1	112.4	242.5	338.5	630.7	269.0	230.5	200.5	117.7	204.1	126.5	174.9	313.5	324.6	300.5	378.6	249.6	301.4	202.6	11.8	31.3	10.7	39.8	34.9	46.2	31.7	30.6	36.8	42.0	22.4	34.1	33.9	4.3	28.3	38.8	17.9	31.3	53.6	10.3	15.1	25.4	26.0	10.9	19.6	19.6	20.7	23.8	21.6	17.8	29.1	63.0	99.3	123.8	43.1	101.7	87.8	228.6	157.2	84.8	88.2	83.4	63.8	337.3	70.1	153.8	99.3	83.4	194.7	114.7	80.8	223.0	151.4	12.1	90.1	98.4	83.1	73.0	75.1	41.1	106.1	132.9	109.6	73.9	126.6	167.8	86.1	43.5	175.9	133.9	99.3	48.4	95.4	148.5	54.1	76.4	12.6	67.4	100.1	83.6	25.3	92.3	92.5	43.3	27.6	43.3	93.8	66.0	72.6	102.3	131.1	85.8	231.3	119.7	89.3	46.0	134.3	136.2	52.5	91.4	93.2	73.9	175.5	130.7	157.9	150.7	141.2
HSPB3	HSPL27	ENSG00000169271	"Heat shock protein family B (small) member 3"	Q12988	5	54455699-54456377	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Stress response"		"Disease variant, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	17	"heart muscle: 406.9;skeletal muscle: 217.2;tongue: 218.9"	"Cell type enriched"	"Detected in some"	18	"Cardiomyocytes: 398.1"	"Cancer enriched"	"Detected in many"	6	"head and neck cancer: 7.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 86.3;fHDF/TERT166: 39.1;HSkMC: 16.3;LHCN-M2: 12.6"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA062124			Supported	"Nuclear speckles"		NA	NA				"Cluster 38: Heart - Muscle contraction"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 54: Cardiomyocytes - Muscle contraction"	"Nuclear speckles"		"HPA062124: AB_2684690"		"unprognostic (1.44e-1)"	"unprognostic (2.21e-1)"	"unprognostic (1.78e-3)"	"unprognostic (3.06e-1)"	"unprognostic (2.25e-3)"		"unprognostic (1.13e-1)"	"unprognostic (4.41e-3)"	"unprognostic (6.42e-2)"	"unprognostic (1.85e-1)"	"unprognostic (2.70e-2)"		"unprognostic (2.73e-1)"	"unprognostic (2.82e-2)"		"unprognostic (7.15e-2)"	1.4	0.2	4.6	0.1	5.6	0.2	2.1	4.0	7.5	0.9	4.1	5.2	0.2	7.5	0.4	16.5	3.0	0.2	406.9	6.3	7.2	0.4	0.1	2.8	0.0	4.1	4.0	1.0	0.1	0.0	3.6	0.1	4.4	8.6	2.1	1.6	6.7	0.8	217.2	2.2	0.9	10.4	4.1	0.7	0.9	1.8	4.1	0.7	0.3	218.9	0.0	3.7	0.8	6.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	86.3	0.1	0.1	0.4	0.0	0.0	0.3	39.1	0.1	4.8	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.4	0.0	0.0	16.3	5.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	12.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	4.4	0.1	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	4.6	5.6	4.0	7.5	6.3	7.2	4.1	4.0	4.4	4.1	4.1	6.4	0.0	0.0	0.0	0.3	0.0	6.4	0.4	3.2	0.0	0.1	0.0	0.0	398.1	0.0	0.3	0.0	0.0	0.1	0.0	10.5	0.0	0.0	0.1	0.7	0.2	3.5	0.0	0.0	4.3	0.0	0.0	14.4	0.0	1.3	0.0	0.1	0.0	0.0	0.1	1.7	6.5	0.0	0.0	0.0	4.9	0.4	0.6	0.2	3.6	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.5	6.6	21.3	7.2	0.4	0.0	0.0	5.3	0.1	0.2	0.1	0.3	0.3
HSPB6	"FLJ32389, Hsp20, PPP1R91"	ENSG00000004776	"Heat shock protein family B (small) member 6"	O14558	19	35754566-35758079	"Predicted intracellular proteins"	"Stress response"	Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 2969.8;tongue: 1759.1"	"Group enriched"	"Detected in many"	4	"Endometrial stromal cells: 165.7;Fibroblasts: 125.2;Leydig cells: 271.8;Peritubular cells: 220.4;Smooth muscle cells: 102.6;Theca cells: 311.0"	"Cancer enhanced"	"Detected in all"		"stomach cancer: 93.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 1774.3;ASC TERT1: 742.0;HHSteC: 599.9;HSkMC: 700.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB001974, HPA044153, HPA054811"	Enhanced		Supported	"Nucleoli,Golgi apparatus,Cytosol"	"Intracellular and membrane"	NA	NA		310000		"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 48: Smooth muscle cells - ECM organization"	Cytosol	"Nucleoli, Golgi apparatus"	"CAB001974: , HPA044153: AB_2678836, HPA054811: AB_2682610"	"unprognostic (3.19e-2)"	"unprognostic (8.07e-2)"	"unprognostic (1.41e-2)"	"unprognostic (1.01e-1)"	"unprognostic (5.21e-3)"	"unprognostic (7.02e-2)"	"unprognostic (9.67e-2)"	"unprognostic (7.57e-2)"	"unprognostic (1.18e-1)"	"unprognostic (7.23e-2)"	"unprognostic (1.20e-1)"	"unprognostic (7.02e-2)"	"prognostic unfavorable (1.93e-5)"	"unprognostic (3.32e-2)"	"unprognostic (6.65e-2)"	"unprognostic (5.61e-2)"	"prognostic unfavorable (1.43e-6)"	650.0	414.0	37.3	45.4	40.6	0.4	394.9	32.5	49.2	581.9	26.1	699.9	28.1	565.1	101.6	112.3	495.1	97.9	1463.9	30.0	43.6	69.0	42.3	126.6	5.7	76.7	48.5	455.2	50.5	4.2	17.5	40.2	73.7	271.2	44.0	21.1	115.9	194.7	2969.8	39.1	180.0	278.2	50.8	15.7	362.1	60.6	53.8	6.2	99.5	1759.1	2.7	537.3	290.6	49.3	0.6	0.7	2.1	2.5	1774.3	742.0	1.2	83.0	1.3	4.9	9.3	1.1	0.4	0.7	0.6	252.4	0.0	0.2	0.4	0.7	3.9	0.9	0.5	0.4	1.3	0.5	599.9	0.2	0.9	700.3	0.0	19.1	0.9	2.2	5.4	0.3	0.5	1.0	0.2	0.3	0.4	1.9	1.2	2.3	0.6	1.5	0.5	0.7	0.0	0.1	0.8	0.7	0.1	0.2	0.7	0.3	0.3	0.5	0.1	153.2	0.9	17.3	0.6	1.0	2.8	0.3	20.5	1.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	37.3	40.6	32.5	49.2	30.0	43.6	76.7	48.5	73.7	50.8	53.8	49.3	11.1	3.2	0.6	1.6	0.1	1.8	0.4	0.0	3.4	7.8	0.5	0.5	29.7	0.0	0.0	0.0	0.0	2.5	0.1	0.1	0.0	0.1	27.0	4.9	165.7	3.6	0.0	5.2	0.2	0.0	2.5	125.2	4.1	3.5	0.0	3.6	17.5	0.3	5.0	0.0	0.5	0.0	0.0	0.3	3.6	18.9	271.8	2.7	1.8	0.0	0.6	44.5	0.0	0.0	0.1	0.2	0.0	220.4	0.1	0.4	0.0	0.4	0.0	2.8	26.3	38.0	102.6	2.3	1.4	1.9	2.0	4.8	1.8	311.0	0.0	0.5
HSPB8	"CMT2L, E2IG1, H11, HSP22"	ENSG00000152137	"Heat shock protein family B (small) member 8"	Q9UJY1	12	119171555-119224855	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Stress response"	Chaperone	"Charcot-Marie-Tooth disease, Disease variant, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 897.3"	"Group enriched"	"Detected in many"	6	"Cardiomyocytes: 599.1;Syncytiotrophoblasts: 1340.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"EFO-21: 89.6;HeLa: 66.0;MCF7: 130.5;U-87 MG: 67.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015876	Approved		Supported	Nucleoplasm,Cytosol		NA	NA				"Cluster 80: Striated muscle - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	Cytosol	Nucleoplasm	"HPA015876: AB_1850458"	"unprognostic (1.52e-2)"	"unprognostic (6.97e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.88e-1)"	"unprognostic (1.99e-3)"	"prognostic unfavorable (2.98e-4)"	"unprognostic (2.47e-1)"	"unprognostic (4.03e-2)"	"unprognostic (7.91e-2)"	"unprognostic (6.48e-3)"	"unprognostic (1.11e-1)"	"unprognostic (1.30e-1)"	"unprognostic (2.05e-3)"	"unprognostic (2.05e-1)"	"unprognostic (6.36e-2)"	"unprognostic (2.17e-2)"	57.0	13.9	172.2	34.4	172.6	0.0	33.4	179.5	141.8	58.1	147.0	381.0	8.9	114.4	10.1	163.2	58.7	43.1	469.3	147.8	231.0	63.3	4.8	95.7	11.4	188.3	206.1	23.4	30.8	183.1	17.5	92.1	193.0	143.5	35.8	28.2	50.8	289.0	897.3	70.5	50.5	114.1	211.5	56.2	110.4	12.0	193.6	40.3	29.2	448.5	98.7	239.2	100.1	235.5	21.1	16.1	0.3	0.0	14.4	11.5	60.2	32.5	28.7	5.9	0.3	40.0	0.6	0.1	89.6	42.4	48.0	2.4	0.3	0.0	0.6	0.1	1.2	0.0	66.0	3.2	11.2	0.0	0.1	14.1	4.1	22.3	1.3	21.6	12.3	0.0	0.2	0.0	13.0	130.5	0.0	0.2	5.7	0.0	23.0	0.0	22.9	2.9	38.3	6.2	0.4	1.0	13.5	1.6	6.8	50.5	29.0	0.2	20.4	15.8	39.8	21.7	1.7	0.0	0.2	0.2	67.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	172.2	172.6	179.5	141.8	147.8	231.0	188.3	206.1	193.0	211.5	193.6	235.5	2.7	44.8	48.2	42.1	0.7	102.3	108.5	4.5	126.3	0.7	95.2	17.5	599.1	7.2	5.4	5.5	8.4	149.1	1.0	0.0	0.0	59.7	12.2	98.1	20.2	27.4	0.0	0.0	6.2	11.4	17.5	82.2	5.6	142.7	1.3	0.0	25.4	0.0	19.4	1.7	6.6	0.0	2.0	1.0	9.4	11.0	1.5	1.6	12.4	2.8	1.0	51.7	0.0	0.0	0.9	12.9	0.0	0.4	0.3	24.6	0.0	52.0	3.1	2.1	6.6	39.8	76.9	0.9	0.2	38.0	28.7	1340.0	3.5	0.1	0.2	72.7
HSPB9	CT51	ENSG00000260325	"Heat shock protein family B (small) member 9"	Q9BQS6	17	42122804-42123352	"Predicted intracellular proteins"	"Stress response"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"testis: 17.8"	"Group enriched"	"Detected in some"	5	"Early spermatids: 375.3;Late spermatids: 1017.0"	"Cancer enhanced"	"Detected in single"		"liver cancer: 1.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 3.3;HEK 293: 3.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA053091			Supported	Nucleoplasm,Vesicles,Cytosol		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 22: Non-specific - Unknown function"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 31: Spermatids - Spermatogenesis"	Nucleoplasm	"Vesicles, Cytosol"	"HPA053091: "	"unprognostic (2.36e-1)"	"unprognostic (2.63e-1)"	"unprognostic (8.35e-2)"	"unprognostic (1.99e-2)"	"unprognostic (5.67e-2)"	"unprognostic (8.37e-2)"	"unprognostic (2.30e-2)"	"unprognostic (3.42e-6)"	"unprognostic (2.31e-1)"	"unprognostic (5.13e-2)"	"unprognostic (3.82e-1)"	"unprognostic (8.62e-2)"	"unprognostic (3.36e-3)"	"unprognostic (3.68e-4)"	"unprognostic (4.78e-2)"	"unprognostic (4.01e-1)"	"unprognostic (1.24e-1)"	0.4	0.2	1.3	0.4	1.4	0.6	0.2	1.6	1.7	0.2	0.9	0.3	0.3	0.2	0.0	0.1	0.7	0.6	0.2	1.2	1.3	0.5	3.6	0.2	0.4	1.4	1.2	1.3	4.8	0.2	0.5	0.2	1.4	0.5	0.0	0.0	2.9	0.5	1.5	0.4	0.4	0.1	1.2	0.5	0.4	17.8	1.4	0.0	0.2	1.0	0.0	0.2	0.2	1.7	0.2	0.2	0.3	0.9	0.0	0.0	3.3	0.0	0.0	0.0	0.3	1.0	0.1	0.3	0.1	0.0	0.1	0.0	0.4	0.2	0.0	0.3	3.0	0.5	1.2	0.4	0.0	0.3	1.0	0.0	0.0	0.1	0.0	0.1	0.0	0.3	0.4	0.2	0.0	0.4	0.3	1.1	0.1	0.3	0.0	0.1	0.2	1.0	0.0	0.7	1.4	0.3	0.0	1.5	0.2	0.1	0.2	0.1	0.4	0.7	0.0	0.6	0.2	0.6	0.3	0.6	0.1	0.5	0.2	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.3	0.5	0.0	0.0	1.3	1.4	1.6	1.7	1.2	1.3	1.4	1.2	1.4	1.2	1.4	1.7	0.7	0.0	0.0	0.0	0.0	0.4	0.5	0.1	0.6	0.6	0.6	0.5	0.6	2.8	0.0	0.0	2.1	3.2	0.2	0.4	19.6	0.0	375.3	0.5	0.3	0.6	0.0	0.0	0.1	1.1	0.8	0.7	0.0	0.3	0.0	0.5	1.8	15.3	0.2	3.3	0.1	0.7	0.0	0.8	0.4	1017.0	7.2	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.4	0.3	6.8	0.0	0.4	0.6	0.9	0.1	0.4	0.0	0.8	0.3	127.3	4.5	0.1	0.3	0.3	0.2	0.6	0.3	0.2
HTATIP2	"CC3, FLJ26963, SDR44U1, TIP30"	ENSG00000109854	"HIV-1 Tat interactive protein 2"	Q9BUP3	11	20363685-20383782	"Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Angiogenesis, Apoptosis, Differentiation, Host-virus interaction"	"Developmental protein, Oxidoreductase"	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Proximal enterocytes: 269.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 283.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006417, HPA024321"	Approved		Supported	Cytosol		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Cytosol		"HPA006417: AB_1079091, HPA024321: AB_1851288"	"unprognostic (8.05e-3)"	"unprognostic (2.13e-1)"	"unprognostic (9.31e-2)"	"unprognostic (3.01e-1)"	"unprognostic (1.36e-2)"	"unprognostic (3.79e-3)"	"prognostic unfavorable (2.86e-4)"	"unprognostic (1.20e-3)"	"unprognostic (1.05e-1)"	"unprognostic (4.93e-2)"	"prognostic unfavorable (6.18e-4)"	"unprognostic (1.75e-1)"	"prognostic unfavorable (8.01e-4)"	"unprognostic (1.20e-1)"	"unprognostic (9.42e-2)"	"unprognostic (1.71e-1)"	"unprognostic (2.03e-1)"	30.0	57.5	29.6	32.3	35.9	18.6	29.6	33.2	46.1	24.2	34.7	88.4	135.9	13.8	31.4	50.0	13.5	44.8	21.2	29.2	31.3	32.6	97.8	39.1	28.5	34.1	31.7	16.2	26.7	27.8	39.9	28.5	34.6	22.4	80.7	1.9	35.0	20.6	46.2	36.0	121.4	14.4	32.3	38.6	75.4	21.4	32.3	20.2	51.3	21.3	27.4	37.7	35.4	45.8	109.6	177.5	3.9	0.2	52.5	39.4	38.7	46.4	45.8	35.3	41.8	103.2	93.8	24.8	93.1	58.3	136.6	149.7	0.0	28.2	33.9	283.9	21.4	30.8	170.1	0.2	125.3	11.3	139.6	57.3	196.0	28.7	44.5	0.0	102.2	0.0	76.8	31.6	66.3	102.0	0.4	7.0	56.5	193.2	87.1	23.2	0.3	89.8	48.1	60.1	47.2	0.5	150.9	59.1	73.6	18.0	123.7	57.0	125.4	25.1	54.8	51.0	1.2	33.5	44.7	0.6	0.4	76.9	111.4	233.4	133.3	171.1	64.3	126.4	73.4	65.9	74.1	69.2	76.9	76.4	63.9	62.7	304.1	64.5	135.2	23.2	140.9	116.7	29.6	35.9	33.2	46.1	29.2	31.3	34.1	31.7	34.6	32.3	32.3	45.8	49.2	25.6	9.6	3.9	28.0	36.3	60.0	74.2	67.2	1.0	32.9	26.7	11.6	102.9	43.7	47.8	0.0	53.7	16.7	175.6	31.3	91.4	51.1	19.3	6.1	29.5	24.1	28.8	12.9	72.3	118.0	23.8	49.5	34.5	22.9	22.7	33.2	77.5	82.8	3.3	9.1	100.3	105.8	54.0	27.6	59.5	19.9	61.3	44.4	8.4	114.6	9.5	39.1	3.5	40.2	94.7	157.3	9.4	21.4	65.2	269.7	69.0	37.4	1.7	13.1	19.2	28.5	45.5	21.5	87.2	42.1	61.6	33.4	13.2	87.8	62.7
HTD2		ENSG00000255154	"Hydroxyacyl-thioester dehydratase type 2"	P86397	3	58306262-58320193	"Enzymes, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	Lyase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 44.1"	"Cell type enhanced"	"Detected in some"		"Club cells: 1.3;granulocytes: 1.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA066812, HPA077228"	Approved		Supported	Nucleoli,Mitochondria		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 60: Granulocytes - Receptor signaling"	Mitochondria	Nucleoli	"HPA066812: AB_2685727, HPA077228: "	"unprognostic (1.95e-1)"	"unprognostic (3.20e-2)"	"unprognostic (1.63e-1)"	"unprognostic (2.63e-2)"	"unprognostic (2.28e-2)"	"unprognostic (2.01e-1)"	"unprognostic (2.56e-1)"	"unprognostic (2.05e-1)"	"unprognostic (9.19e-3)"	"unprognostic (1.11e-1)"	"unprognostic (7.41e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.99e-1)"	"unprognostic (7.50e-2)"	"unprognostic (3.86e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.33e-2)"	7.7	7.2	4.3	6.5	5.0	7.2	8.7	7.3	5.5	6.8	4.7	8.9	12.1	8.4	5.9	8.7	7.8	6.8	12.5	4.8	5.6	11.1	15.2	5.7	6.8	3.6	4.6	12.1	7.4	12.0	5.7	6.7	4.6	7.1	9.1	9.2	7.4	8.6	44.1	7.9	8.7	7.6	4.3	7.2	7.0	7.4	4.5	6.6	10.4	37.8	8.0	6.9	4.9	5.5	10.4	7.1	10.9	8.7	11.6	11.2	15.1	13.8	10.2	17.0	14.4	15.9	7.7	19.9	4.0	10.1	12.8	8.7	18.5	12.6	16.8	11.0	13.1	13.7	16.1	13.9	11.3	16.7	11.4	15.1	15.1	17.3	11.4	11.0	14.6	14.3	12.2	19.9	11.1	6.4	11.2	8.9	17.2	10.2	17.3	7.2	7.2	14.7	12.5	13.8	7.0	10.5	8.4	9.4	17.2	12.1	10.9	15.9	8.1	14.5	10.8	14.3	17.2	15.4	27.6	15.7	12.7	11.9	9.8	17.9	19.2	29.2	19.7	23.7	21.5	28.1	20.0	25.2	20.2	27.6	27.5	21.3	13.6	24.9	20.4	24.5	15.6	15.7	4.3	5.0	7.3	5.5	4.8	5.6	3.6	4.6	4.6	4.3	4.5	5.5	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	1.3	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.3	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
HTR1B	"5-HT1B, 5-HT1DB, HTR1D2, S12"	ENSG00000135312	"5-hydroxytryptamine receptor 1B"	P28222	6	77460924-77463491	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters"	Behavior	"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 9.6;placenta: 6.7;stomach 1: 5.0"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"pancreatic cancer: 0.7;stomach cancer: 0.8;testis cancer: 1.0"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	16	"HUVEC TERT2: 79.4;TIME: 35.1"	"Region enriched"	"Detected in all"	4	"basal ganglia: 38.6"	"Region enhanced"	"Detected in many"		"basal ganglia: 11.7"	HPA028808	Enhanced		Supported	"Endoplasmic reticulum,Plasma membrane"		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"		"Plasma membrane"	"Endoplasmic reticulum"	"HPA028808: AB_2672782"	"unprognostic (3.86e-2)"	"unprognostic (3.56e-1)"	"unprognostic (7.68e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.88e-1)"	"unprognostic (1.18e-2)"	"unprognostic (2.67e-1)"	"unprognostic (2.11e-1)"	"unprognostic (8.96e-2)"	"unprognostic (4.03e-1)"	"unprognostic (1.77e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.10e-3)"	"unprognostic (3.08e-2)"	"unprognostic (2.81e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.02e-1)"	0.8	0.6	2.1	0.4	6.0	0.0	0.2	0.0	3.8	0.8	0.0	0.1	0.1	0.5	0.0	0.0	0.5	0.5	0.0	1.2	2.1	0.5	0.0	0.4	0.0	0.6	4.3	0.3	0.1	0.0	0.2	6.7	1.2	0.2	0.1	0.3	0.2	0.5	0.1	0.2	0.1	0.1	0.1	0.0	5.0	0.5	9.6	0.0	0.2	0.3	0.0	1.3	0.5	1.4	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.4	3.5	1.7	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.6	0.0	0.0	0.1	0.0	0.0	1.2	0.0	0.0	0.4	0.2	0.6	2.2	1.4	79.4	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.2	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	35.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	6.0	0.0	3.8	1.2	2.1	0.6	4.3	1.2	0.1	9.6	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
HTR2B	"5-HT(2B), 5-HT2B"	ENSG00000135914	"5-hydroxytryptamine receptor 2B"	P41595	2	231108230-231125042	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters"	Behavior	"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 17.4;cervix: 21.5;endometrium 1: 18.8;smooth muscle: 16.8"	"Cell type enhanced"	"Detected in some"		"Cone photoreceptor cells: 4.2;Endometrial stromal cells: 17.7;Endothelial cells: 4.1;Hepatic stellate cells: 5.7;Microglial cells: 4.7;monocytes: 6.2;Peritubular cells: 5.3"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	15	"basophil: 1.8;T-reg: 1.0"	"Group enriched"	"Detected in many"	15	"granulocytes: 1.8;T-cells: 1.0"	"Group enriched"	"Detected in some"	4	"HHSteC: 8.7;HSkMC: 16.5;SK-MEL-30: 32.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA012867, HPA063658"	Enhanced		Supported	Nucleoplasm		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 36: Stromal cells - Cell proliferation"	Nucleoplasm		"HPA012867: AB_1856710, HPA063658: AB_2685079"	"unprognostic (1.86e-1)"	"unprognostic (3.55e-2)"	"unprognostic (1.20e-3)"	"unprognostic (1.45e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.53e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.33e-2)"	"unprognostic (1.15e-4)"	"unprognostic (3.59e-1)"	"unprognostic (2.17e-2)"	"unprognostic (1.42e-3)"	"unprognostic (7.44e-4)"	"unprognostic (1.81e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.14e-2)"	0.9	17.4	0.4	1.5	0.4	1.2	0.8	0.9	0.6	21.5	1.2	9.0	1.5	18.8	11.8	0.7	2.4	1.2	4.7	0.4	0.6	3.4	3.6	0.9	1.0	0.5	0.4	0.8	0.2	0.6	0.3	4.1	0.5	0.3	2.1	0.2	0.5	1.4	0.1	0.1	4.8	16.8	0.2	0.4	4.5	0.4	0.4	1.2	3.2	0.3	0.8	2.2	0.8	0.6	0.2	0.3	0.0	0.1	0.5	4.5	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	4.7	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	8.7	0.1	0.3	16.5	0.0	0.0	0.0	0.0	3.2	1.4	0.1	0.0	0.0	0.2	0.0	0.7	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	1.3	0.0	0.1	32.7	0.0	0.0	0.4	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.1	1.1	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.4	0.4	0.9	0.6	0.4	0.6	0.5	0.4	0.5	0.2	0.4	0.6	0.4	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.5	0.1	0.0	0.3	0.0	0.2	0.0	4.2	0.1	0.1	0.0	0.0	0.0	0.2	1.5	17.7	4.1	0.0	0.0	0.7	0.7	0.1	0.8	0.0	3.4	0.0	0.1	5.7	1.5	3.4	1.7	0.9	0.0	0.0	0.8	0.0	0.2	0.6	2.2	0.0	4.7	6.2	0.0	1.0	0.5	0.6	0.2	0.0	5.3	0.0	0.0	0.0	0.0	2.0	0.7	0.0	0.1	0.9	0.0	0.0	0.1	0.0	0.3	0.2	0.3	0.0	0.2
HTR7	5-HT7	ENSG00000148680	"5-hydroxytryptamine receptor 7"	P34969	10	90740823-90858039	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, RAS pathway related proteins"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"brain: 7.6;parathyroid gland: 13.1;testis: 8.7"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 7.0;Excitatory neurons: 5.9;Inhibitory neurons: 24.2;Spermatocytes: 13.1"	"Group enriched"	"Detected in some"	5	"cervical cancer: 0.9;head and neck cancer: 3.3;lung cancer: 0.9;urothelial cancer: 1.3"	"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in single"	12	"myeloid DC: 1.4"	"Lineage enriched"	"Detected in single"	12	"dendritic cells: 1.4"	"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 11.3;hTCEpi: 10.1;hTERT-HME1: 33.4;LHCN-M2: 13.5;U-251 MG: 9.6;U-87 MG: 10.2;WM-115: 13.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB022708, HPA073617"	Approved	Supported	Supported	"Nuclear speckles,Plasma membrane,Cytosol"		NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Plasma membrane"	"Nuclear speckles, Cytosol"	"CAB022708: , HPA073617: AB_2732228"	"unprognostic (1.17e-1)"	"unprognostic (1.24e-2)"	"unprognostic (4.72e-2)"	"unprognostic (1.33e-1)"	"unprognostic (5.51e-3)"	"unprognostic (1.71e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.15e-1)"	"unprognostic (4.58e-3)"	"unprognostic (3.32e-1)"	"unprognostic (1.45e-1)"	"unprognostic (2.89e-1)"	"unprognostic (1.23e-3)"	"unprognostic (1.38e-1)"	"unprognostic (1.84e-2)"	"unprognostic (6.49e-2)"	0.5	0.2	2.4	0.9	1.4	0.3	0.3	0.0	2.5	0.4	0.4	0.6	0.5	0.2	0.1	0.7	0.2	0.9	0.1	2.7	7.1	0.1	0.4	0.2	0.6	1.5	3.2	0.1	0.2	13.1	0.1	0.3	1.9	0.2	0.9	0.1	0.3	0.1	0.9	0.5	1.4	0.3	0.5	1.1	0.7	8.7	7.6	0.2	0.1	0.5	0.3	2.3	0.6	0.8	0.3	0.0	0.0	0.0	0.2	0.9	0.0	0.7	0.3	0.7	1.0	0.0	1.2	0.0	0.0	0.1	2.0	4.7	1.3	11.3	2.8	0.0	0.2	0.0	0.0	0.0	5.1	0.0	0.6	7.8	10.1	3.3	33.4	6.3	0.0	0.0	0.1	0.0	13.5	0.0	0.0	0.2	1.2	0.0	1.6	1.0	0.1	0.0	0.0	1.2	0.4	0.0	0.5	0.0	5.4	0.6	0.0	0.2	0.3	6.1	0.0	0.1	9.6	0.0	0.0	0.0	10.2	0.0	13.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.4	1.4	0.0	2.5	2.7	7.1	1.5	3.2	1.9	0.5	7.6	0.8	0.1	0.0	0.0	0.7	0.3	0.0	0.2	0.7	0.0	0.0	0.0	0.3	0.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.0	0.0	0.3	0.0	0.0	0.4	5.9	0.0	0.0	0.1	0.0	0.1	0.0	0.4	0.4	0.0	1.7	0.0	24.2	0.0	2.0	2.2	0.0	2.7	0.0	2.5	0.0	0.0	0.4	0.0	0.0	0.5	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.2	0.1	13.1	1.3	0.0	0.1	0.1	0.2	0.0	0.0	0.3
HTRA1	"ARMD7, HtrA, IGFBP5-protease, PRSS11"	ENSG00000166033	"HtrA serine peptidase 1"	Q92743	10	122458551-122514907	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"		"Growth factor binding, Hydrolase, Protease, Serine protease"	"Age-related macular degeneration, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Fibroblasts: 269.3;Granulosa cells: 731.6;Horizontal cells: 625.9;Muller glia cells: 373.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 2417.8;ASC TERT1: 889.4;fHDF/TERT166: 862.3;HSkMC: 1581.4;LHCN-M2: 1238.2;U-87 MG: 1004.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036655	Approved		Supported	"Plasma membrane"	"Secreted to blood"	NA	NA	24800000	7600000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 68: Epididymis - Unknown function"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 40: Granulosa cells - Unknown function"	"Plasma membrane"		"HPA036655: AB_10671966"	"unprognostic (3.84e-1)"	"unprognostic (3.42e-2)"	"unprognostic (1.57e-2)"	"unprognostic (1.86e-2)"	"unprognostic (1.22e-3)"	"unprognostic (8.71e-3)"	"unprognostic (2.33e-2)"	"unprognostic (3.83e-1)"	"unprognostic (7.22e-2)"	"unprognostic (3.36e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.54e-1)"	"prognostic unfavorable (7.90e-7)"	"unprognostic (7.12e-3)"	"unprognostic (9.13e-2)"	"unprognostic (1.69e-1)"	"prognostic unfavorable (5.62e-6)"	246.0	81.3	382.1	37.0	436.6	0.5	202.8	422.6	595.7	352.1	316.2	154.8	20.8	197.1	247.1	57.8	122.9	301.2	114.7	377.7	411.4	230.9	226.4	69.9	39.9	427.1	447.0	425.5	55.9	111.8	184.1	281.9	425.3	85.7	51.8	243.6	101.1	114.5	31.1	130.5	73.5	152.3	382.1	54.2	87.3	19.5	423.6	21.2	78.8	80.9	27.3	137.3	188.3	464.2	0.3	45.6	19.4	5.7	2417.8	889.4	0.8	108.3	196.8	44.4	23.6	0.2	0.6	0.0	29.0	862.3	68.6	12.8	7.6	124.4	6.2	0.1	4.9	0.1	65.4	0.3	123.7	0.1	0.9	1581.4	444.6	25.8	205.3	503.6	207.1	0.0	0.1	1.5	1238.2	22.3	0.1	0.7	20.9	0.2	67.6	0.2	1.3	0.4	282.6	2.2	1.2	3.9	272.1	0.2	122.2	91.4	8.6	0.2	136.0	309.9	4.5	141.3	94.1	0.2	0.1	0.3	1004.6	0.2	148.5	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	382.1	436.6	422.6	595.7	377.7	411.4	427.1	447.0	425.3	382.1	423.6	464.2	55.1	22.4	6.9	116.5	0.9	44.1	32.5	10.8	23.9	53.3	5.4	31.2	26.4	14.3	0.9	64.4	54.2	30.9	1.3	0.0	0.0	2.0	3.5	11.3	76.5	107.0	0.0	2.7	2.2	4.6	164.6	269.3	4.6	14.4	1.3	731.6	57.8	157.8	51.3	625.9	31.2	0.3	8.2	18.1	59.9	4.2	31.7	22.0	46.2	86.2	8.5	373.8	0.0	193.0	112.5	2.7	1.3	77.5	1.9	8.7	0.2	22.6	10.1	150.3	6.6	63.3	140.5	0.2	0.7	7.0	30.5	87.7	7.2	2.5	0.6	11.9
HTRA2	"OMI, PARK13, PRSS25"	ENSG00000115317	"HtrA serine peptidase 2"	O43464	2	74529725-74533332	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins"	Apoptosis	"Hydrolase, Protease, Serine protease"	"Disease variant, Epilepsy, Neurodegeneration, Parkinson disease, Parkinsonism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Erythroid cells: 118.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004004, HPA006602, HPA027366"	Uncertain		Supported	Mitochondria		NA	NA		260000	"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 10: Non-specific - Unknown function"	Mitochondria		"CAB004004: AB_326421, HPA006602: AB_2667622, HPA027366: AB_1851301"	"unprognostic (3.09e-1)"	"unprognostic (4.06e-2)"	"unprognostic (2.82e-1)"	"unprognostic (2.58e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.37e-1)"	"prognostic unfavorable (7.77e-8)"	"unprognostic (2.12e-3)"	"unprognostic (4.18e-1)"	"unprognostic (1.15e-1)"	"unprognostic (4.57e-2)"	"unprognostic (8.15e-2)"	"unprognostic (7.23e-3)"	"unprognostic (4.03e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.72e-1)"	"unprognostic (2.06e-2)"	11.4	8.6	8.1	8.1	8.7	11.1	6.8	9.1	9.7	7.1	7.7	6.4	6.9	6.9	1.0	6.0	7.1	4.7	9.4	8.1	8.3	8.1	6.5	6.6	7.8	8.6	8.5	10.9	7.4	9.4	4.7	6.3	8.3	4.8	3.3	2.5	8.5	5.3	14.5	5.4	7.9	5.3	8.2	9.9	6.4	6.2	9.6	9.1	6.8	9.0	4.8	6.5	5.8	9.2	19.1	14.7	14.7	12.6	21.3	9.0	30.1	17.0	10.3	10.3	7.0	21.1	8.5	16.6	12.9	10.7	26.0	19.7	12.0	19.6	2.4	34.0	31.4	33.3	10.8	19.0	19.8	15.3	22.4	9.9	13.7	18.4	19.5	18.4	14.2	23.5	43.9	24.9	9.7	14.1	22.0	31.1	10.0	22.8	37.7	15.8	37.0	17.1	9.6	8.2	15.1	17.7	8.9	18.6	32.5	7.3	9.3	13.2	10.6	19.2	19.7	33.4	35.3	29.5	10.2	9.8	13.6	23.4	13.0	5.8	7.0	4.0	4.8	5.7	5.8	11.0	4.8	4.1	8.6	9.9	4.3	4.1	2.6	5.0	4.5	4.5	5.7	5.5	8.1	8.7	9.1	9.7	8.1	8.3	8.6	8.5	8.3	8.2	9.6	9.2	30.7	0.0	4.8	6.2	27.3	20.6	19.7	33.8	13.6	12.0	17.4	21.7	0.9	21.5	15.7	11.0	0.0	24.7	25.8	12.5	35.2	32.4	30.8	11.9	18.1	29.6	9.0	118.5	6.3	17.7	37.8	23.3	11.2	12.9	27.3	20.9	22.9	12.7	31.5	10.1	6.3	12.3	20.3	10.7	19.4	48.9	24.8	14.6	30.2	2.8	26.3	20.2	30.9	5.5	7.5	26.1	16.8	20.7	36.0	21.3	24.8	36.8	13.5	16.3	26.3	18.7	56.5	64.3	43.3	16.7	22.0	20.2	20.6	27.1	20.0	15.7
HTT	"HD, IT15"	ENSG00000197386	Huntingtin	P42858	4	3041363-3243960	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	Apoptosis		"Disease variant, Mental retardation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cone photoreceptor cells: 181.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002756, HPA026114"	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA		36000	"Cluster 27: Non-specific - Gene expression"	"Cluster 59: Non-specific - Translation"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 9: Photoreceptor cells - Phototransduction"	Nucleoplasm	Cytosol	"CAB002756: , HPA026114: AB_1851330"	"unprognostic (2.05e-1)"	"unprognostic (1.09e-1)"	"unprognostic (8.79e-3)"	"unprognostic (1.08e-1)"	"unprognostic (1.66e-1)"	"prognostic favorable (3.26e-4)"	"unprognostic (1.52e-2)"	"unprognostic (8.33e-2)"	"unprognostic (8.06e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.87e-2)"	"unprognostic (6.04e-2)"	"prognostic favorable (2.41e-12)"	"unprognostic (9.46e-3)"	"unprognostic (1.99e-1)"	"unprognostic (6.53e-2)"	"unprognostic (3.84e-2)"	8.3	9.3	10.5	8.2	11.7	8.1	7.6	7.8	14.2	6.1	8.2	8.1	6.0	7.1	8.3	10.4	6.7	5.1	7.1	15.7	3.5	7.9	8.9	10.1	11.5	8.7	5.2	7.2	21.3	12.3	9.0	6.9	7.8	7.0	6.5	10.3	7.2	5.8	15.3	15.1	9.7	5.8	3.0	11.5	8.9	10.1	6.8	11.3	9.1	12.4	8.8	7.3	7.0	11.0	19.5	14.2	17.6	10.3	30.9	20.2	17.7	9.0	10.4	13.0	12.6	17.3	12.2	28.6	8.9	20.9	21.6	10.7	20.6	15.3	12.0	7.8	15.4	27.4	18.0	18.8	7.5	17.7	37.9	11.1	9.5	25.4	10.7	9.3	14.3	13.0	17.7	9.9	11.4	17.9	22.4	17.1	21.2	9.7	20.7	17.7	16.9	5.7	14.2	18.1	18.5	13.9	15.0	5.7	14.6	12.9	16.1	10.8	20.6	16.8	11.1	12.4	19.0	7.6	8.8	22.9	13.4	16.4	13.3	0.0	0.7	0.9	1.0	1.1	0.7	0.8	0.8	1.3	1.1	0.6	0.4	0.7	0.1	0.9	1.5	0.7	1.2	0.7	10.5	11.7	7.8	14.2	15.7	3.5	8.7	5.2	7.8	3.0	6.8	11.0	15.8	25.6	14.8	41.1	20.7	13.8	8.0	12.4	9.1	48.1	20.4	15.4	10.4	17.2	14.6	14.7	181.4	11.8	26.1	22.4	5.9	12.0	9.4	23.1	20.8	17.2	18.5	18.5	88.8	17.5	11.7	13.9	20.9	25.3	11.4	54.9	22.1	17.1	26.7	45.4	75.1	13.3	4.1	23.4	15.4	10.3	16.1	25.4	8.8	40.3	18.2	20.8	24.7	59.8	52.4	20.0	21.2	11.7	15.3	15.7	20.9	12.2	12.0	50.7	13.1	19.2	13.6	13.0	21.3	21.9	20.0	8.3	19.5	16.8	20.9	11.6
HYLS1	FLJ32915	ENSG00000198331	"HYLS1 centriolar and ciliogenesis associated"	Q96M11	11	125883614-125900646	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cilium biogenesis/degradation"		"Ciliopathy, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 26.5"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 80.8;Late spermatids: 54.9;Spermatocytes: 92.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041210	Enhanced		Supported	"Plasma membrane,Cytosol"		NA	Yes			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 6: T47d - Mammary gland"	"Cluster 29: Early spermatids - Spermatogenesis"	"Plasma membrane, Cytosol"		"HPA041210: AB_10794987"	"unprognostic (2.46e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.49e-1)"	"unprognostic (2.35e-1)"	"unprognostic (3.53e-3)"	"unprognostic (1.17e-2)"	"prognostic unfavorable (1.92e-4)"	"unprognostic (3.28e-1)"	"unprognostic (1.04e-3)"	"unprognostic (6.56e-3)"	"unprognostic (7.63e-2)"	"unprognostic (4.81e-3)"	"unprognostic (3.00e-2)"	"unprognostic (2.19e-1)"	"unprognostic (2.49e-1)"	"unprognostic (1.03e-1)"	"unprognostic (4.56e-2)"	2.9	2.4	5.7	3.0	5.3	2.4	4.3	8.0	8.5	4.2	4.9	4.7	6.0	3.8	6.7	3.7	4.2	2.6	5.0	5.4	5.3	5.5	5.8	2.5	6.2	5.0	4.7	3.9	2.2	2.7	2.3	4.4	5.0	5.0	5.0	4.3	3.1	6.1	2.7	4.8	3.3	6.4	4.5	3.6	5.4	26.5	6.0	5.2	2.5	4.3	9.0	3.8	2.3	5.2	11.2	23.9	8.4	5.9	16.5	11.6	14.8	27.3	10.9	24.8	16.9	0.3	17.2	5.0	11.3	25.4	8.4	15.8	12.2	10.0	28.7	27.1	9.2	3.5	2.3	4.9	12.9	12.4	16.9	7.2	11.0	25.2	28.3	5.1	18.4	11.0	6.1	27.3	33.6	18.6	9.1	36.2	18.4	46.2	40.8	19.0	0.1	16.5	27.3	17.9	11.6	7.2	29.6	22.2	11.0	10.5	53.6	26.9	16.7	1.8	20.9	19.4	4.6	10.1	11.4	11.4	5.1	26.7	22.2	5.7	7.6	1.5	10.6	8.7	10.2	16.1	13.8	12.6	10.0	16.1	13.2	9.7	1.1	6.8	6.3	20.4	15.5	7.1	5.7	5.3	8.0	8.5	5.4	5.3	5.0	4.7	5.0	4.5	6.0	5.2	3.9	0.0	0.5	2.6	9.3	4.2	2.8	8.0	4.6	7.1	4.1	5.3	5.5	1.5	2.2	1.8	4.2	18.6	11.5	4.0	11.7	5.5	80.8	5.8	3.4	3.7	4.9	9.1	14.3	4.2	13.0	5.9	8.6	2.1	0.0	7.1	6.8	5.4	7.6	0.0	13.8	3.2	8.2	3.2	4.0	54.9	8.4	2.5	7.2	6.5	11.9	5.8	12.3	6.0	5.8	3.6	5.8	6.0	4.2	3.3	5.2	12.1	4.8	6.5	6.6	2.3	5.7	92.1	32.3	6.2	4.3	4.4	4.9	7.5	5.5	1.5
HYPK	"C15orf63, FLJ20431, HSPC136"	ENSG00000242028	"Huntingtin interacting protein K"	Q9NX55	15	43796142-43804427	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 54.2"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA055252	Uncertain		Supported	Nucleoplasm,Microtubules		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 9: Photoreceptor cells - Phototransduction"	Nucleoplasm	Microtubules	"HPA055252: AB_2682759"	"unprognostic (2.89e-2)"	"unprognostic (5.82e-2)"	"unprognostic (2.14e-2)"	"unprognostic (7.58e-3)"	"unprognostic (1.15e-1)"	"unprognostic (1.08e-3)"	"unprognostic (3.55e-1)"	"unprognostic (1.48e-1)"	"unprognostic (4.41e-2)"	"unprognostic (1.04e-1)"	"unprognostic (5.36e-3)"	"unprognostic (2.39e-3)"	"unprognostic (6.52e-7)"	"unprognostic (2.05e-1)"	"unprognostic (8.89e-2)"	"unprognostic (2.61e-1)"	"unprognostic (2.78e-4)"	8.9	9.8	13.8	5.9	13.8	4.9	6.5	16.6	22.0	5.0	13.8	5.0	3.7	4.3	5.1	4.2	6.0	2.9	8.5	13.8	15.0	6.5	14.2	7.6	6.5	14.7	15.2	6.2	9.4	6.2	5.6	3.6	14.7	6.8	3.8	8.6	5.5	4.3	19.2	6.1	5.1	4.9	13.4	5.5	5.8	7.9	14.2	6.1	5.2	14.7	7.7	8.3	4.3	15.4	13.5	36.8	17.3	19.5	11.6	11.5	6.5	21.8	13.1	18.9	12.6	23.7	7.4	19.8	25.9	16.7	17.8	23.1	30.3	24.9	14.3	17.3	37.3	26.4	64.6	34.0	17.8	30.4	16.3	10.1	24.2	21.3	18.1	9.3	14.7	20.9	40.5	16.9	17.2	33.5	19.2	33.9	19.5	48.6	40.9	15.4	12.6	22.4	17.7	26.5	33.9	24.7	20.7	31.1	13.3	10.6	23.7	19.5	13.3	22.6	11.8	24.2	55.8	20.5	40.6	46.2	15.1	33.1	26.8	16.8	25.7	22.1	25.0	37.7	26.4	30.0	26.8	26.7	23.5	31.4	29.9	27.9	9.4	26.7	47.7	39.8	27.5	23.5	13.8	13.8	16.6	22.0	13.8	15.0	14.7	15.2	14.7	13.4	14.2	15.4	11.3	6.4	14.5	0.0	11.1	30.0	15.0	8.1	13.6	11.2	14.4	11.9	0.7	8.6	12.1	7.3	54.2	6.6	8.2	6.4	9.8	6.5	2.4	7.2	9.6	10.7	10.7	9.5	0.0	8.4	4.4	12.5	26.0	7.7	8.8	4.5	6.4	6.5	3.9	13.5	0.0	11.6	8.2	4.4	26.2	1.1	5.0	9.1	23.2	0.0	4.7	4.9	6.2	0.0	0.0	6.8	4.7	2.2	11.3	14.8	7.2	10.4	15.4	28.5	0.0	23.2	11.8	3.9	4.7	19.4	37.4	4.9	10.4	9.1	9.4	11.1
IARS1	"IARS, ILRS"	ENSG00000196305	"Isoleucyl-tRNA synthetase 1"	P41252	9	92210207-92293756	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 47.6;Cytotrophoblasts: 29.8;Extravillous trophoblasts: 31.7;Hofbauer cells: 17.2;Syncytiotrophoblasts: 17.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029806	Approved		Approved	Nucleoplasm,Cytosol		NA	NA		100000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 24: Non-specific - Transcription regulation"	"Nucleoplasm, Cytosol"		"HPA029806: AB_10601818"	"unprognostic (1.32e-3)"	"unprognostic (2.94e-2)"	"unprognostic (2.27e-2)"	"unprognostic (8.23e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.26e-2)"	"prognostic unfavorable (4.98e-7)"	"unprognostic (2.00e-2)"	"unprognostic (3.80e-2)"	"unprognostic (1.10e-1)"	"unprognostic (4.96e-2)"	"unprognostic (3.67e-2)"	"unprognostic (1.40e-2)"	"unprognostic (2.88e-2)"	"unprognostic (4.71e-2)"	"unprognostic (2.21e-1)"	"unprognostic (7.76e-3)"	22.2	24.3	6.3	28.8	5.8	13.2	27.4	8.8	11.5	26.4	10.7	29.1	17.9	32.5	15.1	31.8	27.7	16.1	32.2	6.8	10.7	28.4	19.6	18.9	28.3	5.9	7.3	20.4	40.1	52.3	11.7	27.7	8.6	27.7	33.3	25.2	25.5	31.6	43.1	21.7	16.2	42.6	3.6	19.7	31.4	20.0	5.2	27.5	64.6	47.2	37.6	28.2	11.7	6.9	150.7	154.9	83.3	132.2	110.5	142.2	126.8	156.4	146.2	118.8	138.5	52.2	99.0	216.0	54.9	231.4	130.5	194.9	254.4	197.9	149.3	126.1	97.9	135.3	128.3	62.8	235.6	181.3	90.6	134.1	194.9	208.9	348.9	78.3	123.6	230.1	229.2	189.8	145.0	79.3	173.2	31.6	139.7	294.5	143.3	116.2	129.3	103.0	72.9	72.6	110.2	91.5	118.2	117.0	128.8	87.8	95.2	94.4	101.3	89.5	104.6	149.3	119.1	134.8	156.4	99.5	218.7	133.3	173.3	2.8	5.9	0.7	11.9	7.0	16.4	13.9	11.8	11.9	12.7	9.7	12.8	12.7	0.5	19.5	6.3	4.8	10.9	9.0	6.3	5.8	8.8	11.5	6.8	10.7	5.9	7.3	8.6	3.6	5.2	6.9	7.4	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	47.6	0.0	0.0	0.0	0.0	29.8	7.8	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	31.7	8.6	0.0	0.0	0.0	0.0	0.0	0.0	17.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	17.4	1.1	0.0	0.0	0.0
IBA57	"C1orf69, FLJ12734"	ENSG00000181873	"Iron-sulfur cluster assembly factor IBA57"	Q5T440	1	228165804-228182257	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Heme biosynthesis"	Transferase	"Disease variant, Hereditary spastic paraplegia, Neurodegeneration, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Erythroid cells: 49.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030555, HPA030556, HPA030557"	Approved		Supported	Mitochondria		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 6: Erythroid cells - Oxygen transport"	Mitochondria		"HPA030555: AB_2673522, HPA030556: AB_2673523, HPA030557: AB_10670433"	"unprognostic (3.00e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.29e-2)"	"unprognostic (1.34e-1)"	"unprognostic (8.16e-3)"	"unprognostic (1.03e-1)"	"unprognostic (6.11e-2)"	"unprognostic (7.01e-2)"	"unprognostic (8.00e-3)"	"unprognostic (2.87e-2)"	"unprognostic (1.61e-1)"	"prognostic favorable (1.71e-9)"	"unprognostic (4.94e-2)"	"unprognostic (5.02e-1)"	"unprognostic (5.04e-3)"	"unprognostic (7.14e-2)"	2.0	2.7	2.6	1.4	2.3	4.1	1.4	2.9	2.5	1.3	2.2	1.8	1.6	1.8	0.5	1.6	1.3	1.0	3.3	2.1	2.0	2.0	2.8	1.9	1.6	2.7	2.2	1.9	2.9	2.1	0.9	1.4	2.3	1.2	1.4	0.5	1.7	1.0	6.1	3.0	1.7	1.7	2.1	1.7	2.0	1.1	2.8	1.3	1.3	4.0	1.7	1.3	1.2	3.5	2.5	2.5	2.7	1.2	1.3	1.4	3.3	1.5	0.7	1.1	0.6	5.3	2.1	5.3	3.1	1.6	0.6	4.4	2.0	3.2	1.0	1.1	4.5	3.1	3.5	2.6	1.1	3.7	3.5	2.2	1.8	1.3	1.5	1.0	1.6	3.2	5.4	2.4	1.1	2.0	3.6	2.2	2.0	3.4	2.8	4.4	3.1	2.4	1.6	5.1	4.1	2.8	2.4	7.5	1.9	0.5	6.0	4.9	3.8	3.0	2.8	2.1	3.7	1.8	0.9	2.6	1.4	1.6	2.3	1.6	0.4	0.2	0.6	0.4	1.0	0.4	0.5	0.5	0.3	0.7	0.7	0.7	0.5	0.8	0.4	1.0	0.5	0.2	2.6	2.3	2.9	2.5	2.1	2.0	2.7	2.2	2.3	2.1	2.8	3.5	5.7	9.6	11.0	4.2	10.2	8.2	8.8	3.9	2.8	5.8	5.6	5.6	15.3	8.6	9.2	0.0	12.5	10.7	5.0	14.5	7.9	5.4	22.2	5.2	6.0	8.8	7.2	49.3	3.8	6.9	8.6	5.2	5.1	10.3	15.2	6.7	5.3	7.9	5.5	3.3	4.1	8.0	4.1	4.4	6.4	30.7	3.7	6.0	7.2	6.5	4.2	4.4	4.1	3.0	5.8	8.8	6.3	7.2	5.8	6.3	9.4	6.7	3.2	19.5	6.6	9.7	4.7	14.9	11.2	4.4	6.0	16.3	7.2	8.3	11.9	8.3
IBTK	"BTBD26, BTKI, DKFZP564B116"	ENSG00000005700	"Inhibitor of Bruton tyrosine kinase"	Q9P2D0	6	82169986-82247754	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 190.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023826, HPA048438"	Uncertain		Supported	Nucleoplasm		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 22: Epithelial cell types - Mixed function"	Nucleoplasm		"HPA023826: AB_1851378, HPA048438: AB_2680392"	"unprognostic (3.13e-2)"	"prognostic unfavorable (3.86e-4)"	"unprognostic (2.72e-2)"	"unprognostic (1.75e-2)"	"unprognostic (2.48e-1)"	"unprognostic (2.78e-1)"	"unprognostic (5.93e-2)"	"unprognostic (1.97e-2)"	"unprognostic (6.18e-2)"	"unprognostic (1.90e-2)"	"unprognostic (8.81e-2)"	"unprognostic (3.02e-2)"	"unprognostic (1.08e-2)"	"unprognostic (7.33e-2)"	"unprognostic (1.09e-1)"	"unprognostic (7.27e-2)"	"unprognostic (9.78e-2)"	7.3	14.3	2.5	8.1	3.3	3.7	7.9	3.2	2.6	8.9	3.1	8.6	8.4	8.0	4.8	8.3	7.6	6.0	10.0	2.0	2.7	10.3	22.2	7.0	6.7	2.8	3.4	8.8	11.0	12.3	4.8	6.3	3.0	7.7	10.4	8.5	8.9	7.4	21.4	4.1	8.4	7.4	3.5	6.5	11.5	4.0	3.1	7.2	10.3	20.9	7.2	8.6	5.9	3.5	8.3	17.0	12.2	10.3	14.4	19.8	5.5	19.3	21.1	15.5	16.6	9.0	9.6	16.4	11.9	22.8	20.5	8.8	9.8	10.8	18.5	22.5	7.3	17.6	8.8	14.1	20.2	20.7	10.3	17.1	17.6	14.8	36.8	14.5	15.7	11.4	16.4	10.0	16.7	12.7	7.2	6.7	5.5	13.0	9.1	10.2	25.7	6.5	23.2	18.9	8.2	9.0	13.0	16.1	10.3	10.8	15.1	12.5	12.6	9.0	6.7	11.3	15.6	10.3	17.1	7.5	9.9	13.4	11.9	1.3	1.2	1.0	1.8	1.1	2.4	1.6	1.8	1.6	1.9	1.0	1.7	1.6	0.0	1.0	2.3	1.4	2.7	0.8	2.5	3.3	3.2	2.6	2.0	2.7	2.8	3.4	3.0	3.5	3.1	3.5	26.1	41.7	47.6	46.4	33.5	13.6	42.8	19.4	15.4	55.6	27.4	19.0	64.9	40.0	41.2	38.6	54.2	23.9	25.9	62.2	15.6	37.5	4.2	37.4	28.1	27.3	38.9	37.4	102.6	51.6	16.4	34.1	117.8	57.0	36.8	38.1	21.8	77.0	26.7	52.2	97.9	49.3	6.1	33.4	26.1	4.1	25.7	36.1	23.2	44.0	43.6	32.7	25.7	80.9	190.0	52.1	55.5	21.1	68.2	53.4	31.1	28.3	42.1	39.2	26.3	42.0	29.1	21.2	22.9	41.1	11.6	9.4	29.8	67.0	41.9	64.4
ICA1	"ICA69, ICAp69"	ENSG00000003147	"Islet cell autoantigen 1"	Q05084	7	8113184-8262687	"Predicted intracellular proteins, Predicted membrane proteins"	"Neurotransmitter transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"Early spermatids: 594.7;Late spermatids: 867.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	6	"T-reg: 29.9"	"Lineage enriched"	"Detected in many"	9	"T-cells: 29.9"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 47.1;MCF7: 42.5;OE19: 48.4;RT4: 49.4;SCLC-21H: 66.1;SH-SY5Y: 105.8;SK-BR-3: 52.1;T-47d: 43.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017646, HPA061452"	Approved		Supported	Vesicles,Cytosol		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 25: Pancreas - Digestion"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 34: Spermatids - Unknown function"	"Vesicles, Cytosol"		"HPA017646: AB_1851382, HPA061452: AB_2684525"	"unprognostic (1.39e-1)"	"unprognostic (1.37e-1)"	"unprognostic (3.74e-1)"	"unprognostic (6.83e-3)"	"unprognostic (9.49e-2)"	"unprognostic (8.57e-3)"	"unprognostic (1.37e-2)"	"unprognostic (3.54e-1)"	"unprognostic (7.61e-2)"	"unprognostic (3.42e-1)"	"unprognostic (5.84e-2)"	"unprognostic (2.62e-1)"	"prognostic favorable (4.23e-8)"	"unprognostic (1.30e-1)"	"unprognostic (1.29e-1)"	"unprognostic (2.77e-2)"	"unprognostic (4.08e-2)"	15.8	10.4	11.3	5.7	16.2	23.8	21.1	21.5	21.8	16.4	1.2	22.8	13.6	6.8	13.6	9.5	13.7	11.1	44.3	13.4	9.3	16.0	8.8	11.2	13.5	8.0	9.5	1.7	62.7	20.9	19.8	8.2	9.3	22.1	23.5	2.9	37.1	4.9	2.8	12.8	17.8	5.6	5.1	12.4	30.5	24.2	13.3	5.0	14.1	3.3	9.6	13.8	7.4	15.3	0.0	1.5	1.7	0.2	0.2	0.0	4.2	0.0	0.0	0.6	0.2	1.0	47.1	0.3	5.2	0.1	0.9	0.0	0.8	1.9	0.0	0.0	6.8	9.1	0.9	0.0	0.4	9.1	1.8	0.0	3.0	0.0	0.0	0.5	31.5	8.2	26.4	0.0	0.0	42.5	0.4	0.0	9.9	48.4	0.4	0.0	0.0	19.5	19.0	49.4	66.1	105.8	0.0	52.1	0.7	11.6	43.4	14.3	19.8	0.0	0.9	0.2	1.0	14.1	7.5	0.0	0.0	6.9	10.3	1.0	2.4	0.2	0.3	0.8	0.6	0.4	5.4	0.4	2.4	0.7	0.3	0.2	3.4	0.9	0.4	0.6	29.9	1.3	11.3	16.2	21.5	21.8	13.4	9.3	8.0	9.5	9.3	5.1	13.3	15.3	73.4	28.9	24.4	6.5	1.6	20.5	16.2	7.1	9.1	10.4	42.8	28.7	43.2	22.8	20.1	22.0	6.2	2.7	2.1	28.2	43.0	38.4	594.7	34.2	5.8	44.1	77.2	16.4	132.1	74.8	0.8	4.5	56.1	65.4	8.2	11.2	42.1	1.3	23.9	0.0	138.0	80.5	44.7	8.1	9.3	867.0	7.5	9.6	14.2	60.0	6.3	0.8	3.1	49.3	3.9	59.8	53.1	3.0	1.7	53.8	23.8	8.3	17.8	1.7	6.6	1.2	5.6	13.9	9.6	18.4	8.9	2.2	9.5	4.7	41.8	42.7
ICE1	KIAA0947	ENSG00000164151	"Interactor of little elongation complex ELL subunit 1"	Q9Y2F5	5	5420664-5490220	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA054452, HPA061934"	Uncertain		Supported	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 20: HeLa - Mitochondria"	"Cluster 52: Non-specific - Transcription"	"Nucleoplasm, Nuclear bodies"		"HPA054452: AB_2682492, HPA061934: AB_2684641"	"unprognostic (1.45e-2)"	"unprognostic (9.73e-2)"	"unprognostic (6.92e-2)"	"unprognostic (2.39e-3)"	"unprognostic (4.42e-2)"	"unprognostic (1.60e-1)"	"prognostic unfavorable (1.66e-4)"	"unprognostic (1.16e-1)"	"unprognostic (4.29e-1)"	"unprognostic (1.78e-1)"	"unprognostic (3.51e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.25e-2)"	"unprognostic (4.59e-2)"	"unprognostic (2.72e-1)"	"unprognostic (3.02e-2)"	"unprognostic (2.33e-1)"	8.7	6.9	8.1	9.1	8.8	13.7	10.2	11.3	8.4	8.7	4.4	9.0	7.2	11.6	9.0	7.6	8.2	7.1	8.1	10.2	7.0	10.0	7.1	8.1	11.5	6.2	5.7	13.9	9.2	14.1	7.5	12.7	6.4	7.8	7.8	12.8	7.5	8.8	16.5	8.7	7.5	10.3	4.5	10.0	7.7	7.5	7.1	14.5	10.2	15.5	11.3	9.5	6.6	8.1	17.9	22.1	24.8	23.9	23.6	23.1	32.0	15.1	18.0	17.8	19.5	17.1	12.9	24.1	20.6	21.8	35.1	16.5	34.4	17.7	29.8	33.4	17.5	19.5	68.9	12.5	14.3	44.5	15.4	18.5	18.6	21.3	32.8	17.7	22.3	18.0	28.1	19.5	18.8	15.6	32.6	15.9	21.0	11.4	18.6	37.7	22.6	16.3	15.0	19.9	16.0	16.6	52.5	16.9	20.2	23.8	14.7	13.9	25.4	23.0	29.4	29.9	23.9	21.1	26.9	39.6	19.3	32.9	19.9	0.4	0.5	1.1	0.9	0.7	1.1	0.9	0.8	0.9	0.5	0.8	0.7	0.9	0.1	1.1	0.4	1.1	1.1	0.3	8.1	8.8	11.3	8.4	10.2	7.0	6.2	5.7	6.4	4.5	7.1	8.1	29.8	22.4	29.5	42.1	30.3	0.0	17.7	0.0	26.2	40.2	20.1	26.3	33.0	14.3	14.2	16.5	31.3	35.6	35.1	10.8	25.4	22.6	5.8	19.5	37.4	27.5	9.0	23.5	68.2	22.7	22.4	25.0	19.9	25.7	11.4	28.6	15.4	13.8	15.7	45.4	57.3	11.6	0.0	13.8	0.0	5.2	22.4	19.9	0.0	36.5	26.1	24.6	17.5	39.7	62.1	23.0	6.4	22.2	37.5	24.1	11.1	14.8	6.6	34.7	6.6	50.5	27.8	51.6	47.0	25.9	0.0	10.9	33.9	36.4	11.4	16.9
ICE2	"BRCC1, FLJ11896, NARG2"	ENSG00000128915	"Interactor of little elongation complex ELL subunit 2"	Q659A1	15	60419609-60479160	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"parathyroid gland: 34.6"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040058			Supported	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	"Nucleoplasm, Nuclear bodies"		"HPA040058: AB_10795686"	"unprognostic (3.80e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.61e-1)"	"unprognostic (5.59e-3)"	"unprognostic (8.78e-3)"	"unprognostic (2.71e-1)"	"unprognostic (8.29e-2)"	"unprognostic (2.22e-1)"	"unprognostic (8.39e-3)"	"unprognostic (1.68e-1)"	"unprognostic (3.45e-1)"	"unprognostic (3.56e-2)"	"unprognostic (1.18e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.92e-2)"	"unprognostic (1.95e-1)"	"unprognostic (5.74e-2)"	5.5	5.5	3.0	6.2	4.0	5.5	8.4	4.5	3.2	5.0	5.8	4.8	4.4	8.0	5.5	6.6	6.4	6.5	5.3	2.6	3.2	6.5	7.0	4.9	9.1	3.9	3.3	9.9	6.3	34.6	4.2	7.9	4.2	6.6	7.1	4.8	6.0	5.4	4.4	5.0	5.4	6.4	3.4	7.7	5.3	6.8	3.2	12.7	9.3	5.1	9.8	6.1	3.6	6.7	14.7	25.5	21.1	20.3	15.6	16.9	11.0	8.5	13.1	13.3	14.4	20.0	10.6	25.5	18.3	9.2	25.2	27.2	28.3	11.4	18.3	30.9	12.6	25.8	17.4	11.8	8.4	28.8	17.6	8.5	13.6	11.0	19.7	17.7	22.2	24.9	39.9	23.3	16.7	6.3	22.9	7.6	26.3	26.8	17.1	27.1	16.7	22.4	10.7	18.0	23.8	22.8	12.0	12.2	15.1	24.8	19.7	14.6	10.5	18.4	16.0	15.8	26.5	11.0	31.6	37.7	12.1	32.4	17.4	4.0	4.5	5.3	5.7	6.3	9.7	7.6	7.0	7.6	5.9	10.5	9.3	9.1	0.7	4.2	5.8	4.9	8.1	6.0	3.0	4.0	4.5	3.2	2.6	3.2	3.9	3.3	4.2	3.4	3.2	6.7	32.5	19.2	19.6	34.6	30.6	0.0	20.4	0.0	16.5	31.3	24.4	27.7	20.2	15.7	17.3	20.2	39.6	22.7	32.4	8.8	21.5	12.2	15.5	25.6	27.5	25.1	19.2	28.0	39.9	10.4	14.9	21.1	25.0	21.8	29.8	70.6	29.6	20.6	14.0	30.3	42.6	16.1	0.0	16.8	0.0	17.4	25.4	21.1	0.0	49.6	25.3	19.6	25.7	49.3	83.6	14.6	13.7	17.7	15.9	23.0	11.6	18.1	19.7	33.3	0.0	31.4	17.5	22.1	34.8	21.3	0.0	14.6	31.3	39.3	19.4	19.2
ICOSLG	"B7-H2, B7h, B7H2, B7RP-1, B7RP1, CD275, GL50, ICOS-L, ICOSL, KIAA0653"	ENSG00000160223	"Inducible T cell costimulator ligand"	O75144	21	44217014-44240966	"CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, B-cell activation, Immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 18.2;brain: 33.3"	"Cell type enhanced"	"Detected in many"		"B-cells: 28.5;Glandular and luminal cells: 22.7;Langerhans cells: 39.0;monocytes: 21.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"naive B-cell: 2.4"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"Daudi: 19.9"									"CAB026037, HPA029179, CAB079997"	Approved		Approved	"Plasma membrane,Cytoplasmic bodies"		NA	NA		130000000	"Cluster 37: B-cells - Transcription"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 41: Macrophages - Immune response"	"Plasma membrane, Cytoplasmic bodies"		"CAB026037: , CAB079997: , HPA029179: AB_2732445"	"unprognostic (3.03e-2)"	"unprognostic (1.40e-4)"	"unprognostic (3.52e-2)"	"unprognostic (1.94e-2)"	"unprognostic (6.74e-2)"	"unprognostic (9.40e-2)"	"unprognostic (6.94e-2)"	"unprognostic (3.71e-1)"	"unprognostic (1.40e-1)"	"unprognostic (3.76e-2)"	"unprognostic (1.40e-1)"	"unprognostic (2.42e-1)"	"unprognostic (3.00e-2)"	"unprognostic (3.11e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.84e-1)"	3.1	3.6	12.1	4.9	21.8	18.2	2.6	10.7	17.9	3.9	0.2	2.1	2.5	1.9	1.4	5.4	3.4	4.1	5.2	11.7	12.4	8.3	3.3	3.1	8.0	18.7	17.9	0.8	2.1	0.7	1.4	3.1	17.1	3.3	1.8	1.4	3.0	1.4	1.5	6.6	3.8	1.3	11.0	4.3	4.9	1.4	18.2	2.6	2.3	1.8	5.5	3.2	3.5	33.3	0.5	4.6	0.2	3.9	1.0	1.5	10.4	1.0	0.9	0.5	0.3	7.9	0.6	19.9	2.9	0.5	1.8	5.8	2.7	1.6	0.3	2.0	2.0	0.6	4.0	2.3	0.9	8.7	14.1	1.4	2.6	1.2	1.3	0.3	1.1	0.7	3.3	1.7	0.3	5.2	0.4	11.4	2.7	13.2	4.8	17.1	1.3	11.6	0.8	10.3	2.0	0.1	12.9	18.2	0.4	1.4	5.1	12.2	1.1	0.6	4.4	0.4	0.4	16.4	12.2	16.2	5.8	8.0	2.5	0.3	0.3	0.2	0.1	0.3	0.1	1.8	0.3	0.1	0.2	2.4	0.3	0.4	0.3	0.2	0.2	0.7	0.1	0.2	12.1	21.8	10.7	17.9	11.7	12.4	18.7	17.9	17.1	11.0	18.2	33.3	1.2	0.0	1.5	0.3	28.5	7.5	5.8	8.4	3.4	1.7	8.7	5.8	0.6	1.5	2.4	9.2	0.0	0.4	2.0	7.9	0.0	2.0	1.9	9.8	2.1	4.6	5.3	0.8	0.0	0.7	1.1	5.6	4.6	22.7	0.0	0.2	1.4	2.8	3.7	0.0	0.0	4.5	8.2	8.8	39.0	4.0	3.1	15.6	8.8	0.0	21.0	1.2	2.1	0.0	0.5	0.8	3.8	10.9	4.7	16.0	3.6	3.5	0.6	1.2	0.0	4.5	6.1	0.1	0.2	4.7	6.5	0.5	2.9	0.3	4.5	7.9
ID3	"bHLHb25, HEIR-1"	ENSG00000117318	"Inhibitor of DNA binding 3, HLH protein"	Q02535	1	23557926-23559501	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Myogenesis, Transcription, Transcription regulation"	Repressor	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 1710.3;Basal respiratory cells: 1091.1;Hepatic stellate cells: 1508.2;Ionocytes: 1210.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"memory B-cell: 318.8;naive B-cell: 306.1"	"Group enriched"	"Detected in many"	39	"B-cells: 318.8;T-cells: 177.0"	"Cell line enhanced"	"Detected in many"		"U-698: 598.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB021353, HPA024677"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 72: Non-specific - Transcription"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Nucleoplasm		"CAB021353: , HPA024677: AB_2671647"	"unprognostic (6.73e-2)"	"unprognostic (2.48e-1)"	"unprognostic (5.19e-2)"	"prognostic favorable (1.27e-5)"	"unprognostic (5.58e-3)"	"unprognostic (1.46e-1)"	"unprognostic (8.98e-2)"	"unprognostic (7.76e-2)"	"unprognostic (3.89e-2)"	"unprognostic (6.47e-3)"	"unprognostic (2.42e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.52e-2)"	"unprognostic (1.36e-1)"	"unprognostic (2.01e-1)"	"unprognostic (4.37e-3)"	"unprognostic (8.36e-2)"	163.4	49.5	42.5	22.7	37.4	6.9	114.1	38.6	51.6	81.6	39.6	89.2	29.8	84.2	15.5	42.9	134.1	39.1	177.1	39.2	70.3	93.2	31.6	99.6	26.3	59.3	52.2	106.1	41.0	8.3	120.4	51.0	49.5	110.3	22.3	10.1	39.8	108.1	41.3	62.9	76.3	20.9	48.2	41.9	89.0	6.9	53.7	34.8	195.9	52.1	13.3	131.6	90.3	42.9	24.1	152.6	57.2	199.1	27.2	2.8	53.0	154.2	16.8	105.0	14.5	8.9	1.2	150.2	168.2	80.3	21.7	216.1	77.7	25.1	12.3	1.2	68.8	2.4	227.5	89.6	77.9	0.2	0.4	80.1	141.9	2.8	1.5	104.0	91.7	67.1	0.9	2.0	107.8	59.9	21.0	0.6	41.9	140.0	37.6	189.5	82.1	5.6	1.3	66.3	78.3	55.0	148.4	155.8	12.7	49.9	38.1	5.2	162.3	151.5	72.4	69.4	92.2	47.4	45.9	598.1	34.4	1.8	79.0	0.6	1.3	0.3	3.8	1.8	1.3	318.8	69.8	13.9	5.0	306.1	113.3	45.6	3.6	0.7	2.1	6.2	177.0	36.9	42.5	37.4	38.6	51.6	39.2	70.3	59.3	52.2	49.5	48.2	53.7	42.9	1710.3	115.4	62.6	77.7	211.6	205.2	340.3	1091.1	583.4	4.1	128.3	187.3	35.8	20.0	337.1	209.7	10.4	193.4	27.8	384.8	23.5	216.6	1.9	555.2	270.3	988.8	432.3	41.0	0.1	441.5	931.4	496.5	384.3	562.4	15.2	394.7	1508.2	7.0	70.6	5.0	0.2	560.1	1210.5	71.7	254.9	3.7	41.0	91.1	249.1	62.8	21.0	378.5	1.0	0.5	3.1	88.4	388.8	0.7	67.1	168.4	223.1	7.9	110.6	17.7	519.4	266.4	780.2	0.9	2.8	577.6	189.5	279.2	86.7	19.5	323.3	116.5
ID4	bHLHb27	ENSG00000172201	"Inhibitor of DNA binding 4, HLH protein"	P47928	6	19837370-19842197	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"thyroid gland: 274.7"	"Cell type enhanced"	"Detected in many"		"Breast myoepithelial cells: 246.6;Endometrial ciliated cells: 438.4;Endometrial stromal cells: 362.6;Glandular and luminal cells: 335.3;Muller glia cells: 391.8;Smooth muscle cells: 368.8"	"Cancer enhanced"	"Detected in all"		"thyroid cancer: 111.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 45.0;AN3-CA: 50.7;EFO-21: 105.1;HEK 293: 66.0;SCLC-21H: 117.0;SuSa: 37.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA075639			Supported	Nucleoplasm		NA	NA				"Cluster 57: Non-specific - Angiogenesis"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 48: Smooth muscle cells - ECM organization"	Nucleoplasm		"HPA075639: "	"unprognostic (3.25e-3)"	"unprognostic (7.37e-3)"	"unprognostic (1.80e-1)"	"unprognostic (6.34e-3)"	"unprognostic (4.17e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.05e-1)"	"unprognostic (2.87e-1)"	"unprognostic (1.65e-2)"	"prognostic favorable (2.49e-4)"	"unprognostic (7.26e-2)"	"unprognostic (1.66e-3)"	"unprognostic (2.41e-2)"	"unprognostic (3.13e-2)"	"unprognostic (1.03e-3)"	"unprognostic (2.57e-3)"	74.6	5.0	50.1	7.5	47.6	0.2	41.7	33.6	55.4	41.0	22.8	9.8	7.2	30.0	9.4	21.7	70.3	10.2	75.7	48.0	59.6	30.8	4.4	27.8	5.0	42.8	60.8	48.4	19.1	2.5	36.4	22.2	42.2	29.7	6.7	19.4	27.1	44.0	3.6	107.8	11.9	21.0	43.6	20.2	19.8	23.0	58.5	2.0	274.7	3.1	2.1	31.4	33.1	40.2	0.0	0.6	45.0	50.7	1.2	0.1	0.1	5.8	0.1	0.4	0.0	0.0	0.0	0.0	105.1	14.1	0.2	20.3	0.0	0.0	0.4	0.0	66.0	0.0	0.0	0.5	0.3	0.0	0.5	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.2	8.1	6.3	0.0	0.0	0.0	0.2	7.6	14.2	117.0	1.5	0.0	1.8	7.2	37.6	3.2	0.0	0.0	0.2	5.6	0.1	1.6	0.0	0.1	1.1	1.6	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	50.1	47.6	33.6	55.4	48.0	59.6	42.8	60.8	42.2	43.6	58.5	40.2	31.8	96.1	53.0	229.9	1.9	83.1	190.8	16.7	232.8	11.2	143.8	246.6	42.5	7.2	19.6	68.0	2.1	9.9	2.9	15.6	50.9	18.0	2.1	438.4	362.6	19.9	91.6	0.0	1.8	3.3	9.5	83.9	118.3	335.3	0.0	17.6	23.9	0.0	2.7	3.3	1.2	23.4	22.4	0.6	24.8	7.9	8.1	5.3	88.9	2.8	0.0	391.8	0.0	0.5	0.3	1.4	27.1	0.0	1.4	93.6	8.2	76.0	8.4	13.7	0.0	76.3	368.8	1.2	44.9	119.6	78.6	5.9	6.1	0.7	7.8	42.4
IDH1		ENSG00000138413	"Isocitrate dehydrogenase (NADP(+)) 1"	O75874	2	208236229-208266074	"Cancer-related genes, Citric acid cycle related proteins, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Glyoxylate bypass, Tricarboxylic acid cycle"	Oxidoreductase	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 536.3"	"Cell type enhanced"	"Detected in all"		"Cytotrophoblasts: 320.2;Granulosa cells: 257.5;Hepatocytes: 328.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Hep G2: 768.1;RT4: 524.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB033218, HPA035248, HPA057936, CAB062556"	Enhanced		Approved	"Nuclear bodies,Cytosol"		NA	NA		16000000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 85: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 40: Granulosa cells - Unknown function"	"Nuclear bodies, Cytosol"		"CAB033218: AB_2123166, CAB062556: AB_2665593, HPA035248: AB_10600714, HPA057936: AB_2683559"	"unprognostic (2.79e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.02e-1)"	"unprognostic (2.47e-3)"	"unprognostic (1.93e-1)"	"unprognostic (2.39e-2)"	"prognostic unfavorable (6.93e-5)"	"unprognostic (3.32e-1)"	"unprognostic (2.20e-3)"	"unprognostic (8.03e-2)"	"unprognostic (5.54e-2)"	"unprognostic (4.18e-3)"	"prognostic unfavorable (2.45e-5)"	"unprognostic (2.09e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.69e-2)"	150.8	230.8	24.0	37.5	23.9	10.7	63.0	24.6	30.9	67.9	40.8	124.9	179.4	22.9	164.9	92.2	36.6	69.5	25.3	23.5	26.1	122.0	536.3	49.8	33.3	26.4	25.7	84.4	39.9	42.0	16.7	82.5	25.9	214.6	131.2	35.0	59.3	79.1	25.7	23.6	117.4	43.8	25.5	40.1	113.6	57.0	30.0	21.8	45.5	28.1	29.8	153.1	39.9	30.6	66.5	109.6	152.5	63.3	275.1	191.4	86.7	26.3	122.3	44.2	107.3	176.1	159.1	13.1	168.8	84.4	181.6	101.4	112.4	130.7	43.0	8.8	41.7	56.7	87.3	768.1	367.3	37.0	54.7	169.5	278.0	102.7	74.2	69.8	126.1	37.2	58.1	44.5	68.9	42.8	26.3	66.2	284.5	479.7	43.9	25.2	54.8	37.8	206.3	524.0	25.9	45.2	100.5	99.7	351.7	161.2	37.9	111.0	81.1	45.2	44.1	65.3	29.6	20.8	34.5	16.9	148.2	226.7	37.0	12.4	70.1	11.0	9.1	32.3	10.6	10.6	8.2	10.9	50.9	10.1	6.7	7.8	13.8	17.2	15.5	18.8	15.1	29.9	24.0	23.9	24.6	30.9	23.5	26.1	26.4	25.7	25.9	25.5	30.0	30.6	13.9	12.8	49.5	39.2	20.2	12.4	18.8	60.5	52.3	19.5	61.8	31.5	21.8	45.8	69.1	29.5	25.0	320.2	23.7	106.8	21.5	31.1	13.8	31.0	23.4	22.0	58.4	30.3	16.6	86.5	178.8	29.6	76.0	108.8	14.0	257.5	39.7	328.2	175.3	11.8	16.2	98.4	57.0	130.2	23.8	11.2	24.5	71.7	26.6	19.7	47.8	25.4	18.6	66.4	20.0	44.8	55.5	29.3	13.7	53.2	181.2	108.5	21.9	56.6	13.1	7.8	23.6	8.0	26.2	82.4	14.9	95.6	19.8	127.1	129.3	46.7
IDH2		ENSG00000182054	"Isocitrate dehydrogenase (NADP(+)) 2"	P48735	15	90083045-90102477	"Cancer-related genes, Citric acid cycle related proteins, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Glyoxylate bypass, Tricarboxylic acid cycle"	Oxidoreductase	"Cancer-related genes, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"heart muscle: 492.6;skeletal muscle: 1302.3;tongue: 1611.3"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 732.5;Distal tubular cells: 1168.0;Extravillous trophoblasts: 586.7;Syncytiotrophoblasts: 573.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"MOLT-4: 425.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007831	Enhanced		Supported	Mitochondria		NA	NA		5200000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 14: REH - Unknown function"	"Cluster 47: Cytotrophoblasts - Unknown function"	Mitochondria		"HPA007831: AB_1851397"	"unprognostic (2.45e-2)"	"prognostic favorable (5.15e-5)"	"unprognostic (2.92e-1)"	"unprognostic (1.53e-1)"	"unprognostic (3.53e-1)"	"unprognostic (8.46e-2)"	"unprognostic (3.83e-2)"	"unprognostic (2.55e-3)"	"unprognostic (1.86e-2)"	"unprognostic (1.89e-2)"	"unprognostic (2.76e-1)"	"unprognostic (4.90e-2)"	"unprognostic (2.19e-3)"	"unprognostic (3.92e-3)"	"unprognostic (4.46e-1)"	"unprognostic (1.30e-2)"	"unprognostic (2.58e-2)"	32.8	10.5	56.5	60.2	67.8	161.1	51.1	57.1	59.8	36.6	76.6	95.9	97.2	29.0	12.5	140.6	32.7	31.7	492.6	47.2	55.0	208.3	274.7	32.0	77.1	61.0	61.3	13.6	128.7	104.0	15.5	87.3	54.4	76.2	84.1	5.4	163.1	90.4	1302.3	61.8	84.3	79.8	52.9	36.8	175.7	5.3	71.6	148.7	16.0	1611.3	66.0	53.3	49.4	57.6	61.3	33.5	169.9	169.8	23.3	28.3	144.5	74.5	110.8	68.0	72.6	16.1	51.1	72.7	21.0	61.2	65.1	20.8	25.1	22.4	32.0	143.8	16.9	122.9	12.7	119.7	28.1	85.1	118.2	59.7	12.7	16.3	13.0	82.1	141.0	246.4	18.9	59.3	53.0	175.3	425.0	131.2	51.8	81.9	14.3	352.0	122.4	213.7	105.6	71.3	244.5	125.3	92.1	359.8	29.9	94.2	290.9	256.9	34.0	120.4	17.0	16.1	34.9	101.5	20.5	9.0	38.4	175.0	71.2	45.0	112.8	75.6	105.9	199.1	53.2	70.1	77.0	120.1	136.9	47.7	42.9	71.8	22.9	99.9	252.1	79.4	72.4	163.4	56.5	67.8	57.1	59.8	47.2	55.0	61.0	61.3	54.4	52.9	71.6	57.6	16.9	6.4	21.0	40.1	64.2	39.9	98.8	91.6	12.5	6.2	90.5	48.1	445.9	114.4	95.8	75.4	10.4	732.5	84.0	70.0	1168.0	252.8	5.6	96.4	25.7	41.6	61.7	193.8	11.8	288.8	586.7	44.7	88.2	50.9	31.6	29.2	38.2	283.1	263.7	10.1	8.3	158.3	229.9	77.7	101.1	3.2	14.0	79.0	58.7	5.6	85.3	20.9	119.4	16.6	27.3	116.6	105.0	35.3	185.9	170.3	69.6	205.0	167.9	5.4	13.1	60.8	73.4	0.6	15.6	113.3	67.1	573.0	88.1	14.7	305.1	140.1
IDH3G		ENSG00000067829	"Isocitrate dehydrogenase (NAD(+)) 3 non-catalytic subunit gamma"	P51553	X	153785766-153794523	"Citric acid cycle related proteins, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Tricarboxylic acid cycle"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 284.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000425, HPA002017"	Supported		Approved	Nucleoli,Mitochondria		Yes	No		19000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoli, Mitochondria"		"HPA000425: AB_1079097, HPA002017: AB_1079096"	"unprognostic (4.24e-2)"	"unprognostic (1.43e-3)"	"unprognostic (5.75e-2)"	"unprognostic (1.05e-1)"	"unprognostic (6.57e-2)"	"unprognostic (2.25e-1)"	"unprognostic (4.35e-2)"	"unprognostic (1.58e-1)"	"unprognostic (2.24e-2)"	"unprognostic (1.59e-2)"	"unprognostic (2.81e-2)"	"unprognostic (1.96e-1)"	"prognostic favorable (5.73e-6)"	"unprognostic (1.50e-1)"	"unprognostic (3.35e-1)"	"unprognostic (2.91e-2)"	"unprognostic (2.46e-1)"	52.0	67.1	45.5	38.5	50.0	60.3	49.9	47.8	61.3	44.1	46.5	57.2	52.3	50.7	23.5	50.2	44.8	35.0	91.9	54.9	48.8	68.5	49.2	42.0	40.3	50.5	45.7	49.3	48.3	45.5	47.9	28.3	52.3	43.8	34.6	24.4	51.7	39.9	100.5	51.7	54.7	34.5	43.9	51.8	52.2	32.1	49.1	35.2	48.0	82.9	34.9	44.3	43.2	47.2	94.9	90.0	47.3	65.9	74.4	59.4	62.0	47.3	64.1	80.5	84.3	76.0	66.5	121.4	80.2	74.7	68.2	67.2	72.6	69.2	30.0	38.9	101.7	43.0	118.9	59.0	85.5	61.6	87.5	76.1	48.0	64.4	69.4	50.4	65.3	50.3	24.7	60.4	64.7	138.5	72.0	76.0	21.6	84.2	118.0	62.7	43.3	105.8	94.4	61.1	59.5	42.8	30.2	96.3	48.0	20.8	39.6	51.9	56.0	49.9	34.1	76.8	112.5	89.0	22.6	152.1	81.8	75.8	57.6	178.1	159.3	165.8	71.8	163.9	68.0	68.5	73.2	71.2	163.1	78.9	57.9	63.7	57.8	86.5	169.6	101.3	107.5	140.1	45.5	50.0	47.8	61.3	54.9	48.8	50.5	45.7	52.3	43.9	49.1	47.2	44.4	35.3	33.8	5.5	49.2	80.9	67.5	103.9	37.5	34.9	48.4	57.9	55.1	50.1	55.0	51.5	29.2	99.8	48.2	145.0	207.4	93.4	132.0	42.2	39.4	44.6	62.3	41.4	5.6	90.5	98.7	48.2	47.9	39.8	93.8	43.6	43.2	35.4	131.0	18.5	6.4	107.0	79.3	98.0	77.0	284.2	53.4	75.6	67.6	3.7	116.4	50.8	64.9	3.0	5.0	73.5	133.8	58.6	49.7	35.6	222.4	253.1	50.7	49.3	52.6	47.4	68.2	15.9	18.3	50.3	77.4	110.8	55.2	103.0	112.7	64.2
IDUA	"MPS1, MPSI"	ENSG00000127415	Alpha-L-iduronidase	P35475	4	986997-1004564	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Glycosidase, Hydrolase"	"Disease variant, Mucopolysaccharidosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Leydig cells: 19.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"U-266/70: 29.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB025901, HPA046979, HPA054254"	Enhanced		Supported	Vesicles	"Intracellular and membrane"	NA	NA		170000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 72: Non-specific - Transcription"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 55: Plasma cells - Humoral immune response"	Vesicles		"CAB025901: , HPA046979: AB_2679888, HPA054254: AB_2682429"	"unprognostic (3.62e-2)"	"unprognostic (9.08e-2)"	"prognostic unfavorable (3.13e-4)"	"unprognostic (7.23e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.31e-2)"	"unprognostic (1.83e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.43e-2)"	"unprognostic (1.89e-3)"	"unprognostic (2.64e-2)"	"unprognostic (4.61e-3)"	"prognostic unfavorable (7.87e-5)"	"unprognostic (2.24e-1)"	"unprognostic (1.55e-1)"	"unprognostic (2.46e-2)"	"prognostic favorable (8.04e-5)"	13.5	17.6	3.4	2.2	3.4	2.9	16.1	9.2	7.5	17.5	2.9	10.3	3.6	15.4	2.4	9.9	16.3	3.7	11.6	3.8	1.5	15.9	13.6	13.9	3.5	3.2	2.1	17.0	21.0	2.8	17.2	1.7	2.4	18.5	1.8	1.8	16.6	4.5	3.7	8.9	14.3	2.0	1.0	18.9	17.1	5.6	2.9	3.4	17.0	0.7	1.3	12.0	13.9	2.6	1.8	0.4	0.0	1.1	12.7	3.6	5.3	10.7	8.5	1.2	1.7	0.6	6.4	0.8	10.7	5.0	1.0	0.5	0.1	0.3	0.4	6.1	0.6	1.0	0.8	0.1	5.8	0.8	4.6	9.3	3.1	0.6	0.0	3.4	1.0	0.7	0.6	0.0	1.6	0.0	2.2	2.5	0.8	11.9	5.5	2.7	0.0	1.1	3.5	0.9	0.1	3.3	0.3	0.0	5.7	1.3	1.2	2.3	9.3	9.0	1.6	2.6	1.2	29.0	1.4	0.4	7.8	3.3	1.8	0.0	1.5	0.0	1.4	1.2	1.8	0.1	1.1	0.9	1.8	0.2	1.3	0.7	0.0	1.5	1.7	1.1	0.6	0.5	3.4	3.4	9.2	7.5	3.8	1.5	3.2	2.1	2.4	1.0	2.9	2.6	8.7	6.4	5.0	4.9	5.2	3.6	11.5	1.1	8.6	2.0	8.5	9.1	2.6	1.5	1.5	7.3	4.2	0.4	4.3	5.0	0.0	1.6	0.9	4.1	9.0	4.9	10.7	1.3	4.4	2.4	1.7	13.4	16.8	6.0	2.5	8.2	6.1	2.6	6.5	0.0	2.9	4.2	0.0	5.0	3.6	0.9	19.6	7.3	5.4	1.0	1.6	1.1	4.1	5.5	3.3	1.4	6.9	10.5	15.7	7.7	6.9	1.4	1.4	2.1	0.0	5.5	4.4	3.7	1.6	4.7	1.8	0.4	5.6	4.7	4.3	7.9
IER3IP1		ENSG00000134049	"Immediate early response 3 interacting protein 1"	Q9Y5U9	18	47152834-47176364	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Protein transport, Transport"		"Diabetes mellitus, Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Proximal tubular cells: 357.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA010027	Supported		Supported	"Endoplasmic reticulum"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 16: U-266 - Nucleosome"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Endoplasmic reticulum"		"HPA010027: AB_1079098"	"unprognostic (6.13e-2)"	"unprognostic (2.96e-2)"	"unprognostic (3.82e-2)"	"unprognostic (1.45e-2)"	"unprognostic (1.11e-3)"	"unprognostic (2.41e-1)"	"prognostic unfavorable (6.47e-6)"	"unprognostic (9.86e-2)"	"unprognostic (5.13e-2)"	"prognostic favorable (8.59e-4)"	"unprognostic (6.44e-2)"	"unprognostic (6.24e-3)"	"unprognostic (1.53e-3)"	"unprognostic (8.55e-2)"	"unprognostic (2.71e-2)"	"unprognostic (8.75e-2)"	"unprognostic (1.27e-3)"	13.7	17.2	8.1	11.8	8.2	14.5	14.2	11.1	10.0	10.5	11.2	14.1	16.9	11.2	10.9	12.0	9.0	10.2	17.0	8.2	9.1	31.4	19.5	12.3	11.4	8.8	8.9	11.6	13.7	19.2	15.5	10.9	9.0	13.9	13.0	14.1	15.0	7.9	31.1	13.8	15.7	9.5	8.0	11.1	15.9	9.3	8.9	11.1	15.9	21.7	10.6	13.9	11.0	8.9	27.1	15.3	22.9	20.5	30.5	33.8	15.9	62.7	30.5	30.6	32.2	12.5	22.7	26.5	19.3	28.1	25.0	32.3	21.8	22.1	33.2	43.5	19.5	23.3	23.0	38.2	32.5	70.5	33.2	26.8	27.7	27.6	20.6	28.9	26.7	23.7	19.4	39.7	33.0	15.0	25.1	33.7	11.6	11.5	18.4	24.7	35.9	37.9	31.2	26.0	26.4	29.4	21.5	18.1	38.8	16.4	18.0	40.1	38.7	45.2	23.3	22.0	34.7	56.9	66.4	27.9	35.3	44.4	37.2	15.9	17.2	16.1	25.0	16.6	22.2	18.9	21.1	21.5	16.6	20.9	19.6	20.8	1.9	17.3	17.5	34.5	23.6	19.3	8.1	8.2	11.1	10.0	8.2	9.1	8.8	8.9	9.0	8.0	8.9	8.9	80.8	86.6	51.8	7.8	58.9	0.0	64.6	0.0	73.4	48.0	96.0	51.4	63.1	97.2	19.2	51.5	8.4	104.9	61.3	35.6	140.8	124.3	18.4	49.5	47.7	70.8	37.6	51.3	15.7	138.9	126.3	76.2	57.6	55.6	13.9	40.0	83.6	138.8	108.9	40.4	17.4	69.1	0.0	63.6	0.0	13.3	84.8	54.8	0.0	12.2	79.4	69.6	86.5	16.1	19.1	139.3	50.1	48.5	158.8	117.3	125.0	357.0	26.2	48.0	52.6	40.4	61.6	163.3	158.9	88.1	0.0	177.2	54.4	36.7	62.2	109.4
IFI16	"IFNGIP1, PYHIN2"	ENSG00000163565	"Interferon gamma inducible protein 16"	Q16666	1	158999968-159055155	"Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Autophagy, Immunity, Inflammatory response, Innate immunity, Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 378.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			"HPA002134, CAB016293, HPA073514"	Enhanced		Supported	Nucleoplasm,Nucleoli,Cytosol		No	No			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Nucleoplasm, Nucleoli"	Cytosol	"CAB016293: AB_627775, HPA002134: AB_1079099, HPA073514: "	"unprognostic (7.23e-3)"	"unprognostic (2.20e-2)"	"unprognostic (5.15e-2)"	"unprognostic (7.70e-3)"	"unprognostic (1.87e-1)"	"unprognostic (6.08e-2)"	"unprognostic (1.80e-1)"	"unprognostic (5.83e-2)"	"unprognostic (5.04e-2)"	"unprognostic (2.26e-2)"	"unprognostic (5.92e-3)"	"unprognostic (7.62e-2)"	"prognostic unfavorable (1.11e-16)"	"unprognostic (5.07e-2)"	"unprognostic (4.08e-1)"	"unprognostic (7.97e-2)"	"unprognostic (1.14e-1)"	95.7	37.9	13.5	114.5	17.5	35.5	72.8	14.3	14.1	56.8	9.1	38.3	23.8	76.5	22.7	63.6	54.2	100.6	35.0	13.7	20.3	30.1	27.7	68.2	140.6	29.9	22.7	76.8	16.7	9.7	9.3	66.7	27.0	26.5	45.0	7.7	63.7	32.0	16.8	58.8	47.9	87.3	23.6	107.8	30.7	18.8	23.8	116.8	37.4	32.6	133.1	113.6	52.8	26.2	43.5	3.2	14.4	0.6	97.4	319.5	0.4	89.9	238.0	245.7	324.2	0.0	54.1	251.7	75.4	55.3	79.2	122.2	2.2	91.1	97.7	78.4	1.1	64.9	17.2	0.1	181.8	22.8	4.2	302.4	159.5	126.5	177.8	117.8	262.8	218.1	1.4	179.4	138.6	0.0	302.2	21.1	38.4	0.0	32.5	140.6	91.4	295.0	34.4	16.1	6.6	0.1	117.7	1.0	259.5	56.9	0.4	26.3	150.2	63.1	29.7	179.9	38.2	165.8	82.8	235.5	181.2	72.7	155.7	9.1	67.7	0.4	57.5	66.4	51.9	88.4	54.3	59.4	68.3	94.6	33.9	43.3	164.4	91.6	65.3	51.1	82.1	63.8	13.5	17.5	14.3	14.1	13.7	20.3	29.9	22.7	27.0	23.6	23.8	26.2	378.4	38.5	54.6	4.2	217.8	95.0	110.7	197.6	174.8	0.4	47.8	43.8	10.7	37.1	130.7	42.3	0.0	3.4	278.3	7.9	1.9	38.0	4.9	41.9	219.1	286.8	12.1	38.7	1.3	47.8	2.9	207.8	9.7	68.0	138.3	27.7	137.4	3.0	214.2	0.0	2.2	19.9	79.3	163.8	135.0	9.8	117.4	187.2	83.6	116.2	202.4	30.8	329.6	37.2	20.7	47.1	23.5	53.0	143.3	32.6	7.9	4.9	76.6	1.4	85.5	185.3	132.7	2.4	13.2	92.6	68.2	3.3	219.2	70.6	26.4	107.5
IFI30	"GILT, IFI-30, IP-30, IP30, MGC32056"	ENSG00000216490	"IFI30 lysosomal thiol reductase"	P13284	19	18173162-18178117	"Predicted intracellular proteins, Predicted membrane proteins"	Immunity	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lung: 572.7;lymphoid tissue: 708.3"	"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 155.9;Kupffer cells: 205.4;Langerhans cells: 139.3;Macrophages: 426.2;monocytes: 144.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"classical monocyte: 9509.8;eosinophil: 3890.4;intermediate monocyte: 14243.6;myeloid DC: 5699.9;non-classical monocyte: 9865.9"	"Group enriched"	"Detected in all"	8	"dendritic cells: 5699.9;granulocytes: 3890.4;monocytes: 14243.6"	"Cell line enhanced"	"Detected in many"		"Daudi: 655.7;RPMI-8226: 717.7;SK-BR-3: 457.4;U-266/84: 794.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA026650	Enhanced		Supported	Vesicles,Cytosol	"Intracellular and membrane"	NA	NA		110000	"Cluster 7: Monocytes - Unknown function"	"Cluster 64: Macrophages - Immune response"	"Cluster 16: U-266 - Nucleosome"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	"Vesicles, Cytosol"		"HPA026650: AB_10602237"	"unprognostic (4.66e-2)"	"unprognostic (1.25e-4)"	"unprognostic (2.35e-3)"	"unprognostic (7.40e-2)"	"unprognostic (1.76e-2)"	"unprognostic (3.11e-2)"	"unprognostic (8.10e-3)"	"unprognostic (2.40e-1)"	"unprognostic (4.01e-2)"	"unprognostic (9.19e-3)"	"unprognostic (3.04e-1)"	"unprognostic (1.19e-1)"	"unprognostic (7.29e-11)"	"unprognostic (3.50e-1)"	"unprognostic (1.62e-2)"	"unprognostic (3.39e-2)"	"unprognostic (9.59e-3)"	132.4	121.0	18.4	708.3	20.8	283.8	58.6	20.3	104.5	40.8	48.7	129.0	197.3	22.2	26.9	38.7	57.3	109.6	31.2	18.0	23.3	80.3	148.2	572.7	370.7	32.0	24.9	14.8	61.3	75.0	27.9	128.8	40.5	31.6	148.0	2.6	66.3	22.0	12.6	55.0	153.6	165.0	26.8	385.3	112.2	16.0	69.4	91.9	54.2	9.0	221.0	215.7	19.6	49.8	115.5	59.2	0.4	37.9	11.2	19.9	102.6	11.8	17.2	34.6	91.8	132.3	193.1	655.7	96.6	39.7	175.2	85.1	69.9	30.1	3.7	182.5	55.2	8.1	98.1	188.9	111.8	20.1	46.9	70.4	60.4	59.8	19.7	4.4	2.0	23.8	96.8	394.8	16.6	217.3	9.9	2.5	21.2	380.6	68.7	65.8	4.5	717.7	101.1	3.7	5.3	8.0	200.5	457.4	11.3	7.4	31.6	8.8	4.2	55.2	34.2	120.7	12.0	14.6	794.7	368.5	154.1	133.5	8.5	106.9	9509.8	3890.4	40.8	14243.6	38.8	952.6	28.5	31.1	5699.9	708.1	19.7	24.3	2102.8	70.2	9865.9	173.2	41.5	11082.7	18.4	20.8	20.3	104.5	18.0	23.3	32.0	24.9	40.5	26.8	69.4	49.8	6.4	9.6	38.8	0.0	54.2	3.6	2.5	2.1	2.2	0.4	8.6	13.2	1.1	4.3	18.3	12.9	0.0	5.6	4.0	8.3	1.9	1.8	0.3	2.5	1.7	8.4	0.0	4.6	0.1	1.1	14.8	8.1	6.6	4.1	13.9	0.2	3.6	1.3	155.9	0.0	0.1	14.9	2.0	205.4	139.3	0.2	0.3	426.2	5.4	1.0	144.1	0.7	5.2	0.0	0.1	1.2	3.4	0.0	47.7	4.6	5.9	5.4	8.9	0.7	0.0	2.6	1.8	0.2	0.7	3.7	3.3	12.0	9.6	1.5	9.6	1.2
IFI35	IFP35	ENSG00000068079	"Interferon induced protein 35"	P80217	17	43006740-43014456	"Predicted intracellular proteins, Predicted secreted proteins"	"Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Granulosa cells: 122.4;Paneth cells: 116.7;Proximal enterocytes: 128.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+: 204.5;BJ hTERT+ SV40 Large T+ RasG12V: 299.2;GAMG: 108.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045946, HPA075580"	Approved		Supported	"Nucleoplasm,Intermediate filaments,Cytosol"	"Secreted to blood"	NA	NA		120000	"Cluster 7: Monocytes - Unknown function"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 40: Granulosa cells - Unknown function"	"Nucleoplasm, Cytosol"	"Intermediate filaments"	"HPA045946: AB_2679509, HPA075580: "	"prognostic favorable (1.41e-4)"	"unprognostic (1.14e-2)"	"unprognostic (1.82e-1)"	"unprognostic (2.16e-1)"	"unprognostic (1.32e-1)"	"unprognostic (3.26e-1)"	"unprognostic (3.90e-3)"	"unprognostic (1.14e-1)"	"unprognostic (6.92e-2)"	"unprognostic (9.78e-3)"	"unprognostic (6.51e-3)"	"unprognostic (1.22e-1)"	"prognostic unfavorable (4.03e-5)"	"unprognostic (3.55e-1)"	"unprognostic (3.62e-2)"	"unprognostic (1.34e-2)"	"unprognostic (1.49e-1)"	27.5	41.3	15.4	27.2	16.4	24.9	24.2	15.6	18.2	18.4	16.2	27.4	24.6	17.4	11.7	10.2	20.8	20.1	20.9	14.9	16.7	29.7	30.6	25.6	26.4	20.2	16.6	23.8	13.6	10.5	14.2	15.0	17.3	27.8	20.4	1.5	29.4	15.2	6.3	11.3	30.2	21.3	20.3	39.9	22.7	5.0	17.0	23.4	20.8	9.3	19.0	21.1	15.4	17.0	12.7	28.8	0.2	1.5	24.2	29.1	6.1	8.2	84.6	204.5	299.2	10.7	46.2	3.9	16.1	24.7	108.0	7.0	1.6	12.9	16.3	33.5	6.1	9.3	10.5	39.5	59.6	10.5	19.3	40.3	4.9	29.0	3.6	18.6	18.8	8.0	5.4	61.2	8.2	12.5	22.7	8.5	0.1	11.6	13.0	18.4	0.1	23.7	25.7	10.9	5.4	0.2	16.4	6.3	88.2	0.6	26.5	20.3	9.3	15.1	0.3	4.8	13.3	54.1	21.8	1.1	27.1	8.2	14.8	60.7	102.7	61.6	44.3	127.8	40.4	37.8	34.0	41.7	62.0	40.0	26.8	33.6	62.1	56.9	122.0	67.0	51.8	80.5	15.4	16.4	15.6	18.2	14.9	16.7	20.2	16.6	17.3	20.3	17.0	17.0	65.2	16.0	9.7	2.6	28.6	10.5	29.6	31.8	12.5	0.8	16.5	11.3	5.5	11.5	22.7	18.4	2.1	22.7	36.7	83.1	41.1	47.8	9.4	12.3	27.4	32.1	31.7	12.8	0.7	64.0	32.5	32.8	26.5	16.2	7.6	122.4	37.1	31.3	84.8	1.7	0.6	39.4	12.2	36.8	19.2	39.5	28.9	47.8	24.9	5.6	75.5	10.4	64.9	1.0	1.0	41.8	116.7	23.7	54.0	19.1	128.0	93.7	18.0	0.8	6.6	13.2	36.3	0.5	0.4	5.1	9.2	10.4	32.3	25.0	34.6	29.6
IFIT3	"CIG-49, GARG-49, IFI60, IFIT4, IRG2, ISG60, RIG-G"	ENSG00000119917	"Interferon induced protein with tetratricopeptide repeats 3"	O14879	10	89327307-89377473	"Plasma proteins, Predicted intracellular proteins"	"Antiviral defense, Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 89.5;Ductal cells: 70.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 488.1"	"Group enriched"	"Detected in all"	19	"granulocytes: 488.1;monocytes: 125.0"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 198.8;BJ hTERT+ SV40 Large T+: 468.4;BJ hTERT+ SV40 Large T+ RasG12V: 540.2"					"Low region specificity"	"Detected in all"			HPA059914	Approved		Supported	Mitochondria,Cytosol		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Mitochondria, Cytosol"		"HPA059914: AB_2684159"	"unprognostic (2.81e-1)"	"unprognostic (5.62e-2)"	"unprognostic (4.94e-2)"	"unprognostic (5.25e-3)"	"unprognostic (3.33e-3)"	"unprognostic (1.77e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.74e-1)"	"unprognostic (5.18e-3)"	"unprognostic (2.99e-3)"	"unprognostic (5.72e-2)"	"prognostic unfavorable (3.17e-4)"	"unprognostic (1.36e-1)"	"unprognostic (4.69e-2)"	"unprognostic (9.80e-3)"	"unprognostic (5.09e-2)"	21.3	20.1	10.5	20.4	22.7	42.9	14.3	15.9	14.8	11.5	1.5	11.2	25.4	12.9	11.7	6.8	17.7	24.6	15.5	11.8	15.9	19.3	28.6	44.2	9.0	24.7	17.0	18.1	7.4	5.4	6.1	31.1	25.0	6.0	9.0	3.8	34.6	12.5	7.1	6.4	18.7	18.1	37.2	47.6	12.6	6.8	15.7	33.1	7.4	14.8	5.3	13.5	7.8	35.0	38.7	2.7	0.9	10.3	41.7	43.9	0.5	25.4	198.8	468.4	540.2	2.0	54.3	3.3	11.2	39.0	112.0	33.6	0.6	4.9	34.0	5.6	0.7	15.9	10.1	1.2	23.8	4.5	13.8	27.8	0.6	40.6	3.4	17.9	2.8	1.5	1.1	8.3	12.7	0.3	10.7	11.7	0.7	0.1	12.1	10.2	3.3	2.4	13.3	19.1	0.4	0.2	5.9	0.7	96.8	1.4	1.4	5.7	4.0	8.2	1.9	14.7	7.4	13.8	11.3	0.9	12.0	19.9	7.9	105.7	45.8	172.5	4.6	101.9	1.0	9.7	6.6	3.0	15.6	10.9	3.7	4.5	488.1	2.1	125.0	3.5	16.3	19.4	10.5	22.7	15.9	14.8	11.8	15.9	24.7	17.0	25.0	37.2	15.7	35.0	89.5	51.3	10.1	5.9	8.0	3.2	6.7	13.0	4.0	10.7	3.1	5.5	32.5	10.0	12.5	9.2	4.2	5.2	8.3	6.8	21.5	70.6	0.9	26.0	16.6	66.4	0.0	10.3	9.1	36.3	12.8	20.1	4.6	39.3	13.9	19.8	20.0	13.6	34.6	60.6	8.4	4.0	4.1	21.7	4.4	0.5	30.4	26.8	3.6	17.8	22.0	20.8	8.2	6.0	50.2	23.3	9.4	28.2	2.5	10.0	34.6	14.5	12.3	2.1	46.0	16.0	22.2	1.2	1.6	2.9	1.8	1.9	6.3	14.4	3.7	6.2
IFIT5	RI58	ENSG00000152778	"Interferon induced protein with tetratricopeptide repeats 5"	Q13325	10	89414568-89421605	"Predicted intracellular proteins"	"Antiviral defense, Immunity, Innate immunity"	"RNA-binding, tRNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+: 109.1;BJ hTERT+ SV40 Large T+ RasG12V: 128.0"					"Low region specificity"	"Detected in all"			"HPA037957, HPA062180"	Uncertain		Supported	"Plasma membrane"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Plasma membrane"		"HPA037957: AB_10672499, HPA062180: AB_2684705"	"unprognostic (2.17e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.67e-3)"	"unprognostic (4.19e-2)"	"unprognostic (2.88e-2)"	"unprognostic (2.80e-1)"	"unprognostic (1.45e-1)"	"unprognostic (8.89e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.86e-1)"	"unprognostic (3.24e-2)"	"unprognostic (1.48e-1)"	"unprognostic (3.42e-1)"	"unprognostic (2.43e-2)"	"unprognostic (1.73e-1)"	13.3	11.6	11.9	11.1	14.3	16.1	9.7	18.7	13.5	11.4	25.0	9.4	9.4	10.2	9.1	7.4	11.2	12.6	14.6	10.8	14.5	14.2	14.1	17.1	13.2	14.7	13.0	14.1	9.2	22.8	3.7	14.6	14.4	9.7	8.9	9.0	12.2	10.5	3.7	5.5	11.1	14.2	19.2	18.6	9.1	6.3	12.5	10.5	10.8	6.4	11.3	12.3	4.6	16.8	41.8	12.5	17.3	56.9	46.7	43.4	3.7	33.2	59.5	109.1	128.0	1.0	19.0	1.8	12.1	38.7	42.8	34.8	20.9	19.3	26.0	17.8	13.1	5.0	8.9	7.8	52.4	0.4	3.1	34.9	7.4	32.0	23.7	30.8	6.2	10.8	0.0	29.4	30.8	7.7	12.6	3.8	2.2	0.0	21.9	11.0	20.0	4.6	23.7	5.1	1.9	11.1	18.2	6.6	51.6	4.7	6.2	3.5	15.5	14.0	10.3	23.2	20.0	3.8	0.6	0.2	24.2	3.3	11.6	24.7	15.7	19.3	13.9	25.6	16.4	21.4	14.7	13.0	14.2	18.1	16.8	14.1	45.2	8.3	32.1	1.3	14.1	12.3	11.9	14.3	18.7	13.5	10.8	14.5	14.7	13.0	14.4	19.2	12.5	16.8	24.8	6.4	14.8	3.6	12.8	8.5	35.7	15.2	13.6	8.3	4.4	4.3	8.9	11.5	12.4	9.2	0.0	6.3	7.5	7.2	11.7	13.7	0.1	11.2	17.1	23.1	4.9	2.1	3.6	9.1	11.5	17.9	6.1	13.3	15.2	6.2	12.1	16.5	11.0	35.3	7.2	5.5	6.1	8.9	6.0	1.0	21.1	10.8	7.2	4.7	12.3	14.6	7.2	4.5	10.2	10.5	5.9	17.3	6.8	21.0	7.5	17.0	9.6	5.3	19.7	15.4	14.2	17.2	14.4	7.7	3.8	4.5	9.3	4.7	2.5	29.1
IFITM1	"9-27, CD225, DSPA2a, IFI17"	ENSG00000185885	"Interferon induced transmembrane protein 1"	P13164	11	310041-315272	"CD markers, Plasma proteins, Predicted membrane proteins, Transporters"	"Antiviral defense, Immunity, Innate immunity, Osteogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 673.8;Endothelial cells: 364.4;Leydig cells: 300.8;Sertoli cells: 276.1;T-cells: 595.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"eosinophil: 1494.7;gdT-cell: 2906.3;MAIT T-cell: 2003.4;memory CD4 T-cell: 3120.6;memory CD8 T-cell: 3000.3;naive CD4 T-cell: 2939.3;naive CD8 T-cell: 2996.4;neutrophil: 2741.6;NK-cell: 4679.9;T-reg: 1944.8"	"Group enriched"	"Detected in all"	7	"granulocytes: 2741.6;NK-cells: 4679.9;T-cells: 3120.6"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 1038.8;BJ hTERT+ SV40 Large T+: 2266.3;BJ hTERT+ SV40 Large T+ RasG12V: 4016.8;HMC-1: 1138.9"									"HPA004810, CAB017615"	Enhanced		Uncertain	"Golgi apparatus,Plasma membrane,Cytosol"		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 68: Epididymis - Unknown function"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 58: T-cells - T-cell receptor"	"Golgi apparatus"	"Plasma membrane, Cytosol"	"CAB017615: AB_2264496, HPA004810: AB_1851419"	"unprognostic (1.03e-3)"	"unprognostic (6.79e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.98e-1)"	"unprognostic (2.57e-1)"	"unprognostic (9.06e-2)"	"unprognostic (7.58e-2)"	"unprognostic (3.03e-1)"	"unprognostic (6.21e-2)"	"unprognostic (5.53e-2)"	"unprognostic (6.64e-3)"	"unprognostic (1.48e-2)"	"prognostic unfavorable (5.77e-9)"	"unprognostic (7.29e-2)"	"unprognostic (6.29e-2)"	"unprognostic (3.15e-2)"	"unprognostic (3.82e-2)"	477.7	102.3	291.8	282.0	303.4	367.1	401.7	293.8	402.1	563.3	321.5	249.0	128.4	314.6	1152.4	147.4	537.4	247.9	368.4	292.6	305.4	317.5	191.4	246.5	417.2	324.8	295.6	607.5	78.8	154.0	145.1	278.5	322.5	190.6	172.0	14.9	199.8	324.3	134.2	164.6	252.4	367.4	308.6	679.7	141.6	56.3	317.5	296.5	263.4	259.3	295.9	307.4	364.7	304.3	125.7	5.5	1011.4	74.5	79.1	279.8	7.4	250.1	1038.8	2266.3	4016.8	3.7	782.2	3.0	157.9	257.1	23.5	269.0	36.5	26.2	52.0	255.3	51.8	125.9	77.5	11.8	668.2	182.8	1138.9	496.3	0.2	26.6	2.6	27.0	4.2	41.1	450.0	880.7	1.7	23.9	85.1	318.2	264.5	0.5	33.5	27.1	3.1	24.5	654.9	0.0	1.0	2.2	122.7	11.9	196.9	138.5	42.1	17.0	8.8	3.8	4.7	1.5	1.1	61.6	44.8	6.8	3.4	253.8	3.1	544.4	62.1	1494.7	2906.3	312.7	2003.4	364.9	3120.6	3000.3	114.2	323.6	2939.3	2996.4	2741.6	4679.9	539.0	33.7	1944.8	4673.8	291.8	303.4	293.8	402.1	292.6	305.4	324.8	295.6	322.5	308.6	317.5	304.3	240.7	35.3	119.4	2.6	88.2	27.9	17.1	70.2	673.8	0.0	13.0	12.6	8.4	2.8	115.3	33.1	0.0	3.3	258.6	13.7	5.9	1.7	1.4	14.6	96.5	364.4	1.2	27.8	0.0	1.4	30.7	236.0	33.6	20.8	18.9	5.6	164.6	24.6	11.8	0.0	0.0	17.3	10.2	10.1	26.8	3.8	300.8	45.4	78.2	42.2	2.1	0.0	126.7	0.0	0.2	0.7	15.0	124.5	141.2	2.3	15.0	1.0	26.0	0.0	276.1	16.4	213.4	0.6	1.5	50.4	14.3	4.0	595.8	2.1	29.2	5.7
IFITM5	"BRIL, DSPA1, fragilis4, Hrmp1"	ENSG00000206013	"Interferon induced transmembrane protein 5"	A6NNB3	11	298200-299526	"Disease related genes, Human disease related genes, Predicted membrane proteins"	"Mineral balance"	"Developmental protein"	"Disease variant, Osteogenesis imperfecta"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"brain: 4.9;pancreas: 7.3"	"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in some"			"Region enriched"	"Detected in single"	8	"cerebral cortex: 4.9"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"Karpas-707: 1.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA039258			Supported	"Vesicles,Plasma membrane,Cytosol"		NA	NA				"Cluster 22: Non-specific - Unknown function"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 48: Smooth muscle cells - ECM organization"	"Plasma membrane"	"Vesicles, Cytosol"	"HPA039258: AB_10673608"	"unprognostic (9.84e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.38e-1)"	"unprognostic (5.80e-2)"	"unprognostic (7.46e-2)"		"unprognostic (4.20e-2)"	"unprognostic (4.42e-2)"		"unprognostic (8.31e-2)"	"unprognostic (7.99e-3)"		"unprognostic (1.94e-3)"	"unprognostic (1.01e-1)"	"unprognostic (1.47e-1)"		"unprognostic (4.90e-2)"	0.1	0.0	0.0	0.1	0.0	0.7	0.2	0.0	4.9	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.8	0.2	0.4	0.1	0.1	0.1	0.0	7.3	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.1	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	1.2	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.9	0.0	0.0	0.1	0.1	0.6	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
IFNGR1	"CD119, IFNGR"	ENSG00000027697	"Interferon gamma receptor 1"	P15260	6	137197485-137219449	"CD markers, Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"		Receptor	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Basal respiratory cells: 867.1;Club cells: 405.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB025889, HPA029213, HPA063871"	Approved		Supported	"Plasma membrane"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 2: Immune cells - Immune response"	"Cluster 21: OE19 - Mitochondria"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Plasma membrane"		"CAB025889: , HPA029213: AB_10601023, HPA063871: AB_2685138"	"unprognostic (1.73e-1)"	"unprognostic (8.86e-2)"	"unprognostic (9.85e-3)"	"unprognostic (1.71e-1)"	"unprognostic (6.55e-2)"	"unprognostic (1.25e-1)"	"unprognostic (4.05e-1)"	"unprognostic (6.97e-2)"	"unprognostic (9.86e-2)"	"unprognostic (1.57e-2)"	"unprognostic (4.09e-2)"	"unprognostic (2.85e-1)"	"prognostic unfavorable (5.48e-4)"	"unprognostic (1.58e-1)"	"unprognostic (2.87e-2)"	"unprognostic (1.81e-2)"	"unprognostic (5.38e-3)"	155.5	59.3	54.6	131.5	57.8	146.2	121.4	64.5	72.1	74.1	56.8	74.7	97.9	58.1	67.4	65.0	55.7	88.4	103.7	53.1	59.9	44.4	104.0	153.8	140.2	71.9	60.3	43.3	44.5	47.4	26.3	86.1	75.9	53.2	74.4	40.4	57.7	57.4	58.3	66.2	101.2	75.9	69.2	165.9	51.3	27.9	59.9	69.2	58.3	75.5	135.2	112.6	58.0	85.0	23.2	23.4	25.1	33.4	166.8	86.7	23.0	67.0	90.0	38.0	53.3	148.7	39.8	24.5	99.2	36.1	55.1	130.0	24.1	62.6	51.5	49.4	37.4	36.1	23.3	192.9	97.3	112.9	46.6	195.9	232.6	33.3	51.4	36.1	48.7	29.1	32.0	34.9	29.2	27.7	17.7	47.0	22.0	191.9	18.6	51.3	28.4	32.1	65.5	104.4	27.4	39.5	77.3	41.9	57.5	47.8	15.5	68.7	71.1	36.2	27.7	48.5	31.8	25.3	25.5	23.8	19.4	69.2	36.5	158.6	518.4	356.3	106.9	502.6	224.7	91.3	60.0	90.0	309.4	98.3	39.2	43.1	736.0	48.4	375.6	85.1	48.0	519.3	54.6	57.8	64.5	72.1	53.1	59.9	71.9	60.3	75.9	69.2	59.9	85.0	298.7	80.1	59.9	21.5	76.4	127.6	177.6	867.1	84.2	15.4	49.8	37.3	49.6	37.1	405.7	27.6	12.5	78.5	240.8	111.0	7.9	74.2	11.6	91.4	52.7	110.7	13.1	25.7	21.4	101.4	67.1	94.7	33.6	112.8	63.3	10.3	62.8	56.5	149.8	10.1	24.2	25.5	270.6	326.2	220.0	6.1	44.1	261.7	49.8	147.1	138.4	23.5	52.5	25.1	44.9	76.0	57.6	49.2	74.5	129.6	82.0	17.2	150.6	28.1	13.1	45.7	75.7	14.6	22.4	47.3	113.2	209.9	121.5	48.3	33.9	140.2
IFT43	"C14orf179, FLJ32173, MGC16028"	ENSG00000119650	"Intraflagellar transport 43"	Q96FT9	14	75902136-76084585	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cilium biogenesis/degradation"		"Ciliopathy, Disease variant, Ectodermal dysplasia, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Respiratory ciliated cells: 305.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003438	Approved		Supported	"Microtubules,Centriolar satellite"		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 6: T47d - Mammary gland"	"Cluster 49: Ciliated cells - Cilium organization"	Microtubules	"Centriolar satellite"	"HPA003438: AB_1078327"	"unprognostic (1.64e-2)"	"unprognostic (5.75e-3)"	"unprognostic (2.10e-1)"	"unprognostic (1.81e-3)"	"unprognostic (1.48e-1)"	"unprognostic (8.73e-2)"	"unprognostic (1.53e-2)"	"unprognostic (5.27e-2)"	"unprognostic (8.87e-2)"	"unprognostic (1.26e-2)"	"unprognostic (2.32e-2)"	"unprognostic (9.78e-2)"	"unprognostic (4.43e-2)"	"unprognostic (2.51e-1)"	"unprognostic (2.70e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.07e-2)"	21.5	24.0	29.2	12.2	29.5	5.4	25.1	28.9	31.4	24.6	38.7	27.5	23.0	24.6	49.6	18.0	64.5	18.2	43.2	28.7	29.7	38.9	41.5	20.6	11.6	29.5	31.2	16.2	22.6	27.1	32.8	21.5	30.9	26.9	19.4	25.1	16.1	30.5	13.9	15.4	19.3	27.7	29.8	15.5	21.6	40.5	29.4	15.9	33.0	8.8	17.0	25.5	18.4	29.8	34.8	38.2	27.5	42.7	33.9	54.3	19.5	22.3	42.7	33.6	33.5	14.6	34.9	3.9	23.8	39.5	30.4	36.2	26.7	41.3	37.6	18.3	25.6	1.8	22.3	0.1	94.9	3.8	8.0	48.6	44.4	37.1	48.3	48.6	52.1	38.5	9.6	15.2	40.8	69.7	14.3	6.0	14.2	42.7	48.9	9.1	22.2	10.9	77.0	30.0	26.7	31.9	43.9	29.8	31.5	36.9	77.4	10.2	24.3	19.7	24.7	28.9	19.6	20.1	18.8	4.4	76.9	1.6	20.6	34.5	11.6	19.7	13.8	16.4	17.6	33.8	14.9	14.4	15.7	23.1	24.3	23.4	5.8	15.4	16.4	20.2	19.6	13.4	29.2	29.5	28.9	31.4	28.7	29.7	29.5	31.2	30.9	29.8	29.4	29.8	40.9	12.8	27.4	50.3	14.8	18.6	44.1	103.7	38.1	27.8	36.0	45.6	43.8	42.9	66.1	64.4	66.7	41.9	8.7	24.7	64.6	53.8	147.5	171.0	54.5	35.3	15.7	5.9	46.4	38.7	14.7	39.4	38.2	33.2	26.6	28.7	38.6	32.9	22.4	10.1	55.0	30.2	61.1	7.6	20.0	33.2	33.8	11.5	26.6	14.0	32.0	49.8	14.4	38.2	38.5	33.5	18.7	35.0	13.7	25.8	45.1	160.2	305.8	87.7	32.9	31.2	63.5	124.4	37.2	24.6	21.6	41.9	16.2	32.8	26.1	34.5
IGF2BP1	IMP-1	ENSG00000159217	"Insulin like growth factor 2 mRNA binding protein 1"	Q9NZI8	17	48997385-49056145	"Predicted intracellular proteins"	"mRNA transport, Translation regulation, Transport"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"placenta: 5.5;testis: 4.8"	"Group enriched"	"Detected in some"	4	"Extravillous trophoblasts: 37.3;Spermatocytes: 30.4;Spermatogonia: 21.7"	"Cancer enriched"	"Detected in many"	16	"testis cancer: 28.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 146.7;CACO-2: 238.7;Hep G2: 112.0;K-562: 124.4;NTERA-2: 117.6;REH: 140.0;SuSa: 111.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA021367, HPA062273"	Enhanced		Supported	Cytosol		NA	NA		13000		"Cluster 28: Placenta - Pregnancy"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 33: Fibroblasts - ECM organization"	Cytosol		"HPA021367: AB_1851480, HPA062273: AB_2684733"	"unprognostic (6.79e-4)"	"unprognostic (2.76e-1)"	"unprognostic (4.86e-3)"	"unprognostic (2.30e-6)"	"unprognostic (1.95e-2)"	"unprognostic (9.11e-3)"	"unprognostic (1.80e-2)"	"unprognostic (1.01e-2)"	"unprognostic (9.55e-3)"	"unprognostic (2.58e-1)"	"unprognostic (2.86e-2)"	"unprognostic (5.91e-2)"	"unprognostic (2.80e-6)"	"unprognostic (2.58e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.32e-3)"	"unprognostic (1.47e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.1	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	5.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	4.8	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	59.5	146.7	0.1	5.2	7.6	105.0	8.5	0.2	12.1	20.1	238.7	4.0	12.4	0.9	1.0	3.6	0.0	91.4	0.0	21.1	0.0	52.9	91.3	33.6	112.0	6.9	48.8	23.6	10.4	0.0	2.9	0.2	4.1	24.9	16.6	124.4	0.0	16.6	0.9	0.1	42.9	117.6	0.2	0.2	140.0	48.3	0.0	0.0	0.1	0.0	0.0	5.1	0.1	3.6	111.4	0.2	13.5	0.5	0.0	1.4	12.5	0.0	0.1	0.1	80.7	0.1	0.0	11.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	6.4	1.1	0.0	0.1	0.1	0.3	0.0	0.0	0.0	0.1	0.1	5.5	0.0	0.6	0.0	0.0	3.5	0.2	0.0	0.0	0.0	5.3	0.1	0.1	3.9	0.0	2.7	0.2	0.0	37.3	3.7	0.0	0.1	1.3	0.0	0.0	0.0	6.9	0.0	0.2	0.0	0.0	0.0	0.8	4.4	0.3	0.3	0.0	0.0	0.0	0.0	0.0	1.0	0.1	0.0	1.1	0.0	0.0	0.1	0.0	5.3	0.7	0.0	0.0	1.1	1.1	30.4	21.7	0.0	0.1	2.9	0.3	0.1	0.0	0.3
IGF2BP3	"CT98, IMP-3, IMP3"	ENSG00000136231	"Insulin like growth factor 2 mRNA binding protein 3"	O00425	7	23310209-23470491	"Predicted intracellular proteins"	"mRNA transport, Translation regulation, Transport"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 7.3;placenta: 28.9"	"Group enriched"	"Detected in many"	4	"Cytotrophoblasts: 84.8;Early spermatids: 40.8;Extravillous trophoblasts: 93.4;Hofbauer cells: 38.5;Late spermatids: 24.1;Syncytiotrophoblasts: 78.5"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 170.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA002037, HPA076951"	Enhanced		Supported	Cytosol		NA	NA		27000	"Cluster 24: B-cells - Unknown function"	"Cluster 28: Placenta - Pregnancy"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 38: Extravillous trophoblasts - Unknown function"	Cytosol		"HPA002037: AB_1851483, HPA076951: "	"unprognostic (5.72e-2)"	"unprognostic (3.12e-1)"	"unprognostic (7.25e-2)"	"unprognostic (3.56e-3)"	"unprognostic (1.45e-1)"	"unprognostic (3.00e-2)"	"unprognostic (2.64e-3)"	"unprognostic (3.18e-2)"	"unprognostic (2.60e-3)"	"unprognostic (3.67e-1)"	"unprognostic (1.02e-5)"	"unprognostic (8.76e-2)"	"unprognostic (0.00e+0)"	"unprognostic (1.43e-1)"	"unprognostic (7.95e-2)"	"unprognostic (2.87e-4)"	"unprognostic (7.51e-3)"	0.3	0.0	0.6	0.8	0.3	0.6	0.1	0.2	0.4	0.1	0.0	0.1	0.0	0.0	0.8	2.1	0.9	0.2	0.0	0.3	0.0	0.0	0.5	0.5	4.2	0.0	0.0	0.0	0.6	0.3	0.0	28.9	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.1	5.1	0.3	1.6	0.8	0.1	7.3	0.2	0.2	0.1	48.7	14.0	104.5	31.0	16.2	42.8	63.7	8.1	35.7	19.6	24.2	45.0	37.4	36.4	42.1	21.3	86.4	31.2	45.8	35.2	34.2	5.9	18.3	19.3	38.1	37.9	50.3	35.5	13.1	44.1	24.2	15.0	6.3	114.7	170.0	20.0	89.5	0.2	47.8	0.0	21.6	23.5	83.0	36.6	43.3	33.2	34.8	47.1	38.4	4.2	27.4	59.6	4.8	0.3	38.9	118.3	0.0	6.6	68.9	18.6	1.2	40.6	21.0	0.0	15.8	56.7	73.8	38.6	72.8	0.0	0.4	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.1	0.5	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.8	0.6	0.3	0.2	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.2	0.0	0.0	1.0	2.8	0.3	0.7	0.3	0.0	0.5	0.0	0.0	0.5	0.0	0.3	0.0	0.0	84.8	1.4	0.1	0.0	1.2	40.8	5.4	0.2	1.7	0.0	0.0	2.0	0.2	93.4	3.5	0.0	1.5	3.8	0.1	1.1	0.2	38.5	1.7	12.9	0.0	0.0	0.8	0.6	24.1	2.1	11.3	3.6	5.6	2.9	0.2	2.1	1.5	1.8	1.0	0.0	0.0	2.1	0.2	0.0	0.1	2.6	1.6	0.0	0.4	7.7	6.8	3.5	0.7	0.4	78.5	0.3	0.0	0.0	0.6
IGFLR1	"FLJ22573, TMEM149, U2AF1L4"	ENSG00000126246	"IGF like family receptor 1"	Q9H665	19	35738801-35742453	"Predicted intracellular proteins, Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 49.9"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 29.9;granulocytes: 38.7;Langerhans cells: 33.7;Macrophages: 28.8;monocytes: 115.6;Plasma cells: 42.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"plasmacytoid DC: 899.7"	"Lineage enriched"	"Detected in all"	4	"dendritic cells: 899.7"	"Cell line enhanced"	"Detected in many"		"HMC-1: 32.9;Karpas-707: 26.0;U-266/70: 34.0"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"HPA012369, HPA070778"	Uncertain		Approved	"Nucleoplasm,Plasma membrane"	"Intracellular and membrane"	NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 64: Macrophages - Immune response"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 3: Monocytes - Immune response regulation"	"Nucleoplasm, Plasma membrane"		"HPA012369: AB_1858095, HPA070778: "	"unprognostic (5.97e-3)"	"prognostic favorable (6.55e-4)"	"unprognostic (1.94e-1)"	"unprognostic (5.42e-2)"	"unprognostic (8.31e-3)"	"unprognostic (2.34e-4)"	"unprognostic (6.71e-2)"	"unprognostic (1.74e-2)"	"unprognostic (1.87e-2)"	"prognostic favorable (1.59e-5)"	"unprognostic (1.44e-3)"	"unprognostic (3.52e-1)"	"unprognostic (8.72e-12)"	"unprognostic (2.74e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.29e-1)"	"unprognostic (3.32e-3)"	7.6	10.9	6.1	19.5	6.8	14.4	6.2	6.0	9.3	4.9	6.0	6.5	6.1	3.4	5.5	4.0	6.4	6.1	4.5	5.9	11.1	14.0	49.9	11.3	33.0	9.1	6.8	4.4	9.3	1.4	5.5	4.5	7.4	6.2	6.4	4.6	7.8	1.5	4.5	4.4	13.2	4.4	5.6	28.6	7.9	6.7	7.1	12.6	7.2	2.1	23.2	7.3	3.5	7.5	2.2	10.0	3.5	8.3	1.1	1.7	2.0	1.5	1.1	1.8	4.7	3.0	2.4	4.0	3.2	0.7	0.6	1.6	2.0	2.1	0.9	3.3	5.0	15.0	3.4	9.1	2.8	1.7	32.9	2.7	1.3	3.5	0.8	0.6	1.9	7.7	4.9	26.0	0.5	7.4	5.1	16.7	1.6	9.4	2.7	6.0	3.3	8.3	1.7	3.2	2.4	4.5	3.4	2.4	1.8	1.3	3.4	7.8	0.5	4.2	2.0	2.6	4.0	34.0	7.5	2.8	4.9	5.8	3.0	147.9	190.9	184.1	94.2	167.7	106.6	169.3	107.3	88.8	253.2	172.1	95.8	77.0	208.6	144.9	125.3	899.7	136.3	139.5	6.1	6.8	6.0	9.3	5.9	11.1	9.1	6.8	7.4	5.6	7.1	7.5	0.3	0.0	13.5	2.6	24.5	0.6	0.3	0.0	0.0	0.4	1.3	1.3	1.2	1.5	5.0	0.0	0.0	0.6	29.9	1.2	1.9	1.9	0.0	0.8	0.6	0.8	3.0	6.1	0.3	4.2	1.8	0.9	1.1	0.7	38.7	0.6	2.2	20.3	14.6	0.0	0.4	1.8	0.0	15.7	33.7	0.6	0.0	28.8	5.4	1.9	115.6	2.7	12.3	2.5	1.0	1.4	0.3	0.0	42.1	0.2	0.9	10.8	3.6	0.4	0.0	1.0	0.9	0.4	0.5	1.9	0.9	0.3	20.8	0.4	2.4	0.0
IGHMBP2	"CATF1, CMT2S, HCSA, HMN6, SMARD1, SMUBP2, ZFAND7"	ENSG00000132740	"Immunoglobulin mu DNA binding protein 2"	P38935	11	68903863-68940602	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Helicase, Hydrolase, Ribonucleoprotein, RNA-binding, tRNA-binding"	"Charcot-Marie-Tooth disease, Disease variant, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 94.6;Late spermatids: 46.9;Spermatocytes: 51.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA004092, HPA060994"			Supported	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 71: Testis - DNA repair"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm	"Nuclear bodies"	"HPA004092: , HPA060994: AB_2684406"	"unprognostic (1.17e-1)"	"unprognostic (1.04e-1)"	"unprognostic (7.17e-2)"	"unprognostic (3.96e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.69e-1)"	"unprognostic (3.59e-3)"	"unprognostic (4.31e-2)"	"unprognostic (3.81e-1)"	"unprognostic (1.19e-1)"	"prognostic favorable (5.89e-4)"	"unprognostic (1.03e-1)"	"prognostic unfavorable (1.29e-8)"	"unprognostic (1.69e-1)"	"unprognostic (3.73e-2)"	"unprognostic (4.06e-2)"	"unprognostic (2.18e-2)"	5.2	4.0	1.2	2.5	1.3	6.0	5.4	0.7	1.7	7.0	0.1	11.8	1.5	7.8	0.6	5.5	6.7	1.7	5.2	1.6	1.2	4.4	6.3	5.1	3.3	0.8	0.4	6.1	5.2	2.8	4.0	2.0	0.7	6.3	1.5	1.4	6.4	3.1	8.5	7.7	6.3	2.6	0.5	5.7	6.2	15.4	0.6	4.3	4.9	3.8	1.7	6.3	5.8	1.1	5.1	7.3	4.0	7.4	3.6	3.1	5.2	5.8	3.9	7.8	4.6	14.5	7.0	7.3	9.7	3.3	6.9	8.0	5.8	4.9	1.8	8.3	6.2	6.6	9.6	5.6	5.5	6.5	7.4	1.8	4.9	9.2	4.6	4.5	4.6	11.1	10.6	4.6	2.3	5.1	11.1	8.9	2.3	7.9	10.3	9.4	5.7	7.6	3.3	5.9	8.6	5.4	7.4	6.1	16.6	3.0	9.3	6.0	6.6	5.3	3.8	7.7	6.6	6.0	6.3	6.9	5.3	6.1	5.1	0.0	2.0	0.8	1.5	1.8	1.3	1.0	0.9	1.0	1.8	0.6	0.5	0.7	0.6	0.1	1.1	0.3	0.6	1.3	1.2	1.3	0.7	1.7	1.6	1.2	0.8	0.4	0.7	0.5	0.6	1.1	6.6	6.4	7.7	7.5	5.7	5.7	3.8	3.5	6.2	9.1	5.6	3.8	6.3	8.6	6.1	1.8	20.9	4.9	10.2	6.0	1.9	5.1	94.6	7.0	8.1	6.4	3.0	9.3	7.4	5.1	4.4	5.5	6.1	14.0	7.0	10.7	3.3	6.1	5.8	11.8	6.4	4.1	2.0	3.5	4.3	46.9	7.8	7.2	1.8	5.6	7.3	6.6	9.2	6.0	5.2	6.5	8.4	7.2	5.8	7.5	3.9	2.9	3.8	10.1	0.0	5.1	10.1	51.6	7.1	5.3	6.7	6.7	8.0	4.6	7.1	6.3
IGSF8	"CD316, CD81P3, EWI2, PGRL"	ENSG00000162729	"Immunoglobulin superfamily member 8"	Q969P0	1	160091340-160098943	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 155.3"	"Cell type enhanced"	"Detected in all"		"Extravillous trophoblasts: 219.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SK-MEL-30: 177.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011917, HPA075970"	Approved		Supported	Vesicles		NA	NA		280000	"Cluster 32: T-cells - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 38: Extravillous trophoblasts - Unknown function"	Vesicles		"HPA011917: AB_1851536, HPA075970: "	"unprognostic (4.08e-1)"	"prognostic unfavorable (7.32e-4)"	"unprognostic (1.30e-2)"	"unprognostic (9.31e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.01e-3)"	"unprognostic (1.63e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.63e-1)"	"unprognostic (2.31e-1)"	"unprognostic (2.60e-2)"	"unprognostic (2.35e-1)"	"unprognostic (3.74e-3)"	"unprognostic (1.75e-3)"	21.9	19.1	97.9	14.0	119.0	3.7	26.7	91.7	130.7	25.7	39.9	31.7	26.5	19.8	22.7	22.3	28.2	12.3	29.0	106.0	82.4	35.5	53.9	23.6	16.8	109.3	97.8	37.5	31.8	15.8	30.7	11.2	99.9	26.4	10.4	14.3	30.1	18.2	12.4	50.3	28.5	7.0	98.6	24.2	27.5	33.4	94.7	13.6	28.6	7.1	8.9	20.3	25.0	155.3	26.8	15.7	20.1	51.3	11.6	7.3	42.9	12.9	16.8	26.9	25.0	17.9	17.9	39.0	47.1	18.8	23.4	50.3	8.2	18.9	3.8	47.3	15.0	5.1	17.3	31.2	19.2	13.5	41.7	9.0	37.7	17.5	5.6	19.0	5.6	42.0	7.0	21.8	6.3	25.4	33.8	31.3	42.4	55.6	24.8	19.1	10.3	28.7	24.7	27.4	8.5	36.6	14.8	47.4	177.6	17.5	33.7	17.3	5.8	11.8	25.4	21.5	10.6	59.6	71.2	17.7	41.6	5.3	31.6	0.1	5.2	2.4	22.0	7.2	19.5	19.6	18.0	25.6	5.8	22.7	23.4	25.7	1.4	9.2	4.7	9.9	26.9	11.3	97.9	119.0	91.7	130.7	106.0	82.4	109.3	97.8	99.9	98.6	94.7	155.3	12.2	9.6	3.3	18.3	21.1	43.7	30.2	43.1	26.2	55.6	28.0	29.2	3.3	17.2	16.7	38.6	10.4	32.8	15.1	36.1	5.9	34.2	3.8	12.0	7.2	7.8	19.9	7.4	65.3	12.4	219.7	22.4	6.6	26.4	10.2	12.2	13.2	28.8	14.9	65.6	43.8	24.7	44.7	4.3	16.2	1.1	16.8	8.5	42.7	9.4	51.5	75.7	10.3	9.0	107.2	20.6	39.5	15.8	20.0	22.0	47.6	15.8	6.0	11.8	6.6	39.8	15.3	4.0	6.6	21.0	62.4	69.4	19.5	13.6	32.6	26.0
IKBKB	"IKK-beta, IKK2, IKKB, NFKBIKB"	ENSG00000104365	"Inhibitor of nuclear factor kappa B kinase subunit beta"	O14920	8	42271302-42332460	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"	"Host-virus interaction"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Disease variant, FDA approved drug targets, SCID"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cone photoreceptor cells: 135.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001249, CAB004447"	Enhanced		Supported	Cytosol		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 9: Photoreceptor cells - Phototransduction"	Cytosol		"CAB004447: AB_627785, HPA001249: AB_1079126"	"unprognostic (1.04e-1)"	"unprognostic (2.30e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.73e-3)"	"unprognostic (1.26e-1)"	"unprognostic (1.27e-3)"	"unprognostic (1.95e-1)"	"unprognostic (1.25e-3)"	"unprognostic (1.75e-1)"	"unprognostic (1.55e-1)"	"unprognostic (3.27e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.20e-2)"	"unprognostic (1.89e-2)"	"unprognostic (9.20e-2)"	"unprognostic (3.02e-1)"	"prognostic favorable (1.46e-6)"	9.4	8.2	9.1	4.7	9.8	4.8	8.3	9.2	10.9	7.2	11.7	6.8	4.8	8.1	7.3	10.2	11.6	8.6	5.6	9.2	9.5	6.8	6.6	11.3	12.2	10.5	9.9	6.1	6.2	13.5	4.0	8.2	10.0	7.9	6.8	12.3	8.9	9.3	13.7	11.4	4.9	12.7	9.7	10.5	5.5	3.2	10.1	10.8	9.4	24.3	11.6	11.1	6.8	10.2	6.2	15.7	8.0	13.6	17.3	18.9	5.8	9.2	18.2	15.2	17.2	3.1	13.9	14.1	10.0	16.5	12.5	5.6	8.4	18.3	17.8	9.8	10.8	17.8	7.8	5.9	20.9	6.1	24.0	12.3	13.7	15.0	19.1	36.1	20.7	11.6	12.8	6.9	34.6	5.1	13.9	11.3	6.1	18.9	6.0	11.1	15.3	10.0	19.6	5.7	1.3	4.7	6.4	6.4	11.7	10.0	8.7	23.6	13.6	7.2	3.9	13.9	6.1	2.8	4.0	10.3	13.8	7.6	16.7	7.4	5.0	5.6	4.6	4.1	4.3	4.4	5.1	5.5	3.7	4.8	4.8	4.7	5.2	5.1	5.5	8.5	5.9	2.9	9.1	9.8	9.2	10.9	9.2	9.5	10.5	9.9	10.0	9.7	10.1	10.2	31.3	12.8	26.9	19.2	28.4	24.3	34.1	13.9	25.6	12.7	20.6	15.5	8.8	14.3	15.4	16.5	135.5	10.4	34.1	15.9	1.9	13.4	2.3	13.9	15.6	27.4	11.4	10.1	19.7	13.6	5.3	12.4	21.9	16.5	38.0	24.0	19.6	12.0	18.6	18.5	20.6	16.4	8.2	32.3	24.0	3.4	16.4	23.4	19.6	58.1	33.7	8.7	47.4	17.1	30.2	16.6	15.0	12.8	18.2	31.9	13.2	5.5	20.2	47.9	6.6	13.1	11.4	4.8	7.0	17.8	29.1	15.2	24.3	6.2	14.1	30.8
IKBKE	"IKK-i, IKKE, KIAA0151"	ENSG00000263528	"Inhibitor of nuclear factor kappa B kinase subunit epsilon"	Q14164	1	206470476-206496889	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"DNA damage, Host-virus interaction"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 24.3"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 37.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"NB-4: 47.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA015788, CAB025983"	Approved		Supported	Cytosol		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 24: NB-4 - Immune response"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Cytosol		"CAB025983: , HPA015788: AB_1851566"	"unprognostic (6.43e-2)"	"unprognostic (3.04e-1)"	"unprognostic (1.48e-1)"	"unprognostic (5.76e-2)"	"unprognostic (7.78e-3)"	"unprognostic (7.37e-3)"	"unprognostic (1.99e-3)"	"unprognostic (2.82e-1)"	"unprognostic (5.09e-3)"	"unprognostic (1.30e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.27e-1)"	"prognostic unfavorable (5.34e-7)"	"unprognostic (1.48e-2)"	"unprognostic (5.77e-2)"	"unprognostic (2.84e-3)"	"unprognostic (2.84e-2)"	2.4	3.7	2.6	16.7	4.6	8.7	3.1	2.0	3.2	4.1	1.9	7.8	7.4	1.7	3.9	14.6	2.8	5.1	1.4	2.7	3.3	3.4	1.6	4.1	24.3	4.1	3.6	1.2	3.4	1.0	1.9	2.6	3.9	3.6	7.7	0.1	6.9	2.1	0.5	15.0	8.0	2.5	2.7	14.2	7.2	0.7	4.4	16.5	4.5	0.3	20.4	8.4	6.8	4.6	17.8	13.9	3.7	0.4	6.7	9.2	3.9	7.1	22.3	9.4	10.4	11.5	26.9	35.3	18.6	14.5	11.5	23.0	0.1	18.1	2.2	5.5	3.5	4.7	8.8	7.6	8.4	29.5	14.8	12.2	3.2	7.7	1.7	10.9	14.2	9.4	2.3	10.0	10.5	3.6	19.2	47.7	5.2	4.3	10.9	9.7	4.3	27.7	10.7	29.4	0.0	0.0	2.9	22.9	4.2	4.5	13.8	20.3	26.5	9.0	5.5	6.9	8.5	3.5	1.8	23.3	17.1	24.2	3.7	12.2	32.8	0.6	21.2	23.3	14.8	26.4	32.4	30.1	9.5	14.0	25.7	27.3	2.2	23.9	13.4	3.2	52.8	28.6	2.6	4.6	2.0	3.2	2.7	3.3	4.1	3.6	3.9	2.7	4.4	4.6	0.4	0.0	4.5	0.7	13.7	1.9	3.6	37.8	1.8	0.0	4.3	3.7	0.9	4.3	16.3	0.0	0.0	4.2	7.9	11.7	0.0	12.1	3.3	1.5	0.9	0.7	3.6	4.4	1.5	12.6	5.2	3.4	17.3	2.4	5.1	3.7	2.2	0.8	13.8	0.0	1.5	6.4	8.2	12.9	0.7	7.0	0.9	16.0	7.2	1.9	9.0	0.0	14.4	1.0	0.2	15.9	21.5	0.7	6.4	3.2	10.7	3.5	14.5	0.0	0.0	0.7	3.1	0.3	0.9	11.1	4.8	1.5	15.8	3.9	10.2	11.6
IKZF1	"hIk-1, Hs.54452, IKAROS, LyF-1, PPP1R92, ZNFN1A1"	ENSG00000185811	"IKAROS family zinc finger 1"	Q13422	7	50304068-50405101	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transcription factors"	"Cell cycle, Transcription, Transcription regulation"	"Activator, Chromatin regulator, Developmental protein, DNA-binding, Repressor"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	9	"bone marrow: 173.0;lymphoid tissue: 112.5"	"Cell type enhanced"	"Detected in many"		"B-cells: 120.5;dendritic cells: 221.4;Erythroid cells: 89.8;Microglial cells: 91.8;monocytes: 106.6;NK-cells: 150.4;Plasma cells: 128.9;T-cells: 182.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"Daudi: 140.4;HDLM-2: 258.6;HMC-1: 220.4;JURKAT: 128.9;MOLT-4: 184.3;REH: 192.3;U-698: 342.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB009247, HPA035221, HPA035222"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 65: Plasmacytoid DCs - Unknown function"	Nucleoplasm	Cytosol	"CAB009247: AB_2124699, HPA035221: AB_2674524, HPA035222: AB_2674525"	"prognostic favorable (4.28e-4)"	"prognostic favorable (2.02e-4)"	"unprognostic (2.49e-3)"	"unprognostic (2.41e-3)"	"unprognostic (5.59e-1)"	"prognostic favorable (8.63e-4)"	"unprognostic (1.45e-2)"	"unprognostic (1.37e-2)"	"unprognostic (1.15e-2)"	"unprognostic (2.43e-1)"	"unprognostic (6.63e-2)"	"unprognostic (2.95e-1)"	"unprognostic (1.69e-3)"	"unprognostic (1.71e-1)"	"unprognostic (2.84e-2)"	"unprognostic (6.77e-2)"	"unprognostic (4.67e-2)"	5.0	3.2	3.5	53.0	3.4	173.0	4.4	4.0	3.9	3.6	3.3	7.6	7.0	2.5	2.3	4.8	2.2	7.7	1.5	3.0	4.0	1.4	4.9	11.6	87.1	7.7	5.2	1.6	0.8	0.8	0.6	3.6	7.5	2.3	6.8	0.2	4.6	1.9	1.0	2.0	15.6	4.0	7.3	48.6	12.0	1.7	8.7	112.5	2.1	1.2	73.8	9.6	1.8	10.3	0.4	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	140.4	0.4	0.0	0.0	0.2	0.0	0.0	0.0	258.6	0.2	52.1	0.0	0.0	0.0	84.5	220.4	0.0	0.0	0.0	0.0	0.0	0.0	128.9	72.4	15.4	0.0	0.0	184.3	80.9	2.4	0.0	0.0	192.3	0.3	39.6	0.0	0.0	1.6	2.0	0.8	1.0	0.8	0.4	0.2	112.1	0.2	0.0	1.9	0.2	0.4	80.8	49.4	342.7	0.5	89.5	0.5	21.2	14.2	25.0	35.4	43.9	29.1	46.7	36.3	35.0	15.1	40.7	48.2	35.7	20.2	24.3	43.3	23.4	32.6	26.4	3.5	3.4	4.0	3.9	3.0	4.0	7.7	5.2	7.5	7.3	8.7	10.3	2.8	3.2	12.2	0.7	120.5	2.8	0.1	0.0	0.0	0.0	2.8	1.9	1.5	2.8	1.8	1.8	0.0	0.4	221.4	0.3	0.0	0.4	3.8	0.5	0.4	2.6	0.0	89.8	0.2	0.0	0.4	2.5	4.6	0.6	23.4	0.2	3.9	2.0	30.6	0.0	0.3	0.0	0.0	64.3	61.0	5.3	0.0	72.1	19.6	91.8	106.6	0.0	150.4	1.0	0.3	0.1	0.4	0.0	128.9	0.1	0.0	1.0	1.5	0.1	0.0	1.5	1.6	0.1	2.1	0.5	2.7	0.7	182.8	0.1	0.1	0.1
IKZF3	"Aiolos, ZNFN1A3"	ENSG00000161405	"IKAROS family zinc finger 3"	Q9UKT9	17	39757718-39864312	"Predicted intracellular proteins, Transcription factors"	"B-cell activation, Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"intestine: 12.1;lymphoid tissue: 41.0"	"Group enriched"	"Detected in many"	4	"B-cells: 108.1;dendritic cells: 76.5;granulocytes: 47.9;NK-cells: 121.5;Plasma cells: 80.2;T-cells: 99.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"B-cells: 13.2;T-cells: 28.8"	"Cell line enhanced"	"Detected in some"		"Daudi: 69.0;Karpas-707: 35.6;U-266/70: 41.7;U-266/84: 50.0;U-698: 108.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA024377, HPA073266"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	Nucleoplasm	Cytosol	"HPA024377: AB_1859477, HPA073266: "	"unprognostic (5.43e-3)"	"prognostic favorable (6.85e-6)"	"unprognostic (6.10e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.93e-2)"	"prognostic favorable (4.16e-4)"	"unprognostic (1.36e-2)"	"unprognostic (3.14e-3)"	"prognostic favorable (5.42e-4)"	"unprognostic (8.03e-3)"	"unprognostic (1.65e-1)"	"unprognostic (3.19e-1)"	"prognostic unfavorable (7.38e-4)"	"unprognostic (9.13e-2)"	"unprognostic (2.20e-1)"	"unprognostic (5.51e-2)"	"unprognostic (1.05e-3)"	1.0	0.8	0.3	18.8	0.2	5.9	1.8	0.7	0.6	1.5	0.6	3.3	3.5	1.0	0.7	1.5	0.7	3.0	0.5	0.7	0.1	0.6	2.0	3.1	36.5	0.5	0.1	0.7	0.4	0.1	0.2	0.3	0.4	1.0	3.1	0.3	2.2	0.3	0.5	0.9	12.1	0.8	0.1	22.3	6.2	1.6	0.4	23.0	0.9	0.3	41.0	4.5	0.7	1.0	0.2	0.2	0.2	0.3	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.1	0.3	69.0	0.1	0.0	0.1	0.3	0.1	0.2	0.0	15.6	0.3	4.2	0.4	0.2	0.0	0.4	0.4	0.0	0.0	0.0	0.0	0.1	0.0	4.1	1.8	35.6	0.0	0.2	6.2	2.4	0.2	3.9	0.1	0.3	0.2	12.7	0.0	4.2	0.4	0.2	1.2	0.5	0.1	0.1	0.2	0.8	0.3	0.3	0.5	0.2	0.1	41.7	50.0	108.1	0.1	0.2	0.1	1.0	0.2	0.8	26.3	0.1	28.8	13.2	11.0	20.3	0.1	11.9	4.5	12.2	1.1	4.5	0.3	0.6	18.9	8.7	0.3	0.2	0.7	0.6	0.7	0.1	0.5	0.1	0.4	0.1	0.4	1.0	1.1	9.6	21.8	0.3	108.1	0.1	2.2	0.0	0.0	1.7	1.2	0.9	4.0	1.5	5.6	1.8	0.0	0.1	76.5	0.2	0.0	0.1	12.8	1.9	0.9	2.4	0.0	4.0	0.6	0.0	0.4	2.3	3.1	3.9	47.9	0.4	4.2	1.2	0.1	0.0	0.4	0.1	0.0	6.3	0.0	11.8	0.0	4.4	0.0	2.8	3.3	0.2	121.5	0.0	0.1	1.2	0.1	0.0	80.2	1.8	0.0	0.3	0.7	1.7	0.0	4.0	1.2	6.3	2.3	0.6	0.1	0.3	99.9	0.1	0.0	1.6
IKZF4	"Eos, ZNFN1A4"	ENSG00000123411	"IKAROS family zinc finger 4"	Q9H2S9	12	56007659-56038435	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	4	"T-reg: 1.9"	"Lineage enriched"	"Detected in single"	12	"T-cells: 1.9"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 36.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046270, HPA049016"	Approved		Supported	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 35: Glandular cells - Unknown function"	"Nucleoplasm, Nuclear bodies"		"HPA046270: AB_2679607, HPA049016: AB_2680600"	"unprognostic (2.27e-1)"	"unprognostic (7.09e-2)"	"unprognostic (1.34e-1)"	"unprognostic (8.95e-3)"	"unprognostic (5.67e-2)"	"unprognostic (2.08e-2)"	"unprognostic (3.63e-3)"	"prognostic favorable (3.46e-4)"	"unprognostic (2.42e-1)"	"unprognostic (5.43e-2)"	"prognostic favorable (4.37e-4)"	"unprognostic (6.52e-2)"	"unprognostic (7.97e-2)"	"unprognostic (3.64e-1)"	"unprognostic (1.26e-1)"	"unprognostic (9.98e-3)"	"unprognostic (7.74e-3)"	4.9	9.2	5.6	2.1	5.7	3.8	3.7	7.1	6.5	4.8	5.7	5.5	1.6	4.5	4.0	2.6	5.8	2.7	4.1	5.3	5.8	3.7	3.2	3.7	2.1	6.4	6.2	7.6	2.9	8.1	7.5	3.0	5.8	3.9	2.0	8.5	2.7	4.2	9.9	2.5	3.5	2.9	5.5	2.9	4.1	5.0	6.2	4.0	5.1	5.4	2.3	4.3	3.2	6.0	1.7	1.6	11.6	3.9	2.3	2.4	2.7	1.8	3.1	2.1	3.0	6.5	2.5	1.1	2.0	2.9	2.3	1.3	1.5	1.8	4.6	36.2	1.7	7.3	1.7	3.0	2.6	3.3	2.6	4.0	2.1	2.2	1.7	3.9	2.2	0.2	10.7	5.5	3.4	2.0	4.1	1.6	5.1	1.8	1.4	3.6	3.1	1.3	3.1	1.4	4.4	3.8	2.6	0.8	4.3	2.9	3.0	3.3	1.3	1.8	3.1	1.8	1.5	3.5	2.2	1.5	3.7	3.2	2.4	0.0	0.1	0.0	0.1	0.1	0.1	0.1	0.4	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.1	1.9	0.1	5.6	5.7	7.1	6.5	5.3	5.8	6.4	6.2	5.8	5.5	6.2	6.0	5.5	3.2	9.4	10.7	2.5	3.6	1.9	3.4	10.2	20.3	16.6	15.4	7.5	10.0	4.2	3.7	8.4	3.0	0.8	3.9	1.9	2.9	13.8	7.7	10.4	5.3	6.0	4.2	13.3	4.2	2.8	8.8	2.0	8.0	1.3	4.0	8.2	6.7	2.7	8.4	17.7	3.0	4.1	9.8	3.1	2.7	8.7	4.1	5.4	7.5	6.0	18.3	0.0	14.6	15.5	4.3	2.1	10.9	1.6	2.4	1.7	4.9	4.3	12.3	0.0	10.3	9.9	21.2	5.9	10.4	3.3	4.0	3.8	16.0	2.3	2.1
IKZF5	"FLJ22973, Pegasus, ZNFN1A5"	ENSG00000095574	"IKAROS family zinc finger 5"	Q9H5V7	10	122990807-123008812	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015297, HPA051574"			Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 35: Glandular cells - Unknown function"	Nucleoplasm	"Plasma membrane, Cytosol"	"HPA015297: AB_1855183, HPA051574: AB_2681538"	"unprognostic (2.42e-1)"	"unprognostic (1.08e-1)"	"unprognostic (4.64e-2)"	"unprognostic (2.76e-2)"	"unprognostic (1.44e-2)"	"unprognostic (1.66e-3)"	"unprognostic (2.68e-1)"	"unprognostic (9.14e-3)"	"unprognostic (5.43e-2)"	"unprognostic (2.99e-1)"	"unprognostic (6.88e-2)"	"unprognostic (1.63e-2)"	"unprognostic (3.98e-3)"	"unprognostic (4.17e-2)"	"unprognostic (6.03e-2)"	"unprognostic (6.96e-2)"	"unprognostic (3.15e-2)"	8.3	8.5	8.7	7.3	11.5	34.0	12.2	10.2	15.1	8.8	5.9	7.6	6.6	9.3	9.7	7.2	8.4	6.1	7.1	8.3	10.3	8.7	12.2	8.2	11.1	10.4	10.4	13.9	11.1	9.3	10.1	8.1	11.2	8.3	7.1	13.6	8.4	6.0	9.7	11.3	8.5	7.1	10.0	9.2	7.9	10.5	9.8	10.5	10.0	9.4	9.6	7.3	8.4	17.7	7.5	3.7	7.3	12.5	11.5	10.5	7.9	6.2	13.3	8.1	9.8	6.0	8.6	18.8	4.5	7.6	4.4	10.1	13.0	9.3	11.9	10.6	11.5	12.1	6.0	9.0	7.6	14.8	10.6	8.3	12.5	9.7	20.8	11.1	9.0	12.3	16.9	12.2	8.8	5.5	13.6	16.1	6.7	5.6	5.1	10.9	9.1	10.8	6.7	5.1	7.9	7.1	5.1	6.3	12.2	5.8	5.2	9.3	9.3	5.8	4.9	8.6	10.1	11.4	6.6	17.6	7.4	25.5	3.5	6.0	4.1	5.7	5.8	5.3	6.8	4.0	5.3	5.7	4.5	4.7	7.2	8.4	4.0	6.7	5.6	3.1	7.5	4.3	8.7	11.5	10.2	15.1	8.3	10.3	10.4	10.4	11.2	10.0	9.8	17.7	11.2	12.8	13.1	8.8	16.0	32.2	11.0	7.2	20.5	12.7	23.8	15.0	15.6	8.6	11.3	5.5	14.6	5.8	20.5	7.7	9.8	5.1	8.6	12.0	13.2	11.5	18.0	12.4	10.9	5.3	5.7	15.6	7.7	20.7	17.1	11.3	9.7	15.7	6.5	11.8	13.0	9.2	4.1	10.6	11.4	3.7	13.4	11.0	16.0	17.8	8.9	9.0	17.5	13.0	30.9	4.7	4.9	10.5	14.2	16.1	7.4	11.4	10.9	14.1	13.1	14.3	11.6	22.8	22.3	20.4	32.4	14.4	19.3	7.0	6.7	11.9
IL10RA	"CD210, CD210a, CDW210A, HIL-10R, IL10R"	ENSG00000110324	"Interleukin 10 receptor subunit alpha"	Q13651	11	117986370-118003037	"CD markers, Disease related genes, Human disease related genes, Predicted membrane proteins"		Receptor	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 63.6;lymphoid tissue: 73.7"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 87.5;Extravillous trophoblasts: 93.0;Kupffer cells: 190.7;Langerhans cells: 145.0;Macrophages: 128.6;monocytes: 175.7;NK-cells: 110.2;Plasma cells: 129.5;T-cells: 105.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"Daudi: 30.5;HDLM-2: 76.6;Karpas-707: 27.7;RPMI-8226: 35.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA065647, HPA069086"			Supported	"Plasma membrane,Cytosol"		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 2: Immune cells - Immune response"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 24: Non-specific - Transcription regulation"	"Plasma membrane"	Cytosol	"HPA065647: , HPA069086: "	"unprognostic (1.01e-2)"	"unprognostic (2.07e-3)"	"unprognostic (1.58e-2)"	"unprognostic (7.08e-2)"	"unprognostic (8.27e-2)"	"prognostic favorable (4.47e-4)"	"unprognostic (5.27e-2)"	"unprognostic (4.84e-2)"	"unprognostic (7.70e-3)"	"unprognostic (5.94e-2)"	"unprognostic (2.14e-2)"	"unprognostic (3.83e-1)"	"prognostic unfavorable (1.45e-5)"	"unprognostic (1.82e-1)"	"unprognostic (8.43e-3)"	"unprognostic (2.19e-1)"	"unprognostic (1.27e-1)"	13.9	8.9	4.7	39.8	4.9	63.6	6.1	4.4	7.0	5.6	4.9	12.0	8.0	3.5	2.7	6.4	5.2	17.9	5.3	4.2	5.9	4.1	13.1	23.8	51.7	6.9	5.1	3.1	2.4	2.6	3.6	14.2	5.5	4.7	14.5	0.5	5.2	3.2	1.7	3.2	24.8	10.4	6.0	73.7	9.2	1.9	5.3	16.9	4.2	3.3	32.4	20.7	3.7	7.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	30.5	0.2	0.0	0.7	0.0	0.5	0.0	0.0	76.6	0.0	0.2	0.0	0.0	0.0	0.0	8.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	5.6	27.7	0.0	0.0	0.4	6.0	0.1	0.0	0.0	0.0	0.0	35.5	0.0	0.1	0.4	0.1	0.0	0.0	0.0	0.1	0.0	2.2	0.0	0.0	0.0	0.1	0.0	5.6	1.0	8.0	0.0	11.4	0.0	3.3	48.9	2.4	52.8	68.6	38.3	12.6	51.0	62.1	44.7	6.2	17.9	33.3	3.4	70.2	58.6	17.3	88.7	84.1	4.7	4.9	4.4	7.0	4.2	5.9	6.9	5.1	5.5	6.0	5.3	7.5	2.2	6.4	16.0	0.3	52.8	5.7	0.4	0.0	5.7	0.1	1.0	1.9	2.7	0.0	1.3	0.0	0.0	1.3	87.5	0.5	0.0	0.2	0.1	0.4	0.5	4.9	0.0	9.3	0.8	0.8	93.0	2.3	6.6	0.7	12.6	0.0	3.6	1.4	60.4	0.0	1.2	0.0	0.0	190.7	145.0	0.5	0.3	128.6	17.8	22.5	175.7	0.4	110.2	0.0	0.6	0.1	0.1	0.0	129.5	0.0	0.0	1.0	1.5	0.1	0.0	1.6	2.7	0.1	0.3	1.2	4.1	3.3	105.5	0.0	0.7	0.4
IL15	"IL-15, MGC9721"	ENSG00000164136	"Interleukin 15"	P40933	4	141636583-141733987	"Cancer-related genes, Predicted intracellular proteins, Predicted secreted proteins"		Cytokine	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 78.0;monocytes: 72.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 17.6;Karpas-707: 18.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB004457, HPA037738"	Approved		Supported	"Nucleoplasm,Nuclear speckles"	"Secreted to blood"	NA	NA	182000		"Cluster 7: Monocytes - Unknown function"	"Cluster 64: Macrophages - Immune response"	"Cluster 20: HeLa - Mitochondria"	"Cluster 36: Stromal cells - Cell proliferation"	"Nucleoplasm, Nuclear speckles"		"CAB004457: AB_2124575, HPA037738: AB_2675640"	"unprognostic (1.10e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.04e-2)"	"unprognostic (8.57e-2)"	"unprognostic (8.77e-3)"	"unprognostic (1.69e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.90e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.48e-1)"	"unprognostic (5.20e-2)"	"unprognostic (1.74e-2)"	"unprognostic (3.75e-2)"	"unprognostic (1.09e-1)"	"unprognostic (4.03e-2)"	"unprognostic (3.29e-2)"	"unprognostic (1.54e-1)"	7.7	3.4	1.3	7.1	1.4	4.0	6.0	2.1	1.8	5.3	1.4	7.7	6.1	4.5	2.5	4.4	4.5	4.9	5.1	1.2	1.3	7.9	3.6	7.8	9.7	2.3	1.3	1.5	2.7	0.7	3.6	3.1	1.8	4.1	5.3	4.3	3.6	2.7	8.6	3.4	10.0	4.6	1.5	15.4	4.8	2.5	1.8	6.8	15.6	3.4	6.6	4.5	6.4	1.9	2.8	6.3	0.3	0.6	0.9	5.4	1.6	6.7	6.1	6.8	5.5	3.4	8.1	2.5	8.5	6.2	6.0	4.4	0.1	3.4	3.6	17.6	1.7	0.5	16.7	0.5	4.5	1.9	1.3	2.1	1.5	4.4	0.5	13.7	4.3	2.3	4.0	18.8	4.2	0.9	4.2	0.3	3.3	2.3	1.7	1.0	16.0	0.5	9.2	0.8	0.6	1.6	3.1	4.7	3.2	0.8	0.9	0.3	6.6	6.9	4.3	2.0	4.2	13.0	1.8	1.0	7.2	0.8	2.5	10.4	16.1	0.6	2.7	15.1	5.0	4.1	3.3	2.5	5.5	4.0	1.4	1.4	1.2	3.2	16.5	0.2	2.0	6.1	1.3	1.4	2.1	1.8	1.2	1.3	2.3	1.3	1.8	1.5	1.8	1.9	14.8	0.0	2.8	0.3	9.9	6.1	2.5	2.1	2.2	0.6	2.1	1.3	2.9	2.8	5.3	5.5	0.0	1.2	5.0	4.7	0.0	9.4	6.6	6.9	78.0	14.8	0.0	1.3	2.0	14.0	1.6	5.5	4.1	5.9	0.0	0.9	11.4	2.5	4.7	0.0	4.8	5.4	0.0	17.0	22.1	2.5	2.8	16.7	8.8	4.7	72.0	21.1	8.2	3.0	0.2	19.8	8.2	1.2	9.3	6.2	9.9	12.0	3.9	0.9	6.6	7.6	4.0	1.2	0.8	5.6	3.4	0.3	6.0	0.1	2.6	3.0
IL16	"FLJ16806, FLJ42735, HsT19289, IL-16, LCF, prIL-16"	ENSG00000172349	"Interleukin 16"	Q14005	15	81159575-81314058	"Cancer-related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Chemotaxis, Host-virus interaction, Transcription, Transcription regulation"	Cytokine	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 135.3"	"Cell type enhanced"	"Detected in many"		"B-cells: 135.3;dendritic cells: 78.1;Kupffer cells: 59.2;Langerhans cells: 94.4;NK-cells: 121.5;Plasma cells: 55.6;T-cells: 76.3"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	5	"cerebellum: 57.3"	"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"Daudi: 27.7;HEL: 29.4;HMC-1: 50.6;RPMI-8226: 51.0;U-266/70: 60.3;U-698: 25.8;U-937: 35.1"	"Group enriched"	"Detected in all"	11	"cerebellum: 54.5;hippocampal formation: 27.0"	"Region enriched"	"Detected in many"	12	"cerebellum: 48.8"	"CAB005247, HPA018467, HPA048861"	Enhanced		Supported	"Nuclear speckles,Plasma membrane,Cytosol"	"Secreted to blood"	NA	NA	208000	7300	"Cluster 5: Granulocytes - Unknown function"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Nuclear speckles"	"Plasma membrane, Cytosol"	"CAB005247: AB_2124730, HPA018467: AB_1851642, HPA048861: "	"unprognostic (8.23e-3)"	"unprognostic (2.70e-3)"	"unprognostic (1.97e-2)"	"unprognostic (9.61e-4)"	"unprognostic (2.01e-1)"	"unprognostic (5.26e-4)"	"unprognostic (2.63e-2)"	"unprognostic (6.72e-3)"	"unprognostic (2.25e-1)"	"unprognostic (3.91e-1)"	"unprognostic (1.47e-1)"	"unprognostic (6.21e-2)"	"unprognostic (3.16e-3)"	"unprognostic (1.21e-1)"	"unprognostic (3.23e-2)"	"unprognostic (5.26e-2)"	"unprognostic (1.29e-1)"	18.9	6.3	3.5	63.3	3.0	62.1	15.5	57.3	4.1	9.6	13.8	14.4	11.3	9.9	7.7	7.4	17.8	16.2	5.9	2.9	5.7	3.2	9.7	23.7	132.6	5.9	5.7	6.1	2.6	2.3	2.1	9.0	10.5	5.8	16.8	0.5	11.2	4.5	3.3	12.0	39.9	9.8	5.8	86.2	15.6	4.2	5.2	130.4	6.9	8.5	135.3	18.9	10.4	7.6	0.0	0.0	0.0	0.1	17.5	7.2	0.1	0.0	0.0	0.0	0.0	0.0	0.1	27.7	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.4	0.0	29.4	0.0	0.0	0.9	21.0	50.6	0.9	0.0	0.1	0.6	0.0	0.4	3.5	3.2	10.7	0.1	0.0	1.7	22.2	0.0	0.1	0.0	0.1	0.1	51.0	0.0	0.2	0.1	0.1	0.1	0.0	9.9	0.0	0.0	4.6	0.2	0.3	0.2	1.0	0.0	60.3	5.5	25.8	1.8	35.1	1.5	252.8	116.2	321.3	164.5	142.7	185.9	166.0	170.6	180.6	150.9	157.2	224.9	185.6	282.5	213.2	149.1	113.7	197.0	338.0	3.5	3.0	57.3	4.1	2.9	5.7	5.9	5.7	10.5	5.8	5.2	7.6	9.4	3.2	6.6	0.0	135.3	8.2	0.2	0.8	1.2	0.2	0.8	1.4	2.7	8.6	1.9	1.8	0.0	0.3	78.1	0.3	0.0	0.1	1.4	3.1	6.6	7.5	0.0	20.2	3.4	0.2	0.3	15.9	1.1	0.7	27.1	0.0	26.7	9.2	19.0	0.0	4.9	0.3	0.0	59.2	94.4	1.4	10.8	33.1	28.4	18.7	30.2	0.3	121.5	0.0	0.3	0.0	1.2	18.0	55.6	0.1	0.1	0.4	7.7	0.7	6.6	1.1	3.2	2.1	7.5	1.2	3.7	0.4	76.3	0.2	0.7	0.2
IL17RB	"CRL4, EVI27, IL17BR, IL17RH1"	ENSG00000056736	"Interleukin 17 receptor B"	Q9NRM6	3	53846568-53865794	"Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 28.9;kidney: 59.8;liver: 33.3"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 48.3;Enteroendocrine cells: 29.2;Oligodendrocyte precursor cells: 37.7;Proximal tubular cells: 78.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"basophil: 1.3"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"CACO-2: 20.2;Hep G2: 59.5;OE19: 46.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA005482	Enhanced		Approved	"Vesicles,Plasma membrane"	"Intracellular and membrane"	NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Vesicles, Plasma membrane"		"HPA005482: AB_1234567"	"unprognostic (1.85e-3)"	"unprognostic (4.22e-3)"	"unprognostic (1.60e-3)"	"unprognostic (2.86e-2)"	"unprognostic (1.42e-2)"	"unprognostic (6.20e-3)"	"unprognostic (1.62e-2)"	"unprognostic (6.09e-3)"	"unprognostic (1.30e-1)"	"unprognostic (5.41e-2)"	"unprognostic (4.75e-2)"	"unprognostic (4.27e-2)"	"prognostic favorable (6.61e-4)"	"unprognostic (8.10e-2)"	"unprognostic (6.97e-2)"	"unprognostic (5.29e-1)"	"unprognostic (7.15e-3)"	0.9	2.0	20.2	2.3	21.4	0.5	5.7	22.7	28.9	18.1	16.6	6.8	5.8	5.1	0.7	1.7	3.3	2.4	2.7	19.4	20.2	59.8	33.3	3.8	2.5	18.7	19.9	1.5	7.8	1.1	4.2	0.9	19.0	2.4	6.9	4.8	4.9	0.6	1.3	2.2	5.9	0.8	18.9	1.2	3.6	2.5	23.2	0.3	2.9	0.2	0.7	0.8	1.3	23.6	1.5	3.1	4.5	3.4	0.1	0.0	7.1	3.1	0.1	0.1	0.0	20.2	1.4	4.6	1.0	1.0	1.7	0.8	12.2	0.0	0.0	1.6	3.5	6.0	6.1	59.5	0.0	5.6	3.2	0.0	0.0	0.0	0.0	3.8	0.0	1.6	4.9	2.1	0.1	4.2	0.9	2.3	12.1	46.2	2.6	1.7	1.9	5.3	1.4	5.3	6.4	3.7	10.1	2.4	1.9	3.3	9.2	2.0	2.5	3.0	3.3	2.6	3.9	4.7	5.6	2.9	2.7	3.3	1.7	1.3	0.2	0.0	0.2	0.2	0.1	0.1	0.6	0.2	0.0	0.2	0.2	0.2	0.1	0.1	0.0	0.3	0.9	0.1	20.2	21.4	22.7	28.9	19.4	20.2	18.7	19.9	19.0	18.9	23.2	23.6	0.2	0.0	4.1	48.3	0.2	0.3	2.0	0.0	0.0	0.1	8.2	4.4	4.1	17.2	1.3	0.0	0.0	1.4	0.3	4.3	9.8	4.8	1.0	0.5	1.0	0.2	29.2	0.0	0.5	1.6	1.0	0.6	4.6	1.7	2.5	0.4	0.4	13.1	0.1	0.0	2.5	8.7	2.0	0.0	1.1	0.7	1.2	1.2	0.0	1.9	0.0	4.4	0.0	37.7	4.3	1.8	3.0	0.4	0.0	4.4	2.9	78.0	0.0	0.1	0.0	0.3	0.5	0.4	1.0	0.0	0.1	0.4	0.9	0.0	10.2	0.6
IL17RD	"FLJ35755, IL-17RD, IL17RLM, SEF"	ENSG00000144730	"Interleukin 17 receptor D"	Q8NFM7	3	57089982-57170306	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"		Receptor	"Disease variant, Hypogonadotropic hypogonadism, Kallmann syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"choroid plexus: 28.0"	"Cell type enhanced"	"Detected in many"		"Breast myoepithelial cells: 14.0;Early spermatids: 17.9;Late spermatids: 23.7;Microglial cells: 15.0;Peritubular cells: 25.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 25.0;AN3-CA: 67.9;NTERA-2: 39.2;SH-SY5Y: 102.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA039577, HPA043550"	Approved		Supported	"Nucleoplasm,Golgi apparatus"		NA	NA				"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 50: Fibroblasts - ECM organization"	"Golgi apparatus"	Nucleoplasm	"HPA039577: AB_2676580, HPA043550: AB_2678546"	"unprognostic (4.67e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.31e-1)"	"unprognostic (2.72e-2)"	"unprognostic (1.33e-2)"	"unprognostic (9.62e-2)"	"unprognostic (1.17e-2)"	"unprognostic (1.60e-1)"	"unprognostic (3.72e-1)"	"unprognostic (2.11e-3)"	"unprognostic (4.79e-2)"	"unprognostic (1.25e-1)"	"prognostic favorable (2.92e-9)"	"unprognostic (2.90e-1)"	"unprognostic (2.21e-1)"	"unprognostic (2.63e-3)"	"unprognostic (9.58e-3)"	1.9	0.8	4.7	0.9	5.7	0.0	7.4	5.2	4.0	6.0	28.0	5.9	0.4	13.5	10.6	2.4	6.4	3.3	1.9	5.5	6.5	5.7	0.2	0.6	0.3	8.9	8.8	7.4	0.9	9.4	2.3	0.3	5.5	5.1	1.8	0.3	6.0	8.5	0.6	2.0	1.0	12.0	6.2	2.5	1.2	9.7	4.8	0.3	0.5	2.6	0.5	2.8	3.3	6.5	4.0	0.8	25.0	67.9	0.1	0.6	4.0	0.4	0.2	0.3	0.8	0.5	1.9	0.0	0.2	1.4	5.3	0.2	4.8	1.0	0.8	0.0	1.3	0.0	0.0	0.2	0.1	0.0	0.1	1.0	2.6	0.0	0.5	16.6	1.1	0.6	0.0	0.1	1.4	0.5	0.0	0.1	39.2	2.2	1.9	0.0	9.1	0.0	5.2	1.0	0.6	102.0	1.0	1.5	2.9	8.1	0.9	0.0	0.7	1.3	1.6	1.2	4.2	0.0	0.0	0.1	0.7	0.0	1.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	4.7	5.7	5.2	4.0	5.5	6.5	8.9	8.8	5.5	6.2	4.8	6.5	1.4	0.0	2.3	11.4	0.0	0.9	2.0	3.1	0.0	0.1	1.5	14.0	1.6	1.5	2.4	0.0	0.0	0.3	0.1	0.1	0.0	3.1	17.9	0.5	5.5	4.0	0.0	0.0	0.6	0.2	0.1	10.1	0.0	1.0	0.0	2.0	1.1	0.1	0.1	0.0	0.9	0.3	2.0	0.0	1.2	23.7	11.5	0.6	0.0	15.0	0.0	0.6	0.0	7.5	2.1	0.7	0.7	25.9	0.0	2.9	0.0	5.0	1.8	0.0	0.0	4.8	1.3	10.6	7.5	1.1	0.9	0.1	0.3	6.5	0.3	0.7
IL1RL1	"DER4, FIT-1, IL33R, ST2, ST2L, ST2V, T1"	ENSG00000115602	"Interleukin 1 receptor like 1"	Q01638	2	102311502-102352037	"Candidate cardiovascular disease genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"		"Hydrolase, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"kidney: 126.4;lung: 162.0;placenta: 199.8"	"Cell type enriched"	"Detected in many"	9	"granulocytes: 501.5"	"Cancer enriched"	"Detected in many"	5	"thyroid cancer: 7.9"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	64	"basophil: 38.3;eosinophil: 29.3"	"Lineage enriched"	"Detected in single"	72	"granulocytes: 38.3"	"Group enriched"	"Detected in some"	6	"HHSteC: 245.1;HMC-1: 373.7;HUVEC TERT2: 185.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA007406, HPA007917"	Uncertain		Supported	"Plasma membrane,Focal adhesion sites,Cytosol"	"Secreted to blood"	NA	NA	19100000	3100000	"Cluster 2: Granulocytes - Unknown function"	"Cluster 28: Placenta - Pregnancy"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 60: Granulocytes - Receptor signaling"	"Plasma membrane"	"Focal adhesion sites, Cytosol"	"HPA007406: AB_1079128, HPA007917: AB_1079129"	"unprognostic (7.25e-2)"	"unprognostic (9.72e-2)"	"unprognostic (1.44e-1)"	"unprognostic (3.28e-2)"	"unprognostic (5.28e-2)"	"unprognostic (1.98e-2)"	"unprognostic (3.25e-3)"	"unprognostic (2.07e-1)"	"unprognostic (2.77e-1)"	"unprognostic (4.50e-2)"	"unprognostic (8.58e-2)"	"unprognostic (9.74e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.32e-2)"	"unprognostic (1.60e-2)"	"unprognostic (1.17e-1)"	"unprognostic (4.60e-3)"	22.3	30.3	7.5	3.1	9.8	0.7	14.7	7.8	11.0	3.6	12.2	5.2	1.7	2.5	0.6	4.4	2.6	14.7	24.7	7.2	8.2	126.4	16.0	162.0	0.7	7.6	7.7	1.1	4.8	0.8	5.7	199.8	7.7	4.9	3.4	2.8	1.8	4.6	2.5	4.3	8.0	3.7	8.0	1.4	25.1	0.5	9.6	1.3	4.1	0.7	0.8	6.5	3.9	8.9	0.9	0.2	0.7	0.1	15.1	0.6	0.3	0.5	0.7	0.4	0.6	0.3	0.5	0.5	0.7	0.2	0.2	1.4	0.2	6.3	0.4	0.2	0.1	45.7	0.8	0.8	245.1	1.9	373.7	5.1	1.5	6.2	40.0	0.6	185.5	0.2	0.9	0.8	0.7	0.4	0.6	8.7	0.3	0.4	0.7	0.3	0.2	0.2	1.0	0.3	0.6	0.4	0.5	0.3	0.2	0.4	0.3	0.1	15.4	0.5	0.5	3.5	0.5	0.1	0.3	0.4	0.7	0.6	0.5	38.3	0.0	29.3	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	7.5	9.8	7.8	11.0	7.2	8.2	7.6	7.7	7.7	8.0	9.6	8.9	22.6	9.6	13.1	0.0	0.1	8.5	20.3	0.4	0.0	0.0	0.3	0.1	2.7	0.0	7.7	1.8	0.0	0.0	3.3	0.1	0.0	3.2	0.4	1.1	14.8	49.7	0.0	1.3	0.2	0.5	0.1	54.5	0.0	2.5	501.5	0.0	26.4	0.7	0.0	0.0	0.2	0.0	0.0	0.3	19.1	1.3	0.9	3.0	3.6	0.0	0.0	0.0	0.0	0.5	0.1	37.2	0.0	0.0	3.2	15.7	0.0	0.0	6.6	0.3	39.5	1.5	37.7	0.0	0.0	0.0	5.1	0.0	31.5	0.0	0.0	16.4
IL1RN	"ICIL-1RA, IL-1RN, IL1F3, IL1RA, IRAP, MGC10430"	ENSG00000136689	"Interleukin 1 receptor antagonist"	P18510	2	113107214-113134016	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"esophagus: 1969.7"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 184.4;Hofbauer cells: 306.0;Langerhans cells: 292.6;Squamous epithelial cells: 469.7;Suprabasal keratinocytes: 336.6;Urothelial cells: 464.9"	"Cancer enhanced"	"Detected in all"		"head and neck cancer: 92.7"	"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in many"	4	"classical monocyte: 63.8;myeloid DC: 61.7;neutrophil: 240.2"	"Group enriched"	"Detected in many"	694	"dendritic cells: 61.7;granulocytes: 240.2;monocytes: 63.8"	"Cell line enhanced"	"Detected in some"		"A-431: 59.1;HaCaT: 112.3;RT4: 106.6;THP-1: 27.3"	"Not detected"	"Not detected"							"HPA001482, CAB009633"	Enhanced		Approved	Nucleoplasm,Centrosome,Cytosol	"Secreted to blood"	NA	NA	291000	45000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 15: RT4 - Unknown function"	"Cluster 61: Squamous epithelial cells - Keratinization"	Nucleoplasm	"Centrosome, Cytosol"	"CAB009633: AB_2125576, HPA001482: AB_1078437"	"unprognostic (3.85e-3)"	"unprognostic (3.96e-2)"	"unprognostic (1.00e-1)"	"prognostic unfavorable (3.00e-4)"	"unprognostic (2.21e-1)"	"unprognostic (3.63e-2)"	"unprognostic (3.15e-2)"	"unprognostic (2.55e-1)"	"unprognostic (4.46e-2)"	"unprognostic (9.54e-2)"	"prognostic unfavorable (6.85e-4)"	"unprognostic (5.59e-3)"	"prognostic unfavorable (2.66e-6)"	"unprognostic (2.05e-1)"	"prognostic unfavorable (8.23e-4)"	"unprognostic (4.25e-2)"	"unprognostic (1.03e-1)"	13.0	2.1	0.2	46.7	0.4	233.3	9.0	0.4	1.3	278.1	1.1	4.4	10.7	2.5	2.9	1969.7	2.1	17.0	2.5	0.3	0.3	1.6	248.5	20.1	1.4	0.4	0.5	0.9	1.8	2.0	2.3	21.1	0.8	2.4	4.0	0.0	287.1	7.5	0.8	128.6	8.8	3.9	0.8	14.7	45.5	6.4	1.3	5.2	6.4	3.0	311.7	185.7	465.0	0.6	59.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	7.9	0.0	0.2	0.0	0.6	0.2	0.2	0.0	1.1	112.3	0.0	3.3	0.0	0.1	0.0	0.3	0.0	17.3	0.0	0.3	20.3	0.0	14.3	0.7	0.0	2.0	0.0	0.0	0.3	0.3	0.0	0.5	0.1	14.7	0.0	13.2	0.0	0.0	0.1	0.1	0.0	106.6	0.0	0.0	0.1	0.8	0.1	0.0	0.0	27.3	0.3	1.4	0.0	0.7	0.1	0.6	0.1	0.2	10.3	10.5	0.3	0.0	63.8	1.9	0.0	27.7	0.0	0.1	0.0	0.0	61.7	0.1	0.1	0.1	240.2	0.0	13.7	0.8	0.1	19.8	0.2	0.4	0.4	1.3	0.3	0.3	0.4	0.5	0.8	0.8	1.3	0.6	1.7	6.4	7.7	0.0	4.1	184.4	81.3	151.8	56.9	0.0	4.9	3.4	0.4	11.5	60.6	3.7	0.0	1.8	0.2	6.5	0.0	27.5	34.8	7.8	1.4	4.8	0.0	3.2	0.3	28.0	2.9	11.0	44.4	23.6	10.1	0.0	3.3	53.0	306.0	0.0	0.2	1.1	6.1	39.8	292.6	93.3	0.6	111.1	24.9	0.0	22.6	0.0	2.1	0.5	0.2	149.9	0.1	0.4	2.8	58.4	9.3	0.2	20.2	0.0	0.0	0.3	3.8	0.8	0.2	469.7	336.6	4.5	3.3	0.0	3.2	464.9
IL33	"C9orf26, DKFZp586H0523, DVS27, IL1F11, NF-HEV"	ENSG00000137033	"Interleukin 33"	O95760	9	6215786-6257983	"Predicted intracellular proteins, Predicted secreted proteins"	Transcription	Cytokine		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"urinary bladder: 120.7"	"Cell type enhanced"	"Detected in many"		"Endothelial cells: 141.8;Fibroblasts: 87.5;Hepatic stellate cells: 499.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"hTERT-RPE1: 53.6;U-2197: 162.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB007057, HPA022899, HPA024426"	Supported		Supported	Nucleoplasm,Vesicles	"Secreted to blood"	NA	NA				"Cluster 46: Fibroblasts - ECM organization"	"Cluster 18: U-2197 - ECM organization"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Nucleoplasm	Vesicles	"CAB007057: , HPA022899: , HPA024426: AB_1845820"	"prognostic favorable (4.42e-4)"	"unprognostic (8.36e-2)"	"unprognostic (5.67e-3)"	"unprognostic (7.67e-3)"	"unprognostic (4.27e-1)"	"unprognostic (1.63e-1)"	"unprognostic (2.59e-3)"	"unprognostic (2.66e-3)"	"unprognostic (3.18e-1)"	"unprognostic (2.05e-1)"	"unprognostic (1.43e-1)"	"unprognostic (8.08e-2)"	"unprognostic (1.58e-3)"	"unprognostic (4.70e-3)"	"unprognostic (4.10e-2)"	"unprognostic (2.64e-1)"	"unprognostic (6.85e-3)"	38.7	16.7	9.2	44.6	9.3	0.2	27.2	7.0	12.1	56.2	6.4	24.8	8.8	50.0	15.9	24.5	25.9	33.4	40.9	8.5	10.8	5.0	36.7	53.0	47.1	7.8	8.3	5.0	3.4	3.7	5.7	61.1	7.1	30.0	19.4	2.0	18.9	31.5	6.1	44.0	15.6	50.8	8.3	20.5	33.6	5.8	10.8	13.1	12.6	13.8	43.0	120.7	21.2	8.6	0.0	0.0	0.0	0.0	0.3	1.4	0.0	2.9	0.3	0.0	0.0	0.0	0.0	0.1	16.9	0.3	0.0	0.1	0.0	1.2	0.0	0.0	0.1	0.0	0.0	0.0	1.8	0.0	0.0	0.9	0.7	0.3	0.4	53.6	8.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	4.0	0.4	0.0	0.0	0.0	0.0	1.8	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.1	162.9	0.0	0.0	0.0	0.1	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.2	9.3	7.0	12.1	8.5	10.8	7.8	8.3	7.1	8.3	10.8	8.6	63.5	6.4	7.2	39.5	1.0	24.2	17.0	73.9	27.3	0.0	9.4	4.1	5.8	4.3	77.8	0.0	0.0	0.0	0.1	2.2	0.0	3.0	0.5	12.4	7.1	141.8	10.7	8.0	0.2	7.9	0.0	87.5	48.4	20.6	1.3	0.0	499.4	5.0	0.1	0.0	0.1	0.2	2.0	20.8	10.2	1.6	20.5	1.7	1.8	1.0	0.0	9.5	0.0	0.5	0.1	12.1	0.2	12.4	0.2	5.2	0.0	0.0	62.1	0.1	0.0	65.5	11.5	0.0	0.4	3.3	48.4	0.1	1.2	0.1	1.1	4.9
IL36G	"IL-1F9, IL-1H1, IL-1RP2, IL1E, IL1F9, IL1H1"	ENSG00000136688	"Interleukin 36 gamma"	Q9NZH8	2	112973203-112985658	"Predicted intracellular proteins, Predicted secreted proteins"	"Immunity, Inflammatory response, Innate immunity"	Cytokine		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"esophagus: 14.3;lymphoid tissue: 39.4;skin 1: 31.3"	"Group enriched"	"Detected in some"	6	"Basal respiratory cells: 136.0;Club cells: 36.0"	"Cancer enhanced"	"Detected in some"		"head and neck cancer: 36.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"GAMG: 1.1;HaCaT: 1.0"	"Not detected"	"Not detected"							HPA068168			Supported	"Nucleoplasm,Plasma membrane,Cytosol"	"Secreted to blood"	NA	NA		11000		"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 12: NES - Nervous system development"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Cytosol	"Nucleoplasm, Plasma membrane"	"HPA068168: "	"unprognostic (1.56e-2)"	"unprognostic (2.88e-1)"	"unprognostic (7.27e-2)"	"unprognostic (3.15e-2)"	"unprognostic (4.91e-2)"	"unprognostic (1.92e-1)"	"unprognostic (3.68e-1)"	"unprognostic (3.68e-1)"	"unprognostic (2.18e-1)"	"unprognostic (1.32e-1)"	"unprognostic (2.01e-2)"			"unprognostic (5.79e-2)"	"unprognostic (5.58e-2)"		"unprognostic (1.06e-1)"	0.0	0.0	0.0	0.0	0.0	0.2	1.1	0.0	0.1	0.3	0.0	0.1	0.0	0.1	0.0	14.3	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	3.9	0.2	0.0	31.3	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.7	0.0	0.0	39.4	0.8	3.6	0.0	0.4	0.0	0.7	0.0	0.0	0.0	0.2	0.0	0.5	0.0	0.3	0.0	0.0	0.0	0.2	0.0	1.1	1.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.1	0.0	0.3	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.3	136.0	0.0	0.0	0.0	0.0	0.0	0.0	36.0	0.0	0.0	0.0	0.0	0.3	0.0	0.4	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	4.1	0.0	0.7	0.7	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.6	0.0	0.0	3.9	0.0	0.0	0.0	1.3	0.2	0.0	1.7	13.2	0.0	0.0	0.0	0.0	7.8
IL37	"FIL1, FIL1(ZETA), FIL1Z, IL-1F7, IL-1H4, IL-1RP1, IL1F7"	ENSG00000125571	"Interleukin 37"	Q9NZH6	2	112912971-112918882	"Predicted intracellular proteins, Predicted secreted proteins"		Cytokine		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"skin 1: 136.8"	"Cell type enriched"	"Detected in some"	26	"Ionocytes: 73.2"	"Cancer enriched"	"Detected in some"	6	"lung cancer: 6.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 2.7;PC-3: 5.9;RT4: 3.2"									"HPA054371, HPA057950"	Uncertain		Supported	Nucleoplasm,Vesicles	"Secreted to blood"	NA	NA	76700		"Cluster 48: NK-cells - Unknown function"	"Cluster 61: Skin - Cornification"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Nucleoplasm, Vesicles"		"HPA054371: AB_2682465, HPA057950: AB_2683561"	"unprognostic (1.79e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.64e-1)"	"unprognostic (3.71e-5)"	"unprognostic (1.11e-1)"	"unprognostic (2.58e-2)"		"unprognostic (1.09e-2)"	"unprognostic (1.28e-2)"	"unprognostic (9.54e-2)"	"unprognostic (8.26e-3)"			"unprognostic (3.95e-2)"	"unprognostic (1.66e-1)"	"unprognostic (8.92e-2)"	"unprognostic (1.35e-2)"	0.1	0.0	0.0	0.2	0.0	0.2	16.7	0.0	0.1	0.0	0.0	0.5	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.5	0.0	0.0	0.1	0.4	136.8	0.1	0.0	0.0	0.0	0.1	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.4	0.1	0.0	0.0	0.1	0.2	2.7	0.2	0.2	0.2	0.3	0.0	0.2	0.1	0.2	0.1	0.1	0.4	0.8	0.1	0.0	1.0	0.1	0.4	0.0	0.0	0.1	0.0	0.0	0.3	0.6	0.2	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.8	0.2	0.2	5.9	0.0	0.0	0.0	0.0	3.2	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.1	0.1	0.2	0.0	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.0	73.2	0.0	0.4	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.1	0.0	2.8	0.0	0.1	0.0	0.0	0.0
IL4R	CD124	ENSG00000077238	"Interleukin 4 receptor"	P24394	16	27313668-27364778	"Cancer-related genes, CD markers, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters"	Immunity	Receptor	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"B-cells: 92.0;granulocytes: 110.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"naive B-cell: 78.1"	"Group enriched"	"Detected in all"	5	"B-cells: 78.1;granulocytes: 31.1"	"Cell line enhanced"	"Detected in many"		"Daudi: 124.2;HBEC3-KT: 115.0;HDLM-2: 110.6;U-698: 119.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB004451, HPA050124, HPA070380"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Centriolar satellite"	"Secreted to blood"	NA	NA	38500	110000	"Cluster 37: B-cells - Transcription"	"Cluster 64: Macrophages - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 57: B-cells - Immune response"	"Nucleoplasm, Plasma membrane"	"Centriolar satellite"	"CAB004451: AB_626889, HPA050124: AB_2681026, HPA070380: "	"unprognostic (6.80e-2)"	"unprognostic (6.35e-2)"	"unprognostic (2.84e-1)"	"prognostic favorable (6.43e-4)"	"unprognostic (1.12e-1)"	"unprognostic (1.14e-1)"	"unprognostic (2.33e-2)"	"unprognostic (1.95e-3)"	"unprognostic (1.34e-1)"	"unprognostic (1.54e-1)"	"unprognostic (2.41e-1)"	"unprognostic (1.97e-1)"	"prognostic unfavorable (1.23e-5)"	"unprognostic (1.49e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.36e-1)"	"unprognostic (9.58e-2)"	49.4	45.2	22.7	82.3	19.7	103.4	34.1	19.2	22.0	39.7	21.4	97.0	27.3	35.8	5.9	70.8	42.3	41.2	34.2	18.7	21.0	50.8	116.0	119.2	117.1	29.4	22.2	14.3	29.8	31.7	14.9	39.3	24.0	49.9	35.6	2.4	20.5	25.6	9.3	24.4	55.7	37.3	25.5	90.0	55.0	15.5	25.3	22.3	24.2	6.6	89.6	63.2	45.4	23.8	39.9	10.1	6.4	13.1	3.1	14.1	14.3	24.7	27.3	9.3	7.7	20.4	105.2	124.2	30.1	38.5	18.3	39.7	7.3	115.0	8.2	110.6	4.0	22.6	6.6	31.6	40.8	6.1	61.7	23.5	45.0	44.2	26.5	48.7	50.7	6.8	10.5	9.8	15.0	17.3	0.7	18.8	8.0	34.2	9.1	0.4	47.5	10.2	42.9	43.2	1.9	0.6	3.7	24.7	5.0	15.6	8.2	23.5	81.0	21.0	9.8	19.0	17.6	6.1	2.1	119.7	2.1	21.1	0.3	1.4	7.2	13.0	4.2	3.1	3.4	25.8	6.9	4.4	4.1	78.1	10.0	5.0	31.1	8.2	1.8	4.8	5.3	5.8	22.7	19.7	19.2	22.0	18.7	21.0	29.4	22.2	24.0	25.5	25.3	23.8	30.5	28.9	49.2	0.7	92.0	13.3	43.3	34.9	26.2	0.3	9.4	14.2	2.4	34.3	33.4	1.8	0.0	17.6	29.8	60.0	0.0	39.5	0.3	6.6	2.2	39.0	23.4	5.2	1.7	32.3	3.8	17.2	32.1	17.2	110.8	0.7	62.8	45.9	27.2	0.0	0.6	35.5	8.2	30.6	29.9	0.8	0.3	34.3	14.2	38.4	39.3	0.0	7.2	0.5	0.7	49.3	28.7	0.0	13.4	37.7	24.0	1.2	28.5	0.2	39.5	16.4	20.0	0.8	3.3	23.8	14.9	24.9	38.3	0.2	16.7	46.9
IL6ST	"CD130, GP130, sGP130"	ENSG00000134352	"Interleukin 6 signal transducer"	P40189	5	55935095-55995022	"Cancer-related genes, Candidate cardiovascular disease genes, CD markers, Disease related genes, Human disease related genes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"	"Host-virus interaction"	Receptor	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Glandular and luminal cells: 580.3;Hepatic stellate cells: 808.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"naive CD4 T-cell: 16.7"	"Lineage enriched"	"Detected in many"	4	"T-cells: 16.7"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 151.3;BJ hTERT+: 175.2;HHSteC: 155.1;HSkMC: 135.1;TIME: 147.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010558, CAB025784"	Approved		Supported	"Golgi apparatus,Plasma membrane"	"Secreted to blood"	NA	NA		160000000	"Cluster 32: T-cells - Unknown function"	"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 44: Endometrium - Transcription"	"Plasma membrane"	"Golgi apparatus"	"CAB025784: , HPA010558: AB_1078439"	"unprognostic (1.81e-2)"	"unprognostic (1.25e-1)"	"unprognostic (7.61e-2)"	"unprognostic (3.95e-2)"	"unprognostic (8.93e-2)"	"unprognostic (3.99e-2)"	"unprognostic (5.18e-2)"	"unprognostic (9.53e-3)"	"unprognostic (1.89e-2)"	"unprognostic (2.29e-1)"	"unprognostic (4.78e-2)"	"unprognostic (1.59e-1)"	"prognostic unfavorable (5.05e-4)"	"unprognostic (3.69e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.25e-1)"	67.1	46.0	26.8	14.1	31.0	9.6	51.3	30.9	36.7	43.0	21.3	33.9	4.2	35.2	18.5	18.4	34.2	23.6	35.1	23.5	31.4	30.0	77.6	53.3	15.9	32.1	27.0	36.9	21.9	39.6	22.5	101.7	35.9	32.6	14.3	28.6	31.9	29.9	41.0	17.8	31.1	28.7	35.1	34.7	27.8	8.9	25.3	23.6	40.4	34.7	16.2	37.7	35.1	42.9	14.4	35.6	9.4	18.8	75.5	151.3	22.3	54.5	175.2	44.1	62.4	40.5	16.3	1.1	33.7	52.5	71.6	7.8	9.8	19.2	84.1	1.6	8.5	4.6	20.1	14.2	155.1	0.4	6.2	135.1	11.1	103.1	42.7	43.6	101.8	1.9	3.7	51.0	47.0	2.9	0.7	0.8	1.5	1.8	10.1	1.1	22.5	14.4	22.5	12.1	3.8	5.9	26.6	5.7	19.7	13.7	29.5	3.1	147.8	12.4	10.1	44.5	24.6	14.6	8.2	0.5	28.9	1.1	31.1	0.0	3.9	0.1	0.7	3.4	0.3	0.8	3.7	0.8	2.1	0.4	16.7	4.8	0.6	0.8	0.5	1.9	4.1	4.0	26.8	31.0	30.9	36.7	23.5	31.4	32.1	27.0	35.9	35.1	25.3	42.9	221.6	134.6	149.8	59.4	30.0	103.9	98.0	60.6	71.2	56.5	202.4	81.3	81.5	124.4	105.4	68.0	35.5	77.9	33.1	34.5	7.9	85.3	12.3	76.4	227.6	256.2	19.8	41.1	25.7	62.0	75.5	285.5	59.1	580.3	32.9	58.6	808.5	219.8	56.0	16.8	70.0	34.1	46.8	93.7	99.1	16.7	105.9	60.3	80.0	188.3	45.8	190.8	7.2	75.4	64.2	80.8	35.6	130.5	100.6	163.9	33.6	52.2	80.3	39.3	98.6	158.7	150.3	54.4	38.6	44.9	83.5	101.8	75.5	228.7	17.1	106.1
IL7R	"CD127, IL7RA"	ENSG00000168685	"Interleukin 7 receptor"	P16871	5	35852695-35879603	"Cancer-related genes, CD markers, Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"		Receptor	"Cancer-related genes, Disease variant, SCID"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 183.7"	"Group enriched"	"Detected in many"	4	"monocytes: 271.8;T-cells: 973.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"gdT-cell: 102.1;MAIT T-cell: 369.5;memory CD4 T-cell: 213.8;memory CD8 T-cell: 151.1;naive CD4 T-cell: 179.5;naive CD8 T-cell: 124.6;NK-cell: 113.2"	"Group enriched"	"Detected in all"	33	"NK-cells: 113.2;T-cells: 369.5"	"Cell line enhanced"	"Detected in many"		"BJ: 99.8;BJ hTERT+ SV40 Large T+: 87.7;fHDF/TERT166: 187.7;HBF TERT88: 168.3;REH: 406.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"CAB010215, HPA067550"			Supported	"Plasma membrane"	"Intracellular and membrane"	NA	NA		610000	"Cluster 16: MAIT-cells - Unknown function"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 14: REH - Unknown function"	"Cluster 24: Non-specific - Transcription regulation"	"Plasma membrane"		"CAB010215: AB_673727, HPA067550: "	"unprognostic (2.93e-3)"	"unprognostic (3.38e-2)"	"unprognostic (3.82e-3)"	"unprognostic (5.58e-3)"	"unprognostic (3.06e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.51e-3)"	"unprognostic (5.53e-2)"	"unprognostic (1.12e-1)"	"unprognostic (9.29e-3)"	"unprognostic (1.43e-1)"	"unprognostic (2.69e-1)"	"unprognostic (1.76e-2)"	"unprognostic (5.64e-2)"	"unprognostic (3.27e-3)"	"unprognostic (2.22e-1)"	"unprognostic (1.78e-1)"	11.2	14.4	1.5	137.6	1.8	14.0	20.4	7.4	2.7	12.0	1.0	17.3	15.0	3.9	1.6	11.0	5.7	32.4	2.2	2.0	2.5	4.5	12.5	63.9	139.4	1.8	0.5	2.2	5.3	0.8	1.7	2.9	1.6	8.7	20.4	0.9	3.3	3.1	4.1	3.8	56.8	5.6	0.6	70.1	34.1	4.7	4.4	183.7	7.6	1.7	123.0	48.0	7.1	6.2	0.6	0.4	0.7	0.4	0.7	0.6	0.6	99.8	50.6	87.7	51.3	0.5	0.6	9.6	0.3	187.7	15.9	16.0	0.2	6.0	168.3	8.6	1.1	3.2	10.3	0.0	1.5	0.6	7.2	1.6	0.0	18.7	4.3	2.4	2.6	0.7	0.7	0.9	71.3	0.2	2.3	1.0	0.3	0.3	4.6	406.2	5.2	0.6	0.0	5.3	0.4	0.2	15.9	1.7	0.2	0.3	0.6	0.4	7.0	34.5	58.4	14.8	13.4	0.6	0.2	10.4	17.4	9.2	27.8	4.3	1.6	1.0	102.1	1.2	369.5	1.5	213.8	151.1	0.7	2.1	179.5	124.6	7.3	113.2	1.5	1.8	39.7	87.7	1.5	1.8	7.4	2.7	2.0	2.5	1.8	0.5	1.6	0.6	4.4	6.2	8.9	16.0	16.0	0.0	47.4	11.6	2.7	0.0	5.2	0.0	8.6	6.1	4.9	0.0	2.5	0.0	0.0	0.2	136.0	0.6	0.0	1.0	0.1	1.1	0.4	13.2	0.0	16.4	0.0	2.0	0.2	11.6	53.5	1.2	19.6	0.2	13.2	4.4	10.6	0.0	0.0	0.5	0.0	10.6	98.5	0.8	0.0	58.8	21.4	2.8	271.8	0.0	11.3	0.0	0.0	0.1	1.4	0.0	93.5	1.4	0.0	0.8	5.8	0.0	0.0	5.5	7.9	0.2	0.1	1.5	10.4	0.3	973.8	0.4	0.4	3.5
ILF2	NF45	ENSG00000143621	"Interleukin enhancer binding factor 2"	Q12905	1	153661788-153671028	"Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007484	Supported		Supported	Nucleoplasm		No	No		3400000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm		"HPA007484: AB_1079137"	"unprognostic (1.97e-3)"	"unprognostic (8.68e-2)"	"unprognostic (3.44e-2)"	"unprognostic (3.15e-2)"	"unprognostic (8.75e-3)"	"unprognostic (9.70e-2)"	"prognostic unfavorable (5.71e-8)"	"unprognostic (2.64e-1)"	"unprognostic (4.66e-2)"	"unprognostic (3.22e-3)"	"unprognostic (1.94e-2)"	"unprognostic (3.03e-1)"	"prognostic unfavorable (5.57e-4)"	"unprognostic (2.61e-1)"	"unprognostic (4.17e-2)"	"unprognostic (2.65e-1)"	"unprognostic (2.09e-1)"	81.4	84.2	42.3	81.5	44.1	158.1	100.7	45.9	51.1	75.4	51.2	80.5	57.4	75.6	85.7	99.1	77.5	61.0	71.3	43.5	47.9	97.6	69.0	76.1	97.7	44.8	44.9	75.4	79.7	101.7	75.3	86.1	46.1	63.5	91.3	43.4	84.3	61.2	114.6	90.0	63.3	79.2	46.8	78.1	76.9	101.2	44.6	189.7	88.7	85.9	132.4	105.8	69.5	50.6	323.3	244.7	420.1	297.8	173.1	162.4	336.2	233.5	263.6	411.9	294.5	362.1	254.3	441.5	349.5	233.6	198.8	239.3	508.8	248.3	394.6	242.0	328.9	330.5	182.2	310.0	158.6	521.0	234.7	149.6	139.7	314.4	339.1	171.7	389.3	256.0	423.5	203.4	347.2	424.3	702.8	215.4	607.5	468.5	366.2	502.1	367.2	418.3	194.8	304.0	379.5	350.2	272.3	336.1	272.3	392.0	367.2	442.7	239.5	210.7	266.4	191.6	391.8	348.6	522.6	882.9	177.2	314.1	327.2	168.7	158.1	118.1	147.4	156.0	188.0	198.7	169.8	160.3	219.2	165.0	190.7	164.8	14.8	218.5	129.7	212.2	212.6	357.3	42.3	44.1	45.9	51.1	43.5	47.9	44.8	44.9	46.1	46.8	44.6	50.6	101.4	57.7	68.5	6.8	102.1	197.9	220.9	238.0	129.7	38.0	113.5	112.1	62.2	70.1	130.4	38.6	27.1	215.3	99.0	54.2	131.0	209.9	73.9	81.6	84.4	114.0	106.8	113.0	9.4	156.4	259.3	110.8	50.4	103.0	94.4	107.0	49.2	31.5	124.8	28.6	10.5	87.2	164.8	54.9	117.4	33.1	60.0	74.0	112.1	9.4	112.9	82.8	61.8	10.6	17.1	145.4	63.5	65.8	125.4	139.9	45.5	201.6	80.7	36.3	65.7	102.4	124.2	360.3	159.9	119.1	158.8	260.4	101.4	144.9	110.9	181.0
ILF3	"DRBP76, MPHOSPH4, MPP4, MPP4110, NF110, NF110b, NF90, NF90a, NF90c, NF90ctv, NFAR-1, NFAR-2, NFAR110, NFAR90, TCP110"	ENSG00000129351	"Interleukin enhancer binding factor 3"	Q12906	19	10654261-10692417	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Antiviral defense, Transcription, Transcription regulation"	"DNA-binding, RNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001897	Supported		Enhanced	Nucleoplasm,Nucleoli,Mitochondria		No	No		1600000	"Cluster 6: Non-specific - Transcription"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoplasm, Nucleoli, Mitochondria"		"HPA001897: AB_1078703"	"unprognostic (2.39e-1)"	"unprognostic (9.44e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.25e-1)"	"unprognostic (7.53e-2)"	"unprognostic (5.55e-3)"	"unprognostic (1.11e-3)"	"unprognostic (2.96e-1)"	"prognostic unfavorable (1.57e-4)"	"unprognostic (3.45e-2)"	"unprognostic (1.04e-1)"	"unprognostic (4.38e-2)"	"prognostic unfavorable (9.65e-4)"	"unprognostic (7.57e-3)"	"unprognostic (7.61e-2)"	"unprognostic (1.03e-1)"	"unprognostic (6.20e-2)"	49.2	58.5	31.6	79.4	31.5	179.5	49.8	44.2	37.5	60.8	38.5	56.0	52.0	64.5	40.9	60.4	61.1	31.9	49.0	31.4	37.9	43.1	32.1	50.5	82.9	30.6	32.8	76.5	52.6	55.5	53.8	47.8	29.7	52.4	44.8	69.5	54.0	48.8	83.6	58.7	56.1	49.8	29.4	61.7	47.8	78.9	35.4	97.3	61.6	58.2	72.3	56.1	52.1	42.8	285.9	226.7	359.5	330.9	76.5	104.0	208.9	178.1	149.6	291.8	226.5	261.8	160.8	353.2	172.1	160.8	178.0	248.9	392.5	240.7	260.9	227.2	349.5	459.3	206.9	247.5	109.2	334.8	219.5	99.0	105.0	232.1	257.4	111.1	253.1	201.7	400.0	269.4	172.3	233.8	558.1	534.0	433.3	149.2	246.2	405.2	342.2	244.2	116.3	297.1	395.1	286.7	229.0	179.4	131.6	161.6	152.2	212.0	205.2	237.6	224.2	249.3	356.5	228.9	339.7	431.4	132.8	351.6	262.2	20.2	18.1	10.2	24.4	14.1	20.6	19.3	20.2	22.3	22.8	22.9	19.5	20.2	2.7	21.3	21.2	25.1	20.6	11.8	31.6	31.5	44.2	37.5	31.4	37.9	30.6	32.8	29.7	29.4	35.4	42.8	63.6	99.3	133.9	34.3	106.2	86.2	110.0	64.2	104.7	95.4	77.5	64.3	69.7	60.1	98.8	42.3	85.5	90.0	100.0	78.4	27.4	89.0	21.2	89.8	105.7	77.4	114.0	124.3	24.4	80.4	111.1	94.8	101.9	121.4	96.8	145.9	36.8	47.9	71.4	94.2	34.0	85.6	50.8	55.0	68.3	21.0	76.4	75.8	39.2	24.4	66.0	69.2	92.7	31.7	28.9	88.2	55.6	62.4	124.9	144.6	38.8	47.2	82.9	103.6	32.9	100.3	80.1	137.2	120.6	113.8	77.0	70.9	103.5	140.8	111.7	94.9
ILK		ENSG00000166333	"Integrin linked kinase"	Q13418	11	6603708-6610874	"Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004041, HPA048437"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Focal adhesion sites"		NA	NA		30000000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 51: Myeloid cells - Hemostasis"	"Plasma membrane, Focal adhesion sites"	Nucleoplasm	"CAB004041: AB_2127050, HPA048437: AB_2680391"	"unprognostic (1.78e-1)"	"unprognostic (2.26e-2)"	"unprognostic (5.26e-2)"	"unprognostic (2.12e-2)"	"unprognostic (7.57e-2)"	"unprognostic (1.01e-1)"	"unprognostic (6.19e-3)"	"unprognostic (5.25e-3)"	"unprognostic (1.49e-2)"	"unprognostic (9.65e-2)"	"unprognostic (2.64e-1)"	"unprognostic (8.12e-2)"	"prognostic favorable (2.44e-4)"	"unprognostic (4.01e-3)"	"unprognostic (9.27e-2)"	"unprognostic (2.42e-1)"	"unprognostic (6.36e-3)"	108.0	77.2	49.8	85.1	52.4	43.7	91.8	51.7	50.6	151.6	55.0	398.2	66.4	359.1	81.8	115.5	164.2	88.0	175.9	47.4	50.7	78.8	65.9	107.9	72.4	51.8	50.6	101.0	89.3	73.2	47.1	98.8	50.9	182.7	116.8	28.3	69.5	412.2	90.8	61.5	117.4	364.7	51.1	95.5	149.7	26.5	53.7	45.8	72.0	92.0	70.5	226.7	118.8	51.9	127.8	94.4	148.9	51.8	224.8	159.4	67.2	182.2	360.0	211.9	256.0	102.7	145.7	47.0	47.0	304.1	206.9	99.5	84.4	155.6	213.0	83.5	74.3	69.1	84.9	82.8	150.8	55.9	74.7	153.2	72.8	143.8	108.9	217.7	206.9	40.5	63.7	55.0	282.8	97.1	49.4	97.4	94.3	107.5	110.8	51.0	77.8	50.5	160.3	100.8	25.6	57.4	86.0	118.4	103.6	144.0	82.2	62.2	238.8	263.9	118.0	111.1	90.7	38.9	25.9	67.1	195.6	82.8	125.3	314.9	260.0	417.6	127.3	258.1	124.9	96.9	114.4	122.3	242.7	92.9	70.2	88.5	165.5	257.8	254.8	98.5	142.8	402.8	49.8	52.4	51.7	50.6	47.4	50.7	51.8	50.6	50.9	51.1	53.7	51.9	79.5	44.8	17.9	24.2	33.6	50.5	73.7	100.6	24.5	21.5	43.1	68.2	0.5	70.1	49.7	57.0	8.4	119.8	46.0	71.9	58.7	136.1	64.6	33.2	78.1	69.4	37.9	53.7	14.6	125.0	177.7	83.2	50.4	52.5	30.4	41.6	76.4	31.4	127.4	8.4	17.1	50.1	69.2	51.5	97.7	143.7	71.4	115.9	85.4	30.9	143.0	54.3	77.2	15.6	15.3	117.1	60.0	147.4	35.1	42.0	74.5	98.6	31.0	32.9	157.8	53.3	165.8	31.7	17.1	32.3	43.2	110.0	49.3	65.0	50.1	43.9
ILKAP	"DKFZP434J2031, FLJ10181, PPM1O"	ENSG00000132323	"ILK associated serine/threonine phosphatase"	Q9H0C8	2	238170402-238203708	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004752, HPA056099"	Uncertain		Supported	Nucleoplasm		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"HPA004752: AB_1851753, HPA056099: AB_2797255"	"unprognostic (1.50e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.03e-1)"	"unprognostic (6.78e-2)"	"unprognostic (9.75e-2)"	"prognostic unfavorable (1.04e-4)"	"unprognostic (1.60e-1)"	"unprognostic (3.07e-2)"	"unprognostic (3.88e-2)"	"unprognostic (1.37e-3)"	"unprognostic (7.03e-2)"	"prognostic unfavorable (9.89e-6)"	"unprognostic (6.24e-2)"	"unprognostic (6.63e-2)"	"unprognostic (2.63e-2)"	"unprognostic (1.20e-1)"	20.5	17.4	24.3	15.1	25.6	29.0	19.5	26.5	26.9	26.2	22.3	30.8	14.6	25.1	15.3	23.2	23.4	8.7	24.2	23.8	24.9	26.0	26.2	18.6	20.5	24.9	24.2	24.5	20.6	13.1	26.5	12.9	24.1	25.2	12.9	13.0	17.3	14.5	41.4	22.4	23.3	16.1	23.9	25.9	21.4	23.1	24.6	17.9	23.9	18.3	18.1	26.6	21.8	27.4	40.5	25.6	36.9	36.3	28.1	18.6	37.9	41.5	27.9	40.9	35.4	23.7	20.9	25.8	10.5	30.1	48.8	33.8	48.1	34.4	41.2	46.6	49.8	66.7	26.0	52.7	43.3	43.7	50.3	19.6	23.3	43.6	43.6	20.2	31.1	34.0	52.4	16.1	35.4	48.1	43.4	58.0	34.8	37.4	25.9	52.6	75.6	23.7	30.4	18.8	54.1	26.7	28.2	29.6	68.9	27.9	23.3	43.7	28.9	39.7	36.7	53.5	45.1	28.6	31.4	46.7	32.5	47.3	34.3	43.4	19.8	27.1	28.2	25.6	25.4	24.7	24.9	26.4	27.7	24.0	28.8	22.9	7.3	24.8	21.4	20.9	30.7	23.0	24.3	25.6	26.5	26.9	23.8	24.9	24.9	24.2	24.1	23.9	24.6	27.4	27.7	12.8	22.0	43.8	35.4	27.0	29.1	30.8	25.0	28.9	19.4	21.6	23.1	17.2	19.6	25.8	29.2	41.2	51.5	22.4	43.0	27.9	8.1	17.1	20.6	21.5	19.1	64.2	37.7	28.5	43.7	26.7	29.0	16.1	33.7	43.5	22.1	19.2	34.4	38.7	33.2	24.0	16.2	17.0	22.0	12.6	28.3	24.0	30.2	25.3	34.0	25.1	57.7	36.7	72.2	24.8	16.2	29.3	33.6	29.7	24.1	33.4	19.3	28.6	32.9	29.2	47.4	54.4	70.8	29.2	28.7	40.4	36.6	23.0	27.4	23.5
ILRUN	"C6orf106, dJ391O22.4, FLJ22195"	ENSG00000196821	"Inflammation and lipid regulator with UBA-like and NBR1-like domains"	Q9H6K1	6	34587288-34696859	"Predicted intracellular proteins"	"Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 211.7"	"Cell type enhanced"	"Detected in some"		"Adipocytes: 9.9;Cardiomyocytes: 73.7;Cytotrophoblasts: 13.7;dendritic cells: 11.8;Hofbauer cells: 15.6;Syncytiotrophoblasts: 21.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034489, HPA034490"	Approved		Supported	"Nuclear speckles,Centrosome,Cytosol"		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 24: Non-specific - Transcription regulation"	"Nuclear speckles"	"Centrosome, Cytosol"	"HPA034489: AB_10669991, HPA034490: AB_2674186"	"unprognostic (3.76e-2)"	"unprognostic (2.51e-1)"	"unprognostic (7.71e-2)"	"unprognostic (1.02e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.32e-1)"	"unprognostic (8.40e-2)"	"unprognostic (9.94e-2)"	"unprognostic (7.57e-2)"	"unprognostic (5.68e-2)"	"unprognostic (3.55e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.08e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.53e-1)"	57.0	35.3	38.4	31.4	39.3	28.6	35.2	48.8	51.6	26.6	36.2	43.4	30.1	29.5	29.0	42.1	27.2	29.3	76.8	39.8	39.8	43.1	77.1	42.5	34.0	41.6	49.9	25.8	30.3	47.3	24.5	30.4	41.5	30.7	29.8	46.7	33.9	32.4	211.7	37.0	35.7	39.4	39.6	31.6	35.0	67.8	43.7	32.9	37.4	187.4	44.8	40.2	28.1	41.4	94.0	41.8	40.3	59.8	95.7	51.9	48.5	63.5	72.3	72.1	89.4	83.0	42.1	107.0	46.1	62.3	99.5	90.7	120.0	52.6	90.3	151.4	47.0	89.2	47.3	80.0	93.4	76.0	96.2	35.4	108.0	73.3	66.4	49.5	58.6	43.9	103.0	43.6	41.7	56.3	52.7	52.7	37.7	152.0	37.3	40.6	52.2	57.0	57.0	91.2	48.6	38.0	93.3	44.9	91.8	82.1	56.5	63.3	60.1	59.1	45.6	63.0	62.7	63.2	154.3	81.8	21.3	66.7	70.1	23.9	3.7	8.1	8.9	6.6	4.7	6.7	6.4	7.1	4.4	8.1	3.5	5.5	4.6	6.2	8.3	2.2	10.0	5.7	38.4	39.3	48.8	51.6	39.8	39.8	41.6	49.9	41.5	39.6	43.7	41.4	9.9	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	73.7	0.0	0.0	0.0	0.0	13.7	11.8	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	8.6	7.0	0.0	0.0	0.0	0.0	0.0	0.0	15.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.9	0.0	0.0	0.0	0.0	21.6	1.6	0.0	0.0	0.0
IMPDH1	"LCA11, RP10, sWSS2608"	ENSG00000106348	"Inosine monophosphate dehydrogenase 1"	P20839	7	128392277-128410252	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"	"GMP biosynthesis, Purine biosynthesis"	"DNA-binding, Oxidoreductase, RNA-binding"	"Disease variant, FDA approved drug targets, Leber congenital amaurosis, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"retina: 106.2"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 165.8;Cone photoreceptor cells: 141.8;Horizontal cells: 121.1;Rod photoreceptor cells: 205.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"classical monocyte: 89.1;eosinophil: 89.1;intermediate monocyte: 104.5;myeloid DC: 59.9;neutrophil: 197.5;non-classical monocyte: 135.9"	"Group enriched"	"Detected in all"	5	"dendritic cells: 59.9;granulocytes: 197.5;monocytes: 135.9"	"Cell line enhanced"	"Detected in all"		"SK-BR-3: 374.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001400	Approved		Supported	"Cytosol,Rods & Rings"		NA	NA		17000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 79: Retina - Phototransduction"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 56: Bipolar cells - Visual perception"	Cytosol	"Rods & Rings"	"HPA001400: AB_1079139"	"unprognostic (2.84e-1)"	"prognostic unfavorable (3.87e-4)"	"unprognostic (2.23e-2)"	"unprognostic (6.45e-2)"	"prognostic unfavorable (7.31e-5)"	"unprognostic (6.03e-2)"	"prognostic unfavorable (1.12e-7)"	"unprognostic (1.24e-1)"	"unprognostic (7.45e-3)"	"unprognostic (1.03e-2)"	"unprognostic (1.79e-1)"	"unprognostic (2.50e-1)"	"prognostic unfavorable (1.78e-12)"	"unprognostic (1.65e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.10e-1)"	"prognostic unfavorable (3.72e-5)"	54.8	15.9	19.2	33.8	18.5	44.1	38.7	15.7	23.7	18.5	12.7	24.8	8.3	15.1	2.5	30.0	17.7	11.9	23.7	18.1	17.8	15.8	5.7	31.7	25.5	26.3	18.7	20.5	30.1	5.3	26.7	11.4	25.6	27.8	9.8	106.2	29.5	13.1	4.7	23.2	19.1	19.6	17.1	55.9	48.9	16.5	20.0	8.4	11.5	6.2	15.9	29.4	20.4	17.1	111.5	93.2	13.8	102.8	56.5	40.7	38.8	74.1	46.4	61.9	40.1	68.3	35.0	70.8	24.7	111.1	64.4	83.3	78.6	104.1	30.9	25.8	87.1	46.4	66.8	49.1	51.4	62.1	21.1	49.4	49.5	63.2	62.5	29.2	74.5	42.0	46.9	51.8	21.0	76.1	44.1	164.9	77.4	87.7	108.0	51.9	25.2	150.8	27.5	35.1	58.3	55.6	48.0	374.6	68.3	8.6	42.7	119.7	68.5	103.6	37.7	55.0	53.6	38.5	38.3	90.6	53.0	134.0	64.6	11.2	89.1	89.1	22.7	104.5	24.4	15.5	17.9	20.2	59.9	8.9	10.3	12.7	197.5	11.7	135.9	6.0	21.5	58.3	19.2	18.5	15.7	23.7	18.1	17.8	26.3	18.7	25.6	17.1	20.0	17.1	66.8	0.0	11.2	4.6	13.5	8.8	9.3	13.6	9.6	165.8	12.8	9.9	5.1	2.8	8.6	5.5	141.8	3.3	11.1	6.3	5.9	8.1	0.5	4.0	10.9	20.3	9.6	9.7	8.2	17.8	21.3	15.1	44.9	6.5	21.0	46.0	13.6	1.0	46.1	121.1	11.2	10.1	28.5	58.5	21.7	2.0	4.7	38.2	16.0	3.7	65.3	27.3	24.7	2.0	1.5	10.9	3.1	6.8	29.6	21.5	0.8	1.1	7.4	205.5	0.0	9.0	17.3	2.9	16.9	15.8	7.4	2.3	20.4	18.6	11.9	10.3
IMPDH2		ENSG00000178035	"Inosine monophosphate dehydrogenase 2"	P12268	3	49024325-49029447	"Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"GMP biosynthesis, Purine biosynthesis"	"DNA-binding, Oxidoreductase, RNA-binding"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA001400, CAB020717"	Approved		Supported	"Cytosol,Rods & Rings"		NA	NA		340000	"Cluster 30: Non-specific - Translation"	"Cluster 50: Non-specific - Ribosome"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 10: Non-specific - Unknown function"	Cytosol	"Rods & Rings"	"CAB020717: , HPA001400: AB_1079139"	"unprognostic (2.09e-2)"	"unprognostic (2.91e-1)"	"unprognostic (5.96e-2)"	"unprognostic (1.20e-1)"	"unprognostic (7.31e-3)"	"unprognostic (1.56e-1)"	"prognostic unfavorable (3.22e-4)"	"unprognostic (1.30e-1)"	"unprognostic (2.65e-1)"	"unprognostic (2.17e-1)"	"unprognostic (5.44e-2)"	"unprognostic (4.24e-2)"	"unprognostic (1.30e-1)"	"unprognostic (3.85e-1)"	"unprognostic (5.80e-2)"	"unprognostic (2.24e-1)"	"unprognostic (4.47e-2)"	109.1	89.3	42.1	68.0	43.0	105.3	188.6	44.2	41.6	169.6	37.3	100.8	75.3	113.5	48.2	169.0	199.3	64.9	70.0	39.5	45.2	67.5	63.5	83.3	78.7	46.9	43.2	331.0	313.9	55.7	65.0	81.0	46.6	97.6	121.2	22.0	87.9	66.4	272.8	180.0	74.1	100.9	45.1	68.6	93.4	36.1	43.8	95.9	75.1	124.4	122.0	119.7	137.5	48.9	271.8	150.6	201.6	211.3	309.2	558.4	200.6	180.8	298.2	425.5	361.0	265.8	235.2	485.7	128.2	220.7	119.5	183.1	433.6	369.8	371.1	119.9	135.3	362.2	205.0	257.8	264.4	388.4	139.0	497.7	403.1	414.6	756.5	331.8	313.5	337.7	221.7	266.2	354.1	213.4	327.0	258.9	269.0	255.4	300.2	143.5	218.4	487.9	251.7	166.2	130.2	128.9	198.1	216.5	341.3	170.2	277.3	166.1	151.4	181.0	347.7	449.5	468.8	253.3	193.3	227.3	214.1	421.9	188.1	21.8	27.8	10.7	43.6	46.8	81.9	79.7	58.4	47.7	51.1	79.6	84.9	71.6	10.9	60.5	41.6	38.0	40.2	45.2	42.1	43.0	44.2	41.6	39.5	45.2	46.9	43.2	46.6	45.1	43.8	48.9	40.5	64.1	60.9	3.9	92.2	202.7	255.0	253.8	229.9	16.1	202.7	231.8	32.3	74.4	122.4	36.8	14.6	327.3	34.5	51.1	80.3	133.6	2.7	49.0	120.5	60.9	60.7	112.5	2.9	187.1	280.6	104.4	70.3	51.2	66.1	98.0	52.8	24.9	95.3	15.2	4.1	124.4	114.0	55.9	105.4	6.7	123.3	50.0	88.9	1.0	67.3	26.5	24.7	4.0	5.2	108.8	70.8	71.1	64.6	160.1	47.4	92.0	53.7	15.8	39.5	149.4	215.1	22.6	62.5	195.7	195.6	314.0	52.3	166.8	266.5	157.2
INAVA	"C1orf106, FLJ10901"	ENSG00000163362	"Innate immunity activator"	Q3KP66	1	200891048-200915742	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Immunity, Innate immunity"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 44.2;intestine: 55.4;skin 1: 47.0"	"Cell type enhanced"	"Detected in some"		"Ductal cells: 33.3;Endometrial ciliated cells: 26.8;Exocrine glandular cells: 45.5;Glandular and luminal cells: 25.1;Pancreatic endocrine cells: 118.6;Proximal tubular cells: 26.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BEWO: 60.3;CAPAN-2: 49.6;HaCaT: 66.0;OE19: 57.8;RPMI-8226: 54.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA027499, HPA027511, HPA079622"	Uncertain		Supported	"Nucleoplasm,Nuclear bodies"		NA	NA				"Cluster 37: Intestine - Unknown function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 1: Pancreatic cells - Digestion"	Nucleoplasm	"Nuclear bodies"	"HPA027499: AB_10599708, HPA027511: AB_10600334, HPA079622: "	"unprognostic (3.43e-2)"	"unprognostic (1.46e-2)"	"unprognostic (1.98e-1)"	"prognostic unfavorable (1.78e-5)"	"unprognostic (4.56e-2)"	"unprognostic (2.18e-1)"	"unprognostic (2.74e-2)"	"unprognostic (6.62e-3)"	"unprognostic (2.84e-2)"	"unprognostic (9.38e-2)"	"unprognostic (2.52e-2)"	"unprognostic (2.81e-1)"	"unprognostic (3.23e-3)"	"unprognostic (1.67e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.27e-1)"	"unprognostic (7.73e-2)"	0.1	0.0	1.4	4.0	1.4	4.5	1.7	0.8	1.3	8.8	1.8	33.8	47.3	1.1	0.5	44.2	4.2	16.3	0.2	1.4	1.4	15.3	0.4	3.5	0.4	1.1	1.4	0.1	13.2	0.1	0.3	1.9	1.0	7.0	30.1	0.4	12.3	2.6	0.2	47.0	55.4	1.1	1.0	0.3	27.3	1.1	1.5	0.9	0.1	0.0	5.7	17.1	20.3	1.0	27.5	40.8	23.3	0.0	0.0	0.0	60.3	0.0	0.0	0.7	0.5	43.4	49.6	0.0	13.3	0.0	1.1	66.0	0.0	17.4	0.5	0.0	5.0	3.8	1.8	17.2	0.1	8.5	0.8	0.0	26.1	0.4	1.1	0.6	0.0	0.0	0.0	0.0	0.2	0.4	0.1	1.4	45.2	57.8	9.2	0.2	9.7	54.0	24.4	34.9	0.1	2.8	2.6	41.5	0.0	27.3	17.1	7.9	0.0	0.1	10.1	0.1	2.9	46.2	20.6	0.0	0.1	8.6	2.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	1.4	1.4	0.8	1.3	1.4	1.4	1.1	1.4	1.0	1.0	1.5	1.0	0.6	12.8	7.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	2.5	3.3	0.0	0.0	5.0	14.7	0.0	7.6	0.1	0.0	5.9	33.3	0.0	26.8	2.2	0.7	0.0	0.0	0.0	45.5	13.2	0.4	0.0	25.1	1.3	0.7	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	118.6	0.0	0.0	0.0	0.0	0.0	26.0	4.4	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	3.1	0.5	0.3	0.0	0.0
INCENP	FLJ31633	ENSG00000149503	"Inner centromere protein"	Q9NQS7	11	62123998-62153169	"Predicted intracellular proteins"	"Cell cycle, Cell division, Chromosome partition, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 20.9"	"Cell type enhanced"	"Detected in many"		"Squamous epithelial cells: 15.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	7	"basophil: 1.2;NK-cell: 1.1"	"Group enriched"	"Detected in many"	7	"granulocytes: 1.2;NK-cells: 1.1"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013292, HPA051339, HPA070550"	Enhanced		Supported	"Nucleoplasm,Nuclear bodies,Kinetochore,Midbody"		Yes	Yes			"Cluster 15: NK-cells - Transcription"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Nuclear bodies, Kinetochore"	"Nucleoplasm, Midbody"	"CAB013292: AB_2533405, HPA051339: AB_2732566, HPA070550: AB_2686279"	"unprognostic (6.31e-2)"	"unprognostic (7.29e-2)"	"unprognostic (1.65e-3)"	"unprognostic (7.35e-2)"	"unprognostic (3.18e-1)"	"unprognostic (1.91e-1)"	"prognostic unfavorable (1.25e-4)"	"prognostic unfavorable (8.58e-4)"	"unprognostic (1.63e-2)"	"unprognostic (4.37e-2)"	"prognostic unfavorable (5.76e-5)"	"unprognostic (1.74e-2)"	"unprognostic (1.08e-3)"	"unprognostic (1.17e-3)"	"unprognostic (1.22e-1)"	"unprognostic (1.36e-1)"	"unprognostic (2.78e-3)"	3.1	2.5	2.7	7.5	1.1	20.9	2.8	6.2	3.0	4.6	0.0	4.8	6.8	3.0	8.1	14.0	3.5	2.2	2.8	2.9	0.5	2.4	1.9	3.0	11.6	1.6	0.8	3.8	3.1	3.1	1.5	4.1	1.3	2.5	3.6	3.4	6.1	2.9	4.2	7.9	5.7	3.4	0.1	5.5	4.5	6.4	0.5	17.8	5.1	3.4	8.2	2.8	5.5	1.2	74.3	69.4	51.6	45.5	6.8	8.4	28.1	47.6	21.2	44.4	28.3	37.0	50.7	70.0	36.2	16.0	46.2	72.6	52.2	28.4	31.8	60.5	36.6	45.7	68.0	29.6	2.7	53.5	62.1	4.3	6.5	41.3	23.6	6.8	25.8	50.2	48.8	57.6	25.3	59.7	85.0	43.3	56.2	28.0	34.4	79.3	66.4	53.4	12.0	35.8	40.1	42.2	46.8	30.8	27.9	19.8	48.2	19.4	28.5	41.8	51.9	59.8	50.0	29.7	48.3	75.8	23.5	34.7	50.6	1.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.1	0.0	0.0	0.0	0.0	2.7	1.1	6.2	3.0	2.9	0.5	1.6	0.8	1.3	0.1	0.5	1.2	1.2	3.2	2.3	1.3	3.4	5.6	0.8	1.0	2.8	2.4	1.1	0.6	1.3	0.0	3.7	0.0	0.0	4.2	4.2	5.4	0.0	1.9	1.0	2.0	2.1	1.5	0.0	10.9	3.3	2.5	7.1	1.9	9.2	2.7	3.8	5.7	0.0	0.7	4.2	0.0	2.5	3.4	0.0	0.9	1.6	0.5	2.8	3.3	3.6	1.0	5.0	1.5	3.1	2.0	1.5	2.2	1.6	1.5	10.9	1.2	1.3	0.3	2.6	2.3	0.0	1.9	4.3	6.5	7.8	15.1	3.3	2.2	3.7	1.9	4.8	1.1
ING2	"ING1L, p33ING2"	ENSG00000168556	"Inhibitor of growth family member 2"	Q9H160	4	183505058-183512429	"Predicted intracellular proteins"	"Growth regulation, Transcription, Transcription regulation"	"Chromatin regulator"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019486, HPA021517"	Supported		Supported	Nucleoplasm		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 71: Testis - DNA repair"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 40: Granulosa cells - Unknown function"	Nucleoplasm		"HPA019486: AB_1851780, HPA021517: AB_10601914"	"prognostic favorable (5.43e-4)"	"unprognostic (1.04e-1)"	"unprognostic (2.81e-1)"	"unprognostic (3.74e-2)"	"unprognostic (3.89e-3)"	"unprognostic (4.56e-2)"	"prognostic unfavorable (8.87e-4)"	"unprognostic (7.47e-3)"	"unprognostic (2.27e-1)"	"unprognostic (1.09e-3)"	"unprognostic (1.65e-2)"	"unprognostic (1.97e-1)"	"unprognostic (2.30e-3)"	"unprognostic (6.19e-2)"	"unprognostic (4.43e-1)"	"unprognostic (5.52e-2)"	"unprognostic (7.82e-2)"	9.5	42.3	5.2	5.2	5.8	21.7	8.7	6.8	6.8	7.2	5.5	9.4	10.6	5.2	10.2	14.6	8.8	8.9	7.5	5.0	9.6	12.2	10.5	8.6	5.9	6.4	6.4	37.4	15.8	6.1	23.3	6.1	6.0	8.7	6.7	8.6	10.7	4.5	26.1	12.1	14.3	4.6	4.6	9.1	11.5	33.3	8.0	12.5	9.3	14.8	6.7	11.4	9.9	5.3	19.1	11.4	15.5	12.3	28.1	16.4	12.7	20.1	17.4	15.6	13.3	10.4	20.2	13.5	5.2	14.7	12.7	8.3	10.4	15.6	19.8	10.4	7.6	23.4	11.4	13.5	8.5	19.3	25.1	12.7	14.3	17.0	7.1	12.8	7.5	13.0	13.2	49.8	11.5	18.8	24.7	19.6	12.5	5.5	11.1	10.3	8.6	22.5	18.8	8.7	15.3	11.5	13.3	17.6	5.3	10.0	8.3	13.9	6.4	10.5	16.5	7.2	13.0	10.7	8.6	9.1	19.3	14.3	7.6	15.2	6.3	19.7	3.2	6.6	5.0	11.9	6.3	5.7	7.8	8.4	8.8	7.6	6.4	3.8	8.5	7.6	5.4	3.7	5.2	5.8	6.8	6.8	5.0	9.6	6.4	6.4	6.0	4.6	8.0	5.3	18.7	6.4	21.0	6.2	20.1	49.3	20.5	20.7	105.9	25.7	36.3	41.8	12.1	25.8	18.2	16.5	12.5	26.1	18.8	32.7	74.3	20.9	68.4	93.0	26.3	21.7	18.6	26.7	7.1	34.9	94.9	29.1	11.7	82.9	40.0	85.4	15.4	24.1	30.0	25.2	5.3	24.2	16.2	24.2	43.3	35.2	82.6	27.3	26.6	1.0	13.9	40.5	6.2	3.5	5.1	33.3	28.3	53.8	19.5	34.2	112.9	47.8	39.8	23.6	19.7	23.7	28.0	95.3	74.9	71.6	46.2	21.2	25.6	50.4	23.0	39.3
ING4	"my036, p29ING4"	ENSG00000111653	"Inhibitor of growth family member 4"	Q9UNL4	12	6650301-6663142	"Predicted intracellular proteins"	"Apoptosis, Cell cycle"	"Chromatin regulator"	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031817, HPA057338"	Approved		Supported	Nucleoplasm		Yes	No			"Cluster 24: B-cells - Unknown function"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 63: NK-cells & T-cells - Immune response"	Nucleoplasm		"HPA031817: AB_2674056, HPA057338: AB_2683412"	"unprognostic (2.95e-1)"	"unprognostic (1.92e-2)"	"unprognostic (1.40e-1)"	"unprognostic (2.71e-3)"	"unprognostic (9.44e-2)"	"unprognostic (5.76e-3)"	"unprognostic (1.65e-2)"	"prognostic favorable (5.16e-4)"	"unprognostic (3.67e-2)"	"unprognostic (1.80e-1)"	"unprognostic (7.66e-3)"	"unprognostic (1.52e-1)"	"unprognostic (4.32e-2)"	"unprognostic (1.31e-1)"	"unprognostic (9.88e-2)"	"unprognostic (2.17e-1)"	"unprognostic (1.42e-2)"	22.9	26.4	43.8	15.5	44.5	11.6	27.9	45.8	51.7	34.9	40.7	33.7	17.9	27.4	30.7	22.8	27.4	18.1	23.9	44.0	43.9	29.7	25.7	18.6	27.6	44.9	44.0	31.3	19.7	32.0	27.7	21.6	44.8	33.0	21.8	22.3	25.9	23.1	19.3	31.0	26.7	22.5	44.8	37.7	26.9	20.4	44.7	38.5	34.9	23.8	24.5	29.5	27.2	49.3	9.2	12.3	35.8	17.0	27.3	26.9	22.9	12.0	19.4	19.6	23.4	5.6	41.1	15.9	7.8	16.8	15.6	14.3	17.8	14.1	21.7	31.1	26.4	22.9	22.5	11.5	16.0	9.1	10.4	27.3	32.3	10.4	13.3	63.4	29.8	30.6	10.9	8.9	19.0	6.6	33.2	13.9	52.8	20.3	11.7	30.9	18.8	17.0	24.7	10.4	14.7	38.3	18.6	6.2	23.2	51.5	8.2	25.0	22.7	8.1	16.1	9.1	7.9	10.7	15.6	21.6	21.6	14.0	8.3	32.2	31.1	26.8	33.5	43.5	31.2	30.9	27.8	28.7	34.3	48.2	37.9	32.9	20.1	38.0	51.0	26.5	30.9	37.9	43.8	44.5	45.8	51.7	44.0	43.9	44.9	44.0	44.8	44.8	44.7	49.3	20.5	22.4	19.0	15.0	26.8	8.2	11.1	19.1	13.6	31.2	22.2	27.6	10.9	17.2	17.9	18.4	18.8	43.3	37.0	14.4	29.4	25.0	2.0	17.1	21.6	22.4	25.2	18.1	23.1	8.1	11.7	21.8	10.2	14.8	27.9	40.7	20.0	8.9	24.6	35.3	23.0	18.6	30.5	16.6	12.4	6.7	34.5	27.0	10.6	13.1	32.6	34.6	52.5	18.6	20.7	11.9	16.9	37.6	11.7	11.8	21.3	24.4	12.5	26.4	32.9	13.6	21.2	20.7	19.1	9.9	10.1	30.6	22.3	31.8	14.6	9.7
INHBE	"activin, MGC4638"	ENSG00000139269	"Inhibin subunit beta E"	P58166	12	57452323-57459280	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Growth factor, Hormone"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	88	"liver: 148.4"	"Cell type enriched"	"Detected in single"	43	"Hepatocytes: 35.0"	"Cancer enriched"	"Detected in some"	27	"liver cancer: 34.4"	"Region enhanced"	"Detected in some"		"cerebellum: 1.6"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HHSteC: 50.8;Karpas-707: 79.1;RH-30: 36.9;U-266/70: 263.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA016843, CAB034017"	Enhanced		Supported	Vesicles	"Secreted to blood"	NA	NA		3500000	"Cluster 17: Basophils - Unknown function"	"Cluster 62: Liver - Hemostasis"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 2: Hepatocytes - Metabolism"	Vesicles		"CAB034017: AB_2233745, HPA016843: AB_1851796"	"unprognostic (7.34e-2)"	"unprognostic (6.73e-2)"	"unprognostic (3.45e-1)"	"unprognostic (4.69e-5)"	"unprognostic (2.61e-1)"	"unprognostic (2.50e-1)"	"unprognostic (3.13e-1)"	"unprognostic (1.24e-1)"	"unprognostic (8.79e-3)"	"unprognostic (1.44e-1)"	"unprognostic (3.22e-1)"	"unprognostic (2.70e-1)"	"prognostic unfavorable (5.66e-8)"	"unprognostic (4.09e-3)"	"unprognostic (1.56e-1)"	"unprognostic (3.57e-2)"	"unprognostic (7.52e-3)"	0.0	0.0	0.0	0.1	0.1	0.3	0.0	1.6	0.3	0.2	0.0	0.1	0.2	0.2	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.3	148.4	0.1	0.1	0.9	0.0	0.0	0.9	0.1	1.0	0.0	1.1	0.3	0.0	0.1	0.0	0.0	1.5	0.1	0.2	0.0	0.0	0.3	0.0	0.2	0.1	0.0	1.4	0.5	0.0	0.2	0.1	0.2	0.2	0.4	0.3	0.5	0.0	0.5	0.3	2.9	7.8	0.2	9.2	0.4	0.1	4.0	1.9	0.7	0.2	0.4	1.8	0.0	1.2	18.3	0.2	0.1	0.3	11.9	50.8	2.3	2.4	4.9	5.3	1.2	11.4	0.4	0.0	1.8	5.0	79.1	0.0	0.0	0.2	0.2	0.5	0.1	0.3	0.2	36.9	8.8	0.0	0.1	19.5	0.9	0.0	0.0	7.6	0.3	0.6	8.7	0.3	0.2	4.0	0.1	0.6	263.5	9.2	3.8	1.5	0.4	0.3	0.9	0.1	0.1	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.1	0.7	0.1	0.1	0.2	0.0	0.0	0.0	0.1	1.6	0.3	0.1	0.1	0.9	0.0	1.1	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	35.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.8	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1
INIP	"C9orf80, HSPC043, hSSBIP1, MISE, SOSS-C"	ENSG00000148153	"INTS3 and NABP interacting protein"	Q9NRY2	9	112683926-112718149	"Predicted intracellular proteins"	"DNA damage, DNA repair"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020382	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 34: Non-specific - Transcription"	"Cluster 16: U-266 - Nucleosome"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Nucleoplasm		"HPA020382: AB_1845840"	"prognostic unfavorable (7.08e-4)"	"unprognostic (1.67e-1)"	"unprognostic (9.64e-2)"	"unprognostic (2.35e-1)"	"unprognostic (8.05e-2)"	"unprognostic (8.56e-2)"	"unprognostic (1.01e-2)"	"unprognostic (6.29e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.11e-2)"	"unprognostic (4.47e-3)"	"prognostic favorable (2.00e-8)"	"prognostic favorable (2.53e-4)"	"unprognostic (2.28e-1)"	"unprognostic (3.50e-2)"	"unprognostic (1.26e-1)"	7.4	8.7	8.0	8.4	10.9	10.4	11.4	9.7	11.9	8.0	5.4	10.1	10.3	7.2	8.6	9.8	8.4	8.6	7.5	8.1	9.6	10.8	11.0	8.4	14.5	9.2	8.8	8.2	5.0	10.7	6.5	6.1	9.6	6.9	11.5	10.3	8.1	6.5	6.5	9.2	10.9	7.6	8.4	9.7	7.4	5.4	9.6	14.5	10.6	10.0	14.1	9.3	6.2	15.5	16.5	15.6	21.4	31.0	18.2	19.2	21.9	22.7	12.4	19.4	19.3	19.7	13.2	43.8	13.9	15.7	14.6	22.9	21.0	10.9	25.8	53.0	12.3	18.2	17.6	18.0	11.8	37.1	13.3	10.4	14.7	20.6	16.6	9.5	18.2	22.1	31.7	27.5	21.4	27.8	33.3	19.0	11.1	29.8	28.8	36.5	45.1	18.9	22.2	21.9	27.9	20.9	28.7	18.1	15.7	14.2	27.1	23.1	15.4	16.1	24.7	30.9	22.4	13.7	62.4	37.3	20.4	21.3	27.7	30.4	24.8	32.5	15.7	29.3	20.7	15.5	20.1	23.4	27.1	20.0	21.8	18.9	19.8	18.4	27.0	9.7	20.8	20.3	8.0	10.9	9.7	11.9	8.1	9.6	9.2	8.8	9.6	8.4	9.6	15.5	15.6	22.4	15.6	9.1	19.1	36.7	18.1	31.4	13.1	17.1	19.2	16.5	15.5	15.7	22.4	14.7	16.7	21.4	20.6	19.4	56.7	23.4	3.9	21.0	18.8	18.1	22.3	19.4	18.3	16.1	32.0	14.9	12.8	18.7	26.6	11.2	15.7	17.7	26.1	43.7	15.4	17.1	32.6	24.5	33.5	3.2	14.0	26.2	19.6	3.7	42.3	24.7	34.0	16.6	25.2	24.2	12.3	12.0	11.8	17.9	21.7	31.7	13.0	16.9	0.0	17.3	13.1	17.4	15.8	19.4	41.8	14.8	23.0	12.4	19.8	25.2
INKA2	"C1orf183, FAM212B, FLJ31105"	ENSG00000197852	"Inka box actin regulator 2"	Q9NTI7	1	111680630-111755824	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	8	"Hofbauer cells: 4.0"	"Cancer enhanced"	"Detected in many"		"glioma: 6.4"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	13	"neutrophil: 25.2"	"Lineage enriched"	"Detected in many"	13	"granulocytes: 25.2"	"Cell line enhanced"	"Detected in many"		"hTEC/SVTERT24-B: 35.6;U-87 MG: 73.0;WM-115: 28.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027809, HPA027810, HPA027811"	Approved		Supported	Nucleoplasm,Nucleoli,Vesicles		NA	NA			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 47: Non-specific - Unknown function"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 33: Fibroblasts - ECM organization"	Nucleoplasm	"Nucleoli, Vesicles"	"HPA027809: AB_10599616, HPA027810: , HPA027811: AB_10600872"	"unprognostic (1.92e-1)"	"unprognostic (9.70e-3)"	"unprognostic (1.84e-1)"	"unprognostic (1.85e-2)"	"unprognostic (2.81e-2)"	"prognostic favorable (4.51e-5)"	"unprognostic (9.96e-4)"	"unprognostic (1.15e-1)"	"unprognostic (1.36e-2)"	"unprognostic (9.50e-3)"	"unprognostic (9.92e-5)"	"unprognostic (8.66e-2)"	"unprognostic (1.31e-3)"	"unprognostic (2.84e-1)"	"unprognostic (1.42e-1)"	"unprognostic (3.03e-3)"	"unprognostic (5.07e-2)"	7.4	1.0	8.8	3.0	13.0	2.9	4.0	5.0	16.7	2.3	2.0	3.5	1.2	3.9	1.7	6.6	5.1	2.9	13.8	14.6	4.0	2.7	0.9	4.8	1.0	4.3	3.8	2.1	1.2	2.3	0.7	6.1	3.9	3.0	2.4	1.4	2.3	4.0	7.8	5.5	2.4	5.8	3.5	5.3	3.8	2.6	4.0	2.1	2.5	8.9	1.7	2.8	3.4	9.8	2.5	2.3	5.1	3.2	20.5	7.3	1.7	1.8	4.0	3.3	7.8	4.1	0.1	2.0	0.9	1.8	1.6	2.2	2.2	4.9	3.2	4.6	1.9	15.0	1.8	4.0	8.1	1.1	2.3	6.0	20.9	35.6	1.6	0.9	8.9	2.6	0.1	3.3	5.3	2.8	1.1	1.2	1.2	2.4	2.0	2.2	19.4	0.7	0.9	3.5	10.2	3.4	1.1	0.1	9.8	5.6	2.8	3.3	3.5	7.1	11.4	3.9	1.5	20.7	3.8	2.1	73.0	4.5	28.0	0.2	1.8	1.4	0.0	1.4	0.0	0.2	0.1	0.1	1.0	0.4	0.0	0.0	25.2	0.6	2.0	0.5	0.0	0.6	8.8	13.0	5.0	16.7	14.6	4.0	4.3	3.8	3.9	3.5	4.0	9.8	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.1	0.3	0.1	0.0	0.0	0.0	0.0	0.2	0.5	0.0	0.1	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0
INO80	"hINO80, INO80A, INOC1, KIAA1259"	ENSG00000128908	"INO80 complex ATPase subunit"	Q9ULG1	15	40978880-41116280	"Predicted intracellular proteins"	"Cell cycle, Cell division, DNA damage, DNA recombination, DNA repair, Mitosis"	"Actin-binding, DNA-binding, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041484, HPA048601"			Supported	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 15: RT4 - Unknown function"	"Cluster 52: Non-specific - Transcription"	"Nucleoplasm, Nuclear bodies"	Cytosol	"HPA041484: AB_2677506, HPA048601: "	"unprognostic (5.39e-3)"	"unprognostic (2.25e-1)"	"unprognostic (2.73e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.51e-1)"	"unprognostic (3.92e-2)"	"unprognostic (4.24e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.93e-1)"	"unprognostic (6.30e-2)"	"unprognostic (1.18e-1)"	"unprognostic (6.69e-2)"	"prognostic favorable (6.30e-4)"	"unprognostic (1.77e-1)"	"unprognostic (1.76e-1)"	"unprognostic (7.72e-2)"	"unprognostic (1.47e-2)"	9.3	6.5	5.4	7.3	5.7	15.7	8.8	10.1	5.9	8.3	5.3	9.3	7.3	8.9	4.7	9.6	7.7	5.7	6.9	5.3	5.2	7.9	7.8	9.4	9.7	5.9	5.2	9.1	6.9	10.0	5.5	6.8	5.6	7.9	8.6	5.7	7.3	6.6	15.7	10.9	8.7	8.2	5.0	8.9	7.9	7.0	5.8	10.8	8.5	9.6	10.4	9.1	8.5	7.5	13.1	12.9	10.6	10.7	16.5	13.8	11.4	12.2	18.8	17.3	15.0	14.8	10.4	14.0	8.8	17.6	21.6	24.3	19.5	20.7	19.0	17.5	10.0	18.9	17.7	11.8	15.2	17.9	16.2	13.5	18.4	13.8	36.9	11.1	16.8	14.5	20.5	11.6	12.3	10.6	13.2	11.2	11.3	20.6	13.5	19.1	11.2	11.0	12.7	26.1	14.5	9.6	9.6	18.5	7.3	10.4	10.5	19.9	19.2	14.3	11.1	17.3	19.0	12.4	9.6	22.2	16.1	24.7	11.7	0.3	1.0	0.2	0.8	0.5	0.9	1.3	0.8	0.8	0.7	1.1	1.0	1.1	0.3	2.1	0.2	0.6	0.7	0.4	5.4	5.7	10.1	5.9	5.3	5.2	5.9	5.2	5.6	5.0	5.8	7.5	23.7	9.6	25.7	27.4	27.6	8.5	16.2	7.5	23.3	30.4	18.1	15.9	25.1	14.3	16.4	16.5	22.9	13.5	25.4	17.3	7.9	17.6	2.2	17.2	21.5	17.6	13.1	23.8	54.1	13.3	12.0	16.0	32.6	28.9	15.8	18.4	13.2	10.0	9.8	26.9	47.5	11.8	2.0	14.4	6.8	3.3	14.6	18.6	7.2	25.3	20.8	12.9	19.6	43.2	53.3	15.2	16.1	15.8	19.8	21.7	9.5	11.3	16.3	33.0	6.6	28.1	21.3	19.2	24.7	28.2	12.8	19.2	25.8	25.1	13.9	15.1
INO80B	"hIes2, HMGA1L4, HMGIYL4, IES2, PAP-1BP, PAPA-1, ZNHIT4"	ENSG00000115274	"INO80 complex subunit B"	Q9C086	2	74455087-74457944	"Predicted intracellular proteins"	"DNA damage, DNA recombination, DNA repair, Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 28.0;Suprabasal keratinocytes: 31.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA070644, HPA078274"			Supported	"Nucleoplasm,Nucleoli,Nuclear bodies"		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 50: Non-specific - Ribosome"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 1: Pancreatic cells - Digestion"	Nucleoplasm	"Nucleoli, Nuclear bodies"	"HPA070644: AB_2732159, HPA078274: "	"prognostic favorable (2.89e-4)"	"unprognostic (2.24e-2)"	"unprognostic (5.62e-2)"	"unprognostic (6.59e-3)"	"unprognostic (9.45e-2)"	"unprognostic (3.82e-2)"	"unprognostic (2.20e-3)"	"unprognostic (1.21e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.54e-2)"	"unprognostic (7.52e-3)"	"unprognostic (2.18e-1)"	"prognostic unfavorable (1.56e-5)"	"prognostic favorable (8.44e-4)"	"unprognostic (1.51e-1)"	"unprognostic (3.21e-1)"	"unprognostic (1.18e-3)"	26.3	30.5	18.9	18.0	20.7	20.6	29.1	17.2	27.6	38.1	15.7	24.1	19.4	30.4	17.1	31.1	31.5	15.1	20.1	19.6	17.5	27.4	32.1	25.9	18.9	18.4	17.1	48.1	41.9	19.6	42.0	11.6	19.2	34.7	12.3	18.7	29.9	17.9	30.1	40.8	23.9	14.8	14.2	24.5	32.7	31.0	16.7	12.8	39.3	9.1	20.1	27.1	32.2	20.9	27.8	29.0	11.0	14.2	21.0	29.6	28.2	25.7	23.0	19.4	16.3	19.9	34.4	46.7	32.2	18.8	18.2	29.1	9.1	20.4	15.8	42.5	28.8	35.9	14.5	20.5	22.4	33.9	17.2	29.5	35.0	27.8	31.2	48.4	26.2	27.4	20.7	18.5	16.5	32.7	44.3	47.7	7.7	20.2	39.7	26.3	34.9	47.4	23.5	18.9	16.7	31.8	13.5	37.3	15.4	12.1	16.1	11.6	22.1	17.7	27.9	29.7	20.0	65.8	48.4	16.9	33.3	21.3	18.9	3.2	2.5	1.0	1.2	1.9	1.6	2.6	1.4	0.7	1.6	2.1	1.2	1.1	3.2	2.1	1.7	3.2	2.2	0.9	18.9	20.7	17.2	27.6	19.6	17.5	18.4	17.1	19.2	14.2	16.7	20.9	4.4	0.0	2.2	0.0	5.4	28.0	2.8	8.5	2.2	14.0	11.3	6.0	0.9	4.3	6.8	3.7	12.5	4.3	7.1	5.8	0.0	15.9	3.0	6.5	5.7	5.4	4.8	9.3	0.0	27.0	4.7	3.4	2.6	3.8	5.7	2.4	6.8	10.8	5.6	13.5	0.0	7.9	12.2	9.7	21.0	6.5	3.1	4.3	5.4	0.0	12.5	4.7	9.2	0.0	0.0	17.4	3.3	3.0	5.1	2.2	11.6	6.5	12.3	15.0	0.0	2.1	4.9	5.6	1.9	3.3	31.7	5.3	7.5	2.2	6.7	2.0
INO80E	"CCDC95, FLJ90652"	ENSG00000169592	"INO80 complex subunit E"	Q8NBZ0	16	29995715-30005793	"Predicted intracellular proteins"	"DNA damage, DNA recombination, DNA repair, Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043146	Approved		Supported	"Nucleoplasm,Nucleoli rim"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 14: REH - Unknown function"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm	"Nucleoli rim"	"HPA043146: AB_10794923"	"unprognostic (5.61e-2)"	"unprognostic (3.50e-2)"	"unprognostic (3.46e-2)"	"unprognostic (2.75e-2)"	"unprognostic (3.38e-1)"	"unprognostic (5.73e-2)"	"unprognostic (7.14e-2)"	"unprognostic (1.90e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.56e-1)"	"unprognostic (1.13e-2)"	"unprognostic (3.41e-2)"	"unprognostic (2.02e-2)"	"unprognostic (4.74e-3)"	"unprognostic (5.21e-2)"	"unprognostic (2.55e-1)"	"unprognostic (3.98e-3)"	25.9	22.7	36.6	22.1	39.0	33.1	26.4	38.8	43.1	31.6	29.1	35.3	19.9	30.8	29.2	29.7	40.8	24.8	25.3	35.7	36.3	21.9	26.4	28.7	32.9	40.3	38.9	38.0	25.5	39.9	23.2	24.8	38.0	24.1	36.5	13.4	32.4	34.7	30.9	27.6	24.0	40.3	37.1	26.5	24.8	27.8	38.3	42.5	33.3	29.7	46.8	30.8	25.5	42.5	79.1	95.1	59.6	88.0	54.0	45.6	55.0	66.9	75.2	95.4	93.8	54.7	85.7	101.6	100.4	75.3	63.0	52.9	73.8	109.8	80.0	106.7	88.8	50.2	57.7	79.0	63.5	66.4	59.5	53.5	89.1	112.1	87.6	54.9	115.4	137.5	64.4	55.6	89.9	114.7	142.0	87.2	120.3	55.4	55.1	176.9	72.6	104.7	73.2	39.5	90.8	111.3	36.8	65.1	83.7	48.9	80.8	53.0	62.5	68.0	48.3	58.7	84.6	58.9	120.2	92.9	77.3	96.2	97.9	1.5	6.1	5.1	4.3	4.1	3.6	4.5	3.4	5.0	4.9	3.3	3.2	3.3	3.0	3.5	6.8	5.1	5.2	21.4	36.6	39.0	38.8	43.1	35.7	36.3	40.3	38.9	38.0	37.1	38.3	42.5	32.8	38.5	19.6	15.0	27.6	14.8	19.1	34.0	37.0	15.1	23.5	22.6	0.8	22.8	24.1	20.2	20.9	36.9	27.6	32.9	33.2	29.3	1.9	17.1	13.3	25.4	35.2	14.9	6.6	39.3	40.1	20.2	45.9	19.2	15.8	16.4	23.9	18.9	27.8	8.4	6.9	28.4	32.6	22.4	15.0	5.2	26.1	24.0	19.6	14.0	25.2	20.4	29.9	9.0	14.4	38.0	39.7	27.8	35.2	12.4	48.2	29.8	19.7	20.9	26.3	17.3	23.1	44.4	23.3	33.6	17.2	18.1	30.9	13.9	31.6	12.4
INPP4A	INPP4	ENSG00000040933	"Inositol polyphosphate-4-phosphatase type I A"	Q96PE3	2	98444854-98594392	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 150.5;Inhibitory neurons: 124.4;Microglial cells: 73.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"Karpas-707: 67.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001628	Approved		Supported	"Nucleoplasm,Nuclear membrane"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 65: Plasmacytoid DCs - Unknown function"	"Nucleoplasm, Nuclear membrane"		"HPA001628: AB_10961254"	"unprognostic (3.45e-1)"	"unprognostic (2.39e-2)"	"unprognostic (1.74e-2)"	"prognostic unfavorable (3.70e-6)"	"unprognostic (1.58e-1)"	"unprognostic (3.10e-2)"	"unprognostic (1.15e-3)"	"unprognostic (9.44e-2)"	"unprognostic (1.37e-2)"	"unprognostic (1.23e-1)"	"unprognostic (9.65e-2)"	"unprognostic (3.70e-2)"	"unprognostic (2.90e-2)"	"unprognostic (4.89e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.08e-2)"	"unprognostic (1.97e-2)"	8.7	8.2	15.9	13.2	19.5	12.7	6.1	18.8	22.0	7.0	1.0	11.3	7.3	7.5	5.2	7.7	6.6	9.9	10.5	15.9	9.9	5.2	4.1	9.6	17.2	9.2	3.5	7.0	6.6	8.9	7.7	8.1	9.2	6.0	7.9	10.7	5.6	6.3	8.4	4.1	8.8	9.8	4.7	16.7	7.3	5.9	5.9	20.3	5.9	11.6	12.5	10.8	5.5	10.1	12.7	11.0	18.2	14.8	10.4	11.1	19.2	10.0	9.4	10.9	11.3	14.6	11.5	7.8	13.3	15.4	14.0	12.6	12.6	11.1	8.5	27.7	10.9	9.5	9.7	6.5	8.8	17.3	34.3	9.9	9.9	10.6	9.0	9.5	15.1	44.9	8.5	67.4	8.3	16.2	26.3	16.8	17.6	7.4	11.3	12.0	12.5	51.9	5.6	41.6	12.8	15.7	12.1	10.1	9.5	18.7	4.8	13.8	14.3	12.7	17.9	10.1	7.5	50.2	31.1	5.8	10.5	16.2	11.5	1.1	1.0	2.3	2.8	2.2	3.3	0.4	1.6	1.8	1.1	0.1	2.2	2.5	1.1	3.2	3.4	3.3	0.9	1.0	15.9	19.5	18.8	22.0	15.9	9.9	9.2	3.5	9.2	4.7	5.9	10.1	14.6	6.4	13.1	50.9	11.2	8.0	6.4	2.8	9.1	49.7	5.3	4.2	12.6	2.8	7.8	5.5	8.4	10.2	64.6	4.1	3.9	4.0	13.5	6.2	9.1	14.2	5.4	7.2	150.5	1.5	8.7	9.9	6.6	6.3	0.0	22.4	14.3	3.4	10.5	33.7	124.4	5.6	4.1	36.4	18.4	10.9	9.3	25.3	10.6	73.1	26.8	8.4	71.1	55.8	26.1	3.8	2.5	12.0	48.6	5.9	1.2	3.3	5.1	14.1	6.6	9.9	12.4	8.6	14.0	5.2	6.1	9.4	48.3	9.4	3.6	6.8
INPP5B		ENSG00000204084	"Inositol polyphosphate-5-phosphatase B"	P32019	1	37860697-37947057	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 47.5;Inhibitory neurons: 48.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028803	Approved		Supported	Cytosol		NA	NA		8400	"Cluster 46: Basophils - DNA binding"	"Cluster 50: Non-specific - Ribosome"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Cytosol		"HPA028803: AB_10612121"	"unprognostic (2.28e-2)"	"unprognostic (8.91e-3)"	"unprognostic (7.67e-2)"	"unprognostic (2.27e-1)"	"unprognostic (4.30e-2)"	"prognostic favorable (1.11e-4)"	"unprognostic (1.67e-2)"	"unprognostic (1.52e-2)"	"unprognostic (4.75e-2)"	"unprognostic (1.85e-1)"	"prognostic favorable (5.33e-4)"	"unprognostic (8.27e-2)"	"prognostic unfavorable (6.11e-5)"	"unprognostic (1.03e-1)"	"unprognostic (2.00e-1)"	"unprognostic (2.51e-1)"	"unprognostic (1.28e-1)"	13.3	9.3	9.5	10.3	10.7	20.7	11.9	14.7	11.8	16.1	11.5	18.7	6.9	13.9	9.9	7.2	15.7	8.4	12.8	9.2	9.3	10.8	16.2	14.7	18.5	11.5	10.2	23.9	10.5	8.9	11.9	10.4	11.4	10.9	10.0	12.5	8.4	11.1	9.1	10.8	13.4	11.9	9.0	17.3	13.7	7.0	10.5	13.4	12.2	6.0	18.7	16.8	11.7	15.3	6.8	4.6	10.7	15.7	12.3	15.8	18.5	7.5	12.5	9.6	13.2	7.2	9.4	23.2	3.6	12.9	5.0	9.1	14.3	6.0	12.8	16.2	6.3	35.8	15.4	4.9	17.7	19.0	47.4	17.8	3.7	10.2	6.6	9.4	11.0	16.4	11.7	25.6	12.4	5.3	16.7	21.4	15.5	9.5	3.9	18.7	21.3	10.9	5.5	6.2	4.3	6.8	8.8	4.2	18.9	15.7	5.2	15.8	10.6	8.8	7.9	8.5	7.1	20.8	11.8	18.3	10.1	15.8	8.1	27.3	2.9	16.5	7.0	2.3	9.9	7.1	4.8	6.7	6.1	7.6	6.1	5.8	3.7	6.2	6.0	5.4	6.8	4.9	9.5	10.7	14.7	11.8	9.2	9.3	11.5	10.2	11.4	9.0	10.5	15.3	5.7	28.9	26.3	35.3	11.8	2.2	5.8	2.1	4.0	14.7	2.2	2.3	3.2	1.5	6.4	1.8	25.0	4.1	7.9	3.9	0.0	2.4	10.7	2.3	8.4	5.9	3.5	6.5	47.5	4.4	15.4	6.3	16.8	3.3	8.2	6.9	5.3	7.8	5.2	23.5	48.5	5.0	6.1	8.1	5.4	15.9	8.4	8.3	7.2	35.6	11.3	4.6	28.8	20.1	39.4	3.0	4.7	9.1	8.5	4.5	3.5	2.6	5.8	18.9	6.6	7.7	7.1	4.6	8.1	3.4	3.3	4.7	11.2	7.7	4.7	4.1
INPP5D	"hp51CN, SHIP, SHIP1"	ENSG00000168918	"Inositol polyphosphate-5-phosphatase D"	Q92835	2	233059967-233207903	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Immunity"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 50.8;lymphoid tissue: 99.4"	"Cell type enhanced"	"Detected in many"		"B-cells: 94.5;dendritic cells: 95.8;Kupffer cells: 65.6;Microglial cells: 181.8;NK-cells: 193.6;T-cells: 60.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 44.7;HEL: 94.6;HMC-1: 94.8;hTCEpi: 87.1;NB-4: 89.4;THP-1: 62.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016300, HPA070455"	Enhanced		Supported	Cytosol		No	No		4400000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 64: Macrophages - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	Cytosol		"CAB016300: AB_628250, HPA070455: AB_2686267"	"unprognostic (5.29e-2)"	"unprognostic (2.05e-3)"	"unprognostic (1.99e-2)"	"unprognostic (6.71e-3)"	"unprognostic (1.10e-1)"	"prognostic favorable (2.03e-5)"	"unprognostic (1.57e-1)"	"unprognostic (1.08e-1)"	"unprognostic (2.29e-2)"	"unprognostic (3.74e-1)"	"unprognostic (2.56e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.14e-2)"	"unprognostic (1.66e-1)"	"unprognostic (4.82e-2)"	"unprognostic (6.58e-2)"	"unprognostic (6.54e-2)"	15.5	5.8	6.7	19.8	7.3	32.7	11.4	7.6	6.5	9.2	6.7	9.5	3.7	6.3	2.8	7.5	9.2	6.0	8.2	6.0	8.5	9.5	6.5	25.2	34.1	10.8	9.4	3.2	3.1	1.2	6.9	8.4	11.2	11.8	4.7	0.3	26.3	2.9	3.9	7.9	50.8	3.5	9.3	99.4	6.3	3.5	10.4	14.5	7.8	1.7	31.9	9.8	8.4	10.3	0.1	0.1	0.6	0.0	0.0	0.2	4.8	0.1	0.2	0.1	0.0	0.0	1.2	17.9	0.0	0.0	0.0	0.1	0.0	44.7	0.1	15.4	0.2	94.6	0.1	9.0	0.7	28.7	94.8	1.6	87.1	0.3	9.6	0.3	12.7	2.6	0.4	8.0	0.4	0.0	13.2	89.4	2.9	0.0	0.1	27.5	0.1	6.5	0.1	5.5	0.1	0.1	0.0	1.7	0.0	11.1	0.0	62.9	10.7	0.0	1.5	0.0	0.0	0.2	5.2	26.7	0.1	36.5	0.2	13.2	10.8	11.4	16.0	15.8	10.9	14.0	7.1	12.0	12.3	12.6	5.8	8.4	10.3	12.5	20.0	6.1	10.5	17.9	6.7	7.3	7.6	6.5	6.0	8.5	10.8	9.4	11.2	9.3	10.4	10.3	18.1	3.2	15.5	3.3	94.5	1.7	1.6	5.4	9.1	0.5	3.2	5.8	3.6	4.3	5.2	3.7	0.0	0.6	95.8	1.1	0.0	0.5	13.0	0.8	0.3	20.8	0.0	35.7	2.6	0.5	0.8	1.7	2.0	0.5	15.2	0.1	15.0	2.2	29.2	0.0	1.1	0.2	0.0	65.6	17.1	13.4	0.0	51.5	0.0	181.8	51.4	0.0	193.6	4.0	1.8	0.4	2.5	1.2	34.0	0.6	0.1	0.4	5.7	0.0	0.0	2.0	1.7	0.5	1.0	3.1	1.1	1.1	60.6	0.1	0.5	1.5
INPP5E	"CORS1, JBTS1, pharbin, PPI5PIV"	ENSG00000148384	"Inositol polyphosphate-5-phosphatase E"	Q9NRR6	9	136428619-136439845	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Lipid metabolism"	Hydrolase	"Ciliopathy, Disease variant, Joubert syndrome, Mental retardation, Obesity"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA065758	Approved		Approved	"Golgi apparatus,Focal adhesion sites"		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 43: Testis - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 7: Non-specific - Mitochondria"	"Golgi apparatus, Focal adhesion sites"		"HPA065758: AB_2685554"	"unprognostic (1.99e-1)"	"unprognostic (8.68e-2)"	"unprognostic (1.87e-2)"	"unprognostic (1.23e-2)"	"unprognostic (4.00e-1)"	"unprognostic (6.92e-2)"	"unprognostic (9.60e-3)"	"unprognostic (3.21e-1)"	"unprognostic (5.81e-2)"	"unprognostic (2.65e-2)"	"prognostic favorable (1.82e-4)"	"unprognostic (2.03e-1)"	"unprognostic (3.04e-2)"	"unprognostic (3.76e-1)"	"unprognostic (5.48e-2)"	"unprognostic (4.64e-1)"	"unprognostic (2.66e-2)"	12.1	10.8	15.0	6.9	15.0	6.4	11.7	15.3	19.9	15.1	11.3	13.1	5.7	15.2	2.3	10.6	17.6	5.3	13.7	14.0	14.3	13.3	12.2	11.9	8.2	15.1	13.3	16.2	10.8	6.6	14.3	5.7	15.5	12.3	3.3	7.4	9.5	5.3	8.5	11.2	11.7	5.6	11.4	20.8	8.9	20.1	14.8	6.4	15.1	3.8	4.7	12.2	12.0	13.9	8.9	10.3	12.6	13.2	6.5	7.1	14.9	10.7	5.7	7.4	5.1	12.5	6.0	10.8	10.5	11.1	11.9	25.2	6.2	8.6	2.8	36.8	25.4	8.5	27.1	8.4	10.3	9.5	11.9	10.9	8.8	9.8	7.2	10.3	8.9	14.8	14.5	14.0	7.0	22.3	11.4	19.9	8.1	5.3	16.0	21.1	8.7	8.3	7.4	9.8	14.1	12.2	10.4	8.5	7.6	7.6	15.1	15.6	11.8	24.1	9.4	10.1	18.2	11.6	10.6	4.5	12.0	7.8	9.7	0.0	0.1	0.5	0.5	0.0	0.3	0.7	0.6	0.4	0.1	0.4	0.2	0.4	0.1	0.0	0.0	0.2	0.7	0.1	15.0	15.0	15.3	19.9	14.0	14.3	15.1	13.3	15.5	11.4	14.8	13.9	14.7	3.2	6.9	17.0	5.0	5.5	1.8	2.6	5.7	7.4	6.5	6.9	5.0	7.2	3.4	3.7	2.1	2.3	7.6	4.0	1.9	4.8	0.9	11.8	8.1	7.4	6.1	0.8	12.2	5.6	2.8	5.7	3.6	6.8	8.9	8.3	6.1	3.8	3.2	15.2	12.9	2.6	6.1	3.5	3.5	1.3	7.5	3.7	5.4	6.5	3.5	8.9	1.0	8.5	8.5	6.7	1.6	5.7	2.5	3.3	3.4	2.4	10.0	10.8	0.0	5.5	7.5	15.3	9.1	5.4	4.8	0.8	5.3	5.6	3.9	1.6
INPP5F	"hSac2, KIAA0966, SAC2"	ENSG00000198825	"Inositol polyphosphate-5-phosphatase F"	Q9Y2H2	10	119726042-119829147	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 135.3"	"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 79.5;Inhibitory neurons: 130.5;Late spermatids: 88.6;Oligodendrocytes: 70.5"	"Cancer enhanced"	"Detected in all"		"testis cancer: 27.4"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"AF22: 91.4;SK-MEL-30: 149.0;SuSa: 181.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042605			Supported	Vesicles		NA	NA			"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Vesicles		"HPA042605: AB_10793886"	"unprognostic (2.65e-2)"	"unprognostic (3.23e-1)"	"unprognostic (3.42e-2)"	"unprognostic (5.84e-2)"	"unprognostic (1.87e-2)"	"unprognostic (1.57e-3)"	"unprognostic (2.46e-3)"	"unprognostic (2.21e-1)"	"unprognostic (1.12e-1)"	"unprognostic (8.09e-2)"	"unprognostic (2.09e-1)"	"unprognostic (6.46e-2)"	"unprognostic (7.78e-2)"	"unprognostic (1.02e-1)"	"unprognostic (9.91e-2)"	"unprognostic (2.96e-2)"	"unprognostic (6.21e-2)"	9.9	16.8	53.8	9.9	49.4	4.7	7.6	45.3	63.9	15.7	10.1	15.5	4.6	15.4	22.8	9.3	8.3	6.9	5.9	50.6	135.3	10.5	3.2	9.1	10.7	71.2	57.3	12.3	6.7	7.4	57.1	10.9	75.0	10.9	8.0	32.9	10.8	10.0	11.0	13.7	9.5	13.2	50.3	7.5	8.6	14.8	62.7	7.0	10.5	3.8	13.0	9.2	12.5	55.2	13.5	8.2	91.4	14.3	6.9	10.6	8.5	18.4	9.3	8.4	8.4	12.0	15.2	8.3	7.6	19.7	10.6	14.4	7.9	9.8	11.9	6.0	10.3	6.5	3.9	11.0	13.5	4.4	19.0	9.7	8.6	14.2	13.5	15.7	23.2	6.1	5.7	13.8	20.8	7.0	5.5	15.7	9.2	9.9	12.0	7.0	18.8	2.3	12.5	5.3	6.5	70.2	19.8	7.2	149.0	181.5	4.3	3.4	19.6	9.9	12.2	11.0	17.5	15.2	7.7	4.5	11.0	12.8	32.3	0.9	3.4	1.3	1.0	3.0	1.3	6.7	2.2	1.3	6.2	9.1	2.2	1.1	0.8	3.4	3.6	1.4	5.3	1.9	53.8	49.4	45.3	63.9	50.6	135.3	71.2	57.3	75.0	50.3	62.7	55.2	7.8	6.4	4.8	52.5	21.5	9.1	11.7	7.5	10.2	24.2	6.9	9.5	5.4	1.5	7.8	12.9	16.7	9.3	7.9	15.1	11.7	3.6	58.7	4.3	18.3	8.6	1.2	5.2	79.5	4.5	10.6	7.9	5.1	6.9	2.5	9.7	4.2	3.5	9.9	42.1	130.5	5.6	10.2	6.0	27.8	88.6	5.3	13.1	19.6	34.7	16.3	21.7	6.2	52.8	70.5	6.8	6.6	3.8	4.7	8.2	6.5	24.7	4.0	21.6	6.6	7.8	13.8	22.4	41.0	13.1	10.4	13.3	7.7	19.3	6.5	13.1
INPPL1	SHIP2	ENSG00000165458	"Inositol polyphosphate phosphatase like 1"	O15357	11	72223701-72239147	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Cell adhesion, Immunity"	"Actin-binding, Hydrolase"	"Cancer-related genes, Diabetes mellitus, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HeLa: 344.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037601	Approved		Supported	"Golgi apparatus,Cytosol"		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 59: Non-specific - Translation"	"Cluster 20: HeLa - Mitochondria"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Cytosol	"Golgi apparatus"	"HPA037601: AB_10672281"	"unprognostic (2.68e-1)"	"unprognostic (2.69e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.12e-1)"	"unprognostic (3.68e-3)"	"unprognostic (1.58e-1)"	"prognostic unfavorable (7.37e-4)"	"unprognostic (2.49e-2)"	"unprognostic (3.54e-2)"	"unprognostic (1.51e-2)"	"unprognostic (1.64e-1)"	"unprognostic (4.34e-2)"	"unprognostic (3.66e-2)"	"unprognostic (2.33e-1)"	"unprognostic (2.88e-1)"	"unprognostic (1.99e-3)"	"unprognostic (2.07e-1)"	45.2	56.4	39.0	34.4	43.4	51.3	44.7	41.3	40.5	63.8	47.3	87.5	35.9	56.1	18.2	34.6	61.3	33.7	73.6	33.2	42.5	60.0	36.6	61.8	36.8	53.9	43.2	68.6	55.7	36.4	60.5	39.7	45.8	68.7	23.3	14.9	53.8	39.5	116.6	31.4	57.1	33.4	45.0	66.1	60.8	24.2	48.8	19.3	67.7	43.0	23.2	59.9	43.4	41.2	28.7	62.1	71.5	49.8	35.4	41.1	122.5	118.9	61.2	80.6	49.6	84.3	72.2	79.5	125.6	101.7	57.8	106.7	60.4	37.6	28.0	101.9	59.1	84.8	344.5	31.9	68.1	56.1	176.7	58.2	39.1	78.0	31.4	100.5	44.2	29.3	59.7	34.7	45.1	78.8	42.1	224.9	67.7	20.7	93.7	185.0	161.0	18.2	94.8	48.6	33.8	48.6	133.9	85.1	182.8	36.6	88.8	106.0	74.5	86.4	96.7	129.9	43.1	94.5	17.5	80.1	24.7	51.7	47.2	2.5	3.5	3.3	1.9	2.0	1.7	0.9	1.6	1.3	2.4	1.0	1.1	1.6	2.3	2.2	3.6	1.8	1.5	1.8	39.0	43.4	41.3	40.5	33.2	42.5	53.9	43.2	45.8	45.0	48.8	41.2	13.9	3.2	12.8	47.0	8.1	7.1	4.9	10.8	14.2	1.7	20.3	17.3	13.6	11.5	11.7	12.9	27.1	27.9	9.1	28.3	1.9	11.6	1.5	14.6	16.3	11.2	22.7	5.7	2.6	12.5	15.4	10.8	24.5	25.5	7.6	21.0	8.9	12.5	21.7	10.1	2.2	16.4	18.3	27.6	16.2	2.1	9.9	29.8	10.6	18.7	17.6	16.8	14.4	15.1	6.1	14.9	17.5	13.9	7.8	7.8	15.2	16.2	10.2	17.2	6.6	12.9	14.5	1.4	4.9	6.7	4.8	32.4	11.6	10.1	21.8	5.4
INSR	CD220	ENSG00000171105	"Insulin receptor"	P06213	19	7112255-7294414	"CD markers, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins"	"Carbohydrate metabolism"	"Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Diabetes mellitus, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	8	"dendritic cells: 9.8;granulocytes: 5.9;monocytes: 12.5"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 54.9;U-266/70: 40.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036302, HPA036303"	Uncertain		Approved	"Vesicles,Plasma membrane"		NA	Yes		190000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 22: Non-specific - Unknown function"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 52: Non-specific - Transcription"	Vesicles	"Plasma membrane"	"HPA036302: AB_2675048, HPA036303: "	"unprognostic (4.64e-2)"	"unprognostic (2.42e-1)"	"unprognostic (9.65e-3)"	"unprognostic (9.70e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.15e-2)"	"unprognostic (2.58e-1)"	"unprognostic (5.09e-2)"	"unprognostic (1.97e-1)"	"unprognostic (3.05e-1)"	"unprognostic (9.29e-2)"	"unprognostic (1.86e-1)"	"unprognostic (6.33e-2)"	"unprognostic (3.45e-3)"	"unprognostic (2.43e-1)"	"unprognostic (2.75e-1)"	"unprognostic (8.82e-2)"	13.0	22.6	12.5	2.8	16.8	5.6	13.0	17.3	12.8	14.6	18.8	15.0	10.0	18.4	6.3	4.1	16.9	8.2	26.3	10.0	12.2	21.8	33.0	7.2	2.3	18.3	16.3	39.9	64.2	13.0	16.3	7.4	18.7	15.2	10.4	6.5	16.9	9.9	23.5	11.5	12.2	11.5	14.1	48.2	12.5	5.4	16.6	2.7	14.5	13.3	3.5	12.3	9.2	22.5	6.2	3.2	3.6	5.7	18.8	6.1	11.1	3.5	2.9	1.6	1.6	8.4	7.0	9.0	8.2	6.8	4.0	1.6	8.9	1.4	1.2	0.0	6.4	0.0	2.3	22.6	8.2	4.3	6.7	10.0	4.5	0.2	4.9	4.2	3.8	4.8	9.5	54.9	1.8	3.2	3.1	7.8	3.3	3.8	5.2	29.0	2.1	7.6	0.1	27.8	6.6	5.2	6.5	3.8	3.3	6.4	1.4	21.6	3.6	3.4	2.1	8.2	5.1	40.4	23.9	20.2	4.3	7.3	0.0	2.7	8.6	5.9	0.2	8.8	0.3	0.8	0.3	0.1	9.8	1.1	0.7	0.1	1.9	1.0	12.5	8.2	0.0	1.6	12.5	16.8	17.3	12.8	10.0	12.2	18.3	16.3	18.7	14.1	16.6	22.5	75.6	48.1	34.7	64.9	10.6	64.9	63.6	34.7	8.0	40.4	134.0	76.2	92.1	137.2	83.3	62.5	79.2	17.8	6.7	124.1	15.6	55.1	4.7	26.8	106.8	123.9	163.6	25.0	68.3	78.7	53.7	43.7	20.4	42.1	3.8	168.4	255.2	246.0	9.2	38.7	100.8	97.3	32.6	49.0	31.1	9.0	96.3	35.0	51.6	62.8	24.2	31.6	0.0	62.8	183.5	50.7	68.8	245.3	21.8	107.9	122.9	114.1	65.3	23.6	59.2	37.6	44.2	5.2	3.6	3.2	68.8	38.3	4.7	81.4	65.2	130.0
INTS11	"CPSF3L, CPSF73L, FLJ20542, INT11, RC-68"	ENSG00000127054	"Integrator complex subunit 11"	Q5TA45	1	1311585-1324687	"Plasma proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 77.3;Ductal cells: 56.4;Extravillous trophoblasts: 63.9;Syncytiotrophoblasts: 77.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028379, HPA029025"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 72: Non-specific - Transcription"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 7: Non-specific - Mitochondria"	Cytosol	Nucleoplasm	"HPA028379: AB_10599598, HPA029025: AB_10600425"	"unprognostic (7.54e-2)"	"unprognostic (2.14e-3)"	"unprognostic (2.33e-2)"	"unprognostic (2.56e-1)"	"unprognostic (2.99e-2)"	"unprognostic (9.34e-2)"	"prognostic unfavorable (7.44e-4)"	"unprognostic (3.97e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.75e-2)"	"unprognostic (1.33e-2)"	"unprognostic (3.08e-2)"	"unprognostic (1.72e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.76e-3)"	"unprognostic (5.14e-2)"	"unprognostic (5.62e-3)"	39.7	40.8	26.0	24.0	28.6	29.0	39.0	37.2	40.1	64.7	27.7	70.6	32.8	66.6	26.4	43.9	61.1	24.1	54.9	27.2	28.4	40.4	45.7	35.6	31.8	30.3	27.2	63.6	53.6	28.9	40.0	28.2	30.6	52.9	20.8	13.0	38.3	27.6	90.3	47.2	44.9	26.7	24.5	45.4	52.4	76.0	28.0	29.6	40.7	44.2	25.1	67.5	50.6	33.6	58.4	56.2	31.5	62.1	52.4	41.7	34.1	31.2	49.9	67.6	50.1	53.2	71.0	63.2	43.6	60.7	40.6	41.4	46.3	67.7	29.9	60.3	60.5	49.8	79.7	70.2	80.2	39.1	52.5	72.1	35.9	61.7	91.7	38.2	71.7	59.7	59.5	56.3	34.2	50.8	77.6	52.1	39.1	53.6	60.1	61.0	30.8	93.1	47.6	31.3	45.0	42.1	31.9	83.8	91.7	23.4	45.5	57.0	54.5	43.6	39.6	50.8	40.0	87.3	101.8	85.1	60.4	68.7	22.0	66.5	69.6	48.0	65.2	82.1	68.9	50.3	56.4	59.8	81.2	44.0	52.2	50.2	33.2	64.8	101.7	52.9	78.7	81.0	26.0	28.6	37.2	40.1	27.2	28.4	30.3	27.2	30.6	24.5	28.0	33.6	36.4	38.5	33.7	0.0	9.5	0.0	0.0	0.0	0.0	0.0	32.6	33.9	0.0	0.0	13.0	18.4	0.0	77.3	24.1	0.0	31.3	56.4	0.0	27.1	27.2	14.0	0.0	0.0	0.0	53.9	63.9	18.7	0.0	23.2	10.1	40.4	0.0	0.0	42.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.4	0.0	0.0	36.2	0.0	0.0	0.0	0.0	54.8	0.0	0.0	6.8	0.0	0.0	34.4	14.6	0.0	0.0	0.0	17.6	0.0	0.0	0.0	0.0	77.0	12.7	49.8	0.0	0.0
INTS12	"INT12, PHF22, SBBI22"	ENSG00000138785	"Integrator complex subunit 12"	Q96CB8	4	105682627-105895986	"Cancer-related genes, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035772, HPA041814"	Approved		Approved	"Nucleoplasm,Nuclear bodies,Plasma membrane,Cytosol"		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 10: Non-specific - Unknown function"	"Nucleoplasm, Cytosol"	"Nuclear bodies, Plasma membrane"	"HPA035772: AB_10671109, HPA041814: AB_2677687"	"unprognostic (5.30e-2)"	"unprognostic (4.54e-2)"	"unprognostic (1.84e-3)"	"unprognostic (1.78e-1)"	"unprognostic (3.68e-2)"	"unprognostic (2.58e-3)"	"prognostic unfavorable (2.67e-4)"	"unprognostic (3.95e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.53e-3)"	"unprognostic (3.00e-2)"	"unprognostic (3.48e-2)"	"unprognostic (5.93e-3)"	"unprognostic (3.62e-1)"	"unprognostic (1.37e-1)"	"unprognostic (2.16e-2)"	"unprognostic (2.06e-1)"	15.2	11.1	12.8	10.9	13.3	30.4	20.2	14.9	18.0	14.1	12.0	14.7	18.1	14.6	17.8	13.5	13.2	12.7	18.9	12.4	14.9	18.7	22.6	16.4	14.0	12.3	14.0	11.6	12.6	17.2	10.3	11.9	12.5	18.1	15.6	17.2	14.4	13.4	26.5	14.0	15.5	17.1	12.7	12.6	15.0	13.9	14.3	19.9	19.9	26.0	17.0	15.6	11.2	13.7	24.4	12.8	28.5	29.8	27.5	32.6	20.8	28.2	29.1	34.7	35.9	18.1	26.9	34.9	15.4	31.9	26.9	13.8	31.7	40.7	42.8	36.9	19.0	26.3	19.6	25.7	44.3	46.7	23.0	31.0	51.7	34.5	51.4	22.5	32.3	29.1	39.8	26.7	37.8	25.6	55.3	28.9	12.4	35.3	19.5	28.0	31.0	26.8	32.5	16.3	30.7	24.6	19.8	32.6	31.0	22.4	26.4	27.2	21.3	22.7	23.3	24.8	30.5	40.8	40.9	52.2	25.3	31.5	46.0	64.0	23.7	38.5	25.7	26.6	28.9	33.0	29.4	29.4	27.7	32.1	30.6	28.3	17.9	42.9	28.3	42.6	34.8	21.9	12.8	13.3	14.9	18.0	12.4	14.9	12.3	14.0	12.5	12.7	14.3	13.7	19.0	12.8	11.8	14.0	15.1	11.0	11.8	25.8	15.4	10.5	12.1	11.7	18.7	11.5	12.9	3.7	10.4	16.1	13.6	8.3	43.0	25.2	35.8	8.1	11.2	16.8	6.0	15.6	13.8	20.3	18.6	10.8	8.6	8.7	24.7	9.9	11.7	9.3	17.8	10.1	15.7	5.2	30.5	9.0	9.5	28.4	12.2	9.8	7.2	9.4	15.5	14.0	21.6	27.2	19.1	20.5	6.8	8.2	18.9	14.2	16.5	17.1	6.2	9.3	0.0	12.9	20.1	13.4	16.2	14.1	10.4	18.3	13.0	14.9	10.2	11.0
INTS3	"C1orf60, FLJ21919, INT3, SOSS-A"	ENSG00000143624	"Integrator complex subunit 3"	Q68E01	1	153728050-153774808	"Predicted intracellular proteins"	"DNA damage, DNA repair"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"non-classical monocyte: 2.9"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA074391	Approved		Approved	Nucleoplasm,Nucleoli	"Intracellular and membrane"	NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 72: Non-specific - Transcription"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 52: Non-specific - Transcription"	Nucleoli	Nucleoplasm	"HPA074391: AB_2686685"	"unprognostic (2.36e-1)"	"unprognostic (1.94e-2)"	"unprognostic (8.75e-3)"	"unprognostic (6.97e-3)"	"unprognostic (3.26e-1)"	"unprognostic (4.48e-2)"	"unprognostic (1.71e-2)"	"unprognostic (2.85e-1)"	"unprognostic (1.75e-1)"	"unprognostic (2.45e-1)"	"prognostic favorable (5.42e-4)"	"unprognostic (1.79e-1)"	"prognostic unfavorable (1.34e-6)"	"unprognostic (1.21e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.18e-3)"	"unprognostic (8.29e-2)"	14.3	18.7	1.7	10.8	2.0	2.9	14.7	0.5	3.2	16.8	0.9	16.1	4.2	18.3	13.4	12.1	20.7	9.7	13.0	2.2	2.1	15.9	11.8	14.9	8.6	2.7	0.9	23.3	13.0	8.2	17.8	9.6	1.3	11.9	6.5	3.6	12.1	11.3	14.9	12.2	12.9	9.4	0.0	13.2	16.7	12.8	4.4	6.7	15.3	8.3	7.7	13.6	14.4	1.5	26.2	15.8	14.0	19.2	21.3	17.4	19.1	18.2	8.7	21.7	17.4	8.5	24.5	21.3	37.8	24.2	11.8	27.0	28.0	18.7	10.2	24.6	23.0	15.4	37.7	3.8	13.8	18.8	20.5	12.3	7.5	9.5	11.7	17.5	14.4	13.8	19.2	14.6	9.0	8.5	18.6	10.0	23.6	25.5	26.8	24.5	6.4	13.1	8.1	24.7	11.8	15.5	18.9	39.7	11.4	18.4	13.3	25.3	6.1	22.7	6.7	18.1	18.1	17.1	13.7	19.5	24.9	8.9	11.3	0.0	0.8	0.9	0.9	0.5	0.8	0.3	0.3	0.5	1.2	0.3	0.2	0.5	0.8	0.7	2.9	0.3	0.5	0.2	1.7	2.0	0.5	3.2	2.2	2.1	2.7	0.9	1.3	0.0	4.4	1.5	29.1	22.4	22.8	59.7	11.9	10.5	9.5	10.4	15.9	23.7	20.2	22.4	4.6	10.0	11.7	31.3	20.9	13.9	11.6	9.2	0.0	11.9	13.1	39.3	29.4	21.5	12.1	10.9	30.8	8.4	13.4	16.3	23.9	38.8	5.7	32.9	26.7	13.9	12.2	21.9	26.1	16.5	8.2	9.1	22.0	7.6	9.6	14.6	7.2	30.0	17.6	15.4	14.4	27.2	29.7	9.9	14.9	12.0	11.6	10.6	9.8	13.3	25.9	22.4	26.3	11.2	16.5	10.2	12.2	13.9	10.2	10.3	10.0	20.2	14.0	12.2
INTS4	"INT4, MGC16733, MST093"	ENSG00000149262	"Integrator complex subunit 4"	Q96HW7	11	77878720-77994671	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042378	Uncertain		Supported	"Nucleoli rim"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 21: OE19 - Mitochondria"	"Cluster 52: Non-specific - Transcription"	"Nucleoli rim"		"HPA042378: AB_10797388"	"unprognostic (2.72e-1)"	"unprognostic (1.93e-1)"	"unprognostic (4.07e-2)"	"unprognostic (9.09e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.55e-1)"	"prognostic unfavorable (9.44e-6)"	"unprognostic (2.04e-2)"	"unprognostic (1.17e-2)"	"unprognostic (5.59e-2)"	"unprognostic (1.60e-2)"	"unprognostic (1.77e-1)"	"unprognostic (4.20e-2)"	"unprognostic (5.44e-2)"	"unprognostic (4.20e-1)"	"prognostic favorable (9.66e-4)"	"unprognostic (9.39e-2)"	12.8	16.8	13.6	12.8	15.7	18.5	13.4	19.1	14.8	16.7	13.6	13.7	9.5	12.9	11.9	13.7	13.6	9.2	12.8	13.5	15.0	14.3	18.0	12.7	16.7	15.9	14.9	17.0	17.7	11.5	13.1	11.4	16.6	15.7	11.9	14.5	13.2	9.6	11.5	14.2	15.6	10.8	15.8	21.0	13.9	9.9	15.2	17.8	13.8	7.8	16.9	14.4	14.8	21.9	11.1	18.2	23.2	27.3	18.7	16.8	19.1	13.0	14.5	16.6	14.6	37.8	30.0	19.2	27.0	23.3	25.5	27.2	25.6	25.8	26.5	28.0	16.2	29.8	24.2	22.2	17.1	30.5	17.2	17.1	13.9	33.9	29.4	18.1	26.6	20.6	28.9	28.3	25.6	23.2	28.5	49.7	22.1	40.4	19.8	27.2	21.5	36.5	20.8	22.0	16.6	24.0	23.1	15.2	9.9	26.8	28.2	16.3	17.7	22.7	30.4	60.0	16.9	30.7	32.2	40.7	8.1	20.5	22.7	12.6	14.0	7.7	12.3	15.3	17.7	12.2	12.8	14.5	15.1	13.1	17.1	13.3	3.5	17.0	14.0	6.0	17.2	11.3	13.6	15.7	19.1	14.8	13.5	15.0	15.9	14.9	16.6	15.8	15.2	21.9	5.6	9.6	3.1	18.3	15.1	4.8	7.1	8.2	8.6	13.4	5.4	6.3	5.6	10.0	6.0	5.5	16.7	13.4	18.7	5.5	5.9	7.5	5.0	6.8	5.4	7.0	1.8	9.1	20.0	4.0	11.5	7.3	8.2	5.5	12.7	12.8	5.0	3.1	10.2	5.0	19.4	6.4	6.1	8.1	4.5	4.2	6.5	7.9	7.2	20.6	14.8	7.8	13.4	26.2	30.8	6.0	7.8	4.9	7.3	4.4	11.0	6.6	8.6	16.9	6.6	10.0	11.1	12.1	17.7	7.1	2.4	11.5	13.5	8.1	6.4	5.3
INTS5	"INT5, KIAA1698"	ENSG00000185085	"Integrator complex subunit 5"	Q6P9B9	11	62646848-62653302	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046181, HPA056915"	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm	Cytosol	"HPA046181: , HPA056915: AB_2683276"	"unprognostic (2.87e-1)"	"unprognostic (9.51e-2)"	"unprognostic (9.11e-2)"	"unprognostic (9.70e-2)"	"unprognostic (2.71e-1)"	"unprognostic (6.41e-2)"	"unprognostic (1.97e-2)"	"unprognostic (5.52e-2)"	"unprognostic (1.90e-1)"	"unprognostic (5.95e-2)"	"unprognostic (2.33e-1)"	"unprognostic (5.09e-2)"	"prognostic favorable (8.44e-5)"	"unprognostic (7.08e-3)"	"unprognostic (2.97e-2)"	"unprognostic (3.36e-1)"	"unprognostic (1.35e-2)"	8.3	9.3	5.5	8.0	5.7	5.4	8.5	5.7	6.0	10.1	5.5	9.1	7.8	11.4	5.3	12.1	12.9	5.8	8.1	5.7	5.4	8.6	12.6	7.7	10.6	6.0	5.6	10.2	10.3	8.8	6.6	6.0	5.8	9.2	5.8	2.8	11.7	6.9	13.9	12.4	8.8	8.3	5.5	10.5	9.5	6.1	5.8	8.3	7.8	8.3	9.2	9.1	8.7	5.8	17.5	21.1	12.2	11.4	23.5	17.1	11.4	14.2	14.4	18.7	13.4	15.1	19.0	33.1	25.0	18.0	15.5	26.7	24.6	32.9	9.0	20.8	17.1	17.2	15.8	10.2	21.2	19.0	15.7	19.9	25.3	20.1	17.1	14.2	18.8	14.5	26.6	18.9	16.3	35.8	22.0	22.1	18.7	20.7	26.4	22.2	16.5	39.9	14.3	11.3	16.4	13.8	15.9	22.0	22.2	8.6	31.3	12.9	15.7	17.8	13.6	27.6	12.9	26.5	21.9	23.8	20.5	14.3	17.2	4.3	5.3	3.9	6.4	3.5	10.1	4.1	5.9	5.7	5.5	5.0	6.9	6.4	1.9	7.7	4.1	5.5	4.6	6.3	5.5	5.7	5.7	6.0	5.7	5.4	6.0	5.6	5.8	5.5	5.8	5.8	5.0	3.2	7.8	2.3	8.8	2.2	7.1	8.2	4.6	7.5	6.6	6.3	3.1	7.2	9.3	3.7	0.0	14.0	10.7	4.8	11.7	12.0	6.4	5.7	5.0	6.9	6.7	2.5	2.0	10.6	9.3	5.2	4.1	4.4	8.9	6.7	9.7	11.5	8.7	10.1	2.1	7.9	8.2	7.0	3.1	8.9	6.5	4.3	0.0	1.9	12.6	10.4	8.2	2.0	1.0	9.7	2.2	7.9	7.3	8.5	8.7	10.2	13.2	3.8	13.1	5.1	8.6	10.8	11.3	5.4	4.1	19.8	6.8	9.1	7.6	5.9
INTS6	"DBI-1, DDX26, DDX26A, DICE1, HDB, INT6, Notchl2"	ENSG00000102786	"Integrator complex subunit 6"	Q9UL03	13	51354077-51454264	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Skeletal myocytes: 374.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001552, HPA001846"	Supported		Supported	"Nucleoplasm,Actin filaments"		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm	"Actin filaments"	"HPA001552: AB_1078659, HPA001846: AB_1847669"	"unprognostic (1.99e-1)"	"unprognostic (4.81e-2)"	"unprognostic (3.58e-2)"	"unprognostic (4.94e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.14e-1)"	"unprognostic (3.19e-2)"	"unprognostic (6.70e-2)"	"unprognostic (9.16e-2)"	"unprognostic (3.32e-2)"	"unprognostic (3.18e-2)"	"unprognostic (2.80e-1)"	"unprognostic (5.83e-2)"	"unprognostic (2.36e-1)"	"unprognostic (6.26e-2)"	14.0	14.8	7.7	16.6	9.1	15.0	11.8	17.8	10.0	12.8	11.1	12.1	11.2	14.8	11.6	19.7	10.5	14.0	14.0	9.5	9.0	12.9	28.2	10.0	20.9	9.1	8.2	13.7	37.9	15.9	9.4	14.8	10.1	10.7	10.9	18.9	11.5	9.7	8.4	15.2	13.1	13.4	8.2	15.2	15.4	62.1	8.3	20.7	15.7	16.7	17.3	16.0	11.7	18.2	17.6	13.8	32.8	17.2	17.2	40.6	17.8	36.3	33.5	35.9	25.1	16.2	46.9	20.3	8.5	26.3	22.7	31.0	45.2	20.0	50.6	39.3	12.6	38.7	21.9	19.1	41.6	43.4	33.6	25.3	36.5	33.7	50.7	46.1	31.3	25.5	24.1	30.2	35.9	13.3	26.9	26.8	23.5	51.6	12.4	20.2	23.4	20.3	26.8	11.6	18.2	18.0	36.5	30.2	24.3	24.2	15.4	41.5	17.7	22.1	15.2	23.6	20.8	26.5	21.7	33.0	18.2	22.7	39.2	8.0	2.0	3.2	5.9	1.3	6.7	3.9	4.0	5.0	2.1	4.0	5.6	6.5	5.5	5.0	1.5	4.6	5.0	2.4	7.7	9.1	17.8	10.0	9.5	9.0	9.1	8.2	10.1	8.2	8.3	18.2	241.6	25.6	49.5	75.4	121.4	76.3	68.7	12.0	162.8	58.3	157.5	215.6	78.4	47.1	18.3	22.0	118.9	81.4	164.8	107.2	15.6	23.4	94.3	48.4	67.4	94.5	76.0	29.5	82.2	26.3	47.5	127.4	61.7	64.5	48.2	71.4	57.8	37.3	34.8	45.4	66.7	94.8	12.2	44.2	60.1	81.3	44.1	97.5	23.2	78.7	33.3	55.9	53.5	94.0	118.9	25.9	59.7	31.6	90.9	53.7	77.1	11.9	12.9	74.9	26.3	374.7	119.4	122.4	40.5	161.3	72.5	73.7	137.8	66.5	90.3	68.0
INTS7	"C1orf73, DKFZP434B168, INT7"	ENSG00000143493	"Integrator complex subunit 7"	Q9NVH2	1	211940399-212035557	"Predicted intracellular proteins"	"DNA damage"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Late spermatids: 35.6;Oligodendrocytes: 46.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA072611			Supported	"Nuclear bodies"		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Nuclear bodies"		"HPA072611: AB_2732204"	"unprognostic (1.25e-1)"	"unprognostic (2.92e-1)"	"unprognostic (1.81e-1)"	"unprognostic (2.63e-2)"	"unprognostic (4.26e-2)"	"unprognostic (5.74e-2)"	"unprognostic (1.65e-2)"	"unprognostic (4.66e-3)"	"unprognostic (2.80e-3)"	"unprognostic (1.37e-2)"	"unprognostic (9.80e-2)"	"unprognostic (4.46e-1)"	"prognostic unfavorable (1.42e-5)"	"unprognostic (2.48e-1)"	"unprognostic (4.17e-2)"	"unprognostic (2.11e-1)"	"unprognostic (7.44e-2)"	5.5	5.1	5.4	6.3	7.1	7.9	6.7	5.8	8.5	5.1	5.3	6.3	5.8	4.6	6.6	8.2	4.5	4.5	4.7	5.3	5.7	4.4	11.1	5.1	9.1	6.0	6.1	4.3	4.7	2.7	5.6	5.8	6.8	5.5	7.6	7.8	4.2	3.1	5.4	7.6	5.4	7.1	5.5	6.0	5.3	21.4	5.7	13.6	6.6	8.5	10.2	6.4	5.5	9.0	31.1	27.2	21.4	17.1	15.3	16.7	25.7	24.9	15.8	29.2	36.8	25.8	26.4	36.0	13.1	18.1	22.7	27.9	32.2	20.0	24.2	34.8	27.5	31.3	27.9	19.0	16.6	56.3	27.9	14.9	24.1	46.8	35.4	13.8	17.7	19.5	46.8	31.2	24.3	18.1	45.6	16.1	39.2	21.3	26.8	27.9	39.7	53.0	16.9	23.2	36.1	28.2	32.4	34.7	20.6	24.7	28.9	26.7	12.6	23.7	25.5	22.0	37.5	13.5	24.3	42.8	21.0	22.8	27.2	12.6	7.3	6.1	8.7	7.5	7.3	9.4	8.7	10.4	10.9	10.9	5.2	6.4	0.8	22.2	10.0	7.6	15.0	7.6	5.4	7.1	5.8	8.5	5.3	5.7	6.0	6.1	6.8	5.5	5.7	9.0	2.4	0.0	12.0	9.1	7.3	9.9	8.2	4.6	10.8	8.5	5.9	3.7	4.9	5.7	4.6	3.7	4.2	10.5	6.9	6.7	1.9	5.1	35.0	5.1	4.9	4.6	1.2	11.6	20.4	7.0	7.9	5.7	6.6	4.5	4.5	8.1	4.6	10.8	5.5	5.0	24.5	5.6	6.1	4.7	5.1	35.6	5.0	3.8	1.8	19.7	6.2	4.2	10.3	34.7	46.6	5.5	1.9	6.8	9.1	4.2	4.4	3.3	6.2	5.6	0.0	5.4	4.5	31.5	18.8	9.9	11.9	6.8	6.7	17.7	8.3	3.9
IP6K1	"IHPK1, KIAA0263"	ENSG00000176095	"Inositol hexakisphosphate kinase 1"	Q92551	3	49724294-49786542	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040825	Approved		Supported	"Nucleoplasm,Nucleoli fibrillar center,Cytosol"		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 43: Testis - Unknown function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 9: Photoreceptor cells - Phototransduction"	"Nucleoli fibrillar center"	"Nucleoplasm, Cytosol"	"HPA040825: AB_10960426"	"unprognostic (6.18e-2)"	"unprognostic (1.33e-1)"	"unprognostic (3.58e-2)"	"unprognostic (4.71e-2)"	"unprognostic (1.99e-1)"	"prognostic favorable (2.08e-4)"	"unprognostic (9.97e-3)"	"unprognostic (8.45e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.11e-1)"	"prognostic favorable (6.85e-4)"	"unprognostic (1.29e-2)"	"prognostic favorable (5.77e-5)"	"unprognostic (8.75e-2)"	"unprognostic (1.67e-1)"	"unprognostic (9.24e-2)"	"unprognostic (1.64e-2)"	17.9	20.2	32.4	12.1	33.6	12.5	17.2	27.6	34.9	21.5	17.2	24.1	12.1	25.6	12.2	20.0	19.4	12.9	15.8	35.9	27.7	21.3	14.6	17.5	13.3	26.4	28.2	25.5	19.8	22.8	21.5	16.4	27.4	18.1	11.3	18.3	17.4	17.2	12.6	23.1	17.8	16.9	24.5	21.9	18.5	32.2	30.7	17.2	16.2	11.4	13.2	19.1	16.0	29.0	20.6	24.5	27.9	33.1	28.6	21.8	22.5	26.6	27.8	42.7	37.3	31.9	20.9	17.3	16.8	29.7	28.8	14.9	39.8	24.2	24.0	35.6	30.6	40.5	36.1	21.8	31.4	25.0	26.7	25.6	29.4	46.4	27.8	24.0	36.1	20.3	26.7	20.3	21.4	18.2	30.6	25.6	30.2	16.1	37.6	19.1	19.8	35.7	27.7	30.8	15.0	29.8	33.4	21.8	30.6	16.0	17.6	36.2	32.8	23.9	23.6	33.1	31.0	24.3	35.6	18.8	21.9	28.4	24.9	4.7	7.3	12.1	11.7	5.4	11.4	6.0	10.4	12.8	5.6	8.4	12.6	12.7	33.3	10.3	7.0	4.1	11.8	9.5	32.4	33.6	27.6	34.9	35.9	27.7	26.4	28.2	27.4	24.5	30.7	29.0	17.1	25.6	12.3	24.5	25.0	15.6	14.7	7.4	11.4	38.4	19.7	15.0	8.8	18.6	10.1	12.9	89.6	19.2	27.6	22.0	5.9	14.5	88.2	24.9	19.9	19.0	27.6	24.2	42.3	13.0	16.1	14.7	14.8	17.3	19.7	19.6	19.6	12.2	12.8	30.3	46.6	14.1	10.2	15.0	14.2	23.7	21.1	17.8	19.6	31.9	15.9	19.6	35.0	43.7	39.8	19.2	8.8	16.6	28.9	19.6	14.6	12.5	21.8	78.3	19.7	16.2	18.3	24.6	21.9	13.7	18.8	27.5	27.6	30.5	12.8	20.4
IPO11	RanBP11	ENSG00000086200	"Importin 11"	Q9UI26	5	62403972-62628582	"Plasma proteins, Predicted intracellular proteins, Transporters"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 68.4;Hepatic stellate cells: 65.0;Inhibitory neurons: 55.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"NK-cell: 22.7"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HUVEC TERT2: 113.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA065346, HPA067097"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Nucleoplasm	Cytosol	"HPA065346: , HPA067097: AB_2685776"	"unprognostic (9.29e-2)"	"unprognostic (2.88e-2)"	"prognostic favorable (1.70e-4)"	"unprognostic (1.01e-1)"	"unprognostic (3.35e-2)"	"unprognostic (9.21e-2)"	"prognostic unfavorable (4.28e-5)"	"unprognostic (4.26e-2)"	"unprognostic (6.45e-2)"	"unprognostic (1.26e-3)"	"unprognostic (9.63e-2)"	"unprognostic (5.09e-2)"	"unprognostic (8.38e-3)"	"unprognostic (1.62e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.24e-2)"	16.0	9.1	13.4	9.7	13.7	6.6	14.4	13.6	14.6	10.6	16.3	9.2	6.9	9.4	8.5	12.0	10.2	10.7	14.7	14.7	13.7	11.9	11.4	7.7	10.4	14.1	13.7	9.4	8.6	13.4	6.0	16.5	13.6	9.0	8.6	6.3	8.5	8.4	12.6	8.8	7.9	11.0	14.4	13.4	8.5	21.4	13.9	10.0	14.0	14.4	10.1	13.4	9.9	15.7	27.1	25.4	22.3	34.6	17.0	23.4	30.9	28.4	20.5	29.1	31.9	27.5	20.2	45.3	22.2	28.9	35.5	21.4	47.3	32.0	45.6	17.5	24.6	21.6	24.5	24.4	12.8	23.7	11.6	16.7	17.7	34.3	35.7	13.7	113.8	22.4	41.5	14.5	27.9	26.0	26.1	32.2	28.0	15.4	14.5	31.6	33.7	41.6	17.7	26.4	24.1	13.9	24.8	19.3	21.0	21.9	24.9	17.0	51.8	17.4	19.3	19.8	26.4	11.3	20.0	31.3	21.2	33.4	21.3	16.5	2.4	2.2	3.8	3.8	4.5	3.3	3.9	3.9	4.0	4.8	5.5	4.0	2.5	22.7	7.0	2.4	2.8	3.6	13.4	13.7	13.6	14.6	14.7	13.7	14.1	13.7	13.6	14.4	13.9	15.7	39.6	9.6	3.7	35.9	11.8	8.5	4.2	3.3	13.6	4.2	6.2	4.8	13.2	5.7	4.5	7.3	2.1	7.6	7.9	2.7	3.9	4.2	42.2	8.4	7.0	40.0	3.0	21.7	68.4	5.5	6.7	7.6	6.1	5.6	13.3	9.6	65.0	6.2	5.2	5.0	55.0	4.4	2.0	6.5	6.4	25.3	5.6	7.4	3.6	20.6	2.6	3.9	10.3	28.1	48.3	3.3	1.7	4.1	10.7	5.2	2.6	3.6	25.6	4.9	6.6	9.7	8.7	14.6	16.2	10.9	8.8	5.1	8.8	4.6	5.7	4.8
IPO5	"IMB3, KPNB3, MGC2068, Pse1, RANBP5"	ENSG00000065150	"Importin 5"	O00410	13	97953658-98024296	"Plasma proteins, Predicted intracellular proteins, Transporters"	"Host-virus interaction, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 209.8"	"Group enriched"	"Detected in all"	11	"Early spermatids: 1152.2;Late spermatids: 2185.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009110, HPA040983, HPA056548"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA		790000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 31: Spermatids - Spermatogenesis"	Cytosol	Nucleoplasm	"CAB009110: AB_2264985, HPA040983: AB_2677236, HPA056548: AB_2683169"	"unprognostic (5.20e-2)"	"unprognostic (6.94e-2)"	"unprognostic (9.47e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.96e-3)"	"unprognostic (2.16e-3)"	"unprognostic (2.19e-2)"	"unprognostic (5.27e-3)"	"unprognostic (6.19e-2)"	"unprognostic (2.51e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.06e-1)"	"unprognostic (9.64e-2)"	"unprognostic (1.82e-1)"	"unprognostic (2.40e-1)"	"unprognostic (1.66e-1)"	"unprognostic (2.73e-1)"	53.0	27.4	20.2	37.8	26.8	37.6	44.9	20.3	31.9	46.3	14.9	36.9	23.9	45.2	27.3	41.7	45.1	30.1	60.5	28.2	20.0	44.4	42.6	28.6	42.9	20.9	20.0	76.4	63.3	36.8	17.1	36.1	20.5	35.4	40.0	41.4	31.5	47.1	135.1	25.8	24.9	57.9	21.7	30.0	31.8	209.8	18.6	48.5	55.3	115.6	54.8	45.6	23.7	29.2	168.9	111.8	205.0	188.7	136.4	344.0	124.7	241.8	190.3	334.3	235.7	231.4	127.0	485.4	82.3	294.2	75.4	142.5	430.0	166.6	456.6	123.6	135.8	265.1	197.4	183.0	97.4	287.3	90.8	194.5	107.6	271.9	225.4	142.3	193.3	147.0	186.3	63.9	288.1	46.8	219.2	78.4	206.0	253.3	132.3	277.9	232.5	143.4	79.6	109.3	151.0	123.5	123.8	143.6	90.9	247.2	109.5	156.9	137.4	224.0	111.8	113.6	223.3	84.2	102.9	146.8	230.4	179.6	156.9	0.5	5.0	1.3	7.0	8.2	12.3	7.8	8.3	9.1	11.7	7.6	11.5	9.7	0.4	11.4	5.8	5.7	9.3	6.8	20.2	26.8	20.3	31.9	28.2	20.0	20.9	20.0	20.5	21.7	18.6	29.2	27.0	19.2	27.8	27.7	27.0	41.4	45.9	24.3	44.3	32.9	29.9	22.4	76.6	40.0	22.3	22.0	6.2	41.0	19.9	14.5	27.4	31.8	1152.2	24.9	37.5	39.5	35.3	72.8	53.4	42.3	47.5	45.1	21.4	29.3	14.5	75.6	32.9	44.2	23.9	63.9	39.5	24.8	18.3	33.3	31.6	2185.2	52.8	24.7	26.6	14.0	28.4	44.3	16.5	27.6	36.1	35.3	11.9	44.0	46.5	79.4	9.5	42.7	20.7	22.6	26.3	63.7	49.0	142.9	57.8	40.7	36.9	32.3	23.6	47.2	41.1	39.7
IPO7	"Imp7, RANBP7"	ENSG00000205339	"Importin 7"	O95373	11	9384652-9448127	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transporters"	"Host-virus interaction, Protein transport, Transport"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019002, HPA056590"	Approved	Approved	Supported	Nucleoplasm,Cytosol		NA	NA		220000	"Cluster 27: Non-specific - Gene expression"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	"Nucleoplasm, Cytosol"		"HPA019002: AB_1856059, HPA056590: AB_2683180"	"unprognostic (1.92e-1)"	"prognostic unfavorable (4.98e-4)"	"unprognostic (9.50e-2)"	"unprognostic (1.27e-1)"	"unprognostic (3.68e-1)"	"unprognostic (1.60e-2)"	"prognostic unfavorable (6.57e-4)"	"unprognostic (1.19e-2)"	"unprognostic (7.60e-2)"	"unprognostic (2.12e-1)"	"prognostic unfavorable (8.38e-6)"	"unprognostic (3.06e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.13e-1)"	"unprognostic (8.08e-2)"	"unprognostic (2.17e-1)"	"unprognostic (3.90e-3)"	37.9	29.1	24.1	31.3	25.7	22.7	40.4	27.3	30.7	35.7	27.5	34.6	27.2	33.9	29.2	37.9	31.3	31.8	50.4	23.2	28.0	41.4	38.5	28.9	30.1	27.6	27.4	33.1	33.8	38.9	13.0	41.1	27.3	32.1	34.1	47.8	33.3	33.2	110.3	25.3	26.0	43.4	26.8	22.9	25.6	12.7	27.4	31.8	54.0	93.4	34.8	51.8	22.8	29.9	148.7	110.8	130.6	104.4	129.4	165.7	104.4	176.0	112.4	127.1	136.4	99.1	132.6	138.1	62.5	136.3	115.5	113.5	187.5	136.7	210.7	66.3	154.5	114.3	118.8	100.1	80.7	177.0	83.3	106.7	144.8	84.0	195.6	129.5	152.8	46.7	174.7	80.5	167.9	60.3	107.5	86.3	129.0	136.3	130.2	111.4	205.5	63.0	105.3	137.5	51.7	101.5	78.6	153.5	129.1	103.2	70.7	87.6	120.9	155.6	107.4	162.0	190.9	23.2	95.3	93.6	102.0	93.6	86.4	0.1	1.5	0.3	1.4	2.6	2.7	1.9	1.5	2.0	3.2	1.4	1.9	1.7	0.7	3.5	3.8	1.4	1.5	1.0	24.1	25.7	27.3	30.7	23.2	28.0	27.6	27.4	27.3	26.8	27.4	29.9	41.3	67.3	71.5	19.6	46.4	144.0	103.3	44.8	68.9	40.1	65.5	42.4	131.9	25.8	59.7	35.0	58.4	52.8	39.7	27.2	33.2	34.2	4.6	55.9	92.5	55.7	31.1	50.9	43.9	42.2	63.8	58.0	47.4	99.5	37.9	56.5	25.0	46.8	35.3	35.3	49.7	38.8	32.6	48.0	92.2	7.1	28.0	56.6	39.2	17.8	39.2	31.8	13.4	28.1	44.9	45.5	32.9	35.7	47.6	150.6	26.5	45.7	48.4	39.8	13.1	96.2	71.0	21.6	19.8	82.2	147.9	36.7	37.7	49.0	50.9	127.4
IQCB1	"KIAA0036, NPHP5, SLSN5"	ENSG00000173226	"IQ motif containing B1"	Q15051	3	121769761-121835079	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cilium biogenesis/degradation"	Calmodulin-binding	"Ciliopathy, Leber congenital amaurosis, Nephronophthisis, Senior-Loken syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 155.3;Spermatogonia: 96.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-698: 131.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042028	Approved	Approved	Supported	"Microtubules,Cytokinetic bridge,Mitotic spindle"		Yes	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 34: Non-specific - Transcription"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	"Microtubules, Cytokinetic bridge, Mitotic spindle"		"HPA042028: AB_2677806"	"unprognostic (3.82e-2)"	"prognostic favorable (1.77e-4)"	"unprognostic (2.16e-1)"	"unprognostic (4.10e-2)"	"unprognostic (1.24e-2)"	"unprognostic (1.69e-2)"	"prognostic unfavorable (3.08e-5)"	"prognostic favorable (3.67e-4)"	"unprognostic (1.42e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.70e-1)"	"unprognostic (6.78e-3)"	"unprognostic (1.50e-3)"	"unprognostic (2.59e-3)"	"unprognostic (2.75e-1)"	"unprognostic (1.67e-1)"	"unprognostic (4.75e-3)"	11.6	11.2	9.6	14.7	10.0	20.4	23.1	11.0	10.5	15.7	10.8	13.0	12.0	15.5	19.7	12.5	16.6	12.1	9.7	10.1	10.1	12.2	8.9	12.3	24.3	9.7	9.5	17.9	18.3	13.9	15.3	11.5	9.5	15.9	16.2	18.9	15.6	15.5	11.4	15.5	14.1	11.8	9.7	18.3	12.3	28.9	10.4	22.1	10.5	5.7	25.7	14.2	13.7	11.0	38.3	10.1	48.9	55.5	7.5	11.6	57.2	17.4	10.8	19.7	23.8	33.6	18.1	76.8	23.9	10.1	30.2	28.7	30.5	14.5	29.3	15.1	23.8	51.2	22.2	28.7	20.0	64.1	14.8	7.4	27.2	13.7	30.3	10.2	15.2	32.4	31.0	27.9	22.3	19.3	41.7	44.5	40.1	22.6	18.1	40.4	23.4	24.9	11.4	16.9	26.0	20.9	17.3	12.2	31.3	16.0	10.8	49.4	12.9	18.5	22.4	9.1	23.4	66.4	44.9	131.2	17.9	29.0	17.1	3.2	6.6	11.7	7.2	12.3	10.5	22.8	9.8	9.0	9.6	21.6	11.5	7.2	2.8	12.2	14.1	8.7	11.7	6.4	9.6	10.0	11.0	10.5	10.1	10.1	9.7	9.5	9.5	9.7	10.4	11.0	15.8	6.4	15.0	48.3	28.4	18.9	19.2	20.0	19.9	15.2	19.6	17.3	8.4	11.5	26.5	11.0	27.1	26.6	21.9	7.7	3.9	11.1	3.7	31.1	12.7	11.2	7.2	21.5	60.1	12.9	8.2	15.4	11.7	12.6	8.8	21.9	6.8	6.2	10.5	13.5	66.8	8.6	20.3	9.8	14.1	7.4	15.5	11.3	14.2	51.5	15.8	12.8	17.5	49.3	59.5	13.9	8.2	13.5	45.2	15.7	7.9	7.5	69.2	27.7	13.1	17.8	15.9	155.3	96.5	16.2	20.6	14.1	19.9	8.4	11.9	16.3
IQGAP1	"HUMORFA01, KIAA0051, p195, SAR1"	ENSG00000140575	"IQ motif containing GTPase activating protein 1"	P46940	15	90388242-90502239	"Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction"	Calmodulin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013302, HPA014055"	Enhanced		Supported	"Plasma membrane,Cell Junctions"		NA	NA		1500000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 24: Non-specific - Transcription regulation"	"Plasma membrane, Cell Junctions"		"CAB013302: AB_2533146, HPA014055: AB_1851856"	"unprognostic (2.83e-1)"	"unprognostic (7.73e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.02e-2)"	"unprognostic (5.95e-2)"	"unprognostic (4.24e-2)"	"unprognostic (7.07e-2)"	"unprognostic (1.17e-1)"	"unprognostic (3.82e-2)"	"unprognostic (1.52e-1)"	"prognostic unfavorable (5.67e-5)"	"unprognostic (2.01e-1)"	"unprognostic (1.26e-1)"	"unprognostic (2.02e-1)"	"unprognostic (1.03e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.25e-3)"	57.3	31.1	14.4	69.3	30.0	69.7	51.6	19.8	20.5	62.0	26.9	67.1	32.3	72.2	21.3	75.6	45.1	55.0	22.9	17.0	21.5	35.6	18.8	74.2	58.9	29.0	24.6	39.6	30.1	49.7	12.1	79.8	28.1	36.2	66.9	7.1	72.2	38.0	15.0	64.9	37.9	81.3	16.5	57.7	52.6	13.0	27.9	65.4	64.3	25.4	63.4	63.5	31.4	63.4	148.9	81.5	39.8	46.6	99.3	128.4	229.6	139.7	127.0	124.7	132.4	93.6	150.5	82.7	66.2	231.5	111.4	259.2	80.6	153.5	149.5	106.4	56.6	55.5	145.8	34.3	120.2	102.9	113.6	76.2	139.5	147.2	206.5	152.7	172.8	53.0	49.0	112.8	192.3	76.5	55.4	30.8	51.6	235.8	45.6	67.5	106.5	72.1	126.9	233.8	49.5	37.3	195.1	96.9	100.7	162.8	85.1	86.5	224.2	141.1	73.4	120.4	145.6	43.3	67.0	82.4	128.3	98.5	77.5	30.6	27.5	20.0	21.8	25.2	19.3	12.6	13.5	18.9	23.3	12.5	7.9	14.0	89.9	27.6	31.0	13.8	16.1	16.9	14.4	30.0	19.8	20.5	17.0	21.5	29.0	24.6	28.1	16.5	27.9	63.4	180.9	266.0	286.3	36.2	129.2	103.0	124.9	87.7	72.8	4.6	115.1	88.4	18.0	54.3	167.2	77.3	16.7	89.7	215.3	204.5	7.9	95.9	8.8	133.8	127.9	135.7	60.7	46.7	39.7	98.7	159.4	116.5	91.7	242.0	209.3	130.2	95.3	11.6	149.0	1.7	24.4	121.1	63.1	407.5	175.1	13.2	47.8	261.6	71.2	60.9	272.2	13.5	200.8	9.5	316.0	128.1	112.1	48.2	137.3	98.6	72.7	19.6	134.2	30.2	78.9	108.8	131.0	18.9	32.6	99.3	113.4	95.6	176.8	56.0	152.0	151.5
IQSEC1	"ARF-GEP100, BRAG2, GEP100, KIAA0763"	ENSG00000144711	"IQ motif and Sec7 domain ArfGEF 1"	Q6DN90	3	12897043-13283281	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"	"Dwarfism, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 183.0;Cone photoreceptor cells: 193.9;Excitatory neurons: 191.3;Horizontal cells: 235.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BEWO: 66.5;U-266/84: 64.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038143, HPA038144"	Uncertain		Supported	"Nucleoli,Nucleoli rim,Vesicles"		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Nucleoli, Nucleoli rim, Vesicles"		"HPA038143: AB_10697241, HPA038144: AB_2675860"	"prognostic unfavorable (3.03e-5)"	"unprognostic (1.80e-1)"	"unprognostic (6.32e-2)"	"unprognostic (3.01e-1)"	"unprognostic (8.19e-3)"	"unprognostic (2.64e-3)"	"unprognostic (5.60e-2)"	"unprognostic (1.67e-1)"	"unprognostic (3.00e-1)"	"unprognostic (1.14e-2)"	"prognostic favorable (9.07e-4)"	"unprognostic (4.42e-1)"	"prognostic favorable (3.58e-6)"	"unprognostic (1.50e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.00e-3)"	"unprognostic (4.65e-2)"	26.8	38.7	37.0	19.3	49.4	54.9	19.7	13.9	85.6	20.5	0.0	19.6	7.0	19.6	7.4	9.2	19.5	11.0	35.3	42.7	19.9	16.8	30.9	28.4	24.6	48.1	14.2	21.1	19.3	30.9	18.5	19.0	50.6	22.4	7.1	56.3	15.3	13.7	34.4	12.8	22.3	12.3	4.3	46.6	17.7	10.8	17.6	14.0	16.1	27.0	16.4	19.6	15.3	55.1	10.2	13.3	11.4	12.5	9.6	12.8	66.5	10.8	9.1	7.2	5.5	9.1	8.1	21.2	12.0	20.1	7.9	5.8	9.0	5.7	5.3	14.1	19.0	12.6	8.0	38.0	10.3	0.2	5.1	13.0	10.6	14.7	8.3	9.6	6.7	8.6	36.0	20.6	5.1	31.6	8.2	13.1	12.3	7.6	26.4	11.3	3.9	29.6	4.4	12.8	9.5	18.2	7.4	27.5	6.5	10.4	11.6	8.6	17.5	7.5	19.2	6.4	1.5	43.6	64.7	8.1	14.2	6.0	6.1	4.5	2.7	3.9	2.5	2.9	1.9	5.0	1.7	1.9	1.4	4.3	1.7	2.0	8.3	1.3	2.8	4.9	1.3	2.1	37.0	49.4	13.9	85.6	42.7	19.9	48.1	14.2	50.6	4.3	17.6	55.1	29.1	3.2	17.9	59.7	45.6	11.5	7.9	7.8	12.0	110.1	16.1	15.9	183.0	21.5	10.7	3.7	193.9	9.9	48.5	3.4	7.9	6.8	2.9	7.3	13.2	29.8	10.2	46.3	191.3	12.9	42.2	22.8	8.2	5.0	15.2	21.6	24.7	42.7	22.0	235.6	128.4	13.3	4.1	60.4	42.4	4.8	16.8	34.2	7.2	78.7	36.3	16.6	45.3	67.3	78.8	7.8	3.8	22.6	23.3	19.0	3.0	5.8	29.1	123.1	26.3	24.9	30.6	2.2	1.7	3.5	7.7	21.8	24.8	45.2	8.5	13.2
IQSEC3	"KIAA1110, MGC30156"	ENSG00000120645	"IQ motif and Sec7 domain ArfGEF 3"	Q9UPP2	12	66767-178455	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"brain: 39.1"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 50.8;Excitatory neurons: 81.6;Horizontal cells: 114.4;Inhibitory neurons: 76.2;Spermatocytes: 48.6"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 3.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"HEL: 7.1;U-266/70: 9.1;U-266/84: 2.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA039025			Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 6: Brain - Smell perception"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 62: Horizontal cells - Visual perception"	"Nucleoplasm, Cytosol"		"HPA039025: AB_10672768"	"unprognostic (2.73e-2)"	"unprognostic (1.56e-2)"	"unprognostic (1.26e-2)"	"unprognostic (4.24e-3)"	"unprognostic (4.32e-2)"	"unprognostic (1.28e-1)"	"unprognostic (4.44e-2)"	"unprognostic (5.14e-2)"	"unprognostic (3.91e-1)"	"unprognostic (8.82e-3)"	"unprognostic (2.83e-3)"	"unprognostic (7.16e-2)"	"unprognostic (2.28e-2)"	"unprognostic (1.01e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.48e-2)"	"unprognostic (1.36e-2)"	4.0	0.8	6.6	0.5	8.2	0.7	1.4	17.0	39.1	2.2	0.0	0.6	0.4	2.4	0.3	0.3	3.3	1.5	1.3	9.8	5.6	2.0	0.2	2.0	0.4	5.4	2.3	1.6	0.8	0.0	8.7	0.9	1.7	1.2	0.2	7.5	0.3	2.9	1.0	0.2	0.5	1.2	4.7	0.4	0.5	1.4	8.3	3.2	0.4	0.4	0.1	0.9	1.6	15.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.1	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	9.1	2.3	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	6.6	8.2	17.0	39.1	9.8	5.6	5.4	2.3	1.7	4.7	8.3	15.9	9.9	3.2	0.0	1.6	0.0	0.3	0.0	0.0	0.6	50.8	0.1	0.1	2.2	0.0	0.0	0.0	8.4	0.0	2.1	0.1	0.0	0.0	0.8	0.1	0.9	3.3	0.0	0.0	81.6	0.0	0.0	1.3	0.0	0.2	2.5	0.1	2.2	0.4	1.6	114.4	76.2	0.0	0.0	0.8	0.6	4.3	0.6	1.4	0.0	7.5	0.1	6.6	1.0	4.5	1.4	0.2	0.0	0.0	0.0	0.1	0.7	5.2	0.0	16.1	0.0	0.5	1.1	48.6	21.8	0.1	0.1	0.0	0.5	0.1	0.2	0.1
IRAK1	"IRAK, pelle"	ENSG00000184216	"Interleukin 1 receptor associated kinase 1"	P51617	X	154010506-154019902	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Host-virus interaction, Immunity, Innate immunity"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Exocrine glandular cells: 113.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004461, HPA054476"	Supported		Supported	Nucleoplasm,Cytosol		No	No			"Cluster 15: NK-cells - Transcription"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 1: Pancreatic cells - Digestion"	Cytosol	Nucleoplasm	"CAB004461: AB_2249106, HPA054476: AB_2682501"	"unprognostic (4.46e-3)"	"unprognostic (9.32e-2)"	"unprognostic (1.71e-2)"	"unprognostic (5.04e-3)"	"unprognostic (7.09e-3)"	"unprognostic (4.43e-3)"	"prognostic unfavorable (3.03e-4)"	"unprognostic (7.89e-3)"	"unprognostic (3.36e-2)"	"unprognostic (3.69e-2)"	"unprognostic (1.95e-1)"	"unprognostic (6.64e-2)"	"prognostic unfavorable (2.06e-4)"	"unprognostic (2.76e-3)"	"unprognostic (2.36e-1)"	"unprognostic (2.21e-3)"	"unprognostic (3.04e-1)"	48.6	61.2	24.4	37.6	25.3	82.4	40.7	23.6	34.9	29.0	20.0	41.4	43.3	31.8	7.7	69.1	28.8	20.2	34.4	22.3	26.5	44.2	64.7	48.9	33.7	38.1	30.0	28.9	84.9	12.4	37.5	17.8	30.8	46.1	15.0	4.5	41.6	21.0	92.5	44.3	51.1	16.4	29.6	69.9	41.9	20.8	34.3	19.4	24.5	16.8	24.0	47.7	36.5	29.4	467.2	178.9	24.5	201.2	48.4	38.5	108.3	68.8	64.5	104.0	96.0	142.3	199.4	200.8	371.4	73.6	157.6	124.3	57.6	112.4	39.8	156.7	173.4	73.3	158.6	85.7	110.8	174.2	118.7	53.2	96.1	99.0	107.8	53.2	62.8	39.6	130.9	220.3	73.3	171.4	70.8	152.1	60.9	148.4	353.5	181.6	126.4	334.7	68.5	86.3	137.4	98.7	82.2	88.6	135.2	9.5	34.3	179.2	86.4	123.8	194.6	284.6	424.2	274.8	190.6	358.2	179.6	205.1	130.8	1.3	7.2	6.2	5.3	9.2	4.7	6.5	4.3	4.4	4.8	7.9	2.5	4.7	5.2	5.4	7.5	10.9	2.3	3.3	24.4	25.3	23.6	34.9	22.3	26.5	38.1	30.0	30.8	29.6	34.3	29.4	20.2	0.0	13.3	5.9	29.7	13.4	14.5	10.9	5.2	9.1	23.9	19.0	9.3	18.6	16.0	11.0	6.2	11.4	33.0	41.4	7.9	40.5	0.9	9.8	13.5	18.1	20.4	18.1	9.7	113.6	20.9	15.2	18.3	17.3	12.7	25.5	13.2	35.9	57.2	16.8	8.9	27.2	0.0	51.4	24.7	3.8	18.0	43.0	14.2	11.2	24.2	21.8	13.4	4.5	6.6	75.0	28.6	21.4	33.5	30.0	39.4	19.6	10.0	5.3	0.0	14.5	14.9	1.6	8.1	15.1	13.1	12.3	19.6	18.4	39.4	25.3
IRAK4	NY-REN-64	ENSG00000198001	"Interleukin 1 receptor associated kinase 4"	Q9NWZ3	12	43758944-43789543	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Immunity, Innate immunity"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-937: 56.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB016685, CAB022077"	Uncertain		Approved	Nucleoli,Microtubules,Cytosol		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 20: Retina & Lymphoid tissues - Unknown function"	"Cluster 32: U-937 - Innate immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	Microtubules	"Nucleoli, Cytosol"	"CAB016685: AB_1618505, CAB022077: "	"unprognostic (2.76e-2)"	"unprognostic (5.63e-2)"	"unprognostic (1.47e-2)"	"prognostic favorable (3.46e-5)"	"unprognostic (6.15e-2)"	"unprognostic (3.50e-3)"	"unprognostic (1.44e-2)"	"unprognostic (8.49e-2)"	"unprognostic (6.44e-3)"	"unprognostic (7.50e-2)"	"unprognostic (4.00e-3)"	"unprognostic (6.29e-2)"	"unprognostic (4.52e-2)"	"unprognostic (2.95e-1)"	"unprognostic (2.31e-1)"	"unprognostic (1.84e-1)"	"prognostic favorable (4.42e-5)"	8.6	6.5	4.0	13.6	4.6	10.0	8.9	4.5	5.1	7.9	5.1	7.9	9.1	6.8	7.0	10.5	7.0	8.8	5.4	3.9	4.6	8.0	9.2	8.5	17.5	5.5	4.7	5.6	15.1	6.9	6.2	8.3	5.4	7.5	8.4	12.3	8.4	7.0	3.0	13.3	11.9	7.2	4.8	18.6	10.5	5.8	4.9	18.5	10.9	3.2	16.3	7.8	7.9	5.3	9.3	6.8	4.7	6.2	16.5	27.6	6.7	12.9	9.1	10.0	9.1	5.8	8.7	15.8	12.4	10.7	6.6	7.5	5.3	8.3	14.2	22.8	4.9	15.2	5.2	3.7	9.4	21.2	17.7	14.7	12.7	12.7	7.4	17.4	15.0	15.1	14.4	11.6	27.8	5.1	18.6	11.7	1.7	0.0	7.9	12.2	5.8	8.4	7.8	8.8	3.4	3.3	6.3	7.9	6.2	6.4	9.9	18.5	13.4	12.2	2.3	15.1	9.0	14.0	19.4	13.7	12.7	56.2	6.9	20.8	4.0	8.7	6.1	4.6	6.3	3.3	4.9	5.3	3.7	4.4	4.4	4.8	7.9	7.9	5.9	5.1	6.7	4.6	4.0	4.6	4.5	5.1	3.9	4.6	5.5	4.7	5.4	4.8	4.9	5.3	24.1	19.2	15.6	5.2	36.5	10.8	11.3	10.7	17.1	5.8	15.2	11.2	4.5	17.2	11.3	33.1	20.9	14.9	52.1	15.7	21.5	12.7	18.4	14.1	12.4	17.3	3.6	12.0	2.9	17.8	8.4	13.7	33.6	15.2	22.1	10.7	16.1	8.7	16.9	8.4	3.4	11.9	14.2	24.7	20.2	23.2	12.5	25.1	10.6	20.6	28.2	9.9	60.8	2.5	14.7	13.3	7.2	11.3	33.2	8.9	18.6	13.8	9.5	27.2	6.6	9.5	11.0	28.2	12.5	17.2	11.8	27.9	41.1	15.0	9.2	13.5
IRF2		ENSG00000168310	"Interferon regulatory factor 2"	P14316	4	184387729-184474550	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HDLM-2: 163.6;Karpas-707: 165.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030813, CAB032306, HPA057327"	Supported		Enhanced	"Nucleoplasm,Cell Junctions,Cytosol"		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm	"Cell Junctions, Cytosol"	"CAB032306: AB_2249157, HPA030813: AB_10600718, HPA057327: AB_2683410"	"prognostic favorable (6.95e-5)"	"unprognostic (1.69e-3)"	"unprognostic (5.43e-2)"	"unprognostic (1.59e-3)"	"unprognostic (2.70e-2)"	"unprognostic (1.46e-1)"	"unprognostic (2.48e-2)"	"unprognostic (4.05e-2)"	"unprognostic (8.37e-3)"	"unprognostic (2.90e-2)"	"unprognostic (4.00e-2)"	"unprognostic (2.35e-1)"	"unprognostic (6.87e-3)"	"unprognostic (8.55e-3)"	"unprognostic (5.25e-2)"	"prognostic favorable (8.34e-5)"	"unprognostic (1.31e-3)"	25.1	30.1	18.2	47.8	23.4	18.0	21.9	22.1	19.3	25.6	21.4	27.8	31.1	21.8	22.7	26.7	25.3	24.9	19.5	17.5	21.9	18.5	37.4	27.6	62.5	25.3	22.1	28.1	14.8	20.2	12.3	28.9	25.2	20.6	28.7	9.3	29.1	21.2	28.1	19.4	33.3	23.2	21.7	54.9	31.5	6.1	23.5	49.8	21.7	23.8	52.2	35.6	22.5	29.6	20.3	14.9	17.5	12.0	37.4	37.9	10.5	14.4	44.8	34.8	36.0	4.2	37.9	12.2	7.4	21.7	28.4	18.3	12.0	27.4	22.1	163.6	6.6	34.4	7.9	26.8	37.1	21.1	27.7	41.2	24.8	19.8	50.1	29.8	26.7	14.5	6.9	165.3	14.6	14.1	40.6	25.8	4.0	18.5	10.7	52.7	6.9	55.1	26.6	30.4	7.5	11.6	20.4	16.8	31.3	7.3	13.0	18.9	22.0	9.9	10.7	11.3	12.8	47.3	40.6	11.0	20.9	20.3	17.8	106.7	95.7	175.8	76.4	126.3	77.9	104.9	74.5	82.2	79.6	107.7	78.8	78.8	407.6	94.8	145.7	20.2	111.7	100.3	18.2	23.4	22.1	19.3	17.5	21.9	25.3	22.1	25.2	21.7	23.5	29.6	58.9	38.5	24.5	53.5	68.9	49.1	50.5	60.4	45.5	13.1	25.8	27.3	21.9	27.1	36.0	25.8	6.2	31.3	48.8	40.3	37.2	30.9	0.2	53.4	40.2	42.9	30.6	62.7	23.8	30.1	16.2	35.8	34.1	63.2	26.6	23.1	38.2	37.6	48.5	20.2	27.8	29.5	44.7	90.3	53.5	3.0	37.3	65.9	19.6	41.2	144.0	23.4	70.0	43.7	77.1	28.7	38.9	53.0	63.4	72.9	42.1	46.1	58.7	8.4	39.5	25.4	44.8	0.6	2.4	49.5	44.5	26.7	56.3	37.7	22.8	70.9
IRF2BP1	"DKFZP434M154, IRF-2BP1"	ENSG00000170604	"Interferon regulatory factor 2 binding protein 1"	Q8IU81	19	45883608-45886141	"Enzymes, Predicted intracellular proteins"	"Transcription, Transcription regulation, Ubl conjugation pathway"	"Repressor, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in all"		"NB-4: 82.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042164, HPA049480"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 35: Non-specific - Unknown function"	"Cluster 24: NB-4 - Immune response"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm		"HPA042164: AB_2677882, HPA049480: AB_2680785"	"unprognostic (5.90e-2)"	"unprognostic (1.34e-1)"	"unprognostic (8.86e-2)"	"unprognostic (9.49e-2)"	"unprognostic (1.78e-1)"	"unprognostic (2.61e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.67e-1)"	"unprognostic (3.03e-1)"	"unprognostic (1.01e-1)"	"prognostic favorable (2.32e-4)"	"unprognostic (2.60e-1)"	"prognostic favorable (3.85e-5)"	"unprognostic (1.33e-2)"	"unprognostic (6.99e-2)"	"unprognostic (2.66e-1)"	"unprognostic (5.07e-3)"	11.1	15.8	12.2	4.6	11.9	3.6	12.3	13.8	15.8	17.8	3.8	17.6	7.3	20.0	3.6	11.8	16.9	3.2	16.6	12.7	10.8	14.2	21.0	8.3	5.2	15.2	11.9	21.7	15.7	7.1	20.6	3.1	11.8	15.3	2.0	4.3	13.7	6.9	22.0	14.4	13.8	3.0	10.3	13.6	16.4	9.3	11.8	6.1	12.3	7.9	2.8	15.9	12.0	14.8	18.1	27.1	6.5	14.6	5.5	3.4	10.8	13.0	7.4	10.2	8.9	10.1	8.4	14.5	9.6	6.7	6.1	16.7	4.7	4.9	3.0	18.4	46.4	14.6	7.6	13.1	11.1	15.2	13.1	4.8	6.6	5.3	3.8	6.4	6.3	17.8	23.4	11.2	4.0	14.1	31.0	82.8	12.3	6.7	23.8	35.2	7.7	12.6	7.4	9.9	19.4	33.3	13.8	17.8	17.3	2.5	14.8	27.8	9.2	8.8	17.7	6.8	18.6	30.4	36.2	8.6	11.9	14.3	13.0	0.0	0.3	0.1	0.7	0.4	0.7	0.7	0.6	0.6	0.3	0.6	0.9	0.5	0.4	0.7	0.2	0.5	0.6	0.4	12.2	11.9	13.8	15.8	12.7	10.8	15.2	11.9	11.8	10.3	11.8	14.8	6.0	0.0	1.1	2.6	8.4	10.7	5.8	4.1	14.2	15.2	13.5	11.4	1.3	11.5	2.4	11.0	0.0	10.9	8.4	8.9	13.7	7.8	2.0	6.0	6.7	6.3	9.6	10.1	2.2	9.5	6.6	8.2	7.1	6.9	0.0	8.3	7.9	9.3	5.0	10.1	3.2	11.2	0.0	2.2	8.6	1.5	18.6	5.1	8.8	3.7	4.5	10.2	5.2	2.0	3.7	7.5	11.9	10.9	2.5	7.4	9.3	13.5	3.0	7.0	19.7	10.7	11.7	3.8	2.2	8.9	11.2	8.8	7.3	9.9	8.7	3.0
IRF3		ENSG00000126456	"Interferon regulatory factor 3"	Q14653	19	49659569-49665875	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Antiviral defense, Host-virus interaction, Immunity, Innate immunity, Transcription, Transcription regulation"	"Activator, DNA-binding"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004895, CAB013018"	Approved		Supported	Cytosol		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 64: Macrophages - Immune response"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 63: NK-cells & T-cells - Immune response"	Cytosol		"CAB013018: AB_2533904, HPA004895: AB_1851887"	"unprognostic (5.75e-2)"	"unprognostic (1.46e-2)"	"unprognostic (1.26e-3)"	"unprognostic (1.59e-1)"	"unprognostic (9.17e-2)"	"unprognostic (9.60e-2)"	"unprognostic (7.85e-3)"	"unprognostic (7.91e-2)"	"unprognostic (6.98e-2)"	"unprognostic (5.52e-2)"	"unprognostic (5.02e-2)"	"unprognostic (3.85e-3)"	"prognostic unfavorable (1.56e-7)"	"unprognostic (1.61e-2)"	"unprognostic (4.98e-1)"	"unprognostic (3.47e-2)"	"prognostic favorable (3.61e-4)"	32.9	33.7	27.9	20.8	27.4	24.9	33.8	27.4	36.0	46.5	27.8	39.0	18.8	37.0	10.2	37.3	39.7	19.5	31.8	26.4	27.4	46.3	42.4	39.7	42.6	28.3	27.2	44.1	36.6	12.1	37.0	21.1	28.7	46.7	11.4	5.8	34.7	22.8	18.0	43.5	53.0	14.4	27.9	73.9	38.3	16.0	29.7	29.9	43.0	9.4	24.2	40.2	41.1	28.2	82.2	88.3	30.1	44.7	22.6	35.3	68.1	35.1	52.8	59.8	77.7	62.6	93.8	47.7	39.4	32.9	49.8	66.2	32.5	91.0	26.1	66.0	57.6	44.7	33.8	58.2	25.5	33.1	43.9	33.9	63.6	79.2	23.8	30.5	47.9	60.9	50.4	50.7	32.3	79.9	53.4	94.2	36.0	82.3	80.7	60.8	29.4	83.8	43.7	69.2	16.7	21.7	64.5	69.6	35.9	29.5	30.6	64.4	33.6	35.0	32.7	26.7	46.0	69.4	76.9	47.9	40.1	77.2	35.7	25.4	27.6	50.3	58.6	29.3	52.8	37.8	57.1	55.0	22.0	37.9	49.5	45.2	35.1	46.3	36.0	30.2	81.0	39.5	27.9	27.4	27.4	36.0	26.4	27.4	28.3	27.2	28.7	27.9	29.7	28.2	42.5	25.6	33.9	16.0	51.3	54.2	35.6	58.4	29.0	33.0	40.1	39.2	7.9	35.8	51.9	40.5	29.2	78.2	57.6	83.6	19.6	39.4	3.7	30.4	29.5	33.1	44.9	40.0	3.9	46.5	92.0	30.4	76.0	37.0	77.3	33.8	38.6	25.7	39.0	16.8	5.6	70.5	46.8	32.2	29.9	8.9	41.0	33.9	30.2	10.3	71.1	37.9	122.6	7.1	10.8	46.8	60.0	35.7	70.4	26.7	74.8	25.8	45.4	47.7	32.9	23.1	28.2	13.7	15.9	23.2	45.6	49.3	69.2	30.9	63.8	30.1
IRF4	"LSIRF, MUM1"	ENSG00000137265	"Interferon regulatory factor 4"	Q15306	6	391752-411443	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 29.2;cervix: 19.0;lymphoid tissue: 26.1"	"Cell type enhanced"	"Detected in some"		"B-cells: 57.2;dendritic cells: 66.8;Langerhans cells: 109.7;Melanocytes: 44.4;monocytes: 56.1;Plasma cells: 235.6"	"Cancer enriched"	"Detected in many"	9	"melanoma: 27.0"	"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"memory B-cell: 10.4;myeloid DC: 10.6;naive B-cell: 10.8;plasmacytoid DC: 12.1;T-reg: 5.8"	"Group enriched"	"Detected in many"	5	"B-cells: 10.8;dendritic cells: 12.1;T-cells: 5.8"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 221.4;Karpas-707: 197.8;RPMI-8226: 200.0;U-266/70: 177.2;U-266/84: 141.3;WM-115: 109.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA002038, HPA002698, CAB013508"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 2: Immune cells - Immune response"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 65: Plasmacytoid DCs - Unknown function"	Nucleoplasm	Cytosol	"CAB013508: , HPA002038: AB_1079148, HPA002698: AB_1851893"	"prognostic favorable (6.44e-4)"	"unprognostic (1.88e-3)"	"unprognostic (1.00e-3)"	"unprognostic (1.72e-4)"	"unprognostic (2.74e-1)"	"prognostic favorable (1.64e-6)"	"unprognostic (4.72e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.89e-2)"	"unprognostic (5.74e-4)"	"unprognostic (8.51e-2)"	"unprognostic (1.12e-1)"	"unprognostic (9.18e-7)"	"unprognostic (2.38e-1)"	"unprognostic (6.24e-2)"	"unprognostic (2.90e-1)"	"unprognostic (3.65e-2)"	3.1	0.4	0.1	15.9	0.1	29.2	3.2	0.1	0.2	19.0	0.2	6.9	7.6	1.5	0.3	0.9	0.7	2.5	1.0	0.1	0.1	0.4	2.4	2.2	23.2	0.3	0.1	0.6	0.1	0.0	0.3	0.1	0.2	0.5	6.8	0.0	4.5	0.4	0.2	6.8	10.2	0.7	0.2	17.4	7.2	1.1	0.1	7.0	1.1	0.1	26.1	6.3	2.4	0.2	0.4	0.0	0.0	0.0	22.1	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	221.4	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	197.8	0.0	0.0	0.1	0.1	1.2	0.0	0.0	26.1	0.0	200.0	0.0	0.0	0.4	0.0	0.0	0.2	32.0	0.6	0.1	0.3	0.0	0.0	0.1	0.0	0.3	177.2	141.3	58.4	0.2	0.0	109.0	0.1	1.8	0.0	0.6	1.5	0.0	10.4	1.0	1.0	10.6	10.8	1.7	0.7	0.0	0.3	1.5	12.1	5.8	1.5	0.1	0.1	0.1	0.2	0.1	0.1	0.3	0.1	0.2	0.2	0.1	0.2	0.8	0.0	5.3	0.0	57.2	8.3	0.1	0.0	0.0	0.0	0.6	1.5	1.2	1.5	0.0	0.0	0.0	0.0	66.8	0.2	0.0	0.1	0.0	0.3	0.9	0.6	0.0	0.0	0.1	0.7	0.0	1.8	1.5	0.4	0.0	0.0	1.1	0.5	0.3	0.0	0.1	0.1	0.0	0.6	109.7	0.2	3.4	21.7	44.4	0.0	56.1	0.0	0.0	0.0	0.3	0.1	0.1	0.0	235.6	0.2	0.0	0.1	0.0	0.0	0.0	0.4	0.9	0.0	1.0	0.4	4.3	0.1	29.8	0.0	0.1	0.1
IRF7		ENSG00000185507	"Interferon regulatory factor 7"	Q92985	11	612553-615983	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Antiviral defense, Host-virus interaction, Immunity, Innate immunity, Transcription, Transcription regulation"	"Activator, DNA-binding"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 38.2;lymphoid tissue: 33.2"	"Cell type enriched"	"Detected in many"	7	"dendritic cells: 576.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in all"	12	"plasmacytoid DC: 596.9"	"Lineage enriched"	"Detected in all"	12	"dendritic cells: 596.9"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+ SV40 Large T+: 15.5;BJ hTERT+ SV40 Large T+ RasG12V: 9.6;Karpas-707: 6.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017694, HPA052757"	Approved		Supported	Nucleoplasm,Cytosol		No	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 65: Plasmacytoid DCs - Unknown function"	Nucleoplasm	Cytosol	"CAB017694: AB_2280489, HPA052757: AB_2681937"	"unprognostic (1.39e-2)"	"unprognostic (3.26e-2)"	"unprognostic (1.08e-3)"	"unprognostic (2.45e-1)"	"unprognostic (4.52e-2)"	"unprognostic (2.73e-1)"	"unprognostic (1.04e-2)"	"unprognostic (2.52e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.16e-1)"	"unprognostic (7.08e-2)"	"unprognostic (8.13e-2)"	"prognostic unfavorable (1.71e-10)"	"unprognostic (2.50e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.58e-1)"	"unprognostic (4.71e-2)"	10.4	2.6	1.3	1.6	1.6	1.6	7.5	1.5	2.1	11.2	2.2	8.8	0.0	3.4	0.0	12.7	4.7	2.2	7.9	1.2	1.6	15.6	38.2	14.4	0.9	2.7	1.6	4.7	5.9	0.2	6.2	0.7	2.4	9.2	0.3	0.3	8.8	0.8	11.3	7.8	15.3	0.9	1.3	33.2	8.6	1.9	1.6	1.4	10.7	1.3	2.2	5.1	7.3	1.6	0.0	0.0	0.7	0.1	0.0	0.6	0.0	0.4	3.9	15.5	9.6	2.2	0.1	0.0	3.7	0.6	3.7	0.5	0.2	0.1	1.0	0.2	0.0	0.1	0.0	0.2	0.8	0.0	0.0	1.6	0.6	0.0	0.6	0.7	0.1	1.9	0.0	6.5	0.1	0.0	0.7	0.0	0.0	3.1	1.3	0.1	0.2	0.0	0.2	0.1	3.1	0.0	0.6	1.8	0.4	0.3	0.0	1.5	0.0	0.5	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.5	0.0	12.7	20.4	30.6	8.1	46.1	7.8	16.5	6.7	7.0	24.3	20.8	7.5	8.5	12.9	18.7	49.5	596.9	13.5	19.7	1.3	1.6	1.5	2.1	1.2	1.6	2.7	1.6	2.4	1.3	1.6	1.6	65.0	16.0	19.0	2.9	59.2	34.4	32.3	19.6	18.8	0.4	27.7	20.2	4.3	18.6	18.2	20.2	0.0	6.1	576.1	70.1	9.8	29.9	5.9	20.1	6.3	33.0	26.3	4.8	0.0	16.9	39.0	19.3	40.8	21.2	31.7	20.1	17.9	31.7	37.3	0.0	0.1	42.5	22.4	23.2	65.4	28.9	12.2	67.4	37.4	3.7	65.2	2.7	40.2	1.0	1.3	29.9	73.8	4.9	65.1	24.8	37.6	6.3	25.5	4.6	13.1	8.8	19.8	0.4	5.9	8.0	28.4	24.1	42.7	4.6	18.9	34.6
IRF9	ISGF3G	ENSG00000213928	"Interferon regulatory factor 9"	Q00978	14	24161265-24166565	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Antiviral defense, Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"NK-cells: 73.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+: 76.6;BJ hTERT+ SV40 Large T+ RasG12V: 58.9;GAMG: 48.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001862	Approved		Supported	Cytosol		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 64: Macrophages - Immune response"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 52: Non-specific - Transcription"	Cytosol		"HPA001862: AB_1079153"	"unprognostic (4.96e-3)"	"unprognostic (4.91e-2)"	"unprognostic (6.84e-3)"	"unprognostic (8.17e-3)"	"unprognostic (5.32e-2)"	"unprognostic (2.51e-2)"	"unprognostic (2.00e-1)"	"unprognostic (1.77e-2)"	"unprognostic (4.50e-1)"	"unprognostic (9.10e-2)"	"unprognostic (4.08e-2)"	"unprognostic (1.82e-1)"	"prognostic unfavorable (7.58e-8)"	"unprognostic (1.56e-1)"	"unprognostic (4.44e-2)"	"unprognostic (4.40e-2)"	"prognostic favorable (9.92e-4)"	25.2	27.1	16.0	25.0	17.4	25.4	22.5	16.3	15.9	31.6	13.3	29.3	17.6	27.7	13.1	21.8	25.0	24.2	19.1	14.7	17.9	29.1	25.9	28.2	25.2	22.0	17.9	25.0	14.1	11.6	22.1	12.8	17.5	22.1	9.9	3.6	36.4	12.7	9.0	20.7	26.8	17.6	22.2	48.5	25.3	8.3	18.0	22.7	22.8	8.8	20.4	27.0	22.5	21.2	3.9	2.4	2.5	0.9	15.9	17.6	1.6	7.3	37.5	76.6	58.9	5.2	22.5	5.0	7.7	20.3	48.5	6.0	1.6	1.5	19.3	24.3	0.0	11.6	2.1	6.1	25.3	1.1	14.2	17.2	5.3	9.1	1.9	15.1	8.3	1.0	1.7	32.6	10.0	4.5	2.0	4.8	0.4	2.8	7.4	0.8	2.5	3.0	17.2	2.6	0.4	2.6	6.6	3.5	38.9	5.1	1.1	9.7	16.1	8.1	5.7	4.8	1.7	32.4	24.9	4.7	9.4	1.8	7.3	197.2	80.5	112.3	73.4	103.1	58.1	93.3	72.4	62.0	61.7	88.7	64.0	58.4	202.8	74.8	103.9	75.1	103.0	103.4	16.0	17.4	16.3	15.9	14.7	17.9	22.0	17.9	17.5	22.2	18.0	21.2	37.9	25.6	15.1	21.2	22.8	2.3	8.6	6.1	6.2	6.6	8.0	10.3	0.2	10.0	9.7	5.5	8.4	1.5	32.0	6.1	0.0	4.9	0.2	9.0	19.4	21.0	1.8	7.4	5.0	5.5	21.9	14.8	20.9	9.4	24.6	42.0	11.0	1.7	7.0	8.4	4.9	5.3	10.2	8.2	8.0	1.0	12.8	13.4	5.4	26.2	13.4	11.2	73.2	32.2	9.5	6.2	10.9	6.8	13.2	8.4	21.8	2.6	32.3	4.3	13.1	33.7	15.1	1.3	1.7	3.7	2.7	1.6	26.1	24.9	4.9	12.4
IRS1	HIRS-1	ENSG00000169047	"Insulin receptor substrate 1"	P35568	2	226731312-226799820	"Disease related genes, Plasma proteins, Predicted intracellular proteins"		Transducer	"Diabetes mellitus, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Granulosa cells: 75.4;Theca cells: 110.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005261, HPA046433"	Uncertain		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA				"Cluster 52: Non-specific - Ribosome"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 52: Non-specific - Transcription"	"Nucleoplasm, Cytosol"	"Plasma membrane"	"CAB005261: AB_649615, HPA046433: AB_2732524"	"unprognostic (2.20e-1)"	"unprognostic (1.98e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.59e-2)"	"unprognostic (3.86e-3)"	"unprognostic (1.61e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.80e-3)"	"unprognostic (5.47e-2)"	"unprognostic (2.24e-2)"	"unprognostic (5.48e-3)"	"unprognostic (1.10e-1)"	"unprognostic (1.36e-3)"	"unprognostic (1.46e-2)"	"unprognostic (6.92e-2)"	"unprognostic (3.23e-2)"	"unprognostic (7.55e-3)"	7.6	9.7	1.7	2.9	1.6	0.5	11.7	5.2	3.1	14.7	1.8	10.3	3.9	17.4	1.9	3.6	15.0	5.6	5.0	1.6	1.0	3.4	10.5	5.0	1.7	1.8	1.6	20.9	3.5	3.3	1.5	9.5	1.2	7.8	2.7	1.5	3.0	7.0	28.0	5.2	5.1	10.3	2.0	2.0	5.3	0.8	1.6	8.1	20.0	2.9	1.3	11.6	6.6	1.5	5.7	26.0	18.6	0.7	25.0	14.8	0.0	15.6	12.2	20.4	13.0	15.0	14.4	2.3	2.5	10.6	14.0	10.0	1.2	15.0	11.5	5.9	1.0	0.1	1.7	7.1	12.5	0.5	0.1	20.7	8.1	16.1	14.5	12.3	0.0	2.3	3.0	22.7	14.0	22.6	4.9	6.6	7.5	3.6	14.3	1.1	24.1	0.1	9.3	18.9	3.2	0.5	5.0	3.6	8.4	14.9	13.7	0.3	1.3	26.8	24.2	20.9	15.1	10.6	4.6	3.4	26.5	0.5	8.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	1.6	5.2	3.1	1.6	1.0	1.8	1.6	1.2	2.0	1.6	1.5	1.7	19.2	4.6	5.9	2.7	35.4	31.9	29.7	19.4	19.3	36.9	28.1	13.4	14.3	12.8	0.0	0.0	6.4	0.0	13.2	17.6	15.4	1.6	22.1	28.4	2.1	2.4	0.0	17.3	11.4	0.6	28.3	2.0	24.3	0.0	75.4	1.8	57.4	1.7	20.2	31.3	6.5	24.4	1.3	4.6	1.8	22.7	3.6	16.0	15.0	0.8	8.4	0.0	26.7	1.7	11.1	8.2	14.7	9.5	14.5	23.4	3.0	8.1	1.7	13.1	9.5	22.8	1.0	1.2	4.2	23.7	18.3	1.2	110.3	7.7	22.8
IRS2		ENSG00000185950	"Insulin receptor substrate 2"	Q9Y4H2	13	109752695-109786583	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"		Transducer	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 51.3"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"neutrophil: 3.3"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 3.3"	"Cell line enhanced"	"Detected in many"		"hTERT-HME1: 38.1;LHCN-M2: 36.9;SH-SY5Y: 40.2;THP-1: 62.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016944, HPA054664"	Approved		Supported	Aggresome,Cytosol		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 41: Macrophages - Immune response"	Cytosol	Aggresome	"CAB016944: , HPA054664: AB_2682563"	"unprognostic (2.87e-3)"	"unprognostic (5.73e-3)"	"unprognostic (4.39e-2)"	"unprognostic (1.09e-3)"	"unprognostic (1.08e-1)"	"unprognostic (5.49e-3)"	"unprognostic (2.10e-1)"	"unprognostic (9.28e-2)"	"unprognostic (9.70e-2)"	"unprognostic (2.34e-3)"	"unprognostic (1.17e-1)"	"unprognostic (2.09e-2)"	"unprognostic (6.21e-3)"	"unprognostic (1.50e-1)"	"unprognostic (2.82e-1)"	"unprognostic (3.17e-2)"	"unprognostic (1.24e-1)"	26.2	16.5	22.2	5.9	21.8	51.3	18.9	12.1	28.4	10.7	3.9	11.3	4.4	13.0	6.3	4.2	7.7	4.0	13.0	32.2	22.9	3.5	22.1	11.1	2.3	29.4	24.5	18.6	4.3	3.6	19.1	6.7	24.8	13.3	3.4	6.0	11.6	6.1	21.4	15.5	6.0	4.7	13.6	5.4	7.8	3.0	25.2	2.3	5.5	7.7	2.2	7.1	8.6	20.1	5.8	6.6	4.2	0.0	34.5	6.9	2.3	6.3	7.4	3.8	3.1	0.6	7.0	0.0	3.9	4.5	5.4	2.6	2.2	5.6	4.7	2.3	29.5	2.8	9.3	0.0	34.8	10.7	3.3	14.5	29.6	1.1	38.1	24.5	1.4	0.5	1.9	0.0	36.9	3.0	0.1	31.1	4.5	3.2	1.4	13.1	3.8	2.8	10.6	1.5	6.1	40.2	3.3	0.1	27.2	3.5	0.8	62.8	0.1	7.8	0.0	0.5	8.5	0.0	3.1	2.1	5.8	10.2	13.7	1.5	0.6	0.9	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.2	0.2	0.1	3.3	0.0	0.2	0.0	0.2	0.1	22.2	21.8	12.1	28.4	32.2	22.9	29.4	24.5	24.8	13.6	25.2	20.1	13.7	32.1	33.8	53.8	31.1	113.9	48.0	100.2	81.4	25.8	68.9	98.4	72.3	60.1	79.5	31.3	114.7	20.3	40.0	71.2	5.9	36.4	47.6	81.6	110.6	13.4	122.6	34.5	51.3	3.1	11.1	52.0	28.1	188.5	25.3	25.8	20.0	142.9	24.1	25.2	42.2	42.0	52.9	143.5	24.4	12.3	37.3	131.2	129.9	29.0	59.3	32.4	17.5	46.3	34.8	30.8	44.4	20.3	7.9	76.8	77.3	3.9	40.3	30.6	26.3	57.1	44.0	21.2	10.2	74.6	126.2	30.6	37.5	63.1	42.7	53.6
ISCU	"hnifU, ISU2, NIFUN"	ENSG00000136003	"Iron-sulfur cluster assembly enzyme"	Q9H1K1	12	108562582-108569368	"Disease related genes, Human disease related genes, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal tubular cells: 1430.2;Late spermatids: 969.5;Proximal tubular cells: 1315.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"CAB006329, HPA038602, HPA057592"	Approved		Supported	Cytosol		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Cytosol		"CAB006329: AB_425907, HPA038602: AB_2676109, HPA057592: AB_2683478"	"unprognostic (1.72e-1)"	"prognostic favorable (4.90e-7)"	"unprognostic (1.53e-1)"	"unprognostic (3.53e-1)"	"unprognostic (2.43e-1)"	"unprognostic (3.15e-2)"	"unprognostic (1.33e-1)"	"unprognostic (6.69e-3)"	"unprognostic (1.14e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.28e-3)"	"unprognostic (2.49e-2)"	"prognostic favorable (2.73e-7)"	"unprognostic (2.03e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.37e-3)"	"prognostic favorable (6.12e-4)"	174.8	387.6	186.3	89.8	187.5	98.2	166.8	209.9	216.8	174.4	222.2	222.9	88.8	170.2	148.8	91.2	142.5	106.5	507.1	186.2	223.0	341.3	119.9	138.3	138.9	223.4	192.5	169.2	106.2	286.0	228.9	111.1	214.4	150.5	112.0	58.9	123.7	196.1	422.3	111.6	142.7	122.2	187.0	163.9	169.2	123.2	188.0	151.6	184.4	381.5	138.3	179.0	133.4	177.0	47.5	113.8	78.9	47.3	277.4	211.6	191.7	92.8	152.2	69.7	65.7	84.9	66.0	47.4	77.9	128.5	74.6	67.5	76.2	106.8	62.5	147.2	82.0	51.8	60.7	190.6	161.5	124.4	59.0	206.6	234.3	75.4	149.3	176.8	107.7	100.7	98.3	148.8	147.8	102.9	98.1	225.4	76.4	70.9	165.7	64.0	52.5	205.3	204.5	134.6	67.4	62.4	67.5	39.7	108.7	98.3	102.2	99.4	92.3	70.3	59.0	56.8	47.8	175.9	207.8	146.3	109.5	91.8	72.4	478.2	182.1	567.9	224.5	200.5	269.2	564.4	292.6	292.7	128.4	516.7	366.2	305.0	554.2	207.5	239.3	225.2	334.2	400.8	186.3	187.5	209.9	216.8	186.2	223.0	223.4	192.5	214.4	187.0	188.0	177.0	129.8	76.9	158.9	19.9	206.3	98.1	148.6	227.0	98.4	46.2	137.5	212.3	674.1	145.8	148.6	233.6	10.4	453.7	142.2	120.1	1430.2	154.3	433.2	78.1	76.5	140.8	75.0	165.5	52.6	149.8	164.0	165.5	64.2	37.1	116.5	89.1	126.0	112.3	263.0	45.4	53.7	117.6	193.3	140.1	110.2	969.5	202.0	129.9	249.1	23.4	502.4	167.9	163.7	14.6	26.0	141.3	96.3	308.4	299.4	171.8	235.9	1315.1	160.4	45.8	223.5	97.4	158.1	294.5	242.1	92.6	93.1	475.2	153.6	154.2	139.8	177.7
ISM2	"FLJ32147, TAIL1, THSD3"	ENSG00000100593	"Isthmin 2"	Q6H9L7	14	77474394-77498816	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	58	"placenta: 213.4"	"Group enriched"	"Detected in some"	10	"Cytotrophoblasts: 291.0;Extravillous trophoblasts: 617.2;Syncytiotrophoblasts: 177.5"	"Cancer enhanced"	"Detected in some"		"testis cancer: 1.4"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	15	"BEWO: 386.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA039314, HPA039742"	Supported		Supported	Nucleoplasm	"Secreted in female reproductive system"	NA	NA		1100000		"Cluster 28: Placenta - Pregnancy"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 38: Extravillous trophoblasts - Unknown function"	Nucleoplasm		"HPA039314: AB_10673239, HPA039742: AB_10673427"	"unprognostic (5.69e-2)"	"unprognostic (9.17e-3)"	"unprognostic (2.58e-2)"	"unprognostic (1.41e-3)"	"unprognostic (3.73e-2)"	"unprognostic (2.34e-1)"		"unprognostic (2.16e-2)"	"unprognostic (3.09e-3)"	"unprognostic (2.11e-1)"	"unprognostic (4.13e-1)"	"unprognostic (8.10e-2)"	"unprognostic (1.42e-2)"	"unprognostic (9.36e-2)"	"unprognostic (1.83e-1)"	"unprognostic (5.67e-2)"	"unprognostic (3.95e-1)"	0.6	0.0	0.3	0.1	1.2	0.0	0.0	0.0	0.7	0.8	0.8	0.2	0.1	1.2	3.7	0.2	0.4	0.1	0.1	0.2	0.6	0.7	0.0	0.0	0.0	0.1	0.3	0.1	0.6	0.4	0.5	213.4	0.2	1.8	0.0	0.1	0.1	1.4	0.0	0.0	0.0	0.3	0.1	0.0	0.0	1.6	0.8	0.0	0.2	0.0	0.0	0.3	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	386.3	0.0	0.0	0.1	0.0	6.1	0.0	0.0	0.1	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.4	0.0	0.0	25.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.4	0.3	0.5	0.8	0.0	0.0	1.1	0.0	0.0	0.0	0.0	1.0	0.1	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.2	0.0	0.7	0.2	0.6	0.1	0.3	0.2	0.1	0.8	0.1	0.2	0.0	0.0	0.0	0.0	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	291.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.9	0.0	0.0	0.4	0.0	617.2	2.1	0.0	0.0	0.0	0.1	0.0	0.0	33.4	0.0	0.4	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.7	1.7	0.0	0.0	177.5	0.0	0.0	0.0	0.0
IST1	"CHMP8, KIAA0174"	ENSG00000182149	"IST1 factor associated with ESCRT-III"	P53990	16	71845996-71931199	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041802, HPA054532"	Approved		Supported	Vesicles		NA	NA		270000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Vesicles		"HPA041802: AB_10794491, HPA054532: AB_2682517"	"unprognostic (2.15e-1)"	"unprognostic (2.80e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.67e-3)"	"unprognostic (2.04e-2)"	"unprognostic (3.13e-3)"	"unprognostic (2.11e-2)"	"unprognostic (4.49e-2)"	"unprognostic (3.96e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.02e-1)"	"prognostic favorable (4.55e-4)"	"unprognostic (1.64e-2)"	"unprognostic (7.88e-3)"	"unprognostic (8.43e-3)"	"prognostic favorable (8.88e-4)"	47.7	44.1	43.2	38.8	49.7	81.0	50.5	46.2	50.6	49.0	43.9	68.3	52.4	55.9	42.4	50.5	61.4	46.8	50.4	42.9	45.3	68.7	37.9	50.0	64.3	47.2	47.6	60.0	46.9	90.4	57.2	60.1	47.1	45.7	62.9	32.4	52.0	45.8	64.1	52.5	52.0	60.8	45.5	50.6	52.5	47.4	46.1	62.2	59.4	80.8	81.6	53.0	44.3	53.8	57.0	81.9	113.3	73.2	110.7	77.9	95.7	70.0	87.1	95.2	98.9	90.1	77.1	80.5	84.2	81.2	67.7	83.8	112.0	74.2	120.4	53.7	54.1	68.1	46.8	146.9	83.8	66.9	91.9	92.7	100.8	85.5	81.6	94.8	120.6	74.8	94.5	28.7	99.5	94.9	87.4	55.6	129.7	92.7	50.6	135.7	62.0	99.1	78.5	81.8	85.0	63.3	77.2	40.3	63.9	138.2	73.7	82.2	60.7	71.8	70.9	44.5	55.9	75.0	145.5	226.7	60.7	59.2	88.6	234.9	195.1	243.5	158.7	185.4	172.6	179.1	150.6	166.9	180.1	178.5	159.6	150.1	300.0	193.7	185.1	124.9	244.9	293.9	43.2	49.7	46.2	50.6	42.9	45.3	47.2	47.6	47.1	45.5	46.1	53.8	59.7	48.1	51.8	39.8	57.1	70.1	41.2	49.8	39.9	29.2	69.1	50.0	43.9	60.1	48.1	46.0	25.0	56.7	68.4	130.6	35.2	47.1	18.4	50.0	52.8	55.4	75.4	30.7	35.5	41.7	44.3	48.1	42.3	70.1	61.4	55.1	61.1	40.8	53.4	21.9	41.6	76.3	46.8	81.1	73.8	22.5	41.0	57.2	42.7	38.4	75.9	22.2	51.5	34.2	59.7	58.1	88.4	47.8	45.2	51.5	82.2	52.4	56.2	30.3	59.2	45.3	44.4	52.4	57.3	34.4	70.0	65.7	51.8	31.3	57.6	66.4
ISX	RAXLX	ENSG00000175329	"Intestine specific homeobox"	Q2M1V0	22	35066136-35087387	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	69	"intestine: 37.5"	"Group enriched"	"Detected in some"	32	"Distal enterocytes: 24.2;Enteroendocrine cells: 19.4;Intestinal goblet cells: 16.0;Paneth cells: 19.4;Proximal enterocytes: 32.7;Undifferentiated cells: 23.8"	"Cancer enhanced"	"Detected in some"		"colorectal cancer: 6.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	15	"CACO-2: 1.6;Hep G2: 4.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA060328			Supported	"Nucleoplasm,Nuclear bodies"		NA	NA				"Cluster 9: Intestine - Unknown function"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm	"Nuclear bodies"	"HPA060328: AB_2684254"			"unprognostic (5.02e-2)"				"unprognostic (2.68e-1)"				"unprognostic (2.23e-1)"	"unprognostic (3.33e-1)"		"unprognostic (3.86e-1)"	"unprognostic (2.55e-1)"			0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	27.6	37.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	26.0	0.0	0.0	0.0	0.0	0.0	27.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	24.2	0.0	0.0	0.2	0.0	0.0	0.0	19.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.4	0.0	0.0	0.1	32.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	23.8	0.0
ITGA3	"CD49c, GAP-B3, MSK18, VCA-2, VLA3a"	ENSG00000005884	"Integrin subunit alpha 3"	P26006	17	50055968-50090481	"Cancer-related genes, CD markers, Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"	"Integrin, Receptor"	"Cancer-related genes, Disease variant, Epidermolysis bullosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Ductal cells: 111.9;Exocrine glandular cells: 105.1;Pancreatic endocrine cells: 245.6;Urothelial cells: 104.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 647.2;hTERT-RPE1: 572.8;RPTEC TERT1: 562.0;U-87 MG: 920.8;WM-115: 570.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008572, CAB018594"	Enhanced		Supported	"Plasma membrane"		NA	NA		170000		"Cluster 7: Kidney - Transmembrane transport"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 1: Pancreatic cells - Digestion"	"Plasma membrane"		"CAB018594: AB_668044, HPA008572: AB_2668094"	"unprognostic (3.24e-3)"	"prognostic unfavorable (6.75e-4)"	"unprognostic (9.51e-2)"	"unprognostic (3.46e-3)"	"unprognostic (3.45e-3)"	"prognostic unfavorable (1.36e-4)"	"unprognostic (8.28e-3)"	"unprognostic (2.76e-3)"	"unprognostic (1.26e-3)"	"unprognostic (1.82e-2)"	"prognostic unfavorable (5.95e-5)"	"unprognostic (7.05e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.93e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.28e-2)"	"unprognostic (2.35e-2)"	17.5	29.8	5.3	9.9	5.4	0.4	17.3	6.0	6.1	14.8	5.2	25.4	30.4	21.3	11.7	24.1	24.5	17.9	13.2	5.0	10.9	68.9	2.2	65.8	3.0	7.5	6.6	12.8	15.9	17.7	21.1	26.7	11.9	19.5	15.5	4.4	19.4	15.7	9.0	30.8	26.7	15.6	4.2	11.1	24.5	2.1	7.8	5.9	43.5	4.1	6.2	46.7	17.1	4.0	181.8	234.9	1.4	7.5	4.3	17.5	37.3	83.4	177.9	123.1	93.2	5.3	276.2	0.4	507.9	59.5	400.4	126.8	2.2	647.2	73.9	22.9	3.5	0.1	56.8	1.6	105.1	0.3	5.0	21.6	313.5	123.2	540.7	572.8	91.6	9.1	0.1	2.6	236.0	52.9	0.7	0.5	5.5	81.2	141.0	0.4	12.1	13.7	562.0	311.1	9.7	3.9	89.8	12.2	205.0	56.2	21.1	2.4	200.8	541.8	169.4	5.6	329.5	8.1	14.2	5.9	920.8	1.9	570.9	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	5.3	5.4	6.0	6.1	5.0	10.9	7.5	6.6	11.9	4.2	7.8	4.0	8.5	54.5	30.1	3.6	3.4	57.4	63.5	63.5	48.3	18.0	17.1	32.0	5.3	27.1	26.2	77.3	25.0	2.8	1.3	91.2	0.0	111.9	0.5	26.4	3.1	14.7	14.5	0.0	24.3	105.1	3.2	5.3	47.4	20.7	3.8	3.4	8.9	0.3	1.1	3.3	20.0	25.1	16.2	1.2	8.2	0.6	1.8	2.0	17.8	8.4	4.3	3.1	2.1	3.0	0.8	245.6	26.7	4.1	4.5	72.6	69.6	4.4	21.7	16.2	13.1	5.6	23.4	0.5	1.6	17.0	23.2	1.8	3.8	0.9	44.7	104.2
ITGAV	"CD51, MSK8, VNRA, VTNR"	ENSG00000138448	"Integrin subunit alpha V"	P06756	2	186590056-186680901	"Cancer-related genes, CD markers, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Cell adhesion, Host-virus interaction"	"Host cell receptor for virus entry, Integrin, Receptor"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	6	"basophil: 6.2"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 6.2"	"Cell line enhanced"	"Detected in many"		"RT4: 369.7;SuSa: 297.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002499, HPA004856"	Supported		Approved	"Focal adhesion sites,Cytosol"		NA	NA		2000000	"Cluster 34: Basophils - Unknown function"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 15: RT4 - Unknown function"	"Cluster 44: Endometrium - Transcription"	"Focal adhesion sites, Cytosol"		"CAB002499: AB_563594, HPA004856: AB_1846316"	"unprognostic (4.03e-2)"	"unprognostic (5.17e-3)"	"unprognostic (1.22e-2)"	"unprognostic (5.22e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.18e-1)"	"prognostic unfavorable (2.08e-4)"	"unprognostic (1.48e-2)"	"unprognostic (6.95e-2)"	"unprognostic (2.89e-1)"	"prognostic unfavorable (5.07e-4)"	"unprognostic (5.84e-2)"	"unprognostic (2.67e-2)"	"prognostic unfavorable (1.05e-6)"	"unprognostic (2.61e-1)"	"unprognostic (9.11e-2)"	"unprognostic (8.07e-2)"	39.9	38.7	20.1	36.5	30.8	6.4	27.7	39.7	23.5	39.7	40.3	20.1	15.9	36.8	10.5	24.5	26.3	47.3	80.0	18.2	32.7	52.1	18.0	25.7	15.8	42.5	33.0	64.7	25.7	82.7	11.9	47.4	46.4	29.8	21.6	80.4	32.1	28.1	16.3	41.4	16.3	56.7	45.3	21.4	34.2	14.7	30.2	18.0	62.6	30.5	21.6	43.1	16.0	54.6	49.1	57.5	37.4	119.9	134.1	90.0	141.7	93.8	75.5	32.5	32.5	50.7	164.0	0.4	179.7	106.3	113.4	60.2	19.3	88.5	46.7	9.7	17.2	11.7	69.1	69.6	52.8	8.3	7.0	65.8	41.3	72.7	61.1	194.1	78.7	5.9	11.6	23.9	87.4	19.4	5.0	6.8	28.3	29.1	28.5	0.1	76.2	6.8	83.5	369.7	7.7	23.0	108.6	33.2	40.1	297.0	26.2	22.4	240.5	199.4	61.9	41.4	80.3	5.9	10.4	5.5	80.3	3.3	100.6	6.2	0.6	0.9	0.4	1.1	0.3	0.1	0.2	0.4	0.4	0.0	0.2	0.2	0.2	0.2	0.6	0.2	0.6	0.2	20.1	30.8	39.7	23.5	18.2	32.7	42.5	33.0	46.4	45.3	30.2	54.6	39.8	28.9	22.9	134.8	4.9	128.4	64.0	127.7	42.7	118.4	50.4	23.4	145.5	80.1	35.3	77.3	77.2	55.1	9.4	32.4	1.9	78.7	0.6	61.7	61.1	47.2	7.3	2.1	36.3	101.8	26.9	65.4	57.6	100.2	49.5	21.2	27.8	18.2	27.6	15.2	35.9	19.9	14.2	44.3	56.7	3.1	19.3	29.3	46.2	75.9	17.4	70.9	2.1	184.5	156.1	165.9	23.8	25.9	9.2	103.4	11.2	32.4	27.0	60.2	32.9	29.0	63.3	1.7	2.4	27.7	103.7	39.7	10.9	18.1	15.5	77.7
ITGB1	"CD29, FNRB, GPIIA, MDF2, MSK12"	ENSG00000150093	"Integrin subunit beta 1"	P05556	10	32887273-33005792	"Cancer-related genes, CD markers, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Cell adhesion, Host-virus interaction"	"Host cell receptor for virus entry, Integrin, Receptor"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Ductal cells: 1206.9;Pancreatic endocrine cells: 1393.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"hTERT-RPE1: 2711.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003434, HPA059297, HPA069003"	Enhanced		Supported	"Endoplasmic reticulum,Plasma membrane,Focal adhesion sites"		NA	NA		270000000	"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 48: Smooth muscle cells - ECM organization"	"Plasma membrane, Focal adhesion sites"	"Endoplasmic reticulum"	"CAB003434: AB_303570, HPA059297: AB_2732634, HPA069003: AB_2732125"	"unprognostic (3.07e-2)"	"prognostic unfavorable (5.01e-4)"	"unprognostic (8.67e-2)"	"unprognostic (4.36e-1)"	"unprognostic (1.20e-2)"	"unprognostic (3.87e-2)"	"unprognostic (1.60e-2)"	"prognostic unfavorable (3.36e-6)"	"unprognostic (3.22e-1)"	"unprognostic (2.36e-3)"	"unprognostic (3.68e-3)"	"unprognostic (2.42e-1)"	"unprognostic (1.02e-3)"	"unprognostic (1.25e-2)"	"unprognostic (2.23e-1)"	"unprognostic (2.48e-1)"	"unprognostic (3.08e-2)"	491.9	179.3	61.5	241.5	78.2	81.5	216.2	75.0	90.9	259.2	68.3	265.3	147.4	330.4	171.7	168.6	172.0	347.4	390.3	60.2	74.3	180.4	287.1	233.6	118.0	88.4	80.6	157.1	135.3	145.4	59.8	459.5	88.9	248.1	223.6	27.7	130.7	427.7	157.9	92.2	150.8	710.0	76.6	204.7	160.1	91.2	86.4	77.5	161.5	194.5	106.2	357.4	119.1	88.9	638.0	907.0	495.4	559.6	1183.4	1019.5	398.1	2063.9	1239.6	999.0	903.9	215.9	1478.2	164.5	354.1	1830.9	638.0	438.9	149.1	1204.1	1122.0	163.1	112.7	195.8	416.3	253.6	826.4	48.3	195.5	1027.7	658.2	1040.8	426.0	2711.1	1263.6	81.0	136.6	76.5	1700.8	109.0	80.1	46.7	107.4	200.6	428.2	52.0	357.0	30.9	1454.8	186.2	108.0	271.4	649.9	114.6	498.2	813.7	153.9	175.0	1362.6	1280.0	712.2	904.2	719.7	64.7	14.8	91.2	956.6	198.2	518.5	7.5	35.1	16.1	83.4	69.8	22.8	109.6	191.8	138.7	33.9	40.3	24.9	68.4	9.0	90.3	108.2	11.4	266.8	117.2	61.5	78.2	75.0	90.9	60.2	74.3	88.4	80.6	88.9	76.6	86.4	88.9	631.5	342.9	143.8	26.4	118.0	546.7	435.5	531.6	208.3	32.8	147.1	307.5	210.8	241.6	268.1	226.2	31.3	210.3	217.8	179.8	13.7	1206.9	6.6	194.6	437.9	421.1	193.3	153.0	37.2	411.3	515.2	374.7	95.8	406.5	88.7	561.8	375.9	268.1	179.8	38.7	52.4	97.4	213.6	170.1	206.7	18.3	254.5	217.8	343.3	67.5	119.4	72.0	111.2	42.7	66.8	1393.7	128.5	601.8	181.2	412.5	75.6	68.7	171.5	45.5	637.7	236.3	724.0	10.1	76.0	84.4	170.5	219.7	211.3	225.6	127.0	296.1
ITGB1BP1	"ICAP-1A, ICAP-1alpha, ICAP-1B, ICAP1, ICAP1A, ICAP1B"	ENSG00000119185	"Integrin subunit beta 1 binding protein 1"	O14713	2	9403475-9423528	"Predicted intracellular proteins"	"Angiogenesis, Biomineralization, Cell adhesion, Differentiation, Notch signaling pathway, Transcription, Transcription regulation"	Mitogen		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal tubular cells: 391.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA067348, HPA071538"			Supported	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 50: Fibroblasts - ECM organization"	Nucleoplasm	"Nuclear bodies, Cytosol"	"HPA067348: AB_2732765, HPA071538: AB_2686413"	"unprognostic (2.21e-1)"	"unprognostic (8.31e-2)"	"unprognostic (2.09e-1)"	"prognostic unfavorable (1.03e-5)"	"unprognostic (4.39e-2)"	"unprognostic (5.88e-3)"	"prognostic unfavorable (4.67e-5)"	"unprognostic (3.13e-1)"	"unprognostic (1.24e-1)"	"unprognostic (2.33e-1)"	"unprognostic (6.46e-2)"	"unprognostic (4.66e-2)"	"prognostic unfavorable (7.10e-5)"	"unprognostic (3.75e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.14e-3)"	"unprognostic (4.08e-3)"	113.7	23.2	45.5	19.3	63.1	31.3	60.4	50.3	58.0	43.7	49.3	37.3	13.6	31.0	26.6	20.9	24.3	22.6	37.3	46.4	48.3	50.2	13.3	22.8	22.1	48.2	47.0	22.3	11.8	26.2	19.1	24.2	49.9	18.5	24.2	27.5	15.5	23.7	29.8	29.7	19.1	35.9	41.8	15.2	22.9	9.4	54.3	27.0	22.4	33.5	25.7	30.4	32.5	52.7	53.5	35.4	43.4	51.5	148.9	131.2	23.3	94.9	66.2	83.8	66.1	49.5	33.1	55.6	43.1	135.9	56.1	50.1	66.3	62.7	92.8	158.6	30.2	53.2	43.2	61.1	54.1	42.2	57.4	70.5	49.5	78.4	56.5	75.2	76.6	43.0	29.9	46.1	109.0	44.6	74.7	25.5	35.9	90.3	53.9	39.4	59.1	51.4	88.5	40.6	44.1	45.0	54.8	40.3	71.3	38.9	30.5	32.1	48.6	73.8	54.5	103.3	105.7	46.8	111.0	89.0	106.1	54.8	54.5	86.1	43.1	56.0	54.9	54.0	52.5	40.1	46.6	53.2	56.8	33.0	35.2	45.7	9.3	50.4	41.1	52.8	61.7	53.1	45.5	63.1	50.3	58.0	46.4	48.3	48.2	47.0	49.9	41.8	54.3	52.7	90.0	28.9	18.1	18.3	47.1	61.2	40.6	70.4	40.9	25.2	30.4	41.8	104.3	22.8	35.1	38.6	2.1	45.0	70.7	16.1	391.3	72.0	26.3	31.3	51.9	85.5	33.1	49.4	61.6	72.7	73.9	98.6	25.5	30.9	41.7	44.4	53.6	21.6	91.4	35.3	47.3	30.4	32.6	45.0	88.5	25.7	54.3	51.7	97.8	15.9	95.6	64.2	121.5	25.6	40.1	108.9	27.0	57.2	42.7	35.2	24.7	88.4	35.6	30.6	92.1	49.0	102.4	27.8	19.0	47.5	63.1	31.5	63.0	70.7	35.2	60.4
ITGB2	"CD18, LFA-1, MAC-1, MFI7"	ENSG00000160255	"Integrin subunit beta 2"	P05107	21	44885953-44931989	"CD markers, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion, Phagocytosis"	"Integrin, Receptor"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 376.2;lymphoid tissue: 175.2"	"Group enriched"	"Detected in many"	6	"dendritic cells: 417.6;Hofbauer cells: 652.4;Kupffer cells: 485.9;Langerhans cells: 259.1;Macrophages: 527.4;monocytes: 463.8;NK-cells: 959.9;T-cells: 254.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"THP-1: 812.4;U-937: 615.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008877, HPA016894"	Enhanced		Supported	"Plasma membrane,Rods & Rings"		NA	NA		3300000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Plasma membrane"	"Rods & Rings"	"HPA008877: AB_1846256, HPA016894: AB_1846257"	"unprognostic (1.94e-2)"	"unprognostic (7.66e-3)"	"unprognostic (1.23e-1)"	"unprognostic (6.21e-3)"	"unprognostic (2.95e-2)"	"unprognostic (9.73e-3)"	"unprognostic (2.53e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.18e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.20e-1)"	"unprognostic (6.34e-2)"	"unprognostic (1.87e-3)"	"unprognostic (1.42e-1)"	"unprognostic (4.42e-2)"	"unprognostic (2.65e-2)"	"unprognostic (4.83e-2)"	54.5	23.2	8.2	175.2	9.5	376.2	15.4	13.1	9.3	15.5	11.7	25.2	23.8	8.5	2.8	16.2	17.0	36.4	11.8	7.7	14.2	8.4	23.4	78.0	169.1	29.5	19.9	7.2	11.3	5.1	4.6	44.4	28.1	8.8	13.9	1.1	19.5	9.2	6.8	9.3	32.8	46.4	23.9	137.2	29.1	5.9	26.2	87.2	7.3	7.6	68.4	46.3	5.9	50.4	1.9	4.8	0.0	0.0	0.0	0.3	1.7	0.0	2.7	0.1	0.0	0.4	0.4	17.9	128.1	0.2	0.6	0.5	0.0	0.2	0.0	1.5	1.4	18.2	0.0	3.2	0.1	106.6	27.5	1.6	0.1	0.5	0.3	0.1	0.3	58.0	0.7	1.4	7.0	4.0	117.8	126.1	0.4	0.4	2.4	1.5	23.2	64.6	4.7	0.0	0.6	1.3	3.4	2.5	1.7	0.0	0.4	812.4	2.5	0.2	6.6	0.4	3.7	0.8	5.9	2.9	0.1	615.0	0.9	186.6	1848.8	1224.1	726.7	1144.9	326.6	86.1	349.7	506.5	1031.4	115.2	233.1	396.5	1386.1	585.5	1183.5	165.5	288.0	3034.2	8.2	9.5	13.1	9.3	7.7	14.2	29.5	19.9	28.1	23.9	26.2	50.4	7.1	16.0	29.6	0.3	81.7	5.5	0.5	9.6	0.6	0.0	4.1	6.5	4.0	14.3	18.6	5.5	0.0	4.0	417.6	0.3	0.0	3.4	1.0	0.6	0.5	16.8	0.0	19.6	0.5	0.4	4.8	5.3	2.6	0.7	24.1	8.2	9.7	8.6	652.4	0.0	0.3	0.2	2.0	485.9	259.1	2.8	0.6	527.4	5.4	27.2	463.8	0.4	959.9	0.0	0.2	0.6	0.1	1.5	50.5	0.6	1.8	4.2	3.6	0.8	6.6	2.1	3.2	0.2	1.0	0.9	5.1	5.6	254.5	0.0	0.3	0.7
ITGB3	"CD61, GP3A, GPIIIa"	ENSG00000259207	"Integrin subunit beta 3"	P05106	17	47253827-47313743	"Cancer-related genes, CD markers, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion, Host-virus interaction"	"Host cell receptor for virus entry, Integrin, Receptor"	"Cancer-related genes, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"thyroid gland: 51.4"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 3.9;Late spermatids: 8.8;Macrophages: 15.8;Proximal tubular cells: 4.6;Sertoli cells: 6.6"	"Group enriched"	"Detected in many"	6	"melanoma: 7.5;renal cancer: 3.6;thyroid cancer: 11.5"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	19	"basophil: 5.4;neutrophil: 2.5"	"Lineage enriched"	"Detected in single"	26	"granulocytes: 5.4"	"Cell line enhanced"	"Detected in many"		"EFO-21: 167.8;HEL: 163.4;RPTEC TERT1: 109.8;U-87 MG: 78.3;WM-115: 255.9"									HPA027852	Approved		Supported	"Nucleoplasm,Plasma membrane"	"Intracellular and membrane"	NA	NA		38000000	"Cluster 34: Basophils - Unknown function"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 51: Myeloid cells - Hemostasis"	"Plasma membrane"	Nucleoplasm	"HPA027852: AB_10601760"	"unprognostic (1.13e-2)"	"unprognostic (1.97e-3)"	"unprognostic (2.47e-1)"	"unprognostic (3.00e-2)"	"unprognostic (1.91e-2)"	"unprognostic (6.04e-3)"	"unprognostic (3.70e-1)"	"unprognostic (3.00e-1)"	"unprognostic (1.44e-1)"	"unprognostic (3.85e-1)"	"unprognostic (6.35e-2)"	"unprognostic (7.22e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.03e-2)"	"unprognostic (2.72e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.17e-3)"	8.0	0.6	0.3	9.5	0.7	6.2	5.3	0.7	1.0	3.8	1.0	16.9	3.5	13.2	2.6	4.2	7.6	3.5	5.5	0.5	0.8	15.0	3.4	5.6	0.9	2.3	1.0	1.5	0.7	1.2	1.2	4.5	2.0	4.8	7.0	0.9	2.6	16.1	1.5	2.7	5.8	22.9	1.2	2.9	3.8	2.5	1.2	0.3	51.4	2.4	1.2	9.6	2.6	1.1	0.1	1.5	0.7	0.1	8.6	3.8	0.1	4.7	23.1	9.6	8.6	0.3	0.1	0.6	167.8	1.2	13.4	0.0	0.1	0.0	12.6	3.4	0.0	163.4	0.5	0.0	7.8	0.0	0.2	3.4	0.0	54.6	1.4	6.7	43.6	2.5	0.5	0.3	2.1	0.0	1.0	0.1	0.1	0.0	0.8	0.0	4.2	0.0	109.8	0.2	0.0	0.5	5.6	0.0	33.2	8.8	0.1	0.2	47.1	2.1	2.4	1.3	11.7	0.2	0.1	1.1	78.3	0.0	255.9	5.4	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	2.5	0.1	0.1	0.1	0.0	6.8	0.3	0.7	0.7	1.0	0.5	0.8	2.3	1.0	2.0	1.2	1.2	1.1	1.3	0.0	0.0	0.0	0.5	0.1	0.2	0.9	0.0	0.0	0.1	0.3	0.8	0.0	1.0	0.0	0.0	0.1	0.0	0.0	0.0	1.1	3.9	0.8	0.9	3.1	0.0	0.0	0.4	0.4	0.0	2.1	0.0	0.9	0.0	0.6	1.8	0.7	0.8	0.0	0.6	0.0	0.0	0.3	0.7	8.8	0.3	15.8	0.0	1.0	0.4	0.0	0.0	0.0	0.4	1.5	0.0	1.2	0.0	0.3	0.0	4.6	0.2	0.0	6.6	0.3	2.1	0.0	2.0	0.1	0.4	1.2	0.3	0.4	0.0	0.2
ITGB3BP	"CENPR, HSU37139, NRIF3, TAP20"	ENSG00000142856	"Integrin subunit beta 3 binding protein"	Q13352	1	63440770-63593721	"Predicted intracellular proteins"	"Apoptosis, Cell cycle, Cell division, Mitosis, Transcription, Transcription regulation"	"Activator, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 200.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA028463	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"HPA028463: AB_10601435"	"unprognostic (4.98e-2)"	"unprognostic (5.88e-3)"	"unprognostic (6.28e-3)"	"unprognostic (3.96e-2)"	"unprognostic (4.58e-1)"	"prognostic favorable (4.32e-4)"	"prognostic unfavorable (7.24e-5)"	"unprognostic (2.68e-2)"	"unprognostic (7.89e-3)"	"unprognostic (2.15e-2)"	"unprognostic (1.35e-1)"	"unprognostic (4.97e-3)"	"prognostic unfavorable (8.45e-6)"	"unprognostic (1.34e-2)"	"unprognostic (5.24e-2)"	"unprognostic (7.34e-3)"	"unprognostic (6.14e-2)"	6.8	11.5	2.3	7.9	2.3	11.9	15.0	2.5	4.6	7.8	3.7	10.7	8.0	8.8	15.9	9.0	9.3	10.8	4.4	2.2	2.5	12.6	6.4	7.2	18.0	2.5	2.4	14.1	10.1	18.2	5.3	10.1	2.5	8.7	10.1	2.8	7.8	6.2	2.5	9.1	6.0	5.6	2.4	8.9	8.0	20.6	2.3	20.2	13.5	4.4	16.4	10.1	8.3	2.6	63.6	32.9	35.9	28.6	8.6	25.2	32.3	30.3	18.7	51.6	63.4	18.2	29.0	57.4	22.6	7.3	26.2	44.3	28.2	30.8	63.7	43.4	74.2	43.9	41.3	35.1	9.2	60.4	27.6	6.5	22.4	29.9	23.5	24.3	26.6	34.5	51.5	74.6	7.3	27.8	66.4	57.0	45.5	24.1	38.2	42.5	61.4	84.7	34.8	19.4	46.1	28.8	34.7	20.0	50.4	53.0	19.9	20.0	16.1	17.9	26.1	36.6	46.2	37.1	64.1	54.4	30.0	75.4	27.7	14.2	4.0	1.4	6.5	3.2	11.3	15.9	10.2	10.6	5.1	15.4	11.3	10.2	1.1	15.6	3.9	8.8	12.2	6.7	2.3	2.3	2.5	4.6	2.2	2.5	2.5	2.4	2.5	2.4	2.3	2.6	22.0	9.6	13.9	24.2	40.9	33.9	56.3	49.8	34.7	10.7	35.9	43.7	11.5	28.6	38.2	25.8	10.4	45.9	19.3	10.1	29.4	42.2	100.8	45.2	22.1	21.6	17.4	40.0	23.6	34.3	56.3	28.6	20.4	21.1	23.5	40.7	23.9	9.7	30.0	6.7	23.6	18.1	42.7	21.0	26.1	121.4	21.5	18.9	21.4	15.0	23.7	21.2	30.9	18.6	31.0	24.8	4.1	25.9	30.7	13.7	6.0	39.1	54.3	15.8	32.9	18.2	21.9	200.5	54.4	30.8	32.7	19.2	26.6	13.6	31.9	35.8
ITGB4	CD104	ENSG00000132470	"Integrin subunit beta 4"	P16144	17	75721328-75757818	"Cancer-related genes, CD markers, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"	"Integrin, Receptor"	"Cancer-related genes, Disease variant, Epidermolysis bullosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"salivary gland: 200.6;skin 1: 205.9"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 173.6;Distal enterocytes: 133.3;Gastric mucus-secreting cells: 165.1;Pancreatic endocrine cells: 284.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"plasmacytoid DC: 4.6"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 897.3;HaCaT: 345.1;HBEC3-KT: 768.6;hTCEpi: 256.9;RT4: 254.9"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"spinal cord: 37.4"	"CAB002422, CAB005258, HPA036348, HPA036349"	Enhanced		Supported	"Plasma membrane,Cell Junctions"		NA	NA		980000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Plasma membrane, Cell Junctions"		"CAB002422: AB_563480, CAB005258: AB_2129021, HPA036348: AB_2675077, HPA036349: AB_2675078"	"unprognostic (3.17e-3)"	"unprognostic (3.52e-1)"	"unprognostic (4.19e-1)"	"unprognostic (2.27e-1)"	"unprognostic (5.75e-2)"	"unprognostic (6.11e-3)"	"unprognostic (1.28e-1)"	"prognostic unfavorable (7.18e-4)"	"unprognostic (1.05e-1)"	"unprognostic (4.14e-2)"	"prognostic unfavorable (6.39e-4)"	"unprognostic (1.02e-1)"	"unprognostic (2.23e-2)"	"unprognostic (1.65e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.43e-1)"	39.2	5.3	82.8	12.4	87.8	1.6	66.6	74.9	91.8	58.4	76.4	87.5	56.9	24.0	3.6	101.2	43.8	20.0	22.7	80.5	86.9	18.2	5.6	18.4	4.5	104.6	104.8	8.5	24.5	2.8	21.1	35.4	82.6	85.3	15.7	8.7	200.6	18.5	6.8	205.9	75.5	6.4	102.4	76.9	79.9	4.9	82.0	4.1	17.6	6.0	7.2	58.4	98.8	99.6	172.7	148.5	0.3	2.1	0.4	1.3	199.2	0.7	0.6	0.5	0.9	16.1	897.3	0.1	31.5	0.3	1.3	345.1	1.0	768.6	0.5	0.7	0.6	0.9	39.6	17.0	1.2	0.2	1.8	1.1	256.9	0.6	159.2	18.0	5.5	0.6	0.5	15.7	0.1	95.8	2.0	2.0	1.0	92.8	127.8	2.7	4.4	2.2	204.8	254.9	0.2	1.9	4.9	15.2	2.2	5.3	63.9	1.5	16.9	4.6	7.8	0.7	1.9	5.6	2.1	0.7	2.0	0.8	2.7	0.0	0.2	0.0	0.4	0.4	1.1	0.7	0.1	0.5	0.0	2.0	0.4	0.3	0.7	0.0	0.0	4.6	0.8	0.4	82.8	87.8	74.9	91.8	80.5	86.9	104.6	104.8	82.6	102.4	82.0	99.6	26.9	12.8	2.2	50.3	1.4	49.5	45.1	173.6	67.2	0.3	21.2	36.6	7.5	25.8	38.9	23.9	2.1	89.8	1.8	133.3	1.9	33.3	0.4	61.3	5.7	26.8	9.6	0.8	0.7	28.8	20.2	5.2	165.1	60.2	2.5	1.1	17.9	0.4	9.4	0.0	0.7	59.2	18.3	0.3	5.4	0.4	3.7	1.9	12.4	1.9	0.1	34.4	0.0	1.5	0.7	284.4	68.4	1.5	2.6	17.1	94.0	2.6	53.3	1.0	0.0	1.2	5.0	1.1	8.2	28.1	13.1	111.1	1.8	0.5	60.1	42.0
ITGB6		ENSG00000115221	"Integrin subunit beta 6"	P18564	2	160099667-160200313	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted membrane proteins"	"Cell adhesion, Host-virus interaction"	"Host cell receptor for virus entry, Integrin, Receptor"	"Amelogenesis imperfecta, Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 68.3;skeletal muscle: 80.0;tongue: 64.5"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 153.8;Alveolar cells type 2: 202.5;Basal prostatic cells: 153.5;Basal respiratory cells: 125.9;Pancreatic endocrine cells: 195.2;Spermatocytes: 286.0;Urothelial cells: 129.3"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"CAPAN-2: 139.2;RPTEC TERT1: 269.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA023626, CAB073536"	Approved		Approved	"Nucleoplasm,Cell Junctions,Centrosome"		NA	NA				"Cluster 8: Non-specific - Mitochondria"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Nucleoplasm, Cell Junctions"	Centrosome	"CAB073536: , HPA023626: AB_2671267"	"unprognostic (1.27e-1)"	"unprognostic (1.57e-2)"	"unprognostic (6.90e-2)"	"unprognostic (8.22e-3)"	"unprognostic (3.61e-3)"	"unprognostic (1.50e-2)"	"unprognostic (1.72e-3)"	"unprognostic (2.04e-2)"	"unprognostic (1.72e-1)"	"unprognostic (7.06e-2)"	"prognostic unfavorable (5.03e-6)"	"unprognostic (1.04e-1)"	"unprognostic (2.73e-1)"	"unprognostic (4.97e-2)"	"unprognostic (1.23e-1)"	"unprognostic (2.16e-1)"	"unprognostic (1.00e-1)"	0.1	0.0	0.0	1.9	0.0	0.0	20.2	0.0	0.0	2.7	0.0	8.0	8.4	5.4	1.7	14.2	3.4	14.8	0.6	0.0	0.0	68.3	0.1	45.3	0.0	0.0	0.0	0.0	3.3	32.2	1.8	5.5	0.0	5.1	7.4	0.0	3.9	8.9	80.0	2.6	6.3	0.3	0.0	0.0	18.7	0.1	0.0	0.0	4.7	64.5	3.0	44.9	6.5	0.0	14.5	0.2	0.0	0.1	0.0	0.0	14.9	0.0	0.0	0.0	0.0	0.1	139.2	0.1	0.8	0.1	0.0	28.7	0.0	45.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.5	31.4	0.0	0.1	0.4	0.1	0.0	0.0	0.0	3.8	4.3	0.0	0.0	0.0	9.0	0.0	0.0	10.9	0.0	269.9	45.7	0.0	0.1	0.1	43.7	0.0	1.6	0.5	0.0	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	153.8	202.5	0.0	0.0	10.5	153.5	125.9	46.1	0.0	35.5	31.0	38.7	10.0	60.4	71.7	0.0	13.6	0.5	30.3	0.0	57.5	89.4	9.6	0.7	2.6	0.0	0.0	0.3	105.4	7.0	2.6	37.8	24.4	3.8	0.0	1.1	1.0	2.2	0.0	0.2	11.6	24.4	0.3	0.4	48.3	2.8	2.2	1.8	0.0	2.0	1.7	0.0	0.5	0.1	195.2	25.6	1.2	0.0	57.3	10.0	1.9	17.7	0.1	0.0	5.7	3.8	286.0	3.0	42.2	8.5	4.7	2.1	0.0	12.4	129.3
ITK	"EMT, LYK, PSCTK2"	ENSG00000113263	"IL2 inducible T cell kinase"	Q08881	5	157142933-157255185	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Adaptive immunity, Immunity"	"Kinase, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	14	"lymphoid tissue: 57.9"	"Group enriched"	"Detected in some"	6	"dendritic cells: 51.7;granulocytes: 31.8;NK-cells: 42.2;Plasma cells: 34.0;T-cells: 115.7"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	23	"gdT-cell: 39.6;MAIT T-cell: 26.4;memory CD4 T-cell: 55.6;memory CD8 T-cell: 54.9;naive CD4 T-cell: 78.2;naive CD8 T-cell: 65.0;NK-cell: 29.3;T-reg: 73.2"	"Group enriched"	"Detected in many"	23	"NK-cells: 29.3;T-cells: 78.2"	"Group enriched"	"Detected in some"	10	"JURKAT: 62.2;MOLT-4: 23.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA043670			Uncertain	"Plasma membrane,Cytosol"		NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 24: Non-specific - Transcription regulation"	"Plasma membrane, Cytosol"		"HPA043670: "	"unprognostic (2.08e-3)"	"unprognostic (6.57e-4)"	"unprognostic (5.06e-3)"	"unprognostic (4.96e-5)"	"unprognostic (1.52e-2)"	"unprognostic (1.12e-4)"	"unprognostic (8.45e-4)"	"unprognostic (1.56e-2)"	"unprognostic (1.87e-2)"	"unprognostic (5.99e-3)"	"unprognostic (1.76e-1)"	"unprognostic (2.52e-1)"	"unprognostic (4.52e-6)"	"unprognostic (3.64e-1)"	"unprognostic (4.42e-2)"	"unprognostic (1.46e-1)"	"unprognostic (3.26e-2)"	1.0	0.3	0.0	15.9	0.0	3.7	0.9	0.0	0.0	1.0	0.0	1.4	0.7	0.4	0.0	1.4	0.4	4.2	0.2	0.0	0.0	0.3	1.6	3.1	29.3	0.0	0.0	0.1	0.2	0.0	0.0	0.2	0.0	0.4	1.5	0.0	0.3	0.1	0.0	0.2	4.0	0.5	0.0	10.5	3.1	0.5	0.0	57.9	0.5	0.0	24.6	3.9	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	3.9	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.0	62.2	0.0	0.0	0.0	0.0	23.7	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.1	0.0	39.6	0.0	26.4	0.0	55.6	54.9	0.1	0.0	78.2	65.0	1.3	29.3	2.3	0.1	73.2	44.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	6.2	0.0	4.0	2.7	0.6	0.0	0.0	0.0	0.4	0.4	0.9	0.0	0.6	1.8	0.0	0.1	51.7	0.1	0.0	0.1	8.5	0.2	0.3	0.8	0.0	1.7	0.2	0.0	0.0	1.1	7.7	0.4	31.8	0.1	1.8	1.0	0.0	0.0	0.2	0.0	0.0	1.6	5.1	6.7	0.0	2.9	1.8	1.0	2.8	0.0	42.2	0.0	0.1	0.0	0.0	0.0	34.0	0.3	0.0	0.4	0.0	0.0	0.0	1.0	1.0	0.0	0.0	0.2	3.4	0.1	115.7	0.0	0.1	0.6
ITPA	"C20orf37, dJ794I6.3, HLC14-06-P"	ENSG00000125877	"Inosine triphosphatase"	Q9BY32	20	3208868-3223870	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Nucleotide metabolism"	Hydrolase	"Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022824, HPA073963"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA		120000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 37: Intestine - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoplasm, Cytosol"		"HPA022824: AB_1851960, HPA073963: "	"unprognostic (1.58e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.73e-1)"	"unprognostic (3.57e-1)"	"unprognostic (4.63e-2)"	"unprognostic (1.53e-2)"	"prognostic unfavorable (2.54e-5)"	"unprognostic (1.11e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.83e-1)"	"unprognostic (2.28e-1)"	"unprognostic (1.94e-2)"	"unprognostic (8.34e-2)"	"unprognostic (3.63e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.84e-1)"	26.2	37.1	16.7	21.2	17.5	26.4	25.0	16.9	20.0	24.8	18.2	25.3	27.0	24.0	13.0	43.9	29.9	16.7	20.8	18.2	16.8	34.2	28.2	22.4	27.6	17.0	16.5	21.2	21.9	24.2	13.0	19.8	17.0	20.3	19.2	6.9	26.4	16.1	26.5	33.6	23.2	18.5	17.3	27.0	27.1	12.3	18.0	24.8	33.5	15.1	21.4	24.1	25.7	18.5	118.2	91.1	44.0	49.1	29.7	42.7	30.9	50.9	72.4	65.9	58.8	75.0	106.6	52.5	46.9	48.7	65.7	101.9	62.3	79.8	46.6	32.9	91.6	123.9	39.1	117.6	55.5	54.5	41.4	41.5	60.3	64.4	40.9	28.6	52.5	39.5	88.7	34.2	62.6	55.2	66.0	156.5	77.2	132.1	89.6	61.4	60.7	135.0	96.7	39.2	67.4	80.9	41.4	154.0	106.3	19.3	60.1	94.2	37.9	76.5	42.4	51.7	116.0	52.0	68.4	94.2	32.9	102.8	83.0	32.8	61.5	22.9	47.7	78.2	41.7	48.9	43.6	49.0	74.5	50.2	32.4	39.5	3.4	64.5	56.9	70.7	61.0	48.0	16.7	17.5	16.9	20.0	18.2	16.8	17.0	16.5	17.0	17.3	18.0	18.5	29.4	22.4	47.0	15.3	38.0	40.1	50.5	93.2	56.9	20.4	48.8	58.3	9.8	34.3	59.3	44.1	14.6	74.4	45.9	37.5	58.7	104.2	2.7	51.8	64.4	29.4	27.5	24.6	12.0	105.1	128.2	41.8	48.4	60.9	42.5	49.7	29.3	32.1	116.6	5.0	9.2	53.1	54.9	42.4	54.0	3.7	31.1	49.0	40.9	5.6	90.3	21.0	41.2	14.1	21.5	102.2	59.9	22.2	34.5	53.5	51.6	94.5	37.9	24.5	19.7	35.4	45.0	16.8	17.6	58.8	49.2	56.2	47.2	53.3	79.9	66.0
ITPKC	"IP3-3KC, IP3KC"	ENSG00000086544	"Inositol-trisphosphate 3-kinase C"	Q96DU7	19	40717112-40740860	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Calmodulin-binding, Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 96.7"	"Cell type enhanced"	"Detected in many"		"Gastric mucus-secreting cells: 151.4;Glandular and luminal cells: 139.3;Squamous epithelial cells: 160.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"hTCEpi: 46.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA050760, HPA053003"	Approved		Supported	"Nuclear speckles"		No	No			"Cluster 10: Basophils - Unknown function"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 44: Endometrium - Transcription"	"Nuclear speckles"		"HPA050760: AB_2681227, HPA053003: AB_2682011"	"unprognostic (4.27e-2)"	"unprognostic (3.73e-2)"	"unprognostic (8.31e-2)"	"unprognostic (9.12e-3)"	"unprognostic (1.10e-2)"	"unprognostic (9.81e-2)"	"unprognostic (6.06e-2)"	"prognostic unfavorable (4.91e-4)"	"unprognostic (1.48e-1)"	"unprognostic (1.54e-3)"	"unprognostic (1.84e-3)"	"unprognostic (2.63e-1)"	"unprognostic (2.59e-1)"	"unprognostic (1.70e-1)"	"unprognostic (2.86e-2)"	"unprognostic (3.45e-2)"	"unprognostic (3.32e-1)"	45.3	13.9	11.2	10.8	9.6	3.5	29.4	9.4	10.7	32.6	11.6	16.8	11.7	18.6	4.7	96.7	25.0	23.0	19.3	10.0	10.7	18.8	17.7	41.8	6.0	15.0	11.5	12.9	22.8	10.3	22.0	10.3	11.6	27.1	6.8	5.5	31.1	10.5	18.4	51.0	16.9	16.3	10.8	14.5	26.3	6.0	15.2	8.7	17.2	8.9	13.9	22.4	42.0	9.3	12.9	12.0	7.3	11.5	32.2	27.8	11.6	7.5	15.7	7.6	6.7	17.3	13.1	3.5	8.5	9.7	5.7	13.3	7.3	32.6	3.1	6.7	7.5	2.7	4.5	12.3	31.8	3.0	3.6	38.8	46.4	7.2	26.5	10.3	18.9	5.0	10.6	6.1	7.5	15.7	4.4	4.5	3.7	29.4	5.4	4.7	3.6	4.9	12.0	21.5	5.2	6.5	7.6	30.5	7.2	8.4	14.1	7.6	12.2	4.9	7.3	3.3	5.1	3.5	0.9	3.7	7.6	3.1	5.4	0.9	0.7	0.4	0.8	0.3	0.3	0.3	0.6	0.4	0.3	0.7	0.4	0.5	0.3	0.2	0.5	0.5	0.6	0.4	11.2	9.6	9.4	10.7	10.0	10.7	15.0	11.5	11.6	10.8	15.2	9.3	75.4	86.6	35.2	6.5	2.7	60.4	72.4	17.4	39.9	10.0	88.4	44.4	4.1	7.2	29.7	3.7	0.0	7.7	2.8	57.7	1.9	13.9	2.1	67.5	23.2	26.4	16.7	3.2	7.4	12.3	5.5	20.1	151.4	139.3	3.8	4.3	25.7	6.8	2.9	5.0	6.0	27.2	2.0	7.8	9.6	2.2	11.8	6.8	19.6	6.5	3.1	3.7	3.1	9.0	3.5	23.2	50.8	7.5	1.2	65.3	28.7	4.4	29.4	6.2	0.0	7.1	10.1	1.9	2.0	160.8	53.4	16.8	5.2	4.6	18.0	98.6
ITPR2	"CFAP48, IP3R2"	ENSG00000123104	"Inositol 1,4,5-trisphosphate receptor type 2"	Q14571	12	26335352-26833194	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel, Ligand-gated ion channel, Receptor"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 44.3"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 551.4;Excitatory neurons: 287.2;Microglial cells: 802.9;Oligodendrocyte precursor cells: 441.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 32.4"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"TIME: 62.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA059144, HPA062260"	Uncertain		Supported	"Nucleoplasm,Endoplasmic reticulum"		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 15: Liver - Metabolism"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Endoplasmic reticulum"	Nucleoplasm	"HPA059144: AB_2683925, HPA062260: AB_2684728"	"unprognostic (5.65e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.22e-1)"	"unprognostic (4.53e-1)"	"unprognostic (2.25e-1)"	"unprognostic (2.37e-2)"	"unprognostic (3.59e-3)"	"unprognostic (8.70e-2)"	"unprognostic (1.66e-1)"	"unprognostic (8.61e-2)"	"unprognostic (2.06e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.54e-2)"	"unprognostic (2.82e-1)"	"unprognostic (9.13e-2)"	"unprognostic (3.99e-2)"	"unprognostic (3.76e-1)"	8.3	10.4	10.5	8.1	7.3	6.0	17.3	6.3	9.7	4.8	3.4	6.2	5.3	5.2	5.7	7.4	5.5	5.5	3.7	7.7	8.7	12.6	44.3	5.6	7.9	19.1	13.2	5.9	7.7	11.4	2.2	10.9	14.9	5.5	6.6	8.8	16.9	2.9	1.8	10.2	4.9	4.5	13.1	6.7	5.2	2.5	16.1	20.1	4.3	4.1	6.8	4.9	4.7	15.6	4.9	2.0	2.9	4.6	8.5	8.6	3.0	4.4	6.1	3.0	3.1	0.2	2.4	16.5	2.7	5.9	3.3	5.2	15.1	9.3	4.0	3.9	5.1	13.5	4.4	27.1	7.9	12.0	5.8	8.1	1.2	6.3	11.6	6.2	28.5	6.5	6.4	5.1	3.9	4.0	8.6	17.8	12.2	4.4	1.5	2.9	7.0	10.7	7.3	7.4	0.9	4.5	19.8	3.5	11.4	11.3	7.7	6.0	62.6	6.0	2.3	5.9	5.7	4.9	4.2	31.2	5.7	5.6	3.9	32.4	6.4	9.9	2.9	2.7	2.5	5.4	2.6	2.4	1.4	5.0	3.0	2.7	17.3	4.8	4.3	11.9	4.4	1.0	10.5	7.3	6.3	9.7	7.7	8.7	19.1	13.2	14.9	13.1	16.1	15.6	27.1	48.1	52.9	551.4	45.7	20.9	17.8	3.3	31.3	3.2	87.0	57.1	24.5	34.3	8.6	23.9	146.0	21.0	39.1	7.7	7.9	20.8	3.1	13.3	64.9	38.5	78.5	33.4	287.2	23.4	9.5	20.3	16.8	22.7	44.4	60.0	25.0	123.7	39.5	0.0	99.1	46.1	32.6	46.3	8.2	6.7	18.0	68.7	33.8	802.9	28.2	13.0	41.2	441.8	22.3	17.6	37.0	17.7	83.6	25.9	14.5	14.6	5.0	64.7	0.0	22.7	17.6	3.6	6.3	54.3	26.7	27.9	29.2	43.4	11.7	15.8
ITPRID2	"CS-1, KIAA1927, KRAP, SPAG13, SSFA2"	ENSG00000138434	"ITPR interacting domain containing 2"	P28290	2	181891730-181930738	"Plasma proteins, Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 175.8"	"Cell type enhanced"	"Detected in some"		"Adipocytes: 30.7;Cardiomyocytes: 30.0;Cytotrophoblasts: 25.7;Extravillous trophoblasts: 26.8;Hofbauer cells: 20.4;Syncytiotrophoblasts: 33.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"dendritic cells: 2.7;granulocytes: 6.1;monocytes: 5.1"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034665, HPA039989"	Uncertain		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 22: Non-specific - Unknown function"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 24: Non-specific - Transcription regulation"	"Plasma membrane, Cytosol"	Nucleoplasm	"HPA034665: AB_2674271, HPA039989: AB_2676788"	"unprognostic (1.68e-1)"	"unprognostic (3.27e-2)"	"unprognostic (2.17e-2)"	"unprognostic (4.70e-2)"	"unprognostic (8.77e-2)"	"unprognostic (8.87e-2)"	"unprognostic (2.13e-1)"	"unprognostic (4.74e-2)"	"unprognostic (5.63e-2)"	"unprognostic (1.23e-2)"	"prognostic unfavorable (8.19e-4)"	"unprognostic (6.95e-2)"	"prognostic favorable (2.91e-5)"	"unprognostic (3.39e-1)"	"unprognostic (5.54e-2)"	"unprognostic (4.95e-2)"	"prognostic unfavorable (5.79e-5)"	30.8	20.7	55.0	20.6	62.9	42.4	32.1	57.2	66.2	30.9	50.3	50.4	36.4	25.8	18.4	22.8	20.3	37.7	24.4	45.5	61.5	48.4	79.3	44.9	17.6	65.2	60.5	13.6	175.8	20.9	18.3	34.7	63.3	34.0	44.2	16.9	69.9	17.1	31.9	112.9	34.0	25.6	57.3	32.4	56.1	37.4	62.6	24.1	36.5	23.4	16.0	31.3	29.5	61.1	56.0	25.8	71.6	12.6	53.8	41.3	21.7	94.6	82.6	29.1	37.0	25.9	56.0	1.2	30.7	59.7	31.5	46.2	14.5	41.6	56.6	25.2	20.3	52.5	106.6	23.5	45.7	28.5	48.9	30.0	64.4	51.3	57.7	66.7	145.8	22.3	25.0	29.5	82.9	28.7	25.4	41.0	5.0	47.0	62.5	18.7	29.3	19.2	87.0	16.3	13.7	12.1	55.7	19.7	91.0	27.6	14.2	61.6	68.1	73.1	37.0	27.5	50.3	20.9	9.4	21.9	34.0	17.1	57.2	6.1	2.8	4.2	0.9	2.7	0.6	0.4	0.6	0.6	2.7	0.9	0.8	0.7	4.7	0.8	5.1	2.1	0.4	1.3	55.0	62.9	57.2	66.2	45.5	61.5	65.2	60.5	63.3	57.3	62.6	61.1	30.7	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	30.0	0.0	0.0	0.0	0.0	25.7	5.8	0.0	0.0	0.0	0.0	0.0	0.0	9.4	0.0	0.0	0.0	0.0	26.8	7.7	0.0	0.0	0.0	0.0	0.0	0.0	20.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.9	0.0	0.0	0.0	0.0	33.4	1.1	0.0	0.0	0.0
ITSN1	"ITSN, MGC134948, MGC134949, SH3D1A, SH3P17"	ENSG00000205726	"Intersectin 1"	Q15811	21	33642400-33899861	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Endocytosis, Exocytosis, Host-virus interaction, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 217.4;Inhibitory neurons: 151.9;Rod photoreceptor cells: 146.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"eosinophil: 5.5;non-classical monocyte: 5.1"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"BEWO: 115.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018007	Approved		Supported	"Plasma membrane"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 9: Photoreceptor cells - Phototransduction"	"Plasma membrane"		"HPA018007: AB_1851836"	"unprognostic (2.12e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.21e-1)"	"unprognostic (3.91e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.10e-1)"	"unprognostic (3.94e-2)"	"unprognostic (7.33e-3)"	"unprognostic (1.31e-2)"	"unprognostic (3.23e-1)"	"unprognostic (3.25e-2)"	"unprognostic (1.16e-2)"	"unprognostic (6.78e-3)"	"unprognostic (2.37e-1)"	"unprognostic (6.02e-2)"	"unprognostic (5.64e-2)"	55.5	15.5	18.0	9.9	18.4	6.8	27.9	16.4	26.2	19.8	22.8	14.7	8.9	20.3	12.0	11.4	16.7	19.8	20.9	18.3	14.0	10.9	26.4	11.5	6.8	14.5	13.6	19.6	5.0	7.0	6.7	24.4	14.9	14.5	11.0	28.5	7.9	22.3	22.0	11.9	9.7	18.4	8.8	15.4	11.1	12.3	17.0	5.0	10.3	22.0	3.9	15.4	13.4	14.1	36.3	14.9	70.4	23.4	32.3	30.8	115.3	35.8	34.4	20.6	19.8	56.7	27.0	8.5	28.3	43.1	42.7	13.7	42.2	24.9	22.0	3.5	18.6	10.3	30.9	26.7	24.4	7.4	9.9	30.5	22.0	38.6	21.2	23.5	55.3	9.8	13.7	5.8	33.4	8.2	10.3	9.8	104.5	12.6	11.3	13.2	33.7	17.6	30.9	14.7	13.2	14.4	51.4	10.6	12.6	44.6	13.0	7.2	50.2	22.9	30.9	18.1	12.5	7.0	20.8	7.9	20.8	22.9	26.0	0.0	4.2	5.5	0.3	3.2	0.3	0.0	0.5	0.1	1.3	0.0	0.2	0.1	0.2	0.1	5.1	0.3	0.0	0.8	18.0	18.4	16.4	26.2	18.3	14.0	14.5	13.6	14.9	8.8	17.0	14.1	19.8	25.6	18.6	217.4	1.8	18.1	22.6	10.8	36.5	73.1	12.2	8.1	81.8	18.6	14.5	11.0	91.8	20.8	1.1	22.4	0.0	19.9	10.2	13.3	67.7	21.3	9.1	47.4	110.9	12.5	28.0	31.9	19.4	21.0	2.5	30.7	28.2	54.2	55.6	65.6	151.9	7.2	20.3	30.0	10.9	8.6	24.8	27.3	10.6	74.0	10.8	46.9	0.0	80.4	46.4	37.1	10.3	71.5	3.1	18.3	16.8	16.6	18.8	146.2	13.1	20.1	39.7	32.4	47.7	8.9	11.8	15.6	2.7	21.4	10.5	27.2
IVD	ACAD2	ENSG00000128928	"Isovaleryl-CoA dehydrogenase"	P26440	15	40405485-40435947	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	Oxidoreductase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Hepatocytes: 135.0;Theca cells: 105.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041391, HPA044250"	Enhanced		Supported	Nucleoplasm,Mitochondria		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 35: Non-specific - Unknown function"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 52: Non-specific - Transcription"	Mitochondria	Nucleoplasm	"HPA041391: AB_2677449, HPA044250: AB_2678875"	"unprognostic (9.30e-2)"	"unprognostic (3.31e-1)"	"unprognostic (1.36e-2)"	"unprognostic (4.24e-2)"	"unprognostic (7.53e-2)"	"unprognostic (1.74e-1)"	"prognostic favorable (1.95e-5)"	"unprognostic (1.50e-2)"	"unprognostic (2.53e-1)"	"unprognostic (2.84e-2)"	"unprognostic (4.08e-2)"	"unprognostic (2.31e-1)"	"prognostic favorable (2.91e-9)"	"unprognostic (1.40e-1)"	"unprognostic (3.40e-2)"	"unprognostic (1.14e-1)"	"unprognostic (5.46e-3)"	25.8	80.5	35.1	14.5	40.8	15.9	45.3	35.6	40.8	29.4	39.5	31.6	24.3	26.4	29.0	16.0	35.0	21.5	61.7	34.0	41.5	59.1	145.4	24.3	19.6	40.2	38.8	43.3	27.4	39.2	58.3	15.3	37.5	42.1	27.2	13.0	31.8	36.8	55.7	8.6	26.8	23.8	37.9	27.9	46.7	25.0	44.5	16.8	119.2	55.4	19.5	31.1	20.8	45.3	20.9	11.9	22.9	38.9	35.9	32.9	1.0	27.6	32.7	39.4	24.0	36.5	16.0	0.8	57.7	43.4	32.6	20.8	45.9	46.6	30.1	36.4	34.0	52.1	36.2	38.9	64.6	22.0	48.5	45.3	18.5	23.5	55.3	46.3	38.8	60.4	2.5	2.4	42.1	27.1	27.3	38.9	17.8	1.3	33.0	41.2	32.6	27.9	45.2	51.6	37.3	21.5	38.2	83.4	18.7	21.5	69.0	117.6	27.6	29.9	20.2	23.6	24.9	54.5	38.5	1.0	30.9	22.8	28.4	17.0	24.8	36.7	33.3	36.1	31.0	27.5	18.5	26.6	58.8	27.6	18.5	26.7	2.3	39.4	73.1	89.2	26.9	24.3	35.1	40.8	35.6	40.8	34.0	41.5	40.2	38.8	37.5	37.9	44.5	45.3	13.1	28.9	54.5	27.4	19.0	2.3	21.0	17.3	13.1	26.0	27.5	22.2	88.0	45.8	29.9	44.1	14.6	20.3	34.0	17.9	95.9	19.7	5.4	21.4	31.0	18.6	19.7	21.3	15.3	14.9	7.3	20.2	29.6	19.9	34.7	46.5	21.4	135.0	28.1	16.8	16.6	24.4	14.2	18.3	6.2	7.4	20.5	18.6	5.4	21.5	28.8	26.0	26.8	25.1	21.4	14.8	9.4	24.8	10.0	16.6	22.0	97.3	29.3	19.9	19.7	25.0	18.2	16.1	3.7	17.4	0.6	9.9	18.0	105.7	35.4	11.9
IVL		ENSG00000163207	Involucrin	P07476	1	152908546-152911886	"Plasma proteins, Predicted intracellular proteins"	Keratinization			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"cervix: 162.3;esophagus: 298.3;salivary gland: 94.5;skin 1: 160.9;vagina: 235.2"	"Cell type enhanced"	"Detected in some"		"Club cells: 10.4;Squamous epithelial cells: 30.8;Suprabasal keratinocytes: 71.0;Urothelial cells: 13.3"	"Group enriched"	"Detected in many"	5	"cervical cancer: 44.0;head and neck cancer: 145.4;melanoma: 50.9;urothelial cancer: 47.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	25	"HaCaT: 292.9;RT4: 76.9;SK-BR-3: 86.3"					"Not detected"	"Not detected"			"CAB002243, HPA055211"	Enhanced		Supported	"Nuclear bodies,Centrosome,Cytosol"		NA	NA		4700000		"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 61: Squamous epithelial cells - Keratinization"	Cytosol	"Nuclear bodies, Centrosome"	"CAB002243: AB_563785, HPA055211: AB_2682739"	"unprognostic (3.29e-4)"	"unprognostic (1.91e-1)"		"unprognostic (2.92e-2)"		"unprognostic (2.31e-2)"		"unprognostic (7.60e-2)"	"unprognostic (2.22e-1)"		"unprognostic (4.82e-2)"	"unprognostic (3.11e-1)"		"unprognostic (3.66e-1)"		"unprognostic (1.22e-2)"	"unprognostic (1.32e-1)"	0.3	0.1	0.0	0.0	0.0	0.0	5.6	0.0	0.0	162.3	0.0	0.0	0.0	0.0	18.2	298.3	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.6	0.0	0.0	94.5	0.1	0.4	160.9	0.1	0.0	0.0	0.1	0.2	0.1	0.0	3.5	0.1	0.0	36.9	17.4	235.2	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.0	0.0	0.0	6.0	0.0	0.0	0.2	0.0	292.9	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	3.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	76.9	0.0	0.0	0.0	86.3	0.0	0.2	3.6	0.0	0.0	0.0	0.2	0.8	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.6	3.1	3.5	0.0	0.0	0.0	0.0	0.1	0.0	10.4	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	1.2	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	1.1	0.0	0.0	0.0	0.6	0.0	0.0	30.8	71.0	0.0	0.1	0.0	0.0	13.3
IVNS1ABP	"ARA3, HSPC068, KIAA0850, KLHL39, ND1, NS-1, NS1-BP"	ENSG00000116679	"Influenza virus NS1A binding protein"	Q9Y6Y0	1	185296388-185317273	"Predicted intracellular proteins"	"Host-virus interaction"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"bone marrow: 452.5"	"Cell type enhanced"	"Detected in all"		"Granulosa cells: 309.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RPTEC TERT1: 250.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003405	Approved		Supported	Cytosol		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 40: Granulosa cells - Unknown function"	Cytosol		"HPA003405: AB_1079141"	"unprognostic (4.11e-3)"	"unprognostic (9.69e-2)"	"unprognostic (4.29e-2)"	"unprognostic (1.77e-1)"	"unprognostic (2.03e-2)"	"unprognostic (4.42e-2)"	"unprognostic (4.31e-3)"	"unprognostic (4.18e-1)"	"unprognostic (7.04e-2)"	"unprognostic (5.13e-2)"	"unprognostic (4.28e-1)"	"unprognostic (5.42e-3)"	"unprognostic (1.85e-3)"	"unprognostic (3.73e-2)"	"unprognostic (1.28e-1)"	"unprognostic (4.07e-2)"	"unprognostic (4.13e-2)"	43.9	17.8	16.7	46.6	26.5	452.5	50.5	21.1	20.8	24.9	26.9	40.2	38.4	22.4	18.1	27.0	19.6	36.4	28.9	15.2	19.7	94.1	23.0	27.7	26.4	20.9	18.3	28.4	25.5	32.4	17.3	26.0	22.3	22.2	51.1	15.0	55.2	26.4	23.1	33.5	34.8	16.9	18.3	27.3	42.2	15.9	20.0	24.9	34.3	21.6	24.1	37.7	29.8	35.0	24.6	22.1	79.2	31.6	27.1	9.0	68.4	46.6	15.3	30.1	27.5	26.2	39.7	36.8	36.8	24.0	13.4	32.9	29.0	31.8	32.1	24.9	21.6	36.8	39.1	22.6	10.9	26.2	13.9	6.7	35.7	23.1	73.2	67.6	39.6	38.6	23.6	21.2	54.6	18.0	44.6	18.1	48.7	61.8	5.6	24.7	20.2	21.0	250.7	31.4	52.5	44.5	40.6	35.4	31.4	103.4	16.2	13.3	27.2	41.9	24.5	10.4	34.9	28.0	23.8	22.8	32.1	26.0	19.4	7.9	10.9	10.5	10.5	7.1	9.6	6.1	8.0	7.7	12.6	3.7	8.5	8.3	33.0	10.4	10.3	3.4	8.9	12.1	16.7	26.5	21.1	20.8	15.2	19.7	20.9	18.3	22.3	18.3	20.0	35.0	159.1	44.8	59.0	13.7	61.3	188.9	90.4	40.9	163.4	14.5	74.0	51.3	56.0	22.8	57.4	128.8	52.1	17.3	102.0	288.3	164.4	41.6	34.4	93.2	36.7	85.8	60.4	52.8	18.2	41.5	67.5	50.3	90.7	159.7	41.1	309.2	26.4	23.3	34.8	21.9	26.2	109.6	36.7	107.2	242.3	34.9	5.9	141.5	101.4	33.7	41.3	11.3	63.8	37.7	72.9	24.0	56.4	2.6	62.7	60.9	103.2	86.3	45.8	32.7	6.6	51.4	52.6	33.2	19.8	108.9	181.6	18.3	120.0	54.2	102.7	91.7
IYD	"C6orf71, DEHAL1, dJ422F24.1"	ENSG00000009765	"Iodotyrosine deiodinase"	Q6PHW0	6	150368892-150405969	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted membrane proteins"		Oxidoreductase	"Congenital hypothyroidism, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	14	"thyroid gland: 472.7"	"Cell type enhanced"	"Detected in some"		"Distal enterocytes: 23.7;Hepatocytes: 25.1;Intestinal goblet cells: 21.8;Paneth cells: 22.5;Proximal enterocytes: 89.1;Proximal tubular cells: 35.4"	"Cancer enriched"	"Detected in many"	20	"thyroid cancer: 80.7"	"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in some"		"neutrophil: 1.9"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in some"	7	"CACO-2: 1.3;OE19: 3.0;SK-BR-3: 3.2"	"Group enriched"	"Detected in some"	13	"hippocampal formation: 7.4;thalamus: 2.4"	"Low region specificity"	"Detected in all"			HPA059627	Enhanced		Supported	"Plasma membrane"		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 45: Enterocytes - Digestion"	"Plasma membrane"		"HPA059627: AB_2684086"	"unprognostic (3.73e-4)"	"unprognostic (2.93e-2)"	"unprognostic (5.97e-2)"	"unprognostic (1.95e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.98e-2)"	"prognostic favorable (6.22e-4)"	"unprognostic (1.11e-1)"	"unprognostic (3.80e-2)"	"unprognostic (1.17e-1)"	"unprognostic (7.41e-2)"	"unprognostic (1.02e-1)"	"unprognostic (3.07e-9)"	"unprognostic (9.79e-3)"	"unprognostic (2.04e-1)"	"unprognostic (2.03e-2)"	"unprognostic (2.18e-2)"	0.1	0.0	0.4	0.6	0.3	0.3	0.5	0.6	0.6	0.1	0.2	6.4	18.1	0.2	0.6	0.0	0.0	8.9	0.5	0.3	0.1	26.6	33.6	0.7	0.5	0.5	0.4	0.0	0.4	0.0	0.0	0.0	0.6	0.2	6.5	0.2	0.1	0.0	0.0	0.2	19.6	0.2	0.0	0.1	2.0	0.2	0.5	0.0	472.7	0.0	0.2	0.1	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.3	0.1	0.0	0.0	0.0	0.0	1.3	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.2	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.1	3.0	0.1	0.0	0.1	0.1	0.0	0.2	0.1	0.0	0.0	3.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.1	0.0	1.6	0.5	0.3	0.2	0.4	0.2	0.2	0.1	0.1	0.0	0.4	0.2	0.2	1.9	0.7	0.2	0.3	0.2	1.3	0.4	0.3	0.6	0.6	0.3	0.1	0.5	0.4	0.6	0.0	0.5	0.5	0.7	3.2	7.8	0.0	0.0	0.1	0.6	0.2	0.0	0.1	0.3	0.4	0.8	14.3	8.9	0.0	0.0	0.1	0.0	23.7	1.9	0.3	0.0	0.9	0.3	0.4	3.6	2.7	0.1	0.2	0.0	0.7	0.0	2.2	1.3	0.1	1.1	25.1	0.1	0.0	0.1	21.8	0.0	0.0	1.2	0.1	0.0	0.7	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.4	22.5	0.0	0.0	1.0	89.1	35.4	3.6	1.3	0.0	1.7	0.3	0.1	0.1	0.0	0.4	0.3	0.9	0.4	11.5	0.7
JAG2		ENSG00000184916	"Jagged canonical Notch ligand 2"	Q9Y219	14	105140982-105168824	"Predicted membrane proteins"	"Notch signaling pathway"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 56.1;Basal respiratory cells: 30.9;Basal squamous epithelial cells: 27.3;Breast myoepithelial cells: 26.4;Endothelial cells: 34.2;Horizontal cells: 26.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HaCaT: 62.6;HBEC3-KT: 21.0;SCLC-21H: 31.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB025481, HPA030636, HPA050567"	Approved		Supported	Vesicles,Cytosol		NA	NA		370000		"Cluster 31: Skin - Epidermis development"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Vesicles	Cytosol	"CAB025481: , HPA030636: AB_10602607, HPA050567: AB_2681178"	"unprognostic (6.74e-2)"	"unprognostic (4.49e-2)"	"unprognostic (4.28e-2)"	"unprognostic (6.97e-3)"	"unprognostic (3.50e-1)"	"unprognostic (2.13e-2)"	"unprognostic (1.01e-1)"	"unprognostic (6.84e-2)"	"unprognostic (1.18e-2)"	"unprognostic (2.62e-1)"	"unprognostic (1.67e-2)"	"unprognostic (9.19e-2)"	"unprognostic (8.47e-3)"	"unprognostic (1.46e-1)"	"unprognostic (2.58e-1)"	"unprognostic (2.39e-1)"	"unprognostic (2.17e-1)"	7.2	1.0	4.0	1.3	3.6	0.1	9.6	0.9	5.0	4.6	0.5	3.1	1.1	5.3	0.4	8.8	5.3	1.8	12.8	3.5	7.4	4.3	0.9	5.1	0.7	4.6	4.4	1.5	6.8	1.5	17.4	3.0	6.8	8.1	0.2	0.8	7.8	2.8	9.7	19.5	4.0	1.1	2.5	2.0	3.0	3.2	6.5	1.6	4.7	2.8	0.6	5.2	6.8	1.6	16.8	6.7	0.4	1.7	0.0	0.0	20.0	0.2	0.1	0.0	0.0	5.6	20.1	0.0	13.8	0.0	0.1	62.6	4.0	21.0	0.0	2.3	9.7	0.0	20.0	0.0	0.2	0.1	3.9	0.2	9.9	0.0	2.3	0.2	5.1	0.9	4.1	0.0	0.0	7.6	0.0	0.0	2.0	2.1	2.3	5.3	3.9	7.2	0.1	4.4	31.4	1.0	5.6	1.3	0.2	0.3	15.8	2.5	17.2	0.1	1.7	0.0	0.2	0.9	0.1	0.1	0.2	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	3.6	0.9	5.0	3.5	7.4	4.6	4.4	6.8	2.5	6.5	1.6	56.1	6.4	3.2	1.0	0.2	23.3	7.6	30.9	27.3	2.7	3.8	26.4	6.7	2.8	7.6	0.0	25.0	2.2	2.2	2.7	0.0	3.9	0.1	16.5	0.9	34.2	0.0	0.0	12.1	2.7	1.0	1.8	2.0	7.4	0.0	1.1	7.9	0.6	0.7	26.9	9.9	3.6	4.1	0.8	2.9	1.0	1.5	1.1	7.2	15.0	1.3	0.6	1.0	0.5	1.1	3.3	2.1	0.7	0.9	4.4	8.2	0.3	11.5	4.8	0.0	3.7	3.7	0.8	13.5	6.0	6.8	1.4	3.4	0.3	2.7	1.5
JAK2	JTK10	ENSG00000096968	"Janus kinase 2"	O60674	9	4984390-5129948	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Adaptive immunity, Immunity, Innate immunity"	"Chromatin regulator, Kinase, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease variant, FDA approved drug targets, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 93.4;Inhibitory neurons: 122.3;Microglial cells: 106.8;Oligodendrocyte precursor cells: 69.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 132.5"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 132.5"	"Group enriched"	"Detected in many"	5	"ASC diff: 42.2;HDLM-2: 75.0;HEL: 154.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013089, HPA040820, HPA043870"	Approved		Supported	"Nucleoplasm,Plasma membrane,Focal adhesion sites"		No	No			"Cluster 46: Basophils - DNA binding"	"Cluster 16: Immune cells - Immune response"	"Cluster 36: HEL - Hemostasis"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm	"Plasma membrane, Focal adhesion sites"	"CAB013089: AB_2533647, HPA040820: AB_2677151, HPA043870: AB_2678708"	"unprognostic (2.24e-3)"	"unprognostic (2.76e-2)"	"unprognostic (1.50e-2)"	"unprognostic (7.67e-2)"	"unprognostic (5.50e-2)"	"unprognostic (3.09e-2)"	"unprognostic (1.48e-1)"	"unprognostic (7.36e-2)"	"unprognostic (1.09e-1)"	"unprognostic (5.49e-3)"	"unprognostic (1.58e-1)"	"unprognostic (1.72e-2)"	"unprognostic (3.85e-1)"	"unprognostic (4.53e-2)"	"unprognostic (3.43e-2)"	"unprognostic (1.96e-1)"	"unprognostic (7.37e-3)"	15.6	7.6	3.2	19.2	3.7	21.7	8.9	6.3	9.1	8.5	1.1	6.7	6.5	11.3	8.6	8.8	8.0	10.5	24.5	2.7	3.1	6.8	4.5	10.9	18.2	3.3	1.8	11.5	3.8	6.5	2.9	11.0	2.0	6.8	6.5	12.8	4.0	6.2	9.8	11.2	7.7	9.5	3.5	17.6	13.4	9.8	1.7	7.5	4.8	8.9	12.7	11.7	9.1	3.9	6.8	3.7	3.7	6.3	42.2	12.4	1.1	9.1	8.6	7.2	4.6	1.2	2.0	0.3	2.1	5.4	5.4	2.3	4.4	5.1	4.9	75.0	1.4	154.7	7.6	1.7	10.0	10.5	7.1	9.5	2.1	2.8	4.5	7.6	6.6	5.1	10.9	17.4	11.6	2.2	2.9	12.8	3.3	3.3	4.3	5.1	8.2	2.2	4.7	3.5	4.2	2.4	2.6	3.5	2.8	3.6	2.0	15.4	13.1	10.2	3.6	10.7	6.4	3.1	6.4	1.5	13.6	4.7	5.3	132.5	20.5	38.2	5.6	20.1	4.5	5.6	4.1	3.1	26.5	4.9	2.2	2.8	19.2	9.6	16.4	9.7	4.5	7.7	3.2	3.7	6.3	9.1	2.7	3.1	3.3	1.8	2.0	3.5	1.7	3.9	14.3	16.0	7.9	31.6	12.9	9.7	3.3	4.9	10.8	8.0	5.2	3.4	30.0	0.0	6.7	7.3	8.4	1.9	13.9	11.7	1.9	3.3	8.6	5.1	11.2	9.4	3.0	19.8	93.4	3.9	0.9	8.9	38.7	5.6	14.0	11.4	4.6	1.9	14.2	8.4	122.3	4.5	0.0	33.6	28.8	7.1	23.6	38.9	5.4	106.8	49.5	12.6	8.2	69.9	42.3	7.0	20.9	33.4	10.7	3.0	3.9	3.3	7.1	11.2	0.0	9.7	12.5	15.0	5.5	11.6	8.4	3.4	10.4	5.1	4.1	4.5
JAKMIP2	"JAMIP2, KIAA0555"	ENSG00000176049	"Janus kinase and microtubule interacting protein 2"	Q96AA8	5	147585438-147782775	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 24.8"	"Group enriched"	"Detected in many"	6	"Astrocytes: 195.5;Excitatory neurons: 250.7;Horizontal cells: 85.8;Inhibitory neurons: 229.4;Oligodendrocyte precursor cells: 159.3;Oligodendrocytes: 198.5"	"Cancer enriched"	"Detected in some"	6	"glioma: 4.8"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"gdT-cell: 7.3;MAIT T-cell: 5.3;memory CD4 T-cell: 2.8;memory CD8 T-cell: 5.5;naive CD8 T-cell: 4.6;NK-cell: 7.0"	"Group enriched"	"Detected in many"	6	"NK-cells: 7.0;T-cells: 7.3"	"Cell line enhanced"	"Detected in many"		"AF22: 19.9;Karpas-707: 47.5;RH-30: 47.8;RPMI-8226: 16.0;SCLC-21H: 22.4;SH-SY5Y: 15.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046929, HPA065023"	Approved		Supported	"Golgi apparatus"		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Golgi apparatus"		"HPA046929: AB_2679867, HPA065023: AB_2685407"	"unprognostic (3.69e-2)"	"unprognostic (4.22e-3)"	"unprognostic (9.92e-2)"	"unprognostic (3.58e-2)"	"unprognostic (1.63e-1)"	"unprognostic (3.29e-1)"	"unprognostic (1.26e-1)"	"unprognostic (6.71e-2)"	"unprognostic (1.09e-1)"	"unprognostic (3.69e-1)"	"unprognostic (2.21e-4)"	"unprognostic (1.28e-1)"	"unprognostic (5.20e-8)"	"unprognostic (1.54e-3)"	"unprognostic (1.30e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.31e-1)"	0.2	3.3	11.4	1.0	12.5	0.5	0.1	24.8	14.3	0.5	0.1	2.2	0.4	1.0	0.2	1.3	0.1	1.4	0.4	11.4	12.1	0.3	2.6	2.0	0.9	11.7	11.8	0.1	0.8	1.0	8.3	0.1	12.4	0.6	0.5	5.3	0.2	0.4	0.0	0.3	0.6	1.5	10.4	0.8	1.8	2.9	13.0	7.0	0.1	1.6	0.9	0.7	0.2	16.6	0.0	0.0	19.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	8.1	0.0	0.0	4.8	0.1	0.0	0.0	0.0	3.1	6.9	2.0	0.0	0.0	0.3	0.0	5.7	2.4	0.0	0.0	0.0	0.0	0.0	0.7	0.0	47.5	0.0	0.1	5.1	0.0	11.4	0.1	0.1	2.0	47.8	16.0	0.0	0.1	22.4	15.4	0.0	0.3	0.1	2.5	0.0	0.0	0.0	3.5	4.0	0.0	1.1	3.3	2.0	4.6	8.9	0.0	0.0	0.0	0.0	0.4	7.3	0.0	5.3	0.7	2.8	5.5	0.1	0.3	0.7	4.6	0.5	7.0	0.2	1.1	1.3	1.5	11.4	12.5	24.8	14.3	11.4	12.1	11.7	11.8	12.4	10.4	13.0	16.6	0.2	0.0	1.5	195.5	1.5	0.0	0.0	0.0	0.0	23.2	0.0	0.1	0.7	0.0	1.3	0.0	2.1	0.0	13.3	0.0	0.0	0.8	11.3	0.2	0.5	0.3	1.2	3.0	250.7	0.0	0.0	1.2	0.5	0.1	29.1	10.3	0.7	3.1	1.3	85.8	229.4	0.8	0.0	0.9	0.0	8.4	0.0	4.2	0.0	11.2	0.4	24.4	23.7	159.3	198.5	0.2	0.0	0.0	3.1	0.0	0.1	0.1	1.5	7.9	0.0	0.4	0.7	7.8	2.0	0.1	0.1	0.3	13.8	18.9	0.0	0.3
JAM2	"C21orf43, CD322, JAM-B, JAMB, VE-JAM"	ENSG00000154721	"Junctional adhesion molecule 2"	P57087	21	25639258-25717562	"CD markers, Disease related genes, Human disease related genes, Predicted membrane proteins"			"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 63.5"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 173.8;Astrocytes: 81.6;Endothelial cells: 148.7;Hepatic stellate cells: 112.8;Microglial cells: 82.4;Oligodendrocyte precursor cells: 76.9"	"Cancer enriched"	"Detected in all"	9	"glioma: 27.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 25.5;BJ hTERT+: 16.5;HDLM-2: 16.7;hTERT-RPE1: 22.5;U-138 MG: 18.1;U-87 MG: 13.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028789, HPA077346"			Supported	"Nucleoplasm,Plasma membrane"		NA	NA		360000	"Cluster 11: Basophils - Unknown function"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 12: NES - Nervous system development"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Plasma membrane"	Nucleoplasm	"HPA028789: AB_2732443, HPA077346: AB_2732341"	"unprognostic (1.42e-1)"	"unprognostic (6.39e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.73e-1)"	"unprognostic (2.02e-2)"	"unprognostic (1.53e-2)"	"unprognostic (7.51e-4)"	"unprognostic (2.61e-2)"	"unprognostic (4.55e-1)"	"unprognostic (1.02e-1)"	"unprognostic (3.46e-2)"	"unprognostic (3.81e-1)"	"unprognostic (8.86e-2)"	"unprognostic (5.71e-3)"	"unprognostic (2.18e-1)"	"unprognostic (2.20e-1)"	"unprognostic (4.85e-3)"	20.5	15.8	16.6	3.7	21.5	0.3	16.8	24.0	21.8	16.8	12.8	17.8	6.1	18.5	11.2	7.1	16.1	12.9	19.2	19.2	22.0	9.2	2.2	15.5	3.6	25.9	23.1	16.1	2.8	4.3	8.1	63.5	21.3	9.4	7.9	7.1	6.1	15.4	7.8	5.5	10.7	19.6	26.8	1.6	10.2	17.6	25.2	2.6	10.3	13.2	5.0	11.6	13.2	23.0	0.0	0.0	25.5	0.1	1.0	0.2	0.5	0.8	16.5	2.0	7.6	0.0	0.0	0.1	0.0	0.2	9.7	0.1	2.2	0.0	4.6	16.7	0.7	0.1	0.1	0.1	0.0	0.1	0.1	1.4	0.0	1.8	0.1	22.5	0.0	0.6	0.0	0.2	8.0	0.0	0.4	0.1	8.1	0.2	0.0	3.2	5.3	0.1	0.0	0.0	0.4	3.7	0.2	0.3	0.0	0.3	0.9	0.2	0.0	18.1	1.7	0.1	2.5	1.8	0.1	0.0	13.4	0.1	0.7	0.4	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.2	0.1	0.6	0.1	0.2	0.4	0.6	0.1	0.4	0.0	0.1	16.6	21.5	24.0	21.8	19.2	22.0	25.9	23.1	21.3	26.8	25.2	23.0	173.8	0.0	2.3	81.6	0.9	7.5	1.4	0.0	2.2	1.4	1.4	9.1	33.2	0.0	0.0	3.7	14.6	0.3	0.5	0.0	0.0	0.2	16.5	1.0	4.7	148.7	0.0	0.0	15.2	0.2	5.3	28.5	0.5	2.1	0.0	4.5	112.8	0.5	1.3	0.0	45.0	0.0	0.0	1.8	10.7	15.6	9.9	2.8	16.0	82.4	0.0	1.8	0.0	76.9	4.1	0.1	0.0	24.5	1.2	1.5	0.0	0.0	0.7	5.2	0.0	5.7	7.0	6.7	4.4	0.8	6.7	0.8	1.6	2.1	0.0	1.2
JAML	"AMICA, AMICA1, Gm638"	ENSG00000160593	"Junction adhesion molecule like"	Q86YT9	11	118193725-118225094	"Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion, Immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 43.3;lymphoid tissue: 68.7"	"Group enriched"	"Detected in many"	4	"dendritic cells: 136.9;Kupffer cells: 125.8;Macrophages: 166.6;monocytes: 204.7;T-cells: 56.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in all"		"eosinophil: 3529.6"	"Group enriched"	"Detected in all"	5	"dendritic cells: 1017.6;granulocytes: 3529.6;monocytes: 1023.8"	"Cell line enriched"	"Detected in some"	5	"HMC-1: 28.0"					"Region enriched"	"Detected in many"	11	"cerebellum: 58.0"	"HPA005854, HPA047919"	Approved		Supported	"Nucleoplasm,Plasma membrane"		NA	NA		1400000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	"Plasma membrane"	Nucleoplasm	"HPA005854: , HPA047919: AB_2680209"	"unprognostic (3.91e-3)"	"unprognostic (1.55e-3)"	"unprognostic (3.00e-2)"	"unprognostic (1.28e-3)"	"unprognostic (2.87e-3)"	"prognostic favorable (3.11e-4)"	"unprognostic (2.80e-1)"	"prognostic favorable (3.92e-4)"	"unprognostic (1.14e-1)"	"unprognostic (3.17e-1)"	"unprognostic (8.69e-2)"	"unprognostic (5.08e-1)"	"unprognostic (6.43e-3)"	"unprognostic (8.96e-2)"	"unprognostic (3.12e-2)"	"unprognostic (4.10e-2)"	"unprognostic (1.58e-2)"	13.9	4.5	0.9	68.7	1.0	20.9	5.6	2.4	2.1	5.6	2.3	16.8	17.8	3.5	1.5	8.5	4.3	20.4	3.2	0.7	0.9	3.4	9.8	43.3	31.1	1.3	0.9	1.8	2.9	1.0	1.6	7.8	1.0	4.4	22.7	0.3	2.9	3.6	1.2	4.6	32.1	15.3	1.0	60.0	9.4	1.5	1.0	24.3	2.9	7.8	31.6	24.9	3.6	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	5.9	0.0	1.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.7	0.0	0.1	0.0	2.0	0.0	0.0	28.0	0.0	0.0	0.0	0.0	0.0	0.0	5.0	0.0	0.0	0.0	0.0	0.3	3.1	0.4	3.1	0.0	0.0	0.0	0.2	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.2	0.0	0.2	0.0	137.4	1023.8	3529.6	60.1	616.5	386.5	7.1	107.4	113.7	1017.6	2.9	124.7	103.1	2121.1	24.3	310.3	765.1	191.3	844.1	0.9	1.0	2.4	2.1	0.7	0.9	1.3	0.9	1.0	1.0	1.0	1.1	1.2	6.4	34.2	0.0	6.9	0.0	0.2	0.0	0.0	0.3	0.9	1.3	0.0	2.8	5.6	1.8	0.0	0.3	136.9	0.9	0.0	0.1	1.0	0.4	0.2	1.3	0.0	5.0	0.0	0.4	0.4	1.8	2.6	0.6	15.2	0.0	5.7	2.8	31.0	0.0	0.0	0.2	0.0	125.8	0.0	1.1	0.0	166.6	0.0	0.0	204.7	0.0	9.2	0.0	0.0	0.1	0.1	0.0	6.3	0.1	0.6	0.8	2.2	0.2	0.0	0.4	0.5	2.2	5.9	0.2	0.0	0.4	56.0	0.0	0.1	0.2
JARID2	JMJ	ENSG00000008083	"Jumonji and AT-rich interaction domain containing 2"	Q92833	6	15246069-15522042	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	"Chromatin regulator, Developmental protein, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 57.8"	"Cell type enhanced"	"Detected in all"		"Langerhans cells: 195.0"	"Cancer enhanced"	"Detected in all"		"testis cancer: 34.8"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"JURKAT: 73.8;SuSa: 78.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA063889, CAB069890"	Approved		Supported	Nucleoplasm,Mitochondria		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 41: Macrophages - Immune response"	"Nucleoplasm, Mitochondria"		"CAB069890: AB_10000529, HPA063889: AB_2685143"	"unprognostic (5.06e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.05e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.43e-1)"	"unprognostic (4.87e-3)"	"unprognostic (6.35e-2)"	"unprognostic (2.57e-2)"	"unprognostic (1.30e-2)"	"unprognostic (2.18e-1)"	"unprognostic (3.60e-2)"	"unprognostic (3.26e-3)"	"unprognostic (7.04e-2)"	"unprognostic (4.48e-2)"	"unprognostic (2.78e-2)"	"unprognostic (1.99e-1)"	7.3	4.7	6.7	9.2	7.1	57.8	6.0	23.6	8.7	5.3	3.7	5.0	5.7	5.0	6.7	13.7	3.9	4.4	6.4	7.5	6.2	4.1	3.6	7.2	9.0	7.1	6.8	5.7	3.5	3.6	4.4	7.1	7.8	4.5	4.6	20.0	6.4	3.3	11.8	13.4	6.8	4.1	5.2	10.6	7.0	16.0	8.0	20.0	3.8	4.3	9.8	5.8	6.8	8.2	12.4	8.5	34.0	19.6	4.1	4.0	33.5	3.5	8.3	4.5	5.5	8.8	9.4	6.5	12.3	7.1	6.8	6.3	8.0	20.1	4.1	13.0	12.4	23.3	10.6	11.6	4.6	23.9	26.3	5.7	12.3	6.6	26.2	13.4	4.7	73.8	30.5	10.8	2.7	12.6	47.6	44.6	36.4	6.1	3.8	20.9	10.4	18.6	4.2	13.0	26.2	15.0	7.3	24.9	32.1	78.1	8.7	25.0	8.5	20.6	11.4	11.5	12.3	6.9	17.8	11.7	7.0	21.9	26.6	10.1	3.8	3.2	3.4	2.4	2.9	2.5	1.6	2.1	3.1	3.4	2.1	2.9	13.2	4.9	2.7	4.4	1.4	2.1	6.7	7.1	23.6	8.7	7.5	6.2	7.1	6.8	7.8	5.2	8.0	8.2	30.1	6.4	12.8	175.3	40.7	80.4	10.7	23.0	31.9	74.2	28.3	23.1	10.5	15.7	17.1	5.5	87.6	27.0	62.9	10.0	1.9	8.2	89.2	30.7	18.0	27.1	26.8	50.9	125.9	4.4	25.0	17.6	19.9	77.5	25.3	14.8	15.7	13.8	24.0	154.8	124.4	16.4	16.2	61.3	195.0	40.8	8.7	89.5	26.6	97.4	49.1	134.0	54.6	136.7	136.6	15.6	9.3	8.6	34.9	6.8	16.6	3.8	8.7	89.7	6.6	18.1	23.6	9.4	71.1	43.4	151.6	25.2	43.2	17.4	14.7	15.4
JAZF1	"DKFZp761K2222, TIP27, ZNF802"	ENSG00000153814	"JAZF zinc finger 1"	Q86VZ6	7	27830573-28180795	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Lipid metabolism, Transcription, Transcription regulation"		Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 83.8"	"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 160.1;Excitatory neurons: 316.6;Inhibitory neurons: 306.3;Microglial cells: 168.6;Oligodendrocyte precursor cells: 241.3;Oligodendrocytes: 262.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 25.6"	"Group enriched"	"Detected in all"	4	"dendritic cells: 13.7;granulocytes: 25.6"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 53.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB019271, HPA066967"	Approved		Supported	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Nucleoplasm, Nucleoli fibrillar center"		"CAB019271: , HPA066967: AB_2685758"	"unprognostic (1.19e-1)"	"unprognostic (2.14e-1)"	"unprognostic (2.18e-2)"	"unprognostic (7.48e-2)"	"unprognostic (9.08e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.74e-1)"	"unprognostic (8.88e-2)"	"unprognostic (2.50e-1)"	"unprognostic (1.44e-1)"	"unprognostic (8.27e-3)"	"unprognostic (2.32e-2)"	"unprognostic (1.26e-2)"	"unprognostic (7.18e-3)"	"unprognostic (2.10e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.01e-2)"	15.4	83.8	11.1	10.9	12.4	24.4	11.7	11.5	16.5	62.4	12.4	32.8	3.4	41.8	21.3	10.1	16.4	12.4	22.4	13.2	15.3	5.1	15.7	10.1	14.6	7.3	8.3	13.9	6.6	6.3	13.4	16.1	9.1	29.5	8.3	7.8	4.6	35.2	6.9	7.1	8.3	38.6	8.1	14.6	8.3	18.8	17.4	11.5	14.9	6.9	15.9	19.2	27.3	10.0	1.4	0.8	4.8	1.0	35.6	42.9	0.0	11.1	28.6	18.4	22.8	0.1	7.6	33.7	22.6	23.5	12.5	0.7	6.3	8.5	15.0	5.1	10.2	12.2	7.7	0.0	24.2	4.8	3.1	19.4	10.2	13.8	8.9	14.1	11.8	2.2	0.3	53.2	10.3	1.4	1.3	17.5	10.0	0.2	7.7	3.6	2.2	10.1	6.7	0.3	3.0	4.7	9.2	0.3	12.0	14.0	3.5	6.1	11.7	29.0	11.0	8.0	12.9	9.2	2.9	12.5	9.2	12.5	16.2	25.6	3.9	6.9	4.8	3.3	1.3	2.8	1.3	3.2	3.7	3.7	0.5	3.0	1.5	4.1	3.5	13.7	3.2	3.1	11.1	12.4	11.5	16.5	13.2	15.3	7.3	8.3	9.1	8.1	17.4	10.0	10.2	3.2	7.0	57.8	33.4	14.7	3.0	3.8	3.4	6.7	3.5	4.8	25.3	10.0	3.0	1.8	6.2	0.5	37.9	1.3	7.9	14.8	122.1	28.3	160.1	14.5	5.4	115.6	316.6	2.3	1.4	24.6	9.2	18.6	24.1	12.6	3.6	5.5	9.4	16.8	306.3	0.6	2.0	25.7	45.6	89.8	55.0	28.0	23.2	168.6	35.5	4.4	40.2	241.3	262.5	5.3	0.4	34.6	8.7	2.7	0.0	2.4	12.7	4.7	13.1	9.9	15.3	8.7	16.5	3.4	11.2	1.4	25.3	1.6	0.3	1.5
JHY	"C11orf63, FLJ23554"	ENSG00000109944	"Junctional cadherin complex regulator"	Q6NUN7	11	122882683-122963862	"Predicted intracellular proteins"	"Cilium biogenesis/degradation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 35.7"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 12.8;Endometrial ciliated cells: 41.5;Glandular and luminal cells: 8.7;Proximal tubular cells: 12.0;Respiratory ciliated cells: 19.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"GAMG: 13.6"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA039612, HPA040344, HPA077658, HPA077748"	Enhanced		Supported	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 49: Ciliated cells - Cilium organization"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 49: Ciliated cells - Cilium organization"	Nucleoplasm	"Golgi apparatus"	"HPA039612: AB_10674424, HPA040344: AB_2676931, HPA077658: AB_2732355, HPA077748: AB_2732360"	"unprognostic (5.27e-2)"	"unprognostic (1.12e-1)"	"unprognostic (3.93e-2)"	"prognostic favorable (7.94e-5)"	"unprognostic (9.97e-5)"	"unprognostic (1.64e-1)"	"unprognostic (2.02e-3)"	"unprognostic (1.94e-3)"	"unprognostic (1.77e-1)"	"unprognostic (1.49e-1)"	"unprognostic (4.13e-2)"	"unprognostic (2.97e-1)"	"prognostic favorable (8.77e-4)"	"unprognostic (6.46e-3)"	"unprognostic (2.54e-1)"	"prognostic unfavorable (2.58e-4)"	"unprognostic (7.79e-2)"	6.0	1.8	1.7	2.2	2.7	1.1	3.6	3.4	2.4	3.1	17.3	3.5	1.5	2.1	2.7	1.8	7.4	2.6	2.2	1.8	3.8	7.8	0.4	4.5	2.2	4.1	5.4	3.2	2.8	5.6	4.8	1.3	3.8	3.5	1.7	1.6	1.4	2.5	0.2	1.9	1.9	2.0	3.8	2.5	2.0	35.7	3.2	3.2	5.1	0.8	2.0	2.6	1.8	3.6	2.8	3.9	2.2	0.1	0.6	0.4	0.7	5.9	6.8	2.5	1.1	0.3	10.3	0.1	1.5	9.1	13.6	2.4	2.7	1.4	1.1	9.5	2.8	0.1	1.8	0.1	0.9	1.7	4.7	2.8	7.4	0.4	0.6	6.3	3.8	4.1	0.0	0.1	2.0	1.8	0.1	0.6	0.3	8.2	3.5	1.0	0.0	1.3	7.0	3.2	5.8	4.2	7.1	3.9	2.6	2.8	4.7	0.6	1.2	7.9	1.0	0.2	4.8	0.1	0.0	0.1	2.1	2.1	5.3	0.5	0.3	0.1	1.3	0.1	1.8	1.1	1.3	1.7	2.4	0.6	0.9	1.0	0.4	2.4	0.1	0.6	0.3	0.5	1.7	2.7	3.4	2.4	1.8	3.8	4.1	5.4	3.8	3.8	3.2	3.6	4.4	12.8	4.4	0.0	1.1	0.0	0.0	0.0	0.0	0.0	3.3	3.2	0.0	0.0	7.4	5.5	0.0	0.2	2.2	0.0	3.9	5.5	0.0	41.5	3.1	1.1	0.0	0.0	0.0	1.4	0.9	2.2	0.0	8.7	0.0	2.9	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	2.6	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.7	0.0	0.0	12.0	19.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.3	1.8	1.3	0.0	0.0
JMJD6	"KIAA0585, PTDSR, PTDSR1"	ENSG00000070495	"Jumonji domain containing 6, arginine demethylase and lysine hydroxylase"	Q6NYC1	17	76712832-76726799	"Predicted intracellular proteins"	"Differentiation, mRNA processing, mRNA splicing, Transcription, Transcription regulation"	"Chromatin regulator, Developmental protein, Dioxygenase, Oxidoreductase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 121.7"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004548, HPA059156"	Supported		Supported	Nucleoplasm		No	No			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm		"CAB004548: AB_628185, HPA059156: AB_2683934"	"unprognostic (1.26e-1)"	"unprognostic (6.27e-2)"	"unprognostic (8.06e-2)"	"unprognostic (9.46e-2)"	"unprognostic (5.95e-2)"	"unprognostic (4.14e-3)"	"prognostic unfavorable (5.75e-6)"	"unprognostic (4.88e-2)"	"unprognostic (2.16e-1)"	"unprognostic (2.56e-2)"	"prognostic favorable (5.71e-4)"	"unprognostic (5.66e-2)"	"prognostic unfavorable (7.59e-7)"	"unprognostic (1.15e-1)"	"unprognostic (1.31e-1)"	"unprognostic (8.86e-2)"	"unprognostic (3.82e-1)"	30.3	27.0	14.2	17.0	16.3	121.7	19.6	19.2	29.5	20.2	15.3	32.3	15.4	19.4	7.4	18.8	22.4	18.7	41.2	14.3	16.5	18.3	18.5	26.8	15.7	16.2	16.2	27.6	18.0	11.0	22.4	16.2	16.2	19.9	10.3	29.5	15.2	10.7	38.2	15.6	18.4	16.0	14.6	21.1	24.4	17.8	16.9	13.4	16.6	28.1	12.8	23.9	20.4	20.8	39.0	53.3	18.0	23.5	22.6	19.4	17.6	34.7	26.8	49.6	47.6	53.6	18.7	25.3	14.9	37.6	72.6	28.8	57.3	17.3	47.2	18.6	45.9	37.3	37.5	54.4	36.8	19.7	55.0	23.9	26.8	54.2	18.2	31.6	41.6	13.8	57.1	45.2	37.0	24.4	34.7	28.4	15.9	37.3	62.4	27.1	33.6	39.2	16.6	12.1	31.1	31.1	30.2	43.7	43.7	30.4	39.5	28.6	27.7	56.7	33.3	29.9	65.8	50.6	28.8	23.4	55.7	17.4	32.5	50.8	28.6	40.2	24.7	37.8	24.0	20.5	28.4	28.2	25.9	13.0	23.3	22.2	23.3	14.6	39.4	22.4	31.0	20.1	14.2	16.3	19.2	29.5	14.3	16.5	16.2	16.2	16.2	14.6	16.9	20.8	44.1	25.6	22.9	9.1	29.3	83.2	79.9	46.1	67.2	16.5	30.8	42.8	30.5	14.3	29.2	9.2	50.1	29.0	96.5	33.1	17.6	28.1	30.3	39.1	29.6	36.0	39.4	13.0	6.6	27.4	52.9	37.9	33.1	58.6	65.2	18.6	28.2	10.2	32.7	6.7	7.4	32.0	24.4	19.5	79.2	12.5	16.1	52.4	58.7	3.7	26.9	11.8	21.6	7.1	7.9	29.6	32.1	17.7	50.0	38.5	40.8	7.9	20.5	35.4	13.1	32.7	69.2	59.6	27.2	48.8	73.6	30.5	80.4	29.9	31.3	60.2
JPT1	"ARM2, HN1, HN1A"	ENSG00000189159	"Jupiter microtubule associated homolog 1"	Q9UK76	17	75135248-75168281	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 406.9"	"Cell type enhanced"	"Detected in many"		"Ductal cells: 371.3;Exocrine glandular cells: 437.2;Extravillous trophoblasts: 1344.2;monocytes: 375.7;Pancreatic endocrine cells: 1434.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 767.6"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA059729	Approved		Supported	"Nucleoplasm,Nuclear membrane,Nucleoli"		NA	NA		40000	"Cluster 5: Granulocytes - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm	"Nuclear membrane, Nucleoli"	"HPA059729: AB_2684114"	"unprognostic (1.13e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.31e-3)"	"unprognostic (3.57e-3)"	"unprognostic (6.71e-2)"	"unprognostic (2.51e-3)"	"prognostic unfavorable (1.58e-7)"	"unprognostic (3.58e-2)"	"unprognostic (1.37e-1)"	"prognostic favorable (4.91e-4)"	"unprognostic (1.25e-3)"	"unprognostic (8.24e-2)"	"prognostic unfavorable (1.77e-7)"	"unprognostic (1.83e-1)"	"unprognostic (8.99e-2)"	"unprognostic (4.84e-2)"	"unprognostic (1.51e-1)"	26.1	74.9	44.0	87.5	43.7	83.5	21.3	49.4	54.7	44.1	31.0	140.1	119.2	18.0	7.3	225.1	15.5	63.7	23.3	44.3	54.4	72.2	49.1	49.3	87.6	38.6	42.8	13.4	22.6	6.7	24.3	66.3	49.3	28.3	70.4	17.0	62.1	27.8	96.1	40.7	141.6	23.4	34.3	100.5	134.2	406.9	53.1	88.0	16.1	24.3	91.5	93.9	75.7	36.3	775.3	743.0	371.8	384.7	75.5	75.2	309.5	391.8	111.5	364.6	278.0	614.8	449.1	210.1	247.4	303.0	401.7	446.5	344.3	481.9	278.5	215.7	438.3	336.1	275.2	624.8	177.5	256.3	318.3	117.1	218.4	307.3	308.7	107.1	672.2	388.7	197.3	431.3	335.4	561.4	845.0	248.7	216.9	627.8	979.0	520.8	447.5	326.8	392.7	479.1	465.4	373.8	553.8	293.3	213.4	393.8	786.0	154.9	395.1	214.3	615.7	305.0	469.0	165.9	298.1	332.5	186.9	233.4	254.4	241.7	127.0	372.6	79.6	187.8	57.2	102.3	109.3	96.8	100.7	57.2	51.6	76.1	767.6	74.5	206.7	67.4	202.6	118.4	44.0	43.7	49.4	54.7	44.3	54.4	38.6	42.8	49.3	34.3	53.1	36.3	61.6	25.6	18.1	0.0	36.2	0.0	0.0	0.0	0.0	0.0	81.8	133.2	0.0	0.0	18.0	246.5	0.0	137.6	171.2	0.0	99.7	371.3	0.0	113.2	79.7	32.9	0.0	0.0	0.0	437.2	1344.2	40.4	0.0	194.0	7.6	179.6	0.0	0.0	319.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	102.5	0.0	0.0	375.7	0.0	0.0	0.0	0.0	1434.1	0.0	0.0	13.9	0.0	0.0	203.3	16.8	0.0	0.0	0.0	76.2	0.0	0.0	0.0	0.0	96.9	73.9	95.0	0.0	0.0
JPT2	"C16orf34, FLJ13092, HN1L, KIAA1426, L11"	ENSG00000206053	"Jupiter microtubule associated homolog 2"	Q9H910	16	1678256-1702280	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 99.3;Ductal cells: 90.1;Endometrial ciliated cells: 107.3;Extravillous trophoblasts: 205.9;Glandular and luminal cells: 77.5;Pancreatic endocrine cells: 78.9;Syncytiotrophoblasts: 168.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041888, HPA041908"	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA		76000	"Cluster 22: NK-cells - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 38: Extravillous trophoblasts - Unknown function"	"Plasma membrane, Cytosol"		"HPA041888: AB_10793937, HPA041908: AB_10794160"	"unprognostic (1.49e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.30e-3)"	"prognostic favorable (7.85e-4)"	"unprognostic (3.60e-1)"	"unprognostic (2.37e-2)"	"prognostic unfavorable (9.14e-4)"	"unprognostic (1.10e-2)"	"unprognostic (3.14e-2)"	"unprognostic (1.50e-2)"	"unprognostic (1.12e-3)"	"unprognostic (4.27e-2)"	"unprognostic (1.01e-2)"	"unprognostic (9.22e-3)"	"unprognostic (1.65e-1)"	"unprognostic (4.14e-2)"	"unprognostic (2.78e-2)"	21.2	17.0	12.7	18.6	21.1	11.3	36.4	33.2	19.8	39.5	14.1	32.7	21.9	21.1	17.9	47.7	63.4	13.6	20.3	12.0	16.3	48.8	41.1	20.0	19.9	58.0	27.8	19.8	29.6	20.9	15.1	48.1	46.9	47.9	30.5	4.6	26.6	18.2	17.5	31.3	24.2	19.5	28.4	12.8	28.2	18.1	25.6	35.5	27.7	14.0	31.3	31.2	25.9	51.7	148.1	147.5	168.4	93.9	23.9	39.3	151.9	143.6	44.8	117.7	99.8	194.5	188.3	94.6	107.8	71.1	116.4	141.9	223.5	194.2	135.7	77.2	135.2	78.4	80.2	111.4	36.7	93.5	44.8	28.1	121.6	116.4	149.6	64.9	75.7	85.4	187.5	37.0	68.6	169.5	117.1	46.6	185.3	164.4	112.0	212.7	159.3	136.2	186.2	82.5	156.1	85.6	214.9	205.3	66.5	161.1	250.3	59.6	87.9	113.9	201.1	54.8	141.1	31.5	136.3	198.8	35.8	71.5	170.5	2.1	3.7	4.1	5.2	3.3	7.2	4.8	5.8	4.2	2.8	7.6	6.3	5.4	0.3	6.8	1.7	6.6	5.8	4.4	12.7	21.1	33.2	19.8	12.0	16.3	58.0	27.8	46.9	28.4	25.6	51.7	11.9	25.6	10.6	0.0	2.7	0.0	0.0	0.0	0.0	0.0	33.3	23.4	0.0	0.0	12.4	9.2	0.0	99.3	4.5	0.0	43.0	90.1	0.0	107.3	19.2	8.5	0.0	0.0	0.0	25.6	205.9	7.4	0.0	77.5	2.5	23.4	0.0	0.0	41.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.9	0.0	0.0	28.4	0.0	0.0	0.0	0.0	78.9	0.0	0.0	1.2	0.0	0.0	26.0	27.0	0.0	0.0	0.0	10.8	0.0	0.0	0.0	0.0	168.7	3.6	18.9	0.0	0.0
JUNB		ENSG00000171223	"JunB proto-oncogene, AP-1 transcription factor subunit"	P17275	19	12791486-12793315	"Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 679.4"	"Group enriched"	"Detected in all"	5	"granulocytes: 679.4;monocytes: 182.7"	"Cell line enhanced"	"Detected in all"		"HDLM-2: 629.0;U-266/70: 256.4;U-266/84: 411.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004464, HPA019149"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm		"CAB004464: AB_2130023, HPA019149: AB_1852053"	"unprognostic (1.03e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.04e-1)"	"unprognostic (7.17e-2)"	"unprognostic (1.77e-2)"	"unprognostic (2.19e-1)"	"unprognostic (2.13e-2)"	"unprognostic (1.12e-1)"	"prognostic unfavorable (3.65e-4)"	"unprognostic (1.79e-1)"	"unprognostic (9.78e-2)"	"prognostic unfavorable (1.05e-4)"	"unprognostic (7.20e-2)"	"unprognostic (7.06e-2)"	"unprognostic (3.77e-1)"	"unprognostic (1.02e-1)"	722.8	259.5	22.9	110.3	28.0	455.2	248.5	90.1	65.2	283.3	30.4	287.0	52.8	130.1	2.2	449.1	874.8	92.6	383.5	28.3	68.8	184.2	279.0	399.2	65.0	83.5	29.8	649.5	150.0	20.8	351.9	39.4	33.6	195.0	22.0	32.0	131.6	56.1	144.6	605.9	145.0	58.1	51.5	153.3	309.8	30.0	31.3	78.8	198.7	73.3	12.9	333.0	330.6	34.8	52.9	10.4	2.8	6.4	11.3	27.4	10.2	22.8	19.2	11.0	10.0	6.8	30.4	18.2	77.4	8.4	33.5	98.5	2.5	34.3	1.2	629.0	9.9	18.0	42.2	9.0	15.1	24.3	80.5	34.9	97.6	10.0	7.5	22.0	5.3	12.9	48.1	32.6	3.6	158.8	16.8	147.5	1.7	36.1	40.0	22.4	7.7	38.8	7.5	65.5	23.7	36.0	98.4	59.5	30.5	1.7	10.5	27.0	17.6	32.2	18.7	64.3	28.9	256.4	411.4	17.1	37.7	62.7	8.9	29.1	132.2	132.2	33.4	182.7	33.4	30.6	36.8	42.0	87.1	25.4	25.5	28.5	679.4	18.6	177.2	7.9	38.7	124.1	22.9	28.0	90.1	65.2	28.3	68.8	83.5	29.8	33.6	51.5	31.3	34.8	3158.0	115.4	423.2	130.2	1751.7	1463.9	1778.3	2367.7	1985.1	81.0	1296.9	1693.1	374.0	474.7	707.4	154.5	39.6	129.7	1766.9	819.7	49.0	833.3	9.5	468.5	1091.4	1469.5	1502.1	244.8	8.7	546.7	224.7	2182.3	1060.1	627.8	510.5	310.0	852.4	84.6	1178.4	21.9	4.4	1029.3	740.6	674.1	2747.6	27.9	815.2	1583.3	894.6	20.6	379.3	634.6	115.4	4.5	2.4	1026.7	875.3	263.3	842.5	1036.7	701.0	84.2	337.3	168.8	1163.6	2566.6	2624.1	9.4	10.5	1164.3	1804.1	440.3	2362.6	417.0	687.7	472.6
JUND	AP-1	ENSG00000130522	"JunD proto-oncogene, AP-1 transcription factor subunit"	P17535	19	18279694-18281622	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Adipocytes: 2129.8;dendritic cells: 1844.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB005268, HPA063029"	Supported		Supported	Nucleoplasm		No	No			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 35: Non-specific - Unknown function"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm		"CAB005268: AB_2130177, HPA063029: AB_2684925"	"prognostic favorable (6.15e-5)"	"unprognostic (4.18e-3)"	"unprognostic (8.89e-2)"	"unprognostic (2.52e-1)"	"unprognostic (3.70e-1)"	"unprognostic (6.39e-2)"	"unprognostic (1.63e-2)"	"unprognostic (6.35e-2)"	"unprognostic (3.48e-2)"	"unprognostic (2.00e-1)"	"unprognostic (3.37e-3)"	"unprognostic (4.09e-2)"	"unprognostic (3.35e-2)"	"unprognostic (1.22e-1)"	"unprognostic (3.99e-1)"	"unprognostic (5.37e-2)"	"unprognostic (1.49e-1)"	296.3	189.3	190.3	38.9	201.6	429.1	257.3	172.1	208.5	159.7	153.1	185.2	62.9	186.6	37.5	118.3	291.4	30.0	210.6	187.5	192.5	148.8	211.8	227.3	28.8	261.3	213.2	424.2	178.4	40.4	256.4	45.1	180.9	159.1	33.0	25.7	112.7	33.8	81.0	287.7	161.3	57.5	182.5	100.5	201.4	97.4	180.4	58.2	154.8	37.1	15.9	129.5	147.7	263.8	84.2	35.3	33.3	37.9	25.9	28.8	150.5	35.0	40.8	19.2	25.4	38.3	72.9	42.1	39.4	34.8	31.1	46.1	8.2	8.3	9.5	84.6	75.9	62.7	30.3	84.9	58.6	29.5	81.4	27.8	33.7	20.0	25.9	44.5	15.3	18.8	86.5	119.8	5.2	113.6	89.9	92.5	69.7	22.7	50.6	32.7	20.9	94.0	27.8	13.1	184.2	75.1	41.7	45.4	122.0	37.5	38.6	43.9	54.7	11.8	54.8	74.4	20.9	171.3	73.8	36.3	41.5	44.7	27.9	10.5	6.5	6.8	4.9	8.2	3.8	8.4	6.4	4.5	4.9	8.7	4.5	5.0	19.7	4.8	8.3	11.3	5.7	2.4	190.3	201.6	172.1	208.5	187.5	192.5	261.3	213.2	180.9	182.5	180.4	263.8	2129.8	179.5	386.7	104.5	1176.8	317.1	400.4	76.0	188.4	129.8	1147.5	1419.1	158.8	291.7	84.4	257.5	79.2	78.5	1844.7	810.5	31.3	96.5	80.8	1026.0	1289.3	468.1	568.8	78.3	51.6	140.8	112.9	950.9	336.4	1561.4	257.7	514.1	338.4	436.1	100.1	139.7	41.0	569.6	67.1	332.7	506.0	59.2	123.3	847.7	249.1	65.6	91.7	625.2	27.8	44.7	132.0	154.4	464.2	88.8	734.5	253.6	538.1	65.4	90.4	174.3	131.5	1064.7	798.4	11.8	22.7	172.0	394.1	164.3	1158.2	448.7	297.4	232.7
JUP	"CTNNG, DP3, DPIII, PDGB, PKGB"	ENSG00000173801	"Junction plakoglobin"	P14923	17	41754604-41786931	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell adhesion"		"Cancer-related genes, Cardiomyopathy, Disease variant, Palmoplantar keratoderma"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 952.2;skin 1: 932.4"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 315.9;Pancreatic endocrine cells: 356.2;Squamous epithelial cells: 318.3;Suprabasal keratinocytes: 383.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"classical monocyte: 13.1;eosinophil: 28.7;intermediate monocyte: 22.6;memory B-cell: 13.5;myeloid DC: 14.5;naive B-cell: 11.7;non-classical monocyte: 43.8"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HaCaT: 1090.1;OE19: 3919.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002139, HPA032047"	Supported		Supported	"Vesicles,Plasma membrane,Cell Junctions"		NA	NA		64000000	"Cluster 14: Monocytes - Unknown function"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 22: Epithelial cell types - Mixed function"	"Plasma membrane, Cell Junctions"	Vesicles	"CAB002139: AB_563468, HPA032047: AB_2674124"	"unprognostic (3.96e-3)"	"unprognostic (3.40e-1)"	"unprognostic (2.32e-1)"	"unprognostic (4.71e-3)"	"unprognostic (2.49e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.02e-1)"	"unprognostic (8.11e-3)"	"unprognostic (1.41e-2)"	"unprognostic (9.85e-3)"	"unprognostic (2.29e-3)"	"unprognostic (9.60e-2)"	"prognostic favorable (2.06e-10)"	"unprognostic (2.50e-1)"	"unprognostic (9.49e-2)"	"unprognostic (9.05e-2)"	"unprognostic (1.51e-2)"	46.5	16.0	13.6	23.6	21.6	20.7	68.6	20.8	18.9	243.7	25.8	94.9	88.1	57.0	15.3	952.2	69.9	39.8	145.1	14.6	14.3	120.7	70.9	57.1	15.7	20.7	16.2	46.2	59.6	19.9	37.3	51.5	19.6	68.0	49.0	4.7	226.4	41.8	110.8	932.4	95.7	23.1	14.8	22.7	86.3	12.5	16.2	29.6	86.4	62.2	92.0	68.7	432.6	33.6	268.8	217.8	21.7	18.5	0.2	0.1	330.6	15.3	89.2	5.9	5.2	332.6	289.0	5.4	157.8	9.7	7.5	1090.1	31.6	242.4	1.0	0.6	74.2	11.6	165.1	74.4	34.7	7.3	113.6	0.5	538.6	0.9	43.9	64.2	96.1	7.0	99.6	94.0	0.0	342.6	1.9	96.5	42.3	3919.9	36.2	313.5	0.2	202.5	165.8	674.0	52.2	38.6	33.8	652.1	1.9	98.6	545.9	8.0	152.4	0.3	14.8	6.8	5.1	8.2	31.2	5.5	1.5	12.7	2.6	3.9	13.1	28.7	0.0	22.6	0.0	13.5	0.0	0.2	14.5	11.7	0.2	0.1	0.6	0.8	43.8	4.5	0.1	5.7	13.6	21.6	20.8	18.9	14.6	14.3	20.7	16.2	19.6	14.8	16.2	33.6	56.9	60.9	36.8	4.6	10.6	196.9	218.5	104.5	100.2	1.9	87.3	77.0	87.8	48.6	80.9	132.4	4.2	98.9	1.1	315.9	27.4	212.2	28.5	112.6	21.1	55.2	66.8	3.4	0.5	135.4	167.3	25.6	136.1	247.0	11.4	16.5	41.4	34.1	14.4	0.0	1.6	125.0	81.4	7.7	32.7	8.3	5.0	10.9	12.4	2.8	6.3	18.2	0.0	7.1	13.6	356.2	223.7	0.0	3.9	220.1	141.1	35.6	45.7	4.3	6.6	37.4	18.8	2.5	4.5	318.3	383.3	185.7	6.1	3.2	129.2	301.6
KANK1	"ANKRD15, KANK, KIAA0172"	ENSG00000107104	"KN motif and ankyrin repeat domains 1"	Q14678	9	470291-746106	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"		"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 355.5;Late spermatids: 228.7;Oligodendrocyte precursor cells: 322.7;Oligodendrocytes: 191.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"plasmacytoid DC: 4.0"	"Group enriched"	"Detected in many"	15	"B-cells: 1.1;dendritic cells: 4.0;T-cells: 2.4"	"Cell line enhanced"	"Detected in many"		"Hep G2: 96.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005539, HPA056090"	Approved		Supported	"Plasma membrane"		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 15: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 68: Oligodendrocytes - Mixed function"	"Plasma membrane"		"HPA005539: AB_1078164, HPA056090: AB_2683034"	"unprognostic (6.59e-2)"	"unprognostic (3.33e-2)"	"unprognostic (1.06e-3)"	"unprognostic (1.30e-1)"	"unprognostic (2.69e-1)"	"unprognostic (7.53e-2)"	"unprognostic (3.33e-1)"	"unprognostic (1.23e-2)"	"unprognostic (4.91e-2)"	"unprognostic (3.05e-2)"	"unprognostic (2.84e-2)"	"unprognostic (1.24e-1)"	"unprognostic (3.07e-2)"	"unprognostic (2.72e-1)"	"unprognostic (3.06e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.61e-1)"	42.6	9.6	49.0	9.5	52.7	1.5	31.2	42.3	47.5	40.9	61.8	49.2	12.1	62.2	13.0	64.6	31.7	15.2	88.2	45.1	44.9	31.6	101.9	13.6	7.6	51.6	44.9	22.1	28.3	9.4	27.9	25.8	48.3	42.5	14.9	11.0	29.9	31.8	66.4	51.8	23.6	37.4	47.6	6.9	25.9	15.4	48.4	9.4	30.8	39.9	11.8	70.1	52.3	48.9	5.9	12.2	4.0	72.0	57.8	21.9	19.9	37.1	25.8	3.1	3.7	30.2	2.5	46.2	8.9	46.0	7.0	12.3	15.7	30.4	5.3	22.7	8.3	0.1	17.0	96.0	8.1	11.2	0.0	12.6	41.6	3.2	35.6	13.2	31.2	1.6	2.4	56.4	23.1	14.4	4.5	46.9	5.3	8.9	9.0	1.7	7.9	8.6	24.5	36.1	1.8	0.0	3.6	10.9	50.9	33.3	7.1	8.7	46.1	8.4	3.2	10.8	17.1	9.8	61.9	0.2	5.6	21.1	15.8	0.0	0.1	0.0	0.1	0.1	0.0	0.8	1.3	0.4	0.4	1.1	2.4	0.8	0.0	0.1	0.0	4.0	1.7	0.5	49.0	52.7	42.3	47.5	45.1	44.9	51.6	44.9	48.3	47.6	48.4	48.9	18.3	12.8	34.2	355.5	4.9	23.1	102.1	11.4	37.0	22.2	16.8	18.0	94.1	24.3	8.1	18.4	41.7	89.2	15.7	8.3	7.9	11.6	102.3	14.2	15.4	21.9	18.0	9.1	12.1	7.9	6.8	21.8	7.7	13.1	1.3	38.5	23.6	70.0	13.3	0.0	29.0	12.8	4.1	6.9	6.5	228.7	32.3	3.3	23.2	60.9	1.2	6.5	0.0	322.7	191.4	9.6	7.5	20.7	10.7	50.5	17.6	13.6	7.0	20.2	26.3	129.9	24.0	28.4	25.6	36.2	25.7	66.2	4.7	6.9	26.0	63.6
KANK2	"ANKRD25, KIAA1518, MXRA3"	ENSG00000197256	"KN motif and ankyrin repeat domains 2"	Q63ZY3	19	11164270-11197791	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Apoptosis, Transcription, Transcription regulation"		"Disease variant, Palmoplantar keratoderma"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 402.5;Endometrial stromal cells: 149.6;Leydig cells: 126.2;Peritubular cells: 225.7;Smooth muscle cells: 131.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in all"		"ASC diff: 327.8;ASC TERT1: 365.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015643	Approved		Approved	Nucleoplasm,Cytosol		NA	Yes				"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 43: Cardiomyocytes - Nuclear processes"	Nucleoplasm	Cytosol	"HPA015643: AB_1844839"	"unprognostic (2.37e-1)"	"unprognostic (8.03e-2)"	"unprognostic (1.15e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.00e-1)"	"unprognostic (3.23e-3)"	"unprognostic (1.54e-1)"	"unprognostic (8.63e-2)"	"unprognostic (8.98e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.17e-1)"	"prognostic unfavorable (8.73e-5)"	"unprognostic (4.01e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.48e-2)"	150.2	55.5	25.7	50.5	27.2	17.9	97.7	22.8	25.6	275.3	24.5	413.2	36.8	376.9	64.6	139.1	222.1	125.0	200.5	20.0	27.9	54.1	51.3	134.5	20.7	29.5	26.5	213.9	35.4	14.3	29.8	62.3	29.0	140.5	58.7	19.0	39.3	173.6	56.9	49.7	108.0	277.7	23.8	57.8	123.7	25.0	29.5	15.7	71.7	51.1	12.4	255.2	148.5	22.6	42.4	91.1	28.3	30.3	327.8	365.1	20.2	188.9	161.0	92.1	76.2	36.3	27.0	177.2	88.1	234.3	59.6	40.0	25.6	13.7	61.3	9.3	18.4	77.2	105.6	37.5	123.9	11.8	21.4	158.7	20.1	67.3	9.0	237.2	37.8	5.5	51.5	14.3	143.6	75.7	2.3	9.9	31.4	27.5	95.1	59.7	234.8	42.2	65.4	22.7	16.6	51.7	188.2	16.4	22.4	32.7	25.1	41.2	139.1	131.5	52.6	170.1	75.2	13.7	32.9	61.3	111.0	66.3	136.4	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.1	25.7	27.2	22.8	25.6	20.0	27.9	29.5	26.5	29.0	23.8	29.5	22.6	34.1	57.7	28.3	7.8	1.3	6.2	5.5	5.2	2.2	2.0	5.2	7.1	402.5	27.1	12.0	20.2	20.9	6.9	0.6	2.5	3.9	8.1	2.4	12.7	149.6	41.2	0.0	76.2	0.9	4.4	4.9	69.2	13.3	11.9	7.6	7.7	32.5	28.2	22.5	0.0	4.1	2.6	4.1	10.6	15.1	3.8	126.2	6.3	8.8	42.2	0.5	34.9	4.1	1.0	1.4	11.9	1.2	225.7	0.8	6.7	1.6	3.7	8.0	23.4	92.1	79.2	131.0	1.8	7.2	2.8	7.7	2.3	2.3	7.7	5.2	8.4
KANSL1	"CENP-36, DKFZP727C091, KIAA1267, MSL1v1, NSL1"	ENSG00000120071	"KAT8 regulatory NSL complex subunit 1"	Q7Z3B3	17	46029916-46225389	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		"Chromatin regulator"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 334.6;Inhibitory neurons: 326.7;Microglial cells: 327.9;Oligodendrocyte precursor cells: 313.6;Oligodendrocytes: 346.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006874, HPA007208"	Approved		Supported	Nucleoplasm		No	No			"Cluster 22: NK-cells - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA006874: AB_1852393, HPA007208: AB_1852395"	"unprognostic (2.46e-1)"	"unprognostic (2.55e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.37e-1)"	"unprognostic (2.33e-2)"	"unprognostic (4.45e-2)"	"prognostic unfavorable (3.74e-4)"	"unprognostic (1.54e-2)"	"unprognostic (9.28e-2)"	"unprognostic (7.79e-3)"	"unprognostic (2.01e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.84e-2)"	"unprognostic (6.13e-2)"	"unprognostic (1.29e-1)"	"unprognostic (5.76e-2)"	"unprognostic (1.33e-2)"	12.3	9.2	3.7	7.6	4.4	12.9	11.3	13.8	6.7	14.2	2.1	11.7	4.2	15.3	9.1	12.9	11.7	4.1	7.3	4.1	4.0	8.4	5.8	9.4	7.6	4.2	4.7	15.2	12.4	11.9	9.0	7.2	5.4	9.1	8.4	9.4	11.1	4.5	16.4	17.2	12.0	9.8	3.6	9.2	10.0	17.5	4.8	16.9	12.0	9.0	9.7	12.7	13.1	5.8	3.1	2.4	11.2	5.1	2.5	4.0	7.0	3.0	5.8	5.4	6.4	11.6	0.9	11.8	4.9	12.5	16.2	6.7	22.6	8.1	10.7	14.9	11.3	1.6	5.8	14.3	17.3	1.3	4.3	4.1	17.2	12.2	19.6	7.6	13.4	18.6	5.1	12.3	12.1	4.5	42.5	2.9	3.4	2.8	14.1	24.3	21.9	20.2	8.3	7.4	5.7	13.8	15.3	0.5	9.8	29.8	17.4	21.5	11.8	23.2	13.5	9.0	3.2	20.6	15.2	17.6	6.4	6.4	16.2	0.0	0.1	0.3	0.2	0.1	0.2	0.4	0.3	0.5	0.0	0.1	0.3	0.2	0.3	0.3	0.1	0.2	0.3	0.2	3.7	4.4	13.8	6.7	4.1	4.0	4.2	4.7	5.4	3.6	4.8	5.8	53.4	32.1	36.7	226.9	47.7	27.1	19.7	22.4	42.7	68.1	57.4	39.5	13.2	20.0	18.2	47.8	102.2	15.0	95.5	35.0	1.9	37.1	162.9	58.2	80.2	40.9	31.8	22.1	334.6	25.4	20.4	33.3	33.1	85.9	24.1	111.4	30.4	25.3	21.1	69.0	326.7	29.2	28.5	41.7	25.3	136.6	34.8	38.1	21.4	327.9	52.3	23.6	60.8	313.6	346.4	40.8	27.2	30.1	60.1	33.7	28.9	12.7	18.9	78.5	26.3	42.0	43.7	29.4	50.9	48.9	30.1	14.6	70.6	71.6	27.2	32.7
KANSL2	"C12orf41, FLJ20436, NSL2"	ENSG00000139620	"KAT8 regulatory NSL complex subunit 2"	Q9H9L4	12	48653211-48682238	"Predicted intracellular proteins"		"Chromatin regulator"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038497, HPA038498"	Uncertain		Supported	"Nucleoplasm,Plasma membrane,Cytosol"	"Intracellular and membrane"	NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 59: Non-specific - Translation"	"Cluster 32: U-937 - Innate immune response"	"Cluster 7: Non-specific - Mitochondria"	"Nucleoplasm, Plasma membrane, Cytosol"		"HPA038497: AB_10674685, HPA038498: AB_2676046"	"unprognostic (3.87e-3)"	"unprognostic (6.18e-2)"	"unprognostic (3.67e-1)"	"unprognostic (8.89e-2)"	"unprognostic (5.37e-2)"	"unprognostic (4.73e-2)"	"prognostic unfavorable (4.98e-4)"	"unprognostic (5.46e-2)"	"unprognostic (1.35e-3)"	"unprognostic (6.16e-2)"	"unprognostic (6.75e-3)"	"unprognostic (4.19e-3)"	"unprognostic (8.05e-2)"	"unprognostic (2.92e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.18e-1)"	"prognostic favorable (4.32e-4)"	11.9	11.4	6.0	8.2	7.0	41.8	12.2	8.6	8.0	13.9	7.3	11.8	8.1	14.1	11.5	13.3	12.6	7.7	13.4	6.5	6.9	12.2	9.8	10.9	13.9	7.0	6.5	16.3	9.7	12.2	9.3	12.2	6.7	11.1	9.3	11.8	13.0	8.3	40.7	13.4	11.9	9.8	6.7	13.2	10.8	14.6	6.8	14.2	11.5	23.1	13.8	12.4	12.8	8.8	19.5	26.5	21.8	12.8	25.6	22.0	48.1	20.8	17.6	35.9	19.5	45.2	25.1	31.9	39.0	25.5	14.0	18.3	37.1	23.5	29.5	30.4	22.5	37.1	20.2	12.9	29.2	40.0	13.9	20.8	31.2	25.5	46.2	18.0	17.2	24.8	43.7	20.9	25.0	18.7	39.2	29.2	28.6	28.1	26.0	33.4	21.3	35.9	17.2	27.1	25.1	17.6	43.2	30.0	25.7	21.8	40.2	43.4	12.8	25.5	18.9	10.9	19.7	29.8	50.7	46.2	12.4	89.5	13.6	35.3	19.7	23.5	25.1	21.2	23.7	27.3	23.9	25.9	25.8	23.8	27.9	26.9	9.0	24.3	23.0	20.2	32.2	24.0	6.0	7.0	8.6	8.0	6.5	6.9	7.0	6.5	6.7	6.7	6.8	8.8	18.0	3.2	14.3	9.8	24.7	11.9	14.7	17.9	32.5	15.6	15.7	15.5	10.9	8.6	15.0	14.7	29.2	22.5	36.5	10.2	9.8	13.3	24.4	8.2	13.9	13.7	9.0	14.1	11.5	9.8	12.5	15.1	12.2	12.4	11.4	19.8	14.6	9.6	11.9	15.2	13.8	9.1	10.2	11.9	13.2	13.8	12.5	13.7	16.0	7.5	14.8	8.2	11.3	15.1	18.8	12.2	4.7	10.1	16.9	12.1	10.8	15.6	10.2	22.8	26.3	15.7	16.6	38.5	34.8	19.9	11.2	25.3	30.6	15.9	12.4	9.8
KANSL3	"FLJ10081, KIAA1310, NSL3, Rcd1"	ENSG00000114982	"KAT8 regulatory NSL complex subunit 3"	Q9P2N6	2	96593170-96642787	"Metabolic proteins, Predicted intracellular proteins"		"Chromatin regulator"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035017, HPA035018"	Approved		Supported	Nucleoplasm,Vesicles		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 52: Non-specific - Ribosome"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 40: Granulosa cells - Unknown function"	Nucleoplasm	Vesicles	"HPA035017: AB_2674414, HPA035018: AB_10601763"	"unprognostic (2.19e-1)"	"unprognostic (6.94e-2)"	"unprognostic (5.62e-2)"	"unprognostic (8.72e-3)"	"unprognostic (3.28e-1)"	"unprognostic (4.35e-3)"	"prognostic unfavorable (5.34e-4)"	"unprognostic (6.34e-2)"	"unprognostic (1.41e-1)"	"unprognostic (2.02e-1)"	"unprognostic (3.01e-2)"	"unprognostic (2.99e-2)"	"unprognostic (2.04e-3)"	"unprognostic (3.28e-1)"	"unprognostic (1.92e-1)"	"unprognostic (8.30e-3)"	"unprognostic (4.99e-3)"	11.8	9.9	1.9	8.6	2.4	14.9	12.3	1.6	3.1	13.7	8.1	11.8	7.2	15.0	7.7	8.9	12.5	6.9	10.7	2.9	2.6	8.8	6.4	9.9	8.2	2.1	2.9	15.1	9.8	15.1	8.8	9.0	2.3	11.2	6.9	6.3	12.5	14.7	33.9	10.8	12.0	10.6	3.3	10.1	9.8	12.8	3.3	13.1	12.9	21.1	8.9	13.0	10.8	2.3	13.1	7.9	26.0	19.4	10.6	6.4	11.4	9.7	15.2	20.1	21.4	15.1	7.8	18.1	14.6	16.2	14.7	8.2	18.8	9.4	17.5	12.8	14.8	26.0	8.1	16.2	15.0	17.4	9.0	15.0	5.8	12.8	11.4	12.0	11.0	21.0	18.6	12.8	12.8	6.9	32.3	13.5	12.5	6.7	12.8	26.2	16.5	10.6	12.4	12.7	26.8	16.9	12.3	11.8	11.8	14.7	11.4	5.5	15.9	13.5	11.8	9.8	8.9	10.1	6.7	15.7	7.0	19.9	12.2	2.4	1.3	0.5	2.8	1.5	2.1	1.6	1.7	2.9	0.7	1.5	1.2	2.3	0.2	3.1	1.3	0.7	1.1	1.7	1.9	2.4	1.6	3.1	2.9	2.6	2.1	2.9	2.3	3.3	3.3	2.3	11.6	44.8	30.8	29.0	10.5	4.6	9.9	8.1	9.1	15.0	14.8	12.2	23.8	10.0	18.8	11.0	43.8	8.1	10.0	15.0	3.9	10.5	13.4	13.0	13.7	12.1	13.1	6.7	35.6	9.6	4.3	12.7	17.3	13.5	18.3	33.1	15.7	12.7	8.1	15.2	36.2	18.4	10.2	12.5	5.6	28.6	9.9	11.2	7.2	16.9	13.7	10.2	9.2	29.7	37.3	13.2	7.9	12.8	10.6	10.3	10.7	5.8	13.1	29.5	13.1	16.0	13.6	23.3	9.7	11.3	6.5	11.1	14.2	18.3	15.6	10.1
KARS1	"DFNB89, KARS, KARS2"	ENSG00000065427	"Lysyl-tRNA synthetase 1"	Q15046	16	75627474-75648643	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Host-virus interaction, Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase, Transferase"	"Charcot-Marie-Tooth disease, Deafness, Disease variant, Neurodegeneration, Neuropathy, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in some"	7	"Cardiomyocytes: 90.7;Cytotrophoblasts: 122.7;Extravillous trophoblasts: 143.3;Hofbauer cells: 89.5;Syncytiotrophoblasts: 110.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041345, HPA041550"	Enhanced		Supported	"Plasma membrane,Cytosol"	"Intracellular and membrane"	NA	NA		82000	"Cluster 27: Non-specific - Gene expression"	"Cluster 52: Non-specific - Ribosome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 24: Non-specific - Transcription regulation"	Cytosol	"Plasma membrane"	"HPA041345: AB_10795589, HPA041550: AB_10794520"	"unprognostic (1.56e-1)"	"unprognostic (7.93e-2)"	"unprognostic (3.36e-2)"	"unprognostic (1.02e-2)"	"unprognostic (5.39e-2)"	"prognostic unfavorable (8.84e-6)"	"unprognostic (6.24e-3)"	"unprognostic (8.97e-3)"	"unprognostic (1.18e-1)"	"unprognostic (9.11e-3)"	"unprognostic (8.71e-3)"	"unprognostic (8.46e-2)"	"unprognostic (7.86e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.03e-1)"	"unprognostic (3.07e-2)"	"unprognostic (2.13e-1)"	68.5	49.6	45.5	71.6	47.3	86.1	83.0	46.9	63.2	60.3	50.6	75.8	62.4	53.9	75.1	72.5	69.5	50.4	96.0	45.6	48.3	72.2	76.8	53.1	88.3	46.9	47.5	74.9	86.5	76.7	51.5	62.2	46.8	55.2	85.6	69.6	79.6	60.6	213.4	67.3	62.6	69.6	46.8	57.6	66.2	98.9	47.4	96.6	65.3	186.8	107.8	92.1	55.0	48.1	164.2	187.0	133.5	185.4	140.1	140.3	262.4	135.0	164.9	290.2	217.0	332.8	209.0	292.4	145.4	180.8	138.4	229.4	272.0	246.7	314.4	86.0	139.8	161.4	153.1	348.5	255.8	245.5	174.1	166.4	173.8	257.4	414.6	147.7	240.0	253.5	273.4	68.5	222.5	378.0	254.1	262.2	284.3	238.4	135.9	329.2	120.0	358.4	235.4	136.3	200.2	162.9	339.5	122.8	152.2	144.8	166.1	229.2	133.8	159.8	164.9	123.6	196.7	145.1	178.6	696.6	139.5	206.5	199.7	88.6	112.7	130.0	110.7	155.7	202.6	109.5	137.1	132.0	135.7	91.6	126.6	117.1	24.9	127.6	163.1	85.7	155.5	160.5	45.5	47.3	46.9	63.2	45.6	48.3	46.9	47.5	46.8	46.8	47.4	48.1	14.2	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	90.7	0.0	0.0	0.0	0.0	122.7	10.1	0.0	0.0	0.0	0.0	0.0	0.0	8.4	0.0	0.0	0.0	0.0	143.3	14.4	0.0	0.0	0.0	0.0	0.0	0.0	89.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.0	0.0	0.0	0.0	0.0	110.0	2.1	0.0	0.0	0.0
KAT5	"cPLA2, ESA1, HTATIP, HTATIP1, PLIP, TIP60, ZC2HC5"	ENSG00000172977	"Lysine acetyltransferase 5"	Q92993	11	65711996-65719604	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Transcription factors"	"Growth regulation, Host-virus interaction, Transcription, Transcription regulation"	"Activator, Acyltransferase, Chromatin regulator, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016953, HPA074328"	Approved		Supported	Nucleoplasm,Vesicles,Cytosol		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Nucleoplasm	"Vesicles, Cytosol"	"HPA016953: AB_1851277, HPA074328: "	"unprognostic (2.20e-1)"	"unprognostic (3.58e-1)"	"unprognostic (3.59e-2)"	"unprognostic (2.74e-1)"	"unprognostic (9.61e-2)"	"unprognostic (7.16e-2)"	"unprognostic (1.29e-3)"	"unprognostic (1.20e-1)"	"unprognostic (2.01e-1)"	"unprognostic (2.74e-1)"	"unprognostic (2.13e-1)"	"unprognostic (2.54e-1)"	"prognostic favorable (1.10e-13)"	"unprognostic (1.37e-1)"	"unprognostic (2.55e-1)"	"unprognostic (1.85e-1)"	"unprognostic (8.54e-2)"	31.6	30.0	38.7	23.8	41.0	52.9	32.1	41.7	48.8	39.5	38.6	43.6	21.6	45.1	33.7	34.9	44.9	20.5	32.4	37.9	38.9	32.9	26.3	29.5	28.0	40.0	39.5	39.2	32.7	45.6	33.7	29.9	41.2	33.1	27.0	31.0	29.6	36.3	42.8	47.6	32.2	35.2	40.0	34.3	35.9	45.2	39.9	39.3	38.2	34.6	30.2	39.5	34.8	43.8	37.2	44.1	40.1	29.6	31.3	32.7	41.1	26.7	43.6	44.0	38.0	32.6	42.2	34.3	36.2	47.4	47.5	30.8	50.8	45.1	26.4	44.4	32.5	50.6	36.3	38.9	44.6	55.7	56.4	35.2	49.7	28.9	59.0	33.7	28.1	39.1	52.5	51.1	42.0	68.2	45.7	62.3	33.9	26.8	28.4	38.2	26.5	63.3	40.6	56.2	37.1	38.9	25.4	46.5	51.2	20.8	45.9	34.2	36.3	33.9	30.4	27.6	28.0	38.7	43.7	50.4	29.7	27.0	29.3	42.7	33.6	58.8	33.4	32.0	29.6	28.2	28.8	34.2	34.1	30.4	36.5	29.8	34.8	35.8	34.6	20.9	31.0	36.4	38.7	41.0	41.7	48.8	37.9	38.9	40.0	39.5	41.2	40.0	39.9	43.8	17.6	12.8	17.5	10.7	26.0	21.2	44.2	60.2	17.6	44.9	17.3	15.0	1.0	25.8	33.8	29.5	31.3	51.3	25.6	27.1	35.2	42.2	11.1	20.2	14.2	18.7	30.4	12.4	7.5	51.5	42.6	21.1	20.4	19.8	33.7	27.0	18.2	10.9	36.3	38.7	8.7	25.1	42.7	17.6	15.2	11.1	28.0	20.4	42.7	3.7	38.8	40.3	33.0	7.1	13.8	39.4	30.6	38.7	10.4	24.2	23.3	32.6	30.0	44.8	46.0	27.6	27.0	61.1	27.8	14.6	21.3	102.5	21.6	29.2	26.2	31.0
KAT6A	"MOZ, MYST3, RUNXBP2, ZC2HC6A, ZNF220"	ENSG00000083168	"Lysine acetyltransferase 6A"	Q92794	8	41929479-42051994	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Acyltransferase, Chromatin regulator, Repressor, Transferase"	"Cancer-related genes, Mental retardation, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017023, HPA063266, HPA065052"	Supported		Supported	"Nucleoli,Nuclear speckles,Cytosol"		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 34: Non-specific - Transcription"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 24: Non-specific - Transcription regulation"	"Nuclear speckles"	"Nucleoli, Cytosol"	"CAB017023: , HPA063266: AB_2684973, HPA065052: AB_2685414"	"unprognostic (3.51e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.04e-1)"	"unprognostic (3.23e-2)"	"unprognostic (2.28e-1)"	"unprognostic (9.27e-3)"	"unprognostic (3.61e-1)"	"unprognostic (2.29e-1)"	"unprognostic (2.95e-1)"	"unprognostic (2.45e-2)"	"unprognostic (1.50e-1)"	"unprognostic (4.45e-2)"	"unprognostic (4.20e-3)"	"unprognostic (1.18e-1)"	"unprognostic (2.24e-1)"	"unprognostic (8.58e-2)"	"unprognostic (2.95e-2)"	14.4	7.1	8.6	15.4	12.7	38.2	12.3	20.1	10.5	13.7	9.7	10.2	9.6	15.6	8.6	13.4	12.0	11.2	9.1	9.1	12.8	9.1	10.0	16.7	16.8	12.7	12.4	21.5	11.7	18.0	6.7	14.9	12.9	11.0	10.6	18.1	9.6	9.7	13.1	16.6	12.1	13.5	8.2	15.7	11.3	11.4	10.1	27.0	14.2	16.0	17.2	12.0	10.7	16.7	19.6	23.2	34.8	21.8	17.8	20.3	9.8	15.4	20.6	17.9	14.2	16.3	11.5	33.4	13.4	19.0	19.5	17.3	27.3	18.6	23.2	16.1	14.4	60.4	14.2	10.3	14.8	27.3	23.6	17.1	19.1	20.4	24.8	14.5	18.8	29.7	36.6	24.2	16.0	10.4	59.9	9.4	12.8	20.4	8.1	37.7	39.1	9.9	11.0	27.1	17.6	16.7	15.8	12.4	13.8	15.8	26.3	12.9	25.5	21.6	15.3	21.1	15.5	16.8	22.1	33.8	12.6	14.1	17.3	2.5	0.8	1.8	1.6	0.9	1.6	1.4	1.6	2.1	0.6	1.6	1.9	1.8	5.1	1.9	0.9	1.1	1.9	1.2	8.6	12.7	20.1	10.5	9.1	12.8	12.7	12.4	12.9	8.2	10.1	16.7	87.5	35.3	34.9	64.0	54.0	50.3	24.2	15.5	18.2	54.8	31.7	25.5	23.7	18.6	25.3	12.9	54.2	14.4	61.5	23.2	3.9	14.2	2.6	30.3	47.5	56.7	24.7	31.2	62.8	11.8	17.0	32.4	21.4	44.8	35.4	31.9	43.5	25.3	17.0	58.9	76.6	24.9	10.2	44.2	34.5	4.8	28.3	43.7	23.2	120.9	30.3	27.9	61.8	93.5	129.2	15.7	20.2	23.0	38.7	30.7	22.9	10.6	22.8	44.9	19.7	49.3	34.6	37.8	37.0	23.0	61.2	21.1	61.4	19.7	19.3	27.2
KAT7	"HBO1, HBOA, MYST2, ZC2HC7"	ENSG00000136504	"Lysine acetyltransferase 7"	O95251	17	49788648-49835026	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Transcription factors"	"DNA damage, DNA repair, DNA replication, Transcription, Transcription regulation"	"Acyltransferase, Chromatin regulator, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044470, HPA071116"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 42: Non-specific - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm	Cytosol	"HPA044470: AB_10965785, HPA071116: "	"unprognostic (1.30e-1)"	"unprognostic (3.15e-2)"	"unprognostic (6.20e-3)"	"unprognostic (2.20e-2)"	"unprognostic (7.99e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.35e-2)"	"unprognostic (1.72e-2)"	"unprognostic (1.36e-1)"	"unprognostic (6.26e-2)"	"unprognostic (1.44e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.33e-3)"	"unprognostic (2.75e-1)"	"unprognostic (5.03e-2)"	"unprognostic (6.23e-2)"	"unprognostic (7.68e-2)"	17.6	14.2	16.1	8.1	16.9	40.9	16.6	24.2	21.5	20.1	15.1	20.9	7.2	22.6	12.2	20.4	20.3	6.6	22.8	16.5	14.8	17.7	11.7	14.5	10.4	13.6	12.3	20.9	12.4	23.5	17.1	10.0	15.5	17.5	10.0	19.2	17.8	14.0	37.7	25.5	16.0	12.4	10.3	15.9	16.0	38.6	14.9	17.4	21.1	20.1	13.5	22.5	19.0	18.7	17.1	22.6	22.5	17.3	10.1	14.3	27.2	11.2	16.5	24.7	18.7	35.9	11.5	17.8	21.8	13.7	24.7	16.7	23.0	12.8	32.5	18.6	20.3	20.7	14.8	17.8	15.0	21.6	17.2	13.3	16.6	21.1	25.3	14.4	22.7	16.0	23.6	18.9	27.4	28.8	26.4	23.2	79.0	38.4	20.2	20.6	34.7	18.2	12.8	17.6	25.7	15.7	7.6	9.2	14.9	40.5	38.6	22.9	8.8	24.5	13.3	16.0	19.4	21.4	32.7	23.3	17.3	13.6	23.3	17.1	6.8	9.5	8.3	5.4	10.6	5.8	7.8	8.5	7.0	6.1	9.3	8.5	10.1	11.7	7.1	4.3	8.5	7.9	16.1	16.9	24.2	21.5	16.5	14.8	13.6	12.3	15.5	10.3	14.9	18.7	16.0	25.6	21.3	9.4	23.6	16.8	11.7	10.1	25.0	32.6	18.5	16.6	28.5	20.0	15.6	27.6	31.3	22.7	27.6	11.7	9.8	11.9	23.1	22.4	21.0	18.7	25.1	25.4	14.8	7.5	14.5	15.3	15.3	29.9	24.1	18.2	15.4	10.4	13.3	45.4	16.7	13.4	12.2	22.6	13.2	16.5	16.8	15.9	14.2	10.3	19.1	16.5	25.7	13.0	18.3	10.0	8.9	18.4	18.6	15.4	12.8	10.2	18.6	25.1	39.5	21.2	24.2	73.7	31.6	17.9	20.0	33.8	28.4	15.2	12.1	10.2
KAT8	"FLJ14040, hMOF, MOF, MYST1, ZC2HC8"	ENSG00000103510	"Lysine acetyltransferase 8"	Q9H7Z6	16	31114489-31131393	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Acyltransferase, Chromatin regulator, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 113.9;Late spermatids: 147.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"eosinophil: 29.9"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA066324			Supported	Nucleoplasm		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 34: Spermatids - Unknown function"	Nucleoplasm		"HPA066324: AB_2685658"	"unprognostic (8.58e-2)"	"unprognostic (9.53e-2)"	"unprognostic (7.83e-2)"	"unprognostic (1.12e-2)"	"unprognostic (8.59e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.22e-1)"	"prognostic favorable (6.34e-4)"	"unprognostic (3.13e-2)"	"unprognostic (3.05e-1)"	"unprognostic (5.50e-2)"	"unprognostic (9.77e-2)"	"unprognostic (7.33e-2)"	"unprognostic (2.97e-1)"	"unprognostic (1.29e-1)"	"unprognostic (5.00e-1)"	"unprognostic (1.41e-1)"	28.8	30.9	40.4	17.8	41.6	32.9	31.3	50.6	50.4	40.8	38.2	36.9	16.6	39.2	46.5	21.1	41.7	14.7	42.0	41.5	41.6	28.4	29.0	31.3	24.6	42.0	41.3	60.7	31.8	37.4	31.0	20.4	41.3	32.0	17.3	27.5	34.7	23.7	49.8	33.8	30.2	25.5	40.0	39.7	28.2	32.8	41.6	39.6	35.5	49.8	23.3	30.9	31.0	43.1	18.1	27.4	33.5	10.7	38.5	28.9	34.3	16.0	29.6	24.7	26.8	13.6	38.1	42.3	24.5	19.6	22.8	22.5	53.6	26.4	24.1	35.8	35.0	18.7	21.5	43.3	34.5	30.5	31.9	27.9	51.4	18.5	52.4	33.2	23.6	44.1	49.5	33.7	13.1	51.4	47.4	57.2	38.0	43.1	15.9	75.1	28.1	49.5	20.1	10.7	35.2	35.9	9.4	25.9	14.1	20.7	28.6	49.6	14.7	11.0	22.2	12.1	11.6	32.4	34.8	24.2	16.0	40.7	16.3	8.0	7.4	29.9	3.0	4.1	3.7	3.6	3.6	4.1	6.6	2.9	4.6	3.3	28.4	3.2	8.3	2.7	2.4	3.4	40.4	41.6	50.6	50.4	41.5	41.6	42.0	41.3	41.3	40.0	41.6	43.1	26.2	19.2	18.2	16.0	30.4	20.8	41.9	18.1	34.7	19.0	21.5	26.2	16.8	21.5	21.0	9.2	14.6	30.5	20.9	17.8	21.5	21.9	113.9	17.5	18.2	21.8	24.6	29.5	16.4	26.6	21.7	29.4	17.9	18.0	27.3	33.9	23.2	12.4	29.1	32.0	18.6	21.2	18.3	30.1	25.4	147.5	53.7	28.1	24.9	12.2	32.6	41.0	15.5	11.1	13.2	15.0	25.8	54.2	16.5	35.2	25.1	17.5	11.8	26.9	26.3	32.8	30.6	27.5	26.2	20.6	15.6	45.4	24.6	24.5	22.9	23.2
KATNA1		ENSG00000186625	"Katanin catalytic subunit A1"	O75449	6	149594873-149648972	"Enzymes, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	Isomerase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"Early spermatids: 416.6;Late spermatids: 194.2;Spermatocytes: 109.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036207	Approved		Supported	"Nucleoplasm,Centriolar satellite"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 32: U-937 - Innate immune response"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	"Centriolar satellite"	Nucleoplasm	"HPA036207: AB_10672238"	"unprognostic (1.57e-1)"	"unprognostic (2.41e-2)"	"unprognostic (2.95e-2)"	"unprognostic (3.57e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.12e-1)"	"prognostic unfavorable (3.57e-7)"	"unprognostic (9.78e-2)"	"unprognostic (8.89e-2)"	"unprognostic (7.40e-2)"	"unprognostic (2.70e-2)"	"unprognostic (4.50e-2)"	"unprognostic (3.92e-2)"	"unprognostic (2.10e-1)"	"unprognostic (3.37e-1)"	"unprognostic (1.74e-3)"	"unprognostic (8.85e-2)"	12.9	8.2	7.2	10.3	8.4	19.2	12.6	9.6	9.1	13.3	12.3	13.1	8.5	13.3	9.8	12.5	11.8	9.7	11.6	7.0	7.9	13.2	9.0	11.2	14.1	8.2	7.9	19.5	9.5	7.3	7.4	12.7	8.4	9.9	9.9	16.8	9.7	10.9	23.0	12.3	10.0	12.4	7.9	11.8	10.1	45.1	7.8	17.0	11.2	14.3	15.8	12.0	12.7	9.6	22.5	8.3	18.6	42.1	22.9	32.7	28.9	28.7	24.3	29.4	37.2	17.9	11.4	33.7	16.9	28.4	20.4	17.1	34.5	18.5	37.8	30.4	33.8	42.7	17.6	27.9	31.0	60.0	16.4	22.8	22.5	33.3	27.3	27.3	27.8	44.4	46.1	20.7	26.2	32.0	41.2	40.4	19.1	26.2	15.1	30.5	33.3	15.2	21.6	11.6	13.7	20.7	48.9	15.0	22.2	24.3	14.4	61.6	23.7	14.6	23.4	39.2	33.9	20.4	20.3	43.9	19.8	42.7	26.4	39.8	20.4	29.1	25.9	28.5	22.2	27.7	25.2	25.8	26.1	18.3	21.4	20.9	8.7	18.2	25.6	22.3	34.0	20.5	7.2	8.4	9.6	9.1	7.0	7.9	8.2	7.9	8.4	7.9	7.8	9.6	27.6	16.0	11.3	11.8	20.2	29.3	35.7	23.0	12.5	9.1	17.3	26.9	15.5	10.0	15.0	14.7	29.2	23.6	31.4	12.1	17.6	19.5	416.6	23.2	21.6	19.3	6.0	27.4	8.6	12.4	19.4	25.9	11.7	19.3	20.3	23.9	10.0	7.7	17.4	13.5	9.4	9.7	24.4	12.5	19.4	194.2	21.1	17.3	10.6	7.5	22.1	12.2	27.8	13.6	16.3	15.9	12.5	16.6	9.0	19.4	9.7	20.9	23.8	36.1	6.6	40.0	28.5	109.3	58.8	17.7	28.7	25.6	25.6	17.7	12.1	15.4
KATNB1		ENSG00000140854	"Katanin regulatory subunit B1"	Q9BVA0	16	57735739-57757244	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"		"Disease variant, Lissencephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 115.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041165, HPA041839"	Enhanced		Supported	"Plasma membrane,Microtubules,Cytosol"		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 49: Ciliated cells - Cilium organization"	"Plasma membrane, Cytosol"	Microtubules	"HPA041165: AB_10795584, HPA041839: AB_10795598"	"unprognostic (1.37e-1)"	"unprognostic (2.76e-2)"	"unprognostic (1.56e-1)"	"prognostic favorable (9.24e-4)"	"unprognostic (2.54e-1)"	"unprognostic (2.51e-1)"	"prognostic unfavorable (3.93e-4)"	"unprognostic (1.42e-1)"	"unprognostic (2.92e-1)"	"unprognostic (1.75e-1)"	"prognostic favorable (8.44e-4)"	"unprognostic (2.89e-2)"	"unprognostic (1.03e-3)"	"unprognostic (2.20e-1)"	"unprognostic (1.29e-1)"	"unprognostic (6.88e-2)"	"unprognostic (1.54e-1)"	9.9	13.3	16.0	10.8	18.4	23.0	10.6	5.5	24.7	10.1	11.8	9.9	10.6	11.2	4.1	15.9	19.2	6.2	11.7	18.2	11.7	10.3	9.5	11.9	10.5	10.4	9.1	9.6	14.0	10.7	13.7	7.2	10.1	10.2	5.5	5.9	13.1	7.7	10.4	29.0	10.1	6.5	6.6	12.9	10.3	37.1	13.2	12.8	11.0	7.9	8.2	8.7	11.9	16.3	20.8	35.7	19.2	25.0	10.4	9.2	35.2	13.9	18.5	35.2	19.6	30.2	18.3	16.1	28.0	8.8	13.2	27.0	25.8	27.9	16.2	11.1	74.8	21.0	20.4	42.5	11.5	47.6	77.6	9.5	17.3	28.7	16.1	14.8	21.2	58.8	42.8	8.2	15.0	21.6	67.6	60.1	34.0	14.7	61.4	53.7	23.8	59.6	10.6	9.9	97.0	29.2	23.8	27.1	16.8	7.6	10.2	23.9	16.0	24.5	21.9	22.9	31.0	18.5	16.1	19.9	35.2	36.6	15.7	50.8	18.9	46.1	21.0	20.8	20.4	9.3	17.5	16.3	17.8	9.3	16.0	15.5	27.9	16.1	22.7	11.9	20.1	21.7	16.0	18.4	5.5	24.7	18.2	11.7	10.4	9.1	10.1	6.6	13.2	16.3	5.5	3.2	5.5	3.3	5.2	9.1	8.0	11.5	9.6	10.2	8.4	7.1	2.6	4.3	7.7	5.5	6.2	17.3	8.5	13.2	11.7	13.7	115.4	18.8	4.4	6.0	4.8	8.8	14.8	13.6	11.7	6.6	12.8	4.7	5.1	7.6	6.8	4.7	9.9	18.5	11.2	9.2	6.1	5.1	2.5	36.6	7.8	7.6	7.2	3.7	6.1	10.0	11.3	2.5	4.9	10.1	5.1	4.9	13.3	7.3	10.5	8.0	26.2	10.9	6.6	4.9	6.3	41.8	8.3	11.9	13.8	7.7	10.9	8.2	11.8	7.8
KATNBL1	"C15orf29, FLJ22557"	ENSG00000134152	"Katanin regulatory subunit B1 like 1"	Q9H079	15	34140674-34210096	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 128.5"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 128.5"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA062573	Approved		Supported	"Nucleoplasm,Midbody,Cleavage furrow,Mitotic spindle"		Yes	No			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 22: Epithelial cell types - Mixed function"	"Midbody, Mitotic spindle"	"Nucleoplasm, Cleavage furrow"	"HPA062573: AB_2684796"	"unprognostic (5.02e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.35e-2)"	"unprognostic (2.91e-2)"	"unprognostic (2.01e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.01e-1)"	"unprognostic (5.16e-2)"	"unprognostic (3.94e-3)"	"unprognostic (8.00e-3)"	"prognostic unfavorable (4.60e-5)"	"unprognostic (2.71e-2)"	"unprognostic (7.23e-2)"	"unprognostic (2.42e-1)"	"unprognostic (1.43e-1)"	22.0	12.1	16.3	22.9	16.6	16.3	20.8	25.0	20.8	22.5	22.4	19.9	15.9	20.7	19.0	39.9	16.8	15.9	13.4	15.8	14.9	17.0	17.6	18.4	17.6	15.0	13.8	14.4	14.0	14.5	12.1	32.4	16.0	16.9	21.2	31.2	14.6	13.6	13.2	31.4	15.7	25.4	12.9	18.6	17.7	18.0	18.2	15.2	12.5	13.0	20.3	17.8	27.7	25.3	37.1	31.5	49.7	33.4	39.5	39.0	37.0	49.6	30.0	38.7	38.4	17.8	19.9	17.6	31.2	32.2	54.5	47.5	24.9	28.5	45.8	36.9	12.6	31.8	34.6	21.6	27.0	33.9	33.1	23.6	40.8	26.1	51.3	39.7	70.6	45.4	34.3	36.7	53.1	17.6	21.4	27.4	35.8	47.4	25.0	32.3	30.3	16.1	35.9	49.5	28.1	24.8	30.1	21.9	14.7	49.2	27.0	38.8	40.4	51.9	26.7	46.8	39.7	21.5	32.5	37.1	46.5	35.7	38.9	62.8	18.2	29.7	18.4	17.3	23.3	23.9	19.6	18.8	20.7	25.6	21.5	19.2	128.5	13.2	11.5	28.4	17.9	12.0	16.3	16.6	25.0	20.8	15.8	14.9	15.0	13.8	16.0	12.9	18.2	25.3	59.7	38.5	25.2	83.9	41.7	41.3	65.2	60.5	34.7	57.0	42.1	43.1	12.8	24.3	51.6	25.8	52.1	58.6	42.3	30.6	33.2	59.1	75.4	40.5	53.3	47.0	23.9	39.8	104.3	54.5	86.2	38.8	39.3	50.8	44.9	68.7	37.9	20.8	39.1	67.3	96.7	35.6	52.9	27.6	48.8	59.2	31.7	36.2	32.0	64.6	49.9	53.1	27.8	86.0	114.4	105.3	37.4	33.1	41.1	116.8	21.4	41.6	49.6	44.7	59.2	52.2	45.3	47.8	44.3	45.0	54.3	179.5	39.7	31.6	39.1	132.6
KAZN	"C1orf196, FLJ43806, KAZRIN, KIAA1026"	ENSG00000189337	"Kazrin, periplakin interacting protein"	Q674X7	1	13892792-15118043	"Predicted intracellular proteins"	Keratinization			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 91.5"	"Group enriched"	"Detected in many"	12	"Excitatory neurons: 1065.9;Inhibitory neurons: 2872.7;Oligodendrocyte precursor cells: 1360.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	23	"neutrophil: 3.4"	"Lineage enriched"	"Detected in single"	23	"granulocytes: 3.4"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 85.6;SK-BR-3: 46.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA032095, HPA032096"	Approved		Supported	"Nucleoplasm,Nuclear speckles,Cytosol"		NA	NA			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm	"Nuclear speckles, Cytosol"	"HPA032095: AB_2674146, HPA032096: AB_10670826"	"unprognostic (2.81e-1)"	"unprognostic (5.82e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.42e-3)"	"unprognostic (5.34e-2)"	"unprognostic (2.15e-3)"	"unprognostic (6.57e-3)"	"unprognostic (7.88e-3)"	"unprognostic (3.21e-1)"	"unprognostic (4.96e-3)"	"unprognostic (1.10e-1)"	"unprognostic (5.55e-2)"	"prognostic favorable (1.20e-6)"	"unprognostic (3.61e-2)"	"unprognostic (7.93e-2)"	"unprognostic (3.21e-1)"	"unprognostic (1.06e-2)"	12.6	17.7	27.3	3.0	31.5	0.6	11.4	43.6	33.6	17.0	23.9	5.5	5.1	4.2	12.2	34.9	12.6	7.7	6.9	25.0	24.1	24.9	5.8	16.5	1.0	37.1	32.9	16.7	9.2	29.5	5.1	6.3	32.7	7.5	3.9	12.9	21.4	7.4	1.4	23.5	5.3	3.6	29.2	91.5	5.1	4.5	34.1	1.9	10.3	1.6	5.5	8.9	21.3	47.1	17.7	3.0	18.5	85.6	7.9	8.2	6.3	8.3	6.9	15.0	10.8	4.0	9.3	0.0	21.1	17.8	2.7	6.3	4.3	13.5	7.5	0.5	8.4	10.1	10.2	26.6	5.8	0.0	5.0	11.6	17.7	3.5	2.3	6.8	0.1	2.5	4.2	19.8	12.2	12.8	0.1	1.1	5.1	7.9	2.6	6.0	0.4	10.6	25.5	5.4	9.8	7.1	1.5	46.3	33.0	10.5	2.8	6.7	0.0	12.4	11.6	19.8	10.1	3.3	3.0	0.0	11.6	17.4	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	27.3	31.5	43.6	33.6	25.0	24.1	37.1	32.9	32.7	29.2	34.1	47.1	17.6	3.2	1.8	124.1	0.9	50.3	16.6	9.7	31.3	12.4	23.0	27.9	3.4	4.3	9.1	49.7	8.4	1.5	0.9	12.3	17.6	2.0	6.8	51.4	15.8	19.4	7.1	0.0	1065.9	1.6	8.1	27.0	3.6	16.8	3.8	9.7	31.1	0.1	0.8	0.0	2872.7	5.2	18.3	0.9	11.4	9.1	19.0	1.1	46.2	93.7	0.0	74.2	4.1	1360.7	143.5	1.5	1.6	17.3	0.3	19.4	2.0	12.9	30.3	3.2	6.6	33.5	23.6	0.3	3.2	26.2	90.4	46.4	1.4	41.6	3.5	24.8
KCNAB1	"AKR6A3, hKvb3, hKvBeta3, KCNA1B, Kvb1.3"	ENSG00000169282	"Potassium voltage-gated channel subfamily A member regulatory beta subunit 1"	Q14722	3	156037701-156539138	"Predicted intracellular proteins, Transporters"	"Ion transport, Potassium transport, Transport"	"Ion channel, Oxidoreductase, Voltage-gated channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 52.7"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 85.8;Excitatory neurons: 108.6;Inhibitory neurons: 605.4;Oligodendrocyte precursor cells: 206.6;Oligodendrocytes: 97.5;Sertoli cells: 78.9"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 7.4"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"HEL: 3.4;hTEC/SVTERT24-B: 5.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036110, HPA044550"	Approved		Approved	"Nucleoplasm,Vesicles,Plasma membrane"		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 68: Epididymis - Unknown function"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Vesicles	"Nucleoplasm, Plasma membrane"	"HPA036110: , HPA044550: AB_10797032"	"unprognostic (1.52e-1)"	"unprognostic (3.73e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.98e-4)"	"unprognostic (1.24e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.81e-1)"	"unprognostic (2.83e-2)"	"unprognostic (8.51e-2)"	"unprognostic (3.72e-2)"	"unprognostic (5.87e-2)"	"unprognostic (9.70e-2)"	"unprognostic (2.17e-3)"	"unprognostic (2.60e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.06e-1)"	"unprognostic (4.00e-1)"	15.8	6.3	12.7	1.2	52.7	1.6	7.3	15.5	17.3	8.4	4.2	4.1	1.7	5.4	12.8	2.2	4.3	2.9	5.5	25.9	11.6	1.8	2.6	3.3	0.9	7.2	12.1	2.9	4.0	2.0	1.8	1.3	7.2	22.4	1.8	12.8	3.9	19.2	2.0	2.2	2.7	2.7	8.4	5.2	1.6	3.1	14.1	1.8	28.7	5.1	0.3	2.9	5.0	15.4	0.5	0.5	0.7	0.2	0.0	0.0	1.4	1.2	0.0	0.0	0.1	0.9	0.1	0.4	0.7	0.0	0.3	0.3	0.0	0.0	0.0	0.4	1.0	3.4	0.6	1.6	0.0	1.0	0.2	0.0	0.0	5.2	0.0	1.1	2.1	0.5	0.1	0.3	0.2	0.1	0.3	0.6	1.1	1.5	0.2	0.6	0.7	2.8	0.0	0.2	0.8	0.8	0.3	0.6	0.7	0.5	0.8	0.5	2.2	0.8	0.5	1.4	1.2	1.8	0.4	0.4	2.6	1.1	1.0	0.8	0.1	0.0	0.4	0.2	0.8	0.2	0.4	0.3	0.2	0.2	0.3	0.3	0.0	0.3	0.3	1.2	0.5	0.1	12.7	52.7	15.5	17.3	25.9	11.6	7.2	12.1	7.2	8.4	14.1	15.4	7.2	0.0	0.0	7.5	0.7	0.8	0.3	0.0	0.0	85.8	1.4	1.4	4.3	0.0	0.7	0.0	31.3	0.1	0.5	0.1	0.0	0.4	13.7	0.6	2.4	2.8	0.0	0.0	108.6	0.0	0.0	3.8	0.0	2.1	0.0	0.4	0.7	0.0	4.6	0.0	605.4	0.0	0.0	11.1	1.0	7.0	0.0	1.2	1.8	24.4	0.0	2.7	0.0	206.6	97.5	0.0	0.0	2.6	2.3	0.2	0.0	0.1	0.0	6.7	78.9	1.3	73.3	0.3	4.2	1.2	0.9	0.1	0.5	0.2	0.0	0.2
KCNE3	"HOKPP, MiRP2"	ENSG00000175538	"Potassium voltage-gated channel subfamily E regulatory subunit 3"	Q9Y6H6	11	74454841-74467729	"Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"	"Brugada syndrome, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 70.5;stomach 1: 56.2"	"Cell type enhanced"	"Detected in many"		"Gastric mucus-secreting cells: 41.8;granulocytes: 33.7;Hofbauer cells: 40.6;Kupffer cells: 104.0;Macrophages: 37.8;monocytes: 59.0;Undifferentiated cells: 44.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	48	"basophil: 51.4;classical monocyte: 38.5;eosinophil: 23.4;intermediate monocyte: 41.8;myeloid DC: 18.3;neutrophil: 53.1;non-classical monocyte: 36.6"	"Group enriched"	"Detected in many"	115	"dendritic cells: 18.3;granulocytes: 53.1;monocytes: 41.8"	"Cell line enhanced"	"Detected in some"		"HEL: 70.3;NB-4: 44.7;OE19: 155.3;THP-1: 32.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA014849	Approved		Supported	"Plasma membrane"		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 9: Intestine - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	"Plasma membrane"		"HPA014849: AB_1852112"	"unprognostic (1.61e-2)"	"unprognostic (2.94e-1)"	"unprognostic (1.11e-1)"	"unprognostic (8.69e-2)"	"unprognostic (3.58e-1)"	"unprognostic (5.13e-2)"	"prognostic unfavorable (2.28e-4)"	"unprognostic (4.67e-3)"	"unprognostic (4.89e-4)"	"unprognostic (4.12e-3)"	"unprognostic (2.56e-2)"	"unprognostic (2.97e-2)"	"unprognostic (1.45e-3)"	"unprognostic (7.86e-2)"	"unprognostic (1.33e-2)"	"unprognostic (1.73e-1)"	"unprognostic (2.00e-1)"	7.3	2.8	2.8	20.7	2.9	8.2	5.2	2.5	3.6	9.9	7.0	34.9	70.5	8.8	1.9	4.6	9.4	24.6	5.0	3.0	3.0	20.1	5.0	13.8	5.0	3.8	3.6	14.0	10.8	3.6	3.1	12.7	3.6	8.0	47.3	8.1	15.4	3.4	1.3	1.3	40.0	11.1	3.3	12.6	56.2	1.8	4.1	1.9	33.5	3.0	3.2	6.2	4.5	4.9	0.1	0.1	0.1	0.2	8.1	2.1	7.1	0.1	0.0	1.0	0.8	23.0	2.0	0.3	21.3	0.1	0.1	0.3	1.8	0.0	0.7	0.0	0.2	70.3	0.4	4.7	2.9	0.6	12.0	7.1	0.0	0.6	0.0	0.3	0.3	0.1	1.9	0.3	0.8	0.1	0.1	44.7	0.9	155.3	0.1	7.6	0.3	0.5	1.7	0.0	0.0	0.4	0.1	0.0	0.0	5.4	0.1	32.7	0.1	0.1	0.2	0.2	0.1	0.3	0.3	0.4	0.1	12.9	0.1	51.4	38.5	23.4	0.1	41.8	0.2	0.2	0.1	0.1	18.3	0.3	0.1	0.1	53.1	0.2	36.6	0.7	0.0	13.2	2.8	2.9	2.5	3.6	3.0	3.0	3.8	3.6	3.6	3.3	4.1	4.9	4.4	0.0	6.8	0.3	0.7	0.3	0.6	1.1	3.4	0.2	0.2	0.3	0.7	8.6	5.6	1.8	0.0	0.4	0.0	8.6	3.9	0.5	0.1	3.1	3.4	8.9	2.4	2.1	0.2	7.3	7.4	4.5	41.8	5.0	33.7	0.2	5.7	2.0	40.6	0.0	0.3	27.9	4.1	104.0	2.9	0.3	3.7	37.8	0.0	8.4	59.0	22.7	1.0	0.0	0.0	3.3	8.9	2.6	0.2	0.4	8.6	23.4	4.6	1.2	0.0	4.7	0.7	0.0	0.4	2.7	0.1	2.1	1.0	8.8	44.3	0.6
KCNG4	Kv6.4	ENSG00000168418	"Potassium voltage-gated channel modifier subfamily G member 4"	Q8TDN1	16	84218667-84239750	"Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	9	"brain: 3.4;retina: 4.3"	"Cell type enriched"	"Detected in some"	14	"Bipolar cells: 56.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in all"	4	"cerebellum: 90.5;pons and medulla: 27.0"	"Low region specificity"	"Detected in many"			HPA063516			Supported	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 77: Retina - Visual perception"		"Cluster 56: Bipolar cells - Visual perception"	"Plasma membrane"	Nucleoplasm	"HPA063516: "					"unprognostic (3.54e-1)"									"unprognostic (6.67e-2)"				0.1	0.4	0.6	0.0	1.0	0.3	0.0	3.3	0.4	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.7	0.0	0.0	0.0	0.1	3.4	1.5	0.1	0.0	0.0	0.0	0.0	2.4	0.0	0.0	4.3	0.0	0.0	0.1	0.3	0.0	0.0	1.3	0.0	0.0	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.1	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.3	0.2	0.0	0.1	0.0	0.0	0.6	1.0	3.3	0.4	0.5	0.7	3.4	1.5	2.4	1.3	0.8	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	56.7	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	4.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1
KCNH1	"eag, eag1, h-eag, hEAG, Kv10.1"	ENSG00000143473	"Potassium voltage-gated channel subfamily H member 1"	O95259	1	210676823-211134165	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Calmodulin-binding, Ion channel, Potassium channel, Voltage-gated channel"	"Disease variant, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"brain: 17.9"	"Cell type enhanced"	"Detected in some"		"Excitatory neurons: 533.5;Inhibitory neurons: 261.0;Oligodendrocytes: 116.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"LHCN-M2: 6.2;RH-30: 10.1;RPTEC TERT1: 6.0;SH-SY5Y: 12.9;SK-MEL-30: 12.9;T-47d: 9.2"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"basal ganglia: 34.0;cerebellum: 19.1;cerebral cortex: 23.9;hippocampal formation: 17.9;olfactory bulb: 8.9"	"HPA014551, HPA019445, HPA076421"	Enhanced		Supported	Vesicles		NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Vesicles		"HPA014551: AB_2669038, HPA019445: AB_1852118, HPA076421: "	"unprognostic (9.12e-2)"	"unprognostic (4.82e-3)"	"unprognostic (2.63e-1)"	"unprognostic (6.70e-2)"	"unprognostic (3.56e-1)"	"unprognostic (3.63e-2)"	"unprognostic (1.73e-1)"	"unprognostic (9.36e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.46e-2)"	"unprognostic (2.77e-2)"	"unprognostic (1.42e-3)"	"unprognostic (1.17e-1)"	"unprognostic (8.89e-2)"	"unprognostic (1.36e-1)"	"unprognostic (9.70e-2)"	0.2	0.9	6.8	0.4	9.2	0.0	0.2	9.5	17.9	0.7	2.7	0.5	0.3	0.4	0.2	0.1	0.6	0.2	0.0	11.2	5.3	0.1	0.1	0.0	0.0	4.8	4.4	0.1	0.2	0.0	0.7	0.3	4.0	0.5	0.3	0.3	0.1	0.1	0.2	0.1	0.8	0.2	4.0	0.0	0.5	1.5	4.9	0.2	0.1	0.6	0.0	0.2	0.4	8.3	0.0	2.1	0.4	0.1	0.0	0.1	0.1	1.0	0.2	2.1	2.4	0.0	0.0	0.0	0.0	1.4	2.4	0.0	0.0	0.0	0.9	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.5	0.1	0.0	0.4	0.0	0.5	0.0	0.0	0.0	0.0	6.2	0.2	0.0	0.0	0.2	0.0	0.0	0.0	10.1	0.0	6.0	0.0	0.4	12.9	2.4	0.2	12.9	1.7	9.2	0.0	0.0	1.6	0.2	2.0	1.2	0.0	0.0	0.0	0.2	0.0	0.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	6.8	9.2	9.5	17.9	11.2	5.3	4.8	4.4	4.0	4.0	4.9	8.3	0.2	0.0	0.0	8.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	1.8	0.0	0.1	0.0	0.0	0.0	0.0	11.2	0.2	2.8	0.1	0.0	0.0	533.5	0.0	0.0	0.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	261.0	0.0	0.0	0.0	0.0	18.6	0.0	0.0	0.0	7.5	0.0	0.0	0.0	19.1	116.6	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.2	0.1	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
KCNH8	"elk3, Kv12.1"	ENSG00000183960	"Potassium voltage-gated channel subfamily H member 8"	Q96L42	3	19148510-19535642	"Predicted membrane proteins, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 16.0;pituitary gland: 10.7"	"Group enriched"	"Detected in some"	63	"Oligodendrocyte precursor cells: 331.7;Oligodendrocytes: 989.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"naive B-cell: 1.4"	"Lineage enriched"	"Detected in single"	4	"B-cells: 1.4"	"Cell line enhanced"	"Detected in some"		"HAP1: 1.0;OE19: 1.9;SH-SY5Y: 4.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA016586, HPA077537, HPA077773"	Approved		Supported	"Plasma membrane"		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 65: Brain - Ion transport"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Plasma membrane"		"HPA016586: AB_1852127, HPA077537: , HPA077773: "	"unprognostic (6.68e-3)"	"unprognostic (1.68e-1)"	"unprognostic (2.99e-2)"	"unprognostic (8.56e-6)"	"unprognostic (1.04e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.88e-1)"	"unprognostic (9.13e-3)"	"unprognostic (4.86e-2)"	"unprognostic (1.69e-1)"	"unprognostic (5.04e-3)"	"unprognostic (2.90e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.17e-1)"	"unprognostic (3.89e-2)"	"unprognostic (8.71e-5)"	"unprognostic (1.72e-1)"	0.0	1.8	7.3	0.3	11.9	0.2	0.5	6.5	16.0	0.3	2.8	0.6	0.4	0.1	0.1	0.1	0.2	0.4	0.2	6.4	8.8	0.1	0.1	0.0	0.8	8.4	8.8	0.0	1.5	0.1	10.7	0.0	8.2	0.7	0.5	3.4	1.1	0.2	0.0	0.4	1.1	0.1	5.8	1.1	1.4	1.7	9.7	0.4	0.2	0.0	0.7	0.1	0.3	15.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.5	4.3	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	1.4	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	7.3	11.9	6.5	16.0	6.4	8.8	8.4	8.8	8.2	5.8	9.7	15.4	0.0	0.0	0.0	2.0	9.7	0.5	1.6	0.0	0.0	4.2	1.1	2.7	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.9	3.2	0.1	0.1	0.1	3.6	0.0	9.3	0.6	0.0	0.1	2.0	0.2	0.0	0.2	0.0	0.0	0.1	0.0	10.4	1.5	0.0	0.0	0.0	1.9	0.0	0.1	3.6	1.0	0.0	3.4	0.0	331.7	989.4	0.5	0.2	0.0	0.1	1.5	0.0	0.0	0.0	1.0	0.0	0.2	0.5	1.2	3.4	0.0	0.0	0.1	0.3	0.1	0.6	0.4
KCNK17	"K2p17.1, TALK-2, TALK2, TASK-4, TASK4"	ENSG00000124780	"Potassium two pore domain channel subfamily K member 17"	Q96T54	6	39299001-39314461	"Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 7.7;thyroid gland: 6.5"	"Cell type enhanced"	"Detected in some"		"dendritic cells: 11.0;Exocrine glandular cells: 7.9;granulocytes: 6.3;Microglial cells: 17.8;Smooth muscle cells: 5.4"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in some"	34	"plasmacytoid DC: 63.8"	"Lineage enriched"	"Detected in many"	34	"dendritic cells: 63.8"	"Cell line enriched"	"Detected in some"	7	"SCLC-21H: 83.8"					"Not detected"	"Not detected"			HPA043892	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 65: Plasmacytoid DCs - Unknown function"	"Plasma membrane, Cytosol"	Nucleoplasm	"HPA043892: AB_10962838"	"unprognostic (5.33e-3)"	"unprognostic (6.42e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.54e-1)"	"unprognostic (3.70e-2)"	"unprognostic (3.85e-2)"	"unprognostic (4.09e-2)"	"unprognostic (4.95e-1)"	"unprognostic (2.35e-1)"	"unprognostic (1.71e-2)"	"unprognostic (2.54e-1)"	"unprognostic (3.77e-11)"	"unprognostic (5.89e-2)"	"unprognostic (5.36e-1)"	"unprognostic (2.82e-1)"	"unprognostic (3.86e-3)"	0.5	0.3	0.3	0.4	0.4	1.2	0.8	0.3	0.6	0.7	0.2	0.6	1.9	1.2	0.0	0.3	0.8	2.5	5.8	0.2	0.3	0.1	4.0	7.7	0.7	0.4	0.5	0.2	3.9	0.1	1.8	4.0	0.3	0.6	0.5	0.0	0.7	0.2	0.1	0.1	1.1	1.0	0.2	0.7	2.9	0.2	0.5	1.3	6.5	0.5	1.1	0.7	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.2	0.0	0.0	83.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.8	0.0	63.8	0.0	0.3	0.3	0.4	0.3	0.6	0.2	0.3	0.4	0.5	0.3	0.2	0.5	0.3	0.0	0.0	2.6	0.7	0.0	0.0	0.1	0.0	0.0	0.0	0.1	1.9	0.3	0.0	0.0	0.0	0.0	0.0	11.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.1	7.9	0.0	1.8	1.1	0.1	6.3	0.0	0.7	0.2	0.1	0.0	0.1	0.4	0.0	0.6	0.0	0.0	0.0	0.9	0.0	17.8	0.2	0.0	0.0	0.0	0.1	0.7	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	2.3	5.4	0.0	0.2	0.0	0.0	0.0	0.7	0.1	0.0	0.0
KCNN4	"hIKCa1, hKCa4, hSK4, IK, KCa3.1"	ENSG00000104783	"Potassium calcium-activated channel subfamily N member 4"	O15554	19	43766533-43781257	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Immunity, Ion transport, Transport"	"Calmodulin-binding, Ion channel"	"Disease variant, FDA approved drug targets, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"salivary gland: 130.8"	"Group enriched"	"Detected in many"	6	"Cytotrophoblasts: 231.1;Syncytiotrophoblasts: 763.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 85.7;WM-115: 258.6"	"Region enhanced"	"Detected in single"		"olfactory bulb: 1.9"	"Not detected"	"Not detected"			"HPA013367, HPA053841, HPA059622"	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	"Plasma membrane, Cytosol"		"HPA013367: , HPA053841: AB_2682278, HPA059622: AB_2684085"	"unprognostic (1.23e-2)"	"unprognostic (3.22e-2)"	"unprognostic (4.29e-1)"	"unprognostic (3.74e-3)"	"prognostic unfavorable (2.68e-4)"	"unprognostic (1.98e-2)"	"unprognostic (7.33e-2)"	"unprognostic (1.42e-2)"	"unprognostic (2.48e-3)"	"unprognostic (4.12e-2)"	"prognostic unfavorable (4.56e-4)"	"unprognostic (9.96e-3)"	"prognostic unfavorable (1.05e-14)"	"unprognostic (3.70e-2)"	"unprognostic (2.17e-2)"	"unprognostic (7.50e-2)"	"prognostic favorable (1.75e-4)"	3.6	0.7	1.7	11.8	1.9	18.3	12.4	1.3	1.8	11.8	1.4	18.5	6.4	1.6	1.8	6.5	5.8	3.5	1.1	1.5	1.6	1.4	0.8	7.3	12.5	1.6	1.6	0.6	1.0	0.0	0.7	14.3	1.7	28.6	6.2	0.2	130.8	7.5	0.4	29.1	26.0	0.7	1.9	20.5	35.1	2.7	2.0	5.0	2.1	0.2	9.2	18.2	6.5	2.3	22.4	35.2	0.1	0.2	0.0	2.2	55.0	0.8	1.7	0.7	0.1	0.5	85.7	6.7	9.8	0.9	9.1	13.6	0.0	28.8	1.7	40.9	0.0	29.8	48.6	0.5	0.0	0.3	0.3	0.0	2.9	1.3	6.6	52.7	0.0	0.3	2.6	2.3	0.3	18.7	4.8	17.9	0.2	43.1	42.4	16.8	0.7	21.0	13.0	55.3	0.2	0.1	62.2	70.1	32.6	1.7	0.3	15.1	1.5	12.6	75.9	0.4	45.3	0.1	1.4	2.6	45.9	5.1	258.6	5.8	21.1	0.0	0.5	35.3	0.7	37.3	10.4	5.0	30.7	21.6	6.6	6.3	1.1	0.0	20.1	0.9	15.2	11.2	1.7	1.9	1.3	1.8	1.5	1.6	1.6	1.6	1.7	1.9	2.0	2.3	1.6	0.0	1.9	1.3	24.7	2.8	45.7	79.5	3.4	0.2	69.7	56.6	0.4	7.2	18.4	1.8	4.2	231.1	4.1	22.0	0.0	5.9	1.2	1.7	0.2	4.0	0.0	32.4	1.5	3.9	14.1	2.3	57.1	4.2	0.0	0.0	0.4	0.0	43.7	0.0	1.1	8.9	2.0	7.2	78.2	0.3	0.0	23.3	21.4	1.0	2.5	0.1	1.0	0.5	0.8	63.8	22.3	0.0	22.4	63.5	1.0	0.1	2.2	0.5	0.0	0.3	1.4	0.4	1.4	2.1	2.3	763.3	9.5	0.0	51.1	65.6
KCNQ1	"JLNS1, KCNA8, KCNA9, Kv7.1, KVLQT1, LQT, LQT1"	ENSG00000053918	"Potassium voltage-gated channel subfamily Q member 1"	P51787	11	2444684-2849105	"Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Calmodulin-binding, Ion channel, Potassium channel, Voltage-gated channel"	"Atrial fibrillation, Deafness, Diabetes mellitus, Disease variant, FDA approved drug targets, Long QT syndrome, Short QT syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 197.1;stomach 1: 98.9"	"Cell type enhanced"	"Detected in many"		"Granulosa cells: 47.6;Microglial cells: 71.2;Undifferentiated cells: 57.8"	"Cancer enhanced"	"Detected in all"		"colorectal cancer: 42.5"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HMC-1: 33.4;OE19: 41.4;RPMI-8226: 23.2;U-266/70: 11.5;U-937: 13.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"CAB018656, HPA048553, HPA071107"	Enhanced		Supported	"Endoplasmic reticulum,Plasma membrane"		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 21: OE19 - Mitochondria"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Endoplasmic reticulum"	"Plasma membrane"	"CAB018656: AB_2131551, HPA048553: AB_2680438, HPA071107: "	"unprognostic (6.02e-2)"	"unprognostic (2.48e-1)"	"unprognostic (6.39e-3)"	"unprognostic (4.38e-1)"	"unprognostic (1.86e-1)"	"unprognostic (1.83e-1)"	"unprognostic (3.46e-2)"	"unprognostic (7.36e-2)"	"unprognostic (8.07e-2)"	"unprognostic (8.81e-2)"	"unprognostic (1.58e-1)"	"unprognostic (5.39e-2)"	"unprognostic (2.46e-3)"	"prognostic favorable (9.85e-4)"	"unprognostic (3.99e-2)"	"unprognostic (4.19e-2)"	"unprognostic (5.27e-2)"	5.4	197.1	2.1	9.0	2.4	14.2	3.0	2.4	2.6	16.5	5.7	22.6	47.8	2.9	14.1	2.9	8.9	19.5	28.4	2.6	2.6	25.3	1.8	15.9	5.0	4.1	3.1	1.4	61.2	21.4	5.5	7.6	3.9	6.1	15.2	0.7	20.0	50.2	1.0	1.2	39.7	3.1	4.0	8.2	98.9	1.6	4.2	3.6	71.6	1.6	2.9	14.7	1.6	4.4	0.0	0.1	0.0	5.8	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.6	2.6	1.9	5.2	0.0	0.4	0.1	0.7	0.0	0.0	0.4	1.3	0.0	3.7	0.4	0.3	0.0	33.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.7	0.0	0.7	1.3	41.4	0.2	0.1	0.0	23.2	8.0	2.7	0.7	5.6	0.7	0.0	0.0	0.5	0.2	10.3	0.0	0.0	0.3	0.2	0.0	11.5	0.0	0.0	0.0	13.4	0.0	0.7	3.1	3.1	0.0	1.8	0.0	0.8	0.4	0.1	3.8	0.3	1.0	1.2	3.3	0.0	2.8	1.3	0.3	1.0	2.1	2.4	2.4	2.6	2.6	2.6	4.1	3.1	3.9	4.0	4.2	4.4	7.1	3.2	12.9	0.3	8.4	0.6	8.0	4.2	0.0	1.7	6.1	1.8	18.6	14.3	7.1	29.5	0.0	1.1	0.3	34.0	15.6	23.2	2.0	3.3	0.4	6.3	6.6	0.4	13.7	21.7	1.4	1.0	23.4	4.9	19.7	47.6	9.3	1.1	17.3	0.0	20.0	26.1	8.2	25.4	15.9	0.9	0.3	19.6	1.8	71.2	11.0	0.5	1.0	43.7	34.9	15.3	20.2	0.0	6.4	5.2	30.9	2.0	4.4	0.5	6.6	0.4	1.7	0.2	0.2	0.1	1.0	2.1	4.0	16.6	57.8	20.4
KCNS3	Kv9.3	ENSG00000170745	"Potassium voltage-gated channel modifier subfamily S member 3"	Q9BQ31	2	17877847-18361616	"Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"lung: 23.5;skeletal muscle: 86.0;tongue: 45.5"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 28.9;Enteroendocrine cells: 32.5;Theca cells: 30.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"RH-30: 69.2;RPMI-8226: 28.9;RT4: 48.2;U-266/84: 34.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA014864	Approved		Supported	"Golgi apparatus,Plasma membrane,Cytosol"		NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Cytosol	"Golgi apparatus, Plasma membrane"	"HPA014864: AB_1852155"	"unprognostic (5.62e-2)"	"unprognostic (4.27e-3)"	"unprognostic (6.87e-2)"	"unprognostic (1.68e-1)"	"unprognostic (3.19e-1)"	"unprognostic (1.64e-2)"	"unprognostic (3.30e-1)"	"unprognostic (9.47e-3)"	"unprognostic (9.06e-2)"	"unprognostic (8.45e-2)"	"unprognostic (5.82e-2)"	"unprognostic (1.36e-1)"	"prognostic unfavorable (1.53e-4)"	"unprognostic (1.64e-2)"	"unprognostic (2.34e-1)"	"unprognostic (1.67e-1)"	"unprognostic (4.71e-2)"	2.9	1.1	2.6	3.8	2.9	0.0	6.2	3.9	4.0	7.8	9.5	12.5	3.7	3.2	2.6	6.0	3.9	5.4	6.6	2.9	4.2	5.0	3.8	23.5	0.6	10.5	7.9	1.0	9.8	2.9	1.2	11.0	12.5	6.5	5.0	0.4	11.2	3.1	86.0	5.6	5.4	3.3	5.3	1.0	9.5	3.9	4.3	1.4	2.3	45.5	2.0	6.8	6.3	4.4	8.5	1.4	0.7	0.0	1.6	0.8	3.8	2.8	8.5	1.7	2.0	0.1	17.1	0.0	0.9	3.0	1.9	2.7	20.7	0.1	1.8	0.0	5.7	0.0	0.2	0.1	8.1	0.2	0.7	0.7	12.9	0.1	1.2	15.5	0.4	3.9	0.4	0.0	1.0	2.2	0.0	0.0	10.2	11.5	0.2	2.4	69.2	28.9	1.8	48.2	20.3	0.7	0.0	5.3	6.1	4.8	2.8	0.0	0.2	2.7	0.0	0.2	21.6	0.1	34.9	0.1	15.2	0.0	20.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	2.9	3.9	4.0	2.9	4.2	10.5	7.9	12.5	5.3	4.3	4.4	3.8	28.9	8.2	0.0	0.0	13.9	16.8	6.9	21.1	0.2	11.5	7.0	0.5	18.6	6.8	11.0	0.0	0.6	0.0	10.9	0.0	21.5	0.3	0.9	0.6	5.9	32.5	0.0	0.3	0.4	3.5	12.1	8.2	0.9	1.3	4.3	2.5	5.4	0.5	0.0	16.9	5.6	14.2	0.0	4.5	1.2	1.5	0.4	21.4	1.9	0.7	0.1	0.0	7.1	2.5	2.4	4.9	3.8	1.2	13.6	4.1	5.5	1.7	0.2	6.6	13.5	10.6	0.3	3.4	8.0	5.8	0.8	0.6	30.6	10.3	7.1
KCNV1	Kv8.1	ENSG00000164794	"Potassium voltage-gated channel modifier subfamily V member 1"	Q6PIU1	8	109963636-109975771	"Predicted membrane proteins, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	7	"brain: 4.9"	"Group enriched"	"Detected in some"	6	"Enteroendocrine cells: 7.1;Excitatory neurons: 28.2"	"Cancer enhanced"	"Detected in single"		"renal cancer: 0.5"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"cerebral cortex: 36.6"	HPA067233			Supported	"Plasma membrane,Cytokinetic bridge"		Yes	NA				"Cluster 10: Brain - Neuronal signaling"		"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Plasma membrane, Cytokinetic bridge"		"HPA067233: "			"unprognostic (1.41e-1)"		"unprognostic (1.81e-2)"			"unprognostic (5.01e-4)"		"unprognostic (2.30e-1)"	"unprognostic (3.76e-2)"		"unprognostic (1.13e-2)"	"unprognostic (3.89e-2)"	"unprognostic (2.27e-1)"	"unprognostic (4.17e-2)"		0.1	0.1	1.9	0.1	4.9	0.5	0.1	0.0	4.6	0.0	0.0	0.5	0.1	0.1	0.5	0.1	0.1	0.1	0.1	3.3	0.0	0.1	0.1	0.1	0.2	0.0	0.0	0.3	0.4	0.1	0.3	0.2	0.0	0.2	0.4	0.7	0.2	0.1	0.1	0.4	0.3	0.1	0.0	0.1	0.1	0.2	0.0	0.1	0.3	0.0	0.1	0.0	0.0	1.1	0.5	0.6	0.4	0.2	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.4	0.5	0.1	0.0	0.1	0.2	0.1	0.3	0.6	0.1	0.0	0.2	0.3	0.0	0.1	0.1	0.1	0.1	0.1	0.2	0.2	0.6	0.0	0.1	0.2	0.2	0.2	0.1	0.2	0.0	0.2	0.0	0.8	0.2	0.3	0.1	0.1	0.0	0.1	0.4	0.2	0.0	0.2	0.5	0.4	0.3	0.1	0.2	0.1	0.1	0.2	0.1	0.2	0.5	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	1.9	4.9	0.0	4.6	3.3	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.4	0.0	0.0	0.0	7.1	0.0	28.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	1.3	0.0	0.0	0.0	0.4	0.0	0.0	0.0	2.8	0.0	0.0	0.0	1.5	1.7	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	1.3	0.0
KCTD10	"BTBD28, MSTP028"	ENSG00000110906	"Potassium channel tetramerization domain containing 10"	Q9H3F6	12	109448655-109477359	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"NK-cells: 81.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014273	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 63: NK-cells & T-cells - Immune response"	Nucleoplasm	Cytosol	"HPA014273: AB_1852159"	"unprognostic (7.21e-3)"	"unprognostic (3.04e-1)"	"unprognostic (2.45e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.93e-3)"	"unprognostic (2.31e-1)"	"prognostic unfavorable (5.32e-4)"	"unprognostic (1.84e-2)"	"unprognostic (1.85e-1)"	"unprognostic (7.01e-2)"	"unprognostic (9.33e-2)"	"unprognostic (3.45e-1)"	"unprognostic (7.72e-2)"	"unprognostic (5.76e-2)"	"unprognostic (3.26e-1)"	"unprognostic (3.05e-1)"	"unprognostic (1.70e-3)"	40.3	23.4	20.5	26.2	19.7	15.4	32.9	17.2	20.3	34.2	32.1	42.5	14.7	43.8	14.0	36.6	27.4	33.0	24.1	19.7	31.0	23.0	11.4	31.9	21.9	21.1	23.1	18.1	12.4	22.2	17.0	25.4	26.6	29.2	33.2	14.3	20.7	44.3	11.5	30.3	22.3	57.0	19.2	23.2	25.8	16.3	30.1	14.9	47.1	11.7	22.8	39.0	29.4	18.9	28.4	27.9	84.6	27.5	67.8	91.2	18.5	59.0	80.2	38.8	38.2	28.1	23.1	27.5	34.0	136.4	19.2	22.0	30.7	51.6	35.9	26.0	22.0	32.3	19.2	19.3	44.5	24.9	26.7	92.2	30.7	50.0	29.3	54.7	89.5	26.4	21.5	11.5	68.0	15.1	29.8	32.9	48.1	12.7	36.0	29.2	37.7	22.6	38.5	48.9	29.5	44.3	35.6	38.8	41.8	47.5	45.2	18.8	70.0	42.3	15.5	24.0	32.8	26.0	52.8	37.1	48.8	20.2	60.5	10.9	9.5	6.4	13.5	14.4	10.1	6.6	8.0	10.0	11.9	6.2	8.8	11.1	6.5	25.1	17.2	9.0	10.0	14.9	20.5	19.7	17.2	20.3	19.7	31.0	21.1	23.1	26.6	19.2	30.1	18.9	21.1	16.0	29.9	6.2	9.0	14.7	20.1	17.4	11.4	5.4	12.1	13.5	11.5	10.0	13.7	5.5	16.7	9.1	19.4	31.5	5.9	15.3	12.2	9.9	17.8	26.8	11.5	6.5	9.8	13.1	12.8	15.5	10.7	12.8	14.0	11.3	24.7	5.3	11.5	8.4	8.1	13.4	10.2	13.6	13.3	11.3	11.5	14.6	16.0	8.4	15.7	2.8	81.4	8.0	9.4	25.9	11.8	18.8	7.5	12.2	6.4	10.5	12.2	4.4	26.3	13.4	32.6	13.5	6.3	10.2	16.6	13.5	10.6	10.4	15.0	18.1
KCTD13	"FKSG86, PDIP1, POLDIP1"	ENSG00000174943	"Potassium channel tetramerization domain containing 13"	Q8WZ19	16	29905012-29926236	"Disease related genes, Predicted intracellular proteins"	"Ubl conjugation pathway"		"Autism, Autism spectrum disorder, Disease variant, Schizophrenia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 37.5;testis: 36.3"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043524	Enhanced		Supported	"Nucleoplasm,Nuclear bodies"		No	No			"Cluster 5: Granulocytes - Unknown function"	"Cluster 65: Brain - Ion transport"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	"Nucleoplasm, Nuclear bodies"		"HPA043524: AB_2678528"	"unprognostic (6.97e-2)"	"unprognostic (9.06e-3)"	"prognostic unfavorable (8.54e-4)"	"unprognostic (4.00e-2)"	"unprognostic (2.39e-1)"	"unprognostic (3.13e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.45e-2)"	"unprognostic (3.59e-2)"	"unprognostic (1.97e-2)"	"prognostic favorable (9.05e-4)"	"unprognostic (3.92e-3)"	"prognostic unfavorable (8.17e-4)"	"unprognostic (1.16e-2)"	"unprognostic (2.22e-1)"	"unprognostic (3.56e-1)"	"unprognostic (5.49e-3)"	6.0	7.5	27.3	7.8	28.7	8.5	5.4	17.6	37.5	5.0	17.4	6.3	7.3	5.1	9.9	5.9	8.3	7.8	4.4	36.9	24.5	3.9	3.5	4.5	9.8	19.5	21.3	7.5	7.5	7.9	3.6	4.5	19.6	6.7	6.5	9.4	6.5	8.0	2.7	12.2	7.0	5.2	20.5	7.6	5.8	36.3	23.0	9.6	5.7	2.4	7.1	6.0	2.7	28.8	9.7	12.4	6.2	15.5	10.0	8.1	12.5	5.8	7.2	5.7	8.9	3.5	12.6	17.4	11.3	8.5	9.6	14.4	6.8	5.5	4.4	26.5	17.0	3.7	7.1	6.0	13.7	9.2	15.9	10.2	15.3	11.6	8.7	6.1	4.7	19.9	9.1	14.8	7.9	28.1	18.7	14.2	3.6	5.0	6.0	13.9	4.5	9.0	7.8	9.1	15.5	15.4	2.4	7.0	31.7	5.8	10.1	7.2	10.0	5.0	5.1	15.3	10.6	12.4	5.3	3.9	12.0	10.4	14.4	7.2	3.3	8.0	2.9	2.6	3.0	3.0	5.4	5.0	3.5	2.4	5.0	4.7	11.1	3.1	4.4	3.8	4.4	1.9	27.3	28.7	17.6	37.5	36.9	24.5	19.5	21.3	19.6	20.5	23.0	28.8	7.1	0.0	9.7	20.9	10.6	6.0	5.7	10.4	12.5	9.9	8.5	8.0	3.4	5.7	5.8	0.0	8.4	5.3	7.9	5.2	3.9	6.9	17.9	9.1	6.8	4.7	7.7	3.0	15.4	4.2	5.1	6.5	4.6	8.7	2.5	10.9	6.4	2.4	7.6	5.0	20.5	7.2	10.2	4.4	5.6	9.0	6.2	6.3	8.8	12.2	5.7	5.0	11.3	17.6	28.9	11.0	7.4	6.4	3.6	8.7	6.5	2.9	6.3	6.5	0.0	5.0	7.8	20.6	26.5	12.4	9.1	6.7	10.6	5.8	6.1	7.0
KCTD9	"BTBD27, FLJ20038"	ENSG00000104756	"Potassium channel tetramerization domain containing 9"	Q7L273	8	25427847-25458476	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042468, HPA047902"			Supported	"Nucleoplasm,Intermediate filaments,Cytosol"		No	No			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 18: U-2197 - ECM organization"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	Nucleoplasm	"Intermediate filaments, Cytosol"	"HPA042468: , HPA047902: AB_2680205"	"unprognostic (4.18e-2)"	"unprognostic (3.90e-2)"	"prognostic favorable (7.88e-4)"	"unprognostic (7.04e-2)"	"unprognostic (7.41e-2)"	"unprognostic (1.05e-2)"	"unprognostic (2.20e-2)"	"unprognostic (6.01e-2)"	"unprognostic (4.33e-1)"	"unprognostic (2.43e-2)"	"unprognostic (4.49e-3)"	"unprognostic (2.30e-1)"	"unprognostic (1.48e-1)"	"unprognostic (6.62e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.31e-2)"	"unprognostic (4.97e-3)"	18.4	8.2	4.9	11.5	5.8	21.5	22.3	7.9	6.5	15.4	8.6	21.1	19.6	11.3	13.0	23.8	14.6	13.3	38.3	5.5	5.9	12.8	10.8	13.4	12.2	9.1	7.7	14.2	11.2	11.0	9.8	12.0	10.0	17.4	22.6	12.9	17.5	15.6	29.5	19.0	17.7	14.5	7.8	9.4	12.8	12.9	6.9	14.7	13.7	36.7	14.4	15.6	18.7	6.9	46.4	32.4	34.5	11.9	44.0	58.0	28.2	68.6	61.4	44.1	44.5	23.4	33.2	30.1	28.6	69.0	62.3	30.3	30.6	32.3	52.9	15.4	18.2	35.3	30.2	21.7	53.2	12.3	25.1	44.8	38.5	40.2	33.2	26.9	37.8	29.6	37.8	23.0	50.7	12.4	48.2	21.6	16.8	35.8	17.0	18.6	39.8	11.2	45.0	26.1	8.8	11.4	52.7	23.1	35.8	30.8	17.8	14.2	42.2	48.5	28.2	94.1	37.6	6.6	12.9	39.1	33.9	21.8	35.8	0.7	0.5	1.2	1.0	0.7	1.0	0.6	1.0	1.0	0.3	0.3	0.6	0.9	0.5	0.2	0.9	1.0	1.1	0.4	4.9	5.8	7.9	6.5	5.5	5.9	9.1	7.7	10.0	7.8	6.9	6.9	19.5	32.1	18.5	18.6	8.9	74.4	36.4	26.0	31.9	13.7	20.4	12.7	61.1	5.7	24.2	27.6	25.0	9.4	23.3	53.8	13.7	17.6	6.5	12.8	12.7	16.8	10.2	20.2	14.3	27.2	17.6	32.5	8.2	17.9	20.3	10.9	12.5	9.0	9.3	3.3	12.9	16.0	18.3	9.3	18.5	5.2	30.7	12.9	30.2	36.5	8.5	8.1	18.6	17.1	13.6	36.6	21.6	55.7	17.1	52.6	25.8	10.4	17.4	19.6	6.6	21.6	26.2	35.6	26.4	41.6	54.7	11.2	19.8	14.4	17.7	46.0
KDELR1	"ERD2, ERD2.1, HDEL"	ENSG00000105438	"KDEL endoplasmic reticulum protein retention receptor 1"	P24390	19	48382575-48391551	"Predicted membrane proteins, Transporters"	"ER-Golgi transport, Protein transport, Transport"	Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Extravillous trophoblasts: 605.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"NB-4: 856.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB017455	Approved		Supported	"Golgi apparatus,Vesicles,Cytosol"		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 24: NB-4 - Immune response"	"Cluster 55: Plasma cells - Humoral immune response"	"Golgi apparatus"	"Vesicles, Cytosol"	"CAB017455: AB_10615208"	"unprognostic (3.10e-2)"	"unprognostic (4.17e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.94e-1)"	"prognostic unfavorable (3.49e-4)"	"prognostic unfavorable (1.61e-4)"	"unprognostic (2.35e-2)"	"unprognostic (2.26e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.51e-1)"	"unprognostic (7.55e-2)"	"unprognostic (4.97e-2)"	"unprognostic (3.81e-1)"	"unprognostic (2.74e-1)"	"unprognostic (3.06e-1)"	"unprognostic (1.68e-2)"	109.3	124.4	58.0	61.7	56.5	45.8	106.6	54.5	59.7	132.5	78.1	120.3	132.5	110.0	117.3	107.3	112.2	100.9	96.6	56.1	62.5	119.5	127.2	101.4	53.3	61.1	59.1	165.8	138.9	191.7	116.2	128.7	59.0	102.5	128.5	39.0	137.7	105.0	76.8	103.8	114.5	100.6	56.2	79.5	120.1	93.7	62.9	51.6	121.8	58.4	73.2	102.5	102.4	58.0	216.2	305.3	173.1	184.7	379.7	440.6	126.5	207.4	363.9	247.0	281.0	202.3	238.7	89.1	132.6	456.4	154.4	187.6	211.1	222.2	234.0	72.7	224.5	74.4	99.4	382.2	329.6	84.1	133.4	419.6	268.0	168.5	178.5	387.4	233.0	75.3	131.7	160.9	333.1	173.6	79.4	856.7	126.3	426.8	122.5	112.1	103.4	141.0	316.2	176.3	172.9	134.5	182.1	160.6	113.1	196.7	126.6	102.1	182.6	173.4	142.6	145.3	179.3	451.1	382.0	60.2	110.1	112.4	181.1	10.8	41.0	12.6	18.1	34.7	20.8	17.0	17.6	19.7	30.6	14.3	14.3	16.1	9.9	20.2	30.2	45.4	20.4	18.2	58.0	56.5	54.5	59.7	56.1	62.5	61.1	59.1	59.0	56.2	62.9	58.0	150.8	35.3	54.2	8.5	82.2	75.3	130.6	147.1	124.7	39.4	141.0	154.4	28.8	98.7	110.9	93.8	6.2	231.7	59.5	153.0	56.7	224.1	6.2	72.0	188.8	111.4	145.0	56.8	8.7	169.0	605.5	161.0	120.3	166.3	62.7	149.2	102.8	79.6	180.0	40.4	12.7	379.6	93.6	107.6	73.5	14.2	163.5	103.1	92.5	8.4	102.3	89.8	35.0	10.6	10.6	190.3	199.8	132.0	365.9	161.2	213.8	149.6	49.2	28.1	85.5	87.9	131.6	41.8	69.1	127.7	70.2	387.7	55.4	191.3	202.9	157.6
KDELR3		ENSG00000100196	"KDEL endoplasmic reticulum protein retention receptor 3"	O43731	22	38468078-38483447	"Predicted membrane proteins"	"ER-Golgi transport, Protein transport, Transport"	Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 73.2;Fibroblasts: 54.7;Intestinal goblet cells: 70.6;Proximal enterocytes: 40.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in single"		"plasmacytoid DC: 1.6"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 267.0;BJ: 180.5;BJ hTERT+: 182.0;fHDF/TERT166: 289.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043477, HPA076405"	Uncertain		Supported	"Endoplasmic reticulum"		No	No			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 4: Stomach - Digestion"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 33: Fibroblasts - ECM organization"	"Endoplasmic reticulum"		"HPA043477: AB_10962952, HPA076405: AB_2686797"	"unprognostic (1.76e-1)"	"unprognostic (3.77e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.20e-2)"	"unprognostic (2.90e-1)"	"unprognostic (2.05e-2)"	"prognostic unfavorable (1.19e-4)"	"unprognostic (2.26e-1)"	"unprognostic (1.91e-1)"	"unprognostic (1.23e-1)"	"unprognostic (9.25e-3)"	"unprognostic (2.45e-1)"	"prognostic unfavorable (6.05e-10)"	"unprognostic (1.66e-1)"	"unprognostic (1.46e-1)"	"unprognostic (8.24e-2)"	"unprognostic (2.07e-2)"	13.4	4.4	0.9	7.6	1.3	2.0	12.2	2.9	2.1	31.1	8.7	18.1	15.4	7.5	29.5	4.8	7.4	19.6	15.7	1.3	0.9	8.5	12.6	10.3	3.2	1.5	1.7	3.5	15.9	12.1	14.2	16.0	1.1	19.7	22.5	3.1	34.4	10.9	2.1	4.1	18.5	15.5	1.3	2.5	35.0	3.9	1.1	1.7	6.3	3.7	7.2	12.5	4.4	1.5	35.8	11.1	8.7	37.2	142.7	267.0	6.4	180.5	182.0	42.7	105.3	22.1	45.1	0.3	38.2	289.3	15.2	5.1	8.9	10.7	51.0	0.4	21.8	2.5	8.7	55.2	62.9	0.4	24.1	99.9	8.0	53.9	5.7	60.1	52.4	0.3	9.0	0.1	70.7	56.8	0.1	1.3	2.1	150.2	33.2	0.2	2.4	11.8	51.5	4.8	0.7	4.6	46.7	2.7	22.9	3.6	13.3	2.4	41.5	45.8	29.0	160.3	18.0	1.7	0.6	0.2	73.5	0.1	65.0	0.0	0.0	0.0	0.2	0.0	0.8	0.3	0.2	0.1	0.0	0.1	0.2	0.2	0.2	0.0	0.0	1.6	0.2	0.1	0.9	1.3	2.9	2.1	1.3	0.9	1.5	1.7	1.1	1.3	1.1	1.5	14.5	0.0	4.8	0.3	4.5	7.6	5.7	7.5	1.2	1.3	10.0	4.2	2.5	8.6	10.0	14.7	2.1	5.1	0.3	9.1	7.9	19.0	0.2	8.0	19.4	10.2	4.9	0.8	0.7	31.6	73.2	54.7	24.5	11.0	1.3	6.9	14.6	5.3	4.7	0.0	0.5	70.6	0.0	0.9	14.5	0.6	32.6	1.1	16.0	1.9	1.0	6.3	0.0	0.0	0.4	31.5	4.9	16.1	12.8	16.3	40.1	0.8	9.2	1.4	0.0	1.7	20.5	0.5	2.4	1.6	7.1	8.2	2.3	4.2	11.1	7.8
KDM1A	"AOF2, BHC110, KDM1, KIAA0601, LSD1"	ENSG00000004487	"Lysine demethylase 1A"	O60341	1	23019443-23083689	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, Developmental protein, Oxidoreductase, Repressor"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Spermatocytes: 131.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005884, HPA053660"	Supported		Supported	Nucleoplasm,Cytosol	"Intracellular and membrane"	NA	NA		7700	"Cluster 37: B-cells - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 14: REH - Unknown function"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	Nucleoplasm	Cytosol	"CAB005884: AB_443964, HPA053660: AB_2682220"	"unprognostic (1.03e-1)"	"unprognostic (1.17e-1)"	"prognostic favorable (6.31e-4)"	"unprognostic (1.50e-1)"	"unprognostic (6.83e-2)"	"unprognostic (3.95e-2)"	"prognostic unfavorable (4.47e-12)"	"unprognostic (1.80e-2)"	"unprognostic (1.99e-2)"	"unprognostic (9.41e-2)"	"unprognostic (3.34e-3)"	"unprognostic (2.13e-1)"	"unprognostic (2.61e-1)"	"unprognostic (1.41e-1)"	"unprognostic (3.73e-2)"	"unprognostic (7.74e-2)"	"unprognostic (1.39e-1)"	25.7	30.8	24.7	23.5	25.8	48.1	30.6	26.5	27.0	33.1	20.4	31.6	26.4	36.0	46.9	35.0	34.2	25.3	26.1	25.3	28.2	24.7	22.3	24.5	34.7	19.8	22.0	41.4	36.2	51.2	41.5	31.5	21.0	32.2	33.8	30.9	36.6	29.4	47.3	38.2	29.2	30.1	21.2	25.2	29.3	86.9	27.4	55.8	28.5	34.0	37.2	34.6	31.5	21.8	128.1	64.7	180.8	160.7	47.0	59.5	128.4	53.1	66.4	106.0	93.7	61.2	120.5	94.5	74.1	87.6	53.7	139.5	169.5	101.0	133.3	86.3	102.7	133.0	105.7	150.6	59.6	103.7	56.0	55.6	71.4	112.8	78.9	93.0	134.1	171.7	148.0	43.4	76.3	75.9	227.3	79.2	118.3	70.8	93.0	214.7	119.1	64.1	89.0	81.0	225.0	169.9	239.4	62.4	80.2	126.1	62.7	76.2	109.5	47.0	78.4	88.1	73.6	55.6	47.1	109.3	49.2	120.4	68.3	2.0	2.5	4.3	4.1	4.3	3.4	7.4	3.5	3.8	3.1	2.1	4.5	4.9	0.2	3.0	5.5	6.8	4.4	1.4	24.7	25.8	26.5	27.0	25.3	28.2	19.8	22.0	21.0	21.2	27.4	21.8	18.7	19.2	29.1	33.6	15.9	18.6	27.1	19.9	33.0	27.5	20.4	22.1	24.4	11.5	19.0	23.9	27.1	31.6	18.1	15.7	17.6	35.4	43.5	45.9	49.3	20.4	22.8	29.7	51.1	24.7	57.2	24.8	23.4	44.4	12.0	49.5	16.8	17.2	15.0	15.2	51.2	24.9	22.4	15.1	19.7	20.3	21.5	20.2	12.4	30.0	28.1	19.3	12.3	50.3	30.4	28.1	13.5	23.0	28.9	26.3	17.2	15.7	29.5	19.8	0.0	22.2	25.0	131.8	67.1	36.1	12.8	16.6	15.4	34.3	27.6	20.5
KDM1B	"AOF1, bA204B7.3, C6orf193, dJ298J15.2, FLJ33898, FLJ34109, FLJ43328, LSD2"	ENSG00000165097	"Lysine demethylase 1B"	Q8NB78	6	18155329-18223854	"Enzymes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, Developmental protein, Oxidoreductase, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"dendritic cells: 3.7;granulocytes: 7.2;monocytes: 8.6"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031269, HPA055597"	Uncertain		Supported	Nucleoplasm		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 21: OE19 - Mitochondria"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	Nucleoplasm		"HPA031269: AB_10601587, HPA055597: "	"unprognostic (1.93e-1)"	"unprognostic (7.53e-2)"	"prognostic favorable (6.94e-4)"	"unprognostic (2.57e-2)"	"unprognostic (7.25e-2)"	"unprognostic (1.08e-1)"	"unprognostic (5.57e-3)"	"unprognostic (1.32e-2)"	"unprognostic (8.41e-2)"	"unprognostic (6.84e-2)"	"unprognostic (2.16e-1)"	"unprognostic (3.17e-2)"	"unprognostic (6.68e-2)"	"unprognostic (3.02e-2)"	"unprognostic (2.90e-1)"	"unprognostic (7.36e-2)"	"unprognostic (3.53e-1)"	5.9	7.6	5.6	11.4	7.6	27.2	6.3	5.3	7.8	7.6	7.6	14.1	8.0	5.7	3.7	9.1	13.4	6.0	6.8	6.6	5.9	7.8	7.4	8.8	10.4	6.9	6.7	6.7	5.9	3.2	5.8	4.6	6.1	5.2	12.2	12.0	5.7	4.7	17.3	11.2	8.9	6.9	6.2	10.5	5.6	15.7	5.6	10.8	27.2	9.1	9.4	7.7	8.1	9.4	15.1	9.7	11.2	23.0	13.8	20.5	24.5	11.7	12.6	7.5	10.2	16.3	7.4	34.1	31.6	19.2	22.8	15.5	17.8	20.8	16.0	31.6	14.6	17.2	8.6	15.0	6.7	25.5	17.5	10.3	23.4	21.5	17.7	12.1	7.7	15.9	38.3	5.2	12.7	12.6	14.1	10.5	3.8	31.6	12.8	26.8	20.3	24.4	10.7	19.8	34.2	10.6	9.7	23.5	22.9	11.7	22.3	20.3	6.5	16.9	9.5	11.9	15.5	5.2	15.9	20.0	6.4	18.9	37.8	1.2	4.6	7.2	0.5	8.6	0.3	1.2	0.5	0.5	3.7	1.3	0.5	0.2	4.9	0.3	6.9	1.6	0.7	1.3	5.6	7.6	5.3	7.8	6.6	5.9	6.9	6.7	6.1	6.2	5.6	9.4	4.9	0.0	8.2	14.7	8.7	12.7	5.7	3.8	7.4	5.0	7.6	6.6	10.4	11.5	10.4	1.8	10.4	2.7	3.0	23.0	1.9	6.6	0.7	36.2	10.0	4.2	6.7	3.8	19.0	4.3	5.1	5.8	8.2	15.5	2.5	3.3	4.2	7.7	7.5	5.0	10.8	9.6	10.2	36.7	11.7	0.7	3.7	20.6	7.2	22.5	27.7	6.6	8.2	16.1	23.8	7.2	21.2	6.8	3.7	5.4	6.2	11.2	21.0	15.5	0.0	6.9	6.2	0.7	18.2	9.7	15.9	1.4	5.6	3.1	10.6	6.6
KDM2A	"CXXC8, DKFZP434M1735, FBL11, FBL7, FBXL11, FLJ00115, JHDM1A, KIAA1004, LILINA"	ENSG00000173120	"Lysine demethylase 2A"	Q9Y2K7	11	67119263-67258082	"Enzymes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Transcription, Transcription regulation, Ubl conjugation pathway"	"Chromatin regulator, Dioxygenase, DNA-binding, Oxidoreductase, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012272, HPA044251"	Supported		Supported	Nucleoplasm		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 6: T47d - Mammary gland"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm		"CAB012272: , HPA044251: "	"unprognostic (7.43e-2)"	"unprognostic (1.84e-1)"	"unprognostic (4.09e-1)"	"unprognostic (8.66e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.30e-2)"	"unprognostic (6.05e-2)"	"unprognostic (2.84e-1)"	"unprognostic (4.46e-1)"	"unprognostic (2.04e-3)"	"unprognostic (3.27e-2)"	"unprognostic (5.08e-2)"	"unprognostic (2.67e-2)"	"unprognostic (3.30e-1)"	"unprognostic (1.05e-1)"	"unprognostic (5.61e-2)"	"unprognostic (9.45e-3)"	19.5	13.2	10.7	27.2	10.6	47.1	19.7	18.0	12.1	24.3	14.1	23.3	14.7	29.1	17.4	31.9	19.3	19.0	17.4	10.6	11.2	14.3	19.9	24.0	27.5	12.6	10.7	24.5	13.0	16.1	13.1	18.0	10.9	21.6	17.1	18.5	21.3	19.2	33.8	29.4	23.9	24.0	9.7	27.0	18.9	29.0	11.9	27.8	19.0	24.5	28.7	23.9	25.9	10.9	49.9	31.8	17.6	27.7	17.1	27.0	13.5	21.5	26.6	41.0	27.9	48.7	25.4	38.8	37.5	33.3	23.8	48.2	31.3	22.5	33.1	66.4	13.4	28.9	39.2	11.7	16.9	24.5	38.1	21.7	23.9	39.4	25.7	20.7	29.9	22.7	27.4	54.4	18.6	35.4	32.5	18.1	36.1	29.8	25.6	39.9	29.4	21.4	14.7	33.7	24.2	18.9	71.0	38.6	39.0	21.6	59.9	23.9	38.7	25.0	16.7	34.5	18.8	29.3	35.4	25.4	22.0	17.2	17.8	0.4	1.1	0.3	2.5	0.8	2.7	3.6	1.9	2.3	0.6	3.6	1.9	1.9	2.7	2.7	0.5	0.9	2.6	1.9	10.7	10.6	18.0	12.1	10.6	11.2	12.6	10.7	10.9	9.7	11.9	10.9	41.4	38.5	35.8	75.1	56.6	41.2	23.3	23.4	75.7	75.3	40.3	30.9	31.1	34.3	31.0	16.5	137.6	23.9	77.5	43.2	0.0	17.3	20.6	84.8	63.0	38.4	31.8	22.1	89.4	14.5	13.4	32.4	42.8	112.3	27.3	42.1	29.3	35.5	21.5	95.9	89.8	27.5	24.4	46.5	59.6	11.2	21.5	49.1	19.6	104.0	43.3	19.8	33.0	96.0	99.5	25.9	25.5	23.0	72.5	37.2	21.2	10.3	40.0	111.7	19.7	40.2	32.3	52.0	38.1	78.7	47.7	32.3	66.9	33.8	29.5	48.7
KDM2B	"CXXC2, Fbl10, FBXL10, JHDM1B, PCCX2"	ENSG00000089094	"Lysine demethylase 2B"	Q8NHM5	12	121429096-121581023	"Enzymes, Predicted intracellular proteins"	"Transcription, Transcription regulation, Ubl conjugation pathway"	"Chromatin regulator, Dioxygenase, DNA-binding, Oxidoreductase, Repressor, RNA-binding, rRNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA071257			Supported	Nucleoplasm		NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 29: Early spermatids - Spermatogenesis"	Nucleoplasm		"HPA071257: "	"unprognostic (7.67e-2)"	"unprognostic (3.72e-3)"	"unprognostic (2.15e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.37e-1)"	"prognostic favorable (6.74e-6)"	"unprognostic (1.16e-1)"	"unprognostic (5.45e-2)"	"unprognostic (1.01e-2)"	"unprognostic (1.95e-1)"	"prognostic favorable (8.64e-4)"	"unprognostic (1.77e-1)"	"unprognostic (4.44e-3)"	"unprognostic (1.44e-2)"	"unprognostic (3.90e-2)"	"unprognostic (7.07e-2)"	"unprognostic (4.82e-2)"	9.7	8.4	7.1	18.9	8.7	16.9	10.0	12.9	10.7	15.6	7.4	12.2	8.2	11.5	5.5	20.2	12.4	7.0	8.7	7.3	5.6	11.1	15.6	13.1	22.9	8.3	6.3	15.2	11.6	10.8	9.4	7.3	9.2	9.5	7.6	9.7	12.6	6.1	15.2	28.0	18.9	8.3	5.4	21.4	10.9	14.0	7.8	23.1	11.2	6.1	21.6	12.3	16.9	9.0	15.2	19.1	31.3	9.8	8.7	7.6	34.8	12.4	19.1	17.8	14.9	24.0	7.7	69.3	20.6	11.2	9.9	13.1	34.3	13.7	14.4	29.3	24.0	38.0	15.9	19.4	10.3	44.0	29.5	6.9	7.4	16.9	12.3	19.1	12.7	33.6	31.4	8.8	8.5	20.4	54.5	51.8	55.8	11.0	15.1	61.0	16.4	34.1	9.8	24.5	37.1	21.4	23.8	14.0	14.4	29.5	25.0	49.2	17.3	19.0	15.4	19.2	13.9	23.9	21.3	64.5	17.6	35.2	12.3	4.5	2.8	2.4	6.3	2.3	4.9	9.5	4.9	3.5	3.9	9.3	4.3	5.8	0.4	2.0	1.7	3.5	4.6	3.4	7.1	8.7	12.9	10.7	7.3	5.6	8.3	6.3	9.2	5.4	7.8	9.0	6.8	0.0	10.6	28.1	36.8	17.0	7.1	4.0	13.6	20.1	10.3	6.7	14.6	14.3	5.4	11.0	12.5	6.7	43.3	3.8	11.7	7.5	57.0	13.0	7.0	8.8	5.4	22.5	36.2	5.8	11.2	8.3	9.2	12.0	14.0	16.5	9.7	15.4	24.4	15.2	41.6	6.1	6.1	21.1	61.0	60.1	7.8	25.5	16.0	26.2	48.0	4.1	24.7	31.2	44.1	5.8	4.7	7.2	34.1	11.2	6.5	4.2	5.7	16.1	19.7	6.5	8.1	11.4	18.3	13.9	15.2	6.6	24.8	6.2	7.4	6.3
KDM4A	"JHDM3A, JMJD2, JMJD2A, KIAA0677, TDRD14A"	ENSG00000066135	"Lysine demethylase 4A"	O75164	1	43650149-43705518	"Enzymes, Predicted intracellular proteins"	"Host-virus interaction, Transcription, Transcription regulation"	"Chromatin regulator, Dioxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007610	Uncertain		Supported	"Nucleoplasm,Nucleoli fibrillar center,Cytosol"		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 56: Intestine - Transmembrane transport"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 59: Non-specific - Transcription"	"Nucleoli fibrillar center"	"Nucleoplasm, Cytosol"	"HPA007610: AB_1852006"	"unprognostic (7.01e-2)"	"unprognostic (1.50e-1)"	"unprognostic (3.22e-2)"	"unprognostic (6.18e-2)"	"unprognostic (3.54e-2)"	"unprognostic (5.40e-3)"	"prognostic unfavorable (1.39e-5)"	"unprognostic (4.88e-3)"	"unprognostic (1.13e-1)"	"unprognostic (5.47e-1)"	"unprognostic (2.70e-1)"	"unprognostic (7.95e-2)"	"unprognostic (2.81e-1)"	"unprognostic (2.32e-3)"	"unprognostic (2.02e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.28e-1)"	10.6	20.6	10.7	12.2	11.3	12.1	12.8	12.7	12.4	15.1	11.8	18.0	28.0	14.2	13.0	14.4	18.0	11.8	10.0	10.7	9.3	12.7	14.8	14.7	15.6	10.7	10.4	19.7	12.7	19.1	10.9	11.2	10.9	13.7	18.5	19.6	13.3	11.4	11.1	21.8	22.6	14.9	10.0	13.9	14.4	5.7	10.7	21.6	17.3	15.7	18.0	13.7	11.8	11.2	25.1	22.6	36.6	63.6	34.5	32.6	25.3	23.4	26.4	34.7	34.6	26.0	21.7	32.5	23.5	23.4	26.3	25.3	45.1	27.6	35.4	23.2	37.8	46.5	33.7	21.2	32.7	33.4	35.9	35.4	43.2	33.7	42.3	26.6	37.0	27.9	23.5	45.1	25.5	19.6	26.4	28.2	59.9	21.5	23.0	35.0	42.2	23.9	24.3	48.8	32.1	29.1	50.5	34.2	63.3	52.8	20.0	111.5	28.1	20.6	32.8	18.7	31.9	20.7	26.7	29.2	21.3	27.8	39.3	10.2	4.9	9.0	4.4	3.7	4.9	4.3	4.3	3.6	4.1	3.1	2.9	2.6	3.0	4.1	5.2	3.6	4.9	3.5	10.7	11.3	12.7	12.4	10.7	9.3	10.7	10.4	10.9	10.0	10.7	11.2	5.3	9.6	22.3	12.7	14.0	9.2	5.3	8.3	25.6	20.1	8.9	7.5	7.4	8.6	8.2	1.8	37.5	8.5	10.4	19.3	5.9	8.6	9.7	11.2	9.8	9.2	12.0	16.4	21.3	6.7	6.1	9.8	23.4	6.9	13.3	12.0	7.9	13.1	8.9	32.0	17.8	16.6	10.2	9.7	5.5	6.1	12.5	7.9	1.8	5.6	11.6	10.9	13.4	17.6	23.8	10.7	13.5	14.7	14.3	5.4	17.3	6.9	25.4	23.5	6.6	11.1	7.7	0.6	2.9	21.0	4.7	8.1	9.5	13.6	15.4	6.0
KDM4B	"JMJD2B, KIAA0876, TDRD14B"	ENSG00000127663	"Lysine demethylase 4B"	O94953	19	4969113-5153598	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, Dioxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cone photoreceptor cells: 98.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"B-cells: 5.1;dendritic cells: 1.7;granulocytes: 4.7"	"Cell line enhanced"	"Detected in all"		"T-47d: 61.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA071568			Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 72: Non-specific - Transcription"	"Cluster 6: T47d - Mammary gland"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	Cytosol	"HPA071568: "	"prognostic favorable (7.39e-4)"	"unprognostic (1.99e-1)"	"prognostic unfavorable (2.74e-4)"	"prognostic favorable (4.25e-7)"	"unprognostic (5.95e-2)"	"unprognostic (7.96e-3)"	"unprognostic (2.72e-2)"	"unprognostic (1.51e-1)"	"prognostic unfavorable (2.13e-4)"	"unprognostic (3.89e-2)"	"unprognostic (8.24e-3)"	"unprognostic (5.14e-3)"	"unprognostic (8.66e-2)"	"unprognostic (1.98e-1)"	"unprognostic (3.82e-1)"	"unprognostic (4.14e-2)"	"unprognostic (5.44e-2)"	12.4	19.4	7.8	8.9	9.4	13.5	16.8	15.8	10.0	23.4	5.1	14.7	6.6	18.4	6.7	17.0	20.2	4.7	16.0	9.3	5.3	10.4	21.2	12.5	11.7	9.2	7.3	17.8	13.7	6.6	18.4	9.5	7.5	25.6	2.9	14.7	14.1	7.4	32.2	21.7	13.8	4.9	4.7	22.1	12.6	16.1	8.8	8.8	29.4	8.3	7.2	13.4	18.2	11.9	16.1	5.5	12.8	15.4	7.3	7.2	25.7	7.9	5.8	6.8	8.5	9.6	4.4	22.4	8.2	9.1	5.5	8.9	7.8	9.3	4.2	10.1	19.9	7.5	9.9	8.0	13.6	7.6	16.7	11.2	9.9	5.6	4.7	12.3	9.3	12.4	18.7	13.3	6.2	8.3	8.8	11.5	11.3	5.8	13.6	14.7	9.7	19.0	6.8	10.5	23.7	18.1	10.3	11.2	12.5	12.3	61.5	19.7	13.5	10.1	5.7	12.5	8.0	36.5	16.4	17.1	20.0	15.1	6.0	1.5	0.6	1.9	0.3	0.2	0.2	4.2	0.2	0.2	0.3	5.1	0.4	0.5	4.7	0.8	0.3	1.7	0.4	0.3	7.8	9.4	15.8	10.0	9.3	5.3	9.2	7.3	7.5	4.7	8.8	11.9	15.3	6.4	10.4	18.9	73.2	7.4	14.1	10.8	7.4	72.5	36.1	22.2	15.3	10.0	9.4	7.3	98.0	25.7	25.5	15.3	7.9	10.5	17.0	25.4	18.7	16.4	8.4	9.4	33.6	7.6	26.2	14.6	26.5	30.2	8.2	34.3	15.4	30.9	9.0	74.0	30.6	16.7	16.2	14.2	7.8	12.1	18.3	15.8	10.6	27.2	17.0	23.5	19.6	29.7	28.7	18.0	14.1	23.3	23.9	19.3	7.4	6.6	11.7	69.2	6.6	23.1	13.7	25.2	9.1	14.1	15.3	24.1	13.9	29.7	9.5	12.9
KDM5A	"JARID1A, RBBP2"	ENSG00000073614	"Lysine demethylase 5A"	P29375	12	280057-389320	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Transcription, Transcription regulation"	"Activator, Chromatin regulator, Developmental protein, Dioxygenase, Oxidoreductase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 45.5"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006201			Supported	"Nuclear bodies,Cytosol"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 65: Plasmacytoid DCs - Unknown function"	"Nuclear bodies"	Cytosol	"HPA006201: AB_1079160"	"unprognostic (2.75e-1)"	"unprognostic (1.68e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.12e-1)"	"unprognostic (4.46e-2)"	"unprognostic (1.60e-1)"	"unprognostic (3.53e-3)"	"unprognostic (1.81e-2)"	"unprognostic (5.81e-2)"	"unprognostic (3.19e-1)"	"unprognostic (1.77e-3)"	"unprognostic (6.11e-2)"	"unprognostic (1.79e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.52e-1)"	"unprognostic (2.60e-2)"	"unprognostic (7.69e-2)"	8.1	8.7	5.8	11.4	8.3	45.5	11.1	11.6	8.5	8.6	10.0	8.2	7.2	9.7	7.1	8.9	7.6	8.0	5.2	6.2	6.5	7.8	9.9	8.8	15.3	6.8	5.7	11.0	9.4	10.1	4.2	11.8	6.5	8.6	9.9	9.6	6.7	7.3	5.5	12.5	7.3	9.4	6.0	13.5	8.8	21.1	6.7	21.6	9.1	7.6	14.4	8.7	7.2	15.0	14.4	25.3	18.3	14.2	16.1	15.2	20.3	12.5	16.5	18.4	19.8	15.2	17.0	24.0	3.9	21.0	16.0	13.3	19.2	14.2	21.9	37.9	15.9	29.3	26.5	9.0	13.0	38.6	22.1	16.6	13.1	22.6	29.9	18.8	18.8	21.0	17.9	32.7	15.7	9.7	27.9	11.0	28.4	12.3	7.9	25.7	47.5	11.4	8.8	32.6	7.0	20.5	24.5	11.0	13.0	25.0	11.9	24.0	26.0	12.0	17.0	13.6	21.1	11.5	13.6	53.7	15.5	16.5	18.0	64.5	21.8	44.4	31.4	25.0	32.3	27.1	24.6	25.9	22.8	32.0	26.3	22.8	63.0	35.8	28.9	32.0	20.9	22.5	5.8	8.3	11.6	8.5	6.2	6.5	6.8	5.7	6.5	6.0	6.7	15.0	53.1	64.1	61.6	61.7	80.6	33.0	22.2	30.1	48.9	69.0	35.3	27.9	38.2	31.5	39.0	35.0	116.7	48.8	103.3	51.3	3.9	37.4	96.8	60.2	72.8	51.6	69.7	51.3	71.7	31.6	34.7	47.2	39.8	99.8	54.4	106.9	42.8	30.9	30.2	87.5	59.1	40.0	40.7	52.5	37.5	32.5	48.4	63.9	26.6	57.1	82.9	48.3	105.0	68.3	85.9	38.7	37.0	55.7	73.1	32.4	33.6	11.8	40.2	71.9	59.2	64.0	59.9	137.1	104.8	50.1	47.6	71.1	80.1	67.5	40.1	42.0
KDM5B	"CT31, JARID1B, PLU-1, PPP1R98, RBBP2H1A"	ENSG00000117139	"Lysine demethylase 5B"	Q9UGL1	1	202724495-202808487	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Transcription, Transcription regulation"	"Chromatin regulator, Dioxygenase, Oxidoreductase, Repressor"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 62.3"	"Cell type enhanced"	"Detected in all"		"Late spermatids: 243.6;Spermatocytes: 390.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027179, HPA053723, CAB068193"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	Yes			"Cluster 10: Basophils - Unknown function"	"Cluster 71: Testis - DNA repair"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm	Cytosol	"CAB068193: AB_2665696, HPA027179: AB_1851987, HPA053723: AB_2682241"	"unprognostic (1.19e-1)"	"unprognostic (1.74e-2)"	"unprognostic (1.03e-1)"	"unprognostic (4.67e-2)"	"unprognostic (1.92e-2)"	"unprognostic (2.31e-1)"	"unprognostic (3.49e-3)"	"unprognostic (3.02e-2)"	"unprognostic (3.23e-2)"	"unprognostic (6.12e-2)"	"unprognostic (1.61e-2)"	"unprognostic (4.79e-2)"	"unprognostic (8.25e-3)"	"unprognostic (2.56e-2)"	"unprognostic (1.61e-1)"	"unprognostic (5.56e-2)"	"unprognostic (4.13e-1)"	9.1	7.7	1.5	2.6	2.2	14.1	9.9	5.8	4.8	14.7	7.9	10.6	2.1	12.6	3.3	21.0	9.9	2.9	6.0	4.6	1.5	6.2	4.6	10.8	2.2	0.8	0.4	12.8	8.3	2.6	6.9	4.7	0.2	10.6	2.2	17.8	12.5	2.4	4.7	24.3	8.6	3.1	1.0	7.4	8.7	62.3	1.2	4.1	8.4	0.8	2.1	10.9	15.7	2.3	9.9	2.4	14.0	9.8	7.2	6.6	23.7	6.2	9.4	6.2	6.4	2.2	8.8	0.1	5.7	7.9	2.3	11.8	9.0	8.3	5.4	0.5	12.8	7.7	2.4	1.9	5.5	17.7	8.9	9.4	12.1	7.0	7.2	10.1	11.7	7.3	20.9	0.3	4.9	6.3	5.8	16.4	21.9	4.3	28.0	18.7	0.1	0.4	6.5	10.7	10.7	23.4	14.7	7.9	8.7	15.7	16.6	10.5	12.8	8.2	5.8	1.4	5.2	2.3	1.1	8.2	6.0	5.5	4.1	44.6	6.4	19.6	7.7	4.8	4.6	10.9	8.9	4.3	4.2	17.4	9.6	6.0	34.4	12.9	10.4	6.6	7.2	3.9	1.5	2.2	5.8	4.8	4.6	1.5	0.8	0.4	0.2	1.0	1.2	2.3	24.5	89.8	38.5	46.7	22.2	64.4	34.8	53.0	84.2	35.5	57.1	50.0	9.5	11.5	53.6	16.5	62.6	41.8	12.4	23.7	5.9	47.6	191.6	65.2	71.8	31.9	43.6	50.2	75.8	22.3	34.3	42.7	47.9	69.5	27.1	28.6	17.2	10.9	7.7	15.2	53.5	38.1	44.7	15.1	21.9	243.6	36.4	15.5	26.6	40.3	11.3	69.8	10.3	39.7	42.5	45.4	21.8	32.7	25.8	43.1	15.2	8.2	61.9	138.6	32.9	22.8	40.2	390.9	71.0	95.9	116.2	82.4	21.2	61.5	30.2	55.6
KDM5C	"DXS1272E, JARID1C, MRX13, SMCX, XE169"	ENSG00000126012	"Lysine demethylase 5C"	P41229	X	53191321-53225422	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Transcription, Transcription regulation"	"Chromatin regulator, Dioxygenase, Oxidoreductase, Repressor"	"Cancer-related genes, Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038244, HPA046147"			Enhanced	Nucleoplasm,Cytosol		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm	Cytosol	"HPA038244: AB_2675911, HPA046147: AB_2679555"	"unprognostic (1.19e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.56e-2)"	"unprognostic (7.10e-2)"	"unprognostic (9.75e-2)"	"unprognostic (2.19e-1)"	"prognostic unfavorable (2.11e-4)"	"unprognostic (2.08e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.24e-1)"	"unprognostic (5.45e-2)"	"unprognostic (1.58e-2)"	"unprognostic (5.05e-3)"	"unprognostic (1.96e-2)"	"unprognostic (6.91e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.00e-1)"	22.3	29.0	19.2	28.2	19.7	34.8	22.7	23.0	21.7	35.5	22.2	25.5	26.0	35.5	14.8	35.2	33.2	17.1	22.7	19.6	20.1	21.1	24.1	27.2	33.4	19.8	19.0	39.9	26.4	33.8	31.4	23.8	19.0	23.8	15.4	24.6	29.4	18.5	51.0	34.2	28.2	26.9	16.8	30.9	25.8	13.5	20.9	44.2	27.6	25.5	26.5	25.9	35.4	20.8	45.3	60.4	63.6	49.0	43.2	39.1	45.2	27.7	32.2	36.8	34.0	41.3	28.9	41.8	35.0	36.7	103.2	39.5	72.6	59.1	27.8	31.6	107.9	40.6	66.7	29.6	52.9	48.5	77.6	31.0	42.8	72.0	87.7	52.3	55.2	34.2	80.8	27.2	27.3	57.9	35.9	55.4	54.1	23.3	56.3	40.1	37.8	45.9	23.5	42.6	47.6	61.4	84.0	76.8	32.2	58.4	53.9	42.3	37.8	40.6	35.0	36.9	27.2	39.0	34.2	31.5	52.6	56.9	30.8	0.9	1.2	0.8	1.6	1.1	1.4	1.2	1.0	1.6	0.9	0.8	1.2	0.8	1.4	0.8	1.2	1.3	1.3	1.2	19.2	19.7	23.0	21.7	19.6	20.1	19.8	19.0	19.0	16.8	20.9	20.8	17.6	12.8	14.9	33.0	17.8	12.1	10.5	12.1	14.8	24.7	19.7	15.0	10.0	11.5	15.2	7.3	25.0	13.1	21.2	32.2	3.9	15.0	0.8	28.2	25.2	17.7	31.2	17.2	36.1	21.9	15.1	14.2	21.4	35.7	13.3	25.5	15.0	25.5	14.4	25.2	37.0	25.8	16.2	18.2	8.8	2.6	14.6	17.1	14.2	27.2	14.9	9.8	16.5	31.2	49.2	26.4	26.3	15.8	17.0	17.9	22.1	5.8	16.4	16.9	0.0	17.2	16.8	10.3	15.8	16.2	15.9	20.8	18.0	22.6	18.9	21.6
KDR	"CD309, FLK1, VEGFR, VEGFR2"	ENSG00000128052	"Kinase insert domain receptor"	P35968	4	55078481-55125595	"Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted membrane proteins, RAS pathway related proteins"	"Angiogenesis, Differentiation, Host-virus interaction"	"Developmental protein, Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	9	"Adipocytes: 157.8;Endothelial cells: 143.8;Hepatic stellate cells: 158.1;Muller glia cells: 206.6"	"Cancer enhanced"	"Detected in all"		"renal cancer: 27.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	9	"HUVEC TERT2: 74.8;TIME: 83.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004028, HPA073577"	Enhanced		Approved	"Nuclear membrane,Vesicles"	"Intracellular and membrane"	NA	NA		11000000		"Cluster 82: Adipose tissue - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 5: Muller glia cells - Visual perception"	Vesicles	"Nuclear membrane"	"CAB004028: AB_2212507, HPA073577: "	"unprognostic (1.61e-1)"	"unprognostic (2.03e-1)"	"unprognostic (9.65e-2)"	"unprognostic (1.97e-1)"	"unprognostic (9.63e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.78e-3)"	"unprognostic (2.59e-2)"	"unprognostic (1.19e-2)"	"unprognostic (1.10e-1)"	"unprognostic (8.79e-3)"	"unprognostic (1.34e-1)"	"prognostic unfavorable (7.26e-4)"	"unprognostic (4.00e-2)"	"unprognostic (2.30e-1)"	"unprognostic (3.22e-1)"	"unprognostic (1.86e-1)"	41.6	11.7	2.7	4.3	3.8	0.0	26.1	2.8	4.1	14.8	10.4	6.3	2.2	39.5	2.9	4.0	17.9	5.6	20.6	2.1	2.8	15.7	9.2	23.5	2.8	3.2	3.6	5.2	6.2	8.6	11.0	30.9	3.5	11.7	1.0	16.4	5.3	10.0	6.5	5.9	7.5	7.5	3.3	4.4	8.4	1.8	4.5	1.0	34.4	4.6	1.0	8.6	7.5	3.4	0.0	0.0	4.4	0.0	0.4	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.0	0.0	8.5	0.0	0.0	0.9	0.0	0.0	0.4	0.2	74.8	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.9	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	83.4	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	3.8	2.8	4.1	2.1	2.8	3.2	3.6	3.5	3.3	4.5	3.4	157.8	0.0	4.9	0.0	1.4	2.5	0.5	0.1	1.8	11.7	1.3	2.5	9.4	1.5	18.4	0.0	0.0	0.1	0.8	0.0	0.0	0.5	0.8	0.4	2.6	143.8	0.0	2.7	0.1	0.0	0.1	8.3	0.0	0.8	2.5	0.0	158.1	3.3	0.4	0.0	1.3	0.0	0.0	10.6	2.1	0.9	0.0	1.2	7.2	7.5	0.0	206.6	0.0	0.0	6.1	0.5	0.0	0.4	1.3	0.5	0.0	0.0	3.9	7.9	0.0	0.9	7.5	0.3	0.9	0.8	2.7	0.1	0.6	1.6	0.0	1.4
KEAP1	"INrf2, KIAA0132, KLHL19, MGC10630, MGC1114, MGC20887, MGC4407, MGC9454"	ENSG00000079999	"Kelch like ECH associated protein 1"	Q14145	19	10486125-10503558	"Cancer-related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins"	"Host-virus interaction, Ubl conjugation pathway"		"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 178.2"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005558, CAB025337"	Approved		Supported	"Nucleoplasm,Centriolar satellite,Cytosol"		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 24: NB-4 - Immune response"	"Cluster 25: Spermatids - Spermatogenesis"	"Nucleoplasm, Centriolar satellite"	Cytosol	"CAB025337: , HPA005558: AB_1079175"	"unprognostic (1.98e-1)"	"prognostic favorable (3.28e-4)"	"unprognostic (1.61e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.63e-2)"	"unprognostic (2.64e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.48e-1)"	"unprognostic (5.22e-3)"	"unprognostic (2.04e-1)"	"unprognostic (9.99e-2)"	"unprognostic (1.29e-1)"	"unprognostic (7.71e-3)"	"unprognostic (5.06e-1)"	"unprognostic (8.18e-2)"	"unprognostic (1.60e-2)"	31.3	41.2	54.8	20.5	61.6	20.4	30.3	61.8	60.9	32.7	49.7	37.6	26.5	31.3	22.2	55.4	28.9	24.3	60.7	53.2	59.4	32.5	60.9	25.3	23.2	61.4	60.5	25.3	32.8	24.3	30.0	17.0	60.3	36.8	16.5	16.4	34.7	24.9	178.2	38.7	27.5	18.7	58.8	32.2	33.2	20.5	59.6	23.0	35.6	75.7	18.5	41.4	36.3	68.4	58.0	102.8	27.2	35.1	55.8	45.4	30.3	48.1	35.9	46.6	41.6	73.7	54.2	82.9	122.9	53.3	34.8	49.7	55.6	36.9	23.7	78.3	61.7	126.3	29.9	87.9	54.5	65.4	63.9	50.0	51.0	53.5	25.1	39.1	46.3	23.7	79.1	135.4	41.6	79.9	46.1	177.8	80.8	54.2	88.6	84.6	34.8	95.1	30.4	67.4	75.3	40.4	66.8	42.4	42.1	23.9	37.8	82.3	56.5	72.9	41.0	86.0	57.0	86.8	113.0	81.1	58.0	78.5	56.0	36.4	37.9	41.4	55.3	33.8	53.1	26.3	38.5	52.0	45.4	11.7	23.6	33.7	20.9	42.5	34.6	31.4	50.2	41.8	54.8	61.6	61.8	60.9	53.2	59.4	61.4	60.5	60.3	58.8	59.6	68.4	18.3	28.9	20.8	5.5	13.8	21.9	24.4	40.3	27.9	21.5	15.7	11.4	24.0	21.5	25.4	11.0	8.4	27.3	11.6	33.2	13.7	32.8	27.5	13.4	17.1	27.8	26.9	45.2	5.3	36.3	25.2	23.5	18.8	13.3	12.0	22.8	35.3	34.4	29.0	26.9	5.9	21.4	40.7	15.1	13.4	43.9	29.2	16.1	10.6	3.7	41.8	43.0	7.2	11.6	18.3	29.8	27.1	25.9	26.6	33.3	36.8	24.9	17.2	13.9	13.1	17.7	22.4	21.2	16.6	34.7	22.0	26.8	20.1	29.6	31.5	24.8
KEL	"CD238, ECE3"	ENSG00000197993	"Kell metallo-endopeptidase (Kell blood group)"	P23276	7	142941114-142962363	"Blood group antigen proteins, Cancer-related genes, CD markers, Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Blood group antigen, Hydrolase, Metalloprotease, Protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"bone marrow: 56.3;testis: 32.3"	"Cell type enhanced"	"Detected in some"		"Erythroid cells: 79.7;Oligodendrocytes: 30.1;Squamous epithelial cells: 16.8"	"Cancer enhanced"	"Detected in some"		"testis cancer: 2.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	20	"HEL: 31.7;K-562: 26.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA064442			Approved	"Nucleoplasm,Golgi apparatus,Plasma membrane,Cytosol"		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 6: Erythroid cells - Oxygen transport"	"Golgi apparatus, Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA064442: "	"unprognostic (5.78e-3)"	"unprognostic (1.08e-5)"	"unprognostic (5.29e-3)"	"unprognostic (4.85e-3)"	"unprognostic (9.68e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.54e-2)"	"unprognostic (5.18e-2)"	"unprognostic (1.08e-2)"	"unprognostic (3.71e-2)"	"unprognostic (3.57e-2)"	"unprognostic (2.29e-3)"	"unprognostic (9.24e-2)"	"unprognostic (7.05e-2)"	"unprognostic (3.32e-2)"	"unprognostic (3.25e-3)"	0.2	0.0	1.8	0.8	2.7	56.3	0.3	1.7	2.2	0.9	1.4	0.1	0.0	0.2	0.0	0.8	0.5	0.0	0.3	2.0	1.5	0.6	0.3	0.5	10.6	2.5	2.2	0.2	0.2	0.0	0.2	0.4	2.4	0.3	0.0	0.1	0.6	0.1	0.2	0.1	0.9	0.0	1.9	4.9	0.2	32.3	2.4	1.3	0.3	0.0	6.7	0.1	0.4	2.8	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	31.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	26.2	0.0	0.0	0.1	0.5	0.1	0.6	0.0	0.0	0.1	0.0	0.2	0.0	1.4	0.0	0.2	0.0	0.0	0.3	0.4	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	2.7	1.7	2.2	2.0	1.5	2.5	2.2	2.4	1.9	2.4	2.8	0.2	0.0	0.0	0.3	0.0	0.0	1.3	0.2	4.0	0.0	0.3	0.1	0.4	0.0	1.4	3.7	0.0	0.1	0.1	0.0	1.9	0.3	2.4	0.2	0.1	0.1	0.0	79.7	3.0	0.0	0.2	0.4	0.0	0.1	0.0	0.1	0.0	0.0	0.9	0.0	0.5	0.0	0.0	0.0	0.0	0.8	0.6	0.4	0.0	0.0	0.0	0.0	0.0	0.0	30.1	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	3.1	0.0	1.4	0.2	16.8	0.0	0.1	0.0	0.0	0.0	0.9
KHDC4	"BLOM7, KIAA0907, SNORA80EHG"	ENSG00000132680	"KH domain containing 4, pre-mRNA splicing factor"	Q7Z7F0	1	155913045-155934413	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Collecting duct cells: 57.0;Endometrial ciliated cells: 54.7;Glandular and luminal cells: 88.2;Granulosa cells: 48.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008796	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 42: Non-specific - Transcription"	"Cluster 51: Non-specific - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm		"HPA008796: AB_1079369"	"unprognostic (6.31e-2)"	"unprognostic (1.32e-1)"	"unprognostic (4.52e-2)"	"unprognostic (5.22e-3)"	"unprognostic (7.68e-3)"	"unprognostic (1.61e-1)"	"prognostic unfavorable (1.01e-6)"	"unprognostic (3.79e-2)"	"unprognostic (2.44e-2)"	"unprognostic (7.88e-2)"	"unprognostic (3.66e-2)"	"prognostic unfavorable (3.87e-4)"	"prognostic unfavorable (2.78e-10)"	"unprognostic (1.04e-1)"	"unprognostic (2.37e-1)"	"unprognostic (9.10e-2)"	"prognostic favorable (4.36e-5)"	27.9	29.5	21.0	22.3	22.0	11.9	30.8	27.4	25.1	42.5	21.6	34.4	23.0	32.1	45.2	28.8	33.5	15.0	27.7	20.9	21.3	42.6	30.2	34.1	28.9	21.5	21.5	47.7	32.7	18.5	44.6	23.2	21.7	39.2	27.3	55.5	38.3	20.7	39.8	32.5	36.5	15.5	21.5	37.6	37.6	24.7	21.3	27.1	33.6	21.3	29.7	37.0	36.2	25.3	27.6	20.7	43.2	26.2	22.6	31.6	26.6	23.2	18.4	34.6	35.5	21.6	59.6	34.0	25.2	13.3	24.7	49.5	40.0	16.4	34.0	27.2	83.5	30.7	70.8	26.0	15.9	36.3	25.4	20.7	42.4	24.3	18.8	40.8	25.2	38.2	37.4	37.9	31.8	13.3	35.1	35.6	47.7	26.0	29.4	41.0	23.3	30.1	30.7	14.7	29.9	29.7	17.2	17.9	25.1	35.2	37.6	60.5	21.2	33.3	23.2	10.9	31.7	61.3	28.4	30.1	24.0	33.5	25.7	4.1	1.5	3.0	2.1	2.0	2.8	2.7	2.3	2.8	1.5	2.6	2.9	2.7	1.9	2.4	3.0	1.6	2.0	1.0	21.0	22.0	27.4	25.1	20.9	21.3	21.5	21.5	21.7	21.5	21.3	25.3	19.4	12.8	19.2	0.0	10.3	0.0	0.0	0.0	0.0	0.0	35.2	23.5	0.0	0.0	12.4	57.0	0.0	26.5	25.7	0.0	3.9	11.2	0.0	54.7	20.0	9.5	0.0	0.0	0.0	7.2	20.0	11.0	0.0	88.2	6.3	48.2	0.0	0.0	11.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.5	0.0	0.0	13.5	0.0	0.0	0.0	0.0	18.7	0.0	0.0	8.3	0.0	0.0	7.9	12.4	0.0	0.0	0.0	9.1	0.0	0.0	0.0	0.0	30.8	10.5	34.4	0.0	0.0
KHDRBS3	"Etle, etoile, SALP, SLM-2, SLM2, T-STAR"	ENSG00000131773	"KH RNA binding domain containing, signal transduction associated 3"	O75525	8	135457456-135656722	"Predicted intracellular proteins"	"Host-virus interaction, mRNA processing, Transcription, Transcription regulation"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 157.7"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 364.5;Excitatory neurons: 828.6;Inhibitory neurons: 190.8;Microglial cells: 227.7;Oligodendrocyte precursor cells: 578.6;Spermatocytes: 276.1"	"Cancer enhanced"	"Detected in all"		"glioma: 9.0"	"Group enriched"	"Detected in many"	5	"amygdala: 21.4;basal ganglia: 27.9;cerebral cortex: 50.9;hippocampal formation: 29.8;white matter: 41.1"	"Immune cell enriched"	"Detected in single"	13	"eosinophil: 1.2"	"Lineage enriched"	"Detected in single"	13	"granulocytes: 1.2"	"Cell line enhanced"	"Detected in many"		"REH: 87.8;RPTEC TERT1: 76.0;WM-115: 85.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000275, HPA000500, HPA000981"	Enhanced		Supported	Nucleoplasm		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Nucleoplasm		"HPA000275: AB_1079183, HPA000500: AB_1079184, HPA000981: AB_2666164"	"unprognostic (1.36e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.98e-1)"	"unprognostic (6.55e-3)"	"unprognostic (2.75e-1)"	"unprognostic (2.43e-1)"	"unprognostic (1.31e-3)"	"unprognostic (9.36e-2)"	"unprognostic (2.00e-2)"	"unprognostic (2.66e-1)"	"unprognostic (1.91e-2)"	"unprognostic (1.21e-1)"	"prognostic favorable (7.16e-6)"	"unprognostic (6.63e-2)"	"unprognostic (7.85e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.33e-3)"	16.8	16.4	21.4	5.6	27.9	2.6	11.5	0.0	50.9	17.0	0.0	12.5	4.1	6.8	22.8	6.2	6.5	11.5	10.3	29.8	0.6	19.3	12.3	8.8	3.0	7.5	1.4	9.3	9.2	7.6	6.8	2.0	0.4	8.4	8.9	21.1	11.0	12.3	32.6	6.4	5.9	8.7	0.0	2.8	6.9	157.7	5.7	9.2	5.6	31.2	4.2	10.6	9.0	41.1	0.5	1.8	30.9	1.7	6.5	12.0	12.4	20.7	28.6	19.2	9.8	11.1	4.4	0.1	10.9	19.8	0.3	2.7	19.5	20.9	26.0	4.4	33.6	0.1	11.2	22.9	5.0	5.8	69.8	2.6	2.8	10.5	16.1	23.2	15.9	36.7	2.6	51.0	34.5	7.5	2.2	1.2	6.3	16.9	34.0	87.8	42.0	22.6	76.0	0.6	39.5	33.4	1.5	4.4	22.6	19.4	1.4	1.8	1.3	23.6	40.7	0.4	45.2	17.9	0.0	0.1	14.3	0.0	85.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.4	27.9	0.0	50.9	29.8	0.6	7.5	1.4	0.4	0.0	5.7	41.1	15.4	28.9	5.3	20.2	3.1	15.0	14.7	2.3	2.8	160.9	23.8	10.8	12.3	2.8	4.8	7.3	0.0	0.6	0.6	7.0	25.4	14.6	364.5	24.2	21.1	13.7	23.4	0.8	828.6	22.9	1.2	37.2	2.0	40.7	4.5	4.0	5.0	21.8	0.8	6.7	190.8	8.7	10.2	3.5	10.9	142.4	16.1	5.2	14.2	227.7	1.6	7.0	0.0	578.6	34.9	19.8	2.5	8.6	1.1	19.3	2.1	29.0	2.9	16.1	0.0	57.9	34.5	276.1	33.1	3.4	9.2	1.4	2.1	12.7	6.6	12.6
KIAA0319L	"AAVR, KIAA1837"	ENSG00000142687	"KIAA0319 like"	Q8IZA0	1	35433492-35557950	"Predicted intracellular proteins, Predicted membrane proteins"	"Host-virus interaction"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 47.2"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA072692	Supported		Supported	"Nucleoli,Golgi apparatus"		NA	NA		1100000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 12: NES - Nervous system development"	"Cluster 52: Non-specific - Transcription"	"Golgi apparatus"	Nucleoli	"HPA072692: AB_2686549"	"unprognostic (1.40e-1)"	"unprognostic (1.53e-1)"	"unprognostic (4.23e-3)"	"unprognostic (1.75e-1)"	"unprognostic (1.30e-2)"	"unprognostic (1.87e-1)"	"prognostic unfavorable (5.92e-5)"	"unprognostic (3.41e-3)"	"unprognostic (1.19e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.05e-2)"	"unprognostic (3.79e-1)"	"prognostic favorable (1.27e-4)"	"unprognostic (1.47e-1)"	"unprognostic (1.26e-1)"	"unprognostic (5.44e-2)"	"unprognostic (1.84e-1)"	14.3	26.6	28.3	13.0	28.0	15.9	27.8	23.4	28.0	25.6	28.9	25.6	26.3	14.4	26.2	18.3	35.1	21.3	44.5	28.0	27.6	38.2	34.2	30.9	17.7	26.9	29.2	14.9	42.1	45.6	26.9	30.6	25.5	34.9	30.0	34.1	33.5	18.5	37.7	20.1	24.8	14.4	24.8	20.1	34.4	17.1	32.4	17.8	41.4	40.1	16.8	15.8	15.1	24.9	13.5	19.6	39.8	31.5	52.7	36.9	37.8	17.9	37.8	25.5	37.5	21.2	52.9	15.0	48.0	19.6	38.1	26.1	29.7	28.8	28.9	23.8	21.7	20.3	23.4	23.6	41.3	16.9	26.8	52.3	36.2	29.5	38.0	84.3	42.2	18.1	27.2	21.0	35.2	13.6	10.1	14.3	45.3	37.4	11.7	11.3	33.8	18.7	41.8	32.4	8.7	24.6	25.8	30.6	53.3	86.9	32.3	23.1	43.6	17.4	18.7	14.9	28.0	31.1	26.7	9.8	44.3	21.8	17.7	8.8	19.4	9.4	5.0	6.1	4.8	3.4	4.1	4.7	5.6	4.1	5.5	4.0	47.2	9.8	4.0	3.7	4.0	8.7	28.3	28.0	23.4	28.0	28.0	27.6	26.9	29.2	25.5	24.8	32.4	24.9	24.2	73.7	74.1	85.2	18.3	7.9	14.4	16.5	15.4	74.8	33.9	26.0	55.0	47.1	42.4	35.0	108.4	33.3	16.6	35.4	3.9	19.2	9.6	21.0	17.7	24.6	21.6	14.7	93.2	32.5	22.5	19.4	28.5	30.8	21.5	42.7	28.9	47.4	19.1	63.9	95.2	59.5	16.2	31.4	7.6	7.5	17.4	19.2	14.2	62.8	31.4	30.5	29.9	115.1	99.3	30.3	27.6	17.3	17.2	26.0	36.8	17.5	45.4	61.9	6.6	24.5	15.7	22.5	21.2	17.8	9.2	31.2	21.9	30.1	31.2	14.8
KIAA0753	"MNR, OFIP"	ENSG00000198920	KIAA0753	Q2KHM9	17	6578147-6640711	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			Ciliopathy	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 90.9;Excitatory neurons: 46.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in some"							"HPA023057, HPA023494"	Enhanced		Approved	Centrosome,Cytosol		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 29: Early spermatids - Spermatogenesis"	"Centrosome, Cytosol"		"HPA023057: AB_1852338, HPA023494: AB_1852339"	"unprognostic (3.72e-2)"	"unprognostic (5.91e-2)"	"unprognostic (1.60e-2)"	"unprognostic (2.93e-2)"	"unprognostic (5.17e-2)"	"unprognostic (1.47e-1)"	"unprognostic (4.19e-3)"	"unprognostic (1.47e-1)"	"unprognostic (3.01e-3)"	"unprognostic (1.82e-1)"	"unprognostic (6.10e-3)"	"unprognostic (1.47e-2)"	"unprognostic (9.57e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.70e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.77e-3)"	4.9	5.7	6.8	4.6	6.8	3.5	7.3	3.8	7.3	8.4	10.5	7.1	3.5	8.5	11.0	7.1	10.1	5.2	4.1	7.2	6.6	8.7	3.7	5.3	5.0	4.3	4.9	10.1	5.6	14.0	8.8	5.3	3.6	7.7	6.9	10.8	5.7	8.3	2.1	5.7	5.4	8.4	3.4	7.6	6.5	16.6	6.0	8.5	9.0	2.7	5.1	6.4	6.4	5.5	19.9	16.1	19.4	13.2	7.2	11.9	7.7	10.5	10.0	15.1	14.0	11.1	4.8	7.9	7.1	10.4	9.9	18.4	17.8	10.1	23.9	8.1	15.1	4.3	14.8	8.7	12.0	6.9	9.3	7.1	12.9	13.7	13.0	15.5	11.8	9.1	9.9	1.0	12.3	5.9	7.7	6.2	11.8	9.7	8.1	11.1	6.8	2.5	13.9	12.9	7.3	12.7	13.2	3.9	8.9	12.5	6.5	4.5	11.1	13.1	6.7	7.6	16.8	1.8	2.6	2.8	9.8	4.5	10.6	0.0	0.7	0.6	0.5	0.7	0.6	0.8	0.5	0.5	0.4	0.4	0.3	0.3	1.9	0.4	0.4	0.6	0.4	0.2	6.8	6.8	3.8	7.3	7.2	6.6	4.3	4.9	3.6	3.4	6.0	5.5	5.4	6.4	12.3	25.8	3.4	3.2	2.9	2.6	4.6	3.8	5.9	5.2	3.6	7.2	8.3	0.0	16.7	2.4	2.9	5.2	0.0	4.1	90.9	13.2	9.5	5.7	7.2	3.0	46.6	3.8	1.1	6.3	9.7	5.8	1.3	12.9	3.9	2.1	2.5	10.1	29.2	3.9	4.1	3.1	0.6	15.4	4.4	3.2	0.0	25.3	2.8	2.1	2.1	27.2	14.7	3.9	4.9	3.4	5.6	3.6	2.2	2.9	29.3	12.1	0.0	5.9	5.4	15.1	7.8	5.0	2.4	1.2	3.1	9.3	4.4	2.7
KIAA1522		ENSG00000162522	KIAA1522	Q9P206	1	32741830-32774970	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 154.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 125.7;hTCEpi: 103.0;RT4: 117.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA032050, HPA032051, HPA064839"	Approved		Supported	"Nucleoplasm,Plasma membrane,Cell Junctions"		NA	NA				"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Plasma membrane, Cell Junctions"	Nucleoplasm	"HPA032050: AB_10601764, HPA032051: AB_2674126, HPA064839: AB_2685366"	"unprognostic (7.98e-2)"	"unprognostic (1.14e-2)"	"unprognostic (1.44e-2)"	"unprognostic (3.09e-2)"	"unprognostic (6.41e-2)"	"unprognostic (3.63e-3)"	"prognostic unfavorable (6.29e-7)"	"unprognostic (1.58e-1)"	"unprognostic (1.13e-1)"	"unprognostic (5.06e-2)"	"prognostic unfavorable (8.25e-5)"	"unprognostic (4.55e-2)"	"prognostic favorable (1.29e-5)"	"unprognostic (1.35e-2)"	"unprognostic (1.35e-1)"	"unprognostic (3.98e-1)"	"unprognostic (2.12e-1)"	7.9	93.0	14.6	7.0	10.7	1.2	24.3	1.8	15.6	14.5	27.1	42.5	51.7	10.1	12.2	76.7	23.5	16.0	5.1	12.4	6.5	43.9	12.0	18.2	1.2	5.2	5.5	22.3	70.7	37.8	9.1	8.4	4.3	40.9	30.9	1.2	68.3	20.2	3.1	74.1	45.9	6.7	4.2	1.4	61.8	5.1	7.7	8.2	39.4	3.2	12.1	22.2	28.1	8.8	65.7	33.6	5.4	9.3	2.4	4.6	24.6	7.9	15.3	8.9	8.7	37.0	125.7	0.2	32.3	11.6	26.5	95.1	10.3	67.8	4.6	0.2	13.4	13.6	49.4	30.4	4.0	0.2	33.3	1.7	103.0	23.6	28.2	40.1	18.6	2.7	20.1	0.4	4.3	54.3	0.3	0.6	11.0	56.3	20.9	8.7	6.7	16.7	85.8	117.5	4.6	4.7	49.5	70.1	9.7	33.7	74.7	4.3	17.6	14.9	39.3	13.7	17.3	0.8	0.3	0.3	15.2	2.3	17.3	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.6	10.7	1.8	15.6	12.4	6.5	5.2	5.5	4.3	4.2	7.7	8.8	5.7	12.8	56.9	5.5	0.6	73.9	37.0	52.7	59.2	0.6	69.8	42.3	3.8	72.9	52.0	27.6	2.1	15.6	1.5	154.4	9.8	47.3	4.2	54.7	5.6	8.7	28.9	1.3	10.2	66.7	5.2	6.7	51.0	50.2	27.8	10.2	4.6	10.6	2.9	0.0	5.2	54.0	48.8	0.8	6.5	5.1	8.7	2.2	7.2	3.7	2.4	0.8	0.0	2.0	0.4	60.7	64.6	4.9	0.3	80.9	84.7	14.8	60.7	0.1	6.6	3.1	7.5	3.8	2.7	59.7	83.1	7.9	2.1	59.9	65.4	99.6
KIF11	"Eg5, HKSP, KNSL1, TRIP5"	ENSG00000138160	"Kinesin family member 11"	P52732	10	92574105-92655395	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	"Motor protein"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 19.4;lymphoid tissue: 37.9"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 39.1;Granulosa cells: 20.7;Spermatocytes: 38.0;Spermatogonia: 23.4"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA006916, HPA010093, HPA010568, CAB017617"	Enhanced		Supported	"Mitotic spindle,Cytosol"		Yes	Yes			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Cytosol	"Mitotic spindle"	"CAB017617: AB_2131098, HPA006916: AB_1848033, HPA010093: AB_2668281, HPA010568: AB_1848034"	"unprognostic (1.53e-1)"	"unprognostic (1.11e-2)"	"unprognostic (1.59e-2)"	"unprognostic (3.35e-2)"	"unprognostic (2.12e-1)"	"unprognostic (7.82e-2)"	"prognostic unfavorable (8.19e-7)"	"prognostic unfavorable (3.27e-4)"	"unprognostic (1.24e-2)"	"unprognostic (1.09e-1)"	"prognostic unfavorable (2.30e-4)"	"unprognostic (6.59e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (1.35e-3)"	"unprognostic (7.23e-2)"	"unprognostic (9.08e-2)"	"unprognostic (2.01e-1)"	1.1	0.7	0.5	8.5	0.7	19.4	2.5	0.4	0.6	1.4	0.5	6.3	5.5	1.8	1.0	6.7	1.0	1.2	0.6	0.5	0.5	1.0	1.1	1.3	17.5	0.6	0.6	0.6	0.5	0.7	0.3	3.9	0.6	1.0	7.4	0.8	1.3	0.7	0.2	6.0	5.3	2.5	0.5	2.9	3.9	11.6	0.4	37.9	1.6	0.3	18.5	2.3	2.3	0.6	103.1	45.2	100.6	94.5	7.3	10.5	24.2	72.6	62.8	78.8	78.1	39.6	67.2	111.1	36.5	34.4	32.9	72.0	72.1	36.5	92.4	68.3	41.3	70.5	41.4	42.4	1.4	116.0	63.0	3.6	3.3	61.4	55.9	18.3	50.0	46.1	51.2	126.4	61.1	41.4	99.3	65.8	40.3	42.5	30.7	106.6	98.8	40.2	21.0	30.1	30.0	42.9	56.4	25.9	29.2	34.1	67.9	37.6	28.6	35.7	51.3	37.1	96.9	35.4	58.3	113.4	29.5	82.3	50.3	0.8	0.0	0.1	0.0	0.3	0.3	0.6	0.4	0.4	0.2	0.1	0.1	0.2	0.2	1.0	0.1	0.1	1.1	0.2	0.5	0.7	0.4	0.6	0.5	0.5	0.6	0.6	0.6	0.5	0.4	0.6	0.4	0.0	2.0	1.3	3.5	2.9	1.1	1.6	3.4	1.0	1.8	1.8	1.7	1.5	2.5	1.8	0.0	6.7	2.3	2.9	1.9	0.5	16.3	3.4	4.3	2.0	0.0	39.1	2.1	0.6	11.4	4.7	9.2	4.9	0.0	20.7	2.2	0.4	8.2	0.0	1.8	4.3	4.1	4.6	3.4	4.4	0.9	4.0	0.0	0.0	1.0	0.7	2.1	2.5	1.1	0.2	0.4	0.7	15.2	0.8	0.5	0.6	3.7	0.4	0.0	1.7	3.7	38.0	23.4	12.6	3.3	1.5	4.5	2.5	8.0	1.7
KIF14	KIAA0042	ENSG00000118193	"Kinesin family member 14"	Q15058	1	200551497-200620751	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"		"Motor protein"	"Ciliopathy, Disease variant, Meckel syndrome, Primary microcephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 6.5;lymphoid tissue: 10.9"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 27.1;Granulosa cells: 13.2;Spermatocytes: 22.8;Spermatogonia: 16.3"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA038061, HPA058220"	Uncertain		Supported	"Midbody ring,Cytosol"		Yes	Yes			"Cluster 18: Basophils - Vesicular transport"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Cytosol	"Midbody ring"	"HPA038061: AB_10669515, HPA058220: AB_2683642"	"unprognostic (1.84e-1)"	"unprognostic (7.15e-2)"	"unprognostic (2.00e-2)"	"unprognostic (1.87e-2)"	"unprognostic (2.74e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.18e-3)"	"prognostic unfavorable (8.64e-4)"	"unprognostic (8.47e-3)"	"unprognostic (1.02e-1)"	"unprognostic (2.54e-5)"	"unprognostic (2.31e-2)"	"unprognostic (0.00e+0)"	"unprognostic (6.28e-3)"	"unprognostic (3.31e-1)"	"unprognostic (8.14e-2)"	"unprognostic (7.44e-2)"	0.2	0.2	0.1	2.0	0.0	6.5	0.3	0.2	0.3	0.2	0.1	0.9	1.2	0.3	0.0	1.0	0.0	0.2	0.0	0.1	0.1	0.0	0.3	0.2	3.2	0.1	0.2	0.0	0.0	0.0	0.0	0.9	0.1	0.0	1.2	0.1	0.1	0.0	0.0	1.0	1.1	0.6	0.0	0.6	0.6	2.5	0.1	10.9	0.1	0.0	3.2	0.4	0.3	0.1	29.7	17.3	26.8	15.0	0.8	3.0	14.8	20.0	11.7	18.7	16.8	10.5	15.1	18.0	7.0	9.6	11.6	23.0	21.6	13.3	26.7	22.1	11.3	28.8	24.8	10.3	0.1	45.5	15.7	0.6	0.6	20.9	17.8	4.0	13.5	26.3	44.0	22.6	23.5	12.1	26.9	14.2	22.6	8.7	15.0	24.3	35.4	22.8	6.3	8.3	12.7	14.0	28.3	9.5	11.0	19.8	12.9	11.6	11.1	14.7	17.3	16.2	35.3	8.2	8.9	25.8	8.6	24.0	30.5	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.1	0.0	0.2	0.3	0.1	0.1	0.1	0.2	0.1	0.0	0.1	0.1	1.0	0.0	0.0	0.0	1.9	2.4	1.0	1.1	0.6	2.3	1.5	1.9	0.8	0.0	0.9	0.0	2.1	4.2	0.6	2.5	0.0	0.2	4.1	3.7	2.2	1.6	0.0	27.1	1.1	0.0	7.7	3.3	10.2	5.0	2.5	13.2	2.5	0.9	5.4	0.0	0.9	5.2	0.0	2.9	1.9	2.5	0.6	2.3	0.0	0.0	0.4	0.5	0.0	0.5	0.8	0.3	0.0	0.7	11.3	1.2	0.2	0.1	1.4	0.8	6.6	1.4	2.1	22.8	16.3	8.3	0.9	1.4	2.3	0.7	4.3	1.9
KIF18A	"DKFZP434G2226, PPP1R99"	ENSG00000121621	"Kinesin family member 18A"	Q8NI77	11	28020619-28108156	"Predicted intracellular proteins"	"Protein transport, Transport"	"Motor protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"bone marrow: 8.2;lymphoid tissue: 9.6;testis: 13.7"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 43.1;Spermatocytes: 78.7;Spermatogonia: 28.3"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"basophil: 4.1;memory B-cell: 1.0;NK-cell: 1.4;T-reg: 1.1"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"HPA039312, HPA039484"	Approved		Supported	"Microtubules,Cytokinetic bridge"		Yes	Yes			"Cluster 41: Basophils - Cellular respiration"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Microtubules, Cytokinetic bridge"		"HPA039312: AB_10794087, HPA039484: AB_10795252"	"unprognostic (3.79e-1)"	"unprognostic (2.63e-1)"	"unprognostic (7.09e-3)"	"unprognostic (3.80e-2)"	"unprognostic (6.56e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.34e-7)"	"unprognostic (2.43e-3)"	"unprognostic (2.04e-3)"	"unprognostic (1.23e-2)"	"unprognostic (1.72e-4)"	"unprognostic (4.41e-2)"	"unprognostic (0.00e+0)"	"unprognostic (7.88e-3)"	"unprognostic (1.67e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.50e-1)"	0.2	0.1	0.0	1.9	0.1	8.2	0.7	0.0	0.1	0.7	0.1	1.6	1.5	0.5	0.3	1.4	0.3	0.5	0.0	0.1	0.1	0.3	0.3	1.0	4.7	0.1	0.1	0.1	0.1	0.1	0.1	1.5	0.1	0.3	2.0	0.6	0.3	0.4	0.2	1.2	1.4	0.8	0.1	0.7	0.6	13.7	0.2	9.6	1.1	0.1	4.6	0.7	0.5	0.1	27.9	27.4	27.2	19.0	0.9	3.7	9.1	28.3	13.2	44.2	46.0	9.2	11.0	23.3	10.0	14.7	24.1	27.2	23.4	11.1	61.4	23.4	14.2	15.2	17.8	11.8	2.1	22.6	13.4	6.8	1.4	15.5	18.1	7.8	17.2	19.0	24.6	20.0	25.2	14.8	23.1	16.7	13.4	18.0	11.1	17.8	65.0	11.6	12.5	8.0	16.3	12.6	23.7	11.1	7.8	16.5	23.8	6.9	10.1	35.0	27.2	33.2	37.4	7.9	19.8	23.4	21.0	16.5	25.2	4.1	0.0	0.3	0.1	0.2	0.3	1.0	0.4	0.2	0.3	0.4	0.3	0.1	0.0	1.4	0.0	0.3	1.1	0.1	0.0	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.1	1.2	3.2	0.0	0.0	4.7	2.3	1.3	1.4	1.2	0.3	1.3	2.9	0.5	0.0	2.2	0.0	6.2	4.6	2.8	1.9	0.0	0.6	43.1	3.4	2.5	1.1	1.8	15.4	0.2	0.9	7.1	5.4	1.5	3.4	4.5	9.7	1.4	0.0	2.2	0.0	0.1	1.9	0.0	1.6	1.4	8.7	0.6	1.4	0.0	1.0	1.1	0.7	1.0	0.5	0.9	0.5	0.1	0.4	5.1	0.2	0.2	0.6	1.7	1.9	0.0	2.5	1.9	78.7	28.3	4.3	1.0	1.6	3.9	2.7	3.6	0.5
KIF18B		ENSG00000186185	"Kinesin family member 18B"	Q86Y91	17	44924709-44947773	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	"Motor protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 12.7;lymphoid tissue: 14.4"	"Cell type enhanced"	"Detected in some"		"Erythroid cells: 9.0;Extravillous trophoblasts: 3.8;Granulosa cells: 5.9;Oligodendrocyte precursor cells: 7.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Region enhanced"	"Detected in single"		"white matter: 1.4"	"Low region specificity"	"Detected in many"			HPA024205	Enhanced		Supported	"Nucleoplasm,Nuclear bodies,Microtubule ends,Cytosol"		Yes	Yes				"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Nucleoplasm, Microtubule ends"	"Nuclear bodies, Cytosol"	"HPA024205: AB_1852472"	"unprognostic (1.88e-1)"	"unprognostic (9.92e-2)"	"unprognostic (4.61e-2)"	"unprognostic (1.13e-2)"	"unprognostic (4.17e-1)"	"unprognostic (7.27e-3)"	"prognostic unfavorable (2.44e-6)"	"unprognostic (3.34e-3)"	"prognostic unfavorable (6.90e-4)"	"unprognostic (1.98e-1)"	"prognostic unfavorable (2.16e-4)"	"unprognostic (8.18e-2)"	"unprognostic (0.00e+0)"	"unprognostic (4.69e-3)"	"unprognostic (1.93e-1)"	"unprognostic (3.08e-1)"	"unprognostic (1.68e-2)"	0.4	0.4	0.3	3.8	0.4	12.7	0.2	0.7	0.3	0.9	0.3	2.0	2.7	0.4	0.0	5.1	0.2	0.4	0.3	0.3	0.4	0.2	0.4	0.8	5.7	0.5	1.1	0.1	0.1	0.0	0.1	1.9	0.6	0.2	1.7	0.1	0.7	0.0	0.4	3.0	2.5	1.1	0.3	2.9	1.5	2.9	0.6	14.4	0.2	0.0	4.7	0.6	1.6	0.5	31.5	41.7	35.3	32.8	0.8	3.0	28.1	25.8	10.3	34.6	26.9	34.0	27.4	28.3	10.9	10.8	21.5	34.0	25.1	11.3	17.9	56.6	36.4	35.4	51.7	22.1	0.0	30.0	30.2	0.7	0.6	29.7	12.2	4.7	17.9	29.2	28.1	48.0	18.2	25.9	60.0	31.1	25.4	30.4	28.9	43.5	51.8	19.2	5.8	16.7	26.2	24.7	18.0	16.1	9.8	17.0	30.2	21.6	11.2	49.9	48.0	28.8	56.8	15.1	15.7	34.4	16.3	22.9	33.1	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.1	0.1	0.0	0.3	0.4	0.7	0.3	0.3	0.4	0.5	1.1	0.6	0.3	0.6	0.5	0.1	0.0	0.0	0.0	0.9	0.4	0.1	0.2	0.0	0.5	0.5	0.4	2.6	0.0	0.0	0.0	0.0	2.4	0.4	1.9	0.0	0.0	0.0	0.3	0.8	0.6	0.0	9.0	0.3	0.0	3.8	1.4	1.5	0.5	0.0	5.9	0.4	0.3	2.3	0.0	0.3	1.6	0.0	2.2	1.1	0.0	0.0	0.4	0.0	0.0	0.1	0.1	0.0	7.1	0.1	0.1	0.0	0.0	2.1	0.2	0.3	0.0	0.0	0.3	0.0	0.2	0.8	1.1	2.9	2.5	0.4	0.8	1.3	0.3	3.2	0.3
KIF20B	"CT90, KRMP1, MPHOSPH1, MPP1"	ENSG00000138182	"Kinesin family member 20B"	Q96Q89	10	89701590-89774939	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	"Motor protein"	Oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 10.2;lymphoid tissue: 9.8"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 89.2;Spermatocytes: 165.4;Spermatogonia: 96.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			HPA050214	Supported		Supported	"Nucleoplasm,Cytokinetic bridge,Midbody,Cytosol"		Yes	Yes			"Cluster 6: Non-specific - Transcription"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Nucleoplasm, Cytokinetic bridge"	"Midbody, Cytosol"	"HPA050214: AB_2681053"	"unprognostic (2.13e-1)"	"unprognostic (3.01e-2)"	"unprognostic (1.72e-2)"	"unprognostic (3.20e-2)"	"unprognostic (2.65e-1)"	"unprognostic (7.39e-2)"	"unprognostic (8.95e-5)"	"unprognostic (3.32e-3)"	"unprognostic (2.01e-2)"	"unprognostic (8.14e-2)"	"prognostic unfavorable (1.21e-4)"	"unprognostic (1.62e-2)"	"prognostic unfavorable (3.06e-6)"	"unprognostic (4.22e-3)"	"unprognostic (2.70e-1)"	"unprognostic (2.51e-2)"	"unprognostic (6.43e-2)"	1.3	0.7	0.3	4.5	1.0	10.2	2.5	2.4	0.4	1.5	0.1	3.2	3.6	2.3	0.4	3.3	1.2	1.3	0.9	0.3	0.3	1.3	1.3	1.5	8.0	0.5	0.3	2.7	0.7	1.1	0.2	2.4	0.6	1.3	4.0	1.1	1.0	0.9	0.4	2.5	3.4	2.2	0.4	3.3	2.5	6.9	0.6	9.8	1.8	0.7	7.5	1.6	0.7	0.6	84.8	17.0	24.3	21.7	4.7	8.0	20.2	33.8	30.9	34.8	36.3	22.6	38.1	32.5	10.4	17.3	13.0	41.8	27.3	18.9	46.4	39.5	18.6	33.1	30.5	19.5	1.4	57.1	26.3	3.4	2.8	33.7	33.9	12.2	22.8	17.0	32.2	36.5	31.3	14.6	33.6	10.8	25.0	13.8	16.1	23.1	47.8	14.3	10.7	11.2	7.7	13.9	24.4	11.0	12.2	17.3	28.5	16.3	17.9	22.2	22.1	29.1	55.3	10.1	29.5	43.2	21.1	49.4	16.8	13.1	2.4	4.2	5.5	4.1	6.8	13.0	7.4	6.1	1.3	16.0	8.6	8.0	0.2	3.0	4.5	5.2	9.5	2.2	0.3	1.0	2.4	0.4	0.3	0.3	0.5	0.3	0.6	0.4	0.6	0.6	11.5	3.2	13.5	2.3	36.4	17.7	6.2	20.8	6.8	14.3	8.3	8.5	8.7	1.5	10.7	0.0	10.4	21.4	32.3	8.8	3.9	6.9	13.1	10.6	13.2	11.0	1.2	89.2	8.1	4.7	38.1	13.2	14.8	12.9	44.4	37.2	9.3	4.4	20.7	13.5	9.5	8.6	16.2	21.0	17.9	10.5	8.1	17.1	5.4	23.4	11.3	7.5	24.7	9.0	9.1	4.1	5.7	8.6	51.4	3.7	8.9	3.2	6.6	9.8	6.6	16.9	17.1	165.4	96.7	26.1	14.1	5.2	34.2	12.9	25.5	5.2
KIF22	"Kid, KNSL4, OBP-1, OBP-2"	ENSG00000079616	"Kinesin family member 22"	Q14807	16	29790719-29805384	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"		"DNA-binding, Motor protein"	"Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 88.5;lymphoid tissue: 73.0"	"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 288.7;Hepatocytes: 565.5;Proximal tubular cells: 194.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA048213, HPA075670"	Enhanced		Supported	"Nuclear speckles"		NA	Yes			"Cluster 44: Non-specific - Transcription"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 14: REH - Unknown function"	"Cluster 2: Hepatocytes - Metabolism"	"Nuclear speckles"		"HPA048213: AB_2680316, HPA075670: "	"unprognostic (3.71e-2)"	"prognostic favorable (3.87e-8)"	"unprognostic (1.86e-1)"	"unprognostic (2.21e-3)"	"unprognostic (1.25e-1)"	"unprognostic (6.06e-3)"	"unprognostic (5.06e-3)"	"unprognostic (2.70e-1)"	"unprognostic (2.70e-1)"	"unprognostic (4.73e-2)"	"unprognostic (7.84e-2)"	"unprognostic (2.10e-2)"	"unprognostic (2.21e-2)"	"unprognostic (3.67e-2)"	"unprognostic (2.62e-1)"	"unprognostic (3.94e-2)"	"unprognostic (1.67e-1)"	9.2	7.0	9.5	19.7	9.9	88.5	13.4	8.1	10.4	10.5	6.9	22.6	16.6	8.2	8.6	22.3	12.3	6.4	10.8	9.5	8.9	11.2	8.3	8.5	34.1	8.4	8.3	8.2	7.3	33.8	9.2	15.7	8.3	24.9	20.6	8.9	10.5	12.0	8.4	32.8	16.9	8.0	8.9	18.6	11.8	28.3	9.4	73.0	26.0	11.0	34.7	10.1	13.3	9.3	89.3	103.9	120.6	87.6	8.0	11.9	104.8	65.8	52.1	123.1	113.9	97.9	103.3	130.6	60.4	34.4	61.2	90.0	118.9	67.5	57.4	84.8	100.4	72.4	115.1	119.0	2.7	79.1	76.0	6.7	17.7	68.5	51.3	17.1	67.2	144.7	109.4	104.1	65.5	186.5	173.1	196.1	101.8	65.7	59.6	237.9	110.6	122.4	44.9	45.0	99.8	65.4	48.5	94.7	33.1	39.4	84.8	105.2	29.8	63.8	66.6	57.7	72.6	96.6	105.3	141.4	41.9	129.0	83.3	58.7	14.1	39.5	49.7	21.1	37.3	30.4	50.0	53.1	14.7	27.3	40.0	38.4	6.2	31.5	18.3	9.6	56.5	40.5	9.5	9.9	8.1	10.4	9.5	8.9	8.4	8.3	8.3	8.9	9.4	9.3	13.9	32.1	115.4	5.5	23.0	30.8	25.8	56.7	52.9	27.5	56.5	56.4	288.7	57.2	38.5	69.9	25.0	81.7	20.1	44.2	62.6	16.6	9.9	29.5	18.9	29.2	41.4	85.2	4.8	50.1	85.4	50.1	25.0	31.1	43.6	29.5	49.2	565.5	46.3	6.7	6.1	39.5	34.6	47.7	40.4	8.5	15.5	36.7	35.6	4.7	38.6	69.8	29.9	4.0	5.3	17.3	44.0	12.8	49.9	26.1	18.0	194.0	29.7	20.5	13.1	23.7	34.2	50.9	61.6	41.4	27.6	76.9	34.2	12.2	42.3	22.5
KIF23	"KNSL5, MKLP-1, MKLP1"	ENSG00000137807	"Kinesin family member 23"	Q02241	15	69414246-69448427	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	"Motor protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 21.6;lymphoid tissue: 15.9"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 24.2;Erythroid cells: 42.3;Extravillous trophoblasts: 32.4;Granulosa cells: 22.4;Spermatocytes: 70.8"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in some"		"eosinophil: 4.6"	"Group enriched"	"Detected in many"	13	"granulocytes: 4.6;monocytes: 1.2;T-cells: 1.2"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"CAB010414, HPA045208, HPA068831"	Uncertain		Enhanced	"Nucleoplasm,Midbody ring,Mitotic spindle"		Yes	Yes			"Cluster 49: Eosinophils - Unknown function"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	"Midbody ring, Mitotic spindle"	"CAB010414: AB_631959, HPA045208: AB_2679254, HPA068831: AB_2686045"	"unprognostic (1.29e-1)"	"unprognostic (2.40e-1)"	"unprognostic (5.57e-2)"	"prognostic unfavorable (8.62e-4)"	"unprognostic (1.86e-1)"	"unprognostic (7.99e-3)"	"prognostic unfavorable (3.18e-5)"	"unprognostic (1.43e-3)"	"unprognostic (4.25e-3)"	"unprognostic (2.60e-1)"	"prognostic unfavorable (3.69e-5)"	"unprognostic (5.85e-3)"	"unprognostic (0.00e+0)"	"unprognostic (1.15e-2)"	"unprognostic (2.59e-1)"	"unprognostic (1.17e-1)"	"unprognostic (9.17e-2)"	1.0	1.5	0.3	5.7	0.2	21.6	1.4	0.2	0.3	1.5	1.4	4.1	3.9	2.0	0.1	5.3	0.9	1.3	0.6	0.3	0.2	4.6	0.5	1.5	7.9	0.2	0.3	0.7	0.5	0.4	0.1	6.4	0.3	0.9	5.0	0.2	1.1	1.2	0.1	3.7	3.8	4.2	0.2	2.2	2.0	10.6	0.3	15.9	0.3	0.2	9.8	1.8	2.1	0.2	100.7	81.5	64.2	59.0	3.7	7.3	36.3	105.3	57.0	154.8	120.6	50.2	72.4	56.8	31.4	53.1	78.6	110.5	121.6	39.5	158.7	52.9	60.2	55.3	78.8	30.7	2.1	55.6	48.3	3.3	4.2	71.8	60.5	19.4	52.0	46.9	36.0	70.2	95.4	44.1	31.2	28.2	71.6	35.5	33.2	37.0	133.8	31.2	39.3	49.7	32.5	25.3	120.4	51.9	44.9	74.5	50.6	25.3	34.5	90.0	120.8	62.0	157.6	26.3	74.3	48.4	31.5	72.2	78.0	0.0	1.2	4.6	0.0	0.5	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.6	0.0	1.2	0.3	0.3	0.2	0.2	0.3	0.3	0.2	0.2	0.3	0.3	0.2	0.3	0.2	0.4	0.0	0.5	0.0	2.3	1.9	3.7	4.2	0.0	0.2	1.8	2.8	0.8	5.7	4.7	7.3	2.1	24.2	1.4	3.3	3.9	1.8	13.3	13.1	3.6	2.2	1.8	42.3	1.8	0.0	32.4	5.8	3.6	8.7	2.5	22.4	3.9	0.3	8.1	0.0	1.0	3.1	0.0	2.8	3.4	4.8	0.9	3.2	0.0	1.0	8.1	0.2	0.0	0.0	0.2	0.4	0.4	1.9	6.8	1.6	0.8	0.9	3.6	0.1	6.6	0.4	8.2	70.8	20.9	11.3	1.0	2.5	4.2	3.6	8.6	3.3
KIF2B		ENSG00000141200	"Kinesin family member 2B"	Q8N4N8	17	53822927-53825193	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	"Motor protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	508	"testis: 75.3"	"Group enriched"	"Detected in some"	68	"Early spermatids: 744.0;Late spermatids: 623.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA023081, HPA023103, HPA024795"	Uncertain		Supported	"Nucleoli,Microtubules,Cytokinetic bridge,Mitotic spindle"		Yes	NA				"Cluster 74: Testis - Spermatogenesis"		"Cluster 34: Spermatids - Unknown function"	"Microtubules, Cytokinetic bridge, Mitotic spindle"	Nucleoli	"HPA023081: AB_10600082, HPA023103: AB_10611254, HPA024795: AB_10602197"																		0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	75.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	744.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	623.2	6.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.0	0.0	10.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0
KIF2C	"CT139, KNSL6, MCAK"	ENSG00000142945	"Kinesin family member 2C"	Q99661	1	44739818-44767767	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Chromosome partition, Mitosis"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"bone marrow: 33.0;lymphoid tissue: 37.4;testis: 76.5"	"Cell type enriched"	"Detected in many"	4	"Late spermatids: 1860.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"T-reg: 2.9"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Region enhanced"	"Detected in some"		"white matter: 2.1"	"Not detected"	"Not detected"			"HPA006219, HPA079172"	Enhanced		Supported	Nucleoplasm,Midbody,Centrosome		Yes	Yes			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 25: Spermatids - Spermatogenesis"	"Nucleoplasm, Centrosome"	Midbody	"HPA006219: AB_2667540, HPA079172: "	"unprognostic (3.29e-2)"	"unprognostic (1.35e-2)"	"unprognostic (1.03e-2)"	"unprognostic (1.71e-3)"	"unprognostic (2.77e-1)"	"unprognostic (5.17e-2)"	"prognostic unfavorable (3.07e-7)"	"unprognostic (7.49e-3)"	"unprognostic (3.33e-3)"	"unprognostic (3.66e-1)"	"prognostic unfavorable (6.86e-4)"	"unprognostic (4.27e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (2.33e-3)"	"unprognostic (1.49e-1)"	"unprognostic (1.86e-2)"	"unprognostic (2.41e-1)"	0.7	0.8	0.7	7.0	0.7	33.0	1.6	2.3	0.7	1.8	1.1	6.2	5.5	1.8	0.7	7.3	0.9	1.3	1.3	0.6	1.1	0.8	0.7	1.3	16.4	1.1	0.9	0.6	0.5	1.3	0.4	5.4	1.4	0.8	7.6	0.8	1.3	0.7	0.9	6.0	5.1	3.2	0.9	3.7	3.5	76.5	0.8	37.4	1.1	0.7	19.2	2.1	2.7	0.8	119.7	45.8	99.6	79.8	5.3	11.6	66.6	86.9	62.1	175.0	151.3	77.6	84.2	136.2	41.3	43.2	121.7	55.2	102.8	59.6	158.2	89.1	44.4	162.1	83.3	65.5	0.6	121.5	71.8	2.7	5.8	125.0	60.3	16.5	57.6	95.4	130.4	113.1	112.4	46.5	127.5	72.9	97.1	58.4	56.5	101.1	149.3	86.4	29.6	42.8	68.3	48.5	116.1	81.6	71.5	71.9	47.2	90.7	34.7	62.9	124.2	69.0	155.6	59.4	65.0	195.3	40.3	115.4	123.9	0.0	0.0	0.0	0.9	0.0	0.0	0.6	1.7	1.2	0.1	0.1	0.3	0.2	0.0	2.0	0.1	0.8	2.9	0.5	0.7	0.7	2.3	0.7	0.6	1.1	1.1	0.9	1.4	0.9	0.8	0.8	0.1	0.0	0.5	1.6	1.3	1.8	0.5	2.4	0.0	1.0	0.9	0.9	1.6	0.0	1.7	1.8	2.1	12.2	1.9	2.9	1.9	0.3	461.1	1.2	1.4	1.6	0.0	34.5	0.8	0.4	23.4	3.2	3.1	2.1	0.0	13.0	2.9	0.2	9.2	0.0	1.0	3.5	0.0	1.9	1.5	1860.6	9.3	3.4	0.0	1.0	4.3	0.4	0.0	0.5	0.2	0.1	0.2	6.8	7.8	0.8	0.3	0.2	0.3	0.2	6.6	0.8	3.4	60.6	36.8	4.6	0.4	3.7	2.7	0.8	7.4	0.7
KIF4A	"FLJ12530, FLJ12655, FLJ14204, FLJ20631, HSA271784, KIF4, KIF4-G1, MRX100"	ENSG00000090889	"Kinesin family member 4A"	O95239	X	70290104-70420886	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		"DNA-binding, Motor protein"	"Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 11.2;lymphoid tissue: 12.6"	"Cell type enhanced"	"Detected in many"		"Endometrial ciliated cells: 18.6;Erythroid cells: 29.5;Extravillous trophoblasts: 11.5;Granulosa cells: 12.2"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA034745, HPA034746, HPA061583"	Approved		Supported	Nucleoplasm,Midbody		Yes	Yes			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Nucleoplasm, Midbody"		"HPA034745: AB_10670978, HPA034746: AB_10670173, HPA061583: AB_2684564"	"unprognostic (8.17e-3)"	"unprognostic (2.78e-2)"	"unprognostic (1.02e-2)"	"unprognostic (3.46e-3)"	"unprognostic (3.20e-1)"	"unprognostic (1.64e-1)"	"prognostic unfavorable (7.37e-6)"	"unprognostic (2.18e-3)"	"unprognostic (5.06e-3)"	"unprognostic (1.34e-1)"	"prognostic unfavorable (9.44e-6)"	"unprognostic (3.79e-2)"	"unprognostic (0.00e+0)"	"unprognostic (3.09e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.47e-1)"	0.3	0.3	0.3	3.2	0.2	11.2	0.7	0.1	0.3	0.6	0.3	3.7	3.1	0.8	0.0	3.6	1.5	0.5	0.2	0.2	0.5	0.2	0.5	0.5	5.5	0.9	0.7	0.1	0.1	0.1	0.5	2.3	0.6	0.1	4.5	0.6	0.5	0.1	0.1	2.2	3.3	1.3	0.7	2.4	1.7	1.5	0.6	12.6	0.2	0.0	6.6	0.9	1.1	0.2	60.2	41.1	61.0	30.1	2.9	5.1	24.0	44.7	23.8	59.7	51.6	46.7	34.3	36.7	27.4	22.1	46.2	35.1	66.6	24.2	66.8	42.5	33.4	41.7	50.1	33.4	0.7	46.7	27.8	1.7	1.5	49.6	28.2	7.3	37.0	27.7	53.8	79.1	57.0	38.7	43.0	23.1	61.7	63.8	43.2	47.1	82.2	34.6	14.5	23.4	40.1	33.5	72.9	30.5	18.6	30.6	24.5	18.1	26.0	39.3	50.6	42.6	54.1	22.6	41.7	52.0	20.8	50.4	60.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.3	0.2	0.1	0.3	0.2	0.5	0.9	0.7	0.6	0.7	0.6	0.2	0.1	0.0	0.5	1.3	1.3	1.8	0.3	1.4	0.6	0.2	1.1	0.8	0.4	1.5	0.2	0.0	0.0	7.0	0.9	2.2	0.0	0.0	0.4	18.6	1.5	1.3	1.2	29.5	1.9	0.0	11.5	2.1	3.1	1.6	0.0	12.2	1.1	0.1	5.3	0.0	1.9	4.6	2.0	1.3	0.7	0.8	0.0	1.4	0.0	0.0	0.2	3.1	0.0	2.0	0.7	0.1	0.1	0.0	8.2	0.4	0.3	0.1	0.4	0.0	0.0	0.2	2.9	8.7	5.4	7.2	0.3	1.8	1.8	1.3	6.6	0.5
KIF5B	"KNS, KNS1"	ENSG00000170759	"Kinesin family member 5B"	P33176	10	32009015-32056425	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transporters"		"Motor protein"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009846, HPA037589, HPA037590"	Approved		Enhanced	"Centriolar satellite,Cytosol"		NA	Yes		97000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 10: Non-specific - Unknown function"	"Centriolar satellite, Cytosol"		"CAB009846: AB_2280915, HPA037589: AB_2675563, HPA037590: AB_2675564"	"unprognostic (4.94e-3)"	"unprognostic (1.70e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.84e-1)"	"unprognostic (4.00e-2)"	"unprognostic (6.21e-2)"	"unprognostic (1.06e-2)"	"unprognostic (1.84e-1)"	"unprognostic (2.70e-1)"	"unprognostic (6.37e-3)"	"unprognostic (2.03e-1)"	"unprognostic (2.60e-1)"	"unprognostic (1.81e-1)"	"unprognostic (2.43e-2)"	"unprognostic (2.39e-1)"	"unprognostic (8.06e-2)"	"unprognostic (1.76e-1)"	59.7	41.8	110.0	46.7	128.2	84.9	45.3	107.7	149.7	47.3	75.6	66.4	52.0	54.1	30.3	52.7	39.2	59.8	87.4	85.8	100.2	44.7	31.9	52.5	39.9	121.9	123.8	27.6	41.8	91.6	22.9	54.4	120.6	65.9	63.6	45.1	39.1	52.0	65.0	38.9	54.7	81.3	128.1	48.1	51.4	64.4	116.8	44.0	50.5	67.3	36.6	60.8	29.8	143.4	115.8	96.4	127.3	89.9	89.2	97.7	54.4	155.6	73.3	117.6	99.6	106.6	124.0	78.7	65.8	185.8	66.9	93.3	117.6	99.4	156.4	68.4	64.1	100.2	87.9	104.5	102.5	70.5	105.6	79.9	138.0	135.8	94.0	93.4	152.8	68.2	122.9	80.5	164.7	69.7	74.0	39.7	20.7	110.1	43.4	95.7	237.2	32.6	90.6	79.5	123.3	89.9	120.4	47.5	117.3	88.0	57.5	99.4	128.4	118.7	111.0	139.3	117.2	24.2	29.8	90.9	113.2	142.2	114.1	41.8	25.9	44.0	19.1	33.0	18.7	23.7	24.0	20.6	24.7	24.3	21.1	20.8	51.1	24.3	35.7	47.9	29.4	18.4	110.0	128.2	107.7	149.7	85.8	100.2	121.9	123.8	120.6	128.1	116.8	143.4	160.3	182.7	206.8	49.3	86.3	213.1	177.7	200.6	66.0	181.9	119.0	103.8	396.0	115.8	198.4	104.8	100.1	121.0	125.5	145.0	45.0	209.4	185.5	167.8	171.4	181.0	132.3	69.2	44.6	176.0	134.9	141.2	85.6	158.9	91.2	159.7	88.5	46.2	132.7	151.4	56.0	227.3	213.6	111.8	129.1	51.8	59.0	137.2	101.4	84.3	169.3	160.5	82.4	61.9	83.3	202.2	164.9	130.9	84.2	254.1	120.2	59.5	206.1	123.8	85.5	176.0	244.8	566.0	195.6	87.6	236.7	331.9	116.0	137.4	208.1	246.8
KIRREL2	"DKFZp564A1164, FILTRIN, MGC15718, NEPH3, NLG1"	ENSG00000126259	"Kirre like nephrin family adhesion molecule 2"	Q6UWL6	19	35855861-35867136	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"pancreas: 70.0"	"Cell type enriched"	"Detected in some"	9	"Bipolar cells: 58.6"	"Cancer enhanced"	"Detected in some"		"pancreatic cancer: 2.6"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 21.5;HMC-1: 33.0;JURKAT: 19.5;U-937: 7.5"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"HPA071587, HPA074326"	Enhanced		Supported	"Centriolar satellite"	"Intracellular and membrane"	NA	NA				"Cluster 25: Pancreas - Digestion"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 56: Bipolar cells - Visual perception"	"Centriolar satellite"		"HPA071587: AB_2732182, HPA074326: AB_2732251"	"unprognostic (1.28e-2)"	"unprognostic (1.80e-1)"	"unprognostic (3.29e-2)"	"unprognostic (3.16e-3)"	"unprognostic (2.05e-3)"	"unprognostic (2.29e-1)"	"unprognostic (2.00e-1)"	"unprognostic (1.72e-3)"	"unprognostic (3.30e-2)"	"unprognostic (5.56e-2)"	"unprognostic (4.85e-2)"	"unprognostic (2.62e-2)"	"unprognostic (2.43e-6)"	"unprognostic (1.72e-1)"	"unprognostic (4.44e-1)"	"unprognostic (1.48e-2)"	"unprognostic (2.62e-2)"	0.5	0.0	0.5	0.2	1.4	0.1	0.0	0.3	1.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.1	1.1	0.0	0.0	0.8	0.4	0.4	0.0	70.0	0.0	0.9	0.1	0.4	0.0	0.1	11.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.9	0.6	0.5	0.6	0.0	0.0	0.6	0.0	0.0	0.6	0.0	0.7	1.1	0.0	0.0	0.0	1.6	0.1	0.0	0.1	0.0	1.1	0.7	0.0	0.1	0.0	3.6	0.1	2.9	0.0	0.1	21.5	0.1	0.0	0.0	0.3	0.0	0.0	33.0	0.2	0.0	0.0	0.0	0.0	0.0	19.5	0.2	0.3	0.0	0.2	0.6	0.1	0.2	0.1	0.0	5.5	0.0	0.0	0.0	0.0	4.1	1.3	0.0	0.0	0.0	0.1	0.0	5.3	0.0	0.8	1.3	0.3	0.0	0.0	0.0	0.4	0.0	7.5	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	1.4	0.3	1.0	0.8	0.1	0.4	0.4	0.4	0.0	0.5	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	58.6	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.1	1.8	0.1	0.2	0.1	0.0	0.0	0.4	6.0	0.1	0.1	0.0	1.0	0.0	0.0	0.0	0.0	2.8	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	1.0	0.0	0.0	0.7	5.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.8	0.0	0.0	0.0	0.7	1.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0
KISS1R	"AXOR12, GPR54, HOT7T175"	ENSG00000116014	"KISS1 receptor"	Q969F8	19	917287-921005	"Disease related genes, G-protein coupled receptors, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"	"Disease variant, Hypogonadotropic hypogonadism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"brain: 8.5"	"Cell type enriched"	"Detected in some"	9	"Extravillous trophoblasts: 41.9"	"Cancer enhanced"	"Detected in many"		"renal cancer: 3.6"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"K-562: 15.7;RPMI-8226: 37.4;SCLC-21H: 7.4;SH-SY5Y: 20.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"HPA007156, HPA071913"	Approved		Supported	"Vesicles,Plasma membrane"		NA	NA			"Cluster 30: Non-specific - Translation"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 38: Extravillous trophoblasts - Unknown function"	"Plasma membrane"	Vesicles	"HPA007156: , HPA071913: AB_2686471"	"unprognostic (1.54e-1)"	"unprognostic (3.01e-2)"	"unprognostic (9.42e-2)"	"unprognostic (2.15e-1)"	"unprognostic (8.46e-3)"	"unprognostic (9.23e-2)"	"unprognostic (1.65e-2)"	"unprognostic (3.23e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.48e-2)"	"unprognostic (7.17e-2)"	"prognostic unfavorable (3.33e-6)"	"unprognostic (1.87e-1)"	"unprognostic (8.09e-3)"	"unprognostic (1.05e-1)"	"unprognostic (2.05e-2)"	0.0	0.0	2.9	0.1	1.8	0.0	0.0	0.9	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.3	3.8	0.3	0.1	0.1	0.1	4.0	2.2	0.0	1.3	0.3	1.1	0.1	3.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	1.0	0.4	0.0	0.0	8.5	0.0	0.0	0.0	0.0	0.1	0.1	0.8	0.0	0.7	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.1	0.0	0.0	0.0	1.0	0.0	0.0	0.3	4.1	0.0	0.0	4.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	15.7	0.0	0.0	0.3	0.1	0.0	0.6	1.2	0.4	1.0	0.0	37.4	0.0	0.0	7.4	20.0	0.0	0.0	0.0	0.0	0.4	0.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.3	0.1	0.3	0.0	0.0	0.0	0.0	0.0	2.9	1.8	0.9	3.4	1.3	3.8	4.0	2.2	3.9	1.0	8.5	0.8	0.1	0.0	0.0	0.0	1.0	0.1	0.1	0.5	0.0	1.1	1.2	1.4	0.5	0.0	0.2	0.0	0.0	0.4	0.2	0.1	0.0	0.7	0.0	0.3	0.1	0.0	0.0	0.0	0.3	0.2	41.9	0.1	0.0	0.4	0.0	0.1	0.0	0.1	0.7	0.0	0.7	0.0	0.0	0.0	1.5	0.0	0.0	0.3	1.8	0.0	0.0	0.2	1.0	0.0	0.0	0.1	0.0	0.0	4.2	0.2	0.0	0.0	0.0	1.8	0.0	0.0	0.4	0.0	0.3	0.3	0.3	1.6	0.9	0.2	0.1	0.2
KIT	"C-Kit, CD117, PBT, SCFR"	ENSG00000157404	"KIT proto-oncogene, receptor tyrosine kinase"	P10721	4	54657918-54740715	"Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted membrane proteins, RAS pathway related proteins"		"Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease variant, FDA approved drug targets, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"breast: 114.9"	"Cell type enhanced"	"Detected in many"		"Breast glandular cells: 83.1;granulocytes: 529.3;Inhibitory neurons: 111.2;Ionocytes: 101.7;Melanocytes: 211.7"	"Cancer enhanced"	"Detected in many"		"testis cancer: 28.6"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	7	"basophil: 20.3;eosinophil: 12.8;NK-cell: 13.1"	"Group enriched"	"Detected in many"	7	"granulocytes: 20.3;NK-cells: 13.1"	"Group enriched"	"Detected in many"	13	"HEL: 247.2;HMC-1: 496.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003288, HPA004471, CAB068253, CAB072867, HPA073252"	Enhanced	Supported	Supported	"Plasma membrane"		NA	NA		49000000	"Cluster 2: Granulocytes - Unknown function"	"Cluster 5: Breast - Unknown function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 60: Granulocytes - Receptor signaling"	"Plasma membrane"		"CAB003288: AB_2335702, CAB068253: AB_2665717, CAB072867: AB_2665718, HPA004471: AB_1078431, HPA073252: AB_2686589"	"unprognostic (1.55e-2)"	"unprognostic (1.91e-1)"	"unprognostic (4.04e-2)"	"unprognostic (8.19e-2)"	"unprognostic (3.96e-2)"	"unprognostic (2.18e-2)"	"unprognostic (2.33e-2)"	"unprognostic (1.97e-2)"	"unprognostic (3.60e-2)"	"unprognostic (1.64e-1)"	"unprognostic (2.20e-1)"	"unprognostic (1.92e-2)"	"prognostic favorable (5.63e-4)"	"unprognostic (1.34e-3)"	"unprognostic (1.87e-1)"	"unprognostic (1.29e-2)"	"unprognostic (2.30e-1)"	6.6	1.8	8.2	5.3	6.3	6.4	114.9	21.4	6.5	17.6	5.1	13.5	9.2	9.6	5.9	13.0	2.9	20.3	3.4	23.9	5.1	12.4	0.8	21.8	3.4	6.8	12.3	45.0	2.6	1.7	1.9	10.0	8.8	5.6	16.0	3.2	21.4	8.7	1.1	24.5	13.4	10.1	5.9	5.0	17.4	6.2	16.7	3.1	47.1	6.9	6.2	14.5	4.9	5.1	0.0	0.0	3.9	0.0	0.7	0.3	0.0	3.3	4.6	12.6	15.8	0.0	0.0	0.0	0.0	7.3	0.6	0.3	2.6	0.0	10.8	0.0	5.9	247.2	0.0	0.0	0.0	0.0	496.2	0.0	0.0	0.0	0.0	0.0	28.4	4.3	3.5	0.5	0.0	0.0	1.4	2.5	6.9	0.0	0.0	0.8	0.0	0.0	0.0	24.2	6.0	2.1	0.0	0.0	0.0	14.1	0.0	2.6	0.3	0.5	0.0	4.9	0.1	0.4	0.0	0.0	0.5	0.9	0.6	20.3	0.0	12.8	0.1	0.0	2.3	0.0	0.4	0.9	2.3	0.0	0.0	0.0	1.0	13.1	1.4	0.1	0.0	0.2	8.2	6.3	21.4	6.5	23.9	5.1	6.8	12.3	8.8	5.9	16.7	5.1	7.3	6.4	21.9	9.8	1.0	14.3	0.9	0.4	2.2	4.5	83.1	59.2	0.7	4.3	3.6	3.7	0.0	0.1	5.2	0.4	3.9	1.0	0.0	0.2	0.7	9.2	5.4	15.5	0.9	0.0	0.1	2.8	8.6	0.7	529.3	0.5	1.8	0.0	0.3	0.0	111.2	0.5	101.7	0.3	4.2	0.4	1.2	1.6	211.7	14.0	0.2	2.4	0.0	16.1	3.7	0.0	0.1	0.0	3.2	0.5	0.0	0.8	0.1	0.2	0.0	0.7	0.8	0.1	12.3	2.2	3.8	0.3	8.8	63.7	0.6	0.3
KLF1	EKLF	ENSG00000105610	"Kruppel like factor 1"	Q13351	19	12884422-12887201	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Congenital dyserythropoietic anemia, Disease variant, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	14	"bone marrow: 41.2"	"Cell type enriched"	"Detected in some"	199	"Erythroid cells: 519.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in some"		"intermediate monocyte: 1.9;non-classical monocyte: 1.1"	"Lineage enriched"	"Detected in single"	8	"monocytes: 1.9"	"Group enriched"	"Detected in some"	29	"HEL: 61.6;K-562: 150.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA051850	Enhanced		Supported	Nucleoplasm		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 6: Erythroid cells - Oxygen transport"	Nucleoplasm		"HPA051850: AB_2616460"	"unprognostic (1.17e-1)"	"unprognostic (1.38e-4)"	"unprognostic (2.96e-1)"	"unprognostic (1.17e-3)"	"unprognostic (7.13e-2)"	"unprognostic (3.90e-4)"	"unprognostic (3.25e-2)"	"unprognostic (3.19e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.08e-2)"	"unprognostic (6.51e-2)"	"unprognostic (7.71e-2)"	"unprognostic (2.69e-3)"	"unprognostic (1.05e-1)"	"unprognostic (1.06e-1)"	"unprognostic (3.76e-1)"	"unprognostic (2.44e-1)"	0.0	0.0	0.1	0.0	0.1	41.2	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.4	0.3	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.7	0.1	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.1	2.8	0.0	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	61.6	0.0	0.0	0.0	0.8	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.2	150.5	0.0	0.0	0.2	0.3	0.4	0.7	0.1	0.0	0.1	0.0	0.4	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.1	0.7	0.4	0.0	0.0	0.0	0.0	1.0	0.4	0.0	0.0	3.6	0.0	0.0	0.6	0.0	0.0	1.9	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	1.1	0.0	0.0	0.6	0.1	0.1	0.1	0.3	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	1.1	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	519.2	0.0	0.0	0.9	0.7	0.0	0.0	0.0	0.0	0.0	0.1	2.6	0.0	0.0	0.0	0.0	0.9	0.3	0.0	0.0	0.4	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.3	0.1	0.0	0.1	0.1
KLF11	"MODY7, TIEG2, Tieg3"	ENSG00000172059	"Kruppel like factor 11"	O14901	2	10042849-10054836	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Apoptosis, Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"	"Diabetes mellitus, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 135.0;Suprabasal keratinocytes: 86.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 47.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA058276			Supported	"Nucleoplasm,Nuclear bodies,Focal adhesion sites,Cytosol"		Yes	No			"Cluster 7: Monocytes - Unknown function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 29: Early spermatids - Spermatogenesis"	Nucleoplasm	"Nuclear bodies, Focal adhesion sites, Cytosol"	"HPA058276: AB_2683664"	"unprognostic (9.66e-3)"	"unprognostic (1.87e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.06e-2)"	"unprognostic (3.02e-3)"	"unprognostic (2.63e-3)"	"unprognostic (6.34e-2)"	"unprognostic (1.04e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.04e-1)"	"unprognostic (3.17e-3)"	"unprognostic (3.08e-2)"	"unprognostic (2.48e-3)"	"unprognostic (8.96e-2)"	"unprognostic (3.44e-1)"	"unprognostic (1.07e-2)"	"unprognostic (9.24e-2)"	27.7	15.6	4.0	7.6	3.2	27.8	22.3	8.3	3.9	13.5	4.1	17.9	7.5	20.0	9.7	13.2	13.7	18.1	19.1	2.9	3.9	15.7	35.2	22.4	9.3	3.7	3.3	23.9	54.2	18.3	2.5	19.5	3.4	10.1	9.3	3.0	15.9	14.8	12.1	26.9	8.7	16.8	3.2	18.8	12.4	30.0	3.5	4.0	16.5	27.3	5.5	12.6	13.1	5.1	6.9	3.3	7.8	0.7	5.3	9.4	18.8	7.9	7.9	4.4	4.6	7.8	15.8	0.0	13.9	9.6	17.9	1.6	6.8	6.1	2.9	47.6	5.2	3.5	9.7	1.6	5.2	14.6	22.1	14.7	22.3	8.4	2.3	11.4	3.9	1.3	9.7	30.8	4.6	8.2	0.0	2.7	12.5	5.6	6.7	7.8	0.2	13.6	10.8	8.5	10.0	6.2	12.0	24.5	23.4	12.2	5.7	19.6	11.2	19.3	15.9	14.7	2.6	27.9	36.0	18.7	5.0	3.8	10.4	0.0	8.2	2.0	2.6	12.3	0.8	3.2	1.8	1.9	7.3	2.9	0.5	1.1	0.2	6.6	14.8	0.3	3.0	5.4	4.0	3.2	8.3	3.9	2.9	3.9	3.7	3.3	3.4	3.2	3.5	5.1	58.8	6.4	4.6	0.3	12.5	60.5	17.7	5.5	25.6	6.2	14.3	13.2	3.5	10.0	6.1	7.3	6.2	3.2	10.1	2.5	29.4	8.2	135.0	9.1	21.5	33.3	7.1	4.6	1.7	8.5	4.2	17.5	9.7	26.6	8.2	15.5	37.5	38.1	12.5	3.3	1.4	7.0	16.2	32.4	42.4	25.9	14.6	22.0	30.2	1.0	16.6	2.2	3.1	0.5	0.3	8.9	1.5	16.6	5.3	15.0	6.1	8.4	4.3	5.8	32.9	10.4	35.7	13.8	39.0	13.1	86.2	8.2	10.8	11.2	7.8	11.7
KLF15	KKLF	ENSG00000163884	"Kruppel like factor 15"	Q9UIH9	3	126342635-126357408	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 92.5"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 22.9;Cardiomyocytes: 29.7;Distal tubular cells: 29.4;Hepatocytes: 66.9;Peritubular cells: 19.9;Proximal tubular cells: 22.1"	"Cancer enhanced"	"Detected in many"		"liver cancer: 30.9"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 57.4;HHSteC: 34.8;RPMI-8226: 20.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003286, HPA028866"	Uncertain		Supported	"Nucleoplasm,Nuclear speckles,Vesicles"		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 30: Mammary glandular cells - Lactation"	"Nucleoplasm, Nuclear speckles"	Vesicles	"HPA003286: , HPA028866: AB_10600819"	"unprognostic (3.77e-3)"	"unprognostic (1.08e-1)"	"unprognostic (1.99e-2)"	"unprognostic (1.07e-2)"	"unprognostic (2.72e-3)"	"unprognostic (2.11e-1)"	"unprognostic (4.63e-2)"	"unprognostic (1.09e-2)"	"unprognostic (2.91e-1)"	"unprognostic (1.32e-1)"	"unprognostic (3.58e-2)"	"unprognostic (1.10e-1)"	"prognostic favorable (3.27e-7)"	"unprognostic (6.75e-2)"	"unprognostic (7.65e-2)"	"unprognostic (1.91e-2)"	"unprognostic (5.58e-3)"	36.5	6.2	42.2	0.8	50.7	0.1	25.4	45.1	69.5	15.8	37.5	18.6	1.2	19.1	4.1	7.1	29.7	3.5	31.4	41.7	40.6	20.3	92.5	18.6	1.8	64.9	45.9	46.3	48.5	4.5	10.4	1.7	47.2	17.6	0.9	3.9	19.7	5.2	67.3	10.3	10.2	2.5	44.9	3.6	30.2	5.6	44.7	1.2	11.1	32.4	0.8	27.0	12.0	48.4	0.8	0.0	2.2	9.2	57.4	1.0	10.0	0.6	1.4	0.7	1.3	1.1	0.0	3.4	0.9	0.0	1.7	0.1	5.3	0.1	0.2	0.2	2.0	0.1	0.8	7.9	34.8	0.0	0.2	5.4	0.5	0.0	1.2	0.0	0.6	4.5	4.3	7.4	0.2	0.7	0.0	1.3	6.6	1.3	0.3	4.7	0.2	20.2	0.1	0.8	0.7	7.7	0.1	0.3	10.2	3.3	0.5	4.6	0.3	0.3	0.4	0.3	0.3	4.7	0.6	0.7	0.2	1.5	1.3	25.1	7.6	10.3	7.0	10.2	8.2	12.3	7.3	7.4	8.2	11.4	9.4	11.3	16.7	12.8	9.3	9.0	10.5	11.7	42.2	50.7	45.1	69.5	41.7	40.6	64.9	45.9	47.2	44.9	44.7	48.4	1.5	6.4	4.6	22.9	0.8	0.0	2.9	0.2	0.6	1.3	7.8	1.8	29.7	15.7	0.7	0.0	0.0	0.1	0.1	0.0	29.4	0.1	0.1	2.5	4.4	2.1	0.0	2.7	0.6	0.0	0.2	8.1	3.1	3.4	0.0	13.7	8.2	66.9	0.1	0.0	2.8	0.1	0.0	2.6	0.0	0.8	12.2	0.4	1.8	2.8	0.0	12.0	0.0	15.1	5.7	0.4	0.0	19.9	0.9	5.2	0.0	22.1	0.8	3.3	0.0	12.0	5.5	0.1	0.1	0.3	0.0	0.3	0.5	0.6	0.1	1.8
KLF16	"BTEB4, DRRF, NSLP2"	ENSG00000129911	"Kruppel like factor 16"	Q9BXK1	19	1852399-1863579	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 48.9"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 58.7;Rod photoreceptor cells: 53.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052481	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 56: Bipolar cells - Visual perception"	Nucleoplasm		"HPA052481: AB_2681845"	"unprognostic (3.24e-2)"	"unprognostic (4.66e-2)"	"unprognostic (2.48e-1)"	"unprognostic (3.74e-2)"	"unprognostic (4.12e-2)"	"unprognostic (1.37e-1)"	"unprognostic (9.68e-3)"	"unprognostic (1.46e-1)"	"unprognostic (2.92e-3)"	"unprognostic (7.15e-2)"	"unprognostic (3.23e-2)"	"unprognostic (1.22e-1)"	"prognostic unfavorable (2.93e-5)"	"unprognostic (5.85e-3)"	"unprognostic (2.31e-1)"	"unprognostic (1.98e-1)"	"unprognostic (3.76e-2)"	9.1	8.7	31.8	6.5	48.9	13.0	5.6	0.5	35.7	5.3	0.0	9.6	8.5	8.9	1.7	16.1	7.5	2.9	7.8	34.7	6.9	9.3	14.5	10.3	4.4	6.5	3.4	5.8	6.4	2.8	15.3	3.5	6.9	6.4	2.6	11.9	8.0	2.0	3.0	14.5	9.9	3.0	3.0	15.1	7.1	9.6	12.0	3.3	4.5	0.7	3.1	6.7	6.6	9.4	29.8	15.5	7.7	16.2	4.5	5.4	16.9	22.4	5.0	9.1	8.1	12.5	12.9	22.0	18.8	14.5	8.3	27.1	11.9	20.1	5.7	33.8	20.9	22.9	8.1	15.0	10.2	22.0	37.2	8.1	11.9	15.1	18.7	11.1	8.0	14.3	28.6	16.6	7.7	22.5	20.6	27.3	25.4	19.5	22.1	31.8	7.2	24.3	9.7	10.0	33.7	28.4	7.8	11.9	27.1	7.1	11.2	27.4	19.4	14.8	22.6	34.1	30.8	23.3	29.0	25.2	15.3	18.7	15.9	1.3	1.2	1.3	0.8	1.1	0.9	1.2	0.9	0.5	1.0	1.6	0.8	0.6	2.7	0.1	1.1	5.2	1.3	0.7	31.8	48.9	0.5	35.7	34.7	6.9	6.5	3.4	6.9	3.0	12.0	9.4	13.3	0.0	5.8	2.6	10.7	26.8	12.1	6.6	11.4	58.7	30.9	19.6	2.0	7.2	5.5	3.7	22.9	3.7	24.6	38.8	1.9	6.2	49.2	18.6	9.0	10.6	32.9	8.6	2.8	8.1	2.8	6.3	8.2	19.3	4.5	6.8	10.0	15.4	13.4	15.2	1.8	22.6	4.1	10.7	12.5	37.0	5.0	12.7	12.4	5.6	9.6	12.3	1.0	1.5	1.2	12.8	24.9	3.4	8.2	13.2	19.7	6.1	7.7	53.0	0.0	11.6	8.0	1.6	4.3	17.9	27.1	4.0	13.2	7.0	20.6	13.5
KLF4	"EZF, GKLF"	ENSG00000136826	"Kruppel like factor 4"	O43474	9	107484852-107490482	"Cancer-related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skin 1: 254.7"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 1054.7;Basal squamous epithelial cells: 832.1;Distal enterocytes: 789.2;Intestinal goblet cells: 710.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"intermediate monocyte: 1.0;non-classical monocyte: 1.0"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 39.2;hTCEpi: 84.4;hTERT-HME1: 54.5;OE19: 47.2;U-2197: 111.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002926	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 31: Skin - Epidermis development"	"Cluster 18: U-2197 - ECM organization"	"Cluster 41: Macrophages - Immune response"	Nucleoplasm	Cytosol	"HPA002926: AB_1852541"	"unprognostic (2.06e-1)"	"unprognostic (1.42e-2)"	"unprognostic (1.14e-2)"	"unprognostic (2.45e-1)"	"unprognostic (1.55e-1)"	"unprognostic (6.58e-3)"	"unprognostic (3.44e-2)"	"unprognostic (6.49e-2)"	"unprognostic (3.45e-1)"	"unprognostic (1.29e-2)"	"unprognostic (1.18e-2)"	"unprognostic (1.08e-1)"	"prognostic favorable (3.93e-5)"	"unprognostic (2.55e-1)"	"unprognostic (1.67e-1)"	"unprognostic (8.13e-2)"	"unprognostic (8.32e-2)"	73.5	23.9	5.1	21.0	4.7	50.5	63.7	4.0	7.8	53.2	4.6	87.3	28.4	16.0	5.6	102.1	43.0	44.3	31.0	3.7	5.1	6.2	12.4	44.8	5.6	5.0	4.7	29.0	7.0	5.7	4.9	32.4	5.0	16.7	96.0	0.8	27.5	7.6	14.2	254.7	40.5	40.6	4.1	24.1	58.0	17.8	6.0	17.0	25.2	23.2	14.5	43.9	58.9	4.0	13.3	3.9	0.6	0.1	16.6	39.2	5.2	4.4	27.6	6.7	8.1	1.0	18.0	0.0	0.6	6.9	23.7	8.7	6.1	3.9	3.0	0.0	2.2	0.0	7.5	0.3	21.6	0.0	0.0	5.0	84.4	14.0	54.5	1.5	0.6	0.2	0.6	0.0	4.1	7.3	0.0	1.4	4.1	47.2	25.2	0.3	1.6	0.2	2.3	3.7	0.4	0.2	4.0	11.8	15.2	12.7	1.3	5.4	3.5	3.6	0.1	111.5	2.1	0.2	0.1	0.0	3.4	2.6	6.8	0.0	0.9	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.2	0.0	1.0	0.2	0.0	0.1	5.1	4.7	4.0	7.8	3.7	5.1	5.0	4.7	5.0	4.1	6.0	4.0	1054.7	12.8	41.1	0.3	32.2	436.0	284.3	143.0	832.1	0.5	206.7	205.0	70.3	35.8	71.5	1.8	8.4	49.1	15.0	789.2	1.9	24.4	263.1	154.1	216.0	336.6	123.8	4.8	0.0	38.7	75.5	463.2	537.2	297.4	54.7	4.7	216.0	4.6	89.9	0.0	0.2	710.9	83.4	232.9	282.0	163.0	143.8	401.0	206.3	16.9	36.8	2.0	0.0	0.0	0.0	49.3	540.9	60.5	38.3	187.3	198.0	2.1	46.4	2.0	39.5	463.7	130.0	21.6	15.9	639.9	674.0	107.9	26.8	63.5	332.6	236.8
KLF5	"BTEB2, CKLF, IKLF"	ENSG00000102554	"Kruppel like factor 5"	Q13887	13	73054976-73077541	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 242.0;skin 1: 234.9"	"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 1105.5;Basal squamous epithelial cells: 757.5;Glandular and luminal cells: 678.2;Squamous epithelial cells: 1028.4;Suprabasal keratinocytes: 685.9;Urothelial cells: 1495.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in some"	21	"basophil: 24.0"	"Lineage enriched"	"Detected in single"	140	"granulocytes: 24.0"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 111.8;HaCaT: 128.8;HBEC3-KT: 112.2;hTCEpi: 156.1;OE19: 246.3;RT4: 136.3;SiHa: 114.5"	"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"spinal cord: 23.2"	HPA040398	Approved		Supported	"Nucleoplasm,Golgi apparatus,Vesicles"		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 37: Intestine - Unknown function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 22: Epithelial cell types - Mixed function"	Nucleoplasm	"Golgi apparatus, Vesicles"	"HPA040398: AB_10673267"	"unprognostic (7.90e-3)"	"unprognostic (5.11e-2)"	"unprognostic (2.03e-2)"	"unprognostic (1.56e-1)"	"unprognostic (4.69e-2)"	"unprognostic (2.75e-1)"	"unprognostic (1.18e-1)"	"unprognostic (3.97e-2)"	"unprognostic (5.82e-1)"	"unprognostic (1.47e-2)"	"prognostic unfavorable (2.55e-4)"	"unprognostic (4.43e-2)"	"unprognostic (1.42e-3)"	"unprognostic (3.56e-3)"	"unprognostic (3.98e-1)"	"unprognostic (5.09e-2)"	"unprognostic (1.54e-2)"	6.5	5.9	4.2	18.0	9.1	63.5	36.2	0.6	3.3	49.9	2.7	161.2	130.4	6.7	6.6	242.0	37.5	55.9	3.3	2.6	3.4	8.5	4.7	29.6	2.0	0.8	3.4	4.5	11.9	0.5	10.9	18.8	0.7	23.1	145.4	0.4	79.8	14.4	19.2	234.9	146.2	6.6	0.5	1.5	82.2	12.0	4.1	12.0	25.7	7.8	53.6	111.5	122.2	1.0	22.3	31.1	0.2	0.4	1.1	1.5	34.1	12.9	29.8	5.6	6.9	28.5	111.8	0.4	68.9	11.4	2.3	128.8	39.0	112.2	8.9	0.9	11.0	0.4	61.9	2.8	7.8	10.5	1.9	8.1	156.1	1.7	61.1	5.7	0.1	3.8	1.6	2.2	25.5	7.9	2.1	0.8	1.4	246.3	43.3	2.0	28.3	2.5	87.3	136.3	2.9	1.3	114.5	18.3	8.5	13.9	2.5	2.5	0.3	7.8	23.1	0.2	5.4	3.7	1.9	3.8	10.8	2.1	9.5	24.0	0.0	1.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.1	0.1	4.2	9.1	0.6	3.3	2.6	3.4	0.8	3.4	0.7	0.5	4.1	1.0	7.8	163.5	123.3	0.7	5.2	518.9	1105.5	185.6	757.5	0.4	79.9	57.0	6.0	91.5	218.5	36.8	2.1	77.8	4.6	420.7	21.5	31.8	448.3	302.1	44.1	12.5	203.2	0.4	1.6	46.1	98.5	33.4	425.1	678.2	3.8	0.9	2.2	4.7	6.1	10.1	11.6	387.4	46.8	0.9	34.6	241.4	6.5	12.4	58.7	1.9	4.3	0.0	1.0	1.0	0.6	88.6	374.9	1.5	15.7	632.1	260.0	3.5	159.3	0.2	0.0	38.4	32.4	8.8	26.3	1028.4	685.9	58.0	17.4	0.5	505.4	1495.5
KLF6	"BCD1, COPEB, CPBP, GBF, PAC1, ST12, Zf9"	ENSG00000067082	"Kruppel like factor 6"	Q99612	10	3775996-3785281	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 436.6"	"Cell type enhanced"	"Detected in all"		"Squamous epithelial cells: 2075.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013529, HPA069585"	Supported		Supported	Nucleoplasm,Nucleoli,Vesicles,Cytosol		No	No			"Cluster 1: Neutrophils - Mixed function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm	"Nucleoli, Vesicles, Cytosol"	"CAB013529: AB_2533431, HPA069585: AB_2686157"	"unprognostic (1.23e-1)"	"unprognostic (1.53e-2)"	"unprognostic (1.47e-3)"	"unprognostic (4.53e-2)"	"unprognostic (1.47e-1)"	"unprognostic (7.55e-2)"	"unprognostic (2.00e-1)"	"unprognostic (1.08e-3)"	"unprognostic (1.61e-1)"	"unprognostic (2.83e-2)"	"unprognostic (1.36e-2)"	"unprognostic (2.35e-2)"	"prognostic favorable (2.28e-4)"	"unprognostic (8.07e-3)"	"unprognostic (4.85e-2)"	"unprognostic (6.87e-2)"	"unprognostic (1.37e-2)"	211.3	46.9	19.0	122.1	18.0	436.6	129.7	19.2	22.4	95.4	21.9	92.1	55.4	98.1	17.7	165.5	77.2	181.9	49.7	18.0	19.2	64.1	141.8	117.0	65.4	29.4	20.1	47.3	118.3	31.8	12.0	98.2	25.2	32.8	99.6	18.4	73.8	33.7	84.9	197.1	106.0	208.2	22.7	64.3	73.2	14.6	23.0	56.8	193.9	41.3	45.0	136.3	92.7	25.0	55.0	14.7	27.2	9.0	155.1	154.3	17.1	91.7	46.5	95.9	64.8	38.0	71.4	15.6	20.8	100.0	74.5	32.7	17.0	84.9	79.5	76.6	10.2	2.2	17.5	35.8	66.4	10.3	51.5	51.4	158.2	68.6	129.3	34.2	99.3	10.1	17.5	117.9	123.6	4.0	19.4	15.9	10.2	29.2	26.0	12.6	28.2	55.5	94.1	53.4	12.0	11.5	22.5	64.0	142.8	73.5	32.0	8.6	130.9	128.7	17.8	76.9	43.0	22.6	78.1	28.6	34.7	13.7	40.8	318.8	85.2	234.1	129.8	74.2	115.9	81.1	147.4	131.5	67.6	70.9	44.9	69.0	391.6	72.5	104.6	152.8	120.6	148.7	19.0	18.0	19.2	22.4	18.0	19.2	29.4	20.1	25.2	22.7	23.0	25.0	511.0	1246.8	489.4	14.0	716.9	585.5	1298.4	625.8	1227.0	39.6	985.9	630.0	63.6	544.7	451.9	138.0	33.3	163.1	518.3	1507.0	21.5	808.6	58.0	1065.6	618.9	469.9	397.3	77.9	18.5	553.0	473.8	545.5	1120.3	1905.9	626.7	195.9	248.4	309.9	583.6	37.0	10.0	746.7	429.3	968.7	885.1	53.2	130.5	992.1	483.8	58.1	609.8	42.9	150.4	7.5	4.3	857.9	949.9	133.9	1172.5	600.2	1009.9	97.4	342.0	90.1	138.1	194.8	441.8	9.0	19.4	2075.6	628.2	195.9	920.5	67.1	542.0	572.5
KLF7	UKLF	ENSG00000118263	"Kruppel like factor 7"	O75840	2	207074137-207167267	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 95.2;Oligodendrocytes: 160.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 46.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003423, HPA030490"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 41: Macrophages - Immune response"	Nucleoplasm	Cytosol	"HPA003423: , HPA030490: AB_10601922"	"unprognostic (5.93e-2)"	"unprognostic (2.49e-3)"	"unprognostic (2.98e-1)"	"unprognostic (3.99e-3)"	"unprognostic (2.56e-1)"	"unprognostic (2.85e-3)"	"unprognostic (5.44e-2)"	"unprognostic (1.24e-2)"	"unprognostic (6.75e-2)"	"unprognostic (8.78e-2)"	"unprognostic (3.67e-2)"	"unprognostic (1.47e-1)"	"prognostic favorable (4.26e-4)"	"unprognostic (3.27e-3)"	"unprognostic (1.23e-1)"	"unprognostic (1.73e-1)"	"unprognostic (3.47e-2)"	19.9	8.2	8.2	13.8	15.0	40.3	15.0	19.3	9.1	8.9	0.0	11.4	4.6	16.9	5.9	9.7	10.0	11.8	10.1	8.3	13.4	7.9	7.1	15.2	7.7	20.2	17.0	14.2	5.1	3.0	4.9	5.8	20.9	8.2	5.3	4.7	7.4	7.4	4.9	6.8	10.3	20.9	12.1	10.3	9.1	6.8	17.4	14.3	8.8	7.4	7.3	9.8	9.8	20.3	8.8	6.1	16.3	1.1	5.6	14.4	3.4	10.0	8.0	15.3	6.7	0.1	7.1	0.1	6.3	20.6	26.5	21.5	13.9	46.2	8.2	6.0	0.8	0.2	18.5	3.5	9.7	4.6	6.7	19.3	15.3	10.7	35.0	22.0	18.1	4.6	0.0	8.2	11.8	0.2	5.6	1.7	9.7	0.9	3.0	2.4	4.3	6.4	3.7	6.8	25.0	30.5	8.6	12.0	7.8	13.0	2.0	6.9	35.9	30.3	14.5	12.9	12.0	6.2	4.5	0.0	26.7	3.8	6.1	28.9	9.4	12.3	1.6	12.1	0.6	5.7	8.4	1.6	5.3	7.7	14.3	9.9	40.8	22.9	22.7	2.4	7.7	6.1	8.2	15.0	19.3	9.1	8.3	13.4	20.2	17.0	20.9	12.1	17.4	20.3	95.2	41.7	6.7	74.4	15.8	21.9	23.1	35.0	6.2	9.0	9.9	11.4	17.6	14.3	15.1	9.2	12.5	0.5	6.9	0.4	1.9	22.7	10.2	13.9	33.7	65.8	6.0	2.5	46.4	51.5	0.8	22.0	11.7	17.3	12.0	3.6	79.9	14.7	15.6	11.8	31.1	2.6	34.6	50.0	22.9	5.2	13.7	37.6	3.6	61.8	28.3	7.1	8.2	68.9	160.5	79.9	1.4	10.1	4.3	9.2	14.1	4.3	9.8	8.7	46.0	38.6	42.0	0.8	14.8	8.1	15.3	1.1	7.6	7.9	4.3	9.3
KLF8	"BKLF3, DXS741, ZNF741"	ENSG00000102349	"Kruppel like factor 8"	O95600	X	56232356-56291531	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skin 1: 29.4"	"Cell type enhanced"	"Detected in many"		"Leydig cells: 37.6;Peritubular cells: 27.4;Squamous epithelial cells: 27.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HEK 293: 3.7;hTCEpi: 7.8;RPTEC TERT1: 3.9;RT4: 5.0;SK-BR-3: 5.4;T-47d: 9.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA071740			Supported	Nucleoplasm		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 6: T47d - Mammary gland"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Nucleoplasm		"HPA071740: AB_2686440"	"unprognostic (2.32e-1)"	"unprognostic (1.56e-1)"	"unprognostic (3.60e-2)"	"unprognostic (1.50e-8)"	"unprognostic (2.96e-1)"	"prognostic favorable (3.32e-4)"	"unprognostic (6.56e-2)"	"unprognostic (6.93e-2)"	"unprognostic (1.05e-1)"	"unprognostic (6.13e-2)"	"unprognostic (3.15e-1)"	"unprognostic (6.83e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.62e-3)"	"unprognostic (3.15e-1)"	"unprognostic (7.68e-2)"	"unprognostic (2.60e-2)"	14.7	2.1	1.1	1.3	1.7	0.6	13.9	1.5	1.4	11.7	0.6	6.4	0.5	10.0	3.7	23.5	9.5	1.7	4.9	1.3	0.8	7.4	0.7	6.1	1.6	0.5	0.6	9.8	2.0	1.1	2.0	3.9	0.6	4.8	1.8	0.6	9.9	2.0	3.8	29.4	5.8	4.9	0.6	5.2	3.7	3.1	0.8	1.2	6.1	1.8	3.0	7.5	17.8	0.9	1.3	0.0	0.0	0.1	1.1	0.4	0.7	0.2	1.5	0.0	0.0	0.0	0.0	0.4	1.9	0.1	0.0	2.9	0.0	0.0	0.0	2.0	3.7	1.0	0.0	0.0	0.1	0.1	0.3	0.0	7.8	0.0	0.6	0.0	0.0	0.3	0.9	0.6	0.2	0.1	0.3	0.1	1.0	0.0	0.0	0.2	0.0	0.2	3.9	5.0	0.0	0.0	2.4	5.4	0.0	3.3	9.5	0.2	0.0	0.0	0.2	0.0	0.0	0.2	0.1	0.4	0.1	0.0	0.0	0.2	0.1	0.1	0.1	0.0	0.2	1.2	0.3	0.4	0.6	1.2	0.1	0.0	0.2	1.5	0.0	0.2	0.1	0.1	1.1	1.7	1.5	1.4	1.3	0.8	0.5	0.6	0.6	0.6	0.8	0.9	12.1	0.0	4.1	2.3	11.2	6.9	4.5	3.6	6.2	0.4	8.0	4.1	3.5	0.0	2.2	14.7	2.1	6.3	1.3	1.0	0.0	0.8	0.6	1.9	4.1	11.1	0.0	4.8	14.0	1.0	15.0	6.2	0.0	5.6	1.3	3.5	21.4	0.0	1.2	0.0	5.4	0.7	2.0	1.3	13.9	2.0	37.6	3.2	5.4	8.4	2.1	0.5	5.2	2.5	3.6	0.4	0.3	27.4	5.6	7.5	0.4	7.5	1.5	0.1	19.7	5.2	8.1	0.9	1.1	27.0	11.6	4.5	2.2	3.1	1.2	10.9
KLF9	BTEB1	ENSG00000119138	"Kruppel like factor 9"	Q13886	9	70384597-70414624	"Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 264.3;Skeletal myocytes: 223.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 60.4;ASC TERT1: 83.0;HHSteC: 107.4;HSkMC: 71.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029308			Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 52: Non-specific - Ribosome"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	Nucleoplasm	"Plasma membrane, Cytosol"	"HPA029308: AB_10601923"	"unprognostic (2.12e-2)"	"unprognostic (2.56e-1)"	"unprognostic (3.12e-1)"	"unprognostic (2.69e-2)"	"unprognostic (5.86e-2)"	"unprognostic (1.37e-1)"	"unprognostic (3.64e-3)"	"unprognostic (4.34e-1)"	"unprognostic (5.55e-1)"	"unprognostic (9.47e-2)"	"unprognostic (7.86e-2)"	"unprognostic (3.44e-1)"	"prognostic favorable (6.59e-6)"	"unprognostic (1.43e-3)"	"unprognostic (1.75e-1)"	"unprognostic (3.17e-2)"	"unprognostic (1.02e-2)"	82.0	36.5	12.5	22.8	22.1	18.2	67.6	29.8	22.5	29.9	14.9	66.5	15.3	56.5	16.7	41.1	73.0	42.6	54.7	15.7	14.4	54.9	91.3	71.6	14.4	21.3	21.1	63.4	52.9	51.1	25.5	10.2	17.3	36.5	26.2	19.2	35.4	24.4	123.3	40.8	33.2	58.9	15.6	22.9	48.9	7.7	21.7	12.1	57.1	94.7	14.3	43.4	37.2	19.1	0.4	0.6	0.0	7.8	60.4	83.0	0.8	4.1	27.1	1.4	3.0	0.1	3.6	0.1	3.0	7.5	2.0	0.1	11.9	18.4	2.8	0.0	9.3	4.2	13.1	2.4	107.4	2.1	10.9	71.6	18.4	1.1	25.9	37.1	23.9	1.8	8.4	16.4	10.2	1.3	0.3	6.2	0.7	1.2	3.9	0.0	3.7	10.9	5.0	0.0	1.0	5.2	37.3	21.5	45.2	2.5	7.1	6.7	32.8	7.1	5.1	8.2	2.2	11.8	13.5	0.6	6.4	6.6	35.9	0.7	0.1	0.1	0.4	0.1	0.6	0.9	0.5	0.4	0.3	0.6	0.7	0.4	0.0	0.1	0.2	0.4	0.6	0.1	12.5	22.1	29.8	22.5	15.7	14.4	21.3	21.1	17.3	15.6	21.7	19.1	264.3	41.7	25.5	25.8	36.5	48.2	62.7	13.0	97.3	45.3	48.3	34.7	74.1	64.3	22.3	14.7	20.9	0.2	51.0	36.7	31.3	10.5	22.3	40.6	171.6	124.3	13.8	14.5	32.1	13.1	0.5	180.8	55.5	59.6	7.6	2.0	109.9	158.8	3.7	80.8	13.7	32.3	14.2	70.1	44.6	18.1	90.7	81.3	39.2	29.0	9.7	126.1	19.6	3.0	11.1	12.8	26.1	85.0	30.2	74.0	54.5	39.7	17.4	10.1	78.9	223.8	203.5	2.1	3.2	72.7	34.2	0.0	54.9	16.3	31.9	33.3
KLHDC1	MST025	ENSG00000197776	"Kelch domain containing 1"	Q8N7A1	14	49693105-49753150	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 46.4;Excitatory neurons: 41.7;Inhibitory neurons: 51.1;Microglial cells: 49.6;Oligodendrocyte precursor cells: 45.2;Oligodendrocytes: 90.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"ASC diff: 5.7;ASC TERT1: 5.3;HSkMC: 4.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020461	Approved		Supported	Cytosol		No	No			"Cluster 29: Plasmacytoid DCs - Unknown function"	"Cluster 21: Non-specific - Transcription"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Cytosol		"HPA020461: AB_1852556"	"unprognostic (2.97e-2)"	"unprognostic (6.30e-2)"	"unprognostic (8.49e-3)"	"unprognostic (1.26e-2)"	"unprognostic (5.46e-2)"	"unprognostic (1.32e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.95e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.53e-1)"	"prognostic favorable (1.94e-4)"	"unprognostic (3.42e-1)"	"unprognostic (5.61e-2)"	"unprognostic (3.14e-2)"	"unprognostic (1.13e-1)"	"unprognostic (8.45e-2)"	"unprognostic (2.24e-1)"	5.2	4.2	3.3	2.3	5.1	1.4	4.8	4.5	6.0	6.2	1.5	5.5	1.9	6.0	5.7	2.2	5.8	3.1	4.6	2.8	5.4	3.1	3.5	3.1	3.6	5.0	4.2	9.3	3.8	4.1	6.2	2.6	4.3	4.6	2.3	6.0	3.3	4.3	7.2	5.1	3.8	3.5	3.1	3.8	3.9	4.8	4.0	1.9	5.6	4.7	2.6	4.4	4.8	7.4	0.7	0.3	0.6	0.3	5.7	5.3	0.0	1.5	2.1	0.5	0.3	0.0	1.8	0.3	0.3	0.6	0.5	0.5	0.1	0.0	0.4	1.5	0.5	0.2	0.1	0.0	2.9	0.1	0.7	4.5	0.2	0.2	0.2	2.9	1.2	1.0	0.3	0.0	2.2	0.2	0.4	0.8	0.0	0.2	0.2	0.4	0.5	0.0	1.1	0.2	0.2	1.5	0.2	0.0	0.6	0.7	0.6	1.2	1.7	1.3	1.4	0.5	0.1	0.5	0.0	0.4	1.2	0.2	0.7	0.5	0.4	1.0	0.7	0.8	1.4	1.2	1.0	0.9	0.4	0.8	1.7	1.4	0.0	0.6	0.4	1.4	0.3	0.7	3.3	5.1	4.5	6.0	2.8	5.4	5.0	4.2	4.3	3.1	4.0	7.4	7.6	22.4	6.5	46.4	6.1	3.6	3.4	1.5	4.0	10.4	3.3	2.3	10.1	5.7	5.7	0.0	4.2	1.5	2.7	1.7	9.8	0.8	2.1	3.5	5.4	5.7	1.8	5.2	41.7	0.8	0.8	7.3	2.6	1.9	1.3	4.5	4.6	3.2	2.6	13.5	51.1	2.4	2.0	2.2	3.3	3.3	18.0	2.9	5.4	49.6	2.2	15.0	4.1	45.2	90.5	0.4	2.7	10.1	2.9	1.6	4.2	2.5	3.1	15.8	0.0	9.5	6.1	17.9	7.6	1.3	3.3	0.3	3.7	4.2	1.2	1.8
KLHDC2	"HCLP-1, LCP"	ENSG00000165516	"Kelch domain containing 2"	Q9Y2U9	14	49768130-49786385	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000628	Approved		Supported	"Nucleoplasm,Nuclear membrane,Nuclear bodies"		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 10: Non-specific - Unknown function"	"Nucleoplasm, Nuclear membrane"	"Nuclear bodies"	"HPA000628: AB_2666051"	"unprognostic (2.65e-1)"	"unprognostic (8.29e-2)"	"unprognostic (1.30e-2)"	"unprognostic (9.01e-2)"	"unprognostic (2.57e-2)"	"unprognostic (5.52e-3)"	"unprognostic (4.54e-2)"	"unprognostic (9.72e-3)"	"unprognostic (7.43e-2)"	"unprognostic (1.24e-1)"	"unprognostic (4.81e-3)"	"unprognostic (6.77e-3)"	"prognostic favorable (2.75e-10)"	"unprognostic (2.20e-2)"	"unprognostic (2.08e-1)"	"unprognostic (1.32e-2)"	"unprognostic (9.34e-2)"	21.5	22.3	12.8	8.6	13.3	10.1	19.6	13.7	16.1	18.8	15.0	23.8	18.4	20.7	14.8	15.0	17.0	13.8	38.0	14.4	14.0	34.1	49.1	14.5	10.9	12.4	12.3	25.1	30.3	16.8	17.7	12.7	13.9	18.5	18.0	23.9	20.1	20.1	53.0	18.8	21.6	14.1	13.3	12.3	24.4	23.3	12.6	15.2	28.2	38.2	10.5	22.3	16.2	14.9	14.7	12.2	22.5	11.0	31.7	27.5	23.7	15.0	28.8	18.8	19.0	7.1	19.6	29.1	20.4	27.4	10.8	12.8	13.9	13.9	15.9	20.1	14.7	9.1	8.6	17.0	23.1	19.6	7.8	28.6	23.5	8.6	16.9	23.1	17.4	24.6	11.8	21.5	15.1	17.3	20.1	8.6	16.6	17.0	34.8	15.3	24.0	18.1	8.6	31.2	27.4	22.0	25.1	46.4	17.1	17.2	17.8	7.4	14.9	17.2	13.3	13.7	7.8	29.0	19.7	17.1	9.7	10.0	9.2	12.3	9.1	19.9	11.1	6.1	13.8	18.2	16.8	17.4	9.0	19.0	23.5	15.8	8.4	16.8	5.8	6.8	18.0	12.3	12.8	13.3	13.7	16.1	14.4	14.0	12.4	12.3	13.9	13.3	12.6	14.9	40.6	41.7	52.4	30.3	42.1	48.9	53.5	64.8	53.5	65.1	48.6	40.9	9.3	77.2	53.9	47.8	50.1	102.5	40.7	68.9	107.6	59.8	96.8	44.8	41.9	36.4	57.2	47.8	30.6	85.8	68.6	51.2	67.2	38.7	30.4	62.8	45.3	91.8	33.2	65.6	35.4	75.3	63.1	28.7	33.6	27.1	81.4	26.5	39.2	18.7	36.3	73.9	54.6	28.1	33.1	54.8	78.9	77.5	74.5	53.9	143.9	170.1	27.8	98.1	65.7	46.3	90.5	238.7	93.2	42.7	66.3	82.4	44.9	54.7	78.9	55.5
KLHL12	C3IP1	ENSG00000117153	"Kelch like family member 12"	Q53G59	1	202891116-202928636	"Predicted intracellular proteins"	"ER-Golgi transport, Transport, Ubl conjugation pathway, Wnt signaling pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 140.7;Late spermatids: 88.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA071324			Supported	"Vesicles,Centriolar satellite"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	"Vesicles, Centriolar satellite"		"HPA071324: AB_2686389"	"unprognostic (1.69e-2)"	"unprognostic (2.84e-1)"	"unprognostic (2.95e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.93e-1)"	"unprognostic (4.86e-2)"	"unprognostic (2.54e-3)"	"unprognostic (3.35e-2)"	"unprognostic (1.15e-2)"	"unprognostic (9.11e-2)"	"unprognostic (3.44e-1)"	"unprognostic (1.58e-1)"	"unprognostic (2.20e-3)"	"unprognostic (6.22e-2)"	"unprognostic (6.01e-2)"	"unprognostic (3.32e-1)"	"unprognostic (4.87e-2)"	13.3	15.8	26.4	14.6	26.8	18.8	17.3	24.7	27.8	13.8	23.9	19.4	14.5	14.9	22.7	15.8	18.4	12.3	20.4	27.5	29.8	21.8	16.2	15.0	19.0	24.6	26.5	17.7	16.3	21.2	15.2	15.6	27.6	19.3	23.4	24.6	13.7	13.6	14.3	13.5	14.8	17.3	24.6	17.1	16.0	44.8	28.5	20.4	19.8	18.3	22.4	14.2	13.1	26.4	20.4	24.5	30.2	34.3	46.2	34.2	35.6	24.1	28.0	29.7	27.0	23.3	33.0	57.8	18.5	27.7	29.8	25.8	40.5	33.8	32.3	29.9	17.6	20.1	19.5	23.6	33.4	42.3	31.7	33.0	43.0	25.7	56.1	23.5	26.8	56.9	51.5	36.7	41.3	28.0	35.6	20.4	43.4	25.8	18.3	36.5	52.8	37.0	26.1	25.7	22.5	25.8	29.9	27.6	33.2	54.7	49.2	29.4	22.0	29.0	20.2	7.1	21.7	26.4	22.5	48.0	28.6	29.9	28.3	7.5	10.1	15.6	6.9	12.3	10.2	7.1	6.9	8.3	10.5	6.7	7.3	7.9	10.1	8.3	13.2	6.1	11.1	9.2	26.4	26.8	24.7	27.8	27.5	29.8	24.6	26.5	27.6	24.6	28.5	26.4	7.0	6.4	11.5	12.7	13.3	5.4	9.4	8.9	6.2	11.2	8.5	5.7	16.6	12.8	9.2	16.5	12.5	11.9	9.3	17.6	23.5	12.1	140.7	8.6	7.8	7.8	10.8	15.8	14.9	8.9	12.1	9.3	5.6	7.4	3.8	15.0	8.6	7.8	17.2	5.0	19.3	13.2	6.1	15.9	5.6	88.1	8.4	12.9	5.4	14.0	16.8	11.3	10.3	11.1	18.6	11.4	10.1	8.2	9.3	8.7	11.6	15.9	8.2	10.2	6.6	6.9	7.6	26.0	44.9	9.2	6.7	11.1	11.5	9.5	12.5	7.2
KLHL14	KIAA1384	ENSG00000197705	"Kelch like family member 14"	Q9P2G3	18	32672673-32773023	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"seminal vesicle: 12.7;thyroid gland: 13.8"	"Cell type enhanced"	"Detected in some"		"B-cells: 21.9;Inhibitory neurons: 9.8;Muller glia cells: 19.4;Plasma cells: 45.7"	"Group enriched"	"Detected in many"	10	"endometrial cancer: 6.8;ovarian cancer: 15.5;thyroid cancer: 7.0"	"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in some"	90	"memory B-cell: 10.5;naive B-cell: 7.3"	"Lineage enriched"	"Detected in single"	106	"B-cells: 10.5"	"Cell line enhanced"	"Detected in some"		"EFO-21: 3.1;Hep G2: 15.7;REH: 4.2;RPTEC TERT1: 8.4;SCLC-21H: 3.2;U-698: 4.5"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	9	"hippocampal formation: 14.9;olfactory bulb: 8.1"	HPA024777	Uncertain		Supported	"Actin filaments,Cytosol"		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 55: Plasma cells - Humoral immune response"	Cytosol	"Actin filaments"	"HPA024777: AB_1852576"	"unprognostic (3.93e-2)"	"unprognostic (7.87e-2)"	"unprognostic (7.09e-2)"	"unprognostic (5.61e-3)"	"unprognostic (1.87e-1)"	"unprognostic (2.16e-6)"	"unprognostic (2.14e-1)"	"unprognostic (4.30e-2)"	"unprognostic (4.81e-2)"	"unprognostic (2.32e-3)"	"unprognostic (2.32e-1)"	"unprognostic (7.64e-2)"	"unprognostic (8.91e-2)"	"unprognostic (8.03e-2)"	"unprognostic (1.97e-1)"	"unprognostic (2.65e-2)"	"unprognostic (1.43e-2)"	0.5	0.2	0.2	1.8	0.3	2.4	0.5	0.0	0.6	2.9	0.0	0.2	0.2	1.7	1.0	0.2	6.6	0.3	0.1	0.2	0.3	5.0	0.0	0.3	7.1	1.4	2.3	0.3	0.0	6.9	0.3	0.8	0.7	1.4	0.2	4.7	0.4	12.7	0.0	0.1	2.0	0.8	0.8	8.7	0.2	1.0	0.2	0.3	13.8	0.0	5.3	0.6	0.5	0.1	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	3.1	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.3	0.1	0.0	15.7	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	4.2	1.3	0.0	8.4	0.0	3.2	0.4	0.0	0.0	0.7	0.8	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	4.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.5	0.0	0.0	0.0	7.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.3	0.0	0.6	0.2	0.3	1.4	2.3	0.7	0.8	0.2	0.1	1.3	0.0	0.0	0.3	21.9	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.0	7.3	0.0	0.0	0.1	0.0	3.9	0.0	4.5	7.1	0.3	2.0	0.0	0.0	1.6	0.0	0.0	0.0	0.5	1.3	0.0	0.0	0.7	0.0	0.1	1.7	9.8	0.0	0.0	0.6	0.0	1.1	0.0	0.2	0.0	0.0	0.0	19.4	0.0	1.5	0.2	0.0	0.0	0.0	45.7	0.0	0.5	1.1	0.0	0.8	0.0	0.0	0.1	0.7	0.6	0.0	0.3	0.0	0.2	4.7	0.1	0.0
KLHL20	"KHLHX, KLEIP"	ENSG00000076321	"Kelch like family member 20"	Q9Y2M5	1	173714941-173786692	"Predicted intracellular proteins"	"Protein transport, Transport, Ubl conjugation pathway"	Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 132.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA025034, HPA053704"	Approved		Supported	"Golgi apparatus,Cytosol"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 29: Early spermatids - Spermatogenesis"	"Golgi apparatus, Cytosol"		"HPA025034: AB_1852578, HPA053704: AB_2682234"	"unprognostic (2.97e-3)"	"unprognostic (3.11e-2)"	"unprognostic (8.27e-2)"	"unprognostic (6.48e-3)"	"unprognostic (1.56e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.51e-1)"	"unprognostic (3.55e-2)"	"unprognostic (1.84e-2)"	"unprognostic (2.14e-2)"	"unprognostic (5.22e-2)"	"unprognostic (1.03e-1)"	"unprognostic (3.51e-2)"	"unprognostic (8.66e-2)"	"unprognostic (3.02e-1)"	"unprognostic (1.90e-1)"	"unprognostic (2.62e-2)"	13.8	10.2	5.8	7.6	7.1	5.9	8.7	7.3	6.7	11.8	4.7	9.7	6.7	13.6	6.9	9.8	8.1	9.3	10.8	6.5	6.3	10.8	16.2	10.0	9.7	7.4	6.7	12.0	6.0	7.9	5.3	11.4	7.1	13.1	8.9	9.0	6.1	9.3	12.5	9.5	7.8	13.4	6.9	10.3	7.5	15.9	6.5	12.3	8.4	13.9	9.1	10.0	8.2	6.9	12.8	8.0	12.5	13.1	28.7	26.4	10.2	19.7	19.2	14.9	15.6	5.8	8.7	9.0	16.4	21.3	7.9	12.5	11.2	14.2	17.4	11.0	6.0	8.2	10.8	6.9	18.4	15.5	9.3	22.6	16.1	13.8	18.4	17.3	22.2	9.0	18.5	10.0	27.6	4.7	9.1	8.0	13.3	11.3	36.1	9.7	15.4	9.8	11.4	8.1	5.3	14.7	18.0	12.1	12.3	16.9	10.8	18.0	22.2	14.3	8.6	17.6	15.7	13.3	7.4	13.5	9.4	11.0	16.2	7.0	2.9	4.3	4.5	3.2	4.0	3.6	4.4	5.5	2.8	3.5	5.6	5.7	1.6	3.2	2.4	4.6	5.6	2.3	5.8	7.1	7.3	6.7	6.5	6.3	7.4	6.7	7.1	6.9	6.5	6.9	21.8	16.0	25.9	36.2	17.3	11.1	8.1	13.5	8.0	13.3	8.0	8.0	12.8	17.2	12.8	12.9	37.5	13.1	18.1	13.5	1.9	9.9	132.4	4.4	14.0	23.4	9.6	11.1	28.1	12.1	10.1	18.2	16.3	5.6	7.6	14.9	42.1	21.0	11.2	11.8	37.3	9.1	10.2	18.5	9.1	30.2	22.4	10.0	3.6	18.7	9.4	16.4	20.6	33.7	35.2	11.4	8.9	28.6	12.3	8.8	16.3	14.1	8.2	20.7	0.0	20.9	16.4	55.8	35.6	11.3	10.5	9.9	16.9	24.1	9.7	7.8
KLHL21	KIAA0469	ENSG00000162413	"Kelch like family member 21"	Q9UJP4	1	6590724-6614607	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 169.9"	"Cell type enhanced"	"Detected in many"		"Squamous epithelial cells: 104.8;Suprabasal keratinocytes: 72.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"eosinophil: 21.4;neutrophil: 63.0"	"Lineage enriched"	"Detected in all"	8	"granulocytes: 63.0"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051364, HPA059307"	Uncertain		Supported	Centrosome		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 18: U-2197 - ECM organization"	"Cluster 61: Squamous epithelial cells - Keratinization"	Centrosome		"HPA051364: AB_2681455, HPA059307: "	"unprognostic (6.13e-3)"	"unprognostic (5.26e-2)"	"unprognostic (2.30e-2)"	"unprognostic (9.09e-2)"	"unprognostic (4.04e-2)"	"unprognostic (2.39e-2)"	"unprognostic (5.77e-3)"	"unprognostic (2.28e-1)"	"unprognostic (8.52e-2)"	"unprognostic (4.85e-2)"	"unprognostic (4.02e-1)"	"unprognostic (6.33e-3)"	"prognostic favorable (1.71e-4)"	"unprognostic (1.11e-1)"	"unprognostic (3.43e-1)"	"unprognostic (9.74e-2)"	"unprognostic (4.19e-2)"	30.5	29.5	31.3	12.6	37.3	25.5	24.6	33.6	35.9	27.2	73.1	44.7	6.9	35.3	8.7	36.4	24.2	14.4	53.3	32.1	31.5	28.2	22.2	16.4	9.2	41.0	44.0	28.6	33.3	21.5	30.1	6.9	37.4	31.7	5.0	7.6	33.3	28.3	169.9	37.0	15.9	16.4	30.7	17.2	30.0	15.2	35.5	9.7	18.7	101.3	7.6	46.5	25.0	44.3	25.8	15.1	7.5	24.3	41.5	25.8	19.5	35.5	28.1	23.0	13.7	44.1	16.1	0.9	30.8	21.9	20.7	41.7	16.6	39.2	12.8	54.8	26.8	29.7	27.8	40.3	34.4	17.8	17.5	28.9	13.0	52.3	17.6	21.6	9.9	14.8	33.3	23.1	19.0	8.9	18.4	15.7	13.8	13.1	55.5	28.0	31.3	32.3	13.5	7.8	30.2	7.5	27.8	22.0	62.8	6.5	14.5	21.0	33.3	74.4	9.1	68.9	86.1	26.2	35.2	18.0	72.2	33.1	28.4	8.4	6.2	21.4	7.1	2.6	6.2	4.5	6.6	7.0	3.8	2.6	5.3	5.3	63.0	2.9	2.3	3.4	8.2	6.1	31.3	37.3	33.6	35.9	32.1	31.5	41.0	44.0	37.4	30.7	35.5	44.3	11.6	3.2	5.1	19.6	8.9	71.2	46.9	22.3	63.2	4.1	47.1	44.4	68.3	7.2	10.7	9.2	4.2	5.1	15.6	10.1	7.9	12.0	2.7	19.6	14.9	15.6	3.0	2.1	8.2	12.9	7.0	24.7	31.1	35.3	0.0	6.4	7.1	23.6	5.6	5.0	8.9	5.6	14.2	10.4	30.1	7.6	10.8	17.1	26.6	8.4	7.6	12.2	4.1	6.6	14.1	20.0	7.3	15.1	12.6	43.1	5.3	7.6	14.0	5.9	13.1	32.2	25.2	2.0	10.9	104.8	72.0	6.4	15.3	9.2	5.5	31.3
KLHL22	"FLJ14360, KELCHL"	ENSG00000099910	"Kelch like family member 22"	Q53GT1	22	20441519-20495844	"Disease related genes, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, Ubl conjugation pathway"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 41.1;Excitatory neurons: 42.9;Inhibitory neurons: 51.1;Oligodendrocyte precursor cells: 41.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							HPA040766			Supported	"Vesicles,Microtubules,Cytokinetic bridge,Mitotic spindle"		Yes	No			"Cluster 2: Granulocytes - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 12: NES - Nervous system development"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Vesicles, Microtubules, Cytokinetic bridge, Mitotic spindle"		"HPA040766: AB_2732488"	"unprognostic (4.15e-1)"	"unprognostic (9.34e-3)"	"unprognostic (5.37e-2)"	"prognostic favorable (4.88e-6)"	"unprognostic (1.17e-1)"	"unprognostic (2.30e-3)"	"unprognostic (1.00e-2)"	"unprognostic (1.19e-3)"	"unprognostic (2.20e-1)"	"unprognostic (8.99e-2)"	"prognostic favorable (3.85e-6)"	"unprognostic (3.94e-2)"	"prognostic favorable (1.34e-8)"	"unprognostic (3.94e-2)"	"unprognostic (3.10e-1)"	"unprognostic (4.64e-2)"	"unprognostic (1.08e-2)"	13.7	14.2	24.1	10.2	23.0	11.3	11.9	25.9	25.1	20.5	18.2	16.6	7.7	20.4	17.2	8.0	17.9	13.6	14.2	22.9	21.4	15.6	10.8	11.8	17.6	18.0	18.1	22.3	16.5	22.9	19.6	11.6	18.7	18.7	10.6	15.3	14.0	18.0	22.1	11.7	10.4	21.7	14.8	15.6	12.2	10.2	23.1	8.0	20.8	18.0	20.7	13.4	10.9	21.2	17.1	16.5	37.5	29.9	30.6	35.5	9.0	21.4	37.6	21.0	23.6	8.2	6.4	11.9	7.0	37.3	16.9	21.3	25.6	9.2	18.1	25.9	15.1	12.6	17.4	8.3	30.6	2.6	11.7	26.9	14.2	19.3	12.4	26.8	31.3	9.1	32.7	11.4	20.7	25.9	2.5	15.6	6.3	14.1	11.4	23.5	13.8	0.5	12.3	19.9	19.9	20.3	23.0	16.9	15.8	12.3	15.7	9.3	14.2	25.1	12.2	17.5	8.9	6.4	7.4	7.9	13.5	11.1	16.6	8.9	4.6	19.3	8.1	6.3	6.4	8.3	10.2	7.5	15.5	6.2	7.7	8.3	10.6	16.6	8.3	5.6	19.2	6.5	24.1	23.0	25.9	25.1	22.9	21.4	18.0	18.1	18.7	14.8	23.1	21.2	4.6	0.0	3.7	41.1	8.2	1.7	2.8	8.4	4.0	11.7	4.3	5.2	4.8	10.0	5.3	9.2	4.2	17.9	5.2	2.9	3.9	8.4	0.8	3.2	7.1	4.8	3.0	1.3	42.9	2.6	6.6	9.2	5.1	3.9	5.1	14.2	4.2	6.3	7.9	13.5	51.1	5.2	12.2	5.7	4.9	1.8	12.2	4.8	1.8	16.9	4.2	13.9	7.2	41.2	26.8	5.6	3.5	19.9	5.4	3.9	3.0	10.9	4.3	6.7	6.6	4.7	5.3	17.3	15.4	2.8	1.4	13.4	7.8	17.7	3.8	1.8
KLHL4	"DKELCHL, KHL4, KIAA1687"	ENSG00000102271	"Kelch like family member 4"	Q9C0H6	X	87517409-87670050	"Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 26.5;brain: 21.3"	"Group enriched"	"Detected in some"	4	"Oligodendrocytes: 286.2;Theca cells: 109.4"	"Cancer enriched"	"Detected in some"	8	"glioma: 9.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 14.7;GAMG: 18.2;HUVEC TERT2: 32.0;NTERA-2: 24.3;SuSa: 17.8;TIME: 34.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029192	Approved		Supported	"Microtubules,Centriolar satellite"		NA	NA				"Cluster 21: Non-specific - Transcription"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Microtubules	"Centriolar satellite"	"HPA029192: AB_10602341"	"unprognostic (6.70e-2)"	"unprognostic (2.20e-1)"	"unprognostic (8.74e-2)"	"unprognostic (2.84e-3)"	"unprognostic (1.48e-2)"	"unprognostic (5.90e-2)"	"unprognostic (1.71e-2)"	"unprognostic (1.89e-2)"	"unprognostic (5.21e-2)"	"unprognostic (2.63e-1)"	"unprognostic (5.98e-2)"	"unprognostic (1.30e-1)"	"prognostic unfavorable (8.08e-5)"	"unprognostic (2.40e-4)"	"unprognostic (1.05e-1)"	"unprognostic (5.87e-2)"	"unprognostic (7.25e-4)"	1.3	26.5	5.3	0.4	10.2	0.0	0.9	7.3	7.1	1.2	0.6	0.3	0.1	3.0	0.3	0.5	2.5	1.5	0.8	5.2	5.7	1.1	0.6	0.8	0.4	9.6	7.5	7.9	0.3	0.0	0.0	0.1	9.5	0.3	0.3	2.3	0.0	1.4	0.3	0.1	0.3	5.1	7.5	1.3	0.3	7.0	6.7	0.1	0.6	0.3	0.1	0.9	0.2	21.3	0.0	3.6	14.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	18.2	0.0	0.1	0.9	0.0	1.4	0.4	0.0	2.6	0.0	11.0	0.2	0.0	1.6	4.7	6.0	1.3	11.6	32.0	0.0	0.2	2.5	8.1	0.0	0.0	0.0	24.3	0.1	5.7	0.0	8.9	0.0	0.0	0.0	0.0	0.0	6.5	0.0	0.0	17.8	0.0	0.1	34.4	0.0	5.6	0.0	0.5	0.2	0.0	0.1	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	5.3	10.2	7.3	7.1	5.2	5.7	9.6	7.5	9.5	7.5	6.7	21.3	1.7	0.0	0.0	2.0	0.0	0.1	0.0	0.1	0.0	3.6	0.0	0.0	1.5	0.0	0.0	0.0	8.4	0.0	0.2	0.0	0.0	0.0	0.7	0.2	0.1	15.0	0.0	0.0	44.4	0.0	0.0	4.4	0.0	0.1	0.0	4.5	14.3	0.2	0.1	0.0	6.6	0.0	0.0	0.3	0.3	1.5	0.9	0.1	0.0	4.7	0.0	1.5	0.0	36.2	286.2	0.1	0.0	1.5	0.1	0.0	0.0	3.4	2.2	4.1	0.0	1.2	0.5	0.4	0.4	0.0	0.3	0.0	0.7	109.4	0.0	0.0
KLHL41	"KBTBD10, Krp1, SARCOSIN"	ENSG00000239474	"Kelch like family member 41"	O60662	2	169509702-169526258	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			"Disease variant, Nemaline myopathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	42	"skeletal muscle: 5038.6;tongue: 3473.7"	"Group enriched"	"Detected in some"	21	"Cardiomyocytes: 108.1;Skeletal myocytes: 251.8"	"Group enriched"	"Detected in some"	9	"head and neck cancer: 10.8;prostate cancer: 3.3"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	9	"HSkMC: 21.6;LHCN-M2: 35.4;RH-30: 55.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA021165, HPA021753, HPA021760"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA				"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 37: Myocytes - Muscle contraction"	Cytosol	"Nucleoplasm, Plasma membrane"	"HPA021165: AB_1852087, HPA021753: AB_1852089, HPA021760: AB_1852091"	"unprognostic (2.44e-2)"	"unprognostic (6.12e-2)"	"unprognostic (9.01e-2)"	"unprognostic (2.94e-2)"	"unprognostic (2.90e-1)"	"unprognostic (1.36e-3)"	"unprognostic (2.05e-1)"	"unprognostic (5.46e-3)"	"unprognostic (1.88e-1)"	"unprognostic (5.38e-2)"	"unprognostic (6.65e-4)"	"unprognostic (9.64e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.69e-3)"	"unprognostic (1.19e-1)"	"unprognostic (1.12e-2)"	"unprognostic (1.52e-1)"	1.5	0.5	1.7	0.2	1.4	0.0	2.0	3.1	1.8	1.0	1.4	1.4	0.1	0.8	1.5	75.1	1.2	6.7	100.3	1.2	1.6	0.8	0.9	2.7	0.3	0.9	2.5	1.1	1.1	0.5	5.8	0.1	1.5	50.0	0.3	16.1	52.1	0.7	5038.6	4.6	0.8	0.6	0.9	0.8	1.3	2.6	5.1	1.7	2.2	3473.7	0.3	5.9	0.9	1.4	0.0	0.1	0.0	0.6	0.4	2.7	0.0	0.1	0.1	0.3	0.1	0.0	0.0	0.0	0.1	0.1	0.3	0.0	0.1	0.0	0.0	0.0	4.3	0.1	0.0	0.0	0.2	0.2	0.0	21.6	0.5	0.3	0.0	0.2	0.1	0.2	0.1	0.0	35.4	0.1	0.1	0.2	0.0	0.0	0.2	0.0	55.9	0.0	0.2	0.1	0.7	0.1	0.1	0.0	1.5	0.1	0.0	0.1	0.0	0.4	0.2	0.4	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	1.4	3.1	1.8	1.2	1.6	0.9	2.5	1.5	0.9	5.1	1.4	0.0	0.0	0.5	1.3	0.0	0.1	0.5	0.1	0.0	2.4	0.2	0.1	108.1	0.0	2.0	0.0	8.4	0.0	0.0	0.1	0.0	0.5	5.8	1.3	0.2	1.0	1.2	0.0	4.1	0.5	0.0	6.4	0.0	0.1	0.0	0.2	0.4	0.2	0.2	0.0	4.6	0.1	0.0	0.3	0.0	2.9	0.9	0.8	0.0	3.7	0.0	0.7	0.0	1.5	2.3	0.7	0.1	1.2	0.0	0.3	0.0	0.3	4.1	5.8	0.0	251.8	1.8	4.1	0.4	0.0	0.0	0.0	0.3	0.2	0.0	0.1
KLK6	"Bssp, Klk7, neurosin, PRSS18, PRSS9"	ENSG00000167755	"Kallikrein related peptidase 6"	Q92876	19	50958631-50969673	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 253.0;esophagus: 94.2"	"Cell type enhanced"	"Detected in some"		"Breast glandular cells: 23.9;Breast myoepithelial cells: 16.1;Collecting duct cells: 11.0;Oligodendrocytes: 87.9"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 131.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"A-431: 575.5;CAPAN-2: 1346.5"	"Region enhanced"	"Detected in all"		"pons and medulla: 167.8"	"Region enhanced"	"Detected in many"		"spinal cord: 371.7"	HPA051837			Supported	"Nucleoplasm,Nuclear membrane,Cytokinetic bridge"	"Secreted in other tissues"	Yes	No		10000000		"Cluster 70: Brain - Nervous system development"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 30: Mammary glandular cells - Lactation"	Nucleoplasm	"Nuclear membrane, Cytokinetic bridge"	"HPA051837: "	"unprognostic (7.30e-2)"	"unprognostic (3.32e-1)"	"unprognostic (6.58e-2)"	"prognostic unfavorable (1.38e-5)"	"unprognostic (1.10e-1)"	"unprognostic (2.31e-1)"		"prognostic unfavorable (8.85e-4)"	"unprognostic (3.02e-1)"	"unprognostic (2.46e-1)"	"prognostic unfavorable (7.82e-4)"	"unprognostic (4.45e-1)"	"unprognostic (2.72e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.46e-1)"	"unprognostic (9.07e-2)"	"prognostic unfavorable (1.27e-4)"	0.2	0.0	71.8	0.0	135.8	0.0	7.2	170.8	119.8	53.1	45.6	0.1	0.2	1.5	0.4	94.2	28.9	3.5	0.0	72.9	94.3	20.4	0.0	0.0	0.0	213.8	130.8	0.8	0.0	0.0	0.7	0.0	182.1	0.1	0.0	0.0	15.8	2.2	0.0	9.9	0.0	0.0	123.6	5.8	0.1	0.9	118.1	1.5	0.0	0.0	36.4	0.0	27.4	253.0	575.5	0.0	0.0	1.4	0.0	0.0	2.2	0.0	0.0	0.0	0.0	67.7	1346.5	0.0	8.1	0.0	0.6	8.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	1.1	131.0	2.2	0.1	0.0	0.0	16.2	0.0	0.0	0.0	0.0	0.0	5.6	18.2	1.0	1.9	0.0	1.1	46.3	0.0	1.3	0.0	0.4	0.3	0.0	0.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	71.8	135.8	170.8	119.8	72.9	94.3	213.8	130.8	182.1	123.6	118.1	253.0	0.2	0.0	0.0	0.0	0.2	0.0	1.0	0.5	0.0	0.0	23.9	16.1	0.3	0.0	1.7	11.0	0.0	0.1	0.4	0.0	0.0	0.1	2.3	0.6	7.5	0.4	0.0	0.0	0.2	0.2	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	3.7	0.3	0.1	0.0	1.0	0.0	0.0	0.0	0.5	87.9	7.8	0.0	0.0	0.0	0.6	0.0	0.0	1.0	0.0	0.0	0.0	0.1	0.9	0.3	1.6	0.0	0.3	0.1	0.0	0.0	2.4
KLK7	"PRSS6, SCCE"	ENSG00000169035	"Kallikrein related peptidase 7"	P49862	19	50976468-50984099	"Cancer-related genes, Enzymes, Predicted intracellular proteins, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"esophagus: 94.7;skin 1: 201.2"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 6.4;Basal keratinocytes: 5.0;Basal squamous epithelial cells: 4.6;Breast glandular cells: 9.4;Breast myoepithelial cells: 10.4;Squamous epithelial cells: 5.9;Suprabasal keratinocytes: 10.7"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 139.8"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 5.0;CAPAN-2: 8.0;HaCaT: 31.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA018994, CAB026342, HPA062126"	Enhanced		Supported	"Nuclear membrane,Plasma membrane"	"Secreted in other tissues"	NA	NA		3700000	"Cluster 11: Basophils - Unknown function"	"Cluster 31: Skin - Epidermis development"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	"Plasma membrane"	"Nuclear membrane"	"CAB026342: , HPA018994: AB_1852607, HPA062126: AB_2684691"	"unprognostic (1.88e-2)"	"unprognostic (6.41e-2)"	"unprognostic (8.57e-2)"	"prognostic unfavorable (8.06e-5)"	"unprognostic (4.33e-3)"	"unprognostic (2.28e-1)"		"unprognostic (4.44e-3)"	"unprognostic (2.99e-1)"	"unprognostic (1.31e-1)"	"prognostic unfavorable (1.16e-4)"	"unprognostic (2.10e-1)"	"unprognostic (2.82e-3)"	"unprognostic (3.25e-1)"	"unprognostic (4.47e-2)"	"unprognostic (1.12e-2)"	"unprognostic (5.60e-3)"	7.1	0.1	8.4	0.1	9.2	0.3	11.2	0.9	7.4	19.7	1.0	0.1	0.5	0.7	0.2	94.7	16.3	1.3	0.2	6.5	1.4	12.1	0.1	3.1	0.0	4.3	1.4	0.1	0.1	0.3	0.7	0.0	4.9	0.1	0.0	0.1	21.6	0.2	1.0	201.2	0.0	0.2	2.1	0.8	0.3	0.3	7.4	0.9	0.2	0.0	10.9	0.0	30.9	3.0	5.0	0.0	0.0	0.2	0.0	0.0	1.5	0.0	0.0	0.0	0.0	1.8	8.0	0.0	1.1	0.0	0.1	31.7	0.0	1.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.2	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.1	0.1	0.3	0.5	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.2	0.0	0.1	0.0	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	8.4	9.2	0.9	7.4	6.5	1.4	4.3	1.4	4.9	2.1	7.4	3.0	0.0	6.4	1.1	0.0	0.0	5.0	0.1	0.5	4.6	0.0	9.4	10.4	0.2	0.0	2.4	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	2.6	0.2	0.0	0.0	1.7	0.0	0.0	2.9	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.0	0.0	0.0	1.0	0.0	0.0	0.8	0.0	0.0	0.0	0.1	0.0	0.2	5.9	10.7	0.0	0.1	0.0	0.1	2.7
KLLN	killin	ENSG00000227268	"Killin, p53 regulated DNA replication inhibitor"	B2CW77	10	87859158-87863533	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Apoptosis, Cell cycle"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"skeletal muscle: 4.5"	"Cell type enhanced"	"Detected in many"		"granulocytes: 5.7;Sertoli cells: 6.6"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"JURKAT: 5.0;Karpas-707: 5.1"									HPA074502			Supported	Nucleoplasm,Nucleoli		No	No			"Cluster 42: Non-specific - Transcription"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm	Nucleoli	"HPA074502: AB_2686695"	"unprognostic (4.53e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.68e-2)"	"unprognostic (3.71e-1)"	"unprognostic (6.53e-2)"	"unprognostic (1.37e-1)"	"unprognostic (3.59e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.07e-1)"	"unprognostic (3.12e-3)"	"unprognostic (1.57e-2)"	"unprognostic (4.79e-4)"	"unprognostic (1.38e-2)"	"unprognostic (1.00e-1)"	"unprognostic (9.02e-4)"	"unprognostic (1.60e-1)"	1.0	0.7	1.0	0.6	0.7	0.5	0.6	1.5	1.6	0.7	0.6	0.9	0.4	0.5	1.0	0.4	1.4	0.4	0.5	0.7	0.9	0.9	0.9	0.4	0.8	0.5	0.6	0.4	0.2	0.5	0.5	0.6	0.6	0.4	0.8	1.0	0.3	0.5	4.5	0.4	0.4	0.5	0.3	0.8	0.6	1.0	0.6	1.0	0.7	0.5	0.8	0.3	0.3	1.5	0.8	1.0	1.1	0.7	0.5	0.3	0.8	0.7	0.9	0.5	0.7	0.6	2.6	2.0	0.3	0.2	0.5	0.9	0.7	0.8	0.4	0.5	0.3	0.7	1.5	0.6	0.6	1.4	0.5	0.6	0.8	0.7	0.8	0.9	0.3	5.0	0.4	5.1	0.5	1.8	4.1	1.6	0.4	0.6	0.5	2.6	0.1	2.6	0.4	0.8	0.4	1.0	0.9	0.6	0.1	0.7	1.6	1.2	0.3	0.5	0.3	0.9	0.3	2.9	3.3	2.9	0.9	2.9	0.6	1.6	0.3	0.6	0.2	0.5	0.4	0.4	0.3	0.3	0.3	0.5	0.4	0.3	2.5	0.6	0.8	0.5	0.2	0.2	1.0	0.7	1.5	1.6	0.7	0.9	0.5	0.6	0.6	0.3	0.6	1.5	0.6	0.0	0.0	0.3	0.5	0.1	0.3	0.2	0.6	1.7	1.0	1.3	2.7	1.5	1.3	0.0	0.0	0.7	2.0	3.0	0.0	0.2	3.9	0.8	0.9	0.6	0.0	0.8	0.4	0.2	0.4	1.1	3.6	0.4	5.7	0.3	0.7	0.4	0.3	3.3	0.5	1.8	0.0	1.3	0.0	2.0	0.0	0.6	0.0	0.0	0.3	1.6	0.0	0.0	0.1	0.3	2.5	0.0	0.2	0.3	1.8	1.9	2.3	1.0	6.6	1.1	2.9	0.3	1.2	0.6	0.4	0.5	0.7	0.3	1.3	0.2
KLRK1	"CD314, D12S2489E, KLR, NKG2-D, NKG2D"	ENSG00000213809	"Killer cell lectin like receptor K1"	P26718	12	10372353-10391874	"Cancer-related genes, CD markers, Predicted membrane proteins, Transporters"	"Adaptive immunity, Differentiation, Immunity, Innate immunity"	Receptor	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 22.1;lymphoid tissue: 42.9"	"Cell type enhanced"	"Detected in some"		"dendritic cells: 7.2;NK-cells: 6.2;Plasma cells: 4.5;T-cells: 22.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	40	"gdT-cell: 287.4;MAIT T-cell: 111.5;memory CD8 T-cell: 261.2;naive CD8 T-cell: 258.8;NK-cell: 335.8"	"Group enriched"	"Detected in all"	50	"NK-cells: 335.8;T-cells: 287.4"	"Cell line enriched"	"Detected in some"	9	"U-698: 64.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"CAB021896, HPA068877"	Enhanced		Supported	"Plasma membrane"		NA	NA		47000	"Cluster 48: NK-cells - Unknown function"	"Cluster 2: Immune cells - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 58: T-cells - T-cell receptor"	"Plasma membrane"		"CAB021896: , HPA068877: AB_2686052"	"unprognostic (3.34e-4)"	"unprognostic (2.65e-4)"	"unprognostic (3.25e-1)"	"unprognostic (2.59e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.01e-5)"	"unprognostic (5.61e-4)"	"unprognostic (1.00e-3)"	"unprognostic (1.33e-1)"	"unprognostic (9.22e-2)"	"unprognostic (1.28e-2)"	"unprognostic (2.10e-2)"	"unprognostic (6.56e-10)"	"unprognostic (1.24e-2)"	"unprognostic (6.32e-2)"	"unprognostic (7.59e-2)"	"unprognostic (7.08e-10)"	5.5	2.1	1.7	12.6	1.9	22.1	4.1	1.7	2.8	2.2	1.2	3.9	4.7	2.5	2.3	2.2	2.8	7.3	1.8	1.7	2.0	2.0	5.5	12.1	37.0	2.0	1.7	2.4	1.1	0.5	1.1	1.4	1.8	2.5	4.5	0.4	4.4	0.9	0.8	1.3	12.2	1.8	1.7	42.9	7.2	2.5	1.7	9.9	3.6	1.5	19.0	4.5	3.2	2.4	0.3	0.0	0.7	2.8	0.2	7.1	0.7	0.0	0.0	0.0	0.0	0.3	0.0	0.6	0.0	0.0	0.2	0.5	0.0	0.1	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.3	2.6	0.0	0.0	0.2	0.2	0.0	0.7	1.4	0.0	0.3	0.0	0.4	0.2	0.6	0.1	0.0	0.6	0.0	0.0	0.0	0.1	0.8	0.3	0.1	0.1	0.0	2.0	0.2	0.3	0.1	0.1	0.8	0.0	0.0	0.0	0.0	64.2	0.2	0.0	0.3	0.4	0.5	0.2	287.4	0.6	111.5	6.2	1.7	261.2	0.6	6.1	2.3	258.8	4.8	335.8	1.3	1.9	0.7	127.9	1.7	1.9	1.7	2.8	1.7	2.0	2.0	1.7	1.8	1.7	1.7	2.4	0.0	0.0	1.3	0.0	2.4	0.0	0.1	0.2	1.2	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	7.2	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.4	0.2	0.0	0.5	1.8	0.0	0.5	0.0	6.2	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.1	0.0	22.2	1.0	0.0	0.0
KMT2A	"ALL-1, CXXC7, HRX, HTRX1, MLL, MLL1A, TRX1"	ENSG00000118058	"Lysine methyltransferase 2A"	Q03164	11	118436490-118526832	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transcription factors"	"Apoptosis, Biological rhythms, Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding, Methyltransferase, Transferase"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017794, CAB024270, HPA044910"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	Cytosol	"CAB017794: , CAB024270: , HPA044910: AB_2679141"	"unprognostic (6.80e-2)"	"unprognostic (8.93e-2)"	"unprognostic (1.83e-1)"	"unprognostic (4.56e-1)"	"unprognostic (4.96e-2)"	"unprognostic (1.72e-3)"	"unprognostic (4.52e-3)"	"unprognostic (6.07e-2)"	"unprognostic (1.61e-1)"	"unprognostic (8.46e-2)"	"unprognostic (3.21e-1)"	"unprognostic (1.16e-1)"	"unprognostic (5.91e-3)"	"unprognostic (7.90e-2)"	"unprognostic (3.73e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.02e-1)"	9.9	6.7	8.0	8.5	8.6	19.5	9.9	21.2	9.3	10.3	1.6	10.8	5.4	10.7	8.2	6.8	10.3	6.4	6.5	7.4	9.6	6.7	6.0	10.5	12.4	6.3	6.3	21.2	11.1	9.8	10.2	5.6	6.6	9.2	6.4	23.9	9.4	8.4	7.4	10.4	9.8	7.6	3.2	9.7	8.2	5.3	7.0	14.1	9.9	8.4	11.3	10.7	9.3	11.9	17.9	8.6	20.1	14.5	11.1	16.1	6.2	8.7	11.8	9.0	9.6	17.3	11.4	23.1	15.9	10.8	14.6	16.0	22.9	7.2	17.9	26.0	10.0	45.7	8.9	9.3	6.1	28.5	7.8	7.2	7.4	20.3	24.0	8.9	12.8	13.3	32.8	18.8	9.2	12.7	18.2	12.7	13.6	6.6	13.7	13.8	21.9	6.9	9.8	13.8	18.0	11.8	22.0	6.7	3.9	9.8	11.9	9.1	20.4	14.1	12.7	9.4	14.7	5.1	4.4	15.6	4.7	17.6	8.3	2.1	0.6	1.9	1.6	0.6	1.6	2.5	1.8	1.5	0.3	1.8	1.8	1.2	0.5	2.0	0.7	1.4	1.7	0.4	8.0	8.6	21.2	9.3	7.4	9.6	6.3	6.3	6.6	3.2	7.0	11.9	87.1	70.5	65.8	93.4	83.4	86.9	67.6	29.4	64.9	158.1	76.8	73.9	44.5	40.0	32.2	38.6	152.2	13.9	81.0	26.2	3.9	33.0	10.1	62.1	101.4	74.4	66.4	67.3	146.0	25.6	10.2	65.6	44.4	85.2	29.0	57.5	60.0	27.3	16.8	195.2	170.1	29.6	20.3	37.0	63.7	5.8	66.8	44.8	42.7	62.8	49.9	98.9	78.2	106.6	131.9	28.2	20.1	78.6	83.3	88.3	22.7	10.5	52.7	152.4	65.7	113.4	84.6	25.5	30.7	46.3	80.6	6.0	102.8	55.8	30.6	64.8
KMT2E	"HDCMC04P, MLL5"	ENSG00000005483	"Lysine methyltransferase 2E (inactive)"	Q8IZD2	7	105014190-105115019	"Disease related genes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell cycle, Growth arrest, Transcription, Transcription regulation"	"Chromatin regulator"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042866, HPA056125"	Approved		Supported	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm	"Nuclear bodies"	"HPA042866: , HPA056125: AB_2683044"	"unprognostic (1.05e-1)"	"unprognostic (6.33e-2)"	"unprognostic (6.49e-2)"	"unprognostic (4.34e-1)"	"unprognostic (1.94e-1)"	"unprognostic (4.77e-2)"	"unprognostic (2.20e-1)"	"unprognostic (3.98e-3)"	"unprognostic (2.03e-2)"	"unprognostic (3.16e-2)"	"unprognostic (3.53e-2)"	"unprognostic (6.45e-2)"	"prognostic unfavorable (3.80e-5)"	"unprognostic (1.68e-1)"	"unprognostic (1.53e-1)"	"unprognostic (3.57e-2)"	"unprognostic (1.06e-1)"	23.0	16.4	17.6	28.8	23.6	69.9	22.5	53.6	26.1	28.9	11.6	29.0	22.7	33.4	22.1	22.7	24.8	24.5	21.1	16.9	25.9	18.7	16.4	27.9	31.4	19.0	19.2	43.8	22.8	23.1	11.5	26.8	17.7	24.9	28.5	40.5	25.5	23.0	15.0	30.3	22.3	26.8	14.4	33.4	26.7	18.6	17.1	35.6	27.4	22.9	33.0	27.9	14.3	34.4	35.7	24.8	49.3	43.5	29.3	34.5	12.3	24.3	38.2	21.0	25.5	19.0	30.1	28.8	24.7	30.0	27.7	26.2	27.1	25.7	35.0	45.8	17.4	27.0	31.6	19.2	28.1	39.7	34.8	24.2	23.3	28.6	30.6	38.6	40.2	32.3	39.9	76.9	28.7	26.5	62.1	35.0	17.9	19.1	19.1	53.4	30.3	33.5	23.0	34.5	28.8	36.1	35.7	32.3	20.2	32.8	13.6	23.5	47.2	50.0	33.1	57.5	26.4	61.6	50.8	63.5	34.3	29.5	36.3	246.8	73.2	173.1	118.3	56.2	114.6	153.9	109.7	103.0	53.8	152.0	106.0	100.0	290.3	89.9	94.4	103.2	101.5	71.7	17.6	23.6	53.6	26.1	16.9	25.9	19.0	19.2	17.7	14.4	17.1	34.4	169.3	141.1	158.4	108.4	283.5	146.6	115.5	119.2	118.4	236.4	93.4	81.5	102.9	85.8	124.6	115.8	252.3	40.5	278.0	138.0	35.2	82.2	27.0	77.8	89.3	205.6	100.0	90.5	160.2	68.1	50.4	128.8	91.7	112.4	247.9	78.2	119.2	33.6	60.4	185.1	148.9	96.4	89.5	91.8	348.4	27.3	141.1	152.2	140.5	148.9	147.5	104.1	255.4	189.0	236.2	80.7	102.9	131.7	223.1	149.7	82.6	32.4	78.3	297.5	124.9	136.7	168.3	100.0	76.4	86.1	134.7	65.3	278.3	58.2	115.4	159.9
KMT5A	"PR-Set7, SET07, SET8, SETD8"	ENSG00000183955	"Lysine methyltransferase 5A"	Q9NQR1	12	123383773-123409353	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, Transcription, Transcription regulation"	"Chromatin regulator, Methyltransferase, Repressor, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Erythroid cells: 62.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA064495			Supported	Nucleoplasm,Cytosol		NA	Yes			"Cluster 49: Eosinophils - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm	Cytosol	"HPA064495: AB_2685273"	"unprognostic (5.62e-2)"	"unprognostic (4.45e-2)"	"unprognostic (3.90e-1)"	"unprognostic (3.04e-1)"	"unprognostic (2.20e-2)"	"unprognostic (1.73e-1)"	"prognostic unfavorable (6.21e-7)"	"unprognostic (3.88e-3)"	"unprognostic (1.06e-2)"	"unprognostic (1.64e-2)"	"unprognostic (6.13e-2)"	"unprognostic (3.44e-1)"	"unprognostic (4.75e-3)"	"unprognostic (4.27e-2)"	"unprognostic (1.30e-1)"	"unprognostic (4.39e-2)"	"unprognostic (1.06e-1)"	13.7	10.1	22.6	15.3	22.1	39.2	13.1	20.8	23.2	22.2	18.7	17.7	12.8	21.3	12.9	40.7	21.7	13.6	17.0	22.2	20.6	13.7	14.0	15.5	15.4	22.4	22.7	12.0	19.7	11.4	10.7	16.5	22.9	30.2	14.4	11.7	24.0	19.7	24.4	28.1	15.6	16.7	21.4	16.8	16.9	7.9	23.3	17.9	25.7	15.3	16.6	16.6	25.7	23.9	37.3	24.3	27.8	43.5	18.1	30.9	40.1	57.4	26.3	32.0	26.9	28.8	21.9	84.9	33.1	37.5	11.7	35.8	41.6	21.7	33.3	39.3	45.0	68.8	26.4	15.2	26.5	54.8	18.8	15.1	27.1	34.7	32.8	30.2	26.2	36.4	136.8	38.1	27.5	29.9	58.1	84.9	13.8	34.6	29.0	70.4	22.1	24.1	22.8	43.4	37.9	30.9	51.3	28.3	28.6	23.6	39.6	75.3	32.4	35.2	26.0	42.3	42.3	23.0	25.9	75.9	24.6	29.6	29.9	2.3	1.2	4.3	1.3	2.1	2.7	1.7	1.6	2.1	1.0	1.1	0.9	1.1	1.8	2.3	2.1	2.0	1.5	0.3	22.6	22.1	20.8	23.2	22.2	20.6	22.4	22.7	22.9	21.4	23.3	23.9	34.5	12.8	14.5	0.0	12.7	0.0	17.6	0.0	20.5	20.8	32.0	27.3	0.0	7.2	6.8	27.6	6.2	15.1	22.4	10.4	7.9	9.2	10.1	46.8	43.8	20.7	4.9	62.1	0.0	9.4	16.6	14.7	15.8	41.1	2.5	21.3	30.4	19.5	17.7	3.3	0.0	22.2	0.0	16.8	0.0	3.2	16.1	19.6	0.0	0.0	3.4	28.7	7.2	0.0	0.0	13.6	9.6	42.9	15.9	24.1	14.3	13.1	11.7	17.9	6.6	23.2	19.7	9.7	10.2	38.8	0.0	14.2	14.5	18.4	12.7	22.5
KMT5B	"CGI-85, SUV420H1"	ENSG00000110066	"Lysine methyltransferase 5B"	Q4FZB7	11	68154863-68213828	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Myogenesis, Transcription, Transcription regulation"	"Chromatin regulator, Methyltransferase, Repressor, Transferase"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SK-MEL-30: 128.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA063648			Supported	Nucleoplasm		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm		"HPA063648: AB_2685073"	"unprognostic (5.82e-2)"	"unprognostic (4.25e-2)"	"unprognostic (2.54e-1)"	"unprognostic (5.36e-3)"	"unprognostic (3.52e-1)"	"unprognostic (2.94e-1)"	"unprognostic (1.83e-2)"	"unprognostic (1.08e-1)"	"unprognostic (3.16e-2)"	"unprognostic (1.71e-1)"	"unprognostic (5.54e-2)"	"unprognostic (1.21e-1)"	"unprognostic (3.79e-3)"	"unprognostic (2.62e-1)"	"unprognostic (4.26e-2)"	"unprognostic (3.21e-2)"	"prognostic favorable (9.30e-4)"	18.6	16.5	16.3	15.7	17.5	28.5	27.5	26.2	17.6	20.2	17.3	22.3	22.8	26.2	19.0	17.2	18.2	15.0	15.9	15.8	17.2	19.7	22.4	18.1	19.2	16.1	16.3	22.4	22.8	20.6	15.6	22.3	15.6	22.0	21.6	33.4	23.4	16.3	16.9	21.7	21.8	20.7	14.8	17.2	20.7	20.7	16.1	27.0	31.0	16.7	20.4	16.5	17.6	21.3	25.3	18.8	37.6	24.5	8.6	21.4	40.8	17.7	12.3	21.7	12.8	59.7	39.6	20.5	30.2	24.4	21.4	13.0	26.2	20.6	31.6	23.2	15.1	19.4	21.9	24.7	31.0	27.7	25.6	21.3	41.6	26.2	27.3	20.0	21.8	20.3	29.3	23.4	18.7	52.2	19.6	28.9	40.4	50.4	13.9	31.9	29.4	55.4	16.2	24.2	32.7	39.1	27.5	27.4	128.7	20.3	35.1	17.9	23.1	29.2	38.9	22.5	18.4	29.5	13.8	43.0	18.4	17.3	31.8	10.0	3.7	16.5	4.4	5.2	3.1	3.2	4.6	5.4	3.5	3.8	5.3	4.8	10.9	9.6	5.3	5.4	4.1	2.8	16.3	17.5	26.2	17.6	15.8	17.2	16.1	16.3	15.6	14.8	16.1	21.3	39.8	60.9	61.3	0.0	32.9	0.0	42.3	0.0	50.7	50.0	45.8	34.7	0.0	25.8	25.4	25.8	12.5	27.4	37.6	32.6	21.5	27.9	22.0	42.6	46.3	31.7	25.5	31.4	0.0	32.7	29.6	26.3	37.2	44.3	22.7	40.7	30.0	37.7	17.9	63.9	0.0	26.6	0.0	32.4	0.0	21.0	28.0	27.7	0.0	0.0	38.2	29.6	43.3	0.0	0.0	37.1	25.7	31.6	34.8	43.7	36.4	22.7	32.1	39.6	32.9	44.8	28.6	45.8	58.9	38.0	0.0	51.7	30.7	31.8	25.1	53.6
KMT5C	"MGC2705, SUV420H2"	ENSG00000133247	"Lysine methyltransferase 5C"	Q86Y97	19	55339853-55348121	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, Methyltransferase, Repressor, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Bipolar cells: 47.9;Cone photoreceptor cells: 50.1;Horizontal cells: 67.3;Rod photoreceptor cells: 49.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HEK 293: 20.7;SCLC-21H: 19.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052294	Uncertain		Supported	Nucleoplasm		NA	NA				"Cluster 35: Non-specific - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 62: Horizontal cells - Visual perception"	Nucleoplasm		"HPA052294: AB_2681788"	"unprognostic (4.02e-2)"	"unprognostic (3.45e-2)"	"unprognostic (2.92e-3)"	"unprognostic (6.77e-3)"	"unprognostic (2.48e-1)"	"unprognostic (8.27e-2)"	"unprognostic (2.29e-2)"	"unprognostic (1.27e-1)"	"unprognostic (8.69e-2)"	"unprognostic (3.04e-1)"	"unprognostic (9.48e-3)"	"unprognostic (1.49e-2)"	"prognostic unfavorable (1.05e-8)"	"unprognostic (7.39e-2)"	"unprognostic (2.96e-1)"	"unprognostic (9.41e-2)"	"unprognostic (2.39e-2)"	3.7	5.9	5.5	1.3	6.0	5.0	4.6	6.4	6.5	5.6	4.3	5.4	3.5	5.0	0.9	4.8	8.6	1.1	4.5	5.1	4.9	5.2	5.1	5.4	1.5	6.1	5.7	6.3	5.9	1.3	11.1	1.9	5.9	6.7	0.9	2.6	5.2	1.3	2.8	9.2	5.0	0.7	4.9	5.7	4.8	7.1	5.8	1.9	4.6	0.6	0.9	4.6	4.5	7.4	6.2	4.1	4.1	3.3	0.8	1.0	10.5	1.8	0.7	0.6	1.5	2.8	5.1	6.2	2.2	1.3	0.3	3.1	2.8	2.2	0.7	5.5	20.7	4.2	3.7	3.0	1.4	2.7	5.7	1.0	2.9	1.9	1.0	1.4	1.3	6.5	12.4	3.6	0.7	7.1	8.6	6.4	7.0	3.8	6.0	12.3	4.7	6.2	1.0	1.5	19.3	8.2	0.9	4.9	2.4	2.6	5.3	3.7	1.4	2.1	4.4	0.9	1.3	9.8	5.2	4.1	1.2	6.5	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	5.5	6.0	6.4	6.5	5.1	4.9	6.1	5.7	5.9	4.9	5.8	7.4	3.3	6.4	4.1	0.0	4.9	0.0	13.5	0.0	7.4	47.9	11.8	9.3	0.0	8.6	3.1	3.7	50.1	31.1	13.3	7.5	1.9	6.6	2.3	27.4	7.5	3.9	7.3	18.9	0.0	2.9	20.4	5.4	16.3	18.0	2.5	11.1	6.1	1.1	9.6	67.3	0.0	15.0	0.0	5.1	0.0	2.4	7.5	6.2	0.0	0.0	2.2	19.9	8.2	0.0	0.0	8.7	11.9	6.4	9.8	10.6	21.1	2.7	3.6	49.7	6.6	5.4	3.0	21.0	30.5	6.5	0.0	19.8	13.0	23.0	11.3	11.8
KNTC1	"KIAA0166, ROD"	ENSG00000184445	"Kinetochore associated 1"	P50748	12	122527246-122626396	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 42.3"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 30.4;Erythroid cells: 29.5;Plasma cells: 28.7;Spermatocytes: 40.7;Spermatogonia: 39.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA025241	Approved		Supported	"Plasma membrane,Cytosol"		NA	Yes			"Cluster 18: Basophils - Vesicular transport"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 24: NB-4 - Immune response"	"Cluster 12: Non-specific - Cell cycle regulation"	Cytosol	"Plasma membrane"	"HPA025241: AB_1852629"	"unprognostic (1.17e-1)"	"unprognostic (2.12e-3)"	"unprognostic (2.51e-1)"	"unprognostic (1.53e-2)"	"unprognostic (9.34e-2)"	"prognostic favorable (8.69e-4)"	"prognostic unfavorable (4.79e-6)"	"unprognostic (4.04e-2)"	"unprognostic (7.20e-3)"	"unprognostic (1.59e-2)"	"unprognostic (4.78e-2)"	"unprognostic (1.92e-2)"	"prognostic unfavorable (7.89e-8)"	"unprognostic (2.17e-2)"	"unprognostic (3.08e-1)"	"unprognostic (8.04e-2)"	"unprognostic (1.74e-1)"	7.1	7.6	3.7	11.7	3.6	42.3	7.6	4.9	5.3	9.1	3.5	9.8	9.0	5.3	5.2	12.2	6.8	3.4	4.1	3.6	3.4	6.7	6.4	8.0	16.4	3.8	3.4	8.2	6.6	2.9	5.7	5.8	3.9	7.3	11.9	5.5	7.7	2.9	2.5	15.1	14.5	4.6	3.1	18.2	7.2	28.2	4.0	17.8	5.4	1.4	17.4	6.2	8.9	5.0	33.8	27.6	77.8	17.9	5.9	10.8	35.0	30.6	19.8	29.7	27.9	26.2	27.6	40.2	15.6	14.9	19.5	45.4	34.1	19.1	39.1	28.8	23.7	49.7	57.1	27.1	2.0	49.3	32.8	5.8	4.3	30.7	20.2	15.5	20.5	50.5	50.4	29.4	22.6	25.0	40.9	113.0	39.4	16.3	34.5	55.4	37.8	44.8	17.8	35.6	24.1	31.0	55.7	11.7	16.7	46.2	44.4	28.1	15.1	33.7	32.3	33.3	36.3	39.3	42.3	61.0	20.1	31.3	39.6	2.5	0.5	1.8	0.7	0.7	0.6	1.6	1.1	1.3	0.5	0.9	0.8	1.0	1.6	0.9	1.0	0.8	0.5	0.3	3.7	3.6	4.9	5.3	3.6	3.4	3.8	3.4	3.9	3.1	4.0	5.0	4.3	0.0	2.6	3.3	8.1	4.2	1.9	1.9	2.2	2.2	3.1	3.4	1.8	0.0	1.9	5.5	4.2	7.0	3.8	3.0	0.0	1.5	30.4	3.3	3.9	2.9	0.0	29.5	6.2	0.4	5.9	2.9	10.2	5.2	1.3	14.7	2.2	1.3	4.8	0.0	4.5	2.3	0.0	2.2	4.7	17.7	4.7	4.0	1.8	4.7	1.6	1.1	2.1	2.5	4.4	0.8	1.0	3.0	28.7	1.0	1.5	0.5	5.0	5.0	6.6	3.1	2.9	40.7	39.9	4.9	2.3	2.9	5.3	2.1	5.8	1.6
KPNA2	"IPOA1, QIP2, RCH1, SRP1alpha"	ENSG00000182481	"Karyopherin subunit alpha 2"	P52292	17	68035636-68047364	"Plasma proteins, Predicted intracellular proteins, Transporters"	"Host-virus interaction, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 209.1"	"Cell type enhanced"	"Detected in all"		"Early spermatids: 863.9;Extravillous trophoblasts: 279.7;Spermatocytes: 552.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"CAB015460, HPA041270"	Enhanced		Enhanced	Nucleoplasm,Cytosol		Yes	Yes		160000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	Cytosol	"CAB015460: AB_831493, HPA041270: AB_2677385"	"unprognostic (2.78e-2)"	"unprognostic (1.54e-1)"	"prognostic favorable (3.83e-4)"	"unprognostic (2.14e-2)"	"unprognostic (1.64e-1)"	"unprognostic (5.16e-3)"	"prognostic unfavorable (2.12e-10)"	"prognostic unfavorable (5.77e-4)"	"unprognostic (3.34e-2)"	"unprognostic (7.59e-2)"	"unprognostic (3.72e-3)"	"unprognostic (3.08e-2)"	"prognostic unfavorable (1.26e-13)"	"unprognostic (3.07e-2)"	"unprognostic (1.78e-1)"	"unprognostic (9.50e-2)"	"prognostic unfavorable (2.19e-4)"	25.9	15.9	18.9	45.2	19.3	99.2	15.2	18.7	23.3	17.4	15.7	30.7	26.1	17.6	25.7	41.4	10.8	19.4	23.9	20.8	24.7	16.2	23.1	17.9	72.1	19.1	20.5	6.5	10.0	10.6	15.6	43.8	22.2	8.2	35.8	22.2	15.4	11.6	14.8	21.0	23.3	34.6	20.5	28.3	19.0	209.1	20.0	94.7	10.9	16.7	104.9	38.6	17.7	22.7	556.0	712.3	667.1	264.4	95.7	93.9	421.1	467.9	372.9	758.1	587.9	499.5	250.4	514.4	146.7	273.4	375.1	297.4	753.8	359.4	870.7	203.8	437.5	446.5	311.7	482.7	101.9	387.6	294.3	58.1	69.3	426.0	267.2	105.8	746.8	211.0	360.8	346.0	686.1	517.3	484.4	249.8	451.4	455.2	365.8	271.5	605.1	280.6	304.0	250.0	262.2	286.3	269.5	839.1	291.9	609.6	495.6	196.9	288.6	416.7	506.2	290.6	647.3	291.5	451.9	504.7	203.0	334.9	458.0	30.1	31.0	12.7	24.1	46.5	19.2	45.8	18.8	27.3	56.2	39.6	13.3	21.5	0.9	43.9	39.6	41.4	37.7	31.3	18.9	19.3	18.7	23.3	20.8	24.7	19.1	20.5	22.2	20.5	20.0	22.7	41.0	12.8	31.0	6.2	49.4	109.7	32.2	73.7	43.3	20.1	39.8	45.5	13.8	7.2	39.7	18.4	8.4	128.3	96.4	27.7	15.6	31.4	863.9	70.8	55.1	48.6	42.9	70.9	8.5	25.5	279.7	64.9	31.1	68.0	44.4	68.2	21.8	17.2	126.0	32.0	7.3	27.6	97.6	42.9	132.1	266.6	19.3	60.0	53.4	3.7	72.1	31.2	18.6	6.6	5.9	20.7	11.9	14.7	60.3	27.6	9.3	31.2	22.7	20.0	32.9	52.4	74.1	552.9	185.2	61.3	88.5	118.9	79.8	28.0	49.3	24.2
KPNA5	"IPOA6, SRP6"	ENSG00000196911	"Karyopherin subunit alpha 5"	O15131	6	116681187-116741867	"Predicted intracellular proteins, Transporters"	"Host-virus interaction, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 44.1"	"Cell type enhanced"	"Detected in all"		"Alveolar cells type 1: 227.6;Alveolar cells type 2: 240.9;granulocytes: 129.3;Respiratory ciliated cells: 143.6;Spermatocytes: 173.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"CAB026464, HPA054037"	Enhanced		Supported	Cytosol		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 21: Non-specific - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 11: Alveolar cells - Smell perception"	Cytosol		"CAB026464: , HPA054037: AB_2682351"	"unprognostic (9.64e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.72e-2)"	"unprognostic (3.56e-1)"	"unprognostic (6.60e-3)"	"unprognostic (6.98e-2)"	"unprognostic (1.75e-3)"	"unprognostic (5.19e-2)"	"unprognostic (1.10e-1)"	"unprognostic (6.12e-2)"	"unprognostic (1.51e-3)"	"unprognostic (3.02e-1)"	"unprognostic (6.12e-2)"	"unprognostic (8.00e-2)"	"unprognostic (4.79e-1)"	"unprognostic (7.89e-2)"	"unprognostic (1.43e-1)"	4.1	5.4	7.0	5.0	8.2	7.1	6.1	15.9	13.0	6.4	1.9	3.4	3.2	9.4	3.7	5.0	8.1	5.2	4.6	7.6	5.9	5.0	2.5	6.0	8.9	7.7	4.4	19.0	2.5	6.4	4.7	4.4	8.4	6.7	3.2	18.9	4.1	5.3	13.8	3.5	3.6	6.8	3.6	6.5	3.6	44.1	4.8	8.9	10.2	12.7	6.3	4.8	3.6	11.7	2.9	1.7	12.0	7.5	4.4	8.5	4.9	4.2	11.7	7.4	10.5	8.1	3.0	10.8	5.6	4.6	8.4	4.7	6.3	3.7	9.2	6.8	18.1	10.1	5.6	4.5	5.5	7.8	6.0	7.7	2.2	9.0	5.6	8.6	8.3	10.3	15.0	4.6	8.3	3.9	12.5	5.5	5.4	2.0	4.7	10.1	3.9	3.0	5.5	5.5	12.8	11.9	3.2	2.7	4.6	7.7	5.3	7.9	6.8	3.0	6.2	3.2	7.5	11.6	13.4	12.2	3.8	5.6	6.4	27.6	4.7	6.4	13.1	5.1	16.3	25.3	14.8	15.7	2.7	26.6	24.1	17.9	1.3	11.2	6.9	16.7	12.1	4.1	7.0	8.2	15.9	13.0	7.6	5.9	7.7	4.4	8.4	3.6	4.8	11.7	12.5	227.6	240.9	63.0	35.2	13.6	7.1	8.9	13.6	50.9	12.8	13.3	17.1	10.0	118.6	9.2	29.2	4.2	24.2	1.6	9.8	6.1	80.3	22.0	13.0	28.8	33.7	7.6	63.7	5.6	1.8	30.5	6.1	7.9	129.3	18.8	20.3	4.7	4.4	47.1	70.9	7.1	8.2	9.1	9.5	15.2	17.7	21.5	10.6	41.2	7.6	34.7	10.3	64.3	56.7	6.0	1.5	16.6	15.8	8.9	2.4	6.5	143.6	38.8	13.1	16.8	15.4	173.4	10.6	8.8	8.9	3.3	31.9	15.9	4.2	3.8
KRT15	"CK15, K15, K1CO"	ENSG00000171346	"Keratin 15"	P19012	17	41513745-41522529	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"breast: 419.1;esophagus: 1156.7;skin 1: 1319.5;vagina: 423.3"	"Group enriched"	"Detected in many"	4	"Basal prostatic cells: 2789.9;Basal squamous epithelial cells: 8290.4;Squamous epithelial cells: 4637.9"	"Cancer enhanced"	"Detected in many"		"cervical cancer: 178.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	10	"HaCaT: 1156.8;hTCEpi: 1001.5"	"Region enhanced"	"Detected in single"		"white matter: 1.9"	"Not detected"	"Not detected"			"HPA023910, HPA024554"	Enhanced		Supported	"Nucleoplasm,Intermediate filaments"		No	No		480000000		"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 61: Squamous epithelial cells - Keratinization"	"Intermediate filaments"	Nucleoplasm	"HPA023910: AB_1852205, HPA024554: AB_1852207"	"prognostic favorable (4.50e-4)"	"unprognostic (9.14e-2)"	"unprognostic (3.28e-2)"	"unprognostic (1.19e-3)"	"unprognostic (3.57e-2)"	"unprognostic (8.84e-2)"	"unprognostic (6.12e-3)"	"unprognostic (1.70e-1)"	"unprognostic (2.13e-1)"	"unprognostic (8.65e-3)"	"unprognostic (9.91e-3)"	"unprognostic (2.09e-1)"	"unprognostic (2.24e-11)"	"unprognostic (6.91e-3)"	"unprognostic (2.62e-1)"	"unprognostic (1.33e-5)"	"unprognostic (5.35e-2)"	4.7	0.3	0.1	0.2	0.0	0.7	419.1	0.0	0.1	148.2	0.2	1.1	1.5	0.3	2.2	1156.7	32.4	2.8	0.7	0.1	0.0	0.3	0.6	4.3	0.0	0.1	0.1	0.4	1.4	0.0	1.2	0.3	0.1	182.8	1.6	0.0	140.0	4.1	0.7	1319.5	2.3	0.1	0.0	0.3	1.6	8.0	0.1	93.7	0.5	0.0	77.6	9.5	423.3	0.1	56.4	7.4	0.0	0.0	0.0	0.0	0.7	5.3	1.3	0.3	0.2	5.9	20.2	0.0	1.8	0.6	14.0	1156.8	0.0	41.8	0.2	0.6	0.0	0.0	7.7	1.9	0.0	0.1	4.7	0.0	1001.5	2.2	6.9	2.7	3.4	0.0	0.3	0.5	0.2	3.5	0.1	0.5	0.0	3.9	6.2	0.0	0.0	104.9	3.3	5.9	2.6	0.1	1.1	15.0	1.2	0.3	20.3	0.0	18.6	0.3	2.8	0.3	2.2	0.1	0.1	0.0	8.3	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	6.1	12.8	10.3	0.0	2.7	1309.8	2789.9	1190.9	8290.4	0.6	577.7	670.3	0.8	5.7	287.5	1.8	0.0	0.7	16.9	18.3	1.9	8.5	117.6	4.1	0.7	22.9	4.8	0.0	0.1	7.5	7.7	21.7	4.6	8.2	2.5	0.0	0.0	0.0	0.4	0.0	0.1	10.3	189.2	0.0	61.7	44.4	1.5	17.2	320.2	0.0	0.0	0.2	0.0	0.0	0.1	14.1	10.5	0.4	88.7	872.9	8.6	0.1	57.7	0.6	0.0	0.4	32.1	0.6	0.8	4637.9	193.6	1.2	21.6	0.1	7.2	906.0
KRT18		ENSG00000111057	"Keratin 18"	P05783	12	52948871-52952906	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cell cycle, Host-virus interaction"		"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 3698.8;Ductal cells: 6583.8;Exocrine glandular cells: 4826.1;Extravillous trophoblasts: 5496.7;Pancreatic endocrine cells: 6071.5;Syncytiotrophoblasts: 7643.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	7	"basophil: 76.7"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 76.7"	"Cell line enhanced"	"Detected in many"		"A549: 5639.4;BEWO: 3818.0;CACO-2: 6249.4;CAPAN-2: 4576.4;MCF7: 8470.0;SK-BR-3: 4583.8"	"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"spinal cord: 12.1"	"CAB000008, CAB000030, HPA001605"	Enhanced		Supported	Cytosol		NA	NA		140000000	"Cluster 38: Basophils - Unknown function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 1: Pancreatic cells - Digestion"	Cytosol		"CAB000008: , CAB000030: , HPA001605: AB_2666381"	"unprognostic (1.98e-1)"	"unprognostic (1.03e-1)"	"unprognostic (3.31e-1)"	"unprognostic (1.63e-2)"	"unprognostic (1.25e-1)"	"unprognostic (7.26e-3)"	"unprognostic (4.09e-3)"	"prognostic unfavorable (5.06e-4)"	"unprognostic (8.81e-2)"	"unprognostic (4.17e-1)"	"prognostic unfavorable (1.78e-4)"	"unprognostic (3.05e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.19e-1)"	"unprognostic (1.11e-2)"	"unprognostic (1.13e-2)"	170.3	29.0	2.6	77.5	1.4	1.5	209.8	5.3	1.6	243.5	34.8	424.1	324.3	27.8	226.0	118.4	193.5	180.6	38.3	2.2	6.9	247.2	519.5	177.8	8.6	26.1	4.3	16.4	570.2	79.5	251.9	474.5	30.3	183.3	492.3	0.6	323.4	129.5	2.1	44.5	370.7	23.4	2.5	28.5	289.9	8.3	13.9	10.3	244.1	1.4	27.8	199.7	62.2	2.5	2065.1	5639.4	1.1	7.9	0.7	1.1	3818.0	313.3	349.5	368.4	104.6	6249.4	4576.4	1.4	839.8	318.4	196.5	487.2	79.1	2228.5	217.9	2.6	138.2	19.4	865.7	1743.9	942.1	0.6	1.3	13.6	202.9	323.8	437.1	1046.9	399.0	3.4	511.4	0.2	0.3	8470.0	3.8	37.3	471.0	2740.1	457.9	3.0	0.3	236.1	1803.3	1144.9	65.6	3.7	512.7	4583.8	18.8	2696.0	2446.8	6.6	137.9	5.0	441.8	6.9	68.3	1.1	7.3	4.3	0.9	1.2	36.4	76.7	0.3	2.4	0.6	0.2	2.2	4.6	4.5	1.2	2.2	7.4	11.1	4.1	3.2	2.5	0.0	0.1	0.4	2.9	2.6	1.4	5.3	1.6	2.2	6.9	26.1	4.3	30.3	2.5	13.9	2.5	14.4	862.2	286.4	0.3	29.8	14.8	1605.7	912.1	447.3	0.1	814.6	615.6	5.3	1252.5	877.3	623.5	0.0	3698.8	14.2	1942.9	275.9	6583.8	1.0	462.3	60.3	77.8	642.3	15.4	0.0	4826.1	5496.7	203.5	971.5	742.4	48.9	51.2	57.1	610.9	308.3	1.7	0.0	2492.6	1969.3	9.8	13.8	3.8	10.5	28.3	208.1	1.0	41.5	6.2	0.0	0.0	0.0	6071.5	2164.1	0.0	13.7	1205.1	1912.3	718.5	500.8	0.6	0.0	0.6	298.6	2.7	26.0	395.7	6.7	7643.5	38.1	45.0	1635.0	1512.1
KRT19	"CK19, K19, K1CS, MGC15366"	ENSG00000171345	"Keratin 19"	P08727	17	41523617-41528308	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 889.0;salivary gland: 810.7;urinary bladder: 781.4"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 7444.0;Club cells: 5055.9;Ductal cells: 4717.9;Extravillous trophoblasts: 6919.3;Pancreatic endocrine cells: 7374.9;Proximal enterocytes: 8623.3;Urothelial cells: 5959.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 1945.3;HBEC3-KT: 2945.0;MCF7: 2220.9;RT4: 3146.7;SK-BR-3: 5446.1;T-47d: 3674.2"	"Not detected"	"Not detected"							"CAB000031, HPA002465"	Enhanced		Supported	"Intermediate filaments"		NA	NA		300000000	"Cluster 40: NK-cells - Unknown function"	"Cluster 37: Intestine - Unknown function"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Intermediate filaments"		"CAB000031: AB_2234418, HPA002465: AB_1079179"	"unprognostic (1.09e-1)"	"unprognostic (1.83e-1)"	"unprognostic (3.86e-2)"	"unprognostic (1.59e-2)"	"unprognostic (2.24e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.29e-1)"	"unprognostic (2.80e-2)"	"unprognostic (3.14e-1)"	"unprognostic (4.86e-2)"	"prognostic unfavorable (6.82e-5)"	"unprognostic (1.90e-2)"	"prognostic unfavorable (2.98e-5)"	"unprognostic (3.52e-2)"	"unprognostic (2.14e-1)"	"unprognostic (3.08e-2)"	"unprognostic (2.35e-2)"	89.3	18.7	2.0	61.7	2.4	0.3	403.3	7.9	2.5	250.0	1.6	525.7	348.3	57.9	72.0	889.0	176.1	298.6	13.5	1.5	1.7	141.8	7.7	204.1	0.4	1.6	2.9	74.4	48.8	14.3	15.6	175.1	2.2	208.3	359.2	0.1	810.7	194.2	1.3	141.9	776.1	46.5	1.4	1.2	631.5	3.4	1.8	127.8	28.3	1.6	98.3	781.4	317.0	1.8	2.6	343.4	0.0	6.3	0.7	1.8	1169.3	412.1	0.5	12.8	2.9	992.6	1945.3	0.4	393.3	199.0	1.5	1044.6	0.1	2945.0	2.5	0.8	10.4	0.2	213.4	692.3	30.3	0.0	82.0	0.7	524.9	9.0	0.4	0.2	26.2	0.0	148.4	2.5	0.1	2220.9	5.9	3.0	18.5	1323.5	492.7	2.9	0.1	5.8	1335.4	3146.7	40.0	1.7	3.3	5446.1	0.1	266.5	3674.2	0.3	1.7	3.6	6.1	7.7	0.7	1.1	0.8	2.0	1.5	0.3	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	2.0	2.4	7.9	2.5	1.5	1.7	1.6	2.9	2.2	1.4	1.8	1.8	10.5	673.1	185.5	0.0	17.8	5.2	4317.3	7444.0	1715.8	0.0	1393.0	867.5	2.9	662.0	5055.9	892.0	0.0	1160.8	20.5	3599.6	1.9	4717.9	0.1	737.2	102.8	41.9	362.5	0.0	0.1	2589.9	6919.3	171.8	1571.4	1010.7	94.6	1.0	1.1	0.7	179.0	0.0	0.1	1382.4	2720.0	2.6	2.5	2.6	37.9	25.5	190.3	1.0	30.0	0.8	0.0	0.0	0.0	7374.9	3399.6	88.8	19.9	2228.8	8623.3	26.7	1954.3	0.0	0.0	0.0	240.0	1.1	1.6	1302.6	1.1	2127.5	36.1	4.8	1619.0	5959.8
KRT20	"CK20, K20, MGC35423"	ENSG00000171431	"Keratin 20"	P35900	17	40875889-40885242	"Plasma proteins, Predicted intracellular proteins"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"intestine: 646.9"	"Group enriched"	"Detected in some"	6	"Distal enterocytes: 1328.5;Intestinal goblet cells: 421.7;Paneth cells: 1606.6;Proximal enterocytes: 1107.3"	"Group enriched"	"Detected in many"	6	"colorectal cancer: 159.5;stomach cancer: 52.7;urothelial cancer: 99.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"NB-4: 1.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"CAB000032, HPA024309, HPA024684, HPA027236"	Enhanced		Supported	Cytosol		NA	NA		30000000		"Cluster 9: Intestine - Unknown function"	"Cluster 24: NB-4 - Immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Cytosol		"CAB000032: AB_2133718, HPA024309: AB_1852220, HPA024684: AB_1852222, HPA027236: AB_1852224"	"unprognostic (3.49e-1)"	"unprognostic (3.13e-1)"	"unprognostic (1.71e-1)"	"unprognostic (6.38e-3)"	"unprognostic (5.12e-2)"	"unprognostic (2.66e-3)"	"prognostic unfavorable (7.05e-4)"	"unprognostic (2.63e-2)"			"unprognostic (4.87e-3)"	"unprognostic (2.37e-2)"	"prognostic unfavorable (1.32e-4)"	"unprognostic (5.71e-2)"	"unprognostic (6.30e-2)"		"unprognostic (7.27e-2)"	1.3	0.0	0.0	49.9	0.0	0.0	1.6	0.0	0.0	0.1	0.0	597.7	295.9	2.1	0.0	0.3	0.3	0.5	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	480.1	0.0	0.0	1.2	0.0	0.1	646.9	27.0	0.0	0.0	124.9	0.0	0.0	0.0	0.0	0.0	0.0	21.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	4.4	1.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	1328.5	0.0	0.1	0.0	0.0	0.0	0.0	43.9	0.0	0.1	0.0	0.0	0.0	115.7	0.1	13.4	0.0	0.0	0.0	0.1	0.0	0.0	421.7	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1606.6	0.0	0.6	1.9	1107.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	1.6	0.0	160.4	1.4
KRT4	"CK4, CYK4, K4"	ENSG00000170477	"Keratin 4"	P19013	12	52806549-52814116	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"esophagus: 19735.6"	"Cell type enriched"	"Detected in some"	18	"Squamous epithelial cells: 5828.7"	"Group enriched"	"Detected in many"	5	"cervical cancer: 94.3;head and neck cancer: 151.8;stomach cancer: 73.1;urothelial cancer: 38.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	33	"HaCaT: 734.9;SK-BR-3: 361.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB002154, HPA034881"	Enhanced		Supported	"Intermediate filaments"		NA	NA		600000000		"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 61: Squamous epithelial cells - Keratinization"	"Intermediate filaments"		"CAB002154: AB_563803, HPA034881: AB_2674370"	"unprognostic (4.04e-1)"	"unprognostic (3.22e-3)"	"unprognostic (5.16e-3)"	"unprognostic (8.52e-3)"		"unprognostic (1.20e-1)"		"unprognostic (2.64e-1)"	"unprognostic (1.84e-1)"	"prognostic unfavorable (3.26e-4)"	"unprognostic (2.85e-3)"	"unprognostic (2.84e-2)"	"unprognostic (2.58e-11)"	"unprognostic (1.64e-1)"	"unprognostic (6.97e-2)"	"unprognostic (1.16e-1)"	"prognostic unfavorable (6.26e-4)"	1.5	1.5	0.0	0.0	0.0	0.0	0.9	0.0	0.0	513.5	0.0	1.1	0.0	1.2	0.0	19735.6	9.5	3.1	7.2	0.0	0.0	0.9	2.6	17.3	0.0	0.0	0.0	1.8	2.8	0.0	8.9	0.0	0.0	4.3	0.0	0.0	2124.1	0.0	2.6	3.9	1.7	0.9	0.0	1.5	8.6	0.8	0.0	2.0	1.0	0.1	1418.0	4.4	1040.2	0.0	0.0	16.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	1.8	0.0	0.1	0.0	734.9	0.0	0.0	0.0	0.0	0.0	0.6	0.2	0.0	0.0	0.5	1.3	0.0	0.9	0.0	0.0	0.0	0.0	0.0	1.9	0.3	0.0	1.4	0.0	0.2	0.0	15.5	0.0	0.1	0.3	0.0	0.0	0.0	0.2	0.0	1.0	361.6	0.0	0.0	2.0	0.0	2.0	0.0	0.2	0.0	0.0	0.0	1.0	0.9	0.5	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.4	3.3	0.0	0.0	0.0	6.5	36.9	23.3	0.0	0.5	2.9	0.5	0.0	308.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.6	0.2	2.9	0.0	0.0	0.0	0.0	0.0	2.6	0.0	1.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	28.5	0.0	0.0	0.1	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	9.9	6.9	0.0	0.1	53.7	0.0	0.0	0.0	5.3	0.0	0.1	5828.7	0.0	0.0	2.0	0.0	0.0	54.4
KRT7	"CK7, K2C7, K7, SCL"	ENSG00000135480	"Keratin 7"	P08729	12	52232520-52252186	"Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"salivary gland: 905.8;thyroid gland: 593.0"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 1756.7;Ductal cells: 2931.3;Exocrine glandular cells: 2143.5;Extravillous trophoblasts: 4196.1;Pancreatic endocrine cells: 6163.7;Prostatic glandular cells: 2386.6;Urothelial cells: 1900.8"	"Cancer enhanced"	"Detected in many"		"urothelial cancer: 560.1"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	4	"intermediate monocyte: 1.1"	"Lineage enriched"	"Detected in single"	4	"monocytes: 1.1"	"Cell line enhanced"	"Detected in many"		"A549: 2418.2;BEWO: 2737.9;HBEC3-KT: 6225.3;hTERT-HME1: 2433.8;RT4: 7463.2;SiHa: 5833.6;SK-BR-3: 3363.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB000028, HPA007272, HPA007315, CAB079970"	Enhanced		Approved	"Intermediate filaments,Cytosol"		NA	NA		1300000000	"Cluster 7: Monocytes - Unknown function"	"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 15: RT4 - Unknown function"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	"Intermediate filaments"	Cytosol	"CAB000028: AB_2134589, CAB079970: , HPA007272: AB_1079181, HPA007315: "	"unprognostic (2.71e-3)"	"unprognostic (3.09e-1)"	"unprognostic (2.20e-1)"	"prognostic unfavorable (1.99e-4)"	"unprognostic (2.22e-2)"	"unprognostic (8.59e-2)"	"unprognostic (1.27e-1)"	"unprognostic (5.44e-3)"	"unprognostic (2.74e-1)"	"prognostic unfavorable (9.42e-5)"	"prognostic unfavorable (7.78e-5)"	"unprognostic (4.54e-2)"	"prognostic favorable (2.77e-9)"	"unprognostic (2.82e-1)"	"unprognostic (1.43e-2)"	"unprognostic (3.28e-1)"	"unprognostic (3.98e-3)"	27.1	0.7	0.0	1.4	0.0	0.3	272.9	0.0	0.2	48.4	0.0	1.6	0.4	12.9	15.2	91.7	75.9	82.4	5.6	0.0	0.0	147.5	14.2	325.2	1.7	0.2	0.0	2.4	57.4	5.6	12.0	265.1	0.2	58.1	0.7	0.3	905.8	213.2	1.7	78.3	1.3	0.4	0.1	0.8	17.8	0.8	0.1	3.3	593.0	2.0	6.7	389.8	20.1	0.4	4.9	2418.2	0.6	1.7	2.8	0.0	2737.9	509.6	0.6	261.3	23.6	7.6	1683.1	0.3	1.4	176.3	0.8	1871.6	0.2	6225.3	13.3	3.0	0.0	2.2	1179.8	8.0	57.4	1.5	1.5	1.3	380.7	1.3	2433.8	1.0	267.4	0.0	0.7	2.2	0.1	13.7	1.8	3.7	7.6	1.1	2.6	2.0	4.8	38.6	1520.5	7463.2	3.5	2.4	5833.6	3363.4	0.0	27.5	130.3	0.0	2028.2	1.9	3.7	2.4	1.1	1.8	0.4	2.0	2.0	1.6	1.2	0.0	0.1	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.2	0.1	0.1	0.4	8.1	653.9	109.4	0.0	2.5	3.6	1172.6	173.6	8.0	0.0	451.3	426.3	0.8	724.9	684.8	360.5	0.0	1756.7	8.9	2.2	135.0	2931.3	16.1	106.2	20.4	30.6	6.6	0.0	0.1	2143.5	4196.1	29.9	14.3	253.2	3.8	0.1	4.2	2.9	189.9	0.0	0.0	3.5	954.2	3.4	4.6	140.0	3.7	11.0	131.6	0.0	35.6	0.0	0.0	0.0	0.0	6163.7	0.3	0.4	1.4	2386.6	0.2	8.5	249.2	0.0	0.0	7.6	72.1	0.6	1.3	35.3	2.3	1442.5	9.2	0.0	4.4	1900.8
KRT8	"CARD2, CK8, CYK8, K2C8, K8, KO"	ENSG00000170421	"Keratin 8"	P05787	12	52897187-52949954	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction"		"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 1335.5;stomach 1: 800.1"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 4302.8;Ductal cells: 6037.3;Exocrine glandular cells: 5457.6;Extravillous trophoblasts: 5323.4;Pancreatic endocrine cells: 5278.1;Paneth cells: 4937.3;Proximal enterocytes: 6802.6;Syncytiotrophoblasts: 5268.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"plasmacytoid DC: 1.7"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"A549: 6130.6;BEWO: 3998.7;CACO-2: 7686.4;CAPAN-2: 4774.8;MCF7: 10521.8;SK-BR-3: 5126.4;T-47d: 4325.7"	"Low region specificity"	"Detected in many"			"Region enriched"	"Detected in all"	10	"spinal cord: 44.0"	"CAB000131, CAB001696, HPA049866"	Enhanced		Supported	"Intermediate filaments"		NA	NA		1700000000	"Cluster 15: NK-cells - Transcription"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	"Intermediate filaments"		"CAB000131: AB_2281144, CAB001696: , HPA049866: AB_2680923"	"unprognostic (5.72e-2)"	"unprognostic (2.29e-1)"	"unprognostic (2.49e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.76e-2)"	"unprognostic (4.86e-3)"	"unprognostic (3.10e-2)"	"unprognostic (2.52e-2)"	"unprognostic (1.92e-1)"	"unprognostic (4.58e-1)"	"prognostic unfavorable (1.51e-4)"	"unprognostic (8.99e-2)"	"unprognostic (2.08e-2)"	"unprognostic (2.83e-2)"	"unprognostic (3.18e-1)"	"unprognostic (3.68e-1)"	"unprognostic (1.19e-2)"	135.0	43.6	2.2	158.6	1.3	1.0	113.8	2.0	1.6	183.4	21.3	1079.2	1112.0	34.7	66.4	48.2	134.3	217.5	147.8	1.9	1.9	240.2	463.9	172.5	7.9	8.3	4.5	10.3	654.1	59.9	278.7	368.7	8.8	151.6	564.2	0.4	318.0	73.6	1.5	49.3	1335.5	50.6	0.4	16.3	800.1	7.6	4.9	47.6	237.5	0.3	13.8	209.0	36.7	1.7	2787.7	6130.6	0.2	7.8	0.7	3.2	3998.7	11.1	47.9	6.1	6.3	7686.4	4774.8	1.1	1130.2	14.7	6.9	947.1	17.6	752.6	5.9	4.6	130.8	4.3	1184.4	2234.2	212.8	1.2	2.4	9.5	12.6	14.8	50.8	419.9	17.0	1.0	484.7	1.7	0.1	10521.8	6.5	10.6	418.5	2740.6	132.8	3.8	2.2	15.2	1198.1	1354.5	129.9	5.0	1063.2	5126.4	7.8	1263.8	4325.7	10.5	18.8	5.7	443.4	9.3	10.0	1.6	7.0	7.6	3.3	1.7	13.4	1.3	0.1	0.2	0.2	0.2	0.1	0.1	0.1	0.1	0.7	0.2	0.1	0.1	0.4	0.5	0.1	1.7	0.1	0.2	2.2	1.3	2.0	1.6	1.9	1.9	8.3	4.5	8.8	0.4	4.9	1.7	7.7	400.6	176.5	0.3	26.9	6.0	1948.0	684.7	303.3	2.3	521.6	342.8	30.2	1069.5	734.8	491.1	0.0	2208.2	8.5	4302.8	297.4	6037.3	13.9	419.2	41.0	42.3	942.5	8.6	0.5	5457.6	5323.4	94.7	1740.1	557.1	76.3	88.0	24.3	310.9	252.2	1.7	0.5	2876.3	1625.5	9.9	7.2	69.9	8.1	22.2	131.6	0.0	55.0	3.4	1.0	1.0	0.3	5278.1	4937.3	1.9	6.6	994.7	6802.6	569.1	594.8	4.3	0.0	2.2	167.4	2.0	11.4	258.9	1.7	5268.8	33.4	13.4	2337.3	1542.5
KSR1	"KSR, RSU2"	ENSG00000141068	"Kinase suppressor of ras 1"	Q8IVT5	17	27456470-27626438	"Enzymes, Predicted intracellular proteins, RAS pathway related proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 101.4"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 73.0;Glandular and luminal cells: 50.3;Inhibitory neurons: 50.2;Oligodendrocyte precursor cells: 53.3;Oligodendrocytes: 49.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"eosinophil: 3.8"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 393.5;HEL: 140.5;HMC-1: 93.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009623, HPA011215, HPA011878"	Uncertain		Supported	Vesicles,Cytosol		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 22: Non-specific - Unknown function"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 44: Endometrium - Transcription"	Cytosol	Vesicles	"CAB009623: AB_2265455, HPA011215: AB_1852649, HPA011878: "	"unprognostic (2.03e-2)"	"unprognostic (2.74e-1)"	"unprognostic (2.60e-1)"	"unprognostic (3.48e-3)"	"unprognostic (2.90e-1)"	"unprognostic (6.98e-2)"	"unprognostic (1.92e-5)"	"unprognostic (8.36e-3)"	"unprognostic (1.32e-1)"	"unprognostic (3.15e-2)"	"unprognostic (1.12e-3)"	"unprognostic (1.65e-1)"	"prognostic unfavorable (6.54e-4)"	"unprognostic (1.00e-1)"	"unprognostic (7.55e-2)"	"unprognostic (1.74e-2)"	"unprognostic (9.61e-2)"	22.6	17.5	19.6	19.9	22.0	16.7	15.6	17.4	35.8	36.9	13.2	13.1	8.1	26.5	9.9	29.8	20.8	21.4	13.6	33.1	19.3	40.7	6.5	26.2	14.3	28.6	20.2	26.4	101.4	7.3	15.1	44.9	23.0	15.6	8.5	19.4	8.4	18.5	30.0	21.6	15.2	20.0	17.5	22.5	9.3	25.3	22.9	11.6	31.0	14.0	14.6	14.6	23.1	26.7	4.6	18.1	11.1	5.8	9.2	6.5	64.7	4.2	9.1	6.2	7.2	55.0	0.8	4.4	9.5	8.0	40.8	2.8	11.0	2.5	3.7	393.5	12.1	140.5	19.3	23.0	16.0	1.8	93.0	8.1	4.0	17.8	0.5	25.3	34.8	6.1	75.0	0.5	3.6	4.4	2.1	5.4	8.3	4.0	3.2	9.1	61.5	3.2	25.1	3.3	17.1	11.3	22.3	5.1	6.0	29.4	0.7	7.5	32.5	1.8	8.2	5.1	3.0	0.5	0.1	0.1	1.8	7.9	10.5	0.0	1.0	3.8	0.3	2.1	0.3	0.4	0.1	0.2	0.5	0.1	0.1	0.1	1.1	0.9	1.1	0.0	0.5	0.4	19.6	22.0	17.4	35.8	33.1	19.3	28.6	20.2	23.0	17.5	22.9	26.7	19.7	6.4	3.4	33.6	4.1	3.1	3.6	3.1	1.8	11.8	1.9	2.3	1.2	1.5	11.9	14.7	73.0	19.2	4.9	7.1	3.9	2.0	33.4	24.0	21.6	9.1	6.6	0.4	26.2	5.3	21.0	8.2	3.6	50.3	0.0	10.8	11.7	1.3	6.7	10.1	50.2	2.2	0.0	8.3	6.9	47.7	1.5	9.0	8.8	27.2	10.4	5.7	4.1	53.3	49.2	2.1	7.1	2.2	2.8	1.6	6.7	3.2	14.9	25.8	0.0	5.3	4.8	2.6	6.1	11.3	6.0	19.4	5.7	8.4	1.2	6.2
KYAT1	"CCBL1, GTK, KATI"	ENSG00000171097	"Kynurenine aminotransferase 1"	Q16773	9	128832942-128882494	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Aminotransferase, Lyase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	6	"Granulosa cells: 45.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA021176, HPA021177, HPA027736"	Approved		Supported	Cytosol		NA	NA		22000	"Cluster 27: Non-specific - Gene expression"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 20: HeLa - Mitochondria"	"Cluster 40: Granulosa cells - Unknown function"	Cytosol		"HPA021176: AB_1846120, HPA021177: AB_1846119, HPA027736: AB_10611818"	"unprognostic (6.51e-2)"	"unprognostic (8.67e-3)"	"unprognostic (1.05e-2)"	"unprognostic (5.98e-3)"	"unprognostic (2.15e-2)"	"unprognostic (5.44e-2)"	"unprognostic (2.91e-2)"	"unprognostic (1.12e-2)"	"unprognostic (2.47e-1)"	"unprognostic (8.60e-3)"	"unprognostic (1.43e-1)"	"unprognostic (3.65e-2)"	"unprognostic (3.10e-2)"	"unprognostic (5.79e-2)"	"unprognostic (2.03e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.98e-1)"	3.5	4.7	12.3	3.6	13.3	2.3	4.0	13.0	15.5	7.2	10.6	4.7	2.5	5.8	2.9	5.3	6.4	2.7	10.3	12.1	11.8	7.8	12.7	3.6	5.0	13.2	12.3	6.2	3.1	5.5	8.7	2.5	12.8	7.4	1.3	7.5	4.2	4.3	12.6	7.7	4.2	3.1	12.3	5.4	4.9	5.6	12.9	8.9	6.1	8.7	4.8	7.2	6.7	18.0	4.8	9.8	9.3	10.6	6.9	11.4	3.0	5.5	8.0	6.2	8.0	3.9	9.7	8.3	2.9	4.6	7.0	14.9	13.9	11.1	9.3	10.0	7.3	5.7	27.7	9.6	7.7	5.0	1.9	4.5	7.1	7.1	7.7	21.8	11.3	22.7	8.2	9.0	8.5	3.1	14.0	3.4	15.2	18.3	7.6	16.4	6.4	18.9	8.7	1.7	10.5	7.4	9.9	2.9	6.2	12.8	6.6	1.6	7.0	4.6	7.9	7.1	5.0	15.2	11.0	11.6	9.6	8.3	3.2	0.1	1.4	2.9	5.1	1.8	4.5	7.7	5.7	6.0	5.5	3.3	5.9	6.7	0.9	3.3	2.9	2.4	7.0	3.3	12.3	13.3	13.0	15.5	12.1	11.8	13.2	12.3	12.8	12.3	12.9	18.0	2.6	0.0	1.5	0.0	1.5	0.0	0.0	0.0	0.0	0.0	2.0	1.5	0.0	0.0	0.6	0.0	0.0	5.0	0.9	0.0	3.9	1.6	0.0	2.6	3.3	0.7	0.0	0.0	0.0	0.2	2.4	0.7	0.0	4.2	0.0	45.1	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.3	0.0	0.0	7.3	2.9	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	2.1	1.3	1.3	0.0	0.0
KYNU		ENSG00000115919	Kynureninase	Q16719	2	142877657-143055833	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Pyridine nucleotide biosynthesis"	Hydrolase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 88.4;urinary bladder: 51.5"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 136.1;Club cells: 109.6;Ionocytes: 114.0;Langerhans cells: 190.5;Macrophages: 122.9;monocytes: 248.0;Syncytiotrophoblasts: 104.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	17	"classical monocyte: 109.4;intermediate monocyte: 142.7;memory B-cell: 73.6;myeloid DC: 111.2;naive B-cell: 51.3;non-classical monocyte: 123.4;plasmacytoid DC: 77.7"	"Group enriched"	"Detected in many"	19	"B-cells: 73.6;dendritic cells: 111.2;monocytes: 142.7"	"Cell line enhanced"	"Detected in many"		"A549: 185.2;GAMG: 298.5;HeLa: 195.5;Hep G2: 128.3;hTEC/SVTERT24-B: 106.5;U-87 MG: 314.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA031686	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA		590000	"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 85: Liver - Metabolism"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Cytosol	Nucleoplasm	"HPA031686: AB_2673995"	"unprognostic (2.58e-2)"	"unprognostic (3.39e-3)"	"unprognostic (1.21e-2)"	"unprognostic (5.94e-2)"	"unprognostic (1.65e-2)"	"unprognostic (9.04e-2)"	"unprognostic (5.36e-3)"	"unprognostic (3.58e-3)"	"unprognostic (4.88e-2)"	"unprognostic (3.35e-2)"	"unprognostic (2.87e-3)"	"unprognostic (1.51e-1)"	"unprognostic (1.40e-3)"	"unprognostic (3.33e-3)"	"unprognostic (3.65e-2)"	"unprognostic (5.24e-2)"	"unprognostic (1.64e-1)"	5.2	4.0	2.4	24.4	2.1	10.8	30.8	2.7	4.5	4.0	3.6	2.4	1.1	2.5	1.3	6.7	1.2	9.8	1.2	2.0	1.6	18.6	88.4	13.5	15.0	2.8	1.7	0.4	0.9	0.8	1.2	7.3	3.3	0.9	2.9	1.5	1.8	0.7	0.7	1.3	3.0	4.8	0.5	8.9	5.8	16.6	6.6	3.9	2.3	0.3	28.9	51.5	3.4	2.1	0.2	185.2	0.3	0.4	0.4	0.6	0.5	0.4	5.1	0.2	0.2	3.3	2.7	11.9	0.5	0.1	298.5	0.7	0.1	0.2	0.2	0.6	0.2	4.3	195.5	128.3	2.4	0.4	0.8	17.3	15.0	106.5	0.6	0.2	0.2	0.3	0.5	1.1	1.7	96.7	0.2	11.8	0.7	0.2	0.9	0.2	0.9	0.4	3.2	96.0	0.5	0.3	102.2	15.2	1.0	1.0	50.9	26.5	1.5	5.9	0.5	89.1	0.3	0.7	0.3	0.3	314.5	22.2	0.6	0.7	109.4	2.4	0.5	142.7	0.4	73.6	0.6	0.3	111.2	51.3	0.5	0.3	5.8	1.8	123.4	77.7	0.6	49.2	2.4	2.1	2.7	4.5	2.0	1.6	2.8	1.7	3.3	0.5	6.6	2.1	3.0	3.2	2.7	0.7	46.8	4.0	0.5	136.1	0.0	0.5	5.8	0.9	1.6	7.2	109.6	3.7	4.2	3.3	16.1	0.7	5.9	14.5	46.3	1.5	1.1	5.1	0.0	2.5	1.3	9.5	2.3	1.8	20.4	15.7	0.0	0.0	2.5	49.1	38.8	10.1	0.9	0.0	114.0	64.7	190.5	42.8	1.8	122.9	1.8	29.0	248.0	0.2	1.0	0.5	0.8	59.6	1.1	0.4	5.1	1.1	0.0	44.4	21.1	0.6	6.6	0.5	3.9	47.8	8.0	1.5	3.1	104.7	2.2	0.1	1.0	22.6
L1CAM	"CD171, HSAS, HSAS1, MASA, MIC5, S10, SPG1"	ENSG00000198910	"L1 cell adhesion molecule"	P32004	X	153861514-153886173	"CD markers, Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion, Differentiation, Neurogenesis"	"Developmental protein"	"Disease variant, Hereditary spastic paraplegia, Hirschsprung disease, Mental retardation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 42.8;intestine: 48.5"	"Cell type enhanced"	"Detected in some"		"Collecting duct cells: 84.6;Excitatory neurons: 23.7;Horizontal cells: 33.7;Inhibitory neurons: 23.3;Melanocytes: 44.4"	"Cancer enhanced"	"Detected in many"		"melanoma: 34.1"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 372.4;BJ hTERT+ SV40 Large T+ RasG12V: 200.8;HeLa: 258.1;RH-30: 162.6;RPTEC TERT1: 218.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB010896	Enhanced		Approved	"Nucleoplasm,Plasma membrane"		NA	NA		67000000	"Cluster 24: B-cells - Unknown function"	"Cluster 45: Intestine - Brush border"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 62: Horizontal cells - Visual perception"	"Nucleoplasm, Plasma membrane"		"CAB010896: AB_609903"	"unprognostic (1.33e-3)"	"unprognostic (3.43e-2)"	"unprognostic (2.75e-1)"	"prognostic unfavorable (8.51e-10)"	"unprognostic (2.04e-2)"	"prognostic unfavorable (3.81e-4)"	"unprognostic (9.44e-2)"	"prognostic unfavorable (2.36e-6)"	"unprognostic (1.13e-1)"	"unprognostic (9.12e-2)"	"unprognostic (8.52e-3)"	"unprognostic (8.02e-2)"	"prognostic unfavorable (1.17e-4)"	"unprognostic (3.07e-1)"	"unprognostic (6.31e-2)"	"unprognostic (1.69e-1)"	"unprognostic (7.47e-3)"	3.5	27.2	20.4	7.6	23.0	0.5	2.1	23.0	42.8	8.4	0.0	48.5	4.2	2.4	2.1	4.4	3.4	2.4	12.1	12.6	42.4	18.5	0.9	0.6	3.2	9.0	2.5	1.3	2.2	0.1	14.4	0.6	6.1	8.3	4.7	15.7	4.8	9.0	0.9	9.2	13.0	5.4	0.0	0.9	11.3	0.8	3.2	0.7	2.5	2.1	1.8	6.1	9.6	13.2	95.2	7.2	27.6	0.2	0.0	0.0	11.8	131.6	372.4	123.6	200.8	37.8	1.0	0.0	121.8	0.9	103.2	3.9	3.5	2.3	64.1	0.3	1.0	0.0	258.1	6.1	0.4	0.3	20.4	0.9	1.6	18.7	12.9	0.2	0.1	0.1	0.3	0.3	0.6	127.9	0.4	2.6	6.5	0.4	4.7	0.2	162.6	0.9	218.4	1.9	81.4	53.0	73.4	64.2	54.1	61.0	6.7	1.7	0.3	0.1	52.6	5.8	63.7	1.1	1.6	1.0	0.9	1.1	105.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.4	23.0	23.0	42.8	12.6	42.4	9.0	2.5	6.1	0.0	3.2	13.2	0.4	0.0	0.0	2.6	1.3	1.1	0.1	0.6	3.4	11.6	0.0	0.4	1.2	0.0	0.0	84.6	4.2	0.3	0.1	0.0	0.0	0.5	0.0	0.3	0.1	1.9	0.0	0.0	23.7	0.0	0.2	1.3	0.0	0.6	0.0	0.0	1.4	0.0	0.1	33.7	23.3	0.0	0.0	0.0	1.1	0.0	0.9	0.3	44.4	5.6	0.0	1.5	0.0	1.5	1.7	0.0	0.0	0.0	0.1	0.1	0.0	0.3	0.1	10.4	0.0	2.2	0.6	0.4	0.1	0.0	1.3	0.1	1.5	0.0	0.0	0.1
L3MBTL1	"dJ138B7.3, DKFZp586P1522, KIAA0681, L3MBTL, ZC2HC3"	ENSG00000185513	"L3MBTL histone methyl-lysine binding protein 1"	Q9Y468	20	43489442-43550954	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Chromatin regulator, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Inhibitory neurons: 24.4;Oligodendrocyte precursor cells: 31.2;Oligodendrocytes: 25.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"SuSa: 5.1"									HPA059648			Supported	"Nucleoplasm,Nuclear bodies,Midbody ring"		Yes	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 43: Testis - Unknown function"	"Cluster 12: NES - Nervous system development"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm	"Nuclear bodies, Midbody ring"	"HPA059648: "	"unprognostic (2.32e-1)"	"unprognostic (2.77e-1)"	"unprognostic (5.66e-2)"	"unprognostic (7.19e-3)"	"unprognostic (1.28e-1)"	"unprognostic (1.50e-2)"	"unprognostic (7.65e-4)"	"unprognostic (6.02e-2)"	"unprognostic (6.00e-2)"	"unprognostic (2.23e-2)"	"unprognostic (1.15e-3)"	"unprognostic (1.20e-2)"	"unprognostic (1.44e-3)"	"unprognostic (2.01e-1)"	"unprognostic (1.65e-1)"	"unprognostic (2.89e-1)"	"unprognostic (1.56e-4)"	2.7	4.8	8.6	0.8	8.5	0.8	3.9	6.4	10.2	6.4	6.1	6.1	1.1	5.0	2.0	4.2	6.9	0.6	3.9	8.0	9.4	5.9	2.0	3.0	0.8	8.0	8.8	7.5	3.3	1.1	16.7	0.6	8.7	6.4	0.7	3.4	4.6	1.7	5.1	3.9	4.8	0.8	6.1	5.5	3.9	10.1	10.8	0.8	6.9	1.1	0.5	4.8	6.4	7.6	0.1	0.1	1.6	0.9	0.1	0.0	2.6	0.2	0.3	0.5	0.4	0.2	1.7	0.9	0.4	0.9	0.5	1.1	0.0	0.4	0.3	0.0	1.1	0.3	1.4	2.1	0.3	0.0	0.3	0.3	0.6	0.1	0.0	2.9	0.3	0.9	0.6	0.2	0.1	0.3	0.4	1.2	1.0	0.7	1.4	0.6	0.2	0.5	1.2	0.4	0.4	1.3	0.5	0.5	0.1	5.1	0.6	1.7	0.6	0.2	1.1	0.0	0.4	1.0	0.4	0.3	1.5	1.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.1	0.0	0.2	8.6	8.5	6.4	10.2	8.0	9.4	8.0	8.8	8.7	6.1	10.8	7.6	1.2	3.2	3.2	16.0	3.3	0.9	2.0	1.9	8.0	17.2	2.7	2.8	1.9	1.5	4.2	5.5	14.6	2.1	5.2	0.9	1.9	1.3	2.0	2.4	2.6	2.2	1.2	1.7	12.4	0.2	3.3	1.9	2.0	1.8	5.1	8.3	1.8	0.6	1.4	6.7	24.4	2.1	4.1	1.6	1.8	2.8	5.0	2.0	3.6	4.7	1.0	4.7	4.1	31.2	25.4	0.8	1.9	6.0	1.7	2.5	3.1	0.7	6.6	10.8	0.0	4.2	2.8	13.9	12.3	1.5	1.1	1.9	2.3	4.6	1.8	1.4
L3MBTL3	KIAA1798	ENSG00000198945	"L3MBTL histone methyl-lysine binding protein 3"	Q96JM7	6	130013699-130141449	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"granulocytes: 40.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HMC-1: 63.5;HUVEC TERT2: 62.5;TIME: 43.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044382, HPA053035"	Approved		Supported	"Nucleoplasm,Nucleoli,Nucleoli rim"		NA	No			"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 34: Non-specific - Transcription"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 44: Endometrium - Transcription"	"Nucleoli, Nucleoli rim"	Nucleoplasm	"HPA044382: AB_2678920, HPA053035: AB_2682021"	"unprognostic (2.33e-1)"	"unprognostic (9.92e-2)"	"unprognostic (1.40e-1)"	"unprognostic (7.82e-2)"	"unprognostic (4.22e-3)"	"unprognostic (1.28e-2)"	"unprognostic (4.51e-2)"	"unprognostic (1.48e-2)"	"unprognostic (2.90e-1)"	"unprognostic (2.63e-1)"	"unprognostic (7.56e-3)"	"unprognostic (1.07e-1)"	"unprognostic (8.44e-2)"	"unprognostic (3.94e-3)"	"unprognostic (2.88e-1)"	"unprognostic (2.45e-2)"	"unprognostic (1.60e-2)"	4.5	11.0	3.3	9.9	3.3	7.7	4.7	1.7	3.6	9.5	9.6	4.6	2.8	11.2	11.7	2.3	5.5	5.3	2.4	4.1	3.8	4.8	5.8	4.0	11.1	2.5	3.1	10.1	2.3	5.6	5.5	5.7	2.4	7.0	5.0	2.1	4.9	6.2	2.5	2.7	5.1	8.3	2.5	12.6	3.3	7.6	4.5	7.7	6.0	2.1	8.9	5.7	5.3	2.6	1.7	6.5	15.2	2.4	10.4	13.4	3.1	7.8	15.9	3.0	5.5	8.0	8.1	2.7	11.0	9.9	9.3	6.5	8.7	13.6	4.6	6.1	8.8	18.3	3.2	2.0	5.2	10.8	63.5	8.8	9.6	3.6	10.2	15.1	62.5	8.3	13.3	7.1	7.7	0.7	23.2	1.9	7.0	1.7	3.3	8.7	4.2	0.0	9.8	2.5	0.5	2.0	2.9	0.7	6.1	18.2	16.4	9.3	43.0	5.1	6.9	0.9	5.3	1.4	0.1	4.7	2.5	4.5	5.2	8.2	4.9	4.8	3.7	5.5	3.2	10.7	3.5	4.7	1.9	13.4	3.2	4.1	4.9	2.1	22.7	14.8	5.9	1.0	3.3	3.3	1.7	3.6	4.1	3.8	2.5	3.1	2.4	2.5	4.5	2.6	9.1	3.2	6.5	6.5	20.5	5.1	5.1	2.4	10.2	4.2	5.3	2.8	3.9	1.5	3.8	9.2	2.1	13.4	20.7	2.8	1.9	5.6	24.2	6.1	12.8	9.4	3.6	5.0	20.8	5.4	7.1	7.3	4.6	16.1	40.4	24.7	8.9	6.3	4.0	0.0	10.5	9.3	6.1	8.2	4.0	3.1	9.6	9.5	1.8	11.2	12.9	5.3	13.4	15.6	8.5	10.9	5.2	6.0	5.2	4.7	0.5	5.9	4.1	0.7	6.6	11.2	8.6	5.8	7.6	4.0	4.4	6.2	15.6	9.5	5.0	5.5
LACTB	"FLJ14902, MRPL56"	ENSG00000103642	"Lactamase beta"	P83111	15	63121833-63142061	"Enzymes, Predicted intracellular proteins"	"Lipid metabolism"	"Hydrolase, Protease"	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"monocytes: 152.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036361, HPA036362"	Supported		Supported	Mitochondria	"Intracellular and membrane"	NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 3: Monocytes - Immune response regulation"	Mitochondria		"HPA036361: AB_10672244, HPA036362: AB_10670798"	"unprognostic (6.07e-2)"	"unprognostic (2.02e-1)"	"unprognostic (2.22e-2)"	"unprognostic (2.87e-1)"	"unprognostic (1.20e-2)"	"unprognostic (3.10e-2)"	"unprognostic (8.08e-2)"	"unprognostic (6.25e-2)"	"unprognostic (8.98e-2)"	"unprognostic (3.08e-1)"	"unprognostic (6.22e-3)"	"unprognostic (5.16e-3)"	"unprognostic (6.28e-2)"	"unprognostic (3.24e-1)"	"unprognostic (8.64e-2)"	"unprognostic (7.90e-2)"	"unprognostic (3.88e-3)"	17.3	25.4	7.1	21.2	7.4	57.0	12.5	7.2	8.0	8.4	10.8	18.5	19.6	7.6	8.4	14.9	7.0	14.3	22.2	7.2	7.3	23.6	42.4	19.0	19.8	7.3	7.5	8.1	10.6	9.9	6.7	11.8	7.4	9.2	15.9	4.7	9.9	6.8	49.2	12.0	16.9	9.0	7.2	18.3	12.8	22.1	8.3	9.1	9.3	36.3	13.2	19.7	9.2	8.4	60.3	37.0	10.4	7.3	51.9	27.4	8.7	25.7	39.4	43.3	79.9	9.3	37.5	8.0	31.0	37.5	46.9	16.6	35.6	16.7	54.2	55.1	8.9	15.6	12.2	23.7	48.0	14.2	26.1	37.3	35.1	44.5	36.4	64.9	45.2	46.4	14.9	22.1	74.7	22.6	10.9	17.3	15.6	36.7	11.7	8.0	26.6	18.5	23.6	92.5	9.3	4.4	18.6	20.7	59.0	36.0	15.9	23.4	81.5	57.8	44.8	26.2	32.9	23.3	21.8	2.2	44.3	39.2	27.3	4.4	8.4	4.4	1.1	8.3	1.8	3.1	0.9	0.9	9.8	2.6	0.8	1.4	5.3	2.1	7.3	0.8	3.0	2.2	7.1	7.4	7.2	8.0	7.2	7.3	7.3	7.5	7.4	7.2	8.3	8.4	24.6	25.6	22.6	4.9	25.7	58.2	27.2	12.0	19.9	6.5	21.7	16.1	42.5	22.8	10.9	12.9	12.5	15.8	19.3	26.0	25.4	56.0	62.9	13.2	16.4	31.1	7.3	10.8	12.5	43.1	40.5	26.4	17.3	19.3	66.5	12.1	8.9	57.0	88.6	8.4	14.5	27.1	16.2	71.3	72.5	30.6	14.3	97.0	26.6	15.9	152.9	6.9	7.2	10.1	8.1	75.0	19.0	16.1	21.3	35.6	25.2	79.2	9.2	11.3	6.6	37.9	31.5	122.9	25.6	26.3	60.0	18.1	21.8	23.9	20.4	39.6
LACTB2	CGI-83	ENSG00000147592	"Lactamase beta 2"	Q53H82	8	70635318-70669185	"Predicted intracellular proteins"		"Endonuclease, Hydrolase, Nuclease, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 96.0"	"Cell type enhanced"	"Detected in all"		"Early spermatids: 286.3;Proximal tubular cells: 325.7;Spermatocytes: 263.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"SK-BR-3: 437.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044391, HPA053040"	Enhanced		Supported	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA		37000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 81: Kidney & Liver - Metabolism"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Cytosol	"Nucleoplasm, Golgi apparatus"	"HPA044391: AB_10965168, HPA053040: AB_2682022"	"unprognostic (6.33e-3)"	"unprognostic (3.13e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.23e-2)"	"unprognostic (1.82e-1)"	"unprognostic (4.29e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.34e-1)"	"unprognostic (8.10e-2)"	"unprognostic (3.95e-1)"	"unprognostic (7.73e-3)"	"unprognostic (1.96e-1)"	"prognostic favorable (5.60e-4)"	"unprognostic (3.70e-1)"	"unprognostic (7.49e-2)"	"unprognostic (2.93e-1)"	"unprognostic (5.93e-2)"	20.4	39.3	6.4	12.9	8.0	3.2	18.4	8.4	9.0	10.8	8.7	21.9	38.8	9.6	11.5	10.2	9.3	28.7	29.8	5.8	8.3	77.0	96.0	20.1	15.6	8.1	7.9	10.0	14.8	21.0	8.3	10.6	8.9	15.4	21.3	12.7	15.0	9.2	28.2	12.4	33.8	15.7	8.1	11.5	16.0	63.2	7.6	14.5	20.2	32.1	13.5	13.2	7.9	10.6	65.7	66.4	20.8	8.6	35.6	53.7	12.5	36.0	20.7	37.7	28.2	32.3	72.3	0.1	14.4	17.4	75.7	45.9	25.0	38.0	30.2	38.8	26.6	30.5	8.1	18.0	74.0	30.1	25.5	64.6	44.8	18.6	28.2	18.0	10.0	23.2	53.4	60.1	50.6	19.6	17.1	5.5	22.3	88.2	60.3	15.2	12.1	14.0	146.3	33.8	29.6	10.3	79.7	437.8	41.0	27.0	72.7	40.1	16.0	3.0	20.8	67.4	29.4	47.7	38.1	0.2	21.1	50.6	28.7	15.8	13.8	13.0	8.5	16.8	10.6	12.6	8.8	8.4	17.3	11.7	8.3	9.2	5.8	11.0	16.7	11.9	13.4	5.9	6.4	8.0	8.4	9.0	5.8	8.3	8.1	7.9	8.9	8.1	7.6	10.6	15.1	57.7	45.1	3.6	16.0	16.4	22.1	58.9	12.5	15.4	12.1	15.1	38.4	18.6	43.9	18.4	8.4	25.1	12.0	27.2	76.3	51.2	286.3	29.4	11.7	15.3	12.1	19.6	3.9	117.2	15.3	15.1	20.4	31.5	9.5	8.7	19.2	76.1	48.0	8.4	4.6	25.8	34.6	34.5	11.2	40.9	20.5	24.2	16.0	3.7	19.4	35.3	8.2	2.5	10.3	70.2	25.1	15.1	18.3	16.0	59.8	325.7	44.9	14.7	6.6	9.6	14.4	263.1	25.0	12.4	16.8	19.4	13.9	34.2	34.7	11.0
LAGE3	"CVG5, DXS9879E, DXS9951E, ESO3, ITBA2, Pcc1"	ENSG00000196976	"L antigen family member 3"	Q14657	X	154477769-154479257	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"tRNA processing"		"Disease variant, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036122, HPA036123"	Approved		Supported	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm	"Nuclear bodies"	"HPA036122: AB_2674951, HPA036123: AB_10601926"	"unprognostic (1.70e-1)"	"prognostic favorable (5.29e-6)"	"unprognostic (1.09e-2)"	"prognostic unfavorable (7.60e-4)"	"unprognostic (2.28e-1)"	"unprognostic (9.65e-2)"	"prognostic unfavorable (8.63e-5)"	"unprognostic (1.99e-2)"	"unprognostic (2.08e-1)"	"unprognostic (3.04e-2)"	"unprognostic (4.88e-3)"	"unprognostic (6.73e-2)"	"prognostic unfavorable (5.42e-5)"	"unprognostic (7.37e-2)"	"unprognostic (3.57e-2)"	"unprognostic (2.31e-1)"	"unprognostic (1.80e-1)"	11.9	29.1	41.2	7.7	43.0	19.4	12.1	41.2	52.4	16.9	36.9	14.2	6.8	12.3	8.4	15.0	11.1	5.9	21.9	44.3	40.6	14.2	20.9	10.8	10.2	38.9	38.3	18.5	25.1	8.9	34.0	5.4	40.4	16.7	4.7	4.6	16.5	6.5	24.4	19.8	12.2	4.0	39.9	16.2	15.2	9.6	41.1	13.4	9.7	10.2	8.9	17.2	13.6	43.4	44.7	41.6	15.1	32.1	16.0	13.3	44.7	13.3	9.4	19.7	22.0	27.0	23.4	94.2	118.6	17.5	34.9	19.1	37.5	13.2	6.8	53.9	59.9	34.4	38.3	15.6	27.2	46.1	49.1	20.5	8.6	29.6	7.7	15.0	14.1	44.9	34.2	44.4	27.3	104.6	61.9	134.3	28.5	59.5	99.7	54.0	26.0	106.4	11.6	12.0	41.8	38.8	31.0	73.8	57.1	10.4	32.0	33.5	15.8	14.1	41.9	59.6	51.3	104.2	117.5	145.0	24.8	81.8	33.3	27.1	25.8	10.9	26.4	25.5	33.9	40.4	36.5	38.6	35.6	33.7	82.0	41.7	2.8	47.0	20.8	66.5	31.7	40.0	41.2	43.0	41.2	52.4	44.3	40.6	38.9	38.3	40.4	39.9	41.1	43.4	41.7	9.6	14.7	8.5	57.1	58.0	50.1	68.4	70.6	54.9	84.5	107.8	30.8	58.6	34.2	35.0	8.4	62.4	58.5	40.0	127.2	50.7	2.0	15.3	22.4	46.5	56.4	79.7	10.9	93.4	119.9	40.0	27.5	14.8	46.9	75.7	33.5	49.6	126.3	23.5	8.3	50.8	67.1	37.4	93.1	6.3	41.7	55.6	92.5	3.7	63.4	87.2	74.2	4.5	9.3	40.9	28.4	36.9	65.0	46.1	38.5	72.6	33.0	18.4	6.6	35.3	31.0	43.5	100.9	61.4	56.0	56.8	51.8	56.8	54.3	45.2
LAIR1	CD305	ENSG00000167613	"Leukocyte associated immunoglobulin like receptor 1"	Q6GTX8	19	54351384-54370558	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Immunity"	Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 28.1;lymphoid tissue: 46.3"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 106.6;granulocytes: 109.3;Hofbauer cells: 190.9;Kupffer cells: 100.9;Macrophages: 128.9;NK-cells: 98.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"HMC-1: 7.5;Karpas-707: 19.4;THP-1: 22.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA011155	Enhanced		Supported	"Plasma membrane"		NA	NA		350000	"Cluster 49: Eosinophils - Unknown function"	"Cluster 64: Macrophages - Immune response"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 4: Macrophages - Innate immune response"	"Plasma membrane"		"HPA011155: AB_1852685"	"unprognostic (1.91e-1)"	"unprognostic (1.12e-2)"	"unprognostic (2.81e-2)"	"unprognostic (1.25e-2)"	"unprognostic (2.03e-2)"	"unprognostic (4.38e-2)"	"unprognostic (2.16e-2)"	"unprognostic (1.74e-1)"	"unprognostic (5.00e-2)"	"unprognostic (2.24e-1)"	"unprognostic (2.21e-1)"	"unprognostic (7.11e-2)"	"prognostic unfavorable (5.01e-5)"	"unprognostic (1.72e-1)"	"unprognostic (2.72e-3)"	"unprognostic (3.52e-2)"	"unprognostic (5.22e-2)"	23.3	11.6	0.5	3.0	0.3	4.4	12.3	1.6	1.3	4.1	0.5	6.9	0.4	3.8	0.2	2.6	5.5	0.9	3.8	0.4	0.6	4.6	3.5	28.1	5.8	1.0	0.8	2.2	3.8	0.1	4.4	1.0	1.0	5.4	0.2	0.1	5.8	0.2	1.3	2.1	14.3	2.0	0.4	46.3	5.0	1.7	1.1	3.9	3.3	0.1	0.9	6.3	3.0	0.9	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.2	0.0	0.0	0.0	3.3	7.5	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	19.4	0.0	0.0	2.6	1.8	0.0	0.0	0.0	2.6	0.2	3.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	22.9	0.1	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.2	3.2	0.3	13.1	4.2	11.7	7.7	9.8	4.8	2.1	2.3	4.1	0.1	5.8	3.4	4.4	0.7	6.3	11.0	11.2	1.7	3.8	0.5	0.3	1.6	1.3	0.4	0.6	1.0	0.8	1.0	0.4	1.1	0.9	1.9	16.0	25.6	0.3	26.1	0.6	0.6	0.2	0.0	5.6	1.1	2.9	1.5	1.5	11.2	0.0	37.5	5.3	106.6	0.2	0.0	0.1	32.2	0.6	0.7	5.0	0.0	10.9	0.4	0.0	5.2	2.5	0.0	0.7	109.3	0.6	3.6	1.2	190.9	1.7	0.5	0.0	0.0	100.9	17.7	26.1	0.3	128.9	0.0	13.1	22.5	0.9	98.9	0.0	0.6	0.1	0.0	0.0	5.1	0.7	0.3	0.3	11.0	15.4	0.0	0.9	1.3	2.9	1.0	0.4	1.1	10.0	32.1	0.2	0.2	0.9
LAMP2	CD107b	ENSG00000005893	"Lysosomal associated membrane protein 2"	P13473	X	120426148-120469365	"CD markers, Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	Autophagy		"Disease variant, Glycogen storage disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 507.2;Syncytiotrophoblasts: 402.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 556.6"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 556.6"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005272, HPA029100"	Supported		Supported	Vesicles		NA	NA		520000000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 70: Brain - Nervous system development"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Vesicles		"CAB005272: AB_647855, HPA029100: AB_10795022"	"unprognostic (2.99e-3)"	"unprognostic (5.26e-2)"	"unprognostic (2.66e-3)"	"unprognostic (1.74e-1)"	"unprognostic (3.10e-1)"	"unprognostic (2.50e-2)"	"unprognostic (4.84e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.55e-1)"	"unprognostic (9.73e-2)"	"unprognostic (1.11e-2)"	"unprognostic (2.50e-2)"	"unprognostic (2.85e-1)"	"unprognostic (6.78e-2)"	"unprognostic (2.66e-1)"	"unprognostic (5.53e-3)"	54.2	68.7	80.3	38.3	144.2	62.8	56.3	109.1	135.5	64.9	52.7	39.2	44.3	44.3	55.1	79.4	44.1	69.6	45.3	81.6	101.8	85.5	129.9	54.2	34.1	113.0	112.6	49.1	57.8	64.2	32.2	47.9	120.6	62.2	35.0	32.6	102.1	55.1	111.6	67.2	42.4	42.8	100.5	39.5	51.8	26.2	100.9	59.3	61.7	67.4	36.6	43.4	63.3	211.7	53.8	47.5	40.1	49.7	367.0	140.9	91.5	79.3	130.4	77.1	134.4	42.7	90.3	47.9	73.1	132.7	236.2	84.9	56.7	67.2	125.5	43.6	37.2	35.8	46.4	54.3	148.1	158.9	73.2	151.5	114.8	108.1	75.1	188.6	107.5	32.5	42.1	122.9	117.2	79.3	45.3	80.2	29.0	63.7	42.6	35.1	65.3	73.1	102.3	36.9	14.0	22.6	99.7	93.0	196.5	57.4	64.7	173.0	122.5	114.1	58.7	176.2	261.5	68.5	78.6	30.2	131.4	182.4	284.4	30.6	114.9	224.1	27.1	97.1	20.6	17.1	24.3	24.5	64.2	22.5	23.4	21.8	556.6	31.8	96.2	33.4	33.4	66.3	80.3	144.2	109.1	135.5	81.6	101.8	113.0	112.6	120.6	100.5	100.9	211.7	75.7	73.7	53.8	52.2	29.8	100.9	92.5	262.7	64.9	17.6	74.0	58.3	37.3	173.0	155.3	66.2	14.6	163.7	44.3	52.1	39.2	217.7	3.3	103.4	74.1	69.9	36.6	14.1	32.4	70.6	128.3	113.7	38.7	168.1	17.7	46.7	87.8	176.8	208.0	18.5	40.7	32.6	134.3	133.1	80.4	8.6	113.7	135.5	131.6	33.7	132.7	116.3	50.4	57.3	507.2	62.5	54.4	109.9	66.6	100.8	97.5	154.7	75.6	11.5	39.5	176.8	61.7	6.4	13.7	78.8	136.2	402.4	34.5	71.0	34.8	92.9
LAMTOR1	"C11orf59, FLJ20625, p18, p27RF-Rho, Pdro, Ragulator1"	ENSG00000149357	"Late endosomal/lysosomal adaptor, MAPK and MTOR activator 1"	Q6IAA8	11	72085895-72103297	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002997	Approved		Supported	"Golgi apparatus,Vesicles,Plasma membrane"		NA	NA		160000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 51: Myeloid cells - Hemostasis"	"Golgi apparatus"	"Vesicles, Plasma membrane"	"HPA002997: AB_1845531"	"unprognostic (7.32e-2)"	"unprognostic (1.79e-1)"	"unprognostic (3.94e-2)"	"unprognostic (3.77e-2)"	"unprognostic (2.30e-1)"	"unprognostic (2.71e-2)"	"prognostic unfavorable (3.63e-4)"	"unprognostic (1.00e-1)"	"unprognostic (2.18e-1)"	"unprognostic (1.94e-1)"	"unprognostic (5.45e-2)"	"unprognostic (2.10e-3)"	"unprognostic (1.78e-3)"	"unprognostic (3.08e-1)"	"unprognostic (2.46e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.04e-1)"	100.7	143.8	171.2	69.1	177.8	118.6	96.2	173.2	180.4	87.0	162.1	88.6	67.5	86.5	90.0	114.1	74.9	65.8	131.9	163.5	169.5	129.5	114.2	91.3	80.6	177.4	177.2	81.5	85.6	87.0	92.0	67.4	174.9	102.4	76.5	46.6	85.8	71.7	126.4	89.9	82.5	73.7	175.4	130.9	96.6	41.2	176.1	75.4	112.3	109.3	79.4	88.5	77.9	172.5	94.2	181.0	97.3	132.0	224.7	152.3	97.6	129.0	201.6	206.2	151.7	230.9	139.7	93.1	162.3	216.9	214.2	138.1	171.1	260.1	155.8	117.8	99.3	245.6	108.5	156.5	291.4	97.2	147.7	252.3	199.2	224.4	224.0	116.4	173.1	102.5	104.1	96.0	211.4	295.6	86.2	146.1	93.9	291.8	194.9	73.7	178.9	78.8	246.8	195.1	65.7	103.3	127.6	127.5	343.7	106.4	192.6	93.2	125.3	137.5	98.0	323.8	93.0	111.6	139.0	80.4	81.8	81.8	113.0	113.4	414.3	274.1	80.6	228.8	77.7	132.1	75.6	81.1	332.6	146.2	63.4	77.9	229.5	122.8	180.6	197.1	98.8	397.5	171.2	177.8	173.2	180.4	163.5	169.5	177.4	177.2	174.9	175.4	176.1	172.5	132.6	44.8	71.6	9.1	109.7	55.7	161.7	271.1	117.8	58.5	159.9	195.7	66.4	121.5	120.2	128.8	12.5	266.5	110.7	235.4	295.4	276.4	12.4	61.2	98.9	134.9	116.4	133.5	9.8	340.2	300.1	111.6	71.4	85.2	97.7	71.5	142.1	86.9	468.0	77.4	12.9	140.2	170.9	248.5	111.6	19.2	107.8	311.5	113.8	8.4	413.6	223.7	177.1	10.1	24.2	307.3	202.6	102.7	87.9	193.4	230.3	370.9	61.0	56.1	111.7	102.5	116.3	58.7	103.3	126.1	55.4	282.0	89.4	178.5	170.8	157.2
LAMTOR4	C7orf59	ENSG00000188186	"Late endosomal/lysosomal adaptor, MAPK and MTOR activator 4"	Q0VGL1	7	100148907-100155944	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 3294.2"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020998	Enhanced		Supported	Vesicles		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Vesicles		"HPA020998: AB_1845762"	"prognostic favorable (2.48e-4)"	"prognostic favorable (6.08e-4)"	"unprognostic (1.29e-2)"	"unprognostic (1.14e-1)"	"unprognostic (8.21e-3)"	"unprognostic (6.11e-2)"	"unprognostic (1.10e-2)"	"unprognostic (1.32e-2)"	"unprognostic (6.17e-2)"	"unprognostic (1.57e-1)"	"unprognostic (2.42e-3)"	"unprognostic (8.83e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.80e-1)"	"unprognostic (2.68e-1)"	"unprognostic (2.45e-1)"	"unprognostic (1.68e-2)"	145.5	144.7	207.2	92.8	215.4	194.6	143.4	221.1	260.4	148.0	204.4	180.6	89.4	116.7	65.9	117.5	123.1	97.7	167.4	205.7	212.3	188.5	139.1	128.0	159.0	222.1	211.3	142.7	124.2	126.7	162.7	68.1	213.3	160.8	105.8	39.9	116.8	76.2	137.5	478.7	151.0	69.0	217.6	251.9	162.2	86.6	215.8	104.8	133.8	106.0	85.5	145.8	126.7	224.1	105.9	250.9	130.2	165.4	135.2	154.9	105.7	62.1	151.0	113.1	138.9	116.9	165.7	169.1	204.7	94.2	205.7	108.9	124.0	160.0	48.1	172.4	353.2	135.2	245.0	205.4	127.4	106.4	187.1	187.3	155.4	118.5	145.6	125.7	174.9	155.3	129.9	264.4	156.1	501.0	104.0	424.7	138.7	291.1	199.9	107.4	107.1	302.8	129.1	126.9	91.6	169.0	114.3	265.8	211.3	99.0	107.1	207.0	118.3	107.1	158.6	223.7	101.7	159.1	231.2	324.2	171.0	293.5	155.9	1033.3	843.2	3121.0	299.6	795.1	251.1	541.8	377.5	312.8	570.0	475.4	381.8	307.2	3294.2	310.1	756.2	482.6	453.0	893.6	207.2	215.4	221.1	260.4	205.7	212.3	222.1	211.3	213.3	217.6	215.8	224.1	181.8	93.0	150.7	18.9	195.8	274.9	194.0	282.0	167.9	65.3	240.8	277.2	176.6	143.0	172.9	218.8	12.5	258.4	199.9	819.7	534.1	167.3	40.0	152.9	125.8	186.7	299.3	99.3	12.0	326.2	196.5	175.6	146.3	131.4	183.2	120.9	239.1	246.3	531.1	58.9	13.6	423.9	252.3	497.4	351.7	46.6	146.3	365.2	434.0	13.1	411.0	229.9	298.6	11.6	26.2	204.2	867.4	120.4	133.0	169.5	511.6	557.5	194.8	67.0	144.7	142.1	196.9	88.1	101.2	151.3	662.9	201.4	195.9	150.8	511.8	219.0
LAMTOR5	"HBXIP, MGC71071, XIP"	ENSG00000134248	"Late endosomal/lysosomal adaptor, MAPK and MTOR activator 5"	O43504	1	110401249-110407942	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal tubular cells: 1113.2;Proximal tubular cells: 2532.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006812	Approved		Supported	Cytosol		NA	NA		150000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Cytosol		"HPA006812: AB_1079040"	"unprognostic (1.18e-1)"	"unprognostic (1.93e-1)"	"unprognostic (2.29e-1)"	"unprognostic (3.54e-3)"	"unprognostic (2.75e-1)"	"unprognostic (5.29e-3)"	"prognostic unfavorable (2.60e-4)"	"unprognostic (9.97e-2)"	"unprognostic (7.58e-2)"	"prognostic favorable (7.23e-4)"	"unprognostic (2.80e-1)"	"unprognostic (2.93e-1)"	"unprognostic (1.65e-2)"	"unprognostic (3.77e-2)"	"unprognostic (3.80e-3)"	"prognostic favorable (5.52e-4)"	"unprognostic (6.66e-2)"	143.6	134.9	152.2	79.5	156.3	250.3	127.7	167.7	179.0	107.7	168.0	108.3	85.7	86.2	162.6	121.0	93.2	101.9	269.7	150.9	163.6	433.9	150.2	115.2	114.1	159.6	155.4	121.0	95.3	192.3	141.2	120.7	157.9	109.4	110.9	140.0	100.1	77.6	260.3	98.7	102.2	81.5	165.1	126.0	127.8	88.6	161.4	102.2	107.8	277.3	122.6	124.2	109.4	168.1	272.1	223.2	197.3	118.5	325.3	245.3	196.1	224.4	176.5	186.8	176.6	196.0	130.0	214.5	233.0	220.9	228.4	107.5	203.4	189.2	229.8	231.4	227.9	157.7	257.1	402.1	247.1	227.7	188.0	216.3	287.3	193.9	122.6	236.2	227.7	156.9	189.3	196.0	275.8	443.0	208.7	274.7	140.1	151.8	366.9	141.9	355.1	164.2	439.0	302.0	145.4	189.6	198.8	287.7	516.4	169.5	111.0	317.3	217.8	140.5	182.9	355.7	214.4	204.5	250.7	277.2	459.1	225.6	329.6	295.4	223.1	485.8	125.9	229.5	112.1	345.3	146.6	137.6	187.9	322.3	127.1	134.4	347.7	149.2	225.0	321.5	181.1	250.6	152.2	156.3	167.7	179.0	150.9	163.6	159.6	155.4	157.9	165.1	161.4	168.1	131.2	160.3	174.4	16.3	208.2	307.8	284.1	661.5	101.3	111.0	186.0	197.9	597.6	211.6	371.9	445.1	25.0	424.5	141.5	225.1	1113.2	389.2	67.5	215.8	141.8	193.1	222.3	158.9	15.4	331.0	370.7	194.0	99.9	191.1	146.4	97.0	133.9	311.9	424.8	89.2	17.6	302.6	449.6	154.4	189.2	112.8	264.7	175.3	350.4	18.7	320.9	297.9	137.0	9.5	23.3	403.9	296.4	239.2	100.6	360.9	315.4	2532.5	340.9	150.5	170.9	168.2	185.2	297.9	361.3	121.3	322.5	500.5	125.7	163.2	252.0	441.8
LANCL2	"GPR69B, TASP"	ENSG00000132434	"LanC like 2"	Q9NS86	7	55365337-55433737	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 52.5;Late spermatids: 55.3;Oligodendrocyte precursor cells: 52.8;Oligodendrocytes: 67.3"	"Group enriched"	"Detected in all"	5	"glioma: 52.5;testis cancer: 19.2"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in all"	8	"A-431: 144.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019711, HPA029535"	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA		13000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Nucleoplasm, Cytosol"		"HPA019711: AB_1852699, HPA029535: AB_10602342"	"unprognostic (1.11e-1)"	"unprognostic (6.89e-2)"	"unprognostic (7.28e-2)"	"unprognostic (1.28e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.76e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.31e-1)"	"unprognostic (2.56e-1)"	"prognostic favorable (1.89e-4)"	"unprognostic (1.35e-3)"	"unprognostic (5.58e-2)"	"prognostic favorable (1.03e-6)"	"unprognostic (4.58e-3)"	"unprognostic (1.04e-2)"	"unprognostic (3.94e-1)"	"unprognostic (1.45e-1)"	3.9	6.2	17.4	2.6	18.8	3.9	5.9	11.5	18.6	5.7	8.7	4.9	5.1	10.4	5.1	4.1	5.4	3.8	4.1	21.2	14.2	6.0	5.0	3.1	3.5	12.5	12.9	9.1	4.7	9.2	6.0	4.0	12.4	5.8	4.7	8.4	4.7	6.4	7.0	5.5	5.0	6.7	13.2	3.6	4.4	6.2	14.2	4.7	6.5	5.1	2.9	3.9	4.0	17.4	144.8	4.9	9.7	6.6	2.9	5.0	5.4	6.4	7.6	9.7	8.2	5.0	4.1	10.1	5.9	9.3	9.7	6.4	5.2	3.5	5.9	4.4	10.4	3.6	3.8	5.1	5.1	11.2	6.4	9.0	3.7	7.2	2.3	5.1	4.8	4.7	6.4	6.4	9.1	4.4	2.9	5.2	18.8	3.9	6.1	4.3	4.5	5.0	6.3	11.3	16.9	16.0	9.3	13.6	3.9	3.6	5.6	11.8	8.1	6.1	8.3	11.6	12.5	6.1	7.8	10.6	4.8	2.5	11.8	0.1	1.5	0.3	1.0	1.9	1.7	1.1	1.3	1.5	1.9	1.0	1.2	1.0	0.2	1.5	1.4	1.5	2.6	1.1	17.4	18.8	11.5	18.6	21.2	14.2	12.5	12.9	12.4	13.2	14.2	17.4	3.0	3.2	8.9	28.7	5.9	4.0	6.3	5.5	5.7	8.9	6.8	6.7	9.4	10.0	5.1	11.0	6.2	12.5	5.1	8.8	5.9	7.1	52.5	6.7	11.2	5.4	12.6	12.6	41.7	12.2	12.1	16.3	5.1	7.7	11.4	10.2	7.1	10.0	7.7	15.2	39.6	9.1	4.1	7.3	4.8	55.3	9.0	5.4	0.0	8.4	9.5	10.8	6.2	52.8	67.3	7.8	7.6	7.5	5.1	5.5	9.8	27.7	7.7	7.6	0.0	19.4	5.9	22.7	17.8	7.5	3.8	19.0	4.3	12.8	9.7	6.0
LAP3	"LAP, LAPEP, PEPS"	ENSG00000002549	"Leucine aminopeptidase 3"	P28838	4	17577198-17607972	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Aminopeptidase, Hydrolase, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Adipocytes: 230.6;Hofbauer cells: 262.1;Proximal tubular cells: 274.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029606, HPA029607"	Enhanced		Supported	Nucleoplasm,Midbody,Cytosol		Yes	No		3500000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 64: Macrophages - Immune response"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Cytosol	"Nucleoplasm, Midbody"	"HPA029606: AB_10599288, HPA029607: AB_10611381"	"unprognostic (2.10e-2)"	"unprognostic (1.01e-1)"	"unprognostic (6.95e-3)"	"unprognostic (1.46e-1)"	"unprognostic (1.26e-1)"	"unprognostic (2.87e-1)"	"unprognostic (2.16e-1)"	"unprognostic (1.55e-1)"	"unprognostic (5.33e-2)"	"unprognostic (1.44e-3)"	"unprognostic (2.61e-3)"	"unprognostic (1.17e-1)"	"unprognostic (4.29e-3)"	"unprognostic (1.73e-1)"	"unprognostic (3.28e-2)"	"unprognostic (3.06e-1)"	"unprognostic (8.79e-2)"	92.8	52.6	33.0	131.4	34.8	59.2	60.3	39.0	42.9	30.7	31.4	60.3	78.3	34.4	25.4	44.6	45.4	67.3	65.0	31.8	36.3	106.3	190.4	100.6	150.4	46.3	37.7	24.0	30.9	61.0	22.1	70.9	42.2	36.7	62.0	20.0	67.7	31.0	68.1	40.3	61.3	76.2	45.6	94.1	55.3	43.8	41.9	56.8	46.4	63.8	94.3	82.8	25.3	42.9	51.7	44.4	41.6	39.4	80.5	97.9	0.4	79.6	89.1	282.3	340.3	81.4	96.1	202.0	51.7	61.6	167.9	31.3	157.7	56.3	106.7	77.7	45.2	112.1	47.3	107.6	94.1	102.3	69.2	100.0	35.3	92.7	48.6	32.3	99.7	52.2	110.6	139.9	67.6	55.6	91.9	139.5	87.1	96.3	83.9	139.8	39.8	102.7	73.5	59.6	61.4	50.2	72.9	44.4	161.1	57.3	37.9	39.1	65.2	71.3	48.5	76.1	140.6	127.7	208.8	172.7	96.3	167.2	70.8	43.1	200.6	44.7	33.7	210.0	31.0	32.7	31.2	36.3	204.6	23.5	26.7	28.3	28.1	54.0	158.1	116.6	60.2	135.8	33.0	34.8	39.0	42.9	31.8	36.3	46.3	37.7	42.2	45.6	41.9	42.9	230.6	28.9	49.6	10.7	34.4	22.0	26.1	60.1	21.6	8.1	53.5	41.7	48.9	18.6	44.1	27.6	2.1	35.9	68.3	44.2	117.4	68.6	100.5	67.3	45.7	129.7	16.3	31.7	6.4	109.2	54.7	42.0	29.6	40.7	64.1	29.4	71.0	95.5	262.1	6.7	9.6	35.6	42.7	92.1	50.5	31.7	23.0	141.9	42.7	18.7	195.0	103.8	28.8	9.5	21.2	53.3	31.8	35.0	71.2	26.9	52.4	274.0	92.5	15.4	32.9	31.3	57.8	95.7	13.7	32.5	22.9	55.7	42.4	80.7	45.6	27.1
LARP1	"KIAA0731, Lar1, LARP, Lhp1, MGC19556"	ENSG00000155506	"La ribonucleoprotein 1, translational regulator"	Q6PKG0	5	154712843-154817605	"Plasma proteins, Predicted intracellular proteins"	"Protein biosynthesis, Translation regulation"	"Repressor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB015222, HPA051397, HPA054819"	Approved		Supported	"Nucleoplasm,Endoplasmic reticulum,Cytosol"		NA	NA		12000	"Cluster 27: Non-specific - Gene expression"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 54: Cardiomyocytes - Muscle contraction"	"Nucleoplasm, Endoplasmic reticulum, Cytosol"		"CAB015222: , HPA051397: AB_2681467, HPA054819: AB_2682612"	"unprognostic (1.44e-3)"	"unprognostic (1.21e-1)"	"unprognostic (7.69e-2)"	"unprognostic (1.76e-3)"	"unprognostic (3.95e-2)"	"unprognostic (3.08e-3)"	"unprognostic (2.72e-2)"	"unprognostic (3.34e-3)"	"unprognostic (4.12e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.70e-1)"	"unprognostic (6.83e-2)"	"unprognostic (2.07e-1)"	"unprognostic (2.20e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.45e-2)"	"unprognostic (1.83e-1)"	42.5	50.0	30.9	36.5	28.4	37.0	36.4	12.2	44.8	38.4	15.8	38.4	33.8	43.6	37.4	51.6	39.9	29.3	48.6	34.3	25.8	40.0	36.7	34.8	41.1	26.7	40.3	45.0	103.0	70.3	39.8	37.9	47.2	31.3	34.6	32.1	57.4	32.9	78.8	45.4	37.7	38.7	5.4	35.7	44.0	38.2	27.6	42.1	53.8	46.4	44.8	38.0	40.0	37.4	93.3	140.3	107.6	124.1	93.3	73.1	103.1	99.0	101.8	114.7	110.0	218.1	116.8	252.2	128.0	127.5	168.5	92.9	196.1	185.9	135.7	83.4	94.1	187.1	143.8	106.1	117.6	250.6	81.2	91.2	108.4	144.5	185.2	66.4	103.9	114.0	149.2	180.2	111.9	102.9	156.5	100.0	107.3	89.8	60.5	158.8	97.5	120.5	74.1	120.7	180.7	93.5	132.2	215.4	112.3	112.9	126.0	119.0	130.4	140.3	83.0	106.2	170.3	136.8	126.0	219.5	92.1	134.8	99.1	2.2	2.4	0.7	2.6	3.0	3.3	2.5	3.0	3.0	2.4	3.3	2.5	2.6	1.4	5.9	5.6	3.9	2.1	1.7	30.9	28.4	12.2	44.8	34.3	25.8	26.7	40.3	47.2	5.4	27.6	37.4	37.6	44.8	33.8	67.9	37.2	78.3	39.7	38.0	34.7	64.4	45.1	33.0	104.4	50.1	33.7	40.5	37.5	43.7	35.3	45.1	29.4	42.2	14.4	70.1	70.6	48.8	43.9	73.4	72.0	82.5	35.2	46.2	46.9	65.5	17.2	63.2	47.8	66.9	57.9	87.5	92.5	49.6	18.3	53.3	42.6	12.1	69.6	43.6	37.4	46.9	49.1	26.5	33.0	47.7	69.5	62.1	37.7	80.1	47.3	75.2	53.0	50.1	46.5	38.7	13.1	63.6	39.4	56.2	40.5	54.6	84.5	23.9	34.6	71.6	68.8	53.6
LARP7	"DKFZP564K112, HDCMA18P, PIP7S"	ENSG00000174720	"La ribonucleoprotein 7, transcriptional regulator"	Q4G0J3	4	112637107-112657592	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Differentiation, mRNA processing, mRNA splicing, Spermatogenesis, Transcription, Transcription regulation"	RNA-binding	"Disease variant, Dwarfism, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA026842, HPA027930"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoplasm, Cytosol"		"HPA026842: AB_10611116, HPA027930: AB_10601233"	"unprognostic (3.01e-1)"	"unprognostic (6.63e-2)"	"unprognostic (5.72e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.28e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.82e-2)"	"unprognostic (1.12e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.98e-2)"	"unprognostic (1.40e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.28e-2)"	"prognostic favorable (4.33e-4)"	37.2	31.6	26.3	32.8	28.3	44.6	35.7	28.6	34.6	28.0	28.0	36.2	33.8	33.3	29.8	31.7	25.8	30.5	59.6	24.9	33.5	40.2	44.1	28.1	44.9	30.2	30.2	34.2	18.3	29.9	20.1	34.1	31.0	32.1	36.7	31.5	23.2	27.2	46.6	30.6	33.2	29.5	28.3	36.9	31.5	24.6	29.1	42.2	38.7	45.3	40.3	33.0	21.8	30.8	42.9	34.9	77.7	44.3	50.7	61.6	44.0	55.3	40.6	45.3	42.0	27.9	62.0	95.4	43.7	46.9	42.2	29.6	75.1	45.2	60.2	86.8	52.1	56.4	35.2	41.9	41.0	131.6	84.6	49.3	50.7	40.4	25.1	62.6	40.4	47.6	71.4	51.1	55.3	35.2	107.4	56.7	182.2	67.5	28.2	62.9	66.2	44.3	68.8	44.8	46.5	64.4	32.0	83.4	55.4	131.4	35.1	61.0	43.7	42.4	49.5	47.7	57.6	34.7	62.5	97.6	57.7	52.4	49.2	70.1	28.1	49.9	32.8	43.1	30.3	48.1	33.9	34.2	25.3	47.4	32.3	31.3	33.2	38.7	60.7	64.0	37.9	20.8	26.3	28.3	28.6	34.6	24.9	33.5	30.2	30.2	31.0	28.3	29.1	30.8	66.1	96.1	79.2	45.1	68.8	24.9	66.5	102.6	34.1	61.3	48.3	50.4	113.2	95.8	91.6	47.8	29.2	79.0	88.7	83.2	111.6	69.3	17.6	78.7	70.5	63.2	38.9	43.6	18.0	64.4	70.2	60.6	32.1	58.8	104.4	51.5	81.4	160.9	70.4	58.9	19.9	79.7	61.1	93.7	27.1	14.9	94.4	67.2	24.9	32.8	96.0	107.1	107.1	20.6	43.1	62.0	85.6	100.1	39.1	38.8	73.1	117.0	109.8	54.1	118.3	74.5	68.3	83.5	87.8	33.3	20.9	100.4	65.9	74.2	75.6	47.9
LARS2	"KIAA0028, LEURS, MGC26121, mtLeuRS"	ENSG00000011376	"Leucyl-tRNA synthetase 2, mitochondrial"	Q15031	3	45388561-45554726	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase"	"Deafness, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 28.7;Excitatory neurons: 35.4;Inhibitory neurons: 37.8;Oligodendrocyte precursor cells: 22.6;Oligodendrocytes: 25.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035951, HPA045450, HPA066085"	Approved		Supported	Nucleoplasm,Mitochondria		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Mitochondria	Nucleoplasm	"HPA035951: AB_10672997, HPA045450: AB_2679328, HPA066085: AB_2685612"	"unprognostic (3.89e-1)"	"unprognostic (3.89e-1)"	"prognostic favorable (1.71e-4)"	"unprognostic (3.02e-2)"	"unprognostic (3.77e-1)"	"unprognostic (1.45e-1)"	"unprognostic (2.21e-3)"	"unprognostic (9.19e-2)"	"unprognostic (6.13e-2)"	"unprognostic (2.86e-1)"	"unprognostic (4.98e-1)"	"unprognostic (4.37e-2)"	"prognostic favorable (1.32e-11)"	"unprognostic (2.81e-1)"	"unprognostic (5.74e-2)"	"unprognostic (9.90e-2)"	"unprognostic (9.07e-2)"	3.3	4.7	9.5	3.4	10.3	2.4	3.9	10.1	11.7	3.7	9.2	6.9	3.9	4.6	4.3	4.2	4.5	3.0	5.5	9.3	10.5	7.5	8.1	2.9	4.3	9.5	10.2	3.8	2.4	12.3	3.7	4.2	9.5	4.3	6.9	4.2	3.6	4.2	6.2	3.6	2.9	4.4	9.2	3.2	3.6	2.2	11.5	6.9	4.5	6.4	4.8	5.0	3.7	8.5	6.3	11.2	10.7	9.3	11.8	13.0	11.1	11.6	15.7	24.7	16.2	20.3	8.8	13.8	8.9	18.0	18.2	5.8	49.0	30.4	16.0	9.5	12.7	12.9	13.6	18.4	12.1	20.9	4.4	19.0	16.8	26.0	12.5	13.1	14.9	19.5	25.1	5.5	19.0	9.7	21.1	11.6	28.4	15.0	21.9	8.9	9.8	16.9	23.6	18.8	7.6	9.7	17.3	7.9	11.8	13.5	14.6	14.7	9.1	12.1	8.3	8.5	12.3	5.3	12.3	15.4	14.0	16.9	9.5	0.0	0.6	0.6	1.2	0.9	1.5	1.0	0.7	1.1	1.2	0.5	0.8	1.0	0.3	1.9	0.8	1.0	0.6	0.7	9.5	10.3	10.1	11.7	9.3	10.5	9.5	10.2	9.5	9.2	11.5	8.5	3.9	0.0	2.0	28.7	4.8	1.1	1.5	1.8	3.4	5.5	3.2	2.8	9.0	1.5	1.8	5.5	4.2	5.0	3.5	4.4	5.9	2.9	0.6	7.6	5.7	4.2	4.8	5.2	35.4	2.7	5.2	3.2	6.6	4.9	1.3	9.8	2.2	7.7	5.4	1.7	37.8	4.5	0.0	2.9	1.3	1.2	1.2	2.6	1.8	19.7	2.3	4.0	2.1	22.6	25.2	3.2	7.0	2.2	5.0	1.9	2.6	2.4	2.9	4.7	0.0	3.1	2.9	0.7	2.4	4.8	1.3	2.9	3.2	8.3	6.8	1.7
LAS1L	"FLJ12525, Las1"	ENSG00000001497	"LAS1 like ribosome biogenesis factor"	Q9Y4W2	X	65438549-65534810	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"rRNA processing"		"Disease variant, Mental retardation, Obesity"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 148.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044431, HPA061463"	Supported		Approved	"Nucleoplasm,Centriolar satellite,Cytosol"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 43: Testis - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 31: Spermatids - Spermatogenesis"	Nucleoplasm	"Centriolar satellite, Cytosol"	"HPA044431: AB_10965695, HPA061463: AB_2684530"	"unprognostic (9.71e-2)"	"unprognostic (1.62e-3)"	"unprognostic (1.57e-1)"	"unprognostic (1.47e-1)"	"unprognostic (3.39e-2)"	"unprognostic (2.38e-1)"	"unprognostic (7.15e-3)"	"unprognostic (2.83e-2)"	"unprognostic (3.16e-1)"	"unprognostic (2.76e-2)"	"unprognostic (2.14e-1)"	"unprognostic (5.06e-2)"	"unprognostic (6.00e-3)"	"unprognostic (1.26e-1)"	"unprognostic (1.17e-3)"	"unprognostic (2.00e-3)"	"unprognostic (1.53e-1)"	21.5	19.1	36.9	11.4	37.8	16.0	21.2	35.6	53.7	27.1	34.0	26.4	5.8	23.1	6.8	20.0	25.5	6.3	18.6	34.8	34.8	19.1	19.6	17.4	13.1	36.3	37.1	29.9	21.2	12.2	17.5	8.9	36.8	22.7	8.1	9.4	18.8	11.9	19.3	25.4	18.5	10.3	38.1	22.5	20.0	33.6	37.1	12.8	20.5	6.3	14.0	24.2	21.4	37.8	44.1	63.6	36.3	28.5	12.4	16.1	29.1	28.5	14.9	42.8	36.4	30.4	31.3	95.0	31.3	17.8	28.7	31.3	63.9	39.6	50.6	25.6	52.3	32.2	53.2	32.4	16.6	95.9	26.8	17.8	28.7	40.5	25.6	15.1	26.0	46.1	80.3	71.3	25.5	51.8	62.4	53.6	52.6	49.8	63.1	56.2	67.4	79.9	24.7	17.9	24.6	32.9	51.3	26.0	20.1	25.8	19.5	44.6	22.2	26.4	50.9	73.2	44.4	23.7	37.7	94.6	28.1	92.5	13.6	17.7	17.7	11.2	20.1	24.0	21.3	23.9	18.6	23.5	24.2	26.4	23.2	19.8	2.0	22.9	19.3	19.1	21.7	21.0	36.9	37.8	35.6	53.7	34.8	34.8	36.3	37.1	36.8	38.1	37.1	37.8	15.5	12.8	22.3	23.2	21.6	18.2	21.4	24.8	9.1	34.9	12.7	13.6	9.2	21.5	27.0	3.7	29.2	32.8	13.3	6.9	15.6	27.9	58.0	17.5	20.0	17.2	16.7	18.1	19.6	26.6	31.4	16.8	11.7	12.9	18.3	26.0	8.9	14.8	16.3	45.4	17.7	9.4	18.3	8.5	13.4	148.2	17.4	11.7	10.6	8.4	18.1	16.1	12.3	13.0	12.5	21.4	7.7	15.4	26.3	23.5	10.2	14.3	26.7	34.2	13.1	21.8	22.8	24.1	19.1	17.8	18.6	17.8	17.5	22.3	14.1	14.8
LASP1	"Lasp-1, MLN50"	ENSG00000002834	"LIM and SH3 protein 1"	Q14847	17	38869859-38921770	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Ion transport, Transport"	Actin-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 591.7;Proximal enterocytes: 292.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012072, CAB022049"	Enhanced		Supported	"Plasma membrane,Focal adhesion sites,Cytosol"		NA	NA		9400000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 56: Intestine - Transmembrane transport"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 25: Spermatids - Spermatogenesis"	"Plasma membrane, Cytosol"	"Focal adhesion sites"	"CAB022049: , HPA012072: AB_1852714"	"unprognostic (1.23e-1)"	"unprognostic (2.09e-2)"	"unprognostic (1.77e-1)"	"prognostic unfavorable (4.57e-4)"	"unprognostic (1.47e-1)"	"unprognostic (3.03e-2)"	"prognostic unfavorable (2.41e-4)"	"unprognostic (1.06e-3)"	"unprognostic (2.24e-1)"	"unprognostic (9.60e-2)"	"unprognostic (9.87e-3)"	"unprognostic (1.01e-1)"	"unprognostic (9.65e-3)"	"unprognostic (1.29e-3)"	"unprognostic (3.95e-2)"	"unprognostic (1.60e-3)"	"unprognostic (4.53e-2)"	86.4	38.0	60.8	75.9	56.7	126.4	55.5	45.5	56.7	46.9	48.6	93.0	131.9	43.8	32.3	45.9	46.0	56.8	40.3	56.1	61.0	55.9	76.4	68.6	76.1	56.2	63.5	48.5	59.0	25.5	33.0	81.4	59.0	30.9	92.3	26.8	44.8	33.9	23.7	44.4	168.8	51.2	52.9	74.3	96.2	23.9	67.4	74.1	34.9	27.7	78.2	53.2	37.3	50.1	214.1	441.0	124.1	111.0	182.8	196.9	218.7	267.8	257.8	274.5	198.5	134.3	225.8	98.8	214.1	417.3	154.9	332.4	58.5	204.1	239.6	71.6	31.6	47.5	124.2	235.8	173.0	110.4	134.1	176.3	69.6	234.6	66.1	170.7	188.0	59.0	81.9	30.3	389.4	72.0	127.1	163.6	63.0	189.9	109.4	70.7	67.6	123.8	332.7	187.9	19.0	45.4	159.3	160.5	134.7	233.5	255.7	128.2	331.4	160.0	233.0	189.7	162.0	79.7	115.8	75.2	170.2	96.7	197.2	21.8	31.4	35.0	30.7	33.1	20.3	11.7	15.2	20.4	27.3	10.8	12.7	19.8	67.0	34.2	42.1	20.5	21.4	32.5	60.8	56.7	45.5	56.7	56.1	61.0	56.2	63.5	59.0	52.9	67.4	50.1	54.5	41.7	27.6	17.6	41.8	41.8	21.5	26.0	51.8	66.4	82.4	43.2	1.1	55.8	30.4	73.5	10.4	7.5	69.5	225.2	17.6	65.7	89.6	27.5	31.7	54.3	86.5	21.0	16.4	76.5	59.1	50.1	119.3	46.4	52.0	37.4	64.6	115.4	83.9	26.9	16.0	101.9	28.5	127.7	73.0	591.7	51.9	71.9	35.6	24.4	94.3	22.2	164.8	11.1	4.4	111.0	116.4	39.9	32.8	24.2	292.7	72.9	57.3	23.1	65.7	65.4	53.4	2.9	5.7	62.2	28.4	6.4	63.4	19.2	97.8	31.8
LAT	LAT1	ENSG00000213658	"Linker for activation of T cells"	O43561	16	28984826-28990784	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins"	"Adaptive immunity, Immunity, Mast cell degranulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 117.9"	"Group enriched"	"Detected in many"	6	"dendritic cells: 80.7;granulocytes: 78.9;Macrophages: 55.9;NK-cells: 152.4;T-cells: 151.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	19	"basophil: 307.7;gdT-cell: 303.4;MAIT T-cell: 212.5;memory CD4 T-cell: 295.1;memory CD8 T-cell: 307.2;naive CD4 T-cell: 276.0;naive CD8 T-cell: 266.9;NK-cell: 114.6;T-reg: 410.8"	"Group enriched"	"Detected in all"	142	"granulocytes: 307.7;NK-cells: 114.6;T-cells: 410.8"	"Cell line enhanced"	"Detected in many"		"HEL: 189.8;HMC-1: 765.9;MOLT-4: 279.5"	"Not detected"	"Not detected"							"CAB002223, HPA011157, CAB012978, CAB079960"	Enhanced		Supported	"Golgi apparatus,Plasma membrane"	"Intracellular and membrane"	NA	NA		140000	"Cluster 20: T-cells - T-cell receptor"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Plasma membrane"	"Golgi apparatus"	"CAB002223: AB_563852, CAB012978: , CAB079960: , HPA011157: AB_1079237"	"unprognostic (4.35e-3)"	"unprognostic (5.17e-3)"	"unprognostic (1.25e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.62e-1)"	"unprognostic (7.15e-5)"	"unprognostic (1.17e-1)"	"unprognostic (5.17e-2)"	"unprognostic (1.27e-1)"	"unprognostic (3.25e-2)"	"unprognostic (1.52e-3)"	"unprognostic (5.33e-2)"	"unprognostic (1.02e-8)"	"unprognostic (1.04e-2)"	"unprognostic (5.58e-2)"	"unprognostic (3.25e-1)"	"unprognostic (1.51e-4)"	8.1	4.4	9.1	23.9	9.6	17.5	6.6	9.0	11.9	15.6	8.1	31.3	9.2	19.3	5.2	8.1	11.6	9.6	3.9	9.2	8.5	15.3	10.5	14.1	65.9	9.2	8.5	7.7	5.7	2.0	14.2	3.9	9.0	21.6	5.2	3.5	7.8	9.5	4.2	10.7	22.7	5.7	8.0	32.0	13.4	4.1	9.7	117.9	17.6	1.6	29.0	24.7	13.3	8.9	1.0	2.3	1.5	2.5	3.7	2.4	4.9	5.5	1.4	1.7	2.2	2.3	3.0	0.7	7.2	2.2	0.6	2.9	2.6	1.3	0.8	1.6	3.3	189.8	5.4	3.3	1.0	5.9	765.9	2.1	3.8	1.7	0.7	2.8	0.9	62.7	2.6	21.7	0.8	5.6	279.5	38.3	3.4	0.4	2.7	3.2	0.8	24.9	1.9	1.6	5.3	1.0	0.9	1.8	2.7	1.4	2.7	31.7	3.6	3.6	18.0	3.9	1.3	7.6	7.0	3.1	45.5	2.7	2.9	307.7	1.4	0.7	303.4	1.5	212.5	1.7	295.1	307.2	1.1	1.7	276.0	266.9	14.6	114.6	1.3	1.9	410.8	196.5	9.1	9.6	9.0	11.9	9.2	8.5	9.2	8.5	9.0	8.0	9.7	8.9	5.2	0.0	13.1	4.6	6.2	7.1	2.1	1.1	2.8	11.0	3.7	4.3	1.7	7.2	3.1	9.2	6.2	2.6	80.7	1.2	1.9	1.7	0.3	1.5	2.3	4.7	0.0	16.6	4.7	0.5	0.9	3.0	7.7	2.7	78.9	4.9	8.6	2.9	14.3	6.7	5.5	1.5	0.0	7.3	9.4	0.1	1.5	55.9	10.6	5.6	9.2	3.0	152.4	3.0	3.5	1.0	0.7	0.7	17.0	2.2	1.3	1.3	1.3	9.6	0.0	3.0	3.8	1.7	2.1	1.9	5.3	2.7	151.7	1.7	1.4	1.3
LAT2	"HSPC046, LAB, NTAL, WBSCR15, WBSCR5, WSCR5"	ENSG00000086730	"Linker for activation of T cells family member 2"	Q9GZY6	7	74199652-74229834	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Adaptive immunity, Immunity, Mast cell degranulation"		"Williams-Beuren syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 61.3;lymphoid tissue: 56.6"	"Cell type enhanced"	"Detected in many"		"B-cells: 90.6;granulocytes: 171.6;Hofbauer cells: 82.7;Kupffer cells: 71.1;Langerhans cells: 81.9;Macrophages: 89.1;monocytes: 89.6;NK-cells: 70.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 871.6"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"NB-4: 192.2;REH: 205.7;RPMI-8226: 73.3;THP-1: 186.5;U-937: 177.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003462	Enhanced		Supported	"Plasma membrane"	"Intracellular and membrane"	NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 2: Immune cells - Immune response"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 57: B-cells - Immune response"	"Plasma membrane"		"HPA003462: AB_1079238"	"unprognostic (1.24e-2)"	"unprognostic (1.14e-2)"	"unprognostic (1.32e-2)"	"unprognostic (3.55e-3)"	"unprognostic (1.09e-1)"	"unprognostic (3.30e-3)"	"unprognostic (2.79e-2)"	"unprognostic (1.33e-1)"	"unprognostic (9.27e-2)"	"unprognostic (1.19e-1)"	"unprognostic (6.34e-3)"	"unprognostic (6.91e-2)"	"prognostic unfavorable (4.10e-4)"	"unprognostic (1.80e-1)"	"prognostic unfavorable (6.10e-4)"	"unprognostic (7.44e-2)"	"unprognostic (2.03e-1)"	6.8	5.4	9.7	37.7	11.1	61.3	3.8	11.8	12.8	3.7	9.1	6.5	6.3	2.9	2.5	3.6	4.2	9.1	2.3	10.3	12.2	3.3	4.8	19.2	51.6	18.4	13.6	1.7	3.0	2.2	3.0	7.4	17.7	7.1	7.7	1.2	4.5	3.5	3.3	3.0	13.6	8.8	16.5	47.0	6.5	2.0	15.3	12.2	2.8	2.4	56.6	10.1	2.5	20.1	1.7	1.1	1.1	3.1	0.3	0.0	1.1	1.4	1.2	0.6	0.7	2.3	28.9	19.6	0.4	0.5	6.1	1.2	0.4	1.1	0.6	31.4	1.2	8.6	1.8	1.8	0.1	56.1	55.6	0.4	0.8	2.1	0.6	1.2	0.3	1.1	1.6	9.3	0.5	1.7	1.3	192.2	0.9	5.5	2.0	205.7	1.1	73.3	0.2	1.7	0.9	0.8	0.6	1.2	1.2	0.9	1.1	186.5	2.1	2.1	19.9	0.8	1.8	0.9	6.2	32.2	9.4	177.6	1.5	871.6	276.6	46.0	8.8	159.0	0.9	169.3	2.3	1.4	225.2	191.1	1.0	2.9	491.0	73.9	93.9	8.9	4.9	214.7	9.7	11.1	11.8	12.8	10.3	12.2	18.4	13.6	17.7	16.5	15.3	20.1	1.3	3.2	16.2	0.7	90.6	3.4	0.7	0.0	0.6	0.3	1.0	1.9	1.1	5.7	3.1	3.7	0.0	0.6	47.8	0.2	0.0	0.3	2.4	1.3	0.6	3.9	7.8	16.6	1.7	0.2	1.1	1.7	1.1	2.1	171.6	0.4	3.9	4.5	82.7	0.0	1.4	0.8	0.0	71.1	81.9	3.4	0.0	89.1	1.8	20.6	89.6	0.2	70.0	0.5	0.9	0.6	0.1	0.7	18.7	1.2	0.1	0.2	5.9	1.3	0.0	1.9	0.9	0.4	1.4	0.1	2.6	1.2	27.7	0.3	0.8	0.4
LATS2		ENSG00000150457	"Large tumor suppressor kinase 2"	Q9NRM7	13	20973036-21061586	"Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 139.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039191, HPA049037"	Approved		Supported	"Centriolar satellite,Cytosol"		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 44: Endometrium - Transcription"	"Centriolar satellite, Cytosol"		"HPA039191: AB_2676385, HPA049037: AB_2680609"	"unprognostic (2.77e-1)"	"prognostic unfavorable (3.26e-4)"	"unprognostic (6.22e-3)"	"unprognostic (3.38e-2)"	"unprognostic (2.51e-2)"	"unprognostic (1.84e-2)"	"unprognostic (1.88e-1)"	"unprognostic (2.16e-3)"	"unprognostic (4.48e-1)"	"unprognostic (6.57e-3)"	"unprognostic (8.03e-2)"	"unprognostic (4.92e-2)"	"unprognostic (7.85e-2)"	"unprognostic (1.66e-2)"	"unprognostic (1.25e-1)"	"unprognostic (7.97e-2)"	"unprognostic (1.11e-2)"	19.8	12.2	3.9	7.3	4.3	15.1	12.4	4.8	3.7	10.1	7.7	13.1	2.9	12.2	3.0	11.5	9.7	15.1	11.5	5.3	3.3	9.9	9.8	12.4	5.3	5.4	4.6	11.0	10.2	4.3	2.3	13.9	4.5	9.8	4.3	1.3	6.1	8.8	16.7	7.7	6.2	13.1	4.1	11.2	7.8	14.6	5.1	2.4	13.5	13.3	3.3	14.2	8.9	4.7	6.8	7.4	16.0	9.7	18.4	24.1	14.6	22.1	22.8	22.5	19.2	21.1	10.0	0.0	10.5	33.8	8.8	9.6	9.5	10.1	33.1	3.8	2.5	12.4	9.4	16.0	28.6	3.4	4.2	36.0	18.1	14.9	9.9	11.3	32.0	2.8	2.3	0.5	28.9	11.7	0.4	11.6	3.8	7.0	3.5	2.9	28.5	0.0	16.3	3.1	0.3	0.0	17.4	11.3	23.9	13.9	9.8	6.4	40.6	23.8	15.9	17.7	14.1	2.9	1.7	0.0	5.7	3.8	18.6	0.1	0.5	0.5	0.4	0.4	0.9	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.9	0.4	0.2	0.0	0.0	0.1	3.9	4.3	4.8	3.7	5.3	3.3	5.4	4.6	4.5	4.1	5.1	4.7	36.6	41.7	9.9	12.1	2.8	32.9	14.7	8.5	21.6	0.4	12.5	11.0	24.3	15.7	10.5	5.5	0.0	24.8	21.0	6.5	3.9	10.1	139.4	40.3	30.4	35.1	0.0	8.2	0.6	7.3	8.9	37.2	8.6	62.1	5.1	9.8	44.6	19.6	9.9	0.0	0.6	1.9	6.1	17.9	49.3	13.7	25.4	26.0	17.8	21.5	11.0	4.9	13.4	2.0	8.8	18.6	2.8	34.6	8.9	21.7	0.6	9.5	11.6	1.0	6.6	32.3	30.0	8.8	14.5	9.9	25.3	48.0	8.1	7.9	1.5	15.2
LBR	"DHCR14B, TDRD18"	ENSG00000143815	"Lamin B receptor"	Q14739	1	225401502-225428925	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Cholesterol biosynthesis, Cholesterol metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism"	"DNA-binding, Oxidoreductase, Receptor"	"Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Erythroid cells: 248.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA062236	Enhanced		Supported	"Nuclear membrane"		NA	Yes			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 6: Erythroid cells - Oxygen transport"	"Nuclear membrane"		"HPA062236: AB_2684721"	"unprognostic (2.57e-1)"	"unprognostic (1.57e-1)"	"unprognostic (2.14e-3)"	"unprognostic (1.32e-2)"	"unprognostic (7.96e-2)"	"unprognostic (1.98e-1)"	"prognostic unfavorable (7.30e-4)"	"unprognostic (3.60e-2)"	"unprognostic (1.11e-2)"	"unprognostic (3.43e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.99e-1)"	"unprognostic (6.42e-2)"	"unprognostic (2.08e-1)"	"unprognostic (5.45e-1)"	"unprognostic (8.32e-2)"	"unprognostic (2.78e-1)"	28.6	9.1	8.8	53.2	9.7	95.7	17.1	9.3	11.9	27.3	9.2	61.4	40.7	47.0	44.4	29.7	31.8	21.7	10.0	8.5	10.1	19.4	47.3	19.2	81.6	12.0	9.8	19.4	16.9	5.6	6.5	27.6	11.2	23.8	46.2	5.3	11.1	36.7	9.8	13.8	39.9	41.4	10.2	41.5	28.2	20.5	9.5	105.5	11.8	12.8	70.7	32.3	23.0	13.1	122.2	42.0	154.9	69.3	64.8	39.7	77.3	31.2	39.2	65.0	69.0	87.2	207.2	248.4	66.6	32.8	38.6	88.8	114.2	32.9	98.5	142.2	107.1	61.4	40.4	81.5	39.9	274.7	105.5	34.3	21.3	58.9	52.0	33.1	82.9	117.4	189.6	164.6	44.4	16.3	254.9	156.6	140.6	121.8	14.2	164.9	141.4	234.0	75.6	52.7	40.6	53.4	52.7	39.6	26.6	68.2	53.3	181.0	50.5	17.6	91.7	49.3	115.9	56.6	83.0	274.5	24.3	120.5	61.2	83.6	44.3	67.3	43.6	31.6	50.9	39.0	43.5	48.8	38.4	39.5	42.4	52.9	211.4	41.3	25.2	21.5	61.9	69.8	8.8	9.7	9.3	11.9	8.5	10.1	12.0	9.8	11.2	10.2	9.5	13.1	98.1	28.9	36.4	13.4	86.4	27.0	33.4	17.3	21.6	4.5	11.9	11.0	8.5	48.6	34.4	31.3	6.2	40.5	98.3	33.4	5.9	23.6	1.2	31.5	31.0	53.1	27.0	248.9	10.5	19.8	23.9	29.0	29.0	53.9	10.1	24.0	48.5	73.6	44.4	11.8	14.3	43.0	12.2	88.5	18.1	3.4	33.8	71.7	26.6	19.7	56.0	11.6	82.4	37.2	34.1	20.6	24.6	32.4	74.0	32.9	19.3	26.0	26.0	10.4	39.5	13.9	46.6	21.0	26.7	68.4	35.5	11.1	81.3	13.2	73.8	36.7
LCLAT1	"AGPAT8, ALCAT1, FLJ37965, LYCAT"	ENSG00000172954	"Lysocardiolipin acyltransferase 1"	Q6UWP7	2	30447226-30644225	"Enzymes, Metabolic proteins, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	"Acyltransferase, Developmental protein, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 67.3;Inhibitory neurons: 86.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031880, HPA049217"	Uncertain		Supported	"Endoplasmic reticulum,Cytosol"		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 6: Brain - Smell perception"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Endoplasmic reticulum"	Cytosol	"HPA031880: AB_10610002, HPA049217: AB_2680678"	"unprognostic (6.60e-2)"	"unprognostic (2.47e-1)"	"unprognostic (1.12e-1)"	"unprognostic (9.52e-3)"	"unprognostic (4.10e-1)"	"prognostic unfavorable (9.67e-4)"	"prognostic unfavorable (8.72e-4)"	"unprognostic (2.03e-1)"	"unprognostic (1.33e-1)"	"unprognostic (3.88e-2)"	"unprognostic (7.11e-3)"	"unprognostic (2.85e-2)"	"unprognostic (4.14e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.63e-1)"	"unprognostic (3.93e-3)"	"unprognostic (1.10e-1)"	4.2	4.9	6.1	5.0	6.7	9.9	5.3	10.8	9.3	6.7	3.4	7.8	12.3	7.2	9.8	5.1	6.1	6.2	11.3	5.3	7.8	9.5	8.6	5.1	5.4	2.9	3.3	4.9	5.9	6.3	3.2	4.3	3.1	7.8	7.9	10.6	4.6	7.0	9.6	6.6	9.5	8.7	0.8	5.3	5.3	8.3	7.0	6.4	10.9	4.1	5.4	4.9	3.7	10.2	16.9	21.6	11.3	19.3	2.6	5.7	16.3	11.8	11.7	12.3	10.3	21.8	19.0	10.5	10.7	18.4	15.2	18.3	38.8	16.0	12.1	13.6	13.0	19.4	12.8	21.6	12.0	28.1	14.3	4.6	12.4	13.0	18.0	8.0	8.7	6.0	18.3	9.5	9.6	12.8	16.1	16.5	12.5	13.6	12.4	15.6	22.9	21.8	9.7	24.7	13.1	20.5	26.4	17.4	15.7	7.7	12.6	9.5	10.0	22.1	18.2	12.4	18.9	7.0	16.2	23.2	22.7	20.1	17.3	15.9	2.3	5.0	5.2	3.8	6.2	7.5	8.3	6.7	2.8	9.7	11.7	11.5	7.2	4.6	3.6	2.0	4.2	3.0	6.1	6.7	10.8	9.3	5.3	7.8	2.9	3.3	3.1	0.8	7.0	10.2	6.5	9.6	6.9	27.1	11.4	7.1	5.0	8.4	6.8	15.5	6.9	5.3	20.1	18.6	8.7	14.7	27.1	5.2	6.7	10.4	0.0	7.7	3.9	12.0	7.0	7.7	13.1	10.3	67.3	16.4	5.3	6.7	3.1	9.4	3.8	11.6	8.6	21.5	6.1	15.2	86.8	14.3	0.0	5.7	3.9	1.4	5.6	3.4	5.4	45.0	2.4	7.9	5.2	50.8	37.3	12.9	8.6	9.1	5.2	5.4	21.4	12.1	16.6	18.2	6.6	10.9	16.3	13.9	21.0	7.9	6.7	1.9	9.1	10.9	17.0	4.7
LCN2	"24p3, NGAL"	ENSG00000148346	"Lipocalin 2"	P80188	9	128149071-128153453	"Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins"	"Apoptosis, Immunity, Innate immunity, Ion transport, Iron transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 2768.7;gallbladder: 2223.2;salivary gland: 1308.3"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 4054.2;Club cells: 5757.0;Ductal cells: 6457.0;Pancreatic endocrine cells: 5424.3;Respiratory ciliated cells: 3161.5;Urothelial cells: 7112.9"	"Cancer enhanced"	"Detected in many"		"stomach cancer: 944.6"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	88	"basophil: 9.8;neutrophil: 11.9;non-classical monocyte: 4.7"	"Group enriched"	"Detected in many"	83	"granulocytes: 11.9;monocytes: 4.7"	"Group enriched"	"Detected in many"	11	"CAPAN-2: 3623.8;EFO-21: 1450.9"	"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in all"	5	"cerebellum: 149.7;spinal cord: 102.4"	"HPA002695, CAB016549, CAB016550"	Enhanced		Supported	"Endoplasmic reticulum"	"Secreted in other tissues"	NA	NA	297000000	590000000	"Cluster 34: Basophils - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Endoplasmic reticulum"		"CAB016549: , CAB016550: , HPA002695: AB_1852758"	"prognostic favorable (9.61e-4)"	"unprognostic (1.71e-1)"	"unprognostic (2.59e-1)"	"unprognostic (7.38e-3)"	"unprognostic (1.01e-2)"	"unprognostic (4.66e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.01e-1)"	"unprognostic (4.33e-1)"	"unprognostic (1.79e-1)"	"unprognostic (2.36e-2)"	"unprognostic (2.83e-2)"	"unprognostic (1.10e-3)"	"unprognostic (6.15e-2)"	"unprognostic (2.37e-1)"	"unprognostic (3.15e-2)"	"unprognostic (1.11e-2)"	4.9	3.6	0.0	125.5	0.1	2768.7	22.0	0.1	0.5	810.5	2.0	249.1	34.4	14.2	20.5	677.6	52.6	2223.2	3.1	0.0	0.1	31.6	67.8	76.1	1.1	0.3	0.1	1.1	74.8	7.3	21.2	2.6	0.3	74.5	131.0	0.0	1308.3	13.5	1.2	28.1	157.3	11.9	0.1	82.0	363.9	0.5	0.1	14.2	27.1	0.3	199.1	669.9	480.7	0.1	117.7	35.1	0.0	4.5	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.2	3623.8	0.2	1450.9	0.0	3.7	236.4	0.0	6.9	0.1	5.3	0.0	30.4	0.0	0.8	0.2	0.0	1.1	0.1	230.4	0.0	12.1	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.2	0.0	1.9	80.9	0.2	0.2	0.3	0.3	1.0	20.1	0.1	0.1	2.0	65.3	1.0	0.0	8.4	1.8	0.0	2.9	16.9	0.0	2.9	0.6	4.6	4.7	0.2	0.6	2.1	9.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.9	0.0	4.7	0.0	0.0	12.1	0.0	0.1	0.1	0.5	0.0	0.1	0.3	0.1	0.3	0.1	0.1	0.1	0.2	0.0	20.8	0.0	15.9	0.3	376.6	4054.2	1.8	0.0	38.1	29.3	0.2	1328.2	5757.0	138.0	0.0	0.8	1.2	315.6	0.0	6457.0	2.0	25.6	4.3	11.5	57.9	11.2	0.0	1837.0	0.3	12.2	237.0	52.3	13.4	0.0	2.2	43.2	0.6	0.0	0.0	264.3	956.2	2.7	0.0	15.8	3.4	34.9	0.0	0.0	60.3	0.0	1.0	0.0	0.0	5424.3	183.4	0.0	1.4	420.6	509.8	1.6	3161.5	0.0	0.0	0.0	337.7	0.0	0.3	51.1	0.0	0.3	7.7	0.0	475.5	7112.9
LDB2	"CLIM1, LDB1"	ENSG00000169744	"LIM domain binding 2"	O43679	4	16501541-16898678	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 236.5;Endothelial cells: 194.4;Excitatory neurons: 1314.4;Hepatic stellate cells: 364.8;Inhibitory neurons: 196.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	13	"NK-cell: 2.0"	"Lineage enriched"	"Detected in single"	13	"NK-cells: 2.0"	"Cell line enhanced"	"Detected in many"		"AF22: 18.3;fHDF/TERT166: 19.0;HAP1: 34.4;HUVEC TERT2: 65.3;TIME: 17.1;U-138 MG: 25.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017544, HPA068634"	Supported		Supported	"Nucleoplasm,Nucleoli,Plasma membrane"		No	NA			"Cluster 22: NK-cells - Unknown function"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Nucleoplasm, Nucleoli"	"Plasma membrane"	"CAB017544: AB_2137013, HPA068634: AB_2686012"	"unprognostic (3.43e-1)"	"unprognostic (2.77e-1)"	"unprognostic (9.10e-2)"	"unprognostic (4.37e-1)"	"unprognostic (7.25e-2)"	"unprognostic (4.62e-3)"	"unprognostic (2.10e-3)"	"unprognostic (1.57e-1)"	"unprognostic (2.94e-2)"	"unprognostic (2.82e-1)"	"unprognostic (2.67e-2)"	"unprognostic (1.96e-2)"	"unprognostic (2.05e-3)"	"unprognostic (1.26e-3)"	"unprognostic (1.60e-1)"	"unprognostic (9.63e-2)"	"unprognostic (7.10e-3)"	58.9	15.5	13.7	8.0	19.8	0.4	52.2	3.3	45.9	43.5	7.6	12.7	6.5	65.5	23.4	15.8	28.0	31.2	33.7	23.3	7.3	28.0	26.0	58.2	11.5	4.4	10.9	18.2	7.6	17.0	9.0	58.8	4.7	18.0	8.5	5.3	10.8	13.7	14.0	9.4	12.8	53.8	7.1	50.4	11.5	5.0	7.9	8.3	31.3	24.3	4.8	22.5	22.8	19.7	0.0	0.0	18.3	0.1	10.5	16.9	0.0	10.2	8.0	1.2	2.7	0.0	0.0	0.0	0.0	19.0	0.0	0.0	34.4	0.0	7.3	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.1	9.5	0.0	12.5	0.0	2.7	65.3	0.0	0.0	0.1	0.0	0.0	0.0	0.1	2.7	0.0	0.1	8.8	0.0	0.0	0.8	0.0	0.0	2.3	0.0	0.0	0.0	4.9	0.0	0.0	17.1	25.7	0.1	1.2	0.0	8.3	0.1	0.0	0.2	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.0	0.0	0.0	0.0	0.2	13.7	19.8	3.3	45.9	23.3	7.3	4.4	10.9	4.7	7.1	7.9	19.7	236.5	0.0	5.5	44.7	1.5	8.7	0.3	0.0	2.8	27.1	1.7	2.2	8.7	2.8	0.0	0.0	0.0	0.2	6.8	0.0	0.0	4.4	1.3	1.4	36.5	194.4	0.0	8.0	1314.4	0.2	0.2	44.4	4.1	1.1	5.7	0.1	364.8	3.1	0.4	0.0	196.5	0.0	0.0	16.4	13.2	2.6	38.2	1.4	8.8	117.1	0.0	10.4	3.1	120.6	36.7	0.2	0.0	50.4	0.0	0.3	0.0	0.1	0.7	2.1	6.6	2.8	19.3	0.2	0.7	1.3	6.8	0.1	4.9	39.7	0.0	0.5
LDB3	"CMD1C, KIAA0613, PDLIM6, ZASP"	ENSG00000122367	"LIM domain binding 3"	O75112	10	86668507-86736072	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			"Cardiomyopathy, Disease variant, Myofibrillar myopathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	26	"heart muscle: 1423.0;skeletal muscle: 2945.6;tongue: 1809.4"	"Cell type enriched"	"Detected in many"	7	"Cardiomyocytes: 1825.0"	"Group enriched"	"Detected in some"	4	"head and neck cancer: 1.7;melanoma: 2.5;prostate cancer: 3.6;stomach cancer: 1.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HSkMC: 3.0;hTERT-RPE1: 3.3;SCLC-21H: 4.9;SK-MEL-30: 2.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048955	Enhanced		Supported	"Nucleoplasm,Focal adhesion sites,Cytosol"		NA	NA		750000		"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 54: Cardiomyocytes - Muscle contraction"	"Focal adhesion sites, Cytosol"	Nucleoplasm	"HPA048955: AB_2680568"	"unprognostic (1.60e-1)"	"unprognostic (9.01e-2)"	"unprognostic (4.87e-2)"	"unprognostic (6.92e-2)"	"unprognostic (5.55e-2)"	"unprognostic (1.50e-2)"	"unprognostic (2.57e-2)"	"unprognostic (1.36e-1)"	"unprognostic (2.79e-2)"	"unprognostic (7.61e-2)"	"unprognostic (2.54e-3)"	"unprognostic (3.55e-2)"	"unprognostic (4.72e-4)"	"unprognostic (3.07e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.62e-2)"	"unprognostic (3.16e-1)"	11.1	1.4	12.8	2.8	39.6	0.4	6.5	29.8	29.0	10.1	0.1	36.2	2.4	15.1	4.9	54.5	17.3	3.1	1423.0	14.7	23.3	2.0	0.8	5.1	0.5	55.5	36.9	6.4	1.3	0.5	2.4	2.7	46.2	38.1	5.3	0.7	20.8	25.2	2945.6	4.8	8.8	23.7	26.4	0.6	9.0	4.7	38.4	0.7	5.2	1809.4	0.3	7.0	10.3	78.4	0.1	0.1	0.2	1.7	0.2	0.0	0.2	0.2	0.1	0.0	0.1	0.1	0.2	0.1	0.3	0.0	0.3	0.2	0.0	0.0	0.0	0.5	0.4	0.4	0.7	0.0	0.0	0.0	0.9	3.0	0.2	0.0	0.0	3.3	0.0	0.3	0.1	1.0	0.0	0.8	0.2	0.1	0.2	0.2	0.2	0.0	1.1	0.0	0.0	0.6	4.9	0.9	0.2	0.1	2.4	0.7	0.2	0.1	0.0	0.1	0.2	0.2	0.0	0.1	0.3	0.2	0.4	0.1	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	12.8	39.6	29.8	29.0	14.7	23.3	55.5	36.9	46.2	26.4	38.4	78.4	1.5	0.0	0.0	1.0	0.0	1.0	0.5	0.2	0.0	1.5	0.2	0.3	1825.0	0.0	0.2	1.8	0.0	0.1	0.0	0.0	0.0	0.0	23.4	0.1	0.4	15.5	0.0	0.0	4.5	1.1	0.0	31.5	0.0	0.2	0.0	0.9	0.0	0.0	0.1	0.0	2.6	0.0	4.1	0.0	1.2	19.6	11.1	0.5	1.8	1.9	0.0	0.7	0.0	1.5	245.1	0.1	0.0	6.8	0.0	0.3	0.0	0.1	0.1	4.1	39.5	48.0	54.9	1.0	1.0	0.0	0.0	0.0	0.2	0.2	0.0	0.2
LDHA		ENSG00000134333	"Lactate dehydrogenase A"	P00338	11	18394560-18408425	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase	"Cancer-related genes, Disease variant, FDA approved drug targets, Glycogen storage disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Basal keratinocytes: 2198.1;Basal respiratory cells: 2133.0;Extravillous trophoblasts: 2086.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB015336, CAB069404"	Uncertain		Supported	Vesicles,Cytosol		NA	NA		170000000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	Cytosol	Vesicles	"CAB015336: AB_2134947, CAB069404: "	"unprognostic (8.83e-2)"	"prognostic unfavorable (2.78e-5)"	"unprognostic (3.81e-2)"	"unprognostic (1.73e-1)"	"unprognostic (3.43e-3)"	"unprognostic (4.66e-3)"	"prognostic unfavorable (3.26e-8)"	"prognostic unfavorable (2.27e-6)"	"unprognostic (1.08e-1)"	"unprognostic (1.88e-2)"	"prognostic unfavorable (8.09e-6)"	"unprognostic (1.76e-2)"	"prognostic unfavorable (9.69e-9)"	"unprognostic (4.15e-2)"	"unprognostic (1.89e-1)"	"unprognostic (3.07e-1)"	"unprognostic (1.05e-2)"	444.5	358.1	64.3	139.5	68.4	184.6	330.4	54.0	72.1	203.1	58.4	278.5	158.1	151.1	43.8	450.6	189.2	75.5	361.2	68.4	73.7	440.2	729.2	242.0	97.2	73.6	74.9	149.7	171.5	26.6	95.9	113.9	94.9	170.1	117.4	443.8	267.5	81.8	947.5	468.6	296.6	124.2	58.5	185.3	181.1	95.2	67.4	115.3	180.8	500.3	146.5	266.2	314.4	65.9	1261.4	730.9	28.4	415.2	599.8	399.3	400.6	1186.1	1148.5	936.9	1366.4	324.5	196.6	909.3	380.3	1110.8	727.1	979.2	716.1	1715.1	2082.2	331.3	422.6	329.6	629.4	588.5	148.9	811.2	235.8	411.1	760.3	380.3	373.7	1670.8	550.8	292.3	462.8	431.7	1127.7	319.4	674.8	509.3	182.7	413.2	849.4	432.0	298.0	768.0	1546.6	284.5	220.5	279.3	642.7	518.6	230.8	431.4	241.7	192.9	546.9	1228.3	455.3	1094.7	14.3	348.0	545.1	899.4	1767.1	415.0	434.1	98.4	147.1	79.7	93.8	165.0	105.2	70.4	122.1	99.6	202.1	54.4	78.1	81.0	47.1	91.3	169.3	68.0	140.8	237.6	64.3	68.4	54.0	72.1	68.4	73.7	73.6	74.9	94.9	58.5	67.4	65.9	421.7	73.7	201.6	21.5	220.8	2198.1	475.6	2133.0	523.0	464.2	213.6	229.5	241.8	175.8	837.3	309.0	146.0	509.8	427.2	696.1	434.3	1293.9	204.4	180.0	317.4	492.8	45.6	123.2	38.7	1532.3	2086.2	544.4	163.6	485.8	262.9	205.3	205.6	514.4	659.3	514.8	33.5	285.1	649.0	224.4	1155.1	129.6	287.7	373.9	1177.5	20.6	973.4	444.2	170.0	9.5	12.6	1771.4	590.3	205.0	376.0	546.8	1765.0	682.5	178.1	481.4	190.7	251.6	706.3	195.5	44.0	422.9	1723.2	501.7	410.9	196.2	362.1	530.8
LDHB		ENSG00000111716	"Lactate dehydrogenase B"	P07195	12	21635342-21757857	"Disease related genes, Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 1947.7;kidney: 1726.6"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 2502.3;Cytotrophoblasts: 1693.0;Distal tubular cells: 3306.5;Proximal tubular cells: 3483.9;Syncytiotrophoblasts: 1639.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RPTEC TERT1: 6021.8"									"CAB004641, HPA019007"	Enhanced		Supported	Cytosol		No	No		560000000	"Cluster 20: T-cells - T-cell receptor"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 39: Non-specific - Basic cellular processes"	Cytosol		"CAB004641: AB_425525, HPA019007: AB_2670008"	"unprognostic (2.93e-1)"	"unprognostic (9.20e-3)"	"unprognostic (6.10e-2)"	"unprognostic (1.11e-1)"	"unprognostic (5.39e-3)"	"unprognostic (1.36e-3)"	"unprognostic (1.61e-2)"	"unprognostic (1.72e-2)"	"unprognostic (5.34e-2)"	"unprognostic (8.40e-2)"	"unprognostic (2.91e-1)"	"unprognostic (6.41e-2)"	"prognostic favorable (2.51e-4)"	"unprognostic (1.31e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.55e-1)"	"unprognostic (9.32e-2)"	549.9	424.8	509.1	259.2	528.2	352.8	321.1	593.7	617.0	238.6	549.8	320.2	84.4	273.1	169.0	166.6	252.9	232.9	1947.7	484.1	581.9	1726.6	70.5	220.4	425.8	564.4	575.4	472.4	370.3	447.3	161.3	298.2	556.2	240.9	277.0	290.0	162.3	287.2	309.4	81.4	171.3	309.7	537.8	182.0	459.1	119.5	582.5	534.5	348.5	950.4	449.4	417.9	171.2	517.8	647.2	1697.3	1457.5	966.0	1021.7	1126.6	1689.4	879.8	873.0	1201.5	1179.4	2712.9	3.6	2268.6	561.5	597.3	1170.1	315.8	2031.4	1631.4	1518.4	586.5	1413.1	2339.5	1619.0	3.0	975.0	2212.8	967.9	1300.5	572.1	1056.8	1423.4	1416.9	1395.2	1610.8	1304.6	332.6	1342.7	3.2	1895.9	2665.6	4216.4	1051.1	727.7	1681.3	2032.0	1838.7	6021.8	2832.7	467.2	1077.8	403.6	618.1	1586.1	3842.2	5.3	1704.6	548.3	803.7	1048.1	578.5	1684.5	291.0	420.9	2953.4	891.8	1037.5	978.2	540.8	201.9	25.1	346.8	124.7	583.1	349.4	1341.5	723.8	367.2	250.9	1722.4	1124.1	31.7	459.0	95.2	427.7	1405.8	1431.2	509.1	528.2	593.7	617.0	484.1	581.9	564.4	575.4	556.2	537.8	582.5	517.8	89.8	141.1	316.4	68.2	242.2	73.0	439.5	1103.1	221.4	151.5	332.4	325.0	2502.3	298.8	433.9	474.5	68.8	1693.0	208.0	69.6	3306.5	18.4	10.5	224.3	325.0	227.3	92.4	361.2	39.4	314.9	870.1	299.4	222.8	309.4	268.6	412.6	155.7	11.2	612.9	141.3	55.6	152.2	956.2	189.8	104.3	34.3	274.6	174.8	179.7	33.7	197.3	277.6	159.6	47.7	40.3	99.7	84.3	415.2	303.1	310.6	0.2	3483.9	363.0	118.1	236.7	195.2	363.7	21.5	124.3	216.3	64.2	1639.5	398.1	1105.3	257.0	344.9
LDLRAD4	C18orf1	ENSG00000168675	"Low density lipoprotein receptor class A domain containing 4"	O15165	18	13217498-13652755	"Predicted intracellular proteins, Predicted membrane proteins"		"Signal transduction inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 48.2;lymphoid tissue: 49.3"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 338.9;Inhibitory neurons: 308.5;Late spermatids: 231.5;Microglial cells: 429.1;Oligodendrocyte precursor cells: 318.7;Oligodendrocytes: 284.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEL: 35.3;JURKAT: 37.4;MOLT-4: 131.3;REH: 31.6;U-698: 26.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047633, HPA065246"	Approved		Supported	Vesicles		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 65: Plasmacytoid DCs - Unknown function"	Vesicles		"HPA047633: , HPA065246: AB_2685444"	"unprognostic (2.52e-1)"	"unprognostic (4.31e-3)"	"unprognostic (5.30e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.64e-1)"	"unprognostic (3.94e-3)"	"unprognostic (9.73e-2)"	"unprognostic (2.26e-2)"	"unprognostic (2.21e-2)"	"unprognostic (2.92e-2)"	"unprognostic (2.30e-1)"	"unprognostic (3.64e-1)"	"prognostic unfavorable (4.58e-4)"	"unprognostic (2.51e-2)"	"unprognostic (4.38e-2)"	"unprognostic (6.58e-2)"	"unprognostic (8.18e-2)"	6.5	4.3	13.9	7.3	38.0	9.7	6.3	34.6	25.9	7.8	37.4	5.8	6.1	12.4	0.9	3.9	11.3	4.6	16.6	10.7	16.4	4.0	10.3	4.6	6.5	46.1	33.2	2.3	3.3	2.9	6.9	6.2	38.6	8.6	2.1	7.0	3.0	5.3	15.4	4.2	7.2	5.7	27.3	5.6	5.0	9.2	48.2	49.3	4.4	9.5	3.8	5.3	5.3	39.6	0.2	0.3	1.4	0.8	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.1	0.1	0.1	2.7	1.6	0.8	0.4	0.0	0.0	0.0	17.1	1.7	35.3	7.0	1.2	0.0	1.7	0.9	0.0	0.0	0.0	0.0	0.0	0.4	37.4	0.4	0.7	0.0	2.6	131.3	1.1	2.9	0.3	8.9	31.6	0.1	1.2	0.0	1.1	2.4	3.9	0.5	2.2	0.0	1.9	3.8	4.7	2.4	1.3	11.5	0.2	1.9	5.6	0.4	26.1	0.0	6.9	6.4	12.8	7.0	2.1	6.5	7.7	5.7	5.2	5.8	5.6	3.9	4.4	8.2	7.6	12.1	9.1	8.5	5.9	3.4	4.5	13.9	38.0	34.6	25.9	10.7	16.4	46.1	33.2	38.6	27.3	48.2	39.6	19.4	3.2	4.7	143.3	79.2	10.5	2.7	0.8	0.0	5.4	26.0	16.9	18.4	0.0	5.0	1.8	70.9	0.6	21.0	6.8	1.9	5.1	135.2	16.3	22.0	16.6	58.7	7.6	338.9	3.6	0.7	16.5	13.3	7.8	23.5	7.6	25.0	24.4	21.1	0.0	308.5	9.1	2.0	27.4	160.5	231.5	11.1	56.2	14.2	429.1	13.6	4.7	3.1	318.7	284.9	0.7	2.6	24.5	11.7	13.5	15.6	2.3	13.7	18.7	6.6	2.3	9.7	5.4	4.9	0.4	7.7	1.6	66.0	0.2	8.8	3.2
LDOC1	"BCUR1, Mar7, Mart7, RTL7, SIRH7"	ENSG00000182195	"LDOC1 regulator of NFKB signaling"	O95751	X	141111605-141177129	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pituitary gland: 123.3"	"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 43.0;Proximal tubular cells: 43.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"NK-cell: 6.4"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"A549: 24.7;MCF7: 31.9;PC-3: 34.3;U-251 MG: 21.9"	"Region enriched"	"Detected in many"	5	"cerebellum: 19.2"					"HPA051768, HPA061842"	Approved		Supported	Nucleoplasm,Nucleoli		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 48: Smooth muscle cells - ECM organization"	"Nucleoplasm, Nucleoli"		"HPA051768: AB_2681599, HPA061842: AB_2684624"	"unprognostic (4.09e-1)"	"unprognostic (4.72e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.73e-3)"	"unprognostic (2.47e-1)"	"unprognostic (2.42e-1)"	"unprognostic (4.51e-2)"	"unprognostic (2.08e-2)"	"unprognostic (8.92e-2)"	"unprognostic (1.21e-1)"	"unprognostic (6.40e-3)"	"unprognostic (1.21e-1)"	"unprognostic (1.27e-2)"	"unprognostic (1.98e-2)"	"unprognostic (3.06e-2)"	"unprognostic (4.38e-3)"	"unprognostic (2.76e-2)"	32.3	34.0	4.7	0.9	5.5	0.1	28.0	2.9	8.5	45.8	0.2	18.8	0.9	53.9	1.8	21.4	48.5	1.6	15.1	6.2	5.8	33.2	4.8	19.6	0.8	5.3	5.0	46.8	19.3	10.5	123.3	0.0	5.0	34.3	0.3	3.4	55.1	5.9	5.5	31.5	12.5	2.0	1.2	14.2	18.4	10.8	5.0	0.9	53.7	0.4	0.7	33.1	30.6	6.0	0.0	24.7	3.0	8.4	5.0	6.2	0.0	5.0	5.8	6.3	8.8	0.0	8.0	0.0	4.2	7.7	6.1	10.4	3.4	7.1	4.5	0.0	6.6	0.0	11.7	0.0	2.0	0.0	1.9	10.9	3.6	5.5	2.9	5.1	5.7	0.0	0.1	0.0	5.7	31.9	0.0	0.0	3.3	0.0	34.3	0.0	2.7	0.0	7.7	4.7	0.0	3.2	0.0	4.0	0.0	1.6	5.1	0.0	11.9	0.0	6.8	0.0	21.9	0.0	0.0	0.0	3.5	0.0	0.0	3.1	0.0	0.0	1.2	0.0	0.8	0.9	2.5	0.8	0.2	2.1	2.2	1.4	0.0	6.4	0.0	1.4	2.6	1.0	4.7	5.5	2.9	8.5	6.2	5.8	5.3	5.0	5.0	1.2	5.0	6.0	8.6	0.0	5.3	4.2	4.9	6.0	16.8	4.6	16.5	29.3	23.8	20.2	2.2	30.0	8.2	23.9	8.4	2.8	5.7	0.1	43.0	13.8	0.7	7.8	13.5	12.8	5.4	0.8	9.4	14.0	1.8	16.1	3.6	6.0	2.5	8.8	12.8	0.1	0.9	20.2	9.9	0.4	8.2	0.3	1.8	1.1	22.1	1.0	3.6	7.5	0.3	21.2	5.2	7.1	15.0	13.7	0.2	38.7	0.9	11.9	0.0	43.8	4.6	13.0	13.1	15.3	26.2	0.9	7.6	16.7	6.8	1.5	5.2	13.5	0.3	15.0
LECT2	"chm-II, chm2"	ENSG00000145826	"Leukocyte cell derived chemotaxin 2"	O14960	5	135922279-135954983	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	Chemotaxis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	54	"liver: 477.9"	"Group enriched"	"Detected in some"	15	"Early spermatids: 147.7;Hepatocytes: 100.7;Late spermatids: 55.8"	"Cancer enriched"	"Detected in single"	216	"liver cancer: 35.1"	"Region enhanced"	"Detected in some"		"cerebellum: 6.3"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in some"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"HPA043883, HPA058246"	Enhanced		Supported	Vesicles,Cytosol	"Secreted to blood"	NA	NA	26500000	5300000	"Cluster 17: Basophils - Unknown function"	"Cluster 62: Liver - Hemostasis"	"Cluster 20: HeLa - Mitochondria"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	Cytosol	Vesicles	"HPA043883: AB_2678714, HPA058246: "							"prognostic favorable (4.16e-5)"						"unprognostic (2.57e-2)"		"unprognostic (3.52e-1)"			0.2	0.5	0.4	0.4	0.8	2.4	0.4	6.3	2.8	0.1	0.0	0.2	0.5	0.3	0.8	0.4	0.1	0.4	0.1	0.9	0.0	0.6	477.9	0.3	0.9	0.0	0.0	0.3	0.1	0.2	0.0	0.2	0.1	0.4	0.2	3.1	0.7	0.2	2.1	1.4	0.9	0.1	0.0	0.9	0.3	8.8	0.0	0.2	0.4	0.0	0.2	0.1	0.0	1.1	0.3	0.4	0.5	0.7	0.2	0.4	0.6	0.1	0.0	0.0	0.0	0.1	0.4	0.8	0.6	0.3	0.3	0.5	0.0	0.2	0.0	0.3	1.0	0.7	0.7	1.3	0.3	1.0	0.1	0.2	0.1	0.3	0.3	0.6	0.1	0.8	0.2	0.3	0.6	0.0	0.4	0.4	0.5	0.3	0.6	0.5	0.5	0.2	0.2	0.9	0.3	0.6	0.0	0.2	0.0	0.9	0.1	0.5	0.8	0.3	0.4	0.4	0.1	1.1	0.5	0.3	0.3	0.9	0.8	0.6	0.1	0.0	0.1	0.0	0.1	0.2	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.4	0.8	6.3	2.8	0.9	0.0	0.0	0.0	0.1	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	147.7	0.0	0.1	0.3	0.0	2.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	100.7	0.0	0.0	0.1	0.0	0.0	2.9	0.0	55.8	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.1	0.0	0.0	0.0	0.0	6.6	0.0	0.0	1.0	0.5	0.0	0.0	0.0	0.2	0.0	0.0	0.1
LEMD2	"dJ482C21.1, LEM2, NET25"	ENSG00000161904	"LEM domain nuclear envelope protein 2"	Q8NC56	6	33771202-33789130	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"			"Cataract, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017340	Supported		Supported	"Nuclear membrane"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 31: Spermatids - Spermatogenesis"	"Nuclear membrane"		"HPA017340: AB_2296925"	"unprognostic (9.01e-2)"	"unprognostic (7.99e-2)"	"unprognostic (1.18e-1)"	"unprognostic (4.12e-2)"	"unprognostic (2.98e-1)"	"unprognostic (8.29e-3)"	"unprognostic (6.53e-2)"	"unprognostic (5.98e-2)"	"unprognostic (4.42e-2)"	"unprognostic (7.03e-2)"	"unprognostic (1.67e-3)"	"unprognostic (2.11e-2)"	"prognostic unfavorable (1.12e-5)"	"unprognostic (2.43e-1)"	"unprognostic (7.54e-2)"	"unprognostic (3.82e-2)"	"unprognostic (7.12e-2)"	40.5	45.8	46.0	35.0	47.9	63.3	39.6	53.1	50.8	52.6	44.6	45.3	31.9	44.1	29.7	50.2	45.9	30.0	46.7	43.9	44.0	51.5	49.9	51.2	45.4	52.0	47.0	53.7	54.5	39.3	56.5	38.5	47.9	51.9	30.0	29.7	43.3	31.3	37.4	51.8	50.1	30.4	46.3	70.1	44.9	45.5	47.2	46.1	53.0	28.1	41.6	43.8	44.9	54.4	36.6	40.5	67.3	66.1	37.6	40.3	50.9	39.1	59.7	48.5	50.9	30.6	37.8	33.8	53.5	55.6	136.7	62.0	39.4	52.1	34.0	35.9	36.6	12.7	45.8	40.3	78.4	26.1	42.6	44.3	96.5	51.6	88.1	80.0	52.8	43.9	36.3	38.3	42.8	30.8	48.6	64.1	39.2	53.5	23.2	31.8	27.8	28.3	52.0	50.5	47.8	37.8	23.4	74.0	52.6	68.0	49.5	70.7	24.6	67.8	26.3	36.6	46.5	49.8	43.0	24.0	26.7	40.3	83.0	1.6	1.7	3.2	2.3	1.5	2.9	2.2	2.5	2.3	1.7	2.3	2.0	2.3	1.4	1.5	2.1	2.9	2.8	1.2	46.0	47.9	53.1	50.8	43.9	44.0	52.0	47.0	47.9	46.3	47.2	54.4	19.8	3.2	9.0	16.0	17.4	10.8	13.4	7.9	14.2	18.6	10.0	7.1	10.0	8.6	5.2	9.2	18.8	24.9	18.6	24.3	1.9	9.4	24.9	7.5	10.1	18.5	5.4	8.6	14.5	6.8	36.6	12.2	15.3	10.6	12.7	16.6	12.5	7.7	17.5	43.7	17.4	17.7	6.1	14.5	12.4	44.2	10.5	13.5	12.4	14.0	9.4	14.0	13.4	14.6	18.2	13.2	20.1	16.1	11.9	14.6	14.8	6.6	7.2	13.1	19.7	12.7	15.2	24.6	7.4	8.9	10.2	29.8	15.2	12.5	15.9	13.2
LEMD3	MAN1	ENSG00000174106	"LEM domain containing 3"	Q9Y2U8	12	65169583-65248355	"Disease related genes, Human disease related genes, Plasma proteins, Predicted membrane proteins"		DNA-binding	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA025078, HPA076986"	Uncertain		Supported	"Nuclear membrane"		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	"Nuclear membrane"		"HPA025078: AB_10601908, HPA076986: AB_2686821"	"unprognostic (2.10e-2)"	"unprognostic (6.83e-3)"	"unprognostic (1.63e-3)"	"unprognostic (1.76e-3)"	"unprognostic (2.79e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.68e-3)"	"unprognostic (7.22e-2)"	"unprognostic (3.06e-2)"	"unprognostic (4.16e-2)"	"unprognostic (8.89e-2)"	"unprognostic (2.43e-1)"	"prognostic favorable (2.30e-4)"	"unprognostic (4.37e-2)"	"unprognostic (3.93e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.72e-1)"	9.3	7.3	6.6	10.5	8.0	20.8	10.6	12.2	9.4	8.6	6.9	10.4	9.6	12.2	8.8	8.1	9.3	6.9	7.2	8.5	6.3	9.6	9.5	9.3	13.5	6.0	6.9	11.9	9.8	14.7	5.3	7.2	6.4	9.4	10.0	16.6	9.3	7.7	8.7	8.0	9.4	8.3	6.9	11.4	9.7	15.6	6.9	13.6	10.6	9.6	12.3	8.9	8.1	7.7	19.7	10.9	17.1	17.2	11.8	13.6	11.7	22.4	12.0	11.0	9.5	13.7	12.4	53.2	14.1	13.9	8.5	25.8	18.5	16.0	15.9	12.8	21.4	21.7	10.2	10.5	9.0	33.4	15.1	9.9	16.9	13.1	17.6	15.5	13.1	14.6	28.9	24.6	15.6	11.5	17.5	17.3	23.5	8.9	11.1	40.6	16.8	26.8	13.8	21.4	17.8	10.9	22.5	22.7	14.0	16.4	22.6	26.0	18.1	13.4	14.3	12.7	15.7	17.5	17.7	32.3	11.2	16.1	16.8	1.0	0.7	1.4	1.5	0.6	2.0	1.8	2.0	2.0	1.0	1.9	1.9	2.1	0.8	1.6	0.9	2.1	1.9	0.7	6.6	8.0	12.2	9.4	8.5	6.3	6.0	6.9	6.4	6.9	6.9	7.7	21.7	38.5	21.0	29.7	29.0	32.1	19.4	10.4	14.8	20.1	15.3	11.3	14.7	8.6	13.5	11.0	18.8	8.0	32.7	20.2	0.0	10.3	2.1	16.3	18.0	17.4	14.9	16.8	50.0	13.1	4.6	18.5	13.3	19.8	22.2	12.5	14.6	13.3	6.5	16.8	58.2	13.7	12.2	13.7	16.4	3.2	15.8	16.4	17.8	49.6	16.1	20.3	17.5	53.3	52.7	14.6	14.5	12.4	23.6	18.9	7.8	4.3	19.3	21.5	6.6	23.5	19.2	43.3	35.3	17.6	39.1	14.4	21.9	13.7	11.8	22.9
LETM1	SLC55A1	ENSG00000168924	"Leucine zipper and EF-hand containing transmembrane protein 1"	O95202	4	1811479-1856156	"Human disease related genes, Predicted membrane proteins, Transporters"	"Antiport, Calcium transport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal enterocytes: 116.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011029, HPA011100"	Supported		Supported	Mitochondria		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Mitochondria		"HPA011029: AB_1852804, HPA011100: AB_1852802"	"unprognostic (1.16e-1)"	"unprognostic (1.80e-1)"	"unprognostic (3.85e-2)"	"unprognostic (5.04e-2)"	"unprognostic (5.48e-1)"	"unprognostic (1.17e-1)"	"prognostic unfavorable (1.79e-4)"	"unprognostic (1.37e-3)"	"unprognostic (1.87e-1)"	"unprognostic (3.29e-1)"	"unprognostic (1.80e-1)"	"prognostic unfavorable (1.77e-4)"	"prognostic favorable (8.90e-4)"	"unprognostic (8.06e-3)"	"unprognostic (3.24e-1)"	"unprognostic (1.57e-2)"	"unprognostic (2.42e-1)"	13.6	16.3	14.3	7.9	13.7	7.7	10.8	11.7	14.6	8.2	10.8	20.3	13.9	8.4	3.2	23.8	8.0	4.5	19.6	13.4	13.2	13.3	16.4	8.9	7.0	12.7	13.5	9.2	12.5	11.4	8.8	4.9	11.9	8.4	10.7	4.5	9.6	4.2	18.7	15.9	11.7	5.1	12.2	10.7	13.8	14.5	15.0	25.7	10.7	10.9	7.9	8.4	10.6	11.6	22.9	38.1	11.6	36.1	17.4	12.2	20.7	22.1	10.7	21.8	16.9	35.5	24.7	37.5	15.4	23.3	34.0	22.7	29.8	31.2	13.2	25.1	31.1	38.4	30.9	25.6	22.6	39.3	30.3	19.9	22.0	24.9	21.8	10.1	19.0	22.6	51.5	22.9	15.3	25.1	57.3	44.7	30.5	24.7	43.2	32.4	16.2	21.9	17.0	31.3	29.5	26.0	25.2	31.5	13.3	10.0	29.7	20.3	28.8	24.8	14.8	21.1	37.3	19.8	32.7	29.3	22.0	33.8	20.2	3.9	3.7	2.0	5.8	5.0	5.7	4.2	4.9	4.9	4.1	3.6	3.2	4.6	0.5	5.9	5.1	12.9	4.2	2.1	14.3	13.7	11.7	14.6	13.4	13.2	12.7	13.5	11.9	12.2	15.0	11.6	12.2	16.0	11.5	15.0	19.2	40.0	40.7	13.4	8.0	19.4	19.7	10.5	23.3	11.5	14.0	27.6	33.3	17.5	24.9	116.1	31.3	25.5	32.2	9.1	19.4	16.7	15.6	20.4	14.3	31.3	22.6	17.0	32.1	14.7	10.2	17.9	16.1	33.3	21.5	15.2	12.4	29.5	12.2	18.4	19.8	45.1	20.2	13.0	19.6	4.7	13.9	12.7	28.8	9.5	13.2	42.4	52.7	16.6	17.8	58.8	48.8	46.1	5.6	28.4	13.1	23.8	16.1	54.2	44.4	25.2	51.1	15.2	16.7	21.9	53.2	48.4
LETMD1	"HCCR, HCCR-1, HCCR-2, HCCR1, HCCR2, SLC55A3"	ENSG00000050426	"LETM1 domain containing 1"	Q6P1Q0	12	51047962-51060424	"Predicted intracellular proteins, Predicted membrane proteins"			Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA074361			Supported	Nucleoplasm,Nucleoli,Mitochondria		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 32: Non-specific - Translation"	Mitochondria	"Nucleoplasm, Nucleoli"	"HPA074361: AB_2686682"	"unprognostic (2.16e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.08e-1)"	"unprognostic (6.55e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.11e-1)"	"unprognostic (2.20e-2)"	"unprognostic (3.05e-3)"	"unprognostic (1.48e-2)"	"unprognostic (5.05e-2)"	"unprognostic (7.86e-2)"	"unprognostic (6.57e-2)"	"prognostic favorable (3.26e-4)"	"unprognostic (4.07e-1)"	"unprognostic (7.79e-2)"	"unprognostic (2.58e-1)"	"prognostic favorable (3.16e-4)"	31.2	27.0	17.5	11.7	19.2	22.3	29.9	17.8	24.2	19.6	22.8	24.3	36.0	19.4	23.8	13.1	32.4	17.1	18.9	20.0	19.0	32.7	40.3	17.6	18.2	19.3	17.2	36.6	37.1	32.4	19.4	13.7	20.0	18.9	28.3	20.9	27.5	19.4	23.6	19.7	24.5	19.8	18.3	16.5	24.5	13.3	18.7	22.4	37.2	27.8	20.8	17.0	15.5	19.5	19.1	16.7	12.7	33.5	54.9	89.9	12.6	19.4	31.7	19.9	22.2	41.2	38.6	50.2	23.4	20.9	14.2	34.7	25.8	26.1	22.6	18.3	32.4	36.5	23.6	32.8	36.1	32.8	25.6	75.4	82.3	23.7	55.5	60.4	20.3	47.7	38.1	35.4	27.5	29.5	23.2	33.1	8.4	23.6	45.2	19.5	15.0	27.4	25.2	28.3	37.3	16.7	14.7	32.2	45.4	12.4	51.1	29.2	15.6	12.8	13.4	20.9	11.2	32.2	53.8	21.6	23.1	21.1	9.1	3.7	9.6	3.9	10.1	10.8	15.1	15.0	17.0	12.8	9.3	9.2	20.5	19.1	3.0	12.6	16.2	8.3	17.0	12.5	17.5	19.2	17.8	24.2	20.0	19.0	19.3	17.2	20.0	18.3	18.7	19.5	27.0	22.4	29.5	41.1	38.8	49.6	40.0	51.9	66.0	20.9	66.2	64.8	12.6	35.8	20.5	23.9	10.4	49.6	31.7	20.3	92.0	17.2	9.3	23.6	22.2	26.2	27.7	35.5	22.6	32.7	23.3	32.9	31.6	18.4	25.4	29.7	25.7	19.1	30.3	18.5	26.5	36.0	28.5	56.3	35.7	17.0	32.6	27.9	39.2	13.1	31.5	31.8	23.7	16.1	25.4	15.6	26.8	30.5	29.5	26.0	87.0	65.7	25.1	18.9	26.3	33.5	31.8	20.5	26.0	44.2	44.3	27.9	38.8	55.4	52.7	26.6
LGALS13	"PLAC8, PP13"	ENSG00000105198	"Galectin 13"	Q9UHV8	19	39602501-39607474	"Metabolic proteins, Predicted intracellular proteins"	Apoptosis	Hemagglutinin		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	16	"placenta: 11.8"	"Cell type enriched"	"Detected in some"	17	"Syncytiotrophoblasts: 319.9"	"Cancer enriched"	"Detected in single"	4	"thyroid cancer: 0.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	22	"SuSa: 2.1"									HPA046803			Supported	Nucleoplasm		NA	NA				"Cluster 28: Placenta - Pregnancy"	"Cluster 12: NES - Nervous system development"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	Nucleoplasm		"HPA046803: AB_10965990"																		0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.7	0.0	0.0	0.0	0.0	0.2	0.5	0.0	0.0	0.0	0.0	11.8	0.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.6	0.1	0.7	0.2	0.5	0.3	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.7	0.0	0.0	0.0	0.0	4.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.7	0.3	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	17.8	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	319.9	0.0	0.0	0.0	0.0
LGALS14	"CLC2, PPL13"	ENSG00000006659	"Galectin 14"	Q8TCE9	19	39704481-39709444	"Predicted intracellular proteins"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	29	"placenta: 65.5"	"Cell type enriched"	"Detected in some"	11	"Syncytiotrophoblasts: 88.7"	"Cancer enriched"	"Detected in single"	16	"liver cancer: 5.3"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"EFO-21: 4.3;U-266/70: 9.8"									HPA065180			Supported	Nucleoplasm		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 28: Placenta - Pregnancy"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	Nucleoplasm		"HPA065180: "										"unprognostic (1.95e-1)"								0.1	0.0	0.7	0.3	0.8	0.6	0.4	2.2	1.2	0.2	0.4	0.1	0.3	0.2	0.3	0.0	0.0	0.1	0.0	0.7	0.7	0.0	0.0	0.2	0.4	1.1	0.6	0.2	0.5	0.0	0.0	65.5	1.0	0.1	0.1	0.5	0.1	0.0	0.1	0.9	0.1	0.2	0.2	0.4	0.3	0.2	1.2	0.1	0.1	0.2	0.6	0.1	0.0	2.2	0.1	0.0	0.2	0.4	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	4.3	0.1	0.1	0.5	0.0	0.0	0.1	1.2	0.1	0.1	0.5	0.2	0.0	0.1	0.7	0.0	0.1	0.1	0.2	0.4	0.0	0.3	0.1	0.8	0.0	0.3	0.1	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.2	0.2	0.1	0.2	0.1	0.5	0.0	0.1	0.0	0.3	0.4	0.5	0.1	9.8	0.4	0.0	0.2	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.7	0.8	2.2	1.2	0.7	0.7	1.1	0.6	1.0	0.2	1.2	2.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	7.4	0.0	0.1	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.0	1.0	0.2	0.0	0.4	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	88.7	0.2	0.0	0.0	0.0
LGALS3	"GALIG, LGALS2, MAC-2"	ENSG00000131981	"Galectin 3"	P17931	14	55124110-55145423	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Differentiation, Immunity, Innate immunity, mRNA processing, mRNA splicing"	"IgE-binding protein"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 1194.1"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 4097.0;Paneth cells: 3445.9;Proximal enterocytes: 4397.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"classical monocyte: 651.4;intermediate monocyte: 544.6;myeloid DC: 397.8;non-classical monocyte: 441.2;T-reg: 251.9"	"Group enriched"	"Detected in all"	13	"dendritic cells: 397.8;monocytes: 651.4;T-cells: 251.9"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 1169.3;CAPAN-2: 968.0;OE19: 1613.0;SK-MEL-30: 2329.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA003162, CAB005191, HPA076528"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cytosol"	"Secreted to blood"	NA	NA		1900000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 37: Intestine - Unknown function"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Nucleoplasm, Cytosol"	"Plasma membrane"	"CAB005191: AB_2136784, HPA003162: AB_1078937, HPA076528: "	"unprognostic (1.42e-1)"	"unprognostic (9.79e-2)"	"unprognostic (1.14e-1)"	"unprognostic (3.15e-1)"	"unprognostic (2.46e-2)"	"unprognostic (3.34e-2)"	"unprognostic (1.73e-3)"	"unprognostic (1.00e-1)"	"unprognostic (2.13e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.08e-3)"	"unprognostic (5.97e-2)"	"unprognostic (8.52e-2)"	"unprognostic (1.44e-1)"	"unprognostic (2.96e-2)"	"unprognostic (2.65e-3)"	"unprognostic (7.60e-3)"	404.5	72.0	111.4	219.8	111.8	346.9	323.1	110.7	148.1	331.4	104.3	1194.1	691.9	162.3	53.8	437.8	223.1	273.0	246.2	110.3	109.4	120.0	27.3	356.1	84.5	118.6	111.9	251.4	79.9	19.8	60.6	141.2	108.6	143.1	875.4	68.3	358.6	177.4	78.6	473.1	853.4	158.8	110.4	61.9	340.7	63.5	125.2	53.0	72.3	105.6	114.1	300.8	273.5	114.0	298.6	96.5	3.3	2.5	581.2	1169.3	344.9	226.7	496.2	64.0	113.2	225.4	968.0	0.7	121.3	272.8	114.6	289.0	6.1	245.4	37.5	357.1	4.4	1.0	104.7	103.8	446.8	1.0	1.1	363.4	375.2	73.9	152.8	145.1	101.5	0.7	1.4	283.1	148.8	218.5	1.3	74.4	5.6	1613.0	271.1	0.7	11.3	22.4	604.8	434.2	7.8	22.6	529.0	0.9	2329.1	16.2	242.8	31.4	180.5	297.8	41.5	112.0	4.4	154.0	535.6	2.8	426.8	18.6	31.8	18.5	651.4	32.4	15.7	544.6	99.7	11.5	58.4	44.2	397.8	4.7	2.5	8.3	28.7	24.2	441.2	9.6	251.9	449.6	111.4	111.8	110.7	148.1	110.3	109.4	118.6	111.9	108.6	110.4	125.2	114.0	1157.4	721.1	359.8	33.3	42.0	631.3	624.1	1278.9	241.9	2.9	307.3	478.7	218.2	258.7	1463.3	119.5	0.0	766.1	38.8	4097.0	673.1	605.9	21.7	636.2	742.7	397.8	173.4	578.1	0.2	1057.8	1051.7	666.3	281.4	846.8	580.5	6.3	64.6	2.3	1137.4	1.7	0.5	1733.8	1778.1	287.8	844.6	44.4	555.7	651.2	848.4	14.0	639.1	300.1	9.2	2.0	0.3	1289.6	3445.9	384.0	77.4	708.4	4397.2	81.3	1506.5	14.7	144.7	220.2	521.0	11.5	6.6	524.8	797.6	483.8	119.5	2.9	1880.1	1139.7
LHPP	HDHD2B	ENSG00000107902	"Phospholysine phosphohistidine inorganic pyrophosphate phosphatase"	Q9H008	10	124461823-124617888	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 198.8;choroid plexus: 104.0"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 114.9;Late spermatids: 163.3;Proximal tubular cells: 93.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA009163, HPA009269"	Enhanced		Supported	"Nuclear speckles,Cytosol"		NA	NA		820000	"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 70: Brain - Nervous system development"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Nuclear speckles, Cytosol"		"HPA009163: AB_1079250, HPA009269: AB_1079249"	"unprognostic (3.46e-2)"	"unprognostic (1.23e-2)"	"unprognostic (4.78e-2)"	"unprognostic (3.89e-1)"	"unprognostic (2.14e-1)"	"unprognostic (1.96e-1)"	"unprognostic (5.77e-3)"	"unprognostic (2.02e-2)"	"unprognostic (3.58e-1)"	"unprognostic (1.93e-1)"	"unprognostic (6.42e-2)"	"unprognostic (5.55e-2)"	"unprognostic (1.79e-3)"	"unprognostic (2.52e-1)"	"unprognostic (2.10e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.64e-1)"	12.9	32.0	135.1	8.2	173.7	10.5	13.0	159.3	190.6	18.5	104.0	27.1	23.4	20.2	13.4	24.1	10.0	10.2	17.5	129.7	156.5	28.4	60.2	9.2	11.8	179.2	165.8	9.0	15.9	9.2	14.5	8.6	170.7	14.0	8.5	7.5	18.3	12.5	10.2	15.3	21.1	10.2	151.1	14.0	20.1	24.2	156.3	9.7	29.4	4.8	15.2	14.7	16.1	198.8	24.7	12.0	4.7	12.1	18.2	14.7	12.8	8.2	18.0	5.5	10.0	2.1	22.4	24.4	19.7	13.5	6.1	26.1	1.4	4.7	5.7	5.4	16.3	17.6	4.1	11.4	18.5	3.6	27.6	11.0	20.0	5.4	13.0	16.0	8.8	21.4	8.9	9.5	6.9	24.5	12.0	11.3	8.5	10.4	6.8	12.4	5.3	31.8	12.1	3.2	2.7	14.2	6.3	22.6	8.2	6.5	17.2	0.6	4.2	8.5	12.2	7.2	2.3	7.9	2.5	7.8	7.7	6.8	2.0	8.1	28.8	25.3	16.1	24.5	20.8	41.0	18.7	17.2	35.6	43.3	22.4	16.0	4.8	7.9	29.0	13.4	32.1	24.4	135.1	173.7	159.3	190.6	129.7	156.5	179.2	165.8	170.7	151.1	156.3	198.8	5.0	3.2	14.8	22.9	29.1	7.4	9.4	22.1	13.1	6.0	19.8	19.8	15.8	12.8	19.4	7.3	0.0	54.2	6.2	17.9	33.2	5.3	114.9	17.7	12.7	4.6	9.5	19.8	29.4	2.3	24.7	11.2	19.9	8.2	10.8	23.3	6.1	61.1	26.5	11.8	27.8	21.3	24.4	16.0	8.1	163.3	5.9	12.9	17.8	8.4	15.6	9.8	8.2	15.6	76.4	3.3	30.2	10.5	19.7	6.7	80.5	93.8	24.9	6.4	13.1	5.2	9.5	33.1	11.3	30.7	5.4	24.2	12.1	12.4	23.0	16.3
LHX1	"LIM-1, LIM1"	ENSG00000273706	"LIM homeobox 1"	P48742	17	36936785-36944612	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	12	"kidney: 10.7"	"Cell type enriched"	"Detected in some"	8	"Horizontal cells: 361.7"	"Group enriched"	"Detected in some"	4	"ovarian cancer: 8.1;testis cancer: 2.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HAP1: 3.8;HMC-1: 1.6;WM-115: 7.0"	"Region enhanced"	"Detected in many"		"cerebellum: 19.1"	"Region enriched"	"Detected in many"	4	"cerebellum: 15.7"	"HPA044307, HPA073521, HPA074382"	Enhanced		Supported	"Nucleoplasm,Nuclear membrane,Golgi apparatus"		NA	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 62: Horizontal cells - Visual perception"	Nucleoplasm	"Nuclear membrane, Golgi apparatus"	"HPA044307: , HPA073521: AB_2732226, HPA074382: "	"unprognostic (3.86e-5)"	"unprognostic (1.64e-1)"		"prognostic unfavorable (3.63e-5)"	"unprognostic (3.85e-2)"	"unprognostic (1.06e-4)"		"unprognostic (2.67e-2)"	"unprognostic (2.72e-1)"	"unprognostic (1.52e-1)"	"unprognostic (4.20e-3)"		"unprognostic (1.74e-5)"	"unprognostic (1.33e-1)"	"unprognostic (8.62e-2)"		"unprognostic (3.05e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.6	10.7	0.0	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.1	0.0	3.8	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	1.6	0.0	0.0	0.0	1.1	0.4	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.1	0.1	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.0	0.0	1.1	0.0	1.0	0.0	0.0	0.0	0.0	0.0	7.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.6	0.5	0.2	0.5	0.1	0.2	0.0	0.2	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.4	0.0	0.4	2.1	0.0	0.0	42.3	0.0	0.0	0.1	0.1	0.0	0.0	0.3	0.6	0.0	0.1	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	361.7	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	13.0	0.0	1.6	0.0	0.0	0.2	1.1	2.3	0.0	0.0	0.4	0.3	0.0	0.2	0.0
LIF	"CDF, DIA, HILDA"	ENSG00000128342	"LIF interleukin 6 family cytokine"	P15018	22	30240453-30246759	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Cytokine, Growth factor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 47.7;urinary bladder: 91.0"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 95.5;Club cells: 56.3;Endometrial ciliated cells: 71.7;Fibroblasts: 51.9;Glandular and luminal cells: 192.9;granulocytes: 67.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"GAMG: 88.3;hTEC/SVTERT24-B: 113.0;hTERT-RPE1: 104.4;U-138 MG: 123.9;U-251 MG: 94.5;U-87 MG: 97.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA018844, CAB025985"	Uncertain		Supported	Cytosol	"Secreted in other tissues"	NA	NA				"Cluster 82: Adipose tissue - ECM organization"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 44: Endometrium - Transcription"	Cytosol		"CAB025985: , HPA018844: AB_1852814"	"unprognostic (1.28e-2)"	"prognostic unfavorable (9.01e-4)"	"unprognostic (8.79e-2)"	"unprognostic (4.61e-2)"	"unprognostic (7.36e-3)"	"unprognostic (4.18e-3)"	"unprognostic (1.17e-2)"	"unprognostic (1.41e-2)"	"unprognostic (3.18e-3)"	"unprognostic (1.22e-1)"	"unprognostic (8.10e-2)"	"unprognostic (9.65e-2)"	"prognostic unfavorable (6.78e-8)"	"unprognostic (2.02e-1)"	"unprognostic (6.40e-2)"	"unprognostic (8.99e-2)"	"unprognostic (4.71e-3)"	37.9	4.3	0.6	22.4	0.7	1.6	4.7	0.6	1.7	6.8	6.6	7.5	6.7	11.7	0.6	3.1	9.8	47.7	18.4	0.9	0.8	14.2	5.0	29.9	4.3	1.2	1.3	2.3	13.4	0.4	10.4	2.7	0.9	12.0	8.0	3.0	4.9	2.1	0.8	10.7	9.3	8.3	1.1	1.5	7.8	0.6	2.6	1.3	5.4	1.0	1.7	91.0	2.4	1.1	29.0	47.9	1.3	10.6	0.0	3.9	17.1	4.1	17.2	5.1	12.1	7.7	47.3	0.0	10.1	0.2	88.3	7.3	1.1	13.1	6.9	6.8	2.1	3.7	19.7	10.9	4.5	0.1	36.7	4.3	2.5	113.0	3.3	104.4	0.0	0.2	0.8	0.1	22.6	21.5	0.6	0.1	1.8	27.0	29.5	0.9	15.9	0.0	40.7	11.0	0.2	0.6	4.9	0.4	8.8	5.0	1.0	0.5	0.3	123.9	45.3	47.3	94.5	0.0	0.2	0.1	97.4	0.1	58.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.7	0.6	1.7	0.9	0.8	1.2	1.3	0.9	1.1	2.6	1.1	0.6	22.4	44.2	0.3	0.0	3.4	14.0	95.5	0.0	0.1	40.0	10.9	0.2	10.0	56.3	5.5	0.0	0.2	2.9	3.9	0.0	39.6	0.3	71.7	16.2	3.6	0.0	0.0	0.0	3.4	0.7	51.9	0.5	192.9	67.0	0.2	0.0	0.0	1.1	0.0	0.0	3.5	10.2	0.6	3.2	0.0	0.0	3.9	0.0	0.0	0.0	1.7	0.0	0.0	0.0	40.3	3.8	0.0	0.4	15.7	5.3	1.0	15.6	0.2	0.0	17.7	30.2	0.1	0.2	1.5	2.8	0.3	5.5	0.1	7.1	20.3
LIG1		ENSG00000105486	"DNA ligase 1"	P18858	19	48115445-48170603	"Enzymes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, DNA damage, DNA recombination, DNA repair, DNA replication"	Ligase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 34.5"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB037015, HPA041431, HPA048071"	Approved		Supported	"Nucleoplasm,Golgi apparatus,Vesicles"		Yes	No			"Cluster 15: NK-cells - Transcription"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 24: NB-4 - Immune response"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	"Golgi apparatus, Vesicles"	"CAB037015: , HPA041431: AB_2677476, HPA048071: AB_2680248"	"unprognostic (1.83e-1)"	"unprognostic (1.48e-3)"	"unprognostic (6.45e-2)"	"unprognostic (9.76e-2)"	"unprognostic (9.47e-2)"	"unprognostic (9.24e-3)"	"unprognostic (1.17e-3)"	"unprognostic (2.28e-1)"	"unprognostic (6.03e-3)"	"unprognostic (4.26e-1)"	"unprognostic (1.78e-2)"	"unprognostic (1.10e-3)"	"prognostic unfavorable (5.75e-5)"	"unprognostic (3.59e-2)"	"unprognostic (4.09e-2)"	"unprognostic (1.59e-2)"	"unprognostic (1.55e-2)"	2.8	3.2	3.3	9.0	3.2	34.5	3.6	3.6	3.5	5.5	2.3	6.8	8.6	4.0	2.5	7.4	5.9	2.3	1.6	2.9	3.2	2.9	4.0	3.4	15.6	4.4	2.9	6.0	7.0	4.2	4.8	5.1	4.5	4.0	4.2	2.7	4.8	3.0	3.8	10.4	9.6	2.2	2.6	6.0	5.2	8.2	3.1	20.7	5.1	1.0	9.7	3.5	5.0	3.9	43.4	64.1	57.1	37.6	2.6	4.2	41.7	27.0	19.1	44.1	47.2	35.0	42.9	83.7	15.3	11.2	11.9	30.1	24.7	26.7	16.9	45.2	48.8	56.4	38.7	47.5	1.0	63.0	43.7	5.7	2.5	23.0	3.4	5.0	24.0	51.0	46.3	29.8	23.3	44.0	107.3	123.7	33.6	46.7	15.9	84.1	48.4	43.6	12.3	64.8	36.3	36.5	32.3	33.6	10.1	12.5	22.7	44.5	22.6	31.7	54.3	23.9	40.3	29.3	49.0	83.1	12.7	38.0	33.3	0.0	1.6	2.6	7.8	6.8	7.7	10.9	8.8	8.3	1.6	10.0	11.5	8.2	1.3	12.1	3.3	1.5	10.9	5.7	3.3	3.2	3.6	3.5	2.9	3.2	4.4	2.9	4.5	2.6	3.1	3.9	3.9	3.2	13.6	5.9	16.1	8.3	9.5	8.7	24.5	21.5	7.8	12.3	3.9	7.2	10.3	3.7	10.4	31.1	9.6	10.2	7.9	5.8	19.3	12.0	5.1	8.3	0.0	36.2	4.2	5.2	35.8	6.8	5.1	8.3	6.3	23.1	5.0	5.3	16.4	8.4	5.6	10.0	6.1	3.5	6.8	8.5	2.1	6.6	3.6	3.7	7.2	10.9	11.3	3.5	8.4	3.0	4.4	1.9	23.0	2.8	7.6	4.7	19.5	11.3	13.1	4.5	6.5	13.5	26.1	15.9	9.1	10.0	13.9	6.0	15.3	8.7
LIG3	"LIG2, LIG3alpha"	ENSG00000005156	"DNA ligase 3"	P49916	17	34980512-35009743	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, DNA damage, DNA recombination, DNA repair, DNA replication"	Ligase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 80.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006723	Supported		Supported	Nucleoplasm		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 31: Spermatids - Spermatogenesis"	Nucleoplasm		"HPA006723: AB_1847781"	"unprognostic (6.05e-3)"	"unprognostic (2.98e-1)"	"unprognostic (1.24e-1)"	"unprognostic (2.83e-1)"	"unprognostic (1.57e-1)"	"unprognostic (8.76e-2)"	"unprognostic (2.40e-2)"	"unprognostic (2.78e-1)"	"unprognostic (2.25e-1)"	"unprognostic (1.02e-2)"	"unprognostic (8.77e-3)"	"unprognostic (1.31e-1)"	"unprognostic (6.67e-3)"	"unprognostic (3.39e-1)"	"unprognostic (3.28e-1)"	"unprognostic (3.29e-2)"	"unprognostic (4.71e-2)"	4.9	6.4	3.2	7.3	3.3	7.1	8.7	3.8	4.4	7.9	4.7	8.2	5.9	12.5	6.4	8.9	11.9	5.3	7.6	3.4	1.9	6.6	6.3	5.2	7.2	2.2	2.0	11.5	8.7	13.7	6.6	8.3	1.8	11.1	9.0	7.2	10.6	9.0	10.6	8.4	6.7	10.2	1.0	7.6	6.6	21.1	2.1	13.9	10.1	9.3	8.5	8.9	7.2	3.1	16.6	32.6	38.3	33.9	7.4	9.3	29.2	15.7	11.4	20.9	20.8	15.8	8.8	27.0	12.7	20.6	20.5	15.2	43.9	20.3	26.7	12.8	29.4	28.4	14.6	23.2	11.7	44.9	48.1	7.0	17.5	15.5	24.0	10.3	25.6	40.8	45.3	30.2	15.2	18.6	56.7	14.1	36.8	20.6	13.7	30.4	35.2	28.6	10.2	17.7	31.2	22.3	23.6	19.0	15.2	55.9	34.5	22.3	12.3	13.5	16.8	16.8	25.6	27.0	31.5	35.1	9.7	20.9	26.5	0.6	3.4	4.2	4.6	5.1	6.7	3.7	3.1	4.1	8.4	3.0	4.1	3.0	0.3	9.3	2.8	4.9	2.1	3.9	3.2	3.3	3.8	4.4	3.4	1.9	2.2	2.0	1.8	1.0	2.1	3.1	7.6	3.2	10.3	1.6	8.0	5.0	10.5	3.6	12.0	18.2	10.0	7.5	10.1	10.0	9.2	12.9	16.7	14.6	11.9	7.0	9.8	6.7	41.8	18.5	11.9	8.5	6.7	8.2	5.0	6.0	17.8	7.3	16.8	15.8	9.5	16.7	3.6	8.9	7.9	16.8	5.2	7.9	8.2	5.3	2.7	80.0	7.2	6.7	3.6	2.8	6.4	7.6	16.5	4.0	5.8	3.6	7.5	7.9	15.4	11.6	6.8	6.5	5.3	17.7	6.6	11.8	7.0	32.7	13.2	11.2	5.3	21.6	8.9	10.8	9.5	10.2
LIG4		ENSG00000174405	"DNA ligase 4"	P49917	13	108207439-108218368	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, Cell division, DNA damage, DNA recombination, DNA repair, DNA replication"	Ligase	"Cancer-related genes, Disease variant, SCID"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001334, HPA057325"	Approved		Supported	"Nucleoplasm,Cytoplasmic bodies"		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 20: Retina & Lymphoid tissues - Unknown function"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	"Cytoplasmic bodies"	"HPA001334: AB_1078689, HPA057325: AB_2732608"	"unprognostic (9.93e-2)"	"unprognostic (1.56e-1)"	"unprognostic (2.35e-1)"	"unprognostic (2.00e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.56e-1)"	"unprognostic (7.97e-2)"	"unprognostic (2.43e-1)"	"unprognostic (4.87e-1)"	"unprognostic (1.96e-2)"	"unprognostic (4.21e-3)"	"unprognostic (1.94e-2)"	"unprognostic (3.04e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.50e-2)"	"unprognostic (9.03e-3)"	7.2	8.3	6.3	8.6	6.5	3.9	5.6	6.1	9.0	4.0	8.7	5.7	7.2	4.4	8.5	4.2	4.5	6.8	6.7	7.1	10.2	8.2	12.0	6.9	11.0	6.8	6.6	5.8	3.8	11.3	5.2	5.8	6.8	5.6	6.6	23.1	4.6	5.2	7.1	5.3	7.0	6.6	6.1	8.3	7.8	9.8	7.1	21.8	7.7	6.5	8.3	6.9	2.3	7.9	15.5	5.8	15.3	10.2	12.4	13.3	5.4	14.9	11.2	11.2	13.3	6.9	6.7	26.0	11.9	9.8	13.7	6.3	10.2	9.9	19.2	15.4	9.8	12.3	13.8	3.6	14.8	16.6	12.5	12.3	16.3	10.8	9.6	10.7	13.5	47.0	4.4	4.7	17.4	8.3	27.7	12.1	3.9	12.6	3.6	25.1	6.0	4.2	14.6	9.7	9.6	9.9	3.3	9.0	11.7	11.7	7.7	25.4	20.1	6.6	7.2	7.5	13.5	12.4	8.7	41.7	25.4	9.4	15.2	0.6	1.6	4.8	1.1	2.5	1.6	1.6	1.2	1.2	1.4	2.2	1.2	1.7	2.2	1.9	8.3	1.0	1.8	1.0	6.3	6.5	6.1	9.0	7.1	10.2	6.8	6.6	6.8	6.1	7.1	7.9	5.6	9.6	9.5	13.4	9.2	2.7	2.8	4.9	3.4	10.7	4.9	2.8	11.6	1.5	10.0	1.8	8.4	2.3	7.3	7.9	9.8	5.3	11.6	8.3	5.7	4.3	9.6	0.4	16.6	7.5	1.0	4.2	7.7	6.0	3.8	3.6	4.6	9.8	5.8	18.5	16.1	5.3	2.0	7.5	3.9	5.1	2.8	7.4	1.8	10.3	9.3	7.3	4.1	13.6	24.9	8.9	6.3	6.0	6.2	2.5	3.5	6.3	21.9	13.6	13.1	4.6	3.8	19.1	4.4	4.0	5.7	1.8	4.1	8.7	2.9	3.7
LIMD1		ENSG00000144791	"LIM domains containing 1"	Q9UGP4	3	45555394-45686341	"Plasma proteins, Predicted intracellular proteins"	"RNA-mediated gene silencing, Transcription, Transcription regulation"	Repressor	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Oligodendrocyte precursor cells: 74.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA064220, HPA071736"	Approved		Supported	"Nucleoplasm,Focal adhesion sites"		NA	NA		8100	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 16: U-266 - Nucleosome"	"Cluster 68: Oligodendrocytes - Mixed function"	"Nucleoplasm, Focal adhesion sites"		"HPA064220: AB_2685216, HPA071736: "	"unprognostic (2.77e-1)"	"unprognostic (3.22e-2)"	"unprognostic (5.43e-2)"	"unprognostic (7.78e-2)"	"unprognostic (6.53e-2)"	"unprognostic (2.07e-2)"	"unprognostic (9.44e-2)"	"unprognostic (1.53e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.42e-1)"	"unprognostic (6.88e-2)"	"unprognostic (2.11e-3)"	"prognostic favorable (6.73e-5)"	"unprognostic (8.02e-2)"	"unprognostic (3.06e-2)"	"unprognostic (2.86e-2)"	"unprognostic (6.61e-3)"	7.1	3.8	4.3	7.8	4.7	6.0	5.4	3.5	4.8	5.4	9.5	7.3	7.1	6.6	4.6	5.6	6.1	7.2	9.7	3.5	3.8	3.7	11.1	17.1	10.6	8.3	5.4	4.1	10.2	9.0	2.8	6.4	6.6	6.2	7.5	2.8	9.8	4.8	17.4	6.5	7.9	5.5	4.7	10.8	8.2	2.5	6.9	8.0	12.2	8.6	8.6	6.0	4.8	6.9	13.3	24.7	8.8	11.9	7.6	14.7	17.7	12.4	17.0	12.7	11.0	11.7	6.8	1.7	8.1	11.4	26.1	8.8	18.8	10.0	10.5	28.1	11.7	14.7	20.5	9.7	7.7	13.3	18.2	6.2	8.3	19.1	10.0	9.2	11.3	14.7	12.4	40.0	12.6	8.7	16.2	8.3	14.2	10.4	23.7	7.9	10.3	20.2	6.8	23.3	4.1	8.0	10.5	18.8	12.4	9.0	11.4	11.8	20.7	14.3	12.9	14.5	13.4	38.1	52.7	6.5	30.9	11.7	16.0	3.8	0.9	1.1	1.0	2.0	0.6	2.4	0.8	0.8	0.9	4.0	0.8	0.8	1.0	0.7	4.0	5.8	0.8	0.8	4.3	4.7	3.5	4.8	3.5	3.8	8.3	5.4	6.6	4.7	6.9	6.9	5.0	38.5	27.4	17.6	17.8	2.9	5.7	4.3	4.0	1.6	5.2	3.8	16.5	21.5	12.4	7.3	2.1	6.4	23.9	8.0	1.9	7.2	1.2	7.9	10.2	5.9	6.7	10.3	1.4	5.3	12.8	9.0	9.7	10.7	3.8	11.1	9.7	22.9	17.1	6.7	3.6	15.9	10.2	17.0	10.1	0.9	11.8	13.5	5.4	18.7	11.1	4.8	12.3	74.4	22.5	6.2	6.9	3.4	9.7	9.1	5.9	2.9	11.9	1.5	6.6	8.2	15.2	1.0	3.5	4.1	2.3	5.3	7.9	2.5	9.6	5.4
LIMD2	MGC10986	ENSG00000136490	"LIM domain containing 2"	Q9BT23	17	63695888-63701172	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 112.1;lymphoid tissue: 222.2"	"Cell type enhanced"	"Detected in many"		"B-cells: 436.9;dendritic cells: 306.6;Kupffer cells: 216.1;monocytes: 188.2;NK-cells: 510.9;T-cells: 264.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 243.0;NB-4: 171.7;SH-SY5Y: 163.3;THP-1: 127.6;U-698: 260.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA062432, HPA075172"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	Nucleoplasm	Cytosol	"HPA062432: , HPA075172: "	"unprognostic (2.90e-3)"	"unprognostic (2.89e-3)"	"unprognostic (6.34e-2)"	"unprognostic (6.53e-2)"	"unprognostic (8.72e-2)"	"unprognostic (2.00e-3)"	"unprognostic (1.81e-1)"	"unprognostic (2.67e-2)"	"unprognostic (6.68e-2)"	"unprognostic (2.01e-2)"	"unprognostic (1.20e-2)"	"unprognostic (1.42e-1)"	"prognostic unfavorable (5.36e-11)"	"unprognostic (1.21e-1)"	"unprognostic (2.21e-1)"	"unprognostic (2.26e-2)"	"unprognostic (6.08e-2)"	12.5	7.9	26.2	106.9	31.3	112.1	8.2	18.8	35.4	12.1	19.1	11.2	13.6	7.8	2.0	6.4	8.9	17.5	9.8	29.9	22.6	17.3	10.4	24.8	222.2	22.9	22.1	7.1	7.1	3.3	10.7	15.5	22.3	16.3	9.4	1.0	12.9	5.5	3.1	6.7	61.0	9.1	21.8	170.8	20.5	14.0	22.8	111.3	9.3	3.4	149.8	20.3	8.2	23.7	0.8	7.7	92.9	22.9	0.8	2.4	2.3	2.6	1.4	9.4	6.4	4.2	1.9	243.0	20.5	11.6	9.4	3.9	20.4	0.9	2.6	84.3	8.7	72.4	1.8	20.6	17.6	95.2	7.6	22.8	1.0	9.6	0.3	11.0	25.5	16.5	6.7	13.8	10.7	1.3	84.7	171.7	50.3	0.0	4.4	34.6	37.4	43.6	13.1	1.0	111.2	163.3	11.8	0.2	22.2	23.9	0.6	127.6	32.2	12.8	28.1	0.7	3.4	2.9	1.0	260.4	1.4	13.3	22.7	2144.2	601.8	1434.7	368.9	716.3	364.8	688.5	512.2	432.9	609.8	855.0	679.3	496.3	1248.9	553.2	783.9	230.5	664.2	991.4	26.2	31.3	18.8	35.4	29.9	22.6	22.9	22.1	22.3	21.8	22.8	23.7	11.0	0.0	4.6	0.7	436.9	7.5	7.7	20.5	2.2	1.9	5.0	7.2	1.0	4.3	8.6	11.0	4.2	1.6	306.6	1.1	5.9	20.5	18.8	2.3	14.2	23.6	22.2	99.2	18.7	8.9	3.6	10.1	5.6	4.2	53.3	15.7	30.4	2.0	137.6	3.3	2.2	2.1	26.4	216.1	93.9	57.5	3.4	148.0	37.4	12.2	188.2	8.4	510.9	3.5	2.9	19.8	4.7	4.9	154.3	17.7	0.4	3.7	2.4	1.1	6.6	2.9	30.5	7.8	7.5	1.1	6.0	1.5	264.3	4.7	2.5	4.3
LIMK1	LIMK	ENSG00000106683	"LIM domain kinase 1"	P53667	7	74082933-74122525	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Williams-Beuren syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 77.9"	"Cell type enhanced"	"Detected in many"		"Granulosa cells: 27.6;Horizontal cells: 35.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-87 MG: 136.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028516, HPA073571"	Approved		Supported	"Nuclear speckles,Cytosol"		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 70: Brain - Nervous system development"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 4: Macrophages - Innate immune response"	"Nuclear speckles, Cytosol"		"HPA028516: AB_10601751, HPA073571: "	"unprognostic (1.45e-2)"	"unprognostic (2.75e-1)"	"prognostic unfavorable (4.95e-5)"	"unprognostic (2.77e-2)"	"unprognostic (1.40e-3)"	"unprognostic (3.35e-2)"	"prognostic unfavorable (7.79e-6)"	"unprognostic (1.90e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.18e-1)"	"unprognostic (3.32e-2)"	"unprognostic (3.16e-2)"	"prognostic unfavorable (6.63e-8)"	"unprognostic (4.14e-2)"	"unprognostic (7.00e-2)"	"unprognostic (3.84e-2)"	"unprognostic (5.79e-2)"	11.1	10.5	31.1	18.7	32.7	6.8	9.4	28.3	77.9	21.4	0.2	8.9	6.6	13.1	3.5	11.3	7.3	10.1	9.4	35.0	43.8	10.8	4.6	13.2	23.5	75.5	40.0	13.2	11.4	5.8	13.9	7.3	73.0	12.3	4.1	4.0	17.9	8.2	23.7	11.4	12.1	7.1	31.8	22.3	9.2	15.6	59.1	8.1	11.2	7.8	18.2	13.1	14.7	38.3	47.4	37.2	27.2	45.4	35.1	47.0	20.0	28.8	27.3	22.6	25.4	21.3	45.6	30.2	12.7	35.5	76.9	28.1	10.1	17.8	8.6	53.7	18.6	23.2	13.1	24.6	40.5	17.2	81.4	46.8	15.6	18.5	9.6	68.3	34.4	20.9	15.1	9.0	28.8	41.4	14.8	31.4	52.1	16.6	23.7	21.1	43.3	18.2	26.5	10.1	10.7	25.2	18.6	43.7	23.5	29.7	13.9	15.4	41.1	36.0	33.7	94.5	47.7	10.2	12.5	54.9	136.5	12.4	25.2	0.1	6.1	3.5	1.8	6.0	1.4	3.4	0.4	1.2	7.0	1.7	0.1	0.5	0.5	5.8	3.8	0.7	0.3	3.3	31.1	32.7	28.3	77.9	35.0	43.8	75.5	40.0	73.0	31.8	59.1	38.3	2.9	3.2	2.7	7.5	14.4	2.9	5.2	6.6	1.8	6.6	7.7	6.9	3.4	7.2	3.8	1.8	2.1	2.5	11.9	2.9	0.0	6.6	1.2	2.7	9.7	4.1	2.4	0.4	15.4	6.5	6.3	9.2	3.1	5.1	5.7	27.6	3.3	2.1	25.0	35.3	20.8	2.7	0.0	13.5	10.8	2.2	7.2	15.6	3.6	6.5	14.9	3.5	22.6	6.6	2.4	13.5	2.3	6.0	10.0	9.0	0.3	2.8	3.1	3.3	0.0	5.3	4.5	3.4	11.5	1.8	3.1	3.7	11.1	6.9	2.4	7.2
LIMK2		ENSG00000182541	"LIM domain kinase 2"	P53671	22	31212239-31280080	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Syncytiotrophoblasts: 115.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"eosinophil: 40.0;neutrophil: 96.9"	"Lineage enriched"	"Detected in all"	6	"granulocytes: 96.9"	"Cell line enhanced"	"Detected in all"		"BEWO: 135.5;hTCEpi: 251.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008183, CAB019313, HPA053882"	Approved		Supported	Nucleoplasm,Cytosol		NA	Yes			"Cluster 5: Granulocytes - Unknown function"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm	Cytosol	"CAB019313: , HPA008183: AB_1079252, HPA053882: AB_2682291"	"unprognostic (1.79e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.04e-2)"	"unprognostic (2.59e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.42e-2)"	"unprognostic (4.02e-2)"	"unprognostic (5.99e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.95e-1)"	"unprognostic (3.96e-1)"	"unprognostic (1.43e-1)"	"prognostic unfavorable (4.57e-6)"	"unprognostic (4.48e-2)"	"unprognostic (1.48e-2)"	"unprognostic (5.72e-2)"	"unprognostic (1.37e-1)"	20.1	14.4	25.5	39.8	27.3	53.8	30.9	25.8	22.1	26.4	32.6	34.0	21.2	17.0	7.7	71.8	34.2	21.3	14.3	20.8	27.7	27.7	33.0	46.8	23.2	37.8	34.2	21.6	28.8	27.0	21.9	48.0	32.8	36.7	34.7	25.5	50.7	19.1	18.8	71.5	29.3	15.9	32.7	37.5	30.0	19.2	33.6	21.3	42.0	9.2	17.8	25.7	45.3	33.1	26.6	4.4	17.9	10.0	7.6	8.8	135.5	17.2	8.0	16.9	14.2	22.7	12.2	25.8	29.9	26.0	8.1	52.6	20.9	90.3	10.6	19.1	22.8	18.8	21.1	24.7	11.4	35.1	33.1	14.3	251.5	13.7	41.0	114.5	43.6	20.6	10.7	18.2	23.3	20.9	21.5	12.0	16.7	68.3	6.7	28.1	30.0	14.3	19.6	62.3	22.8	20.4	13.0	82.1	35.1	54.8	68.7	13.9	26.6	15.1	23.5	8.3	16.3	10.0	16.2	22.4	9.6	16.4	6.6	5.8	5.1	40.0	3.1	3.5	5.9	2.0	5.7	4.3	1.9	2.4	5.6	4.4	96.9	6.7	1.4	4.4	15.2	4.4	25.5	27.3	25.8	22.1	20.8	27.7	37.8	34.2	32.8	32.7	33.6	33.1	19.5	32.1	17.9	16.3	5.2	35.9	37.7	24.8	59.2	9.4	18.0	23.2	25.1	10.0	32.6	5.5	20.9	69.8	15.3	39.3	3.9	13.0	1.4	49.6	19.2	22.4	13.2	10.3	6.4	45.0	52.4	7.6	48.9	41.6	23.5	8.6	14.3	7.1	18.2	3.3	11.3	42.8	18.3	8.9	8.2	1.6	4.4	13.8	3.6	16.9	5.4	16.6	2.1	2.5	15.5	25.9	21.2	4.5	6.2	27.1	12.0	10.5	36.3	22.8	19.7	7.5	17.2	15.6	18.4	46.1	39.1	115.5	9.3	7.1	51.7	29.9
LIMS2	"PINCH-2, PINCH2"	ENSG00000072163	"LIM zinc finger domain containing 2"	Q7Z4I7	2	127638381-127681786	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Disease variant, Limb-girdle muscular dystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 510.1"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 109.4;Cardiomyocytes: 91.7;Endothelial cells: 105.1;Granulosa cells: 134.1;Hepatic stellate cells: 134.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"naive B-cell: 22.5"	"Group enriched"	"Detected in many"	13	"B-cells: 22.5;T-cells: 10.7"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 27.0;fHDF/TERT166: 31.2;HHSteC: 32.7;MOLT-4: 40.2;TIME: 83.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA058340	Enhanced		Supported	"Focal adhesion sites"		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 40: Granulosa cells - Unknown function"	"Focal adhesion sites"		"HPA058340: AB_2683683"	"unprognostic (2.51e-2)"	"unprognostic (1.25e-1)"	"unprognostic (5.82e-3)"	"unprognostic (4.51e-2)"	"unprognostic (9.25e-2)"	"unprognostic (3.49e-1)"	"prognostic favorable (6.53e-7)"	"unprognostic (3.98e-2)"	"unprognostic (3.73e-1)"	"unprognostic (2.29e-1)"	"unprognostic (3.78e-2)"	"unprognostic (8.86e-2)"	"unprognostic (3.33e-1)"	"unprognostic (4.60e-3)"	"unprognostic (3.64e-2)"	"unprognostic (1.77e-1)"	"unprognostic (4.00e-2)"	104.6	21.6	29.4	17.9	27.9	0.4	93.9	24.9	32.3	104.4	25.1	510.1	15.8	261.4	16.9	42.1	139.5	25.7	266.4	25.6	24.1	72.7	46.6	114.3	12.9	28.7	27.2	29.0	14.1	6.4	15.6	27.7	29.3	132.1	15.2	0.6	27.1	98.8	33.4	32.8	95.7	81.9	24.3	121.8	123.1	12.0	32.2	13.1	51.6	26.8	5.4	220.5	85.1	24.0	0.8	1.6	0.5	0.0	4.6	1.0	0.3	19.1	27.0	20.2	18.1	4.7	0.1	0.1	10.3	31.2	1.1	0.1	0.3	0.0	4.2	0.0	0.8	0.0	11.9	3.6	32.7	0.0	0.0	0.2	0.0	7.0	0.2	10.7	12.9	15.3	0.0	0.0	10.0	0.0	40.2	1.0	1.3	0.0	2.4	9.0	1.7	1.0	1.3	0.0	0.1	0.2	3.0	1.7	0.7	6.7	0.7	0.0	83.7	0.1	12.9	15.2	0.1	0.0	0.0	0.2	0.0	1.6	0.0	0.0	0.2	0.0	0.1	0.3	0.0	15.2	5.3	1.1	0.2	22.5	10.7	4.4	0.3	0.0	0.2	1.2	8.0	2.5	29.4	27.9	24.9	32.3	25.6	24.1	28.7	27.2	29.3	24.3	32.2	24.0	109.4	22.4	6.1	0.3	10.1	9.4	0.3	0.2	1.2	0.2	1.9	17.1	91.7	4.3	1.3	0.0	0.0	0.6	0.8	0.1	0.0	1.2	1.3	2.9	5.3	105.1	0.0	5.7	0.4	0.2	12.4	22.5	1.1	0.9	2.5	134.1	134.6	16.3	1.0	0.0	0.3	0.0	0.0	6.5	13.0	3.1	19.9	1.7	10.6	30.9	0.0	0.3	0.0	4.0	0.3	0.5	0.0	49.7	1.7	0.3	0.0	0.5	0.8	0.9	26.3	4.2	35.4	0.8	2.1	0.6	6.7	1.0	2.3	1.8	0.0	0.3
LIN28A	"CSDD1, FLJ12457, LIN-28, LIN28, ZCCHC1"	ENSG00000131914	"Lin-28 homolog A"	Q9H9Z2	1	26410817-26429728	"Predicted intracellular proteins"	"RNA-mediated gene silencing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"testis: 5.2"	"Group enriched"	"Detected in some"	43	"Early spermatids: 35.2;Late spermatids: 69.5"	"Cancer enriched"	"Detected in single"	261	"testis cancer: 101.9"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"NTERA-2: 861.2;SuSa: 300.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"CAB020785, HPA063074, HPA068814"	Enhanced		Supported	"Nucleoli,Cytosol,Rods & Rings"		NA	NA				"Cluster 78: Testis - Spermatogenesis"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 31: Spermatids - Spermatogenesis"	Cytosol	"Nucleoli, Rods & Rings"	"CAB020785: , HPA063074: , HPA068814: "	"unprognostic (9.64e-3)"	"unprognostic (1.69e-1)"		"unprognostic (1.35e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.55e-1)"		"unprognostic (1.17e-2)"	"unprognostic (1.85e-1)"	"unprognostic (2.21e-1)"			"unprognostic (2.49e-2)"	"unprognostic (1.83e-1)"	"unprognostic (1.13e-1)"		"unprognostic (6.82e-2)"	0.0	0.0	0.1	0.0	0.2	0.2	0.0	1.1	0.3	0.0	0.4	0.0	0.1	0.1	0.2	0.1	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.1	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.1	0.0	0.2	0.2	0.0	0.0	0.0	0.1	0.1	5.2	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	84.3	0.5	0.0	0.0	62.7	0.1	0.0	0.0	0.0	2.0	0.5	0.0	0.1	0.0	0.0	0.2	11.6	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.1	861.2	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.2	0.0	300.9	27.2	0.2	0.1	0.4	0.1	0.1	0.0	0.2	0.0	0.1	0.0	0.1	0.2	0.4	0.0	0.1	0.1	0.0	0.0	0.2	0.0	0.1	0.0	0.2	0.1	0.1	0.3	0.1	0.0	0.1	0.0	0.0	0.1	0.2	1.1	0.3	0.1	0.2	0.2	0.3	0.2	0.0	0.4	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	35.2	0.1	0.1	0.2	0.0	0.0	0.1	0.0	0.1	0.2	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	69.5	0.6	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.9	0.0	1.1	0.4	1.2	0.4	0.0	0.1	0.0	0.2	0.0	0.0	0.2
LIN28B	"CSDD2, FLJ16517"	ENSG00000187772	"Lin-28 homolog B"	Q6ZN17	6	104936616-105083332	"Predicted intracellular proteins"	"RNA-mediated gene silencing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	16	"placenta: 65.4"	"Group enriched"	"Detected in some"	5	"Cytotrophoblasts: 75.4;Early spermatids: 27.5;Excitatory neurons: 40.2;Extravillous trophoblasts: 83.0;Late spermatids: 25.2;Syncytiotrophoblasts: 55.8"	"Cancer enriched"	"Detected in single"	25	"testis cancer: 12.6"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 49.1;BEWO: 252.1;Hep G2: 44.0;K-562: 86.9;NTERA-2: 44.8;SuSa: 44.5"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in single"			"HPA036630, HPA061745"	Enhanced		Supported	Nucleoplasm,Nucleoli,Cytosol		NA	NA				"Cluster 28: Placenta - Pregnancy"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 38: Extravillous trophoblasts - Unknown function"	"Nucleoplasm, Nucleoli"	Cytosol	"HPA036630: AB_10669911, HPA061745: AB_2684601"				"unprognostic (2.00e-4)"	"unprognostic (6.75e-2)"					"unprognostic (2.02e-1)"				"unprognostic (2.57e-2)"	"unprognostic (1.59e-2)"		"unprognostic (4.10e-2)"	0.1	0.1	0.4	0.0	0.8	0.5	0.0	0.0	1.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.7	0.0	0.0	0.0	0.1	0.4	0.2	0.0	0.0	0.0	0.3	65.4	0.1	0.0	0.0	1.5	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.1	4.2	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.1	3.2	49.1	10.0	0.0	0.0	252.1	0.1	0.0	0.0	0.0	16.6	0.1	0.1	0.0	0.1	3.0	0.1	31.2	0.0	0.0	0.0	24.1	36.6	0.0	44.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	86.9	1.2	0.0	0.0	5.6	6.2	44.8	0.0	0.0	0.0	0.0	2.2	0.0	0.1	0.1	11.6	0.1	0.3	4.0	44.5	0.0	10.6	1.0	0.1	5.3	0.2	0.1	14.8	22.6	0.1	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.4	0.8	0.0	1.3	0.6	0.7	0.4	0.2	0.1	0.0	0.3	0.3	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.2	0.0	0.0	0.0	6.2	75.4	0.0	0.0	0.0	0.0	27.5	0.0	0.0	8.3	0.0	0.0	40.2	0.0	83.0	3.7	0.0	0.1	0.0	0.0	0.0	0.0	9.7	1.7	5.7	0.0	0.0	0.0	0.0	25.2	0.3	0.0	0.0	1.0	0.0	0.5	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.7	6.6	0.0	0.0	6.3	9.9	0.0	0.0	55.8	0.0	0.0	0.0	0.0
LIN37	"F25965, lin-37, ZK418.4"	ENSG00000267796	"Lin-37 DREAM MuvB core complex component"	Q96GY3	19	35748361-35754519	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043253, HPA047809"	Uncertain		Supported	Nucleoplasm		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm		"HPA043253: AB_2678391, HPA047809: AB_2680162"	"unprognostic (7.10e-2)"	"unprognostic (1.32e-1)"	"unprognostic (7.07e-2)"	"unprognostic (2.45e-3)"	"unprognostic (7.77e-3)"	"unprognostic (5.85e-3)"	"unprognostic (1.62e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.93e-1)"	"unprognostic (2.56e-1)"	"prognostic favorable (1.67e-4)"	"unprognostic (9.88e-3)"	"prognostic unfavorable (1.62e-6)"	"unprognostic (2.53e-2)"	"unprognostic (8.89e-2)"	"unprognostic (4.35e-1)"	"unprognostic (5.14e-2)"	10.1	9.9	21.5	6.7	22.2	9.7	9.1	22.5	26.9	13.0	18.9	11.1	9.2	11.2	7.7	7.0	10.8	6.9	12.6	21.6	22.4	7.4	7.6	7.5	9.6	21.1	21.4	15.9	8.5	9.2	11.0	11.7	21.6	8.9	5.0	8.6	7.9	8.4	15.7	10.4	7.9	8.2	20.5	8.6	7.9	9.0	22.2	9.7	7.8	12.7	7.5	9.5	8.9	21.7	13.7	29.7	11.4	15.5	18.4	14.4	12.0	14.4	15.7	22.8	24.6	9.8	6.3	7.8	16.3	17.1	15.3	6.9	8.2	12.1	8.8	26.5	11.6	10.0	14.6	15.0	42.2	8.0	22.6	13.4	22.1	20.4	34.9	15.0	16.9	20.8	10.4	15.1	16.5	27.6	13.3	11.0	3.2	22.4	12.9	5.9	7.5	8.4	15.1	6.4	9.8	11.2	13.5	26.7	12.5	9.1	11.1	17.0	16.4	17.2	10.1	16.8	18.3	22.3	19.0	7.3	18.3	12.0	12.9	16.8	7.9	26.4	18.3	8.6	17.2	19.6	19.8	21.4	9.0	18.8	20.6	18.7	32.0	18.4	8.1	18.8	22.2	13.7	21.5	22.2	22.5	26.9	21.6	22.4	21.1	21.4	21.6	20.5	22.2	21.7	2.0	0.0	1.1	2.9	5.0	3.8	0.7	2.5	8.0	1.5	2.2	1.4	0.1	1.5	0.8	3.7	2.1	4.2	1.9	2.8	3.9	1.5	5.5	1.0	1.0	2.0	1.2	4.8	5.9	1.2	3.4	3.3	5.6	0.7	4.5	1.0	1.1	1.0	1.9	1.7	5.6	0.7	2.0	3.1	4.4	5.8	4.1	3.2	5.4	0.0	2.6	1.0	3.1	3.5	4.3	2.8	2.8	3.4	7.3	0.7	9.8	3.2	1.3	2.4	6.6	1.5	3.0	9.2	2.3	6.4	5.4	11.5	5.6	1.0	1.3	0.3
LIN9	TGS	ENSG00000183814	"Lin-9 DREAM MuvB core complex component"	Q5TKA1	1	226231149-226309869	"Predicted intracellular proteins"	"Cell cycle, DNA synthesis"		"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 20.2;Spermatocytes: 36.3;Spermatogonia: 18.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030241	Uncertain		Supported	Nucleoplasm		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"HPA030241: AB_10601542"	"unprognostic (9.90e-2)"	"unprognostic (8.00e-2)"	"unprognostic (1.23e-1)"	"unprognostic (8.82e-3)"	"unprognostic (1.21e-1)"	"unprognostic (1.42e-2)"	"unprognostic (3.51e-5)"	"unprognostic (2.80e-2)"	"unprognostic (9.84e-3)"	"unprognostic (2.65e-2)"	"unprognostic (3.59e-3)"	"unprognostic (1.17e-1)"	"unprognostic (1.09e-3)"	"unprognostic (8.08e-2)"	"unprognostic (1.79e-1)"	"unprognostic (3.22e-1)"	"unprognostic (8.26e-2)"	1.8	1.6	0.9	2.8	1.0	6.6	3.5	3.5	1.6	1.8	0.6	3.2	4.1	3.2	1.6	3.2	2.4	1.5	12.8	0.9	0.7	2.1	1.4	2.5	5.0	0.6	0.8	5.0	2.0	2.2	0.6	4.0	0.7	2.1	3.9	1.8	2.0	1.9	3.6	3.4	3.9	2.8	0.7	2.6	3.0	9.7	0.7	8.1	2.2	3.5	4.8	1.9	1.7	1.1	15.9	10.0	16.2	11.6	1.5	3.8	31.2	11.4	7.3	20.2	18.1	10.8	20.0	15.0	14.1	5.3	8.9	14.4	15.9	6.1	18.0	14.4	28.1	9.4	12.2	7.7	1.4	18.6	9.7	1.5	4.3	10.5	10.6	4.9	10.0	13.7	33.5	17.8	12.3	5.8	19.5	12.0	26.0	20.1	18.2	18.7	27.5	19.4	6.6	8.2	14.2	19.9	20.3	23.6	14.7	10.0	13.4	23.8	4.8	11.4	16.3	15.7	29.4	8.2	20.2	31.0	6.6	16.7	27.2	4.1	1.0	1.1	1.2	1.3	1.9	2.2	1.9	2.7	0.5	1.6	3.4	2.6	0.2	1.7	2.8	0.6	2.8	1.0	0.9	1.0	3.5	1.6	0.9	0.7	0.6	0.8	0.7	0.7	0.7	1.1	3.1	9.6	5.1	3.3	3.3	3.3	1.4	2.8	3.4	1.2	2.1	2.2	15.7	1.5	2.2	0.0	0.0	13.0	2.8	1.6	1.9	2.3	20.2	2.0	3.4	3.1	2.4	16.4	11.1	3.3	6.9	3.3	2.0	1.6	1.3	4.3	2.2	1.4	2.8	3.3	8.7	2.5	0.0	3.5	1.1	4.0	4.4	1.9	0.0	6.5	0.4	1.9	2.1	10.1	4.7	2.8	3.8	4.5	6.4	1.2	2.0	1.7	3.7	1.0	0.0	3.0	4.5	36.3	18.7	5.1	1.8	15.5	2.8	1.9	4.9	1.5
LINGO1	"FLJ14594, LERN1, LRRN6A"	ENSG00000169783	"Leucine rich repeat and Ig domain containing 1"	Q96FE5	15	77613027-77820900	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"			"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 56.1"	"Group enriched"	"Detected in many"	4	"Astrocytes: 271.0;Excitatory neurons: 271.6;Horizontal cells: 132.9;Inhibitory neurons: 220.5;Microglial cells: 167.7;Oligodendrocyte precursor cells: 240.8;Oligodendrocytes: 324.2"	"Low cancer specificity"	"Detected in all"			"Group enriched"	"Detected in many"	10	"amygdala: 37.4;basal ganglia: 43.9;cerebral cortex: 56.1;hippocampal formation: 49.1"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 23.9;AN3-CA: 20.1;HAP1: 30.2;HEK 293: 21.0;MCF7: 13.5;NTERA-2: 56.9;SuSa: 21.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA074653	Enhanced		Supported	"Plasma membrane"		NA	NA		25000		"Cluster 10: Brain - Neuronal signaling"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 64: Astrocytes - Nervous system maintenance"	"Plasma membrane"		"HPA074653: AB_2686706"	"unprognostic (1.06e-1)"	"unprognostic (7.07e-2)"	"unprognostic (2.16e-2)"	"unprognostic (1.48e-2)"	"unprognostic (3.09e-1)"	"unprognostic (2.20e-1)"	"unprognostic (2.84e-2)"	"unprognostic (3.77e-2)"	"unprognostic (3.40e-1)"	"unprognostic (1.10e-1)"	"unprognostic (7.36e-2)"	"unprognostic (2.74e-2)"	"prognostic unfavorable (3.23e-7)"	"unprognostic (2.07e-1)"	"unprognostic (7.06e-2)"	"unprognostic (2.85e-1)"	"unprognostic (2.59e-2)"	3.9	1.1	37.4	1.2	43.9	0.0	3.5	0.0	56.1	4.6	0.0	2.2	1.5	4.5	2.2	0.9	2.7	2.1	11.8	49.1	0.0	4.2	0.8	1.0	0.7	0.0	0.0	2.3	2.5	4.1	1.9	6.7	0.0	1.6	0.8	16.2	3.2	2.0	0.8	2.8	1.7	4.6	0.0	3.3	1.4	5.3	0.2	0.3	2.2	1.4	0.3	2.3	2.9	4.6	0.0	2.1	23.9	20.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	1.4	0.0	0.4	0.1	30.2	0.0	0.0	0.0	21.0	0.0	0.0	0.4	0.3	0.0	0.0	0.3	0.6	0.0	0.0	0.0	0.0	0.0	3.3	0.2	0.0	13.5	0.0	0.0	56.9	1.3	0.0	0.0	0.0	0.5	0.0	0.0	4.2	1.2	0.1	2.4	4.9	21.6	0.3	0.4	2.1	0.0	5.1	0.0	0.1	0.1	0.0	0.0	0.1	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	37.4	43.9	0.0	56.1	49.1	0.0	0.0	0.0	0.0	0.0	0.2	4.6	2.1	0.0	0.0	271.0	0.0	0.3	0.1	0.0	0.0	21.8	0.7	0.3	7.3	1.5	0.0	0.0	2.1	0.1	0.0	1.8	0.0	0.3	8.6	0.8	3.7	2.3	0.0	0.0	271.6	0.2	0.2	1.8	0.0	0.2	0.0	14.9	4.2	0.0	0.3	132.9	220.5	0.3	0.0	0.0	0.0	16.5	0.3	0.1	3.6	167.7	0.0	51.1	0.0	240.8	324.2	0.2	7.7	0.4	0.0	0.0	0.0	0.0	0.0	19.5	26.3	0.0	21.9	0.2	3.1	0.0	0.1	0.3	0.1	0.5	0.2	0.0
LIPA	"CESD, LAL"	ENSG00000107798	"Lipase A, lysosomal acid type"	P38571	10	89213569-89414557	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Lipid degradation, Lipid metabolism"	Hydrolase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 398.4"	"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 515.0;Kupffer cells: 714.8;Macrophages: 303.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"classical monocyte: 167.3;intermediate monocyte: 355.1;myeloid DC: 123.6;non-classical monocyte: 198.5"	"Group enriched"	"Detected in all"	6	"dendritic cells: 123.6;monocytes: 355.1"	"Cell line enhanced"	"Detected in many"		"A-431: 354.4;AN3-CA: 367.8;ASC TERT1: 450.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034892, HPA057052"	Enhanced		Supported	"Nucleoplasm,Nucleoli fibrillar center,Vesicles,Cytosol"	"Intracellular and membrane"	NA	NA		280000	"Cluster 7: Monocytes - Unknown function"	"Cluster 64: Macrophages - Immune response"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 4: Macrophages - Innate immune response"	"Vesicles, Cytosol"	"Nucleoplasm, Nucleoli fibrillar center"	"CAB034892: AB_784329, HPA057052: AB_2683322"	"unprognostic (1.27e-1)"	"unprognostic (3.23e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.61e-1)"	"unprognostic (2.55e-2)"	"unprognostic (7.14e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.19e-1)"	"unprognostic (4.28e-2)"	"unprognostic (1.08e-1)"	"unprognostic (7.30e-3)"	"unprognostic (1.39e-2)"	"unprognostic (1.40e-1)"	"unprognostic (4.42e-2)"	"unprognostic (3.42e-2)"	"unprognostic (5.71e-2)"	76.0	46.3	43.5	66.7	65.2	39.8	47.8	64.1	74.4	54.0	39.0	67.7	167.6	38.8	21.7	28.6	37.8	83.5	24.2	43.5	53.1	44.9	218.9	169.5	159.3	74.7	55.5	32.7	21.4	68.9	12.7	79.1	82.2	30.7	72.0	12.6	22.5	33.8	11.8	18.7	227.5	47.7	65.4	398.4	34.3	13.4	57.0	44.5	31.6	22.5	45.5	58.4	19.3	115.5	354.4	49.4	30.7	367.8	343.5	450.8	10.0	171.4	194.8	65.5	121.5	18.6	176.6	63.9	34.0	264.4	73.7	338.7	13.8	92.8	53.6	86.1	34.7	25.1	19.1	81.5	87.6	48.8	48.9	190.4	69.2	72.9	40.6	88.2	14.9	45.4	0.3	108.5	58.3	28.2	45.7	34.6	22.7	62.4	60.0	26.4	39.0	60.5	69.2	50.9	10.5	21.8	41.4	49.9	133.9	20.4	64.4	65.8	26.2	58.8	15.5	132.1	44.6	60.0	65.7	25.8	71.4	112.9	82.1	4.2	167.3	16.9	40.0	355.1	40.6	31.9	35.8	38.8	123.6	33.4	36.7	40.4	7.1	29.8	198.5	25.0	38.2	159.6	43.5	65.2	64.1	74.4	43.5	53.1	74.7	55.5	82.2	65.4	57.0	115.5	75.5	41.7	33.8	11.1	35.9	17.7	30.3	58.1	25.6	5.4	16.1	14.1	9.6	45.8	31.9	33.1	0.0	34.8	31.4	2.8	21.5	35.1	6.8	11.4	20.4	56.7	21.8	27.4	34.4	36.2	32.9	34.6	21.4	15.5	28.5	10.8	54.7	66.7	515.0	16.8	15.1	8.9	40.7	714.8	69.0	2.7	11.5	303.1	48.0	30.0	71.7	33.1	29.9	15.1	143.0	19.3	12.0	21.8	15.4	11.3	161.0	14.0	28.8	2.2	6.6	19.7	21.0	5.1	13.8	31.9	12.5	20.0	33.1	17.6	9.1	24.0
LIPE	HSL	ENSG00000079435	"Lipase E, hormone sensitive type"	Q05469	19	42401514-42427388	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Cholesterol metabolism, Lipid degradation, Lipid metabolism, Steroid metabolism, Sterol metabolism"	Hydrolase	"Diabetes mellitus, Obesity"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"adipose tissue: 834.5;breast: 524.7"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 76.1;Early spermatids: 127.8;Late spermatids: 236.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in many"	7	"ASC diff: 136.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006567, CAB017700"	Enhanced		Supported	Cytosol		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 25: Spermatids - Spermatogenesis"	Cytosol		"CAB017700: AB_2135504, HPA006567: AB_2667618"	"unprognostic (4.24e-2)"	"unprognostic (2.46e-2)"	"unprognostic (8.99e-3)"	"unprognostic (3.74e-2)"	"unprognostic (1.77e-1)"	"unprognostic (3.38e-3)"	"unprognostic (5.68e-2)"	"unprognostic (2.84e-1)"	"unprognostic (3.11e-1)"	"unprognostic (9.44e-2)"	"prognostic favorable (1.15e-4)"	"unprognostic (1.52e-1)"	"unprognostic (3.63e-10)"	"unprognostic (1.47e-1)"	"unprognostic (1.83e-1)"	"unprognostic (3.76e-2)"	"unprognostic (2.34e-3)"	834.5	45.1	22.7	7.7	71.7	5.0	524.7	77.2	41.5	5.1	0.6	10.9	5.3	6.4	1.2	8.6	5.8	3.7	32.5	23.8	42.6	7.7	1.5	3.7	7.3	100.3	73.9	4.9	6.2	4.7	6.9	2.9	90.0	7.1	1.4	2.0	17.2	2.6	19.7	23.6	24.4	2.6	44.0	14.4	8.5	68.6	57.1	6.9	9.6	23.3	3.7	14.2	7.7	116.9	12.7	9.6	6.0	2.3	136.8	1.3	0.1	5.8	3.1	9.2	8.5	2.3	4.6	20.6	6.3	1.8	4.5	5.6	3.7	11.5	1.0	4.0	6.1	5.8	5.3	0.2	2.7	0.1	13.9	1.2	10.7	1.5	2.1	1.3	2.6	8.5	2.7	12.8	1.2	0.1	14.8	0.5	0.8	9.7	2.7	12.2	1.1	6.9	2.6	13.1	8.5	8.8	5.1	5.7	5.6	0.3	1.5	7.5	4.7	2.5	7.8	1.1	5.3	9.7	8.5	15.6	6.3	0.7	8.7	11.0	8.6	3.8	2.5	4.7	2.3	3.4	3.2	3.7	3.6	4.5	2.8	2.5	1.5	3.6	2.7	2.9	3.0	3.1	22.7	71.7	77.2	41.5	23.8	42.6	100.3	73.9	90.0	44.0	57.1	116.9	76.1	0.0	3.3	4.2	8.1	4.1	12.1	2.4	4.6	11.0	4.8	2.9	2.5	0.0	2.0	1.8	10.4	0.1	4.8	1.3	1.9	8.0	127.8	0.9	3.4	10.2	0.0	5.3	4.6	2.7	0.1	2.0	3.6	1.5	0.0	6.6	17.9	0.0	0.6	8.4	6.7	2.0	6.1	2.2	2.4	236.5	3.1	0.8	5.4	4.7	0.9	4.0	6.2	6.0	37.9	1.8	0.7	1.5	3.0	6.7	18.4	1.5	0.8	13.9	0.0	7.2	2.1	39.4	13.1	2.5	2.4	0.0	5.1	5.2	2.9	10.7
LIPI	"CT17, LPDL, mPA-PLA1beta, PLA1C, PRED5"	ENSG00000188992	"Lipase I"	Q6XZB0	21	14108813-14210955	"Disease related genes, Predicted intracellular proteins, Predicted secreted proteins"	"Lipid degradation, Lipid metabolism"	"Heparin-binding, Hydrolase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	167	"epididymis: 421.0"	"Group enriched"	"Detected in some"	4	"Early spermatids: 1.7;Excitatory neurons: 1.5;Inhibitory neurons: 2.0;Microglial cells: 1.9;Oligodendrocyte precursor cells: 2.0"	"Cancer enriched"	"Detected in single"	6	"thyroid cancer: 0.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA049665			Supported	"Plasma membrane"	"Secreted in male reproductive system"	NA	NA				"Cluster 30: Epididymis - Antimicrobial activity"		"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Plasma membrane"		"HPA049665: "	"unprognostic (2.60e-2)"	"unprognostic (3.49e-1)"		"unprognostic (1.12e-3)"	"unprognostic (1.14e-1)"	"unprognostic (1.08e-2)"		"unprognostic (1.19e-1)"	"unprognostic (2.05e-2)"	"unprognostic (1.68e-1)"	"unprognostic (4.53e-2)"	"unprognostic (2.90e-1)"	"unprognostic (3.64e-13)"	"unprognostic (2.82e-1)"	"unprognostic (4.14e-2)"	"unprognostic (2.90e-1)"	"unprognostic (7.87e-3)"	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.2	0.2	0.0	0.2	0.0	0.5	421.0	0.2	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	2.5	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.3	0.2	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.2	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.4	0.0	0.0	0.0	0.2	0.7	0.4	0.0	0.1	0.6	0.1	0.4	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.1	0.2	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.1	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.9	0.0	0.0	0.0	2.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0
LITAF	"FLJ38636, PIG7, SIMPLE, TP53I7"	ENSG00000189067	"Lipopolysaccharide induced TNF factor"	Q99732	16	11547722-11636381	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Transcription, Transcription regulation"	DNA-binding	"Charcot-Marie-Tooth disease, Disease variant, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Langerhans cells: 701.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in all"	5	"neutrophil: 2578.1"	"Lineage enriched"	"Detected in all"	6	"granulocytes: 2578.1"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006960	Approved		Supported	"Nucleoplasm,Golgi apparatus,Vesicles"		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 41: Macrophages - Immune response"	Nucleoplasm	"Golgi apparatus, Vesicles"	"HPA006960: AB_1079254"	"unprognostic (2.26e-1)"	"unprognostic (4.96e-2)"	"unprognostic (2.32e-3)"	"unprognostic (1.03e-1)"	"prognostic unfavorable (2.02e-4)"	"unprognostic (4.07e-2)"	"unprognostic (8.75e-3)"	"unprognostic (3.60e-1)"	"unprognostic (6.15e-3)"	"unprognostic (1.04e-1)"	"unprognostic (4.61e-2)"	"unprognostic (5.01e-1)"	"unprognostic (1.85e-2)"	"unprognostic (9.49e-2)"	"prognostic unfavorable (6.25e-4)"	"unprognostic (3.57e-2)"	"unprognostic (1.60e-1)"	139.3	43.7	53.5	165.8	81.9	207.0	95.5	79.6	70.0	121.2	70.5	121.1	46.3	100.5	77.8	62.7	108.2	114.1	63.9	52.2	63.0	182.3	107.7	192.1	112.3	94.0	79.4	67.6	64.6	56.5	39.0	71.3	92.7	105.9	116.1	63.9	116.4	83.4	36.3	71.6	57.9	93.5	77.3	119.6	70.7	10.6	77.6	68.6	116.8	37.6	123.7	214.1	83.1	109.4	79.2	157.8	89.4	43.8	13.9	11.0	90.7	100.2	309.0	93.6	139.1	62.6	206.3	39.9	126.8	86.1	108.7	95.5	40.1	186.4	88.4	304.2	45.8	2.8	117.1	310.3	212.9	12.5	12.9	35.0	320.8	79.6	210.7	84.4	0.3	2.7	25.3	149.5	1.5	75.8	1.8	183.3	146.4	104.0	0.6	12.1	19.6	228.2	79.0	110.4	22.2	68.0	172.9	219.4	183.9	136.3	122.5	66.7	0.8	38.7	65.3	23.0	24.2	59.2	140.6	100.5	45.1	95.8	225.5	508.8	149.5	284.0	459.6	130.2	277.2	174.0	284.0	412.7	178.0	173.9	318.9	381.4	2578.1	274.5	81.9	220.1	350.3	584.9	53.5	81.9	79.6	70.0	52.2	63.0	94.0	79.4	92.7	77.3	77.6	109.4	297.5	44.8	70.0	7.5	176.7	157.4	336.2	365.4	68.3	2.2	180.5	157.6	48.8	148.7	222.2	163.7	0.0	56.4	505.5	305.4	485.2	245.8	2.3	112.2	151.9	76.3	17.5	18.3	1.1	72.9	471.9	156.7	39.8	108.1	214.9	1.1	94.2	52.9	227.8	0.0	1.6	153.1	175.0	156.9	701.0	11.3	56.2	422.0	156.5	7.5	391.8	232.7	433.5	11.6	59.5	123.3	236.1	68.4	186.3	239.8	23.3	104.3	150.3	5.4	52.6	89.6	176.1	0.2	5.4	37.1	132.1	37.1	278.7	16.6	88.9	368.6
LLGL2	"HGL, Hugl-2"	ENSG00000073350	"LLGL scribble cell polarity complex component 2"	Q6P1M3	17	75525080-75575209	"Predicted intracellular proteins"	"Cell cycle, Cell division, Exocytosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 297.5;Pancreatic endocrine cells: 249.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"gdT-cell: 3.1"	"Group enriched"	"Detected in many"	6	"dendritic cells: 1.1;NK-cells: 2.1;T-cells: 3.1"	"Cell line enhanced"	"Detected in many"		"CACO-2: 92.6;CAPAN-2: 134.2;MCF7: 132.1;OE19: 101.6;RT4: 92.9;SK-BR-3: 127.5;T-47d: 96.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA022913	Uncertain		Supported	Vesicles,Cytosol		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Cytosol	Vesicles	"HPA022913: AB_1852930"	"unprognostic (1.18e-1)"	"unprognostic (4.18e-2)"	"unprognostic (2.89e-2)"	"unprognostic (1.34e-1)"	"unprognostic (3.43e-1)"	"prognostic favorable (9.25e-4)"	"unprognostic (2.60e-2)"	"unprognostic (2.40e-1)"	"unprognostic (7.97e-2)"	"unprognostic (3.49e-1)"	"prognostic favorable (6.00e-5)"	"unprognostic (6.22e-3)"	"prognostic favorable (6.14e-9)"	"unprognostic (1.14e-2)"	"unprognostic (2.77e-2)"	"unprognostic (4.15e-3)"	"unprognostic (1.56e-2)"	3.9	7.8	2.7	14.2	6.0	4.6	9.0	6.2	3.6	16.3	9.5	64.5	54.5	4.1	24.0	55.5	14.9	21.3	3.4	2.1	4.1	56.7	26.9	27.6	5.1	6.0	5.9	4.9	74.5	17.3	11.2	6.3	6.2	14.7	28.4	10.4	43.4	12.5	1.3	34.1	55.4	1.9	4.0	24.5	64.2	6.9	4.5	2.3	17.8	0.9	5.7	9.6	25.9	9.8	60.1	54.7	0.3	10.4	0.0	0.0	22.7	0.4	0.6	1.1	0.6	92.6	134.2	4.0	13.6	0.2	5.0	73.7	10.1	10.1	0.2	5.1	18.1	4.0	16.1	35.1	0.6	0.6	8.5	0.0	13.6	0.2	2.1	1.3	2.0	5.8	7.9	5.4	0.0	132.1	3.5	7.1	7.4	101.6	21.2	6.9	0.2	14.9	28.4	92.9	22.1	4.5	11.8	127.5	4.0	12.2	96.6	9.4	0.5	0.2	0.6	0.2	1.0	6.4	9.3	1.8	0.4	0.3	2.7	0.0	0.1	0.1	3.1	0.3	0.7	0.3	0.7	2.1	0.1	0.3	0.1	1.2	0.1	2.1	0.1	1.1	0.5	0.4	2.7	6.0	6.2	3.6	2.1	4.1	6.0	5.9	6.2	4.0	4.5	9.8	7.7	89.8	51.6	3.6	9.0	10.6	34.7	17.3	12.0	15.5	28.8	20.1	3.8	74.4	40.5	90.1	166.8	3.7	44.7	297.5	31.3	84.1	0.6	88.7	7.2	9.0	95.1	0.8	1.1	138.9	8.5	3.5	158.5	87.7	22.2	7.2	4.6	25.0	6.0	8.4	0.8	113.0	32.6	3.8	6.0	1.0	4.7	4.7	3.6	5.6	5.5	28.1	50.4	0.5	49.9	249.4	159.8	4.1	16.1	37.6	84.5	47.0	53.9	117.5	6.6	1.3	6.4	1.5	18.9	27.5	21.7	4.4	21.8	7.5	136.1	89.7
LLPH	"C12orf31, hLLP, MGC14817"	ENSG00000139233	"LLP homolog, long-term synaptic facilitation factor"	Q9BRT6	12	66116555-66130750	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA048920, HPA058786"			Enhanced	"Nucleoli,Mitotic chromosome"		Yes	No			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 32: U-937 - Innate immune response"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoli	"Mitotic chromosome"	"HPA048920: AB_2680556, HPA058786: AB_2683820"	"unprognostic (3.60e-3)"	"unprognostic (4.94e-2)"	"unprognostic (4.07e-2)"	"unprognostic (3.03e-2)"	"unprognostic (2.13e-1)"	"unprognostic (4.31e-2)"	"prognostic unfavorable (6.44e-7)"	"unprognostic (7.15e-2)"	"unprognostic (1.30e-2)"	"unprognostic (8.49e-3)"	"unprognostic (2.15e-2)"	"unprognostic (1.07e-2)"	"unprognostic (3.87e-2)"	"unprognostic (9.65e-3)"	"unprognostic (2.49e-2)"	"unprognostic (3.37e-1)"	"unprognostic (2.94e-2)"	21.6	34.4	12.3	24.4	13.5	50.3	18.6	12.7	16.0	13.2	11.2	20.1	19.2	15.2	18.6	19.5	13.2	14.7	23.2	12.8	13.7	20.9	21.2	15.5	26.3	13.5	14.3	17.6	17.2	17.0	10.7	17.5	13.7	15.3	20.3	7.4	14.5	14.1	29.7	13.8	18.2	19.4	13.0	18.2	19.1	22.1	13.5	22.1	17.3	25.3	25.6	27.3	14.0	14.2	77.0	61.1	36.4	44.2	42.6	40.8	44.5	87.0	56.4	63.9	53.6	52.8	31.0	87.0	70.6	58.6	50.7	63.6	57.2	52.9	85.7	78.4	48.8	94.5	41.7	47.3	49.8	162.5	61.8	41.9	53.6	53.7	58.3	50.1	56.6	44.1	81.5	60.9	76.1	81.3	74.1	110.4	77.9	61.6	63.0	61.9	67.2	62.7	63.3	90.8	36.3	45.1	57.0	58.3	97.4	38.0	77.4	89.5	60.5	48.3	71.3	60.9	80.4	45.7	77.6	130.2	65.4	76.0	76.8	34.3	32.0	35.5	27.8	38.0	32.0	29.2	32.3	30.6	31.3	27.5	27.4	29.2	43.8	27.4	48.4	27.0	38.9	28.8	12.3	13.5	12.7	16.0	12.8	13.7	13.5	14.3	13.7	13.0	13.5	14.2	34.2	12.8	33.9	2.9	47.6	27.1	53.9	86.3	30.1	15.9	24.5	28.4	25.1	41.5	64.3	31.3	4.2	66.3	49.4	34.1	66.5	68.3	63.3	40.5	45.4	32.5	13.8	33.4	5.0	71.3	70.4	34.8	35.7	46.6	89.4	61.2	35.7	60.2	64.2	21.9	4.4	31.1	85.5	50.4	26.5	17.0	43.8	45.6	35.6	3.7	84.1	30.8	59.8	3.0	5.8	96.3	43.3	30.1	27.3	46.3	44.0	86.5	35.8	15.2	26.3	29.7	36.8	126.6	48.6	30.6	30.5	72.7	43.8	126.4	36.1	60.6
LMAN1	"ERGIC-53, ERGIC53, F5F8D, FMFD1, gp58, MCFD1, MR60"	ENSG00000074695	"Lectin, mannose binding 1"	P49257	18	59327823-59359265	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"ER-Golgi transport, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Plasma cells: 502.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002320, CAB037163"	Supported		Supported	"Endoplasmic reticulum,Vesicles"		NA	NA		18000000	"Cluster 44: Non-specific - Transcription"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 55: Plasma cells - Humoral immune response"	Vesicles	"Endoplasmic reticulum"	"CAB037163: AB_532237, HPA002320: AB_1079256"	"unprognostic (5.64e-2)"	"unprognostic (8.96e-3)"	"unprognostic (4.20e-3)"	"unprognostic (1.61e-1)"	"unprognostic (2.46e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.65e-1)"	"unprognostic (5.40e-3)"	"unprognostic (1.16e-1)"	"unprognostic (2.03e-1)"	"unprognostic (2.40e-2)"	"unprognostic (1.06e-1)"	"unprognostic (5.79e-2)"	"unprognostic (4.28e-2)"	"unprognostic (5.37e-3)"	"unprognostic (7.05e-2)"	"unprognostic (3.71e-3)"	36.0	43.3	14.8	39.4	16.4	21.7	43.8	16.9	19.4	66.0	20.1	34.1	45.7	46.1	52.9	31.1	48.8	31.9	42.6	13.8	19.4	64.5	181.1	33.6	28.4	17.1	16.0	43.3	53.1	74.3	32.7	54.8	17.4	58.4	39.3	40.0	69.0	43.7	33.3	20.3	49.1	37.7	16.2	27.4	59.3	21.2	16.0	32.1	86.5	41.1	34.8	40.1	21.2	20.4	90.6	52.7	55.1	46.4	125.6	215.6	110.7	159.6	227.9	105.7	140.5	52.7	85.2	16.0	110.7	191.0	75.7	108.1	79.0	90.5	191.0	61.7	50.4	52.5	65.4	109.5	148.9	183.6	77.0	144.7	106.8	102.5	208.1	198.1	108.1	54.3	89.7	173.6	104.2	24.5	53.5	37.9	37.8	45.8	64.5	60.0	100.1	176.0	58.9	67.6	37.5	40.9	80.6	78.0	91.6	76.8	57.8	70.8	89.8	170.5	59.9	55.2	94.0	131.6	71.3	76.2	179.1	96.0	142.6	6.0	2.5	0.7	7.3	3.7	10.0	7.1	7.9	7.7	3.5	5.1	7.5	7.7	0.3	10.0	2.1	8.8	9.6	4.0	14.8	16.4	16.9	19.4	13.8	19.4	17.1	16.0	17.4	16.2	16.0	20.4	120.0	102.5	97.1	15.0	104.0	69.8	120.3	213.5	84.8	39.2	104.5	97.2	134.6	71.4	171.2	80.9	106.3	149.3	86.7	32.8	21.5	130.6	28.1	117.5	203.7	97.7	51.6	49.6	17.2	84.6	304.8	162.4	106.0	200.7	33.6	96.9	75.0	394.0	80.2	58.9	22.1	181.4	107.8	41.9	40.1	10.3	110.6	52.5	67.6	22.5	53.5	76.8	54.6	20.1	33.5	71.6	45.5	85.4	502.1	214.1	95.5	75.6	164.7	66.7	65.7	95.4	142.3	47.2	65.1	80.7	57.0	231.2	69.5	149.6	89.7	129.5
LMBRD1	"bA810I22.1, C6orf209, cblF, FLJ11240"	ENSG00000168216	"LMBR1 domain containing 1"	Q9NUN5	6	69672757-69867236	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Endocytosis, Gastrulation, Host-virus interaction, Transport"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"naive B-cell: 21.0"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"RPMI-8226: 37.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016491, HPA019547"	Uncertain		Supported	Vesicles		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 59: Non-specific - Transcription"	Vesicles		"HPA016491: , HPA019547: AB_2281256"	"unprognostic (1.44e-1)"	"unprognostic (3.84e-2)"	"unprognostic (7.67e-2)"	"unprognostic (7.64e-2)"	"unprognostic (2.41e-1)"	"unprognostic (5.37e-2)"	"unprognostic (2.26e-1)"	"unprognostic (4.39e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.97e-1)"	"unprognostic (2.22e-1)"	"unprognostic (1.47e-1)"	"prognostic favorable (1.07e-7)"	"unprognostic (7.99e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.60e-2)"	"unprognostic (2.68e-2)"	33.3	49.4	10.3	11.5	10.8	4.2	31.4	20.7	17.0	28.9	13.3	26.4	13.5	22.5	27.7	25.7	26.3	16.0	27.7	11.1	11.5	53.0	42.9	27.9	12.1	13.6	11.9	34.5	36.5	31.7	26.5	17.2	12.3	19.1	20.5	10.7	33.2	20.0	28.8	28.1	28.6	12.7	11.4	21.8	29.6	10.4	10.2	9.1	35.1	13.1	16.8	30.1	29.4	16.1	3.8	3.8	6.0	10.2	16.5	23.7	17.9	2.2	7.1	2.6	5.6	4.8	8.2	6.5	9.2	8.8	5.8	7.5	3.8	9.8	2.4	16.3	11.9	6.2	4.9	7.8	13.7	3.4	8.7	7.6	9.6	0.8	5.7	19.1	7.4	5.5	9.4	6.1	6.0	8.1	2.5	4.7	4.6	8.5	4.8	0.3	15.4	37.8	17.0	13.8	5.5	8.5	0.9	7.0	13.3	3.0	4.6	25.3	1.1	3.9	4.6	4.3	2.8	8.8	5.5	2.8	2.3	4.0	12.3	6.5	2.2	3.9	2.0	2.5	2.5	12.1	2.9	1.9	1.7	21.0	3.1	2.3	11.4	2.6	4.8	2.2	3.7	2.1	10.3	10.8	20.7	17.0	11.1	11.5	13.6	11.9	12.3	11.4	10.2	16.1	49.7	64.1	38.3	82.3	93.4	29.1	41.9	45.2	71.2	73.7	39.2	25.4	40.6	50.1	56.0	58.8	110.5	69.6	36.2	79.0	19.6	49.0	28.8	48.3	22.7	41.1	18.7	18.5	119.2	49.6	59.2	56.1	36.7	61.7	40.5	15.7	44.6	60.5	42.1	55.5	144.6	37.6	44.7	66.9	36.3	9.3	35.4	52.0	32.0	79.6	49.3	56.3	28.8	122.2	156.6	42.0	51.0	33.8	82.7	19.6	78.7	64.1	65.5	90.8	26.3	36.4	33.9	22.5	16.9	43.4	38.1	77.4	43.2	26.9	31.7	34.2
LMCD1		ENSG00000071282	"LIM and cysteine rich domains 1"	Q9NZU5	3	8501807-8574668	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 573.4"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 287.6;Ductal cells: 122.0;Endothelial cells: 161.9;Pancreatic endocrine cells: 114.1;Smooth muscle cells: 112.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	6	"T-reg: 20.5"	"Lineage enriched"	"Detected in many"	6	"T-cells: 20.5"	"Cell line enhanced"	"Detected in many"		"HHSteC: 88.9;HSkMC: 124.9;hTEC/SVTERT24-B: 93.8;U-2197: 83.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024059	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cell Junctions,Cytosol"		No	No		6600	"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Nucleoplasm, Cytosol"	"Plasma membrane, Cell Junctions"	"HPA024059: AB_1852950"	"unprognostic (2.46e-1)"	"unprognostic (1.79e-1)"	"unprognostic (5.13e-3)"	"unprognostic (1.30e-1)"	"unprognostic (2.28e-2)"	"unprognostic (2.10e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.96e-1)"	"unprognostic (8.21e-3)"	"unprognostic (4.29e-1)"	"unprognostic (2.54e-2)"	"prognostic unfavorable (8.66e-5)"	"unprognostic (3.80e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.01e-3)"	"unprognostic (3.68e-3)"	131.4	14.3	9.5	45.6	9.5	0.1	97.5	13.5	10.8	27.2	38.8	18.1	9.0	90.3	18.4	36.1	57.8	67.2	90.6	14.0	9.7	33.0	9.7	131.7	17.3	14.0	11.0	65.8	37.7	30.0	8.7	54.5	12.1	34.8	7.0	15.2	42.2	16.8	573.4	28.8	20.1	63.3	13.2	55.6	46.4	11.3	12.6	4.7	18.5	260.9	10.2	110.6	31.5	14.8	9.4	52.0	8.6	6.6	62.0	34.6	8.9	37.9	19.4	20.5	50.0	38.8	11.5	0.0	4.2	44.2	8.8	0.8	4.9	9.9	8.4	16.0	3.6	11.6	3.5	7.6	88.9	0.0	1.1	124.9	0.2	93.8	0.7	11.9	10.1	0.0	0.0	0.0	26.8	6.7	0.0	0.1	16.8	12.0	2.3	0.2	28.2	0.1	19.1	3.6	0.3	21.3	6.4	31.1	20.6	23.9	40.7	0.1	5.0	20.4	40.3	83.0	25.9	5.1	6.2	2.6	4.1	2.9	27.0	0.0	0.0	0.0	0.0	0.4	0.1	2.0	2.9	0.6	3.3	0.3	0.0	0.1	0.0	0.0	0.0	1.0	20.5	0.3	9.5	9.5	13.5	10.8	14.0	9.7	14.0	11.0	12.1	13.2	12.6	14.8	287.6	9.6	10.7	2.0	2.1	31.6	42.1	7.4	9.6	13.0	20.4	17.0	14.7	14.3	13.5	5.5	10.4	3.9	1.7	1.4	3.9	122.0	1.1	9.6	77.7	161.9	12.1	0.0	0.8	48.5	4.2	64.5	7.1	4.8	10.2	44.2	30.7	12.6	3.4	97.6	1.2	2.4	4.1	0.8	47.0	2.3	11.5	3.2	53.4	29.0	9.0	38.9	1.0	4.0	8.7	114.1	0.9	32.4	8.0	8.4	0.3	45.5	12.0	8.0	0.0	57.0	112.9	6.4	9.1	29.0	27.1	4.4	5.3	21.5	4.7	7.5
LMLN	"Gp63, LMNL1, Msp"	ENSG00000185621	"Leishmanolysin like peptidase"	Q96KR4	3	197960200-198043720	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Cell cycle, Cell division, Mitosis"	"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 39.7;Endometrial ciliated cells: 35.2;Respiratory ciliated cells: 37.5;Spermatocytes: 33.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016481, HPA028844"	Uncertain		Supported	"Focal adhesion sites,Cytosol"		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 16: U-266 - Nucleosome"	"Cluster 49: Ciliated cells - Cilium organization"	Cytosol	"Focal adhesion sites"	"HPA016481: AB_1852955, HPA028844: AB_10602347"	"unprognostic (2.54e-1)"	"unprognostic (3.15e-1)"	"unprognostic (7.63e-2)"	"prognostic favorable (6.77e-4)"	"unprognostic (1.14e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.30e-1)"	"unprognostic (4.07e-2)"	"unprognostic (1.94e-1)"	"unprognostic (2.31e-1)"	"unprognostic (6.36e-2)"	"unprognostic (2.98e-1)"	"unprognostic (4.82e-3)"	"unprognostic (8.78e-2)"	"unprognostic (7.65e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.63e-1)"	2.1	2.6	2.7	1.2	3.4	1.2	2.2	3.6	4.7	3.1	4.7	2.1	1.0	2.2	10.7	2.2	4.9	2.6	3.3	2.7	3.7	3.4	2.2	2.5	1.3	4.2	3.3	3.3	3.8	3.8	6.5	2.0	4.5	2.3	2.0	9.7	2.4	3.4	2.4	3.4	1.4	2.0	3.0	1.5	2.0	10.1	4.0	1.1	4.1	2.0	1.2	1.9	2.3	3.2	7.7	2.8	3.3	4.0	6.4	9.0	2.9	3.9	3.6	6.9	5.6	2.8	2.7	2.4	17.7	2.8	14.9	2.8	3.1	3.1	10.0	0.3	2.3	1.4	2.3	2.1	4.0	4.4	2.0	4.3	6.8	8.6	5.5	4.0	3.0	6.0	7.5	4.5	6.7	5.7	2.6	3.8	3.8	5.5	6.7	3.0	0.8	2.6	7.1	2.0	5.4	1.5	5.4	4.8	3.9	3.7	12.5	3.2	6.6	8.4	1.3	10.3	6.7	8.0	16.7	0.7	12.0	7.4	7.8	0.0	0.1	0.1	0.2	0.4	0.3	0.4	0.1	0.3	0.4	0.2	0.4	0.5	0.1	0.3	0.2	0.1	0.0	0.2	2.7	3.4	3.6	4.7	2.7	3.7	4.2	3.3	4.5	3.0	4.0	3.2	4.4	16.0	14.8	24.5	1.7	2.0	1.5	2.6	4.0	8.1	6.4	4.8	11.6	2.8	9.2	9.2	16.7	3.6	1.2	2.2	0.0	3.5	39.7	35.2	11.5	3.2	4.8	0.8	25.3	2.7	2.2	5.5	1.5	11.5	2.5	6.3	4.2	3.1	5.0	8.4	23.1	3.6	0.0	1.9	2.3	21.9	4.7	2.3	3.6	9.4	1.1	5.9	1.0	6.6	13.7	2.1	1.0	5.7	2.1	1.8	0.7	3.5	37.5	17.7	0.0	6.6	3.8	33.2	23.6	3.7	1.7	2.9	2.1	10.6	2.8	1.1
LMNA	"CMD1A, HGPS, LGMD1B, LMN1, LMNL1, MADA, PRO1"	ENSG00000160789	"Lamin A/C"	P02545	1	156082573-156140081	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			"Cancer-related genes, Cardiomyopathy, Charcot-Marie-Tooth disease, Congenital muscular dystrophy, Disease variant, Emery-Dreifuss muscular dystrophy, Limb-girdle muscular dystrophy, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Langerhans cells: 1533.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"myeloid DC: 85.1;T-reg: 83.2"	"Group enriched"	"Detected in all"	8	"dendritic cells: 85.1;granulocytes: 23.9;T-cells: 83.2"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004022, HPA006523, HPA006660"	Supported		Supported	"Nuclear speckles"		NA	NA		5700000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 31: Skin - Epidermis development"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 24: Non-specific - Transcription regulation"	"Nuclear speckles"		"CAB004022: AB_2136278, HPA006523: , HPA006660: AB_1079231"	"unprognostic (2.22e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.04e-2)"	"unprognostic (5.75e-2)"	"unprognostic (7.43e-3)"	"unprognostic (1.47e-1)"	"unprognostic (5.23e-3)"	"unprognostic (3.27e-2)"	"unprognostic (8.33e-2)"	"unprognostic (5.90e-2)"	"unprognostic (5.10e-2)"	"unprognostic (6.34e-2)"	"unprognostic (1.41e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.89e-1)"	"unprognostic (3.08e-2)"	"unprognostic (1.44e-2)"	280.2	174.8	17.6	64.9	27.1	58.1	231.5	24.1	20.6	221.7	33.0	183.3	72.8	271.4	14.5	256.2	173.8	92.1	221.7	15.8	23.1	120.9	93.2	188.5	18.2	30.3	25.2	178.2	81.8	21.3	76.9	53.0	26.1	125.3	38.2	4.7	176.1	42.8	190.0	364.3	136.8	78.8	21.0	84.1	160.6	61.9	30.9	15.3	147.4	23.8	22.9	168.7	217.6	41.8	518.8	269.7	26.2	72.4	119.5	238.7	169.4	607.3	379.6	221.3	146.8	68.3	311.9	2.8	338.7	417.9	94.6	515.4	31.4	227.8	70.3	188.6	50.8	175.4	168.4	130.8	124.0	25.7	412.9	133.0	92.0	154.8	134.7	120.2	207.5	0.7	82.8	21.9	205.8	193.1	1.0	67.8	32.1	202.9	706.0	1.6	195.9	137.7	128.9	105.6	33.8	114.9	414.3	154.2	427.4	56.2	230.1	74.2	727.9	241.6	233.0	389.1	393.3	39.5	10.5	4.9	449.2	24.8	760.4	23.9	8.3	0.4	2.8	2.1	2.5	2.4	17.8	7.3	85.1	0.2	0.2	0.7	2.1	3.7	0.2	0.3	83.2	14.6	17.6	27.1	24.1	20.6	15.8	23.1	30.3	25.2	26.1	21.0	30.9	41.8	353.5	262.8	350.0	16.0	179.1	610.5	1235.3	446.2	531.6	7.2	542.5	374.9	94.1	191.6	320.3	161.8	47.9	478.8	239.8	614.1	109.5	429.3	38.6	215.4	209.4	386.0	431.5	70.4	9.9	360.2	387.8	622.1	505.1	270.5	1181.8	145.5	277.7	103.1	343.0	13.5	15.1	601.2	177.0	60.6	1533.4	45.4	288.6	409.0	859.2	10.3	20.4	37.2	3.1	17.1	20.1	513.0	384.1	287.3	331.3	340.6	262.6	125.0	170.5	17.8	203.8	1028.4	766.8	107.4	42.2	404.1	602.4	680.9	472.3	111.6	513.8	942.6
LMNB1		ENSG00000113368	"Lamin B1"	P20700	5	126776623-126837020	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			Leukodystrophy	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 34.0;lymphoid tissue: 49.2"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 92.5;Erythroid cells: 67.3;Extravillous trophoblasts: 68.2;granulocytes: 93.6;Late spermatids: 72.1;monocytes: 59.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005269, HPA050524, CAB079757, CAB079954"	Supported		Supported	"Nuclear membrane"		NA	NA		2100000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 32: U-937 - Innate immune response"	"Cluster 12: Non-specific - Cell cycle regulation"	"Nuclear membrane"		"CAB005269: AB_648156, CAB079757: AB_2665863, CAB079954: , HPA050524: AB_2681156"	"unprognostic (1.52e-1)"	"unprognostic (2.53e-2)"	"unprognostic (4.96e-3)"	"unprognostic (3.70e-2)"	"unprognostic (1.61e-1)"	"unprognostic (8.65e-3)"	"prognostic unfavorable (3.08e-6)"	"unprognostic (2.06e-2)"	"unprognostic (6.62e-3)"	"unprognostic (5.28e-2)"	"unprognostic (2.13e-3)"	"unprognostic (2.33e-2)"	"prognostic unfavorable (3.33e-16)"	"unprognostic (1.33e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.08e-1)"	"unprognostic (2.55e-1)"	4.2	1.6	1.9	26.6	1.8	34.0	2.9	9.8	2.1	3.7	0.5	14.9	11.2	2.8	0.5	14.2	1.8	3.4	1.5	1.6	3.3	3.5	4.9	6.0	34.8	2.9	2.3	2.2	2.4	0.7	2.0	6.7	2.4	1.6	13.0	6.4	3.4	1.6	1.0	8.6	14.2	3.5	2.1	13.3	7.9	2.2	2.3	49.2	1.6	1.4	29.2	6.8	4.8	1.8	132.7	43.4	131.6	126.6	3.3	9.3	170.6	60.6	17.8	66.1	71.3	113.4	107.2	229.4	103.2	21.4	31.5	72.4	90.9	42.1	72.2	162.9	112.1	147.5	49.1	67.2	1.4	176.6	95.6	3.0	0.9	35.2	16.0	12.8	54.9	92.0	87.1	86.3	46.6	109.7	322.8	347.5	99.0	54.1	60.0	152.6	259.4	93.1	36.6	59.6	151.4	80.3	98.4	41.7	36.6	45.2	76.2	202.0	46.9	48.7	132.0	36.6	131.3	56.8	46.4	197.3	25.0	247.1	73.8	1.4	14.4	4.8	2.1	5.6	1.6	4.2	4.3	2.8	15.3	2.9	3.1	2.8	9.3	2.4	1.5	4.6	12.4	6.4	1.9	1.8	9.8	2.1	1.6	3.3	2.9	2.3	2.4	2.1	2.3	1.8	3.4	0.0	4.3	0.3	20.1	5.0	1.9	2.0	8.0	6.4	4.3	5.1	1.6	4.3	3.3	0.0	8.4	39.4	56.0	7.7	1.9	1.8	92.5	3.9	4.8	8.8	6.1	67.3	6.8	0.8	68.2	8.1	11.7	7.6	93.6	23.9	3.6	3.1	21.8	5.0	9.1	19.3	0.0	13.1	17.9	72.1	2.1	27.9	1.8	1.9	59.5	3.8	13.4	5.5	1.1	1.1	8.4	0.4	50.6	1.1	3.8	2.1	1.9	17.5	0.0	2.5	7.3	3.4	8.9	27.3	5.4	4.7	34.2	3.0	35.8	1.4
LMNB2	LMN2	ENSG00000176619	"Lamin B2"	Q03252	19	2427638-2456959	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			"Disease variant, Epilepsy, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"Early spermatids: 220.2;Extravillous trophoblasts: 81.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022593, HPA047863, HPA062477"	Enhanced		Supported	"Nuclear membrane"		NA	NA		110000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 29: Early spermatids - Spermatogenesis"	"Nuclear membrane"		"CAB022593: , HPA047863: AB_2680189, HPA062477: AB_2684776"	"unprognostic (3.92e-2)"	"unprognostic (1.61e-1)"	"unprognostic (4.76e-2)"	"unprognostic (4.05e-2)"	"unprognostic (9.65e-2)"	"unprognostic (1.17e-1)"	"prognostic unfavorable (1.32e-4)"	"unprognostic (2.53e-3)"	"prognostic unfavorable (5.88e-4)"	"unprognostic (1.96e-1)"	"unprognostic (3.09e-3)"	"prognostic unfavorable (9.53e-5)"	"prognostic unfavorable (9.34e-5)"	"prognostic favorable (3.98e-4)"	"unprognostic (4.03e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.53e-2)"	9.7	10.1	8.9	15.3	8.6	17.3	7.7	11.5	9.8	11.9	6.4	13.1	10.9	11.9	2.4	32.1	10.7	3.4	10.6	8.5	10.1	9.5	6.0	11.2	12.8	8.7	9.0	13.4	8.1	3.6	12.3	14.6	8.4	9.8	6.2	3.5	9.1	4.9	14.9	10.6	12.2	5.5	8.0	12.3	10.4	10.9	10.5	23.1	8.7	5.2	10.5	10.0	12.4	8.0	181.5	114.0	80.8	105.7	17.3	27.2	107.5	119.2	57.7	117.7	88.8	152.0	75.6	83.5	47.8	55.9	68.1	185.6	72.4	84.8	60.0	102.4	86.3	66.4	40.3	119.8	20.9	93.5	64.6	24.5	21.4	63.4	49.7	22.0	60.9	76.2	117.8	51.9	56.4	105.4	107.9	51.8	154.0	97.8	98.6	150.1	102.4	70.0	33.7	89.8	118.7	68.8	99.6	65.6	39.6	44.7	65.9	95.7	85.1	112.5	116.6	174.8	180.6	45.6	41.8	83.5	91.3	88.5	148.3	0.0	0.6	0.8	1.0	0.6	1.6	0.4	1.1	1.0	0.8	0.9	1.1	1.3	0.0	0.9	2.1	3.5	0.4	0.6	8.9	8.6	11.5	9.8	8.5	10.1	8.7	9.0	8.4	8.0	10.5	8.0	8.6	3.2	4.2	2.6	9.4	20.6	14.8	7.9	10.2	8.2	8.8	8.1	5.7	2.8	5.3	5.5	8.4	30.4	9.7	17.5	9.8	7.0	220.2	7.7	14.9	12.7	6.0	19.6	3.0	11.8	81.6	14.3	14.3	11.7	4.5	31.4	8.2	2.7	21.2	13.5	3.9	15.1	6.1	6.8	18.2	31.4	9.3	10.3	1.8	3.7	12.2	9.4	11.3	2.0	3.3	12.7	9.1	7.9	25.5	24.4	12.7	4.9	5.7	10.8	13.1	14.3	11.2	8.6	15.0	30.0	20.0	13.8	11.4	12.0	23.1	19.2
LMO4		ENSG00000143013	"LIM domain only 4"	P61968	1	87328880-87348923	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Endometrial stromal cells: 508.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"AN3-CA: 586.8;T-47d: 373.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022345, HPA045877, HPA061638"	Approved		Supported	"Nucleoplasm,Midbody ring"		Yes	No			"Cluster 10: Basophils - Unknown function"	"Cluster 65: Brain - Ion transport"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 36: Stromal cells - Cell proliferation"	Nucleoplasm	"Midbody ring"	"CAB022345: , HPA045877: AB_2679480, HPA061638: AB_2684572"	"unprognostic (5.39e-2)"	"unprognostic (4.62e-3)"	"unprognostic (2.67e-2)"	"unprognostic (4.33e-3)"	"unprognostic (1.37e-1)"	"unprognostic (2.05e-2)"	"prognostic unfavorable (5.25e-4)"	"unprognostic (3.97e-3)"	"unprognostic (7.44e-2)"	"prognostic favorable (1.47e-4)"	"unprognostic (3.46e-2)"	"unprognostic (6.82e-2)"	"unprognostic (1.14e-2)"	"unprognostic (2.86e-2)"	"unprognostic (2.87e-2)"	"prognostic favorable (1.42e-4)"	"unprognostic (1.70e-1)"	49.0	16.3	102.1	28.6	116.5	21.9	34.7	79.8	173.7	51.7	70.8	44.7	26.7	43.2	39.4	50.9	32.4	45.5	42.2	117.4	82.9	42.7	33.3	38.2	29.5	82.1	78.9	39.6	25.5	22.9	31.6	63.9	80.1	56.4	31.6	34.5	87.4	81.0	47.6	39.7	43.1	30.3	79.4	38.7	90.7	28.0	83.2	23.5	33.8	25.5	87.8	38.8	54.0	100.6	55.1	42.3	32.3	586.8	96.6	113.9	81.8	48.4	38.3	44.9	49.8	104.3	34.0	127.5	60.3	57.2	72.4	44.7	13.1	33.8	44.5	68.6	32.4	116.5	87.2	32.3	92.9	63.6	151.2	60.2	76.4	70.0	39.8	80.9	30.8	48.7	26.8	109.8	24.5	22.3	1.8	41.3	118.1	58.6	39.3	72.8	45.0	28.5	56.1	206.7	26.5	1.7	195.3	28.7	149.6	61.1	373.3	171.8	20.1	208.9	39.0	50.6	161.7	99.7	70.6	28.8	26.1	13.8	30.7	30.5	9.1	19.5	7.8	11.6	9.0	10.1	6.9	8.0	6.9	6.9	1.8	4.4	15.0	22.4	11.5	10.3	2.1	5.1	102.1	116.5	79.8	173.7	117.4	82.9	82.1	78.9	80.1	79.4	83.2	100.6	103.5	44.8	24.1	50.9	88.6	98.4	49.3	105.6	245.3	226.2	170.0	191.5	72.4	153.0	78.1	36.8	73.0	322.8	116.5	50.0	62.6	74.2	2.1	106.5	508.1	65.6	31.1	48.1	204.4	127.6	363.3	149.0	159.6	131.5	307.4	19.5	78.1	85.7	74.0	111.0	37.5	80.6	14.2	138.4	73.2	7.5	95.1	76.1	65.8	22.5	74.6	82.7	83.4	52.8	25.8	107.2	29.9	235.5	174.6	49.3	90.3	56.8	31.0	35.9	32.9	80.6	175.5	4.4	97.9	200.3	92.9	256.0	77.9	61.7	64.9	37.5
LMO7	"FBX20, FBXO20, KIAA0858"	ENSG00000136153	"LIM domain 7"	Q8WWI1	13	75620434-75859870	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 248.8"	"Cell type enhanced"	"Detected in all"		"Alveolar cells type 1: 1682.7;Urothelial cells: 435.7"	"Low cancer specificity"	"Detected in all"			"Group enriched"	"Detected in many"	177	"amygdala: 12.6;basal ganglia: 19.9;cerebral cortex: 25.6;hippocampal formation: 14.9;white matter: 15.4"	"Immune cell enhanced"	"Detected in many"		"naive CD4 T-cell: 13.6"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BJ: 343.4;fHDF/TERT166: 568.2;LHCN-M2: 525.9"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"amygdala: 20.8;basal ganglia: 32.8;cerebral cortex: 26.6;hippocampal formation: 33.8"	"HPA020923, HPA050184"	Enhanced		Supported	"Actin filaments,Cytosol"		NA	NA		8200	"Cluster 32: T-cells - Unknown function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 22: Epithelial cell types - Mixed function"	"Actin filaments"	Cytosol	"HPA020923: AB_1852963, HPA050184: AB_2681045"	"unprognostic (2.07e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.28e-1)"	"prognostic unfavorable (5.12e-4)"	"unprognostic (1.75e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.57e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.52e-2)"	"unprognostic (3.42e-2)"	"prognostic unfavorable (3.51e-4)"	"unprognostic (2.14e-1)"	"prognostic favorable (7.75e-12)"	"unprognostic (2.49e-1)"	"unprognostic (2.82e-1)"	"unprognostic (1.08e-1)"	"unprognostic (8.33e-2)"	4.4	5.3	12.6	10.6	19.9	4.1	9.3	0.0	25.6	12.8	4.8	47.4	66.3	5.7	12.1	153.7	14.5	43.3	248.8	14.9	0.0	44.1	61.9	178.7	11.0	0.0	0.0	18.6	25.5	11.8	6.4	41.3	0.0	27.3	32.5	4.8	32.4	15.1	143.5	21.1	79.7	7.9	0.0	5.0	62.7	18.2	0.0	56.8	53.5	99.5	37.1	24.5	38.4	15.4	77.8	43.6	1.7	1.3	86.5	61.4	14.9	343.4	168.3	85.4	91.6	107.4	97.8	6.6	25.7	568.2	21.2	73.5	18.9	16.6	97.8	105.4	4.5	47.8	229.2	102.2	25.0	15.3	24.0	42.0	31.1	37.0	42.3	207.9	36.2	14.7	1.7	0.5	525.9	30.4	11.6	6.4	2.2	119.6	65.0	7.2	159.5	1.6	36.0	18.1	5.4	11.6	62.2	10.8	13.8	8.6	14.0	11.3	55.6	208.7	38.7	25.4	84.9	22.6	18.4	27.8	61.6	17.0	97.0	4.5	0.2	2.7	0.6	0.5	0.9	1.1	3.2	1.0	0.4	2.3	13.6	8.6	0.1	0.6	0.4	1.1	1.4	2.6	12.6	19.9	0.0	25.6	14.9	0.0	0.0	0.0	0.0	0.0	0.0	15.4	1.5	1682.7	279.7	22.2	4.3	24.0	74.7	59.9	72.8	6.8	10.5	13.2	362.6	51.5	317.2	62.5	2.1	45.5	3.6	378.5	15.6	81.5	6.2	92.0	19.0	9.0	71.2	3.6	162.3	37.8	8.7	38.0	276.3	244.4	20.3	9.5	6.1	72.7	6.0	6.7	82.5	96.6	67.1	3.5	4.4	8.0	42.0	6.4	16.0	39.4	2.8	1.9	3.1	30.7	48.4	228.8	351.2	42.5	2.1	344.9	213.8	15.5	199.5	10.5	13.1	27.2	18.1	11.2	6.3	100.9	45.3	17.0	12.9	2.5	75.2	435.7
LNPK	"KIAA1715, LNP, LNP1, Ul"	ENSG00000144320	"Lunapark, ER junction formation factor"	Q9C0E8	2	175923882-176002839	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"Developmental protein"	"Disease variant, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Breast glandular cells: 19.3;Endometrial stromal cells: 24.6;Hofbauer cells: 24.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-138 MG: 159.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014205	Approved		Supported	"Nucleoplasm,Endoplasmic reticulum"		NA	NA		15000	"Cluster 15: NK-cells - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 7: Non-specific - Mitochondria"	"Endoplasmic reticulum"	Nucleoplasm	"HPA014205: AB_2234186"	"unprognostic (4.93e-2)"	"unprognostic (3.35e-2)"	"unprognostic (1.20e-1)"	"unprognostic (7.45e-2)"	"unprognostic (2.92e-1)"	"unprognostic (3.85e-2)"	"unprognostic (1.08e-2)"	"unprognostic (8.73e-2)"	"unprognostic (1.27e-1)"	"unprognostic (3.15e-1)"	"unprognostic (2.72e-2)"	"unprognostic (3.13e-1)"	"unprognostic (4.17e-3)"	"unprognostic (1.63e-1)"	"unprognostic (9.27e-2)"	"unprognostic (2.35e-3)"	"unprognostic (3.43e-2)"	13.5	8.9	6.3	7.7	10.1	30.1	9.8	10.2	8.7	12.0	4.2	12.0	7.6	8.6	6.2	13.1	6.3	7.7	12.2	7.6	13.2	8.2	14.4	6.7	7.2	11.3	9.2	10.7	5.5	15.6	6.0	6.1	14.1	10.1	10.2	24.1	6.4	8.2	34.1	12.1	7.5	9.6	11.3	5.9	7.8	24.5	9.3	14.0	8.8	26.8	7.9	7.6	9.2	19.0	24.5	12.3	28.3	40.1	58.5	36.1	14.3	70.8	33.7	32.2	45.1	17.0	28.2	24.4	39.4	31.5	42.3	26.5	26.9	18.9	44.6	37.5	27.4	27.6	14.8	15.2	13.8	47.2	32.9	29.9	17.5	31.4	15.4	26.4	6.0	19.3	28.9	31.5	44.9	16.0	31.4	18.8	9.2	24.9	23.4	31.3	28.6	18.0	13.6	22.2	32.6	32.9	31.3	17.5	24.1	26.6	26.2	15.4	9.2	159.0	23.6	53.9	33.7	18.5	36.6	20.3	49.4	15.2	30.4	3.7	4.2	7.9	4.9	4.8	5.8	4.3	4.2	5.4	3.9	3.3	4.2	6.7	3.4	6.5	4.5	4.4	7.8	3.4	6.3	10.1	10.2	8.7	7.6	13.2	11.3	9.2	14.1	11.3	9.3	19.0	10.8	19.2	13.6	0.0	4.4	0.0	0.0	0.0	0.0	0.0	19.3	15.0	0.0	0.0	6.2	16.5	0.0	5.7	14.5	0.0	5.9	14.0	0.0	10.1	24.6	3.5	0.0	0.0	0.0	9.6	17.3	12.8	0.0	12.7	11.4	10.6	0.0	0.0	24.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.1	0.0	0.0	2.0	0.0	0.0	0.0	0.0	12.0	0.0	0.0	3.3	0.0	0.0	9.1	8.7	0.0	0.0	0.0	12.6	0.0	0.0	0.0	0.0	8.3	7.2	12.0	0.0	0.0
LNX1	"LNX, MPDZ, PDZRN2"	ENSG00000072201	"Ligand of numb-protein X 1"	Q8TBB1	4	53459301-53701405	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 77.5;Early spermatids: 171.7;Excitatory neurons: 123.8;Glandular and luminal cells: 83.0"	"Low cancer specificity"	"Detected in all"			"Group enriched"	"Detected in many"	9	"amygdala: 2.7;basal ganglia: 6.0;cerebral cortex: 10.3;hippocampal formation: 7.5;white matter: 3.1"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"OE19: 17.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002235, HPA071091"	Approved		Supported	"Cell Junctions,Cytosol"	"Intracellular and membrane"	NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 21: OE19 - Mitochondria"	"Cluster 44: Endometrium - Transcription"	"Cell Junctions"	Cytosol	"HPA002235: AB_1079261, HPA071091: AB_2686344"	"unprognostic (4.95e-2)"	"unprognostic (1.74e-2)"	"unprognostic (2.00e-2)"	"unprognostic (3.16e-2)"	"unprognostic (2.79e-1)"	"unprognostic (2.31e-1)"	"unprognostic (1.31e-1)"	"unprognostic (5.62e-2)"	"unprognostic (8.14e-2)"	"unprognostic (1.06e-1)"	"unprognostic (5.18e-2)"	"unprognostic (8.56e-2)"	"prognostic favorable (3.08e-7)"	"unprognostic (2.67e-1)"	"unprognostic (5.49e-2)"	"unprognostic (6.81e-2)"	"unprognostic (3.05e-2)"	21.9	2.5	2.7	2.1	6.0	1.0	14.3	0.1	10.3	6.1	0.0	6.7	9.4	4.2	0.6	24.4	6.4	5.5	8.7	7.5	0.1	10.6	4.4	2.7	2.1	0.0	0.1	2.1	16.3	11.9	4.3	24.6	0.4	5.9	6.9	3.8	25.1	7.2	5.9	11.8	9.0	3.0	0.0	0.9	9.5	4.4	0.6	3.3	17.9	12.0	4.1	4.3	7.9	3.1	1.4	0.5	1.6	0.9	2.7	5.8	8.0	1.2	0.6	0.0	0.0	2.9	8.9	1.7	1.1	4.3	0.4	1.4	0.0	0.2	0.0	0.4	4.6	2.2	1.5	1.5	1.3	2.4	0.7	4.4	0.2	0.3	0.0	1.9	2.7	0.8	1.9	0.8	6.4	4.5	2.2	1.7	4.3	17.7	0.7	1.2	0.6	0.7	5.6	8.2	2.2	2.1	0.6	10.8	0.9	9.1	5.7	1.1	7.8	10.0	2.6	3.1	1.6	3.6	0.5	1.1	8.7	2.0	1.5	0.3	0.0	0.0	0.1	0.1	0.2	0.2	0.2	0.2	0.1	0.1	0.2	0.2	0.0	0.7	0.4	0.2	0.2	0.0	2.7	6.0	0.1	10.3	7.5	0.1	0.0	0.1	0.4	0.0	0.6	3.1	77.5	0.0	3.9	4.9	1.7	8.2	18.0	14.5	24.5	7.5	13.3	7.1	1.6	12.8	15.5	7.3	6.2	30.6	1.5	18.5	19.6	13.7	171.7	37.7	7.6	16.0	13.8	3.6	123.8	11.7	22.1	4.8	14.3	83.0	2.5	1.5	2.9	6.2	2.5	42.1	42.2	13.4	14.2	0.3	2.1	47.9	4.4	1.3	5.4	11.2	0.4	2.2	2.1	43.7	4.0	12.3	26.5	8.6	0.9	8.5	14.5	2.9	17.9	5.8	0.0	10.0	2.2	0.9	2.6	32.2	11.9	14.9	1.9	1.4	14.2	15.2
LPAR1	"edg-2, EDG2, Gpcr26, GPR26, LPA1, Mrec1.3, rec.1.3, vzg-1"	ENSG00000198121	"Lysophosphatidic acid receptor 1"	Q92633	9	110873263-111038458	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 358.4;choroid plexus: 122.2"	"Cell type enriched"	"Detected in many"	4	"Oligodendrocytes: 626.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"classical monocyte: 9.1;eosinophil: 19.0"	"Group enriched"	"Detected in many"	6	"granulocytes: 19.0;monocytes: 9.1"	"Cell line enhanced"	"Detected in many"		"ASC diff: 582.0;ASC TERT1: 337.0;BJ hTERT+: 426.7;HSkMC: 246.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA050667			Approved	"Nuclear speckles,Plasma membrane"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 70: Brain - Nervous system development"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Nuclear speckles"	"Plasma membrane"	"HPA050667: "	"unprognostic (1.35e-1)"	"unprognostic (1.41e-1)"	"unprognostic (4.79e-2)"	"unprognostic (6.08e-3)"	"unprognostic (1.03e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.17e-2)"	"unprognostic (2.10e-1)"	"unprognostic (1.40e-2)"	"unprognostic (4.13e-2)"	"unprognostic (1.02e-1)"	"unprognostic (4.29e-3)"	"unprognostic (2.12e-2)"	"unprognostic (5.42e-3)"	"unprognostic (2.78e-2)"	"unprognostic (9.97e-3)"	"unprognostic (1.65e-1)"	30.5	13.3	251.0	18.8	315.0	0.2	25.9	208.8	318.6	57.7	122.2	24.5	13.9	17.0	17.1	15.2	15.8	14.1	24.1	199.5	201.3	9.6	2.6	16.3	17.6	299.6	277.5	12.1	6.6	2.2	5.0	38.8	249.2	21.0	18.3	0.8	16.7	23.6	6.6	20.1	18.3	20.5	224.0	14.8	11.8	6.9	266.2	6.8	16.5	17.5	17.2	27.6	31.7	358.4	11.7	22.2	30.4	0.1	582.0	337.0	0.0	151.6	426.7	104.1	46.8	3.0	1.8	0.0	0.1	157.7	18.6	45.5	0.4	118.5	85.0	0.0	4.1	0.0	1.1	0.0	157.1	0.1	0.2	246.6	6.8	51.4	96.9	62.3	1.8	0.2	0.0	0.2	80.8	0.1	0.0	0.1	5.9	0.0	121.6	0.1	22.4	0.0	23.5	20.6	0.9	7.2	3.1	0.0	0.0	6.2	10.4	0.5	0.1	48.9	1.3	35.3	0.1	1.5	0.0	0.0	7.4	0.0	54.9	1.5	9.1	19.0	0.0	3.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	1.9	2.1	1.3	0.2	0.0	2.1	251.0	315.0	208.8	318.6	199.5	201.3	299.6	277.5	249.2	224.0	266.2	358.4	1.9	0.0	1.1	6.2	0.2	13.0	15.5	8.5	4.0	0.0	3.4	6.0	1.4	1.5	9.1	0.0	0.0	0.5	0.3	6.6	1.9	1.8	1.4	3.6	40.4	1.9	0.0	0.0	1.0	2.9	0.4	61.4	6.1	8.7	0.0	0.0	2.5	0.0	3.3	0.0	15.6	3.7	4.1	4.1	15.1	2.7	38.8	3.6	14.2	141.5	12.0	1.0	1.0	1.0	626.8	2.0	2.9	70.7	0.7	12.7	4.5	0.2	3.0	0.2	0.0	13.3	6.3	0.3	2.4	15.2	9.2	0.8	1.2	0.2	4.2	6.7
LPAR3	"Edg-7, EDG7, HOFNH30, LP-A3, LPA3, RP4-678I3"	ENSG00000171517	"Lysophosphatidic acid receptor 3"	Q9UBY5	1	84811602-84893206	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 36.4"	"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 15.6;Cardiomyocytes: 31.2;Endometrial ciliated cells: 36.9;Glandular and luminal cells: 51.6;Respiratory ciliated cells: 18.7"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 24.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HAP1: 19.0;HBEC3-KT: 22.2;hTCEpi: 25.0;NTERA-2: 20.3;PC-3: 19.0;SK-MEL-30: 24.1"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			HPA013421			Supported	"Plasma membrane"		NA	NA				"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 44: Endometrium - Transcription"	"Plasma membrane"		"HPA013421: AB_1847990"	"unprognostic (2.85e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.66e-1)"	"unprognostic (4.42e-1)"	"unprognostic (2.72e-2)"	"unprognostic (6.46e-3)"	"unprognostic (1.15e-1)"	"unprognostic (1.29e-2)"	"unprognostic (1.20e-1)"	"prognostic favorable (4.31e-5)"	"unprognostic (1.11e-2)"	"unprognostic (7.52e-2)"	"unprognostic (1.13e-4)"	"unprognostic (4.11e-2)"	"unprognostic (1.19e-1)"	"unprognostic (4.27e-2)"	"unprognostic (5.43e-2)"	0.0	1.3	2.4	0.2	3.3	0.3	0.9	2.1	5.1	10.4	2.0	0.5	0.1	2.9	5.9	7.0	36.4	0.5	10.5	3.8	1.7	0.0	0.1	1.5	0.2	8.2	2.7	1.5	10.4	0.1	0.1	1.4	2.6	13.4	0.6	0.1	5.7	1.0	0.4	4.3	0.1	0.1	1.9	0.1	0.3	10.4	2.3	2.3	0.2	0.0	1.0	5.1	5.3	3.2	0.7	0.1	0.0	0.1	0.0	0.0	0.7	0.3	1.7	1.4	1.1	0.0	0.0	0.1	0.3	0.0	0.0	0.4	19.0	22.2	1.4	0.2	3.1	0.0	0.0	0.0	0.5	0.0	0.0	0.1	25.0	4.8	1.7	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	20.3	0.0	19.0	0.0	0.0	0.0	0.0	5.8	1.3	1.1	0.0	0.5	24.1	1.4	0.0	2.0	0.1	1.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	2.4	3.3	2.1	5.1	3.8	1.7	8.2	2.7	2.6	1.9	2.3	3.2	0.0	0.0	0.5	12.7	0.0	3.4	15.6	5.6	7.4	0.0	1.8	3.7	31.2	0.0	6.5	0.0	0.0	0.5	0.1	0.3	0.0	0.0	2.9	36.9	3.6	0.5	0.0	0.0	0.2	1.3	0.0	1.2	0.0	51.6	0.0	0.5	0.4	0.0	0.4	0.0	0.1	0.2	2.0	0.0	1.5	2.4	0.6	0.7	1.8	1.9	0.0	0.0	0.0	0.0	0.1	1.0	0.3	0.0	0.0	13.1	0.0	0.0	18.7	0.0	0.0	0.0	1.2	0.7	3.4	7.7	9.1	0.1	1.5	0.6	0.4	13.5
LPAR4	"GPR23, LPA4, P2RY9, P2Y5-LIKE, P2Y9"	ENSG00000147145	"Lysophosphatidic acid receptor 4"	Q99677	X	78747709-78757094	"G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 3.8;ovary: 3.6"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 10.1;Fibroblasts: 4.2;Leydig cells: 20.2;Oligodendrocyte precursor cells: 3.5;Skeletal myocytes: 3.6"	"Cancer enhanced"	"Detected in single"		"glioma: 0.9"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	19	"basophil: 6.3"	"Lineage enriched"	"Detected in single"	19	"granulocytes: 6.3"	"Cell line enhanced"	"Detected in some"		"AF22: 9.3;NTERA-2: 15.2;RH-30: 6.4;U-937: 3.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA046563, HPA054951, HPA055571"	Uncertain		Supported	"Nuclear bodies,Vesicles,Plasma membrane"		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 12: NES - Nervous system development"	"Cluster 50: Fibroblasts - ECM organization"	"Plasma membrane"	"Nuclear bodies, Vesicles"	"HPA046563: AB_2732529, HPA054951: AB_2682646, HPA055571: AB_2682853"	"unprognostic (1.62e-1)"	"unprognostic (3.53e-1)"	"unprognostic (1.58e-1)"	"unprognostic (5.81e-4)"	"unprognostic (3.12e-2)"	"unprognostic (4.85e-3)"	"unprognostic (2.81e-1)"	"unprognostic (2.57e-1)"	"unprognostic (6.75e-2)"	"unprognostic (6.73e-2)"	"unprognostic (8.91e-2)"	"unprognostic (4.86e-4)"	"unprognostic (2.99e-5)"	"unprognostic (9.27e-3)"	"unprognostic (1.00e-1)"	"unprognostic (3.58e-2)"	"unprognostic (6.03e-3)"	0.5	0.0	1.8	0.4	1.3	0.3	0.8	1.1	1.7	0.6	1.1	0.3	0.0	1.1	0.3	0.6	0.3	0.8	0.7	3.0	1.2	0.1	0.1	0.1	0.0	1.8	1.7	3.6	0.4	0.0	0.1	0.0	1.3	0.2	0.4	0.1	0.3	0.1	0.0	0.5	0.3	0.5	2.6	0.1	0.4	0.3	1.1	0.7	0.1	0.3	0.4	0.3	0.2	3.8	0.0	0.0	9.3	0.0	0.0	0.0	0.0	0.0	0.6	1.0	1.2	0.0	0.0	0.0	0.1	0.1	0.6	0.0	0.6	0.0	1.1	0.0	0.0	0.2	0.0	0.0	0.0	1.0	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.8	0.0	0.1	2.1	0.0	0.4	1.7	15.2	0.0	0.2	0.8	6.4	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	3.4	0.0	2.6	0.0	0.0	0.2	0.0	0.6	1.2	0.0	0.7	0.7	3.7	1.5	6.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	1.8	1.3	1.1	1.7	3.0	1.2	1.8	1.7	1.3	2.6	1.1	3.8	1.2	0.0	0.0	10.1	0.0	0.0	0.1	0.0	0.6	0.0	0.1	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	1.1	0.8	0.0	0.0	0.1	0.0	0.0	4.2	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.4	0.5	20.2	0.1	1.8	1.0	0.6	1.0	0.0	3.5	0.1	0.0	0.0	2.6	0.1	0.2	0.0	0.1	0.0	0.0	0.0	3.6	0.4	0.0	0.3	1.5	0.4	0.0	0.4	0.2	0.0	0.2
LPCAT1	"AGPAT10, AGPAT9, AYTL2, FLJ12443"	ENSG00000153395	"Lysophosphatidylcholine acyltransferase 1"	Q8NF37	5	1456480-1523962	"Enzymes, Metabolic proteins, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 57.3;lymphoid tissue: 38.2"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 324.0;Cone photoreceptor cells: 146.0;Rod photoreceptor cells: 148.2"	"Cancer enhanced"	"Detected in all"		"lung cancer: 79.2"	"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"BEWO: 89.1;EFO-21: 82.4;PC-3: 60.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012501, HPA022268"	Enhanced		Supported	"Endoplasmic reticulum,Lipid droplets"		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 64: Macrophages - Immune response"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 11: Alveolar cells - Smell perception"	"Endoplasmic reticulum"	"Lipid droplets"	"HPA012501: AB_1845224, HPA022268: AB_1845225"	"unprognostic (5.33e-3)"	"prognostic unfavorable (7.11e-5)"	"unprognostic (3.11e-1)"	"prognostic unfavorable (3.67e-4)"	"unprognostic (3.13e-2)"	"unprognostic (1.26e-2)"	"prognostic unfavorable (1.88e-8)"	"unprognostic (5.90e-2)"	"unprognostic (6.37e-2)"	"unprognostic (2.08e-2)"	"prognostic favorable (4.90e-5)"	"unprognostic (4.89e-2)"	"prognostic unfavorable (2.64e-7)"	"unprognostic (2.60e-1)"	"unprognostic (3.13e-1)"	"unprognostic (1.52e-1)"	"unprognostic (4.03e-1)"	11.1	9.4	3.4	2.4	3.5	1.4	8.4	0.6	13.3	10.6	3.2	8.8	0.8	12.4	0.1	4.6	10.8	0.8	7.7	6.0	8.3	6.1	3.9	57.3	1.6	3.3	5.0	8.6	5.1	0.6	10.0	1.4	6.3	6.8	0.1	2.1	8.3	0.8	2.5	5.0	11.2	0.4	2.3	38.2	6.9	2.8	5.1	0.5	7.3	0.0	0.3	11.5	7.0	1.0	5.5	8.1	1.5	8.6	1.0	1.3	89.1	19.2	1.1	1.0	0.9	3.1	2.6	17.7	82.4	0.5	3.8	15.7	1.7	0.5	0.5	41.5	36.1	4.4	12.7	5.8	1.7	4.7	11.8	1.5	0.4	1.0	0.2	1.3	1.1	6.2	9.8	3.5	0.0	11.8	17.3	7.3	31.2	0.5	60.7	32.2	1.5	13.7	3.6	7.5	11.5	11.1	16.5	14.8	5.1	0.9	6.9	7.4	9.8	1.6	19.0	6.1	7.3	10.9	11.0	4.4	3.7	7.7	5.5	0.0	0.2	0.2	1.1	0.5	1.1	0.2	0.2	0.5	0.1	0.1	0.0	0.3	0.8	0.5	0.4	0.0	0.2	0.2	3.4	3.5	0.6	13.3	6.0	8.3	3.3	5.0	6.3	2.3	5.1	1.0	12.6	86.6	324.0	18.9	41.9	6.2	2.5	5.3	6.8	65.8	8.9	6.3	4.0	5.7	14.4	14.7	146.0	9.0	97.4	6.7	0.0	22.4	1.7	4.8	13.7	13.5	14.9	3.6	13.9	13.6	81.9	13.1	7.1	5.2	8.2	44.7	16.4	5.2	27.0	23.5	16.7	9.6	2.0	29.2	20.5	2.8	10.8	42.6	7.2	22.5	15.7	30.3	96.8	14.1	1.7	20.3	0.3	15.4	39.9	6.2	2.0	4.6	5.7	148.2	0.0	6.3	11.5	3.4	12.2	1.5	4.0	31.7	30.7	22.5	5.3	1.7
LPCAT2	"AGPAT11, AYTL1, FLJ20481, LysoPAFAT"	ENSG00000087253	"Lysophosphatidylcholine acyltransferase 2"	Q7L5N7	16	55509072-55586666	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 88.3;thyroid gland: 86.3"	"Cell type enhanced"	"Detected in many"		"granulocytes: 173.3;Microglial cells: 224.9"	"Cancer enhanced"	"Detected in all"		"thyroid cancer: 23.1"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 151.4;eosinophil: 199.2"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 199.2"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 115.9;HaCaT: 89.2;HL-60: 103.0;HMC-1: 161.7;hTERT-RPE1: 162.9;WM-115: 117.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007891, HPA008433"	Enhanced	Supported	Supported	"Endoplasmic reticulum,Lipid droplets"		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 60: Granulocytes - Receptor signaling"	"Endoplasmic reticulum"	"Lipid droplets"	"HPA007891: AB_1845223, HPA008433: "	"unprognostic (1.43e-1)"	"unprognostic (2.44e-2)"	"prognostic favorable (3.43e-4)"	"prognostic favorable (8.03e-6)"	"unprognostic (2.91e-1)"	"unprognostic (9.65e-3)"	"unprognostic (8.12e-3)"	"unprognostic (3.26e-3)"	"unprognostic (1.67e-1)"	"unprognostic (7.97e-2)"	"unprognostic (3.18e-3)"	"unprognostic (9.16e-2)"	"unprognostic (1.93e-1)"	"unprognostic (2.33e-1)"	"unprognostic (4.15e-2)"	"unprognostic (1.96e-1)"	"unprognostic (3.53e-2)"	9.8	9.0	5.6	14.4	7.7	88.3	12.2	10.6	5.2	14.0	10.7	9.0	7.4	18.5	36.7	7.8	8.8	10.5	5.7	4.8	8.5	10.9	3.9	10.4	5.0	13.7	8.5	15.8	5.4	13.6	1.0	16.0	15.9	7.0	9.3	7.7	8.4	28.6	2.2	12.0	9.1	15.0	12.7	11.8	9.0	4.1	7.9	3.5	86.3	5.8	4.0	9.5	7.5	22.4	33.5	4.2	3.5	0.3	10.8	4.1	5.6	14.1	13.5	6.8	6.9	7.5	115.9	0.0	46.6	19.9	5.5	89.2	2.2	19.4	10.9	9.1	9.6	34.2	10.2	17.3	4.1	103.0	161.7	2.1	19.2	7.5	6.3	162.9	53.5	1.8	1.5	0.4	11.6	2.1	0.0	41.8	5.1	9.5	0.4	10.4	3.8	5.1	6.8	12.9	2.2	25.3	27.1	10.8	19.9	15.8	4.6	25.8	60.3	0.3	0.1	6.9	9.6	0.6	0.2	0.2	0.5	49.4	117.8	151.4	17.5	199.2	0.0	27.4	0.0	0.0	0.0	0.0	21.0	0.1	0.0	0.0	47.0	0.0	39.1	0.7	0.0	6.5	5.6	7.7	10.6	5.2	4.8	8.5	13.7	8.5	15.9	12.7	7.9	22.4	68.6	6.4	25.7	2.9	1.1	15.4	37.2	68.3	17.1	5.5	8.8	33.9	2.2	4.3	22.3	68.0	10.4	0.7	3.3	7.0	1.9	8.3	1.7	6.4	4.8	41.0	1.2	9.7	8.1	9.7	7.5	20.7	10.2	13.9	173.3	0.4	12.1	2.0	36.5	0.0	11.7	12.2	18.3	71.9	57.7	3.1	16.4	74.4	17.8	224.9	40.6	24.0	0.0	4.5	66.5	32.8	23.0	12.8	1.0	9.0	3.4	3.5	8.1	5.3	0.0	20.0	4.2	49.6	24.0	14.2	15.3	1.9	5.6	7.0	11.6	17.6
LPIN3	"LIPN3L, SMP2"	ENSG00000132793	"Lipin 3"	Q9BQK8	20	41340821-41360582	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Late spermatids: 214.9;Proximal enterocytes: 76.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"NK-cell: 2.3"	"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in some"			"HPA051466, HPA052667, HPA070640"	Approved		Supported	Cytosol		NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 31: Spermatids - Spermatogenesis"	Cytosol		"HPA051466: , HPA052667: AB_2681908, HPA070640: AB_2686288"	"unprognostic (2.31e-1)"	"unprognostic (4.73e-2)"	"unprognostic (1.68e-1)"	"prognostic unfavorable (9.74e-4)"	"unprognostic (1.88e-1)"	"unprognostic (1.04e-1)"	"unprognostic (6.91e-3)"	"unprognostic (4.26e-2)"	"unprognostic (1.74e-1)"	"prognostic unfavorable (1.74e-4)"	"unprognostic (4.29e-2)"	"unprognostic (7.79e-2)"	"prognostic unfavorable (1.14e-5)"	"unprognostic (5.60e-3)"	"unprognostic (2.02e-1)"	"unprognostic (1.35e-1)"	"unprognostic (3.37e-3)"	19.1	7.3	5.6	3.7	5.4	0.3	18.0	4.6	6.8	19.4	8.4	24.0	41.6	14.1	13.1	32.2	17.7	5.8	17.9	5.6	5.2	31.5	30.0	9.1	2.1	6.1	5.2	14.5	15.1	10.3	12.6	3.6	5.4	19.7	13.2	1.3	16.9	9.6	3.3	40.6	32.4	5.9	5.3	5.7	12.3	3.3	6.2	2.0	26.9	2.5	3.2	13.3	26.2	6.1	12.4	12.0	0.7	7.1	18.6	28.8	9.1	7.5	10.3	9.0	12.1	22.3	10.7	0.6	9.1	16.7	9.5	30.6	3.6	19.6	5.6	0.3	6.9	0.6	19.8	11.5	3.0	0.0	8.1	20.8	24.3	15.3	5.9	10.4	2.3	0.3	3.2	0.4	11.3	26.5	0.1	0.3	1.0	7.6	12.1	0.1	0.2	0.9	30.9	15.5	0.9	0.2	10.0	12.6	6.4	5.6	14.8	6.2	0.7	0.6	2.9	10.1	0.1	5.8	3.3	0.1	0.2	0.1	0.6	0.8	0.1	0.2	0.1	0.1	0.2	0.2	0.2	0.1	0.1	0.3	0.2	0.2	0.6	2.3	0.3	0.2	0.1	0.1	5.6	5.4	4.6	6.8	5.6	5.2	6.1	5.2	5.4	5.3	6.2	6.1	7.2	6.4	12.3	12.1	0.8	14.4	8.2	10.0	3.4	0.0	12.7	11.3	0.8	10.0	6.0	11.0	0.0	2.8	0.2	44.4	5.9	8.7	21.6	10.0	12.5	3.2	14.9	2.7	1.0	3.8	3.5	9.4	19.9	33.1	1.3	16.2	5.0	44.1	3.3	0.0	0.3	21.9	4.1	2.2	6.0	214.9	3.1	1.0	10.6	8.4	0.0	5.2	0.0	1.0	0.2	6.4	28.4	2.6	0.1	3.8	76.9	11.8	4.2	0.5	32.9	8.8	8.2	1.0	2.7	4.7	12.6	2.6	1.0	5.2	23.2	4.8
LPL	LIPD	ENSG00000175445	"Lipoprotein lipase"	P06858	8	19901717-19967259	"Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Lipid degradation, Lipid metabolism"	"Heparin-binding, Hydrolase"	"Disease variant, FDA approved drug targets, Hyperlipidemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 937.4;heart muscle: 407.8"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 453.0;Cardiomyocytes: 489.0;Granulosa cells: 495.2;Horizontal cells: 206.9;Sertoli cells: 236.7"	"Cancer enhanced"	"Detected in all"		"glioma: 39.2"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"non-classical monocyte: 4.2"	"Lineage enriched"	"Detected in single"	6	"monocytes: 4.2"	"Cell line enriched"	"Detected in some"	5	"AF22: 391.6"	"Region enhanced"	"Detected in many"		"basal ganglia: 45.3"	"Group enriched"	"Detected in all"	5	"basal ganglia: 79.2;spinal cord: 59.3"	HPA048749			Supported	Vesicles	"Secreted to blood"	NA	NA		4200000	"Cluster 7: Monocytes - Unknown function"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 12: NES - Nervous system development"	"Cluster 40: Granulosa cells - Unknown function"	Vesicles		"HPA048749: AB_2680511"	"unprognostic (5.52e-2)"	"unprognostic (3.16e-1)"	"unprognostic (6.41e-2)"	"unprognostic (3.03e-1)"	"unprognostic (4.14e-2)"	"unprognostic (1.01e-2)"	"unprognostic (1.88e-4)"	"unprognostic (1.05e-1)"	"unprognostic (6.78e-2)"	"unprognostic (8.20e-2)"	"unprognostic (2.54e-2)"	"unprognostic (5.28e-1)"	"unprognostic (1.18e-1)"	"unprognostic (4.20e-3)"	"unprognostic (4.16e-3)"	"unprognostic (1.19e-1)"	"prognostic unfavorable (6.07e-4)"	937.4	15.9	6.8	9.1	53.2	0.9	255.4	20.3	12.2	2.7	8.9	12.0	1.5	3.7	0.5	2.8	2.7	8.6	407.8	10.7	9.5	19.1	0.7	62.1	8.5	7.4	7.7	10.6	6.3	181.5	4.1	14.7	7.9	3.8	5.8	11.1	24.4	64.7	86.4	8.3	13.3	4.1	5.5	1.6	8.4	1.0	11.5	4.3	10.6	127.3	2.8	6.1	4.7	8.8	0.0	0.0	391.6	0.1	8.1	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.4	0.0	0.7	0.0	0.8	0.0	0.0	0.1	0.3	0.0	71.5	0.0	0.2	8.6	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.1	0.0	0.0	0.1	0.7	9.6	0.0	0.0	0.0	0.0	68.4	0.0	0.0	8.4	0.2	0.0	0.0	0.1	13.5	0.0	1.8	0.0	0.0	8.1	0.0	3.5	0.0	0.1	0.1	0.1	0.1	32.6	0.0	0.9	0.7	0.0	1.7	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	4.2	0.0	0.0	0.2	6.8	53.2	20.3	12.2	10.7	9.5	7.4	7.7	7.9	5.5	11.5	8.8	453.0	12.8	104.9	1.0	0.4	1.5	0.1	0.0	0.6	2.8	114.7	5.7	489.0	0.0	0.6	0.0	2.1	0.4	0.9	0.1	15.6	0.0	0.8	0.2	2.5	56.1	0.0	0.0	1.9	0.0	0.7	13.6	0.0	0.3	6.3	495.2	2.9	0.0	108.5	206.9	0.4	1.0	0.0	14.8	4.2	1.3	1.2	38.2	14.2	1.9	2.0	2.3	0.0	9.0	0.1	0.0	0.0	0.0	0.0	0.3	0.3	0.4	2.9	2.7	236.7	91.4	68.1	0.4	0.2	0.2	0.6	0.4	2.3	4.3	2.8	0.1
LPP		ENSG00000145012	"LIM domain containing preferred translocation partner in lipoma"	Q93052	3	188153284-188890671	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell adhesion"	Activator	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 566.5;Late spermatids: 1737.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 18.9"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 97.0;EFO-21: 115.2;U-698: 200.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA011133, HPA017342"	Enhanced		Supported	"Focal adhesion sites,Cytosol"		NA	NA		2700000	"Cluster 1: Neutrophils - Mixed function"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 31: Spermatids - Spermatogenesis"	"Focal adhesion sites, Cytosol"		"HPA011133: AB_1853247, HPA017342: AB_1853249"	"unprognostic (1.50e-1)"	"unprognostic (4.97e-3)"	"unprognostic (1.41e-1)"	"unprognostic (2.18e-1)"	"unprognostic (1.86e-1)"	"unprognostic (4.05e-1)"	"unprognostic (2.43e-3)"	"unprognostic (7.97e-2)"	"unprognostic (2.17e-1)"	"unprognostic (5.56e-2)"	"unprognostic (3.44e-3)"	"unprognostic (2.10e-1)"	"unprognostic (2.57e-3)"	"unprognostic (2.25e-2)"	"unprognostic (6.86e-2)"	"unprognostic (2.82e-3)"	"unprognostic (1.48e-1)"	29.3	10.8	6.7	28.4	8.9	9.9	18.8	9.1	9.7	27.5	27.3	73.3	13.8	61.9	11.8	49.4	32.2	21.3	16.7	6.1	11.2	11.5	12.1	19.1	17.2	15.6	7.9	14.7	8.8	9.9	2.9	11.5	12.6	39.0	31.7	2.4	12.0	53.1	12.4	12.0	23.0	81.3	6.6	10.8	32.7	18.6	13.8	8.0	8.8	9.1	21.4	57.0	22.1	7.8	25.6	23.3	16.7	11.3	35.3	36.0	17.9	16.0	20.9	11.8	7.8	42.2	12.1	97.0	115.2	37.3	14.7	10.7	5.2	11.0	29.5	10.7	5.7	4.6	18.4	11.1	15.0	2.0	5.5	25.7	15.3	26.4	22.5	16.9	20.1	5.2	0.2	2.0	21.0	8.1	5.1	2.1	6.6	16.3	7.6	6.2	12.3	0.5	13.1	26.8	1.1	0.3	35.3	11.4	19.2	27.3	9.0	8.8	43.7	27.1	20.8	19.6	41.1	0.2	4.0	200.0	13.6	4.3	24.9	0.8	4.9	2.2	5.1	4.5	3.3	3.3	4.5	3.8	2.6	5.6	2.4	2.9	18.9	4.8	4.6	5.3	1.8	1.9	6.7	8.9	9.1	9.7	6.1	11.2	15.6	7.9	12.6	6.6	13.8	7.8	104.7	89.8	69.8	357.5	48.5	78.0	84.9	65.0	70.0	9.5	141.8	111.5	143.0	100.1	86.2	69.9	14.6	44.7	65.7	207.1	29.4	139.7	566.5	49.3	134.4	91.8	77.5	12.0	132.8	90.9	24.1	124.9	97.9	93.6	18.3	136.6	126.4	94.8	42.5	5.0	191.2	91.7	44.7	65.1	121.0	1737.1	225.3	75.8	80.0	308.2	55.8	24.8	54.6	395.6	214.9	120.2	158.1	476.9	24.6	172.5	127.5	80.2	60.9	7.1	335.2	159.2	368.2	9.8	8.0	64.2	68.2	18.6	55.3	46.8	151.3	149.3
LPXN	LDPL	ENSG00000110031	Leupaxin	O60711	11	58526871-58578220	"Predicted intracellular proteins"	"Cell adhesion, Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 118.5"	"Cell type enhanced"	"Detected in many"		"B-cells: 75.9;dendritic cells: 80.7;Langerhans cells: 154.6;Macrophages: 81.7;Plasma cells: 82.2;T-cells: 90.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 200.7;HMC-1: 329.3;Karpas-707: 285.0;U-2197: 199.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043741, CAB046478, HPA061441"	Enhanced		Supported	"Nuclear speckles,Focal adhesion sites,Cytosol"		No	No			"Cluster 13: T-cells - Unknown function"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 58: T-cells - T-cell receptor"	"Focal adhesion sites"	"Nuclear speckles, Cytosol"	"CAB046478: AB_10603113, HPA043741: AB_2678647, HPA061441: AB_2684518"	"unprognostic (1.61e-3)"	"unprognostic (6.91e-2)"	"unprognostic (6.54e-2)"	"prognostic favorable (8.81e-4)"	"unprognostic (5.16e-2)"	"unprognostic (2.07e-3)"	"unprognostic (2.16e-2)"	"unprognostic (8.87e-3)"	"unprognostic (5.18e-2)"	"unprognostic (3.96e-2)"	"unprognostic (2.39e-2)"	"unprognostic (3.05e-1)"	"unprognostic (3.60e-3)"	"unprognostic (1.91e-1)"	"unprognostic (5.25e-2)"	"unprognostic (2.55e-1)"	"unprognostic (2.41e-3)"	10.4	8.3	7.5	48.3	8.2	10.2	10.2	7.8	11.8	7.9	4.5	14.5	10.9	7.4	11.9	5.2	7.6	15.1	5.3	7.1	7.8	10.6	14.0	33.5	87.1	9.1	8.8	9.5	8.6	6.5	7.2	5.2	10.2	9.4	19.6	7.0	11.0	7.1	3.8	5.9	26.2	9.7	8.6	44.1	13.0	10.2	10.0	103.3	10.2	5.1	118.5	32.4	6.0	10.9	1.7	2.1	2.0	3.9	7.4	9.3	1.4	50.5	200.7	12.4	22.0	0.4	5.1	149.8	2.0	61.9	9.2	2.0	1.7	137.7	51.4	65.4	0.9	6.8	1.3	1.0	12.8	41.1	329.3	7.2	3.2	170.8	22.0	12.0	80.9	90.0	1.9	285.0	101.5	1.1	144.8	51.6	1.6	2.3	45.8	2.1	2.5	129.2	8.3	71.2	1.0	1.6	2.2	3.2	20.1	2.8	2.7	11.7	79.8	30.8	9.5	199.5	45.9	18.4	18.9	146.5	71.6	36.8	71.6	6.3	74.3	12.2	101.3	41.8	148.9	71.9	102.9	117.6	137.5	46.2	79.6	95.9	14.1	79.2	22.2	124.4	152.1	98.8	7.5	8.2	7.8	11.8	7.1	7.8	9.1	8.8	10.2	8.6	10.0	10.9	4.1	0.0	6.7	22.9	75.9	9.7	6.6	7.2	3.4	4.1	4.0	4.7	2.3	4.3	2.8	0.0	4.2	2.8	80.7	4.2	3.9	2.5	23.0	2.8	1.9	5.9	6.1	13.3	18.2	5.6	1.3	6.6	13.3	2.3	51.5	5.4	2.5	7.6	44.0	1.7	19.8	3.1	6.1	63.7	154.6	8.7	1.8	81.7	19.6	30.0	52.9	2.8	49.4	11.6	27.3	4.1	5.2	3.8	82.2	3.6	6.9	5.7	4.3	4.4	6.6	3.6	3.8	9.2	4.2	2.6	9.7	2.5	90.3	2.9	5.2	27.6
LRFN2	"FIGLER2, KIAA1246, SALM1"	ENSG00000156564	"Leucine rich repeat and fibronectin type III domain containing 2"	Q9ULH4	6	40391591-40587364	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 6.4;retina: 3.2"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 24.2;Cone photoreceptor cells: 62.6;Excitatory neurons: 111.5;Inhibitory neurons: 62.8;Oligodendrocyte precursor cells: 49.8"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"basal ganglia: 6.4;cerebral cortex: 5.9"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"REH: 1.7;SH-SY5Y: 4.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA076660	Enhanced		Supported	"Plasma membrane"		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 58: Brain - Synaptic function"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Plasma membrane"		"HPA076660: AB_2686812"	"unprognostic (1.93e-2)"	"unprognostic (2.04e-1)"	"unprognostic (3.61e-2)"	"unprognostic (4.58e-4)"	"unprognostic (3.10e-1)"	"unprognostic (1.21e-1)"	"unprognostic (2.69e-1)"	"unprognostic (5.75e-3)"	"unprognostic (4.94e-2)"	"unprognostic (1.80e-1)"	"unprognostic (9.05e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.64e-1)"	"unprognostic (2.98e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.66e-4)"	0.0	0.3	1.6	0.0	6.4	0.3	0.0	0.0	5.9	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.7	0.2	0.0	0.0	0.0	0.0	3.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	1.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.0	1.7	0.0	0.0	0.0	0.1	0.7	4.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.6	6.4	0.0	5.9	1.3	0.0	0.0	0.0	0.0	0.0	0.4	1.3	0.0	0.0	0.0	24.2	0.0	0.0	0.0	0.0	0.0	10.8	0.1	0.3	0.6	0.0	0.1	0.0	62.6	0.4	0.3	0.1	0.0	0.0	1.5	0.0	0.0	0.1	4.2	0.0	111.5	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	62.8	1.0	0.0	0.0	0.0	1.5	0.3	0.0	0.0	3.7	0.0	0.8	0.0	49.8	2.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	9.6	0.0	0.0	0.0	1.9	0.0	1.0	0.0	0.3	0.2	0.0	0.1	0.1
LRIF1	"C1orf103, FLJ11269, RIF1"	ENSG00000121931	"Ligand dependent nuclear receptor interacting factor 1"	Q5T3J3	1	110947190-110963965	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044515	Uncertain		Supported	"Nucleoplasm,Centriolar satellite"		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 21: Non-specific - Transcription"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 57: B-cells - Immune response"	Nucleoplasm	"Centriolar satellite"	"HPA044515: AB_10796800"	"unprognostic (5.06e-2)"	"unprognostic (4.82e-2)"	"unprognostic (4.74e-1)"	"unprognostic (3.66e-2)"	"unprognostic (2.20e-2)"	"unprognostic (2.72e-1)"	"unprognostic (1.27e-3)"	"unprognostic (1.85e-1)"	"unprognostic (1.64e-1)"	"prognostic favorable (1.73e-4)"	"unprognostic (5.14e-2)"	"unprognostic (9.23e-3)"	"unprognostic (3.94e-2)"	"unprognostic (2.82e-1)"	"unprognostic (2.48e-1)"	"unprognostic (3.88e-2)"	"unprognostic (2.70e-1)"	6.6	9.4	8.7	10.3	9.1	5.5	11.4	10.7	18.5	6.2	8.5	6.5	6.0	6.8	19.8	5.6	8.1	5.0	14.5	9.2	10.3	7.9	13.2	6.8	16.0	8.4	8.7	15.5	6.1	6.5	7.7	10.0	8.7	8.2	6.4	21.5	7.2	5.4	18.2	9.3	6.0	4.7	8.7	13.0	7.1	25.7	9.5	13.3	10.9	17.3	17.4	7.6	4.5	10.0	33.2	14.4	26.8	18.4	12.3	19.8	30.2	19.9	22.7	33.8	27.2	36.4	40.4	25.2	27.5	15.1	36.5	21.0	12.9	12.0	40.6	45.9	15.2	27.9	14.3	37.4	35.8	52.7	32.5	12.5	32.3	23.5	41.0	14.4	18.6	26.4	88.3	111.5	23.2	11.1	5.4	41.4	40.0	20.1	32.6	35.0	43.4	30.5	8.8	17.0	22.3	24.4	0.1	33.8	59.1	16.3	28.0	83.6	13.5	30.0	1.0	35.4	16.3	51.7	19.4	46.9	17.1	59.2	53.6	24.8	8.3	18.6	21.0	9.4	26.6	29.9	16.6	22.1	16.8	22.7	18.1	24.8	31.4	28.2	13.0	15.0	16.9	12.8	8.7	9.1	10.7	18.5	9.2	10.3	8.4	8.7	8.7	8.7	9.5	10.0	22.5	12.8	8.4	11.8	39.4	14.4	48.4	21.0	19.9	22.4	27.9	35.1	27.8	8.6	17.0	9.2	18.8	19.5	21.9	15.5	15.6	18.8	15.3	15.9	15.2	21.5	11.3	24.8	17.9	19.9	32.3	16.5	23.0	18.5	8.2	11.2	17.5	31.8	13.9	15.2	16.5	13.2	18.3	10.7	53.1	11.4	15.8	23.2	32.0	3.7	20.1	28.6	49.4	4.0	16.1	23.4	12.9	13.9	28.4	56.8	10.0	11.8	22.3	35.1	13.1	20.0	19.0	49.9	54.8	25.1	17.6	37.8	31.5	21.4	11.3	50.9
LRMDA	"C10orf11, CDA017, OCA7"	ENSG00000148655	"Leucine rich melanocyte differentiation associated"	Q9H2I8	10	75431624-76560168	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	Differentiation		Albinism	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 61.5;epididymis: 59.5"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 42.4;Distal tubular cells: 33.2;Endometrial ciliated cells: 27.8;Hofbauer cells: 56.9;Proximal tubular cells: 113.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"classical monocyte: 57.6;eosinophil: 22.1;intermediate monocyte: 28.8;myeloid DC: 67.5;non-classical monocyte: 17.1"	"Group enriched"	"Detected in many"	7	"dendritic cells: 67.5;granulocytes: 22.1;monocytes: 57.6"	"Cell line enhanced"	"Detected in many"		"Hep G2: 46.3;HMC-1: 34.0;NB-4: 65.6;SK-MEL-30: 93.0;THP-1: 48.7;U-937: 43.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA047446, HPA050419"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm	Cytosol	"HPA047446: AB_2680050, HPA050419: AB_2756316"	"unprognostic (1.04e-1)"	"unprognostic (8.03e-2)"	"unprognostic (2.40e-1)"	"unprognostic (7.97e-2)"	"unprognostic (2.03e-1)"	"unprognostic (1.58e-2)"	"unprognostic (1.31e-1)"	"unprognostic (8.57e-3)"	"unprognostic (5.86e-2)"	"unprognostic (6.80e-2)"	"unprognostic (8.34e-2)"	"unprognostic (1.26e-1)"	"unprognostic (7.34e-3)"	"unprognostic (7.26e-2)"	"unprognostic (6.50e-2)"	"unprognostic (4.98e-3)"	"unprognostic (3.64e-2)"	16.1	61.5	8.0	5.4	8.6	27.5	10.3	7.7	7.7	12.0	4.7	8.1	5.8	6.4	59.5	7.5	9.7	10.2	13.3	7.8	8.4	20.6	35.8	12.8	5.2	11.5	9.6	13.0	24.9	20.6	10.1	12.7	11.8	10.7	7.2	2.4	9.2	10.0	2.7	3.1	4.5	9.0	10.2	10.5	16.8	3.7	10.9	4.1	18.6	4.8	5.1	11.4	4.5	11.5	0.3	5.7	0.2	0.1	2.9	3.5	0.1	0.7	0.0	0.3	0.5	7.6	13.4	0.0	25.8	0.0	0.1	0.3	0.0	0.0	0.1	0.5	1.6	1.6	2.9	46.3	1.1	9.4	34.0	1.4	1.0	0.6	0.1	5.5	0.8	0.1	0.0	1.4	0.1	1.0	0.1	65.6	0.3	3.9	2.2	0.1	0.2	0.1	0.6	8.3	0.3	0.4	8.1	0.0	93.0	0.2	0.5	48.7	0.9	0.3	3.1	2.4	5.3	0.4	0.2	0.2	22.6	43.6	11.3	6.4	57.6	22.1	0.1	28.8	0.3	0.1	0.0	0.0	67.5	0.1	0.1	0.1	3.2	7.1	17.1	0.5	0.2	18.9	8.0	8.6	7.7	7.7	7.8	8.4	11.5	9.6	11.8	10.2	10.9	11.5	42.4	22.4	19.8	0.0	0.3	0.0	0.0	0.0	0.0	0.0	4.1	5.7	0.0	0.0	3.7	12.9	0.0	1.1	0.8	0.0	33.2	16.6	0.0	27.8	2.5	13.2	0.0	0.0	0.0	15.8	0.8	4.5	0.0	10.0	7.6	16.1	0.0	0.0	56.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.3	0.0	0.0	6.7	0.0	0.0	0.0	0.0	13.9	0.0	0.0	0.1	0.0	0.0	113.4	6.6	0.0	0.0	0.0	5.9	0.0	0.0	0.0	0.0	1.2	0.6	25.7	0.0	0.0
LRP1	"A2MR, APOER, APR, CD91, IGFBP-3R, IGFBP3R1, LRP, LRP1A"	ENSG00000123384	"LDL receptor related protein 1"	Q07954	12	57128483-57213361	"Candidate cardiovascular disease genes, CD markers, Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Endocytosis	"Developmental protein, Receptor"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adipose tissue: 109.2"	"Cell type enhanced"	"Detected in many"		"Fibroblasts: 273.4;Hepatocytes: 188.4;Leydig cells: 233.3;Peritubular cells: 184.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	18	"classical monocyte: 4.3;intermediate monocyte: 2.2;myeloid DC: 1.6;non-classical monocyte: 2.4"	"Group enriched"	"Detected in many"	21	"dendritic cells: 1.6;monocytes: 4.3"	"Cell line enhanced"	"Detected in many"		"ASC diff: 484.8;ASC TERT1: 488.4;fHDF/TERT166: 222.2;HSkMC: 318.5;hTERT-RPE1: 248.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004182, CAB018621, HPA022903"	Supported		Approved	Nucleoplasm,Vesicles	"Intracellular and membrane"	NA	NA		180000000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	Vesicles	Nucleoplasm	"CAB018621: AB_627893, HPA004182: AB_2667163, HPA022903: AB_10602426"	"unprognostic (1.65e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.71e-1)"	"unprognostic (5.00e-2)"	"unprognostic (4.33e-2)"	"unprognostic (3.98e-1)"	"unprognostic (8.68e-2)"	"unprognostic (1.70e-1)"	"unprognostic (3.37e-3)"	"unprognostic (1.48e-1)"	"unprognostic (1.25e-1)"	"prognostic unfavorable (1.52e-5)"	"unprognostic (2.81e-3)"	"unprognostic (6.13e-2)"	"unprognostic (2.80e-2)"	"prognostic unfavorable (1.29e-5)"	109.2	14.1	21.3	29.0	36.3	8.2	40.0	30.2	19.7	32.3	8.0	24.1	23.2	36.9	6.2	19.3	30.3	31.5	35.5	16.7	21.9	5.7	35.0	34.0	4.9	46.0	31.5	71.0	10.7	7.8	10.2	39.8	27.9	13.8	11.2	9.9	20.3	20.2	13.0	20.4	18.4	28.9	27.1	13.6	15.1	7.3	48.9	5.6	17.6	23.5	2.7	25.5	29.3	27.6	7.7	14.5	30.4	24.2	484.8	488.4	91.2	85.3	109.0	27.5	26.7	26.9	12.4	0.4	10.4	222.2	6.0	33.6	5.3	8.7	9.7	0.7	1.3	0.4	17.9	56.4	66.5	0.5	14.6	318.5	3.1	61.8	7.2	248.7	1.7	1.1	0.4	1.3	87.2	1.7	0.2	0.4	34.8	11.0	8.8	3.2	171.0	1.6	1.9	2.2	1.4	16.4	19.0	0.6	13.2	42.0	2.9	1.2	1.2	96.0	35.0	53.9	5.2	1.1	0.1	0.2	167.4	0.1	18.7	0.0	4.3	0.0	0.0	2.2	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.1	0.0	0.0	2.4	0.0	0.0	1.6	21.3	36.3	30.2	19.7	16.7	21.9	46.0	31.5	27.9	27.1	48.9	27.6	24.6	12.8	8.4	113.6	3.2	24.0	11.9	28.7	19.9	29.2	4.9	19.3	14.8	15.7	14.7	1.8	0.0	87.5	1.1	81.7	0.0	7.4	1.9	9.7	111.4	13.0	4.2	0.8	39.3	1.8	53.0	273.4	49.5	4.2	6.3	36.9	11.0	188.4	73.8	8.4	41.6	14.1	6.1	145.3	28.6	8.4	233.3	102.9	28.4	89.9	48.8	154.7	1.0	173.4	6.6	14.7	27.2	184.3	4.4	5.5	86.0	2.1	15.1	7.3	39.5	129.7	77.0	1.6	2.4	35.4	16.1	125.9	4.2	11.4	25.0	12.3
LRPAP1	"A2MRAP, HBP44, RAP"	ENSG00000163956	"LDL receptor related protein associated protein 1"	P30533	4	3503612-3532446	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		Heparin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cytotrophoblasts: 584.3;Syncytiotrophoblasts: 693.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008001, CAB025518"	Enhanced	Supported	Supported	"Endoplasmic reticulum"		NA	NA		810000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 35: Non-specific - Unknown function"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Endoplasmic reticulum"		"CAB025518: , HPA008001: AB_1853292"	"unprognostic (3.20e-3)"	"unprognostic (7.01e-2)"	"unprognostic (2.30e-1)"	"unprognostic (2.22e-2)"	"unprognostic (1.37e-2)"	"unprognostic (9.61e-2)"	"unprognostic (1.01e-2)"	"unprognostic (3.89e-3)"	"unprognostic (8.58e-2)"	"unprognostic (6.12e-2)"	"unprognostic (2.14e-3)"	"unprognostic (2.19e-1)"	"prognostic favorable (4.67e-11)"	"unprognostic (6.25e-2)"	"unprognostic (1.56e-1)"	"unprognostic (2.58e-1)"	"unprognostic (5.61e-2)"	6.6	9.0	6.6	2.6	10.3	6.0	6.4	8.6	7.6	8.9	10.7	7.6	3.3	8.6	3.2	5.8	7.5	1.9	19.3	5.8	8.1	12.7	9.6	8.5	2.1	8.0	6.9	9.5	14.4	7.7	14.4	6.3	7.9	8.2	1.7	2.8	10.1	4.1	8.9	6.3	6.7	1.9	5.2	8.6	9.2	9.2	7.5	1.6	8.9	2.4	1.4	7.3	6.3	6.3	3.7	7.4	5.7	8.2	5.5	2.9	12.5	5.9	4.8	4.3	3.1	14.9	7.0	2.1	6.0	4.2	7.0	6.2	3.4	5.8	2.4	1.6	7.9	2.9	7.8	10.4	4.2	4.7	12.5	4.0	4.3	3.9	1.9	4.7	5.2	3.9	5.1	7.0	3.6	5.9	3.1	18.4	4.9	5.1	7.8	4.3	4.2	7.1	4.8	8.6	5.6	4.6	7.4	3.0	8.1	3.4	6.7	8.6	5.6	5.1	4.7	4.1	8.2	4.2	2.9	2.8	5.9	13.3	7.2	21.9	23.2	60.1	9.3	19.7	8.1	9.9	8.6	8.8	13.3	10.0	9.4	8.6	20.5	11.7	19.1	10.2	11.5	27.3	6.6	10.3	8.6	7.6	5.8	8.1	8.0	6.9	7.9	5.2	7.5	6.3	95.0	109.0	90.9	21.2	78.0	67.8	174.6	267.7	52.9	70.6	75.3	84.2	165.9	108.7	158.7	195.0	45.9	584.3	75.8	147.7	50.9	159.3	40.4	85.5	229.6	88.2	82.6	35.7	22.5	107.9	184.0	152.5	79.0	71.2	81.1	102.3	62.4	92.6	243.1	38.7	20.6	121.6	164.8	100.5	80.2	60.0	126.2	154.2	147.7	16.9	107.1	140.0	91.6	28.1	16.7	95.4	153.4	151.6	205.2	124.5	204.6	273.7	144.8	86.2	78.9	82.8	108.1	272.5	161.4	40.7	61.4	693.5	86.0	99.9	109.9	140.5
LRRC1	"dJ523E19.1, FLJ10775, FLJ11834, LANO"	ENSG00000137269	"Leucine rich repeat containing 1"	Q9BTT6	6	53794497-53924125	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 115.1;Late spermatids: 117.0;Oligodendrocytes: 138.8;Syncytiotrophoblasts: 107.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"RT4: 57.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031603, HPA031604"	Enhanced		Supported	Cytosol		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 37: Intestine - Unknown function"	"Cluster 15: RT4 - Unknown function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Cytosol		"HPA031603: AB_10601753, HPA031604: AB_10601224"	"unprognostic (2.90e-1)"	"unprognostic (8.01e-2)"	"unprognostic (9.59e-3)"	"unprognostic (2.46e-2)"	"unprognostic (7.04e-3)"	"unprognostic (1.55e-2)"	"unprognostic (2.19e-3)"	"unprognostic (6.37e-2)"	"unprognostic (7.02e-2)"	"unprognostic (7.12e-3)"	"prognostic unfavorable (1.18e-4)"	"unprognostic (3.97e-1)"	"prognostic favorable (2.21e-7)"	"unprognostic (1.74e-1)"	"unprognostic (2.31e-1)"	"unprognostic (2.09e-1)"	"unprognostic (9.84e-3)"	14.0	2.2	8.7	5.1	13.8	2.9	13.3	10.1	11.2	13.2	13.7	25.5	17.3	5.1	7.5	18.2	8.5	7.8	4.2	9.2	10.4	7.7	0.8	7.6	2.7	13.9	10.8	4.8	8.8	22.6	7.9	11.1	14.2	8.7	25.4	7.1	16.7	6.7	1.5	22.5	18.1	5.1	10.9	1.5	14.8	14.5	11.1	13.9	15.3	1.4	10.7	14.5	18.0	24.1	45.2	5.7	6.1	10.9	1.6	0.8	42.8	6.1	12.3	5.2	7.1	49.4	21.7	6.4	4.9	3.9	9.7	21.7	47.9	19.4	6.6	7.9	13.8	3.9	4.5	33.5	15.2	4.9	2.9	1.6	15.8	0.4	11.5	8.1	9.4	23.1	0.9	5.8	2.9	19.7	33.6	0.6	4.8	33.5	4.2	6.8	10.2	3.3	14.1	57.4	15.7	1.5	7.3	31.7	9.9	15.2	20.6	5.0	4.3	3.9	12.6	0.2	5.6	5.8	4.9	4.6	4.4	6.7	4.8	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.2	0.2	0.3	0.5	0.1	0.1	0.0	0.7	0.0	0.3	0.0	0.0	8.7	13.8	10.1	11.2	9.2	10.4	13.9	10.8	14.2	10.9	11.1	24.1	19.8	41.7	3.9	53.2	2.9	52.6	25.5	16.3	12.0	43.0	16.0	8.1	3.5	11.5	20.6	16.5	4.2	54.5	2.3	115.1	7.9	20.5	88.5	38.8	9.4	18.8	18.0	1.7	11.9	15.6	62.0	5.9	26.0	74.3	5.7	10.5	8.6	0.3	5.1	8.4	21.9	23.6	12.2	0.6	7.1	117.0	9.3	1.3	10.6	26.2	2.5	32.7	6.2	35.2	138.8	29.5	62.5	10.1	4.2	18.5	32.5	12.3	14.1	3.0	6.6	3.5	3.7	27.3	7.3	19.9	52.7	107.4	3.1	1.6	24.5	32.5
LRRC23	"B7, LRPB7"	ENSG00000010626	"Leucine rich repeat containing 23"	Q53EV4	12	6873569-6914241	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"fallopian tube: 101.8"	"Cell type enhanced"	"Detected in many"		"Endometrial ciliated cells: 204.6;Respiratory ciliated cells: 244.2;Rod photoreceptor cells: 138.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA037766, HPA057533"	Enhanced		Supported	"Nucleoli,Nucleoli rim"		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 49: Ciliated cells - Cilium organization"	"Nucleoli, Nucleoli rim"		"HPA037766: AB_10672609, HPA057533: AB_2683459"	"prognostic favorable (6.02e-4)"	"unprognostic (7.51e-2)"	"unprognostic (2.69e-3)"	"unprognostic (4.37e-3)"	"unprognostic (1.23e-1)"	"unprognostic (5.90e-2)"	"unprognostic (7.94e-3)"	"unprognostic (1.42e-1)"	"unprognostic (3.54e-2)"	"unprognostic (4.64e-1)"	"unprognostic (2.00e-1)"	"unprognostic (3.84e-2)"	"unprognostic (2.29e-1)"	"unprognostic (6.57e-2)"	"unprognostic (1.60e-1)"	"unprognostic (2.68e-1)"	"unprognostic (6.25e-2)"	2.5	3.2	11.3	1.1	11.4	2.5	3.6	11.1	11.2	5.2	20.5	3.4	0.9	5.0	12.5	1.8	101.8	3.0	4.7	11.3	12.4	6.2	2.5	8.9	1.8	18.6	22.4	4.8	2.1	6.7	7.4	2.2	16.9	3.6	2.1	25.1	2.8	3.7	6.3	2.4	2.0	3.6	16.6	2.4	3.4	26.3	12.6	3.1	6.2	5.8	2.7	2.9	2.6	13.2	5.2	9.9	1.6	3.6	7.2	5.4	5.8	2.0	7.0	3.3	6.3	2.1	10.4	4.5	2.2	5.4	9.6	1.3	2.9	4.3	7.1	3.6	1.5	3.2	3.7	4.1	5.8	1.8	3.0	3.8	7.8	6.4	5.7	8.6	4.6	11.0	1.9	2.5	3.9	5.9	4.0	1.2	1.0	7.7	2.8	3.7	8.1	5.3	6.6	1.5	2.6	6.3	3.2	4.3	6.6	10.2	2.2	4.1	2.0	3.3	8.6	3.8	2.3	2.3	1.6	3.8	8.1	2.3	4.8	0.6	2.7	6.4	2.2	2.6	3.0	5.7	2.2	1.9	2.6	2.8	2.4	2.4	0.5	4.0	2.6	3.9	0.1	1.3	11.3	11.4	11.1	11.2	11.3	12.4	18.6	22.4	16.9	16.6	12.6	13.2	12.6	0.0	22.4	11.4	12.6	6.5	10.0	15.1	11.4	17.8	15.3	19.3	8.2	20.0	34.4	12.9	50.1	8.2	9.4	5.2	37.2	13.6	43.4	204.6	13.1	9.7	18.0	7.4	5.8	17.3	12.5	12.6	10.7	12.9	5.7	12.1	14.6	7.5	13.5	13.5	4.4	8.6	16.2	11.9	8.9	47.0	8.4	13.7	8.8	6.5	11.0	38.6	11.3	1.5	6.4	15.3	4.7	12.4	10.5	6.4	4.5	46.5	244.2	138.1	13.1	21.1	13.5	63.6	13.1	8.4	5.8	4.5	11.8	7.1	5.6	7.3
LRRC25	"FLJ38116, MAPA"	ENSG00000175489	"Leucine rich repeat containing 25"	Q8N386	19	18391137-18397622	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"bone marrow: 32.4;lymphoid tissue: 61.2"	"Group enriched"	"Detected in some"	6	"Hofbauer cells: 47.0;Kupffer cells: 123.6;Macrophages: 90.0;monocytes: 74.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	8	"classical monocyte: 320.6;eosinophil: 356.2;intermediate monocyte: 512.1;myeloid DC: 229.3;neutrophil: 573.0;non-classical monocyte: 706.7"	"Group enriched"	"Detected in all"	60	"dendritic cells: 229.3;granulocytes: 573.0;monocytes: 706.7"	"Cell line enhanced"	"Detected in some"		"Hep G2: 1.0;HMC-1: 1.8;THP-1: 1.7;U-937: 1.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA029459	Approved		Approved	"Endoplasmic reticulum,Microtubules,Cytosol"		NA	NA		630000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 2: Immune cells - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	"Endoplasmic reticulum, Microtubules, Cytosol"		"HPA029459: AB_10610005"	"unprognostic (2.72e-2)"	"unprognostic (6.08e-2)"	"unprognostic (1.76e-2)"	"unprognostic (2.07e-1)"	"unprognostic (3.77e-2)"	"unprognostic (9.15e-2)"	"unprognostic (5.80e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.20e-2)"	"unprognostic (4.63e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.19e-3)"	"unprognostic (5.77e-2)"	"prognostic unfavorable (6.93e-4)"	"unprognostic (1.74e-1)"	"unprognostic (1.14e-1)"	9.4	9.4	2.4	21.8	2.5	32.4	3.1	3.3	2.9	1.8	3.2	3.3	3.7	1.6	0.7	2.3	3.9	5.3	2.5	2.3	3.1	2.4	5.9	11.5	9.9	4.6	4.0	1.5	2.0	0.7	1.2	5.4	4.2	2.0	2.8	0.3	2.6	1.2	3.7	1.0	4.8	6.7	2.8	61.2	2.3	1.2	5.4	3.0	1.2	8.7	4.0	7.0	1.3	4.7	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.7	0.3	1.0	0.8	0.4	1.8	0.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.4	0.2	0.1	0.0	0.1	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	1.7	0.4	0.2	0.1	0.1	0.1	0.1	0.0	0.0	0.2	1.5	0.1	55.4	320.6	356.2	0.9	512.1	1.9	7.3	0.6	0.7	229.3	8.4	0.5	0.6	573.0	4.6	706.7	32.1	1.3	229.2	2.4	2.5	3.3	2.9	2.3	3.1	4.6	4.0	4.2	2.8	5.4	4.7	0.7	0.0	1.3	0.0	5.0	0.0	0.1	0.1	0.0	0.1	0.3	1.0	0.3	0.0	0.7	0.0	0.0	0.1	2.9	0.1	5.9	0.1	1.9	0.2	0.1	0.9	0.0	2.1	0.1	0.0	0.4	0.5	0.0	0.4	10.2	0.0	1.8	0.5	47.0	0.0	0.1	0.0	0.0	123.6	12.5	0.5	0.0	90.0	1.8	1.0	74.9	0.0	6.2	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.3	0.0	2.4	0.2	0.0	0.2	0.0	0.1	0.4	1.1	0.2	0.1	0.1
LRRC26	bA350O14.10	ENSG00000184709	"Leucine rich repeat containing 26"	Q2I0M4	9	137168758-137170051	"Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"salivary gland: 290.0"	"Cell type enriched"	"Detected in many"	5	"Intestinal goblet cells: 598.0"	"Cancer enriched"	"Detected in many"	5	"prostate cancer: 47.6"	"Region enriched"	"Detected in single"	5	"cerebellum: 2.6"	"Immune cell enriched"	"Detected in single"	1177	"plasmacytoid DC: 117.6"	"Lineage enriched"	"Detected in single"	1177	"dendritic cells: 117.6"	"Cell line enriched"	"Detected in some"	6	"RPMI-8226: 130.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA056312	Approved		Supported	"Nucleoli fibrillar center,Plasma membrane"		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 27: Mucus-secreting cells - Mucin production"	"Plasma membrane"	"Nucleoli fibrillar center"	"HPA056312: AB_2683098"	"unprognostic (1.75e-1)"	"unprognostic (2.28e-2)"	"unprognostic (1.04e-2)"	"prognostic favorable (4.82e-6)"	"unprognostic (3.39e-1)"	"unprognostic (1.67e-2)"	"unprognostic (1.82e-1)"	"unprognostic (2.13e-2)"		"unprognostic (1.98e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.75e-1)"		"prognostic favorable (3.48e-4)"	"unprognostic (3.27e-1)"		"unprognostic (2.29e-1)"	0.1	0.0	0.2	0.3	0.4	0.0	7.3	2.6	0.5	0.4	0.0	11.2	1.7	1.1	0.0	2.8	1.1	0.0	0.0	0.1	0.5	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.6	0.0	0.1	0.0	0.1	53.1	0.5	0.0	290.0	0.5	0.0	5.1	7.2	0.0	0.2	0.1	5.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.4	0.0	0.0	0.0	5.4	0.7	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.1	0.9	0.1	0.3	0.7	20.8	0.1	130.9	0.0	0.0	1.0	0.2	0.5	6.0	0.0	0.0	2.7	0.5	0.1	0.0	0.1	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	117.6	0.0	0.5	0.2	0.4	2.6	0.5	0.1	0.5	0.0	0.1	0.1	0.2	0.0	0.0	0.6	0.0	0.0	0.3	1.2	1.0	1.7	0.5	0.0	0.0	101.2	64.4	0.4	4.3	1.0	0.0	0.0	0.1	81.8	15.2	1.9	0.1	0.5	13.0	1.6	1.0	9.0	0.0	0.1	0.4	0.0	0.4	9.2	21.3	0.0	0.0	0.0	0.0	0.1	0.0	0.3	598.0	4.1	0.0	0.9	1.1	0.0	1.4	56.9	0.0	0.6	0.0	0.0	0.0	0.1	0.2	11.8	0.0	0.6	28.4	28.8	0.1	0.4	0.0	0.0	0.0	0.4	0.2	2.8	3.5	0.3	0.0	0.6	0.0	24.3	3.7
LRRC45	MGC20806	ENSG00000169683	"Leucine rich repeat containing 45"	Q96CN5	17	82023305-82031151	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 27.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023372, HPA023382, HPA024768"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Centrosome,Cytosol"		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Centrosome, Cytosol"	"Nucleoplasm, Plasma membrane"	"HPA023372: AB_1853317, HPA023382: AB_1853318, HPA024768: AB_10602348"	"unprognostic (6.69e-2)"	"unprognostic (6.10e-2)"	"unprognostic (6.86e-2)"	"unprognostic (1.38e-2)"	"unprognostic (6.92e-2)"	"unprognostic (4.41e-3)"	"unprognostic (4.70e-3)"	"unprognostic (1.23e-1)"	"unprognostic (6.10e-2)"	"unprognostic (1.78e-3)"	"unprognostic (6.17e-3)"	"unprognostic (7.46e-2)"	"prognostic unfavorable (1.54e-4)"	"unprognostic (1.22e-3)"	"unprognostic (1.24e-1)"	"unprognostic (4.79e-2)"	"unprognostic (3.58e-1)"	5.0	6.1	2.3	3.8	2.2	7.0	5.8	7.5	5.4	6.1	2.2	8.7	5.7	5.4	0.9	10.3	9.0	1.6	5.0	2.5	1.9	7.5	18.0	6.4	3.2	3.0	2.8	4.5	10.1	2.0	5.9	2.4	3.0	8.4	1.7	0.6	9.6	2.2	2.5	8.7	8.6	1.2	2.1	9.5	10.5	4.0	2.2	3.1	8.9	0.5	1.5	6.1	6.9	2.3	18.6	20.7	6.2	12.7	2.5	3.3	24.0	12.7	5.2	7.5	6.3	18.6	12.4	13.9	11.2	2.5	7.8	21.3	6.0	7.6	1.7	8.5	38.6	8.8	43.1	25.5	2.1	10.4	21.2	3.3	3.1	4.5	1.2	3.1	11.1	13.0	6.3	6.0	2.0	31.6	23.5	34.5	6.4	15.0	27.4	19.0	12.2	7.8	4.8	16.9	19.1	18.6	5.8	29.9	11.2	3.0	24.4	12.0	6.5	13.1	16.3	20.8	21.9	11.5	3.1	2.1	7.0	8.9	13.9	2.3	1.2	1.5	1.4	0.9	1.4	0.6	1.6	1.6	0.8	0.7	0.8	1.1	0.0	1.1	0.4	1.3	1.4	1.4	2.3	2.2	7.5	5.4	2.5	1.9	3.0	2.8	3.0	2.1	2.2	2.3	3.9	6.4	2.2	4.2	4.1	4.5	5.0	2.9	1.8	5.2	8.5	8.6	2.7	14.3	7.0	3.7	0.0	12.7	7.8	18.1	5.9	7.3	1.5	19.0	3.4	3.7	4.8	10.3	2.5	4.7	27.9	4.8	13.3	5.0	4.5	13.3	7.1	12.6	8.7	5.0	2.9	12.2	4.1	6.3	3.2	4.4	7.2	4.2	8.8	0.0	4.3	5.6	7.2	1.0	1.8	5.8	9.4	6.4	8.5	2.4	10.9	10.2	24.4	4.1	0.0	2.8	5.2	2.3	11.9	6.3	2.4	3.0	7.0	4.9	18.4	3.7
LRRC7	"densin-180, KIAA1365"	ENSG00000033122	"Leucine rich repeat containing 7"		1	69567922-70151945	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Tissue enriched"	"Detected in some"	9	"brain: 20.2"	"Group enriched"	"Detected in many"	20	"Excitatory neurons: 1132.4;Inhibitory neurons: 996.9;Oligodendrocyte precursor cells: 1038.0;Oligodendrocytes: 408.2"	"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"amygdala: 6.9;basal ganglia: 17.0;cerebral cortex: 20.2;hippocampal formation: 17.7;thalamus: 11.4"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"HaCaT: 12.6;HEL: 44.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA005625			Supported	"Nucleoplasm,Plasma membrane,Centrosome,Cytosol"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 36: HEL - Hemostasis"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Plasma membrane, Cytosol"	"Nucleoplasm, Centrosome"	"HPA005625: AB_1853340"	"unprognostic (2.81e-2)"	"unprognostic (1.62e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.98e-3)"	"unprognostic (2.47e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.04e-1)"	"unprognostic (3.50e-2)"	"unprognostic (4.84e-3)"	"unprognostic (2.92e-2)"	"unprognostic (1.06e-3)"	"unprognostic (1.46e-1)"	"unprognostic (5.64e-6)"	"unprognostic (1.31e-2)"	"unprognostic (1.74e-2)"	"unprognostic (5.13e-3)"	"unprognostic (2.08e-3)"	0.1	0.2	6.9	0.1	17.0	0.2	0.0	0.0	20.2	0.2	0.0	0.4	0.1	0.2	0.1	0.2	0.0	1.0	1.4	17.7	1.7	0.8	0.2	0.0	0.1	0.0	2.2	0.1	0.8	0.1	0.0	0.2	0.0	0.3	0.6	1.5	0.0	0.1	1.0	0.2	0.2	0.2	0.0	0.0	0.2	1.6	11.4	0.0	2.2	0.0	0.0	0.1	0.1	2.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.4	4.4	0.0	0.0	12.6	0.3	0.0	0.0	0.0	0.6	44.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.0	4.7	0.5	0.5	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.9	0.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.3	0.1	0.0	0.0	0.0	0.0	6.9	17.0	0.0	20.2	17.7	1.7	0.0	2.2	0.0	0.0	11.4	2.9	0.8	0.0	0.0	41.4	2.5	0.8	0.6	0.4	1.8	44.4	0.3	0.3	6.2	2.8	0.2	0.0	2.1	0.4	2.4	0.0	0.0	0.0	29.4	0.5	1.4	1.2	0.0	3.2	1132.4	0.0	0.5	1.8	0.0	1.4	0.0	0.6	2.9	6.5	0.3	6.7	996.9	0.0	0.0	2.8	3.6	6.3	0.6	0.5	5.4	17.8	1.7	1.0	2.1	1038.0	408.2	0.0	0.0	3.0	1.3	0.9	0.0	1.6	0.1	8.3	0.0	1.4	1.5	9.2	3.0	0.5	1.3	0.1	2.3	0.1	0.0	0.1
LRRCC1	"CLERC, KIAA1764, VFL1"	ENSG00000133739	"Leucine rich repeat and coiled-coil centrosomal protein 1"	Q9C099	8	85107215-85146080	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 33.5"	"Group enriched"	"Detected in all"	5	"Early spermatids: 192.2;Late spermatids: 166.0;Spermatocytes: 224.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in all"		"HDLM-2: 41.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012893, HPA075880"	Uncertain		Supported	Centrosome		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 66: Spermatocytes - Spermatogenesis"	Centrosome		"HPA012893: AB_1852434, HPA075880: "	"unprognostic (1.01e-1)"	"unprognostic (3.08e-2)"	"unprognostic (3.68e-3)"	"unprognostic (2.37e-2)"	"unprognostic (7.67e-2)"	"unprognostic (7.76e-2)"	"unprognostic (1.47e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.31e-1)"	"unprognostic (4.45e-2)"	"unprognostic (2.94e-1)"	"unprognostic (3.35e-2)"	"unprognostic (2.43e-2)"	"unprognostic (2.67e-2)"	"unprognostic (7.37e-2)"	"unprognostic (1.52e-1)"	4.9	4.8	5.8	3.8	6.6	7.4	6.4	6.1	9.7	4.9	4.5	9.0	6.7	6.3	3.8	3.8	4.4	4.1	4.1	5.5	6.2	5.4	3.9	5.2	4.9	6.5	6.4	8.1	3.7	3.8	1.8	2.1	6.8	5.0	9.0	3.0	2.6	5.1	0.7	5.9	6.5	4.5	6.3	4.3	6.0	33.5	6.4	6.6	8.7	1.9	3.6	4.3	4.2	7.0	7.3	1.6	13.4	3.1	6.3	5.6	10.4	7.4	4.8	1.6	2.9	3.5	10.2	5.4	1.2	4.6	8.6	9.8	16.0	4.5	2.6	41.9	1.4	21.2	4.0	5.4	1.9	8.1	5.5	3.1	1.2	4.6	1.0	3.0	1.8	13.7	24.1	4.8	8.5	2.6	24.9	6.3	4.6	28.0	3.3	18.2	8.3	3.7	4.5	5.5	1.7	4.5	3.7	7.1	2.8	8.6	15.8	17.5	2.4	6.3	8.5	6.8	10.3	6.4	6.9	10.5	5.1	20.6	12.5	0.0	0.2	0.0	0.4	0.3	0.2	0.4	0.3	0.5	0.8	0.2	0.4	0.7	0.0	0.7	0.3	0.5	1.1	0.1	5.8	6.6	6.1	9.7	5.5	6.2	6.5	6.4	6.8	6.3	6.4	7.0	12.2	32.1	32.8	6.5	5.8	9.3	11.8	7.7	13.1	7.2	11.3	9.8	12.6	11.5	22.1	25.8	12.5	8.0	9.9	9.3	33.2	7.7	192.2	14.1	12.6	12.0	7.8	33.6	5.3	7.6	11.7	13.9	12.8	8.1	15.2	13.1	11.4	6.8	6.9	25.2	8.3	14.4	2.0	4.1	8.7	166.0	10.2	10.1	5.4	5.6	6.3	10.8	12.3	22.1	13.8	2.9	5.9	14.3	9.1	5.6	7.7	7.9	20.7	5.0	19.7	13.3	15.5	224.3	38.3	14.1	6.5	1.1	6.5	9.8	20.6	10.8
LRRFIP1	"FLAP-1, FLIIAP1, GCF-2, HUFI-1, TRIP"	ENSG00000124831	"LRR binding FLII interacting protein 1"	Q32MZ4	2	237627587-237813682	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HDLM-2: 322.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006979	Approved		Supported	Cytosol		NA	NA		580000	"Cluster 52: Eosinophils - Transcription"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 41: Macrophages - Immune response"	Cytosol		"HPA006979: AB_1079282"	"unprognostic (2.07e-1)"	"unprognostic (2.99e-2)"	"unprognostic (4.09e-1)"	"unprognostic (5.96e-2)"	"unprognostic (1.22e-3)"	"unprognostic (1.24e-1)"	"unprognostic (1.09e-1)"	"unprognostic (6.50e-2)"	"unprognostic (9.68e-3)"	"unprognostic (3.08e-2)"	"unprognostic (3.99e-3)"	"unprognostic (8.90e-2)"	"unprognostic (4.70e-2)"	"unprognostic (7.29e-2)"	"unprognostic (2.69e-2)"	"unprognostic (8.07e-2)"	"unprognostic (7.64e-2)"	44.2	21.0	11.3	49.2	9.0	86.8	34.0	3.8	11.0	34.1	23.0	63.2	35.9	64.3	15.7	58.2	32.1	39.4	69.7	11.7	10.8	51.7	48.9	61.7	45.4	7.3	6.9	16.0	21.2	55.1	14.8	41.4	7.0	40.9	40.3	6.4	38.0	31.2	111.0	23.7	35.9	58.8	5.9	45.7	49.6	5.4	9.4	43.5	37.8	50.7	52.6	69.4	43.4	7.3	99.1	50.1	17.5	45.9	25.4	55.6	77.7	67.4	62.3	37.8	37.2	19.2	64.6	8.4	27.4	108.8	81.2	80.9	54.0	100.4	80.2	322.6	34.7	78.0	55.1	54.8	58.5	104.2	71.0	23.9	205.8	88.2	216.0	50.6	59.8	54.0	58.4	77.8	79.5	47.8	60.5	79.5	29.6	73.3	45.1	87.9	125.3	80.1	122.0	141.8	46.3	24.0	33.5	76.2	92.2	37.6	42.9	129.2	99.4	42.4	41.1	49.5	77.0	15.8	14.3	53.2	63.4	102.7	51.0	78.5	104.1	248.4	74.8	97.5	55.1	55.9	89.0	77.3	84.1	60.1	46.1	52.2	326.2	46.9	168.9	73.1	76.7	61.4	11.3	9.0	3.8	11.0	11.7	10.8	7.3	6.9	7.0	5.9	9.4	7.3	236.4	487.2	307.3	35.6	249.6	307.0	391.9	166.0	113.3	46.4	128.6	86.2	160.3	127.2	269.9	172.9	37.5	111.2	347.1	319.5	52.8	229.7	7.9	368.3	88.2	213.0	190.5	62.4	175.9	333.0	359.2	109.1	159.0	426.3	241.0	56.9	122.0	149.1	175.8	21.9	237.5	168.3	79.3	271.2	721.3	7.9	29.8	398.9	167.2	57.1	365.0	25.1	213.1	111.1	12.5	389.6	220.6	23.3	146.6	430.5	152.8	49.5	286.1	6.0	78.9	147.3	182.9	10.1	27.4	179.3	243.1	25.3	288.5	158.3	150.0	588.4
LRRK1	"FLJ23119, KIAA1790, RIPK6, Roco1"	ENSG00000154237	"Leucine rich repeat kinase 1"	Q38SD2	15	100919327-101078257	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 64.6;Microglial cells: 107.7"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in some"		"cerebral cortex: 3.6"	"Immune cell enhanced"	"Detected in some"		"plasmacytoid DC: 1.3"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"U-698: 27.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA010537	Uncertain		Supported	Mitochondria,Cytosol		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 64: Macrophages - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Cytosol	Mitochondria	"HPA010537: AB_1079283"	"unprognostic (3.74e-2)"	"unprognostic (1.41e-1)"	"unprognostic (2.82e-1)"	"unprognostic (3.72e-1)"	"unprognostic (6.68e-2)"	"unprognostic (6.35e-2)"	"unprognostic (1.94e-1)"	"unprognostic (4.75e-2)"	"unprognostic (3.43e-2)"	"unprognostic (3.34e-2)"	"unprognostic (2.95e-2)"	"unprognostic (8.50e-2)"	"prognostic unfavorable (5.71e-5)"	"unprognostic (2.92e-2)"	"unprognostic (1.82e-2)"	"unprognostic (3.13e-1)"	"unprognostic (5.25e-2)"	2.9	1.0	1.3	5.8	0.5	6.4	2.3	0.0	3.6	3.8	0.0	5.3	3.8	3.8	1.7	4.5	4.9	3.2	1.4	0.8	0.0	0.9	0.8	3.3	7.2	0.0	0.0	3.8	5.9	2.0	0.9	4.1	0.1	4.0	5.1	0.2	3.9	3.5	1.0	4.7	5.0	3.0	0.0	6.2	3.7	5.2	0.0	2.2	1.6	1.3	7.9	2.9	3.0	1.3	4.5	15.3	0.3	0.0	4.9	3.9	1.8	3.7	7.1	2.3	2.0	3.1	7.2	20.2	4.2	6.3	0.0	17.3	5.2	2.8	2.8	3.1	2.8	17.4	12.8	0.0	2.0	5.2	9.0	3.3	4.7	3.0	6.3	2.3	2.4	0.4	3.6	18.4	1.1	0.4	0.0	4.2	1.4	5.1	5.2	2.9	2.0	15.3	0.0	0.6	0.4	3.3	8.8	2.5	6.2	0.4	1.5	4.4	6.3	0.0	3.1	5.2	0.1	15.9	18.2	27.4	1.1	2.1	6.7	0.0	0.4	1.2	0.0	0.1	0.0	1.0	0.0	0.0	0.4	0.4	0.0	0.0	0.3	0.0	0.4	1.3	0.0	0.0	1.3	0.5	0.0	3.6	0.8	0.0	0.0	0.0	0.1	0.0	0.0	1.3	8.3	16.0	13.6	2.9	17.3	3.2	8.0	3.5	7.4	0.9	5.7	5.1	2.9	2.8	6.0	0.0	6.2	9.6	13.6	19.8	0.0	4.5	3.7	12.6	19.4	8.8	13.8	3.4	64.6	3.3	4.2	11.5	3.6	6.6	1.3	1.4	9.7	0.4	10.7	0.0	10.0	11.7	0.0	24.8	10.1	4.6	32.3	19.9	3.6	107.7	28.3	0.6	1.0	12.5	1.2	7.5	11.4	21.4	14.2	10.7	11.6	0.3	6.3	0.7	6.6	11.2	3.9	6.5	1.5	6.6	3.4	3.6	1.3	2.8	12.5	9.9
LRRK2	"DKFZp434H2111, FLJ45829, PARK8, RIPK7, ROCO2"	ENSG00000188906	"Leucine rich repeat kinase 2"	Q5S007	12	40196744-40369285	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Autophagy, Differentiation"	"GTPase activation, Hydrolase, Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Disease variant, Neurodegeneration, Parkinson disease, Parkinsonism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"lung: 52.4"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 502.2;Excitatory neurons: 92.0;monocytes: 133.1;Oligodendrocyte precursor cells: 256.9"	"Cancer enhanced"	"Detected in many"		"renal cancer: 17.1;thyroid cancer: 22.7"	"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in many"	8	"neutrophil: 58.2"	"Lineage enriched"	"Detected in many"	8	"granulocytes: 58.2"	"Cell line enhanced"	"Detected in some"		"A549: 4.6;ASC TERT1: 5.6;BJ hTERT+: 3.2;RPTEC TERT1: 7.8;T-47d: 3.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014293, CAB037160"	Approved		Supported	Vesicles		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 11: Alveolar cells - Smell perception"	Vesicles		"CAB037160: AB_1840989, HPA014293: AB_1853353"	"unprognostic (2.67e-1)"	"unprognostic (1.75e-1)"	"unprognostic (6.45e-3)"	"unprognostic (1.06e-1)"	"unprognostic (3.00e-2)"	"unprognostic (6.10e-3)"	"unprognostic (2.71e-1)"	"unprognostic (3.14e-1)"	"unprognostic (2.25e-1)"	"unprognostic (9.07e-2)"	"unprognostic (2.76e-1)"	"unprognostic (1.23e-1)"	"prognostic favorable (3.02e-6)"	"unprognostic (2.55e-2)"	"unprognostic (3.43e-2)"	"unprognostic (2.01e-3)"	"unprognostic (5.21e-3)"	4.8	3.1	1.1	10.1	1.9	9.0	2.6	0.9	2.1	5.1	1.2	4.3	0.6	4.8	1.9	7.0	4.1	6.2	3.9	1.3	1.1	10.9	5.6	52.4	6.8	1.7	1.1	5.4	3.6	8.4	2.1	1.2	1.4	2.6	1.8	1.5	3.5	2.0	5.5	2.1	3.6	4.0	1.1	10.8	2.1	0.8	1.2	2.5	2.9	7.9	5.4	4.5	5.5	1.9	0.0	4.6	0.0	0.0	2.3	5.6	0.0	1.3	3.2	0.1	0.1	0.0	0.0	0.0	0.0	0.8	0.1	0.0	0.0	0.0	0.2	0.0	0.3	0.2	0.1	0.0	0.6	0.4	0.0	2.1	0.4	0.0	0.0	2.5	0.4	0.0	0.0	0.0	0.4	0.0	0.0	0.8	0.1	0.0	0.0	0.0	0.0	0.0	7.8	0.0	0.0	0.3	0.0	0.5	2.7	0.1	3.1	1.5	1.0	0.4	0.5	0.6	0.4	0.0	0.0	0.0	1.3	0.0	1.7	0.0	7.2	2.2	0.0	5.2	0.0	1.8	0.0	0.0	2.1	1.7	0.0	0.0	58.2	0.0	6.9	0.3	0.0	1.3	1.1	1.9	0.9	2.1	1.3	1.1	1.7	1.1	1.4	1.1	1.2	1.9	7.4	32.1	502.2	17.3	29.9	2.4	1.8	0.4	2.8	8.6	1.3	1.4	7.8	5.7	17.3	27.6	0.0	0.0	1.9	0.0	1.9	1.3	0.5	0.4	2.6	7.0	0.0	2.1	92.0	2.7	0.1	16.1	0.5	0.4	13.9	2.7	13.2	8.2	4.6	47.1	28.0	0.0	0.0	55.8	8.7	1.2	19.0	52.2	12.4	73.1	133.1	8.6	3.1	256.9	3.1	0.8	1.1	12.0	2.8	0.6	0.0	22.5	3.4	1.0	0.0	22.5	4.8	0.3	1.0	12.6	3.1	0.4	3.4	11.2	0.0	0.7
LRRTM3		ENSG00000198739	"Leucine rich repeat transmembrane neuronal 3"	Q86VH5	10	66926036-67101551	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"adrenal gland: 2.6;brain: 4.8;ovary: 2.7;pituitary gland: 3.4"	"Group enriched"	"Detected in some"	22	"Early spermatids: 164.0;Excitatory neurons: 485.6;Inhibitory neurons: 577.7;Late spermatids: 178.7;Oligodendrocyte precursor cells: 601.7;Oligodendrocytes: 253.5"	"Cancer enriched"	"Detected in single"	7	"glioma: 2.9"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 1.4;HAP1: 4.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA070444, HPA078598"			Supported	"Nucleoplasm,Nuclear bodies"		NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm	"Nuclear bodies"	"HPA070444: , HPA078598: "					"unprognostic (1.21e-2)"					"unprognostic (4.85e-2)"	"unprognostic (1.12e-1)"	"unprognostic (4.02e-2)"		"unprognostic (1.15e-4)"	"unprognostic (8.11e-2)"		"unprognostic (4.77e-1)"	0.1	2.6	2.7	0.0	3.1	0.0	0.0	1.0	4.8	0.2	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	3.9	0.7	0.0	0.0	0.2	0.0	0.0	0.6	2.7	1.0	0.0	3.4	0.0	0.0	0.1	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	1.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	1.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.8	0.0	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	3.1	1.0	4.8	3.9	0.7	0.0	0.6	0.0	0.1	1.0	3.4	0.0	0.0	0.0	16.6	0.0	0.0	0.0	0.0	0.0	5.1	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	164.0	0.0	0.2	0.2	0.0	0.0	485.6	0.0	0.0	1.1	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	577.7	0.0	0.0	0.0	0.0	178.7	8.7	0.1	0.0	8.4	0.0	0.4	0.0	601.7	253.5	0.1	0.0	12.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.8	0.3	2.5	1.5	0.0	0.0	0.0	0.0	5.7	0.0	0.0
LRWD1	"CENP-33, DKFZp434K1815, ORCA"	ENSG00000161036	"Leucine rich repeats and WD repeat domain containing 1"	Q9UFC0	7	102464956-102473168	"Predicted intracellular proteins"	"DNA replication"	"Chromatin regulator"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	11	"testis: 275.2"	"Group enriched"	"Detected in many"	4	"Early spermatids: 1002.6;Spermatocytes: 677.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021320	Enhanced		Supported	"Nucleoplasm,Nucleoli,Nucleoli rim,Vesicles"		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 16: U-266 - Nucleosome"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Nucleoli, Nucleoli rim"	"Nucleoplasm, Vesicles"	"HPA021320: AB_1853372"	"unprognostic (1.50e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.31e-2)"	"unprognostic (7.66e-3)"	"unprognostic (1.60e-2)"	"unprognostic (2.08e-3)"	"unprognostic (1.72e-3)"	"unprognostic (4.97e-2)"	"unprognostic (3.34e-1)"	"unprognostic (3.04e-2)"	"prognostic favorable (8.71e-5)"	"unprognostic (1.00e-1)"	"prognostic unfavorable (1.25e-4)"	"unprognostic (1.46e-2)"	"unprognostic (4.14e-2)"	"unprognostic (7.82e-2)"	"unprognostic (9.20e-2)"	8.2	16.8	10.7	6.8	10.7	14.9	7.9	11.4	13.1	10.4	10.7	8.9	5.3	10.0	2.3	7.7	13.8	3.9	9.7	13.0	11.5	11.4	15.0	10.1	8.1	12.1	14.4	9.4	9.3	8.7	17.6	3.1	12.2	8.6	2.3	3.4	7.6	6.1	13.2	6.7	17.1	4.2	10.8	24.3	9.0	275.2	12.1	8.7	10.0	5.3	7.3	8.9	7.3	10.2	18.6	24.6	13.0	36.8	9.4	7.2	21.0	19.6	11.9	30.5	20.9	23.7	10.3	44.8	27.5	13.9	36.3	19.2	18.7	16.4	9.0	16.6	39.2	10.0	11.1	14.8	12.7	17.6	17.4	6.7	9.9	35.4	7.5	10.2	16.2	33.9	44.5	13.3	16.8	54.3	53.4	42.1	28.7	22.0	37.8	28.2	12.2	48.5	9.2	11.3	17.7	50.7	21.0	20.1	19.3	14.6	11.2	14.4	11.1	17.3	37.7	54.8	30.8	50.5	94.3	43.6	19.3	17.1	31.4	10.6	2.6	9.9	9.7	4.0	9.0	10.0	8.4	8.4	2.7	11.8	5.2	6.9	5.5	10.5	3.8	9.7	9.3	6.0	10.7	10.7	11.4	13.1	13.0	11.5	12.1	14.4	12.2	10.8	12.1	10.2	9.1	0.0	1.1	5.5	10.6	10.5	6.4	16.5	3.4	11.7	5.5	5.0	0.8	2.8	12.8	12.9	2.1	9.2	10.8	8.6	7.9	12.3	1002.6	54.4	7.3	6.5	7.8	13.7	4.7	10.5	12.4	7.0	10.7	13.7	0.0	14.8	5.7	7.2	8.8	5.0	5.0	9.8	18.3	3.4	4.0	172.3	19.0	5.0	5.4	2.8	7.2	7.9	10.3	4.5	2.8	12.4	11.2	15.8	20.2	3.9	8.6	15.9	65.3	11.4	0.0	5.4	13.6	677.0	38.3	4.5	9.8	6.2	9.3	22.2	7.5	3.4
LSG1	FLJ11301	ENSG00000041802	"Large 60S subunit nuclear export GTPase 1"	Q9H089	3	194640791-194672463	"Plasma proteins, Predicted intracellular proteins"	"Protein transport, Transport"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037704, HPA037705"	Approved		Supported	"Nucleoplasm,Nuclear bodies,Cytosol"		No	No			"Cluster 27: Non-specific - Gene expression"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 60: Granulocytes - Receptor signaling"	"Nuclear bodies, Cytosol"	Nucleoplasm	"HPA037704: AB_10672912, HPA037705: AB_2675621"	"unprognostic (5.72e-3)"	"unprognostic (9.38e-3)"	"unprognostic (2.63e-1)"	"unprognostic (1.23e-2)"	"unprognostic (3.74e-2)"	"unprognostic (3.03e-1)"	"prognostic unfavorable (3.21e-7)"	"unprognostic (4.63e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.07e-1)"	"unprognostic (1.60e-2)"	"unprognostic (4.86e-3)"	"unprognostic (1.42e-1)"	"unprognostic (3.00e-2)"	"unprognostic (2.70e-1)"	"unprognostic (6.77e-2)"	"unprognostic (2.07e-1)"	14.9	12.8	13.2	15.8	13.8	28.1	15.8	13.9	15.9	12.8	14.0	15.1	17.2	15.2	19.8	15.9	14.5	12.6	14.0	13.1	14.5	16.6	21.7	12.8	18.7	14.7	16.4	14.2	15.5	16.8	11.1	17.2	15.8	14.6	18.1	14.0	13.8	13.9	23.0	19.3	14.9	14.5	14.0	15.4	13.6	14.4	14.4	17.2	15.5	18.9	21.3	18.2	14.3	15.4	55.6	36.0	21.2	35.3	32.3	17.8	43.1	31.0	30.1	42.9	37.6	47.9	25.1	43.1	93.5	29.4	75.5	39.5	68.2	35.0	52.1	56.3	32.5	46.8	38.4	27.6	22.9	51.1	42.4	17.3	31.5	44.4	41.7	16.0	47.1	29.4	39.5	46.2	36.0	76.6	46.3	30.8	57.7	73.5	65.6	56.2	35.0	49.3	23.7	46.9	40.5	27.9	39.9	38.2	40.0	39.7	90.3	32.9	36.5	32.4	37.3	46.2	66.6	50.6	71.1	97.7	26.2	64.7	52.4	3.5	10.1	13.6	15.3	13.2	17.1	16.6	12.5	13.9	17.2	14.3	14.4	12.9	1.3	21.0	8.9	9.0	15.4	10.6	13.2	13.8	13.9	15.9	13.1	14.5	14.7	16.4	15.8	14.0	14.4	15.4	25.0	19.2	29.6	10.4	22.5	16.2	13.4	8.9	25.0	18.3	12.1	11.9	17.2	18.6	27.9	9.2	12.5	25.1	21.2	14.0	5.9	23.3	12.0	22.1	24.5	23.7	7.8	16.2	10.5	22.4	19.4	17.7	21.9	24.0	53.7	21.9	11.7	14.0	13.0	15.2	8.3	14.2	12.2	4.4	10.2	8.9	15.5	15.5	12.4	8.4	14.0	18.2	12.3	12.5	12.2	19.7	8.0	14.7	23.8	11.5	10.8	9.7	34.3	18.6	19.7	22.1	14.6	26.4	35.7	30.5	16.1	28.5	24.0	23.2	17.6	9.0
LSM10	MGC15749	ENSG00000181817	"LSM10, U7 small nuclear RNA associated"	Q969L4	1	36391238-36397908	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048469			Supported	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 57: B-cells - Immune response"	Nucleoplasm	"Nuclear bodies"	"HPA048469: AB_2756307"	"unprognostic (2.15e-2)"	"unprognostic (4.10e-2)"	"unprognostic (1.76e-1)"	"unprognostic (2.64e-1)"	"unprognostic (6.21e-2)"	"unprognostic (2.14e-1)"	"prognostic unfavorable (1.83e-4)"	"unprognostic (1.22e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.90e-2)"	"prognostic favorable (4.89e-4)"	"unprognostic (1.04e-1)"	"prognostic unfavorable (6.40e-6)"	"unprognostic (1.84e-1)"	"unprognostic (2.80e-1)"	"unprognostic (3.59e-2)"	"unprognostic (8.54e-2)"	39.2	32.7	53.1	32.0	54.2	23.9	32.8	54.5	67.5	31.9	55.0	62.3	20.1	36.3	30.4	26.8	31.6	22.7	72.9	53.4	58.7	42.3	51.7	30.6	52.3	54.4	55.2	31.7	30.5	36.9	41.8	18.0	55.3	40.8	17.7	9.7	29.1	30.5	165.0	30.1	36.7	27.9	55.2	55.3	38.7	28.9	57.8	27.2	31.0	110.3	47.6	42.8	28.2	54.3	54.6	81.2	29.9	80.7	68.9	67.2	31.0	47.9	69.4	75.1	57.1	36.4	50.6	127.4	64.5	65.0	55.6	29.3	51.2	62.1	49.5	87.1	61.2	64.1	47.1	87.1	83.8	49.0	90.3	56.8	54.4	67.6	47.6	40.7	77.8	71.7	60.2	60.5	53.4	96.3	54.8	55.5	77.5	67.0	83.3	40.9	28.8	86.3	73.6	32.6	38.1	28.7	38.7	49.4	120.6	47.9	25.5	41.3	52.2	34.0	47.3	90.0	76.0	79.5	115.7	102.4	68.4	73.9	78.7	240.2	264.1	340.1	125.3	266.4	139.0	386.4	125.1	132.0	189.4	388.0	112.1	120.7	346.4	111.6	256.4	243.9	172.3	301.8	53.1	54.2	54.5	67.5	53.4	58.7	54.4	55.2	55.3	55.2	57.8	54.3	27.8	12.8	14.4	3.9	82.2	32.2	37.2	53.3	13.1	17.4	40.9	44.4	55.9	21.5	30.4	46.0	6.2	56.1	58.5	23.4	140.8	40.7	9.7	18.6	32.7	31.7	28.2	40.2	8.6	47.1	58.8	36.8	19.4	23.3	41.2	25.7	32.2	66.8	105.7	18.5	9.1	23.4	63.1	77.0	89.3	32.9	38.8	67.6	51.6	7.5	72.0	41.0	66.9	3.5	6.7	47.4	35.3	47.0	67.0	40.3	47.7	106.4	12.4	14.3	13.1	28.4	38.8	7.8	23.4	27.7	40.1	40.0	51.0	43.3	28.5	27.3
LSM11	FLJ38273	ENSG00000155858	"LSM11, U7 small nuclear RNA associated"	P83369	5	157743712-157760709	"Predicted intracellular proteins"	"mRNA processing"	"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Bipolar cells: 26.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039587	Uncertain		Supported	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm	"Nuclear bodies"	"HPA039587: AB_10796330"	"unprognostic (3.99e-2)"	"unprognostic (2.05e-1)"	"unprognostic (2.38e-2)"	"unprognostic (6.90e-2)"	"unprognostic (2.32e-2)"	"unprognostic (1.90e-1)"	"unprognostic (6.61e-3)"	"unprognostic (9.68e-3)"	"unprognostic (1.70e-1)"	"unprognostic (2.89e-2)"	"unprognostic (3.77e-2)"	"unprognostic (3.57e-1)"	"unprognostic (1.62e-3)"	"unprognostic (1.44e-1)"	"unprognostic (1.07e-1)"	"unprognostic (6.11e-2)"	"unprognostic (3.01e-2)"	2.0	2.1	3.6	1.9	3.8	1.7	2.2	3.8	4.8	4.3	0.2	6.4	2.3	5.3	1.5	2.2	3.1	2.3	1.2	4.0	2.3	1.3	1.3	1.8	2.1	2.7	3.0	3.4	1.9	1.8	2.2	2.1	3.0	4.3	2.6	7.1	1.8	4.7	1.4	2.2	2.3	3.3	3.0	1.6	2.3	4.1	2.7	1.8	1.2	1.4	2.1	9.8	3.5	3.0	3.2	2.3	6.2	6.6	2.7	3.5	5.4	4.3	1.9	3.6	4.7	6.9	3.1	7.0	4.9	2.5	2.5	3.7	8.1	4.7	3.9	5.0	7.6	2.9	8.6	4.4	1.0	8.7	3.5	1.6	3.1	4.3	4.4	4.0	5.9	5.7	5.5	3.7	3.9	3.0	4.9	5.1	1.8	2.6	6.9	7.7	7.7	2.9	1.8	2.9	3.6	5.7	2.8	3.8	3.8	4.5	3.2	5.3	4.2	6.9	2.7	4.1	6.9	3.0	2.0	6.9	2.8	8.9	3.1	0.4	0.1	0.0	0.2	0.1	0.3	0.1	0.3	0.2	0.1	0.1	0.2	0.2	0.1	0.4	0.0	0.0	0.2	0.1	3.6	3.8	3.8	4.8	4.0	2.3	2.7	3.0	3.0	3.0	2.7	3.0	3.6	6.4	4.1	2.3	2.7	3.6	3.5	1.3	2.2	26.1	3.3	2.5	2.2	1.5	3.1	3.7	6.2	2.1	4.7	3.1	0.0	1.7	10.6	0.8	3.7	3.2	3.0	1.3	11.7	0.9	4.8	3.6	2.0	1.6	1.3	5.5	3.9	2.2	2.2	8.4	11.8	2.0	0.0	4.2	5.7	15.7	1.5	2.6	0.0	1.0	3.5	2.2	4.1	1.5	2.4	1.8	6.2	4.1	2.4	3.7	2.1	1.5	1.9	7.8	0.0	4.3	9.1	10.5	10.9	1.9	4.3	1.2	2.8	2.1	5.5	4.0
LSM14A	"C19orf13, DKFZP434D1335, FAM61A, RAP55, RAP55A"	ENSG00000257103	"LSM14A mRNA processing body assembly factor"	Q8ND56	19	34172504-34229288	"Predicted intracellular proteins"	"Translation regulation"	"Developmental protein, Repressor, Ribonucleoprotein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017961	Approved		Supported	"Cytosol,Cytoplasmic bodies"		NA	NA		18000	"Cluster 15: NK-cells - Transcription"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 32: Non-specific - Translation"	"Cytoplasmic bodies"	Cytosol	"HPA017961: AB_1845610"	"unprognostic (2.38e-1)"	"unprognostic (3.30e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.45e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.01e-2)"	"unprognostic (2.45e-3)"	"unprognostic (1.88e-1)"	"unprognostic (9.62e-3)"	"unprognostic (5.77e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.19e-1)"	"unprognostic (4.98e-2)"	"unprognostic (4.17e-2)"	"unprognostic (2.52e-2)"	"unprognostic (5.55e-2)"	"unprognostic (1.56e-1)"	43.9	38.5	26.4	27.5	26.2	72.0	42.0	28.0	39.2	46.2	29.4	49.4	24.8	47.8	31.7	41.2	40.6	22.7	36.4	25.5	26.0	37.7	37.6	37.7	46.5	26.1	27.1	51.7	32.9	33.8	30.4	37.5	26.4	36.5	29.2	52.8	36.4	32.3	74.2	47.1	38.2	33.0	28.3	36.7	32.8	33.1	26.1	50.7	45.9	43.7	40.8	44.2	41.8	27.7	66.0	46.1	62.9	49.7	33.4	42.9	20.4	24.7	39.5	43.9	42.9	50.2	27.7	107.9	28.9	46.7	14.7	17.6	57.0	42.7	70.8	71.5	10.4	102.2	30.0	50.5	58.7	82.1	34.6	39.4	63.0	33.3	47.8	56.1	63.3	36.3	56.6	44.8	45.6	32.0	64.8	62.2	59.9	61.0	7.5	42.7	44.1	40.7	58.4	32.9	52.8	40.8	56.7	85.2	61.5	56.2	54.8	102.0	38.7	66.3	25.6	25.5	53.1	43.3	59.0	78.6	42.0	57.5	40.4	16.5	9.3	18.9	11.4	12.1	15.2	11.9	13.4	12.8	10.9	8.0	14.3	12.7	8.1	17.8	14.6	5.2	13.4	11.1	26.4	26.2	28.0	39.2	25.5	26.0	26.1	27.1	26.4	28.3	26.1	27.7	64.3	25.6	42.8	81.9	118.7	123.9	70.2	64.6	86.0	92.3	68.1	50.0	70.6	61.5	58.4	58.8	20.9	161.2	108.2	39.0	68.4	77.7	65.6	54.3	64.2	75.5	57.2	100.4	68.0	54.1	176.6	70.1	37.8	57.0	62.1	64.6	63.9	50.6	67.0	62.2	70.1	52.7	73.2	63.7	96.7	75.5	126.2	73.5	67.6	85.3	137.2	104.3	232.8	92.0	113.4	59.6	40.2	127.2	80.2	110.0	49.9	88.0	47.6	78.8	78.9	64.2	78.8	194.9	151.6	75.4	131.6	137.4	101.5	69.2	51.4	71.7
LSM14B	"bA11M20.3, C20orf40, FAM61B, FLJ25473, FT005, LSM13, RAP55B"	ENSG00000149657	"LSM family member 14B"	Q9BX40	20	62122461-62135374	"Predicted intracellular proteins"	"Translation regulation"	"Developmental protein, Ribonucleoprotein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	16	"Early spermatids: 215.2;Late spermatids: 560.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"eosinophil: 2.2"	"Lineage enriched"	"Detected in single"	4	"granulocytes: 2.2"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041274, HPA061189"	Approved		Supported	Vesicles		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 21: Non-specific - Transcription"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 25: Spermatids - Spermatogenesis"	Vesicles		"HPA041274: AB_2677388, HPA061189: AB_2684448"	"unprognostic (2.24e-1)"	"unprognostic (2.35e-1)"	"unprognostic (2.89e-1)"	"unprognostic (1.85e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.42e-1)"	"prognostic unfavorable (3.61e-5)"	"unprognostic (4.99e-2)"	"unprognostic (2.28e-1)"	"unprognostic (5.43e-2)"	"unprognostic (4.93e-3)"	"unprognostic (4.69e-2)"	"unprognostic (3.34e-3)"	"unprognostic (6.61e-2)"	"unprognostic (2.00e-1)"	"unprognostic (4.53e-3)"	"unprognostic (1.98e-1)"	19.7	23.9	29.3	21.0	30.1	26.7	19.8	39.5	34.5	27.5	21.6	27.4	23.4	31.2	14.2	31.6	25.7	14.5	37.7	32.3	24.1	19.0	24.4	19.3	23.5	24.2	26.6	37.4	30.4	21.3	24.9	14.9	25.9	22.0	14.3	31.2	23.7	17.4	71.6	34.6	22.8	17.6	23.2	21.7	23.3	51.9	27.1	28.8	20.9	45.3	17.8	26.5	27.3	27.2	44.4	41.6	65.0	62.5	29.0	30.3	55.3	46.0	34.1	93.7	40.9	123.4	30.1	46.5	51.7	31.9	67.9	62.9	31.5	39.6	46.4	19.2	22.9	112.3	57.8	74.3	40.0	48.6	65.1	26.1	70.4	39.1	36.1	36.7	24.3	53.8	61.4	32.7	33.0	58.7	81.2	72.7	40.2	70.8	61.0	104.3	128.5	36.9	25.5	51.7	88.8	77.0	83.9	73.5	61.3	37.5	91.6	60.9	31.8	132.9	90.0	69.1	47.3	40.8	52.1	56.8	58.5	31.7	43.4	0.0	0.4	2.2	0.3	0.3	0.1	0.5	0.2	0.4	0.3	0.5	0.2	0.3	0.6	0.0	0.2	0.4	0.2	0.1	29.3	30.1	39.5	34.5	32.3	24.1	24.2	26.6	25.9	23.2	27.1	27.2	8.6	9.6	6.8	9.1	7.3	9.7	3.5	4.7	5.2	15.1	8.4	7.1	22.8	7.2	7.9	1.8	8.4	6.4	15.3	13.5	1.9	5.0	215.2	13.3	14.1	8.0	13.9	9.5	6.2	5.3	6.0	7.5	8.2	10.3	5.1	14.8	5.0	11.6	8.6	8.4	6.8	12.0	6.1	13.2	6.8	560.0	13.4	8.8	3.6	7.5	8.2	17.2	7.2	5.0	8.4	7.1	8.2	15.8	4.7	9.2	9.7	6.7	12.1	20.3	0.0	9.5	6.4	11.2	23.1	7.6	10.1	5.2	6.9	13.4	12.4	3.0
LSMEM1	"C7orf53, FLJ39575"	ENSG00000181016	"Leucine rich single-pass membrane protein 1"	Q8N8F7	7	112480853-112491062	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"skeletal muscle: 81.6"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 49.2;Glandular and luminal cells: 27.7;Late spermatids: 67.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	7	"HeLa: 8.7"	"Group enriched"	"Detected in many"	4	"amygdala: 1.4;basal ganglia: 1.0;cerebellum: 4.0;olfactory bulb: 3.3"	"Low region specificity"	"Detected in many"			"HPA013753, HPA047988"	Uncertain		Supported	Vesicles,Cytosol		NA	NA				"Cluster 33: Striated muscle - Muscle contraction"	"Cluster 20: HeLa - Mitochondria"	"Cluster 7: Non-specific - Mitochondria"	Cytosol	Vesicles	"HPA013753: AB_1848926, HPA047988: AB_2680229"	"unprognostic (6.87e-2)"	"unprognostic (5.94e-2)"	"unprognostic (2.79e-2)"	"unprognostic (2.77e-2)"	"unprognostic (1.38e-1)"	"unprognostic (3.01e-1)"	"unprognostic (2.34e-1)"	"unprognostic (1.36e-1)"	"unprognostic (2.17e-1)"	"unprognostic (6.68e-2)"	"unprognostic (3.54e-2)"	"unprognostic (2.80e-3)"	"unprognostic (1.47e-6)"	"unprognostic (1.56e-1)"	"unprognostic (1.36e-1)"	"unprognostic (4.25e-2)"	"unprognostic (3.42e-2)"	2.2	2.1	1.2	0.2	1.7	0.3	1.5	2.1	2.5	1.7	1.1	2.0	0.5	1.0	1.0	2.0	1.6	0.1	2.9	1.2	1.7	4.0	7.2	4.3	0.1	1.2	1.1	1.7	5.5	0.0	2.3	0.2	1.1	2.5	0.3	0.8	1.7	0.3	81.6	1.4	2.2	0.1	0.8	4.2	2.7	2.9	1.3	0.1	2.2	17.0	0.0	1.8	2.2	1.5	0.0	0.1	0.1	0.6	0.5	0.5	0.0	0.0	0.1	0.1	0.1	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.2	0.3	0.0	0.0	0.2	0.2	8.7	0.4	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.2	0.0	0.1	0.1	0.2	0.2	0.0	0.1	0.9	0.2	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.4	0.7	1.3	0.0	0.2	0.4	0.1	0.0	0.2	0.5	0.3	0.1	0.2	0.0	0.0	0.2	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	1.7	2.1	2.5	1.2	1.7	1.2	1.1	1.1	0.8	1.3	1.5	16.8	0.0	2.8	5.9	5.1	5.5	2.7	1.3	9.6	2.1	12.8	23.4	9.9	2.8	2.2	1.8	2.1	1.3	9.5	17.5	0.0	0.8	49.2	12.7	18.4	5.3	3.0	0.0	8.5	0.9	1.1	7.2	7.7	27.7	0.0	0.5	1.1	1.0	4.0	0.0	7.6	5.7	0.0	1.2	4.8	67.8	0.9	13.6	1.8	3.7	1.8	0.6	0.0	1.5	5.0	0.8	7.1	0.4	4.2	6.1	5.2	0.5	1.4	3.2	0.0	22.3	8.1	0.5	0.5	9.5	4.7	1.9	6.3	2.2	5.4	3.6
LSR	"ILDR3, LISCH7"	ENSG00000105699	"Lipolysis stimulated lipoprotein receptor"	Q86X29	19	35248330-35267964	"Predicted intracellular proteins, Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 144.8"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 335.6;Ductal cells: 260.5;Exocrine glandular cells: 278.9;Pancreatic endocrine cells: 336.0;Paneth cells: 273.6;Syncytiotrophoblasts: 248.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"A-431: 500.5;CACO-2: 215.6;CAPAN-2: 225.3;HaCaT: 203.9;OE19: 300.4;RT4: 198.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007270, HPA075309"	Approved		Supported	"Plasma membrane"		NA	NA		3500000	"Cluster 44: Non-specific - Transcription"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Plasma membrane"		"HPA007270: AB_1079253, HPA075309: "	"unprognostic (3.90e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.34e-2)"	"unprognostic (2.67e-3)"	"unprognostic (2.28e-2)"	"unprognostic (6.07e-3)"	"unprognostic (1.55e-1)"	"unprognostic (9.84e-2)"	"unprognostic (2.17e-1)"	"unprognostic (2.70e-2)"	"unprognostic (2.23e-2)"	"unprognostic (3.42e-2)"	"prognostic favorable (8.09e-4)"	"unprognostic (1.64e-1)"	"unprognostic (1.84e-1)"	"unprognostic (2.99e-2)"	"unprognostic (1.54e-2)"	15.7	31.3	15.7	17.8	13.6	3.6	25.4	13.2	14.7	20.4	39.0	96.9	85.0	14.4	13.9	60.0	29.7	36.4	7.7	12.5	13.2	28.9	144.8	30.0	14.4	17.1	14.8	6.4	114.2	16.8	27.3	46.9	15.5	25.6	43.7	8.6	69.4	18.5	4.4	51.9	75.0	5.3	12.9	17.9	133.1	27.2	17.7	6.6	32.9	2.7	14.1	29.9	29.3	14.8	500.5	8.1	0.7	1.0	1.4	0.5	86.8	1.2	1.9	2.2	1.6	215.6	225.3	19.6	73.0	1.3	7.2	203.9	44.3	75.0	0.3	30.1	82.6	0.2	6.5	96.1	1.7	0.3	0.9	1.0	81.2	2.0	24.2	1.0	0.8	0.6	80.2	17.2	1.1	177.4	0.9	1.1	69.0	300.4	3.2	3.8	0.8	54.6	46.2	198.2	37.7	1.4	40.9	130.5	35.8	21.7	112.5	2.6	0.4	3.9	44.7	3.1	2.2	27.2	52.5	45.7	3.4	0.8	12.4	6.4	0.2	0.1	2.5	0.0	2.6	4.3	5.8	5.4	0.1	3.0	4.2	4.9	0.0	5.6	0.0	0.2	4.1	2.9	15.7	13.6	13.2	14.7	12.5	13.2	17.1	14.8	15.5	12.9	17.7	14.8	38.2	16.0	21.7	0.3	26.3	51.7	123.4	90.7	50.1	2.1	60.9	49.7	5.6	78.6	71.2	36.8	16.7	210.3	4.7	335.6	11.7	260.5	9.4	41.7	27.4	44.6	56.4	3.2	0.8	278.9	93.0	11.9	214.1	61.5	31.1	30.3	20.3	89.7	21.7	0.0	0.9	145.5	73.2	2.2	14.3	2.9	6.5	4.6	14.2	22.5	7.2	11.5	3.1	1.5	0.8	336.0	273.6	3.4	41.1	113.6	117.8	24.6	43.8	12.3	0.0	4.1	24.4	7.9	19.1	57.2	51.7	248.0	24.3	3.4	124.2	206.3
LST1	"B144, D6S49E, LST-1"	ENSG00000204482	"Leukocyte specific transcript 1"	O00453	6	31586124-31588909	"Predicted intracellular proteins, Predicted membrane proteins"	"Cell shape, Immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"bone marrow: 100.3;lung: 48.8;lymphoid tissue: 181.9"	"Group enriched"	"Detected in many"	11	"Hofbauer cells: 407.1;Kupffer cells: 1326.9;Langerhans cells: 1240.5;Macrophages: 871.6;monocytes: 1096.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"non-classical monocyte: 1746.7"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"HEL: 39.3;HMC-1: 73.6;MOLT-4: 39.6;NB-4: 76.2;THP-1: 179.9;U-937: 92.9"	"Low region specificity"	"Detected in all"							HPA079451			Supported	"Plasma membrane,Cytosol"		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 2: Immune cells - Immune response"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	"Plasma membrane, Cytosol"		"HPA079451: "	"unprognostic (1.08e-2)"	"prognostic favorable (7.89e-4)"	"unprognostic (6.99e-2)"	"unprognostic (4.16e-3)"	"unprognostic (3.13e-1)"	"unprognostic (3.92e-2)"	"unprognostic (3.65e-1)"	"unprognostic (7.06e-3)"	"unprognostic (2.81e-3)"	"unprognostic (2.12e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.28e-1)"	"prognostic unfavorable (5.97e-5)"	"unprognostic (1.47e-1)"	"prognostic unfavorable (7.62e-4)"	"unprognostic (1.03e-1)"	"unprognostic (1.95e-1)"	15.2	10.2	4.3	22.0	4.3	100.3	7.9	4.6	7.2	5.6	5.0	7.9	7.1	3.7	1.4	5.5	6.6	3.1	7.6	4.6	5.5	10.8	14.4	48.8	13.8	6.1	4.9	3.0	4.7	0.9	6.1	4.7	6.6	8.9	3.0	0.5	6.9	2.3	2.1	7.8	15.0	5.1	5.4	181.9	5.7	1.8	5.2	15.1	4.6	1.9	7.1	9.1	5.1	6.0	0.3	0.6	0.0	0.8	0.0	0.0	0.0	0.0	0.3	0.0	0.5	0.0	0.2	2.5	0.6	0.0	0.0	0.5	0.3	0.4	0.3	12.9	0.0	39.3	0.0	0.0	0.7	29.3	73.6	0.0	0.3	0.1	1.2	0.3	0.9	0.8	0.1	0.2	0.0	0.0	39.6	76.2	0.1	0.0	0.0	18.4	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	179.9	0.3	0.0	0.4	0.0	0.2	0.1	0.0	5.9	0.0	92.9	0.0	112.2	419.7	681.6	9.4	1273.9	80.7	32.8	15.9	20.2	392.9	21.9	10.9	9.0	1133.0	21.6	1746.7	69.9	12.0	541.6	4.3	4.3	4.6	7.2	4.6	5.5	6.1	4.9	6.6	5.4	5.2	6.0	5.4	35.3	86.7	0.7	43.7	35.2	0.3	0.2	0.0	0.3	3.2	12.2	1.9	7.2	13.0	11.0	0.0	2.9	42.8	1.0	0.0	0.6	1.5	0.4	1.9	12.9	0.0	15.1	0.2	0.2	3.8	9.2	1.5	0.4	70.3	0.1	22.9	5.8	407.1	0.0	0.3	0.0	2.0	1326.9	1240.5	5.4	3.7	871.6	44.4	24.4	1096.6	0.7	60.8	0.5	0.1	0.1	1.1	1.2	4.7	1.0	0.0	3.8	11.0	0.2	26.3	2.2	2.8	2.4	4.6	0.4	28.3	5.3	43.6	0.0	0.4	0.3
LTA4H		ENSG00000111144	"Leukotriene A4 hydrolase"	P09960	12	96000753-96043520	"Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Leukotriene biosynthesis, Lipid metabolism"	"Hydrolase, Metalloprotease, Protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Hofbauer cells: 207.2;Kupffer cells: 255.8;monocytes: 245.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008399, CAB015221, HPA017017"	Supported		Approved	Nucleoplasm,Cytosol		NA	NA		86000000	"Cluster 7: Monocytes - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	"Nucleoplasm, Cytosol"		"CAB015221: , HPA008399: AB_1852816, HPA017017: AB_1852818"	"prognostic favorable (9.79e-4)"	"unprognostic (6.62e-2)"	"unprognostic (6.04e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.38e-2)"	"unprognostic (2.59e-2)"	"unprognostic (4.25e-3)"	"prognostic favorable (8.96e-4)"	"unprognostic (1.72e-1)"	"unprognostic (1.75e-2)"	"unprognostic (3.38e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.04e-1)"	"unprognostic (3.50e-2)"	"unprognostic (1.34e-1)"	40.2	66.9	24.6	64.5	25.5	180.4	53.6	29.4	30.6	55.6	33.8	48.2	78.1	51.1	38.4	110.1	61.7	40.3	35.5	25.0	27.8	58.1	43.9	190.8	64.1	26.3	25.4	110.5	54.9	53.3	37.4	27.4	26.0	41.1	49.6	36.9	41.2	40.9	45.0	67.8	60.5	58.3	25.7	57.8	46.6	19.9	28.1	49.2	49.4	45.0	96.4	51.9	52.7	33.0	85.2	90.4	123.5	73.4	104.2	115.1	53.8	33.7	101.8	67.5	78.1	66.6	72.0	190.0	42.0	51.9	52.8	108.3	103.4	140.1	92.3	63.3	97.0	68.5	54.3	81.8	61.8	35.7	39.4	110.1	118.4	91.9	114.5	305.3	134.9	101.1	42.9	32.5	98.7	59.2	96.7	115.0	145.8	100.7	115.5	88.9	90.5	109.7	125.7	107.7	63.9	75.5	64.2	80.4	78.3	95.1	98.7	44.7	49.0	28.3	47.6	40.2	38.2	42.8	79.4	85.4	19.1	66.2	22.3	4.4	662.9	17.7	33.4	699.2	63.4	126.1	46.6	43.4	282.3	157.5	65.0	50.5	46.0	120.4	638.8	70.4	51.2	591.5	24.6	25.5	29.4	30.6	25.0	27.8	26.3	25.4	26.0	25.7	28.1	33.0	32.8	38.5	135.0	15.3	82.8	51.9	64.8	96.6	52.3	21.4	41.8	41.1	25.3	25.8	110.2	38.6	33.3	29.3	47.9	17.6	74.3	42.9	74.3	18.4	20.8	38.2	21.6	50.5	21.3	28.0	28.2	29.7	38.2	27.3	7.6	31.5	57.8	21.7	207.2	11.8	18.5	40.4	40.7	255.8	76.6	16.4	36.7	183.3	21.4	10.3	245.5	35.5	26.8	19.6	17.5	20.8	27.1	41.0	40.1	35.4	73.2	69.3	45.0	55.6	6.6	26.7	35.4	46.9	11.6	108.0	74.9	20.8	39.1	32.9	70.4	49.7
LTB4R2	"BLT2, BLTR2, JULF2, NOP9"	ENSG00000213906	"Leukotriene B4 receptor 2"	Q9NPC1	14	24305734-24312053	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in many"		"esophagus: 37.7;skin 1: 46.4"	"Group enriched"	"Detected in some"	4	"Basal squamous epithelial cells: 18.2;Squamous epithelial cells: 15.7"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 4.1"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HaCaT: 15.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB022689, HPA029680, HPA072921"	Uncertain		Supported	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 59: Non-specific - Transcription"	"Plasma membrane"	Nucleoplasm	"CAB022689: , HPA029680: AB_10603013, HPA072921: AB_2686557"	"unprognostic (2.01e-1)"	"unprognostic (1.04e-1)"	"unprognostic (9.53e-2)"	"unprognostic (8.82e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.12e-2)"	"unprognostic (1.40e-1)"	"unprognostic (7.22e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.48e-3)"	"unprognostic (7.18e-2)"	"unprognostic (7.05e-11)"	"unprognostic (1.84e-1)"	"unprognostic (1.04e-1)"	"unprognostic (4.23e-2)"	"unprognostic (1.19e-1)"	5.1	5.8	0.4	2.1	0.5	5.4	4.7	0.5	0.4	15.8	0.4	2.7	2.6	3.0	0.8	37.7	4.0	0.9	2.2	0.3	0.3	2.8	4.0	4.7	2.0	1.2	0.4	4.9	4.7	0.2	3.9	1.0	0.5	5.0	0.5	2.1	11.7	1.2	3.0	46.4	5.1	0.5	0.5	13.5	2.7	4.2	0.6	1.7	3.9	0.1	3.2	2.7	21.6	0.8	2.4	3.9	1.6	1.7	0.3	0.5	7.1	0.8	0.4	1.2	0.7	3.1	1.3	2.9	1.4	0.5	1.6	15.0	1.1	2.5	0.8	3.7	4.4	2.0	3.7	1.5	0.4	3.4	3.7	0.5	3.1	1.7	2.0	1.0	0.5	5.3	2.6	3.3	0.5	4.4	1.8	3.5	0.9	0.1	4.7	7.4	1.5	1.7	0.3	2.8	3.1	1.5	1.5	1.8	1.3	1.7	3.4	2.5	1.5	2.3	2.8	3.6	1.3	7.1	2.1	4.7	0.5	5.5	1.8	0.0	0.5	0.3	0.6	0.3	0.3	0.0	0.5	0.5	0.5	0.0	0.3	0.2	0.2	0.2	0.2	0.1	0.1	0.3	0.4	0.5	0.5	0.4	0.3	0.3	1.2	0.4	0.5	0.5	0.6	0.8	2.3	0.0	0.0	0.0	0.7	0.3	3.4	0.1	18.2	0.4	0.6	1.3	0.0	0.0	0.0	1.8	0.0	0.2	1.2	0.5	0.0	0.2	0.0	1.9	0.2	1.6	1.8	2.1	0.0	1.4	0.1	0.5	1.5	0.4	0.0	0.2	1.1	1.0	0.7	3.3	0.0	0.4	0.0	1.9	0.0	0.0	0.3	1.8	0.0	0.0	0.2	0.2	1.0	0.0	0.0	0.4	1.2	0.0	3.0	0.4	1.1	0.3	0.7	0.5	0.0	0.3	0.2	0.9	0.2	15.7	0.1	0.3	2.3	0.3	0.8	0.8
LTBR	"D12S370, TNF-R-III, TNFCR, TNFR-RP, TNFR2-RP, TNFRSF3"	ENSG00000111321	"Lymphotoxin beta receptor"	P36941	12	6375045-6391571	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Apoptosis, Host-virus interaction"	Receptor	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"classical monocyte: 71.3;intermediate monocyte: 66.3;myeloid DC: 49.8;neutrophil: 45.0;non-classical monocyte: 50.1"	"Group enriched"	"Detected in many"	36	"dendritic cells: 49.8;granulocytes: 45.0;monocytes: 71.3"	"Cell line enhanced"	"Detected in many"		"HHSteC: 393.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB026202, HPA061617"	Uncertain		Supported	"Golgi apparatus"		NA	Yes			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 85: Liver - Metabolism"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 61: Squamous epithelial cells - Keratinization"	"Golgi apparatus"		"CAB026202: , HPA061617: AB_2732666"	"unprognostic (2.60e-2)"	"unprognostic (1.24e-2)"	"unprognostic (7.75e-3)"	"unprognostic (2.23e-2)"	"unprognostic (3.01e-2)"	"unprognostic (3.24e-3)"	"prognostic unfavorable (5.13e-4)"	"unprognostic (2.08e-2)"	"unprognostic (2.24e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.45e-3)"	"unprognostic (1.91e-1)"	"prognostic unfavorable (5.92e-4)"	"unprognostic (3.66e-2)"	"unprognostic (9.84e-3)"	"unprognostic (6.91e-2)"	"unprognostic (2.86e-1)"	67.6	64.4	13.9	36.4	14.6	11.7	60.3	14.7	15.9	65.8	18.0	72.7	48.6	68.1	20.7	81.3	49.6	48.3	37.2	13.3	15.8	55.1	135.8	66.0	14.6	19.6	17.3	46.3	78.7	54.9	26.3	48.6	18.8	61.9	34.3	1.9	61.5	44.0	26.3	75.1	51.1	62.6	17.4	44.8	67.7	13.3	18.1	11.7	57.2	23.5	18.0	65.8	65.1	17.0	98.2	130.3	0.0	41.1	245.9	183.7	89.9	67.9	153.1	98.8	101.1	62.0	148.7	0.1	39.5	145.7	0.5	112.2	0.5	140.5	38.9	0.0	0.2	58.1	53.2	36.6	393.1	4.1	94.6	270.8	255.2	70.7	197.1	102.6	91.2	0.0	55.5	0.5	115.0	93.5	0.4	29.3	1.2	155.7	74.4	0.0	6.6	0.2	149.2	112.2	0.7	0.5	63.6	122.9	143.6	5.0	20.5	105.3	58.0	34.6	39.6	129.0	72.1	0.0	0.4	0.1	14.6	35.9	129.5	5.4	71.3	0.5	0.2	66.3	0.0	0.1	0.1	0.1	49.8	0.1	0.3	0.2	45.0	1.5	50.1	11.8	0.1	27.2	13.9	14.6	14.7	15.9	13.3	15.8	19.6	17.3	18.8	17.4	18.1	17.0	47.0	60.9	68.9	2.9	3.6	39.0	87.2	46.4	72.3	4.1	33.9	35.9	15.5	45.8	60.7	31.3	0.0	31.3	12.4	78.3	9.8	52.2	0.7	23.8	48.6	49.3	52.0	15.8	0.5	99.8	43.6	50.5	89.7	45.2	29.7	30.1	50.7	66.5	48.7	0.0	0.5	57.1	34.6	77.3	34.6	5.1	52.8	50.8	23.2	14.0	43.1	9.6	11.3	5.5	1.1	69.5	82.3	39.9	3.3	110.7	136.9	30.1	42.8	1.6	26.3	33.1	42.0	1.6	0.9	78.9	61.7	37.5	4.9	28.0	63.4	97.6
LTC4S	MGC33147	ENSG00000213316	"Leukotriene C4 synthase"	Q16873	5	179793980-179796647	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins"	"Leukotriene biosynthesis, Lipid biosynthesis, Lipid metabolism"	"Lyase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enriched"	"Detected in many"	4	"granulocytes: 327.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"basophil: 20.2;eosinophil: 63.1"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 63.1"	"Cell line enriched"	"Detected in some"	11	"HMC-1: 102.0"					"Low region specificity"	"Detected in many"			HPA044688			Approved	"Nucleoplasm,Endoplasmic reticulum,Cytosol"		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm	"Endoplasmic reticulum, Cytosol"	"HPA044688: "	"unprognostic (8.94e-2)"	"unprognostic (2.40e-2)"			"unprognostic (9.35e-3)"		"unprognostic (3.57e-2)"	"unprognostic (1.24e-2)"		"unprognostic (9.40e-2)"	"unprognostic (4.53e-5)"	"unprognostic (2.27e-2)"	"unprognostic (1.06e-1)"	"unprognostic (9.99e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.98e-2)"	"unprognostic (4.62e-1)"	8.9	6.9	1.1	0.5	0.8	2.3	5.5	1.5	1.3	4.2	0.7	3.3	0.7	5.7	0.0	3.1	11.8	0.3	12.4	1.0	1.4	7.1	1.9	7.7	0.2	2.1	1.5	5.7	2.0	0.2	3.5	0.4	1.4	4.8	0.2	0.0	4.3	0.8	1.0	3.1	3.2	0.4	2.9	6.1	3.0	1.5	2.6	0.0	5.9	0.0	0.1	4.8	4.0	4.7	0.1	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.9	0.9	8.9	0.2	0.4	0.3	0.6	102.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.1	0.1	6.5	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.1	0.0	0.3	0.0	0.0	0.0	3.2	0.5	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.3	1.0	0.1	20.2	0.5	63.1	0.8	0.6	3.0	0.3	2.1	1.5	8.6	0.2	0.4	1.0	0.3	4.7	0.0	0.4	0.2	0.6	1.1	0.8	1.5	1.3	1.0	1.4	2.1	1.5	1.4	2.9	2.6	4.7	32.3	0.0	3.2	2.9	2.3	9.9	9.6	11.2	14.8	0.4	26.4	38.6	0.0	14.3	6.2	14.7	0.0	10.4	5.0	0.6	1.9	5.9	0.3	4.0	1.5	49.5	3.0	2.1	0.8	2.4	1.9	8.3	3.1	5.6	327.4	0.5	72.1	0.9	41.5	0.0	0.7	1.7	0.0	20.8	46.3	0.9	16.4	53.9	1.8	28.1	2.0	0.1	2.1	1.0	1.5	1.9	0.5	47.4	10.0	3.7	2.2	54.8	5.8	0.5	0.0	0.8	1.6	0.1	0.7	5.2	7.0	3.0	10.0	1.5	3.1	10.0
LURAP1	"C1orf190, FLJ25163, LRAP35a"	ENSG00000171357	"Leucine rich adaptor protein 1"	Q96LR2	1	46203334-46221256	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	6	"Early spermatids: 140.9;Late spermatids: 335.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 5.4;RPTEC TERT1: 5.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030060, HPA030061"	Uncertain		Supported	Vesicles,Cytosol		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 21: Non-specific - Transcription"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 31: Spermatids - Spermatogenesis"	Cytosol	Vesicles	"HPA030060: AB_10599997, HPA030061: AB_10601990"	"unprognostic (3.88e-2)"	"unprognostic (6.21e-2)"	"unprognostic (3.22e-3)"	"unprognostic (8.82e-2)"	"unprognostic (1.91e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.03e-1)"	"unprognostic (6.47e-2)"	"unprognostic (2.44e-2)"	"unprognostic (2.95e-2)"	"unprognostic (4.14e-2)"	"unprognostic (1.33e-1)"	"prognostic favorable (8.81e-8)"	"unprognostic (1.32e-2)"	"unprognostic (2.80e-1)"	"unprognostic (3.11e-2)"	"unprognostic (2.39e-2)"	2.1	3.5	2.4	0.9	6.5	1.7	2.1	5.7	5.7	4.5	2.5	3.1	0.8	3.2	2.2	2.0	3.3	1.7	5.4	3.1	4.7	5.3	0.4	1.6	0.5	9.7	5.4	3.9	0.3	9.5	2.1	0.9	7.3	4.6	1.0	1.3	2.6	4.8	1.1	2.0	1.3	2.7	4.0	1.6	2.7	8.9	6.2	1.2	10.5	1.0	0.8	3.8	4.0	13.6	0.1	0.1	2.1	0.1	2.8	3.8	2.1	1.5	3.8	2.0	2.3	0.1	0.1	0.2	0.1	3.6	0.7	0.2	2.2	4.8	1.6	0.4	1.0	0.2	0.5	0.2	0.8	0.1	0.1	1.8	3.0	4.0	1.8	5.4	3.0	0.5	1.9	0.3	1.1	0.2	0.2	0.2	0.8	0.0	0.3	0.7	1.0	0.0	5.3	0.0	0.3	0.8	0.0	0.1	3.4	0.8	1.1	0.2	0.2	1.2	1.5	1.0	0.3	0.1	0.1	0.2	1.2	0.2	0.3	0.2	0.2	0.1	0.1	0.1	0.3	0.2	0.1	0.1	0.1	0.3	0.3	0.2	0.8	0.3	0.1	0.2	0.0	0.1	2.4	6.5	5.7	5.7	3.1	4.7	9.7	5.4	7.3	4.0	6.2	13.6	2.2	0.0	0.0	6.8	0.0	5.0	15.6	4.5	8.0	0.2	2.7	4.1	3.1	0.0	1.3	11.0	0.0	4.1	0.1	0.2	15.6	0.1	140.9	1.3	1.6	2.9	1.2	0.0	10.0	0.4	2.3	4.0	0.0	1.3	0.0	2.5	3.3	0.1	4.4	0.0	5.5	0.3	0.0	0.3	3.3	335.2	9.3	1.2	14.2	5.6	0.7	2.0	1.0	1.0	25.3	0.0	0.1	9.8	0.0	8.6	0.1	5.3	3.3	0.2	6.6	2.6	4.7	36.3	2.2	2.7	3.4	7.7	0.2	2.7	0.1	5.5
LYN	JTK8	ENSG00000254087	"LYN proto-oncogene, Src family tyrosine kinase"	P07948	8	55879835-56014169	"Cancer-related genes, Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Adaptive immunity, Host-virus interaction, Immunity, Inflammatory response, Innate immunity"	"Kinase, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 73.8;lymphoid tissue: 85.4"	"Cell type enhanced"	"Detected in many"		"B-cells: 237.5;Kupffer cells: 183.7;Macrophages: 226.0;monocytes: 182.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 64.4"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEL: 198.4;HMC-1: 193.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001231, CAB004492"	Enhanced		Supported	"Golgi apparatus,Vesicles,Plasma membrane"		NA	NA		770000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 2: Immune cells - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 57: B-cells - Immune response"	"Golgi apparatus, Plasma membrane"	Vesicles	"CAB004492: AB_627897, HPA001231: AB_1079286"	"unprognostic (7.87e-2)"	"unprognostic (4.89e-2)"	"unprognostic (9.04e-2)"	"unprognostic (3.74e-1)"	"unprognostic (8.12e-2)"	"unprognostic (2.17e-1)"	"unprognostic (5.70e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.79e-1)"	"unprognostic (8.80e-2)"	"unprognostic (3.68e-2)"	"unprognostic (7.15e-2)"	"prognostic unfavorable (3.43e-4)"	"unprognostic (2.13e-1)"	"unprognostic (2.72e-3)"	"unprognostic (1.21e-1)"	"unprognostic (7.39e-2)"	17.2	7.3	3.9	79.2	4.0	73.8	9.2	7.4	8.7	11.0	7.8	14.2	36.3	6.2	4.8	8.6	10.0	23.5	5.4	4.4	5.5	5.9	14.9	28.2	49.2	9.4	7.2	3.6	9.5	6.3	4.8	23.5	8.3	5.6	13.3	8.9	17.0	9.7	1.6	3.7	31.6	14.2	7.2	85.4	13.3	3.1	9.0	10.4	10.6	4.4	53.1	29.7	5.7	11.2	47.2	24.6	6.9	0.7	0.5	0.0	43.6	34.6	54.7	21.0	15.7	18.0	15.5	41.2	15.0	12.1	15.3	19.3	22.2	23.8	14.6	70.0	19.8	198.4	6.9	5.5	4.0	20.6	193.4	0.8	7.8	0.6	13.6	13.1	27.2	0.0	98.3	90.2	3.0	3.3	0.1	21.5	38.6	72.9	2.1	3.3	9.6	5.0	9.8	24.9	4.5	74.8	17.3	0.1	7.5	44.9	3.4	41.4	33.1	0.0	10.0	0.1	15.0	26.4	13.2	102.4	1.5	38.8	1.7	4.5	12.2	22.7	1.6	28.3	1.3	15.9	0.3	0.6	10.3	16.1	0.2	0.7	64.4	4.3	49.1	16.2	0.0	5.0	3.9	4.0	7.4	8.7	4.4	5.5	9.4	7.2	8.3	7.2	9.0	11.2	21.0	35.3	37.5	27.7	237.5	5.4	23.8	32.4	4.6	6.3	10.3	7.0	2.2	18.6	44.5	9.2	2.1	2.9	130.0	14.5	0.0	21.8	0.9	14.6	26.2	28.1	6.0	40.4	1.1	53.0	65.2	13.6	18.8	15.9	72.8	0.5	22.9	13.2	126.6	0.0	2.5	14.1	14.2	183.7	96.1	2.4	3.4	226.0	5.4	92.8	182.6	54.3	94.7	13.0	1.7	40.7	13.3	1.2	58.9	62.9	26.0	2.1	40.9	2.6	19.7	3.7	6.4	1.2	2.1	4.9	5.8	38.7	25.0	62.5	17.1	82.4
LYPLAL1	Q96AV0	ENSG00000143353	"Lysophospholipase like 1"	Q5VWZ2	1	219173869-219212865	"Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal tubular cells: 209.4;Proximal tubular cells: 349.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045806	Approved		Supported	Cytosol		NA	NA		8600	"Cluster 30: Non-specific - Translation"	"Cluster 81: Kidney & Liver - Metabolism"	"Cluster 6: T47d - Mammary gland"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Cytosol		"HPA045806: AB_10966647"	"unprognostic (1.27e-2)"	"unprognostic (1.29e-1)"	"unprognostic (3.98e-2)"	"unprognostic (8.64e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.49e-1)"	"unprognostic (2.01e-1)"	"unprognostic (3.73e-2)"	"unprognostic (4.08e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.76e-2)"	"prognostic favorable (1.31e-4)"	"unprognostic (1.68e-1)"	"unprognostic (5.87e-2)"	"unprognostic (1.73e-1)"	"unprognostic (4.65e-2)"	9.3	17.9	7.5	3.8	7.6	1.1	10.0	7.8	11.3	8.5	7.2	5.6	8.6	7.3	3.6	7.9	5.4	8.6	36.5	7.3	8.5	42.3	27.3	7.0	8.6	7.9	7.5	9.8	7.6	11.8	5.8	8.2	7.9	13.2	5.9	6.5	8.5	6.5	7.4	9.6	7.5	7.8	8.0	4.4	6.1	6.5	7.4	5.8	16.2	12.1	7.7	6.0	3.9	8.8	9.1	9.4	4.1	0.0	8.1	16.3	10.3	5.3	5.9	4.8	5.6	4.3	12.9	10.0	13.9	4.5	4.7	4.9	8.6	12.1	7.3	13.7	9.3	5.8	4.9	9.8	32.9	12.6	4.3	19.5	11.1	4.8	12.1	11.3	14.5	9.5	16.8	10.2	11.4	6.1	6.1	10.3	7.8	8.6	15.4	3.3	10.5	17.5	19.9	7.1	10.1	5.6	6.3	16.9	17.7	13.5	16.2	15.6	7.8	4.0	2.0	8.2	6.2	8.7	5.3	6.8	13.5	10.1	9.0	0.9	2.0	1.5	0.8	1.8	1.9	3.3	1.3	1.0	1.8	2.0	2.3	1.8	2.2	1.4	1.8	1.5	1.6	1.3	7.5	7.6	7.8	11.3	7.3	8.5	7.9	7.5	7.9	8.0	7.4	8.8	23.6	25.6	35.5	93.0	37.1	22.2	18.7	75.5	29.0	28.5	23.9	25.4	105.9	31.5	42.0	51.5	8.4	89.5	12.8	10.8	209.4	49.3	40.9	7.7	17.4	16.3	18.6	10.3	50.2	53.2	35.4	29.7	11.7	23.6	17.1	18.5	22.9	39.8	64.8	18.5	51.7	18.0	44.7	26.8	21.2	7.8	27.1	49.3	42.7	79.6	27.1	108.7	20.6	82.9	123.4	37.5	16.9	30.9	15.0	13.0	33.4	349.2	38.2	28.9	13.1	24.8	23.3	36.0	24.8	24.9	29.3	62.5	14.2	26.5	15.8	12.3
LYRM1	A211C6.1	ENSG00000102897	"LYR motif containing 1"	O43325	16	20899868-20925006	"Disease related genes, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 188.1;Late spermatids: 464.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 154.9"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 154.9"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059840			Supported	Nucleoplasm,Midbody		Yes	No			"Cluster 2: Granulocytes - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 25: Spermatids - Spermatogenesis"	Nucleoplasm	Midbody	"HPA059840: AB_2684137"	"unprognostic (4.44e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.66e-2)"	"prognostic favorable (7.48e-7)"	"unprognostic (3.04e-1)"	"unprognostic (1.10e-1)"	"unprognostic (3.47e-1)"	"unprognostic (8.60e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.04e-2)"	"unprognostic (1.49e-2)"	"unprognostic (3.39e-1)"	"prognostic unfavorable (4.80e-4)"	"unprognostic (1.57e-1)"	"unprognostic (6.18e-2)"	"unprognostic (3.86e-1)"	"prognostic favorable (9.50e-4)"	37.8	31.1	26.7	16.4	27.2	24.2	30.0	28.7	31.4	30.4	31.6	32.0	13.8	27.6	35.2	18.7	34.4	16.2	50.8	27.1	28.3	51.8	95.8	18.8	24.2	28.1	27.7	34.0	27.3	33.5	21.2	13.6	28.7	29.1	20.4	26.5	16.2	26.8	42.3	19.2	18.0	22.6	27.3	16.9	27.9	37.6	27.7	25.1	22.8	34.1	21.9	34.8	23.0	28.5	33.2	29.7	30.3	25.9	74.1	64.0	9.6	27.9	39.3	14.8	21.7	42.8	39.2	22.6	92.2	31.5	21.6	21.6	14.1	25.5	25.6	41.6	19.8	10.1	8.3	112.1	56.6	35.9	20.4	45.0	24.5	40.0	98.6	41.4	58.5	37.3	23.2	39.6	59.0	43.5	39.1	26.3	34.3	46.5	17.2	47.8	18.4	30.8	56.3	15.1	29.8	27.7	16.6	26.3	45.1	18.5	27.5	19.5	16.0	21.4	15.8	35.1	19.6	35.1	51.2	38.5	59.7	35.6	20.1	154.9	16.7	59.3	19.7	21.8	28.2	29.5	29.8	24.2	14.3	24.8	24.3	24.1	63.8	22.1	25.9	17.9	33.0	24.5	26.7	27.2	28.7	31.4	27.1	28.3	28.1	27.7	28.7	27.3	27.7	28.5	32.5	19.2	18.9	9.1	29.9	21.0	57.6	26.8	25.6	28.9	41.2	39.4	55.1	27.1	17.2	23.9	14.6	29.1	24.6	9.6	76.3	41.3	188.1	24.2	12.9	35.8	30.0	8.4	10.6	44.2	10.6	30.8	21.9	15.9	15.8	20.5	15.0	53.9	16.5	15.2	14.1	15.0	28.5	16.4	14.5	464.6	28.9	16.2	17.8	4.7	45.7	48.0	22.6	9.5	11.2	30.2	14.6	38.0	15.8	41.6	19.2	125.4	25.4	34.0	13.1	25.8	26.3	112.5	27.5	18.2	20.9	14.9	22.9	16.3	24.5	56.7
LYRM4	"C6orf149, CGI-203, ISD11"	ENSG00000214113	"LYR motif containing 4"	Q9HD34	6	5103629-5260950	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA030362	Approved		Supported	"Nuclear bodies"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 32: Non-specific - Translation"	"Nuclear bodies"		"HPA030362: AB_10601546"	"unprognostic (2.41e-2)"	"unprognostic (3.72e-2)"	"unprognostic (7.68e-2)"	"unprognostic (8.58e-2)"	"unprognostic (1.30e-1)"	"unprognostic (8.73e-2)"	"unprognostic (1.85e-3)"	"unprognostic (4.58e-2)"	"unprognostic (7.83e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.26e-1)"	"unprognostic (2.79e-3)"	"unprognostic (1.43e-1)"	"unprognostic (2.76e-1)"	"unprognostic (9.80e-2)"	"unprognostic (5.23e-1)"	16.9	18.8	22.8	14.6	22.5	19.0	19.0	21.4	31.0	16.2	24.0	14.7	7.7	18.1	18.1	13.4	19.1	11.2	20.5	22.3	22.1	14.5	13.6	12.1	22.9	22.7	21.7	27.1	19.4	15.9	20.4	14.2	22.3	12.3	16.2	15.9	13.0	10.2	14.4	17.1	10.4	16.6	22.3	15.9	14.1	16.0	21.8	20.8	19.5	11.0	21.8	16.9	14.2	24.1	28.9	27.4	41.1	32.0	41.3	60.1	37.1	27.1	44.0	36.9	38.0	57.8	19.2	44.7	51.7	35.8	51.6	25.4	58.9	34.2	41.0	79.4	45.9	19.7	20.9	77.4	25.9	52.2	19.2	47.9	53.1	33.1	43.3	34.9	35.8	42.4	64.3	15.2	32.1	15.6	49.6	70.5	39.6	45.9	42.1	49.2	30.8	82.2	38.6	23.4	55.2	35.6	23.8	14.6	65.5	58.6	39.8	44.7	29.5	39.2	26.3	32.9	44.8	22.4	82.4	42.7	19.0	36.6	54.2	1.9	18.8	2.1	11.7	19.8	15.6	31.3	17.5	13.3	34.4	26.2	26.6	24.6	4.3	23.6	17.5	23.0	19.1	17.6	22.8	22.5	21.4	31.0	22.3	22.1	22.7	21.7	22.3	22.3	21.8	24.1	75.6	25.6	16.2	28.4	45.0	73.5	55.6	80.9	25.0	16.4	51.9	48.4	29.1	28.6	33.9	18.4	8.4	49.5	23.0	12.3	31.3	44.1	38.8	26.0	29.3	40.3	32.3	32.0	103.4	43.8	72.2	37.6	11.2	19.0	41.3	39.6	41.7	35.9	65.2	11.8	57.4	26.5	32.6	46.8	93.0	91.7	46.3	31.7	69.4	32.8	74.2	45.1	23.7	80.4	50.8	34.1	15.3	35.3	32.6	108.9	7.2	90.0	26.6	16.8	32.9	32.2	34.8	79.4	78.7	32.1	82.8	47.2	29.5	43.9	38.6	63.5
LYZ		ENSG00000090382	Lysozyme	P61626	12	69348381-69354234	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted secreted proteins"		"Antimicrobial, Bacteriolytic enzyme, Glycosidase, Hydrolase"	"Amyloidosis, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 10588.1;salivary gland: 21115.5;stomach 1: 8941.1"	"Cell type enhanced"	"Detected in many"		"Gastric mucus-secreting cells: 3106.1;Kupffer cells: 2841.2;Langerhans cells: 4859.1;Macrophages: 4870.7;monocytes: 7063.0;Pancreatic endocrine cells: 3152.5"	"Cancer enhanced"	"Detected in all"		"stomach cancer: 976.9"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"classical monocyte: 25266.2;myeloid DC: 14438.7"	"Group enriched"	"Detected in all"	20	"dendritic cells: 14438.7;monocytes: 25266.2"	"Cell line enriched"	"Detected in many"	13	"OE19: 12130.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB000055, HPA048284, HPA066182"	Enhanced		Approved	"Nucleoplasm,Golgi apparatus,Actin filaments"	"Secreted to blood"	NA	NA	1500000000	1500000000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 21: OE19 - Mitochondria"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	"Golgi apparatus, Actin filaments"	Nucleoplasm	"CAB000055: AB_2341230, HPA048284: AB_2680339, HPA066182: AB_2732741"	"unprognostic (8.52e-2)"	"unprognostic (6.12e-3)"	"unprognostic (2.83e-1)"	"unprognostic (7.29e-2)"	"unprognostic (7.91e-2)"	"prognostic favorable (7.45e-4)"	"unprognostic (1.21e-1)"	"unprognostic (7.40e-2)"	"unprognostic (1.41e-1)"	"unprognostic (2.08e-2)"	"unprognostic (1.44e-1)"	"unprognostic (3.13e-1)"	"unprognostic (2.50e-1)"	"unprognostic (2.37e-1)"	"unprognostic (3.65e-2)"	"unprognostic (5.78e-2)"	"unprognostic (3.62e-2)"	95.8	27.8	3.5	802.1	4.0	10588.1	128.2	3.7	18.5	156.2	11.4	309.0	3605.0	65.7	4.2	106.3	33.9	1054.6	34.8	2.6	4.3	32.4	138.0	1355.2	739.7	8.0	7.3	20.4	63.1	13.8	7.2	91.3	12.2	40.2	273.8	4.4	21115.5	21.8	34.0	58.7	1322.2	123.9	5.4	621.0	8941.1	21.8	10.9	321.8	27.8	36.4	652.8	428.5	16.2	11.7	0.6	0.1	0.0	0.2	0.0	0.0	4.8	0.0	0.0	0.0	0.3	9.5	6.5	4.2	1.5	0.0	3.6	1.2	0.0	0.0	0.2	1.2	0.1	62.4	1.0	960.4	0.0	110.6	50.5	0.0	0.1	0.0	0.0	0.2	0.0	0.3	7.7	0.3	0.0	0.2	2.6	109.5	2.3	12130.8	0.2	1.6	1.4	16.7	0.3	0.5	0.8	3.6	0.5	0.1	0.5	0.7	0.0	489.0	0.6	0.0	2.6	2.3	0.9	2.6	1.1	1.2	0.1	518.5	0.0	443.4	25266.2	298.2	32.6	4798.4	52.3	100.5	20.1	22.7	14438.7	20.8	20.0	17.8	1007.7	108.1	880.1	301.2	31.1	25392.1	3.5	4.0	3.7	18.5	2.6	4.3	8.0	7.3	12.2	5.4	10.9	11.7	24.0	86.6	285.8	0.0	80.8	57.2	1.7	1.2	1.2	0.3	1205.7	32.3	0.2	734.9	51.1	27.6	0.0	5.6	39.6	32.1	0.0	55.1	1.9	2.6	1.9	25.1	12.5	264.6	0.2	547.3	9.4	26.8	3106.1	2.9	123.6	0.5	29.6	25.4	887.1	0.0	0.2	112.4	0.0	2841.2	4859.1	17.4	4.1	4870.7	53.4	0.0	7063.0	0.1	176.1	0.0	0.3	3152.5	600.5	2.2	9.0	2.7	41.8	6.6	33.8	1.0	39.5	7.4	9.9	0.7	3.9	1.5	38.2	8.5	50.6	0.3	111.4	38.3
LZTFL1	BBS17	ENSG00000163818	"Leucine zipper transcription factor like 1"	Q9NQ48	3	45823316-45916042	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Bardet-Biedl syndrome, Ciliopathy, Disease variant, Obesity"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"Early spermatids: 119.0;Endometrial ciliated cells: 56.7;Respiratory ciliated cells: 142.2;Spermatocytes: 170.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043466, HPA048447"	Enhanced		Supported	Cytosol		NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 49: Ciliated cells - Cilium organization"	Cytosol		"HPA043466: AB_2678491, HPA048447: AB_2680398"	"unprognostic (1.64e-2)"	"unprognostic (1.34e-1)"	"unprognostic (3.14e-2)"	"unprognostic (1.26e-2)"	"unprognostic (2.65e-2)"	"unprognostic (5.42e-2)"	"unprognostic (1.15e-2)"	"unprognostic (2.26e-2)"	"unprognostic (4.20e-2)"	"unprognostic (2.94e-2)"	"unprognostic (7.83e-2)"	"unprognostic (5.32e-2)"	"unprognostic (1.30e-3)"	"unprognostic (6.27e-3)"	"unprognostic (8.31e-2)"	"unprognostic (4.27e-3)"	"unprognostic (4.19e-1)"	5.2	6.2	7.1	4.5	8.2	6.0	12.4	5.8	10.1	12.4	17.5	5.7	7.0	13.2	15.0	5.5	18.9	6.9	4.6	8.7	7.7	12.0	10.0	9.0	4.7	6.7	7.3	11.4	5.6	14.2	11.7	5.9	6.5	7.9	6.2	15.8	7.2	8.8	2.8	6.0	5.7	8.4	6.6	6.0	5.8	25.4	7.1	30.7	18.9	3.5	5.7	4.7	4.1	6.9	10.1	5.0	7.8	5.1	7.2	17.9	4.0	5.3	10.0	12.2	15.8	2.4	7.5	2.7	3.1	7.5	15.2	6.4	9.5	8.6	15.9	0.2	6.1	2.6	6.7	4.5	9.4	9.9	2.8	9.3	29.6	16.8	10.8	7.8	6.0	16.5	8.9	6.7	5.9	1.6	34.1	9.6	8.1	6.7	4.2	3.7	0.8	10.7	14.7	4.7	5.4	11.0	7.0	6.0	13.2	8.7	7.1	18.3	9.9	4.5	3.1	12.2	7.1	18.3	10.0	0.1	14.3	11.7	3.7	0.0	0.9	0.4	1.3	1.2	1.7	4.3	1.1	1.2	2.3	2.4	1.8	1.7	1.0	1.5	0.8	2.5	2.0	1.6	7.1	8.2	5.8	10.1	8.7	7.7	6.7	7.3	6.5	6.6	7.1	6.9	7.6	28.9	25.2	7.8	10.8	13.5	10.5	14.9	12.0	7.9	16.9	14.9	7.6	11.5	23.6	14.7	14.6	3.1	8.4	3.7	15.6	13.3	119.0	56.7	10.5	10.2	11.4	11.6	22.3	6.9	5.1	13.3	6.1	12.3	8.2	10.1	11.7	13.5	6.6	23.5	9.9	10.4	10.2	7.3	7.0	19.2	9.9	5.3	8.8	5.6	10.8	17.8	7.2	6.6	12.2	5.6	5.6	13.5	11.6	5.9	3.2	23.0	142.2	14.6	13.1	15.7	9.2	170.0	24.1	8.4	9.9	2.1	10.5	14.2	8.9	5.6
LZTS2	"KIAA1813, LAPSER1"	ENSG00000107816	"Leucine zipper tumor suppressor 2"	Q9BRK4	10	100996618-101007836	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, Wnt signaling pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 70.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044956	Approved		Approved	"Plasma membrane,Cytosol"		No	Yes			"Cluster 39: Non-specific - mRNA processing"	"Cluster 35: Non-specific - Unknown function"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 10: Non-specific - Unknown function"	"Plasma membrane, Cytosol"		"HPA044956: AB_10795989"	"unprognostic (1.42e-2)"	"unprognostic (1.96e-1)"	"prognostic unfavorable (8.23e-4)"	"unprognostic (8.18e-2)"	"unprognostic (4.64e-2)"	"unprognostic (1.56e-1)"	"unprognostic (5.49e-3)"	"unprognostic (3.56e-1)"	"unprognostic (7.57e-2)"	"unprognostic (4.58e-2)"	"unprognostic (2.72e-1)"	"unprognostic (1.38e-1)"	"prognostic unfavorable (3.39e-4)"	"unprognostic (7.63e-2)"	"unprognostic (1.86e-1)"	"unprognostic (5.46e-3)"	"unprognostic (1.76e-3)"	69.9	66.0	46.8	14.9	65.5	14.4	63.3	58.0	54.1	74.3	25.8	96.3	17.5	90.3	17.7	41.0	69.2	19.8	58.9	41.2	45.8	51.8	18.0	57.1	12.1	63.7	64.3	78.6	29.5	29.1	43.6	28.5	58.5	69.5	8.9	5.9	44.3	40.6	37.8	48.9	43.0	26.6	49.0	44.4	54.9	36.2	64.1	10.8	57.6	18.0	8.1	84.1	54.4	78.9	32.9	43.1	34.6	59.7	45.0	36.3	70.8	38.7	72.8	31.9	36.0	50.5	26.6	13.1	35.1	52.5	23.0	54.6	21.5	28.2	7.8	12.8	31.9	12.1	46.4	66.3	63.6	6.4	15.2	66.1	20.2	25.1	30.1	67.3	32.8	15.6	38.7	7.3	28.7	31.6	5.8	15.8	38.8	12.6	35.2	74.7	101.3	13.5	24.4	39.3	8.4	62.8	26.3	11.9	99.9	18.6	61.0	51.6	42.1	37.9	42.6	40.5	20.7	14.0	10.2	3.3	64.0	17.7	19.4	0.0	0.7	0.4	2.7	0.4	3.7	2.3	3.4	3.0	1.1	2.9	3.5	3.0	0.3	2.9	0.1	1.8	3.0	1.5	46.8	65.5	58.0	54.1	41.2	45.8	63.7	64.3	58.5	49.0	64.1	78.9	34.7	16.0	10.5	20.2	5.3	13.4	9.0	12.4	19.4	14.4	21.7	20.3	5.2	11.5	9.4	5.5	6.2	18.6	1.9	8.0	7.9	19.1	6.8	7.9	20.5	22.9	16.7	5.0	6.8	12.6	13.2	21.8	14.8	13.0	1.3	38.9	18.5	2.6	22.2	18.5	7.7	17.8	16.2	7.2	9.2	4.1	25.7	8.4	16.0	13.1	4.8	18.9	4.1	9.0	70.3	13.3	7.9	29.3	5.4	18.1	6.5	8.3	6.1	4.0	26.3	21.1	40.7	3.8	15.0	10.8	12.1	47.1	6.0	26.9	15.1	9.7
MACF1	"ABP620, ACF7, FLJ45612, FLJ46776, KIAA0465, KIAA1251, MACF"	ENSG00000127603	"Microtubule actin crosslinking factor 1"	Q9UPN3	1	39081316-39487177	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Wnt signaling pathway"	Actin-binding	"Disease variant, Lissencephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 1079.0;Cone photoreceptor cells: 779.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA013713, HPA068064, HPA068103"	Approved		Supported	"Plasma membrane,Cell Junctions,Actin filaments"		NA	NA		25000	"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 9: Photoreceptor cells - Phototransduction"	"Plasma membrane, Cell Junctions, Actin filaments"		"HPA013713: AB_10600821, HPA068064: AB_2685946, HPA068103: AB_2685953"	"unprognostic (2.71e-1)"	"unprognostic (3.14e-2)"	"unprognostic (5.18e-2)"	"unprognostic (1.02e-2)"	"unprognostic (9.00e-2)"	"unprognostic (6.19e-3)"	"unprognostic (1.32e-1)"	"unprognostic (7.40e-3)"	"unprognostic (5.45e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.34e-1)"	"unprognostic (3.98e-1)"	"prognostic favorable (2.77e-5)"	"unprognostic (1.07e-1)"	"unprognostic (1.81e-1)"	"unprognostic (8.57e-2)"	"unprognostic (4.22e-2)"	69.1	62.5	172.0	27.7	197.5	36.2	54.6	174.6	181.6	65.9	119.1	148.6	18.6	130.3	48.7	46.4	92.0	46.4	127.0	159.7	166.1	85.7	63.8	183.6	35.9	190.2	179.0	92.6	51.2	96.9	69.3	34.6	182.9	68.2	25.1	121.2	57.7	41.6	73.0	121.0	62.6	54.2	155.6	84.9	71.3	50.2	193.2	39.3	73.3	55.2	22.8	80.3	62.7	185.3	48.1	54.9	66.7	29.3	53.8	47.3	29.8	62.2	79.4	38.0	33.7	34.3	56.5	24.4	64.6	84.0	62.1	30.6	12.5	45.7	51.2	43.5	33.1	34.0	43.4	56.5	66.0	30.8	15.9	37.0	46.5	105.1	54.3	83.5	104.7	52.0	63.2	25.7	137.0	16.0	23.3	52.7	95.8	20.0	31.7	38.5	89.6	4.5	206.0	50.8	38.2	38.6	24.9	17.2	62.5	76.3	7.5	37.9	115.1	61.6	48.5	28.8	101.9	19.4	19.7	28.8	101.0	32.6	55.2	7.5	1.3	3.8	12.2	2.7	5.9	2.2	5.8	7.8	1.8	3.8	4.7	6.1	1.3	6.5	2.9	2.5	3.0	2.0	172.0	197.5	174.6	181.6	159.7	166.1	190.2	179.0	182.9	155.6	193.2	185.3	135.3	150.6	128.2	1079.0	68.7	154.4	74.9	43.0	60.3	387.7	52.5	50.9	246.1	61.5	70.7	80.9	779.8	52.6	120.5	35.4	0.0	113.3	9.6	140.6	124.4	164.3	36.1	57.6	320.6	114.6	62.1	108.2	65.2	180.1	77.7	194.3	132.1	47.9	52.1	117.8	367.5	27.2	22.4	59.7	46.3	11.8	43.8	74.8	71.2	342.9	59.0	107.8	158.6	494.6	410.7	193.5	17.7	112.5	81.0	89.7	22.5	20.6	71.3	398.5	105.2	95.5	136.7	62.6	33.7	43.5	191.5	69.9	131.2	76.5	19.7	78.8
MACROD1	LRP16	ENSG00000133315	"Mono-ADP ribosylhydrolase 1"	Q9BQ69	11	63998558-64166113	"Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"DNA damage"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 290.1"	"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 137.0;Proximal tubular cells: 333.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"MCF7: 73.8;RPMI-8226: 145.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041031, HPA071075"	Uncertain		Supported	Nucleoplasm		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 59: Non-specific - Translation"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Nucleoplasm		"HPA041031: AB_10794435, HPA071075: AB_2686341"	"unprognostic (1.19e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.38e-1)"	"unprognostic (3.14e-2)"	"unprognostic (3.88e-2)"	"unprognostic (6.03e-2)"	"unprognostic (1.95e-2)"	"unprognostic (2.82e-1)"	"unprognostic (2.44e-2)"	"unprognostic (1.34e-1)"	"prognostic unfavorable (2.90e-4)"	"unprognostic (1.15e-1)"	"prognostic favorable (4.68e-6)"	"unprognostic (2.45e-2)"	"unprognostic (9.92e-2)"	"unprognostic (2.36e-1)"	"unprognostic (2.86e-2)"	14.9	14.1	6.4	1.3	5.9	2.8	17.3	6.8	12.7	15.6	5.9	21.3	5.7	13.8	0.9	18.6	15.3	2.2	111.6	6.4	8.2	55.1	50.2	10.4	1.1	8.6	7.9	21.6	49.5	4.1	11.8	1.6	8.8	19.6	1.4	1.2	30.1	5.5	290.1	26.0	10.7	1.1	6.6	6.5	27.2	4.7	9.1	1.0	32.0	58.9	0.5	17.4	16.8	7.4	12.7	5.7	1.9	10.2	1.7	1.0	10.9	7.5	3.2	5.3	5.1	5.3	33.2	44.9	25.4	0.6	2.6	29.8	1.9	0.1	0.6	3.6	21.9	16.8	23.3	29.7	6.1	13.8	1.8	2.5	3.4	0.6	1.7	4.5	1.8	14.7	15.2	8.5	1.1	73.8	20.1	45.1	5.5	4.3	24.4	18.7	11.5	145.4	1.8	0.7	15.7	31.2	5.7	40.3	41.4	0.2	29.8	1.0	2.9	4.9	7.4	7.0	0.8	17.8	3.1	7.4	3.4	13.4	4.6	0.0	0.0	0.0	0.4	0.2	0.4	0.1	0.4	0.2	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.2	0.0	0.0	6.4	5.9	6.8	12.7	6.4	8.2	8.6	7.9	8.8	6.6	9.1	7.4	19.4	0.0	4.6	6.8	7.1	28.0	39.8	7.5	57.5	15.1	46.2	45.0	32.5	30.0	8.6	42.3	0.0	35.6	1.3	34.6	137.0	20.8	7.1	19.0	13.3	11.9	22.9	8.0	7.1	40.4	16.1	15.9	20.9	22.7	0.0	41.6	9.7	45.3	11.7	11.8	12.4	55.2	8.2	6.9	5.1	26.8	24.8	7.2	39.2	4.7	2.4	16.9	1.0	13.6	6.9	19.2	35.2	14.3	12.9	37.6	23.0	333.4	3.1	20.6	19.7	55.7	19.1	8.2	32.5	46.3	37.1	23.9	6.1	18.8	67.9	49.8
MACROD2	"C20orf133, dJ631M13.5"	ENSG00000172264	"Mono-ADP ribosylhydrolase 2"	A1Z1Q3	20	13995369-16053197	"Metabolic proteins, Predicted intracellular proteins"	"DNA damage"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 349.7;Excitatory neurons: 752.7;Inhibitory neurons: 1058.5;Oligodendrocyte precursor cells: 672.0;Oligodendrocytes: 301.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"memory B-cell: 8.9;naive B-cell: 13.2;neutrophil: 3.4"	"Group enriched"	"Detected in many"	5	"B-cells: 13.2;granulocytes: 3.4"	"Cell line enhanced"	"Detected in many"		"EFO-21: 15.5;Karpas-707: 19.1;RT4: 8.4;SCLC-21H: 10.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049076	Enhanced		Supported	Nucleoplasm,Nucleoli		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 68: Epididymis - Unknown function"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Nucleoplasm, Nucleoli"		"HPA049076: "	"unprognostic (1.70e-1)"	"unprognostic (7.36e-2)"	"unprognostic (1.59e-1)"	"unprognostic (5.68e-3)"	"unprognostic (2.03e-1)"	"unprognostic (1.63e-3)"	"unprognostic (1.24e-1)"	"unprognostic (2.32e-2)"	"unprognostic (3.02e-1)"	"unprognostic (2.96e-2)"	"unprognostic (4.02e-1)"	"unprognostic (7.83e-2)"	"unprognostic (4.15e-5)"	"unprognostic (9.80e-2)"	"unprognostic (9.91e-3)"	"unprognostic (3.23e-1)"	"unprognostic (2.02e-2)"	1.9	3.1	3.9	2.2	8.4	1.2	2.8	2.3	4.7	3.1	0.1	1.3	0.7	5.0	2.3	1.4	7.3	2.8	1.1	4.8	2.8	3.9	1.8	10.9	4.0	3.3	3.6	2.9	2.9	2.5	2.2	1.1	3.7	4.7	1.3	4.9	1.3	9.9	1.5	2.7	0.9	4.0	2.1	5.0	2.3	5.1	7.3	1.8	2.6	0.6	5.3	4.5	1.2	4.3	1.0	0.4	3.0	1.2	0.8	0.7	0.5	0.3	2.1	1.2	0.7	0.4	0.7	2.0	15.5	1.4	2.6	1.5	0.3	0.7	1.9	1.0	0.9	1.2	1.2	2.4	3.4	0.3	0.3	1.9	1.3	0.0	0.5	1.1	1.1	0.2	1.4	19.1	3.1	0.5	0.5	0.8	0.9	7.1	0.6	1.2	0.5	4.0	2.2	8.4	10.6	1.9	1.6	0.2	0.6	1.1	1.0	1.8	0.7	1.4	3.2	0.3	0.0	0.7	0.3	2.1	0.9	1.0	1.7	0.1	0.5	0.5	0.2	1.2	0.2	8.9	0.2	0.2	0.4	13.2	0.2	0.3	3.4	0.1	1.6	0.2	0.0	0.5	3.9	8.4	2.3	4.7	4.8	2.8	3.3	3.6	3.7	2.1	7.3	4.3	1.6	51.3	203.8	349.7	18.3	4.5	49.8	1.4	5.2	94.0	7.6	6.9	5.9	11.5	37.5	12.9	39.6	7.1	0.1	1.8	9.8	11.9	35.4	8.6	2.5	3.0	1.2	0.4	752.7	1.6	0.4	4.6	9.2	6.7	1.3	7.6	7.1	4.8	0.9	8.4	1058.5	4.5	0.0	0.3	2.1	62.2	3.4	0.9	3.6	87.1	0.0	10.2	0.0	672.0	301.4	6.6	1.7	17.7	2.8	6.2	2.4	8.6	9.8	20.3	6.6	2.1	6.0	23.7	18.8	5.8	6.7	2.1	0.9	13.2	2.8	5.4
MACROH2A1	"H2AFY, macroH2A1.2"	ENSG00000113648	"MacroH2A.1 histone"	O75367	5	135333900-135399914	"Plasma proteins, Predicted intracellular proteins"		"Chromatin regulator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 67.2;Cytotrophoblasts: 151.6;Extravillous trophoblasts: 148.8;Hofbauer cells: 419.5;Syncytiotrophoblasts: 183.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041189, HPA050962"	Supported		Supported	Nucleoplasm		NA	NA		2700000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 32: U-937 - Innate immune response"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm		"HPA041189: AB_2677357, HPA050962: AB_2681292"	"unprognostic (1.05e-1)"	"unprognostic (3.63e-2)"	"unprognostic (1.60e-3)"	"unprognostic (2.78e-2)"	"unprognostic (1.27e-1)"	"unprognostic (7.88e-2)"	"prognostic unfavorable (2.89e-5)"	"unprognostic (3.17e-1)"	"unprognostic (3.34e-2)"	"unprognostic (2.53e-3)"	"unprognostic (9.43e-2)"	"unprognostic (2.21e-1)"	"unprognostic (8.89e-3)"	"unprognostic (8.34e-2)"	"unprognostic (5.96e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.15e-1)"	64.4	58.7	44.3	97.0	45.2	247.8	55.6	46.8	49.0	59.4	52.2	111.5	115.0	48.0	49.1	146.1	61.5	70.6	56.4	45.6	51.7	52.7	50.4	72.7	126.0	45.0	48.5	39.3	31.2	85.6	57.2	78.7	49.2	54.1	118.7	114.1	64.6	36.3	90.8	95.7	117.4	61.4	47.7	75.1	81.3	26.0	48.3	219.4	53.2	73.4	130.9	99.6	76.2	51.6	303.5	208.8	314.9	217.5	144.5	85.6	282.8	124.2	133.1	215.8	151.8	331.3	295.6	356.5	206.5	101.2	182.8	200.7	239.2	526.1	160.8	194.4	237.7	426.3	227.7	226.0	105.7	205.0	179.7	91.3	140.0	180.5	192.3	132.0	140.6	239.0	150.9	142.4	124.4	264.5	594.1	388.7	123.7	359.4	110.5	528.3	179.2	252.5	270.7	339.4	441.1	277.6	241.8	232.2	204.4	164.2	275.8	558.0	114.7	188.1	158.2	140.1	259.1	67.9	296.2	334.5	157.0	455.0	135.5	16.1	178.7	84.3	40.3	122.6	34.0	47.2	51.1	49.8	203.0	67.8	49.2	40.4	93.2	87.8	80.1	147.2	65.3	138.4	44.3	45.2	46.8	49.0	45.6	51.7	45.0	48.5	49.2	47.7	48.3	51.6	57.6	0.0	0.0	0.0	6.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	67.2	0.0	0.0	0.0	0.0	151.6	38.3	0.0	0.0	0.0	0.0	0.0	0.0	15.3	0.0	0.0	0.0	0.0	148.8	30.4	0.0	0.0	0.0	0.0	0.0	0.0	419.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	31.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.1	0.0	0.0	0.0	0.0	183.5	5.8	0.0	0.0	0.0
MACROH2A2	H2AFY2	ENSG00000099284	"MacroH2A.2 histone"	Q9P0M6	10	70052544-70112282	"Predicted intracellular proteins"		"Chromatin regulator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 7.1;Fibroblasts: 1.7;Hofbauer cells: 4.9;Syncytiotrophoblasts: 1.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"myeloid DC: 12.6"	"Group enriched"	"Detected in many"	5	"dendritic cells: 12.6;monocytes: 5.4"	"Cell line enhanced"	"Detected in many"		"AF22: 173.9;AN3-CA: 111.5;SCLC-21H: 137.0;SH-SY5Y: 132.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035865, HPA041189"	Enhanced		Supported	Nucleoplasm		No	No			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 12: NES - Nervous system development"	"Cluster 33: Fibroblasts - ECM organization"	Nucleoplasm		"HPA035865: AB_10672099, HPA041189: AB_2677357"	"unprognostic (1.62e-2)"	"unprognostic (9.62e-2)"	"unprognostic (1.46e-2)"	"unprognostic (1.46e-2)"	"unprognostic (7.71e-3)"	"unprognostic (1.85e-1)"	"unprognostic (3.44e-2)"	"unprognostic (5.37e-2)"	"unprognostic (1.67e-1)"	"unprognostic (9.17e-2)"	"unprognostic (7.32e-2)"	"unprognostic (1.80e-2)"	"unprognostic (1.31e-2)"	"unprognostic (3.27e-2)"	"unprognostic (4.58e-2)"	"unprognostic (8.78e-2)"	"unprognostic (4.66e-2)"	3.8	3.2	5.3	5.6	4.5	1.9	10.2	7.3	6.3	14.7	3.3	10.8	9.5	18.3	11.6	17.4	16.5	8.7	13.5	4.1	4.9	15.2	5.2	5.6	4.9	3.8	3.9	13.3	7.8	14.9	14.0	2.1	3.7	13.1	10.5	3.2	10.9	14.4	6.5	10.7	10.1	15.3	3.6	2.7	8.6	11.8	4.2	7.4	10.2	8.6	7.2	13.2	11.8	4.4	4.7	31.1	173.9	111.5	2.5	5.1	0.1	8.6	0.3	16.2	11.0	0.5	55.8	0.0	23.5	2.8	9.1	27.4	15.3	44.8	5.1	81.1	63.4	0.0	0.2	59.1	11.2	1.9	0.8	8.1	30.4	6.4	8.5	23.4	0.0	6.3	0.1	0.6	15.7	37.5	0.2	0.9	74.8	0.2	44.9	0.4	0.5	0.6	30.7	34.0	137.0	132.4	28.6	0.2	0.0	35.2	41.5	20.3	0.0	0.3	32.3	12.4	6.2	0.4	0.1	0.3	0.0	0.2	0.3	1.6	2.4	0.8	0.6	5.4	1.1	0.3	0.9	0.8	12.6	0.3	0.8	0.9	1.4	1.1	3.0	0.2	0.5	1.6	5.3	4.5	7.3	6.3	4.1	4.9	3.8	3.9	3.7	3.6	4.2	4.4	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.1	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.4	1.7	0.0	0.0	0.0	0.0	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.0	0.1	0.0	0.0	0.0
MAD1L1	"HsMAD1, MAD1, PIG9, TP53I9, TXBP181"	ENSG00000002822	"Mitotic arrest deficient 1 like 1"	Q9Y6D9	7	1815793-2233243	"Disease related genes, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"Early spermatids: 316.9;Late spermatids: 685.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003635, CAB015338"	Supported		Supported	"Nucleoplasm,Nuclear membrane"		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 2: Immune cells - Immune response"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 31: Spermatids - Spermatogenesis"	"Nucleoplasm, Nuclear membrane"		"CAB015338: AB_627901, HPA003635: AB_1853472"	"unprognostic (1.85e-1)"	"unprognostic (3.76e-2)"	"unprognostic (4.26e-3)"	"unprognostic (8.32e-2)"	"unprognostic (1.42e-2)"	"unprognostic (3.83e-2)"	"unprognostic (2.70e-2)"	"unprognostic (1.18e-2)"	"unprognostic (4.78e-2)"	"unprognostic (5.76e-2)"	"unprognostic (1.89e-1)"	"unprognostic (2.48e-1)"	"unprognostic (2.33e-3)"	"unprognostic (5.18e-2)"	"unprognostic (1.33e-1)"	"unprognostic (2.36e-1)"	"unprognostic (4.57e-1)"	9.4	6.0	6.2	11.1	8.3	14.9	9.0	4.6	8.4	11.4	5.1	7.7	6.0	9.3	2.5	9.2	7.4	4.8	8.8	5.6	6.7	6.5	6.4	10.2	17.8	7.8	6.6	7.4	5.6	4.1	7.1	5.0	7.6	8.2	3.4	4.0	7.3	5.6	13.6	14.5	9.7	5.3	5.5	18.2	6.6	10.7	7.0	15.3	8.6	5.0	10.7	8.3	10.1	9.4	37.2	15.5	16.5	30.1	11.1	11.2	26.5	25.6	13.0	26.0	20.7	28.5	21.5	23.4	10.4	14.7	39.9	28.5	12.4	18.3	15.7	11.1	17.8	30.1	19.4	45.0	15.7	21.1	55.1	13.9	13.3	28.8	14.0	6.3	14.9	13.7	30.3	17.4	10.3	45.4	8.7	61.0	30.7	5.8	20.5	38.5	16.7	17.5	12.7	18.7	10.7	33.4	20.0	24.9	65.2	11.2	17.1	48.9	17.6	21.8	60.0	62.3	26.0	30.3	31.4	27.3	18.1	60.6	80.3	60.4	36.2	25.4	71.3	62.4	66.6	54.6	69.2	72.3	63.4	63.0	92.0	66.0	8.6	22.7	60.1	26.0	131.5	53.6	6.2	8.3	4.6	8.4	5.6	6.7	7.8	6.6	7.6	5.5	7.0	9.4	9.3	3.2	10.4	12.1	33.8	17.6	13.9	14.0	15.4	8.3	6.2	6.5	7.4	14.3	11.9	7.3	10.4	16.2	35.7	12.4	15.6	12.3	316.9	5.5	6.7	10.7	32.4	19.1	20.9	11.4	16.3	11.4	11.7	6.9	41.8	15.5	6.4	36.4	39.6	23.5	24.4	9.4	16.2	31.4	84.1	685.9	12.5	28.2	37.4	21.5	25.7	24.3	47.4	16.1	32.4	16.5	7.9	10.5	14.9	9.4	5.4	15.2	6.6	13.9	19.7	11.2	10.2	60.3	33.8	9.3	21.5	24.5	43.1	17.5	8.8	9.7
MAD2L1BP	"CMT2, dJ261G23.1, KIAA0110"	ENSG00000124688	"MAD2L1 binding protein"	Q15013	6	43629540-43640941	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"OE19: 221.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028729			Supported	"Nucleoplasm,Nuclear membrane,Nucleoli"		Yes	No			"Cluster 44: Non-specific - Transcription"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 21: OE19 - Mitochondria"	"Cluster 51: Myeloid cells - Hemostasis"	Nucleoplasm	"Nuclear membrane, Nucleoli"	"HPA028729: AB_2672752"	"unprognostic (2.60e-1)"	"unprognostic (2.06e-1)"	"unprognostic (3.92e-2)"	"unprognostic (6.97e-2)"	"unprognostic (6.91e-2)"	"unprognostic (6.92e-2)"	"unprognostic (5.74e-3)"	"unprognostic (2.67e-3)"	"unprognostic (3.60e-1)"	"unprognostic (7.18e-2)"	"unprognostic (1.71e-1)"	"unprognostic (6.64e-2)"	"unprognostic (4.61e-2)"	"unprognostic (1.18e-1)"	"unprognostic (3.34e-1)"	"unprognostic (1.16e-1)"	"unprognostic (3.25e-3)"	13.3	16.2	13.6	14.1	13.8	53.5	17.3	14.1	15.8	14.6	15.4	25.9	23.6	12.4	17.3	17.6	16.7	14.4	25.4	14.3	14.9	17.5	21.9	14.9	21.7	13.8	13.2	13.0	16.7	21.1	12.6	14.0	14.2	14.4	27.7	15.2	22.8	13.5	28.5	13.2	18.8	14.5	13.6	17.4	19.3	20.4	14.3	29.3	15.6	44.6	26.6	21.4	10.6	13.8	53.9	24.4	37.7	42.2	32.1	34.7	22.7	31.7	50.9	68.5	63.8	50.3	21.4	41.6	17.6	37.3	62.2	34.4	59.2	43.9	52.6	38.5	46.0	51.5	26.1	43.8	34.6	30.6	29.9	35.3	53.0	51.1	31.0	34.5	52.2	32.8	67.2	21.8	48.4	50.6	27.4	56.5	23.3	221.1	31.3	31.3	29.3	39.4	48.9	42.5	44.7	45.3	22.8	34.5	152.2	28.6	40.6	80.3	28.7	36.5	30.7	24.4	51.3	27.7	25.8	99.0	33.2	51.3	41.0	105.4	41.4	49.4	46.3	42.8	46.5	52.6	54.7	51.4	52.7	47.9	56.5	51.2	35.2	55.6	41.3	34.9	78.9	43.6	13.6	13.8	14.1	15.8	14.3	14.9	13.8	13.2	14.2	13.6	14.3	13.8	11.6	25.6	12.7	3.3	18.2	14.4	20.5	44.9	17.6	12.8	11.6	9.3	10.8	15.7	32.5	3.7	12.5	21.1	11.1	30.7	27.4	28.0	47.0	13.2	8.6	12.5	17.4	20.6	3.0	21.2	21.5	12.0	14.3	10.8	31.6	7.8	11.4	12.7	17.6	10.1	3.2	17.1	32.6	10.4	8.6	36.5	12.2	19.6	28.4	1.9	17.3	13.9	11.3	3.0	5.0	24.7	29.5	12.0	11.1	11.5	28.2	21.2	21.1	15.1	26.3	8.3	13.4	26.4	18.3	12.6	9.7	6.2	14.8	11.9	23.4	27.2
MAD2L2	"FANCV, MAD2B, POLZ2, REV7"	ENSG00000116670	"Mitotic arrest deficient 2 like 2"	Q9UI95	1	11674480-11691650	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cell cycle, Cell division, DNA damage, DNA repair, Mitosis, Transcription, Transcription regulation"		"Cancer-related genes, Disease variant, Fanconi anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 148.1;Late spermatids: 522.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB008110, HPA024176, HPA024612"	Approved		Supported	Nucleoli,Cytosol		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 43: Testis - Unknown function"	"Cluster 24: NB-4 - Immune response"	"Cluster 25: Spermatids - Spermatogenesis"	Cytosol	Nucleoli	"CAB008110: AB_217976, HPA024176: AB_2671467, HPA024612: "	"unprognostic (1.26e-2)"	"unprognostic (2.55e-1)"	"unprognostic (2.43e-1)"	"unprognostic (3.27e-1)"	"unprognostic (2.41e-1)"	"unprognostic (6.84e-2)"	"unprognostic (3.04e-3)"	"unprognostic (1.48e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.34e-1)"	"unprognostic (4.60e-2)"	"unprognostic (1.24e-1)"	"unprognostic (9.09e-3)"	"unprognostic (1.54e-1)"	"unprognostic (9.27e-2)"	"unprognostic (8.43e-2)"	"unprognostic (2.36e-1)"	25.6	19.5	30.3	22.2	32.0	59.8	25.2	33.2	35.9	23.5	27.6	24.6	11.6	19.3	15.0	14.6	20.4	13.4	26.5	30.2	33.1	37.7	49.8	29.6	27.7	34.9	30.2	21.7	39.9	13.3	22.7	10.6	31.7	22.3	7.5	5.0	28.6	11.2	49.3	23.5	17.1	15.5	31.6	25.2	28.8	64.3	35.3	55.1	15.4	31.5	26.1	23.1	17.8	35.9	62.8	57.2	90.8	106.8	28.6	55.1	37.3	56.5	64.8	110.4	97.8	75.2	59.2	87.6	67.6	58.1	64.4	27.4	115.1	60.1	60.5	133.3	129.6	40.1	87.5	93.4	50.2	80.5	62.7	36.1	60.7	81.0	68.9	41.6	51.4	116.7	165.6	138.3	55.5	94.6	365.6	381.3	235.1	25.9	91.2	245.6	100.2	109.6	40.8	13.5	167.8	118.1	93.6	36.5	168.1	61.2	52.6	172.1	26.8	90.7	114.1	85.6	81.8	109.5	82.0	233.7	67.2	281.5	71.8	45.3	85.2	42.8	82.1	97.3	66.8	58.5	55.4	64.8	100.8	43.8	37.0	54.9	36.7	43.3	86.8	139.1	69.9	92.0	30.3	32.0	33.2	35.9	30.2	33.1	34.9	30.2	31.7	31.6	35.3	35.9	24.8	0.0	5.0	4.2	26.1	38.6	26.5	35.7	18.8	5.7	26.9	26.9	15.9	11.5	14.1	14.7	4.2	18.2	49.6	3.7	50.9	40.8	148.1	8.4	21.6	28.2	34.0	69.5	1.7	76.6	50.7	30.6	12.2	11.4	14.0	17.3	29.6	59.1	41.7	11.8	2.3	10.6	54.9	36.4	88.1	522.5	31.1	32.5	48.0	1.9	82.6	10.8	53.5	4.0	5.5	40.7	4.5	17.0	42.9	35.8	4.5	29.6	6.0	3.5	39.5	25.1	26.5	76.0	40.6	14.3	34.7	8.3	37.7	18.8	8.6	17.6
MADD	"DENN, KIAA0358, RAB3GEP"	ENSG00000110514	"MAP kinase activating death domain"	Q8WXG6	11	47269161-47330031	"Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	Apoptosis	"Guanine-nucleotide releasing factor"	"Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 133.2"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 80.9;Cone photoreceptor cells: 125.1;Horizontal cells: 132.9;Rod photoreceptor cells: 106.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	4	"basophil: 33.3"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 33.3"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038568	Uncertain		Supported	"Plasma membrane,Cytosol"		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 58: Brain - Synaptic function"	"Cluster 15: RT4 - Unknown function"	"Cluster 62: Horizontal cells - Visual perception"	"Plasma membrane, Cytosol"		"HPA038568: AB_10795030"	"unprognostic (3.16e-1)"	"unprognostic (1.81e-1)"	"unprognostic (8.51e-3)"	"prognostic favorable (6.62e-5)"	"unprognostic (1.27e-1)"	"unprognostic (6.36e-3)"	"unprognostic (4.82e-3)"	"unprognostic (1.16e-1)"	"unprognostic (1.91e-1)"	"unprognostic (3.78e-2)"	"prognostic favorable (5.69e-5)"	"unprognostic (1.53e-1)"	"unprognostic (3.55e-1)"	"unprognostic (8.07e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.76e-1)"	"prognostic favorable (8.25e-4)"	15.1	24.6	32.4	17.7	32.2	28.4	14.8	46.7	44.5	16.1	0.3	17.9	12.4	15.1	12.0	11.1	14.0	12.2	24.6	40.5	21.2	17.1	13.0	19.0	20.9	18.2	18.8	18.8	17.5	18.4	65.7	16.0	22.1	20.7	16.6	133.2	16.6	17.1	30.1	22.8	19.0	14.6	7.0	22.0	18.8	28.5	16.7	23.6	14.4	23.4	17.9	18.7	15.0	32.1	14.0	28.7	30.8	27.6	20.6	14.3	6.9	19.3	25.8	24.2	25.9	21.0	12.9	29.6	6.0	21.3	31.1	27.2	25.2	13.6	20.8	33.1	25.6	52.7	55.0	18.3	14.8	36.1	69.4	13.9	14.3	12.7	15.9	16.4	22.4	18.7	34.5	21.1	21.5	19.7	17.2	38.6	18.4	32.8	19.6	23.2	49.5	19.7	12.4	66.0	48.4	31.5	24.9	29.0	17.6	18.1	22.8	27.0	19.2	22.4	14.1	32.3	13.2	24.9	27.9	16.6	20.9	25.1	21.5	33.3	3.4	6.5	5.6	5.6	5.0	4.0	3.9	4.6	5.2	4.2	4.5	3.6	0.9	5.7	7.9	2.7	7.5	6.2	32.4	32.2	46.7	44.5	40.5	21.2	18.2	18.8	22.1	7.0	16.7	32.1	10.6	12.8	9.2	21.5	11.7	10.7	4.1	6.1	6.8	80.9	11.3	10.2	23.4	7.2	5.8	7.3	125.1	4.6	29.0	21.2	0.0	7.5	14.6	5.3	7.0	11.5	16.3	8.6	37.4	4.9	2.3	7.8	23.4	8.3	26.6	13.9	14.6	7.0	11.5	132.9	33.7	17.7	4.1	19.4	14.9	4.9	7.2	14.9	10.6	21.5	11.1	14.4	23.7	14.1	22.4	12.0	12.2	12.8	17.7	8.0	12.2	5.1	6.2	106.8	6.6	8.7	7.7	14.9	23.2	6.7	8.2	4.4	15.4	16.2	13.7	5.9
MAF1	DKFZp586G1123	ENSG00000179632	"MAF1 homolog, negative regulator of RNA polymerase III"	Q9H063	8	144104461-144107611	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA024821, HPA058548"	Uncertain		Supported	Nucleoplasm,Nucleoli,Vesicles		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 59: Non-specific - Translation"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm	"Nucleoli, Vesicles"	"HPA024821: AB_2671696, HPA058548: AB_2683751"	"unprognostic (2.26e-1)"	"unprognostic (3.05e-1)"	"unprognostic (2.71e-2)"	"unprognostic (2.21e-1)"	"unprognostic (8.51e-2)"	"unprognostic (9.67e-2)"	"prognostic unfavorable (7.09e-4)"	"unprognostic (6.12e-2)"	"unprognostic (4.92e-2)"	"unprognostic (5.90e-3)"	"unprognostic (9.42e-2)"	"unprognostic (6.48e-2)"	"unprognostic (9.40e-3)"	"unprognostic (9.02e-2)"	"unprognostic (2.59e-1)"	"unprognostic (2.38e-1)"	"unprognostic (3.99e-2)"	96.2	84.4	86.6	61.7	89.7	164.4	92.4	87.3	98.3	97.1	82.5	186.9	62.1	101.9	63.6	81.8	93.3	63.0	193.4	83.5	82.7	89.8	61.1	78.0	78.6	91.2	87.6	110.3	84.6	87.4	71.0	65.1	86.4	103.6	58.3	35.4	77.5	94.6	413.1	69.6	92.2	80.5	85.3	96.5	102.1	76.4	88.7	90.8	78.6	294.7	69.5	130.7	84.1	90.5	119.8	187.1	85.4	86.3	229.0	113.3	68.9	91.8	151.0	140.5	142.1	69.2	129.1	131.0	150.4	154.9	78.1	71.4	117.4	129.9	103.0	115.4	139.5	144.5	127.8	109.6	154.1	62.0	94.4	100.7	150.0	112.8	211.4	156.7	153.6	94.1	112.5	86.9	85.0	281.2	230.9	112.3	64.0	216.3	490.2	90.3	119.7	141.8	89.0	88.8	123.8	102.2	122.0	156.7	152.6	79.5	106.7	93.9	93.0	65.0	146.0	116.1	117.5	102.7	86.0	62.2	107.8	113.7	44.0	50.4	98.0	126.5	72.8	76.1	81.0	110.2	105.0	117.5	107.6	129.9	110.9	105.0	52.9	93.1	78.4	81.0	84.1	111.9	86.6	89.7	87.3	98.3	83.5	82.7	91.2	87.6	86.4	85.3	88.7	90.5	76.8	16.0	15.6	6.8	95.2	92.9	92.4	51.6	53.5	41.4	76.5	77.8	54.2	42.9	24.8	44.1	14.6	106.4	113.9	82.6	105.7	101.1	86.1	30.0	39.3	69.7	93.3	129.0	5.0	107.9	103.6	66.3	28.5	43.6	32.5	77.3	67.5	29.3	97.6	37.0	5.5	89.7	32.6	72.3	85.6	41.0	88.3	84.9	78.2	6.5	138.0	82.0	138.0	7.1	10.7	106.0	97.4	93.3	60.3	170.3	155.0	110.2	12.9	37.6	98.6	65.5	84.8	96.1	43.3	54.0	89.8	144.3	87.6	72.4	88.5	122.4
MAFF	hMafF	ENSG00000185022	"MAF bZIP transcription factor F"	Q9ULX9	22	38200767-38216507	"Predicted intracellular proteins, Transcription factors"	"Stress response, Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Glandular and luminal cells: 682.0;Syncytiotrophoblasts: 479.1;Urothelial cells: 409.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"basophil: 23.9;neutrophil: 8.7;NK-cell: 21.1"	"Group enriched"	"Detected in many"	6	"granulocytes: 23.9;NK-cells: 21.1"	"Cell line enhanced"	"Detected in many"		"hTEC/SVTERT24-B: 79.2;SK-MEL-30: 104.9"	"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"spinal cord: 5.6"	"CAB025341, HPA055371"	Approved		Approved	Nucleoplasm,Mitochondria		No	No			"Cluster 10: Basophils - Unknown function"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm	Mitochondria	"CAB025341: , HPA055371: AB_2682797"	"prognostic favorable (4.32e-4)"	"unprognostic (2.54e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.67e-1)"	"unprognostic (1.99e-2)"	"unprognostic (2.13e-3)"	"unprognostic (5.06e-3)"	"unprognostic (3.42e-3)"	"unprognostic (7.83e-3)"	"unprognostic (5.36e-3)"	"unprognostic (1.23e-3)"	"unprognostic (2.44e-1)"	"unprognostic (3.24e-2)"	"unprognostic (2.84e-1)"	"unprognostic (4.08e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.68e-2)"	102.9	22.8	9.4	12.9	9.0	36.2	69.9	9.3	10.7	37.4	9.4	26.6	8.1	28.8	2.1	53.4	64.2	41.4	53.8	8.2	11.9	32.0	30.8	59.2	4.7	14.5	10.0	53.9	19.7	5.3	19.5	34.5	13.4	39.5	10.3	19.6	28.6	5.5	73.3	45.7	19.6	23.2	10.5	9.3	45.4	3.0	14.1	7.4	25.0	6.9	11.3	53.8	41.4	16.6	20.8	3.3	4.4	6.6	6.9	21.3	20.6	41.4	54.2	19.8	21.0	6.1	16.0	0.7	3.9	16.9	29.5	13.5	1.1	15.7	33.2	3.9	0.6	2.1	2.1	5.2	18.0	1.3	7.1	9.3	25.7	79.2	43.6	17.6	42.1	1.9	4.2	18.6	15.6	4.9	0.8	5.2	3.3	22.0	16.8	1.4	3.8	4.3	19.9	30.6	2.2	3.7	6.1	15.4	104.9	10.7	3.3	1.5	57.9	24.7	19.2	18.8	13.7	7.2	8.0	0.7	37.4	1.4	15.9	23.9	0.4	0.3	2.9	0.7	2.8	0.8	1.7	2.1	1.4	0.5	2.1	1.6	8.7	21.1	3.5	0.2	0.7	1.8	9.4	9.0	9.3	10.7	8.2	11.9	14.5	10.0	13.4	10.5	14.1	16.6	215.4	54.5	43.4	1.0	19.3	125.9	344.1	56.8	169.0	2.9	302.9	214.1	18.6	67.2	49.5	11.0	0.0	37.8	112.5	134.2	7.9	49.9	0.5	284.7	149.3	97.3	104.8	5.7	0.8	24.2	77.5	134.7	132.5	682.0	22.2	11.5	22.1	8.2	26.0	0.0	1.6	112.5	34.6	14.0	131.1	0.4	9.9	113.5	58.7	1.0	10.2	36.0	17.5	1.5	1.3	76.0	181.0	3.8	25.8	258.4	67.6	3.7	37.9	3.6	19.7	265.2	153.1	2.4	1.0	139.5	103.1	479.1	59.0	8.4	75.5	409.2
MAGEA1	"CT1.1, MAGE1, MGC9326"	ENSG00000198681	"MAGE family member A1"	P43355	X	153179284-153183880	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Tumor antigen"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	46	"testis: 4.5"	"Group enriched"	"Detected in some"	36	"Spermatocytes: 26.2;Spermatogonia: 38.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEL: 74.4;HMC-1: 123.9;RPMI-8226: 64.3;U-2 OS: 117.8;U-266/70: 177.4;U-266/84: 305.3"									CAB002620	Enhanced		Supported	Cytosol		NA	NA				"Cluster 83: Testis - Spermatogenesis"	"Cluster 16: U-266 - Nucleosome"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	Cytosol		"CAB002620: "						"unprognostic (8.65e-2)"	"unprognostic (1.33e-1)"	"unprognostic (6.40e-3)"	"unprognostic (1.39e-1)"	"unprognostic (1.23e-1)"				"unprognostic (1.15e-1)"	"unprognostic (1.18e-1)"		"unprognostic (2.35e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	1.4	0.1	0.0	0.0	0.0	0.1	0.0	74.4	12.9	0.0	0.0	0.0	123.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1.1	0.0	0.0	0.2	0.0	0.1	0.0	1.7	0.1	0.0	64.3	0.0	0.2	0.0	0.0	0.0	0.4	0.3	0.0	7.8	0.5	0.0	0.0	117.8	0.5	0.7	177.4	305.3	0.1	8.3	0.1	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	26.2	38.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0
MAGEA10	"CT1.10, MAGE10, MGC10599"	ENSG00000124260	"MAGE family member A10"	P43363	X	152133310-152138578	"Predicted intracellular proteins"		"Tumor antigen"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	12	"placenta: 9.5;testis: 2.6"	"Cell type enhanced"	"Detected in some"		"Sertoli cells: 6.6;Spermatocytes: 57.3;Spermatogonia: 26.2;Syncytiotrophoblasts: 11.2"	"Cancer enhanced"	"Detected in many"		"urothelial cancer: 3.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	6	"GAMG: 78.6"					"Not detected"	"Not detected"			"HPA003333, HPA070780"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 28: Placenta - Pregnancy"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	Nucleoplasm	Cytosol	"HPA003333: AB_10962837, HPA070780: AB_2686310"		"unprognostic (1.92e-1)"				"unprognostic (1.06e-1)"		"unprognostic (2.02e-1)"	"unprognostic (6.95e-2)"	"unprognostic (9.91e-2)"				"unprognostic (5.97e-3)"	"unprognostic (1.11e-1)"		"unprognostic (1.25e-1)"	0.1	0.1	0.1	0.1	0.2	0.3	0.0	0.3	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	9.5	0.2	0.0	0.0	0.1	0.1	0.0	0.1	0.5	0.1	0.0	0.0	0.1	0.0	2.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	78.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.3	0.2	0.0	0.0	0.1	0.0	0.0	8.2	0.0	0.1	0.0	0.0	0.0	0.2	4.9	0.0	0.1	0.0	0.2	0.1	0.0	0.1	0.0	0.1	0.0	0.0	1.0	6.0	0.0	0.4	0.0	12.7	0.5	0.1	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.1	0.4	0.2	0.1	0.1	0.0	0.0	0.1	0.2	0.3	0.2	0.1	0.1	0.0	0.1	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.0	0.0	57.3	26.2	0.0	0.0	11.2	0.0	0.0	0.0	0.1
MAGEA11	"CT1.11, MAGE-11, MAGE11, MAGEA-11, MGC10511"	ENSG00000185247	"MAGE family member A11"	P43364	X	149688228-149717268	"Predicted intracellular proteins"		"Tumor antigen"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"epididymis: 21.0"	"Group enriched"	"Detected in some"	5	"Spermatocytes: 29.4;Spermatogonia: 30.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"U-2 OS: 23.8"									HPA052687			Supported	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA				"Cluster 68: Epididymis - Unknown function"	"Cluster 9: U-2 OS - Unknown function"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	"Nucleoplasm, Nuclear bodies"	Cytosol	"HPA052687: AB_2681915"	"unprognostic (4.06e-3)"	"unprognostic (2.05e-1)"	"unprognostic (7.21e-2)"	"unprognostic (1.09e-2)"		"unprognostic (9.64e-2)"		"unprognostic (1.32e-1)"	"unprognostic (6.13e-2)"	"unprognostic (1.16e-1)"				"unprognostic (6.67e-4)"	"unprognostic (1.14e-1)"		"unprognostic (1.33e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.8	0.1	0.1	0.0	0.0	0.0	0.0	23.8	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.1	0.0	0.0	0.3	0.0	0.2	0.1	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	29.4	30.9	0.0	0.0	5.9	0.0	0.0	0.0	0.0
MAGEC2	"CT10, HCA587, MAGE-C2, MAGEE1"	ENSG00000046774	"MAGE family member C2"	Q9UBF1	X	142202342-142205290	"Cancer-related genes, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Tumor antigen"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	197	"testis: 19.6"	"Group enriched"	"Detected in some"	13	"Spermatocytes: 84.6;Spermatogonia: 91.5"	"Cancer enhanced"	"Detected in many"		"melanoma: 19.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"K-562: 87.3;U-266/84: 99.8"									HPA062230	Enhanced		Supported	Nucleoplasm,Cytosol		Yes	NA				"Cluster 36: Testis - Spermatogenesis"	"Cluster 16: U-266 - Nucleosome"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	Nucleoplasm	Cytosol	"HPA062230: AB_2684718"					"unprognostic (1.25e-1)"		"unprognostic (5.68e-2)"	"unprognostic (3.99e-1)"	"unprognostic (2.82e-1)"						"unprognostic (1.04e-1)"		"unprognostic (4.00e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	9.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	87.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.9	3.7	0.0	0.0	0.0	0.2	5.7	0.9	11.3	0.0	0.1	99.8	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.0	0.0	84.6	91.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0
MAGEH1	APR1	ENSG00000187601	"MAGE family member H1"	Q9H213	X	55452127-55453566	"Predicted membrane proteins"		"Tumor antigen"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	9	"epididymis: 515.9"	"Cell type enhanced"	"Detected in many"		"Peritubular cells: 63.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011324, HPA011971"	Uncertain		Supported	"Nucleoli,Nucleoli rim"		NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 68: Epididymis - Unknown function"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 33: Fibroblasts - ECM organization"	"Nucleoli, Nucleoli rim"		"HPA011324: AB_1853499, HPA011971: "	"unprognostic (2.50e-1)"	"unprognostic (3.01e-1)"	"unprognostic (4.07e-2)"	"prognostic unfavorable (1.37e-4)"	"unprognostic (3.95e-2)"	"unprognostic (8.50e-2)"	"unprognostic (1.13e-2)"	"unprognostic (9.93e-3)"	"unprognostic (1.47e-1)"	"unprognostic (3.20e-3)"	"prognostic favorable (2.60e-4)"	"unprognostic (6.37e-2)"	"unprognostic (1.81e-2)"	"unprognostic (1.29e-3)"	"unprognostic (1.90e-1)"	"unprognostic (3.95e-2)"	"unprognostic (2.52e-1)"	20.2	29.9	46.8	17.6	48.2	5.1	18.4	40.9	59.3	29.6	59.4	21.0	10.2	30.9	515.9	10.0	45.3	18.1	24.1	47.1	60.0	25.5	19.6	23.5	22.7	41.9	47.7	36.3	28.1	25.5	54.1	20.9	45.7	48.8	11.5	22.0	18.6	44.3	12.9	11.3	17.1	27.3	45.5	20.4	25.3	33.8	50.3	32.0	28.6	16.9	17.0	17.9	16.7	48.8	0.1	5.7	32.6	0.0	51.5	31.0	0.4	36.0	32.9	9.7	26.0	0.1	7.4	0.0	48.2	36.4	18.4	4.9	12.5	13.5	15.2	42.5	2.0	11.4	0.0	4.6	17.0	0.6	14.1	25.8	1.2	5.6	4.1	9.1	15.0	12.0	6.5	43.8	10.8	22.0	30.8	9.8	9.3	0.0	6.8	19.1	4.1	24.0	17.9	0.0	0.2	24.5	0.0	9.5	15.5	24.4	4.7	8.5	17.7	13.3	15.4	8.2	1.9	25.9	35.1	4.9	24.8	15.8	17.2	14.0	9.0	20.5	21.5	14.3	19.4	18.9	35.4	24.6	13.7	17.9	48.2	30.5	1.2	18.9	18.5	28.5	52.1	19.0	46.8	48.2	40.9	59.3	47.1	60.0	41.9	47.7	45.7	45.5	50.3	48.8	24.9	6.4	14.4	4.9	18.3	8.0	7.8	20.0	5.2	36.7	8.0	14.1	10.4	18.6	12.5	12.9	10.4	2.8	15.7	1.9	13.7	32.2	1.6	2.8	33.5	29.0	15.8	3.0	14.2	10.7	2.0	42.9	3.1	1.9	12.7	11.1	32.9	14.0	15.0	37.0	17.5	8.4	4.1	3.8	11.2	4.0	47.2	6.2	21.4	6.5	9.3	56.8	23.7	18.6	28.4	4.7	8.8	63.9	39.8	13.7	0.8	20.1	6.7	19.6	26.3	44.5	35.0	1.4	2.7	3.3	6.3	1.6	19.9	19.7	4.6	4.8
MAGI1	"AIP3, BAIAP1, BAP1, MAGI-1, TNRC19, WWP3"	ENSG00000151276	"Membrane associated guanylate kinase, WW and PDZ domain containing 1"	Q96QZ7	3	65353525-66038834	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 497.7;Inhibitory neurons: 809.8;Oligodendrocyte precursor cells: 368.4;Oligodendrocytes: 532.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HEL: 36.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031851, HPA031853, HPA077002"	Supported		Supported	"Nucleoplasm,Cell Junctions"		NA	NA				"Cluster 18: Non-specific - Mitochondria"	"Cluster 36: HEL - Hemostasis"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Cell Junctions"	Nucleoplasm	"HPA031851: AB_10599289, HPA031853: AB_10602095, HPA077002: "	"unprognostic (5.00e-2)"	"unprognostic (9.84e-2)"	"unprognostic (6.00e-3)"	"unprognostic (1.73e-3)"	"unprognostic (1.64e-1)"	"unprognostic (2.17e-2)"	"unprognostic (1.46e-3)"	"unprognostic (9.46e-3)"	"unprognostic (8.59e-2)"	"unprognostic (2.19e-1)"	"unprognostic (6.58e-2)"	"unprognostic (2.05e-3)"	"prognostic favorable (4.55e-8)"	"unprognostic (3.51e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.68e-2)"	"unprognostic (8.03e-2)"	11.3	5.0	3.7	1.3	4.8	0.0	12.5	6.3	5.9	5.5	3.9	9.7	5.0	6.2	2.0	8.0	5.8	5.3	9.0	4.7	5.3	10.2	13.4	8.8	1.1	3.7	3.8	2.7	12.6	5.9	7.7	5.3	2.6	7.1	4.2	7.0	11.6	4.9	3.8	12.5	6.4	3.1	2.7	11.9	14.7	10.3	4.1	2.0	13.4	4.1	1.8	5.4	7.2	4.9	4.1	2.2	12.3	1.3	2.4	1.7	5.5	7.0	5.9	2.6	4.0	15.1	3.5	0.0	1.0	8.3	2.1	1.2	3.4	2.4	4.1	0.0	1.9	36.1	4.3	10.2	1.5	0.0	1.1	2.7	2.0	8.9	1.8	6.8	6.0	4.7	15.6	0.0	2.8	3.1	0.0	0.0	16.6	12.2	2.1	0.0	3.5	0.9	3.1	13.5	3.9	10.8	2.7	3.3	0.1	8.0	6.4	0.0	1.6	8.2	6.0	2.1	2.9	0.0	0.0	0.0	4.8	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	4.8	6.3	5.9	4.7	5.3	3.7	3.8	2.6	2.7	4.1	4.9	102.8	76.9	29.8	204.7	1.3	22.3	17.7	7.9	26.2	98.3	46.5	37.5	35.6	102.9	22.5	23.9	75.0	20.2	0.5	51.0	3.9	44.3	179.1	35.8	35.5	55.5	36.5	2.7	497.7	31.8	2.4	9.6	47.4	50.8	1.3	78.4	82.5	60.9	4.8	232.2	809.8	40.3	12.2	5.0	3.6	27.0	6.5	1.8	5.4	170.5	0.6	15.2	0.0	368.4	532.1	40.3	25.4	8.6	0.2	14.7	33.2	12.2	40.3	26.4	32.9	7.0	17.5	44.7	12.3	12.7	18.8	5.1	2.7	27.1	26.3	11.9
MAGI3	MAGI-3	ENSG00000081026	"Membrane associated guanylate kinase, WW and PDZ domain containing 3"	Q5TCQ9	1	113390515-113685923	"Predicted intracellular proteins"	"Host-virus interaction"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 34.8"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 266.0;Excitatory neurons: 206.7;Oligodendrocyte precursor cells: 128.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008444			Supported	"Cell Junctions"		NA	NA				"Cluster 77: Retina - Visual perception"	"Cluster 12: NES - Nervous system development"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Cell Junctions"		"HPA008444: AB_2668069"	"unprognostic (4.07e-1)"	"unprognostic (3.59e-2)"	"unprognostic (1.54e-3)"	"unprognostic (2.32e-2)"	"unprognostic (2.31e-2)"	"unprognostic (5.21e-3)"	"unprognostic (2.23e-1)"	"unprognostic (7.06e-2)"	"unprognostic (2.80e-2)"	"prognostic favorable (4.29e-4)"	"unprognostic (1.09e-2)"	"unprognostic (1.03e-1)"	"prognostic favorable (2.60e-8)"	"unprognostic (1.71e-2)"	"unprognostic (7.85e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.50e-2)"	2.8	3.3	5.4	2.3	7.1	0.2	7.6	2.8	8.6	3.5	2.8	9.2	5.9	4.9	6.5	7.6	3.7	3.8	3.2	5.4	5.4	7.1	6.2	13.2	1.2	4.0	7.4	6.0	10.7	3.9	4.7	7.4	6.6	4.2	8.2	34.8	4.3	2.6	1.5	1.9	7.5	4.6	2.0	2.3	11.6	4.1	5.2	2.4	10.9	2.4	3.8	2.7	4.0	5.9	8.8	10.8	10.0	4.5	4.4	6.4	2.7	6.1	3.0	4.8	5.3	9.5	2.6	0.4	4.5	5.7	4.1	3.9	9.1	4.7	5.9	9.5	8.6	4.0	9.6	4.3	1.0	3.3	5.6	3.4	2.3	5.1	11.0	5.7	6.7	4.2	4.7	8.4	6.6	5.9	5.2	0.9	3.5	15.3	6.3	7.3	16.1	1.0	5.5	4.0	8.9	9.0	7.4	12.1	2.2	12.3	6.3	1.7	11.6	7.8	9.8	7.1	8.7	3.1	2.8	0.0	4.1	1.5	6.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.0	5.4	7.1	2.8	8.6	5.4	5.4	4.0	7.4	6.6	2.0	5.2	5.9	14.0	266.0	103.2	106.7	1.3	10.8	9.1	9.2	21.1	97.1	27.1	16.0	9.2	14.3	60.7	12.9	50.1	16.0	1.0	51.8	7.9	10.9	39.4	11.2	19.7	11.9	13.8	3.2	206.7	10.7	2.4	14.9	37.8	15.9	6.3	12.1	12.1	14.4	4.1	40.4	100.1	23.6	4.1	2.2	6.9	28.4	10.2	2.6	12.4	92.8	0.5	35.6	0.0	128.7	17.7	13.5	40.2	11.3	8.8	9.5	32.6	5.3	17.5	45.6	13.1	13.4	10.7	23.8	9.6	23.4	7.5	5.5	4.1	8.7	28.9	10.5
MAGOH	"MAGOH1, MAGOHA"	ENSG00000162385	"Mago homolog, exon junction complex subunit"	P61326	1	53226900-53238518	"Predicted intracellular proteins, Transporters"	"mRNA processing, mRNA splicing, mRNA transport, Nonsense-mediated mRNA decay, Translation regulation, Transport"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB015425, HPA043036, HPA047754"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"CAB015425: AB_629914, HPA043036: AB_2678279, HPA047754: AB_2680148"	"prognostic favorable (1.85e-4)"	"unprognostic (2.61e-2)"	"unprognostic (5.39e-2)"	"unprognostic (2.33e-1)"	"unprognostic (3.59e-1)"	"unprognostic (6.34e-3)"	"unprognostic (3.07e-3)"	"unprognostic (2.18e-1)"	"unprognostic (5.17e-2)"	"unprognostic (1.46e-2)"	"unprognostic (8.54e-2)"	"unprognostic (1.39e-2)"	"prognostic unfavorable (1.45e-5)"	"unprognostic (2.01e-2)"	"unprognostic (1.63e-1)"	"unprognostic (3.60e-2)"	"unprognostic (6.75e-3)"	51.4	48.5	36.5	59.0	36.5	141.1	51.8	37.8	47.1	41.0	38.4	61.2	53.1	57.2	59.0	48.1	55.9	37.9	43.3	36.6	38.1	53.6	76.4	44.8	85.0	37.5	37.1	49.2	43.8	50.4	34.9	67.9	37.9	39.9	55.5	34.4	44.5	37.4	43.8	42.9	55.2	50.7	37.5	55.2	46.8	32.3	36.8	101.7	51.7	42.5	86.3	62.1	38.9	38.1	207.8	101.0	169.4	150.2	88.1	56.9	197.6	152.3	92.0	202.4	204.5	233.2	97.1	293.5	168.8	93.1	248.4	125.9	228.3	136.7	242.3	197.1	249.6	266.1	127.4	253.3	141.4	459.3	143.3	62.7	95.3	184.4	150.6	77.7	136.8	260.8	279.6	63.8	109.9	169.3	377.2	316.0	310.0	171.1	218.4	256.1	323.2	154.5	109.1	208.3	142.7	115.7	202.0	161.2	250.1	206.8	85.1	330.2	122.0	122.6	167.7	170.7	354.9	93.6	184.8	453.4	109.4	289.5	127.0	31.5	34.8	53.9	49.3	51.9	48.1	47.4	46.9	51.5	50.0	42.9	42.6	44.9	41.9	52.9	50.2	58.6	54.2	32.7	36.5	36.5	37.8	47.1	36.6	38.1	37.5	37.1	37.9	37.5	36.8	38.1	134.5	51.3	47.6	10.1	93.5	144.4	121.3	231.6	99.0	31.0	62.1	85.9	50.6	60.1	106.9	57.0	14.6	206.9	123.5	47.0	178.1	96.2	44.9	123.9	83.7	89.6	54.4	90.9	13.0	84.9	195.4	83.5	46.9	102.2	83.6	78.4	57.8	44.2	116.0	23.5	12.4	89.2	130.2	47.8	103.2	16.1	75.5	80.0	81.8	7.5	102.5	67.2	84.5	10.6	15.1	87.4	70.9	68.1	62.6	92.3	69.0	152.0	100.4	36.4	59.2	93.9	148.1	90.0	67.9	82.7	120.8	241.9	107.6	89.5	87.1	92.1
MAK16	"MAK16L, RBM13"	ENSG00000198042	"MAK16 homolog"	Q9BXY0	8	33485182-33501262	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044417, HPA050574"	Uncertain		Approved	Nucleoli,Vesicles		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 52: Non-specific - Ribosome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	"Nucleoli, Vesicles"		"HPA044417: AB_2678935, HPA050574: AB_2681181"	"unprognostic (2.10e-1)"	"unprognostic (1.74e-1)"	"unprognostic (8.48e-3)"	"unprognostic (2.28e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.24e-1)"	"prognostic unfavorable (1.00e-4)"	"unprognostic (2.07e-1)"	"unprognostic (1.62e-1)"	"unprognostic (4.00e-2)"	"unprognostic (3.08e-1)"	"unprognostic (1.81e-1)"	"prognostic unfavorable (3.66e-4)"	"unprognostic (8.04e-2)"	"unprognostic (1.20e-1)"	"unprognostic (6.74e-2)"	"unprognostic (1.47e-1)"	9.9	6.2	4.7	9.3	4.8	9.2	8.9	5.1	5.7	6.6	4.1	5.7	5.4	7.2	5.1	8.0	5.9	6.5	7.0	4.5	6.4	7.2	9.0	5.6	11.1	5.3	6.3	7.5	9.3	5.9	4.5	7.8	5.8	6.1	6.5	4.0	5.6	5.6	8.4	7.4	5.0	7.7	5.3	6.5	5.4	5.6	5.5	8.8	8.5	8.0	10.8	12.2	5.1	6.0	14.1	19.3	13.2	30.6	15.2	18.1	19.9	25.0	16.2	26.4	24.6	28.5	12.0	49.7	23.8	22.1	22.5	18.3	45.6	27.8	35.0	10.8	12.3	46.9	13.2	25.6	22.9	19.3	27.4	19.1	24.8	34.8	40.4	9.4	19.6	33.5	59.5	27.5	22.0	16.1	68.9	22.4	71.4	34.4	13.2	23.9	20.1	22.2	22.2	23.7	33.6	26.7	15.5	21.1	30.4	16.2	14.7	19.5	17.8	24.9	19.3	32.6	28.9	13.8	16.4	50.4	15.3	39.7	27.0	0.0	2.4	0.6	3.2	5.0	3.6	2.0	3.2	2.8	2.9	2.5	4.0	4.3	0.4	4.4	7.9	3.0	2.6	2.3	4.7	4.8	5.1	5.7	4.5	6.4	5.3	6.3	5.8	5.3	5.5	6.0	12.8	16.0	9.7	3.6	12.8	15.6	15.2	5.6	13.1	5.1	7.9	9.0	12.9	10.0	11.3	9.2	2.1	11.5	7.8	3.9	7.9	10.6	1.8	9.8	19.8	12.7	1.8	15.8	5.8	7.8	15.8	15.8	8.2	10.5	9.5	10.8	5.3	7.3	8.7	10.1	6.0	6.7	6.1	5.3	4.7	1.3	9.0	7.8	1.8	2.8	7.7	2.9	10.3	7.1	4.7	11.5	5.0	7.5	12.1	15.3	4.1	10.2	10.5	5.1	6.6	17.6	14.4	13.8	19.2	12.7	14.9	7.5	9.9	13.8	7.4	12.3
MAML1	"KIAA0200, Mam-1"	ENSG00000161021	"Mastermind like transcriptional coactivator 1"	Q92585	5	179732822-179777283	"Predicted intracellular proteins"	"Notch signaling pathway, Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 10.8;BJ hTERT+ SV40 Large T+: 11.2;hTCEpi: 11.3;SK-MEL-30: 19.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037687, HPA057531"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 72: Non-specific - Transcription"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Nucleoplasm		"HPA037687: AB_10672604, HPA057531: AB_2683458"	"unprognostic (2.64e-1)"	"unprognostic (2.06e-1)"	"unprognostic (3.01e-2)"	"unprognostic (5.41e-3)"	"unprognostic (5.79e-2)"	"unprognostic (2.45e-1)"	"unprognostic (1.75e-3)"	"unprognostic (3.01e-1)"	"prognostic unfavorable (9.70e-4)"	"unprognostic (1.49e-1)"	"unprognostic (1.59e-1)"	"unprognostic (2.83e-2)"	"prognostic unfavorable (1.84e-5)"	"unprognostic (3.44e-1)"	"unprognostic (6.05e-2)"	"unprognostic (1.06e-1)"	"unprognostic (6.69e-2)"	14.6	15.8	0.4	2.5	0.6	4.9	14.0	0.6	0.8	17.2	0.4	17.7	3.3	17.8	5.1	15.3	16.9	0.0	12.2	0.3	0.3	11.1	11.0	13.9	1.6	0.5	0.4	20.2	15.2	0.0	12.7	3.0	0.4	15.7	2.6	1.5	13.4	0.0	12.5	16.5	14.7	3.7	0.3	16.2	13.9	9.7	0.4	0.0	14.4	3.7	0.0	15.8	15.4	0.5	0.0	0.0	0.0	0.0	9.3	9.1	0.0	5.9	10.8	11.2	8.1	0.0	0.0	7.1	8.2	0.0	0.0	0.3	0.0	0.0	7.1	0.0	0.0	0.0	8.7	0.0	8.2	0.0	0.1	0.0	11.3	0.0	7.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	5.7	0.2	0.1	0.0	0.0	0.2	19.8	10.1	8.9	0.0	9.0	0.1	1.4	0.3	8.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	1.0	0.4	0.2	0.1	0.7	0.2	0.3	0.1	0.5	0.2	0.2	0.7	0.2	0.5	0.2	0.1	0.3	0.4	0.6	0.6	0.8	0.3	0.3	0.5	0.4	0.4	0.3	0.4	0.5	15.0	16.0	9.3	11.8	14.0	25.0	12.1	12.1	20.5	12.5	13.9	15.2	7.2	15.7	7.5	9.2	18.8	10.1	20.8	12.0	1.9	6.4	2.4	10.1	15.6	26.4	9.0	16.2	18.1	6.5	12.0	11.6	13.7	13.9	56.0	14.4	33.5	9.9	13.0	21.9	18.2	11.6	12.2	24.2	26.7	2.3	17.4	16.6	5.4	9.4	19.6	7.9	13.4	18.6	14.8	6.7	6.4	25.2	14.0	12.6	7.7	3.9	6.1	9.4	13.1	11.6	14.1	6.1	10.0	19.7	29.8	9.3	17.1	9.7	12.3	16.0
MAML2	"KIAA1819, MAM3"	ENSG00000184384	"Mastermind like transcriptional coactivator 2"	Q8IZL2	11	95976598-96343195	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Notch signaling pathway, Transcription, Transcription regulation"	Activator	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 690.5;Microglial cells: 579.9;Oligodendrocyte precursor cells: 1300.8;Oligodendrocytes: 311.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 52.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035223	Approved		Supported	"Nucleoplasm,Nuclear bodies,Cytosol"		No	No			"Cluster 40: NK-cells - Unknown function"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 68: Oligodendrocytes - Mixed function"	"Nuclear bodies"	"Nucleoplasm, Cytosol"	"HPA035223: AB_10671101"	"unprognostic (8.11e-2)"	"unprognostic (2.51e-1)"	"unprognostic (7.08e-2)"	"unprognostic (9.07e-2)"	"unprognostic (3.57e-3)"	"unprognostic (3.32e-2)"	"unprognostic (3.66e-2)"	"unprognostic (2.33e-1)"	"unprognostic (3.99e-2)"	"unprognostic (8.05e-2)"	"prognostic unfavorable (3.89e-4)"	"unprognostic (9.11e-2)"	"prognostic favorable (1.90e-4)"	"unprognostic (9.76e-2)"	"unprognostic (1.73e-2)"	"unprognostic (1.99e-1)"	"unprognostic (7.19e-2)"	10.9	2.7	5.8	6.3	5.5	3.1	14.2	17.2	3.9	10.6	6.9	6.1	3.0	5.4	1.8	5.5	8.0	7.7	4.4	7.1	10.6	9.9	2.4	9.8	8.7	9.0	9.0	7.9	5.9	5.9	4.0	12.2	7.4	7.4	6.2	6.8	11.0	5.7	2.0	7.9	4.8	6.5	7.0	10.3	4.8	2.3	7.5	13.7	6.5	4.8	7.0	8.8	6.5	6.6	10.7	2.0	17.8	4.7	18.1	20.7	3.8	12.1	17.9	7.8	8.1	1.3	22.1	2.3	27.7	28.1	4.1	9.6	3.6	11.7	10.7	52.8	1.3	1.4	3.7	4.1	10.5	0.1	0.0	30.4	1.1	13.9	8.2	14.3	4.5	0.3	6.1	3.2	14.0	0.9	0.2	2.9	1.9	5.5	3.3	3.7	3.4	12.3	11.6	14.8	0.1	1.6	4.5	1.9	5.0	5.7	1.7	0.5	19.7	13.6	3.2	4.7	7.7	2.2	0.4	3.3	6.5	2.0	25.6	0.1	0.6	0.0	0.8	0.3	1.3	0.9	1.6	2.1	0.6	1.2	3.2	2.2	2.6	2.4	0.4	0.5	0.6	1.2	5.8	5.5	17.2	3.9	7.1	10.6	9.0	9.0	7.4	7.0	7.5	6.6	43.5	16.0	8.6	690.5	35.4	19.5	21.5	12.6	19.9	44.1	28.6	43.1	5.3	18.6	16.6	12.9	91.8	15.4	21.8	31.0	11.7	19.3	1.4	61.6	49.4	24.0	6.7	2.7	81.6	0.4	26.0	41.6	20.9	52.3	1.3	44.0	9.3	0.4	18.6	0.0	36.8	7.6	4.1	19.2	21.2	3.0	8.7	29.3	12.4	579.9	26.0	21.9	16.5	1300.8	311.4	15.0	16.8	8.6	18.1	19.1	9.4	17.1	24.2	25.9	32.9	3.6	51.5	0.6	0.8	19.4	13.5	13.0	38.1	9.0	14.3	19.2
MAML3	"CAGH3, GDN, KIAA1816, MAM2, TNRC3"	ENSG00000196782	"Mastermind like transcriptional coactivator 3"	Q96JK9	4	139716753-140154184	"Predicted intracellular proteins"	"Notch signaling pathway, Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Inhibitory neurons: 125.6;Microglial cells: 355.1;Oligodendrocytes: 150.8"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in many"	5	"cerebellum: 16.8"	"Immune cell enhanced"	"Detected in many"		"basophil: 12.2"	"Group enriched"	"Detected in many"	5	"granulocytes: 12.2;NK-cells: 3.4"	"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 15.0;SCLC-21H: 15.7;SH-SY5Y: 23.9;WM-115: 20.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA037717	Approved		Supported	"Nuclear speckles"		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 21: Non-specific - Transcription"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Nuclear speckles"		"HPA037717: AB_10794323"	"unprognostic (1.83e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.17e-1)"	"unprognostic (7.83e-3)"	"unprognostic (4.73e-2)"	"unprognostic (2.63e-1)"	"unprognostic (3.36e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.48e-1)"	"unprognostic (3.89e-1)"	"unprognostic (5.52e-3)"	"unprognostic (1.73e-1)"	"prognostic favorable (7.60e-5)"	"unprognostic (3.38e-1)"	"unprognostic (1.20e-1)"	"unprognostic (7.22e-2)"	"unprognostic (2.88e-1)"	3.3	3.4	1.5	2.4	0.9	3.2	3.4	16.8	2.1	5.0	0.1	3.8	4.8	6.7	5.3	5.9	5.5	4.1	2.0	2.2	2.8	2.0	2.6	3.8	2.6	3.4	2.3	8.6	6.8	3.3	4.5	5.0	3.4	4.9	3.9	1.7	5.9	4.5	1.7	7.8	4.5	6.0	2.4	3.3	3.4	3.0	2.2	6.0	4.3	2.1	2.3	3.6	5.1	2.2	0.5	8.1	5.4	2.7	2.1	4.4	4.9	1.0	4.4	0.5	0.3	3.2	2.2	1.8	0.4	0.8	0.3	0.1	2.1	1.8	0.3	0.0	1.2	5.9	1.9	0.3	0.4	2.8	8.7	4.3	1.5	0.1	0.9	3.3	15.0	0.1	1.6	0.0	0.3	0.9	0.5	1.2	1.4	3.6	3.5	3.5	0.5	3.6	2.5	11.2	15.7	23.9	0.0	4.2	5.5	4.2	2.3	0.8	13.1	0.6	1.3	0.1	1.7	2.9	3.5	0.1	0.8	9.2	20.2	12.2	1.5	2.9	0.0	1.1	0.1	0.0	0.0	0.0	1.5	0.4	0.4	0.4	3.6	3.4	0.9	1.2	0.0	1.2	1.5	0.9	16.8	2.1	2.2	2.8	3.4	2.3	3.4	2.4	2.2	2.2	21.2	3.2	11.5	39.5	3.1	8.0	8.1	4.2	7.4	4.6	12.6	9.3	3.0	11.5	8.7	5.5	18.8	5.8	3.9	13.6	5.9	5.1	3.6	12.6	9.4	11.7	14.9	9.4	60.2	5.1	7.3	5.3	8.6	19.9	19.6	34.4	13.2	17.5	7.5	11.8	125.6	12.1	2.0	22.6	13.3	9.0	4.1	19.6	3.6	355.1	18.3	3.1	1.0	7.5	150.8	3.0	14.0	3.8	2.1	5.7	8.2	6.1	7.2	3.7	0.0	2.9	13.7	0.5	2.2	19.0	13.5	8.2	5.3	8.5	11.0	8.9
MAMLD1	"CG1, CXorf6, F18"	ENSG00000013619	"Mastermind like domain containing 1"	Q13495	X	150361422-150514178	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 33.0;Excitatory neurons: 27.5;Leydig cells: 33.8;Oligodendrocyte precursor cells: 81.4;Peritubular cells: 24.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+ RasG12V: 23.3;U-2197: 36.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003923	Uncertain		Supported	Nucleoplasm		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 43: Testis - Unknown function"	"Cluster 18: U-2197 - ECM organization"	"Cluster 68: Oligodendrocytes - Mixed function"	Nucleoplasm		"HPA003923: AB_10602034"	"unprognostic (4.18e-3)"	"unprognostic (1.74e-1)"	"unprognostic (1.63e-1)"	"unprognostic (4.29e-2)"	"unprognostic (4.16e-2)"	"unprognostic (5.09e-2)"	"unprognostic (2.31e-1)"	"unprognostic (7.68e-2)"	"unprognostic (2.08e-2)"	"unprognostic (9.74e-2)"	"unprognostic (9.86e-3)"	"unprognostic (4.82e-2)"	"unprognostic (1.86e-1)"	"unprognostic (3.33e-2)"	"unprognostic (3.58e-2)"	"unprognostic (1.41e-3)"	"unprognostic (9.76e-3)"	4.7	2.6	4.9	1.4	5.6	1.6	3.4	0.1	4.6	4.2	0.0	3.1	0.9	5.3	2.2	1.7	5.0	2.4	2.0	4.3	9.3	1.9	1.7	4.8	1.6	1.8	1.3	12.9	3.1	2.0	4.3	1.7	4.4	3.1	1.1	2.9	1.8	6.6	4.5	1.8	1.3	3.1	1.0	1.4	1.9	10.3	11.1	0.8	1.1	1.9	1.0	3.7	2.3	0.1	7.3	2.9	3.8	7.6	10.9	4.1	0.0	6.8	14.3	10.3	23.3	0.0	0.4	0.0	3.4	16.3	8.1	0.2	4.2	3.2	14.0	10.4	0.3	0.1	8.8	0.2	8.1	0.4	0.0	5.6	0.6	11.7	1.4	5.2	2.2	0.6	0.2	0.0	9.9	1.4	0.0	0.1	0.7	0.0	5.4	0.5	14.7	0.4	1.7	0.1	0.9	0.8	2.4	0.2	3.8	0.9	0.2	0.1	2.8	5.5	6.9	36.8	12.2	0.4	0.5	0.2	15.2	2.9	7.6	0.0	0.0	0.0	0.2	0.0	0.3	0.6	0.4	0.3	0.0	0.2	0.3	0.7	0.1	0.1	0.0	0.0	0.5	0.2	4.9	5.6	0.1	4.6	4.3	9.3	1.8	1.3	4.4	1.0	11.1	0.1	3.3	0.0	0.5	33.0	0.4	3.4	0.9	1.2	0.0	1.5	1.9	0.9	1.9	5.7	0.2	0.0	10.4	0.0	0.1	0.0	1.9	3.2	1.1	1.4	5.2	5.5	3.6	3.2	27.5	2.5	0.0	4.8	0.0	3.3	0.0	5.4	4.6	4.8	0.5	13.5	18.3	0.6	0.0	0.8	20.5	4.6	33.8	2.3	3.6	11.2	0.6	2.2	0.0	81.4	5.0	2.2	0.1	24.0	0.3	3.1	0.0	0.4	0.1	0.6	6.6	2.8	3.4	0.3	0.4	0.2	4.1	0.0	1.9	8.3	0.0	0.4
MAN1A1		ENSG00000111885	"Mannosidase alpha class 1A member 1"	P33908	6	119177205-119349761	"Enzymes, Metabolic proteins, Plasma proteins, Predicted membrane proteins"		"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 154.6"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 232.5;Excitatory neurons: 165.0;Hepatocytes: 270.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 273.1;Hep G2: 204.0;Karpas-707: 219.6;U-266/70: 294.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB037058, HPA053198, HPA063561"	Uncertain		Supported	"Golgi apparatus"		NA	NA		460000000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 4: Macrophages - Innate immune response"	"Golgi apparatus"		"CAB037058: AB_477183, HPA053198: AB_2682078, HPA063561: AB_2685042"	"unprognostic (1.50e-1)"	"unprognostic (7.36e-3)"	"unprognostic (4.83e-2)"	"unprognostic (2.21e-2)"	"unprognostic (2.95e-2)"	"unprognostic (2.19e-1)"	"unprognostic (3.33e-3)"	"unprognostic (3.44e-2)"	"unprognostic (2.04e-1)"	"unprognostic (5.11e-2)"	"unprognostic (1.68e-3)"	"unprognostic (4.62e-1)"	"unprognostic (2.37e-2)"	"unprognostic (3.49e-2)"	"unprognostic (2.25e-1)"	"unprognostic (6.89e-2)"	"unprognostic (3.40e-1)"	102.2	48.5	4.2	32.8	12.3	28.9	34.3	1.2	8.9	25.9	5.1	36.1	52.7	23.8	8.8	22.7	16.0	47.1	15.3	8.0	4.6	66.6	154.6	35.8	34.8	2.9	5.0	20.1	32.7	25.8	4.6	79.4	2.5	18.1	29.3	6.2	42.7	15.0	7.6	14.3	69.8	27.2	3.3	36.5	25.9	7.0	8.4	18.9	22.6	31.0	25.9	56.0	17.1	5.9	0.2	0.0	3.4	0.0	273.1	119.9	6.6	6.9	41.4	5.1	12.5	19.8	2.6	43.2	0.3	26.5	65.7	0.4	7.6	0.1	6.4	64.5	19.4	36.3	3.9	204.0	27.2	0.1	17.7	82.4	5.3	41.6	25.3	22.1	3.4	12.6	128.1	219.6	39.7	6.1	1.7	0.3	2.3	20.0	10.0	12.1	4.2	66.6	13.4	35.4	14.1	21.0	0.1	0.6	0.0	8.3	10.4	4.8	24.8	16.9	15.4	32.0	15.8	294.5	44.6	84.8	50.2	0.7	10.4	4.3	0.3	1.1	1.1	0.5	2.3	0.7	0.6	0.6	0.3	0.4	0.3	0.9	1.9	0.9	0.5	2.8	0.7	0.3	4.2	12.3	1.2	8.9	8.0	4.6	2.9	5.0	2.5	3.3	8.4	5.9	37.1	9.6	46.1	19.9	31.0	31.7	5.7	1.2	5.2	28.1	18.8	5.8	4.4	44.3	6.9	106.7	0.0	6.8	40.6	23.3	5.9	9.4	232.5	5.9	63.9	42.1	48.0	40.4	165.0	37.8	12.4	98.4	18.8	10.7	3.8	24.0	97.5	270.5	101.1	0.0	79.4	61.1	0.0	84.6	91.2	39.3	26.4	98.0	28.4	128.4	13.5	1.7	42.2	4.5	3.7	14.8	18.9	4.1	147.5	5.3	92.2	33.5	4.6	5.0	6.6	12.9	27.8	2.8	3.9	3.4	27.8	6.2	24.3	14.6	18.9	9.7
MAN2A1	"GOLIM7, MANA2"	ENSG00000112893	"Mannosidase alpha class 2A member 1"	Q16706	5	109689927-109869625	"Enzymes, Metabolic proteins, Plasma proteins, Predicted membrane proteins"		"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 107.8"	"Cell type enriched"	"Detected in many"	9	"Oligodendrocytes: 2117.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022377, HPA026896"	Enhanced		Supported	"Golgi apparatus"		NA	NA		110000000	"Cluster 14: Monocytes - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Golgi apparatus"		"CAB022377: , HPA026896: AB_1853512"	"unprognostic (1.62e-2)"	"unprognostic (4.06e-2)"	"unprognostic (1.25e-2)"	"unprognostic (6.96e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.08e-1)"	"unprognostic (5.80e-2)"	"unprognostic (4.20e-2)"	"unprognostic (3.91e-1)"	"unprognostic (2.90e-2)"	"unprognostic (4.73e-2)"	"unprognostic (1.23e-1)"	"unprognostic (6.77e-3)"	"unprognostic (2.03e-2)"	"unprognostic (1.20e-2)"	"unprognostic (1.11e-3)"	"unprognostic (5.31e-3)"	11.2	17.0	28.0	13.9	66.1	12.7	11.3	41.4	29.6	13.8	3.8	20.7	30.1	12.0	4.2	8.5	9.0	18.1	3.7	21.7	31.5	17.4	42.4	10.1	15.8	64.5	49.9	9.8	22.2	20.7	0.9	15.3	62.1	9.1	20.8	1.7	6.5	10.2	6.0	7.4	25.7	18.3	39.4	14.1	15.7	9.5	42.8	22.7	14.7	11.5	14.7	16.1	2.7	107.8	23.1	18.6	26.5	11.0	56.2	42.2	97.5	49.3	78.0	26.1	46.7	23.2	37.0	17.4	30.7	63.3	18.5	26.5	14.5	56.0	59.7	16.3	9.7	32.6	13.5	30.7	34.6	15.9	15.5	39.7	25.0	43.4	61.4	37.3	54.5	16.9	8.8	87.0	70.5	13.8	27.6	9.1	20.4	17.9	7.3	10.8	40.0	78.5	34.1	32.8	3.7	3.3	22.6	24.9	16.1	29.1	20.5	17.1	56.4	53.7	21.3	30.1	32.9	48.7	58.7	13.6	41.8	22.4	30.3	4.1	2.0	0.6	1.6	2.8	1.3	1.9	2.8	2.8	1.8	1.6	3.3	2.7	1.6	0.5	4.4	2.0	2.8	1.1	28.0	66.1	41.4	29.6	21.7	31.5	64.5	49.9	62.1	39.4	42.8	107.8	20.9	6.4	8.4	100.9	41.1	17.8	15.8	12.7	29.6	0.6	20.0	9.5	7.6	34.3	14.7	31.3	0.0	19.4	28.9	65.8	1.9	27.1	13.7	10.2	35.8	21.6	24.7	29.2	220.8	35.3	98.0	32.3	45.3	33.3	15.2	19.2	36.8	130.3	18.0	0.0	115.2	35.2	22.4	74.8	24.6	8.3	9.9	47.4	26.6	102.1	39.6	5.9	13.4	46.8	2117.7	28.8	28.4	6.8	84.0	39.8	60.6	24.7	12.1	0.2	19.7	52.6	16.5	16.5	19.9	33.6	23.7	23.7	34.7	14.2	49.6	24.2
MAN2B1	"LAMAN, MANB"	ENSG00000104774	"Mannosidase alpha class 2B member 1"	O00754	19	12646511-12666742	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Glycosidase, Hydrolase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Macrophages: 32.8;Plasma cells: 78.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"classical monocyte: 201.8;intermediate monocyte: 178.8;myeloid DC: 158.8;non-classical monocyte: 138.4;plasmacytoid DC: 187.5"	"Group enriched"	"Detected in all"	5	"dendritic cells: 187.5;monocytes: 201.8"	"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA041530, HPA053404"	Supported		Approved	Nucleoplasm,Vesicles	"Intracellular and membrane"	NA	NA		3200000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 2: Immune cells - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 55: Plasma cells - Humoral immune response"	"Nucleoplasm, Vesicles"		"HPA041530: AB_10795639, HPA053404: "	"unprognostic (6.63e-2)"	"unprognostic (3.61e-1)"	"unprognostic (2.20e-2)"	"unprognostic (5.48e-2)"	"unprognostic (3.81e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.84e-2)"	"unprognostic (9.55e-2)"	"unprognostic (1.95e-1)"	"unprognostic (2.79e-2)"	"unprognostic (1.50e-1)"	"prognostic unfavorable (1.94e-5)"	"unprognostic (4.00e-1)"	"unprognostic (4.17e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.51e-1)"	35.8	21.4	5.3	54.6	6.4	83.6	24.8	6.6	5.9	19.6	18.5	30.3	31.0	21.8	9.0	19.8	19.9	28.4	16.0	4.9	7.4	17.3	23.7	46.8	52.1	10.3	6.7	16.7	39.7	16.6	9.9	24.6	9.5	20.5	22.6	1.6	35.2	14.9	12.1	28.9	33.6	20.2	8.9	70.1	32.7	6.4	9.7	23.1	16.3	9.4	39.3	35.6	16.7	12.4	52.4	26.3	26.4	31.3	85.8	57.3	74.0	37.9	79.2	33.1	32.4	21.3	21.4	56.9	44.9	30.4	9.4	40.1	13.6	25.6	15.7	28.5	41.6	19.8	13.6	34.9	43.5	131.6	130.2	68.5	49.2	18.5	23.3	35.6	31.7	21.1	25.6	41.9	17.8	40.9	17.9	74.2	21.9	26.2	32.8	40.8	36.1	28.8	38.9	59.8	8.2	25.5	37.7	32.0	63.0	15.8	49.4	80.0	42.0	44.8	18.4	44.0	36.2	55.4	65.5	28.0	30.4	127.5	51.2	12.2	201.8	29.7	31.9	178.8	35.4	32.9	28.9	29.0	158.8	26.4	15.4	15.9	29.4	13.2	138.4	187.5	30.7	150.3	5.3	6.4	6.6	5.9	4.9	7.4	10.3	6.7	9.5	8.9	9.7	12.4	1.6	6.4	7.5	8.5	25.1	3.6	2.0	2.7	14.2	2.6	1.9	1.0	0.9	2.8	2.0	1.8	0.0	2.5	20.5	2.0	1.9	1.7	3.7	1.4	2.5	3.1	1.8	9.4	7.8	2.3	2.8	7.2	20.9	1.3	1.3	3.4	1.8	0.8	8.4	0.0	6.4	0.9	0.0	15.4	24.7	11.1	3.7	32.8	1.8	17.8	11.0	1.5	9.2	3.5	13.4	1.5	2.5	4.5	78.1	2.5	3.8	1.5	3.9	4.0	13.1	2.3	2.0	0.6	1.6	11.5	3.3	2.7	9.4	2.7	2.0	2.0
MANBA		ENSG00000109323	"Mannosidase beta"	O00462	4	102630770-102760994	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Macrophages: 74.0;Microglial cells: 111.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"eosinophil: 16.6"	"Group enriched"	"Detected in many"	5	"dendritic cells: 5.3;granulocytes: 16.6;monocytes: 9.1"	"Cell line enhanced"	"Detected in many"		"ASC diff: 15.5;hTCEpi: 13.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053478	Approved		Supported	Vesicles		NA	NA		15000000	"Cluster 49: Eosinophils - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 57: B-cells - Immune response"	Vesicles		"HPA053478: AB_2682165"	"unprognostic (2.29e-2)"	"unprognostic (1.40e-1)"	"unprognostic (3.80e-1)"	"unprognostic (1.70e-1)"	"prognostic unfavorable (7.56e-5)"	"unprognostic (4.11e-2)"	"prognostic unfavorable (3.74e-6)"	"unprognostic (1.32e-1)"	"unprognostic (2.19e-1)"	"unprognostic (4.87e-2)"	"unprognostic (7.78e-2)"	"unprognostic (1.44e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.75e-2)"	"unprognostic (7.12e-2)"	"unprognostic (4.81e-2)"	"unprognostic (2.13e-1)"	7.1	12.4	1.9	1.5	2.4	7.0	6.4	4.7	2.2	6.5	2.2	6.7	1.6	6.1	0.2	3.8	6.3	1.3	6.6	1.1	2.1	4.8	4.7	10.5	2.1	3.8	2.9	8.8	8.3	3.0	5.0	3.7	4.7	4.3	1.1	2.7	8.9	2.0	3.0	4.5	8.5	2.4	3.0	12.0	9.1	1.6	3.5	1.2	7.1	0.1	2.0	8.1	5.8	3.7	2.9	1.4	0.6	1.6	15.5	12.1	0.9	1.1	6.9	1.8	4.1	1.7	1.0	3.6	1.4	2.7	3.9	1.0	3.0	2.2	1.1	2.2	0.7	3.0	1.1	0.7	2.7	2.8	8.2	3.7	13.7	7.6	3.4	8.9	3.0	1.2	3.6	2.0	3.4	1.4	2.0	2.3	1.3	1.9	1.1	1.9	1.6	0.6	3.4	2.3	1.4	0.5	1.4	1.9	1.5	5.4	4.5	1.8	0.2	2.0	1.3	9.3	1.2	1.3	5.8	0.5	3.1	1.5	1.6	4.0	6.8	16.6	0.4	6.1	0.7	1.7	0.0	0.7	5.3	2.1	0.4	0.6	6.1	1.8	9.1	1.2	0.5	3.1	1.9	2.4	4.7	2.2	1.1	2.1	3.8	2.9	4.7	3.0	3.5	3.7	6.4	32.1	35.6	24.5	45.4	5.9	8.4	13.2	12.0	6.2	11.6	8.1	14.6	14.3	13.5	9.2	6.2	42.3	14.3	5.1	1.9	8.1	2.8	6.9	6.9	8.1	1.8	19.7	36.4	2.7	7.3	13.8	25.5	12.8	34.8	5.5	10.4	17.7	43.6	6.7	66.5	10.5	2.0	58.5	29.6	1.6	9.0	74.0	0.0	111.5	52.8	5.2	17.5	31.2	66.8	5.5	17.3	19.9	17.5	7.5	5.2	9.8	5.8	7.5	0.0	10.8	6.7	0.2	1.4	12.6	4.5	22.6	16.9	12.6	11.2	9.7
MANEA	"FLJ12838, mandaselin"	ENSG00000172469	"Mannosidase endo-alpha"	Q5SRI9	6	95577535-95609452	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Hepatocytes: 59.8;Plasma cells: 113.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011046, HPA011069"	Enhanced		Supported	"Golgi apparatus"		NA	NA		140000	"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 55: Plasma cells - Humoral immune response"	"Golgi apparatus"		"HPA011046: AB_1079303, HPA011069: AB_1079304"	"unprognostic (6.00e-2)"	"unprognostic (7.81e-2)"	"prognostic favorable (3.04e-4)"	"unprognostic (1.17e-2)"	"unprognostic (1.11e-1)"	"unprognostic (5.03e-2)"	"unprognostic (2.98e-3)"	"unprognostic (2.74e-1)"	"unprognostic (5.71e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.44e-1)"	"unprognostic (9.07e-2)"	"unprognostic (2.86e-3)"	"unprognostic (5.18e-2)"	"unprognostic (3.08e-1)"	"unprognostic (9.68e-2)"	"unprognostic (7.47e-2)"	11.9	6.9	3.1	7.9	3.6	3.3	8.9	3.7	3.7	8.4	4.2	8.1	8.8	6.8	6.3	8.0	6.4	7.9	5.6	2.5	3.7	12.0	24.0	7.3	9.2	4.3	3.3	9.7	8.4	11.1	2.1	6.3	4.4	7.0	8.7	6.1	5.6	7.9	1.4	6.8	8.8	6.7	3.6	9.6	12.1	6.1	3.7	9.1	11.6	3.4	11.2	9.0	3.5	5.6	6.5	5.3	20.4	16.6	33.1	38.5	7.7	17.7	16.2	10.1	14.8	6.1	16.0	12.3	21.7	11.7	14.9	10.4	14.1	12.0	23.2	20.9	12.6	16.6	4.7	10.2	11.5	22.3	14.4	38.4	13.7	12.0	8.5	14.6	24.3	12.1	26.2	28.1	22.0	4.5	13.1	9.5	3.0	17.1	5.5	15.4	19.9	18.8	15.5	11.2	16.3	8.8	10.0	7.2	6.5	14.3	11.4	20.7	22.0	10.1	7.1	18.4	17.8	20.9	12.9	15.2	18.2	19.1	23.6	8.5	2.3	1.3	3.2	4.1	4.6	4.5	3.9	3.8	2.5	2.3	4.5	3.1	0.5	2.9	3.7	1.0	7.7	2.4	3.1	3.6	3.7	3.7	2.5	3.7	4.3	3.3	4.4	3.6	3.7	5.6	11.6	12.8	8.4	7.8	15.5	7.4	4.4	6.4	8.6	8.1	8.4	7.4	4.5	10.0	7.4	12.9	4.2	5.4	5.4	1.8	5.9	4.1	16.7	7.3	14.4	10.7	1.8	8.2	6.0	7.3	5.6	12.0	8.2	8.1	2.5	17.8	28.2	59.8	11.0	11.8	7.3	4.6	0.0	12.0	5.8	11.7	5.9	7.9	8.8	8.4	6.8	10.5	3.1	16.1	18.7	3.4	2.8	15.8	113.4	3.4	4.8	8.5	8.5	5.3	13.1	9.8	17.1	7.1	12.1	11.8	7.0	1.4	9.2	13.5	5.0	3.5
MANF	"ARMET, ARP"	ENSG00000145050	"Mesencephalic astrocyte derived neurotrophic factor"	P55145	3	51385291-51389397	"Plasma proteins, Predicted secreted proteins"	"Stress response, Unfolded protein response"	"Growth factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Plasma cells: 426.1;Syncytiotrophoblasts: 459.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"plasmacytoid DC: 109.8"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA011175	Approved		Supported	"Endoplasmic reticulum"	"Secreted to blood"	NA	NA		7500000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 55: Plasma cells - Humoral immune response"	"Endoplasmic reticulum"		"HPA011175: AB_1845039"	"unprognostic (2.90e-2)"	"unprognostic (5.24e-2)"	"unprognostic (1.11e-2)"	"unprognostic (2.51e-2)"	"unprognostic (5.84e-2)"	"prognostic unfavorable (9.58e-6)"	"prognostic unfavorable (7.48e-4)"	"unprognostic (7.37e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.12e-3)"	"unprognostic (1.35e-1)"	"unprognostic (3.01e-1)"	"unprognostic (1.21e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.99e-2)"	"unprognostic (1.27e-1)"	"unprognostic (5.10e-2)"	39.4	36.7	34.4	70.9	34.5	35.3	41.8	37.8	50.5	59.4	44.2	55.4	42.5	48.2	169.3	53.2	42.8	32.1	51.1	34.8	42.7	48.6	109.2	44.3	50.5	38.4	35.7	28.7	81.1	38.8	56.4	59.9	37.2	51.3	58.8	17.7	51.0	50.5	12.4	36.6	39.5	47.2	36.2	56.1	59.5	43.2	37.9	47.7	117.8	20.8	76.1	67.8	35.5	38.1	128.6	61.2	164.7	207.7	107.8	139.4	173.8	200.2	160.6	194.0	184.5	99.6	292.6	271.6	162.6	121.9	449.8	77.7	201.4	200.0	187.3	128.9	92.2	220.2	93.5	230.3	349.8	108.2	137.1	60.6	168.5	201.3	271.7	189.9	252.7	112.3	48.3	299.5	181.6	75.5	184.8	215.6	144.6	298.0	237.6	76.4	105.3	288.7	162.8	86.9	64.4	201.6	165.3	104.2	130.3	175.8	83.7	141.2	129.3	117.4	112.1	140.4	222.6	247.9	105.0	186.5	195.4	217.5	221.2	73.2	15.3	9.4	28.8	13.0	35.5	17.4	20.2	27.5	16.0	12.1	14.9	16.0	8.5	26.0	8.3	109.8	13.4	16.9	34.4	34.5	37.8	50.5	34.8	42.7	38.4	35.7	37.2	36.2	37.9	38.1	55.9	32.1	21.5	5.2	134.1	163.1	223.7	232.5	31.3	15.1	50.5	40.5	69.3	61.5	104.0	55.2	6.2	188.1	142.8	75.7	43.0	172.6	99.0	73.3	101.9	88.3	116.6	26.1	5.8	124.6	387.0	101.2	71.9	99.4	62.9	77.9	79.6	156.1	179.5	11.8	8.5	235.9	118.0	36.1	170.6	123.3	60.0	63.0	181.5	7.5	79.1	39.6	117.4	5.0	9.5	167.8	90.5	51.6	426.1	245.0	47.7	78.9	71.1	19.1	65.7	59.7	194.2	176.8	91.1	42.8	160.5	459.0	94.8	40.6	120.9	202.0
MAOA		ENSG00000189221	"Monoamine oxidase A"	P21397	X	43654907-43746824	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted membrane proteins"	"Catecholamine metabolism, Neurotransmitter degradation"	Oxidoreductase	"Disease variant, FDA approved drug targets, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 230.3"	"Cell type enhanced"	"Detected in many"		"Proximal enterocytes: 819.8;Proximal tubular cells: 569.9;Undifferentiated cells: 285.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 162.1;HHSteC: 302.9;HSkMC: 76.1;hTCEpi: 87.2;RT4: 131.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009437, HPA054807, HPA059299"	Enhanced		Supported	Mitochondria,Cytosol		No	No				"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Mitochondria	Cytosol	"CAB009437: AB_2137260, HPA054807: AB_2682607, HPA059299: AB_2683970"	"unprognostic (9.54e-3)"	"unprognostic (1.63e-1)"	"unprognostic (7.99e-2)"	"unprognostic (3.07e-1)"	"unprognostic (6.75e-2)"	"unprognostic (3.32e-1)"	"unprognostic (9.51e-2)"	"unprognostic (6.89e-3)"	"unprognostic (2.21e-1)"	"unprognostic (4.29e-2)"	"unprognostic (3.94e-1)"	"unprognostic (3.54e-1)"	"unprognostic (1.45e-3)"	"unprognostic (1.16e-2)"	"unprognostic (1.47e-1)"	"unprognostic (4.04e-2)"	"unprognostic (2.98e-3)"	143.9	27.7	24.7	8.6	27.6	0.4	71.6	26.5	26.6	26.6	13.9	116.4	163.4	24.0	14.1	46.7	39.1	16.9	49.6	22.3	31.7	76.9	119.1	63.5	2.4	26.9	32.5	40.7	39.1	31.4	4.0	30.2	56.4	46.3	117.9	28.2	77.3	35.0	33.5	37.4	230.3	24.0	21.3	6.3	55.9	3.7	41.4	9.9	118.4	34.3	5.3	65.0	38.8	19.0	0.0	3.7	0.6	9.9	162.1	0.0	0.6	0.2	0.0	0.0	0.0	0.4	0.4	0.0	0.2	0.0	4.6	17.2	6.1	22.3	0.1	0.0	2.5	6.9	0.5	18.6	302.9	0.0	16.9	76.1	87.2	0.2	45.2	0.1	20.0	0.0	0.3	0.4	5.7	2.9	0.1	0.8	1.6	20.7	5.0	0.0	0.3	0.5	22.3	131.8	3.1	7.8	0.0	0.0	0.3	0.4	0.5	0.0	8.7	0.0	8.2	0.7	0.0	0.3	0.0	0.0	9.5	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	24.7	27.6	26.5	26.6	22.3	31.7	26.9	32.5	56.4	21.3	41.4	19.0	35.2	70.5	146.9	23.2	4.6	11.0	177.7	32.3	116.7	5.0	13.6	10.2	101.3	94.4	49.3	60.7	22.9	11.5	0.2	248.0	121.3	36.7	25.2	50.4	42.5	43.6	38.0	4.8	4.0	13.4	21.3	24.3	40.2	175.1	5.7	7.3	53.6	193.7	6.6	3.3	5.0	137.5	67.1	12.2	2.1	33.9	5.6	6.7	10.6	21.5	17.1	25.4	0.0	7.5	1.3	49.5	140.5	0.0	2.6	64.6	819.8	569.9	32.8	27.4	6.6	4.4	30.5	1.3	0.8	120.6	14.3	207.0	3.7	3.5	285.1	129.0
MAP1LC3C	ATG8J	ENSG00000197769	"Microtubule associated protein 1 light chain 3 gamma"	Q9BXW4	1	241995490-241999098	"Predicted intracellular proteins"	"Autophagy, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 13.6;breast: 13.9"	"Cell type enhanced"	"Detected in some"		"Fibroblasts: 2.4;granulocytes: 1.3"	"Cancer enhanced"	"Detected in many"		"glioma: 2.8"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"SuSa: 28.0"					"Low region specificity"	"Detected in all"			HPA072670			Supported	"Cytoplasmic bodies"		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 12: NES - Nervous system development"	"Cluster 50: Fibroblasts - ECM organization"	"Cytoplasmic bodies"		"HPA072670: AB_2686546"	"unprognostic (2.27e-2)"	"unprognostic (1.74e-1)"	"unprognostic (9.44e-3)"	"prognostic unfavorable (1.34e-7)"	"unprognostic (1.08e-1)"	"unprognostic (4.72e-2)"	"unprognostic (3.41e-2)"	"unprognostic (3.73e-2)"	"unprognostic (1.04e-1)"	"unprognostic (2.42e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.89e-3)"	"unprognostic (6.17e-3)"	"unprognostic (1.26e-1)"	"unprognostic (8.65e-2)"	"unprognostic (7.73e-2)"	13.6	0.6	0.7	0.7	0.8	0.1	13.9	0.7	2.0	0.3	1.0	1.9	0.2	0.4	0.2	1.6	4.6	0.5	0.7	0.8	0.6	0.4	0.3	5.9	4.6	0.8	0.7	3.2	0.4	0.6	0.7	10.7	0.8	0.2	0.3	0.0	7.7	0.1	3.7	5.6	2.8	0.7	0.5	0.9	4.6	0.3	0.9	0.5	1.7	3.4	3.8	2.2	1.0	0.8	0.1	0.1	5.9	0.0	0.2	5.4	3.8	0.1	0.0	0.0	0.2	0.5	0.0	0.0	3.3	1.3	0.3	0.0	0.1	0.0	0.0	0.0	1.1	0.2	0.2	0.2	0.0	0.0	0.1	1.5	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.1	2.2	0.0	0.0	0.2	1.8	0.1	0.0	0.0	1.3	0.2	0.0	0.1	0.0	0.0	0.0	0.1	0.3	28.0	0.0	0.0	0.0	0.0	1.4	0.0	0.2	0.0	0.0	0.0	0.2	0.1	0.0	0.6	0.1	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.6	0.1	0.0	0.0	0.7	0.8	0.7	2.0	0.8	0.6	0.8	0.7	0.8	0.5	0.9	0.8	0.2	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.1	1.3	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.5	0.0	0.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.3	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0
MAP1S	"BPY2IP1, C19orf5, FLJ10669, MAP8, VCY2IP1"	ENSG00000130479	"Microtubule associated protein 1S"	Q66K74	19	17719242-17734513	"Predicted intracellular proteins"	Apoptosis	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 82.9"	"Group enriched"	"Detected in all"	4	"Early spermatids: 98.1;Late spermatids: 293.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA050934, HPA054637"	Approved		Supported	"Nucleoplasm,Nucleoli,Cell Junctions,Cytosol"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 25: Spermatids - Spermatogenesis"	Cytosol	"Nucleoplasm, Nucleoli, Cell Junctions"	"HPA050934: AB_2681281, HPA054637: AB_2682552"	"unprognostic (8.47e-2)"	"unprognostic (2.39e-2)"	"unprognostic (1.60e-1)"	"unprognostic (2.72e-1)"	"unprognostic (3.70e-1)"	"unprognostic (8.23e-2)"	"prognostic unfavorable (5.29e-4)"	"unprognostic (2.53e-1)"	"unprognostic (6.17e-2)"	"unprognostic (4.39e-2)"	"prognostic favorable (2.65e-4)"	"unprognostic (6.33e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.72e-1)"	"unprognostic (2.09e-1)"	"unprognostic (8.65e-2)"	20.5	13.9	48.2	8.7	51.9	11.2	19.1	36.8	82.9	18.9	30.1	21.5	7.7	24.8	5.4	11.9	19.2	7.9	18.8	51.4	40.5	15.4	12.4	23.5	9.0	44.7	41.1	21.6	15.6	5.4	22.0	9.7	43.3	17.4	2.4	2.8	19.7	6.5	32.4	12.2	17.7	3.6	39.2	18.3	20.1	74.7	40.6	6.1	16.1	5.4	3.9	21.6	14.6	47.7	30.1	43.2	12.4	16.9	10.4	15.4	34.0	18.3	8.8	10.9	12.3	61.3	16.0	17.3	33.8	11.4	12.8	15.3	10.5	14.5	4.6	21.8	61.1	15.1	36.3	39.2	22.1	16.8	20.9	16.7	8.3	16.7	10.5	7.9	22.6	12.5	24.2	9.5	6.0	39.0	20.8	42.0	28.7	17.1	50.8	33.3	10.2	17.5	14.8	43.4	23.0	26.5	10.7	14.8	18.9	9.0	9.9	17.8	37.3	19.7	18.2	40.7	27.2	18.1	23.3	17.4	23.7	26.7	25.1	18.5	22.6	25.9	15.7	22.2	15.1	15.7	12.3	15.6	25.9	15.5	10.1	13.9	31.4	13.0	17.9	21.2	12.2	19.0	48.2	51.9	36.8	82.9	51.4	40.5	44.7	41.1	43.3	39.2	40.6	47.7	11.1	3.2	7.5	4.2	14.7	10.3	14.0	13.1	13.1	11.1	12.3	8.6	5.5	15.7	12.1	3.7	8.4	21.7	14.0	30.9	3.9	22.2	98.1	12.9	11.5	18.5	20.4	3.8	8.4	17.2	16.9	12.3	19.4	26.9	10.2	12.0	20.7	4.8	26.1	40.4	5.5	16.6	12.2	18.7	25.1	293.2	22.4	20.7	1.8	2.8	17.4	8.1	8.2	4.5	7.1	24.2	15.8	31.6	8.8	14.9	19.0	5.9	6.2	6.3	13.1	7.7	13.0	25.9	21.4	5.4	3.3	33.8	11.3	8.1	18.3	13.7
MAP2K2	"MEK2, PRKMK2"	ENSG00000126934	"Mitogen-activated protein kinase kinase 2"	P36507	19	4090321-4124122	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, RAS pathway related proteins"		"Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Cardiomyopathy, Disease variant, Ectodermal dysplasia, FDA approved drug targets, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 724.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB003835, HPA051993"	Supported		Supported	Cytosol		NA	NA		140000	"Cluster 52: Eosinophils - Transcription"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 25: Spermatids - Spermatogenesis"	Cytosol		"CAB003835: AB_562312, HPA051993: AB_2681685"	"unprognostic (4.39e-1)"	"prognostic favorable (3.72e-4)"	"unprognostic (4.24e-1)"	"unprognostic (1.26e-3)"	"unprognostic (2.58e-1)"	"prognostic favorable (7.98e-4)"	"unprognostic (2.08e-3)"	"unprognostic (2.11e-1)"	"unprognostic (2.65e-1)"	"unprognostic (1.06e-1)"	"unprognostic (7.45e-3)"	"unprognostic (4.95e-2)"	"unprognostic (1.32e-1)"	"prognostic favorable (5.43e-5)"	"unprognostic (2.91e-2)"	"unprognostic (2.25e-1)"	"unprognostic (4.90e-2)"	73.9	118.4	145.5	54.1	143.1	102.4	69.1	151.5	190.7	76.6	150.4	103.4	134.0	72.3	23.2	121.6	64.7	30.4	156.6	145.9	147.3	82.6	123.3	66.8	57.1	149.6	152.9	84.1	134.3	54.9	99.3	36.4	154.3	93.9	42.7	68.0	79.6	37.6	289.0	95.8	101.0	31.7	143.5	89.1	92.7	131.6	150.7	69.3	74.6	132.1	41.0	77.2	75.2	142.8	163.1	175.4	93.7	132.8	127.1	151.9	93.8	104.5	138.8	139.6	125.8	153.0	85.5	137.7	95.9	120.0	111.9	114.3	74.2	111.6	107.4	118.1	90.4	50.5	91.4	171.7	194.0	93.6	101.8	168.8	106.8	98.2	129.5	185.5	125.2	123.0	98.1	263.1	119.3	203.5	186.3	130.6	107.8	118.6	125.9	140.7	61.9	159.1	123.5	102.7	126.8	126.3	95.7	130.6	344.1	107.3	101.0	158.5	111.8	113.6	98.2	293.4	163.9	263.1	172.4	100.2	176.5	166.8	199.3	27.5	13.0	45.4	16.9	16.6	13.6	13.0	13.3	17.2	15.9	18.2	12.3	15.9	21.2	18.8	14.1	9.0	14.3	7.3	145.5	143.1	151.5	190.7	145.9	147.3	149.6	152.9	154.3	143.5	150.7	142.8	77.7	9.6	31.9	22.5	62.3	35.4	93.3	21.3	15.4	85.1	92.9	95.4	62.9	44.3	22.8	40.5	41.7	28.7	102.3	300.5	146.8	20.7	248.1	59.5	68.3	52.1	63.2	123.1	17.6	45.5	38.6	60.3	64.7	48.8	19.7	124.4	49.2	48.1	55.0	121.1	23.2	107.7	16.2	56.0	38.2	724.3	35.8	65.6	42.7	10.3	28.5	121.1	62.8	13.0	24.2	47.0	151.8	23.0	79.9	103.2	166.1	92.8	18.9	106.8	26.3	93.1	71.8	23.5	17.4	42.9	63.9	35.6	77.0	120.2	119.9	113.1
MAP2K3	"MAPKK3, MEK3, MKK3, PRKMK3"	ENSG00000034152	"Mitogen-activated protein kinase kinase 3"	P46734	17	21284672-21315232	"Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 212.4"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 325.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB018548	Approved		Supported	Nucleoplasm,Cytosol		NA	NA		28000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 44: Endometrium - Transcription"	"Nucleoplasm, Cytosol"		"CAB018548: AB_631927"	"unprognostic (2.31e-1)"	"unprognostic (6.39e-2)"	"unprognostic (4.63e-2)"	"unprognostic (3.68e-1)"	"unprognostic (3.54e-3)"	"unprognostic (1.60e-1)"	"unprognostic (2.97e-2)"	"unprognostic (1.35e-2)"	"unprognostic (5.25e-3)"	"unprognostic (1.88e-2)"	"unprognostic (3.16e-2)"	"unprognostic (2.18e-2)"	"unprognostic (1.33e-1)"	"unprognostic (6.48e-2)"	"unprognostic (1.22e-2)"	"unprognostic (2.92e-1)"	"unprognostic (1.77e-1)"	47.3	32.5	12.9	35.3	12.1	212.4	30.7	17.6	23.2	22.7	22.6	33.1	49.0	17.1	14.5	62.7	29.9	40.0	66.7	11.5	14.4	45.7	95.7	67.5	34.0	13.6	14.3	12.6	33.6	17.9	37.1	28.9	14.2	28.9	24.1	6.0	45.3	16.5	132.7	53.1	41.0	22.5	14.3	60.4	42.8	6.2	15.8	20.9	24.0	74.6	41.1	54.1	33.4	17.0	75.5	73.9	9.7	44.5	57.7	36.6	36.3	113.0	121.8	88.3	80.5	82.9	46.6	68.1	44.7	178.3	74.2	72.4	31.0	100.5	62.1	69.5	56.9	39.2	42.0	76.1	18.2	51.9	76.7	28.5	28.2	120.6	35.9	27.7	40.0	38.6	7.7	33.2	74.7	74.1	25.5	49.3	28.1	134.1	42.3	53.0	62.2	50.0	50.5	77.4	26.3	9.4	41.7	45.9	82.0	95.7	22.5	17.7	36.8	83.0	68.4	90.1	73.9	39.8	21.8	88.1	80.2	44.3	44.1	54.1	49.3	77.8	35.9	72.1	31.1	33.3	29.1	33.6	49.6	25.5	17.9	24.1	145.6	15.3	104.7	35.4	44.5	35.6	12.9	12.1	17.6	23.2	11.5	14.4	13.6	14.3	14.2	14.3	15.8	17.0	44.2	38.5	53.6	2.6	51.5	258.0	188.4	57.0	97.9	7.1	69.3	51.3	21.9	44.3	50.5	22.0	4.2	73.3	117.4	109.1	74.3	99.1	1.5	130.5	44.8	49.4	120.4	325.0	7.2	79.8	82.0	43.7	68.3	237.8	94.0	11.5	22.1	73.1	49.0	18.5	8.0	77.0	28.5	59.4	278.7	1.8	12.2	118.1	87.2	4.7	48.3	17.3	35.0	5.5	2.0	129.1	135.3	16.6	85.2	158.7	60.8	44.2	40.4	7.4	0.0	61.9	42.4	1.1	5.3	97.3	218.1	67.0	62.6	10.5	58.5	255.7
MAP2K6	"MAPKK6, MEK6, MKK6, PRKMK6, SAPKK3"	ENSG00000108984	"Mitogen-activated protein kinase kinase 6"	P52564	17	69414697-69553865	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Apoptosis, Stress response, Transcription, Transcription regulation"	"Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 40.5"	"Cell type enhanced"	"Detected in many"		"Endometrial ciliated cells: 53.9;Glandular and luminal cells: 82.7;Oligodendrocytes: 52.5"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 8.1"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	7	"classical monocyte: 22.0;neutrophil: 45.9;plasmacytoid DC: 78.3"	"Group enriched"	"Detected in all"	9	"dendritic cells: 78.3;granulocytes: 45.9;monocytes: 22.0"	"Cell line enhanced"	"Detected in many"		"A549: 40.0;AN3-CA: 21.4;HUVEC TERT2: 28.4;MOLT-4: 21.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB007744, HPA031134"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 44: Endometrium - Transcription"	"Nucleoplasm, Cytosol"		"CAB007744: AB_562318, HPA031134: AB_10603016"	"prognostic favorable (2.27e-6)"	"unprognostic (2.24e-1)"	"unprognostic (8.46e-2)"	"unprognostic (4.10e-2)"	"unprognostic (3.75e-2)"	"unprognostic (1.23e-1)"	"unprognostic (7.61e-3)"	"unprognostic (9.52e-2)"	"unprognostic (3.67e-1)"	"unprognostic (4.09e-3)"	"prognostic favorable (7.52e-4)"	"unprognostic (3.61e-2)"	"unprognostic (2.29e-2)"	"unprognostic (7.48e-2)"	"unprognostic (9.43e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.03e-2)"	5.2	1.3	4.2	8.4	4.0	15.9	20.4	11.6	4.0	27.0	7.6	30.7	10.3	6.1	3.2	3.1	4.5	7.2	1.4	2.7	6.2	5.5	12.2	1.8	8.0	5.4	3.8	3.1	8.3	0.3	1.6	1.6	3.9	3.3	31.7	5.8	2.5	3.1	40.5	2.0	10.8	3.3	4.4	4.0	7.4	1.3	5.7	11.5	3.3	21.1	5.9	3.3	1.2	7.7	0.1	40.0	17.6	21.4	7.4	4.0	2.5	0.3	5.8	1.6	2.4	1.2	1.7	1.1	14.2	0.8	1.3	1.9	6.1	0.8	0.5	1.3	3.2	0.1	10.3	11.4	7.4	1.7	1.3	19.0	0.5	0.3	0.0	1.4	28.4	5.3	0.1	2.5	0.0	0.3	21.6	0.7	12.5	0.9	7.3	7.7	1.8	0.5	7.8	5.4	7.8	11.8	1.7	1.3	3.9	9.3	5.4	2.3	5.1	1.9	2.3	1.6	0.5	1.7	2.2	0.5	1.6	2.5	1.5	2.5	22.0	4.0	2.8	2.6	5.0	4.1	3.1	3.5	7.1	5.2	3.6	3.4	45.9	4.7	1.1	78.3	5.0	6.2	4.2	4.0	11.6	4.0	2.7	6.2	5.4	3.8	3.9	4.4	5.7	7.7	11.2	3.2	6.7	27.7	7.7	2.7	4.1	0.8	8.6	5.2	14.3	29.1	1.3	5.7	3.6	0.0	2.1	9.7	29.2	42.3	23.5	1.9	10.2	53.9	11.5	7.9	45.6	5.0	26.0	4.1	6.6	5.0	9.2	82.7	1.3	13.4	4.2	2.5	6.2	3.3	22.4	22.9	0.0	6.8	7.4	2.9	4.4	6.9	3.6	24.4	9.6	31.8	10.3	32.6	52.5	1.1	16.7	3.8	10.7	1.3	14.5	1.5	4.2	4.2	0.0	3.9	5.7	0.1	1.8	4.8	4.3	0.8	13.3	1.4	30.6	2.8
MAP3K11	"MEKK11, MLK3, PTK1, SPRK"	ENSG00000173327	"Mitogen-activated protein kinase kinase kinase 11"	Q16584	11	65597756-65615382	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal enterocytes: 123.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB010165	Approved		Supported	"Centriolar satellite,Cytosol"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Centriolar satellite, Cytosol"		"CAB010165: AB_631936"	"unprognostic (8.36e-2)"	"unprognostic (1.17e-2)"	"unprognostic (1.06e-1)"	"unprognostic (9.99e-2)"	"unprognostic (3.40e-1)"	"unprognostic (1.87e-1)"	"unprognostic (7.56e-3)"	"unprognostic (3.10e-2)"	"unprognostic (4.50e-2)"	"unprognostic (4.30e-1)"	"unprognostic (4.69e-2)"	"unprognostic (2.77e-2)"	"unprognostic (3.13e-2)"	"unprognostic (2.01e-2)"	"unprognostic (7.62e-2)"	"unprognostic (1.95e-1)"	"unprognostic (8.27e-3)"	47.6	32.6	39.9	36.9	51.7	24.4	42.9	45.1	48.4	27.2	27.2	40.0	48.3	29.7	7.4	35.6	31.3	13.5	53.2	36.1	38.8	48.5	95.3	62.7	23.7	48.8	50.3	21.0	35.8	12.1	27.8	21.6	44.6	39.2	11.7	2.8	29.1	12.6	20.1	35.9	51.0	10.0	41.5	78.3	36.3	21.3	50.5	19.3	37.3	10.4	11.3	29.2	28.3	60.1	48.0	43.4	23.1	22.6	7.0	8.0	21.7	19.3	11.9	19.9	14.9	43.4	43.9	16.4	65.5	13.0	33.0	40.9	12.2	19.5	7.1	40.2	15.5	50.0	28.2	50.9	18.6	28.9	71.2	12.4	19.1	14.5	13.3	21.6	57.4	21.5	21.6	32.7	10.9	58.2	34.0	50.9	24.2	31.0	48.1	56.1	13.3	36.2	19.2	43.1	19.6	22.9	22.0	58.1	107.7	10.4	46.6	45.8	68.8	31.3	35.8	48.1	32.4	23.3	27.5	15.8	35.3	33.1	75.1	7.5	10.5	13.1	3.1	15.3	3.0	2.7	3.2	4.5	10.1	3.0	2.4	1.8	17.3	2.4	15.4	3.0	1.8	9.5	39.9	51.7	45.1	48.4	36.1	38.8	48.8	50.3	44.6	41.5	50.5	60.1	70.0	22.4	21.1	4.2	22.1	21.0	25.3	18.4	20.5	24.4	28.9	23.4	8.7	31.5	14.1	11.0	25.0	24.7	26.4	123.5	19.6	21.9	13.5	15.4	11.3	78.9	41.9	13.0	4.1	27.5	17.7	11.4	44.4	26.1	26.0	19.6	58.5	56.2	53.3	18.5	3.5	54.9	20.3	50.6	65.5	68.5	9.6	48.3	21.4	21.5	50.2	16.1	23.7	3.0	29.5	33.7	99.0	6.4	15.5	28.1	113.1	27.6	10.3	54.7	32.9	10.5	12.8	12.2	18.3	24.8	30.0	34.3	24.0	28.9	55.2	34.6
MAP3K14	"FTDCR1B, HS, HSNIK, NIK"	ENSG00000006062	"Mitogen-activated protein kinase kinase kinase 14"	Q99558	17	45263119-45317029	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"monocytes: 33.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"A549: 40.6;U-251 MG: 43.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA027269, HPA027270"	Approved		Supported	"Nucleoplasm,Nucleoli fibrillar center,Vesicles,Cytosol"		NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 59: Non-specific - Translation"	"Cluster 9: U-2 OS - Unknown function"	"Cluster 3: Monocytes - Immune response regulation"	"Vesicles, Cytosol"	"Nucleoplasm, Nucleoli fibrillar center"	"HPA027269: AB_2732436, HPA027270: AB_2732437"	"unprognostic (1.05e-2)"	"prognostic favorable (5.27e-5)"	"unprognostic (2.71e-2)"	"unprognostic (9.42e-2)"	"unprognostic (5.31e-2)"	"unprognostic (2.61e-3)"	"unprognostic (2.70e-2)"	"unprognostic (1.72e-1)"	"unprognostic (3.40e-1)"	"unprognostic (3.45e-1)"	"unprognostic (1.07e-2)"	"unprognostic (1.78e-1)"	"prognostic unfavorable (2.78e-4)"	"unprognostic (8.82e-2)"	"unprognostic (3.49e-2)"	"unprognostic (1.03e-2)"	"unprognostic (2.28e-1)"	5.9	4.7	2.6	12.5	5.0	5.2	6.4	2.9	2.3	7.1	2.8	15.6	8.1	5.7	1.9	7.8	6.6	5.9	9.9	3.2	2.7	5.1	7.3	8.1	17.7	3.6	4.6	6.0	8.3	4.6	5.9	2.7	3.1	7.0	5.2	2.2	8.1	4.7	28.0	8.5	10.3	5.9	2.5	12.4	7.6	6.9	4.8	13.4	5.8	9.9	16.0	7.2	7.1	2.1	17.1	40.6	3.6	6.5	2.4	7.1	9.4	4.5	3.4	14.9	9.1	5.5	21.0	7.4	24.1	5.3	14.6	11.6	1.5	6.5	7.6	24.3	3.1	1.4	10.1	2.1	7.1	1.1	6.9	10.0	3.6	7.3	3.6	15.6	3.0	3.2	2.7	30.1	8.1	6.1	6.8	1.7	1.8	11.1	5.1	9.5	12.1	17.9	10.5	2.6	3.5	3.0	7.6	3.4	5.0	5.5	2.8	0.4	5.6	6.5	10.2	5.7	43.1	29.1	12.1	4.1	3.9	4.0	9.2	0.0	2.0	0.8	1.6	1.8	1.0	4.2	1.1	1.0	1.4	4.4	1.2	0.9	1.6	2.0	0.6	1.7	2.9	1.6	2.6	5.0	2.9	2.3	3.2	2.7	3.6	4.6	3.1	2.5	4.8	2.1	5.8	3.2	12.8	23.5	15.3	0.0	14.7	0.0	14.8	4.5	5.6	4.8	2.3	18.6	2.5	0.0	4.2	0.9	14.5	13.9	0.0	4.8	4.7	7.0	4.0	6.1	13.1	1.3	8.9	2.7	1.5	6.3	10.2	5.6	1.3	2.1	6.4	9.2	4.9	1.7	15.6	7.8	0.0	9.4	0.0	6.2	4.7	11.3	0.0	26.2	33.4	1.9	5.2	6.6	5.5	3.3	9.6	1.2	8.5	6.2	13.4	3.8	5.1	2.9	0.0	12.9	2.8	4.2	3.0	7.9	0.0	0.0	10.6	2.4	8.5	6.8
MAP3K2	"MEKK2, MEKK2B"	ENSG00000169967	"Mitogen-activated protein kinase kinase kinase 2"	Q9Y2U5	2	127298730-127388465	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 11.3"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021540	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 65: Plasmacytoid DCs - Unknown function"	"Nucleoplasm, Cytosol"		"HPA021540: AB_2670742"	"unprognostic (5.81e-2)"	"unprognostic (2.76e-1)"	"unprognostic (1.58e-1)"	"unprognostic (9.46e-2)"	"unprognostic (1.02e-1)"	"unprognostic (5.76e-2)"	"unprognostic (7.19e-2)"	"unprognostic (4.50e-1)"	"unprognostic (1.27e-1)"	"unprognostic (4.00e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.39e-1)"	"unprognostic (4.97e-3)"	"unprognostic (7.56e-2)"	"unprognostic (8.93e-2)"	"unprognostic (8.88e-2)"	"unprognostic (2.11e-1)"	12.6	8.9	12.1	13.4	16.3	37.6	10.5	13.5	15.9	12.0	9.9	12.5	15.3	11.2	8.3	9.5	9.0	12.9	6.6	10.3	14.3	11.9	22.3	10.8	12.9	18.0	14.9	10.6	10.6	14.0	7.8	9.9	17.4	8.9	10.1	15.6	10.2	9.0	13.4	12.6	14.1	12.7	15.2	13.5	14.7	11.3	18.3	14.4	17.9	9.1	13.8	10.4	8.3	24.8	29.4	12.3	9.6	9.7	13.2	17.4	16.0	17.9	19.4	17.2	13.9	14.8	12.7	19.2	30.0	25.7	16.0	24.3	15.6	12.0	19.3	48.6	12.1	17.9	22.3	13.0	15.2	18.2	37.2	15.7	12.9	21.0	25.5	15.1	8.1	14.2	8.6	37.3	17.2	10.7	21.4	12.9	9.9	8.2	15.8	14.0	18.0	14.5	7.0	27.1	19.0	10.2	26.1	15.8	16.4	7.8	10.3	13.7	18.7	33.6	31.3	15.7	24.5	38.4	30.0	19.5	16.1	11.7	14.8	3.4	2.5	1.7	1.3	1.5	1.6	2.7	1.2	1.3	2.1	2.2	1.5	1.6	11.3	2.0	2.0	4.2	1.1	1.0	12.1	16.3	13.5	15.9	10.3	14.3	18.0	14.9	17.4	15.2	18.3	24.8	45.7	83.3	46.0	53.8	88.9	72.0	36.9	34.3	55.2	53.6	42.2	32.1	30.1	45.8	44.2	29.5	106.3	20.5	107.9	72.6	13.7	21.2	4.6	77.0	71.0	36.9	45.4	27.8	60.6	34.0	19.8	54.9	42.3	90.2	60.9	42.2	25.4	69.1	47.7	72.3	57.7	40.1	30.5	80.1	113.7	7.6	42.3	107.7	56.9	50.6	79.1	25.9	30.9	49.8	87.7	49.0	28.8	51.9	57.3	48.3	54.5	33.1	58.5	59.2	19.7	69.2	47.4	42.3	52.6	43.5	78.6	26.3	65.5	51.7	31.8	46.1
MAP3K20	"MLK7, MLTK, MLTKalpha, MLTKbeta, MRK, ZAK"	ENSG00000091436	"Mitogen-activated protein kinase kinase kinase 20"	Q9NYL2	2	173075435-173268015	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Cell cycle"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 261.9;tongue: 279.7"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 57.5;Alveolar cells type 2: 57.7;Cytotrophoblasts: 52.6;Endometrial stromal cells: 96.7;Granulosa cells: 100.7;Smooth muscle cells: 83.2;Theca cells: 70.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"myeloid DC: 15.5"	"Group enriched"	"Detected in many"	5	"dendritic cells: 15.5;monocytes: 9.4"	"Cell line enhanced"	"Detected in many"		"U-138 MG: 176.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017205	Approved		Supported	Cytosol		NA	Yes			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 7: Non-specific - Mitochondria"	Cytosol		"HPA017205: AB_1858933"	"unprognostic (2.90e-2)"	"unprognostic (9.99e-3)"	"unprognostic (4.63e-3)"	"unprognostic (1.98e-1)"	"unprognostic (7.63e-2)"	"unprognostic (5.02e-2)"	"unprognostic (2.34e-2)"	"unprognostic (3.89e-3)"	"unprognostic (2.83e-2)"	"unprognostic (9.27e-2)"	"unprognostic (4.54e-2)"	"unprognostic (1.74e-1)"	"prognostic unfavorable (3.41e-6)"	"unprognostic (2.34e-1)"	"unprognostic (1.86e-1)"	"unprognostic (2.23e-1)"	"unprognostic (1.19e-2)"	71.0	11.4	9.5	20.5	9.7	4.7	21.4	10.3	8.5	44.9	15.7	65.8	13.0	76.4	18.6	50.0	48.0	31.4	195.7	9.3	12.1	7.5	25.2	22.5	9.8	13.8	14.7	69.5	11.7	49.3	3.8	27.6	11.2	44.0	20.9	2.5	12.4	57.1	261.9	14.1	19.2	75.0	11.1	12.5	31.5	10.6	12.5	11.5	16.4	279.7	10.2	56.1	21.2	9.4	34.6	28.6	22.0	29.1	62.7	92.5	13.8	121.9	94.7	55.9	59.6	19.5	22.2	26.5	31.2	122.5	48.8	22.9	33.1	64.6	124.2	52.0	22.0	43.3	30.5	4.1	24.8	39.3	43.8	74.7	27.2	105.2	164.2	46.3	37.5	28.5	19.8	4.9	36.8	14.8	24.8	19.0	12.2	28.9	16.0	36.2	45.0	0.1	13.6	19.6	12.9	12.4	47.0	11.3	19.7	35.6	12.9	20.9	37.9	176.3	71.4	53.1	27.9	0.1	0.1	5.5	126.2	10.6	18.9	0.2	9.4	0.0	1.0	8.3	1.0	1.6	0.8	1.7	15.5	2.5	0.0	0.8	2.6	0.5	8.2	0.3	0.8	3.4	9.5	9.7	10.3	8.5	9.3	12.1	13.8	14.7	11.2	11.1	12.5	9.4	57.5	38.5	57.7	0.0	2.8	0.0	0.0	0.0	0.0	0.0	20.0	44.4	0.0	0.0	7.4	11.0	0.0	52.6	2.3	0.0	1.9	43.9	0.0	36.7	96.7	14.1	0.0	0.0	0.0	27.6	21.9	36.5	0.0	35.6	5.1	100.7	0.0	0.0	19.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.2	0.0	0.0	15.5	0.0	0.0	0.0	0.0	38.6	0.0	0.0	1.4	0.0	0.0	1.9	13.1	0.0	0.0	0.0	83.2	0.0	0.0	0.0	0.0	21.6	3.6	70.5	0.0	0.0
MAP3K5	"ASK1, MAPKKK5, MEKK5"	ENSG00000197442	"Mitogen-activated protein kinase kinase kinase 5"	Q99683	6	136557046-136792477	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Host-virus interaction, Immunity, Innate immunity, Stress response"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 88.1"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 383.6;Excitatory neurons: 170.4;Inhibitory neurons: 204.8;Microglial cells: 216.4;Oligodendrocyte precursor cells: 210.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 42.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB007824, HPA063245"	Supported		Supported	Cytosol		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 35: Non-specific - Unknown function"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Cytosol		"CAB007824: AB_598175, HPA063245: AB_2684969"	"unprognostic (1.37e-1)"	"unprognostic (3.21e-2)"	"unprognostic (2.85e-2)"	"unprognostic (1.38e-1)"	"unprognostic (3.19e-1)"	"prognostic favorable (6.08e-4)"	"unprognostic (8.76e-2)"	"unprognostic (1.41e-2)"	"unprognostic (2.84e-1)"	"unprognostic (1.90e-2)"	"prognostic unfavorable (5.91e-4)"	"unprognostic (3.97e-1)"	"unprognostic (3.75e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.72e-1)"	"unprognostic (2.72e-2)"	"unprognostic (6.59e-3)"	13.2	88.1	21.7	11.7	23.6	14.1	9.5	21.6	18.9	8.4	7.0	8.7	7.3	11.3	7.7	10.0	12.9	7.5	11.3	18.6	18.9	10.6	9.0	11.9	12.1	17.2	20.7	49.3	30.9	1.9	16.2	5.3	16.1	18.0	9.7	14.5	7.1	7.1	6.3	8.0	9.0	5.1	16.6	11.7	14.8	12.0	24.8	8.2	12.8	6.1	12.3	18.5	9.2	15.7	5.6	3.4	0.0	0.0	7.6	20.2	1.9	8.0	42.6	4.0	3.8	0.3	5.6	3.3	11.5	11.1	3.0	7.6	13.6	4.1	10.5	4.6	10.6	28.9	7.6	0.0	36.3	13.6	0.1	26.8	5.3	6.3	17.9	15.4	13.6	4.1	7.3	31.2	28.7	10.9	0.3	11.6	1.3	10.9	4.5	7.6	8.9	13.2	16.2	35.3	9.7	6.4	6.6	6.3	1.8	1.4	1.4	12.0	12.0	6.7	2.1	0.4	7.5	25.3	18.0	0.0	5.3	18.6	6.0	3.5	1.8	2.1	1.5	1.4	2.9	1.1	2.5	2.2	1.5	1.5	0.2	0.8	5.2	2.3	1.4	1.5	4.6	0.9	21.7	23.6	21.6	18.9	18.6	18.9	17.2	20.7	16.1	16.6	24.8	15.7	11.9	6.4	22.0	383.6	14.3	5.0	20.5	32.0	3.4	18.2	10.0	5.0	21.2	4.3	35.1	11.0	6.2	1.0	25.9	12.3	3.9	3.0	6.4	17.3	31.4	7.7	34.8	14.9	170.4	23.1	1.1	12.1	20.9	62.5	5.7	67.7	9.7	11.2	8.0	0.0	204.8	18.2	14.2	23.5	10.2	4.2	23.6	26.6	0.0	216.4	21.7	43.3	12.3	210.1	4.2	17.8	8.7	14.3	13.5	18.8	7.2	8.3	20.5	2.6	13.1	5.3	17.9	3.4	15.5	13.1	10.1	2.7	18.5	16.2	11.2	23.4
MAP3K7	"MEKK7, TAK1"	ENSG00000135341	"Mitogen-activated protein kinase kinase kinase 7"	O43318	6	90513573-90587072	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Apoptosis, Host-virus interaction, Stress response, Transcription, Transcription regulation"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 137.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007633, HPA075335"	Approved		Supported	"Nuclear speckles,Plasma membrane,Cytosol"		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 21: Non-specific - Transcription"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Cytosol	"Nuclear speckles, Plasma membrane"	"HPA007633: AB_1079359, HPA075335: "	"unprognostic (1.48e-1)"	"unprognostic (3.45e-2)"	"unprognostic (1.35e-1)"	"unprognostic (6.48e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.84e-1)"	"prognostic unfavorable (3.51e-4)"	"unprognostic (9.77e-2)"	"unprognostic (6.51e-2)"	"unprognostic (1.98e-2)"	"unprognostic (1.44e-1)"	"unprognostic (2.79e-1)"	"unprognostic (2.56e-3)"	"unprognostic (4.76e-2)"	"unprognostic (1.95e-1)"	"unprognostic (2.08e-1)"	"unprognostic (1.17e-1)"	11.8	12.5	13.1	12.5	15.1	8.7	14.3	15.6	17.3	14.3	11.7	11.6	9.2	16.6	16.5	10.6	11.0	12.7	16.9	14.7	14.9	11.4	11.6	10.4	16.4	15.3	13.7	15.8	9.7	16.3	13.0	17.4	15.8	14.9	10.9	23.5	12.1	13.3	16.9	13.9	9.8	14.0	15.3	17.6	10.8	9.9	13.8	20.8	14.7	18.4	16.8	14.3	12.2	22.4	16.7	14.4	41.3	35.6	29.5	39.1	29.0	32.7	37.7	28.8	36.1	18.6	15.5	36.9	20.4	35.6	25.6	17.3	26.3	25.5	48.7	19.0	27.7	32.9	19.9	24.9	30.8	36.9	24.4	32.5	30.5	28.2	34.2	33.1	27.4	31.8	67.0	29.3	41.8	20.3	17.2	31.2	34.0	25.7	18.0	29.3	73.9	18.0	24.2	18.4	20.8	29.5	22.9	15.6	24.8	32.2	15.5	64.7	26.5	23.3	14.7	21.6	30.9	25.9	24.7	15.8	35.7	39.7	35.0	18.2	11.5	18.4	12.8	15.9	14.5	13.0	12.3	12.5	14.6	9.9	13.7	13.4	11.5	17.9	17.6	8.9	20.8	13.4	13.1	15.1	15.6	17.3	14.7	14.9	15.3	13.7	15.8	15.3	13.8	22.4	16.1	16.0	26.9	47.0	24.3	36.3	20.8	19.5	21.6	23.3	17.9	12.3	31.0	14.3	16.9	16.5	27.1	31.8	17.8	12.4	7.9	17.6	3.6	10.9	19.8	21.2	12.1	14.1	85.7	20.9	34.6	23.2	16.3	14.8	13.9	25.9	25.7	20.7	24.3	28.6	63.8	13.7	20.3	27.3	24.6	3.2	26.8	21.7	21.4	36.5	35.2	19.6	16.5	50.8	137.2	20.1	9.1	41.0	18.8	30.1	11.1	16.6	21.4	21.5	19.7	28.0	18.5	25.9	24.9	21.3	37.2	48.4	22.7	18.1	15.1	24.8
MAP3K8	"c-COT, COT, EST, ESTF, MEKK8, Tpl-2"	ENSG00000107968	"Mitogen-activated protein kinase kinase kinase 8"	P41279	10	30434021-30461833	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Immunity"	"Kinase, Serine/threonine-protein kinase, Transferase"	Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"bone marrow: 332.1"	"Cell type enhanced"	"Detected in many"		"Macrophages: 225.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HMC-1: 44.2"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"CAB005120, HPA017962"	Supported		Supported	Cytosol		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 41: Macrophages - Immune response"	Cytosol		"CAB005120: AB_2140669, HPA017962: AB_1853776"	"unprognostic (1.91e-2)"	"unprognostic (2.94e-1)"	"unprognostic (3.07e-1)"	"unprognostic (9.29e-2)"	"unprognostic (6.73e-2)"	"unprognostic (1.00e-2)"	"unprognostic (1.44e-1)"	"unprognostic (3.36e-2)"	"unprognostic (1.41e-2)"	"unprognostic (8.04e-3)"	"unprognostic (8.23e-2)"	"unprognostic (2.96e-1)"	"prognostic unfavorable (8.76e-7)"	"unprognostic (1.88e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.63e-2)"	"unprognostic (5.98e-3)"	69.1	18.8	7.2	39.9	5.8	332.1	31.8	5.9	8.0	15.1	22.1	19.6	8.3	18.3	5.9	23.2	38.0	37.4	18.5	6.7	13.5	12.7	16.2	64.5	33.7	10.7	8.1	12.0	7.4	6.9	8.4	46.5	8.8	11.1	16.4	10.9	12.5	11.2	6.6	36.0	21.1	35.6	9.3	41.7	20.3	3.0	15.9	9.3	14.7	6.1	28.8	49.4	20.4	7.9	15.5	13.7	3.6	7.7	18.3	15.4	17.3	3.8	20.3	8.2	9.6	9.4	34.2	10.3	9.2	8.1	8.1	28.2	8.4	3.7	3.0	23.3	4.4	19.2	25.6	30.8	16.0	6.0	44.2	19.5	2.1	7.4	1.6	7.7	3.6	0.2	8.8	14.7	1.4	8.8	0.2	22.3	1.4	8.3	4.9	1.3	3.0	5.8	7.9	30.8	0.3	1.6	13.7	11.3	1.9	10.0	3.7	12.7	0.1	4.8	4.3	18.0	0.6	22.4	22.7	3.2	6.9	25.3	0.2	45.8	14.7	53.1	15.7	26.4	8.7	20.8	3.3	10.3	14.5	38.0	0.2	6.0	35.5	28.3	38.7	30.0	1.0	10.3	7.2	5.8	5.9	8.0	6.7	13.5	10.7	8.1	8.8	9.3	15.9	7.9	51.0	38.5	49.6	11.8	147.3	116.9	50.0	91.1	109.8	19.0	51.7	24.3	10.1	11.5	67.5	3.7	0.0	29.3	203.6	13.6	1.9	31.4	0.5	149.3	51.4	55.7	12.0	21.2	7.7	11.3	86.8	66.2	33.1	205.6	71.1	1.1	25.0	3.1	128.2	0.0	7.1	6.3	83.4	113.8	205.5	1.1	8.4	225.1	42.7	30.9	64.7	6.1	36.0	2.0	0.7	23.4	20.7	4.1	107.8	46.8	3.9	3.5	78.8	1.6	6.6	23.6	62.3	0.3	0.8	129.1	84.8	159.4	97.8	1.5	6.5	195.6
MAP4		ENSG00000047849	"Microtubule associated protein 4"	P27816	3	47850690-48089272	"FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"			"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 743.9"	"Cell type enhanced"	"Detected in all"		"Bipolar cells: 392.2;Cardiomyocytes: 921.5;Cone photoreceptor cells: 625.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038149, HPA038150"	Enhanced		Approved	"Plasma membrane,Microtubules,Cytosol"		NA	NA		880000	"Cluster 27: Non-specific - Gene expression"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 54: Cardiomyocytes - Muscle contraction"	"Microtubules, Cytosol"	"Plasma membrane"	"HPA038149: AB_10672471, HPA038150: AB_10672505"	"unprognostic (2.51e-1)"	"unprognostic (4.48e-1)"	"unprognostic (2.72e-1)"	"unprognostic (1.95e-2)"	"unprognostic (3.36e-1)"	"unprognostic (4.57e-1)"	"prognostic unfavorable (1.82e-4)"	"unprognostic (6.82e-2)"	"unprognostic (1.46e-2)"	"unprognostic (5.02e-2)"	"unprognostic (2.23e-2)"	"unprognostic (1.30e-2)"	"unprognostic (2.25e-2)"	"unprognostic (8.89e-2)"	"unprognostic (6.45e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.21e-3)"	127.4	55.7	475.5	50.4	483.4	16.1	98.0	433.2	406.8	118.0	215.5	193.2	35.1	111.7	69.7	90.7	94.7	52.9	380.9	351.2	408.7	88.3	66.0	105.0	35.0	567.9	490.6	90.0	71.4	31.4	56.1	64.8	509.2	92.7	47.6	149.0	71.4	88.1	743.9	120.6	80.6	94.5	526.1	64.0	93.9	80.0	552.3	42.1	61.1	491.0	37.8	135.5	115.2	533.2	121.9	95.7	117.1	89.3	168.6	298.5	49.5	222.6	241.2	184.1	204.9	81.3	74.4	102.3	50.7	337.9	172.8	79.2	151.4	201.6	204.7	148.7	63.8	69.3	102.8	106.0	228.6	48.6	53.9	251.4	246.4	224.0	271.6	167.1	245.1	70.6	91.2	115.3	146.9	69.1	69.5	58.9	70.9	59.9	195.0	36.6	110.1	128.1	118.2	100.1	46.4	72.3	171.0	68.3	118.6	163.0	50.1	44.8	334.5	172.7	132.3	182.9	144.4	80.4	66.9	47.8	222.2	58.6	167.3	10.5	6.6	3.7	15.6	10.6	7.5	12.3	10.2	12.7	7.1	11.5	4.9	7.6	2.6	13.4	27.3	10.8	13.0	9.7	475.5	483.4	433.2	406.8	351.2	408.7	567.9	490.6	509.2	526.1	552.3	533.2	147.9	70.5	48.2	124.4	45.1	74.8	55.4	53.1	42.7	392.2	34.7	36.2	921.5	48.6	53.4	80.9	625.5	33.8	54.6	43.7	27.4	97.8	116.2	78.2	143.2	110.4	28.8	21.6	63.7	65.3	81.0	105.5	39.8	93.4	27.8	81.6	50.0	57.3	38.0	47.1	71.2	31.7	34.6	28.3	50.5	38.8	77.0	40.0	78.2	95.5	72.0	82.8	47.4	77.9	167.2	92.0	28.0	103.0	47.2	89.0	37.1	39.2	43.6	97.5	72.3	149.0	119.0	65.6	64.3	58.7	69.6	22.4	60.5	137.4	39.5	44.7
MAP7	E-MAP-115	ENSG00000135525	"Microtubule associated protein 7"	Q14244	6	136342281-136550819	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 130.4"	"Cell type enriched"	"Detected in many"	4	"Oligodendrocytes: 1501.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 12.2"	"Group enriched"	"Detected in many"	4	"dendritic cells: 5.7;granulocytes: 12.2;monocytes: 3.1"	"Cell line enhanced"	"Detected in many"		"CACO-2: 59.8;HeLa: 69.2;MCF7: 88.5;OE19: 55.3;RT4: 68.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029712, HPA029713"	Enhanced		Supported	Microtubules,Cytosol		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 45: Intestine - Brush border"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Cytosol	Microtubules	"HPA029712: AB_10600303, HPA029713: AB_10601339"	"unprognostic (8.68e-3)"	"prognostic unfavorable (9.70e-5)"	"unprognostic (2.33e-3)"	"unprognostic (4.35e-3)"	"unprognostic (6.95e-2)"	"unprognostic (3.35e-1)"	"prognostic favorable (9.22e-4)"	"unprognostic (1.24e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.72e-1)"	"unprognostic (4.61e-2)"	"unprognostic (3.33e-1)"	"prognostic favorable (5.07e-7)"	"unprognostic (1.62e-3)"	"unprognostic (7.84e-2)"	"unprognostic (3.62e-1)"	"unprognostic (6.51e-2)"	2.7	8.4	36.6	4.9	81.2	4.8	13.1	53.0	49.8	6.1	0.6	24.6	29.0	2.4	19.5	15.8	10.0	8.2	1.4	40.2	59.8	32.6	17.2	7.0	1.5	78.0	67.2	1.5	25.1	24.9	12.0	6.8	75.8	20.0	23.2	57.3	20.3	6.4	0.8	17.1	26.6	2.4	43.3	1.8	18.7	27.4	63.0	5.1	16.1	0.2	5.1	12.0	9.6	130.4	25.6	39.2	0.3	0.1	0.2	0.2	40.4	0.7	1.2	0.4	0.7	59.8	26.3	0.1	5.3	0.8	6.7	38.2	11.1	34.6	0.7	0.2	24.6	26.6	69.2	0.5	0.3	26.1	3.0	0.1	31.5	0.2	2.4	1.0	0.2	2.0	18.4	0.6	0.1	88.5	0.2	2.6	5.2	55.3	5.7	0.1	1.0	4.8	23.6	68.4	24.4	5.2	27.4	51.7	0.6	9.1	20.5	2.6	0.5	0.1	1.9	0.4	1.7	4.6	6.4	0.2	0.5	10.1	0.7	2.8	2.3	0.0	0.0	1.6	0.3	1.4	0.5	0.0	5.7	1.6	0.1	0.0	12.2	0.7	3.1	0.0	0.2	0.7	36.6	81.2	53.0	49.8	40.2	59.8	78.0	67.2	75.8	43.3	63.0	130.4	4.0	57.7	51.4	117.2	1.9	28.2	48.7	21.7	33.6	367.0	29.5	18.4	3.0	28.6	42.9	18.4	146.0	33.1	0.7	67.9	31.3	35.8	293.9	30.4	5.9	4.9	117.7	35.1	217.1	49.0	23.1	4.4	42.8	60.8	0.0	1.2	0.7	37.0	16.3	304.5	258.6	81.5	22.4	3.2	8.5	53.1	6.8	6.2	17.8	15.0	3.2	50.9	0.0	26.2	1501.2	37.2	51.9	3.4	4.4	56.6	60.7	81.8	56.0	104.7	19.7	2.0	5.2	37.5	23.4	49.0	30.4	76.2	3.4	2.8	64.2	62.8
MAPK1	"ERK, ERK2, MAPK2, p41mapk, PRKM1, PRKM2"	ENSG00000100030	"Mitogen-activated protein kinase 1"	P28482	22	21759657-21867680	"Cancer-related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"	"Apoptosis, Cell cycle, Host-virus interaction, Transcription, Transcription regulation"	"DNA-binding, Kinase, Repressor, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"K-562: 341.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003995, CAB004229, HPA005700, HPA030069, CAB079930, CAB079932, CAB079933"	Enhanced		Supported	"Nuclear speckles,Cytosol"		NA	NA		140000	"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 65: Brain - Ion transport"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 63: NK-cells & T-cells - Immune response"	Cytosol	"Nuclear speckles"	"CAB004229: AB_627547, CAB079930: , CAB079932: , CAB079933: , HPA003995: AB_1078751, HPA005700: AB_1078750, HPA030069: AB_10602035"	"unprognostic (9.41e-3)"	"unprognostic (2.68e-1)"	"unprognostic (2.50e-3)"	"unprognostic (4.17e-1)"	"unprognostic (4.44e-3)"	"unprognostic (1.72e-1)"	"prognostic unfavorable (4.95e-4)"	"unprognostic (2.29e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.58e-1)"	"unprognostic (8.43e-3)"	"unprognostic (1.04e-1)"	"unprognostic (1.35e-2)"	"unprognostic (2.08e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.41e-1)"	"unprognostic (6.49e-2)"	31.1	33.1	64.8	35.9	84.4	41.2	29.8	37.3	80.9	31.4	32.9	36.1	25.8	29.6	30.1	43.0	29.0	28.9	42.2	91.3	46.4	42.1	34.2	38.5	36.8	29.1	45.1	29.2	38.1	51.7	12.0	33.1	35.9	32.8	36.2	30.3	28.9	32.7	38.1	45.0	29.5	39.1	43.8	40.5	33.9	43.7	60.1	44.4	46.1	41.9	41.9	35.5	18.9	43.2	78.7	48.0	60.5	37.2	75.9	76.7	25.9	84.7	77.5	73.2	72.0	43.8	40.8	45.8	41.3	112.7	67.5	74.6	73.9	67.9	97.8	180.4	72.1	78.9	43.0	67.7	73.5	113.2	80.5	56.9	60.1	89.4	81.6	58.0	101.7	45.4	341.9	50.5	97.5	36.6	72.0	38.5	24.4	104.5	46.8	79.4	149.6	13.2	55.5	62.9	50.0	28.6	91.5	64.2	57.2	60.4	42.4	47.1	90.1	61.5	79.6	71.9	54.2	47.1	59.4	65.8	60.0	60.0	68.4	1.4	4.9	7.2	15.9	6.0	4.9	2.3	3.6	6.0	4.1	2.6	3.5	6.1	16.5	9.3	6.9	4.0	3.4	4.0	64.8	84.4	37.3	80.9	91.3	46.4	29.1	45.1	35.9	43.8	60.1	43.2	36.8	48.1	35.8	97.6	44.0	60.2	28.4	25.1	28.5	25.5	32.5	24.5	41.5	42.9	31.2	51.5	54.2	21.8	151.7	74.4	19.6	28.5	49.0	33.5	40.3	39.9	59.6	63.8	109.2	39.2	23.2	38.4	52.0	45.0	92.8	28.8	52.1	63.5	53.2	28.6	91.2	42.2	26.4	89.0	77.1	14.7	32.6	74.9	40.9	68.4	75.0	35.8	143.2	82.4	75.1	45.3	35.2	44.4	37.0	43.8	32.8	46.0	32.2	22.4	32.9	44.6	37.3	74.1	53.4	44.9	61.8	19.2	91.4	43.3	38.6	38.8
MAPK14	"CSBP1, CSBP2, CSPB1, Mxi2, p38, PRKM14, PRKM15"	ENSG00000112062	"Mitogen-activated protein kinase 14"	Q16539	6	36027677-36111236	"Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Apoptosis, Stress response, Transcription, Transcription regulation"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 104.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"basophil: 79.0;neutrophil: 24.9"	"Lineage enriched"	"Detected in all"	7	"granulocytes: 79.0"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010285, CAB040578, HPA051825"	Approved		Supported	"Nuclear speckles,Cytosol"		NA	NA		970000	"Cluster 38: Basophils - Unknown function"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 32: U-937 - Innate immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	"Nuclear speckles"	Cytosol	"CAB010285: AB_632140, CAB040578: , HPA051825: "	"unprognostic (6.76e-3)"	"unprognostic (6.28e-2)"	"unprognostic (6.30e-3)"	"unprognostic (3.30e-3)"	"unprognostic (6.98e-2)"	"unprognostic (4.04e-2)"	"unprognostic (8.10e-2)"	"unprognostic (1.93e-1)"	"unprognostic (2.20e-3)"	"unprognostic (8.39e-2)"	"unprognostic (6.27e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.47e-2)"	"unprognostic (3.66e-3)"	"unprognostic (6.66e-2)"	"unprognostic (3.25e-1)"	"unprognostic (1.58e-1)"	29.9	26.1	15.2	31.5	16.5	89.3	23.8	19.2	17.1	30.8	19.3	26.6	27.9	37.2	15.8	32.3	25.7	23.5	25.7	17.2	18.2	23.9	41.4	28.3	28.0	11.5	11.7	22.2	18.3	20.6	19.3	44.6	12.1	19.6	29.0	14.8	21.0	24.4	33.5	34.4	26.2	39.0	13.0	44.9	22.5	9.1	18.1	38.6	31.1	31.9	33.3	32.3	29.2	13.8	49.7	26.7	28.3	44.9	60.0	59.8	62.2	50.2	64.8	58.7	60.3	67.3	24.8	40.4	49.6	54.9	28.0	34.8	47.2	43.7	60.9	47.3	37.6	94.9	37.2	53.1	33.2	60.3	54.9	43.1	40.5	42.2	40.9	47.6	67.1	67.2	52.4	49.1	40.3	21.1	62.2	62.5	17.0	29.9	26.2	71.7	45.5	37.5	38.5	67.6	21.8	17.2	46.0	33.5	50.3	34.1	40.8	99.9	47.9	52.5	29.8	33.6	47.7	24.3	59.8	39.5	23.2	112.1	43.9	79.0	10.3	6.3	4.5	7.2	5.5	3.1	4.4	5.1	8.2	5.3	4.6	4.7	24.9	6.1	10.8	4.0	5.8	5.1	15.2	16.5	19.2	17.1	17.2	18.2	11.5	11.7	12.1	13.0	18.1	13.8	24.4	32.1	13.9	37.2	22.6	15.9	11.0	13.9	28.5	18.9	14.0	11.7	25.0	14.3	18.5	18.4	31.3	45.4	26.8	29.0	1.9	13.9	3.6	18.7	25.8	22.6	16.8	47.1	104.9	11.3	18.7	25.9	21.9	30.7	21.0	17.7	28.9	52.9	25.3	11.8	79.2	25.4	10.2	51.7	24.9	5.2	24.5	38.5	10.6	52.5	58.7	10.9	39.1	46.8	69.6	22.8	16.2	26.7	27.7	10.3	33.7	17.2	20.9	22.5	13.1	20.4	15.7	9.9	8.5	27.1	19.0	23.9	28.0	12.3	18.8	10.7
MAPK3	"ERK1, p44erk1, p44mapk, PRKM3"	ENSG00000102882	"Mitogen-activated protein kinase 3"	P27361	16	30114105-30123506	"Cancer-related genes, Enzymes, FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins, RAS pathway related proteins"	"Apoptosis, Cell cycle, Host-virus interaction"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal enterocytes: 336.9;Early spermatids: 267.2;Proximal enterocytes: 235.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"eosinophil: 49.1;neutrophil: 21.5"	"Lineage enriched"	"Detected in all"	7	"granulocytes: 49.1"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002683, HPA003995, HPA005700, HPA030069"	Approved		Supported	Nucleoplasm		NA	NA		46000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm		"CAB002683: , HPA003995: AB_1078751, HPA005700: AB_1078750, HPA030069: AB_10602035"	"unprognostic (5.03e-2)"	"unprognostic (4.62e-2)"	"unprognostic (3.46e-2)"	"unprognostic (1.60e-1)"	"unprognostic (4.70e-3)"	"unprognostic (2.75e-1)"	"prognostic unfavorable (1.11e-4)"	"unprognostic (2.09e-2)"	"unprognostic (3.59e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.55e-1)"	"unprognostic (3.51e-2)"	"unprognostic (8.78e-2)"	"unprognostic (1.45e-1)"	"unprognostic (3.01e-2)"	"unprognostic (2.38e-1)"	"unprognostic (1.19e-2)"	99.5	64.3	178.7	42.4	162.3	45.2	86.3	113.0	200.9	93.3	86.0	117.2	103.1	74.9	27.4	129.6	71.6	65.3	65.4	168.6	132.7	49.4	21.2	71.3	37.8	135.6	148.7	78.7	33.7	61.2	55.8	70.2	142.3	49.2	91.9	71.5	61.0	43.3	51.7	77.6	113.2	58.7	127.4	57.4	86.4	31.6	129.5	31.4	58.0	57.0	49.3	64.8	89.0	130.9	56.3	30.0	62.2	35.7	153.7	202.4	35.1	40.7	101.1	63.4	75.3	36.4	110.0	56.3	39.7	115.5	73.2	20.6	53.3	47.8	61.0	106.9	61.8	17.3	31.6	61.8	154.2	13.0	46.2	125.8	27.3	72.5	32.2	96.1	163.7	60.3	24.3	70.0	85.2	147.1	59.2	21.5	16.9	113.6	26.1	68.9	37.3	127.4	58.0	35.0	55.2	39.3	23.2	81.8	24.1	50.5	53.5	30.7	117.2	41.7	35.4	48.4	14.5	79.1	39.3	29.6	83.3	27.1	30.0	6.2	5.1	49.1	1.6	3.7	2.6	2.3	3.7	3.0	2.8	2.5	2.6	2.9	21.5	2.2	2.0	2.8	6.6	2.8	178.7	162.3	113.0	200.9	168.6	132.7	135.6	148.7	142.3	127.4	129.5	130.9	95.5	22.4	17.5	7.5	10.7	9.8	22.2	11.4	5.7	30.4	23.3	19.9	15.4	20.0	13.0	9.2	22.9	77.6	15.2	336.9	23.5	39.8	267.2	24.8	25.1	68.1	54.7	6.1	7.7	61.2	134.2	34.7	79.0	15.7	2.5	19.1	71.7	7.0	45.2	8.4	10.3	159.3	22.4	26.4	12.3	176.0	32.3	20.6	23.2	7.5	24.5	67.0	13.4	7.1	9.8	118.8	167.2	27.4	6.2	13.5	235.6	23.9	24.7	41.5	19.7	18.8	29.3	10.9	19.8	15.8	13.2	33.8	14.5	40.0	94.9	22.4
MAPK6	"ERK3, HsT17250, p97MAPK, PRKM6"	ENSG00000069956	"Mitogen-activated protein kinase 6"	Q16659	15	51952106-52067375	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Cell cycle"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 218.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005184, HPA030262, HPA047825"	Approved	Supported	Supported	Cytosol		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 44: Endometrium - Transcription"	Cytosol		"CAB005184: AB_2140298, HPA030262: AB_10601868, HPA047825: "	"unprognostic (6.61e-2)"	"unprognostic (1.75e-2)"	"unprognostic (5.05e-2)"	"unprognostic (3.40e-3)"	"unprognostic (2.72e-1)"	"unprognostic (5.52e-2)"	"unprognostic (6.13e-2)"	"unprognostic (2.32e-3)"	"unprognostic (3.99e-2)"	"unprognostic (8.54e-2)"	"unprognostic (3.68e-2)"	"unprognostic (3.90e-2)"	"unprognostic (3.27e-3)"	"unprognostic (2.03e-1)"	"unprognostic (1.72e-1)"	"unprognostic (3.07e-2)"	"unprognostic (2.31e-2)"	10.9	7.0	8.6	12.1	11.1	32.4	13.9	14.5	13.3	15.3	7.6	20.3	17.5	16.4	10.9	28.0	8.2	17.5	7.7	10.5	10.5	15.2	35.3	8.8	10.8	10.5	10.8	6.2	8.3	11.0	8.0	12.6	10.6	10.1	18.7	17.9	15.3	8.7	27.7	23.1	24.5	13.7	9.7	8.3	16.9	29.3	10.6	14.5	13.9	32.9	13.6	27.3	21.3	12.0	27.1	36.0	69.1	26.7	21.1	34.3	50.5	38.0	38.0	34.2	40.1	43.3	15.9	38.9	26.0	48.9	50.0	37.5	53.8	72.4	46.5	24.0	16.8	58.0	20.3	68.9	50.4	43.9	118.6	36.8	130.0	41.5	106.8	36.4	32.7	26.1	76.5	64.3	44.2	61.3	30.8	34.4	24.7	33.6	17.2	26.8	44.5	62.3	32.8	112.3	33.8	31.9	30.7	24.6	56.5	94.9	22.6	64.3	32.9	40.7	43.9	26.8	51.4	33.2	104.4	47.5	50.4	62.9	51.2	1.7	2.5	0.7	1.9	2.3	2.3	2.5	2.8	2.2	2.3	1.3	2.6	1.9	0.3	3.6	1.5	1.0	4.3	1.9	8.6	11.1	14.5	13.3	10.5	10.5	10.5	10.8	10.6	9.7	10.6	12.0	31.3	28.9	31.5	24.5	24.2	111.9	123.8	50.6	24.5	55.6	39.3	19.3	21.9	25.8	43.1	16.5	16.7	16.9	15.9	110.2	17.6	35.2	147.5	61.3	75.7	28.8	31.0	17.1	29.1	50.1	39.5	39.2	35.7	126.4	137.9	19.3	17.9	59.6	28.0	33.7	31.0	42.9	42.7	41.8	66.6	218.1	22.7	50.5	30.2	17.8	15.7	32.3	11.3	28.6	63.7	69.1	46.5	23.7	35.3	89.0	110.6	60.3	42.9	23.8	19.7	24.7	33.9	72.7	81.0	49.6	110.7	33.1	23.0	13.9	28.6	174.0
MAPK7	"BMK1, ERK5, PRKM7"	ENSG00000166484	"Mitogen-activated protein kinase 7"	Q13164	17	19377721-19383544	"Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Differentiation"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Spermatocytes: 33.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"ASC diff: 43.1;SuSa: 53.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB018561, HPA031031"	Uncertain		Enhanced	Nucleoplasm,Cytosol		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 71: Testis - DNA repair"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 41: Macrophages - Immune response"	Nucleoplasm	Cytosol	"CAB018561: AB_2140544, HPA031031: AB_2673706"	"unprognostic (1.63e-1)"	"unprognostic (2.75e-2)"	"unprognostic (1.72e-1)"	"unprognostic (2.90e-2)"	"unprognostic (4.38e-2)"	"unprognostic (1.20e-3)"	"prognostic unfavorable (1.86e-4)"	"unprognostic (5.67e-3)"	"unprognostic (1.62e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.83e-2)"	"unprognostic (4.75e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.90e-1)"	"unprognostic (5.71e-1)"	"unprognostic (1.55e-1)"	"unprognostic (3.78e-2)"	8.3	13.7	4.0	4.0	4.4	5.2	7.7	4.0	5.9	14.3	4.4	10.6	5.5	11.1	3.3	16.3	8.7	4.5	6.2	3.9	4.5	7.7	3.9	8.7	3.7	5.3	6.1	12.5	3.4	2.9	6.1	6.7	4.4	8.9	3.5	2.2	6.7	6.1	5.0	12.5	7.3	6.7	3.3	9.4	6.7	11.8	5.0	3.5	7.4	3.4	3.6	10.1	15.2	4.1	6.9	11.0	9.9	7.7	43.1	17.2	10.4	9.0	8.3	13.0	12.4	12.2	1.4	4.1	7.3	16.5	10.4	8.2	10.4	9.4	7.8	7.2	8.3	1.9	8.4	5.4	21.2	1.9	7.8	21.6	6.2	18.2	7.2	12.0	9.5	7.5	3.7	1.4	13.2	4.8	13.0	7.4	10.7	8.4	6.7	8.6	12.9	3.0	5.4	3.7	4.4	12.3	9.7	1.0	5.0	53.7	6.1	3.1	6.0	14.6	10.8	15.5	6.7	2.6	4.0	1.2	16.5	1.6	9.2	0.8	3.4	10.7	3.7	6.5	2.0	1.8	1.8	3.2	2.3	1.0	1.6	2.0	1.1	4.9	6.0	1.4	1.0	3.1	4.0	4.4	4.0	5.9	3.9	4.5	5.3	6.1	4.4	3.3	5.0	4.1	10.7	6.4	3.3	2.6	7.8	5.5	6.1	9.5	13.6	2.4	5.8	4.6	5.3	2.8	5.6	5.5	2.1	5.7	6.7	16.2	5.9	8.1	8.7	3.0	7.9	8.5	10.7	1.7	2.0	6.2	8.0	9.6	12.2	5.2	2.5	7.7	7.5	1.1	7.7	0.0	2.1	6.9	10.2	6.9	6.1	5.7	11.5	14.4	3.6	6.5	3.4	13.1	17.5	1.0	2.0	8.0	20.8	11.7	9.3	6.3	9.0	3.5	3.2	2.1	26.3	8.4	11.1	33.2	16.4	9.8	4.3	5.1	6.2	7.7	6.7	5.3
MAPK9	"JNK2, p54a, PRKM9, SAPK"	ENSG00000050748	"Mitogen-activated protein kinase 9"	P45984	5	180233143-180292099	"Enzymes, Metabolic proteins, Predicted intracellular proteins, RAS pathway related proteins"	"Biological rhythms"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Inhibitory neurons: 64.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	6	"basophil: 16.3"	"Lineage enriched"	"Detected in all"	6	"granulocytes: 16.3"	"Cell line enhanced"	"Detected in all"		"HDLM-2: 211.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB008910, HPA072462"	Enhanced		Approved	"Nuclear speckles,Plasma membrane,Cytosol"		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Plasma membrane, Cytosol"	"Nuclear speckles"	"CAB008910: , HPA072462: "	"unprognostic (5.04e-3)"	"unprognostic (2.06e-2)"	"prognostic favorable (1.11e-4)"	"unprognostic (8.53e-2)"	"unprognostic (1.75e-1)"	"unprognostic (5.06e-3)"	"unprognostic (6.83e-3)"	"unprognostic (3.16e-1)"	"unprognostic (4.93e-2)"	"unprognostic (3.76e-1)"	"unprognostic (5.97e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.13e-1)"	"unprognostic (2.29e-1)"	"unprognostic (9.38e-3)"	"unprognostic (2.40e-1)"	19.3	21.1	28.4	18.4	32.6	21.3	17.5	36.5	41.4	17.7	7.2	22.4	18.5	15.3	16.2	15.4	15.3	13.9	25.7	34.2	25.8	21.1	17.7	19.5	19.9	25.7	19.7	14.6	45.7	30.1	12.9	19.7	26.4	20.0	26.4	21.4	19.1	21.6	40.8	11.7	19.3	19.9	16.9	16.6	22.5	17.8	22.2	22.5	26.7	34.8	21.1	17.4	11.1	29.8	52.7	42.7	37.0	46.5	35.7	39.3	79.4	49.6	43.5	40.5	40.5	56.4	36.7	55.9	83.1	52.6	89.3	39.6	38.4	82.8	47.5	211.8	36.9	23.2	46.8	40.3	27.1	49.0	39.2	29.3	36.5	39.5	38.0	42.5	48.9	43.0	26.2	39.5	55.9	68.9	49.2	20.4	25.8	64.8	25.0	46.9	62.7	26.9	30.8	49.7	42.5	29.9	58.2	55.8	40.4	45.8	56.9	41.7	35.5	48.3	49.2	69.3	75.2	28.2	35.6	37.9	51.5	44.8	32.9	16.3	0.5	2.2	1.6	1.1	1.6	0.8	1.2	1.4	0.8	1.3	0.8	0.9	0.7	1.2	2.3	1.2	2.7	0.3	28.4	32.6	36.5	41.4	34.2	25.8	25.7	19.7	26.4	16.9	22.2	29.8	20.5	32.1	14.4	26.1	10.5	10.1	7.0	6.5	9.1	21.9	16.8	12.2	27.6	12.8	8.5	9.2	16.7	15.3	20.5	20.7	5.9	8.0	1.2	17.6	14.2	12.2	16.7	9.5	62.5	16.0	23.3	11.1	15.8	18.6	11.4	14.5	12.5	16.7	11.7	13.5	64.3	17.9	4.1	24.2	20.5	3.1	10.5	15.0	5.4	31.9	13.9	11.4	15.5	25.1	32.9	13.1	12.3	13.5	15.6	10.2	13.4	11.0	6.9	14.8	13.1	13.5	13.7	17.0	17.1	9.4	11.4	17.8	14.7	8.2	15.4	8.8
MAPKAP1	"MGC2745, MIP1, SIN1"	ENSG00000119487	"MAPK associated protein 1"	Q9BPZ7	9	125437393-125707234	"Predicted intracellular proteins"	"Stress response"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029091, HPA029092"	Supported		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 25: Spermatids - Spermatogenesis"	Nucleoplasm	Cytosol	"HPA029091: AB_10599732, HPA029092: AB_10601568"	"unprognostic (6.65e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.31e-2)"	"unprognostic (1.33e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.09e-1)"	"unprognostic (5.11e-2)"	"unprognostic (2.57e-2)"	"unprognostic (1.68e-1)"	"unprognostic (8.94e-2)"	"unprognostic (2.59e-1)"	"unprognostic (8.08e-2)"	"prognostic favorable (7.23e-6)"	"unprognostic (1.66e-1)"	"unprognostic (2.04e-1)"	"unprognostic (2.98e-1)"	"unprognostic (4.27e-2)"	42.9	47.1	43.4	36.7	48.6	34.7	32.8	39.2	45.6	36.4	44.9	47.3	30.4	29.1	35.9	44.0	29.2	28.0	69.7	44.3	41.6	48.0	46.0	30.1	34.8	47.8	46.2	26.1	36.9	53.3	19.2	30.2	41.9	30.3	38.5	42.9	42.1	36.1	103.7	26.2	32.6	46.2	43.2	28.8	36.2	42.0	51.6	36.6	47.4	76.4	37.9	39.4	31.6	40.9	87.4	97.1	64.3	68.3	86.7	82.2	107.9	108.6	110.0	82.0	57.2	97.9	94.9	89.1	65.9	151.6	89.7	119.1	99.5	126.9	110.8	101.8	41.1	64.3	111.9	95.1	97.3	116.0	72.1	80.9	114.6	117.0	121.7	91.2	123.0	85.8	103.6	67.7	176.4	180.3	87.5	46.8	102.4	204.3	122.0	72.4	152.0	119.3	90.2	62.3	77.9	76.7	109.7	100.9	70.0	86.6	115.8	67.1	79.7	115.3	76.1	140.5	182.5	86.1	225.2	89.9	165.5	52.5	127.6	4.4	6.1	5.7	4.3	6.0	5.9	8.2	4.7	4.8	4.9	7.4	4.1	7.1	19.1	5.8	5.6	7.2	5.8	2.5	43.4	48.6	39.2	45.6	44.3	41.6	47.8	46.2	41.9	43.2	51.6	40.9	22.3	12.8	17.0	64.6	33.5	15.8	30.2	15.3	25.6	25.6	30.6	24.1	68.3	22.8	27.5	14.7	41.7	35.4	31.7	28.9	54.8	48.3	80.2	26.2	42.6	27.1	9.6	22.3	82.6	65.6	50.9	27.0	32.1	29.3	17.7	31.2	19.6	34.5	50.7	32.0	80.1	20.8	22.4	29.5	23.4	116.9	19.0	37.3	23.2	59.0	55.1	30.1	35.0	97.0	96.4	59.2	20.1	17.7	32.3	45.2	27.2	84.6	14.6	26.2	6.6	29.1	33.0	75.4	71.4	29.1	19.5	50.9	29.5	38.4	27.6	37.8
MAPKAPK2	MK2	ENSG00000162889	"MAPK activated protein kinase 2"	P49137	1	206684905-206734281	"Cancer-related genes, Enzymes, Metabolic proteins, Predicted membrane proteins"	"DNA damage"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"dendritic cells: 185.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	6	"plasmacytoid DC: 21.9"	"Lineage enriched"	"Detected in all"	6	"dendritic cells: 21.9"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010297, HPA045556, HPA063708, HPA064435"	Approved		Supported	Nucleoplasm,Centrosome		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 59: Non-specific - Translation"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 65: Plasmacytoid DCs - Unknown function"	Nucleoplasm	Centrosome	"CAB010297: AB_2250405, HPA045556: AB_2679367, HPA063708: AB_2685100, HPA064435: AB_2685263"	"unprognostic (7.93e-2)"	"unprognostic (1.83e-1)"	"unprognostic (5.27e-2)"	"unprognostic (5.12e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.32e-2)"	"prognostic unfavorable (1.93e-4)"	"unprognostic (9.85e-2)"	"unprognostic (1.68e-1)"	"unprognostic (2.00e-1)"	"unprognostic (1.01e-2)"	"unprognostic (1.35e-1)"	"prognostic unfavorable (4.58e-6)"	"unprognostic (2.12e-1)"	"unprognostic (1.37e-1)"	"unprognostic (6.96e-2)"	"unprognostic (3.29e-2)"	61.9	80.4	34.8	56.2	39.1	174.6	50.5	36.9	33.9	47.3	38.7	50.3	65.5	53.3	24.1	55.8	50.8	52.5	190.1	30.8	36.6	79.5	66.8	79.3	57.8	53.1	42.1	44.8	53.8	38.0	63.3	25.7	43.9	42.8	35.3	17.6	54.9	33.1	196.7	54.4	61.7	45.4	40.1	78.3	68.2	46.9	45.2	45.6	47.7	94.3	54.4	63.5	46.6	38.6	85.4	33.1	44.8	50.6	128.4	75.0	55.1	57.3	130.0	86.0	80.7	63.8	40.4	40.6	38.8	116.9	54.1	63.0	33.8	61.7	61.4	46.5	25.4	69.1	41.7	41.3	99.0	102.3	219.5	104.1	77.3	82.8	91.3	71.8	71.7	54.1	79.7	180.2	70.5	105.2	41.2	73.3	51.5	29.9	45.1	103.7	94.0	13.5	64.9	51.5	35.7	45.7	68.0	114.2	83.1	83.0	55.4	97.2	68.7	77.6	64.7	91.0	79.7	232.0	220.6	33.2	87.8	60.9	26.0	1.6	0.8	1.8	1.8	1.4	1.6	1.1	1.3	1.7	0.7	1.2	0.6	1.2	3.7	2.6	1.3	21.9	1.8	0.7	34.8	39.1	36.9	33.9	30.8	36.6	53.1	42.1	43.9	40.1	45.2	38.6	49.2	54.5	49.9	15.7	27.9	85.4	52.3	18.3	20.5	12.4	61.4	37.8	102.5	37.1	26.8	31.3	20.9	6.4	185.9	51.9	15.6	30.6	76.2	32.2	40.9	43.7	61.7	15.4	4.7	58.5	9.2	33.4	32.1	46.6	34.9	24.8	19.2	40.0	24.8	0.0	10.6	38.1	16.2	34.6	82.7	36.1	22.7	60.9	33.8	13.1	23.7	21.7	74.2	8.5	17.4	61.6	34.4	17.3	69.6	67.3	22.2	25.0	14.4	16.0	26.3	36.9	48.5	13.7	10.3	31.5	72.0	16.6	46.0	19.2	30.5	75.0
MAPKAPK3	"3pK, MAPKAP3, MK-3, MK3"	ENSG00000114738	"MAPK activated protein kinase 3"	Q16644	3	50611520-50649291	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"bone marrow: 106.5;heart muscle: 256.3;skeletal muscle: 224.2;tongue: 284.3"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 226.6;Hofbauer cells: 102.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"dendritic cells: 142.8;granulocytes: 126.3;monocytes: 341.5"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA058275			Supported	Nucleoplasm		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 32: U-937 - Innate immune response"	"Cluster 54: Cardiomyocytes - Muscle contraction"	Nucleoplasm		"HPA058275: AB_2683663"	"unprognostic (6.46e-3)"	"unprognostic (1.84e-1)"	"prognostic favorable (8.08e-5)"	"unprognostic (1.17e-1)"	"unprognostic (1.93e-1)"	"unprognostic (9.96e-2)"	"unprognostic (8.77e-3)"	"unprognostic (7.68e-3)"	"unprognostic (1.11e-1)"	"unprognostic (5.87e-2)"	"unprognostic (2.19e-3)"	"unprognostic (1.01e-1)"	"prognostic favorable (1.90e-8)"	"unprognostic (2.15e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.86e-1)"	"unprognostic (1.69e-1)"	15.3	43.3	18.0	29.8	19.6	106.5	15.8	19.2	19.2	15.0	21.3	19.7	30.2	11.3	10.3	49.6	15.1	12.1	256.3	18.0	19.7	40.0	18.7	28.2	21.7	23.6	20.5	14.2	36.2	47.2	23.5	13.9	22.5	18.4	20.0	4.7	27.7	12.6	224.2	53.4	24.2	15.9	21.6	25.3	27.6	9.2	21.1	42.0	41.2	284.3	24.2	20.3	22.2	21.6	99.6	30.3	12.4	35.9	18.4	45.7	27.9	23.8	33.7	35.7	30.3	47.1	90.2	39.8	23.5	79.5	88.5	34.6	85.9	92.7	31.9	88.3	22.3	209.5	40.6	43.5	36.8	152.1	106.4	36.9	57.0	83.1	112.2	35.6	31.9	70.2	59.7	25.4	76.1	40.5	65.3	153.3	46.4	34.6	127.0	28.5	29.9	60.1	165.5	56.2	23.0	16.5	21.3	58.9	27.7	20.6	37.8	93.4	23.8	28.1	64.5	146.4	59.5	17.2	33.7	33.1	148.3	234.7	11.8	45.3	169.5	126.3	27.6	271.6	27.3	15.1	30.9	32.1	142.8	8.8	23.9	27.8	104.4	42.1	341.5	91.2	28.0	132.6	18.0	19.6	19.2	19.2	18.0	19.7	23.6	20.5	22.5	21.6	21.1	21.6	3.5	9.6	14.0	8.5	8.6	11.3	26.9	14.0	19.4	1.1	15.3	12.3	226.6	15.7	10.4	11.0	0.0	6.0	38.1	16.2	64.6	45.6	34.5	3.4	2.7	7.1	6.0	19.1	0.3	30.4	7.4	14.9	11.7	5.4	36.2	8.3	5.3	14.2	102.1	0.0	0.7	15.4	10.2	68.0	23.9	86.2	7.2	59.4	7.2	0.0	76.6	17.1	41.2	0.5	2.0	76.2	15.6	3.4	12.7	30.9	30.7	35.4	5.7	2.3	26.3	9.7	12.0	4.1	4.6	34.2	20.2	5.1	24.3	22.0	28.2	33.5
MAPKAPK5	"MK5, PRAK"	ENSG00000089022	"MAPK activated protein kinase 5"	Q8IW41	12	111842228-111902222	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004546, HPA015515"	Supported		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Nucleoplasm, Cytosol"		"CAB004546: AB_627910, HPA015515: AB_1853569"	"unprognostic (6.45e-2)"	"unprognostic (7.29e-2)"	"unprognostic (1.27e-3)"	"unprognostic (1.09e-2)"	"unprognostic (5.52e-2)"	"unprognostic (3.76e-2)"	"prognostic unfavorable (2.98e-8)"	"unprognostic (1.88e-1)"	"unprognostic (3.09e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.25e-2)"	"unprognostic (3.20e-1)"	"unprognostic (6.03e-2)"	"unprognostic (3.39e-2)"	"unprognostic (9.41e-2)"	"unprognostic (3.25e-2)"	18.1	20.8	12.6	17.9	14.4	27.1	20.4	14.9	15.0	15.2	15.7	28.2	25.5	15.7	20.7	17.2	16.1	12.2	16.7	15.3	14.3	20.3	19.4	17.5	20.7	12.3	12.4	18.1	20.4	21.4	11.6	20.3	11.8	17.0	30.7	27.2	17.4	15.6	30.4	20.1	28.2	18.9	11.3	15.6	18.0	15.9	12.9	23.2	19.3	25.3	19.3	18.5	14.4	13.8	32.4	42.1	40.0	33.7	28.2	28.4	60.6	31.7	38.1	47.7	32.7	54.8	25.9	48.6	22.9	37.7	28.4	31.6	53.1	33.2	44.4	32.6	29.0	43.4	29.5	44.2	34.1	55.1	29.4	30.2	46.7	45.6	53.7	36.0	35.6	43.4	61.0	18.7	35.3	36.4	55.2	86.6	56.9	79.1	29.4	53.7	29.1	46.9	37.9	46.2	49.0	41.4	36.1	60.5	46.3	36.2	49.1	62.0	31.2	26.8	27.2	27.9	40.4	37.8	50.1	57.4	32.7	39.4	38.9	1.1	3.3	2.3	4.2	2.4	2.2	3.5	2.7	3.0	2.2	3.1	4.2	3.1	1.6	2.9	8.8	2.6	4.8	1.8	12.6	14.4	14.9	15.0	15.3	14.3	12.3	12.4	11.8	11.3	12.9	13.8	16.9	3.2	23.1	12.1	22.3	20.5	22.3	12.5	21.1	47.0	18.3	14.0	20.1	22.8	15.4	3.7	41.7	29.9	32.4	34.1	13.7	28.2	17.2	14.2	17.3	16.0	36.6	15.8	24.6	29.6	33.3	19.4	20.9	15.2	2.5	22.3	14.6	13.4	19.9	23.5	22.3	47.3	14.2	21.2	17.7	7.3	15.5	15.0	8.8	14.0	27.8	19.6	25.7	15.6	21.8	36.3	27.4	17.7	21.6	37.5	63.6	21.8	12.0	36.4	19.7	22.6	19.8	30.7	40.3	23.6	21.3	30.1	22.2	22.5	32.3	32.3
MAPKBP1	"KIAA0596, NPHP20"	ENSG00000137802	"Mitogen-activated protein kinase binding protein 1"	O60336	15	41774434-41827855	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Disease variant, Nephronophthisis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 204.3;Excitatory neurons: 62.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030832, HPA030833"	Approved		Supported	"Nucleoplasm,Nucleoli,Nucleoli rim"		No	No			"Cluster 46: Basophils - DNA binding"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 9: Photoreceptor cells - Phototransduction"	"Nucleoli, Nucleoli rim"	Nucleoplasm	"HPA030832: AB_10601869, HPA030833: AB_2673628"	"unprognostic (2.53e-1)"	"unprognostic (9.18e-2)"	"unprognostic (6.56e-2)"	"prognostic favorable (1.47e-4)"	"unprognostic (1.16e-1)"	"unprognostic (2.22e-1)"	"unprognostic (9.84e-3)"	"unprognostic (1.32e-1)"	"unprognostic (1.52e-1)"	"prognostic unfavorable (6.80e-4)"	"unprognostic (1.08e-3)"	"unprognostic (6.03e-3)"	"unprognostic (7.94e-2)"	"unprognostic (1.68e-1)"	"unprognostic (8.98e-2)"	"unprognostic (1.72e-1)"	"unprognostic (2.28e-2)"	6.2	10.5	10.9	4.6	12.4	4.4	7.7	31.1	13.7	11.1	10.1	10.2	9.6	9.9	4.5	18.6	10.4	4.6	6.4	9.9	8.5	7.1	4.1	6.0	3.9	9.0	8.0	15.1	5.5	4.2	12.7	5.4	9.0	8.9	3.6	9.0	7.5	5.9	5.1	24.2	9.9	9.0	5.3	8.0	9.3	34.4	9.1	6.3	13.4	3.7	6.8	12.2	12.0	10.2	7.4	3.8	10.0	9.5	10.9	10.8	6.9	10.1	25.5	9.1	6.6	7.6	2.7	1.8	8.1	8.3	12.5	17.2	9.8	28.5	6.5	6.7	2.7	7.3	12.8	2.6	4.7	4.7	14.5	5.6	22.3	14.3	25.9	14.8	13.4	11.9	4.6	3.4	12.9	1.5	4.0	4.2	1.1	4.3	7.6	4.3	7.2	0.7	5.3	8.1	11.3	6.3	5.7	5.9	4.5	10.2	7.1	3.7	10.6	13.0	6.2	12.4	10.0	7.3	12.7	4.3	8.7	6.3	11.0	1.1	0.4	0.3	0.8	0.1	0.6	0.4	0.4	0.3	0.5	0.4	0.6	0.5	0.1	0.6	0.5	0.1	0.2	0.5	10.9	12.4	31.1	13.7	9.9	8.5	9.0	8.0	9.0	5.3	9.1	10.2	7.1	6.4	10.3	33.0	3.5	54.7	10.0	8.6	36.5	14.5	5.4	8.9	3.4	2.8	7.3	3.7	204.3	6.8	5.6	4.0	0.0	3.0	15.7	10.9	7.1	9.5	4.8	0.8	62.2	3.7	4.4	5.8	9.2	8.9	1.3	12.2	5.3	2.6	3.9	15.2	55.1	1.7	4.1	2.5	6.1	27.1	7.2	5.0	8.8	33.7	4.2	4.4	3.1	34.7	51.9	4.6	1.8	7.9	5.1	12.5	8.1	0.5	13.0	8.9	13.1	7.8	5.7	12.7	4.2	27.7	53.6	5.3	5.8	8.0	2.5	15.2
MAPT	"DDPAC, FLJ31424, FTDP-17, MAPTL, MGC138549, MSTD, MTBT1, MTBT2, PPND, PPP1R103, tau"	ENSG00000186868	"Microtubule associated protein tau"	P10636	17	45894527-46028334	"Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"			"Alzheimer disease, Disease variant, FDA approved drug targets, Neurodegeneration, Parkinsonism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 67.7;skeletal muscle: 79.0"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 142.4;Bipolar cells: 314.4;Early spermatids: 199.9;Excitatory neurons: 189.2;Horizontal cells: 361.7;Inhibitory neurons: 153.7;Late spermatids: 416.6;Muller glia cells: 145.7;Oligodendrocytes: 163.8"	"Cancer enhanced"	"Detected in many"		"breast cancer: 9.5;glioma: 13.3"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"non-classical monocyte: 1.7"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in many"	5	"HDLM-2: 69.0;SCLC-21H: 21.1;T-47d: 34.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000151, HPA048895, HPA069524, HPA069570, CAB072344"	Enhanced		Supported	"Nuclear speckles,Plasma membrane"	"Secreted to blood"	NA	NA		7100	"Cluster 35: T-regs - Unknown function"	"Cluster 47: Non-specific - Unknown function"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 62: Horizontal cells - Visual perception"	"Plasma membrane"	"Nuclear speckles"	"CAB000151: , CAB072344: , HPA048895: AB_2680550, HPA069524: AB_2686145, HPA069570: AB_2686155"	"unprognostic (1.78e-3)"	"unprognostic (7.51e-2)"	"unprognostic (3.71e-2)"	"unprognostic (8.40e-5)"	"unprognostic (1.40e-1)"	"unprognostic (1.31e-2)"	"unprognostic (4.06e-5)"	"unprognostic (6.04e-2)"	"unprognostic (2.19e-2)"	"unprognostic (3.49e-2)"	"unprognostic (3.88e-3)"	"unprognostic (2.65e-1)"	"unprognostic (1.72e-3)"	"unprognostic (6.53e-2)"	"unprognostic (3.43e-1)"	"unprognostic (1.85e-2)"	"unprognostic (5.47e-2)"	4.7	4.3	26.2	0.3	27.1	0.0	9.1	8.3	67.7	2.4	0.0	8.4	0.5	1.0	0.2	8.4	1.0	0.8	9.4	30.0	20.4	14.7	0.6	0.8	0.3	11.6	11.4	0.6	1.5	2.9	29.5	3.4	22.4	5.4	0.3	17.6	8.5	3.4	79.0	6.3	1.8	0.3	2.7	0.4	1.7	20.3	14.8	0.4	0.9	27.4	0.2	10.2	2.3	19.7	2.9	0.5	0.3	6.4	0.3	0.9	1.8	0.1	0.3	0.1	0.0	0.2	0.0	0.0	0.6	0.4	0.5	0.1	2.3	0.3	0.0	69.0	3.4	0.0	0.3	4.2	0.0	0.1	0.1	0.0	0.5	0.1	0.3	0.1	0.0	4.4	0.7	3.6	0.0	7.7	1.0	0.2	0.2	0.7	2.0	0.0	4.0	8.5	0.0	9.1	21.1	9.1	2.5	0.0	1.8	1.0	34.7	0.1	0.1	0.3	0.8	1.7	0.3	0.9	0.3	0.0	0.6	2.0	0.5	0.1	0.0	0.0	0.2	0.7	0.2	0.0	0.1	0.5	0.0	0.0	0.2	0.3	0.2	0.1	1.7	0.0	0.7	0.0	26.2	27.1	8.3	67.7	30.0	20.4	11.6	11.4	22.4	2.7	14.8	19.7	1.9	0.0	9.8	142.4	1.0	1.0	1.4	0.2	1.2	314.4	26.7	21.2	35.2	0.0	0.1	1.8	64.6	0.2	0.4	0.1	7.9	0.5	199.9	0.4	1.7	1.8	0.0	0.0	189.2	0.4	9.1	3.7	0.5	1.3	4.5	1.6	1.1	0.5	0.3	361.7	153.7	0.0	2.0	0.6	1.7	416.6	2.8	0.8	5.4	8.4	0.7	145.7	0.0	129.7	163.8	0.6	0.0	2.6	0.1	2.5	0.1	76.1	0.0	28.3	0.0	28.2	6.0	18.4	8.1	22.7	3.3	0.3	1.5	0.8	0.3	0.6
MARCHF1	"FLJ20668, MARCH-I, MARCH1, RNF171"	ENSG00000145416	"Membrane associated ring-CH-type finger 1"	Q8TCQ1	4	163524298-164384050	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Immunity, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 31.6;retina: 27.5"	"Group enriched"	"Detected in some"	4	"B-cells: 21.4;Hofbauer cells: 46.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	94	"classical monocyte: 41.8;eosinophil: 25.5;intermediate monocyte: 41.0;memory B-cell: 42.3;myeloid DC: 44.2;naive B-cell: 35.8;non-classical monocyte: 45.4;plasmacytoid DC: 16.5"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Daudi: 7.1;U-266/70: 7.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014600, HPA048024"	Uncertain		Supported	"Endoplasmic reticulum,Golgi apparatus,Vesicles"		NA	NA			"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 16: Immune cells - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 41: Macrophages - Immune response"	Vesicles	"Endoplasmic reticulum, Golgi apparatus"	"HPA014600: AB_1853573, HPA048024: "	"unprognostic (7.29e-2)"	"unprognostic (5.82e-2)"	"unprognostic (1.48e-1)"	"unprognostic (9.09e-2)"	"unprognostic (8.25e-2)"	"unprognostic (2.98e-2)"	"unprognostic (4.79e-3)"	"unprognostic (9.00e-2)"	"unprognostic (3.00e-2)"	"unprognostic (2.18e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.20e-1)"	"unprognostic (1.24e-1)"	"unprognostic (7.00e-2)"	"unprognostic (2.48e-2)"	"unprognostic (2.70e-1)"	"unprognostic (2.91e-2)"	6.4	3.5	7.8	21.5	8.1	3.9	2.7	3.6	7.7	3.1	1.8	3.5	3.9	2.5	0.7	3.0	2.8	5.3	1.7	6.6	10.1	1.8	4.1	8.0	31.6	8.0	8.2	2.7	2.8	0.8	2.5	9.9	6.9	2.3	4.5	27.5	3.2	1.2	1.0	4.5	7.0	6.2	7.0	25.8	3.9	1.7	12.1	5.6	2.1	1.0	25.5	7.7	2.9	14.4	0.6	0.5	2.1	1.2	0.0	0.0	1.3	0.9	0.0	0.0	0.0	1.2	2.4	7.1	2.5	0.0	0.2	1.0	0.0	0.0	0.0	0.8	0.7	5.0	3.0	0.5	0.0	3.1	1.6	0.0	0.0	0.0	0.1	2.8	0.0	1.3	1.9	3.6	2.4	0.7	1.8	1.9	2.6	0.2	0.9	2.0	0.3	0.5	0.1	1.1	1.0	0.9	0.6	1.0	0.4	1.4	2.9	0.5	2.3	0.8	1.4	0.5	1.7	7.0	2.5	1.9	0.9	1.5	1.1	0.0	41.8	25.5	0.1	41.0	0.0	42.3	0.1	0.0	44.2	35.8	0.0	0.0	0.3	0.3	45.4	16.5	0.0	18.4	7.8	8.1	3.6	7.7	6.6	10.1	8.0	8.2	6.9	7.0	12.1	14.4	0.1	0.0	0.0	0.0	21.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.3	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	46.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.8	0.1	0.0	0.0	0.0
MARCHF2	"HSPC240, MARCH-II, MARCH2, RNF172"	ENSG00000099785	"Membrane associated ring-CH-type finger 2"	Q9P0N8	19	8413270-8439017	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Endocytosis, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Adipocytes: 23.1;Cardiomyocytes: 42.3;Extravillous trophoblasts: 11.6;Hofbauer cells: 66.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014063	Approved		Supported	"Endoplasmic reticulum,Cytosol"		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 24: Non-specific - Transcription regulation"	"Endoplasmic reticulum"	Cytosol	"HPA014063: AB_1853576"	"unprognostic (1.15e-2)"	"unprognostic (4.01e-3)"	"prognostic unfavorable (6.48e-4)"	"prognostic favorable (1.05e-5)"	"unprognostic (3.00e-1)"	"prognostic favorable (8.29e-4)"	"unprognostic (3.43e-2)"	"unprognostic (6.95e-2)"	"unprognostic (3.06e-3)"	"unprognostic (2.32e-1)"	"prognostic favorable (6.21e-4)"	"unprognostic (2.01e-1)"	"unprognostic (3.52e-1)"	"unprognostic (1.01e-1)"	"unprognostic (3.16e-1)"	"unprognostic (9.91e-2)"	"unprognostic (1.80e-2)"	65.7	33.0	102.2	20.3	101.5	29.4	49.8	99.5	106.6	24.2	66.4	96.2	15.7	34.4	53.9	32.4	27.1	15.3	101.1	90.9	94.3	35.6	59.1	41.9	19.5	113.7	102.5	15.8	19.2	15.3	30.5	19.8	106.0	40.8	14.0	9.1	25.5	28.8	89.5	34.5	31.4	30.1	109.2	51.2	32.9	18.9	105.1	14.2	47.9	48.6	14.5	49.8	26.1	96.7	11.4	14.2	6.3	29.5	37.9	12.6	10.7	12.3	14.7	9.5	9.8	7.0	5.5	4.4	34.8	26.7	12.6	8.1	8.2	17.5	7.3	22.7	20.3	34.2	6.6	15.9	20.5	5.0	49.6	14.7	20.1	9.2	8.1	13.9	38.2	17.8	4.9	24.5	7.5	21.5	7.0	16.7	13.3	14.0	34.2	11.0	2.0	11.4	22.4	13.9	3.1	17.7	0.8	12.9	24.2	21.5	10.2	10.8	38.9	13.3	8.4	44.5	10.4	21.7	28.2	5.0	21.6	10.2	10.7	52.6	18.5	31.3	10.6	28.6	10.8	7.2	10.6	8.6	13.1	7.3	7.2	9.6	23.4	7.9	25.7	51.8	14.9	17.4	102.2	101.5	99.5	106.6	90.9	94.3	113.7	102.5	106.0	109.2	105.1	96.7	23.1	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	42.3	0.0	0.0	0.0	0.0	8.1	9.9	0.0	0.0	0.0	0.0	0.0	0.0	5.0	0.0	0.0	0.0	0.0	11.6	7.7	0.0	0.0	0.0	0.0	0.0	0.0	66.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.6	0.0	0.0	0.0	0.0	5.7	1.5	0.0	0.0	0.0
MARCHF3	"MARCH-III, MARCH3, MGC48332, RNF173"	ENSG00000173926	"Membrane associated ring-CH-type finger 3"	Q86UD3	5	126867714-127030558	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Endocytosis, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"Cytotrophoblasts: 43.8;Syncytiotrophoblasts: 98.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"memory B-cell: 10.5;naive B-cell: 12.1"	"Lineage enriched"	"Detected in many"	4	"B-cells: 12.1"	"Cell line enhanced"	"Detected in many"		"hTEC/SVTERT24-B: 40.4;HUVEC TERT2: 27.4;TIME: 33.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043406	Uncertain		Supported	Vesicles		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 77: Retina - Visual perception"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	Vesicles		"HPA043406: AB_10793947"	"unprognostic (5.96e-3)"	"unprognostic (1.46e-2)"	"unprognostic (1.91e-2)"	"unprognostic (4.21e-2)"	"unprognostic (9.00e-3)"	"unprognostic (1.17e-2)"	"unprognostic (7.75e-3)"	"unprognostic (9.41e-2)"	"unprognostic (8.93e-2)"	"unprognostic (2.05e-3)"	"unprognostic (3.15e-2)"	"unprognostic (1.82e-1)"	"unprognostic (5.60e-6)"	"unprognostic (7.74e-2)"	"unprognostic (7.64e-2)"	"unprognostic (1.05e-1)"	"unprognostic (3.64e-1)"	5.6	2.8	6.1	2.9	5.6	3.7	2.6	5.3	4.1	0.9	1.9	5.3	0.9	1.4	0.0	1.4	1.5	5.2	7.8	3.9	5.7	0.8	0.7	2.4	2.5	11.5	7.1	1.1	2.4	0.3	2.4	1.7	7.9	0.6	5.6	7.4	4.6	0.2	6.5	5.8	2.4	2.9	8.3	1.6	2.4	5.6	7.8	1.3	1.4	3.3	2.1	7.6	0.7	8.5	0.4	1.8	3.9	2.1	3.4	3.2	1.2	14.2	5.9	11.1	16.3	1.9	0.8	3.8	1.3	1.9	2.4	1.1	4.9	2.5	15.3	0.8	4.7	12.2	3.2	1.9	5.6	5.0	3.0	2.4	0.7	40.4	4.8	2.6	27.4	0.6	5.1	0.7	9.3	1.3	0.5	2.3	3.3	3.0	4.6	1.5	15.5	1.2	0.9	2.0	1.3	0.9	3.3	0.5	1.6	1.9	2.9	5.0	33.5	2.2	1.8	12.6	1.6	1.9	2.3	2.3	8.3	3.8	2.0	0.0	0.2	2.8	0.5	0.4	0.1	10.5	0.6	0.3	0.1	12.1	2.3	0.5	0.8	2.3	0.3	0.7	2.9	0.8	6.1	5.6	5.3	4.1	3.9	5.7	11.5	7.1	7.9	8.3	7.8	8.5	3.8	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.4	0.0	0.0	0.0	0.0	43.8	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	3.2	5.8	0.0	0.0	0.0	0.0	0.0	0.0	8.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	98.6	0.6	0.0	0.0	0.0
MARCHF5	"FLJ20445, MARCH-V, MARCH5, MITOL, RNF153"	ENSG00000198060	"Membrane associated ring-CH-type finger 5"	Q9NX47	10	92291167-92353964	"Enzymes, Metabolic proteins, Predicted membrane proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Adipocytes: 23.8;Cardiomyocytes: 28.6;Cytotrophoblasts: 39.2;Extravillous trophoblasts: 44.0;Hofbauer cells: 34.9;Syncytiotrophoblasts: 65.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA056596			Supported	Mitochondria		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 24: Non-specific - Transcription regulation"	Mitochondria		"HPA056596: AB_2683181"	"unprognostic (4.00e-2)"	"unprognostic (5.15e-2)"	"unprognostic (1.25e-1)"	"unprognostic (4.10e-2)"	"unprognostic (5.47e-3)"	"unprognostic (2.33e-3)"	"unprognostic (4.43e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.24e-2)"	"unprognostic (9.77e-2)"	"unprognostic (5.50e-3)"	"unprognostic (4.02e-3)"	"unprognostic (6.14e-2)"	"unprognostic (2.87e-1)"	"unprognostic (1.62e-1)"	"unprognostic (4.53e-1)"	"unprognostic (2.85e-2)"	13.6	14.0	9.1	7.7	9.6	17.3	15.0	9.1	11.9	12.2	10.4	9.8	11.3	13.3	12.6	19.3	10.1	10.7	12.8	9.6	9.4	15.1	20.1	10.4	9.0	9.0	9.4	14.0	9.2	12.5	7.0	7.8	8.8	15.1	10.1	8.8	13.7	7.8	18.2	9.8	11.6	10.7	9.6	8.9	10.5	8.8	9.3	12.5	17.2	16.1	9.8	10.7	12.2	9.7	28.0	14.8	28.7	33.1	19.2	19.8	14.8	24.5	26.7	29.8	30.4	10.0	19.6	16.2	16.5	24.1	13.0	22.4	20.3	20.5	42.5	12.3	23.9	13.1	13.6	23.7	23.2	21.1	12.4	20.4	27.0	19.7	40.9	39.6	26.6	17.0	14.5	19.7	24.2	17.7	18.7	24.1	6.7	18.1	22.1	20.0	29.4	9.8	30.8	17.8	13.3	24.5	21.3	15.5	26.7	13.7	27.1	16.1	26.0	13.9	15.3	15.3	34.0	19.9	16.2	14.2	12.7	28.7	9.5	4.2	6.0	7.0	5.1	7.5	5.2	5.2	5.7	5.5	6.9	4.5	5.7	5.5	12.2	5.0	6.7	4.6	5.9	5.0	9.1	9.6	9.1	11.9	9.6	9.4	9.0	9.4	8.8	9.6	9.3	9.7	23.8	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	28.6	0.0	0.0	0.0	0.0	39.2	12.9	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	44.0	9.3	0.0	0.0	0.0	0.0	0.0	0.0	34.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.4	0.0	0.0	0.0	0.0	65.3	2.8	0.0	0.0	0.0
MARCHF6	"MARCH-VI, MARCH6, RNF176, TEB4"	ENSG00000145495	"Membrane associated ring-CH-type finger 6"	O60337	5	10353695-10440388	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Ubl conjugation pathway"	Transferase	Epilepsy	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Adipocytes: 38.5;Cardiomyocytes: 102.5;Cytotrophoblasts: 54.4;dendritic cells: 25.8;Extravillous trophoblasts: 30.0;Hofbauer cells: 36.4;Syncytiotrophoblasts: 81.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040841, HPA063246"	Approved		Supported	"Endoplasmic reticulum"		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 20: HeLa - Mitochondria"	"Cluster 24: Non-specific - Transcription regulation"	"Endoplasmic reticulum"		"HPA040841: AB_2677162, HPA063246: AB_2684970"	"unprognostic (3.31e-2)"	"unprognostic (2.04e-1)"	"unprognostic (2.85e-2)"	"unprognostic (3.80e-3)"	"unprognostic (4.00e-1)"	"unprognostic (2.26e-1)"	"unprognostic (3.06e-2)"	"unprognostic (9.52e-3)"	"unprognostic (1.53e-1)"	"unprognostic (1.05e-3)"	"unprognostic (3.94e-2)"	"unprognostic (5.58e-2)"	"unprognostic (5.08e-3)"	"unprognostic (1.61e-1)"	"unprognostic (2.88e-1)"	"unprognostic (3.57e-1)"	"unprognostic (8.50e-3)"	22.1	25.5	16.1	20.3	23.7	76.5	25.9	28.3	20.7	20.1	2.9	26.9	32.8	22.7	25.5	20.9	24.9	24.5	30.8	22.0	30.4	34.1	32.5	25.1	24.7	13.7	17.5	36.0	39.3	62.4	20.8	22.8	16.9	22.7	19.8	36.6	25.6	23.8	48.4	24.8	30.3	18.9	13.8	28.2	30.2	29.9	27.9	32.3	29.3	51.8	23.3	23.7	18.6	33.5	37.4	55.1	90.1	69.9	50.6	40.4	73.7	57.7	53.7	48.9	61.8	52.8	97.0	39.4	85.4	54.4	67.2	52.3	48.2	37.7	65.4	82.9	43.0	50.7	179.7	36.2	35.6	61.4	54.6	47.4	40.6	49.0	53.1	50.0	45.8	41.4	62.1	85.1	45.0	42.4	33.1	47.2	32.8	29.9	38.5	50.9	37.6	57.0	38.0	72.4	38.7	56.0	107.2	57.9	38.4	41.3	48.2	32.5	44.8	58.4	56.8	29.1	43.7	59.3	94.1	55.7	43.1	40.7	42.8	15.6	7.4	12.6	11.2	8.4	12.8	11.7	10.8	11.0	6.3	9.6	12.5	12.4	12.1	9.1	11.1	5.0	10.4	9.1	16.1	23.7	28.3	20.7	22.0	30.4	13.7	17.5	16.9	13.8	27.9	33.5	38.5	0.0	0.0	0.0	13.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	102.5	0.0	0.0	0.0	0.0	54.4	25.8	0.0	0.0	0.0	0.0	0.0	0.0	10.4	0.0	0.0	0.0	0.0	30.0	19.3	0.0	0.0	0.0	0.0	0.0	0.0	36.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.0	0.0	0.0	0.0	0.0	81.3	5.8	0.0	0.0	0.0
MARCHF7	"AXOT, MARCH-VII, MARCH7, RNF177"	ENSG00000136536	"Membrane associated ring-CH-type finger 7"	Q9H992	2	159712457-159771027	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Adipocytes: 33.3;Cardiomyocytes: 88.4;Cytotrophoblasts: 36.2;dendritic cells: 28.2;Extravillous trophoblasts: 38.8;Hofbauer cells: 34.0;Syncytiotrophoblasts: 44.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014275, HPA022152"	Enhanced		Supported	"Plasma membrane,Cytosol"		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 24: Non-specific - Transcription regulation"	"Plasma membrane, Cytosol"		"HPA014275: AB_10599820, HPA022152: AB_10601107"	"unprognostic (2.42e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.02e-2)"	"unprognostic (1.92e-2)"	"unprognostic (1.62e-2)"	"unprognostic (2.10e-1)"	"prognostic unfavorable (2.41e-4)"	"unprognostic (2.46e-2)"	"unprognostic (6.42e-2)"	"unprognostic (3.44e-1)"	"unprognostic (3.17e-2)"	"unprognostic (3.53e-2)"	"prognostic unfavorable (1.84e-4)"	"unprognostic (1.41e-3)"	"unprognostic (1.38e-1)"	"unprognostic (2.57e-1)"	"unprognostic (1.61e-1)"	38.3	30.0	16.4	37.9	21.7	43.2	48.2	32.3	21.5	38.6	25.1	33.2	30.0	45.0	34.2	67.3	37.5	38.1	48.9	15.8	16.1	32.8	40.1	38.2	47.9	17.4	17.1	47.5	22.3	36.6	22.7	46.9	17.7	38.1	36.9	37.9	26.9	36.3	55.2	38.6	30.0	50.6	14.9	45.1	33.5	62.0	17.1	60.8	47.5	44.1	52.2	39.0	37.5	21.8	50.3	35.3	88.7	40.7	61.9	81.9	89.1	83.9	81.1	82.5	73.9	70.9	57.5	71.0	36.8	84.2	46.8	61.3	55.4	74.5	102.9	75.9	43.2	96.0	53.8	53.3	60.7	79.9	72.6	72.7	83.0	99.5	86.5	92.5	99.3	50.7	75.6	65.6	82.9	44.2	52.4	73.8	84.6	54.6	47.3	75.0	64.5	59.3	74.6	112.1	51.9	48.6	65.6	48.2	67.0	94.3	56.9	94.4	93.5	86.9	51.9	53.9	47.2	51.5	61.0	96.8	54.1	46.8	84.0	83.5	28.8	59.6	28.6	29.5	33.3	27.6	30.4	32.4	27.6	26.4	36.3	35.9	127.5	39.4	43.4	22.3	34.3	30.9	16.4	21.7	32.3	21.5	15.8	16.1	17.4	17.1	17.7	14.9	17.1	21.8	33.3	0.0	0.0	0.0	7.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	88.4	0.0	0.0	0.0	0.0	36.2	28.2	0.0	0.0	0.0	0.0	0.0	0.0	8.9	0.0	0.0	0.0	0.0	38.8	13.5	0.0	0.0	0.0	0.0	0.0	0.0	34.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.0	0.0	0.0	0.0	0.0	44.2	5.8	0.0	0.0	0.0
MARCKS	"80K-L, MACS, PKCSL"	ENSG00000277443	"Myristoylated alanine rich protein kinase C substrate"	P29966	6	113857345-113863475	"Plasma proteins, Predicted intracellular proteins"		"Actin-binding, Calmodulin-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"intermediate monocyte: 12.7;neutrophil: 18.7"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AF22: 405.8;TIME: 326.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022062, HPA054820, HPA067595, HPA069443"	Enhanced		Approved	"Nucleoplasm,Endoplasmic reticulum,Plasma membrane,Cytosol"		NA	NA		19000000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 70: Brain - Nervous system development"	"Cluster 12: NES - Nervous system development"	"Cluster 50: Fibroblasts - ECM organization"	"Plasma membrane"	"Nucleoplasm, Endoplasmic reticulum, Cytosol"	"CAB022062: AB_309681, HPA054820: AB_2682613, HPA067595: AB_2732772, HPA069443: AB_2732133"	"unprognostic (4.71e-1)"	"unprognostic (1.91e-2)"	"unprognostic (2.46e-1)"	"unprognostic (5.51e-3)"	"unprognostic (8.22e-3)"	"unprognostic (2.38e-2)"	"prognostic unfavorable (2.78e-8)"	"unprognostic (7.82e-2)"	"unprognostic (2.57e-1)"	"unprognostic (6.92e-2)"	"unprognostic (2.27e-1)"	"unprognostic (3.56e-2)"	"prognostic unfavorable (4.85e-4)"	"unprognostic (1.36e-3)"	"unprognostic (2.77e-2)"	"unprognostic (8.07e-2)"	"unprognostic (2.70e-2)"	42.8	16.8	65.1	58.2	64.1	104.6	50.2	73.2	78.5	31.9	21.6	75.7	38.9	31.2	13.5	45.1	27.3	35.8	18.2	56.8	89.2	24.6	26.1	35.0	45.4	81.0	87.6	39.0	42.4	7.0	20.6	63.0	73.1	37.8	68.2	22.0	28.0	18.0	15.7	32.1	43.3	30.1	106.8	57.0	62.8	10.3	85.5	44.8	16.2	12.9	45.3	86.2	34.5	102.8	39.2	22.6	405.8	22.3	134.0	86.6	2.2	123.0	171.4	84.9	140.6	40.7	54.1	0.1	25.3	228.0	67.3	118.0	67.9	35.7	109.7	0.3	40.2	0.0	22.2	53.3	89.2	10.3	0.7	90.2	68.8	81.8	77.4	231.9	243.1	0.4	4.6	107.6	122.1	0.4	1.3	0.3	52.7	43.5	29.4	0.2	40.7	4.1	26.9	73.6	56.4	163.4	78.7	39.6	89.6	95.0	2.1	11.3	326.0	78.3	0.5	129.9	212.7	288.3	22.4	11.4	60.2	55.8	153.4	0.0	3.9	0.0	0.0	12.7	0.0	4.6	0.0	0.0	1.1	1.9	0.0	0.0	18.7	0.0	7.5	0.0	0.0	0.5	65.1	64.1	73.2	78.5	56.8	89.2	81.0	87.6	73.1	106.8	85.5	102.8	211.2	9.6	15.5	44.7	139.0	504.1	540.7	232.3	275.4	157.0	213.2	176.7	16.6	57.2	115.0	38.6	29.2	7.2	5.5	629.5	37.2	144.3	55.7	111.2	444.0	271.6	336.3	2.5	33.0	229.9	11.2	372.6	135.1	130.4	2.5	526.1	236.0	8.8	371.6	84.1	21.0	369.4	126.1	286.3	605.5	35.7	120.5	381.3	273.9	60.0	447.2	315.5	2.1	194.5	9.7	208.1	223.1	67.0	105.2	380.1	89.9	6.9	145.0	37.7	39.5	89.8	222.8	22.7	16.2	326.3	638.5	29.4	22.3	62.3	352.3	620.2
MARCKSL1	"F52, MacMARCKS, MLP, MLP1"	ENSG00000175130	"MARCKS like 1"	P49006	1	32333839-32336233	"Predicted intracellular proteins"		"Actin-binding, Calmodulin-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 712.7"	"Cell type enhanced"	"Detected in many"		"monocytes: 941.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in all"	8	"eosinophil: 252.7"	"Lineage enriched"	"Detected in all"	8	"granulocytes: 252.7"	"Cell line enhanced"	"Detected in many"		"AF22: 1016.3;NTERA-2: 984.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB020787, HPA030528"	Enhanced		Supported	"Nucleoplasm,Actin filaments,Cytosol"		NA	Yes		170000	"Cluster 52: Eosinophils - Transcription"	"Cluster 70: Brain - Nervous system development"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	Cytosol	"Nucleoplasm, Actin filaments"	"CAB020787: , HPA030528: AB_2673514"	"unprognostic (8.08e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.04e-2)"	"unprognostic (1.38e-1)"	"unprognostic (3.16e-3)"	"prognostic unfavorable (1.78e-6)"	"unprognostic (3.65e-1)"	"unprognostic (1.72e-1)"	"unprognostic (8.41e-3)"	"unprognostic (2.91e-1)"	"unprognostic (1.76e-2)"	"prognostic unfavorable (1.20e-4)"	"unprognostic (1.50e-1)"	"unprognostic (8.16e-3)"	"unprognostic (1.08e-1)"	"unprognostic (3.22e-2)"	63.4	59.9	363.5	82.1	510.3	50.1	102.9	540.1	438.2	81.2	206.4	108.1	61.8	93.4	155.8	15.1	72.2	97.2	55.0	343.0	408.0	51.1	38.7	40.0	176.0	631.5	504.7	358.0	23.7	6.5	22.9	42.9	534.9	84.7	116.5	37.9	75.9	49.9	8.7	28.3	56.1	42.7	467.9	63.1	132.8	139.2	466.4	166.0	110.3	11.0	199.5	77.8	27.1	712.7	82.9	73.3	1016.3	418.6	22.5	8.3	181.0	34.0	21.2	99.9	66.0	176.0	59.9	185.7	124.4	23.2	0.3	43.0	333.1	3.8	73.3	4.5	246.5	10.0	27.0	392.4	68.7	48.8	0.9	114.8	13.7	75.0	2.1	154.2	295.0	312.6	291.5	2.2	135.7	197.5	613.5	205.9	984.3	267.4	168.1	754.8	109.4	87.7	152.1	163.1	629.0	597.8	178.8	194.2	587.8	411.9	135.4	85.8	87.8	41.8	241.3	3.9	66.1	27.8	2.3	489.8	4.7	73.6	225.7	3.1	4.0	252.7	3.8	23.1	1.4	20.0	7.4	4.9	6.6	27.7	15.3	6.4	18.2	1.1	30.3	9.0	4.8	4.9	363.5	510.3	540.1	438.2	343.0	408.0	631.5	504.7	534.9	467.9	466.4	712.7	242.5	0.0	1.3	27.1	191.1	93.7	114.7	43.5	40.5	27.7	465.7	385.8	8.5	178.7	68.8	60.7	6.2	16.1	110.1	194.1	82.2	389.7	37.4	68.7	190.3	326.9	746.2	74.4	4.2	307.2	116.4	124.3	246.2	115.2	22.3	378.6	462.3	5.3	21.2	10.1	21.9	514.2	236.0	61.0	365.3	66.7	613.3	82.0	300.6	9.4	941.4	464.3	46.4	93.0	428.3	751.6	292.8	641.3	39.5	418.8	30.2	9.8	15.6	14.8	131.5	40.3	210.0	14.8	102.7	22.5	83.1	13.4	89.8	172.0	447.1	586.9
MARF1	"KIAA0430, LKAP, LMKB, PPP1R34"	ENSG00000166783	"Meiosis regulator and mRNA stability factor 1"	Q9Y4F3	16	15594387-15643154	"Predicted intracellular proteins"	"Differentiation, Meiosis, Oogenesis"	RNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 28.7;Breast glandular cells: 26.3;Endometrial stromal cells: 27.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017992	Uncertain		Approved	"Golgi apparatus,Vesicles"		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 52: Non-specific - Ribosome"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 7: Non-specific - Mitochondria"	"Golgi apparatus, Vesicles"		"HPA017992: AB_1852921"	"unprognostic (2.33e-1)"	"unprognostic (6.44e-3)"	"unprognostic (8.84e-2)"	"unprognostic (3.78e-2)"	"unprognostic (1.28e-1)"	"unprognostic (6.13e-3)"	"unprognostic (2.35e-1)"	"unprognostic (2.10e-2)"	"unprognostic (2.47e-2)"	"unprognostic (6.93e-2)"	"unprognostic (8.44e-3)"	"unprognostic (1.35e-1)"	"unprognostic (6.94e-3)"	"unprognostic (3.08e-2)"	"unprognostic (1.24e-1)"	"unprognostic (8.74e-2)"	"unprognostic (7.94e-2)"	10.5	7.1	2.1	10.8	5.2	9.7	9.4	1.5	6.6	10.0	3.7	16.0	10.4	12.8	1.0	12.3	13.7	12.5	9.2	4.5	3.4	13.5	8.3	9.3	14.6	3.6	4.5	18.2	12.9	12.3	5.9	9.4	2.6	10.4	12.1	8.4	14.4	13.7	18.3	10.5	11.2	12.0	0.0	12.1	10.1	4.9	4.4	12.7	14.8	15.2	22.0	12.1	8.8	4.5	8.3	9.4	15.0	8.2	12.1	22.4	7.2	9.6	12.4	8.2	13.5	2.7	6.2	29.8	17.0	12.3	6.7	5.6	7.7	12.4	13.6	11.6	5.0	13.1	12.3	10.4	13.4	15.7	10.5	13.4	13.4	15.3	15.5	16.9	19.5	12.8	12.6	13.3	15.6	7.7	13.9	2.6	5.6	7.1	7.2	19.5	22.0	5.9	7.1	6.4	9.1	10.8	7.7	8.9	14.3	6.7	9.2	13.2	19.7	11.2	5.5	11.6	6.3	12.3	12.9	15.9	12.4	9.6	16.4	2.5	0.7	4.6	1.1	1.2	0.7	4.1	1.7	1.3	0.8	5.2	1.9	1.4	7.1	0.9	1.8	0.3	1.7	0.9	2.1	5.2	1.5	6.6	4.5	3.4	3.6	4.5	2.6	0.0	4.4	4.5	21.4	22.4	28.7	0.0	10.7	0.0	0.0	0.0	0.0	0.0	26.3	19.8	0.0	0.0	18.6	23.9	0.0	5.7	14.7	0.0	15.6	10.4	0.0	17.8	27.5	8.4	0.0	0.0	0.0	14.2	5.9	7.7	0.0	20.0	11.4	23.0	0.0	0.0	10.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.7	0.0	0.0	7.2	0.0	0.0	0.0	0.0	13.7	0.0	0.0	6.8	0.0	0.0	19.0	17.5	0.0	0.0	0.0	8.9	0.0	0.0	0.0	0.0	7.7	7.8	17.9	0.0	0.0
MARK2	"EMK1, PAR-1, PAR-1B, Par1b"	ENSG00000072518	"Microtubule affinity regulating kinase 2"	Q7KZI7	11	63838928-63911020	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Differentiation, Wnt signaling pathway"	"Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038790, HPA074905"	Approved		Supported	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Plasma membrane"	Nucleoplasm	"HPA038790: AB_10674840, HPA074905: AB_2686722"	"unprognostic (1.33e-2)"	"unprognostic (2.45e-2)"	"unprognostic (1.64e-1)"	"prognostic unfavorable (3.21e-4)"	"unprognostic (7.13e-2)"	"unprognostic (3.82e-2)"	"prognostic unfavorable (1.30e-4)"	"unprognostic (2.73e-3)"	"unprognostic (4.41e-1)"	"unprognostic (5.79e-2)"	"unprognostic (3.94e-3)"	"unprognostic (3.77e-1)"	"unprognostic (5.20e-3)"	"unprognostic (5.15e-3)"	"unprognostic (6.78e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.40e-1)"	11.3	13.8	12.6	21.1	16.1	24.0	16.8	8.1	16.3	18.5	10.8	25.9	26.1	14.6	7.7	51.8	16.6	14.1	20.9	14.9	9.3	13.9	13.1	17.0	21.5	11.8	9.3	12.0	22.4	19.4	19.8	14.9	11.5	20.5	22.4	8.8	27.0	13.1	20.8	40.9	25.1	16.3	7.3	24.1	20.9	10.6	9.5	23.2	19.5	13.7	24.0	19.3	25.0	17.9	52.0	34.1	26.6	28.6	14.6	18.6	35.2	20.8	20.0	29.5	22.3	34.1	49.5	37.8	35.6	20.8	32.0	57.5	26.9	28.7	24.6	26.7	20.9	40.7	23.9	20.3	17.0	45.9	51.4	10.9	36.8	27.0	21.4	13.5	24.7	33.6	35.7	36.5	19.5	64.4	49.3	29.9	31.7	36.0	24.2	39.9	20.4	39.7	19.1	39.8	37.9	25.4	34.7	90.2	24.3	28.9	65.1	26.4	22.7	30.3	19.1	39.6	23.4	24.5	28.8	36.7	20.1	23.2	25.3	1.4	0.7	2.1	1.3	0.7	2.1	0.9	1.0	1.3	1.0	1.6	0.8	0.9	3.6	1.6	1.1	0.9	0.6	0.7	12.6	16.1	8.1	16.3	14.9	9.3	11.8	9.3	11.5	7.3	9.5	17.9	17.3	6.4	6.8	29.7	18.5	25.2	21.1	9.1	19.4	26.8	30.0	18.2	12.8	27.1	11.9	20.2	8.4	26.0	33.4	90.3	1.9	20.2	0.6	29.5	15.8	14.7	29.9	14.7	43.6	21.4	20.6	11.7	27.0	41.0	17.2	21.1	13.6	13.0	17.9	20.2	30.3	39.9	10.2	26.7	18.5	0.9	12.8	25.0	3.6	29.0	17.0	18.8	36.0	31.7	51.8	27.3	39.4	10.9	15.6	30.4	33.4	8.1	14.5	18.1	19.7	19.6	13.1	9.1	18.4	39.9	34.4	65.0	23.6	16.0	33.6	44.3
MARK4	"FLJ90097, KIAA1860, MARKL1, Nbla00650, PAR-1D"	ENSG00000007047	"Microtubule affinity regulating kinase 4"	Q96L34	19	45079288-45305284	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell cycle, Cell division, Cilium biogenesis/degradation, Mitosis"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Horizontal cells: 119.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039186	Approved		Supported	Cytosol		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 12: NES - Nervous system development"	"Cluster 62: Horizontal cells - Visual perception"	Cytosol		"HPA039186: AB_10796223"	"unprognostic (1.64e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.57e-3)"	"prognostic unfavorable (8.31e-8)"	"unprognostic (2.02e-1)"	"prognostic unfavorable (3.05e-5)"	"unprognostic (1.90e-1)"	"unprognostic (2.16e-2)"	"unprognostic (6.26e-2)"	"unprognostic (5.64e-3)"	"unprognostic (1.24e-3)"	"unprognostic (7.50e-2)"	"unprognostic (3.80e-2)"	"unprognostic (6.89e-2)"	"unprognostic (7.23e-2)"	"unprognostic (4.65e-2)"	"unprognostic (3.02e-2)"	13.1	13.5	27.5	7.2	31.4	8.5	13.0	16.1	37.7	17.1	11.3	16.5	5.0	15.5	16.6	16.4	14.8	10.6	17.3	31.6	19.6	13.5	21.8	13.9	8.3	24.0	25.2	21.7	14.0	20.5	16.6	11.6	22.6	16.2	5.8	26.0	12.7	13.0	38.7	26.9	9.1	14.6	14.1	11.4	14.3	40.4	29.9	13.1	12.7	12.0	9.6	19.0	16.7	26.1	20.3	7.7	36.6	23.8	25.3	36.8	8.8	15.3	25.1	21.8	20.8	4.0	10.8	8.5	12.0	28.9	20.6	13.5	26.4	22.5	14.2	15.7	16.0	20.7	8.5	17.0	47.6	4.4	15.1	48.1	31.9	18.7	22.8	43.3	29.5	22.1	22.6	21.8	24.9	14.4	16.7	14.5	12.3	18.6	4.7	61.5	11.4	6.3	23.4	16.0	58.8	27.1	20.5	17.5	12.5	35.9	9.0	29.3	21.6	16.7	12.9	12.2	9.0	22.7	21.8	10.8	17.9	8.4	12.7	1.1	1.0	0.2	1.0	0.7	0.2	0.2	0.3	1.3	0.3	0.2	0.6	0.7	0.9	0.7	0.7	0.9	0.8	0.4	27.5	31.4	16.1	37.7	31.6	19.6	24.0	25.2	22.6	14.1	29.9	26.1	8.7	12.8	3.1	30.7	6.0	25.0	11.3	7.2	15.4	20.9	10.2	7.0	9.1	11.5	4.4	9.2	25.0	4.3	8.1	3.7	11.7	8.4	2.3	6.6	9.5	12.2	6.1	6.1	31.1	6.1	1.5	8.4	10.2	10.5	2.5	18.9	18.5	10.7	7.0	119.5	36.5	4.7	4.1	9.5	11.0	6.3	16.1	8.2	3.6	16.9	5.9	19.6	12.3	23.1	16.4	9.5	3.5	13.9	7.7	13.0	4.7	6.5	2.5	15.6	0.0	7.6	8.4	1.2	8.3	12.5	24.2	11.5	10.3	26.1	3.2	15.5
MARVELD2	"DFNB49, FLJ30532, MRVLDC2, TRIC"	ENSG00000152939	"MARVEL domain containing 2"	Q8N4S9	5	69415065-69444330	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Hearing		"Deafness, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"thyroid gland: 15.7"	"Cell type enhanced"	"Detected in many"		"Urothelial cells: 46.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BEWO: 29.5;CAPAN-2: 24.1;HaCaT: 18.9;RT4: 21.1;SCLC-21H: 26.7;T-47d: 18.3"	"Region enriched"	"Detected in some"	8	"cerebellum: 7.9"	"Low region specificity"	"Detected in all"			"HPA018119, HPA061726"	Uncertain		Supported	"Cell Junctions"		NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 22: Epithelial cell types - Mixed function"	"Cell Junctions"		"HPA018119: AB_2669771, HPA061726: AB_2684595"	"unprognostic (4.11e-2)"	"unprognostic (3.05e-1)"	"unprognostic (1.22e-2)"	"unprognostic (2.44e-3)"	"unprognostic (1.68e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.49e-1)"	"unprognostic (8.84e-2)"	"unprognostic (2.43e-1)"	"unprognostic (3.47e-2)"	"unprognostic (2.60e-2)"	"unprognostic (1.75e-1)"	"prognostic favorable (2.84e-13)"	"unprognostic (1.78e-1)"	"unprognostic (1.19e-1)"	"unprognostic (3.67e-2)"	"unprognostic (1.82e-1)"	0.3	0.2	0.5	0.9	0.5	0.2	4.0	0.5	0.6	2.1	3.2	5.7	7.7	1.1	1.3	6.9	3.9	2.9	0.4	0.5	0.5	8.0	10.7	5.6	0.1	0.7	0.7	0.1	9.3	4.6	2.9	1.8	0.7	3.0	6.2	0.3	4.6	2.6	0.0	4.3	7.7	0.4	0.4	0.2	8.1	1.5	0.7	1.0	15.7	0.0	1.3	3.0	3.4	0.7	10.8	3.5	0.1	0.0	0.0	0.0	29.5	0.2	0.2	0.2	0.7	14.1	24.1	0.1	2.0	1.8	0.0	18.9	0.0	14.0	0.5	0.2	5.8	0.0	1.1	7.8	1.7	0.0	0.1	0.4	15.3	0.1	1.9	0.7	0.9	0.1	0.0	0.1	0.0	9.8	0.0	0.0	1.8	6.3	0.3	0.0	0.1	0.5	10.0	21.1	26.7	0.0	2.3	2.0	0.3	4.3	18.3	0.0	1.5	0.0	0.1	0.0	0.0	0.1	3.5	0.0	0.0	0.2	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.2	0.3	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.5	0.5	0.5	0.6	0.5	0.5	0.7	0.7	0.7	0.4	0.7	0.7	1.0	22.4	26.5	0.7	1.0	5.0	22.2	14.8	10.2	0.3	15.5	8.5	2.8	35.8	23.1	16.5	2.1	22.9	0.2	31.4	17.6	25.1	5.8	33.5	3.4	4.1	16.8	3.4	0.5	25.8	8.2	1.1	17.9	30.4	1.3	3.7	5.0	37.9	1.9	0.0	0.4	23.1	18.3	0.6	0.9	3.2	0.0	0.6	1.8	1.0	7.8	0.5	0.0	0.5	0.6	25.0	29.7	0.0	0.6	25.5	33.5	6.1	38.4	0.6	0.0	0.8	1.5	4.1	2.4	19.4	6.5	12.0	0.9	2.9	25.6	46.9
MASP2	MASP1P1	ENSG00000009724	"Mannan binding lectin serine peptidase 2"	O00187	1	11026523-11047239	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted secreted proteins"	"Complement pathway, Immunity, Innate immunity"	"Hydrolase, Protease, Serine protease"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	64	"liver: 476.5"	"Cell type enriched"	"Detected in some"	52	"Hepatocytes: 658.6"	"Cancer enriched"	"Detected in some"	71	"liver cancer: 41.9"	"Region enriched"	"Detected in single"	9	"cerebellum: 6.4"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	6	"Hep G2: 16.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA029313, HPA029314"	Uncertain		Supported	"Golgi apparatus"	"Secreted to blood"	NA	NA	340000000	820000000		"Cluster 62: Liver - Hemostasis"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 2: Hepatocytes - Metabolism"	"Golgi apparatus"		"HPA029313: AB_10669654, HPA029314: AB_10670029"	"unprognostic (7.00e-2)"	"unprognostic (8.37e-2)"	"unprognostic (2.75e-2)"	"unprognostic (2.89e-1)"	"unprognostic (1.86e-1)"	"unprognostic (3.26e-3)"	"prognostic favorable (1.60e-4)"	"unprognostic (2.92e-3)"	"unprognostic (3.13e-2)"	"unprognostic (4.04e-2)"	"unprognostic (6.90e-3)"	"unprognostic (8.30e-4)"	"unprognostic (7.14e-2)"	"unprognostic (3.91e-1)"	"unprognostic (2.62e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.09e-4)"	2.1	1.2	0.0	1.7	0.0	7.4	2.2	6.4	0.7	2.4	0.0	2.7	1.6	2.8	0.0	1.2	2.7	1.2	1.3	0.1	0.0	1.0	476.5	1.8	2.7	0.0	0.0	2.9	2.9	0.0	2.3	0.6	0.2	1.6	0.0	6.9	2.5	0.0	5.1	5.3	3.4	0.0	0.0	2.5	2.4	1.5	0.0	0.0	1.9	0.0	0.0	2.1	1.6	0.4	0.5	0.3	2.6	1.6	0.0	0.1	0.4	0.7	0.0	0.0	0.0	1.2	1.0	2.3	0.6	0.0	0.5	0.7	0.0	0.0	0.0	0.6	2.3	1.3	2.7	16.4	0.0	2.0	1.5	0.0	0.0	0.1	0.0	1.8	0.0	1.7	0.7	0.5	0.0	0.5	0.6	1.1	0.3	0.2	0.7	1.6	0.9	0.6	0.0	1.3	1.7	0.7	0.9	0.4	0.4	1.6	0.6	1.2	1.2	0.9	0.5	0.8	0.5	0.5	0.9	1.5	0.5	1.7	0.4	0.1	0.0	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	6.4	0.7	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.0	4.6	1.1	0.9	0.2	0.0	0.6	0.2	0.2	0.0	0.5	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.9	0.0	5.3	9.5	0.0	0.0	0.1	0.0	0.1	1.3	0.0	8.2	658.6	0.1	0.0	8.3	0.0	0.0	12.6	0.3	0.0	0.0	0.0	1.8	1.9	0.0	0.1	0.0	8.0	10.4	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.7	0.4	0.0	0.7	0.2	0.0	0.0	0.4	0.6	0.0	0.8	0.1	0.0	0.1
MAST1	"KIAA0973, SAST"	ENSG00000105613	"Microtubule associated serine/threonine kinase 1"	Q9Y2H9	19	12833951-12874952	"Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 37.7;pituitary gland: 23.3;retina: 15.4"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 24.7;Cone photoreceptor cells: 43.8;Excitatory neurons: 64.7;Inhibitory neurons: 70.3;Oligodendrocyte precursor cells: 22.1;Rod photoreceptor cells: 20.4"	"Cancer enhanced"	"Detected in many"		"glioma: 3.5"	"Region enhanced"	"Detected in many"		"cerebral cortex: 37.7"	"Immune cell enhanced"	"Detected in single"		"MAIT T-cell: 1.0"	"Lineage enriched"	"Detected in single"	9	"T-cells: 1.0"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 23.3;SCLC-21H: 40.5;SH-SY5Y: 20.2;U-266/70: 16.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028181, HPA073106"	Enhanced		Supported	Vesicles,Cytosol		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 58: Brain - Synaptic function"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Vesicles	Cytosol	"HPA028181: AB_10603872, HPA073106: AB_2732218"	"unprognostic (6.32e-2)"	"unprognostic (3.66e-2)"	"unprognostic (3.93e-2)"	"unprognostic (2.83e-5)"	"unprognostic (1.72e-1)"	"unprognostic (4.19e-2)"	"unprognostic (2.38e-1)"	"unprognostic (8.72e-2)"	"unprognostic (1.04e-1)"	"unprognostic (3.64e-1)"	"unprognostic (8.89e-3)"	"unprognostic (3.43e-2)"	"unprognostic (3.84e-3)"	"unprognostic (1.19e-1)"	"unprognostic (7.04e-2)"	"unprognostic (2.49e-2)"	"unprognostic (1.96e-1)"	0.0	2.2	6.5	0.3	12.1	0.3	0.1	7.3	37.7	0.2	0.0	1.2	0.3	0.0	0.0	0.2	0.1	0.2	0.2	8.3	2.4	0.1	0.6	0.1	0.1	11.2	1.1	0.3	0.6	0.5	23.3	0.0	9.5	0.2	0.1	15.4	0.2	0.0	0.0	3.7	0.4	0.0	0.0	0.1	0.6	5.0	1.2	0.8	0.1	0.0	0.0	0.2	0.3	3.0	3.6	1.6	1.5	23.3	0.0	0.0	1.9	0.2	0.1	0.3	0.9	0.8	1.5	5.8	2.6	0.0	3.9	0.1	6.8	0.1	0.1	4.1	4.5	0.5	5.8	2.6	0.0	1.3	1.2	0.5	0.1	0.8	0.7	1.3	0.0	15.2	5.2	3.0	0.0	0.8	2.4	0.6	6.9	0.6	7.2	15.9	4.6	8.3	0.3	0.2	40.5	20.2	0.8	1.4	4.3	1.2	3.8	2.1	0.0	2.8	4.2	3.1	0.8	16.7	14.5	3.7	5.1	3.1	0.1	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.0	6.5	12.1	7.3	37.7	8.3	2.4	11.2	1.1	9.5	0.0	1.2	3.0	0.5	0.0	2.4	7.8	0.2	0.9	1.6	0.6	0.6	24.7	0.8	2.5	1.0	0.0	0.3	0.0	43.8	0.6	0.4	0.6	0.0	0.4	14.0	0.2	0.2	1.3	0.0	0.0	64.7	0.5	0.6	1.3	0.0	0.3	1.3	0.5	1.1	0.5	0.2	15.2	70.3	0.1	0.0	1.0	1.2	8.2	0.6	0.7	5.4	6.5	0.1	3.7	0.0	22.1	3.0	0.3	2.5	1.2	0.0	1.0	0.9	0.2	1.0	20.4	0.0	2.0	0.5	8.0	5.2	0.7	1.4	0.3	1.0	0.4	0.7	1.2
MATK	"CHK, CTK, DKFZp434N1212, HHYLTK, HYL, HYLTK, Lsk, MGC1708, MGC2101"	ENSG00000007264	"Megakaryocyte-associated tyrosine kinase"	P42679	19	3777970-3802129	"Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Transferase, Tyrosine-protein kinase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 20.5;brain: 41.9"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 177.0;Hofbauer cells: 57.4;NK-cells: 422.2;T-cells: 99.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"NK-cell: 76.8"	"Group enriched"	"Detected in many"	57	"NK-cells: 76.8;T-cells: 46.2"	"Cell line enhanced"	"Detected in some"		"HL-60: 108.3;HMC-1: 30.9;K-562: 48.9;MCF7: 34.4;NB-4: 74.8;SCLC-21H: 30.9;THP-1: 27.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004847, HPA066547"	Approved		Approved	"Microtubules,Cytokinetic bridge,Mitotic spindle,Centriolar satellite,Cytosol"		Yes	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 63: NK-cells & T-cells - Immune response"	Microtubules	"Cytokinetic bridge, Mitotic spindle, Centriolar satellite, Cytosol"	"HPA004847: AB_1079316, HPA066547: "	"prognostic favorable (5.27e-4)"	"unprognostic (1.28e-2)"	"unprognostic (1.84e-1)"	"unprognostic (3.54e-2)"	"unprognostic (3.36e-1)"	"unprognostic (3.39e-2)"	"unprognostic (9.50e-2)"	"unprognostic (1.23e-1)"	"unprognostic (7.91e-2)"	"unprognostic (3.19e-3)"	"unprognostic (2.07e-2)"	"unprognostic (4.51e-2)"	"unprognostic (1.16e-2)"	"unprognostic (7.59e-2)"	"unprognostic (1.66e-1)"	"unprognostic (2.26e-1)"	"unprognostic (2.33e-2)"	4.7	1.3	18.3	6.6	21.3	20.5	2.5	2.9	41.9	1.1	1.6	2.1	6.6	0.9	0.1	2.1	4.0	4.4	1.4	25.9	8.7	2.4	3.2	9.9	9.4	10.4	11.0	0.7	1.2	0.7	2.7	1.0	8.8	1.3	1.1	2.2	3.2	0.7	0.8	1.9	6.2	0.8	4.7	16.5	4.0	3.1	14.1	3.8	1.6	0.2	4.0	1.6	1.1	23.6	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.5	0.0	0.2	1.7	0.0	1.0	10.6	13.8	0.4	0.0	0.0	18.1	12.0	1.5	2.9	0.0	108.3	30.9	0.1	0.0	0.2	0.1	0.0	0.0	1.2	48.9	0.1	0.0	34.4	0.3	74.8	8.4	9.0	0.3	0.0	0.1	0.0	0.0	0.0	30.9	0.1	0.1	0.1	0.1	0.9	0.0	27.4	3.3	0.0	0.6	1.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	46.2	0.0	31.3	0.0	5.7	29.3	0.8	0.9	2.7	16.4	1.0	76.8	0.2	0.3	0.4	7.6	18.3	21.3	2.9	41.9	25.9	8.7	10.4	11.0	8.8	4.7	14.1	23.6	1.4	0.0	1.1	0.3	11.1	0.4	0.1	0.0	0.0	1.4	4.9	7.2	1.3	0.0	0.0	0.0	12.5	0.3	177.0	0.3	0.0	0.0	2.0	0.2	0.5	1.9	7.1	28.6	17.7	0.0	0.5	0.8	11.7	0.5	44.5	0.1	8.6	1.1	57.4	0.0	8.3	0.3	0.0	6.0	14.6	5.1	0.0	11.5	1.8	4.7	3.0	1.3	422.2	2.0	1.6	0.0	1.1	0.0	17.1	0.1	0.3	0.2	0.7	2.0	0.0	0.5	1.2	0.4	4.5	1.3	1.1	0.3	99.7	0.0	1.1	0.0
MAU2	"KIAA0892, mau-2, MAU2L, MGC75361, SCC4"	ENSG00000129933	"MAU2 sister chromatid cohesion factor"	Q9Y6X3	19	19320829-19358754	"Predicted intracellular proteins"	"Cell cycle, Cell division, Chromosome partition, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059897			Supported	"Nucleoplasm,Nuclear bodies"	"Intracellular and membrane"	NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	"Nuclear bodies"	"HPA059897: AB_2684154"	"unprognostic (3.53e-1)"	"unprognostic (2.94e-2)"	"unprognostic (1.18e-1)"	"unprognostic (9.57e-3)"	"unprognostic (1.87e-1)"	"prognostic favorable (3.90e-5)"	"unprognostic (1.68e-2)"	"unprognostic (3.49e-3)"	"unprognostic (5.56e-3)"	"unprognostic (3.56e-1)"	"unprognostic (3.98e-3)"	"unprognostic (1.28e-1)"	"unprognostic (4.27e-3)"	"unprognostic (2.42e-2)"	"unprognostic (1.10e-1)"	"unprognostic (6.67e-3)"	"unprognostic (2.96e-2)"	16.2	15.9	15.9	12.6	19.1	21.2	15.8	16.4	19.4	18.8	15.1	17.9	13.1	18.4	11.8	20.2	18.4	10.6	19.6	15.1	15.2	15.1	14.3	14.2	14.6	20.1	17.4	23.4	16.5	13.4	21.1	12.2	18.7	17.6	7.6	10.9	15.5	12.1	36.0	21.7	16.5	11.2	15.7	22.2	15.0	19.7	17.6	17.4	17.0	17.6	12.0	16.5	17.2	26.1	13.6	10.4	18.0	16.1	14.5	15.1	24.9	12.7	12.9	16.8	15.1	14.8	18.9	16.9	26.7	13.7	8.5	15.9	15.5	12.8	7.8	9.0	39.3	13.0	16.5	13.2	16.8	23.7	19.5	16.7	14.4	12.1	13.8	17.4	16.3	15.0	18.0	20.3	11.3	15.5	24.3	32.5	15.8	18.7	29.1	27.1	11.6	18.2	11.8	17.6	26.0	23.8	15.7	16.2	16.1	9.1	14.0	32.9	14.8	25.9	6.0	25.7	19.3	26.1	23.5	16.9	12.8	24.8	19.9	3.1	5.8	4.3	6.0	5.0	6.8	4.6	5.3	5.7	5.1	4.5	5.6	5.4	10.4	6.5	11.1	4.9	5.4	6.1	15.9	19.1	16.4	19.4	15.1	15.2	20.1	17.4	18.7	15.7	17.6	26.1	16.4	19.2	18.3	33.6	17.3	6.2	5.5	8.5	18.8	30.4	13.1	15.2	19.1	11.5	10.5	11.0	54.2	10.4	16.4	15.8	3.9	8.2	9.7	16.5	17.0	13.4	14.4	17.4	26.1	9.4	7.1	13.0	15.8	14.5	10.1	26.0	14.6	8.6	8.8	50.5	31.8	11.9	4.1	13.8	6.4	12.3	15.2	13.9	10.6	14.0	15.4	12.0	20.6	26.7	55.3	11.8	10.7	13.9	12.8	10.5	13.7	6.2	21.0	29.3	6.6	17.2	14.8	31.9	12.6	11.8	9.7	15.2	13.6	21.1	13.1	8.6
MAX	"bHLHd4, bHLHd5, bHLHd6, bHLHd7, bHLHd8"	ENSG00000125952	"MYC associated factor X"	P61244	14	65006174-65102695	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HMC-1: 390.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000328, HPA003474"	Supported		Supported	"Nucleoplasm,Golgi apparatus,Vesicles"		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 51: Myeloid cells - Hemostasis"	Nucleoplasm	"Golgi apparatus, Vesicles"	"CAB000328: AB_2281783, HPA003474: AB_1079317"	"unprognostic (4.50e-3)"	"unprognostic (1.51e-3)"	"unprognostic (4.08e-2)"	"unprognostic (2.87e-1)"	"unprognostic (8.37e-2)"	"unprognostic (2.42e-2)"	"unprognostic (1.13e-3)"	"unprognostic (1.30e-3)"	"unprognostic (1.53e-2)"	"unprognostic (7.36e-3)"	"unprognostic (7.19e-2)"	"unprognostic (1.66e-2)"	"prognostic unfavorable (5.57e-4)"	"unprognostic (2.99e-1)"	"unprognostic (4.68e-2)"	"prognostic favorable (2.12e-4)"	"unprognostic (6.03e-2)"	48.1	36.3	57.4	43.5	63.2	105.1	41.2	74.6	62.9	61.0	44.8	51.1	41.3	51.1	29.2	75.8	67.2	36.2	52.8	55.0	59.4	39.5	36.8	51.6	63.7	65.5	61.8	56.2	29.3	31.3	32.5	39.8	65.0	52.2	31.8	23.6	43.5	38.7	43.8	55.3	51.7	39.5	59.4	66.3	39.4	21.5	62.1	63.7	42.7	54.0	55.1	51.3	68.7	65.3	117.1	40.4	27.8	44.6	73.4	58.0	35.4	39.9	62.3	47.5	58.4	29.1	86.7	88.1	33.1	48.8	45.0	60.4	63.4	52.7	37.3	84.5	40.5	143.4	29.9	32.0	90.9	56.2	390.3	67.6	43.5	42.7	54.9	71.9	54.9	71.8	66.8	42.4	53.1	63.9	140.1	217.6	36.3	71.3	70.6	75.2	42.7	47.3	49.2	38.8	61.8	38.2	49.6	60.6	60.4	25.1	58.0	71.6	69.7	47.8	55.8	42.0	33.6	50.7	43.6	61.7	56.9	56.1	46.0	667.6	141.9	540.8	125.7	126.4	140.1	115.7	147.5	130.5	119.9	114.9	151.1	127.9	305.1	126.9	120.3	114.6	194.0	314.2	57.4	63.2	74.6	62.9	55.0	59.4	65.5	61.8	65.0	59.4	62.1	65.3	45.8	28.9	27.4	31.0	74.5	170.2	66.0	63.3	126.3	28.2	59.8	43.1	27.4	32.9	42.0	18.4	20.9	38.4	79.1	116.3	52.8	38.8	45.5	38.1	43.6	59.9	44.3	40.4	50.7	31.4	43.4	46.7	32.6	36.0	62.8	38.2	71.0	23.8	59.9	47.1	43.3	49.7	38.7	81.8	66.7	115.6	77.9	147.2	56.9	32.8	67.1	47.3	69.0	28.1	60.4	61.6	96.7	60.2	58.0	80.3	100.6	66.4	32.9	16.9	138.1	47.4	76.3	43.2	28.4	84.8	180.6	54.0	83.9	25.4	29.7	76.2
MBD3		ENSG00000071655	"Methyl-CpG binding domain protein 3"	O95983	19	1573596-1592865	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Syncytiotrophoblasts: 121.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB013265	Supported		Supported	Nucleoplasm		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 20: HeLa - Mitochondria"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm		"CAB013265: "	"unprognostic (1.41e-1)"	"unprognostic (2.12e-2)"	"unprognostic (3.44e-2)"	"prognostic favorable (5.08e-4)"	"unprognostic (1.85e-1)"	"unprognostic (1.00e-2)"	"prognostic unfavorable (2.99e-4)"	"unprognostic (2.50e-1)"	"unprognostic (3.12e-1)"	"unprognostic (1.40e-1)"	"prognostic favorable (1.76e-5)"	"unprognostic (1.59e-1)"	"unprognostic (1.19e-1)"	"unprognostic (4.42e-2)"	"unprognostic (5.89e-2)"	"unprognostic (3.17e-1)"	"unprognostic (4.24e-2)"	40.1	46.1	12.7	7.0	11.3	12.8	36.2	18.2	16.5	41.5	7.2	45.8	7.6	46.2	7.6	42.4	40.6	6.6	60.3	13.7	9.0	45.3	59.3	38.3	9.6	12.9	11.7	48.9	32.8	7.4	50.0	9.0	10.7	54.8	6.4	4.1	30.4	7.0	74.0	40.2	34.6	7.4	10.1	49.8	39.0	43.4	12.2	9.0	45.3	4.7	9.1	41.1	33.8	13.0	26.4	56.3	22.5	34.9	21.6	15.0	20.8	20.9	13.5	21.5	19.5	44.9	15.6	49.9	12.1	26.7	7.5	35.8	37.8	23.7	13.0	41.2	36.8	24.6	77.4	27.9	17.6	28.2	24.5	20.3	23.1	35.6	17.4	14.2	25.2	25.7	55.8	34.2	17.6	56.6	32.7	30.5	29.4	12.6	25.5	31.1	23.3	21.2	14.1	50.0	64.5	36.8	25.2	18.3	12.6	12.2	23.5	21.1	20.0	28.9	15.5	65.5	42.1	31.8	39.8	38.6	21.2	37.0	27.7	0.7	0.4	0.1	0.3	0.4	0.3	0.2	0.2	0.2	0.3	0.4	0.3	0.3	0.5	0.3	0.2	0.5	0.1	0.2	12.7	11.3	18.2	16.5	13.7	9.0	12.9	11.7	10.7	10.1	12.2	13.0	21.6	12.8	24.3	14.4	10.6	10.8	8.9	9.4	5.2	22.6	23.8	20.6	20.8	12.8	11.0	11.0	14.6	46.4	17.4	48.1	5.9	15.0	3.1	9.8	20.5	19.8	14.9	14.9	8.4	26.2	42.7	20.0	18.3	16.1	3.8	48.4	24.7	42.6	27.2	18.5	9.2	26.4	14.2	32.0	10.3	8.1	22.4	16.9	5.4	15.9	17.5	40.5	14.4	10.6	12.3	19.3	16.8	25.6	9.7	14.9	20.8	19.1	4.8	11.3	39.5	21.6	18.7	9.2	10.3	11.0	12.8	121.5	10.8	36.0	40.6	8.8
MBD4	MED1	ENSG00000129071	"Methyl-CpG binding domain 4, DNA glycosylase"	O95243	3	129430947-129440179	"Cancer-related genes, Predicted intracellular proteins"	"DNA damage, DNA repair"	"DNA-binding, Hydrolase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002031	Supported		Supported	"Nuclear speckles"		NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 34: Non-specific - Transcription"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 57: B-cells - Immune response"	"Nuclear speckles"		"HPA002031: AB_1079319"	"unprognostic (2.70e-2)"	"unprognostic (3.48e-3)"	"unprognostic (1.18e-2)"	"unprognostic (6.37e-2)"	"unprognostic (4.31e-2)"	"unprognostic (7.11e-2)"	"unprognostic (4.70e-2)"	"unprognostic (3.25e-2)"	"unprognostic (2.02e-2)"	"unprognostic (5.73e-2)"	"prognostic unfavorable (2.18e-4)"	"prognostic unfavorable (4.75e-4)"	"prognostic unfavorable (2.73e-6)"	"unprognostic (9.27e-2)"	"unprognostic (1.59e-2)"	"unprognostic (8.58e-2)"	"unprognostic (3.35e-2)"	18.6	18.4	16.8	34.0	18.4	44.2	21.6	19.6	20.7	33.2	16.8	19.3	23.7	23.3	24.8	16.4	19.3	21.3	25.3	17.0	17.4	25.4	38.0	22.9	66.5	17.5	17.2	30.3	22.9	18.1	19.3	19.7	17.7	18.7	22.9	19.6	19.5	17.8	25.8	23.7	27.5	19.7	17.3	39.2	27.8	17.3	18.4	30.0	19.3	22.3	74.0	18.5	17.5	20.6	46.2	27.4	32.5	36.5	36.8	32.8	37.5	39.0	36.9	36.7	43.3	33.8	30.1	64.6	31.1	24.5	33.7	40.7	25.2	24.1	44.2	37.0	16.6	38.9	32.0	24.6	58.7	71.2	49.2	39.1	33.8	31.2	27.4	36.5	35.1	37.2	43.9	47.1	27.5	43.3	41.4	50.0	28.7	38.8	23.5	38.7	19.2	44.7	40.9	22.7	36.5	20.3	49.3	25.3	42.5	28.0	32.3	62.5	23.6	34.5	26.3	37.6	26.2	31.9	20.9	111.9	29.4	40.1	29.2	80.3	25.0	35.2	31.1	23.1	24.0	116.5	33.2	30.9	21.0	110.8	40.6	33.3	43.0	28.9	30.0	25.2	31.5	25.6	16.8	18.4	19.6	20.7	17.0	17.4	17.5	17.2	17.7	17.3	18.4	20.6	36.5	19.2	52.9	15.3	111.2	17.3	32.5	38.4	29.6	37.0	26.7	29.6	35.9	27.1	36.4	44.1	18.8	49.2	61.4	22.4	45.0	32.1	19.8	49.6	41.2	33.5	33.6	46.3	18.1	69.0	46.2	35.6	55.0	45.0	58.9	33.1	31.4	32.1	71.8	21.9	12.8	27.5	40.7	41.8	24.7	10.6	32.9	48.0	21.4	24.4	62.9	21.2	54.6	14.1	22.0	39.3	23.4	36.5	75.5	31.1	29.4	55.5	39.5	46.3	39.5	39.6	30.9	49.5	71.6	30.4	19.6	37.1	54.2	33.2	26.3	35.6
MBD5	"FLJ11113, KIAA1461"	ENSG00000204406	"Methyl-CpG binding domain protein 5"	Q9P267	2	148021011-148516971	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"Astrocytes: 317.4;Excitatory neurons: 510.1;Inhibitory neurons: 456.0;Microglial cells: 288.6;Oligodendrocyte precursor cells: 604.2;Oligodendrocytes: 438.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035964			Supported	Nucleoplasm,Midbody		Yes	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 6: Brain - Smell perception"	"Cluster 12: NES - Nervous system development"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Nucleoplasm, Midbody"		"HPA035964: AB_2674891"	"unprognostic (1.10e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.12e-1)"	"prognostic unfavorable (3.72e-4)"	"unprognostic (5.81e-2)"	"unprognostic (2.12e-1)"	"unprognostic (2.22e-2)"	"unprognostic (1.65e-1)"	"unprognostic (9.86e-2)"	"unprognostic (7.72e-2)"	"unprognostic (2.00e-1)"	"unprognostic (1.94e-1)"	"unprognostic (2.39e-2)"	"unprognostic (9.12e-2)"	"unprognostic (1.12e-1)"	"unprognostic (6.59e-2)"	"unprognostic (1.82e-1)"	2.5	3.2	3.7	2.2	4.3	2.0	2.3	7.2	5.1	3.1	0.5	5.2	1.8	3.2	1.6	2.6	2.2	3.2	2.8	3.9	3.1	3.4	2.0	2.3	2.4	2.2	2.2	3.7	1.7	4.1	3.8	3.0	2.1	3.0	1.9	5.7	1.8	2.5	2.8	1.9	2.3	2.7	2.0	2.6	2.7	3.1	3.3	4.2	3.4	3.0	2.2	3.7	2.2	4.1	1.1	1.1	4.4	4.1	3.5	3.6	2.9	4.0	3.9	3.1	2.3	2.8	2.9	1.9	0.9	3.4	1.7	0.8	3.1	5.1	4.1	1.6	1.6	3.5	2.8	1.5	2.0	0.6	0.6	2.9	4.1	4.5	3.3	5.0	4.1	2.7	1.9	3.6	4.8	2.7	1.5	2.7	2.2	2.5	1.7	1.6	1.2	0.8	3.2	3.8	2.9	3.5	3.2	1.6	3.0	3.2	2.3	3.4	2.8	3.7	1.8	0.6	1.9	2.4	1.1	1.5	4.8	1.6	3.6	0.8	0.1	0.5	0.3	0.1	0.2	0.2	0.3	0.3	0.2	0.2	0.3	0.4	0.2	0.2	0.3	0.3	0.1	0.1	3.7	4.3	7.2	5.1	3.9	3.1	2.2	2.2	2.1	2.0	3.3	4.1	27.3	16.0	13.7	317.4	23.4	3.8	11.9	4.1	10.8	24.7	16.5	15.0	10.5	11.5	14.8	12.9	37.5	7.3	23.8	5.0	3.9	18.6	94.5	14.8	25.8	15.2	11.5	36.6	510.1	15.7	9.8	15.5	12.2	18.0	3.8	35.9	15.0	8.4	7.0	13.5	456.0	4.9	6.1	16.9	3.3	37.6	18.0	15.1	0.0	288.6	13.6	8.1	24.7	604.2	438.3	20.4	4.6	10.5	22.8	7.8	9.4	14.0	8.5	17.4	6.6	16.5	16.8	15.7	9.4	10.4	3.3	8.5	27.7	23.7	5.8	12.6
MBIP		ENSG00000151332	"MAP3K12 binding inhibitory protein 1"	Q9NS73	14	36298564-36320637	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Alveolar cells type 1: 218.0;Alveolar cells type 2: 316.0"	"Cancer enhanced"	"Detected in all"		"thyroid cancer: 30.5"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003388	Supported		Supported	Nucleoplasm,Nucleoli,Cytosol		NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 11: Alveolar cells - Smell perception"	Cytosol	"Nucleoplasm, Nucleoli"	"HPA003388: AB_1079322"	"unprognostic (8.79e-2)"	"unprognostic (9.92e-2)"	"unprognostic (5.07e-2)"	"unprognostic (8.66e-2)"	"unprognostic (9.85e-2)"	"unprognostic (4.71e-2)"	"unprognostic (2.71e-1)"	"prognostic favorable (1.52e-4)"	"unprognostic (5.24e-2)"	"prognostic favorable (1.14e-4)"	"unprognostic (4.65e-1)"	"unprognostic (9.27e-2)"	"prognostic favorable (1.25e-4)"	"unprognostic (2.95e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.74e-3)"	"unprognostic (1.09e-1)"	16.2	19.4	17.4	12.1	18.5	35.1	24.9	20.7	22.0	27.9	17.9	17.0	16.9	26.6	21.3	16.5	16.5	16.5	14.2	16.7	19.7	26.2	29.0	76.7	17.4	15.9	17.5	32.2	17.6	19.7	22.4	19.1	16.4	18.5	22.2	22.3	15.9	16.3	7.2	28.5	17.3	20.2	17.2	15.6	31.2	18.2	20.0	17.9	81.7	9.3	16.0	15.2	13.5	21.4	29.6	15.4	31.7	32.1	31.3	30.0	24.1	24.8	30.7	32.2	33.6	31.2	28.9	28.0	36.8	32.1	16.8	22.1	33.7	22.9	39.3	40.5	25.5	16.4	14.7	55.0	33.9	33.8	17.5	30.8	35.1	21.1	27.2	33.2	20.4	38.3	28.4	33.8	24.2	28.8	32.5	27.7	26.9	25.2	44.6	15.4	27.7	19.5	37.2	22.7	47.3	18.8	20.4	19.5	33.4	27.3	31.9	21.6	16.0	35.6	23.2	26.3	26.0	27.8	34.5	44.0	13.6	17.3	25.3	2.0	12.6	3.0	14.6	9.9	18.5	16.4	17.6	18.0	12.8	12.3	22.6	18.5	7.0	12.9	8.1	14.5	23.6	13.3	17.4	18.5	20.7	22.0	16.7	19.7	15.9	17.5	16.4	17.2	20.0	21.4	16.0	218.0	316.0	18.3	14.9	90.2	30.7	41.5	22.2	24.9	15.3	23.0	10.7	10.0	106.7	25.8	2.1	24.7	12.2	16.1	58.7	21.2	4.2	20.9	28.2	18.3	31.5	9.7	21.2	19.0	21.1	29.7	13.3	35.6	13.3	30.2	16.1	25.2	18.7	92.5	24.8	15.5	20.3	9.5	15.4	4.2	32.0	14.5	21.4	9.4	11.5	29.0	12.3	31.7	27.0	17.8	18.6	27.1	18.9	29.0	18.9	49.6	34.9	24.1	13.1	18.0	27.8	50.1	35.5	17.9	65.5	19.8	20.6	25.5	21.1	21.4
MBNL1	"EXP, EXP35, EXP40, EXP42, KIAA0428, MBNL"	ENSG00000152601	"Muscleblind like splicing regulator 1"	Q9NR56	3	152243828-152465780	"Disease related genes, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding	"Corneal dystrophy, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Microglial cells: 537.7;Oligodendrocytes: 471.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016398, HPA035098"	Enhanced		Enhanced	Nucleoplasm,Cytosol		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 52: Non-specific - Ribosome"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm	Cytosol	"CAB016398: AB_784435, HPA035098: AB_2674461"	"unprognostic (5.46e-3)"	"unprognostic (6.01e-3)"	"unprognostic (1.94e-3)"	"unprognostic (1.99e-1)"	"unprognostic (3.44e-2)"	"unprognostic (5.82e-3)"	"unprognostic (2.75e-2)"	"unprognostic (9.49e-3)"	"unprognostic (5.18e-2)"	"unprognostic (1.70e-2)"	"unprognostic (2.78e-3)"	"unprognostic (1.01e-1)"	"prognostic unfavorable (2.90e-7)"	"unprognostic (7.53e-3)"	"unprognostic (6.15e-2)"	"unprognostic (1.77e-1)"	"unprognostic (2.98e-1)"	116.4	35.8	18.2	105.0	24.9	90.4	48.1	22.9	22.3	76.9	18.9	69.0	43.6	68.0	30.1	65.3	38.4	75.2	63.2	18.7	23.0	31.5	47.6	78.1	138.4	25.5	20.1	45.1	24.3	26.5	11.8	29.9	26.0	55.1	71.1	17.7	32.3	66.0	188.8	61.5	58.3	116.5	25.0	92.3	40.5	14.9	25.2	108.4	31.8	131.0	135.1	78.4	32.7	32.5	133.8	107.8	17.3	38.9	132.5	135.8	12.7	163.3	131.5	105.6	87.8	48.0	76.3	136.3	81.3	230.8	32.8	59.7	32.1	94.5	155.0	106.9	43.7	149.3	52.2	22.7	73.8	180.5	104.5	63.8	50.2	121.9	94.0	80.8	219.5	54.1	77.3	180.5	103.6	45.9	169.0	66.0	7.2	38.9	85.4	170.5	53.0	171.6	53.7	66.3	13.8	15.7	71.1	38.2	69.8	6.2	53.1	270.5	186.6	143.6	55.1	96.4	142.7	186.9	115.9	154.6	83.8	220.6	79.1	95.3	53.7	90.1	79.4	61.7	84.4	56.2	64.5	66.5	70.1	49.7	80.6	70.7	78.4	79.6	54.7	24.9	62.6	104.3	18.2	24.9	22.9	22.3	18.7	23.0	25.5	20.1	26.0	25.0	25.2	32.5	175.5	150.6	193.7	179.2	252.1	213.6	49.0	25.9	156.0	28.5	51.8	48.0	179.8	52.9	89.5	38.6	64.6	26.1	266.0	164.7	21.5	36.0	2.6	64.0	92.2	142.9	47.3	160.2	258.6	63.6	9.2	122.9	78.0	68.5	162.6	31.5	90.0	91.5	60.9	32.0	185.5	68.8	14.2	216.4	195.5	9.7	89.5	235.0	103.2	537.7	249.4	18.2	230.7	224.7	471.9	57.3	90.3	71.5	181.3	61.2	121.4	42.2	63.1	84.1	98.6	102.7	145.6	4.3	12.7	149.4	243.6	14.8	340.1	46.8	80.7	50.1
MBNL2	"MBLL, MBLL39"	ENSG00000139793	"Muscleblind like splicing regulator 2"	Q5VZF2	13	97221434-97394120	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 325.5;Oligodendrocytes: 702.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA062685			Supported	Nucleoplasm		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 15: Liver - Metabolism"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Nucleoplasm		"HPA062685: AB_2684834"	"unprognostic (8.02e-2)"	"unprognostic (7.78e-2)"	"unprognostic (6.37e-2)"	"unprognostic (5.46e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.58e-1)"	"unprognostic (3.54e-1)"	"unprognostic (1.44e-3)"	"unprognostic (1.08e-1)"	"unprognostic (1.57e-1)"	"prognostic unfavorable (1.99e-4)"	"unprognostic (1.00e-1)"	"unprognostic (5.26e-3)"	"unprognostic (1.01e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.73e-1)"	"unprognostic (9.17e-2)"	64.4	64.6	34.6	20.7	52.0	8.5	35.1	51.4	58.5	38.7	18.3	31.8	21.1	35.0	16.0	38.2	21.7	44.8	36.8	32.9	38.6	36.9	94.9	29.6	20.8	47.5	46.6	59.3	46.4	25.8	23.8	52.6	49.0	31.9	24.5	50.1	41.4	38.4	41.6	18.9	19.1	41.5	45.2	19.8	30.5	14.4	42.2	24.2	36.6	87.9	24.2	34.9	24.5	80.6	34.7	12.1	13.5	13.7	68.9	36.1	1.3	77.8	38.4	34.8	35.3	14.8	49.8	11.7	31.4	106.3	39.5	48.6	6.1	34.1	44.6	31.2	5.9	14.2	26.4	34.7	101.7	1.6	12.4	37.9	56.7	28.6	54.7	39.5	67.4	15.5	18.1	6.0	17.6	9.2	8.2	4.9	0.4	4.2	20.2	3.8	27.9	9.8	46.2	41.1	17.3	28.7	45.0	44.6	76.2	30.3	18.9	2.0	21.1	5.2	16.1	9.7	16.2	16.0	4.3	3.1	33.1	4.0	93.2	15.0	5.4	8.0	8.1	7.1	10.3	7.6	7.3	7.4	5.7	6.2	6.3	8.6	0.8	4.9	5.4	4.7	8.3	6.2	34.6	52.0	51.4	58.5	32.9	38.6	47.5	46.6	49.0	45.2	42.2	80.6	153.8	83.3	45.1	148.9	52.3	70.2	27.4	15.7	129.1	23.7	50.7	49.9	69.8	50.1	40.1	29.5	47.9	25.3	31.6	22.6	19.6	26.6	3.1	59.1	113.8	66.6	48.6	24.8	325.5	42.7	78.0	75.7	83.6	50.0	17.7	40.5	45.3	78.8	14.4	47.1	108.3	29.0	8.2	32.1	30.6	9.1	70.5	31.2	56.9	144.3	19.5	84.8	18.6	144.3	702.4	54.0	14.5	44.8	169.1	22.3	16.3	40.1	54.5	112.6	46.0	29.9	80.8	1.1	1.0	54.2	48.6	25.0	40.8	28.2	17.9	30.3
MBOAT4	"FKSG89, GOAT, OACT4"	ENSG00000177669	"Membrane bound O-acyltransferase domain containing 4"	Q96T53	8	30131671-30144665	"Metabolic proteins, Predicted membrane proteins, Transporters"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"pancreas: 3.6;stomach 1: 3.7"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 3.6;Cholangiocytes: 12.8;Ductal cells: 3.1;Enteroendocrine cells: 3.5;Excitatory neurons: 2.4;Inhibitory neurons: 3.1;Oligodendrocyte precursor cells: 3.0;Oligodendrocytes: 5.4"	"Cancer enhanced"	"Detected in some"		"pancreatic cancer: 1.7"	"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"Hep G2: 3.1;OE19: 3.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA044509			Supported	"Golgi apparatus"		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 25: Pancreas - Digestion"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 41: Macrophages - Immune response"	"Golgi apparatus"		"HPA044509: AB_2678966"	"unprognostic (4.35e-3)"	"unprognostic (2.08e-1)"	"unprognostic (2.55e-1)"	"unprognostic (3.99e-1)"	"unprognostic (1.03e-2)"	"unprognostic (1.76e-2)"	"unprognostic (1.85e-3)"	"unprognostic (4.48e-2)"	"unprognostic (2.56e-1)"	"unprognostic (1.07e-1)"	"unprognostic (6.30e-2)"	"unprognostic (7.02e-2)"	"unprognostic (4.24e-6)"	"unprognostic (9.87e-3)"	"unprognostic (1.58e-1)"	"unprognostic (2.18e-1)"	"unprognostic (3.66e-2)"	0.1	0.5	0.1	0.2	0.1	0.5	0.1	0.1	0.1	0.1	0.0	0.1	0.4	0.1	0.0	0.1	1.7	0.9	0.2	0.1	0.1	0.1	0.4	0.3	0.4	0.1	0.1	0.1	3.6	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.4	0.0	0.0	0.4	3.7	0.2	0.1	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.1	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.8	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.1	0.1	0.0	3.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.2	0.0	0.0	0.2	0.1	0.0	3.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.4	0.3	0.1	0.1	0.1	0.6	0.1	0.4	0.7	0.0	0.4	0.6	0.2	1.0	0.7	1.2	0.8	0.8	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	12.8	0.0	0.0	0.0	0.0	0.1	0.1	0.0	3.1	1.1	0.0	0.0	0.0	3.5	0.0	2.4	0.0	0.0	0.0	0.0	0.4	0.0	0.3	0.4	0.0	0.0	0.0	3.1	0.0	0.0	0.6	0.0	0.6	0.0	0.2	0.0	1.0	0.0	0.0	0.0	3.0	5.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
MC5R		ENSG00000176136	"Melanocortin 5 receptor"	P33032	18	13824149-13827323	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"epididymis: 2.4;lymphoid tissue: 1.0"	"Cell type enriched"	"Detected in single"	17	"Squamous epithelial cells: 1.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"U-138 MG: 1.8"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"HPA042365, HPA058088"	Approved		Supported	"Plasma membrane"		NA	NA				"Cluster 68: Epididymis - Unknown function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 61: Squamous epithelial cells - Keratinization"	"Plasma membrane"		"HPA042365: AB_2677961, HPA058088: "	"unprognostic (1.57e-2)"				"unprognostic (1.37e-1)"			"unprognostic (8.77e-2)"	"unprognostic (7.10e-2)"		"unprognostic (2.64e-2)"	"unprognostic (1.30e-2)"		"unprognostic (9.04e-3)"	"unprognostic (1.54e-1)"			0.1	0.0	0.1	0.0	0.2	0.0	0.0	0.1	0.2	0.0	0.2	0.0	0.0	0.0	2.4	0.5	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.4	0.3	1.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	1.8	0.4	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.2	0.1	0.3	0.1	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0
MCAT	"fabD, FASN2C, MCT, MCT1, MT, NET62"	ENSG00000100294	"Malonyl-CoA-acyl carrier protein transacylase"	Q8IVS2	22	43132209-43143398	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Proximal tubular cells: 94.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003122, HPA035471"	Approved		Supported	Mitochondria		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Mitochondria		"HPA003122: AB_2666795, HPA035471: AB_10670590"	"unprognostic (1.05e-1)"	"unprognostic (1.57e-2)"	"unprognostic (1.39e-2)"	"prognostic favorable (5.53e-4)"	"unprognostic (3.52e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.36e-3)"	"unprognostic (4.71e-2)"	"unprognostic (5.13e-2)"	"unprognostic (2.94e-1)"	"unprognostic (1.32e-1)"	"unprognostic (9.86e-2)"	"prognostic favorable (2.18e-4)"	"prognostic favorable (3.89e-4)"	"unprognostic (3.67e-2)"	"unprognostic (1.76e-1)"	"unprognostic (3.08e-1)"	10.2	21.6	11.8	5.7	12.5	9.0	11.7	11.1	14.4	9.2	17.1	12.5	6.7	11.5	9.9	15.5	14.3	6.6	18.2	13.6	12.5	25.1	22.7	8.7	5.1	11.9	11.6	11.3	15.0	17.6	16.6	4.6	12.2	13.5	7.1	7.2	13.3	6.6	21.9	14.9	8.6	5.8	10.6	8.1	14.8	17.1	12.0	7.8	13.1	10.1	6.1	10.8	10.3	11.0	14.1	18.2	12.6	22.3	10.4	11.0	12.9	15.4	13.6	20.3	18.8	18.3	14.1	23.6	15.5	11.5	11.5	23.3	24.1	20.4	15.1	8.2	71.3	8.8	21.6	20.6	16.6	42.3	10.3	8.3	19.5	19.9	15.7	11.8	14.7	14.1	21.1	9.4	10.1	26.0	19.9	46.0	12.3	19.8	31.8	26.0	12.4	37.7	25.7	12.1	16.6	8.8	16.6	32.0	24.3	5.7	16.5	27.1	8.9	8.8	17.4	19.2	22.0	16.6	18.4	17.1	19.0	16.0	10.8	0.0	11.4	0.8	8.8	11.1	11.5	9.4	9.7	11.4	16.4	12.4	10.9	7.9	2.9	14.5	6.9	16.2	7.0	7.3	11.8	12.5	11.1	14.4	13.6	12.5	11.9	11.6	12.2	10.6	12.0	11.0	8.0	6.4	6.8	3.9	6.9	17.8	12.3	19.6	5.7	11.2	13.6	11.4	9.5	31.5	10.6	20.2	0.0	18.7	5.7	12.3	50.9	32.0	23.4	28.5	8.3	9.4	14.5	17.9	3.6	21.8	11.9	8.8	12.2	9.2	3.8	10.8	17.5	22.3	15.5	6.7	3.7	14.7	14.2	6.3	4.3	11.8	7.5	6.1	7.2	0.0	8.2	12.5	4.1	1.5	2.1	23.7	15.2	16.6	5.6	17.3	12.5	94.3	27.7	9.6	19.7	11.2	10.0	30.0	11.7	9.0	21.0	9.2	4.8	30.5	22.4	11.5
MCC		ENSG00000171444	"MCC regulator of WNT signaling pathway"	P23508	5	113022099-113488823	"Predicted intracellular proteins"	"Wnt signaling pathway"		"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ovary: 70.6"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 170.7;Bipolar cells: 115.5;Inhibitory neurons: 128.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"plasmacytoid DC: 2.7"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 52.9;hTCEpi: 34.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037390, HPA037391"	Approved	Approved	Supported	"Nucleoplasm,Cytosol,Cytoplasmic bodies"		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 56: Bipolar cells - Visual perception"	"Nucleoplasm, Cytosol"	"Cytoplasmic bodies"	"HPA037390: AB_2675451, HPA037391: AB_10671248"	"unprognostic (6.60e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.23e-1)"	"unprognostic (8.40e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.20e-1)"	"unprognostic (5.21e-2)"	"unprognostic (9.59e-2)"	"unprognostic (8.02e-3)"	"unprognostic (1.56e-1)"	"unprognostic (1.74e-1)"	"prognostic favorable (6.19e-4)"	"unprognostic (1.70e-3)"	"unprognostic (3.34e-1)"	"unprognostic (2.47e-2)"	"unprognostic (2.90e-1)"	10.0	2.9	8.2	4.8	11.6	0.4	8.4	12.4	8.8	18.1	1.7	3.7	2.3	12.1	5.1	12.8	12.1	5.0	12.7	6.4	15.0	5.2	18.9	6.2	4.6	15.7	24.5	70.6	3.1	32.9	3.1	10.7	11.0	10.3	3.1	14.6	7.9	12.8	8.3	20.8	2.9	9.1	11.6	5.0	4.9	3.5	18.9	4.7	4.3	6.3	6.4	12.4	11.9	8.2	0.8	0.2	13.5	1.0	10.9	9.8	12.8	2.2	5.7	2.4	2.8	0.5	12.5	0.1	14.3	1.0	6.6	15.7	8.2	52.9	1.2	4.6	5.0	0.1	4.9	3.6	3.3	0.7	0.3	12.9	34.5	6.7	24.2	12.4	16.0	1.6	0.1	20.3	5.2	1.0	0.2	0.3	7.3	0.0	1.0	0.2	11.8	3.5	0.2	30.7	5.7	12.8	11.2	0.1	29.8	4.6	3.7	0.1	19.3	8.7	7.9	14.5	4.3	5.9	0.1	0.0	24.6	0.1	9.7	0.0	0.1	0.0	0.2	0.1	0.6	0.1	0.2	0.2	0.0	0.0	0.1	0.2	0.5	0.0	0.0	2.7	0.7	0.0	8.2	11.6	12.4	8.8	6.4	15.0	15.7	24.5	11.0	11.6	18.9	8.2	50.2	0.0	1.1	170.7	1.8	37.6	27.3	27.3	23.9	115.5	11.7	8.8	16.8	11.5	10.4	3.7	56.3	0.8	8.5	0.2	0.0	3.5	12.5	11.5	50.1	32.1	4.8	0.0	29.5	1.4	2.4	30.2	4.1	25.4	0.0	22.9	24.7	56.9	2.3	37.0	128.7	0.2	12.2	2.9	12.3	34.3	21.1	2.2	16.0	72.1	3.2	7.1	3.1	34.7	13.2	4.6	1.3	27.1	5.4	8.5	0.0	2.2	7.1	9.2	0.0	22.0	13.1	7.9	9.3	33.4	47.2	1.2	8.0	24.9	0.5	16.0
MCCC1	MCCA	ENSG00000078070	"Methylcrotonoyl-CoA carboxylase 1"	Q96RQ3	3	183015218-183116075	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Ligase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"T-47d: 153.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008310	Approved		Supported	Mitochondria	"Intracellular and membrane"	NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 81: Kidney & Liver - Metabolism"	"Cluster 6: T47d - Mammary gland"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Mitochondria		"HPA008310: AB_1853620"	"unprognostic (4.01e-2)"	"unprognostic (1.83e-3)"	"unprognostic (2.05e-2)"	"unprognostic (2.59e-3)"	"unprognostic (3.46e-2)"	"unprognostic (4.16e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.10e-3)"	"unprognostic (2.57e-3)"	"unprognostic (9.82e-2)"	"unprognostic (9.74e-2)"	"unprognostic (7.65e-2)"	"prognostic favorable (3.68e-4)"	"unprognostic (4.73e-1)"	"unprognostic (2.21e-1)"	"unprognostic (2.95e-1)"	"unprognostic (1.36e-1)"	37.9	22.6	9.5	9.5	10.9	13.9	33.2	9.9	13.4	12.3	13.8	17.4	16.1	10.1	14.6	17.6	12.2	11.9	34.2	9.2	9.3	58.8	59.3	17.9	11.7	9.5	9.1	17.2	31.2	18.7	8.4	6.3	10.6	15.1	18.6	10.8	18.0	13.4	21.9	12.2	13.8	10.6	9.3	11.8	21.7	9.1	11.1	16.0	18.9	26.3	15.5	26.5	9.4	13.3	43.1	16.5	10.3	10.6	42.6	19.1	20.4	19.5	26.4	21.1	23.5	22.9	17.1	47.6	31.0	17.2	35.8	22.0	15.4	12.9	26.4	16.6	17.0	40.0	18.3	23.9	28.7	27.5	22.0	21.6	14.5	10.0	23.3	14.0	28.6	40.7	22.7	24.7	23.6	35.4	27.1	15.9	11.2	66.3	17.9	22.4	22.6	60.1	32.2	67.2	22.0	16.4	75.3	100.1	21.1	10.7	153.9	37.8	14.0	15.8	12.5	12.8	28.6	24.3	48.8	48.2	16.8	38.4	15.2	14.4	13.3	25.0	10.7	15.6	12.3	17.9	14.1	11.8	26.6	15.4	14.7	13.1	2.1	25.4	16.8	17.3	9.6	10.7	9.5	10.9	9.9	13.4	9.2	9.3	9.5	9.1	10.6	9.3	11.1	13.3	6.2	9.6	53.9	44.7	14.6	7.0	20.1	17.9	15.9	13.0	10.6	9.5	32.8	31.5	20.2	27.6	10.4	35.4	6.3	7.2	33.2	25.3	5.4	11.0	10.2	6.6	6.0	10.9	66.6	17.2	5.4	10.3	21.4	21.9	7.6	19.0	6.1	36.5	16.5	8.4	56.9	13.6	16.2	11.1	8.6	5.5	8.7	10.5	7.2	44.0	10.5	12.0	4.1	47.7	61.6	13.4	15.8	10.5	12.5	10.4	13.5	40.6	21.4	11.2	6.6	11.6	9.6	8.1	4.4	22.3	5.8	28.3	10.1	24.3	20.5	21.7
MCEMP1	"C19orf59, MGC132456"	ENSG00000183019	"Mast cell expressed membrane protein 1"	Q8IX19	19	7676628-7679826	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	11	"bone marrow: 65.9;lung: 74.2;lymphoid tissue: 35.1"	"Cell type enriched"	"Detected in some"	4	"Macrophages: 147.5"	"Cancer enhanced"	"Detected in many"		"lung cancer: 3.7"	"Region enhanced"	"Detected in single"		"cerebral cortex: 2.1"	"Group enriched"	"Detected in some"	5	"classical monocyte: 102.1;neutrophil: 45.9"	"Group enriched"	"Detected in many"	5	"granulocytes: 45.9;monocytes: 102.1"	"Group enriched"	"Detected in some"	6	"THP-1: 53.7;U-937: 166.6"	"Region enhanced"	"Detected in single"		"cerebellum: 1.3"	"Not detected"	"Not detected"			HPA014731	Enhanced		Supported	"Plasma membrane"		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 32: U-937 - Innate immune response"	"Cluster 11: Alveolar cells - Smell perception"	"Plasma membrane"		"HPA014731: AB_1845619"	"unprognostic (4.84e-2)"	"unprognostic (9.81e-4)"	"unprognostic (2.41e-1)"	"unprognostic (4.36e-2)"	"unprognostic (8.85e-3)"	"unprognostic (2.62e-3)"	"unprognostic (5.57e-3)"	"unprognostic (1.42e-1)"	"unprognostic (2.19e-1)"	"unprognostic (4.36e-2)"	"unprognostic (1.77e-2)"	"unprognostic (3.50e-1)"	"unprognostic (2.69e-5)"	"unprognostic (1.15e-2)"	"unprognostic (7.37e-2)"	"unprognostic (1.93e-2)"	"unprognostic (7.95e-2)"	4.0	0.5	0.0	19.7	0.0	65.9	0.5	0.0	2.1	0.1	0.0	0.4	0.2	0.1	0.0	0.5	1.7	0.6	1.3	0.0	0.0	0.7	1.5	74.2	0.1	0.0	0.0	0.2	0.7	0.0	0.2	1.8	0.9	0.5	0.1	0.0	0.8	0.0	0.3	0.1	0.6	5.1	0.0	35.1	0.9	0.2	0.7	0.9	0.4	1.5	0.1	4.7	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	8.4	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	2.5	0.0	0.0	0.0	1.4	17.7	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.2	4.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	53.7	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	166.6	0.0	0.0	102.1	2.8	0.2	6.0	0.0	0.0	0.3	0.0	14.9	0.0	0.0	0.3	45.9	0.6	0.4	0.9	0.2	38.3	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.9	0.0	0.7	0.0	0.4	19.2	34.5	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1.5	11.2	0.0	0.0	0.2	0.3	0.1	0.0	0.0	0.1	0.0	0.0	2.2	0.0	3.6	0.0	0.0	1.0	2.9	0.0	0.0	7.6	0.0	0.0	0.3	28.8	0.0	0.0	0.0	0.0	28.3	0.0	0.1	0.0	147.5	0.0	0.0	26.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.0	0.0	0.2	5.1	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.8	2.9	0.0	0.0	0.1
MCIDAS	"IDAS, MCI, MCIN"	ENSG00000234602	"Multiciliate differentiation and DNA synthesis associated cell cycle protein"	D6RGH6	5	55219564-55227315	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cell cycle, Cilium biogenesis/degradation, Transcription, Transcription regulation"	Activator	"Ciliopathy, Disease variant, Primary ciliary dyskinesia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in single"		"parathyroid gland: 2.8"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 3.2;Collecting duct cells: 1.8;Endometrial ciliated cells: 1.2;Respiratory ciliated cells: 3.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BEWO: 4.9;HeLa: 6.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA049981, HPA058073"	Uncertain		Supported	"Nuclear bodies"		NA	NA				"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 20: HeLa - Mitochondria"	"Cluster 49: Ciliated cells - Cilium organization"	"Nuclear bodies"		"HPA049981: , HPA058073: AB_2683596"	"unprognostic (3.11e-2)"	"unprognostic (7.50e-4)"	"unprognostic (2.48e-1)"	"unprognostic (2.89e-2)"	"unprognostic (1.76e-1)"	"unprognostic (3.57e-2)"	"unprognostic (2.41e-3)"	"unprognostic (1.50e-2)"	"unprognostic (1.16e-1)"	"unprognostic (3.63e-2)"	"unprognostic (3.17e-2)"	"unprognostic (4.67e-1)"	"unprognostic (2.90e-3)"	"unprognostic (4.17e-2)"	"unprognostic (1.79e-1)"	"unprognostic (2.88e-2)"	"unprognostic (2.70e-2)"	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.1	0.2	0.0	0.1	0.0	0.2	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.2	0.0	0.0	0.8	0.0	0.0	0.1	0.0	0.0	2.9	0.4	0.0	0.6	0.0	0.0	4.9	0.0	0.0	0.4	0.7	4.0	4.4	0.0	0.4	0.0	1.2	0.7	2.9	0.2	0.0	0.2	4.0	0.0	6.6	0.0	0.0	1.0	0.0	0.0	0.2	0.0	0.0	0.8	0.0	1.9	1.4	0.0	0.0	1.6	0.0	0.1	0.2	0.7	2.2	0.8	1.5	0.0	1.7	2.6	1.3	0.0	2.1	0.5	2.2	0.0	4.0	0.4	0.0	0.0	3.4	0.2	0.1	3.3	4.2	0.0	0.0	3.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.7	0.0	0.9	1.8	0.0	0.1	0.0	0.0	0.0	0.1	0.4	1.2	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.1	0.6	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1
MCM10	"CNA43, DNA43, PRO2249"	ENSG00000065328	"Minichromosome maintenance 10 replication initiation factor"	Q7L590	10	13161558-13211110	"Predicted intracellular proteins"	"DNA damage, DNA replication"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 9.2;lymphoid tissue: 8.1"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 11.8;Erythroid cells: 23.5;Extravillous trophoblasts: 20.9;Plasma cells: 15.3;Spermatocytes: 15.8;Spermatogonia: 12.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA045899, HPA071952"	Approved		Supported	Nucleoplasm,Nucleoli		Yes	Yes			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Nucleoplasm, Nucleoli"		"HPA045899: AB_10960529, HPA071952: AB_2686477"	"unprognostic (9.76e-3)"	"unprognostic (1.60e-1)"	"unprognostic (2.31e-1)"	"unprognostic (2.29e-3)"	"unprognostic (1.41e-1)"	"unprognostic (6.58e-3)"	"unprognostic (1.78e-8)"	"unprognostic (2.42e-3)"	"unprognostic (3.51e-2)"	"unprognostic (6.26e-2)"	"unprognostic (2.78e-4)"	"unprognostic (7.81e-2)"	"unprognostic (0.00e+0)"	"unprognostic (8.87e-2)"	"unprognostic (1.29e-1)"	"unprognostic (9.73e-2)"	"unprognostic (1.05e-1)"	1.2	0.1	0.0	3.3	0.1	9.2	0.8	0.1	0.2	0.4	0.1	1.7	1.5	0.4	0.1	1.9	0.2	0.2	0.1	0.0	0.0	0.1	0.7	0.3	4.8	0.0	0.1	0.2	0.1	0.2	0.1	2.1	0.1	0.1	2.2	0.1	0.3	0.0	0.5	1.1	1.2	0.8	0.0	1.0	0.8	1.5	0.2	8.1	0.3	0.1	4.5	0.6	0.6	0.1	38.0	42.0	48.6	36.9	1.6	2.9	21.2	38.7	5.9	42.7	44.0	41.3	26.4	56.7	17.1	9.9	15.7	43.3	69.0	22.8	39.2	29.7	32.9	70.9	17.6	27.7	0.0	36.6	30.8	0.6	0.8	43.3	4.0	3.5	14.0	45.0	85.2	37.6	23.4	34.0	87.7	15.7	28.9	36.3	10.3	68.3	43.0	34.6	9.8	13.7	9.7	36.6	31.3	22.0	5.9	25.2	27.7	24.9	8.6	27.0	50.3	41.0	42.4	11.7	49.0	74.3	17.2	39.6	21.5	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.4	0.9	0.3	0.1	0.1	0.7	0.4	0.1	0.1	0.0	0.4	0.4	0.0	0.1	0.1	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.2	0.1	1.7	0.0	0.0	0.0	1.8	1.7	0.4	0.8	0.0	0.0	0.8	0.5	2.4	0.0	0.8	0.0	0.0	11.8	0.8	2.4	0.0	0.4	1.0	0.3	1.2	1.4	0.0	23.5	0.4	0.2	20.9	1.8	1.1	1.0	0.0	7.2	0.0	0.2	5.3	0.0	0.4	1.2	2.0	0.6	0.4	1.3	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.8	0.1	0.4	15.3	0.2	0.2	0.0	0.0	0.0	0.0	0.4	6.4	15.8	12.9	3.6	0.4	3.4	1.2	0.8	3.1	0.4
MCM3		ENSG00000112118	"Minichromosome maintenance complex component 3"	P25205	6	52264014-52284881	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, DNA replication"	"DNA-binding, Helicase, Hydrolase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 122.7;Erythroid cells: 92.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002162, HPA004789, HPA004790"	Supported		Supported	Nucleoplasm		NA	Yes		150000	"Cluster 35: T-regs - Unknown function"	"Cluster 63: T-cells - Adaptive immune response"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"CAB002162: AB_564115, HPA004789: AB_1079336, HPA004790: AB_1079335"	"unprognostic (9.14e-2)"	"prognostic favorable (1.89e-4)"	"unprognostic (2.37e-1)"	"unprognostic (1.53e-2)"	"unprognostic (2.14e-1)"	"unprognostic (5.48e-3)"	"prognostic unfavorable (1.40e-4)"	"unprognostic (1.36e-1)"	"prognostic unfavorable (4.40e-5)"	"unprognostic (1.01e-3)"	"unprognostic (2.96e-2)"	"unprognostic (1.15e-1)"	"unprognostic (8.35e-2)"	"unprognostic (1.16e-2)"	"unprognostic (1.00e-1)"	"prognostic favorable (3.13e-5)"	"unprognostic (1.34e-2)"	24.3	15.9	12.8	41.5	13.6	55.5	29.1	13.7	13.7	27.5	13.4	32.9	19.6	30.8	23.8	33.4	29.2	16.4	25.4	11.9	12.7	27.5	18.8	21.4	68.8	14.1	13.6	31.9	17.0	28.9	10.8	40.0	14.1	19.7	39.3	19.3	19.2	30.7	16.0	32.2	29.3	37.0	14.5	31.3	24.1	21.1	14.0	81.1	18.3	17.7	78.5	28.1	24.5	13.9	187.9	121.7	208.0	196.9	43.9	39.4	136.1	135.8	103.7	226.6	230.3	251.6	99.2	202.8	132.5	79.7	147.8	145.4	277.4	165.9	226.9	230.0	261.4	383.6	233.2	358.2	11.8	381.7	150.8	23.7	38.1	166.6	46.2	55.6	117.3	240.4	318.1	452.9	118.3	123.8	386.9	293.5	173.1	369.8	84.8	338.3	317.0	271.2	101.1	195.8	210.3	160.5	142.2	81.1	125.3	289.4	159.7	266.9	60.5	153.5	163.6	160.8	206.4	132.9	163.5	356.4	132.2	323.8	184.0	30.5	18.3	27.3	50.0	31.3	42.8	47.7	49.9	50.3	30.0	41.2	47.6	51.2	2.6	55.0	18.3	19.0	71.6	46.9	12.8	13.6	13.7	13.7	11.9	12.7	14.1	13.6	14.1	14.5	14.0	13.9	24.3	22.4	12.3	3.3	26.4	19.2	20.0	24.9	12.5	16.1	14.1	17.1	19.9	7.2	19.2	22.0	4.2	122.7	18.6	10.9	13.7	30.9	1.1	9.6	16.7	30.9	7.3	92.6	2.5	20.2	63.6	22.3	15.8	15.1	37.4	48.3	15.0	10.5	36.0	0.0	2.1	20.4	8.2	10.1	7.5	3.6	27.1	12.1	7.2	8.4	12.5	17.8	34.0	2.5	6.1	17.3	10.5	21.1	37.6	10.9	7.3	7.5	17.0	16.0	6.6	16.8	27.9	22.5	64.0	24.5	10.1	27.4	26.0	19.0	37.1	13.9
MCM3AP	"GANP, KIAA0572, Map80, SAC3"	ENSG00000160294	"Minichromosome maintenance complex component 3 associated protein"	O60318	21	46235133-46286297	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	"Immunity, mRNA transport, Protein transport, Translocation, Transport"	"Acyltransferase, Transferase"	"Mental retardation, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021527, HPA032103"	Approved		Supported	"Nucleoplasm,Nuclear membrane,Cytosol"		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 59: Non-specific - Transcription"	"Nuclear membrane, Cytosol"	Nucleoplasm	"HPA021527: AB_1853626, HPA032103: AB_2674152"	"unprognostic (1.75e-1)"	"unprognostic (1.31e-1)"	"unprognostic (2.31e-1)"	"unprognostic (2.20e-1)"	"unprognostic (1.72e-1)"	"unprognostic (6.31e-3)"	"unprognostic (1.48e-2)"	"unprognostic (2.06e-1)"	"unprognostic (4.17e-2)"	"unprognostic (4.76e-3)"	"prognostic favorable (2.05e-4)"	"unprognostic (1.96e-1)"	"unprognostic (2.81e-3)"	"unprognostic (1.04e-1)"	"unprognostic (1.05e-1)"	"unprognostic (3.85e-3)"	"unprognostic (2.28e-1)"	16.8	12.0	10.0	20.3	11.5	19.7	13.6	8.9	10.7	14.7	17.0	15.1	14.0	16.5	8.3	14.3	15.2	14.2	15.1	8.5	7.8	13.0	9.7	16.0	21.0	10.8	10.4	17.6	15.4	16.9	9.2	16.3	9.5	14.2	15.0	12.8	13.7	13.4	41.3	13.8	16.1	17.1	9.4	19.6	15.4	14.1	11.0	21.7	16.0	28.7	21.5	13.6	11.2	14.6	38.0	36.3	41.8	45.5	33.1	41.4	38.0	40.8	48.1	37.1	30.2	33.1	21.9	53.6	32.9	43.2	40.3	21.9	55.9	34.0	32.7	55.7	50.8	87.9	35.0	25.9	29.6	40.6	47.7	31.7	28.7	51.2	35.2	25.4	40.7	31.7	107.3	39.6	43.3	21.1	43.5	26.8	72.3	40.0	30.2	56.3	26.6	48.9	17.8	34.1	35.2	37.6	52.4	33.7	39.0	31.5	46.0	41.2	51.6	39.1	29.7	33.1	31.0	71.8	86.2	33.0	35.3	38.0	51.8	0.6	2.0	1.6	2.3	1.9	2.4	1.1	1.3	2.6	1.9	1.6	1.2	1.3	1.2	1.1	1.1	1.6	1.8	2.1	10.0	11.5	8.9	10.7	8.5	7.8	10.8	10.4	9.5	9.4	11.0	14.6	17.3	9.6	18.9	28.1	21.3	7.0	7.1	9.0	22.2	21.8	13.8	13.0	4.7	14.3	12.7	11.0	20.9	11.4	20.6	17.5	1.9	11.3	3.5	16.8	23.7	14.8	12.0	18.5	28.0	14.2	11.7	12.8	27.0	17.7	8.8	20.1	11.7	18.6	15.4	16.8	34.2	19.2	10.2	19.7	8.4	4.3	18.3	18.6	10.6	34.7	24.3	9.3	16.5	37.2	35.3	15.9	8.6	14.3	21.6	14.0	13.8	6.6	15.5	21.7	19.7	17.9	12.9	19.7	15.0	21.2	10.4	9.3	19.1	16.0	17.9	7.9
MCM8	"C20orf154, dJ967N21.5, MGC119522, MGC119523, MGC12866, MGC4816, REC"	ENSG00000125885	"Minichromosome maintenance 8 homologous recombination repair factor"	Q9UJA3	20	5950652-5998977	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, DNA damage, DNA repair, DNA replication"	"DNA-binding, Helicase, Hydrolase"	"Disease variant, Premature ovarian failure"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Spermatocytes: 71.8;Spermatogonia: 37.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"											"HPA045141, HPA066433"			Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	Nucleoplasm	Cytosol	"HPA045141: AB_2679230, HPA066433: "	"unprognostic (6.55e-2)"	"unprognostic (2.46e-2)"	"unprognostic (4.43e-1)"	"unprognostic (2.22e-3)"	"unprognostic (1.90e-1)"	"unprognostic (5.78e-2)"	"prognostic unfavorable (9.30e-8)"	"unprognostic (5.21e-2)"	"unprognostic (5.14e-2)"	"unprognostic (2.50e-1)"	"prognostic unfavorable (7.50e-4)"	"unprognostic (6.74e-2)"	"unprognostic (1.11e-2)"	"unprognostic (5.53e-2)"	"unprognostic (2.76e-1)"	"unprognostic (2.66e-2)"	"unprognostic (3.47e-1)"	2.9	2.9	3.0	4.6	4.1	10.2	2.8	6.8	4.4	4.0	4.2	3.9	3.6	3.1	2.1	3.7	3.2	1.7	3.3	3.1	3.4	2.4	1.8	2.4	7.5	2.9	3.1	2.6	3.1	2.0	1.6	3.3	3.1	3.6	3.2	5.3	2.9	1.8	6.9	4.7	3.7	2.1	2.6	3.6	3.3	13.4	3.1	9.0	2.4	4.6	6.5	3.4	3.6	5.8	48.6	33.0	27.7	30.3	4.6	6.6	27.4	38.1	12.3	26.6	32.0	35.4	27.6	48.3	11.3	10.2	51.5	50.9	46.1	25.7	47.9	13.4	21.5	49.3	16.8	27.9	0.9	56.6	7.4	2.5	3.8	47.2	17.6	5.3	12.3	28.7	56.7	45.8	27.1	12.3	27.6	30.0	40.3	25.3	21.6	34.8	50.9	18.6	5.0	15.3	21.6	23.2	40.0	36.3	22.5	28.6	27.1	16.4	9.6	51.5	43.2	28.2	56.8	20.1	53.8	82.2	9.6	33.5	43.4	1.0	0.1	0.4	0.4	0.1	0.7	0.3	0.2	0.4	0.0	0.3	0.2	0.4	0.4	0.4	0.2	0.4	0.5	0.1	3.0	4.1	6.8	4.4	3.1	3.4	2.9	3.1	3.1	2.6	3.1	5.8	3.3	0.0	4.4	1.6	6.0	2.3	3.0	1.9	4.6	7.3	2.1	2.8	10.3	7.2	2.4	12.9	16.7	7.2	4.2	5.8	0.0	1.9	8.5	4.9	3.5	4.2	4.2	14.9	3.7	2.8	6.3	5.0	3.1	5.4	1.3	24.4	2.9	1.9	4.5	6.7	2.9	4.0	6.1	2.8	4.6	3.2	3.7	3.7	1.8	2.8	0.3	3.7	8.2	3.5	6.6	3.6	3.9	3.0	9.2	3.3	4.7	2.4	4.0	11.5	6.6	5.7	4.8	71.8	37.1	5.0	2.6	4.0	6.0	3.0	6.3	2.2
MCOLN1	"ML4, MLIV, MST080, MSTP080, TRPM-L1, TRPML1"	ENSG00000090674	"Mucolipin 1"	Q9GZU1	19	7522624-7534009	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Adaptive immunity, Calcium transport, Immunity, Ion transport, Transport"	"Ion channel"	"Disease variant, Mucolipidosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Hofbauer cells: 109.4;Kupffer cells: 117.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"basophil: 117.5;classical monocyte: 45.2;eosinophil: 105.7;intermediate monocyte: 95.5;neutrophil: 41.1;non-classical monocyte: 105.1"	"Group enriched"	"Detected in all"	5	"granulocytes: 117.5;monocytes: 105.1"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031763, CAB032637, HPA069495"	Uncertain		Supported	"Nucleoplasm,Golgi apparatus,Vesicles"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 64: Macrophages - Immune response"	"Cluster 18: U-2197 - ECM organization"	"Cluster 4: Macrophages - Innate immune response"	"Golgi apparatus, Vesicles"	Nucleoplasm	"CAB032637: AB_2142964, HPA031763: AB_10600822, HPA069495: "	"unprognostic (5.51e-2)"	"unprognostic (1.31e-2)"	"unprognostic (1.35e-2)"	"unprognostic (3.30e-2)"	"unprognostic (2.66e-1)"	"unprognostic (4.07e-2)"	"unprognostic (8.38e-3)"	"unprognostic (1.57e-1)"	"unprognostic (1.79e-2)"	"unprognostic (1.47e-1)"	"prognostic favorable (5.60e-5)"	"unprognostic (1.36e-1)"	"prognostic favorable (5.67e-4)"	"unprognostic (2.58e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.83e-1)"	21.2	37.4	6.4	9.2	6.5	10.4	15.3	7.0	8.4	11.7	8.3	13.6	8.3	11.6	2.7	11.0	12.2	10.1	15.7	7.0	7.4	11.7	14.7	20.3	13.2	8.2	7.4	10.0	9.9	10.2	21.7	15.9	9.0	8.7	5.6	5.0	12.3	6.1	22.2	20.8	12.1	8.1	7.1	48.2	12.8	5.6	8.2	6.2	8.5	11.7	4.1	15.8	10.9	9.9	11.6	11.7	5.6	19.1	32.0	10.3	16.1	21.2	16.9	25.2	21.6	9.0	10.0	6.5	25.5	14.5	22.2	5.3	9.5	7.3	7.4	12.7	21.1	5.8	11.0	7.3	28.0	6.6	24.5	14.5	16.8	24.1	4.2	7.9	10.7	14.2	10.9	27.9	14.7	3.9	9.1	6.6	12.6	6.1	24.8	12.6	9.4	13.8	9.6	9.9	14.4	17.8	9.1	15.8	26.8	6.1	9.6	11.4	13.5	12.0	6.9	48.8	16.0	21.5	35.5	4.7	19.2	9.2	18.4	117.5	45.2	105.7	7.7	95.5	6.3	4.2	6.5	6.3	19.2	4.1	6.0	6.5	41.1	10.3	105.1	21.1	10.0	17.1	6.4	6.5	7.0	8.4	7.0	7.4	8.2	7.4	9.0	7.1	8.2	9.9	15.1	3.2	2.6	5.9	8.0	13.4	6.5	16.9	10.2	27.3	15.9	15.0	2.3	15.7	8.1	31.3	22.9	11.6	12.1	32.0	1.9	23.7	4.8	5.0	19.8	14.1	16.8	21.7	10.6	23.1	20.0	16.0	9.7	6.5	1.3	22.2	13.6	13.6	109.4	58.9	8.0	10.0	22.4	117.1	32.2	17.0	16.4	70.6	21.4	7.5	18.0	23.0	16.5	7.5	11.4	23.4	19.3	15.8	8.0	5.6	21.8	12.3	6.5	44.1	6.6	11.2	14.8	10.3	14.7	8.9	17.3	29.6	8.7	17.3	9.4	4.8
MCRS1	"ICP22BP, INO80Q, MCRS2, MSP58, P78"	ENSG00000187778	"Microspherule protein 1"	Q96EZ8	12	49556544-49568145	"Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA recombination, DNA repair, Host-virus interaction, Transcription, Transcription regulation"	"Chromatin regulator"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039057	Supported		Supported	Nucleoplasm		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm		"HPA039057: AB_10794085"	"unprognostic (2.60e-3)"	"unprognostic (5.23e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.89e-2)"	"unprognostic (1.68e-1)"	"unprognostic (4.60e-2)"	"prognostic unfavorable (2.30e-4)"	"unprognostic (2.26e-2)"	"unprognostic (2.83e-3)"	"unprognostic (6.11e-2)"	"unprognostic (9.94e-3)"	"unprognostic (1.23e-1)"	"prognostic favorable (2.70e-4)"	"unprognostic (2.28e-1)"	"unprognostic (1.69e-1)"	"unprognostic (4.35e-2)"	"unprognostic (3.26e-2)"	22.3	29.7	29.2	27.3	29.9	32.1	23.4	28.3	33.4	26.4	27.8	30.3	27.3	31.3	23.7	34.9	30.1	22.9	68.2	29.6	27.2	34.5	24.6	24.3	33.2	29.9	28.1	23.6	32.7	35.7	24.0	24.5	28.5	31.3	25.9	17.2	27.0	26.9	53.2	26.9	29.2	26.1	28.2	32.8	31.8	35.2	29.4	39.4	35.5	61.4	31.1	29.3	26.2	31.4	43.8	81.5	62.9	54.5	33.2	40.9	69.3	37.5	40.4	95.7	53.2	127.3	69.7	72.6	76.4	66.0	43.7	48.5	97.8	89.0	38.3	57.6	120.3	72.4	53.4	46.9	59.6	85.0	76.0	47.7	68.3	63.8	51.3	56.0	71.0	66.0	90.9	48.0	55.4	77.8	59.1	51.1	87.4	40.7	60.1	69.1	50.7	84.0	59.4	40.3	60.6	63.5	40.8	51.7	36.5	42.8	84.4	101.7	51.6	45.8	58.4	44.7	56.7	47.3	50.9	69.2	60.1	49.8	27.8	96.2	63.7	76.4	63.2	82.7	49.1	44.5	53.6	68.1	79.1	46.1	46.8	51.0	31.8	90.7	64.7	53.5	60.4	76.3	29.2	29.9	28.3	33.4	29.6	27.2	29.9	28.1	28.5	28.2	29.4	31.4	17.0	35.3	13.8	6.2	23.3	10.7	25.1	38.5	10.8	15.6	19.8	19.7	24.2	28.6	22.4	23.9	8.4	52.1	22.1	34.3	52.8	37.7	32.1	16.3	15.3	17.4	27.5	35.1	12.8	36.1	51.8	20.2	39.8	15.7	27.3	24.3	15.0	10.5	40.6	23.5	12.6	27.2	28.5	22.0	12.5	37.8	27.4	20.9	28.4	9.4	38.0	28.1	40.2	7.1	12.3	39.7	37.1	27.1	24.3	26.7	34.1	45.4	22.8	20.5	6.6	14.7	26.9	41.6	64.0	27.4	12.6	59.2	25.6	23.7	33.8	27.0
MCTS1	MCT-1	ENSG00000232119	"MCTS1 re-initiation and release factor"	Q9ULC4	X	120594010-120621159	"Predicted intracellular proteins"	"Cell cycle, DNA damage, Growth regulation, Protein biosynthesis, Transcription, Transcription regulation"	"Initiation factor"	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001045			Supported	"Plasma membrane,Cytosol"		NA	NA		160000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 55: Plasma cells - Humoral immune response"	Cytosol	"Plasma membrane"	"HPA001045: "	"prognostic unfavorable (1.38e-4)"	"unprognostic (1.44e-1)"	"unprognostic (4.50e-1)"	"unprognostic (9.37e-3)"	"unprognostic (7.29e-2)"	"prognostic unfavorable (3.27e-5)"	"unprognostic (2.94e-3)"	"unprognostic (9.59e-2)"	"unprognostic (8.28e-2)"	"unprognostic (4.89e-2)"	"unprognostic (7.42e-2)"	"unprognostic (2.82e-1)"	"prognostic unfavorable (4.35e-5)"	"unprognostic (1.95e-1)"	"unprognostic (7.58e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.49e-1)"	28.1	31.1	5.5	3.9	5.6	3.9	26.4	5.7	7.0	24.5	4.3	25.9	4.6	19.7	6.3	38.9	19.3	3.0	32.9	6.0	6.0	35.9	40.7	20.8	5.5	5.2	5.0	17.0	39.5	4.9	34.3	3.9	5.2	20.4	5.2	5.5	26.8	3.7	28.5	24.1	23.9	3.1	5.0	28.9	30.5	11.9	5.4	6.7	21.5	6.4	6.7	22.6	24.4	5.7	13.9	8.2	8.2	9.9	16.2	19.2	9.9	13.8	11.9	15.2	17.0	6.6	15.8	18.6	14.3	18.3	23.6	9.6	18.0	17.7	23.4	9.7	8.5	6.3	11.3	6.4	15.6	13.6	10.3	14.1	14.2	14.9	14.2	12.6	19.5	11.0	14.5	10.8	21.9	13.5	11.3	17.5	10.3	27.9	15.7	10.5	7.6	19.2	17.7	6.4	11.0	10.0	8.5	15.2	9.0	10.1	9.1	10.6	16.5	13.3	6.4	14.3	20.7	7.5	12.5	22.2	14.3	18.8	12.9	3.4	5.0	3.5	3.5	5.9	5.6	6.1	4.6	4.4	6.5	4.9	4.2	4.3	2.3	4.9	5.9	8.4	6.1	4.1	5.5	5.6	5.7	7.0	6.0	6.0	5.2	5.0	5.2	5.0	5.4	5.7	53.5	19.2	22.9	13.1	65.4	32.2	65.5	108.4	27.9	14.5	49.3	46.9	80.8	42.9	63.5	46.0	8.4	97.0	52.0	71.3	129.1	87.4	54.4	53.1	55.6	49.9	55.7	22.5	28.2	88.5	182.0	48.5	50.0	43.9	52.0	50.4	51.4	84.4	132.6	15.2	25.5	111.0	71.2	81.7	43.2	88.7	42.0	60.4	62.2	10.3	67.6	27.0	39.1	15.1	25.3	92.7	83.7	27.8	92.0	52.6	118.2	153.5	57.4	21.0	39.5	25.3	66.1	17.7	15.0	50.4	34.5	112.9	46.5	90.0	82.2	75.3
MCU	"C10orf42, CCDC109A, FLJ46135"	ENSG00000156026	"Mitochondrial calcium uniporter"	Q8NE86	10	72692131-72887694	"Predicted intracellular proteins, Predicted membrane proteins"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"tongue: 53.7"	"Cell type enhanced"	"Detected in many"		"Gastric mucus-secreting cells: 68.3;Inhibitory neurons: 65.6;Oligodendrocyte precursor cells: 72.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA016480	Approved		Supported	Mitochondria		No	No		17000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Mitochondria		"HPA016480: AB_2071893"	"unprognostic (2.42e-2)"	"unprognostic (1.58e-2)"	"unprognostic (3.01e-2)"	"unprognostic (5.37e-2)"	"unprognostic (7.84e-2)"	"unprognostic (3.05e-1)"	"prognostic unfavorable (6.06e-5)"	"unprognostic (1.23e-1)"	"unprognostic (2.28e-1)"	"unprognostic (2.33e-1)"	"unprognostic (5.12e-3)"	"unprognostic (1.73e-1)"	"prognostic favorable (5.07e-4)"	"unprognostic (4.51e-2)"	"unprognostic (3.79e-1)"	"unprognostic (2.74e-2)"	"unprognostic (2.48e-2)"	6.1	3.8	2.8	7.4	2.5	19.9	5.7	10.4	3.6	8.3	6.4	28.7	27.8	8.9	3.0	14.2	10.8	12.7	7.8	3.9	2.8	10.6	7.0	10.2	4.9	3.4	3.2	4.9	5.5	10.0	1.9	12.8	3.2	5.8	30.8	2.3	6.7	5.7	41.8	6.8	24.5	13.5	3.0	5.0	43.2	4.3	3.3	5.7	6.4	53.7	7.7	14.9	5.1	2.8	41.7	66.1	16.8	12.2	25.0	28.0	17.1	25.0	35.5	24.5	26.0	39.6	38.6	17.7	19.6	30.8	13.3	36.9	22.2	29.8	32.5	19.5	20.8	22.1	23.5	22.1	19.5	56.0	17.9	28.7	24.9	22.0	46.6	38.4	29.8	18.5	14.0	12.9	23.0	24.3	15.2	12.0	18.5	45.2	13.6	15.7	35.8	4.7	32.7	22.4	17.8	7.9	30.8	34.1	7.5	20.2	6.8	14.5	24.3	11.8	19.9	25.7	16.9	9.4	12.8	12.1	15.8	27.5	9.2	1.8	6.7	18.6	3.0	7.3	3.1	3.5	2.9	3.6	5.8	1.7	2.3	2.6	8.8	2.2	8.9	2.0	5.2	4.2	2.8	2.5	10.4	3.6	3.9	2.8	3.4	3.2	3.2	3.0	3.3	2.8	13.7	35.3	17.0	21.2	4.2	11.7	14.4	8.9	10.8	3.0	5.9	3.9	6.6	8.6	22.0	18.4	2.1	7.3	4.8	38.2	1.9	11.1	14.5	23.3	9.9	9.7	8.4	10.8	58.2	25.2	10.1	7.2	68.3	26.4	8.2	3.4	8.9	5.8	6.7	0.0	65.6	28.2	12.2	6.0	2.9	7.2	5.3	6.7	8.8	37.5	5.7	5.4	2.1	72.4	40.3	40.7	15.6	4.1	5.7	9.7	19.8	8.6	22.6	3.9	13.1	6.8	12.1	5.1	5.2	6.2	12.4	9.3	5.0	12.7	24.5	26.8
MDC1	"Em:AB023051.5, KIAA0170, NFBD1"	ENSG00000137337	"Mediator of DNA damage checkpoint 1"	Q14676	6	30699807-30717447	"Cancer-related genes, Predicted intracellular proteins"	"Cell cycle, DNA damage, DNA repair"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	4	"Spermatocytes: 74.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	4	"NK-cell: 3.2"	"Lineage enriched"	"Detected in single"	4	"NK-cells: 3.2"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006915	Enhanced		Supported	"Nucleoplasm,Nuclear bodies,Focal adhesion sites"		No	No			"Cluster 48: NK-cells - Unknown function"	"Cluster 71: Testis - DNA repair"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	"Nucleoplasm, Nuclear bodies"	"Focal adhesion sites"	"HPA006915: AB_1853669"	"unprognostic (8.52e-2)"	"unprognostic (4.32e-1)"	"unprognostic (4.11e-2)"	"unprognostic (2.66e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.61e-1)"	"unprognostic (5.40e-3)"	"unprognostic (1.13e-1)"	"unprognostic (1.09e-2)"	"unprognostic (9.44e-2)"	"unprognostic (2.74e-3)"	"unprognostic (1.31e-1)"	"unprognostic (1.62e-2)"	"unprognostic (3.86e-2)"	"unprognostic (2.99e-1)"	"unprognostic (4.39e-3)"	"unprognostic (3.23e-1)"	11.3	7.0	2.7	8.6	3.2	13.0	10.9	4.1	5.2	12.4	3.3	11.0	4.9	13.7	8.5	6.2	12.3	4.6	9.5	2.4	4.1	8.2	9.7	9.5	10.2	4.5	3.3	16.8	10.8	8.6	12.8	7.4	3.5	10.1	6.9	14.1	9.1	8.2	11.0	9.4	10.9	8.9	2.0	11.3	8.4	28.2	3.4	14.5	16.4	5.8	11.3	10.7	9.3	3.6	36.7	11.1	47.4	34.8	6.3	10.0	23.0	14.8	10.0	25.2	21.3	22.7	8.5	37.7	17.5	17.0	23.5	20.2	63.0	28.6	34.9	29.9	65.6	43.4	28.7	12.5	4.1	27.1	16.9	7.9	9.2	48.6	27.3	9.0	11.5	25.7	61.0	36.7	19.1	14.7	14.6	20.0	20.6	8.4	7.8	33.2	24.7	37.4	11.0	10.7	39.9	23.2	11.5	26.2	13.5	29.1	21.8	16.8	13.8	24.8	26.4	19.2	26.3	19.3	21.6	34.5	7.8	63.9	34.3	0.1	0.1	0.1	0.6	0.1	0.3	0.4	0.4	0.5	0.1	0.7	0.5	0.5	0.0	3.2	0.1	0.7	0.0	0.3	2.7	3.2	4.1	5.2	2.4	4.1	4.5	3.3	3.5	2.0	3.4	3.6	9.7	16.0	13.0	10.1	13.4	4.5	5.5	5.6	15.9	11.5	6.8	8.6	7.6	7.2	5.7	5.5	8.4	7.9	11.0	2.5	3.9	5.3	4.7	8.0	8.7	9.7	6.7	14.5	8.3	6.2	11.4	11.2	4.1	13.7	17.1	12.8	6.1	12.0	6.7	5.0	8.1	3.3	12.2	6.0	5.7	3.9	7.8	7.3	1.8	11.2	5.9	10.6	14.4	12.5	9.9	5.2	1.1	6.0	16.9	2.9	1.2	3.0	8.0	17.1	13.1	16.2	8.3	74.5	18.0	8.7	3.7	1.9	12.1	7.7	6.0	1.9
MDFIC	"HIC, MDFIC1"	ENSG00000135272	"MyoD family inhibitor domain containing"	Q9P1T7	7	114922359-115019202	"Predicted intracellular proteins, Predicted membrane proteins"	"Host-virus interaction, Transcription, Transcription regulation"	"Activator, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Muller glia cells: 139.7;Skeletal myocytes: 131.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"U-2197: 109.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030716	Approved		Supported	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 16: Immune cells - Immune response"	"Cluster 18: U-2197 - ECM organization"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Nucleoplasm, Golgi apparatus"		"HPA030716: AB_10671364"	"unprognostic (1.24e-3)"	"unprognostic (4.15e-1)"	"unprognostic (2.38e-2)"	"unprognostic (2.29e-2)"	"unprognostic (1.39e-1)"	"unprognostic (3.13e-3)"	"unprognostic (1.73e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.47e-1)"	"unprognostic (8.02e-2)"	"unprognostic (6.38e-3)"	"unprognostic (3.68e-2)"	"prognostic unfavorable (3.65e-4)"	"unprognostic (6.13e-3)"	"unprognostic (7.10e-2)"	"unprognostic (1.42e-1)"	"unprognostic (3.55e-1)"	44.9	17.3	4.9	22.5	4.3	11.1	14.5	4.7	5.2	21.1	25.5	10.6	7.2	20.6	5.1	17.2	12.2	13.2	24.6	4.1	7.2	12.6	13.3	23.3	32.1	12.1	9.0	16.1	5.0	16.7	4.6	20.2	8.8	10.2	10.3	21.1	15.7	11.1	27.6	10.3	9.4	17.7	12.8	33.7	10.5	1.8	6.0	17.2	19.3	14.2	30.0	16.4	8.2	9.2	0.1	13.2	18.3	0.1	37.8	52.0	7.1	69.9	83.9	15.9	19.8	0.4	41.7	9.8	0.8	46.4	25.4	7.7	5.7	12.2	27.1	34.0	12.3	0.0	16.8	0.0	19.5	22.2	14.2	43.7	11.5	35.7	11.1	40.2	10.7	9.7	0.0	66.8	54.2	0.2	0.1	1.8	14.8	0.6	15.6	0.2	53.5	21.5	16.2	16.9	0.7	0.0	30.5	28.3	32.5	24.7	9.0	19.7	30.2	58.2	16.4	109.1	34.1	27.5	0.1	0.2	40.8	0.1	50.9	0.2	0.9	0.6	1.8	1.2	2.8	2.3	4.1	3.6	1.5	2.4	2.3	2.1	0.0	1.6	1.8	5.5	3.5	0.7	4.9	4.3	4.7	5.2	4.1	7.2	12.1	9.0	8.8	12.8	6.0	9.2	61.3	16.0	26.1	32.7	41.5	9.4	7.0	2.2	17.6	0.5	13.1	10.2	24.8	24.3	12.2	14.7	0.0	7.5	58.1	1.5	9.8	2.3	2.5	9.4	12.7	42.8	0.0	1.7	27.2	2.9	5.3	25.8	5.6	1.3	2.5	29.9	59.6	18.6	21.9	0.0	5.4	2.7	0.0	55.6	34.0	1.3	4.4	41.1	37.4	55.3	22.0	139.7	21.6	6.6	0.8	9.2	2.0	2.6	63.2	6.6	0.1	5.1	15.1	5.0	6.6	131.8	13.8	0.2	1.0	20.0	13.8	3.7	70.6	38.2	4.6	10.2
MDGA1	"GPIM, MAMDC3"	ENSG00000112139	"MAM domain containing glycosylphosphatidylinositol anchor 1"	Q8NFP4	6	37630679-37699306	"Predicted intracellular proteins"	"Differentiation, Neurogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	12	"brain: 79.9"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 34.0;Cone photoreceptor cells: 50.1;Horizontal cells: 57.2"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in all"	9	"cerebellum: 79.9"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 12.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA031235, HPA050382"	Enhanced		Supported	"Golgi apparatus,Plasma membrane"	"Intracellular and membrane"	NA	NA		1200000	"Cluster 32: T-cells - Unknown function"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 62: Horizontal cells - Visual perception"	"Plasma membrane"	"Golgi apparatus"	"HPA031235: AB_10603017, HPA050382: AB_2681108"	"unprognostic (4.67e-2)"	"unprognostic (6.97e-3)"	"unprognostic (3.24e-1)"	"unprognostic (5.69e-4)"	"unprognostic (2.75e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.45e-2)"	"unprognostic (2.00e-1)"	"unprognostic (2.02e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.16e-2)"	"unprognostic (3.00e-1)"	"unprognostic (1.52e-5)"	"unprognostic (9.19e-3)"	"unprognostic (5.28e-3)"	"unprognostic (3.80e-3)"	"unprognostic (4.60e-2)"	2.6	2.9	4.2	2.6	3.9	0.3	1.6	79.9	5.3	5.4	0.0	2.6	0.5	3.4	1.8	3.7	2.7	3.2	2.3	8.8	4.9	1.2	0.6	3.1	2.6	4.3	4.7	6.5	2.4	4.1	4.8	0.3	7.4	2.1	1.1	4.0	1.1	1.3	1.1	4.9	2.8	2.5	1.0	3.1	2.0	1.5	2.1	0.8	1.4	1.7	2.1	1.9	4.4	3.2	0.2	3.5	4.8	2.4	12.3	4.3	2.2	2.8	2.2	3.5	3.2	0.0	0.0	0.7	0.5	1.7	3.0	5.4	0.5	0.0	1.0	4.9	3.4	0.0	0.3	0.0	0.5	0.0	1.1	1.0	0.0	1.4	0.0	6.8	0.0	0.1	0.0	0.0	1.2	0.0	0.0	0.4	0.0	0.1	0.4	5.9	1.7	0.0	0.8	3.7	4.3	0.0	1.5	0.3	2.6	0.2	3.1	0.6	0.3	3.4	1.4	1.2	4.3	0.0	0.1	0.0	4.2	1.0	2.0	0.0	0.0	0.0	0.3	0.0	0.1	0.2	0.2	0.1	0.0	0.2	0.6	0.1	0.0	0.0	0.0	0.0	0.3	0.1	4.2	3.9	79.9	5.3	8.8	4.9	4.3	4.7	7.4	1.0	2.1	3.2	3.0	9.6	0.5	12.7	2.0	2.3	2.4	0.7	1.2	34.0	0.4	0.6	5.7	1.5	0.8	3.7	50.1	0.2	3.1	0.0	0.0	0.5	2.6	0.6	1.8	1.6	1.8	0.0	4.9	0.0	1.4	4.4	0.5	0.5	0.0	1.1	1.4	0.0	0.1	57.2	4.9	0.0	0.0	0.3	1.1	0.2	10.2	0.3	1.8	1.9	0.0	2.6	4.1	4.0	2.1	0.6	0.0	4.9	1.7	2.0	0.0	0.5	1.9	2.0	0.0	2.6	3.0	2.1	1.3	2.8	3.0	0.7	2.9	0.2	0.0	5.1
MDH1		ENSG00000014641	"Malate dehydrogenase 1"	P40925	2	63588609-63607197	"Cancer-related genes, Citric acid cycle related proteins, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Tricarboxylic acid cycle"	Oxidoreductase	"Cancer-related genes, Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 1349.1;tongue: 1843.8"	"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 1926.9;Proximal tubular cells: 1428.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027296, CAB047333, HPA054276"	Uncertain		Supported	Centrosome,Cytosol		NA	NA		49000000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 39: Non-specific - Basic cellular processes"	"Centrosome, Cytosol"		"CAB047333: , HPA027296: AB_10611118, HPA054276: AB_2682434"	"unprognostic (1.01e-1)"	"unprognostic (6.52e-3)"	"unprognostic (1.61e-2)"	"prognostic unfavorable (7.13e-4)"	"unprognostic (1.83e-1)"	"unprognostic (8.84e-3)"	"unprognostic (5.81e-2)"	"unprognostic (2.79e-2)"	"unprognostic (9.52e-2)"	"unprognostic (2.05e-1)"	"unprognostic (3.26e-1)"	"unprognostic (8.80e-2)"	"prognostic favorable (9.95e-4)"	"unprognostic (6.37e-2)"	"unprognostic (1.75e-1)"	"unprognostic (5.97e-2)"	"unprognostic (3.05e-1)"	274.6	213.6	235.9	86.7	249.7	79.1	137.9	245.9	353.6	89.6	230.2	167.7	154.7	82.0	161.3	125.3	114.5	87.2	1349.1	253.2	261.5	371.6	266.3	89.8	131.9	248.5	218.3	80.4	69.9	411.8	107.2	92.5	253.3	125.5	190.9	240.7	122.0	142.0	792.5	87.7	133.1	171.5	215.7	71.6	192.6	70.5	259.1	170.4	125.5	1843.8	165.4	131.5	62.8	237.7	268.2	219.5	257.8	173.2	369.6	280.9	282.3	215.1	295.9	300.6	304.1	252.5	215.4	355.2	112.8	264.1	358.8	214.3	303.0	355.0	425.5	207.6	253.1	337.0	173.2	376.8	202.1	384.1	223.9	277.7	241.3	271.5	152.7	236.2	235.3	308.1	183.7	217.3	395.1	157.8	300.6	317.5	158.0	376.3	266.5	235.2	349.7	310.5	460.9	251.0	249.9	153.6	182.5	257.7	384.1	205.6	191.9	341.9	149.6	220.3	211.9	187.1	252.9	264.6	264.8	407.6	266.2	312.2	184.1	271.3	186.3	200.2	202.7	267.8	218.8	258.5	236.6	224.6	241.0	258.5	230.3	221.6	28.1	214.6	253.4	184.3	320.9	321.2	235.9	249.7	245.9	353.6	253.2	261.5	248.5	218.3	253.3	215.7	259.1	237.7	44.4	60.9	54.3	54.9	78.7	81.6	109.4	562.9	50.7	165.4	81.0	86.7	1926.9	95.8	227.2	134.3	70.9	248.7	78.4	128.4	630.0	186.2	12.4	116.1	72.6	61.0	62.8	62.9	120.2	108.1	257.0	134.7	112.7	68.8	80.5	95.0	36.0	153.2	397.0	122.8	130.0	115.9	380.5	85.2	65.8	15.1	100.0	98.4	177.9	43.1	155.0	136.3	73.2	51.3	58.8	91.3	99.8	109.1	82.1	48.8	177.4	1428.3	224.5	164.1	59.2	68.3	167.8	58.0	65.6	82.7	84.0	149.5	84.3	137.4	167.8	102.6
MDM1		ENSG00000111554	"Mdm1 nuclear protein"	Q8TC05	12	68272443-68332381	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Respiratory ciliated cells: 44.0;Spermatocytes: 56.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040411, HPA041594"	Uncertain		Supported	"Centriolar satellite,Cytosol"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 34: Non-specific - Transcription"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 49: Ciliated cells - Cilium organization"	"Centriolar satellite"	Cytosol	"HPA040411: AB_10805711, HPA041594: AB_10793968"	"unprognostic (7.41e-2)"	"prognostic favorable (6.01e-4)"	"unprognostic (8.58e-2)"	"unprognostic (2.62e-3)"	"unprognostic (1.21e-1)"	"unprognostic (3.50e-3)"	"unprognostic (4.24e-3)"	"unprognostic (3.89e-2)"	"unprognostic (2.80e-3)"	"unprognostic (2.92e-1)"	"unprognostic (2.56e-3)"	"unprognostic (3.13e-2)"	"unprognostic (4.29e-3)"	"unprognostic (1.29e-1)"	"unprognostic (2.84e-1)"	"unprognostic (4.63e-2)"	"unprognostic (5.23e-3)"	5.3	5.7	6.3	9.5	7.2	16.5	9.1	6.8	7.2	9.0	13.2	25.7	4.8	13.9	11.2	4.3	18.2	5.9	4.7	5.7	7.5	8.1	4.6	6.4	13.0	8.5	9.1	9.6	5.3	7.1	9.4	5.6	8.2	9.3	9.8	29.2	6.4	13.9	3.0	3.7	7.1	13.0	9.2	9.4	6.6	20.6	7.3	15.2	10.0	3.3	13.0	10.9	6.4	8.5	8.4	6.9	13.0	12.7	6.3	8.5	10.0	11.0	6.1	17.2	15.7	8.3	3.8	19.3	7.1	5.0	8.4	8.6	9.0	5.9	19.4	25.4	8.6	42.5	9.1	5.7	9.8	23.8	16.1	3.9	7.6	11.6	11.2	9.3	9.9	21.9	8.2	21.1	10.0	6.1	33.7	16.7	6.9	8.3	8.4	32.8	11.7	5.7	8.2	7.3	11.8	6.3	10.6	6.3	11.1	10.3	15.1	16.9	5.2	13.7	6.0	8.7	10.3	10.9	34.0	13.3	7.2	15.3	8.9	9.9	5.1	15.0	5.0	12.0	8.1	7.5	6.5	5.2	4.4	6.9	7.6	6.2	3.3	7.2	19.4	2.5	6.7	5.7	6.3	7.2	6.8	7.2	5.7	7.5	8.5	9.1	8.2	9.2	7.3	8.5	8.3	3.2	4.6	14.0	12.9	4.8	3.9	5.3	5.2	16.0	8.0	9.0	10.8	2.8	6.8	7.3	0.0	4.7	13.2	2.8	9.8	4.8	26.0	35.4	16.0	6.6	2.4	25.2	12.5	3.5	4.2	5.7	5.6	5.3	7.0	12.0	6.1	4.9	6.3	8.4	11.7	2.8	10.2	4.7	5.1	13.5	9.0	14.5	16.0	8.4	7.3	25.7	18.6	9.5	18.7	3.0	4.7	13.5	9.3	1.8	1.8	10.4	44.0	34.6	6.6	7.4	8.2	56.3	22.3	6.3	4.1	0.3	13.9	8.6	4.9	1.7
MDM2	"HDM2, MGC5370"	ENSG00000135679	"MDM2 proto-oncogene"	Q00987	12	68808177-68850686	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Apoptosis, Host-virus interaction, Ubl conjugation pathway"	Transferase	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Endometrial ciliated cells: 257.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HBEC3-KT: 504.6;U-698: 517.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000086, CAB016303, CAB079977"	Supported		Supported	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 49: Ciliated cells - Cilium organization"	"Nucleoplasm, Cytosol"	"Golgi apparatus"	"CAB000086: AB_563872, CAB016303: AB_627920, CAB079977: "	"unprognostic (1.16e-1)"	"prognostic favorable (3.23e-4)"	"unprognostic (6.16e-2)"	"prognostic favorable (4.51e-7)"	"unprognostic (7.25e-2)"	"unprognostic (6.91e-2)"	"unprognostic (3.77e-2)"	"unprognostic (1.72e-1)"	"unprognostic (2.45e-2)"	"unprognostic (3.23e-1)"	"unprognostic (1.80e-3)"	"unprognostic (2.36e-1)"	"unprognostic (4.22e-2)"	"unprognostic (4.59e-2)"	"unprognostic (1.81e-1)"	"unprognostic (2.68e-1)"	"unprognostic (8.95e-2)"	14.0	11.6	5.4	10.4	10.0	28.6	11.9	7.4	7.6	13.9	28.0	20.7	6.4	9.5	7.1	13.0	14.1	12.0	6.8	3.8	7.4	9.5	26.9	14.3	13.8	9.9	8.5	10.8	14.3	10.9	5.0	16.4	9.2	11.3	21.9	14.2	9.6	11.5	18.6	10.9	7.5	12.4	6.0	11.4	10.0	6.6	9.2	15.6	15.4	12.9	17.0	15.1	10.8	12.8	18.7	42.1	43.5	22.6	55.9	51.5	223.4	49.7	50.3	26.2	41.5	26.8	8.4	188.6	13.5	34.7	7.3	11.0	31.4	504.6	42.1	51.0	22.0	35.3	36.0	115.0	55.7	32.6	31.0	77.8	46.5	101.5	69.4	26.9	73.7	32.1	37.1	45.4	50.8	28.0	43.1	10.7	36.9	10.1	8.2	149.4	31.7	16.2	16.0	146.0	34.3	20.2	32.0	25.0	11.3	88.8	58.3	21.4	82.3	20.2	38.0	16.8	18.5	68.2	47.7	517.6	31.3	12.8	81.2	6.1	5.4	5.2	4.1	4.1	3.7	4.7	3.5	4.1	3.0	5.4	3.6	3.5	19.2	3.7	7.2	3.9	4.1	3.6	5.4	10.0	7.4	7.6	3.8	7.4	9.9	8.5	9.2	6.0	9.2	12.8	23.1	32.1	56.3	26.1	36.4	15.6	30.5	42.6	22.8	26.8	21.4	17.1	20.9	24.3	75.8	25.8	33.3	47.5	32.1	19.3	13.7	19.5	2.5	257.4	34.5	22.0	25.1	29.9	28.8	24.2	28.0	31.9	28.5	74.8	32.9	33.2	15.7	45.0	18.3	30.3	32.9	23.4	32.6	49.0	25.0	2.9	19.3	44.9	12.4	37.5	35.4	27.8	10.3	25.6	71.8	22.4	20.1	15.1	117.7	39.8	15.8	21.3	141.7	35.3	19.7	30.0	32.4	17.3	20.0	59.5	22.0	94.3	31.8	49.4	20.9	82.0
MDM4	"HDMX, MDMX"	ENSG00000198625	"MDM4 regulator of p53"	O15151	1	204516379-204558120	"Cancer-related genes, Human disease related genes, Predicted intracellular proteins"			"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"BEWO: 58.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018919, HPA048821"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA018919: AB_1853694, HPA048821: AB_2680531"	"unprognostic (4.63e-2)"	"unprognostic (3.73e-1)"	"unprognostic (6.38e-2)"	"unprognostic (1.50e-1)"	"unprognostic (3.84e-2)"	"unprognostic (1.68e-3)"	"unprognostic (2.33e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.51e-2)"	"unprognostic (2.34e-2)"	"unprognostic (1.17e-2)"	"prognostic unfavorable (9.87e-4)"	"prognostic unfavorable (7.06e-6)"	"unprognostic (1.20e-1)"	"unprognostic (1.73e-1)"	"unprognostic (2.49e-2)"	"prognostic favorable (2.49e-4)"	13.7	10.5	9.2	13.4	18.7	56.1	14.3	16.3	12.1	17.6	35.0	12.4	5.8	12.0	18.6	11.5	13.6	6.7	11.4	10.6	17.8	14.4	14.8	16.3	18.8	17.5	14.6	18.9	18.8	5.3	16.3	10.1	17.5	14.6	9.6	25.2	11.9	7.3	10.5	20.7	16.7	7.1	10.5	22.6	13.2	19.9	15.9	30.4	15.8	4.2	17.4	12.1	13.7	36.0	6.5	12.7	12.5	17.3	8.6	9.4	58.7	4.8	4.9	6.1	8.9	6.6	8.7	22.4	4.5	6.7	5.1	6.8	8.5	7.2	8.2	6.8	6.0	17.8	32.0	7.6	6.5	14.0	16.9	9.4	4.5	9.9	17.4	6.3	6.0	14.2	10.4	31.5	5.4	21.9	8.6	12.3	17.3	2.4	5.3	10.1	10.2	7.5	6.0	31.1	5.6	12.6	4.9	9.1	9.1	12.4	18.0	8.1	6.1	6.8	12.1	4.5	7.9	15.8	6.2	18.2	4.7	5.9	10.1	7.5	4.3	5.8	5.7	4.2	4.9	7.9	4.4	4.1	3.6	11.9	6.1	5.4	6.4	4.1	3.8	7.8	2.6	2.5	9.2	18.7	16.3	12.1	10.6	17.8	17.5	14.6	17.5	10.5	15.9	36.0	73.6	28.9	56.9	76.0	118.1	61.6	48.2	31.0	22.8	96.0	55.2	33.7	38.5	47.1	51.2	69.9	168.9	52.0	135.7	35.5	13.7	29.9	82.3	39.6	74.2	54.5	65.0	64.4	61.8	26.7	26.1	53.0	36.7	63.2	65.9	82.6	87.1	61.0	35.5	42.1	65.7	48.3	54.9	96.4	128.3	160.2	80.2	62.0	42.7	83.4	81.8	40.1	90.6	106.6	170.3	26.5	42.3	54.2	81.0	66.3	49.0	18.6	32.0	192.7	52.6	99.6	50.5	75.7	64.8	23.0	68.3	60.9	73.7	58.2	51.1	48.3
MDN1	"KIAA0301, Rea1"	ENSG00000112159	"Midasin AAA ATPase 1"	Q9NU22	6	89642498-89819794	"Plasma proteins, Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 82.5;Inhibitory neurons: 79.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"K-562: 24.7;NTERA-2: 22.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029666, HPA029667, HPA029668, HPA029669"	Uncertain		Approved	"Nucleoplasm,Nucleoli,Intermediate filaments,Cytosol"		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	"Nucleoli, Cytosol"	"Nucleoplasm, Intermediate filaments"	"HPA029666: AB_10600888, HPA029667: AB_10696207, HPA029668: AB_10669868, HPA029669: AB_10670429"	"unprognostic (2.00e-1)"	"unprognostic (4.46e-2)"	"unprognostic (7.62e-2)"	"unprognostic (2.26e-2)"	"unprognostic (6.14e-3)"	"unprognostic (3.46e-1)"	"unprognostic (6.68e-2)"	"unprognostic (1.40e-1)"	"unprognostic (3.51e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.77e-2)"	"unprognostic (9.07e-2)"	"unprognostic (2.54e-3)"	"unprognostic (6.28e-3)"	"unprognostic (9.22e-2)"	"unprognostic (2.02e-1)"	"unprognostic (6.09e-2)"	4.2	4.6	3.4	1.9	3.6	4.2	4.3	4.4	3.3	4.5	1.7	4.4	1.2	5.6	2.1	4.9	5.0	1.2	4.9	3.1	3.3	4.4	9.1	3.9	2.6	3.3	3.1	7.6	5.9	3.0	4.6	1.2	3.7	3.6	1.8	3.0	3.9	1.5	8.3	7.1	5.0	1.7	2.2	4.5	4.6	6.5	3.3	2.8	6.0	3.4	2.5	4.2	4.3	5.7	4.2	4.1	4.1	3.8	6.6	6.3	4.1	2.8	2.1	3.1	3.8	9.4	1.5	12.5	3.1	2.9	3.3	3.6	10.7	3.8	5.5	4.9	7.1	13.5	5.6	6.1	2.5	17.7	3.2	3.9	3.1	8.3	7.6	1.9	5.6	5.6	24.7	2.9	3.1	5.0	2.8	6.6	22.7	3.4	3.5	5.5	7.8	3.1	2.7	5.8	7.5	3.3	3.9	2.3	2.5	5.4	1.6	7.7	7.2	2.1	3.8	2.8	6.5	3.3	3.9	5.9	2.8	9.8	3.7	3.2	0.3	0.6	0.7	0.2	0.6	1.0	1.0	0.8	0.2	1.3	1.3	1.0	0.0	1.1	0.3	3.0	0.4	0.1	3.4	3.6	4.4	3.3	3.1	3.3	3.3	3.1	3.7	2.2	3.3	5.7	13.2	28.9	19.1	55.2	19.2	29.3	8.2	6.0	30.7	24.4	14.0	11.0	39.2	11.5	16.9	14.7	25.0	5.5	25.2	6.6	0.0	6.3	7.5	20.1	21.9	15.0	7.7	58.5	82.5	8.1	7.2	13.3	19.4	25.2	6.3	26.4	6.4	48.5	6.6	18.5	79.5	7.7	6.1	6.3	9.5	4.3	7.2	8.6	12.4	33.7	6.6	8.0	9.2	35.7	74.8	6.9	3.7	8.6	26.0	18.1	4.7	2.5	12.9	18.7	0.0	33.1	12.7	37.5	50.1	26.1	30.1	3.4	19.4	17.4	10.3	8.5
ME1		ENSG00000065833	"Malic enzyme 1"	P48163	6	83210402-83431051	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 71.8;Excitatory neurons: 117.1;Inhibitory neurons: 70.6;Kupffer cells: 74.4;Muller glia cells: 100.6;Oligodendrocyte precursor cells: 123.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	7	"MAIT T-cell: 16.0"	"Lineage enriched"	"Detected in many"	10	"T-cells: 16.0"	"Cell line enhanced"	"Detected in many"		"CACO-2: 139.4;OE19: 158.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006493	Enhanced		Uncertain	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA		3600000	"Cluster 16: MAIT-cells - Unknown function"	"Cluster 54: Non-specific - Microtubule organization"	"Cluster 21: OE19 - Mitochondria"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Nucleoplasm, Plasma membrane"	Cytosol	"HPA006493: AB_1078272"	"unprognostic (7.21e-2)"	"unprognostic (3.99e-2)"	"unprognostic (2.24e-1)"	"unprognostic (3.12e-3)"	"prognostic unfavorable (7.73e-4)"	"unprognostic (7.98e-3)"	"prognostic unfavorable (4.57e-5)"	"unprognostic (3.24e-1)"	"unprognostic (4.44e-3)"	"unprognostic (1.41e-3)"	"unprognostic (7.10e-3)"	"unprognostic (2.43e-1)"	"prognostic unfavorable (1.81e-7)"	"unprognostic (4.07e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.85e-2)"	"unprognostic (4.51e-2)"	41.4	44.4	13.4	5.2	15.4	0.4	29.9	14.5	18.1	8.0	8.5	7.7	21.7	4.2	6.5	28.6	4.2	15.5	18.6	13.1	17.4	3.6	9.8	8.8	4.2	15.0	19.1	10.8	3.4	19.9	12.5	2.9	18.3	8.4	11.0	30.0	10.3	17.2	34.7	14.4	10.4	7.8	13.4	7.3	23.8	16.1	16.8	5.6	6.7	30.5	4.5	15.3	12.0	13.5	29.0	59.1	1.4	0.0	48.0	44.4	0.1	18.4	47.0	19.2	37.1	139.4	24.9	0.0	46.8	43.4	38.2	29.8	43.4	16.4	20.9	0.0	24.4	0.0	33.8	0.0	61.4	14.3	50.3	49.0	32.3	38.7	26.3	32.1	30.4	0.0	20.4	0.1	26.4	32.7	0.0	16.2	0.0	158.3	23.0	0.0	48.5	27.9	56.8	13.7	5.8	14.9	31.2	45.7	1.0	25.0	0.0	34.5	32.4	11.9	14.1	3.9	0.1	10.9	13.3	0.1	0.0	0.0	35.9	0.0	1.6	0.0	0.8	0.3	16.0	0.0	0.2	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	13.4	15.4	14.5	18.1	13.1	17.4	15.0	19.1	18.3	13.4	16.8	13.5	0.9	19.2	12.1	71.8	0.6	1.9	5.1	12.5	6.8	17.1	2.5	0.9	41.0	7.2	12.7	5.5	2.1	0.6	0.5	12.7	1.9	12.3	5.5	0.7	6.8	2.3	0.0	0.0	117.1	9.5	0.9	8.5	62.7	0.2	0.0	11.2	4.2	12.1	7.1	13.5	70.6	4.1	8.2	74.4	25.6	6.5	25.7	16.7	0.0	23.4	5.5	100.6	0.0	123.6	38.6	15.0	4.5	37.2	0.5	5.2	15.2	3.1	7.2	7.5	0.0	4.5	8.3	7.5	2.3	22.3	3.4	0.8	1.8	33.6	8.9	3.3
ME2		ENSG00000082212	"Malic enzyme 2"	P23368	18	50879080-50954257	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Allosteric enzyme, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Granulosa cells: 176.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008247, HPA008880"	Enhanced		Supported	Mitochondria		NA	NA		84000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 40: Granulosa cells - Unknown function"	Mitochondria		"HPA008247: AB_1853704, HPA008880: AB_1853702"	"unprognostic (1.23e-1)"	"unprognostic (3.26e-1)"	"unprognostic (9.57e-3)"	"unprognostic (2.22e-1)"	"unprognostic (4.97e-2)"	"unprognostic (1.23e-1)"	"prognostic unfavorable (8.29e-8)"	"unprognostic (1.97e-1)"	"unprognostic (3.66e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.34e-2)"	"unprognostic (4.75e-2)"	"unprognostic (1.43e-2)"	"unprognostic (4.27e-3)"	"unprognostic (2.30e-1)"	"unprognostic (2.47e-1)"	"unprognostic (4.09e-1)"	12.1	15.7	12.7	21.9	13.6	15.6	9.3	14.1	16.8	8.9	55.5	30.6	38.3	9.0	8.9	12.8	8.5	12.7	45.0	14.8	15.4	12.6	15.1	11.6	25.8	15.6	16.2	8.0	20.9	32.2	10.0	13.1	16.2	13.8	32.4	14.6	7.2	19.9	26.2	8.8	32.3	18.1	13.9	27.2	26.5	18.8	15.4	21.4	10.9	22.9	22.6	16.8	3.4	14.3	40.5	39.9	52.0	61.0	23.2	25.6	24.2	33.2	24.7	42.2	35.5	18.4	21.8	143.3	12.8	29.7	38.5	32.6	78.1	33.3	48.2	60.0	11.6	36.5	22.8	21.5	68.1	123.9	42.5	16.0	40.3	53.1	85.8	27.8	55.0	83.5	39.9	34.1	29.1	8.4	90.4	12.3	34.8	29.0	15.9	58.0	25.8	41.1	45.9	8.6	63.9	34.0	31.0	18.7	33.0	31.0	14.4	59.0	34.6	30.0	32.7	15.8	44.7	62.9	27.1	70.6	30.2	86.5	32.5	7.5	16.4	20.7	6.5	19.0	5.1	7.1	4.2	7.9	13.3	7.2	3.6	4.5	18.1	9.8	25.7	4.4	4.4	7.4	12.7	13.6	14.1	16.8	14.8	15.4	15.6	16.2	16.2	13.9	15.4	14.3	20.9	9.6	11.9	40.1	32.8	15.2	20.2	13.6	12.5	17.0	10.9	10.0	103.6	11.5	22.6	14.7	14.6	16.7	37.9	39.0	39.2	31.9	18.0	18.5	22.6	18.7	12.0	16.6	35.6	38.6	16.3	19.1	43.3	19.1	16.4	176.4	24.3	9.1	89.7	8.4	45.9	27.3	18.3	93.8	15.1	6.7	11.5	54.5	12.4	47.8	48.3	18.0	48.4	52.3	32.5	35.6	22.3	16.6	61.5	25.0	72.4	17.1	10.6	55.0	6.6	23.0	23.2	59.8	30.6	13.2	10.7	8.6	28.1	22.4	36.5	17.4
MEAK7	"KIAA1609, mEAK-7, TLDC1"	ENSG00000140950	"MTOR associated protein, eak-7 homolog"	Q6P9B6	16	84476355-84554033	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"Cytotrophoblasts: 40.4;Syncytiotrophoblasts: 47.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HBEC3-KT: 56.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041020	Approved		Supported	Nucleoplasm,Nucleoli,Cytosol		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 47: Cytotrophoblasts - Unknown function"	Cytosol	"Nucleoplasm, Nucleoli"	"HPA041020: AB_10794184"	"unprognostic (8.35e-3)"	"unprognostic (4.27e-2)"	"unprognostic (1.48e-1)"	"unprognostic (5.45e-2)"	"unprognostic (1.49e-2)"	"unprognostic (3.39e-3)"	"unprognostic (5.97e-4)"	"prognostic unfavorable (1.03e-5)"	"unprognostic (3.94e-1)"	"unprognostic (2.85e-2)"	"prognostic unfavorable (7.05e-5)"	"unprognostic (2.92e-2)"	"unprognostic (6.78e-3)"	"unprognostic (9.87e-2)"	"unprognostic (1.83e-1)"	"unprognostic (1.56e-2)"	"unprognostic (2.16e-2)"	3.0	2.2	3.5	3.6	3.0	1.3	4.7	2.1	2.8	4.6	3.4	4.8	4.1	4.7	5.6	12.8	3.7	4.3	2.4	4.0	2.0	4.5	3.4	4.1	4.5	4.1	1.7	5.1	2.6	6.4	2.0	10.8	4.2	4.7	4.9	6.4	3.8	3.8	3.0	7.2	5.4	4.2	0.3	3.4	4.0	2.2	2.3	4.5	4.9	2.1	6.4	7.2	6.6	4.2	29.1	20.0	17.1	9.2	7.8	13.3	8.1	21.1	18.8	21.2	6.1	11.5	34.2	4.0	11.1	40.8	15.5	31.5	4.9	56.1	27.7	2.2	4.2	3.2	9.7	10.0	9.6	2.5	9.6	9.5	23.9	19.8	25.8	17.1	9.0	11.1	5.3	4.7	14.3	6.8	2.2	2.5	5.2	15.1	7.0	9.0	4.3	1.3	18.7	15.9	5.6	4.0	19.1	13.5	9.4	17.9	19.1	3.9	22.0	14.6	6.7	7.8	8.8	3.7	6.7	10.6	8.8	1.3	5.1	16.9	2.9	4.0	3.3	2.4	3.1	2.8	5.6	4.6	2.5	2.3	6.1	3.8	2.3	2.8	3.2	0.6	8.0	2.5	3.5	3.0	2.1	2.8	4.0	2.0	4.1	1.7	4.2	0.3	2.3	4.2	5.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	40.4	0.7	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	10.9	2.7	0.0	0.0	0.0	0.0	0.0	0.0	8.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	47.1	0.2	0.0	0.0	0.0
MECOM	"EVI1, KMT8E, MDS1, MDS1-EVI1, PRDM3"	ENSG00000085276	"MDS1 and EVI1 complex locus"	Q03112	3	169083499-169663775	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Transcription factors"	"Apoptosis, Differentiation, Transcription, Transcription regulation"	"Developmental protein, DNA-binding, Methyltransferase, Transferase"	"Cancer-related genes, Disease variant, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"stomach 1: 73.3"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 184.8;Collecting duct cells: 125.0;Gastric mucus-secreting cells: 111.1;Glandular and luminal cells: 107.7;Microglial cells: 346.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"plasmacytoid DC: 1.6"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 55.5;RPTEC TERT1: 71.2;RT4: 119.6;TIME: 53.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046537	Supported		Supported	"Nuclear speckles"		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 15: RT4 - Unknown function"	"Cluster 44: Endometrium - Transcription"	"Nuclear speckles"		"HPA046537: AB_2679689"	"unprognostic (4.09e-2)"	"unprognostic (1.96e-1)"	"unprognostic (3.24e-3)"	"unprognostic (7.29e-2)"	"unprognostic (2.87e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.83e-2)"	"unprognostic (4.77e-3)"	"unprognostic (1.53e-2)"	"unprognostic (3.27e-3)"	"prognostic unfavorable (2.59e-4)"	"unprognostic (1.87e-1)"	"unprognostic (2.60e-3)"	"unprognostic (6.54e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.81e-2)"	"unprognostic (3.37e-3)"	16.0	0.9	7.3	7.3	7.2	1.4	12.3	8.5	7.3	21.3	2.4	24.9	19.8	17.3	4.4	13.5	23.4	8.3	13.0	4.9	6.3	41.3	1.4	25.5	1.5	9.1	7.2	2.3	23.3	1.7	4.2	17.4	8.9	6.9	30.0	1.8	8.8	8.0	4.3	2.6	10.2	8.0	4.1	6.2	73.3	3.0	8.1	2.0	5.7	12.0	5.3	30.4	7.5	6.3	25.8	0.7	0.9	0.2	3.7	2.7	1.1	3.7	4.2	1.1	2.2	10.7	26.1	0.9	39.1	0.6	5.5	13.4	10.2	15.7	3.1	1.4	16.6	16.7	7.6	1.1	0.4	0.3	5.1	5.7	2.2	1.0	12.1	12.0	55.5	1.4	13.0	1.8	10.3	9.8	0.9	0.4	1.7	13.5	6.6	9.8	13.1	0.3	71.2	119.6	1.0	3.1	1.3	6.7	0.3	1.5	7.1	1.1	53.4	9.7	6.6	2.5	16.9	1.4	0.7	0.9	4.8	1.0	1.6	0.9	0.4	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.5	0.2	0.0	0.0	0.3	0.4	0.5	1.6	0.1	0.0	7.3	7.2	8.5	7.3	4.9	6.3	9.1	7.2	8.9	4.1	8.1	6.3	80.2	60.9	184.8	16.0	0.6	2.2	33.3	29.4	10.2	0.0	1.2	0.9	11.4	2.8	69.6	125.0	0.0	1.1	0.1	25.5	52.8	1.6	10.4	71.9	5.8	70.5	19.9	7.4	10.3	75.4	0.2	4.8	111.1	107.7	9.5	0.8	69.3	0.2	0.0	0.0	9.1	29.0	20.3	0.6	1.9	3.2	0.3	2.6	1.8	346.6	1.0	0.0	0.0	6.0	13.8	49.8	19.3	0.0	0.3	13.9	6.2	0.7	53.2	0.1	0.0	1.4	5.7	3.0	1.2	39.4	1.4	0.4	1.3	0.5	53.9	45.4
MECR	"CGI-63, ETR1, FASN2B, NRBF1"	ENSG00000116353	"Mitochondrial trans-2-enoyl-CoA reductase"	Q9BV79	1	29192657-29230942	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism"	Oxidoreductase	"Disease variant, Dystonia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 42.1"	"Cell type enhanced"	"Detected in all"		"Late spermatids: 82.5;Rod photoreceptor cells: 68.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA022018, HPA022030, HPA028740"	Enhanced		Supported	Mitochondria		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 59: Non-specific - Translation"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 46: Photoreceptor cells - Phototransduction"	Mitochondria		"HPA022018: AB_1853714, HPA022030: AB_1853716, HPA028740: AB_10601133"	"unprognostic (2.53e-1)"	"unprognostic (1.09e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.46e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.07e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.69e-1)"	"unprognostic (3.06e-2)"	"unprognostic (8.66e-2)"	"prognostic favorable (5.81e-6)"	"unprognostic (7.01e-3)"	"unprognostic (3.29e-2)"	"unprognostic (2.59e-1)"	"prognostic unfavorable (5.29e-4)"	14.7	14.6	5.1	1.7	5.1	1.8	13.4	3.3	6.2	10.2	3.1	10.3	1.4	12.9	2.5	12.5	9.4	1.3	24.8	6.0	3.9	14.1	15.8	7.3	2.0	5.2	4.0	10.0	8.9	4.5	7.2	3.5	5.4	7.9	2.6	9.9	12.3	3.0	42.1	15.4	7.2	3.1	3.2	6.7	11.1	7.6	4.3	1.4	8.3	5.8	2.1	9.6	9.6	5.2	3.9	4.5	3.2	4.6	2.9	2.5	6.8	3.7	3.8	4.7	3.9	2.3	5.6	7.3	5.1	3.7	1.3	3.0	5.4	6.3	4.0	4.4	6.9	6.4	3.4	4.1	6.6	6.1	1.9	4.3	5.9	3.1	11.0	3.8	3.5	6.9	5.8	4.2	4.7	4.5	3.9	2.9	6.5	5.8	4.3	3.5	4.2	9.3	5.9	2.4	5.1	4.5	4.1	4.7	7.0	4.4	2.3	5.4	3.8	2.4	2.9	4.1	4.7	2.7	2.2	5.0	3.9	8.4	5.2	0.1	2.2	0.0	1.5	2.1	4.1	2.2	1.6	1.7	1.9	1.1	2.3	1.6	0.3	2.9	1.6	2.5	2.4	1.2	5.1	5.1	3.3	6.2	6.0	3.9	5.2	4.0	5.4	3.2	4.3	5.2	8.8	12.8	3.9	14.7	9.1	5.6	15.6	26.9	7.4	12.8	12.0	14.6	19.8	21.5	21.4	20.2	10.4	46.0	3.8	7.4	41.1	24.3	40.8	19.7	13.6	9.1	7.8	10.1	25.1	19.7	42.4	12.8	4.6	12.8	5.7	17.5	7.1	19.7	20.8	8.4	20.3	9.4	12.2	6.0	5.1	82.5	13.7	5.3	16.0	3.7	10.8	14.5	10.3	11.6	15.2	16.3	8.0	10.9	10.3	20.6	10.9	46.0	11.3	68.5	13.1	13.2	12.9	8.5	16.1	14.0	7.4	27.9	6.0	25.8	18.3	20.5
MED1	"CRSP1, CRSP200, DRIP230, PBP, PPARBP, PPARGBP, RB18A, TRAP220, TRIP2"	ENSG00000125686	"Mediator complex subunit 1"	Q15648	17	39404285-39451272	"Cancer-related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SK-BR-3: 206.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017696, HPA052818"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"CAB017696: AB_1128703, HPA052818: AB_2681962"	"unprognostic (1.77e-1)"	"unprognostic (1.63e-1)"	"unprognostic (9.26e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.18e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.21e-2)"	"unprognostic (4.50e-1)"	"unprognostic (7.86e-2)"	"unprognostic (1.95e-3)"	"unprognostic (4.09e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.78e-2)"	"unprognostic (2.00e-1)"	"unprognostic (5.94e-2)"	"unprognostic (9.40e-2)"	"unprognostic (5.79e-2)"	10.3	8.7	7.2	11.3	7.7	12.9	10.6	8.5	8.2	9.7	7.4	10.6	7.7	11.0	5.9	9.8	9.3	7.6	9.6	6.9	7.4	8.8	9.0	8.7	13.3	7.2	7.3	11.3	7.9	16.8	6.0	10.4	7.5	8.3	9.5	8.0	8.6	7.7	13.7	11.1	9.7	11.2	7.4	11.2	8.6	10.7	7.7	16.9	9.1	12.2	14.7	10.9	9.1	8.8	20.1	24.5	32.5	22.7	23.1	23.7	25.8	24.0	25.6	30.6	30.1	24.9	20.1	51.4	26.2	28.9	37.2	38.3	38.0	22.9	50.0	49.2	31.8	32.3	24.1	24.0	24.4	59.8	33.9	22.1	23.6	39.3	55.0	20.1	28.1	30.6	42.1	28.4	25.7	10.7	56.5	23.2	20.9	19.4	15.1	41.3	43.1	22.9	18.5	22.4	20.3	23.2	30.9	206.2	27.6	28.0	38.5	33.4	23.7	24.8	31.1	28.1	42.3	25.3	36.4	53.6	24.3	28.4	32.0	1.3	1.4	1.8	1.6	1.4	1.9	2.2	1.8	1.8	1.5	2.0	1.8	2.1	1.2	1.9	0.8	1.5	1.5	1.0	7.2	7.7	8.5	8.2	6.9	7.4	7.2	7.3	7.5	7.4	7.7	8.8	18.8	25.6	13.9	10.1	24.7	27.1	14.2	13.1	19.4	13.7	18.0	13.8	18.9	12.8	21.0	9.2	14.6	17.2	20.6	12.7	3.9	12.3	7.9	19.0	27.1	21.2	13.8	26.9	13.4	12.0	12.8	19.7	10.7	27.0	9.5	19.9	17.2	20.2	14.9	11.8	13.9	14.8	16.2	20.0	16.5	7.7	14.6	16.4	21.4	11.2	21.0	13.5	17.5	11.1	16.0	13.7	12.1	18.0	20.2	19.9	9.4	8.5	17.4	12.0	19.7	26.1	21.2	22.3	17.0	21.7	32.7	22.2	22.8	18.7	15.0	18.7
MED13	"KIAA0593, THRAP1, TRAP240"	ENSG00000108510	"Mediator complex subunit 13"	Q9UHV7	17	61942605-62065278	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, Repressor"	"Cancer-related genes, Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA067939			Supported	Nucleoplasm		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm		"HPA067939: AB_2685928"	"unprognostic (7.26e-2)"	"unprognostic (4.50e-2)"	"prognostic favorable (1.43e-4)"	"unprognostic (8.79e-2)"	"unprognostic (1.69e-2)"	"unprognostic (3.56e-1)"	"unprognostic (1.33e-1)"	"unprognostic (5.69e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.88e-1)"	"unprognostic (3.92e-2)"	"unprognostic (2.63e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.21e-1)"	"unprognostic (4.51e-3)"	"unprognostic (2.30e-1)"	12.4	9.6	7.9	10.7	12.4	34.1	11.2	16.4	9.6	12.3	11.3	12.5	11.5	11.8	8.8	11.2	9.3	12.7	8.8	9.2	6.9	13.6	22.1	10.9	12.7	9.5	9.8	13.5	12.5	17.6	5.5	15.3	10.6	10.2	12.7	17.8	10.0	8.9	19.4	11.4	10.6	11.9	8.0	11.5	12.2	19.5	10.2	20.7	15.9	28.1	12.7	13.3	8.4	15.3	24.9	29.0	22.0	18.0	19.8	21.4	16.7	13.4	19.4	26.5	25.5	22.2	13.2	26.4	12.3	21.2	19.9	15.0	28.2	17.5	36.9	17.2	16.6	43.1	20.9	14.3	20.7	38.1	19.3	16.6	19.8	29.0	32.8	19.1	20.3	20.4	35.8	43.9	18.3	41.8	34.6	11.4	11.7	28.9	14.8	28.1	56.2	16.2	18.6	28.8	17.3	32.6	28.0	8.0	17.5	21.7	28.8	26.7	25.6	30.2	44.3	15.9	25.6	21.2	25.8	35.4	16.0	16.7	17.6	1.1	1.1	1.3	1.3	0.5	1.6	1.0	1.3	1.4	1.1	1.5	0.9	1.6	4.0	1.4	2.9	2.8	1.6	0.4	7.9	12.4	16.4	9.6	9.2	6.9	9.5	9.8	10.6	8.0	10.2	15.3	54.7	64.1	54.0	107.7	37.7	78.0	45.9	23.6	45.5	52.3	45.8	28.1	27.8	52.9	36.6	23.9	45.9	19.1	57.2	57.9	9.8	16.7	47.4	48.1	63.7	42.0	44.3	42.3	96.9	20.0	11.7	45.2	35.7	83.3	26.0	42.0	35.3	45.5	19.1	62.2	107.3	41.7	32.6	30.5	78.6	60.1	30.7	52.0	32.0	89.0	36.7	36.5	24.7	135.2	136.7	28.6	38.4	32.7	41.1	62.6	33.4	19.1	29.9	40.3	32.9	81.6	45.9	48.1	22.6	48.0	81.7	43.4	40.7	32.3	32.9	81.0
MED15	"Arc105, CAG7A, PCQAP, TIG-1, TNRC7"	ENSG00000099917	"Mediator complex subunit 15"	Q96RN5	22	20495913-20587632	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"K-562: 240.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003179	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 59: Non-specific - Translation"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 63: NK-cells & T-cells - Immune response"	Nucleoplasm		"HPA003179: AB_1079581"	"unprognostic (7.98e-2)"	"unprognostic (2.26e-1)"	"unprognostic (1.70e-1)"	"prognostic favorable (7.30e-5)"	"unprognostic (2.53e-1)"	"unprognostic (1.76e-3)"	"prognostic unfavorable (3.71e-4)"	"unprognostic (3.73e-2)"	"unprognostic (1.12e-3)"	"unprognostic (3.46e-1)"	"prognostic unfavorable (9.09e-4)"	"unprognostic (1.18e-1)"	"prognostic unfavorable (1.61e-4)"	"unprognostic (1.32e-2)"	"unprognostic (2.50e-1)"	"unprognostic (3.60e-2)"	"unprognostic (5.57e-2)"	33.0	32.6	16.4	28.5	20.5	42.1	28.7	24.8	33.5	31.0	12.9	34.1	31.7	40.5	6.2	33.4	26.2	23.1	26.4	17.9	18.4	24.1	14.9	35.8	31.6	14.9	15.7	26.5	22.4	15.2	20.6	25.0	18.5	26.2	11.9	8.8	26.7	14.9	55.1	36.1	30.9	17.3	9.1	31.8	23.9	20.1	13.5	23.2	23.3	15.8	16.1	33.9	30.7	26.2	73.6	38.5	24.2	29.3	25.0	24.2	44.3	72.9	52.9	56.4	51.9	58.8	32.5	29.6	32.9	51.8	25.4	74.1	22.1	54.2	22.7	42.5	39.5	56.4	42.2	43.2	41.4	51.7	49.6	29.7	41.7	44.7	45.0	31.8	44.3	22.2	240.2	26.8	36.4	49.0	21.7	29.4	26.2	32.2	26.0	37.7	54.7	12.1	34.3	52.7	22.7	39.0	55.0	54.9	77.4	15.7	31.0	28.7	80.4	90.3	67.6	48.7	59.4	35.3	34.3	22.6	65.3	31.5	82.5	6.3	11.8	10.5	24.3	12.4	11.5	5.7	16.9	27.8	10.1	6.3	9.7	16.4	13.0	21.9	23.1	9.0	28.9	15.0	16.4	20.5	24.8	33.5	17.9	18.4	14.9	15.7	18.5	9.1	13.5	26.2	24.4	51.3	30.9	26.4	19.4	29.8	26.3	25.1	22.8	20.2	18.7	17.5	4.6	12.8	26.5	25.8	18.8	48.9	33.4	46.9	15.6	32.3	34.3	36.3	24.9	25.6	18.0	10.3	31.4	28.6	42.0	21.4	39.8	49.1	20.8	21.3	23.6	9.7	31.4	15.2	32.7	26.0	14.2	24.1	35.1	19.8	14.3	31.1	24.9	34.7	30.7	13.8	47.4	21.6	28.2	67.8	43.4	14.7	24.8	40.2	36.5	11.9	33.1	16.3	46.0	23.2	23.3	22.6	15.4	26.2	27.6	61.8	43.7	24.7	25.4	36.5
MED25	"ACID1, ARC92, DKFZp434K0512, TCBAP0758"	ENSG00000104973	"Mediator complex subunit 25"	Q71SY5	19	49818282-49840383	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	Activator	"Charcot-Marie-Tooth disease, Disease variant, Mental retardation, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 111.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 13.8"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 13.8"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA068802	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 59: Non-specific - Translation"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 49: Ciliated cells - Cilium organization"	Nucleoplasm		"HPA068802: AB_2686039"	"unprognostic (1.72e-1)"	"unprognostic (5.22e-3)"	"unprognostic (6.67e-2)"	"unprognostic (8.16e-2)"	"unprognostic (2.20e-1)"	"prognostic favorable (9.85e-4)"	"unprognostic (1.02e-3)"	"unprognostic (2.10e-1)"	"unprognostic (3.59e-2)"	"unprognostic (2.57e-1)"	"unprognostic (1.72e-2)"	"unprognostic (1.38e-2)"	"unprognostic (1.04e-2)"	"unprognostic (9.85e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.39e-1)"	"unprognostic (3.04e-3)"	21.6	76.1	16.2	18.5	14.4	34.5	23.7	14.7	23.4	28.6	28.4	30.5	18.6	36.2	8.7	32.3	33.3	14.8	42.5	16.3	15.5	27.7	15.8	26.4	18.3	16.3	17.5	44.9	30.6	15.8	43.7	18.9	15.8	23.8	13.2	16.0	26.9	11.9	97.8	28.7	27.9	16.0	13.2	30.5	39.3	82.1	16.6	16.9	39.8	18.4	17.8	27.3	26.4	12.9	44.6	65.3	30.5	33.3	20.8	18.4	30.7	23.6	27.4	37.3	36.6	58.7	50.1	51.2	16.3	30.9	25.6	38.4	32.8	34.0	23.1	30.9	58.3	33.7	45.6	41.2	24.6	36.0	46.1	22.7	28.3	32.8	22.9	31.4	32.3	29.0	61.6	36.3	20.8	25.5	36.0	69.8	22.5	36.9	40.6	43.5	30.3	53.3	33.6	64.1	54.4	50.1	32.4	48.9	15.2	23.3	29.1	27.1	39.3	40.1	29.2	19.4	26.6	41.3	63.1	55.3	35.6	30.8	24.4	0.8	2.2	3.8	1.3	1.7	1.5	2.3	1.1	1.4	1.8	3.3	1.2	0.8	13.8	0.9	1.6	2.2	1.4	2.0	16.2	14.4	14.7	23.4	16.3	15.5	16.3	17.5	15.8	13.2	16.6	12.9	10.6	35.3	22.9	17.0	18.5	5.6	15.8	16.0	10.2	10.8	17.7	13.3	5.7	8.6	16.8	20.2	43.8	27.5	16.1	28.8	1.9	23.6	54.3	58.3	18.3	10.8	44.3	54.7	10.5	24.3	22.8	15.8	23.0	24.1	7.6	62.5	7.1	5.8	21.5	8.4	12.6	18.8	18.3	13.8	11.6	111.7	15.8	16.5	3.6	7.5	22.8	9.1	11.3	10.6	10.9	28.7	28.6	11.3	20.4	8.8	27.8	17.6	77.4	28.3	13.1	11.9	19.8	49.1	39.0	11.3	5.3	33.8	14.5	62.0	18.0	16.5
MED27	"CRSP34, CRSP8, MED3, TRAP37"	ENSG00000160563	"Mediator complex subunit 27"	Q6P2C8	9	131852928-132079867	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 87.7;Oligodendrocytes: 130.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007002	Approved		Supported	Nucleoplasm,Nucleoli,Cytosol		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Nucleoplasm, Nucleoli"	Cytosol	"HPA007002: AB_1078574"	"unprognostic (8.81e-2)"	"prognostic favorable (1.59e-4)"	"unprognostic (2.42e-2)"	"unprognostic (2.21e-2)"	"unprognostic (9.57e-2)"	"unprognostic (1.32e-2)"	"unprognostic (1.55e-2)"	"unprognostic (6.07e-2)"	"unprognostic (6.63e-3)"	"unprognostic (1.63e-1)"	"unprognostic (8.59e-3)"	"unprognostic (5.93e-2)"	"unprognostic (7.45e-3)"	"unprognostic (9.16e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.32e-1)"	"unprognostic (4.60e-2)"	14.6	14.7	20.4	10.1	22.7	18.4	14.8	19.6	22.1	14.0	17.6	16.6	8.3	19.0	23.5	17.0	15.2	9.6	18.5	22.8	19.7	14.6	9.9	14.0	15.4	20.3	19.2	12.8	9.0	15.8	17.1	13.1	19.6	15.5	11.1	13.7	11.3	13.7	20.9	20.5	11.7	16.7	19.3	14.2	12.9	18.2	19.3	28.2	13.3	14.4	14.1	17.3	13.7	21.7	33.1	29.8	40.9	32.0	28.4	24.7	33.3	34.7	48.8	73.9	58.8	53.0	29.4	31.7	21.5	39.3	48.1	60.9	54.5	51.8	46.8	34.6	36.1	24.5	31.1	31.3	42.7	43.2	33.4	28.9	37.9	57.9	61.4	22.9	41.4	52.1	36.7	29.0	57.2	57.8	52.4	30.8	40.6	36.5	62.6	44.7	51.0	43.6	31.0	17.8	72.5	28.9	44.4	22.7	26.5	25.7	37.6	22.1	29.5	71.8	31.4	52.6	51.5	10.8	32.0	57.2	40.3	33.9	50.6	5.7	18.1	21.2	26.5	28.6	21.5	16.7	20.2	26.3	28.3	19.3	16.5	21.8	7.0	27.8	24.9	29.2	30.0	18.7	20.4	22.7	19.6	22.1	22.8	19.7	20.3	19.2	19.6	19.3	19.3	21.7	10.4	16.0	7.8	55.8	12.0	6.0	14.4	28.2	18.8	24.6	3.8	6.7	6.2	2.8	17.2	12.9	18.8	33.1	14.5	4.7	13.7	15.0	14.3	8.6	10.3	12.4	5.3	6.3	87.7	16.7	20.4	12.0	10.2	8.3	10.8	12.6	6.8	5.2	17.5	21.9	63.3	5.5	18.3	3.1	5.0	8.4	14.3	9.1	7.2	33.7	10.1	25.0	3.1	69.4	130.0	16.1	2.0	17.0	13.9	7.0	2.3	7.8	9.2	20.0	6.6	16.7	17.0	24.2	28.7	10.9	5.1	54.7	15.5	18.8	4.8	10.1
MED28	"DKFZP434N185, EG1, magicin"	ENSG00000118579	"Mediator complex subunit 28"	Q9H204	4	17614641-17634105	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Actin-binding, Activator"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035900, HPA035901"	Uncertain		Supported	Nucleoplasm		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 50: Non-specific - Ribosome"	"Cluster 24: NB-4 - Immune response"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"HPA035900: AB_10673223, HPA035901: AB_2674853"	"unprognostic (1.14e-3)"	"unprognostic (6.97e-2)"	"unprognostic (1.95e-1)"	"unprognostic (6.08e-3)"	"unprognostic (8.22e-3)"	"unprognostic (3.90e-1)"	"unprognostic (1.55e-2)"	"unprognostic (5.47e-2)"	"unprognostic (5.71e-2)"	"unprognostic (2.43e-1)"	"unprognostic (2.27e-2)"	"unprognostic (7.00e-2)"	"unprognostic (1.16e-2)"	"unprognostic (6.30e-2)"	"unprognostic (8.46e-2)"	"unprognostic (1.14e-1)"	"unprognostic (5.07e-3)"	6.9	5.6	8.8	7.5	9.3	12.2	9.2	9.4	8.8	12.2	8.8	9.8	5.9	11.5	9.7	7.9	10.6	5.2	6.4	8.4	9.4	7.7	6.2	9.7	10.8	9.4	8.8	14.8	7.3	6.6	10.3	8.5	8.4	9.1	6.9	11.7	9.2	7.3	12.6	10.2	9.6	7.2	8.6	10.2	8.7	6.0	9.6	11.2	9.8	5.9	11.1	9.1	9.9	11.9	4.6	2.9	23.2	11.7	10.0	7.8	9.4	6.5	7.7	8.6	7.8	8.1	10.9	12.6	4.5	6.0	7.6	4.5	14.1	7.0	8.6	5.0	7.0	22.2	10.1	12.3	7.0	15.7	10.7	7.6	9.6	5.4	4.5	9.0	7.5	18.0	20.0	11.3	7.7	4.5	23.3	27.0	16.1	9.1	4.8	17.8	8.5	5.9	8.2	6.8	16.6	8.3	5.7	4.9	5.7	13.6	9.3	16.0	9.4	5.6	3.9	4.0	6.2	8.4	4.0	16.1	5.1	14.9	6.1	5.2	6.6	6.5	4.5	5.2	4.4	5.5	4.9	4.2	6.4	5.6	6.4	5.0	9.0	5.5	4.4	4.4	4.2	7.5	8.8	9.3	9.4	8.8	8.4	9.4	9.4	8.8	8.4	8.6	9.6	11.9	45.7	19.2	27.6	4.9	67.6	92.2	114.0	86.2	46.1	42.6	54.9	65.8	19.5	38.6	55.2	22.0	16.7	114.5	69.9	25.9	84.1	61.6	11.6	31.2	47.3	63.9	44.3	93.2	5.1	53.8	167.8	57.9	19.4	35.5	59.1	78.4	52.5	31.5	93.9	33.7	5.8	41.2	65.1	74.1	103.0	20.4	56.5	61.7	60.5	5.6	115.4	58.9	94.7	9.5	8.9	57.2	47.4	47.0	33.0	110.2	33.6	58.8	40.6	35.1	32.9	50.5	74.7	76.0	100.5	46.0	93.5	134.6	61.3	62.7	47.5	104.6
MED29	"DKFZp434H247, IXL, MED2"	ENSG00000063322	"Mediator complex subunit 29"	Q9NX70	19	39391303-39400641	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA055956			Supported	Nucleoplasm		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm		"HPA055956: AB_2682986"	"unprognostic (3.30e-2)"	"unprognostic (3.51e-2)"	"unprognostic (1.51e-1)"	"prognostic unfavorable (7.27e-4)"	"unprognostic (2.68e-1)"	"unprognostic (1.92e-1)"	"unprognostic (2.85e-2)"	"unprognostic (1.71e-1)"	"unprognostic (5.36e-3)"	"unprognostic (1.46e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.70e-2)"	"prognostic favorable (5.15e-5)"	"unprognostic (9.51e-2)"	"unprognostic (4.84e-2)"	"unprognostic (2.17e-1)"	"unprognostic (1.87e-2)"	18.8	28.6	38.3	16.0	39.5	18.1	19.0	37.5	39.5	22.6	27.9	23.1	17.2	23.2	21.4	16.3	28.7	17.1	24.1	37.8	37.0	21.8	27.9	17.4	19.1	39.6	39.2	31.9	24.0	42.0	27.9	15.6	37.7	23.1	13.1	18.3	23.1	22.8	38.0	17.7	17.4	18.5	37.2	19.7	20.2	16.5	42.1	18.6	29.9	14.1	16.7	20.7	17.5	38.9	28.3	73.2	21.7	22.3	31.0	23.5	17.3	29.9	31.9	27.1	21.8	36.2	26.6	20.9	38.9	27.7	23.7	14.5	20.3	25.4	16.1	40.8	37.3	26.9	28.8	24.6	25.2	25.8	22.7	25.0	20.3	28.5	31.5	29.3	21.8	39.4	18.1	25.3	27.9	36.7	25.3	7.7	16.6	34.5	25.4	41.3	29.8	29.6	26.3	47.0	33.3	30.1	60.8	39.4	26.6	13.1	30.8	27.9	25.2	22.9	23.8	29.0	30.4	32.5	40.3	35.2	32.3	19.2	37.7	48.2	48.3	41.2	38.3	59.7	38.2	46.5	35.7	35.2	36.9	43.0	42.4	40.6	54.2	40.0	77.5	30.0	46.8	47.0	38.3	39.5	37.5	39.5	37.8	37.0	39.6	39.2	37.7	37.2	42.1	38.9	33.6	28.9	41.1	8.8	36.5	22.2	30.2	31.9	25.6	24.9	45.0	57.9	36.5	25.8	30.1	31.3	12.5	36.6	34.9	53.3	52.8	28.0	49.8	46.6	40.6	30.4	32.8	27.8	8.1	28.4	31.4	36.3	126.9	46.7	43.7	28.0	37.5	43.4	40.7	23.5	10.1	40.2	40.7	40.3	72.5	71.6	38.5	46.9	28.4	8.4	38.1	37.5	26.8	5.5	13.5	25.5	60.2	32.4	47.8	17.6	86.8	62.3	37.1	15.9	52.6	33.3	52.5	34.8	16.4	29.3	20.3	28.9	40.1	27.9	32.7	17.9
MED4	"DRIP36, HSPC126, TRAP36, VDRIP"	ENSG00000136146	"Mediator complex subunit 4"	Q9NPJ6	13	48053323-48095131	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006232	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 34: Non-specific - Transcription"	"Cluster 14: REH - Unknown function"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm		"HPA006232: AB_1079351"	"unprognostic (1.10e-1)"	"unprognostic (2.14e-1)"	"unprognostic (3.03e-1)"	"unprognostic (2.80e-1)"	"unprognostic (5.79e-1)"	"unprognostic (2.56e-2)"	"unprognostic (4.09e-1)"	"unprognostic (7.97e-2)"	"unprognostic (7.34e-3)"	"unprognostic (3.21e-1)"	"unprognostic (2.35e-1)"	"unprognostic (2.45e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.86e-3)"	"unprognostic (6.54e-3)"	"unprognostic (1.94e-2)"	"unprognostic (1.84e-1)"	44.2	34.1	26.5	34.0	26.0	78.6	46.7	33.6	35.1	37.2	25.2	41.3	40.6	40.3	43.5	41.1	31.2	32.9	49.4	26.5	26.7	38.4	51.4	36.9	46.7	25.7	25.5	31.9	27.4	43.2	31.4	45.6	27.0	36.7	46.4	41.4	33.6	38.5	57.7	39.9	41.1	43.2	25.7	35.9	33.9	55.9	26.2	63.7	41.1	58.4	55.5	43.4	35.8	28.4	40.2	25.8	86.1	47.8	55.8	71.4	59.5	57.1	70.9	66.8	47.1	49.3	66.9	65.2	16.0	60.5	41.3	59.6	63.1	54.2	86.7	85.0	51.9	85.6	49.5	77.6	51.7	128.1	76.4	49.6	75.2	39.7	58.2	65.2	63.1	64.8	61.9	40.7	75.5	40.6	121.3	121.4	85.4	128.2	33.5	87.4	58.3	52.9	87.0	61.7	38.0	61.2	46.5	57.8	63.4	55.5	49.3	94.6	51.1	37.5	43.4	47.0	52.7	39.2	61.7	100.2	32.2	65.9	72.6	105.0	65.5	106.3	74.6	70.0	82.6	65.4	84.2	76.6	64.5	58.0	80.4	77.0	69.8	86.6	74.3	58.5	101.6	91.2	26.5	26.0	33.6	35.1	26.5	26.7	25.7	25.5	27.0	25.7	26.2	28.4	71.3	96.1	53.4	12.7	71.1	91.3	72.8	164.9	34.7	51.5	48.1	42.9	100.8	60.1	116.5	57.0	16.7	116.4	96.0	51.7	152.6	79.4	87.9	46.4	69.8	73.8	26.9	106.9	24.7	63.4	104.4	74.1	31.6	60.5	98.1	43.9	59.3	66.8	70.3	37.0	20.1	51.2	124.1	51.9	65.4	185.6	76.7	51.2	78.2	14.0	136.6	65.2	102.0	20.1	20.4	66.8	67.4	77.5	46.5	69.7	66.1	100.1	62.8	50.2	52.6	58.7	78.7	141.4	162.8	48.6	97.3	134.9	79.4	61.1	56.9	71.5
MED6	NY-REN-28	ENSG00000133997	"Mediator complex subunit 6"	O75586	14	70581257-70600690	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030764, HPA069039"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA030764: AB_2673601, HPA069039: AB_2686070"	"unprognostic (1.65e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.22e-3)"	"unprognostic (1.04e-1)"	"unprognostic (1.72e-2)"	"prognostic unfavorable (1.04e-4)"	"unprognostic (1.74e-1)"	"prognostic unfavorable (2.75e-4)"	"unprognostic (2.23e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.48e-1)"	"unprognostic (6.93e-2)"	"unprognostic (2.86e-1)"	"unprognostic (3.32e-1)"	"unprognostic (1.01e-1)"	"unprognostic (3.15e-2)"	13.0	14.9	13.3	14.0	13.3	21.6	17.2	22.5	17.3	14.8	10.6	13.2	11.8	14.8	17.7	17.2	15.0	12.2	14.6	12.6	13.8	11.5	16.8	13.0	24.3	10.3	11.6	19.0	11.2	12.2	12.1	15.3	10.8	11.2	13.0	22.0	12.3	12.4	23.2	18.6	12.2	14.4	10.1	15.0	12.4	13.7	12.9	24.3	14.8	22.6	26.5	16.4	13.9	13.3	81.0	43.5	56.1	24.2	29.6	32.0	44.9	39.6	42.7	60.8	60.3	43.8	48.9	60.9	22.7	34.6	36.0	37.9	67.5	41.0	64.4	44.0	35.7	44.8	31.6	59.5	36.0	39.5	34.4	36.1	47.2	43.1	39.7	26.7	48.1	45.8	42.3	37.4	45.2	60.3	56.7	53.2	41.9	56.7	53.7	46.5	51.9	32.0	37.8	42.4	37.9	40.3	41.8	44.3	47.0	32.6	69.2	49.1	37.7	49.7	71.2	24.8	37.3	39.2	63.7	85.8	43.1	34.1	34.7	19.1	16.2	24.6	17.6	18.9	20.9	17.9	23.1	20.3	18.5	20.2	21.3	21.7	15.8	22.6	22.9	13.9	23.4	14.1	13.3	13.3	22.5	17.3	12.6	13.8	10.3	11.6	10.8	10.1	12.9	13.3	36.7	19.2	25.7	16.0	48.7	19.4	34.2	50.3	28.5	73.5	23.0	21.1	7.4	12.8	34.5	18.4	79.2	39.1	49.4	13.9	5.9	30.3	7.6	22.7	24.9	27.6	22.1	22.5	27.1	23.1	44.3	30.1	24.5	30.5	46.3	29.5	25.4	15.0	26.2	26.9	24.2	14.0	20.3	19.2	15.4	6.3	27.1	21.4	17.8	16.9	30.4	38.5	47.4	18.6	18.6	27.2	19.5	29.3	41.6	38.3	22.5	14.1	37.2	97.7	26.3	28.0	26.4	25.3	37.7	23.5	20.0	49.0	44.7	25.2	14.8	39.2
MED7	"CRSP33, CRSP9"	ENSG00000155868	"Mediator complex subunit 7"	O43513	5	157137424-157159019	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"Early spermatids: 314.5;Late spermatids: 289.0;Spermatocytes: 112.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA067181			Supported	"Nuclear bodies"		No	No			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 6: T47d - Mammary gland"	"Cluster 29: Early spermatids - Spermatogenesis"	"Nuclear bodies"		"HPA067181: AB_2685798"	"unprognostic (1.63e-1)"	"unprognostic (1.29e-1)"	"unprognostic (7.81e-3)"	"unprognostic (8.12e-2)"	"unprognostic (1.45e-3)"	"unprognostic (6.05e-2)"	"prognostic unfavorable (2.37e-5)"	"unprognostic (7.32e-2)"	"unprognostic (1.11e-1)"	"unprognostic (5.01e-2)"	"unprognostic (2.46e-2)"	"unprognostic (2.12e-1)"	"prognostic favorable (8.69e-5)"	"unprognostic (9.68e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.31e-1)"	"unprognostic (2.39e-3)"	10.1	11.4	7.9	9.2	8.3	10.5	12.6	9.9	11.1	8.4	10.3	10.5	6.3	9.2	13.5	8.5	7.9	7.6	10.2	8.3	8.4	15.5	10.1	8.0	12.9	8.7	8.2	10.8	6.9	10.9	8.0	8.2	8.5	10.3	11.0	12.0	7.6	7.1	14.3	6.0	8.8	9.0	7.6	12.3	10.0	26.5	8.4	9.7	11.8	10.9	11.6	9.3	6.4	9.0	13.2	15.3	20.6	14.5	17.2	12.2	15.3	20.5	11.8	15.2	19.2	20.7	24.8	23.4	17.8	15.4	29.1	16.3	11.5	23.0	22.2	10.1	11.1	8.7	15.3	11.1	15.4	12.6	11.9	14.5	16.5	13.5	14.8	13.3	19.5	15.2	8.1	17.4	24.5	12.9	12.5	11.0	6.1	18.3	18.9	11.2	17.9	12.9	32.6	18.2	15.9	11.9	13.8	14.1	19.7	16.1	36.0	12.8	14.7	22.3	18.3	11.6	18.6	16.7	19.4	11.3	14.0	17.7	18.1	40.9	22.3	30.8	19.3	24.6	23.0	35.4	23.2	24.4	16.1	34.5	34.4	24.8	19.3	26.1	35.7	15.0	28.3	22.2	7.9	8.3	9.9	11.1	8.3	8.4	8.7	8.2	8.5	7.6	8.4	9.0	12.3	9.6	10.1	6.2	17.1	7.1	14.8	52.4	7.4	22.7	9.6	11.3	20.8	10.0	26.6	23.9	22.9	38.0	10.7	15.3	52.8	28.0	314.5	10.7	12.9	12.3	11.4	17.7	9.1	18.7	22.9	14.4	13.3	9.4	20.3	15.7	16.4	9.4	22.8	18.5	9.5	12.0	32.6	19.9	12.0	289.0	18.6	13.8	3.6	5.6	20.4	22.0	35.0	4.5	10.7	18.9	14.1	16.6	11.8	11.3	16.1	40.2	21.7	14.3	6.6	10.5	18.1	112.9	43.0	7.5	6.0	30.5	16.1	22.4	11.5	14.2
MEF2A	"RSRFC4, RSRFC9"	ENSG00000068305	"Myocyte enhancer factor 2A"	Q02078	15	99565417-99716466	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Apoptosis, Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 262.8;Microglial cells: 708.3;Oligodendrocytes: 264.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004499, HPA046597"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 38: Heart - Muscle contraction"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"CAB004499: AB_627921, HPA046597: AB_2679714"	"unprognostic (1.89e-1)"	"unprognostic (8.82e-2)"	"unprognostic (5.91e-2)"	"unprognostic (8.04e-2)"	"unprognostic (8.68e-2)"	"unprognostic (2.05e-1)"	"unprognostic (2.25e-1)"	"unprognostic (6.26e-2)"	"unprognostic (1.93e-2)"	"unprognostic (1.91e-2)"	"unprognostic (7.08e-3)"	"unprognostic (1.46e-1)"	"prognostic favorable (6.93e-4)"	"prognostic unfavorable (7.96e-4)"	"unprognostic (4.69e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.69e-3)"	32.8	22.9	18.7	20.3	25.4	18.3	22.1	16.4	27.6	27.7	12.9	23.5	12.8	34.5	23.8	21.7	21.8	22.6	89.7	21.9	12.1	24.8	24.5	30.4	25.0	17.4	20.7	30.1	12.8	37.6	9.8	26.4	15.4	23.0	15.0	24.2	19.5	23.7	61.5	54.8	17.6	35.7	18.4	27.2	17.8	15.0	28.4	23.3	19.7	81.9	22.9	22.5	16.6	25.7	17.9	10.1	16.7	8.5	20.7	26.3	8.2	17.8	40.8	14.4	19.5	10.4	24.4	22.3	24.5	38.6	22.1	19.3	17.1	14.1	18.6	15.3	24.8	45.2	22.3	9.4	35.4	18.1	21.3	17.6	23.2	19.3	39.7	59.6	26.5	18.3	16.3	41.6	27.0	7.4	29.7	26.3	8.9	11.9	14.6	43.3	36.1	18.5	29.5	24.9	10.7	14.8	27.2	11.6	51.0	17.6	11.0	16.4	43.7	39.8	21.9	19.9	21.7	22.6	27.8	48.5	27.8	19.6	38.7	7.7	12.1	14.3	3.9	15.6	3.3	15.8	3.6	3.6	13.3	12.1	5.0	3.9	10.8	6.5	19.3	7.8	2.6	5.6	18.7	25.4	16.4	27.6	21.9	12.1	17.4	20.7	15.4	18.4	28.4	25.7	152.7	80.1	43.9	113.9	87.2	88.6	31.7	26.9	62.0	52.0	31.6	37.0	175.8	20.0	40.7	29.5	50.1	7.7	32.9	26.5	25.4	18.0	10.4	80.3	60.6	100.6	12.7	24.8	262.8	18.8	3.4	61.5	34.7	130.7	31.0	30.5	50.3	41.0	39.5	30.3	174.9	17.2	12.2	107.5	63.1	7.8	55.9	104.1	35.6	708.3	65.8	25.2	23.7	157.3	264.4	26.8	22.6	64.7	55.6	27.0	18.9	19.7	51.7	44.9	72.3	62.4	69.4	29.9	29.6	29.4	50.4	9.2	27.8	28.8	17.9	26.8
MEF2C		ENSG00000081189	"Myocyte enhancer factor 2C"	Q06413	5	88717117-88904257	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Apoptosis, Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"	"Disease variant, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"skeletal muscle: 555.4;tongue: 246.8"	"Cell type enhanced"	"Detected in many"		"B-cells: 471.5;Excitatory neurons: 735.7;Inhibitory neurons: 759.5;Microglial cells: 730.7"	"Low cancer specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"amygdala: 29.7;basal ganglia: 58.6;cerebral cortex: 75.3;hippocampal formation: 55.7"	"Group enriched"	"Detected in many"	4	"classical monocyte: 72.0;intermediate monocyte: 82.6;memory B-cell: 141.6;myeloid DC: 95.2;naive B-cell: 187.9;non-classical monocyte: 71.5;plasmacytoid DC: 100.3"	"Group enriched"	"Detected in many"	5	"B-cells: 187.9;dendritic cells: 100.3;monocytes: 82.6"	"Cell line enhanced"	"Detected in many"		"Daudi: 103.6;HEL: 229.3;Karpas-707: 121.6;REH: 261.8;WM-115: 145.2"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"amygdala: 70.0;cerebral cortex: 253.1;hippocampal formation: 220.0;olfactory bulb: 66.8"	"HPA005533, CAB068196, CAB068197"	Enhanced		Supported	Nucleoplasm,Vesicles		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 36: HEL - Hemostasis"	"Cluster 57: B-cells - Immune response"	"Nucleoplasm, Vesicles"		"CAB068196: AB_2665646, CAB068197: AB_2665645, HPA005533: AB_1079352"	"unprognostic (2.74e-1)"	"unprognostic (1.64e-2)"	"unprognostic (2.37e-2)"	"unprognostic (8.78e-2)"	"unprognostic (9.75e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.06e-1)"	"unprognostic (3.19e-2)"	"unprognostic (3.52e-2)"	"unprognostic (8.73e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.38e-1)"	"prognostic unfavorable (1.01e-4)"	"unprognostic (7.18e-3)"	"unprognostic (1.58e-1)"	"unprognostic (4.42e-2)"	"unprognostic (1.42e-2)"	28.9	26.8	29.7	39.2	58.6	11.1	17.5	0.0	75.3	18.8	0.0	15.9	6.9	25.9	7.3	13.6	17.3	28.5	35.2	55.7	0.0	10.4	10.5	21.3	62.9	0.0	0.0	34.9	5.6	9.3	6.3	45.5	0.0	20.0	15.4	34.2	9.0	17.7	555.4	4.9	11.2	31.5	0.0	43.8	12.7	9.4	0.0	12.8	21.7	246.8	77.7	21.3	7.6	11.0	1.6	0.0	7.1	0.0	7.7	4.6	0.2	2.2	4.5	0.3	1.0	0.2	1.0	103.6	0.6	12.0	2.5	3.1	9.6	9.1	0.2	31.7	12.5	229.3	12.3	0.0	2.8	10.4	0.6	21.6	0.0	0.3	0.0	1.4	35.1	0.0	12.3	121.6	9.0	0.0	0.3	0.1	2.2	0.1	8.4	261.8	63.1	50.5	0.0	1.2	0.0	8.3	0.0	0.7	29.5	3.9	0.3	58.0	40.4	5.6	1.0	0.6	5.4	92.0	11.5	62.0	1.5	70.1	145.2	0.6	72.0	0.2	0.2	82.6	0.1	141.6	0.2	0.1	95.2	187.9	0.2	0.2	24.3	16.7	71.5	100.3	0.5	34.4	29.7	58.6	0.0	75.3	55.7	0.0	0.0	0.0	0.0	0.0	0.0	11.0	367.4	32.1	52.0	117.5	471.5	10.7	4.2	0.0	7.4	22.6	5.2	26.5	86.4	10.0	21.7	1.8	214.8	0.8	138.6	9.2	27.4	0.8	11.0	0.8	13.4	197.5	1.2	59.1	735.7	12.7	1.2	26.8	2.0	1.0	5.1	107.5	283.4	3.4	171.1	5.0	759.5	1.5	0.0	205.8	127.5	8.6	29.8	205.1	67.6	730.7	202.7	61.8	8.2	119.6	18.7	0.4	3.0	71.8	314.7	2.1	0.2	0.8	3.7	202.9	335.2	72.7	257.6	4.0	29.5	2.5	8.4	1.6	12.2	58.6	6.3	2.3
MEFV	"FMF, MEF, TRIM20"	ENSG00000103313	"MEFV innate immuity regulator, pyrin"	O15553	16	3242027-3256633	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Immunity, Inflammatory response, Innate immunity"	Actin-binding	"Amyloidosis, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 6.1;lymphoid tissue: 8.9"	"Group enriched"	"Detected in some"	6	"Cardiomyocytes: 7.6;Kupffer cells: 15.1;Macrophages: 15.5;monocytes: 26.4"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in single"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 8.3"	"Group enriched"	"Detected in many"	4	"granulocytes: 8.3;monocytes: 5.7"	"Cell line enriched"	"Detected in some"	6	"THP-1: 6.6"	"Not detected"	"Not detected"							HPA077497			Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 2: Immune cells - Immune response"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	Nucleoplasm	Cytosol	"HPA077497: "	"unprognostic (2.67e-1)"	"unprognostic (1.06e-1)"	"unprognostic (4.96e-2)"	"unprognostic (2.01e-1)"	"unprognostic (2.49e-2)"	"unprognostic (3.10e-1)"	"unprognostic (7.06e-2)"	"unprognostic (3.35e-2)"	"unprognostic (2.97e-2)"	"unprognostic (1.09e-1)"	"unprognostic (8.89e-2)"	"unprognostic (3.27e-1)"	"unprognostic (7.58e-7)"	"unprognostic (1.08e-1)"	"unprognostic (7.16e-4)"	"unprognostic (1.73e-3)"	"unprognostic (1.48e-1)"	2.4	0.6	0.1	6.5	0.2	6.1	0.3	0.4	1.0	0.2	0.3	0.4	0.5	0.2	0.2	0.3	0.6	1.0	0.5	0.3	0.1	0.4	0.7	4.0	0.4	0.3	0.2	0.1	0.2	0.0	0.2	0.8	0.5	0.2	0.3	0.2	0.3	0.0	0.7	0.2	0.6	1.0	0.0	8.9	0.4	1.3	0.3	0.4	0.3	0.3	0.3	1.8	0.3	0.4	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	6.6	0.0	0.1	0.0	0.0	0.0	0.2	0.2	0.1	0.2	1.1	0.0	2.4	3.2	0.1	0.0	3.4	0.0	0.1	0.1	0.0	1.7	0.2	0.0	0.1	8.3	0.3	5.7	0.1	0.0	1.2	0.1	0.2	0.4	1.0	0.3	0.1	0.3	0.2	0.5	0.0	0.3	0.4	0.2	0.0	1.3	0.0	0.2	0.3	0.1	0.0	0.0	0.0	0.0	0.3	7.6	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	2.5	0.0	0.4	0.2	1.0	0.0	0.1	0.0	0.0	15.1	2.4	0.3	0.0	15.5	0.0	0.0	26.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.7	0.0	0.0	0.5	0.2	0.3	0.7	0.0	0.1	0.0	0.6	0.0	0.0	0.1
MEIS1		ENSG00000143995	"Meis homeobox 1"	O00470	2	66433452-66573869	"Disease related genes, Predicted intracellular proteins, Transcription factors"	Transcription	"Activator, Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 110.5;Endometrial stromal cells: 117.2;Horizontal cells: 82.4;Oligodendrocytes: 227.5;Rod photoreceptor cells: 121.0"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 18.2"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"NK-cell: 1.6;plasmacytoid DC: 1.3"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 43.5;HeLa: 29.3;HHSteC: 31.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011521, HPA056000, HPA058641"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 51: Non-specific - Unknown function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 36: Stromal cells - Cell proliferation"	Nucleoplasm		"CAB011521: AB_776272, HPA056000: AB_2683004, HPA058641: AB_2683784"	"unprognostic (6.84e-2)"	"unprognostic (1.08e-1)"	"unprognostic (3.43e-2)"	"unprognostic (1.34e-1)"	"unprognostic (4.22e-1)"	"prognostic favorable (2.70e-5)"	"unprognostic (2.45e-2)"	"unprognostic (7.78e-3)"	"unprognostic (2.36e-2)"	"unprognostic (5.91e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.92e-1)"	"prognostic unfavorable (1.69e-4)"	"unprognostic (6.52e-2)"	"unprognostic (9.71e-2)"	"unprognostic (4.13e-2)"	"unprognostic (2.01e-2)"	21.8	52.0	7.0	12.0	10.4	2.5	13.1	33.1	8.7	89.8	4.0	72.2	5.7	84.0	23.0	23.0	82.7	15.7	13.8	4.1	8.0	9.5	3.8	34.1	2.3	14.0	10.5	43.6	45.0	6.9	1.6	15.3	18.1	33.8	12.2	43.0	39.0	35.4	5.6	11.7	19.7	50.0	11.3	18.4	31.7	2.9	8.8	4.7	5.8	3.4	6.9	39.2	55.9	19.4	0.3	1.6	12.4	2.7	16.3	10.9	1.6	17.0	43.5	14.4	15.2	1.5	12.3	0.0	4.2	13.5	0.8	2.0	7.7	7.5	14.1	0.0	6.9	20.3	29.3	3.1	31.3	0.0	5.8	9.6	8.8	6.0	2.4	11.5	6.7	3.3	1.8	0.0	0.6	0.7	1.8	0.4	0.3	1.6	1.8	0.0	3.3	3.6	1.2	4.0	3.8	26.2	3.0	1.0	1.3	9.4	1.3	2.5	2.1	3.1	4.8	2.3	4.8	3.4	1.1	0.1	2.3	18.2	0.8	0.8	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.5	1.6	0.0	1.3	0.1	2.1	7.0	10.4	33.1	8.7	4.1	8.0	14.0	10.5	18.1	11.3	8.8	19.4	0.6	0.0	0.5	55.5	0.2	3.2	11.9	10.1	15.4	19.8	2.5	1.4	18.7	1.5	8.3	0.0	110.5	5.7	0.4	2.1	0.0	21.6	10.3	36.8	117.2	4.4	1.2	5.9	6.5	17.5	1.6	19.4	7.1	27.9	0.0	0.2	16.1	1.8	2.2	82.4	5.8	0.7	10.2	1.4	1.9	14.1	34.5	10.3	3.6	15.9	0.5	21.4	1.0	54.3	227.5	20.1	67.3	28.2	0.0	2.4	0.6	3.2	6.8	121.0	19.7	6.7	12.5	2.7	2.0	17.9	2.3	1.9	2.0	6.3	1.2	18.8
MEN1		ENSG00000133895	"Menin 1"	O00255	11	64803510-64811294	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding, Repressor"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030342	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm	Cytosol	"HPA030342: AB_10610138"	"unprognostic (2.06e-1)"	"unprognostic (1.76e-1)"	"unprognostic (3.78e-2)"	"unprognostic (2.31e-2)"	"unprognostic (1.05e-1)"	"unprognostic (8.41e-2)"	"prognostic unfavorable (1.08e-4)"	"unprognostic (2.66e-1)"	"unprognostic (2.59e-1)"	"unprognostic (1.42e-2)"	"unprognostic (4.96e-2)"	"unprognostic (1.36e-1)"	"unprognostic (7.39e-2)"	"prognostic favorable (6.31e-5)"	"unprognostic (1.40e-1)"	"unprognostic (3.03e-1)"	"unprognostic (3.76e-1)"	15.1	24.2	13.1	8.4	13.7	6.5	15.7	12.7	15.0	19.3	13.0	16.8	7.8	17.4	8.1	23.9	16.3	5.5	12.4	14.3	12.7	19.4	30.3	16.1	10.9	12.5	12.5	20.8	26.2	6.3	21.7	7.8	12.6	20.2	4.7	4.7	21.3	7.7	11.0	24.0	20.9	5.3	11.9	25.5	20.6	16.3	13.5	17.1	24.5	5.8	10.2	16.4	18.7	12.9	30.8	33.7	22.4	37.7	30.4	17.4	24.8	19.2	23.3	35.6	21.2	19.0	25.5	43.6	33.8	16.7	29.8	39.0	36.4	28.3	19.3	30.5	48.1	35.6	17.3	30.9	27.2	23.6	22.8	19.2	18.2	26.8	21.9	16.5	33.7	49.3	51.5	15.7	18.9	54.2	60.3	29.3	36.7	30.3	54.7	45.1	29.8	44.1	23.2	22.8	33.6	28.9	26.0	36.9	27.9	16.5	56.6	27.1	17.4	23.5	28.8	36.5	16.7	21.8	30.4	22.1	25.5	16.2	21.0	0.5	0.5	1.4	1.5	0.6	1.8	1.8	1.1	1.9	0.6	1.8	1.9	0.9	0.1	0.9	0.2	1.3	0.9	0.5	13.1	13.7	12.7	15.0	14.3	12.7	12.5	12.5	12.6	11.9	13.5	12.9	6.9	3.2	5.4	5.9	10.6	5.7	4.6	5.3	7.4	8.5	10.2	11.0	4.5	4.3	2.8	3.7	6.2	19.4	8.0	9.2	3.9	8.9	0.9	7.9	11.0	7.0	4.2	10.8	7.4	7.1	21.7	6.9	13.7	12.1	1.3	14.1	7.9	10.9	9.0	3.3	6.2	9.0	6.1	3.1	2.3	0.9	12.2	4.8	8.8	8.4	6.3	7.7	6.2	4.5	5.0	7.5	10.7	3.8	8.4	6.1	9.3	8.0	4.0	6.5	13.1	5.4	5.6	14.2	13.0	9.4	7.0	16.3	8.9	14.3	10.2	3.3
MESD	"BOCA, KIAA0081, MESDC2"	ENSG00000117899	"Mesoderm development LRP chaperone"	Q14696	15	80946289-80989828	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Wnt signaling pathway"	Chaperone	"Disease variant, Osteogenesis imperfecta"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 341.4;Extravillous trophoblasts: 279.3;Syncytiotrophoblasts: 436.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039414, HPA041721"	Approved		Supported	"Nuclear bodies,Endoplasmic reticulum,Cytosol"	"Intracellular and membrane"	NA	NA		1600000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 7: Non-specific - Mitochondria"	"Endoplasmic reticulum"	"Nuclear bodies, Cytosol"	"HPA039414: AB_10674981, HPA041721: AB_2756310"	"unprognostic (9.21e-2)"	"unprognostic (4.50e-2)"	"unprognostic (8.02e-2)"	"prognostic favorable (2.31e-4)"	"unprognostic (4.93e-3)"	"unprognostic (2.32e-3)"	"unprognostic (3.47e-2)"	"unprognostic (3.09e-3)"	"unprognostic (4.04e-1)"	"prognostic favorable (1.12e-4)"	"unprognostic (7.93e-2)"	"unprognostic (3.05e-2)"	"unprognostic (3.42e-2)"	"unprognostic (1.68e-1)"	"unprognostic (4.32e-2)"	"unprognostic (3.83e-1)"	"unprognostic (1.88e-1)"	14.4	17.4	11.9	13.7	13.6	5.4	13.9	13.7	13.0	17.8	14.6	14.6	12.8	11.3	42.7	14.6	12.4	11.5	12.8	11.7	14.2	14.4	20.6	14.1	14.0	13.4	13.1	17.4	19.2	14.0	17.8	26.9	13.8	18.2	14.5	10.4	18.4	14.3	7.7	10.9	12.7	11.1	13.4	13.8	15.3	9.8	13.8	14.2	33.7	10.6	13.2	15.4	14.4	15.0	26.8	40.2	34.6	22.3	57.1	32.4	54.0	40.0	47.4	42.7	51.6	36.0	72.9	22.4	45.4	32.3	45.1	43.8	54.1	41.1	40.3	50.2	35.5	28.3	33.0	61.9	43.7	33.8	30.0	33.9	46.6	36.1	42.4	35.7	41.1	27.0	34.7	55.5	36.7	34.0	20.9	28.3	41.9	39.3	16.4	31.7	21.3	59.7	35.6	36.3	29.9	17.6	43.9	29.3	70.0	62.4	34.0	26.8	32.4	40.9	39.1	22.1	52.2	35.0	48.0	30.2	38.5	59.7	43.8	39.4	26.1	19.1	35.6	24.9	41.8	34.5	37.2	35.4	27.2	35.4	34.6	34.7	8.1	44.8	22.5	45.2	42.5	31.1	11.9	13.6	13.7	13.0	11.7	14.2	13.4	13.1	13.8	13.4	13.8	15.0	59.7	80.1	59.6	0.0	20.6	0.0	0.0	0.0	0.0	0.0	51.0	44.2	0.0	0.0	27.9	58.8	0.0	341.4	41.6	0.0	13.7	100.9	0.0	41.4	79.4	36.9	0.0	0.0	0.0	111.9	279.3	48.4	0.0	69.8	36.6	56.4	0.0	0.0	122.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	38.0	0.0	0.0	86.3	0.0	0.0	0.0	0.0	82.5	0.0	0.0	18.8	0.0	0.0	48.8	43.0	0.0	0.0	0.0	36.8	0.0	0.0	0.0	0.0	436.0	25.8	63.6	0.0	0.0
MESP1	"bHLHc5, MGC10676"	ENSG00000166823	"Mesoderm posterior bHLH transcription factor 1"	Q9BRJ9	15	89748661-89751310	"Predicted intracellular proteins, Transcription factors"	"Notch signaling pathway, Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 4.5;prostate: 7.3;skeletal muscle: 4.5"	"Cell type enhanced"	"Detected in many"		"Breast glandular cells: 52.2;Breast myoepithelial cells: 58.9;Distal enterocytes: 40.1;Exocrine glandular cells: 43.0;Spermatocytes: 41.5"	"Cancer enriched"	"Detected in many"	4	"prostate cancer: 26.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 3.5;HDLM-2: 3.1;HEK 293: 3.0;PC-3: 5.7;SCLC-21H: 2.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA069981			Supported	Nucleoplasm,Nucleoli		NA	NA				"Cluster 47: Non-specific - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Nucleoplasm	Nucleoli	"HPA069981: AB_2686225"	"unprognostic (4.17e-2)"	"unprognostic (1.52e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.27e-1)"	"unprognostic (4.83e-2)"	"unprognostic (7.21e-2)"	"unprognostic (2.68e-2)"	"unprognostic (4.95e-3)"	"unprognostic (2.26e-2)"	"unprognostic (2.47e-1)"	"unprognostic (8.38e-2)"	"unprognostic (2.06e-1)"	"unprognostic (2.24e-3)"	"unprognostic (2.22e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.10e-1)"	"unprognostic (7.03e-2)"	4.5	1.4	2.4	0.0	2.7	0.1	3.0	1.7	3.5	0.5	0.5	1.4	0.1	0.1	0.0	0.3	0.2	0.0	1.3	2.7	2.1	0.7	0.8	0.2	0.0	1.7	1.5	0.2	1.2	0.2	1.0	0.0	1.9	7.3	0.0	0.2	2.1	0.1	4.5	0.2	0.5	0.0	1.2	0.1	0.5	1.3	2.6	0.0	0.5	0.3	0.0	0.3	0.4	2.0	3.5	1.3	0.0	0.3	0.0	0.0	0.0	0.3	0.0	0.1	0.1	0.0	0.2	0.0	1.3	0.0	0.4	0.0	0.2	0.0	0.0	3.1	3.0	0.1	0.6	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.9	0.0	0.1	0.0	0.1	0.5	0.8	0.0	0.0	5.7	0.1	0.0	0.8	0.0	0.0	2.6	0.1	0.7	1.1	0.8	0.0	0.0	0.4	0.0	0.0	0.2	2.0	0.6	1.3	0.5	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	2.7	1.7	3.5	2.7	2.1	1.7	1.5	1.9	1.2	2.6	2.0	1.7	0.0	1.1	2.6	2.9	0.3	2.8	5.1	0.6	11.6	52.2	58.9	6.3	17.2	33.9	1.8	10.4	3.0	3.2	40.1	11.7	18.6	5.3	0.3	0.3	2.1	6.1	3.0	2.8	43.0	0.2	3.5	0.5	0.9	4.5	22.1	4.2	12.8	2.0	8.4	3.0	7.4	12.2	1.6	2.1	2.1	1.2	2.5	7.2	1.0	2.1	19.2	2.1	1.5	1.7	4.8	17.9	0.0	4.6	35.7	7.2	16.2	8.7	20.6	0.0	4.0	3.7	41.5	21.7	2.0	0.3	0.3	2.2	18.0	15.5	6.2
METAP2	"MAP2, MNPEP, p67"	ENSG00000111142	"Methionyl aminopeptidase 2"	P50579	12	95473520-95515839	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Aminopeptidase, Hydrolase, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013025, HPA019095"	Enhanced		Supported	"Plasma membrane,Cytosol"		NA	NA		70000	"Cluster 6: Non-specific - Transcription"	"Cluster 52: Non-specific - Ribosome"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 10: Non-specific - Unknown function"	"Plasma membrane, Cytosol"		"CAB013025: AB_2533993, HPA019095: AB_1853823"	"unprognostic (1.91e-1)"	"unprognostic (1.02e-1)"	"unprognostic (5.92e-2)"	"unprognostic (2.44e-1)"	"unprognostic (3.27e-2)"	"unprognostic (2.57e-2)"	"prognostic unfavorable (4.51e-6)"	"unprognostic (1.25e-1)"	"unprognostic (2.28e-2)"	"unprognostic (1.40e-2)"	"unprognostic (8.53e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.49e-1)"	"unprognostic (2.51e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.95e-2)"	"unprognostic (1.03e-1)"	52.5	58.0	41.1	51.6	44.5	102.2	55.0	45.0	53.2	46.0	39.7	50.7	36.7	54.2	52.6	54.7	42.6	47.0	65.9	40.2	49.9	55.6	84.5	49.0	78.0	46.5	43.8	60.5	52.7	52.3	36.6	51.3	48.8	43.3	50.9	30.8	40.6	101.0	119.5	58.3	37.7	54.9	42.4	40.3	37.4	61.8	44.7	69.1	51.8	78.7	125.0	62.2	41.5	50.2	192.3	157.8	163.7	129.6	98.4	156.4	125.9	186.0	127.6	177.7	125.7	228.0	88.6	542.1	113.5	133.4	101.9	120.5	187.4	142.4	203.8	131.2	161.2	244.9	113.7	165.6	104.5	313.5	117.1	137.5	148.1	164.9	164.0	210.7	192.9	184.2	321.8	60.5	135.3	125.8	230.3	213.0	204.5	109.4	233.4	179.6	141.5	178.5	123.5	198.3	127.0	165.3	166.0	132.7	169.0	140.6	159.4	146.5	165.1	100.7	98.5	115.0	195.7	87.7	246.8	585.1	58.1	173.7	129.9	77.5	70.5	32.0	60.0	52.2	74.3	114.2	66.8	67.8	66.0	101.8	79.2	74.1	3.4	72.8	65.6	85.3	71.6	46.4	41.1	44.5	45.0	53.2	40.2	49.9	46.5	43.8	48.8	42.4	44.7	50.2	87.0	282.0	238.9	22.9	101.3	233.2	130.2	141.3	97.3	70.6	119.7	95.9	143.6	100.1	133.3	290.6	66.7	146.2	87.7	96.8	164.4	115.2	189.5	114.9	260.0	110.2	91.7	278.4	35.1	145.8	161.5	112.2	53.0	153.7	122.9	140.5	112.1	314.6	98.1	75.7	49.5	119.7	73.2	141.0	89.8	123.3	100.3	83.8	92.5	20.6	103.5	72.6	81.4	26.2	41.4	130.1	105.8	106.8	87.0	108.1	93.4	186.6	92.4	83.8	98.6	137.4	133.4	378.4	207.6	95.2	215.0	172.0	80.7	101.4	144.8	110.5
METTL14	KIAA1627	ENSG00000145388	"Methyltransferase like 14"	Q9HCE5	4	118685392-118715433	"Cancer-related genes, Metabolic proteins, Predicted intracellular proteins"	"Differentiation, Spermatogenesis"	RNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 96.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038002	Supported		Supported	Nucleoplasm		Yes	No			"Cluster 44: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	Nucleoplasm		"HPA038002: AB_10672401"	"unprognostic (4.48e-1)"	"unprognostic (5.13e-2)"	"unprognostic (5.98e-3)"	"unprognostic (3.44e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.83e-1)"	"unprognostic (3.75e-2)"	"unprognostic (4.40e-1)"	"unprognostic (9.97e-2)"	"unprognostic (2.40e-2)"	"unprognostic (3.64e-2)"	"unprognostic (3.33e-3)"	"prognostic favorable (1.46e-5)"	"unprognostic (1.05e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.76e-3)"	"unprognostic (7.76e-3)"	8.9	8.8	5.2	8.6	6.0	19.5	11.5	6.8	6.3	8.8	5.5	8.8	8.8	11.7	10.7	8.9	8.8	7.7	8.3	4.8	6.3	10.2	14.9	9.1	11.6	5.5	5.2	12.7	7.8	10.9	8.2	9.0	6.3	9.7	8.2	11.7	7.6	8.0	8.4	10.9	9.2	9.2	5.4	10.8	7.9	15.1	5.7	12.5	10.6	7.7	11.0	8.5	7.9	7.4	19.6	8.9	19.0	17.8	11.7	14.7	13.8	17.1	13.0	12.6	14.4	12.9	22.8	22.0	9.8	12.0	12.6	9.4	16.2	14.1	16.1	17.5	9.8	18.5	11.4	14.4	13.3	30.2	21.2	13.1	15.8	14.6	9.6	16.5	11.5	17.4	20.1	18.2	17.5	13.2	29.7	24.7	16.2	16.7	7.7	16.8	23.7	11.2	13.8	12.7	15.4	17.3	12.0	22.0	17.2	17.2	10.0	28.5	15.8	18.1	16.6	16.3	13.7	15.2	17.0	24.9	12.9	16.5	15.1	37.7	12.8	29.0	17.0	19.6	19.3	24.3	17.8	17.7	15.3	25.3	21.0	19.0	10.3	21.8	23.7	12.1	20.8	13.7	5.2	6.0	6.8	6.3	4.8	6.3	5.5	5.2	6.3	5.4	5.7	7.4	18.6	25.6	25.9	14.7	20.6	10.8	18.3	10.6	16.5	16.8	13.4	12.6	15.7	17.2	20.8	23.9	22.9	18.7	28.3	13.7	11.7	11.9	96.9	14.5	21.7	17.3	12.1	8.4	18.7	15.6	10.2	16.8	9.2	18.0	22.1	18.3	16.4	32.1	12.1	8.4	17.0	15.2	6.1	17.9	7.6	16.7	18.6	13.3	7.2	14.0	14.0	13.4	25.7	14.1	26.9	14.8	13.0	13.9	8.2	17.1	15.4	20.6	15.2	25.4	13.1	15.3	15.5	42.2	28.1	12.4	11.9	15.3	20.6	17.0	12.8	16.0
METTL16	"METT10D, MGC3329"	ENSG00000127804	"Methyltransferase like 16"	Q86W50	17	2405562-2511891	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Methyltransferase, RNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020352, HPA059798"	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	Cytosol	"HPA020352: AB_1853828, HPA059798: AB_2684128"	"unprognostic (4.94e-3)"	"unprognostic (2.86e-2)"	"unprognostic (2.29e-2)"	"unprognostic (5.66e-3)"	"unprognostic (1.50e-1)"	"unprognostic (5.47e-2)"	"unprognostic (3.35e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.25e-1)"	"unprognostic (3.46e-1)"	"prognostic favorable (3.06e-4)"	"unprognostic (5.35e-2)"	"unprognostic (4.85e-3)"	"unprognostic (2.91e-2)"	"unprognostic (2.32e-1)"	"unprognostic (1.61e-1)"	"unprognostic (2.68e-2)"	6.8	6.2	4.4	6.6	6.2	8.8	7.8	5.1	5.2	7.2	4.3	6.0	5.3	9.5	5.7	5.9	9.1	4.9	7.2	4.0	4.4	6.3	3.8	7.0	8.3	4.7	5.2	12.3	7.5	10.1	4.5	4.2	4.9	7.4	5.8	7.7	6.6	7.0	6.6	6.4	5.2	8.5	5.0	6.9	4.7	5.4	4.8	10.4	9.3	7.4	8.3	6.4	5.3	7.9	9.0	25.3	12.7	12.9	9.7	12.1	12.3	11.8	9.6	12.4	10.3	34.5	6.1	28.1	11.9	10.1	13.3	12.5	30.2	15.3	16.8	11.0	20.7	14.2	21.2	16.0	10.8	13.3	11.0	10.2	14.0	17.3	24.9	8.5	13.0	16.1	19.1	14.8	8.4	11.0	19.1	7.8	14.9	10.9	10.1	31.8	13.8	12.7	9.2	8.3	6.8	11.4	16.7	9.3	9.0	13.5	11.9	8.6	10.2	11.6	7.3	16.3	16.3	8.3	11.3	19.4	15.5	11.1	15.8	1.6	2.1	0.8	3.5	1.4	4.4	3.5	3.3	3.4	1.5	2.9	4.9	3.7	0.0	1.3	1.0	2.0	2.3	1.4	4.4	6.2	5.1	5.2	4.0	4.4	4.7	5.2	4.9	5.0	4.8	7.9	17.5	12.8	33.5	19.2	25.7	11.5	21.4	12.6	9.6	28.7	14.9	14.1	15.8	15.7	25.8	7.3	45.9	8.9	19.3	11.8	13.7	9.9	20.8	18.8	21.7	13.9	20.4	6.3	20.9	10.8	9.1	18.9	15.3	15.0	24.7	25.5	17.5	9.2	10.4	26.9	21.6	13.7	10.2	10.0	5.9	7.6	14.9	11.6	8.8	17.8	13.7	20.2	30.9	23.6	42.2	9.7	6.3	12.8	14.5	20.1	23.2	9.0	26.3	37.4	6.6	28.0	21.3	11.8	16.7	14.7	12.8	6.0	25.5	28.7	16.8	17.0
METTL22	"C16orf68, FLJ12433,MGC2654"	ENSG00000067365	"Methyltransferase like 22"	Q9BUU2	16	8621683-8649654	"Metabolic proteins, Predicted intracellular proteins"		"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"Early spermatids: 119.9;Late spermatids: 357.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 9.7"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040803, HPA059882, HPA074173"	Uncertain		Supported	"Nucleoplasm,Nucleoli rim"		Yes	No			"Cluster 1: Neutrophils - Mixed function"	"Cluster 21: Non-specific - Transcription"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 25: Spermatids - Spermatogenesis"	"Nucleoli rim"	Nucleoplasm	"HPA040803: AB_10795479, HPA059882: AB_2684150, HPA074173: AB_2686672"	"unprognostic (1.74e-1)"	"unprognostic (6.50e-2)"	"unprognostic (3.02e-1)"	"unprognostic (1.41e-1)"	"unprognostic (7.83e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.58e-2)"	"unprognostic (1.80e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.94e-3)"	"unprognostic (3.82e-2)"	"prognostic unfavorable (2.79e-8)"	"unprognostic (1.78e-2)"	"unprognostic (2.81e-1)"	"unprognostic (1.15e-2)"	"unprognostic (8.90e-2)"	4.4	5.8	9.0	5.7	10.2	7.7	4.5	16.4	13.2	6.7	9.5	5.9	4.9	5.9	6.1	5.3	5.4	4.4	9.3	8.8	9.1	5.1	6.6	4.7	6.1	12.7	10.7	6.4	6.1	3.1	5.1	5.0	13.3	7.2	4.0	10.4	4.7	5.2	20.2	8.4	4.1	4.7	9.1	4.7	5.1	13.7	12.6	4.0	5.2	5.9	5.0	5.5	5.8	12.9	4.3	8.7	9.7	9.3	3.6	9.1	8.4	7.2	3.8	8.4	9.5	8.5	9.8	6.7	6.3	6.4	3.1	7.9	6.1	11.5	5.5	9.8	8.4	6.9	17.3	24.6	10.8	7.2	5.1	9.2	8.2	9.2	10.1	5.1	6.8	9.2	9.4	6.6	6.5	15.2	7.4	17.0	5.2	1.9	8.5	11.1	7.3	13.9	4.1	4.5	11.9	7.9	6.3	7.3	4.7	5.2	8.0	5.9	5.4	10.0	8.7	8.2	3.3	8.9	5.3	10.4	3.6	9.3	4.7	1.6	2.5	2.0	0.9	1.9	0.9	0.9	0.9	1.0	2.3	0.8	1.1	0.5	9.7	1.6	2.2	1.3	1.2	1.0	9.0	10.2	16.4	13.2	8.8	9.1	12.7	10.7	13.3	9.1	12.6	12.9	5.1	9.6	5.6	8.5	7.6	3.3	6.9	7.5	8.6	13.8	5.8	6.1	18.3	4.3	6.0	0.0	4.2	12.8	2.7	4.9	11.7	9.3	119.9	3.5	6.5	7.2	7.2	18.5	13.4	9.8	9.8	7.4	9.2	3.5	8.2	11.3	5.7	7.4	29.5	1.7	14.3	7.0	2.0	31.8	9.6	357.8	10.8	27.5	1.8	12.2	17.6	4.9	11.3	12.5	13.3	8.4	6.8	13.9	7.7	11.0	8.3	8.9	3.4	11.8	0.0	9.0	8.5	39.6	15.7	7.5	2.7	13.3	6.6	7.8	6.5	8.1
METTL7A	DKFZP586A0522	ENSG00000185432	"Methyltransferase like 7A"	Q9H8H3	12	50923472-50932510	"Metabolic proteins, Predicted membrane proteins"		"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 440.5"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 986.4;Kupffer cells: 308.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"basophil: 95.7;classical monocyte: 35.7;eosinophil: 70.7;intermediate monocyte: 38.0;memory B-cell: 32.4;myeloid DC: 31.0;naive B-cell: 34.4;non-classical monocyte: 59.5;plasmacytoid DC: 25.3"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 420.7;Karpas-707: 401.7;RPMI-8226: 238.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA017434			Supported	"Lipid droplets"		NA	NA		18000	"Cluster 46: Basophils - DNA binding"	"Cluster 85: Liver - Metabolism"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 15: Hepatocytes - Hemostasis"	"Lipid droplets"		"HPA017434: AB_1853835"	"unprognostic (2.31e-2)"	"unprognostic (2.82e-2)"	"unprognostic (9.85e-3)"	"unprognostic (9.43e-2)"	"unprognostic (1.52e-1)"	"unprognostic (3.38e-2)"	"unprognostic (1.09e-3)"	"unprognostic (2.68e-3)"	"unprognostic (5.48e-2)"	"unprognostic (9.94e-2)"	"unprognostic (2.57e-2)"	"unprognostic (4.49e-2)"	"prognostic favorable (0.00e+0)"	"unprognostic (8.64e-2)"	"unprognostic (5.94e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.22e-2)"	143.6	86.7	59.6	35.2	71.9	15.2	54.6	66.1	53.6	43.9	67.7	67.7	62.8	42.9	29.7	39.1	89.1	79.6	28.1	48.4	66.9	144.9	440.5	60.1	49.4	79.6	79.1	90.7	115.6	48.1	17.3	25.4	69.0	28.5	63.3	15.5	60.7	41.6	64.6	26.1	60.5	62.0	61.9	53.6	87.4	19.3	68.8	29.7	243.2	53.2	50.2	50.7	35.4	68.0	1.5	0.2	8.4	61.3	420.7	115.0	130.0	1.1	8.9	1.0	1.5	4.7	5.2	69.7	5.2	4.6	1.0	8.2	6.1	6.9	0.3	7.1	15.4	17.0	11.1	43.2	88.0	4.5	33.7	118.0	0.9	0.9	0.5	2.1	26.9	2.5	10.1	401.7	3.9	0.0	3.3	19.8	44.6	1.6	0.0	3.7	0.5	238.2	20.3	79.1	21.9	37.3	1.5	41.0	1.0	11.5	114.4	4.1	17.1	1.0	1.2	4.8	0.5	18.7	3.7	30.3	7.8	8.4	0.5	95.7	35.7	70.7	2.4	38.0	1.5	32.4	1.0	2.2	31.0	34.4	0.3	1.6	2.1	10.3	59.5	25.3	9.4	17.7	59.6	71.9	66.1	53.6	48.4	66.9	79.6	79.1	69.0	61.9	68.8	68.0	73.5	201.9	125.6	96.0	47.2	8.7	53.4	41.8	30.1	2.9	37.4	26.7	14.1	240.2	72.5	71.7	0.0	76.7	19.9	159.0	43.0	11.9	2.2	64.2	48.1	43.5	67.9	131.8	4.1	37.3	29.6	83.0	75.4	28.4	32.9	16.5	140.7	986.4	37.3	8.4	5.1	64.4	30.5	308.8	23.1	10.6	216.6	73.2	12.4	45.0	59.8	114.2	29.9	43.2	10.6	3.5	59.3	149.0	65.7	30.2	134.6	145.6	263.1	5.3	52.6	57.3	42.2	1.6	1.4	28.3	9.2	38.3	12.9	52.7	74.8	46.2
MEX3A	"RKHD4, RNF162"	ENSG00000254726	"Mex-3 RNA binding family member A"	A1L020	1	156072013-156082465	"Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"ovary: 4.4"	"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 16.5;Breast glandular cells: 20.8;Breast myoepithelial cells: 20.2;Granulosa cells: 26.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 60.4;NTERA-2: 55.7;SCLC-21H: 57.4;SH-SY5Y: 105.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA062703			Supported	Cytosol		NA	NA				"Cluster 89: Fibroblasts - ECM organization"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 40: Granulosa cells - Unknown function"	Cytosol		"HPA062703: AB_2684840"	"unprognostic (8.63e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.55e-3)"	"unprognostic (6.18e-2)"	"unprognostic (2.71e-2)"	"prognostic unfavorable (9.23e-8)"	"unprognostic (4.25e-2)"	"unprognostic (1.79e-1)"	"unprognostic (2.09e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.08e-3)"	"unprognostic (4.73e-2)"	"unprognostic (3.21e-2)"	"unprognostic (1.75e-1)"	"unprognostic (4.96e-2)"	0.3	0.1	0.9	0.5	0.8	0.4	1.2	1.1	0.8	2.2	0.3	0.4	0.4	3.2	0.3	0.7	0.8	0.5	0.2	0.8	0.8	0.8	1.0	0.4	0.2	1.1	0.8	4.4	0.4	0.3	0.2	0.3	0.8	0.8	0.4	1.0	1.1	0.3	0.0	0.5	0.3	0.8	1.1	0.2	0.3	0.5	1.0	0.9	0.4	0.0	0.3	0.8	0.8	1.0	1.1	1.9	60.4	15.2	0.7	0.9	7.3	1.5	0.3	2.5	2.2	3.7	0.9	2.0	7.3	0.7	1.5	1.3	26.5	1.2	2.9	3.2	7.4	1.5	3.2	6.3	1.2	0.9	1.3	1.8	2.0	1.2	1.0	6.2	11.7	14.2	14.9	0.2	3.5	4.2	7.4	1.2	55.7	2.6	8.1	23.6	4.9	0.4	2.1	2.9	57.4	105.2	1.8	6.9	3.7	25.2	12.0	4.7	4.2	3.8	9.4	1.1	3.7	1.4	1.0	3.4	0.4	1.9	8.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.8	1.1	0.8	0.8	0.8	1.1	0.8	0.8	1.1	1.0	1.0	3.6	0.0	0.5	0.0	0.8	4.0	2.4	3.7	16.5	1.7	20.8	20.2	1.0	0.0	1.7	0.0	10.4	0.8	1.4	0.6	1.9	11.8	0.2	4.3	13.3	7.6	6.0	3.8	0.2	1.5	2.2	4.1	1.1	7.7	0.0	26.8	8.6	6.7	2.2	3.3	0.6	1.8	10.2	1.0	1.5	0.4	5.0	1.2	5.4	0.0	0.0	1.4	0.0	5.5	0.7	3.5	0.2	1.2	0.4	8.3	0.0	11.9	4.3	3.1	0.0	3.4	12.5	0.3	4.3	6.0	3.4	0.3	1.2	4.3	2.5	1.9
MFAP1	AMP	ENSG00000140259	"Microfibril associated protein 1"	P55081	15	43804492-43824690	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Syncytiotrophoblasts: 147.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015583, HPA042370"	Uncertain		Supported	Nucleoplasm,Centrosome		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm	Centrosome	"HPA015583: , HPA042370: AB_10796904"	"unprognostic (1.05e-1)"	"unprognostic (5.94e-2)"	"unprognostic (2.56e-2)"	"unprognostic (1.23e-2)"	"unprognostic (2.06e-1)"	"unprognostic (5.28e-2)"	"prognostic unfavorable (2.50e-4)"	"unprognostic (4.08e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.66e-2)"	"unprognostic (3.12e-1)"	"unprognostic (7.02e-2)"	"prognostic favorable (1.04e-9)"	"unprognostic (1.66e-2)"	"unprognostic (9.68e-2)"	"unprognostic (3.82e-3)"	"unprognostic (1.54e-2)"	15.9	24.0	17.5	17.6	18.0	12.9	21.4	21.3	23.2	16.6	19.7	17.1	14.5	18.8	23.4	22.2	18.4	14.9	22.1	17.7	19.3	23.7	18.1	15.2	26.6	18.3	19.3	24.8	15.3	33.2	14.5	23.2	18.7	22.8	18.1	25.0	17.0	17.7	26.3	20.5	15.0	19.1	17.7	17.1	16.8	19.3	18.5	24.4	24.7	23.2	32.4	20.6	17.5	19.1	40.1	41.0	69.4	46.0	57.9	36.3	42.7	63.1	43.8	50.3	58.2	64.1	25.6	42.8	58.7	39.4	50.9	70.8	62.5	51.7	58.9	72.9	37.6	103.7	71.6	48.5	45.4	62.3	53.2	34.1	55.3	48.0	43.3	48.0	49.8	48.3	95.8	35.7	60.9	30.0	51.1	47.0	49.2	74.2	35.4	73.9	69.6	27.6	52.0	59.0	43.8	43.0	55.6	47.0	27.0	55.2	70.7	39.5	47.4	50.6	35.8	56.3	51.7	43.5	112.2	91.8	42.5	58.4	37.9	42.5	25.5	56.9	35.3	34.8	34.7	35.0	35.1	33.6	32.6	28.3	35.7	35.0	22.6	50.5	29.1	26.8	44.1	26.3	17.5	18.0	21.3	23.2	17.7	19.3	18.3	19.3	18.7	17.7	18.5	19.1	30.4	35.3	30.2	5.2	32.8	30.3	59.6	50.1	35.9	41.8	22.4	28.8	31.0	25.8	43.2	51.5	6.2	94.6	33.2	27.4	56.7	44.2	6.2	43.1	39.9	35.6	11.3	32.0	9.0	29.4	55.0	29.8	21.4	39.4	46.3	37.6	20.7	18.8	35.4	32.0	8.6	24.4	38.7	20.7	20.5	6.3	28.0	25.5	26.6	5.6	30.6	51.5	33.0	2.0	8.2	26.8	27.1	35.7	20.6	39.3	22.1	42.9	60.0	35.2	19.7	35.9	41.7	49.7	84.8	28.1	27.7	147.4	33.6	39.4	21.3	50.6
MFAP3L	"KIAA0626, NYD-sp9"	ENSG00000198948	"Microfibril associated protein 3 like"	O75121	4	169986597-170033031	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 65.5;choroid plexus: 88.8"	"Cell type enriched"	"Detected in many"	4	"Late spermatids: 1840.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"basophil: 5.7;eosinophil: 1.8;neutrophil: 3.5"	"Lineage enriched"	"Detected in single"	8	"granulocytes: 5.7"	"Cell line enhanced"	"Detected in many"		"HMC-1: 22.5;RT4: 38.0;SK-BR-3: 34.3;SuSa: 19.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017986, HPA062306, HPA077490"	Enhanced		Supported	"Nucleoplasm,Cell Junctions"	"Intracellular and membrane"	NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 31: Spermatids - Spermatogenesis"	Nucleoplasm	"Cell Junctions"	"HPA017986: AB_1853842, HPA062306: , HPA077490: AB_2686842"	"unprognostic (8.04e-3)"	"unprognostic (8.67e-3)"	"unprognostic (3.74e-1)"	"unprognostic (1.28e-2)"	"unprognostic (4.51e-2)"	"unprognostic (7.92e-2)"	"unprognostic (3.50e-2)"	"unprognostic (3.14e-2)"	"unprognostic (2.67e-1)"	"unprognostic (2.33e-1)"	"unprognostic (3.96e-1)"	"unprognostic (7.58e-2)"	"prognostic favorable (1.42e-8)"	"unprognostic (6.59e-3)"	"unprognostic (2.12e-1)"	"unprognostic (1.62e-4)"	"unprognostic (2.40e-3)"	2.0	3.4	32.9	0.9	61.0	3.2	12.0	49.1	34.4	13.0	88.8	2.7	0.6	5.1	38.9	0.8	4.2	2.6	1.7	35.2	40.1	30.0	37.4	2.7	0.9	46.3	58.3	0.6	1.5	6.5	4.1	3.0	48.5	2.8	2.0	25.0	2.1	12.8	5.1	24.5	1.0	4.1	38.8	1.5	1.3	46.3	54.9	0.6	2.8	2.3	0.5	10.1	1.8	65.5	0.4	5.7	3.0	3.1	2.6	1.3	1.1	6.2	0.9	2.8	2.5	1.9	0.4	0.0	0.2	9.6	5.4	2.9	10.9	1.4	1.2	0.0	4.7	0.0	6.7	2.4	1.4	0.0	22.5	1.8	3.4	0.3	1.0	1.5	0.3	3.5	0.9	1.1	5.8	3.4	1.0	0.8	3.1	0.7	4.7	0.0	1.8	0.0	8.1	38.0	2.5	5.5	5.1	34.3	11.6	19.1	1.9	0.0	0.2	2.9	11.2	5.5	11.9	0.6	0.0	0.0	7.5	1.2	11.4	5.7	0.1	1.8	0.6	0.7	0.3	0.0	0.5	0.1	0.2	0.0	0.2	0.1	3.5	0.0	0.0	0.5	0.1	4.6	32.9	61.0	49.1	34.4	35.2	40.1	46.3	58.3	48.5	38.8	54.9	65.5	1.0	0.0	5.6	112.6	0.6	2.5	0.4	0.1	2.8	12.2	8.5	9.7	3.4	0.0	0.2	36.8	20.9	3.1	0.2	0.6	5.9	0.5	417.5	8.5	1.1	2.0	2.4	11.2	36.3	1.1	1.0	0.6	0.0	12.4	4.5	11.0	3.3	49.1	1.2	3.3	25.0	0.3	0.0	1.0	0.7	1840.0	5.3	13.5	7.2	3.7	1.5	2.9	2.1	53.8	127.6	1.4	0.3	9.1	0.5	0.9	0.3	24.0	0.3	15.8	19.7	1.7	4.2	17.6	13.2	0.3	8.4	9.4	0.6	1.4	0.8	2.2
MFF	"C2orf33, GL004"	ENSG00000168958	"Mitochondrial fission factor"	Q9GZY8	2	227325151-227357836	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 985.9;Late spermatids: 1746.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010968, HPA074625"	Enhanced		Supported	Mitochondria		No	No		62000	"Cluster 2: Granulocytes - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 20: HeLa - Mitochondria"	"Cluster 25: Spermatids - Spermatogenesis"	Mitochondria		"HPA010968: AB_1845714, HPA074625: AB_2686704"	"unprognostic (2.75e-2)"	"unprognostic (1.35e-1)"	"unprognostic (2.16e-1)"	"unprognostic (1.15e-2)"	"unprognostic (1.73e-2)"	"unprognostic (1.46e-1)"	"prognostic unfavorable (1.20e-4)"	"unprognostic (3.07e-2)"	"unprognostic (1.32e-1)"	"unprognostic (6.07e-2)"	"unprognostic (3.00e-2)"	"unprognostic (6.24e-3)"	"unprognostic (5.50e-2)"	"unprognostic (1.00e-1)"	"unprognostic (2.70e-2)"	"unprognostic (1.51e-1)"	"unprognostic (3.22e-1)"	52.3	58.0	61.2	29.3	66.6	48.1	46.9	67.4	71.8	49.0	63.5	60.9	41.0	46.6	37.9	48.4	49.0	31.0	66.2	60.0	67.3	68.8	44.2	38.9	39.4	66.4	61.7	51.6	57.2	60.0	42.7	33.4	66.1	42.5	40.9	80.4	43.8	47.9	100.4	44.8	40.5	42.3	67.3	38.7	49.0	199.2	63.5	51.5	37.1	86.5	44.5	50.1	45.9	74.5	71.1	60.6	72.4	100.5	92.7	88.6	95.3	69.1	93.7	82.6	88.7	66.4	49.8	40.3	80.1	76.9	87.5	57.8	121.0	88.5	112.6	86.4	97.3	85.8	144.5	165.0	122.4	84.2	73.6	79.6	113.9	79.0	84.3	109.6	72.7	91.6	76.7	117.8	75.3	72.5	88.9	127.3	98.6	76.7	62.5	79.0	91.8	78.7	124.2	66.5	76.3	70.8	153.3	68.7	106.7	59.4	44.8	82.0	49.7	80.6	67.0	119.2	78.3	95.2	69.6	81.9	106.1	73.6	111.7	118.5	66.8	133.6	65.2	74.0	69.9	84.0	67.5	63.9	72.0	77.9	70.4	60.2	65.1	67.7	70.0	71.9	97.5	76.3	61.2	66.6	67.4	71.8	60.0	67.3	66.4	61.7	66.1	67.3	63.5	74.5	40.4	32.1	46.7	53.8	74.8	48.3	62.1	70.3	90.5	33.1	54.9	64.1	79.3	44.3	57.0	60.7	31.3	95.3	49.8	46.2	127.2	95.2	985.9	36.7	40.3	45.6	32.3	73.6	95.8	94.8	89.8	67.6	42.8	52.0	22.1	66.4	43.5	56.1	78.4	40.4	97.7	60.3	61.1	61.5	56.4	1746.9	88.0	63.0	81.8	47.8	64.0	204.4	74.2	135.2	151.3	91.7	63.8	85.7	127.7	66.5	69.5	135.7	32.3	65.5	59.2	69.1	62.1	392.3	96.9	87.6	47.3	91.9	57.2	63.7	73.0	71.6
MFN1	FLJ20693	ENSG00000171109	"Mitofusin 1"	Q8IWA4	3	179347709-179394936	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Inhibitory neurons: 92.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB033437, HPA059230"	Approved		Supported	Mitochondria		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 6: T47d - Mammary gland"	"Cluster 44: Endometrium - Transcription"	Mitochondria		"CAB033437: AB_2250540, HPA059230: AB_2683952"	"unprognostic (2.94e-2)"	"unprognostic (5.56e-2)"	"unprognostic (5.44e-3)"	"prognostic unfavorable (6.70e-4)"	"prognostic favorable (6.11e-4)"	"unprognostic (1.23e-1)"	"prognostic unfavorable (8.08e-5)"	"unprognostic (6.37e-2)"	"unprognostic (1.86e-2)"	"unprognostic (3.70e-2)"	"unprognostic (3.76e-3)"	"unprognostic (7.91e-2)"	"unprognostic (7.90e-2)"	"unprognostic (1.58e-1)"	"unprognostic (3.83e-1)"	"unprognostic (6.24e-2)"	"unprognostic (9.79e-2)"	9.5	9.0	5.6	9.4	6.6	8.4	11.0	8.8	8.5	9.5	8.8	12.5	8.9	11.4	14.9	14.1	10.2	9.6	23.4	5.6	5.5	10.4	8.8	8.8	12.8	6.3	5.8	9.1	17.9	13.3	6.7	7.9	6.0	12.4	10.5	10.3	14.1	9.6	14.0	14.5	9.8	11.4	5.2	9.9	10.8	9.0	5.7	8.6	10.4	16.4	11.9	12.7	8.9	9.5	32.2	9.4	17.9	29.1	25.1	23.2	23.6	19.6	20.2	20.2	23.9	23.5	13.0	10.8	20.0	29.1	40.9	18.5	25.4	19.4	35.3	17.2	19.5	17.8	19.4	13.1	20.5	9.5	16.3	16.2	16.7	21.9	15.4	16.8	26.0	17.9	13.2	14.1	28.6	17.1	14.0	7.1	21.3	32.1	17.3	9.7	28.1	40.4	19.1	33.4	16.8	23.9	18.3	48.5	26.6	18.2	66.6	6.8	22.0	17.6	19.4	27.6	29.0	18.6	21.9	18.0	19.7	15.8	19.5	4.2	2.5	5.8	2.6	3.1	4.5	5.1	3.0	2.7	2.3	6.2	2.7	3.2	5.8	2.9	2.4	2.8	2.9	1.4	5.6	6.6	8.8	8.5	5.6	5.5	6.3	5.8	6.0	5.2	5.7	9.5	21.3	25.6	36.8	39.8	27.3	16.7	12.3	12.6	20.5	18.8	19.1	14.4	29.3	14.3	23.7	18.4	39.6	11.2	20.9	18.2	9.8	12.6	6.6	36.9	28.5	16.3	10.2	24.0	77.2	17.4	11.0	22.6	26.0	43.4	8.8	22.1	14.6	18.3	7.8	11.8	92.5	18.2	12.2	11.7	11.4	3.3	13.4	14.9	12.4	28.1	12.2	11.2	18.6	56.8	85.1	16.5	11.8	17.7	21.2	20.0	10.4	13.4	31.9	16.5	6.6	26.8	21.2	33.2	13.7	24.9	27.0	13.1	15.1	25.3	16.6	20.7
MFN2	"CMT2A2, CPRP1, KIAA0214, MARF"	ENSG00000116688	"Mitofusin 2"	O95140	1	11980181-12015211	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Apoptosis, Autophagy, Unfolded protein response"	Hydrolase	"Charcot-Marie-Tooth disease, Disease variant, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 270.4;skeletal muscle: 310.5;tongue: 337.6"	"Cell type enriched"	"Detected in all"	7	"Cardiomyocytes: 336.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030554, CAB079902"	Uncertain		Supported	Mitochondria		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 54: Cardiomyocytes - Muscle contraction"	Mitochondria		"CAB079902: AB_2724683, HPA030554: AB_10603018"	"unprognostic (9.52e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.42e-1)"	"unprognostic (4.38e-2)"	"unprognostic (8.36e-2)"	"unprognostic (9.71e-2)"	"unprognostic (1.89e-1)"	"unprognostic (2.44e-1)"	"unprognostic (3.45e-1)"	"unprognostic (2.19e-2)"	"unprognostic (1.43e-1)"	"unprognostic (3.55e-1)"	"prognostic favorable (2.36e-8)"	"unprognostic (4.69e-2)"	"unprognostic (2.76e-1)"	"unprognostic (8.84e-3)"	"unprognostic (2.12e-1)"	34.7	31.4	39.9	20.9	42.4	26.7	31.8	39.1	41.4	29.3	17.4	59.7	41.9	37.0	12.7	57.3	26.2	21.8	270.4	34.7	43.0	36.5	58.5	31.1	19.8	41.1	44.8	27.0	22.5	76.7	28.7	27.6	40.6	36.3	38.1	35.0	32.2	62.3	310.5	58.9	46.3	41.2	43.5	31.5	44.9	25.4	48.8	26.1	56.1	337.6	30.4	51.2	36.2	40.5	93.6	54.0	52.6	72.7	59.7	47.2	58.8	76.0	66.1	96.5	72.6	88.7	51.8	68.8	74.8	92.6	60.6	80.5	101.7	156.1	90.6	60.6	75.4	94.5	81.8	54.2	53.8	114.2	51.9	57.0	105.1	133.1	124.5	40.1	66.2	26.4	106.1	53.6	69.7	30.2	60.2	15.2	39.7	57.8	77.4	68.2	95.8	58.5	44.9	61.4	68.2	44.6	88.4	81.0	74.6	41.4	43.8	49.2	71.2	63.1	58.3	88.4	71.2	59.0	86.4	120.7	69.0	99.6	69.8	10.4	11.5	7.6	8.9	14.0	10.2	6.7	6.7	7.9	9.7	4.8	5.0	6.2	16.2	6.2	18.3	4.2	8.1	15.7	39.9	42.4	39.1	41.4	34.7	43.0	41.1	44.8	40.6	43.5	48.8	40.5	18.1	22.4	15.8	16.6	10.2	22.8	9.4	18.9	19.9	26.7	17.4	16.4	336.9	7.2	14.9	14.7	12.5	15.1	12.5	39.2	21.5	13.6	4.7	8.9	12.1	18.5	18.0	32.4	21.5	20.4	15.5	17.3	17.3	12.8	10.8	12.8	11.7	46.3	16.0	30.3	24.5	22.2	18.3	23.9	9.7	8.0	7.2	19.1	17.8	8.4	17.3	14.6	8.2	11.1	16.7	18.5	16.8	15.1	10.9	13.9	41.8	14.3	12.9	21.0	13.1	16.0	16.5	25.9	15.6	25.1	30.1	25.2	10.3	12.5	26.4	16.6
MFSD2A	"FLJ14490, MFSD2"	ENSG00000168389	"Major facilitator superfamily domain containing 2A"	Q8NA29	1	39955112-39969968	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Lipid transport, Symport, Transport"		"Disease variant, Primary microcephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 96.9;liver: 162.0;skin 1: 87.8"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 136.2;Hepatocytes: 299.6;Proximal enterocytes: 235.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	10	"classical monocyte: 13.2;intermediate monocyte: 6.6;myeloid DC: 14.7;plasmacytoid DC: 24.3"	"Group enriched"	"Detected in many"	12	"dendritic cells: 24.3;monocytes: 13.2"	"Cell line enhanced"	"Detected in many"		"hTEC/SVTERT24-B: 52.0;THP-1: 169.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043107	Uncertain		Approved	"Plasma membrane,Cytosol,Cytoplasmic bodies"		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 15: Liver - Metabolism"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 2: Hepatocytes - Metabolism"	Cytosol	"Plasma membrane, Cytoplasmic bodies"	"HPA043107: AB_10794387"	"unprognostic (2.20e-1)"	"unprognostic (1.15e-1)"	"unprognostic (5.23e-3)"	"unprognostic (1.06e-1)"	"unprognostic (1.30e-1)"	"unprognostic (6.92e-2)"	"unprognostic (2.61e-2)"	"unprognostic (2.45e-2)"	"unprognostic (1.60e-1)"	"unprognostic (4.33e-1)"	"unprognostic (2.85e-1)"	"unprognostic (1.06e-1)"	"prognostic unfavorable (4.22e-6)"	"unprognostic (9.26e-2)"	"unprognostic (4.11e-1)"	"unprognostic (1.09e-1)"	"prognostic favorable (2.33e-4)"	6.3	1.4	34.0	3.4	31.7	8.4	13.4	34.8	36.0	4.8	22.2	7.2	14.6	8.5	96.9	12.5	3.5	2.3	1.4	30.9	33.4	5.8	162.0	36.1	2.3	38.5	33.8	2.2	0.6	0.7	8.0	17.1	38.6	2.4	5.0	2.6	4.0	79.2	0.5	87.8	32.0	3.5	32.8	1.5	1.9	33.9	37.2	1.6	7.5	0.1	3.6	20.2	14.1	33.1	6.2	2.7	12.5	18.9	8.7	1.6	0.0	5.9	11.2	12.8	15.1	0.8	3.4	38.0	3.4	3.0	8.8	15.0	12.4	21.8	9.8	4.9	6.0	4.6	0.1	0.1	28.8	6.8	21.8	9.7	13.3	52.0	21.5	2.3	3.1	11.5	0.0	9.5	5.7	0.8	10.6	10.4	10.1	21.4	4.7	7.4	18.5	8.7	2.1	17.9	4.4	6.7	4.5	31.7	3.0	1.1	1.5	169.8	2.0	2.7	5.3	9.5	24.9	1.8	3.5	8.5	28.9	26.0	9.2	0.0	13.2	1.4	0.1	6.6	0.2	1.5	0.1	0.2	14.7	0.2	0.0	0.1	0.7	0.2	1.2	24.3	0.0	3.6	34.0	31.7	34.8	36.0	30.9	33.4	38.5	33.8	38.6	32.8	37.2	33.1	0.5	19.2	136.2	3.3	6.3	52.8	21.2	40.0	51.2	2.0	6.3	2.3	0.6	12.8	30.8	16.5	0.0	0.5	5.7	62.2	0.0	3.4	1.0	25.8	5.5	22.9	1.2	5.7	1.5	24.8	7.6	9.7	24.5	61.8	17.2	0.1	7.1	299.6	6.7	0.0	1.3	34.5	12.2	9.8	43.3	2.7	0.6	16.1	0.0	38.4	5.5	38.8	0.0	0.0	1.6	27.2	39.3	0.4	5.0	13.9	235.1	6.1	33.9	2.7	0.0	5.0	3.3	1.0	1.3	49.3	54.8	52.5	3.3	0.1	20.7	26.6
MFSD8	"CLN7, MGC33302"	ENSG00000164073	"Major facilitator superfamily domain containing 8"	Q8NHS3	4	127917799-127966034	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	Transport		"Disease variant, Neurodegeneration, Neuronal ceroid lipofuscinosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044802	Approved		Supported	Nucleoplasm,Vesicles		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 16: U-266 - Nucleosome"	"Cluster 52: Non-specific - Transcription"	Vesicles	Nucleoplasm	"HPA044802: AB_10963221"	"unprognostic (1.67e-1)"	"unprognostic (1.95e-1)"	"unprognostic (4.47e-2)"	"unprognostic (8.10e-2)"	"unprognostic (1.57e-1)"	"unprognostic (4.12e-2)"	"unprognostic (1.18e-1)"	"unprognostic (8.99e-2)"	"unprognostic (2.19e-2)"	"unprognostic (8.69e-2)"	"unprognostic (4.51e-2)"	"unprognostic (3.44e-2)"	"unprognostic (3.93e-3)"	"unprognostic (1.70e-1)"	"unprognostic (5.61e-3)"	"unprognostic (3.14e-1)"	"prognostic favorable (2.21e-4)"	4.6	5.7	1.3	6.8	1.3	2.6	6.9	1.9	1.6	6.2	1.1	6.8	10.0	5.6	3.9	5.4	5.5	4.8	3.8	1.1	1.7	6.4	10.0	4.8	5.4	1.4	1.3	6.8	8.1	9.1	7.1	5.9	1.5	5.5	8.2	4.6	5.8	4.4	3.7	5.9	7.6	5.8	1.1	7.3	6.4	3.9	0.8	5.2	7.0	4.4	7.9	5.3	5.9	2.2	10.9	7.3	9.5	4.6	7.2	6.9	7.0	8.3	10.3	10.2	10.5	5.2	14.3	5.2	14.5	14.3	14.8	7.8	10.2	7.4	14.4	10.8	7.9	5.7	9.1	8.0	9.4	6.0	6.6	8.3	2.7	8.6	7.7	5.0	10.6	6.6	9.5	5.9	14.6	8.9	5.0	1.9	1.7	11.8	5.2	5.3	0.6	4.7	7.5	13.9	8.5	2.9	9.0	12.0	3.5	6.4	5.6	5.1	6.7	2.9	3.1	10.7	7.8	12.5	22.1	9.6	10.3	5.3	8.8	1.9	1.6	2.8	2.5	2.4	2.4	2.5	2.7	2.2	1.6	1.1	2.4	2.6	2.5	2.4	3.7	2.2	3.4	1.2	1.3	1.3	1.9	1.6	1.1	1.7	1.4	1.3	1.5	1.1	0.8	2.2	9.5	12.8	14.1	17.0	18.8	3.2	4.9	8.5	10.2	17.2	8.1	5.3	3.0	5.7	14.0	16.5	20.9	12.5	17.9	7.2	1.9	8.5	10.4	7.7	7.2	7.2	4.2	3.8	32.1	7.0	7.3	8.6	11.7	8.2	12.7	18.4	8.9	10.1	7.6	11.8	34.9	6.8	10.2	8.5	3.3	14.7	9.3	6.5	3.6	27.2	10.5	8.6	20.6	20.6	24.6	7.8	9.5	9.4	19.9	5.4	11.1	6.3	12.1	24.9	6.6	5.8	6.6	12.6	8.4	8.9	5.7	22.0	13.7	11.4	7.3	4.8
MGARP	"C4orf49, CESP-1, HUMMR, OSAP"	ENSG00000137463	"Mitochondria localized glutamic acid rich protein"	Q8TDB4	4	139266165-139280225	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"adrenal gland: 228.0;retina: 116.9"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 151.3;Granulosa cells: 93.5;Horizontal cells: 208.6;Muller glia cells: 508.9;Theca cells: 474.8"	"Cancer enhanced"	"Detected in some"		"renal cancer: 4.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ: 20.4;fHDF/TERT166: 30.7;HHSteC: 23.6;HUVEC TERT2: 61.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA015994, HPA070835"	Enhanced		Supported	Mitochondria		NA	NA				"Cluster 77: Retina - Visual perception"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 5: Muller glia cells - Visual perception"	Mitochondria		"HPA015994: AB_2630370, HPA070835: "	"unprognostic (2.68e-1)"	"unprognostic (1.73e-1)"	"unprognostic (8.18e-2)"	"unprognostic (4.25e-2)"	"unprognostic (3.54e-2)"	"unprognostic (3.11e-2)"	"unprognostic (3.42e-2)"	"unprognostic (1.02e-3)"	"unprognostic (2.90e-2)"	"unprognostic (4.96e-2)"	"unprognostic (1.50e-2)"	"unprognostic (1.31e-1)"	"unprognostic (4.08e-2)"	"unprognostic (1.47e-2)"	"unprognostic (9.91e-2)"	"unprognostic (2.09e-2)"	"unprognostic (2.36e-1)"	9.4	228.0	3.2	0.3	3.2	0.1	1.8	7.8	4.6	2.0	3.1	1.0	0.2	5.0	1.8	0.4	2.2	0.9	3.0	3.1	4.0	1.8	0.2	0.7	0.9	3.7	4.0	23.9	0.3	0.2	11.8	0.3	3.7	2.6	0.3	116.9	0.4	4.0	0.8	0.4	0.3	3.8	3.2	0.8	0.4	8.6	3.6	0.3	0.8	0.3	0.6	1.1	2.5	3.6	0.0	1.1	0.6	0.5	1.5	0.7	0.1	20.4	0.1	3.0	0.1	0.1	0.2	0.1	0.2	30.7	8.7	0.5	4.4	0.1	1.7	0.0	2.0	0.0	0.1	0.2	23.6	0.2	0.2	7.2	0.7	3.3	0.2	7.1	61.7	0.2	0.4	0.4	5.1	0.1	0.8	0.5	1.1	0.4	0.1	0.1	0.0	0.0	0.7	0.3	0.6	1.2	0.0	0.0	0.2	0.3	0.0	0.4	0.5	0.1	0.1	0.0	0.0	0.8	0.7	0.5	8.3	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.2	0.1	0.0	0.1	0.0	0.0	0.0	0.0	3.2	3.2	7.8	4.6	3.1	4.0	3.7	4.0	3.7	3.2	3.6	3.6	0.6	0.0	0.0	0.0	0.2	1.7	0.7	0.4	1.2	151.3	0.7	10.8	3.5	0.0	0.1	0.0	8.4	0.2	0.3	0.1	1.9	0.0	0.3	0.8	1.2	1.1	0.0	0.0	1.3	0.0	0.2	10.7	0.0	0.3	0.0	93.5	0.4	0.4	0.5	208.6	2.5	0.0	0.0	0.0	0.3	0.6	17.1	0.6	0.0	0.0	0.0	508.9	2.1	5.0	0.7	0.1	0.0	24.8	0.3	0.3	0.1	9.2	0.0	32.6	0.0	1.9	3.4	0.8	0.4	0.7	0.9	0.3	0.6	474.8	0.1	0.3
MGAT2	GNT-II	ENSG00000168282	"Alpha-1,6-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase"	Q10469	14	49620799-49623481	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"	"Congenital disorder of glycosylation, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043721, HPA056824"	Approved		Supported	"Golgi apparatus"		NA	Yes		5100000	"Cluster 44: Non-specific - Transcription"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 55: Plasma cells - Humoral immune response"	"Golgi apparatus"		"HPA043721: AB_2678636, HPA056824: AB_2683248"	"unprognostic (1.20e-2)"	"prognostic unfavorable (3.22e-4)"	"unprognostic (2.84e-1)"	"unprognostic (5.49e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.70e-1)"	"unprognostic (3.77e-1)"	"unprognostic (1.92e-2)"	"unprognostic (1.14e-1)"	"unprognostic (7.44e-2)"	"unprognostic (7.12e-2)"	"unprognostic (5.63e-2)"	"unprognostic (2.59e-3)"	"unprognostic (9.14e-2)"	"unprognostic (3.74e-2)"	"unprognostic (4.72e-2)"	"unprognostic (2.12e-2)"	16.8	17.6	5.9	24.3	5.8	10.3	13.3	6.9	6.8	17.4	9.0	23.6	23.1	12.7	21.7	11.8	11.9	15.2	11.7	5.6	6.7	14.2	40.7	13.8	25.3	6.4	6.3	13.1	23.8	8.2	7.9	22.0	6.6	14.1	21.9	8.2	15.8	13.7	5.0	9.3	22.5	16.0	6.9	20.2	21.0	24.3	7.2	16.4	13.3	5.6	25.1	20.9	8.8	7.3	63.5	30.7	23.2	39.2	53.6	51.7	15.1	68.6	67.7	62.2	55.8	37.5	47.1	63.7	56.9	62.9	36.0	49.5	32.9	39.7	66.7	65.5	29.1	40.7	21.7	37.2	42.3	94.5	91.2	39.8	31.2	36.8	51.8	45.5	75.5	31.4	31.7	170.4	66.3	24.2	32.9	60.1	23.8	22.2	49.1	36.7	67.1	55.6	49.3	36.2	24.0	25.6	49.3	12.9	39.8	22.2	39.1	63.6	78.9	56.1	60.8	41.1	49.6	182.8	94.6	56.7	27.3	46.5	38.6	49.4	38.6	39.3	36.6	34.1	39.3	25.1	33.3	33.1	39.9	15.9	19.3	26.8	11.6	22.3	39.8	47.2	31.6	44.8	5.9	5.8	6.9	6.8	5.6	6.7	6.4	6.3	6.6	6.9	7.2	7.3	17.4	12.8	8.6	2.0	31.7	15.7	25.7	28.8	14.2	13.7	15.5	8.9	0.1	24.3	18.0	11.0	4.2	26.4	46.9	34.6	9.8	31.0	7.9	12.5	20.7	20.8	12.1	19.0	3.0	34.4	40.3	24.3	13.7	11.7	17.1	27.7	27.1	63.0	37.2	18.5	4.3	20.5	40.7	34.5	28.8	6.0	17.4	26.3	21.4	2.8	40.6	16.7	63.8	6.0	4.5	36.5	25.1	22.2	77.1	27.0	26.7	15.2	23.5	15.8	6.6	15.8	34.6	56.4	13.0	15.2	14.1	5.3	31.5	23.2	20.0	25.5
MGME1	"bA504H3.4, C20orf72, DDK1"	ENSG00000125871	"Mitochondrial genome maintenance exonuclease 1"	Q9BQP7	20	17969018-17991122	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"DNA damage, DNA repair"	"Exonuclease, Hydrolase, Nuclease"	"Disease variant, Primary mitochondrial disease, Progressive external ophthalmoplegia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040913	Approved		Supported	Mitochondria		NA	Yes			"Cluster 2: Granulocytes - Unknown function"	"Cluster 31: Skin - Epidermis development"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 6: Erythroid cells - Oxygen transport"	Mitochondria		"HPA040913: AB_10962835"	"unprognostic (5.81e-3)"	"unprognostic (5.96e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.29e-3)"	"unprognostic (5.42e-2)"	"unprognostic (1.44e-2)"	"prognostic unfavorable (6.98e-8)"	"unprognostic (5.31e-2)"	"unprognostic (7.05e-2)"	"unprognostic (2.91e-2)"	"unprognostic (1.06e-2)"	"unprognostic (7.45e-2)"	"prognostic unfavorable (1.13e-7)"	"unprognostic (2.04e-1)"	"unprognostic (3.22e-2)"	"unprognostic (8.70e-2)"	"unprognostic (6.89e-2)"	6.5	14.4	7.5	11.7	8.2	16.0	18.4	8.0	9.7	7.3	7.9	11.4	13.4	5.2	10.4	13.1	6.2	7.3	10.8	7.2	7.5	12.8	14.4	7.7	19.9	8.6	8.1	5.9	8.8	7.8	4.7	12.8	8.7	7.5	13.4	7.8	9.0	7.4	21.3	34.2	11.9	6.7	8.3	17.7	9.3	10.7	7.9	19.8	11.9	12.1	20.8	8.9	9.5	9.3	44.7	51.0	41.0	38.7	16.5	29.0	54.9	36.8	27.1	34.8	47.4	63.4	44.7	53.4	20.3	16.4	39.6	64.9	43.1	55.1	52.7	19.9	34.7	34.7	29.6	97.2	12.3	22.9	56.2	17.6	37.3	52.3	27.4	16.3	28.2	26.0	48.0	33.3	70.7	33.4	40.5	29.9	36.3	26.8	44.0	30.5	91.4	50.8	30.1	32.3	31.6	26.1	26.1	62.8	57.7	33.2	59.7	15.5	22.8	59.1	48.1	29.8	40.3	24.6	59.6	45.3	15.2	17.3	44.7	57.5	15.2	44.6	8.1	14.9	10.9	21.0	10.5	10.9	12.6	24.2	7.5	6.9	14.4	16.7	15.0	19.5	17.1	8.4	7.5	8.2	8.0	9.7	7.2	7.5	8.6	8.1	8.7	8.3	7.9	9.3	10.6	0.0	10.0	19.9	24.6	46.4	15.7	12.7	40.9	7.9	19.9	39.4	12.6	15.7	11.9	7.3	8.4	22.9	21.0	14.3	39.2	13.1	9.8	11.2	15.6	11.9	7.2	52.6	3.1	10.2	25.9	8.1	5.1	13.3	48.0	25.5	20.0	9.9	31.4	8.4	2.9	12.1	6.1	34.4	15.4	5.5	8.4	18.8	21.4	9.4	16.4	11.4	28.8	17.6	12.6	10.4	10.6	5.7	13.2	12.3	31.0	26.5	5.9	10.0	13.1	10.3	10.8	38.6	47.0	20.5	46.9	18.1	14.9	27.1	19.0	12.8
MGRN1	"KIAA0544, RNF156"	ENSG00000102858	"Mahogunin ring finger 1"	O60291	16	4616493-4690974	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 16.2"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007653, HPA008033"	Approved		Supported	"Endoplasmic reticulum,Vesicles"		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 18: U-2197 - ECM organization"	"Cluster 52: Non-specific - Transcription"	Vesicles	"Endoplasmic reticulum"	"HPA007653: AB_1846304, HPA008033: "	"unprognostic (2.27e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.04e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.97e-2)"	"unprognostic (4.24e-1)"	"unprognostic (1.26e-2)"	"unprognostic (9.96e-2)"	"unprognostic (1.70e-1)"	"unprognostic (4.03e-2)"	"unprognostic (9.47e-2)"	"unprognostic (6.41e-2)"	"unprognostic (2.32e-1)"	"unprognostic (9.06e-2)"	"unprognostic (1.79e-1)"	"unprognostic (5.04e-2)"	23.3	34.3	18.6	25.0	20.6	32.6	22.8	11.9	25.4	28.3	4.9	30.6	28.9	36.9	6.8	20.4	32.1	19.7	26.9	26.4	11.4	24.0	53.5	30.3	18.1	14.1	10.4	30.5	34.6	18.5	33.2	18.5	8.8	30.1	10.9	9.0	25.6	20.5	52.1	23.0	29.9	17.5	8.1	37.7	35.3	18.0	12.0	11.7	28.8	16.7	10.9	28.2	20.6	24.3	13.6	63.9	32.4	33.2	19.0	18.4	44.0	28.7	20.0	23.6	20.0	42.5	31.4	40.0	36.2	35.0	17.6	21.4	26.0	23.6	7.0	56.0	28.8	22.0	45.2	59.6	34.7	32.1	52.3	34.2	15.0	33.0	14.1	17.0	23.0	26.0	32.7	28.6	16.4	59.7	33.3	42.9	48.0	19.2	27.4	60.7	17.0	54.3	20.8	39.3	51.8	42.8	47.6	50.6	28.2	14.8	30.7	31.4	40.8	43.7	24.1	124.3	25.0	44.6	37.8	27.2	18.6	31.8	32.0	5.4	3.5	3.8	2.5	3.9	2.3	1.3	1.4	2.3	2.4	1.5	3.2	1.9	16.2	1.4	2.6	4.1	1.7	3.7	18.6	20.6	11.9	25.4	26.4	11.4	14.1	10.4	8.8	8.1	12.0	24.3	14.7	25.6	34.0	24.2	22.2	9.2	29.5	10.0	6.2	27.3	15.8	11.0	11.4	22.8	9.6	18.4	43.8	23.5	28.2	27.7	5.9	18.6	16.2	20.1	24.2	16.9	37.0	13.7	26.6	22.7	17.7	19.0	44.9	24.5	14.0	30.4	15.0	34.8	30.4	25.2	25.0	23.5	4.1	30.1	21.4	27.2	26.8	27.0	21.4	8.4	36.5	20.8	23.7	18.6	29.8	32.0	15.8	24.8	29.0	23.7	31.7	13.9	11.1	35.2	0.0	20.4	17.6	9.3	12.5	11.9	16.3	34.2	24.0	29.8	23.1	27.8
MGST2	MGST-II	ENSG00000085871	"Microsomal glutathione S-transferase 2"	Q99735	4	139665768-139740745	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Leukotriene biosynthesis, Lipid metabolism"	"Lyase, Oxidoreductase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 393.2"	"Cell type enhanced"	"Detected in all"		"Proximal enterocytes: 441.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"plasmacytoid DC: 194.6"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 276.3;OE19: 558.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA010690, HPA010707"	Enhanced		Uncertain	"Endoplasmic reticulum,Cytosol"		NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 37: Intestine - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 22: Epithelial cell types - Mixed function"	Cytosol	"Endoplasmic reticulum"	"HPA010690: , HPA010707: AB_1853922"	"unprognostic (9.35e-2)"	"unprognostic (6.13e-2)"	"unprognostic (4.33e-2)"	"prognostic favorable (5.26e-5)"	"unprognostic (1.58e-1)"	"unprognostic (8.26e-2)"	"unprognostic (1.02e-2)"	"unprognostic (1.18e-1)"	"unprognostic (4.38e-2)"	"unprognostic (2.77e-2)"	"unprognostic (8.78e-2)"	"unprognostic (6.41e-2)"	"prognostic favorable (3.22e-9)"	"unprognostic (4.10e-1)"	"unprognostic (9.91e-2)"	"unprognostic (1.77e-2)"	"unprognostic (1.01e-2)"	61.8	92.7	43.5	30.4	42.9	42.6	66.6	45.1	60.6	63.6	54.8	112.5	132.5	39.2	82.1	177.6	70.8	87.6	118.3	42.6	45.7	99.2	393.2	49.0	36.0	46.6	44.6	26.3	66.2	102.0	44.6	75.6	46.5	74.9	121.2	7.8	90.6	50.0	104.2	97.1	143.5	57.4	46.6	60.5	72.5	50.6	45.3	35.1	45.8	118.4	64.6	86.7	78.4	48.9	40.8	58.5	28.7	0.3	4.8	15.4	17.7	7.2	66.1	3.2	10.7	62.3	276.3	0.1	158.2	17.5	13.6	74.8	52.7	81.2	4.9	22.3	47.7	174.9	57.3	251.5	13.3	152.7	130.0	53.0	197.2	2.1	12.5	63.9	166.3	0.3	75.9	25.7	23.3	33.9	0.2	24.7	6.5	558.9	59.4	12.7	33.4	54.0	153.0	87.4	71.9	21.6	53.2	83.2	64.8	2.0	52.9	202.2	104.9	5.6	27.3	7.8	6.4	29.7	22.5	9.7	3.8	254.8	12.6	43.8	103.8	30.4	4.1	64.8	2.9	1.3	7.6	3.5	147.0	2.4	2.3	2.6	17.7	26.4	22.2	194.6	37.7	39.4	43.5	42.9	45.1	60.6	42.6	45.7	46.6	44.6	46.5	46.6	45.3	48.9	327.9	25.6	36.6	5.5	7.7	61.1	295.9	316.7	75.7	7.8	99.1	57.3	100.5	205.9	185.5	95.6	25.0	85.3	71.0	168.3	90.1	121.0	6.3	132.5	27.1	238.4	121.8	60.2	19.4	138.6	62.8	31.8	90.2	172.9	43.2	56.9	203.1	419.3	378.1	6.7	24.2	215.1	170.9	107.8	77.8	12.8	44.4	85.3	39.2	49.6	83.6	14.1	27.8	11.6	4.7	121.8	213.1	33.4	7.1	94.6	441.1	277.2	126.6	3.5	13.1	44.6	49.6	4.6	15.1	264.0	124.9	67.2	15.2	43.6	258.2	344.9
MIA2	"cTAGE-5A, cTAGE-5B, cTAGE-5C, cTAGE-5D, CTAGE5, FLJ22404, MEA6, MGEA, MGEA11, MGEA6, TALI"	ENSG00000150527	"MIA SH3 domain ER export factor 2"	Q96PC5	14	39230231-39388513	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 138.9"	"Cell type enhanced"	"Detected in many"		"Collecting duct cells: 44.1;Ductal cells: 42.9;Endometrial ciliated cells: 78.7;Exocrine glandular cells: 42.7;Glandular and luminal cells: 93.5;Pancreatic endocrine cells: 41.3;Proximal tubular cells: 61.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"CAPAN-2: 125.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000387, HPA000922, HPA054066, HPA055459"	Approved		Supported	"Endoplasmic reticulum"	"Intracellular and membrane"	NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 7: Non-specific - Mitochondria"	"Endoplasmic reticulum"		"HPA000387: AB_1078582, HPA000922: AB_1078581, HPA054066: AB_2682368, HPA055459: AB_2682819"	"unprognostic (2.62e-1)"	"unprognostic (7.17e-3)"	"unprognostic (2.33e-1)"	"unprognostic (5.27e-4)"	"unprognostic (3.21e-4)"	"unprognostic (2.63e-1)"	"unprognostic (2.48e-1)"	"unprognostic (7.18e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.21e-2)"	"unprognostic (4.31e-2)"	"unprognostic (1.78e-1)"	"prognostic favorable (2.81e-4)"	"unprognostic (6.93e-2)"	"unprognostic (8.08e-2)"	"unprognostic (2.91e-1)"	"unprognostic (3.97e-2)"	12.1	26.6	5.6	16.8	6.9	23.6	22.1	5.8	7.9	29.7	58.0	30.8	80.4	15.7	40.2	26.9	22.2	30.3	16.6	9.4	6.5	78.4	138.9	15.5	16.2	5.6	4.7	9.6	43.6	40.5	15.5	11.2	6.4	21.1	34.6	12.8	52.5	19.2	54.5	9.9	78.4	12.3	4.1	14.5	45.3	21.0	5.1	14.3	46.7	20.7	19.8	16.2	17.2	7.1	23.0	25.1	10.4	18.5	20.6	23.2	14.5	13.3	13.9	9.3	9.6	19.7	125.4	27.5	40.1	15.0	18.9	34.1	12.7	15.0	11.0	21.4	10.6	17.2	11.5	106.1	48.2	23.2	30.7	14.4	83.7	9.2	69.2	59.0	15.3	31.8	16.6	68.3	14.0	22.1	14.9	18.9	12.0	87.2	20.8	15.2	18.3	34.9	42.7	24.7	8.7	5.1	31.0	32.5	20.4	13.1	31.2	24.8	24.3	14.1	9.2	10.4	8.8	38.7	35.7	27.2	7.9	14.5	12.0	40.9	16.3	25.9	15.4	18.0	14.0	11.7	11.6	14.4	17.8	13.1	14.2	13.2	34.5	14.6	21.0	12.3	11.8	11.8	5.6	6.9	5.8	7.9	9.4	6.5	5.6	4.7	6.4	4.1	5.1	7.1	26.7	0.0	0.0	0.0	11.8	0.0	0.0	0.0	0.0	0.0	33.1	19.9	0.0	5.7	0.0	44.1	0.0	5.6	35.9	0.8	7.9	42.9	0.5	78.7	30.7	7.1	0.0	0.0	0.1	42.7	5.0	4.6	0.0	93.5	0.0	10.3	0.0	3.8	7.6	0.0	0.1	1.8	0.0	0.0	0.0	0.6	0.0	12.7	0.0	0.0	23.8	0.0	1.0	0.0	0.0	41.3	0.0	0.0	8.1	0.0	6.6	61.0	0.0	0.0	0.0	0.0	6.9	0.0	0.0	0.0	0.0	7.0	13.6	20.0	0.2	0.0
MIB1	"DIP-1, KIAA1323, MIB, ZZANK2, ZZZ6"	ENSG00000101752	"Mindbomb E3 ubiquitin protein ligase 1"	Q86YT6	18	21704957-21870953	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Notch signaling pathway, Ubl conjugation pathway"	Transferase	"Cardiomyopathy, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Oligodendrocyte precursor cells: 121.2;Oligodendrocytes: 109.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in all"		"REH: 121.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019100, CAB037044"	Approved		Supported	"Vesicles,Plasma membrane"		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 68: Epididymis - Unknown function"	"Cluster 14: REH - Unknown function"	"Cluster 44: Endometrium - Transcription"	"Plasma membrane"	Vesicles	"CAB037044: AB_1841007, HPA019100: AB_1853934"	"unprognostic (1.38e-1)"	"unprognostic (6.92e-2)"	"unprognostic (7.29e-2)"	"unprognostic (6.99e-2)"	"unprognostic (5.66e-2)"	"unprognostic (3.23e-2)"	"unprognostic (8.45e-3)"	"unprognostic (2.70e-1)"	"unprognostic (5.42e-2)"	"unprognostic (4.69e-2)"	"unprognostic (3.78e-2)"	"unprognostic (4.70e-2)"	"unprognostic (8.33e-3)"	"unprognostic (4.91e-3)"	"unprognostic (1.73e-1)"	"unprognostic (4.86e-2)"	"unprognostic (1.85e-2)"	8.1	6.3	9.1	6.0	9.1	4.9	11.2	9.2	8.5	11.0	8.0	7.1	5.1	13.0	9.5	8.0	7.1	8.6	6.0	8.4	9.2	11.1	10.4	7.2	7.6	9.5	10.2	11.7	8.1	9.8	5.2	11.0	8.6	10.1	7.0	8.3	8.4	8.5	5.8	9.1	5.2	10.2	10.1	7.2	7.6	8.7	10.3	11.5	13.6	7.0	7.9	8.4	8.2	9.6	19.9	7.6	36.4	25.8	19.5	23.0	9.0	15.6	17.2	10.8	15.6	11.3	7.1	16.9	14.1	21.4	11.8	13.2	21.4	21.0	24.4	22.4	10.4	18.8	9.7	15.9	15.8	38.3	7.8	14.8	23.0	12.6	32.0	16.0	27.8	6.6	26.5	47.5	17.2	9.5	18.9	14.7	9.5	12.2	10.2	121.1	30.3	42.5	18.7	16.9	12.1	30.1	26.8	12.4	13.9	18.6	8.8	25.1	23.9	27.8	14.2	11.7	21.1	25.6	9.5	25.4	11.8	24.1	16.9	0.7	0.3	0.1	0.2	0.1	0.2	0.2	0.3	0.2	0.1	0.1	0.2	0.1	0.3	0.5	0.1	0.2	0.4	0.1	9.1	9.1	9.2	8.5	8.4	9.2	9.5	10.2	8.6	10.1	10.3	9.6	35.7	48.1	22.7	68.2	11.9	21.9	15.1	19.8	24.5	28.8	24.1	19.7	18.1	25.8	31.8	16.5	25.0	13.3	18.2	20.8	3.9	13.4	7.0	29.0	59.2	30.8	24.0	23.1	106.7	12.9	7.5	33.1	10.2	32.4	14.5	16.8	24.3	30.0	12.9	15.2	92.6	17.1	26.4	17.2	16.2	5.6	20.5	14.2	26.6	67.5	19.4	17.7	15.5	121.2	109.6	18.8	7.0	24.8	18.1	48.5	8.7	15.9	30.6	14.5	0.0	35.4	26.9	26.2	12.0	23.4	24.6	25.3	14.5	21.8	10.4	25.3
MICAL3	KIAA0819	ENSG00000243156	"Microtubule associated monooxygenase, calponin and LIM domain containing 3"	Q7RTP6	22	17787649-18024561	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Cell cycle, Cell division, Exocytosis"	"Actin-binding, Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 104.9"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 176.5;Inhibitory neurons: 164.6;Oligodendrocytes: 216.0"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"cerebellum: 104.9"	"Immune cell enriched"	"Detected in some"	4	"basophil: 11.1"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 11.1"	"Cell line enhanced"	"Detected in all"		"WM-115: 131.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000639, HPA003421, HPA034882"	Approved		Supported	"Nucleoplasm,Plasma membrane,Midbody ring,Cytosol"		Yes	No			"Cluster 38: Basophils - Unknown function"	"Cluster 21: Non-specific - Transcription"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Nucleoplasm, Midbody ring"	"Plasma membrane, Cytosol"	"HPA000639: AB_10301319, HPA003421: AB_10601134, HPA034882: AB_2674371"	"unprognostic (1.65e-1)"	"unprognostic (1.02e-1)"	"unprognostic (3.67e-2)"	"unprognostic (2.00e-2)"	"unprognostic (7.68e-2)"	"unprognostic (2.06e-1)"	"unprognostic (4.71e-2)"	"unprognostic (3.07e-3)"	"unprognostic (3.41e-1)"	"unprognostic (1.01e-1)"	"unprognostic (4.58e-1)"	"unprognostic (3.82e-1)"	"unprognostic (8.86e-3)"	"unprognostic (1.36e-2)"	"unprognostic (1.23e-1)"	"unprognostic (2.03e-2)"	"unprognostic (6.64e-2)"	15.9	12.0	18.3	14.9	20.3	17.3	11.2	104.9	34.5	16.5	3.6	28.1	11.0	31.0	17.0	19.6	38.6	13.4	35.6	14.3	13.7	10.9	18.8	8.3	23.0	13.2	6.4	26.5	14.0	38.5	7.2	16.7	15.6	16.4	20.6	14.1	10.9	19.8	48.2	18.9	14.5	37.3	1.9	17.8	10.7	24.4	12.7	6.0	14.7	20.8	20.3	15.9	12.0	45.9	34.0	39.6	20.2	33.7	15.6	19.2	25.6	32.6	33.1	43.6	34.5	36.1	4.8	35.1	15.5	39.3	51.2	38.7	30.1	31.9	43.0	35.6	25.2	35.9	44.6	11.9	9.6	17.1	20.2	14.4	25.9	46.9	43.7	25.2	24.9	9.7	47.6	22.8	16.9	26.6	16.9	10.7	13.0	27.3	26.4	23.2	30.3	1.9	32.1	24.8	53.5	21.1	40.6	26.0	65.2	31.5	10.8	7.0	43.9	46.0	28.4	29.7	63.6	16.4	30.2	50.8	40.0	7.7	131.6	11.1	0.0	0.1	0.3	0.0	0.6	2.5	0.3	0.3	0.0	2.6	0.2	0.1	0.1	0.9	0.0	0.2	0.7	0.2	18.3	20.3	104.9	34.5	14.3	13.7	13.2	6.4	15.6	1.9	12.7	45.9	19.6	3.2	10.2	57.1	32.1	11.2	15.2	17.9	13.1	20.9	13.7	15.5	16.5	12.8	13.2	12.9	52.1	14.1	6.2	43.5	0.0	23.9	10.5	36.4	10.2	16.4	10.2	19.3	176.5	9.8	40.3	10.5	13.3	38.8	19.0	9.7	8.9	37.3	3.1	1.7	164.6	20.8	8.2	3.2	9.6	13.9	4.1	4.2	8.8	23.4	6.0	38.2	5.2	71.9	216.0	24.6	23.6	6.4	12.5	14.4	19.8	5.5	27.8	12.2	0.0	11.0	12.1	19.8	13.8	11.2	11.8	11.2	9.1	24.2	21.5	10.1
MICALL1	"KIAA1668, MICAL-L1, MIRAB13"	ENSG00000100139	"MICAL like 1"	Q8N3F8	22	37905657-37942822	"Plasma proteins, Predicted intracellular proteins"	"Endocytosis, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Syncytiotrophoblasts: 39.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in all"		"hTCEpi: 101.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043480, HPA051956"	Approved		Supported	"Cell Junctions,Centriolar satellite,Cytosol"		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	"Cell Junctions, Centriolar satellite, Cytosol"		"HPA043480: AB_10793950, HPA051956: AB_2681671"	"unprognostic (2.13e-1)"	"unprognostic (1.13e-1)"	"unprognostic (4.94e-2)"	"unprognostic (4.90e-1)"	"unprognostic (1.57e-1)"	"unprognostic (2.37e-1)"	"prognostic unfavorable (3.08e-6)"	"unprognostic (3.46e-2)"	"unprognostic (1.04e-1)"	"unprognostic (7.68e-2)"	"unprognostic (2.42e-3)"	"unprognostic (1.57e-2)"	"unprognostic (6.96e-3)"	"unprognostic (6.61e-2)"	"unprognostic (8.53e-2)"	"unprognostic (1.30e-1)"	"unprognostic (3.92e-2)"	9.6	5.8	8.2	9.3	14.8	6.2	10.2	15.7	10.3	18.4	8.0	38.6	6.4	28.4	3.1	46.6	13.6	6.4	10.7	8.7	9.8	8.7	7.0	11.7	5.9	19.7	16.8	4.8	18.5	10.6	4.4	17.3	17.4	17.0	4.6	0.8	17.8	24.0	10.8	36.6	12.5	19.7	14.1	7.2	44.0	10.8	15.3	5.4	10.0	5.2	7.1	25.4	26.0	22.2	25.4	13.7	13.0	15.4	10.4	11.9	59.9	32.3	17.5	34.8	25.3	17.3	13.1	10.8	10.5	22.2	22.7	65.0	9.1	69.9	17.2	21.2	31.3	5.7	11.6	16.7	24.0	11.6	11.8	11.3	101.2	42.5	70.1	10.4	22.1	4.9	8.9	8.1	22.7	10.6	2.9	6.7	5.0	12.9	12.1	16.6	27.4	6.1	8.1	53.0	9.6	8.5	19.3	19.7	20.2	15.4	10.8	10.9	34.3	61.1	47.3	37.8	27.5	9.4	3.7	7.2	55.2	5.8	29.0	0.1	0.2	0.1	0.4	0.2	0.3	0.3	0.3	0.5	0.3	0.5	0.3	0.2	0.5	0.5	0.1	0.6	0.1	0.4	8.2	14.8	15.7	10.3	8.7	9.8	19.7	16.8	17.4	14.1	15.3	22.2	10.9	0.0	7.8	1.3	4.8	7.5	10.1	12.8	23.9	0.7	7.3	7.9	11.9	7.2	9.5	5.5	0.0	31.0	7.8	7.7	1.9	10.5	18.1	11.3	5.4	12.2	3.5	1.3	0.7	10.2	26.3	4.3	27.5	6.8	1.3	5.8	6.4	5.9	8.7	5.0	4.4	3.9	6.1	4.4	3.4	28.8	1.8	4.3	1.8	1.0	7.2	0.7	7.2	2.5	17.8	15.4	2.2	4.1	6.4	13.6	4.4	2.7	6.0	0.7	0.0	3.5	9.4	5.5	2.2	27.2	9.1	39.4	5.2	1.5	3.7	15.2
MICOS10	"C1orf151, FLJ36999, Mic10, MINOS1, MIO10, RP5-1056L3.2"	ENSG00000173436	"Mitochondrial contact site and cristae organizing system subunit 10"	Q5TGZ0	1	19484403-19629821	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"Cardiomyocytes: 453.9;Cytotrophoblasts: 283.4;Extravillous trophoblasts: 279.7;Hofbauer cells: 531.0;Syncytiotrophoblasts: 183.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA059930	Enhanced		Supported	Mitochondria		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 24: Non-specific - Transcription regulation"	Mitochondria		"HPA059930: AB_2684167"	"unprognostic (3.84e-2)"	"unprognostic (8.74e-3)"	"unprognostic (2.66e-2)"	"unprognostic (3.03e-1)"	"unprognostic (1.35e-1)"	"unprognostic (6.98e-2)"	"prognostic unfavorable (7.23e-4)"	"unprognostic (2.88e-1)"	"unprognostic (8.74e-2)"	"unprognostic (3.96e-1)"	"unprognostic (1.37e-1)"	"unprognostic (2.43e-2)"	"unprognostic (1.24e-3)"	"unprognostic (7.13e-2)"	"unprognostic (1.20e-1)"	"unprognostic (2.03e-2)"	"prognostic favorable (8.11e-4)"	4.9	5.0	11.5	3.1	11.6	2.6	6.0	11.9	13.6	8.6	11.0	9.3	5.1	7.0	6.2	7.2	7.3	4.1	12.6	11.5	13.1	9.7	4.0	4.6	4.3	12.9	11.7	6.4	5.2	11.1	9.5	4.0	13.1	8.5	8.8	5.9	5.1	8.3	14.3	4.8	6.0	7.0	11.3	3.6	6.7	3.4	13.8	4.0	6.5	16.8	5.9	7.0	6.2	11.1	10.0	13.3	7.3	8.4	13.7	13.6	4.5	8.3	9.6	9.5	10.1	9.3	8.7	8.1	6.8	11.0	7.7	6.9	12.8	10.9	15.2	12.7	9.1	7.1	21.2	13.0	6.0	11.6	5.1	10.7	17.5	9.5	11.6	7.4	14.1	6.0	15.8	5.9	14.4	17.2	5.8	15.0	6.2	12.5	16.7	5.7	9.3	10.8	23.3	5.9	15.4	6.7	9.6	7.4	7.1	5.7	7.1	6.7	9.3	7.4	5.7	9.5	8.3	3.8	6.8	8.4	5.8	21.3	7.1	3.8	4.8	5.7	3.6	6.6	3.3	4.3	4.9	4.1	5.1	4.1	6.3	4.5	3.2	2.3	7.0	5.0	4.9	5.9	11.5	11.6	11.9	13.6	11.5	13.1	12.9	11.7	13.1	11.3	13.8	11.1	63.3	0.0	0.0	0.0	6.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	453.9	0.0	0.0	0.0	0.0	283.4	25.0	0.0	0.0	0.0	0.0	0.0	0.0	27.1	0.0	0.0	0.0	0.0	279.7	52.8	0.0	0.0	0.0	0.0	0.0	0.0	531.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	30.7	0.0	0.0	0.0	0.0	183.5	5.3	0.0	0.0	0.0
MICOS13	"C19orf70, MIC13, P117, QIL1"	ENSG00000174917	"Mitochondrial contact site and cristae organizing system subunit 13"	Q5XKP0	19	5678421-5680516	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"Cardiomyocytes: 344.8;Cytotrophoblasts: 154.4;Extravillous trophoblasts: 196.7;Hofbauer cells: 242.2;Syncytiotrophoblasts: 125.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042672	Approved		Supported	Nucleoplasm,Mitochondria	"Intracellular and membrane"	NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 24: Non-specific - Transcription regulation"	Mitochondria	Nucleoplasm	"HPA042672: AB_10794531"	"unprognostic (9.54e-2)"	"unprognostic (4.90e-3)"	"unprognostic (3.04e-1)"	"unprognostic (3.21e-3)"	"unprognostic (1.52e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.65e-1)"	"unprognostic (2.53e-3)"	"unprognostic (2.14e-2)"	"unprognostic (9.32e-2)"	"unprognostic (2.50e-2)"	"unprognostic (1.57e-1)"	"prognostic favorable (7.60e-5)"	"unprognostic (1.08e-1)"	"unprognostic (5.94e-2)"	"unprognostic (2.27e-1)"	"unprognostic (5.47e-2)"	71.0	68.8	139.7	48.4	143.6	54.1	59.3	153.6	180.2	44.4	137.0	76.5	78.6	46.9	44.0	86.9	67.3	53.8	271.2	141.2	154.5	93.5	78.3	44.2	60.4	148.7	143.8	44.7	86.7	97.4	59.8	37.9	147.1	50.1	40.7	18.6	95.3	60.7	279.3	59.7	66.7	43.8	142.0	45.0	61.8	149.2	151.4	38.8	57.9	186.5	35.2	61.3	49.3	146.7	175.7	167.9	43.4	87.6	98.3	117.1	58.7	100.7	121.0	142.6	120.3	132.6	85.2	82.0	157.6	105.2	65.3	124.7	25.8	175.5	34.6	128.9	311.9	76.1	101.2	153.4	162.5	105.8	79.2	133.0	157.9	71.5	92.6	68.0	104.9	112.5	120.5	220.6	101.2	186.3	145.7	129.2	45.1	118.5	474.3	79.5	57.8	286.7	145.3	126.1	111.5	134.8	37.8	198.1	152.2	25.2	128.3	123.8	87.4	121.9	50.5	217.4	169.2	315.8	280.6	66.9	174.5	183.6	126.0	76.8	214.3	77.8	198.9	274.7	237.5	291.6	228.5	225.8	261.4	235.7	222.8	211.3	29.6	192.1	238.8	302.5	211.1	278.1	139.7	143.6	153.6	180.2	141.2	154.5	148.7	143.8	147.1	142.0	151.4	146.7	44.6	0.0	0.0	0.0	8.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	344.8	0.0	0.0	0.0	0.0	154.4	24.5	0.0	0.0	0.0	0.0	0.0	0.0	16.9	0.0	0.0	0.0	0.0	196.7	46.9	0.0	0.0	0.0	0.0	0.0	0.0	242.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	30.1	0.0	0.0	0.0	0.0	125.9	5.8	0.0	0.0	0.0
MICU1	"CALC, CBARA1, EFHA3, FLJ12684"	ENSG00000107745	"Mitochondrial calcium uptake 1"	Q9BPX6	10	72367327-72626191	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	"Calcium transport, Ion transport, Transport"		Allergen	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 185.5;Inhibitory neurons: 205.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037479, HPA037480"	Approved		Supported	Mitochondria		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Mitochondria		"HPA037479: AB_2675495, HPA037480: AB_10696934"	"unprognostic (8.18e-2)"	"unprognostic (6.98e-3)"	"unprognostic (6.71e-2)"	"unprognostic (8.06e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.06e-1)"	"unprognostic (8.91e-2)"	"unprognostic (3.60e-2)"	"unprognostic (2.96e-3)"	"unprognostic (3.38e-2)"	"unprognostic (7.43e-2)"	"unprognostic (2.23e-2)"	"prognostic favorable (4.66e-7)"	"unprognostic (1.70e-1)"	"unprognostic (1.55e-1)"	"unprognostic (5.35e-2)"	"unprognostic (6.70e-2)"	30.9	55.3	34.4	21.2	37.2	34.2	26.4	51.4	47.1	28.8	27.8	30.1	37.4	36.5	23.8	20.7	34.6	32.3	43.9	37.8	32.2	105.3	116.7	29.6	20.1	32.2	30.7	41.6	20.0	43.3	24.4	23.6	33.7	24.8	32.9	31.5	20.8	22.3	72.2	29.0	32.7	38.4	29.0	27.0	43.3	20.2	30.4	26.1	22.9	76.9	21.6	30.8	21.7	34.1	42.2	71.8	45.4	53.3	70.8	66.6	20.6	45.8	101.6	65.7	89.8	42.2	77.2	56.8	37.3	63.5	54.0	49.1	57.7	40.7	76.9	51.9	46.6	38.3	37.1	61.2	56.4	53.3	40.1	66.6	36.2	72.4	66.5	90.4	57.7	53.4	60.0	64.5	77.6	37.9	46.7	49.9	19.0	45.0	17.3	50.5	60.9	37.4	80.8	31.0	34.8	49.8	54.2	65.9	42.0	45.2	39.3	50.5	36.2	32.6	50.1	65.7	38.4	33.9	62.6	39.2	65.1	69.6	22.5	21.5	60.0	110.8	16.8	49.8	14.7	15.1	14.7	15.5	26.0	17.5	14.4	12.0	48.8	15.2	54.5	16.5	15.3	35.4	34.4	37.2	51.4	47.1	37.8	32.2	32.2	30.7	33.7	29.0	30.4	34.1	30.4	54.5	36.0	47.7	23.4	9.9	16.0	22.6	14.2	31.9	25.3	19.6	35.8	25.8	38.3	35.0	20.9	20.7	16.9	25.9	80.3	35.6	10.7	42.0	43.0	22.7	14.4	25.0	185.5	26.7	18.8	31.1	45.9	48.2	18.3	31.5	23.9	60.4	34.8	16.8	205.9	24.4	16.2	36.9	13.4	12.5	26.8	40.1	12.4	64.6	38.0	51.3	10.3	146.8	97.5	51.4	24.9	25.9	25.0	10.7	29.3	110.7	34.0	33.8	6.6	29.0	27.2	54.5	40.0	14.2	14.2	21.5	19.0	73.4	23.6	14.2
MICU2	EFHA1	ENSG00000165487	"Mitochondrial calcium uptake 2"	Q8IYU8	13	21492691-21604181	"Predicted intracellular proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045511, HPA058790"	Approved		Approved	Nucleoplasm,Mitochondria		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm	Mitochondria	"HPA045511: AB_10959894, HPA058790: AB_2683821"	"unprognostic (4.32e-3)"	"unprognostic (1.50e-2)"	"unprognostic (2.00e-1)"	"unprognostic (7.01e-2)"	"unprognostic (9.80e-2)"	"unprognostic (4.11e-2)"	"unprognostic (1.47e-2)"	"unprognostic (8.01e-2)"	"unprognostic (4.79e-3)"	"unprognostic (1.63e-3)"	"unprognostic (1.58e-1)"	"unprognostic (1.56e-1)"	"prognostic favorable (1.40e-7)"	"unprognostic (3.81e-2)"	"unprognostic (8.94e-2)"	"unprognostic (5.15e-2)"	"unprognostic (3.50e-1)"	22.6	44.4	19.3	24.5	21.0	36.3	32.4	23.9	29.7	26.2	24.2	37.6	26.5	22.1	27.8	23.2	25.1	20.2	57.5	20.4	20.4	76.3	32.2	23.0	26.9	21.8	20.6	22.7	21.3	45.9	27.0	24.5	20.2	28.5	34.1	45.7	23.4	22.1	56.4	22.9	27.4	21.1	20.8	22.6	30.6	27.0	19.7	28.8	37.6	61.5	29.7	23.5	18.7	24.2	35.2	20.0	46.2	29.6	40.4	53.8	39.7	58.3	47.5	60.8	42.0	29.0	55.6	54.4	36.8	56.0	31.3	45.9	45.9	49.1	83.4	55.5	46.5	94.2	20.5	34.3	48.7	71.4	52.7	46.8	47.7	34.5	24.4	54.4	41.2	50.5	33.9	23.9	100.3	30.8	47.9	68.1	31.5	123.2	30.3	51.9	117.2	36.6	121.3	28.6	36.9	28.6	39.8	46.4	39.6	40.2	45.3	66.7	51.1	26.4	23.6	54.1	48.9	17.7	24.8	39.6	26.1	59.0	66.8	34.0	24.8	35.1	30.6	30.5	28.0	42.1	26.9	30.9	27.3	24.4	23.7	30.2	23.3	30.2	25.6	25.1	40.3	23.9	19.3	21.0	23.9	29.7	20.4	20.4	21.8	20.6	20.2	20.8	19.7	24.2	22.0	38.5	26.8	70.2	51.3	30.0	39.8	51.9	26.2	27.1	24.0	17.8	74.5	30.0	46.8	51.5	22.9	60.7	31.8	52.2	144.8	43.3	40.7	39.7	28.4	24.3	30.5	65.2	126.1	27.2	42.6	32.0	27.0	28.7	24.7	26.5	17.9	24.0	36.5	42.1	142.5	25.7	57.0	28.8	22.1	16.2	33.8	28.5	48.0	55.3	43.1	63.9	43.3	77.9	121.7	36.9	51.7	36.1	29.3	27.8	31.3	108.4	56.0	49.0	59.2	37.6	30.7	86.9	48.5	23.0	25.6	70.3	45.5	47.4	34.2	30.0
MID1	"FXY, OS, RNF59, TRIM18"	ENSG00000101871	"Midline 1"	O15344	X	10445310-10833654	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Ubl conjugation pathway"	Transferase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 129.3;Basal squamous epithelial cells: 82.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A549: 156.1;AF22: 132.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA002878, HPA003715"	Approved		Uncertain	"Golgi apparatus,Centriolar satellite,Cytosol"		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 64: Astrocytes - Nervous system maintenance"	"Centriolar satellite"	"Golgi apparatus, Cytosol"	"HPA002878: , HPA003715: AB_1079384"	"unprognostic (1.99e-1)"	"unprognostic (2.81e-1)"	"unprognostic (4.66e-2)"	"unprognostic (2.79e-1)"	"unprognostic (2.78e-1)"	"unprognostic (2.61e-1)"	"prognostic unfavorable (3.06e-4)"	"unprognostic (1.19e-1)"	"unprognostic (3.61e-1)"	"unprognostic (2.09e-1)"	"unprognostic (2.87e-1)"	"unprognostic (9.43e-2)"	"unprognostic (1.25e-3)"	"unprognostic (9.89e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.12e-3)"	"unprognostic (5.88e-2)"	5.9	2.5	6.9	5.0	7.7	1.7	5.3	17.2	5.0	7.0	6.5	17.3	5.7	8.9	4.9	7.0	6.4	6.8	9.3	7.0	4.9	7.3	4.2	6.5	2.2	3.6	10.4	4.4	3.5	2.8	4.2	6.2	4.9	10.4	10.6	12.3	4.9	12.9	0.7	2.9	5.8	12.3	2.1	1.0	3.8	3.6	8.2	2.3	4.2	2.2	3.1	11.7	6.2	4.4	33.2	156.1	132.5	16.7	8.1	9.2	14.6	16.2	17.8	19.7	20.7	31.0	9.7	10.6	6.5	21.9	58.4	22.5	11.0	15.1	23.0	1.3	11.0	2.7	24.3	1.1	2.8	0.3	1.2	12.1	7.0	16.1	15.8	20.4	23.1	5.1	2.1	3.2	9.6	8.0	5.3	0.5	32.7	5.1	10.0	3.9	28.9	0.4	18.7	36.2	7.1	3.5	7.4	23.5	10.1	42.7	19.2	0.2	13.7	7.2	1.0	34.1	17.0	2.8	1.2	0.4	13.5	0.3	31.3	0.5	0.1	0.6	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.3	0.0	0.1	0.7	0.0	0.1	0.4	0.0	0.1	6.9	7.7	17.2	5.0	7.0	4.9	3.6	10.4	4.9	2.1	8.2	4.4	16.5	35.3	20.7	129.3	0.7	21.4	31.5	24.7	82.6	10.7	8.5	13.2	4.8	8.6	19.6	23.9	18.8	9.1	1.3	22.6	1.9	13.4	2.2	39.8	8.9	25.4	12.1	2.7	15.5	8.7	26.9	16.2	10.7	38.5	1.3	13.4	69.9	4.0	1.5	69.0	44.3	9.0	2.0	2.5	5.8	7.9	30.1	1.2	3.6	23.4	0.0	37.0	0.0	66.4	59.2	7.3	17.2	41.3	0.2	8.2	11.3	1.5	19.3	2.9	6.6	3.7	3.3	0.3	2.4	36.1	10.1	20.0	0.8	9.7	20.0	49.2
MIEF1	"FLJ20232, L0R8F8, MiD51, SMCR7L"	ENSG00000100335	"Mitochondrial elongation factor 1"	Q9NQG6	22	39499432-39518132	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"Early spermatids: 266.3;Late spermatids: 377.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA061059			Approved	"Intermediate filaments,Mitochondria"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 25: Spermatids - Spermatogenesis"	"Intermediate filaments, Mitochondria"		"HPA061059: "	"unprognostic (5.35e-2)"	"unprognostic (2.66e-2)"	"unprognostic (2.86e-3)"	"unprognostic (1.11e-2)"	"unprognostic (3.74e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.95e-3)"	"unprognostic (1.85e-2)"	"unprognostic (5.72e-2)"	"unprognostic (1.76e-1)"	"unprognostic (3.24e-1)"	"unprognostic (6.65e-2)"	"prognostic favorable (3.96e-5)"	"unprognostic (1.53e-3)"	"unprognostic (1.08e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.30e-1)"	9.6	8.1	10.9	7.9	10.4	12.8	8.4	10.9	10.4	6.3	8.5	9.5	12.0	7.6	6.8	9.3	7.1	5.5	8.8	10.2	9.9	13.1	16.3	7.4	11.2	10.4	11.5	7.7	9.5	10.9	5.1	8.6	11.1	6.9	9.3	8.3	9.8	8.1	8.4	7.9	10.4	6.8	10.8	9.2	8.2	17.1	11.4	9.5	8.4	9.3	11.7	7.3	6.3	10.3	16.0	15.9	16.5	26.6	15.5	17.0	19.5	15.0	17.4	16.7	15.0	25.9	8.1	44.4	12.2	15.7	10.9	20.0	37.6	20.4	20.1	18.8	36.3	18.1	22.4	26.2	30.1	63.7	23.1	22.3	24.3	14.7	30.7	16.1	17.9	14.5	32.5	23.4	16.7	11.0	20.5	17.8	15.4	32.5	17.2	27.7	23.4	44.6	19.0	18.8	15.3	12.7	16.6	27.6	42.8	17.3	12.3	22.7	17.8	15.7	22.1	14.0	18.6	42.2	47.5	43.9	18.1	28.0	24.7	0.4	5.6	4.7	5.2	6.2	6.4	4.8	5.0	5.1	6.0	4.7	5.4	5.1	0.4	6.8	6.2	3.3	4.7	6.3	10.9	10.4	10.9	10.4	10.2	9.9	10.4	11.5	11.1	10.8	11.4	10.3	10.9	12.8	18.7	7.5	13.6	19.5	16.0	11.4	10.8	19.0	13.6	12.1	19.3	20.0	8.6	16.5	25.0	19.6	17.0	22.0	25.4	13.1	266.3	5.2	14.3	13.1	9.7	14.7	7.4	13.8	19.8	10.4	8.2	8.9	9.5	14.2	16.8	49.8	15.8	6.7	8.3	11.5	24.4	20.7	20.5	377.2	15.5	12.2	16.0	9.4	19.0	18.7	7.2	2.0	8.9	17.6	7.6	13.9	29.1	23.4	21.9	27.8	8.9	15.2	0.0	14.1	10.2	20.4	28.0	16.2	23.0	13.0	10.8	14.7	20.7	19.1
MIEN1	"C17orf37, C35, MGC14832, ORB3, Rdx12, XTP4"	ENSG00000141741	"Migration and invasion enhancer 1"	Q9BRT3	17	39728496-39730532	"Predicted intracellular proteins"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in all"	14	"OE19: 1667.9;SK-BR-3: 502.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA056650, HPA061344"	Approved		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 35: Non-specific - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	"Plasma membrane, Cytosol"	Nucleoplasm	"HPA056650: , HPA061344: AB_2684484"	"unprognostic (2.48e-1)"	"unprognostic (3.18e-2)"	"unprognostic (3.04e-1)"	"unprognostic (1.13e-2)"	"unprognostic (3.04e-1)"	"unprognostic (1.17e-1)"	"unprognostic (4.47e-2)"	"unprognostic (8.37e-2)"	"unprognostic (6.72e-2)"	"unprognostic (2.03e-1)"	"unprognostic (1.90e-1)"	"unprognostic (3.17e-1)"	"unprognostic (2.99e-2)"	"unprognostic (3.70e-1)"	"unprognostic (2.00e-1)"	"unprognostic (3.88e-3)"	"unprognostic (2.22e-3)"	29.1	35.9	33.4	17.5	35.4	27.0	31.5	36.2	44.8	31.1	34.2	42.4	26.3	29.0	14.6	47.3	27.2	12.1	49.5	32.5	35.3	57.2	53.7	29.6	20.2	34.5	34.8	18.5	40.7	21.6	39.6	13.5	34.5	46.3	12.8	4.8	46.2	13.8	47.2	35.0	37.5	9.5	32.9	36.2	48.5	41.3	35.4	13.9	37.0	5.3	13.7	31.0	32.0	37.2	38.8	59.7	13.4	34.5	16.3	12.0	16.2	40.7	21.4	24.2	23.6	12.9	27.2	28.1	55.5	15.1	39.0	47.1	15.6	13.8	8.2	58.2	65.8	26.5	29.8	36.5	28.2	33.9	39.2	10.8	23.3	11.7	12.0	18.8	15.6	52.9	38.2	48.9	14.7	22.5	70.1	38.2	12.5	1667.9	26.4	32.2	23.6	56.8	12.2	21.8	43.6	41.7	40.8	502.3	70.7	12.0	66.1	48.1	41.5	16.4	41.8	78.9	47.1	62.3	62.8	55.1	64.5	41.1	32.4	138.5	76.2	107.3	80.1	100.9	43.4	109.2	56.2	72.3	54.5	88.3	43.9	63.1	132.9	58.7	104.2	79.4	94.6	119.9	33.4	35.4	36.2	44.8	32.5	35.3	34.5	34.8	34.5	32.9	35.4	37.2	59.8	44.8	64.2	7.8	60.9	60.2	138.1	185.1	95.6	25.7	127.0	114.2	59.6	82.9	129.3	99.3	4.2	150.2	69.1	226.6	303.3	137.0	136.2	81.6	48.7	58.9	188.8	72.0	11.0	176.1	74.4	50.9	76.5	77.3	81.8	43.8	54.7	118.9	148.0	35.3	9.6	178.3	254.3	101.3	42.8	76.7	42.3	81.3	138.7	12.2	80.1	90.7	130.7	4.5	20.8	216.8	283.7	49.7	54.0	194.8	188.5	224.9	122.1	17.3	46.0	31.5	61.1	108.5	68.0	131.7	70.3	266.1	65.4	51.7	128.1	204.0
MIF4GD	"AD023, MGC45027, MIFD, SLIP1"	ENSG00000125457	"MIF4G domain containing"	A9UHW6	17	75266228-75271231	"Predicted intracellular proteins"	"Translation regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051222	Approved		Supported	"Nucleoli,Golgi apparatus,Cytosol"		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 59: Non-specific - Translation"	"Cluster 6: T47d - Mammary gland"	"Cluster 65: Plasmacytoid DCs - Unknown function"	Nucleoli	"Golgi apparatus, Cytosol"	"HPA051222: AB_2681393"	"unprognostic (1.05e-1)"	"unprognostic (9.17e-2)"	"unprognostic (1.94e-2)"	"unprognostic (3.82e-3)"	"unprognostic (2.92e-1)"	"unprognostic (1.31e-1)"	"unprognostic (2.36e-2)"	"unprognostic (4.21e-2)"	"unprognostic (1.44e-1)"	"unprognostic (8.15e-2)"	"prognostic favorable (2.70e-4)"	"unprognostic (2.18e-1)"	"unprognostic (9.20e-2)"	"unprognostic (9.88e-2)"	"unprognostic (2.29e-1)"	"unprognostic (7.12e-2)"	"unprognostic (7.31e-2)"	29.7	22.5	15.6	18.7	17.7	43.6	23.4	16.9	16.4	22.2	12.9	24.1	12.6	23.1	8.2	28.4	18.2	17.3	23.0	15.1	16.5	24.5	17.6	25.4	33.2	17.3	17.2	14.2	27.6	21.5	11.8	12.3	18.4	16.4	15.1	6.0	19.9	14.4	63.2	32.8	25.1	16.9	17.4	35.7	19.5	17.9	16.6	24.5	16.6	26.8	27.0	23.7	21.6	18.6	25.6	43.5	8.9	20.3	17.9	5.4	12.7	6.2	19.1	13.0	9.5	14.4	29.8	38.7	11.7	11.9	14.6	19.8	13.6	24.4	10.5	19.2	27.3	20.2	16.5	14.1	19.9	18.9	20.4	4.8	37.7	8.7	39.7	17.7	27.3	44.7	25.7	50.0	3.6	47.6	58.6	39.0	3.5	29.0	21.3	36.6	11.3	58.6	29.4	14.1	11.7	17.1	13.9	34.5	33.0	23.4	65.9	41.2	9.7	5.6	13.8	7.2	12.1	67.8	17.5	33.3	11.7	31.3	8.7	27.5	77.6	44.4	54.6	41.1	56.6	49.3	43.0	47.9	91.4	44.2	37.1	39.9	13.1	56.4	55.4	226.4	68.3	60.3	15.6	17.7	16.9	16.4	15.1	16.5	17.3	17.2	18.4	17.4	16.6	18.6	33.2	0.0	11.0	3.3	30.5	11.5	14.8	11.1	5.2	3.8	23.8	23.4	4.2	31.5	15.3	12.9	0.0	15.0	73.4	12.1	21.5	45.2	32.6	11.6	4.7	20.1	15.6	11.1	3.0	43.4	9.4	12.3	9.2	12.0	31.8	13.0	17.5	9.0	44.9	1.7	3.1	18.0	28.5	47.4	45.1	19.8	9.3	45.4	16.0	7.5	47.7	30.5	53.5	5.0	8.2	24.8	22.7	15.8	22.5	14.3	22.3	29.3	17.6	6.0	19.7	13.0	22.0	19.6	22.1	23.2	18.9	9.3	33.5	7.4	16.9	14.1
MIGA1	"FAM73A, FLJ35093"	ENSG00000180488	"Mitoguardin 1"	Q8NAN2	1	77779624-77879539	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 33.2;Alveolar cells type 1: 35.3;Breast glandular cells: 28.1;Glandular and luminal cells: 29.1;Proximal tubular cells: 31.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017589	Approved		Supported	Mitochondria		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 18: U-2197 - ECM organization"	"Cluster 7: Non-specific - Mitochondria"	Mitochondria		"HPA017589: AB_1848409"	"unprognostic (3.27e-1)"	"unprognostic (1.19e-2)"	"unprognostic (7.31e-3)"	"unprognostic (4.62e-3)"	"unprognostic (2.40e-1)"	"unprognostic (3.48e-2)"	"unprognostic (2.70e-2)"	"unprognostic (7.27e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.30e-1)"	"unprognostic (6.82e-2)"	"unprognostic (3.13e-3)"	"unprognostic (1.89e-1)"	"unprognostic (1.68e-1)"	"unprognostic (4.71e-2)"	"unprognostic (4.75e-2)"	8.8	7.9	6.0	5.4	10.3	6.8	14.2	8.2	9.1	7.2	0.0	6.2	7.3	8.8	5.2	6.3	6.5	7.7	6.5	6.7	9.3	14.9	8.5	6.1	5.3	10.8	9.0	9.0	6.1	18.9	3.4	7.7	11.0	9.6	5.7	5.6	9.2	6.6	7.1	4.6	8.1	7.4	9.5	5.9	7.5	5.2	8.5	4.5	16.5	9.4	4.2	6.0	3.6	19.3	11.8	7.5	4.6	5.9	11.1	14.3	12.1	16.7	7.8	9.6	9.8	7.7	8.0	5.1	18.0	11.5	11.6	7.9	6.3	9.9	18.0	7.4	6.4	6.0	8.9	3.9	11.4	5.6	4.5	10.4	10.5	19.7	14.2	13.8	9.8	4.5	3.4	6.7	14.8	1.9	5.5	3.2	3.9	5.8	9.2	2.9	11.3	2.6	11.6	12.5	9.2	7.4	7.7	11.4	21.8	7.6	4.4	3.6	15.8	13.7	6.3	20.9	17.6	4.0	6.0	3.2	12.1	4.8	6.0	3.7	2.2	2.7	2.1	2.7	2.2	1.7	1.6	1.7	1.5	2.1	2.4	2.1	1.2	2.4	1.7	1.1	1.7	1.2	6.0	10.3	8.2	9.1	6.7	9.3	10.8	9.0	11.0	9.5	8.5	19.3	33.2	35.3	26.0	0.0	5.5	0.0	0.0	0.0	0.0	0.0	28.1	20.6	0.0	0.0	10.5	23.9	0.0	17.0	16.5	0.0	5.9	16.4	0.0	15.6	27.0	9.9	0.0	0.0	0.0	14.7	14.0	12.9	0.0	29.1	12.6	18.8	0.0	0.0	8.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.8	0.0	0.0	2.6	0.0	0.0	0.0	0.0	18.9	0.0	0.0	5.5	0.0	0.0	31.2	8.7	0.0	0.0	0.0	12.4	0.0	0.0	0.0	0.0	13.3	7.5	16.2	0.0	0.0
MIGA2	"C9orf54, FAM73B, FLJ00199, FLJ14596"	ENSG00000148343	"Mitoguardin 2"	Q7L4E1	9	129036621-129072082	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Granulosa cells: 18.7;Theca cells: 22.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041363	Approved		Approved	"Cell Junctions,Cytosol"		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 45: Intestine - Brush border"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	Cytosol	"Cell Junctions"	"HPA041363: AB_10794664"	"unprognostic (2.10e-1)"	"unprognostic (4.82e-3)"	"unprognostic (1.07e-1)"	"unprognostic (2.70e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.35e-2)"	"unprognostic (1.01e-1)"	"unprognostic (3.93e-2)"	"unprognostic (3.07e-3)"	"unprognostic (2.90e-2)"	"prognostic favorable (3.04e-6)"	"unprognostic (1.12e-2)"	"unprognostic (1.44e-3)"	"unprognostic (8.57e-3)"	"unprognostic (1.25e-1)"	"unprognostic (4.63e-2)"	"unprognostic (4.15e-3)"	6.7	13.6	7.5	5.3	7.6	12.6	5.8	8.4	8.1	6.2	5.1	11.8	15.2	7.2	2.9	11.9	6.7	3.9	17.3	7.0	8.4	7.8	7.8	4.8	4.6	10.4	8.3	6.8	4.7	6.6	8.1	1.6	9.1	9.3	3.1	2.3	7.3	6.9	9.8	10.1	14.0	4.3	7.0	7.0	10.1	4.6	9.1	4.4	9.2	7.7	3.6	9.3	6.3	7.6	4.8	9.7	2.9	14.9	7.9	4.1	6.5	8.4	6.3	9.5	6.0	8.4	9.8	7.2	3.7	6.6	8.3	22.3	4.0	6.3	1.4	6.6	5.9	5.2	20.4	6.3	8.7	6.0	11.5	5.8	4.9	8.6	4.4	3.1	6.6	6.7	7.7	2.9	5.2	12.7	6.0	12.3	6.7	11.4	13.9	12.2	8.7	12.0	5.0	9.2	9.3	6.6	9.4	14.7	5.2	1.7	10.6	6.4	6.7	6.1	7.0	10.4	6.5	4.0	6.2	6.7	8.7	4.7	7.4	7.2	1.5	1.4	1.5	1.6	3.3	1.2	1.1	2.0	1.6	1.3	1.1	0.7	2.5	0.6	0.9	2.2	1.0	1.2	7.5	7.6	8.4	8.1	7.0	8.4	10.4	8.3	9.1	7.0	9.1	7.6	7.1	3.2	7.4	0.0	1.7	0.0	0.0	0.0	0.0	0.0	7.1	7.2	0.0	0.0	3.1	7.3	0.0	3.3	8.1	0.0	1.9	5.4	0.0	4.2	4.4	1.8	0.0	0.0	0.0	4.7	2.6	2.4	0.0	7.3	0.0	18.7	0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	3.6	0.0	0.0	0.0	0.0	5.8	0.0	0.0	1.8	0.0	0.0	4.5	2.9	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	5.6	3.0	22.1	0.0	0.0
MINDY3	"C10orf97, CARP, DERP5, FAM188A, FLJ13397, my042"	ENSG00000148481	"MINDY lysine 48 deubiquitinase 3"	Q9H8M7	10	15778170-15860507	"Enzymes, Predicted intracellular proteins"	"Apoptosis, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 22.4;Hofbauer cells: 40.2;Syncytiotrophoblasts: 32.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038400, HPA038406"	Uncertain		Supported	"Nucleoplasm,Nuclear membrane"		NA	NA		23000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 34: Non-specific - Transcription"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 7: Non-specific - Mitochondria"	"Nucleoplasm, Nuclear membrane"		"HPA038400: AB_10669724, HPA038406: AB_2676001"	"unprognostic (9.20e-2)"	"unprognostic (5.84e-2)"	"unprognostic (3.09e-1)"	"unprognostic (3.26e-1)"	"unprognostic (1.99e-2)"	"unprognostic (3.67e-1)"	"unprognostic (8.29e-2)"	"unprognostic (2.81e-2)"	"unprognostic (3.85e-2)"	"unprognostic (9.63e-2)"	"unprognostic (6.48e-3)"	"unprognostic (6.50e-2)"	"unprognostic (1.32e-1)"	"unprognostic (2.97e-1)"	"unprognostic (1.04e-2)"	"unprognostic (1.76e-1)"	"unprognostic (3.19e-1)"	15.0	22.4	12.8	8.6	16.3	19.1	19.2	21.9	19.0	18.6	2.9	15.0	9.3	19.5	20.6	14.1	15.6	14.2	9.9	14.7	10.5	16.8	17.5	12.1	12.4	10.6	11.4	18.5	13.7	20.5	5.3	21.1	10.9	19.3	18.7	20.0	11.5	16.4	4.3	16.4	11.6	16.4	11.3	10.5	15.7	21.3	15.5	7.5	18.3	2.4	11.6	15.3	10.3	17.7	12.4	11.1	21.5	22.9	30.9	28.9	17.9	38.1	19.4	28.4	33.1	9.6	19.0	9.2	7.2	41.8	19.9	11.2	18.5	22.8	25.5	28.2	25.5	30.0	16.0	10.8	39.3	6.2	24.3	22.5	19.6	25.3	18.1	27.4	23.1	21.7	18.6	7.6	28.5	13.4	13.2	7.5	7.8	19.9	21.6	6.5	12.5	6.4	32.1	9.2	17.6	19.2	18.5	17.5	16.1	19.2	20.4	13.4	23.9	18.5	14.4	31.4	11.2	45.6	18.8	15.7	21.2	13.6	15.1	2.6	1.7	1.5	2.2	3.5	1.8	1.3	1.5	2.4	1.9	1.9	1.0	2.0	1.5	1.7	4.0	2.0	3.1	1.5	12.8	16.3	21.9	19.0	14.7	10.5	10.6	11.4	10.9	11.3	15.5	17.7	17.3	22.4	14.4	0.0	3.9	0.0	0.0	0.0	0.0	0.0	9.7	7.4	0.0	0.0	3.7	14.7	0.0	18.7	10.7	0.0	19.6	11.6	0.0	8.2	18.1	5.2	0.0	0.0	0.0	8.3	17.0	7.5	0.0	9.7	1.3	11.5	0.0	0.0	40.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.3	0.0	0.0	1.6	0.0	0.0	0.0	0.0	9.0	0.0	0.0	4.0	0.0	0.0	17.7	11.7	0.0	0.0	0.0	7.7	0.0	0.0	0.0	0.0	32.7	3.0	13.7	0.0	0.0
MINDY4	"C7orf67, FAM188B, FLJ22374"	ENSG00000106125	"MINDY lysine 48 deubiquitinase 4"	Q4G0A6	7	30771417-30892387	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 9.6;Collecting duct cells: 12.9;Endometrial ciliated cells: 36.7;Endometrial stromal cells: 8.9;Respiratory ciliated cells: 18.2"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"K-562: 19.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019475, HPA030129, HPA030130"	Approved		Supported	Vesicles,Cytosol		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 49: Ciliated cells - Cilium organization"	"Vesicles, Cytosol"		"HPA019475: AB_1848806, HPA030129: AB_10599621, HPA030130: AB_10601565"	"unprognostic (2.96e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.62e-1)"	"unprognostic (2.10e-2)"	"unprognostic (1.64e-1)"	"unprognostic (4.07e-1)"	"unprognostic (6.01e-3)"	"unprognostic (3.81e-2)"	"unprognostic (5.25e-3)"	"unprognostic (1.97e-1)"	"unprognostic (5.59e-3)"	"unprognostic (2.96e-2)"	"unprognostic (1.92e-1)"	"unprognostic (9.55e-2)"	"unprognostic (1.12e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.18e-1)"	6.7	3.7	2.1	1.2	3.5	2.4	4.4	0.4	4.2	5.7	10.6	4.6	1.3	5.4	8.4	2.9	11.5	5.6	4.7	1.9	1.8	4.9	2.1	9.5	1.2	2.8	4.5	8.9	3.4	4.8	5.6	3.3	2.2	5.9	2.1	2.1	3.1	8.1	2.3	3.2	2.2	5.9	1.8	1.2	3.2	9.0	2.4	1.2	6.7	3.5	0.9	4.3	3.7	2.5	2.4	6.0	3.1	9.5	2.7	10.3	4.5	3.5	6.0	2.6	2.2	0.0	4.4	0.0	3.9	2.3	3.6	2.6	2.1	2.0	2.5	0.0	3.5	1.9	3.2	0.0	3.3	2.7	1.3	5.3	3.1	7.7	1.5	0.2	3.8	1.7	19.2	1.1	2.2	0.0	1.5	0.8	8.9	8.5	1.4	0.4	0.0	0.6	7.1	1.2	5.7	7.7	2.3	12.5	1.3	3.5	6.4	2.0	2.3	0.1	1.4	2.7	1.5	2.5	3.5	0.0	4.9	0.1	11.1	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.1	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	2.1	3.5	0.4	4.2	1.9	1.8	2.8	4.5	2.2	1.8	2.4	2.5	5.2	9.6	3.9	0.0	0.2	0.0	0.0	0.0	0.0	0.0	2.1	2.4	0.0	0.0	1.8	12.9	0.0	2.3	0.5	0.0	3.9	2.8	0.0	36.7	8.9	2.3	0.0	0.0	0.0	1.3	4.1	2.7	0.0	3.9	2.5	4.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.1	0.0	0.0	2.4	18.2	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.5	0.2	4.1	0.0	0.0
MKKS	BBS6	ENSG00000125863	"McKusick-Kaufman syndrome"	Q9NPJ1	20	10401009-10434222	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Sensory transduction, Vision"	Chaperone	"Bardet-Biedl syndrome, Ciliopathy, Disease variant, Mental retardation, Obesity"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041071, HPA044233"	Enhanced		Supported	Centrosome		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 2: Hepatocytes - Metabolism"	Centrosome		"HPA041071: AB_10960408, HPA044233: AB_10962986"	"unprognostic (9.53e-2)"	"unprognostic (6.70e-2)"	"unprognostic (3.00e-1)"	"unprognostic (3.17e-2)"	"unprognostic (1.84e-1)"	"unprognostic (5.65e-2)"	"prognostic unfavorable (9.84e-5)"	"unprognostic (5.54e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.58e-1)"	"unprognostic (1.01e-2)"	"unprognostic (1.85e-1)"	"prognostic favorable (3.79e-9)"	"unprognostic (3.69e-1)"	"unprognostic (6.18e-2)"	"unprognostic (1.63e-2)"	"unprognostic (3.01e-1)"	12.0	13.3	15.3	6.7	16.6	1.9	12.3	17.9	19.2	14.3	19.6	18.9	17.3	12.6	13.7	12.7	13.1	12.7	20.6	17.0	17.2	28.8	26.0	9.9	8.4	16.4	15.2	13.8	12.4	25.5	14.8	9.6	17.0	15.0	19.4	22.8	13.0	15.4	25.4	9.3	14.5	14.3	15.4	11.8	13.9	16.2	16.3	12.2	17.6	40.6	10.7	14.4	13.3	16.0	18.9	23.3	21.7	32.9	23.3	20.9	6.7	12.7	14.4	16.6	13.3	7.7	9.6	16.2	5.3	12.4	30.0	25.0	27.6	25.1	20.6	2.9	10.4	37.1	5.8	20.9	15.8	23.4	7.5	18.5	47.5	16.0	31.7	28.0	13.5	14.8	18.8	11.7	19.7	7.1	22.3	14.2	15.6	60.8	16.4	13.2	21.5	14.5	25.7	8.6	33.0	20.9	11.9	61.3	29.7	14.5	16.8	15.5	6.3	14.6	12.4	17.8	23.3	8.6	36.3	6.9	12.1	24.3	15.3	19.5	16.0	13.4	11.7	14.2	13.8	11.3	13.0	9.9	16.8	7.8	15.1	14.1	7.9	11.9	16.9	10.8	11.0	16.4	15.3	16.6	17.9	19.2	17.0	17.2	16.4	15.2	17.0	15.4	16.3	16.0	15.0	3.2	17.9	20.5	29.8	33.9	56.5	143.1	39.9	39.1	11.5	13.7	225.7	118.7	67.0	9.2	12.5	101.6	50.3	116.4	68.4	27.0	95.4	14.7	11.5	41.2	71.2	43.5	30.2	19.8	83.4	40.1	37.8	11.5	22.8	9.1	57.5	182.4	127.1	69.0	36.1	90.0	89.5	62.5	67.5	41.7	62.4	34.5	49.8	11.2	51.1	70.7	55.6	25.6	24.7	17.6	92.9	63.9	31.5	87.4	99.6	47.4	54.7	40.1	52.6	43.9	51.5	229.1	73.6	86.4	42.8	96.9	23.5	13.0	100.7	75.5
MKNK1	MNK1	ENSG00000079277	"MAPK interacting serine/threonine kinase 1"	Q9BUB5	1	46557407-46616843	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Translation regulation"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 128.6"	"Cell type enhanced"	"Detected in all"		"Hofbauer cells: 142.8;Microglial cells: 100.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB027355, CAB037310, HPA071293"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 25: Pancreas - Digestion"	"Cluster 36: HEL - Hemostasis"	"Cluster 4: Macrophages - Innate immune response"	Nucleoplasm		"CAB027355: AB_2266303, CAB037310: AB_1854049, HPA071293: AB_2686382"	"unprognostic (4.05e-3)"	"prognostic favorable (7.05e-4)"	"unprognostic (5.28e-2)"	"unprognostic (3.47e-2)"	"unprognostic (1.64e-1)"	"unprognostic (7.38e-2)"	"prognostic unfavorable (1.24e-5)"	"unprognostic (3.50e-2)"	"unprognostic (1.77e-1)"	"unprognostic (2.60e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.14e-2)"	"prognostic unfavorable (1.51e-5)"	"unprognostic (7.02e-2)"	"unprognostic (3.19e-2)"	"unprognostic (4.67e-1)"	"unprognostic (5.67e-3)"	30.6	21.8	15.5	23.5	14.4	30.3	23.1	19.0	18.0	22.8	17.0	27.4	15.6	18.5	12.0	23.5	21.4	16.1	22.3	15.1	14.6	17.5	21.8	31.5	17.0	14.2	13.3	19.0	128.6	12.0	18.4	22.1	14.4	19.4	17.7	3.9	16.7	8.5	23.9	18.0	24.9	18.4	13.7	48.1	23.1	12.4	16.6	22.6	16.2	23.9	13.8	20.1	20.7	16.5	34.1	21.7	13.5	15.7	12.0	17.9	18.0	16.7	16.4	20.7	27.1	26.4	13.5	23.1	20.2	17.8	23.0	38.5	23.8	27.5	23.1	37.7	21.4	47.8	28.3	21.7	17.3	25.4	34.8	22.0	17.7	25.2	13.4	10.8	24.1	26.2	24.7	16.6	12.2	21.5	18.3	21.8	9.9	19.6	24.8	16.7	30.5	22.1	20.2	35.2	10.4	9.0	32.3	27.9	25.6	26.5	21.5	28.6	18.5	7.6	1.4	22.2	19.9	12.6	23.7	21.2	14.6	31.9	13.4	9.7	26.3	36.1	15.3	25.7	44.7	9.9	12.9	14.2	13.1	11.6	9.2	13.9	69.7	11.2	20.6	9.7	10.6	14.5	15.5	14.4	19.0	18.0	15.1	14.6	14.2	13.3	14.4	13.7	16.6	16.5	20.3	12.8	21.5	41.4	15.3	13.9	17.8	15.2	9.1	19.4	17.8	12.3	19.2	15.7	17.8	22.0	2.1	21.6	23.7	27.9	7.9	18.9	15.5	12.5	12.8	18.3	16.8	21.9	42.2	37.1	34.2	20.5	11.7	13.3	12.0	22.8	18.2	22.7	142.8	18.5	52.7	12.0	4.1	84.5	61.0	23.8	21.5	49.9	10.6	100.2	26.7	5.2	21.6	21.6	8.5	32.3	17.7	36.5	13.3	19.5	27.8	15.7	11.1	5.0	6.6	31.2	15.0	15.3	17.2	22.6	11.1	18.5	25.2	35.1	15.0	29.6
MKNK2	"GPRK7, MNK2"	ENSG00000099875	"MAPK interacting serine/threonine kinase 2"	Q9HBH9	19	2037465-2051244	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Apoptosis, Translation regulation"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 475.7;tongue: 551.1"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HHSteC: 367.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021875, CAB037253, HPA070499"	Supported		Supported	"Nuclear bodies"		No	No			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 7: Non-specific - Mitochondria"	"Nuclear bodies"		"CAB037253: AB_1079401, HPA021875: AB_1854050, HPA070499: AB_2732157"	"unprognostic (8.76e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.64e-1)"	"prognostic favorable (4.86e-5)"	"unprognostic (3.08e-1)"	"unprognostic (1.59e-2)"	"unprognostic (6.42e-3)"	"unprognostic (1.35e-1)"	"unprognostic (4.32e-2)"	"unprognostic (7.52e-2)"	"unprognostic (1.08e-1)"	"unprognostic (6.56e-2)"	"unprognostic (4.07e-2)"	"prognostic favorable (4.01e-4)"	"unprognostic (1.63e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.59e-1)"	87.2	50.2	70.5	51.3	78.0	133.6	39.5	109.2	131.2	41.9	80.6	55.2	47.4	24.7	47.8	114.5	38.1	26.7	54.8	67.2	65.4	27.6	71.2	51.8	66.8	80.3	70.7	34.5	191.9	34.5	39.6	35.3	74.6	38.6	30.0	35.7	133.8	39.7	475.7	63.8	57.3	21.8	68.2	80.2	55.1	21.6	75.7	34.5	54.6	551.1	58.6	39.9	60.9	91.0	64.9	71.8	30.1	66.3	219.5	79.0	65.1	37.3	27.1	26.5	26.8	45.5	111.8	88.2	50.7	77.4	27.9	78.4	38.4	110.9	12.0	122.1	34.4	36.8	62.1	49.2	367.4	72.3	61.6	84.1	262.0	50.8	107.2	61.9	63.5	59.2	62.0	155.4	18.6	37.7	42.8	59.3	78.6	49.6	78.1	81.8	8.6	113.1	48.1	41.2	39.9	48.2	89.0	125.1	166.4	33.5	52.7	89.5	96.5	9.5	37.5	38.5	46.0	238.9	97.0	85.7	78.2	53.5	17.9	4.4	9.2	9.8	8.1	10.2	7.5	16.9	8.4	9.4	7.7	15.0	5.4	6.6	41.7	9.5	13.6	9.2	12.5	3.6	70.5	78.0	109.2	131.2	67.2	65.4	80.3	70.7	74.6	68.2	75.7	91.0	102.2	38.5	56.5	9.8	91.4	82.5	105.6	84.5	50.1	55.7	99.0	103.5	54.5	38.6	65.5	36.8	25.0	23.5	106.5	155.3	9.8	27.3	8.7	60.2	28.0	51.9	150.2	80.2	5.6	56.6	47.2	45.0	57.6	76.2	29.2	14.5	82.5	60.3	36.9	42.1	5.9	104.1	46.8	52.5	134.6	13.0	20.2	68.0	56.9	8.4	41.8	63.6	30.9	6.0	5.2	47.2	86.6	20.3	55.4	94.2	98.8	18.6	55.2	47.5	19.7	132.6	48.7	18.1	19.5	97.8	117.2	56.5	69.3	18.1	79.7	114.0
MLC1	"KIAA0027, LVM, MLC, VL"	ENSG00000100427	"Modulator of VRAC current 1"	Q15049	22	50059391-50085426	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"brain: 262.7;choroid plexus: 145.6"	"Cell type enriched"	"Detected in some"	6	"Astrocytes: 115.6"	"Cancer enriched"	"Detected in some"	69	"glioma: 122.0"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"NK-cell: 20.2"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HL-60: 228.2;NB-4: 219.8;THP-1: 401.5;U-266/70: 131.6;U-266/84: 120.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003040	Enhanced		Supported	Cytosol		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 64: Astrocytes - Nervous system maintenance"	Cytosol		"HPA003040: AB_1079387"	"unprognostic (2.68e-2)"	"unprognostic (5.46e-6)"	"unprognostic (5.41e-3)"	"unprognostic (1.51e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.42e-3)"	"unprognostic (9.54e-3)"	"unprognostic (7.21e-2)"	"unprognostic (2.24e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.51e-3)"	"unprognostic (8.39e-4)"	"unprognostic (1.40e-1)"	"unprognostic (1.55e-1)"	"unprognostic (3.66e-2)"	"unprognostic (2.92e-1)"	0.3	0.1	239.3	0.7	235.7	36.4	0.1	212.7	261.8	3.0	145.6	0.1	0.4	0.3	1.0	0.1	1.8	1.0	0.6	225.8	234.5	0.1	0.4	1.6	0.3	262.7	243.1	0.3	0.1	0.0	1.1	2.3	221.8	4.8	0.0	4.1	0.1	1.4	0.1	1.0	0.1	0.2	231.9	2.2	0.2	3.8	231.5	0.5	0.1	0.0	0.5	0.4	11.9	217.2	0.4	0.0	2.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	68.1	0.0	0.0	0.1	228.2	68.4	0.0	0.6	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.0	0.0	1.8	219.8	0.3	0.0	0.1	24.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.0	401.5	0.0	0.0	0.2	0.1	0.3	131.6	120.2	0.4	0.3	35.7	2.2	0.0	1.1	0.0	3.9	6.8	0.1	0.1	0.3	1.6	0.9	0.0	0.1	1.8	0.1	20.2	9.2	0.2	0.1	4.0	239.3	235.7	212.7	261.8	225.8	234.5	262.7	243.1	221.8	231.9	231.5	217.2	0.0	0.0	0.5	115.6	0.3	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.7	0.0	0.6	0.0	0.0	0.1	17.2	0.0	0.0	0.0	1.1	0.1	0.4	0.1	0.0	7.8	0.4	0.0	0.1	2.4	0.0	0.1	1.3	4.4	0.4	0.0	3.5	0.0	0.5	0.0	0.0	0.3	0.0	0.7	0.0	0.6	1.8	7.5	0.6	16.3	18.6	0.5	0.8	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.2	1.0	0.0	0.0	0.1	0.3	0.4	0.0	0.0	0.3	2.7	0.1	0.0	0.0
MLKL	FLJ34389	ENSG00000168404	"Mixed lineage kinase domain like pseudokinase"	Q8NB16	16	74671855-74700960	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Transporters"	Necrosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 32.1;Endothelial cells: 25.9;granulocytes: 29.1;Macrophages: 28.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA078638			Supported	"Plasma membrane,Cell Junctions,Cytosol"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 11: Alveolar cells - Smell perception"	"Plasma membrane"	"Cell Junctions, Cytosol"	"HPA078638: "	"unprognostic (7.53e-2)"	"unprognostic (1.74e-2)"	"unprognostic (2.57e-1)"	"prognostic favorable (2.16e-4)"	"unprognostic (1.23e-1)"	"unprognostic (3.07e-1)"	"unprognostic (5.69e-2)"	"unprognostic (3.67e-3)"	"unprognostic (1.90e-1)"	"unprognostic (6.64e-3)"	"unprognostic (1.37e-1)"	"unprognostic (2.74e-1)"	"unprognostic (1.60e-3)"	"unprognostic (5.30e-2)"	"unprognostic (1.26e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.53e-3)"	20.0	7.1	8.4	20.3	8.7	30.7	12.1	8.6	12.7	9.0	9.6	11.0	11.0	6.0	2.0	15.6	8.0	11.5	10.6	7.8	8.2	15.4	9.3	25.6	15.4	10.1	9.8	3.0	9.9	1.6	3.7	9.2	9.3	8.4	11.4	0.3	13.3	4.3	3.1	4.9	14.4	7.6	9.1	36.1	10.8	1.2	10.3	6.7	8.7	3.1	13.8	12.3	11.5	9.6	13.5	24.4	0.1	0.1	6.0	12.4	0.2	17.0	14.8	15.4	22.4	13.9	26.6	0.3	19.1	14.2	13.7	21.7	4.3	24.9	5.8	8.3	0.6	18.8	17.6	16.2	4.2	12.3	18.6	8.5	2.4	16.8	5.7	9.0	37.3	21.3	2.7	2.5	11.9	22.0	7.0	24.3	2.2	29.3	30.0	13.5	1.8	23.8	22.0	10.2	1.0	0.8	13.4	8.7	7.2	0.1	6.2	12.5	41.4	7.8	4.8	7.0	11.7	11.2	40.2	3.2	13.7	42.3	3.9	21.9	36.2	45.8	11.2	22.2	15.4	8.1	12.6	12.0	18.9	6.7	6.8	10.4	48.6	3.6	23.3	1.2	17.4	16.0	8.4	8.7	8.6	12.7	7.8	8.2	10.1	9.8	9.3	9.1	10.3	9.6	32.1	3.2	10.7	1.0	9.8	3.4	6.8	3.1	7.4	0.2	3.3	3.4	3.1	2.8	5.5	1.8	0.0	0.2	9.6	8.9	1.9	4.6	3.5	1.2	1.9	25.9	1.2	3.4	0.5	5.2	0.8	7.1	15.3	1.6	29.1	0.3	16.8	1.3	16.6	1.7	0.5	10.9	0.0	18.2	7.8	5.2	0.9	28.9	7.2	11.2	16.7	0.1	11.3	1.5	5.2	4.9	9.4	0.4	18.5	2.8	5.5	0.6	2.0	0.6	0.0	3.0	3.1	0.1	0.2	13.4	2.8	0.3	16.5	0.2	9.5	7.5
MLLT1	"ENL, LTG19, YEATS1"	ENSG00000130382	"MLLT1 super elongation complex subunit"	Q03111	19	6210381-6279975	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	Activator	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	14	"Cytotrophoblasts: 570.1;Syncytiotrophoblasts: 1138.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031166	Approved		Supported	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 35: Non-specific - Unknown function"	"Cluster 20: HeLa - Mitochondria"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	Nucleoplasm	"Nucleoli fibrillar center"	"HPA031166: AB_10601874"	"unprognostic (3.21e-1)"	"unprognostic (2.75e-3)"	"unprognostic (4.84e-2)"	"unprognostic (3.36e-2)"	"unprognostic (2.47e-1)"	"prognostic favorable (6.03e-5)"	"unprognostic (1.30e-3)"	"unprognostic (1.44e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.98e-1)"	"unprognostic (3.93e-3)"	"unprognostic (4.76e-2)"	"unprognostic (3.65e-3)"	"unprognostic (1.14e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.66e-2)"	"unprognostic (7.99e-3)"	28.9	22.4	33.3	16.5	31.5	8.7	26.4	32.2	38.0	42.9	26.7	41.4	12.2	40.5	13.2	25.6	42.6	9.9	35.5	36.4	26.2	30.0	37.5	33.5	10.9	25.8	28.3	47.7	26.8	20.9	28.9	42.6	21.8	40.8	5.6	13.5	24.0	15.6	34.8	30.8	24.3	13.3	19.8	27.0	30.0	16.8	29.9	11.9	36.8	12.7	7.5	37.3	28.8	27.0	49.5	23.8	28.7	34.1	22.0	19.0	33.3	29.9	19.3	24.7	25.1	39.5	16.2	35.6	38.1	39.4	27.6	30.2	22.9	29.4	14.6	30.2	35.9	44.3	66.0	30.1	42.2	29.0	39.0	30.7	25.2	23.6	19.1	27.1	28.2	31.5	43.6	40.4	16.4	27.1	49.8	27.8	35.0	24.6	49.5	42.3	21.4	28.7	13.4	30.1	49.7	45.2	30.9	33.8	37.8	14.1	30.6	34.1	29.8	34.3	26.5	53.7	41.8	49.1	41.0	28.0	39.6	49.3	49.9	0.1	0.8	0.2	0.7	1.2	0.9	0.5	0.4	0.7	0.6	0.5	0.4	0.5	2.0	0.8	1.5	2.0	0.2	0.7	33.3	31.5	32.2	38.0	36.4	26.2	25.8	28.3	21.8	19.8	29.9	27.0	20.5	22.4	32.7	12.1	5.2	0.1	13.2	0.0	2.8	29.8	13.6	13.5	23.4	5.7	8.6	12.9	18.8	570.1	11.1	5.8	7.9	12.6	27.5	34.8	21.7	21.7	4.9	1.3	10.8	16.6	38.6	14.8	13.3	14.5	10.1	16.2	23.6	18.9	60.9	58.9	13.3	9.9	0.0	15.6	0.0	57.8	19.0	12.1	0.0	11.2	13.2	35.6	10.3	8.0	16.7	13.0	3.6	18.4	8.6	17.8	8.4	6.9	4.4	15.8	26.3	20.7	11.0	10.6	5.7	7.2	0.1	1138.2	5.8	19.5	9.6	14.7
MLLT10	AF10	ENSG00000078403	"MLLT10 histone lysine methyltransferase DOT1L cofactor"	P55197	10	21524646-21743630	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Transcription, Transcription regulation"	DNA-binding	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 93.0"	"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 201.3;Spermatocytes: 233.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005736, HPA005747, HPA072790"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm	Cytosol	"HPA005736: , HPA005747: AB_1079393, HPA072790: "	"unprognostic (6.58e-2)"	"unprognostic (1.57e-1)"	"unprognostic (7.32e-2)"	"unprognostic (1.47e-2)"	"unprognostic (1.31e-2)"	"prognostic favorable (8.75e-4)"	"unprognostic (1.03e-3)"	"unprognostic (9.56e-3)"	"unprognostic (9.29e-2)"	"unprognostic (1.78e-1)"	"unprognostic (2.69e-2)"	"unprognostic (7.85e-2)"	"unprognostic (6.57e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.67e-1)"	15.6	13.0	11.9	12.0	13.6	30.5	14.4	21.5	16.0	18.2	16.6	20.8	9.1	18.7	16.0	16.1	17.4	11.4	17.1	11.5	15.2	15.1	15.6	14.6	15.3	14.6	11.9	24.7	13.5	18.6	12.6	16.4	14.1	13.0	12.7	20.6	13.7	11.8	15.6	25.4	13.2	16.8	11.9	12.8	12.3	93.0	13.7	23.2	21.8	14.2	14.5	19.1	16.5	18.6	32.1	29.6	38.3	22.2	23.3	25.0	44.1	19.6	10.6	21.7	21.6	29.5	31.3	34.9	10.8	20.7	21.1	24.1	43.3	25.1	22.2	25.0	21.9	59.2	24.5	44.5	29.6	1.6	33.4	21.3	28.6	17.7	19.2	21.8	30.1	34.3	65.4	26.5	19.3	28.1	44.1	28.5	17.3	17.5	9.2	36.6	23.5	31.7	23.2	12.6	13.8	39.6	24.7	29.0	45.8	30.7	13.3	37.1	29.8	14.7	24.6	26.7	18.9	23.5	32.2	43.4	15.4	21.5	9.9	10.3	6.5	13.5	5.0	4.1	4.6	5.3	6.1	6.1	5.1	4.3	6.6	6.0	4.8	4.6	4.7	7.5	5.5	2.5	11.9	13.6	21.5	16.0	11.5	15.2	14.6	11.9	14.1	11.9	13.7	18.6	33.3	28.9	40.4	155.7	25.1	37.7	17.4	22.4	44.3	38.4	19.9	20.7	31.5	18.6	19.6	18.4	43.8	34.0	24.9	13.3	13.7	14.6	66.1	16.1	26.6	28.7	3.5	30.9	201.3	12.8	58.6	26.6	21.9	21.3	25.2	28.6	26.0	22.7	28.9	30.3	169.6	16.3	26.4	36.1	23.0	109.0	39.4	28.6	48.0	107.7	29.7	17.8	21.6	148.3	160.0	13.2	14.6	48.2	23.5	22.7	18.8	23.1	18.7	53.7	39.5	31.4	35.7	233.8	57.4	48.5	43.9	50.2	29.5	24.2	18.0	13.5
MLLT11	AF1Q	ENSG00000213190	"MLLT11 transcription factor 7 cofactor"	Q13015	1	151060397-151069544	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"			"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 109.3"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 54.1;Early spermatids: 76.9;Excitatory neurons: 57.9;Late spermatids: 215.6"	"Cancer enriched"	"Detected in all"	4	"glioma: 29.9"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AF22: 216.7;EFO-21: 164.9;SH-SY5Y: 238.6;U-698: 207.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000540	Uncertain		Supported	Nucleoplasm,Cytosol		No	No			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 25: Spermatids - Spermatogenesis"	"Nucleoplasm, Cytosol"		"HPA000540: AB_2666024"	"unprognostic (2.96e-2)"	"unprognostic (1.98e-2)"	"unprognostic (1.08e-2)"	"prognostic unfavorable (4.26e-5)"	"unprognostic (1.69e-1)"	"unprognostic (1.96e-2)"	"unprognostic (5.80e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.01e-2)"	"unprognostic (2.49e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.01e-1)"	"prognostic unfavorable (4.25e-12)"	"unprognostic (5.66e-3)"	"unprognostic (1.42e-1)"	"unprognostic (1.29e-1)"	"unprognostic (3.94e-3)"	5.3	19.0	59.4	4.7	61.8	2.0	2.5	41.1	109.3	4.5	8.8	7.2	1.6	10.7	1.3	4.0	6.2	6.0	38.1	66.2	80.6	3.8	2.0	3.8	2.1	63.1	50.5	8.2	3.1	16.2	10.4	1.0	66.1	4.3	3.6	35.6	3.8	1.5	11.3	2.6	4.9	13.8	29.9	4.6	5.1	2.8	49.7	20.6	3.8	10.8	2.1	4.0	3.9	57.1	6.3	31.0	216.7	34.4	3.5	5.8	1.4	11.6	15.2	13.2	24.0	3.0	12.6	10.0	164.9	10.6	35.9	4.5	54.3	13.0	7.6	65.8	14.5	28.9	17.7	0.9	6.9	0.8	1.0	9.9	1.6	73.5	2.9	42.2	100.1	43.3	30.8	2.3	43.6	1.4	106.4	19.0	95.7	0.6	4.4	99.8	28.1	0.6	25.5	1.7	132.8	238.6	0.8	1.3	6.9	142.5	5.3	2.7	65.9	27.0	29.0	9.2	24.7	2.4	3.2	207.1	70.0	0.6	51.7	1.1	0.3	1.4	5.9	0.6	2.7	2.5	3.9	6.2	0.7	1.9	5.3	9.1	1.6	4.0	0.9	1.4	4.1	3.2	59.4	61.8	41.1	109.3	66.2	80.6	63.1	50.5	66.1	29.9	49.7	57.1	1.4	0.0	1.1	11.8	4.2	3.6	5.0	14.6	4.6	54.1	2.5	4.8	10.2	1.5	2.2	3.7	8.4	2.9	15.3	0.1	17.6	3.9	76.9	0.8	11.3	5.2	10.7	6.3	57.9	1.2	2.5	17.5	2.0	0.9	4.5	4.3	4.2	0.4	6.0	37.0	40.6	0.1	16.2	6.6	14.5	215.6	2.1	12.3	5.4	10.3	33.3	20.6	19.6	16.1	14.4	3.0	0.2	3.8	4.8	1.3	0.2	2.4	0.6	26.3	0.0	3.4	30.0	8.6	12.3	2.8	3.4	7.4	9.9	3.0	0.2	4.3
MLLT3	"AF-9, AF9, YEATS3"	ENSG00000171843	"MLLT3 super elongation complex subunit"	P42568	9	20341669-20622499	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"Astrocytes: 144.6;Excitatory neurons: 284.0;Inhibitory neurons: 288.4;Intestinal goblet cells: 112.3;Microglial cells: 114.3;Oligodendrocyte precursor cells: 254.3;Oligodendrocytes: 216.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"NK-cells: 5.1;T-cells: 16.3"	"Cell line enriched"	"Detected in many"	5	"HEL: 316.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001824	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 36: HEL - Hemostasis"	"Cluster 27: Mucus-secreting cells - Mucin production"	Nucleoplasm	Cytosol	"HPA001824: AB_1079394"	"unprognostic (3.31e-1)"	"unprognostic (2.22e-1)"	"unprognostic (1.23e-3)"	"unprognostic (1.27e-2)"	"unprognostic (1.99e-1)"	"unprognostic (7.57e-2)"	"unprognostic (3.83e-2)"	"unprognostic (1.01e-3)"	"unprognostic (2.12e-1)"	"unprognostic (3.92e-3)"	"unprognostic (1.05e-1)"	"unprognostic (2.03e-2)"	"prognostic favorable (1.84e-4)"	"unprognostic (1.85e-1)"	"unprognostic (4.81e-2)"	"unprognostic (1.40e-2)"	"unprognostic (1.68e-1)"	6.7	15.4	11.6	10.0	16.0	37.3	12.7	9.7	16.4	11.7	2.6	28.8	8.1	12.6	10.6	8.8	12.8	13.9	8.9	17.4	10.9	12.3	2.4	12.6	11.3	6.4	7.8	11.9	4.8	10.1	9.8	11.9	6.6	12.7	37.8	8.2	25.3	12.8	11.1	7.0	15.7	12.3	6.4	6.9	20.1	4.2	9.1	24.3	27.2	11.1	8.3	10.6	6.3	12.0	8.7	24.4	8.4	9.6	19.8	11.7	5.4	22.3	37.8	9.6	11.5	22.8	8.2	36.1	11.9	10.6	3.2	4.4	8.5	38.0	9.2	68.0	23.6	316.4	68.3	12.3	13.8	4.9	20.1	9.4	15.4	3.8	25.3	34.7	9.8	13.8	0.4	42.5	21.7	6.8	24.9	18.6	5.1	50.8	6.8	0.0	15.4	8.8	50.0	13.4	27.2	11.0	18.1	10.2	10.1	8.4	9.3	11.9	6.5	0.0	5.6	6.0	8.3	18.4	18.7	13.1	0.4	10.6	4.8	2.3	0.4	0.6	4.5	0.3	4.3	0.6	8.6	6.5	0.9	1.4	16.3	10.3	0.1	5.1	0.4	0.6	10.8	3.6	11.6	16.0	9.7	16.4	17.4	10.9	6.4	7.8	6.6	6.4	9.1	12.0	20.0	28.9	30.0	144.6	8.0	8.3	15.9	18.7	21.1	7.8	21.2	12.3	13.5	18.6	32.5	22.0	33.3	0.9	17.3	23.5	13.7	29.2	3.0	10.3	17.5	13.7	33.0	28.4	284.0	8.2	6.1	18.0	23.0	19.5	12.0	8.7	11.4	2.2	2.4	5.0	288.4	112.3	16.2	1.9	6.5	7.4	13.7	7.1	23.2	114.3	2.7	31.9	17.5	254.3	216.6	27.3	23.6	9.4	18.2	14.5	13.8	9.0	11.7	2.2	0.0	25.2	21.6	1.0	10.5	14.2	8.4	1.6	33.3	9.8	27.0	15.7
MLNR	GPR38	ENSG00000102539	"Motilin receptor"	O43193	13	49220338-49222377	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 1.3;thyroid gland: 1.7"	"Not detected"	"Not detected"			"Cancer enriched"	"Detected in single"	7	"testis cancer: 2.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"NTERA-2: 1.3;THP-1: 4.0"					"Not detected"	"Not detected"			HPA070324			Approved	"Plasma membrane,Cytosol"		NA	NA				"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 43: THP-1 - Innate immune response"		"Plasma membrane, Cytosol"		"HPA070324: "	"unprognostic (9.75e-2)"	"unprognostic (2.13e-2)"		"unprognostic (2.90e-1)"	"unprognostic (1.13e-1)"	"unprognostic (6.03e-2)"		"unprognostic (7.80e-2)"	"unprognostic (1.54e-2)"	"unprognostic (7.79e-2)"	"unprognostic (1.88e-2)"	"unprognostic (3.74e-1)"	"unprognostic (2.61e-4)"	"unprognostic (3.53e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.38e-1)"		0.0	0.0	0.1	0.0	0.3	1.3	0.0	0.1	0.1	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.3	0.1	0.0	0.0	0.0	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.2	0.0	0.4	0.1	0.4	0.1	1.7	0.0	0.0	0.0	0.0	0.3	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.2	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.3	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.1	0.1	0.1	0.3	0.3	0.4	0.3	0.2	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0
MLX	"bHLHd13, MAD7, MXD7, TCFL4"	ENSG00000108788	"MAX dimerization protein MLX"	Q9UH92	17	42567072-42573239	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB025329, HPA052766, HPA064438"	Approved		Supported	"Nucleoplasm,Nuclear membrane,Cytosol"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 45: Enterocytes - Digestion"	Nucleoplasm	"Nuclear membrane, Cytosol"	"CAB025329: , HPA052766: AB_2681940, HPA064438: AB_2685265"	"unprognostic (2.28e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.19e-3)"	"unprognostic (1.21e-3)"	"unprognostic (3.88e-1)"	"unprognostic (2.46e-2)"	"unprognostic (8.55e-3)"	"unprognostic (2.49e-1)"	"unprognostic (4.87e-2)"	"unprognostic (8.66e-2)"	"unprognostic (9.66e-2)"	"unprognostic (2.89e-1)"	"unprognostic (1.61e-2)"	"unprognostic (7.43e-2)"	"unprognostic (4.67e-2)"	"unprognostic (2.05e-1)"	"unprognostic (3.25e-1)"	31.3	28.0	15.8	21.7	16.4	16.4	26.2	16.6	18.0	19.3	19.1	38.5	47.5	15.7	16.6	29.1	17.2	20.3	55.5	16.2	16.9	28.7	51.5	27.9	27.5	16.9	15.9	14.8	32.7	19.6	18.8	21.5	16.8	18.2	38.8	9.3	24.7	18.1	74.4	25.6	42.2	20.3	16.7	24.1	35.4	8.1	16.8	30.1	24.8	86.4	29.4	27.9	20.8	17.2	36.8	41.5	32.1	33.1	48.0	55.3	22.0	53.5	47.5	57.1	51.4	38.0	37.5	43.6	36.8	46.4	51.6	54.4	59.4	34.8	50.0	35.2	55.5	45.4	27.2	43.1	56.3	61.6	63.4	47.9	38.4	45.6	41.8	38.9	42.9	52.2	50.7	38.3	66.2	49.3	87.0	31.3	22.9	90.9	37.3	39.2	66.1	47.5	46.8	44.7	49.9	24.6	23.9	31.2	61.8	42.5	63.3	72.1	30.2	50.7	32.5	55.7	80.8	38.7	47.2	41.2	56.5	39.2	60.8	43.3	64.0	91.4	34.2	80.1	37.6	35.2	35.0	34.6	66.5	30.2	30.5	31.1	82.7	33.7	90.9	35.7	48.0	68.3	15.8	16.4	16.6	18.0	16.2	16.9	16.9	15.9	16.8	16.7	16.8	17.2	31.6	67.3	69.8	9.4	35.6	41.9	28.1	41.5	33.0	29.4	39.8	30.4	24.1	40.0	47.2	27.6	25.0	37.8	35.8	97.7	60.7	48.9	19.1	30.5	29.1	28.2	25.8	42.7	8.0	68.9	49.5	26.0	55.5	26.3	46.7	18.7	27.8	49.7	68.6	25.2	8.1	46.9	30.5	63.4	62.3	24.5	35.1	59.5	32.0	7.5	58.3	13.1	51.5	5.5	7.1	77.5	86.4	31.2	61.8	24.4	132.3	62.1	30.4	31.7	52.6	22.9	31.4	9.3	41.2	45.2	49.9	44.1	38.3	48.0	54.2	36.4
MLXIPL	"bHLHd14, CHREBP, MIO, MONDOB, WBSCR14, WS-bHLH"	ENSG00000009950	"MLX interacting protein like"	Q9NP71	7	73593194-73624543	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"	"Williams-Beuren syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"liver: 609.7"	"Group enriched"	"Detected in many"	4	"Cholangiocytes: 84.4;Enteroendocrine cells: 90.1;Hepatocytes: 286.6;Proximal enterocytes: 108.9"	"Cancer enriched"	"Detected in many"	6	"liver cancer: 60.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Hep G2: 46.5;K-562: 15.2;SCLC-21H: 25.5;T-47d: 11.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA064640			Supported	Nucleoplasm	"Intracellular and membrane"	NA	NA				"Cluster 62: Liver - Hemostasis"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 2: Hepatocytes - Metabolism"	Nucleoplasm		"HPA064640: AB_2685309"	"unprognostic (1.11e-1)"	"unprognostic (1.14e-1)"	"unprognostic (2.18e-2)"	"unprognostic (4.86e-2)"	"unprognostic (5.04e-1)"	"unprognostic (1.06e-3)"	"unprognostic (3.46e-3)"	"unprognostic (9.12e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.43e-1)"	"unprognostic (6.13e-3)"	"unprognostic (4.91e-2)"	"unprognostic (2.25e-2)"	"unprognostic (1.12e-1)"	"unprognostic (3.46e-2)"	"unprognostic (2.46e-2)"	"unprognostic (7.72e-3)"	72.3	85.1	5.5	0.7	4.1	0.2	51.2	16.3	9.4	3.0	0.2	7.8	58.8	0.6	16.3	3.4	12.9	5.5	3.5	4.5	1.4	36.2	609.7	2.7	0.0	5.6	1.4	4.9	23.1	6.3	13.4	0.0	6.1	3.7	1.5	0.7	8.7	0.8	58.1	4.5	46.8	0.5	1.3	0.3	4.7	30.9	2.2	0.9	7.3	13.8	0.0	2.0	2.7	2.1	0.2	2.5	0.0	5.9	4.8	0.0	0.1	0.0	0.0	0.0	0.0	0.3	7.5	0.0	0.3	0.0	0.6	1.2	0.0	0.0	0.0	0.2	6.1	0.0	4.8	46.5	1.3	0.2	1.7	0.8	0.0	0.0	0.0	0.1	0.0	0.0	15.2	0.0	0.1	6.3	0.1	0.0	0.7	8.2	1.0	0.0	0.0	1.2	0.0	0.1	25.5	0.7	1.0	4.4	0.0	0.1	11.4	6.2	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.5	4.1	16.3	9.4	4.5	1.4	5.6	1.4	6.1	1.3	2.2	2.1	0.6	0.0	16.2	2.3	1.6	1.1	4.8	0.6	0.6	9.9	1.4	1.3	3.4	84.4	4.7	3.7	20.9	0.1	0.3	3.2	1.9	2.9	3.2	0.7	0.2	2.5	90.1	16.0	33.4	1.0	0.1	6.5	4.6	0.8	0.0	0.1	12.8	286.6	0.4	1.7	29.1	19.6	0.0	11.2	1.5	1.2	2.8	2.8	7.2	30.9	0.2	2.0	1.0	2.0	0.9	1.4	13.9	1.2	0.1	2.2	108.9	14.1	3.2	6.5	0.0	23.9	1.0	5.1	1.1	0.5	0.9	0.5	1.7	0.0	31.9	4.0
MMAA	cblA	ENSG00000151611	"Metabolism of cobalamin associated A"	Q8IVH4	4	145599042-145660033	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"		"Chaperone, Hydrolase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 24.5"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 31.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037361, HPA058187"	Supported		Supported	Cytosol		No	No			"Cluster 27: Non-specific - Gene expression"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Cytosol		"HPA037361: AB_10672107, HPA058187: "	"unprognostic (1.20e-1)"	"unprognostic (5.07e-2)"	"prognostic favorable (3.38e-4)"	"unprognostic (1.97e-3)"	"unprognostic (1.44e-1)"	"unprognostic (4.83e-3)"	"unprognostic (1.31e-3)"	"unprognostic (3.98e-1)"	"unprognostic (7.03e-2)"	"unprognostic (7.26e-2)"	"unprognostic (3.19e-3)"	"unprognostic (1.46e-1)"	"prognostic favorable (2.23e-5)"	"unprognostic (3.40e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.14e-1)"	"prognostic favorable (3.21e-4)"	4.1	3.2	1.4	3.0	1.9	1.7	4.2	2.7	2.3	3.0	1.3	5.8	7.4	2.4	4.0	4.1	2.7	3.8	3.3	1.5	1.4	7.3	24.5	3.7	3.1	1.3	1.5	2.3	2.0	4.2	0.7	2.8	1.3	2.3	5.3	1.9	3.5	2.8	4.7	3.8	6.2	2.6	1.2	3.5	3.6	4.5	1.3	5.2	3.1	6.0	3.7	4.7	0.8	1.6	2.5	1.4	4.0	2.1	8.4	9.8	1.1	7.1	4.0	2.3	1.4	1.7	4.3	12.1	2.1	4.4	1.1	2.2	2.0	4.4	1.7	7.5	0.8	4.0	1.3	1.5	6.5	5.6	3.3	5.5	6.1	2.6	5.8	3.7	7.2	8.1	1.1	4.6	5.1	3.4	7.2	1.4	1.5	6.2	2.7	3.7	2.2	1.4	13.3	1.3	1.9	1.4	3.5	6.0	3.3	2.4	3.9	1.5	7.0	2.8	1.4	5.0	1.6	2.2	2.0	3.3	4.4	5.5	2.8	3.9	3.1	3.0	4.5	6.1	4.0	3.1	5.3	4.6	3.2	2.6	4.0	5.3	0.5	4.8	7.4	3.3	5.2	2.3	1.4	1.9	2.7	2.3	1.5	1.4	1.3	1.5	1.3	1.2	1.3	1.6	3.6	12.8	5.6	5.5	3.6	2.9	10.4	7.7	5.7	3.4	3.0	2.4	7.6	14.3	13.0	11.0	2.1	7.9	6.5	7.7	15.6	11.1	10.5	5.0	4.5	4.1	2.4	1.7	5.7	12.5	2.8	4.8	7.1	5.7	8.2	3.4	7.9	31.8	4.9	0.0	5.7	6.5	8.2	4.1	1.6	6.3	4.7	3.6	1.8	3.7	5.6	2.3	9.2	8.0	7.4	8.4	7.3	3.0	2.8	6.5	10.9	21.1	6.8	1.6	0.0	4.2	3.8	8.7	5.2	4.4	1.1	7.7	4.5	5.7	6.7	12.2
MMACHC	"cblC, DKFZP564I122"	ENSG00000132763	"Metabolism of cobalamin associated C"	Q9Y4U1	1	45500300-45513382	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"		"Oxidoreductase, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 17.4"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 22.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027394, HPA027399, HPA027402"	Uncertain		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm	"Plasma membrane, Cytosol"	"HPA027394: AB_10601669, HPA027399: AB_10601987, HPA027402: AB_2672255"	"unprognostic (3.34e-1)"	"unprognostic (1.63e-1)"	"unprognostic (7.03e-3)"	"unprognostic (3.14e-2)"	"unprognostic (4.05e-1)"	"unprognostic (1.16e-2)"	"unprognostic (9.04e-2)"	"unprognostic (1.03e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.05e-2)"	"unprognostic (3.88e-2)"	"unprognostic (6.81e-2)"	"unprognostic (2.61e-3)"	"unprognostic (2.08e-3)"	"unprognostic (8.83e-2)"	"unprognostic (2.50e-2)"	"unprognostic (2.58e-2)"	2.0	3.1	3.3	1.7	5.3	1.2	3.5	5.1	4.2	2.9	2.3	3.7	3.3	1.7	3.0	2.8	3.5	1.3	6.9	3.4	5.1	3.5	17.4	1.2	1.8	4.1	5.6	3.5	2.9	5.5	1.3	1.5	3.9	2.0	4.4	2.1	5.0	2.4	10.8	2.0	2.4	2.3	3.5	1.6	2.3	4.3	5.6	2.2	2.3	6.6	2.0	1.7	1.5	6.0	7.7	3.9	6.6	10.0	6.1	3.7	8.1	5.9	3.9	10.5	9.4	8.3	4.7	12.0	7.4	4.9	2.0	6.2	12.3	14.0	9.6	3.3	11.4	9.4	6.5	9.2	5.8	13.5	3.3	5.3	7.8	11.6	12.6	3.7	5.1	12.5	10.8	6.7	8.1	8.2	9.1	4.3	10.9	8.8	8.9	11.1	2.7	13.2	6.2	6.0	10.5	5.4	8.8	14.5	19.3	4.9	8.3	4.6	2.3	7.3	9.9	8.3	3.3	9.9	8.5	6.9	5.3	6.4	6.9	2.3	0.5	0.5	0.5	0.8	0.8	0.7	0.7	0.4	0.6	0.6	1.3	0.6	0.9	0.8	2.7	1.3	0.4	0.4	3.3	5.3	5.1	4.2	3.4	5.1	4.1	5.6	3.9	3.5	5.6	6.0	1.1	3.2	5.5	1.6	2.1	0.1	1.8	0.8	5.7	1.3	2.7	1.5	9.8	4.3	2.2	1.8	0.0	3.7	0.6	2.8	5.9	1.3	1.0	3.6	4.8	1.5	4.2	4.8	2.6	1.4	4.3	3.6	7.1	3.2	2.5	2.9	2.5	22.9	3.3	3.3	2.7	3.2	2.0	3.2	0.9	1.2	1.8	2.7	0.0	0.0	0.6	1.4	3.1	1.5	5.3	1.8	2.3	1.5	10.4	1.7	2.0	4.6	1.2	5.2	0.0	5.0	2.4	7.4	2.1	11.5	0.1	2.7	2.4	3.9	5.8	1.8
MMP25	"MMP20, MMPL1, MT6-MMP"	ENSG00000008516	"Matrix metallopeptidase 25"	Q9NPA2	16	3046062-3060726	"Enzymes, Predicted secreted proteins"		"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 33.1;lymphoid tissue: 81.8"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 6.7;Langerhans cells: 5.8;monocytes: 15.0"	"Cancer enriched"	"Detected in many"	5	"testis cancer: 7.1"	"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in some"	5	"basophil: 18.3;neutrophil: 20.3"	"Lineage enriched"	"Detected in single"	39	"granulocytes: 20.3"	"Cell line enriched"	"Detected in some"	15	"HMC-1: 102.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"CAB025177, HPA055640"	Uncertain		Supported	"Plasma membrane"	"Secreted to blood"	NA	NA		120000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 2: Immune cells - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 3: Monocytes - Immune response regulation"	"Plasma membrane"		"CAB025177: , HPA055640: "	"unprognostic (4.51e-3)"	"unprognostic (9.28e-3)"	"unprognostic (7.57e-2)"	"unprognostic (2.95e-3)"	"unprognostic (2.26e-1)"	"prognostic favorable (1.09e-5)"	"unprognostic (1.36e-1)"	"unprognostic (7.39e-3)"	"unprognostic (7.63e-3)"	"unprognostic (2.29e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.53e-2)"	"unprognostic (2.37e-3)"	"unprognostic (1.17e-2)"	"unprognostic (8.30e-2)"	"unprognostic (4.01e-1)"	"unprognostic (2.02e-1)"	5.8	0.4	0.5	15.1	0.4	33.1	1.4	0.3	1.6	0.7	0.6	1.7	1.1	0.5	0.1	1.3	6.2	1.1	2.4	0.3	0.3	1.4	2.9	14.4	2.6	0.6	0.5	0.4	1.2	0.2	0.8	1.0	0.6	1.0	1.4	0.0	1.2	0.1	0.5	0.7	3.5	0.9	0.3	81.8	1.9	0.4	0.7	1.4	1.2	3.5	1.9	2.2	0.9	0.3	0.0	0.0	1.2	2.9	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.7	0.7	0.1	0.0	6.7	0.5	0.0	0.0	0.0	0.0	0.2	102.2	0.1	0.1	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.3	0.0	5.7	2.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.2	0.3	7.0	0.3	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.1	1.1	0.1	18.3	0.2	4.0	0.0	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.0	20.3	0.5	0.0	0.4	0.2	0.0	0.5	0.4	0.3	1.6	0.3	0.3	0.6	0.5	0.6	0.3	0.7	0.3	1.0	3.2	6.7	0.0	0.7	0.4	0.4	0.2	0.0	0.8	2.0	1.3	1.0	0.0	0.8	1.8	0.0	0.0	1.8	0.2	0.0	0.4	0.0	1.2	1.2	1.0	0.0	2.7	1.6	0.6	0.2	0.6	1.1	3.8	1.3	0.2	0.0	0.3	0.1	0.0	1.9	0.2	0.0	3.5	5.8	0.0	0.0	3.3	0.0	1.0	15.0	0.3	3.1	1.5	0.5	1.3	0.0	0.7	0.8	0.4	1.2	0.2	0.1	0.0	0.0	0.7	0.9	0.1	0.2	0.6	0.3	0.0	4.0	0.1	0.3	0.3
MMP3	"STMY, STMY1"	ENSG00000149968	"Matrix metallopeptidase 3"	P08254	11	102835801-102843609	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"	"Collagen degradation"	"Hydrolase, Metalloprotease, Protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 90.7;salivary gland: 286.1"	"Cell type enhanced"	"Detected in some"		"Basal prostatic cells: 20.4;Basal respiratory cells: 25.8;Early spermatids: 24.2;Extravillous trophoblasts: 13.4;Fibroblasts: 17.9;Prostatic glandular cells: 11.9;Smooth muscle cells: 10.2"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 59.9"	"Region enriched"	"Detected in some"	4	"thalamus: 7.3"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	18	"BJ: 1545.7;BJ hTERT+: 4229.3;fHDF/TERT166: 1846.6"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in some"		"hippocampal formation: 3.2"	HPA007875	Uncertain		Supported	Vesicles	"Secreted to extracellular matrix"	NA	NA	2540000	460000		"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	Vesicles		"HPA007875: AB_1079396"	"unprognostic (2.27e-1)"	"prognostic unfavorable (9.73e-4)"	"unprognostic (1.63e-3)"	"unprognostic (5.11e-3)"	"unprognostic (3.78e-1)"	"unprognostic (5.11e-2)"	"unprognostic (5.26e-6)"	"unprognostic (3.46e-2)"	"unprognostic (7.14e-2)"	"unprognostic (2.87e-1)"	"prognostic unfavorable (4.09e-4)"	"unprognostic (3.26e-2)"	"unprognostic (1.22e-15)"	"unprognostic (3.17e-1)"	"unprognostic (1.55e-1)"	"unprognostic (3.43e-2)"	"unprognostic (2.34e-1)"	90.7	0.1	0.3	20.1	0.4	0.0	36.6	0.2	1.6	0.3	0.1	6.1	2.4	38.1	0.2	0.8	0.2	1.9	0.2	0.4	1.6	0.4	1.6	0.3	0.0	0.4	0.4	0.1	0.3	0.1	0.9	0.4	0.3	2.2	2.3	0.0	286.1	2.2	39.6	63.7	4.5	1.6	0.3	0.0	10.5	0.1	7.3	0.1	2.6	0.4	1.3	13.9	0.5	0.3	0.0	0.0	0.0	0.1	0.4	0.0	0.0	1545.7	4229.3	27.0	8.7	0.1	0.2	0.0	0.0	1846.6	96.9	0.0	0.1	0.1	45.1	0.0	0.0	0.0	0.0	1.0	0.7	0.0	0.0	4.6	0.2	122.0	5.3	0.0	0.0	0.0	0.2	0.3	4.7	0.0	0.0	0.0	0.2	0.4	0.9	0.0	0.2	0.0	0.1	0.0	0.1	0.0	2.3	0.0	0.0	0.9	0.0	0.3	0.0	140.5	13.1	1.6	0.5	0.0	0.0	0.2	56.8	0.0	7.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.2	1.6	0.4	1.6	0.4	0.4	0.3	0.3	7.3	0.3	0.0	3.2	0.0	0.0	0.0	8.4	20.4	25.8	0.0	0.0	0.1	0.1	0.3	4.3	7.6	0.0	0.0	0.1	0.0	0.0	0.0	0.8	24.2	0.0	0.3	0.5	0.0	0.0	0.2	1.4	13.4	17.9	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	4.1	0.0	2.2	1.2	0.0	0.3	0.0	0.0	0.6	0.0	0.0	0.0	0.0	3.5	4.0	0.0	0.0	11.9	1.0	0.9	0.1	0.0	0.0	1.8	10.2	0.0	1.8	0.0	3.4	0.3	0.6	0.0	0.8	7.4
MMS22L	"C6orf167, dJ39B17.2"	ENSG00000146263	"MMS22 like, DNA repair protein"	Q6ZRQ5	6	97142161-97283217	"Predicted intracellular proteins"	"DNA damage, DNA repair"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 67.8;Oligodendrocytes: 52.3;Spermatocytes: 56.9;Spermatogonia: 45.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in single"			HPA067042			Supported	Nucleoplasm		NA	Yes			"Cluster 27: Non-specific - Gene expression"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"HPA067042: AB_2685768"	"unprognostic (3.61e-2)"	"unprognostic (2.80e-1)"	"unprognostic (2.26e-2)"	"unprognostic (1.97e-3)"	"unprognostic (1.70e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.00e-5)"	"unprognostic (9.63e-2)"	"unprognostic (5.81e-3)"	"unprognostic (8.21e-3)"	"unprognostic (9.39e-2)"	"unprognostic (6.58e-2)"	"unprognostic (1.34e-6)"	"unprognostic (3.48e-2)"	"unprognostic (2.00e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.29e-1)"	1.1	1.1	0.7	2.0	1.8	7.0	2.3	1.3	1.2	1.6	0.7	1.6	1.2	1.5	0.5	1.7	1.4	1.0	0.7	0.7	1.0	0.8	0.9	1.1	3.4	2.1	1.4	1.4	1.3	1.4	0.5	2.0	1.8	1.3	2.3	2.4	1.0	0.8	0.6	2.9	1.6	1.5	1.2	1.4	1.1	6.8	1.5	5.2	1.1	0.5	3.4	1.3	1.1	2.4	7.5	8.2	13.5	14.8	2.2	4.0	10.6	15.0	6.9	13.8	20.1	11.4	8.6	16.4	9.0	5.7	16.0	13.4	17.1	8.3	27.4	14.1	12.7	16.7	11.3	7.2	1.3	25.8	11.3	2.2	4.3	19.5	9.0	2.8	6.0	15.2	23.1	25.6	13.1	8.9	9.5	10.4	5.2	12.1	6.1	15.8	12.8	5.8	5.9	9.7	7.7	6.6	9.8	4.9	4.0	7.6	7.6	15.7	4.5	14.0	13.3	11.8	20.8	3.2	10.3	18.3	8.0	16.0	15.7	0.5	0.4	0.9	0.6	0.7	1.0	0.5	0.9	1.0	1.1	0.7	0.8	1.1	0.4	0.6	1.6	1.2	0.9	0.4	0.7	1.8	1.3	1.2	0.7	1.0	2.1	1.4	1.8	1.2	1.5	2.4	5.9	3.2	8.6	16.6	9.7	9.2	5.8	4.0	4.0	11.6	6.1	6.2	4.2	5.7	6.9	3.7	41.7	12.5	14.6	3.3	1.9	2.9	67.8	4.4	6.1	6.5	1.2	26.3	11.3	4.1	11.2	6.1	7.7	2.8	7.6	24.0	10.8	3.1	6.4	3.3	7.7	8.4	8.2	7.5	6.0	17.2	9.9	6.8	7.2	36.5	6.4	6.1	6.2	22.6	52.3	3.0	2.0	5.7	13.1	2.9	5.4	0.8	6.1	31.9	6.6	7.9	5.1	56.9	45.8	7.1	8.2	3.6	9.6	5.2	10.3	3.0
MNDA	PYHIN3	ENSG00000163563	"Myeloid cell nuclear differentiation antigen"	P41218	1	158831351-158849506	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"bone marrow: 292.9;lymphoid tissue: 107.8"	"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 219.1;Kupffer cells: 408.5;Langerhans cells: 241.7;Macrophages: 412.0;monocytes: 1118.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in all"	4	"neutrophil: 6012.8"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 6012.8"	"Group enriched"	"Detected in some"	14	"NB-4: 151.8;THP-1: 282.7;U-937: 185.5"					"Low region specificity"	"Detected in all"			"HPA034532, HPA073215"	Enhanced		Supported	"Nucleoplasm,Nucleoli,Nucleoli rim,Vesicles,Cytosol"		NA	NA		400000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	Nucleoplasm	"Nucleoli, Nucleoli rim, Vesicles, Cytosol"	"HPA034532: AB_10669677, HPA073215: AB_2686582"	"unprognostic (1.53e-2)"	"unprognostic (7.84e-3)"	"unprognostic (2.45e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.41e-2)"	"unprognostic (2.02e-2)"	"unprognostic (7.99e-3)"	"unprognostic (1.58e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.65e-1)"	"unprognostic (9.89e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.07e-1)"	"unprognostic (4.95e-2)"	"unprognostic (2.81e-2)"	"unprognostic (1.02e-1)"	24.2	14.9	2.7	82.4	2.8	292.9	6.0	2.9	4.4	6.3	3.2	6.7	3.7	4.0	1.4	7.4	5.7	26.6	4.3	2.6	3.1	3.6	11.5	47.3	15.6	5.2	4.3	2.2	4.8	3.7	1.6	20.4	4.3	3.8	7.7	12.1	5.7	3.5	3.8	5.1	7.7	20.7	5.1	107.8	4.5	5.1	4.2	14.4	3.8	19.0	14.5	23.4	1.8	5.4	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	14.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	151.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	282.7	0.0	0.0	0.0	0.2	0.2	0.1	0.0	0.2	0.0	185.5	0.0	155.4	1354.4	243.8	2.6	534.3	3.7	33.5	1.6	1.9	616.5	15.3	1.6	1.4	6012.8	2.8	270.6	9.6	1.5	1099.5	2.7	2.8	2.9	4.4	2.6	3.1	5.2	4.3	4.3	5.1	4.2	5.4	2.6	35.3	56.0	0.0	34.7	2.4	0.0	0.0	0.0	1.2	1.1	3.4	0.9	5.7	9.3	0.0	0.0	0.9	5.9	0.0	0.0	0.0	0.4	0.1	0.1	5.0	0.0	22.3	0.0	0.4	1.3	6.5	0.5	0.1	44.1	0.0	3.9	2.2	219.1	0.0	0.1	0.0	0.0	408.5	241.7	3.3	1.2	412.0	1.8	33.7	1118.9	136.1	26.8	0.5	0.1	0.0	0.0	0.0	1.1	0.0	0.0	1.7	8.0	4.8	13.1	1.5	8.2	0.9	0.3	0.4	2.3	1.0	11.7	0.0	0.0	0.1
MOB1B	"MOB4A, MOBKL1A"	ENSG00000173542	"MOB kinase activator 1B"	Q7L9L4	4	70902326-71022449	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Erythroid cells: 99.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"HEL: 71.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047088, HPA071690"	Supported		Approved	Nucleoplasm,Nucleoli,Cytosol		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 36: HEL - Hemostasis"	"Cluster 65: Plasmacytoid DCs - Unknown function"	Cytosol	"Nucleoplasm, Nucleoli"	"HPA047088: AB_2679927, HPA071690: AB_2686432"	"unprognostic (1.05e-1)"	"unprognostic (1.48e-2)"	"unprognostic (1.84e-1)"	"unprognostic (2.96e-2)"	"unprognostic (1.99e-1)"	"unprognostic (3.96e-1)"	"prognostic unfavorable (4.92e-4)"	"unprognostic (2.94e-1)"	"unprognostic (1.36e-1)"	"unprognostic (3.45e-1)"	"unprognostic (1.42e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.09e-3)"	"unprognostic (2.70e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.25e-1)"	"unprognostic (7.53e-3)"	7.3	7.5	9.4	9.6	12.0	30.0	8.4	5.4	13.0	7.5	19.4	5.8	4.8	7.8	5.0	7.5	8.9	6.9	8.5	19.1	13.5	22.5	6.5	9.6	11.3	9.7	11.3	7.8	8.6	12.5	4.0	8.8	10.0	9.6	6.3	4.9	8.5	5.4	6.1	8.8	5.4	7.7	12.9	8.8	8.1	6.0	8.1	20.0	11.0	6.3	10.3	6.9	5.3	15.8	8.2	6.6	24.2	19.9	12.9	16.2	20.2	24.2	13.2	13.3	11.5	8.8	15.3	45.6	11.5	21.6	9.1	5.7	15.2	20.3	31.9	25.1	5.5	71.5	7.4	6.8	12.9	15.6	13.8	13.5	10.9	14.9	12.0	14.8	15.9	23.4	45.0	14.5	21.3	8.9	49.2	9.7	8.0	5.3	8.5	15.6	23.5	6.1	22.1	14.1	8.4	16.5	10.6	4.7	32.9	12.9	10.9	10.0	19.3	36.6	18.9	16.8	10.0	9.2	3.4	19.1	12.8	11.5	17.2	0.3	1.2	1.1	0.5	0.6	0.4	0.1	0.2	0.2	1.7	0.2	0.3	0.2	0.1	0.2	0.4	2.1	0.6	0.5	9.4	12.0	5.4	13.0	19.1	13.5	9.7	11.3	10.0	12.9	8.1	15.8	11.1	25.6	19.1	42.4	8.9	17.8	6.0	6.1	18.8	3.3	13.7	8.8	17.4	5.7	10.2	44.1	18.8	5.6	31.5	2.6	9.8	5.4	0.8	27.2	16.0	12.8	37.8	99.1	38.4	4.6	5.6	12.1	7.1	25.6	10.8	24.5	9.7	7.1	11.2	6.7	36.5	8.9	4.1	29.2	39.7	1.6	4.4	33.5	10.6	65.6	45.6	6.0	8.2	41.7	12.1	9.4	2.1	8.6	6.9	11.5	1.4	17.1	16.9	4.5	26.3	8.7	23.0	6.4	9.0	15.1	17.0	5.7	10.3	23.4	6.6	9.4
MOB2	HCCA2	ENSG00000182208	"MOB kinase activator 2"	Q70IA6	11	1469457-1501247	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046313	Uncertain		Supported	Nucleoplasm,Nucleoli,Cytosol		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 48: Smooth muscle cells - ECM organization"	Nucleoli	"Nucleoplasm, Cytosol"	"HPA046313: AB_10959882"	"unprognostic (5.02e-1)"	"unprognostic (5.71e-2)"	"unprognostic (6.24e-3)"	"unprognostic (4.42e-3)"	"prognostic unfavorable (4.64e-4)"	"unprognostic (8.30e-2)"	"unprognostic (1.06e-3)"	"unprognostic (3.06e-2)"	"unprognostic (1.77e-1)"	"unprognostic (2.80e-2)"	"unprognostic (5.30e-2)"	"unprognostic (2.87e-1)"	"prognostic favorable (2.02e-4)"	"unprognostic (2.67e-1)"	"unprognostic (8.56e-2)"	"unprognostic (9.78e-2)"	"unprognostic (1.15e-1)"	32.3	19.6	34.7	19.2	36.3	24.2	28.3	37.8	39.7	27.4	36.2	61.1	18.0	30.7	36.5	51.9	34.4	27.8	43.5	35.3	36.5	18.6	20.0	24.7	26.8	36.1	36.8	28.1	32.8	34.9	11.2	25.7	36.5	32.5	34.8	14.6	35.2	42.3	50.9	50.0	28.6	49.0	36.1	25.1	27.9	14.2	37.1	34.1	24.2	70.4	27.0	39.9	31.6	37.8	29.3	31.2	18.3	15.7	44.2	30.8	17.1	22.5	30.9	40.4	31.8	20.1	39.0	20.9	16.7	50.6	26.0	34.8	28.1	48.6	24.3	28.8	44.3	16.0	11.7	26.2	30.2	21.2	24.2	25.1	57.9	21.9	25.3	32.7	43.6	27.0	26.3	21.2	20.7	20.6	27.4	37.7	23.0	54.3	29.4	19.9	19.0	22.2	34.4	26.9	34.6	37.3	27.3	34.0	27.9	23.0	15.9	21.3	37.7	25.6	13.1	8.3	14.5	21.6	22.3	21.8	17.9	20.3	19.8	9.7	8.7	11.9	16.2	9.2	13.6	8.1	14.1	13.7	10.6	11.0	11.6	10.2	7.1	12.1	13.4	7.5	15.3	10.6	34.7	36.3	37.8	39.7	35.3	36.5	36.1	36.8	36.5	36.1	37.1	37.8	84.8	6.4	10.0	6.5	20.2	82.2	30.1	39.4	12.0	18.4	27.8	33.3	14.8	12.8	18.4	7.3	12.5	31.1	64.5	58.6	27.4	33.5	24.3	18.9	17.7	58.2	20.9	36.2	15.2	38.5	31.0	23.3	16.8	29.2	24.8	20.3	33.9	9.0	26.4	43.7	10.9	32.8	32.6	18.2	39.3	12.1	23.9	28.1	56.9	11.2	29.4	21.5	81.4	6.6	14.8	39.6	63.2	51.1	17.0	48.6	54.3	23.9	12.9	21.4	85.5	20.8	68.3	29.8	41.1	13.7	82.0	59.4	36.4	20.2	27.7	37.6
MOBP		ENSG00000168314	"Myelin associated oligodendrocyte basic protein"	Q13875	3	39467198-39529479	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"brain: 918.8"	"Cell type enriched"	"Detected in some"	14	"Oligodendrocytes: 1607.0"	"Cancer enriched"	"Detected in single"	63	"glioma: 4.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	50	"HAP1: 18.6"	"Low region specificity"	"Detected in all"							HPA035152	Enhanced		Supported	"Cytoplasmic bodies"		NA	NA				"Cluster 70: Brain - Nervous system development"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Cytoplasmic bodies"		"HPA035152: AB_10603020"	"unprognostic (1.76e-2)"	"unprognostic (2.34e-1)"	"unprognostic (3.53e-2)"	"unprognostic (7.35e-2)"	"unprognostic (5.67e-2)"	"unprognostic (3.60e-2)"	"unprognostic (7.47e-2)"	"unprognostic (2.82e-1)"	"unprognostic (7.49e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.01e-1)"	"unprognostic (2.07e-1)"	"unprognostic (2.04e-5)"	"unprognostic (2.28e-1)"	"unprognostic (8.98e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.41e-2)"	0.2	0.1	366.9	0.1	539.9	0.0	0.1	443.3	488.6	0.2	112.1	0.7	0.0	0.5	0.0	0.0	1.5	0.1	0.2	308.8	382.8	0.3	0.1	0.7	0.0	836.4	490.3	0.8	0.1	2.5	0.4	0.0	714.6	0.1	0.2	0.2	0.3	0.0	0.2	0.2	0.1	0.1	565.7	0.0	0.1	5.5	519.1	0.0	0.1	0.0	0.0	0.3	0.1	918.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.6	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.3	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	366.9	539.9	443.3	488.6	308.8	382.8	836.4	490.3	714.6	565.7	519.1	918.8	0.1	0.0	0.0	3.3	0.0	0.6	0.1	0.0	0.0	0.1	0.2	0.3	0.7	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	105.1	1.5	0.1	0.2	0.0	0.0	6.1	0.0	0.0	0.2	0.0	0.8	11.4	40.9	0.0	0.0	0.0	0.0	3.8	0.2	0.0	0.0	1.6	113.0	1.5	0.2	0.0	1.0	0.0	0.2	0.0	4.0	1607.0	0.1	0.4	0.7	0.0	0.1	0.0	0.0	1.1	0.4	0.0	0.1	0.5	41.8	6.1	0.0	0.4	0.0	0.1	0.0	0.4	0.0
MOCS2	"MOCO1, MOCS2A, MOCS2B"	ENSG00000164172	"Molybdenum cofactor synthesis 2"	"O96007, O96033"	5	53095679-53110063	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Molybdenum cofactor biosynthesis"	Transferase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal tubular cells: 573.2;Proximal tubular cells: 281.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037679, HPA037680"	Approved		Supported	"Nucleoplasm,Nuclear speckles,Cytosol"		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 39: Non-specific - Basic cellular processes"	Cytosol	"Nucleoplasm, Nuclear speckles"	"HPA037679: AB_2675604, HPA037680: AB_10673635"	"unprognostic (3.27e-1)"	"unprognostic (3.11e-2)"	"unprognostic (2.82e-1)"	"unprognostic (8.37e-3)"	"unprognostic (2.12e-1)"	"unprognostic (3.48e-2)"	"unprognostic (1.60e-2)"	"unprognostic (1.33e-1)"	"unprognostic (6.66e-2)"	"unprognostic (7.59e-2)"	"unprognostic (2.41e-3)"	"unprognostic (1.85e-1)"	"prognostic favorable (3.68e-6)"	"unprognostic (1.04e-1)"	"unprognostic (1.04e-2)"	"unprognostic (2.04e-1)"	"unprognostic (5.86e-2)"	48.7	79.4	79.1	24.9	84.9	9.1	42.1	80.3	107.6	34.7	74.4	41.9	40.8	30.0	45.9	35.2	26.5	31.3	87.0	84.3	86.3	114.8	126.2	28.2	26.1	79.2	80.5	43.5	42.4	89.6	30.5	35.9	82.4	36.8	32.3	59.3	48.9	44.9	109.3	16.6	40.2	34.4	85.6	23.6	37.2	26.0	88.0	28.3	55.4	111.8	25.2	30.8	24.6	87.4	79.4	62.7	42.9	109.9	85.0	83.2	51.6	99.5	91.9	74.4	89.8	79.7	56.5	76.7	143.5	69.9	127.1	45.0	91.7	96.7	117.2	19.6	84.8	61.7	58.2	75.9	94.4	65.0	43.0	65.1	41.7	91.7	83.5	81.0	85.1	101.4	58.7	44.2	129.5	115.5	72.7	31.8	37.0	34.2	130.1	36.0	93.0	67.0	144.1	56.6	29.4	33.7	69.4	57.3	72.9	56.9	107.2	15.4	55.6	76.9	81.0	69.1	120.5	49.4	84.8	91.5	106.7	16.8	125.1	14.5	21.8	15.6	36.9	26.9	46.2	37.5	42.7	42.8	29.8	40.5	55.3	49.2	3.8	43.5	25.4	27.8	44.9	28.9	79.1	84.9	80.3	107.6	84.3	86.3	79.2	80.5	82.4	85.6	88.0	87.4	51.7	54.5	29.7	14.4	23.5	13.4	40.1	48.5	19.9	30.2	55.7	50.5	122.9	62.9	37.9	69.9	27.1	95.4	19.4	18.2	573.2	43.7	7.3	22.6	29.0	37.6	26.4	18.7	19.1	43.7	37.3	55.7	19.9	26.8	10.1	38.8	26.0	132.6	41.3	6.7	18.4	22.7	44.7	31.2	20.1	14.6	50.7	28.7	23.2	6.5	12.2	67.5	29.9	4.5	11.9	22.1	18.2	68.8	26.7	34.5	65.7	281.7	32.9	21.7	32.9	73.8	49.4	46.7	62.9	37.5	15.6	32.3	25.8	64.2	30.9	34.5
MOGS	"CWH41, DER7, GCS1"	ENSG00000115275	"Mannosyl-oligosaccharide glucosidase"	Q13724	2	74461057-74465410	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosidase, Hydrolase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 222.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011322, HPA011969"	Approved		Supported	"Endoplasmic reticulum"		NA	NA		1500000	"Cluster 41: Basophils - Cellular respiration"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 25: Spermatids - Spermatogenesis"	"Endoplasmic reticulum"		"HPA011322: AB_2668483, HPA011969: AB_1849579"	"unprognostic (5.66e-2)"	"unprognostic (1.98e-2)"	"prognostic unfavorable (5.33e-4)"	"unprognostic (1.91e-2)"	"unprognostic (4.67e-2)"	"unprognostic (2.04e-1)"	"prognostic unfavorable (2.34e-6)"	"unprognostic (1.48e-2)"	"unprognostic (2.66e-2)"	"unprognostic (3.32e-2)"	"unprognostic (6.21e-2)"	"unprognostic (4.36e-1)"	"prognostic unfavorable (2.79e-8)"	"unprognostic (1.40e-2)"	"unprognostic (3.06e-2)"	"unprognostic (2.66e-1)"	"unprognostic (7.59e-3)"	18.4	18.3	8.1	20.2	9.1	8.5	18.6	9.0	13.3	19.2	9.2	22.8	41.7	18.3	5.5	22.5	20.0	14.4	16.9	8.3	9.0	20.9	34.3	24.9	21.6	9.4	8.7	18.6	42.3	21.5	21.7	34.5	9.9	23.3	13.4	9.6	31.1	14.6	21.3	24.9	29.7	11.4	9.3	31.7	35.5	19.0	8.9	19.8	21.9	16.2	18.1	20.1	19.1	9.8	53.1	46.2	23.5	29.6	55.3	38.9	90.1	38.7	58.3	59.8	58.2	81.9	58.7	45.2	34.9	36.3	46.7	50.6	40.2	43.3	32.5	46.7	39.9	20.3	14.4	68.6	54.9	49.8	46.6	25.6	77.1	41.9	39.0	62.2	68.4	27.8	39.6	51.6	28.5	58.8	32.3	62.0	42.6	64.1	22.5	35.5	57.4	74.1	38.0	19.5	19.7	29.2	15.5	84.8	62.7	21.8	38.7	34.3	40.1	26.5	49.7	36.3	56.5	66.5	36.5	22.7	46.9	49.3	39.0	6.7	2.4	1.9	2.6	1.5	3.3	1.2	2.3	2.5	2.1	1.9	1.4	1.6	0.4	8.4	3.3	2.1	3.3	1.7	8.1	9.1	9.0	13.3	8.3	9.0	9.4	8.7	9.9	9.3	8.9	9.8	13.9	6.4	15.9	16.3	22.0	15.8	21.8	20.8	18.2	14.9	18.9	12.8	8.6	24.3	21.3	23.9	18.8	39.5	34.6	18.7	5.9	21.9	65.6	12.4	12.2	13.3	13.9	16.4	13.9	26.1	50.5	12.3	40.8	17.4	4.5	20.9	17.9	25.6	19.9	6.7	12.1	25.7	20.3	12.9	14.8	222.0	15.2	17.9	10.6	12.2	25.5	7.0	30.9	11.1	10.7	22.3	19.7	7.2	43.6	22.7	37.7	7.4	17.7	14.1	13.1	9.4	12.7	13.0	5.1	15.2	17.3	52.0	21.2	16.5	23.3	19.6
MOK	"RAGE, RAGE1, STK30"	ENSG00000080823	"MOK protein kinase"	Q9UQ07	14	102224500-102305190	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 125.8;testis: 54.0"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 185.6;Early spermatids: 212.8;Late spermatids: 185.8;Respiratory ciliated cells: 156.9;Rod photoreceptor cells: 465.7"	"Cancer enriched"	"Detected in many"	4	"melanoma: 7.4"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"NK-cell: 8.0"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HBF TERT88: 149.0;hTEC/SVTERT24-B: 383.5;NB-4: 499.1;U-138 MG: 200.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027292			Supported	"Endoplasmic reticulum"		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 77: Retina - Visual perception"	"Cluster 24: NB-4 - Immune response"	"Cluster 46: Photoreceptor cells - Phototransduction"	"Endoplasmic reticulum"		"HPA027292: AB_10600989"	"unprognostic (8.16e-2)"	"unprognostic (1.82e-1)"	"unprognostic (6.68e-2)"	"unprognostic (6.05e-3)"	"unprognostic (1.34e-2)"	"unprognostic (1.81e-2)"	"unprognostic (4.43e-2)"	"unprognostic (3.49e-4)"	"unprognostic (2.19e-1)"	"unprognostic (2.03e-2)"	"unprognostic (2.93e-1)"	"unprognostic (3.01e-3)"	"unprognostic (5.97e-2)"	"unprognostic (1.81e-1)"	"unprognostic (2.17e-1)"	"unprognostic (1.26e-2)"	"unprognostic (2.48e-1)"	9.2	11.2	15.7	1.8	16.0	3.0	6.8	14.8	18.6	8.9	26.9	5.3	3.4	7.8	7.3	4.3	21.2	4.6	13.0	17.2	16.9	12.6	5.8	5.3	1.7	16.2	17.2	12.9	9.7	7.1	18.6	2.4	15.9	7.6	1.8	125.8	6.3	3.5	2.2	6.8	3.0	3.9	15.0	4.7	9.3	54.0	17.1	1.7	14.8	0.7	1.3	8.4	5.5	15.6	18.9	16.5	2.2	9.5	3.8	13.1	4.2	37.7	11.0	53.4	63.7	1.5	45.4	14.5	3.1	7.2	11.5	4.1	3.3	19.4	149.0	16.2	14.1	3.4	2.3	12.7	15.9	1.6	17.9	11.1	4.9	383.5	35.3	41.3	2.0	2.9	3.4	1.0	35.3	12.5	1.2	499.1	0.7	8.3	39.4	2.2	1.0	0.3	21.9	0.8	6.0	3.9	6.8	2.6	109.4	0.8	11.2	1.5	1.4	200.4	10.4	7.7	12.1	1.3	2.4	1.2	40.2	1.2	93.1	0.0	0.7	0.0	0.5	0.6	0.8	0.0	0.4	1.4	3.0	0.5	0.7	1.7	0.5	8.0	0.1	0.0	0.0	0.9	15.7	16.0	14.8	18.6	17.2	16.9	16.2	17.2	15.9	15.0	17.1	15.6	5.8	19.2	17.5	68.6	1.0	10.7	6.3	12.0	7.4	40.9	19.1	17.3	12.3	10.0	27.5	12.9	185.6	1.4	2.4	6.1	5.9	8.3	212.8	122.1	16.9	7.2	4.8	3.6	54.7	16.0	2.6	17.6	12.2	10.7	3.8	12.2	8.6	2.0	2.1	16.8	37.5	2.4	6.1	1.3	5.3	185.8	30.4	2.5	80.0	7.5	0.5	59.5	1.0	16.1	6.8	6.5	1.2	16.1	1.1	2.7	3.5	11.1	156.9	465.7	26.3	22.4	13.4	121.4	32.0	5.4	5.8	1.2	4.2	13.4	4.2	3.8
MORC2	"AC004542.C22.1, KIAA0852, ZCW3, ZCWCC1"	ENSG00000133422	"MORC family CW-type zinc finger 2"	Q9Y6X9	22	30925130-30968774	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	Hydrolase	"Charcot-Marie-Tooth disease, Disease variant, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Lineage enriched"	"Detected in all"	5	"T-cells: 16.5"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000436, HPA077137"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 71: Testis - DNA repair"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	Nucleoplasm	Cytosol	"HPA000436: AB_1079404, HPA077137: "	"unprognostic (3.43e-2)"	"unprognostic (1.71e-2)"	"unprognostic (1.60e-3)"	"unprognostic (1.44e-2)"	"unprognostic (6.15e-2)"	"unprognostic (3.56e-3)"	"unprognostic (2.89e-3)"	"unprognostic (4.63e-1)"	"unprognostic (6.76e-2)"	"unprognostic (1.60e-1)"	"unprognostic (5.46e-3)"	"unprognostic (1.32e-1)"	"prognostic unfavorable (6.54e-8)"	"unprognostic (5.64e-2)"	"unprognostic (2.38e-1)"	"unprognostic (1.02e-2)"	"unprognostic (6.66e-3)"	15.6	14.4	6.6	7.0	6.7	6.6	16.6	8.5	8.3	20.6	6.6	20.7	5.3	18.1	6.8	17.0	18.7	5.3	19.2	6.6	6.5	16.7	26.9	14.6	9.0	6.6	6.9	20.0	20.1	7.4	16.6	7.5	6.7	21.8	5.9	5.8	14.8	7.7	26.8	19.5	15.6	7.7	6.4	19.5	16.2	45.2	7.0	8.0	15.6	10.2	7.3	21.2	18.5	7.3	19.2	12.2	20.2	23.3	21.4	18.3	15.5	15.6	12.9	16.1	16.7	17.5	10.2	26.9	11.7	14.3	9.4	17.2	17.7	6.9	18.2	15.5	23.8	20.5	12.4	15.3	15.6	18.1	19.8	15.3	12.1	15.1	18.9	12.0	14.0	9.5	26.3	19.0	17.2	23.7	16.2	17.9	23.0	23.9	12.6	31.5	12.8	22.9	12.5	19.1	20.5	17.2	18.8	21.9	8.8	19.6	16.2	21.2	16.3	17.8	18.7	14.3	12.3	15.0	19.0	22.2	10.3	9.1	13.3	0.8	1.6	1.0	12.0	2.9	10.0	2.3	15.1	9.6	1.6	2.1	15.2	11.0	0.3	1.8	3.3	3.2	16.5	5.2	6.6	6.7	8.5	8.3	6.6	6.5	6.6	6.9	6.7	6.4	7.0	7.3	8.7	0.0	4.6	14.0	4.5	7.4	7.3	3.9	6.2	7.9	8.8	9.1	4.6	2.8	6.2	11.0	10.4	8.4	5.9	6.0	3.9	7.3	30.8	6.1	7.8	7.3	9.0	8.6	9.5	8.0	11.4	6.2	4.1	6.0	1.3	8.9	5.7	8.8	5.4	13.5	11.7	4.8	6.1	3.8	4.1	10.3	7.8	4.5	7.2	10.3	2.8	4.1	6.2	11.1	8.8	11.7	4.1	10.1	3.2	11.6	4.6	3.7	3.8	10.4	19.7	7.7	7.7	26.6	24.1	6.0	9.2	6.3	7.8	7.0	7.3	5.6
MORF4L1	"Eaf3, HsT17725, MEAF3, MORFRG15, MRG15"	ENSG00000185787	"Mortality factor 4 like 1"	Q9UBU8	15	78810487-78898139	"Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA recombination, DNA repair, Growth regulation, Transcription, Transcription regulation"	"Chromatin regulator"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA042360, HPA062010"	Approved		Supported	"Nuclear speckles"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 12: NES - Nervous system development"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Nuclear speckles"		"HPA042360: AB_10794275, HPA062010: AB_2684655"	"unprognostic (5.36e-2)"	"unprognostic (4.30e-1)"	"unprognostic (3.68e-1)"	"unprognostic (9.69e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.83e-3)"	"unprognostic (3.61e-3)"	"unprognostic (8.61e-3)"	"unprognostic (3.15e-1)"	"unprognostic (3.58e-2)"	"unprognostic (6.96e-2)"	"unprognostic (3.69e-1)"	"unprognostic (5.77e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.12e-1)"	"unprognostic (3.92e-2)"	"unprognostic (2.60e-3)"	272.8	306.3	183.9	237.6	193.6	427.6	241.5	197.6	285.5	283.8	188.9	270.1	169.4	305.1	213.0	201.1	257.9	256.5	396.6	187.9	240.5	332.2	258.9	243.4	251.8	232.8	221.6	318.2	165.5	263.6	175.1	300.9	223.4	228.7	225.7	265.5	195.9	282.7	559.3	140.5	187.4	331.5	205.4	217.4	186.9	588.7	220.1	297.6	270.2	425.2	279.6	266.2	184.3	227.9	362.0	480.3	863.5	355.4	603.2	620.4	453.2	644.3	636.0	570.7	554.0	436.9	532.7	446.7	517.2	649.1	376.0	442.1	1054.3	432.8	534.3	446.0	420.3	493.5	483.5	406.5	617.9	410.4	424.3	436.7	482.5	323.1	447.6	550.1	689.1	309.7	526.3	398.2	659.2	335.3	392.9	301.6	930.7	472.9	208.5	431.8	673.0	431.0	459.2	488.1	443.6	457.7	578.1	367.2	825.7	871.1	441.7	533.9	543.1	667.2	471.6	359.0	549.6	256.4	770.6	499.2	412.3	647.4	501.4	118.5	195.0	197.5	123.0	188.4	149.4	172.7	176.9	141.6	225.5	163.7	241.9	174.2	154.9	145.1	155.8	214.4	214.2	318.6	183.9	193.6	197.6	285.5	187.9	240.5	232.8	221.6	223.4	205.4	220.1	227.9	374.2	301.3	249.0	38.2	300.0	418.1	624.1	724.2	256.6	104.5	236.1	198.9	372.2	286.0	512.3	290.6	62.6	611.9	309.4	173.4	686.7	545.5	740.6	377.8	352.6	391.1	275.2	298.0	69.6	312.8	815.0	468.2	153.4	282.5	465.8	179.5	372.3	328.6	379.1	200.2	68.5	263.6	451.6	310.9	601.3	504.6	389.5	325.7	501.6	52.5	450.8	322.0	306.9	40.2	80.0	407.4	185.5	464.9	232.0	489.8	178.6	805.1	582.5	97.5	315.5	368.3	500.6	1322.3	467.9	185.3	370.4	663.0	338.2	279.9	199.0	597.1
MOSPD2	MGC26706	ENSG00000130150	"Motile sperm domain containing 2"	Q8NHP6	X	14873421-14922327	"Predicted intracellular proteins, Predicted membrane proteins"	Chemotaxis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 48.9"	"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 125.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 53.4"	"Group enriched"	"Detected in all"	6	"granulocytes: 53.4;monocytes: 15.8"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003334	Uncertain		Supported	"Endoplasmic reticulum"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 70: Brain - Nervous system development"	"Cluster 18: U-2197 - ECM organization"	"Cluster 10: Non-specific - Unknown function"	"Endoplasmic reticulum"		"HPA003334: AB_2146004"	"unprognostic (2.74e-1)"	"unprognostic (4.39e-2)"	"unprognostic (6.52e-2)"	"unprognostic (2.29e-1)"	"unprognostic (7.57e-2)"	"unprognostic (6.39e-2)"	"prognostic unfavorable (8.91e-4)"	"unprognostic (1.51e-1)"	"unprognostic (7.24e-2)"	"unprognostic (4.21e-3)"	"unprognostic (1.00e-1)"	"unprognostic (8.64e-2)"	"unprognostic (1.04e-1)"	"unprognostic (4.56e-1)"	"unprognostic (1.37e-1)"	"unprognostic (2.69e-1)"	"unprognostic (1.96e-2)"	8.3	6.9	9.8	10.7	19.8	8.1	8.5	17.2	21.3	10.7	1.3	6.7	8.2	8.9	7.4	13.1	6.8	11.5	5.1	10.0	12.0	8.6	9.5	14.2	11.6	25.9	15.8	10.5	5.4	6.5	3.6	15.4	24.8	7.1	7.2	7.3	6.6	6.9	2.4	19.4	7.7	8.6	15.7	14.0	8.0	4.0	19.0	8.7	15.0	4.5	9.9	8.6	8.0	48.9	9.4	13.4	9.6	4.9	33.1	20.8	9.4	22.8	21.4	16.2	19.2	7.0	11.1	13.0	6.1	39.0	25.0	15.4	12.6	9.8	20.7	9.0	11.1	4.5	12.5	5.5	20.4	8.6	10.0	19.0	13.5	14.4	19.0	15.6	14.4	12.7	5.8	12.5	15.3	4.5	7.9	7.0	6.6	8.7	12.0	8.2	12.7	10.6	13.2	6.2	3.0	6.9	17.1	7.8	38.5	36.8	6.6	12.7	14.9	13.9	5.6	48.9	8.8	7.6	9.7	8.1	18.3	6.6	20.3	11.8	14.7	6.6	2.7	14.4	3.3	2.1	3.0	2.2	5.1	3.1	3.2	3.4	53.4	5.4	15.8	1.6	3.6	5.8	9.8	19.8	17.2	21.3	10.0	12.0	25.9	15.8	24.8	15.7	19.0	48.9	18.3	22.4	18.2	16.3	15.5	8.5	7.3	5.7	14.8	7.3	10.2	8.3	6.0	11.5	10.9	22.0	6.2	15.5	12.6	9.1	9.8	7.0	5.8	20.3	10.6	14.4	12.6	6.7	17.2	6.1	9.4	14.3	12.2	16.6	7.6	8.7	18.9	8.2	21.8	6.7	17.2	6.7	10.2	28.9	7.1	24.3	10.5	32.7	10.6	23.4	32.5	8.0	8.2	14.1	125.8	6.9	5.7	15.1	12.6	6.7	7.8	11.4	15.4	4.7	13.1	11.6	13.4	9.9	7.9	16.8	12.8	23.5	10.3	11.4	6.4	6.7
MPDU1	"CDGIf, Lec35, PQLC5, SL15, SLC66A5"	ENSG00000129255	"Mannose-P-dolichol utilization defect 1"	O75352	17	7583529-7592789	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	Transport		"Congenital disorder of glycosylation, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Syncytiotrophoblasts: 157.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014845	Uncertain		Supported	"Endoplasmic reticulum,Mitochondria"		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Endoplasmic reticulum"	Mitochondria	"HPA014845: AB_1854072"	"unprognostic (1.96e-1)"	"unprognostic (8.75e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.36e-2)"	"unprognostic (5.00e-2)"	"unprognostic (5.44e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.65e-1)"	"unprognostic (4.70e-2)"	"unprognostic (3.37e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.95e-1)"	"unprognostic (2.34e-3)"	"unprognostic (9.00e-2)"	"unprognostic (2.60e-1)"	"unprognostic (2.48e-3)"	"unprognostic (2.93e-1)"	31.9	41.1	33.0	32.8	34.1	63.3	39.2	35.5	34.5	33.3	41.9	65.5	53.3	17.4	33.5	37.7	32.0	35.7	20.4	31.7	34.2	72.2	107.0	33.3	30.7	34.3	33.9	10.9	39.7	57.4	15.6	37.1	33.7	33.7	69.6	25.4	33.6	18.4	21.3	29.0	48.5	28.7	34.2	28.4	54.5	14.5	36.2	25.9	35.7	21.3	38.0	43.2	21.9	34.9	51.0	111.8	75.9	54.1	83.8	74.4	50.5	81.1	104.6	142.4	98.6	58.0	85.0	28.8	54.8	128.1	65.0	98.4	102.2	134.3	116.6	63.8	118.8	55.7	65.8	98.7	101.0	49.3	89.8	77.9	105.2	133.4	76.4	64.7	105.8	84.9	87.1	38.6	151.6	70.1	35.9	48.4	85.2	107.4	55.8	81.6	56.4	60.7	145.1	52.1	45.8	90.1	104.4	75.9	34.4	59.5	83.8	50.1	76.5	67.5	36.9	36.8	111.2	20.3	34.6	27.0	97.1	62.3	103.5	16.8	44.2	14.0	16.9	73.1	12.8	18.1	16.1	22.1	52.4	16.5	15.4	18.3	6.5	17.4	69.1	48.5	26.4	24.9	33.0	34.1	35.5	34.5	31.7	34.2	34.3	33.9	33.7	34.2	36.2	34.9	30.1	9.6	23.0	5.5	30.4	10.7	34.9	51.0	22.2	18.1	34.7	22.7	5.1	34.3	31.0	23.9	12.5	111.5	26.5	106.8	35.2	62.7	3.2	22.2	23.3	28.2	37.2	96.8	4.5	76.1	93.8	27.5	53.5	28.1	14.5	28.6	25.0	49.7	79.7	16.8	5.6	68.9	40.7	30.5	23.6	5.7	17.1	46.1	24.9	4.7	35.9	28.5	21.6	6.6	9.3	69.7	76.8	6.4	38.5	37.1	78.0	48.0	20.3	23.3	26.3	30.6	24.7	22.9	26.4	20.7	12.6	157.6	26.0	37.1	77.1	40.9
MPG	MDG	ENSG00000103152	"N-methylpurine DNA glycosylase"	P29372	16	77007-85851	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"DNA damage, DNA repair"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006531	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	Cytosol	"HPA006531: AB_1854075"	"unprognostic (1.78e-2)"	"unprognostic (8.48e-2)"	"unprognostic (9.99e-2)"	"prognostic favorable (2.82e-5)"	"unprognostic (8.54e-2)"	"unprognostic (3.27e-1)"	"unprognostic (2.75e-2)"	"unprognostic (1.63e-1)"	"unprognostic (2.14e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.85e-2)"	"unprognostic (1.83e-2)"	"unprognostic (1.39e-2)"	"unprognostic (1.86e-3)"	"unprognostic (3.88e-2)"	"unprognostic (1.86e-2)"	"unprognostic (3.26e-1)"	45.6	63.1	28.6	24.5	28.4	32.8	45.8	28.3	43.8	45.5	25.8	43.0	23.7	46.6	9.4	39.8	40.4	27.5	59.7	28.1	28.7	33.6	66.9	44.6	40.4	27.4	27.5	43.1	59.2	11.9	44.4	21.2	27.4	50.3	7.6	2.0	55.6	21.2	69.2	37.9	37.1	14.7	28.3	53.0	46.8	16.2	29.5	14.2	46.6	21.1	15.1	46.7	38.4	28.5	50.2	70.4	18.1	54.9	34.1	77.2	51.9	78.0	95.1	44.1	49.3	44.2	61.5	40.2	65.0	39.8	20.5	64.7	13.1	30.4	6.7	67.6	59.3	25.3	34.3	67.1	99.3	25.4	141.9	75.4	41.9	50.0	20.4	57.4	80.0	39.9	56.1	58.6	57.8	167.5	43.6	118.1	36.4	27.3	86.1	84.2	25.7	140.5	37.5	17.1	15.5	42.5	41.0	36.2	91.9	8.3	54.1	119.4	80.6	34.1	47.9	49.4	34.4	67.7	23.6	49.6	67.8	71.2	129.9	47.3	75.3	80.9	60.6	56.6	55.0	92.5	57.1	60.3	80.3	85.9	42.5	43.7	38.9	130.2	47.6	110.3	90.8	67.0	28.6	28.4	28.3	43.8	28.1	28.7	27.4	27.5	27.4	28.3	29.5	28.5	72.6	3.2	25.6	14.0	73.9	35.8	82.9	102.9	47.8	13.8	76.8	80.4	1.3	37.1	63.0	40.5	4.2	78.7	74.2	59.1	33.2	76.4	9.9	33.5	63.1	59.3	49.8	39.9	14.2	114.2	89.4	78.7	43.8	36.1	56.3	57.1	62.8	55.6	89.8	10.1	13.9	92.5	83.4	69.4	43.7	5.0	65.9	55.6	56.9	10.3	77.9	39.8	66.9	14.1	12.9	134.8	78.6	57.9	80.1	110.6	83.1	67.7	43.5	11.4	85.5	51.5	73.3	15.1	36.7	53.9	41.1	61.8	59.8	197.2	68.3	114.0
MPHOSPH10	"CT90, MPP10, MPP10P, PPP1R106"	ENSG00000124383	"M-phase phosphoprotein 10"	O00566	2	71130632-71150101	"Predicted intracellular proteins, Predicted membrane proteins"	"Ribosome biogenesis, rRNA processing"	Ribonucleoprotein		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035059, HPA035060, HPA049907"	Enhanced		Enhanced	"Nucleoli,Nucleoli rim,Mitotic chromosome"		Yes	No			"Cluster 44: Non-specific - Transcription"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 10: Non-specific - Unknown function"	"Nucleoli, Nucleoli rim"	"Mitotic chromosome"	"HPA035059: AB_2674436, HPA035060: AB_10601875, HPA049907: AB_2680947"	"unprognostic (3.20e-3)"	"unprognostic (1.59e-1)"	"unprognostic (8.51e-2)"	"unprognostic (5.77e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.62e-1)"	"unprognostic (3.58e-2)"	"unprognostic (1.01e-1)"	"unprognostic (6.41e-3)"	"unprognostic (6.13e-2)"	"unprognostic (3.50e-2)"	"unprognostic (1.02e-1)"	"prognostic unfavorable (3.89e-7)"	"unprognostic (1.24e-1)"	"unprognostic (2.91e-1)"	"unprognostic (2.47e-1)"	"unprognostic (2.23e-2)"	22.6	18.4	15.2	20.4	16.4	26.5	25.0	17.7	21.4	19.9	15.4	17.6	17.7	22.1	27.5	28.6	16.6	18.4	23.2	15.3	17.7	17.8	30.8	16.9	25.2	17.1	17.0	25.9	19.7	22.9	15.8	20.3	17.0	24.6	19.1	15.1	21.0	16.7	33.1	26.7	15.5	16.8	15.6	19.6	17.8	15.4	16.3	22.5	21.7	24.0	27.5	23.8	18.1	17.6	45.8	33.7	42.7	51.3	39.1	36.7	58.3	49.8	39.6	40.6	29.7	60.7	32.9	64.3	30.5	35.3	31.0	41.1	54.8	35.3	54.1	44.7	43.2	77.3	26.3	139.1	34.1	101.0	58.2	32.0	44.4	33.4	44.4	27.4	34.8	39.1	113.5	49.1	41.0	49.1	81.6	101.5	71.0	63.5	38.1	66.6	66.7	75.4	33.1	49.0	51.8	40.0	33.6	75.0	49.9	36.1	38.2	44.5	36.0	47.2	51.1	45.3	64.0	41.0	50.6	104.1	40.5	82.8	49.1	17.6	12.4	9.8	15.2	17.8	20.2	18.0	19.6	18.8	15.3	15.0	21.4	19.2	1.9	17.1	26.1	16.3	18.3	11.3	15.2	16.4	17.7	21.4	15.3	17.7	17.1	17.0	17.0	15.6	16.3	17.6	38.6	35.3	55.5	8.1	36.8	33.4	42.7	37.8	30.7	37.2	26.0	36.8	44.5	30.0	53.0	18.4	4.2	50.5	47.7	17.9	25.4	47.8	6.0	40.4	52.4	40.4	18.0	26.9	9.8	41.8	48.1	43.2	19.9	65.4	48.1	31.2	21.8	33.2	27.2	18.5	11.4	21.6	26.4	17.7	20.8	6.3	48.7	19.0	12.4	15.0	39.2	25.5	47.4	12.1	15.9	33.1	15.0	43.6	25.6	40.6	14.2	22.7	29.2	53.2	39.5	62.2	49.1	70.2	84.5	35.6	33.5	32.4	39.9	42.8	28.2	31.9
MPHOSPH6	MPP6	ENSG00000135698	"M-phase phosphoprotein 6"	Q99547	16	82147798-82170224	"Predicted intracellular proteins"	"rRNA processing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003674, HPA026948"	Approved		Supported	Nucleoplasm,Nucleoli		No	No			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Nucleoplasm, Nucleoli"		"CAB003674: , HPA026948: AB_1854077"	"unprognostic (2.58e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.65e-2)"	"unprognostic (2.01e-1)"	"unprognostic (3.57e-1)"	"unprognostic (2.97e-3)"	"prognostic unfavorable (4.36e-5)"	"unprognostic (2.00e-2)"	"unprognostic (2.29e-3)"	"prognostic favorable (3.41e-5)"	"unprognostic (7.52e-2)"	"prognostic unfavorable (1.59e-4)"	"unprognostic (3.05e-1)"	"unprognostic (2.95e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.17e-1)"	"unprognostic (9.43e-2)"	19.8	21.3	26.7	25.5	26.8	20.0	72.5	29.6	32.8	23.6	19.1	22.7	13.8	25.8	22.4	36.2	15.9	16.5	13.9	26.7	28.3	17.8	15.9	18.7	24.7	22.1	24.7	13.4	9.0	16.2	21.3	24.4	23.1	15.3	24.9	31.6	26.0	13.0	18.0	40.1	15.9	22.8	21.7	16.7	15.7	14.1	27.5	20.7	11.6	17.5	26.2	34.7	21.0	28.4	67.8	36.2	79.0	38.9	37.7	52.7	43.5	71.1	84.7	60.6	29.3	58.5	38.4	55.2	42.0	39.2	44.7	69.2	76.2	73.6	80.8	41.3	49.9	44.5	31.2	106.5	37.5	111.9	65.9	33.6	64.7	36.2	102.8	30.5	70.6	75.7	106.2	15.3	93.4	54.8	86.5	131.2	72.4	83.4	49.5	105.5	36.6	36.5	55.3	69.8	54.1	23.3	119.6	52.5	53.6	32.4	92.2	68.6	56.0	56.5	56.3	50.2	51.3	22.4	58.0	217.9	51.0	89.9	73.2	26.1	38.3	36.9	38.2	46.5	48.5	35.6	38.7	39.9	44.9	29.2	41.1	38.8	4.9	33.1	33.8	27.2	44.3	28.3	26.7	26.8	29.6	32.8	26.7	28.3	22.1	24.7	23.1	21.7	27.5	28.4	13.2	19.2	38.3	20.5	22.9	38.7	40.3	123.9	19.4	14.5	74.3	50.0	31.5	14.3	66.2	20.2	10.4	56.9	23.0	21.7	50.9	45.2	6.5	13.9	18.5	19.3	9.0	23.1	38.5	28.1	46.1	31.4	15.8	22.0	18.3	21.9	20.0	19.0	49.6	20.2	35.6	20.7	40.7	29.1	42.7	7.5	11.1	55.9	32.0	12.2	56.0	61.1	34.0	29.7	17.1	56.4	28.4	10.1	22.3	38.6	12.2	46.5	32.7	24.5	19.7	15.4	30.1	36.9	57.5	30.6	54.0	32.8	27.4	26.3	34.0	48.1
MPHOSPH8	"HSMPP8, mpp8"	ENSG00000196199	"M-phase phosphoprotein 8"	Q99549	13	19633659-19673441	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039701, HPA040035"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 35: Non-specific - Unknown function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	"Plasma membrane, Cytosol"	"HPA039701: AB_10805484, HPA040035: AB_10794207"	"unprognostic (4.22e-1)"	"unprognostic (5.58e-2)"	"unprognostic (2.66e-1)"	"unprognostic (4.01e-3)"	"unprognostic (3.05e-2)"	"unprognostic (1.86e-1)"	"unprognostic (2.81e-3)"	"unprognostic (4.90e-2)"	"unprognostic (4.55e-2)"	"unprognostic (1.59e-1)"	"unprognostic (3.52e-3)"	"unprognostic (3.40e-2)"	"unprognostic (6.49e-2)"	"unprognostic (3.86e-2)"	"unprognostic (4.93e-2)"	"unprognostic (2.10e-1)"	"unprognostic (1.02e-1)"	29.0	32.5	32.4	30.0	31.9	27.9	28.7	36.5	48.7	38.6	31.1	39.7	22.5	36.1	31.6	23.3	34.0	23.4	36.1	31.6	40.2	22.9	21.1	28.7	39.2	31.8	35.7	51.4	28.2	26.3	31.6	25.4	31.5	31.2	24.4	36.9	32.3	31.2	23.4	33.6	33.3	26.6	26.8	39.9	28.3	21.5	33.6	23.2	32.9	18.5	26.4	32.3	31.7	36.5	26.0	16.4	23.9	39.0	30.3	38.2	42.2	38.2	27.5	23.6	20.1	25.1	44.5	40.8	29.7	23.1	36.6	42.2	44.4	26.7	30.2	51.1	22.7	65.7	27.8	30.8	27.0	47.8	51.4	22.8	33.8	18.6	26.1	35.8	31.6	32.5	32.5	25.5	22.2	25.1	36.8	39.9	23.4	48.0	18.1	29.3	55.2	32.6	40.7	19.8	32.7	20.0	35.7	32.3	35.3	39.8	19.7	39.1	37.3	18.1	16.4	34.8	19.6	17.2	19.2	40.1	13.8	43.4	28.7	133.6	23.4	42.5	31.5	18.2	28.1	64.3	35.6	31.1	11.4	54.1	42.5	34.8	69.2	30.4	27.8	35.8	30.9	9.9	32.4	31.9	36.5	48.7	31.6	40.2	31.8	35.7	31.5	26.8	33.6	36.5	117.3	93.0	110.6	42.1	129.7	69.0	102.1	99.0	97.3	201.0	74.8	95.0	94.4	110.1	92.2	103.0	83.4	151.1	132.0	95.1	49.0	57.6	84.3	82.3	129.2	109.0	58.8	78.9	94.7	54.6	83.7	118.8	62.7	118.8	144.2	101.0	133.2	81.3	72.9	210.3	89.4	113.2	67.1	74.5	55.5	37.9	179.3	71.4	67.6	51.5	99.8	114.9	166.9	56.3	78.7	48.2	99.7	157.2	118.5	80.8	100.5	61.6	66.6	219.0	177.5	111.5	118.5	211.0	203.7	57.9	74.0	58.7	142.7	105.3	86.8	65.3
MPHOSPH9	MPP9	ENSG00000051825	"M-phase phosphoprotein 9"	Q99550	12	123152320-123244014	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 114.7;Excitatory neurons: 87.7;Inhibitory neurons: 84.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037485	Approved		Uncertain	"Nucleoplasm,Golgi apparatus,Plasma membrane,Centrosome,Cytosol"		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 24: NB-4 - Immune response"	"Cluster 9: Photoreceptor cells - Phototransduction"	"Plasma membrane, Cytosol"	"Nucleoplasm, Golgi apparatus, Centrosome"	"HPA037485: AB_10672792"	"unprognostic (2.98e-2)"	"unprognostic (5.00e-1)"	"unprognostic (4.36e-3)"	"unprognostic (1.45e-2)"	"unprognostic (1.62e-1)"	"unprognostic (2.81e-1)"	"unprognostic (5.81e-3)"	"unprognostic (1.64e-1)"	"unprognostic (1.58e-2)"	"unprognostic (1.88e-1)"	"unprognostic (8.34e-2)"	"unprognostic (1.08e-2)"	"unprognostic (6.53e-3)"	"unprognostic (1.31e-2)"	"unprognostic (2.75e-1)"	"unprognostic (5.14e-3)"	"unprognostic (1.17e-1)"	4.6	5.4	13.7	8.0	15.2	26.2	5.0	21.6	19.8	4.7	18.9	6.1	6.8	5.3	11.1	3.1	5.3	3.6	5.6	14.3	13.2	6.2	9.6	3.9	12.1	13.8	13.7	4.5	4.0	8.9	4.4	5.2	13.9	4.6	6.8	21.3	5.5	4.4	6.8	5.0	5.2	5.2	13.4	8.1	5.1	12.4	14.4	32.8	5.2	7.8	10.3	4.2	1.9	16.0	15.0	15.9	23.9	28.0	10.7	10.1	9.1	15.7	7.8	18.7	15.2	15.1	7.2	29.6	10.6	10.1	15.7	10.2	30.3	11.1	26.0	17.6	20.7	30.5	17.9	15.0	6.6	27.0	24.6	10.5	4.7	18.2	16.1	15.6	19.5	40.1	21.4	12.7	17.3	12.9	32.6	44.6	17.1	9.4	17.2	27.6	24.9	19.1	14.7	14.8	31.4	15.0	23.7	9.3	15.4	22.4	17.5	21.2	11.1	15.3	21.5	17.5	22.1	19.0	33.8	24.4	12.2	26.4	32.4	11.5	3.7	5.4	10.1	3.7	7.2	6.5	8.4	9.5	3.7	6.0	11.6	12.0	0.8	10.1	3.3	5.3	7.8	2.8	13.7	15.2	21.6	19.8	14.3	13.2	13.8	13.7	13.9	13.4	14.4	16.0	7.3	9.6	9.5	50.3	15.6	4.5	4.5	5.7	8.6	43.5	5.8	5.2	16.3	10.0	7.2	7.3	114.7	12.2	25.3	2.8	5.9	4.8	57.9	21.2	12.4	8.5	14.3	33.6	87.7	1.8	7.1	10.6	5.1	6.5	2.5	23.6	7.9	31.1	8.6	53.8	84.7	5.6	6.1	15.3	7.4	73.3	7.2	10.4	3.6	24.4	17.0	14.7	32.0	46.3	48.1	1.8	1.6	11.3	21.4	3.0	4.3	11.0	14.9	65.9	0.0	11.6	7.2	31.7	20.4	8.4	2.3	1.6	26.8	17.2	9.8	2.7
MPL	"CD110, THPOR, TPOR"	ENSG00000117400	"MPL proto-oncogene, thrombopoietin receptor"	P40238	1	43337818-43354466	"Cancer-related genes, CD markers, Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"		Receptor	"Cancer-related genes, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in some"			"Group enriched"	"Detected in some"	5	"Erythroid cells: 3.0;Excitatory neurons: 2.0;Oligodendrocytes: 1.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in single"		"neutrophil: 1.4"	"Lineage enriched"	"Detected in single"	4	"granulocytes: 1.4"	"Cell line enriched"	"Detected in some"	57	"HEL: 77.4"	"Region enhanced"	"Detected in single"		"cerebral cortex: 1.5"	"Low region specificity"	"Detected in many"			HPA007619			Supported	"Nuclear membrane,Plasma membrane"		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 36: HEL - Hemostasis"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Plasma membrane"	"Nuclear membrane"	"HPA007619: AB_1854080"	"unprognostic (2.74e-1)"	"unprognostic (6.56e-2)"	"unprognostic (2.95e-1)"	"unprognostic (8.71e-2)"	"unprognostic (1.37e-2)"	"unprognostic (1.06e-3)"	"unprognostic (1.19e-1)"	"unprognostic (1.22e-2)"	"unprognostic (5.83e-2)"	"unprognostic (1.03e-1)"	"unprognostic (5.94e-4)"	"unprognostic (1.51e-1)"	"unprognostic (1.19e-4)"	"unprognostic (2.39e-1)"	"unprognostic (3.26e-1)"	"unprognostic (1.03e-4)"	"unprognostic (1.42e-1)"	0.6	0.4	0.8	0.2	1.7	1.8	0.4	0.8	1.3	0.3	0.1	0.3	0.3	0.7	1.2	0.5	0.8	0.3	1.0	0.6	1.2	0.4	0.4	0.6	0.2	1.2	1.0	2.9	0.8	0.4	0.0	0.3	1.1	0.9	0.4	1.5	0.4	0.7	0.6	0.5	0.2	0.7	0.7	0.4	0.5	1.2	1.1	0.1	0.9	0.3	0.1	0.2	0.0	2.8	0.4	0.7	0.1	0.2	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.7	1.3	0.1	0.3	0.1	0.0	0.6	0.0	0.2	0.0	0.4	0.1	77.4	1.2	0.4	0.0	0.1	0.0	0.0	0.2	0.0	0.2	0.3	0.0	0.1	0.0	0.1	0.0	0.3	0.0	0.2	0.5	0.1	0.1	0.2	0.0	0.2	0.7	0.6	0.4	0.2	0.6	0.1	0.2	0.2	0.3	0.0	0.1	0.1	0.2	0.1	0.1	0.2	0.2	0.0	0.0	0.0	0.0	0.9	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.0	0.0	0.2	0.2	0.2	1.4	0.1	0.1	0.3	0.1	1.8	0.8	1.7	0.8	1.3	0.6	1.2	1.2	1.0	1.1	0.7	1.1	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	3.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
MPLKIP	"C7orf11, ORF20, TTDN1"	ENSG00000168303	"M-phase specific PLK1 interacting protein"	Q8TAP9	7	40126027-40134622	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA058457, HPA065463"	Uncertain		Supported	"Nucleoplasm,Golgi apparatus,Vesicles"		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 24: NB-4 - Immune response"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm	"Golgi apparatus, Vesicles"	"HPA058457: AB_2683724, HPA065463: AB_2685493"	"unprognostic (5.59e-2)"	"unprognostic (1.74e-1)"	"unprognostic (9.40e-2)"	"unprognostic (2.39e-2)"	"unprognostic (5.55e-2)"	"unprognostic (1.34e-3)"	"unprognostic (2.73e-1)"	"unprognostic (3.40e-2)"	"unprognostic (3.94e-2)"	"unprognostic (1.65e-1)"	"unprognostic (3.16e-3)"	"unprognostic (8.89e-2)"	"unprognostic (1.61e-2)"	"unprognostic (8.44e-2)"	"unprognostic (2.91e-2)"	"unprognostic (1.91e-2)"	"unprognostic (6.08e-2)"	2.9	3.8	2.6	2.0	2.6	2.4	2.8	4.7	3.0	2.8	3.0	2.8	2.2	2.6	2.0	3.1	2.5	1.2	2.1	2.6	2.3	4.2	8.0	2.1	2.6	2.4	2.3	2.8	2.9	2.5	3.0	1.8	2.6	2.5	1.8	3.1	2.7	1.5	2.4	3.0	2.6	1.1	2.0	3.1	2.4	2.3	2.5	3.3	3.0	1.4	2.0	2.5	2.7	4.0	8.2	2.5	4.8	6.6	4.3	4.9	4.9	3.1	3.3	4.4	4.3	3.1	4.0	6.8	4.2	3.0	8.7	10.3	3.0	5.3	5.6	5.2	9.2	5.4	3.7	6.9	4.9	6.7	5.2	4.8	6.7	3.4	4.1	4.5	5.1	7.5	13.1	5.5	4.4	4.1	6.8	20.4	6.7	6.7	7.4	9.6	3.3	8.9	5.0	2.1	7.1	8.4	5.0	4.8	7.7	6.2	6.1	9.3	5.5	2.8	7.5	3.6	4.7	8.6	9.6	10.9	4.4	10.5	7.6	20.6	11.2	16.8	8.0	10.8	9.0	16.9	10.1	9.4	11.8	15.3	11.3	9.9	9.2	10.6	10.4	13.1	14.2	13.1	2.6	2.6	4.7	3.0	2.6	2.3	2.4	2.3	2.6	2.0	2.5	4.0	49.8	51.3	34.5	6.5	53.3	110.1	96.2	151.8	58.6	43.5	53.8	66.2	18.0	67.2	79.6	58.8	25.0	110.8	41.3	60.3	117.4	66.6	118.4	73.6	62.3	58.0	48.6	52.2	7.4	54.6	79.7	51.1	35.7	56.6	51.3	63.6	47.2	133.4	69.0	53.8	8.1	63.4	85.5	59.3	62.6	38.6	75.8	50.4	58.7	7.5	74.6	52.9	66.9	12.1	12.5	59.9	97.2	55.3	36.3	76.2	61.6	190.5	91.1	50.1	52.6	57.1	58.4	66.6	53.9	67.1	134.1	95.6	46.8	125.7	82.3	105.7
MPO		ENSG00000005381	Myeloperoxidase	P05164	17	58269855-58280935	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Hydrogen peroxide"	"Oxidoreductase, Peroxidase"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	61	"bone marrow: 4023.1"	"Cell type enriched"	"Detected in some"	30	"Erythroid cells: 87.4"	"Cancer enhanced"	"Detected in single"		"stomach cancer: 1.1"	"Low region specificity"	"Detected in some"			"Immune cell enhanced"	"Detected in some"		"classical monocyte: 6.2"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	94	"HL-60: 3517.4;NB-4: 4589.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB000059, HPA021147, HPA061464"	Enhanced		Supported	Nucleoplasm,Vesicles	"Intracellular and membrane"	No	NA	576000000	24000000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 24: NB-4 - Immune response"	"Cluster 12: Non-specific - Cell cycle regulation"	Vesicles	Nucleoplasm	"CAB000059: AB_2335676, HPA021147: AB_1854083, HPA061464: AB_2684531"	"unprognostic (1.91e-1)"	"unprognostic (9.08e-2)"	"unprognostic (4.62e-2)"	"unprognostic (2.90e-2)"	"unprognostic (2.13e-3)"	"unprognostic (2.78e-1)"	"unprognostic (3.23e-1)"	"unprognostic (2.91e-1)"	"unprognostic (2.56e-1)"	"unprognostic (1.68e-1)"	"unprognostic (6.92e-2)"	"unprognostic (8.34e-3)"	"unprognostic (4.91e-2)"	"unprognostic (3.07e-3)"	"unprognostic (2.83e-1)"	"unprognostic (1.14e-2)"	"unprognostic (8.05e-2)"	0.5	0.4	0.8	0.6	0.6	4023.1	0.3	0.6	1.1	0.0	0.3	0.2	0.0	0.2	1.1	0.1	0.1	0.3	1.1	0.8	0.7	0.2	1.8	8.4	1.7	0.9	1.0	0.1	0.1	0.0	1.5	1.4	0.9	0.2	0.2	0.4	66.3	0.1	1.1	4.3	0.2	0.3	0.8	21.7	0.1	0.4	0.8	10.9	0.3	0.3	0.2	0.5	0.1	0.7	0.4	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.1	3517.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4589.9	0.0	0.0	0.0	5.3	3.2	0.6	0.0	0.0	0.0	0.5	1.1	0.0	0.0	0.0	0.0	43.1	0.0	0.0	0.0	1.3	0.0	0.0	0.0	1.1	0.0	4.0	0.0	0.0	6.2	0.0	0.0	3.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	1.4	0.0	0.6	0.0	0.1	7.5	0.8	0.6	0.6	1.1	0.8	0.7	0.9	1.0	0.9	0.8	0.8	0.7	0.0	0.0	0.5	0.7	0.3	0.0	0.0	0.0	0.0	0.4	0.2	0.3	0.4	0.0	0.0	0.0	0.0	0.0	1.8	0.0	1.9	0.0	0.5	0.1	0.0	0.1	0.0	87.4	0.3	0.2	0.9	0.7	0.0	0.0	0.0	0.0	0.7	0.3	0.9	0.0	0.2	0.0	0.0	1.2	0.0	1.3	0.0	2.9	0.0	0.0	2.3	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.2	0.0	1.2	0.1	0.1	0.3	0.1	0.0	0.1	0.6	0.0	0.0	0.0
MPP1	"DXS552E, PEMP"	ENSG00000130830	"Membrane palmitoylated protein 1"	Q00013	X	154778684-154821007	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 116.8"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 410.9;Erythroid cells: 393.8;Hofbauer cells: 291.9;Macrophages: 155.9;Syncytiotrophoblasts: 454.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"eosinophil: 215.7;neutrophil: 202.1"	"Group enriched"	"Detected in all"	8	"dendritic cells: 57.7;granulocytes: 215.7;monocytes: 98.8"	"Cell line enhanced"	"Detected in many"		"HEL: 218.0;REH: 136.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA076675	Enhanced		Supported	"Plasma membrane,Centriolar satellite"		NA	NA		650000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Plasma membrane"	"Centriolar satellite"	"HPA076675: "	"unprognostic (2.15e-1)"	"unprognostic (4.06e-2)"	"unprognostic (4.52e-2)"	"unprognostic (1.83e-3)"	"unprognostic (7.14e-2)"	"unprognostic (2.60e-2)"	"unprognostic (7.47e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.82e-1)"	"unprognostic (7.79e-2)"	"unprognostic (3.77e-3)"	"unprognostic (1.70e-3)"	"prognostic favorable (4.60e-6)"	"unprognostic (6.69e-2)"	"unprognostic (2.53e-2)"	"unprognostic (4.68e-2)"	"unprognostic (6.67e-3)"	24.1	27.2	21.0	27.1	22.0	116.8	16.5	26.2	29.7	11.6	18.6	17.2	59.4	13.4	5.3	10.5	15.7	24.3	26.0	22.5	25.2	42.9	37.5	28.3	24.9	28.3	21.9	10.6	34.6	30.7	9.7	86.5	30.7	15.5	17.6	10.6	23.7	18.1	29.2	10.2	47.3	19.7	22.5	40.9	11.8	7.1	27.3	72.8	14.0	27.2	12.5	21.3	10.0	28.2	41.4	8.3	18.7	18.7	19.0	20.1	59.5	15.3	23.3	25.3	30.8	23.7	3.7	32.8	29.3	17.1	67.9	4.6	21.6	6.9	19.9	34.9	38.0	218.0	5.7	25.3	28.6	44.4	121.4	19.4	9.0	28.2	7.0	25.9	58.5	42.1	96.1	5.3	28.7	0.2	102.6	60.3	1.9	3.8	28.2	136.0	4.8	15.5	14.8	3.3	4.7	7.5	12.7	1.2	13.3	18.5	3.2	25.8	26.6	23.2	12.5	51.8	41.7	36.6	52.9	12.5	32.7	61.7	11.1	49.7	95.6	215.7	5.1	76.6	6.0	7.8	5.9	5.7	57.7	2.7	15.4	7.9	202.1	10.1	98.8	15.5	3.5	79.1	21.0	22.0	26.2	29.7	22.5	25.2	28.3	21.9	30.7	22.5	27.3	28.2	18.3	3.2	11.2	8.1	6.3	8.7	4.8	0.2	8.0	10.2	7.1	5.1	17.0	41.5	6.2	7.3	4.2	410.9	6.9	16.3	21.5	11.7	0.6	3.5	5.7	18.9	11.5	393.8	16.1	2.8	27.0	11.4	1.1	6.4	90.6	9.6	11.7	10.6	291.9	16.8	17.1	4.4	0.0	104.7	30.2	2.4	8.7	155.9	10.6	15.9	52.5	15.4	9.2	6.0	5.9	3.7	4.1	13.2	8.1	3.1	57.4	66.3	2.2	8.2	0.0	8.6	10.3	0.7	6.8	6.4	6.0	454.4	9.9	14.5	5.8	1.2
MPP4	DLG6	ENSG00000082126	"Membrane palmitoylated protein 4"	Q96JB8	2	201644870-201698694	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	194	"retina: 286.2"	"Group enriched"	"Detected in some"	36	"Cone photoreceptor cells: 1586.7;Rod photoreceptor cells: 808.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HBF TERT88: 22.2;hTEC/SVTERT24-B: 21.0;LHCN-M2: 85.8;TIME: 16.4;U-87 MG: 21.3"	"Low region specificity"	"Detected in single"			"Region enhanced"	"Detected in single"		"cerebellum: 2.7"	HPA057393			Supported	"Actin filaments,Cytosol"		No	No				"Cluster 79: Retina - Phototransduction"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 9: Photoreceptor cells - Phototransduction"	Cytosol	"Actin filaments"	"HPA057393: AB_2732612"	"unprognostic (1.42e-2)"	"unprognostic (1.82e-2)"	"unprognostic (2.55e-1)"	"unprognostic (2.50e-2)"	"unprognostic (2.22e-2)"	"unprognostic (6.66e-2)"	"unprognostic (1.09e-2)"	"unprognostic (9.42e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.19e-1)"	"unprognostic (9.20e-2)"	"unprognostic (3.33e-16)"	"unprognostic (1.82e-2)"	"unprognostic (8.23e-2)"	"unprognostic (1.29e-1)"	"unprognostic (3.34e-2)"	0.1	0.5	0.3	0.1	0.3	0.0	0.1	1.3	0.4	0.7	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.4	0.2	0.1	0.1	0.1	0.0	0.6	0.1	0.1	0.0	0.0	0.3	0.1	0.2	0.1	0.0	286.2	0.0	0.1	0.1	0.8	0.0	0.0	0.1	1.4	0.0	0.5	0.1	0.0	0.1	0.1	0.0	0.1	0.5	0.3	0.0	0.0	0.0	0.0	0.1	6.6	0.0	11.2	2.7	6.6	6.7	0.0	0.0	0.0	0.0	2.6	1.0	0.0	0.0	0.8	22.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.9	0.7	0.0	21.0	0.1	3.2	12.3	0.1	0.0	0.0	85.8	0.0	0.0	0.0	0.6	0.0	2.0	0.0	1.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	16.4	8.4	2.6	2.0	7.8	0.0	0.0	0.0	21.3	0.0	7.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	1.3	0.4	0.4	0.2	0.6	0.1	0.2	0.1	0.1	0.3	0.7	3.2	8.6	0.3	0.0	0.4	0.0	0.2	0.0	20.0	0.4	0.0	0.2	1.5	6.2	1.8	1586.7	0.1	0.2	0.0	0.0	0.2	2.8	0.4	0.4	2.6	0.0	0.0	7.3	0.2	0.1	0.6	0.0	0.1	3.8	0.1	0.0	0.1	0.1	18.5	2.8	0.0	0.0	0.3	0.9	2.5	0.0	0.4	1.8	0.0	0.1	33.0	1.0	2.0	0.3	0.2	0.0	0.0	0.0	0.1	0.2	0.1	6.7	808.3	0.0	1.4	1.1	0.1	0.4	0.0	0.4	0.0	0.3	0.1	0.2	0.0
MPP7	FLJ32798	ENSG00000150054	"Membrane palmitoylated protein 7"	Q5T2T1	10	28050993-28334486	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 37.1"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 82.3;Excitatory neurons: 76.7;Suprabasal keratinocytes: 61.1"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"cerebellum: 4.7"	"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BEWO: 23.3;CACO-2: 45.2;CAPAN-2: 27.9;T-47d: 89.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037597, HPA037598"	Approved		Supported	"Nucleoplasm,Cell Junctions"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 6: T47d - Mammary gland"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Cell Junctions"	Nucleoplasm	"HPA037597: AB_2675569, HPA037598: AB_10696941"	"unprognostic (1.12e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.59e-3)"	"unprognostic (1.49e-1)"	"unprognostic (6.64e-2)"	"unprognostic (7.78e-2)"	"unprognostic (9.31e-3)"	"prognostic favorable (5.88e-4)"	"unprognostic (2.15e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.88e-1)"	"unprognostic (2.26e-1)"	"prognostic favorable (2.79e-14)"	"unprognostic (2.46e-1)"	"unprognostic (1.88e-1)"	"unprognostic (4.66e-2)"	"unprognostic (1.03e-2)"	3.8	2.7	0.1	5.7	1.0	8.8	9.7	4.7	2.2	6.4	0.1	10.7	6.0	5.1	1.9	37.1	11.8	6.4	6.6	0.4	0.0	12.2	1.9	10.1	2.6	0.0	0.0	3.4	12.1	11.8	2.2	11.7	0.1	8.0	9.3	9.7	7.6	4.8	13.8	24.8	7.2	8.7	0.0	2.4	8.8	9.0	0.0	3.2	14.4	14.3	6.9	9.7	9.6	1.1	5.9	0.1	0.6	0.0	0.1	0.1	23.3	1.2	0.9	4.7	7.4	45.2	27.9	0.0	0.3	3.4	3.4	10.4	3.9	7.5	10.9	0.0	7.5	0.0	1.3	2.8	0.0	0.0	0.0	0.3	11.6	0.7	0.4	0.0	0.0	2.2	1.1	0.0	6.2	10.9	2.3	0.0	1.4	8.9	2.1	1.2	13.3	0.0	0.4	19.0	1.1	0.0	2.3	11.3	0.0	3.6	89.3	1.1	0.0	1.8	12.5	0.0	1.0	0.2	0.0	0.1	0.1	10.7	0.0	0.0	7.7	9.0	3.8	2.5	5.6	0.6	4.2	2.6	7.8	0.5	7.9	5.7	3.1	5.0	1.5	0.1	1.1	5.1	0.1	1.0	4.7	2.2	0.4	0.0	0.0	0.0	0.1	0.0	0.0	1.1	1.6	44.8	48.3	10.4	5.5	23.1	10.9	9.5	7.4	1.1	14.7	8.6	12.1	10.0	24.3	14.7	16.7	50.0	9.8	15.3	9.8	5.5	82.3	9.3	0.6	11.7	6.7	4.2	76.7	12.9	3.5	2.6	11.2	6.6	1.3	0.7	2.9	3.2	5.4	3.3	30.3	10.4	8.2	4.7	5.3	20.3	0.9	8.1	7.2	12.2	16.2	24.0	4.1	4.5	2.5	6.6	7.8	0.4	5.1	7.5	12.1	9.5	19.3	8.5	0.0	1.5	7.6	5.4	9.5	48.0	61.1	46.5	16.3	0.1	11.3	17.4
MPPE1	"Cdc1, PGAP5"	ENSG00000154889	"Metallophosphoesterase 1"	Q53F39	18	11882622-11908366	"Predicted intracellular proteins, Predicted membrane proteins"	"ER-Golgi transport, GPI-anchor biosynthesis, Transport"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"eosinophil: 100.8;neutrophil: 293.9"	"Lineage enriched"	"Detected in all"	7	"granulocytes: 293.9"	"Cell line enhanced"	"Detected in all"		"OE19: 65.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA012639	Uncertain		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 21: OE19 - Mitochondria"	"Cluster 63: NK-cells & T-cells - Immune response"	"Nucleoplasm, Golgi apparatus"		"HPA012639: AB_1854088"	"unprognostic (9.23e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.38e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.06e-1)"	"unprognostic (4.51e-1)"	"unprognostic (7.92e-3)"	"prognostic unfavorable (1.35e-4)"	"unprognostic (1.00e-2)"	"unprognostic (4.46e-1)"	"unprognostic (1.61e-1)"	"prognostic favorable (6.45e-7)"	"unprognostic (1.26e-1)"	"unprognostic (1.38e-1)"	"unprognostic (7.79e-2)"	"unprognostic (6.15e-2)"	14.9	13.1	11.3	20.0	11.7	28.3	15.4	11.0	11.9	16.1	11.7	21.5	17.7	17.0	20.6	17.2	16.4	21.8	18.6	10.9	11.9	28.8	23.8	25.6	16.0	12.6	11.8	12.7	31.8	20.1	15.0	14.1	12.5	16.3	21.4	15.9	15.0	19.0	23.5	29.0	20.3	15.8	10.6	15.9	22.8	8.5	12.1	16.0	47.1	11.7	14.7	14.9	13.7	13.1	7.8	11.1	8.4	19.9	22.9	26.7	7.9	18.6	26.0	10.6	16.5	20.8	21.6	15.8	39.2	17.6	10.7	8.6	5.8	10.1	9.9	17.7	10.4	4.6	22.9	4.9	31.9	20.3	30.9	40.1	13.3	9.4	6.6	15.7	6.5	13.9	5.8	14.5	17.8	18.1	15.1	13.6	5.6	65.9	3.1	6.0	5.4	18.8	17.2	11.9	11.8	6.7	17.1	13.5	16.0	9.3	9.8	25.9	13.5	21.4	8.3	20.5	10.3	22.6	21.5	19.7	15.8	10.4	21.5	20.6	42.9	100.8	24.8	34.5	18.1	17.9	15.2	23.9	37.3	21.7	18.5	23.8	293.9	29.2	24.6	29.6	27.0	31.8	11.3	11.7	11.0	11.9	10.9	11.9	12.6	11.8	12.5	10.6	12.1	13.1	19.3	57.7	33.0	13.4	24.5	18.0	16.2	20.7	12.5	17.4	14.6	11.6	2.4	24.3	23.1	22.0	12.5	27.9	35.7	43.9	21.5	30.5	20.5	17.9	14.8	15.5	9.6	13.3	20.9	41.9	32.5	16.6	29.6	22.6	27.8	23.5	15.7	27.6	25.4	8.4	21.4	23.4	14.2	33.2	25.7	36.0	12.8	24.8	19.6	20.6	24.2	23.3	52.5	12.5	24.4	36.3	18.4	15.1	16.0	10.1	36.3	27.0	26.7	20.5	13.1	17.2	13.9	7.0	8.7	21.8	20.0	16.7	33.7	16.4	16.1	22.0
MPRIP	"M-RIP, p116Rip, RHOIP3"	ENSG00000133030	"Myosin phosphatase Rho interacting protein"	Q6WCQ1	17	17042457-17217679	"Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"T-reg: 60.9"	"Lineage enriched"	"Detected in all"	6	"T-cells: 60.9"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022034, HPA022901"	Enhanced		Supported	"Actin filaments,Cytosol"		NA	NA		29000	"Cluster 35: T-regs - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 20: HeLa - Mitochondria"	"Cluster 48: Smooth muscle cells - ECM organization"	"Actin filaments"	Cytosol	"HPA022034: AB_1854093, HPA022901: AB_2297761"	"unprognostic (1.92e-2)"	"unprognostic (1.53e-3)"	"unprognostic (5.81e-3)"	"unprognostic (9.92e-3)"	"unprognostic (1.01e-1)"	"unprognostic (5.16e-2)"	"unprognostic (4.19e-1)"	"unprognostic (3.55e-2)"	"unprognostic (5.18e-2)"	"unprognostic (9.01e-3)"	"unprognostic (1.55e-1)"	"unprognostic (1.60e-1)"	"unprognostic (6.56e-2)"	"unprognostic (2.38e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.92e-1)"	"unprognostic (5.04e-2)"	126.1	110.0	166.8	74.9	213.0	68.1	102.7	165.7	184.3	128.6	113.4	128.4	78.6	172.7	83.7	151.7	120.5	73.8	245.6	184.5	142.9	156.8	129.1	144.5	80.4	165.5	157.1	90.3	137.5	96.7	116.0	70.5	170.7	113.0	59.9	59.0	83.2	91.8	168.3	96.2	103.3	133.6	145.0	102.2	141.2	99.2	173.6	89.7	139.4	84.6	76.9	133.0	135.3	168.2	328.5	241.7	103.6	85.1	107.2	79.3	146.0	155.2	117.6	131.9	96.9	189.2	242.3	129.3	151.0	251.4	108.9	292.1	133.4	227.3	139.3	127.7	69.8	70.3	216.9	68.6	72.3	38.6	49.4	76.8	133.4	149.9	114.0	189.8	138.9	97.9	43.5	73.1	213.3	113.0	158.1	131.9	46.6	324.2	275.9	127.6	162.4	48.9	101.6	155.3	57.3	94.4	174.7	144.2	81.4	414.0	68.8	60.3	130.8	118.4	128.0	321.3	280.2	51.6	45.0	61.1	221.3	69.1	297.7	2.4	2.5	3.5	8.5	1.9	18.3	9.3	34.8	14.4	2.4	6.9	24.8	12.1	1.1	4.5	1.8	10.0	60.9	9.9	166.8	213.0	165.7	184.3	184.5	142.9	165.5	157.1	170.7	145.0	173.6	168.2	75.9	32.1	48.0	87.1	22.2	27.0	27.9	22.7	12.5	104.6	26.2	29.2	59.9	31.5	30.6	25.8	81.3	25.9	32.9	46.9	3.9	31.8	28.5	43.7	47.4	62.1	22.7	25.0	94.0	28.7	36.2	39.7	72.4	79.4	16.5	51.3	37.9	21.7	12.3	97.6	75.6	17.3	26.4	14.3	18.6	32.4	29.2	17.7	32.0	43.1	13.5	31.3	17.5	73.4	84.4	92.4	26.4	43.2	19.0	40.2	27.9	9.2	30.6	49.3	78.9	71.0	110.4	24.3	31.4	22.4	27.4	31.7	35.0	49.4	27.1	103.0
MPV17L	"FLJ39599, MLPH1, MLPH2, MPV17L1"	ENSG00000156968	"MPV17 mitochondrial inner membrane protein like"	Q2QL34	16	15395754-15413271	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 14.1"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HMC-1: 29.5;SK-BR-3: 8.2"					"Low region specificity"	"Detected in all"			HPA041180	Approved		Supported	Vesicles		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 50: Fibroblasts - ECM organization"	Vesicles		"HPA041180: AB_10794266"	"unprognostic (9.65e-2)"	"unprognostic (8.74e-2)"	"unprognostic (4.16e-1)"	"unprognostic (1.35e-3)"	"unprognostic (6.68e-2)"	"unprognostic (2.84e-1)"	"unprognostic (2.73e-1)"	"unprognostic (4.38e-3)"	"unprognostic (8.41e-2)"	"unprognostic (8.99e-3)"	"unprognostic (8.70e-2)"	"unprognostic (6.36e-3)"	"prognostic favorable (1.48e-11)"	"unprognostic (2.84e-1)"	"unprognostic (7.60e-2)"	"unprognostic (6.61e-3)"	"unprognostic (3.87e-2)"	1.8	2.5	1.2	1.8	0.1	4.4	6.4	1.9	2.2	2.8	0.0	2.3	3.4	2.0	0.3	1.0	1.8	2.4	1.6	0.1	0.0	3.3	9.1	0.9	2.3	0.1	0.0	2.1	14.1	2.4	3.2	0.6	0.3	2.0	1.0	4.4	7.1	1.8	8.0	4.5	2.3	0.8	0.0	1.8	1.8	1.0	0.5	0.2	2.2	2.4	0.6	1.9	1.3	0.4	1.0	1.9	0.8	0.8	0.2	0.1	1.2	0.5	0.0	0.0	0.0	1.9	3.4	1.5	1.3	0.6	0.5	1.5	3.0	0.0	0.0	1.2	0.8	5.9	4.6	3.9	0.3	3.6	29.5	0.3	0.4	0.1	0.2	0.5	0.0	1.6	2.3	3.3	0.1	1.9	1.4	2.3	1.7	0.3	0.1	2.0	0.6	1.6	0.5	0.8	4.8	1.6	2.7	8.2	0.2	0.9	1.8	2.6	2.6	1.3	0.8	1.1	1.1	1.4	0.6	1.7	0.7	1.7	0.5	1.7	1.2	0.2	0.8	0.9	0.6	0.8	0.5	0.8	0.4	1.2	0.4	0.8	1.8	1.1	0.4	0.7	0.4	0.6	1.2	0.1	1.9	2.2	0.1	0.0	0.1	0.0	0.3	0.0	0.5	0.4	2.5	6.4	8.8	3.9	2.0	7.9	14.4	8.2	0.0	12.8	11.4	6.0	6.0	14.3	13.1	0.0	10.4	0.5	4.1	2.7	15.6	7.5	4.6	5.4	9.2	6.6	1.2	2.1	5.6	12.9	0.5	8.1	2.0	10.7	6.3	7.6	4.2	29.1	1.0	8.4	5.9	8.7	2.0	13.6	20.6	0.8	7.2	6.0	21.4	2.8	0.7	6.2	0.0	7.5	3.2	5.9	15.3	14.3	1.4	9.6	9.3	19.9	21.0	16.6	0.0	23.5	6.7	9.0	2.0	0.6	11.5	0.5	9.9	4.4	12.1	10.1
MPZL1	"FLJ21047, PZR"	ENSG00000197965	"Myelin protein zero like 1"	O95297	1	167721192-167791919	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	4	"neutrophil: 183.8"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 183.8"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026966, HPA063538"	Approved		Supported	"Vesicles,Plasma membrane"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 50: Fibroblasts - ECM organization"	"Vesicles, Plasma membrane"		"HPA026966: AB_10600931, HPA063538: AB_2685034"	"unprognostic (6.54e-2)"	"unprognostic (9.26e-3)"	"unprognostic (4.59e-2)"	"unprognostic (4.88e-1)"	"unprognostic (2.18e-1)"	"unprognostic (2.57e-2)"	"prognostic unfavorable (4.27e-6)"	"prognostic unfavorable (3.98e-4)"	"unprognostic (1.22e-1)"	"unprognostic (3.41e-2)"	"unprognostic (2.59e-1)"	"unprognostic (2.27e-1)"	"prognostic unfavorable (3.99e-7)"	"unprognostic (3.55e-1)"	"unprognostic (2.35e-1)"	"prognostic unfavorable (8.08e-4)"	"unprognostic (4.21e-2)"	74.8	34.1	23.1	49.2	21.6	8.3	91.6	22.0	21.8	63.1	40.1	60.1	40.8	50.0	27.4	52.9	60.1	67.7	52.4	22.1	28.3	28.6	23.0	42.3	35.2	25.7	30.0	46.4	27.5	28.4	33.0	68.9	30.7	41.8	59.4	12.7	73.1	38.9	14.7	34.0	41.0	62.6	26.4	29.2	43.8	48.2	28.6	29.3	39.5	26.8	45.9	74.7	51.3	24.9	88.5	126.3	96.9	75.8	303.4	137.2	304.8	134.5	172.7	86.3	106.4	234.4	119.5	31.0	152.9	171.6	76.1	144.2	97.5	149.0	72.6	70.9	52.8	25.5	63.5	56.7	188.5	30.2	16.1	126.1	183.5	137.8	153.4	121.4	116.4	93.6	97.1	63.5	103.0	29.3	103.6	36.2	61.9	176.7	53.5	62.5	82.7	137.5	131.4	84.6	55.7	91.8	119.6	122.4	69.7	221.9	66.6	16.0	132.8	97.9	44.1	127.5	73.8	94.0	157.2	142.8	140.8	35.3	15.8	7.7	29.1	20.0	2.8	24.8	1.3	14.7	2.8	4.1	38.5	8.8	7.7	2.6	183.8	10.4	34.6	43.9	0.5	11.0	23.1	21.6	22.0	21.8	22.1	28.3	25.7	30.0	30.7	26.4	28.6	24.9	52.9	28.9	30.0	31.0	15.1	76.3	78.5	57.6	35.9	8.8	75.9	73.9	6.3	20.0	49.6	20.2	6.2	128.7	21.1	67.1	5.9	63.2	1.8	14.5	40.4	56.7	47.8	10.1	32.8	75.6	145.2	118.2	41.3	23.0	3.8	75.3	24.3	23.3	37.7	10.1	27.9	39.7	20.3	28.2	31.9	4.9	69.9	23.5	16.0	60.0	84.0	11.8	3.1	141.8	1.7	81.0	41.6	83.8	23.5	141.7	55.5	10.1	28.3	13.9	19.7	18.6	48.6	8.9	26.8	41.2	55.5	76.9	8.6	49.4	61.0	57.7
MR1	HLALS	ENSG00000153029	"Major histocompatibility complex, class I-related"	Q95460	1	181033425-181061938	"FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Immunity, Innate immunity"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA048304			Supported	"Plasma membrane"	"Intracellular and membrane"	NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 34: Non-specific - Transcription"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Plasma membrane"		"HPA048304: AB_2680347"	"unprognostic (6.89e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.31e-2)"	"unprognostic (1.96e-1)"	"unprognostic (8.66e-3)"	"unprognostic (4.37e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.36e-2)"	"unprognostic (2.03e-1)"	"unprognostic (1.18e-1)"	"unprognostic (3.49e-2)"	"unprognostic (6.41e-2)"	"unprognostic (1.05e-2)"	"unprognostic (7.40e-3)"	"unprognostic (4.69e-2)"	"unprognostic (2.39e-1)"	"unprognostic (1.07e-2)"	8.6	9.6	3.2	14.2	3.3	11.1	9.7	2.2	3.5	10.2	5.8	6.7	7.4	9.5	9.6	9.6	10.4	12.7	6.2	3.1	3.8	9.9	10.6	18.0	14.6	4.7	3.3	13.6	3.7	14.0	8.9	13.5	3.7	10.9	8.1	1.5	5.9	10.5	2.1	8.7	6.9	12.5	3.8	12.3	8.7	2.6	4.4	20.2	16.7	3.8	15.2	16.3	7.4	4.8	7.9	5.4	0.1	4.6	32.2	38.8	13.9	15.5	42.2	12.7	21.5	2.2	31.9	9.7	31.6	28.1	9.9	20.5	0.7	18.3	11.1	29.6	5.2	14.2	5.6	9.8	10.8	11.5	40.6	25.2	49.6	18.9	20.3	23.7	1.3	17.8	26.7	25.6	24.9	8.8	12.1	8.3	0.1	0.1	0.8	13.7	0.3	27.3	13.9	23.1	0.2	0.3	8.2	14.8	10.9	6.0	15.4	24.6	8.1	12.5	1.7	21.8	7.7	42.2	15.3	17.9	11.7	14.7	1.2	32.6	21.8	22.9	16.3	27.4	14.6	14.3	14.6	14.6	18.8	18.3	10.8	16.2	14.7	19.0	23.6	10.2	17.0	15.2	3.2	3.3	2.2	3.5	3.1	3.8	4.7	3.3	3.7	3.8	4.4	4.8	4.4	19.2	32.4	8.8	14.7	5.0	8.3	32.6	12.0	0.8	7.7	6.1	4.1	8.6	20.9	14.7	0.0	17.5	15.9	1.6	5.9	10.8	0.3	5.9	12.1	4.9	2.4	11.4	3.1	6.4	9.5	12.8	2.6	7.3	17.1	13.5	3.6	8.9	25.8	0.0	1.7	2.7	32.6	25.2	9.1	0.4	10.8	25.3	7.2	11.2	30.8	4.1	26.8	0.0	0.5	7.5	4.5	12.0	9.1	7.4	2.2	2.4	15.3	0.6	0.0	8.6	9.2	0.4	1.6	10.9	5.4	24.5	15.7	22.4	3.5	13.4
MRAP	"B27, C21orf61, FALP"	ENSG00000170262	"Melanocortin 2 receptor accessory protein"	Q8TCY5	21	32291813-32314784	"Disease related genes, Human disease related genes, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	27	"adipose tissue: 75.6;adrenal gland: 166.5;breast: 44.2"	"Group enriched"	"Detected in some"	5	"Early spermatids: 16.1;Granulosa cells: 43.7;Horizontal cells: 43.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in single"		"NK-cell: 1.9"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in some"	5	"Hep G2: 1.5;HSkMC: 1.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA011024, HPA011093"	Uncertain		Supported	"Endoplasmic reticulum,Vesicles"		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 17: Adrenal gland - Steroid metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 40: Granulosa cells - Unknown function"	"Endoplasmic reticulum"	Vesicles	"HPA011024: AB_10599292, HPA011093: AB_10600889"	"unprognostic (1.38e-1)"	"unprognostic (1.55e-3)"	"unprognostic (1.53e-1)"		"unprognostic (1.11e-1)"	"unprognostic (9.53e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.27e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.80e-2)"	"unprognostic (4.12e-1)"	"unprognostic (6.30e-6)"	"unprognostic (3.32e-2)"	"unprognostic (2.37e-1)"	"unprognostic (1.18e-1)"	"unprognostic (5.76e-2)"	75.6	166.5	0.1	1.8	0.1	0.0	44.2	0.0	0.5	0.1	0.8	1.2	0.2	0.0	0.0	0.1	0.0	0.6	2.0	0.1	0.0	0.3	2.4	1.0	0.1	0.2	0.0	2.0	0.7	0.0	0.1	1.7	0.1	0.0	0.2	1.0	2.0	0.0	0.2	1.3	3.5	0.1	0.0	0.0	0.6	0.5	0.0	0.1	0.7	0.2	0.0	1.4	0.4	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.3	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.3	0.2	0.2	0.7	0.2	0.4	0.2	0.8	0.2	0.5	0.0	1.9	0.1	0.5	0.7	0.0	0.1	0.1	0.0	0.5	0.1	0.0	0.2	0.0	0.1	0.0	0.0	0.1	1.1	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.1	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.1	0.4	0.0	0.1	0.0	0.0	0.7	0.0	0.1	1.3	0.0	0.0	0.0	43.7	0.0	1.7	0.1	43.7	0.6	0.0	0.0	0.0	0.0	6.6	0.6	0.1	0.0	0.0	0.0	0.3	0.0	2.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.2	0.6	1.6	0.1	0.0	0.0	0.0	0.0	1.9	0.0	0.0
MRFAP1	"PAM14, PGR1"	ENSG00000179010	"Morf4 family associated protein 1"	Q9Y605	4	6640091-6642745	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB042447, HPA056367"	Approved		Supported	Nucleoplasm		No	No			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 47: Cytotrophoblasts - Unknown function"	Nucleoplasm		"CAB042447: AB_2145271, HPA056367: AB_2683107"	"unprognostic (1.28e-1)"	"unprognostic (1.67e-1)"	"unprognostic (3.82e-2)"	"unprognostic (1.31e-2)"	"unprognostic (7.03e-2)"	"unprognostic (9.55e-2)"	"unprognostic (1.14e-3)"	"unprognostic (1.86e-3)"	"unprognostic (1.30e-1)"	"unprognostic (5.51e-2)"	"unprognostic (7.78e-3)"	"unprognostic (1.02e-1)"	"prognostic favorable (2.90e-7)"	"unprognostic (1.24e-1)"	"unprognostic (9.93e-2)"	"unprognostic (2.27e-1)"	"unprognostic (1.79e-1)"	227.9	291.8	348.2	126.4	355.0	108.2	209.1	360.6	382.1	222.2	330.6	254.2	147.1	254.8	207.9	189.0	221.4	134.3	260.4	335.9	359.7	266.1	245.3	203.4	114.8	409.8	362.8	243.2	156.1	260.7	262.1	194.2	367.5	193.0	132.7	165.7	164.8	207.0	372.3	179.8	163.4	215.1	358.3	181.3	196.1	154.7	359.7	131.0	177.7	308.2	132.8	220.3	194.6	389.3	344.4	371.8	311.7	360.9	373.9	336.6	245.7	444.2	407.3	401.1	398.9	368.7	362.7	214.4	333.0	411.9	455.0	192.2	425.4	462.3	482.5	85.4	306.6	319.6	430.5	405.8	349.7	241.6	151.2	351.0	416.2	369.2	371.6	380.2	452.2	185.9	427.9	136.4	401.2	432.5	182.2	565.1	387.7	297.6	472.6	233.6	564.5	182.3	490.3	255.6	488.0	381.6	287.7	204.2	429.7	270.4	569.8	291.2	408.6	350.3	235.2	262.6	592.2	196.8	266.4	351.5	362.5	507.6	347.7	202.0	186.2	163.2	126.9	154.0	127.9	89.4	125.3	127.0	177.8	94.8	127.8	126.3	198.6	137.1	153.1	143.8	147.1	196.4	348.2	355.0	360.6	382.1	335.9	359.7	409.8	362.8	367.5	358.3	359.7	389.3	141.8	160.3	158.9	14.4	84.7	188.5	262.6	155.6	130.9	113.9	148.6	155.2	227.0	163.0	124.4	88.3	16.7	547.5	103.7	83.8	219.2	241.8	43.1	161.8	184.2	196.4	178.1	123.1	18.7	204.2	312.7	197.2	69.8	166.8	150.4	141.4	171.4	179.7	200.4	111.0	20.9	129.7	130.2	144.4	114.1	65.1	314.0	106.8	126.3	12.2	158.5	270.7	113.3	12.5	33.7	189.0	121.3	304.6	61.1	257.3	168.0	252.6	126.0	111.5	216.9	230.7	197.7	349.3	211.8	126.3	173.8	322.2	121.4	337.1	138.3	236.7
MRGBP	"C20orf20, Eaf7, FLJ10914, MRG15BP"	ENSG00000101189	"MRG domain binding protein"	Q9NV56	20	62796473-62801729	"Plasma proteins, Predicted intracellular proteins"	"Growth regulation, Transcription, Transcription regulation"	"Activator, Chromatin regulator"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 48.0"	"Group enriched"	"Detected in many"	7	"Early spermatids: 124.0;Late spermatids: 408.9;Spermatocytes: 113.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA017012	Enhanced		Supported	Nucleoplasm		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 31: Spermatids - Spermatogenesis"	Nucleoplasm		"HPA017012: AB_1845679"	"unprognostic (1.90e-1)"	"unprognostic (1.60e-1)"	"unprognostic (2.07e-1)"	"prognostic unfavorable (2.33e-4)"	"unprognostic (8.56e-2)"	"unprognostic (1.80e-3)"	"prognostic unfavorable (3.80e-6)"	"unprognostic (2.02e-2)"	"unprognostic (3.06e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.17e-1)"	"unprognostic (8.79e-2)"	"prognostic unfavorable (2.48e-6)"	"unprognostic (1.36e-1)"	"unprognostic (1.28e-1)"	"unprognostic (2.25e-1)"	"unprognostic (6.01e-3)"	7.0	7.5	8.8	5.5	8.9	6.7	6.8	9.4	9.8	7.9	7.9	8.8	8.1	6.7	3.2	7.5	6.8	4.6	9.8	8.7	8.7	8.4	13.6	7.1	7.8	8.7	8.8	10.8	6.7	8.7	7.8	7.3	8.7	7.1	4.0	6.6	7.4	4.4	9.2	7.2	8.8	3.2	8.0	9.7	7.6	48.0	9.0	7.0	7.5	6.7	5.3	7.3	7.5	10.2	32.2	20.0	16.1	24.8	8.7	13.1	15.6	18.2	23.5	69.2	30.0	71.5	25.1	29.3	35.4	14.1	34.3	26.7	18.5	30.7	38.9	9.2	15.8	21.4	22.9	41.8	13.5	25.2	38.7	11.3	22.2	18.9	20.0	14.7	16.6	27.8	29.6	15.7	17.5	48.8	48.0	47.7	13.6	33.5	35.7	42.5	30.5	21.8	10.5	13.1	22.6	18.2	25.9	22.9	33.9	8.9	28.3	36.5	17.4	42.9	44.6	29.4	39.2	20.9	13.7	34.9	42.3	24.8	24.6	0.0	0.6	0.9	0.5	1.0	0.7	0.4	0.6	0.7	0.4	0.4	0.5	1.0	0.7	0.1	0.4	0.5	0.8	0.3	8.8	8.9	9.4	9.8	8.7	8.7	8.7	8.8	8.7	8.0	9.0	10.2	15.2	0.0	2.2	6.2	17.1	14.7	14.8	9.0	13.1	12.3	14.4	11.9	9.4	18.6	5.3	12.9	8.4	12.6	18.0	9.2	19.6	23.3	124.0	9.3	11.5	12.0	2.4	12.8	7.9	22.2	24.7	13.1	12.8	9.7	1.3	14.5	11.0	14.5	14.3	13.5	7.3	9.6	8.2	11.3	16.5	408.9	12.2	16.1	7.2	2.8	12.4	16.5	8.2	5.0	5.2	24.3	8.0	7.9	18.8	23.5	12.4	18.6	3.2	14.5	0.0	10.2	13.8	113.0	27.8	16.4	13.1	14.6	15.6	19.5	12.0	17.6
MRGPRF	"GPR140, GPR168, MGC21621, mrgF"	ENSG00000172935	"MAS related GPR family member F"	Q96AM1	11	69004395-69013382	"G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"endometrium 1: 171.2;intestine: 159.2"	"Cell type enhanced"	"Detected in many"		"Fibroblasts: 33.3;Leydig cells: 66.2;Peritubular cells: 100.8;Sertoli cells: 52.6;Smooth muscle cells: 63.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 67.6;ASC TERT1: 30.0;BJ: 39.5;BJ hTERT+: 99.1;BJ hTERT+ SV40 Large T+: 36.8;fHDF/TERT166: 30.8;U-2197: 46.8"	"Region enriched"	"Detected in many"	5	"cerebellum: 14.8"	"Region enhanced"	"Detected in some"		"spinal cord: 4.8"	HPA028811	Approved		Supported	"Nuclear membrane,Plasma membrane"		NA	NA				"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 48: Smooth muscle cells - ECM organization"	"Nuclear membrane, Plasma membrane"		"HPA028811: AB_10603875"	"unprognostic (2.49e-2)"	"unprognostic (3.89e-2)"	"unprognostic (1.20e-1)"	"unprognostic (9.03e-2)"	"unprognostic (5.16e-2)"	"unprognostic (6.52e-3)"	"unprognostic (3.20e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.36e-1)"	"unprognostic (8.32e-2)"	"unprognostic (1.47e-1)"	"unprognostic (4.55e-7)"	"unprognostic (2.75e-2)"	"unprognostic (2.27e-1)"	"unprognostic (2.86e-2)"	"unprognostic (3.62e-3)"	41.7	3.8	2.6	12.8	2.9	0.0	32.5	12.0	3.9	103.6	5.5	159.2	9.3	171.2	14.2	16.2	98.0	16.7	13.7	2.4	3.1	17.1	7.0	18.7	4.5	4.7	2.8	37.0	3.4	0.5	4.1	11.6	3.3	48.3	8.9	0.2	10.8	45.6	5.1	15.2	38.3	59.3	2.8	13.4	44.1	7.3	2.8	0.7	10.7	3.0	1.3	75.2	65.6	2.5	0.0	0.1	0.1	0.0	67.6	30.0	1.4	39.5	99.1	36.8	24.3	0.0	1.8	0.0	0.8	30.8	0.1	0.1	0.1	0.0	6.8	0.0	0.0	0.0	2.8	0.0	8.5	0.0	0.0	22.1	0.0	23.5	0.0	0.1	0.0	0.2	0.0	0.0	0.6	0.0	0.0	2.9	1.5	0.8	0.1	0.0	3.4	0.1	0.0	0.0	0.1	0.2	0.0	0.1	0.0	2.5	0.0	0.0	0.0	22.4	0.0	46.8	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	2.9	12.0	3.9	2.4	3.1	4.7	2.8	3.3	2.8	2.8	2.5	3.2	0.0	0.0	0.0	0.6	5.0	0.2	0.0	1.2	0.0	0.3	2.3	0.6	2.8	0.0	11.0	0.0	0.7	0.1	0.0	0.0	0.0	4.9	1.1	20.6	2.3	0.0	0.0	1.1	0.0	0.6	33.3	0.5	0.8	0.0	0.0	3.9	3.8	1.1	0.0	0.2	0.0	0.0	0.0	7.3	7.9	66.2	0.2	7.2	3.7	0.0	3.0	0.0	0.0	0.2	0.1	0.0	100.8	0.1	0.3	0.0	0.9	0.0	0.3	52.6	19.1	63.7	1.3	0.5	0.4	3.8	1.1	0.6	0.6	0.0	0.4
MRI1	"MGC3207, MRDI, mtnA, Ypr118w"	ENSG00000037757	"Methylthioribose-1-phosphate isomerase 1"	Q9BV20	19	13764522-13774282	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Amino-acid biosynthesis, Methionine biosynthesis"	Isomerase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042744, CAB045988"	Approved		Supported	"Nucleoplasm,Nucleoli fibrillar center,Cytosol"		No	No		880000	"Cluster 17: Basophils - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 52: Non-specific - Transcription"	"Nucleoplasm, Cytosol"	"Nucleoli fibrillar center"	"CAB045988: AB_2145566, HPA042744: AB_2678141"	"unprognostic (1.16e-1)"	"unprognostic (1.20e-1)"	"unprognostic (2.14e-1)"	"unprognostic (7.36e-2)"	"unprognostic (4.14e-2)"	"unprognostic (1.05e-1)"	"unprognostic (3.24e-1)"	"unprognostic (1.57e-2)"	"unprognostic (4.27e-3)"	"unprognostic (1.61e-1)"	"unprognostic (8.98e-2)"	"unprognostic (1.50e-3)"	"unprognostic (1.75e-2)"	"unprognostic (1.18e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.28e-1)"	15.8	19.2	7.9	9.0	8.2	9.5	18.5	9.3	8.5	24.8	7.0	17.3	9.6	21.6	4.1	20.5	21.8	5.3	12.9	7.6	7.5	22.3	23.8	15.8	10.5	8.9	7.7	24.4	19.6	7.8	18.0	11.9	8.7	19.3	6.4	5.3	20.5	8.8	11.6	26.0	21.1	5.2	7.1	23.1	18.3	3.6	8.4	7.8	23.0	4.4	8.7	17.6	22.4	10.9	14.7	9.3	5.5	13.1	6.1	9.5	13.0	17.9	9.3	13.8	12.4	9.9	11.5	7.9	6.5	6.6	7.3	25.4	24.5	15.5	10.8	12.6	39.3	6.6	18.5	12.0	4.7	20.3	14.8	9.9	9.4	7.1	6.0	14.3	13.7	7.9	11.6	0.6	7.4	18.7	21.9	14.3	9.1	6.0	27.2	20.5	7.6	17.4	8.1	11.4	10.4	9.9	6.6	13.9	14.5	7.7	11.1	8.2	8.2	8.2	7.6	29.3	8.8	11.0	11.3	2.4	6.8	22.5	9.7	3.4	1.8	0.7	1.7	1.7	1.8	1.5	1.7	2.2	1.4	1.6	1.3	1.1	1.6	1.8	1.1	2.7	1.5	1.3	7.9	8.2	9.3	8.5	7.6	7.5	8.9	7.7	8.7	7.1	8.4	10.9	9.2	9.6	19.8	15.0	10.8	11.1	8.9	10.8	6.8	4.3	9.0	8.4	0.9	8.6	13.4	16.5	8.4	13.2	17.2	8.1	5.9	9.2	0.7	11.5	14.4	13.8	9.1	13.3	22.3	12.7	8.7	12.3	14.3	14.2	13.3	9.9	12.8	10.0	7.2	1.7	19.6	9.3	6.1	7.2	8.4	1.7	17.4	7.4	1.8	9.4	10.5	5.0	17.5	18.1	15.2	6.8	11.0	15.1	13.3	4.7	16.5	10.5	19.2	9.3	26.3	10.8	13.3	0.3	4.5	13.3	11.4	5.3	16.0	22.2	9.8	6.8
MRM1	FLJ22578	ENSG00000278619	"Mitochondrial rRNA methyltransferase 1"	Q6IN84	17	36601583-36608964	"Metabolic proteins, Predicted intracellular proteins"	"rRNA processing"	"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							HPA021598	Supported		Supported	Mitochondria		NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 21: OE19 - Mitochondria"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Mitochondria		"HPA021598: AB_1854097"	"unprognostic (9.07e-3)"	"unprognostic (1.50e-1)"	"unprognostic (1.86e-1)"	"unprognostic (1.19e-1)"	"unprognostic (4.86e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.08e-2)"	"unprognostic (2.46e-1)"	"unprognostic (1.42e-1)"	"unprognostic (4.90e-2)"	"unprognostic (2.47e-2)"	"unprognostic (8.56e-2)"	"unprognostic (2.75e-1)"	"unprognostic (5.67e-2)"	"unprognostic (2.36e-1)"	"unprognostic (3.95e-1)"	"unprognostic (1.74e-2)"	3.4	6.0	2.2	1.1	2.6	2.1	3.9	1.8	4.5	4.5	1.1	6.0	2.8	4.5	1.4	5.2	4.1	0.3	7.4	2.0	2.3	5.7	7.3	2.8	3.0	2.2	2.2	5.0	6.2	2.6	2.9	0.7	2.3	4.8	3.1	0.6	4.1	2.4	8.1	3.6	6.0	0.7	1.8	5.9	4.6	2.3	2.5	1.9	4.2	4.7	0.6	5.8	4.3	2.6	1.5	8.7	0.0	5.0	4.3	5.1	15.5	0.3	0.0	0.0	0.0	0.7	0.2	0.7	9.5	0.0	4.0	20.0	0.2	0.4	0.0	7.5	2.9	15.2	5.1	8.9	2.2	7.9	7.5	4.0	0.4	10.2	0.0	1.4	5.2	6.7	9.9	4.9	6.0	0.2	14.6	4.6	0.2	19.9	0.1	12.1	0.0	19.5	4.4	9.3	4.1	3.1	0.0	6.1	6.5	5.5	6.8	2.6	2.0	5.0	8.9	5.7	0.1	11.9	15.3	6.5	0.0	8.0	4.0	0.0	2.0	0.0	2.8	3.0	5.3	4.4	2.2	2.7	2.1	3.9	3.5	3.8	0.0	6.0	1.5	2.4	2.0	2.4	2.2	2.6	1.8	4.5	2.0	2.3	2.2	2.2	2.3	1.8	2.5	2.6	1.3	0.0	1.5	4.9	3.8	1.1	2.9	2.7	2.8	1.1	2.6	1.7	7.8	2.8	1.6	3.7	4.2	7.0	0.6	5.3	9.8	4.2	0.1	1.0	2.9	2.9	1.8	5.0	9.6	1.8	7.4	1.8	3.1	1.3	0.0	3.9	1.8	2.1	6.2	6.7	8.2	5.3	2.0	1.0	0.4	0.0	3.4	1.5	1.8	0.0	2.2	1.7	2.1	5.5	4.0	2.2	5.4	1.5	2.2	5.6	5.4	5.1	0.6	1.2	0.0	1.9	2.0	1.3	3.0	3.3	0.4	1.8	2.2	4.5	9.0	2.2
MRM3	"FLJ10581, HC90, RMTL1, RNMTL1"	ENSG00000171861	"Mitochondrial rRNA methyltransferase 3"	Q9HC36	17	782353-792509	"Metabolic proteins, Predicted intracellular proteins"	"rRNA processing"	"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 27.1;Distal tubular cells: 19.6;Ductal cells: 18.9;Exocrine glandular cells: 18.4;Extravillous trophoblasts: 24.6;Proximal tubular cells: 20.0;Syncytiotrophoblasts: 19.6;Theca cells: 28.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022534, HPA023031, HPA023292"	Enhanced		Supported	Mitochondria		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 7: Non-specific - Mitochondria"	Mitochondria		"HPA022534: AB_1856386, HPA023031: AB_1856387, HPA023292: AB_1856388"	"unprognostic (1.66e-1)"	"unprognostic (5.83e-3)"	"unprognostic (6.72e-2)"	"prognostic favorable (2.81e-4)"	"unprognostic (2.67e-1)"	"unprognostic (1.83e-1)"	"unprognostic (2.48e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.46e-1)"	"unprognostic (8.20e-2)"	"unprognostic (3.72e-3)"	"unprognostic (8.47e-2)"	"prognostic favorable (3.00e-4)"	"unprognostic (3.82e-2)"	"unprognostic (9.98e-2)"	"unprognostic (1.05e-2)"	"unprognostic (1.42e-2)"	9.3	12.9	7.9	6.8	8.4	17.6	8.7	9.9	9.2	6.7	9.7	9.7	7.8	7.6	5.2	11.6	8.0	4.8	17.3	8.2	7.9	9.7	20.5	6.0	10.4	8.2	8.7	8.7	19.6	9.1	6.2	6.9	8.6	7.5	7.5	4.3	9.5	6.0	29.4	14.7	8.2	6.6	7.7	9.9	13.0	18.6	8.6	8.3	7.0	18.7	9.3	8.6	7.2	8.3	26.4	53.9	11.3	19.8	16.2	13.8	22.5	13.6	12.8	27.3	22.8	31.8	12.0	47.3	14.1	10.6	13.1	21.7	33.0	12.0	24.8	16.2	55.9	18.3	30.6	27.9	16.7	15.8	16.0	16.7	16.2	29.0	23.9	13.6	20.7	28.3	31.3	20.1	14.5	28.5	27.5	20.8	16.9	19.3	28.2	33.1	7.9	25.3	18.2	14.2	15.1	17.6	19.8	16.6	26.5	9.0	20.6	14.2	16.6	14.6	11.2	21.0	38.3	8.0	11.8	18.9	18.3	22.1	20.0	12.5	24.6	14.7	25.0	20.6	27.0	38.2	27.1	30.8	25.8	38.4	32.8	28.4	1.8	32.7	21.1	20.8	31.9	26.8	7.9	8.4	9.9	9.2	8.2	7.9	8.2	8.7	8.6	7.7	8.6	8.3	11.3	6.4	1.1	0.0	4.2	0.0	0.0	0.0	0.0	0.0	9.8	10.4	0.0	0.0	1.3	5.5	0.0	27.1	7.6	0.0	19.6	18.9	0.0	8.3	8.0	5.1	0.0	0.0	0.0	18.4	24.6	4.1	0.0	8.8	3.8	15.6	0.0	0.0	12.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.0	10.3	0.0	0.0	0.0	0.0	14.2	0.0	0.0	0.5	0.0	0.0	20.0	0.7	0.0	0.0	0.0	5.0	0.0	0.0	0.0	0.0	19.6	4.4	28.9	0.0	0.0
MRPL11		ENSG00000174547	"Mitochondrial ribosomal protein L11"	Q9Y3B7	11	66435075-66466738	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA057685	Approved		Supported	Mitochondria		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 59: Non-specific - Translation"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"HPA057685: AB_2683502"	"unprognostic (1.96e-1)"	"unprognostic (2.36e-1)"	"unprognostic (2.21e-2)"	"unprognostic (1.79e-2)"	"unprognostic (9.30e-2)"	"unprognostic (1.12e-2)"	"unprognostic (1.81e-3)"	"unprognostic (1.58e-1)"	"unprognostic (4.87e-1)"	"unprognostic (8.32e-3)"	"unprognostic (2.85e-2)"	"unprognostic (3.21e-1)"	"unprognostic (1.31e-2)"	"unprognostic (9.34e-2)"	"unprognostic (6.36e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.72e-1)"	14.6	11.0	12.5	11.8	13.2	23.0	17.3	13.1	21.8	12.8	14.6	21.8	16.5	13.8	16.0	19.4	16.6	8.0	20.6	12.8	12.8	17.1	22.1	10.3	19.0	12.8	12.8	17.7	18.9	17.1	7.9	12.2	13.0	11.6	23.7	11.1	18.0	13.1	49.3	13.3	17.2	14.4	12.6	14.3	17.3	9.8	14.2	18.5	11.6	35.9	20.5	14.7	12.7	12.8	62.1	48.3	44.9	43.3	22.0	24.5	64.2	35.2	40.0	65.8	50.2	135.8	74.7	77.3	59.8	33.6	73.0	52.9	66.5	69.1	46.2	35.8	44.1	48.6	42.6	72.9	26.4	81.4	31.4	29.3	40.6	40.6	49.9	31.7	49.5	73.1	72.1	32.9	28.9	105.6	94.1	129.5	82.3	165.7	69.8	59.2	89.5	97.6	29.1	42.0	47.0	40.8	38.9	58.0	127.4	37.9	66.0	42.4	28.1	39.3	53.1	37.6	42.1	24.1	40.3	87.0	40.7	51.8	27.1	2.1	34.3	7.7	35.9	44.9	38.1	51.6	39.1	35.3	54.5	40.3	40.9	37.8	2.3	37.9	40.7	32.9	43.8	42.5	12.5	13.2	13.1	21.8	12.8	12.8	12.8	12.8	13.0	12.6	14.2	12.8	45.7	12.8	28.3	3.6	61.9	49.8	94.2	80.8	58.1	21.8	69.4	96.3	66.6	60.1	49.0	33.1	8.4	139.6	46.5	66.3	123.3	67.7	40.7	38.0	47.3	51.8	51.0	63.9	4.5	85.6	196.6	54.2	47.4	35.2	31.6	93.9	50.7	82.9	126.2	20.2	4.7	97.3	30.5	60.6	60.3	11.1	50.7	59.5	67.6	1.9	77.6	32.3	66.9	2.5	4.5	59.6	69.4	45.9	61.4	75.0	94.4	124.5	43.7	22.1	26.3	48.9	77.1	78.9	60.5	95.7	49.0	77.4	51.7	68.5	165.2	91.4
MRPL12	"MRPL7, MRPL7/L12, RPML12"	ENSG00000262814	"Mitochondrial ribosomal protein L12"	P52815	17	81703367-81707517	"Human disease related genes, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"	"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal enterocytes: 303.2;Undifferentiated cells: 364.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022853, HPA023043"	Supported		Supported	Mitochondria		NA	NA		49000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Mitochondria		"HPA022853: AB_1854099, HPA023043: AB_1854100"	"unprognostic (1.16e-1)"	"unprognostic (1.65e-1)"	"unprognostic (6.59e-2)"	"unprognostic (1.66e-2)"	"unprognostic (9.52e-2)"	"unprognostic (5.97e-2)"	"unprognostic (5.97e-3)"	"prognostic unfavorable (2.35e-4)"	"unprognostic (1.78e-1)"	"unprognostic (6.47e-3)"	"unprognostic (8.17e-2)"	"unprognostic (3.07e-1)"	"unprognostic (8.77e-3)"	"unprognostic (3.41e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.18e-1)"	"unprognostic (9.26e-2)"	57.8	73.7	39.4	28.4	39.9	31.0	44.0	46.8	51.9	34.4	50.4	79.7	47.3	39.1	11.0	96.8	35.1	10.9	209.9	39.0	42.2	86.9	184.9	34.9	25.5	40.7	43.1	26.7	60.6	45.9	39.1	19.5	41.0	44.9	37.3	7.3	48.1	21.5	169.7	51.1	51.3	20.6	38.8	53.8	57.9	32.3	46.2	20.1	34.0	148.1	27.7	45.4	46.5	39.4	153.6	256.8	67.5	78.2	50.2	55.0	124.3	117.0	71.3	173.2	128.3	216.5	71.6	236.5	69.2	77.5	116.7	127.1	87.6	150.7	87.6	55.9	438.3	181.1	140.2	246.5	74.0	200.5	90.9	63.4	108.5	119.4	132.4	55.4	146.1	115.6	179.4	75.6	87.1	194.2	171.6	295.9	106.0	165.9	330.6	160.7	109.5	176.4	129.8	126.1	171.4	220.7	86.1	366.1	199.8	69.1	186.2	180.5	76.7	131.0	155.8	103.4	241.2	146.2	54.3	137.0	89.3	143.0	100.6	17.7	63.1	9.0	37.9	84.8	52.6	66.2	37.8	42.6	93.7	62.1	39.2	36.0	6.9	43.5	49.8	77.0	35.8	48.9	39.4	39.9	46.8	51.9	39.0	42.2	40.7	43.1	41.0	38.8	46.2	39.4	43.0	19.2	12.8	4.9	42.2	53.3	83.7	101.7	8.6	17.1	67.2	85.0	88.7	84.4	47.6	46.0	4.2	172.4	29.1	303.2	219.2	113.0	38.9	40.6	39.8	47.8	104.0	40.4	4.5	118.5	187.2	38.9	28.5	33.6	30.5	75.7	39.7	223.4	167.0	23.5	6.0	257.7	44.7	62.2	34.5	127.2	39.4	36.8	58.7	1.9	59.7	29.7	45.3	3.0	4.6	126.5	126.9	32.7	24.4	137.1	196.2	258.5	35.0	17.3	32.9	30.8	65.1	46.5	56.9	30.1	60.5	112.5	25.2	126.0	364.0	109.8
MRPL14	"MRP-L32, RPML32"	ENSG00000180992	"Mitochondrial ribosomal protein L14"	Q6P1L8	6	44113451-44127452	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 182.1"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"OE19: 622.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038769, HPA076790"	Uncertain		Supported	Mitochondria		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 21: OE19 - Mitochondria"	"Cluster 10: Non-specific - Unknown function"	Mitochondria		"HPA038769: AB_10673288, HPA076790: AB_2686815"	"unprognostic (4.58e-1)"	"unprognostic (8.39e-2)"	"unprognostic (1.84e-1)"	"unprognostic (7.25e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.20e-2)"	"unprognostic (1.19e-2)"	"unprognostic (3.21e-2)"	"unprognostic (7.20e-2)"	"prognostic favorable (4.81e-4)"	"unprognostic (1.74e-2)"	"unprognostic (3.75e-1)"	"prognostic unfavorable (7.46e-5)"	"unprognostic (7.13e-2)"	"unprognostic (1.65e-1)"	"prognostic favorable (1.08e-4)"	"unprognostic (3.27e-2)"	26.5	41.0	25.7	22.4	26.1	20.7	25.0	25.2	28.5	23.7	24.7	38.0	36.1	29.4	25.5	41.9	22.9	16.2	48.8	25.8	25.3	34.7	80.3	57.8	26.0	25.5	24.7	16.2	24.9	20.6	23.2	26.3	25.5	25.0	34.8	23.6	30.0	19.2	182.1	43.4	29.5	27.7	25.8	26.0	30.1	51.4	26.2	35.3	24.3	109.4	28.6	35.9	27.6	26.5	216.0	90.2	62.5	87.1	53.0	51.4	79.6	78.5	77.8	102.6	101.6	189.1	73.8	93.1	86.7	67.4	98.2	85.9	71.2	127.9	80.8	111.2	193.8	96.1	77.2	235.1	65.3	92.1	64.8	48.2	68.5	96.7	57.1	78.7	85.9	78.8	205.9	58.3	91.7	216.3	111.4	144.6	54.8	622.6	85.8	78.8	70.2	126.7	170.8	104.9	138.8	54.2	50.4	97.5	101.7	53.9	89.5	93.1	69.1	90.4	135.6	65.6	137.9	71.9	68.3	221.8	102.3	90.5	67.4	45.3	115.6	26.3	79.0	113.7	95.1	111.9	100.3	90.5	108.3	105.3	79.2	81.1	6.7	171.4	78.4	122.2	76.1	107.1	25.7	26.1	25.2	28.5	25.8	25.3	25.5	24.7	25.5	25.8	26.2	26.5	48.2	375.0	250.0	3.6	64.5	231.1	200.5	362.7	65.4	29.8	126.6	146.3	136.9	112.9	217.2	57.0	31.3	179.5	51.1	257.9	203.5	205.3	293.1	94.9	66.0	82.0	93.4	78.4	5.0	220.2	206.2	76.4	82.0	101.5	44.4	83.4	50.3	341.2	279.8	33.7	5.3	158.3	219.7	52.0	164.6	122.9	74.6	66.1	69.4	3.7	152.9	66.0	85.5	4.5	7.3	333.0	278.5	53.4	73.7	376.8	203.7	258.7	157.5	70.0	46.0	63.3	149.4	199.2	122.3	116.6	281.3	160.1	56.3	100.5	199.5	376.3
MRPL15	"HSPC145, L15mt, MRP-L15, MRP-L7, RPML7"	ENSG00000137547	"Mitochondrial ribosomal protein L15"	Q9P015	8	54135241-54148514	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 291.2;tongue: 279.4"	"Cell type enhanced"	"Detected in all"		"Distal tubular cells: 248.4;Syncytiotrophoblasts: 198.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044425	Enhanced		Supported	Mitochondria		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Mitochondria		"HPA044425: AB_10969629"	"unprognostic (5.67e-3)"	"unprognostic (8.89e-2)"	"unprognostic (1.58e-1)"	"prognostic unfavorable (5.37e-4)"	"unprognostic (9.30e-2)"	"unprognostic (1.90e-2)"	"unprognostic (2.57e-2)"	"unprognostic (3.10e-3)"	"unprognostic (1.39e-1)"	"unprognostic (3.39e-2)"	"unprognostic (1.94e-3)"	"unprognostic (1.57e-2)"	"unprognostic (2.56e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.06e-2)"	42.5	34.4	33.2	36.4	34.1	25.1	49.3	37.0	50.5	32.6	38.7	70.8	58.6	28.6	27.7	48.8	35.6	29.0	169.6	33.5	38.3	83.8	89.2	26.5	42.9	36.6	35.7	30.5	29.2	83.4	18.6	49.6	35.8	27.5	67.5	63.1	41.4	29.0	291.2	38.5	50.6	45.4	33.8	27.3	38.4	14.7	38.3	38.1	35.2	279.4	57.4	64.1	26.3	33.0	164.1	118.9	98.0	122.6	76.1	110.5	125.8	128.4	93.0	173.3	150.2	134.1	197.1	253.9	170.3	112.1	164.4	161.5	206.2	165.5	190.4	109.9	109.5	165.8	62.4	168.5	114.5	92.0	168.9	103.3	167.4	159.5	165.6	74.7	366.7	89.4	208.2	80.8	251.3	156.1	262.4	177.3	206.2	313.9	60.8	169.5	63.6	136.3	210.8	147.1	56.5	83.7	66.8	204.0	167.0	97.4	195.2	96.6	129.6	95.8	111.7	139.5	151.5	94.6	128.4	207.1	88.8	137.8	153.4	40.1	93.8	27.3	50.7	123.4	63.8	100.6	64.8	68.4	141.1	76.6	59.0	56.9	3.3	54.0	115.7	88.9	79.8	85.8	33.2	34.1	37.0	50.5	33.5	38.3	36.6	35.7	35.8	33.8	38.3	33.0	28.0	25.6	14.4	9.4	33.1	23.6	40.7	114.5	19.4	28.2	25.0	37.2	120.9	55.8	50.4	36.8	29.2	160.3	17.6	38.7	248.4	103.2	18.7	34.0	34.4	34.8	18.0	31.7	10.9	70.9	155.2	32.8	23.9	39.2	25.4	37.9	26.4	59.2	106.1	25.2	12.4	52.5	75.3	44.5	22.9	4.3	24.8	37.9	33.8	7.5	56.5	37.4	20.6	11.1	6.0	97.5	34.3	22.6	35.3	33.9	66.8	127.0	32.1	58.8	13.1	32.1	70.1	14.8	34.3	37.3	34.4	198.9	19.7	91.3	78.3	41.8
MRPL19	"KIAA0104, MRP-L15, RLX1, RPML15"	ENSG00000115364	"Mitochondrial ribosomal protein L19"	P49406	2	75646783-75690851	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Proximal tubular cells: 167.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046805, HPA056622"	Approved		Supported	Mitochondria		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"HPA046805: AB_2679816, HPA056622: AB_2683195"	"unprognostic (9.24e-2)"	"unprognostic (3.84e-2)"	"prognostic favorable (7.39e-4)"	"unprognostic (8.40e-2)"	"unprognostic (1.59e-2)"	"unprognostic (7.52e-3)"	"unprognostic (5.75e-2)"	"unprognostic (9.86e-2)"	"unprognostic (6.21e-3)"	"unprognostic (9.71e-3)"	"prognostic unfavorable (1.97e-5)"	"unprognostic (2.42e-1)"	"unprognostic (3.67e-2)"	"unprognostic (1.55e-1)"	"unprognostic (3.30e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.20e-1)"	31.3	30.1	21.8	18.9	27.4	13.9	28.6	26.5	23.5	29.1	14.8	27.8	23.7	21.7	25.2	25.0	18.1	20.7	35.0	18.8	26.7	56.0	63.7	17.8	20.3	23.4	24.4	17.4	23.6	45.2	12.2	25.7	25.4	21.6	30.9	19.3	24.1	25.1	66.4	23.9	19.9	29.0	26.8	16.9	18.4	16.5	24.9	24.3	36.9	44.8	25.1	24.5	15.1	32.5	100.7	57.5	53.3	48.3	57.0	68.1	75.6	63.4	57.0	78.5	62.2	88.5	40.6	56.5	62.1	69.2	73.8	69.5	83.7	95.8	117.8	63.2	72.4	77.4	44.4	114.3	61.0	82.9	44.5	45.6	72.4	79.7	72.3	49.6	84.1	60.8	86.4	32.3	78.5	61.9	76.1	64.9	69.9	102.9	65.2	94.5	116.5	74.5	134.1	61.9	58.8	50.2	62.2	71.2	72.4	53.3	61.1	32.8	57.0	68.3	75.4	61.2	94.6	33.3	53.8	47.1	53.9	81.0	61.1	17.7	20.2	14.2	22.1	26.8	25.1	26.8	22.7	23.8	29.7	22.7	19.9	24.6	1.4	24.4	24.9	35.0	26.5	17.2	21.8	27.4	26.5	23.5	18.8	26.7	23.4	24.4	25.4	26.8	24.9	32.5	31.8	19.2	29.6	10.7	27.4	29.1	28.6	77.8	21.1	38.3	32.4	29.5	40.2	25.8	49.4	49.7	52.1	90.3	26.3	24.0	125.2	88.7	27.6	42.7	48.4	27.7	27.6	32.8	13.9	61.1	87.3	33.7	36.7	50.3	19.0	35.8	27.1	67.6	47.3	48.8	14.3	36.5	44.7	14.6	17.0	11.2	35.4	23.7	33.8	12.2	35.0	39.6	34.0	15.1	20.0	53.6	27.7	36.5	36.5	36.1	36.5	167.7	32.8	50.9	19.7	31.4	38.1	55.5	17.6	44.3	28.3	57.7	25.3	62.2	50.7	35.6
MRPL2	"CGI-22, MRP-L14, RPML14"	ENSG00000112651	"Mitochondrial ribosomal protein L2"	Q5T653	6	43054029-43059438	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal tubular cells: 185.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007455, HPA064814"	Approved		Supported	Nucleoplasm,Mitochondria	"Intracellular and membrane"	NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 21: OE19 - Mitochondria"	"Cluster 10: Non-specific - Unknown function"	Mitochondria	Nucleoplasm	"HPA007455: AB_1079410, HPA064814: AB_2685358"	"unprognostic (2.31e-1)"	"unprognostic (1.49e-2)"	"unprognostic (3.06e-1)"	"unprognostic (1.48e-2)"	"unprognostic (3.34e-1)"	"unprognostic (1.62e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.01e-1)"	"unprognostic (3.17e-1)"	"prognostic favorable (6.01e-4)"	"unprognostic (3.07e-1)"	"unprognostic (1.79e-1)"	"unprognostic (3.24e-2)"	"unprognostic (6.42e-2)"	"unprognostic (2.33e-2)"	"unprognostic (3.13e-1)"	"unprognostic (2.78e-1)"	26.5	32.4	27.9	12.6	28.8	20.0	26.0	31.0	37.6	23.2	27.9	27.5	25.6	23.5	13.7	24.6	22.2	10.1	48.2	28.3	31.7	33.7	51.2	18.6	13.4	29.8	28.9	24.5	27.1	29.6	29.5	13.3	30.1	22.0	16.8	10.9	22.6	17.6	75.1	25.1	20.3	12.0	27.4	19.9	23.6	19.7	29.0	17.7	26.7	56.7	14.4	22.6	21.4	28.9	47.9	43.1	20.3	39.3	28.4	20.7	38.9	20.4	24.8	47.3	41.3	109.0	15.4	61.8	42.3	24.6	36.2	49.9	50.5	48.7	27.8	30.4	90.9	46.8	34.9	109.5	57.2	43.5	21.0	27.6	51.4	52.5	82.8	22.6	32.6	68.7	84.6	36.6	23.6	84.0	48.1	127.1	22.7	175.7	49.5	59.0	25.1	77.3	38.2	26.3	51.3	27.4	18.2	39.4	73.4	18.6	41.4	73.9	27.3	27.6	40.0	35.7	58.7	47.7	44.9	115.2	21.5	65.2	27.8	17.5	37.8	30.2	28.4	40.9	36.5	46.5	31.8	33.6	54.3	48.6	32.7	32.3	9.8	38.5	33.7	56.1	39.2	31.3	27.9	28.8	31.0	37.6	28.3	31.7	29.8	28.9	30.1	27.4	29.0	28.9	36.8	22.4	18.6	5.5	27.5	24.3	32.0	86.5	19.4	22.7	25.9	30.0	37.5	38.6	48.9	60.7	27.1	74.0	21.3	43.1	185.9	59.1	94.0	30.6	34.1	32.1	30.6	35.3	5.3	53.7	53.1	31.1	30.1	32.5	28.5	43.1	33.2	75.9	49.3	5.0	5.8	44.2	69.2	23.7	26.6	37.0	55.0	22.9	53.4	2.8	41.3	44.7	43.3	2.0	5.5	44.2	51.3	51.6	35.6	31.6	77.6	159.4	40.4	23.4	26.3	32.5	82.7	53.1	41.7	35.7	27.1	63.5	27.2	59.0	65.7	28.7
MRPL20	FLJ10024	ENSG00000242485	"Mitochondrial ribosomal protein L20"	Q9BYC9	1	1401909-1407293	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047074	Supported		Supported	Mitochondria		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"HPA047074: AB_10964064"	"unprognostic (4.04e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.55e-2)"	"unprognostic (5.79e-2)"	"unprognostic (3.71e-1)"	"unprognostic (2.66e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.35e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.78e-2)"	"unprognostic (2.80e-2)"	"unprognostic (2.33e-1)"	"unprognostic (4.18e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.25e-1)"	"unprognostic (4.34e-2)"	"unprognostic (1.64e-1)"	111.5	120.2	144.2	81.8	156.1	72.1	110.0	144.3	178.5	86.5	148.7	126.7	83.6	89.7	135.0	117.2	90.2	68.5	189.8	146.7	154.3	140.9	152.7	86.7	100.4	152.4	154.1	84.2	136.6	100.6	117.3	68.6	147.2	110.9	86.9	59.6	131.9	90.3	277.2	97.7	91.3	75.4	158.1	100.2	116.8	60.5	168.6	71.8	102.3	160.9	102.5	107.6	87.6	158.1	216.1	204.2	149.7	152.8	113.4	122.7	110.6	188.3	143.8	240.7	171.1	244.9	255.4	228.5	256.8	162.9	111.4	133.8	247.6	203.8	185.9	199.0	350.3	247.0	369.0	244.8	156.5	367.3	152.7	143.9	76.8	184.8	196.4	138.4	181.1	213.8	254.6	131.8	204.8	216.3	285.2	279.2	155.8	249.6	409.1	186.0	138.3	291.3	189.9	142.8	265.4	218.5	179.2	369.9	288.7	124.7	158.8	268.0	155.2	144.9	170.0	219.6	236.2	200.6	313.5	450.5	224.2	296.4	103.7	124.6	191.2	146.5	164.8	190.1	183.7	189.3	181.9	163.3	198.2	177.2	204.1	199.0	89.2	163.1	150.8	289.2	175.0	219.6	144.2	156.1	144.3	178.5	146.7	154.3	152.4	154.1	147.2	158.1	168.6	158.1	97.5	67.3	115.5	19.9	120.3	130.3	134.8	206.8	99.0	77.8	153.0	171.4	255.2	145.8	166.0	161.8	35.5	234.5	129.2	138.6	530.2	232.6	39.3	153.1	121.8	118.4	138.2	152.7	13.7	325.9	265.0	113.6	87.7	126.3	106.2	92.7	131.0	384.0	220.6	50.5	13.8	185.5	177.0	139.7	111.0	30.7	107.8	117.9	138.7	11.2	200.8	279.3	183.4	9.5	20.8	261.8	167.4	110.9	163.3	254.8	194.1	543.9	146.9	107.7	65.7	121.8	135.7	131.7	202.7	179.9	157.7	226.2	109.2	121.9	216.1	170.2
MRPL23	"L23MRP, RPL23L"	ENSG00000214026	"Mitochondrial ribosomal protein L23"	Q16540	11	1947278-1984522	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEK 293: 342.1"									HPA050406	Approved		Supported	"Nucleoli fibrillar center,Mitochondria"		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Mitochondria	"Nucleoli fibrillar center"	"HPA050406: AB_2681116"	"unprognostic (5.74e-2)"	"unprognostic (1.24e-1)"	"unprognostic (6.16e-2)"	"prognostic favorable (3.97e-4)"	"unprognostic (3.45e-2)"	"unprognostic (2.08e-1)"	"unprognostic (2.40e-1)"	"unprognostic (2.56e-1)"	"unprognostic (2.34e-2)"	"unprognostic (8.32e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.53e-1)"	"unprognostic (8.43e-2)"	"unprognostic (1.82e-1)"	"unprognostic (6.33e-2)"	"unprognostic (7.23e-3)"	"unprognostic (4.08e-2)"	67.5	123.1	18.3	16.4	19.2	42.4	66.3	19.4	26.0	64.2	20.3	74.8	27.1	54.0	14.3	125.9	57.8	10.9	128.4	18.8	20.1	96.6	140.1	67.4	26.7	19.7	18.7	90.8	118.0	23.5	92.3	8.5	19.6	71.8	19.1	7.0	90.4	14.6	159.5	124.0	67.1	13.1	19.3	81.7	94.3	27.1	19.0	17.7	71.5	39.6	23.9	59.7	70.9	20.5	69.3	74.9	39.7	49.2	15.9	44.0	67.4	20.9	28.0	31.8	23.4	4.8	79.2	72.9	43.6	44.4	44.5	70.6	64.5	88.8	15.0	75.4	342.1	28.1	24.5	98.2	41.7	65.2	40.8	34.9	34.0	22.0	6.4	37.3	23.0	38.3	24.9	34.6	46.5	71.4	57.9	55.8	64.1	58.5	71.9	77.7	27.2	92.0	28.4	25.0	86.5	81.6	25.0	56.2	45.6	22.0	1.4	78.1	30.8	43.6	32.4	11.0	44.0	58.4	47.7	68.7	68.2	56.0	0.1	2.7	18.5	16.8	8.0	14.5	6.4	36.4	11.8	9.4	23.9	34.6	25.7	8.1	1.0	8.3	10.4	10.6	20.0	5.2	18.3	19.2	19.4	26.0	18.8	20.1	19.7	18.7	19.6	19.3	19.0	20.5	33.9	12.8	6.3	17.0	79.1	186.3	69.9	154.6	19.4	7.0	105.4	111.6	69.7	95.8	88.7	38.6	0.0	125.3	43.6	298.1	123.3	126.6	10.2	57.9	29.1	37.5	136.2	117.8	9.4	232.6	224.4	43.3	54.6	40.2	96.6	54.7	57.8	178.9	178.5	5.0	9.9	258.7	99.7	163.9	214.3	18.5	23.0	78.4	200.9	3.7	133.6	30.6	63.8	7.5	12.2	171.1	273.6	36.5	76.8	61.9	175.4	245.0	98.7	11.7	39.5	33.5	69.2	24.4	39.8	47.5	258.7	90.6	50.2	67.0	256.1	82.8
MRPL28	"MAAT1, p15"	ENSG00000086504	"Mitochondrial ribosomal protein L28"	Q13084	16	366969-371289	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030594, CAB033542, HPA055589"	Supported		Supported	Mitochondria		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 31: Spermatids - Spermatogenesis"	Mitochondria		"CAB033542: AB_2145899, HPA030594: AB_10601136, HPA055589: AB_2682855"	"unprognostic (2.39e-1)"	"unprognostic (7.39e-3)"	"unprognostic (1.53e-1)"	"unprognostic (1.26e-1)"	"unprognostic (2.15e-2)"	"unprognostic (9.92e-2)"	"unprognostic (2.92e-1)"	"unprognostic (3.45e-3)"	"unprognostic (6.76e-2)"	"unprognostic (1.73e-1)"	"unprognostic (7.69e-2)"	"unprognostic (1.71e-1)"	"unprognostic (2.62e-2)"	"unprognostic (2.43e-1)"	"unprognostic (4.36e-1)"	"unprognostic (2.60e-1)"	"unprognostic (6.56e-2)"	43.3	63.2	43.2	25.8	46.6	43.7	43.6	41.6	55.9	40.8	39.9	48.9	31.4	47.0	20.6	58.0	39.4	23.3	101.0	46.9	42.7	74.9	79.9	38.7	30.4	41.2	41.7	36.4	32.2	46.6	44.0	21.1	42.5	45.3	18.1	20.4	37.9	23.8	87.6	45.9	43.0	25.8	41.2	52.2	43.8	85.2	42.2	36.8	44.2	59.3	27.1	43.1	42.3	43.9	72.8	135.8	68.3	82.9	37.9	48.6	90.1	82.6	107.3	147.2	143.2	175.4	95.9	105.5	88.6	85.0	75.3	87.6	107.8	172.6	78.2	95.4	211.8	78.7	110.0	149.2	123.9	98.1	96.1	73.8	84.6	136.3	110.5	69.0	109.5	99.5	143.8	75.6	93.0	249.0	152.9	98.2	109.1	72.3	82.5	181.7	85.2	149.1	121.4	41.3	115.2	102.4	102.5	100.3	84.6	66.4	131.1	92.4	85.5	86.0	118.6	70.8	92.4	111.1	100.3	143.0	60.0	68.4	140.8	95.4	105.7	122.1	71.0	107.2	59.1	93.3	62.0	68.9	96.6	105.0	43.0	54.7	120.5	79.3	115.1	119.0	125.8	97.9	43.2	46.6	41.6	55.9	46.9	42.7	41.2	41.7	42.5	41.2	42.2	43.9	44.2	38.5	34.1	8.5	43.6	34.7	50.4	134.5	25.6	34.8	35.6	36.4	55.4	40.0	69.0	69.9	8.4	87.0	46.8	70.2	193.7	112.5	97.7	35.3	30.0	44.9	64.1	51.3	5.8	111.9	108.0	41.2	37.2	31.2	26.6	57.2	47.2	66.6	99.7	28.6	5.0	54.6	77.3	66.5	36.1	232.6	38.2	47.8	71.2	2.8	136.1	56.1	45.3	3.0	5.4	107.0	76.5	38.4	47.2	46.7	106.3	180.0	55.4	42.5	39.5	31.0	61.9	122.2	50.5	38.9	32.4	45.8	37.1	86.6	65.8	52.9
MRPL36	"BRIP1, L36mt, MRP-L36, PRPL36, RPMJ"	ENSG00000171421	"Mitochondrial ribosomal protein L36"	Q9P0J6	5	1798385-1801366	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 472.3;Late spermatids: 471.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047238	Approved		Supported	"Nuclear bodies,Mitochondria"		No	No			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 20: HeLa - Mitochondria"	"Cluster 39: Non-specific - Basic cellular processes"	"Nuclear bodies, Mitochondria"		"HPA047238: AB_10965331"	"unprognostic (2.23e-2)"	"unprognostic (1.04e-1)"	"unprognostic (3.57e-2)"	"unprognostic (7.83e-3)"	"unprognostic (2.03e-2)"	"unprognostic (2.01e-2)"	"unprognostic (1.09e-3)"	"unprognostic (1.68e-1)"	"unprognostic (1.90e-2)"	"unprognostic (1.37e-2)"	"unprognostic (5.39e-2)"	"unprognostic (2.67e-1)"	"prognostic unfavorable (2.21e-4)"	"unprognostic (8.53e-2)"	"unprognostic (9.83e-2)"	"unprognostic (3.20e-1)"	"unprognostic (1.33e-1)"	46.2	60.4	35.6	24.7	36.9	19.2	42.1	40.9	44.2	31.5	36.3	49.6	27.9	38.6	26.3	51.1	32.3	22.0	77.3	36.6	38.4	70.4	76.1	28.6	30.1	37.8	36.9	35.1	44.4	34.6	29.1	21.8	38.4	44.0	20.0	22.6	36.5	21.6	140.2	39.3	33.7	26.9	38.3	34.3	44.9	97.4	38.3	29.1	27.4	86.1	25.9	38.8	34.2	38.3	93.3	134.9	61.7	116.9	111.3	91.2	80.9	79.4	69.4	92.7	88.2	98.4	73.4	124.2	140.2	85.7	136.1	99.1	139.9	130.9	66.8	136.1	155.8	60.2	285.1	158.4	142.0	78.9	45.5	80.9	98.9	103.6	133.4	80.8	91.1	72.3	93.4	77.9	133.6	169.4	93.2	177.5	60.1	102.2	164.0	73.8	46.0	149.6	84.6	74.9	68.5	46.8	172.6	133.1	89.8	56.3	78.2	84.5	55.5	79.9	87.1	54.7	89.4	74.0	100.3	167.4	100.4	144.5	111.3	88.4	103.2	68.6	90.6	104.8	109.6	132.6	101.5	111.1	127.3	103.3	89.1	106.3	29.7	101.7	92.9	476.0	143.0	142.0	35.6	36.9	40.9	44.2	36.6	38.4	37.8	36.9	38.4	38.3	38.3	38.3	52.6	32.1	29.0	6.8	37.6	106.0	108.8	150.2	89.4	23.0	61.5	93.2	163.1	50.1	83.6	58.8	6.2	93.4	66.0	47.3	307.2	84.1	472.3	45.4	63.9	63.7	26.4	50.9	7.9	75.0	74.0	62.7	35.2	33.1	27.9	46.2	35.7	118.2	88.2	15.2	7.9	53.8	107.8	43.0	52.4	471.3	74.9	32.0	60.5	2.8	62.5	76.0	70.0	7.1	9.6	92.1	58.7	59.8	45.6	148.8	79.2	199.6	63.2	31.2	65.7	51.1	68.6	188.6	76.2	92.4	124.9	87.4	37.3	79.8	65.7	112.6
MRPL37	"MRP-L2, RPML2"	ENSG00000116221	"Mitochondrial ribosomal protein L37"	Q9BZE1	1	54184041-54225464	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA025767, HPA025826, HPA025951"	Supported		Supported	Mitochondria		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Mitochondria		"HPA025767: AB_1854105, HPA025826: AB_1854106, HPA025951: AB_1854107"	"unprognostic (2.00e-1)"	"unprognostic (6.81e-2)"	"prognostic favorable (6.99e-4)"	"unprognostic (1.71e-3)"	"unprognostic (8.24e-2)"	"unprognostic (1.00e-1)"	"prognostic unfavorable (6.45e-5)"	"unprognostic (2.49e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.92e-2)"	"unprognostic (1.84e-1)"	"unprognostic (3.07e-1)"	"prognostic favorable (9.25e-4)"	"unprognostic (2.43e-1)"	"unprognostic (2.62e-1)"	"unprognostic (7.67e-3)"	44.7	73.8	28.6	32.4	30.6	67.4	41.5	35.5	37.2	36.1	42.7	50.7	51.5	34.7	26.9	65.8	38.2	25.5	86.3	31.5	29.8	55.4	108.1	30.2	41.1	32.5	30.3	41.0	67.7	47.2	20.8	31.5	33.2	33.8	53.5	21.8	41.3	29.8	167.9	56.2	41.0	41.6	27.4	34.6	49.2	31.4	30.8	41.2	28.5	154.2	51.3	37.9	40.5	28.7	168.3	94.9	84.6	114.5	83.4	110.9	150.5	111.2	103.5	194.0	167.7	190.7	75.4	226.1	98.2	125.3	184.8	131.6	168.2	164.6	150.6	111.1	211.7	194.8	186.9	194.8	142.9	233.3	87.1	123.2	138.7	201.8	156.5	108.7	176.1	174.2	219.2	66.1	140.2	123.3	161.7	226.4	173.5	134.4	208.2	175.3	171.7	191.6	110.8	123.4	166.3	77.6	153.8	261.4	214.0	110.6	113.2	260.7	88.5	123.6	112.2	157.7	227.1	83.1	126.0	175.5	161.1	234.2	119.9	53.0	103.4	45.4	67.5	91.8	79.1	120.4	81.9	76.1	120.4	105.1	82.0	72.8	5.6	94.0	88.7	101.5	116.4	126.6	28.6	30.6	35.5	37.2	31.5	29.8	32.5	30.3	33.2	27.4	30.8	28.7	24.0	22.4	18.7	3.9	33.4	34.7	43.8	84.6	45.5	8.9	46.3	57.0	71.3	55.8	43.1	18.4	2.1	118.0	15.5	36.6	80.3	81.2	31.0	25.7	23.2	30.3	33.1	103.3	7.5	96.3	145.8	37.3	41.8	33.1	14.5	40.6	37.5	156.5	87.0	6.7	8.4	53.0	52.9	43.6	25.6	57.5	26.1	30.9	23.2	4.7	53.1	9.2	24.7	4.5	5.4	69.0	41.1	28.6	72.2	54.2	73.8	105.2	29.4	8.7	13.1	28.8	34.3	23.6	50.4	79.6	37.4	73.9	24.5	57.2	86.0	55.2
MRPL38	"HSPC262, MGC4810, MRP-L3, RPML3"	ENSG00000204316	"Mitochondrial ribosomal protein L38"	Q96DV4	17	75898644-75905093	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 34.7;Gastric mucus-secreting cells: 35.2;Plasma cells: 60.1;Squamous epithelial cells: 46.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023054, HPA023135"	Approved		Supported	Mitochondria		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 59: Non-specific - Transcription"	Mitochondria		"HPA023054: AB_1854109, HPA023135: AB_1854110"	"unprognostic (1.17e-1)"	"unprognostic (3.77e-3)"	"unprognostic (1.83e-1)"	"unprognostic (3.68e-3)"	"unprognostic (2.47e-2)"	"unprognostic (1.50e-2)"	"unprognostic (4.44e-2)"	"unprognostic (1.61e-1)"	"unprognostic (7.59e-2)"	"unprognostic (5.24e-2)"	"prognostic favorable (4.23e-4)"	"unprognostic (2.16e-3)"	"prognostic unfavorable (5.58e-4)"	"unprognostic (3.06e-2)"	"unprognostic (2.40e-1)"	"unprognostic (3.72e-1)"	"prognostic favorable (9.21e-5)"	23.3	34.7	37.5	16.3	37.4	21.9	22.8	39.7	48.9	20.2	37.8	31.1	26.8	24.0	14.4	30.0	30.6	14.6	51.5	37.7	38.2	31.3	46.8	18.2	23.8	39.4	37.6	22.3	36.8	28.7	19.6	17.3	39.8	22.6	19.2	6.7	36.6	26.2	103.2	26.9	21.9	20.3	38.1	22.5	28.6	25.3	40.4	23.8	20.6	84.7	22.4	25.9	21.0	38.6	82.2	114.2	28.3	39.2	32.5	26.5	86.5	26.4	44.5	96.3	69.5	134.4	49.3	72.7	31.2	45.9	55.1	59.1	79.2	71.1	27.3	24.0	130.5	51.0	39.9	133.7	72.0	69.5	48.6	36.6	77.3	66.8	52.4	29.3	92.6	89.7	64.6	45.6	36.6	163.0	92.9	75.1	33.6	101.8	97.2	69.1	74.7	92.3	76.3	51.0	48.6	51.4	45.3	121.3	104.5	26.1	112.4	74.4	26.3	45.8	67.2	38.6	75.4	51.1	32.1	24.7	50.0	57.1	41.3	24.4	74.1	37.9	84.2	80.8	84.0	101.8	86.0	79.1	106.7	113.7	84.8	81.7	7.0	95.7	69.1	78.1	93.7	83.6	37.5	37.4	39.7	48.9	37.7	38.2	39.4	37.6	39.8	38.1	40.4	38.6	1.7	19.2	7.3	14.7	19.3	1.5	0.8	2.7	34.7	1.0	2.4	1.1	2.3	0.0	5.5	3.7	0.0	5.1	6.6	11.4	3.9	23.8	1.1	2.2	1.8	4.7	10.3	20.2	11.9	21.4	3.7	8.1	35.2	1.8	3.8	1.0	2.5	2.4	3.3	1.7	13.2	13.9	2.0	0.8	1.9	1.9	3.1	6.1	7.2	5.6	14.2	0.9	5.2	7.5	15.7	19.2	17.9	3.0	60.1	1.3	16.3	5.6	9.8	2.9	0.0	0.9	8.3	1.9	1.9	46.2	1.4	3.4	13.6	1.2	20.9	0.8
MRPL39	"C21orf92, FLJ20451, L39mt, MGC104174, MGC3400, MRP-L5, MSTP003, PRED22, PRED66, RPML5"	ENSG00000154719	"Mitochondrial ribosomal protein L39"	Q9NYK5	21	25585656-25607517	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 241.5;Spermatocytes: 103.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018331	Approved		Supported	Mitochondria		NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	Mitochondria		"HPA018331: AB_1854111"	"unprognostic (3.81e-3)"	"unprognostic (5.34e-2)"	"unprognostic (8.55e-3)"	"unprognostic (4.61e-1)"	"unprognostic (2.61e-1)"	"unprognostic (4.32e-2)"	"unprognostic (6.75e-2)"	"unprognostic (2.35e-1)"	"unprognostic (4.74e-2)"	"unprognostic (1.94e-1)"	"prognostic unfavorable (5.84e-4)"	"unprognostic (7.48e-2)"	"unprognostic (7.32e-3)"	"unprognostic (9.81e-2)"	"unprognostic (1.66e-1)"	"unprognostic (2.45e-2)"	"unprognostic (6.89e-2)"	23.1	35.6	18.2	19.7	19.6	22.7	26.7	22.1	28.7	16.7	18.4	29.2	25.5	18.0	41.7	26.5	20.4	13.5	51.4	18.3	19.2	40.4	55.3	15.3	34.2	18.7	18.1	17.6	25.2	71.0	13.4	26.2	19.8	20.0	32.1	21.5	21.8	17.8	58.6	20.3	23.1	22.0	19.0	17.6	22.9	54.7	18.2	24.9	20.1	56.7	37.3	22.3	18.8	21.6	89.6	43.0	60.1	38.1	29.7	42.9	92.3	56.1	50.0	77.0	64.7	85.2	49.2	97.9	30.9	35.4	69.8	25.5	128.5	76.4	85.9	49.1	66.3	100.1	43.0	91.4	34.6	102.4	31.7	34.8	66.7	76.3	62.2	42.7	58.2	99.6	112.3	78.4	77.1	56.0	67.5	55.5	95.6	88.9	65.4	77.8	97.0	103.1	80.6	35.7	37.9	36.3	51.6	94.5	76.3	42.3	68.3	57.6	36.4	40.8	61.0	43.9	69.6	54.9	74.6	121.9	61.2	109.1	62.5	41.9	16.9	20.7	37.0	30.3	46.9	62.0	45.0	42.3	31.0	49.1	43.9	39.3	2.8	36.7	21.6	43.2	56.4	18.6	18.2	19.6	22.1	28.7	18.3	19.2	18.7	18.1	19.8	19.0	18.2	21.6	18.3	25.6	10.5	9.8	17.6	20.0	20.3	71.0	7.4	20.4	14.0	23.5	78.2	10.0	36.2	25.8	10.4	46.8	14.1	8.7	31.3	36.0	241.5	20.9	12.7	22.2	7.8	22.3	11.4	33.8	41.7	19.4	7.1	11.8	15.2	11.3	18.9	19.8	30.8	10.1	11.7	11.4	30.5	10.6	15.7	37.0	14.9	11.3	19.6	9.4	17.1	19.0	11.3	9.5	13.2	26.5	9.3	23.3	13.6	13.2	20.4	46.8	41.8	15.0	46.0	18.1	25.4	103.0	29.4	10.7	16.9	36.9	14.9	25.7	20.1	17.3
MRPL40	"MRP-L22, NLVCF"	ENSG00000185608	"Mitochondrial ribosomal protein L40"	Q9NQ50	22	19432545-19436075	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006181	Uncertain		Supported	Nucleoli,Mitochondria		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria	Nucleoli	"HPA006181: AB_1079411"	"unprognostic (4.12e-2)"	"prognostic favorable (7.57e-4)"	"unprognostic (2.64e-2)"	"unprognostic (1.29e-1)"	"unprognostic (5.76e-2)"	"unprognostic (4.52e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.60e-2)"	"unprognostic (4.08e-2)"	"unprognostic (1.19e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.18e-3)"	"unprognostic (2.67e-2)"	"unprognostic (1.75e-1)"	"unprognostic (8.07e-2)"	"unprognostic (2.29e-1)"	"unprognostic (3.14e-2)"	39.4	54.4	59.9	26.1	61.6	28.3	47.6	63.9	79.7	50.0	60.3	33.6	26.1	31.3	77.4	35.6	54.8	31.5	100.7	59.0	62.3	69.1	118.8	28.9	35.5	62.5	60.6	44.5	57.1	85.0	11.2	30.7	62.5	46.4	35.9	35.0	72.1	43.0	135.8	29.2	24.7	32.6	63.6	27.1	33.8	31.4	61.7	29.7	79.0	142.0	40.9	36.4	7.0	65.0	84.8	83.8	26.9	64.0	111.5	98.8	45.4	62.1	95.6	116.9	133.6	105.5	49.0	73.2	71.0	93.7	67.8	82.9	118.8	141.2	122.6	69.8	129.7	72.8	76.0	184.4	158.1	117.7	46.1	102.3	123.6	101.1	179.8	77.3	95.6	35.0	265.8	91.2	127.5	106.9	44.9	77.6	22.7	190.2	100.3	49.7	110.6	44.2	135.9	67.9	45.6	48.3	100.7	94.0	159.7	60.2	80.2	52.9	60.6	118.6	127.3	41.6	64.0	78.1	115.7	147.6	79.2	71.6	99.5	45.1	88.3	76.6	71.7	108.9	82.7	162.7	72.4	74.6	100.1	155.6	85.9	75.6	10.4	90.5	90.2	106.5	91.9	103.5	59.9	61.6	63.9	79.7	59.0	62.3	62.5	60.6	62.5	63.6	61.7	65.0	43.3	44.8	35.3	8.8	53.8	40.4	73.3	181.9	52.3	31.0	59.4	85.9	86.1	71.4	106.6	47.8	12.5	129.6	42.9	35.2	260.3	83.8	114.9	104.4	61.9	40.3	34.9	27.1	3.6	97.9	128.9	55.9	32.1	46.1	33.7	44.2	40.0	146.3	135.6	21.9	5.8	47.8	91.6	43.6	40.0	152.4	72.4	42.9	85.4	4.7	73.9	120.4	37.0	3.5	12.0	73.9	48.6	72.2	92.6	53.6	89.8	254.9	163.5	50.3	46.0	53.9	74.3	82.9	72.1	64.8	38.5	62.9	35.1	103.8	49.3	52.2
MRPL41	"BMRP, MRP-L27, MRPL27, PIG3, RPML27"	ENSG00000182154	"Mitochondrial ribosomal protein L41"	Q8IXM3	9	137551879-137552555	"Predicted intracellular proteins, Ribosomal proteins"	"Apoptosis, Cell cycle"	"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 340.5;skeletal muscle: 407.5"	"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 909.5;Distal tubular cells: 972.4;Hepatocytes: 856.2;Late spermatids: 839.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"MCF7: 503.2;PC-3: 471.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024550, HPA027160"	Supported		Supported	Mitochondria		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"HPA024550: AB_1854112, HPA027160: AB_1854113"	"unprognostic (3.92e-1)"	"unprognostic (1.61e-2)"	"unprognostic (6.92e-2)"	"unprognostic (1.22e-3)"	"unprognostic (5.86e-3)"	"unprognostic (8.04e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.14e-1)"	"unprognostic (4.83e-3)"	"unprognostic (3.24e-2)"	"unprognostic (2.06e-3)"	"unprognostic (3.28e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.43e-1)"	"unprognostic (3.32e-2)"	83.7	74.7	222.0	22.9	206.1	26.1	57.4	203.8	340.5	53.9	169.2	66.4	45.4	45.9	8.4	42.4	46.6	14.8	325.4	210.3	190.6	79.8	157.8	42.1	24.6	209.0	190.7	61.1	44.8	42.2	55.1	12.2	187.9	113.0	17.4	9.9	69.6	26.2	407.5	58.6	56.8	12.2	183.4	54.2	79.1	40.3	227.1	16.1	44.9	129.4	13.1	59.4	45.4	188.9	93.7	165.9	25.5	61.9	40.7	35.5	122.1	112.8	33.1	59.1	47.4	122.6	49.6	71.0	148.4	31.5	78.0	186.5	37.4	60.0	6.4	97.9	208.6	62.0	91.9	193.6	92.8	101.1	211.4	67.3	85.4	51.5	18.2	23.4	55.4	58.7	147.8	26.8	32.6	503.2	33.7	337.6	94.6	118.0	471.6	40.1	44.0	95.9	50.5	67.7	85.7	88.6	78.0	138.6	194.5	15.2	124.0	91.5	95.4	93.1	121.3	162.9	153.4	78.4	146.2	133.7	101.8	104.4	70.9	425.2	305.5	251.8	225.6	272.9	211.5	313.8	235.0	257.0	260.3	249.7	221.0	206.2	38.3	180.8	254.2	422.6	332.2	350.3	222.0	206.1	203.8	340.5	210.3	190.6	209.0	190.7	187.9	183.4	227.1	188.9	99.0	28.9	33.6	59.7	90.7	140.1	138.3	239.3	121.3	52.4	193.9	221.5	909.5	178.7	121.1	263.0	10.4	115.9	89.7	670.5	972.4	157.8	299.6	165.2	136.0	103.1	268.5	66.0	30.6	192.1	147.7	127.1	192.7	136.7	54.0	85.4	102.1	856.2	244.8	28.6	47.7	332.9	229.9	122.7	115.4	839.0	121.8	106.0	224.1	15.9	162.1	102.7	95.8	8.0	31.1	222.8	446.5	104.6	146.9	223.1	458.4	657.6	134.9	47.5	111.7	66.8	143.8	112.6	79.7	175.6	166.1	82.2	112.8	249.9	348.8	176.8
MRPL42	"HSPC204, MRP-L31, MRPL31, MRPS32, PTD007, RPML31"	ENSG00000198015	"Mitochondrial ribosomal protein L42"	Q9Y6G3	12	93467514-93516214	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 397.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039398	Approved		Supported	"Plasma membrane,Mitochondria"		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	"Plasma membrane, Mitochondria"		"HPA039398: AB_10673529"	"unprognostic (9.32e-2)"	"unprognostic (4.18e-2)"	"unprognostic (4.50e-2)"	"unprognostic (3.89e-2)"	"unprognostic (1.27e-2)"	"unprognostic (1.75e-1)"	"prognostic unfavorable (7.49e-4)"	"unprognostic (6.13e-2)"	"unprognostic (3.66e-2)"	"unprognostic (1.95e-1)"	"unprognostic (2.18e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.45e-2)"	"unprognostic (4.92e-1)"	"unprognostic (1.62e-1)"	"prognostic favorable (8.12e-4)"	15.7	26.7	6.8	8.8	8.3	13.9	14.9	11.6	9.0	15.7	9.9	16.9	13.5	14.5	10.9	19.3	14.2	8.1	17.2	7.9	9.8	21.4	20.4	12.8	12.2	7.5	8.3	14.3	13.8	23.4	15.4	11.3	8.6	15.9	16.8	6.1	14.0	10.5	12.0	14.9	13.5	13.8	6.3	10.8	15.9	14.4	7.7	19.2	14.0	14.4	14.9	16.6	16.6	11.7	30.5	42.3	53.5	33.8	25.5	36.8	36.5	43.0	33.0	45.4	32.9	51.8	11.6	49.9	16.3	32.1	29.8	22.4	61.5	48.0	74.3	50.6	40.5	45.0	26.8	61.9	41.9	74.0	21.3	31.0	44.4	48.4	60.5	42.2	46.5	53.0	61.3	19.0	54.0	36.1	67.2	49.3	65.1	52.8	55.9	48.1	25.5	40.4	49.2	77.0	39.8	32.0	36.0	39.3	41.3	42.0	35.5	33.4	29.1	26.5	22.1	21.3	49.6	31.2	49.0	46.1	12.2	45.7	41.5	21.0	14.4	20.4	14.7	21.2	18.9	25.9	19.4	16.6	16.4	23.7	21.3	21.8	8.3	27.0	20.4	11.2	28.1	16.3	6.8	8.3	11.6	9.0	7.9	9.8	7.5	8.3	8.6	6.3	7.7	11.7	55.0	28.9	35.5	13.4	59.9	67.3	97.6	131.6	50.1	34.9	48.7	38.1	82.6	42.9	82.5	46.0	60.5	96.7	41.4	38.2	213.2	86.2	397.6	87.5	61.3	48.7	93.2	66.7	16.2	77.4	133.1	54.5	48.9	48.6	58.4	50.7	32.9	48.4	54.0	47.1	22.1	66.8	107.8	34.1	47.9	165.0	51.6	32.6	60.5	6.5	35.2	22.1	54.6	20.1	20.3	89.8	49.9	56.1	59.8	109.8	44.9	146.5	96.7	41.6	52.6	42.3	59.8	230.5	66.6	59.7	75.0	95.5	51.7	100.1	82.1	115.4
MRPL43	bMRP36a	ENSG00000055950	"Mitochondrial ribosomal protein L43"	Q8N983	10	100969458-100987515	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA073022			Approved	Nucleoplasm,Mitochondria		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 72: Non-specific - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Nucleoplasm, Mitochondria"		"HPA073022: "	"unprognostic (2.65e-1)"	"unprognostic (1.10e-2)"	"unprognostic (2.01e-2)"	"unprognostic (4.11e-3)"	"unprognostic (6.07e-2)"	"unprognostic (3.74e-1)"	"unprognostic (1.97e-1)"	"unprognostic (2.12e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.33e-2)"	"unprognostic (2.03e-1)"	"unprognostic (6.04e-3)"	"unprognostic (3.02e-1)"	"unprognostic (3.53e-2)"	"unprognostic (7.29e-2)"	"unprognostic (2.53e-2)"	58.5	84.9	26.4	21.0	30.2	25.4	61.6	34.0	37.7	63.3	27.6	69.2	28.6	56.3	7.4	63.7	57.7	18.9	65.2	25.0	27.9	79.4	82.8	45.0	23.6	30.1	29.0	71.4	76.3	27.5	51.7	21.7	30.4	62.5	6.9	9.2	65.7	30.8	117.9	71.8	50.7	7.5	30.5	50.7	68.1	41.1	27.7	12.5	65.3	18.2	7.4	66.5	57.5	34.3	102.5	113.6	23.3	41.5	24.0	30.6	72.4	69.7	62.2	52.9	53.4	65.1	78.0	87.1	92.8	29.3	28.9	62.8	8.5	58.1	7.0	66.4	146.1	68.9	76.6	102.6	51.1	55.1	53.2	47.8	44.6	45.1	19.8	25.2	50.0	54.7	34.9	43.3	16.3	107.7	51.4	124.5	37.9	27.7	105.8	54.7	77.8	59.4	29.4	51.9	26.1	67.6	51.0	24.5	80.7	7.5	130.9	26.1	62.4	49.4	65.9	53.4	74.4	89.9	73.5	44.5	63.1	101.5	36.4	100.4	62.2	70.8	58.0	58.8	59.4	67.1	63.5	57.7	69.7	62.8	59.9	54.9	20.9	72.3	58.7	54.3	77.0	68.0	26.4	30.2	34.0	37.7	25.0	27.9	30.1	29.0	30.4	30.5	27.7	34.3	84.3	44.8	49.6	9.8	64.5	55.7	70.6	97.2	60.3	44.0	93.6	130.8	34.3	88.6	74.7	75.4	41.7	135.3	63.7	47.2	180.0	101.1	114.1	74.3	53.2	58.8	61.1	52.6	8.9	127.2	140.6	68.9	53.5	44.5	46.9	64.8	69.3	75.7	98.4	18.5	13.4	77.7	67.1	51.5	43.6	51.5	85.4	47.6	64.0	7.5	67.6	91.5	71.1	12.1	31.0	91.0	77.4	73.7	70.8	72.0	94.3	221.0	79.7	62.4	52.6	66.1	82.2	277.1	76.6	82.6	68.5	103.7	61.6	98.1	80.6	79.2
MRPL44	"FLJ12701, FLJ13990"	ENSG00000135900	"Mitochondrial ribosomal protein L44"	Q9H9J2	2	223957463-223967714	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Ribosomal proteins"		"Endonuclease, Hydrolase, Nuclease, Ribonucleoprotein, Ribosomal protein, RNA-binding"	"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038147, HPA038148"	Approved		Approved	"Nucleoplasm,Nuclear bodies,Plasma membrane,Mitochondria"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 47: Cytotrophoblasts - Unknown function"	Mitochondria	"Nucleoplasm, Nuclear bodies, Plasma membrane"	"HPA038147: AB_10671521, HPA038148: AB_2675863"	"unprognostic (5.21e-2)"	"unprognostic (3.48e-1)"	"unprognostic (3.38e-2)"	"unprognostic (3.00e-1)"	"unprognostic (7.05e-2)"	"unprognostic (1.58e-1)"	"prognostic unfavorable (1.29e-4)"	"unprognostic (2.16e-2)"	"unprognostic (3.32e-1)"	"unprognostic (7.65e-2)"	"unprognostic (8.33e-2)"	"unprognostic (6.65e-2)"	"prognostic favorable (2.02e-4)"	"unprognostic (2.47e-2)"	"unprognostic (1.14e-1)"	"unprognostic (9.93e-2)"	"unprognostic (2.49e-1)"	16.2	26.9	16.2	14.9	17.4	45.4	17.6	17.1	20.3	12.9	19.0	21.8	19.3	12.7	13.2	18.0	16.3	17.5	33.8	17.1	18.8	37.4	39.3	12.5	32.5	16.2	16.1	15.2	17.4	19.7	11.6	20.0	16.8	15.3	22.9	10.0	16.1	13.2	42.6	15.7	17.9	14.4	17.5	17.8	16.2	18.2	17.8	21.4	16.2	40.6	26.5	17.1	11.5	17.9	27.3	22.6	33.1	38.3	30.6	36.1	52.4	30.0	33.6	48.0	50.4	81.0	33.4	41.1	31.9	26.0	43.9	35.3	54.5	41.5	44.1	39.0	38.7	45.0	24.0	64.4	44.9	50.0	33.1	42.5	50.9	29.1	38.7	40.4	47.8	41.4	43.7	31.6	38.9	31.9	37.8	62.9	49.4	54.8	23.6	43.8	40.6	25.5	64.3	22.8	45.0	25.7	22.0	49.0	74.8	48.6	41.4	71.2	31.5	31.8	24.7	27.3	24.5	34.5	25.9	58.7	32.2	47.4	35.6	55.7	44.5	35.3	28.5	44.8	36.5	45.9	30.4	34.4	42.2	42.3	36.5	32.3	58.1	33.8	41.2	33.9	33.7	36.3	16.2	17.4	17.1	20.3	17.1	18.8	16.2	16.1	16.8	17.5	17.8	17.9	11.7	6.4	13.1	3.9	31.3	17.8	27.4	52.6	23.9	17.3	15.6	17.4	10.4	27.1	30.0	27.6	0.0	95.3	29.5	25.0	82.2	45.3	8.1	17.1	22.3	20.7	13.1	26.5	6.5	35.1	64.8	24.9	14.3	26.6	18.4	22.0	20.7	51.5	46.6	11.8	6.9	22.0	48.8	33.3	14.5	7.9	18.0	25.4	33.8	4.7	35.3	16.5	20.6	7.5	9.7	37.2	18.1	18.0	24.8	21.7	23.6	106.1	25.6	12.7	19.7	14.2	18.8	41.1	56.3	22.8	16.6	48.7	20.9	40.9	28.3	37.6
MRPL46	"C15orf4, LIECG2, P2ECSL"	ENSG00000259494	"Mitochondrial ribosomal protein L46"	Q9H2W6	15	88459477-88467390	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 119.3;Proximal tubular cells: 133.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA050166, HPA076046"	Approved		Supported	"Nucleoplasm,Cell Junctions,Mitochondria"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria	"Nucleoplasm, Cell Junctions"	"HPA050166: AB_2681039, HPA076046: "	"unprognostic (1.42e-1)"	"unprognostic (6.94e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.21e-2)"	"unprognostic (3.28e-2)"	"unprognostic (5.16e-2)"	"unprognostic (6.22e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.79e-1)"	"unprognostic (4.64e-3)"	"unprognostic (7.78e-2)"	"unprognostic (5.65e-2)"	"prognostic favorable (2.09e-6)"	"unprognostic (7.73e-2)"	"unprognostic (9.18e-2)"	"unprognostic (6.96e-3)"	"unprognostic (1.63e-1)"	25.1	51.5	20.3	12.9	21.7	11.3	22.7	23.7	25.4	14.6	22.0	24.2	20.0	17.1	18.2	26.4	17.1	13.0	76.1	20.8	23.6	34.7	70.9	12.7	20.9	23.1	22.1	17.2	16.2	24.6	16.2	19.6	23.6	14.9	23.6	16.8	17.1	15.2	73.3	17.9	19.7	18.4	21.7	19.1	24.8	28.1	22.7	18.9	17.2	84.6	20.3	20.7	16.2	22.6	27.8	87.2	27.2	29.8	38.0	28.6	51.5	38.6	35.5	56.9	50.4	108.6	59.3	64.9	38.6	34.9	51.0	65.9	107.4	47.4	44.8	26.3	86.4	53.6	61.5	114.3	24.6	54.2	40.4	32.7	56.6	42.8	28.7	29.0	50.2	63.2	60.7	26.6	42.7	59.6	44.2	68.4	43.5	50.5	52.9	51.9	37.9	49.2	44.5	88.2	42.1	26.5	36.6	57.7	81.8	44.6	64.8	65.7	31.3	44.0	41.9	23.3	56.4	24.2	55.7	53.0	48.5	58.1	34.2	27.1	45.5	33.7	60.0	60.5	69.6	78.8	63.3	58.7	58.7	69.5	69.5	61.6	7.9	62.9	45.0	50.5	68.0	61.5	20.3	21.7	23.7	25.4	20.8	23.6	23.1	22.1	23.6	21.7	22.7	22.6	18.9	0.0	10.3	5.2	21.0	13.8	22.4	59.8	9.6	21.2	17.3	21.3	70.4	37.1	32.3	36.8	27.1	94.3	10.7	20.4	119.3	35.0	67.1	20.0	16.6	18.4	28.3	17.7	4.2	38.0	42.1	19.2	19.9	19.5	22.2	25.8	17.2	105.0	35.6	15.2	5.9	20.6	44.7	13.4	5.5	16.3	14.3	10.8	7.2	3.7	42.1	25.1	20.6	4.5	6.1	31.7	18.4	18.8	17.3	21.9	32.1	133.6	26.2	28.4	26.3	19.5	25.5	55.3	27.4	27.1	23.3	80.7	18.5	66.9	36.1	29.4
MRPL47	"CGI-204, NCM1"	ENSG00000136522	"Mitochondrial ribosomal protein L47"	Q9HD33	3	179588285-179604649	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 399.7;Spermatocytes: 301.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037553, HPA047779"	Approved		Supported	Mitochondria		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	Mitochondria		"HPA037553: AB_10671375, HPA047779: AB_2680154"	"unprognostic (6.37e-2)"	"prognostic favorable (6.44e-4)"	"unprognostic (7.21e-2)"	"prognostic unfavorable (3.15e-4)"	"unprognostic (1.53e-1)"	"unprognostic (8.55e-3)"	"unprognostic (1.16e-2)"	"unprognostic (1.82e-2)"	"unprognostic (1.58e-1)"	"unprognostic (8.03e-3)"	"unprognostic (1.70e-2)"	"unprognostic (1.29e-2)"	"unprognostic (5.64e-2)"	"unprognostic (3.06e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.71e-1)"	"unprognostic (8.84e-2)"	27.2	34.8	30.6	24.0	31.7	48.8	27.2	34.2	41.1	19.4	34.2	32.1	23.7	23.0	22.8	31.8	18.9	18.5	54.9	29.4	34.7	44.4	35.5	20.1	30.0	32.0	31.8	16.6	17.4	33.9	24.0	22.2	32.6	20.6	31.8	26.6	21.1	18.9	52.5	21.5	22.6	24.7	33.3	24.3	26.2	53.1	32.6	33.3	21.0	56.9	30.4	32.0	21.7	34.2	128.6	48.6	83.0	76.7	51.5	53.5	95.2	73.2	65.1	112.3	93.2	198.6	51.8	104.7	140.6	62.5	137.2	94.5	103.5	76.9	120.5	121.0	90.9	99.8	46.1	112.5	99.8	182.2	54.2	49.6	65.7	83.4	84.7	53.1	77.2	95.9	59.5	81.4	88.1	98.9	98.4	168.4	144.3	115.4	114.6	102.7	81.1	175.3	120.4	79.6	71.8	83.5	80.7	128.6	151.2	61.9	198.6	136.6	61.6	60.7	87.4	77.1	204.5	102.1	182.4	229.3	70.7	147.4	75.8	38.2	32.4	44.2	31.7	43.8	32.2	35.1	35.1	34.7	48.4	31.8	30.4	31.7	8.5	41.5	54.4	41.9	48.9	35.8	30.6	31.7	34.2	41.1	29.4	34.7	32.0	31.8	32.6	33.3	32.6	34.2	45.3	22.4	21.7	5.5	51.4	74.9	82.0	179.7	38.7	20.2	36.4	33.4	89.7	54.3	78.6	57.0	10.4	100.0	61.2	46.3	258.2	112.3	399.7	72.8	56.0	55.5	54.9	62.9	7.1	115.9	109.6	51.8	36.2	50.0	56.4	34.0	44.3	62.5	99.3	10.1	9.2	52.8	105.8	42.4	55.7	95.4	42.9	53.5	48.0	4.7	80.3	43.4	39.1	7.1	12.4	118.7	53.6	49.2	54.6	72.6	45.2	201.7	85.5	26.0	59.2	57.9	68.2	301.2	54.0	52.2	70.5	104.1	57.8	102.3	71.9	83.8
MRPL48	CGI-118	ENSG00000175581	"Mitochondrial ribosomal protein L48"	Q96GC5	11	73787872-73865133	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SK-MEL-30: 156.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040241, HPA040864"	Approved		Supported	Mitochondria		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"HPA040241: AB_2676899, HPA040864: AB_2677175"	"unprognostic (2.41e-1)"	"unprognostic (1.80e-2)"	"unprognostic (1.56e-2)"	"unprognostic (1.18e-3)"	"unprognostic (1.99e-1)"	"unprognostic (2.90e-2)"	"prognostic unfavorable (3.30e-4)"	"unprognostic (8.89e-2)"	"unprognostic (4.41e-2)"	"unprognostic (3.97e-2)"	"unprognostic (1.14e-1)"	"unprognostic (5.85e-2)"	"unprognostic (4.61e-3)"	"unprognostic (1.25e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.23e-2)"	"unprognostic (3.30e-1)"	10.8	17.4	30.3	10.2	33.8	12.1	13.3	33.6	50.0	16.8	31.1	17.5	14.1	12.3	14.8	16.6	13.6	5.6	22.5	30.0	31.9	24.2	21.2	10.2	12.8	35.5	32.3	14.2	19.3	21.2	10.9	10.6	36.5	14.6	15.8	11.5	13.9	10.0	28.6	12.5	14.8	8.1	31.6	14.5	15.1	5.8	31.9	23.2	14.1	26.9	14.4	12.3	14.6	41.5	29.6	33.2	36.7	20.8	20.9	16.8	16.2	18.0	20.3	27.9	23.0	63.9	26.6	71.0	35.7	25.6	18.7	35.6	37.3	37.7	24.6	28.3	40.9	36.3	33.3	45.4	24.5	61.5	24.9	14.1	41.0	23.8	33.0	24.5	39.1	40.5	46.9	37.7	28.1	47.1	72.9	58.9	27.5	95.5	35.0	32.1	43.8	81.3	31.0	35.3	28.9	28.0	14.2	48.8	156.9	17.0	31.4	38.5	13.6	21.6	27.9	15.3	24.2	18.1	39.3	103.1	9.5	39.8	18.0	40.7	23.6	12.5	25.8	30.4	27.3	27.5	30.1	31.6	33.6	29.8	32.3	31.3	4.1	28.1	28.1	37.6	35.3	29.5	30.3	33.8	33.6	50.0	30.0	31.9	35.5	32.3	36.5	31.6	31.9	41.5	17.3	9.6	20.5	11.1	29.4	19.2	35.3	66.7	25.6	10.2	28.5	35.1	33.0	21.5	33.9	25.8	4.2	92.0	27.6	28.3	88.0	37.1	6.3	31.0	21.0	18.9	24.1	36.6	16.1	39.7	73.5	22.5	19.9	22.9	21.0	32.5	16.4	28.0	42.9	15.2	22.6	38.0	42.7	25.4	19.4	16.5	18.3	20.5	44.4	3.7	29.4	16.6	22.6	24.6	45.2	30.9	36.1	18.0	30.0	22.0	63.4	76.5	39.1	8.5	0.0	22.5	29.7	18.6	26.3	38.2	19.7	59.8	26.8	26.6	49.1	37.1
MRPL50	"FLJ20493, MRP-L50"	ENSG00000136897	"Mitochondrial ribosomal protein L50"	Q8N5N7	9	101387633-101398618	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Basal respiratory cells: 203.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA022925	Approved		Supported	Mitochondria,Cytosol		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Mitochondria	Cytosol	"HPA022925: AB_1854117"	"unprognostic (6.17e-2)"	"unprognostic (6.03e-2)"	"unprognostic (4.65e-2)"	"unprognostic (2.03e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.27e-2)"	"unprognostic (5.75e-3)"	"unprognostic (1.59e-1)"	"unprognostic (1.55e-1)"	"unprognostic (6.99e-2)"	"unprognostic (1.19e-2)"	"unprognostic (3.46e-2)"	"prognostic favorable (1.21e-10)"	"unprognostic (7.06e-2)"	"unprognostic (2.39e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.06e-1)"	9.6	16.0	10.6	8.3	11.6	4.0	11.8	15.8	13.5	7.8	9.7	8.1	8.6	7.8	12.7	7.1	8.0	7.2	14.5	11.1	11.2	13.3	14.0	7.1	11.0	10.0	11.1	11.9	11.9	13.1	8.9	8.2	10.3	9.8	8.6	19.0	8.4	8.0	10.9	5.7	8.3	7.2	10.8	9.4	10.1	6.5	10.8	8.6	9.1	14.9	11.6	10.3	5.7	11.5	12.6	14.9	23.3	13.6	16.0	17.0	16.5	16.0	15.2	17.3	14.6	20.4	12.3	30.6	10.1	12.5	21.3	28.4	23.0	19.2	18.6	18.6	13.7	15.0	16.4	59.0	17.2	27.5	13.9	14.0	21.9	14.0	25.5	13.0	15.9	15.9	32.1	16.1	17.8	20.7	17.0	20.3	25.6	73.9	20.2	17.1	33.1	19.2	25.8	13.7	22.4	16.6	17.0	16.9	18.5	15.9	11.9	17.0	13.2	11.8	17.6	20.7	15.4	12.0	38.0	12.8	15.0	16.0	16.9	9.8	12.5	9.9	13.9	15.2	16.8	20.6	19.3	16.0	16.3	19.5	22.4	20.3	2.2	14.7	15.9	13.0	23.1	16.8	10.6	11.6	15.8	13.5	11.1	11.2	10.0	11.1	10.3	10.8	10.8	11.5	33.0	16.0	20.8	11.4	46.4	90.5	133.6	203.4	51.2	19.1	31.0	31.9	76.0	35.8	86.9	57.0	12.5	74.8	29.3	15.3	152.6	66.8	10.4	31.4	33.6	41.0	19.8	30.1	12.5	69.4	73.8	46.9	23.4	25.7	44.5	24.0	32.2	43.9	51.9	5.0	15.1	28.0	162.8	25.9	50.6	7.4	34.2	28.3	30.2	5.6	32.1	21.9	27.8	8.0	17.2	66.8	32.7	40.6	39.4	112.8	26.4	186.5	67.4	18.2	46.0	37.6	52.4	44.7	39.3	41.6	99.3	76.5	43.2	63.1	34.3	130.4
MRPL51	"bMRP64, CDA09, HSPC241, MRP64"	ENSG00000111639	"Mitochondrial ribosomal protein L51"	Q4U2R6	12	6491886-6493841	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 950.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039923	Approved		Supported	Mitochondria		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"HPA039923: AB_10795373"	"unprognostic (1.31e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.97e-1)"	"unprognostic (1.44e-2)"	"unprognostic (1.75e-1)"	"unprognostic (2.87e-1)"	"unprognostic (3.81e-3)"	"unprognostic (4.95e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.18e-2)"	"unprognostic (1.43e-1)"	"unprognostic (3.06e-1)"	"unprognostic (1.50e-1)"	"unprognostic (3.36e-1)"	"unprognostic (2.62e-1)"	"unprognostic (1.17e-1)"	"unprognostic (8.33e-2)"	95.7	128.2	151.3	77.1	158.1	88.1	83.2	161.6	239.9	88.4	151.8	119.2	65.5	80.2	99.3	146.1	82.4	49.4	252.5	151.0	159.2	157.9	158.5	75.9	104.5	158.5	155.3	78.9	119.7	128.2	109.3	70.0	158.6	105.8	91.5	64.4	87.0	63.7	262.7	93.2	85.9	70.9	157.3	99.6	112.3	233.3	156.2	131.4	90.6	240.5	126.7	104.2	90.7	165.5	263.4	286.8	334.5	244.1	235.8	212.8	390.6	187.7	222.5	277.1	258.1	398.4	325.4	376.3	124.4	278.2	330.2	220.8	272.4	298.1	409.8	456.3	294.7	256.3	415.2	340.8	217.7	352.4	206.2	205.7	237.2	251.1	331.4	357.9	265.4	291.0	186.1	114.0	356.2	374.3	356.7	463.3	707.1	471.1	287.1	248.2	384.5	264.8	232.6	319.7	126.4	222.2	320.9	355.8	305.4	662.7	107.6	323.7	218.1	226.0	318.5	188.8	406.3	109.0	177.7	850.0	279.8	243.3	305.6	224.5	202.0	231.8	181.6	196.4	206.8	229.3	193.2	201.4	234.6	211.9	196.4	201.4	77.5	203.3	197.8	318.4	234.4	294.0	151.3	158.1	161.6	239.9	151.0	159.2	158.5	155.3	158.6	157.3	156.2	165.5	98.5	105.8	77.4	11.4	113.8	136.1	167.4	410.5	131.5	47.1	180.4	265.8	302.6	178.7	195.4	171.0	12.5	277.1	111.8	126.2	469.5	239.1	950.6	159.7	159.1	129.5	149.9	152.5	9.6	277.8	404.4	146.6	65.7	122.2	92.6	202.3	144.2	374.1	263.9	43.7	10.0	188.3	244.1	147.6	117.9	523.6	153.1	109.4	193.9	10.3	301.6	133.8	121.5	7.1	16.1	247.4	160.3	147.8	171.9	250.0	153.9	538.2	157.5	47.5	111.7	132.7	155.7	534.2	195.4	188.4	157.0	215.5	98.1	244.4	221.2	182.8
MRPL52		ENSG00000172590	"Mitochondrial ribosomal protein L52"	Q86TS9	14	22829879-22835037	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Proximal tubular cells: 549.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA012319	Approved		Supported	Nucleoplasm,Mitochondria		Yes	No			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 35: Non-specific - Unknown function"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 7: Non-specific - Mitochondria"	Mitochondria	Nucleoplasm	"HPA012319: AB_1854118"	"unprognostic (8.98e-2)"	"unprognostic (9.07e-2)"	"unprognostic (1.36e-1)"	"unprognostic (3.18e-1)"	"unprognostic (1.36e-1)"	"unprognostic (4.74e-2)"	"unprognostic (4.01e-3)"	"unprognostic (1.29e-1)"	"unprognostic (6.52e-2)"	"unprognostic (8.05e-3)"	"unprognostic (8.07e-2)"	"unprognostic (2.87e-1)"	"unprognostic (7.46e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.40e-1)"	"unprognostic (3.16e-1)"	"unprognostic (1.41e-1)"	76.5	105.6	106.9	53.7	109.6	51.9	72.4	113.6	130.8	66.5	109.4	88.3	70.0	72.8	30.8	141.6	61.0	20.6	193.7	107.7	110.4	130.8	154.2	73.5	41.7	113.4	109.8	59.9	108.7	70.6	70.1	32.9	113.6	83.5	33.9	15.2	79.6	35.6	155.2	96.6	77.7	25.6	111.5	96.3	113.4	67.7	112.0	62.0	83.2	55.4	41.3	85.0	78.2	112.9	237.5	181.4	97.4	121.4	59.3	69.1	236.8	161.2	115.0	140.8	133.4	224.1	321.9	178.8	172.5	111.3	143.4	210.8	79.8	223.4	105.6	190.8	132.6	133.6	65.6	518.5	180.3	211.9	183.6	104.8	150.4	182.7	154.5	111.2	226.6	222.7	139.4	172.8	104.6	329.2	172.5	320.0	180.1	292.5	397.5	210.2	121.5	210.4	149.9	138.7	96.8	125.1	124.5	120.6	178.3	68.9	116.0	198.9	176.5	146.4	172.0	185.1	249.2	169.4	219.1	228.0	133.3	143.3	239.6	101.5	111.2	60.2	74.5	128.9	69.5	140.9	82.2	68.2	159.1	111.6	75.9	74.2	19.1	74.5	96.4	131.3	100.7	98.5	106.9	109.6	113.6	130.8	107.7	110.4	113.4	109.8	113.6	111.5	112.0	112.9	105.5	73.7	85.4	5.2	132.5	121.2	88.0	169.2	98.4	23.2	131.2	145.2	103.4	167.3	118.0	136.1	18.8	177.3	82.5	220.9	277.8	245.2	72.4	106.5	89.8	104.4	138.0	112.5	5.7	314.5	287.7	65.8	165.1	116.3	123.0	70.5	106.4	291.0	236.2	20.2	6.2	268.0	107.8	140.2	125.1	58.3	55.9	120.1	124.5	6.5	221.5	80.4	107.1	5.5	9.1	396.9	215.6	49.2	156.4	111.8	313.7	549.8	99.9	33.7	65.7	70.7	147.7	135.4	105.3	190.8	149.2	126.0	85.0	80.3	233.8	98.8
MRPL53		ENSG00000204822	"Mitochondrial ribosomal protein L53"	Q96EL3	2	74471982-74472687	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA034612, HPA056185"	Uncertain		Supported	Mitochondria		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 7: Non-specific - Mitochondria"	Mitochondria		"HPA034612: , HPA056185: AB_2683060"	"unprognostic (2.22e-2)"	"unprognostic (1.94e-2)"	"unprognostic (2.81e-2)"	"unprognostic (1.81e-1)"	"unprognostic (2.04e-1)"	"unprognostic (2.88e-2)"	"prognostic unfavorable (7.36e-5)"	"unprognostic (3.60e-2)"	"unprognostic (1.24e-1)"	"unprognostic (4.06e-2)"	"prognostic favorable (1.37e-4)"	"unprognostic (1.26e-1)"	"prognostic unfavorable (1.16e-8)"	"unprognostic (8.76e-2)"	"unprognostic (2.79e-1)"	"unprognostic (4.13e-1)"	"unprognostic (2.45e-2)"	60.9	82.9	68.8	46.8	72.2	61.8	38.9	77.0	98.9	31.3	79.2	41.5	48.0	28.7	39.1	41.0	50.2	34.0	114.4	67.1	72.3	54.5	65.1	34.2	78.4	72.3	69.3	61.5	118.0	72.1	35.1	34.8	72.7	46.0	20.3	27.1	107.1	36.2	169.7	27.3	45.9	24.4	74.2	54.7	55.0	23.1	70.2	50.3	47.1	89.0	42.3	44.7	27.0	76.5	101.5	271.0	60.0	58.5	77.9	69.7	103.4	79.8	73.7	70.5	60.9	224.7	130.1	87.6	78.8	61.4	97.3	76.3	32.5	105.7	24.5	174.6	188.3	77.7	115.6	133.7	70.7	88.4	85.6	96.7	75.1	90.4	59.0	82.3	75.3	109.0	93.0	156.6	63.8	316.5	118.6	163.3	57.5	166.0	204.5	89.1	196.0	212.9	88.9	115.6	103.5	128.0	74.1	195.6	137.3	40.8	102.3	111.1	83.6	115.9	119.6	101.7	135.2	292.3	260.6	141.1	116.4	94.8	125.8	244.9	293.8	133.8	168.2	277.6	188.5	350.0	215.9	173.1	250.3	367.5	282.0	211.4	185.5	167.6	271.8	360.3	275.3	345.5	68.8	72.2	77.0	98.9	67.1	72.3	72.3	69.3	72.7	74.2	70.2	76.5	5.2	9.6	23.2	4.6	18.0	17.2	6.0	9.7	12.0	2.0	24.0	16.4	1.6	4.3	12.1	11.0	0.0	14.7	10.5	29.5	21.5	32.8	8.9	7.2	4.3	11.2	39.7	18.9	3.4	56.9	17.5	10.9	15.3	4.7	33.6	3.0	16.1	23.8	18.0	1.7	3.5	27.2	6.1	25.9	23.9	2.3	8.7	15.6	26.6	2.8	35.8	4.6	15.5	2.0	7.1	35.8	43.5	4.5	34.8	4.9	41.8	45.3	46.1	4.0	6.6	7.7	11.2	11.2	6.8	16.6	25.1	15.7	14.6	3.3	21.7	6.9
MRPL57	MRP63	ENSG00000173141	"Mitochondrial ribosomal protein L57"	Q9BQC6	13	21176658-21179084	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Proximal tubular cells: 719.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039779, HPA059370"	Supported		Supported	Mitochondria		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"HPA039779: AB_10673362, HPA059370: AB_2683993"	"unprognostic (1.00e-1)"	"unprognostic (1.92e-1)"	"unprognostic (4.32e-2)"	"unprognostic (9.57e-3)"	"unprognostic (1.51e-1)"	"unprognostic (5.54e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.68e-1)"	"unprognostic (2.64e-1)"	"unprognostic (1.68e-2)"	"prognostic favorable (8.35e-4)"	"unprognostic (7.65e-2)"	"unprognostic (2.01e-1)"	"unprognostic (5.72e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.10e-1)"	"unprognostic (6.78e-2)"	13.6	27.0	16.0	8.4	16.1	11.0	13.9	16.8	18.3	12.1	15.3	17.2	10.8	12.9	11.7	17.6	13.4	5.2	28.1	16.7	20.5	24.7	29.1	11.7	8.8	16.8	17.0	16.1	16.9	15.3	27.9	7.1	16.9	17.9	6.8	15.5	14.9	8.4	38.8	14.9	13.7	5.6	16.3	14.8	16.2	11.8	17.3	17.0	16.4	18.3	6.6	14.8	12.4	16.5	16.9	30.3	20.8	19.0	15.6	12.8	21.9	20.0	12.4	18.5	13.9	39.6	30.6	9.7	22.7	12.5	14.5	28.7	18.3	19.0	13.9	25.8	30.8	44.2	21.3	45.3	23.2	24.6	21.3	13.2	20.8	14.8	13.9	11.2	17.9	39.0	19.5	12.4	13.2	59.3	53.7	64.8	15.1	54.8	35.0	32.1	31.4	17.2	23.1	20.3	41.4	19.4	16.2	20.1	31.2	14.0	20.2	22.8	12.6	9.6	17.9	20.5	17.9	17.2	14.9	17.7	8.6	28.5	24.6	51.1	70.4	56.3	49.8	59.0	56.4	63.1	62.4	53.2	64.0	60.5	69.6	55.6	10.4	54.5	50.4	102.2	70.2	72.4	16.0	16.1	16.8	18.3	16.7	20.5	16.8	17.0	16.9	16.3	17.3	16.5	93.3	80.1	124.4	12.1	95.4	0.0	107.2	0.0	84.2	88.3	172.1	195.7	495.7	140.2	56.3	176.6	45.9	233.6	118.8	171.7	508.7	159.8	256.0	188.6	98.8	91.6	149.5	165.6	16.8	245.1	205.0	94.2	116.2	107.6	72.2	104.5	117.8	478.4	231.4	77.4	21.3	218.9	0.0	126.6	0.0	341.6	115.2	104.1	0.0	8.4	166.2	181.4	109.2	6.6	17.9	171.6	190.7	98.9	141.9	160.4	266.5	719.5	80.9	100.7	52.6	69.0	74.0	83.6	48.9	175.7	0.0	223.1	99.0	179.5	204.1	112.2
MRPL58	"DS-1, ICT1"	ENSG00000167862	"Mitochondrial ribosomal protein L58"	Q14197	17	75012670-75021261	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Ribosomal proteins"	"Protein biosynthesis"	"Hydrolase, Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 60.1;Distal tubular cells: 56.7;Ductal cells: 50.9;Exocrine glandular cells: 60.3;Hofbauer cells: 48.1;Pancreatic endocrine cells: 53.7;Proximal tubular cells: 121.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003634, HPA076987"	Approved		Supported	"Nucleoplasm,Plasma membrane,Mitochondria"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 7: Non-specific - Mitochondria"	Mitochondria	"Nucleoplasm, Plasma membrane"	"HPA003634: AB_1851388, HPA076987: "	"unprognostic (2.04e-1)"	"unprognostic (1.57e-2)"	"unprognostic (1.94e-3)"	"unprognostic (7.12e-2)"	"unprognostic (3.16e-2)"	"unprognostic (4.35e-2)"	"unprognostic (1.38e-3)"	"unprognostic (1.52e-1)"	"unprognostic (2.57e-1)"	"unprognostic (3.79e-3)"	"unprognostic (4.98e-2)"	"unprognostic (2.43e-2)"	"prognostic unfavorable (2.09e-4)"	"unprognostic (1.10e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.66e-2)"	"unprognostic (1.71e-1)"	22.7	36.3	22.1	18.0	22.8	22.8	24.6	24.4	23.0	17.1	31.9	25.9	19.1	19.4	18.2	32.1	17.5	13.1	49.1	21.9	23.6	34.7	47.2	16.3	24.4	23.4	22.6	14.2	27.4	25.0	14.0	19.3	23.4	18.6	22.8	11.2	21.8	18.6	79.0	28.4	21.7	18.8	23.3	21.6	26.0	10.5	22.9	18.3	18.7	50.3	23.8	24.5	19.9	24.5	81.1	111.4	36.5	42.1	38.3	37.9	50.5	46.7	50.7	95.7	80.7	86.3	49.5	56.0	37.3	46.8	58.9	56.3	75.6	80.7	100.2	28.1	87.7	43.8	50.5	72.2	72.5	92.5	28.8	40.9	37.8	63.3	101.0	32.3	73.8	57.0	71.7	39.9	54.8	100.9	80.7	63.4	27.5	125.3	147.1	41.2	64.8	81.2	71.1	58.5	33.5	64.1	40.3	72.5	92.9	46.7	97.5	75.6	31.6	50.8	56.0	54.3	89.7	41.0	34.8	63.2	58.5	102.5	43.5	26.6	41.2	21.4	30.8	40.9	27.1	33.8	38.0	31.4	55.3	29.3	27.8	31.1	4.0	42.2	36.1	37.2	67.2	42.5	22.1	22.8	24.4	23.0	21.9	23.6	23.4	22.6	23.4	23.3	22.9	24.5	18.8	32.1	8.7	0.0	4.3	0.0	0.0	0.0	0.0	0.0	22.5	32.8	0.0	0.0	8.1	25.8	0.0	60.1	11.4	0.0	56.7	50.9	0.0	29.3	18.3	8.4	0.0	0.0	0.0	60.3	40.5	8.9	0.0	19.0	1.3	22.3	0.0	0.0	48.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.3	0.0	0.0	15.0	0.0	0.0	0.0	0.0	53.7	0.0	0.0	0.8	0.0	0.0	121.1	21.1	0.0	0.0	0.0	12.8	0.0	0.0	0.0	0.0	29.1	7.4	43.5	0.0	0.0
MRPL9		ENSG00000143436	"Mitochondrial ribosomal protein L9"	Q9BYD2	1	151759647-151763496	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008579	Approved		Supported	Mitochondria		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 59: Non-specific - Translation"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"HPA008579: AB_1079412"	"unprognostic (2.55e-1)"	"unprognostic (1.75e-1)"	"unprognostic (2.34e-1)"	"unprognostic (7.43e-3)"	"unprognostic (7.66e-2)"	"unprognostic (2.73e-1)"	"prognostic unfavorable (1.04e-7)"	"unprognostic (1.47e-1)"	"unprognostic (5.22e-2)"	"unprognostic (9.51e-3)"	"unprognostic (1.18e-1)"	"unprognostic (1.35e-1)"	"prognostic unfavorable (1.44e-5)"	"unprognostic (1.79e-1)"	"unprognostic (1.79e-1)"	"unprognostic (2.10e-2)"	"unprognostic (6.30e-2)"	33.2	27.6	26.2	28.6	27.3	41.1	33.5	29.5	29.3	28.7	24.9	35.1	27.0	33.0	30.9	32.2	28.8	21.2	31.0	26.9	29.4	35.6	29.8	25.4	39.9	28.4	27.7	32.6	30.4	49.0	22.6	29.1	28.2	30.8	28.0	18.1	40.4	28.6	71.3	35.1	29.4	28.9	28.2	32.2	30.7	24.5	27.4	46.5	30.8	55.3	38.8	32.2	28.4	28.8	120.3	98.6	63.8	74.6	44.9	50.5	103.9	66.4	62.7	102.3	80.5	151.9	113.3	79.5	126.7	67.8	65.7	106.3	111.8	84.8	81.6	107.3	107.2	64.0	81.7	99.5	71.4	177.1	56.7	56.3	77.7	89.7	113.6	68.3	100.2	119.7	133.3	104.4	80.5	284.6	112.9	134.8	134.6	139.4	141.1	93.6	74.0	155.7	63.0	96.5	103.2	108.2	79.5	113.1	98.7	88.6	169.4	210.1	69.4	79.2	79.5	66.6	149.5	113.2	168.1	252.5	96.2	116.8	91.7	58.1	42.7	29.5	82.0	54.4	94.7	96.2	94.4	96.3	98.7	89.0	89.1	84.8	5.2	85.4	49.0	83.0	122.0	73.5	26.2	27.3	29.5	29.3	26.9	29.4	28.4	27.7	28.2	28.2	27.4	28.8	31.5	28.9	21.8	8.1	41.0	31.4	48.0	52.9	30.7	19.9	46.2	51.3	4.3	28.6	38.1	33.1	6.2	98.4	43.4	17.2	64.6	69.6	100.0	21.9	27.6	43.8	28.7	39.5	7.5	64.4	124.4	29.2	19.4	22.1	41.1	44.8	43.9	28.4	65.6	18.5	7.7	31.6	42.7	32.4	38.2	36.0	39.1	26.6	35.6	3.7	64.0	32.1	54.6	7.1	7.8	67.1	24.6	47.0	26.9	44.6	29.5	86.8	33.4	19.8	72.3	37.6	35.5	56.3	36.4	33.0	31.7	74.6	43.9	42.5	46.8	40.2
MRPS11	"FLJ22512, FLJ23406, HCC-2"	ENSG00000181991	"Mitochondrial ribosomal protein S11"	P82912	15	88467453-88480776	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043752, HPA050345"	Enhanced		Supported	Mitochondria		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"HPA043752: AB_2678653, HPA050345: AB_2681100"	"unprognostic (2.66e-1)"	"prognostic favorable (3.60e-4)"	"unprognostic (6.51e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.12e-1)"	"unprognostic (3.21e-1)"	"unprognostic (3.45e-1)"	"unprognostic (1.44e-1)"	"unprognostic (6.45e-2)"	"prognostic favorable (4.75e-4)"	"unprognostic (8.31e-2)"	"unprognostic (3.37e-1)"	"unprognostic (1.83e-1)"	"unprognostic (9.44e-2)"	"unprognostic (7.26e-2)"	"unprognostic (7.85e-2)"	"unprognostic (1.74e-1)"	9.4	16.9	12.0	4.0	12.1	2.8	8.6	12.8	18.3	5.3	11.4	9.3	7.9	5.3	3.8	10.9	4.8	4.5	26.1	12.5	12.1	14.0	20.5	5.2	5.6	12.7	12.3	3.5	10.5	3.8	7.6	2.3	12.9	7.4	3.5	2.5	6.0	3.4	24.7	7.2	7.4	4.3	11.7	8.0	9.6	9.0	12.7	5.1	9.6	15.0	4.4	8.4	5.6	12.1	10.5	41.1	6.1	10.4	13.8	6.6	16.1	8.3	14.6	10.7	11.5	28.9	16.0	9.7	17.0	7.1	11.3	14.8	17.9	11.5	5.5	12.8	43.8	13.2	23.1	32.0	16.5	4.5	8.3	13.4	11.1	9.2	9.2	5.8	14.3	12.3	9.6	4.3	18.1	45.1	9.3	19.0	16.3	13.4	43.8	19.0	11.6	23.0	15.5	28.4	19.3	9.6	8.6	21.6	33.6	5.3	19.8	24.7	6.8	15.2	16.8	9.9	12.5	8.5	16.5	11.7	18.3	11.2	16.3	31.1	25.1	19.3	15.1	27.6	17.6	27.5	17.2	17.8	29.5	18.2	18.1	17.6	9.5	30.1	17.8	31.9	35.1	26.0	12.0	12.1	12.8	18.3	12.5	12.1	12.7	12.3	12.9	11.7	12.7	12.1	42.1	6.4	20.4	10.4	30.4	22.8	27.5	69.2	31.9	36.9	38.1	47.2	6.3	35.8	39.6	46.0	47.9	91.0	34.6	85.5	135.0	63.9	30.2	27.1	37.8	34.2	24.7	40.6	14.0	66.8	89.7	32.7	25.0	32.5	33.6	40.4	44.6	92.6	90.5	26.9	15.0	60.3	50.8	33.1	24.5	34.2	33.2	31.0	32.0	8.4	65.0	44.4	72.1	16.6	16.8	67.0	70.7	42.5	36.5	32.2	90.8	145.3	29.7	45.1	19.7	29.7	51.8	90.3	42.0	49.1	28.3	89.6	32.3	96.0	64.6	34.5
MRPS14	HSMRPS14	ENSG00000120333	"Mitochondrial ribosomal protein S14"	O60783	1	175010789-175023425	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"	"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051087	Uncertain		Supported	"Nuclear membrane,Mitochondria"	"Intracellular and membrane"	NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 68: Epididymis - Unknown function"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 10: Non-specific - Unknown function"	Mitochondria	"Nuclear membrane"	"HPA051087: AB_2681339"	"unprognostic (9.24e-2)"	"unprognostic (6.37e-2)"	"unprognostic (1.50e-1)"	"unprognostic (3.46e-1)"	"unprognostic (3.44e-2)"	"unprognostic (5.39e-2)"	"unprognostic (1.61e-2)"	"unprognostic (3.01e-2)"	"unprognostic (7.32e-2)"	"unprognostic (4.85e-2)"	"unprognostic (7.67e-2)"	"unprognostic (3.10e-2)"	"unprognostic (1.31e-3)"	"unprognostic (1.67e-1)"	"unprognostic (8.04e-2)"	"unprognostic (2.42e-1)"	"unprognostic (3.21e-2)"	17.2	20.3	24.9	11.2	26.8	4.5	20.6	26.5	28.3	16.2	20.0	13.4	12.4	17.4	21.7	9.5	15.4	13.9	15.1	23.4	26.9	20.4	19.2	13.2	15.8	26.7	25.8	18.4	14.8	28.0	12.2	13.9	26.7	20.2	15.7	22.5	17.0	16.9	13.0	11.4	11.9	14.9	26.6	14.3	14.1	11.2	25.0	17.5	23.2	14.2	15.1	12.0	9.3	28.3	16.2	12.8	29.5	10.5	32.6	23.4	9.4	13.8	16.8	23.0	23.7	16.7	13.9	20.4	16.5	18.6	10.1	14.0	18.5	16.1	24.3	22.6	25.4	16.8	25.6	19.2	13.8	18.9	14.5	25.6	19.4	13.6	9.4	20.3	19.4	17.4	20.7	17.6	16.2	8.9	20.8	13.7	16.2	30.1	6.7	17.8	15.6	24.4	15.8	12.8	24.8	17.4	20.0	18.3	13.8	23.1	21.7	19.7	15.9	7.8	8.6	16.4	12.5	19.1	17.5	25.1	11.1	17.5	16.6	9.3	15.2	7.7	14.8	15.1	21.2	17.5	15.5	15.8	16.2	17.3	20.8	17.6	5.2	18.2	12.3	14.0	19.0	14.3	24.9	26.8	26.5	28.3	23.4	26.9	26.7	25.8	26.7	26.6	25.0	28.3	29.8	28.9	24.5	5.5	38.4	22.0	52.6	105.9	22.2	17.5	31.6	33.8	78.1	44.3	64.0	55.2	14.6	95.4	26.7	26.4	137.0	69.8	23.8	26.5	35.8	39.1	31.8	46.3	7.8	44.8	107.0	41.4	20.4	26.6	18.3	34.8	33.9	67.2	80.7	1.7	9.4	35.8	103.7	34.7	23.9	12.9	46.6	25.6	49.8	9.4	73.9	46.1	45.3	6.6	10.4	47.7	45.7	42.9	48.7	50.0	35.3	126.1	50.6	22.6	39.5	25.1	66.4	96.9	39.1	36.7	29.3	56.1	28.8	43.0	48.8	52.6
MRPS15	FLJ11564	ENSG00000116898	"Mitochondrial ribosomal protein S15"	P82914	1	36455718-36464384	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 287.3"	"Cell type enhanced"	"Detected in all"		"Early spermatids: 776.7;Late spermatids: 2209.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028100, HPA028134, HPA067137"	Supported		Supported	Mitochondria		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 31: Spermatids - Spermatogenesis"	Mitochondria		"HPA028100: AB_10600216, HPA028134: AB_10600890, HPA067137: AB_2685787"	"unprognostic (2.05e-2)"	"unprognostic (6.98e-2)"	"unprognostic (7.57e-2)"	"unprognostic (4.53e-1)"	"unprognostic (3.29e-2)"	"unprognostic (1.44e-1)"	"prognostic unfavorable (3.59e-4)"	"unprognostic (2.20e-2)"	"unprognostic (3.28e-2)"	"prognostic favorable (7.83e-4)"	"unprognostic (8.48e-2)"	"unprognostic (1.45e-1)"	"prognostic unfavorable (3.55e-4)"	"unprognostic (2.31e-1)"	"unprognostic (1.44e-1)"	"unprognostic (8.94e-2)"	"unprognostic (1.39e-1)"	77.3	68.9	54.1	37.4	55.7	81.7	62.4	58.5	70.4	38.8	61.8	63.7	41.1	42.5	62.6	70.9	37.1	30.2	133.8	54.8	59.8	82.0	122.1	47.4	45.4	57.9	56.8	33.2	63.2	77.0	46.3	45.0	58.3	45.1	50.7	21.0	58.1	37.8	287.3	53.0	41.6	40.0	54.4	41.3	68.7	151.2	58.1	44.1	40.0	196.9	47.9	54.2	43.0	56.0	162.3	88.7	94.4	115.8	91.9	132.6	233.9	88.3	126.1	214.3	195.7	157.9	169.3	148.8	140.0	117.3	128.1	138.9	139.5	223.3	192.3	97.4	177.0	152.5	104.1	175.2	171.6	190.2	103.2	123.1	196.1	191.2	153.7	82.5	178.0	109.5	168.1	114.0	134.5	112.2	184.7	203.8	169.8	137.2	154.2	140.4	165.6	218.6	193.0	135.1	139.4	77.0	122.2	153.9	236.0	139.7	95.1	129.0	84.3	119.7	126.8	149.0	189.4	113.2	169.1	211.3	136.1	128.1	170.8	18.7	78.9	22.3	61.8	89.7	77.3	72.5	70.3	71.2	122.0	73.5	65.6	64.4	5.3	64.5	61.2	83.6	87.8	90.7	54.1	55.7	58.5	70.4	54.8	59.8	57.9	56.8	58.3	54.4	58.1	56.0	50.6	38.5	52.0	10.1	57.2	65.4	70.3	119.6	55.8	23.2	85.6	79.9	136.7	65.8	74.7	71.7	14.6	245.9	49.2	84.8	322.9	132.8	776.7	53.2	58.6	62.6	66.0	118.2	8.7	162.4	260.3	61.7	69.3	75.4	42.5	71.1	62.4	140.6	153.8	13.5	8.7	97.7	85.5	81.1	68.9	2209.2	62.7	75.7	56.9	4.7	86.7	31.3	56.7	5.5	7.2	143.1	64.2	74.4	108.4	128.8	118.3	361.6	50.3	23.5	65.7	56.3	103.2	502.4	76.0	107.0	80.4	281.6	59.0	113.1	127.2	118.3
MRPS16	CGI-132	ENSG00000182180	"Mitochondrial ribosomal protein S16"	Q9Y3D3	10	73248843-73252693	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"	"Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA050081, HPA054538"	Supported		Supported	Mitochondria,Cytosol		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 39: Non-specific - Basic cellular processes"	"Mitochondria, Cytosol"		"HPA050081: AB_2681007, HPA054538: AB_2682519"	"unprognostic (9.19e-2)"	"unprognostic (5.19e-2)"	"unprognostic (2.34e-1)"	"unprognostic (1.26e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.62e-1)"	"prognostic unfavorable (4.57e-5)"	"unprognostic (1.68e-2)"	"unprognostic (6.44e-2)"	"unprognostic (2.98e-2)"	"unprognostic (3.21e-2)"	"unprognostic (2.87e-1)"	"unprognostic (1.50e-2)"	"unprognostic (1.17e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.20e-1)"	"unprognostic (5.84e-2)"	24.0	37.8	12.0	18.3	12.7	20.2	22.6	13.3	13.8	18.7	15.8	27.5	24.8	21.6	14.5	32.1	19.1	12.6	47.2	12.3	12.3	32.0	39.5	17.5	22.3	13.0	12.3	18.5	27.4	21.8	20.5	12.9	12.4	19.6	22.0	8.3	23.7	15.3	76.1	25.3	22.4	16.7	12.6	23.3	27.3	21.0	12.8	21.4	17.7	46.3	22.5	20.8	20.2	14.8	84.5	120.5	40.7	55.6	29.1	27.2	65.7	36.7	62.7	49.6	50.5	147.1	78.4	97.8	40.3	36.9	45.2	74.5	43.1	73.2	30.6	54.6	50.4	59.6	61.0	108.5	58.4	79.3	51.4	40.5	54.5	51.4	120.4	37.9	54.2	83.3	92.4	52.2	49.7	92.3	83.4	70.1	52.7	53.7	211.1	75.1	56.1	69.4	48.4	51.3	26.9	49.8	43.5	164.2	83.7	22.5	121.1	38.1	44.8	46.9	83.3	50.3	74.6	79.0	91.4	75.0	50.5	89.5	32.1	31.3	33.0	26.3	26.1	37.3	28.2	42.9	28.4	24.8	27.3	47.5	29.9	26.9	15.0	28.1	30.1	41.8	31.4	39.5	12.0	12.7	13.3	13.8	12.3	12.3	13.0	12.3	12.4	12.6	12.8	14.8	38.0	6.4	32.4	13.7	59.9	35.1	73.9	103.1	42.7	28.0	76.5	87.6	101.1	58.6	71.4	47.8	31.3	118.0	34.0	77.4	248.4	103.7	68.1	54.6	57.8	56.3	54.5	79.8	18.2	119.7	160.7	45.0	52.0	48.4	30.4	52.5	46.8	157.2	154.5	20.2	19.3	102.8	75.3	64.5	36.0	37.8	62.1	57.2	65.8	13.1	78.3	47.9	52.5	9.0	10.7	127.5	55.9	41.8	88.8	126.6	88.6	239.2	51.1	36.2	0.0	38.7	69.0	124.5	70.8	92.8	44.2	106.9	42.6	87.5	114.9	99.0
MRPS18B	"C6orf14, HSPC183, MRPS18-2, PTD017"	ENSG00000204568	"Mitochondrial ribosomal protein S18B"	Q9Y676	6	30617840-30626395	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043485, HPA050334"	Supported		Supported	"Cell Junctions,Mitochondria"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria	"Cell Junctions"	"HPA043485: AB_2678506, HPA050334: AB_2681091"	"unprognostic (8.18e-3)"	"unprognostic (1.14e-1)"	"unprognostic (8.96e-2)"	"unprognostic (2.51e-2)"	"unprognostic (4.20e-2)"	"unprognostic (7.40e-2)"	"unprognostic (9.45e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.89e-1)"	"unprognostic (2.98e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.40e-2)"	"prognostic favorable (3.99e-5)"	"unprognostic (1.89e-1)"	"unprognostic (1.64e-1)"	"unprognostic (5.14e-2)"	"unprognostic (5.39e-2)"	37.2	52.0	43.6	27.6	45.7	20.3	61.0	46.8	44.3	41.1	43.2	52.3	49.8	31.3	57.6	39.3	62.5	27.4	108.1	40.5	44.1	77.9	99.8	39.4	43.6	46.0	45.2	63.0	47.0	74.0	29.2	38.4	46.2	32.0	62.3	41.6	58.0	42.4	180.2	45.1	39.4	38.1	45.2	39.3	44.4	22.0	46.1	43.7	54.1	229.0	63.6	33.0	29.4	48.2	112.7	68.3	51.1	73.5	72.9	101.8	92.6	39.8	92.6	122.8	75.5	117.7	51.8	112.6	91.5	61.7	91.3	86.1	115.0	109.9	122.0	68.7	122.9	107.9	45.1	124.2	67.2	105.7	45.4	88.8	139.4	99.5	273.8	82.7	72.4	104.7	171.3	107.7	112.2	83.1	70.6	111.4	40.6	86.1	81.8	91.2	69.8	220.7	114.8	49.5	111.3	38.4	34.7	147.1	163.0	46.0	190.6	58.4	39.6	79.2	80.8	47.3	70.8	89.5	114.1	99.2	38.3	154.6	121.7	79.2	72.4	42.5	77.0	94.4	104.7	153.5	104.3	86.3	79.8	140.3	129.6	103.5	7.2	120.3	101.4	74.3	108.1	108.4	43.6	45.7	46.8	44.3	40.5	44.1	46.0	45.2	46.2	45.2	46.1	48.2	59.4	60.9	56.1	7.2	58.4	36.8	65.9	114.0	58.6	47.4	56.6	73.0	175.5	117.2	75.0	47.8	64.6	121.2	43.7	39.1	193.7	103.8	54.2	37.5	42.8	59.4	31.3	45.4	6.0	92.1	124.9	47.4	39.3	30.8	37.4	53.1	61.8	121.6	81.4	43.7	7.9	59.5	75.3	53.2	30.4	37.4	70.2	39.7	60.5	1.9	80.0	46.9	70.0	4.5	14.4	69.5	49.9	44.8	56.8	53.2	89.6	201.6	60.4	69.4	52.6	50.0	53.0	29.6	57.4	61.7	44.9	96.5	43.9	144.4	85.3	50.1
MRPS2	CGI-91	ENSG00000122140	"Mitochondrial ribosomal protein S2"	Q9Y399	9	135499984-135504673	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"	"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029487, HPA057261"	Approved		Supported	Mitochondria		NA	NA			"Cluster 22: NK-cells - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 44: Endometrium - Transcription"	Mitochondria		"HPA029487: , HPA057261: AB_2683385"	"unprognostic (3.18e-3)"	"unprognostic (9.42e-3)"	"unprognostic (1.46e-1)"	"unprognostic (7.81e-2)"	"unprognostic (3.55e-1)"	"unprognostic (8.45e-2)"	"unprognostic (1.63e-1)"	"unprognostic (5.63e-3)"	"unprognostic (3.83e-1)"	"unprognostic (2.90e-2)"	"unprognostic (4.81e-2)"	"unprognostic (7.58e-2)"	"prognostic favorable (6.96e-9)"	"unprognostic (2.74e-2)"	"unprognostic (1.06e-1)"	"unprognostic (8.29e-2)"	"unprognostic (2.24e-1)"	32.6	56.9	30.7	14.7	31.3	23.2	30.8	30.3	37.9	29.2	34.9	35.4	23.0	29.6	12.9	37.7	35.7	15.8	67.0	31.2	30.2	46.1	79.7	22.0	21.0	29.9	31.3	34.9	45.8	32.2	26.4	16.8	31.1	33.1	17.3	7.7	31.3	21.2	75.5	39.1	28.1	15.2	29.7	32.0	39.3	17.0	33.1	16.2	25.8	50.4	17.7	33.8	28.8	30.8	59.9	98.4	35.3	48.0	39.1	43.5	60.0	43.0	39.0	71.7	53.0	149.0	55.4	75.4	57.2	40.1	75.8	132.6	88.9	101.4	27.7	46.2	137.4	37.4	96.1	101.8	68.4	76.6	44.3	58.6	77.6	78.3	55.6	45.7	67.9	74.2	125.1	54.3	42.3	185.8	73.9	133.7	80.2	110.8	153.9	81.3	57.3	159.5	59.9	50.8	104.9	55.2	58.8	110.9	63.2	23.6	92.4	60.5	42.4	52.3	58.4	90.3	78.8	58.9	124.5	84.1	53.0	69.2	49.1	8.4	28.4	13.6	30.0	27.5	34.5	34.4	30.1	32.4	29.1	34.3	32.4	32.9	2.4	28.7	24.0	25.1	41.8	26.4	30.7	31.3	30.3	37.9	31.2	30.2	29.9	31.3	31.1	29.7	33.1	30.8	23.8	12.8	14.1	4.9	32.5	44.7	38.8	55.0	33.0	22.2	37.3	51.7	31.2	42.9	31.6	12.9	6.2	71.3	19.0	21.5	72.4	50.7	14.7	27.8	34.2	32.6	21.7	41.4	4.6	38.6	65.8	27.9	21.4	77.7	8.2	37.9	21.8	46.5	42.5	25.2	5.9	37.9	28.5	17.6	15.4	32.5	24.2	21.0	19.6	1.9	31.7	24.8	20.6	4.0	4.5	39.9	27.1	23.0	38.6	48.6	36.3	84.5	14.7	17.0	32.9	27.1	29.4	13.3	21.5	47.1	45.7	37.4	23.4	77.5	55.7	35.5
MRPS21		ENSG00000266472	"Mitochondrial ribosomal protein S21"	P82921	1	150293861-150308979	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 863.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA078289			Supported	Mitochondria		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"HPA078289: AB_2686881"	"unprognostic (3.48e-2)"	"unprognostic (1.94e-2)"	"unprognostic (5.46e-2)"	"unprognostic (2.33e-1)"	"unprognostic (2.88e-1)"	"unprognostic (8.45e-2)"	"prognostic unfavorable (2.62e-4)"	"unprognostic (1.15e-2)"	"unprognostic (2.60e-1)"	"unprognostic (3.14e-2)"	"unprognostic (4.13e-2)"	"unprognostic (9.71e-2)"	"unprognostic (7.59e-2)"	"unprognostic (2.12e-2)"	"unprognostic (4.02e-2)"	"unprognostic (3.97e-2)"	"unprognostic (1.46e-1)"	46.8	76.7	91.7	35.7	93.8	39.0	51.7	92.9	121.4	48.7	97.4	51.8	38.4	46.7	53.7	54.5	46.3	27.6	72.7	93.2	95.0	67.1	59.9	39.2	42.8	93.8	92.7	56.6	51.1	65.4	70.1	32.5	94.5	51.5	28.9	42.3	43.7	39.1	55.6	45.0	45.2	38.7	89.0	53.3	52.1	52.2	95.2	49.0	53.1	66.5	46.6	47.9	45.8	92.3	112.7	88.4	112.9	57.5	108.3	108.2	93.9	80.5	69.1	77.0	74.5	18.0	101.6	111.9	54.2	89.3	22.8	102.9	96.8	86.4	67.8	77.7	125.9	64.3	133.4	137.0	84.7	98.4	53.8	119.2	87.0	93.4	105.8	47.0	100.3	96.8	106.7	144.3	107.1	255.8	84.3	89.1	196.0	216.3	159.3	75.9	59.0	195.8	93.7	79.9	83.7	182.1	68.4	131.9	136.4	126.3	73.4	143.0	71.7	28.1	56.7	81.6	90.9	120.4	136.4	112.7	39.5	53.1	58.3	41.1	78.4	50.7	70.1	79.7	86.6	116.8	92.7	82.5	89.1	102.1	103.8	89.6	17.8	71.5	73.6	136.2	97.2	104.9	91.7	93.8	92.9	121.4	93.2	95.0	93.8	92.7	94.5	89.0	95.2	92.3	124.7	112.2	115.8	24.8	152.7	120.3	199.9	466.6	191.8	72.6	189.3	246.4	295.6	201.6	227.8	263.0	33.3	283.8	110.4	114.4	526.3	226.2	863.2	217.2	216.0	150.2	138.5	151.7	31.8	311.4	245.5	172.3	152.4	155.7	132.9	157.8	189.2	366.9	288.2	48.8	34.7	141.6	266.5	196.2	162.3	605.4	230.2	143.7	181.5	18.7	234.1	140.3	118.4	23.1	27.1	300.8	133.1	233.2	156.5	197.6	230.1	703.7	291.7	59.5	98.6	115.4	211.1	276.4	112.1	262.6	147.2	235.2	144.4	183.8	168.5	200.9
MRPS22	"C3orf5, GIBT, GK002, MRP-S22"	ENSG00000175110	"Mitochondrial ribosomal protein S22"	P82650	3	139005806-139357223	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"	"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006083, HPA007830"	Enhanced		Supported	Mitochondria	"Intracellular and membrane"	NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	Mitochondria		"HPA006083: AB_1854122, HPA007830: AB_1854123"	"unprognostic (8.38e-2)"	"unprognostic (1.52e-2)"	"unprognostic (3.04e-2)"	"prognostic unfavorable (1.35e-5)"	"unprognostic (5.22e-3)"	"unprognostic (5.45e-3)"	"unprognostic (4.85e-2)"	"unprognostic (2.18e-2)"	"unprognostic (2.78e-2)"	"unprognostic (4.49e-3)"	"prognostic unfavorable (1.55e-5)"	"prognostic unfavorable (1.85e-4)"	"unprognostic (3.22e-3)"	"unprognostic (2.56e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.77e-1)"	"unprognostic (3.40e-1)"	25.5	55.6	23.1	20.7	24.2	37.9	25.2	27.2	31.5	21.9	22.2	35.0	37.0	20.2	19.3	37.4	20.5	17.3	61.3	23.4	27.3	38.0	57.4	17.0	22.8	24.9	23.4	22.6	32.0	31.7	13.7	25.6	26.0	17.1	31.9	17.9	22.0	20.2	83.0	21.8	33.1	23.9	25.8	17.0	25.0	35.4	24.4	23.5	22.8	77.3	24.4	27.3	21.6	27.4	101.2	40.4	40.0	44.5	49.1	41.7	79.1	58.9	72.3	97.1	80.7	130.0	68.3	66.5	106.9	67.1	98.9	109.9	64.6	76.5	96.4	39.0	64.1	105.2	35.8	97.2	56.2	99.3	58.1	45.2	59.6	58.3	61.8	49.2	61.0	76.2	149.2	41.7	61.2	72.4	51.9	85.9	64.4	102.3	73.3	65.0	61.3	98.9	75.0	61.4	43.4	40.4	94.2	141.4	154.6	37.0	97.1	93.7	47.5	42.4	42.3	82.4	55.9	66.3	38.5	119.5	56.9	70.6	42.3	42.8	38.4	36.1	34.9	53.4	43.0	40.3	37.5	39.4	45.8	36.1	41.0	38.9	9.2	38.1	53.6	29.7	47.6	36.3	23.1	24.2	27.2	31.5	23.4	27.3	24.9	23.4	26.0	25.8	24.4	27.4	30.7	19.2	13.4	8.8	21.8	22.8	29.7	63.3	19.4	19.9	15.3	18.0	50.3	25.8	33.3	18.4	14.6	62.9	24.9	26.5	68.4	47.5	84.3	19.9	30.5	26.6	15.6	31.2	8.7	60.3	48.0	27.7	16.3	22.0	27.3	24.9	18.2	38.9	48.6	20.2	13.8	26.5	32.6	21.9	16.1	14.3	23.3	22.5	16.0	4.7	38.0	21.8	24.7	10.1	10.1	42.0	27.1	23.7	38.4	16.6	45.4	59.4	35.5	26.2	39.5	32.2	39.1	102.2	51.4	34.8	20.5	75.4	24.7	74.1	46.5	31.2
MRPS23	"CGI-138, HSPC329, MRP-S23"	ENSG00000181610	"Mitochondrial ribosomal protein S23"	Q9Y3D9	17	57834781-57850056	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"	"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 187.7;Proximal tubular cells: 190.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023453	Supported		Supported	"Nuclear membrane,Mitochondria"		No	No			"Cluster 44: Non-specific - Transcription"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 16: U-266 - Nucleosome"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria	"Nuclear membrane"	"HPA023453: AB_1854125"	"unprognostic (3.84e-3)"	"unprognostic (3.36e-1)"	"unprognostic (1.75e-2)"	"unprognostic (2.00e-2)"	"unprognostic (7.96e-2)"	"unprognostic (3.06e-3)"	"prognostic unfavorable (9.52e-4)"	"unprognostic (3.71e-1)"	"unprognostic (7.92e-2)"	"unprognostic (2.63e-3)"	"unprognostic (1.39e-2)"	"unprognostic (8.74e-2)"	"unprognostic (3.74e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.63e-1)"	"unprognostic (2.75e-3)"	"unprognostic (2.83e-1)"	21.7	37.5	22.7	26.4	23.5	24.4	25.4	22.9	29.6	17.8	21.4	22.2	23.8	25.3	29.7	25.1	24.8	16.7	86.3	23.6	23.3	38.5	24.5	21.9	31.1	23.3	23.7	20.2	39.6	47.5	20.3	20.6	24.8	36.2	20.3	31.9	20.9	24.8	61.5	19.8	20.7	21.8	23.5	21.7	39.4	23.4	23.2	30.3	36.7	44.5	26.9	28.2	18.0	25.2	137.6	137.0	71.7	75.7	42.6	49.5	82.5	86.9	64.9	118.4	90.8	102.6	80.1	173.1	251.9	67.0	109.3	66.3	113.8	102.3	98.2	137.7	135.9	125.4	51.3	179.9	80.9	165.7	115.9	45.4	89.9	87.9	90.8	54.0	75.8	90.9	190.5	60.4	94.0	117.8	154.8	96.1	86.8	153.7	142.8	111.1	120.4	144.0	91.7	65.1	95.8	149.2	65.5	54.5	177.6	52.0	169.1	121.8	66.9	100.0	127.5	100.8	186.3	131.6	301.3	197.5	95.1	102.3	93.7	67.7	41.2	66.2	39.2	51.5	41.2	44.3	38.9	39.9	57.8	47.9	41.3	41.5	6.6	47.2	37.8	54.6	41.3	45.8	22.7	23.5	22.9	29.6	23.6	23.3	23.3	23.7	24.8	23.5	23.2	25.2	34.9	48.1	33.6	3.6	30.2	33.4	40.4	109.4	26.7	41.6	30.1	42.4	187.7	27.1	60.5	47.8	12.5	81.6	30.0	18.4	148.7	84.8	5.9	42.5	37.0	40.0	22.1	28.4	6.1	100.0	87.0	37.4	29.6	36.3	23.4	43.9	24.3	39.7	85.5	50.5	6.8	29.2	69.2	35.2	23.5	10.0	32.6	31.5	40.9	4.7	67.1	63.1	48.4	2.5	10.0	87.7	25.5	39.5	29.1	58.9	20.8	190.8	55.6	64.4	26.3	37.5	43.8	38.3	85.9	39.3	32.5	42.5	27.4	65.4	40.9	34.2
MRPS25	"DKFZp313H0817, FLJ00023, MRP-S25, RPMS25"	ENSG00000131368	"Mitochondrial ribosomal protein S25"	P82663	3	15042460-15065317	"Human disease related genes, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 367.5;Late spermatids: 1316.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043490	Approved		Supported	Mitochondria		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 31: Spermatids - Spermatogenesis"	Mitochondria		"HPA043490: AB_10794888"	"unprognostic (3.98e-2)"	"unprognostic (5.36e-2)"	"unprognostic (4.58e-3)"	"unprognostic (1.24e-2)"	"unprognostic (4.66e-2)"	"unprognostic (1.82e-2)"	"unprognostic (3.33e-2)"	"unprognostic (4.93e-3)"	"unprognostic (2.23e-1)"	"unprognostic (2.10e-1)"	"unprognostic (6.29e-2)"	"unprognostic (2.68e-3)"	"prognostic favorable (3.60e-7)"	"unprognostic (2.84e-2)"	"unprognostic (1.93e-1)"	"unprognostic (5.06e-2)"	"unprognostic (2.91e-3)"	20.5	23.7	14.4	18.1	14.2	12.5	19.1	15.0	15.3	21.7	23.6	33.0	29.7	20.0	11.0	25.4	22.7	8.2	68.0	13.4	13.9	33.4	46.5	22.7	17.6	13.2	13.9	25.9	21.1	19.1	32.1	10.3	13.8	22.6	20.8	43.4	19.6	13.6	54.8	22.2	29.8	12.6	11.8	26.0	26.3	35.2	14.0	9.7	43.5	28.8	17.6	25.9	21.9	12.4	18.0	26.1	20.9	29.2	21.7	18.4	66.8	24.1	9.3	19.0	16.3	29.9	19.1	46.8	12.5	10.6	12.6	22.8	30.5	22.8	16.3	18.8	42.9	38.9	60.2	37.6	15.1	34.7	28.5	22.4	21.2	29.9	9.1	12.9	17.9	31.2	42.0	27.3	14.3	57.3	27.3	33.5	21.7	41.6	41.1	36.5	18.1	48.7	23.9	30.7	16.5	24.9	17.6	33.0	35.9	12.8	44.7	29.9	22.1	17.1	25.2	23.7	30.6	26.3	30.1	33.7	17.3	43.8	16.3	3.3	27.2	7.2	17.4	34.6	20.2	39.4	16.2	18.0	29.3	35.2	25.6	21.0	1.8	13.8	37.2	24.0	14.2	18.1	14.4	14.2	15.0	15.3	13.4	13.9	13.2	13.9	13.8	11.8	14.0	12.4	22.8	51.3	34.6	47.3	49.4	38.5	61.0	76.2	31.9	58.2	37.2	39.9	271.5	44.3	57.7	36.8	164.7	94.6	30.5	78.5	223.0	50.0	367.5	31.1	45.1	31.0	54.0	36.6	37.7	34.0	74.6	40.0	51.0	28.3	26.0	45.5	21.0	101.0	93.4	67.3	43.9	81.3	54.9	29.8	36.6	1316.8	46.0	35.3	37.4	8.4	41.0	25.7	43.3	32.2	29.3	47.4	49.5	30.1	41.6	74.4	152.8	201.6	40.7	106.2	72.3	35.6	43.0	139.1	30.0	56.1	48.6	72.7	28.4	97.4	125.8	73.9
MRPS26	"C20orf193, dJ534B8.3, MRP-S13, MRP-S26, RPMS13"	ENSG00000125901	"Mitochondrial ribosomal protein S26"	Q9BYN8	20	3046052-3048250	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045472, HPA054610"	Supported		Supported	Mitochondria		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 35: Non-specific - Unknown function"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"HPA045472: AB_10962052, HPA054610: AB_2682541"	"unprognostic (1.53e-1)"	"unprognostic (2.18e-1)"	"unprognostic (3.71e-1)"	"unprognostic (4.41e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.68e-1)"	"unprognostic (8.13e-3)"	"unprognostic (3.14e-1)"	"unprognostic (6.83e-2)"	"unprognostic (8.21e-2)"	"unprognostic (9.65e-3)"	"unprognostic (2.14e-1)"	"unprognostic (1.14e-2)"	"unprognostic (3.77e-1)"	"unprognostic (4.11e-2)"	"unprognostic (2.95e-1)"	"unprognostic (3.93e-3)"	36.9	69.5	61.1	17.1	62.4	18.1	38.3	63.9	69.6	41.6	64.2	50.8	26.9	40.9	34.8	48.6	42.4	11.3	69.7	59.7	65.3	60.6	104.1	27.9	19.2	64.8	62.0	48.0	50.0	38.9	64.8	19.4	63.5	56.3	18.8	14.2	41.0	30.4	56.7	48.6	35.7	19.8	60.6	34.9	45.4	21.3	63.5	18.3	51.1	25.6	20.9	48.6	38.3	63.7	119.0	157.5	34.7	63.6	37.3	28.4	91.0	45.4	30.6	51.4	39.2	138.9	53.0	117.7	56.3	23.7	67.0	109.9	69.6	94.1	29.9	30.2	149.0	53.6	60.8	234.6	51.9	85.2	25.3	32.0	72.0	42.7	64.2	35.7	38.7	68.9	88.1	27.0	31.1	103.6	88.4	149.6	170.8	89.9	154.0	96.4	60.0	126.5	51.2	78.9	108.9	140.7	52.0	171.7	109.2	34.3	77.4	47.5	36.2	33.2	52.6	60.0	84.9	120.0	169.0	72.6	21.6	70.7	37.8	36.1	64.2	33.0	68.6	77.5	87.9	114.4	76.3	74.6	87.5	104.9	87.3	74.9	5.1	97.0	63.6	53.3	65.9	73.2	61.1	62.4	63.9	69.6	59.7	65.3	64.8	62.0	63.5	60.6	63.5	63.7	50.9	16.0	26.8	18.3	61.4	82.0	62.9	113.7	86.6	40.0	87.4	136.5	64.6	54.3	61.5	55.2	35.5	188.1	50.2	72.6	209.4	77.6	4.3	56.9	70.8	43.1	55.1	49.2	20.3	54.8	117.5	57.6	60.1	50.3	14.0	94.0	32.5	120.0	81.1	47.1	20.3	104.1	103.7	23.6	37.5	10.6	69.0	29.2	67.6	5.6	35.3	88.5	56.7	18.1	19.3	52.6	62.0	61.7	46.2	115.3	108.6	239.8	44.4	45.4	59.2	47.3	66.8	60.8	68.7	101.9	92.2	78.5	44.8	164.6	124.2	54.0
MRPS27	KIAA0264	ENSG00000113048	"Mitochondrial ribosomal protein S27"	Q92552	5	72219403-72320646	"Predicted intracellular proteins, Ribosomal proteins"	"Translation regulation"	"Ribonucleoprotein, Ribosomal protein, RNA-binding, rRNA-binding, tRNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 101.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA071751	Approved		Supported	Nucleoli,Mitochondria		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 54: Cardiomyocytes - Muscle contraction"	Mitochondria	Nucleoli	"HPA071751: AB_2686442"	"unprognostic (3.05e-1)"	"unprognostic (3.09e-1)"	"unprognostic (1.14e-3)"	"unprognostic (3.60e-2)"	"unprognostic (2.23e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.79e-2)"	"unprognostic (7.20e-3)"	"unprognostic (2.12e-1)"	"unprognostic (3.22e-3)"	"unprognostic (5.07e-2)"	"unprognostic (3.26e-2)"	"unprognostic (6.58e-3)"	"unprognostic (1.33e-1)"	"unprognostic (5.27e-2)"	"unprognostic (7.73e-2)"	"unprognostic (3.95e-2)"	25.5	36.1	23.8	21.8	25.3	18.9	31.8	23.6	27.8	27.0	33.8	26.2	20.4	25.8	27.6	32.4	31.3	19.0	55.5	25.0	23.1	30.5	38.5	17.5	36.9	24.6	24.1	39.5	27.1	32.7	20.9	21.2	24.6	25.2	31.5	17.7	22.4	30.3	58.7	31.7	22.0	26.9	24.5	25.9	25.7	15.1	25.0	30.7	35.6	89.1	41.9	29.7	26.0	24.1	49.7	65.2	56.8	94.4	73.1	93.5	73.0	46.7	66.4	86.9	69.7	81.9	68.5	128.2	63.8	54.8	94.9	54.0	111.8	166.1	93.6	48.6	69.2	66.0	71.3	91.1	72.7	58.4	49.0	88.1	68.7	91.3	101.5	79.0	94.2	92.2	67.2	37.5	73.0	59.7	87.8	70.4	65.7	35.8	40.4	92.0	94.4	131.5	80.7	52.4	87.5	46.7	78.5	63.8	58.5	52.2	97.8	69.9	54.1	35.3	51.8	50.3	85.2	37.7	61.0	89.1	60.9	94.6	57.0	15.5	23.4	8.1	24.9	27.5	37.1	36.1	30.6	30.4	44.2	32.1	35.2	37.9	3.2	43.3	23.0	16.6	34.6	31.5	23.8	25.3	23.6	27.8	25.0	23.1	24.6	24.1	24.6	24.5	25.0	24.1	13.9	9.6	11.7	32.7	27.6	20.4	22.3	21.6	23.3	11.4	26.5	22.2	101.9	7.2	15.6	11.0	16.7	41.5	18.6	9.1	25.4	20.5	2.2	16.1	21.8	17.2	16.2	36.8	43.9	17.3	48.2	18.8	17.9	12.1	7.6	29.3	15.7	34.8	24.8	10.1	38.4	21.0	8.2	28.6	13.3	4.4	19.0	15.0	10.6	30.0	31.4	15.3	17.5	38.7	51.1	14.9	15.3	25.2	16.8	13.5	10.7	28.8	12.6	13.2	13.1	18.2	17.6	10.3	18.7	32.3	17.6	28.9	21.2	30.4	31.4	14.8
MRPS28	"HSPC007, MRP-S28, MRPS35"	ENSG00000147586	"Mitochondrial ribosomal protein S28"	Q9Y2Q9	8	79918717-80030289	"Human disease related genes, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"	"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SK-BR-3: 359.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027202	Approved		Supported	Mitochondria		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Mitochondria		"HPA027202: AB_1854126"	"unprognostic (3.63e-3)"	"unprognostic (6.41e-2)"	"unprognostic (9.61e-3)"	"unprognostic (1.31e-1)"	"unprognostic (4.41e-2)"	"unprognostic (1.43e-3)"	"unprognostic (2.17e-1)"	"unprognostic (1.27e-1)"	"unprognostic (3.23e-1)"	"unprognostic (4.55e-1)"	"unprognostic (4.18e-1)"	"unprognostic (2.11e-1)"	"prognostic favorable (1.20e-6)"	"unprognostic (4.48e-2)"	"unprognostic (3.13e-1)"	"unprognostic (1.18e-1)"	"unprognostic (7.18e-2)"	47.5	88.8	65.1	32.9	67.7	29.1	47.5	70.0	85.3	33.3	73.0	52.9	30.9	27.3	38.3	41.0	35.2	28.8	104.0	64.0	70.2	79.2	110.9	30.4	37.7	70.1	69.8	28.6	32.3	69.6	40.4	40.9	70.1	31.3	41.0	51.7	35.4	33.4	160.3	29.0	29.4	32.8	69.7	26.7	35.3	24.3	66.9	44.9	53.7	137.7	37.9	39.0	30.7	75.3	85.2	84.1	73.0	17.3	60.9	77.2	79.8	94.3	85.7	122.1	104.2	74.0	66.4	107.2	105.3	75.6	124.2	68.5	102.1	105.5	99.0	85.3	89.8	128.8	74.8	114.4	67.7	57.6	55.3	66.4	88.9	71.8	97.4	67.1	81.0	85.2	93.4	42.3	123.7	81.3	133.8	93.5	29.8	219.5	139.5	89.9	58.1	62.0	158.0	81.8	34.8	58.6	41.1	359.5	91.1	83.8	86.6	68.1	59.0	45.8	116.4	81.6	82.7	46.5	81.4	97.2	77.4	66.7	36.8	95.4	53.8	29.1	48.2	77.3	52.3	51.2	52.8	59.4	98.8	54.4	64.1	62.1	11.1	71.5	70.1	111.1	73.0	49.8	65.1	67.7	70.0	85.3	64.0	70.2	70.1	69.8	70.1	69.7	66.9	75.3	32.5	22.4	22.2	57.8	20.8	35.2	19.5	124.5	36.5	10.9	23.4	28.1	51.6	42.9	67.0	33.1	4.2	78.7	20.9	18.1	101.8	67.3	15.1	28.5	16.1	26.2	37.3	21.7	39.0	47.4	74.3	21.2	17.9	24.1	50.0	10.5	23.9	65.5	49.5	5.0	42.5	23.5	69.2	25.5	28.5	10.4	17.7	26.9	44.4	70.3	40.0	23.7	26.8	93.5	81.8	36.0	20.6	22.2	19.9	13.4	24.5	126.9	79.7	17.2	32.9	31.1	26.1	18.6	33.4	41.6	37.8	59.4	20.0	23.2	36.4	16.0
MRPS31	IMOGN38	ENSG00000102738	"Mitochondrial ribosomal protein S31"	Q92665	13	40729128-40771190	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Respiratory ciliated cells: 412.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039083, HPA046344"	Uncertain		Supported	Nucleoli,Mitochondria		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 49: Ciliated cells - Cilium organization"	Mitochondria	Nucleoli	"HPA039083: AB_2676340, HPA046344: AB_2679629"	"unprognostic (9.62e-3)"	"unprognostic (2.62e-1)"	"unprognostic (1.82e-2)"	"unprognostic (3.26e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.15e-2)"	"unprognostic (5.96e-3)"	"unprognostic (1.84e-3)"	"unprognostic (2.87e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.72e-3)"	"unprognostic (3.92e-2)"	"unprognostic (3.13e-3)"	"unprognostic (2.80e-2)"	"unprognostic (1.66e-3)"	"unprognostic (1.86e-2)"	"unprognostic (2.54e-2)"	11.7	14.8	9.1	14.0	9.6	14.4	16.9	10.5	12.5	10.7	9.1	15.8	14.8	16.6	13.8	14.7	15.1	10.2	24.0	8.7	9.5	19.6	28.8	11.5	23.5	9.6	9.7	19.2	10.4	14.3	7.5	12.6	10.1	11.3	15.6	13.7	13.7	11.0	27.5	13.5	15.3	15.2	9.3	13.2	15.0	17.9	9.2	17.8	19.6	26.2	24.9	13.2	10.0	11.8	19.0	17.9	29.5	19.5	19.8	23.2	29.6	23.7	16.5	30.7	20.5	46.0	27.4	110.5	22.6	13.7	41.3	48.8	37.4	29.6	36.2	29.4	28.1	45.9	12.7	29.7	16.5	47.4	21.3	18.8	21.4	25.3	21.2	20.3	23.8	31.2	31.3	11.3	19.8	21.5	37.2	46.2	28.7	64.2	20.9	35.0	24.3	20.8	40.3	21.6	12.9	18.7	16.5	27.0	39.3	35.1	23.7	41.5	14.6	9.5	16.0	22.3	24.9	8.7	17.4	55.7	19.5	33.3	18.6	30.9	15.3	24.9	29.4	16.4	28.8	36.8	32.5	29.9	19.5	33.5	38.5	34.3	11.3	28.7	18.4	19.1	36.5	17.8	9.1	9.6	10.5	12.5	8.7	9.5	9.6	9.7	10.1	9.3	9.2	11.8	27.5	48.1	19.2	24.5	35.0	9.7	33.0	106.0	33.0	35.1	22.4	31.6	73.7	28.6	77.2	22.0	18.8	62.7	31.2	18.7	109.5	43.0	74.9	55.5	38.6	32.5	23.4	29.8	28.8	33.6	41.5	27.9	18.8	38.1	23.4	32.8	37.9	76.9	26.0	42.1	37.8	37.4	91.6	17.0	12.5	14.2	35.4	18.1	19.6	26.2	39.8	32.3	32.0	36.7	45.1	30.0	19.5	30.5	52.1	15.8	32.4	93.4	412.5	51.2	46.0	39.5	38.1	72.6	49.8	30.2	13.4	68.0	37.7	45.2	35.5	25.5
MRPS34	"MGC2616, MRP-S12"	ENSG00000074071	"Mitochondrial ribosomal protein S34"	P82930	16	1771890-1773150	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"	"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HEK 293: 354.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042112	Supported		Supported	Mitochondria		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"HPA042112: AB_10796899"	"unprognostic (2.02e-1)"	"unprognostic (4.83e-2)"	"unprognostic (6.79e-2)"	"unprognostic (3.42e-2)"	"unprognostic (2.27e-1)"	"unprognostic (9.59e-2)"	"unprognostic (1.42e-2)"	"unprognostic (2.49e-1)"	"unprognostic (3.03e-1)"	"unprognostic (2.22e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.50e-1)"	"unprognostic (3.52e-1)"	"unprognostic (1.37e-2)"	"unprognostic (6.60e-2)"	"unprognostic (3.18e-1)"	"unprognostic (5.44e-2)"	40.2	84.4	15.0	8.2	15.6	14.9	38.9	18.8	30.2	39.6	8.4	56.9	17.6	41.4	1.8	74.2	38.1	3.9	66.5	14.3	14.7	53.4	83.8	33.1	9.6	20.1	14.9	32.5	85.4	7.5	43.2	6.0	18.3	44.2	3.0	1.5	51.9	9.7	88.1	63.3	48.9	3.0	17.3	59.4	55.9	22.3	17.2	6.6	35.2	6.2	4.3	43.9	43.6	19.7	72.4	77.1	10.6	26.9	9.1	10.7	86.5	75.8	14.9	26.2	20.2	51.7	40.7	89.1	120.7	9.6	14.9	82.3	15.7	37.3	4.0	63.2	354.6	63.9	68.2	56.3	19.9	116.7	63.3	9.8	17.5	16.1	7.1	11.8	20.4	45.1	105.7	18.6	7.5	113.3	63.1	209.4	101.5	19.1	229.5	137.9	51.9	201.0	10.2	19.4	132.2	100.6	85.8	42.4	82.5	2.9	54.9	46.5	51.9	28.2	88.9	37.1	62.8	154.8	116.9	141.9	22.1	65.3	36.1	68.6	185.4	108.3	144.9	172.6	153.3	189.3	160.0	154.2	205.6	224.2	150.2	135.6	40.6	165.1	153.9	192.1	204.7	189.6	15.0	15.6	18.8	30.2	14.3	14.7	20.1	14.9	18.3	17.3	17.2	19.7	72.0	38.5	31.7	13.1	92.5	100.3	60.8	132.6	103.6	45.6	108.8	127.9	59.9	101.5	77.3	97.5	10.4	181.3	87.9	170.1	250.5	116.1	5.9	65.3	82.8	59.6	91.1	90.6	10.1	182.5	181.9	66.2	105.0	66.2	36.1	75.6	65.3	168.1	173.3	55.5	12.0	174.0	109.9	96.1	66.2	11.6	72.7	74.8	81.8	8.4	108.8	87.8	110.2	11.6	17.1	155.4	153.4	70.0	183.8	94.0	265.6	261.8	43.1	38.2	19.7	48.2	73.7	30.9	49.2	192.3	120.6	68.4	83.2	140.7	232.3	75.7
MRPS5	"MRP-S5, S5mt"	ENSG00000144029	"Mitochondrial ribosomal protein S5"	P82675	2	95085369-95149434	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA055765	Approved		Supported	Mitochondria		No	No			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"HPA055765: AB_2682911"	"unprognostic (1.18e-1)"	"unprognostic (7.79e-2)"	"unprognostic (1.73e-2)"	"prognostic unfavorable (7.98e-7)"	"unprognostic (7.51e-3)"	"unprognostic (6.30e-3)"	"prognostic unfavorable (7.73e-5)"	"unprognostic (8.59e-2)"	"unprognostic (1.87e-1)"	"unprognostic (2.76e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.99e-2)"	"unprognostic (1.32e-2)"	"unprognostic (2.34e-2)"	"unprognostic (1.29e-1)"	"prognostic favorable (6.36e-4)"	"unprognostic (1.25e-1)"	26.0	33.6	5.6	3.8	5.7	7.6	22.3	6.9	7.1	24.4	6.3	34.5	6.9	24.1	4.7	34.5	24.3	3.6	53.6	5.7	5.6	34.6	53.6	24.3	5.5	5.7	5.5	24.9	24.1	6.8	19.9	3.7	5.8	18.5	6.9	5.0	24.7	2.9	71.2	19.4	26.8	5.1	5.1	25.0	30.1	19.5	5.8	6.2	23.8	13.7	5.4	23.7	24.8	6.3	18.8	14.8	8.1	7.8	8.6	10.6	15.3	9.5	4.2	7.1	7.6	28.7	12.9	18.4	7.5	8.4	17.1	11.3	14.0	11.8	13.8	13.0	11.2	11.6	12.3	22.8	11.6	16.5	7.3	10.5	9.3	12.0	12.5	9.0	12.3	10.4	18.0	7.8	10.4	15.1	18.6	17.8	9.0	16.5	13.5	10.5	8.0	21.3	17.4	18.5	12.4	7.8	8.2	17.2	17.6	12.8	7.4	16.0	9.5	10.6	12.9	15.1	15.5	7.6	8.9	14.0	8.8	16.3	9.6	2.5	5.4	3.8	3.6	7.2	4.4	4.5	4.8	4.2	4.8	3.3	4.2	4.4	2.2	3.6	7.4	3.3	5.9	4.2	5.6	5.7	6.9	7.1	5.7	5.6	5.7	5.5	5.8	5.1	5.8	6.3	46.3	80.1	84.6	33.3	52.3	34.8	59.1	112.5	56.9	52.8	42.1	40.5	130.2	58.6	74.4	66.2	50.1	81.8	51.2	68.3	185.9	74.8	68.3	48.5	69.9	48.1	59.4	79.3	31.8	55.4	83.8	53.9	51.0	43.0	40.4	90.7	50.3	129.8	74.1	47.1	29.3	65.0	109.9	51.8	41.2	48.9	51.3	55.3	44.4	7.5	61.5	29.7	44.3	30.7	40.3	50.2	44.2	53.4	69.7	68.1	87.3	131.8	72.3	69.0	39.5	52.2	59.5	80.9	99.1	78.7	32.0	39.4	57.4	60.7	104.5	48.2
MRPS6	"C21orf101, MRP-S6, RPMS6"	ENSG00000243927	"Mitochondrial ribosomal protein S6"	P82932	21	34073224-34143034	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 281.0"	"Cell type enhanced"	"Detected in all"		"Distal tubular cells: 747.4;Prostatic glandular cells: 568.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007861, HPA008163, HPA049676"	Supported		Supported	Mitochondria		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 22: Epithelial cell types - Mixed function"	Mitochondria		"HPA007861: AB_2667920, HPA008163: AB_2667998, HPA049676: AB_2680846"	"unprognostic (2.71e-2)"	"unprognostic (4.85e-2)"	"unprognostic (5.16e-3)"	"unprognostic (4.01e-2)"	"unprognostic (9.84e-3)"	"unprognostic (3.72e-2)"	"unprognostic (7.58e-3)"	"unprognostic (1.80e-1)"	"unprognostic (8.19e-2)"	"unprognostic (2.28e-3)"	"unprognostic (5.87e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.02e-3)"	"unprognostic (9.37e-2)"	"unprognostic (5.13e-2)"	"unprognostic (5.51e-2)"	"prognostic favorable (1.06e-5)"	67.6	72.5	53.9	33.8	56.1	15.6	46.1	53.0	118.1	42.7	85.9	81.6	22.7	37.1	50.7	31.3	37.9	24.8	57.3	55.4	60.8	281.0	50.6	37.8	46.7	54.7	56.5	41.7	22.2	24.2	39.4	51.8	55.6	33.1	36.5	25.6	26.2	41.6	96.1	53.5	39.0	36.7	58.9	28.6	51.3	44.8	63.3	38.3	97.5	76.8	49.8	50.6	33.7	57.8	70.8	56.6	211.0	77.2	74.1	72.9	71.4	79.5	185.4	68.7	70.0	181.8	134.9	105.6	51.7	104.0	92.8	28.7	124.6	106.0	73.4	193.5	65.4	89.6	34.3	47.8	35.4	45.2	31.7	35.0	107.8	127.2	116.5	104.2	47.4	45.2	116.5	28.0	140.7	66.0	73.4	104.1	136.9	135.4	122.1	99.6	37.4	101.5	307.4	60.4	187.5	50.0	84.5	46.2	103.6	112.6	87.3	58.7	24.3	62.8	36.6	115.4	46.3	132.5	125.8	96.3	204.2	118.4	62.8	67.0	53.8	60.4	90.3	53.7	66.6	74.9	67.0	81.4	56.1	48.4	83.8	87.3	46.8	115.7	57.5	101.4	74.0	79.6	53.9	56.1	53.0	118.1	55.4	60.8	54.7	56.5	55.6	58.9	63.3	57.8	45.1	22.4	40.9	32.3	83.9	266.8	229.8	226.6	126.9	40.5	78.9	125.9	59.8	28.6	75.8	252.0	10.4	195.2	103.0	56.3	747.4	41.1	83.1	85.2	88.6	58.0	91.5	45.4	25.7	36.7	237.0	111.7	32.6	58.6	137.7	184.5	25.7	95.7	126.5	8.4	57.9	211.0	75.3	36.4	207.6	73.1	28.0	104.8	101.4	32.8	164.0	37.9	108.1	45.2	6.2	52.8	138.5	102.7	102.0	568.4	61.0	159.2	66.0	26.5	118.3	26.9	104.8	90.4	136.5	71.0	331.0	182.4	124.2	49.8	99.9	335.6
MRPS9	"MRP-S9, RPMS9, S9mt"	ENSG00000135972	"Mitochondrial ribosomal protein S9"	P82933	2	105038069-105099960	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043476, HPA048479"	Supported		Supported	Mitochondria		No	No			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 66: Spermatocytes - Spermatogenesis"	Mitochondria		"HPA043476: AB_2678498, HPA048479: AB_2680412"	"unprognostic (8.10e-3)"	"unprognostic (4.75e-3)"	"unprognostic (3.69e-1)"	"unprognostic (3.80e-3)"	"unprognostic (5.25e-1)"	"unprognostic (1.39e-1)"	"prognostic unfavorable (4.43e-4)"	"unprognostic (1.88e-1)"	"unprognostic (1.16e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.13e-1)"	"unprognostic (3.78e-1)"	"unprognostic (2.62e-3)"	"unprognostic (4.62e-2)"	"unprognostic (5.28e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.12e-1)"	17.2	33.5	21.4	17.9	22.7	24.6	23.3	24.1	26.5	18.3	25.7	29.8	29.5	20.7	19.2	23.8	24.2	13.4	64.1	21.4	23.3	32.7	31.8	15.4	24.7	24.0	22.8	30.8	24.2	32.8	19.6	12.9	24.3	23.4	33.3	22.3	23.3	21.6	98.6	21.9	23.4	19.8	22.7	18.5	25.9	33.5	22.8	30.8	21.4	97.0	27.1	20.2	17.9	25.1	68.2	28.9	59.4	55.1	30.6	31.5	69.6	42.6	40.6	66.2	59.2	155.0	46.4	70.6	41.1	33.9	68.9	59.8	118.0	62.1	69.9	44.0	77.5	69.7	42.4	94.4	51.0	52.2	29.9	37.9	41.5	54.6	45.4	38.3	51.6	84.8	101.5	35.9	45.7	54.9	70.6	68.6	93.9	57.4	62.6	88.9	50.9	98.3	83.2	47.3	51.4	30.9	49.4	71.5	59.9	58.0	58.9	52.2	34.0	38.8	78.2	38.9	46.6	32.6	41.5	56.3	33.6	79.1	33.3	21.7	23.8	10.1	39.3	31.5	43.3	44.4	43.0	41.7	43.0	35.3	42.9	42.4	2.8	46.0	39.9	32.1	49.9	31.7	21.4	22.7	24.1	26.5	21.4	23.3	24.0	22.8	24.3	22.7	22.8	25.1	18.2	22.4	28.2	28.1	21.0	19.5	25.3	56.4	22.2	24.7	15.4	22.2	110.2	22.8	30.4	22.0	12.5	39.9	29.1	17.7	107.6	40.7	51.7	35.9	18.6	22.5	19.7	47.5	43.4	42.7	40.7	21.2	18.8	12.9	22.8	34.6	18.2	31.2	28.8	8.4	54.2	27.9	24.4	15.2	9.9	14.6	23.9	15.9	30.2	17.8	26.2	21.2	29.9	49.3	69.4	22.6	18.3	27.1	25.0	17.4	23.1	72.3	42.1	32.0	39.5	24.8	28.1	112.8	40.7	23.4	13.2	20.4	25.2	62.9	40.5	19.0
MRTFA	"BSAC, KIAA1438, MAL, MKL, MKL1, MRTF-A"	ENSG00000196588	"Myocardin related transcription factor A"	Q969V6	22	40410281-40636719	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	Actin-binding	"Cancer-related genes, Disease variant, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Adipocytes: 4.5;Cardiomyocytes: 8.7;Cytotrophoblasts: 8.9;Extravillous trophoblasts: 8.7;Fibroblasts: 4.3;Hofbauer cells: 12.7;Syncytiotrophoblasts: 7.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"eosinophil: 189.4"	"Group enriched"	"Detected in all"	5	"dendritic cells: 93.1;granulocytes: 189.4;monocytes: 58.8"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030782	Approved		Supported	Nucleoplasm,Cytosol		No	No			"Cluster 52: Eosinophils - Transcription"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm	Cytosol	"HPA030782: AB_10600930"	"unprognostic (7.90e-3)"	"unprognostic (4.51e-2)"	"unprognostic (2.99e-1)"	"unprognostic (1.29e-1)"	"unprognostic (9.04e-2)"	"unprognostic (9.37e-2)"	"unprognostic (4.38e-3)"	"unprognostic (1.02e-3)"	"unprognostic (1.30e-1)"	"unprognostic (1.35e-2)"	"unprognostic (1.51e-1)"	"unprognostic (3.74e-2)"	"prognostic unfavorable (1.58e-7)"	"unprognostic (9.05e-2)"	"unprognostic (8.15e-2)"	"unprognostic (1.30e-2)"	"unprognostic (3.98e-1)"	21.1	15.4	15.8	27.3	18.0	80.7	19.9	10.9	22.8	25.5	12.3	20.8	11.7	33.1	7.3	16.6	22.6	11.7	21.3	20.2	10.0	14.6	12.3	24.5	27.5	9.3	8.7	20.9	16.1	8.9	13.8	18.3	7.9	19.4	8.8	11.1	18.2	15.2	19.1	24.4	18.6	16.3	6.7	29.7	19.1	35.9	9.5	21.7	22.1	8.0	22.8	22.0	19.6	15.3	26.5	33.9	14.5	17.5	21.6	15.9	27.8	25.6	16.6	23.1	22.8	19.1	7.9	27.2	10.2	27.0	20.3	35.5	12.7	31.9	13.8	32.0	29.2	46.3	39.9	24.7	17.8	53.5	79.8	15.5	36.7	22.4	15.1	17.5	18.3	15.0	12.9	12.3	11.5	25.3	20.7	57.4	11.7	14.2	12.1	35.4	17.5	16.4	16.9	22.1	8.7	8.7	43.7	19.4	13.8	18.3	16.0	59.0	27.8	14.7	38.7	21.4	20.9	16.1	16.5	39.1	12.1	25.6	26.5	49.0	53.5	189.4	18.5	43.7	16.9	13.0	15.8	13.6	64.3	18.6	21.1	18.1	57.2	16.8	58.8	93.1	22.0	34.2	15.8	18.0	10.9	22.8	20.2	10.0	9.3	8.7	7.9	6.7	9.5	15.3	4.5	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.7	0.0	0.0	0.0	0.0	8.9	3.1	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	8.7	4.3	0.0	0.0	0.0	0.0	0.0	0.0	12.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	7.8	0.6	0.0	0.0	0.0
MRTFB	"FLJ31823, MKL2, MRTF-B"	ENSG00000186260	"Myocardin related transcription factor B"	Q9ULH7	16	14071319-14266773	"Disease related genes, Predicted intracellular proteins"	"Differentiation, Myogenesis, Transcription, Transcription regulation"	"Activator, Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Adipocytes: 43.9;Cardiomyocytes: 26.9;Cytotrophoblasts: 9.9;Endothelial cells: 9.6;Extravillous trophoblasts: 10.0;Smooth muscle cells: 14.9;Syncytiotrophoblasts: 10.4"	"Low cancer specificity"	"Detected in all"			"Group enriched"	"Detected in many"	170	"amygdala: 9.4;basal ganglia: 15.1;cerebral cortex: 21.4;hippocampal formation: 21.7"	"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA011286	Enhanced		Supported	"Nuclear speckles"		NA	NA			"Cluster 30: Non-specific - Translation"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 43: Cardiomyocytes - Nuclear processes"	"Nuclear speckles"		"HPA011286: AB_1853973"	"unprognostic (2.00e-1)"	"unprognostic (5.28e-1)"	"unprognostic (1.30e-2)"	"unprognostic (3.62e-1)"	"unprognostic (7.16e-2)"	"unprognostic (7.14e-3)"	"unprognostic (1.21e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.41e-1)"	"unprognostic (2.38e-1)"	"unprognostic (3.19e-1)"	"unprognostic (2.32e-1)"	"prognostic favorable (6.20e-4)"	"unprognostic (5.22e-2)"	"unprognostic (3.55e-1)"	"unprognostic (2.47e-2)"	"unprognostic (5.96e-2)"	21.4	7.3	9.4	8.6	15.1	3.8	18.3	0.0	21.4	19.0	0.0	9.9	9.7	14.9	9.1	14.5	14.0	13.3	11.8	21.7	0.0	8.4	5.9	13.2	7.6	0.0	0.0	7.1	12.1	22.2	4.9	21.7	0.0	15.5	10.8	8.6	11.6	15.2	11.9	16.6	7.9	15.6	0.0	5.1	10.1	17.5	0.0	10.3	16.9	14.5	8.1	11.3	12.2	0.0	17.6	17.8	17.8	13.2	5.9	11.0	8.0	4.9	13.3	7.4	10.6	7.7	16.4	9.4	12.4	8.4	9.3	13.8	12.9	14.4	13.5	23.1	7.0	6.0	13.6	13.3	8.2	4.2	5.4	8.4	14.6	12.8	8.3	7.8	14.7	12.2	7.9	9.7	5.6	15.1	13.4	2.8	6.0	4.7	4.8	20.5	13.7	8.1	7.3	17.3	6.2	10.8	23.9	10.2	4.9	8.2	18.0	3.5	9.4	15.3	14.9	4.4	6.4	6.6	8.8	8.4	16.6	7.1	11.7	0.2	0.5	0.0	1.1	0.7	1.7	3.7	1.9	0.9	0.7	1.5	2.4	1.3	0.3	1.1	0.8	1.7	0.9	0.6	9.4	15.1	0.0	21.4	21.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	43.9	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	26.9	0.0	0.0	0.0	0.0	9.9	1.5	0.0	0.0	0.0	0.0	0.0	0.0	9.6	0.0	0.0	0.0	0.0	10.0	4.8	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.9	0.0	0.0	0.0	0.0	10.4	0.4	0.0	0.0	0.0
MRTO4	"C1orf33, dJ657E11.4, MRT4"	ENSG00000053372	"MRT4 homolog, ribosome maturation factor"	Q9UKD2	1	19251805-19260128	"Predicted intracellular proteins, Ribosomal proteins"	"Ribosome biogenesis"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026446	Approved		Approved	"Nucleoplasm,Nuclear membrane,Nucleoli"		Yes	No			"Cluster 15: NK-cells - Transcription"	"Cluster 52: Non-specific - Ribosome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoplasm, Nuclear membrane"	Nucleoli	"HPA026446: AB_10601441"	"unprognostic (3.99e-1)"	"unprognostic (1.75e-1)"	"unprognostic (2.18e-2)"	"unprognostic (2.94e-1)"	"unprognostic (4.12e-1)"	"unprognostic (4.22e-2)"	"prognostic unfavorable (1.56e-8)"	"unprognostic (7.46e-2)"	"unprognostic (5.58e-2)"	"unprognostic (2.61e-2)"	"unprognostic (2.69e-2)"	"unprognostic (1.09e-1)"	"prognostic unfavorable (4.11e-8)"	"unprognostic (5.87e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.50e-1)"	"unprognostic (3.23e-2)"	18.9	18.5	17.0	16.8	17.1	13.4	20.2	14.8	17.9	13.0	13.7	13.5	16.8	15.8	12.9	23.7	17.6	8.9	14.4	17.4	16.1	17.9	20.3	11.1	20.0	15.8	16.0	17.0	23.4	12.5	8.9	12.1	16.1	12.9	16.5	7.2	12.3	10.5	22.7	17.4	19.5	16.7	15.4	13.8	15.5	14.0	16.1	14.8	11.1	11.4	22.8	21.4	14.1	16.4	90.9	65.9	51.1	67.0	24.2	38.6	44.7	69.0	38.9	116.7	76.1	92.9	92.0	133.6	56.7	60.5	50.4	70.1	142.7	104.6	114.0	47.4	109.6	98.4	55.4	80.8	30.3	133.4	38.7	34.0	69.8	131.6	69.6	31.7	66.1	59.0	151.1	42.3	68.9	68.0	106.3	96.5	65.0	95.6	95.4	99.3	62.7	100.5	64.8	31.3	82.9	59.2	54.0	73.0	75.4	37.6	50.8	76.5	44.2	61.9	77.5	97.6	118.0	33.8	64.3	178.2	61.2	172.4	102.5	1.4	11.6	1.3	11.4	12.7	22.9	23.1	13.7	15.9	17.6	19.7	18.4	16.7	1.4	16.6	10.2	19.7	10.6	11.4	17.0	17.1	14.8	17.9	17.4	16.1	15.8	16.0	16.1	15.4	16.1	16.4	30.0	6.4	14.5	6.2	31.2	37.3	59.1	45.8	42.7	20.4	23.6	37.7	10.3	38.6	26.4	7.3	10.4	50.4	14.9	15.7	41.1	61.8	23.3	19.1	46.8	32.1	21.6	31.3	8.4	55.0	69.9	29.5	19.4	21.1	26.0	36.8	15.4	16.3	47.1	15.2	7.3	25.4	36.7	13.3	18.2	36.5	23.0	21.0	19.6	1.9	32.0	25.7	16.5	4.5	4.3	57.5	17.0	20.3	29.0	57.4	6.0	37.9	15.8	16.4	19.7	44.8	35.9	55.6	49.7	48.2	33.5	26.0	18.6	58.1	34.8	36.7
MS4A1	"B1, Bp35, CD20, MS4A2"	ENSG00000156738	"Membrane spanning 4-domains A1"	P11836	11	60455846-60470752	"CD markers, Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"B-cell activation"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"lymphoid tissue: 673.3"	"Cell type enriched"	"Detected in some"	35	"B-cells: 970.5"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	96	"memory B-cell: 625.4;naive B-cell: 627.0"	"Lineage enriched"	"Detected in many"	96	"B-cells: 627.0"	"Group enriched"	"Detected in some"	26	"Daudi: 731.3;U-698: 364.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB000015, HPA014341, HPA014391"	Enhanced		Supported	"Plasma membrane"		NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 57: B-cells - Immune response"	"Plasma membrane"		"CAB000015: AB_2282030, HPA014341: AB_1846265, HPA014391: AB_1846264"	"prognostic favorable (4.34e-5)"	"unprognostic (4.45e-4)"	"unprognostic (1.19e-4)"	"unprognostic (2.04e-3)"	"unprognostic (1.06e-1)"	"unprognostic (5.53e-7)"	"unprognostic (2.46e-3)"	"unprognostic (1.85e-3)"	"unprognostic (3.06e-2)"	"unprognostic (2.89e-4)"	"unprognostic (6.96e-2)"	"unprognostic (2.84e-2)"	"unprognostic (3.96e-5)"	"unprognostic (2.23e-1)"	"unprognostic (8.04e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.30e-1)"	3.6	0.4	0.0	149.7	0.0	19.1	0.8	0.0	0.1	0.5	0.1	9.0	3.0	2.2	1.0	4.2	0.5	8.4	1.8	0.0	0.1	3.4	2.1	4.0	500.4	0.2	0.0	0.3	0.2	7.3	0.3	0.9	0.1	5.1	10.6	0.0	8.9	0.3	0.8	0.1	123.5	1.2	0.1	253.8	18.4	1.2	0.1	50.6	6.7	0.1	673.3	16.3	1.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	731.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.3	0.5	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.2	0.4	0.0	0.5	0.2	0.0	0.1	0.0	364.1	0.0	0.2	0.0	0.8	0.5	0.3	2.4	0.1	3.7	625.4	2.8	5.5	0.5	627.0	0.5	2.1	2.0	6.5	0.6	0.5	0.8	32.1	0.0	0.0	0.0	0.1	0.0	0.1	0.2	0.0	0.1	0.1	0.1	0.1	0.3	0.0	3.8	0.0	970.5	0.1	0.1	0.0	0.0	0.0	0.4	0.3	0.4	0.0	0.0	0.0	0.0	0.0	14.5	0.3	0.0	0.0	4.5	0.7	0.1	0.3	0.0	7.0	0.0	0.0	0.1	1.8	2.0	0.1	2.5	0.0	1.1	0.3	0.1	0.0	0.0	0.2	0.0	0.6	0.3	2.0	0.0	4.6	7.2	0.0	2.5	0.0	2.1	0.0	0.0	0.0	0.3	0.0	9.1	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.5	0.2	0.1	0.8	0.1	0.0	27.3	0.7	0.2	0.0
MSANTD2	"C11orf61, FLJ23342"	ENSG00000120458	"Myb/SANT DNA binding domain containing 2"	Q6P1R3	11	124766498-124800706	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 33.5;Microglial cells: 31.9;Oligodendrocyte precursor cells: 33.7;Oligodendrocytes: 48.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038694, HPA038695"	Approved		Supported	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 35: Non-specific - Unknown function"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Nuclear bodies"	Nucleoplasm	"HPA038694: AB_2676155, HPA038695: AB_10674693"	"unprognostic (2.20e-1)"	"unprognostic (1.86e-1)"	"unprognostic (7.06e-2)"	"unprognostic (2.31e-1)"	"unprognostic (2.06e-1)"	"unprognostic (6.19e-2)"	"unprognostic (7.77e-4)"	"unprognostic (4.77e-3)"	"unprognostic (3.32e-2)"	"unprognostic (3.91e-1)"	"unprognostic (1.14e-1)"	"unprognostic (2.60e-3)"	"prognostic unfavorable (2.50e-4)"	"unprognostic (5.67e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.85e-1)"	"prognostic favorable (2.65e-4)"	9.8	6.3	8.0	3.8	9.0	0.7	9.9	8.2	10.8	16.2	8.5	10.2	4.0	11.5	7.5	7.5	12.8	2.8	7.2	7.4	8.6	19.1	8.3	9.3	4.5	8.4	8.6	14.1	14.2	3.2	15.3	5.1	8.6	13.5	3.8	5.9	9.3	4.0	4.7	8.4	10.1	2.8	7.8	13.7	10.5	4.7	8.4	3.4	25.3	1.9	3.9	9.4	11.4	10.9	3.0	0.9	10.5	9.9	5.2	6.7	6.1	6.4	3.6	2.3	3.0	4.3	6.2	3.5	5.9	3.3	3.4	5.5	4.5	2.1	3.6	5.8	4.0	3.3	3.9	4.5	2.6	1.9	2.7	3.4	3.8	4.0	3.3	9.1	5.3	3.0	3.9	4.7	5.8	2.6	1.4	9.4	8.0	5.5	14.4	4.2	2.6	3.3	4.4	2.6	3.3	13.0	2.9	3.7	1.9	7.7	8.6	2.1	6.8	15.4	4.3	4.5	6.4	3.0	2.2	2.1	3.2	3.4	8.0	0.0	0.2	0.6	0.6	0.4	0.3	0.3	0.5	0.9	0.3	0.8	0.5	0.4	0.0	0.2	0.5	0.2	1.1	0.2	8.0	9.0	8.2	10.8	7.4	8.6	8.4	8.6	8.6	7.8	8.4	10.9	10.9	3.2	10.3	28.7	7.7	8.8	4.4	2.5	9.6	8.7	6.7	6.7	3.3	5.7	1.8	7.3	2.1	2.9	7.7	3.4	3.9	4.6	5.2	3.2	11.1	9.4	1.2	1.3	33.5	1.0	4.4	10.1	6.6	5.6	1.3	9.0	10.4	3.0	3.0	13.5	30.6	3.1	4.1	3.8	7.3	1.5	9.6	4.1	1.8	31.9	4.4	5.6	8.2	33.7	48.4	4.6	4.0	7.2	4.3	5.0	2.2	3.6	2.9	6.2	13.1	11.3	14.0	2.4	1.6	4.4	4.1	1.9	5.8	7.3	5.0	3.2
MSC	"ABF-1, bHLHa22"	ENSG00000178860	Musculin	O60682	8	71841560-71844412	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Exocrine glandular cells: 40.9;Fibroblasts: 31.4;Leydig cells: 42.6;Melanocytes: 26.6;monocytes: 50.7;Pancreatic endocrine cells: 27.5;Peritubular cells: 41.3;Sertoli cells: 26.3;Skeletal myocytes: 70.0;Smooth muscle cells: 27.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"memory CD8 T-cell: 25.8"	"Group enriched"	"Detected in many"	37	"B-cells: 6.9;dendritic cells: 6.4;T-cells: 25.8"	"Cell line enriched"	"Detected in many"	15	"HDLM-2: 819.3"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	8	"cerebral cortex: 16.3;hippocampal formation: 13.2"	HPA062878			Supported	Nucleoplasm		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 48: Smooth muscle cells - ECM organization"	Nucleoplasm		"HPA062878: AB_2684891"	"unprognostic (2.58e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.86e-1)"	"unprognostic (1.35e-3)"	"prognostic unfavorable (5.21e-4)"	"unprognostic (3.70e-2)"	"prognostic unfavorable (4.83e-5)"	"unprognostic (3.95e-2)"	"unprognostic (7.92e-2)"	"unprognostic (3.75e-2)"	"unprognostic (3.73e-1)"	"unprognostic (2.31e-1)"	"prognostic unfavorable (1.07e-13)"	"unprognostic (1.65e-2)"	"unprognostic (1.45e-1)"	"unprognostic (7.48e-2)"	"unprognostic (1.40e-2)"	13.3	8.9	2.5	11.4	1.2	3.9	7.0	0.4	4.5	6.7	0.9	3.0	2.2	4.8	0.9	3.1	4.2	11.1	19.9	5.9	0.6	6.3	3.6	9.5	12.1	3.1	0.7	5.1	5.2	0.3	3.3	16.3	1.0	5.5	1.1	0.0	4.3	3.1	3.0	3.5	5.3	2.3	0.6	6.4	5.4	3.0	0.7	1.6	4.4	2.4	3.5	20.5	6.5	2.8	0.1	6.2	0.0	0.0	28.1	4.9	0.0	1.2	23.8	0.5	1.3	0.0	0.0	0.0	0.3	4.8	28.5	1.3	0.0	1.5	0.0	819.3	0.3	0.0	0.0	0.0	49.8	0.0	2.8	11.1	0.0	49.2	30.1	11.9	0.0	0.0	0.0	0.0	1.0	0.0	0.0	1.2	6.7	0.0	0.0	0.0	55.3	0.0	0.0	0.0	2.4	0.0	0.1	0.0	44.9	0.5	0.0	5.5	0.0	0.2	0.1	7.8	0.3	5.0	0.2	0.1	20.4	0.1	34.5	0.0	0.1	0.0	5.2	0.1	7.2	6.9	9.2	25.8	0.1	6.2	0.2	8.7	0.2	0.0	0.3	6.4	13.0	3.2	2.5	1.2	0.4	4.5	5.9	0.6	3.1	0.7	1.0	0.6	0.7	2.8	1.2	0.0	0.0	0.0	2.7	5.1	0.2	0.4	0.0	0.0	0.2	0.3	1.9	0.0	0.0	1.8	0.0	0.1	4.3	0.0	0.0	16.1	0.6	0.3	1.0	4.5	0.0	0.0	1.1	40.9	0.1	31.4	1.5	0.1	0.0	0.0	3.9	0.0	1.8	0.0	0.1	0.0	0.0	0.3	8.9	1.5	42.6	5.8	26.6	0.0	50.7	0.0	0.0	0.0	0.2	27.5	0.0	41.3	7.0	0.7	0.0	1.2	0.0	0.0	26.3	70.0	27.8	0.4	0.3	0.3	3.3	0.0	10.0	8.1	0.0	0.3
MSH2	"COCA1, HNPCC, HNPCC1"	ENSG00000095002	"MutS homolog 2"	P43246	2	47403067-47663146	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair"	DNA-binding	"Cancer-related genes, Disease variant, Hereditary nonpolyposis colorectal cancer, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Cancer enhanced"	"Detected in all"		"testis cancer: 46.2"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009572, HPA066845, CAB070867"	Approved		Supported	Nucleoplasm,Vesicles		NA	Yes		28000	"Cluster 48: NK-cells - Unknown function"	"Cluster 20: Retina & Lymphoid tissues - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	Vesicles	"CAB009572: AB_2144828, CAB070867: , HPA066845: AB_2732752"	"unprognostic (2.35e-1)"	"unprognostic (1.54e-2)"	"unprognostic (2.89e-3)"	"prognostic unfavorable (4.44e-4)"	"unprognostic (2.23e-1)"	"unprognostic (6.31e-3)"	"prognostic unfavorable (1.72e-9)"	"unprognostic (1.77e-1)"	"unprognostic (7.09e-3)"	"unprognostic (8.57e-2)"	"prognostic unfavorable (4.63e-4)"	"unprognostic (5.38e-2)"	"unprognostic (3.29e-3)"	"unprognostic (1.20e-3)"	"unprognostic (5.74e-1)"	"unprognostic (8.46e-2)"	"unprognostic (1.48e-1)"	8.1	7.5	8.3	12.8	10.5	15.7	15.7	14.6	10.6	9.7	12.2	11.9	7.8	11.7	14.0	9.5	12.4	5.8	10.1	9.6	9.0	8.2	6.7	8.1	23.7	8.6	8.0	8.7	6.5	14.8	6.2	11.6	9.5	8.6	15.0	34.9	8.5	7.7	7.1	11.1	9.3	8.8	8.5	10.8	8.1	16.2	7.9	32.6	15.8	7.2	25.0	7.9	6.4	8.9	114.3	35.3	103.3	57.9	7.3	21.2	64.3	62.9	33.3	80.9	76.9	72.3	50.1	141.2	84.6	23.8	56.6	49.8	78.6	37.4	122.3	68.1	55.8	99.3	42.3	65.6	7.7	97.7	34.9	12.3	11.2	68.1	19.0	19.1	45.2	3.9	165.1	34.0	63.1	44.2	119.6	75.4	195.7	69.3	45.1	151.1	182.2	84.4	35.8	57.3	85.9	91.6	58.4	49.2	48.0	83.6	46.9	38.8	18.7	55.5	70.9	57.1	74.6	20.8	63.4	180.1	33.1	72.5	35.4	3.0	1.3	4.9	8.0	4.4	9.3	6.7	7.7	10.3	2.5	7.9	12.6	13.1	1.0	14.2	3.9	3.4	11.8	6.5	8.3	10.5	14.6	10.6	9.6	9.0	8.6	8.0	9.5	8.5	7.9	8.9	14.7	9.6	11.5	18.6	13.0	8.3	7.9	14.4	8.6	17.4	7.5	7.1	15.6	5.7	12.6	9.2	45.9	19.9	14.2	6.6	3.9	11.5	17.8	21.0	11.3	13.4	3.5	54.1	59.9	8.4	20.7	12.2	7.1	18.8	12.0	28.2	5.0	1.6	11.4	11.8	58.0	12.1	14.2	4.1	4.6	22.8	5.3	5.1	8.8	16.9	5.5	22.6	17.5	35.7	54.7	7.3	5.0	6.4	12.4	2.8	5.4	4.5	23.3	41.1	0.0	9.8	9.0	56.5	50.8	9.3	6.5	5.1	12.8	24.3	13.5	3.8
MSH6	GTBP	ENSG00000116062	"MutS homolog 6"	P52701	2	47695530-47810063	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, Host-virus interaction"	DNA-binding	"Cancer-related genes, Disease variant, Hereditary nonpolyposis colorectal cancer"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Granulosa cells: 119.6;Theca cells: 114.9"	"Cancer enhanced"	"Detected in all"		"testis cancer: 31.8"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009091, HPA028376, HPA028446, CAB070870"	Enhanced		Supported	"Nucleoplasm,Golgi apparatus,Vesicles"		NA	Yes		15000	"Cluster 44: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 40: Granulosa cells - Unknown function"	Nucleoplasm	"Golgi apparatus, Vesicles"	"CAB009091: AB_670083, CAB070870: AB_2144959, HPA028376: AB_10598909, HPA028446: AB_10602182"	"unprognostic (5.10e-2)"	"unprognostic (5.87e-3)"	"unprognostic (3.29e-2)"	"prognostic unfavorable (1.34e-4)"	"unprognostic (1.98e-1)"	"unprognostic (3.09e-2)"	"prognostic unfavorable (7.86e-4)"	"unprognostic (1.79e-1)"	"unprognostic (2.35e-3)"	"unprognostic (1.01e-1)"	"unprognostic (1.74e-3)"	"unprognostic (8.99e-2)"	"prognostic unfavorable (1.06e-7)"	"unprognostic (1.22e-1)"	"unprognostic (2.31e-1)"	"unprognostic (9.68e-2)"	"unprognostic (3.48e-2)"	11.7	22.7	9.3	17.7	13.7	24.0	16.2	15.0	12.7	15.5	12.7	13.0	9.0	27.7	10.2	11.7	17.8	10.9	9.3	8.9	11.5	12.1	19.8	11.6	28.4	12.7	11.7	53.0	31.3	17.0	9.8	20.3	13.0	15.0	12.4	21.6	10.8	15.6	10.5	13.1	9.8	27.2	10.7	12.7	10.9	35.3	11.3	36.3	17.2	11.2	31.0	12.8	12.2	19.9	116.5	77.6	128.4	37.5	42.3	46.3	67.9	63.6	51.1	60.2	59.8	67.2	41.4	158.1	84.5	59.5	82.0	46.0	130.3	74.3	82.1	80.7	69.0	117.0	60.8	71.1	28.8	131.5	37.8	38.6	28.3	60.7	41.6	53.8	40.8	5.3	115.9	69.8	61.8	85.5	144.2	80.1	130.7	81.3	37.7	219.6	204.3	84.7	44.5	76.2	92.8	100.3	79.1	40.4	42.7	124.3	54.6	42.6	33.4	72.2	92.3	54.6	80.6	63.8	79.3	276.2	61.9	77.9	42.4	7.7	3.7	3.8	4.8	6.2	5.5	4.3	5.5	5.0	5.5	4.2	8.4	4.5	2.5	5.9	6.4	2.7	5.3	3.6	9.3	13.7	15.0	12.7	8.9	11.5	12.7	11.7	13.0	10.7	11.3	19.9	19.8	28.9	21.4	5.9	19.2	25.2	22.0	12.3	31.9	25.4	14.4	15.1	8.6	2.8	21.8	7.3	35.5	35.6	20.7	7.4	3.9	15.7	46.4	27.1	31.1	18.4	4.8	47.1	8.5	9.6	21.8	24.0	8.6	31.7	17.7	119.6	13.6	10.2	13.0	15.2	12.1	9.7	20.3	5.6	13.2	17.5	25.4	16.8	3.6	7.5	10.0	22.7	8.2	9.5	27.4	9.1	3.7	22.6	31.1	16.1	2.6	6.7	22.1	31.4	6.6	27.4	33.0	54.3	48.8	22.0	17.5	9.6	19.8	114.9	12.1	11.7
MSI2		ENSG00000153944	"Musashi RNA binding protein 2"	Q96DH6	17	57255851-57684689	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"		RNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Astrocytes: 830.2;Cone photoreceptor cells: 754.8;Rod photoreceptor cells: 500.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"REH: 184.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022300, HPA068990"	Approved		Supported	Cytosol		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 14: REH - Unknown function"	"Cluster 9: Photoreceptor cells - Phototransduction"	Cytosol		"CAB022300: , HPA068990: "	"unprognostic (4.73e-2)"	"unprognostic (2.28e-1)"	"unprognostic (3.42e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.08e-1)"	"unprognostic (4.20e-2)"	"unprognostic (2.20e-2)"	"unprognostic (4.89e-2)"	"unprognostic (2.96e-1)"	"unprognostic (4.17e-2)"	"unprognostic (1.18e-1)"	"prognostic favorable (9.22e-8)"	"prognostic favorable (2.00e-4)"	"unprognostic (4.87e-2)"	"unprognostic (1.57e-1)"	"unprognostic (2.72e-3)"	7.5	69.1	52.2	13.2	52.8	20.2	18.9	53.0	43.4	12.1	105.7	14.1	10.3	14.0	49.9	9.3	22.9	18.3	33.4	42.0	74.6	36.8	7.5	8.3	22.2	82.5	88.6	46.4	12.8	88.6	44.7	22.6	63.4	21.5	15.6	126.0	17.0	21.0	60.7	8.0	11.7	7.6	63.5	17.2	16.6	15.4	58.8	46.5	25.6	43.4	19.6	19.8	8.2	56.0	11.8	18.8	79.0	28.6	7.7	7.8	53.9	13.7	16.4	16.8	10.1	23.6	20.4	56.9	47.1	9.4	13.1	11.8	50.6	18.1	34.8	77.1	31.7	26.2	46.5	58.7	17.8	28.0	23.9	10.4	24.3	2.4	29.9	24.1	19.3	46.6	52.5	42.3	67.6	27.1	136.8	7.2	26.0	64.0	33.2	184.3	109.8	45.5	46.2	84.0	76.6	154.5	22.1	22.9	63.7	33.8	36.9	21.0	22.4	11.2	27.2	9.2	23.0	57.3	51.7	68.8	29.9	16.7	70.2	2.7	0.1	1.9	0.7	0.1	0.6	0.7	0.8	0.7	0.2	0.4	0.6	0.7	0.1	0.8	0.8	1.1	1.6	0.2	52.2	52.8	53.0	43.4	42.0	74.6	82.5	88.6	63.4	63.5	58.8	56.0	20.5	6.4	28.7	830.2	50.5	24.0	74.9	54.5	34.7	202.1	53.2	33.9	99.1	54.3	42.3	75.4	754.8	117.9	37.5	29.5	123.3	49.3	15.3	150.2	30.8	28.1	98.2	35.5	67.6	14.2	25.9	34.2	34.1	70.8	41.8	178.7	29.6	31.5	20.4	294.4	175.5	51.8	109.9	12.6	16.4	27.2	64.7	20.1	39.2	158.3	13.2	220.6	22.6	249.3	111.6	12.8	24.3	77.5	88.8	74.7	11.6	51.2	106.0	500.1	13.1	42.3	30.6	3.1	7.6	28.2	16.1	149.3	50.6	113.5	37.8	92.4
MSLN	"CAK1, MPF"	ENSG00000102854	Mesothelin	Q13421	16	760734-768865	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 93.4;fallopian tube: 278.2"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 189.1;Alveolar cells type 2: 85.6;Club cells: 121.9;Glandular and luminal cells: 57.1;Paneth cells: 214.4"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 343.4"	"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"myeloid DC: 5.9"	"Group enriched"	"Detected in many"	39	"dendritic cells: 5.9;monocytes: 1.8"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 513.4;EFO-21: 77.4;HeLa: 173.4;hTCEpi: 111.5;OE19: 96.4"	"Low region specificity"	"Detected in many"			"Region enriched"	"Detected in single"	9	"spinal cord: 1.7"	"CAB002216, HPA017172"	Enhanced		Supported	Nucleoplasm,Vesicles	"Intracellular and membrane"	NA	NA		17000000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Vesicles	Nucleoplasm	"CAB002216: AB_563874, HPA017172: AB_1853819"	"unprognostic (1.73e-1)"	"unprognostic (1.77e-1)"	"unprognostic (2.06e-2)"	"unprognostic (1.33e-1)"	"unprognostic (3.43e-2)"	"unprognostic (3.95e-2)"	"unprognostic (2.46e-1)"	"unprognostic (9.47e-2)"	"unprognostic (8.57e-2)"	"unprognostic (4.69e-2)"	"prognostic unfavorable (6.66e-4)"	"unprognostic (2.63e-1)"	"prognostic favorable (5.91e-4)"	"unprognostic (2.00e-2)"	"unprognostic (1.60e-1)"	"unprognostic (2.14e-2)"	"unprognostic (3.35e-2)"	93.4	0.2	0.7	1.1	1.0	3.2	0.5	0.6	1.5	15.9	0.3	8.9	7.1	6.2	24.1	7.1	278.2	16.4	8.4	0.7	0.8	6.5	0.2	71.8	0.2	1.9	1.2	3.7	0.9	0.1	0.7	2.7	1.3	3.8	4.0	0.7	39.3	9.9	0.0	1.4	2.9	3.4	1.0	0.4	13.0	1.1	1.2	0.8	0.2	0.0	27.2	2.9	2.9	1.0	0.4	2.1	0.0	1.0	0.0	0.0	2.3	0.3	7.7	8.7	2.0	7.4	513.4	0.0	77.4	0.7	0.1	1.3	0.0	0.7	0.7	0.2	0.3	0.0	173.4	5.9	4.4	0.2	0.1	0.0	111.5	0.0	2.0	7.8	0.0	0.1	0.0	0.0	0.0	0.8	0.1	0.1	0.6	96.4	0.8	0.2	0.2	0.6	2.4	0.1	0.1	0.0	29.7	0.1	0.0	0.1	0.7	0.0	0.0	0.4	12.1	0.1	0.0	0.3	0.3	0.4	0.0	0.0	0.6	0.0	0.1	0.0	0.0	1.0	0.0	0.0	0.0	0.0	5.9	0.0	0.0	0.0	0.0	0.0	1.8	0.1	0.0	0.3	0.7	1.0	0.6	1.5	0.7	0.8	1.9	1.2	1.3	1.0	1.2	1.0	0.0	189.1	85.6	0.0	0.0	0.3	3.0	49.0	0.0	1.4	0.3	0.3	1.6	52.9	121.9	25.8	0.0	0.2	0.0	4.1	0.0	9.3	1.6	35.8	3.3	0.7	3.0	0.0	0.0	0.9	0.0	4.6	0.0	57.1	0.0	0.0	0.4	0.1	2.9	0.0	0.0	1.6	22.4	1.0	1.9	7.4	4.7	3.7	1.8	1.0	4.4	0.0	0.0	0.0	0.0	33.0	214.4	0.0	1.4	3.3	1.7	0.1	54.2	0.6	0.0	0.0	2.8	0.6	0.7	0.5	0.1	0.1	1.3	0.0	3.1	50.8
MSMP	"PC-3, PSMP"	ENSG00000215183	"Microseminoprotein, prostate associated"	Q1L6U9	9	35752990-35756613	"Predicted intracellular proteins, Predicted secreted proteins"	"Chemotaxis, Inflammatory response"	Cytokine		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 1.5;choroid plexus: 1.1;pituitary gland: 1.5;placenta: 1.2"	"Group enriched"	"Detected in some"	50	"Early spermatids: 96.3;Late spermatids: 216.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"HUVEC TERT2: 85.7;PC-3: 108.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA055174	Uncertain		Supported	Vesicles,Cytosol	"Secreted in other tissues"	No	No		30000	"Cluster 10: Basophils - Unknown function"	"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 34: Spermatids - Unknown function"	Vesicles	Cytosol	"HPA055174: AB_2682726"																		0.2	0.0	0.6	0.2	0.3	0.0	0.1	0.4	0.8	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.3	0.1	0.0	0.1	0.2	1.5	0.4	0.0	0.0	0.0	1.5	1.2	0.9	0.0	0.1	0.2	0.0	0.0	0.5	0.1	0.0	0.0	0.6	0.0	0.0	0.1	0.3	0.0	0.2	0.4	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.1	85.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	108.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.3	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.3	0.0	0.0	0.1	0.1	0.6	0.3	0.4	0.8	0.3	0.3	1.5	0.4	0.9	0.6	0.3	0.4	1.3	0.0	1.1	0.0	1.1	0.4	1.0	0.0	0.0	0.1	0.3	0.3	0.0	0.0	0.1	0.0	0.0	0.4	0.1	0.1	0.0	1.4	96.3	0.6	0.1	3.1	0.0	0.0	0.0	2.0	0.2	0.3	0.0	0.2	0.0	0.5	2.5	0.0	0.1	0.0	0.1	0.3	0.0	0.0	0.8	216.6	0.3	0.1	1.8	0.0	0.0	0.4	0.0	0.0	0.0	1.8	0.1	0.7	0.1	1.5	0.0	0.4	0.2	0.5	0.0	0.0	0.1	0.8	0.5	0.0	0.1	0.3	0.2	0.1	0.3	1.3
MSRA		ENSG00000175806	"Methionine sulfoxide reductase A"	Q9UJ68	8	10054292-10428891	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 86.0;liver: 64.0"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 625.8;Inhibitory neurons: 318.6;Oligodendrocyte precursor cells: 268.9;Proximal tubular cells: 666.1"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in many"	5	"cerebellum: 28.4"	"Immune cell enhanced"	"Detected in some"		"eosinophil: 5.6"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HMC-1: 12.3"	"Low region specificity"	"Detected in all"							"HPA023804, HPA075766"	Approved		Supported	"Nucleoplasm,Plasma membrane,Actin filaments,Cytosol"	"Intracellular and membrane"	No	No		55000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 81: Kidney & Liver - Metabolism"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Nucleoplasm, Cytosol"	"Plasma membrane, Actin filaments"	"HPA023804: AB_1853826, HPA075766: "	"unprognostic (1.55e-1)"	"unprognostic (4.30e-3)"	"unprognostic (1.45e-3)"	"unprognostic (1.00e-2)"	"unprognostic (4.21e-2)"	"unprognostic (1.62e-2)"	"unprognostic (1.49e-2)"	"unprognostic (6.40e-2)"	"unprognostic (9.69e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.80e-1)"	"unprognostic (4.58e-2)"	"unprognostic (1.07e-3)"	"unprognostic (6.43e-3)"	"unprognostic (4.02e-1)"	"unprognostic (6.36e-3)"	"unprognostic (3.07e-1)"	17.0	20.4	2.2	1.1	3.0	13.5	16.1	28.4	5.4	9.1	0.0	13.9	1.1	10.7	0.1	11.6	7.4	0.4	29.0	3.8	0.0	86.0	64.0	12.2	0.6	0.0	0.4	6.4	14.5	0.7	9.2	0.8	1.8	9.2	0.6	0.6	10.5	1.0	14.5	9.5	20.1	0.8	0.0	18.6	14.2	15.2	0.3	1.5	9.6	1.3	0.6	11.6	8.2	2.8	0.1	0.9	1.3	4.3	1.2	1.4	0.5	2.5	0.2	0.3	1.7	0.6	2.1	0.0	0.6	2.5	5.8	2.3	0.4	0.1	1.3	0.2	0.0	0.3	1.5	2.2	4.3	0.8	12.3	0.4	3.2	0.3	0.0	1.4	0.6	0.3	0.4	0.2	4.9	0.1	0.0	0.3	0.6	3.3	0.8	1.6	1.3	2.0	1.1	1.1	2.5	1.5	4.6	0.2	0.5	0.4	2.3	2.8	2.6	1.7	2.0	0.4	1.2	0.2	0.1	0.7	4.8	0.8	3.1	0.5	1.9	5.6	0.4	1.2	0.3	0.6	0.4	0.3	1.2	0.1	0.3	0.2	2.2	0.7	0.9	0.2	0.3	0.2	2.2	3.0	28.4	5.4	3.8	0.0	0.0	0.4	1.8	0.0	0.3	2.8	44.1	0.0	7.4	152.8	21.4	16.4	29.3	10.8	14.2	10.1	21.2	21.8	21.6	25.8	7.2	25.8	31.3	7.7	12.4	26.4	92.0	32.3	80.6	13.6	8.7	30.3	9.6	3.4	625.8	47.1	4.6	13.1	14.8	11.8	80.7	13.7	19.6	97.2	47.0	16.8	318.6	20.8	4.1	33.6	48.3	167.9	9.3	38.0	30.2	85.3	22.3	14.6	11.3	268.9	60.7	51.1	37.8	9.8	16.2	33.8	195.5	666.1	5.6	6.2	13.1	11.3	16.9	39.3	26.5	20.1	14.1	8.3	18.0	14.1	24.5	31.1
MSX1	"HOX7, HYD1, OFC5"	ENSG00000163132	"Msh homeobox 1"	P28360	4	4859665-4863936	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding, Repressor"	"Disease variant, Ectodermal dysplasia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix: 57.0;choroid plexus: 98.0"	"Group enriched"	"Detected in many"	6	"Adipocytes: 118.4;Endometrial ciliated cells: 364.0;Glandular and luminal cells: 462.0"	"Cancer enriched"	"Detected in all"	17	"endometrial cancer: 246.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"CACO-2: 47.9;EFO-21: 21.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB026198, HPA063895, HPA073604"	Enhanced		Supported	Nucleoplasm		NA	NA				"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm		"CAB026198: , HPA063895: AB_2685145, HPA073604: AB_2686617"	"unprognostic (1.12e-1)"	"unprognostic (1.93e-2)"	"unprognostic (3.39e-2)"	"prognostic favorable (1.64e-7)"	"unprognostic (9.13e-2)"	"unprognostic (1.16e-3)"	"unprognostic (4.07e-3)"	"unprognostic (3.81e-2)"	"unprognostic (1.48e-2)"	"unprognostic (2.21e-3)"	"unprognostic (4.78e-2)"	"unprognostic (1.17e-1)"	"prognostic unfavorable (1.18e-5)"	"unprognostic (4.35e-2)"	"unprognostic (2.06e-1)"	"unprognostic (2.34e-3)"	"unprognostic (1.33e-2)"	18.4	6.0	12.2	0.7	11.8	0.2	12.8	12.2	16.9	57.0	98.0	1.8	0.5	17.5	0.3	0.9	9.6	1.3	10.3	18.8	12.2	2.9	0.5	4.3	0.6	17.2	11.8	3.5	2.3	0.4	21.1	4.1	11.8	5.5	0.1	0.6	8.8	3.6	20.1	5.2	1.1	3.2	15.1	4.5	2.0	0.7	13.0	0.2	9.2	2.0	0.4	11.2	14.5	12.3	2.5	1.5	0.5	2.8	8.0	5.1	8.9	6.1	2.8	3.5	1.7	47.9	15.3	0.3	21.4	4.4	17.0	0.1	10.6	0.0	1.2	2.0	12.2	0.1	8.0	17.4	0.6	0.1	1.4	1.0	0.8	2.6	0.9	1.1	0.8	4.1	7.9	0.3	1.9	1.2	1.3	2.4	0.2	0.7	11.1	6.4	6.4	0.6	0.2	1.5	0.4	0.3	5.4	0.3	4.0	0.8	0.9	2.1	2.0	4.1	9.1	13.0	9.9	1.0	0.9	5.7	2.6	3.1	4.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	12.2	11.8	12.2	16.9	18.8	12.2	17.2	11.8	11.8	15.1	13.0	12.3	118.4	0.0	0.0	17.3	0.5	7.1	2.4	0.3	4.6	0.8	8.6	24.3	5.5	0.0	0.0	0.0	4.2	0.3	1.6	3.9	0.0	0.2	0.4	364.0	35.7	48.1	0.0	0.0	1.1	0.9	0.1	34.8	1.1	462.0	0.0	1.1	5.7	0.2	0.5	0.0	1.2	2.5	0.0	0.6	8.8	0.0	1.2	4.4	16.0	3.7	0.0	0.7	0.0	1.0	0.3	0.3	0.1	0.4	1.6	3.3	0.6	0.5	0.0	0.7	0.0	13.6	18.2	0.8	1.5	2.6	4.7	0.3	4.8	14.6	2.6	2.0
MSX2	"CRS2, FPP, HOX8, MSH, PFM, PFM1"	ENSG00000120149	"Msh homeobox 2"	P35548	5	174724582-174730896	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Osteogenesis, Transcription, Transcription regulation"	"Developmental protein, DNA-binding, Repressor"	"Craniosynostosis, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"parathyroid gland: 25.8;placenta: 33.6;urinary bladder: 17.5"	"Group enriched"	"Detected in many"	6	"Cytotrophoblasts: 162.6;Endometrial ciliated cells: 65.7;Glandular and luminal cells: 62.2;Syncytiotrophoblasts: 233.8"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 18.6"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in many"	5	"BEWO: 322.0"	"Region enriched"	"Detected in some"	5	"cerebellum: 6.2"	"Low region specificity"	"Detected in many"			HPA005652	Uncertain		Supported	"Nuclear speckles"		NA	NA				"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Nuclear speckles"		"HPA005652: AB_1079418"	"unprognostic (1.29e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.84e-1)"	"prognostic favorable (8.43e-5)"	"unprognostic (2.50e-2)"	"unprognostic (1.22e-2)"	"unprognostic (3.13e-1)"	"prognostic unfavorable (6.93e-4)"	"unprognostic (2.08e-2)"	"unprognostic (1.60e-1)"	"unprognostic (2.51e-2)"	"unprognostic (7.26e-2)"	"unprognostic (1.36e-4)"	"unprognostic (7.64e-3)"	"unprognostic (5.06e-2)"	"unprognostic (2.12e-6)"	"unprognostic (1.43e-2)"	2.1	0.3	0.7	0.5	1.0	0.0	8.1	4.3	1.1	2.7	1.1	0.9	0.3	6.8	0.0	0.6	0.9	0.9	1.6	1.2	1.4	0.3	0.0	0.8	0.1	7.8	1.3	0.2	0.4	25.8	0.3	33.6	4.1	2.5	0.1	0.0	0.8	0.8	1.9	6.9	0.8	1.4	5.4	0.8	2.8	5.6	1.3	0.1	0.7	1.8	0.1	17.5	1.8	5.4	0.4	4.0	1.1	3.2	0.0	0.0	322.0	2.2	3.6	0.7	0.1	56.6	23.0	0.0	8.6	0.2	19.6	6.2	17.6	6.4	0.2	0.0	10.7	0.0	1.4	0.0	2.4	0.0	3.0	3.7	4.5	3.1	3.5	0.0	0.0	0.0	0.0	0.0	5.0	27.7	0.0	0.4	2.5	38.3	8.5	0.0	8.8	0.1	4.0	35.3	0.0	2.5	0.0	43.0	2.9	69.6	25.7	0.2	0.0	1.1	5.5	17.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	1.0	4.3	1.1	1.2	1.4	7.8	1.3	4.1	5.4	1.3	5.4	1.5	0.0	0.0	2.3	0.0	9.6	2.4	0.1	3.4	0.2	15.8	18.9	1.7	0.0	0.1	0.0	0.0	162.6	0.2	0.3	0.0	0.6	0.2	65.7	4.9	0.7	0.0	0.0	0.0	0.0	13.9	5.3	5.1	62.2	4.5	0.1	0.4	0.0	11.3	0.0	0.0	1.9	0.0	0.6	2.9	0.6	0.0	1.0	1.8	0.0	0.0	1.6	0.0	0.0	0.0	1.0	0.0	0.0	0.1	2.3	1.9	0.1	0.1	0.0	0.0	8.9	4.8	1.4	4.5	2.0	11.4	233.8	1.0	0.6	1.2	9.8
MT-CO1	"COI, COX1, MTCO1"	ENSG00000198804	"Mitochondrially encoded cytochrome c oxidase I"	P00395	MT	5904-7445	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Electron transport, Respiratory chain, Transport"	Translocase	"Deafness, Disease variant, Leber hereditary optic neuropathy, Non-syndromic deafness, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 222644.8;heart muscle: 255389.3"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 107039.5;Hepatocytes: 59794.3;Proximal enterocytes: 98329.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HeLa: 54167.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016241, HPA069328"	Enhanced		Supported	Mitochondria		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 20: HeLa - Mitochondria"	"Cluster 54: Cardiomyocytes - Muscle contraction"	Mitochondria		"CAB016241: AB_2229888, HPA069328: AB_2686122"	"unprognostic (4.39e-1)"	"unprognostic (2.45e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.21e-1)"	"unprognostic (1.59e-1)"	"unprognostic (3.31e-1)"	"prognostic favorable (2.29e-4)"	"unprognostic (8.28e-2)"	"unprognostic (1.01e-1)"	"unprognostic (5.56e-3)"	"unprognostic (1.20e-2)"	"unprognostic (6.60e-2)"	"unprognostic (2.83e-2)"	"unprognostic (5.06e-3)"	"unprognostic (4.50e-2)"	"unprognostic (2.15e-2)"	"unprognostic (2.44e-2)"	22006.8	46968.9	171347.0	8727.7	151652.8	11321.8	17952.5	132201.9	222644.8	10440.9	179120.2	42606.0	27505.7	11582.9	14226.0	20791.8	10700.5	11452.7	255389.3	151507.6	137459.2	63061.8	96575.5	12744.7	9111.4	176794.8	152802.2	8124.5	19467.4	41236.2	7420.2	10527.8	168465.9	12427.0	28389.7	12503.0	23260.1	17753.2	147209.5	26849.0	35366.3	13146.2	138626.1	16284.7	44852.9	10932.5	176888.2	7461.1	14056.3	184587.7	8381.2	17415.3	10559.7	131378.4	5837.6	8554.3	11384.1	12431.0	25510.2	11563.1	12037.2	12867.2	4284.9	3189.4	5257.4	10383.6	18320.5	15138.9	6040.7	9857.6	3118.2	21430.9	1326.6	11407.4	4515.1	7226.0	8040.6	9130.6	54167.9	19725.4	3521.2	5336.1	11055.5	13603.9	11589.8	3149.9	6917.5	14668.4	3902.1	8485.5	5916.3	10551.1	9525.6	14037.0	4378.4	23591.9	2905.0	7814.2	6900.5	5664.0	3401.6	9177.9	15910.6	15016.1	5414.7	7189.1	4466.7	17018.9	8305.7	13626.1	9809.7	17703.3	15637.8	12617.8	8438.9	12565.9	6642.1	4951.2	5072.9	3542.6	6235.7	13711.8	6294.4	5305.8	9759.2	3824.6	3085.1	4907.9	3420.5	5374.6	3047.3	3425.6	3444.6	5567.3	3080.8	3911.2	1900.4	3759.1	5775.1	4847.5	2947.7	3929.0	171347.0	151652.8	132201.9	222644.8	151507.6	137459.2	176794.8	152802.2	168465.9	138626.1	176888.2	131378.4	3924.0	2900.6	3897.1	0.0	13282.9	9769.7	9713.9	22625.0	20857.7	0.0	12033.2	11841.6	107039.5	30777.5	16135.4	19596.3	0.0	0.0	9288.4	40726.1	4255.4	7191.4	1555.3	13044.7	9033.9	7847.9	7514.7	45610.3	0.0	5089.4	0.0	6305.3	19235.7	25645.6	3832.6	20400.0	25951.4	59794.3	0.0	0.0	0.0	24302.1	19071.0	45533.4	7744.0	7398.4	11696.4	12124.7	6894.2	0.0	15180.0	0.0	8901.3	0.0	0.0	6410.5	23865.9	8490.1	13829.3	9441.3	98329.8	33652.6	10474.0	0.0	13614.6	11019.8	9403.5	12096.5	14338.7	27110.9	11475.1	0.0	11502.4	15179.6	27138.6	21770.7
MT-CYB	"COB, CYTB, MTCYB, UQCR3"	ENSG00000198727	"Mitochondrially encoded cytochrome b"	P00156	MT	14747-15887	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted membrane proteins"	"Electron transport, Respiratory chain, Transport"		"Cardiomyopathy, Cataract, Deafness, Disease variant, Leber hereditary optic neuropathy, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 130283.4"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 87067.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"ASC diff: 14365.7;HeLa: 18945.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB032215, HPA068400, HPA074796"	Approved		Supported	Mitochondria		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 20: HeLa - Mitochondria"	"Cluster 54: Cardiomyocytes - Muscle contraction"	Mitochondria		"CAB032215: AB_2261378, HPA068400: AB_2685982, HPA074796: "	"unprognostic (4.50e-1)"	"unprognostic (2.56e-1)"	"unprognostic (9.12e-2)"	"unprognostic (3.88e-2)"	"unprognostic (9.22e-2)"	"unprognostic (3.50e-1)"	"prognostic favorable (5.96e-4)"	"unprognostic (1.63e-2)"	"unprognostic (8.53e-2)"	"unprognostic (1.49e-2)"	"unprognostic (1.01e-3)"	"unprognostic (6.09e-2)"	"unprognostic (1.40e-1)"	"unprognostic (7.90e-3)"	"unprognostic (3.07e-1)"	"unprognostic (4.09e-2)"	"unprognostic (1.54e-2)"	17885.7	25075.8	39972.4	2636.6	41108.8	2926.5	15122.5	36592.4	54341.4	6621.5	47885.4	19364.4	8941.2	7119.4	6555.4	10592.2	7498.6	3433.7	130283.4	39044.7	39534.1	60620.7	59133.6	6549.1	2529.8	46506.6	40032.7	6068.7	15418.7	9106.2	11552.0	5320.4	42841.1	15142.5	8793.2	8513.5	12205.1	7331.2	52625.7	13392.0	17520.7	5804.8	34579.6	7362.7	25263.2	7372.2	41908.6	1737.2	9758.2	63751.5	3582.0	12844.4	7620.0	35340.5	2322.4	3039.1	3687.6	3950.3	14365.7	2287.8	2963.8	2587.3	1076.5	668.0	1136.3	3013.8	4943.2	5840.7	1240.7	3087.3	794.6	7063.3	556.2	3180.7	1613.0	2880.4	2458.9	3277.0	18945.0	5461.7	2697.8	1862.5	3828.3	4981.3	4631.2	1257.6	2679.7	4457.1	1715.5	2341.4	1709.0	3565.6	3417.2	6354.8	1735.3	3789.4	824.1	2230.7	2036.7	2028.2	1449.8	3681.4	5134.1	5275.9	1308.0	2302.7	1802.1	3352.1	2587.4	5497.2	4911.1	6332.5	5398.3	2302.7	2984.2	4256.3	2037.2	972.6	1390.1	2557.4	1385.7	2822.6	1485.0	8811.6	3750.4	4806.7	1834.1	1738.1	2355.1	2806.2	2123.9	2376.2	1485.5	3034.9	2241.0	2781.9	2755.9	1680.5	1944.8	1468.0	1511.0	1612.6	39972.4	41108.8	36592.4	54341.4	39044.7	39534.1	46506.6	40032.7	42841.1	34579.6	41908.6	35340.5	3091.7	1185.9	1390.0	0.0	5710.5	3319.9	7605.2	9945.0	8512.3	0.0	4026.8	5510.1	87067.0	11564.1	5338.9	7470.6	0.0	0.0	3723.1	10971.1	2163.9	2555.0	789.7	9063.7	5550.2	5673.6	2863.2	16130.5	0.0	3523.1	0.0	4692.6	4895.1	15794.2	1889.0	16261.2	9871.2	17132.6	0.0	0.0	0.0	9502.4	5486.9	14290.0	2254.1	3983.1	7943.2	4269.6	2612.9	0.0	4118.1	0.0	2612.8	0.0	0.0	2977.1	8823.6	5402.0	5725.9	4425.8	25108.7	14736.3	4210.2	0.0	5798.2	9579.6	5914.9	4807.6	4136.3	9142.3	3422.9	0.0	5502.2	11093.2	10319.6	9796.7
MT-ND4	"LHON, MTND4, NAD4, ND4"	ENSG00000198886	"Mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 4"	P03905	MT	10760-12137	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins"	"Electron transport, Respiratory chain, Transport"	Translocase	"Disease variant, Dystonia, Leber hereditary optic neuropathy, MELAS syndrome, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 196536.0"	"Cell type enriched"	"Detected in many"	7	"Cardiomyocytes: 253563.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 13456.8"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HeLa: 41594.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053928	Approved		Supported	Mitochondria		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 20: HeLa - Mitochondria"	"Cluster 54: Cardiomyocytes - Muscle contraction"	Mitochondria		"HPA053928: AB_2682313"	"unprognostic (8.39e-2)"	"unprognostic (1.83e-1)"	"unprognostic (7.29e-2)"	"unprognostic (9.54e-2)"	"unprognostic (5.41e-2)"	"unprognostic (3.78e-2)"	"unprognostic (2.50e-3)"	"unprognostic (8.16e-2)"	"unprognostic (1.45e-1)"	"prognostic favorable (1.76e-4)"	"unprognostic (1.01e-2)"	"unprognostic (7.23e-2)"	"unprognostic (2.79e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.43e-1)"	"unprognostic (3.14e-2)"	"unprognostic (4.24e-2)"	23701.9	43566.1	86386.5	4193.8	83474.8	3652.7	19363.5	76852.9	119139.4	8711.6	100909.6	30312.4	11021.5	10764.3	6795.9	15885.7	10624.6	4622.9	196536.0	81116.7	85290.4	76204.1	101401.1	11855.8	3820.4	102081.7	90689.2	8957.6	21476.2	15709.9	12834.3	7692.4	97098.9	22214.5	15007.9	14112.1	17508.5	11691.2	61489.1	18268.8	25046.6	7116.7	75024.9	12782.7	39594.1	13571.1	91494.4	3233.7	14785.3	70605.7	4913.1	19417.4	10309.3	74806.7	4251.7	4285.9	5449.6	8075.1	12523.6	3123.1	3808.6	4184.0	1603.2	958.4	1834.2	6555.4	4688.4	7428.4	3608.7	3590.8	1396.3	7685.0	496.1	6777.9	1691.7	4330.2	2654.6	4592.7	41594.9	11166.3	1884.9	4672.8	5223.9	5330.2	7007.6	1403.3	4977.9	8925.4	2344.4	3683.1	3908.9	8930.2	3461.9	9508.0	1848.1	10481.0	1551.2	3650.3	2876.4	2481.0	1712.1	4518.2	6770.1	8938.3	1999.0	2694.8	2434.3	7967.3	4267.8	9600.3	5601.2	10888.7	6532.2	3851.7	3726.9	5232.7	3330.8	5307.6	2292.6	3407.7	2514.1	7881.4	2100.8	13456.8	3334.1	7103.1	1902.0	2192.8	2614.3	3555.5	2129.5	2285.7	1616.0	3624.4	2452.9	3095.1	2513.1	2106.5	2329.2	2112.6	1668.2	1840.0	86386.5	83474.8	76852.9	119139.4	81116.7	85290.4	102081.7	90689.2	97098.9	75024.9	91494.4	74806.7	3065.0	1269.2	1516.1	0.0	6183.3	4404.5	9073.3	7719.8	2713.0	0.0	6210.4	6965.6	253563.4	15377.3	4975.3	12806.1	0.0	0.0	4005.7	20185.0	2435.8	2924.2	1109.7	6731.7	4298.6	9316.2	5090.0	20898.0	0.0	4058.3	0.0	5843.3	5601.5	11920.4	2188.6	15486.9	13931.3	35046.7	0.0	0.0	0.0	14557.8	5771.7	22254.8	3452.7	5132.5	8834.9	4749.3	3799.3	0.0	6280.7	0.0	4212.2	0.0	0.0	3710.0	12363.2	5788.3	3409.4	5872.9	28978.7	17714.1	4527.9	0.0	6310.9	8264.3	7732.9	6461.4	6003.0	3008.8	4937.6	0.0	5125.3	7671.5	15595.2	11405.7
MTA1		ENSG00000182979	"Metastasis associated 1"	Q13330	14	105419820-105470729	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB004508, HPA005544"	Supported		Enhanced	Nucleoplasm,Cytosol		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 35: Non-specific - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 30: Mammary glandular cells - Lactation"	Nucleoplasm	Cytosol	"CAB004508: AB_627969, HPA005544: AB_1079420"	"unprognostic (6.79e-3)"	"unprognostic (4.22e-2)"	"unprognostic (1.06e-1)"	"unprognostic (6.36e-2)"	"unprognostic (2.91e-2)"	"unprognostic (7.74e-2)"	"prognostic unfavorable (4.62e-4)"	"unprognostic (6.59e-2)"	"unprognostic (1.47e-1)"	"unprognostic (6.72e-3)"	"prognostic favorable (9.48e-5)"	"unprognostic (4.57e-3)"	"unprognostic (1.39e-2)"	"unprognostic (2.88e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.18e-1)"	23.1	23.8	24.1	10.8	23.4	15.4	24.6	23.7	31.0	31.7	19.4	31.2	13.1	29.9	11.6	22.6	31.8	6.2	39.2	24.1	20.1	24.7	24.1	19.6	12.1	22.2	21.5	38.6	30.1	9.4	36.9	9.2	20.1	31.8	5.6	8.3	23.6	12.7	25.6	21.1	22.1	9.0	20.0	26.7	22.5	37.6	22.5	16.5	30.4	7.7	9.1	29.2	24.4	22.3	33.6	26.3	47.9	48.2	18.0	30.5	42.3	26.2	19.9	25.4	24.3	34.4	44.1	65.4	26.7	19.3	17.9	45.3	35.1	25.0	17.1	43.2	59.0	34.1	25.2	35.5	39.6	43.2	25.3	34.4	30.9	18.0	41.1	35.5	36.4	48.0	39.3	27.7	13.4	60.4	78.3	85.2	69.1	47.7	55.1	73.1	29.1	21.5	20.6	26.0	76.9	80.1	35.5	40.5	40.8	24.3	36.7	40.7	26.6	20.4	21.6	34.1	27.8	55.9	28.9	41.3	25.6	28.7	36.6	0.1	0.2	0.8	0.3	0.2	0.3	0.3	0.2	0.2	0.2	0.3	0.3	0.4	0.0	0.4	0.1	0.9	0.2	0.2	24.1	23.4	23.7	31.0	24.1	20.1	22.2	21.5	20.1	20.0	22.5	22.3	32.1	3.2	16.0	37.9	20.9	15.6	28.8	14.6	13.1	0.0	64.8	38.6	9.2	27.1	15.2	35.0	0.0	11.6	17.7	17.2	17.6	13.2	32.8	25.0	28.4	20.4	18.6	25.4	17.2	19.6	8.0	21.8	28.1	23.9	5.7	47.6	18.2	15.5	11.0	0.0	16.1	21.6	10.2	18.5	13.5	11.3	36.1	15.7	12.4	21.5	13.8	0.0	20.6	32.6	27.0	16.3	11.5	32.0	17.8	45.4	18.5	8.8	27.0	0.0	19.7	30.5	25.4	21.5	13.3	16.8	19.0	9.3	18.7	27.1	24.9	46.2
MTA3	KIAA1266	ENSG00000057935	"Metastasis associated 1 family member 3"	Q9BTC8	2	42494569-42756947	"Plasma proteins, Predicted intracellular proteins, Transcription factors"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 70.4"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 137.0;Oligodendrocyte precursor cells: 106.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039433	Approved		Supported	Nucleoplasm,Vesicles		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 63: T-cells - Adaptive immune response"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Nucleoplasm	Vesicles	"HPA039433: AB_10794747"	"unprognostic (5.40e-2)"	"unprognostic (4.89e-2)"	"unprognostic (5.28e-2)"	"prognostic unfavorable (2.30e-4)"	"unprognostic (4.13e-2)"	"unprognostic (2.88e-1)"	"prognostic unfavorable (4.69e-4)"	"unprognostic (7.55e-2)"	"unprognostic (2.04e-1)"	"unprognostic (5.43e-2)"	"unprognostic (2.27e-1)"	"unprognostic (1.58e-1)"	"unprognostic (2.64e-2)"	"unprognostic (9.03e-2)"	"unprognostic (2.05e-1)"	"unprognostic (3.47e-1)"	"unprognostic (1.28e-2)"	11.8	41.8	16.4	5.6	18.9	1.6	14.9	9.1	19.4	18.5	7.1	16.6	7.8	16.8	27.5	21.8	16.1	10.0	12.4	21.9	14.9	13.6	7.9	8.8	10.7	12.3	13.9	29.2	18.8	17.3	15.1	15.3	18.8	14.4	13.2	9.3	13.6	16.8	9.1	19.1	11.4	12.0	11.7	7.8	16.8	21.0	16.1	70.4	12.6	9.9	14.5	15.3	17.8	14.8	13.0	16.6	20.1	14.3	17.4	28.0	46.6	7.4	18.6	21.7	19.2	22.2	26.2	45.4	12.6	22.1	15.9	8.2	51.6	25.2	34.2	14.1	21.0	6.7	8.8	36.4	21.9	5.0	29.0	29.5	29.1	13.4	16.6	28.1	30.4	23.9	16.5	6.1	25.7	27.8	30.3	22.0	84.4	20.8	9.7	18.4	18.9	0.0	25.7	12.1	12.3	37.1	13.5	45.5	17.8	61.6	23.2	7.0	14.2	8.9	12.1	7.2	8.1	11.5	4.7	63.5	12.6	5.7	11.1	2.5	0.9	0.0	1.7	0.6	2.6	1.2	2.0	2.9	1.5	1.3	4.4	3.0	0.2	1.8	0.9	0.4	1.1	1.5	16.4	18.9	9.1	19.4	21.9	14.9	12.3	13.9	18.8	11.7	16.1	14.8	12.7	12.8	12.5	60.4	10.8	15.3	21.1	33.0	15.4	0.0	24.6	19.6	12.5	15.7	25.7	22.0	0.0	58.5	5.1	19.1	17.6	22.9	10.7	44.5	23.1	13.1	9.6	2.5	137.0	28.0	42.0	21.7	31.1	32.3	12.0	72.3	20.7	13.3	12.4	0.0	81.8	20.0	50.8	6.6	7.1	26.0	33.8	5.2	17.8	53.4	6.9	0.0	9.2	106.1	65.9	20.2	21.8	39.9	10.9	17.7	25.2	33.1	18.4	0.0	13.1	15.8	35.9	25.5	41.1	24.5	18.3	59.9	12.6	44.5	21.5	17.3
MTAP	"c86fus, MSAP"	ENSG00000099810	"Methylthioadenosine phosphorylase"	Q13126	9	21802636-21937651	"Disease related genes, Enzymes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Purine salvage"	"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046915, CAB080036, CAB080037"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA		3000000	"Cluster 15: NK-cells - Transcription"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 22: Epithelial cell types - Mixed function"	Cytosol	Nucleoplasm	"CAB080036: AB_11128130, CAB080037: AB_11129069, HPA046915: AB_2679862"	"unprognostic (1.40e-2)"	"unprognostic (1.83e-1)"	"unprognostic (2.21e-1)"	"unprognostic (2.58e-3)"	"unprognostic (2.78e-1)"	"unprognostic (6.16e-2)"	"prognostic unfavorable (4.68e-4)"	"unprognostic (9.47e-2)"	"unprognostic (2.03e-1)"	"unprognostic (8.63e-2)"	"unprognostic (4.76e-3)"	"unprognostic (4.27e-2)"	"unprognostic (6.28e-3)"	"unprognostic (2.18e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.85e-1)"	5.9	6.5	4.1	5.4	4.8	5.8	8.5	4.2	5.7	7.8	7.6	6.7	4.8	8.8	7.1	8.8	7.1	4.9	7.0	3.8	4.0	6.9	10.9	5.8	6.3	5.0	4.5	12.1	6.6	8.4	2.8	8.9	5.1	7.2	8.0	3.9	6.5	7.0	4.5	7.0	5.9	9.0	4.0	7.3	7.2	2.9	5.4	6.8	7.2	5.4	7.3	10.1	7.4	6.0	30.4	1.0	23.0	19.0	19.4	19.0	28.3	42.3	21.0	21.9	24.3	21.7	14.6	15.3	13.4	21.1	16.3	15.2	24.4	59.5	36.8	0.3	19.8	0.3	56.8	28.8	18.6	24.5	26.3	23.5	0.1	38.6	42.6	24.4	22.6	0.5	0.3	20.1	21.9	3.1	26.8	0.7	27.5	14.7	35.2	0.4	18.0	26.0	18.3	0.4	14.4	15.3	14.4	17.1	21.1	17.9	10.9	0.6	23.8	0.3	15.7	0.2	34.4	13.7	25.5	30.0	0.2	24.3	12.0	1.2	5.6	0.2	3.6	4.5	6.1	5.9	5.3	4.2	6.9	8.4	4.6	4.2	0.7	6.7	2.9	6.3	3.2	2.7	4.1	4.8	4.2	5.7	3.8	4.0	5.0	4.5	5.1	4.0	5.4	6.0	18.8	22.4	19.8	26.1	16.3	14.1	58.4	22.4	16.5	0.0	20.2	23.9	22.4	24.3	27.9	14.7	0.0	52.3	11.4	6.8	15.6	38.6	77.9	28.8	28.5	14.9	9.6	19.1	14.8	28.0	80.0	18.7	15.3	40.6	10.8	30.0	17.5	22.2	27.1	0.0	9.1	14.3	30.5	25.5	11.1	14.8	14.9	15.1	10.6	48.7	15.0	0.0	10.3	40.7	32.9	41.5	6.8	14.7	13.7	45.0	9.2	19.5	19.1	0.0	13.1	20.6	23.1	1.3	13.9	35.1	13.1	22.6	15.1	33.0	20.7	62.9
MTARC1	"FLJ22390, MARC1, MOSC1"	ENSG00000186205	"Mitochondrial amidoxime reducing component 1"	Q5VT66	1	220786913-220819659	"Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adipose tissue: 192.3;breast: 86.2;liver: 84.5"	"Group enriched"	"Detected in some"	6	"Cytotrophoblasts: 109.8;Extravillous trophoblasts: 47.9;Syncytiotrophoblasts: 75.1"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 14.3"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	12	"basophil: 30.2;classical monocyte: 33.6;eosinophil: 12.3;neutrophil: 42.8"	"Group enriched"	"Detected in many"	31	"granulocytes: 42.8;monocytes: 33.6"	"Cell line enhanced"	"Detected in many"		"BEWO: 126.5;HeLa: 56.2;Hep G2: 67.6;NTERA-2: 57.8;OE19: 49.4"									HPA028702	Approved		Supported	Mitochondria		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 47: Cytotrophoblasts - Unknown function"	Mitochondria		"HPA028702: AB_10601135"	"unprognostic (3.15e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.16e-2)"	"unprognostic (5.04e-2)"	"unprognostic (2.90e-1)"	"unprognostic (2.31e-1)"	"unprognostic (3.71e-3)"	"unprognostic (1.39e-1)"	"unprognostic (7.51e-2)"	"unprognostic (7.71e-3)"	"unprognostic (3.71e-1)"	"unprognostic (4.30e-1)"	"prognostic unfavorable (4.51e-4)"	"unprognostic (3.85e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.50e-1)"	192.3	7.4	9.4	6.8	10.5	17.9	86.2	9.8	13.2	7.9	7.9	18.9	7.6	2.8	14.0	7.6	6.2	4.1	8.4	10.0	11.7	10.2	84.5	9.3	2.8	10.1	11.8	5.5	9.6	5.4	7.0	16.0	9.6	36.2	17.3	5.7	27.2	13.5	11.0	3.6	9.7	4.0	9.1	10.2	9.3	1.4	14.3	1.6	53.5	9.2	2.1	8.8	5.0	8.5	15.0	7.8	5.9	0.2	1.3	0.3	126.5	1.4	1.2	0.8	1.5	45.4	1.0	0.1	5.3	1.6	0.1	0.1	28.3	2.9	2.1	0.2	25.7	0.1	56.2	67.6	2.7	0.3	0.5	4.5	1.3	0.2	0.0	0.2	1.1	0.1	4.3	0.3	1.1	14.7	0.1	31.9	57.8	49.4	23.8	0.1	0.0	0.3	7.1	17.4	16.4	36.1	8.1	11.4	0.2	16.4	38.5	34.7	0.4	0.1	12.6	0.1	0.1	0.2	0.1	0.1	0.2	0.0	1.1	30.2	33.6	12.3	0.1	2.5	0.0	0.4	0.0	0.0	1.2	0.2	0.1	0.0	42.8	0.0	1.3	0.3	0.0	9.2	9.4	10.5	9.8	13.2	10.0	11.7	10.1	11.8	9.6	9.1	14.3	8.5	11.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.8	0.0	0.0	0.0	0.0	109.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	47.9	0.7	0.0	0.0	0.0	0.0	0.0	0.0	11.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	75.1	0.0	0.0	0.0	0.0
MTERF1	MTERF	ENSG00000127989	"Mitochondrial transcription termination factor 1"	Q99551	7	91692008-91880702	"Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation, Transcription termination"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA044894, HPA069560"	Uncertain		Supported	Mitochondria		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 34: Non-specific - Transcription"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 59: Non-specific - Transcription"	Mitochondria		"HPA044894: AB_10966284, HPA069560: AB_2686154"	"unprognostic (5.57e-2)"	"unprognostic (7.31e-2)"	"unprognostic (2.15e-2)"	"unprognostic (1.50e-2)"	"unprognostic (2.55e-1)"	"unprognostic (1.81e-1)"	"unprognostic (3.15e-3)"	"unprognostic (1.25e-2)"	"unprognostic (1.46e-3)"	"unprognostic (7.62e-2)"	"unprognostic (2.67e-1)"	"unprognostic (5.19e-2)"	"unprognostic (3.21e-2)"	"unprognostic (1.14e-1)"	"unprognostic (3.90e-2)"	"unprognostic (2.67e-1)"	"unprognostic (2.22e-3)"	4.7	6.1	4.0	7.9	5.1	10.1	9.2	4.7	5.1	5.5	4.1	7.6	7.0	7.0	7.6	7.3	5.9	5.4	5.9	4.2	5.2	8.4	11.3	5.2	14.0	4.5	4.1	8.3	5.9	6.5	5.0	7.1	5.0	6.1	7.8	6.5	7.5	5.9	5.0	6.3	6.8	6.1	4.1	9.7	8.1	6.6	4.8	11.4	7.5	8.9	13.3	5.7	5.8	6.8	17.3	15.0	13.3	9.0	12.2	13.9	12.6	14.2	14.3	15.8	19.6	16.9	17.7	36.8	11.9	11.0	21.3	15.2	21.3	13.4	23.9	1.9	14.5	16.1	17.2	13.4	11.6	29.3	15.7	17.2	16.3	15.8	18.5	11.4	12.9	8.1	31.2	15.0	18.1	22.2	31.5	27.0	22.2	20.1	16.5	9.3	19.2	23.4	15.8	17.5	12.8	23.4	13.9	30.1	29.0	24.3	10.9	19.4	9.5	18.4	22.2	25.4	14.9	19.4	21.9	48.7	13.0	9.4	26.9	46.0	12.9	18.5	14.6	11.2	18.5	22.0	19.2	21.9	14.1	23.9	26.1	20.7	6.2	16.1	13.5	11.2	20.1	15.1	4.0	5.1	4.7	5.1	4.2	5.2	4.5	4.1	5.0	4.1	4.8	6.8	5.5	9.6	10.6	6.2	10.5	0.0	3.9	0.0	14.8	0.0	5.3	6.7	5.3	5.7	2.5	3.7	0.0	9.3	8.0	3.4	5.9	5.9	1.5	4.5	7.0	4.9	1.2	8.2	7.9	5.2	6.3	6.2	7.7	4.0	5.1	8.3	6.4	9.6	5.1	0.0	7.2	2.6	0.0	6.0	0.0	2.1	6.8	5.9	0.0	5.6	7.1	0.0	10.3	8.0	15.2	4.1	3.1	7.2	12.6	3.9	7.2	8.2	1.5	0.0	13.1	5.0	5.3	14.0	10.5	6.3	0.0	4.5	8.0	8.5	4.1	2.7
MTERF3	"CGI-12, FLJ10939, MTERFD1"	ENSG00000156469	"Mitochondrial transcription termination factor 3"	Q96E29	8	96239398-96261610	"Predicted intracellular proteins"	"Ribosome biogenesis, Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007355			Supported	Mitochondria,Cytosol		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 21: OE19 - Mitochondria"	"Cluster 47: Cytotrophoblasts - Unknown function"	Mitochondria	Cytosol	"HPA007355: "	"unprognostic (4.08e-2)"	"unprognostic (1.46e-1)"	"unprognostic (4.68e-2)"	"unprognostic (2.31e-2)"	"unprognostic (3.86e-2)"	"unprognostic (6.66e-2)"	"unprognostic (2.75e-3)"	"unprognostic (3.11e-3)"	"unprognostic (6.43e-2)"	"unprognostic (2.00e-1)"	"unprognostic (3.84e-2)"	"unprognostic (8.56e-2)"	"prognostic unfavorable (5.88e-5)"	"unprognostic (8.67e-3)"	"unprognostic (8.81e-2)"	"unprognostic (2.27e-1)"	"unprognostic (1.74e-3)"	15.0	16.3	16.3	15.3	16.9	11.5	17.9	18.6	21.8	14.0	20.9	14.7	12.6	13.5	22.9	11.6	12.7	12.4	27.8	16.1	17.3	18.3	23.1	12.1	18.2	16.4	16.3	12.1	15.5	22.3	12.6	16.7	17.2	13.5	14.4	16.0	12.9	17.2	30.2	17.0	11.5	16.6	15.9	16.0	12.7	11.8	16.6	16.7	11.9	38.2	19.4	16.4	12.0	17.8	41.1	25.9	38.1	30.3	26.4	27.4	17.5	30.8	25.0	43.9	44.2	18.8	29.6	36.5	63.3	18.2	22.5	22.8	39.7	24.1	53.2	35.6	29.3	52.5	20.6	22.8	37.1	17.9	20.7	27.5	35.4	35.6	33.5	22.9	36.5	39.0	45.1	18.7	44.7	26.9	76.6	52.8	19.8	71.6	39.8	45.9	31.2	28.8	32.7	21.8	25.9	20.4	23.0	6.6	33.8	24.5	34.3	25.0	16.3	30.9	20.8	36.0	27.7	21.3	28.9	43.2	33.4	47.3	41.3	39.5	13.4	6.1	15.6	15.9	22.6	20.4	17.7	17.8	20.2	17.7	19.8	20.2	2.2	23.8	15.8	24.3	18.6	10.1	16.3	16.9	18.6	21.8	16.1	17.3	16.4	16.3	17.2	15.9	16.6	17.8	10.4	3.2	6.9	7.8	10.8	0.0	21.2	0.0	10.8	0.0	6.6	8.5	31.2	5.7	5.6	5.5	0.0	30.4	10.8	0.9	13.7	12.5	5.6	6.2	10.1	8.1	0.0	12.4	12.9	9.8	21.0	12.7	4.1	5.4	6.3	11.2	6.1	8.0	16.2	0.0	12.6	3.6	0.0	5.2	0.0	4.1	13.7	7.1	0.0	4.7	16.0	0.0	15.5	7.5	14.2	7.7	3.3	13.9	7.0	22.9	3.3	11.1	5.1	0.0	13.1	10.3	9.9	28.2	21.2	9.1	0.0	17.4	8.8	9.5	5.3	11.7
MTERF4	"MGC61716, MTERFD2"	ENSG00000122085	"Mitochondrial transcription termination factor 4"	Q7Z6M4	2	241072169-241102332	"Predicted intracellular proteins"	"rRNA processing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA027097	Uncertain		Supported	Mitochondria,Cytosol		Yes	No			"Cluster 32: T-cells - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 63: NK-cells & T-cells - Immune response"	"Mitochondria, Cytosol"		"HPA027097: AB_10603879"	"unprognostic (4.58e-2)"	"unprognostic (3.66e-1)"	"unprognostic (2.82e-1)"	"unprognostic (5.95e-2)"	"unprognostic (1.50e-1)"	"unprognostic (6.70e-2)"	"unprognostic (1.17e-3)"	"unprognostic (2.99e-2)"	"unprognostic (2.68e-2)"	"unprognostic (1.20e-2)"	"prognostic favorable (3.48e-4)"	"unprognostic (2.28e-2)"	"unprognostic (1.65e-2)"	"unprognostic (1.92e-1)"	"unprognostic (4.41e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.13e-1)"	15.4	15.7	8.7	22.7	10.6	23.8	21.8	17.5	14.5	21.8	6.7	18.2	16.1	25.3	16.1	19.4	19.0	14.2	17.3	9.1	10.3	15.7	20.4	17.0	38.8	9.1	8.3	27.9	17.5	16.2	15.3	14.2	9.6	33.8	19.9	29.4	19.8	18.1	54.4	17.6	22.0	20.1	6.4	22.0	18.3	10.2	9.1	25.1	34.7	41.8	30.8	14.8	16.0	12.7	17.2	14.9	29.7	16.4	38.2	17.5	22.1	27.4	31.5	25.8	36.0	10.5	23.2	24.7	10.0	31.0	30.8	17.6	41.0	38.5	33.8	35.4	28.9	32.2	30.5	46.5	25.5	40.2	23.3	29.0	37.8	30.2	35.6	32.8	30.2	32.4	29.4	10.5	31.9	24.0	28.2	26.4	33.7	35.5	25.8	27.7	33.1	14.1	24.8	31.5	26.2	22.9	20.3	26.8	20.7	19.5	19.6	19.4	39.3	23.4	23.0	27.3	25.7	28.0	7.9	61.2	19.8	24.1	21.4	8.3	10.8	24.9	18.6	10.5	22.7	32.3	29.1	26.8	12.3	31.8	46.0	36.7	3.4	18.1	8.7	9.1	32.5	22.1	8.7	10.6	17.5	14.5	9.1	10.3	9.1	8.3	9.6	6.4	9.1	12.7	20.7	12.8	27.7	40.8	45.6	0.0	20.3	0.0	15.9	0.0	19.8	23.9	19.8	27.1	13.0	20.2	0.0	30.2	34.1	12.1	41.1	24.1	49.2	11.7	19.1	22.4	10.9	22.9	31.2	24.6	28.2	18.6	14.3	12.0	11.4	37.9	20.0	30.6	24.8	0.0	28.8	20.7	0.0	24.5	0.0	61.0	23.3	17.0	0.0	25.3	31.6	0.0	42.2	33.2	39.8	23.7	20.7	26.4	44.8	22.0	43.4	51.4	17.5	0.0	39.5	22.7	18.4	59.0	34.3	23.4	0.0	23.7	37.0	42.9	17.2	17.1
MTF1		ENSG00000188786	"Metal regulatory transcription factor 1"	Q14872	1	37809574-37859592	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 20.5"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028604, HPA028689"	Uncertain		Supported	Nucleoplasm		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm		"HPA028604: AB_10600304, HPA028689: AB_10611384"	"unprognostic (5.74e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.56e-2)"	"unprognostic (2.89e-1)"	"unprognostic (8.33e-2)"	"unprognostic (8.15e-3)"	"unprognostic (1.34e-2)"	"unprognostic (5.07e-2)"	"unprognostic (1.91e-1)"	"unprognostic (4.58e-2)"	"unprognostic (3.20e-2)"	"unprognostic (2.30e-2)"	"unprognostic (3.70e-2)"	"unprognostic (4.37e-3)"	"unprognostic (2.98e-1)"	"unprognostic (6.32e-2)"	"unprognostic (2.19e-1)"	4.7	3.5	4.6	5.2	6.0	20.5	4.1	4.7	5.4	4.7	5.5	4.4	2.8	4.2	2.6	8.4	5.6	3.5	2.7	4.2	4.3	3.8	2.5	4.3	4.0	5.6	5.6	5.5	4.0	6.1	3.4	3.3	5.2	3.3	4.6	4.8	3.2	3.1	5.3	4.5	3.0	4.6	4.6	4.5	3.3	6.6	5.1	4.3	3.8	6.4	5.8	5.3	4.0	6.2	7.5	4.5	4.4	3.9	11.0	7.6	8.4	7.2	7.4	8.4	8.0	4.9	4.2	7.9	5.4	8.2	5.5	6.8	7.6	6.0	9.7	27.5	4.7	7.5	6.4	3.8	6.2	8.9	8.0	7.1	10.4	11.9	12.0	6.0	5.4	5.6	4.9	6.2	6.3	4.2	4.5	4.6	6.2	3.9	4.4	4.7	10.4	4.8	5.6	7.3	6.7	4.9	8.6	6.9	6.2	6.1	4.2	7.3	7.7	5.2	5.9	6.0	9.6	11.4	13.8	4.4	7.1	9.1	4.6	2.8	3.7	2.4	1.8	3.6	1.5	1.3	1.5	1.3	2.3	1.6	1.6	1.3	3.7	1.1	6.0	0.8	1.1	1.8	4.6	6.0	4.7	5.4	4.2	4.3	5.6	5.6	5.2	4.6	5.1	6.2	9.7	9.6	10.3	10.7	15.4	20.6	11.4	11.0	15.9	0.0	13.2	10.8	12.7	8.6	8.8	7.3	0.0	10.0	11.2	20.4	1.9	11.8	50.0	30.0	14.2	13.0	23.8	9.9	16.3	15.6	23.2	10.7	9.2	30.4	16.5	9.2	13.2	7.2	10.2	0.0	14.3	8.8	16.2	20.1	9.1	18.2	9.6	22.6	7.2	8.4	26.8	0.0	11.3	9.5	20.7	12.9	8.6	11.7	15.7	14.8	11.5	6.2	28.8	0.0	6.6	18.2	12.1	33.7	22.5	23.2	29.7	17.1	12.9	7.1	9.2	16.0
MTFR1	"CHPPR, FAM54A2, KIAA0009"	ENSG00000066855	"Mitochondrial fission regulator 1"	Q15390	8	65644734-65771261	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"Early spermatids: 365.5;Late spermatids: 792.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in all"		"hTERT-HME1: 107.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023152, HPA056120"	Uncertain		Supported	Mitochondria,Cytosol		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 34: Spermatids - Unknown function"	Mitochondria	Cytosol	"HPA023152: AB_1854176, HPA056120: AB_2683043"	"prognostic unfavorable (4.06e-4)"	"unprognostic (4.58e-2)"	"unprognostic (4.01e-2)"	"unprognostic (4.57e-2)"	"unprognostic (6.56e-3)"	"unprognostic (3.93e-2)"	"unprognostic (1.66e-1)"	"unprognostic (3.28e-2)"	"unprognostic (1.50e-1)"	"unprognostic (3.53e-1)"	"unprognostic (5.69e-3)"	"unprognostic (5.44e-2)"	"unprognostic (6.63e-3)"	"unprognostic (1.84e-1)"	"unprognostic (1.26e-1)"	"prognostic unfavorable (5.21e-4)"	"unprognostic (8.25e-2)"	9.9	15.2	4.4	6.2	6.1	4.9	10.0	4.7	6.9	9.8	4.6	11.3	12.4	8.4	12.0	10.2	6.3	6.6	7.6	4.3	4.9	31.8	34.9	5.9	4.7	5.2	5.5	6.2	8.8	11.6	3.9	7.6	5.1	7.3	12.0	34.0	8.4	8.5	9.7	8.2	12.5	9.5	4.5	4.0	14.7	19.7	5.3	4.6	11.5	7.3	6.8	8.9	7.6	6.6	34.3	25.1	19.7	22.7	25.7	25.6	15.7	22.3	20.3	26.8	27.9	21.5	34.5	19.0	7.0	21.7	26.6	21.9	44.3	30.0	35.6	6.9	24.0	23.6	16.8	43.1	32.7	6.2	10.9	17.5	31.1	34.7	107.9	15.2	33.1	13.8	32.8	19.0	30.8	30.9	21.1	14.2	20.5	74.9	22.5	10.7	26.9	15.9	32.5	30.2	8.6	12.9	21.9	36.7	29.6	19.6	40.5	13.3	25.8	15.9	22.4	38.8	19.6	18.4	12.9	13.6	19.8	25.0	21.6	1.3	0.8	0.3	0.5	0.6	0.7	0.4	0.7	0.6	0.8	0.3	0.6	0.7	0.2	0.2	0.3	0.5	0.7	0.4	4.4	6.1	4.7	6.9	4.3	4.9	5.2	5.5	5.1	4.5	5.3	6.6	6.8	19.2	9.8	5.9	6.1	16.8	12.3	13.5	10.2	0.0	9.7	4.8	7.4	18.6	12.2	11.0	0.0	25.0	6.9	11.9	56.7	22.6	365.5	7.5	10.0	10.0	4.8	12.6	13.1	24.1	29.0	10.1	14.3	8.2	5.1	9.2	8.9	39.9	9.7	0.0	16.4	12.6	20.3	6.3	7.0	792.9	16.8	6.5	14.2	11.2	3.8	0.0	4.1	18.6	42.4	20.0	9.6	12.0	10.7	20.6	20.0	112.7	16.1	0.0	6.6	7.5	13.1	93.0	35.9	18.4	19.5	39.1	4.5	20.6	15.7	16.6
MTG1	GTPBP7	ENSG00000148824	"Mitochondrial ribosome associated GTPase 1"	Q9BT17	10	133394094-133422520	"Predicted intracellular proteins"	"Translation regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Gastric mucus-secreting cells: 43.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037826, HPA037827"	Approved		Supported	Mitochondria		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 59: Non-specific - Transcription"	Mitochondria		"HPA037826: AB_2675692, HPA037827: AB_10670959"	"unprognostic (2.94e-2)"	"unprognostic (8.08e-2)"	"unprognostic (5.90e-3)"	"unprognostic (1.03e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.29e-2)"	"unprognostic (5.85e-2)"	"unprognostic (6.20e-2)"	"unprognostic (1.32e-1)"	"unprognostic (2.21e-1)"	"prognostic favorable (5.08e-4)"	"unprognostic (4.63e-3)"	"prognostic unfavorable (6.79e-7)"	"unprognostic (3.88e-2)"	"unprognostic (5.96e-2)"	"unprognostic (5.19e-2)"	"prognostic favorable (1.03e-5)"	15.1	28.1	10.0	13.6	9.9	12.5	16.3	11.0	12.2	17.0	11.4	16.0	19.7	15.2	2.8	21.4	15.0	8.4	15.0	9.7	9.6	27.1	48.4	13.0	16.2	10.8	9.9	17.2	19.7	17.6	16.2	11.2	10.2	19.3	11.2	3.4	16.3	10.4	18.5	17.7	18.9	10.1	9.3	26.1	18.4	31.2	10.4	12.7	18.0	13.0	14.1	15.4	15.4	9.9	42.5	43.3	28.3	63.4	17.0	12.5	42.0	24.2	20.8	38.5	31.4	55.0	25.8	31.2	36.2	20.5	16.3	33.5	30.6	43.2	17.4	29.8	37.7	30.5	23.5	52.1	40.2	20.6	30.4	31.5	22.9	37.3	58.6	27.7	56.5	27.9	26.2	28.0	30.6	47.4	20.2	28.9	39.3	45.2	14.4	29.6	28.0	7.1	34.6	29.6	10.7	37.9	36.4	32.1	51.4	15.8	28.2	29.6	37.1	14.2	29.2	14.6	26.1	13.5	8.3	43.3	25.2	18.3	19.8	0.5	21.5	23.0	26.9	35.5	27.7	41.5	23.8	22.7	20.3	48.8	18.6	19.2	3.1	47.5	42.9	42.8	27.5	20.3	10.0	9.9	11.0	12.2	9.7	9.6	10.8	9.9	10.2	9.3	10.4	9.9	4.5	9.6	3.6	30.7	27.1	4.2	5.9	8.8	33.0	0.0	6.1	5.3	1.6	8.6	5.9	3.7	0.0	9.4	8.1	8.4	5.9	13.5	2.2	5.9	9.9	7.7	12.6	26.1	25.1	9.6	7.3	9.0	43.8	5.9	6.3	10.8	7.5	5.5	5.4	0.0	31.8	7.5	4.1	6.3	4.7	5.4	9.0	7.1	5.4	21.5	8.1	0.0	12.3	29.7	33.9	10.4	9.2	4.9	37.5	7.2	12.5	6.9	6.1	0.0	13.1	6.1	6.0	9.0	9.3	32.9	3.4	6.7	16.6	6.7	10.1	7.4
MTHFD2		ENSG00000065911	"Methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 2, methenyltetrahydrofolate cyclohydrolase"	P13995	2	74186172-74217565	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"One-carbon metabolism"	"Hydrolase, Multifunctional enzyme, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Langerhans cells: 243.6;monocytes: 184.1;Smooth muscle cells: 239.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003684, HPA049657"	Approved		Supported	Mitochondria	"Intracellular and membrane"	NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 52: Non-specific - Ribosome"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 48: Smooth muscle cells - ECM organization"	Mitochondria		"CAB003684: AB_425867, HPA049657: AB_2680842"	"unprognostic (1.82e-3)"	"unprognostic (4.60e-2)"	"unprognostic (8.12e-2)"	"prognostic unfavorable (2.07e-5)"	"prognostic favorable (1.01e-4)"	"unprognostic (3.10e-3)"	"unprognostic (2.24e-3)"	"unprognostic (4.75e-3)"	"unprognostic (2.64e-2)"	"unprognostic (3.96e-2)"	"unprognostic (3.76e-3)"	"unprognostic (3.57e-3)"	"prognostic unfavorable (1.11e-16)"	"unprognostic (3.66e-2)"	"unprognostic (6.52e-2)"	"unprognostic (9.07e-2)"	"unprognostic (2.34e-3)"	40.0	12.3	11.2	54.5	13.0	25.8	34.8	12.7	14.7	28.5	11.2	30.6	18.6	21.5	14.5	23.0	34.2	20.1	19.6	10.0	16.6	19.6	7.3	23.0	45.6	16.6	15.8	11.7	65.9	9.8	18.0	17.7	17.1	16.3	33.7	2.9	17.7	16.7	36.7	11.8	16.0	27.3	14.8	19.0	36.1	17.7	13.1	28.5	18.5	55.3	57.8	48.0	20.5	15.7	197.4	107.8	89.2	235.6	90.0	113.9	186.1	286.2	185.2	156.2	216.7	242.8	81.8	391.0	65.4	154.2	167.5	70.7	296.7	142.0	314.9	248.9	100.9	424.6	55.4	181.9	319.8	360.1	234.8	202.9	423.4	188.5	794.4	74.8	99.0	636.5	192.2	548.0	157.5	159.6	209.5	261.0	161.1	293.3	95.8	222.6	266.3	339.4	72.0	80.8	198.2	143.8	97.4	238.3	549.7	56.9	208.5	324.4	52.9	39.1	359.9	97.7	286.5	484.5	257.6	379.2	111.4	304.1	132.5	43.9	24.0	31.1	8.5	56.6	13.0	13.4	15.2	10.1	34.9	12.2	11.5	7.9	3.2	29.3	57.0	13.0	36.8	22.0	11.2	13.0	12.7	14.7	10.0	16.6	16.6	15.8	17.1	14.8	13.1	15.7	19.7	16.0	20.2	0.3	49.7	89.3	58.8	54.1	27.3	0.0	53.2	38.0	11.5	4.3	28.2	1.8	0.0	31.5	48.2	19.9	3.9	55.7	3.9	9.7	104.7	35.1	19.1	104.1	1.0	107.9	56.9	45.6	68.8	21.7	53.3	8.7	19.2	0.8	66.2	0.0	3.7	64.0	38.7	61.6	243.6	3.8	22.7	100.6	71.2	12.2	184.1	0.0	27.8	6.6	1.1	81.2	7.5	21.1	141.2	95.7	3.3	3.3	8.5	0.0	138.1	126.3	239.0	36.5	54.9	42.0	74.6	14.0	71.4	21.6	34.0	64.2
MTHFS	HsT19268	ENSG00000136371	"Methenyltetrahydrofolate synthetase"	P49914	15	79833585-79897379	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		Ligase	"Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"liver: 253.4"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 205.5;monocytes: 150.8;Proximal tubular cells: 201.6;Syncytiotrophoblasts: 253.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 134.1"	"Group enriched"	"Detected in all"	5	"granulocytes: 134.1;monocytes: 49.1"	"Low cell line specificity"	"Detected in many"											"HPA008067, HPA054177"	Approved		Supported	Cytosol		NA	NA		13000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 62: Liver - Hemostasis"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	Cytosol		"HPA008067: AB_1078882, HPA054177: AB_2682405"	"unprognostic (4.57e-2)"	"unprognostic (9.76e-2)"	"unprognostic (6.11e-2)"	"unprognostic (1.82e-1)"	"prognostic unfavorable (8.52e-4)"	"unprognostic (9.13e-3)"	"prognostic favorable (1.29e-6)"	"unprognostic (1.34e-2)"	"unprognostic (1.03e-1)"	"unprognostic (6.18e-3)"	"unprognostic (2.91e-2)"	"unprognostic (2.76e-1)"	"prognostic favorable (2.04e-4)"	"unprognostic (1.36e-1)"	"unprognostic (2.85e-1)"	"unprognostic (7.60e-2)"	"unprognostic (2.90e-1)"	21.9	19.8	8.0	4.6	8.2	5.0	19.0	9.6	12.7	9.9	6.9	12.0	13.7	9.0	10.3	10.1	9.4	7.0	19.0	8.0	9.2	53.1	253.4	17.8	6.4	8.7	9.3	8.6	32.8	26.3	21.5	8.3	9.1	19.5	6.4	5.9	13.6	5.5	20.2	6.2	14.5	6.2	8.8	14.9	19.5	12.1	8.7	10.6	15.9	11.1	10.8	12.4	9.9	9.1	12.6	35.8	5.0	2.6	15.8	12.0	11.9	8.8	13.0	16.4	10.5	34.5	22.4	15.1	25.1	15.5	15.0	19.5	31.9	10.7	15.4	14.7	28.4	14.8	22.9	39.8	25.3	7.8	0.8	17.5	27.8	8.1	23.0	19.6	7.4	16.0	28.8	12.0	17.4	36.0	10.2	36.1	15.6	51.4	17.0	10.8	17.2	25.8	35.1	34.3	8.9	4.8	25.1	14.2	43.8	20.0	17.3	13.0	3.3	5.7	11.1	3.6	7.1	6.8	20.2	17.8	3.3	25.9	6.2	17.5	25.7	73.5	9.4	35.3	12.4	13.5	13.7	12.9	12.3	11.1	16.5	12.6	134.1	17.8	49.1	13.3	15.7	19.1	8.0	8.2	9.6	12.7	8.0	9.2	8.7	9.3	9.1	8.8	8.7	9.1	11.3	19.2	44.0	0.0	20.7	10.7	9.9	63.0	35.9	0.0	25.5	32.5	0.7	58.6	34.3	22.0	0.0	68.1	10.1	10.0	64.6	55.8	2.2	11.9	7.8	10.5	17.6	36.6	0.0	75.7	37.1	13.5	39.8	11.0	8.8	7.2	21.8	205.5	45.7	0.0	0.0	18.7	24.4	22.1	34.8	3.8	13.7	29.3	21.4	0.0	150.8	0.0	35.0	0.0	0.0	75.3	35.9	15.8	13.3	13.3	101.7	201.6	29.9	0.0	13.1	8.4	10.5	6.7	8.5	21.1	8.1	253.8	22.2	9.2	24.9	7.7
MTIF3	"IF-3mt, IF3(mt)"	ENSG00000122033	"Mitochondrial translational initiation factor 3"	Q9H2K0	13	27435643-27450591	"Predicted intracellular proteins"	"Protein biosynthesis"	"Initiation factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 610.0;Proximal tubular cells: 475.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039791	Approved		Supported	Nucleoplasm,Mitochondria		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 21: OE19 - Mitochondria"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria	Nucleoplasm	"HPA039791: AB_10795296"	"unprognostic (1.82e-1)"	"unprognostic (1.44e-2)"	"unprognostic (2.59e-1)"	"unprognostic (3.26e-3)"	"unprognostic (1.49e-2)"	"unprognostic (8.01e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.49e-1)"	"unprognostic (3.77e-1)"	"unprognostic (1.64e-2)"	"unprognostic (1.62e-1)"	"unprognostic (2.40e-1)"	"unprognostic (3.24e-2)"	"unprognostic (1.13e-1)"	"unprognostic (9.27e-2)"	"prognostic favorable (8.41e-4)"	61.8	55.0	59.5	29.2	59.8	17.1	51.0	61.0	93.4	36.7	60.4	46.7	42.8	28.4	67.1	39.9	30.4	37.0	133.4	59.0	61.7	63.1	65.5	29.2	44.5	60.9	60.2	37.1	54.4	43.4	50.8	30.9	60.9	45.3	44.6	74.7	82.9	43.9	90.8	39.9	41.8	30.5	58.8	49.6	48.1	61.8	60.6	47.3	36.9	109.8	46.1	36.7	34.0	62.0	29.9	21.9	48.5	23.5	53.2	78.8	22.6	44.0	51.1	33.8	33.8	28.3	37.5	33.3	28.4	50.8	22.8	25.1	27.2	37.1	46.3	34.3	31.2	42.6	19.1	36.7	52.2	43.8	38.8	44.6	65.5	27.7	35.1	75.6	60.0	33.8	24.0	13.6	51.2	54.0	39.7	54.2	24.4	100.1	24.0	22.8	24.3	37.5	69.8	31.3	32.9	20.6	28.4	39.1	50.7	51.8	31.3	62.5	38.1	21.4	12.5	56.1	29.5	10.0	14.9	19.1	21.5	44.3	31.1	85.8	53.0	75.4	30.8	51.2	32.9	49.1	38.9	31.1	55.2	42.8	34.0	35.2	36.5	37.2	48.3	88.2	47.4	41.3	59.5	59.8	61.0	93.4	59.0	61.7	60.9	60.2	60.9	58.8	60.6	62.0	88.5	28.9	47.4	29.0	74.0	34.0	34.0	103.9	43.9	0.0	91.6	95.4	179.1	87.2	76.3	115.8	0.0	102.6	60.4	102.2	326.8	89.6	610.0	93.7	63.4	70.3	64.1	59.7	22.8	104.1	67.0	62.7	47.4	74.5	71.7	50.6	79.9	223.0	102.3	0.0	26.4	112.8	103.7	114.8	50.2	283.4	139.8	67.7	106.7	24.4	106.4	0.0	80.3	30.7	43.7	98.3	108.8	124.8	71.1	43.7	142.8	475.5	83.2	0.0	124.9	48.8	69.2	243.6	87.6	62.8	42.5	56.8	58.5	69.6	96.8	44.8
MTM1		ENSG00000171100	"Myotubularin 1"	Q13496	X	150568621-150673143	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Lipid metabolism, Protein transport, Transport"	"Hydrolase, Protein phosphatase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 52.2;Oligodendrocytes: 47.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010008, HPA010665"	Approved		Supported	"Plasma membrane"		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 59: Non-specific - Transcription"	"Plasma membrane"		"HPA010008: AB_1079426, HPA010665: AB_1079425"	"unprognostic (3.66e-3)"	"unprognostic (8.43e-3)"	"unprognostic (3.52e-3)"	"unprognostic (2.13e-1)"	"unprognostic (1.08e-1)"	"unprognostic (6.45e-2)"	"unprognostic (4.98e-2)"	"unprognostic (1.22e-1)"	"unprognostic (4.74e-1)"	"unprognostic (2.35e-2)"	"unprognostic (1.08e-1)"	"unprognostic (4.59e-2)"	"prognostic favorable (7.40e-7)"	"unprognostic (4.46e-2)"	"unprognostic (1.25e-1)"	"unprognostic (4.99e-2)"	"unprognostic (2.46e-1)"	6.8	11.1	7.4	9.7	8.3	11.3	7.6	8.0	8.4	5.7	6.1	19.8	11.7	6.5	8.4	7.5	9.6	7.1	7.3	6.9	8.5	12.9	18.4	11.2	12.4	7.8	8.6	11.7	4.9	16.0	3.8	6.3	8.0	8.0	19.2	5.4	6.3	10.7	11.8	8.2	12.1	6.9	7.7	11.9	7.8	11.5	8.8	8.4	11.2	10.1	9.7	7.1	4.7	8.8	14.3	6.1	8.5	3.1	7.5	7.3	5.4	6.1	8.5	7.0	7.9	4.7	7.3	22.2	11.4	8.3	21.9	9.9	6.1	11.5	8.6	6.4	5.2	5.6	5.4	15.0	5.8	25.2	19.1	4.5	14.3	5.7	11.9	6.9	9.4	9.3	3.9	19.8	8.8	4.5	6.9	25.2	4.3	13.4	7.4	8.0	4.9	4.5	11.7	6.9	2.2	2.4	5.5	11.3	8.5	11.9	4.1	35.2	8.2	5.0	3.1	12.4	7.1	4.2	10.0	20.3	6.0	14.8	8.0	34.8	9.5	27.9	2.0	10.8	6.8	8.0	9.6	7.3	12.0	10.6	9.0	5.4	11.6	14.6	9.8	7.4	12.2	7.1	7.4	8.3	8.0	8.4	6.9	8.5	7.8	8.6	8.0	7.7	8.8	8.8	9.9	9.6	20.0	52.2	13.9	15.2	8.3	5.8	2.2	0.0	5.8	3.9	15.0	4.3	6.0	3.7	0.0	2.1	8.4	33.0	1.9	3.4	35.6	7.7	5.0	11.5	9.6	7.4	44.0	4.3	2.8	6.6	8.2	4.8	8.8	3.3	16.4	13.2	8.0	0.0	41.5	17.7	2.0	16.3	10.4	18.8	6.2	13.0	5.4	24.4	12.0	0.0	0.0	27.6	47.7	4.7	9.5	12.8	8.0	6.8	11.2	14.7	13.4	0.0	0.0	5.2	6.9	5.1	4.1	4.9	19.0	7.3	12.8	4.8	13.8	9.7
MTMR2	"CMT4B, KIAA1073"	ENSG00000087053	"Myotubularin related protein 2"	Q13614	11	95821766-95925315	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Lipid metabolism"	Hydrolase	"Charcot-Marie-Tooth disease, Disease variant, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Late spermatids: 120.1;Oligodendrocytes: 226.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049831	Approved		Supported	Vesicles		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 77: Retina - Visual perception"	"Cluster 15: RT4 - Unknown function"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Vesicles		"HPA049831: AB_2680904"	"unprognostic (1.71e-2)"	"unprognostic (2.55e-3)"	"unprognostic (7.81e-3)"	"unprognostic (4.16e-1)"	"unprognostic (4.18e-3)"	"unprognostic (5.36e-2)"	"prognostic unfavorable (1.61e-8)"	"unprognostic (3.23e-3)"	"unprognostic (3.42e-2)"	"unprognostic (1.77e-2)"	"prognostic unfavorable (3.60e-4)"	"unprognostic (1.12e-1)"	"unprognostic (2.34e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.14e-1)"	"unprognostic (8.03e-3)"	14.7	9.3	11.0	11.2	16.8	4.4	11.8	16.3	18.3	12.2	12.2	12.9	7.1	12.3	6.2	14.7	12.4	14.3	13.5	10.8	14.3	16.4	4.3	12.3	9.5	15.1	14.4	11.5	7.8	12.7	6.4	24.5	15.8	16.1	13.9	18.6	20.5	11.4	6.2	8.2	8.3	18.0	13.5	8.6	13.0	31.0	14.1	15.1	9.9	8.9	12.1	15.2	10.4	22.4	24.1	25.3	54.1	39.2	19.2	29.0	47.5	43.3	37.9	42.4	37.8	57.3	47.1	16.2	50.3	45.5	35.9	30.9	47.7	48.2	38.9	30.8	21.3	31.5	55.0	33.0	42.8	59.3	26.7	24.0	31.2	56.6	54.5	41.8	64.4	35.4	44.7	14.2	39.6	17.9	29.0	27.2	46.6	59.0	34.9	23.2	32.2	16.8	43.9	125.0	35.6	40.6	43.6	36.4	19.2	35.1	27.6	26.5	64.4	47.7	45.1	34.4	41.1	13.1	42.4	14.3	20.4	15.6	50.6	9.8	3.9	1.7	12.4	4.7	13.4	5.8	7.9	15.7	7.6	4.9	4.0	11.3	0.9	14.1	7.2	3.7	8.1	7.8	11.0	16.8	16.3	18.3	10.8	14.3	15.1	14.4	15.8	13.5	14.1	22.4	19.6	3.2	8.6	28.7	9.6	10.3	15.0	9.0	8.6	0.0	8.0	6.7	17.3	0.0	11.6	9.2	0.0	9.0	8.8	9.1	9.8	17.8	74.8	18.1	14.1	20.2	16.2	12.8	69.8	16.9	34.3	17.0	9.7	8.7	19.0	49.1	11.0	1.0	12.5	0.0	37.5	9.8	24.4	10.3	8.2	120.1	11.1	8.3	3.6	40.3	6.8	0.0	14.4	63.8	226.6	17.7	4.7	12.0	7.0	15.1	6.0	29.3	17.0	0.0	32.9	7.9	29.0	46.8	19.2	15.4	6.0	9.0	8.8	12.9	10.6	15.6
MTMR3	"FYVE-DSP1, KIAA0371, ZFYVE10"	ENSG00000100330	"Myotubularin related protein 3"	Q13615	22	29883169-30030868	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Lipid metabolism"	"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 81.6"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 111.3;Inhibitory neurons: 78.3;Microglial cells: 90.9;Oligodendrocyte precursor cells: 96.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034515, HPA034516, HPA061399"	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 64: Astrocytes - Nervous system maintenance"	Nucleoplasm	Cytosol	"HPA034515: AB_10669726, HPA034516: AB_10669727, HPA061399: "	"unprognostic (4.39e-3)"	"unprognostic (7.84e-2)"	"unprognostic (2.46e-2)"	"unprognostic (1.76e-2)"	"unprognostic (5.61e-2)"	"unprognostic (4.51e-3)"	"unprognostic (2.25e-2)"	"unprognostic (3.20e-2)"	"unprognostic (3.42e-1)"	"unprognostic (4.39e-1)"	"unprognostic (8.33e-4)"	"unprognostic (1.28e-1)"	"unprognostic (5.35e-4)"	"unprognostic (7.96e-2)"	"unprognostic (7.64e-2)"	"unprognostic (2.49e-1)"	"unprognostic (8.38e-2)"	17.8	18.4	18.5	13.0	19.4	81.6	17.0	21.2	18.6	18.9	17.0	15.5	11.1	16.0	12.8	22.4	16.4	12.5	13.9	20.8	19.3	11.7	10.8	20.7	11.5	19.2	19.8	20.4	16.5	18.3	17.0	15.0	17.3	16.0	12.7	21.2	17.2	11.3	36.7	25.5	14.5	14.8	18.6	21.7	15.7	26.2	21.6	16.2	17.2	30.0	13.9	15.1	19.4	16.6	13.4	11.7	17.0	18.3	16.7	12.1	12.8	12.2	17.4	15.7	18.2	10.0	7.9	10.2	7.6	22.1	12.4	16.0	18.5	14.3	16.6	21.0	15.4	18.6	10.6	10.1	15.3	15.9	45.0	12.8	22.9	14.9	26.9	14.7	15.3	10.7	11.6	17.5	10.3	16.2	10.7	11.1	6.5	13.7	7.5	12.5	23.3	10.4	14.1	24.3	19.2	13.1	22.1	19.7	11.7	14.1	11.2	15.3	16.8	25.3	16.7	5.5	8.3	14.7	11.1	9.3	11.0	7.5	11.8	8.3	7.4	11.2	3.2	4.9	4.0	2.3	2.5	3.4	4.1	2.4	3.1	2.7	17.8	4.1	5.4	1.5	2.9	4.3	18.5	19.4	21.2	18.6	20.8	19.3	19.2	19.8	17.3	18.6	21.6	16.6	15.9	3.2	14.8	111.3	13.3	16.7	9.8	11.5	14.8	0.0	13.7	11.0	4.2	10.0	17.7	12.9	0.0	13.6	10.4	21.5	1.9	9.5	14.0	16.8	14.9	10.6	12.5	21.0	61.2	8.8	7.0	12.6	31.6	24.5	7.6	14.7	13.9	10.1	10.9	0.0	78.3	9.2	46.8	20.6	11.7	16.7	13.7	20.8	14.2	90.9	22.3	0.0	12.3	96.5	73.2	12.3	11.1	11.3	13.0	14.6	12.2	7.3	16.4	0.0	6.6	15.3	11.0	26.8	28.0	18.1	13.8	13.7	13.0	8.9	11.5	21.2
MTMR7		ENSG00000003987	"Myotubularin related protein 7"	Q9Y216	8	17296794-17413528	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 11.9;retina: 28.4"	"Group enriched"	"Detected in some"	8	"Excitatory neurons: 79.2;Inhibitory neurons: 116.4;Oligodendrocyte precursor cells: 83.9;Oligodendrocytes: 171.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"NTERA-2: 3.7;SCLC-21H: 9.5;SH-SY5Y: 5.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA075682			Approved	Nucleoplasm,Cytosol		NA	NA				"Cluster 77: Retina - Visual perception"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Nucleoplasm, Cytosol"		"HPA075682: "	"unprognostic (1.01e-1)"	"unprognostic (6.10e-2)"	"unprognostic (1.05e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.31e-2)"	"unprognostic (4.15e-2)"	"unprognostic (1.41e-2)"	"unprognostic (1.92e-1)"	"unprognostic (2.45e-1)"	"unprognostic (2.07e-4)"	"unprognostic (1.46e-2)"	"unprognostic (1.97e-7)"	"unprognostic (1.12e-1)"	"unprognostic (1.42e-1)"	"unprognostic (4.17e-2)"	"unprognostic (2.66e-3)"	1.4	2.1	6.3	0.7	6.9	1.7	0.8	9.0	8.2	1.1	0.0	0.9	0.7	0.9	0.1	0.6	1.1	0.5	0.7	8.2	5.2	0.9	1.3	1.0	0.6	5.9	6.0	2.2	1.2	3.8	6.9	0.6	7.5	0.7	0.3	28.4	0.6	0.2	1.0	1.3	1.0	0.2	5.8	0.7	0.9	1.4	9.2	0.1	3.0	0.2	0.0	0.8	0.8	11.9	0.5	0.4	0.8	0.6	0.0	0.0	0.7	1.3	0.0	0.0	0.0	0.7	0.2	0.6	0.3	0.0	0.5	0.2	2.6	0.0	0.0	0.1	2.1	0.9	1.2	0.4	0.7	0.5	0.6	0.1	0.0	0.0	0.0	0.6	0.1	0.3	0.4	0.5	0.0	0.4	0.9	1.2	3.7	0.5	0.4	0.3	1.1	0.4	0.0	2.3	9.5	5.5	0.4	0.5	0.7	1.3	0.2	0.6	1.1	0.6	0.3	1.4	0.8	0.2	0.3	0.4	1.8	0.9	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	6.3	6.9	9.0	8.2	8.2	5.2	5.9	6.0	7.5	5.8	9.2	11.9	0.0	0.0	0.0	3.6	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.1	1.7	0.0	0.0	0.0	0.0	2.3	0.2	0.1	0.0	0.0	14.0	0.5	0.4	0.2	3.6	0.4	79.2	0.5	0.5	0.5	1.5	1.1	0.0	0.0	0.0	0.0	0.4	0.0	116.4	0.1	0.0	0.0	0.0	5.6	0.0	0.0	0.0	5.6	0.0	0.0	0.0	83.9	171.9	0.2	1.1	0.0	0.5	0.1	0.0	0.0	0.0	0.0	6.6	0.2	1.5	0.9	1.8	0.4	0.1	1.4	0.1	0.1	0.0	0.0
MTPAP	"FLJ10486, PAPD1, SPAX4, TENT6"	ENSG00000107951	"Mitochondrial poly(A) polymerase"	Q9NVV4	10	30309801-30374448	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"mRNA processing, Transcription"	"Nucleotidyltransferase, RNA-binding, Transferase"	"Disease variant, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 36.8"	"Cell type enriched"	"Detected in many"	7	"Early spermatids: 240.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038620, HPA058232"	Approved		Supported	Mitochondria		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	Mitochondria		"HPA038620: AB_10673015, HPA058232: AB_2683646"	"unprognostic (2.76e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.73e-1)"	"unprognostic (3.43e-3)"	"unprognostic (3.05e-2)"	"unprognostic (1.01e-1)"	"prognostic unfavorable (4.20e-6)"	"unprognostic (1.16e-1)"	"unprognostic (2.04e-1)"	"unprognostic (4.78e-2)"	"unprognostic (1.77e-1)"	"unprognostic (3.56e-2)"	"unprognostic (9.02e-2)"	"unprognostic (6.28e-3)"	"unprognostic (3.77e-1)"	"unprognostic (1.14e-2)"	"unprognostic (4.39e-2)"	8.9	7.4	4.9	10.3	4.8	36.8	9.7	12.6	6.7	6.1	3.1	9.6	10.6	9.0	6.2	8.3	6.6	5.2	8.8	4.8	4.3	9.6	10.6	6.3	10.7	3.4	3.5	8.2	10.0	8.4	2.7	9.6	3.9	7.2	11.0	7.1	8.0	4.9	13.2	8.4	9.0	9.1	3.2	9.3	7.1	5.1	3.6	9.2	10.2	12.0	10.3	8.1	5.2	6.2	26.0	25.3	15.8	23.0	15.2	14.2	20.6	17.6	6.2	17.7	18.4	27.0	35.4	36.9	12.3	11.7	16.3	29.7	31.1	20.7	21.6	18.7	24.0	37.3	23.7	27.5	16.0	24.6	28.2	14.3	19.0	19.9	11.7	9.8	19.6	34.0	41.2	28.1	13.5	21.8	29.8	21.8	10.8	19.5	13.3	29.6	27.9	34.4	16.2	17.1	25.9	20.8	16.0	16.4	24.7	14.8	15.8	15.6	18.7	18.4	23.8	26.0	19.8	6.2	16.3	50.8	15.9	44.5	6.6	27.4	25.2	27.3	21.7	35.0	23.0	20.8	20.4	21.1	33.0	17.1	21.6	22.0	4.2	25.1	27.9	17.3	23.1	13.1	4.9	4.8	12.6	6.7	4.8	4.3	3.4	3.5	3.9	3.2	3.6	6.2	12.2	9.6	7.4	9.1	11.2	25.2	13.9	7.4	4.6	0.0	9.8	9.8	16.7	15.7	9.2	3.7	0.0	13.1	13.9	8.1	19.6	9.6	240.7	9.9	14.8	12.9	4.2	16.6	12.7	9.1	12.0	12.7	7.7	12.5	5.1	18.8	12.5	14.6	14.7	0.0	14.5	15.6	6.1	15.8	13.6	34.3	12.2	10.8	8.8	8.4	14.8	0.0	5.2	4.5	14.4	8.9	5.2	16.6	5.3	14.1	8.7	14.2	8.6	0.0	13.1	14.7	10.8	25.3	19.5	11.4	24.9	11.5	8.8	12.6	18.4	16.6
MTR	cblG	ENSG00000116984	"5-methyltetrahydrofolate-homocysteine methyltransferase"	Q99707	1	236795260-236921278	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"	"Amino-acid biosynthesis, Methionine biosynthesis"	"Methyltransferase, Transferase"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 100.0;Glandular and luminal cells: 130.9;Inhibitory neurons: 106.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044474, HPA054915"	Approved		Supported	Cytosol		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 24: NB-4 - Immune response"	"Cluster 44: Endometrium - Transcription"	Cytosol		"HPA044474: AB_10966696, HPA054915: AB_2732589"	"unprognostic (2.12e-1)"	"unprognostic (1.03e-1)"	"unprognostic (6.96e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.76e-1)"	"unprognostic (4.87e-1)"	"unprognostic (1.02e-1)"	"unprognostic (2.48e-2)"	"unprognostic (3.34e-1)"	"unprognostic (5.73e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.67e-2)"	"unprognostic (8.84e-3)"	"unprognostic (1.88e-1)"	"prognostic unfavorable (5.75e-4)"	"unprognostic (8.10e-2)"	9.1	6.6	4.3	6.9	5.4	4.6	8.0	5.2	5.4	10.1	6.5	11.1	4.8	10.2	10.5	5.0	11.9	8.9	15.0	4.9	4.6	12.7	6.0	7.1	8.1	6.7	5.3	14.6	13.0	20.2	6.4	11.6	6.9	7.6	5.0	5.6	6.4	9.1	16.6	9.3	7.1	8.7	4.8	9.4	9.0	9.0	4.8	10.0	13.4	18.1	7.0	10.3	7.6	6.5	17.6	11.0	13.0	8.8	22.6	20.3	15.3	14.9	14.8	18.8	19.0	12.6	12.5	40.0	13.2	16.6	8.7	10.6	18.4	13.1	20.4	19.8	13.7	23.7	14.2	18.3	15.1	37.2	13.3	28.9	7.0	22.9	17.9	11.5	22.3	19.8	33.1	16.4	13.1	10.1	19.6	10.3	16.2	12.9	5.4	20.9	24.8	24.2	11.2	21.3	11.1	27.8	17.7	11.9	14.8	9.3	16.7	13.0	28.8	24.1	9.1	19.6	18.8	34.4	12.3	22.7	17.2	21.1	26.2	0.6	0.5	1.5	1.1	0.8	2.3	0.7	1.4	1.4	0.7	0.8	1.4	1.5	0.0	0.9	0.5	0.5	0.9	0.9	4.3	5.4	5.2	5.4	4.9	4.6	6.7	5.3	6.9	4.8	4.8	6.5	23.0	57.7	35.0	53.8	25.8	8.2	8.3	8.3	17.1	0.0	10.7	11.9	100.0	20.0	10.9	40.5	0.0	24.2	25.9	3.4	1.9	13.8	9.8	57.5	80.1	21.4	8.4	23.5	87.7	14.8	9.2	22.8	15.8	130.9	30.4	35.0	15.4	10.8	14.4	0.0	106.8	7.7	4.1	16.6	6.8	6.2	23.9	17.1	10.6	47.8	15.3	0.0	19.6	62.8	73.6	12.3	8.0	33.1	20.3	14.9	9.7	9.1	13.3	0.0	6.6	39.4	23.2	17.2	22.0	11.5	5.1	22.6	26.1	40.2	12.0	6.4
MTREX	"Dob1, fSAP118, KIAA0052, Mtr4, SKIV2L2"	ENSG00000039123	"Mtr4 exosome RNA helicase"	P42285	5	55307989-55425579	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"DNA damage, mRNA processing, mRNA splicing, rRNA processing"	"Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 42.3;Endometrial stromal cells: 44.0;Exocrine glandular cells: 40.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037379	Supported		Supported	Nucleoplasm		NA	NA		13000	"Cluster 27: Non-specific - Gene expression"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm		"HPA037379: AB_10601713"	"unprognostic (7.71e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.33e-3)"	"unprognostic (1.32e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.08e-1)"	"unprognostic (1.79e-2)"	"unprognostic (5.08e-1)"	"unprognostic (4.17e-2)"	"unprognostic (1.46e-2)"	"unprognostic (5.05e-2)"	"unprognostic (7.67e-2)"	"unprognostic (1.11e-2)"	"unprognostic (2.09e-1)"	"unprognostic (3.98e-1)"	"unprognostic (2.86e-1)"	"unprognostic (2.11e-1)"	20.4	22.7	10.2	21.9	11.5	18.5	22.0	17.4	12.7	22.5	14.4	17.7	24.6	22.1	14.1	19.1	17.8	19.8	24.3	9.7	11.2	20.8	19.6	16.7	25.9	11.1	10.8	20.1	21.2	26.6	17.2	18.9	11.5	21.6	19.9	17.8	18.9	14.7	29.9	20.8	24.1	13.8	11.4	19.2	20.9	23.4	10.3	21.9	25.8	22.5	21.8	21.0	19.8	14.9	40.9	49.2	38.4	39.9	32.8	35.0	49.5	33.4	28.3	39.7	50.1	57.1	51.2	79.3	37.4	33.1	52.9	28.5	76.8	50.3	59.9	14.2	53.2	51.6	45.4	45.9	31.3	33.4	44.8	27.5	31.3	42.9	51.6	33.6	35.1	29.7	60.9	45.0	37.9	35.8	32.3	36.5	38.4	16.8	46.6	39.5	44.1	33.9	41.3	56.9	42.0	28.8	40.4	24.5	35.4	42.4	52.5	44.8	33.2	10.0	27.5	28.4	62.0	31.5	33.6	59.0	27.0	69.5	40.8	3.6	5.0	5.4	7.2	4.7	6.9	6.1	5.7	6.8	6.4	6.4	6.1	6.2	1.3	4.5	7.9	6.7	5.6	4.1	10.2	11.5	17.4	12.7	9.7	11.2	11.1	10.8	11.5	11.4	10.3	14.9	27.6	32.1	42.3	0.0	10.1	0.0	0.0	0.0	0.0	0.0	22.3	13.8	0.0	0.0	21.7	20.2	0.0	25.0	24.6	0.0	11.7	32.0	0.0	28.2	44.0	10.0	0.0	0.0	0.0	40.7	21.5	16.2	0.0	26.2	25.2	30.8	0.0	0.0	15.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.5	0.0	0.0	13.9	0.0	0.0	0.0	0.0	35.7	0.0	0.0	8.3	0.0	0.0	22.3	26.2	0.0	0.0	0.0	12.2	0.0	0.0	0.0	0.0	34.9	11.6	31.7	0.0	0.0
MTRR	cblE	ENSG00000124275	"5-methyltetrahydrofolate-homocysteine methyltransferase reductase"	Q9UBK8	5	7851186-7906025	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Amino-acid biosynthesis, Methionine biosynthesis"	Oxidoreductase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 70.1;Late spermatids: 99.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038113	Supported		Approved	"Nucleoplasm,Intermediate filaments,Cytosol"		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 20: HeLa - Mitochondria"	"Cluster 11: Alveolar cells - Smell perception"	"Nucleoplasm, Cytosol"	"Intermediate filaments"	"HPA038113: AB_10671520"	"unprognostic (1.06e-1)"	"unprognostic (1.08e-1)"	"unprognostic (5.32e-2)"	"unprognostic (1.17e-2)"	"unprognostic (1.63e-1)"	"unprognostic (2.43e-1)"	"prognostic unfavorable (6.60e-4)"	"unprognostic (2.56e-2)"	"unprognostic (5.82e-2)"	"unprognostic (7.43e-2)"	"unprognostic (1.29e-1)"	"unprognostic (9.11e-3)"	"unprognostic (3.44e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.60e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.12e-1)"	11.2	10.6	5.1	9.5	11.2	5.7	6.3	10.1	10.9	7.2	3.4	8.3	8.9	11.7	12.3	9.3	9.6	11.8	14.4	6.5	9.0	18.7	19.4	13.1	11.1	10.9	10.4	11.4	11.9	12.8	6.7	10.8	10.6	9.0	10.1	19.2	10.5	7.1	28.9	9.1	10.2	12.0	8.2	6.7	6.7	7.1	9.3	7.5	9.0	32.9	10.6	14.4	5.5	20.0	19.3	18.1	10.2	20.0	34.0	13.6	25.1	31.1	18.5	16.5	15.4	27.8	15.1	32.6	27.9	24.6	27.4	11.8	17.0	14.2	27.9	22.9	15.8	14.6	62.0	15.3	21.9	23.4	6.8	18.3	11.4	24.6	18.4	20.4	10.4	8.0	21.9	24.2	9.8	4.2	14.2	11.7	7.3	29.4	19.0	12.4	9.5	14.1	16.2	16.0	14.0	2.5	51.6	33.7	28.6	18.1	10.7	17.5	14.6	31.9	19.7	24.1	22.7	34.7	13.5	27.3	23.1	50.5	19.1	5.3	4.0	3.0	4.1	5.5	7.0	3.3	6.5	5.7	3.6	3.3	4.1	3.6	0.1	3.1	4.4	2.3	9.1	3.3	5.1	11.2	10.1	10.9	6.5	9.0	10.9	10.4	10.6	8.2	9.3	20.0	7.7	16.0	70.1	10.1	11.1	16.3	9.4	4.6	12.0	0.0	9.7	5.1	12.9	5.7	9.0	9.2	0.0	9.9	11.4	11.0	21.5	10.2	50.1	10.0	10.7	8.0	9.6	12.4	25.4	5.5	8.9	11.8	9.2	6.7	10.2	6.5	8.6	19.3	7.7	0.0	20.8	9.1	0.0	11.1	9.4	99.2	10.5	9.7	1.8	15.0	8.1	0.0	7.2	20.1	50.9	7.2	6.0	11.7	26.5	14.3	8.7	28.9	10.1	0.0	6.6	10.7	10.1	17.4	13.1	10.5	20.6	11.2	13.8	11.8	9.4	8.7
MTSS2	"ABBA, ABBA-1, LOC92154, MTSS1L"	ENSG00000132613	"MTSS I-BAR domain containing 2"	Q765P7	16	70661204-70686053	"Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 372.5"	"Cell type enriched"	"Detected in some"	5	"Extravillous trophoblasts: 48.0"	"Cancer enhanced"	"Detected in all"		"glioma: 26.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"Hep G2: 299.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA048531, HPA066469"	Approved		Supported	"Focal adhesion sites"		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 20: HeLa - Mitochondria"	"Cluster 38: Extravillous trophoblasts - Unknown function"	"Focal adhesion sites"		"HPA048531: AB_2680430, HPA066469: AB_2685671"	"prognostic unfavorable (2.85e-4)"	"unprognostic (8.85e-2)"	"unprognostic (7.01e-2)"	"unprognostic (5.99e-2)"	"unprognostic (3.21e-1)"	"unprognostic (2.98e-1)"	"unprognostic (1.86e-1)"	"unprognostic (1.82e-1)"	"unprognostic (5.30e-2)"	"unprognostic (1.31e-1)"	"unprognostic (5.59e-3)"	"unprognostic (3.88e-1)"	"unprognostic (2.92e-3)"	"unprognostic (9.87e-2)"	"unprognostic (9.92e-2)"	"unprognostic (6.74e-2)"	"unprognostic (2.25e-2)"	31.7	40.5	299.2	20.9	295.8	9.4	26.9	283.7	279.1	66.1	102.2	89.2	14.3	78.9	6.1	50.7	47.4	29.0	36.7	296.0	324.9	25.3	106.0	47.2	10.1	372.5	316.2	35.6	13.7	12.8	25.0	36.0	311.5	42.1	8.2	25.6	30.6	37.1	81.1	32.6	27.4	60.0	254.5	58.3	29.9	10.8	313.2	42.5	21.3	29.9	7.9	46.6	46.0	278.5	67.2	157.4	38.9	40.4	31.6	31.2	146.4	98.8	122.0	83.0	68.5	63.8	41.9	0.8	34.6	155.5	33.0	136.9	42.5	43.2	31.5	1.2	56.9	23.2	137.7	299.9	278.1	35.0	1.1	129.3	92.6	38.6	133.0	35.7	27.6	35.0	88.8	1.4	74.8	164.1	33.4	177.8	34.2	22.6	33.1	70.6	72.5	0.4	72.4	99.0	91.1	61.0	210.5	90.6	27.2	36.6	69.9	67.2	41.9	64.3	72.6	59.0	62.7	23.4	6.4	1.2	58.3	1.0	22.5	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.1	299.2	295.8	283.7	279.1	296.0	324.9	372.5	316.2	311.5	254.5	313.2	278.5	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.1	0.0	0.0	0.0	0.0	4.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	48.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	9.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	6.2	0.0	0.0	0.0	0.0
MTTP	"ABL, MTP"	ENSG00000138823	"Microsomal triglyceride transfer protein"	P55157	4	99564081-99623997	"Disease related genes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"	"Lipid transport, Transport"		"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	21	"intestine: 275.2;liver: 266.6"	"Group enriched"	"Detected in many"	9	"Hepatocytes: 244.2;Proximal enterocytes: 605.4"	"Cancer enriched"	"Detected in many"	13	"liver cancer: 28.7"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"AF22: 10.8;Hep G2: 12.2"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"HPA051170, HPA054862"	Uncertain		Approved	"Endoplasmic reticulum,Cytosol"	"Intracellular and membrane"	NA	NA		640000		"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 45: Enterocytes - Digestion"	"Endoplasmic reticulum, Cytosol"		"HPA051170: , HPA054862: AB_2682628"	"unprognostic (1.66e-2)"	"unprognostic (1.14e-1)"	"unprognostic (5.64e-2)"	"unprognostic (5.33e-2)"	"unprognostic (3.49e-3)"	"unprognostic (7.38e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.74e-2)"	"unprognostic (1.08e-1)"	"unprognostic (3.66e-2)"	"unprognostic (1.00e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.27e-3)"	"unprognostic (2.02e-2)"	"unprognostic (3.64e-1)"	"unprognostic (1.53e-2)"	"unprognostic (1.31e-1)"	0.3	0.1	0.9	0.2	0.9	0.0	0.2	0.8	0.9	0.1	0.3	1.3	243.2	0.1	1.0	0.1	0.6	1.3	0.9	0.8	1.5	12.9	266.6	0.3	0.3	1.1	1.6	2.0	0.0	0.0	0.5	0.0	1.3	0.5	0.3	5.6	0.1	0.2	0.4	0.1	275.2	0.5	1.2	0.0	0.8	9.6	1.2	0.2	0.1	0.3	0.1	0.9	0.0	1.9	0.0	0.2	10.8	0.0	0.0	0.0	0.9	0.0	0.1	0.0	0.1	0.3	0.0	0.3	0.1	0.0	0.0	0.0	0.1	0.0	0.0	2.7	0.0	0.2	0.1	12.2	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.1	0.6	0.5	0.1	0.2	0.1	0.1	1.0	0.0	0.0	0.7	0.8	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.9	0.8	0.9	0.8	1.5	1.1	1.6	1.3	1.2	1.2	1.9	0.1	0.0	0.0	4.6	0.9	0.0	0.0	0.0	0.0	0.0	0.3	0.4	2.8	4.3	0.1	1.8	0.0	0.2	0.2	0.2	0.0	0.0	44.2	1.0	0.1	0.1	0.0	2.7	1.6	0.0	0.0	0.8	1.5	0.2	0.0	30.1	3.6	244.2	0.1	0.0	0.7	16.7	2.0	3.5	0.0	12.0	0.9	0.2	0.0	0.0	0.6	0.0	0.0	0.0	2.0	0.2	12.5	0.4	0.1	0.0	605.4	23.5	1.0	0.0	6.6	0.5	0.5	32.1	5.7	0.0	0.0	0.0	0.4	12.0	21.0	0.0
MTUS1	"ATBP, ATIP1, ATIP3, DKFZp586D1519, FLJ14295, ICIS, KIAA1288, MP44, MTSG1"	ENSG00000129422	"Microtubule associated scaffold protein 1"	Q9ULD2	8	17643795-17800917	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"			"Disease variant, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 408.9;Alveolar cells type 2: 281.0;Oligodendrocytes: 469.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"naive CD4 T-cell: 1.8;naive CD8 T-cell: 1.4"	"Lineage enriched"	"Detected in single"	19	"T-cells: 1.8"	"Cell line enhanced"	"Detected in many"		"A549: 115.7;AN3-CA: 100.1;HUVEC TERT2: 296.8;SK-MEL-30: 84.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA067903, HPA069795"			Enhanced	Nucleoli,Microtubules		No	No			"Cluster 32: T-cells - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Nucleoli, Microtubules"		"HPA067903: AB_2685921, HPA069795: AB_2686198"	"unprognostic (3.20e-1)"	"unprognostic (3.29e-1)"	"prognostic favorable (1.05e-4)"	"unprognostic (2.50e-2)"	"unprognostic (2.27e-1)"	"unprognostic (7.72e-3)"	"unprognostic (1.36e-1)"	"unprognostic (1.86e-3)"	"unprognostic (2.44e-1)"	"unprognostic (9.73e-2)"	"unprognostic (7.93e-3)"	"unprognostic (3.33e-1)"	"prognostic favorable (2.76e-4)"	"unprognostic (2.04e-1)"	"unprognostic (2.38e-2)"	"unprognostic (2.53e-3)"	"unprognostic (2.43e-1)"	52.9	39.0	65.6	13.4	100.4	0.3	45.0	97.4	81.7	34.5	59.3	36.6	32.6	31.4	22.6	38.0	28.7	37.9	85.6	66.0	76.9	26.2	56.8	40.4	9.0	106.4	90.8	51.4	98.2	65.2	22.9	70.0	104.2	31.9	39.1	56.9	49.9	24.7	106.2	26.0	33.4	38.2	75.7	16.1	42.2	12.2	87.6	22.8	27.3	167.4	14.5	35.8	31.0	151.1	21.9	115.7	18.5	100.1	0.1	0.6	33.2	1.1	7.8	0.6	2.3	8.7	7.8	2.8	8.5	0.0	4.8	22.2	30.8	10.9	1.1	15.8	13.2	0.0	19.2	55.8	6.6	0.0	0.4	9.1	16.4	2.4	33.3	0.0	296.8	7.7	0.0	43.3	0.1	5.7	4.4	5.7	26.5	44.1	2.9	0.1	17.0	11.5	5.9	44.4	9.2	2.2	14.8	26.6	84.7	11.0	19.2	0.3	61.4	0.1	24.0	0.1	0.2	5.9	3.5	0.0	0.3	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.2	0.0	0.0	1.8	1.4	0.0	0.0	0.0	0.0	0.0	0.4	65.6	100.4	97.4	81.7	66.0	76.9	106.4	90.8	104.2	75.7	87.6	151.1	408.9	70.5	281.0	139.1	2.9	21.0	56.4	38.9	58.1	0.0	42.7	31.6	141.6	55.8	88.4	20.2	0.0	23.8	1.6	58.5	11.7	50.1	18.5	71.4	53.8	154.5	15.0	0.0	6.1	174.2	40.0	83.8	94.8	144.2	9.5	7.6	29.3	71.2	58.2	0.0	81.8	47.3	22.4	4.1	16.1	24.5	76.4	9.0	28.4	174.3	2.7	0.0	2.1	39.2	469.2	56.5	19.1	57.2	15.3	77.9	52.4	10.4	49.4	0.0	19.7	69.7	60.1	2.4	8.3	45.3	20.3	54.0	7.1	79.8	49.3	81.3
MTUS2	"CAZIP, ICIS, KIAA0774, TIP150"	ENSG00000132938	"Microtubule associated scaffold protein 2"	Q5JR59	13	28820339-29505947	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"heart muscle: 50.2"	"Group enriched"	"Detected in some"	4	"Excitatory neurons: 548.4;Inhibitory neurons: 671.8"	"Cancer enhanced"	"Detected in some"		"urothelial cancer: 0.9"	"Region enhanced"	"Detected in many"		"cerebral cortex: 9.7"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"HaCaT: 13.2;HeLa: 5.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031473, HPA031474, HPA031475"	Enhanced		Supported	"Microtubules,Cytokinetic bridge"		Yes	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Microtubules, Cytokinetic bridge"		"HPA031473: AB_2673901, HPA031474: AB_10600109, HPA031475: AB_10600442"	"unprognostic (1.67e-1)"	"unprognostic (3.07e-1)"	"unprognostic (1.96e-1)"	"unprognostic (3.33e-3)"	"unprognostic (1.00e-1)"	"unprognostic (1.22e-2)"	"unprognostic (2.79e-1)"	"unprognostic (1.35e-1)"	"unprognostic (2.87e-1)"	"unprognostic (4.97e-2)"	"unprognostic (1.30e-3)"	"unprognostic (3.45e-2)"	"unprognostic (3.91e-5)"	"unprognostic (2.51e-2)"	"unprognostic (5.46e-2)"	"unprognostic (5.93e-2)"	"unprognostic (9.62e-2)"	0.2	0.2	0.4	0.1	1.7	0.1	0.1	1.2	9.7	0.6	1.8	0.9	0.1	1.5	0.0	0.3	0.8	0.1	50.2	1.0	0.0	0.1	0.9	0.1	0.6	0.0	0.1	7.5	4.8	0.0	6.1	0.0	0.0	0.3	0.2	4.6	1.0	0.1	0.1	0.2	0.4	1.2	2.2	0.5	1.3	1.2	1.0	0.2	0.5	0.1	0.1	1.3	0.2	2.4	0.0	0.0	0.8	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.1	0.2	13.2	0.4	0.0	0.0	0.0	0.5	0.0	5.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.6	0.1	0.0	0.0	0.0	0.0	1.0	0.0	2.3	1.6	0.1	0.4	0.0	0.2	0.2	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.7	0.2	0.1	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	1.7	1.2	9.7	1.0	0.0	0.0	0.1	0.0	2.2	1.0	2.4	0.1	0.0	0.5	10.4	0.1	0.5	0.7	0.1	0.0	0.0	0.3	0.4	145.8	0.0	1.3	0.0	0.0	0.1	0.0	0.1	0.0	0.0	5.4	0.3	1.0	0.7	0.0	0.8	548.4	0.6	0.0	5.9	0.0	1.1	0.0	1.2	0.4	0.5	0.1	0.0	671.8	0.7	0.0	0.0	0.8	3.3	0.9	0.2	1.8	15.0	0.1	0.0	0.0	18.1	16.2	0.4	0.0	0.0	0.1	0.2	0.0	0.0	3.6	0.0	0.0	1.6	1.0	0.1	4.1	1.8	0.1	0.3	0.3	19.6	0.0	1.1
MTX2		ENSG00000128654	"Metaxin 2"	O75431	2	176269395-176338025	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 201.5;Spermatocytes: 247.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031550, HPA031551, HPA031552"	Approved	Approved	Supported	Nucleoli,Mitochondria	"Intracellular and membrane"	NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 66: Spermatocytes - Spermatogenesis"	Mitochondria	Nucleoli	"HPA031550: AB_10599733, HPA031551: AB_10601442, HPA031552: AB_10794616"	"unprognostic (2.61e-1)"	"unprognostic (9.86e-2)"	"unprognostic (6.54e-2)"	"prognostic unfavorable (5.06e-4)"	"unprognostic (1.92e-2)"	"unprognostic (1.62e-2)"	"unprognostic (1.05e-2)"	"unprognostic (1.29e-1)"	"unprognostic (2.87e-2)"	"unprognostic (3.97e-2)"	"unprognostic (1.80e-2)"	"unprognostic (8.30e-2)"	"unprognostic (1.22e-1)"	"unprognostic (2.03e-1)"	"unprognostic (9.92e-2)"	"unprognostic (3.15e-2)"	"unprognostic (1.33e-2)"	20.4	37.4	31.8	15.2	33.6	9.2	27.0	32.8	46.7	22.1	35.9	31.2	22.8	18.7	39.3	38.1	28.9	14.5	49.8	33.3	34.4	46.4	30.8	15.6	14.2	33.9	32.0	21.1	26.3	48.1	29.5	25.8	33.2	26.4	35.5	47.3	20.4	22.6	74.4	23.4	20.2	25.7	34.0	15.6	24.4	64.3	33.5	18.2	20.4	70.9	20.8	25.1	24.7	35.6	52.2	31.0	60.8	37.8	40.0	45.9	58.3	54.5	52.0	49.8	58.3	53.1	55.8	66.4	91.4	49.1	79.9	34.5	67.1	67.6	67.9	66.6	49.4	63.9	39.1	94.9	62.7	98.9	20.7	51.1	83.5	52.2	89.1	60.3	72.0	64.3	86.8	50.2	59.6	47.4	34.9	102.9	58.3	101.8	45.5	0.0	44.0	60.8	142.4	93.3	87.0	74.4	45.7	60.9	120.7	116.4	33.7	64.0	63.5	49.2	43.5	52.1	57.9	55.4	62.1	79.8	61.1	49.7	60.8	8.0	9.3	4.1	9.6	15.8	13.1	18.9	12.4	11.1	14.8	13.7	14.9	15.4	0.0	19.6	14.4	12.1	16.9	9.9	31.8	33.6	32.8	46.7	33.3	34.4	33.9	32.0	33.2	34.0	33.5	35.6	34.4	19.2	22.6	50.6	20.8	31.1	36.2	130.9	37.5	0.0	38.2	43.8	69.2	31.5	63.6	57.0	0.0	78.8	11.1	38.8	201.5	51.8	22.3	60.9	25.7	31.4	41.5	19.5	106.0	39.5	63.3	30.2	28.1	33.9	43.1	25.7	16.4	33.7	47.8	0.0	106.3	47.7	103.7	21.7	15.7	18.8	35.4	19.6	35.6	43.1	26.1	0.0	12.3	93.5	180.2	49.8	26.1	32.7	23.1	48.2	39.6	106.3	63.8	0.0	39.5	24.9	52.4	247.8	127.1	56.5	41.9	65.0	18.8	55.8	52.6	53.7
MUC1	"ADMCKD, ADMCKD1, CD227, MCD, MCKD, MCKD1, PEM, PUM"	ENSG00000185499	"Mucin 1, cell surface associated"	P15941	1	155185824-155192916	"Cancer-related genes, CD markers, Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"			"Cancer-related genes, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 485.8;stomach 1: 1064.7"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 1370.0;Collecting duct cells: 491.1;Exocrine glandular cells: 1164.9;Gastric mucus-secreting cells: 640.6;Pancreatic endocrine cells: 1074.8;Respiratory ciliated cells: 555.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"T-reg: 1.2"	"Lineage enhanced"	"Detected in single"		"T-cells: 1.2"	"Group enriched"	"Detected in many"	6	"CAPAN-2: 1146.1;OE19: 548.3;RPTEC TERT1: 870.2;T-47d: 383.6"	"Not detected"	"Not detected"							"CAB000036, CAB001986, HPA004179, HPA007235, HPA008855"	Enhanced		Supported	"Plasma membrane"	"Secreted in other tissues"	NA	NA		4000000	"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	"Plasma membrane"		"CAB000036: AB_2148557, CAB001986: , HPA004179: AB_1846282, HPA007235: AB_1846281, HPA008855: AB_1846283"	"unprognostic (4.74e-2)"	"unprognostic (2.84e-2)"	"unprognostic (2.19e-1)"	"unprognostic (8.01e-2)"	"unprognostic (1.32e-2)"	"unprognostic (1.70e-1)"	"unprognostic (2.61e-3)"	"unprognostic (6.34e-2)"	"unprognostic (1.43e-1)"	"unprognostic (3.23e-1)"	"prognostic unfavorable (4.60e-4)"	"unprognostic (4.75e-1)"	"unprognostic (2.05e-2)"	"unprognostic (1.13e-1)"	"unprognostic (8.12e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.21e-1)"	15.2	6.3	5.3	21.9	5.7	9.4	78.2	4.7	8.6	194.2	4.7	176.0	21.4	40.2	61.6	209.9	120.0	125.8	6.8	5.1	5.7	485.8	3.9	321.5	1.8	7.8	6.3	9.8	358.5	1.0	14.1	3.3	6.0	43.9	103.6	1.3	135.0	34.4	1.9	20.6	35.2	20.0	6.1	5.4	1064.7	47.9	6.8	1.2	54.8	0.7	18.8	102.0	50.0	5.2	15.3	8.2	5.1	4.8	3.9	4.2	1.7	5.6	12.2	6.2	15.2	0.2	1146.1	0.0	81.9	9.5	2.7	23.2	1.0	0.3	1.8	10.4	0.8	1.8	101.5	0.0	2.4	0.4	36.1	9.5	2.1	2.8	2.2	12.7	2.1	1.9	9.2	15.4	4.3	120.0	1.6	1.2	3.5	548.3	2.1	2.3	0.6	29.3	870.2	0.9	5.1	2.1	28.0	48.3	1.5	4.1	383.6	5.6	2.2	3.9	6.7	10.5	1.2	17.7	9.8	0.2	5.9	1.1	1.4	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.6	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	1.2	0.1	5.3	5.7	4.7	8.6	5.1	5.7	7.8	6.3	6.0	6.1	6.8	5.2	2.3	432.7	1370.0	5.9	6.4	0.6	18.5	126.4	0.0	1.3	219.2	48.5	0.4	327.5	374.9	491.1	4.2	0.5	1.5	271.8	35.2	177.3	32.7	245.2	28.8	8.0	30.6	1.3	0.3	1164.9	1.1	7.0	640.6	282.8	48.0	0.3	1.8	0.9	0.2	1.7	0.3	351.5	164.8	2.2	1.0	81.0	2.5	7.2	5.4	1.0	24.3	1.7	0.0	0.5	0.1	1074.8	60.5	1.5	1.3	16.3	6.8	1.3	555.3	0.2	0.0	2.0	22.0	5.8	0.8	3.5	1.1	0.3	10.3	0.1	220.8	154.5
MUC5B	"MG1, MUC5"	ENSG00000117983	"Mucin 5B, oligomeric mucus/gel-forming"	Q9HC84	11	1223066-1262172	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	11	"salivary gland: 2621.9"	"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 443.2;Distal enterocytes: 158.4;Intestinal goblet cells: 210.1;Undifferentiated cells: 183.1"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"OE19: 113.9;PC-3: 120.0"	"Not detected"	"Not detected"							"HPA008246, CAB009396"	Enhanced		Supported	Vesicles	"Secreted in other tissues"	NA	NA		1300000		"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 21: OE19 - Mitochondria"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Vesicles		"CAB009396: AB_2282256, HPA008246: AB_1854203"	"unprognostic (2.01e-2)"	"unprognostic (1.46e-1)"	"unprognostic (9.39e-2)"	"unprognostic (2.76e-3)"	"unprognostic (5.46e-2)"	"unprognostic (1.22e-1)"	"unprognostic (4.89e-2)"	"unprognostic (7.80e-3)"	"unprognostic (3.75e-1)"	"unprognostic (1.11e-1)"	"unprognostic (4.18e-2)"	"unprognostic (8.95e-2)"	"unprognostic (2.57e-7)"	"unprognostic (2.71e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.07e-1)"	"unprognostic (8.13e-2)"	0.1	0.7	0.2	2.0	0.1	0.0	1.3	0.0	0.4	229.4	0.0	58.0	0.1	0.3	0.0	101.0	1.1	221.3	0.1	0.0	0.0	0.1	2.4	7.5	0.0	0.1	0.0	0.1	9.8	0.0	0.4	0.0	0.0	0.6	17.1	0.0	2621.9	0.0	0.3	0.4	2.6	0.6	0.0	0.0	6.9	0.3	0.0	0.0	0.2	0.0	0.4	0.2	0.1	0.0	0.0	17.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.5	0.1	0.2	0.0	113.9	120.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	32.8	0.0	2.3	0.0	0.0	6.7	0.6	0.0	6.4	4.3	12.4	443.2	64.0	0.0	0.0	0.1	0.0	158.4	0.0	0.9	0.0	1.4	0.8	0.9	24.5	0.0	0.1	0.0	0.1	1.1	12.8	7.2	4.5	0.0	0.0	1.2	0.2	0.0	0.0	210.1	2.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	53.4	0.0	1.4	1.3	0.1	0.2	24.5	0.0	0.0	0.0	3.0	0.0	0.5	1.6	0.0	0.1	0.7	0.1	183.1	1.1
MUL1	"C1orf166, FLJ12875, GIDE, MAPL, MULAN, RNF218"	ENSG00000090432	"Mitochondrial E3 ubiquitin protein ligase 1"	Q969V5	1	20499448-20508151	"Enzymes, Metabolic proteins, Predicted membrane proteins"	"Apoptosis, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026827			Approved	Nucleoplasm,Mitochondria,Cytosol		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Nucleoplasm, Mitochondria, Cytosol"		"HPA026827: AB_10601137"	"unprognostic (1.39e-1)"	"unprognostic (2.73e-2)"	"unprognostic (1.32e-2)"	"unprognostic (1.51e-1)"	"unprognostic (4.82e-3)"	"unprognostic (1.85e-3)"	"unprognostic (6.05e-3)"	"unprognostic (1.01e-1)"	"unprognostic (6.31e-2)"	"unprognostic (5.86e-3)"	"unprognostic (4.05e-1)"	"unprognostic (9.10e-2)"	"prognostic favorable (6.15e-14)"	"unprognostic (1.59e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.05e-2)"	"unprognostic (2.37e-1)"	16.7	18.1	18.1	12.0	18.7	28.8	16.2	19.9	19.4	15.9	23.3	21.2	14.2	20.4	11.1	21.2	19.6	14.9	33.7	17.8	19.4	19.5	24.6	15.8	13.6	20.3	19.1	19.1	19.8	36.3	14.6	16.3	20.1	16.0	15.7	7.4	19.3	20.0	35.5	21.8	15.8	20.0	18.7	15.2	18.7	12.2	19.5	12.0	16.2	50.4	15.0	19.2	15.5	19.9	34.1	32.1	18.1	37.9	38.5	21.6	19.6	32.9	39.1	40.1	38.2	19.9	54.8	25.4	35.9	46.8	30.4	50.3	32.9	47.5	28.9	25.4	26.1	19.4	20.4	29.2	45.2	27.0	32.0	35.3	61.6	41.1	42.3	23.4	26.5	22.5	25.8	30.1	44.1	17.3	16.4	18.1	18.7	28.1	30.3	15.8	22.8	32.9	47.1	18.7	18.4	27.3	29.6	31.2	40.5	14.6	22.0	25.6	30.2	38.8	22.3	34.1	29.9	34.9	32.9	27.3	30.4	36.1	36.7	36.2	30.0	38.2	33.1	34.7	34.4	25.3	24.8	33.8	29.6	22.8	28.1	27.6	26.7	32.3	30.7	22.8	37.9	34.0	18.1	18.7	19.9	19.4	17.8	19.4	20.3	19.1	20.1	18.7	19.5	19.9	14.5	22.4	10.3	10.4	9.8	5.2	9.2	13.9	5.2	13.5	12.3	11.9	16.6	10.0	9.5	18.4	6.2	37.1	13.2	21.6	11.7	26.3	2.2	7.7	9.5	13.1	8.5	8.6	4.9	23.4	22.5	13.9	7.7	9.4	3.8	14.7	13.6	17.6	23.0	13.5	6.8	12.9	16.2	10.0	6.5	4.0	13.1	9.3	19.6	2.8	15.5	16.0	16.5	5.5	6.0	25.6	14.6	15.4	13.1	9.2	13.2	10.6	9.6	11.9	19.7	11.9	14.7	14.6	15.4	7.4	7.1	37.6	9.2	18.0	12.2	10.7
MUS81	"FLJ44872, SLX3"	ENSG00000172732	"MUS81 structure-specific endonuclease subunit"	Q96NY9	11	65857126-65867653	"Predicted intracellular proteins"	"DNA damage, DNA recombination, DNA repair"	"Endonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 130.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059530	Approved		Supported	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 72: Non-specific - Transcription"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 34: Spermatids - Unknown function"	"Nucleoli fibrillar center"	Nucleoplasm	"HPA059530: AB_2684052"	"unprognostic (2.34e-3)"	"unprognostic (2.52e-1)"	"unprognostic (8.68e-2)"	"unprognostic (1.35e-1)"	"unprognostic (6.31e-2)"	"unprognostic (1.87e-1)"	"prognostic unfavorable (6.05e-4)"	"unprognostic (2.06e-1)"	"unprognostic (7.18e-2)"	"unprognostic (5.24e-2)"	"unprognostic (9.64e-2)"	"unprognostic (4.27e-2)"	"unprognostic (1.05e-3)"	"unprognostic (5.37e-2)"	"unprognostic (2.98e-1)"	"unprognostic (1.20e-1)"	"unprognostic (8.86e-2)"	20.6	18.0	15.2	13.3	15.6	11.3	20.3	15.7	20.0	32.0	14.4	31.4	16.9	35.4	7.7	16.9	30.8	10.9	25.3	14.6	13.4	28.8	19.4	21.6	18.6	16.6	15.6	29.8	19.9	10.2	22.4	11.0	15.9	26.2	7.1	8.1	16.6	15.9	24.3	14.1	23.7	12.4	14.8	29.0	22.5	16.6	16.7	16.1	23.5	16.9	13.6	29.7	22.5	18.8	21.6	13.3	22.1	22.0	9.5	11.5	28.2	22.7	17.9	28.2	18.8	17.7	34.4	20.4	30.0	17.8	35.2	20.6	19.9	19.9	6.3	44.5	14.7	37.3	39.8	10.8	29.0	26.9	38.2	18.3	36.2	35.8	28.0	20.7	24.0	36.5	22.9	55.4	18.7	14.2	38.1	41.0	16.1	14.1	29.2	37.2	10.6	39.7	21.5	13.3	22.1	25.3	15.5	27.7	48.7	13.5	32.6	27.3	21.5	21.2	18.0	27.3	24.9	37.6	26.9	29.7	24.1	17.5	36.3	22.6	13.7	27.4	21.0	16.3	21.0	13.1	15.9	18.4	14.7	10.4	12.3	15.4	9.4	13.3	18.5	14.7	15.1	13.0	15.2	15.6	15.7	20.0	14.6	13.4	16.6	15.6	15.9	14.8	16.7	18.8	19.3	12.8	18.4	15.0	17.2	8.0	21.5	13.5	10.2	19.2	11.8	15.6	10.0	11.5	16.0	7.3	20.9	20.8	22.0	27.0	5.9	24.7	62.8	12.2	22.0	16.1	16.8	25.7	9.0	22.2	23.6	13.5	27.0	13.0	14.0	15.0	16.8	9.2	19.6	23.5	8.8	23.9	10.2	13.3	8.8	130.0	21.8	14.3	10.6	9.4	27.1	15.0	32.0	8.5	12.9	26.6	24.5	27.1	12.6	11.0	36.1	12.4	16.0	24.7	39.5	11.5	21.9	27.9	16.7	8.4	7.4	19.7	19.9	15.0	21.4	10.2
MUTYH	MYH	ENSG00000132781	"MutY DNA glycosylase"	Q9UIF7	1	45329163-45340893	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair"	"Glycosidase, Hydrolase"	"Cancer-related genes, Disease variant, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 40.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA008732	Uncertain		Supported	Nucleoplasm		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 70: Brain - Nervous system development"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 47: Cytotrophoblasts - Unknown function"	Nucleoplasm		"HPA008732: AB_1854219"	"unprognostic (6.30e-3)"	"unprognostic (7.12e-2)"	"unprognostic (6.29e-2)"	"unprognostic (8.80e-2)"	"unprognostic (3.43e-1)"	"unprognostic (5.16e-3)"	"prognostic unfavorable (4.76e-8)"	"unprognostic (2.80e-2)"	"unprognostic (7.12e-3)"	"unprognostic (3.05e-2)"	"unprognostic (7.80e-2)"	"unprognostic (1.14e-1)"	"prognostic unfavorable (7.25e-5)"	"unprognostic (3.50e-3)"	"unprognostic (1.62e-1)"	"unprognostic (5.57e-2)"	"unprognostic (5.49e-3)"	5.0	5.0	11.9	5.5	12.7	6.7	5.3	16.7	15.6	7.6	10.6	6.0	6.4	6.3	4.6	5.1	5.7	4.2	4.0	11.6	11.9	7.0	5.9	4.4	7.7	12.8	12.4	7.3	5.1	5.1	5.9	6.4	12.7	5.8	5.6	4.9	4.5	5.0	5.6	5.9	6.1	3.6	11.7	7.8	5.8	3.3	12.2	9.8	6.6	4.7	7.0	5.9	5.8	14.4	7.9	6.9	15.5	10.5	11.3	8.4	26.6	5.7	7.4	11.8	9.2	14.3	11.2	22.5	9.0	3.6	9.5	11.3	8.7	11.0	5.4	18.1	7.0	10.2	11.4	10.5	10.0	9.4	7.1	4.6	10.3	16.0	25.7	3.1	8.6	28.6	17.5	7.4	5.0	13.3	27.3	8.7	39.6	19.5	7.9	36.2	12.6	12.3	6.1	14.6	14.5	11.8	11.3	8.7	18.2	20.1	6.7	11.1	4.9	8.3	6.2	7.2	8.2	11.6	14.6	13.3	8.0	14.6	7.5	1.6	7.0	2.9	11.5	11.8	17.2	8.1	11.8	11.5	8.1	8.0	12.7	12.2	1.4	8.8	9.1	6.5	13.4	8.6	11.9	12.7	16.7	15.6	11.6	11.9	12.8	12.4	12.7	11.7	12.2	14.4	10.0	0.0	5.6	17.0	12.1	6.9	10.7	8.1	6.2	15.6	6.7	8.8	3.2	1.5	6.9	7.3	2.1	40.2	8.8	16.5	3.9	6.5	0.9	3.2	5.1	7.6	7.8	6.7	4.0	5.3	14.3	7.5	16.8	3.2	10.8	8.4	5.7	4.3	10.0	5.0	7.0	15.1	12.2	4.0	10.2	1.6	10.8	5.6	7.2	8.4	8.2	12.0	10.3	11.6	12.7	3.8	16.4	12.0	7.5	9.5	12.9	12.2	8.6	20.1	13.1	8.7	7.6	10.5	11.2	5.2	5.4	22.2	13.9	9.5	13.5	8.0
MVB12A	"FAM125A, FLJ32495"	ENSG00000141971	"Multivesicular body subunit 12A"	Q96EY5	19	17405722-17433724	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041885, HPA042231"	Approved		Supported	Vesicles		NA	No			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 64: Macrophages - Immune response"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Vesicles		"HPA041885: AB_10964218, HPA042231: AB_10961043"	"unprognostic (1.34e-2)"	"prognostic favorable (3.26e-4)"	"unprognostic (1.48e-1)"	"unprognostic (2.35e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.52e-2)"	"unprognostic (5.96e-3)"	"unprognostic (8.49e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.77e-1)"	"unprognostic (9.93e-2)"	"unprognostic (3.87e-2)"	"unprognostic (2.29e-1)"	"unprognostic (2.54e-1)"	"unprognostic (2.89e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.33e-2)"	21.3	28.4	10.5	17.3	11.5	18.2	21.4	11.4	12.3	18.6	11.8	16.7	29.1	17.3	7.4	29.5	22.0	18.7	13.1	10.0	10.3	20.2	19.9	15.5	21.7	14.0	11.0	34.0	20.0	22.2	7.4	19.2	11.6	13.7	11.6	1.2	24.2	17.5	14.4	24.7	22.0	11.6	12.3	22.3	20.9	5.2	11.4	24.0	21.2	12.4	19.3	17.0	18.0	13.5	51.2	23.4	12.1	33.9	15.7	28.8	71.1	18.3	28.4	33.8	40.8	20.1	60.5	32.7	52.7	28.2	28.8	25.5	19.5	35.5	9.0	37.6	60.7	9.5	41.8	44.0	50.3	13.0	29.1	28.2	28.5	29.1	18.0	25.5	40.7	29.9	26.8	65.2	15.6	32.2	24.6	26.2	17.0	40.8	63.9	34.7	14.8	53.1	32.4	21.2	25.3	40.7	19.6	30.2	77.6	10.9	40.1	30.9	21.7	31.5	18.4	35.1	20.5	59.3	72.9	35.0	34.1	49.3	38.9	57.4	61.7	42.9	33.0	66.9	31.0	23.3	34.0	32.0	60.5	29.8	28.0	27.5	36.0	38.2	53.4	53.3	57.2	36.2	10.5	11.5	11.4	12.3	10.0	10.3	14.0	11.0	11.6	12.3	11.4	13.5	67.5	9.6	8.2	5.9	16.4	39.0	41.4	65.1	42.1	5.3	53.6	61.8	5.6	48.6	33.5	46.0	6.2	60.7	18.1	85.0	54.8	78.7	13.5	30.1	26.8	47.7	26.5	8.4	2.2	48.4	99.0	38.6	43.3	30.2	21.6	45.7	62.4	28.0	72.3	3.3	3.2	48.5	50.8	44.9	30.8	16.3	43.5	31.2	32.0	11.2	46.7	32.7	19.6	4.0	7.3	63.4	84.1	47.0	23.5	19.0	104.4	61.3	36.4	13.8	6.6	22.8	40.9	11.8	12.3	58.3	43.9	40.6	21.2	44.3	57.1	45.0
MVK	"LRBP, MK"	ENSG00000110921	"Mevalonate kinase"	Q03426	12	109573255-109598125	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Cholesterol biosynthesis, Cholesterol metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism"	"Kinase, Transferase"	"Cataract, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 69.1"	"Cell type enhanced"	"Detected in all"		"Early spermatids: 60.5;Horizontal cells: 62.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016961, HPA044110"	Approved		Supported	Vesicles,Cytosol		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 37: Intestine - Unknown function"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 15: Hepatocytes - Hemostasis"	"Vesicles, Cytosol"		"HPA016961: AB_1854220, HPA044110: "	"unprognostic (3.10e-1)"	"unprognostic (2.27e-2)"	"unprognostic (1.85e-1)"	"unprognostic (4.43e-2)"	"unprognostic (3.66e-2)"	"unprognostic (2.08e-2)"	"unprognostic (4.30e-2)"	"unprognostic (8.98e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.73e-2)"	"unprognostic (8.23e-2)"	"unprognostic (1.30e-1)"	"unprognostic (6.43e-2)"	"unprognostic (2.09e-1)"	"unprognostic (1.58e-1)"	"unprognostic (3.88e-1)"	"unprognostic (3.28e-1)"	7.9	29.8	12.7	6.1	13.7	8.3	14.7	16.7	15.0	14.5	9.6	11.2	13.9	7.3	10.2	45.5	6.3	5.3	9.4	11.1	13.2	32.1	69.1	11.4	6.9	36.1	15.5	10.7	10.0	11.5	11.6	5.4	38.6	12.3	8.6	7.3	13.7	7.0	12.1	33.3	9.8	5.0	15.3	6.7	11.8	28.5	15.3	4.2	15.1	8.8	9.1	9.5	20.1	24.4	30.1	25.0	29.9	13.7	11.2	27.3	14.4	9.5	21.7	30.0	32.8	31.4	33.8	17.7	7.8	11.7	48.1	36.0	31.6	50.0	13.2	19.0	18.1	9.9	15.7	53.7	31.5	11.1	13.0	27.2	42.1	48.8	13.6	12.6	20.9	19.0	18.7	17.4	13.6	34.5	12.0	34.6	22.6	14.9	32.3	10.5	22.1	37.0	67.4	40.9	25.1	18.7	19.8	58.7	14.0	11.0	59.7	21.1	14.1	13.2	14.5	12.0	12.8	13.3	20.6	28.2	16.1	29.2	16.6	1.0	6.9	4.0	12.6	6.5	11.3	9.4	7.4	12.4	8.6	14.1	10.9	8.3	1.6	11.0	4.6	7.0	7.6	6.4	12.7	13.7	16.7	15.0	11.1	13.2	36.1	15.5	38.6	15.3	15.3	24.4	6.1	12.8	12.4	6.8	8.3	4.7	5.2	39.7	4.6	12.4	13.1	11.0	5.7	11.5	25.8	14.7	18.8	33.0	7.3	10.4	21.5	15.6	60.5	5.8	2.3	7.1	9.0	4.8	5.1	18.1	15.3	6.8	9.7	5.1	1.3	14.7	6.4	32.7	15.6	62.2	5.2	7.8	10.2	3.4	2.2	42.5	8.1	4.8	7.2	3.7	10.3	10.6	10.3	4.0	15.3	13.2	3.2	7.2	4.1	5.5	16.4	52.4	13.5	12.2	6.6	4.0	8.2	33.9	16.8	12.0	8.5	47.9	6.1	44.8	11.1	4.6
MVP	"LRP, VAULT1"	ENSG00000013364	"Major vault protein"	Q14764	16	29820394-29848039	"Cancer-related genes, Predicted intracellular proteins, Transporters"	"mRNA transport, Protein transport, Translocation, Transport"	Ribonucleoprotein	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 504.7;Exocrine glandular cells: 310.8;Paneth cells: 338.3;Proximal enterocytes: 514.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"TIME: 429.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002321, CAB002752, CAB022717, HPA064740"	Enhanced		Supported	Cytosol		NA	NA		110000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Cytosol		"CAB002752: , CAB022717: , HPA002321: AB_1079277, HPA064740: AB_2685342"	"prognostic favorable (4.51e-4)"	"unprognostic (1.06e-1)"	"unprognostic (2.77e-1)"	"unprognostic (1.80e-1)"	"unprognostic (8.17e-2)"	"unprognostic (3.03e-2)"	"unprognostic (1.11e-2)"	"unprognostic (2.22e-2)"	"unprognostic (6.03e-3)"	"unprognostic (2.19e-1)"	"unprognostic (6.85e-3)"	"unprognostic (2.86e-1)"	"prognostic favorable (5.49e-5)"	"unprognostic (2.22e-1)"	"unprognostic (5.19e-2)"	"unprognostic (5.69e-3)"	"unprognostic (2.65e-2)"	84.4	181.7	26.2	96.0	35.7	46.4	71.0	29.9	33.7	76.6	32.5	165.6	154.7	73.1	14.3	75.4	73.3	74.3	64.4	26.0	31.9	113.4	66.9	121.9	71.1	43.1	36.4	103.3	101.9	18.9	47.5	38.0	35.5	59.7	96.5	6.3	77.1	38.9	50.6	61.1	158.9	69.0	32.6	114.0	107.8	39.4	42.3	31.3	60.6	32.4	47.6	80.0	72.9	38.3	64.8	191.8	0.8	1.7	212.0	275.0	25.9	163.4	258.5	88.0	121.4	24.7	216.8	3.1	134.9	231.0	108.9	78.1	0.8	129.5	42.2	166.4	1.8	3.0	81.6	87.6	190.1	2.3	60.2	366.9	96.1	207.0	58.3	170.5	274.5	6.2	0.5	92.1	167.7	18.3	0.8	4.3	2.4	93.4	11.6	2.1	0.7	32.5	229.1	114.6	10.5	7.6	41.8	53.8	31.8	6.5	9.5	18.7	429.3	124.2	59.4	119.9	62.0	66.6	45.1	2.7	294.6	4.8	24.9	50.4	140.8	56.3	70.9	214.3	55.1	36.6	80.7	73.6	113.1	27.2	59.4	54.0	160.0	73.7	204.0	69.2	90.7	164.4	26.2	35.7	29.9	33.7	26.0	31.9	43.1	36.4	35.5	32.6	42.3	38.3	34.2	48.1	115.5	9.8	31.2	19.6	39.3	120.3	16.5	4.8	17.9	10.0	12.9	82.9	112.0	69.9	2.1	113.6	31.2	504.7	45.0	272.7	4.9	43.9	25.9	40.9	56.5	8.6	3.2	310.8	71.4	52.8	120.8	65.9	33.7	14.8	36.4	23.8	78.0	8.4	3.4	177.1	95.6	41.0	27.1	21.1	57.5	55.0	32.0	9.4	223.3	3.0	59.8	0.0	23.1	278.5	338.3	47.8	36.4	25.0	514.8	194.8	110.3	4.9	19.7	23.8	51.3	2.7	1.8	20.7	21.9	264.5	45.1	24.7	206.8	56.7
MX1	"IFI-78K, lncMX1-215, MxA"	ENSG00000157601	"MX dynamin like GTPase 1"	P20591	21	41420020-41470071	"Predicted intracellular proteins"	"Antiviral defense, Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"salivary gland: 127.0"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 101.8;Extravillous trophoblasts: 77.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+: 820.2;BJ hTERT+ SV40 Large T+ RasG12V: 734.3;Karpas-707: 160.6;SK-MEL-30: 259.3"					"Low region specificity"	"Detected in all"			"HPA030917, HPA030918, HPA049724"	Approved	Approved	Supported	"Nuclear membrane,Cytosol"		No	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 64: Macrophages - Immune response"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Nuclear membrane, Cytosol"		"HPA030917: AB_10602010, HPA030918: , HPA049724: AB_2680862"	"unprognostic (3.62e-1)"	"unprognostic (6.84e-2)"	"unprognostic (3.41e-2)"	"unprognostic (2.55e-2)"	"unprognostic (3.97e-1)"	"unprognostic (2.27e-1)"	"unprognostic (1.35e-3)"	"unprognostic (5.86e-2)"	"unprognostic (1.77e-1)"	"unprognostic (3.50e-2)"	"unprognostic (1.03e-2)"	"unprognostic (6.88e-2)"	"prognostic unfavorable (1.57e-4)"	"unprognostic (9.95e-2)"	"unprognostic (8.10e-2)"	"unprognostic (3.24e-1)"	"unprognostic (1.81e-1)"	25.6	14.9	17.5	29.0	18.9	51.7	23.8	19.4	18.2	37.7	14.4	19.7	30.7	15.9	20.5	42.4	25.2	37.7	22.7	14.3	27.8	27.5	25.3	31.7	38.8	35.9	22.5	27.0	13.1	15.3	30.3	20.7	30.2	15.1	11.6	4.3	127.0	16.4	7.6	11.6	28.8	24.4	62.5	75.3	35.3	8.6	23.2	65.0	26.6	9.7	36.8	29.7	24.4	21.5	16.4	0.5	0.7	1.2	0.6	6.8	0.2	1.0	25.6	820.2	734.3	5.3	33.6	0.2	6.5	2.7	7.8	1.6	0.3	0.8	15.9	4.2	0.2	0.9	2.3	1.9	7.3	0.4	0.4	7.4	2.3	48.8	1.1	0.4	2.8	2.7	0.0	160.6	0.4	1.3	14.5	1.8	2.6	0.5	8.3	12.6	0.1	26.4	3.3	9.9	0.7	0.3	1.1	1.3	259.3	0.1	10.6	6.7	1.7	0.8	0.7	0.1	0.7	35.9	37.6	1.0	0.9	2.2	1.8	31.6	45.0	25.6	17.9	47.6	25.8	38.6	27.3	21.9	31.0	36.7	23.3	16.9	64.7	18.9	44.5	44.7	51.9	35.0	17.5	18.9	19.4	18.2	14.3	27.8	35.9	22.5	30.2	62.5	23.2	21.5	101.8	32.1	25.3	2.6	41.9	6.4	17.6	13.0	15.9	3.7	8.0	8.9	8.8	11.5	22.4	23.9	0.0	3.2	47.2	10.1	19.6	38.6	0.7	16.0	11.1	66.8	0.0	2.1	7.7	56.1	77.3	21.5	34.1	15.9	1.3	38.1	20.3	5.8	53.3	1.7	7.1	16.7	2.0	20.8	16.2	1.2	10.8	50.9	19.6	24.4	32.0	6.8	11.3	2.5	1.2	38.8	4.3	16.6	28.7	9.9	29.2	5.0	32.1	2.4	0.0	7.7	17.8	0.4	4.0	32.6	3.4	4.1	28.3	13.4	7.5	34.2
MXD4	"bHLHc12, MAD4, MST149, MSTP149"	ENSG00000123933	"MAX dimerization protein 4"	Q14582	4	2247432-2262109	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Adipocytes: 169.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"TIME: 68.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053363			Supported	Cytosol		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 35: Non-specific - Unknown function"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 7: Non-specific - Mitochondria"	Cytosol		"HPA053363: AB_2682128"	"unprognostic (1.26e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.37e-2)"	"unprognostic (2.84e-2)"	"unprognostic (3.54e-2)"	"prognostic favorable (2.21e-5)"	"unprognostic (1.64e-1)"	"unprognostic (5.94e-2)"	"unprognostic (8.37e-2)"	"unprognostic (1.57e-1)"	"prognostic favorable (1.39e-5)"	"unprognostic (5.65e-2)"	"unprognostic (1.09e-3)"	"unprognostic (2.13e-1)"	"unprognostic (1.46e-1)"	"unprognostic (2.64e-2)"	"unprognostic (4.12e-2)"	38.6	42.0	43.9	11.3	39.8	29.8	35.9	62.1	58.4	31.1	38.2	35.2	18.3	37.1	11.6	21.0	27.9	15.1	36.2	40.9	37.7	38.8	20.6	38.5	20.2	40.6	40.5	23.2	25.3	12.4	63.5	14.3	39.7	33.0	7.2	5.9	35.0	25.0	24.1	25.9	28.6	14.0	37.5	57.6	31.2	22.1	41.2	23.2	33.4	14.4	9.1	25.1	19.4	39.6	2.3	8.3	12.9	15.5	44.2	32.6	3.0	16.4	16.6	12.0	12.2	2.0	7.1	7.1	36.1	25.0	6.4	11.2	3.7	13.0	3.1	6.3	39.5	1.3	29.0	23.6	32.4	5.5	14.5	51.1	22.9	3.9	6.1	26.5	28.9	10.3	9.8	11.6	11.3	16.2	12.6	31.6	5.1	9.6	36.4	8.5	4.4	15.1	14.2	13.0	20.8	38.7	15.4	7.5	12.3	15.7	35.2	34.4	68.7	13.3	5.3	9.9	3.7	17.6	13.2	2.8	18.2	4.9	4.0	7.2	2.7	3.4	3.3	3.0	2.7	2.2	3.0	3.3	2.5	2.0	1.5	1.5	1.1	2.0	3.0	7.2	4.0	1.4	43.9	39.8	62.1	58.4	40.9	37.7	40.6	40.5	39.7	37.5	41.2	39.6	169.7	19.2	19.9	48.0	37.9	19.1	15.3	13.6	7.4	81.6	67.8	67.1	18.4	17.2	16.1	60.7	87.6	44.3	129.6	47.9	15.6	16.5	10.1	39.6	81.9	54.7	33.6	20.6	11.6	18.3	48.4	53.6	23.0	42.8	24.1	37.9	103.5	35.5	50.3	65.6	20.5	55.9	10.2	72.9	27.5	28.8	33.2	58.8	23.2	27.2	21.6	67.9	68.0	19.1	19.7	17.5	31.8	56.4	54.0	28.7	44.0	22.1	13.4	97.1	26.3	39.6	48.5	7.0	37.0	17.3	26.3	32.7	54.7	100.5	38.2	13.1
MXI1	"bHLHc11, MAD2, MXD2, MXI"	ENSG00000119950	"MAX interactor 1, dimerization protein"	P50539	10	110207605-110287365	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"	"Cancer-related genes, Disease variant, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Erythroid cells: 264.7;Oligodendrocytes: 214.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"hTERT-RPE1: 108.2;SK-MEL-30: 167.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035319, HPA035320, HPA056762"	Approved		Supported	"Nucleoplasm,Nucleoli,Nucleoli rim,Cytosol"		Yes	No			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm	"Nucleoli, Nucleoli rim, Cytosol"	"HPA035319: AB_10670588, HPA035320: , HPA056762: AB_2683229"	"unprognostic (1.77e-2)"	"unprognostic (2.02e-1)"	"unprognostic (3.34e-1)"	"unprognostic (3.03e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.71e-2)"	"unprognostic (1.08e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.37e-2)"	"unprognostic (1.59e-1)"	"unprognostic (9.26e-3)"	"prognostic unfavorable (9.17e-4)"	"prognostic unfavorable (1.02e-5)"	"unprognostic (3.05e-2)"	"unprognostic (1.36e-2)"	"unprognostic (2.29e-1)"	"unprognostic (2.96e-1)"	34.0	32.7	86.8	13.2	98.0	68.0	45.1	92.9	106.1	38.8	67.0	55.9	24.4	45.6	36.2	52.3	42.4	32.8	63.2	84.9	91.1	39.2	51.1	26.4	13.8	93.9	91.8	81.4	44.7	50.6	22.1	28.5	94.7	41.0	35.0	80.2	80.1	52.1	47.3	47.6	29.6	29.8	89.3	14.8	28.0	23.3	94.9	31.2	54.5	53.2	12.3	34.6	41.2	110.8	18.2	8.3	18.0	39.6	30.7	21.4	7.4	11.1	39.2	7.1	23.1	3.2	33.5	24.6	17.6	20.0	11.3	24.3	23.5	27.8	20.0	13.5	30.9	7.3	15.7	14.5	19.5	14.3	14.4	21.7	96.0	12.4	55.2	108.2	7.1	17.5	26.9	54.9	11.3	12.3	10.1	26.1	7.7	31.0	21.2	6.1	26.0	39.9	22.8	1.6	34.3	52.4	11.1	7.3	167.1	23.3	9.9	42.2	7.7	13.5	21.0	13.6	5.6	44.6	26.1	10.0	34.3	46.1	12.7	1.8	2.7	9.7	2.7	2.3	5.1	3.9	5.1	2.8	1.6	3.6	7.7	1.9	5.6	1.4	5.0	1.7	4.8	2.0	86.8	98.0	92.9	106.1	84.9	91.1	93.9	91.8	94.7	89.3	94.9	110.8	28.9	16.0	16.8	139.1	27.9	58.0	57.9	22.8	51.2	49.9	67.2	66.8	80.2	41.5	27.6	33.1	47.9	5.4	23.0	160.7	46.9	19.3	5.1	29.1	36.4	34.1	16.9	264.7	60.8	14.8	20.1	36.0	15.8	37.3	3.8	19.1	27.8	56.6	11.1	52.2	102.5	20.1	18.3	24.1	20.5	8.8	45.1	22.6	104.9	30.9	29.9	144.2	9.2	131.7	214.9	10.4	52.5	55.7	22.5	73.4	57.0	67.1	25.3	46.0	46.0	69.6	63.0	23.8	28.2	37.4	67.3	9.7	36.9	27.4	16.6	36.9
MYB	c-myb	ENSG00000118513	"MYB proto-oncogene, transcription factor"	P10242	6	135181308-135219173	"Cancer-related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"bone marrow: 35.2;breast: 20.1;intestine: 26.5;lymphoid tissue: 66.1"	"Cell type enhanced"	"Detected in many"		"Breast glandular cells: 47.8;Erythroid cells: 83.2;granulocytes: 26.0;Intestinal goblet cells: 32.7;Ionocytes: 26.4;Respiratory ciliated cells: 37.2;Undifferentiated cells: 52.0"	"Group enriched"	"Detected in many"	5	"breast cancer: 17.7;colorectal cancer: 16.4;stomach cancer: 5.6"	"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in some"	5	"basophil: 4.6;eosinophil: 5.4;plasmacytoid DC: 1.5"	"Group enriched"	"Detected in many"	5	"dendritic cells: 1.5;granulocytes: 5.4"	"Cell line enhanced"	"Detected in many"		"HL-60: 219.8;MOLT-4: 403.1;NB-4: 208.5;REH: 244.9;THP-1: 343.8;U-937: 186.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB017704, HPA071605"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm	Cytosol	"CAB017704: , HPA071605: "	"unprognostic (1.69e-1)"	"unprognostic (5.82e-2)"	"unprognostic (1.82e-3)"	"unprognostic (1.37e-2)"	"unprognostic (4.06e-1)"	"unprognostic (8.35e-3)"	"unprognostic (1.13e-3)"	"unprognostic (2.48e-2)"	"unprognostic (6.44e-2)"	"unprognostic (1.00e-1)"	"unprognostic (3.71e-2)"	"prognostic favorable (9.65e-4)"	"unprognostic (2.41e-11)"	"prognostic favorable (9.87e-4)"	"unprognostic (8.35e-2)"	"unprognostic (3.04e-2)"	"unprognostic (9.40e-2)"	0.3	0.5	1.6	5.3	1.7	35.2	20.1	0.0	0.7	1.6	0.4	25.3	10.9	1.0	0.1	3.0	8.4	0.9	0.1	0.3	0.2	0.1	0.4	2.0	6.3	0.9	1.0	0.0	0.3	3.6	0.0	0.4	0.6	1.4	26.5	0.3	0.6	0.9	0.1	3.0	9.4	1.4	0.2	1.2	2.0	0.7	0.3	66.1	0.1	0.0	7.0	1.1	1.3	0.1	1.8	0.3	1.9	3.0	0.0	0.1	0.3	1.0	0.6	1.1	1.1	0.3	1.4	10.9	0.4	0.3	0.4	0.9	5.6	0.0	0.7	18.0	2.5	138.8	1.0	0.5	0.1	219.8	105.1	0.0	0.1	0.6	0.0	0.5	0.3	133.4	114.6	20.1	1.1	11.6	403.1	208.5	1.5	19.2	1.7	244.9	5.9	33.2	0.3	1.5	10.5	6.9	0.5	10.4	0.6	0.5	7.9	343.8	0.4	0.3	1.6	7.9	2.4	27.7	7.7	66.0	0.1	186.1	2.3	4.6	0.7	5.4	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	1.5	0.4	0.2	1.6	1.7	0.0	0.7	0.3	0.2	0.9	1.0	0.6	0.2	0.3	0.1	0.2	0.0	1.3	0.0	2.3	2.7	1.3	1.3	0.6	0.9	47.8	12.6	0.4	2.8	7.1	0.0	0.0	1.4	9.1	18.1	0.0	0.0	0.1	24.3	0.3	0.3	17.6	83.2	0.6	0.8	0.4	0.5	4.6	2.2	26.0	0.4	0.0	0.0	1.1	0.0	2.7	32.7	26.4	1.2	1.7	0.2	0.0	2.1	8.8	0.0	2.8	0.9	0.0	0.0	0.2	0.1	10.2	0.0	4.6	2.1	2.3	0.0	37.2	0.0	0.0	0.6	0.9	0.0	1.8	10.2	7.0	0.3	3.6	0.1	52.0	2.2
MYBBP1A	"FLJ37886, P160, PAP2, Pol5"	ENSG00000132382	"MYB binding protein 1a"	Q9BQG0	17	4538897-4555386	"Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Biological rhythms, Ribosome biogenesis, Transcription, Transcription regulation"	"Activator, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005466	Supported		Supported	Nucleoli,Vesicles		No	No		47000	"Cluster 27: Non-specific - Gene expression"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoli	Vesicles	"HPA005466: AB_2667327"	"unprognostic (8.06e-2)"	"unprognostic (2.33e-1)"	"unprognostic (1.71e-1)"	"unprognostic (9.01e-2)"	"unprognostic (7.81e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.57e-3)"	"unprognostic (2.22e-1)"	"prognostic unfavorable (8.47e-4)"	"unprognostic (1.84e-1)"	"prognostic favorable (1.61e-4)"	"unprognostic (3.88e-3)"	"prognostic unfavorable (5.95e-4)"	"unprognostic (1.78e-1)"	"unprognostic (1.32e-1)"	"prognostic unfavorable (8.12e-4)"	"unprognostic (9.70e-2)"	12.3	11.0	3.8	13.4	3.8	11.4	15.9	1.3	7.6	13.3	0.8	11.9	9.6	14.6	4.6	17.0	15.2	6.2	11.0	5.0	4.2	9.8	10.8	11.4	13.8	5.2	4.9	14.1	24.4	6.7	12.7	5.2	3.5	17.1	5.1	3.8	18.9	10.1	27.9	22.0	12.9	7.3	2.1	14.0	12.4	8.1	3.4	7.4	11.2	8.0	8.7	14.9	13.8	3.8	60.1	90.0	11.9	56.2	15.4	17.1	40.8	39.8	17.5	39.5	30.8	67.1	24.4	80.4	47.2	23.9	19.8	74.2	50.1	61.3	19.0	40.3	133.8	38.8	58.3	62.2	25.2	45.5	34.7	25.7	34.6	58.8	29.1	11.0	26.6	45.0	64.2	37.1	18.2	51.4	54.2	19.5	56.0	19.1	48.0	69.8	19.7	54.0	9.8	45.5	25.5	48.5	40.8	29.7	28.2	8.6	27.5	19.1	34.3	35.1	31.5	32.7	118.6	32.1	26.5	34.4	32.5	53.9	45.3	0.0	1.9	0.3	2.8	1.6	3.4	2.9	2.3	3.1	2.9	1.7	2.5	2.8	0.1	2.4	3.4	2.1	1.0	2.7	3.8	3.8	1.3	7.6	5.0	4.2	5.2	4.9	3.5	2.1	3.4	3.8	13.4	9.6	14.5	4.6	13.1	12.9	6.8	7.1	12.0	8.2	12.9	14.4	4.1	8.6	13.3	3.7	12.5	2.9	5.8	9.2	0.0	7.7	0.5	6.7	15.3	17.0	11.4	7.2	11.3	12.7	5.4	10.2	10.7	8.5	5.1	12.2	8.6	7.8	6.5	10.1	6.1	8.0	4.1	4.5	6.8	0.6	5.6	6.3	3.6	7.5	3.8	3.8	6.2	3.5	6.5	8.2	4.5	12.0	13.7	13.9	4.6	3.2	12.2	6.2	6.6	10.8	12.9	2.6	11.1	12.8	11.9	1.1	9.7	13.8	12.4	6.2
MYBL1	"A-myb, AMYB"	ENSG00000185697	"MYB proto-oncogene like 1"	P10243	8	66562175-66614247	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Differentiation, Spermatogenesis, Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 20.1;testis: 11.8"	"Group enriched"	"Detected in many"	6	"dendritic cells: 127.3;NK-cells: 107.1;Plasma cells: 40.2;Spermatocytes: 35.8;T-cells: 89.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"gdT-cell: 1.9;MAIT T-cell: 1.3"	"Lineage enhanced"	"Detected in single"		"T-cells: 1.9"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+: 82.5;BJ hTERT+ SV40 Large T+ RasG12V: 69.4;Daudi: 87.7;HBF TERT88: 113.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA008791	Uncertain		Supported	Nucleoplasm		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm		"HPA008791: AB_1078540"	"unprognostic (1.11e-1)"	"unprognostic (2.47e-2)"	"unprognostic (2.57e-1)"	"unprognostic (7.23e-4)"	"unprognostic (2.26e-1)"	"unprognostic (1.89e-2)"	"unprognostic (6.67e-3)"	"unprognostic (2.38e-1)"	"unprognostic (1.25e-1)"	"unprognostic (3.78e-2)"	"unprognostic (1.13e-2)"	"unprognostic (3.74e-3)"	"prognostic unfavorable (2.03e-8)"	"unprognostic (2.04e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.75e-1)"	"unprognostic (5.87e-2)"	1.0	0.7	1.1	6.1	2.2	2.5	1.7	2.0	1.7	0.7	0.3	1.0	1.3	1.1	0.5	0.7	0.8	2.3	3.4	1.0	1.3	0.4	2.0	2.3	20.1	2.9	1.7	0.6	0.2	0.4	0.4	0.9	3.2	1.2	1.4	5.9	0.5	1.6	0.9	1.2	1.9	2.3	1.9	7.6	1.3	11.8	1.6	2.5	0.6	0.8	16.1	1.1	0.8	3.7	35.4	11.9	3.7	10.1	1.0	2.1	2.6	47.7	21.8	82.5	69.4	1.6	34.9	87.7	4.2	40.4	31.0	10.0	3.5	4.0	113.0	10.6	5.5	1.8	13.4	1.6	0.2	0.8	3.4	0.7	0.4	22.7	19.0	14.8	2.7	6.4	0.4	28.3	51.0	3.1	5.8	1.3	2.8	3.3	15.8	1.9	14.1	2.2	19.4	1.2	8.2	3.3	8.4	3.0	8.6	5.6	50.6	2.3	14.5	49.4	11.3	11.1	44.2	8.2	12.1	25.7	13.0	5.3	20.0	0.0	0.0	0.0	1.9	0.0	1.3	0.0	0.3	0.8	0.0	0.0	0.0	0.3	0.0	0.5	0.0	0.0	0.0	0.1	1.1	2.2	2.0	1.7	1.0	1.3	2.9	1.7	3.2	1.9	1.6	3.7	3.0	0.0	2.3	3.3	4.0	1.8	0.4	0.3	1.8	10.4	4.7	6.6	9.1	2.8	0.1	0.0	2.1	2.0	127.3	0.5	0.0	0.5	3.9	0.8	2.4	1.7	0.0	6.6	3.9	0.0	0.7	2.7	3.1	1.4	0.0	5.6	4.2	0.9	0.7	5.0	2.7	0.4	0.0	1.6	3.2	4.2	0.9	5.1	1.8	8.4	1.6	10.3	107.1	5.5	12.4	0.2	1.1	0.0	40.2	0.3	0.0	0.5	1.5	9.1	0.0	2.5	4.5	35.8	6.8	3.2	0.4	1.5	89.1	1.4	0.8	0.3
MYBL2	"B-MYB, BMYB"	ENSG00000101057	"MYB proto-oncogene like 2"	P10244	20	43667019-43716495	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"bone marrow: 91.8;lymphoid tissue: 55.5"	"Cell type enhanced"	"Detected in many"		"B-cells: 33.0;dendritic cells: 32.6;Erythroid cells: 82.3;Extravillous trophoblasts: 32.3;Plasma cells: 139.6;Spermatogonia: 33.6"	"Cancer enriched"	"Detected in all"	5	"testis cancer: 295.8"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in some"	34	"plasmacytoid DC: 91.5"	"Lineage enriched"	"Detected in many"	34	"dendritic cells: 91.5"	"Cell line enhanced"	"Detected in many"		"MCF7: 763.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB017114, HPA030530, HPA055416"	Uncertain		Supported	Nucleoplasm,Cytosol		Yes	Yes			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 65: Plasmacytoid DCs - Unknown function"	Nucleoplasm	Cytosol	"CAB017114: , HPA030530: AB_2673515, HPA055416: AB_2682811"	"unprognostic (9.75e-3)"	"unprognostic (1.29e-2)"	"unprognostic (3.20e-1)"	"prognostic unfavorable (9.73e-4)"	"unprognostic (2.35e-1)"	"unprognostic (1.67e-1)"	"prognostic unfavorable (2.11e-7)"	"unprognostic (2.66e-3)"	"unprognostic (9.23e-3)"	"unprognostic (1.78e-1)"	"unprognostic (2.38e-3)"	"unprognostic (1.32e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (1.42e-1)"	"unprognostic (2.27e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.84e-1)"	1.6	0.6	0.1	24.2	0.1	91.8	1.6	0.1	0.2	1.1	0.2	8.6	7.0	1.4	0.1	10.1	0.4	1.0	0.4	0.1	0.1	0.6	1.1	1.8	55.5	0.1	0.1	0.3	11.2	0.1	0.2	5.7	0.1	0.5	6.9	0.0	1.6	0.2	0.1	4.2	7.8	2.1	0.1	27.8	6.1	15.6	0.4	33.3	0.5	0.0	53.5	3.5	2.5	0.1	195.8	121.8	105.4	109.6	1.0	3.5	136.2	87.0	29.0	265.6	194.6	600.2	118.8	393.6	49.2	37.8	55.8	116.1	192.1	59.6	98.8	74.2	124.1	183.2	118.7	164.2	0.2	168.6	121.7	2.4	5.1	101.6	22.9	5.9	72.2	189.6	188.1	470.3	23.8	763.7	346.0	236.3	121.8	155.4	105.4	237.3	216.3	222.1	49.6	39.7	96.7	140.6	255.6	253.3	26.1	110.4	167.2	183.1	34.0	16.3	264.3	118.3	151.5	162.1	363.8	606.5	34.2	142.3	103.9	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.3	0.0	1.4	0.0	0.0	0.1	0.2	0.0	91.5	1.3	0.8	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.4	0.1	0.2	0.0	0.0	0.0	33.0	4.2	0.8	0.8	0.0	0.0	2.5	3.4	2.0	1.5	0.1	0.0	0.0	14.4	32.6	3.4	0.0	0.4	5.9	0.9	1.3	1.8	0.0	82.3	0.4	0.9	32.3	4.8	10.2	2.9	0.0	18.9	0.7	1.4	13.5	0.0	0.3	5.1	0.0	2.4	2.6	14.1	0.0	3.2	1.8	0.0	0.0	0.0	1.0	0.0	0.5	0.7	1.1	0.0	139.6	0.3	0.5	0.0	0.0	0.0	0.0	0.1	3.9	7.0	33.6	8.2	2.4	3.7	3.0	1.2	8.6	2.4
MYCBP2	"FLJ10106, KIAA0916, PAM, PHR1"	ENSG00000005810	"MYC binding protein 2"	O75592	13	77044657-77327094	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Biological rhythms, Ubl conjugation pathway"	"Guanine-nucleotide releasing factor, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 425.4;Inhibitory neurons: 471.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HL-60: 110.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA058807			Supported	Nucleoplasm,Vesicles,Cytosol	"Intracellular and membrane"	NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 32: U-937 - Innate immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm	"Vesicles, Cytosol"	"HPA058807: AB_2732627"	"unprognostic (1.79e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.75e-1)"	"unprognostic (2.03e-2)"	"unprognostic (8.36e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.48e-1)"	"unprognostic (6.42e-2)"	"prognostic favorable (5.01e-5)"	"unprognostic (2.63e-1)"	"unprognostic (9.84e-2)"	"unprognostic (4.04e-2)"	"unprognostic (1.00e-1)"	69.9	22.2	42.3	19.0	46.2	32.8	49.3	37.3	52.4	43.4	18.8	29.4	9.0	27.2	29.8	45.9	29.2	12.5	32.9	48.6	35.9	22.6	24.5	28.3	40.0	34.6	29.6	43.1	30.9	14.9	32.3	10.9	36.9	28.0	12.5	28.9	29.1	13.3	26.5	79.7	34.8	11.9	30.1	56.4	24.9	26.3	33.9	34.6	27.2	18.1	37.8	30.4	41.5	38.7	21.6	10.8	12.9	14.1	62.9	27.9	7.5	13.4	19.8	11.5	14.7	9.7	11.0	61.4	8.3	26.6	11.2	19.5	22.4	24.7	15.5	24.5	22.2	52.2	22.2	20.1	21.4	110.8	17.7	31.5	20.2	10.6	20.8	11.4	26.5	22.3	11.3	18.8	20.7	13.1	30.5	74.3	6.8	28.7	13.6	34.2	13.1	15.0	19.6	21.1	20.2	9.4	16.2	23.1	12.8	13.0	8.6	83.8	35.0	10.9	9.1	7.3	13.0	20.3	15.0	42.7	22.1	89.2	11.3	1.4	2.0	2.0	3.2	2.1	2.8	4.9	3.6	2.8	1.9	4.3	4.1	3.2	1.8	2.8	1.6	2.7	4.5	1.4	42.3	46.2	37.3	52.4	48.6	35.9	34.6	29.6	36.9	30.1	33.9	38.7	92.2	38.5	52.2	158.7	170.3	82.3	39.9	32.6	63.7	229.3	36.8	38.4	69.7	25.8	30.9	35.0	104.3	46.1	109.2	14.2	1.9	26.1	56.0	50.9	61.1	83.8	32.6	46.9	425.4	33.1	31.5	80.6	38.2	66.6	48.2	34.0	44.6	52.4	41.8	218.7	471.3	19.7	26.4	106.9	48.2	23.4	65.9	100.4	32.0	282.9	116.7	121.5	120.5	338.8	212.5	30.2	15.8	96.3	121.9	53.7	15.2	13.2	19.5	94.8	105.2	76.7	76.0	81.5	71.6	129.1	150.7	43.9	121.5	67.4	28.1	42.4
MYCBPAP	"AMAP-1, DKFZp434N1415"	ENSG00000136449	"MYCBP associated protein"	Q8TBZ2	17	50508384-50531501	"Predicted intracellular proteins"	"Differentiation, Spermatogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	12	"testis: 65.1"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 224.2;Late spermatids: 145.2;Respiratory ciliated cells: 40.4;Spermatocytes: 69.9;Theca cells: 54.9"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 4.4;JURKAT: 3.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA023257, HPA024405"	Enhanced		Approved	Vesicles		NA	NA			"Cluster 22: NK-cells - Unknown function"	"Cluster 49: Ciliated cells - Cilium organization"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 34: Spermatids - Unknown function"	Vesicles		"HPA023257: AB_2671126, HPA024405: "	"unprognostic (2.05e-2)"	"unprognostic (1.79e-2)"	"unprognostic (9.13e-3)"	"unprognostic (3.98e-5)"	"unprognostic (8.62e-4)"	"unprognostic (3.65e-2)"	"unprognostic (1.52e-3)"	"unprognostic (1.61e-1)"	"unprognostic (2.38e-3)"	"unprognostic (1.11e-1)"	"unprognostic (7.32e-4)"	"unprognostic (2.52e-1)"	"unprognostic (1.39e-4)"	"unprognostic (7.15e-2)"	"unprognostic (1.97e-1)"	"unprognostic (7.37e-2)"	"unprognostic (2.02e-2)"	0.7	0.8	1.7	0.6	1.8	1.3	0.4	2.4	3.4	1.2	3.4	0.4	0.2	0.9	1.1	0.8	5.3	1.0	0.6	1.3	1.0	0.8	0.2	1.5	1.0	2.9	2.4	2.5	0.2	0.4	0.9	0.3	1.4	1.0	0.4	1.1	0.8	1.3	1.1	1.0	0.3	0.9	1.5	0.6	0.4	65.1	1.6	0.9	0.8	0.3	0.6	0.3	0.5	1.1	0.1	0.8	0.3	0.3	0.8	0.4	0.8	0.7	0.3	0.2	0.2	0.4	2.0	0.2	0.1	0.2	0.8	0.3	0.1	0.9	0.2	4.4	0.2	1.3	1.3	0.4	0.7	0.1	0.2	1.2	0.2	0.4	1.8	0.8	0.6	3.8	0.2	0.4	0.6	0.1	0.2	0.3	0.1	0.1	0.5	0.1	0.2	0.2	0.0	0.2	0.6	1.6	0.3	0.2	0.1	0.5	0.3	0.8	2.0	0.3	0.4	0.1	0.1	2.3	0.8	0.1	0.5	0.2	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.1	0.0	1.7	1.8	2.4	3.4	1.3	1.0	2.9	2.4	1.4	1.5	1.6	1.1	0.3	0.0	1.7	7.2	0.7	0.1	1.4	0.7	0.0	3.6	0.4	0.3	0.9	0.0	6.5	1.8	0.0	2.4	1.7	0.4	0.0	0.1	224.2	18.6	1.2	1.1	0.0	3.6	2.5	0.4	0.3	2.0	0.0	0.6	0.0	5.6	0.0	0.0	0.4	0.0	2.2	1.8	0.0	0.6	0.5	145.2	6.8	0.6	0.0	2.8	0.0	4.3	3.1	0.5	1.0	0.1	0.1	3.8	0.6	1.1	1.4	0.2	40.4	0.5	0.0	2.7	1.4	69.9	7.6	0.1	0.4	0.1	1.4	54.9	0.4	0.8
MYCT1	"FLJ21269, MTLC"	ENSG00000120279	"MYC target 1"	Q8N699	6	152697895-152724567	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 49.6"	"Group enriched"	"Detected in some"	5	"Adipocytes: 123.0;Endothelial cells: 141.3;Hepatic stellate cells: 230.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	33	"eosinophil: 30.7"	"Lineage enriched"	"Detected in single"	248	"granulocytes: 30.7"	"Group enriched"	"Detected in some"	5	"HUVEC TERT2: 124.6;TIME: 104.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA047992			Approved	Nucleoplasm,Vesicles		NA	NA		120000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Nucleoplasm	Vesicles	"HPA047992: "	"unprognostic (2.92e-1)"	"unprognostic (1.82e-1)"	"unprognostic (5.95e-2)"	"unprognostic (2.06e-1)"	"unprognostic (6.73e-2)"	"unprognostic (6.80e-2)"	"unprognostic (4.64e-3)"	"unprognostic (6.78e-2)"	"unprognostic (9.90e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.66e-2)"	"unprognostic (2.18e-2)"	"prognostic unfavorable (4.73e-4)"	"unprognostic (1.26e-3)"	"unprognostic (1.08e-1)"	"unprognostic (1.25e-1)"	"unprognostic (3.36e-2)"	26.6	3.2	6.8	5.2	6.9	1.2	21.4	6.9	10.2	9.0	5.2	6.1	3.5	10.1	4.5	4.6	9.2	10.5	17.1	6.3	7.1	6.6	13.1	15.6	6.2	7.7	6.9	3.6	2.7	4.3	2.2	20.7	8.6	4.4	5.8	1.0	3.7	3.8	12.8	4.7	5.6	12.4	6.8	49.6	4.5	1.8	10.0	2.5	12.2	20.5	3.0	8.1	7.3	7.5	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.9	0.0	17.7	0.1	0.0	0.2	0.0	0.1	0.0	23.0	0.3	0.0	0.7	0.1	0.1	0.0	0.2	0.2	0.3	0.0	124.6	0.0	0.3	0.3	0.4	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.0	2.1	0.0	0.0	104.4	0.5	0.8	1.5	0.0	1.1	0.0	15.6	0.0	0.0	0.0	0.9	0.0	30.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.1	0.0	0.1	0.0	0.6	6.8	6.9	6.9	10.2	6.3	7.1	7.7	6.9	8.6	6.8	10.0	7.5	123.0	0.0	5.2	0.7	0.8	7.1	0.2	0.1	2.8	0.2	0.4	0.9	3.1	2.8	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.2	10.2	1.3	0.2	141.3	0.0	13.7	0.1	0.2	0.0	4.0	0.0	0.1	1.3	0.0	230.6	2.1	0.1	0.0	0.1	0.0	0.0	7.3	7.3	3.7	0.3	13.3	14.2	30.9	0.1	0.0	0.0	0.5	0.2	0.1	0.0	0.0	0.6	0.5	0.0	0.0	17.7	0.0	0.0	1.5	2.2	0.1	0.1	0.5	5.5	0.0	0.9	0.5	0.0	0.7
MYD88		ENSG00000172936	"MYD88 innate immune signal transduction adaptor"	Q99836	3	38138478-38143022	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Immunity, Inflammatory response, Innate immunity"		"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Kupffer cells: 75.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SK-BR-3: 172.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB009104	Approved		Supported	Vesicles,Mitochondria,Cytosol		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 64: Macrophages - Immune response"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	Cytosol	"Vesicles, Mitochondria"	"CAB009104: AB_2146724"	"prognostic favorable (8.45e-4)"	"unprognostic (1.19e-1)"	"unprognostic (4.31e-2)"	"unprognostic (2.51e-2)"	"unprognostic (4.77e-2)"	"unprognostic (4.38e-3)"	"unprognostic (4.37e-2)"	"unprognostic (3.63e-1)"	"unprognostic (1.67e-1)"	"unprognostic (7.28e-2)"	"unprognostic (1.01e-2)"	"unprognostic (7.30e-2)"	"unprognostic (2.11e-2)"	"unprognostic (4.41e-1)"	"unprognostic (4.17e-2)"	"unprognostic (1.65e-1)"	"unprognostic (2.08e-2)"	20.1	14.2	6.9	43.5	7.4	51.8	15.0	7.2	7.5	15.2	8.0	30.3	32.2	12.1	18.6	36.6	14.4	23.5	9.4	6.7	7.7	13.7	61.1	42.6	35.2	9.5	7.5	11.4	11.6	11.6	9.2	22.6	8.0	14.3	31.7	2.1	18.0	12.0	3.2	17.7	32.2	24.5	8.6	40.7	27.6	7.7	9.2	38.3	9.4	8.8	41.6	47.4	20.3	8.5	25.1	34.2	5.9	33.2	25.0	32.0	10.8	23.6	39.0	68.1	72.9	22.7	30.9	52.8	13.8	44.7	15.8	30.9	43.2	24.2	22.1	39.5	8.7	28.5	16.6	36.6	21.4	36.2	72.0	38.4	26.6	39.2	15.3	13.2	39.9	40.3	13.3	22.3	36.8	25.7	61.3	12.2	22.1	52.8	35.7	24.8	7.0	23.1	37.6	58.9	3.0	12.0	33.4	172.1	22.3	4.8	25.8	40.8	35.5	13.8	7.9	60.6	24.0	28.9	32.9	38.5	25.0	63.0	28.9	288.5	236.9	296.9	67.2	333.6	58.1	43.7	60.6	69.3	203.6	35.2	42.1	59.5	284.7	54.6	436.1	99.9	87.4	257.3	6.9	7.4	7.2	7.5	6.7	7.7	9.5	7.5	8.0	8.6	9.2	8.5	13.4	6.4	15.2	2.0	19.5	14.4	13.5	12.7	14.2	1.0	11.3	10.8	1.6	5.7	16.4	5.5	0.0	14.6	35.3	40.8	7.9	24.5	1.4	10.9	30.2	15.9	9.6	9.7	0.2	27.3	24.4	10.8	23.9	18.6	24.1	10.0	10.4	33.2	32.2	0.0	0.4	14.9	10.2	75.4	40.5	0.9	13.7	61.5	3.6	1.9	58.1	4.1	28.8	2.5	0.3	64.0	34.8	10.5	12.9	16.0	28.0	12.2	12.1	0.1	13.1	4.3	7.2	8.6	0.6	15.1	17.2	12.0	19.6	10.2	15.9	49.4
MYEF2	"FLJ11213, HsT18564, KIAA1341, MEF-2"	ENSG00000104177	"Myelin expression factor 2"		15	48134632-48178353	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Inhibitory neurons: 87.8;Oligodendrocyte precursor cells: 88.4;Spermatocytes: 106.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 101.9;SCLC-21H: 90.8;SK-MEL-30: 91.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004883	Supported		Supported	Nucleoplasm		NA	NA			"Cluster 22: NK-cells - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 62: Horizontal cells - Visual perception"	Nucleoplasm		"HPA004883: AB_1079436"	"unprognostic (4.30e-2)"	"unprognostic (8.59e-2)"	"unprognostic (5.01e-2)"	"unprognostic (2.17e-1)"	"unprognostic (2.02e-2)"	"unprognostic (7.18e-3)"	"unprognostic (2.76e-3)"	"unprognostic (6.81e-2)"	"unprognostic (2.35e-1)"	"unprognostic (4.09e-2)"	"unprognostic (1.55e-5)"	"unprognostic (1.32e-2)"	"unprognostic (3.76e-3)"	"unprognostic (7.94e-2)"	"unprognostic (2.51e-2)"	"unprognostic (7.26e-2)"	"unprognostic (4.05e-1)"	4.7	15.0	17.2	4.9	18.1	1.6	7.7	26.0	23.5	2.3	13.5	11.4	3.6	5.7	10.0	2.5	12.1	6.9	8.8	17.4	21.1	17.8	0.5	5.8	7.0	17.6	17.1	1.7	14.2	13.9	22.8	1.4	16.9	8.9	4.9	33.1	6.4	10.5	1.4	4.4	4.9	7.5	17.2	6.2	9.2	28.2	17.4	10.4	5.5	2.2	7.6	3.7	1.3	20.8	0.3	30.1	101.9	63.9	1.0	0.1	0.0	31.4	8.3	15.7	6.9	12.1	12.8	22.1	40.2	7.1	10.9	0.2	43.1	1.9	20.9	60.3	16.5	13.5	0.0	5.1	5.1	15.6	10.5	0.5	1.2	0.2	2.1	47.5	28.5	30.5	2.2	30.5	12.8	17.6	24.0	0.2	44.1	7.5	5.3	0.0	8.0	0.7	51.2	5.8	90.8	69.7	0.0	9.2	91.9	47.6	49.3	19.7	18.6	5.0	24.3	18.9	73.6	13.5	54.4	0.1	9.3	0.1	20.2	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.1	0.1	0.2	0.0	0.2	0.1	0.0	0.4	0.0	0.2	0.2	0.0	17.2	18.1	26.0	23.5	17.4	21.1	17.6	17.1	16.9	17.2	17.4	20.8	15.9	12.8	16.8	56.8	13.9	0.8	2.3	1.2	1.2	80.4	26.2	17.0	9.4	7.2	11.6	49.7	79.2	0.6	7.9	3.3	31.3	20.5	70.7	40.1	3.0	10.9	52.1	8.8	80.8	11.3	0.2	5.5	4.1	18.3	4.5	47.6	6.8	0.1	0.4	82.4	87.8	8.2	2.0	1.0	6.8	41.0	2.1	3.9	10.6	22.5	3.8	33.5	3.1	88.4	43.9	11.0	6.8	1.2	5.8	7.3	0.5	26.7	47.7	61.0	0.0	7.1	13.2	106.1	25.3	0.5	1.0	0.0	7.8	2.8	6.9	1.6
MYF5	bHLHc2	ENSG00000111049	"Myogenic factor 5"	P13349	12	80716912-80719671	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Myogenesis, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	23	"skeletal muscle: 5.6;tongue: 8.9"	"Cell type enriched"	"Detected in single"	1159	"Skeletal myocytes: 347.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	22	"LHCN-M2: 478.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA041691			Supported	Nucleoplasm		NA	NA				"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 50: Fibroblasts - ECM organization"	Nucleoplasm		"HPA041691: AB_10796780"						"unprognostic (2.65e-2)"												0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	5.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	478.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	347.9	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
MYG1	"C12orf10, Gamm1, MYG"	ENSG00000139637	"MYG1 exonuclease"	Q9HB07	12	53299695-53307177	"Disease related genes, Predicted intracellular proteins"		"Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 16.4;Cytotrophoblasts: 38.4;Extravillous trophoblasts: 60.7;Hofbauer cells: 70.1;Syncytiotrophoblasts: 25.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038626, HPA038627"	Approved	Supported	Supported	Nucleoplasm	"Intracellular and membrane"	NA	NA		20000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 43: Testis - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm		"HPA038626: AB_10674692, HPA038627: AB_2676123"	"unprognostic (5.33e-2)"	"unprognostic (4.41e-2)"	"unprognostic (6.77e-2)"	"unprognostic (2.44e-2)"	"unprognostic (3.59e-1)"	"unprognostic (7.56e-2)"	"unprognostic (1.61e-3)"	"unprognostic (2.73e-1)"	"unprognostic (1.97e-1)"	"unprognostic (3.58e-2)"	"unprognostic (2.71e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.81e-1)"	"unprognostic (6.41e-2)"	"unprognostic (2.18e-1)"	"unprognostic (2.16e-1)"	"unprognostic (1.61e-1)"	33.8	35.8	40.0	18.0	41.4	20.8	31.8	45.5	66.7	35.0	40.4	33.2	18.6	32.8	21.2	24.9	35.7	20.7	32.0	39.7	44.0	36.9	28.0	20.8	22.5	45.4	45.6	40.6	45.4	31.4	29.0	15.4	46.8	25.3	14.9	17.3	26.1	20.8	48.0	31.3	21.1	19.8	41.9	20.5	33.2	104.8	43.5	22.7	30.6	26.3	19.9	34.4	27.5	42.2	42.3	78.0	33.8	53.5	35.1	52.4	3.9	27.3	43.6	62.0	44.1	74.5	44.9	40.6	63.2	38.3	35.1	46.6	46.8	60.8	32.8	34.0	78.9	41.7	60.4	91.5	81.0	43.8	27.1	49.7	40.1	57.4	58.1	61.7	53.8	46.8	2.4	81.0	41.5	164.8	58.9	71.0	55.0	42.7	73.9	54.9	31.9	93.6	53.7	41.0	66.7	63.9	30.9	60.3	68.3	19.3	94.8	42.0	37.3	60.3	55.8	43.7	43.9	73.3	81.8	43.8	75.7	37.2	47.6	24.2	55.0	26.1	35.8	44.4	52.6	49.9	46.3	35.5	63.5	41.5	47.8	44.3	14.6	42.4	32.9	39.8	69.5	50.1	40.0	41.4	45.5	66.7	39.7	44.0	45.4	45.6	46.8	41.9	43.5	42.2	13.8	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.4	0.0	0.0	0.0	0.0	38.4	6.8	0.0	0.0	0.0	0.0	0.0	0.0	5.1	0.0	0.0	0.0	0.0	60.7	9.7	0.0	0.0	0.0	0.0	0.0	0.0	70.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.3	0.0	0.0	0.0	0.0	25.9	1.5	0.0	0.0	0.0
MYH9	"DFNA17, EPSTS, FTNS, MHA, NMHC-II-A, NMMHCA"	ENSG00000100345	"Myosin heavy chain 9"	P35579	22	36281280-36387967	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell adhesion, Cell shape"	"Actin-binding, Calmodulin-binding, Motor protein, Myosin"	"Alport syndrome, Cancer-related genes, Cataract, Deafness, Disease variant, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"TIME: 1343.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001644, CAB015386, HPA064783"	Enhanced		Supported	"Nuclear bodies,Plasma membrane,Actin filaments,Cytosol"		No	No		410000000	"Cluster 41: Basophils - Cellular respiration"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 1: Pancreatic cells - Digestion"	"Plasma membrane, Actin filaments"	"Nuclear bodies, Cytosol"	"CAB015386: AB_784698, HPA001644: AB_1079439, HPA064783: AB_2732721"	"unprognostic (1.38e-1)"	"unprognostic (9.12e-2)"	"unprognostic (4.21e-2)"	"unprognostic (6.34e-2)"	"unprognostic (1.49e-1)"	"unprognostic (3.90e-2)"	"unprognostic (9.56e-2)"	"unprognostic (8.28e-2)"	"unprognostic (5.50e-2)"	"unprognostic (6.38e-2)"	"unprognostic (1.93e-2)"	"unprognostic (1.61e-1)"	"unprognostic (7.98e-2)"	"unprognostic (9.48e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.59e-2)"	295.9	95.5	42.3	181.1	42.1	245.9	231.5	40.6	54.7	181.2	65.5	192.6	107.0	356.4	39.3	153.8	182.2	134.5	161.1	50.8	39.4	140.7	101.6	286.2	161.7	52.7	51.7	121.1	160.3	55.0	52.6	166.5	48.1	131.8	89.8	9.7	177.2	98.4	84.0	160.6	163.5	174.1	48.8	232.5	135.8	38.2	52.1	125.1	141.2	46.3	104.1	168.8	166.8	48.2	612.2	277.0	86.2	74.2	156.8	195.1	437.3	398.4	507.5	554.6	413.2	302.1	170.3	156.9	230.1	666.1	265.0	412.7	125.2	779.4	559.6	356.1	120.9	302.6	294.3	259.9	481.1	346.9	463.8	233.0	234.7	751.9	626.4	540.3	461.8	113.2	67.3	205.8	448.9	161.9	124.4	204.0	51.7	171.1	169.2	233.3	267.3	146.7	314.5	581.5	129.6	53.0	559.7	217.0	251.6	218.5	162.4	177.1	1343.7	1222.6	370.3	237.5	731.5	135.2	114.7	129.0	463.2	172.3	363.1	72.6	25.2	64.7	32.4	19.8	28.4	13.4	23.5	26.4	17.2	11.9	18.3	20.4	41.2	9.0	26.5	8.0	26.3	54.5	42.3	42.1	40.6	54.7	50.8	39.4	52.7	51.7	48.1	48.8	52.1	48.2	303.9	118.6	87.1	12.7	108.4	144.0	182.4	123.1	72.8	2.6	90.5	89.4	62.6	80.1	89.7	92.0	2.1	87.0	151.7	359.8	7.9	309.4	35.8	89.7	121.6	258.7	73.8	51.9	42.5	245.8	193.1	82.9	123.8	194.7	93.1	117.1	132.8	102.8	100.4	82.4	6.7	131.0	59.0	119.6	124.2	37.4	68.0	168.8	85.4	61.8	196.6	11.9	137.0	7.5	33.3	344.6	186.8	211.4	125.9	184.4	159.8	27.5	51.5	5.3	203.8	39.9	275.2	6.9	10.4	133.6	135.1	46.4	213.2	141.3	139.5	134.3
MYLK	"MLCK, MLCK1, MYLK1, smMLCK"	ENSG00000065534	"Myosin light chain kinase"	Q15746	3	123610049-123884332	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Actin-binding, Calmodulin-binding, Kinase, Serine/threonine-protein kinase, Transferase"	"Aortic aneurysm, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"seminal vesicle: 1700.3;smooth muscle: 2137.7"	"Cell type enhanced"	"Detected in many"		"Breast myoepithelial cells: 728.5;Hepatocytes: 208.7;Peritubular cells: 690.5;Sertoli cells: 276.1;Smooth muscle cells: 448.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"basophil: 7.4"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BJ: 200.0;BJ hTERT+: 298.2;fHDF/TERT166: 260.2;hTERT-RPE1: 202.7;RPTEC TERT1: 291.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB020789, HPA031677, HPA048055"	Enhanced		Enhanced	"Plasma membrane,Actin filaments"		NA	NA		1500000	"Cluster 34: Basophils - Unknown function"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 48: Smooth muscle cells - ECM organization"	"Actin filaments"	"Plasma membrane"	"CAB020789: , HPA031677: AB_10794617, HPA048055: AB_2732543"	"unprognostic (2.80e-2)"	"unprognostic (5.05e-2)"	"unprognostic (5.55e-2)"	"unprognostic (2.85e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.41e-1)"	"unprognostic (4.86e-2)"	"unprognostic (8.55e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.40e-1)"	"unprognostic (8.21e-2)"	"unprognostic (1.58e-1)"	"prognostic unfavorable (2.04e-6)"	"unprognostic (5.26e-3)"	"unprognostic (9.60e-2)"	"unprognostic (3.00e-1)"	"prognostic unfavorable (4.46e-4)"	143.6	57.4	37.6	188.7	64.8	3.3	163.4	72.1	42.4	281.3	14.1	551.5	110.9	669.2	232.9	420.6	289.8	250.4	33.6	33.6	46.7	64.4	67.2	85.2	33.6	104.6	64.8	95.9	15.3	11.6	2.6	70.2	99.3	907.6	299.1	13.6	140.1	1700.3	10.0	20.1	125.1	2137.7	55.6	89.5	122.7	50.5	52.2	8.0	22.2	14.9	19.1	505.7	84.8	112.1	14.4	38.4	10.8	7.8	10.8	1.9	4.7	200.0	298.2	137.3	92.1	8.1	7.4	0.6	42.5	260.2	67.0	4.8	5.2	1.8	149.0	0.2	0.7	102.4	0.9	28.9	56.1	0.6	9.8	36.9	3.5	24.4	34.4	202.7	8.9	1.3	1.2	0.5	90.9	1.7	0.2	2.5	12.0	0.5	5.1	13.5	6.8	36.7	291.9	8.5	1.4	6.4	21.8	1.9	3.1	25.0	1.0	0.3	33.4	39.5	13.9	10.3	30.7	3.4	4.2	0.3	104.0	1.0	9.6	7.4	1.6	0.4	0.1	0.2	0.0	0.2	0.0	0.0	3.5	0.1	0.2	0.1	5.0	0.0	0.0	3.3	0.2	20.9	37.6	64.8	72.1	42.4	33.6	46.7	104.6	64.8	99.3	55.6	52.2	112.1	45.9	16.0	38.3	43.4	2.5	20.5	27.2	24.8	1.2	2.9	19.9	728.5	25.2	37.1	5.7	27.6	125.1	0.8	3.5	88.1	3.9	6.0	40.7	45.9	46.6	56.9	11.4	3.2	25.2	3.9	0.8	40.1	3.1	54.4	2.5	3.2	45.3	208.7	4.9	3.3	3.4	3.9	8.2	7.9	37.0	33.8	104.7	20.8	19.6	8.4	1.2	4.7	0.0	5.5	37.0	4.0	18.7	690.5	3.3	8.6	14.2	17.2	17.6	19.9	276.1	5.6	448.7	4.7	4.6	1.3	20.2	2.5	3.2	4.5	4.2	3.7
MYLK2	"KMLC, MLCK2, skMLCK"	ENSG00000101306	"Myosin light chain kinase 2"	Q9H1R3	20	31819308-31834689	"Disease related genes, Enzymes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Calmodulin-binding, Kinase, Serine/threonine-protein kinase, Transferase"	"Cardiomyopathy, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	12	"skeletal muscle: 732.0"	"Cell type enriched"	"Detected in some"	5	"Skeletal myocytes: 15.9"	"Cancer enhanced"	"Detected in some"		"glioma: 1.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Karpas-707: 4.1;RH-30: 10.5;RPMI-8226: 8.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA059704, HPA059890"	Enhanced		Supported	"Endoplasmic reticulum"		NA	NA				"Cluster 33: Striated muscle - Muscle contraction"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 37: Myocytes - Muscle contraction"	"Endoplasmic reticulum"		"HPA059704: AB_2684108, HPA059890: AB_2684153"	"unprognostic (1.74e-2)"	"unprognostic (1.87e-1)"	"unprognostic (8.84e-2)"	"unprognostic (5.27e-2)"	"prognostic favorable (4.00e-4)"	"unprognostic (5.58e-2)"	"unprognostic (1.38e-7)"	"unprognostic (2.29e-1)"	"unprognostic (2.60e-3)"	"unprognostic (1.99e-1)"	"unprognostic (1.20e-1)"	"unprognostic (4.73e-2)"	"unprognostic (7.25e-11)"	"unprognostic (2.01e-1)"	"unprognostic (3.15e-1)"	"unprognostic (2.60e-2)"	"unprognostic (2.70e-2)"	0.1	0.0	0.6	0.1	0.6	0.4	0.1	0.6	0.7	0.0	0.5	0.2	0.0	0.1	0.1	4.7	0.1	0.0	0.3	0.6	0.6	0.0	0.0	0.1	0.0	0.6	0.7	0.1	5.5	0.0	0.1	0.0	0.7	1.1	0.0	0.0	2.4	0.0	732.0	0.6	0.1	0.1	0.6	0.3	0.2	0.2	0.7	0.2	0.2	60.3	0.0	0.0	0.0	0.6	0.3	0.0	0.7	0.6	0.0	0.0	0.4	0.1	0.0	0.3	0.0	0.2	0.2	0.5	0.3	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.6	0.3	0.0	0.0	0.5	0.1	0.0	0.0	0.3	0.0	1.3	0.8	0.5	0.1	4.1	0.1	0.6	0.5	0.3	0.5	0.0	0.3	0.6	10.5	8.8	0.0	0.1	0.5	0.5	2.7	0.1	0.0	0.1	0.1	0.1	2.1	0.2	0.7	0.4	2.4	0.0	0.8	0.2	0.1	2.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.6	0.6	0.7	0.6	0.6	0.6	0.7	0.7	0.6	0.7	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	1.2	0.0	0.0	0.1	0.4	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	1.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	2.8	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.9	0.3	0.3	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0
MYNN	"SBBIZ1, ZBTB31, ZNF902"	ENSG00000085274	Myoneurin	Q9NPC7	3	169773396-169789716	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045149	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm		"HPA045149: AB_10960839"	"unprognostic (7.13e-2)"	"unprognostic (2.28e-2)"	"unprognostic (3.67e-2)"	"unprognostic (2.19e-2)"	"unprognostic (1.17e-2)"	"unprognostic (2.02e-1)"	"unprognostic (3.09e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.03e-2)"	"unprognostic (2.77e-1)"	"unprognostic (8.25e-3)"	"unprognostic (1.25e-3)"	"unprognostic (1.34e-3)"	"unprognostic (1.05e-1)"	"unprognostic (1.52e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.36e-3)"	6.0	5.3	3.4	6.5	4.1	14.8	9.7	7.2	4.5	7.9	4.4	5.7	5.1	10.3	6.3	7.1	6.8	6.2	5.8	3.1	3.4	6.8	7.9	6.4	8.7	3.0	3.5	10.0	7.3	8.4	3.6	7.1	3.3	7.2	7.0	15.3	6.3	6.3	7.9	7.8	6.8	8.4	3.5	7.9	7.0	9.9	3.4	7.6	8.5	10.8	9.8	7.4	5.5	5.2	13.1	6.0	6.9	13.6	14.2	12.2	8.7	8.6	12.4	13.0	14.3	7.3	13.1	19.7	15.3	9.4	10.3	10.2	12.5	10.9	17.2	17.7	9.8	18.4	9.1	7.2	12.0	17.1	12.9	10.8	13.9	7.9	22.8	10.5	11.7	8.6	7.9	18.9	13.0	11.0	10.1	8.8	10.4	16.1	6.6	11.1	9.7	21.4	8.6	22.1	9.6	11.3	10.4	23.5	14.8	9.0	29.0	12.5	8.7	11.9	5.4	11.1	16.6	21.6	16.4	26.8	9.5	10.6	11.7	22.2	4.8	11.2	7.3	5.2	10.0	8.1	8.4	7.1	5.5	7.9	10.0	7.7	6.7	10.8	4.5	5.5	9.1	7.7	3.4	4.1	7.2	4.5	3.1	3.4	3.0	3.5	3.3	3.5	3.4	5.2	25.8	28.9	21.6	10.7	25.2	41.3	31.1	21.4	46.7	9.0	14.9	12.1	14.7	14.3	20.3	11.0	22.9	14.6	20.1	9.8	13.7	10.4	46.3	15.8	14.8	20.3	14.3	14.5	15.6	9.4	17.0	16.6	19.4	20.3	7.6	12.7	11.4	7.3	8.2	10.1	15.0	8.4	20.3	7.5	14.0	12.6	17.1	12.3	16.0	13.1	12.7	13.3	19.6	12.5	14.0	9.9	9.4	18.8	31.6	18.1	12.2	12.3	18.3	31.7	6.6	15.7	14.7	34.9	18.8	27.3	38.4	20.8	25.5	12.0	9.6	25.7
MYO10	KIAA0799	ENSG00000145555	"Myosin X"	Q9HD67	5	16661907-16936288	"Plasma proteins, Predicted intracellular proteins"	Transport	"Actin-binding, Calmodulin-binding, Motor protein, Myosin"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Granulosa cells: 189.5;Muller glia cells: 233.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	4	"non-classical monocyte: 2.5"	"Lineage enriched"	"Detected in single"	5	"monocytes: 2.5"	"Cell line enhanced"	"Detected in many"		"HeLa: 182.1;SK-MEL-30: 205.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB015224, HPA024223"	Enhanced		Supported	"Nucleoli rim,Plasma membrane,Cytosol"		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 22: Non-specific - Unknown function"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 40: Granulosa cells - Unknown function"	"Plasma membrane, Cytosol"	"Nucleoli rim"	"CAB015224: , HPA024223: AB_1854248"	"unprognostic (1.13e-2)"	"prognostic unfavorable (4.35e-4)"	"unprognostic (7.63e-2)"	"unprognostic (1.04e-1)"	"unprognostic (4.43e-2)"	"unprognostic (2.96e-2)"	"unprognostic (4.40e-2)"	"unprognostic (8.34e-2)"	"unprognostic (2.51e-2)"	"unprognostic (3.16e-2)"	"unprognostic (8.42e-2)"	"unprognostic (1.85e-1)"	"prognostic favorable (2.75e-4)"	"unprognostic (8.93e-2)"	"unprognostic (9.86e-2)"	"unprognostic (4.56e-2)"	"unprognostic (1.84e-1)"	13.8	3.0	47.4	6.2	46.3	3.2	7.9	24.6	41.1	6.7	55.1	19.3	22.8	6.2	3.5	9.3	4.3	8.4	4.5	39.8	24.8	14.7	7.7	19.0	1.3	32.6	30.9	15.8	32.2	10.7	9.5	31.5	27.6	5.8	19.1	15.1	11.0	5.0	8.2	15.6	19.5	4.9	27.3	13.9	32.0	15.6	46.4	4.9	37.5	4.4	2.0	11.1	7.8	45.7	68.2	108.3	31.3	14.9	24.7	17.0	35.1	117.2	89.2	35.5	27.4	63.1	10.2	1.5	78.9	52.9	42.3	33.4	139.1	73.7	57.1	0.2	16.7	0.1	182.1	13.7	81.5	0.4	1.5	30.9	26.8	78.5	92.1	57.4	110.5	0.2	0.2	4.8	28.7	10.5	0.2	0.4	80.5	56.6	37.2	26.1	10.3	66.9	22.0	49.6	5.2	2.8	27.0	11.4	205.0	53.2	8.1	9.1	137.8	77.6	23.6	0.7	61.1	0.7	0.5	0.5	38.3	11.2	76.2	0.5	0.2	0.2	0.1	0.5	0.1	0.1	0.1	0.1	0.2	0.3	0.2	0.2	0.3	0.1	2.5	0.1	0.1	0.1	47.4	46.3	24.6	41.1	39.8	24.8	32.6	30.9	27.6	27.3	46.4	45.7	53.5	35.3	34.6	158.7	1.4	40.9	31.0	23.0	29.6	11.0	18.6	11.6	3.8	55.8	26.3	31.3	18.8	20.4	0.3	46.4	17.6	110.8	30.2	118.5	20.8	61.3	74.0	0.0	3.9	40.6	63.4	13.7	68.3	116.0	27.8	189.5	77.1	1.7	5.6	82.4	5.4	53.2	20.3	7.1	4.8	9.5	12.8	5.7	67.6	87.1	3.8	233.8	0.0	103.5	23.5	114.7	50.3	19.2	0.4	42.6	28.3	4.2	18.8	9.2	65.7	8.2	31.5	3.8	12.2	30.7	31.8	147.8	2.4	4.1	66.9	38.6
MYO18B	BK125H2.1	ENSG00000133454	"Myosin XVIIIB"	Q8IUG5	22	25742144-26031045	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		"Actin-binding, Motor protein, Myosin"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"heart muscle: 120.8;skeletal muscle: 262.7;tongue: 55.6"	"Group enriched"	"Detected in some"	21	"Cardiomyocytes: 95.5;Early spermatids: 61.4;Late spermatids: 37.3;Skeletal myocytes: 32.8"	"Cancer enhanced"	"Detected in some"		"head and neck cancer: 0.8"	"Region enhanced"	"Detected in single"		"thalamus: 2.3"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 10.6;REH: 15.0;RH-30: 30.5;U-2 OS: 13.2;U-266/70: 9.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA000953	Uncertain		Supported	Nucleoplasm,Centrosome		NA	NA				"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 54: Cardiomyocytes - Muscle contraction"	"Nucleoplasm, Centrosome"		"HPA000953: AB_1079440"	"unprognostic (3.28e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.86e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.66e-2)"	"unprognostic (1.01e-2)"	"unprognostic (5.93e-4)"	"unprognostic (2.46e-1)"	"unprognostic (1.22e-1)"	"unprognostic (7.14e-2)"	"unprognostic (4.36e-3)"	"unprognostic (2.96e-3)"	"unprognostic (3.93e-7)"	"unprognostic (1.14e-1)"	"unprognostic (3.12e-1)"	"unprognostic (5.06e-2)"	"unprognostic (1.65e-1)"	0.2	0.1	0.3	0.1	0.1	1.1	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	120.8	0.1	0.3	0.1	0.0	0.1	0.1	0.3	0.8	0.0	0.1	0.0	0.2	0.0	0.3	1.0	0.0	0.0	2.7	0.0	262.7	0.5	0.0	0.0	0.2	0.0	1.5	10.2	2.3	1.9	0.1	55.6	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.6	0.0	5.3	0.0	0.0	0.0	0.0	0.4	0.8	0.0	0.0	0.0	0.0	0.0	0.0	2.6	1.0	4.0	0.0	0.4	1.6	0.0	0.0	0.0	15.0	30.5	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	13.2	0.0	0.0	9.5	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.1	0.2	0.1	0.3	0.3	0.8	0.3	0.2	2.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	95.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	61.4	0.0	0.2	1.2	0.0	0.0	1.8	0.0	0.0	1.7	2.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.6	0.0	0.0	0.0	0.0	37.3	0.3	0.0	0.0	1.0	0.0	0.0	0.0	0.0	1.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	32.8	0.7	0.9	2.3	0.0	0.0	0.0	0.0	0.4	0.0	0.1
MYO1C	myr2	ENSG00000197879	"Myosin IC"	O00159	17	1464186-1492686	"Predicted intracellular proteins, Transporters"	"mRNA transport, Protein transport, Translocation, Transport"	"Actin-binding, Calmodulin-binding, Motor protein, Myosin"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001768, HPA005924, CAB037023"	Enhanced		Enhanced	"Nuclear bodies,Plasma membrane"		NA	NA		3800000	"Cluster 43: B-cells - Humoral immune response"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Nuclear bodies, Plasma membrane"		"CAB037023: AB_477180, HPA001768: AB_1854252, HPA005924: AB_2667469"	"unprognostic (3.60e-1)"	"unprognostic (4.71e-3)"	"unprognostic (2.89e-1)"	"unprognostic (2.96e-3)"	"unprognostic (1.38e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.63e-1)"	"prognostic unfavorable (5.22e-4)"	"unprognostic (4.65e-2)"	"unprognostic (2.00e-2)"	"unprognostic (2.48e-1)"	"unprognostic (3.07e-2)"	"unprognostic (1.99e-2)"	"unprognostic (5.02e-2)"	"unprognostic (4.66e-2)"	"unprognostic (4.93e-2)"	"unprognostic (3.47e-2)"	169.3	27.0	12.4	34.4	11.8	4.9	115.9	13.3	12.7	77.4	17.1	104.9	47.4	97.1	21.5	64.7	66.4	46.1	97.5	10.2	14.7	56.8	39.5	87.2	24.1	14.8	11.2	43.6	69.3	34.3	22.9	56.9	14.6	69.9	41.7	2.1	91.7	58.2	49.5	57.7	65.6	65.7	11.9	30.8	76.3	17.1	13.7	21.3	60.6	35.8	25.1	86.3	67.8	10.8	169.8	182.1	19.3	79.5	88.8	87.6	74.2	168.6	138.9	108.7	91.0	122.3	90.7	16.9	118.7	261.1	72.7	139.9	29.2	117.2	56.3	75.2	74.5	16.2	96.4	46.2	131.7	1.6	81.5	68.7	57.3	100.2	57.3	99.5	141.7	10.5	13.1	13.7	93.5	129.5	1.9	1.4	12.4	105.8	34.0	6.9	26.4	30.7	100.5	86.9	7.8	43.0	105.9	152.6	67.4	47.5	125.3	8.7	187.9	156.6	119.1	77.7	147.8	10.7	9.1	7.2	124.7	4.1	138.8	0.1	0.9	0.0	0.9	2.0	0.4	4.8	2.1	0.9	1.1	3.8	0.7	0.4	0.5	0.0	1.7	1.0	1.9	1.5	12.4	11.8	13.3	12.7	10.2	14.7	14.8	11.2	14.6	11.9	13.7	10.8	133.7	125.0	35.9	5.5	20.8	39.8	38.2	27.8	31.9	4.1	44.0	33.0	75.4	48.6	36.3	86.5	0.0	57.8	2.5	159.0	21.5	62.3	17.4	26.3	44.4	78.0	39.5	13.5	2.5	52.0	28.4	51.8	66.3	75.5	12.0	25.4	83.6	38.5	20.0	5.0	3.8	111.8	14.2	14.5	43.4	11.4	42.3	16.7	64.0	15.0	20.3	5.6	0.0	2.5	1.0	92.8	88.7	48.5	12.8	64.7	92.8	15.4	12.9	2.1	118.3	37.7	90.6	9.4	7.5	39.5	42.6	47.6	10.0	10.6	88.1	39.2
MYO1G	HA-2	ENSG00000136286	"Myosin IG"	B0I1T2	7	44962662-44979088	"Predicted intracellular proteins"	"Adaptive immunity, Immunity"	"Actin-binding, Calmodulin-binding, Motor protein, Myosin"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 43.6;lymphoid tissue: 27.2"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 81.3;Langerhans cells: 65.1;Macrophages: 74.2;monocytes: 392.2;NK-cells: 252.4;T-cells: 87.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 52.6;HEL: 64.1;HL-60: 39.9;JURKAT: 85.9;MOLT-4: 97.3;NB-4: 52.1;THP-1: 68.6;U-937: 57.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA021252	Enhanced		Supported	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 3: Monocytes - Immune response regulation"	"Plasma membrane"	Nucleoplasm	"HPA021252: AB_1854254"	"unprognostic (2.74e-2)"	"prognostic favorable (8.26e-4)"	"unprognostic (5.20e-3)"	"unprognostic (9.91e-3)"	"unprognostic (1.27e-2)"	"unprognostic (1.27e-3)"	"unprognostic (1.74e-1)"	"unprognostic (1.35e-1)"	"unprognostic (4.54e-3)"	"unprognostic (6.47e-2)"	"unprognostic (6.40e-2)"	"unprognostic (6.24e-2)"	"prognostic unfavorable (8.71e-8)"	"unprognostic (3.20e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.85e-1)"	"unprognostic (7.92e-2)"	2.2	0.8	0.4	16.6	0.3	43.6	1.0	0.3	0.6	0.8	0.3	2.0	3.3	0.7	0.3	1.5	1.2	3.5	0.9	0.3	1.0	0.9	1.3	12.0	25.1	1.4	0.7	0.3	0.7	0.1	0.5	1.2	0.6	1.1	1.8	0.0	2.3	0.7	0.3	0.9	7.8	2.8	0.6	19.0	3.3	0.4	1.6	27.2	1.6	0.4	14.8	6.1	0.9	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	52.6	0.0	64.1	2.7	0.0	0.0	39.9	0.6	0.0	0.0	0.0	0.0	0.0	0.0	85.9	0.0	0.0	0.0	0.0	97.3	52.1	0.0	0.0	0.0	18.5	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.1	0.0	0.0	68.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.7	0.0	57.3	0.0	41.5	58.3	18.5	61.5	95.5	38.4	27.7	40.5	55.6	42.7	18.9	14.1	29.6	6.0	23.9	129.8	4.5	79.9	79.9	0.4	0.3	0.3	0.6	0.3	1.0	1.4	0.7	0.6	0.6	1.6	0.8	0.9	3.2	7.7	0.0	55.7	2.8	0.4	0.0	0.0	0.2	1.2	1.3	1.1	1.5	1.3	0.0	0.0	0.2	81.3	0.2	0.0	0.3	0.6	0.3	0.5	1.0	0.0	6.3	0.1	1.1	0.3	2.3	2.0	0.6	30.4	0.4	2.2	1.4	10.5	3.3	0.0	0.2	0.0	58.7	65.1	1.6	0.0	74.2	3.6	0.0	392.2	0.3	252.4	0.5	0.0	0.2	0.1	0.4	33.4	0.4	0.0	0.6	0.7	0.2	6.6	2.0	1.4	3.8	1.2	0.2	1.7	0.1	87.1	1.2	0.1	0.2
MYO3A	DFNB30	ENSG00000095777	"Myosin IIIA"	Q8NEV4	10	25934229-26212532	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Hearing, Sensory transduction, Vision"	"Actin-binding, Kinase, Motor protein, Myosin, Serine/threonine-protein kinase, Transferase"	"Deafness, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"retina: 15.5;testis: 5.2"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 156.6;Late spermatids: 58.2;Muller glia cells: 74.8;Spermatocytes: 31.7"	"Cancer enhanced"	"Detected in many"		"cervical cancer: 1.7"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 1.3;CAPAN-2: 1.2;HEK 293: 1.5;SCLC-21H: 1.4;U-2 OS: 2.4;U-698: 6.3"	"Not detected"	"Not detected"							"HPA051893, HPA075413"	Enhanced		Supported	"Plasma membrane,Actin filaments,Cytoplasmic bodies"		No	No				"Cluster 77: Retina - Visual perception"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 5: Muller glia cells - Visual perception"	"Actin filaments, Cytoplasmic bodies"	"Plasma membrane"	"HPA051893: , HPA075413: "	"unprognostic (5.00e-3)"	"unprognostic (3.36e-2)"	"unprognostic (1.53e-1)"	"unprognostic (3.20e-3)"	"unprognostic (2.96e-1)"	"unprognostic (4.37e-2)"		"unprognostic (5.29e-2)"	"unprognostic (2.74e-1)"	"unprognostic (4.31e-2)"	"unprognostic (1.03e-1)"	"unprognostic (5.66e-3)"	"unprognostic (7.96e-3)"	"unprognostic (6.34e-2)"	"unprognostic (1.46e-2)"	"unprognostic (6.62e-2)"	"unprognostic (9.69e-2)"	0.1	0.1	0.4	0.0	1.8	0.1	0.1	0.0	0.8	0.1	0.2	0.1	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.1	0.6	0.3	0.0	0.1	0.0	0.6	0.5	0.0	0.7	0.0	0.5	0.0	0.5	0.1	0.3	15.5	0.0	0.1	0.0	0.7	0.1	0.0	0.2	0.0	0.2	5.2	0.3	0.2	0.2	0.1	0.2	0.0	0.3	0.3	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.9	0.8	0.0	0.0	0.7	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	6.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1.8	0.0	0.8	0.1	0.6	0.6	0.5	0.5	0.2	0.3	0.3	0.2	0.0	0.5	2.0	0.1	1.8	0.3	0.0	0.0	0.9	0.6	0.3	0.6	0.0	2.5	0.0	0.0	0.0	0.0	0.2	1.9	0.8	156.6	0.6	0.1	0.3	1.8	0.0	2.2	0.0	0.4	0.6	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	5.9	0.4	0.0	0.0	0.0	58.2	1.2	0.1	0.0	1.9	0.0	74.8	0.0	1.0	0.4	0.2	0.0	1.2	0.0	0.3	0.0	1.0	0.0	3.9	0.0	0.0	2.4	31.7	14.2	2.4	1.0	0.0	0.0	0.0	0.4	0.3
MYO5C	MGC74969	ENSG00000128833	"Myosin VC"	Q9NQX4	15	52192322-52295804	"Predicted intracellular proteins"		"Actin-binding, Calmodulin-binding, Motor protein, Myosin"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 68.5;Alveolar cells type 1: 131.4;Alveolar cells type 2: 84.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A549: 25.4;MCF7: 46.3;OE19: 41.2;RT4: 26.4;SK-BR-3: 34.0;T-47d: 40.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB020790, HPA032115, HPA032116"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 11: Alveolar cells - Smell perception"	Cytosol	Nucleoplasm	"CAB020790: , HPA032115: AB_2674158, HPA032116: AB_2674159"	"unprognostic (1.85e-1)"	"unprognostic (1.29e-1)"	"unprognostic (3.49e-2)"	"prognostic favorable (5.18e-5)"	"unprognostic (2.94e-1)"	"unprognostic (4.01e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.53e-1)"	"unprognostic (4.53e-3)"	"unprognostic (1.02e-1)"	"unprognostic (4.04e-3)"	"unprognostic (4.82e-2)"	"prognostic favorable (2.47e-5)"	"prognostic favorable (5.82e-4)"	"unprognostic (9.15e-2)"	"unprognostic (2.34e-1)"	"unprognostic (2.32e-1)"	11.1	1.5	3.0	2.8	3.3	0.8	13.2	7.9	3.1	14.1	17.0	14.0	5.3	4.2	12.8	7.0	11.5	6.9	1.6	2.6	2.9	5.6	3.4	13.8	1.9	5.1	2.8	1.6	27.3	13.7	7.3	2.5	6.3	10.3	17.7	1.6	21.1	4.4	2.1	4.8	5.1	4.0	7.3	3.5	19.4	4.7	3.3	1.9	17.9	2.6	2.4	4.4	4.4	5.9	21.4	25.4	3.5	0.0	0.0	0.1	3.0	0.0	0.3	0.1	0.0	3.9	8.8	1.2	5.3	0.1	0.2	3.4	5.3	7.4	0.0	1.1	8.4	0.1	17.3	15.7	0.0	0.0	0.2	0.0	7.2	0.0	6.8	3.6	5.6	0.9	0.0	0.3	0.1	46.3	1.3	0.2	1.4	41.2	12.0	17.6	2.1	10.6	19.5	26.4	3.5	3.9	1.6	34.0	0.0	5.4	40.9	0.0	0.0	0.0	0.2	0.0	3.3	0.7	0.7	2.1	0.1	0.2	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.3	0.7	0.0	3.0	3.3	7.9	3.1	2.6	2.9	5.1	2.8	6.3	7.3	3.3	5.9	68.5	131.4	84.5	3.9	1.5	0.6	20.5	10.2	2.2	0.4	22.4	10.9	4.9	18.6	47.1	22.0	0.0	2.3	0.3	26.5	3.9	21.1	2.8	34.1	4.8	26.1	5.4	2.1	29.3	29.6	1.5	3.7	41.3	50.4	3.8	5.1	2.5	5.1	0.9	0.0	3.9	47.1	22.4	0.8	3.1	3.2	1.8	1.4	7.2	14.0	0.1	5.6	1.0	8.0	2.8	39.0	21.5	0.4	2.7	28.1	2.1	1.3	49.8	0.5	0.0	1.3	1.5	9.0	5.9	14.1	1.4	0.7	1.6	2.0	25.8	38.7
MYO6	"DFNA22, DFNB37, KIAA0389"	ENSG00000196586	"Myosin VI"	Q9UM54	6	75749192-75919537	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Endocytosis, Hearing, Protein transport, Transport"	"Actin-binding, Calmodulin-binding, Motor protein, Myosin"	"Cardiomyopathy, Deafness, Disease variant, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Oligodendrocytes: 409.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"gdT-cell: 5.5;MAIT T-cell: 3.0;memory CD4 T-cell: 1.8;memory CD8 T-cell: 3.1;naive CD8 T-cell: 3.0;NK-cell: 2.9"	"Group enriched"	"Detected in many"	7	"NK-cells: 2.9;T-cells: 5.5"	"Cell line enhanced"	"Detected in many"		"RT4: 103.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010762, HPA035482, HPA035483"	Enhanced		Supported	Nucleoplasm		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 15: RT4 - Unknown function"	"Cluster 22: Epithelial cell types - Mixed function"	Nucleoplasm		"CAB010762: AB_477166, HPA035482: , HPA035483: AB_2674647"	"unprognostic (6.29e-2)"	"unprognostic (6.34e-2)"	"unprognostic (3.63e-3)"	"unprognostic (1.30e-1)"	"unprognostic (8.98e-2)"	"unprognostic (2.73e-2)"	"unprognostic (3.41e-3)"	"unprognostic (1.23e-2)"	"unprognostic (1.23e-2)"	"unprognostic (2.66e-2)"	"unprognostic (7.78e-2)"	"unprognostic (2.78e-2)"	"prognostic favorable (1.27e-12)"	"unprognostic (1.57e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.41e-1)"	"unprognostic (2.49e-2)"	9.9	9.5	18.6	7.1	29.3	0.3	28.3	22.6	32.0	18.5	32.6	22.1	33.0	7.6	22.9	32.0	11.5	27.0	5.3	19.6	19.5	51.4	15.2	23.2	4.7	23.7	24.4	4.7	21.6	40.4	14.5	7.6	24.3	17.2	19.2	49.0	25.9	19.9	3.4	16.8	33.9	5.7	16.0	7.6	27.6	14.6	23.9	5.1	15.9	3.1	12.8	24.0	15.8	34.6	52.2	13.0	12.3	8.9	29.7	23.7	42.6	20.7	23.6	12.3	18.3	22.2	44.2	0.1	16.1	25.7	14.0	40.0	15.3	29.2	18.6	17.0	30.3	17.4	5.6	14.1	25.0	0.0	22.2	17.5	21.6	19.3	14.5	24.0	43.3	7.9	22.4	7.2	15.4	48.3	0.2	0.8	7.7	44.1	3.8	0.7	29.1	1.6	51.1	103.6	26.8	14.8	5.6	46.6	6.8	28.3	16.5	35.8	59.4	13.7	9.3	0.6	20.0	13.2	16.1	0.3	10.9	0.2	5.3	0.2	0.1	0.1	5.5	0.0	3.0	0.2	1.8	3.1	0.0	0.1	0.4	3.0	0.6	2.9	0.1	0.1	0.2	0.8	18.6	29.3	22.6	32.0	19.6	19.5	23.7	24.4	24.3	16.0	23.9	34.6	74.8	141.1	207.0	286.3	4.7	30.1	87.5	49.2	18.2	83.6	99.6	35.9	8.1	38.6	91.3	150.8	120.9	32.0	14.7	112.2	54.8	128.9	7.0	86.9	26.9	57.2	85.0	0.0	147.8	120.3	23.8	30.5	91.7	169.2	26.0	81.0	37.9	33.8	6.3	95.9	167.2	76.4	116.0	2.9	6.1	9.6	30.1	6.7	30.2	105.9	2.7	307.3	12.3	179.4	409.1	197.0	99.7	43.2	11.4	165.9	105.7	97.6	109.5	188.4	13.1	26.5	32.7	14.4	32.1	28.3	34.1	78.4	13.4	191.8	77.5	199.7
MYO9B	CELIAC4	ENSG00000099331	"Myosin IXB"	Q13459	19	17075781-17214537	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		"Actin-binding, Calmodulin-binding, GTPase activation, Motor protein, Myosin"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cone photoreceptor cells: 204.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB037190, HPA042043"	Approved		Supported	Cytosol		NA	NA		8400	"Cluster 52: Eosinophils - Transcription"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 9: Photoreceptor cells - Phototransduction"	Cytosol		"CAB037190: AB_477214, HPA042043: AB_10796897"	"unprognostic (1.92e-1)"	"unprognostic (1.79e-3)"	"unprognostic (4.35e-2)"	"unprognostic (6.63e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.18e-3)"	"unprognostic (1.99e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.61e-2)"	"prognostic unfavorable (2.61e-4)"	"unprognostic (7.97e-2)"	"unprognostic (1.45e-2)"	"prognostic unfavorable (5.66e-6)"	"unprognostic (1.97e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.36e-2)"	"unprognostic (5.53e-2)"	41.0	43.6	38.6	52.6	53.3	98.9	32.3	46.7	56.7	44.9	32.6	45.3	17.5	44.5	12.4	32.9	30.3	20.6	37.2	39.2	46.8	26.9	39.1	78.2	60.3	60.3	53.5	22.5	26.4	6.9	25.6	21.3	56.4	46.1	14.8	40.2	28.3	13.5	12.7	29.6	62.0	17.4	45.8	158.1	36.2	64.2	61.3	33.1	26.3	5.1	35.9	48.1	41.5	77.6	55.6	25.4	33.2	38.9	23.7	24.7	95.7	51.6	26.4	31.8	27.8	20.5	27.7	51.4	28.0	45.5	28.4	34.3	14.2	25.2	23.9	92.4	29.4	62.1	31.2	19.7	30.2	49.1	95.8	22.8	13.0	44.1	17.1	19.5	33.6	22.5	25.9	34.1	22.2	23.1	66.8	90.8	25.0	17.8	55.4	72.3	24.9	14.8	12.6	46.4	11.3	25.3	32.1	25.2	67.8	17.8	25.0	50.7	65.7	58.9	26.2	92.1	44.1	48.7	33.6	32.8	58.2	63.4	75.0	4.5	3.2	6.1	2.7	4.0	1.7	2.8	2.0	2.2	1.9	2.4	1.3	1.9	12.2	2.6	2.6	3.7	3.5	2.0	38.6	53.3	46.7	56.7	39.2	46.8	60.3	53.5	56.4	45.8	61.3	77.6	20.5	9.6	23.0	17.0	47.2	19.6	70.3	9.9	10.8	11.9	15.3	13.7	10.3	11.5	10.7	5.5	204.3	17.3	43.5	34.2	1.9	7.8	6.0	14.5	45.3	28.9	7.2	19.8	36.0	7.7	24.8	22.2	35.7	28.1	22.1	24.1	23.2	15.8	74.8	8.4	26.0	14.8	8.2	68.5	91.0	13.6	12.5	103.6	44.4	49.6	65.4	11.1	66.9	40.7	112.8	12.4	18.2	17.0	37.2	40.7	10.9	3.2	9.6	98.8	6.6	16.1	24.6	8.5	14.3	10.5	18.0	14.4	47.0	18.9	17.1	46.9
MYOF	"FER1L3, KIAA1207"	ENSG00000138119	Myoferlin	Q9NZM1	10	93306429-93482334	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Glandular and luminal cells: 123.4;Pancreatic endocrine cells: 153.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"intermediate monocyte: 20.4;non-classical monocyte: 26.6"	"Group enriched"	"Detected in many"	57	"dendritic cells: 8.1;monocytes: 26.6"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 452.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA014245	Enhanced		Supported	"Vesicles,Plasma membrane"		NA	NA		190000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Vesicles	"Plasma membrane"	"HPA014245: AB_1848495"	"unprognostic (3.41e-2)"	"unprognostic (3.85e-1)"	"unprognostic (2.88e-2)"	"unprognostic (7.44e-2)"	"unprognostic (3.50e-2)"	"unprognostic (8.57e-3)"	"unprognostic (3.48e-2)"	"unprognostic (7.75e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.04e-1)"	"prognostic unfavorable (1.40e-4)"	"unprognostic (1.55e-1)"	"unprognostic (5.74e-3)"	"unprognostic (1.87e-1)"	"unprognostic (1.94e-2)"	"unprognostic (9.17e-2)"	"unprognostic (9.18e-2)"	31.7	8.1	2.9	20.6	4.1	1.5	43.3	5.0	2.5	56.4	37.4	22.4	5.3	27.5	7.1	36.4	36.9	26.6	13.8	3.4	4.1	10.9	2.9	32.2	4.4	8.9	6.8	9.8	5.9	23.8	3.8	55.2	8.1	27.5	29.3	0.9	19.7	31.4	3.6	56.1	9.0	44.3	6.2	6.5	13.4	2.2	5.4	5.1	35.7	6.2	9.1	62.0	29.4	6.2	228.9	206.3	21.4	14.6	159.4	318.4	62.0	190.3	452.7	110.1	109.2	51.1	177.1	0.0	76.9	353.7	116.2	350.0	1.8	204.7	82.6	1.4	0.9	0.0	80.8	2.1	55.2	0.0	0.2	183.0	71.6	77.7	323.8	289.4	299.7	0.0	0.0	0.5	275.6	39.4	0.1	0.9	1.6	72.0	171.6	0.0	15.8	0.1	314.3	281.5	0.1	0.0	130.4	29.7	46.1	83.1	141.5	4.7	378.5	167.3	11.8	111.3	113.9	0.2	0.3	0.3	128.2	2.6	201.0	0.0	5.4	0.0	0.0	20.4	0.0	0.0	0.0	0.0	8.1	0.0	0.0	0.0	0.3	0.0	26.6	2.8	0.2	1.6	2.9	4.1	5.0	2.5	3.4	4.1	8.9	6.8	8.1	6.2	5.4	6.2	42.5	60.9	52.5	1.6	1.2	23.7	63.0	101.4	39.3	0.1	48.4	34.3	9.2	14.3	91.5	22.0	0.0	56.6	3.8	74.1	1.9	54.8	0.6	50.9	45.9	28.8	1.8	0.0	2.7	33.7	23.7	38.1	23.0	123.4	1.3	1.7	35.7	0.4	22.9	0.0	0.8	29.6	42.7	29.2	20.2	0.6	5.9	28.5	8.8	60.0	12.8	0.1	0.0	2.0	0.7	153.7	22.2	9.1	0.8	86.7	0.6	1.5	60.7	0.8	6.6	15.9	39.6	0.1	0.3	53.4	30.7	51.2	1.9	8.3	18.7	100.7
MYOG	"bHLHc3, MYF4"	ENSG00000122180	Myogenin	P15173	1	203083129-203086012	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Cell cycle, Differentiation, Myogenesis, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	18	"skeletal muscle: 101.0;tongue: 46.7"	"Cell type enriched"	"Detected in single"	36	"Skeletal myocytes: 11.0"	"Group enriched"	"Detected in some"	6	"head and neck cancer: 3.9;testis cancer: 1.7"	"Region enriched"	"Detected in single"	5	"cerebellum: 2.5"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	222	"HSkMC: 29.6;RH-30: 57.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			HPA028336			Supported	Nucleoplasm		NA	NA				"Cluster 33: Striated muscle - Muscle contraction"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 37: Myocytes - Muscle contraction"	Nucleoplasm		"HPA028336: AB_2672562"	"unprognostic (1.71e-1)"				"unprognostic (1.64e-1)"	"unprognostic (1.05e-3)"				"unprognostic (2.22e-1)"			"unprognostic (2.79e-9)"	"unprognostic (3.96e-1)"	"unprognostic (2.56e-1)"			0.0	0.0	0.4	0.0	0.2	0.0	0.0	2.5	0.4	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.3	2.2	0.0	0.2	4.1	0.0	101.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.2	1.6	0.0	46.7	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	29.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	57.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.5	0.0	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.2	0.2	0.1	0.1	0.0	0.4	0.2	2.5	0.4	0.5	0.0	0.2	0.0	0.3	0.0	0.2	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1
MYSM1	KIAA1915	ENSG00000162601	"Myb like, SWIRM and MPN domains 1"	Q5VVJ2	1	58643440-58700077	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Immunity, Transcription, Transcription regulation, Ubl conjugation pathway"	"Activator, Chromatin regulator, DNA-binding, Hydrolase, Metalloprotease, Protease"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 106.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054291, HPA057306"	Approved		Supported	Nucleoplasm,Nucleoli		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 50: Non-specific - Ribosome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	Nucleoli	"HPA054291: AB_2682438, HPA057306: "	"unprognostic (2.95e-3)"	"unprognostic (3.64e-2)"	"unprognostic (3.20e-2)"	"unprognostic (8.68e-2)"	"unprognostic (2.08e-2)"	"prognostic favorable (5.09e-5)"	"unprognostic (8.12e-3)"	"unprognostic (9.63e-3)"	"unprognostic (5.72e-3)"	"unprognostic (3.74e-1)"	"unprognostic (2.25e-1)"	"unprognostic (4.56e-2)"	"unprognostic (2.38e-3)"	"unprognostic (4.22e-2)"	"unprognostic (1.83e-1)"	"unprognostic (8.45e-2)"	"unprognostic (1.44e-2)"	11.2	7.5	4.0	4.4	3.9	12.5	12.0	4.3	5.9	11.9	4.2	11.8	5.4	10.6	6.2	10.0	10.2	3.1	10.5	4.1	3.9	7.2	8.0	10.1	6.3	3.9	3.7	13.2	12.1	5.9	8.7	4.4	3.9	9.6	4.4	8.4	11.8	4.1	10.0	10.5	12.6	3.6	3.7	11.4	9.9	4.4	3.9	5.3	11.5	3.1	4.9	9.3	11.1	4.4	10.1	2.6	5.0	6.7	6.0	7.2	10.5	5.9	5.6	5.1	3.9	5.3	4.2	10.3	1.8	3.8	4.8	7.4	7.7	2.1	11.0	6.2	4.3	11.3	2.1	5.1	7.4	19.6	9.7	5.4	5.9	7.5	3.8	6.1	1.2	4.2	12.6	6.3	6.8	2.6	7.8	16.3	11.4	3.5	3.5	7.3	16.4	6.1	4.6	3.8	5.8	6.6	4.4	9.4	13.9	9.0	3.1	10.6	4.9	9.3	4.6	6.4	11.3	10.8	5.8	13.9	5.8	13.7	11.6	0.9	0.3	0.1	0.3	0.4	0.2	0.4	0.3	0.3	0.1	0.3	0.5	0.4	1.0	0.1	0.5	0.4	0.4	0.1	4.0	3.9	4.3	5.9	4.1	3.9	3.9	3.7	3.9	3.7	3.9	4.4	36.5	22.4	33.7	47.7	26.0	19.1	22.8	13.5	30.7	19.5	25.6	21.0	28.2	10.0	35.1	11.0	25.0	8.4	36.6	22.1	15.6	8.8	3.9	22.1	34.8	25.4	16.2	14.1	87.4	9.4	5.7	20.8	19.9	36.9	56.3	30.1	23.9	16.3	11.3	18.5	58.2	17.0	24.4	13.9	14.2	6.3	12.8	22.2	8.8	35.6	21.3	12.7	22.6	58.3	106.9	12.7	13.1	17.3	29.5	19.3	19.2	8.8	21.2	27.8	26.3	28.8	21.5	15.5	20.6	25.0	18.5	11.4	30.8	22.0	18.5	26.4
MYT1	"MTF1, MYTI, NZF2, PLPB1, ZC2H2C1, ZC2HC4A"	ENSG00000196132	"Myelin transcription factor 1"	Q01538	20	64102394-64242253	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 24.6;retina: 8.3"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 31.9;Cone photoreceptor cells: 60.5;Horizontal cells: 26.9;Oligodendrocyte precursor cells: 112.1;Rod photoreceptor cells: 29.0"	"Cancer enhanced"	"Detected in some"		"glioma: 3.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"REH: 7.6;SCLC-21H: 23.1;SH-SY5Y: 6.0"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"cerebellum: 17.5"	HPA006303	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA				"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 68: Oligodendrocytes - Mixed function"	Nucleoplasm	Cytosol	"HPA006303: AB_1079446"	"unprognostic (1.09e-1)"	"unprognostic (4.65e-2)"	"unprognostic (3.68e-2)"	"unprognostic (2.05e-7)"	"unprognostic (1.28e-1)"	"unprognostic (8.34e-2)"	"unprognostic (1.20e-1)"	"unprognostic (7.10e-2)"	"unprognostic (9.33e-3)"	"unprognostic (2.28e-2)"	"unprognostic (8.45e-4)"	"unprognostic (9.73e-2)"	"unprognostic (1.01e-1)"	"unprognostic (5.45e-2)"	"unprognostic (9.68e-2)"	"unprognostic (2.91e-3)"	"unprognostic (1.23e-1)"	0.2	3.5	5.8	0.2	3.8	1.1	0.1	24.6	4.3	0.0	0.0	0.2	0.8	0.1	0.2	0.0	0.2	0.1	0.1	3.8	6.6	0.1	0.1	0.1	0.1	5.0	5.6	0.1	0.6	0.3	5.5	0.1	5.2	0.1	0.2	8.3	0.0	0.1	0.0	0.1	0.2	0.1	2.7	0.2	0.6	0.7	5.9	0.1	0.6	0.0	0.1	0.1	0.0	3.6	0.0	0.1	0.8	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.7	0.1	0.7	0.3	0.1	0.3	0.0	2.4	0.2	0.1	0.0	0.3	0.0	0.1	0.1	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.1	0.1	0.7	0.2	1.7	0.0	0.1	1.8	0.1	0.9	0.0	0.5	7.6	0.2	0.2	0.0	0.1	23.1	6.0	0.0	0.2	0.1	0.3	0.1	0.3	0.0	0.0	0.7	0.0	0.1	0.0	0.0	2.2	0.1	1.8	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	5.8	3.8	24.6	4.3	3.8	6.6	5.0	5.6	5.2	2.7	5.9	3.6	0.2	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	31.9	0.1	0.0	1.2	4.3	0.0	0.0	60.5	0.0	0.0	0.0	0.0	0.1	1.6	0.2	0.0	0.4	2.4	2.7	1.4	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.4	0.2	0.5	26.9	5.8	0.3	0.0	0.0	0.0	0.4	0.0	0.0	0.0	1.9	0.0	5.0	0.0	112.1	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	29.0	0.0	0.4	0.1	1.6	8.3	0.0	0.0	0.0	0.0	2.7	0.0	0.0
MZF1	"MZF-1, MZF1B, Zfp98, ZNF42, ZSCAN6"	ENSG00000099326	"Myeloid zinc finger 1"	P28698	19	58561931-58573575	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HEK 293: 46.0;HeLa: 41.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA001757	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 49: Ciliated cells - Cilium organization"	Nucleoplasm		"HPA001757: AB_1080718"	"unprognostic (8.25e-3)"	"unprognostic (2.33e-1)"	"unprognostic (5.12e-2)"	"unprognostic (5.16e-3)"	"unprognostic (7.15e-2)"	"unprognostic (4.29e-3)"	"unprognostic (1.84e-2)"	"unprognostic (4.62e-1)"	"unprognostic (8.10e-2)"	"unprognostic (7.03e-2)"	"prognostic favorable (7.97e-4)"	"unprognostic (2.87e-2)"	"prognostic unfavorable (2.83e-8)"	"unprognostic (1.47e-1)"	"unprognostic (1.80e-1)"	"unprognostic (4.64e-2)"	"prognostic favorable (4.09e-5)"	7.5	13.5	5.4	6.5	5.5	5.8	8.5	6.5	8.5	14.7	12.7	11.3	11.6	12.0	7.0	9.6	17.5	4.4	7.5	5.5	5.1	13.5	11.4	10.0	5.9	8.1	6.6	15.8	11.4	6.7	16.9	3.6	6.3	15.4	4.0	9.2	10.1	6.0	10.8	10.3	10.4	4.3	5.4	8.2	12.8	6.6	6.2	4.5	19.0	2.4	2.9	10.7	10.6	7.2	8.0	19.9	8.1	5.0	4.5	4.0	10.1	7.2	3.5	1.2	2.4	4.3	9.4	5.7	3.5	1.9	5.9	9.0	2.0	4.7	0.6	10.3	46.0	6.0	41.5	2.6	2.7	4.5	10.0	2.7	12.3	1.8	5.3	7.7	4.1	6.4	5.0	7.0	1.8	8.8	2.7	2.6	3.1	4.6	8.1	7.4	2.0	10.5	4.1	16.9	7.9	11.0	3.7	6.7	4.6	1.6	7.1	6.1	5.1	13.0	4.1	2.3	3.7	12.6	15.3	4.9	10.5	5.0	3.4	0.0	0.9	0.4	2.1	0.6	3.2	2.1	3.6	2.6	1.6	2.7	5.9	3.8	1.7	5.3	0.7	0.4	2.4	2.4	5.4	5.5	6.5	8.5	5.5	5.1	8.1	6.6	6.3	5.4	6.2	7.2	7.9	12.8	17.0	28.4	15.0	8.0	11.4	11.9	22.2	39.4	22.0	22.4	5.9	10.0	8.0	11.0	33.3	6.0	11.1	20.3	3.9	8.3	22.1	39.1	9.8	7.2	16.8	10.7	23.4	5.4	3.6	8.8	43.3	16.7	4.5	15.8	9.7	10.7	4.9	30.3	20.1	14.5	16.2	5.3	3.3	28.7	10.5	7.6	10.6	7.5	4.2	19.4	15.5	10.6	21.3	6.5	13.4	13.2	9.0	9.6	14.7	10.6	29.8	47.8	19.7	16.6	7.7	10.2	3.8	11.2	8.2	6.4	12.5	16.3	11.9	7.8
MZT2A	"FAM128A, MOZART2A"	ENSG00000173272	"Mitotic spindle organizing protein 2A"	Q6P582	2	131464900-131492743	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 252.2"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"eosinophil: 79.5"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"NB-4: 421.1"									"HPA051758, HPA052623"	Approved		Supported	Centrosome,Cytosol		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 32: Non-specific - Translation"	Centrosome	Cytosol	"HPA051758: , HPA052623: AB_2681888"	"prognostic favorable (3.04e-4)"	"unprognostic (3.82e-2)"	"unprognostic (7.14e-2)"	"unprognostic (1.78e-1)"	"unprognostic (5.39e-2)"	"unprognostic (5.32e-2)"	"unprognostic (1.99e-2)"	"unprognostic (2.44e-2)"	"unprognostic (6.47e-2)"	"unprognostic (3.55e-2)"	"unprognostic (2.16e-1)"	"unprognostic (3.72e-2)"	"prognostic unfavorable (3.04e-11)"	"unprognostic (1.51e-2)"	"unprognostic (5.55e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.66e-1)"	41.7	68.6	31.8	11.6	28.4	40.5	44.4	16.1	74.7	82.9	23.9	59.7	31.8	60.7	2.5	102.7	85.8	6.6	252.2	32.6	24.5	50.8	81.1	28.3	19.2	22.5	23.1	87.9	94.7	14.4	38.2	4.7	24.8	74.4	2.6	0.7	52.6	9.1	48.0	54.5	45.8	2.1	15.3	37.8	64.8	36.8	27.7	7.2	55.0	5.6	4.2	55.1	69.8	23.9	212.0	115.2	3.0	40.9	3.3	7.7	44.1	70.6	17.3	27.8	28.2	286.2	71.3	136.7	88.3	3.4	2.8	94.6	7.2	49.8	1.0	54.5	346.6	56.8	135.3	353.8	17.3	100.7	20.4	22.3	27.8	18.7	8.8	6.4	23.8	122.7	114.1	138.7	6.9	196.1	137.1	421.1	73.0	28.1	259.8	114.5	37.3	317.5	18.7	102.2	160.1	20.4	71.6	46.5	135.2	2.1	74.7	177.8	61.6	70.2	168.9	28.3	68.6	128.9	105.6	116.9	97.2	64.3	41.3	22.1	2.0	79.5	8.5	1.4	9.4	32.4	18.9	10.9	7.7	18.8	20.7	10.2	1.1	7.1	0.8	12.0	21.7	4.9	31.8	28.4	16.1	74.7	32.6	24.5	22.5	23.1	24.8	15.3	27.7	23.9	60.4	16.0	13.8	11.8	126.6	148.1	138.9	81.9	124.1	55.6	196.7	284.6	305.6	111.5	47.3	71.7	20.9	88.7	101.1	159.7	170.2	210.3	25.5	42.2	89.7	68.7	108.8	75.7	15.8	167.8	223.9	100.4	115.2	70.4	23.6	189.2	99.2	128.0	123.1	26.9	16.4	240.7	54.9	79.4	138.1	89.8	152.8	71.4	103.2	4.7	105.2	112.9	114.4	10.1	13.0	269.2	167.0	205.4	140.8	163.1	240.1	255.6	28.9	41.9	92.1	83.2	85.9	44.4	166.3	269.5	142.9	42.4	155.8	156.7	270.4	133.6
MZT2B	"FAM128B, FLJ14346, MOZART2B"	ENSG00000152082	"Mitotic spindle organizing protein 2B"	Q6NZ67	2	130181737-130190729	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 1258.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"NB-4: 962.4"					"Low region specificity"	"Detected in all"			"HPA051758, HPA052623"	Approved		Supported	Centrosome,Cytosol		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 7: Non-specific - Mitochondria"	Centrosome	Cytosol	"HPA051758: , HPA052623: AB_2681888"	"unprognostic (8.09e-3)"	"unprognostic (5.38e-2)"	"unprognostic (2.40e-2)"	"unprognostic (1.31e-2)"	"unprognostic (5.60e-2)"	"unprognostic (1.65e-2)"	"prognostic unfavorable (9.65e-4)"	"unprognostic (1.06e-1)"	"unprognostic (1.14e-1)"	"unprognostic (2.28e-2)"	"unprognostic (1.68e-2)"	"unprognostic (1.05e-1)"	"prognostic unfavorable (9.37e-8)"	"unprognostic (1.67e-1)"	"unprognostic (2.04e-1)"	"unprognostic (3.04e-1)"	"unprognostic (2.09e-1)"	125.3	170.2	161.7	59.9	150.5	159.3	130.6	131.7	284.6	169.3	145.5	174.2	79.5	140.6	18.2	164.8	162.4	16.4	401.3	150.5	141.8	143.8	199.5	86.3	60.3	150.0	142.2	190.3	250.9	49.3	117.1	32.9	133.9	144.2	19.6	11.4	172.6	41.2	202.4	147.1	102.8	20.4	133.4	103.6	160.7	195.1	157.4	48.1	159.0	29.9	25.5	131.8	143.1	151.4	462.9	239.6	38.6	173.1	20.7	49.8	190.5	203.1	56.7	72.2	59.6	384.0	168.3	251.5	288.1	39.5	47.2	223.4	19.7	68.9	11.2	376.3	667.0	132.8	313.5	485.9	71.5	155.1	97.1	65.7	77.6	45.4	26.9	58.4	80.6	251.8	189.6	268.9	35.8	572.5	336.0	962.4	137.8	85.7	435.8	447.0	105.4	626.6	55.3	140.2	304.7	377.8	121.3	201.1	369.8	15.1	218.5	374.8	164.7	199.8	354.7	155.3	203.4	378.1	257.5	257.9	244.6	203.3	133.3	0.4	19.9	83.0	18.6	21.5	16.5	37.6	25.5	24.7	25.4	38.5	29.1	24.2	10.7	27.3	20.4	48.1	21.3	12.2	161.7	150.5	131.7	284.6	150.5	141.8	150.0	142.2	133.9	133.4	157.4	151.4	240.2	41.7	29.4	20.5	253.6	297.2	321.4	193.4	248.2	175.2	543.9	739.1	326.5	243.1	104.6	242.8	43.8	282.8	238.0	378.4	467.6	358.4	327.3	115.5	326.7	210.0	173.0	308.2	21.7	591.7	466.6	250.1	166.7	171.7	50.8	484.6	250.2	363.5	342.0	131.2	22.8	453.0	99.7	232.7	365.6	1258.6	249.8	202.4	268.6	14.0	179.7	358.3	150.4	16.6	24.5	584.9	281.6	143.7	278.7	375.9	181.7	801.3	61.7	110.6	164.3	169.1	277.3	165.4	183.3	418.2	377.2	165.1	282.3	338.4	360.7	358.0
NAA10	"ARD1, ARD1A, DXS707, TE2"	ENSG00000102030	"N-alpha-acetyltransferase 10, NatA catalytic subunit"	P41227	X	153929225-153935080	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		"Acyltransferase, Transferase"	"Disease variant, Microphthalmia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB006269, HPA030711"	Supported		Supported	Nucleoli,Cytosol		No	No			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 59: Non-specific - Translation"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Cytosol	Nucleoli	"CAB006269: AB_425759, HPA030711: AB_2673579"	"unprognostic (7.57e-2)"	"unprognostic (1.40e-2)"	"unprognostic (1.81e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.02e-2)"	"unprognostic (1.94e-2)"	"unprognostic (4.52e-3)"	"unprognostic (1.22e-1)"	"unprognostic (1.68e-1)"	"unprognostic (1.04e-1)"	"unprognostic (9.01e-2)"	"unprognostic (9.63e-2)"	"prognostic unfavorable (3.29e-8)"	"unprognostic (1.28e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.29e-2)"	"unprognostic (7.48e-3)"	38.4	39.5	19.6	17.2	20.1	13.2	34.6	20.4	27.2	26.5	19.2	34.1	15.3	32.3	15.1	40.5	24.4	10.3	56.3	20.0	21.8	34.1	35.9	26.0	19.7	20.8	20.3	23.8	45.8	13.7	22.5	12.5	20.8	27.6	10.2	7.3	25.3	12.2	98.4	30.9	24.9	18.1	20.4	28.8	35.9	9.1	21.2	10.2	21.7	24.9	15.3	35.9	26.8	20.4	133.4	136.0	25.8	83.0	36.7	36.9	71.2	46.3	28.6	63.8	57.0	88.5	41.0	102.0	147.6	38.7	79.2	63.0	57.9	56.8	23.9	42.1	255.2	36.8	85.8	91.3	49.1	71.4	76.8	28.8	62.2	57.9	59.1	30.7	72.0	39.2	75.1	41.5	41.6	172.8	115.0	106.4	42.9	124.4	189.0	90.1	65.7	111.5	47.7	59.7	54.0	65.7	18.7	71.0	113.7	23.9	38.4	58.8	41.1	25.6	88.5	89.5	142.0	86.3	107.2	196.0	34.7	91.0	75.5	35.3	53.1	81.3	60.0	65.3	78.1	75.2	63.4	65.6	69.4	77.7	37.4	56.7	49.8	64.7	76.0	75.9	102.9	70.6	19.6	20.1	20.4	27.2	20.0	21.8	20.8	20.3	20.8	20.4	21.2	20.4	126.9	9.6	30.2	27.1	76.0	70.1	66.1	90.6	68.3	29.5	82.6	113.8	45.1	47.1	52.8	38.6	12.5	125.9	77.0	94.5	95.9	121.1	2.9	46.0	60.7	98.7	58.1	78.9	18.6	149.9	179.0	57.3	76.5	43.4	67.9	64.2	77.8	78.7	123.1	37.0	14.6	92.2	54.9	66.5	96.0	12.5	46.6	66.4	119.2	9.4	84.8	37.9	85.5	14.1	19.1	144.6	75.2	46.6	104.3	136.9	91.5	197.0	40.2	30.4	65.7	56.6	98.3	7.6	33.1	120.7	90.5	108.8	74.8	97.7	110.3	85.9
NAA11	"ARD1B, ARD2, hARD2"	ENSG00000156269	"N-alpha-acetyltransferase 11, NatA catalytic subunit"	Q9BSU3	4	79225694-79326061	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	9	"brain: 2.6;placenta: 4.2;testis: 6.2"	"Group enriched"	"Detected in some"	12	"Cytotrophoblasts: 19.4;Early spermatids: 30.6;Extravillous trophoblasts: 16.4;Late spermatids: 23.9;Spermatocytes: 25.1;Spermatogonia: 15.9;Syncytiotrophoblasts: 13.3"	"Cancer enriched"	"Detected in some"	4	"testis cancer: 2.1"	"Region enriched"	"Detected in single"	5	"cerebellum: 2.6"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"GAMG: 19.3;K-562: 12.3;U-266/70: 32.9;U-266/84: 11.3"					"Not detected"	"Not detected"			HPA035922	Approved		Supported	"Nucleoplasm,Golgi apparatus,Centrosome,Cytosol"		NA	NA				"Cluster 78: Testis - Spermatogenesis"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm	"Golgi apparatus, Centrosome, Cytosol"	"HPA035922: AB_10673490"					"unprognostic (7.37e-2)"							"unprognostic (7.58e-2)"		"unprognostic (1.36e-1)"	"unprognostic (1.20e-1)"		"unprognostic (4.67e-1)"	0.0	0.0	0.2	0.0	0.2	0.0	0.0	2.6	0.1	0.0	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.5	0.4	0.1	0.0	0.0	0.0	4.2	0.3	0.1	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.1	0.3	0.0	0.0	6.2	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.1	0.0	19.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	12.3	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.2	3.3	0.0	0.3	0.3	0.0	0.2	0.0	0.2	0.1	0.0	0.0	0.2	0.0	32.9	11.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	2.6	0.1	0.1	0.2	0.5	0.4	0.3	0.3	0.5	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	19.4	0.0	0.0	0.0	0.0	30.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	16.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	23.9	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	25.1	15.9	0.0	0.0	13.3	0.0	0.0	0.0	0.0
NAA15	"FLJ13340, NARG1, NATH, TBDN100"	ENSG00000164134	"N-alpha-acetyltransferase 15, NatA auxiliary subunit"	Q9BXJ9	4	139301505-139420033	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"	"Angiogenesis, Differentiation, Transcription, Transcription regulation"	"Developmental protein"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023589, HPA050661"	Approved		Supported	"Nuclear bodies,Cytosol"		NA	NA		140000	"Cluster 44: Non-specific - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Cytosol	"Nuclear bodies"	"HPA023589: AB_1854311, HPA050661: AB_2681208"	"unprognostic (6.25e-3)"	"unprognostic (5.95e-2)"	"unprognostic (7.80e-3)"	"unprognostic (8.45e-2)"	"unprognostic (2.88e-1)"	"unprognostic (8.67e-2)"	"prognostic unfavorable (2.03e-4)"	"unprognostic (2.16e-2)"	"unprognostic (9.20e-3)"	"unprognostic (1.07e-2)"	"unprognostic (5.21e-3)"	"unprognostic (1.99e-2)"	"unprognostic (8.65e-2)"	"unprognostic (7.37e-3)"	"unprognostic (2.12e-1)"	"unprognostic (8.28e-3)"	"unprognostic (1.58e-1)"	9.1	8.9	6.5	11.4	7.3	16.4	9.9	12.4	8.3	7.3	7.3	8.4	7.6	8.9	6.0	12.5	7.1	7.0	10.0	6.5	6.7	7.5	10.9	6.4	14.5	7.3	6.8	7.9	7.8	9.7	5.8	10.6	7.7	8.3	9.1	9.2	6.2	7.2	17.0	9.3	7.0	8.7	6.9	8.5	7.9	13.1	6.9	13.4	9.0	16.3	15.5	14.5	7.7	10.5	44.7	32.1	30.4	49.2	21.7	26.4	37.3	42.2	27.6	39.9	30.6	45.3	38.2	91.1	25.3	35.0	34.6	28.1	80.5	51.7	57.2	42.8	29.6	49.0	29.6	29.8	23.0	90.5	30.5	18.7	31.0	50.4	39.1	21.1	40.5	35.2	92.1	38.7	42.9	35.6	86.8	26.8	50.7	83.4	25.0	53.4	40.9	47.0	31.8	37.2	39.3	30.8	28.2	45.7	28.8	30.6	27.8	35.2	35.0	38.3	27.0	36.7	48.7	46.5	89.0	88.7	32.9	64.6	37.4	4.2	3.4	1.1	5.0	3.9	5.9	4.8	5.3	5.9	4.7	5.3	5.1	5.8	2.6	4.5	3.9	4.0	5.5	2.1	6.5	7.3	12.4	8.3	6.5	6.7	7.3	6.8	7.7	6.9	6.9	10.5	28.4	48.1	33.8	28.4	39.7	93.4	69.6	20.7	29.0	34.0	28.1	15.7	46.9	22.8	32.3	20.2	20.9	39.9	22.8	14.4	15.6	28.1	9.0	40.3	38.9	31.5	15.6	34.5	44.0	19.5	50.8	32.9	21.4	40.5	34.8	35.7	16.8	28.1	32.5	40.4	45.9	20.8	18.3	24.1	35.0	11.3	25.4	27.8	28.4	29.0	26.6	27.7	32.0	42.3	57.6	26.5	16.2	29.0	23.4	53.8	10.2	16.4	34.0	36.3	32.9	69.0	47.4	90.0	59.7	44.0	99.3	41.7	31.7	32.1	32.5	70.2
NAA20	"dJ1002M8.1, NAT3, NAT5"	ENSG00000173418	"N-alpha-acetyltransferase 20, NatB catalytic subunit"	P61599	20	20017310-20033655	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 399.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA063344			Supported	Cytosol		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Cytosol		"HPA063344: AB_2684991"	"unprognostic (2.94e-2)"	"unprognostic (1.14e-1)"	"unprognostic (7.14e-2)"	"unprognostic (2.59e-1)"	"unprognostic (1.89e-1)"	"prognostic unfavorable (1.96e-4)"	"unprognostic (2.00e-2)"	"unprognostic (1.11e-2)"	"unprognostic (2.40e-1)"	"unprognostic (6.18e-2)"	"unprognostic (9.30e-2)"	"unprognostic (3.85e-1)"	"unprognostic (2.93e-1)"	"unprognostic (1.72e-1)"	"unprognostic (2.13e-1)"	"unprognostic (2.28e-1)"	"unprognostic (1.32e-1)"	50.4	53.3	38.9	34.8	40.6	46.5	65.3	41.6	51.6	40.8	54.0	41.9	27.9	41.7	54.2	113.5	41.6	32.6	61.7	40.2	42.9	85.2	82.5	40.2	37.3	40.9	41.3	33.0	62.7	103.9	26.7	53.0	41.9	43.5	42.8	49.6	47.1	46.9	84.9	38.2	33.9	46.2	42.3	31.8	42.1	66.6	41.5	37.1	59.7	73.6	51.0	51.3	44.1	44.5	212.7	139.9	50.1	69.4	95.0	116.6	67.7	149.2	100.3	132.1	123.8	67.0	137.7	108.4	80.6	113.6	125.5	156.3	85.8	233.2	153.2	51.4	75.7	79.4	49.6	132.6	141.2	102.2	65.9	122.4	182.1	132.8	153.9	93.2	139.7	80.4	126.7	115.7	157.6	177.2	128.6	149.9	37.9	181.5	180.7	69.8	191.9	148.3	190.0	70.4	84.1	62.2	81.9	254.1	170.7	42.5	145.4	171.1	113.7	106.6	75.4	137.8	153.8	130.0	171.9	116.9	66.5	76.2	76.7	39.7	86.2	70.1	55.5	97.5	83.6	63.3	65.9	65.4	92.9	56.6	63.5	75.0	12.5	70.3	81.8	77.7	75.6	100.6	38.9	40.6	41.6	51.6	40.2	42.9	40.9	41.3	41.9	42.3	41.5	44.5	60.5	67.3	42.2	17.0	44.9	108.7	113.6	312.4	45.5	52.9	62.9	75.2	73.1	77.2	147.8	104.8	25.0	111.8	51.4	32.6	230.9	194.0	399.9	99.5	87.6	77.4	41.3	28.8	18.0	169.0	102.2	66.4	31.1	75.8	51.3	46.5	50.3	72.9	255.9	69.0	22.7	43.8	164.8	66.8	56.1	60.5	69.9	68.6	71.2	31.9	100.1	91.5	58.7	16.1	25.2	198.0	37.1	74.9	44.2	184.5	45.7	242.6	199.9	60.7	39.5	75.8	90.8	354.2	58.3	122.5	118.8	85.5	40.8	99.5	54.2	141.7
NAA25	"C12orf30, FLJ13089"	ENSG00000111300	"N-alpha-acetyltransferase 25, NatB auxiliary subunit"	Q14CX7	12	112026689-112108796	"Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cone photoreceptor cells: 146.0;Oligodendrocytes: 109.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039322	Approved		Supported	"Golgi apparatus,Cytosol"		No	No			"Cluster 27: Non-specific - Gene expression"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 9: Photoreceptor cells - Phototransduction"	"Golgi apparatus, Cytosol"		"HPA039322: AB_10697548"	"unprognostic (1.26e-1)"	"unprognostic (1.31e-1)"	"unprognostic (3.91e-2)"	"prognostic unfavorable (2.26e-4)"	"unprognostic (1.91e-1)"	"unprognostic (6.87e-2)"	"prognostic unfavorable (5.53e-5)"	"unprognostic (9.09e-3)"	"unprognostic (3.24e-2)"	"unprognostic (1.04e-1)"	"unprognostic (2.06e-1)"	"unprognostic (8.34e-2)"	"prognostic unfavorable (1.32e-8)"	"unprognostic (2.44e-2)"	"unprognostic (2.01e-1)"	"unprognostic (9.34e-2)"	"unprognostic (9.18e-2)"	5.5	6.1	4.6	6.0	5.0	9.8	6.8	6.4	8.1	6.8	8.5	6.8	3.9	5.5	4.3	7.6	5.8	3.7	5.6	5.3	5.1	4.6	5.6	4.9	6.6	5.6	4.7	7.0	6.9	5.9	4.3	5.3	7.7	5.4	4.2	14.8	4.9	4.4	14.9	7.5	4.8	5.4	3.6	5.3	4.9	5.1	4.9	6.0	5.7	9.9	6.9	6.4	6.7	8.0	16.7	16.1	14.8	11.9	8.1	14.0	17.9	15.3	12.4	18.3	12.4	16.2	8.6	28.9	14.4	12.3	10.5	19.2	32.8	13.0	25.1	16.6	22.9	23.6	15.9	15.0	13.2	34.0	13.7	12.1	15.9	21.3	21.8	15.5	16.1	12.6	35.3	3.7	16.7	13.5	19.6	24.9	22.1	34.2	18.6	21.5	15.2	19.7	14.0	27.0	19.1	10.5	16.9	19.8	15.0	14.0	19.3	13.4	13.7	15.2	13.6	17.0	21.3	15.0	30.4	33.0	19.4	14.7	15.5	0.0	1.7	0.5	2.4	1.9	3.7	2.5	3.0	2.3	3.5	2.8	4.2	4.1	0.0	1.6	2.5	3.7	2.5	1.6	4.6	5.0	6.4	8.1	5.3	5.1	5.6	4.7	7.7	3.6	4.9	8.0	16.1	9.6	16.2	44.1	23.3	66.7	34.5	17.1	22.8	38.9	18.9	12.4	23.5	12.8	26.5	7.3	146.0	25.6	20.4	10.1	3.9	15.3	26.5	15.1	23.9	17.4	16.2	17.0	71.6	19.4	21.6	17.8	15.8	14.8	20.3	20.7	15.4	19.4	14.0	23.5	68.0	11.9	28.5	15.4	25.2	8.6	17.4	16.5	16.0	30.0	83.8	13.0	12.3	48.2	109.6	17.4	7.5	12.8	15.7	61.5	7.4	4.7	25.0	67.7	6.6	28.7	22.7	31.5	29.5	28.5	70.2	22.6	15.3	20.0	14.7	48.1
NAA30	"C14orf35, FLJ35355, MAK3, Mak3p, NAT12"	ENSG00000139977	"N-alpha-acetyltransferase 30, NatC catalytic subunit"	Q147X3	14	57390544-57415906	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 107.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA057824	Uncertain		Supported	Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 66: Spermatocytes - Spermatogenesis"	Cytosol		"HPA057824: AB_2683539"	"unprognostic (5.13e-2)"	"unprognostic (7.59e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.52e-2)"	"unprognostic (5.22e-2)"	"unprognostic (6.31e-2)"	"unprognostic (1.84e-2)"	"unprognostic (5.44e-2)"	"unprognostic (2.59e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.67e-1)"	"unprognostic (5.21e-2)"	"prognostic favorable (1.25e-8)"	"unprognostic (1.77e-1)"	"unprognostic (1.67e-1)"	"unprognostic (5.75e-3)"	"unprognostic (1.63e-1)"	9.6	7.7	9.7	7.2	11.3	15.0	9.6	10.6	11.8	7.8	6.5	8.4	9.9	9.1	7.1	11.3	7.4	7.1	14.2	11.6	11.6	12.4	16.7	6.4	9.0	8.6	9.3	14.9	9.0	12.5	5.7	13.4	9.2	10.1	7.9	12.0	8.0	10.1	31.8	8.3	8.7	10.1	9.3	8.3	7.0	18.5	12.4	9.0	10.6	27.3	9.1	8.2	6.0	9.4	19.4	18.2	10.2	16.7	16.8	21.9	17.1	22.1	21.3	16.5	15.0	16.5	13.9	14.1	19.0	18.4	12.5	20.1	18.5	14.3	27.4	24.7	9.4	11.4	10.1	14.5	17.5	23.1	12.8	15.0	20.7	15.0	24.9	18.4	25.8	17.3	11.3	13.6	22.1	22.1	19.5	13.4	11.0	17.8	20.0	15.3	29.4	11.0	16.9	17.4	21.8	11.5	18.7	18.3	23.0	18.2	23.6	11.9	22.7	25.7	27.0	14.2	14.3	10.1	13.2	16.9	17.1	11.5	18.7	0.8	0.4	0.2	1.2	0.9	1.2	1.0	1.1	1.8	0.3	1.1	1.2	1.2	0.2	2.4	2.8	0.6	1.7	0.4	9.7	11.3	10.6	11.8	11.6	11.6	8.6	9.3	9.2	9.3	12.4	9.4	11.8	9.6	6.3	10.1	16.7	41.0	11.8	8.6	25.0	13.5	16.5	10.9	34.9	17.2	8.0	3.7	18.8	18.3	20.1	11.6	9.8	12.5	107.1	9.0	13.1	17.0	21.0	9.0	20.3	11.6	15.6	13.1	12.8	10.8	7.0	14.9	11.0	25.5	9.9	10.1	20.3	13.7	6.1	13.2	12.1	37.6	13.7	8.2	23.2	10.3	9.9	13.3	8.2	16.6	18.9	14.5	13.8	13.5	18.1	18.9	13.6	17.9	9.5	15.3	19.7	13.3	15.4	69.2	20.5	25.5	41.2	22.2	17.0	13.3	12.6	16.7
NAA35	"bA379P1.1, FLJ21613, FLJ22643, MAK10"	ENSG00000135040	"N-alpha-acetyltransferase 35, NatC auxiliary subunit"	Q5VZE5	9	85941146-86025462	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021547	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 10: Non-specific - Unknown function"	"Nucleoplasm, Plasma membrane, Cytosol"		"HPA021547: AB_1853505"	"unprognostic (5.87e-2)"	"unprognostic (2.41e-1)"	"unprognostic (4.71e-3)"	"unprognostic (9.25e-3)"	"unprognostic (2.37e-2)"	"unprognostic (6.39e-2)"	"prognostic unfavorable (1.16e-7)"	"unprognostic (1.86e-1)"	"unprognostic (5.22e-3)"	"unprognostic (1.56e-1)"	"unprognostic (8.30e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.36e-3)"	"unprognostic (1.88e-1)"	"unprognostic (4.34e-2)"	"unprognostic (9.18e-2)"	"unprognostic (1.07e-2)"	7.7	12.2	6.9	6.3	7.3	6.6	9.3	9.8	7.0	8.9	8.2	11.1	8.6	9.4	7.8	10.9	8.4	5.7	8.8	6.9	7.2	8.4	8.7	7.1	6.2	6.3	6.0	9.9	10.8	9.4	12.0	7.4	6.2	9.7	10.5	14.3	10.1	6.8	17.4	9.1	8.1	7.0	6.4	6.5	8.8	15.4	8.4	7.3	10.4	13.2	7.2	9.0	9.1	8.9	25.4	15.8	17.7	13.5	9.8	13.1	24.8	15.5	15.1	16.1	13.1	12.4	15.7	8.4	8.5	15.4	13.1	34.9	15.0	18.4	16.8	22.3	13.1	21.6	19.9	14.6	16.6	30.4	17.6	13.1	15.2	17.0	24.6	12.4	14.0	15.6	25.3	15.6	14.9	14.6	15.7	16.0	17.8	28.0	18.2	14.4	26.9	12.6	17.3	20.4	16.7	15.5	17.6	15.8	13.6	17.0	11.9	11.7	14.0	11.2	12.4	16.9	15.0	22.3	29.1	5.7	16.3	12.5	10.2	1.7	2.5	5.1	3.4	2.6	4.3	9.5	3.5	3.1	3.0	9.3	4.6	3.4	1.3	3.5	1.9	2.2	3.1	2.6	6.9	7.3	9.8	7.0	6.9	7.2	6.3	6.0	6.2	6.4	8.4	8.9	14.6	3.2	14.1	58.4	16.8	16.3	20.2	19.0	19.9	25.5	18.0	13.1	23.3	18.6	22.8	11.0	22.9	22.6	14.9	20.2	1.9	19.7	8.7	29.4	18.6	14.3	20.9	14.5	51.8	25.8	18.9	13.6	16.3	22.5	12.0	32.9	9.3	9.8	12.2	21.9	58.7	14.5	30.5	11.0	8.4	5.3	9.3	10.7	14.2	52.5	12.3	18.7	14.4	44.7	68.8	18.3	16.6	11.7	17.1	22.0	12.0	8.9	33.7	36.6	13.1	21.4	24.7	56.7	36.3	17.7	16.6	31.1	15.8	24.4	16.6	19.2
NAA38	"LSMD1, MGC14151, PFAAP2"	ENSG00000183011	"N-alpha-acetyltransferase 38, NatC auxiliary subunit"	Q9BRA0	17	7856685-7885238	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 1601.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059189			Supported	Nucleoplasm	"Intracellular and membrane"	No	No			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 34: Spermatids - Unknown function"	Nucleoplasm		"HPA059189: "	"unprognostic (6.84e-2)"	"unprognostic (1.65e-3)"	"unprognostic (1.30e-2)"	"unprognostic (1.85e-3)"	"unprognostic (2.76e-2)"	"unprognostic (3.35e-1)"	"unprognostic (4.72e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.27e-1)"	"unprognostic (7.28e-3)"	"unprognostic (1.48e-3)"	"unprognostic (3.31e-1)"	"unprognostic (5.83e-3)"	"unprognostic (1.58e-1)"	"unprognostic (6.02e-2)"	"unprognostic (2.66e-1)"	"unprognostic (9.75e-2)"	72.1	102.2	137.4	33.3	142.4	76.0	67.3	143.6	188.0	58.3	135.3	77.4	30.8	54.9	30.9	65.8	57.4	29.1	99.7	139.4	139.3	87.6	67.8	50.7	45.7	137.7	137.3	45.3	60.1	76.6	73.0	22.6	137.9	71.5	27.0	29.4	56.2	31.8	130.4	59.5	49.2	24.5	138.1	72.6	65.9	97.8	142.5	45.2	60.1	93.4	31.4	60.0	55.5	142.0	131.4	234.9	129.4	132.9	70.8	78.3	44.8	59.7	68.4	108.3	89.9	89.0	54.6	89.6	98.5	63.6	69.2	105.4	69.8	110.3	26.8	134.1	318.2	137.3	279.7	131.0	68.4	38.6	101.9	114.3	60.4	71.0	46.3	74.5	105.9	201.9	29.1	95.3	63.6	157.3	140.0	91.6	29.2	98.9	271.5	142.0	59.6	59.4	101.0	72.6	57.6	110.5	46.6	111.1	87.3	18.7	68.8	100.0	57.6	72.2	52.0	59.0	170.8	39.1	43.8	34.8	121.5	159.1	72.2	313.1	275.2	196.9	176.1	244.0	163.4	273.8	186.3	181.9	332.4	234.2	167.1	173.6	201.1	152.9	239.8	304.0	215.3	299.0	137.4	142.4	143.6	188.0	139.4	139.3	137.7	137.3	137.9	138.1	142.5	142.0	263.1	76.9	140.5	16.3	117.8	94.1	85.8	171.8	144.5	98.5	218.1	305.4	344.3	128.7	107.7	253.8	50.1	160.2	107.4	227.2	518.5	100.6	646.3	189.4	104.9	183.6	226.6	201.2	18.3	158.4	128.0	102.6	80.5	133.1	100.1	131.1	213.5	381.3	210.5	40.4	21.7	211.2	146.5	222.8	96.8	1601.4	116.8	149.9	76.5	14.0	195.2	221.6	182.3	34.7	13.3	134.0	161.6	113.2	161.7	86.8	184.1	468.0	107.1	126.5	111.7	70.2	109.8	120.5	132.4	182.1	99.4	91.9	103.5	175.3	289.5	129.3
NAA40	"FLJ13848, NAT11"	ENSG00000110583	"N-alpha-acetyltransferase 40, NatD catalytic subunit"	Q86UY6	11	63938959-63957319	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Horizontal cells: 102.6;Late spermatids: 130.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037816, HPA056142"	Uncertain		Supported	"Nucleoplasm,Centriolar satellite,Cytosol"		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 62: Horizontal cells - Visual perception"	Nucleoplasm	"Centriolar satellite, Cytosol"	"HPA037816: AB_10672289, HPA056142: "	"unprognostic (3.52e-1)"	"unprognostic (4.12e-1)"	"unprognostic (1.40e-1)"	"unprognostic (6.88e-3)"	"unprognostic (1.50e-1)"	"unprognostic (2.11e-1)"	"prognostic unfavorable (1.43e-7)"	"unprognostic (1.45e-1)"	"unprognostic (1.13e-2)"	"unprognostic (1.58e-1)"	"unprognostic (7.01e-3)"	"unprognostic (6.29e-3)"	"unprognostic (3.42e-2)"	"unprognostic (6.43e-3)"	"unprognostic (2.49e-1)"	"unprognostic (1.55e-1)"	"unprognostic (5.25e-2)"	3.3	8.9	5.1	3.9	5.1	2.5	4.4	4.5	5.7	4.0	5.7	5.2	5.7	3.0	3.3	6.7	6.8	3.6	9.5	5.3	4.9	9.1	3.8	3.6	7.5	5.6	5.3	2.7	6.5	15.1	10.4	6.7	5.2	4.2	4.7	7.2	6.6	4.0	4.7	2.7	5.7	3.1	5.0	8.8	4.8	15.3	5.2	10.0	6.1	8.5	7.3	4.2	3.6	5.0	15.5	17.3	21.7	11.8	6.0	5.9	13.8	11.3	12.0	27.3	19.1	14.8	19.3	9.5	13.6	10.2	18.9	13.7	18.3	8.2	20.1	12.5	11.2	13.0	11.1	16.9	7.9	20.9	10.8	6.0	7.4	17.0	4.6	10.6	18.0	16.1	22.4	6.9	12.9	11.8	22.3	16.3	20.2	14.3	11.8	21.9	19.5	12.1	18.5	11.8	28.7	15.1	17.7	15.2	9.2	15.8	25.1	9.2	11.6	15.1	18.3	8.9	9.3	8.3	5.6	16.5	9.2	8.9	11.9	2.3	0.5	2.7	6.9	0.4	2.4	2.7	1.8	3.3	2.7	2.4	1.1	2.6	0.1	5.2	0.2	3.5	0.5	2.3	5.1	5.1	4.5	5.7	5.3	4.9	5.6	5.3	5.2	5.0	5.2	5.0	4.3	3.2	4.8	12.1	8.1	2.8	2.0	4.5	10.8	30.9	11.5	7.0	14.8	5.7	9.4	18.4	33.3	9.6	12.1	13.6	0.0	5.7	46.3	20.0	7.4	7.6	17.5	7.4	14.3	5.4	12.8	4.8	6.1	8.5	1.3	14.3	9.7	5.2	9.5	102.6	15.6	6.1	10.2	10.3	5.3	130.5	4.7	7.3	1.8	15.0	4.4	8.6	17.5	11.6	10.1	5.9	3.5	7.2	12.2	2.1	10.6	4.1	22.5	23.9	0.0	4.3	4.4	27.4	16.5	6.5	2.8	4.1	8.9	10.4	7.3	1.8
NAA50	"FLJ13194, MAK3, NAT13, NAT5, San"	ENSG00000121579	"N-alpha-acetyltransferase 50, NatE catalytic subunit"	Q9GZZ1	3	113716458-113746300	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 320.7"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA074489	Approved		Supported	Nucleoli		NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 59: Non-specific - Translation"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 22: Epithelial cell types - Mixed function"	Nucleoli		"HPA074489: "	"unprognostic (9.74e-2)"	"unprognostic (1.49e-1)"	"unprognostic (3.19e-2)"	"prognostic unfavorable (2.32e-4)"	"unprognostic (4.75e-2)"	"unprognostic (1.51e-1)"	"prognostic unfavorable (1.51e-5)"	"unprognostic (1.62e-3)"	"unprognostic (6.82e-2)"	"unprognostic (3.43e-1)"	"prognostic unfavorable (7.92e-5)"	"unprognostic (2.97e-3)"	"unprognostic (1.09e-1)"	"unprognostic (2.25e-2)"	"unprognostic (9.59e-2)"	"unprognostic (7.13e-3)"	"unprognostic (2.43e-1)"	88.2	64.2	21.8	72.0	24.7	87.3	58.4	25.2	29.4	49.2	27.2	62.5	48.9	50.1	31.4	93.4	38.5	50.6	50.9	23.7	24.4	64.4	90.3	43.5	84.9	23.6	25.0	51.7	58.7	59.8	23.1	45.0	25.3	52.8	54.1	31.5	69.7	42.1	320.7	53.4	47.5	51.2	25.2	52.6	65.6	53.2	26.6	56.8	58.5	154.4	90.7	87.6	46.3	28.2	589.6	250.7	135.2	158.5	179.4	144.6	281.4	308.5	172.4	186.0	212.4	362.3	205.7	403.4	185.8	164.6	146.9	236.5	238.0	211.1	338.6	85.2	121.5	435.7	182.7	220.3	164.4	459.1	135.7	124.0	163.0	208.8	298.3	122.1	168.7	167.3	279.3	157.8	194.3	277.0	306.2	99.3	303.4	228.3	365.3	309.5	207.2	318.9	141.7	439.9	207.4	119.6	223.6	164.1	229.0	116.5	228.1	150.4	156.9	255.1	253.9	109.1	235.7	174.1	314.2	736.0	200.2	253.2	160.6	17.7	40.8	22.5	45.5	40.5	40.6	55.2	33.7	43.1	44.4	37.1	29.4	39.1	51.8	31.8	38.1	25.6	39.9	52.5	21.8	24.7	25.2	29.4	23.7	24.4	23.6	25.0	25.3	25.2	26.6	28.2	33.9	48.1	39.9	24.8	75.7	168.4	86.6	42.6	76.2	24.8	52.3	31.6	47.5	25.8	45.8	36.8	8.4	46.0	78.2	51.3	78.2	52.9	68.0	44.4	53.1	45.7	19.9	79.5	41.5	55.1	94.6	55.2	35.7	94.3	47.5	45.5	29.3	66.1	61.9	40.4	39.0	31.5	42.7	55.3	148.8	50.7	30.7	60.1	62.2	20.6	49.9	29.7	29.9	33.2	28.4	65.2	36.8	31.2	74.9	142.0	31.4	71.0	30.0	18.4	19.7	53.1	64.1	53.5	60.8	99.8	177.9	62.5	74.7	37.7	49.3	193.3
NABP1	"DKFZp667M1322, FLJ13624, FLJ22833, hSSB2, MGC111163, OBFC2A, SOSS-B2, SSB2"	ENSG00000173559	"Nucleic acid binding protein 1"	Q96AH0	2	191678068-191741097	"Predicted intracellular proteins"	"DNA damage, DNA repair"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 36.7"	"Cell type enhanced"	"Detected in all"		"Alveolar cells type 2: 452.0;Langerhans cells: 301.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Karpas-707: 76.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054978, HPA067802"			Enhanced	Nucleoplasm,Cytosol		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 64: Macrophages - Immune response"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 11: Alveolar cells - Smell perception"	Nucleoplasm	Cytosol	"HPA054978: AB_2682660, HPA067802: AB_2685899"	"unprognostic (5.43e-2)"	"unprognostic (5.33e-2)"	"unprognostic (2.80e-1)"	"unprognostic (4.73e-2)"	"unprognostic (1.48e-1)"	"unprognostic (6.89e-2)"	"unprognostic (8.07e-4)"	"unprognostic (1.33e-1)"	"unprognostic (2.89e-2)"	"unprognostic (2.99e-1)"	"unprognostic (2.82e-2)"	"unprognostic (6.17e-2)"	"prognostic unfavorable (8.20e-7)"	"unprognostic (5.64e-2)"	"unprognostic (7.50e-2)"	"unprognostic (1.48e-1)"	"unprognostic (6.02e-2)"	22.0	5.3	2.3	23.2	1.8	5.5	9.8	1.5	2.4	4.7	4.9	5.2	10.0	4.6	0.6	13.2	5.4	7.4	3.9	2.5	2.5	10.5	9.8	21.1	12.4	2.7	2.7	4.5	3.8	0.8	4.3	7.6	2.5	4.4	3.8	1.0	5.2	3.2	2.8	4.4	18.8	3.7	2.2	36.7	4.7	9.2	5.1	6.3	3.2	3.3	11.6	18.4	7.6	3.6	36.2	5.5	1.5	1.6	15.7	16.4	10.2	53.4	31.3	28.6	15.1	30.9	18.7	2.6	43.1	26.3	23.9	11.5	5.7	22.1	29.0	21.2	5.5	18.4	10.8	5.6	14.3	9.8	16.5	22.5	20.3	47.9	23.4	13.8	8.3	4.8	28.7	76.3	31.8	3.3	3.5	10.8	3.6	6.8	31.4	7.1	6.1	16.8	30.2	22.2	2.0	1.3	21.3	7.7	14.1	18.7	2.7	4.7	31.4	28.2	24.6	15.4	33.6	25.2	12.7	9.1	25.1	9.7	6.4	20.0	10.4	8.8	13.2	17.1	19.1	10.8	17.3	13.7	7.3	3.5	8.0	10.7	38.8	6.6	21.5	6.9	28.5	8.5	2.3	1.8	1.5	2.4	2.5	2.5	2.7	2.7	2.5	2.2	5.1	3.6	42.2	214.7	452.0	2.0	66.5	53.0	141.0	15.7	32.5	3.3	33.1	34.3	9.3	8.6	106.2	11.0	2.1	23.6	46.9	79.0	3.9	16.7	212.8	64.9	28.1	34.0	4.2	9.1	3.5	5.7	43.5	62.2	32.1	179.6	139.6	2.2	10.8	8.6	54.9	3.3	3.6	20.2	8.2	113.8	301.8	69.9	10.2	151.3	40.9	18.7	108.8	1.9	18.6	1.5	1.7	30.7	85.7	3.8	43.9	44.8	109.2	22.4	57.6	3.6	6.6	101.5	46.3	25.7	18.4	35.6	45.3	146.3	111.6	12.2	31.7	112.8
NADK2	"C5orf33, FLJ30596, MNADK, NADKD1"	ENSG00000152620	"NAD kinase 2, mitochondrial"	Q4G0N4	5	36192589-36242279	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	11	"liver: 328.0"	"Group enriched"	"Detected in many"	5	"Astrocytes: 105.4;Early spermatids: 324.5;Hepatocytes: 211.9;Late spermatids: 154.9"	"Cancer enhanced"	"Detected in all"		"liver cancer: 36.9"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038366, HPA038367, HPA061492"	Enhanced		Supported	Mitochondria		NA	NA		30000	"Cluster 24: B-cells - Unknown function"	"Cluster 62: Liver - Hemostasis"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	Mitochondria		"HPA038366: AB_2675977, HPA038367: AB_10672743, HPA061492: AB_2684538"	"unprognostic (1.15e-2)"	"unprognostic (2.63e-2)"	"unprognostic (3.01e-2)"	"unprognostic (3.10e-3)"	"unprognostic (1.64e-1)"	"unprognostic (1.97e-2)"	"unprognostic (4.06e-3)"	"unprognostic (8.84e-2)"	"unprognostic (3.32e-2)"	"unprognostic (1.93e-3)"	"unprognostic (1.09e-1)"	"unprognostic (1.76e-1)"	"unprognostic (9.73e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.58e-1)"	"unprognostic (2.54e-2)"	"unprognostic (1.75e-2)"	13.6	20.1	26.6	9.3	23.3	10.6	15.4	21.9	24.2	13.7	14.0	13.9	16.6	13.3	7.9	10.4	12.7	11.9	20.2	22.2	27.1	23.2	328.0	8.4	9.5	25.4	27.4	19.6	26.9	10.7	5.5	16.9	25.3	19.0	13.8	11.2	13.0	16.2	29.4	6.6	12.9	14.2	31.0	8.6	17.1	18.2	25.3	10.3	17.3	29.8	11.4	27.9	8.8	30.3	21.5	14.6	22.4	23.5	32.2	27.2	27.5	19.5	13.2	17.5	13.2	41.4	27.4	74.3	14.0	23.3	23.0	14.9	20.0	14.3	24.2	21.2	16.3	22.0	43.1	23.9	22.7	46.5	8.0	28.9	22.5	21.6	29.9	22.4	18.4	30.2	52.0	27.8	18.0	9.0	42.3	18.2	10.7	18.1	19.2	40.2	51.6	15.8	24.2	18.2	8.7	20.1	102.0	32.4	10.5	16.7	22.9	39.8	15.1	34.1	18.2	27.0	23.9	23.7	30.3	23.2	14.5	57.2	14.2	8.2	1.2	1.1	1.3	1.4	1.8	1.3	1.9	1.5	2.3	5.3	1.6	1.4	0.1	6.7	3.3	1.2	2.1	1.4	26.6	23.3	21.9	24.2	22.2	27.1	25.4	27.4	25.3	31.0	25.3	30.3	9.6	3.2	6.9	105.4	7.5	6.8	6.8	5.4	6.2	5.7	18.3	11.2	29.3	25.8	7.1	5.5	8.4	9.2	9.6	7.4	25.4	5.0	324.5	6.1	9.4	6.8	7.2	13.7	23.8	9.5	8.9	12.5	5.6	7.1	1.3	10.0	12.1	211.9	8.9	3.3	18.3	11.7	4.1	10.4	9.6	154.9	19.9	6.4	14.2	11.2	3.7	16.9	5.2	21.1	23.6	6.9	8.8	23.0	14.3	14.9	6.6	23.1	7.2	5.4	0.0	11.6	13.5	35.1	11.0	7.7	5.7	7.3	6.9	26.4	11.6	12.3
NADSYN1	FLJ10631	ENSG00000172890	"NAD synthetase 1"	Q6IA69	11	71453109-71524107	"Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		Ligase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017798, HPA038523, HPA038524"	Approved		Approved	"Golgi apparatus,Vesicles,Cytosol"		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 37: Intestine - Unknown function"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 45: Enterocytes - Digestion"	Vesicles	"Golgi apparatus, Cytosol"	"CAB017798: , HPA038523: AB_2676060, HPA038524: AB_2676061"	"unprognostic (1.45e-1)"	"unprognostic (1.29e-1)"	"unprognostic (7.30e-2)"	"unprognostic (2.63e-3)"	"unprognostic (1.75e-1)"	"unprognostic (1.60e-1)"	"prognostic unfavorable (5.17e-6)"	"unprognostic (1.19e-2)"	"unprognostic (4.38e-2)"	"unprognostic (1.41e-1)"	"unprognostic (9.41e-2)"	"unprognostic (1.99e-2)"	"prognostic unfavorable (8.72e-5)"	"unprognostic (4.12e-3)"	"unprognostic (1.38e-1)"	"unprognostic (1.54e-2)"	"prognostic favorable (5.10e-4)"	29.5	34.1	18.8	24.1	20.4	67.6	26.2	18.5	21.2	30.4	20.3	48.6	39.5	26.0	24.2	56.3	31.2	25.8	20.3	17.8	18.3	33.2	49.8	35.3	33.3	22.4	19.6	27.6	29.5	13.4	36.0	16.5	21.0	45.3	36.0	6.9	32.9	22.8	11.0	31.1	51.1	19.3	18.8	58.4	34.3	25.6	21.7	27.9	31.8	5.1	28.2	43.4	33.4	24.4	15.9	37.8	12.0	21.6	35.0	50.6	32.4	29.7	27.2	15.4	17.0	32.4	25.7	13.4	33.1	35.3	20.7	55.2	15.9	42.6	8.2	27.9	12.8	22.2	27.6	36.3	43.3	45.1	40.9	72.0	65.8	19.9	17.8	34.9	54.6	24.2	11.9	18.5	21.9	49.7	22.4	29.9	7.0	69.6	21.3	27.5	37.2	13.5	37.8	72.1	8.9	12.7	21.2	27.9	56.0	17.9	24.9	24.4	66.2	16.7	14.2	30.9	11.8	24.3	11.0	11.7	29.9	25.6	12.0	6.1	28.0	17.3	15.3	25.0	12.7	12.2	13.5	13.8	31.1	9.2	8.8	11.4	17.7	16.3	22.6	23.0	17.7	21.4	18.8	20.4	18.5	21.2	17.8	18.3	22.4	19.6	21.0	18.8	21.7	24.4	12.6	22.4	32.3	4.2	24.0	6.2	17.8	18.4	26.2	7.8	13.5	10.9	8.3	12.8	19.8	11.0	4.2	17.4	27.3	65.3	3.9	16.5	22.6	21.1	11.1	15.6	23.4	20.2	5.1	17.3	14.5	12.8	51.0	19.7	22.1	23.1	13.9	16.7	20.1	13.5	5.8	30.3	16.2	23.2	18.5	60.9	9.3	25.4	8.8	8.4	25.8	5.9	29.9	7.5	18.5	20.0	55.8	10.1	18.0	17.9	73.3	16.2	16.5	7.3	13.1	9.6	9.8	15.9	5.0	38.3	12.8	17.2	22.3	17.1	43.7	24.2
NAF1		ENSG00000145414	"Nuclear assembly factor 1 ribonucleoprotein"	Q96HR8	4	163110073-163166890	"Predicted intracellular proteins"	"Ribosome biogenesis, rRNA processing"	"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036241, HPA036242, HPA066090"	Approved		Enhanced	Nucleoplasm,Cytosol		NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm	Cytosol	"HPA036241: AB_2675017, HPA036242: AB_10673616, HPA066090: AB_2685614"	"unprognostic (6.24e-2)"	"unprognostic (1.20e-2)"	"unprognostic (1.20e-2)"	"unprognostic (2.58e-1)"	"unprognostic (8.99e-2)"	"unprognostic (2.00e-2)"	"unprognostic (1.18e-2)"	"unprognostic (1.56e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.64e-3)"	"unprognostic (1.45e-1)"	"unprognostic (8.73e-3)"	"unprognostic (2.04e-1)"	"unprognostic (1.77e-1)"	"unprognostic (3.17e-2)"	"unprognostic (3.05e-1)"	9.5	8.1	4.7	7.6	5.9	7.6	8.3	3.9	7.1	8.7	9.2	7.2	4.7	10.4	6.1	7.0	12.3	7.0	6.5	6.2	3.5	6.8	7.1	7.0	8.7	2.4	3.7	10.9	7.7	10.7	4.8	6.6	1.8	8.5	8.1	13.5	7.6	8.6	19.4	8.3	4.9	8.7	3.1	7.3	6.0	13.3	2.5	7.1	10.2	10.3	7.9	9.5	4.8	4.0	15.2	12.7	16.0	16.4	9.2	14.5	18.8	17.6	11.7	15.1	15.0	14.4	17.8	39.4	5.0	10.9	12.2	12.5	32.7	18.9	19.7	17.5	20.2	41.7	11.4	12.3	16.1	27.2	14.3	13.7	16.5	18.5	14.9	15.6	13.6	12.5	47.7	20.3	20.4	15.0	31.8	15.5	20.9	11.5	12.5	26.1	11.8	20.7	15.0	6.9	17.3	13.1	11.6	20.9	13.0	13.9	11.3	11.8	14.4	18.0	15.6	14.1	20.2	12.7	19.1	30.2	17.1	15.6	18.2	0.0	0.5	0.0	0.7	0.5	0.2	0.6	0.7	1.0	0.8	0.7	1.0	0.7	0.0	0.4	0.5	0.8	0.2	0.5	4.7	5.9	3.9	7.1	6.2	3.5	2.4	3.7	1.8	3.1	2.5	4.0	15.2	6.4	16.7	24.8	25.9	32.4	23.6	10.5	19.4	10.9	10.7	12.8	4.0	11.5	8.0	9.2	18.8	14.3	19.0	4.2	3.9	9.8	48.0	35.7	13.3	9.2	19.2	11.1	44.8	6.8	15.6	25.1	9.2	22.1	10.8	10.2	12.1	5.0	11.7	8.4	30.9	8.2	4.1	17.9	13.3	19.1	6.8	32.8	8.8	19.7	6.0	10.3	4.1	31.7	29.8	7.8	4.0	5.3	16.4	14.4	2.8	8.9	30.3	14.7	32.9	29.8	24.7	23.6	16.2	14.8	41.1	21.3	24.9	13.0	8.0	13.1
NAGS	"AGAS, ARGA, NAT7"	ENSG00000161653	"N-acetylglutamate synthase"	Q8N159	17	44004622-44009068	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Urea cycle"	"Acyltransferase, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"intestine: 15.9;liver: 48.2"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 21.7;Proximal enterocytes: 44.2;Proximal tubular cells: 20.7;Spermatocytes: 16.0"	"Cancer enhanced"	"Detected in all"		"liver cancer: 12.4"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC TERT1: 5.5;HHSteC: 5.2;TIME: 7.1;U-87 MG: 10.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA027300			Supported	Mitochondria	"Intracellular and membrane"	NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 66: Spermatocytes - Spermatogenesis"	Mitochondria		"HPA027300: AB_2672207"	"unprognostic (1.51e-3)"	"unprognostic (9.24e-2)"	"unprognostic (1.68e-1)"	"unprognostic (8.67e-2)"	"unprognostic (1.44e-2)"	"unprognostic (1.30e-3)"	"unprognostic (2.38e-2)"	"unprognostic (1.98e-1)"	"unprognostic (3.14e-2)"	"unprognostic (2.73e-2)"	"unprognostic (2.53e-3)"	"unprognostic (1.46e-1)"	"unprognostic (5.19e-2)"	"unprognostic (6.99e-2)"	"unprognostic (1.29e-2)"	"unprognostic (1.22e-1)"	"unprognostic (2.27e-1)"	0.9	0.7	2.0	0.5	1.2	0.0	1.4	0.9	2.0	0.8	0.0	2.4	15.9	0.8	1.8	1.4	0.7	0.4	1.2	1.0	3.5	4.9	48.2	1.9	0.3	2.0	1.4	0.6	0.3	3.3	0.5	0.1	2.2	1.1	0.5	0.0	1.0	1.4	0.2	1.0	13.6	0.1	1.3	0.4	0.4	0.6	3.6	0.1	4.4	0.2	0.1	0.4	1.0	1.0	2.9	0.1	0.0	0.4	0.0	5.5	0.1	0.5	0.1	0.1	0.2	1.7	0.7	0.0	1.1	0.0	0.1	1.3	0.1	1.5	0.3	0.2	0.7	0.1	0.2	2.2	5.2	0.0	0.0	3.2	0.0	0.7	0.0	0.6	1.4	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.4	1.5	2.7	0.0	0.3	0.0	0.1	0.0	2.1	0.0	0.9	0.0	0.0	0.2	0.2	0.0	7.1	2.5	0.7	0.2	0.6	0.1	0.1	0.1	10.0	0.0	0.3	0.8	0.5	0.7	0.9	0.4	0.7	0.3	0.6	0.8	0.5	0.3	0.3	0.4	0.3	0.2	0.8	0.1	0.5	0.3	2.0	1.2	0.9	2.0	1.0	3.5	2.0	1.4	2.2	1.3	3.6	1.0	1.8	3.2	4.2	0.0	0.9	1.5	0.9	1.9	6.8	0.4	3.5	4.8	2.6	2.8	2.9	12.9	0.0	0.9	1.1	10.5	7.9	1.9	5.8	0.5	0.2	2.3	7.2	0.0	0.0	4.2	1.9	0.9	2.0	0.2	0.0	0.3	0.7	21.7	1.1	0.0	0.3	3.8	4.1	1.9	5.3	5.3	1.5	2.1	0.0	1.0	6.1	1.0	3.1	0.0	0.0	5.1	11.1	0.7	0.0	0.6	44.2	20.7	1.1	0.5	0.0	0.2	0.9	16.0	2.5	1.0	0.9	0.4	1.4	0.7	6.6	0.6
NANOG	"FLJ12581, FLJ40451"	ENSG00000111704	"Nanog homeobox"	Q9H9S0	12	7787794-7799146	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in single"		"brain: 1.9"	"Cell type enhanced"	"Detected in some"		"Cone photoreceptor cells: 8.4;Spermatocytes: 5.5"	"Cancer enriched"	"Detected in single"	1164	"testis cancer: 58.1"	"Low region specificity"	"Detected in single"			"Immune cell enhanced"	"Detected in some"		"plasmacytoid DC: 1.7"	"Group enriched"	"Detected in many"	5	"dendritic cells: 1.7;granulocytes: 1.5"	"Cell line enriched"	"Detected in some"	5	"NTERA-2: 125.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB019380, HPA072117"	Supported		Supported	Nucleoplasm,Vesicles		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 9: Photoreceptor cells - Phototransduction"	Nucleoplasm	Vesicles	"CAB019380: , HPA072117: "	"unprognostic (1.76e-1)"	"unprognostic (1.86e-1)"		"unprognostic (1.01e-1)"	"unprognostic (1.78e-1)"	"unprognostic (8.59e-3)"	"unprognostic (3.50e-1)"	"unprognostic (3.46e-2)"		"unprognostic (6.35e-2)"	"unprognostic (1.10e-1)"	"unprognostic (3.87e-1)"	"unprognostic (4.51e-7)"	"unprognostic (3.46e-2)"	"unprognostic (2.09e-1)"	"unprognostic (1.51e-1)"	"unprognostic (3.85e-2)"	0.0	0.1	0.3	0.1	0.7	0.4	0.1	1.9	0.4	0.0	0.3	0.0	0.1	0.1	0.0	0.1	0.0	0.1	0.0	0.3	0.1	0.0	0.2	0.4	0.1	0.3	0.1	0.0	0.1	0.0	0.0	0.0	0.3	0.1	0.0	0.1	0.0	0.0	0.3	0.3	0.0	0.1	0.1	0.2	0.2	0.9	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	125.5	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	25.3	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.1	1.5	0.2	0.1	0.1	0.1	0.1	0.2	0.1	0.1	0.0	0.3	0.2	0.2	0.7	0.3	0.2	1.7	0.1	0.0	0.3	0.7	1.9	0.4	0.3	0.1	0.3	0.1	0.3	0.1	0.4	0.7	0.4	0.0	0.0	0.0	0.2	1.7	1.8	0.8	0.0	2.2	0.3	0.1	0.8	0.0	0.3	0.0	8.4	1.6	1.4	0.1	0.0	0.4	1.0	0.3	0.5	0.6	0.0	0.0	0.0	0.4	0.2	0.4	0.0	0.3	0.0	2.1	0.7	0.6	0.5	0.0	0.0	0.3	2.0	0.3	0.0	0.3	1.5	0.1	0.0	0.0	0.0	1.1	0.0	0.0	0.1	0.2	0.4	1.5	0.0	0.9	0.0	0.3	0.9	1.0	0.0	1.7	0.4	5.5	0.6	0.0	0.6	0.7	0.7	0.7	0.4	1.8
NANOGP8		ENSG00000255192	"Nanog homeobox retrogene P8"	Q6NSW7	15	35083410-35085295	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enriched"	"Detected in single"	5	"brain: 3.7"	"Not detected"	"Not detected"			"Cancer enriched"	"Detected in single"	415	"testis cancer: 20.7"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	69	"NTERA-2: 33.2;SuSa: 11.6"									HPA072117			Supported	Nucleoplasm,Vesicles		NA	NA				"Cluster 6: Brain - Smell perception"	"Cluster 5: NTERA-2 - Transcription"		Nucleoplasm	Vesicles	"HPA072117: "										"unprognostic (1.58e-1)"			"unprognostic (9.05e-3)"	"unprognostic (1.48e-1)"	"unprognostic (2.37e-1)"			0.1	0.1	0.7	0.0	3.7	0.2	0.1	2.1	1.8	0.1	0.0	0.1	0.1	0.2	0.1	0.0	0.1	0.0	0.1	0.2	0.5	0.2	0.1	0.1	0.0	0.3	0.2	0.2	0.2	0.0	0.2	0.0	0.4	0.2	0.0	0.2	0.1	0.0	0.0	0.3	0.0	0.0	0.2	0.1	0.0	0.7	1.2	0.0	0.1	0.0	0.0	0.1	0.1	0.6	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	33.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.7	3.7	2.1	1.8	0.2	0.5	0.3	0.2	0.4	0.2	1.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
NANOS1	"NOS1, ZC2HC12A"	ENSG00000188613	"Nanos C2HC-type zinc finger 1"	Q8WY41	10	119029714-119033730	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Translation regulation"	"Repressor, RNA-binding"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 38.6"	"Cell type enhanced"	"Detected in many"		"Breast glandular cells: 10.2;Cardiomyocytes: 11.3;Cone photoreceptor cells: 10.4;Muller glia cells: 14.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"SH-SY5Y: 80.4;SK-BR-3: 46.7;SK-MEL-30: 37.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			CAB012219	Approved		Approved	Nucleoplasm,Cytosol		NA	NA				"Cluster 80: Striated muscle - Unknown function"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 7: Non-specific - Mitochondria"	"Nucleoplasm, Cytosol"		"CAB012219: "	"prognostic unfavorable (1.52e-4)"	"unprognostic (1.17e-1)"	"unprognostic (1.50e-3)"	"unprognostic (1.59e-3)"	"unprognostic (7.07e-3)"	"unprognostic (2.01e-1)"	"unprognostic (2.19e-2)"	"unprognostic (4.76e-3)"	"unprognostic (1.97e-1)"	"unprognostic (2.70e-1)"	"unprognostic (8.22e-3)"	"unprognostic (8.79e-2)"	"unprognostic (2.64e-4)"	"unprognostic (7.89e-2)"	"unprognostic (6.99e-2)"	"unprognostic (2.78e-2)"	"unprognostic (2.52e-3)"	9.5	11.3	7.4	0.3	7.3	0.2	8.3	7.4	7.7	1.9	5.0	2.9	0.3	2.1	1.7	1.0	1.0	0.2	10.3	5.9	11.8	4.6	0.3	1.1	0.4	8.8	8.9	0.3	2.2	0.3	2.8	6.3	8.5	1.0	0.4	4.1	1.3	0.9	38.6	1.6	0.9	1.8	7.1	0.3	3.4	1.9	9.2	0.3	7.1	1.7	0.3	3.3	1.0	10.9	16.4	1.3	2.2	0.4	7.4	1.1	9.7	0.4	0.5	0.4	0.2	2.0	5.6	8.7	2.2	0.1	0.0	5.8	2.7	2.9	0.7	2.6	6.6	0.2	3.8	1.8	3.5	1.0	0.0	1.5	11.7	0.1	1.6	2.4	0.4	3.0	1.7	1.0	0.5	2.3	2.2	2.8	7.1	3.4	1.3	0.0	2.7	5.9	3.1	1.3	6.3	80.4	4.7	46.7	37.4	12.2	7.4	4.7	0.5	0.0	3.4	0.1	0.8	2.4	8.6	3.2	0.7	2.1	0.1	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	7.4	7.3	7.4	7.7	5.9	11.8	8.8	8.9	8.5	7.1	9.2	10.9	5.7	6.4	1.1	2.0	1.3	0.8	5.0	1.3	0.6	4.1	10.2	6.1	11.3	1.5	1.2	1.8	10.4	6.5	6.3	4.4	0.0	0.6	0.2	3.9	2.8	1.7	3.0	0.0	0.5	0.2	0.4	4.0	1.1	3.7	0.0	2.6	0.7	0.1	0.7	1.7	2.3	3.8	0.0	0.0	2.1	0.1	1.8	0.9	0.0	0.0	0.0	14.7	1.0	2.0	0.2	0.3	0.1	0.7	1.6	2.9	0.2	0.5	1.2	2.1	0.0	7.7	3.9	0.4	1.0	0.8	1.3	1.0	2.9	0.7	2.1	1.3
NAP1L4	NAP2	ENSG00000205531	"Nucleosome assembly protein 1 like 4"	Q99733	11	2944431-2992377	"Plasma proteins, Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB011567	Approved		Supported	Nucleoplasm		NA	NA		3100000	"Cluster 46: Basophils - DNA binding"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm		"CAB011567: AB_776638"	"unprognostic (1.61e-1)"	"prognostic favorable (9.77e-4)"	"unprognostic (8.99e-2)"	"unprognostic (9.64e-3)"	"unprognostic (2.96e-3)"	"unprognostic (2.24e-2)"	"prognostic unfavorable (1.68e-7)"	"unprognostic (1.80e-1)"	"unprognostic (6.44e-2)"	"unprognostic (1.77e-1)"	"unprognostic (6.73e-2)"	"unprognostic (2.31e-1)"	"unprognostic (6.10e-3)"	"unprognostic (1.19e-1)"	"unprognostic (1.29e-1)"	"prognostic favorable (1.55e-4)"	"unprognostic (1.54e-1)"	39.6	43.5	44.3	36.1	59.2	50.3	41.3	53.0	178.1	46.7	70.3	60.3	20.1	45.4	17.3	79.6	41.2	32.5	111.4	41.3	52.1	63.7	56.2	40.5	65.7	57.2	53.8	42.9	38.0	63.5	61.4	36.8	60.2	51.9	34.2	38.6	66.4	32.1	146.1	49.0	53.8	39.1	52.2	59.0	56.6	87.4	56.4	78.8	44.6	110.7	75.8	61.9	52.1	72.2	82.8	59.9	81.7	65.7	83.9	92.4	37.7	159.8	104.1	145.4	132.5	129.7	208.4	149.5	95.3	98.0	15.1	140.0	21.9	136.3	166.8	159.2	57.5	106.7	151.4	168.2	57.7	93.0	110.5	77.8	65.1	78.6	59.1	12.0	88.9	77.6	139.3	150.7	128.0	74.5	206.4	4.2	199.8	98.9	75.2	101.4	98.1	117.0	12.2	131.7	121.4	104.3	80.5	118.1	78.3	82.5	7.3	7.4	67.8	112.5	104.4	152.4	13.8	79.3	136.5	201.5	8.4	66.0	75.3	67.5	22.9	32.6	42.3	24.0	39.9	24.7	51.9	53.0	27.2	28.4	45.7	52.1	14.5	57.6	30.4	25.0	70.5	48.0	44.3	59.2	53.0	178.1	41.3	52.1	57.2	53.8	60.2	52.2	56.4	72.2	53.6	44.8	49.8	56.2	64.3	70.1	67.4	76.9	83.1	80.4	54.6	48.3	200.4	42.9	69.0	75.4	45.9	103.8	99.4	37.2	97.8	78.7	97.0	107.7	65.9	55.4	45.4	168.7	36.9	50.4	109.2	56.6	54.0	91.1	74.6	100.6	43.5	50.0	47.3	65.6	56.6	41.4	67.1	30.8	44.7	142.6	48.1	49.7	35.6	38.4	65.3	67.5	95.8	60.8	125.3	74.1	26.8	50.0	100.7	76.1	39.8	76.9	92.6	68.1	46.0	58.8	64.7	166.1	129.0	102.3	66.9	91.3	123.8	79.7	55.1	83.7
NAPRT	"NAPRT1, PP3856"	ENSG00000147813	"Nicotinate phosphoribosyltransferase"	Q6XQN6	8	143574785-143578649	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Pyridine nucleotide biosynthesis"	"Ligase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 63.1"	"Cell type enhanced"	"Detected in many"		"Proximal enterocytes: 597.2;Proximal tubular cells: 203.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"OE19: 49.8;RPMI-8226: 73.4;SK-BR-3: 84.1"	"Low region specificity"	"Detected in all"							"HPA023739, HPA024017, CAB068206, CAB068207"	Enhanced		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA		2300000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Golgi apparatus"	"Nucleoplasm, Cytosol"	"CAB068206: AB_2665644, CAB068207: AB_2665681, HPA023739: AB_1854308, HPA024017: AB_1854309"	"unprognostic (7.08e-2)"	"unprognostic (1.55e-1)"	"unprognostic (5.76e-3)"	"unprognostic (2.94e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.30e-1)"	"unprognostic (7.65e-2)"	"unprognostic (2.19e-1)"	"unprognostic (2.84e-1)"	"unprognostic (1.08e-2)"	"unprognostic (1.75e-1)"	"unprognostic (4.13e-2)"	"prognostic favorable (6.28e-4)"	"unprognostic (6.02e-2)"	"unprognostic (3.97e-1)"	"unprognostic (2.28e-2)"	"unprognostic (1.61e-2)"	15.7	13.6	4.1	6.3	4.7	21.9	14.6	3.9	8.7	15.8	4.6	22.2	61.4	9.7	1.7	37.1	10.6	5.8	10.8	4.3	4.8	15.7	63.1	13.8	6.6	5.4	4.1	9.6	12.4	5.0	6.0	5.4	4.0	11.3	3.9	0.2	29.2	10.5	10.1	27.9	47.3	2.9	4.4	19.4	22.5	10.5	4.7	4.1	9.8	4.6	5.2	13.2	18.1	5.6	14.8	7.2	0.6	1.4	3.2	2.0	4.0	0.7	7.5	4.5	1.7	5.6	34.3	1.8	7.8	0.5	0.0	25.6	1.8	34.6	0.4	4.3	12.1	16.7	25.5	1.9	42.5	2.1	14.8	3.2	16.6	0.3	0.0	0.1	18.1	32.9	21.5	8.8	0.1	11.1	6.7	8.0	5.6	49.8	4.2	13.8	0.3	73.4	16.0	2.0	7.4	0.9	9.1	84.1	30.7	0.6	2.1	20.3	3.8	0.9	10.1	8.0	2.9	0.8	0.8	3.1	1.8	41.8	16.1	6.9	11.4	14.1	2.9	12.7	1.9	2.0	4.4	1.9	6.7	1.3	1.3	2.4	10.6	0.8	23.0	6.9	1.9	5.8	4.1	4.7	3.9	8.7	4.3	4.8	5.4	4.1	4.0	4.4	4.7	5.6	50.6	35.3	23.1	7.5	16.2	0.0	64.9	0.0	24.5	12.1	18.3	14.7	10.0	54.3	9.3	75.4	18.8	48.8	21.8	88.0	68.4	62.7	44.2	18.5	26.0	32.7	10.9	63.8	3.8	54.3	74.8	20.6	100.9	26.8	7.6	21.7	49.6	117.4	80.6	16.8	3.2	70.4	0.0	89.7	0.0	59.8	32.0	55.0	0.0	7.5	108.9	23.7	28.8	1.5	2.8	111.7	124.6	21.8	12.7	44.2	597.2	203.7	1.5	13.4	13.1	15.8	16.5	41.7	16.0	35.9	0.0	56.2	17.2	29.7	100.9	73.9
NARF	"DKFZp434G0420, FLJ10067, IOP2"	ENSG00000141562	"Nuclear prelamin A recognition factor"	Q9UHQ1	17	82458180-82490537	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Erythroid cells: 292.6;Late spermatids: 474.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053006			Supported	Nucleoplasm,Nucleoli		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 71: Testis - DNA repair"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 6: Erythroid cells - Oxygen transport"	Nucleoplasm	Nucleoli	"HPA053006: AB_2682013"	"unprognostic (1.84e-1)"	"prognostic favorable (1.15e-4)"	"unprognostic (2.00e-1)"	"unprognostic (1.10e-2)"	"unprognostic (4.14e-1)"	"unprognostic (6.52e-2)"	"unprognostic (6.62e-3)"	"unprognostic (2.37e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.54e-1)"	"unprognostic (3.42e-3)"	"unprognostic (3.80e-3)"	"prognostic unfavorable (1.48e-10)"	"unprognostic (3.57e-1)"	"unprognostic (7.72e-2)"	"unprognostic (2.47e-2)"	"unprognostic (1.83e-2)"	19.2	18.0	17.2	12.4	18.5	32.9	17.4	19.5	21.7	15.8	16.1	23.4	10.3	14.5	5.8	21.5	16.1	7.7	38.7	17.7	16.8	19.6	23.1	15.1	10.7	17.8	17.0	16.9	20.6	6.6	18.7	7.4	17.8	17.0	6.5	11.5	18.4	8.2	49.2	25.1	19.1	7.1	15.8	28.7	23.3	59.1	16.9	14.6	16.5	25.9	8.9	19.9	16.3	19.1	21.2	23.3	32.8	50.6	15.2	14.3	18.2	13.1	12.7	21.2	21.2	23.6	8.4	14.0	13.6	9.8	23.8	18.6	23.8	15.5	14.2	15.3	55.7	29.0	30.4	27.7	13.1	30.9	50.6	21.9	26.4	16.5	5.7	20.7	39.2	44.9	67.5	9.6	9.2	18.1	51.2	49.8	13.7	16.3	44.1	42.6	34.3	21.6	9.7	23.3	40.1	55.9	32.1	21.3	38.8	20.7	18.4	23.2	21.7	26.4	22.4	22.4	21.7	94.1	38.4	30.1	24.3	20.6	15.9	94.5	33.0	96.2	34.2	30.0	38.1	38.2	33.1	33.7	32.0	40.9	37.7	31.2	156.0	53.7	23.9	26.2	44.1	38.6	17.2	18.5	19.5	21.7	17.7	16.8	17.8	17.0	17.8	15.8	16.9	19.1	45.2	12.8	23.2	25.1	50.7	37.3	32.9	55.4	28.5	38.1	30.4	30.1	43.2	21.5	40.0	5.5	54.2	32.4	87.9	38.5	39.2	53.3	194.2	46.2	23.3	53.1	56.9	292.6	30.6	66.7	57.7	30.1	80.5	25.3	52.7	24.4	45.7	18.5	34.3	50.5	31.6	32.4	95.6	23.8	35.3	474.5	25.1	39.3	62.2	15.0	56.7	24.2	72.1	12.5	20.8	65.7	29.6	18.0	89.9	23.7	41.9	22.1	61.6	37.3	13.1	36.9	36.0	152.5	87.6	20.7	35.4	30.6	57.4	28.4	36.3	30.2
NARS1	NARS	ENSG00000134440	"Asparaginyl-tRNA synthetase 1"	O43776	18	57600656-57622213	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"Cardiomyocytes: 221.3;Cytotrophoblasts: 116.0;Extravillous trophoblasts: 85.2;Hofbauer cells: 117.4;Syncytiotrophoblasts: 158.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034257, HPA040017"	Enhanced		Supported	Cytosol		NA	NA		76000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 16: U-266 - Nucleosome"	"Cluster 24: Non-specific - Transcription regulation"	Cytosol		"CAB034257: AB_2151043, HPA040017: AB_2676801"	"unprognostic (9.85e-2)"	"unprognostic (1.88e-1)"	"unprognostic (3.86e-3)"	"unprognostic (1.68e-1)"	"unprognostic (2.61e-1)"	"unprognostic (1.28e-1)"	"prognostic unfavorable (1.23e-7)"	"unprognostic (1.78e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.62e-2)"	"unprognostic (1.98e-1)"	"unprognostic (8.82e-2)"	"prognostic favorable (1.73e-7)"	"unprognostic (1.24e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.51e-1)"	67.2	65.9	51.7	62.1	53.8	48.8	68.3	58.8	77.7	57.5	60.1	108.7	87.3	52.7	66.5	64.2	58.5	56.0	94.8	53.4	60.4	135.1	75.5	51.7	52.8	59.6	55.6	45.4	63.1	125.3	33.2	56.1	58.5	68.4	99.5	68.2	68.8	65.4	127.2	49.6	72.0	65.5	55.9	46.8	79.4	32.7	63.7	59.1	95.0	130.6	67.3	78.0	41.9	60.1	215.1	133.2	129.6	199.1	172.8	130.7	202.5	302.5	161.7	179.2	215.4	100.3	97.0	270.7	136.2	208.7	172.1	241.7	211.0	191.6	259.0	127.5	75.5	217.8	105.4	171.8	299.9	433.0	212.5	146.0	331.2	233.8	245.8	130.6	154.6	169.4	246.5	201.6	200.9	86.2	172.4	111.9	189.6	145.1	118.6	139.8	154.5	229.9	340.3	224.4	140.9	147.6	153.1	184.0	309.4	137.3	108.8	242.6	179.7	190.5	127.7	78.8	215.8	449.1	559.2	260.3	175.1	285.7	227.7	50.9	108.5	38.8	41.8	92.6	50.9	52.6	43.3	44.7	71.7	51.4	58.2	52.6	34.4	43.6	76.8	64.0	49.4	74.9	51.7	53.8	58.8	77.7	53.4	60.4	59.6	55.6	58.5	55.9	63.7	60.1	26.2	0.0	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	221.3	0.0	0.0	0.0	0.0	116.0	19.0	0.0	0.0	0.0	0.0	0.0	0.0	9.0	0.0	0.0	0.0	0.0	85.2	23.1	0.0	0.0	0.0	0.0	0.0	0.0	117.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.8	0.0	0.0	0.0	0.0	158.6	3.5	0.0	0.0	0.0
NARS2	"DFNB94, FLJ23441, SLM5"	ENSG00000137513	"Asparaginyl-tRNA synthetase 2, mitochondrial"	Q96I59	11	78435968-78574874	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase"	"Deafness, Disease variant, Leigh syndrome, Non-syndromic deafness, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026793	Supported		Approved	Nucleoplasm,Mitochondria,Cytosol		No	No			"Cluster 27: Non-specific - Gene expression"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 21: OE19 - Mitochondria"	"Cluster 59: Non-specific - Transcription"	"Nucleoplasm, Mitochondria"	Cytosol	"HPA026793: AB_1848833"	"unprognostic (1.80e-1)"	"unprognostic (1.95e-1)"	"unprognostic (5.73e-3)"	"unprognostic (1.79e-3)"	"unprognostic (1.40e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.28e-1)"	"unprognostic (5.62e-2)"	"unprognostic (4.62e-3)"	"prognostic favorable (1.39e-5)"	"unprognostic (1.96e-1)"	"unprognostic (1.56e-1)"	"prognostic favorable (1.22e-6)"	"unprognostic (8.57e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.93e-1)"	"unprognostic (1.60e-1)"	7.3	11.9	10.7	6.8	12.3	6.2	11.1	12.4	13.3	9.6	19.8	11.3	10.3	9.1	11.2	8.1	9.9	7.0	11.7	10.4	11.7	19.0	23.5	7.6	9.6	11.7	13.9	11.4	10.6	11.4	7.6	8.0	13.1	10.8	10.9	13.4	10.7	7.3	23.5	7.2	9.7	7.4	11.3	7.4	9.9	7.5	11.4	11.7	11.5	19.6	9.7	8.7	8.1	12.3	16.7	22.8	23.5	15.4	16.1	13.5	19.5	13.5	13.1	20.6	16.9	39.4	17.4	40.9	34.1	8.7	19.8	21.5	39.9	26.3	28.3	27.0	21.3	28.9	17.3	33.7	13.3	31.3	10.1	9.4	16.8	18.1	32.0	18.3	17.9	33.7	44.5	11.0	23.1	19.4	32.7	50.3	25.6	67.3	27.3	33.6	38.2	55.5	27.2	23.0	27.8	17.5	20.1	25.4	35.5	25.1	24.1	12.3	10.9	27.7	32.8	32.0	23.1	18.1	33.1	91.1	5.4	27.7	19.2	9.5	9.3	4.4	11.1	10.4	13.8	17.6	12.8	12.5	16.6	15.0	18.5	16.7	2.0	20.3	12.8	12.7	10.5	10.3	10.7	12.3	12.4	13.3	10.4	11.7	11.7	13.9	13.1	11.3	11.4	12.3	5.8	19.2	26.4	27.7	14.5	13.5	14.2	12.0	12.5	5.2	9.4	6.5	8.8	5.7	10.3	5.5	2.1	20.0	4.4	4.0	29.4	9.5	13.1	10.1	7.4	6.6	12.0	9.2	34.7	7.3	23.6	9.0	10.2	9.0	8.2	14.0	2.5	19.8	12.4	0.0	45.1	8.3	22.4	6.3	11.6	5.4	7.8	6.3	17.8	45.0	2.9	6.3	4.1	42.7	47.7	7.5	9.9	4.9	14.6	17.5	7.0	28.9	10.2	9.0	6.6	7.5	8.8	8.6	19.5	12.0	13.8	15.3	7.8	9.0	14.6	10.7
NAT10	"FLJ10774, FLJ12179, hALP, KIAA1709, Kre33, NET43"	ENSG00000135372	"N-acetyltransferase 10"	Q9H0A0	11	34105617-34147670	"Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"rRNA processing, tRNA processing"	"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB035546, HPA057576, HPA071628"	Approved		Enhanced	Nucleoli,Midbody		Yes	No			"Cluster 27: Non-specific - Gene expression"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	Nucleoli	Midbody	"CAB035546: , HPA057576: AB_2683475, HPA071628: AB_2686426"	"unprognostic (3.04e-1)"	"unprognostic (9.24e-2)"	"unprognostic (2.46e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.92e-2)"	"prognostic unfavorable (1.07e-4)"	"prognostic unfavorable (9.61e-8)"	"unprognostic (1.15e-1)"	"unprognostic (2.57e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.12e-2)"	"unprognostic (2.25e-1)"	"prognostic unfavorable (8.83e-5)"	"unprognostic (1.24e-1)"	"unprognostic (7.18e-2)"	"unprognostic (9.55e-2)"	"unprognostic (8.69e-2)"	20.6	24.2	16.0	17.3	15.4	20.4	19.6	14.7	17.4	20.1	14.0	17.0	10.2	20.0	13.7	25.7	19.2	9.4	18.4	15.1	15.4	19.5	22.3	14.9	23.4	14.3	13.6	23.1	25.3	16.8	17.5	15.1	14.7	19.4	15.5	16.3	16.7	12.2	24.8	28.9	17.5	15.5	12.6	22.8	18.7	22.0	15.6	19.4	17.2	12.5	27.5	20.3	20.5	16.9	40.0	55.5	29.3	62.0	34.2	30.2	33.6	38.8	28.5	48.4	38.4	62.6	22.6	127.6	28.3	33.0	41.8	59.5	110.5	59.4	59.5	35.9	70.2	58.0	44.5	58.9	31.0	147.3	40.7	31.1	40.0	31.5	88.3	22.8	37.4	60.6	128.6	43.5	40.8	76.0	120.5	65.7	41.9	69.3	65.7	89.3	98.0	53.7	27.8	68.5	43.1	32.6	52.3	54.9	23.6	28.2	55.0	41.0	30.5	42.8	34.0	63.7	72.8	47.0	61.0	120.3	43.3	60.0	43.4	0.7	8.3	2.8	11.7	13.7	15.5	12.2	12.6	13.4	15.5	10.6	12.7	13.2	0.9	15.0	12.9	11.6	12.0	9.1	16.0	15.4	14.7	17.4	15.1	15.4	14.3	13.6	14.7	12.6	15.6	16.9	8.5	6.4	20.7	10.4	12.7	12.2	11.3	6.9	12.5	12.2	8.8	10.2	12.6	7.2	15.1	14.7	12.5	18.1	8.0	5.8	5.9	9.2	6.1	10.1	18.3	10.9	7.2	21.0	22.8	9.6	13.4	14.5	5.6	12.2	5.1	17.3	5.7	7.5	12.0	11.8	21.7	8.9	4.1	5.5	4.4	3.4	9.3	8.5	1.8	6.5	12.9	5.3	7.2	11.6	16.0	8.7	3.5	13.2	9.8	14.8	3.7	5.8	10.6	11.0	13.1	19.6	8.4	20.5	21.6	13.1	13.8	14.4	11.0	19.7	14.3	7.6
NAV2	"FLJ10633, FLJ11030, FLJ23707, HELAD1, KIAA1419, POMFIL2, RAINB1"	ENSG00000166833	"Neuron navigator 2"	Q8IVL1	11	19350724-20121601	"Enzymes, Predicted intracellular proteins"		"Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 55.7;heart muscle: 61.2"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 466.8;Excitatory neurons: 333.8;Inhibitory neurons: 525.7;Oligodendrocyte precursor cells: 863.6;Oligodendrocytes: 354.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"hTERT-HME1: 89.9;SH-SY5Y: 81.9;TIME: 65.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011755, HPA011891"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 68: Oligodendrocytes - Mixed function"	Nucleoplasm		"HPA011755: AB_1854319, HPA011891: AB_1854318"	"unprognostic (7.71e-2)"	"unprognostic (2.37e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.02e-1)"	"unprognostic (3.01e-1)"	"unprognostic (1.76e-3)"	"unprognostic (3.01e-2)"	"unprognostic (3.86e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.00e-1)"	"unprognostic (3.53e-3)"	"unprognostic (1.84e-1)"	"unprognostic (2.83e-2)"	"unprognostic (3.85e-2)"	"unprognostic (1.08e-1)"	"unprognostic (6.43e-2)"	"unprognostic (3.28e-2)"	7.4	1.6	11.6	3.3	18.8	1.8	12.0	16.1	10.8	6.3	3.5	16.2	4.4	7.6	11.1	6.5	4.4	1.8	61.2	9.6	13.8	9.5	14.9	9.5	1.8	55.7	43.7	3.1	8.8	6.0	5.1	14.8	36.5	6.2	4.9	8.7	15.0	9.3	2.6	6.7	4.1	8.5	39.3	1.4	7.2	0.9	27.7	2.5	16.9	9.4	3.9	5.7	7.4	35.6	16.2	4.7	10.2	1.4	33.7	21.6	11.0	13.3	22.6	17.2	13.0	18.2	2.1	0.1	0.6	20.1	28.0	1.9	0.6	10.4	20.1	3.8	1.2	0.4	25.1	20.9	6.1	0.0	0.5	14.1	26.5	8.3	89.9	12.7	23.2	0.1	1.9	8.0	50.2	17.2	0.0	0.1	26.4	5.3	13.1	0.1	47.1	2.6	14.8	4.6	18.2	81.9	10.3	7.9	14.8	54.2	0.3	0.0	65.2	39.6	6.3	47.7	12.7	2.7	2.0	0.1	13.5	0.8	12.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	11.6	18.8	16.1	10.8	9.6	13.8	55.7	43.7	36.5	39.3	27.7	35.6	5.5	64.1	22.6	466.8	1.4	4.2	23.6	13.8	14.2	4.6	33.6	31.0	14.3	8.6	18.3	20.2	0.0	31.8	0.8	2.8	13.7	20.3	2.6	34.4	4.6	14.5	10.8	0.0	333.8	21.3	23.3	16.5	11.2	62.1	1.3	152.4	11.7	47.0	10.7	26.9	525.7	10.1	18.3	1.4	5.0	7.9	0.9	3.2	16.0	194.9	1.0	28.9	0.0	863.6	354.4	37.5	0.8	4.1	0.4	33.7	1.8	0.4	24.0	2.4	0.0	30.7	17.8	1.5	0.6	23.1	3.7	14.6	1.7	54.7	9.2	17.8
NBEA	"BCL8B, FLJ10197, KIAA1544, LYST2"	ENSG00000172915	Neurobeachin	Q8NFP9	13	34942270-35673022	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 23.5;retina: 65.7"	"Group enriched"	"Detected in many"	4	"Excitatory neurons: 1016.1;Inhibitory neurons: 953.0;Oligodendrocyte precursor cells: 466.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 33.1;SH-SY5Y: 80.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039730, HPA040385"	Enhanced		Supported	"Nucleoplasm,Nucleoli,Golgi apparatus,Cytosol"		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 58: Brain - Synaptic function"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Golgi apparatus"	"Nucleoplasm, Nucleoli, Cytosol"	"HPA039730: AB_10794202, HPA040385: AB_10795523"	"unprognostic (1.80e-2)"	"unprognostic (2.90e-1)"	"unprognostic (4.99e-2)"	"unprognostic (3.89e-4)"	"unprognostic (3.59e-1)"	"unprognostic (2.04e-1)"	"unprognostic (8.75e-2)"	"unprognostic (6.95e-3)"	"unprognostic (5.01e-1)"	"unprognostic (7.43e-2)"	"unprognostic (1.03e-3)"	"unprognostic (2.45e-1)"	"prognostic favorable (7.86e-8)"	"unprognostic (2.28e-2)"	"unprognostic (9.35e-2)"	"unprognostic (1.17e-1)"	"unprognostic (6.46e-2)"	2.4	7.2	7.7	1.5	10.7	0.3	4.9	19.0	23.5	3.5	2.8	5.8	1.4	6.1	2.2	3.3	5.5	3.4	6.9	17.4	2.8	4.1	0.6	2.0	1.6	4.1	0.1	6.2	3.1	7.1	8.3	0.6	4.8	6.6	2.5	65.7	4.7	8.4	5.6	1.5	2.5	6.5	0.4	3.2	2.7	3.5	0.0	5.6	6.3	5.7	1.2	3.6	2.8	4.5	0.0	4.5	10.9	6.1	0.7	0.1	0.3	7.0	10.8	7.9	6.6	0.1	1.0	3.0	0.0	12.9	4.7	0.3	3.7	1.5	16.3	1.4	3.6	0.0	3.4	1.2	0.5	1.9	4.7	2.1	1.2	0.1	0.7	33.1	1.8	1.2	0.1	17.6	1.1	1.9	1.1	0.0	4.6	6.2	2.0	1.1	4.7	0.9	9.3	2.1	6.2	80.1	5.4	0.1	3.6	8.1	2.0	0.4	0.1	2.0	1.2	0.0	1.6	1.9	0.5	1.3	5.4	0.6	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.3	0.0	0.0	0.0	0.2	0.0	0.0	7.7	10.7	19.0	23.5	17.4	2.8	4.1	0.1	4.8	0.4	0.0	4.5	19.7	28.9	9.2	132.9	5.2	1.0	5.3	2.7	1.2	124.8	5.0	6.5	51.8	11.5	14.1	9.2	146.0	0.1	4.4	0.3	1.9	9.2	19.3	5.6	18.4	10.1	22.9	0.8	1016.1	1.8	0.1	12.3	2.0	0.6	25.2	20.7	11.0	0.3	0.9	47.1	953.0	2.1	6.1	3.5	3.9	13.6	17.7	3.5	7.2	150.9	1.2	69.1	0.0	466.9	163.7	2.3	0.1	19.2	5.8	8.5	0.2	7.6	56.5	87.0	6.6	22.2	13.1	8.5	8.0	0.3	0.9	0.0	1.2	11.9	1.1	13.5
NBR1	"1A1-3B, CA125, KIAA0049, M17S2"	ENSG00000188554	"NBR1 autophagy cargo receptor"	Q14596	17	43170481-43211689	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"Early spermatids: 276.9;Late spermatids: 909.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022944, HPA022999, HPA023999"	Approved		Supported	"Nucleoplasm,Nuclear bodies,Vesicles"		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 25: Spermatids - Spermatogenesis"	Vesicles	"Nucleoplasm, Nuclear bodies"	"HPA022944: AB_2671001, HPA022999: AB_1859532, HPA023999: AB_1859533"	"unprognostic (1.85e-1)"	"unprognostic (1.78e-1)"	"unprognostic (3.26e-2)"	"unprognostic (3.28e-2)"	"unprognostic (3.27e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.98e-1)"	"unprognostic (2.18e-1)"	"unprognostic (1.02e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.54e-2)"	"prognostic favorable (2.00e-5)"	"unprognostic (1.65e-1)"	"unprognostic (4.88e-2)"	"unprognostic (2.10e-1)"	"unprognostic (1.39e-1)"	45.7	52.3	48.4	39.4	54.5	20.1	55.9	52.1	48.2	52.0	51.2	66.2	70.1	48.9	39.9	40.3	53.4	44.5	67.3	43.7	49.9	84.7	91.3	47.3	41.0	52.2	50.4	69.7	43.9	97.1	28.8	60.1	52.9	64.7	70.4	80.1	49.4	52.0	112.2	42.9	73.8	49.3	52.1	53.0	52.6	141.0	51.6	59.0	68.2	116.0	45.4	47.3	34.5	65.2	42.3	49.8	42.6	44.6	93.5	95.2	41.0	77.1	147.2	60.5	50.4	26.6	65.1	22.7	77.8	105.1	62.6	46.1	48.5	97.4	90.3	70.0	51.2	27.1	62.0	60.0	89.4	23.2	40.1	108.4	111.6	67.2	133.7	127.3	96.0	50.8	58.1	58.7	83.7	23.9	48.9	17.7	13.6	50.0	32.8	16.5	65.6	73.3	81.6	48.0	25.9	45.8	53.1	26.1	79.8	70.7	70.7	38.0	82.2	89.9	34.1	42.7	31.5	69.9	61.8	29.1	61.8	31.5	63.6	41.6	25.7	40.1	20.3	23.3	20.7	13.7	18.1	19.6	19.3	9.4	17.0	16.6	34.4	24.3	36.4	12.0	26.4	25.0	48.4	54.5	52.1	48.2	43.7	49.9	52.2	50.4	52.9	52.1	51.6	65.2	36.9	41.7	44.1	24.5	21.9	23.8	29.2	28.1	54.1	37.3	33.8	27.4	86.4	35.8	40.4	36.8	39.6	28.0	34.6	94.2	19.6	25.4	276.9	40.5	30.4	39.0	40.2	53.2	24.7	21.9	19.4	37.6	31.1	33.0	25.9	53.1	45.3	67.8	22.0	20.2	28.2	56.4	20.3	62.9	19.9	909.9	58.7	35.7	26.6	29.0	35.6	49.3	44.3	33.2	41.4	25.8	64.5	44.4	26.1	41.1	100.3	57.4	63.4	56.9	39.5	33.9	36.2	49.6	30.9	26.7	27.3	15.7	31.9	68.6	52.4	38.7
NCAM2	"MGC51008, NCAM21"	ENSG00000154654	"Neural cell adhesion molecule 2"	O15394	21	20998409-21543329	"Plasma proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 12.0;brain: 26.0"	"Group enriched"	"Detected in some"	19	"Astrocytes: 713.0;Excitatory neurons: 866.5;Inhibitory neurons: 909.2;Oligodendrocyte precursor cells: 1729.1;Oligodendrocytes: 1526.6"	"Group enriched"	"Detected in some"	4	"breast cancer: 2.6;glioma: 5.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"T-47d: 92.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030900, HPA030901"	Enhanced	Supported	Supported	"Nuclear bodies,Plasma membrane"		No	No		120000000		"Cluster 65: Brain - Ion transport"	"Cluster 6: T47d - Mammary gland"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Nuclear bodies, Plasma membrane"		"HPA030900: AB_10602037, HPA030901: AB_2673650"	"unprognostic (9.70e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.54e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.37e-2)"	"unprognostic (3.01e-2)"	"unprognostic (5.90e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.31e-1)"	"unprognostic (5.61e-1)"	"unprognostic (3.07e-4)"	"unprognostic (2.47e-4)"	"unprognostic (1.62e-1)"	"unprognostic (8.05e-2)"	"unprognostic (1.35e-3)"	0.7	12.0	14.1	0.9	19.0	0.0	1.6	8.4	17.5	1.6	0.0	2.0	0.2	1.0	0.5	0.5	0.6	1.2	2.0	21.3	22.7	0.2	6.7	2.8	0.1	8.6	14.4	0.3	0.2	0.6	0.8	0.5	8.8	0.9	1.0	1.2	0.7	1.0	0.4	0.8	0.7	1.4	8.8	0.8	0.6	6.3	26.0	0.1	0.3	0.8	0.2	0.6	1.2	21.6	0.0	0.0	0.5	0.0	4.6	4.7	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.8	0.1	0.0	0.0	0.0	0.5	1.3	0.0	0.5	1.3	0.0	2.2	0.0	0.1	11.3	0.0	3.5	0.0	0.4	0.0	0.0	11.4	2.4	0.2	15.4	0.2	0.0	0.4	0.0	0.0	1.0	0.0	4.7	0.0	0.0	0.0	5.3	0.0	0.8	0.6	0.1	92.1	7.2	0.0	1.3	0.9	0.1	0.0	0.6	0.0	0.0	2.5	0.0	22.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.1	19.0	8.4	17.5	21.3	22.7	8.6	14.4	8.8	8.8	26.0	21.6	0.4	3.2	1.3	713.0	0.1	0.5	0.3	0.0	0.0	1.0	2.0	1.4	1.8	0.0	0.0	0.0	0.0	1.7	0.3	0.0	0.0	0.0	57.6	0.3	6.1	0.4	0.0	0.0	866.5	0.0	0.4	4.8	0.0	0.2	0.0	0.2	2.2	0.0	0.3	0.0	909.2	0.0	0.0	0.0	0.3	24.7	0.9	0.1	1.8	30.9	0.0	1.0	0.0	1729.1	1526.6	0.0	0.0	0.4	0.0	0.7	0.0	0.1	0.0	0.1	0.0	2.4	1.6	3.7	9.6	0.1	0.1	0.3	0.2	1.9	0.0	0.2
NCAPD2	"CAP-D2, CNAP1, hCAP-D2, KIAA0159"	ENSG00000010292	"Non-SMC condensin I complex subunit D2"	Q15021	12	6493356-6531955	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, DNA condensation, Mitosis"		"Disease variant, Primary microcephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 76.8"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 48.0;Late spermatids: 34.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012423, HPA036947, HPA037363"	Approved		Supported	Nucleoplasm,Nucleoli,Cytosol		NA	Yes		34000	"Cluster 44: Non-specific - Transcription"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Cytosol	"Nucleoplasm, Nucleoli"	"CAB012423: , HPA036947: AB_10671367, HPA037363: AB_10672483"	"unprognostic (1.51e-1)"	"unprognostic (1.88e-1)"	"unprognostic (2.20e-1)"	"unprognostic (1.31e-2)"	"unprognostic (1.03e-2)"	"unprognostic (7.84e-2)"	"prognostic unfavorable (1.79e-8)"	"unprognostic (2.73e-3)"	"unprognostic (1.45e-2)"	"unprognostic (5.00e-2)"	"unprognostic (5.41e-3)"	"unprognostic (4.53e-1)"	"prognostic unfavorable (1.13e-7)"	"unprognostic (4.80e-3)"	"unprognostic (1.18e-1)"	"unprognostic (4.53e-1)"	"unprognostic (8.75e-2)"	8.3	7.4	7.3	21.5	11.4	35.5	10.9	9.9	8.3	10.2	7.4	17.9	17.0	10.7	10.6	15.9	11.2	9.8	7.6	7.2	8.0	7.4	4.8	10.6	38.1	11.0	10.0	8.0	7.7	11.3	5.5	17.5	11.7	9.4	20.4	11.1	11.8	10.2	7.9	21.9	16.0	13.4	8.4	16.1	12.1	18.2	10.2	76.8	11.3	10.2	44.8	10.1	9.3	13.9	125.3	99.3	134.6	97.9	29.9	28.4	159.2	76.1	69.8	138.3	109.1	123.5	150.8	135.8	24.2	63.2	126.7	128.6	188.0	105.4	194.1	214.1	92.8	112.2	113.8	79.4	12.5	145.0	96.5	20.5	31.6	112.4	107.8	61.9	89.9	94.0	71.0	63.4	104.7	79.6	162.2	73.8	207.5	129.9	78.2	153.7	260.6	77.7	39.5	64.1	54.0	61.9	121.5	64.9	44.3	189.1	27.0	101.7	51.0	94.1	149.6	60.8	168.4	45.3	51.7	181.0	55.7	92.2	126.1	11.0	1.7	3.7	7.1	2.8	5.3	5.1	6.4	7.3	3.4	3.5	7.3	7.3	1.4	8.1	2.2	4.1	8.3	3.9	7.3	11.4	9.9	8.3	7.2	8.0	11.0	10.0	11.7	8.4	10.2	13.9	4.3	6.4	7.4	4.9	11.0	3.6	3.8	4.4	17.1	3.7	4.7	6.9	4.1	5.7	3.4	1.8	8.4	13.5	8.9	7.3	0.0	4.5	18.3	5.3	6.3	5.4	1.2	48.0	5.6	3.7	17.8	6.4	7.1	5.8	3.8	20.0	8.9	3.3	10.1	5.0	5.0	9.9	6.1	16.4	4.4	34.3	5.9	10.8	0.0	2.8	9.5	11.8	15.5	2.5	17.8	5.3	4.6	6.0	22.6	4.1	6.0	2.4	4.2	8.4	0.0	4.2	5.2	21.3	13.7	19.3	3.4	6.3	12.0	6.1	14.7	4.1
NCAPD3	"CAP-D3, FLJ42888, hCAP-D3, hcp-6, hHCP-6, KIAA0056"	ENSG00000151503	"Non-SMC condensin II complex subunit D3"	P42695	11	134150113-134225454	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, DNA condensation, Mitosis"		"Disease variant, Primary microcephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"prostate: 58.5"	"Low cell type specificity"	"Detected in many"			"Cancer enriched"	"Detected in all"	8	"prostate cancer: 50.8"	"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040286			Supported	Nucleoplasm		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 72: Non-specific - Transcription"	"Cluster 36: HEL - Hemostasis"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"HPA040286: AB_2676918"	"unprognostic (4.27e-2)"	"unprognostic (6.05e-2)"	"unprognostic (7.78e-3)"	"unprognostic (8.22e-3)"	"unprognostic (2.79e-1)"	"unprognostic (4.29e-2)"	"unprognostic (2.15e-3)"	"unprognostic (2.56e-1)"	"unprognostic (4.32e-2)"	"unprognostic (4.75e-1)"	"unprognostic (2.79e-3)"	"unprognostic (1.16e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.93e-2)"	"unprognostic (3.35e-2)"	"unprognostic (3.94e-1)"	"unprognostic (3.48e-1)"	4.7	5.5	1.9	3.1	2.0	10.0	4.9	4.0	3.8	4.2	2.3	4.4	3.5	4.0	3.3	7.1	3.8	2.6	5.0	3.1	1.6	3.6	8.8	4.9	4.2	2.0	1.1	3.4	4.5	1.9	7.0	3.1	1.1	58.5	1.5	4.5	5.7	0.9	3.7	9.0	5.4	1.3	0.9	6.2	5.1	9.5	1.6	3.1	6.0	0.9	1.7	3.7	5.2	3.0	5.5	1.9	12.3	25.3	1.8	1.3	10.6	11.5	1.9	3.5	4.0	5.6	3.4	6.1	11.1	3.5	9.8	6.1	3.5	5.2	4.4	9.2	21.7	26.6	5.1	8.5	2.3	13.1	15.4	1.7	1.1	5.1	2.0	3.6	2.6	11.6	7.1	4.7	4.2	6.0	10.9	15.1	8.6	5.5	13.8	2.9	13.7	8.5	4.1	3.2	22.1	13.4	9.1	5.9	1.7	10.0	9.7	6.9	1.7	11.8	5.7	11.8	9.9	4.5	4.5	5.5	8.3	16.4	15.2	1.6	3.3	1.6	5.7	2.7	2.2	2.3	3.7	3.8	2.5	5.2	5.5	5.8	1.6	1.7	2.2	8.0	6.5	1.9	1.9	2.0	4.0	3.8	3.1	1.6	2.0	1.1	1.1	0.9	1.6	3.0	7.7	3.2	8.1	8.5	12.1	9.2	4.4	6.0	8.0	20.2	9.9	8.6	6.7	2.8	7.0	12.9	10.4	13.0	13.2	5.4	0.0	2.7	7.2	7.8	12.8	5.6	7.8	32.8	19.7	2.6	9.9	7.5	7.7	9.0	2.5	19.6	5.7	9.7	8.8	11.8	16.7	7.2	10.2	6.4	8.7	10.4	4.7	10.9	1.8	15.0	17.1	9.0	17.5	11.1	16.0	2.8	1.6	4.1	22.9	8.8	3.2	3.6	4.9	20.9	0.0	9.5	9.2	21.5	14.4	10.7	9.1	4.5	14.2	11.3	11.6	3.4
NCAPG2	"CAP-G2, FLJ20311, hCAP-G2, LUZP5, MTB"	ENSG00000146918	"Non-SMC condensin II complex subunit G2"	Q86XI2	7	158631169-158704804	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cell cycle, Cell division, DNA condensation, Mitosis"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 24.4;lymphoid tissue: 27.9"	"Cell type enhanced"	"Detected in many"		"Spermatocytes: 48.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026631, HPA049637"	Approved		Supported	"Nucleoplasm,Nuclear speckles"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	"Nuclear speckles"	"HPA026631: AB_1845983, HPA049637: "	"unprognostic (2.73e-2)"	"unprognostic (1.77e-1)"	"unprognostic (6.81e-2)"	"prognostic unfavorable (7.94e-4)"	"unprognostic (1.66e-1)"	"prognostic favorable (1.91e-4)"	"prognostic unfavorable (3.00e-5)"	"unprognostic (5.33e-3)"	"prognostic unfavorable (3.21e-4)"	"unprognostic (7.79e-2)"	"prognostic unfavorable (8.50e-4)"	"unprognostic (5.19e-2)"	"prognostic unfavorable (4.06e-5)"	"unprognostic (2.58e-3)"	"unprognostic (1.28e-1)"	"unprognostic (8.21e-2)"	"unprognostic (7.37e-2)"	3.7	2.5	2.0	8.8	2.2	24.4	5.4	2.5	2.1	4.0	1.3	6.9	4.4	4.3	2.1	6.9	3.0	2.9	2.9	2.2	2.1	2.6	4.1	3.1	12.4	2.0	1.7	3.1	2.2	4.6	3.5	5.9	2.1	2.8	7.6	2.8	3.5	2.8	3.4	6.8	5.8	4.8	1.6	4.6	5.6	14.8	1.8	27.9	3.2	4.1	13.8	4.0	3.9	2.4	103.9	53.7	64.1	41.8	9.5	15.4	25.3	74.3	47.4	89.0	99.0	48.5	52.0	64.0	45.0	30.3	95.1	51.7	53.7	33.8	117.2	68.4	40.4	57.2	64.8	38.8	4.2	72.2	62.3	6.8	3.7	73.1	21.0	16.2	50.4	72.9	71.9	91.6	82.8	111.4	119.2	48.8	63.7	58.8	43.3	69.7	67.8	60.6	22.6	45.9	69.6	54.5	91.6	35.0	20.2	40.4	31.4	46.5	25.9	60.6	45.9	166.2	120.6	61.3	48.2	77.2	64.6	89.6	118.5	5.9	0.9	1.1	5.2	1.2	7.5	1.6	5.2	3.6	2.3	1.0	1.6	1.8	0.7	5.2	5.1	1.1	7.2	2.2	2.0	2.2	2.5	2.1	2.2	2.1	2.0	1.7	2.1	1.6	1.8	2.4	3.6	6.4	1.5	3.9	4.1	4.0	2.1	2.8	1.8	3.9	3.7	3.3	4.8	2.8	4.6	1.8	0.0	6.7	5.1	3.4	0.0	2.3	15.1	4.0	4.6	4.3	0.0	19.6	10.7	3.3	10.4	4.5	4.1	5.9	1.3	12.6	2.9	2.6	7.3	8.4	7.2	2.9	2.0	3.8	5.2	7.2	2.8	4.4	1.8	3.7	2.7	2.1	2.1	10.1	10.7	2.3	0.4	4.1	11.0	1.1	0.3	1.3	6.0	2.8	6.6	4.3	5.7	48.2	18.5	6.1	2.0	2.6	4.9	5.0	5.7	3.0
NCAPH	"BRRN1, CAP-H, hCAP-H"	ENSG00000121152	"Non-SMC condensin I complex subunit H"	Q15003	2	96335766-96377091	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cell cycle, Cell division, DNA condensation, Mitosis"		"Disease variant, Primary microcephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 35.2;lymphoid tissue: 37.4;testis: 35.4"	"Cell type enhanced"	"Detected in many"		"Plasma cells: 26.3;Spermatocytes: 89.3;Spermatogonia: 29.4"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in some"		"T-reg: 6.2"	"Group enriched"	"Detected in many"	5	"granulocytes: 3.8;T-cells: 6.2"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"HPA002647, HPA003008"	Enhanced		Supported	Nucleoplasm,Cytosol		Yes	Yes			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Cytosol	Nucleoplasm	"HPA002647: AB_1078300, HPA003008: AB_1078301"	"unprognostic (5.52e-2)"	"unprognostic (7.37e-2)"	"unprognostic (2.93e-2)"	"unprognostic (2.85e-3)"	"unprognostic (1.92e-1)"	"unprognostic (7.51e-2)"	"prognostic unfavorable (9.53e-6)"	"prognostic unfavorable (6.73e-4)"	"unprognostic (1.50e-3)"	"unprognostic (1.18e-1)"	"prognostic unfavorable (1.02e-4)"	"unprognostic (3.16e-2)"	"unprognostic (0.00e+0)"	"unprognostic (3.00e-2)"	"unprognostic (2.38e-1)"	"unprognostic (2.14e-1)"	"unprognostic (2.30e-2)"	1.2	0.7	0.3	9.9	0.4	35.2	1.8	0.9	0.9	1.3	0.1	7.7	5.6	0.9	0.2	6.3	0.5	1.6	0.4	0.3	0.2	0.4	1.0	1.1	20.3	0.1	0.0	0.3	0.3	0.5	0.2	5.2	0.3	0.4	9.3	1.8	1.5	0.2	0.3	4.7	6.2	2.8	0.0	3.7	3.6	35.4	0.1	37.4	0.4	0.1	22.0	2.6	2.0	0.3	134.1	52.0	115.1	60.6	3.9	6.1	80.8	58.7	40.3	115.1	118.4	93.5	71.5	121.0	41.8	26.6	106.2	57.2	100.2	39.6	117.2	110.0	63.4	123.7	49.3	74.5	0.7	112.2	101.3	1.8	4.2	89.1	35.9	10.2	46.6	89.7	89.5	88.8	53.0	59.5	183.8	104.2	85.9	57.6	56.6	133.4	106.7	95.5	23.6	49.6	71.2	52.3	34.8	46.5	19.9	42.4	36.6	80.0	24.1	83.5	126.3	76.9	101.9	44.4	70.1	134.0	33.7	111.5	95.3	3.8	0.0	0.2	0.8	0.9	0.1	0.9	1.2	1.0	0.4	0.9	0.0	0.4	0.3	0.1	0.0	0.0	6.2	0.5	0.3	0.4	0.9	0.9	0.3	0.2	0.1	0.0	0.3	0.0	0.1	0.3	4.9	0.0	0.0	0.0	3.5	0.6	0.7	1.9	1.2	0.4	1.0	0.8	0.5	0.0	1.6	0.0	8.4	9.4	2.0	2.1	0.0	0.5	5.9	1.7	0.9	1.8	0.0	16.4	0.4	0.0	16.3	1.8	4.1	1.2	1.3	5.5	1.4	0.4	8.5	0.0	0.3	2.8	0.0	3.8	3.7	4.9	0.9	2.2	1.8	0.0	0.2	8.5	0.0	0.5	1.0	0.2	0.1	0.4	26.3	0.7	0.4	0.0	1.6	2.3	0.0	0.2	3.5	89.3	29.4	8.8	0.9	1.9	5.1	0.6	5.7	1.1
NCAPH2	"384D8-2, CAP-H2, hCAP-H2"	ENSG00000025770	"Non-SMC condensin II complex subunit H2"	Q6IBW4	22	50508224-50524780	"Predicted intracellular proteins"	"DNA condensation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 111.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA067932, HPA069056"	Enhanced		Supported	"Nucleoplasm,Cytokinetic bridge"		Yes	No			"Cluster 46: Basophils - DNA binding"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	"Cytokinetic bridge"	"HPA067932: AB_2685926, HPA069056: AB_2686076"	"unprognostic (2.01e-1)"	"prognostic favorable (2.24e-8)"	"unprognostic (3.65e-2)"	"unprognostic (2.81e-1)"	"unprognostic (5.04e-2)"	"unprognostic (1.57e-2)"	"prognostic unfavorable (8.25e-4)"	"unprognostic (2.92e-2)"	"unprognostic (8.66e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.26e-2)"	"unprognostic (6.31e-2)"	"unprognostic (2.04e-3)"	"unprognostic (2.64e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.41e-1)"	"unprognostic (3.00e-1)"	25.7	21.9	32.9	24.5	33.6	78.8	26.9	32.7	39.2	31.8	25.4	29.3	17.7	29.8	12.4	30.3	30.0	13.0	36.7	32.0	30.9	26.6	27.6	28.2	27.6	32.6	29.0	37.6	40.7	16.7	38.6	17.1	28.7	28.4	11.7	15.5	25.7	16.6	30.7	32.6	28.4	14.7	27.5	33.2	30.2	52.3	28.5	29.6	28.9	19.3	20.2	25.9	26.9	33.5	60.7	32.1	53.8	57.1	15.8	18.4	71.6	45.8	31.6	81.8	89.5	67.2	41.4	68.8	25.5	32.9	45.5	47.1	49.0	44.2	23.5	40.3	82.8	39.8	86.7	63.6	19.1	90.3	69.5	16.1	27.6	64.4	22.2	12.2	26.2	59.4	51.5	132.5	33.4	83.9	61.7	109.9	39.3	34.9	37.9	103.3	71.0	77.2	23.8	40.6	35.6	47.5	36.7	55.4	44.3	16.5	37.5	86.7	17.6	64.2	80.5	54.4	72.3	67.7	45.8	110.1	48.8	45.7	62.3	11.9	9.8	18.2	18.7	11.6	22.9	16.0	19.4	19.1	8.0	14.2	19.9	17.3	11.4	13.9	14.4	11.8	19.3	15.5	32.9	33.6	32.7	39.2	32.0	30.9	32.6	29.0	28.7	27.5	28.5	33.5	10.1	22.4	24.5	12.1	15.9	18.9	23.8	17.5	6.2	18.3	11.5	12.6	19.6	15.7	10.4	9.2	4.2	36.3	15.5	24.6	15.6	16.6	36.8	8.5	7.5	12.9	13.1	31.5	8.6	23.5	55.1	13.8	14.8	14.5	17.1	16.3	8.9	10.6	19.3	8.4	8.8	18.8	6.1	7.9	16.3	111.5	17.4	9.2	12.4	3.7	16.2	14.7	18.6	3.0	8.2	17.3	13.5	17.3	26.6	15.2	18.4	9.5	5.9	16.1	19.7	17.8	16.9	36.2	39.7	10.9	18.5	31.5	15.9	7.6	22.6	18.2
NCBP1	"CBP80, NCBP, Sto1"	ENSG00000136937	"Nuclear cap binding protein subunit 1"	Q09161	9	97633668-97673748	"Predicted intracellular proteins, Transporters"	"mRNA capping, mRNA processing, mRNA splicing, mRNA transport, Nonsense-mediated mRNA decay, RNA-mediated gene silencing, Translation regulation, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042411, HPA049031"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA		25000	"Cluster 27: Non-specific - Gene expression"	"Cluster 34: Non-specific - Transcription"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 59: Non-specific - Transcription"	Cytosol	Nucleoplasm	"HPA042411: AB_2677985, HPA049031: AB_2680606"	"unprognostic (4.76e-3)"	"unprognostic (2.16e-1)"	"prognostic favorable (5.28e-4)"	"unprognostic (4.63e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.14e-3)"	"unprognostic (1.53e-2)"	"unprognostic (3.26e-2)"	"unprognostic (9.46e-2)"	"unprognostic (3.16e-1)"	"prognostic unfavorable (4.17e-4)"	"unprognostic (4.11e-2)"	"unprognostic (3.84e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.17e-1)"	"unprognostic (7.04e-2)"	10.9	11.0	11.9	16.0	13.7	29.5	11.7	28.3	13.6	10.5	13.7	15.4	12.7	11.7	10.0	12.3	8.8	11.4	12.2	11.8	11.8	11.0	16.6	9.7	19.8	11.6	11.1	12.7	13.2	10.1	10.5	14.6	11.7	12.2	17.9	30.6	10.8	10.2	18.7	15.8	12.6	11.4	11.2	13.3	13.0	16.9	10.9	21.3	15.7	14.9	18.7	14.0	10.6	17.4	57.7	40.6	44.2	41.0	30.8	30.9	41.6	41.2	25.9	40.1	37.4	54.7	30.2	49.0	17.9	41.1	38.5	62.1	72.3	51.6	57.3	33.8	22.2	45.8	58.5	34.4	30.0	60.8	43.2	23.5	25.0	47.3	35.8	28.5	42.4	35.4	68.6	27.0	68.5	43.5	44.3	33.5	46.4	85.4	39.8	41.9	100.4	20.4	33.0	42.9	55.2	35.4	44.2	38.5	23.5	37.9	23.7	38.7	35.2	31.1	28.0	61.9	44.5	21.7	34.3	25.7	27.3	48.6	40.9	14.0	10.0	9.4	7.2	13.4	8.0	5.3	7.7	7.2	12.7	6.5	6.6	8.0	2.9	12.7	13.9	4.5	7.9	7.4	11.9	13.7	28.3	13.6	11.8	11.8	11.6	11.1	11.7	11.2	10.9	17.4	9.8	6.4	11.1	34.9	13.9	13.6	6.8	9.3	13.1	21.9	7.9	5.6	23.4	10.0	13.7	9.2	20.9	13.7	9.7	16.0	3.9	8.9	20.3	12.2	16.7	10.4	9.1	21.4	26.1	6.9	15.0	11.7	17.3	13.2	8.2	12.8	7.1	16.5	11.3	21.9	25.5	12.1	14.2	12.0	9.6	9.8	6.5	12.0	5.4	12.2	15.8	8.9	11.3	20.1	24.4	9.7	7.8	7.5	15.9	7.9	9.0	5.3	15.1	23.4	6.6	10.4	11.2	29.4	14.1	14.3	7.4	14.4	15.0	9.5	10.9	8.4
NCDN	"NCDN-1, NCDN-2"	ENSG00000020129	Neurochondrin	Q9UBB6	1	35557473-35567274	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	11	"brain: 424.1"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 39.7;Inhibitory neurons: 35.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023676	Enhanced	Supported	Supported	Cytosol		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Cytosol		"HPA023676: AB_1854325"	"unprognostic (1.15e-1)"	"unprognostic (7.11e-2)"	"unprognostic (1.08e-1)"	"unprognostic (6.05e-2)"	"unprognostic (6.12e-3)"	"unprognostic (2.39e-1)"	"prognostic unfavorable (1.91e-5)"	"unprognostic (4.66e-2)"	"unprognostic (1.41e-1)"	"unprognostic (4.36e-2)"	"prognostic favorable (3.73e-4)"	"unprognostic (5.91e-3)"	"unprognostic (5.34e-3)"	"unprognostic (5.88e-3)"	"unprognostic (2.87e-1)"	"unprognostic (3.24e-2)"	"unprognostic (2.23e-2)"	10.7	23.9	197.0	9.4	424.1	4.9	9.8	51.0	360.4	20.5	0.0	16.9	5.3	17.1	6.5	12.1	16.1	9.7	23.1	364.2	118.3	13.4	10.3	11.8	9.6	114.1	115.9	18.9	10.0	10.6	38.7	6.7	112.0	17.2	3.4	21.3	11.0	11.3	14.6	10.1	10.6	9.6	168.3	11.4	14.9	15.3	215.9	7.4	16.6	9.0	6.6	16.2	15.9	191.3	17.3	20.5	16.8	26.6	23.8	29.4	11.6	22.3	22.9	23.0	18.3	20.6	24.8	19.6	21.1	20.7	16.5	26.0	16.6	27.1	8.4	19.2	34.3	24.4	32.2	10.7	33.0	22.3	26.9	28.2	22.2	40.7	16.3	18.9	12.3	11.6	26.9	30.4	18.9	31.0	20.5	14.2	75.7	19.1	35.6	16.6	9.4	25.4	15.6	19.0	20.9	30.0	25.4	23.2	32.1	13.3	22.2	14.4	17.0	29.1	20.9	21.5	30.9	42.4	32.6	14.7	36.3	35.1	27.1	0.0	2.6	0.4	1.6	1.5	2.0	3.7	2.5	2.5	1.5	1.4	3.3	2.9	0.3	1.8	2.6	0.9	1.5	3.8	197.0	424.1	51.0	360.4	364.2	118.3	114.1	115.9	112.0	168.3	215.9	191.3	3.8	3.2	12.0	15.7	1.9	3.4	0.5	4.0	1.8	4.7	5.8	7.1	13.8	2.8	12.6	7.3	0.0	5.6	2.0	2.9	1.9	3.7	2.5	3.9	8.1	4.4	3.6	2.1	39.7	4.4	2.6	6.1	8.6	5.1	3.8	6.5	3.3	4.3	3.5	6.7	35.0	3.5	6.1	6.7	1.0	1.4	6.5	2.6	5.4	12.2	1.7	2.1	2.1	9.5	16.4	3.8	2.1	4.1	6.5	0.6	0.8	4.7	14.7	2.9	0.0	1.7	5.4	5.1	2.2	2.7	3.0	5.6	4.9	8.0	1.7	0.6
NCF2	"NOXA2, p67phox"	ENSG00000116701	"Neutrophil cytosolic factor 2"	P19878	1	183555562-183590876	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			"Chronic granulomatous disease, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 191.9;lung: 74.6;lymphoid tissue: 78.8"	"Group enriched"	"Detected in many"	5	"Ductal cells: 68.6;Hofbauer cells: 212.0;Kupffer cells: 137.9;Langerhans cells: 129.5;Macrophages: 194.4;monocytes: 223.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"eosinophil: 1313.6"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"A-431: 26.4;HMC-1: 21.4;hTERT-HME1: 51.6;RPMI-8226: 20.0;U-2 OS: 50.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA002327, HPA006040, CAB022160"	Enhanced		Supported	Cytosol		NA	NA		12000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	Cytosol		"CAB022160: , HPA002327: AB_1079550, HPA006040: AB_1854906"	"unprognostic (4.97e-2)"	"unprognostic (3.48e-2)"	"unprognostic (2.40e-2)"	"unprognostic (1.22e-3)"	"unprognostic (5.83e-3)"	"unprognostic (4.04e-2)"	"prognostic unfavorable (7.91e-6)"	"unprognostic (1.29e-1)"	"unprognostic (2.45e-1)"	"unprognostic (2.33e-1)"	"unprognostic (5.70e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.57e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.41e-2)"	"unprognostic (8.24e-2)"	"unprognostic (2.36e-2)"	29.9	5.8	2.7	76.9	3.0	191.9	7.0	3.2	14.6	9.5	4.5	10.4	8.5	4.1	1.6	7.6	8.0	23.8	5.6	2.3	3.9	3.7	12.7	74.6	17.3	6.2	4.2	2.1	4.6	2.8	2.7	39.7	6.8	2.9	12.5	0.8	6.6	3.5	3.7	15.9	12.4	20.4	4.5	78.8	5.8	2.1	12.0	11.3	3.0	11.5	16.9	24.2	5.9	7.8	26.4	0.8	0.0	0.0	0.0	0.0	0.3	1.9	2.4	3.4	1.6	0.2	0.8	3.2	4.3	0.8	0.6	14.3	0.1	19.0	3.1	16.2	0.0	0.0	7.3	6.0	0.0	2.0	21.4	0.0	4.1	3.4	51.6	2.2	0.0	0.1	0.0	5.6	5.8	0.2	0.2	1.1	0.4	1.5	1.5	7.0	2.2	20.0	0.8	0.2	0.0	0.1	0.3	0.1	0.9	1.7	2.8	9.1	1.2	0.1	50.2	0.0	4.9	0.9	1.4	0.6	0.4	10.3	0.0	199.5	489.2	1313.6	1.0	348.8	1.6	14.1	4.0	1.6	246.0	10.8	2.2	1.3	799.7	2.1	326.1	13.5	11.1	298.9	2.7	3.0	3.2	14.6	2.3	3.9	6.2	4.2	6.8	4.5	12.0	7.8	0.7	9.6	15.7	0.0	8.4	5.5	0.2	13.7	1.8	0.3	0.1	0.3	1.3	7.2	17.3	0.0	0.0	1.0	9.6	0.1	3.9	68.6	1.1	1.9	0.5	3.5	0.0	1.7	0.3	3.9	1.1	2.0	0.5	1.3	7.6	0.0	3.3	1.0	212.0	0.0	0.3	0.2	26.4	137.9	129.5	2.9	0.6	194.4	7.2	3.7	223.6	0.0	6.2	0.0	0.2	27.3	2.6	0.0	3.2	0.6	0.0	0.3	32.0	0.7	13.1	0.7	6.8	0.1	0.6	0.6	4.3	1.9	3.7	0.2	0.0	1.2
NCK1	"NCK, NCKalpha"	ENSG00000158092	"NCK adaptor protein 1"	P16333	3	136862208-136951606	"Predicted intracellular proteins"	"Translation regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Basal respiratory cells: 225.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005063, HPA030766"	Supported		Approved	"Plasma membrane,Cytosol"		NA	NA		17000	"Cluster 38: Basophils - Unknown function"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Plasma membrane, Cytosol"		"CAB005063: AB_562169, HPA030766: AB_2673602"	"unprognostic (7.47e-2)"	"unprognostic (2.07e-1)"	"unprognostic (3.98e-2)"	"unprognostic (3.03e-2)"	"unprognostic (1.06e-2)"	"unprognostic (8.77e-3)"	"unprognostic (4.24e-3)"	"unprognostic (8.30e-2)"	"unprognostic (9.31e-2)"	"unprognostic (1.22e-1)"	"prognostic unfavorable (9.14e-5)"	"unprognostic (5.96e-2)"	"prognostic unfavorable (1.08e-4)"	"unprognostic (1.64e-1)"	"unprognostic (2.58e-1)"	"unprognostic (1.66e-1)"	"unprognostic (4.17e-2)"	34.4	17.9	12.8	26.2	13.0	32.0	28.6	17.0	15.3	27.3	20.4	27.7	15.3	23.7	17.0	38.7	20.4	20.1	20.2	12.9	14.6	16.1	30.9	27.0	41.8	14.2	14.3	23.3	17.2	24.2	13.7	30.7	14.2	21.4	27.8	18.4	24.6	19.2	27.5	30.2	15.8	23.6	12.8	28.8	18.4	19.6	13.9	52.9	26.9	29.1	44.5	29.3	36.2	15.8	50.1	22.0	28.4	23.4	65.3	62.7	31.5	36.6	65.3	41.8	43.4	32.3	49.9	49.0	74.9	43.0	54.5	37.9	40.3	37.1	54.3	35.7	16.3	43.0	31.1	25.4	106.0	31.3	28.2	57.4	47.3	40.8	80.0	41.9	64.4	46.1	26.3	42.7	44.2	28.2	71.8	25.3	26.8	45.6	27.6	37.6	26.4	47.6	38.9	34.4	19.8	19.2	66.5	28.1	62.2	34.2	42.0	33.8	32.5	27.1	17.1	38.8	21.3	42.2	36.6	62.5	27.8	27.6	29.3	61.1	22.3	24.7	32.8	50.5	33.6	13.9	25.7	33.7	24.4	14.2	20.8	24.5	12.8	21.6	26.4	9.4	27.6	23.6	12.8	13.0	17.0	15.3	12.9	14.6	14.2	14.3	14.2	12.8	13.9	15.8	58.6	9.6	15.9	25.5	41.6	74.8	77.1	225.1	79.6	20.1	23.7	19.9	11.1	27.1	144.3	9.2	6.2	45.4	54.0	29.6	15.6	50.4	11.6	27.9	31.9	61.4	13.8	17.5	28.6	27.3	52.7	42.8	9.2	31.2	9.5	14.9	31.8	37.5	48.3	25.2	37.9	17.7	46.8	36.6	62.8	8.9	44.1	38.0	42.7	70.3	49.6	20.2	88.6	42.7	36.9	37.9	25.3	26.7	36.2	98.0	15.6	23.9	75.7	14.6	13.1	24.9	32.1	55.2	36.6	66.1	83.3	61.0	70.4	21.8	18.8	142.9
NCL	"C23, Nsr1"	ENSG00000115053	Nucleolin	P19338	2	231453531-231483641	"Plasma proteins, Predicted intracellular proteins"		"DNA-binding, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004210, HPA023981, HPA071110"	Supported		Enhanced	"Nucleoplasm,Nucleoli,Nucleoli rim,Mitotic chromosome"		Yes	No		1400000	"Cluster 27: Non-specific - Gene expression"	"Cluster 52: Non-specific - Ribosome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	"Nucleoplasm, Nucleoli, Nucleoli rim"	"Mitotic chromosome"	"CAB004210: AB_670270, HPA023981: AB_1854688, HPA071110: "	"unprognostic (1.91e-1)"	"unprognostic (2.53e-1)"	"unprognostic (1.57e-1)"	"prognostic unfavorable (2.28e-4)"	"unprognostic (1.63e-2)"	"unprognostic (2.72e-3)"	"prognostic unfavorable (1.41e-6)"	"unprognostic (3.74e-2)"	"unprognostic (4.31e-3)"	"unprognostic (9.78e-2)"	"unprognostic (6.70e-3)"	"unprognostic (6.07e-2)"	"unprognostic (1.66e-2)"	"unprognostic (2.57e-2)"	"unprognostic (9.70e-2)"	"unprognostic (2.84e-2)"	"unprognostic (1.42e-2)"	212.0	192.8	128.8	226.0	146.3	301.4	228.7	129.1	139.6	180.0	114.1	183.6	160.7	205.2	150.2	228.8	173.2	132.2	164.3	115.9	152.3	166.2	218.5	147.4	289.7	148.8	141.5	258.2	209.0	258.9	115.9	203.4	140.4	155.4	219.2	147.1	157.0	160.9	350.9	197.1	157.4	201.0	137.9	176.3	164.7	126.2	142.1	347.0	198.4	228.2	329.0	271.1	169.1	143.9	718.3	691.8	715.7	640.1	485.7	592.0	823.0	790.4	497.2	690.8	628.2	1227.4	521.4	1083.7	608.6	651.0	892.6	719.5	1614.4	1059.9	1284.7	554.6	644.0	1587.3	605.9	1749.5	544.0	1930.4	632.7	513.5	613.2	872.3	1019.6	394.9	834.2	770.5	1745.4	378.6	760.5	1176.4	1443.2	1086.7	1202.0	728.7	435.9	1290.8	1452.0	918.4	583.8	959.9	749.0	502.0	555.8	704.5	706.9	625.7	476.8	985.3	686.3	611.4	626.7	714.5	1063.7	624.3	554.5	1885.9	467.2	1173.1	685.2	27.3	95.6	62.5	136.5	100.3	152.8	113.5	118.4	121.9	130.6	111.9	130.3	114.2	16.8	177.8	121.7	102.0	102.3	151.0	128.8	146.3	129.1	139.6	115.9	152.3	148.8	141.5	140.4	137.9	142.1	143.9	286.2	291.7	411.7	8.1	468.9	459.9	633.8	241.0	644.9	145.0	315.2	303.8	320.9	147.3	401.6	195.0	47.9	386.9	596.2	215.0	230.9	294.4	20.6	348.7	669.8	291.1	200.0	419.2	9.3	254.4	444.6	370.9	292.0	421.8	451.7	262.7	130.6	242.0	239.5	80.8	10.4	319.6	156.6	133.7	231.1	32.2	217.2	281.8	165.4	10.3	268.9	199.6	346.1	14.1	14.9	268.0	153.9	159.9	543.5	651.1	120.1	277.6	250.3	141.0	151.2	548.9	442.0	433.3	532.4	707.9	441.4	379.0	454.0	442.6	380.6	449.1
NCOA2	"bHLHe75, GRIP1, KAT13C, NCoA-2, TIF2"	ENSG00000140396	"Nuclear receptor coactivator 2"	Q15596	8	70109782-70403808	"Cancer-related genes, Disease related genes, Metabolic proteins, Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Transcription, Transcription regulation"	Activator	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Astrocytes: 161.6;Excitatory neurons: 158.9;Inhibitory neurons: 314.8;Microglial cells: 233.3;Oligodendrocyte precursor cells: 249.8;Oligodendrocytes: 186.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA060243			Supported	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 34: Non-specific - Transcription"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Nucleoplasm, Nuclear bodies"		"HPA060243: AB_2684229"	"unprognostic (9.79e-3)"	"unprognostic (1.40e-1)"	"unprognostic (2.72e-1)"	"unprognostic (4.94e-3)"	"unprognostic (1.91e-2)"	"unprognostic (2.18e-3)"	"unprognostic (1.30e-1)"	"unprognostic (6.77e-2)"	"unprognostic (2.06e-1)"	"unprognostic (7.00e-2)"	"unprognostic (2.20e-2)"	"unprognostic (2.63e-2)"	"prognostic favorable (5.08e-4)"	"unprognostic (2.52e-1)"	"unprognostic (3.35e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.76e-1)"	8.4	8.9	8.9	9.9	10.5	23.3	13.4	8.9	10.0	10.0	1.5	10.6	11.6	10.1	29.6	15.3	10.9	8.9	15.0	13.6	13.2	14.4	23.8	10.0	11.6	8.0	6.8	16.2	7.3	15.2	7.3	12.1	7.7	12.9	10.6	26.1	11.3	12.1	8.3	10.5	12.1	9.0	4.6	12.4	10.9	14.7	9.9	15.3	12.1	15.9	12.5	10.0	9.9	6.1	13.7	16.9	18.2	10.3	16.2	16.5	18.6	7.8	7.8	5.9	5.5	8.6	15.6	16.3	3.1	14.3	9.7	8.0	22.5	10.7	6.5	38.7	17.9	28.5	8.5	13.8	8.5	5.8	7.2	14.5	11.7	7.9	11.3	9.2	4.0	11.7	9.2	24.0	6.9	13.7	14.5	5.8	9.6	15.7	7.9	14.1	7.6	10.3	9.3	22.5	13.8	10.2	13.4	7.1	11.0	12.7	16.7	10.5	5.3	8.4	10.6	10.8	4.2	31.5	17.3	15.4	8.6	7.6	12.5	3.1	1.6	2.2	2.2	2.3	1.5	1.3	1.3	1.9	1.5	2.1	1.5	1.6	5.7	1.4	5.2	0.6	2.0	1.2	8.9	10.5	8.9	10.0	13.6	13.2	8.0	6.8	7.7	4.6	9.9	6.1	20.9	12.8	25.1	161.6	27.3	16.2	8.6	10.8	17.6	25.8	29.5	17.5	34.1	28.6	25.8	25.8	52.1	22.1	26.9	30.8	11.7	9.3	6.4	23.6	26.4	17.7	25.2	28.8	158.9	12.4	12.5	21.6	21.4	38.0	22.2	23.2	22.1	65.9	17.4	74.0	314.8	17.4	10.2	46.8	17.8	7.6	19.9	28.1	21.4	233.3	23.1	14.3	19.6	249.8	186.0	12.8	14.8	22.2	49.9	15.5	22.7	17.6	19.0	33.4	26.3	22.5	20.2	13.3	16.5	18.8	21.5	31.7	36.6	10.9	17.0	15.8
NCOA3	"ACTR, AIB1, bHLHe42, CAGH16, KAT13B, p/CIP, RAC3, SRC-3, SRC3, TNRC16, TRAM-1"	ENSG00000124151	"Nuclear receptor coactivator 3"	Q9Y6Q9	20	47501887-47656877	"Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Acyltransferase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"B-cells: 155.8;Plasma cells: 168.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"MCF7: 187.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009800, HPA024210"	Supported		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 57: B-cells - Immune response"	Nucleoplasm	Cytosol	"CAB009800: AB_2251314, HPA024210: AB_10602011"	"unprognostic (7.26e-3)"	"unprognostic (1.00e-1)"	"unprognostic (2.69e-1)"	"unprognostic (3.23e-2)"	"unprognostic (5.78e-2)"	"unprognostic (4.33e-2)"	"prognostic unfavorable (8.09e-4)"	"unprognostic (2.83e-2)"	"unprognostic (1.47e-1)"	"unprognostic (5.22e-3)"	"unprognostic (2.09e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.05e-1)"	"unprognostic (1.95e-1)"	"unprognostic (2.04e-2)"	"unprognostic (4.18e-1)"	"unprognostic (1.63e-1)"	14.7	8.2	4.7	22.9	4.7	13.4	11.5	5.7	9.0	11.1	3.8	9.9	8.8	11.8	7.1	14.3	10.7	10.3	13.3	4.0	5.5	9.4	10.5	14.8	35.0	6.5	5.3	14.1	11.1	11.2	6.0	28.1	6.9	9.6	11.2	11.6	11.3	8.8	25.2	14.0	14.8	11.5	5.3	27.5	14.8	7.5	5.9	17.9	12.9	16.5	39.2	15.3	12.5	6.4	17.6	50.1	16.1	21.5	37.5	41.9	105.2	16.4	24.2	27.3	14.1	25.2	19.0	61.8	11.0	28.5	36.1	43.2	12.2	20.7	20.9	31.3	6.4	8.1	15.3	39.3	22.6	6.8	43.3	19.9	61.2	24.4	30.3	23.5	20.0	10.0	18.7	14.0	16.2	187.0	9.9	12.8	5.8	14.2	20.6	17.8	11.0	27.4	16.8	38.2	3.1	5.7	41.0	53.7	18.8	18.0	24.3	17.8	35.8	16.4	12.9	20.5	7.4	38.5	35.9	60.6	19.4	7.0	10.8	2.8	3.9	3.0	2.5	5.2	2.2	9.3	2.3	2.2	5.0	6.8	2.6	2.9	4.5	2.1	5.0	4.2	3.1	2.6	4.7	4.7	5.7	9.0	4.0	5.5	6.5	5.3	6.9	5.3	5.9	6.4	86.7	12.8	23.7	27.7	155.8	34.5	15.7	25.0	52.9	18.1	23.8	13.8	26.1	20.0	29.0	14.7	8.4	69.5	39.9	12.5	5.9	12.9	12.1	36.4	29.1	49.8	14.9	14.9	48.5	19.6	26.2	26.4	26.5	78.8	8.8	15.3	68.2	20.0	22.8	13.5	64.3	10.7	36.7	46.8	62.2	6.0	24.8	58.2	33.8	109.6	46.1	9.3	28.8	49.3	54.1	21.0	16.9	27.4	168.8	28.1	9.0	6.5	39.8	23.8	19.7	19.7	30.3	43.2	30.0	63.3	51.7	89.2	47.6	14.2	11.7	59.2
NCOA5	"bA465L10.6, CIA"	ENSG00000124160	"Nuclear receptor coactivator 5"	Q9HCD5	20	46060991-46089962	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA050231	Uncertain		Supported	"Nucleoplasm,Actin filaments"		NA	NA			"Cluster 29: Plasmacytoid DCs - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 59: Non-specific - Transcription"	"Nucleoplasm, Actin filaments"		"HPA050231: AB_2681058"	"unprognostic (1.78e-1)"	"unprognostic (1.54e-1)"	"unprognostic (2.43e-2)"	"unprognostic (7.93e-2)"	"unprognostic (2.30e-1)"	"unprognostic (1.43e-2)"	"prognostic unfavorable (1.41e-5)"	"prognostic favorable (8.07e-4)"	"unprognostic (2.32e-1)"	"unprognostic (7.75e-2)"	"prognostic favorable (1.09e-4)"	"unprognostic (7.46e-2)"	"unprognostic (4.40e-1)"	"unprognostic (2.06e-2)"	"unprognostic (1.07e-1)"	"unprognostic (8.78e-2)"	"unprognostic (1.91e-2)"	19.1	17.0	15.8	18.5	16.7	9.5	19.6	21.7	17.4	25.1	17.2	22.2	14.2	24.8	19.4	18.6	21.8	12.2	15.6	16.1	17.6	18.8	15.3	15.2	25.1	16.5	15.7	28.5	20.5	20.3	21.8	18.7	15.2	21.4	16.3	23.1	20.4	14.6	19.6	21.9	21.6	17.7	15.7	25.7	19.2	25.8	16.9	26.2	20.7	14.6	25.0	20.8	19.6	17.4	39.5	34.2	47.4	49.0	22.2	23.3	37.8	26.7	24.0	42.5	34.7	47.8	30.6	64.3	44.0	26.0	36.1	51.2	39.6	33.5	36.5	39.1	19.9	38.7	33.4	40.7	23.5	53.4	36.1	16.8	43.8	22.5	20.4	22.2	30.6	33.1	36.3	50.9	33.9	50.9	74.2	41.3	43.2	33.3	41.8	55.6	31.4	28.0	25.1	44.3	42.5	38.5	42.8	51.7	37.3	26.9	41.1	62.3	28.7	44.6	33.8	27.1	42.2	32.9	50.5	43.2	31.1	31.1	29.1	3.9	9.5	13.4	13.4	10.3	15.4	13.1	14.3	13.6	9.8	17.7	13.3	12.4	7.0	8.8	10.7	21.6	10.0	7.1	15.8	16.7	21.7	17.4	16.1	17.6	16.5	15.7	15.2	15.7	16.9	17.4	7.3	9.6	12.6	24.2	12.5	6.4	3.1	6.7	10.8	13.2	9.7	8.0	5.2	10.0	7.3	9.2	22.9	11.2	11.8	8.2	0.0	8.9	7.5	6.9	11.7	9.1	9.5	9.7	29.4	12.4	8.8	7.9	12.2	7.7	1.3	11.6	9.3	9.3	7.8	3.3	31.6	10.4	4.1	10.1	3.2	5.0	13.7	6.7	3.6	42.2	9.2	7.4	13.4	19.6	35.8	11.7	3.2	15.4	12.1	4.4	4.5	5.2	8.6	9.0	6.6	10.7	7.0	28.1	15.7	8.7	5.4	6.7	8.7	8.4	9.2	3.6
NCOA6	"AIB3, ASC2, KIAA0181, NRC, PRIP, RAP250, TRBP"	ENSG00000198646	"Nuclear receptor coactivator 6"	Q14686	20	34689097-34825651	"Metabolic proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 130.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004198, HPA050211"	Supported		Supported	Nucleoplasm		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"HPA004198: AB_1078228, HPA050211: AB_2681052"	"unprognostic (2.48e-1)"	"unprognostic (4.81e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.37e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.10e-1)"	"prognostic unfavorable (4.65e-4)"	"unprognostic (2.05e-1)"	"unprognostic (2.16e-1)"	"unprognostic (1.40e-1)"	"unprognostic (3.87e-2)"	"unprognostic (1.51e-1)"	"prognostic favorable (8.78e-5)"	"unprognostic (9.04e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.12e-1)"	"unprognostic (4.42e-2)"	10.2	9.0	5.2	9.1	6.7	14.0	9.2	12.7	12.4	10.8	4.8	12.9	13.2	10.7	12.2	11.7	11.3	8.8	9.2	6.1	8.2	9.9	8.4	10.4	8.9	6.3	4.6	11.6	12.6	22.0	10.0	13.5	4.6	9.8	14.5	26.7	12.9	11.3	12.7	13.5	12.0	13.2	2.3	9.4	11.4	18.8	7.4	18.1	13.8	13.1	10.3	10.4	10.5	9.6	25.2	14.7	32.6	19.7	17.5	19.4	21.3	12.0	15.3	21.1	16.9	37.9	17.2	17.7	12.9	21.5	25.8	30.0	29.3	20.2	23.9	9.0	13.2	41.6	16.7	22.4	19.3	23.5	29.4	14.8	36.5	19.8	24.5	14.6	20.2	20.1	21.5	23.7	17.7	16.3	37.5	14.8	6.7	21.0	21.1	24.9	39.3	15.9	15.6	16.6	27.2	18.5	22.0	52.5	20.5	15.0	22.2	18.5	20.0	34.1	20.7	25.6	20.2	26.9	24.3	20.0	22.5	13.5	15.5	1.1	0.6	2.5	0.9	0.5	0.8	1.0	0.8	0.8	1.1	0.8	0.7	0.5	1.5	0.7	0.7	1.0	0.5	0.5	5.2	6.7	12.7	12.4	6.1	8.2	6.3	4.6	4.6	2.3	7.4	9.6	17.3	25.6	16.0	54.9	11.0	17.0	9.1	10.6	13.6	28.8	14.3	10.9	20.1	18.6	11.6	16.5	29.2	13.0	12.2	31.9	5.9	12.5	23.5	16.4	21.3	14.0	10.8	13.3	50.9	12.4	12.1	14.5	15.8	23.3	6.3	18.5	13.9	12.1	10.8	33.7	58.8	17.4	20.3	12.2	10.3	17.3	18.0	13.0	10.6	45.9	17.6	11.5	13.4	54.3	130.4	15.4	12.4	13.5	14.2	16.9	20.3	9.3	17.5	29.8	26.3	16.6	16.9	25.6	27.1	19.2	20.9	15.9	13.1	13.6	17.6	14.6
NCOR2	"CTG26, SMRT, SMRTE, TNRC14, TRAC-1"	ENSG00000196498	"Nuclear receptor corepressor 2"	Q9Y618	12	124324415-124567589	"Cancer-related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"basophil: 6.0;non-classical monocyte: 2.5"	"Group enriched"	"Detected in many"	4	"granulocytes: 6.0;monocytes: 2.5"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001928	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 72: Non-specific - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA001928: AB_1079454"	"unprognostic (9.51e-3)"	"unprognostic (7.37e-3)"	"unprognostic (4.66e-2)"	"unprognostic (2.55e-3)"	"unprognostic (2.14e-1)"	"unprognostic (7.37e-2)"	"unprognostic (3.19e-2)"	"unprognostic (8.86e-2)"	"unprognostic (2.21e-2)"	"unprognostic (2.90e-3)"	"unprognostic (6.42e-3)"	"unprognostic (1.96e-1)"	"unprognostic (9.86e-2)"	"unprognostic (6.26e-2)"	"unprognostic (1.59e-1)"	"unprognostic (7.56e-2)"	"unprognostic (8.90e-2)"	48.1	51.1	41.2	34.3	15.8	29.9	49.7	27.2	45.6	62.9	13.6	56.2	25.2	58.6	9.0	33.3	49.0	21.4	56.7	61.3	12.6	37.6	27.5	62.8	19.5	56.4	29.2	70.8	49.3	18.1	84.1	20.2	53.0	57.7	10.9	20.7	55.1	22.0	109.2	56.2	36.8	22.5	5.4	35.7	45.8	26.1	26.4	19.9	40.5	19.9	11.2	47.4	43.9	27.0	78.6	143.6	40.4	38.7	23.0	31.1	120.4	79.3	39.0	45.2	20.1	76.9	56.3	78.7	57.0	65.1	40.7	72.6	16.2	84.7	18.5	83.6	31.5	63.6	142.1	48.0	46.0	48.3	77.5	50.1	30.9	56.6	33.4	69.2	43.7	35.5	83.3	22.9	41.2	67.4	174.3	55.5	56.4	29.8	139.0	55.8	67.1	40.2	21.6	89.9	106.0	77.1	97.3	81.1	47.7	30.2	66.3	59.8	212.0	104.5	178.9	104.3	170.5	43.5	48.0	48.1	59.4	35.4	100.1	6.0	0.4	1.0	1.0	0.2	0.3	0.3	0.3	0.8	0.2	0.1	0.3	0.2	0.9	0.1	2.5	0.9	0.0	0.3	41.2	15.8	27.2	45.6	61.3	12.6	56.4	29.2	53.0	5.4	26.4	27.0	30.6	115.4	58.9	46.4	14.7	33.3	24.6	22.2	33.0	95.3	33.3	28.3	30.4	18.6	38.8	18.4	39.6	8.8	27.4	39.1	3.9	22.1	2.2	28.0	53.4	28.2	18.7	11.6	61.9	27.2	39.7	50.6	37.8	32.4	42.3	43.5	18.5	19.0	28.4	121.1	37.0	20.3	4.1	50.0	48.7	7.1	62.1	44.8	16.0	51.5	27.0	28.0	20.6	70.9	65.9	38.0	22.2	65.1	22.6	23.7	25.4	8.0	16.8	65.9	6.6	63.0	35.5	1.8	11.6	17.7	24.4	12.6	25.1	69.4	21.9	23.1
NDC1	"FLJ10407, NET3, TMEM48"	ENSG00000058804	"NDC1 transmembrane nucleoporin"	Q9BTX1	1	53765478-53838463	"Metabolic proteins, Predicted membrane proteins, Transporters"	"mRNA transport, Protein transport, Translocation, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA069751, HPA070882"	Approved		Supported	"Nuclear membrane,Plasma membrane,Actin filaments"		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Nuclear membrane"	"Plasma membrane, Actin filaments"	"HPA069751: AB_2686189, HPA070882: AB_2686320"	"unprognostic (2.51e-1)"	"unprognostic (1.93e-1)"	"prognostic favorable (4.48e-5)"	"unprognostic (6.96e-3)"	"unprognostic (1.31e-1)"	"unprognostic (1.36e-3)"	"prognostic unfavorable (7.52e-7)"	"unprognostic (3.46e-3)"	"unprognostic (1.53e-2)"	"unprognostic (2.01e-1)"	"prognostic unfavorable (3.58e-4)"	"unprognostic (9.27e-2)"	"unprognostic (6.22e-3)"	"unprognostic (3.00e-3)"	"unprognostic (4.38e-2)"	"unprognostic (9.24e-2)"	"unprognostic (6.07e-2)"	5.4	5.2	3.4	9.5	3.5	8.4	11.1	3.6	4.1	5.7	3.6	11.9	8.9	6.5	7.4	7.7	7.5	4.6	4.5	3.6	3.4	6.9	7.8	4.7	15.7	3.2	3.3	5.9	4.7	9.5	1.7	8.0	3.3	4.8	14.2	6.0	4.2	5.2	4.3	7.3	8.2	7.1	3.5	5.6	6.4	7.5	3.5	14.2	6.8	5.2	18.4	7.1	4.2	3.9	61.6	31.2	42.8	43.7	15.5	15.5	49.3	40.9	31.0	63.8	51.1	47.5	40.4	119.0	26.2	18.6	51.2	72.0	73.2	43.3	89.8	29.8	50.9	58.5	42.9	40.5	14.3	95.3	31.9	9.4	17.0	62.9	37.5	18.6	39.1	44.2	67.7	16.9	35.6	22.2	47.2	38.2	101.0	52.2	49.9	52.0	68.4	66.0	29.8	41.7	25.4	32.2	36.5	71.5	35.9	45.3	55.3	50.2	22.7	32.9	32.6	45.5	74.9	17.9	48.8	84.7	27.3	71.6	42.2	0.0	2.3	1.5	3.0	5.0	4.7	3.6	2.8	2.7	2.6	2.8	5.3	4.1	0.1	3.1	3.3	2.3	3.4	2.4	3.4	3.5	3.6	4.1	3.6	3.4	3.2	3.3	3.3	3.5	3.5	3.9	4.4	6.4	6.3	12.4	8.7	10.1	6.4	9.0	12.0	4.5	10.1	6.3	8.1	4.3	5.4	5.5	2.1	11.5	5.9	7.9	0.0	8.5	2.3	5.0	5.6	6.1	0.0	19.4	13.8	9.1	20.2	6.3	8.6	4.6	7.6	21.5	5.3	7.1	11.8	3.3	11.0	10.3	16.2	8.2	8.9	2.1	2.8	7.1	7.2	13.1	4.7	3.3	3.1	11.6	19.4	7.0	5.8	3.4	20.1	8.9	2.9	4.5	5.5	2.9	6.6	6.3	15.7	11.8	14.3	18.2	8.5	6.8	6.7	4.3	18.2	6.5
NDC80	"HEC, HEC1, hsNDC80, KNTC2, TID3"	ENSG00000080986	"NDC80 kinetochore complex component"	O14777	18	2571557-2616635	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 31.2;lymphoid tissue: 29.2"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 63.4;Spermatocytes: 82.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"B-cells: 7.2;granulocytes: 8.3;T-cells: 11.3"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			HPA066330			Supported	Nucleoplasm,Centrosome		NA	Yes			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	Centrosome	"HPA066330: AB_2685661"	"unprognostic (1.96e-1)"	"unprognostic (5.38e-2)"	"unprognostic (2.96e-1)"	"unprognostic (2.21e-3)"	"unprognostic (1.87e-1)"	"unprognostic (3.63e-2)"	"prognostic unfavorable (2.53e-8)"	"unprognostic (1.16e-2)"	"unprognostic (2.58e-3)"	"unprognostic (2.86e-2)"	"unprognostic (3.19e-3)"	"unprognostic (7.74e-2)"	"unprognostic (0.00e+0)"	"unprognostic (9.69e-3)"	"unprognostic (1.69e-1)"	"unprognostic (3.50e-2)"	"unprognostic (1.71e-1)"	1.8	0.9	1.4	9.6	1.3	31.2	2.5	2.2	1.7	2.7	0.1	7.0	5.9	4.3	2.1	5.6	1.2	2.5	1.2	1.0	0.6	1.2	1.6	1.5	20.5	1.9	0.6	0.8	0.9	0.5	0.1	10.4	2.9	5.3	9.8	0.7	1.1	14.0	0.9	7.9	6.2	5.0	0.4	5.5	3.8	15.1	1.2	29.2	1.6	0.6	19.3	3.2	4.6	2.5	80.3	17.7	86.5	38.6	4.5	9.8	44.5	91.7	49.1	117.7	99.7	49.2	44.0	86.6	40.4	35.9	49.7	47.9	98.2	39.9	123.6	32.2	24.6	68.8	49.5	38.1	1.5	133.2	55.1	5.1	3.7	67.8	47.8	12.0	54.3	52.8	56.8	107.1	104.0	36.2	65.1	57.2	44.9	51.6	25.3	71.0	88.6	69.7	31.0	38.0	69.3	31.4	84.4	21.7	32.7	34.0	36.7	52.4	33.2	75.7	168.1	60.7	123.2	46.5	78.6	116.0	33.5	60.8	65.8	3.5	0.6	2.5	1.8	0.4	1.7	7.2	3.2	3.8	0.2	5.3	2.0	2.0	8.3	1.7	0.5	1.3	11.3	1.3	1.4	1.3	2.2	1.7	1.0	0.6	1.9	0.6	2.9	0.4	1.2	2.5	2.8	0.0	0.6	0.3	5.8	2.3	0.7	3.8	0.6	0.0	0.6	0.9	15.8	0.0	2.4	0.0	0.0	15.5	4.8	2.1	0.0	0.9	22.0	1.3	3.7	1.9	0.0	63.4	0.6	0.4	21.7	6.8	2.6	2.1	0.0	20.8	5.7	0.5	11.5	0.0	0.5	2.8	8.2	3.2	2.4	7.6	7.5	1.7	0.0	1.0	0.4	0.0	7.2	0.5	0.5	0.3	0.1	23.3	14.1	0.4	0.4	0.2	1.4	0.0	19.7	0.6	6.8	82.8	21.1	4.2	0.6	2.1	8.7	9.8	6.2	1.5
NDFIP2	"KIAA1165, N4wbp5a"	ENSG00000102471	"Nedd4 family interacting protein 2"	Q9NV92	13	79481124-79556075	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Basal keratinocytes: 342.7;Late spermatids: 290.4;Suprabasal keratinocytes: 367.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"basophil: 12.1;eosinophil: 22.7;naive CD4 T-cell: 5.6"	"Group enriched"	"Detected in many"	16	"granulocytes: 22.7;T-cells: 5.6"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA009160	Uncertain		Supported	Vesicles		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 28: Keratinocytes - Keratinization"	Vesicles		"HPA009160: AB_1079456"	"unprognostic (2.56e-1)"	"unprognostic (5.51e-3)"	"unprognostic (1.95e-3)"	"unprognostic (9.61e-2)"	"unprognostic (2.60e-1)"	"prognostic unfavorable (5.99e-4)"	"unprognostic (1.50e-1)"	"unprognostic (5.53e-2)"	"unprognostic (2.30e-1)"	"unprognostic (3.12e-1)"	"unprognostic (1.52e-2)"	"unprognostic (2.63e-2)"	"prognostic favorable (4.18e-5)"	"unprognostic (1.32e-1)"	"unprognostic (1.31e-1)"	"unprognostic (6.47e-2)"	"unprognostic (1.02e-1)"	13.9	19.2	17.0	11.4	20.9	2.6	22.7	10.0	25.2	15.5	7.0	42.7	52.7	10.1	22.5	54.4	17.1	20.1	26.0	27.1	8.1	45.9	46.3	17.7	13.0	10.1	7.3	7.0	31.8	29.6	6.4	31.9	12.3	22.7	47.0	21.7	21.4	15.6	30.9	71.3	64.3	9.1	10.6	11.7	25.9	18.1	9.2	16.0	19.3	19.9	19.6	35.6	25.2	21.5	134.6	22.6	23.2	29.4	27.7	50.3	43.6	48.5	66.9	50.1	83.0	49.9	146.1	5.6	32.6	64.0	28.5	178.2	20.5	84.9	75.3	69.7	57.1	6.2	66.5	27.1	50.5	106.2	17.8	40.4	109.3	33.4	52.7	55.8	24.1	10.4	27.5	10.0	56.8	19.3	8.7	24.1	17.1	109.7	22.7	0.5	45.7	25.2	123.1	76.7	23.3	33.4	54.9	52.4	40.0	37.8	43.8	88.2	20.4	16.0	20.4	31.1	32.8	37.6	44.2	21.1	65.6	0.5	65.6	12.1	0.0	22.7	3.2	0.0	2.7	0.2	2.8	2.6	0.0	0.6	5.6	3.1	0.1	0.8	0.0	0.2	3.2	2.4	17.0	20.9	10.0	25.2	27.1	8.1	10.1	7.3	12.3	10.6	9.2	21.5	17.5	41.7	28.9	26.4	4.4	342.7	137.0	180.6	118.4	30.9	32.7	18.8	29.4	57.2	93.2	47.8	6.2	112.6	6.9	161.0	23.5	85.6	271.2	51.5	17.2	22.0	69.4	4.2	189.0	72.2	152.7	33.2	31.1	49.8	88.2	11.5	20.7	69.2	14.4	16.8	44.2	88.1	95.6	17.0	23.5	290.4	17.4	4.0	33.8	27.2	2.7	22.8	5.2	42.3	100.3	101.7	96.7	12.8	13.8	105.6	204.3	104.6	112.6	15.5	13.1	22.2	24.0	56.5	45.1	102.2	367.7	109.7	24.9	35.2	73.3	145.5
NDNF	"C4orf31, FLJ23191"	ENSG00000173376	"Neuron derived neurotrophic factor"	Q8TB73	4	121035613-121073021	"Disease related genes, Predicted secreted proteins"	Neurogenesis		"Disease variant, Hypogonadotropic hypogonadism, Kallmann syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 106.5;placenta: 60.1;retina: 57.4"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 246.8;Bipolar cells: 69.8;Early spermatids: 217.1;Late spermatids: 221.7"	"Cancer enriched"	"Detected in many"	4	"lung cancer: 12.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"fHDF/TERT166: 48.5;U-266/70: 20.8;U-266/84: 85.8"	"Group enriched"	"Detected in all"	4	"basal ganglia: 11.1;olfactory bulb: 34.0"	"Low region specificity"	"Detected in all"			HPA048881			Supported	Vesicles	"Secreted in other tissues"	NA	NA				"Cluster 19: Lung - Lung function"	"Cluster 16: U-266 - Nucleosome"	"Cluster 31: Spermatids - Spermatogenesis"	Vesicles		"HPA048881: "	"unprognostic (2.84e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.04e-1)"	"unprognostic (3.94e-1)"	"unprognostic (6.26e-2)"	"unprognostic (2.22e-1)"	"unprognostic (2.93e-2)"	"unprognostic (6.65e-4)"	"unprognostic (2.18e-3)"	"unprognostic (6.27e-2)"	"unprognostic (3.44e-2)"	"prognostic unfavorable (3.26e-4)"	"unprognostic (2.38e-3)"	"unprognostic (1.20e-1)"	"unprognostic (1.18e-4)"	"unprognostic (1.74e-1)"	4.8	2.6	1.1	0.9	1.7	0.0	3.2	4.7	1.2	14.2	9.3	6.5	2.9	6.0	4.3	7.7	20.4	9.4	5.2	1.8	2.6	27.1	0.4	106.5	0.3	8.8	12.9	42.5	0.5	0.7	5.3	60.1	15.2	16.7	8.3	57.4	2.2	4.4	4.3	1.7	4.7	3.5	7.6	0.3	4.1	10.4	3.7	2.4	1.3	14.0	0.2	9.0	1.9	5.4	0.2	0.0	10.6	0.0	13.9	11.3	0.2	0.2	0.5	0.2	0.5	1.6	0.0	0.0	0.0	48.5	0.8	0.0	0.0	0.0	1.1	0.9	1.7	0.0	0.0	0.0	0.0	0.1	0.0	2.7	0.0	0.0	0.2	0.6	0.0	0.0	0.0	14.3	1.0	0.0	0.2	0.1	0.9	7.4	2.1	0.0	0.0	0.1	0.0	0.0	0.0	3.5	0.0	0.0	0.0	2.6	0.2	0.0	0.0	11.5	0.0	0.2	0.5	20.8	85.8	0.0	3.9	0.0	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	1.7	4.7	1.2	1.8	2.6	8.8	12.9	15.2	7.6	3.7	5.4	10.9	246.8	48.3	1.6	0.0	1.1	0.0	0.0	0.0	69.8	0.2	0.1	1.6	8.6	28.6	12.9	18.8	0.3	0.0	5.3	0.0	0.0	217.1	0.9	4.7	11.7	1.8	0.0	0.0	0.2	0.0	14.9	0.0	0.1	2.5	0.1	2.9	0.0	0.1	1.7	8.0	0.8	0.0	0.0	0.8	221.7	3.4	0.4	5.4	6.5	0.0	12.2	0.0	0.0	0.0	0.1	0.5	0.7	0.0	0.0	0.0	0.0	12.5	20.0	0.0	1.2	3.6	6.4	5.0	0.3	0.9	0.5	0.3	13.0	1.2	0.1
NDP	"EVR2, norrin"	ENSG00000124479	"Norrin cystine knot growth factor NDP"	Q00604	X	43948776-43973395	"Disease related genes, Human disease related genes, Predicted secreted proteins"	"Sensory transduction, Vision, Wnt signaling pathway"		"Deafness, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 35.8;ovary: 46.2"	"Group enriched"	"Detected in some"	4	"Granulosa cells: 181.3;Muller glia cells: 105.5"	"Cancer enriched"	"Detected in many"	5	"glioma: 25.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	16	"U-87 MG: 72.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003095			Supported	Nucleoplasm,Nucleoli,Vesicles	"Secreted to extracellular matrix"	NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 68: Epididymis - Unknown function"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 40: Granulosa cells - Unknown function"	Vesicles	"Nucleoplasm, Nucleoli"	"HPA003095: AB_1079457"	"unprognostic (1.12e-1)"	"unprognostic (7.12e-2)"	"unprognostic (2.27e-2)"	"unprognostic (2.55e-3)"	"unprognostic (6.84e-3)"	"unprognostic (1.51e-1)"		"unprognostic (9.09e-2)"	"unprognostic (2.29e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.86e-1)"	"unprognostic (1.40e-1)"	"unprognostic (3.02e-2)"	"unprognostic (2.22e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.87e-3)"	0.5	0.0	31.5	0.0	33.4	0.0	3.3	30.9	35.8	20.9	22.4	0.2	0.1	15.4	22.0	0.0	20.8	0.4	0.3	31.5	29.6	0.1	0.0	0.0	0.2	30.1	33.2	46.2	0.0	0.2	0.1	4.0	31.6	7.1	0.2	19.2	0.1	13.1	0.0	0.6	0.2	11.4	32.4	0.1	0.3	1.0	34.2	0.0	0.2	0.0	0.2	0.5	2.3	32.4	0.0	0.0	0.2	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.1	0.0	0.0	1.5	0.0	0.0	0.1	1.9	0.0	0.0	0.0	1.8	0.0	4.3	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.2	0.0	0.0	2.2	0.0	0.0	0.0	72.9	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	31.5	33.4	30.9	35.8	31.5	29.6	30.1	33.2	31.6	32.4	34.2	32.4	0.0	0.0	0.0	29.0	0.0	0.1	0.0	1.2	0.0	0.6	1.3	0.1	0.3	0.0	0.5	0.0	0.0	0.1	0.1	0.0	0.0	2.0	0.0	9.1	17.7	0.2	0.0	0.0	4.2	0.0	0.3	0.9	0.0	17.0	0.0	181.3	0.0	0.0	0.1	0.0	0.8	0.0	2.0	0.0	0.0	0.7	13.4	0.6	0.0	0.0	0.0	105.5	0.0	1.5	9.5	1.2	0.0	9.8	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	5.4	0.1	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.2
NDRG1	"CAP43, DRG1, NDR1, RTP, TDD5"	ENSG00000104419	"N-myc downstream regulated 1"	Q92597	8	133237175-133302022	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"			"Cancer-related genes, Charcot-Marie-Tooth disease, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 613.9"	"Cell type enhanced"	"Detected in all"		"Basal keratinocytes: 571.9;Distal enterocytes: 405.4;Horizontal cells: 588.9;Suprabasal keratinocytes: 667.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"hTCEpi: 606.9;hTERT-HME1: 1226.9;U-87 MG: 772.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006881	Approved		Supported	Microtubules,Cytosol		NA	NA		200000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 28: Keratinocytes - Keratinization"	Cytosol	Microtubules	"HPA006881: AB_1078392"	"unprognostic (6.96e-3)"	"unprognostic (3.31e-3)"	"unprognostic (8.53e-2)"	"unprognostic (1.41e-3)"	"unprognostic (1.54e-3)"	"unprognostic (2.60e-2)"	"prognostic unfavorable (1.47e-4)"	"unprognostic (3.04e-3)"	"unprognostic (5.33e-2)"	"unprognostic (4.29e-2)"	"unprognostic (9.09e-2)"	"unprognostic (2.46e-1)"	"prognostic unfavorable (4.13e-4)"	"unprognostic (7.27e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.47e-3)"	"unprognostic (4.28e-2)"	161.2	72.9	299.1	55.9	523.6	130.0	107.6	413.5	300.2	169.4	132.8	130.0	242.2	92.9	34.3	343.1	106.4	87.8	99.8	254.5	316.6	192.4	49.6	116.6	38.7	523.2	500.0	126.1	52.8	69.1	82.2	110.8	476.8	354.3	77.8	86.0	130.8	60.0	28.2	262.6	258.1	61.9	333.7	39.4	154.0	28.1	423.1	55.1	80.5	44.6	88.1	105.5	273.8	613.9	191.6	24.0	1.7	0.8	116.3	86.8	26.0	13.7	103.0	9.8	52.5	12.5	27.6	1.5	133.0	58.0	21.9	62.4	1.7	316.8	18.0	13.3	226.8	1.9	55.6	14.7	46.3	7.0	4.6	79.2	606.9	51.2	1226.9	124.2	45.2	27.9	2.0	138.3	17.2	11.0	19.1	20.8	3.0	69.8	155.8	1.7	19.4	86.2	29.7	28.0	13.8	13.0	31.0	312.1	73.3	48.6	1.3	20.0	58.5	84.4	43.6	40.7	10.4	96.3	280.3	0.8	772.5	69.5	161.5	10.9	4.3	0.0	5.8	3.4	9.1	1.6	5.3	6.9	6.0	1.4	3.9	3.1	4.0	1.5	4.2	13.0	8.1	3.7	299.1	523.6	413.5	300.2	254.5	316.6	523.2	500.0	476.8	333.7	423.1	613.9	123.0	144.2	47.4	14.4	23.6	571.9	141.3	207.3	42.1	68.8	28.6	31.2	20.6	80.1	102.9	187.6	2.1	12.8	68.1	405.4	33.2	33.2	5.3	57.4	59.0	217.7	22.1	17.4	7.7	13.7	138.2	90.5	151.4	167.7	22.2	41.0	112.8	64.0	16.5	588.9	5.7	140.9	83.4	31.1	109.5	5.9	49.0	42.7	101.4	28.1	25.7	81.2	14.4	20.6	136.2	62.9	155.9	44.0	23.5	264.3	402.5	87.5	38.7	40.3	46.0	65.2	44.3	1.2	7.1	113.0	667.4	43.4	45.7	32.6	124.7	280.8
NDRG2	"KIAA1248, SYLD"	ENSG00000165795	"NDRG family member 2"	Q9UN36	14	21016763-21070872	"Predicted intracellular proteins, Predicted membrane proteins"	"Differentiation, Neurogenesis, Wnt signaling pathway"	"Developmental protein"	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 1885.3;salivary gland: 2081.6;skeletal muscle: 1828.7"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 379.0;Distal tubular cells: 485.2;Muller glia cells: 548.0;Sertoli cells: 598.2"	"Cancer enhanced"	"Detected in all"		"glioma: 78.5"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	11	"myeloid DC: 204.4"	"Lineage enriched"	"Detected in all"	11	"dendritic cells: 204.4"	"Cell line enhanced"	"Detected in many"		"Hep G2: 57.0;HMC-1: 39.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002896, HPA003590, CAB017491"	Enhanced		Approved	"Nucleoplasm,Centriolar satellite,Cytosol"		NA	NA		460000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 5: Muller glia cells - Visual perception"	"Centriolar satellite"	"Nucleoplasm, Cytosol"	"CAB017491: AB_2298331, HPA002896: AB_1079459, HPA003590: AB_1079458"	"unprognostic (9.27e-3)"	"unprognostic (2.97e-3)"	"unprognostic (1.26e-2)"	"unprognostic (5.09e-3)"	"unprognostic (2.00e-2)"	"unprognostic (2.92e-2)"	"prognostic favorable (6.71e-4)"	"unprognostic (1.85e-3)"	"unprognostic (5.57e-2)"	"unprognostic (3.46e-2)"	"unprognostic (1.69e-1)"	"unprognostic (5.10e-2)"	"prognostic favorable (1.43e-12)"	"unprognostic (1.46e-1)"	"unprognostic (5.56e-2)"	"unprognostic (6.11e-2)"	"unprognostic (4.19e-2)"	192.0	400.6	1613.1	27.4	1885.3	2.8	321.6	1623.2	1666.4	395.4	1189.8	198.3	72.1	229.7	260.3	229.5	305.0	130.7	327.2	1551.7	1590.0	150.1	544.4	115.5	48.6	1690.6	1686.1	476.1	93.7	278.5	88.5	45.3	1581.9	171.3	111.0	134.1	2081.6	208.0	1828.7	220.3	125.4	127.7	1584.5	152.0	130.9	33.3	1752.7	40.1	99.9	1591.4	100.4	158.0	265.8	1597.9	10.9	2.3	6.8	12.6	1.1	0.0	1.0	0.2	4.5	3.9	2.2	15.1	20.0	0.6	4.0	0.3	6.2	17.6	30.3	6.3	5.4	0.1	10.9	14.3	2.2	57.0	1.3	1.3	39.0	11.8	13.1	0.9	1.9	6.3	0.0	12.6	29.0	1.2	0.6	9.4	5.0	4.0	17.9	35.2	0.8	14.6	0.7	3.7	7.6	27.4	0.1	19.4	3.0	3.3	14.4	17.3	26.6	8.2	0.0	1.2	20.8	0.4	0.4	6.1	4.8	0.3	1.8	0.3	4.7	0.0	6.5	0.7	8.3	1.5	11.4	6.4	12.6	11.9	204.4	4.4	18.7	14.0	1.4	3.0	0.1	7.0	9.4	15.3	1613.1	1885.3	1623.2	1666.4	1551.7	1590.0	1690.6	1686.1	1581.9	1584.5	1752.7	1597.9	98.0	0.0	11.9	379.0	6.7	28.7	83.7	86.4	12.0	6.3	240.7	201.2	180.2	151.5	110.9	40.5	10.4	11.5	9.1	81.4	485.2	104.9	6.3	33.3	11.0	53.9	33.5	8.4	1.1	21.7	0.7	62.3	18.8	40.2	48.8	79.0	164.2	214.9	20.7	3.3	3.9	77.4	57.0	30.8	137.6	14.4	348.6	30.4	321.9	47.8	8.7	548.0	1.0	42.7	71.0	16.3	37.9	166.3	1.2	68.5	18.5	41.3	70.8	15.5	598.2	167.7	162.8	1.7	5.5	21.6	30.4	21.6	11.9	66.8	118.9	155.9
NDUFA10	CI-42k	ENSG00000130414	"NADH:ubiquinone oxidoreductase subunit A10"	O95299	2	239892450-240025743	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"	"Electron transport, Respiratory chain, Transport"		"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"tongue: 332.0"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA059529, HPA067045, CAB070846"	Approved		Supported	Mitochondria	"Intracellular and membrane"	NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"CAB070846: AB_11152346, HPA059529: AB_2684051, HPA067045: AB_2732756"	"unprognostic (2.12e-2)"	"unprognostic (8.94e-3)"	"unprognostic (8.73e-2)"	"unprognostic (2.02e-2)"	"unprognostic (8.96e-2)"	"unprognostic (2.53e-1)"	"unprognostic (8.78e-2)"	"unprognostic (1.09e-1)"	"prognostic unfavorable (2.95e-4)"	"unprognostic (5.71e-2)"	"unprognostic (2.47e-2)"	"unprognostic (1.05e-1)"	"prognostic favorable (2.09e-7)"	"unprognostic (1.16e-1)"	"unprognostic (4.96e-2)"	"unprognostic (1.98e-1)"	"unprognostic (2.95e-1)"	55.4	91.1	36.3	29.6	40.2	50.3	50.3	39.8	51.2	41.0	38.9	83.2	81.6	37.8	28.3	74.6	43.6	31.2	184.8	41.7	36.0	94.2	103.6	35.4	32.3	41.9	39.4	45.4	58.5	99.3	38.5	37.9	41.3	33.1	84.3	31.2	55.9	33.1	206.4	72.4	64.3	39.8	34.0	37.7	71.7	35.3	37.7	45.3	38.8	332.0	49.7	47.3	49.2	39.4	74.4	65.5	46.3	81.5	54.8	95.4	75.5	49.0	70.9	71.3	77.8	72.8	82.8	51.0	31.8	64.2	60.8	96.2	109.8	103.1	92.6	59.7	90.9	72.9	65.6	174.6	72.4	96.9	58.6	95.5	80.3	68.5	85.0	66.6	96.6	74.6	102.0	34.8	81.8	124.8	95.6	110.5	56.3	114.4	81.0	93.2	114.4	81.2	108.7	152.1	70.5	54.6	55.3	131.8	108.9	33.3	121.2	97.4	69.9	52.7	60.7	70.7	75.8	77.3	24.6	79.2	60.3	80.9	72.8	30.2	106.3	47.1	72.9	115.8	93.8	95.4	70.7	77.5	147.9	77.0	68.2	69.4	26.7	97.6	103.3	49.7	92.7	104.6	36.3	40.2	39.8	51.2	41.7	36.0	41.9	39.4	41.3	34.0	37.7	39.4	66.8	76.9	74.1	31.6	63.5	104.9	96.5	193.5	60.3	80.8	88.4	89.5	354.8	87.2	114.0	77.3	62.6	216.4	58.1	137.3	311.0	112.5	47.5	66.8	83.2	67.4	92.9	57.6	83.1	78.5	124.0	71.7	62.2	76.6	65.9	103.7	66.4	139.1	125.2	50.5	68.5	152.3	103.7	90.5	82.0	85.3	50.1	65.2	112.1	27.2	107.8	72.2	53.5	37.7	71.4	77.7	125.5	49.2	56.7	62.1	182.7	303.0	77.7	110.4	65.7	74.6	77.3	84.2	73.4	107.2	118.9	218.1	63.0	185.3	234.2	110.0
NDUFA12	"B17.2, DAP13"	ENSG00000184752	"NADH:ubiquinone oxidoreductase subunit A12"	Q9UI09	12	94897055-95003748	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"	"Electron transport, Respiratory chain, Transport"		"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 558.6;tongue: 563.1"	"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 2159.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039903	Supported		Supported	Mitochondria,Cytosol		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 54: Cardiomyocytes - Muscle contraction"	Mitochondria	Cytosol	"HPA039903: AB_10795516"	"unprognostic (2.76e-1)"	"unprognostic (5.32e-3)"	"unprognostic (1.17e-1)"	"unprognostic (2.56e-2)"	"unprognostic (2.85e-1)"	"unprognostic (4.03e-2)"	"unprognostic (3.05e-2)"	"unprognostic (6.68e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.47e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.64e-1)"	"unprognostic (3.13e-3)"	"unprognostic (2.32e-1)"	"unprognostic (1.65e-1)"	"unprognostic (6.13e-2)"	"unprognostic (3.27e-2)"	100.2	94.1	158.6	73.9	162.8	93.2	77.1	168.9	228.1	67.8	159.8	148.6	109.3	66.8	87.1	89.8	77.8	52.9	361.8	161.3	172.6	133.8	143.7	70.3	92.5	166.4	162.1	64.7	59.6	159.5	73.5	79.5	164.1	74.7	143.9	106.8	75.3	77.8	558.6	74.2	101.5	98.4	162.6	97.6	87.7	58.9	165.1	108.9	89.6	563.1	122.0	81.0	73.0	161.1	255.3	281.1	223.6	160.8	183.3	171.8	165.8	118.8	178.5	258.5	234.6	347.6	125.8	293.7	68.8	187.6	141.1	188.2	236.1	278.4	296.7	254.8	282.9	241.2	218.6	358.8	186.3	344.0	285.3	183.0	352.4	215.7	266.9	270.4	222.2	246.0	235.2	130.4	260.8	381.1	238.6	533.6	167.0	313.7	484.0	179.9	189.4	335.2	262.5	393.9	213.2	128.5	201.3	287.3	164.6	193.9	287.2	226.9	243.5	134.1	134.0	195.0	204.2	207.5	349.9	443.7	80.6	293.6	211.2	643.9	420.5	228.2	354.8	512.5	336.4	482.8	479.5	429.9	576.2	415.5	631.9	455.9	62.0	464.6	506.6	355.5	570.8	814.8	158.6	162.8	168.9	228.1	161.3	172.6	166.4	162.1	164.1	162.6	165.1	161.1	213.5	73.7	68.4	26.8	81.3	108.6	163.9	364.5	71.2	67.4	87.9	171.7	2159.0	135.8	168.3	108.5	64.6	254.0	127.9	172.0	620.3	162.0	240.0	110.3	98.9	206.0	85.3	86.5	19.6	163.9	254.5	172.6	67.2	100.7	58.3	103.5	109.2	149.1	192.3	37.0	29.0	171.8	244.1	103.6	161.9	122.1	97.6	111.1	160.1	13.1	203.5	141.6	199.8	20.6	22.3	234.6	228.8	133.5	98.8	123.8	229.9	338.3	134.7	130.5	105.2	120.8	291.2	156.3	109.8	127.9	127.7	209.6	120.2	181.9	219.2	182.0
NDUFA13	"B16.6, CDA016, CGI-39, GRIM-19, GRIM19"	ENSG00000186010	"NADH:ubiquinone oxidoreductase subunit A13"	Q9P0J0	19	19515736-19529054	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted membrane proteins"	"Apoptosis, Electron transport, Host-virus interaction, Respiratory chain, Transport"		"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 2947.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041213	Supported		Supported	Mitochondria		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 25: Spermatids - Spermatogenesis"	Mitochondria		"HPA041213: AB_10794988"	"unprognostic (2.87e-1)"	"unprognostic (2.88e-3)"	"unprognostic (9.98e-2)"	"unprognostic (1.11e-1)"	"unprognostic (3.36e-2)"	"unprognostic (5.78e-2)"	"unprognostic (6.00e-2)"	"unprognostic (3.30e-2)"	"unprognostic (2.81e-1)"	"unprognostic (1.83e-3)"	"unprognostic (1.26e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.45e-2)"	"unprognostic (1.33e-1)"	"unprognostic (2.37e-1)"	"unprognostic (2.15e-2)"	"unprognostic (2.15e-2)"	268.1	248.1	586.0	184.1	601.2	318.9	226.6	612.2	726.3	188.2	632.2	324.0	268.5	129.8	414.0	288.3	253.0	165.0	987.1	577.4	609.2	274.5	301.3	154.8	234.9	600.9	585.1	168.3	274.3	541.3	154.7	186.6	588.3	216.1	212.4	100.7	272.8	220.4	1093.2	183.1	245.1	193.5	593.6	160.6	251.2	208.5	624.2	254.5	221.2	1102.9	178.5	250.9	103.5	607.7	371.4	405.5	443.7	531.6	460.2	416.2	606.4	345.8	488.3	500.0	492.2	639.4	584.9	442.6	952.2	495.2	261.4	307.2	313.0	477.6	177.3	276.5	1052.6	308.9	590.9	834.1	448.0	601.1	517.0	546.5	483.7	322.7	335.5	296.3	382.8	533.1	428.6	728.2	400.3	1115.4	811.2	880.9	528.4	846.6	1004.4	536.0	263.0	830.2	711.1	782.6	508.9	633.2	350.0	551.7	481.1	225.2	367.7	1035.9	307.3	538.4	177.5	583.8	541.0	543.6	430.6	510.3	428.4	624.2	390.8	1210.3	1162.6	963.4	758.6	1263.4	678.0	1284.6	874.1	838.9	1165.9	1097.3	831.6	775.7	411.9	779.9	1054.3	979.4	1246.2	2090.8	586.0	601.2	612.2	726.3	577.4	609.2	600.9	585.1	588.3	593.6	624.2	607.7	155.1	131.4	184.8	33.0	194.5	129.0	75.9	346.9	117.8	64.8	211.3	181.2	514.5	224.4	251.2	250.1	25.0	426.6	136.6	951.6	610.5	566.0	411.8	154.5	111.5	131.4	556.3	185.3	22.7	578.5	357.2	173.1	225.3	130.5	259.3	51.3	182.4	422.6	333.6	42.1	27.2	719.7	268.5	307.4	197.9	2947.1	153.4	198.3	263.3	19.7	456.7	186.3	183.4	17.6	41.2	490.5	931.9	129.1	272.0	75.0	1114.7	772.0	236.5	84.2	92.1	91.6	196.2	80.6	111.5	210.0	127.0	498.4	177.5	48.0	683.0	87.4
NDUFA4	"CI-9k, COXFA4, MLRQ"	ENSG00000189043	"NDUFA4 mitochondrial complex associated"	O00483	7	10931943-10940153	"Disease related genes, Metabolic proteins, Predicted membrane proteins"	"Electron transport, Respiratory chain, Transport"		"Leigh syndrome, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 513.5;skeletal muscle: 525.0;tongue: 652.5"	"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 4615.5;Distal tubular cells: 3960.0;Proximal tubular cells: 3331.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055323, HPA078265"	Approved		Supported	Mitochondria		NA	NA		50000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"HPA055323: , HPA078265: "	"unprognostic (1.83e-1)"	"unprognostic (6.64e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.16e-1)"	"unprognostic (4.97e-3)"	"unprognostic (3.85e-1)"	"unprognostic (2.25e-1)"	"unprognostic (1.69e-1)"	"unprognostic (3.90e-2)"	"unprognostic (8.65e-3)"	"unprognostic (1.74e-1)"	"prognostic favorable (4.61e-8)"	"unprognostic (1.24e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.44e-3)"	"unprognostic (2.08e-1)"	78.6	90.1	188.7	40.8	196.2	67.5	76.0	192.9	263.4	54.7	192.8	84.1	74.2	74.2	81.1	66.9	69.5	36.2	513.5	201.9	205.0	156.6	140.3	62.8	42.5	194.4	189.6	60.1	61.3	251.9	23.3	31.6	197.6	66.0	56.6	128.4	108.6	84.4	525.0	58.3	58.8	60.9	194.1	59.6	107.0	24.3	194.3	64.0	66.3	652.5	46.1	73.7	54.1	200.1	55.3	90.9	155.0	176.8	84.0	78.4	70.3	68.2	63.2	61.3	53.6	115.2	144.7	104.6	63.0	96.7	168.0	94.1	102.1	79.4	66.5	52.2	74.0	88.2	93.4	108.6	73.2	123.3	84.3	84.8	78.4	75.4	66.0	116.7	86.6	92.7	133.2	139.0	129.8	103.8	56.2	109.3	169.2	364.2	181.6	74.7	108.6	118.6	158.0	115.4	95.2	99.7	106.9	303.7	64.7	210.3	191.6	149.6	76.8	73.3	102.0	107.0	115.0	84.6	115.8	120.5	101.3	130.8	232.5	236.7	110.2	160.6	74.3	135.8	88.3	95.7	103.3	93.9	138.9	74.6	106.1	93.3	25.3	79.4	146.4	131.2	131.6	192.8	188.7	196.2	192.9	263.4	201.9	205.0	194.4	189.6	197.6	194.1	194.3	200.1	422.2	490.4	470.7	52.9	366.9	407.1	605.8	1642.7	307.9	521.0	742.3	936.0	4615.5	843.6	879.3	952.7	266.9	875.9	357.5	543.8	3960.0	865.1	160.6	626.2	471.6	447.0	209.7	358.3	54.1	955.5	763.9	557.9	404.7	477.7	576.4	507.5	656.1	1887.5	964.5	158.2	72.7	780.8	1373.2	589.0	589.8	106.8	493.6	517.6	916.0	49.6	596.6	721.5	374.9	36.7	57.9	776.6	626.7	784.3	467.9	696.6	596.2	3331.1	803.0	666.0	335.2	546.5	846.5	172.7	295.5	581.7	482.9	658.8	389.1	443.5	712.4	803.2
NDUFA7	B14.5a	ENSG00000267855	"NADH:ubiquinone oxidoreductase subunit A7"	O95182	19	8308768-8321375	"Predicted intracellular proteins"	"Electron transport, Respiratory chain, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 245.6"	"Cell type enhanced"	"Detected in many"		"Pancreatic endocrine cells: 167.5;Proximal enterocytes: 183.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA059251, HPA071866"	Enhanced		Supported	Mitochondria		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 59: Non-specific - Transcription"	Mitochondria		"HPA059251: AB_2683960, HPA071866: AB_2686465"	"unprognostic (6.55e-2)"	"unprognostic (1.02e-3)"	"unprognostic (1.11e-1)"	"unprognostic (3.85e-1)"	"unprognostic (2.18e-1)"	"unprognostic (5.65e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.43e-2)"	"unprognostic (3.40e-1)"	"unprognostic (1.13e-3)"	"unprognostic (1.81e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.09e-2)"	"unprognostic (5.53e-2)"	"unprognostic (1.29e-2)"	"unprognostic (2.59e-2)"	"unprognostic (9.35e-3)"	39.4	87.5	86.2	19.8	90.0	34.2	33.1	89.8	96.1	21.3	95.9	46.6	24.2	27.7	53.5	57.6	42.3	25.1	168.1	87.6	90.0	88.3	83.4	31.0	29.6	87.1	88.1	25.1	37.1	103.7	86.4	23.4	87.3	41.2	33.5	32.3	43.5	20.7	245.6	30.7	34.0	22.8	87.3	42.0	54.7	18.7	89.1	40.8	41.3	244.7	32.2	35.5	28.2	87.7	78.9	62.8	64.7	43.3	42.6	32.3	44.2	16.5	18.0	56.0	44.1	57.7	59.7	36.1	25.1	42.6	35.0	65.1	29.0	97.4	33.8	88.3	173.6	26.6	90.1	157.7	63.9	45.8	45.1	43.3	61.7	25.2	39.1	57.1	72.3	141.2	57.0	217.7	80.6	89.4	93.5	236.1	65.1	119.9	187.7	52.2	13.7	99.0	117.6	40.8	65.9	50.5	19.0	90.6	58.5	40.1	33.0	74.8	26.4	42.5	34.0	61.6	60.1	79.2	58.0	49.9	67.8	80.2	77.3	61.9	104.5	80.2	62.1	124.6	65.4	83.3	66.7	58.2	130.5	81.6	66.0	61.6	30.5	81.8	117.6	186.1	95.3	82.6	86.2	90.0	89.8	96.1	87.6	90.0	87.1	88.1	87.3	87.3	89.1	87.7	19.5	44.8	68.4	10.1	28.4	0.0	10.3	0.0	21.1	14.9	51.6	38.1	0.0	44.3	20.4	53.3	6.2	62.0	32.6	57.6	99.7	147.3	38.9	36.1	10.5	19.8	87.4	44.2	9.5	157.2	45.4	15.0	28.1	19.4	21.5	8.4	27.5	64.0	52.8	8.4	13.3	101.6	0.0	42.7	0.0	17.7	13.4	30.4	0.0	10.3	122.5	27.9	45.3	9.5	13.2	167.5	110.2	13.2	61.6	14.7	183.8	97.6	70.7	17.1	6.6	7.3	19.6	24.8	27.5	53.3	0.0	46.9	20.9	11.7	107.6	12.1
NDUFA8	"MGC793, PGIV"	ENSG00000119421	"NADH:ubiquinone oxidoreductase subunit A8"	P51970	9	122144058-122159779	"Metabolic proteins, Predicted intracellular proteins"	"Electron transport, Respiratory chain, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 380.1;tongue: 363.3"	"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 579.5;Distal tubular cells: 614.3;Early spermatids: 499.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041510, HPA041600"	Enhanced		Supported	Mitochondria		NA	NA		25000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 21: OE19 - Mitochondria"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"HPA041510: AB_10794379, HPA041600: AB_10796778"	"unprognostic (2.90e-1)"	"unprognostic (2.27e-3)"	"unprognostic (3.58e-1)"	"unprognostic (3.42e-2)"	"unprognostic (2.32e-1)"	"unprognostic (2.20e-2)"	"unprognostic (1.07e-2)"	"unprognostic (1.98e-2)"	"unprognostic (2.33e-2)"	"unprognostic (6.98e-2)"	"unprognostic (1.46e-2)"	"unprognostic (4.12e-2)"	"prognostic favorable (4.17e-6)"	"unprognostic (1.80e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.04e-1)"	"unprognostic (4.62e-2)"	54.2	74.2	139.4	33.9	146.0	28.6	53.9	146.0	159.3	44.8	142.6	101.4	65.8	46.6	86.8	57.1	62.3	39.3	380.1	144.7	148.4	97.9	81.5	37.0	43.0	141.4	139.7	35.7	46.1	137.4	56.9	48.2	141.6	57.9	88.2	72.0	72.3	61.9	259.1	44.2	53.6	73.9	138.7	41.4	75.3	95.5	145.8	48.6	53.3	363.3	56.2	57.8	40.9	141.7	84.8	154.1	99.5	132.0	105.7	96.4	123.3	96.0	114.1	130.0	108.5	197.0	81.9	123.1	92.6	113.6	234.6	206.8	191.3	208.7	127.0	121.5	132.6	96.9	254.2	172.6	113.3	172.7	95.5	106.1	200.3	130.0	82.9	118.1	189.1	134.8	151.0	89.6	150.3	215.6	108.1	112.1	91.2	377.1	293.1	85.0	156.7	179.4	189.4	116.0	172.1	67.6	151.0	176.7	122.6	100.9	187.6	82.1	123.2	71.2	70.9	135.2	109.3	100.1	176.1	123.8	148.0	110.7	120.2	17.4	82.1	66.8	78.3	100.9	76.2	88.0	71.3	77.3	109.2	92.8	76.0	80.3	13.7	79.0	88.7	114.2	91.9	74.7	139.4	146.0	146.0	159.3	144.7	148.4	141.4	139.7	141.6	138.7	145.8	141.7	70.6	28.9	40.4	16.3	38.6	48.3	73.8	298.1	43.9	47.2	61.0	73.5	579.5	48.6	128.0	82.8	29.2	130.5	34.1	87.3	614.3	103.8	499.0	80.1	52.4	98.5	77.4	100.6	19.4	101.6	113.1	70.3	47.9	52.9	20.3	68.5	60.7	110.9	124.4	45.4	26.0	105.7	185.1	40.5	42.0	121.1	56.5	48.8	94.3	18.7	72.9	91.3	65.9	14.1	17.9	100.8	80.3	75.2	56.9	91.1	163.4	249.8	113.0	59.0	26.3	52.5	114.8	294.9	116.2	67.0	56.8	126.6	36.6	104.4	136.3	86.4
NDUFAB1	"ACP, ACP1, FASN2A, SDAP"	ENSG00000004779	"NADH:ubiquinone oxidoreductase subunit AB1"	O14561	16	23581014-23596316	"Metabolic proteins, Predicted intracellular proteins"	"Electron transport, Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Respiratory chain, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 588.8"	"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 1366.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054364, HPA076020"	Approved		Supported	Nucleoplasm,Mitochondria		No	No		100000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 38: Heart - Muscle contraction"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria	Nucleoplasm	"HPA054364: AB_2682463, HPA076020: "	"unprognostic (3.33e-3)"	"unprognostic (9.38e-2)"	"unprognostic (1.14e-2)"	"unprognostic (9.10e-2)"	"unprognostic (2.33e-1)"	"unprognostic (5.71e-2)"	"unprognostic (1.22e-1)"	"unprognostic (5.97e-2)"	"unprognostic (1.97e-1)"	"unprognostic (7.57e-2)"	"unprognostic (3.89e-1)"	"unprognostic (5.60e-2)"	"prognostic favorable (1.94e-7)"	"unprognostic (1.77e-1)"	"unprognostic (1.07e-1)"	"unprognostic (4.83e-2)"	"unprognostic (3.16e-1)"	89.7	127.1	104.3	49.6	106.8	60.4	81.0	114.8	157.6	64.0	117.4	123.0	102.9	68.8	50.1	98.8	66.5	32.0	588.8	107.1	113.5	132.9	165.8	61.9	52.2	110.4	105.6	54.3	84.5	110.4	94.2	47.5	112.0	63.5	89.0	91.9	75.7	58.6	425.0	71.9	90.1	51.1	107.5	72.1	109.6	61.7	108.2	60.2	66.0	432.0	59.2	79.8	70.7	106.9	172.8	125.6	151.8	136.8	107.5	116.0	212.9	129.4	96.8	129.2	105.7	110.1	135.8	284.0	206.6	94.7	158.2	138.6	271.2	155.4	102.6	161.8	312.6	151.8	203.0	507.0	112.2	284.8	121.0	108.0	212.6	95.2	102.2	120.0	167.0	249.5	326.6	139.6	142.7	262.1	221.6	431.9	394.7	254.5	288.5	299.5	171.0	389.3	120.2	140.6	209.8	163.1	144.6	260.8	258.2	167.2	211.2	235.0	131.1	116.5	122.4	113.4	180.5	175.2	283.2	321.9	130.2	228.7	134.9	77.1	179.9	80.0	127.0	222.8	142.3	171.7	150.7	143.4	239.4	151.6	139.0	145.8	37.9	117.8	175.8	268.1	177.6	204.7	104.3	106.8	114.8	157.6	107.1	113.5	110.4	105.6	112.0	107.5	108.2	106.9	136.2	99.3	99.7	9.8	96.1	122.1	142.9	416.9	79.6	91.1	131.7	191.5	1366.5	105.8	200.3	112.2	45.9	290.9	101.3	210.9	708.3	187.3	129.5	185.5	113.2	129.4	202.4	125.1	13.1	210.2	312.2	153.3	119.3	110.8	84.9	124.4	93.9	300.6	263.2	52.2	14.3	253.5	321.4	109.0	89.1	39.6	96.9	114.3	156.5	5.6	179.6	165.0	109.2	7.5	13.2	227.1	174.8	121.5	166.9	180.3	316.8	611.4	261.6	127.6	92.1	134.0	261.9	142.9	118.8	181.5	142.2	224.5	94.5	256.6	360.0	190.7
NDUFAF1	"CGI-65, CIA30"	ENSG00000137806	"NADH:ubiquinone oxidoreductase complex assembly factor 1"	Q9Y375	15	41387218-41409403	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		Chaperone	"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Proximal tubular cells: 85.3;Spermatocytes: 84.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039933, HPA040064"	Supported		Approved	Mitochondria,Cytosol		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Mitochondria, Cytosol"		"HPA039933: AB_10795265, HPA040064: AB_10795687"	"unprognostic (2.02e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.72e-1)"	"unprognostic (2.10e-3)"	"unprognostic (2.38e-1)"	"unprognostic (1.20e-1)"	"prognostic favorable (2.88e-5)"	"unprognostic (3.01e-1)"	"unprognostic (2.34e-1)"	"unprognostic (8.92e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.46e-1)"	"prognostic favorable (3.34e-6)"	"unprognostic (1.68e-1)"	"unprognostic (3.23e-1)"	"unprognostic (3.17e-2)"	"unprognostic (2.05e-1)"	16.0	33.4	20.0	9.5	20.7	4.2	12.4	21.6	29.6	9.7	22.8	12.7	12.6	10.5	15.5	13.8	9.8	7.7	42.7	20.7	21.4	29.0	38.7	9.3	11.5	21.1	21.0	9.7	11.8	18.3	11.5	8.0	21.3	10.1	10.4	12.4	12.2	13.2	63.5	9.7	10.9	10.8	21.5	11.9	14.1	21.1	20.8	10.9	10.5	60.9	13.1	12.8	9.9	22.9	15.9	13.3	16.4	13.3	30.0	28.3	14.9	26.1	25.1	23.6	21.3	22.5	8.1	16.7	38.2	24.9	17.5	25.0	20.1	15.9	19.3	32.9	23.9	22.4	25.0	13.8	27.1	24.7	17.0	30.0	18.5	20.8	18.0	19.9	19.0	31.9	38.2	17.2	30.6	17.5	19.9	28.6	12.6	27.5	17.9	15.0	17.4	40.6	41.9	27.8	17.5	13.8	13.2	31.8	12.6	16.9	25.1	50.2	15.4	18.0	10.1	30.5	24.2	15.8	34.7	28.0	24.0	43.5	19.3	35.0	12.8	16.2	7.8	15.0	9.1	13.8	9.6	9.5	11.8	11.8	10.6	8.6	9.4	13.4	13.3	18.2	16.8	8.5	20.0	20.7	21.6	29.6	20.7	21.4	21.1	21.0	21.3	21.5	20.8	22.9	7.7	12.8	10.1	6.5	14.6	4.7	15.8	43.8	9.6	15.7	12.3	11.9	58.7	15.7	27.3	22.0	12.5	36.3	19.8	8.5	64.6	30.5	59.5	14.2	14.2	11.1	6.7	13.5	8.8	31.3	34.6	12.5	12.2	13.1	7.0	16.3	8.6	28.2	28.8	6.7	9.1	8.5	30.5	12.8	7.0	15.0	16.4	16.2	10.6	3.7	23.4	20.7	16.5	4.0	10.3	20.9	3.7	16.1	15.0	11.8	23.3	85.3	30.6	19.2	26.3	15.3	17.3	84.7	21.6	11.3	7.7	50.3	12.3	32.6	11.9	16.3
NDUFAF4	"bA22L21.1, C6orf66, HRPAP20, HSPC125, My013"	ENSG00000123545	"NADH:ubiquinone oxidoreductase complex assembly factor 4"	Q9P032	6	96889315-96897891	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Host-virus interaction"	Calmodulin-binding	"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 168.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046560	Uncertain		Supported	Mitochondria		NA	Yes			"Cluster 30: Non-specific - Translation"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"HPA046560: AB_10966700"	"prognostic unfavorable (1.31e-4)"	"unprognostic (1.32e-1)"	"unprognostic (1.09e-2)"	"unprognostic (1.14e-3)"	"unprognostic (2.89e-1)"	"unprognostic (7.53e-3)"	"unprognostic (6.89e-2)"	"unprognostic (1.27e-1)"	"unprognostic (5.57e-2)"	"unprognostic (2.78e-2)"	"unprognostic (2.03e-2)"	"unprognostic (1.13e-1)"	"unprognostic (4.20e-3)"	"unprognostic (6.32e-2)"	"unprognostic (1.11e-1)"	"unprognostic (4.87e-2)"	"unprognostic (1.31e-1)"	5.7	7.9	13.3	3.4	14.7	2.2	7.0	16.8	21.4	6.4	10.4	7.4	4.9	5.5	4.7	5.4	4.4	4.5	25.6	14.7	15.6	12.6	9.3	3.2	4.7	14.9	14.5	7.8	5.5	10.1	2.5	4.8	15.6	7.2	7.5	9.8	6.2	9.6	23.2	4.8	4.4	5.6	12.3	4.9	4.7	4.6	16.6	5.3	7.4	31.1	4.7	7.8	3.7	13.7	2.2	6.1	10.5	14.3	10.3	5.9	5.6	6.0	5.6	8.8	6.6	8.4	3.7	20.6	10.7	5.6	8.4	4.4	24.7	9.3	8.5	14.5	19.5	23.0	3.2	7.4	11.2	24.4	9.2	5.7	14.2	7.6	7.7	4.4	6.9	14.3	21.0	13.6	13.9	7.0	15.7	13.1	20.1	11.3	10.0	7.4	5.9	10.7	14.6	6.0	17.9	8.4	3.1	10.7	17.5	10.2	3.3	16.1	5.8	4.6	3.5	16.2	9.9	3.1	5.4	20.0	6.2	18.1	6.9	0.2	1.8	0.5	4.0	3.6	5.3	5.1	5.2	5.4	3.3	5.4	7.6	6.9	0.3	3.0	2.3	3.8	5.9	3.2	13.3	14.7	16.8	21.4	14.7	15.6	14.9	14.5	15.6	12.3	16.6	13.7	31.9	9.6	19.8	9.8	43.2	108.8	74.4	82.6	60.9	15.1	28.5	48.1	126.9	25.8	37.3	23.9	0.0	49.6	27.9	23.5	168.3	37.7	3.3	19.2	18.3	30.7	39.3	23.3	18.5	27.6	47.6	34.4	33.6	15.9	20.3	42.5	26.0	51.8	53.9	26.9	17.8	44.3	67.1	18.3	33.7	6.2	26.1	20.2	55.2	11.2	19.7	20.7	24.7	8.0	13.1	21.4	19.7	24.8	40.6	63.7	24.2	118.0	16.6	16.6	26.3	57.8	49.1	42.3	63.7	63.1	96.7	32.8	34.3	43.4	58.1	46.4
NDUFB1	"CI-MNLL, MNLL"	ENSG00000183648	"NADH:ubiquinone oxidoreductase subunit B1"	O75438	14	92116122-92121917	"Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Electron transport, Respiratory chain, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 2435.4;Hepatocytes: 1690.0;Proximal tubular cells: 1614.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA063737	Supported		Supported	"Nuclear speckles,Mitochondria"		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 54: Cardiomyocytes - Muscle contraction"	Mitochondria	"Nuclear speckles"	"HPA063737: AB_2685109"	"unprognostic (1.12e-2)"	"unprognostic (1.31e-3)"	"unprognostic (6.70e-2)"	"unprognostic (2.67e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.54e-2)"	"unprognostic (6.91e-2)"	"unprognostic (3.74e-3)"	"unprognostic (5.35e-3)"	"unprognostic (4.55e-3)"	"unprognostic (1.18e-2)"	"unprognostic (4.15e-2)"	"prognostic favorable (1.31e-5)"	"unprognostic (7.35e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.16e-1)"	"unprognostic (5.05e-3)"	260.8	396.4	370.4	109.0	381.4	167.4	231.8	388.5	588.6	178.3	409.2	313.4	165.7	164.9	178.3	281.5	177.1	61.2	1221.5	381.0	401.1	512.7	503.2	182.3	118.4	379.8	374.6	162.7	206.3	373.5	314.7	61.1	383.2	221.5	122.4	260.9	233.5	59.5	862.6	153.6	225.9	69.4	381.2	214.0	292.4	112.3	376.4	230.6	250.4	1053.8	106.1	192.1	202.4	391.0	198.3	388.3	332.5	208.4	219.1	160.7	143.0	243.2	143.7	147.5	135.4	236.9	341.0	187.0	215.7	151.3	205.8	249.6	198.4	212.3	133.9	280.8	425.1	361.3	665.8	308.5	178.2	290.4	196.4	202.5	132.0	159.5	140.7	334.8	136.7	353.7	199.0	370.1	211.8	759.0	286.6	250.0	166.4	779.6	492.1	253.3	309.7	274.2	397.7	491.3	210.8	152.8	486.6	289.7	338.3	277.7	432.0	435.0	291.8	89.3	173.0	181.3	161.7	288.4	477.2	422.0	278.4	208.5	187.9	456.1	566.8	447.5	247.4	409.6	288.5	373.7	361.5	286.0	508.6	306.8	355.4	343.9	721.3	296.6	386.6	604.6	438.9	653.6	370.4	381.4	388.5	588.6	381.0	401.1	379.8	374.6	383.2	381.2	376.4	391.0	158.5	166.7	227.4	11.4	187.4	128.7	102.1	334.5	96.8	84.6	328.2	353.6	2435.4	467.5	237.0	389.9	39.6	260.3	170.4	627.2	1166.1	245.4	175.8	326.0	208.6	188.2	317.4	256.1	18.4	427.7	118.8	203.6	189.6	225.8	215.8	96.2	397.3	1690.0	422.3	55.5	21.7	515.9	268.5	619.8	179.3	57.3	262.5	281.7	332.6	10.3	478.1	223.3	241.0	11.1	15.0	294.4	628.7	241.1	201.6	97.9	845.2	1614.3	337.6	183.3	223.5	172.4	188.2	138.8	151.5	204.5	176.2	205.8	163.7	97.4	540.6	116.3
NDUFB4	B15	ENSG00000065518	"NADH:ubiquinone oxidoreductase subunit B4"	O95168	3	120596328-120602507	"Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Electron transport, Respiratory chain, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 945.3"	"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 1493.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051739, HPA064441"	Enhanced		Supported	"Nucleoplasm,Nuclear membrane,Mitochondria"		No	No			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria	"Nucleoplasm, Nuclear membrane"	"HPA051739: AB_2681585, HPA064441: "	"unprognostic (1.75e-1)"	"unprognostic (2.57e-3)"	"unprognostic (6.95e-2)"	"unprognostic (4.69e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.72e-2)"	"unprognostic (1.62e-2)"	"unprognostic (1.47e-1)"	"unprognostic (4.35e-3)"	"unprognostic (9.66e-3)"	"unprognostic (7.97e-2)"	"unprognostic (2.84e-1)"	"unprognostic (3.69e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.12e-1)"	"prognostic favorable (1.79e-4)"	148.6	338.4	159.7	90.3	169.1	112.4	145.1	175.9	203.2	126.2	173.2	170.0	147.8	117.9	133.8	159.5	113.0	85.7	619.5	163.5	178.4	232.4	187.4	102.9	93.8	168.3	163.0	119.8	137.4	260.3	170.2	76.8	168.6	118.1	148.7	100.2	148.4	117.4	945.3	144.5	135.6	103.4	170.7	112.1	162.3	106.5	161.7	125.6	113.1	562.2	114.2	133.5	142.1	172.8	294.8	204.3	246.7	248.5	151.0	181.4	199.2	157.0	212.1	205.4	224.5	200.9	219.8	147.8	311.6	177.8	255.6	272.5	191.3	202.7	155.7	227.5	212.6	226.1	205.7	208.1	90.4	202.7	256.8	161.3	268.5	98.9	125.8	246.0	258.5	271.7	138.5	219.2	220.9	224.1	398.6	294.8	193.9	478.9	554.7	228.8	141.0	325.8	337.3	177.9	273.8	283.4	186.5	205.7	360.0	162.0	348.0	319.9	199.8	179.0	233.2	76.9	226.5	263.2	260.1	454.3	283.6	279.8	250.8	205.0	164.8	197.2	156.0	229.5	162.2	231.6	215.2	176.8	213.9	176.3	182.2	181.8	101.6	152.7	238.2	267.9	300.6	205.7	159.7	169.1	175.9	203.2	163.5	178.4	168.3	163.0	168.6	170.7	161.7	172.8	274.1	163.5	162.6	36.9	167.0	222.3	289.0	612.6	190.6	137.8	290.1	351.3	1493.1	311.7	348.3	320.0	58.4	366.0	158.1	472.4	1226.7	556.7	999.2	259.9	188.9	235.7	298.7	196.9	22.6	620.9	421.0	213.7	175.3	293.5	174.8	139.4	183.5	513.9	330.3	84.1	22.0	526.3	451.6	240.2	247.9	164.6	275.2	196.2	434.0	15.9	339.2	340.7	186.4	13.0	31.2	567.9	581.8	277.2	283.2	243.2	613.4	1225.1	266.2	168.4	256.4	208.1	259.0	418.9	87.5	288.4	251.5	352.4	168.1	271.3	462.8	344.0
NDUFB5	"CI-SGDH, MGC12314, SGDH"	ENSG00000136521	"NADH:ubiquinone oxidoreductase subunit B5"	O43674	3	179604690-179627647	"Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Electron transport, Respiratory chain, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 241.4"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005640	Enhanced		Supported	Nucleoplasm,Mitochondria	"Intracellular and membrane"	NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria	Nucleoplasm	"HPA005640: AB_1079461"	"unprognostic (6.76e-2)"	"unprognostic (1.09e-2)"	"unprognostic (6.33e-2)"	"unprognostic (3.51e-3)"	"unprognostic (1.38e-1)"	"unprognostic (7.35e-3)"	"unprognostic (1.33e-2)"	"unprognostic (1.63e-1)"	"unprognostic (4.46e-2)"	"unprognostic (5.96e-3)"	"unprognostic (4.83e-2)"	"unprognostic (7.11e-2)"	"prognostic favorable (3.32e-5)"	"unprognostic (3.05e-1)"	"unprognostic (1.36e-1)"	"unprognostic (6.50e-2)"	"unprognostic (1.95e-1)"	61.0	88.4	35.6	29.0	38.5	19.5	47.8	39.4	57.3	37.7	52.8	64.0	75.1	30.2	15.6	56.7	33.4	28.8	217.0	38.4	40.0	93.5	74.0	34.4	36.1	37.1	36.6	41.9	52.3	66.6	40.2	27.0	37.4	32.6	36.1	22.7	43.7	20.2	241.4	43.6	57.0	22.3	35.4	46.3	63.8	42.2	39.8	31.4	41.6	166.9	24.8	46.2	41.5	38.9	96.5	23.2	51.2	66.8	52.3	66.0	75.6	58.5	42.0	48.1	50.7	79.8	53.4	72.7	193.4	32.7	119.5	89.9	48.9	47.4	38.9	182.5	43.1	90.4	31.2	44.8	52.3	97.9	64.0	64.9	60.7	31.2	51.0	61.0	62.8	62.1	71.2	98.7	51.8	68.8	55.8	60.5	80.2	138.7	80.8	64.2	63.3	205.1	82.5	46.8	41.1	62.4	34.9	169.9	126.7	36.2	265.9	151.2	64.5	46.6	47.8	61.7	139.9	158.0	193.6	122.5	75.8	91.7	67.9	94.6	104.5	49.9	43.8	127.8	64.5	90.2	60.0	51.6	145.5	67.2	59.8	62.9	18.9	48.1	154.8	81.0	84.0	105.6	35.6	38.5	39.4	57.3	38.4	40.0	37.1	36.6	37.4	35.4	39.8	38.9	113.6	48.1	48.5	17.3	90.2	85.1	115.2	374.4	73.4	45.9	121.0	138.6	362.3	88.6	164.3	88.3	33.3	234.0	54.5	115.9	508.7	132.5	162.6	118.4	79.0	89.2	117.5	75.3	16.1	105.7	150.0	87.1	77.5	62.9	93.8	120.1	105.7	118.3	253.5	40.4	22.6	196.0	266.5	261.3	133.0	28.9	81.1	133.6	135.2	15.9	180.0	107.2	70.0	19.6	25.8	81.5	163.4	70.0	75.0	89.8	293.5	462.8	157.9	73.4	72.3	87.1	98.5	265.7	128.3	105.9	88.7	230.0	72.9	257.4	268.8	163.4
NDUFB9	"B22, LYRM3, UQOR22"	ENSG00000147684	"NADH:ubiquinone oxidoreductase subunit B9"	Q9Y6M9	8	124539101-124580648	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"	"Electron transport, Respiratory chain, Transport"		"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 1314.9;tongue: 1486.4"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SK-BR-3: 2950.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042768	Approved		Supported	Mitochondria		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 10: Non-specific - Unknown function"	Mitochondria		"HPA042768: AB_10797508"	"unprognostic (1.18e-2)"	"unprognostic (2.00e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.03e-3)"	"unprognostic (8.32e-2)"	"unprognostic (9.71e-2)"	"unprognostic (3.25e-1)"	"unprognostic (1.14e-1)"	"unprognostic (4.16e-2)"	"unprognostic (3.80e-2)"	"unprognostic (1.51e-1)"	"unprognostic (3.64e-1)"	"prognostic favorable (3.42e-5)"	"unprognostic (9.54e-2)"	"unprognostic (9.64e-2)"	"unprognostic (4.94e-2)"	"unprognostic (2.74e-1)"	155.6	158.2	259.0	78.5	263.8	265.2	157.8	281.1	381.2	109.7	245.0	226.4	184.6	129.5	147.4	209.2	126.0	70.4	789.5	257.6	288.7	324.9	325.0	122.9	96.5	279.3	277.8	107.1	209.4	282.9	124.0	81.2	281.5	117.8	191.0	135.8	210.9	115.1	1314.9	149.3	162.9	111.1	253.4	116.8	241.2	204.7	286.2	102.8	154.2	1486.4	104.1	139.9	124.7	274.1	348.2	316.8	236.1	321.2	240.6	204.2	196.0	165.2	189.3	297.4	222.4	417.7	327.6	341.0	421.0	193.6	153.9	385.5	347.3	266.7	279.9	395.8	464.8	831.3	199.6	505.9	320.8	261.8	218.2	239.6	382.1	271.9	587.9	160.1	275.9	241.1	523.7	277.6	243.4	1089.0	415.8	522.7	237.5	1247.0	692.7	276.3	179.9	468.0	400.0	288.8	326.6	255.0	362.4	2950.7	382.8	141.1	407.3	348.2	219.7	172.5	444.1	162.9	399.5	354.8	517.7	392.5	298.6	515.4	233.1	302.2	253.1	136.2	210.5	179.2	209.6	260.9	275.8	237.1	247.5	201.4	269.1	223.9	49.2	188.9	136.1	183.1	346.0	345.8	259.0	263.8	281.1	381.2	257.6	288.7	279.3	277.8	281.5	253.4	286.2	274.1	169.0	125.0	124.8	7.8	147.7	217.8	277.5	448.3	178.7	77.4	247.3	313.0	1005.6	260.2	267.3	286.9	98.0	494.6	119.9	525.0	800.3	338.0	389.8	120.7	100.6	164.1	233.7	227.6	10.5	405.7	296.0	187.9	169.7	109.2	139.4	149.9	167.4	517.7	380.6	37.0	14.9	421.0	488.3	206.0	137.6	865.4	158.8	183.0	247.3	15.9	226.3	144.1	171.0	7.1	18.2	378.1	450.0	152.7	169.1	290.3	584.6	789.7	208.6	91.1	170.9	221.2	511.8	317.6	264.8	377.0	188.4	523.0	155.6	216.0	521.7	315.8
NDUFC2	"B14.5b, HLC-1"	ENSG00000151366	"NADH:ubiquinone oxidoreductase subunit C2"	O95298	11	78068297-78079862	"Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Electron transport, Respiratory chain, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA038873, HPA056195"	Approved		Supported	Mitochondria		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 2: Hepatocytes - Metabolism"	Mitochondria		"HPA038873: AB_10673480, HPA056195: AB_2683063"	"unprognostic (7.32e-2)"	"unprognostic (5.91e-3)"	"unprognostic (4.00e-2)"	"unprognostic (6.14e-2)"	"unprognostic (1.94e-1)"	"unprognostic (8.97e-2)"	"unprognostic (1.60e-1)"	"unprognostic (4.23e-3)"	"unprognostic (4.75e-3)"	"unprognostic (3.32e-3)"	"unprognostic (1.34e-1)"	"unprognostic (2.11e-1)"	"prognostic favorable (5.00e-5)"	"unprognostic (6.32e-2)"	"unprognostic (3.01e-1)"	"unprognostic (4.18e-2)"	"unprognostic (3.61e-3)"	202.3	278.0	118.8	84.5	126.1	126.1	143.0	128.7	150.7	103.0	125.6	143.6	218.4	125.3	68.4	142.6	120.2	108.6	240.7	129.0	145.8	151.1	286.8	100.0	109.1	121.6	117.1	96.2	168.8	186.1	133.5	74.8	124.2	88.7	66.1	59.8	275.1	83.2	487.6	121.9	194.3	63.6	136.8	96.2	130.0	103.0	126.1	73.5	207.0	254.0	62.8	97.1	100.1	136.3	287.6	342.2	183.3	118.8	168.3	105.6	227.2	335.7	190.9	252.4	179.9	910.4	311.8	166.3	583.3	155.8	210.2	293.1	136.1	190.9	99.5	318.8	386.7	183.8	337.4	727.9	270.9	409.7	164.2	147.9	177.8	195.6	75.2	156.0	172.9	158.8	365.3	278.4	137.9	478.7	254.5	722.4	212.4	670.4	415.6	224.5	352.5	570.5	196.4	420.7	261.2	229.0	235.0	499.5	182.3	158.8	391.4	328.2	241.0	256.4	314.9	611.8	297.9	251.5	541.9	400.4	146.4	236.6	251.0	374.5	337.6	354.0	150.1	293.0	138.3	230.8	172.4	163.4	363.5	212.1	144.5	159.8	102.2	225.4	243.0	290.4	202.7	410.9	118.8	126.1	128.7	150.7	129.0	145.8	121.6	117.1	124.2	136.8	126.1	136.3	256.6	166.7	194.7	0.0	106.4	95.5	166.1	443.7	40.5	145.8	346.2	414.0	240.9	243.1	288.2	391.8	66.7	408.8	166.4	206.3	305.2	395.6	311.8	413.8	129.3	183.7	167.9	106.5	0.0	431.5	392.8	165.7	43.3	241.7	153.2	158.1	184.9	856.9	346.2	90.9	0.0	317.9	429.3	174.5	110.7	84.7	215.6	129.4	245.5	0.0	246.7	310.0	175.1	0.0	0.0	456.5	329.1	201.6	102.5	239.0	461.8	454.6	300.0	131.6	236.7	154.5	222.7	384.4	162.1	67.5	114.4	387.1	109.9	226.3	373.2	215.6
NDUFC2-KCTD14		ENSG00000259112	"NDUFC2-KCTD14 readthrough"	E9PQ53	11	78016971-78079865	"Predicted intracellular proteins, Predicted membrane proteins"	"Electron transport, Respiratory chain, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Alveolar cells type 2: 2.0;Club cells: 1.3;Excitatory neurons: 4.0;Inhibitory neurons: 3.2;Melanocytes: 1.8;Oligodendrocyte precursor cells: 2.5;Oligodendrocytes: 2.4;Respiratory ciliated cells: 1.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"CACO-2: 58.3;EFO-21: 47.1"									"HPA038873, HPA056195"	Approved		Supported	Mitochondria		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Mitochondria		"HPA038873: AB_10673480, HPA056195: AB_2683063"																		6.8	6.4	5.3	3.3	5.9	10.6	6.1	6.3	9.4	3.5	3.6	5.1	12.3	1.9	0.9	4.0	7.1	3.6	10.5	6.0	5.9	2.8	5.6	3.6	7.8	5.4	4.8	1.7	2.7	4.8	0.3	2.9	4.9	5.2	2.7	1.3	11.6	11.8	10.9	4.9	8.1	3.6	5.1	2.5	7.2	2.3	4.7	10.4	10.1	17.0	3.8	3.6	0.4	5.8	4.6	12.6	4.2	1.2	4.2	2.7	6.4	12.8	13.1	14.8	10.8	58.3	6.1	6.6	47.1	6.8	11.1	5.8	4.5	11.5	1.9	17.2	18.1	3.5	3.9	42.1	26.7	3.0	15.7	3.4	4.8	11.3	3.0	8.6	11.0	28.9	9.0	3.8	10.7	19.9	18.8	13.3	5.9	36.1	27.0	9.8	5.6	23.9	7.1	8.3	4.9	8.0	12.0	2.6	6.3	1.8	7.0	8.5	5.1	3.7	19.4	17.4	5.0	7.5	16.7	14.4	2.5	7.9	5.8	113.1	104.9	108.0	98.8	82.2	84.2	119.8	98.4	93.8	131.3	103.5	89.8	84.1	31.4	69.4	93.3	213.4	135.7	194.6	5.3	5.9	6.3	9.4	6.0	5.9	5.4	4.8	4.9	5.1	4.7	5.8	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	3.2	0.5	0.0	0.0	0.0	0.0	0.0	0.1	1.8	1.0	0.0	0.0	0.0	2.5	2.4	0.0	0.2	0.0	0.0	0.1	0.6	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.1	0.3	0.0
NDUFS1	CI-75k	ENSG00000023228	"NADH:ubiquinone oxidoreductase core subunit S1"	P28331	2	206114817-206159509	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Electron transport, Respiratory chain, Transport"	"Oxidoreductase, Translocase"	"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 181.7;skeletal muscle: 221.6;tongue: 225.2"	"Cell type enriched"	"Detected in all"	4	"Cardiomyocytes: 582.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA064605, CAB070844"	Enhanced		Supported	Mitochondria		NA	NA		48000	"Cluster 14: Monocytes - Unknown function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 54: Cardiomyocytes - Muscle contraction"	Mitochondria		"CAB070844: , HPA064605: AB_2685297"	"prognostic unfavorable (3.85e-4)"	"unprognostic (1.76e-1)"	"unprognostic (9.22e-3)"	"unprognostic (5.01e-2)"	"unprognostic (8.63e-3)"	"unprognostic (3.75e-1)"	"unprognostic (3.72e-2)"	"unprognostic (6.18e-2)"	"unprognostic (2.30e-2)"	"unprognostic (3.28e-1)"	"unprognostic (2.00e-2)"	"unprognostic (1.28e-1)"	"prognostic favorable (1.47e-12)"	"unprognostic (1.17e-1)"	"unprognostic (1.29e-1)"	"unprognostic (4.76e-2)"	"unprognostic (4.73e-2)"	27.1	61.6	8.3	13.3	10.8	13.2	23.8	14.9	16.1	19.5	39.7	35.3	29.9	19.3	10.8	36.2	16.3	10.5	181.7	10.7	13.7	48.0	51.8	18.3	12.6	10.1	10.1	14.6	19.2	47.2	20.2	14.4	11.7	15.8	30.0	24.4	27.7	15.6	221.6	26.6	26.1	16.4	9.2	16.8	37.1	20.8	14.2	15.6	17.9	225.2	16.9	22.4	22.4	12.5	28.3	27.6	39.2	28.6	35.8	28.9	45.4	40.4	43.4	66.0	47.6	72.0	32.1	31.7	34.8	50.8	65.5	38.5	52.9	39.2	58.2	14.6	24.9	63.5	65.1	64.9	37.0	46.2	27.5	35.3	22.5	51.9	40.4	29.6	52.3	39.3	69.8	31.1	43.6	35.2	38.5	30.7	36.5	47.2	48.6	38.3	54.7	55.1	54.7	50.7	38.1	29.8	46.7	45.1	67.1	53.3	39.8	44.2	40.1	36.2	32.0	35.8	39.1	29.8	38.4	46.9	36.3	37.5	37.8	14.1	12.9	15.7	12.4	15.2	9.6	9.6	10.8	11.8	14.7	9.0	9.6	11.1	9.2	12.5	22.5	7.8	15.9	9.5	8.3	10.8	14.9	16.1	10.7	13.7	10.1	10.1	11.7	9.2	14.2	12.5	32.4	60.9	33.0	45.1	23.8	16.2	21.7	40.8	30.1	97.1	19.3	14.0	582.5	48.6	42.8	38.6	120.9	48.4	18.8	74.5	93.9	44.2	14.5	49.8	49.8	36.6	51.0	42.0	67.8	28.2	33.7	42.3	48.4	54.5	37.3	42.3	29.3	94.5	34.0	117.8	72.8	47.9	54.9	31.2	10.7	7.0	33.5	27.7	30.2	28.1	37.2	62.7	27.8	45.2	41.6	32.1	46.4	44.8	31.0	19.9	77.8	102.3	53.5	81.5	32.9	55.2	60.8	58.2	49.5	40.8	16.6	52.5	23.7	71.5	69.9	26.6
NDUFS2	CI-49	ENSG00000158864	"NADH:ubiquinone oxidoreductase core subunit S2"	O75306	1	161197104-161214723	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Electron transport, Respiratory chain, Transport"	"Oxidoreductase, Translocase"	"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 464.8;tongue: 633.7"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055140, HPA061953"	Enhanced		Supported	Mitochondria		NA	NA		25000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 10: Non-specific - Unknown function"	Mitochondria		"HPA055140: AB_2682713, HPA061953: AB_2684646"	"unprognostic (2.13e-2)"	"unprognostic (2.24e-2)"	"unprognostic (8.47e-2)"	"unprognostic (7.78e-2)"	"unprognostic (9.81e-2)"	"unprognostic (2.70e-1)"	"unprognostic (1.10e-2)"	"unprognostic (1.51e-1)"	"unprognostic (3.10e-1)"	"unprognostic (1.57e-2)"	"unprognostic (3.17e-2)"	"unprognostic (1.11e-1)"	"prognostic favorable (2.32e-4)"	"unprognostic (2.35e-1)"	"unprognostic (2.80e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.82e-1)"	60.2	98.2	38.7	37.4	41.6	39.5	49.6	46.4	48.8	40.2	76.6	96.5	102.4	41.4	33.4	62.0	52.5	36.8	273.7	40.5	47.5	137.0	177.4	48.5	42.4	49.5	40.7	51.6	47.7	156.5	35.8	41.6	53.1	45.7	101.8	36.2	53.5	49.0	464.8	51.4	81.5	58.6	41.6	43.6	73.3	29.5	47.9	48.3	45.0	633.7	60.1	57.5	40.0	49.2	101.8	129.4	95.2	104.0	115.1	102.8	77.0	85.7	105.8	139.6	107.5	143.9	98.5	108.4	168.1	113.0	81.3	135.9	129.1	131.8	122.1	84.2	108.0	105.9	109.5	136.5	117.7	116.0	105.3	147.2	112.3	121.1	137.2	96.8	160.5	115.4	139.9	72.7	132.5	93.5	81.7	58.4	175.3	288.5	116.5	72.0	83.3	172.0	157.8	109.4	97.2	152.0	93.0	237.0	151.5	116.4	221.7	342.2	108.6	84.5	66.3	65.5	123.7	125.2	172.0	95.1	123.6	109.3	105.4	150.0	159.3	85.7	82.0	193.2	82.6	81.4	86.6	86.3	217.8	68.4	86.6	88.1	86.7	93.5	190.7	128.7	130.8	167.5	38.7	41.6	46.4	48.8	40.5	47.5	49.5	40.7	53.1	41.6	47.9	49.2	70.5	35.3	45.7	30.7	47.1	38.9	52.4	277.8	52.9	74.6	58.9	50.7	232.6	74.4	148.4	77.3	31.3	146.8	47.6	187.5	332.6	184.3	11.3	43.5	57.0	67.5	72.0	78.9	28.0	143.2	111.3	69.7	80.5	41.3	69.7	99.7	65.7	206.5	150.5	92.5	30.1	122.6	242.1	87.8	42.0	7.8	43.5	66.5	83.6	14.0	97.9	57.0	35.0	18.1	48.3	147.7	105.1	33.4	49.5	25.6	221.9	345.5	103.0	57.3	46.0	41.9	176.6	42.0	27.5	68.8	43.3	158.4	50.0	192.0	172.5	57.5
NDUFS3	CI-30	ENSG00000213619	"NADH:ubiquinone oxidoreductase core subunit S3"	O75489	11	47565336-47584562	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Electron transport, Respiratory chain, Transport"	"Oxidoreductase, Translocase"	"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 292.3"	"Cell type enhanced"	"Detected in all"		"Distal tubular cells: 405.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004484, CAB034894"	Enhanced		Supported	"Nuclear bodies,Mitochondria"		NA	NA		14000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria	"Nuclear bodies"	"CAB034894: AB_2151118, HPA004484: AB_1079464"	"unprognostic (2.18e-1)"	"unprognostic (7.42e-3)"	"unprognostic (1.75e-1)"	"unprognostic (5.01e-2)"	"unprognostic (7.51e-2)"	"unprognostic (3.13e-2)"	"unprognostic (6.40e-2)"	"unprognostic (6.24e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.41e-2)"	"unprognostic (6.75e-3)"	"unprognostic (7.73e-2)"	"prognostic favorable (2.61e-6)"	"unprognostic (2.77e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.88e-2)"	"unprognostic (3.17e-3)"	52.4	91.3	47.4	16.5	52.6	44.1	50.7	55.6	50.2	43.5	59.4	97.5	53.8	49.7	26.2	78.7	42.6	18.1	210.3	49.3	51.9	94.2	96.2	40.5	25.5	48.8	49.3	37.3	56.7	53.6	67.5	17.6	49.4	44.0	52.7	23.5	60.9	27.5	292.3	66.2	69.4	26.6	50.3	55.5	81.4	48.2	54.7	33.8	49.7	194.2	33.3	51.4	52.0	47.7	37.7	68.7	59.8	62.9	48.8	52.3	48.2	35.0	60.3	84.6	80.4	103.6	65.1	81.8	34.8	49.7	63.0	64.9	81.7	61.8	69.4	44.2	137.2	49.5	90.6	106.5	49.7	121.5	62.1	50.1	46.6	32.0	52.2	37.5	55.3	69.2	73.7	57.1	57.7	118.6	87.0	164.9	83.6	109.6	97.7	100.7	81.8	68.7	76.4	60.2	63.9	47.1	43.4	76.9	83.5	35.2	84.4	118.2	37.0	49.3	56.4	57.0	80.4	61.2	93.5	91.8	50.1	94.9	51.3	38.3	69.3	48.9	43.2	79.8	46.4	60.6	45.2	47.5	83.3	59.2	42.4	46.0	18.4	45.6	66.7	89.3	61.3	90.3	47.4	52.6	55.6	50.2	49.3	51.9	48.8	49.3	49.4	50.3	54.7	47.7	54.7	54.5	42.6	23.5	54.6	65.6	67.4	217.5	62.6	45.6	60.2	72.5	176.9	81.5	108.5	69.9	41.7	122.0	70.8	183.1	405.0	113.0	132.3	56.8	58.6	60.0	84.7	73.8	12.7	111.3	116.5	60.8	81.1	40.5	57.7	67.1	58.5	126.3	195.9	60.6	14.5	162.8	173.0	66.9	59.3	63.2	67.4	62.8	119.2	7.5	83.9	117.9	58.7	12.5	13.1	91.7	109.3	69.2	69.8	53.0	257.8	297.0	109.7	59.5	105.2	55.5	154.8	85.5	74.7	115.3	75.9	89.1	55.5	128.3	210.7	85.3
NDUFS4	"AQDQ, CI-18"	ENSG00000164258	"NADH:ubiquinone oxidoreductase subunit S4"	O43181	5	53560633-53683338	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"	"Electron transport, Respiratory chain, Transport"		"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"tongue: 397.4"	"Cell type enhanced"	"Detected in all"		"Distal tubular cells: 553.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003884	Supported		Supported	Mitochondria		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"HPA003884: AB_1079465"	"unprognostic (1.25e-1)"	"unprognostic (3.61e-3)"	"unprognostic (3.44e-2)"	"unprognostic (8.11e-2)"	"unprognostic (1.46e-1)"	"unprognostic (6.73e-3)"	"unprognostic (6.93e-2)"	"unprognostic (1.11e-1)"	"unprognostic (3.93e-1)"	"unprognostic (4.38e-1)"	"unprognostic (1.72e-2)"	"unprognostic (3.11e-1)"	"prognostic favorable (3.85e-6)"	"unprognostic (9.19e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.81e-1)"	94.2	80.6	71.3	37.0	71.8	50.9	99.9	75.1	101.8	82.0	70.6	93.2	83.6	65.0	68.6	80.6	69.5	50.2	190.5	70.3	78.3	137.2	147.9	55.7	45.7	72.3	70.4	101.7	45.4	125.8	58.2	63.0	73.8	65.9	89.6	59.1	63.6	73.6	346.2	76.7	71.9	72.2	75.3	42.9	80.7	37.9	75.1	59.8	74.0	397.4	60.7	71.3	73.0	77.7	118.8	102.9	200.5	119.1	133.9	192.7	167.9	140.7	136.6	153.0	185.8	126.7	151.4	83.9	180.2	121.1	146.3	85.3	72.0	167.9	175.4	77.4	137.2	57.8	97.1	115.6	142.4	141.0	95.8	161.2	190.2	105.8	184.8	167.7	135.1	93.4	50.2	88.5	141.9	110.5	106.7	116.9	60.9	45.3	115.1	126.4	113.1	166.2	165.1	113.0	92.7	99.5	96.4	92.5	175.2	106.8	148.2	145.2	104.4	93.6	98.9	68.7	186.9	67.6	91.5	102.1	99.7	202.7	137.3	19.4	83.9	7.9	49.1	101.8	55.3	72.7	61.9	58.0	121.6	50.3	68.2	70.0	6.8	79.4	108.3	93.8	72.4	68.2	71.3	71.8	75.1	101.8	70.3	78.3	72.3	70.4	73.8	75.3	75.1	77.7	62.1	38.5	56.6	49.0	52.6	125.8	150.4	382.0	56.3	44.8	100.0	119.1	328.4	82.9	170.6	84.6	41.7	168.4	43.2	124.5	553.7	174.1	61.5	65.5	87.7	84.6	90.4	47.1	55.9	167.3	163.3	113.1	47.9	68.7	76.0	146.9	99.2	137.8	144.3	30.3	73.2	135.3	215.7	76.4	127.3	61.5	157.5	70.4	117.4	38.4	161.4	113.6	63.8	52.8	68.4	179.4	153.4	152.7	38.4	95.3	188.7	425.9	112.2	76.0	124.9	145.1	173.4	76.8	75.0	79.3	101.4	179.9	50.0	96.4	171.2	158.2
NDUFV1	CI-51K	ENSG00000167792	"NADH:ubiquinone oxidoreductase core subunit V1"	P49821	11	67605653-67612554	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Electron transport, Respiratory chain, Transport"	"Oxidoreductase, Translocase"	"Disease variant, Leigh syndrome, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 526.2"	"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 482.4;Proximal tubular cells: 499.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045211, HPA075051"	Enhanced		Supported	Mitochondria,Cytosol		No	No		37000	"Cluster 27: Non-specific - Gene expression"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria	Cytosol	"HPA045211: AB_10962830, HPA075051: AB_2686732"	"unprognostic (4.57e-2)"	"unprognostic (2.17e-2)"	"unprognostic (2.84e-1)"	"unprognostic (7.07e-2)"	"unprognostic (1.54e-1)"	"unprognostic (4.54e-3)"	"unprognostic (1.19e-1)"	"unprognostic (3.31e-2)"	"unprognostic (2.19e-1)"	"unprognostic (4.95e-2)"	"unprognostic (4.02e-2)"	"unprognostic (3.03e-2)"	"prognostic favorable (7.49e-10)"	"unprognostic (1.12e-2)"	"unprognostic (1.80e-1)"	"unprognostic (2.12e-1)"	"unprognostic (1.16e-1)"	95.0	126.5	87.6	52.5	93.7	72.5	90.9	105.6	107.1	93.9	104.8	142.3	124.5	85.2	33.8	114.0	84.6	47.1	400.2	91.6	97.0	188.4	187.0	77.1	66.7	103.3	91.5	101.9	117.2	169.8	84.5	46.7	110.4	77.4	73.7	81.6	90.2	73.2	526.2	117.7	96.6	51.1	86.9	98.8	132.0	76.0	104.9	51.6	107.6	440.5	62.8	88.1	88.6	99.9	132.9	133.6	68.8	141.3	85.6	83.4	130.6	84.1	76.4	122.2	82.6	256.8	155.3	241.9	167.3	69.2	99.7	176.8	146.1	126.4	38.4	125.2	114.9	100.0	189.1	127.9	119.0	136.9	106.9	126.7	119.0	100.4	88.0	76.9	109.3	173.9	180.9	192.6	75.8	190.2	163.1	268.0	68.5	295.3	168.8	184.5	135.8	399.1	99.3	95.3	109.9	104.6	104.3	347.4	275.3	46.0	177.4	138.0	90.7	118.9	88.8	172.3	87.5	187.7	116.8	122.6	138.0	144.6	117.7	39.0	72.8	38.1	65.1	83.4	71.6	59.8	55.0	63.2	110.7	60.1	50.2	63.7	13.1	104.0	51.2	73.0	78.1	77.0	87.6	93.7	105.6	107.1	91.6	97.0	103.3	91.5	110.4	86.9	104.9	99.9	54.6	60.9	75.0	33.3	76.2	80.3	95.9	187.6	77.4	68.7	82.1	94.4	482.4	61.5	120.7	86.5	50.1	203.5	72.8	235.7	397.2	114.9	74.0	43.1	47.5	56.7	98.5	85.0	32.9	112.1	158.8	82.4	137.1	55.2	61.4	99.6	56.4	136.2	136.5	63.9	36.5	155.9	152.5	68.8	81.4	222.7	65.6	68.4	113.8	13.1	81.0	89.3	60.8	19.1	34.6	70.1	122.8	59.0	146.6	55.0	199.4	499.2	80.3	78.5	46.0	90.8	136.9	100.7	83.3	127.0	80.6	189.1	79.3	145.9	274.8	111.7
NECAB3	"APBA2BP, dJ63M2.4, dJ63M2.5, EFCBP3, NIP1, SYTIP2, XB51"	ENSG00000125967	"N-terminal EF-hand calcium binding protein 3"	Q96P71	20	33657087-33674463	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 93.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044785, HPA070595, HPA071786"	Supported		Supported	"Golgi apparatus"	"Intracellular and membrane"	NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 45: Enterocytes - Digestion"	"Golgi apparatus"		"HPA044785: AB_2679086, HPA070595: AB_2732158, HPA071786: AB_2732186"	"unprognostic (8.95e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.89e-2)"	"prognostic unfavorable (9.57e-4)"	"unprognostic (1.44e-1)"	"unprognostic (4.05e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.80e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.62e-1)"	"prognostic favorable (3.19e-5)"	"unprognostic (3.13e-2)"	"prognostic unfavorable (7.81e-4)"	"unprognostic (6.13e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.82e-1)"	10.2	55.9	20.1	2.2	21.2	1.5	10.4	18.9	33.9	11.8	20.4	14.4	13.6	9.1	6.9	8.9	10.9	4.5	45.7	21.7	21.2	13.3	13.3	11.1	2.3	23.3	19.1	41.2	19.1	17.5	10.3	3.9	24.4	27.2	4.4	6.5	13.6	7.8	60.3	6.9	10.6	3.7	16.6	6.5	30.5	10.6	23.2	1.9	19.2	31.7	1.7	14.6	10.0	22.3	8.2	7.1	5.1	10.5	4.0	7.8	24.6	11.2	4.2	7.1	6.2	33.2	5.3	9.1	26.2	6.6	16.7	9.7	5.3	3.3	2.6	3.2	7.7	8.7	30.7	39.3	10.5	2.1	8.0	9.7	4.8	6.6	2.1	7.6	4.8	4.8	12.6	4.8	9.3	12.5	3.3	8.6	2.2	8.7	17.5	9.7	13.3	15.9	6.6	6.1	32.4	9.0	26.1	28.7	12.0	5.6	36.6	10.4	4.0	8.6	12.4	11.3	12.7	17.7	7.8	17.1	16.9	4.0	3.8	0.0	1.3	1.8	0.3	1.3	0.9	0.2	0.6	0.3	1.2	0.9	0.4	0.1	0.0	1.2	3.5	0.0	1.6	0.6	20.1	21.2	18.9	33.9	21.7	21.2	23.3	19.1	24.4	16.6	23.2	22.3	5.4	16.0	45.5	14.7	4.1	3.1	6.5	2.7	8.6	19.4	20.5	11.6	29.9	10.0	5.9	5.5	8.4	20.6	3.8	22.5	33.2	3.7	93.1	5.7	7.2	2.4	19.9	4.0	13.0	7.5	26.1	12.5	26.5	5.4	3.8	14.0	2.2	9.1	8.9	8.4	14.5	16.2	4.1	6.0	6.2	54.0	26.4	5.5	12.4	1.0	3.6	18.2	2.1	6.0	4.5	4.4	15.1	23.7	11.7	14.2	45.9	12.2	3.8	20.8	6.6	9.2	12.1	20.5	20.6	9.3	3.1	20.7	5.4	23.9	20.0	10.0
NECTIN4	"LNIR, nectin-4, PRR4, PVRL4"	ENSG00000143217	"Nectin cell adhesion molecule 4"	Q96NY8	1	161070998-161089558	"Disease related genes, Human disease related genes, Predicted membrane proteins, Predicted secreted proteins"	"Cell adhesion, Host-virus interaction"	"Host cell receptor for virus entry, Receptor"	"Disease variant, Ectodermal dysplasia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 98.9;skin 1: 113.6;vagina: 57.3"	"Cell type enriched"	"Detected in some"	5	"Syncytiotrophoblasts: 384.2"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 56.5;HaCaT: 37.0;MCF7: 24.0;OE19: 24.6;SK-BR-3: 47.8;T-47d: 31.1"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			HPA010775	Enhanced		Supported	"Plasma membrane"	"Secreted in other tissues"	No	No		170000	"Cluster 1: Neutrophils - Mixed function"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	"Plasma membrane"		"HPA010775: AB_1079720"	"unprognostic (1.09e-3)"	"unprognostic (1.52e-1)"	"unprognostic (3.51e-1)"	"unprognostic (1.11e-2)"	"unprognostic (5.69e-3)"	"unprognostic (2.09e-2)"	"unprognostic (6.69e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.18e-1)"	"unprognostic (6.49e-3)"	"unprognostic (1.13e-1)"	"unprognostic (2.24e-8)"	"unprognostic (2.98e-2)"	"unprognostic (2.43e-1)"	"unprognostic (3.68e-2)"	"unprognostic (4.97e-2)"	0.4	0.1	0.1	0.5	0.1	0.7	13.7	0.3	0.2	26.5	0.0	1.5	0.7	1.2	6.9	98.9	2.9	3.8	0.1	0.1	0.0	3.1	0.1	3.5	0.1	0.1	0.1	0.0	4.5	0.4	0.6	12.2	0.1	9.4	1.7	0.1	33.6	4.3	0.6	113.6	0.6	0.1	0.0	0.0	8.8	0.6	0.3	0.8	0.2	0.0	14.5	16.8	57.3	0.4	10.9	0.4	0.0	0.1	0.0	0.1	56.5	0.1	0.1	0.1	0.2	0.0	14.6	0.0	0.2	0.0	0.1	37.0	0.0	1.2	0.2	0.0	0.5	0.0	0.8	11.1	0.0	0.1	0.7	0.0	14.6	3.0	3.6	0.1	0.0	0.0	0.0	0.1	0.1	24.0	0.1	0.1	0.1	24.6	0.0	0.0	0.0	0.1	0.0	17.5	0.0	0.2	0.2	47.8	0.0	6.4	31.1	0.0	0.0	0.1	2.4	0.5	0.2	0.2	0.1	0.1	0.1	0.0	0.2	0.4	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.3	0.2	0.1	0.0	0.1	0.1	0.1	0.0	0.3	0.4	0.2	6.4	9.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	41.6	17.8	0.0	0.0	8.1	16.5	0.0	39.4	0.4	0.0	0.0	41.7	0.0	28.1	2.9	0.6	0.0	0.0	0.0	30.0	67.1	1.2	0.0	43.1	0.0	0.0	0.0	0.0	6.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	1.0	0.0	0.0	0.0	0.0	67.1	0.0	0.0	0.0	0.0	0.0	0.1	10.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	384.2	0.4	0.1	0.0	0.0
NEDD1	"GCP-WD, TUBGCP7"	ENSG00000139350	"NEDD1 gamma-tubulin ring complex targeting factor"	Q8NHV4	12	96907224-96953780	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 255.8;Late spermatids: 92.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"BJ: 133.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038591	Approved		Approved	Nucleoplasm,Centrosome		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	"Nucleoplasm, Centrosome"		"HPA038591: AB_10674688"	"unprognostic (7.93e-2)"	"unprognostic (3.18e-1)"	"unprognostic (7.00e-2)"	"unprognostic (1.19e-2)"	"unprognostic (2.21e-1)"	"unprognostic (5.92e-2)"	"prognostic unfavorable (1.94e-4)"	"prognostic unfavorable (3.70e-4)"	"unprognostic (1.81e-2)"	"unprognostic (9.29e-2)"	"unprognostic (1.83e-2)"	"unprognostic (1.56e-1)"	"unprognostic (2.46e-3)"	"unprognostic (7.29e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.34e-1)"	"unprognostic (5.59e-2)"	9.1	5.8	3.4	9.7	4.3	15.2	12.8	4.0	3.9	9.9	7.7	8.3	7.1	12.7	6.4	10.0	9.1	7.5	9.2	3.1	4.7	8.9	6.3	8.8	15.4	5.0	4.5	9.8	7.1	14.9	3.8	11.0	4.7	10.6	9.7	7.2	6.8	8.2	38.0	8.2	6.9	13.1	4.8	13.4	7.2	23.6	3.7	22.5	10.5	25.6	15.2	9.6	6.1	6.3	39.4	25.8	43.3	26.8	21.1	19.0	30.7	133.1	47.0	60.5	51.7	17.0	14.2	24.1	12.6	107.7	28.8	34.5	29.5	31.0	80.7	46.7	26.2	30.2	16.1	15.1	17.5	41.8	26.2	14.1	24.9	37.2	28.3	39.8	30.0	41.0	17.8	17.3	43.9	16.3	76.1	19.0	23.8	20.6	80.8	40.0	43.7	24.0	25.0	25.7	13.4	23.6	37.4	20.9	23.7	33.5	28.2	14.6	21.5	38.0	28.8	27.2	31.9	17.0	22.0	32.3	11.7	20.9	46.7	14.1	8.5	25.6	13.8	13.8	15.8	11.1	15.4	15.0	7.4	10.4	15.7	12.5	6.3	19.9	10.2	5.7	17.8	9.4	3.4	4.3	4.0	3.9	3.1	4.7	5.0	4.5	4.7	4.8	3.7	6.3	18.8	9.6	11.5	11.4	19.1	19.4	28.1	7.3	13.1	8.0	10.4	6.9	10.5	21.5	11.9	16.5	0.0	8.2	20.5	6.3	9.8	9.8	255.8	15.3	10.0	14.6	6.1	34.1	3.7	8.2	13.9	13.3	8.6	9.7	16.5	9.3	15.0	4.8	8.6	18.5	3.0	7.5	4.1	8.1	9.2	92.0	12.5	9.4	7.2	15.9	7.5	11.5	17.5	9.0	15.1	8.3	8.3	10.1	13.3	49.6	4.7	11.2	21.8	8.4	19.7	13.9	13.6	34.3	26.0	12.0	14.1	4.0	24.6	9.8	8.0	18.3
NEDD9	"CAS-L, CASS2, HEF1"	ENSG00000111859	"Neural precursor cell expressed, developmentally down-regulated 9"	Q14511	6	11183298-11382348	"Plasma proteins, Predicted intracellular proteins"	"Cell adhesion, Cell cycle, Cell division, Growth regulation, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Adipocytes: 323.2;Alveolar cells type 1: 471.1;Glandular and luminal cells: 337.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"EFO-21: 137.3;HSkMC: 67.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA009689, CAB009720, HPA038768, HPA039270, HPA072955"	Uncertain		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	Yes			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 44: Endometrium - Transcription"	"Nucleoplasm, Cytosol"	"Plasma membrane"	"CAB009720: , HPA009689: , HPA038768: AB_2676196, HPA039270: AB_2676422, HPA072955: "	"unprognostic (2.83e-3)"	"unprognostic (2.33e-2)"	"unprognostic (1.08e-2)"	"unprognostic (6.93e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.62e-1)"	"unprognostic (9.54e-2)"	"unprognostic (3.05e-2)"	"unprognostic (2.09e-1)"	"unprognostic (2.90e-1)"	"unprognostic (1.64e-1)"	"unprognostic (5.59e-3)"	"unprognostic (2.25e-2)"	"unprognostic (2.37e-1)"	"unprognostic (2.41e-1)"	"unprognostic (1.05e-1)"	94.7	8.6	8.3	23.3	8.1	8.6	64.2	6.4	12.3	26.6	14.4	30.7	15.5	19.2	17.5	14.5	22.7	31.4	32.7	7.7	6.4	33.8	20.7	91.9	25.8	8.3	7.3	8.3	17.1	9.5	8.1	69.2	8.5	22.4	30.2	9.8	26.7	29.8	27.2	20.6	38.1	25.8	7.4	25.2	23.5	6.9	9.7	22.2	25.6	12.0	22.2	34.5	15.3	7.9	4.4	29.0	26.4	0.4	17.7	2.3	27.7	6.6	8.2	12.2	22.4	9.3	1.9	9.2	137.3	14.7	1.5	12.6	36.0	13.5	15.8	4.1	1.0	0.8	4.4	62.3	8.3	10.1	0.4	67.7	4.0	7.9	1.3	4.4	21.0	0.8	0.1	7.6	27.7	1.3	5.8	4.0	4.1	34.6	2.9	1.6	0.7	5.4	6.1	39.8	0.6	4.8	1.1	31.2	55.5	29.3	2.3	7.7	53.8	8.2	14.3	0.8	16.5	7.8	34.8	11.4	0.2	7.9	36.6	24.2	13.3	37.3	18.3	28.5	14.7	10.9	12.2	17.5	14.1	12.3	6.4	9.9	80.9	12.3	50.6	8.7	12.1	17.1	8.3	8.1	6.4	12.3	7.7	6.4	8.3	7.3	8.5	7.4	9.7	7.9	323.2	471.1	135.1	11.1	34.9	60.5	235.6	83.5	98.4	4.7	43.1	38.0	14.2	50.1	89.0	44.1	25.0	56.3	45.9	103.4	9.8	62.0	8.2	244.8	24.8	148.1	108.3	2.5	18.2	19.8	42.6	37.2	107.6	337.0	64.5	15.7	86.7	21.6	14.7	10.1	11.3	108.4	12.2	29.8	28.9	4.3	7.5	51.4	24.9	34.7	15.4	84.1	64.9	8.0	4.9	69.1	43.6	29.0	34.8	66.1	100.5	26.7	64.4	12.4	26.3	8.8	30.0	2.1	1.1	11.4	20.6	42.8	59.4	37.2	46.6	90.3
NEIL1	"FLJ22402, FPG1, hFPG1, NEI1"	ENSG00000140398	"Nei like DNA glycosylase 1"	Q96FI4	15	75346955-75357115	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair"	"DNA-binding, Glycosidase, Hydrolase, Lyase, Multifunctional enzyme"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in all"		"Granulosa cells: 105.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"gdT-cell: 5.2;memory B-cell: 4.8;naive B-cell: 6.4;NK-cell: 15.8"	"Group enriched"	"Detected in many"	11	"B-cells: 6.4;NK-cells: 15.8;T-cells: 5.2"	"Cell line enhanced"	"Detected in many"		"Daudi: 11.5;HeLa: 11.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054084	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 20: HeLa - Mitochondria"	"Cluster 40: Granulosa cells - Unknown function"	Nucleoplasm		"HPA054084: AB_2682372"	"unprognostic (9.84e-3)"	"unprognostic (1.19e-1)"	"unprognostic (1.15e-2)"	"unprognostic (4.62e-3)"	"unprognostic (3.21e-2)"	"unprognostic (1.81e-2)"	"unprognostic (2.24e-2)"	"unprognostic (1.17e-3)"	"unprognostic (1.67e-1)"	"unprognostic (1.33e-1)"	"prognostic favorable (2.09e-4)"	"unprognostic (3.50e-3)"	"unprognostic (8.60e-2)"	"unprognostic (9.24e-2)"	"unprognostic (2.05e-1)"	"unprognostic (3.03e-1)"	"unprognostic (2.27e-3)"	8.0	14.6	2.0	3.1	3.1	4.3	11.6	6.2	5.0	14.7	2.0	9.3	5.8	10.0	1.7	7.3	12.9	3.9	5.8	2.2	1.7	8.8	12.8	8.3	6.1	1.4	0.4	13.3	10.9	3.3	11.0	2.5	0.7	12.4	1.1	2.6	16.6	4.1	9.0	8.9	8.3	1.9	0.0	8.8	10.5	3.7	1.1	2.7	10.7	0.6	3.0	8.2	10.9	2.2	2.2	3.6	2.3	1.4	0.7	0.8	4.5	1.3	0.0	0.5	0.1	0.6	4.0	11.5	2.1	0.2	1.1	6.1	1.4	0.4	0.0	5.7	9.1	2.0	11.8	1.7	0.9	2.1	2.6	0.3	1.7	0.6	0.0	5.6	1.4	1.1	1.4	3.3	0.3	2.9	0.4	6.3	2.1	0.4	0.8	2.1	1.5	0.5	2.1	2.4	1.4	2.8	2.2	1.0	3.2	1.2	4.2	3.5	6.3	1.3	2.3	1.8	1.2	5.2	5.5	9.7	1.1	9.4	1.2	0.0	0.6	0.0	5.2	0.3	1.3	4.8	0.9	1.2	0.2	6.4	1.4	1.4	0.8	15.8	0.2	0.3	0.3	1.4	2.0	3.1	6.2	5.0	2.2	1.7	1.4	0.4	0.7	0.0	1.1	2.2	15.9	22.4	19.2	19.9	33.7	6.4	15.4	10.1	23.3	20.0	22.1	15.9	2.9	10.0	21.9	14.7	10.4	10.8	19.1	13.6	1.9	9.0	20.4	31.8	7.3	16.9	21.6	8.0	33.5	8.3	3.6	7.7	22.4	15.4	11.4	105.6	24.3	11.5	3.4	10.1	29.9	20.0	10.2	5.7	7.0	2.6	19.0	3.3	8.8	8.4	1.7	14.6	55.6	5.5	4.5	7.3	16.0	13.5	9.1	9.2	21.4	8.9	41.9	6.5	6.6	6.6	6.4	1.6	1.5	11.0	5.8	4.8	10.0	2.0	14.5	8.7
NEK1	"KIAA1901, NY-REN-55"	ENSG00000137601	"NIMA related kinase 1"	Q96PY6	4	169392809-169612627	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, Cell division, Cilium biogenesis/degradation, Mitosis"	"Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase"	"Amyotrophic lateral sclerosis, Ciliopathy, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Astrocytes: 162.6;Excitatory neurons: 126.3;Inhibitory neurons: 170.5;Oligodendrocytes: 196.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020873, HPA040413"	Approved		Supported	"Nucleoplasm,Centriolar satellite,Cytosol"		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 21: Non-specific - Transcription"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Cytosol	"Nucleoplasm, Centriolar satellite"	"HPA020873: AB_10671583, HPA040413: AB_10671169"	"unprognostic (4.10e-2)"	"unprognostic (2.97e-1)"	"unprognostic (1.59e-2)"	"unprognostic (1.97e-1)"	"unprognostic (6.98e-2)"	"unprognostic (3.10e-1)"	"unprognostic (3.95e-1)"	"unprognostic (3.29e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.78e-1)"	"unprognostic (4.06e-3)"	"unprognostic (2.21e-1)"	"prognostic favorable (1.42e-4)"	"unprognostic (1.07e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.10e-2)"	"unprognostic (3.46e-1)"	6.0	6.1	5.1	4.9	6.8	4.2	5.2	7.1	5.3	7.6	2.7	4.0	3.2	7.3	2.8	4.6	9.3	6.1	6.9	3.5	8.8	5.9	4.2	4.6	5.3	7.5	7.7	9.4	4.0	6.5	2.9	4.3	7.6	6.7	4.4	8.7	4.2	6.0	3.3	2.3	3.5	6.6	7.6	5.1	4.9	11.8	5.3	6.8	7.9	4.6	4.6	5.6	2.8	7.7	5.8	2.5	10.0	11.0	15.5	17.1	3.3	11.9	10.6	9.3	8.8	3.3	6.7	15.4	2.2	10.4	9.0	1.9	9.7	10.1	10.5	16.9	6.5	10.3	10.4	3.9	9.0	10.6	7.9	13.7	5.9	9.5	16.7	19.1	9.3	14.5	18.6	28.2	12.1	3.7	13.6	4.6	3.3	3.6	6.0	8.4	6.5	4.9	9.7	6.8	11.0	12.5	8.6	4.2	8.1	7.7	5.3	4.6	11.2	6.0	5.4	6.2	8.1	11.3	18.6	11.6	9.7	5.1	10.7	5.1	0.9	0.9	1.9	1.5	2.2	2.0	1.5	1.2	0.7	2.0	2.2	2.3	0.6	1.1	0.7	1.6	1.6	0.7	5.1	6.8	7.1	5.3	3.5	8.8	7.5	7.7	7.6	7.6	5.3	7.7	12.2	12.8	16.4	162.6	34.2	9.6	15.8	12.1	21.1	21.8	11.3	12.7	37.2	4.3	17.8	18.4	29.2	20.8	17.0	6.4	17.6	10.4	109.7	67.2	21.6	13.2	7.2	26.7	126.3	6.2	8.6	25.0	17.3	23.7	18.3	20.1	9.7	7.8	10.7	18.5	170.5	5.6	20.3	7.0	7.4	48.2	23.6	14.5	5.4	53.4	6.6	26.1	15.5	115.1	196.1	8.9	4.0	31.6	23.2	6.9	5.3	9.6	68.4	24.9	13.1	32.8	25.5	67.9	37.3	21.3	6.3	29.6	22.0	26.0	6.3	9.2
NEK11	FLJ23495	ENSG00000114670	"NIMA related kinase 11"	Q8NG66	3	131026850-131350465	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Cell cycle"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"choroid plexus: 26.2"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 60.7;Early spermatids: 156.4;Endometrial ciliated cells: 69.2;Excitatory neurons: 91.0;Late spermatids: 109.2;Respiratory ciliated cells: 102.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA016908	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 49: Ciliated cells - Cilium organization"	Nucleoplasm		"HPA016908: AB_1854364"	"unprognostic (9.15e-3)"	"prognostic favorable (7.10e-4)"	"unprognostic (1.05e-1)"	"unprognostic (1.08e-1)"	"unprognostic (9.96e-2)"	"unprognostic (4.85e-3)"	"unprognostic (2.48e-5)"	"unprognostic (5.38e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.18e-1)"	"unprognostic (2.27e-1)"	"unprognostic (1.79e-1)"	"prognostic favorable (5.92e-6)"	"unprognostic (2.46e-2)"	"unprognostic (1.60e-1)"	"unprognostic (2.72e-2)"	"unprognostic (1.58e-1)"	3.1	4.3	8.3	0.5	8.3	0.1	6.6	6.9	7.7	5.4	26.2	2.1	1.3	4.9	7.1	2.3	21.4	4.6	2.1	7.3	9.0	6.3	0.6	4.3	1.0	14.2	15.5	6.4	2.2	4.8	5.6	2.2	12.4	2.9	2.4	5.6	2.9	3.7	1.1	2.2	1.8	2.7	12.8	1.2	1.6	15.5	9.3	0.9	9.6	0.8	1.2	2.8	2.5	12.8	5.7	2.2	1.6	4.8	6.2	9.3	0.9	2.7	5.0	4.1	3.1	2.1	7.7	0.2	1.9	4.8	3.9	3.0	0.4	4.6	5.6	0.5	0.6	0.8	0.3	1.0	2.1	0.6	1.3	3.9	7.7	4.2	1.9	4.3	0.8	2.4	0.2	0.8	6.9	3.9	0.1	0.4	0.5	0.9	2.1	0.0	0.1	0.1	9.3	2.2	2.0	2.2	1.3	0.1	1.9	0.7	4.4	0.1	0.9	4.1	2.0	3.3	1.3	1.2	2.2	0.1	2.9	0.2	0.7	0.0	0.0	0.2	0.1	0.3	0.2	0.1	0.6	0.5	0.1	0.1	0.2	0.1	0.1	0.0	0.2	0.2	0.3	0.0	8.3	8.3	6.9	7.7	7.3	9.0	14.2	15.5	12.4	12.8	9.3	12.8	2.5	16.0	3.2	60.7	1.5	4.2	3.4	4.5	4.6	2.6	7.3	7.5	1.6	4.3	18.8	1.8	6.2	1.0	1.4	3.3	5.9	6.4	156.4	69.2	6.1	3.5	2.4	0.4	91.0	2.5	1.1	7.7	2.6	6.6	0.0	8.1	5.7	0.6	2.0	0.0	42.0	3.5	6.1	0.3	1.7	109.2	6.8	2.0	0.0	21.5	0.8	6.4	1.0	38.7	38.9	3.7	3.9	6.0	0.8	1.6	1.7	10.6	102.7	7.3	6.6	7.2	3.7	33.4	5.2	2.6	2.0	1.6	1.4	11.5	2.4	2.7
NEK2	"NEK2A, NLK1, PPP1R111, RP67"	ENSG00000117650	"NIMA related kinase 2"	P51955	1	211658657-211675630	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, Cell division, Chromosome partition, Meiosis, Mitosis"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"bone marrow: 17.9;lymphoid tissue: 19.2;testis: 67.1"	"Group enriched"	"Detected in many"	4	"Early spermatids: 76.1;Spermatocytes: 244.2"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"cerebellum: 5.7"	"Low region specificity"	"Detected in all"			"CAB017530, HPA064967"	Enhanced		Supported	Nucleoplasm,Centrosome		NA	Yes			"Cluster 41: Basophils - Cellular respiration"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Nucleoplasm, Centrosome"		"CAB017530: AB_1126558, HPA064967: AB_2685393"	"unprognostic (1.28e-1)"	"unprognostic (2.33e-1)"	"unprognostic (1.02e-1)"	"unprognostic (8.51e-2)"	"unprognostic (1.83e-1)"	"unprognostic (1.35e-2)"	"prognostic unfavorable (9.47e-6)"	"prognostic unfavorable (9.11e-4)"	"unprognostic (1.95e-2)"	"unprognostic (2.00e-2)"	"unprognostic (1.09e-3)"	"unprognostic (8.49e-2)"	"unprognostic (0.00e+0)"	"unprognostic (8.21e-2)"	"unprognostic (4.11e-2)"	"unprognostic (1.25e-2)"	"unprognostic (2.71e-1)"	0.7	0.4	0.5	5.3	0.4	17.9	1.5	0.9	0.6	1.1	0.6	5.9	7.4	1.3	0.5	4.4	2.2	0.8	0.4	0.5	0.3	0.3	0.7	0.7	9.0	0.4	0.2	0.4	0.1	0.1	0.0	3.2	0.3	2.5	7.6	1.5	0.8	0.2	0.4	4.3	6.9	2.0	0.2	1.7	2.7	67.1	0.6	19.2	0.4	0.2	10.6	1.3	1.6	0.9	86.0	60.5	45.3	32.6	2.6	4.5	49.7	32.4	30.1	55.4	47.5	32.3	81.7	45.1	15.2	25.2	35.1	44.5	39.9	24.2	69.6	69.5	33.2	21.6	51.4	44.2	0.4	43.2	28.3	1.4	2.9	42.9	45.9	13.4	36.3	45.2	59.9	76.9	56.0	23.6	47.3	28.8	43.0	55.0	30.5	46.2	69.2	68.7	19.7	24.2	41.0	45.0	46.6	51.5	39.3	38.4	79.4	25.1	19.0	27.6	54.1	54.8	88.3	31.6	62.6	59.6	24.1	32.6	46.8	1.2	0.1	0.1	0.1	0.1	0.0	0.5	0.1	0.1	0.0	0.4	0.3	0.2	0.7	1.5	0.1	0.2	1.6	0.3	0.5	0.4	0.9	0.6	0.5	0.3	0.4	0.2	0.3	0.2	0.6	0.9	0.1	0.0	0.5	0.3	1.7	2.9	0.7	3.8	0.6	11.3	1.9	2.2	0.5	0.0	2.9	0.0	0.0	9.4	0.8	1.9	0.0	0.2	76.1	15.2	0.7	0.8	0.0	39.6	0.8	0.2	14.1	1.4	5.6	1.5	0.0	3.6	3.6	0.7	5.8	3.3	0.0	3.2	10.2	2.5	1.1	39.0	2.5	2.1	0.0	0.0	0.0	1.6	2.1	0.0	0.1	0.0	2.5	0.7	5.4	0.7	2.1	0.1	5.2	1.8	6.6	0.0	1.5	244.2	26.1	8.6	1.7	1.4	2.0	0.9	9.5	1.4
NEK4	"NRK2, pp12301, STK2"	ENSG00000114904	"NIMA related kinase 4"	P51957	3	52708444-52770946	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 46.0"	"Cell type enhanced"	"Detected in all"		"Spermatocytes: 75.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015750, HPA058543"	Enhanced		Supported	Cytosol		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	Cytosol		"HPA015750: AB_1854367, HPA058543: AB_2732623"	"unprognostic (1.32e-1)"	"unprognostic (1.57e-1)"	"prognostic favorable (2.69e-5)"	"unprognostic (9.65e-3)"	"unprognostic (3.42e-1)"	"unprognostic (6.64e-2)"	"unprognostic (8.75e-3)"	"unprognostic (2.27e-1)"	"unprognostic (7.85e-2)"	"unprognostic (5.52e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.32e-1)"	"unprognostic (3.74e-3)"	"unprognostic (5.11e-2)"	"unprognostic (2.85e-1)"	"unprognostic (1.51e-2)"	"unprognostic (8.39e-2)"	6.3	8.2	6.1	7.4	6.7	7.0	9.4	9.1	7.4	8.5	8.6	7.3	6.5	8.7	8.9	6.7	13.6	6.2	6.1	5.9	7.8	9.7	10.8	6.7	8.3	6.8	8.9	13.3	8.1	11.5	7.3	7.6	6.3	7.7	8.2	16.9	7.3	9.0	8.0	3.5	5.6	8.1	6.9	7.2	9.6	46.0	7.8	9.5	13.5	6.1	9.4	7.9	4.9	5.9	19.9	15.2	20.5	16.2	18.2	13.1	22.1	13.9	18.6	25.3	25.4	13.5	14.4	20.4	6.4	13.6	27.9	9.2	25.2	16.3	33.8	20.4	10.6	16.0	18.4	17.3	11.4	39.4	15.4	8.1	14.8	32.5	21.5	13.5	9.6	17.4	20.2	16.1	16.1	17.1	21.4	14.4	17.7	20.9	14.9	18.5	17.8	15.1	14.3	28.3	15.0	9.0	29.1	17.7	14.1	15.7	16.5	23.4	8.9	16.9	17.1	27.3	26.0	17.8	27.9	19.7	19.3	18.2	18.7	13.6	9.8	5.0	3.5	6.1	3.7	2.8	3.0	3.6	5.2	3.5	3.6	3.1	1.4	4.0	4.2	2.6	2.6	5.2	6.1	6.7	9.1	7.4	5.9	7.8	6.8	8.9	6.3	6.9	7.8	5.9	6.2	12.8	8.2	19.2	11.8	4.1	5.3	3.4	4.6	14.1	10.6	6.2	4.6	2.8	11.6	5.5	12.5	7.0	4.8	6.5	9.8	7.0	20.7	24.0	10.6	7.3	4.8	13.3	30.5	9.6	8.1	7.8	12.8	9.9	7.6	14.0	6.8	14.5	8.2	6.7	29.4	9.3	6.1	16.8	4.6	19.5	14.6	10.4	1.8	7.5	14.0	19.4	10.3	16.6	19.3	8.5	2.9	12.4	10.6	5.3	5.4	17.1	22.4	18.9	6.6	12.6	7.3	75.9	27.9	6.9	4.1	6.7	5.8	11.8	9.1	5.2
NEK6	SID6-1512	ENSG00000119408	"NIMA related kinase 6"	Q9HC98	9	124257606-124353307	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Transporters"	"Apoptosis, Cell cycle, Cell division, Chromosome partition, Mitosis"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 121.0;Hofbauer cells: 112.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HMC-1: 250.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB045993, HPA056828"	Approved		Supported	"Nucleoplasm,Centriolar satellite,Cytosol"		NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 15: Liver - Metabolism"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 38: Extravillous trophoblasts - Unknown function"	"Nucleoplasm, Cytosol"	"Centriolar satellite"	"CAB045993: AB_2150651, HPA056828: AB_2683250"	"unprognostic (6.27e-2)"	"unprognostic (1.02e-2)"	"unprognostic (4.15e-2)"	"unprognostic (1.65e-2)"	"unprognostic (5.22e-2)"	"unprognostic (2.47e-2)"	"unprognostic (3.13e-3)"	"unprognostic (2.13e-2)"	"unprognostic (2.38e-1)"	"unprognostic (3.30e-2)"	"unprognostic (1.38e-3)"	"unprognostic (6.53e-2)"	"unprognostic (5.03e-3)"	"unprognostic (1.97e-1)"	"prognostic unfavorable (7.66e-4)"	"unprognostic (5.27e-2)"	"unprognostic (4.77e-3)"	18.0	6.1	33.5	32.6	34.3	19.6	14.7	28.1	32.4	26.1	26.5	22.3	17.5	12.2	3.4	8.5	11.2	25.4	7.4	31.8	37.0	17.2	68.2	24.3	27.4	49.8	41.2	9.0	16.7	1.9	6.1	30.2	33.9	19.6	22.5	11.3	20.6	16.7	8.2	5.4	25.8	18.7	34.4	16.6	27.1	7.8	44.2	10.2	7.3	3.1	31.7	24.3	6.4	30.4	31.8	50.0	47.8	18.8	88.3	113.9	59.3	38.8	61.1	58.4	48.4	47.7	57.0	38.2	61.0	74.6	133.2	5.9	24.7	111.7	39.4	43.7	21.8	104.4	42.1	85.4	105.2	19.4	250.0	152.8	17.8	55.4	56.9	152.3	64.3	17.6	19.5	1.7	105.6	32.6	0.9	20.8	12.2	163.7	45.5	40.6	35.6	19.6	62.6	11.4	21.4	7.5	12.6	23.6	54.5	48.3	51.4	76.4	127.5	42.2	42.8	29.5	26.7	8.4	11.4	21.6	53.5	42.3	57.5	28.1	47.6	76.4	9.2	32.1	5.9	52.5	5.5	7.8	29.0	30.2	0.9	3.8	58.8	23.3	41.4	26.9	7.6	21.6	33.5	34.3	28.1	32.4	31.8	37.0	49.8	41.2	33.9	34.4	44.2	30.4	8.4	9.6	4.7	37.9	24.5	2.4	13.8	18.9	4.6	1.0	9.4	6.5	3.3	18.6	8.8	3.7	0.0	47.1	11.3	8.5	1.9	41.3	18.2	9.4	17.7	8.4	6.0	4.0	8.3	23.3	121.0	11.1	19.4	22.2	22.2	1.1	5.0	43.5	112.0	0.0	5.3	18.2	18.3	10.4	22.5	20.0	5.0	31.2	7.2	12.2	57.7	34.6	8.2	15.1	2.4	30.6	11.9	3.8	5.5	17.1	17.2	38.0	3.3	2.1	0.0	4.9	6.4	1.3	17.1	2.4	1.1	36.1	4.5	2.1	18.7	10.2
NEK7		ENSG00000151414	"NIMA related kinase 7"	Q8TDX7	1	198156994-198322420	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Transporters"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 140.4"	"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 172.6;Oligodendrocyte precursor cells: 131.2;Oligodendrocytes: 153.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"BJ: 554.5;fHDF/TERT166: 753.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015520, HPA018193"	Approved		Supported	Nucleoplasm		Yes	No			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 54: Cardiomyocytes - Muscle contraction"	Nucleoplasm		"HPA015520: AB_1854371, HPA018193: AB_1854372"	"unprognostic (2.08e-1)"	"unprognostic (2.98e-2)"	"unprognostic (1.65e-1)"	"unprognostic (5.38e-2)"	"unprognostic (4.26e-2)"	"unprognostic (3.00e-2)"	"unprognostic (2.14e-2)"	"unprognostic (5.47e-2)"	"unprognostic (4.77e-2)"	"unprognostic (3.21e-1)"	"unprognostic (1.46e-3)"	"unprognostic (2.82e-1)"	"unprognostic (1.13e-2)"	"unprognostic (1.26e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.05e-2)"	"unprognostic (1.56e-1)"	63.8	49.9	48.3	29.3	58.7	11.1	27.7	45.9	53.3	26.1	35.7	30.0	21.1	26.6	19.7	31.2	22.3	27.2	140.4	39.5	56.1	29.3	30.0	41.6	30.8	61.1	51.3	29.6	20.3	25.1	12.3	42.1	60.0	27.1	23.3	19.6	22.3	36.5	56.6	14.9	25.3	32.2	59.7	32.1	20.1	13.7	49.1	27.7	26.8	63.7	23.6	30.9	20.1	64.2	47.8	12.3	14.8	6.0	37.5	42.6	17.4	554.5	227.6	218.7	102.9	23.0	46.2	17.1	39.4	753.3	12.6	29.0	22.7	30.3	220.8	56.0	32.7	23.6	48.7	9.6	45.3	40.2	46.3	26.7	25.3	144.8	43.5	82.2	42.4	140.0	18.8	41.2	102.3	15.1	34.7	23.4	8.4	37.5	9.9	18.5	36.5	30.7	37.3	24.5	9.5	17.0	92.1	53.0	63.5	20.6	38.8	36.0	95.7	61.8	52.0	178.6	58.9	29.3	28.5	11.8	26.9	36.3	48.7	1.8	2.2	3.3	2.9	1.8	12.8	1.4	3.2	4.1	2.0	1.9	2.7	3.1	6.0	3.6	1.6	1.3	6.0	1.4	48.3	58.7	45.9	53.3	39.5	56.1	61.1	51.3	60.0	59.7	49.1	64.2	34.3	28.9	30.7	78.0	32.4	51.4	15.0	10.2	33.6	8.2	22.8	18.2	172.6	10.0	18.7	18.4	14.6	15.0	32.9	25.8	11.7	10.6	2.8	21.6	20.9	29.3	19.8	32.6	17.0	19.6	15.9	30.0	18.8	19.6	8.8	11.8	40.4	23.5	17.5	3.3	34.6	19.5	8.2	49.5	51.6	3.3	29.2	35.5	30.2	124.6	29.0	11.4	15.5	131.2	153.5	50.1	19.3	38.4	28.5	30.6	25.1	16.6	27.9	24.2	19.7	28.1	35.9	7.7	6.0	29.2	49.2	64.3	41.6	28.7	15.6	33.1
NELFA	"NELF-A, WHSC2"	ENSG00000185049	"Negative elongation factor complex member A"	Q9H3P2	4	1982717-2041903	"Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009960, HPA039858, HPA043931"	Supported		Enhanced	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 64: Macrophages - Immune response"	"Cluster 24: NB-4 - Immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Nucleoplasm, Nuclear bodies"		"CAB009960: AB_2288566, HPA039858: AB_2676711, HPA043931: AB_2678737"	"unprognostic (1.66e-1)"	"unprognostic (2.23e-1)"	"unprognostic (3.01e-1)"	"unprognostic (1.17e-1)"	"unprognostic (3.32e-1)"	"unprognostic (1.73e-2)"	"prognostic unfavorable (4.35e-4)"	"unprognostic (2.40e-1)"	"unprognostic (1.12e-1)"	"unprognostic (9.38e-2)"	"unprognostic (2.74e-2)"	"unprognostic (1.88e-3)"	"unprognostic (1.58e-1)"	"unprognostic (3.76e-2)"	"unprognostic (2.77e-1)"	"unprognostic (2.43e-1)"	"unprognostic (3.05e-2)"	9.3	7.8	7.5	10.8	8.6	14.2	6.0	8.0	11.5	7.1	6.1	9.4	13.4	11.3	6.3	9.5	12.4	5.7	6.3	8.0	6.9	6.8	5.8	6.6	10.8	8.7	8.9	15.5	16.7	10.1	3.0	10.3	6.8	8.9	4.7	7.0	18.2	8.4	12.0	12.8	13.4	5.7	8.1	12.1	12.7	16.5	7.4	9.4	7.4	4.6	7.4	6.8	1.8	9.5	27.2	24.6	21.0	38.8	8.5	8.9	41.6	14.3	10.1	16.9	13.4	41.1	45.7	47.8	20.1	9.3	21.0	25.2	21.3	17.9	8.2	24.5	33.2	31.5	18.0	39.4	12.4	33.1	30.9	7.6	15.6	11.3	12.0	12.5	13.0	26.6	60.5	22.3	7.4	31.7	63.8	94.4	60.8	23.2	36.5	57.6	18.3	30.2	12.1	22.5	57.1	35.7	16.4	19.3	24.4	13.0	37.1	24.5	14.7	17.0	19.2	19.8	31.9	47.2	52.7	53.6	19.4	34.5	21.4	7.0	14.4	14.9	15.4	16.9	18.5	16.3	17.9	13.9	13.9	24.0	15.0	12.0	5.3	15.4	14.0	17.3	22.1	13.1	7.5	8.6	8.0	11.5	8.0	6.9	8.7	8.9	6.8	8.1	7.4	9.5	11.1	12.8	17.9	30.7	18.5	32.6	18.6	20.3	17.6	19.2	17.6	19.3	4.6	14.3	19.1	12.9	39.6	27.9	16.2	14.6	9.8	18.7	24.0	25.2	17.7	13.2	16.2	17.2	55.9	13.6	28.1	14.7	13.3	28.5	9.5	23.3	11.4	8.3	16.4	37.0	40.9	17.8	14.2	10.1	12.1	7.4	15.5	11.3	14.2	13.1	19.6	18.1	19.6	31.7	30.2	16.2	18.7	13.2	14.0	23.6	17.5	8.9	17.3	21.9	0.0	15.4	15.2	32.9	39.4	29.8	38.2	28.5	18.8	15.8	20.1	27.0
NELFB	"COBRA1, KIAA1182, NELF-B"	ENSG00000188986	"Negative elongation factor complex member B"		9	137255327-137273542	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020259	Supported		Supported	Nucleoplasm		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 35: Non-specific - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm		"HPA020259: AB_1847072"	"unprognostic (2.56e-2)"	"unprognostic (5.14e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.14e-2)"	"unprognostic (3.27e-1)"	"unprognostic (4.06e-1)"	"unprognostic (5.58e-3)"	"unprognostic (7.74e-3)"	"unprognostic (2.04e-1)"	"unprognostic (1.46e-1)"	"unprognostic (5.03e-3)"	"unprognostic (6.46e-2)"	"prognostic favorable (4.31e-6)"	"unprognostic (6.74e-3)"	"unprognostic (1.01e-1)"	"unprognostic (2.66e-2)"	"unprognostic (4.04e-2)"	25.7	24.5	40.1	21.8	36.4	23.9	25.1	33.6	52.1	28.8	28.0	29.5	23.9	24.9	6.9	34.6	23.2	15.7	37.1	38.5	35.0	32.8	30.2	25.0	27.4	41.4	40.1	28.2	37.4	18.2	20.6	18.5	36.4	30.5	11.5	7.6	29.6	16.1	36.3	36.2	26.6	13.0	36.4	31.5	30.3	28.4	40.0	21.6	24.0	21.2	16.7	29.0	27.9	35.3	50.4	79.5	41.1	53.1	34.8	24.8	62.1	42.0	28.4	48.0	33.9	84.7	56.9	70.2	60.8	40.0	56.3	96.0	41.0	47.8	14.0	68.2	64.9	45.4	97.9	69.7	35.3	66.5	54.2	29.7	47.2	44.3	25.8	28.9	45.0	46.9	77.8	57.7	28.6	116.8	51.0	106.2	67.2	88.8	92.9	83.6	76.1	114.7	27.1	43.9	60.8	57.2	56.7	59.7	40.6	21.4	79.3	79.7	59.9	71.1	56.1	113.4	65.9	32.1	55.2	59.1	56.9	47.4	64.6	1.1	3.3	5.5	4.3	2.8	2.9	3.5	3.6	3.3	2.9	3.5	3.3	3.5	1.9	4.0	2.7	4.7	4.3	2.2	40.1	36.4	33.6	52.1	38.5	35.0	41.4	40.1	36.4	36.4	40.0	35.3	31.6	6.4	17.9	16.6	11.7	14.9	11.8	12.7	5.7	19.7	21.8	20.6	12.4	17.2	14.1	23.9	18.8	24.3	24.7	40.0	13.7	27.9	3.7	14.7	18.1	19.8	28.2	13.0	8.9	38.5	27.8	17.4	13.3	21.8	18.4	39.1	20.3	19.5	26.5	43.7	8.4	37.2	12.2	14.0	15.6	5.6	23.3	17.6	7.2	11.2	37.7	33.8	22.6	9.5	11.7	33.5	18.7	20.7	13.8	18.9	29.2	13.9	9.9	17.1	39.5	15.5	20.6	10.7	23.6	12.6	13.9	15.6	15.4	35.0	31.5	13.5
NELFCD	"HSPC130, NELF-C, NELF-D, TH1, TH1L"	ENSG00000101158	"Negative elongation factor complex member C/D"	Q8IXH7	20	58981208-58995133	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Repressor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA050641, HPA066262, HPA074936"	Enhanced		Supported	"Nucleoplasm,Nuclear bodies,Vesicles,Cytosol"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Nucleoplasm, Nuclear bodies"	"Vesicles, Cytosol"	"HPA050641: AB_2681198, HPA066262: AB_2685644, HPA074936: "	"unprognostic (1.70e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.60e-1)"	"prognostic unfavorable (4.98e-5)"	"unprognostic (6.20e-2)"	"unprognostic (2.42e-1)"	"prognostic unfavorable (1.90e-4)"	"unprognostic (1.47e-1)"	"unprognostic (3.58e-1)"	"unprognostic (1.02e-1)"	"unprognostic (6.07e-3)"	"prognostic unfavorable (3.37e-4)"	"unprognostic (4.62e-2)"	"unprognostic (2.96e-1)"	"unprognostic (9.88e-2)"	"unprognostic (1.34e-1)"	"unprognostic (2.59e-1)"	18.9	29.5	20.5	17.7	22.8	23.8	24.5	21.7	23.4	20.7	21.2	18.2	19.3	18.2	16.3	32.9	24.4	16.2	16.9	19.6	21.0	31.7	31.2	14.7	26.4	21.2	20.9	25.2	21.2	30.7	31.8	25.6	21.8	20.4	17.9	31.9	30.0	17.1	29.4	25.9	19.6	14.1	20.8	20.7	19.3	27.9	21.5	31.5	28.5	20.5	27.9	22.6	22.7	24.3	54.7	57.6	68.5	71.9	22.5	38.9	49.6	42.4	38.8	117.1	66.8	189.6	70.7	68.3	64.0	39.8	60.8	89.1	90.1	98.0	94.8	22.4	64.1	90.5	72.4	150.5	26.7	64.2	60.1	40.9	34.3	44.2	32.8	32.8	68.3	54.0	118.1	51.8	53.3	198.2	135.6	95.4	40.3	151.5	122.9	78.4	56.6	121.1	49.0	76.5	75.9	112.6	126.0	148.3	85.9	38.2	157.5	75.0	30.2	91.6	88.8	36.3	67.7	44.4	80.0	71.1	53.7	57.3	80.6	20.0	44.6	22.9	42.0	51.5	50.0	48.6	39.7	51.2	64.9	44.5	37.7	40.1	5.6	47.1	68.8	33.0	39.7	49.0	20.5	22.8	21.7	23.4	19.6	21.0	21.2	20.9	21.8	20.8	21.5	24.3	23.0	9.6	27.6	18.3	50.5	30.2	62.6	43.8	40.9	67.3	32.7	34.2	10.9	47.1	24.3	22.0	41.7	133.1	35.5	14.5	50.9	57.0	18.8	26.2	33.3	26.7	23.4	60.0	23.0	31.4	69.2	26.2	26.5	27.4	16.5	50.9	23.2	24.1	36.9	55.5	22.8	21.9	26.4	15.3	24.0	32.1	37.0	24.0	26.6	10.3	48.1	52.9	49.4	21.1	23.6	34.9	14.4	26.4	37.4	37.8	27.8	49.9	15.0	61.5	39.5	31.6	34.2	63.1	94.9	40.5	31.4	103.0	48.5	43.9	36.2	52.8
NEO1	"HsT17534, IGDCC2, NGN, NTN1R2"	ENSG00000067141	"Neogenin 1"	Q92859	15	73051710-73305205	"Cancer-related genes, Plasma proteins, Predicted membrane proteins"	"Cell adhesion"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 231.8;Excitatory neurons: 124.5;Oligodendrocyte precursor cells: 120.1;Oligodendrocytes: 439.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009320, HPA027804, HPA027805, HPA027806"	Uncertain		Approved	"Nucleoplasm,Golgi apparatus,Plasma membrane"		NA	NA		390000000	"Cluster 16: MAIT-cells - Unknown function"	"Cluster 45: Intestine - Brush border"	"Cluster 12: NES - Nervous system development"	"Cluster 64: Astrocytes - Nervous system maintenance"	"Nucleoplasm, Plasma membrane"	"Golgi apparatus"	"CAB009320: AB_2150998, HPA027804: AB_10600771, HPA027805: AB_10601755, HPA027806: AB_10601006"	"unprognostic (1.90e-1)"	"unprognostic (2.38e-2)"	"unprognostic (7.60e-3)"	"unprognostic (3.76e-2)"	"unprognostic (5.44e-1)"	"unprognostic (3.83e-2)"	"unprognostic (8.30e-2)"	"unprognostic (2.31e-1)"	"unprognostic (3.22e-1)"	"unprognostic (3.30e-2)"	"unprognostic (5.51e-2)"	"unprognostic (8.05e-2)"	"prognostic favorable (4.39e-4)"	"unprognostic (1.51e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.33e-2)"	"unprognostic (3.75e-1)"	9.6	7.4	28.9	8.9	43.8	1.5	16.7	38.1	31.4	18.2	10.7	46.0	27.3	19.6	9.9	11.5	21.9	19.6	7.8	29.4	29.2	23.4	8.7	15.9	3.9	34.6	38.0	24.8	17.2	41.8	6.7	1.7	35.6	33.0	55.1	19.5	18.3	36.0	30.9	37.5	26.5	23.3	28.7	5.3	22.9	13.5	36.6	7.2	18.2	24.8	6.2	10.5	9.6	60.0	8.9	42.9	50.1	33.2	29.6	8.6	12.5	3.3	4.1	8.2	1.7	6.4	42.8	2.5	4.9	9.4	30.8	1.9	35.3	19.5	3.5	15.8	26.0	29.0	0.5	6.0	8.6	0.8	0.9	21.3	35.4	1.6	16.2	9.5	0.0	22.3	0.2	53.9	2.0	26.8	10.5	0.7	47.9	6.7	3.6	23.9	26.8	5.8	15.8	23.7	22.7	32.1	40.2	17.6	20.7	39.9	18.6	5.3	0.1	38.0	19.9	12.5	9.3	22.8	45.2	6.2	8.2	8.3	10.9	0.0	0.0	0.1	0.4	0.0	0.7	0.0	0.2	0.3	0.0	0.0	0.1	0.1	0.3	0.2	0.0	0.0	0.0	0.1	28.9	43.8	38.1	31.4	29.4	29.2	34.6	38.0	35.6	28.7	36.6	60.0	3.1	9.6	10.4	231.8	2.3	14.1	8.2	20.7	13.6	15.7	14.2	18.2	6.9	21.5	11.4	22.0	14.6	0.5	4.8	55.6	1.9	11.6	3.3	14.4	13.4	3.4	60.1	3.0	124.5	6.4	0.8	14.6	20.9	24.6	0.0	11.8	5.7	8.9	0.9	10.1	72.8	51.2	10.2	1.2	2.7	7.1	31.7	1.2	10.6	62.8	0.1	12.5	2.1	120.1	439.4	9.9	40.0	62.8	2.6	11.5	39.6	15.5	12.7	21.9	6.6	22.2	10.2	11.8	20.3	14.7	25.4	0.3	6.0	3.1	60.5	7.2
NEPRO	"C3orf17, DKFZP434F2021, NET17"	ENSG00000163608	"Nucleolus and neural progenitor protein"	Q6NW34	3	113002444-113019861	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"		"Developmental protein"	"Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Theca cells: 33.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA069654			Supported	Nucleoplasm,Nucleoli		Yes	No			"Cluster 15: NK-cells - Transcription"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 36: HEL - Hemostasis"	"Cluster 7: Non-specific - Mitochondria"	"Nucleoplasm, Nucleoli"		"HPA069654: AB_2686164"	"unprognostic (8.45e-3)"	"unprognostic (3.84e-2)"	"unprognostic (1.14e-1)"	"prognostic unfavorable (1.13e-4)"	"unprognostic (2.29e-2)"	"unprognostic (2.43e-2)"	"prognostic unfavorable (4.25e-4)"	"unprognostic (2.04e-1)"	"unprognostic (1.49e-2)"	"unprognostic (4.98e-2)"	"unprognostic (1.72e-2)"	"unprognostic (9.29e-3)"	"unprognostic (5.40e-2)"	"unprognostic (1.69e-1)"	"unprognostic (2.78e-1)"	"unprognostic (1.69e-1)"	"unprognostic (3.28e-2)"	6.7	6.7	4.7	7.0	5.4	10.6	8.8	6.9	6.5	6.5	6.3	7.0	7.1	8.4	10.3	6.0	6.5	7.4	8.4	5.2	4.9	6.3	5.9	6.4	12.3	5.8	5.3	8.1	8.2	6.9	6.6	6.7	5.6	6.6	5.4	11.7	6.9	6.1	18.7	10.8	7.0	5.8	5.1	8.8	8.3	11.3	5.3	9.4	11.5	7.7	7.8	6.7	5.3	7.9	13.6	10.9	17.3	13.0	5.5	10.1	9.2	12.6	8.1	6.9	4.7	10.1	8.5	17.6	6.6	4.3	9.6	13.7	12.7	5.8	9.4	3.5	8.0	27.3	10.0	7.5	10.0	17.4	9.4	15.7	10.0	5.5	14.2	18.8	6.1	17.2	9.5	13.5	5.2	8.6	15.1	10.3	18.1	12.0	14.0	12.1	13.7	9.3	7.8	11.2	11.9	17.3	7.3	9.1	21.4	12.7	10.4	14.7	12.4	9.4	9.3	3.6	9.1	13.3	11.2	20.6	15.2	13.6	7.0	1.9	1.3	1.6	2.2	1.6	2.3	1.8	2.6	1.9	1.8	1.4	3.2	3.2	0.8	4.3	0.7	1.3	1.2	1.4	4.7	5.4	6.9	6.5	5.2	4.9	5.8	5.3	5.6	5.1	5.3	7.9	16.3	9.6	12.8	0.0	7.6	0.0	0.0	0.0	0.0	0.0	17.4	16.9	0.0	0.0	10.5	18.4	0.0	18.4	23.4	0.0	17.6	14.1	0.0	11.9	20.7	6.3	0.0	0.0	0.0	12.6	15.5	9.3	0.0	16.1	17.7	24.0	0.0	0.0	15.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.1	0.0	0.0	9.3	0.0	0.0	0.0	0.0	14.4	0.0	0.0	4.5	0.0	0.0	14.8	8.7	0.0	0.0	0.0	10.2	0.0	0.0	0.0	0.0	20.4	9.1	33.9	0.0	0.0
NEU1	NEU	ENSG00000204386	"Neuraminidase 1"	Q99519	6	31857659-31862905	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Carbohydrate metabolism, Lipid degradation, Lipid metabolism"	"Glycosidase, Hydrolase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Syncytiotrophoblasts: 197.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"neutrophil: 3.0"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 3.0"	"Cell line enhanced"	"Detected in some"		"GAMG: 5.4;U-266/84: 9.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015634, HPA021506"	Approved		Supported	"Vesicles,Cell Junctions"		NA	NA		180000	"Cluster 1: Neutrophils - Mixed function"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 16: U-266 - Nucleosome"	"Cluster 7: Non-specific - Mitochondria"	Vesicles	"Cell Junctions"	"HPA015634: AB_1854386, HPA021506: AB_1854385"	"unprognostic (3.84e-2)"	"unprognostic (7.47e-2)"	"unprognostic (9.64e-2)"	"unprognostic (4.65e-2)"	"unprognostic (3.00e-1)"	"unprognostic (4.42e-3)"	"unprognostic (1.38e-3)"	"unprognostic (8.58e-3)"	"unprognostic (7.49e-2)"	"unprognostic (5.21e-2)"	"unprognostic (4.44e-3)"	"unprognostic (1.27e-1)"	"unprognostic (2.70e-2)"	"unprognostic (6.22e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.12e-1)"	"unprognostic (2.13e-3)"	23.9	57.2	0.7	0.4	0.8	0.0	22.4	2.5	1.2	21.2	1.2	25.1	0.7	19.5	0.0	14.9	16.8	1.0	22.5	0.7	0.6	43.7	29.9	28.9	0.3	0.8	0.5	20.3	35.9	0.3	33.0	0.2	0.8	26.5	0.0	1.6	38.6	0.0	21.3	20.1	24.3	0.1	0.3	25.3	29.8	8.2	1.0	0.0	31.8	0.0	0.0	23.2	16.2	1.7	0.3	0.2	0.8	1.4	1.8	0.4	0.7	0.2	0.2	0.3	0.3	1.5	0.6	0.7	0.4	0.1	5.4	0.3	2.2	0.0	0.4	2.5	0.3	0.6	0.9	1.2	1.4	0.9	1.8	1.0	0.2	1.4	0.7	0.2	0.6	0.9	1.1	1.2	0.5	0.3	0.6	0.0	0.6	0.5	0.4	0.9	0.4	0.9	1.0	0.4	0.7	0.4	0.2	0.3	0.7	0.9	0.9	0.5	0.7	1.1	0.8	0.7	0.6	3.7	9.6	0.9	1.7	0.4	0.4	1.3	0.3	0.4	0.2	0.3	0.1	0.2	0.2	0.1	0.2	0.6	0.2	0.3	3.0	0.3	0.2	0.3	0.2	0.1	0.7	0.8	2.5	1.2	0.7	0.6	0.8	0.5	0.8	0.3	1.0	1.7	65.7	25.6	46.3	5.2	57.0	34.3	48.5	45.0	39.9	26.4	87.7	55.8	29.0	51.5	54.8	47.8	25.0	62.8	100.5	83.7	9.8	114.2	0.8	29.3	53.5	42.8	113.5	4.6	6.3	59.6	57.8	73.8	32.6	60.8	67.9	17.4	30.7	34.5	170.9	10.1	7.6	39.9	79.3	63.0	65.9	1.4	27.7	93.0	71.2	9.4	25.8	48.8	9.2	5.0	4.0	34.4	88.1	23.3	81.7	89.0	115.0	59.9	29.2	32.7	26.3	60.8	43.7	5.4	10.0	29.3	41.6	197.0	81.7	40.3	41.1	34.6
NEU3		ENSG00000162139	"Neuraminidase 3"	Q9UQ49	11	74988279-75018893	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Carbohydrate metabolism, Lipid degradation, Lipid metabolism"	"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 62.6;Spermatocytes: 32.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038729, HPA070381"	Approved		Supported	Nucleoplasm,Vesicles		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 9: Photoreceptor cells - Phototransduction"	Nucleoplasm	Vesicles	"HPA038729: AB_2676179, HPA070381: "	"unprognostic (1.67e-1)"	"unprognostic (2.10e-1)"	"unprognostic (2.55e-2)"	"unprognostic (1.13e-3)"	"unprognostic (2.95e-2)"	"unprognostic (5.42e-2)"	"unprognostic (1.63e-1)"	"unprognostic (5.11e-2)"	"unprognostic (3.91e-3)"	"unprognostic (8.50e-2)"	"prognostic favorable (5.98e-4)"	"unprognostic (3.57e-3)"	"unprognostic (3.80e-2)"	"unprognostic (3.79e-1)"	"unprognostic (2.38e-1)"	"unprognostic (3.73e-1)"	"unprognostic (1.84e-1)"	3.2	12.7	8.1	6.4	9.7	23.7	6.5	5.1	10.8	3.8	2.9	4.2	4.3	4.9	5.2	2.6	4.2	4.5	6.2	5.3	5.0	5.1	8.2	5.1	8.3	4.1	4.0	8.0	6.1	10.4	5.7	3.9	5.4	11.5	6.4	10.4	4.2	3.2	26.4	8.0	4.3	4.8	1.1	6.2	4.8	13.9	5.1	12.3	8.1	22.6	7.8	3.5	2.5	7.5	9.1	8.2	6.7	11.7	5.2	4.4	7.1	8.7	5.7	9.4	7.7	24.3	7.2	25.7	8.5	7.2	12.9	8.1	16.1	11.4	14.7	13.2	7.9	21.8	14.4	10.8	5.6	34.7	19.3	5.5	9.4	9.9	15.0	6.5	7.2	37.3	35.1	17.5	11.2	9.7	33.1	16.8	8.0	18.5	10.3	27.0	17.5	22.2	12.8	9.3	12.0	7.2	13.7	8.4	37.0	8.0	18.9	8.2	10.4	11.6	11.7	8.0	9.1	15.5	15.8	51.8	3.6	17.2	9.8	1.2	2.6	2.4	1.5	1.4	1.1	1.0	1.2	1.5	1.5	1.2	1.2	1.5	1.5	0.5	1.8	1.1	0.9	0.9	8.1	9.7	5.1	10.8	5.3	5.0	4.1	4.0	5.4	1.1	5.1	7.5	1.4	3.2	4.6	4.6	5.3	0.5	2.0	0.4	0.6	8.6	3.5	3.9	7.7	2.8	2.7	1.8	62.6	2.1	4.1	1.0	0.0	1.2	9.2	2.2	2.3	2.3	7.2	5.0	12.5	3.1	1.4	2.1	3.1	2.7	1.3	3.7	3.6	6.9	5.4	11.8	10.3	2.9	2.0	10.1	1.1	7.6	1.5	6.2	0.0	8.4	6.8	3.4	3.1	9.5	9.9	2.6	1.0	1.9	5.8	3.0	1.6	3.7	1.6	6.4	0.0	5.8	1.8	32.0	2.2	1.6	0.6	1.4	3.9	3.8	2.8	0.6
NEURL1B	"DKFZP761M1511, Neur2, RNF67B"	ENSG00000214357	"Neuralized E3 ubiquitin protein ligase 1B"	A8MQ27	5	172641263-172691540	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Notch signaling pathway, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 82.8;Distal enterocytes: 82.5;Endothelial cells: 53.8;Leydig cells: 54.7;Paneth cells: 42.1;Proximal enterocytes: 53.4;Smooth muscle cells: 58.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"REH: 43.7;T-47d: 20.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA037612	Approved		Supported	"Actin filaments,Cytosol"		NA	Yes				"Cluster 46: Fibroblasts - ECM organization"	"Cluster 14: REH - Unknown function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Cytosol	"Actin filaments"	"HPA037612: AB_10795573"	"unprognostic (3.56e-2)"	"unprognostic (8.46e-2)"	"unprognostic (6.72e-3)"	"unprognostic (2.70e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.55e-1)"	"unprognostic (6.58e-2)"	"unprognostic (2.95e-1)"	"unprognostic (2.86e-1)"	"unprognostic (1.09e-1)"	"unprognostic (7.13e-3)"	"unprognostic (6.81e-2)"	"prognostic unfavorable (3.00e-6)"	"unprognostic (1.79e-1)"	"unprognostic (1.40e-1)"	"unprognostic (4.67e-2)"	"unprognostic (3.22e-3)"	25.0	16.0	8.4	5.2	10.3	2.0	21.1	2.3	24.1	18.3	3.4	28.4	6.9	24.7	24.1	13.5	22.0	11.7	32.2	17.1	6.9	11.0	6.0	12.6	3.7	3.5	4.6	14.7	5.3	3.2	8.2	6.1	3.8	17.6	13.7	0.3	6.6	32.1	14.0	18.1	17.6	20.4	3.6	0.7	7.7	4.3	6.3	5.9	10.3	16.0	3.9	25.7	17.3	6.5	7.2	3.7	2.0	8.9	0.6	0.3	0.1	8.0	3.5	4.1	6.0	13.7	3.2	0.0	2.1	5.2	5.0	2.1	0.7	3.6	2.8	13.2	0.5	9.8	13.3	0.1	0.6	0.0	2.9	0.0	15.1	0.9	4.1	1.2	0.6	1.4	0.0	3.0	8.9	8.0	2.3	0.2	1.3	3.1	0.3	43.7	9.4	1.4	0.1	1.6	1.6	8.9	7.6	11.9	0.3	3.5	20.0	1.5	1.3	3.1	18.1	2.2	5.1	1.2	0.4	0.0	9.0	0.2	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.4	10.3	2.3	24.1	17.1	6.9	3.5	4.6	3.8	3.6	6.3	6.5	82.8	0.0	1.9	0.3	0.6	4.8	0.7	3.0	0.6	0.6	1.5	1.3	9.3	1.5	4.8	0.0	0.0	0.3	0.4	82.5	0.0	0.7	2.6	1.9	2.5	53.8	13.9	11.4	5.2	0.7	0.2	10.3	2.0	0.6	0.0	4.9	30.4	0.3	0.3	0.0	1.0	10.2	2.0	1.9	2.6	6.6	54.7	2.2	7.2	4.7	0.7	0.7	0.0	5.0	13.0	4.5	42.1	12.4	0.1	1.9	53.4	0.8	12.8	0.3	26.3	11.6	58.8	2.5	3.4	7.7	5.4	0.1	0.7	2.5	20.0	1.2
NEXMIF	"KIAA2022, KIDLIA, MRX98, XPN"	ENSG00000050030	"Neurite extension and migration factor"	Q5QGS0	X	74732856-74925472	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Neurogenesis, Transcription, Transcription regulation"	"Developmental protein"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 6.7"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 2: 3.6;Breast glandular cells: 1.4;Club cells: 2.5;Hofbauer cells: 1.3;Respiratory ciliated cells: 2.9"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"HAP1: 3.7;Karpas-707: 5.9;SiHa: 5.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000407	Uncertain		Supported	"Nucleoplasm,Midbody,Mitotic spindle,Cytosol"		Yes	NA				"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm	"Midbody, Mitotic spindle, Cytosol"	"HPA000407: AB_2665984"	"unprognostic (1.04e-3)"	"unprognostic (6.07e-5)"	"unprognostic (1.81e-2)"	"unprognostic (2.07e-5)"	"unprognostic (2.15e-1)"	"unprognostic (2.18e-2)"	"unprognostic (3.37e-1)"	"unprognostic (1.74e-3)"	"unprognostic (3.71e-1)"	"unprognostic (1.79e-2)"	"unprognostic (1.64e-3)"	"unprognostic (8.25e-2)"	"unprognostic (7.58e-3)"	"unprognostic (1.37e-2)"	"unprognostic (3.80e-2)"	"unprognostic (2.79e-4)"	"unprognostic (6.94e-4)"	0.1	0.9	3.0	0.1	3.1	0.0	0.3	1.0	2.5	0.4	0.0	0.8	0.1	0.5	0.2	0.3	0.3	0.1	0.0	2.6	6.7	0.7	0.0	0.1	0.1	0.3	0.7	0.4	1.5	1.8	1.7	0.1	0.5	0.9	0.3	1.0	0.4	0.6	0.0	0.3	0.4	0.7	0.2	0.1	0.6	0.2	4.8	0.0	0.4	0.1	0.1	0.2	0.2	0.7	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	5.9	0.0	0.1	0.2	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.0	5.3	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	3.1	1.0	2.5	2.6	6.7	0.3	0.7	0.5	0.2	4.8	0.7	0.3	0.0	3.6	0.0	0.6	0.0	0.0	0.0	0.0	0.0	1.4	0.6	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.4	0.2	0.1	0.0	0.0	0.0	0.9	0.1	0.4	0.0	0.5	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.2	2.9	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
NEXN	"NELIN, nexilin"	ENSG00000162614	"Nexilin F-actin binding protein"	Q0ZGT2	1	77888513-77943895	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		Actin-binding	"Cardiomyopathy, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"heart muscle: 404.8;skeletal muscle: 676.9;tongue: 548.9"	"Cell type enriched"	"Detected in many"	6	"Cardiomyocytes: 2329.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BJ: 152.2;LHCN-M2: 135.1;RH-30: 108.5"	"Region enhanced"	"Detected in all"		"basal ganglia: 40.4"	"Group enriched"	"Detected in all"	4	"basal ganglia: 9.0;midbrain: 13.4;pons: 10.0;thalamus: 25.2"	"HPA011185, HPA011904"	Approved		Supported	"Plasma membrane,Actin filaments"		NA	NA		2900000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 54: Cardiomyocytes - Muscle contraction"	"Plasma membrane, Actin filaments"		"HPA011185: AB_1854409, HPA011904: "	"unprognostic (9.73e-2)"	"unprognostic (6.72e-2)"	"prognostic unfavorable (5.60e-4)"	"unprognostic (1.72e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.42e-2)"	"unprognostic (1.62e-2)"	"unprognostic (1.09e-1)"	"unprognostic (3.03e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.46e-1)"	"unprognostic (3.25e-1)"	"unprognostic (5.41e-2)"	"unprognostic (5.60e-2)"	"unprognostic (2.48e-1)"	"unprognostic (9.65e-3)"	"unprognostic (3.68e-2)"	42.8	22.3	2.3	24.5	3.1	0.6	16.2	1.7	1.6	21.9	2.5	89.2	10.2	79.0	10.7	49.4	47.5	28.7	404.8	1.3	1.8	8.0	5.6	25.2	5.6	1.4	3.3	15.2	10.0	1.5	1.4	10.6	1.5	62.5	15.7	0.6	11.5	69.8	676.9	6.8	26.7	70.6	1.2	8.6	44.1	5.7	4.7	2.1	10.3	548.9	1.8	49.7	19.5	1.7	26.0	1.5	4.5	0.2	79.5	75.3	12.3	152.2	65.5	29.8	20.2	4.6	0.2	0.0	8.6	54.7	34.4	3.4	3.3	14.3	53.3	0.7	3.4	6.2	7.5	1.5	59.3	1.3	0.2	56.6	3.3	40.7	23.8	65.2	22.8	6.0	0.3	0.0	135.1	0.0	29.9	1.8	23.8	0.0	18.6	24.3	108.5	0.2	35.5	1.2	0.1	1.1	13.3	0.0	1.0	29.9	0.0	3.5	23.4	71.7	53.6	31.2	76.1	0.2	0.2	0.1	4.0	2.8	0.2	0.0	1.7	0.0	0.2	1.0	0.0	0.7	0.1	0.2	0.9	0.5	0.3	0.1	1.4	0.3	0.8	0.6	0.0	3.6	2.3	3.1	1.7	1.6	1.3	1.8	1.4	3.3	1.5	1.2	4.7	1.7	8.3	105.8	4.9	11.4	2.1	1.8	0.9	4.6	1.2	2.7	1.4	33.1	2329.6	0.0	5.4	0.0	4.2	0.8	4.1	0.4	1.9	15.3	24.0	2.6	24.2	17.4	0.0	1.7	26.6	32.4	4.0	93.2	1.1	3.2	1.3	29.7	38.6	1.5	1.2	1.7	27.6	0.5	0.0	4.4	2.2	9.0	73.3	44.9	0.0	16.9	5.8	0.7	0.0	24.6	27.3	21.8	0.1	346.1	0.3	1.3	5.3	0.7	0.4	3.8	216.9	70.4	177.2	0.7	3.6	0.8	0.9	0.3	2.3	13.0	2.1	0.4
NF2	"ACN, BANF, merlin, SCH"	ENSG00000186575	"Neurofibromin 2"	P35240	22	29603556-29698598	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			"Cancer-related genes, Deafness, Disease variant, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 77.1;Late spermatids: 121.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003097, CAB005385"	Supported		Enhanced	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 31: Spermatids - Spermatogenesis"	"Plasma membrane"	"Nucleoplasm, Cytosol"	"CAB005385: AB_2298548, HPA003097: AB_1079473"	"unprognostic (3.27e-1)"	"unprognostic (1.34e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.76e-2)"	"unprognostic (3.14e-1)"	"unprognostic (1.62e-1)"	"unprognostic (5.76e-3)"	"unprognostic (1.61e-1)"	"unprognostic (3.67e-2)"	"unprognostic (2.16e-2)"	"unprognostic (2.01e-3)"	"unprognostic (4.66e-1)"	"prognostic favorable (2.89e-5)"	"unprognostic (7.73e-3)"	"unprognostic (1.31e-1)"	"unprognostic (2.24e-1)"	"unprognostic (9.62e-2)"	8.8	13.6	19.7	8.4	17.2	8.0	7.6	13.6	28.7	8.9	10.7	10.8	6.2	11.1	6.2	13.4	8.6	5.3	21.4	27.3	13.9	17.2	10.5	9.3	6.4	14.4	18.1	8.5	12.7	27.4	9.5	4.6	14.3	9.9	5.4	7.3	8.5	6.7	22.8	10.2	8.8	8.0	14.3	9.9	10.0	20.9	17.6	9.3	11.1	19.1	7.1	9.3	7.7	16.6	75.8	36.7	12.2	74.3	21.5	22.0	7.7	57.3	37.9	74.1	53.7	32.7	18.4	21.1	50.4	69.9	48.9	27.1	25.1	37.8	52.0	31.9	12.5	26.8	24.4	26.4	22.4	35.1	28.6	20.1	16.4	53.3	51.0	21.8	47.7	13.7	12.0	18.7	64.5	35.1	21.4	16.6	8.3	16.9	20.4	24.2	56.8	18.8	68.5	37.3	17.0	11.6	36.0	24.5	14.0	9.4	14.9	15.4	92.7	101.1	109.6	44.8	112.5	30.0	26.7	25.5	27.0	14.5	68.5	10.0	10.0	4.2	15.5	14.7	13.1	8.3	11.5	10.4	15.1	8.6	9.7	9.2	2.3	13.2	21.0	10.2	10.7	12.2	19.7	17.2	13.6	28.7	27.3	13.9	14.4	18.1	14.3	14.3	17.6	16.6	8.1	6.4	20.1	14.7	9.4	14.1	11.6	9.8	8.6	16.3	14.5	9.0	23.1	18.6	10.0	14.7	10.4	11.7	12.7	9.0	21.5	40.0	77.1	14.5	17.7	13.2	13.1	13.9	27.5	24.9	6.7	12.5	7.7	15.2	22.9	12.2	11.7	14.4	13.5	30.3	27.1	7.9	6.1	14.7	7.5	121.4	7.2	10.2	8.8	18.7	8.6	19.1	14.4	17.6	16.7	40.1	14.5	12.4	14.7	13.6	10.5	30.1	8.6	9.6	6.6	13.7	15.6	29.5	8.1	15.5	14.3	3.8	12.9	17.4	11.2	9.5
NFAT5	"KIAA0827, NF-AT5, NFATL1, NFATZ, OREBP, TONEBP"	ENSG00000102908	"Nuclear factor of activated T cells 5"	O94916	16	69565094-69704666	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 281.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"SiHa: 22.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA057304, HPA069711"	Approved		Supported	Nucleoplasm,Cytosol		Yes	No			"Cluster 10: Basophils - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm	Cytosol	"HPA057304: AB_2683407, HPA069711: AB_2686180"	"unprognostic (2.71e-1)"	"unprognostic (1.50e-2)"	"unprognostic (1.77e-1)"	"unprognostic (3.57e-2)"	"unprognostic (5.65e-3)"	"unprognostic (2.08e-1)"	"unprognostic (2.97e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.83e-1)"	"unprognostic (3.56e-2)"	"unprognostic (4.05e-3)"	"unprognostic (1.87e-1)"	"prognostic favorable (1.08e-4)"	"unprognostic (1.62e-1)"	"unprognostic (1.37e-1)"	"unprognostic (6.32e-2)"	"unprognostic (9.42e-2)"	2.3	3.1	0.6	2.8	1.2	5.6	2.1	0.5	3.7	3.7	0.0	2.0	0.7	3.3	0.7	2.9	1.9	1.5	2.0	1.4	2.2	2.6	2.3	3.1	1.1	0.0	0.6	2.5	1.6	4.0	2.0	4.2	0.0	2.3	1.5	4.2	3.7	2.4	2.7	3.5	1.9	1.8	0.0	2.5	2.3	1.4	3.0	2.2	3.6	4.8	1.4	2.7	3.1	0.0	8.4	10.1	4.8	5.0	5.8	6.0	6.4	7.2	8.6	6.6	4.2	4.5	4.2	4.5	5.8	5.8	3.4	7.3	3.9	3.1	4.2	2.9	3.2	2.6	2.8	6.2	3.4	3.5	5.5	3.5	1.1	6.4	5.9	5.4	5.5	2.3	7.2	1.1	3.3	3.2	2.8	1.7	2.5	1.1	2.5	4.5	2.2	1.7	2.5	8.0	3.1	0.9	22.2	1.3	2.6	4.1	3.3	1.3	13.1	5.7	5.6	4.8	2.2	4.6	4.9	7.3	5.1	3.4	3.6	0.4	0.1	0.2	0.2	0.1	0.2	0.2	0.1	0.3	0.1	0.2	0.1	0.0	0.9	0.0	0.2	0.5	0.1	0.0	0.6	1.2	0.5	3.7	1.4	2.2	0.0	0.6	0.0	0.0	3.0	0.0	65.0	48.1	49.7	236.7	55.7	148.1	94.8	42.5	155.4	51.8	61.6	42.9	9.2	30.0	43.3	145.3	85.5	60.6	69.4	27.8	5.9	17.8	7.2	93.7	87.8	93.6	24.5	27.3	281.8	12.7	15.9	60.9	38.2	158.3	19.7	31.0	52.8	28.3	17.6	60.6	189.3	29.1	28.5	21.7	169.5	6.9	59.4	58.2	58.7	172.4	37.4	45.7	36.0	177.4	167.2	23.7	29.3	54.9	50.2	83.1	24.7	14.6	31.8	62.4	26.3	72.0	51.4	84.5	48.8	77.9	140.1	50.9	57.4	43.1	20.8	105.7
NFATC1	"NF-ATC, NFAT2, NFATc"	ENSG00000131196	"Nuclear factor of activated T cells 1"	O95644	18	79395856-79529325	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"B-cells: 50.4;Skeletal myocytes: 52.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-698: 60.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004513, HPA071732"	Enhanced		Supported	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 59: Non-specific - Translation"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 41: Macrophages - Immune response"	"Nuclear bodies"	Nucleoplasm	"CAB004513: AB_628011, HPA071732: AB_2686439"	"unprognostic (3.53e-2)"	"unprognostic (2.16e-3)"	"unprognostic (3.08e-3)"	"unprognostic (3.40e-2)"	"unprognostic (4.54e-2)"	"unprognostic (2.79e-2)"	"unprognostic (1.92e-1)"	"unprognostic (4.85e-3)"	"unprognostic (7.02e-2)"	"unprognostic (8.37e-2)"	"unprognostic (1.90e-2)"	"unprognostic (1.38e-1)"	"unprognostic (5.87e-2)"	"unprognostic (1.38e-1)"	"unprognostic (4.54e-2)"	"unprognostic (5.04e-2)"	"unprognostic (3.11e-3)"	12.8	4.6	4.8	11.7	6.0	3.9	10.6	5.6	4.1	6.0	27.9	10.1	3.0	7.7	0.9	3.0	8.0	10.0	15.5	4.3	5.4	4.8	2.7	13.6	21.2	8.3	7.2	7.2	7.0	4.1	3.4	4.1	6.4	6.4	1.5	0.5	6.4	2.9	32.7	10.6	13.2	3.2	7.5	18.7	5.4	8.5	7.2	8.3	7.7	9.3	13.5	7.1	6.1	6.4	0.0	4.0	1.9	3.6	3.3	3.6	6.9	2.4	0.3	0.6	0.3	0.3	3.6	22.0	1.5	3.2	5.6	0.4	9.9	0.0	0.8	15.3	8.0	15.4	0.9	0.1	7.3	4.9	8.2	4.3	0.0	1.2	0.1	0.0	12.2	9.0	12.5	4.5	2.4	8.4	12.8	1.7	3.5	2.9	2.6	4.0	2.5	5.0	1.8	1.6	0.0	0.0	3.2	2.6	5.6	4.2	3.2	19.7	11.4	5.0	20.9	0.0	0.3	0.1	0.1	60.2	0.0	6.6	9.3	1.8	3.4	7.5	4.0	9.1	4.2	7.6	6.2	5.5	3.1	10.0	5.2	3.7	2.9	2.1	13.6	3.0	5.0	4.7	4.8	6.0	5.6	4.1	4.3	5.4	8.3	7.2	6.4	7.5	7.2	6.4	19.4	0.0	6.0	13.4	50.4	37.2	30.0	7.0	6.2	0.1	19.2	13.5	8.4	5.7	8.1	0.0	0.0	0.3	11.8	0.1	0.0	5.7	12.1	10.6	5.4	25.2	0.0	5.9	0.2	4.0	7.2	24.3	8.6	16.1	31.8	1.2	39.3	0.6	12.3	0.0	0.2	0.0	2.0	12.6	35.4	20.3	8.4	21.9	10.6	9.4	6.9	2.5	13.4	4.0	1.3	4.9	0.0	9.8	8.9	12.0	0.0	0.5	4.4	0.1	0.0	52.1	14.2	11.4	13.2	1.5	29.7	0.5	29.4	2.1	0.1	7.7
NFATC2	"NF-ATP, NFAT1, NFATp"	ENSG00000101096	"Nuclear factor of activated T cells 2"	Q13469	20	51386957-51562831	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"choroid plexus: 26.0"	"Cell type enhanced"	"Detected in many"		"Microglial cells: 96.5;NK-cells: 105.0;Skeletal myocytes: 152.0;T-cells: 65.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 24.5;HMC-1: 26.8;SK-MEL-30: 20.4;WM-115: 41.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA008789, CAB018567, HPA024369"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 58: T-cells - T-cell receptor"	"Nucleoplasm, Cytosol"		"CAB018567: AB_628012, HPA008789: AB_1079474, HPA024369: AB_1854413"	"unprognostic (2.69e-3)"	"unprognostic (2.92e-2)"	"unprognostic (2.31e-1)"	"unprognostic (1.58e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.26e-2)"	"unprognostic (3.94e-2)"	"unprognostic (4.05e-2)"	"unprognostic (9.26e-2)"	"unprognostic (3.74e-3)"	"unprognostic (2.17e-2)"	"unprognostic (4.86e-2)"	"prognostic unfavorable (1.57e-4)"	"unprognostic (9.25e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.05e-2)"	"unprognostic (6.59e-2)"	7.6	2.1	2.8	7.4	5.4	4.8	4.6	2.8	3.2	3.8	26.0	4.2	7.9	3.9	3.4	3.6	4.2	16.5	3.1	2.1	3.6	1.7	6.1	4.8	16.1	6.5	7.4	2.1	8.0	3.1	1.4	7.5	4.6	2.4	3.7	0.1	4.8	2.5	3.3	3.8	6.1	2.8	3.5	12.6	10.7	1.6	6.7	5.0	3.5	0.9	13.6	6.5	2.0	3.7	2.7	2.9	0.0	3.6	0.0	0.0	7.5	0.4	1.9	1.2	0.6	14.0	2.5	18.7	2.1	0.9	2.5	0.0	0.9	0.0	1.1	24.5	0.4	8.0	2.1	3.6	0.0	2.2	26.8	0.0	0.0	1.0	0.1	0.2	8.4	6.5	8.0	12.1	0.0	3.1	3.3	13.3	0.3	1.7	6.6	1.4	0.0	8.3	0.4	0.0	0.3	0.0	8.6	2.1	20.4	1.7	3.3	5.3	0.9	1.7	3.0	4.1	0.2	10.2	7.2	18.6	1.7	8.7	41.1	0.4	0.0	3.1	5.3	0.5	2.2	1.3	2.9	4.3	1.2	1.1	1.6	3.0	0.1	5.7	0.2	0.5	1.7	1.3	2.8	5.4	2.8	3.2	2.1	3.6	6.5	7.4	4.6	3.5	6.7	3.7	16.0	6.4	5.4	14.0	38.1	14.4	16.1	0.9	0.6	0.0	8.7	4.3	3.6	4.3	5.6	0.0	0.0	3.3	42.7	1.9	1.9	3.7	1.6	13.1	12.1	28.0	7.8	18.1	1.7	5.6	0.8	37.2	23.4	12.2	15.2	0.2	30.7	7.5	37.1	0.0	1.0	6.2	0.0	32.5	56.6	0.8	2.1	19.0	62.2	96.5	5.0	0.0	105.0	2.5	5.0	11.4	1.8	0.4	55.8	5.3	1.4	0.3	9.3	0.0	0.0	152.0	15.2	0.4	0.7	3.8	12.9	1.0	65.5	0.0	7.0	6.6
NFATC3	"NFAT4, NFATX"	ENSG00000072736	"Nuclear factor of activated T cells 3"	Q12968	16	68084751-68229259	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 102.0"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HMC-1: 105.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA050665			Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 63: T-cells - Adaptive immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Nucleoplasm, Cytosol"		"HPA050665: AB_2681210"	"unprognostic (1.19e-1)"	"unprognostic (1.56e-2)"	"unprognostic (7.74e-2)"	"unprognostic (7.25e-3)"	"unprognostic (6.41e-2)"	"unprognostic (1.28e-2)"	"unprognostic (7.28e-3)"	"unprognostic (2.97e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.32e-1)"	"unprognostic (8.93e-2)"	"unprognostic (9.07e-3)"	"unprognostic (1.60e-1)"	"unprognostic (1.58e-1)"	"unprognostic (4.04e-2)"	"unprognostic (1.30e-1)"	10.5	6.5	11.3	12.0	13.2	23.0	11.3	15.0	12.3	11.4	13.0	9.2	11.8	10.0	9.1	10.7	10.6	8.4	7.2	10.2	11.2	11.0	19.8	17.6	23.4	13.1	12.4	11.7	11.6	23.1	5.1	11.2	12.5	10.3	10.2	10.4	10.6	9.8	28.6	22.6	11.7	11.4	11.6	17.6	9.1	27.2	12.2	102.0	14.0	22.2	22.8	9.4	6.9	14.6	12.8	15.5	24.6	26.3	20.9	13.6	21.4	8.3	10.7	23.6	19.9	21.4	11.0	43.0	12.4	14.1	7.7	18.7	29.0	14.4	22.1	8.6	18.9	44.0	15.2	48.3	13.6	37.1	105.0	10.2	17.4	23.5	12.6	12.1	20.0	35.4	54.5	12.7	17.3	25.5	60.5	51.0	15.0	19.4	7.7	34.3	23.0	44.7	9.9	14.4	17.7	18.5	62.6	15.0	8.1	14.3	20.7	28.4	11.9	12.0	12.5	14.2	12.5	16.2	30.7	77.7	9.3	34.9	16.6	17.7	3.5	7.7	20.4	5.3	19.3	7.3	11.6	20.5	4.1	8.2	11.6	18.3	4.7	20.4	11.2	4.4	8.5	15.0	11.3	13.2	15.0	12.3	10.2	11.2	13.1	12.4	12.5	11.6	12.2	14.6	26.4	35.3	49.5	50.3	41.8	78.4	41.7	39.4	33.0	28.8	64.0	36.4	1.5	78.6	32.5	58.8	33.3	53.1	64.9	20.8	23.5	27.2	155.3	33.8	17.0	27.2	26.0	34.0	46.2	21.9	16.0	19.7	7.1	37.4	49.4	24.3	37.1	117.0	23.7	37.0	53.8	37.3	34.6	51.0	28.9	99.9	21.8	29.5	23.2	91.8	40.6	9.1	129.8	45.8	73.5	33.1	33.1	26.7	28.6	75.3	57.6	53.5	31.3	27.3	19.7	27.9	18.0	68.6	61.7	25.9	143.2	85.0	59.4	19.7	39.1	58.1
NFATC4	NFAT3	ENSG00000100968	"Nuclear factor of activated T cells 4"	Q14934	14	24365673-24379604	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 58.8;Endometrial stromal cells: 28.3;Fibroblasts: 22.8;Sertoli cells: 26.3;Smooth muscle cells: 27.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 36.8;BJ hTERT+: 49.5;hTERT-RPE1: 42.5"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA031641, CAB032859, HPA076526"	Uncertain		Supported	"Nuclear speckles,Cytosol"		No	No				"Cluster 72: Non-specific - Transcription"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 48: Smooth muscle cells - ECM organization"	"Nuclear speckles, Cytosol"		"CAB032859: AB_1128521, HPA031641: AB_10600826, HPA076526: AB_2686805"	"unprognostic (3.51e-1)"	"unprognostic (5.61e-2)"	"prognostic unfavorable (5.84e-4)"	"unprognostic (8.08e-2)"	"unprognostic (1.67e-1)"	"unprognostic (6.57e-2)"	"unprognostic (3.24e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.27e-1)"	"unprognostic (4.18e-2)"	"unprognostic (1.39e-1)"	"unprognostic (9.11e-2)"	"prognostic unfavorable (1.81e-6)"	"unprognostic (1.47e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.35e-1)"	"unprognostic (4.19e-2)"	48.4	54.9	9.1	6.0	9.4	0.6	47.2	8.6	10.5	126.0	9.0	71.9	4.5	82.1	13.7	22.2	82.6	17.8	30.2	9.0	9.3	35.5	5.6	30.2	4.8	10.3	9.4	142.7	13.8	9.0	37.9	18.2	8.8	51.5	5.0	2.8	20.5	16.2	9.0	25.0	29.9	18.8	8.2	17.7	35.5	42.7	9.7	1.7	50.4	2.5	3.6	66.2	65.9	8.5	0.0	0.1	17.8	0.0	25.4	36.8	0.1	17.3	49.5	23.0	20.0	0.0	14.6	14.9	0.5	25.0	1.6	0.0	7.1	0.3	13.9	0.0	0.6	11.3	20.6	0.0	12.3	0.0	0.0	26.8	0.3	13.9	0.1	42.5	18.2	4.7	3.7	0.0	4.5	0.8	0.0	1.7	2.3	1.0	0.1	1.1	1.6	2.0	0.0	0.2	2.9	11.9	0.0	3.3	5.7	8.7	10.3	4.5	10.3	21.3	4.4	20.5	0.0	10.4	1.6	11.0	4.4	0.0	8.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.1	9.4	8.6	10.5	9.0	9.3	10.3	9.4	8.8	8.2	9.7	8.5	4.1	3.2	8.1	58.8	1.1	4.5	0.9	1.9	0.6	1.3	3.3	2.8	7.8	0.0	4.8	0.0	0.0	0.6	0.0	0.8	0.0	2.8	4.4	2.5	28.3	4.6	7.7	0.0	0.1	0.2	0.6	22.8	3.6	6.4	0.0	4.1	1.4	0.2	0.6	0.0	0.2	3.4	10.2	0.0	6.8	6.5	17.4	0.4	7.2	13.1	0.0	7.6	0.0	1.0	0.2	0.6	0.3	7.5	0.2	0.8	0.4	0.2	2.1	1.5	26.3	4.3	27.1	12.5	2.9	1.0	3.4	0.5	0.9	6.0	1.6	2.3
NFE2L2	NRF2	ENSG00000116044	"Nuclear factor, erythroid 2 like 2"	Q16236	2	177227595-177392697	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Host-virus interaction, Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002990, CAB020317, HPA043438"	Supported		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 37: Intestine - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 41: Macrophages - Immune response"	"Nucleoplasm, Plasma membrane"	Cytosol	"CAB020317: , HPA002990: AB_1079476, HPA043438: AB_2678482"	"unprognostic (2.11e-1)"	"unprognostic (3.12e-2)"	"unprognostic (5.22e-2)"	"unprognostic (1.41e-1)"	"unprognostic (5.95e-2)"	"unprognostic (3.90e-1)"	"unprognostic (5.27e-2)"	"unprognostic (9.58e-2)"	"unprognostic (3.48e-2)"	"unprognostic (9.86e-2)"	"unprognostic (4.86e-2)"	"unprognostic (1.83e-1)"	"prognostic favorable (2.26e-4)"	"unprognostic (1.97e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.26e-1)"	"unprognostic (9.77e-3)"	87.0	73.6	64.8	65.4	83.9	58.9	78.3	74.9	86.7	83.2	78.7	83.4	100.1	92.6	97.2	257.0	88.5	97.7	77.6	66.5	71.6	143.5	176.6	88.5	50.4	82.0	77.5	137.3	47.3	60.4	58.4	80.4	84.5	72.7	85.8	68.2	79.7	90.5	64.4	162.3	82.9	91.8	70.4	69.0	176.9	65.2	75.7	68.2	130.4	65.9	93.8	160.7	108.7	91.8	53.1	57.3	52.2	56.4	181.4	190.2	61.7	91.8	124.9	81.4	90.5	75.9	97.9	52.8	93.8	102.8	148.4	96.9	65.1	136.7	111.5	40.8	41.1	65.9	95.9	156.3	231.2	39.3	60.6	134.0	314.5	115.5	169.3	184.4	80.9	39.7	72.7	91.4	111.8	49.8	42.3	101.9	58.8	277.2	58.9	34.0	46.5	54.6	120.9	182.1	69.0	45.0	202.9	64.8	216.6	147.8	49.1	105.0	119.9	80.4	54.5	89.5	54.7	70.1	44.7	43.1	81.6	43.3	159.4	130.6	89.3	55.4	55.2	84.3	62.9	61.8	64.0	57.0	100.4	51.9	101.2	66.8	103.2	68.1	83.0	38.8	66.6	66.0	64.8	83.9	74.9	86.7	66.5	71.6	82.0	77.5	84.5	70.4	75.7	91.8	193.3	157.0	93.5	66.3	143.3	295.8	241.8	448.4	306.7	61.3	90.0	113.7	67.9	117.2	247.0	154.5	16.7	113.2	249.1	120.7	393.2	154.5	81.4	238.1	126.9	139.6	75.6	58.0	25.3	170.8	34.5	206.6	170.7	279.9	212.7	141.5	120.0	93.2	88.1	57.2	26.6	73.5	321.4	111.6	569.9	39.0	287.7	266.0	96.0	88.1	170.6	191.4	55.6	63.8	113.0	128.3	91.8	214.0	118.8	150.5	94.9	85.0	205.9	48.4	39.5	211.8	152.4	66.1	32.1	617.9	315.4	186.2	150.6	153.5	119.6	225.2
NFIB	"NFI-RED, NFIB2, NFIB3"	ENSG00000147862	"Nuclear factor I B"	O00712	9	14081843-14398983	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"DNA replication, Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes, Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 542.6;Oligodendrocyte precursor cells: 565.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 160.3;HBEC3-KT: 65.9;HEL: 61.3;HUVEC TERT2: 64.8;TIME: 64.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003956	Supported		Supported	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			"Cluster 42: Non-specific - Transcription"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Nucleoplasm, Nucleoli fibrillar center"		"HPA003956: AB_1854424"	"unprognostic (1.93e-1)"	"unprognostic (3.18e-2)"	"unprognostic (4.00e-1)"	"unprognostic (2.16e-3)"	"unprognostic (1.12e-1)"	"unprognostic (2.55e-2)"	"unprognostic (1.32e-1)"	"unprognostic (4.72e-3)"	"unprognostic (7.46e-2)"	"unprognostic (9.35e-2)"	"unprognostic (3.68e-1)"	"unprognostic (1.12e-1)"	"prognostic favorable (3.53e-4)"	"unprognostic (4.69e-1)"	"unprognostic (2.39e-1)"	"unprognostic (1.87e-2)"	"unprognostic (1.62e-1)"	28.3	8.8	22.6	7.2	19.3	0.2	36.8	35.7	25.9	12.5	5.8	16.8	10.1	13.0	15.1	9.8	17.5	15.9	25.7	23.7	9.1	16.7	20.3	15.9	7.8	13.2	14.7	14.1	15.6	5.0	4.9	13.0	13.1	20.3	8.7	10.0	39.7	16.9	21.5	22.0	13.0	15.7	17.6	9.7	14.2	2.4	10.9	7.1	17.4	18.9	5.6	17.7	13.3	15.2	19.7	14.7	8.6	160.3	39.8	22.9	0.5	0.5	0.0	3.7	13.7	0.2	7.9	0.5	12.1	1.2	12.0	4.3	7.8	65.9	7.3	2.8	7.4	61.3	31.6	1.8	13.2	1.8	0.3	20.3	9.0	14.2	49.5	15.4	64.8	0.0	1.8	0.5	5.3	9.0	0.1	0.4	3.0	8.8	15.9	0.2	7.5	0.2	11.9	7.4	13.5	49.9	13.5	16.9	5.7	0.5	34.0	0.1	64.6	12.1	18.1	9.7	12.2	1.6	1.4	4.8	11.2	0.3	15.7	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.2	22.6	19.3	35.7	25.9	23.7	9.1	13.2	14.7	13.1	17.6	10.9	15.2	328.7	51.3	31.4	542.6	4.6	268.9	165.7	63.0	115.5	60.8	238.6	317.4	195.6	214.4	59.1	46.0	0.0	5.1	2.1	42.1	39.2	70.7	3.6	147.8	39.0	230.9	22.8	2.7	278.5	125.2	1.2	190.9	62.2	135.9	3.8	5.7	228.5	104.0	2.2	0.0	352.9	35.4	28.5	8.4	48.9	5.0	133.9	7.3	94.3	157.4	1.7	238.0	0.0	565.5	206.0	68.1	48.7	48.5	4.1	166.2	101.9	190.7	55.6	11.5	85.5	270.5	160.8	0.9	9.7	78.6	169.2	1.6	7.1	6.5	74.2	64.3
NFIC	"CTF, CTF5, NF-I, NFI"	ENSG00000141905	"Nuclear factor I C"	P08651	19	3314403-3469217	"Predicted intracellular proteins, Transcription factors"	"DNA replication, Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"skeletal muscle: 293.6"	"Cell type enhanced"	"Detected in all"		"Hepatocytes: 394.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"SiHa: 168.4;U-2197: 164.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004300, CAB004674, HPA052625"	Supported		Supported	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 33: Striated muscle - Muscle contraction"	"Cluster 18: U-2197 - ECM organization"	"Cluster 2: Hepatocytes - Metabolism"	"Nucleoplasm, Nucleoli fibrillar center"		"CAB004300: , CAB004674: AB_425564, HPA052625: AB_2681889"	"unprognostic (2.59e-1)"	"unprognostic (5.07e-3)"	"unprognostic (2.11e-1)"	"prognostic favorable (1.52e-6)"	"unprognostic (8.38e-2)"	"unprognostic (1.71e-3)"	"unprognostic (1.14e-1)"	"unprognostic (3.04e-1)"	"unprognostic (9.66e-2)"	"unprognostic (1.73e-1)"	"unprognostic (6.81e-2)"	"unprognostic (3.16e-2)"	"unprognostic (2.03e-2)"	"unprognostic (2.54e-1)"	"unprognostic (9.65e-2)"	"unprognostic (2.85e-2)"	"unprognostic (1.80e-3)"	42.9	51.0	18.8	18.0	28.4	9.3	38.5	27.2	46.4	50.5	14.1	58.9	9.2	53.6	10.1	32.5	44.7	16.3	62.6	15.5	17.1	21.2	56.8	34.7	6.3	40.0	33.6	52.3	68.7	29.5	29.2	7.5	39.4	39.2	7.7	10.5	45.3	33.1	293.6	42.0	22.9	28.8	31.4	20.1	43.1	13.1	35.7	7.8	33.7	63.1	5.7	46.3	36.3	30.0	63.5	92.8	1.1	53.7	47.9	41.2	5.6	55.6	30.3	36.9	25.7	2.3	20.8	0.5	19.2	51.1	26.4	30.1	15.4	37.8	15.6	44.6	13.7	11.6	75.1	19.2	37.2	19.0	22.8	34.8	25.9	50.2	19.8	24.3	34.9	3.6	32.8	55.3	28.1	45.7	11.1	4.0	3.0	2.8	37.8	28.1	34.0	23.1	14.7	13.3	12.6	32.1	168.4	16.4	17.0	0.8	48.7	14.1	49.5	61.7	56.2	164.1	76.3	1.9	2.5	0.5	83.9	38.6	91.8	1.5	4.1	1.8	2.3	4.0	1.9	1.5	2.2	2.2	3.1	1.6	1.5	1.5	8.7	5.9	0.9	1.2	0.8	3.0	18.8	28.4	27.2	46.4	15.5	17.1	40.0	33.6	39.4	31.4	35.7	30.0	96.4	80.1	82.6	40.8	18.9	100.1	136.5	85.5	174.8	189.5	117.1	101.2	124.8	270.2	50.0	92.0	58.4	9.7	12.4	25.6	52.8	146.5	32.0	77.7	156.3	101.9	47.9	31.1	42.2	190.8	5.9	174.6	80.5	140.1	26.0	85.5	112.5	394.2	55.9	80.8	34.4	41.9	63.1	146.1	50.2	22.0	252.5	58.2	46.2	46.9	56.8	151.1	11.3	21.1	44.5	113.8	32.0	253.2	20.8	175.1	27.0	59.4	67.7	65.4	72.3	285.7	110.8	14.6	39.2	124.7	97.7	8.5	26.1	62.3	59.3	101.2
NFIX	NF1A	ENSG00000008441	"Nuclear factor I X"	Q14938	19	12995475-13098796	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"DNA replication, Transcription, Transcription regulation"	"Activator, DNA-binding"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 410.3"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 145.2;Oligodendrocytes: 140.9;Skeletal myocytes: 174.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 149.5;fHDF/TERT166: 211.3;U-138 MG: 191.5;U-2197: 185.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007533	Supported		Supported	Nucleoplasm		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 18: U-2197 - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	Nucleoplasm		"HPA007533: AB_2667855"	"unprognostic (3.32e-1)"	"unprognostic (1.37e-2)"	"unprognostic (2.84e-1)"	"unprognostic (2.20e-1)"	"unprognostic (2.29e-1)"	"unprognostic (8.12e-2)"	"prognostic favorable (4.66e-4)"	"prognostic favorable (2.35e-4)"	"unprognostic (1.26e-1)"	"unprognostic (2.01e-2)"	"unprognostic (3.25e-1)"	"unprognostic (2.63e-2)"	"unprognostic (1.08e-2)"	"unprognostic (3.46e-2)"	"unprognostic (2.92e-2)"	"unprognostic (3.06e-2)"	"unprognostic (4.38e-2)"	76.4	14.9	30.4	19.7	80.2	14.9	48.0	99.8	97.7	67.2	4.0	60.4	20.9	88.5	10.9	72.4	69.5	53.9	60.9	54.0	15.0	8.9	20.3	50.0	6.2	50.9	45.1	73.8	23.8	13.2	18.9	11.8	39.4	85.0	19.7	11.7	150.4	60.0	410.3	99.2	24.3	67.8	45.6	11.3	37.3	16.0	46.9	11.6	31.0	138.2	6.2	45.0	52.7	105.2	39.2	16.2	1.0	119.9	111.7	149.5	1.3	48.1	68.6	45.7	31.8	1.3	3.3	0.6	13.4	211.3	31.4	17.5	12.8	37.4	20.1	25.8	19.7	20.2	7.6	17.2	53.8	8.5	10.3	99.0	10.9	44.1	24.6	80.3	12.4	8.6	6.7	6.2	29.3	12.1	14.9	5.7	0.5	8.6	132.3	43.5	22.2	23.1	0.4	8.5	17.9	47.6	34.5	0.3	43.0	0.0	22.7	17.3	12.2	191.5	23.5	185.1	68.5	4.5	1.7	0.3	49.9	12.1	62.0	0.1	0.1	0.0	0.5	0.2	0.5	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.1	30.4	80.2	99.8	97.7	54.0	15.0	50.9	45.1	39.4	45.6	46.9	105.2	19.5	12.8	59.3	62.7	6.8	58.8	45.5	22.4	134.9	13.3	57.9	74.2	33.2	27.1	15.9	14.7	4.2	0.2	3.7	16.5	1.9	24.3	64.0	12.1	40.1	20.0	12.1	145.2	69.0	12.7	0.3	89.7	32.6	3.0	3.8	4.3	17.9	33.9	1.0	0.0	38.1	25.8	2.0	4.1	15.2	43.1	112.2	5.8	26.6	17.8	1.9	93.7	0.0	52.3	140.9	15.2	12.0	126.0	2.5	60.3	8.4	10.0	19.0	3.0	6.6	174.7	38.3	15.6	13.2	99.4	51.4	0.3	3.8	56.0	29.5	31.8
NFKB1	"KBF1, NF-kappaB, NF-kB1, NFkappaB, NFKB-p50, p105, p50"	ENSG00000109320	"Nuclear factor kappa B subunit 1"	P19838	4	102501331-102617302	"Cancer-related genes, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins, Transcription factors"	"Apoptosis, Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Langerhans cells: 610.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004031, HPA027305"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 41: Macrophages - Immune response"	Nucleoplasm	Cytosol	"CAB004031: AB_330564, HPA027305: AB_1854429"	"unprognostic (1.06e-1)"	"unprognostic (1.61e-2)"	"unprognostic (4.37e-2)"	"unprognostic (2.38e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.20e-1)"	"unprognostic (2.04e-2)"	"unprognostic (8.98e-2)"	"unprognostic (1.96e-1)"	"unprognostic (9.03e-3)"	"unprognostic (2.28e-1)"	"unprognostic (2.71e-1)"	"prognostic favorable (1.76e-4)"	"unprognostic (1.84e-2)"	"unprognostic (6.75e-3)"	"unprognostic (1.74e-1)"	"unprognostic (6.92e-3)"	26.7	16.2	3.9	30.3	7.0	34.6	19.8	6.5	5.7	22.0	5.5	20.4	15.2	18.9	2.7	23.0	19.1	20.8	15.8	4.2	5.8	17.4	16.4	25.0	33.1	7.6	6.1	18.8	16.0	11.7	7.7	21.2	7.8	17.3	19.6	4.9	18.9	17.8	20.9	23.7	20.3	17.0	5.6	23.0	17.5	7.6	6.4	37.0	16.3	10.7	35.1	48.5	19.9	10.1	36.8	19.2	11.2	13.6	27.0	28.5	10.9	20.0	64.2	27.7	27.1	21.5	40.8	58.0	17.6	32.6	39.4	29.5	22.0	34.5	35.2	53.6	10.8	22.7	14.5	15.0	20.0	44.3	44.3	19.7	20.2	22.0	34.4	15.0	34.5	18.1	25.8	34.1	17.6	17.7	4.1	9.1	5.0	24.3	15.4	33.4	25.9	24.0	15.3	38.8	7.1	11.8	38.3	37.2	16.3	8.3	8.6	24.2	40.5	32.5	16.6	14.5	26.4	17.0	13.3	52.0	20.8	19.4	44.1	0.0	2.1	2.6	0.9	3.0	1.9	1.9	3.0	1.6	4.8	1.7	4.5	3.2	1.9	3.7	3.1	1.5	0.8	1.6	3.9	7.0	6.5	5.7	4.2	5.8	7.6	6.1	7.8	5.6	6.4	10.1	32.5	41.7	49.4	42.1	90.0	165.4	91.5	57.1	31.3	6.6	41.5	32.6	19.1	24.3	40.8	20.2	6.2	14.4	119.6	41.1	3.9	28.5	7.6	82.5	62.0	47.6	33.6	13.0	78.4	37.3	16.9	63.1	29.6	207.0	111.1	19.8	23.9	23.9	24.8	20.2	77.2	43.2	18.3	56.2	610.3	2.4	23.9	178.3	55.2	59.0	207.9	9.5	23.7	66.9	127.4	46.3	27.1	34.6	56.3	78.5	21.1	24.4	31.5	6.7	0.0	73.7	41.2	2.5	8.1	35.3	150.3	14.2	88.2	16.7	35.4	90.2
NFKBIE	IKBE	ENSG00000146232	"NFKB inhibitor epsilon"	O00221	6	44258166-44265788	"Cancer-related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Langerhans cells: 151.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002692, HPA005941, CAB010272"	Supported		Supported	"Nucleoplasm,Nucleoli fibrillar center,Cytosol"		NA	NA			"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 2: Immune cells - Immune response"	"Cluster 24: NB-4 - Immune response"	"Cluster 41: Macrophages - Immune response"	"Nucleoli fibrillar center"	"Nucleoplasm, Cytosol"	"CAB010272: AB_2235977, HPA002692: AB_1079479, HPA005941: AB_1079478"	"prognostic favorable (1.72e-5)"	"unprognostic (1.43e-1)"	"unprognostic (1.39e-2)"	"unprognostic (2.37e-2)"	"unprognostic (6.32e-3)"	"unprognostic (1.28e-1)"	"prognostic unfavorable (3.50e-4)"	"unprognostic (4.88e-2)"	"unprognostic (1.09e-1)"	"unprognostic (3.43e-2)"	"unprognostic (3.36e-1)"	"unprognostic (2.60e-1)"	"prognostic unfavorable (1.37e-6)"	"unprognostic (2.61e-2)"	"unprognostic (8.83e-2)"	"unprognostic (1.37e-2)"	"prognostic favorable (8.07e-4)"	6.8	5.8	10.9	19.1	10.8	31.5	5.9	12.1	17.6	4.1	10.7	7.2	7.4	3.7	4.7	5.9	3.3	8.3	5.3	11.3	10.6	16.1	10.5	13.6	19.9	11.5	11.4	2.7	8.3	5.3	4.5	5.5	11.2	8.3	5.9	3.7	7.4	3.3	3.5	9.9	12.1	3.6	11.7	35.0	7.0	10.7	11.8	9.9	5.3	3.9	25.1	16.3	5.0	12.3	28.4	7.9	9.5	15.1	3.7	2.8	5.3	4.9	23.8	14.9	15.4	15.0	12.9	15.7	17.0	5.1	39.7	6.2	10.3	15.4	16.6	26.1	6.0	7.9	3.0	17.0	11.4	26.1	23.0	7.1	6.7	13.8	8.8	12.5	10.7	7.2	7.7	39.2	3.9	14.4	5.2	52.7	5.0	44.1	4.0	9.9	8.5	14.0	34.7	30.3	6.1	7.8	3.4	12.5	20.9	8.0	8.6	29.9	18.1	8.4	9.8	5.3	15.4	25.0	11.4	28.7	7.4	28.4	16.1	8.8	7.5	4.0	1.6	9.4	3.2	8.6	2.2	1.5	6.6	6.5	1.0	1.6	3.0	0.8	11.1	8.1	3.1	1.7	10.9	10.8	12.1	17.6	11.3	10.6	11.5	11.4	11.2	11.7	11.8	12.3	7.5	0.0	9.7	1.0	26.0	38.2	28.7	11.6	14.8	3.4	15.3	9.9	5.4	22.8	9.2	3.7	2.1	5.2	12.5	12.2	17.6	49.5	17.3	10.0	6.2	15.9	14.9	1.7	1.1	21.0	8.0	17.3	10.7	12.8	32.5	2.5	6.1	2.0	57.2	3.3	2.0	11.9	6.1	22.6	151.2	34.1	1.8	48.6	48.0	3.7	55.2	3.3	1.0	0.5	0.9	58.9	33.3	2.6	18.7	32.6	14.3	14.4	6.1	4.1	6.6	11.8	11.0	25.9	12.3	11.6	39.2	5.3	13.8	7.0	8.5	34.7
NFKBIL1	"IKBL, NFKBIL"	ENSG00000204498	"NFKB inhibitor like 1"	Q9UBC1	6	31546870-31558829	"Disease related genes, Predicted intracellular proteins, Transcription factors"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC TERT1: 5.8;HBEC3-KT: 5.0;HEK 293: 20.2;JURKAT: 9.8;U-266/70: 10.8;U-266/84: 9.6;U-698: 5.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006298			Supported	Nucleoplasm		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 50: Non-specific - Ribosome"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"HPA006298: AB_1079480"	"unprognostic (1.11e-1)"	"unprognostic (3.18e-1)"	"unprognostic (2.01e-1)"	"prognostic unfavorable (3.38e-4)"	"unprognostic (1.21e-1)"	"unprognostic (3.63e-1)"	"unprognostic (2.51e-2)"	"unprognostic (6.29e-2)"	"unprognostic (5.41e-2)"	"unprognostic (5.97e-3)"	"unprognostic (5.54e-2)"	"unprognostic (1.33e-1)"	"unprognostic (2.16e-1)"	"unprognostic (8.73e-2)"	"unprognostic (9.92e-2)"	"unprognostic (3.15e-1)"	"unprognostic (7.50e-2)"	20.4	18.3	0.0	0.5	0.0	0.0	21.5	0.0	0.3	22.8	0.0	26.9	0.0	21.1	2.2	17.5	22.3	0.0	19.4	0.0	0.0	20.8	23.4	16.7	0.0	0.0	0.0	33.0	42.8	0.0	23.9	0.0	0.0	24.3	0.0	0.4	19.8	0.0	27.6	24.2	16.5	0.0	0.0	19.4	30.4	17.4	0.0	0.0	23.4	0.0	0.0	23.1	19.4	0.1	0.0	4.0	0.0	0.1	4.4	5.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	2.8	0.0	0.0	5.0	0.0	0.0	20.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.8	9.6	5.9	0.0	0.0	0.0	0.2	0.3	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.1	0.2	0.2	0.9	0.4	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	18.7	6.4	3.6	7.8	14.9	20.8	26.7	31.4	30.1	18.8	25.6	25.5	5.7	25.8	12.8	25.8	2.1	21.8	13.2	23.1	39.2	27.0	8.7	15.9	14.6	18.4	7.8	9.2	5.6	31.8	28.1	19.6	25.5	12.9	7.0	25.2	24.3	15.8	24.4	6.7	6.1	27.1	14.2	29.3	16.1	8.9	25.4	17.4	8.8	1.9	26.2	26.8	24.7	3.5	5.2	32.7	22.4	25.9	8.3	24.3	61.4	24.8	13.0	17.9	26.3	20.2	30.9	12.7	10.0	17.4	18.8	29.6	11.6	30.7	26.2	22.3
NFKBIZ	"FLJ34463, INAP, MAIL"	ENSG00000144802	"NFKB inhibitor zeta"	Q9BYH8	3	101827991-101861022	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"bone marrow: 406.0"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"non-classical monocyte: 33.9"	"Group enriched"	"Detected in many"	5	"granulocytes: 24.7;monocytes: 33.9"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 72.1;RPTEC TERT1: 71.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA010547, HPA075363"	Enhanced		Supported	"Nuclear speckles,Cytoplasmic bodies"		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 41: Macrophages - Immune response"	"Nuclear speckles"	"Cytoplasmic bodies"	"HPA010547: AB_1854442, HPA075363: AB_2686745"	"unprognostic (2.20e-2)"	"unprognostic (1.11e-2)"	"unprognostic (6.76e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.54e-2)"	"unprognostic (1.68e-2)"	"unprognostic (1.62e-2)"	"unprognostic (1.62e-1)"	"unprognostic (9.22e-2)"	"unprognostic (5.96e-2)"	"unprognostic (1.40e-1)"	"unprognostic (8.82e-2)"	"prognostic unfavorable (4.30e-8)"	"unprognostic (2.69e-1)"	"unprognostic (8.90e-2)"	"unprognostic (3.30e-1)"	"unprognostic (8.52e-3)"	57.5	12.0	2.8	44.4	5.2	406.0	31.7	4.7	6.0	13.4	19.1	24.5	52.6	36.3	3.7	26.9	64.8	51.3	23.6	3.4	4.8	29.2	52.4	48.2	27.2	6.7	4.2	19.1	27.0	3.6	12.5	22.3	5.5	26.6	30.6	8.0	80.8	7.4	4.6	45.7	23.2	54.6	6.2	26.9	30.5	3.7	6.8	18.8	24.7	10.2	22.7	71.3	18.3	5.0	6.5	5.2	3.5	4.4	9.7	16.7	5.3	26.2	72.1	11.3	10.7	6.3	7.8	12.2	32.4	7.2	34.8	20.5	2.5	11.4	29.2	35.9	2.3	11.7	10.2	3.4	14.7	0.8	0.7	11.6	17.3	30.5	13.7	27.8	8.4	0.3	2.0	24.6	16.2	8.1	0.2	6.9	6.0	2.3	15.3	1.5	15.7	1.5	71.0	42.7	1.5	1.9	4.4	5.3	29.6	7.4	6.3	4.8	10.6	18.1	18.0	6.9	8.6	20.4	7.8	8.1	32.9	2.2	2.5	11.7	5.9	1.7	1.4	13.1	1.7	2.9	2.1	1.6	3.8	4.6	6.0	4.2	24.7	0.8	33.9	6.0	1.3	2.3	2.8	5.2	4.7	6.0	3.4	4.8	6.7	4.2	5.5	6.2	6.8	5.0	199.5	86.6	266.6	10.7	91.3	281.7	61.2	123.0	103.0	9.0	108.7	105.8	20.6	84.4	143.0	66.2	2.1	19.3	98.6	157.8	0.0	213.0	4.6	116.1	221.4	135.3	73.6	21.0	23.7	132.1	41.0	214.2	277.8	291.9	381.8	17.9	82.1	65.2	56.5	10.1	20.2	69.7	59.0	150.6	291.5	1.3	20.2	318.4	71.2	16.9	79.0	25.7	12.3	17.1	79.3	127.6	115.8	0.7	128.5	88.8	91.2	5.6	117.3	8.9	19.7	218.4	131.1	0.6	2.6	136.4	251.7	25.6	134.0	19.2	111.7	70.5
NFS1	"IscS, NifS"	ENSG00000244005	"NFS1 cysteine desulfurase"	Q9Y697	20	35668052-35699355	"Enzymes, Predicted intracellular proteins"	"Molybdenum cofactor biosynthesis"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Proximal tubular cells: 56.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034314, HPA051801, HPA054755"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Nucleoplasm, Cytosol"		"CAB034314: AB_2235980, HPA051801: AB_2681616, HPA054755: AB_2682594"	"unprognostic (1.72e-1)"	"unprognostic (2.96e-1)"	"unprognostic (1.27e-2)"	"unprognostic (5.88e-3)"	"unprognostic (1.05e-1)"	"unprognostic (4.33e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.02e-1)"	"unprognostic (9.00e-2)"	"unprognostic (1.73e-1)"	"unprognostic (6.52e-3)"	"unprognostic (3.93e-2)"	"prognostic favorable (4.72e-6)"	"unprognostic (2.33e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.64e-2)"	"unprognostic (5.54e-2)"	12.0	28.7	17.8	7.7	19.0	4.5	10.6	19.5	20.4	11.6	19.0	13.1	12.4	9.1	10.3	11.0	12.5	8.5	22.6	18.2	20.0	42.2	37.7	6.8	8.6	17.4	17.7	13.1	11.9	25.9	12.3	8.6	19.8	9.9	14.1	17.1	13.5	12.6	25.3	10.6	11.1	11.0	17.3	7.7	12.1	19.0	19.6	9.3	10.7	36.5	12.1	9.7	9.1	19.4	29.6	36.0	12.3	13.0	32.7	29.9	24.9	21.9	23.1	32.2	20.9	65.4	16.3	25.1	42.1	20.6	33.3	36.3	42.6	44.5	29.3	11.3	20.0	53.7	37.6	51.4	27.1	22.9	9.9	24.2	41.6	25.5	27.9	24.1	24.6	29.0	38.9	16.3	23.1	45.3	25.8	24.0	14.3	67.1	53.3	10.1	39.9	42.2	33.0	19.6	15.4	14.1	54.9	52.3	36.9	28.6	46.9	20.1	18.2	36.4	17.4	21.6	21.9	23.5	34.3	22.6	30.9	24.2	18.5	3.0	6.8	6.5	5.8	6.7	7.7	8.4	6.7	8.9	9.4	5.6	7.8	7.2	2.7	10.6	5.2	4.5	9.6	5.5	17.8	19.0	19.5	20.4	18.2	20.0	17.4	17.7	19.8	17.3	19.6	19.4	9.7	6.4	15.0	9.4	8.0	6.1	8.1	16.7	6.2	14.9	11.7	10.3	20.6	21.5	10.4	18.4	10.4	35.2	5.4	12.3	33.2	15.9	6.0	7.2	8.5	6.9	6.7	13.9	9.0	11.2	22.5	10.7	11.2	8.8	7.0	8.7	6.8	26.8	16.1	15.2	9.9	7.0	16.2	8.9	4.8	4.4	5.6	7.0	10.6	6.5	12.3	15.2	5.2	4.5	12.6	10.9	11.0	10.5	5.8	5.6	17.3	56.6	7.6	13.5	13.1	8.6	9.1	50.7	19.7	9.1	5.7	21.1	7.4	25.4	14.8	7.9
NFU1	"CGI-33, HIRIP5, NifU, NIFUC"	ENSG00000169599	"NFU1 iron-sulfur cluster scaffold"	Q9UMS0	2	69396113-69437628	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal tubular cells: 189.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035826	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 38: Heart - Muscle contraction"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Cytosol	Nucleoplasm	"HPA035826: AB_2674803"	"unprognostic (4.49e-3)"	"unprognostic (5.62e-2)"	"unprognostic (5.40e-2)"	"unprognostic (1.84e-1)"	"unprognostic (2.81e-1)"	"unprognostic (2.16e-3)"	"unprognostic (2.63e-2)"	"unprognostic (1.76e-1)"	"unprognostic (6.12e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.31e-1)"	"unprognostic (2.12e-1)"	"unprognostic (2.21e-3)"	"unprognostic (2.63e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.91e-2)"	"unprognostic (2.87e-1)"	66.8	46.3	36.8	22.5	39.3	33.4	56.8	40.0	56.0	35.6	37.4	51.4	31.3	35.9	51.9	27.9	35.3	29.0	110.4	37.5	40.9	64.2	39.5	31.8	30.0	40.2	39.7	38.0	39.9	43.3	45.1	38.1	41.4	34.3	38.1	56.9	41.2	36.5	140.8	22.3	33.4	33.1	39.9	31.0	43.8	34.6	39.0	22.8	41.9	120.2	29.5	44.8	31.1	42.0	59.3	59.2	56.1	55.5	70.4	75.4	61.6	61.0	62.0	59.0	47.8	114.7	56.9	42.4	30.0	57.0	85.6	25.4	63.7	64.2	79.5	77.8	62.3	43.5	38.2	102.0	70.1	73.7	59.2	58.4	37.2	67.5	41.2	56.0	65.6	41.8	80.1	41.8	99.1	11.9	39.1	119.0	53.9	62.9	64.3	42.6	85.5	15.6	83.5	57.6	45.9	34.3	35.2	32.2	92.5	57.6	40.8	49.4	67.8	71.3	47.1	52.2	80.8	53.8	48.4	23.1	54.2	74.7	55.8	20.2	13.6	25.5	15.9	18.6	15.6	21.7	16.3	18.9	12.4	25.1	16.9	18.6	4.3	18.0	28.5	25.0	24.8	12.3	36.8	39.3	40.0	56.0	37.5	40.9	40.2	39.7	41.4	39.9	39.0	42.0	30.6	32.1	22.5	9.8	37.0	16.2	35.9	96.7	21.1	23.9	33.2	29.6	92.3	37.1	42.6	38.6	12.5	113.9	34.1	34.6	189.8	56.9	111.0	40.0	27.1	34.9	53.3	25.7	15.4	60.9	70.5	30.9	20.4	25.3	58.3	21.6	33.5	32.0	82.6	18.5	18.8	47.7	57.0	35.8	24.0	34.2	34.8	30.2	39.2	10.3	66.8	55.6	46.4	21.1	27.1	50.3	39.7	36.9	25.4	28.8	56.3	163.0	58.9	33.4	46.0	36.9	44.1	82.9	60.4	18.8	14.9	61.3	33.3	42.7	46.3	35.4
NFX1	"MGC20369, NFX2, TEG-42, Tex42"	ENSG00000086102	"Nuclear transcription factor, X-box binding 1"	Q12986	9	33290512-33371157	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Host-virus interaction, Transcription, Transcription regulation, Ubl conjugation pathway"	"Activator, DNA-binding, Repressor, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA056310, HPA061382, HPA073519"	Approved		Enhanced	Nucleoplasm,Cytosol		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 29: Early spermatids - Spermatogenesis"	"Nucleoplasm, Cytosol"		"HPA056310: AB_2683097, HPA061382: AB_2684496, HPA073519: AB_2686614"	"unprognostic (3.90e-2)"	"unprognostic (6.01e-2)"	"unprognostic (1.19e-2)"	"unprognostic (1.40e-1)"	"unprognostic (3.07e-2)"	"unprognostic (2.02e-2)"	"unprognostic (9.11e-2)"	"unprognostic (1.81e-2)"	"unprognostic (8.71e-2)"	"prognostic favorable (3.75e-4)"	"unprognostic (3.40e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.13e-3)"	"unprognostic (3.36e-2)"	"unprognostic (1.14e-2)"	"unprognostic (9.62e-2)"	"unprognostic (3.20e-2)"	16.8	16.8	13.7	15.6	14.5	21.9	20.6	20.4	17.6	15.5	15.9	17.1	16.9	17.4	15.7	18.3	15.4	12.4	23.4	13.8	15.0	14.6	27.7	16.0	22.3	13.7	12.8	21.9	15.8	23.4	13.5	13.5	13.5	16.5	19.1	19.4	17.9	16.0	37.7	25.5	17.5	15.7	10.9	18.2	15.8	12.2	14.0	26.3	22.9	26.5	25.2	16.8	15.7	18.2	29.8	24.0	21.4	20.3	31.3	35.1	21.5	27.6	27.4	30.6	30.5	21.7	11.9	46.0	17.0	32.0	20.5	16.3	38.8	29.8	28.4	33.9	18.9	24.1	58.2	24.5	38.1	43.3	25.6	32.7	48.9	26.1	65.4	27.3	18.9	25.6	37.6	38.3	32.2	20.9	28.3	40.7	34.7	21.9	26.8	30.0	23.3	25.2	20.7	28.1	29.3	20.6	27.5	29.3	15.9	25.1	17.0	42.7	23.8	24.8	20.6	18.1	30.4	20.4	19.9	44.6	27.3	21.5	14.4	35.9	5.5	10.4	9.8	8.9	10.5	13.0	10.7	10.8	9.0	10.3	11.8	11.9	3.5	9.3	7.4	15.4	7.6	6.7	13.7	14.5	20.4	17.6	13.8	15.0	13.7	12.8	13.5	10.9	14.0	18.2	16.0	60.9	42.5	35.3	41.9	8.4	24.6	12.5	21.6	29.3	13.2	13.5	36.9	22.8	35.4	27.6	54.2	12.5	17.2	20.6	7.9	16.1	65.9	16.7	19.0	14.9	9.1	25.2	59.7	13.2	11.8	18.5	26.5	19.8	18.9	15.7	17.5	32.4	15.0	21.9	59.0	23.9	12.2	19.4	10.2	17.0	18.3	19.0	3.6	47.8	16.4	13.7	16.5	37.7	55.0	12.4	21.6	23.0	47.1	25.3	23.3	8.2	43.7	32.2	13.1	27.3	17.5	16.1	14.8	20.9	11.2	18.1	20.9	19.2	16.7	21.0
NFYA	"CBF-B, HAP2, NF-YA"	ENSG00000001167	"Nuclear transcription factor Y subunit alpha"	P23511	6	41072945-41099976	"Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 41.4;Late spermatids: 44.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009250, HPA050779"	Enhanced		Supported	Nucleoplasm		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 21: OE19 - Mitochondria"	"Cluster 31: Spermatids - Spermatogenesis"	Nucleoplasm		"CAB009250: AB_2152107, HPA050779: AB_2681234"	"unprognostic (2.56e-1)"	"unprognostic (4.48e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.95e-2)"	"unprognostic (4.57e-1)"	"unprognostic (1.94e-2)"	"prognostic unfavorable (8.74e-4)"	"unprognostic (1.97e-2)"	"unprognostic (2.24e-2)"	"unprognostic (5.23e-3)"	"unprognostic (5.62e-3)"	"unprognostic (1.03e-1)"	"unprognostic (1.92e-3)"	"unprognostic (3.11e-1)"	"unprognostic (5.98e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.92e-3)"	10.8	8.9	13.3	14.0	18.1	40.7	15.6	14.3	13.2	11.3	9.6	11.9	9.9	14.9	14.7	10.8	11.6	12.5	8.8	12.5	13.4	10.1	14.3	11.8	19.5	15.8	16.6	18.7	11.5	15.3	9.0	13.8	15.5	13.6	14.6	21.5	9.4	8.0	9.3	10.6	11.2	10.8	13.6	14.5	12.6	38.5	14.8	41.5	18.4	12.4	20.5	14.6	9.4	24.3	32.8	26.3	49.2	82.7	19.9	19.3	20.9	24.2	22.4	37.2	31.4	34.6	23.3	39.4	19.7	16.0	19.6	21.0	30.1	29.1	40.9	28.4	38.0	51.7	23.2	49.4	14.1	55.0	43.3	12.3	24.4	29.8	40.0	18.1	32.6	64.5	51.4	46.4	36.9	32.4	62.5	22.1	22.1	95.8	25.9	50.3	27.1	29.6	27.2	43.8	49.8	34.3	21.1	18.9	37.5	31.2	17.7	55.1	32.2	65.7	35.6	13.2	46.9	18.2	19.8	64.2	13.0	46.2	26.5	2.7	2.9	4.8	5.8	3.9	7.6	3.7	5.4	6.4	3.3	4.1	5.7	6.3	8.0	6.5	3.5	4.3	6.7	3.2	13.3	18.1	14.3	13.2	12.5	13.4	15.8	16.6	15.5	13.6	14.8	24.3	7.6	9.6	3.9	6.2	11.1	14.5	9.9	4.2	2.8	4.1	13.2	7.1	4.7	11.5	5.3	11.0	4.2	7.7	11.7	9.3	1.9	11.3	41.4	7.4	7.7	7.5	4.8	12.2	4.4	7.4	12.5	6.8	5.1	8.1	2.5	11.9	7.5	7.0	10.0	0.0	5.1	4.2	4.1	9.3	14.0	44.4	3.7	6.4	7.2	10.3	7.2	3.3	7.2	5.0	13.8	9.6	9.6	3.0	5.6	12.8	5.1	2.6	6.9	5.0	0.0	4.3	8.3	20.0	8.2	6.3	15.9	10.8	10.1	5.6	7.6	18.7
NFYB	"CBF-A, HAP3, NF-YB"	ENSG00000120837	"Nuclear transcription factor Y subunit beta"	P25208	12	104117086-104138241	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	4	"Syncytiotrophoblasts: 433.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SK-BR-3: 132.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004211, HPA065646"	Supported		Supported	Nucleoplasm		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	Nucleoplasm		"CAB004211: AB_628018, HPA065646: "	"unprognostic (5.82e-2)"	"unprognostic (2.44e-3)"	"unprognostic (4.90e-2)"	"unprognostic (7.10e-3)"	"unprognostic (2.67e-1)"	"unprognostic (4.65e-2)"	"unprognostic (2.10e-2)"	"unprognostic (2.44e-1)"	"unprognostic (7.36e-2)"	"unprognostic (2.63e-1)"	"unprognostic (9.39e-2)"	"unprognostic (8.51e-2)"	"prognostic unfavorable (9.28e-5)"	"unprognostic (1.62e-3)"	"unprognostic (4.98e-2)"	"unprognostic (1.36e-1)"	"unprognostic (4.81e-3)"	32.9	40.8	34.0	15.2	34.3	14.7	27.2	30.5	50.8	28.6	26.8	60.4	15.0	30.5	33.1	16.1	30.1	18.5	37.4	31.0	31.2	24.0	30.6	29.0	24.7	32.9	34.0	23.2	21.3	21.7	17.4	23.6	32.0	39.0	18.4	21.2	20.6	67.9	36.2	18.4	21.7	21.1	34.7	19.4	26.3	22.6	32.1	26.3	22.7	36.3	22.8	38.1	23.9	36.2	30.1	25.3	55.3	35.7	34.2	35.6	48.6	31.5	27.2	37.2	25.6	21.2	14.0	44.4	15.1	30.3	22.9	22.0	46.5	20.9	37.4	28.9	14.7	27.4	31.0	19.7	31.0	35.0	17.6	49.3	25.6	14.5	25.5	62.0	24.0	40.1	27.1	16.2	31.6	29.6	53.2	40.5	52.8	22.1	26.0	43.5	30.9	18.8	27.3	25.3	31.3	26.2	58.0	132.5	19.3	36.8	53.1	42.9	15.2	21.3	13.1	17.5	24.0	28.5	29.5	42.0	12.5	23.7	22.8	18.0	5.7	18.5	12.1	7.8	16.6	12.3	12.1	12.5	5.7	8.5	13.0	13.7	7.2	13.5	9.0	5.0	16.9	9.1	34.0	34.3	30.5	50.8	31.0	31.2	32.9	34.0	32.0	34.7	32.1	36.2	42.5	54.5	26.7	8.8	21.1	37.3	106.8	42.9	15.9	22.7	24.3	31.8	39.5	12.8	30.3	18.4	4.2	58.8	24.5	13.3	37.2	24.2	6.2	20.4	36.4	36.5	12.0	39.4	13.1	18.3	86.3	43.0	11.2	17.5	21.5	30.8	77.1	31.2	23.1	15.2	13.7	15.4	30.5	14.4	29.8	5.4	34.2	19.2	28.4	8.4	20.2	43.3	22.6	11.1	25.3	27.3	16.9	30.5	17.1	54.5	12.6	42.5	26.7	27.2	19.7	35.4	40.0	90.0	32.4	18.0	37.1	433.2	25.6	18.8	18.3	55.7
NFYC	"CBF-C, NF-YC"	ENSG00000066136	"Nuclear transcription factor Y subunit gamma"	Q13952	1	40691648-40771603	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"THP-1: 347.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA055011			Supported	Nucleoplasm		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 59: Non-specific - Translation"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 47: Cytotrophoblasts - Unknown function"	Nucleoplasm		"HPA055011: AB_2682671"	"unprognostic (1.20e-3)"	"unprognostic (1.51e-2)"	"unprognostic (9.77e-2)"	"unprognostic (1.37e-3)"	"unprognostic (8.53e-2)"	"unprognostic (1.92e-2)"	"prognostic unfavorable (7.24e-4)"	"unprognostic (1.47e-2)"	"unprognostic (5.66e-3)"	"unprognostic (3.53e-3)"	"unprognostic (2.75e-1)"	"unprognostic (2.60e-2)"	"prognostic favorable (1.24e-4)"	"unprognostic (2.25e-2)"	"unprognostic (3.63e-1)"	"unprognostic (3.12e-1)"	"unprognostic (7.75e-3)"	27.2	26.9	29.4	29.8	30.6	40.6	29.6	37.7	35.3	31.9	37.2	31.3	28.9	32.4	24.0	33.6	31.1	23.7	60.8	31.0	28.9	31.8	33.8	24.3	37.1	28.6	29.6	40.6	32.7	50.2	20.9	30.2	28.5	25.8	23.5	27.7	46.7	24.5	72.9	42.9	29.6	28.9	28.0	39.7	31.2	22.7	31.4	41.1	34.8	63.5	33.8	29.4	30.3	33.8	34.7	46.6	67.3	51.0	26.6	24.1	67.2	28.3	31.5	49.4	46.2	65.4	85.7	83.0	43.2	27.1	43.7	40.8	54.6	42.5	51.5	50.6	57.7	90.1	33.8	59.9	31.6	48.0	73.8	26.8	45.2	48.9	51.4	38.0	32.6	62.4	40.3	51.5	23.7	47.6	86.6	47.3	58.2	41.4	36.0	64.2	71.7	74.9	46.6	41.9	45.8	42.4	33.9	73.4	77.4	77.2	33.3	347.6	29.8	22.9	77.9	40.5	42.4	47.6	84.0	68.9	53.2	61.1	62.8	54.8	61.8	64.7	28.4	69.3	29.2	47.0	37.6	32.2	59.8	43.1	40.3	30.5	103.2	41.3	81.1	46.2	44.2	41.0	29.4	30.6	37.7	35.3	31.0	28.9	28.6	29.6	28.5	28.0	31.4	33.8	27.3	19.2	21.3	51.6	40.0	29.2	28.1	25.5	31.3	18.6	22.6	24.5	32.6	15.7	20.6	11.0	10.4	74.4	22.6	23.7	37.2	27.6	9.2	14.8	22.0	29.0	16.3	39.5	37.6	37.5	51.9	21.7	25.5	21.7	38.0	25.2	26.0	23.1	51.9	25.2	46.8	21.9	30.5	30.5	31.6	6.2	27.7	33.0	17.8	49.6	44.2	29.3	25.7	39.2	41.9	26.8	18.7	21.4	33.6	19.6	25.2	22.3	10.7	12.6	19.7	24.0	27.5	43.8	39.1	27.3	32.4	76.1	30.2	27.7	27.4	25.1
NGFR	"CD271, p75NTR, TNFRSF16"	ENSG00000064300	"Nerve growth factor receptor"	P08138	17	49495293-49515008	"Cancer-related genes, CD markers, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins"	"Apoptosis, Biological rhythms, Differentiation, Neurogenesis"	"Developmental protein, Receptor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 63.6"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 52.4;Basal squamous epithelial cells: 36.5;Ionocytes: 89.5;Leydig cells: 96.0;Muller glia cells: 151.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	8	"plasmacytoid DC: 1.2"	"Lineage enriched"	"Detected in single"	8	"dendritic cells: 1.2"	"Group enriched"	"Detected in some"	7	"RH-30: 200.1;WM-115: 225.3"	"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"basal ganglia: 10.1"	"CAB000143, CAB001995, HPA004765"	Enhanced		Approved	"Nucleoplasm,Plasma membrane"		NA	NA		490000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 5: Muller glia cells - Visual perception"	"Nucleoplasm, Plasma membrane"		"CAB000143: , CAB001995: , HPA004765: AB_1079233"	"unprognostic (6.25e-3)"	"unprognostic (1.06e-3)"	"unprognostic (3.39e-3)"	"unprognostic (6.67e-2)"	"unprognostic (1.46e-2)"	"unprognostic (2.26e-1)"	"unprognostic (8.22e-2)"	"unprognostic (4.94e-2)"	"unprognostic (1.08e-2)"	"unprognostic (4.10e-3)"	"unprognostic (1.85e-2)"	"unprognostic (1.25e-1)"	"unprognostic (3.37e-2)"	"unprognostic (4.01e-2)"	"unprognostic (3.06e-2)"	"unprognostic (2.77e-3)"	"prognostic unfavorable (3.40e-4)"	36.8	20.7	4.1	8.2	12.1	0.4	20.3	17.3	63.6	13.1	1.4	16.8	2.4	12.0	4.0	6.5	20.2	9.4	40.9	3.2	25.1	8.0	22.8	2.9	5.0	16.9	15.2	4.1	10.9	1.3	10.5	14.7	15.1	19.1	2.4	45.1	21.2	7.6	4.8	15.9	8.0	8.2	10.9	23.0	7.9	7.7	17.2	2.0	28.9	1.3	3.9	15.3	13.2	27.8	0.0	0.1	6.3	10.2	0.0	0.1	0.1	0.0	0.0	0.1	0.3	0.2	0.1	0.0	2.1	0.1	3.4	4.8	1.5	4.6	0.0	0.4	0.7	0.4	0.0	3.8	0.4	0.3	0.3	20.9	0.3	0.6	1.5	0.1	0.0	0.0	0.0	0.1	29.5	0.6	0.0	0.1	3.8	0.0	0.2	3.9	200.1	0.2	0.0	0.0	1.9	1.3	0.1	0.0	14.0	7.4	0.4	0.2	0.0	0.1	3.4	0.6	10.2	0.2	0.3	0.1	0.2	1.9	225.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.2	0.0	0.0	4.1	12.1	17.3	63.6	3.2	25.1	16.9	15.2	15.1	10.9	17.2	27.8	1.2	0.0	0.0	0.0	1.1	3.6	33.1	52.4	36.5	4.8	2.4	10.9	0.7	0.0	3.8	0.0	4.2	0.5	4.0	0.0	0.0	0.1	0.7	0.2	0.6	1.3	0.0	0.0	0.1	0.0	0.5	7.3	0.5	0.2	0.0	0.0	1.8	0.2	0.1	0.0	0.0	0.0	89.5	0.0	3.1	2.9	96.0	0.7	16.0	0.0	0.0	151.7	0.0	0.0	6.5	0.0	0.0	27.8	1.0	3.7	0.0	0.1	1.7	7.0	32.9	1.7	12.9	0.4	0.9	1.8	1.7	0.1	2.3	0.4	0.0	2.9
NGRN	DSC92	ENSG00000182768	"Neugrin, neurite outgrowth associated"	Q9NPE2	15	90265659-90275778	"Predicted intracellular proteins"	Differentiation	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 385.3;skeletal muscle: 376.8"	"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 75.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA041367, HPA076267"	Approved		Supported	"Nucleoplasm,Cytokinetic bridge,Mitochondria"	"Intracellular and membrane"	Yes	No			"Cluster 35: T-regs - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 16: U-266 - Nucleosome"	"Cluster 59: Non-specific - Transcription"	Mitochondria	"Nucleoplasm, Cytokinetic bridge"	"HPA041367: AB_10796668, HPA076267: "	"unprognostic (2.82e-1)"	"unprognostic (1.04e-2)"	"unprognostic (1.66e-3)"	"unprognostic (2.34e-1)"	"unprognostic (2.21e-1)"	"unprognostic (3.19e-2)"	"unprognostic (2.94e-2)"	"unprognostic (5.00e-2)"	"unprognostic (7.78e-2)"	"unprognostic (1.93e-2)"	"unprognostic (5.22e-2)"	"unprognostic (7.22e-2)"	"unprognostic (3.31e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.05e-1)"	"unprognostic (1.68e-3)"	"unprognostic (3.21e-1)"	61.0	91.8	322.8	32.9	334.0	31.7	61.4	312.4	385.3	68.8	312.1	47.0	39.7	63.4	98.3	51.7	65.3	47.1	133.0	332.8	329.8	71.7	59.1	50.3	31.8	316.3	322.1	67.8	46.4	87.6	3.0	46.4	318.1	80.1	51.1	157.0	46.3	88.9	376.8	32.6	35.6	74.6	324.8	37.0	41.5	54.2	334.5	39.6	74.0	291.8	37.4	69.2	2.7	320.9	62.1	127.8	151.7	99.7	138.4	63.9	70.4	100.7	88.4	110.5	94.0	133.2	90.5	38.4	113.8	108.9	110.2	118.2	120.3	64.7	121.5	42.6	104.6	61.0	88.4	110.6	117.7	44.5	36.1	83.4	183.3	60.8	132.9	83.7	79.5	45.7	105.0	64.7	112.8	106.5	35.9	53.5	152.7	198.8	55.0	65.6	72.8	63.1	109.8	168.3	145.8	117.0	107.1	90.1	239.1	149.1	141.9	82.6	64.6	138.3	92.3	85.7	161.7	96.9	268.2	66.4	76.8	90.1	106.4	66.4	62.1	99.0	87.2	65.2	109.9	107.7	106.1	101.9	59.2	105.7	122.6	106.8	23.4	86.7	76.0	62.8	133.5	108.0	322.8	334.0	312.4	385.3	332.8	329.8	316.3	322.1	318.1	324.8	334.5	320.9	10.8	19.2	27.4	21.5	26.2	7.1	10.6	3.7	75.1	10.4	9.1	5.8	10.1	1.5	21.6	5.5	10.4	5.9	5.0	12.1	5.9	33.6	1.9	16.2	14.6	15.8	26.5	12.0	58.3	23.4	4.5	23.0	30.1	9.4	20.3	5.5	7.5	3.8	4.2	16.8	54.0	14.4	4.1	3.8	3.6	4.0	9.0	8.4	8.8	16.9	11.6	15.1	0.0	12.5	22.2	29.9	20.0	8.6	25.0	9.2	12.6	7.8	59.8	11.2	13.1	10.5	19.6	5.2	4.3	55.2	5.1	6.7	19.9	5.7	15.4	8.7
NHEJ1	"Cernunnos, FLJ12610, XLF"	ENSG00000187736	"Non-homologous end joining factor 1"	Q9H9Q4	2	219069357-219160865	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"DNA damage, DNA repair"	DNA-binding	"Disease variant, SCID"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 7.8;Microglial cells: 11.2;Oligodendrocytes: 8.1"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012334, HPA043869"	Approved		Supported	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 71: Testis - DNA repair"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm	"Nucleoli fibrillar center"	"CAB012334: , HPA043869: AB_2678707"	"unprognostic (5.66e-2)"	"unprognostic (3.01e-2)"	"unprognostic (3.16e-1)"	"unprognostic (2.73e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.06e-2)"	"unprognostic (5.92e-2)"	"unprognostic (5.16e-2)"	"unprognostic (6.04e-2)"	"unprognostic (3.51e-2)"	"unprognostic (6.87e-2)"	"unprognostic (1.58e-3)"	"unprognostic (4.52e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.82e-1)"	"unprognostic (8.90e-2)"	"unprognostic (8.29e-2)"	10.2	8.4	2.4	4.4	2.5	4.5	8.5	3.8	3.8	9.4	2.2	14.0	6.9	8.7	4.3	7.2	7.4	4.8	6.2	2.4	2.9	12.8	8.1	6.9	6.1	3.3	2.5	9.1	8.4	3.4	2.8	4.6	3.2	6.7	8.4	3.4	5.7	4.3	17.1	8.4	12.2	8.1	2.7	6.9	9.0	18.7	2.7	6.1	4.6	7.6	5.8	10.4	8.7	3.5	5.5	8.2	13.9	12.6	15.6	17.9	8.0	10.9	9.6	13.2	15.4	25.4	5.9	12.2	8.4	11.4	13.4	7.2	20.5	10.9	11.8	13.8	9.0	18.1	10.0	17.5	12.5	8.5	13.9	15.5	21.2	10.5	12.5	8.9	11.1	7.8	22.3	11.8	10.7	4.6	11.5	10.3	15.9	5.1	8.0	14.6	10.2	9.8	10.5	8.2	10.2	11.4	5.0	7.1	15.8	15.6	6.4	8.0	9.9	10.0	9.3	4.4	9.1	6.3	8.0	13.2	6.1	16.2	10.3	6.3	11.9	6.6	7.0	17.7	12.2	12.0	11.4	9.3	8.7	9.0	14.1	10.4	3.3	11.6	15.6	4.8	12.8	9.1	2.4	2.5	3.8	3.8	2.4	2.9	3.3	2.5	3.2	2.7	2.7	3.5	0.3	0.0	0.0	5.9	3.5	0.4	0.0	0.2	5.7	0.0	0.2	0.1	0.1	0.0	0.7	0.0	0.0	0.2	1.7	7.8	0.0	1.6	0.7	0.1	0.3	1.0	2.4	3.8	4.7	1.9	0.3	0.6	5.6	0.2	0.0	0.0	0.0	0.3	0.3	0.0	5.1	3.4	0.0	0.0	0.0	0.2	0.3	2.1	0.0	11.2	3.1	0.0	0.0	5.0	8.1	1.0	2.9	0.0	6.1	0.2	3.4	0.4	0.0	0.0	0.0	0.1	1.3	0.2	0.5	5.9	0.0	0.3	2.6	0.2	3.1	0.0
NHS		ENSG00000188158	"NHS actin remodeling regulator"	Q6T4R5	X	17375200-17735994	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			Cataract	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enriched"	"Detected in many"	6	"Inhibitory neurons: 264.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in single"		"neutrophil: 1.3"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"EFO-21: 12.7;RPTEC TERT1: 19.2;RT4: 12.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA031497, HPA076257"	Uncertain		Supported	"Cell Junctions"		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Cell Junctions"		"HPA031497: AB_10610144, HPA076257: AB_2686789"	"unprognostic (1.39e-2)"	"unprognostic (3.34e-1)"	"unprognostic (1.17e-1)"	"prognostic favorable (1.68e-4)"	"unprognostic (2.58e-1)"	"unprognostic (1.69e-1)"	"unprognostic (9.92e-3)"	"unprognostic (3.27e-3)"	"unprognostic (1.08e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.61e-3)"	"unprognostic (2.54e-1)"	"unprognostic (1.72e-2)"	"unprognostic (1.07e-2)"	"unprognostic (1.21e-1)"	"unprognostic (8.83e-3)"	"unprognostic (1.83e-3)"	3.2	4.1	2.9	1.3	2.4	0.4	2.8	0.0	4.2	6.1	6.8	4.1	0.8	4.8	2.8	1.8	2.7	1.6	0.9	1.8	2.5	5.1	0.2	1.1	0.5	3.3	2.8	3.5	0.5	0.3	2.8	2.6	3.0	3.4	1.6	7.8	2.0	2.7	0.4	2.3	1.5	2.5	1.7	1.0	2.2	2.5	3.8	2.2	2.6	0.7	0.5	4.0	3.7	0.9	7.9	3.1	5.5	0.0	0.1	0.2	8.7	3.5	2.4	1.5	0.8	0.3	1.5	0.5	12.7	2.4	7.5	6.8	3.5	4.4	2.2	0.1	1.1	0.0	5.4	0.0	0.0	0.0	0.0	0.7	3.1	0.1	6.8	6.7	0.0	0.0	0.0	0.0	0.8	3.8	0.0	0.0	6.7	3.6	2.0	0.0	0.0	0.3	19.2	12.0	1.4	2.8	9.6	0.0	0.0	3.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	8.0	0.1	8.4	0.0	0.4	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	1.3	0.2	0.0	0.0	0.0	0.1	2.9	2.4	0.0	4.2	1.8	2.5	3.3	2.8	3.0	1.7	3.8	0.9	0.6	3.2	0.0	22.5	0.0	8.3	10.6	4.6	8.6	11.4	2.0	2.4	1.7	0.0	14.7	1.8	22.9	6.0	0.1	1.3	5.9	0.8	0.9	12.4	20.1	3.5	4.2	0.0	40.1	2.2	5.4	6.1	3.6	25.0	0.0	0.2	0.7	0.0	1.4	3.3	264.4	1.9	2.0	4.6	2.6	2.3	16.8	2.4	3.6	40.3	5.0	11.9	0.0	14.1	8.1	6.8	2.4	31.2	0.0	7.0	0.9	7.8	8.2	18.9	6.6	2.0	11.9	0.3	0.6	5.1	3.8	2.6	0.9	4.5	4.3	12.8
NIBAN1	"C1orf24, FAM129A, GIG39, NIBAN"	ENSG00000135842	"Niban apoptosis regulator 1"	Q9BZQ8	1	184790724-184974508	"Cancer-related genes, Predicted intracellular proteins"	"Stress response, Translation regulation"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 164.1"	"Cell type enriched"	"Detected in some"	13	"Cardiomyocytes: 692.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 72.1"	"Lineage enriched"	"Detected in all"	6	"granulocytes: 72.1"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 83.8;Karpas-707: 85.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA028172, HPA028231, HPA028657"	Approved		Supported	"Plasma membrane,Cytosol"		NA	NA		120000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 24: Non-specific - Transcription regulation"	"Plasma membrane, Cytosol"		"HPA028172: AB_10599602, HPA028231: AB_10601886, HPA028657: AB_10601680"	"unprognostic (4.61e-3)"	"unprognostic (3.45e-2)"	"unprognostic (1.64e-3)"	"unprognostic (9.46e-2)"	"unprognostic (2.77e-1)"	"unprognostic (3.87e-1)"	"unprognostic (3.23e-2)"	"unprognostic (1.30e-2)"	"unprognostic (1.68e-1)"	"unprognostic (6.32e-2)"	"unprognostic (4.12e-1)"	"unprognostic (1.32e-1)"	"unprognostic (2.94e-3)"	"unprognostic (9.01e-3)"	"unprognostic (4.38e-2)"	"unprognostic (3.73e-2)"	"prognostic unfavorable (4.52e-4)"	18.2	7.8	1.4	38.9	1.6	8.8	24.0	1.5	1.9	14.8	3.1	104.7	8.5	24.2	6.2	61.2	22.1	27.7	164.1	1.5	2.0	3.3	2.7	18.1	11.3	3.9	2.4	4.9	85.7	4.2	2.1	6.2	3.1	59.6	15.9	0.8	100.6	43.1	60.9	8.8	18.5	41.0	2.8	12.3	58.9	1.9	2.2	12.2	15.3	41.2	17.3	105.8	14.6	3.2	42.0	0.5	0.2	0.1	28.0	42.2	1.6	21.1	42.9	17.7	22.3	0.0	17.3	0.0	13.6	54.2	4.6	46.0	2.4	1.5	28.4	83.8	3.2	17.5	8.2	0.0	65.2	57.2	19.1	39.1	65.3	52.1	62.4	12.6	0.1	6.3	4.2	85.5	0.5	0.2	1.9	10.0	11.1	0.0	4.3	13.3	9.9	0.8	24.5	0.8	2.3	2.1	0.4	0.1	29.9	7.0	9.0	17.9	3.3	35.0	0.1	6.3	43.5	71.1	30.2	8.7	68.8	23.4	35.3	20.4	3.6	10.9	5.1	2.1	4.4	1.0	4.7	5.0	5.2	0.3	0.4	1.8	72.1	5.7	0.8	0.5	11.9	2.2	1.4	1.6	1.5	1.9	1.5	2.0	3.9	2.4	3.1	2.8	2.2	3.2	20.1	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	692.7	0.0	0.0	0.0	0.0	0.4	52.8	0.0	0.0	0.0	0.0	0.0	0.0	5.3	0.0	0.0	0.0	0.0	1.2	24.7	0.0	0.0	0.0	0.0	0.0	0.0	12.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	43.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	30.0	0.0	0.0	0.0	0.0	0.4	27.4	0.0	0.0	0.0
NIBAN2	"bA356B19.6, C9orf88, DKFZP434H0820, FAM129B, FLJ13518, FLJ22151, FLJ22298, MINERVA"	ENSG00000136830	"Niban apoptosis regulator 2"	Q96TA1	9	127505339-127578989	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 606.7"	"Cell type enhanced"	"Detected in some"		"Cytotrophoblasts: 73.6;Extravillous trophoblasts: 40.5;Hofbauer cells: 23.0;Syncytiotrophoblasts: 120.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"classical monocyte: 1.1"	"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021284, HPA021417, HPA023261, HPA024312"	Enhanced		Enhanced	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA		1500000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	"Plasma membrane, Cytosol"	Nucleoplasm	"HPA021284: AB_1848373, HPA021417: AB_1848374, HPA023261: AB_1848375, HPA024312: AB_1848376"	"unprognostic (3.05e-3)"	"unprognostic (9.47e-2)"	"unprognostic (1.14e-3)"	"unprognostic (4.07e-2)"	"unprognostic (3.80e-3)"	"unprognostic (1.09e-1)"	"unprognostic (3.14e-2)"	"unprognostic (2.57e-3)"	"unprognostic (1.40e-1)"	"unprognostic (1.68e-2)"	"unprognostic (1.17e-3)"	"unprognostic (6.45e-2)"	"unprognostic (3.75e-2)"	"unprognostic (1.24e-2)"	"unprognostic (1.31e-1)"	"unprognostic (8.40e-2)"	"unprognostic (8.20e-3)"	48.7	107.5	26.7	36.6	24.7	27.3	42.0	25.2	24.5	96.0	45.3	74.6	50.8	38.9	12.6	606.7	39.4	39.6	39.4	22.7	35.0	72.3	16.7	121.9	6.6	48.9	34.3	31.6	142.6	26.2	34.0	84.8	36.3	66.5	30.3	2.7	142.1	32.2	13.6	111.3	53.9	22.0	39.7	32.2	83.3	11.0	34.7	5.6	110.6	11.3	53.6	68.4	189.6	31.9	134.0	149.8	29.9	39.3	87.9	170.1	138.2	259.1	238.5	140.1	86.4	48.2	143.7	0.4	100.4	295.5	172.9	217.5	25.9	192.2	45.9	25.2	27.5	22.8	218.9	50.4	173.1	1.0	62.0	187.3	118.3	231.4	80.8	256.8	213.6	8.4	43.5	1.2	269.8	157.3	1.6	37.6	30.9	228.0	194.4	16.0	99.9	70.1	120.5	105.6	47.4	22.1	212.3	149.0	93.4	42.1	98.2	7.5	279.9	143.1	62.4	182.2	218.0	2.5	5.1	0.6	403.3	21.6	271.1	0.2	1.1	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.7	26.7	24.7	25.2	24.5	22.7	35.0	48.9	34.3	36.3	39.7	34.7	31.9	12.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.0	73.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	4.2	0.0	0.0	0.0	0.0	40.5	4.2	0.0	0.0	0.0	0.0	0.0	0.0	23.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	120.9	0.1	0.0	0.0	0.0
NICN1	MGC12936	ENSG00000145029	"Nicolin 1"	Q9BSH3	3	49422333-49429326	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 24.3;Late spermatids: 52.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA058014			Supported	Nucleoplasm		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 35: Non-specific - Unknown function"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 31: Spermatids - Spermatogenesis"	Nucleoplasm		"HPA058014: AB_2683579"	"unprognostic (4.10e-2)"	"unprognostic (1.08e-2)"	"unprognostic (7.31e-2)"	"unprognostic (1.33e-3)"	"unprognostic (1.14e-1)"	"unprognostic (1.31e-2)"	"unprognostic (1.31e-2)"	"unprognostic (4.50e-3)"	"unprognostic (1.04e-2)"	"unprognostic (2.88e-2)"	"prognostic favorable (1.11e-4)"	"unprognostic (2.46e-1)"	"prognostic favorable (8.81e-7)"	"unprognostic (3.11e-2)"	"unprognostic (2.37e-1)"	"unprognostic (1.03e-2)"	"unprognostic (2.96e-2)"	7.8	11.2	20.1	4.6	22.5	2.6	7.8	16.9	24.0	9.7	15.6	11.7	4.3	10.5	8.1	5.8	10.2	5.5	11.5	21.8	18.0	16.9	10.5	8.3	6.9	18.8	18.2	11.1	7.6	9.9	11.6	4.5	20.4	11.5	4.0	9.0	9.1	6.8	12.5	6.7	7.9	6.6	17.8	9.9	9.7	11.8	20.0	10.6	13.6	9.9	6.5	9.1	8.1	21.6	3.7	10.9	11.8	9.6	5.1	6.1	3.8	4.6	4.0	3.8	5.2	2.6	10.9	10.8	4.0	9.1	8.0	3.1	6.4	5.6	4.3	18.2	4.2	10.6	12.2	13.0	9.5	4.2	6.6	13.0	7.2	8.7	3.1	19.8	5.8	22.6	6.5	0.2	4.2	3.5	6.7	6.3	3.5	4.1	3.4	5.9	3.8	13.5	7.0	2.1	1.9	4.6	3.8	3.1	8.0	22.1	5.9	2.1	12.2	3.1	3.2	3.0	1.7	13.7	4.1	3.7	9.3	11.6	5.1	5.3	3.7	3.1	4.1	3.1	2.7	5.0	2.4	5.0	3.3	2.1	3.1	3.7	0.8	4.1	5.2	4.2	6.2	3.8	20.1	22.5	16.9	24.0	21.8	18.0	18.8	18.2	20.4	17.8	20.0	21.6	0.0	0.0	1.1	4.9	3.7	4.1	5.6	7.6	1.8	6.8	0.0	0.0	14.3	5.7	3.3	0.0	10.4	6.2	4.0	2.3	0.0	0.0	24.3	0.0	0.0	2.9	12.1	6.5	4.4	0.0	2.2	3.3	8.6	0.0	1.3	0.0	3.9	5.5	5.8	3.3	4.9	4.2	0.0	5.2	3.0	52.7	9.6	1.7	3.6	1.9	1.0	6.2	9.2	3.0	2.9	0.0	1.6	6.0	3.5	2.2	5.4	0.0	3.0	6.8	6.6	4.7	2.8	11.0	2.3	3.3	3.3	3.3	3.8	0.1	3.4	4.6
NIFK	"hNIFK, MKI67IP, Nopp34"	ENSG00000155438	"Nucleolar protein interacting with the FHA domain of MKI67"	Q9BYG3	2	121726945-121736911	"Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB015382, HPA035735, HPA035736, CAB075728, CAB075729"	Supported		Enhanced	"Nucleoli,Nucleoli rim,Mitotic chromosome"		Yes	No			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 50: Non-specific - Ribosome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoli, Nucleoli rim"	"Mitotic chromosome"	"CAB015382: AB_2142390, CAB075728: AB_2665734, CAB075729: AB_2665735, HPA035735: AB_2674758, HPA035736: AB_2674759"	"unprognostic (3.53e-2)"	"unprognostic (1.67e-1)"	"unprognostic (3.49e-1)"	"prognostic unfavorable (5.57e-4)"	"unprognostic (1.21e-1)"	"unprognostic (4.15e-3)"	"prognostic unfavorable (2.92e-6)"	"unprognostic (7.74e-3)"	"unprognostic (4.63e-2)"	"unprognostic (3.21e-2)"	"unprognostic (6.02e-3)"	"unprognostic (9.50e-2)"	"prognostic unfavorable (5.01e-11)"	"unprognostic (1.72e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.28e-1)"	29.3	24.8	18.1	31.9	18.6	31.5	37.3	18.7	21.8	25.4	17.9	24.8	25.1	28.5	21.9	34.6	27.5	25.1	22.9	19.3	18.7	25.7	34.1	17.9	47.2	18.5	17.8	36.5	32.6	17.9	16.7	25.6	18.4	24.6	25.6	23.0	17.9	17.8	38.3	34.5	20.1	24.8	19.1	22.3	22.5	21.8	18.3	32.9	25.2	18.3	42.4	43.3	24.5	20.1	118.4	37.6	68.8	68.3	57.9	80.6	90.2	90.6	75.2	105.0	113.2	105.9	55.0	152.4	111.4	66.9	93.1	72.9	149.4	116.4	153.4	101.3	85.7	155.0	44.5	92.9	82.6	141.1	81.7	80.6	126.7	137.4	184.4	48.7	75.9	60.3	174.5	73.9	90.5	58.2	109.5	140.9	175.3	132.4	122.5	102.5	80.7	191.2	92.1	72.4	88.1	91.8	56.6	105.1	200.7	62.2	52.0	123.1	45.7	72.8	123.5	85.6	129.3	87.5	150.6	182.1	55.7	143.9	101.5	41.8	54.2	28.8	59.2	65.3	83.4	73.6	72.3	68.6	72.1	74.8	84.5	79.4	4.0	81.5	62.5	64.0	68.9	75.1	18.1	18.6	18.7	21.8	19.3	18.7	18.5	17.8	18.4	19.1	18.3	20.1	51.1	44.8	25.9	8.1	56.3	98.4	128.9	87.0	81.4	25.8	51.2	88.8	21.5	24.3	62.2	14.7	12.5	74.9	62.7	18.9	46.9	64.2	23.7	43.8	126.9	47.7	28.1	41.8	8.2	45.2	90.6	68.7	32.6	39.9	54.5	47.9	26.0	33.2	54.4	13.5	7.2	41.3	42.7	34.5	32.8	8.0	57.5	39.0	23.2	10.3	59.1	48.0	54.6	13.0	8.0	51.5	28.4	45.1	33.3	107.0	18.4	58.4	41.9	45.8	39.5	72.7	54.3	81.1	83.9	79.3	101.4	48.8	52.5	97.7	60.5	125.2
NIN		ENSG00000100503	Ninein	Q8N4C6	14	50719763-50831162	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			"Cancer-related genes, Disease variant, Dwarfism, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 43.2"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 240.5;Muller glia cells: 150.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in all"		"basophil: 31.9"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005939, HPA070691"	Approved		Approved	"Nucleoplasm,Nucleoli,Nucleoli rim,Centrosome"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Nucleoli, Nucleoli rim, Centrosome"	Nucleoplasm	"HPA005939: AB_2667474, HPA070691: AB_2686296"	"unprognostic (1.98e-1)"	"unprognostic (1.06e-1)"	"unprognostic (3.54e-2)"	"unprognostic (3.96e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.43e-2)"	"unprognostic (3.41e-2)"	"unprognostic (3.31e-1)"	"unprognostic (5.81e-3)"	"unprognostic (1.78e-2)"	"unprognostic (2.07e-1)"	"unprognostic (4.06e-1)"	"unprognostic (2.46e-2)"	"unprognostic (2.67e-1)"	"unprognostic (1.28e-1)"	"unprognostic (2.58e-2)"	"unprognostic (7.66e-3)"	11.2	4.4	10.1	19.9	10.8	43.2	8.9	9.5	15.0	7.2	0.0	8.3	4.8	7.7	2.8	12.9	10.5	8.9	18.2	10.4	0.9	6.7	5.7	9.5	25.9	0.0	1.3	9.7	7.2	9.0	8.9	16.8	0.0	6.9	8.6	19.1	5.4	5.4	6.0	12.9	7.1	10.3	0.0	16.2	9.3	5.2	3.0	19.9	7.7	7.4	23.7	13.6	5.7	7.5	29.1	21.6	42.4	36.8	16.7	26.8	20.4	26.5	22.1	21.4	18.0	14.7	14.6	48.5	17.7	35.5	19.9	32.5	34.2	16.3	45.3	34.7	10.4	25.1	13.2	12.3	9.8	41.6	57.5	18.4	11.4	37.2	14.9	13.3	34.6	25.9	6.6	26.3	31.8	36.8	22.6	14.0	6.4	10.1	23.6	37.1	81.6	5.7	20.1	42.9	18.6	22.2	34.0	9.6	25.1	10.2	21.2	39.3	50.9	55.2	74.3	20.5	29.0	18.6	12.1	34.3	14.4	32.8	30.4	31.9	2.9	24.0	3.9	2.5	3.3	8.9	2.4	6.2	2.0	6.2	5.1	4.7	9.6	2.9	2.1	7.7	2.5	1.4	10.1	10.8	9.5	15.0	10.4	0.9	0.0	1.3	0.0	0.0	3.0	7.5	34.0	6.4	7.7	100.2	85.6	18.4	9.1	10.2	18.8	13.3	13.3	10.9	68.0	14.3	27.1	11.0	62.6	12.4	102.7	8.7	3.9	7.3	22.2	17.3	28.5	26.7	12.6	29.0	240.5	4.2	11.3	32.9	7.7	14.9	31.6	3.9	21.8	4.4	22.7	6.7	110.4	5.7	20.3	46.8	42.2	10.4	8.4	61.3	23.2	63.7	63.2	150.2	57.7	105.6	75.1	5.2	6.2	9.4	48.1	16.5	3.2	7.3	29.4	21.0	32.9	44.9	24.1	0.2	4.3	20.1	21.0	9.7	56.2	21.8	6.9	15.5
NINJ2		ENSG00000171840	"Ninjurin 2"	Q9NZG7	12	564296-663779	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 45.1"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 29.8;Alveolar cells type 2: 39.9;Erythroid cells: 35.4;Hofbauer cells: 30.7;Kupffer cells: 38.3;Oligodendrocytes: 109.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEL: 153.5;MOLT-4: 263.8;THP-1: 54.4;U-698: 49.3"	"Low region specificity"	"Detected in all"							"HPA058980, HPA067226"			Approved	"Nucleoplasm,Endoplasmic reticulum,Plasma membrane,Centriolar satellite,Cytosol"		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 70: Brain - Nervous system development"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Endoplasmic reticulum"	"Nucleoplasm, Plasma membrane, Centriolar satellite, Cytosol"	"HPA058980: AB_2683869, HPA067226: "	"unprognostic (1.16e-1)"	"unprognostic (2.19e-1)"	"unprognostic (9.51e-2)"	"unprognostic (6.25e-3)"	"unprognostic (1.37e-1)"	"prognostic favorable (5.31e-4)"	"unprognostic (5.72e-3)"	"unprognostic (1.90e-3)"	"unprognostic (4.60e-2)"	"unprognostic (4.98e-3)"	"unprognostic (5.88e-2)"	"unprognostic (5.12e-2)"	"unprognostic (2.68e-2)"	"unprognostic (9.05e-2)"	"unprognostic (1.03e-2)"	"unprognostic (3.51e-3)"	"unprognostic (1.23e-1)"	20.6	1.8	21.0	11.3	30.8	38.3	16.5	25.9	29.6	7.8	14.5	5.7	5.2	4.3	2.5	9.6	4.1	5.3	12.2	21.8	23.7	2.1	18.7	36.8	14.8	30.5	26.7	1.0	1.9	0.8	1.5	4.4	28.5	4.3	4.9	0.5	7.4	2.9	38.2	11.3	6.4	5.5	23.9	13.3	4.2	5.5	26.0	8.8	4.0	12.8	11.2	8.5	6.5	45.1	1.7	0.4	0.1	1.8	0.3	0.6	2.9	0.2	0.0	0.0	0.1	3.1	11.8	0.0	0.6	6.1	1.7	0.2	0.2	0.0	0.0	8.6	0.1	153.5	34.2	1.9	0.0	4.3	6.1	2.2	0.2	0.0	0.0	0.0	3.1	3.2	9.0	25.5	0.1	0.1	263.8	8.5	2.6	0.1	0.0	6.8	0.2	0.8	2.7	0.0	0.1	0.0	28.3	0.2	0.0	0.3	0.3	54.4	0.7	0.0	1.5	9.8	0.2	0.1	4.2	49.3	0.4	28.5	0.1	6.7	58.1	48.3	32.8	47.2	9.8	18.8	36.2	34.9	49.9	17.7	7.7	16.7	112.9	21.4	39.4	26.2	157.3	33.4	21.0	30.8	25.9	29.6	21.8	23.7	30.5	26.7	28.5	23.9	26.0	45.1	29.8	22.4	39.9	0.3	5.3	5.7	0.3	2.5	6.2	0.0	1.3	1.3	1.5	1.5	8.7	0.0	0.0	2.6	8.9	2.1	1.9	0.2	3.1	5.5	1.6	9.4	4.2	35.4	1.7	0.0	3.9	13.5	1.1	1.2	2.5	0.4	4.2	11.2	30.7	0.0	1.0	3.5	0.0	38.3	7.8	3.1	8.1	18.0	7.2	11.2	12.4	0.2	7.2	3.5	109.7	0.8	2.6	4.1	8.1	0.1	2.1	0.2	5.0	0.1	0.0	1.3	1.6	3.3	3.1	7.6	5.5	0.8	12.5	0.1	3.1	0.2
NINL	"KIAA0980, NLP"	ENSG00000101004	"Ninein like"	Q9Y2I6	20	25452697-25585531	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 42.4;Granulosa cells: 29.6;Inhibitory neurons: 32.6;Oligodendrocyte precursor cells: 47.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"Hep G2: 37.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA000686	Uncertain		Uncertain	"Microtubules,Cytokinetic bridge,Cytosol"		Yes	No				"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 40: Granulosa cells - Unknown function"	"Microtubules, Cytokinetic bridge, Cytosol"		"HPA000686: AB_1079193"	"unprognostic (7.33e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.63e-2)"	"unprognostic (4.84e-2)"	"unprognostic (4.64e-2)"	"unprognostic (1.16e-1)"	"unprognostic (8.56e-2)"	"unprognostic (2.50e-1)"	"unprognostic (7.56e-2)"	"prognostic favorable (1.47e-4)"	"unprognostic (3.39e-1)"	"prognostic favorable (1.03e-5)"	"unprognostic (3.95e-2)"	"unprognostic (2.72e-1)"	"unprognostic (1.51e-1)"	"unprognostic (6.26e-2)"	4.0	8.6	4.9	2.0	5.9	0.6	4.0	10.4	6.1	10.1	8.8	9.8	3.2	7.2	7.2	5.8	5.2	3.3	4.0	4.4	6.9	15.1	8.1	4.1	2.2	7.9	7.1	18.9	5.4	8.2	9.9	1.5	7.0	8.8	2.1	4.7	4.4	3.7	4.5	2.4	3.9	3.5	5.5	4.9	6.3	7.7	6.5	15.7	10.2	1.2	2.2	3.6	8.5	6.8	1.0	10.8	23.0	15.1	2.6	7.5	7.1	3.6	3.1	3.1	4.4	2.8	7.5	0.6	5.0	5.6	7.6	0.8	3.4	0.7	2.6	0.5	4.7	1.6	5.0	37.5	5.4	0.6	0.1	9.2	0.7	3.6	0.0	8.8	6.8	17.8	1.9	0.3	3.8	9.6	21.7	0.7	6.5	0.1	1.1	0.5	17.9	0.8	1.5	1.3	22.7	16.0	8.2	3.0	9.1	18.3	4.9	6.4	0.3	0.1	8.6	0.1	0.2	2.3	4.4	0.1	0.2	0.6	3.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	4.9	5.9	10.4	6.1	4.4	6.9	7.9	7.1	7.0	5.5	6.5	6.8	1.2	0.0	14.6	42.4	0.8	2.0	4.9	2.5	5.7	3.0	2.8	3.3	6.5	12.8	4.8	7.3	25.0	2.8	0.6	0.4	0.0	5.6	0.6	4.2	7.3	2.3	6.1	0.0	7.4	1.2	1.3	8.7	4.6	3.4	0.0	29.6	8.9	8.4	2.3	8.4	32.6	2.3	8.2	0.3	2.0	2.7	13.1	0.8	0.0	12.2	0.0	3.2	2.1	47.3	19.4	2.8	1.5	12.4	0.9	4.5	0.7	8.8	13.7	1.9	6.6	10.8	4.7	2.5	5.0	4.3	0.9	1.5	1.1	21.0	2.5	1.9
NIP7	"CGI-37, FLJ10296, HSPC031, KD93"	ENSG00000132603	"Nucleolar pre-rRNA processing protein NIP7"	Q9Y221	16	69337996-69343106	"Predicted intracellular proteins"	"Ribosome biogenesis"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040856, HPA059850"	Supported		Supported	Nucleoplasm,Nucleoli		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoplasm, Nucleoli"		"HPA040856: AB_2677171, HPA059850: AB_2684142"	"unprognostic (2.14e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.76e-1)"	"unprognostic (8.02e-2)"	"unprognostic (6.47e-2)"	"prognostic unfavorable (1.52e-4)"	"unprognostic (1.04e-3)"	"unprognostic (1.37e-3)"	"unprognostic (5.72e-2)"	"unprognostic (3.86e-2)"	"prognostic unfavorable (6.69e-5)"	"unprognostic (6.99e-2)"	"unprognostic (1.18e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.58e-1)"	"unprognostic (3.33e-2)"	17.9	14.1	7.1	17.9	7.5	26.2	16.0	7.8	8.1	11.4	9.6	16.6	14.4	11.3	14.2	17.2	12.1	12.9	7.7	7.8	7.3	13.2	17.2	10.6	23.6	7.7	7.3	7.4	10.3	11.4	5.2	14.5	8.1	9.8	16.1	3.5	8.5	8.9	8.7	12.7	12.0	14.1	7.6	13.1	11.5	12.3	8.1	21.4	11.2	9.8	26.9	24.9	8.6	8.5	57.9	39.7	31.2	43.0	44.0	38.5	48.8	52.7	40.6	87.8	62.7	66.7	61.6	105.5	57.1	48.3	36.5	60.1	63.7	80.0	112.5	28.9	51.2	53.8	27.0	83.6	42.6	118.1	34.0	42.2	63.1	83.1	88.7	25.7	50.5	60.7	115.1	17.5	62.3	69.8	78.6	81.9	94.4	50.9	47.7	108.6	34.3	95.7	54.6	38.8	41.3	57.8	107.8	31.0	59.8	35.0	44.3	72.4	43.5	63.5	54.7	49.5	97.0	54.4	45.0	250.2	37.9	69.4	63.4	16.7	12.7	9.8	28.4	14.9	29.9	28.9	25.2	33.3	22.8	21.1	23.3	30.1	4.3	24.8	21.4	20.7	28.9	16.9	7.1	7.5	7.8	8.1	7.8	7.3	7.7	7.3	8.1	7.6	8.1	8.5	28.2	3.2	12.7	3.9	33.7	53.7	58.1	34.6	45.5	8.8	21.7	18.3	5.5	14.3	21.1	20.2	16.7	33.2	33.2	14.7	21.5	35.9	43.8	24.5	32.0	28.3	3.0	37.9	5.1	26.1	36.5	24.0	11.2	23.2	17.7	20.5	18.2	12.1	24.8	11.8	4.5	12.7	30.5	12.2	19.2	41.4	17.1	14.7	19.6	1.9	18.3	9.2	35.0	3.0	6.4	37.5	16.6	17.3	15.6	46.2	14.6	28.9	25.6	8.1	13.1	35.2	25.9	40.7	43.8	43.0	52.6	25.6	33.2	36.2	20.8	42.2
NIPBL	"DKFZp434L1319, FLJ11203, FLJ12597, FLJ13354, FLJ13648, IDN3, Scc2"	ENSG00000164190	"NIPBL cohesin loading factor"	Q6KC79	5	36876769-37066413	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Transcription, Transcription regulation"	"Activator, Developmental protein"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 303.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040834, HPA058239"	Approved		Supported	Nucleoplasm,Vesicles,Cytosol		No	No			"Cluster 18: Basophils - Vesicular transport"	"Cluster 34: Non-specific - Transcription"	"Cluster 20: HeLa - Mitochondria"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm	"Vesicles, Cytosol"	"HPA040834: AB_10796562, HPA058239: AB_2683650"	"unprognostic (4.92e-2)"	"unprognostic (9.77e-2)"	"unprognostic (5.28e-2)"	"unprognostic (8.10e-2)"	"unprognostic (9.38e-2)"	"unprognostic (6.02e-2)"	"unprognostic (7.34e-2)"	"unprognostic (3.04e-2)"	"unprognostic (3.85e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.12e-1)"	"unprognostic (6.39e-2)"	"unprognostic (6.59e-2)"	"unprognostic (2.33e-1)"	"unprognostic (3.41e-1)"	"unprognostic (1.04e-1)"	"unprognostic (3.40e-2)"	11.5	9.4	5.6	14.7	8.6	25.1	13.5	12.0	7.3	12.9	7.8	12.2	10.0	13.4	6.6	11.4	10.5	11.1	7.7	5.3	5.9	11.6	12.7	11.9	16.5	7.3	6.6	17.6	13.1	19.6	5.0	13.9	8.2	11.1	12.2	22.4	11.2	10.7	9.5	14.2	13.2	12.4	6.3	15.3	13.4	14.2	6.9	29.8	17.2	14.3	16.7	12.6	7.5	11.1	22.5	13.1	33.3	15.6	20.7	22.3	24.4	17.6	19.3	18.9	15.7	18.2	22.6	33.5	11.3	21.6	22.2	19.2	28.9	15.9	27.0	27.9	14.7	40.9	57.4	13.3	14.0	48.4	26.4	16.5	19.3	21.3	28.1	18.1	24.0	20.8	39.3	24.5	17.9	10.8	33.8	18.1	16.0	12.9	11.3	28.2	51.9	13.0	13.1	31.4	24.5	17.2	84.6	22.5	18.0	26.2	23.0	27.3	26.3	24.9	27.1	21.0	13.3	17.7	25.5	39.1	13.6	32.4	19.1	10.9	2.9	4.3	3.2	2.2	3.0	2.8	2.7	2.9	2.3	3.1	2.9	3.3	7.7	2.8	3.3	3.4	2.1	1.6	5.6	8.6	12.0	7.3	5.3	5.9	7.3	6.6	8.2	6.3	6.9	11.1	80.6	131.4	108.6	169.8	84.8	48.4	66.2	34.2	58.1	62.6	43.6	49.4	87.0	38.6	63.3	33.1	77.2	44.1	107.1	45.9	5.9	55.5	13.4	72.9	75.7	74.1	41.5	85.4	179.2	46.7	34.1	64.3	61.2	91.7	84.0	77.7	44.6	28.2	37.1	40.4	165.5	46.3	38.7	51.8	46.6	15.1	66.5	86.7	24.9	236.1	103.3	49.2	97.9	229.2	303.7	55.0	48.6	56.4	84.5	66.4	45.2	12.2	65.2	72.8	52.6	102.9	80.1	185.8	133.6	58.2	47.0	75.9	92.0	73.8	42.9	88.0
NIPSNAP2	GBAS	ENSG00000146729	"Nipsnap homolog 2"	O75323	7	55951793-56000181	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	7	"heart muscle: 266.5;skeletal muscle: 645.5;tongue: 784.2"	"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 226.9;Endometrial ciliated cells: 107.5;Proximal tubular cells: 106.8"	"Cancer enhanced"	"Detected in all"		"glioma: 73.3"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"A-431: 301.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA063084	Enhanced		Supported	Mitochondria		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 7: Non-specific - Mitochondria"	Mitochondria		"HPA063084: AB_2684938"	"unprognostic (6.88e-2)"	"unprognostic (6.53e-3)"	"unprognostic (8.20e-3)"	"unprognostic (4.95e-2)"	"unprognostic (5.79e-2)"	"unprognostic (1.53e-3)"	"unprognostic (5.95e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.77e-1)"	"unprognostic (6.38e-3)"	"unprognostic (2.47e-1)"	"unprognostic (1.31e-1)"	"prognostic favorable (3.02e-8)"	"unprognostic (1.79e-2)"	"unprognostic (1.88e-1)"	"unprognostic (6.65e-3)"	"unprognostic (3.59e-1)"	61.2	70.3	46.0	25.4	48.4	39.2	59.0	47.2	56.9	45.4	50.8	56.0	31.4	41.1	36.6	49.0	50.4	27.5	266.5	45.1	49.5	63.8	14.5	36.9	26.4	45.2	48.7	34.7	49.2	70.4	27.1	31.0	47.1	53.4	53.8	27.6	79.2	55.9	645.5	21.9	32.4	46.6	49.0	26.1	46.5	20.5	50.0	40.1	86.5	784.2	28.7	40.8	26.0	47.6	301.3	52.3	67.5	112.6	38.7	65.8	33.1	24.7	58.2	69.7	53.5	36.5	64.9	43.8	40.5	46.6	67.5	39.1	51.4	52.2	68.7	27.9	75.4	31.1	27.6	46.9	54.6	68.0	30.2	60.3	78.4	23.8	64.5	79.1	74.6	62.2	56.2	41.9	54.8	13.4	68.1	70.4	66.7	66.5	52.3	68.0	31.3	90.8	94.6	46.7	71.7	80.8	56.2	67.0	78.3	53.0	129.9	72.3	43.9	31.7	47.4	11.3	52.0	34.1	30.9	81.2	35.1	41.9	95.7	48.2	86.6	39.1	22.6	86.4	27.2	37.7	28.8	23.8	91.7	37.0	34.2	25.2	15.3	41.9	69.1	38.1	37.9	72.4	46.0	48.4	47.2	56.9	45.1	49.5	45.2	48.7	47.1	49.0	50.0	47.6	45.4	51.3	57.7	0.0	10.3	0.0	0.0	0.0	0.0	0.0	80.4	63.8	0.0	0.0	43.3	62.5	0.0	76.0	20.1	0.0	226.9	74.8	0.0	107.5	56.1	22.1	0.0	0.0	0.0	57.2	56.4	23.4	0.0	57.6	16.4	64.7	0.0	0.0	88.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	31.6	0.0	0.0	39.8	0.0	0.0	0.0	0.0	46.2	0.0	0.0	5.2	0.0	0.0	106.8	88.2	0.0	0.0	0.0	26.7	0.0	0.0	0.0	0.0	51.4	12.3	74.0	0.0	0.0
NISCH	"I-1, IRAS, KIAA0975"	ENSG00000010322	Nischarin	Q9Y2I1	3	52455118-52493068	"FDA approved drug targets, Predicted intracellular proteins"	Apoptosis	Receptor	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Enteroendocrine cells: 169.3;Peritubular cells: 246.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023189	Approved		Approved	"Nucleoplasm,Vesicles,Microtubules,Cytokinetic bridge,Cytosol"		Yes	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 20: HeLa - Mitochondria"	"Cluster 17: Intestinal endocrine cells - Hormone signaling"	"Nucleoplasm, Cytosol"	"Vesicles, Microtubules, Cytokinetic bridge"	"HPA023189: AB_1854495"	"unprognostic (6.66e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.59e-3)"	"unprognostic (4.11e-3)"	"unprognostic (1.64e-1)"	"unprognostic (8.08e-3)"	"unprognostic (1.60e-2)"	"unprognostic (6.56e-3)"	"unprognostic (4.96e-2)"	"unprognostic (8.33e-3)"	"prognostic favorable (1.91e-4)"	"unprognostic (1.40e-2)"	"unprognostic (5.10e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.94e-2)"	"unprognostic (1.47e-1)"	"unprognostic (7.05e-3)"	55.2	69.8	46.5	28.7	55.5	38.7	60.5	78.2	56.6	105.8	22.2	68.5	24.3	76.2	34.0	51.3	72.0	29.9	48.5	56.3	38.7	54.6	45.6	56.2	32.5	20.9	32.6	93.0	54.1	32.5	181.8	39.1	32.9	107.5	20.6	19.0	53.6	51.6	36.3	80.7	55.3	33.0	9.1	54.1	52.7	84.5	35.2	30.1	60.8	16.3	23.3	78.1	71.6	35.2	15.6	16.0	48.8	40.1	35.7	39.2	40.0	32.8	21.5	25.7	26.0	24.2	22.8	21.7	9.0	45.6	21.0	20.4	26.1	35.7	15.1	22.3	28.2	39.2	65.2	23.9	32.4	23.2	33.6	61.9	28.2	27.7	23.5	54.0	42.0	42.4	21.1	23.4	24.3	22.2	41.8	51.2	30.1	19.8	27.1	24.5	13.4	25.4	29.2	30.6	20.6	35.9	35.6	9.3	23.1	42.3	28.9	38.5	46.3	36.0	34.1	36.9	24.1	38.7	23.8	27.3	24.7	37.3	22.4	5.2	4.5	3.5	3.0	4.0	3.1	2.5	2.6	4.0	2.3	2.8	3.1	3.3	1.5	3.2	0.6	3.4	3.0	3.6	46.5	55.5	78.2	56.6	56.3	38.7	20.9	32.6	32.9	9.1	35.2	35.2	26.1	25.6	32.3	34.0	14.9	27.5	14.6	23.3	40.5	40.9	29.2	37.1	20.4	8.6	19.1	14.7	8.4	32.4	24.2	20.5	9.8	12.1	10.3	14.5	26.7	22.1	169.3	4.6	64.9	9.4	14.0	23.4	23.4	18.9	25.3	40.2	46.1	15.3	30.5	28.6	44.0	19.1	22.4	50.5	14.5	25.9	88.3	24.3	19.6	15.0	13.0	12.1	17.5	21.1	26.1	10.0	14.2	246.0	12.4	12.6	16.5	15.6	15.2	22.4	26.3	17.2	24.8	31.2	18.0	16.7	22.3	24.2	18.4	47.6	15.7	11.7
NIT2		ENSG00000114021	"Nitrilase family member 2"	Q9NQR4	3	100334739-100361635	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 26.4"	"Cell type enhanced"	"Detected in all"		"Proximal tubular cells: 705.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036999, HPA041289"	Approved		Supported	Centrosome,Cytosol		NA	NA		1700000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 81: Kidney & Liver - Metabolism"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Cytosol	Centrosome	"HPA036999: AB_10672105, HPA041289: "	"unprognostic (3.27e-1)"	"unprognostic (1.29e-1)"	"unprognostic (7.06e-3)"	"prognostic unfavorable (4.62e-4)"	"unprognostic (6.28e-2)"	"unprognostic (2.10e-1)"	"unprognostic (4.56e-1)"	"unprognostic (1.12e-1)"	"unprognostic (6.60e-3)"	"unprognostic (2.21e-1)"	"unprognostic (6.68e-2)"	"unprognostic (7.92e-2)"	"unprognostic (1.37e-2)"	"unprognostic (4.48e-2)"	"unprognostic (1.29e-1)"	"unprognostic (8.26e-2)"	"unprognostic (1.47e-3)"	5.1	3.9	1.3	1.4	2.4	3.5	6.8	1.4	1.9	3.4	1.7	3.8	2.7	4.1	5.5	4.4	4.1	3.4	5.2	1.6	1.3	18.5	26.4	3.2	2.4	0.7	0.8	3.3	3.7	3.9	2.7	2.4	0.9	3.6	3.4	3.6	3.8	4.9	10.1	5.0	2.8	3.0	0.9	2.2	4.1	1.2	1.2	2.5	5.9	7.6	3.7	5.2	3.6	1.4	12.3	12.1	1.4	6.2	10.3	14.1	7.4	4.9	7.3	11.5	10.9	10.4	13.7	12.3	7.4	7.2	4.9	9.1	5.4	13.2	13.7	3.8	2.8	9.0	4.1	5.3	12.6	5.9	5.8	8.8	19.9	6.1	10.1	6.0	7.4	6.9	4.2	9.8	14.2	11.9	3.9	5.3	5.4	15.3	18.0	4.3	5.0	12.0	19.4	7.7	8.2	3.8	6.8	11.6	7.3	3.7	8.6	5.4	5.5	7.2	2.9	3.5	4.4	5.9	7.0	10.6	11.4	9.9	9.3	0.2	0.7	0.4	1.0	0.7	1.4	1.5	1.0	0.8	2.0	1.5	1.2	1.1	0.4	1.1	0.5	0.6	1.2	0.3	1.3	2.4	1.4	1.9	1.6	1.3	0.7	0.8	0.9	0.9	1.2	1.4	22.3	12.8	17.2	8.5	31.5	32.6	51.7	92.0	37.0	12.8	43.7	56.1	56.4	45.8	53.5	58.8	16.7	92.5	26.1	14.6	187.9	73.6	3.1	53.6	47.2	16.7	24.0	17.0	12.0	52.7	73.7	38.0	29.6	42.3	21.0	55.3	15.0	183.6	63.5	13.5	8.8	22.0	65.1	23.5	39.9	4.1	44.1	26.9	49.8	4.7	89.9	15.4	22.6	12.1	8.0	62.1	20.6	37.6	20.8	54.3	24.1	705.6	60.5	24.9	39.5	23.9	51.6	2.7	17.5	53.7	41.6	59.2	27.7	118.1	36.7	53.0
NKAP	FLJ22626	ENSG00000101882	"NFKB activating protein"	Q8N5F7	X	119920672-119943751	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Notch signaling pathway, Transcription, Transcription regulation"	Repressor	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000916	Supported		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 38: Extravillous trophoblasts - Unknown function"	Nucleoplasm	Cytosol	"HPA000916: AB_1079486"	"prognostic unfavorable (4.20e-4)"	"unprognostic (4.28e-3)"	"unprognostic (9.14e-2)"	"unprognostic (1.33e-3)"	"unprognostic (2.66e-1)"	"unprognostic (3.42e-2)"	"unprognostic (3.49e-3)"	"unprognostic (4.18e-3)"	"unprognostic (3.70e-2)"	"unprognostic (1.05e-2)"	"unprognostic (1.05e-2)"	"unprognostic (1.03e-1)"	"unprognostic (4.14e-3)"	"unprognostic (1.72e-1)"	"unprognostic (1.53e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.49e-2)"	9.5	13.1	10.6	9.8	11.5	13.6	10.6	11.8	16.2	9.2	11.1	9.8	10.3	10.6	10.7	7.3	11.0	8.9	11.0	10.5	11.6	11.3	14.5	10.5	14.4	11.9	11.5	14.1	10.1	14.2	2.7	13.5	11.4	10.4	10.1	9.6	9.9	13.5	18.2	7.4	12.7	10.3	11.2	12.5	9.3	8.5	11.0	12.7	10.1	14.4	13.0	9.7	2.4	13.0	25.0	24.3	17.6	22.3	15.3	24.7	28.9	17.7	20.4	23.4	17.2	15.9	20.9	17.6	29.9	14.6	45.8	18.3	33.7	20.6	27.9	29.6	31.2	11.1	20.6	23.3	25.1	25.2	20.4	17.9	26.4	25.1	24.7	25.3	23.2	23.8	30.6	25.5	18.4	33.8	21.4	47.0	23.6	32.4	32.8	22.8	24.3	32.7	17.5	9.6	19.2	27.2	36.8	19.7	52.3	20.9	16.8	21.1	17.4	14.8	9.0	38.4	27.4	25.4	26.7	30.2	20.4	18.9	26.1	39.7	23.5	55.6	20.8	20.0	21.6	32.2	25.4	21.2	20.6	36.6	25.6	24.3	44.5	22.2	23.1	32.5	26.6	14.3	10.6	11.5	11.8	16.2	10.5	11.6	11.9	11.5	11.4	11.2	11.0	13.0	39.9	22.4	40.4	5.2	36.1	25.9	36.1	45.5	26.7	34.0	26.2	33.3	30.3	15.7	42.3	20.2	25.0	62.5	36.0	17.5	37.2	36.7	8.8	33.6	37.4	40.3	22.8	20.6	7.2	44.3	132.0	39.1	17.9	26.7	47.4	41.6	41.4	46.3	53.0	55.5	9.0	27.9	22.4	28.0	23.2	8.9	45.1	33.9	35.6	4.7	35.3	56.3	36.0	7.5	11.0	37.5	23.3	55.3	30.6	40.3	25.8	51.3	49.4	38.5	13.1	33.4	45.0	82.7	69.6	19.6	28.7	72.9	41.5	48.3	23.1	33.7
NKIRAS1	"kappaB-Ras1, KBRAS1"	ENSG00000197885	"NFKB inhibitor interacting Ras like 1"	Q9NYS0	3	23889951-23946591	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cone photoreceptor cells: 64.6;Rod photoreceptor cells: 59.7;Spermatocytes: 68.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-266/84: 64.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA077387	Approved		Approved	"Endoplasmic reticulum,Cytosol"		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 54: Non-specific - Microtubule organization"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 9: Photoreceptor cells - Phototransduction"	"Endoplasmic reticulum, Cytosol"		"HPA077387: "	"unprognostic (1.36e-2)"	"unprognostic (1.88e-2)"	"unprognostic (2.25e-1)"	"prognostic unfavorable (8.31e-4)"	"unprognostic (1.08e-2)"	"unprognostic (4.25e-2)"	"unprognostic (5.30e-2)"	"prognostic favorable (3.69e-4)"	"unprognostic (3.69e-3)"	"unprognostic (8.07e-3)"	"unprognostic (1.19e-2)"	"unprognostic (3.37e-2)"	"prognostic favorable (7.71e-13)"	"unprognostic (1.98e-1)"	"unprognostic (4.90e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.63e-3)"	10.0	13.4	23.0	4.5	23.4	8.0	8.7	23.9	29.9	9.0	16.0	9.4	3.4	8.7	8.4	8.4	7.9	6.2	16.4	24.1	25.1	16.4	25.0	6.2	4.4	22.8	22.9	11.9	5.2	37.8	14.9	6.3	23.9	9.5	4.0	47.3	6.9	13.1	32.8	4.9	4.1	9.2	20.9	5.9	6.2	22.9	22.1	3.8	9.8	27.2	4.5	6.6	6.1	21.7	13.3	12.9	11.0	11.7	31.6	14.6	11.4	32.4	19.8	23.5	18.9	10.9	3.6	7.0	14.4	18.8	13.9	7.0	20.4	14.1	20.0	28.7	13.8	3.4	10.2	10.5	17.1	6.0	3.4	12.1	19.1	30.3	13.9	21.3	7.0	6.6	6.7	26.6	26.1	6.4	4.5	5.5	15.2	8.2	15.6	6.7	17.3	6.0	16.2	5.2	4.3	21.6	11.0	14.5	23.4	11.4	11.7	9.9	12.6	10.9	11.8	28.2	26.5	57.1	64.0	4.2	14.4	10.3	9.0	13.9	5.1	6.7	8.9	4.1	9.8	6.1	6.2	8.5	5.1	8.1	9.6	7.8	2.4	4.3	4.3	3.6	5.3	4.5	23.0	23.4	23.9	29.9	24.1	25.1	22.8	22.9	23.9	20.9	22.1	21.7	5.7	6.4	8.2	7.5	5.3	11.2	10.3	18.0	13.6	34.1	9.0	8.3	22.3	4.3	13.1	5.5	64.6	12.2	6.0	3.0	15.6	7.5	27.5	18.0	12.0	5.5	1.2	3.0	15.3	4.5	9.7	11.6	3.1	21.0	7.0	5.7	6.1	13.3	7.3	13.5	16.9	2.2	14.2	3.2	12.9	7.7	7.5	6.8	10.6	5.6	4.6	44.0	3.1	11.6	10.7	5.3	2.4	9.1	4.2	8.1	4.1	23.2	17.2	59.7	13.1	7.3	12.9	68.6	41.1	7.9	9.9	10.4	6.7	10.7	3.0	7.2
NKRF	"ITBA4, NRF"	ENSG00000186416	"NFKB repressing factor"	O15226	X	119588337-119606443	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Langerhans cells: 33.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001476			Supported	Nucleoplasm,Nucleoli		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 41: Macrophages - Immune response"	Nucleoli	Nucleoplasm	"HPA001476: AB_1079488"	"unprognostic (6.12e-3)"	"unprognostic (7.58e-2)"	"unprognostic (8.10e-2)"	"unprognostic (2.39e-1)"	"unprognostic (9.92e-2)"	"unprognostic (4.74e-3)"	"prognostic unfavorable (4.92e-5)"	"unprognostic (2.47e-1)"	"unprognostic (1.20e-1)"	"unprognostic (2.65e-1)"	"unprognostic (1.33e-2)"	"unprognostic (9.56e-3)"	"unprognostic (2.62e-2)"	"unprognostic (5.06e-2)"	"unprognostic (1.04e-2)"	"unprognostic (2.20e-3)"	"unprognostic (3.08e-3)"	4.4	6.5	11.3	5.7	11.8	6.9	5.4	9.6	16.9	4.2	7.3	3.7	4.1	3.9	4.0	5.6	4.4	3.5	4.1	11.5	13.1	6.1	6.0	4.1	8.7	11.2	10.1	6.1	3.8	5.2	5.5	6.5	11.5	4.1	3.5	5.3	4.0	3.5	5.5	6.2	4.3	4.0	9.4	5.9	4.1	1.9	11.4	9.5	4.6	4.6	8.4	6.3	4.3	10.6	17.9	18.3	10.4	11.3	8.7	8.5	15.5	10.7	8.5	14.1	15.0	19.8	15.3	31.8	18.4	9.2	12.1	20.4	43.8	16.4	17.2	16.4	28.9	16.8	20.3	12.9	8.3	33.5	11.8	9.5	13.2	16.3	19.2	9.6	14.1	15.3	18.5	12.6	12.5	27.6	20.8	25.2	23.1	26.2	19.9	16.5	15.2	32.7	18.8	12.7	16.7	14.2	15.2	23.1	16.5	10.6	9.7	20.0	12.2	8.7	9.5	19.3	27.1	10.5	14.1	32.9	9.3	36.3	10.1	1.1	0.5	0.7	1.0	0.8	1.1	1.3	1.2	1.3	0.6	1.2	1.9	1.6	0.1	0.5	0.3	0.9	1.8	0.8	11.3	11.8	9.6	16.9	11.5	13.1	11.2	10.1	11.5	9.4	11.4	10.6	5.4	6.4	8.9	5.9	11.1	19.4	10.4	4.1	6.8	13.3	6.1	6.9	4.5	8.6	3.1	5.5	27.1	14.4	8.5	3.0	1.9	4.2	0.1	6.1	7.4	7.0	10.7	2.5	20.6	3.6	14.3	6.1	3.1	8.1	14.7	6.6	3.3	3.9	6.4	8.4	20.6	4.4	10.2	7.5	33.1	0.6	7.8	11.6	5.4	7.5	5.6	4.4	1.0	9.0	9.2	4.1	1.9	6.8	5.2	10.7	3.6	4.4	3.9	7.9	0.0	10.1	7.2	1.7	1.9	6.9	25.7	14.9	15.7	6.9	7.4	9.5
NKTR	p104	ENSG00000114857	"Natural killer cell triggering receptor"	P30414	3	42600655-42648735	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Isomerase, Rotamase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022120, HPA051576"	Approved		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		No	No			"Cluster 42: Non-specific - Transcription"	"Cluster 51: Non-specific - Unknown function"	"Cluster 20: HeLa - Mitochondria"	"Cluster 52: Non-specific - Transcription"	"Nucleoplasm, Plasma membrane, Cytosol"		"HPA022120: AB_1854513, HPA051576: AB_2681540"	"unprognostic (2.73e-3)"	"unprognostic (3.11e-1)"	"unprognostic (2.33e-1)"	"unprognostic (2.06e-1)"	"unprognostic (5.27e-3)"	"prognostic favorable (1.26e-4)"	"unprognostic (4.62e-2)"	"unprognostic (5.65e-2)"	"unprognostic (4.02e-2)"	"unprognostic (1.61e-1)"	"unprognostic (5.33e-2)"	"prognostic unfavorable (6.01e-4)"	"prognostic unfavorable (5.02e-4)"	"unprognostic (3.82e-1)"	"unprognostic (4.57e-1)"	"unprognostic (1.40e-1)"	"prognostic favorable (1.05e-5)"	17.4	19.2	16.4	17.6	18.7	46.5	19.3	22.3	17.1	28.4	17.9	17.7	13.2	18.4	22.4	17.0	23.0	11.4	17.8	15.0	20.3	18.2	21.1	23.9	22.1	20.5	16.4	29.0	22.1	10.6	36.5	11.1	17.6	23.2	13.4	41.3	17.5	10.5	19.5	32.6	25.4	10.7	14.0	36.7	16.3	18.0	18.2	15.4	25.4	10.4	20.0	18.3	22.6	27.8	15.1	7.7	32.3	15.6	16.6	19.3	14.9	22.8	6.8	9.9	12.9	14.7	13.3	25.9	10.7	9.1	9.0	12.6	16.1	8.4	19.2	11.0	13.1	31.4	30.5	24.6	7.3	25.4	19.9	9.6	12.2	18.4	10.5	19.1	17.4	7.1	30.3	20.2	18.6	6.9	17.8	35.5	23.1	7.6	12.3	17.3	12.0	10.5	15.7	12.7	9.4	8.5	24.1	11.1	4.8	16.3	17.5	17.8	28.0	18.0	13.1	21.4	23.2	17.2	21.7	17.7	10.1	30.0	11.3	7.8	3.6	7.5	5.7	4.6	5.3	5.5	5.6	4.9	2.9	5.3	5.6	4.9	5.3	7.0	6.8	5.1	5.3	2.3	16.4	18.7	22.3	17.1	15.0	20.3	20.5	16.4	17.6	14.0	18.2	27.8	221.8	109.0	141.4	169.4	129.5	59.0	60.3	57.8	66.0	200.0	76.3	69.8	68.7	65.8	73.2	88.3	246.0	72.5	156.0	60.3	17.6	47.3	23.9	114.4	125.5	166.2	71.8	76.6	143.5	38.8	51.1	83.3	86.6	132.4	96.8	210.0	110.7	58.6	45.9	132.9	170.0	70.2	61.1	53.8	70.2	21.8	167.7	78.9	51.6	194.9	97.4	101.9	163.7	180.0	267.2	47.6	59.2	134.3	131.3	77.5	106.8	17.0	53.3	279.9	92.1	103.5	88.9	246.2	186.1	42.4	57.3	31.3	164.4	104.5	75.0	54.2
NKX3-1	"BAPX2, NKX3.1, NKX3A"	ENSG00000167034	"NK3 homeobox 1"	Q99801	8	23678697-23682938	"Cancer-related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"	"Cancer-related genes, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"prostate: 303.3"	"Group enriched"	"Detected in many"	6	"Basal prostatic cells: 51.0;Prostatic glandular cells: 124.8"	"Cancer enriched"	"Detected in many"	65	"prostate cancer: 392.7"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"eosinophil: 54.0;neutrophil: 51.6"	"Lineage enriched"	"Detected in many"	21	"granulocytes: 54.0"	"Cell line enhanced"	"Detected in many"		"GAMG: 25.7;SiHa: 26.1;U-138 MG: 25.8;U-251 MG: 23.0"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"HPA025693, HPA078571"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 51: Non-specific - Unknown function"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 35: Glandular cells - Unknown function"	Nucleoplasm	Cytosol	"HPA025693: AB_1854522, HPA078571: AB_2732384"	"unprognostic (1.47e-2)"	"unprognostic (4.03e-2)"	"unprognostic (2.67e-1)"	"unprognostic (5.87e-2)"	"unprognostic (2.56e-6)"	"unprognostic (6.90e-3)"	"unprognostic (1.13e-1)"	"unprognostic (4.11e-3)"	"unprognostic (9.42e-2)"	"unprognostic (1.41e-1)"	"unprognostic (3.00e-2)"	"unprognostic (1.87e-1)"	"unprognostic (4.37e-2)"	"unprognostic (4.60e-2)"	"unprognostic (3.88e-2)"	"unprognostic (3.09e-2)"	"unprognostic (1.69e-1)"	1.7	3.9	1.0	1.5	1.2	2.2	2.1	1.4	1.4	1.1	0.9	1.4	1.4	1.5	1.3	3.7	1.8	1.1	2.6	1.2	1.6	1.4	4.1	1.4	1.2	1.8	1.5	2.8	1.8	1.0	0.9	0.8	1.6	303.3	0.5	1.7	62.0	1.8	3.2	0.4	1.0	1.9	1.7	0.8	1.4	24.0	1.5	0.5	0.7	3.9	1.6	2.9	1.9	1.4	4.9	3.7	0.0	8.7	3.1	0.7	7.1	6.7	4.2	13.8	16.2	2.1	5.5	0.0	1.0	5.0	25.7	1.2	3.5	7.6	10.9	0.0	1.8	3.4	2.6	5.5	6.0	0.0	1.2	1.2	2.0	14.0	0.8	8.5	0.7	20.1	0.2	0.0	5.5	1.6	11.8	1.0	2.0	0.0	2.6	0.0	5.5	0.5	0.8	5.7	1.6	0.4	26.1	4.8	0.4	9.9	3.5	0.5	0.9	25.8	9.1	2.0	23.0	0.0	0.0	0.0	12.5	2.6	3.2	10.2	0.0	54.0	1.0	0.1	0.2	2.2	0.4	1.0	0.1	1.8	1.4	2.5	51.6	0.6	0.1	0.0	0.0	0.3	1.0	1.2	1.4	1.4	1.2	1.6	1.8	1.5	1.6	1.7	1.5	1.4	6.0	3.2	5.3	0.0	4.1	5.6	51.0	4.1	4.6	3.7	13.5	6.5	9.8	1.5	4.7	0.0	8.4	0.3	0.3	1.0	0.0	2.7	2.7	1.3	2.0	6.8	6.6	0.0	0.4	7.0	1.4	9.1	5.1	2.2	0.0	0.8	4.6	4.9	0.3	3.3	0.4	1.2	2.0	0.3	9.4	6.1	2.1	2.5	1.8	0.0	0.6	4.9	0.0	0.5	0.1	5.2	0.1	6.4	1.0	124.8	0.4	0.7	1.4	4.5	0.0	11.4	5.1	1.8	2.1	2.5	2.0	0.3	2.5	0.8	1.1	12.2
NLE1	"FLJ10458, NLE"	ENSG00000073536	"Notchless homolog 1"	Q9NVX2	17	35128730-35142304	"Predicted intracellular proteins"	"Notch signaling pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018807	Approved		Supported	Nucleoplasm,Nucleoli		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoli	Nucleoplasm	"HPA018807: AB_1848658"	"unprognostic (9.19e-2)"	"unprognostic (8.40e-2)"	"unprognostic (4.69e-2)"	"unprognostic (4.27e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.77e-1)"	"prognostic unfavorable (8.64e-8)"	"unprognostic (8.67e-3)"	"unprognostic (1.98e-1)"	"unprognostic (1.26e-2)"	"unprognostic (6.49e-2)"	"unprognostic (3.90e-2)"	"unprognostic (2.00e-1)"	"unprognostic (4.21e-2)"	"unprognostic (1.75e-1)"	"unprognostic (2.55e-1)"	"prognostic unfavorable (6.39e-4)"	7.3	7.4	5.0	5.8	5.0	6.2	8.8	5.1	5.3	7.4	3.4	5.6	4.0	6.8	2.9	8.4	7.4	3.1	4.2	5.0	4.5	6.5	7.3	4.6	6.8	4.7	4.0	12.0	23.7	3.9	4.2	4.9	4.0	6.0	4.0	2.5	7.6	4.6	8.0	6.8	5.1	4.1	3.5	6.2	7.6	4.4	5.0	6.6	5.1	3.5	5.4	7.4	5.8	4.6	15.9	36.8	12.5	22.7	6.9	11.4	19.6	14.0	12.7	24.4	19.3	26.1	14.8	34.9	18.6	12.0	18.0	21.0	26.8	35.6	15.1	5.6	44.2	14.9	18.2	33.2	10.3	29.9	12.0	12.9	19.0	25.6	38.3	10.7	15.5	33.9	42.4	12.7	14.6	22.1	47.1	25.5	23.6	13.5	16.6	37.6	20.9	38.5	14.3	14.8	25.6	14.8	13.1	13.4	17.1	11.1	32.4	22.4	14.5	13.3	18.3	13.0	47.4	9.8	7.8	29.1	9.3	24.9	25.8	0.1	2.2	0.0	4.0	2.4	6.2	3.4	3.8	4.2	3.4	4.6	5.2	3.5	0.3	1.8	1.2	0.8	2.1	2.2	5.0	5.0	5.1	5.3	5.0	4.5	4.7	4.0	4.0	3.5	5.0	4.6	4.7	3.2	1.1	0.3	8.6	8.7	8.6	7.4	9.6	4.7	12.3	14.0	2.6	10.0	3.7	3.7	2.1	12.1	2.4	3.9	0.0	8.9	1.0	2.1	5.4	5.0	4.9	8.8	1.3	15.4	20.9	7.4	6.6	2.8	3.8	9.4	5.3	6.6	7.6	1.7	1.5	8.1	2.0	4.6	2.6	5.4	4.1	2.8	1.8	1.0	3.8	1.9	2.1	1.0	0.7	8.5	3.6	4.9	5.1	8.6	3.4	7.1	2.8	3.1	0.0	6.5	7.2	4.2	6.5	12.5	10.1	4.9	4.1	9.2	13.4	5.5
NLGN3	"ASPGX1, AUTSX1, HNL3, KIAA1480"	ENSG00000196338	"Neuroligin 3"	Q9NZ94	X	71144831-71171201	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"		"Asperger syndrome, Autism, Autism spectrum disorder, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 11.1;seminal vesicle: 12.5"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 19.6;Inhibitory neurons: 12.7;Oligodendrocyte precursor cells: 92.0;Oligodendrocytes: 43.7;Peritubular cells: 17.3"	"Cancer enriched"	"Detected in many"	19	"glioma: 37.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 6.7;NTERA-2: 5.3;SH-SY5Y: 2.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003183, HPA004066"	Enhanced		Supported	"Golgi apparatus,Cell Junctions"	"Intracellular and membrane"	NA	NA				"Cluster 68: Epididymis - Unknown function"	"Cluster 12: NES - Nervous system development"	"Cluster 68: Oligodendrocytes - Mixed function"	"Golgi apparatus, Cell Junctions"		"HPA003183: AB_1079469, HPA004066: AB_2732397"	"unprognostic (4.06e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.59e-2)"	"unprognostic (2.38e-2)"	"unprognostic (2.42e-1)"	"unprognostic (3.87e-1)"	"unprognostic (6.52e-2)"	"unprognostic (1.63e-1)"	"unprognostic (7.10e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.94e-1)"	"unprognostic (6.18e-2)"	"unprognostic (4.27e-9)"	"unprognostic (4.28e-2)"	"unprognostic (1.90e-1)"	"unprognostic (2.22e-5)"	"unprognostic (9.01e-2)"	0.5	6.6	10.1	0.8	8.5	1.4	0.4	6.4	11.1	1.9	0.0	1.8	0.2	2.7	6.4	0.6	4.3	1.4	1.1	10.3	10.2	0.3	0.1	0.6	0.4	7.3	7.0	4.4	0.3	0.5	1.0	0.6	4.8	6.0	0.5	1.9	0.6	12.5	0.1	0.7	0.7	1.9	5.5	0.6	0.6	2.6	7.3	0.4	0.4	0.4	0.2	0.7	1.2	9.7	0.0	0.5	6.7	0.2	1.6	0.6	1.2	0.0	0.0	0.0	0.1	0.1	0.3	0.5	0.5	0.1	0.0	0.1	0.2	0.0	0.1	0.4	0.9	0.4	0.4	0.0	0.0	0.1	0.4	0.4	0.1	0.2	0.0	0.3	0.1	2.0	0.5	1.5	0.0	0.3	0.5	1.2	5.3	0.0	0.0	0.6	0.2	0.3	0.0	0.8	1.7	2.5	0.2	0.0	0.6	0.8	0.0	0.3	0.1	0.1	0.8	0.2	0.0	1.1	1.1	0.5	0.1	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	10.1	8.5	6.4	11.1	10.3	10.2	7.3	7.0	4.8	5.5	7.3	9.7	0.3	0.0	0.0	19.6	0.0	0.6	0.3	0.2	1.2	2.6	0.3	0.9	0.4	0.0	0.1	0.0	0.0	1.0	0.2	0.2	0.0	0.1	1.3	0.2	1.1	0.5	0.0	0.0	11.3	0.0	0.2	1.3	0.0	0.4	0.0	1.0	0.7	0.0	0.1	0.0	12.7	0.0	0.0	0.0	0.8	3.9	2.1	0.2	0.0	2.8	0.1	2.5	0.0	92.0	43.7	0.2	0.1	17.3	0.0	0.2	0.0	0.0	0.0	0.7	0.0	0.2	0.6	0.2	0.0	0.1	0.4	0.3	0.2	4.5	0.1	0.3
NLRC3	"CLR16.2, FLJ00348, NOD3"	ENSG00000167984	"NLR family CARD domain containing 3"	Q7RTR2	16	3539033-3577403	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 6.5;lymphoid tissue: 13.6"	"Cell type enhanced"	"Detected in many"		"B-cells: 10.3;dendritic cells: 18.8;NK-cells: 37.0;T-cells: 23.8"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"Daudi: 8.8;HEL: 8.7;HL-60: 18.6;HMC-1: 9.0;JURKAT: 9.2;NB-4: 19.7;U-698: 28.9;U-937: 13.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			HPA048062			Supported	"Vesicles,Centriolar satellite,Cytosol"		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 16: Immune cells - Immune response"	"Cluster 24: NB-4 - Immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	Cytosol	"Vesicles, Centriolar satellite"	"HPA048062: AB_2680242"	"unprognostic (4.93e-3)"	"unprognostic (3.84e-4)"	"unprognostic (7.61e-4)"	"unprognostic (4.94e-7)"	"unprognostic (9.56e-2)"	"unprognostic (3.76e-5)"	"unprognostic (1.86e-3)"	"unprognostic (6.70e-3)"	"unprognostic (2.66e-2)"	"unprognostic (7.02e-2)"	"unprognostic (3.40e-2)"	"unprognostic (5.20e-2)"	"unprognostic (1.40e-2)"	"unprognostic (5.13e-2)"	"unprognostic (7.15e-3)"	"unprognostic (4.54e-2)"	"unprognostic (2.08e-2)"	1.0	0.8	0.3	7.8	0.4	4.1	0.7	0.8	0.7	0.9	1.0	1.5	1.7	0.9	0.4	0.8	1.2	1.4	1.5	0.3	0.0	1.3	1.1	2.4	13.6	0.3	0.3	0.7	0.5	0.2	0.9	0.9	0.1	1.1	1.2	1.1	1.1	0.3	1.1	0.5	6.5	0.5	0.0	11.8	2.1	0.9	0.3	11.3	1.5	0.9	11.1	1.5	0.8	0.1	0.1	0.0	0.2	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	8.8	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.4	0.2	8.7	0.1	0.0	0.0	18.6	9.0	0.0	0.0	0.0	0.0	0.5	0.2	9.2	0.2	0.0	0.0	0.4	7.7	19.7	0.0	0.0	0.1	5.1	0.0	0.1	0.0	0.0	0.2	0.2	0.0	0.0	0.3	0.1	0.1	4.9	0.5	0.3	0.1	0.2	0.1	0.4	0.2	28.9	0.2	13.6	0.1	2.9	0.0	0.0	2.3	0.0	2.1	0.8	1.7	2.2	0.0	0.6	1.4	1.5	0.0	2.6	0.0	0.0	2.0	2.1	0.3	0.4	0.8	0.7	0.3	0.0	0.3	0.3	0.1	0.0	0.3	0.1	1.7	3.2	0.0	1.0	10.3	0.0	0.3	0.0	0.0	1.6	0.4	0.3	4.6	1.5	0.6	1.8	4.2	0.0	18.8	0.0	0.0	0.0	4.0	1.3	0.8	2.3	0.0	6.5	3.8	0.0	0.0	0.5	1.5	0.7	2.5	0.2	3.9	0.1	0.1	0.0	3.7	0.0	0.0	1.0	0.0	1.3	0.0	1.1	0.0	1.9	1.3	0.3	37.0	1.0	0.6	0.0	0.0	0.0	6.2	0.1	0.0	0.1	0.7	5.1	0.0	0.9	0.7	0.5	0.3	0.0	0.0	0.0	23.8	0.1	0.0	0.3
NLRC4	"CARD12, CLAN, CLAN1, CLANA, CLANB, CLANC, CLAND, CLR2.1, ipaf"	ENSG00000091106	"NLR family CARD domain containing 4"	Q9NPP4	2	32224453-32265732	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Immunity, Inflammatory response, Innate immunity"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 8.3;lung: 6.2;lymphoid tissue: 11.4"	"Cell type enhanced"	"Detected in some"		"Hofbauer cells: 11.9;Kupffer cells: 21.0;Macrophages: 14.5;Microglial cells: 10.3;monocytes: 18.4"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	7	"classical monocyte: 49.3;intermediate monocyte: 56.9;myeloid DC: 32.2;neutrophil: 24.6;non-classical monocyte: 44.2"	"Group enriched"	"Detected in many"	32	"dendritic cells: 32.2;granulocytes: 24.6;monocytes: 56.9"	"Cell line enhanced"	"Detected in some"		"HL-60: 3.1"	"Not detected"	"Not detected"							"HPA006592, HPA075894"	Uncertain		Approved	Vesicles,Cytosol		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 2: Immune cells - Immune response"	"Cluster 32: U-937 - Innate immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	"Vesicles, Cytosol"		"HPA006592: AB_2667620, HPA075894: "	"unprognostic (7.59e-2)"	"unprognostic (1.08e-1)"	"unprognostic (6.25e-2)"	"unprognostic (1.97e-1)"	"unprognostic (8.88e-2)"	"unprognostic (2.45e-2)"	"unprognostic (1.17e-2)"	"unprognostic (2.09e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.26e-1)"	"unprognostic (6.33e-2)"	"unprognostic (6.33e-2)"	"unprognostic (6.03e-6)"	"unprognostic (7.42e-2)"	"unprognostic (2.06e-3)"	"unprognostic (2.02e-2)"	"unprognostic (1.63e-1)"	3.4	1.4	0.4	8.7	0.5	8.3	0.7	0.4	0.8	0.6	0.6	0.9	0.9	0.4	0.0	0.6	0.8	1.4	1.2	0.4	0.4	0.5	1.6	6.2	2.3	0.6	0.5	0.3	0.8	0.1	0.6	2.1	0.6	0.4	0.8	0.6	0.5	0.2	1.0	0.3	1.3	2.3	0.5	11.4	0.6	0.4	0.9	0.7	0.4	0.3	1.2	2.0	0.3	0.8	0.1	0.2	0.3	0.7	0.1	0.0	0.4	0.3	0.0	0.0	0.0	0.3	0.3	0.3	0.2	0.0	0.2	0.2	0.0	0.0	0.0	0.7	0.3	0.5	0.1	0.4	0.0	3.1	0.5	0.0	0.3	0.0	1.4	0.4	0.0	0.1	0.3	0.2	0.0	0.0	0.2	1.4	0.1	0.2	0.2	0.1	0.4	0.5	0.0	0.3	0.3	0.7	0.2	0.2	1.2	0.5	0.1	1.4	0.1	0.3	0.3	0.2	0.4	0.3	0.8	1.2	0.4	1.3	0.4	0.5	49.3	5.8	0.1	56.9	0.4	0.6	0.0	0.0	32.2	1.1	0.0	0.1	24.6	0.3	44.2	0.4	0.2	18.6	0.4	0.5	0.4	0.8	0.4	0.4	0.6	0.5	0.6	0.5	0.9	0.8	0.2	0.0	1.8	1.0	0.8	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.5	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	2.7	4.0	0.0	0.1	0.1	0.0	0.0	1.3	0.0	1.1	0.0	11.9	0.0	3.3	0.0	0.0	21.0	1.0	0.0	0.0	14.5	0.0	10.3	18.4	0.0	1.0	1.0	1.3	0.0	0.0	0.0	0.3	0.0	0.0	0.3	0.0	0.2	0.0	0.3	0.1	0.0	0.2	0.0	0.1	0.3	0.2	0.1	0.0	0.0
NLRC5	"CLR16.1, FLJ21709, NOD27"	ENSG00000140853	"NLR family CARD domain containing 5"	Q86WI3	16	56989485-57083531	"Predicted intracellular proteins"	"Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 34.6;lymphoid tissue: 32.8"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 35.8;Distal enterocytes: 43.2;Gastric mucus-secreting cells: 41.8;NK-cells: 39.1;T-cells: 42.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEL: 94.2;NB-4: 51.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA060405, HPA074724"			Supported	Centrosome,Cytosol		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 2: Immune cells - Immune response"	"Cluster 36: HEL - Hemostasis"	"Cluster 63: NK-cells & T-cells - Immune response"	Cytosol	Centrosome	"HPA060405: AB_2684277, HPA074724: "	"unprognostic (9.66e-2)"	"prognostic favorable (9.69e-4)"	"unprognostic (1.64e-2)"	"unprognostic (1.23e-2)"	"unprognostic (3.12e-1)"	"unprognostic (9.27e-3)"	"unprognostic (1.05e-1)"	"unprognostic (9.25e-2)"	"unprognostic (2.24e-2)"	"prognostic favorable (2.30e-4)"	"unprognostic (2.69e-1)"	"unprognostic (3.46e-1)"	"prognostic unfavorable (2.44e-4)"	"unprognostic (2.99e-2)"	"unprognostic (3.91e-2)"	"unprognostic (5.06e-2)"	"unprognostic (2.75e-3)"	5.8	3.6	2.4	24.1	2.9	34.6	2.9	2.1	2.6	2.7	1.2	8.5	6.0	4.2	1.5	5.5	2.7	8.4	4.1	1.8	2.5	2.4	2.6	11.3	28.9	7.4	3.1	2.8	2.6	3.0	4.8	2.7	5.5	2.9	6.8	0.7	8.6	2.5	3.1	13.6	8.8	6.0	3.3	32.8	9.2	1.2	4.1	10.6	2.8	4.8	17.3	7.0	2.7	3.7	11.3	2.1	0.3	0.8	0.7	3.6	0.1	6.1	9.4	19.1	18.4	0.0	19.0	22.9	4.5	10.0	7.5	7.3	2.4	0.6	2.1	1.0	0.7	94.2	21.8	2.3	6.5	3.3	5.4	7.0	0.2	15.6	1.7	6.1	7.5	3.2	0.1	4.5	4.0	0.4	5.2	51.8	0.1	0.3	2.0	24.5	6.9	9.4	2.1	0.9	0.7	0.8	12.4	1.1	2.6	0.0	1.3	12.3	9.7	9.1	3.2	33.7	5.1	9.0	5.0	23.9	16.3	6.9	1.7	7.2	3.8	12.6	5.8	1.9	3.5	4.6	3.4	5.7	1.5	2.7	2.1	2.3	8.5	2.3	2.3	1.1	4.1	3.0	2.4	2.9	2.1	2.6	1.8	2.5	7.4	3.1	5.5	3.3	4.1	3.7	29.8	0.0	11.2	6.2	28.0	6.8	0.9	1.1	2.2	0.9	3.1	2.8	5.3	0.0	3.6	5.5	0.0	0.1	35.8	43.2	0.0	5.6	0.5	5.1	8.5	16.9	8.4	4.8	0.5	8.4	0.2	3.4	41.8	16.7	9.5	2.2	7.9	5.5	4.5	0.0	0.8	20.7	4.1	16.2	5.4	0.5	0.9	14.2	0.0	26.2	17.8	0.2	39.1	1.5	4.5	9.4	14.1	0.4	14.7	2.3	3.0	0.9	2.5	1.3	0.0	3.7	6.4	0.1	0.1	3.3	9.9	0.1	42.2	7.8	15.9	3.5
NLRP1	"CARD7, CLR17.1, DEFCAP, DKFZp586O1822, KIAA0926, NAC, NALP1, SLEV1, VAMAS1"	ENSG00000091592	"NLR family pyrin domain containing 1"	Q9C000	17	5499427-5619424	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, Immunity, Inflammatory response, Innate immunity, Necrosis"	"Hydrolase, Protease"	"Disease variant, Ectodermal dysplasia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 561.7;Muller glia cells: 151.8"	"Cancer enhanced"	"Detected in all"		"glioma: 20.2"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 55.4;Karpas-707: 90.9;U-266/70: 45.0"									"CAB009189, HPA064431"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 64: Macrophages - Immune response"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	"Nucleoplasm, Cytosol"		"CAB009189: , HPA064431: AB_2685262"	"unprognostic (4.40e-2)"	"unprognostic (1.02e-1)"	"unprognostic (3.16e-2)"	"unprognostic (3.65e-2)"	"unprognostic (4.00e-2)"	"unprognostic (1.23e-3)"	"unprognostic (4.13e-2)"	"unprognostic (1.50e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.32e-1)"	"prognostic favorable (7.57e-4)"	"unprognostic (2.99e-1)"	"prognostic unfavorable (1.60e-5)"	"unprognostic (6.69e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.34e-2)"	27.9	4.0	3.6	27.8	3.7	25.0	22.1	3.2	5.3	22.9	3.5	10.8	5.8	13.8	1.8	16.2	14.4	13.4	15.7	2.9	3.7	9.4	5.3	26.9	38.1	5.5	3.8	5.8	3.2	1.8	4.1	12.1	5.5	13.2	7.8	0.3	10.8	9.0	7.7	50.8	31.1	9.7	3.7	56.3	6.9	6.1	4.0	15.1	21.8	7.7	32.4	15.8	27.7	4.1	14.2	0.0	0.0	0.0	8.6	10.2	1.8	6.9	6.3	2.6	5.7	0.2	5.5	5.3	20.8	7.6	1.1	6.5	0.0	23.4	4.0	55.4	0.0	1.4	4.8	0.5	7.1	0.0	1.6	6.6	14.5	20.7	13.7	10.4	25.6	1.1	13.0	90.9	11.8	0.0	0.1	4.6	0.0	0.0	0.3	6.0	4.0	23.0	0.0	4.8	0.7	0.0	0.0	0.2	0.4	0.6	0.0	0.5	25.2	5.3	3.0	3.2	1.1	45.0	15.9	4.1	8.7	0.6	0.3	18.3	7.1	5.0	5.9	4.9	6.6	4.4	5.1	6.3	5.0	4.9	5.5	5.2	18.9	4.2	8.6	0.5	7.7	4.6	3.6	3.7	3.2	5.3	2.9	3.7	5.5	3.8	5.5	3.7	4.0	4.1	46.4	0.0	7.8	1.3	29.0	17.7	7.1	8.0	15.4	60.6	2.7	6.2	4.9	2.8	10.4	7.3	4.2	0.8	30.3	0.3	3.9	0.4	561.7	4.9	18.0	26.9	77.9	3.6	2.9	0.0	1.1	31.6	3.6	1.0	3.8	7.8	44.6	0.6	7.0	85.8	1.5	1.2	0.0	23.0	24.3	93.4	25.4	26.2	7.2	56.2	27.0	151.8	26.8	1.5	0.8	7.0	0.0	28.2	25.9	2.0	0.0	0.4	12.7	11.6	6.6	33.1	17.3	25.0	11.0	10.7	24.9	1.5	37.6	3.6	0.2	8.0
NLRP11	"CLR19.6, NALP11, NOD17, PAN10, PYPAF6"	ENSG00000179873	"NLR family pyrin domain containing 11"	P59045	19	55785397-55836800	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"epididymis: 1.1;liver: 1.0"	"Group enriched"	"Detected in some"	5	"Early spermatids: 13.0;Late spermatids: 5.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Daudi: 115.6;RPMI-8226: 66.1;U-266/70: 110.2;U-266/84: 51.2;U-698: 83.9"					"Not detected"	"Not detected"			"HPA046402, HPA078027"	Uncertain		Supported	Cytosol		NA	NA				"Cluster 68: Epididymis - Unknown function"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 34: Spermatids - Unknown function"	Cytosol		"HPA046402: AB_10962951, HPA078027: AB_2732369"	"unprognostic (2.36e-2)"	"unprognostic (3.59e-1)"	"unprognostic (1.09e-1)"	"unprognostic (4.36e-3)"	"unprognostic (3.31e-2)"	"unprognostic (7.88e-2)"	"unprognostic (9.95e-3)"	"unprognostic (8.04e-2)"	"unprognostic (1.94e-1)"	"unprognostic (2.52e-1)"	"unprognostic (3.75e-2)"	"unprognostic (3.14e-2)"	"unprognostic (1.10e-2)"	"unprognostic (2.06e-1)"	"unprognostic (2.89e-2)"	"unprognostic (1.76e-2)"	"unprognostic (7.61e-2)"	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	1.1	0.0	0.0	0.1	0.0	0.0	0.0	0.2	1.0	0.0	0.2	0.0	0.0	0.3	0.1	0.2	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.8	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	115.6	0.0	0.0	1.4	0.0	0.5	0.0	0.0	0.0	3.2	0.1	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	24.0	0.0	0.0	0.4	0.7	0.1	0.0	0.4	0.0	2.0	66.1	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.0	0.6	0.1	1.8	1.9	0.1	0.1	110.2	51.2	83.9	2.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	13.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.7	0.0	0.0	0.2	0.0	0.0	0.3	0.3	5.1	0.3	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.8	1.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0
NLRP2	"CLR19.9, FLJ20510, NALP2, NBS1, PAN1, PYPAF2"	ENSG00000022556	"NLR family pyrin domain containing 2"	Q9NX02	19	54953130-55001142	"Predicted intracellular proteins"	"Apoptosis, Immunity, Inflammatory response, Innate immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 45.2;Extravillous trophoblasts: 216.1;Syncytiotrophoblasts: 97.3"	"Cancer enriched"	"Detected in many"	7	"testis cancer: 78.1"	"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"A549: 42.2;BEWO: 177.9;OE19: 79.7;SuSa: 80.3;T-47d: 46.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA021183			Supported	"Golgi apparatus,Vesicles,Cytosol"		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 38: Extravillous trophoblasts - Unknown function"	"Golgi apparatus, Vesicles, Cytosol"		"HPA021183: AB_2670615"	"unprognostic (1.66e-2)"	"unprognostic (9.28e-2)"	"unprognostic (6.60e-2)"	"unprognostic (6.50e-3)"	"unprognostic (1.09e-2)"	"unprognostic (4.57e-3)"	"unprognostic (4.27e-1)"	"unprognostic (1.79e-2)"	"unprognostic (2.39e-1)"	"unprognostic (1.30e-1)"	"prognostic unfavorable (2.91e-4)"	"unprognostic (3.63e-1)"	"unprognostic (2.34e-2)"	"unprognostic (2.55e-1)"	"unprognostic (2.30e-1)"	"unprognostic (8.86e-2)"	"unprognostic (7.57e-2)"	0.4	0.3	0.9	2.7	0.6	1.0	1.0	0.0	0.8	2.6	0.1	1.7	1.8	1.1	1.8	7.9	1.9	0.9	0.4	0.7	0.1	1.9	0.4	1.6	2.1	0.1	0.2	0.3	1.6	0.4	1.2	7.1	0.1	1.5	1.9	3.1	2.4	1.1	0.6	3.0	1.7	0.8	0.0	2.1	2.5	7.2	0.3	3.4	4.4	0.0	1.9	7.1	4.3	0.2	20.4	42.2	15.8	0.4	0.2	0.1	177.9	0.1	0.0	0.6	0.2	35.9	0.7	14.7	0.1	0.1	0.1	8.1	0.0	24.4	0.3	1.7	0.2	9.8	0.5	0.1	0.4	0.1	0.4	0.2	0.3	0.0	0.1	0.1	0.9	0.0	32.7	0.2	0.0	0.3	0.1	1.3	5.0	79.7	0.0	8.8	0.0	24.0	26.4	0.7	5.3	0.7	0.0	8.1	0.0	80.3	46.7	0.2	0.0	0.3	0.7	0.4	0.3	5.2	16.6	0.7	0.4	1.0	0.0	0.1	0.2	0.0	1.8	0.3	1.3	0.6	0.4	0.7	0.2	0.6	0.3	0.8	0.2	3.0	0.1	1.0	1.3	0.4	0.9	0.6	0.0	0.8	0.7	0.1	0.1	0.2	0.1	0.0	0.3	0.2	0.0	9.6	7.3	0.3	1.5	0.5	1.9	8.1	0.0	2.7	1.9	1.5	0.8	4.3	10.1	1.8	4.2	45.2	3.5	2.9	0.0	5.3	23.1	8.6	1.3	0.7	2.4	0.8	3.0	1.9	216.1	1.1	2.0	13.1	4.5	0.7	0.0	0.0	11.6	0.0	1.9	3.0	6.1	0.3	0.5	7.2	0.9	1.1	0.0	0.0	3.0	0.7	8.2	0.5	0.5	6.7	1.0	0.0	1.5	2.5	0.8	0.4	8.4	2.7	0.0	0.3	0.8	16.8	11.7	0.0	1.3	97.3	2.4	0.3	3.0	4.7
NLRP5	"CLR19.8, MATER, NALP5, PAN11, PYPAF8"	ENSG00000171487	"NLR family pyrin domain containing 5"	P59047	19	55999726-56061810	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	50	"parathyroid gland: 22.4"	"Cell type enhanced"	"Detected in some"		"Microglial cells: 1.0;Oligodendrocyte precursor cells: 2.0;Oligodendrocytes: 1.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	13	"Karpas-707: 1.3;U-2 OS: 3.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA047260, HPA056271"	Uncertain		Supported	"Golgi apparatus,Vesicles"	"Intracellular and membrane"	NA	NA				"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 9: U-2 OS - Unknown function"	"Cluster 44: Endometrium - Transcription"	"Golgi apparatus"	Vesicles	"HPA047260: , HPA056271: AB_2683083"	"unprognostic (9.67e-2)"			"unprognostic (2.22e-2)"								"unprognostic (5.03e-1)"		"unprognostic (7.78e-2)"	"unprognostic (1.72e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	22.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.4	0.1	0.1	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	1.0	0.0	0.0	0.0	2.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0
NLRX1	"CLR11.3, NOD9"	ENSG00000160703	"NLR family member X1"	Q86UT6	11	119166568-119184016	"Predicted intracellular proteins"	"Host-virus interaction, Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 43.2"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"eosinophil: 15.4"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 15.4"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA061516	Supported		Supported	"Plasma membrane,Cell Junctions,Mitochondria"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 6: T47d - Mammary gland"	"Cluster 54: Cardiomyocytes - Muscle contraction"	Mitochondria	"Plasma membrane, Cell Junctions"	"HPA061516: AB_2684548"	"unprognostic (7.58e-2)"	"unprognostic (3.71e-1)"	"unprognostic (6.36e-2)"	"prognostic favorable (2.47e-5)"	"unprognostic (5.60e-3)"	"unprognostic (2.59e-2)"	"unprognostic (2.06e-1)"	"unprognostic (2.43e-2)"	"unprognostic (8.80e-2)"	"unprognostic (1.17e-1)"	"unprognostic (3.49e-1)"	"unprognostic (3.29e-1)"	"prognostic favorable (2.59e-6)"	"unprognostic (3.06e-2)"	"unprognostic (1.70e-1)"	"unprognostic (2.83e-2)"	"unprognostic (4.22e-2)"	8.1	10.7	4.9	4.7	5.0	6.5	7.0	4.7	5.5	10.5	6.4	10.8	4.8	10.1	3.4	43.2	9.8	5.2	17.0	4.7	4.6	8.8	9.1	5.5	5.0	5.3	5.1	4.0	9.6	6.0	4.8	4.2	5.4	8.3	3.4	2.7	10.3	6.8	24.1	21.5	6.4	5.8	5.1	8.1	7.3	3.5	5.1	4.7	7.9	13.7	10.5	9.6	16.5	5.2	5.3	15.6	1.6	12.2	5.1	5.9	2.4	7.0	8.0	3.4	5.9	0.9	13.0	9.5	21.0	8.9	5.1	13.1	4.7	4.0	1.1	12.5	5.0	12.6	5.5	8.6	7.7	4.4	7.0	6.6	16.4	4.5	8.7	6.9	7.0	12.5	0.1	6.2	3.6	14.2	7.5	10.7	7.5	6.9	8.6	14.6	2.1	3.1	8.2	6.8	2.3	7.9	10.4	5.5	4.5	2.4	17.7	13.0	8.2	6.8	6.0	6.1	3.6	2.2	2.6	3.3	1.0	13.4	4.9	2.8	3.5	15.4	0.8	1.5	1.0	0.5	0.8	1.2	2.1	0.4	0.9	1.0	8.1	1.4	1.4	0.9	1.4	2.3	4.9	5.0	4.7	5.5	4.7	4.6	5.3	5.1	5.4	5.1	5.1	5.2	3.0	0.0	7.9	5.9	3.2	2.5	1.7	4.5	2.8	1.3	4.1	4.2	12.8	2.8	4.2	7.3	2.1	3.6	1.4	7.3	1.9	7.1	2.0	8.7	2.8	3.8	2.4	3.8	5.9	3.8	2.2	3.5	8.2	4.1	0.0	5.7	5.3	10.2	6.5	0.0	4.0	3.7	2.0	6.0	1.8	4.7	1.2	4.0	1.8	2.8	6.2	6.1	5.2	5.5	2.8	5.5	7.6	1.2	1.8	1.6	3.9	5.3	7.2	3.2	0.0	2.9	2.7	1.9	2.0	10.8	4.7	0.5	2.8	2.1	5.5	1.2
NMBR	"BB1, BB1R"	ENSG00000135577	"Neuromedin B receptor"	P28336	6	142058330-142088799	"G-protein coupled receptors, Plasma proteins, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 1.5;testis: 1.4"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 3.3;Early spermatids: 7.0;Excitatory neurons: 2.3;Inhibitory neurons: 4.5;Late spermatids: 2.1;Oligodendrocyte precursor cells: 2.0;Oligodendrocytes: 2.5;Spermatocytes: 3.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA026665			Supported	"Plasma membrane,Cytosol"		NA	NA				"Cluster 49: Ciliated cells - Cilium organization"		"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Plasma membrane, Cytosol"		"HPA026665: AB_1854527"	"unprognostic (6.24e-2)"	"unprognostic (3.05e-1)"		"unprognostic (2.77e-2)"	"unprognostic (7.88e-2)"			"unprognostic (3.54e-2)"		"unprognostic (8.21e-2)"	"unprognostic (3.63e-2)"	"unprognostic (1.54e-1)"	"unprognostic (3.95e-1)"	"unprognostic (7.94e-3)"	"unprognostic (3.44e-1)"	"unprognostic (2.11e-1)"	"unprognostic (8.45e-2)"	0.0	0.0	0.7	0.0	1.0	0.0	0.1	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.8	0.0	0.0	0.2	1.3	0.0	0.0	0.1	0.0	1.0	1.1	0.1	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	1.1	0.0	0.0	1.4	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.4	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	1.0	0.0	0.6	0.2	1.3	1.0	1.1	1.5	1.1	0.5	0.2	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.0	0.3	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	1.0	0.0	0.0	0.0	2.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
NMD3	CGI-07	ENSG00000169251	"NMD3 ribosome export adaptor"	Q96D46	3	161104696-161253532	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035019			Supported	Nucleoplasm,Nucleoli		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 10: Non-specific - Unknown function"	"Nucleoplasm, Nucleoli"		"HPA035019: AB_10600922"	"unprognostic (1.37e-2)"	"unprognostic (2.71e-1)"	"unprognostic (9.50e-2)"	"unprognostic (9.39e-3)"	"unprognostic (1.95e-3)"	"unprognostic (1.18e-2)"	"unprognostic (1.03e-1)"	"unprognostic (4.41e-2)"	"unprognostic (2.00e-1)"	"unprognostic (1.28e-1)"	"prognostic unfavorable (2.03e-5)"	"unprognostic (7.97e-2)"	"unprognostic (5.57e-2)"	"unprognostic (6.17e-2)"	"unprognostic (8.71e-2)"	"unprognostic (2.26e-2)"	"unprognostic (5.86e-3)"	26.9	21.5	13.1	18.1	13.8	64.7	32.3	19.3	14.1	27.0	12.8	18.6	17.6	26.3	15.3	24.4	20.2	22.6	40.0	11.2	14.2	29.2	77.7	19.7	22.3	10.8	13.4	26.4	34.9	21.9	12.7	25.6	11.8	27.7	21.2	17.0	32.8	20.0	60.3	17.2	15.4	28.3	12.1	21.1	42.5	16.0	13.0	18.7	25.2	34.5	24.7	39.3	16.5	13.9	68.7	39.2	37.8	38.6	46.3	63.1	51.9	76.3	57.9	55.9	64.8	66.5	54.9	86.4	94.8	53.8	39.3	43.8	60.9	56.1	86.4	90.2	37.4	89.0	31.4	41.7	50.7	108.0	51.7	53.2	40.9	39.7	129.1	59.4	61.4	29.9	66.3	46.3	66.8	155.7	49.6	41.3	47.4	82.1	61.7	59.8	54.5	87.9	53.1	153.2	59.8	37.3	43.5	105.2	63.9	40.9	78.3	49.0	54.2	44.1	31.5	51.3	93.4	75.6	54.5	87.1	55.5	69.5	61.5	30.5	16.6	8.9	16.5	17.6	25.9	17.3	19.2	20.4	19.8	15.6	25.3	20.1	3.6	35.4	11.4	11.0	26.8	20.7	13.1	13.8	19.3	14.1	11.2	14.2	10.8	13.4	11.8	12.1	13.0	13.9	30.6	19.2	14.6	22.9	25.3	64.9	52.9	23.8	34.7	24.7	26.8	16.5	43.9	21.5	25.1	11.0	14.6	33.3	25.2	14.0	35.2	25.6	19.3	13.8	29.6	30.1	13.8	32.2	16.6	38.9	48.8	34.0	31.1	19.3	25.4	20.3	22.1	41.6	23.4	30.3	15.3	19.4	26.4	33.1	47.0	7.0	25.4	21.6	24.9	12.2	26.1	12.8	21.6	19.6	18.2	33.0	13.9	27.4	20.9	46.7	19.7	39.9	18.5	20.8	26.3	29.1	87.5	39.2	27.4	33.4	74.3	56.6	25.8	24.4	21.2	72.7
NME1	"NDPKA, NM23, NM23-H1"	ENSG00000239672	"NME/NM23 nucleoside diphosphate kinase 1"	P15531	17	51153559-51162428	"Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Differentiation, Endocytosis, Neurogenesis, Nucleotide metabolism"	"Kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008467, CAB040571, HPA041113"	Supported		Supported	"Nucleoplasm,Plasma membrane,Cytosol"	"Intracellular and membrane"	NA	NA		21000000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 77: Retina - Visual perception"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Cytosol	"Nucleoplasm, Plasma membrane"	"CAB040571: , HPA008467: AB_1079492, HPA041113: AB_2677305"	"unprognostic (2.24e-1)"	"unprognostic (2.01e-1)"	"unprognostic (3.48e-3)"	"unprognostic (5.96e-2)"	"unprognostic (9.71e-2)"	"unprognostic (2.33e-3)"	"prognostic unfavorable (2.60e-5)"	"unprognostic (4.54e-2)"	"unprognostic (3.35e-1)"	"unprognostic (2.33e-3)"	"unprognostic (2.90e-2)"	"unprognostic (1.01e-1)"	"prognostic unfavorable (2.07e-9)"	"unprognostic (9.01e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.83e-1)"	"unprognostic (9.46e-2)"	63.6	84.4	79.3	74.7	81.6	77.0	63.1	78.7	102.2	38.2	79.0	60.1	38.8	49.7	46.8	91.0	48.6	20.8	37.7	88.0	92.0	65.4	83.2	41.3	73.9	83.9	78.4	33.6	67.8	52.8	47.4	39.2	82.4	38.7	77.6	218.4	50.7	30.4	35.6	57.5	33.1	66.3	76.5	48.5	41.8	25.3	81.0	61.1	41.3	20.9	95.8	72.2	48.9	80.1	483.6	833.1	285.9	444.8	118.6	183.7	479.7	355.3	227.3	652.2	489.7	656.9	288.1	754.2	372.4	304.1	272.4	252.1	542.5	553.3	553.4	398.4	729.3	504.9	605.8	975.9	237.1	575.8	243.8	177.8	341.7	493.1	458.6	120.6	404.6	247.8	739.0	270.0	392.8	720.4	715.2	647.1	390.7	957.5	739.3	446.9	587.6	751.3	511.5	320.2	418.6	461.1	188.1	521.0	385.3	246.2	554.0	419.6	279.5	476.9	452.2	307.0	774.4	374.0	840.9	956.3	286.2	480.4	385.8	1.1	55.0	2.1	47.2	77.1	69.3	96.4	50.3	53.8	134.0	67.6	54.3	60.4	1.7	69.6	48.6	84.8	49.1	68.4	79.3	81.6	78.7	102.2	88.0	92.0	83.9	78.4	82.4	76.5	81.0	80.1	53.1	32.1	30.5	0.0	71.3	132.4	97.5	198.8	88.8	283.3	98.8	118.1	34.2	65.8	92.3	71.7	285.7	180.0	25.4	54.2	150.6	211.3	34.2	40.2	107.2	85.1	89.7	81.8	0.0	201.5	269.7	85.0	64.2	37.2	45.7	113.5	27.8	123.3	207.1	40.4	0.0	107.4	101.7	25.7	88.9	93.7	61.2	48.9	129.9	0.0	47.2	105.6	27.8	0.0	0.0	194.0	50.5	58.6	113.8	170.6	12.2	195.2	42.0	323.7	13.1	83.0	182.9	22.7	98.8	139.4	133.1	88.5	38.0	215.5	157.7	98.2
NME2	"NDPKB, NM23-H2"	ENSG00000243678	"NME/NM23 nucleoside diphosphate kinase 2"	P22392	17	51165435-51171744	"Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Nucleotide metabolism, Transcription, Transcription regulation"	"Activator, DNA-binding, Kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 918.0;Gastric mucus-secreting cells: 438.3;Plasma cells: 778.5;Squamous epithelial cells: 1490.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"CAB036213, CAB036214, CAB036215, HPA041113"	Approved		Supported	"Plasma membrane,Midbody ring,Cytosol"		Yes	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 50: Non-specific - Ribosome"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 61: Squamous epithelial cells - Keratinization"	Cytosol	"Plasma membrane, Midbody ring"	"CAB036213: , CAB036214: , CAB036215: , HPA041113: AB_2677305"	"unprognostic (7.21e-3)"	"prognostic unfavorable (4.74e-4)"	"unprognostic (4.85e-2)"	"unprognostic (1.15e-2)"	"unprognostic (8.86e-2)"	"unprognostic (1.42e-2)"	"prognostic unfavorable (7.09e-4)"	"unprognostic (6.62e-3)"	"unprognostic (5.68e-2)"	"unprognostic (2.31e-1)"	"unprognostic (1.38e-1)"	"unprognostic (6.41e-2)"	"prognostic unfavorable (1.55e-6)"	"unprognostic (2.82e-1)"	"unprognostic (9.09e-2)"	"unprognostic (8.87e-2)"	"unprognostic (3.19e-2)"	503.5	428.3	308.0	259.5	319.0	329.4	489.1	328.0	379.9	439.2	431.1	409.2	335.1	383.4	236.1	610.6	350.6	187.0	403.9	313.7	338.6	478.1	428.4	339.6	288.9	326.6	320.7	500.1	632.0	201.8	234.9	204.8	321.3	367.7	330.4	63.3	432.4	247.5	545.7	540.3	307.6	286.2	326.8	336.0	403.5	77.8	333.3	190.0	305.3	353.7	289.1	463.5	464.2	333.4	1638.6	2233.9	466.1	913.7	969.3	1399.2	1449.2	1091.7	954.0	1404.8	1053.5	1789.7	792.3	1314.3	1662.9	913.0	706.6	956.2	947.3	1273.3	1035.7	1604.8	3283.2	1120.3	1345.8	2513.4	1116.1	1736.0	760.5	1324.1	1420.0	901.9	1466.4	914.6	860.9	856.5	1541.7	773.7	956.1	2741.9	931.3	2144.8	831.4	2974.6	3364.2	875.9	1731.8	2157.2	1417.9	1800.2	1160.6	641.9	674.1	1472.7	1583.0	806.1	1201.7	1268.5	1013.5	1462.8	1158.2	1135.2	1774.8	1520.9	2176.6	1558.1	815.1	919.1	819.2	66.8	243.4	14.0	166.7	325.5	235.6	338.9	211.9	183.3	439.5	259.2	153.5	170.0	13.8	251.6	282.5	478.1	211.2	298.2	308.0	319.0	328.0	379.9	313.7	338.6	326.6	320.7	321.3	326.8	333.3	333.4	9.7	28.9	67.2	0.0	146.8	14.5	8.3	10.8	918.0	0.9	41.6	35.9	0.0	22.8	85.7	5.5	0.0	10.0	10.1	7.1	37.2	47.4	0.6	16.4	34.3	60.9	14.6	298.2	0.0	34.5	27.8	99.0	438.3	21.3	42.9	6.8	22.9	37.6	16.4	0.0	0.0	19.3	8.2	34.8	17.4	2.1	25.7	136.7	10.6	0.0	55.5	0.4	2.1	0.0	0.0	40.7	15.6	12.8	778.5	7.6	11.7	33.8	63.6	0.8	6.6	10.2	43.3	0.6	5.6	1490.1	14.9	8.8	87.0	6.8	25.0	11.0
NME4	"NDPKD, nm23-H4, NM23H4"	ENSG00000103202	"NME/NM23 nucleoside diphosphate kinase 4"	O00746	16	396725-410367	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Lipid transport, Nucleotide metabolism, Transport"	"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 250.5;Erythroid cells: 311.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB045997, HPA072588"	Approved		Supported	Mitochondria		Yes	No			"Cluster 26: Non-specific - Mitochondria"	"Cluster 15: Liver - Metabolism"	"Cluster 14: REH - Unknown function"	"Cluster 33: Fibroblasts - ECM organization"	Mitochondria		"CAB045997: AB_11126630, HPA072588: AB_2686538"	"unprognostic (3.27e-1)"	"prognostic unfavorable (6.53e-4)"	"unprognostic (3.70e-2)"	"unprognostic (7.16e-3)"	"unprognostic (1.32e-1)"	"unprognostic (2.00e-1)"	"unprognostic (4.40e-2)"	"unprognostic (4.46e-3)"	"unprognostic (1.98e-1)"	"unprognostic (3.12e-1)"	"unprognostic (3.74e-2)"	"unprognostic (7.79e-3)"	"prognostic unfavorable (1.61e-7)"	"unprognostic (3.78e-2)"	"unprognostic (2.16e-1)"	"unprognostic (6.04e-2)"	"unprognostic (3.08e-1)"	89.3	136.1	78.3	26.2	75.6	127.7	72.9	73.5	101.5	88.1	77.3	192.9	21.9	79.5	55.7	50.1	89.1	41.2	101.2	76.4	81.7	60.4	175.2	48.3	21.1	88.6	77.9	86.8	43.7	56.7	64.3	30.8	79.8	143.7	23.5	11.1	70.4	81.9	34.7	31.4	59.7	51.9	78.6	43.8	97.7	44.7	80.3	29.3	51.6	27.2	15.8	145.6	64.3	73.6	1.0	305.4	265.6	366.7	104.0	181.0	59.5	143.6	170.4	211.8	180.6	205.4	176.2	3.0	105.8	230.2	76.9	3.9	145.0	153.9	62.0	126.5	218.7	151.9	40.2	279.9	195.7	111.0	53.1	234.7	79.8	130.5	12.8	152.2	137.6	210.7	159.6	25.8	160.4	255.4	98.5	139.2	271.8	76.1	67.8	485.8	59.3	79.0	150.6	1.2	77.7	419.2	36.8	2.7	139.9	97.2	178.3	257.5	174.0	149.7	216.8	101.8	36.8	2.7	2.0	83.1	65.8	19.8	177.2	12.9	13.3	39.8	14.9	11.9	12.7	27.6	14.4	16.3	17.6	29.9	26.0	13.4	4.2	2.5	10.6	58.3	0.9	10.7	78.3	75.6	73.5	101.5	76.4	81.7	88.6	77.9	79.8	78.6	80.3	73.6	52.2	0.0	13.9	18.6	40.6	32.2	56.3	49.0	40.9	15.2	116.6	135.8	44.5	52.9	25.1	58.8	2.1	71.7	45.7	19.3	250.5	116.5	5.0	30.8	113.3	55.3	45.1	311.8	16.8	40.3	26.1	87.3	29.6	59.8	29.9	199.9	55.6	132.2	131.2	8.4	21.1	38.6	26.4	46.5	68.6	21.6	89.2	35.4	62.2	10.3	46.5	45.9	19.6	10.1	3.6	58.3	23.8	94.8	34.5	121.8	9.0	75.5	7.9	5.6	52.6	40.1	105.8	1.7	32.7	38.6	24.6	21.8	26.2	89.4	54.9	60.9
NME8	"CILD6, NM23-H8, SPTRX2, TXNDC3"	ENSG00000086288	"NME/NM23 family member 8"	Q8N427	7	37848597-37900397	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Differentiation, Spermatogenesis"	"Developmental protein"	"Ciliopathy, Primary ciliary dyskinesia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	10	"bone marrow: 12.3;testis: 10.4"	"Cell type enhanced"	"Detected in some"		"dendritic cells: 22.8;Early spermatids: 46.3;Late spermatids: 23.4;NK-cells: 17.5;Oligodendrocytes: 9.8;Spermatocytes: 26.5"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in some"			"Immune cell enhanced"	"Detected in some"		"plasmacytoid DC: 4.6"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HMC-1: 1.2;NB-4: 2.0;NTERA-2: 1.7;THP-1: 1.7;U-937: 5.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB016416, HPA019259, HPA029572"	Enhanced		Supported	"Nuclear speckles,Cytosol"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 32: U-937 - Innate immune response"	"Cluster 66: Spermatocytes - Spermatogenesis"	Cytosol	"Nuclear speckles"	"CAB016416: , HPA019259: AB_1858475, HPA029572: "	"unprognostic (7.44e-3)"	"unprognostic (2.32e-2)"	"unprognostic (9.11e-2)"	"unprognostic (2.97e-2)"	"unprognostic (6.05e-2)"	"unprognostic (1.20e-2)"	"unprognostic (6.56e-2)"	"unprognostic (4.22e-2)"	"unprognostic (7.17e-2)"	"unprognostic (1.05e-1)"	"unprognostic (3.24e-1)"	"unprognostic (2.34e-2)"	"unprognostic (8.13e-8)"	"unprognostic (5.90e-2)"	"unprognostic (3.36e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.86e-1)"	0.1	0.1	0.4	0.6	0.9	12.3	0.1	0.5	0.7	0.1	0.5	0.3	0.1	0.1	0.1	0.2	0.1	0.5	0.0	0.3	0.7	0.0	0.1	0.4	0.5	1.1	0.6	0.0	0.0	0.0	0.0	0.2	0.9	0.1	0.1	0.0	0.1	0.1	0.0	0.4	0.2	0.1	0.7	1.0	0.2	10.4	0.9	0.3	0.0	0.0	0.3	0.2	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.2	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	1.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	5.3	0.0	0.0	1.1	0.9	0.3	0.2	0.0	0.0	0.0	0.7	0.9	0.0	0.0	0.3	2.1	0.1	0.0	4.6	0.0	0.4	0.4	0.9	0.5	0.7	0.3	0.7	1.1	0.6	0.9	0.7	0.9	1.0	0.1	0.0	2.5	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.1	22.8	0.0	0.0	0.0	46.3	0.0	0.1	0.1	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	5.1	0.0	0.0	0.0	0.8	0.0	0.4	0.0	0.0	1.9	5.1	23.4	0.0	3.3	0.0	0.0	2.6	0.0	17.5	0.0	9.8	0.0	0.0	0.0	0.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	26.5	0.7	0.0	0.0	0.0	2.2	0.0	0.0	0.0
NMI		ENSG00000123609	"N-myc and STAT interactor"	Q13287	2	151270470-151289894	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"NB-4: 207.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008588	Approved		Supported	Nucleoplasm,Cytosol	"Secreted to blood"	NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 32: U-937 - Innate immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	"Nucleoplasm, Cytosol"		"HPA008588: AB_1079493"	"unprognostic (5.28e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.54e-1)"	"unprognostic (2.41e-2)"	"unprognostic (9.25e-2)"	"unprognostic (3.63e-2)"	"prognostic unfavorable (1.15e-4)"	"unprognostic (1.42e-2)"	"unprognostic (1.08e-1)"	"unprognostic (4.51e-3)"	"prognostic unfavorable (3.54e-4)"	"unprognostic (1.21e-1)"	"prognostic unfavorable (1.57e-7)"	"unprognostic (1.91e-1)"	"unprognostic (4.69e-2)"	"unprognostic (1.52e-2)"	"unprognostic (4.57e-2)"	20.6	15.7	7.3	44.5	7.1	74.5	23.3	7.0	10.4	15.2	7.4	25.9	33.7	13.9	16.6	19.0	19.8	24.0	7.5	7.1	7.7	14.0	35.5	28.6	43.4	8.6	7.7	16.8	7.8	6.3	4.2	34.2	8.2	13.2	26.7	1.4	20.2	17.2	4.8	19.4	33.8	20.9	8.2	47.5	24.9	6.6	7.9	44.4	16.9	8.3	33.5	27.9	10.5	8.2	53.2	25.7	1.3	0.0	14.4	39.4	49.3	14.6	36.8	74.1	112.0	5.9	119.9	51.0	55.4	23.5	24.5	29.6	5.6	13.8	18.6	110.0	3.0	144.9	27.3	3.1	63.1	139.9	40.2	25.7	18.3	44.1	10.0	32.1	91.8	56.4	74.0	12.6	14.4	41.6	116.4	207.7	29.5	10.9	37.6	125.5	2.9	45.8	60.9	46.1	7.4	0.3	32.0	35.1	20.5	5.1	5.6	157.9	47.5	10.5	23.3	33.8	22.3	1.8	2.0	3.2	24.5	166.4	11.3	251.3	121.3	140.5	62.7	172.8	74.3	64.8	66.1	63.4	108.8	58.5	52.1	54.3	466.8	98.1	170.0	43.3	62.3	104.3	7.3	7.1	7.0	10.4	7.1	7.7	8.6	7.7	8.2	8.2	7.9	8.2	37.3	25.6	24.9	2.9	22.9	16.7	21.1	47.0	15.4	0.3	13.8	15.1	7.0	18.6	35.6	12.9	0.0	76.4	33.4	21.4	15.6	66.6	3.4	36.2	9.0	41.1	18.0	55.5	0.4	41.1	69.4	19.1	15.3	23.8	36.1	17.7	27.5	17.8	80.2	0.0	0.2	25.1	8.2	49.7	25.6	1.7	19.6	51.5	1.8	12.2	86.5	7.4	57.7	5.0	0.7	40.2	34.5	13.9	12.9	19.1	35.3	35.3	47.4	0.1	6.6	11.7	15.2	3.6	2.2	19.4	17.8	54.5	36.2	23.1	24.9	23.3
NMNAT1	"LCA9, NMNAT, PNAT1"	ENSG00000173614	"Nicotinamide nucleotide adenylyltransferase 1"	Q9HAN9	1	9943428-9985501	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Pyridine nucleotide biosynthesis"	"Nucleotidyltransferase, Transferase"	"Disease variant, Leber congenital amaurosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059447	Approved		Supported	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Nucleoplasm, Nuclear bodies"		"HPA059447: AB_2684022"	"unprognostic (1.94e-1)"	"unprognostic (3.81e-3)"	"unprognostic (7.54e-3)"	"unprognostic (1.01e-1)"	"unprognostic (3.50e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.56e-1)"	"unprognostic (2.29e-1)"	"unprognostic (4.45e-3)"	"unprognostic (4.55e-2)"	"unprognostic (1.12e-1)"	"unprognostic (3.57e-1)"	"prognostic favorable (3.85e-14)"	"unprognostic (3.11e-3)"	"unprognostic (1.17e-1)"	"unprognostic (1.47e-3)"	"unprognostic (5.16e-2)"	5.2	7.4	5.4	4.4	6.0	2.5	5.7	4.8	7.7	5.4	9.2	9.0	6.0	3.8	5.8	5.2	4.8	3.4	10.7	5.1	5.2	8.2	7.8	3.2	4.3	5.6	5.4	2.9	4.9	8.2	3.8	3.7	5.5	4.5	9.0	5.3	5.2	5.4	23.3	5.7	6.1	5.0	4.7	5.0	4.4	4.3	5.9	4.2	7.3	16.9	4.6	4.0	3.6	7.2	4.6	5.4	7.5	7.1	13.4	12.2	1.8	9.1	7.2	10.3	6.7	2.4	7.7	4.8	5.7	12.9	4.5	4.6	9.4	12.4	11.0	10.4	4.8	7.6	3.0	7.6	11.4	6.7	7.7	13.3	14.2	12.1	17.4	9.5	10.2	10.4	9.7	3.1	10.9	8.0	3.8	4.4	0.9	10.2	10.2	4.2	4.7	2.7	11.9	2.5	5.4	2.8	11.8	9.7	10.4	3.8	3.5	7.2	10.2	4.1	3.3	8.7	4.2	4.5	4.3	4.5	7.1	13.8	8.6	7.5	3.7	3.2	1.6	2.6	0.8	4.9	1.6	1.9	3.3	2.3	1.4	1.8	9.1	2.5	3.9	3.2	1.5	1.8	5.4	6.0	4.8	7.7	5.1	5.2	5.6	5.4	5.5	4.7	5.9	7.2	5.6	3.2	4.4	10.1	3.7	2.3	5.6	14.3	2.2	7.7	6.1	5.1	14.4	4.3	7.3	7.3	6.2	10.1	3.7	18.8	23.5	9.1	7.8	5.5	8.1	7.9	3.0	2.1	13.0	6.9	4.7	5.7	4.1	6.1	4.5	9.2	7.5	9.0	12.9	10.1	14.3	7.6	12.2	10.3	2.7	3.7	6.5	7.2	5.4	4.7	13.5	9.6	12.3	6.0	13.2	6.0	6.2	6.4	0.9	5.9	19.0	14.3	8.6	7.1	6.6	5.9	5.1	17.3	8.3	3.6	1.8	9.0	3.6	13.1	14.5	4.8
NMNAT3	PNAT3	ENSG00000163864	"Nicotinamide nucleotide adenylyltransferase 3"	Q96T66	3	139560180-139678017	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Pyridine nucleotide biosynthesis"	"Nucleotidyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 50.1"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 567.3;Alveolar cells type 2: 566.9;Club cells: 217.6;granulocytes: 278.8;Late spermatids: 223.3;Respiratory ciliated cells: 250.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEL: 31.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA039077, HPA057402"	Approved		Supported	Mitochondria		NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 6: Brain - Smell perception"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 11: Alveolar cells - Smell perception"	Mitochondria		"HPA039077: AB_2676336, HPA057402: AB_2683427"	"unprognostic (9.45e-3)"	"prognostic favorable (9.67e-4)"	"unprognostic (2.29e-1)"	"unprognostic (1.56e-3)"	"unprognostic (2.33e-2)"	"unprognostic (2.33e-1)"	"unprognostic (2.77e-3)"	"unprognostic (6.22e-2)"	"unprognostic (9.69e-2)"	"unprognostic (1.92e-1)"	"prognostic favorable (7.29e-5)"	"unprognostic (4.57e-2)"	"prognostic favorable (1.95e-5)"	"unprognostic (4.13e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.44e-1)"	"unprognostic (3.07e-1)"	7.5	7.4	17.7	4.9	26.7	19.3	8.3	46.5	45.4	6.7	8.2	6.9	9.2	9.4	8.1	5.4	13.6	5.4	11.6	21.5	10.9	9.2	6.6	4.3	4.8	8.6	5.3	20.1	12.0	8.9	5.5	2.2	15.1	6.5	7.5	30.6	9.3	5.5	29.6	19.0	7.8	5.6	2.5	5.4	5.6	11.3	14.6	3.0	7.6	20.3	5.3	5.5	6.8	50.1	9.2	3.6	4.0	4.6	0.9	0.9	5.0	3.7	0.4	0.6	0.5	5.1	6.4	5.9	10.8	0.7	4.3	4.5	3.0	1.2	0.7	5.8	5.3	31.4	9.1	6.9	2.4	5.6	5.5	1.4	7.8	1.0	1.7	9.3	0.5	3.6	5.0	13.1	0.6	6.2	5.3	4.6	9.0	16.5	3.7	4.4	4.5	4.3	1.2	6.3	9.2	5.4	9.2	4.8	3.3	7.3	12.6	15.6	5.6	5.7	12.6	7.2	5.5	23.1	11.0	4.2	3.8	9.0	5.4	11.4	3.6	2.2	2.8	3.4	1.9	2.7	2.4	2.4	2.8	4.5	3.4	3.6	7.0	4.0	3.4	2.9	1.6	1.7	17.7	26.7	46.5	45.4	21.5	10.9	8.6	5.3	15.1	2.5	14.6	50.1	5.5	567.3	566.9	34.9	1.9	4.1	6.3	6.6	6.2	2.7	8.2	7.1	9.7	8.6	217.6	9.2	4.2	0.4	0.8	2.3	11.7	3.3	128.2	2.1	2.4	38.8	6.7	27.1	37.2	3.1	0.2	38.3	3.1	1.7	278.8	9.7	2.5	2.7	2.0	1.7	26.0	6.5	8.2	4.1	2.9	223.3	7.8	31.8	7.2	12.2	1.8	12.3	0.0	46.8	16.9	0.8	2.9	6.4	0.7	6.1	3.5	16.1	250.6	18.5	6.6	13.2	3.8	67.1	3.5	4.4	9.7	0.1	21.5	5.9	10.6	4.8
NMT1	NMT	ENSG00000136448	"N-myristoyltransferase 1"	P30419	17	44957992-45109016	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Hepatocytes: 344.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022949, HPA022963"	Supported		Supported	"Plasma membrane,Cytosol"		NA	NA		94000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 21: OE19 - Mitochondria"	"Cluster 2: Hepatocytes - Metabolism"	Cytosol	"Plasma membrane"	"HPA022949: AB_1854534, HPA022963: AB_1854535"	"unprognostic (1.40e-1)"	"unprognostic (2.87e-1)"	"unprognostic (1.30e-2)"	"unprognostic (6.14e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.64e-1)"	"prognostic unfavorable (4.94e-4)"	"unprognostic (4.96e-3)"	"unprognostic (3.86e-1)"	"unprognostic (3.04e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.98e-1)"	"unprognostic (3.77e-3)"	"unprognostic (1.01e-2)"	"unprognostic (4.89e-2)"	"unprognostic (4.17e-3)"	"unprognostic (9.45e-2)"	28.3	31.8	36.2	22.3	37.7	19.5	25.8	30.3	43.4	24.7	27.9	27.8	23.6	26.4	15.7	28.8	27.7	20.3	28.3	38.8	36.4	27.3	39.5	26.5	33.6	35.4	33.7	26.3	22.2	37.8	23.3	36.6	35.0	24.5	29.2	25.7	32.1	27.6	44.6	23.9	26.4	32.9	33.9	28.4	24.5	24.9	37.2	35.2	30.7	47.6	39.5	33.0	23.5	34.9	51.5	88.8	53.7	42.3	82.9	75.0	60.6	41.4	87.6	115.9	101.0	83.9	57.0	54.0	86.2	80.4	78.4	51.5	94.5	92.3	132.9	117.9	73.3	49.0	60.7	84.4	53.7	71.0	62.6	66.4	64.1	79.1	69.2	64.1	87.1	60.9	81.8	38.1	63.1	49.2	76.2	31.7	42.4	151.5	87.8	57.5	67.2	52.2	73.6	78.8	39.2	32.9	33.0	30.2	38.0	112.8	73.1	46.0	50.1	69.9	49.5	55.8	68.1	41.4	61.0	69.9	64.5	44.5	56.4	34.9	49.4	20.0	23.8	33.3	19.9	42.3	19.9	20.1	26.2	31.0	23.7	18.8	26.5	21.1	27.6	115.5	25.7	11.8	36.2	37.7	30.3	43.4	38.8	36.4	35.4	33.7	35.0	33.9	37.2	34.9	50.1	38.5	29.5	49.3	53.8	13.9	15.4	48.8	24.5	97.8	74.1	57.1	46.5	97.2	33.6	69.9	116.7	73.7	87.5	48.7	78.2	69.4	31.1	51.5	63.1	46.4	50.9	72.0	30.3	71.2	61.9	39.6	21.9	62.3	22.8	28.1	85.3	344.4	47.6	129.5	30.7	43.0	28.5	86.5	15.9	12.2	55.0	34.6	10.6	18.7	97.9	41.5	59.8	20.1	19.3	67.9	52.0	51.1	31.0	15.3	84.1	108.1	24.0	123.5	59.2	16.1	46.3	67.6	35.5	20.5	14.1	81.8	40.1	25.4	68.6	18.6
NMT2		ENSG00000152465	"N-myristoyltransferase 2"	O60551	10	15102584-15168693	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"granulocytes: 93.6;Hepatocytes: 141.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	7	"basophil: 14.5;eosinophil: 13.6;gdT-cell: 11.0;MAIT T-cell: 19.8;memory CD4 T-cell: 17.5;memory CD8 T-cell: 12.9;naive CD4 T-cell: 21.8;naive CD8 T-cell: 14.5;NK-cell: 20.8;T-reg: 29.5"	"Group enriched"	"Detected in many"	8	"granulocytes: 14.5;NK-cells: 20.8;T-cells: 29.5"	"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 102.6;TIME: 147.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001303	Approved		Supported	"Golgi apparatus,Plasma membrane,Cytosol"		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 2: Hepatocytes - Metabolism"	"Golgi apparatus, Plasma membrane, Cytosol"		"HPA001303: AB_1079494"	"unprognostic (1.08e-1)"	"unprognostic (7.65e-2)"	"unprognostic (8.78e-2)"	"unprognostic (1.15e-3)"	"unprognostic (6.97e-2)"	"unprognostic (2.24e-1)"	"unprognostic (7.11e-2)"	"unprognostic (5.13e-2)"	"unprognostic (3.20e-1)"	"unprognostic (4.01e-3)"	"unprognostic (3.31e-1)"	"unprognostic (2.00e-1)"	"unprognostic (7.06e-2)"	"unprognostic (3.79e-3)"	"unprognostic (2.00e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.16e-1)"	25.9	4.4	7.3	6.1	8.7	3.7	17.5	12.2	10.0	9.8	4.0	8.8	6.6	12.7	3.5	7.0	8.3	7.0	8.7	7.0	4.9	9.4	16.8	6.3	8.9	5.0	7.6	15.4	5.6	16.5	5.5	4.4	5.1	9.0	9.2	7.0	5.2	7.7	8.3	10.1	10.9	10.5	4.3	9.4	7.9	13.4	9.1	27.0	5.9	8.5	8.0	8.6	7.9	7.3	8.8	11.3	12.7	9.3	33.7	35.9	2.3	18.8	15.3	17.0	23.0	10.9	38.7	0.4	12.7	102.6	46.6	10.6	11.4	10.7	28.3	11.7	13.9	23.4	5.4	15.2	22.4	1.7	84.0	31.9	10.8	23.8	7.2	62.2	65.8	16.3	11.2	1.5	63.7	10.9	18.3	4.4	9.3	10.0	10.5	13.6	18.5	1.8	12.6	1.8	3.9	14.4	22.8	3.7	6.3	10.5	11.7	7.3	147.1	16.7	24.4	75.0	13.7	13.0	14.3	1.0	20.7	6.3	12.4	14.5	0.5	13.6	11.0	0.7	19.8	2.2	17.5	12.9	0.5	2.5	21.8	14.5	1.9	20.8	0.8	0.5	29.5	6.5	7.3	8.7	12.2	10.0	7.0	4.9	5.0	7.6	5.1	4.3	9.1	7.3	52.5	9.6	8.8	25.1	16.0	16.6	23.4	8.3	7.4	20.6	14.7	13.1	13.5	57.2	10.9	27.6	4.2	1.3	16.9	32.8	9.8	33.9	6.6	4.7	20.5	21.7	18.0	15.1	39.6	19.5	3.0	16.3	9.2	10.3	93.6	13.2	25.4	141.9	2.8	20.2	30.1	11.4	4.1	7.9	7.1	14.5	21.8	5.8	12.4	17.8	10.1	12.9	40.2	12.5	15.3	27.1	15.9	20.7	10.0	17.9	38.4	63.2	5.3	17.2	0.0	13.4	21.0	8.1	46.8	6.8	14.8	2.6	33.9	11.0	18.1	16.7
NMUR2	NMU2R	ENSG00000132911	"Neuromedin U receptor 2"	Q9GZQ4	5	152391546-152433368	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"brain: 6.2"	"Group enriched"	"Detected in some"	13	"Gastric mucus-secreting cells: 5.1;Oligodendrocytes: 8.5"	"Cancer enhanced"	"Detected in some"		"pancreatic cancer: 1.8;stomach cancer: 2.3"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	8	"EFO-21: 9.6"	"Region enhanced"	"Detected in single"		"hypothalamus: 1.7"	"Low region specificity"	"Detected in all"			"HPA027800, HPA045836"	Enhanced		Supported	"Plasma membrane"		NA	NA				"Cluster 70: Brain - Nervous system development"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Plasma membrane"		"HPA027800: , HPA045836: AB_10968856"	"unprognostic (1.82e-1)"	"unprognostic (3.83e-1)"	"unprognostic (2.66e-1)"	"unprognostic (9.29e-2)"	"unprognostic (5.87e-2)"	"unprognostic (6.44e-3)"		"unprognostic (3.13e-1)"		"unprognostic (6.47e-2)"	"unprognostic (5.63e-2)"	"unprognostic (8.20e-3)"	"unprognostic (8.90e-5)"	"unprognostic (1.48e-2)"	"unprognostic (9.24e-2)"	"unprognostic (9.56e-2)"	"unprognostic (2.29e-1)"	0.0	0.1	1.0	0.0	3.5	0.0	0.0	1.4	1.8	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.7	3.0	0.4	0.0	0.3	0.0	4.5	2.1	0.0	0.0	0.0	0.1	0.0	4.1	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.1	0.0	3.8	0.0	1.0	1.5	3.0	0.6	0.5	0.0	0.0	0.0	0.0	6.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.4	9.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	1.2	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	3.5	1.4	1.8	0.7	3.0	4.5	2.1	4.1	3.8	3.0	6.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.5	0.0	0.0	0.1	0.0	0.1	0.0	5.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1
NNMT		ENSG00000166741	"Nicotinamide N-methyltransferase"	P40261	11	114257787-114313536	"Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Methyltransferase, Transferase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 388.9"	"Group enriched"	"Detected in many"	6	"Hepatocytes: 3913.2;Skeletal myocytes: 1639.1"	"Cancer enhanced"	"Detected in all"		"renal cancer: 204.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HSkMC: 255.3;LHCN-M2: 144.1;RPTEC TERT1: 479.6"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA059180	Approved		Approved	"Golgi apparatus,Cytosol"		NA	NA		410000		"Cluster 85: Liver - Metabolism"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 2: Hepatocytes - Metabolism"	"Golgi apparatus"	Cytosol	"HPA059180: AB_2683940"	"unprognostic (1.62e-1)"	"unprognostic (2.33e-2)"	"unprognostic (1.61e-2)"	"unprognostic (6.14e-2)"	"unprognostic (3.51e-1)"	"prognostic unfavorable (2.07e-4)"	"unprognostic (1.76e-1)"	"unprognostic (5.84e-2)"	"unprognostic (2.71e-2)"	"unprognostic (2.48e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.69e-2)"	"prognostic unfavorable (1.02e-6)"	"prognostic unfavorable (1.75e-4)"	"unprognostic (1.11e-1)"	"unprognostic (3.37e-3)"	"unprognostic (2.77e-2)"	130.9	11.4	1.0	25.2	1.1	0.9	91.9	1.4	1.5	36.0	1.9	37.1	1.5	31.0	2.8	15.4	55.0	43.1	35.5	1.3	1.4	24.1	388.9	64.6	9.6	3.9	1.6	21.3	11.4	1.6	10.6	23.8	2.2	31.9	8.7	0.3	21.1	3.1	73.1	49.3	32.2	30.1	1.7	36.7	30.1	2.2	1.2	2.7	33.0	5.3	8.8	48.6	33.9	3.1	0.2	17.6	0.3	18.6	92.0	118.3	0.1	21.2	58.7	35.2	69.2	0.0	17.5	0.2	58.1	45.1	4.2	0.2	0.0	8.0	34.1	0.2	0.0	0.2	16.7	0.0	123.3	0.2	0.0	255.3	89.4	24.1	37.3	29.8	50.1	0.1	0.3	0.2	144.1	0.1	0.1	0.2	0.1	0.0	0.5	0.2	79.0	0.0	479.6	0.1	0.2	0.2	97.7	0.1	0.3	5.3	0.0	0.2	37.4	18.3	34.3	23.8	3.1	0.3	0.3	0.4	6.4	0.3	1.4	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	1.0	1.1	1.4	1.5	1.3	1.4	3.9	1.6	2.2	1.7	1.2	3.1	411.8	44.8	411.3	1.0	11.2	103.6	13.2	16.5	2.2	1.9	38.5	73.9	4.7	75.8	13.3	80.9	0.0	1.0	1.6	0.0	9.8	238.3	0.3	19.0	89.9	190.0	5.3	147.2	1.3	157.0	2.5	452.2	5.1	80.5	13.9	0.5	195.2	3913.2	28.4	0.0	1.6	0.0	0.0	126.8	142.1	1.6	74.3	9.2	96.0	1.9	5.7	0.0	0.0	0.0	0.2	323.1	0.0	13.2	1.5	10.8	0.0	99.2	11.9	0.2	0.0	1639.1	154.3	0.3	0.8	1.9	92.1	2.2	20.1	0.0	0.0	3.1
NOA1	"C4orf14, hAtNOS1, hNOA1, MGC3232, MTG3"	ENSG00000084092	"Nitric oxide associated 1"	Q8NC60	4	56963350-56977606	"Predicted intracellular proteins"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035838, HPA035839"	Approved		Supported	Mitochondria	"Intracellular and membrane"	NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 50: Non-specific - Ribosome"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 32: Non-specific - Translation"	Mitochondria		"HPA035838: AB_10669531, HPA035839: AB_10669658"	"unprognostic (6.61e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.65e-3)"	"unprognostic (5.19e-2)"	"unprognostic (9.06e-2)"	"unprognostic (1.49e-2)"	"unprognostic (2.04e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.01e-3)"	"unprognostic (3.64e-2)"	"unprognostic (1.33e-1)"	"prognostic favorable (2.38e-4)"	"unprognostic (8.97e-2)"	"unprognostic (6.87e-2)"	"unprognostic (1.79e-2)"	"unprognostic (4.27e-2)"	10.4	8.8	6.9	10.3	7.9	17.5	15.5	8.2	7.6	12.3	7.8	15.8	19.5	11.1	11.3	11.3	16.8	9.6	10.9	7.2	6.8	11.0	8.6	9.1	16.7	7.5	6.8	15.1	22.9	10.9	4.1	8.3	7.8	11.3	14.2	6.9	16.0	10.7	21.8	17.8	14.7	10.2	7.4	11.6	13.3	6.7	6.9	17.6	12.0	16.1	17.5	11.4	8.5	8.7	18.9	17.2	12.3	21.9	22.7	40.5	33.9	14.6	26.5	16.7	16.8	30.3	34.4	67.8	24.5	12.5	13.1	19.7	24.2	26.2	15.8	12.4	30.8	16.8	14.2	33.0	17.7	30.8	17.4	37.7	31.4	15.4	26.7	34.9	28.5	28.6	28.9	22.0	22.8	27.9	44.3	41.2	16.2	36.0	26.4	30.5	13.2	25.4	24.1	28.1	28.5	24.3	15.1	60.2	22.5	15.8	26.9	21.6	18.4	13.0	31.2	15.8	27.3	29.5	13.2	34.5	13.2	19.4	17.1	14.2	33.1	16.7	26.2	31.3	40.8	45.6	40.1	33.8	39.4	35.7	48.3	40.6	8.0	48.1	28.3	30.3	52.0	35.8	6.9	7.9	8.2	7.6	7.2	6.8	7.5	6.8	7.8	7.4	6.9	8.7	10.3	3.2	5.8	5.2	21.3	25.4	20.9	31.4	35.9	6.6	24.7	20.6	16.2	17.2	18.4	7.3	4.2	31.5	19.8	10.6	19.6	19.0	27.0	30.9	14.3	13.2	17.5	27.3	6.8	22.8	32.7	15.6	15.3	15.2	8.2	19.1	10.4	5.1	17.8	1.7	6.8	20.6	16.2	20.3	16.2	12.5	16.1	14.2	12.4	1.9	26.9	10.0	25.7	5.0	8.0	16.9	20.3	23.3	14.7	16.7	31.4	14.8	25.0	9.4	13.1	15.5	19.8	13.0	8.9	24.4	24.7	27.9	18.2	30.8	34.5	20.6
NOC3L	"AD24, C10orf117, FAD24, FLJ12820"	ENSG00000173145	"NOC3 like DNA replication regulator"	Q8WTT2	10	94333226-94362959	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA063958, HPA067638, HPA070981"			Enhanced	"Nucleoplasm,Nucleoli,Nucleoli rim"		NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	"Nucleoli, Nucleoli rim"	Nucleoplasm	"HPA063958: AB_2685160, HPA067638: AB_2685876, HPA070981: AB_2686331"	"unprognostic (1.29e-1)"	"unprognostic (2.25e-1)"	"unprognostic (5.25e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.27e-3)"	"unprognostic (4.58e-2)"	"unprognostic (6.49e-3)"	"unprognostic (3.34e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.34e-1)"	"unprognostic (9.93e-2)"	"unprognostic (5.50e-2)"	"unprognostic (1.47e-2)"	"unprognostic (3.24e-2)"	"unprognostic (2.48e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.30e-1)"	8.6	9.0	5.1	9.5	6.5	3.6	11.2	5.9	5.9	6.7	5.9	5.2	5.4	8.5	6.4	9.0	6.2	5.7	5.3	4.6	5.8	7.2	9.9	5.2	13.1	6.5	6.4	8.2	5.3	9.1	4.3	8.9	6.5	7.4	6.3	6.2	5.3	6.5	9.4	9.3	5.4	7.1	6.4	11.4	5.5	10.4	5.8	7.5	11.1	10.4	13.2	10.3	6.4	7.1	38.4	20.6	13.6	44.1	13.9	22.4	16.1	29.9	23.6	40.2	46.3	35.1	26.4	41.3	21.4	15.0	20.6	26.9	39.2	18.0	64.6	28.3	29.3	28.1	16.6	22.6	27.8	45.0	12.2	13.0	17.3	42.5	42.2	26.2	18.1	15.1	44.2	20.3	40.0	12.9	28.5	33.2	28.9	22.3	22.4	12.5	31.3	22.8	23.7	11.7	9.7	24.1	21.4	10.7	33.9	15.2	27.6	17.1	17.7	25.6	25.9	23.4	50.9	19.1	40.8	56.8	23.4	42.6	19.5	0.1	2.6	0.6	4.3	4.3	5.4	14.4	4.4	5.5	4.6	12.8	5.7	5.2	0.1	8.2	5.0	4.1	4.3	3.3	5.1	6.5	5.9	5.9	4.6	5.8	6.5	6.4	6.5	6.4	5.8	7.1	33.5	19.2	13.7	11.4	38.0	23.7	32.7	17.0	33.0	20.7	16.4	20.7	22.5	14.3	31.8	22.0	8.4	21.1	17.7	5.1	25.4	20.6	3.9	20.3	50.1	26.1	5.4	26.7	11.7	13.8	15.1	27.0	10.2	17.0	29.2	26.9	11.7	12.9	13.2	13.5	15.5	8.1	12.2	17.0	11.9	5.0	18.3	15.0	12.4	11.2	23.3	20.5	20.6	19.6	23.6	15.3	3.4	24.8	26.3	34.1	1.7	22.7	21.1	20.9	13.1	37.8	23.7	64.0	64.5	25.5	21.7	15.2	17.3	44.5	10.7	19.1
NOC4L	"MGC3162, NET49, Noc4, UTP19"	ENSG00000184967	"Nucleolar complex associated 4 homolog"	Q9BVI4	12	132144457-132152473	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 72.6;Late spermatids: 80.3;Spermatogonia: 77.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053424			Supported	Nucleoplasm,Nucleoli		No	No			"Cluster 24: B-cells - Unknown function"	"Cluster 71: Testis - DNA repair"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	Nucleoli	Nucleoplasm	"HPA053424: AB_2682147"	"unprognostic (9.44e-2)"	"unprognostic (1.96e-2)"	"unprognostic (5.44e-2)"	"unprognostic (8.48e-2)"	"unprognostic (1.13e-1)"	"unprognostic (4.63e-2)"	"unprognostic (4.79e-3)"	"unprognostic (8.08e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.64e-1)"	"unprognostic (8.36e-3)"	"unprognostic (1.76e-1)"	"unprognostic (3.85e-3)"	"unprognostic (1.05e-1)"	"unprognostic (2.51e-2)"	"unprognostic (2.17e-1)"	"unprognostic (1.61e-1)"	12.6	11.5	2.0	3.3	2.0	6.1	12.8	1.9	3.1	13.1	1.5	11.1	4.2	12.6	1.6	13.8	11.9	1.9	10.8	2.6	2.2	13.2	13.4	10.5	3.6	2.4	1.9	14.4	13.6	2.4	11.3	2.7	2.1	11.1	1.8	0.8	11.5	2.2	24.3	15.6	11.3	1.8	1.5	13.5	12.3	33.2	2.0	3.5	11.7	3.2	2.3	11.4	11.2	2.7	14.4	26.0	5.7	9.0	2.8	3.0	29.0	9.7	5.0	12.0	6.5	21.4	6.7	21.8	10.4	5.0	7.1	12.7	10.2	10.7	2.5	8.7	28.3	14.7	8.8	14.4	7.6	17.3	16.5	4.3	7.2	9.2	7.3	4.5	8.3	16.8	25.4	4.9	4.8	17.1	16.6	40.6	16.7	8.6	20.7	21.2	6.3	19.5	6.3	10.6	13.9	11.0	8.2	11.1	7.5	3.3	15.6	10.7	11.1	7.0	17.7	11.3	16.5	12.4	8.2	19.1	10.6	14.8	15.0	1.6	8.4	4.3	7.5	11.7	7.2	9.1	6.9	7.5	11.1	10.7	5.9	5.7	1.2	5.8	9.1	13.1	6.2	5.9	2.0	2.0	1.9	3.1	2.6	2.2	2.4	1.9	2.1	1.5	2.0	2.7	10.9	9.6	9.1	2.3	15.5	22.3	15.6	20.6	12.0	8.2	11.5	12.1	8.0	20.0	12.4	3.7	0.0	32.3	15.5	15.6	7.9	35.5	72.6	12.1	8.4	13.6	7.3	7.8	2.2	32.9	33.9	14.6	15.3	11.1	15.9	15.8	10.4	11.6	24.9	8.4	2.0	14.5	24.4	11.0	15.8	80.3	14.6	13.2	14.2	1.9	14.5	8.3	6.2	1.5	3.1	28.0	11.2	7.9	12.0	15.4	19.2	21.7	6.2	6.2	19.7	14.2	15.0	37.1	77.1	11.2	21.6	30.5	13.6	24.4	22.7	15.0
NOCT	"Ccr4c, CCR4L, CCRN4L, NOC"	ENSG00000151014	Nocturnin	Q9UK39	4	139015781-139045939	"Predicted intracellular proteins"	"Biological rhythms"	"Hydrolase, Repressor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 36.3"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 14.6;Glandular and luminal cells: 20.6;Syncytiotrophoblasts: 12.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012287, HPA053714"	Uncertain		Supported	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 32: U-937 - Innate immune response"	"Cluster 41: Macrophages - Immune response"	"Nuclear bodies"	"Nucleoplasm, Cytosol"	"HPA012287: AB_2668640, HPA053714: AB_2682238"	"unprognostic (2.16e-1)"	"unprognostic (2.16e-3)"	"unprognostic (1.47e-1)"	"unprognostic (2.29e-1)"	"unprognostic (3.36e-3)"	"unprognostic (2.00e-3)"	"unprognostic (3.24e-1)"	"prognostic unfavorable (5.28e-5)"	"unprognostic (1.86e-1)"	"unprognostic (5.64e-3)"	"unprognostic (4.63e-2)"	"unprognostic (1.01e-3)"	"prognostic unfavorable (1.05e-5)"	"unprognostic (2.54e-1)"	"unprognostic (1.14e-1)"	"unprognostic (3.52e-4)"	"prognostic unfavorable (6.23e-4)"	8.2	2.0	2.8	3.2	2.6	36.3	4.5	1.7	7.1	1.4	0.0	1.8	1.2	1.6	0.5	1.9	1.0	5.5	2.9	5.0	2.9	3.6	13.9	2.9	2.1	1.5	3.4	0.6	3.0	1.7	2.2	5.6	2.6	1.0	1.6	3.4	1.6	0.5	6.5	2.2	2.2	3.0	1.4	1.7	1.7	2.2	4.4	1.9	1.5	6.1	2.6	4.9	1.3	2.9	6.5	7.1	2.9	5.7	6.6	2.7	17.2	9.4	6.9	13.7	10.0	10.3	2.8	22.7	7.4	7.3	18.4	4.5	15.8	8.9	13.7	9.5	6.1	10.3	4.4	8.7	6.2	15.3	6.0	3.2	4.4	15.4	10.4	2.7	6.3	4.3	18.6	7.0	6.6	8.0	10.0	7.8	10.1	3.0	8.1	8.5	8.6	7.7	9.4	4.3	11.3	7.3	6.0	6.8	5.6	11.2	5.0	11.2	8.7	7.7	9.4	7.2	11.8	5.9	5.5	14.0	7.0	29.8	9.9	0.8	0.5	0.3	1.0	0.6	0.5	0.4	0.4	0.5	0.2	0.7	0.3	0.6	2.7	0.6	1.6	0.6	0.3	0.1	2.8	2.6	1.7	7.1	5.0	2.9	1.5	3.4	2.6	1.4	4.4	2.9	10.9	9.6	1.1	0.0	2.8	0.0	2.7	0.0	5.7	5.6	2.7	2.5	0.0	1.5	0.6	0.0	14.6	6.1	4.7	0.6	1.9	2.3	0.7	10.4	6.3	2.6	0.0	1.7	0.0	0.2	11.8	2.9	6.1	20.6	2.5	0.8	1.1	2.6	1.5	1.7	0.0	0.4	0.0	1.6	0.0	0.1	0.9	6.9	0.0	0.0	0.1	0.6	4.1	0.0	0.0	2.5	0.0	0.0	5.5	2.5	2.6	4.0	0.7	5.2	0.0	5.4	4.3	1.0	3.9	6.5	0.0	12.0	4.3	0.8	0.2	2.3
NOL10	"FLJ14075, PQBP5"	ENSG00000115761	"Nucleolar protein 10"	Q9BSC4	2	10570754-10689987	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 189.3;Late spermatids: 163.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035286, HPA043075"	Approved		Supported	Nucleoli		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	Nucleoli		"HPA035286: AB_2674552, HPA043075: AB_10794652"	"unprognostic (6.53e-3)"	"unprognostic (1.61e-1)"	"unprognostic (6.84e-2)"	"prognostic unfavorable (2.92e-5)"	"unprognostic (1.31e-1)"	"unprognostic (1.08e-2)"	"prognostic unfavorable (1.43e-7)"	"unprognostic (1.25e-1)"	"unprognostic (3.29e-2)"	"unprognostic (1.86e-2)"	"unprognostic (1.61e-2)"	"unprognostic (1.74e-2)"	"prognostic unfavorable (7.51e-5)"	"unprognostic (2.43e-2)"	"unprognostic (2.92e-1)"	"unprognostic (3.82e-1)"	"unprognostic (3.87e-2)"	12.6	14.8	6.6	10.1	8.0	16.2	11.3	10.2	8.2	9.6	5.1	10.8	8.1	9.3	11.0	13.7	7.8	6.6	11.2	7.5	7.1	13.7	14.4	9.0	10.3	6.2	6.6	9.1	16.0	12.1	8.3	10.9	6.1	10.0	10.6	6.2	12.9	8.6	19.4	13.1	9.0	8.8	6.3	9.6	11.7	13.1	7.3	9.9	10.2	11.9	11.7	12.3	10.7	8.8	19.7	33.2	18.6	32.6	22.1	24.2	34.9	33.1	25.8	36.9	27.5	37.5	24.0	45.4	19.5	32.1	30.8	24.5	43.8	38.7	43.6	32.2	33.8	43.8	20.3	46.6	28.0	52.8	23.9	22.6	28.7	40.7	39.1	16.7	25.5	25.0	59.4	28.5	33.9	38.2	36.4	37.4	49.7	51.8	28.8	32.0	49.2	41.4	26.1	30.6	31.6	34.3	24.2	39.4	29.1	20.2	20.8	20.4	24.2	33.8	41.1	33.6	53.9	37.9	63.7	52.4	28.1	49.7	41.5	1.5	3.9	2.2	4.0	5.2	5.9	4.8	4.2	4.2	4.9	3.7	3.2	4.8	0.5	4.8	5.9	3.1	6.0	2.8	6.6	8.0	10.2	8.2	7.5	7.1	6.2	6.6	6.1	6.3	7.3	8.8	22.2	16.0	16.7	31.6	17.1	33.0	29.9	17.2	17.1	13.0	16.3	12.8	19.2	11.5	16.1	12.9	12.5	32.7	16.4	9.9	15.6	27.5	189.3	8.9	19.5	22.9	11.4	19.8	72.9	24.1	33.7	20.2	13.3	17.8	14.0	20.2	12.5	12.2	15.4	16.8	57.6	12.4	18.3	9.8	13.0	163.0	17.1	12.2	8.8	36.5	23.8	13.9	20.6	54.3	54.2	19.0	7.0	16.6	22.1	30.3	10.6	17.0	7.3	16.7	13.1	36.4	22.5	26.4	42.1	17.8	34.2	29.6	17.7	30.4	18.3	22.3
NOL11	DKFZP586L0724	ENSG00000130935	"Nucleolar protein 11"	Q9H8H0	17	67717931-67744531	"Predicted intracellular proteins"	"Ribosome biogenesis, rRNA processing, Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA022010	Supported		Supported	Nucleoli		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoli		"HPA022010: AB_2267158"	"unprognostic (6.81e-2)"	"unprognostic (2.85e-2)"	"prognostic favorable (1.00e-6)"	"unprognostic (3.07e-3)"	"unprognostic (5.04e-2)"	"unprognostic (2.55e-2)"	"prognostic unfavorable (2.59e-6)"	"unprognostic (1.37e-2)"	"unprognostic (1.25e-3)"	"unprognostic (4.77e-3)"	"unprognostic (8.74e-2)"	"unprognostic (4.41e-3)"	"unprognostic (6.55e-2)"	"unprognostic (2.16e-2)"	"unprognostic (2.19e-1)"	"unprognostic (8.44e-2)"	"unprognostic (3.11e-1)"	12.4	8.2	5.0	14.4	5.5	20.8	16.3	9.6	13.0	14.8	6.1	14.8	12.2	15.0	12.7	14.9	14.5	12.7	12.3	5.0	5.3	15.5	18.9	9.8	22.9	5.8	5.4	14.8	14.4	15.6	3.3	17.8	5.9	11.9	15.5	10.3	9.4	11.3	15.5	11.9	10.9	15.6	5.8	12.6	10.2	11.5	5.8	19.7	15.2	17.0	24.5	18.4	6.0	8.9	54.3	63.4	45.7	29.6	21.1	25.3	52.2	37.1	28.6	71.0	58.5	53.5	36.2	86.5	26.8	36.4	47.1	38.4	112.9	54.0	105.7	26.8	92.7	57.9	36.3	48.3	24.7	74.8	34.0	19.8	34.2	52.7	36.9	20.7	67.8	39.1	96.6	25.8	58.8	49.2	89.1	29.6	50.6	61.0	74.4	63.6	101.4	59.8	31.0	57.6	39.4	37.8	32.8	84.7	40.3	63.3	60.5	44.0	26.5	64.3	44.7	21.7	75.7	16.2	45.5	93.7	26.4	54.8	37.6	12.8	6.3	4.6	9.7	7.6	10.4	10.6	10.2	11.9	8.9	13.0	16.4	11.9	0.8	13.1	7.7	6.5	11.8	9.4	5.0	5.5	9.6	13.0	5.0	5.3	5.8	5.4	5.9	5.8	5.8	8.9	25.5	28.9	18.6	10.4	33.7	33.4	38.9	30.5	27.9	21.9	15.8	11.8	18.6	21.5	27.8	9.2	14.6	45.4	33.8	13.1	11.7	23.5	1.7	17.1	28.9	26.0	27.5	24.2	11.3	17.8	37.1	25.0	20.4	18.7	24.1	31.9	16.8	25.3	20.3	25.2	11.4	16.8	26.4	11.8	11.8	4.3	20.8	15.7	17.8	8.4	19.5	15.8	21.6	13.0	16.3	16.6	9.2	19.2	17.4	24.9	12.2	28.6	24.8	32.7	6.6	25.9	21.8	30.2	35.0	26.8	33.2	33.0	32.0	27.0	21.9	25.4
NOL3	"ARC, CARD2, MYP, NOP30"	ENSG00000140939	"Nucleolar protein 3"	O60936	16	67170154-67175735	"Disease related genes, Predicted intracellular proteins"	"Apoptosis, mRNA processing, mRNA splicing"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"classical monocyte: 3.5"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"T-47d: 75.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB009208	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA		26000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 6: T47d - Mammary gland"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Nucleoplasm, Cytosol"		"CAB009208: AB_634091"	"unprognostic (2.83e-2)"	"unprognostic (1.63e-2)"	"unprognostic (3.34e-3)"	"unprognostic (1.07e-1)"	"unprognostic (2.70e-3)"	"unprognostic (2.83e-1)"	"prognostic unfavorable (6.43e-5)"	"unprognostic (5.74e-2)"	"unprognostic (4.07e-2)"	"unprognostic (1.83e-1)"	"unprognostic (2.15e-1)"	"unprognostic (8.08e-3)"	"prognostic unfavorable (2.41e-4)"	"unprognostic (1.39e-2)"	"unprognostic (3.65e-2)"	"unprognostic (3.90e-2)"	"unprognostic (1.48e-2)"	34.4	77.5	36.1	3.8	37.1	0.7	35.4	36.7	36.2	37.1	30.7	32.5	6.7	27.8	11.4	48.6	35.4	10.2	99.3	32.9	35.0	33.0	52.0	28.9	3.1	43.9	36.2	29.3	50.6	37.7	60.2	11.6	39.6	70.1	7.6	28.6	51.1	13.8	142.2	79.2	18.1	8.0	35.4	15.9	28.2	7.6	36.9	2.8	35.6	97.5	4.1	38.7	39.8	38.1	14.9	23.9	3.9	22.1	19.2	14.5	22.0	11.8	12.5	12.6	7.4	5.2	38.2	0.3	38.0	13.8	3.3	24.3	5.4	18.3	3.0	13.4	8.3	0.6	19.8	7.8	12.0	1.3	2.9	8.9	33.1	9.9	7.0	35.9	5.3	5.2	5.5	15.3	24.0	38.7	0.3	1.9	3.7	13.5	58.1	13.3	8.3	29.8	21.5	4.5	31.1	16.6	49.5	35.3	5.7	5.1	75.5	4.0	12.4	16.5	14.1	16.3	10.3	22.1	7.5	4.2	46.4	3.7	5.7	0.0	3.5	0.0	0.1	0.3	0.0	0.0	1.7	0.1	1.1	0.0	0.0	0.2	0.8	0.4	0.1	1.1	0.0	1.3	36.1	37.1	36.7	36.2	32.9	35.0	43.9	36.2	39.6	35.4	36.9	38.1	5.1	28.9	33.6	19.2	2.7	13.8	27.6	70.6	21.6	18.5	29.3	32.6	51.2	35.8	28.8	3.7	16.7	8.1	0.8	18.2	15.6	61.3	1.2	8.6	14.0	10.1	22.3	0.0	5.0	34.7	11.3	13.8	11.2	16.4	2.5	7.6	13.2	30.9	11.4	55.5	7.6	23.7	38.7	4.1	4.5	0.7	25.1	3.4	21.4	4.7	14.6	36.3	1.0	4.0	11.3	44.2	11.4	30.1	10.4	28.5	15.5	26.2	21.3	47.9	13.1	38.7	32.3	0.3	1.2	16.4	19.7	11.1	3.2	3.6	16.4	31.6
NOL4	"CT125, HRIHFB2255, NOLP"	ENSG00000101746	"Nucleolar protein 4"	O94818	18	33851100-34224952	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"brain: 11.8;pituitary gland: 8.0;retina: 6.3;testis: 12.6"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 133.9;Early spermatids: 268.1;Excitatory neurons: 195.6;Inhibitory neurons: 207.7;Late spermatids: 95.7;Oligodendrocyte precursor cells: 326.8"	"Cancer enhanced"	"Detected in some"		"glioma: 1.9"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"SCLC-21H: 36.0;SH-SY5Y: 9.5;U-698: 7.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046740			Supported	Nucleoplasm		No	NA				"Cluster 58: Brain - Synaptic function"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 68: Oligodendrocytes - Mixed function"	Nucleoplasm		"HPA046740: AB_10960527"	"unprognostic (7.86e-2)"	"unprognostic (1.58e-1)"	"unprognostic (3.61e-1)"	"unprognostic (5.43e-7)"	"unprognostic (5.76e-2)"		"unprognostic (1.56e-2)"	"unprognostic (7.19e-2)"		"unprognostic (3.45e-1)"	"unprognostic (1.12e-2)"	"unprognostic (4.78e-2)"	"unprognostic (3.52e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.39e-1)"	"unprognostic (7.77e-2)"	"unprognostic (7.71e-2)"	0.0	1.8	6.1	0.1	7.2	0.0	0.1	7.6	7.8	0.5	0.0	0.3	0.1	0.0	0.5	0.0	0.0	0.0	0.1	8.2	11.6	0.7	2.2	0.2	0.2	0.8	4.1	0.0	1.7	0.0	8.0	0.0	1.0	0.3	0.7	6.3	0.2	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.7	12.6	11.8	0.0	1.6	0.0	0.2	0.5	0.0	3.4	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	3.2	0.1	0.0	0.0	0.0	36.0	9.5	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	7.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.1	7.2	7.6	7.8	8.2	11.6	0.8	4.1	1.0	2.5	11.8	3.4	0.0	0.0	0.0	133.9	0.0	0.0	0.0	0.0	0.0	17.0	0.5	1.0	0.6	0.0	0.0	0.0	2.1	0.2	0.0	0.4	1.9	0.0	268.1	0.0	0.0	0.5	73.8	0.0	195.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	2.7	0.1	32.0	207.7	0.2	0.0	0.0	0.0	95.7	2.5	0.1	0.0	22.5	0.0	11.6	0.0	326.8	4.5	0.1	0.1	2.2	0.0	0.0	0.0	5.3	0.0	2.1	0.0	0.0	0.0	10.9	2.8	0.0	0.0	0.0	0.0	0.0	0.3	0.1
NOL7	"C6orf90, dJ223E5.2, NOP27, PQBP3, RARG-1"	ENSG00000225921	"Nucleolar protein 7"	Q9UMY1	6	13615335-13632739	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029185	Supported		Supported	"Nucleoli,Mitotic chromosome,Mitochondria"		Yes	Yes			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 72: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoli, Mitotic chromosome"	Mitochondria	"HPA029185: AB_10601274"	"unprognostic (8.76e-2)"	"unprognostic (8.94e-2)"	"unprognostic (8.38e-2)"	"unprognostic (1.15e-2)"	"unprognostic (3.75e-1)"	"unprognostic (5.77e-2)"	"unprognostic (2.50e-3)"	"unprognostic (1.57e-1)"	"unprognostic (4.64e-2)"	"prognostic favorable (3.64e-5)"	"unprognostic (1.26e-1)"	"unprognostic (2.03e-2)"	"unprognostic (8.04e-3)"	"unprognostic (2.58e-1)"	"unprognostic (1.17e-1)"	"unprognostic (4.86e-2)"	"unprognostic (4.79e-2)"	44.3	43.9	29.5	21.7	30.8	29.5	42.0	32.2	34.0	37.5	28.2	44.8	26.8	37.7	23.4	38.2	35.5	16.6	48.2	28.7	31.1	58.5	37.9	32.2	25.8	30.9	31.4	40.7	48.9	40.2	35.9	21.1	31.0	35.1	19.8	16.6	38.0	19.2	44.5	36.9	36.4	16.0	30.8	37.8	37.9	41.7	30.7	15.2	37.1	17.1	20.3	41.4	34.9	33.8	71.7	37.2	31.7	42.7	26.9	26.1	74.4	71.8	29.3	48.4	44.4	60.0	24.9	97.8	137.4	34.4	57.7	46.5	46.9	42.4	47.8	57.5	105.0	91.2	36.3	104.0	45.4	112.0	61.4	25.5	41.5	42.5	24.2	29.8	33.6	45.5	135.7	22.2	44.7	38.1	70.6	147.6	42.1	37.0	74.1	74.4	46.8	140.5	57.9	21.7	92.5	60.3	40.9	88.0	94.9	36.2	53.6	42.8	65.7	48.0	51.9	57.8	108.3	66.2	123.2	100.2	30.7	70.7	75.6	34.5	59.6	82.1	59.2	76.4	68.2	104.0	84.7	71.4	73.2	87.8	90.7	69.0	27.4	61.9	82.9	91.4	96.0	67.9	29.5	30.8	32.2	34.0	28.7	31.1	30.9	31.4	31.0	30.8	30.7	33.8	103.1	93.0	73.5	10.4	112.5	90.8	117.3	151.0	50.1	62.1	78.9	97.0	214.9	68.6	112.0	57.0	22.9	137.4	71.5	72.7	123.3	188.7	202.3	105.8	95.0	109.2	37.1	89.4	14.0	261.2	153.8	90.9	58.1	91.6	90.6	67.0	61.1	61.8	115.1	48.8	17.1	97.8	130.2	52.6	81.8	38.9	82.6	78.5	101.4	8.4	119.7	124.2	78.2	13.6	19.0	175.0	94.3	79.4	138.8	121.7	81.2	163.6	135.6	61.7	65.7	92.5	119.4	186.3	112.9	70.8	90.5	155.3	99.5	99.2	91.0	117.2
NOL8	"C9orf34, FLJ20736, Nop132"	ENSG00000198000	"Nucleolar protein 8"	Q76FK4	9	92297358-92325636	"Predicted intracellular proteins"	"rRNA processing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044440, HPA062922"	Uncertain		Supported	"Nucleoli,Mitotic chromosome"		Yes	No			"Cluster 44: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	Nucleoli	"Mitotic chromosome"	"HPA044440: AB_10963212, HPA062922: "	"unprognostic (3.44e-2)"	"unprognostic (1.67e-1)"	"unprognostic (9.72e-2)"	"unprognostic (1.65e-2)"	"unprognostic (1.40e-1)"	"unprognostic (9.73e-2)"	"prognostic unfavorable (1.50e-4)"	"unprognostic (1.85e-1)"	"unprognostic (6.16e-3)"	"unprognostic (5.17e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.22e-2)"	"prognostic unfavorable (1.02e-5)"	"unprognostic (4.69e-2)"	"unprognostic (5.38e-2)"	"unprognostic (4.58e-1)"	"unprognostic (5.53e-2)"	8.6	5.8	4.2	8.0	5.8	6.8	10.0	5.0	5.3	8.2	5.2	8.6	6.0	9.8	7.4	8.7	7.4	6.5	6.8	4.1	5.3	7.2	5.5	6.9	12.0	5.6	5.4	11.2	7.1	12.6	3.2	7.6	5.6	7.4	8.3	5.8	7.8	8.5	6.3	7.2	5.9	9.9	4.6	9.8	6.2	6.1	6.0	12.6	10.5	6.2	12.6	8.6	5.1	7.1	18.9	27.1	13.4	24.2	28.5	24.3	19.8	19.7	14.9	20.9	18.7	11.2	18.5	54.2	16.3	20.1	33.8	39.9	43.5	25.8	22.3	36.3	21.4	37.1	25.9	22.4	20.3	63.2	30.5	24.0	23.5	22.0	31.6	16.7	23.7	16.3	60.7	17.1	22.5	29.7	42.7	24.8	21.4	28.4	26.8	29.8	37.9	23.0	10.6	13.4	23.0	12.3	25.3	25.1	18.0	17.3	9.5	21.2	24.9	18.3	14.0	26.7	25.0	17.7	37.5	26.7	18.5	37.4	26.6	18.9	8.3	11.3	11.4	10.8	15.8	13.0	11.3	11.8	12.1	12.9	13.3	11.7	3.1	13.2	15.7	10.2	13.8	7.1	4.2	5.8	5.0	5.3	4.1	5.3	5.6	5.4	5.6	4.6	6.0	7.1	25.4	19.2	33.4	15.7	33.8	13.0	18.4	15.3	21.1	17.9	14.7	20.6	28.4	14.3	19.8	11.0	10.4	19.5	37.7	10.1	15.6	23.5	13.9	17.9	46.2	23.9	9.0	37.6	12.1	12.9	20.1	25.8	23.9	20.8	52.4	30.6	16.1	11.5	26.5	28.6	12.5	16.9	6.1	17.7	12.1	9.4	32.0	23.9	10.6	18.7	34.5	12.4	43.3	15.6	25.9	16.1	11.2	23.7	36.5	23.3	10.3	15.8	21.2	17.7	6.6	29.3	21.5	73.3	50.2	25.4	15.9	14.6	30.1	33.4	20.3	12.2
NOL9	"FLJ23323, Grc3, NET6"	ENSG00000162408	"Nucleolar protein 9"	Q5SY16	1	6521347-6554513	"Metabolic proteins, Predicted intracellular proteins"	"rRNA processing"	"Kinase, RNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036347			Supported	"Nucleoli,Intermediate filaments"		NA	NA			"Cluster 30: Non-specific - Translation"	"Cluster 2: Immune cells - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 59: Non-specific - Transcription"	Nucleoli	"Intermediate filaments"	"HPA036347: AB_2675076"	"unprognostic (3.03e-1)"	"unprognostic (4.93e-2)"	"unprognostic (4.99e-2)"	"unprognostic (3.14e-3)"	"unprognostic (2.12e-1)"	"unprognostic (1.30e-1)"	"prognostic unfavorable (3.69e-5)"	"unprognostic (2.48e-1)"	"unprognostic (1.31e-1)"	"unprognostic (8.90e-2)"	"unprognostic (1.44e-3)"	"unprognostic (2.32e-1)"	"unprognostic (3.80e-2)"	"unprognostic (3.32e-2)"	"unprognostic (3.40e-1)"	"unprognostic (3.54e-2)"	"unprognostic (4.65e-2)"	3.8	4.6	4.5	3.5	5.0	7.5	3.7	4.9	5.6	4.7	1.9	5.0	2.4	5.0	3.6	4.7	4.3	2.3	4.5	6.2	4.2	4.4	5.3	3.2	5.2	3.3	3.8	4.8	6.0	3.4	4.0	3.0	3.8	4.1	3.1	4.3	3.6	3.1	7.0	6.0	4.8	3.9	2.7	8.8	4.5	3.7	4.6	3.8	3.4	4.5	5.1	4.5	3.8	4.0	6.4	9.1	5.0	15.2	6.6	4.0	5.4	6.3	4.1	6.4	6.8	12.6	8.6	17.9	7.3	7.1	5.5	8.3	10.2	8.6	10.9	7.3	5.5	12.2	14.7	9.9	6.6	10.4	6.4	5.8	2.6	13.6	11.8	3.7	7.6	7.8	14.3	7.3	6.6	11.2	10.2	9.2	6.9	5.0	8.7	12.7	11.7	8.3	5.1	5.8	9.7	4.4	9.7	12.1	8.1	5.1	7.9	4.8	10.0	10.1	8.1	7.2	10.6	6.1	6.2	31.9	9.4	11.4	4.9	3.5	1.9	1.6	3.1	1.9	3.2	2.9	4.5	2.9	1.3	3.7	4.6	3.8	1.2	1.7	3.2	3.5	3.2	1.2	4.5	5.0	4.9	5.6	6.2	4.2	3.3	3.8	3.8	2.7	4.6	4.0	15.0	19.2	19.5	9.4	16.2	15.4	6.9	6.9	10.8	17.1	9.8	13.2	15.0	11.5	7.4	7.3	14.6	14.8	17.3	6.7	15.6	8.9	6.0	13.7	19.7	15.2	6.7	11.6	18.9	8.6	12.6	15.3	11.7	15.6	5.1	18.3	14.3	13.2	9.1	10.1	18.5	10.9	4.1	13.8	7.3	17.0	9.6	8.6	1.8	10.3	13.4	8.1	12.3	13.0	20.1	9.0	6.2	12.8	17.9	7.3	7.6	10.7	9.0	18.2	0.0	22.6	12.7	11.7	21.5	16.0	14.8	12.7	17.3	19.1	13.2	7.3
NONO	"NMT55, NRB54, P54, P54NRB, PPP1R114"	ENSG00000147140	"Non-POU domain containing octamer binding"	Q15233	X	71254814-71301522	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Biological rhythms, DNA damage, DNA recombination, DNA repair, Immunity, Innate immunity, mRNA processing, mRNA splicing, Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor, RNA-binding"	"Cancer-related genes, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022069, HPA054094, HPA054559"	Enhanced		Enhanced	"Nucleoplasm,Nucleoli fibrillar center,Nuclear speckles"		NA	NA		450000	"Cluster 44: Non-specific - Transcription"	"Cluster 63: T-cells - Adaptive immune response"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm	"Nucleoli fibrillar center, Nuclear speckles"	"CAB022069: , HPA054094: AB_2682376, HPA054559: AB_2682522"	"unprognostic (2.39e-3)"	"unprognostic (2.22e-2)"	"unprognostic (2.64e-1)"	"prognostic unfavorable (9.29e-4)"	"unprognostic (8.87e-2)"	"unprognostic (5.54e-2)"	"unprognostic (1.02e-3)"	"unprognostic (9.34e-2)"	"unprognostic (2.32e-2)"	"unprognostic (1.41e-2)"	"unprognostic (3.12e-1)"	"unprognostic (2.07e-1)"	"unprognostic (7.29e-3)"	"unprognostic (6.79e-2)"	"unprognostic (5.73e-3)"	"unprognostic (2.76e-2)"	"unprognostic (3.04e-2)"	106.4	147.2	58.6	96.4	57.7	115.3	109.2	71.5	64.9	116.8	64.4	101.3	86.2	130.2	107.9	111.9	115.4	100.7	81.2	55.3	69.9	103.3	121.5	103.2	136.5	60.3	61.5	197.9	164.8	114.8	97.1	99.1	60.5	97.0	101.2	70.2	106.8	89.6	99.1	112.2	102.0	113.5	59.2	109.5	114.3	55.2	68.5	255.5	116.0	86.1	165.2	116.8	102.6	61.0	421.2	539.7	595.3	344.4	251.2	238.5	345.3	330.9	319.2	459.3	388.5	413.4	312.9	481.4	379.9	320.5	309.7	310.5	949.5	299.4	488.1	383.9	605.7	394.8	498.4	398.0	212.3	547.7	338.7	272.0	206.0	473.1	305.7	370.5	382.0	342.1	535.3	509.0	406.2	413.9	756.0	466.8	771.3	433.9	365.2	660.0	657.3	414.0	345.9	426.1	431.7	519.4	467.8	299.1	392.5	354.9	271.4	354.0	343.9	268.0	438.6	402.9	400.1	297.3	503.2	516.0	216.8	627.1	433.8	107.5	117.3	91.1	107.9	120.0	119.9	107.4	107.9	106.4	118.7	107.2	115.1	115.6	50.8	119.6	140.7	101.1	128.0	178.1	58.6	57.7	71.5	64.9	55.3	69.9	60.3	61.5	60.5	59.2	68.5	61.0	72.9	76.9	81.1	16.3	97.2	126.3	99.9	105.8	116.7	62.3	111.4	83.6	63.5	90.1	99.8	44.1	41.7	132.3	103.6	52.0	56.7	147.8	11.8	81.6	137.8	95.4	139.8	144.6	16.2	111.4	179.9	93.9	71.4	104.8	88.0	135.9	83.9	128.3	112.6	53.8	20.7	105.6	95.6	153.2	107.7	15.9	106.6	95.0	56.9	13.1	132.0	84.8	96.8	19.6	22.8	110.7	75.4	127.9	115.2	94.9	89.0	121.0	71.1	50.3	65.7	78.7	127.8	45.7	66.5	137.3	122.3	130.1	108.5	163.7	117.2	103.0
NOP10	"MGC70651, NOLA3, NOP10P"	ENSG00000182117	"NOP10 ribonucleoprotein"	Q9NPE3	15	34341719-34343136	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Ribosome biogenesis, rRNA processing"	Ribonucleoprotein	"Disease variant, Dyskeratosis congenita"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Hofbauer cells: 878.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059198	Supported		Supported	"Nuclear bodies"		NA	NA			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 52: Non-specific - Ribosome"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 10: Non-specific - Unknown function"	"Nuclear bodies"		"HPA059198: AB_2683945"	"unprognostic (2.65e-1)"	"unprognostic (1.72e-2)"	"unprognostic (1.08e-1)"	"prognostic favorable (1.48e-5)"	"unprognostic (3.12e-1)"	"unprognostic (2.39e-3)"	"unprognostic (8.11e-3)"	"unprognostic (9.99e-2)"	"unprognostic (2.28e-1)"	"unprognostic (8.31e-3)"	"unprognostic (1.77e-3)"	"unprognostic (1.76e-1)"	"unprognostic (1.83e-3)"	"unprognostic (2.61e-1)"	"unprognostic (2.59e-1)"	"unprognostic (1.05e-1)"	"unprognostic (6.77e-3)"	154.9	145.7	119.9	104.8	122.2	208.3	151.7	124.3	149.6	118.6	120.1	164.3	109.3	91.9	285.5	175.0	120.0	90.2	179.4	120.7	129.1	167.7	241.1	148.0	146.2	125.3	123.2	63.3	90.4	142.5	90.5	126.8	125.6	98.2	202.1	48.4	93.6	102.2	184.4	114.4	110.2	163.6	125.1	167.5	119.0	41.7	132.7	213.2	112.8	227.4	218.6	213.6	121.2	132.8	212.2	471.9	325.1	205.3	520.4	443.7	172.4	281.3	471.8	555.4	703.6	358.5	200.3	146.7	328.6	457.7	627.3	292.8	599.1	502.8	526.0	216.0	341.7	461.6	396.5	523.7	724.2	303.2	228.6	513.8	471.0	508.3	588.1	305.0	795.6	399.9	417.0	206.4	695.3	295.8	234.0	486.1	319.8	628.7	453.3	252.2	223.4	241.8	754.0	475.5	210.4	279.5	202.1	211.7	221.4	442.9	235.4	619.4	331.2	295.3	219.6	418.2	242.7	198.9	427.1	406.8	377.5	495.8	214.5	1080.4	852.4	889.6	368.7	867.8	394.9	723.0	476.7	442.7	636.3	639.5	503.6	441.2	2797.7	534.1	696.7	824.6	700.1	1065.2	119.9	122.2	124.3	149.6	120.7	129.1	125.3	123.2	125.6	125.1	132.7	132.8	202.7	109.0	153.3	7.2	175.1	239.5	179.8	470.8	130.3	30.9	158.6	195.2	299.7	143.0	273.9	149.0	12.5	210.7	158.0	286.1	446.1	365.6	15.0	230.7	148.1	257.5	195.7	169.5	6.7	351.9	402.1	154.2	122.9	234.0	164.0	81.3	240.9	359.7	878.9	13.5	7.1	283.9	315.3	504.5	321.5	16.8	103.8	309.2	190.3	12.2	322.1	70.0	250.3	5.0	10.0	600.6	362.9	100.1	209.5	251.2	304.2	668.9	298.6	33.7	105.2	91.7	336.0	19.0	101.8	224.8	302.8	214.0	154.2	128.7	241.0	451.3
NOP53	"GLTSCR2, PICT-1, PICT1"	ENSG00000105373	"NOP53 ribosome biogenesis factor"	Q9NZM5	19	47745546-47757058	"Predicted intracellular proteins"	"Host-virus interaction, Ribosome biogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Breast glandular cells: 605.5;Breast myoepithelial cells: 415.5;Cytotrophoblasts: 454.3;Exocrine glandular cells: 989.2;Extravillous trophoblasts: 570.3;Syncytiotrophoblasts: 506.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"B-cells: 311.8;NK-cells: 96.7;T-cells: 244.1"	"Cell line enhanced"	"Detected in all"		"NB-4: 1305.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018999, HPA049600"	Approved		Supported	Nucleoli		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 50: Non-specific - Ribosome"	"Cluster 24: NB-4 - Immune response"	"Cluster 7: Non-specific - Mitochondria"	Nucleoli		"HPA018999: AB_1849733, HPA049600: AB_2680831"	"unprognostic (2.08e-3)"	"unprognostic (1.84e-1)"	"unprognostic (4.02e-3)"	"prognostic favorable (2.35e-4)"	"unprognostic (1.76e-2)"	"unprognostic (1.16e-1)"	"unprognostic (5.83e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.56e-2)"	"unprognostic (3.62e-3)"	"unprognostic (1.89e-1)"	"unprognostic (9.27e-2)"	"unprognostic (2.99e-1)"	"unprognostic (3.11e-1)"	"unprognostic (2.12e-1)"	"unprognostic (1.32e-2)"	400.7	245.3	101.7	175.2	105.0	242.1	420.4	97.4	125.9	589.9	106.6	440.5	185.0	405.7	77.3	320.0	424.5	39.4	273.8	93.6	99.7	259.3	224.7	219.1	213.6	114.7	103.5	790.1	1016.5	123.0	201.7	78.4	105.4	386.3	64.1	70.2	397.0	104.5	308.6	635.8	333.6	60.1	108.4	358.9	445.3	116.5	107.3	225.3	302.8	110.0	128.3	411.8	422.5	105.6	99.7	103.0	90.7	214.6	110.6	184.2	176.8	60.6	110.5	57.8	85.3	95.5	194.8	440.3	87.0	71.2	44.2	139.8	52.9	88.8	30.2	133.0	177.8	142.6	85.1	113.5	163.0	207.4	271.6	162.5	198.9	50.8	136.1	188.0	92.3	183.1	176.8	206.5	52.3	86.9	577.2	1305.4	209.4	173.4	60.0	380.4	160.8	209.8	112.6	151.9	96.8	340.9	50.6	330.7	330.0	65.8	156.2	493.7	114.4	56.4	150.2	49.2	125.8	306.3	290.6	120.9	71.2	145.4	92.4	21.5	23.3	26.3	55.3	35.3	74.5	311.8	108.2	96.0	33.1	238.5	244.1	108.6	3.3	96.7	25.1	41.6	120.0	15.8	101.7	105.0	97.4	125.9	93.6	99.7	114.7	103.5	105.4	108.4	107.3	105.6	229.4	41.7	120.7	0.0	210.4	0.0	0.0	0.0	0.0	0.0	605.5	415.5	0.0	0.0	69.3	104.8	0.0	454.3	224.1	0.0	266.1	266.5	0.0	100.6	156.9	94.5	0.0	0.0	0.0	989.2	570.3	107.2	0.0	115.5	68.1	268.3	0.0	0.0	259.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	108.1	0.0	0.0	269.8	0.0	0.0	0.0	0.0	348.1	0.0	0.0	61.8	0.0	0.0	369.7	18.2	0.0	0.0	0.0	108.6	0.0	0.0	0.0	0.0	506.8	131.3	226.3	0.0	0.0
NOS1	"nNOS, NOS"	ENSG00000089250	"Nitric oxide synthase 1"	P29475	12	117208142-117452170	"Cancer-related genes, Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Calmodulin-binding, Oxidoreductase"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	11	"brain: 23.0;skeletal muscle: 36.9;tongue: 57.2"	"Cell type enhanced"	"Detected in some"		"Basal prostatic cells: 10.0;Hepatic stellate cells: 18.2;Inhibitory neurons: 32.1;Oligodendrocyte precursor cells: 48.2"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HaCaT: 4.6;RH-30: 9.4;RPTEC TERT1: 5.8;U-2 OS: 1.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002167, HPA058312, HPA069509"	Enhanced		Supported	"Nucleoplasm,Plasma membrane"		NA	NA				"Cluster 80: Striated muscle - Unknown function"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Plasma membrane"	Nucleoplasm	"CAB002167: AB_564073, HPA058312: AB_2683676, HPA069509: "	"unprognostic (1.63e-1)"	"unprognostic (3.14e-2)"	"unprognostic (2.18e-2)"	"unprognostic (6.64e-3)"	"unprognostic (4.91e-2)"	"unprognostic (2.74e-1)"	"unprognostic (2.54e-1)"	"unprognostic (9.12e-3)"	"unprognostic (2.51e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.07e-1)"	"unprognostic (7.56e-2)"	"unprognostic (1.01e-1)"	"unprognostic (3.73e-2)"	"unprognostic (1.34e-1)"	"unprognostic (5.97e-4)"	"unprognostic (1.87e-1)"	0.1	0.1	12.7	0.4	12.4	0.2	0.1	5.7	7.0	0.3	0.0	2.2	0.1	0.1	0.2	0.8	0.3	0.0	0.0	4.0	16.2	1.3	0.0	0.8	0.1	12.1	11.0	0.0	1.4	0.0	0.9	0.0	12.2	0.9	0.4	0.3	3.4	0.1	36.9	1.9	0.4	0.3	2.3	0.0	0.2	0.5	23.0	0.0	0.1	57.2	0.1	0.0	0.7	3.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	4.6	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	1.1	0.0	9.4	0.0	5.8	0.0	0.2	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	12.7	12.4	5.7	7.0	4.0	16.2	12.1	11.0	12.2	2.3	23.0	3.3	0.0	0.0	0.0	1.3	0.0	3.8	10.0	2.4	4.0	0.0	0.0	0.0	1.9	0.0	0.1	0.0	0.0	0.0	0.0	0.1	1.9	0.0	3.0	5.1	0.4	3.0	0.0	0.0	2.0	0.0	0.0	0.7	0.0	8.4	0.0	0.0	18.2	0.0	0.0	0.0	32.1	0.2	0.0	0.3	0.7	0.6	0.3	0.2	1.8	1.9	0.0	0.0	0.0	48.2	5.7	0.0	0.0	0.0	0.0	4.2	0.0	0.0	0.0	0.0	0.0	1.9	0.5	0.1	1.8	0.1	0.6	0.0	0.2	0.0	0.0	1.0
NOTCH2		ENSG00000134250	"Notch receptor 2"	Q04721	1	119911553-120100779	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Differentiation, Notch signaling pathway, Transcription, Transcription regulation"	"Activator, Developmental protein, Receptor"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048743	Approved		Supported	"Nucleoplasm,Plasma membrane"		NA	NA		160000000	"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 28: Placenta - Pregnancy"	"Cluster 18: U-2197 - ECM organization"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	"Nucleoplasm, Plasma membrane"		"HPA048743: AB_2680508"	"unprognostic (1.33e-1)"	"unprognostic (1.43e-2)"	"unprognostic (2.66e-1)"	"unprognostic (1.40e-3)"	"unprognostic (7.98e-2)"	"unprognostic (4.01e-2)"	"unprognostic (1.22e-1)"	"unprognostic (7.32e-2)"	"unprognostic (1.18e-2)"	"prognostic unfavorable (5.24e-4)"	"prognostic unfavorable (9.48e-4)"	"unprognostic (3.86e-2)"	"unprognostic (6.12e-3)"	"unprognostic (1.55e-2)"	"unprognostic (2.65e-2)"	"unprognostic (1.12e-2)"	"unprognostic (7.35e-3)"	27.1	12.9	16.4	20.4	13.6	13.7	24.8	11.9	16.4	31.0	20.3	16.0	5.4	21.2	20.8	24.9	25.7	18.5	14.2	15.9	13.7	10.9	19.6	20.2	16.7	20.6	18.6	33.9	20.1	12.1	5.5	24.9	13.9	20.4	13.6	19.3	17.1	22.2	6.4	32.3	11.9	26.6	15.7	25.3	10.5	25.4	19.3	15.3	21.2	8.9	17.9	19.0	24.1	14.8	54.2	17.7	27.0	20.7	108.5	92.7	26.6	39.7	54.8	51.8	55.8	16.3	14.2	1.4	32.6	75.3	46.2	20.1	42.8	35.3	82.5	64.0	27.2	32.1	45.7	1.6	40.5	32.7	8.0	75.5	22.5	155.2	103.7	78.4	26.9	14.5	0.8	65.3	63.7	59.2	13.9	9.2	34.6	5.0	19.6	9.1	94.2	36.1	27.3	33.4	1.1	13.4	54.5	50.0	27.9	53.4	28.0	11.7	97.0	67.0	45.8	102.7	63.1	27.9	16.8	16.5	98.7	29.5	65.2	15.0	14.9	22.9	1.4	7.3	1.4	39.0	1.6	0.9	23.7	33.3	3.1	2.0	8.9	2.4	10.5	12.3	3.8	4.4	16.4	13.6	11.9	16.4	15.9	13.7	20.6	18.6	13.9	15.7	19.3	14.8	4.6	35.3	19.5	125.4	36.6	46.3	56.6	14.8	31.3	3.3	38.1	25.3	16.0	24.3	28.5	18.4	6.2	1.6	26.0	6.2	0.0	46.8	17.7	33.8	21.9	5.4	6.1	18.3	4.2	12.9	8.9	67.8	5.1	61.1	15.8	78.3	3.9	41.5	32.7	3.3	22.6	7.9	20.3	74.7	78.2	12.6	55.0	76.6	39.2	43.1	79.3	46.2	15.5	75.4	0.6	26.8	105.5	85.4	14.2	37.2	3.2	4.9	16.4	10.5	19.7	83.6	34.0	10.0	4.3	75.1	88.9	1.6	18.5	22.0	15.8	66.9
NOTCH3	"CADASIL, CASIL"	ENSG00000074181	"Notch receptor 3"	Q9UM47	19	15159038-15200995	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Differentiation, Notch signaling pathway, Transcription, Transcription regulation"	"Activator, Developmental protein, Receptor"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Sertoli cells: 414.2;Skeletal myocytes: 131.6;Smooth muscle cells: 317.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 66.3;MCF7: 66.9;RT4: 41.2;U-87 MG: 45.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005393, HPA044392"	Approved		Supported	"Nucleoplasm,Actin filaments,Cytosol"		NA	NA		46000000	"Cluster 41: Basophils - Cellular respiration"	"Cluster 31: Skin - Epidermis development"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 48: Smooth muscle cells - ECM organization"	"Nucleoplasm, Cytosol"	"Actin filaments"	"CAB005393: AB_2151246, HPA044392: AB_2678926"	"unprognostic (4.97e-2)"	"unprognostic (3.89e-2)"	"unprognostic (7.06e-3)"	"prognostic unfavorable (5.92e-4)"	"unprognostic (9.20e-2)"	"unprognostic (1.73e-2)"	"unprognostic (2.72e-1)"	"unprognostic (9.04e-2)"	"unprognostic (3.90e-3)"	"unprognostic (1.23e-1)"	"unprognostic (1.19e-1)"	"unprognostic (3.13e-1)"	"prognostic unfavorable (2.53e-7)"	"unprognostic (3.35e-2)"	"unprognostic (8.34e-3)"	"unprognostic (4.40e-2)"	"unprognostic (2.00e-3)"	85.7	5.3	14.8	10.4	12.4	0.2	50.5	11.0	21.3	49.4	7.1	14.8	5.5	39.9	16.9	74.3	35.8	23.5	43.6	9.5	11.3	26.0	3.2	38.3	9.2	12.0	15.2	18.9	10.7	12.6	10.3	59.8	14.3	22.0	4.2	0.5	24.4	16.5	29.7	82.1	14.3	16.9	8.2	15.0	11.6	3.8	15.8	34.1	32.3	25.1	10.4	26.3	55.1	10.0	13.0	8.1	66.3	30.3	9.2	7.3	29.8	10.2	0.4	0.4	0.3	15.6	13.4	0.4	7.7	18.9	0.1	15.1	12.1	0.2	0.6	0.1	3.1	0.4	12.4	3.5	4.5	0.0	1.2	8.4	7.3	15.5	1.6	0.6	0.8	4.6	0.5	0.6	1.2	66.9	15.9	0.1	38.8	11.2	0.0	0.1	3.7	0.3	0.0	41.2	1.9	21.4	0.1	37.8	0.0	19.6	40.3	0.1	0.0	1.9	21.0	0.3	0.1	0.1	0.7	0.0	45.7	0.4	1.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	14.8	12.4	11.0	21.3	9.5	11.3	12.0	15.2	14.3	8.2	15.8	10.0	39.6	9.6	1.5	5.9	0.4	24.1	7.8	17.8	4.6	0.4	41.5	30.7	60.7	0.0	28.5	16.5	0.0	20.2	1.0	0.0	5.9	14.8	0.5	4.8	13.5	32.0	0.0	0.0	0.6	0.0	3.9	24.2	2.0	11.8	0.0	5.9	4.2	0.0	2.8	0.0	0.3	0.3	6.1	10.4	12.3	0.1	9.0	4.1	17.8	13.1	0.7	0.8	0.0	0.0	0.2	0.9	0.1	11.7	0.0	13.0	0.1	0.0	4.2	0.8	414.2	131.6	317.0	0.9	1.2	72.1	72.2	31.5	2.0	1.2	0.2	36.0
NOVA1	NOVA-1	ENSG00000139910	"NOVA alternative splicing regulator 1"	P51513	14	26443090-26598033	"Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 85.4"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 222.9;Excitatory neurons: 414.9;Oligodendrocyte precursor cells: 1269.7;Oligodendrocytes: 319.5"	"Cancer enriched"	"Detected in many"	5	"glioma: 14.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 53.3;ASC diff: 25.6;HAP1: 23.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004155	Uncertain		Supported	Nucleoplasm,Nucleoli		NA	NA				"Cluster 70: Brain - Nervous system development"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	Nucleoli	Nucleoplasm	"HPA004155: AB_1079497"	"unprognostic (1.46e-1)"	"unprognostic (4.43e-3)"	"unprognostic (6.55e-3)"	"unprognostic (4.00e-2)"	"unprognostic (6.69e-3)"	"unprognostic (4.29e-2)"	"unprognostic (3.74e-3)"	"unprognostic (2.41e-1)"	"unprognostic (5.21e-1)"	"unprognostic (4.32e-2)"	"unprognostic (5.04e-4)"	"unprognostic (2.40e-1)"	"unprognostic (1.93e-3)"	"unprognostic (9.27e-4)"	"unprognostic (9.20e-2)"	"unprognostic (5.62e-2)"	"unprognostic (1.31e-4)"	23.4	5.4	44.0	2.4	39.7	0.1	28.9	85.4	56.3	12.1	18.9	11.6	1.4	8.5	4.9	2.9	6.7	4.8	3.3	38.8	65.3	6.1	0.9	1.4	3.4	50.3	51.2	5.0	1.2	2.4	19.3	0.1	48.5	5.6	5.1	13.4	2.7	15.9	4.3	4.7	3.6	9.5	49.2	0.9	3.3	8.8	71.1	1.2	3.4	8.7	4.5	5.9	8.4	45.5	0.0	11.6	53.3	0.0	25.6	14.6	0.1	0.0	0.0	0.0	0.0	0.1	1.4	0.0	0.7	0.7	7.1	0.1	23.7	0.2	0.0	0.0	1.8	0.0	0.1	0.3	8.5	0.0	2.1	16.8	0.0	3.6	2.9	17.8	10.3	8.7	0.0	0.1	8.4	0.0	9.8	0.1	13.5	0.0	10.9	1.3	14.8	0.2	6.8	9.1	15.5	9.4	0.0	0.0	0.0	4.2	1.1	0.0	0.0	6.5	7.7	5.2	1.4	0.0	0.0	0.0	8.8	0.0	7.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	44.0	39.7	85.4	56.3	38.8	65.3	50.3	51.2	48.5	49.2	71.1	45.5	24.8	0.0	1.5	141.0	0.2	5.2	5.9	0.0	4.6	222.9	51.5	29.6	1.1	5.7	0.0	14.7	4.2	0.1	1.4	6.6	9.8	0.4	20.1	0.6	15.0	9.4	65.9	0.0	414.9	0.4	0.0	188.8	0.5	0.2	0.0	18.2	38.6	0.5	0.2	136.3	203.5	7.1	0.0	0.6	10.5	16.5	150.4	2.1	3.6	93.7	0.0	32.3	0.0	1269.7	319.5	2.0	11.7	65.8	1.9	6.7	0.3	30.3	4.4	12.0	6.6	28.6	17.7	163.1	64.3	0.7	3.1	0.0	1.5	30.0	8.4	0.6
NPAP1	C15orf2	ENSG00000185823	"Nuclear pore associated protein 1"	Q9NZP6	15	24675775-24683393	"Predicted intracellular proteins, Transporters"	"Differentiation, Spermatogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 1.8;testis: 2.9"	"Cell type enriched"	"Detected in some"	5	"Granulosa cells: 125.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA018828, HPA019562"	Uncertain		Supported	"Nucleoplasm,Vesicles,Plasma membrane"		NA	NA				"Cluster 78: Testis - Spermatogenesis"		"Cluster 40: Granulosa cells - Unknown function"	Nucleoplasm	"Vesicles, Plasma membrane"	"HPA018828: AB_2669941, HPA019562: AB_2670190"										"unprognostic (4.40e-2)"	"unprognostic (1.85e-2)"		"unprognostic (6.98e-3)"	"unprognostic (7.45e-2)"	"unprognostic (9.90e-2)"	"unprognostic (1.08e-2)"	"unprognostic (5.11e-3)"	0.0	0.0	0.9	0.0	1.8	0.4	0.1	0.1	1.1	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.0	0.5	1.7	0.9	0.0	0.0	0.1	0.9	0.7	0.5	0.4	0.0	0.5	0.0	0.5	0.1	0.0	0.2	0.0	0.0	0.1	0.3	0.0	0.0	0.5	0.1	0.1	2.9	1.5	0.0	0.5	0.0	0.0	0.1	0.0	1.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.2	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.9	1.8	0.1	1.1	0.5	1.7	0.9	0.7	0.5	0.5	1.5	1.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	4.1	0.2	0.7	0.1	0.0	0.0	1.2	0.0	0.0	0.1	0.0	0.1	0.0	125.9	0.0	0.0	0.1	0.0	3.5	0.0	0.0	0.0	0.0	0.8	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	1.3	24.1	12.7	0.0	0.0	0.0	0.0	0.5	0.0	0.2
NPAS3	"bHLHe12, MOP6, PASD6"	ENSG00000151322	"Neuronal PAS domain protein 3"	Q8IXF0	14	32934396-33820863	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 22.8"	"Group enriched"	"Detected in many"	6	"Astrocytes: 3405.1;Inhibitory neurons: 1408.3;Oligodendrocyte precursor cells: 1893.0;Oligodendrocytes: 1772.0"	"Group enriched"	"Detected in some"	4	"endometrial cancer: 6.4;glioma: 7.7;ovarian cancer: 3.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	12	"AF22: 9.3;U-266/70: 23.6;U-266/84: 7.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA075337	Enhanced		Supported	Nucleoplasm		NA	NA				"Cluster 70: Brain - Nervous system development"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm		"HPA075337: "	"unprognostic (6.02e-3)"	"unprognostic (2.37e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.31e-2)"	"unprognostic (3.24e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.14e-2)"	"unprognostic (5.65e-2)"	"unprognostic (2.74e-1)"	"unprognostic (3.12e-3)"	"unprognostic (5.29e-3)"	"unprognostic (1.38e-1)"	"unprognostic (3.18e-3)"	"unprognostic (2.65e-3)"	"unprognostic (1.50e-1)"	"unprognostic (2.69e-3)"	"unprognostic (3.27e-1)"	0.8	0.8	17.3	0.1	19.9	0.0	0.9	14.6	12.9	6.0	0.0	1.4	0.3	3.9	0.8	0.3	3.9	0.7	0.4	14.0	15.0	0.9	0.1	0.2	0.1	22.8	18.0	2.7	0.4	0.5	1.0	0.5	15.8	0.8	0.3	1.4	0.8	1.3	0.2	0.2	0.4	0.6	18.0	1.1	1.0	1.3	15.9	0.4	1.8	0.2	0.2	0.5	0.5	18.3	0.0	0.0	9.3	0.0	0.2	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.5	0.0	0.5	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.3	0.0	1.0	0.0	0.0	0.0	0.0	0.1	1.1	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.2	0.0	0.6	23.6	7.0	0.0	0.3	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.3	19.9	14.6	12.9	14.0	15.0	22.8	18.0	15.8	18.0	15.9	18.3	5.1	0.0	0.0	3405.1	0.1	1.0	1.0	0.0	0.6	8.9	3.8	5.1	2.1	0.0	0.1	1.8	0.0	1.5	0.1	0.1	1.9	0.1	22.2	24.6	5.7	3.2	1.2	0.0	341.9	0.0	0.1	3.5	0.0	72.3	0.0	0.7	4.2	0.1	0.5	10.1	1408.3	0.0	0.0	0.0	1.4	17.0	7.2	0.7	0.0	116.2	0.0	7.4	0.0	1893.0	1772.0	0.2	0.0	5.3	0.1	0.5	0.0	0.5	1.8	0.7	0.0	11.5	3.1	0.2	0.8	0.1	0.4	0.3	1.0	1.1	0.0	0.5
NPC1	SLC65A1	ENSG00000141458	"NPC intracellular cholesterol transporter 1"	O15118	18	23506184-23586506	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Cholesterol metabolism, Host-virus interaction, Lipid metabolism, Lipid transport, Steroid metabolism, Sterol metabolism, Transport"	"Host cell receptor for virus entry, Receptor"	"Disease variant, Niemann-Pick disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 110.6"	"Cell type enhanced"	"Detected in many"		"Oligodendrocytes: 182.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"plasmacytoid DC: 70.9"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"hTERT-HME1: 273.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026618, CAB070132, HPA077445"	Approved		Supported	Nucleoplasm,Vesicles		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Nucleoplasm, Vesicles"		"CAB070132: AB_10001101, HPA026618: AB_1854580, HPA077445: "	"unprognostic (1.74e-1)"	"unprognostic (1.53e-3)"	"unprognostic (2.67e-1)"	"unprognostic (1.25e-1)"	"unprognostic (3.20e-2)"	"unprognostic (1.50e-1)"	"prognostic unfavorable (2.26e-6)"	"unprognostic (1.31e-1)"	"unprognostic (1.01e-2)"	"unprognostic (7.36e-3)"	"unprognostic (1.07e-2)"	"unprognostic (1.09e-3)"	"unprognostic (2.78e-2)"	"unprognostic (1.89e-1)"	"unprognostic (2.73e-2)"	"unprognostic (1.38e-1)"	"unprognostic (2.08e-3)"	17.5	76.7	35.1	16.9	69.6	42.6	20.0	55.3	47.8	16.7	28.6	13.7	14.5	16.7	15.0	20.5	13.4	15.3	11.5	41.1	44.3	16.8	15.2	29.0	20.4	73.3	55.8	16.0	11.9	72.6	15.0	27.8	66.6	13.1	12.0	28.0	36.8	13.2	22.9	24.3	17.8	15.1	49.8	17.1	20.4	13.7	55.8	12.2	11.8	14.1	15.6	15.8	18.0	110.6	21.5	41.4	17.8	29.3	55.8	44.6	40.7	37.3	81.1	38.8	84.3	28.1	30.7	18.4	28.0	55.0	132.8	59.3	22.6	63.2	35.2	15.0	17.9	6.8	35.7	63.2	79.2	25.0	28.5	42.2	61.3	81.7	273.2	76.8	40.3	20.7	20.1	47.5	44.2	32.4	10.6	14.9	12.5	24.4	37.3	15.3	28.1	45.0	88.8	51.9	7.5	14.5	44.6	62.0	54.3	27.7	15.9	19.5	50.0	81.1	15.3	32.4	32.3	29.7	97.1	12.2	177.7	21.8	37.1	4.4	9.0	8.8	29.7	8.7	20.5	5.0	12.4	20.7	4.0	6.7	5.5	15.0	7.9	10.5	13.8	70.9	17.4	10.6	35.1	69.6	55.3	47.8	41.1	44.3	73.3	55.8	66.6	49.8	55.8	110.6	18.4	25.6	56.1	32.7	9.6	9.3	34.1	16.5	8.0	6.7	10.5	9.4	4.4	11.5	21.8	9.2	18.8	15.1	61.0	24.8	0.0	11.2	1.2	23.3	12.2	16.4	3.6	2.5	23.8	15.1	7.8	13.0	15.3	53.9	10.8	31.6	6.8	9.8	28.9	3.3	20.2	7.3	2.0	11.9	6.5	1.5	9.0	21.0	12.4	59.0	7.2	15.1	25.7	39.2	182.0	34.4	22.6	10.5	15.6	41.5	8.3	5.4	10.0	12.7	0.0	10.3	14.4	13.9	25.1	17.6	14.5	23.8	19.1	52.4	7.6	64.0
NPEPPS	"MP100, PSA"	ENSG00000141279	"Aminopeptidase puromycin sensitive"	P55786	17	47522942-47624665	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Aminopeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021453, HPA045649"	Uncertain		Supported	Cytosol		No	No		3000000	"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 59: Non-specific - Translation"	"Cluster 6: T47d - Mammary gland"	"Cluster 44: Endometrium - Transcription"	Cytosol		"HPA021453: AB_2670709, HPA045649: AB_2679406"	"unprognostic (1.63e-1)"	"unprognostic (3.15e-2)"	"prognostic favorable (3.39e-5)"	"unprognostic (2.66e-2)"	"unprognostic (1.53e-1)"	"unprognostic (5.92e-2)"	"prognostic unfavorable (3.67e-5)"	"unprognostic (3.84e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.77e-1)"	"unprognostic (3.85e-2)"	"unprognostic (3.63e-2)"	"unprognostic (1.93e-1)"	"unprognostic (8.55e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.23e-2)"	"unprognostic (1.07e-1)"	32.2	50.0	30.6	19.4	34.8	7.3	30.1	30.7	41.1	41.5	26.1	38.6	20.3	32.0	11.1	92.2	32.6	22.2	30.6	32.9	30.3	30.9	23.8	30.5	18.4	35.7	34.2	39.9	34.2	30.1	26.7	27.3	35.7	27.9	27.4	21.0	44.4	20.6	114.5	47.3	37.1	33.7	26.1	31.9	33.4	19.2	34.2	26.4	26.8	86.6	27.5	34.8	58.2	30.5	105.7	81.7	67.3	49.4	92.1	81.9	147.5	47.5	63.9	70.4	66.5	55.7	100.6	68.4	76.1	69.2	70.1	62.0	83.7	44.8	108.7	31.5	73.2	76.5	62.3	59.2	48.3	48.8	46.6	61.5	41.1	52.7	26.8	99.2	77.5	20.1	72.5	30.7	109.9	37.2	66.0	34.7	47.8	74.4	68.0	50.5	107.2	60.1	82.6	81.0	59.7	46.0	59.1	34.9	44.7	122.0	256.3	35.5	88.6	44.1	35.2	72.5	34.9	63.7	81.1	39.9	64.8	25.3	33.5	14.2	9.9	12.4	8.8	7.9	9.6	7.7	7.2	9.2	9.7	6.9	6.3	7.8	28.4	8.8	9.1	10.1	8.8	6.3	30.6	34.8	30.7	41.1	32.9	30.3	35.7	34.2	35.7	26.1	34.2	30.5	32.0	83.3	59.1	68.6	44.7	77.9	68.9	40.2	109.8	144.6	76.6	33.8	60.3	55.8	53.6	42.3	268.9	81.2	35.6	87.0	27.4	69.3	34.2	95.2	80.9	45.4	44.3	44.6	98.0	54.4	74.4	66.0	58.1	158.1	41.7	62.7	45.7	32.5	40.5	112.7	95.3	44.1	38.7	51.0	62.1	50.8	52.8	45.4	58.7	37.5	51.5	38.7	38.1	69.4	74.9	103.4	61.6	50.0	52.5	106.2	58.7	46.5	63.8	153.3	78.9	53.8	53.5	52.0	28.6	101.6	102.6	104.7	40.4	45.9	51.5	195.2
NPFFR2	"GPR74, NPFF2, NPGPR"	ENSG00000056291	"Neuropeptide FF receptor 2"	Q9Y5X5	4	72031804-72148067	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 7.2;seminal vesicle: 3.2"	"Cell type enhanced"	"Detected in some"		"Breast glandular cells: 22.1;Cytotrophoblasts: 6.6;Excitatory neurons: 14.5;Extravillous trophoblasts: 12.3;Muller glia cells: 4.9;Syncytiotrophoblasts: 9.7"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"GAMG: 28.1;NTERA-2: 9.2;RPTEC TERT1: 11.9;SH-SY5Y: 14.0;U-2 OS: 13.7"	"Region enriched"	"Detected in some"	4	"olfactory bulb: 4.3"	"Low region specificity"	"Detected in all"			HPA026825			Approved	"Plasma membrane,Actin filaments"		NA	NA				"Cluster 63: T-cells - Adaptive immune response"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 30: Mammary glandular cells - Lactation"	"Plasma membrane"	"Actin filaments"	"HPA026825: AB_10603123"	"unprognostic (1.28e-1)"		"unprognostic (1.05e-2)"		"unprognostic (1.53e-1)"	"unprognostic (1.23e-1)"	"unprognostic (6.07e-2)"	"unprognostic (4.68e-2)"	"unprognostic (5.77e-2)"	"unprognostic (1.43e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.40e-5)"	"unprognostic (5.75e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.68e-1)"	"unprognostic (1.48e-1)"	0.1	0.0	1.0	0.2	0.9	0.0	0.2	0.0	0.6	0.1	0.0	0.1	0.1	0.0	0.9	0.0	0.2	0.1	0.0	0.9	1.1	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.1	1.6	0.3	0.1	0.2	0.7	0.0	3.2	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.4	0.2	7.2	0.3	0.2	0.1	0.5	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	28.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.2	0.0	0.0	0.0	0.0	0.0	11.9	0.0	0.0	14.0	0.0	0.0	0.0	2.0	0.0	0.0	1.3	0.0	13.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.0	0.9	0.0	0.6	0.9	1.1	0.5	0.0	0.3	0.0	0.2	0.5	0.1	0.0	0.0	0.7	0.0	0.4	0.0	0.0	0.0	0.0	22.1	0.0	0.5	0.0	0.0	0.0	0.0	6.6	0.0	0.1	0.0	0.2	0.8	0.0	0.0	0.3	0.0	0.0	14.5	0.2	12.3	1.5	0.0	0.0	0.0	0.0	0.0	0.0	1.0	3.3	3.5	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	4.9	0.0	0.0	0.5	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.2	1.7	0.0	0.0	9.7	0.0	0.0	0.0	0.1
NPHP4	"KIAA0673, POC10, SLSN4"	ENSG00000131697	"Nephrocystin 4"	O75161	1	5862811-5992473	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"			"Ciliopathy, Disease variant, Leber congenital amaurosis, Nephronophthisis, Senior-Loken syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 24.2;Cone photoreceptor cells: 33.3;Excitatory neurons: 47.1;Inhibitory neurons: 30.8"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in some"		"cerebral cortex: 2.7;hippocampal formation: 3.1"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA063852, HPA065526"	Approved		Approved	"Nucleoplasm,Nuclear bodies,Vesicles,Cytosol"		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 71: Testis - DNA repair"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Nucleoplasm, Cytosol"	"Nuclear bodies, Vesicles"	"HPA063852: , HPA065526: AB_2685505"	"unprognostic (1.82e-1)"	"unprognostic (1.57e-2)"	"unprognostic (1.76e-1)"	"unprognostic (7.30e-2)"	"unprognostic (5.83e-2)"	"unprognostic (2.53e-2)"	"unprognostic (1.08e-2)"	"unprognostic (1.95e-1)"	"unprognostic (2.52e-1)"	"unprognostic (1.23e-2)"	"unprognostic (7.49e-3)"	"unprognostic (9.00e-2)"	"unprognostic (1.75e-2)"	"unprognostic (2.96e-2)"	"unprognostic (1.34e-1)"	"unprognostic (2.54e-1)"	"unprognostic (1.37e-1)"	2.7	2.2	1.0	2.3	0.8	3.7	2.7	0.0	2.7	2.9	2.5	2.2	2.1	2.8	2.3	2.0	7.9	2.1	1.9	3.1	0.0	2.2	1.3	3.0	2.3	0.0	0.0	2.9	2.4	2.7	7.8	1.6	0.0	2.2	1.2	2.4	2.2	2.3	2.2	4.9	2.1	2.2	0.0	2.2	2.0	5.3	0.0	2.5	6.7	1.9	1.1	2.1	2.5	0.0	7.8	4.8	5.4	4.3	4.7	6.8	4.1	3.9	3.9	5.3	4.2	4.1	6.5	4.0	9.6	4.6	3.6	7.4	2.7	6.6	2.7	5.1	7.3	3.4	8.1	4.1	3.7	6.5	5.1	5.6	3.2	6.3	3.9	3.4	3.8	9.4	6.2	4.1	2.4	5.9	8.3	7.1	1.0	4.0	5.5	7.1	3.4	6.5	2.6	1.0	17.0	5.5	6.1	4.5	6.5	2.3	6.0	7.2	3.7	7.6	3.2	13.0	4.8	5.0	7.0	4.2	3.4	8.3	2.0	0.7	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.1	1.0	0.8	0.0	2.7	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	1.1	24.2	1.3	4.0	1.2	1.8	3.4	7.3	3.0	3.6	3.1	4.3	3.9	3.7	33.3	0.6	2.2	2.1	1.9	1.6	2.0	10.2	3.3	2.9	3.6	3.2	47.1	1.8	0.5	3.5	4.1	3.0	0.0	4.0	1.8	1.5	2.0	5.0	30.8	2.2	2.0	3.5	3.7	1.4	4.1	2.4	10.6	14.0	1.8	6.3	2.1	10.6	17.3	2.1	2.2	2.2	2.6	1.8	1.1	1.9	10.9	18.2	6.6	1.6	2.7	11.6	6.5	1.9	5.3	1.1	1.7	4.0	1.7	1.1
NPLOC4	"FLJ20657, KIAA1499, NPL4"	ENSG00000182446	"NPL4 homolog, ubiquitin recognition factor"	Q8TAT6	17	81556887-81648465	"Predicted intracellular proteins, Transporters"	"Ubl conjugation pathway"	Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 164.3"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"classical monocyte: 20.0"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021560, HPA023295"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA		30000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 59: Non-specific - Translation"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 29: Early spermatids - Spermatogenesis"	"Nucleoplasm, Cytosol"		"HPA021560: AB_1854586, HPA023295: AB_1854587"	"unprognostic (3.17e-1)"	"unprognostic (2.98e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.00e-3)"	"unprognostic (8.72e-2)"	"unprognostic (2.33e-2)"	"prognostic unfavorable (1.16e-5)"	"unprognostic (1.06e-2)"	"unprognostic (4.42e-1)"	"unprognostic (2.97e-1)"	"unprognostic (4.15e-3)"	"unprognostic (1.21e-1)"	"prognostic unfavorable (6.95e-7)"	"unprognostic (1.01e-1)"	"unprognostic (6.98e-2)"	"unprognostic (6.51e-2)"	"unprognostic (1.72e-1)"	37.3	46.6	27.2	32.4	27.6	41.7	32.0	22.2	28.3	30.4	27.1	35.2	24.5	35.3	23.5	51.5	28.8	23.3	58.4	26.6	31.2	42.2	54.8	37.9	33.2	31.8	27.2	25.9	36.7	29.7	33.2	27.1	28.5	33.3	21.3	20.1	32.4	22.7	164.3	42.1	34.4	29.3	24.1	42.8	36.8	42.8	28.7	33.4	28.4	55.5	28.8	33.2	31.7	32.8	91.9	118.6	46.2	72.1	56.0	46.0	57.2	74.2	82.3	120.4	110.6	90.7	80.2	67.2	57.9	87.7	87.8	72.5	46.0	62.6	104.5	43.0	60.8	77.5	95.5	81.5	53.4	83.4	95.4	45.8	59.1	113.2	40.1	57.7	124.8	62.0	84.1	99.1	73.6	59.5	113.0	45.2	54.3	45.5	74.0	73.6	73.8	54.4	43.6	86.8	61.6	70.6	92.6	127.4	85.7	87.1	100.1	60.9	89.6	156.1	108.1	86.1	121.4	74.8	57.9	84.0	124.6	55.2	102.9	4.1	20.0	4.4	4.6	4.9	2.8	4.7	3.1	3.7	6.3	3.3	2.8	3.7	5.6	2.8	3.1	4.8	3.2	10.0	27.2	27.6	22.2	28.3	26.6	31.2	31.8	27.2	28.5	24.1	28.7	32.8	19.2	12.8	18.1	24.8	15.3	17.6	16.2	12.7	7.4	24.3	19.5	16.1	44.5	11.5	18.5	20.2	29.2	19.5	22.2	38.9	1.9	19.0	96.2	32.8	19.6	22.2	30.5	20.6	38.0	37.4	21.3	15.9	26.0	38.8	3.8	29.2	27.1	54.3	19.1	20.2	36.4	17.2	8.2	27.3	18.7	79.6	17.7	22.8	12.4	19.7	28.7	19.6	14.4	23.1	38.6	47.2	22.8	12.8	16.5	28.4	22.2	27.9	21.5	33.5	19.7	22.3	18.5	29.7	23.9	15.7	24.2	37.1	16.9	19.3	18.9	28.7
NQO1	"DHQU, DIA4, DTD, NMOR1, QR1"	ENSG00000181019	"NAD(P)H quinone dehydrogenase 1"	P15559	16	69706996-69726668	"Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins"		Oxidoreductase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"stomach 1: 522.7"	"Cell type enhanced"	"Detected in many"		"Gastric mucus-secreting cells: 539.8;Respiratory ciliated cells: 471.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"A549: 2434.0;OE19: 4177.0;SiHa: 2756.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007308, CAB012421"	Enhanced		Supported	Cytosol		NA	NA		490000	"Cluster 48: NK-cells - Unknown function"	"Cluster 22: Non-specific - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 49: Ciliated cells - Cilium organization"	Cytosol		"CAB012421: , HPA007308: AB_1079501"	"unprognostic (1.04e-2)"	"unprognostic (1.95e-3)"	"unprognostic (3.14e-1)"	"unprognostic (3.76e-3)"	"unprognostic (9.03e-2)"	"prognostic unfavorable (1.45e-4)"	"unprognostic (1.05e-3)"	"unprognostic (1.97e-1)"	"unprognostic (5.07e-2)"	"unprognostic (1.24e-2)"	"unprognostic (1.49e-2)"	"unprognostic (2.25e-1)"	"unprognostic (2.41e-2)"	"unprognostic (6.36e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.98e-1)"	"unprognostic (3.27e-1)"	100.9	95.1	88.9	20.7	97.2	0.8	264.8	88.1	165.6	24.3	113.4	85.6	106.8	16.1	27.2	162.2	29.3	183.1	24.3	86.7	95.0	93.9	5.6	36.5	4.8	83.5	86.2	8.9	9.2	19.5	15.3	12.0	85.9	20.7	74.0	21.4	47.7	25.1	34.2	11.7	56.1	35.0	83.0	22.8	522.7	6.4	93.6	4.3	112.7	27.0	16.5	79.0	34.2	86.8	224.2	2434.0	203.4	901.3	473.1	682.7	77.5	363.1	632.7	363.9	547.0	302.0	1395.7	7.1	433.1	1850.6	634.3	232.1	79.1	410.3	185.2	91.3	3.3	10.9	564.4	2169.9	631.7	53.8	170.6	166.2	246.8	642.8	74.4	537.9	903.9	18.5	95.3	16.3	1914.1	725.9	11.6	98.7	107.0	4177.0	237.1	18.9	44.0	101.6	708.3	781.5	73.0	17.2	2756.6	384.8	1690.4	226.6	631.3	173.1	626.5	368.8	155.8	140.0	297.1	12.7	53.1	11.2	470.2	29.1	1864.0	1.1	3.9	0.3	6.3	0.4	3.1	5.7	7.3	8.3	3.8	2.4	2.2	5.3	0.9	18.7	0.4	1.3	15.6	5.1	88.9	97.2	88.1	165.6	86.7	95.0	83.5	86.2	85.9	83.0	93.6	86.8	88.5	25.6	14.6	8.8	2.9	5.2	26.4	185.5	32.5	10.0	31.1	30.5	4.8	138.7	90.9	42.3	4.2	1.7	3.5	165.7	146.8	25.6	0.4	117.2	11.7	81.0	20.4	1.3	1.9	147.5	4.3	32.9	539.8	65.7	19.7	10.1	28.5	2.6	15.2	3.3	1.6	81.7	107.8	3.5	7.6	1.2	25.1	10.9	17.8	4.7	128.5	10.6	7.2	0.0	5.0	75.1	59.4	12.0	2.3	22.6	62.9	44.3	471.3	15.1	6.6	21.1	72.1	0.3	1.3	128.3	4.5	1.9	5.6	17.3	51.5	40.6
NQO2	"DHQV, DIA6, NMOR2, QR2"	ENSG00000124588	"N-ribosyldihydronicotinamide:quinone reductase 2"	P16083	6	2987987-3019755	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Hepatocytes: 202.5;Proximal tubular cells: 730.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 240.2"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021283, HPA021332"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA		6000000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 16: U-266 - Nucleosome"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Cytosol	Nucleoplasm	"HPA021283: AB_1854600, HPA021332: AB_1854601"	"unprognostic (7.11e-3)"	"unprognostic (1.43e-3)"	"unprognostic (2.41e-1)"	"unprognostic (3.01e-2)"	"unprognostic (1.00e-2)"	"unprognostic (3.58e-1)"	"prognostic unfavorable (8.40e-4)"	"unprognostic (1.77e-1)"	"unprognostic (1.15e-1)"	"unprognostic (4.90e-2)"	"unprognostic (6.59e-2)"	"unprognostic (3.60e-2)"	"unprognostic (8.28e-2)"	"unprognostic (2.03e-1)"	"unprognostic (3.32e-2)"	"unprognostic (3.96e-1)"	"unprognostic (2.02e-1)"	60.0	121.5	48.1	27.0	48.8	72.1	45.0	61.1	65.4	32.6	64.3	28.2	35.3	25.8	32.9	32.8	30.0	31.5	76.5	48.5	49.6	190.3	124.2	30.4	19.5	61.8	47.9	29.8	42.6	33.5	21.2	28.6	61.4	28.1	19.6	31.1	61.9	28.9	123.6	50.7	35.6	19.8	42.9	39.3	36.1	18.2	51.5	18.3	26.8	144.9	18.2	31.8	29.0	53.2	45.7	75.7	42.1	95.3	73.0	42.9	45.4	40.5	51.2	37.1	40.9	80.0	16.1	36.9	144.7	71.1	86.4	33.7	45.4	28.5	28.9	95.9	37.1	23.6	83.0	77.3	59.7	24.4	73.9	27.8	34.2	44.9	40.9	53.4	36.8	47.9	142.3	24.1	30.8	95.5	27.0	44.4	54.9	87.6	59.8	49.3	50.1	108.2	56.6	24.0	11.4	15.9	59.5	25.9	128.9	75.0	35.4	16.9	60.7	34.8	14.4	45.9	18.1	45.4	116.7	12.3	43.3	69.5	72.7	25.2	91.8	52.8	33.1	64.2	24.4	12.1	29.6	29.8	61.7	9.1	17.8	19.6	240.2	30.0	60.8	6.5	37.2	43.2	48.1	48.8	61.1	65.4	48.5	49.6	61.8	47.9	61.4	42.9	51.5	53.2	30.3	9.6	16.1	9.8	16.3	35.2	41.5	32.7	12.5	34.8	34.2	32.1	72.8	47.1	21.3	25.8	10.4	42.6	18.2	21.2	162.4	29.1	51.6	15.1	21.4	28.0	4.8	43.8	47.0	63.4	53.9	51.5	33.1	9.0	13.9	11.0	25.7	202.5	76.6	42.1	46.7	23.3	30.5	44.7	105.7	62.8	35.8	75.4	67.6	19.7	148.6	54.0	20.6	10.6	9.1	55.8	18.3	41.0	15.0	38.6	103.7	730.3	28.7	22.5	26.3	35.0	42.9	24.8	11.4	35.4	41.2	31.2	20.8	21.9	25.4	41.8
NR0B1	"AHC, AHCH, DAX1, DSS"	ENSG00000169297	"Nuclear receptor subfamily 0 group B member 1"	P51843	X	30304206-30309390	"Cancer-related genes, Disease related genes, Human disease related genes, Nuclear receptors, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Receptor, Repressor"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"adrenal gland: 32.7;testis: 19.3"	"Cell type enhanced"	"Detected in some"		"Enteroendocrine cells: 5.4;Ionocytes: 8.2;monocytes: 2.6;Oligodendrocyte precursor cells: 10.6;Theca cells: 4.9"	"Cancer enhanced"	"Detected in many"		"lung cancer: 4.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"A549: 62.5;RT4: 19.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA061948, HPA067207"			Supported	"Nuclear speckles,Vesicles,Centriolar satellite"		NA	NA				"Cluster 17: Adrenal gland - Steroid metabolism"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 68: Oligodendrocytes - Mixed function"	"Nuclear speckles"	"Vesicles, Centriolar satellite"	"HPA061948: AB_2732673, HPA067207: AB_2732761"		"unprognostic (1.50e-2)"			"unprognostic (9.68e-2)"			"unprognostic (9.47e-3)"	"unprognostic (1.23e-1)"	"unprognostic (2.81e-1)"	"unprognostic (7.45e-3)"		"unprognostic (4.83e-2)"	"unprognostic (9.00e-2)"	"unprognostic (1.33e-3)"			0.2	32.7	1.4	0.0	1.3	0.0	0.2	1.0	1.5	2.4	0.7	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	1.3	1.8	0.0	0.0	0.0	0.0	1.4	1.3	3.6	2.1	0.0	2.5	0.0	1.3	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	1.2	0.1	0.7	19.3	5.9	0.0	0.0	0.0	0.0	0.0	2.0	1.4	0.0	62.5	0.0	0.0	2.3	1.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	7.1	0.0	2.7	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	19.4	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	8.8	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	1.3	1.0	1.5	1.3	1.8	1.4	1.3	1.3	1.2	5.9	1.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.1	0.0	0.1	5.4	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.3	8.2	0.0	0.0	1.9	1.2	0.1	1.8	0.0	2.6	0.0	0.0	10.6	0.0	1.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.6	0.8	0.0	0.1	0.0	0.0	4.9	0.0	0.1
NR0B2	SHP	ENSG00000131910	"Nuclear receptor subfamily 0 group B member 2"	Q15466	1	26911489-26913975	"Disease related genes, Human disease related genes, Nuclear receptors, Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Transcription, Transcription regulation"	"Receptor, Repressor"	"Disease variant, Obesity"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 76.9;liver: 142.4"	"Cell type enhanced"	"Detected in some"		"Cholangiocytes: 97.2;Distal tubular cells: 52.8;Exocrine glandular cells: 42.4;Gastric mucus-secreting cells: 90.2;Hepatocytes: 173.4;Proximal enterocytes: 49.8"	"Cancer enriched"	"Detected in many"	5	"liver cancer: 52.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	33	"Hep G2: 78.2"	"Region enriched"	"Detected in single"	6	"cerebellum: 1.7"	"Not detected"	"Not detected"			HPA003983			Supported	Nucleoplasm,Vesicles		NA	NA				"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 15: Hepatocytes - Hemostasis"	Nucleoplasm	Vesicles	"HPA003983: "	"unprognostic (2.99e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.95e-3)"	"unprognostic (4.68e-3)"	"unprognostic (9.21e-2)"	"unprognostic (8.22e-2)"	"unprognostic (3.97e-2)"	"unprognostic (2.44e-2)"		"unprognostic (1.83e-1)"	"unprognostic (3.09e-1)"	"unprognostic (2.11e-2)"	"unprognostic (6.74e-3)"	"unprognostic (1.04e-1)"	"unprognostic (2.03e-1)"	"unprognostic (4.12e-3)"	"unprognostic (1.10e-2)"	0.0	21.4	0.0	0.1	0.0	0.0	0.2	0.2	0.1	0.0	0.0	0.5	76.9	0.0	0.0	0.0	0.0	10.1	12.9	0.0	0.0	33.8	142.4	2.4	0.0	0.0	0.0	0.0	30.6	1.6	0.3	0.0	0.1	0.0	0.4	0.2	0.0	0.0	2.7	0.0	26.5	0.0	0.0	11.5	26.4	1.1	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	78.2	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.1	0.1	0.2	0.0	0.0	0.0	0.3	0.0	0.3	2.3	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	3.2	15.8	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	8.4	97.2	0.7	12.9	0.0	0.0	0.0	0.9	52.8	31.3	0.4	0.1	0.0	0.2	24.4	8.0	0.0	42.4	0.0	0.3	90.2	0.0	0.0	3.0	2.5	173.4	0.1	28.6	0.0	7.6	16.2	3.8	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	15.2	0.3	0.0	0.2	0.0	49.8	0.1	0.0	0.4	0.0	0.0	0.2	0.8	0.1	0.0	0.0	0.0	0.3	0.1	11.0	0.2
NR1D1	"ear-1, hRev, Rev-ErbAalpha, REVERBA, REVERBalpha, THRA1, THRAL"	ENSG00000126368	"Nuclear receptor subfamily 1 group D member 1"	P20393	17	40092793-40100589	"Metabolic proteins, Nuclear receptors, Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Differentiation, Transcription, Transcription regulation"	"Activator, DNA-binding, Receptor, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skin 1: 325.5"	"Cell type enhanced"	"Detected in all"		"Squamous epithelial cells: 95.5;Suprabasal keratinocytes: 81.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"MAIT T-cell: 18.5"	"Group enriched"	"Detected in many"	6	"monocytes: 5.5;T-cells: 18.5"	"Cell line enhanced"	"Detected in all"		"Karpas-707: 60.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007935	Uncertain		Supported	"Nuclear bodies"		NA	Yes			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 31: Skin - Epidermis development"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 61: Squamous epithelial cells - Keratinization"	"Nuclear bodies"		"HPA007935: AB_10601277"	"unprognostic (1.38e-2)"	"unprognostic (3.46e-2)"	"prognostic unfavorable (1.94e-4)"	"unprognostic (2.53e-1)"	"unprognostic (2.24e-2)"	"unprognostic (1.05e-1)"	"unprognostic (4.50e-2)"	"unprognostic (1.03e-1)"	"prognostic favorable (1.36e-4)"	"unprognostic (1.93e-3)"	"unprognostic (9.93e-3)"	"unprognostic (2.73e-1)"	"unprognostic (9.15e-3)"	"unprognostic (4.54e-3)"	"unprognostic (2.49e-1)"	"unprognostic (3.09e-1)"	"unprognostic (1.34e-1)"	72.3	53.7	23.5	6.3	27.0	5.4	63.1	52.9	49.7	109.6	10.6	53.3	14.3	35.8	4.5	42.5	27.7	7.1	60.8	24.9	17.2	38.0	43.2	49.2	9.3	18.1	20.9	71.3	24.3	9.0	32.0	6.0	15.9	40.5	4.0	50.4	52.9	16.3	99.0	325.5	23.0	7.5	12.9	11.6	31.5	12.5	34.0	6.3	32.1	38.1	5.4	42.5	96.5	25.2	5.5	7.8	1.6	6.2	9.0	6.2	2.2	11.9	19.5	3.9	4.9	5.1	19.5	6.7	6.9	13.8	12.9	15.4	4.1	18.0	2.9	5.6	4.1	4.8	7.9	13.5	14.6	7.2	6.9	13.5	12.8	13.3	28.2	12.6	4.9	7.7	7.2	60.6	3.8	3.8	10.7	6.1	3.0	10.8	12.3	7.5	2.2	20.7	5.4	4.9	5.1	2.9	7.6	9.7	12.4	2.7	4.6	5.8	4.7	17.2	16.7	14.1	9.5	21.5	35.7	2.6	23.4	4.0	13.6	0.0	0.5	0.0	4.4	2.0	18.5	1.7	5.5	6.4	1.1	2.1	4.8	3.5	0.2	1.0	5.5	1.4	8.0	1.8	23.5	27.0	52.9	49.7	24.9	17.2	18.1	20.9	15.9	12.9	34.0	25.2	16.4	3.2	2.0	17.3	5.7	64.5	47.5	20.5	67.2	71.4	9.4	15.1	5.7	8.6	11.9	1.8	4.2	2.6	4.9	26.0	7.9	16.1	2.3	25.4	30.6	18.6	8.3	3.6	7.1	11.8	1.2	26.5	31.1	64.2	2.5	2.7	6.8	31.8	2.5	42.1	6.2	7.2	8.2	3.4	19.4	1.5	21.8	7.7	19.6	8.4	1.2	39.0	5.2	5.0	1.2	26.0	14.7	38.7	10.5	35.4	58.8	7.9	5.0	29.7	6.6	9.6	19.4	2.0	11.1	95.5	81.1	2.3	11.9	13.7	6.0	28.7
NR2C1	"TR2, TR2-11"	ENSG00000120798	"Nuclear receptor subfamily 2 group C member 1"	P13056	12	95020229-95073628	"Nuclear receptors, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Receptor, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035040, HPA035041, HPA067767"	Supported		Supported	"Nucleoplasm,Cell Junctions,Cytosol"		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 51: Non-specific - Unknown function"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm	"Cell Junctions, Cytosol"	"HPA035040: AB_2674426, HPA035041: AB_2674427, HPA067767: AB_2685898"	"unprognostic (2.44e-1)"	"unprognostic (8.04e-3)"	"unprognostic (3.17e-2)"	"unprognostic (2.51e-1)"	"unprognostic (3.56e-3)"	"unprognostic (3.01e-2)"	"prognostic unfavorable (5.18e-5)"	"unprognostic (1.30e-2)"	"unprognostic (1.29e-2)"	"unprognostic (1.86e-1)"	"unprognostic (3.83e-2)"	"unprognostic (4.56e-2)"	"prognostic unfavorable (1.03e-6)"	"unprognostic (2.31e-1)"	"unprognostic (1.42e-1)"	"unprognostic (2.16e-1)"	"prognostic favorable (5.62e-5)"	8.3	10.4	4.9	5.0	5.6	9.3	7.7	14.0	9.3	9.3	8.2	8.6	5.6	10.3	9.9	5.4	10.2	4.4	10.0	5.1	5.1	6.6	10.0	8.6	5.5	4.7	4.9	9.9	8.2	6.1	7.2	5.8	5.6	6.7	6.2	15.6	5.2	7.5	14.3	6.1	7.6	7.8	4.6	9.2	6.1	11.9	5.6	5.7	11.9	5.5	5.3	8.1	7.4	6.9	11.4	13.9	23.0	10.2	5.8	10.0	30.5	10.9	7.9	10.6	9.9	12.2	6.2	13.8	3.8	7.3	6.8	11.8	10.7	8.6	8.1	6.0	23.1	16.7	11.5	15.4	11.1	11.3	7.0	10.2	7.0	7.9	9.5	13.3	11.6	16.8	12.9	5.2	12.9	8.3	12.4	26.0	14.5	9.1	24.0	11.7	15.0	8.1	12.3	13.9	11.1	8.8	17.6	7.4	8.4	11.8	12.9	7.5	10.9	8.6	8.4	10.7	6.2	7.7	13.1	13.0	2.1	13.0	4.2	0.3	2.4	2.1	3.9	2.6	5.0	2.0	3.1	3.3	3.7	2.3	4.0	2.8	1.5	2.1	2.3	3.6	2.3	2.3	4.9	5.6	14.0	9.3	5.1	5.1	4.7	4.9	5.6	4.6	5.6	6.9	18.7	35.3	15.4	28.4	14.4	8.3	14.4	7.8	15.4	44.8	7.6	7.5	18.5	8.6	5.6	11.0	18.8	15.3	19.9	10.3	3.9	11.6	25.2	14.8	23.3	15.5	7.2	15.6	55.4	9.4	12.7	17.4	16.3	18.8	10.1	28.0	13.2	12.7	9.5	25.2	73.4	11.4	12.2	11.1	9.5	6.4	43.8	10.9	14.2	34.7	10.7	14.9	12.3	26.2	51.1	18.7	9.9	30.1	13.7	9.4	5.8	8.1	19.6	49.6	6.6	17.3	14.6	67.0	25.9	12.1	7.4	7.8	15.0	18.0	13.3	20.2
NR2C2AP	TRA16	ENSG00000184162	"Nuclear receptor 2C2 associated protein"	Q86WQ0	19	19201409-19203414	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Prostatic glandular cells: 67.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042054, HPA055653"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 30: Non-specific - Translation"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 32: Non-specific - Translation"	Nucleoplasm		"HPA042054: AB_10965022, HPA055653: AB_2682877"	"unprognostic (9.54e-2)"	"unprognostic (2.93e-3)"	"prognostic unfavorable (8.53e-4)"	"unprognostic (2.36e-2)"	"unprognostic (6.81e-2)"	"unprognostic (6.26e-3)"	"prognostic unfavorable (5.63e-5)"	"unprognostic (1.60e-2)"	"unprognostic (1.53e-1)"	"unprognostic (8.77e-2)"	"unprognostic (3.65e-3)"	"unprognostic (5.89e-2)"	"unprognostic (7.62e-3)"	"unprognostic (1.17e-2)"	"unprognostic (5.99e-2)"	"prognostic favorable (1.65e-4)"	"unprognostic (2.10e-2)"	14.5	10.0	13.8	12.5	14.2	7.6	15.6	14.3	14.2	14.6	12.6	15.0	8.2	14.8	13.7	17.0	14.9	6.7	10.7	14.2	13.8	16.2	10.6	9.5	13.6	14.4	14.1	16.4	15.3	7.8	8.2	7.6	14.4	14.8	11.0	3.5	13.3	10.6	12.6	21.0	12.4	11.4	14.5	13.4	13.4	5.5	14.1	10.2	11.1	7.8	13.6	17.8	14.6	15.6	50.7	29.2	13.6	28.9	11.1	11.1	52.7	28.3	16.0	37.9	35.8	19.7	60.4	27.3	77.2	15.0	26.5	44.2	36.0	37.3	23.1	24.3	39.0	15.6	18.0	21.9	12.9	30.5	23.2	11.3	45.1	26.3	35.4	10.7	15.2	31.0	28.4	35.0	22.8	130.0	51.2	27.6	24.4	72.9	58.8	36.3	22.0	53.3	23.5	26.4	45.2	20.7	24.3	47.1	37.0	16.5	25.6	18.9	12.2	24.5	23.3	61.7	54.7	20.7	32.4	36.3	28.5	51.3	33.2	2.6	14.9	1.5	31.4	21.5	41.2	43.6	40.7	30.4	12.6	42.8	42.3	39.7	2.7	27.4	17.4	24.7	37.7	26.3	13.8	14.2	14.3	14.2	14.2	13.8	14.4	14.1	14.4	14.5	14.1	15.6	14.7	0.0	9.4	2.3	19.2	31.7	41.3	19.8	38.1	3.8	26.8	31.8	2.5	5.7	12.3	7.3	0.0	24.8	17.2	10.3	7.9	20.8	0.7	8.9	7.8	13.5	4.8	8.8	2.9	16.2	34.3	12.1	6.6	11.4	14.0	14.0	5.3	4.5	18.5	8.4	1.7	12.8	10.2	5.0	11.0	1.2	16.4	9.3	10.6	1.0	15.2	5.5	11.3	2.0	2.4	19.0	5.4	13.5	8.0	67.8	7.6	10.9	9.2	3.9	0.0	11.7	10.9	4.6	16.7	26.3	25.1	12.6	16.3	8.7	17.9	36.0
NR2F6	"EAR-2, EAR2, ERBAL2"	ENSG00000160113	"Nuclear receptor subfamily 2 group F member 6"	P10588	19	17231883-17245919	"Nuclear receptors, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Receptor, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 104.0"	"Cell type enhanced"	"Detected in all"		"Distal enterocytes: 206.0;Hepatocytes: 148.4;Horizontal cells: 151.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"BEWO: 187.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB079917			Supported	"Nuclear speckles,Cytosol"		NA	Yes			"Cluster 15: NK-cells - Transcription"	"Cluster 85: Liver - Metabolism"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Nuclear speckles"	Cytosol	"CAB079917: AB_2635238"	"unprognostic (1.48e-1)"	"unprognostic (1.30e-1)"	"unprognostic (2.17e-1)"	"prognostic unfavorable (4.36e-4)"	"unprognostic (1.08e-1)"	"unprognostic (1.12e-1)"	"unprognostic (3.07e-1)"	"unprognostic (3.67e-1)"	"unprognostic (7.20e-2)"	"unprognostic (1.02e-2)"	"unprognostic (2.39e-1)"	"unprognostic (6.62e-2)"	"unprognostic (9.68e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.29e-2)"	"unprognostic (7.28e-3)"	"unprognostic (1.37e-3)"	17.0	21.8	19.3	5.0	16.9	1.2	17.7	15.8	22.8	18.8	23.8	39.4	31.2	19.8	14.3	47.4	19.1	2.9	39.0	16.8	20.2	32.8	104.0	17.5	1.7	23.9	21.4	12.1	44.6	10.4	22.0	13.1	18.6	25.3	9.3	6.6	28.0	9.8	27.9	23.9	25.4	4.5	17.5	9.9	38.6	14.3	20.4	1.8	21.6	9.9	2.7	25.5	22.2	15.6	65.0	38.1	20.3	37.2	7.9	8.8	187.2	35.7	12.9	15.2	13.1	26.1	55.5	15.2	108.8	16.0	8.9	31.9	15.6	20.5	6.7	20.4	90.0	13.9	24.4	47.3	17.3	6.7	18.8	11.6	23.2	7.0	11.3	15.9	9.5	6.8	33.3	3.7	6.7	34.7	5.9	24.7	55.8	48.1	58.5	11.6	12.7	13.2	21.2	41.3	16.3	46.7	19.9	68.7	43.1	19.6	38.2	21.1	15.8	10.7	26.1	20.6	28.8	21.0	7.9	10.9	13.1	9.9	13.4	0.0	0.6	1.1	1.7	0.0	1.4	0.3	2.3	1.5	1.1	2.3	3.8	1.3	0.1	4.6	0.1	0.5	2.4	0.8	19.3	16.9	15.8	22.8	16.8	20.2	23.9	21.4	18.6	17.5	20.4	15.6	21.2	9.6	22.9	6.8	4.7	10.6	14.1	12.8	11.4	71.9	65.9	54.7	36.4	34.3	20.8	25.8	77.2	65.4	3.7	206.0	29.4	23.2	13.3	51.7	32.5	20.8	46.0	4.4	7.2	47.8	65.3	17.6	47.4	60.0	1.3	26.1	15.0	148.4	16.3	151.4	7.6	80.2	24.4	4.7	4.6	6.0	17.7	5.2	10.6	8.4	2.4	45.7	1.0	6.6	5.8	50.4	78.5	18.8	1.2	23.2	72.3	30.2	25.9	54.3	6.6	17.3	24.5	1.6	9.0	24.3	10.5	79.8	4.2	44.3	75.3	18.2
NR3C1	"GR, GRL"	ENSG00000113580	"Nuclear receptor subfamily 3 group C member 1"	P04150	5	143277931-143435512	"Disease related genes, FDA approved drug targets, Human disease related genes, Nuclear receptors, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Apoptosis, Cell cycle, Cell division, Chromosome partition, Mitosis, Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding, Receptor, RNA-binding"	"Disease variant, FDA approved drug targets, Pseudohermaphroditism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 411.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004248, CAB010435"	Supported		Supported	Nucleoplasm,Mitochondria,Cytosol		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 65: Plasmacytoid DCs - Unknown function"	"Nucleoplasm, Cytosol"	Mitochondria	"CAB010435: AB_2155784, HPA004248: AB_1078976"	"unprognostic (1.38e-1)"	"unprognostic (1.93e-1)"	"unprognostic (1.17e-1)"	"prognostic unfavorable (3.64e-5)"	"unprognostic (1.43e-2)"	"unprognostic (2.74e-1)"	"unprognostic (4.19e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.46e-2)"	"unprognostic (3.87e-2)"	"unprognostic (2.15e-1)"	"unprognostic (6.85e-2)"	"prognostic unfavorable (1.72e-6)"	"unprognostic (9.06e-3)"	"unprognostic (1.02e-1)"	"unprognostic (2.43e-3)"	"unprognostic (2.45e-2)"	35.3	11.8	15.2	22.6	18.1	49.4	25.5	34.0	24.7	19.7	18.2	13.7	19.2	18.8	13.6	25.7	18.8	21.1	24.2	14.9	25.0	19.2	39.8	31.9	25.6	18.1	14.9	21.1	14.7	33.8	16.2	46.9	16.1	19.7	14.5	9.5	16.1	20.0	45.0	20.4	18.0	23.8	15.0	24.5	16.0	11.1	21.6	40.0	25.6	40.1	27.3	18.2	16.0	28.5	30.4	60.6	4.4	0.1	38.2	42.3	5.2	46.5	55.3	39.3	45.1	4.5	39.7	26.8	20.8	68.6	46.0	28.1	0.3	36.6	48.3	15.2	21.0	6.9	77.0	13.5	35.7	28.1	20.6	30.8	46.3	64.7	62.5	49.0	15.0	12.1	10.3	98.8	35.1	10.9	16.7	20.0	11.9	5.1	13.0	6.0	41.4	58.0	11.5	2.1	8.0	6.1	81.3	11.7	19.4	4.9	5.3	39.8	35.8	94.7	18.7	45.7	35.9	20.1	19.7	41.5	49.7	28.5	33.6	67.4	21.3	38.9	18.3	24.2	15.1	15.9	18.6	17.9	28.5	22.3	17.8	17.2	68.4	23.1	23.6	25.9	12.8	17.3	15.2	18.1	34.0	24.7	14.9	25.0	18.1	14.9	16.1	15.0	21.6	28.5	152.3	67.3	69.1	71.2	134.1	58.8	35.9	37.9	79.6	13.1	39.0	55.8	43.4	57.2	41.2	25.8	16.7	48.9	158.3	22.9	17.6	30.8	165.6	8.1	30.1	82.3	28.1	55.9	411.4	33.3	39.5	112.2	23.9	10.4	89.3	7.5	63.5	193.9	53.2	37.0	169.5	4.1	10.2	66.3	99.2	144.1	63.0	97.4	53.4	241.7	87.6	34.6	83.4	240.3	237.5	35.9	17.9	71.5	115.1	46.2	25.3	67.9	37.9	65.0	151.2	181.9	105.0	24.5	40.1	57.4	56.3	36.5	204.5	12.6	12.9	14.3
NR3C2	"MLR, MR"	ENSG00000151623	"Nuclear receptor subfamily 3 group C member 2"	P08235	4	148078762-148444698	"Disease related genes, FDA approved drug targets, Human disease related genes, Nuclear receptors, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Receptor"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 265.8;Excitatory neurons: 275.7;Inhibitory neurons: 269.9;Microglial cells: 176.1;Oligodendrocyte precursor cells: 230.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"MAIT T-cell: 1.8"	"Lineage enriched"	"Detected in single"	6	"T-cells: 1.8"	"Cell line enhanced"	"Detected in some"		"hTERT-RPE1: 9.7;HUVEC TERT2: 6.0;Karpas-707: 6.9;PC-3: 6.1;RPTEC TERT1: 7.8;TIME: 8.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009155, HPA074979"	Enhanced		Supported	Nucleoplasm		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm		"CAB009155: AB_2155949, HPA074979: AB_2686724"	"unprognostic (2.75e-3)"	"unprognostic (2.63e-2)"	"unprognostic (6.70e-3)"	"unprognostic (1.52e-1)"	"unprognostic (4.09e-1)"	"unprognostic (7.82e-3)"	"unprognostic (1.04e-2)"	"unprognostic (1.11e-2)"	"unprognostic (1.14e-1)"	"unprognostic (4.35e-2)"	"unprognostic (4.97e-2)"	"unprognostic (2.39e-1)"	"prognostic favorable (3.10e-11)"	"unprognostic (1.42e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.27e-1)"	4.6	4.5	4.5	3.7	5.6	1.0	4.8	9.2	11.7	5.6	4.0	21.8	8.7	6.2	3.8	3.1	5.9	5.8	9.4	13.7	3.5	12.1	8.5	7.3	3.1	3.0	5.9	14.7	7.6	12.5	5.5	1.8	3.0	3.7	26.2	8.5	10.7	4.3	12.1	3.0	15.3	4.9	3.2	5.2	8.3	4.3	6.1	2.9	19.7	14.1	2.1	5.9	3.3	4.8	0.0	0.0	0.0	0.0	0.4	0.3	0.4	0.0	0.0	0.0	0.4	0.0	0.0	1.4	2.6	1.0	0.2	0.0	1.3	0.7	0.1	0.2	2.3	0.2	0.6	0.0	0.0	1.7	0.3	0.1	0.0	0.0	0.0	9.7	6.0	0.9	0.0	6.9	2.0	0.0	0.0	0.0	0.1	1.2	6.1	0.5	0.0	0.1	7.8	0.1	0.1	0.0	0.0	1.4	0.6	0.1	0.7	0.0	8.7	4.3	2.5	0.1	0.8	0.0	0.0	0.1	1.4	0.6	1.0	0.0	0.0	0.0	0.5	0.0	1.8	0.1	0.7	0.4	0.0	0.2	1.0	1.1	0.0	0.0	0.2	0.0	0.2	0.1	4.5	5.6	9.2	11.7	13.7	3.5	3.0	5.9	3.0	3.2	6.1	4.8	11.9	28.9	13.9	265.8	5.1	2.0	2.2	0.4	6.2	10.3	6.2	5.8	20.3	7.2	6.7	11.0	18.8	0.9	1.0	76.1	9.8	3.0	68.2	2.1	1.1	8.2	18.0	0.0	275.7	5.8	0.5	5.9	13.7	2.6	5.7	6.4	8.6	7.0	0.6	13.5	269.9	44.6	6.1	2.9	2.4	41.8	4.4	1.7	7.2	176.1	1.2	8.1	1.0	230.2	95.7	3.2	26.8	3.8	0.8	1.8	26.4	2.3	4.7	9.6	0.0	14.7	5.1	1.8	5.6	2.6	1.7	0.1	4.9	1.8	21.5	2.1
NR4A1	"GFRP1, HMR, N10, NAK-1, NGFIB, NUR77, TR3"	ENSG00000123358	"Nuclear receptor subfamily 4 group A member 1"	P22736	12	52022832-52059507	"Nuclear receptors, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 879.9;Basal squamous epithelial cells: 729.1;Glandular and luminal cells: 739.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	12	"intermediate monocyte: 36.7;non-classical monocyte: 54.2"	"Lineage enriched"	"Detected in many"	15	"monocytes: 54.2"	"Cell line enhanced"	"Detected in many"		"HeLa: 78.4;MCF7: 86.9;SK-BR-3: 80.5;SK-MEL-30: 150.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA059742, HPA070142"	Approved		Supported	"Nucleoplasm,Nuclear membrane,Cytosol"		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm	"Nuclear membrane, Cytosol"	"HPA059742: AB_2684119, HPA070142: AB_2732149"	"unprognostic (2.40e-2)"	"unprognostic (2.57e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.26e-2)"	"unprognostic (1.94e-1)"	"unprognostic (1.92e-2)"	"unprognostic (2.22e-3)"	"unprognostic (1.90e-1)"	"unprognostic (1.16e-1)"	"prognostic favorable (6.99e-4)"	"unprognostic (3.41e-2)"	"unprognostic (2.71e-1)"	"unprognostic (1.84e-2)"	"unprognostic (8.89e-3)"	709.0	562.0	21.7	96.9	19.6	34.5	227.6	141.0	79.9	151.6	44.4	227.1	29.7	124.6	7.2	133.6	495.8	377.4	671.5	21.5	28.5	203.5	95.5	290.9	45.9	21.8	17.4	876.0	88.4	86.9	442.4	41.9	21.0	303.2	71.4	28.3	146.5	85.9	294.1	225.7	111.9	144.2	13.0	36.0	264.6	32.4	21.5	59.1	301.7	71.9	3.8	296.5	186.0	22.6	5.7	28.2	5.6	10.2	4.0	1.3	21.3	5.4	10.8	4.3	6.0	28.2	5.4	5.9	2.3	9.7	4.2	3.2	16.9	2.6	2.5	0.3	6.0	8.1	78.4	8.3	4.1	3.1	26.5	0.8	3.3	4.2	0.3	2.9	1.3	6.6	7.9	1.4	0.3	86.9	2.2	8.5	15.3	9.2	3.1	2.7	0.9	14.6	0.2	2.2	4.6	14.0	17.4	80.5	150.9	3.8	5.1	9.1	0.0	4.2	13.3	2.8	4.7	46.8	25.2	13.0	2.8	2.3	23.7	0.3	1.3	0.0	0.2	36.7	0.3	0.9	0.1	0.1	3.7	0.8	0.5	0.1	0.4	0.2	54.2	0.3	0.2	2.0	21.7	19.6	141.0	79.9	21.5	28.5	21.8	17.4	21.0	13.0	21.5	22.6	328.9	240.4	879.9	4.2	259.5	445.7	289.5	211.3	729.1	34.8	353.8	384.9	9.8	65.8	178.4	86.5	125.1	64.5	102.1	195.7	5.9	19.9	19.7	346.9	183.5	209.6	345.3	16.0	17.4	12.3	34.7	378.8	380.7	739.1	674.8	45.3	227.0	10.1	54.1	16.8	5.9	492.5	105.8	64.4	527.4	7.3	30.4	283.0	371.8	8.4	6.3	85.4	0.0	6.6	1.3	5.1	277.2	23.7	244.1	160.6	74.6	0.9	92.6	94.6	124.9	268.0	379.3	2.5	13.4	200.2	472.8	110.5	135.1	85.1	259.0	86.8
NR4A2	"HZF-3, NOT, NURR1, RNR1, TINUR"	ENSG00000153234	"Nuclear receptor subfamily 4 group A member 2"	P43354	2	156324437-156342348	"Cancer-related genes, Human disease related genes, Nuclear receptors, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Receptor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 129.3;bone marrow: 130.8;ovary: 129.2"	"Cell type enhanced"	"Detected in many"		"B-cells: 511.7;dendritic cells: 410.4;Langerhans cells: 782.3;Macrophages: 577.5;T-cells: 465.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 6.5"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HeLa: 16.0;HMC-1: 10.9;SK-MEL-30: 8.1;U-266/70: 14.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000543, CAB010481"	Uncertain		Supported	"Nuclear speckles"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 20: HeLa - Mitochondria"	"Cluster 41: Macrophages - Immune response"	"Nuclear speckles"		"CAB010481: AB_2298676, HPA000543: AB_1854631"	"unprognostic (4.26e-2)"	"unprognostic (2.14e-1)"	"unprognostic (3.42e-2)"	"unprognostic (4.10e-2)"	"unprognostic (3.04e-2)"	"unprognostic (5.26e-2)"	"unprognostic (2.30e-1)"	"unprognostic (6.14e-2)"	"unprognostic (8.63e-2)"	"unprognostic (3.88e-2)"	"unprognostic (1.60e-2)"	"unprognostic (2.89e-1)"	"unprognostic (2.39e-2)"	"unprognostic (3.58e-2)"	"unprognostic (3.43e-1)"	"unprognostic (9.29e-3)"	"unprognostic (1.11e-1)"	40.0	129.3	4.3	24.5	44.1	130.8	15.6	36.2	8.8	18.3	5.9	9.5	2.9	15.0	1.7	11.4	28.2	32.7	36.6	15.1	3.6	19.2	20.2	18.8	6.3	3.2	9.2	129.2	9.2	8.8	54.0	5.2	2.8	25.6	18.7	5.3	19.2	15.5	11.6	12.8	7.8	14.5	0.9	4.6	19.9	5.6	2.5	9.7	15.2	7.8	1.4	50.9	14.0	6.4	0.9	1.3	0.5	1.8	3.2	0.7	0.9	1.1	5.5	0.4	1.3	0.0	3.3	0.0	1.2	0.4	0.4	1.6	2.6	0.7	0.4	1.3	1.4	1.0	16.0	0.0	0.6	0.7	10.9	0.6	1.2	0.4	0.4	2.1	0.3	0.0	1.6	1.0	1.1	1.9	0.0	0.8	2.1	1.5	0.8	0.2	0.7	3.3	0.6	0.8	2.7	0.1	2.6	4.1	8.1	0.3	0.2	1.0	0.7	2.9	0.8	0.7	0.4	14.2	1.8	0.0	5.3	1.0	7.0	1.9	1.7	2.4	1.0	0.3	0.5	0.4	0.3	0.5	1.9	0.3	0.5	0.2	6.5	0.0	0.7	0.0	0.4	0.5	4.3	44.1	36.2	8.8	15.1	3.6	3.2	9.2	2.8	0.9	2.5	6.4	70.7	25.6	124.7	7.8	511.7	218.6	25.8	87.5	298.7	11.8	120.8	160.1	11.9	17.2	58.3	71.7	50.1	4.7	410.4	35.0	0.0	13.1	36.7	209.6	33.9	111.9	206.4	12.0	5.8	9.1	6.5	164.9	103.9	349.7	349.3	4.3	45.0	6.8	125.1	0.0	0.8	95.4	42.7	161.1	782.3	37.2	4.1	577.5	241.9	5.6	7.9	1.6	3.1	4.0	2.3	11.7	41.9	0.7	203.5	49.1	25.9	0.4	54.6	33.4	13.1	63.0	169.8	1.8	3.3	230.2	213.7	9.9	465.1	34.4	57.5	29.5
NR5A1	"AD4BP, ELP, FTZ1, FTZF1, hSF-1, SF-1, SF1"	ENSG00000136931	"Nuclear receptor subfamily 5 group A member 1"	Q13285	9	124481236-124507420	"Disease related genes, Human disease related genes, Nuclear receptors, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Receptor"	"Disease variant, Premature ovarian failure"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"adrenal gland: 188.3;lymphoid tissue: 142.8"	"Group enriched"	"Detected in some"	8	"Granulosa cells: 47.9;Theca cells: 180.1"	"Group enriched"	"Detected in some"	5	"head and neck cancer: 1.7;ovarian cancer: 2.4;testis cancer: 2.6"	"Region enriched"	"Detected in some"	9	"thalamus: 18.3"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEL: 82.9;Hep G2: 59.2;K-562: 20.6"	"Region enriched"	"Detected in single"	52	"hypothalamus: 5.2"	"Region enriched"	"Detected in single"	8	"hypothalamus: 1.2"	HPA079181			Supported	Nucleoplasm,Cytosol		NA	NA				"Cluster 64: Macrophages - Immune response"	"Cluster 36: HEL - Hemostasis"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	Cytosol	"HPA079181: "	"unprognostic (1.66e-1)"	"unprognostic (3.08e-1)"	"unprognostic (6.13e-5)"	"unprognostic (2.32e-7)"	"unprognostic (3.95e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.60e-2)"	"unprognostic (9.74e-2)"	"unprognostic (4.14e-2)"			"unprognostic (4.75e-3)"	"unprognostic (1.14e-1)"		"unprognostic (1.49e-2)"	0.1	188.3	0.1	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.2	2.0	0.0	0.1	0.0	0.1	0.0	0.0	35.8	0.0	0.0	21.1	0.0	0.3	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	142.8	0.1	14.1	18.3	0.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	82.9	0.0	59.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.6	0.1	0.0	0.0	0.6	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.1	0.2	2.0	0.0	0.0	0.3	0.0	18.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.9	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	47.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	11.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.5	0.0	0.0	0.0	0.0	0.0	0.0	13.1	0.0	1.4	0.3	0.2	0.0	0.0	0.0	0.0	180.1	0.0	0.0
NRAS	N-ras	ENSG00000213281	"NRAS proto-oncogene, GTPase"	P01111	1	114704469-114716771	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins"		Hydrolase	"Cancer-related genes, Disease variant, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010157, HPA049830, CAB079912"	Uncertain		Supported	"Plasma membrane"		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	"Plasma membrane"		"CAB010157: AB_632073, CAB079912: AB_2784586, HPA049830: AB_2680903"	"unprognostic (4.75e-2)"	"unprognostic (2.81e-1)"	"unprognostic (1.09e-3)"	"unprognostic (2.11e-2)"	"unprognostic (8.59e-3)"	"unprognostic (1.14e-1)"	"prognostic unfavorable (3.03e-7)"	"unprognostic (7.76e-3)"	"unprognostic (1.57e-2)"	"unprognostic (1.01e-3)"	"prognostic unfavorable (1.36e-4)"	"unprognostic (6.60e-3)"	"prognostic unfavorable (7.87e-4)"	"unprognostic (2.68e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.16e-1)"	"unprognostic (3.33e-2)"	19.0	9.1	10.3	25.7	11.2	58.5	18.0	11.5	12.3	12.5	8.6	27.8	21.5	12.4	7.8	20.7	10.3	17.2	8.3	10.2	12.2	20.9	24.9	18.5	30.4	12.3	12.1	9.6	11.4	9.0	4.3	28.3	12.3	11.4	26.6	6.6	10.9	7.1	7.7	19.8	22.5	14.1	11.7	18.6	21.8	9.6	11.4	39.0	16.1	7.8	29.7	22.2	8.6	13.4	93.7	24.9	65.2	24.9	26.4	56.3	46.5	43.5	48.4	79.5	89.0	50.4	33.9	70.4	56.3	58.9	55.4	26.0	88.2	70.6	113.4	96.5	34.2	47.8	34.5	60.2	52.3	120.0	71.0	51.1	56.1	91.5	66.2	25.0	102.8	54.6	77.3	78.5	71.0	248.9	83.5	46.4	111.0	30.2	17.9	62.9	116.0	44.1	70.6	49.5	39.4	59.0	44.7	36.4	107.1	75.4	31.9	96.2	79.2	43.3	82.2	81.5	90.3	137.7	101.6	81.6	86.4	64.6	159.0	38.7	12.8	12.6	11.7	19.2	10.5	12.8	9.3	11.6	12.6	10.5	9.9	12.9	3.4	15.5	17.6	9.6	13.4	13.1	10.3	11.2	11.5	12.3	10.2	12.2	12.3	12.1	12.3	11.7	11.4	13.4	22.7	16.0	16.5	8.1	25.9	30.7	31.2	23.1	15.4	5.2	18.5	13.6	5.6	18.6	19.3	22.0	8.4	22.4	27.7	49.2	13.7	34.1	3.9	22.9	24.7	29.2	24.6	31.6	5.8	31.5	50.4	16.1	29.0	38.0	31.1	22.2	33.2	29.7	49.2	5.0	5.2	28.1	30.5	44.9	30.7	5.9	8.1	30.4	23.2	9.4	41.6	7.8	22.6	5.0	8.1	51.4	32.9	6.4	39.6	30.6	28.1	39.4	23.1	3.3	6.6	12.8	15.3	7.3	15.4	24.6	36.2	31.2	21.9	13.8	28.8	40.2
NRBP1	"BCON3, MADM, MUDPNP, NRBP"	ENSG00000115216	"Nuclear receptor binding protein 1"	Q9UHY1	2	27427790-27442259	"Enzymes, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 234.3;Extravillous trophoblasts: 231.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029527, CAB033078"	Supported		Supported	Cytosol		NA	NA		39000	"Cluster 2: Granulocytes - Unknown function"	"Cluster 59: Non-specific - Translation"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 29: Early spermatids - Spermatogenesis"	Cytosol		"CAB033078: AB_2154375, HPA029527: AB_10601379"	"unprognostic (4.95e-3)"	"unprognostic (1.29e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.38e-1)"	"unprognostic (3.62e-2)"	"unprognostic (3.95e-1)"	"prognostic unfavorable (2.22e-5)"	"unprognostic (7.36e-2)"	"unprognostic (1.44e-1)"	"unprognostic (6.11e-2)"	"unprognostic (3.13e-1)"	"unprognostic (2.60e-1)"	"prognostic unfavorable (5.84e-5)"	"unprognostic (1.26e-1)"	"unprognostic (2.69e-1)"	"unprognostic (2.75e-2)"	"unprognostic (3.48e-3)"	59.7	49.6	38.1	49.4	38.9	109.1	55.2	39.3	42.1	76.1	44.3	72.0	52.2	69.7	43.1	99.9	55.1	53.5	57.6	37.7	44.5	44.7	55.2	50.3	54.0	43.1	44.2	63.7	51.0	44.5	46.9	83.0	45.6	51.6	46.5	47.6	57.2	60.7	126.2	70.7	52.4	75.6	36.8	51.2	51.8	71.1	42.1	51.9	42.4	90.3	67.2	67.3	70.8	37.5	123.7	121.0	98.1	130.9	148.2	146.6	119.0	114.8	143.1	159.8	123.5	123.5	49.1	35.5	83.7	182.9	158.6	82.9	98.4	102.9	102.3	70.0	61.4	70.8	47.0	163.5	124.1	40.0	91.1	120.8	127.3	163.7	108.6	103.9	178.5	38.8	40.5	54.8	142.3	185.6	53.0	96.1	124.0	108.5	75.7	40.5	209.5	40.0	113.8	84.1	26.3	74.1	135.6	96.5	72.4	108.8	53.3	43.9	143.0	140.6	138.5	85.1	94.2	114.3	122.7	42.4	109.8	68.6	71.9	203.6	88.6	187.0	96.7	118.0	85.6	59.3	82.3	87.9	90.2	55.1	73.9	77.1	117.9	91.0	111.5	57.4	107.8	117.4	38.1	38.9	39.3	42.1	37.7	44.5	43.1	44.2	45.6	36.8	42.1	37.5	47.3	6.4	21.4	15.7	46.4	57.2	57.8	73.9	56.9	37.8	34.3	31.5	25.9	28.6	47.2	35.0	35.5	155.7	72.6	67.4	31.3	88.7	234.3	47.5	66.8	54.9	28.1	42.7	14.8	95.9	231.5	61.8	30.1	64.1	20.8	39.3	47.2	38.8	77.3	28.6	15.9	42.7	38.7	35.2	44.7	38.6	46.0	46.6	30.2	8.4	67.2	46.8	51.5	13.0	17.0	100.0	45.6	60.5	72.2	49.7	67.4	52.6	36.5	56.3	32.9	37.4	77.6	92.8	106.8	50.3	52.4	203.2	67.2	36.9	30.8	58.8
NRDE2	"C14orf102, FLJ14051"	ENSG00000119720	"NRDE-2, necessary for RNA interference, domain containing"	Q9H7Z3	14	90267860-90331969	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell cycle, Cell division, DNA damage, Mitosis, mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 7.3"	"Cell type enhanced"	"Detected in many"		"Rod photoreceptor cells: 111.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047050, HPA050583"	Uncertain		Supported	Nucleoplasm,Mitochondria		NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 20: HeLa - Mitochondria"	"Cluster 52: Non-specific - Transcription"	"Nucleoplasm, Mitochondria"		"HPA047050: AB_2679917, HPA050583: AB_2681182"	"unprognostic (1.24e-2)"	"unprognostic (3.58e-1)"	"unprognostic (1.24e-1)"	"unprognostic (3.02e-1)"	"unprognostic (4.51e-2)"	"unprognostic (1.08e-2)"	"unprognostic (9.60e-2)"	"unprognostic (8.91e-3)"	"unprognostic (1.10e-1)"	"unprognostic (4.88e-3)"	"unprognostic (3.26e-3)"	"unprognostic (1.35e-2)"	"unprognostic (2.31e-3)"	"unprognostic (8.27e-2)"	"unprognostic (6.56e-2)"	"unprognostic (3.13e-2)"	"unprognostic (3.49e-2)"	1.0	1.0	2.1	1.4	3.0	3.5	1.2	7.3	2.9	1.3	2.3	1.3	2.5	1.6	1.3	1.1	1.2	0.9	1.2	2.1	2.8	1.1	1.7	1.2	1.2	2.5	2.1	1.5	1.2	1.4	1.8	1.1	2.4	1.3	1.0	3.1	1.4	0.9	1.6	2.0	1.5	1.1	1.8	1.6	1.3	0.9	2.8	1.7	1.7	1.0	1.1	1.1	1.2	3.6	0.7	1.4	2.0	1.2	0.3	1.0	1.4	1.4	0.9	1.0	1.1	1.8	1.3	1.3	0.7	1.4	1.3	1.9	1.1	1.9	1.9	2.5	1.7	1.7	5.0	1.3	0.5	4.6	2.2	1.8	1.3	1.0	0.6	2.1	0.9	3.3	0.8	2.0	0.9	1.4	2.1	1.9	0.7	0.6	1.1	1.8	2.9	0.5	0.6	2.9	1.8	2.1	0.6	3.8	1.0	0.7	1.7	1.9	1.2	1.5	0.7	0.9	0.6	1.6	1.9	1.3	1.4	0.8	1.8	1.6	0.8	1.0	0.8	0.5	0.6	0.8	0.5	0.6	0.4	1.0	0.5	0.6	1.3	0.7	0.4	1.1	0.5	0.2	2.1	3.0	7.3	2.9	2.1	2.8	2.5	2.1	2.4	1.8	2.8	3.6	18.2	35.3	29.7	11.4	21.6	5.9	7.0	13.3	17.1	79.4	19.7	14.9	13.2	37.1	18.8	18.4	87.6	19.1	26.4	23.3	7.9	16.6	8.6	15.2	23.8	20.8	24.7	13.7	10.0	14.6	13.0	16.7	18.8	18.0	38.6	24.7	28.2	42.1	11.8	53.8	12.2	24.2	14.2	17.6	6.7	9.7	23.6	12.8	8.8	4.7	25.1	30.4	30.9	15.1	18.8	14.0	17.7	33.1	9.4	8.0	36.5	18.6	11.4	111.3	0.0	26.6	16.5	24.3	39.4	9.3	6.3	25.2	18.6	18.3	23.7	5.5
NRF1	"ALPHA-PAL, EWG"	ENSG00000106459	"Nuclear respiratory factor 1"	Q16656	7	129611720-129757082	"Metabolic proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	7	"Astrocytes: 127.0;Excitatory neurons: 115.4;Inhibitory neurons: 109.4;Microglial cells: 75.9;Oligodendrocyte precursor cells: 143.2;Oligodendrocytes: 122.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029329	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Nucleoplasm	Cytosol	"HPA029329: AB_10601240"	"unprognostic (2.80e-2)"	"unprognostic (2.20e-3)"	"unprognostic (4.51e-1)"	"unprognostic (4.04e-2)"	"unprognostic (2.01e-1)"	"unprognostic (4.20e-3)"	"prognostic unfavorable (6.02e-4)"	"unprognostic (1.09e-1)"	"unprognostic (2.13e-2)"	"unprognostic (3.69e-2)"	"unprognostic (1.18e-3)"	"unprognostic (2.99e-3)"	"unprognostic (1.83e-2)"	"unprognostic (2.06e-1)"	"unprognostic (6.52e-2)"	"unprognostic (4.20e-1)"	"unprognostic (2.06e-3)"	8.3	5.6	9.2	7.9	9.9	16.7	7.9	13.3	11.1	10.8	11.5	8.8	6.4	9.9	6.4	7.2	12.8	5.5	9.4	9.3	10.7	9.0	6.1	8.0	12.3	11.1	10.6	16.6	7.3	8.5	7.7	7.0	10.1	8.0	6.8	12.7	7.5	6.2	15.6	9.3	8.3	7.7	9.1	10.3	6.7	5.6	10.2	18.0	9.7	8.8	11.1	8.7	8.0	13.0	15.9	12.8	18.1	15.9	10.7	8.5	14.4	10.9	11.2	16.3	12.6	15.6	10.4	18.3	7.8	12.3	10.2	11.9	19.7	11.0	16.5	17.5	14.1	15.1	11.0	10.3	7.8	18.7	14.5	7.3	10.2	16.1	15.5	9.4	12.1	17.4	18.6	13.7	10.1	14.5	36.9	17.6	16.9	14.5	11.3	23.2	14.6	16.2	9.2	11.5	15.6	17.1	16.4	16.8	11.0	14.7	10.5	17.4	9.4	9.2	12.6	10.8	20.3	14.7	15.7	32.0	9.7	17.0	18.1	5.6	4.2	10.6	8.2	5.2	9.8	5.5	6.3	7.7	5.5	5.9	6.8	6.0	8.8	5.0	5.8	3.6	7.2	5.8	9.2	9.9	13.3	11.1	9.3	10.7	11.1	10.6	10.1	9.1	10.2	13.0	6.8	3.2	6.5	127.0	15.8	6.6	3.2	3.4	4.6	10.8	5.4	5.1	6.2	2.8	4.8	3.7	10.4	2.8	11.3	5.5	0.0	2.3	0.4	8.9	6.4	7.1	6.7	3.0	115.4	3.6	4.1	6.0	7.1	5.7	5.1	6.9	7.1	4.1	3.1	10.1	109.4	5.3	4.1	7.7	9.5	1.9	5.3	5.4	5.4	75.9	4.0	6.4	12.3	143.2	122.3	3.0	10.2	4.5	14.2	6.8	3.7	2.3	13.1	11.2	6.6	10.0	6.4	9.0	6.6	6.2	7.7	3.4	13.8	2.3	4.2	5.4
NRG2	"Don-1, HRG2, NTAK"	ENSG00000158458	"Neuregulin 2"	O14511	5	139846779-140043299	"Cancer-related genes, Predicted membrane proteins, Predicted secreted proteins"		"Growth factor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 71.5;Excitatory neurons: 89.9;Inhibitory neurons: 136.6;Oligodendrocyte precursor cells: 142.2;Oligodendrocytes: 50.8"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 6.0;HDLM-2: 4.0;Karpas-707: 4.4;PC-3: 11.1;RPTEC TERT1: 5.8;SCLC-21H: 4.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA038935, HPA047973"	Approved		Supported	Nucleoplasm,Nucleoli	"Secreted in other tissues"	No	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 35: Non-specific - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm	Nucleoli	"HPA038935: AB_10672833, HPA047973: AB_2680226"	"unprognostic (8.66e-4)"	"unprognostic (2.17e-1)"	"unprognostic (1.21e-1)"	"unprognostic (6.04e-2)"	"unprognostic (3.22e-1)"	"unprognostic (2.96e-2)"	"unprognostic (8.66e-3)"	"unprognostic (1.11e-1)"	"unprognostic (3.99e-1)"	"unprognostic (1.88e-1)"	"unprognostic (4.26e-3)"	"unprognostic (4.00e-2)"	"unprognostic (7.79e-3)"	"unprognostic (3.64e-3)"	"unprognostic (9.54e-2)"	"unprognostic (2.23e-2)"	"unprognostic (2.07e-2)"	2.3	3.4	2.9	0.5	2.8	0.0	3.3	8.5	3.1	5.8	0.0	2.1	0.2	1.2	1.1	1.6	3.3	1.2	1.2	2.0	2.4	0.8	0.1	0.4	0.8	3.2	2.6	7.5	2.7	8.1	3.5	0.3	3.0	3.1	0.1	1.3	6.5	1.9	5.0	3.6	0.7	0.3	1.5	1.7	0.8	2.1	2.6	0.5	0.7	0.1	0.4	3.1	1.8	2.3	0.0	1.6	0.1	6.0	0.0	0.0	0.0	0.0	0.2	0.2	0.1	0.0	0.0	0.0	0.3	0.0	2.8	2.1	0.3	0.1	0.1	4.0	3.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.4	0.6	0.1	0.1	0.0	4.4	0.0	0.2	0.0	0.0	0.1	0.0	11.1	0.1	0.0	0.0	5.8	1.5	4.2	2.5	0.0	2.7	2.6	0.0	0.0	0.0	0.1	1.9	0.3	0.0	1.3	0.8	0.0	0.0	2.7	0.0	0.5	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.9	2.8	8.5	3.1	2.0	2.4	3.2	2.6	3.0	1.5	2.6	2.3	15.9	0.0	0.0	71.5	1.6	2.8	9.7	0.9	29.0	16.6	4.0	16.0	2.2	0.0	0.5	1.8	0.0	0.1	3.2	0.1	1.9	0.4	0.6	2.6	8.2	2.6	0.0	0.0	89.9	2.2	0.0	2.7	0.5	0.4	0.0	1.3	1.8	0.0	0.1	6.7	136.6	0.1	0.0	0.3	1.3	0.6	9.6	0.6	3.6	8.4	0.3	11.2	5.2	142.2	50.8	0.5	0.0	10.1	2.7	2.6	0.0	1.7	1.0	1.0	6.6	10.9	2.2	2.7	9.4	1.0	0.3	0.0	2.8	4.0	0.1	6.2
NRIP1	RIP140	ENSG00000180530	"Nuclear receptor interacting protein 1"	P48552	21	14961235-15065936	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Biological rhythms, Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Microglial cells: 219.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"REH: 92.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029785, HPA046571, HPA060036"	Approved		Supported	Nucleoplasm,Nucleoli,Cytosol		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 14: REH - Unknown function"	"Cluster 44: Endometrium - Transcription"	"Nucleoplasm, Nucleoli"	Cytosol	"HPA029785: , HPA046571: AB_2679704, HPA060036: AB_2684193"	"unprognostic (5.60e-2)"	"unprognostic (1.87e-1)"	"unprognostic (5.20e-3)"	"unprognostic (4.64e-3)"	"unprognostic (7.98e-2)"	"unprognostic (2.59e-2)"	"unprognostic (2.74e-1)"	"unprognostic (2.75e-3)"	"unprognostic (8.94e-3)"	"unprognostic (1.55e-1)"	"unprognostic (2.64e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.80e-2)"	"unprognostic (6.53e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.72e-1)"	"unprognostic (2.80e-1)"	30.4	10.2	5.8	10.2	5.2	26.4	14.2	14.9	6.9	24.7	6.5	18.2	16.8	18.2	13.4	9.4	21.4	10.3	5.4	6.4	8.1	15.9	26.9	8.9	8.7	4.8	4.5	13.3	14.4	7.4	3.2	14.6	5.3	10.3	18.1	31.8	6.1	8.4	22.3	4.1	18.3	20.1	6.4	13.1	8.9	8.1	6.7	17.0	5.6	23.8	7.2	14.1	8.4	8.3	22.1	43.5	34.6	0.0	17.4	11.3	12.6	26.1	11.7	16.0	12.5	8.7	17.3	0.1	14.5	23.3	7.9	11.0	2.2	15.6	33.9	0.0	10.0	33.4	15.3	27.2	10.5	16.7	6.7	14.1	21.3	17.6	20.5	17.8	12.6	4.8	24.1	17.4	11.4	11.8	7.8	0.1	14.5	8.8	13.9	92.4	28.0	0.8	9.8	35.8	3.2	0.1	21.7	11.3	8.8	27.7	27.2	12.9	22.0	13.7	9.1	21.4	10.8	8.5	0.2	0.1	29.0	0.0	6.8	0.0	0.4	0.2	0.3	0.2	1.8	0.3	0.3	0.4	0.6	1.0	0.5	0.2	0.1	0.5	0.5	0.6	0.2	0.2	5.8	5.2	14.9	6.9	6.4	8.1	4.8	4.5	5.3	6.4	6.7	8.3	33.2	48.1	37.6	60.7	27.4	18.6	122.6	16.2	22.8	33.9	52.9	26.8	18.3	21.5	40.9	29.5	50.1	16.4	20.7	50.1	9.8	23.0	15.8	60.9	99.1	43.0	37.7	24.2	123.7	27.6	120.8	42.3	26.5	130.9	31.5	94.0	27.1	44.7	45.7	21.9	95.0	41.6	18.3	50.4	21.9	19.3	37.6	57.9	8.8	219.2	40.4	56.2	27.8	102.1	78.2	31.4	42.6	27.1	10.1	49.5	43.0	36.5	15.9	63.1	32.9	112.1	38.6	12.1	6.3	23.1	18.8	14.1	19.9	71.0	47.7	99.8
NRL	"D14S46E, NRL-MAF, RP27"	ENSG00000129535	"Neural retina leucine zipper"	P54845	14	24078662-24115010	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Sensory transduction, Transcription, Transcription regulation, Vision"	"Activator, Developmental protein, DNA-binding"	"Disease variant, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	75	"retina: 317.3"	"Cell type enriched"	"Detected in many"	5	"Rod photoreceptor cells: 3720.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"SuSa: 4.8"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"CAB026066, HPA064599"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 79: Retina - Phototransduction"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 46: Photoreceptor cells - Phototransduction"	Nucleoplasm	Cytosol	"CAB026066: , HPA064599: AB_2685295"	"unprognostic (2.71e-2)"	"unprognostic (8.17e-4)"	"unprognostic (4.60e-2)"	"unprognostic (1.80e-1)"	"unprognostic (7.23e-2)"	"unprognostic (1.99e-2)"	"unprognostic (5.29e-2)"	"unprognostic (1.88e-5)"	"unprognostic (3.59e-2)"	"unprognostic (7.84e-3)"	"unprognostic (1.75e-3)"	"unprognostic (3.49e-2)"	"unprognostic (2.38e-5)"	"unprognostic (2.56e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.35e-3)"	0.8	2.5	1.7	0.5	1.5	0.5	1.0	2.3	2.2	1.1	0.6	0.9	1.1	1.1	0.7	1.1	1.0	0.9	2.2	1.5	1.5	3.1	3.6	1.0	1.0	2.3	1.8	1.2	1.7	1.9	2.4	0.3	1.7	1.5	0.3	317.3	1.0	0.7	2.5	0.7	1.3	0.3	1.7	2.1	1.2	4.2	1.6	1.2	2.7	1.4	0.7	1.1	0.8	1.7	0.3	1.2	1.6	1.6	0.3	0.2	0.4	0.3	0.3	0.5	0.3	0.7	0.5	1.2	0.4	0.5	1.0	0.5	0.6	0.3	0.2	0.6	0.5	0.7	0.6	2.2	0.6	1.4	1.6	0.4	0.5	0.2	0.7	0.7	0.5	2.2	0.7	1.2	0.3	0.9	1.2	0.6	1.8	1.8	0.9	1.2	1.5	0.0	0.4	1.3	1.7	1.2	0.8	0.7	0.8	4.8	0.9	1.5	0.4	1.1	0.5	0.1	0.7	3.6	1.9	1.5	0.3	0.9	1.1	0.2	0.3	1.3	0.2	0.4	0.1	1.0	0.2	0.4	0.3	0.7	0.8	0.6	0.1	0.5	0.3	0.4	0.2	0.3	1.7	1.5	2.3	2.2	1.5	1.5	2.3	1.8	1.7	1.7	1.6	1.7	1.4	0.0	0.5	5.5	6.2	0.8	1.6	0.1	1.2	434.4	2.0	1.9	2.1	0.0	0.7	7.3	431.6	1.4	3.2	1.5	13.7	0.6	2.7	1.3	0.7	24.1	1.8	3.2	1.8	1.1	0.9	0.7	2.6	1.0	0.0	0.7	0.7	3.3	2.0	250.7	2.6	1.7	0.0	1.3	0.4	4.2	1.2	1.4	1.8	0.0	1.1	636.4	5.2	2.0	4.4	0.3	5.3	1.9	1.7	2.0	5.6	6.7	0.1	3720.7	0.0	1.2	0.7	9.7	4.3	2.2	0.4	2.5	2.6	2.3	1.0	2.1
NRXN1	"Hs.22998, KIAA0578"	ENSG00000179915	"Neurexin 1"	"P58400, Q9ULB1"	2	49918503-51225575	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Angiogenesis, Cell adhesion"		"Mental retardation, Schizophrenia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	13	"brain: 145.0"	"Group enriched"	"Detected in many"	5	"Astrocytes: 4025.1;Excitatory neurons: 3206.3;Inhibitory neurons: 2116.2;Oligodendrocyte precursor cells: 4897.8"	"Cancer enriched"	"Detected in single"	8	"glioma: 3.0"	"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in single"	6	"neutrophil: 1.3"	"Lineage enriched"	"Detected in single"	13	"granulocytes: 1.3"	"Cell line enriched"	"Detected in some"	7	"SCLC-21H: 31.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA071400			Supported	"Plasma membrane"	"Intracellular and membrane"	NA	NA		1400000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 6: Brain - Smell perception"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Plasma membrane"		"HPA071400: AB_2732180"	"unprognostic (7.01e-2)"	"unprognostic (9.96e-2)"	"unprognostic (7.68e-2)"	"unprognostic (1.74e-4)"	"unprognostic (2.46e-1)"	"unprognostic (8.95e-2)"		"unprognostic (2.02e-2)"	"unprognostic (1.85e-1)"	"unprognostic (8.19e-2)"	"unprognostic (6.37e-4)"	"unprognostic (2.85e-2)"	"unprognostic (6.68e-7)"	"unprognostic (3.40e-2)"	"unprognostic (1.75e-1)"	"unprognostic (5.57e-2)"	"unprognostic (1.99e-3)"	1.1	2.0	40.9	1.1	60.9	0.3	0.8	145.0	74.4	2.2	0.0	11.3	0.9	1.1	3.0	2.0	0.8	1.2	5.2	62.7	16.8	0.4	0.5	0.4	0.3	0.0	2.2	0.9	1.4	0.0	6.0	0.0	7.2	2.8	2.6	7.2	2.4	8.4	0.2	0.9	2.6	1.0	4.7	0.2	2.3	5.6	15.7	1.2	0.6	0.8	0.2	2.3	3.1	22.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.3	0.0	0.0	31.3	1.2	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.2	0.0	0.0	0.2	3.1	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	40.9	60.9	145.0	74.4	62.7	16.8	0.0	2.2	7.2	4.7	15.7	22.0	0.1	0.0	0.0	4025.1	0.0	0.0	0.3	0.0	3.4	116.0	3.1	3.7	19.4	0.0	0.0	0.0	2.1	0.0	0.0	0.0	1.9	0.1	201.6	0.1	2.8	1.0	1.8	0.0	3206.3	0.0	0.0	2.3	0.0	0.1	0.0	0.2	3.3	0.2	0.1	77.4	2116.2	0.0	0.0	0.0	0.6	103.4	2.5	0.6	1.8	174.3	0.0	22.7	0.0	4897.8	678.0	0.2	0.0	0.7	1.4	0.5	0.0	0.2	0.0	9.7	0.0	2.5	1.3	13.3	5.8	0.6	0.1	0.3	0.1	0.1	0.0	0.1
NSD1	"ARA267, FLJ22263, KMT3B, STO"	ENSG00000165671	"Nuclear receptor binding SET domain protein 1"	Q96L73	5	177133025-177300213	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, Chromatin regulator, Methyltransferase, Repressor, Transferase"	"Cancer-related genes, Disease variant, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA048431, HPA070333, HPA073705"	Supported		Supported	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 52: Non-specific - Transcription"	"Nucleoplasm, Plasma membrane"		"HPA048431: AB_2680388, HPA070333: AB_2686255, HPA073705: AB_2732239"	"unprognostic (3.48e-2)"	"unprognostic (7.46e-2)"	"unprognostic (7.14e-3)"	"unprognostic (2.64e-3)"	"unprognostic (1.38e-1)"	"unprognostic (9.67e-2)"	"unprognostic (2.29e-2)"	"unprognostic (7.08e-2)"	"unprognostic (1.68e-3)"	"unprognostic (8.04e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.09e-1)"	"unprognostic (7.77e-3)"	"unprognostic (3.53e-2)"	"unprognostic (1.01e-1)"	"unprognostic (7.51e-2)"	"unprognostic (7.32e-2)"	8.7	7.2	8.9	12.0	13.4	21.2	10.9	26.2	10.4	11.1	9.8	10.1	8.4	11.5	10.3	11.4	10.1	8.0	9.1	7.7	10.0	10.6	6.6	9.2	13.7	9.7	10.8	12.3	11.3	12.8	9.0	10.7	12.2	9.3	10.8	11.9	10.4	9.6	13.6	12.0	9.4	12.0	6.6	11.3	8.9	23.2	12.0	20.2	15.5	11.5	14.7	9.3	7.9	17.5	20.5	25.9	26.0	22.8	12.5	16.1	0.9	18.2	17.9	24.6	22.8	5.7	16.6	41.7	19.9	24.8	22.7	17.0	41.9	40.0	29.7	72.9	25.9	18.6	29.5	0.2	20.7	40.4	21.2	15.2	23.6	29.4	27.3	17.5	36.4	26.0	25.9	14.3	25.2	42.3	28.3	13.1	28.5	13.7	22.5	31.0	3.4	12.9	15.9	24.4	31.6	21.9	46.7	20.1	13.8	24.1	20.2	33.0	27.4	17.1	25.0	11.0	22.6	16.7	15.7	29.5	9.9	19.3	18.7	14.7	9.0	10.5	7.2	6.1	6.0	8.5	6.1	5.0	7.2	10.3	7.5	6.0	18.6	11.3	12.2	9.4	6.4	3.4	8.9	13.4	26.2	10.4	7.7	10.0	9.7	10.8	12.2	6.6	12.0	17.5	37.4	22.4	31.4	84.9	71.7	17.0	32.8	27.2	34.1	94.4	29.8	25.7	44.5	34.3	35.0	55.2	150.1	43.6	66.1	19.7	17.6	27.8	31.9	27.1	65.7	36.4	41.9	48.3	107.0	21.2	23.7	32.7	41.8	41.9	41.7	64.0	33.5	19.9	27.7	89.2	110.3	25.6	12.2	36.8	25.7	50.3	51.0	47.1	16.0	115.2	75.0	29.2	95.8	140.8	157.5	23.7	31.0	33.1	55.8	29.4	33.6	19.2	17.3	112.3	52.6	42.9	36.1	83.7	62.1	41.8	20.6	35.4	62.0	55.9	28.2	30.0
NSD2	"KMT3G, MMSET, WHSC1"	ENSG00000109685	"Nuclear receptor binding SET domain protein 2"	O96028	4	1871393-1982207	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding, Methyltransferase, Transferase"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Glandular and luminal cells: 20.3;Granulosa cells: 69.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015801, CAB068246, CAB068247"	Enhanced		Supported	Nucleoplasm		No	No			"Cluster 17: Basophils - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 40: Granulosa cells - Unknown function"	Nucleoplasm		"CAB068246: AB_2665690, CAB068247: AB_2665689, HPA015801: AB_1858830"	"unprognostic (3.70e-1)"	"unprognostic (9.80e-2)"	"unprognostic (3.33e-2)"	"unprognostic (1.77e-1)"	"unprognostic (4.01e-1)"	"unprognostic (1.31e-2)"	"prognostic unfavorable (2.61e-4)"	"unprognostic (3.24e-2)"	"unprognostic (6.22e-2)"	"unprognostic (7.66e-2)"	"unprognostic (2.09e-1)"	"unprognostic (9.25e-3)"	"prognostic unfavorable (7.19e-4)"	"unprognostic (3.89e-2)"	"unprognostic (2.95e-1)"	"unprognostic (1.31e-1)"	"unprognostic (6.15e-2)"	10.1	8.4	12.7	16.5	13.0	54.9	9.9	23.6	15.2	9.4	0.8	19.6	18.6	10.7	7.3	13.6	8.4	8.3	15.8	11.8	11.5	9.8	8.3	12.6	25.4	9.8	8.6	7.7	13.5	12.0	13.8	12.2	12.0	9.7	22.5	28.5	11.6	8.4	16.7	11.6	18.3	12.4	4.4	14.1	12.5	37.2	12.6	59.8	17.4	13.7	24.3	9.7	9.2	14.9	124.0	58.6	168.3	71.2	17.5	26.5	44.2	98.2	85.4	115.2	128.8	44.6	141.4	117.5	31.4	78.0	158.5	50.2	114.4	74.3	195.0	58.3	47.7	151.3	81.7	25.5	18.6	89.5	74.9	9.9	19.8	101.2	89.9	60.1	92.2	123.4	81.7	132.2	95.8	42.1	243.3	99.7	68.8	60.1	77.1	137.8	106.7	42.9	45.4	57.4	115.6	82.7	78.4	29.2	31.7	71.4	68.9	52.2	64.9	109.0	87.4	72.8	188.1	54.1	72.9	113.7	66.0	81.9	108.0	4.0	1.1	1.3	1.0	0.8	1.1	0.9	1.5	1.2	1.2	1.7	1.1	0.8	3.4	1.2	0.5	2.1	2.9	0.7	12.7	13.0	23.6	15.2	11.8	11.5	9.8	8.6	12.0	4.4	12.6	14.9	12.6	12.8	18.4	0.0	4.1	0.0	0.0	0.0	0.0	0.0	15.3	9.1	0.0	0.0	8.1	12.9	0.0	15.7	7.2	0.0	3.9	10.4	0.0	13.0	11.7	6.3	0.0	0.0	0.0	7.1	10.0	6.0	0.0	20.3	2.5	69.3	0.0	0.0	13.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.3	0.0	0.0	5.7	0.0	0.0	0.0	0.0	11.4	0.0	0.0	4.9	0.0	0.0	4.0	7.3	0.0	0.0	0.0	8.4	0.0	0.0	0.0	0.0	3.4	5.2	3.7	0.0	0.0
NSD3	"FLJ20353, KMT3F, WHISTLE, WHSC1L1"	ENSG00000147548	"Nuclear receptor binding SET domain protein 3"	Q9BZ95	8	38269704-38382272	"Cancer-related genes, Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, Methyltransferase, Transferase"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 173.8;Syncytiotrophoblasts: 130.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005659, CAB013721, HPA018893"	Uncertain		Approved	Nucleoplasm,Mitochondria		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 7: Non-specific - Mitochondria"	Mitochondria	Nucleoplasm	"CAB013721: , HPA005659: AB_1080596, HPA018893: AB_1858833"	"unprognostic (6.21e-2)"	"unprognostic (3.73e-2)"	"unprognostic (2.18e-2)"	"unprognostic (4.12e-1)"	"unprognostic (2.25e-1)"	"unprognostic (1.53e-2)"	"unprognostic (4.35e-2)"	"unprognostic (1.97e-2)"	"unprognostic (2.49e-1)"	"unprognostic (5.72e-2)"	"prognostic unfavorable (7.48e-4)"	"unprognostic (5.06e-2)"	"unprognostic (5.60e-3)"	"unprognostic (6.69e-2)"	"unprognostic (4.04e-1)"	"unprognostic (1.05e-2)"	"unprognostic (1.60e-2)"	22.4	14.4	10.0	24.8	13.7	60.2	23.4	28.4	20.5	24.0	0.7	22.4	24.1	22.9	17.4	22.9	23.5	24.5	13.7	12.8	22.3	20.0	16.6	20.6	35.3	3.1	4.8	36.4	20.1	24.8	17.3	33.5	5.3	20.9	26.6	23.3	19.9	24.3	14.4	19.8	26.7	19.8	0.1	26.9	29.0	14.4	10.4	38.3	27.6	16.0	31.0	23.3	23.1	18.7	62.1	34.9	58.7	39.9	40.3	46.0	43.4	50.8	55.9	43.1	49.7	18.8	33.6	73.5	45.5	35.0	41.7	36.4	47.0	40.6	61.0	29.4	27.6	93.6	28.6	22.1	41.2	41.7	32.5	24.9	40.4	39.0	78.6	40.3	50.1	79.8	67.9	47.4	41.5	22.3	122.8	35.4	40.0	48.0	16.4	55.5	64.1	23.4	30.3	47.3	33.0	44.6	41.4	35.8	35.3	37.5	45.1	31.4	48.3	44.5	46.0	67.0	30.3	41.9	53.8	69.2	37.6	41.3	33.0	37.4	11.8	21.9	17.2	5.6	11.0	43.1	25.5	15.5	9.3	60.7	31.9	13.7	57.9	19.6	3.6	12.6	43.4	7.3	10.0	13.7	28.4	20.5	12.8	22.3	3.1	4.8	5.3	0.1	10.4	18.7	75.1	67.3	57.3	0.0	57.8	0.0	0.0	0.0	0.0	0.0	73.4	69.1	0.0	0.0	30.3	51.5	0.0	101.6	101.9	0.0	23.5	73.0	0.0	109.1	81.3	28.0	0.0	0.0	0.0	61.0	173.8	33.1	0.0	97.5	8.8	99.7	0.0	0.0	44.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	30.1	0.0	0.0	49.7	0.0	0.0	0.0	0.0	64.7	0.0	0.0	48.9	0.0	0.0	31.7	34.2	0.0	0.0	0.0	35.8	0.0	0.0	0.0	0.0	130.8	55.6	81.7	0.0	0.0
NSF	"SEC18, SKD2"	ENSG00000073969	"N-ethylmaleimide sensitive factor, vesicle fusing ATPase"	P46459	17	46590669-46757464	"Enzymes, Predicted intracellular proteins, Transporters"	"Protein transport, Transport"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 276.3;Inhibitory neurons: 284.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003154, CAB009324, HPA071089"	Enhanced		Supported	"Golgi apparatus,Cytosol"		NA	NA		59000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 58: Brain - Synaptic function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Cytosol	"Golgi apparatus"	"CAB009324: AB_653479, HPA003154: AB_1079508, HPA071089: AB_2686343"	"unprognostic (5.70e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.07e-3)"	"unprognostic (1.98e-1)"	"unprognostic (1.52e-1)"	"unprognostic (2.04e-1)"	"unprognostic (2.30e-2)"	"unprognostic (1.09e-1)"	"unprognostic (3.95e-2)"	"unprognostic (5.48e-2)"	"unprognostic (2.37e-2)"	"unprognostic (3.25e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.07e-2)"	"unprognostic (3.09e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.74e-1)"	13.5	20.2	29.9	8.0	28.8	5.7	12.5	7.7	58.7	14.1	0.0	18.3	4.9	11.8	7.3	21.6	9.7	8.0	11.3	39.2	28.6	12.9	13.7	11.6	9.6	36.8	14.3	7.0	22.9	15.3	43.1	7.7	36.6	12.4	13.9	63.0	18.4	5.8	38.9	16.5	16.1	6.4	4.1	14.9	15.6	16.7	15.6	7.9	11.9	13.5	10.0	13.2	14.3	21.1	11.7	25.4	16.6	1.2	9.6	13.4	13.5	15.6	18.2	14.7	14.3	17.5	0.1	28.5	27.3	34.8	15.3	2.0	18.9	5.8	23.9	10.1	24.6	1.0	17.4	24.2	14.3	0.8	6.1	12.3	7.8	29.8	12.3	7.8	23.4	7.0	19.4	15.0	32.9	22.8	19.4	7.5	9.4	36.0	29.9	13.7	16.1	26.7	16.7	24.0	15.2	17.2	23.1	0.1	11.1	17.5	28.5	35.1	19.3	41.2	14.4	22.0	23.7	32.0	19.9	16.4	11.5	15.2	29.7	9.3	11.5	6.6	6.1	9.8	6.7	5.4	6.2	8.1	12.6	6.1	5.1	6.1	4.8	5.9	10.8	5.0	9.4	7.5	29.9	28.8	7.7	58.7	39.2	28.6	36.8	14.3	36.6	4.1	15.6	21.1	16.3	9.6	11.3	54.9	28.2	4.0	3.6	6.7	6.2	106.6	14.0	10.0	8.1	7.2	10.9	22.0	87.6	13.0	18.8	32.3	11.7	12.4	45.2	8.3	19.7	11.5	30.5	8.6	276.3	16.2	14.4	10.9	13.7	11.2	9.5	8.2	11.0	19.3	18.8	43.7	284.7	26.3	24.4	29.9	10.9	45.8	5.9	20.5	10.6	69.3	35.4	24.5	8.2	98.5	71.8	13.7	17.4	8.6	21.7	9.0	18.5	14.7	8.7	89.9	0.0	10.6	12.9	40.6	31.4	9.5	5.7	18.5	14.8	18.3	20.6	8.6
NSL1	"C1orf48, DC8, DKFZP566O1646, MIS14"	ENSG00000117697	"NSL1 component of MIS12 kinetochore complex"	Q96IY1	1	212726153-212791782	"Predicted intracellular proteins"	"Cell cycle, Cell division, Chromosome partition, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA045761, HPA053721"	Enhanced		Supported	"Nuclear speckles"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	"Nuclear speckles"		"HPA045761: AB_2679444, HPA053721: AB_2682240"	"unprognostic (1.47e-1)"	"unprognostic (1.67e-1)"	"unprognostic (8.08e-2)"	"unprognostic (2.67e-2)"	"unprognostic (2.58e-2)"	"unprognostic (1.78e-2)"	"unprognostic (8.22e-3)"	"unprognostic (3.55e-1)"	"unprognostic (4.78e-2)"	"unprognostic (6.09e-3)"	"unprognostic (3.44e-3)"	"unprognostic (1.58e-1)"	"unprognostic (3.10e-3)"	"unprognostic (2.59e-1)"	"unprognostic (1.04e-2)"	"unprognostic (1.67e-1)"	"unprognostic (6.66e-2)"	16.7	14.5	13.8	19.4	16.9	19.1	11.2	17.1	17.5	12.8	15.0	13.3	17.5	14.5	8.0	15.3	13.9	15.0	24.9	13.4	14.9	16.0	19.3	12.5	27.0	18.0	14.9	16.8	12.5	13.9	11.0	17.6	17.5	12.8	10.1	12.6	13.9	10.0	22.5	8.8	17.5	13.1	17.3	19.4	11.7	13.5	14.8	22.7	15.0	15.6	16.7	13.6	10.1	21.3	39.7	44.3	45.0	43.3	18.9	19.5	59.4	32.5	22.1	38.7	33.2	37.3	42.2	55.6	29.4	18.7	21.6	28.4	35.6	29.9	20.1	102.9	33.6	37.0	31.2	61.8	21.7	62.5	34.9	20.2	14.6	39.6	19.8	17.8	28.8	62.9	83.0	45.7	24.6	23.1	80.6	24.6	82.9	20.6	32.8	69.2	68.1	61.5	31.3	19.8	41.1	57.0	46.0	22.3	55.7	33.3	65.6	44.9	33.3	39.4	34.1	36.4	54.5	26.4	76.3	73.8	33.7	42.2	50.7	21.8	49.3	63.1	35.9	62.3	43.0	59.0	38.8	39.2	55.6	47.4	46.7	41.9	49.6	45.3	64.3	53.8	51.2	60.7	13.8	16.9	17.1	17.5	13.4	14.9	18.0	14.9	17.5	17.3	14.8	21.3	39.4	16.0	20.7	25.5	43.5	14.8	21.2	51.4	31.3	34.1	22.8	26.8	22.4	31.5	28.1	18.4	14.6	64.0	40.9	14.7	43.0	32.2	29.2	19.9	29.0	32.0	21.7	50.7	50.2	21.1	62.2	28.9	13.3	15.1	15.2	31.6	29.6	27.9	61.6	33.7	50.1	14.1	30.5	68.2	28.5	15.2	34.8	44.6	19.6	33.7	56.0	37.1	35.0	36.2	68.9	22.7	15.9	32.7	26.7	10.5	32.5	58.5	25.6	32.7	59.2	30.2	32.6	48.7	65.5	22.7	16.2	20.9	36.6	27.0	18.5	10.3
NSMCE1	NSE1	ENSG00000169189	"NSE1 homolog, SMC5-SMC6 complex component"	Q8WV22	16	27224994-27268772	"Enzymes, Predicted intracellular proteins"	"DNA damage, DNA recombination, DNA repair, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"granulocytes: 275.5;Late spermatids: 420.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041567, HPA043091"	Supported		Supported	Nucleoplasm,Vesicles		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 43: Testis - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 31: Spermatids - Spermatogenesis"	"Nucleoplasm, Vesicles"		"HPA041567: AB_10964260, HPA043091: AB_10962722"	"unprognostic (6.27e-2)"	"unprognostic (8.17e-2)"	"unprognostic (2.52e-2)"	"unprognostic (2.48e-3)"	"unprognostic (4.17e-1)"	"unprognostic (4.52e-3)"	"unprognostic (1.59e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.93e-1)"	"unprognostic (9.91e-2)"	"unprognostic (1.40e-1)"	"unprognostic (5.45e-3)"	"unprognostic (3.58e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.29e-1)"	43.8	68.3	58.8	32.2	61.7	35.1	52.5	65.2	71.7	43.3	66.0	53.1	25.3	42.3	55.0	45.5	62.2	35.8	47.6	57.4	63.3	58.3	55.9	42.4	54.5	65.5	61.4	45.0	59.3	86.1	37.3	37.3	64.6	57.4	36.8	24.9	46.2	51.7	45.2	40.7	37.0	45.2	64.0	33.5	51.3	79.8	61.3	56.4	53.0	44.9	54.7	51.4	39.1	67.0	56.5	80.6	53.8	58.6	85.8	114.2	43.1	58.9	60.4	44.5	46.1	62.7	134.1	110.0	137.7	91.1	45.7	59.5	101.9	178.6	57.3	136.3	70.6	51.0	68.6	122.1	149.1	59.9	37.4	112.6	122.3	111.7	211.5	127.8	60.3	104.3	69.6	33.8	82.9	96.7	80.0	67.5	46.8	94.0	54.7	69.1	65.8	174.7	129.9	36.3	56.4	51.0	40.2	55.9	104.3	65.1	92.3	71.9	37.8	53.3	33.2	61.1	57.8	101.0	78.1	85.9	114.0	59.4	23.3	125.3	91.2	86.2	78.9	81.6	86.3	84.2	111.1	95.7	128.4	133.1	126.7	99.7	29.6	213.8	81.5	124.6	113.0	120.3	58.8	61.7	65.2	71.7	57.4	63.3	65.5	61.4	64.6	64.0	61.3	67.0	34.8	35.3	36.4	8.5	38.1	28.3	57.6	110.7	33.0	14.9	60.7	83.8	49.6	62.9	58.5	44.1	2.1	126.2	41.2	45.6	129.1	79.2	209.9	40.3	32.9	33.9	58.7	24.0	5.4	73.0	63.3	44.5	17.3	29.6	275.5	37.4	52.8	64.0	83.2	13.5	6.7	65.8	44.7	53.3	45.6	420.8	24.2	39.5	46.2	12.2	98.1	64.7	43.3	12.5	14.8	40.1	45.7	39.9	28.1	49.0	83.9	173.8	94.6	18.8	26.3	58.1	50.1	119.0	39.4	43.5	32.7	64.3	55.3	39.9	46.7	48.3
NSMCE2	"C8orf36, FLJ32440, MMS21, NSE2, ZMIZ7"	ENSG00000156831	"NSE2 (MMS21) homolog, SMC5-SMC6 complex SUMO ligase"	Q96MF7	8	125091679-125367120	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cell cycle, Cell division, DNA damage, DNA recombination, DNA repair, Mitosis, Ubl conjugation pathway"	Transferase	"Dwarfism, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"Astrocytes: 136.1;Excitatory neurons: 150.1;Inhibitory neurons: 156.8;Microglial cells: 157.4;Oligodendrocyte precursor cells: 139.2;Oligodendrocytes: 386.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051614, HPA065734"	Supported		Supported	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 52: Non-specific - Ribosome"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Nucleoplasm	"Nuclear bodies"	"HPA051614: AB_2681551, HPA065734: AB_2685549"	"unprognostic (1.14e-3)"	"unprognostic (1.29e-1)"	"unprognostic (6.56e-2)"	"unprognostic (1.22e-3)"	"unprognostic (8.65e-2)"	"unprognostic (8.89e-3)"	"prognostic unfavorable (7.54e-4)"	"unprognostic (3.99e-2)"	"unprognostic (2.48e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.53e-2)"	"unprognostic (1.33e-1)"	"unprognostic (3.09e-2)"	"unprognostic (1.17e-1)"	"unprognostic (7.53e-2)"	"unprognostic (2.61e-2)"	"unprognostic (6.85e-2)"	19.9	18.1	11.0	14.1	12.8	30.3	23.7	12.4	12.9	17.0	13.4	18.6	12.5	15.8	18.6	17.0	13.4	15.9	23.8	11.2	12.4	18.9	17.8	14.2	21.7	12.2	11.9	19.0	12.8	17.8	11.2	19.6	12.6	13.2	17.5	16.7	16.0	13.9	33.6	15.8	12.3	16.1	11.8	14.5	16.6	15.5	12.7	26.0	18.1	27.2	26.1	20.7	14.7	16.1	43.0	36.3	42.3	26.9	32.7	48.9	20.5	33.5	62.5	58.2	67.0	23.4	39.9	53.2	38.5	32.0	42.9	31.1	33.4	28.2	58.8	60.0	32.4	75.4	20.0	34.1	47.7	22.8	22.1	36.5	38.4	33.6	43.6	38.8	53.2	27.5	44.1	34.2	51.4	74.3	58.9	20.9	9.3	48.4	48.0	33.3	29.4	48.6	35.5	32.1	28.0	29.7	40.1	119.2	56.3	24.9	50.9	25.9	33.3	22.3	62.9	27.8	48.3	45.1	86.6	67.6	35.4	43.4	35.3	12.9	23.9	69.4	22.0	21.7	24.3	25.0	23.1	24.8	24.4	25.5	23.7	25.9	11.3	22.0	23.3	14.2	37.6	24.5	11.0	12.8	12.4	12.9	11.2	12.4	12.2	11.9	12.6	11.8	12.7	16.1	21.8	9.6	13.1	136.1	22.0	23.8	36.3	39.1	21.1	23.8	23.3	24.8	20.1	21.5	26.0	11.0	16.7	34.2	20.3	16.2	27.4	33.1	28.0	26.4	19.7	23.0	13.8	36.2	150.1	42.5	27.8	21.4	13.7	20.7	25.4	24.1	23.2	13.7	44.3	15.2	156.8	17.7	18.3	26.5	24.3	9.9	23.3	24.4	17.8	157.4	29.4	18.4	20.6	139.2	386.0	34.2	19.5	24.5	20.2	28.1	20.6	35.2	23.4	26.4	6.6	20.7	23.4	44.4	31.7	16.0	18.9	46.7	24.6	20.9	19.8	37.6
NSMF	NELF	ENSG00000165802	"NMDA receptor synaptonuclear signaling and neuronal migration factor"	Q6X4W1	9	137447570-137459334	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Disease variant, Hypogonadotropic hypogonadism, Kallmann syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"brain: 361.3"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 71.5;Peritubular cells: 71.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"eosinophil: 3.5;intermediate monocyte: 13.8;myeloid DC: 6.3;non-classical monocyte: 12.1"	"Group enriched"	"Detected in many"	5	"dendritic cells: 6.3;granulocytes: 3.5;monocytes: 13.8"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044316	Supported		Supported	Nucleoplasm		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 65: Brain - Ion transport"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm		"HPA044316: AB_10964877"	"unprognostic (1.48e-1)"	"unprognostic (4.03e-2)"	"unprognostic (5.40e-2)"	"unprognostic (3.92e-2)"	"unprognostic (8.54e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.52e-1)"	"unprognostic (2.35e-1)"	"unprognostic (7.96e-2)"	"unprognostic (3.26e-2)"	"unprognostic (2.38e-3)"	"unprognostic (2.34e-3)"	"prognostic favorable (1.85e-6)"	"unprognostic (1.97e-2)"	"unprognostic (4.14e-2)"	"unprognostic (4.61e-2)"	"unprognostic (3.97e-2)"	23.1	14.5	167.1	12.6	154.3	12.2	20.3	66.6	361.3	24.2	73.4	22.7	29.9	32.8	10.7	16.3	28.7	9.7	16.1	360.8	115.1	30.8	23.5	19.8	13.0	99.7	153.1	22.5	31.6	17.9	70.6	7.1	75.1	31.2	10.4	12.1	20.2	13.8	8.9	20.6	24.9	13.9	109.9	17.0	23.5	18.9	210.5	8.4	23.9	3.9	10.3	22.2	17.5	105.4	24.4	19.3	33.7	50.4	77.1	36.4	28.9	23.0	30.2	21.5	16.5	51.7	14.3	30.2	30.3	34.0	48.1	72.7	50.0	30.9	12.9	39.7	53.8	23.5	46.7	69.5	41.7	16.2	51.5	41.7	57.9	25.1	58.3	48.5	23.1	0.8	55.0	4.9	29.2	56.4	0.7	69.8	42.9	97.6	51.4	14.6	53.3	68.0	14.9	12.1	135.7	112.8	55.0	30.3	35.7	13.9	21.5	33.0	58.6	37.9	30.9	92.9	39.6	10.3	17.0	45.8	21.6	21.2	35.6	1.6	2.1	3.5	1.5	13.8	0.3	0.2	0.5	0.9	6.3	0.1	0.5	0.7	0.3	0.0	12.1	0.2	0.8	1.8	167.1	154.3	66.6	361.3	360.8	115.1	99.7	153.1	75.1	109.9	210.5	105.4	9.9	0.0	3.9	71.5	5.9	13.6	9.4	3.6	7.4	9.6	14.3	12.4	6.1	11.5	2.3	11.0	8.4	0.4	17.7	40.7	5.9	8.2	7.1	7.6	18.3	9.5	19.2	1.7	24.2	21.4	1.3	11.0	10.2	11.1	2.5	12.0	9.7	26.3	6.7	28.6	14.9	21.3	8.2	8.6	21.2	15.3	23.9	10.5	16.0	15.9	9.8	10.3	6.2	16.1	5.3	21.4	34.3	71.5	8.5	32.6	43.4	29.7	2.9	12.9	13.1	8.3	10.9	3.0	5.9	6.3	14.6	1.5	8.0	11.0	20.5	16.7
NSRP1	"CCDC55, DKFZP434K1421, NSrp70"	ENSG00000126653	"Nuclear speckle splicing regulatory protein 1"	Q9H0G5	17	30115521-30186475	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015593, HPA015603"	Enhanced		Supported	Nucleoplasm		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm		"HPA015593: AB_2072217, HPA015603: AB_1846157"	"unprognostic (3.96e-1)"	"unprognostic (2.16e-2)"	"unprognostic (5.45e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.89e-1)"	"unprognostic (7.76e-2)"	"unprognostic (1.83e-1)"	"unprognostic (5.93e-3)"	"unprognostic (6.12e-2)"	"unprognostic (2.21e-1)"	"unprognostic (3.08e-2)"	"unprognostic (1.31e-3)"	"unprognostic (2.02e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.43e-1)"	23.1	18.8	25.0	18.8	28.4	25.0	21.9	34.0	34.4	18.6	32.5	25.0	16.8	22.9	22.5	19.5	19.6	19.6	25.8	21.7	28.5	21.4	20.2	18.8	22.3	29.8	25.5	22.8	20.3	24.2	17.9	22.0	27.9	20.5	18.3	19.5	18.0	17.9	25.2	25.0	17.9	21.1	25.0	19.4	19.1	19.3	26.9	17.6	25.5	20.8	19.9	21.1	18.0	34.7	30.9	27.3	26.3	21.0	35.0	33.0	18.6	41.8	42.6	31.4	33.5	28.3	19.6	56.1	32.6	39.8	38.5	44.4	41.1	32.2	50.8	13.5	55.7	25.6	43.8	21.1	56.5	40.0	29.8	38.3	41.5	50.1	64.6	36.5	29.7	20.3	41.0	35.6	43.8	22.1	26.9	39.0	17.4	33.8	22.0	30.8	43.3	37.8	32.5	32.9	24.8	21.6	32.1	84.2	38.6	26.4	44.1	44.3	32.4	37.7	26.7	40.0	67.1	25.8	36.9	44.1	46.5	35.5	44.1	66.1	39.7	33.1	32.2	38.2	36.0	62.1	35.8	32.1	21.5	57.9	34.6	31.5	59.5	32.8	44.4	62.4	35.6	14.5	25.0	28.4	34.0	34.4	21.7	28.5	29.8	25.5	27.9	25.0	26.9	34.7	97.5	76.9	91.0	49.0	59.2	67.6	95.9	124.0	88.8	62.6	51.4	64.1	147.3	72.9	80.6	84.6	35.5	58.3	54.0	57.5	97.8	71.7	259.2	79.2	89.6	91.9	31.3	68.0	30.6	75.2	69.5	76.3	37.8	76.6	83.4	43.6	94.9	143.7	53.6	74.0	41.9	65.1	59.0	63.1	46.5	137.0	77.0	52.3	49.8	69.3	70.6	78.7	63.8	52.8	88.5	71.1	54.1	71.5	48.2	75.8	57.9	90.6	84.9	56.8	72.3	113.1	97.1	186.9	105.8	40.7	52.0	110.8	52.5	56.1	54.3	63.2
NT5C	"cdN, DNT-1, DNT1, PN-I, UMPH2"	ENSG00000125458	"5', 3'-nucleotidase, cytosolic"	Q8TCD5	17	75130225-75131757	"Metabolic proteins, Predicted intracellular proteins"	"Nucleotide metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA021581, HPA023632"	Approved		Supported	Cytosol		NA	NA		760000	"Cluster 10: Basophils - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Cytosol		"HPA021581: AB_1854663, HPA023632: AB_1854662"	"unprognostic (3.83e-2)"	"unprognostic (4.45e-2)"	"unprognostic (2.39e-1)"	"unprognostic (3.61e-2)"	"unprognostic (1.26e-1)"	"unprognostic (9.21e-2)"	"prognostic unfavorable (3.05e-4)"	"unprognostic (1.26e-1)"	"unprognostic (7.25e-2)"	"unprognostic (8.26e-3)"	"unprognostic (7.15e-2)"	"unprognostic (2.22e-1)"	"unprognostic (6.57e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.13e-1)"	"prognostic favorable (7.66e-4)"	31.6	31.4	14.5	17.9	15.9	16.3	31.8	16.5	17.4	37.0	14.8	43.0	24.5	34.7	5.2	45.9	32.1	8.4	32.6	14.1	16.7	47.8	29.1	29.2	18.3	17.1	15.5	37.5	33.7	11.7	18.9	10.2	15.6	35.7	13.1	8.7	25.8	15.3	41.1	33.8	43.7	7.6	16.6	40.7	36.8	15.2	15.5	16.0	37.7	16.1	15.2	37.9	35.9	18.4	52.5	77.7	25.3	26.5	7.5	15.4	33.7	29.5	26.2	29.7	18.8	29.5	58.3	35.5	21.5	21.0	5.2	33.7	18.1	37.7	16.5	16.1	51.3	40.5	68.7	50.0	38.0	38.8	17.2	23.1	17.4	21.3	57.0	11.9	33.0	27.6	38.4	16.8	30.2	51.2	28.0	39.0	26.5	43.6	50.6	24.9	32.9	50.9	39.3	26.7	30.0	60.1	28.3	34.8	43.9	14.0	49.8	27.2	20.4	25.0	62.1	9.8	40.3	33.3	5.6	41.1	23.8	23.3	40.4	183.7	29.7	48.9	39.2	49.6	27.7	94.9	25.5	33.6	37.9	87.4	21.6	33.5	14.4	72.6	50.7	50.4	45.2	30.2	14.5	15.9	16.5	17.4	14.1	16.7	17.1	15.5	15.6	16.6	15.5	18.4	23.0	32.1	19.5	22.2	132.9	47.4	86.1	108.8	90.5	66.0	58.8	101.9	16.4	77.2	35.2	58.8	20.9	64.9	85.8	272.8	78.2	102.2	2.1	53.2	53.5	26.6	64.1	59.5	7.7	121.4	100.4	59.8	181.5	43.2	46.3	59.0	11.7	41.9	74.5	42.1	8.0	133.4	52.9	55.7	64.4	6.8	59.4	56.2	58.7	18.7	108.4	55.9	98.9	19.6	19.2	127.5	221.6	47.4	51.2	115.8	231.6	144.2	31.1	65.5	32.9	39.0	107.6	19.0	49.6	89.4	44.3	31.2	67.4	98.4	152.8	85.9
NT5C3A	"cN-III, hUMP1, NT5C3, p36, P5'N-1, PN-I, POMP, PSN1, UMPH, UMPH1"	ENSG00000122643	"5'-nucleotidase, cytosolic IIIA"	Q9H0P0	7	33014114-33062797	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Nucleotide metabolism"	"Hydrolase, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 87.4"	"Cell type enhanced"	"Detected in all"		"Distal enterocytes: 191.0;Paneth cells: 186.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010520, HPA010630, HPA029058"	Uncertain		Supported	"Nucleoplasm,Nuclear bodies,Endoplasmic reticulum,Cytosol"	"Intracellular and membrane"	NA	NA		10000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 33: Striated muscle - Muscle contraction"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 51: Myeloid cells - Hemostasis"	"Endoplasmic reticulum, Cytosol"	"Nucleoplasm, Nuclear bodies"	"HPA010520: , HPA010630: AB_2668319, HPA029058: AB_10601380"	"unprognostic (7.50e-2)"	"unprognostic (3.10e-1)"	"unprognostic (1.14e-1)"	"unprognostic (2.69e-2)"	"unprognostic (1.22e-1)"	"unprognostic (5.56e-2)"	"prognostic unfavorable (2.42e-4)"	"unprognostic (3.25e-2)"	"unprognostic (3.12e-2)"	"unprognostic (2.82e-3)"	"unprognostic (2.08e-2)"	"unprognostic (1.98e-1)"	"prognostic unfavorable (1.70e-4)"	"unprognostic (9.37e-2)"	"unprognostic (2.05e-1)"	"unprognostic (2.12e-3)"	"unprognostic (3.43e-3)"	12.4	14.3	11.4	26.1	11.4	32.6	21.3	15.2	15.6	12.6	10.8	51.9	40.0	16.9	14.3	18.6	15.9	23.4	16.6	11.5	11.5	22.4	11.8	17.6	30.8	11.1	11.8	13.4	21.4	9.7	7.5	16.3	11.5	12.3	51.0	20.4	9.7	10.0	87.4	28.7	37.3	13.2	12.7	22.9	27.0	9.5	12.0	22.5	17.1	51.0	45.8	23.8	14.4	13.1	42.2	27.6	25.2	29.6	21.2	16.1	20.3	44.8	30.5	29.2	38.9	19.9	115.1	100.4	27.7	29.6	48.3	63.8	28.3	30.8	40.4	16.2	36.2	54.7	36.5	28.7	23.3	55.6	36.9	21.7	23.8	35.9	63.0	16.4	22.2	33.2	43.3	24.8	37.3	29.9	25.0	87.8	27.8	47.1	31.2	25.9	22.9	60.0	87.8	39.8	28.1	37.0	31.1	52.4	66.6	24.5	35.2	33.5	19.8	25.1	20.9	42.6	55.7	50.6	69.0	54.8	20.6	34.9	42.5	112.5	25.9	82.5	26.6	32.7	30.6	64.0	34.2	30.8	22.1	63.6	34.5	29.1	103.8	28.2	39.2	20.6	56.2	37.9	11.4	11.4	15.2	15.6	11.5	11.5	11.1	11.8	11.5	12.7	12.0	13.1	39.1	22.4	13.7	30.7	85.1	46.8	40.9	85.3	47.8	23.9	22.6	18.9	16.9	32.9	40.4	16.5	41.7	36.9	42.5	191.0	29.4	34.4	5.7	40.9	21.0	40.8	119.6	127.1	45.3	79.0	31.6	35.2	42.8	21.4	17.7	38.3	30.0	18.9	25.0	1.7	49.4	98.9	40.7	31.2	23.5	5.0	33.8	111.4	26.6	29.0	37.0	23.4	55.6	48.2	52.4	48.3	186.6	22.2	43.8	45.7	91.8	84.8	53.7	27.1	13.1	30.7	24.9	46.4	24.0	35.5	38.9	28.3	53.7	23.3	71.0	65.9
NT5E	"CALJA, CD73, eN, eNT, NT5"	ENSG00000135318	"5'-nucleotidase ecto"	P21589	6	85449584-85495791	"CD markers, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		Hydrolase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix: 112.6;retina: 94.4"	"Cell type enhanced"	"Detected in many"		"Glandular and luminal cells: 58.0;Oligodendrocyte precursor cells: 61.3;Pancreatic endocrine cells: 124.8;Rod photoreceptor cells: 81.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"naive B-cell: 33.0;naive CD8 T-cell: 30.7"	"Group enriched"	"Detected in many"	41	"B-cells: 33.0;T-cells: 30.7"	"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 807.8;LHCN-M2: 934.3;TIME: 546.2;U-87 MG: 821.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017357	Approved		Supported	"Nucleoplasm,Plasma membrane,Cytosol"	"Intracellular and membrane"	NA	NA		3000000	"Cluster 21: B-cells - Adaptive immune response"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 50: Fibroblasts - ECM organization"	"Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA017357: AB_1846330"	"unprognostic (1.92e-2)"	"unprognostic (4.44e-3)"	"unprognostic (1.54e-1)"	"unprognostic (1.57e-3)"	"unprognostic (9.33e-2)"	"unprognostic (1.82e-3)"	"unprognostic (1.20e-2)"	"prognostic unfavorable (6.66e-4)"	"unprognostic (5.45e-2)"	"unprognostic (1.80e-1)"	"prognostic unfavorable (1.32e-5)"	"unprognostic (1.39e-1)"	"unprognostic (3.11e-2)"	"prognostic unfavorable (1.02e-4)"	"unprognostic (3.49e-2)"	"unprognostic (2.26e-1)"	"unprognostic (2.78e-1)"	20.7	6.0	9.8	11.9	11.9	0.6	14.1	11.2	10.7	112.6	14.9	29.4	40.1	49.4	6.3	8.6	20.7	17.2	8.7	8.5	11.3	17.2	54.8	6.8	9.6	11.7	14.1	39.3	1.8	1.8	11.8	25.3	13.0	13.3	31.9	94.4	6.6	34.2	2.1	6.4	20.9	73.9	14.7	13.0	8.1	10.4	12.7	5.2	23.7	9.8	11.3	15.8	28.5	12.1	48.9	26.0	42.9	0.8	95.1	302.4	0.4	306.1	332.7	147.5	275.2	0.4	469.6	0.0	107.3	270.2	379.0	24.5	0.1	308.0	348.8	0.8	0.1	0.1	7.3	6.0	47.5	0.2	0.7	77.4	3.7	302.0	191.3	807.8	124.9	0.3	0.3	1.4	934.3	8.3	0.0	0.2	0.8	8.2	34.6	1.5	9.5	1.3	323.1	21.8	0.3	5.5	3.8	18.8	104.9	2.2	0.4	8.3	546.2	120.6	0.9	152.9	506.8	22.7	15.3	0.5	821.7	0.4	385.3	0.0	0.0	0.5	3.7	0.0	6.4	23.7	4.2	11.7	0.0	33.0	4.1	30.7	0.5	0.7	0.0	0.1	1.7	6.4	9.8	11.9	11.2	10.7	8.5	11.3	11.7	14.1	13.0	14.7	12.7	12.1	6.4	0.0	5.8	36.9	21.6	5.2	1.7	6.1	2.8	4.4	1.2	0.3	1.7	27.1	4.8	1.8	10.4	0.6	2.2	49.2	3.9	3.8	0.6	19.3	20.8	20.5	0.0	0.0	1.6	4.1	2.5	39.4	11.2	58.0	0.0	0.1	49.6	33.7	1.3	0.0	2.1	27.7	0.0	3.5	8.2	1.3	13.1	2.1	7.2	11.2	0.5	9.1	0.0	61.3	0.7	124.8	46.0	25.6	3.6	1.5	8.3	27.6	4.8	81.6	0.0	3.3	9.6	0.0	0.3	0.6	4.8	15.2	5.0	0.1	18.0	9.6
NTAQ1	"C8orf32, FLJ10204, WDYHV1"	ENSG00000156795	"N-terminal glutamine amidase 1"	Q96HA8	8	123416726-123470028	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Adipocytes: 5.5;Cardiomyocytes: 21.9;Cytotrophoblasts: 13.9;Extravillous trophoblasts: 23.0;Hofbauer cells: 13.2;Syncytiotrophoblasts: 10.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SK-BR-3: 109.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024823, HPA053680"	Approved		Supported	Nucleoplasm,Vesicles		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm	Vesicles	"HPA024823: AB_1845773, HPA053680: AB_2682228"	"unprognostic (9.97e-2)"	"unprognostic (4.82e-2)"	"unprognostic (3.48e-1)"	"prognostic unfavorable (4.93e-5)"	"unprognostic (1.69e-1)"	"unprognostic (5.00e-2)"	"prognostic unfavorable (3.47e-4)"	"unprognostic (1.93e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.19e-1)"	"unprognostic (5.79e-2)"	"unprognostic (2.81e-2)"	"unprognostic (1.26e-1)"	"unprognostic (5.39e-2)"	"unprognostic (7.46e-2)"	"unprognostic (2.37e-1)"	7.1	10.9	16.2	5.1	16.7	5.9	13.5	16.3	24.0	12.8	15.5	7.5	4.3	8.1	8.9	6.9	7.5	6.7	20.1	14.8	17.8	13.0	6.8	6.8	7.4	17.0	17.9	18.2	9.6	11.0	10.5	6.8	17.4	10.2	7.9	14.9	6.9	8.8	16.0	7.7	4.4	9.5	15.8	5.2	8.5	12.7	20.0	7.1	12.8	17.6	10.1	8.8	7.2	17.7	26.6	26.9	39.2	18.1	15.3	40.9	14.5	19.1	21.3	23.4	26.1	15.8	17.8	19.7	19.8	23.8	32.7	12.8	25.8	29.7	31.4	53.1	15.8	25.6	13.2	22.4	21.2	12.7	10.9	24.1	16.0	29.3	32.8	27.1	22.6	41.2	18.8	29.0	33.5	84.3	30.2	14.4	12.3	65.6	20.5	13.5	20.0	20.4	31.1	22.6	18.6	34.1	20.7	109.0	35.8	44.5	17.6	12.2	9.8	26.5	46.2	19.7	26.4	17.4	38.1	24.1	18.8	14.1	19.1	16.3	5.7	2.1	6.2	8.7	7.4	5.0	7.3	7.7	9.0	4.1	6.2	6.9	1.5	16.0	3.8	5.2	10.6	4.6	16.2	16.7	16.3	24.0	14.8	17.8	17.0	17.9	17.4	15.8	20.0	17.7	5.5	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.9	0.0	0.0	0.0	0.0	13.9	2.1	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	23.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	13.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	10.0	0.3	0.0	0.0	0.0
NTN1	NTN1L	ENSG00000065320	"Netrin 1"	O95631	17	9021510-9244000	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins"	Apoptosis		"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 37.1;heart muscle: 59.4"	"Cell type enriched"	"Detected in many"	4	"Oligodendrocyte precursor cells: 137.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BEWO: 27.5;T-47d: 16.6;U-2 OS: 14.4;U-251 MG: 22.1;WM-115: 12.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA056419	Approved		Approved	"Nucleoplasm,Actin filaments,Cytosol"	"Secreted to extracellular matrix"	NA	NA		110000		"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 68: Oligodendrocytes - Mixed function"	Cytosol	"Nucleoplasm, Actin filaments"	"HPA056419: AB_2683124"	"unprognostic (2.72e-1)"	"unprognostic (2.59e-2)"	"unprognostic (7.12e-2)"	"unprognostic (5.25e-2)"	"unprognostic (2.51e-1)"	"unprognostic (9.33e-3)"	"unprognostic (9.42e-2)"	"unprognostic (2.20e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.33e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.49e-2)"	"unprognostic (2.20e-2)"	"unprognostic (2.60e-1)"	"unprognostic (6.07e-3)"	"unprognostic (8.31e-3)"	6.4	0.5	4.5	3.6	6.4	0.1	5.3	10.1	4.9	9.3	2.8	14.7	6.7	9.6	3.5	18.9	10.3	7.3	59.4	3.8	7.0	2.0	6.9	4.3	0.2	12.7	37.1	0.9	2.3	4.3	3.0	0.9	14.4	3.9	3.9	0.4	10.9	2.0	2.1	8.1	10.5	6.0	13.8	0.1	17.5	3.1	10.1	2.9	2.0	2.6	2.1	10.2	5.4	8.8	0.1	0.0	1.3	4.6	4.2	0.1	27.5	0.3	0.4	0.3	0.5	0.1	5.7	0.0	6.2	0.0	9.0	0.1	1.2	0.9	0.0	6.4	10.4	1.4	0.0	0.0	0.1	0.5	0.1	0.1	2.1	0.8	0.0	0.0	0.0	1.0	0.0	0.0	0.1	5.6	0.1	0.6	1.8	0.0	0.0	3.4	4.8	0.0	0.0	0.3	0.0	0.0	0.1	4.7	1.1	4.5	16.6	0.3	0.0	6.7	14.4	0.0	22.1	0.0	0.0	0.0	0.0	0.0	12.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	6.4	10.1	4.9	3.8	7.0	12.7	37.1	14.4	13.8	10.1	8.8	0.7	0.0	0.0	10.7	0.3	3.3	6.6	21.8	9.6	2.9	4.7	4.4	28.1	0.0	23.9	1.8	0.0	0.3	0.2	0.5	0.0	3.1	9.3	5.8	2.0	3.1	0.0	0.0	4.8	1.7	1.2	9.7	1.1	7.9	0.0	0.0	2.2	12.4	0.1	0.0	7.1	1.4	24.4	0.6	5.9	4.6	0.3	0.1	1.8	9.4	0.6	0.3	0.0	137.2	1.0	1.4	0.1	0.0	0.0	4.0	0.7	0.2	11.1	0.2	0.0	3.9	6.8	1.6	2.0	12.7	2.8	0.5	0.5	0.0	0.6	3.5
NTNG1	"KIAA0976, Lmnt1"	ENSG00000162631	"Netrin G1"	Q9Y2I2	1	107140007-107484923	"Predicted intracellular proteins"	"Differentiation, Neurogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"brain: 75.1"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 59.7;Excitatory neurons: 122.1;Inhibitory neurons: 162.5;Oligodendrocyte precursor cells: 425.3"	"Low cancer specificity"	"Detected in some"			"Region enhanced"	"Detected in all"		"thalamus: 75.1"	"Immune cell enhanced"	"Detected in single"		"memory B-cell: 1.1"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 48.7;fHDF/TERT166: 25.0;RPTEC TERT1: 27.4;U-138 MG: 21.8;U-251 MG: 16.9;U-87 MG: 24.8"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"hippocampal formation: 19.7;midbrain: 61.3;pons: 56.0;thalamus: 76.4"	HPA065954			Supported	"Plasma membrane"	"Intracellular and membrane"	NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Plasma membrane"		"HPA065954: AB_2685585"	"unprognostic (1.79e-1)"	"unprognostic (4.63e-2)"	"unprognostic (1.67e-2)"	"unprognostic (9.38e-5)"	"unprognostic (1.93e-3)"	"unprognostic (9.87e-3)"		"unprognostic (3.34e-1)"	"unprognostic (8.38e-3)"	"unprognostic (1.03e-1)"	"unprognostic (2.02e-1)"	"unprognostic (5.68e-2)"	"unprognostic (2.05e-2)"	"unprognostic (3.10e-4)"	"unprognostic (2.00e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.93e-5)"	3.1	4.4	17.2	0.2	3.8	0.0	0.2	6.3	6.7	3.2	0.0	2.2	0.0	0.6	0.0	0.1	0.4	0.6	0.1	7.8	15.2	8.8	0.0	3.8	0.4	5.8	28.3	0.4	0.1	0.1	2.5	1.1	4.6	3.4	0.4	10.3	0.2	4.7	0.0	1.3	0.4	0.1	3.2	0.3	0.2	0.4	75.1	0.5	0.1	0.2	0.6	4.0	1.8	2.7	0.0	0.0	2.8	0.0	5.0	48.7	0.0	13.9	2.1	1.2	1.1	0.0	0.0	0.0	0.6	25.0	0.0	0.0	0.0	1.5	2.8	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	13.9	0.3	3.5	1.8	14.7	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	1.0	0.0	6.1	0.0	3.1	0.0	27.4	0.0	0.3	0.4	0.0	0.0	0.0	0.8	0.0	0.1	0.2	21.8	4.3	8.1	16.9	0.1	0.0	0.0	24.8	0.0	2.5	0.3	0.0	0.0	0.0	0.0	0.1	1.1	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.0	0.0	17.2	3.8	6.3	6.7	7.8	15.2	5.8	28.3	4.6	3.2	75.1	2.7	0.2	0.0	0.0	46.4	3.1	0.5	6.5	0.4	0.0	59.7	0.1	0.0	0.9	0.0	0.2	7.3	0.0	0.1	0.0	0.0	0.0	0.0	10.5	0.1	0.8	0.9	0.0	0.0	122.1	0.0	0.0	2.8	0.0	0.4	0.0	6.1	0.4	0.0	0.0	0.0	162.5	0.0	6.1	0.0	1.3	1.8	8.1	0.0	1.8	18.7	0.0	1.0	0.0	425.3	2.5	0.3	0.0	0.0	1.0	1.1	0.0	0.0	0.0	2.9	6.6	0.2	2.7	0.2	1.1	0.1	0.6	0.0	0.1	7.2	0.0	4.3
NTRK2	TRKB	ENSG00000148053	"Neurotrophic receptor tyrosine kinase 2"	Q16620	9	84668551-85027054	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted membrane proteins, RAS pathway related proteins"	"Differentiation, Neurogenesis"	"Developmental protein, Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease variant, Epilepsy, FDA approved drug targets, Obesity"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 230.0;thyroid gland: 116.9"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 1144.3;Excitatory neurons: 750.1;Inhibitory neurons: 877.7;Oligodendrocyte precursor cells: 557.9"	"Group enriched"	"Detected in many"	5	"glioma: 31.6;head and neck cancer: 8.0;lung cancer: 9.8;thyroid cancer: 26.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 8.7;HaCaT: 3.0;RPTEC TERT1: 9.7;SH-SY5Y: 11.2;SuSa: 4.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007637, CAB010346, HPA074873"	Enhanced		Supported	"Plasma membrane"		NA	NA		20000000		"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Plasma membrane"		"CAB010346: AB_2155274, HPA007637: AB_1080385, HPA074873: "	"unprognostic (2.75e-3)"	"unprognostic (3.48e-2)"	"unprognostic (1.82e-2)"	"unprognostic (3.26e-1)"	"unprognostic (9.26e-2)"	"unprognostic (2.56e-2)"	"unprognostic (1.29e-2)"	"unprognostic (9.16e-2)"	"unprognostic (6.13e-2)"	"unprognostic (1.05e-1)"	"unprognostic (4.25e-2)"	"unprognostic (2.18e-2)"	"unprognostic (2.66e-2)"	"unprognostic (1.20e-2)"	"unprognostic (1.21e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.39e-3)"	40.5	2.7	201.9	1.7	177.8	0.1	62.2	133.3	190.6	9.8	69.8	5.9	0.4	3.9	3.9	8.2	5.6	33.3	15.2	173.3	230.0	20.4	1.8	10.0	3.1	119.4	218.9	9.7	34.3	2.5	10.1	1.8	151.7	4.7	3.6	41.2	14.4	19.1	2.9	11.6	1.6	3.3	116.6	10.9	1.9	2.4	222.1	4.0	116.9	13.8	4.3	4.9	12.0	117.7	0.0	0.0	8.7	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	1.4	0.0	0.2	0.0	0.0	3.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	9.7	0.7	0.7	11.2	0.0	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.1	0.0	0.3	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	201.9	177.8	133.3	190.6	173.3	230.0	119.4	218.9	151.7	116.6	222.1	117.7	17.4	0.0	0.5	1144.3	0.7	56.6	1.0	1.8	93.9	30.3	144.1	116.8	11.4	0.0	0.2	9.2	6.2	0.0	1.0	8.7	27.4	36.1	1.8	1.2	0.4	8.0	0.0	0.0	750.1	0.7	0.1	76.6	0.0	2.3	0.0	0.1	5.0	0.0	0.2	242.3	877.7	0.7	0.0	0.0	14.2	3.6	104.1	1.4	17.8	65.6	0.6	241.0	0.0	557.9	109.5	0.5	7.0	48.2	0.3	0.9	0.0	7.1	1.7	12.2	124.9	9.9	114.4	0.8	2.3	5.2	24.6	0.0	3.3	0.2	7.2	0.9
NTRK3	TRKC	ENSG00000140538	"Neurotrophic receptor tyrosine kinase 3"	Q16288	15	87859751-88256768	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Differentiation, Neurogenesis"	"Developmental protein, Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 38.8"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 239.3;Early spermatids: 119.6;Excitatory neurons: 360.0;Inhibitory neurons: 277.8;Late spermatids: 148.9;Microglial cells: 177.1;Oligodendrocyte precursor cells: 499.6"	"Group enriched"	"Detected in some"	4	"glioma: 2.5;testis cancer: 1.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	8	"U-138 MG: 100.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009233, HPA027484, HPA048065"	Approved		Supported	"Nuclear membrane,Nucleoli,Nucleoli rim"		NA	NA		19000000		"Cluster 10: Brain - Neuronal signaling"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Nucleoli, Nucleoli rim"	"Nuclear membrane"	"CAB009233: AB_632555, HPA027484: AB_2672297, HPA048065: AB_2680245"	"unprognostic (1.27e-3)"	"unprognostic (1.24e-2)"	"unprognostic (1.98e-2)"	"unprognostic (2.04e-2)"	"unprognostic (1.65e-1)"	"unprognostic (3.34e-1)"	"unprognostic (3.18e-2)"	"unprognostic (2.23e-2)"	"unprognostic (2.34e-1)"	"unprognostic (3.91e-1)"	"unprognostic (2.88e-1)"	"unprognostic (1.09e-1)"	"unprognostic (5.78e-3)"	"unprognostic (6.45e-3)"	"unprognostic (1.06e-2)"	"unprognostic (1.26e-2)"	"unprognostic (2.49e-3)"	12.8	3.7	31.3	0.8	33.2	0.1	7.8	30.7	34.3	12.8	0.0	3.4	0.5	10.4	3.2	1.3	15.0	1.6	5.8	38.8	25.8	5.1	1.0	5.3	1.2	21.5	19.6	7.2	1.0	0.1	12.2	1.0	22.1	9.0	2.0	5.2	6.8	4.3	1.8	4.8	2.2	3.7	10.9	2.5	3.2	9.8	33.4	1.2	3.0	1.9	2.0	8.7	7.4	21.5	0.0	13.1	2.7	0.3	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.0	0.0	0.2	0.3	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.3	0.0	0.0	0.0	0.2	0.1	0.0	0.1	0.0	2.5	0.0	0.0	0.0	2.6	0.1	0.1	0.1	0.7	0.1	0.0	0.0	0.0	0.9	0.1	0.1	0.0	100.6	1.8	0.0	1.3	0.0	0.0	0.0	3.0	0.1	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	31.3	33.2	30.7	34.3	38.8	25.8	21.5	19.6	22.1	10.9	33.4	21.5	0.5	0.0	0.0	239.3	0.0	0.5	6.4	0.0	0.0	53.8	3.7	6.0	5.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	119.6	0.4	25.0	1.2	0.0	0.0	360.0	0.0	0.0	5.7	0.0	0.5	0.0	0.0	2.2	0.0	1.0	1.7	277.8	0.0	0.0	0.0	0.6	148.9	3.4	0.6	0.0	177.1	0.0	8.6	0.0	499.6	7.4	0.0	0.0	27.4	0.0	1.3	0.0	0.1	0.0	3.7	52.6	20.3	40.9	11.0	3.7	0.0	0.1	0.1	0.2	0.0	0.0	0.7
NTS		ENSG00000133636	Neurotensin	P30990	12	85874295-85882992	"Predicted secreted proteins"		Vasoactive		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"intestine: 165.8"	"Cell type enriched"	"Detected in some"	13	"Intestinal goblet cells: 1683.2"	"Cancer enhanced"	"Detected in many"		"lung cancer: 155.1"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"SuSa: 205.5"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in many"		"basal ganglia: 154.3"	"HPA026664, HPA071012"	Enhanced		Supported	Vesicles	"Secreted to digestive system"	NA	NA		1600000		"Cluster 56: Intestine - Transmembrane transport"	"Cluster 12: NES - Nervous system development"	"Cluster 27: Mucus-secreting cells - Mucin production"	Vesicles		"HPA026664: AB_2671936, HPA071012: "	"unprognostic (3.63e-1)"	"prognostic favorable (9.94e-5)"	"unprognostic (8.18e-2)"	"prognostic unfavorable (5.10e-4)"	"unprognostic (1.99e-2)"	"unprognostic (3.04e-1)"	"unprognostic (7.62e-2)"	"unprognostic (2.43e-1)"	"unprognostic (1.53e-3)"	"unprognostic (8.83e-2)"	"unprognostic (1.74e-2)"	"unprognostic (3.76e-2)"	"unprognostic (1.30e-6)"	"unprognostic (2.94e-2)"	"unprognostic (2.25e-1)"	"unprognostic (2.17e-1)"	"unprognostic (7.48e-2)"	6.2	1.2	3.3	3.6	0.6	0.0	5.2	0.9	8.4	0.7	0.5	1.8	6.6	0.3	0.7	5.6	0.9	1.3	0.9	2.5	18.1	1.7	1.4	1.2	11.7	11.7	10.2	0.6	0.4	0.1	32.3	0.5	6.2	0.3	1.5	0.0	0.1	0.6	0.0	0.2	165.8	1.1	3.2	0.1	36.4	0.3	26.8	0.5	0.8	0.2	1.0	3.1	0.3	3.6	0.0	5.0	0.3	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	1.9	0.1	0.0	0.0	0.0	0.0	0.0	1.0	50.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.2	10.7	0.0	4.1	0.0	1.7	0.0	0.0	0.0	5.4	1.6	0.0	0.0	0.0	205.5	0.4	0.0	0.0	0.1	0.0	0.4	0.0	2.4	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.6	0.9	8.4	2.5	18.1	11.7	10.2	6.2	3.2	26.8	3.6	3.6	0.0	0.5	0.0	0.0	1.3	0.7	22.6	0.0	0.0	10.1	0.0	0.3	0.0	27.0	9.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	68.4	2.4	0.0	0.0	0.0	0.3	0.5	0.0	0.0	0.0	0.0	44.3	0.0	0.2	0.0	1.2	1683.2	2.0	0.3	2.6	0.0	0.0	0.2	1.8	0.0	0.0	0.0	0.0	0.0	0.1	0.5	15.0	0.0	0.0	2.5	120.8	0.0	3.5	0.0	0.0	0.0	0.9	0.8	0.1	1.2	2.3	0.1	1.3	0.0	8.1	60.4
NTSR1	NTR	ENSG00000101188	"Neurotensin receptor 1"	P30989	20	62708836-62762771	"G-protein coupled receptors, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	18	"brain: 11.2;intestine: 11.2"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 4.4;Cardiomyocytes: 1.1;Excitatory neurons: 1.6;Inhibitory neurons: 1.3;Kupffer cells: 2.9;Microglial cells: 1.0;monocytes: 1.4"	"Cancer enhanced"	"Detected in some"		"pancreatic cancer: 2.9"	"Region enriched"	"Detected in many"	7	"midbrain: 11.2"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"PC-3: 57.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA050299			Supported	"Plasma membrane"		NA	NA				"Cluster 57: Non-specific - Angiogenesis"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 56: Bipolar cells - Visual perception"	"Plasma membrane"		"HPA050299: "	"unprognostic (4.14e-2)"	"unprognostic (2.02e-2)"	"unprognostic (2.75e-2)"	"unprognostic (8.87e-4)"	"unprognostic (9.27e-3)"	"unprognostic (1.45e-1)"	"unprognostic (4.17e-2)"	"unprognostic (2.80e-3)"	"unprognostic (7.16e-2)"	"unprognostic (3.10e-3)"	"unprognostic (3.55e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.27e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.49e-1)"	0.0	0.0	1.1	0.0	1.5	0.6	0.0	0.0	1.4	0.0	0.0	11.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.4	0.0	0.0	0.0	0.0	0.4	11.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.2	0.2	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.0	0.0	2.0	10.9	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.3	0.0	0.0	2.8	0.2	2.7	0.3	1.1	57.7	1.8	0.0	9.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	10.8	7.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	1.5	0.0	1.4	1.4	0.4	0.4	11.2	0.1	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.3	0.0	4.4	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.3	0.0	0.0	2.9	0.3	0.0	0.0	0.5	0.0	1.0	1.4	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0
NUAK1	"ARK5, KIAA0537"	ENSG00000074590	"NUAK family kinase 1"	O60285	12	106063345-106138954	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Cell adhesion, DNA damage"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Endothelial cells: 111.7;Excitatory neurons: 150.5;Hepatic stellate cells: 136.3;Microglial cells: 93.7;Oligodendrocytes: 73.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 58.0;EFO-21: 55.1;RH-30: 77.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA057143			Approved	"Nucleoplasm,Nucleoli fibrillar center,Microtubules"		Yes	No				"Cluster 47: Non-specific - Unknown function"	"Cluster 12: NES - Nervous system development"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Nucleoli fibrillar center"	"Nucleoplasm, Microtubules"	"HPA057143: AB_2683349"	"unprognostic (4.20e-2)"	"unprognostic (8.42e-2)"	"unprognostic (3.71e-2)"	"prognostic unfavorable (9.83e-4)"	"unprognostic (4.13e-2)"	"unprognostic (2.34e-1)"	"unprognostic (1.43e-1)"	"unprognostic (4.80e-2)"	"unprognostic (9.91e-2)"	"unprognostic (4.06e-3)"	"unprognostic (3.29e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.93e-3)"	"prognostic unfavorable (4.27e-4)"	"unprognostic (2.31e-1)"	"unprognostic (8.70e-2)"	"unprognostic (4.47e-2)"	17.5	3.6	12.6	2.3	17.5	0.6	12.1	9.4	25.4	9.8	0.0	4.1	2.2	9.5	3.1	3.5	9.0	4.9	18.8	17.4	5.6	4.2	4.0	9.3	3.2	6.1	5.9	6.1	3.2	17.5	2.7	4.5	8.3	6.0	3.9	5.4	3.4	6.0	20.6	20.8	4.3	10.2	5.5	0.8	3.8	2.6	5.5	3.3	4.3	17.2	2.3	4.8	8.1	31.8	13.0	8.3	58.0	0.6	23.7	2.5	27.0	14.2	9.5	9.9	8.0	4.3	2.1	0.0	55.1	27.4	5.0	11.9	12.6	11.2	4.8	0.2	3.4	0.0	9.7	4.7	5.0	0.1	0.1	11.0	8.1	6.0	1.7	19.2	21.2	0.1	0.0	40.3	7.8	1.3	0.2	0.6	11.1	0.2	3.3	0.1	77.7	10.5	6.6	13.3	6.8	0.4	6.9	1.9	0.5	37.2	2.9	0.4	16.6	9.4	29.7	3.3	17.0	0.0	0.0	0.7	2.8	0.0	9.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	12.6	17.5	9.4	25.4	17.4	5.6	6.1	5.9	8.3	5.5	5.5	31.8	56.4	0.0	2.4	15.7	0.6	13.5	32.9	29.8	10.2	32.3	2.1	4.2	48.9	10.0	7.2	7.3	0.0	0.8	13.5	0.9	3.9	6.2	0.4	5.1	6.6	111.7	0.0	5.3	150.5	9.6	5.2	17.9	2.0	3.8	0.0	2.9	136.3	12.1	8.0	40.4	55.4	2.3	12.2	8.4	8.8	2.6	4.1	1.3	10.6	93.7	0.6	1.9	1.0	15.6	73.5	18.4	0.5	3.0	3.2	10.6	0.2	1.8	2.2	2.9	0.0	7.1	26.4	1.0	5.5	2.5	15.9	0.3	2.7	0.4	0.8	5.2
NUBP1	"CIAO5, NBP1, NBP35"	ENSG00000103274	"Nucleotide binding protein 1"	P53384	16	10743786-10769351	"Predicted intracellular proteins"	"Cilium biogenesis/degradation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041656, HPA041799"	Enhanced		Supported	Cytosol		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 3: Monocytes - Immune response regulation"	Cytosol		"HPA041656: AB_10960278, HPA041799: AB_10960692"	"unprognostic (2.51e-2)"	"prognostic favorable (2.81e-5)"	"unprognostic (4.01e-3)"	"unprognostic (1.66e-3)"	"unprognostic (2.81e-1)"	"unprognostic (7.04e-2)"	"unprognostic (1.33e-1)"	"unprognostic (7.30e-3)"	"unprognostic (8.28e-2)"	"unprognostic (5.08e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.50e-1)"	"prognostic favorable (7.61e-8)"	"unprognostic (2.12e-1)"	"unprognostic (1.04e-1)"	"unprognostic (8.23e-2)"	"unprognostic (1.69e-2)"	22.7	39.3	12.6	25.9	12.7	31.0	22.0	13.6	16.5	19.9	15.2	27.4	21.6	21.3	24.8	19.7	25.6	19.6	46.7	12.5	13.1	27.8	31.1	21.2	31.1	13.2	12.7	22.9	31.9	30.3	17.0	19.6	13.1	21.1	20.0	12.0	21.7	21.0	37.7	15.7	22.1	22.7	13.5	28.5	28.7	17.3	12.9	21.4	23.5	34.7	36.9	24.4	16.8	13.8	31.3	55.9	37.2	23.1	16.8	31.0	35.5	29.9	27.9	51.4	42.6	49.0	33.2	53.7	60.5	36.7	40.0	33.5	34.9	30.7	38.2	84.8	43.9	30.3	39.3	80.4	33.7	27.7	34.3	29.2	23.0	35.2	19.2	28.6	34.2	20.6	43.3	31.7	38.3	72.0	18.2	40.2	46.1	25.5	29.9	72.5	48.2	58.6	37.0	37.7	22.9	33.5	51.8	38.6	29.2	23.7	39.3	30.2	30.5	40.0	40.8	49.9	38.2	56.0	52.0	42.4	36.7	55.3	48.0	3.8	82.7	41.3	39.2	88.2	35.9	75.6	34.7	39.1	89.7	69.3	29.9	31.1	9.7	35.2	66.7	44.0	46.5	52.9	12.6	12.7	13.6	16.5	12.5	13.1	13.2	12.7	13.1	13.5	12.9	13.8	20.3	6.4	23.1	3.9	33.7	14.3	26.6	39.8	10.8	17.0	14.9	17.3	6.0	34.3	32.2	23.9	6.2	49.6	19.0	12.3	66.5	54.2	2.4	17.3	12.2	21.3	16.8	12.0	8.4	79.1	29.2	16.7	15.8	17.2	24.1	17.3	14.6	29.6	56.4	6.7	8.1	19.2	40.7	38.4	91.2	3.6	25.7	38.0	16.0	3.7	72.7	30.1	20.6	3.0	5.2	48.7	18.4	19.5	17.6	17.9	27.2	65.0	31.6	18.5	6.6	20.0	15.9	33.1	29.4	12.3	11.9	60.7	17.8	25.3	18.0	29.2
NUBPL	"C14orf127, FLJ12660, huInd1, IND1"	ENSG00000151413	"Nucleotide binding protein like"	Q8TB37	14	31489956-31861224	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Astrocytes: 68.2;Inhibitory neurons: 74.8;Oligodendrocyte precursor cells: 87.9;Oligodendrocytes: 99.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029203	Approved		Supported	Mitochondria	"Intracellular and membrane"	NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Mitochondria		"HPA029203: AB_10602810"	"unprognostic (1.49e-1)"	"unprognostic (1.71e-2)"	"unprognostic (5.21e-3)"	"unprognostic (8.28e-2)"	"unprognostic (8.25e-2)"	"unprognostic (1.94e-3)"	"unprognostic (1.67e-1)"	"unprognostic (1.93e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.35e-1)"	"unprognostic (2.15e-1)"	"unprognostic (2.80e-1)"	"prognostic favorable (3.64e-8)"	"unprognostic (2.82e-2)"	"unprognostic (6.60e-2)"	"unprognostic (3.67e-3)"	"unprognostic (1.56e-2)"	9.7	6.4	4.2	3.9	4.6	1.8	8.9	4.5	4.8	4.9	4.2	7.6	4.9	5.8	7.6	4.6	6.4	5.3	17.0	4.0	5.0	12.2	12.3	4.1	5.7	4.9	4.7	6.8	5.5	7.9	3.8	5.5	4.5	6.3	7.8	5.2	11.9	6.1	11.9	4.7	5.8	5.4	4.3	6.6	4.7	3.5	5.0	5.5	8.0	17.4	5.4	4.2	3.2	5.8	13.6	8.5	6.4	3.3	8.9	16.4	11.5	7.3	8.2	8.9	10.2	5.9	15.3	9.8	9.2	9.1	7.5	11.7	8.6	15.5	15.3	7.1	11.1	3.5	6.3	30.4	8.8	10.4	3.0	10.7	17.0	6.0	12.8	7.3	5.0	7.0	6.4	4.9	9.8	7.4	7.7	7.1	5.4	10.8	13.1	8.6	13.4	5.3	10.2	10.0	6.0	6.2	12.2	10.8	14.5	7.2	21.1	5.4	4.9	8.6	5.9	5.6	6.8	8.1	9.7	9.3	5.5	7.3	7.9	0.0	1.1	0.4	2.1	1.2	1.7	2.6	2.7	2.3	4.4	1.7	3.0	2.4	0.4	2.5	0.7	2.2	1.8	0.9	4.2	4.6	4.5	4.8	4.0	5.0	4.9	4.7	4.5	4.3	5.0	5.8	6.9	12.8	9.8	68.2	10.1	9.6	8.6	5.4	9.1	15.3	10.2	7.1	36.9	15.7	10.6	9.2	20.9	11.2	7.5	6.3	7.9	6.8	24.1	12.6	10.8	6.3	7.2	6.7	48.2	5.7	10.2	12.0	7.1	5.4	14.5	16.4	4.6	15.3	4.9	10.1	74.8	12.0	2.0	4.1	16.1	7.4	6.5	6.1	12.4	54.4	2.8	16.2	5.2	87.9	99.6	5.2	5.8	11.7	8.0	4.4	5.1	19.1	18.7	28.4	13.1	11.8	9.8	15.7	5.2	7.3	11.6	5.7	6.4	23.1	18.2	5.9
NUCB1	"Calnuc, NUC"	ENSG00000104805	"Nucleobindin 1"	Q02818	19	48900312-48923372	"Plasma proteins, Predicted secreted proteins"		"DNA-binding, Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Proximal enterocytes: 453.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008176	Supported		Supported	"Golgi apparatus,Microtubules"	"Secreted to blood"	NA	NA		27000000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 16: U-266 - Nucleosome"	"Cluster 45: Enterocytes - Digestion"	"Golgi apparatus"	Microtubules	"HPA008176: AB_1845923"	"unprognostic (2.13e-1)"	"unprognostic (2.83e-1)"	"unprognostic (4.36e-3)"	"unprognostic (6.28e-2)"	"unprognostic (1.06e-2)"	"unprognostic (2.95e-1)"	"unprognostic (6.86e-2)"	"unprognostic (1.98e-1)"	"unprognostic (9.51e-2)"	"unprognostic (8.14e-3)"	"unprognostic (2.34e-3)"	"unprognostic (9.89e-2)"	"unprognostic (5.04e-3)"	"unprognostic (1.19e-1)"	"unprognostic (1.39e-1)"	"unprognostic (8.90e-3)"	"unprognostic (3.41e-1)"	181.3	103.5	55.8	106.8	60.4	82.3	141.6	65.5	68.1	115.0	79.4	122.1	179.9	127.6	61.3	111.2	116.9	108.3	204.0	58.2	63.0	154.6	264.5	157.1	82.1	65.9	62.9	125.6	130.1	173.5	69.5	114.8	67.5	109.2	54.8	30.2	117.8	103.0	180.1	96.6	163.6	106.0	57.7	111.1	118.8	34.7	73.1	49.5	122.2	110.7	53.1	130.1	108.9	61.6	54.8	182.1	84.2	188.5	304.6	249.2	97.6	208.1	189.9	103.3	144.2	92.9	203.1	54.7	151.8	250.6	98.9	132.0	48.6	107.0	43.3	194.6	90.3	141.6	119.0	131.6	156.6	85.1	183.6	288.0	52.1	96.8	62.9	275.2	167.2	60.7	173.1	278.8	107.0	71.6	42.3	68.6	42.2	132.1	93.5	78.7	125.3	114.9	90.2	134.6	61.2	123.2	247.1	152.2	88.1	79.7	78.8	112.1	234.6	172.3	114.3	107.0	99.3	210.8	501.1	37.1	132.5	54.3	207.3	102.9	108.5	105.7	100.6	128.5	75.3	46.8	67.5	77.2	79.0	37.3	55.3	56.7	104.7	69.2	114.2	113.9	74.6	129.5	55.8	60.4	65.5	68.1	58.2	63.0	65.9	62.9	67.5	57.7	73.1	61.6	154.5	41.7	72.1	17.6	51.0	48.3	67.2	81.3	66.0	21.7	57.6	57.5	58.0	78.6	51.5	69.9	14.6	101.5	69.6	153.0	41.1	148.0	10.8	27.4	65.5	116.0	74.4	54.5	14.5	118.3	150.9	126.7	76.0	50.2	95.2	64.1	122.0	149.2	213.7	20.2	18.9	109.9	69.2	138.3	74.6	9.3	110.3	101.9	101.4	17.8	120.3	52.6	74.2	8.5	11.8	100.0	149.2	124.1	126.3	63.8	453.3	135.4	24.4	20.5	92.1	51.0	79.0	21.9	37.6	65.6	49.9	102.1	73.0	103.9	123.3	68.1
NUCKS1	NUCKS	ENSG00000069275	"Nuclear casein kinase and cyclin dependent kinase substrate 1"	Q9H1E3	1	205712822-205750182	"Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA062351, HPA063843"	Supported		Supported	Nucleoplasm,Nucleoli		No	No		13000	"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 2: Hepatocytes - Metabolism"	Nucleoplasm	Nucleoli	"HPA062351: AB_2684745, HPA063843: AB_2685134"	"unprognostic (1.68e-1)"	"unprognostic (3.92e-1)"	"unprognostic (3.38e-1)"	"prognostic unfavorable (1.41e-4)"	"unprognostic (1.87e-1)"	"unprognostic (2.93e-1)"	"unprognostic (9.20e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.47e-2)"	"unprognostic (5.16e-3)"	"unprognostic (1.18e-3)"	"unprognostic (1.37e-1)"	"unprognostic (5.82e-3)"	"unprognostic (7.45e-3)"	"unprognostic (1.44e-1)"	"unprognostic (2.25e-2)"	"unprognostic (7.57e-2)"	63.3	57.2	88.6	43.3	98.3	33.4	72.8	86.2	102.7	70.8	53.7	52.5	29.5	83.4	62.0	54.4	71.8	46.7	98.3	80.7	88.8	70.4	104.2	48.7	61.2	93.8	87.8	108.9	41.2	96.1	39.0	49.6	94.1	71.7	48.1	81.4	46.8	71.1	113.7	51.4	33.2	69.8	94.6	56.5	43.0	25.8	87.9	97.4	98.1	101.6	60.7	47.8	45.2	115.8	223.5	134.6	354.2	140.8	96.0	131.7	166.1	157.3	161.3	215.6	172.6	74.4	250.0	246.1	89.0	154.2	68.2	160.0	272.6	131.9	245.7	118.6	135.8	160.3	113.2	81.8	70.6	255.0	54.9	105.1	116.9	128.6	221.7	115.6	171.4	156.3	261.9	76.7	170.7	258.1	233.2	128.0	363.0	88.9	99.4	239.1	436.4	141.1	121.4	135.4	146.9	270.9	232.2	183.3	127.5	272.4	280.3	189.9	172.8	164.5	144.8	190.0	282.8	69.9	88.0	192.6	112.8	140.5	226.2	5.6	3.2	3.9	9.1	4.9	8.8	5.6	8.3	8.0	4.6	6.9	10.1	10.7	0.6	10.7	4.2	7.3	5.5	3.8	88.6	98.3	86.2	102.7	80.7	88.8	93.8	87.8	94.1	94.6	87.9	115.8	258.4	214.7	283.4	73.4	179.5	258.1	277.4	212.9	282.9	356.2	221.2	229.7	412.4	318.8	241.8	303.5	73.0	301.5	174.5	125.5	385.4	202.5	61.3	227.0	410.3	254.5	179.0	324.2	85.9	171.5	381.3	356.5	131.0	299.5	215.4	329.0	258.5	668.2	264.1	316.3	88.7	219.2	116.0	216.8	266.4	52.6	512.0	164.0	174.3	71.2	162.1	546.9	195.7	56.8	126.2	117.2	113.2	485.2	128.2	295.3	49.4	384.5	187.8	200.2	315.5	458.0	358.1	70.0	104.1	321.4	243.9	177.2	190.5	443.9	265.1	220.8
NUDCD1	"CML66, FLJ14991"	ENSG00000120526	"NudC domain containing 1"	Q96RS6	8	109240919-109334121	"Predicted intracellular proteins"	Immunity	"Tumor antigen"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 122.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023183	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA		7300	"Cluster 39: Non-specific - mRNA processing"	"Cluster 28: Placenta - Pregnancy"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	Nucleoplasm	Cytosol	"HPA023183: AB_1854695"	"unprognostic (5.08e-3)"	"unprognostic (3.73e-2)"	"unprognostic (2.52e-2)"	"unprognostic (9.03e-3)"	"unprognostic (7.52e-2)"	"unprognostic (3.62e-3)"	"prognostic unfavorable (1.39e-5)"	"prognostic unfavorable (4.37e-5)"	"unprognostic (2.13e-1)"	"unprognostic (9.49e-2)"	"prognostic unfavorable (6.94e-4)"	"unprognostic (8.22e-2)"	"prognostic unfavorable (8.71e-6)"	"unprognostic (1.95e-1)"	"unprognostic (1.63e-1)"	"unprognostic (3.35e-1)"	"unprognostic (1.65e-1)"	11.1	5.0	3.3	6.0	3.5	1.3	9.5	3.7	4.2	7.7	3.1	5.5	2.8	7.2	5.2	5.7	6.9	4.8	6.6	3.3	3.5	7.8	6.4	7.0	9.3	3.7	3.6	6.3	6.9	5.8	4.2	15.1	3.4	5.9	6.7	4.7	6.1	6.8	6.1	4.3	5.1	7.9	4.1	7.3	5.8	13.0	3.4	10.1	9.0	9.3	8.5	11.4	6.8	3.8	28.9	16.7	24.7	13.7	13.1	18.0	13.1	20.6	24.8	57.8	54.4	17.6	21.8	18.5	13.1	22.5	16.3	17.1	36.3	34.3	79.8	23.6	12.6	28.8	9.9	19.6	27.2	13.7	10.6	12.7	18.4	28.1	40.3	18.3	53.0	22.7	32.2	9.5	49.5	23.3	33.3	15.1	17.3	59.7	22.7	21.4	20.4	18.3	35.6	14.8	20.5	18.1	9.4	26.1	21.6	25.6	19.2	9.9	14.2	28.2	17.2	12.1	17.6	6.9	9.4	22.3	10.4	22.2	24.1	0.0	0.4	0.5	0.8	1.3	1.4	1.2	1.0	1.6	1.4	1.1	1.1	1.6	0.0	1.7	1.7	0.9	1.5	0.7	3.3	3.5	3.7	4.2	3.3	3.5	3.7	3.6	3.4	4.1	3.4	3.8	25.4	3.2	10.0	6.2	11.3	17.7	24.4	19.4	10.2	5.0	7.4	6.3	11.3	2.8	23.2	3.7	6.2	23.4	9.7	2.5	7.9	17.1	122.3	11.2	19.2	26.5	9.0	14.5	22.9	11.0	21.2	16.2	5.6	10.2	17.7	11.8	8.9	6.2	9.8	5.0	23.5	5.7	14.2	4.7	11.5	22.5	13.1	8.7	7.2	13.1	16.9	4.4	5.2	15.1	15.3	14.1	4.7	6.8	12.1	29.6	3.4	13.0	15.4	9.0	0.0	13.7	15.8	53.3	36.4	8.9	16.8	8.2	9.5	12.5	9.9	22.7
NUDCD2	"DKFZp686E10109, NudCL2"	ENSG00000170584	"NudC domain containing 2"	Q8WVJ2	5	163446526-163460102	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037384, HPA037385"	Uncertain		Supported	"Microtubules,Cytokinetic bridge,Mitotic spindle,Cytosol"		Yes	NA		18000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Microtubules	"Cytokinetic bridge, Mitotic spindle, Cytosol"	"HPA037384: AB_2675447, HPA037385: AB_10673630"	"unprognostic (3.96e-1)"	"unprognostic (3.69e-2)"	"prognostic favorable (2.80e-4)"	"unprognostic (1.46e-1)"	"unprognostic (9.12e-2)"	"unprognostic (3.75e-3)"	"unprognostic (1.84e-1)"	"unprognostic (4.74e-1)"	"unprognostic (3.47e-2)"	"unprognostic (7.63e-3)"	"unprognostic (1.81e-1)"	"unprognostic (2.45e-1)"	"unprognostic (3.91e-2)"	"unprognostic (1.34e-2)"	"unprognostic (6.86e-2)"	"unprognostic (3.40e-2)"	"unprognostic (7.85e-2)"	13.9	11.8	11.1	13.2	13.2	11.7	11.2	13.2	14.0	8.1	10.2	11.2	14.5	10.2	6.4	12.8	9.7	5.7	8.3	11.0	11.4	11.7	15.3	8.7	15.1	12.8	12.6	8.9	15.4	6.8	9.3	10.3	13.7	8.9	6.1	7.3	14.0	3.6	20.9	10.7	13.3	6.3	12.8	12.8	11.8	10.4	12.5	8.1	9.4	5.0	9.8	9.2	10.3	17.7	62.3	32.3	23.5	37.1	14.1	10.4	31.3	24.6	7.0	8.7	13.9	28.6	46.3	35.5	57.5	4.0	39.8	30.6	12.6	13.9	10.7	70.6	36.6	32.4	42.0	26.4	15.3	37.3	35.3	3.8	7.7	8.4	12.1	12.3	9.8	39.1	35.1	42.6	8.9	25.2	55.1	80.9	25.8	18.4	35.2	45.7	39.2	63.0	8.0	14.3	59.6	33.6	38.7	24.7	66.3	13.8	47.2	37.8	21.9	29.4	43.8	32.6	56.7	35.0	63.8	61.5	34.2	63.2	31.4	49.9	48.3	32.5	60.2	59.8	76.5	91.7	84.0	71.8	68.0	68.0	88.7	79.0	6.2	83.8	51.5	81.1	83.5	69.1	11.1	13.2	13.2	14.0	11.0	11.4	12.8	12.6	13.7	12.8	12.5	17.7	58.0	28.9	23.8	9.1	47.5	59.4	54.9	92.6	42.7	30.7	70.4	88.6	43.1	35.8	53.1	38.6	22.9	118.7	43.8	25.4	148.7	63.6	95.1	57.6	44.1	47.4	43.8	78.4	18.8	64.0	55.8	48.6	32.1	38.3	31.6	35.7	36.0	55.1	69.8	10.1	14.0	45.3	87.5	41.8	42.7	24.5	51.6	35.7	49.8	11.2	46.4	51.4	52.5	11.1	36.0	59.9	33.6	51.1	55.5	95.2	31.5	112.5	65.1	38.2	39.5	51.3	46.5	87.6	44.2	56.0	67.6	56.8	48.3	64.8	68.6	59.3
NUDT1	MTH1	ENSG00000106268	"Nudix hydrolase 1"	P36639	7	2242226-2251146	"Cancer-related genes, Enzymes, Predicted intracellular proteins"		"Hydrolase, RNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 77.6"	"Cell type enhanced"	"Detected in many"		"Late spermatids: 121.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA012636	Approved		Supported	Cytosol		No	No		21000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Cytosol		"HPA012636: AB_1854696"	"unprognostic (1.31e-1)"	"unprognostic (1.19e-2)"	"unprognostic (2.13e-2)"	"unprognostic (2.37e-1)"	"unprognostic (3.01e-3)"	"unprognostic (3.37e-1)"	"prognostic unfavorable (4.44e-4)"	"unprognostic (2.15e-2)"	"unprognostic (4.77e-1)"	"unprognostic (3.81e-2)"	"unprognostic (3.81e-2)"	"unprognostic (1.53e-1)"	"prognostic unfavorable (1.30e-7)"	"unprognostic (1.29e-1)"	"unprognostic (6.71e-2)"	"unprognostic (3.49e-2)"	"unprognostic (1.70e-1)"	19.1	8.0	13.7	23.8	16.6	77.6	15.0	14.6	18.0	16.9	10.9	19.1	16.2	12.4	5.4	29.1	12.0	10.5	18.7	15.4	13.6	8.9	6.3	12.4	37.1	16.1	14.1	9.3	9.1	3.2	4.4	10.5	15.6	11.3	11.0	4.3	12.4	7.0	21.3	33.8	16.8	9.2	15.0	23.6	12.2	65.5	14.5	59.4	7.6	13.5	31.5	14.6	18.5	17.9	98.4	155.2	83.3	111.0	30.0	41.3	61.0	42.3	36.5	57.0	65.8	84.2	72.1	102.8	33.7	47.0	115.5	117.1	63.8	64.3	33.1	46.2	109.4	80.6	136.3	72.7	7.2	63.2	78.0	27.4	16.7	82.3	29.0	18.6	31.0	147.1	65.0	111.6	64.5	250.2	119.1	245.3	179.5	48.5	94.7	163.5	123.4	86.4	31.7	54.9	83.5	115.6	43.7	126.9	20.8	59.8	83.9	165.8	29.1	54.2	205.1	126.8	102.3	85.2	70.6	108.9	54.6	155.1	199.8	31.5	60.2	44.4	42.8	78.6	34.3	71.0	49.6	45.6	94.3	65.1	48.9	42.3	16.2	39.4	66.8	211.5	75.5	45.7	13.7	16.6	14.6	18.0	15.4	13.6	16.1	14.1	15.6	15.0	14.5	17.9	13.0	6.4	7.5	1.0	34.2	40.1	26.5	22.6	14.8	11.2	25.3	39.0	16.8	10.0	13.7	11.0	4.2	38.5	46.1	39.6	19.6	24.3	54.7	14.9	24.3	12.8	7.8	111.7	0.5	37.4	80.0	29.6	13.7	10.7	61.0	32.4	7.9	5.2	89.4	0.0	0.5	35.7	32.6	46.2	86.7	121.2	22.1	52.6	46.2	0.0	47.1	27.4	47.4	1.0	4.3	20.4	18.4	18.8	33.1	21.5	17.3	14.1	13.0	7.9	32.9	27.5	32.4	70.2	54.8	41.0	37.1	23.7	37.3	13.7	45.1	27.3
NUDT15	"FLJ10956, MTH2"	ENSG00000136159	"Nudix hydrolase 15"	Q9NV35	13	48037726-48047221	"Enzymes, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 79.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038968, HPA038969"	Approved		Supported	Nucleoplasm		Yes	No			"Cluster 22: NK-cells - Unknown function"	"Cluster 37: Intestine - Unknown function"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 38: Extravillous trophoblasts - Unknown function"	Nucleoplasm		"HPA038968: AB_10697402, HPA038969: AB_2676295"	"unprognostic (9.48e-2)"	"unprognostic (5.91e-3)"	"unprognostic (2.64e-2)"	"unprognostic (9.00e-3)"	"unprognostic (4.99e-2)"	"unprognostic (2.50e-3)"	"unprognostic (2.29e-2)"	"unprognostic (7.47e-3)"	"prognostic unfavorable (1.25e-5)"	"unprognostic (1.04e-1)"	"unprognostic (8.50e-2)"	"unprognostic (3.69e-1)"	"unprognostic (4.63e-2)"	"unprognostic (1.84e-3)"	"unprognostic (3.35e-1)"	"unprognostic (9.58e-2)"	"unprognostic (8.93e-3)"	12.2	13.0	7.1	10.1	7.2	18.0	16.4	8.6	8.3	12.9	6.9	20.2	20.8	9.7	13.8	16.3	11.6	9.0	11.0	6.9	8.5	17.2	14.1	9.2	7.5	7.2	7.7	8.6	9.4	8.2	9.4	12.6	7.8	15.1	22.1	10.3	12.1	10.0	11.9	8.7	16.3	10.5	6.8	5.5	13.0	10.7	7.6	10.7	13.4	18.7	10.3	12.9	10.3	7.8	47.5	28.4	52.4	23.1	21.2	30.3	37.8	37.7	35.8	41.3	39.7	42.1	45.2	34.6	20.7	30.3	36.7	54.3	51.3	56.1	63.4	18.3	41.8	34.1	28.0	46.2	19.8	52.0	31.2	20.9	35.3	33.3	46.7	18.4	45.3	34.5	30.7	13.5	67.2	23.2	40.5	48.4	83.0	72.8	32.2	27.6	33.8	22.7	46.2	35.8	31.4	33.1	25.6	43.8	30.3	44.7	22.5	38.7	23.0	28.5	34.7	36.2	53.3	6.9	12.5	43.6	14.8	40.1	47.4	1.6	4.8	3.5	2.9	6.9	2.9	3.1	4.6	3.6	4.9	2.6	5.3	5.8	1.0	2.8	4.8	3.7	3.4	2.7	7.1	7.2	8.6	8.3	6.9	8.5	7.2	7.7	7.8	6.8	7.6	7.8	12.0	12.8	15.7	0.7	14.7	16.6	34.6	18.1	19.9	9.2	14.0	11.6	12.5	12.8	20.7	7.3	2.1	36.2	12.6	30.4	49.0	17.3	16.7	45.7	20.4	15.1	8.4	10.5	3.9	17.6	79.4	12.8	18.3	39.5	9.5	8.7	7.5	17.4	16.8	38.7	3.1	23.5	26.4	7.8	10.5	9.3	16.8	11.4	10.6	1.9	10.3	10.8	6.2	0.5	3.0	16.4	18.3	12.4	16.8	41.9	18.9	40.8	13.6	9.0	0.0	9.5	17.1	8.9	34.4	34.9	20.5	38.0	13.2	15.3	31.9	42.0
NUDT16	FLJ31265	ENSG00000198585	"Nudix hydrolase 16"	Q96DE0	3	131381671-131388830	"Enzymes, Predicted intracellular proteins"	"Nucleotide metabolism"	"Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Kupffer cells: 179.8;Proximal enterocytes: 334.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"classical monocyte: 41.7;eosinophil: 47.0;intermediate monocyte: 54.6;myeloid DC: 32.4;neutrophil: 34.0;non-classical monocyte: 63.4"	"Group enriched"	"Detected in all"	4	"dendritic cells: 32.4;granulocytes: 47.0;monocytes: 63.4"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA060452, HPA062492"	Uncertain		Supported	Nucleoplasm,Nucleoli		NA	NA		38000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 45: Intestine - Brush border"	"Cluster 18: U-2197 - ECM organization"	"Cluster 45: Enterocytes - Digestion"	"Nucleoplasm, Nucleoli"		"HPA060452: AB_2684279, HPA062492: AB_2684781"	"unprognostic (4.85e-3)"	"prognostic favorable (9.39e-5)"	"unprognostic (3.19e-3)"	"unprognostic (9.21e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.22e-2)"	"unprognostic (9.96e-2)"	"unprognostic (1.15e-1)"	"unprognostic (5.16e-2)"	"unprognostic (1.94e-1)"	"unprognostic (1.77e-1)"	"unprognostic (5.88e-2)"	"prognostic favorable (1.05e-7)"	"unprognostic (3.29e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.00e-2)"	"unprognostic (9.44e-2)"	30.6	19.0	39.3	15.2	40.1	10.4	22.9	35.9	49.3	17.1	28.6	25.6	22.2	19.4	11.0	11.1	22.7	9.8	32.9	34.1	38.3	27.7	33.8	26.2	12.3	40.7	39.6	25.2	14.7	48.6	15.8	8.1	40.9	17.8	19.5	18.8	16.1	13.6	24.7	11.6	57.6	12.6	41.7	36.0	21.3	12.2	41.2	6.7	24.4	24.5	10.1	20.9	14.0	40.8	20.8	10.8	17.5	9.2	34.3	31.0	8.1	16.5	15.1	10.9	11.3	16.8	9.0	3.4	14.1	15.4	21.5	14.8	15.7	10.4	17.3	10.4	11.5	8.7	15.3	16.4	22.0	14.9	15.4	27.8	9.0	7.2	19.5	9.7	17.2	0.0	10.2	17.4	10.7	21.5	0.0	4.0	13.6	20.6	16.0	11.6	12.6	26.1	10.8	16.6	8.6	15.0	9.9	9.9	15.6	14.7	21.6	11.7	17.1	17.7	7.6	32.8	13.0	17.1	18.1	0.5	11.5	11.2	10.0	7.2	41.7	47.0	6.0	54.6	6.2	11.2	6.0	5.5	32.4	10.5	5.3	5.4	34.0	9.8	63.4	4.3	10.7	17.4	39.3	40.1	35.9	49.3	34.1	38.3	40.7	39.6	40.9	41.7	41.2	40.8	56.1	16.0	41.1	4.6	13.0	8.4	12.3	21.1	10.8	22.8	22.2	20.2	85.2	44.3	23.9	20.2	8.4	21.0	11.5	58.8	68.4	24.7	77.8	27.2	25.5	33.0	25.3	17.9	5.6	36.9	26.1	27.8	36.2	33.1	19.6	23.0	78.1	107.5	65.1	43.7	3.0	74.7	18.3	179.8	25.3	37.5	26.4	73.6	17.8	3.7	64.6	14.2	17.5	3.0	4.6	31.1	66.7	39.5	14.3	19.5	334.3	109.4	19.8	19.2	26.3	22.1	30.7	28.2	6.3	15.4	5.4	7.3	15.1	68.2	48.5	16.0
NUDT18	"FLJ22494, MTH3"	ENSG00000275074	"Nudix hydrolase 18"	Q6ZVK8	8	22106874-22109419	"Enzymes, Predicted intracellular proteins"	"Nucleotide metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Proximal enterocytes: 41.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028581, HPA030125"	Approved		Supported	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 25: Pancreas - Digestion"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 45: Enterocytes - Digestion"	Nucleoplasm	"Golgi apparatus"	"HPA028581: AB_10601381, HPA030125: AB_2673324"	"unprognostic (9.90e-3)"	"prognostic favorable (1.43e-4)"	"unprognostic (4.88e-3)"	"prognostic favorable (2.49e-6)"	"unprognostic (1.29e-2)"	"unprognostic (6.82e-3)"	"unprognostic (1.20e-1)"	"unprognostic (1.54e-2)"	"unprognostic (5.30e-2)"	"unprognostic (1.67e-1)"	"prognostic favorable (2.47e-4)"	"unprognostic (1.43e-1)"	"prognostic favorable (8.30e-4)"	"unprognostic (3.59e-3)"	"unprognostic (1.05e-1)"	"unprognostic (6.84e-2)"	"unprognostic (2.32e-1)"	7.4	6.4	5.1	4.8	5.2	4.4	6.7	5.4	5.5	4.9	4.3	5.7	6.5	5.4	12.9	8.0	5.3	4.2	4.8	5.4	4.8	6.8	5.6	6.1	8.8	5.3	4.8	2.3	17.0	2.7	9.1	2.7	5.7	7.8	4.7	1.2	8.5	4.6	2.3	7.1	7.6	3.6	4.4	10.4	8.9	7.7	5.4	6.8	8.2	1.2	6.3	5.7	5.5	4.6	8.1	16.8	0.5	3.6	12.4	4.6	9.0	4.8	12.6	6.1	7.0	4.0	6.3	6.0	7.5	5.7	15.5	13.8	2.3	7.7	2.0	7.5	2.3	5.1	4.9	3.9	8.3	1.7	15.2	8.5	7.2	2.4	6.4	7.9	7.7	13.0	3.8	9.9	6.0	8.6	6.9	4.6	0.9	4.8	4.1	3.0	1.5	6.5	9.0	7.1	1.8	2.8	3.3	4.0	4.2	3.7	9.4	8.3	6.4	4.0	2.2	5.4	2.5	4.4	0.5	1.9	7.0	4.5	9.8	0.0	1.5	3.0	2.2	1.6	2.1	1.4	1.8	1.3	1.0	2.0	2.0	1.1	0.3	4.0	1.3	1.9	0.7	0.9	5.1	5.2	5.4	5.5	5.4	4.8	5.3	4.8	5.7	4.4	5.4	4.6	5.6	3.2	2.2	1.0	7.3	2.0	3.4	5.2	1.2	3.3	5.9	4.6	1.9	8.6	3.0	5.5	0.0	6.7	6.8	12.5	5.9	9.5	14.6	5.9	2.4	4.7	3.0	5.2	1.6	13.6	9.6	5.9	6.1	4.1	0.0	6.3	5.7	4.0	14.5	3.3	1.7	10.9	2.0	16.8	1.3	15.1	3.1	9.0	5.4	2.8	15.3	4.1	19.6	0.5	1.6	10.1	14.6	3.4	6.2	4.6	41.2	13.6	7.0	1.2	0.0	3.1	3.7	3.5	2.7	6.3	1.8	3.1	7.9	5.3	7.0	2.3
NUDT21	"CFIM25, CPSF5"	ENSG00000167005	"Nudix hydrolase 21"	O43809	16	56429133-56452199	"Predicted intracellular proteins"	"Differentiation, mRNA processing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 445.9;Late spermatids: 230.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019863, HPA074228"	Uncertain		Supported	"Nuclear bodies,Centriolar satellite"		NA	NA		12000	"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 34: Spermatids - Unknown function"	"Nuclear bodies"	"Centriolar satellite"	"HPA019863: AB_2670299, HPA074228: AB_2686675"	"unprognostic (4.95e-2)"	"unprognostic (4.42e-2)"	"unprognostic (4.25e-3)"	"unprognostic (1.31e-1)"	"unprognostic (5.85e-3)"	"unprognostic (1.29e-2)"	"unprognostic (8.80e-3)"	"unprognostic (6.87e-3)"	"unprognostic (4.09e-2)"	"unprognostic (3.19e-1)"	"unprognostic (3.76e-3)"	"unprognostic (4.27e-2)"	"unprognostic (1.39e-2)"	"unprognostic (2.85e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.04e-1)"	"unprognostic (3.27e-2)"	29.5	32.0	23.4	37.7	27.1	64.4	39.4	27.0	28.7	39.7	19.9	39.3	49.3	39.2	27.4	39.9	35.9	28.4	31.4	28.9	32.2	42.6	37.0	27.7	56.7	20.7	22.5	55.8	32.3	40.2	22.0	38.5	25.3	29.6	40.1	36.0	30.5	32.1	28.0	25.0	34.7	34.7	22.6	34.5	34.0	71.0	22.6	58.3	37.7	37.9	65.7	39.7	26.0	26.9	143.8	79.3	144.3	116.8	78.0	110.0	131.1	96.2	112.2	135.9	94.7	167.7	146.6	193.5	98.5	90.5	84.8	129.8	190.2	116.8	206.0	67.2	78.5	126.6	73.0	146.2	63.6	183.0	124.8	65.5	83.4	113.7	80.3	78.2	127.5	145.8	137.5	69.1	111.2	88.1	195.5	130.1	178.9	106.6	133.0	286.2	196.3	165.4	94.5	121.9	161.1	107.2	184.0	88.0	77.6	99.2	107.6	106.5	74.8	107.4	153.3	93.1	104.1	103.1	120.0	364.7	71.4	117.9	100.1	32.0	24.9	32.9	28.0	26.1	27.7	22.8	29.4	26.1	25.8	20.9	27.1	27.4	27.2	25.5	29.2	19.9	49.6	22.2	23.4	27.1	27.0	28.7	28.9	32.2	20.7	22.5	25.3	22.6	22.6	26.9	30.7	28.9	37.8	23.8	45.5	60.9	52.9	78.4	47.8	19.5	46.3	34.3	39.3	27.1	54.4	42.3	18.8	63.8	29.1	29.2	66.5	63.4	445.9	32.9	40.2	45.2	31.1	69.9	26.5	86.5	90.6	45.8	25.0	38.7	35.5	35.9	48.9	39.1	67.2	35.3	27.9	57.7	20.3	58.8	50.5	230.2	44.7	42.7	37.4	13.1	61.1	25.6	18.6	18.1	34.6	62.5	36.0	41.0	70.0	60.3	49.2	78.3	47.7	24.2	39.5	33.9	59.6	217.4	96.9	67.4	60.0	68.3	49.7	39.5	64.0	70.1
NUDT9	MGC3037	ENSG00000170502	"Nudix hydrolase 9"	Q9BW91	4	87422573-87459455	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RPTEC TERT1: 160.7"	"Low region specificity"	"Detected in all"							"HPA036917, HPA044866, HPA078535"	Approved		Approved	"Nuclear membrane,Nuclear bodies,Cell Junctions,Mitochondria"	"Intracellular and membrane"	NA	NA		9900	"Cluster 27: Non-specific - Gene expression"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Nuclear bodies, Mitochondria"	"Nuclear membrane, Cell Junctions"	"HPA036917: AB_10696790, HPA044866: AB_2679120, HPA078535: AB_2686885"	"unprognostic (7.22e-2)"	"unprognostic (2.59e-2)"	"unprognostic (1.45e-2)"	"prognostic favorable (7.43e-5)"	"unprognostic (2.05e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.33e-1)"	"unprognostic (3.47e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.09e-2)"	"unprognostic (4.23e-1)"	"prognostic favorable (8.00e-11)"	"unprognostic (1.21e-1)"	"unprognostic (1.99e-1)"	"unprognostic (1.19e-1)"	"unprognostic (5.77e-3)"	23.6	36.1	20.8	16.2	21.4	6.7	19.7	25.5	38.5	27.6	39.1	27.0	42.6	24.8	32.2	19.6	24.9	16.2	28.8	21.9	24.7	40.4	46.6	23.0	13.7	21.0	20.5	26.7	67.6	55.3	29.1	19.9	21.9	30.4	27.1	20.1	28.1	23.8	42.1	16.6	40.3	23.8	19.6	14.7	22.3	22.5	22.1	13.4	28.8	45.0	14.8	22.4	24.3	26.0	30.8	25.6	34.0	19.8	67.6	39.6	26.0	59.8	35.6	21.3	21.1	17.1	53.1	47.6	58.9	47.6	41.0	21.1	32.1	38.1	33.2	34.5	24.0	13.4	34.5	31.8	42.4	25.6	21.2	41.5	52.4	25.6	22.6	45.5	41.6	13.7	40.3	30.0	38.7	33.4	39.1	23.2	29.1	68.5	12.0	45.0	31.8	27.0	160.7	24.2	41.3	28.7	37.6	63.0	30.8	44.5	36.8	38.2	43.7	34.7	34.3	25.8	27.8	21.5	18.7	37.9	51.3	21.9	48.2	1.6	17.9	5.9	19.1	21.2	18.2	22.2	18.5	19.5	21.4	18.8	22.5	26.0	1.8	15.6	24.0	20.6	19.0	16.0	20.8	21.4	25.5	38.5	21.9	24.7	21.0	20.5	21.9	19.6	22.1	26.0	32.6	67.3	44.8	20.2	14.9	9.9	40.4	45.0	9.6	15.3	11.3	13.1	40.9	30.0	55.0	23.9	27.1	33.2	13.1	21.0	41.1	44.7	28.6	26.0	26.2	25.8	16.8	6.7	21.7	36.5	32.5	29.4	8.6	27.0	20.8	23.3	18.2	47.5	33.2	6.7	24.0	18.0	40.7	12.7	11.0	11.5	25.4	14.7	10.6	20.6	16.4	26.8	8.2	18.6	24.8	29.4	37.0	26.7	15.8	32.9	55.7	56.2	41.0	18.6	26.3	36.9	23.7	44.5	23.6	15.7	9.5	37.6	12.1	29.8	24.9	27.3
NUF2	"CDCA1, CT106, NUF2R"	ENSG00000143228	"NUF2 component of NDC80 kinetochore complex"	Q9BZD4	1	163266576-163355764	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"bone marrow: 28.4;lymphoid tissue: 26.0;testis: 53.5"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 60.8;Spermatocytes: 208.2;Spermatogonia: 40.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Immune cell enhanced"	"Detected in many"		"T-reg: 4.3"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA059692, HPA076604"			Supported	Nucleoplasm,Kinetochore,Cytosol		Yes	Yes			"Cluster 35: T-regs - Unknown function"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	"Kinetochore, Cytosol"	"HPA059692: AB_2684103, HPA076604: "	"unprognostic (9.41e-2)"	"unprognostic (2.61e-1)"	"unprognostic (2.56e-1)"	"unprognostic (5.32e-3)"	"unprognostic (6.20e-2)"	"unprognostic (3.77e-2)"	"prognostic unfavorable (1.04e-5)"	"prognostic unfavorable (9.16e-4)"	"prognostic unfavorable (4.83e-4)"	"unprognostic (8.45e-2)"	"prognostic unfavorable (9.75e-4)"	"unprognostic (3.70e-2)"	"unprognostic (0.00e+0)"	"unprognostic (9.79e-2)"	"unprognostic (7.88e-2)"	"unprognostic (2.69e-1)"	"unprognostic (5.96e-2)"	0.8	0.6	0.5	6.9	0.8	28.4	1.2	0.5	0.8	1.0	0.4	4.2	4.3	1.1	0.3	5.8	0.4	1.0	0.3	0.6	0.6	0.3	0.7	0.9	18.2	0.9	0.8	0.4	0.2	0.6	0.2	4.7	0.9	0.4	5.3	1.5	0.9	0.3	0.1	4.1	4.3	2.3	0.7	3.6	2.6	53.5	0.8	26.0	0.5	0.2	16.7	1.8	1.8	1.0	90.8	30.8	80.5	33.9	2.5	8.1	43.6	55.9	39.3	88.9	77.3	23.7	77.7	77.4	45.5	22.6	37.0	51.6	49.6	21.0	111.5	81.4	35.6	30.3	34.8	34.4	0.3	53.0	60.2	1.0	2.0	45.0	31.6	16.8	41.1	74.5	58.1	103.9	85.0	17.6	97.3	70.6	43.9	66.1	47.0	65.0	70.3	68.4	25.3	12.4	59.9	68.9	29.9	32.2	30.6	49.7	49.3	109.5	29.4	65.9	73.8	50.1	115.1	73.9	111.5	148.9	22.0	42.9	74.7	1.4	0.1	1.3	1.2	0.0	0.5	0.6	1.8	1.2	0.2	0.7	1.2	1.0	0.4	1.8	0.1	0.3	4.3	0.4	0.5	0.8	0.5	0.8	0.6	0.6	0.9	0.8	0.9	0.7	0.8	1.0	0.5	0.0	0.5	1.3	5.3	5.9	1.9	4.2	1.2	1.2	1.3	2.7	0.9	0.0	3.3	0.0	0.0	21.7	3.6	2.6	0.0	0.8	17.7	2.5	2.5	1.8	0.0	60.8	1.1	0.2	29.7	3.4	5.6	3.0	4.5	18.3	3.3	0.4	14.0	0.0	1.4	3.3	0.0	5.2	3.6	21.4	2.5	3.1	0.0	1.0	0.9	2.0	6.2	0.5	3.6	0.2	0.1	2.2	17.8	0.8	0.9	0.2	0.7	2.3	6.6	0.9	4.2	208.2	40.3	10.6	2.4	4.0	5.0	1.7	9.0	3.8
NUFIP2	"182-FIP, 82-FIP, FIP-82, KIAA1321, MGC117262, PIG1"	ENSG00000108256	"Nuclear FMR1 interacting protein 2"	Q7Z417	17	29255839-29294148	"Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 79.9"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA067443			Supported	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm	"Nuclear bodies, Cytosol"	"HPA067443: AB_2685841"	"unprognostic (6.51e-2)"	"unprognostic (6.96e-3)"	"unprognostic (1.17e-1)"	"unprognostic (2.95e-2)"	"unprognostic (3.38e-1)"	"unprognostic (2.12e-1)"	"unprognostic (4.94e-3)"	"unprognostic (1.40e-1)"	"unprognostic (3.79e-2)"	"unprognostic (9.42e-3)"	"unprognostic (1.60e-3)"	"unprognostic (5.24e-2)"	"unprognostic (1.28e-3)"	"unprognostic (3.45e-1)"	"unprognostic (1.79e-1)"	"unprognostic (7.18e-2)"	"unprognostic (6.04e-3)"	15.3	14.9	4.4	22.7	3.6	79.9	12.5	10.3	20.4	12.7	11.7	14.9	16.2	11.5	11.9	17.2	10.9	14.0	13.6	5.1	19.9	13.0	24.0	21.0	19.8	12.1	14.7	12.0	14.7	18.4	11.0	29.6	11.0	12.1	13.0	23.1	15.5	9.8	15.9	12.1	13.2	10.3	2.1	20.7	18.7	14.2	10.8	18.0	13.5	17.6	17.5	16.4	14.2	14.1	42.5	67.1	38.9	27.2	32.8	38.0	65.1	41.3	24.8	31.1	28.4	75.0	22.5	68.5	60.1	28.5	27.7	58.6	31.4	28.9	39.3	74.0	55.9	51.8	64.7	19.8	30.3	66.6	53.8	33.1	34.5	34.4	36.7	35.9	23.2	24.8	86.2	49.5	32.1	34.8	70.6	30.1	40.2	32.2	24.9	57.2	66.8	29.4	26.1	68.4	37.1	23.5	73.6	136.6	44.6	51.5	47.3	44.2	38.5	59.1	59.1	35.0	71.3	68.4	68.9	79.3	39.0	34.9	51.6	13.6	6.1	8.5	5.6	5.9	4.3	8.5	5.5	6.2	5.2	7.6	7.0	5.9	25.4	5.1	9.6	12.1	3.2	2.3	4.4	3.6	10.3	20.4	5.1	19.9	12.1	14.7	11.0	2.1	10.8	14.1	139.7	80.1	67.0	58.1	76.8	99.5	78.2	40.0	118.4	55.3	105.0	124.8	81.7	38.6	69.3	31.3	95.9	69.2	124.3	72.6	15.6	33.9	35.2	108.2	139.0	85.9	48.3	55.6	47.4	27.9	31.3	86.4	82.6	154.2	46.2	41.2	55.0	54.6	44.6	57.2	47.1	62.5	20.3	74.7	108.8	24.9	35.4	122.9	40.9	41.2	50.0	35.2	37.0	44.7	85.9	37.4	43.1	35.0	65.2	91.8	26.5	27.6	88.8	60.6	19.7	171.7	78.5	36.6	29.8	120.8	97.7	182.0	93.8	51.8	57.1	111.9
NUMA1		ENSG00000137497	"Nuclear mitotic apparatus protein 1"	Q14980	11	72002864-72080693	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Chromosome partition, Mitosis"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019841, HPA019859, HPA029912"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	Yes		62000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm	Cytosol	"HPA019841: AB_1854708, HPA019859: AB_1854709, HPA029912: AB_10602811"	"unprognostic (1.60e-2)"	"unprognostic (3.31e-1)"	"unprognostic (2.06e-2)"	"unprognostic (2.84e-1)"	"unprognostic (1.14e-1)"	"unprognostic (6.47e-2)"	"unprognostic (5.75e-2)"	"unprognostic (8.74e-3)"	"unprognostic (5.91e-2)"	"unprognostic (9.45e-2)"	"unprognostic (1.60e-2)"	"unprognostic (2.51e-2)"	"prognostic favorable (7.92e-4)"	"unprognostic (1.28e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.39e-1)"	55.2	59.9	27.8	51.1	45.6	69.6	67.1	37.4	40.5	75.4	36.2	77.7	59.6	111.2	43.3	67.9	82.7	62.7	47.6	24.0	33.0	49.9	29.8	65.4	57.9	40.4	34.3	112.3	68.8	98.6	42.1	60.8	41.9	111.4	54.5	46.2	78.1	85.6	82.5	93.8	61.9	86.7	28.4	56.8	59.0	42.4	36.0	79.3	73.9	54.8	53.2	75.2	65.9	83.4	64.4	80.0	97.2	66.4	85.1	88.2	48.8	85.0	97.2	86.4	74.6	83.9	115.5	86.7	72.0	104.0	61.6	134.2	89.7	85.8	78.0	89.9	43.1	105.8	130.4	64.1	69.1	81.1	74.0	94.0	55.7	84.1	84.3	133.0	74.0	76.7	63.4	101.1	59.4	124.2	105.6	45.2	61.2	122.3	57.6	127.9	170.0	67.6	64.2	98.6	117.3	166.6	134.9	123.5	123.6	42.3	166.4	47.1	103.0	90.6	69.9	130.1	56.9	64.8	69.7	120.0	61.1	38.0	53.0	3.7	4.1	1.9	6.4	2.3	4.7	3.4	4.0	5.0	3.5	5.8	4.9	3.6	2.8	5.0	4.4	8.2	5.2	6.0	27.8	45.6	37.4	40.5	24.0	33.0	40.4	34.3	41.9	28.4	36.0	83.4	52.4	41.7	41.3	42.7	36.6	25.9	30.1	25.3	74.0	60.7	62.3	63.4	5.7	34.3	32.2	53.3	73.0	25.5	42.6	56.3	17.6	27.9	31.9	55.5	48.5	44.9	47.4	43.3	27.5	32.1	13.4	41.9	57.6	92.8	31.0	84.7	37.9	23.6	28.7	52.2	34.0	68.3	32.6	32.1	24.9	17.8	69.0	36.3	19.6	33.7	26.8	51.8	53.5	27.6	58.9	30.9	31.2	50.8	40.8	29.6	57.0	26.9	35.4	59.8	39.5	64.3	36.9	14.8	21.4	51.9	28.1	45.0	44.8	44.2	52.2	26.0
NUP107	NUP84	ENSG00000111581	"Nucleoporin 107"	P57740	12	68686951-68745809	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"mRNA transport, Protein transport, Translocation, Transport"		"Disease variant, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 89.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031679			Uncertain	"Nucleoplasm,Nuclear membrane,Centrosome"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	Nucleoplasm	"Nuclear membrane, Centrosome"	"HPA031679: AB_2673992"	"unprognostic (2.89e-1)"	"unprognostic (3.32e-1)"	"unprognostic (4.10e-1)"	"unprognostic (5.43e-2)"	"unprognostic (1.60e-1)"	"unprognostic (6.32e-2)"	"prognostic unfavorable (3.12e-9)"	"unprognostic (4.03e-2)"	"unprognostic (1.23e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.08e-2)"	"prognostic unfavorable (1.28e-6)"	"unprognostic (3.43e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.96e-1)"	15.4	11.1	5.0	17.9	6.3	24.0	17.8	8.2	6.0	12.9	6.3	13.0	10.3	16.7	14.3	10.7	13.5	9.3	11.4	4.6	5.0	10.6	11.8	12.8	25.8	5.6	5.7	16.3	9.3	11.8	6.8	13.8	5.5	12.0	16.2	14.7	10.3	12.2	11.7	15.8	12.9	14.0	5.4	15.8	11.0	20.9	5.5	25.6	10.3	12.1	25.5	12.4	10.7	7.6	53.1	66.8	77.8	56.7	22.6	28.6	84.1	56.6	32.4	83.0	68.9	67.6	43.7	96.3	53.7	27.2	36.9	59.4	88.4	41.7	109.8	90.8	65.6	110.1	46.2	57.4	14.2	97.9	35.6	15.2	19.4	66.5	43.2	29.0	50.3	54.9	133.7	67.3	52.8	64.3	81.3	85.2	85.8	20.3	64.6	81.9	93.6	57.8	36.1	55.3	45.7	46.9	62.7	46.5	34.4	60.4	69.8	46.7	31.1	45.0	45.8	53.0	69.9	29.2	62.2	115.2	34.7	70.2	54.2	10.5	9.2	14.4	17.7	12.5	23.4	18.7	17.5	19.3	10.2	18.7	21.5	19.5	2.4	30.5	23.2	8.1	20.0	11.8	5.0	6.3	8.2	6.0	4.6	5.0	5.6	5.7	5.5	5.4	5.5	7.6	18.3	12.8	17.7	13.7	38.1	17.3	18.4	28.1	25.0	23.8	12.5	11.4	13.5	12.8	18.9	9.2	18.8	30.7	30.3	12.2	11.7	22.8	45.3	12.6	18.2	20.6	8.5	64.4	23.8	17.6	30.8	19.6	16.3	10.2	15.8	35.6	15.4	7.0	17.5	13.5	20.1	12.6	42.7	13.9	16.2	9.6	38.8	18.3	19.6	15.9	27.0	16.7	36.0	21.6	34.3	22.1	9.9	21.8	22.9	19.4	10.5	6.4	21.9	29.6	13.1	18.4	18.2	89.4	51.9	18.7	17.6	14.1	27.0	24.5	16.8	12.5
NUP133	FLJ10814	ENSG00000069248	"Nucleoporin 133"	Q8WUM0	1	229440259-229508341	"Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"mRNA transport, Protein transport, Translocation, Transport"		"Disease variant, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Oligodendrocytes: 60.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059767	Approved		Supported	"Nuclear membrane"		NA	NA		6300	"Cluster 27: Non-specific - Gene expression"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 59: Non-specific - Transcription"	"Nuclear membrane"		"HPA059767: AB_2684123"	"unprognostic (2.05e-2)"	"unprognostic (3.54e-1)"	"unprognostic (5.75e-3)"	"unprognostic (1.46e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.17e-1)"	"unprognostic (3.02e-2)"	"unprognostic (2.20e-2)"	"unprognostic (5.72e-2)"	"unprognostic (2.21e-1)"	"unprognostic (4.93e-2)"	"unprognostic (3.48e-1)"	"unprognostic (8.31e-2)"	"unprognostic (2.22e-1)"	"unprognostic (7.01e-2)"	"unprognostic (4.26e-2)"	"unprognostic (3.30e-2)"	12.3	10.7	9.2	11.2	10.8	12.6	15.8	13.1	11.9	11.7	7.5	11.2	8.6	14.4	11.2	10.6	13.9	8.6	15.2	9.2	9.2	12.2	10.1	10.8	14.3	9.5	9.0	16.5	10.0	17.9	9.9	15.1	9.8	11.7	11.4	19.1	10.0	11.8	17.9	13.4	9.6	13.2	10.1	11.6	9.8	13.0	8.9	16.8	13.8	14.3	15.4	11.1	10.4	14.5	30.6	24.3	37.0	19.2	26.0	27.8	71.9	24.8	25.1	36.0	32.4	28.8	29.4	44.1	20.9	24.8	16.1	39.4	51.8	26.3	38.4	26.8	64.2	26.7	23.6	21.8	20.9	54.8	20.8	21.8	19.4	25.9	30.8	25.0	30.5	37.1	61.2	20.6	28.6	13.7	40.8	23.4	55.6	42.7	21.8	39.1	38.5	43.6	20.3	26.6	31.7	39.3	36.9	22.9	27.6	18.0	35.7	42.8	26.8	16.3	19.9	28.5	37.3	19.7	26.1	46.8	18.6	31.2	34.6	5.5	5.7	4.4	5.6	5.7	7.0	5.8	5.9	6.2	7.1	4.4	5.9	6.3	1.9	5.5	10.2	4.0	5.9	5.2	9.2	10.8	13.1	11.9	9.2	9.2	9.5	9.0	9.8	10.1	8.9	14.5	10.4	9.6	18.9	26.4	19.9	9.1	6.8	10.1	13.6	16.5	9.9	8.5	21.2	14.3	10.7	14.7	8.4	21.4	11.5	4.4	5.9	8.3	1.5	10.9	8.7	10.3	10.2	21.7	48.9	8.5	13.8	13.8	15.8	8.4	7.6	17.1	11.7	12.0	9.8	16.8	44.1	7.5	8.2	13.6	8.6	3.7	12.5	10.8	7.2	25.3	13.4	12.4	5.2	28.1	60.2	7.0	4.9	12.0	19.0	6.7	4.7	7.9	13.1	12.3	0.0	16.3	10.7	12.6	18.2	14.6	10.7	18.3	13.6	11.8	9.0	6.6
NUP35	MP44	ENSG00000163002	"Nucleoporin 35"	Q8NFH5	2	183117513-183161680	"Metabolic proteins, Predicted intracellular proteins, Transporters"	"mRNA transport, Protein transport, Translocation, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	7	"Early spermatids: 151.6;Late spermatids: 424.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018401, HPA018410, HPA018441"	Enhanced		Supported	"Nucleoplasm,Nuclear membrane,Plasma membrane"		No	No			"Cluster 27: Non-specific - Gene expression"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 25: Spermatids - Spermatogenesis"	"Nucleoplasm, Nuclear membrane"	"Plasma membrane"	"HPA018401: AB_1854719, HPA018410: AB_1854721, HPA018441: AB_1854720"	"unprognostic (6.18e-3)"	"unprognostic (3.15e-1)"	"unprognostic (1.83e-1)"	"unprognostic (3.58e-3)"	"unprognostic (1.37e-1)"	"unprognostic (9.91e-2)"	"prognostic unfavorable (5.02e-4)"	"unprognostic (3.95e-1)"	"unprognostic (6.21e-3)"	"prognostic favorable (3.45e-4)"	"unprognostic (2.32e-2)"	"unprognostic (1.61e-3)"	"unprognostic (1.78e-3)"	"unprognostic (6.78e-2)"	"unprognostic (3.47e-2)"	"unprognostic (1.24e-1)"	"unprognostic (3.96e-2)"	7.7	8.9	5.9	6.9	7.3	4.6	13.1	8.9	7.8	8.5	5.0	7.6	6.3	8.1	7.7	8.7	8.9	6.9	6.2	6.1	5.9	10.2	14.4	5.9	9.1	5.5	5.9	10.4	10.2	8.9	6.3	7.8	5.5	7.8	9.1	9.0	8.4	7.0	7.4	9.0	6.5	8.9	6.6	5.7	7.2	24.2	5.5	10.4	8.2	8.7	11.0	9.2	8.0	6.4	19.7	19.7	32.5	20.5	11.8	11.5	23.2	23.0	18.8	35.3	33.5	37.6	24.7	34.6	22.0	12.4	40.9	17.4	45.4	26.7	57.8	29.6	27.8	32.6	16.4	43.9	8.2	23.6	21.8	8.2	13.8	29.9	28.9	7.9	20.8	20.5	28.7	25.3	27.8	23.7	28.7	29.1	57.9	31.6	61.9	34.3	25.2	25.0	34.0	24.7	29.4	20.3	21.6	26.6	26.0	24.4	17.0	16.2	10.6	28.6	19.7	23.3	26.5	16.4	38.3	37.9	19.3	16.8	39.2	0.0	4.1	1.4	4.9	5.5	8.6	7.2	6.3	6.0	3.2	6.5	7.5	6.7	0.2	5.6	6.6	3.1	6.7	4.1	5.9	7.3	8.9	7.8	6.1	5.9	5.5	5.9	5.5	6.6	5.5	6.4	9.6	9.6	6.8	6.5	10.3	26.0	20.7	17.5	12.5	10.8	9.3	8.9	4.7	14.3	13.8	16.5	18.8	23.6	8.5	3.3	11.7	15.5	151.6	5.3	8.1	10.2	3.6	12.6	11.5	12.7	20.2	10.8	5.1	6.4	8.2	8.1	12.8	12.6	8.4	6.7	12.0	7.5	16.2	4.4	9.9	424.7	9.6	3.6	21.4	2.8	5.0	11.4	7.2	17.1	12.8	11.1	5.1	8.2	7.5	12.8	4.2	14.5	6.9	19.1	13.1	18.7	11.6	39.8	21.1	11.3	27.4	9.4	11.5	9.0	9.6	11.2
NUP42	"CG1, H_RG271G13.9, hCG1, NLP_1, NUPL2"	ENSG00000136243	"Nucleoporin 42"	O15504	7	23181841-23201011	"Metabolic proteins, Predicted intracellular proteins, Transporters"	"mRNA transport, Protein transport, Translocation, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Adipocytes: 7.7;Cardiomyocytes: 20.3;Cytotrophoblasts: 17.1;dendritic cells: 10.5;Extravillous trophoblasts: 11.6;Hofbauer cells: 28.1;Syncytiotrophoblasts: 6.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049036, HPA057251"			Supported	Nucleoplasm		No	No			"Cluster 17: Basophils - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm		"HPA049036: , HPA057251: "	"unprognostic (3.81e-2)"	"unprognostic (2.53e-1)"	"unprognostic (3.97e-1)"	"unprognostic (3.87e-1)"	"unprognostic (4.16e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.33e-3)"	"unprognostic (2.16e-1)"	"unprognostic (1.09e-2)"	"unprognostic (1.42e-2)"	"unprognostic (1.30e-3)"	"unprognostic (2.07e-2)"	"unprognostic (4.74e-3)"	"unprognostic (1.32e-1)"	"unprognostic (2.00e-3)"	"unprognostic (3.59e-1)"	"unprognostic (1.32e-2)"	10.8	14.7	12.9	10.8	8.8	20.6	11.4	21.2	13.8	11.2	18.0	11.1	14.9	14.2	15.1	13.6	12.9	13.1	19.7	11.2	10.4	15.1	13.9	10.0	21.6	11.6	9.9	12.0	6.2	17.1	6.4	8.6	8.9	12.1	14.3	8.2	10.7	10.1	11.6	16.4	12.4	15.0	3.6	15.8	11.6	18.9	10.7	19.4	14.4	9.0	18.3	13.2	7.7	22.6	31.1	14.0	21.5	44.5	21.3	25.0	17.8	23.1	16.6	25.2	26.4	21.2	31.9	52.4	22.0	16.1	54.1	41.6	37.9	17.2	32.6	15.9	39.0	32.0	36.5	21.7	24.6	67.4	47.1	11.6	25.5	21.8	14.5	20.4	29.0	22.0	58.9	31.4	25.5	7.7	32.5	54.6	45.1	38.4	21.9	31.6	19.0	40.5	27.1	21.6	33.2	31.2	22.9	14.0	44.9	41.2	17.0	86.3	21.6	16.5	21.8	28.3	39.7	44.9	64.8	52.3	17.6	46.7	44.4	33.2	10.3	8.1	11.0	10.1	10.7	18.8	12.8	12.1	15.0	13.6	10.6	12.7	8.0	17.8	9.3	14.4	16.2	11.1	12.9	8.8	21.2	13.8	11.2	10.4	11.6	9.9	8.9	3.6	10.7	22.6	7.7	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.3	0.0	0.0	0.0	0.0	17.1	10.5	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	11.6	5.2	0.0	0.0	0.0	0.0	0.0	0.0	28.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.6	0.0	0.0	0.0	0.0	6.6	1.3	0.0	0.0	0.0
NUP43	"bA350J20.1, FLJ13287"	ENSG00000120253	"Nucleoporin 43"	Q8NFH3	6	149724315-149749665	"Metabolic proteins, Predicted intracellular proteins, Transporters"	"Cell cycle, Cell division, Chromosome partition, Mitosis, mRNA transport, Protein transport, Translocation, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Late spermatids: 78.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027126, HPA027291, HPA028500"	Enhanced		Approved	"Nucleoplasm,Nuclear speckles,Cytosol"		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 16: Immune cells - Immune response"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	"Nucleoplasm, Nuclear speckles"	Cytosol	"HPA027126: AB_10599301, HPA027291: AB_10601851, HPA028500: AB_10602287"	"prognostic unfavorable (2.08e-4)"	"unprognostic (3.02e-1)"	"unprognostic (3.86e-2)"	"unprognostic (1.45e-3)"	"unprognostic (2.29e-1)"	"unprognostic (8.19e-3)"	"prognostic unfavorable (7.13e-7)"	"unprognostic (5.14e-2)"	"unprognostic (2.45e-1)"	"unprognostic (2.35e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.06e-2)"	"unprognostic (2.74e-2)"	"unprognostic (6.25e-3)"	"unprognostic (2.02e-1)"	"unprognostic (2.72e-2)"	"unprognostic (3.60e-2)"	8.4	8.6	6.2	11.4	7.5	6.2	13.6	7.2	6.9	9.7	6.5	9.4	8.7	9.8	7.5	9.5	8.2	6.4	10.8	5.6	6.6	9.9	9.6	8.0	15.9	6.6	6.6	9.1	12.2	8.9	5.6	11.4	6.9	10.3	9.7	9.8	8.8	9.2	14.2	13.5	10.9	9.4	6.6	13.6	9.8	7.9	6.5	12.8	11.1	11.6	17.0	9.0	9.1	8.3	21.1	34.9	31.1	49.6	20.0	23.7	48.9	36.3	20.3	34.0	43.0	49.5	19.5	61.4	36.6	20.2	32.1	33.5	54.6	31.6	58.3	27.8	38.2	70.9	35.5	49.6	13.4	73.2	44.1	15.3	16.4	49.9	33.1	13.0	27.5	34.6	71.4	33.6	29.6	20.7	52.2	30.4	28.3	24.1	21.0	50.2	43.2	20.6	23.2	28.9	12.9	21.2	43.4	27.1	14.2	25.6	28.7	30.9	21.3	28.3	30.2	41.2	53.9	20.5	43.3	63.9	25.2	49.3	40.5	2.9	4.9	3.4	3.5	5.4	3.8	4.3	4.2	3.5	2.6	6.2	4.3	5.5	1.9	3.7	4.8	5.0	4.9	2.2	6.2	7.5	7.2	6.9	5.6	6.6	6.6	6.6	6.9	6.6	6.5	8.3	5.8	3.2	7.8	9.1	11.5	7.9	5.5	4.7	2.8	11.9	4.5	5.0	14.3	11.5	5.2	3.7	6.2	10.9	11.3	4.7	3.9	9.0	33.3	4.3	8.7	5.7	10.2	7.6	4.8	7.8	12.2	6.4	6.1	6.0	0.0	12.8	8.2	4.4	7.8	6.7	5.1	6.9	2.0	11.9	6.9	78.9	10.2	6.5	8.8	9.4	15.1	10.5	9.2	11.1	17.4	6.6	2.3	10.5	8.7	6.2	3.9	5.4	4.2	9.5	13.1	6.9	22.1	7.1	9.2	5.5	8.5	6.6	7.6	7.4	8.4	6.7
NUP62	"DKFZp547L134, FLJ20822, FLJ43869, IBSN, MGC841, p62, SNDI"	ENSG00000213024	"Nucleoporin 62"	P37198	19	49906825-49929763	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Host-virus interaction, mRNA transport, Protein transport, Translocation, Transport"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Langerhans cells: 119.2;Late spermatids: 315.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005435, CAB020724"	Supported		Supported	"Nucleoplasm,Nuclear membrane"		NA	Yes		31000	"Cluster 27: Non-specific - Gene expression"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 16: U-266 - Nucleosome"	"Cluster 25: Spermatids - Spermatogenesis"	"Nuclear membrane"	Nucleoplasm	"CAB020724: , HPA005435: AB_1079510"	"unprognostic (2.26e-1)"	"unprognostic (4.06e-2)"	"unprognostic (9.92e-2)"	"unprognostic (9.68e-2)"	"unprognostic (7.83e-2)"	"unprognostic (1.12e-2)"	"prognostic unfavorable (2.50e-7)"	"unprognostic (2.76e-2)"	"unprognostic (3.61e-3)"	"unprognostic (3.97e-2)"	"unprognostic (4.06e-2)"	"unprognostic (2.03e-2)"	"prognostic unfavorable (5.71e-12)"	"unprognostic (3.89e-3)"	"unprognostic (3.62e-1)"	"unprognostic (3.96e-1)"	"unprognostic (3.27e-3)"	19.9	29.4	14.2	37.3	13.2	27.1	18.9	18.4	15.9	22.5	14.0	22.5	23.7	27.6	11.0	25.0	24.8	18.4	20.4	13.9	15.7	18.5	31.7	19.4	38.3	15.5	14.2	29.8	21.0	18.0	22.8	22.4	15.8	19.9	21.1	11.1	21.8	17.5	33.7	23.4	24.3	27.7	13.6	29.8	19.4	50.4	14.7	41.9	16.3	24.5	37.7	24.6	20.1	16.9	126.7	115.5	88.8	74.0	26.0	30.0	79.7	92.8	65.8	99.3	98.8	79.8	71.9	141.2	51.7	60.8	65.9	73.6	108.3	62.1	96.1	211.6	112.0	109.8	59.4	72.6	30.9	108.8	106.8	28.6	44.8	62.0	54.8	44.1	71.5	82.7	138.6	135.5	69.2	59.7	196.7	83.6	82.0	117.4	102.8	170.3	99.9	120.3	46.9	93.7	96.2	68.8	88.2	103.8	46.3	63.8	78.8	51.5	53.0	150.2	85.3	49.1	155.4	96.3	295.9	132.5	62.2	90.1	113.9	12.3	33.4	6.7	17.7	34.7	24.1	15.1	17.6	19.6	33.1	14.9	11.9	15.4	5.2	22.0	20.1	29.0	17.2	22.1	14.2	13.2	18.4	15.9	13.9	15.7	15.5	14.2	15.8	13.6	14.7	16.9	16.8	25.6	22.4	0.0	28.4	34.2	16.5	16.0	21.1	11.4	23.7	26.0	15.4	21.5	18.3	9.2	6.2	37.0	24.4	24.9	9.8	23.7	113.5	19.2	23.9	27.7	21.6	39.1	0.0	16.3	48.4	19.5	20.4	25.6	23.4	30.4	30.4	13.3	49.5	63.9	0.0	27.0	16.2	36.1	119.2	315.1	24.8	41.5	21.4	0.0	77.1	19.1	22.6	0.0	0.0	22.9	22.8	23.0	23.3	24.1	20.6	16.1	19.2	16.3	19.7	18.0	16.0	71.0	39.3	20.0	32.0	21.8	24.4	17.2	33.4	16.6
NUP85	"FLJ12549, NUP75"	ENSG00000125450	"Nucleoporin 85"	Q9BW27	17	75205659-75235758	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"mRNA transport, Protein transport, Translocation, Transport"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA061910, HPA062595"	Supported		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm	Cytosol	"HPA061910: AB_2684634, HPA062595: AB_2684801"	"unprognostic (2.30e-1)"	"unprognostic (5.10e-2)"	"unprognostic (5.12e-3)"	"unprognostic (2.52e-3)"	"unprognostic (2.25e-1)"	"unprognostic (1.01e-2)"	"prognostic unfavorable (1.73e-7)"	"unprognostic (3.46e-1)"	"unprognostic (1.09e-2)"	"unprognostic (9.93e-2)"	"unprognostic (2.94e-1)"	"unprognostic (3.33e-2)"	"prognostic unfavorable (3.32e-6)"	"unprognostic (1.03e-3)"	"unprognostic (2.16e-1)"	"unprognostic (9.10e-3)"	"unprognostic (2.11e-1)"	20.9	12.9	15.2	18.6	15.7	20.8	20.0	21.8	17.0	21.5	15.4	18.7	15.8	20.8	16.1	20.5	20.9	11.6	16.4	15.6	14.7	18.9	22.1	18.7	26.5	15.8	15.1	20.8	18.7	12.1	12.7	19.0	16.0	18.9	21.0	11.2	16.7	14.3	16.7	23.9	20.5	19.6	14.9	25.3	16.9	22.2	15.3	33.2	18.0	14.1	27.0	17.9	19.5	17.0	66.5	74.0	53.4	37.3	20.3	31.5	74.0	47.3	37.4	108.5	101.7	63.2	61.4	61.1	26.6	41.1	70.5	55.9	88.8	50.6	96.1	19.3	70.1	51.0	83.3	56.3	16.6	52.8	40.7	30.3	30.5	76.1	32.8	24.9	84.7	49.0	63.3	38.1	53.8	73.0	100.2	64.8	40.0	82.2	67.4	68.9	115.1	55.5	42.1	47.5	40.6	38.5	58.2	73.7	42.5	59.4	83.3	59.1	30.8	80.2	74.4	52.5	76.3	23.6	21.0	79.2	41.4	47.3	50.6	8.1	24.9	21.5	16.1	22.6	22.9	16.1	17.5	15.9	20.5	21.5	17.0	12.8	8.2	16.7	16.5	22.5	16.6	17.3	15.2	15.7	21.8	17.0	15.6	14.7	15.8	15.1	16.0	14.9	15.3	17.0	13.2	6.4	12.5	7.2	13.9	6.1	8.9	19.1	6.2	7.8	10.3	7.5	9.0	8.6	15.0	7.3	10.4	23.0	11.7	9.1	7.9	16.0	3.7	11.1	13.6	15.0	7.7	16.2	13.5	19.4	22.1	13.8	9.7	10.3	11.4	13.0	21.0	23.1	23.0	6.7	9.9	11.0	16.2	13.3	7.2	3.9	14.3	13.7	8.8	10.3	15.8	4.8	22.6	3.5	10.6	18.3	7.5	9.8	8.6	7.9	8.8	11.7	11.8	8.8	32.9	7.9	19.2	24.9	29.3	7.3	7.1	12.7	10.9	7.4	13.3	8.0
NUPR1	"COM1, p8"	ENSG00000176046	"Nuclear protein 1, transcriptional regulator"	O60356	16	28532708-28539008	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 1157.3"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 1162.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"basophil: 14.3"	"Lineage enriched"	"Detected in single"	16	"granulocytes: 14.3"	"Cell line enhanced"	"Detected in many"		"HHSteC: 280.6;hTCEpi: 446.5;SK-MEL-30: 344.9;T-47d: 199.1;U-87 MG: 173.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006349			Supported	"Nucleoplasm,Cytokinetic bridge"		Yes	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 25: Pancreas - Digestion"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Nucleoplasm	"Cytokinetic bridge"	"HPA006349: "	"unprognostic (2.64e-2)"	"unprognostic (2.77e-2)"	"unprognostic (3.76e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.01e-1)"	"unprognostic (4.40e-2)"	"unprognostic (7.72e-3)"	"unprognostic (5.77e-3)"	"unprognostic (3.61e-2)"	"unprognostic (2.77e-1)"	"unprognostic (1.04e-2)"	"unprognostic (2.32e-2)"	"unprognostic (3.27e-2)"	"unprognostic (1.51e-1)"	"unprognostic (6.14e-2)"	"unprognostic (6.36e-3)"	"unprognostic (2.80e-2)"	190.1	270.7	66.9	32.2	71.3	1.2	185.8	70.4	83.7	148.5	55.3	221.1	12.3	137.8	81.8	110.1	146.3	70.7	108.8	64.7	82.8	87.8	345.4	164.4	29.9	83.9	77.0	188.9	1157.3	26.4	39.5	54.5	81.0	204.1	59.9	9.0	255.3	124.3	87.9	205.1	71.3	63.4	76.6	35.8	130.6	67.9	72.9	23.3	354.6	17.3	13.9	178.0	152.4	75.8	1.4	10.5	0.0	73.3	108.0	94.7	58.6	66.5	57.3	2.3	54.6	0.2	0.2	0.2	37.2	101.2	8.8	1.9	0.4	2.1	2.3	0.4	3.7	0.1	6.2	52.1	280.6	0.3	0.5	90.2	446.5	31.2	148.5	76.8	0.4	0.1	0.1	3.5	34.0	13.7	0.3	1.4	0.4	0.2	38.7	0.2	0.2	3.1	0.0	6.9	0.6	0.5	19.6	78.5	344.9	1.5	199.1	12.0	0.2	21.3	51.7	55.2	10.5	0.5	0.6	0.6	173.1	0.3	2.6	14.3	0.4	3.6	0.3	0.3	0.3	0.3	0.3	0.2	0.1	0.5	0.3	0.3	2.4	0.8	0.4	0.6	0.2	0.1	66.9	71.3	70.4	83.7	64.7	82.8	83.9	77.0	81.0	76.6	72.9	75.8	179.9	288.4	336.2	11.1	9.7	316.9	318.4	1162.8	253.8	3.5	379.6	348.1	146.1	121.5	639.3	323.7	2.1	142.3	5.2	276.3	21.5	242.0	14.8	186.4	291.8	165.4	61.1	53.5	0.2	567.2	73.6	407.5	58.6	597.3	20.3	198.3	262.3	734.9	296.8	1.7	0.5	464.9	225.9	45.2	115.2	61.0	528.8	100.6	154.7	3.7	6.3	200.2	1.0	0.5	4.7	222.5	71.1	704.5	7.7	374.2	0.9	272.6	514.1	5.3	203.8	129.5	368.3	9.8	4.9	211.2	531.8	707.8	20.0	66.3	376.1	483.8
NWD1		ENSG00000188039	"NACHT and WD repeat domain containing 1"	Q149M9	19	16719847-16817963	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	15	"choroid plexus: 192.4"	"Group enriched"	"Detected in some"	4	"Astrocytes: 41.4;Endometrial ciliated cells: 83.9;Respiratory ciliated cells: 92.0"	"Cancer enriched"	"Detected in many"	6	"prostate cancer: 9.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"U-937: 11.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA075476			Approved	Nucleoli,Cytosol		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 32: U-937 - Innate immune response"	"Cluster 49: Ciliated cells - Cilium organization"	"Nucleoli, Cytosol"		"HPA075476: "	"unprognostic (5.29e-3)"	"unprognostic (3.08e-2)"	"unprognostic (3.05e-2)"	"prognostic favorable (2.55e-4)"	"unprognostic (2.49e-1)"	"unprognostic (4.20e-4)"	"unprognostic (6.54e-2)"	"unprognostic (5.15e-2)"	"unprognostic (2.95e-1)"	"unprognostic (1.60e-1)"	"unprognostic (7.94e-2)"	"unprognostic (1.76e-1)"	"unprognostic (9.20e-2)"	"unprognostic (1.31e-1)"	"unprognostic (5.09e-2)"	"unprognostic (3.53e-2)"	"unprognostic (3.25e-1)"	0.0	0.0	5.4	0.0	6.2	0.1	0.2	7.6	4.9	1.3	192.4	0.5	0.0	0.2	0.4	0.2	12.6	0.2	0.0	12.2	5.2	0.2	0.0	1.3	0.0	6.2	8.8	0.0	1.5	0.0	0.7	0.0	6.1	6.8	0.1	1.1	1.3	1.8	0.0	0.2	0.0	0.0	3.2	0.0	0.8	0.2	10.1	0.2	0.7	0.0	0.0	0.1	0.0	3.7	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.4	2.4	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.4	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	11.7	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	5.4	6.2	7.6	4.9	12.2	5.2	6.2	8.8	6.1	3.2	10.1	3.7	0.0	0.0	1.5	41.4	0.3	0.3	1.7	3.5	0.0	0.2	0.5	0.3	0.9	0.0	4.5	0.0	0.0	0.1	0.0	0.4	0.0	0.1	17.9	83.9	0.8	0.3	1.2	0.0	2.4	0.0	0.2	0.3	0.0	3.7	0.0	0.1	0.0	0.0	0.1	0.0	1.4	0.6	2.0	0.0	0.4	3.3	0.6	0.3	0.0	0.0	0.0	8.9	0.0	1.5	1.2	0.2	0.4	0.0	0.0	4.0	0.0	0.1	92.0	0.6	0.0	1.1	1.4	0.0	0.2	0.0	0.1	1.1	0.4	0.0	0.4	1.4
NXF1	"DKFZp667O0311, Mex67, TAP"	ENSG00000162231	"Nuclear RNA export factor 1"	Q9UBU9	11	62792123-62806302	"Predicted intracellular proteins, Transporters"	"Host-virus interaction, mRNA transport, Protein transport, Translocation, Transport"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016327, HPA061593"	Supported		Supported	Nucleoplasm		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm		"CAB016327: AB_627608, HPA061593: AB_2684565"	"unprognostic (2.45e-2)"	"unprognostic (1.15e-3)"	"unprognostic (2.34e-1)"	"unprognostic (1.68e-3)"	"unprognostic (2.36e-1)"	"unprognostic (1.45e-2)"	"unprognostic (5.40e-3)"	"unprognostic (7.21e-3)"	"unprognostic (2.54e-2)"	"unprognostic (2.64e-1)"	"prognostic favorable (4.08e-4)"	"unprognostic (4.33e-3)"	"unprognostic (8.08e-2)"	"unprognostic (1.18e-1)"	"unprognostic (3.38e-1)"	"unprognostic (3.66e-3)"	"unprognostic (1.25e-2)"	90.2	103.4	57.2	47.9	56.8	204.6	81.8	61.6	71.9	100.1	66.8	106.0	39.4	94.6	55.2	80.2	86.8	51.8	78.0	57.3	59.0	100.3	130.0	82.0	69.9	56.6	57.2	97.3	98.3	63.8	136.7	58.9	56.1	107.2	45.6	49.9	77.3	57.8	75.7	110.6	96.1	66.6	55.2	143.8	97.1	59.5	58.2	75.5	123.1	41.5	56.1	83.1	78.8	59.9	44.6	48.5	82.8	56.5	69.6	50.2	50.2	67.5	60.5	89.0	52.6	66.8	35.1	70.0	39.1	54.4	35.7	54.1	89.9	42.3	80.2	55.5	61.3	52.9	82.1	56.4	52.8	66.3	73.6	74.5	59.9	65.6	31.5	66.5	58.9	60.7	69.3	50.7	64.4	61.1	81.3	85.1	50.4	54.8	41.6	77.5	46.0	74.6	61.7	51.7	43.6	36.5	66.4	52.8	49.8	59.9	60.3	57.9	60.3	51.2	41.5	64.6	61.3	61.4	56.8	70.2	39.6	55.2	52.1	7.6	21.3	23.5	18.9	26.0	20.5	16.0	18.4	18.5	23.6	12.8	19.6	18.4	16.1	20.2	23.6	18.3	24.0	17.1	57.2	56.8	61.6	71.9	57.3	59.0	56.6	57.2	56.1	55.2	58.2	59.9	53.2	38.5	45.3	14.7	40.2	83.4	27.0	29.4	42.7	13.2	45.9	74.7	24.6	21.5	23.4	22.0	31.3	50.4	44.1	42.2	9.8	17.6	32.6	30.4	36.8	36.8	31.6	17.7	11.0	12.3	25.9	35.1	43.3	51.7	49.9	19.8	26.0	18.6	28.6	5.0	13.0	35.9	22.4	33.8	43.2	12.3	36.7	62.5	32.0	11.2	21.8	12.7	21.6	7.1	10.1	14.7	28.6	25.9	29.7	22.0	24.0	10.2	18.6	17.2	26.3	48.6	40.4	28.2	19.9	53.4	70.0	99.2	42.3	15.4	30.4	15.2
NXF3		ENSG00000147206	"Nuclear RNA export factor 3"	Q9H4D5	X	103075810-103093143	"Predicted intracellular proteins"	"mRNA transport, Transport"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"fallopian tube: 25.0;testis: 57.8"	"Cell type enhanced"	"Detected in some"		"Cholangiocytes: 2.8;Early spermatids: 2.4;Endometrial ciliated cells: 8.4;Hepatic stellate cells: 2.9;Kupffer cells: 2.6;Late spermatids: 4.2;Paneth cells: 3.9;Undifferentiated cells: 2.8"	"Cancer enhanced"	"Detected in many"		"pancreatic cancer: 2.2"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEL: 48.6;HL-60: 46.6;NB-4: 43.0;THP-1: 33.0;U-2197: 135.9;U-937: 101.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA003132, HPA046757"	Approved		Supported	Nucleoplasm		NA	NA				"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 32: U-937 - Innate immune response"	"Cluster 49: Ciliated cells - Cilium organization"	Nucleoplasm		"HPA003132: AB_1079514, HPA046757: AB_2679789"	"unprognostic (1.20e-3)"	"unprognostic (6.72e-2)"	"unprognostic (2.74e-1)"	"unprognostic (3.05e-2)"	"unprognostic (6.75e-4)"	"unprognostic (1.72e-1)"	"unprognostic (1.21e-1)"	"unprognostic (8.86e-2)"	"unprognostic (6.19e-2)"	"unprognostic (3.13e-2)"	"unprognostic (3.63e-2)"	"unprognostic (1.88e-1)"	"unprognostic (2.21e-10)"	"unprognostic (1.90e-2)"	"unprognostic (4.51e-2)"	"unprognostic (3.99e-2)"	"unprognostic (1.56e-1)"	0.6	0.8	0.0	0.1	0.0	3.9	0.2	0.0	0.1	1.4	0.1	0.3	0.6	0.1	10.9	0.1	25.0	7.2	0.4	0.0	0.0	1.1	1.1	4.9	0.1	0.1	0.0	0.2	0.2	0.0	0.1	0.1	0.0	0.1	0.9	0.0	1.1	0.1	0.0	0.1	3.0	0.0	0.0	0.6	0.1	57.8	0.1	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	1.8	0.2	0.0	0.0	0.1	0.5	0.2	0.0	48.6	0.5	0.0	0.0	46.6	0.0	0.0	0.0	1.9	0.0	0.6	0.0	2.2	0.0	8.6	1.0	0.0	0.2	43.0	0.0	0.4	0.2	0.0	0.9	2.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	33.0	0.0	0.0	0.1	135.9	0.1	0.1	0.0	0.0	0.7	101.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	2.8	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.1	2.4	8.4	0.1	0.4	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.2	0.0	0.1	2.9	0.0	0.5	0.0	0.1	0.9	0.0	2.6	0.0	4.2	0.3	1.4	0.0	1.0	0.1	0.0	0.0	0.0	0.1	0.6	3.9	0.0	0.0	0.0	0.7	0.0	0.8	0.0	0.0	0.0	0.1	0.8	1.6	0.0	0.0	0.0	0.0	0.0	2.8	0.0
NXT1	"MTR2, P15"	ENSG00000132661	"Nuclear transport factor 2 like export factor 1"	Q9UKK6	20	23350791-23354771	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Basal keratinocytes: 235.3;Suprabasal keratinocytes: 253.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-937: 200.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047471			Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 32: U-937 - Innate immune response"	"Cluster 28: Keratinocytes - Keratinization"	Nucleoplasm	Cytosol	"HPA047471: AB_2680061"	"unprognostic (6.44e-2)"	"unprognostic (2.89e-1)"	"unprognostic (3.07e-2)"	"unprognostic (1.02e-3)"	"unprognostic (1.99e-1)"	"unprognostic (2.57e-2)"	"unprognostic (1.28e-3)"	"unprognostic (5.89e-2)"	"unprognostic (1.17e-1)"	"unprognostic (6.89e-2)"	"unprognostic (5.54e-2)"	"unprognostic (1.17e-1)"	"prognostic unfavorable (1.15e-7)"	"unprognostic (2.07e-1)"	"unprognostic (1.98e-1)"	"unprognostic (9.11e-3)"	"unprognostic (9.31e-2)"	26.4	14.2	10.4	12.4	10.4	46.8	20.6	11.0	11.7	18.7	11.0	16.0	6.9	17.8	16.7	19.6	22.8	10.1	15.7	9.9	11.0	19.8	13.7	18.9	13.7	11.1	11.1	23.9	12.5	9.6	17.9	13.0	11.3	14.9	10.1	9.4	12.8	11.6	11.6	22.7	13.8	14.9	11.2	17.6	15.2	17.6	11.2	18.3	14.4	9.5	18.3	21.5	16.9	11.1	46.3	50.6	29.9	31.4	20.7	20.0	27.9	27.7	31.0	44.3	44.5	33.7	44.2	55.0	40.3	27.7	73.0	52.8	35.6	72.6	43.3	26.5	33.2	40.5	10.4	60.4	30.9	43.6	29.5	17.9	47.6	42.8	60.4	17.5	35.7	39.5	54.7	52.6	34.7	60.1	90.7	76.4	25.2	82.3	110.9	61.9	48.4	64.7	27.0	38.5	48.4	28.4	25.4	66.7	53.3	18.2	37.5	50.1	22.7	44.6	36.9	37.7	54.1	35.9	37.2	64.0	12.6	200.8	33.9	43.6	46.7	34.5	80.2	68.7	99.2	141.5	80.4	84.3	69.5	131.4	97.9	88.3	11.5	107.9	51.1	113.5	62.1	87.8	10.4	10.4	11.0	11.7	9.9	11.0	11.1	11.1	11.3	11.2	11.2	11.1	63.4	16.0	13.1	1.0	67.0	235.3	141.0	82.9	132.1	10.1	73.1	91.4	7.6	17.2	36.1	20.2	4.2	75.4	64.7	8.2	41.1	39.7	20.3	34.0	39.3	62.1	18.7	41.9	1.5	31.2	77.1	63.7	5.6	37.8	76.2	23.5	27.5	13.4	45.3	11.8	2.2	23.9	59.0	16.6	141.2	12.8	51.6	36.9	108.5	1.9	23.9	24.5	35.0	2.5	2.8	41.3	11.0	40.3	46.0	111.3	8.3	24.1	24.0	18.3	6.6	89.5	70.5	89.6	76.4	87.4	253.5	40.2	66.7	27.8	27.9	118.1
NXT2	P15-2	ENSG00000101888	"Nuclear transport factor 2 like export factor 2"	Q9NPJ8	X	109535781-109544698	"Predicted intracellular proteins"	"mRNA transport, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HL-60: 157.3;U-937: 166.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024199, HPA072010"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 32: U-937 - Innate immune response"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	"Nucleoplasm, Cytosol"		"HPA024199: AB_1854738, HPA072010: AB_2686483"	"unprognostic (1.72e-1)"	"unprognostic (1.39e-2)"	"unprognostic (7.99e-2)"	"unprognostic (5.31e-2)"	"unprognostic (6.58e-2)"	"unprognostic (3.69e-2)"	"unprognostic (5.39e-2)"	"unprognostic (3.14e-1)"	"unprognostic (8.77e-2)"	"unprognostic (3.36e-3)"	"unprognostic (2.83e-3)"	"unprognostic (1.14e-1)"	"unprognostic (2.16e-3)"	"unprognostic (2.59e-2)"	"unprognostic (5.70e-2)"	"unprognostic (2.56e-1)"	"unprognostic (4.90e-2)"	7.6	4.8	5.3	8.0	5.6	17.5	15.2	6.0	6.8	9.2	4.0	7.8	9.2	5.6	7.2	8.9	7.0	6.1	2.7	4.8	5.8	9.3	11.9	8.0	12.3	6.0	5.8	6.5	4.3	7.3	1.2	8.4	6.4	6.4	8.5	2.2	7.7	4.3	1.9	12.2	7.5	4.5	6.8	7.5	8.7	27.6	5.4	14.8	7.9	3.4	14.1	8.8	4.4	6.9	14.2	12.2	11.6	20.3	17.1	13.5	25.6	8.8	14.9	11.1	14.4	9.6	19.5	18.1	27.1	11.1	30.0	10.5	15.4	13.8	16.9	23.5	9.5	15.1	10.6	15.8	7.0	157.3	60.9	9.9	11.8	10.6	6.6	8.3	10.0	18.7	16.1	72.2	11.0	14.6	23.9	16.6	18.6	19.8	18.0	9.4	16.4	21.6	10.4	13.9	4.6	14.6	37.7	21.2	12.0	10.1	9.0	52.1	7.5	15.9	9.0	21.2	9.3	14.8	19.5	27.7	13.9	166.9	16.6	4.7	7.2	3.6	9.2	9.8	6.0	6.3	6.7	7.5	9.7	6.2	6.6	6.5	1.4	10.8	8.1	5.9	8.4	8.0	5.3	5.6	6.0	6.8	4.8	5.8	6.0	5.8	6.4	6.8	5.4	6.9	4.8	3.2	6.5	2.0	10.1	19.2	21.0	10.4	9.6	1.4	18.0	11.3	30.0	2.8	12.8	3.7	0.0	15.1	12.9	7.9	21.5	12.5	21.5	9.3	6.0	5.4	1.2	12.4	0.5	14.0	24.8	7.5	7.1	15.0	5.7	6.0	4.6	5.4	11.4	0.0	0.4	4.4	10.2	10.1	20.0	5.9	4.7	9.9	1.8	1.0	31.9	9.2	26.8	1.5	2.5	9.0	7.6	4.5	12.3	20.3	7.6	16.6	10.5	1.4	13.1	5.3	5.2	31.7	33.7	17.0	23.3	29.1	9.4	6.6	6.4	21.3
OARD1	"C6orf130, dJ34B21.3, MGC19570, TARG1"	ENSG00000124596	"O-acyl-ADP-ribose deacylase 1"	Q9Y530	6	41033627-41097787	"Disease related genes, Metabolic proteins, Predicted intracellular proteins"		Hydrolase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 193.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"OE19: 294.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029036	Approved		Supported	Nucleoplasm,Nucleoli		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 21: OE19 - Mitochondria"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	"Nucleoplasm, Nucleoli"		"HPA029036: AB_10602336"	"unprognostic (2.33e-2)"	"unprognostic (5.23e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.92e-1)"	"unprognostic (6.50e-2)"	"unprognostic (1.45e-1)"	"unprognostic (3.62e-2)"	"unprognostic (7.06e-2)"	"unprognostic (5.54e-2)"	"unprognostic (3.99e-3)"	"unprognostic (3.46e-2)"	"unprognostic (2.15e-1)"	"prognostic favorable (1.13e-4)"	"unprognostic (4.78e-1)"	"unprognostic (7.85e-2)"	"unprognostic (1.70e-1)"	"unprognostic (2.15e-1)"	20.9	25.5	26.4	20.3	30.5	26.3	30.1	28.5	32.3	19.5	26.5	28.8	31.4	17.6	38.3	23.3	30.1	19.3	22.0	26.0	28.4	44.3	59.2	17.3	28.5	29.7	28.3	35.7	40.6	34.9	22.6	20.0	30.4	25.0	31.1	43.8	25.6	22.0	25.5	21.6	30.2	15.0	28.8	23.0	39.5	58.6	28.2	39.7	30.9	37.1	33.4	20.0	20.1	35.6	44.2	25.0	55.8	40.6	32.1	37.6	36.9	28.0	36.5	29.1	31.4	39.7	33.1	61.7	29.3	15.4	32.1	33.4	38.1	33.1	41.0	53.2	18.6	73.8	28.0	75.4	29.1	50.1	47.6	28.7	45.6	28.1	102.2	26.5	20.3	77.4	95.4	48.8	32.2	59.0	88.1	55.1	51.4	294.4	17.3	36.8	52.4	54.7	58.0	21.4	60.5	38.7	25.5	25.2	88.6	43.2	41.9	42.3	21.9	32.0	39.3	20.0	43.6	65.8	72.7	140.1	25.2	48.5	27.1	49.1	21.8	42.4	26.2	23.3	34.3	45.7	30.6	26.6	26.8	43.2	37.2	36.9	20.8	45.0	28.2	26.0	37.2	22.7	26.4	30.5	28.5	32.3	26.0	28.4	29.7	28.3	30.4	28.8	28.2	35.6	30.5	16.0	40.9	7.8	49.8	28.6	40.3	51.8	38.7	63.2	47.5	41.1	43.4	52.9	40.6	60.7	45.9	89.5	44.1	28.5	86.1	42.9	164.2	43.3	19.6	34.2	22.1	56.4	2.9	48.0	60.2	23.5	37.8	29.8	48.2	21.7	35.0	69.5	45.6	42.1	3.9	52.2	50.8	53.4	37.0	153.8	28.3	33.4	35.6	3.7	42.1	75.9	59.8	4.0	13.1	34.6	44.0	25.9	29.3	37.1	63.0	112.9	56.6	70.5	26.3	23.9	26.7	193.0	148.0	43.4	29.3	45.6	47.5	34.2	61.7	32.4
OAS1	"IFI-4, OIAS, OIASI"	ENSG00000089127	"2'-5'-oligoadenylate synthetase 1"	P00973	12	112905856-112933219	"Enzymes, Predicted intracellular proteins"	"Antiviral defense, Immunity, Innate immunity"	"Nucleotidyltransferase, RNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"salivary gland: 91.0;urinary bladder: 111.1"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 151.0;Hofbauer cells: 105.6;Paneth cells: 127.9;Urothelial cells: 171.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"non-classical monocyte: 572.0"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+: 247.1;BJ hTERT+ SV40 Large T+ RasG12V: 336.6;OE19: 307.6;U-266/70: 272.9;U-266/84: 210.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA003657, CAB021104"	Uncertain		Supported	Nucleoplasm,Cytosol	"Intracellular and membrane"	NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 37: Intestine - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Nucleoplasm, Cytosol"		"CAB021104: AB_10057722, HPA003657: AB_1854747"	"unprognostic (1.03e-1)"	"unprognostic (6.59e-2)"	"unprognostic (8.56e-3)"	"unprognostic (2.20e-3)"	"unprognostic (2.78e-1)"	"unprognostic (1.30e-1)"	"unprognostic (2.00e-2)"	"unprognostic (3.16e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.20e-2)"	"prognostic unfavorable (3.02e-4)"	"unprognostic (5.37e-2)"	"unprognostic (1.63e-2)"	"unprognostic (6.91e-2)"	"unprognostic (3.68e-2)"	"unprognostic (5.67e-2)"	"prognostic favorable (6.12e-6)"	17.0	11.5	6.8	27.3	7.3	14.3	13.1	6.5	9.7	29.6	6.1	49.0	51.7	8.0	8.1	57.1	10.0	22.5	9.5	6.6	6.9	22.3	38.6	23.1	27.2	15.4	8.0	8.1	4.4	9.0	8.3	20.4	11.5	9.1	45.1	1.5	91.0	7.3	2.4	10.3	39.8	14.6	21.2	50.5	43.6	4.8	8.4	28.1	7.7	7.4	25.6	111.1	22.7	9.9	4.7	24.4	0.0	0.1	9.4	6.6	1.5	0.1	38.8	247.1	336.6	18.5	34.1	42.3	12.2	0.3	121.8	10.8	0.2	4.2	2.2	21.0	0.0	0.7	35.2	4.6	2.9	0.6	1.4	0.5	7.2	8.0	0.0	3.1	13.5	0.7	0.0	17.4	0.2	0.4	0.6	17.0	0.7	307.6	22.5	5.8	0.2	20.5	11.6	89.4	0.2	0.9	3.7	4.2	85.2	0.4	0.9	5.1	50.4	0.0	0.5	3.2	0.4	272.9	210.3	23.9	2.9	6.6	1.4	6.3	253.6	3.2	26.5	403.9	25.3	108.8	36.3	34.3	153.9	93.1	14.3	18.8	24.4	24.9	572.0	144.5	108.7	217.8	6.8	7.3	6.5	9.7	6.6	6.9	15.4	8.0	11.5	21.2	8.4	9.9	23.0	3.2	2.2	0.0	21.1	3.4	16.6	24.0	10.8	0.2	6.0	8.1	3.1	14.3	35.4	5.5	0.0	12.6	31.5	151.0	5.9	19.5	0.4	1.9	3.6	17.2	4.2	3.6	0.6	12.0	36.4	11.1	28.5	4.1	5.1	15.4	14.3	11.9	105.6	0.0	1.0	59.3	26.4	36.9	11.4	1.2	7.2	52.9	5.4	13.1	36.2	15.0	18.6	3.5	0.1	19.5	127.9	10.5	24.1	7.4	50.9	25.4	17.5	0.4	6.6	3.0	7.5	0.0	0.5	18.3	2.3	5.7	9.1	12.7	14.6	171.9
OAS3		ENSG00000111331	"2'-5'-oligoadenylate synthetase 3"	Q9Y6K5	12	112938051-112976460	"Enzymes, Predicted intracellular proteins"	"Antiviral defense, Immunity, Innate immunity"	"Nucleotidyltransferase, RNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"monocytes: 30.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"non-classical monocyte: 15.3"	"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"BJ hTERT+ SV40 Large T+: 202.5;BJ hTERT+ SV40 Large T+ RasG12V: 224.5;GAMG: 89.8;RT4: 62.6"	"Not detected"	"Not detected"							"HPA041253, HPA041372"	Uncertain		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		Yes	No		21000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Nucleoplasm, Cytosol"	"Plasma membrane"	"HPA041253: AB_10794990, HPA041372: AB_10795590"	"unprognostic (8.47e-2)"	"unprognostic (9.13e-2)"	"unprognostic (1.27e-2)"	"unprognostic (4.39e-3)"	"unprognostic (2.59e-2)"	"unprognostic (1.45e-1)"	"unprognostic (4.14e-3)"	"unprognostic (8.06e-3)"	"unprognostic (3.19e-1)"	"unprognostic (1.73e-2)"	"unprognostic (2.29e-3)"	"unprognostic (2.48e-1)"	"prognostic unfavorable (2.23e-5)"	"unprognostic (4.25e-2)"	"unprognostic (1.37e-2)"	"unprognostic (3.29e-2)"	"unprognostic (2.93e-2)"	8.1	4.1	3.2	11.5	3.1	20.9	6.0	2.3	2.5	11.0	1.1	7.1	7.1	3.9	1.5	15.8	5.2	11.3	7.0	2.2	2.4	5.6	4.4	12.6	6.0	8.7	3.6	3.8	3.8	3.2	3.5	11.1	6.4	3.4	6.2	0.6	27.7	2.7	3.0	5.4	6.5	9.3	11.8	17.9	11.0	2.3	4.1	16.1	4.1	5.9	6.4	14.4	7.8	3.0	23.2	34.4	0.3	5.5	1.0	4.6	2.1	2.6	25.3	202.5	224.5	24.1	20.5	0.7	7.3	8.1	89.8	15.7	3.3	22.7	11.2	9.7	1.2	15.9	16.3	4.0	3.9	4.5	6.6	0.9	7.2	32.8	1.3	4.0	11.7	3.9	0.5	3.1	2.0	13.3	8.0	2.7	1.4	33.7	22.8	13.5	11.6	0.1	7.0	62.6	0.6	0.1	19.8	5.5	14.8	0.2	25.7	1.1	9.5	4.6	4.0	5.5	6.5	0.8	21.0	0.2	4.9	12.9	16.7	1.0	7.8	0.8	1.4	7.4	1.7	2.3	2.0	2.3	4.1	1.0	1.8	1.7	9.7	2.7	15.3	0.3	2.6	3.5	3.2	3.1	2.3	2.5	2.2	2.4	8.7	3.6	6.4	11.8	4.1	3.0	19.9	3.2	3.9	0.7	3.8	3.4	5.6	13.5	5.2	0.4	3.1	2.7	1.7	0.0	5.1	3.7	0.0	5.4	1.8	14.7	3.9	11.2	5.9	1.8	4.1	20.8	1.8	0.8	0.3	9.8	20.9	5.5	16.3	5.6	1.3	21.9	9.3	1.7	18.7	0.0	0.4	6.8	8.2	5.8	7.0	10.8	10.2	16.7	1.8	5.6	30.2	3.0	8.2	3.5	0.0	21.2	8.2	15.1	1.4	11.8	4.5	2.0	2.3	0.5	0.0	2.5	5.0	0.8	0.7	14.4	4.7	1.9	6.5	9.2	5.4	26.8
OASL	"OASL1, p59OASL, TRIP14"	ENSG00000135114	"2'-5'-oligoadenylate synthetase like"	Q15646	12	121017763-121039242	"Predicted intracellular proteins"	"Antiviral defense, Immunity, Innate immunity"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 35.7;stomach 1: 22.3"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 54.1;Distal enterocytes: 82.3;Gastric mucus-secreting cells: 97.9;Paneth cells: 71.4;T-cells: 43.9;Urothelial cells: 96.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 132.8"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+: 126.9;BJ hTERT+ SV40 Large T+ RasG12V: 66.2;GAMG: 35.3;hTEC/SVTERT24-B: 50.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA001474	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Nucleoplasm, Cytosol"		"HPA001474: AB_1079518"	"unprognostic (2.39e-2)"	"unprognostic (7.50e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.47e-2)"	"unprognostic (2.76e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.62e-2)"	"unprognostic (6.22e-2)"	"unprognostic (5.93e-3)"	"prognostic unfavorable (9.20e-4)"	"unprognostic (4.61e-1)"	"prognostic unfavorable (3.70e-9)"	"unprognostic (2.52e-1)"	"unprognostic (2.72e-2)"	"unprognostic (1.18e-1)"	"unprognostic (3.17e-2)"	2.3	0.8	0.7	4.2	0.8	35.7	2.4	0.7	0.8	3.3	0.6	7.5	2.7	0.5	0.5	4.0	0.7	3.6	1.1	0.6	0.5	2.3	11.8	11.9	3.6	1.4	0.7	0.4	0.7	0.1	0.6	1.4	1.4	0.5	3.4	0.2	4.1	0.4	0.4	0.9	2.0	1.3	3.3	5.3	22.3	2.1	1.1	3.3	1.1	0.6	1.7	7.8	1.4	0.9	2.6	0.6	0.2	0.9	1.0	1.6	0.1	0.2	0.9	126.9	66.2	0.3	13.0	0.6	4.0	0.1	35.3	6.4	0.1	0.9	7.2	25.2	0.1	0.1	13.8	0.0	0.7	0.2	1.8	0.8	0.6	50.7	0.1	0.3	0.3	1.0	0.1	5.3	1.1	1.7	0.1	3.1	0.1	4.5	3.7	0.1	0.2	1.4	0.1	13.7	0.1	0.2	1.1	0.6	18.5	0.1	0.4	1.7	0.1	0.7	1.2	2.1	0.2	4.9	10.1	0.3	19.9	1.3	0.4	12.3	29.6	65.8	53.1	32.5	14.3	2.5	36.2	62.1	8.9	0.8	9.9	38.5	132.8	20.3	23.5	0.5	27.8	33.2	0.7	0.8	0.7	0.8	0.6	0.5	1.4	0.7	1.4	3.3	1.1	0.9	28.6	0.0	4.2	0.7	4.6	2.2	5.0	2.7	1.8	0.0	3.3	4.7	0.6	1.5	3.9	0.0	0.0	0.2	54.1	82.3	0.0	2.5	6.6	2.0	0.6	4.5	1.8	0.8	0.2	3.8	1.3	2.4	97.9	2.8	11.4	1.0	2.2	4.5	12.6	0.0	0.2	30.7	4.1	3.1	7.2	3.4	0.3	16.7	0.0	1.0	6.0	0.0	9.2	0.0	0.0	12.7	71.4	0.0	14.3	2.2	2.4	0.3	3.8	0.0	0.0	0.7	2.8	2.4	0.1	14.6	1.0	0.1	43.9	0.2	5.1	96.3
OAT	HOGA	ENSG00000065154	"Ornithine aminotransferase"	P04181	10	124397303-124418976	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		"Aminotransferase, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 781.8"	"Cell type enhanced"	"Detected in all"		"Proximal enterocytes: 1222.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB033576, HPA040098, HPA064742"	Enhanced		Supported	Nucleoplasm,Mitochondria		NA	NA		12000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 56: Intestine - Transmembrane transport"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 45: Enterocytes - Digestion"	Mitochondria	Nucleoplasm	"CAB033576: AB_2298892, HPA040098: AB_10793955, HPA064742: AB_2685343"	"unprognostic (1.61e-2)"	"unprognostic (1.70e-2)"	"unprognostic (9.96e-2)"	"unprognostic (1.02e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.03e-1)"	"unprognostic (4.43e-3)"	"unprognostic (1.65e-1)"	"unprognostic (2.37e-2)"	"unprognostic (2.45e-1)"	"unprognostic (7.62e-2)"	"unprognostic (1.70e-2)"	"unprognostic (2.21e-1)"	"unprognostic (2.19e-1)"	"unprognostic (2.72e-2)"	"unprognostic (2.00e-2)"	60.0	119.6	69.4	40.8	71.2	106.4	150.1	74.6	97.4	99.7	75.4	75.6	750.0	82.5	63.7	105.0	56.0	68.7	52.3	71.2	78.7	114.6	162.5	42.7	38.1	76.5	72.0	77.0	36.1	46.1	53.5	65.0	85.2	74.3	67.2	51.1	225.4	94.6	58.2	71.6	781.8	97.8	73.6	34.1	70.1	56.2	73.3	30.2	67.7	60.0	69.1	58.9	63.8	81.7	241.5	42.8	27.5	98.7	272.4	260.8	93.4	142.2	288.0	124.2	135.2	110.5	30.8	0.5	101.0	241.8	118.0	249.4	126.5	265.7	134.0	42.4	174.9	268.1	28.1	82.7	139.9	0.4	169.3	172.1	134.5	111.9	129.5	204.9	147.1	48.4	470.8	50.0	175.5	62.6	72.1	15.3	55.1	73.2	59.6	66.3	104.5	65.3	119.8	3.9	57.3	60.9	89.7	235.1	209.5	156.6	78.6	65.8	114.3	70.5	65.3	117.9	90.2	42.4	47.6	64.6	97.4	72.0	34.4	38.0	39.6	36.0	28.8	35.3	31.2	15.2	24.0	30.5	44.3	16.2	29.5	29.8	40.0	16.9	37.2	9.4	24.6	29.6	69.4	71.2	74.6	97.4	71.2	78.7	76.5	72.0	85.2	73.6	73.3	81.7	49.0	19.2	49.7	37.9	44.7	151.3	144.0	362.8	185.5	35.2	154.2	163.7	21.8	18.6	182.7	35.0	27.1	120.8	80.3	38.2	90.1	34.6	30.4	37.0	90.4	37.7	43.1	317.0	31.8	13.4	90.5	124.2	55.5	40.6	43.8	32.2	37.5	152.2	66.2	43.7	33.4	104.1	197.4	31.8	68.1	15.2	104.1	56.7	85.4	17.8	34.8	37.4	18.6	22.1	41.9	12.6	74.6	120.0	32.9	82.6	1222.6	196.4	76.4	24.4	78.9	106.1	115.1	46.3	33.2	161.8	126.0	48.2	65.0	92.4	214.5	82.2
OCLN	PPP1R115	ENSG00000197822	Occludin	Q16625	5	69492292-69558104	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"			"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"thyroid gland: 31.4"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 109.0;Glandular and luminal cells: 119.7;Urothelial cells: 224.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"neutrophil: 2.7"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 2.7"	"Cell line enhanced"	"Detected in many"		"A-431: 23.3;CAPAN-2: 39.8;HaCaT: 33.4;RPTEC TERT1: 25.7;SK-BR-3: 27.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005933, CAB013075, CAB068212, CAB068213, CAB068214"	Enhanced		Supported	"Plasma membrane,Cell Junctions"	"Intracellular and membrane"	NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 22: Epithelial cell types - Mixed function"	"Plasma membrane, Cell Junctions"		"CAB013075: AB_2533101, CAB068212: AB_2665711, CAB068213: AB_2665712, CAB068214: AB_2665713, HPA005933: AB_1079520"	"unprognostic (2.28e-1)"	"unprognostic (1.88e-1)"	"unprognostic (2.50e-2)"	"unprognostic (9.94e-2)"	"unprognostic (3.65e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.08e-2)"	"unprognostic (8.25e-2)"	"unprognostic (8.20e-2)"	"unprognostic (2.58e-2)"	"unprognostic (3.48e-1)"	"prognostic favorable (6.59e-11)"	"unprognostic (2.83e-1)"	"unprognostic (4.01e-1)"	"unprognostic (1.33e-1)"	"unprognostic (3.35e-1)"	1.2	0.7	6.2	1.6	6.5	1.8	7.8	7.2	6.7	6.8	22.2	11.0	10.3	2.1	4.0	11.6	7.5	8.5	1.5	5.9	5.4	11.0	18.8	15.1	0.6	9.3	7.7	2.3	20.2	8.3	3.4	3.9	8.3	3.5	11.2	2.3	6.7	4.6	0.6	11.3	10.0	0.6	5.4	2.1	15.2	2.4	6.5	0.9	31.4	0.6	2.8	5.0	7.9	7.4	23.3	4.5	0.6	0.9	0.6	0.9	15.1	0.3	1.6	2.5	3.3	20.7	39.8	0.5	5.9	1.1	8.3	33.4	7.2	4.3	7.8	0.3	12.2	2.4	1.1	9.8	0.3	1.2	2.5	0.1	6.4	4.1	1.0	1.6	1.4	3.1	0.1	0.4	0.1	22.4	1.5	1.2	3.1	8.0	2.1	0.2	6.0	1.1	25.7	22.2	2.7	2.8	0.3	27.2	0.9	5.0	14.7	4.0	1.2	0.4	7.7	1.8	2.7	0.5	0.4	0.3	0.3	0.3	0.6	1.0	0.2	0.5	0.2	0.1	0.2	0.3	0.2	0.1	0.1	0.4	0.2	0.2	2.7	0.5	0.1	0.4	0.1	0.1	6.2	6.5	7.2	6.7	5.9	5.4	9.3	7.7	8.3	5.4	6.5	7.4	4.8	109.0	67.3	1.6	3.2	3.7	60.8	7.6	1.8	5.7	49.7	16.9	1.4	64.3	51.0	25.8	14.6	30.3	3.6	94.1	9.8	65.6	1.9	78.5	12.1	10.7	26.3	2.5	1.3	61.6	2.5	5.8	46.4	119.7	2.5	6.5	18.2	48.3	3.0	6.7	1.1	45.1	16.2	12.9	1.2	1.6	3.1	2.4	1.8	16.9	3.9	2.8	1.0	0.5	1.5	64.6	61.8	1.5	1.1	101.5	42.3	10.5	63.0	6.3	13.1	3.3	4.4	4.7	8.2	29.5	15.5	16.4	4.3	0.7	47.9	224.0
ODAM	"APin, FLJ20513"	ENSG00000109205	"Odontogenic, ameloblast associated"	A1E959	4	70196496-70204576	"Cancer-related genes, Predicted intracellular proteins"	Biomineralization		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	38	"salivary gland: 371.5"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 2: 4.2;Breast glandular cells: 10.3;Ductal cells: 6.5;Exocrine glandular cells: 8.2;Gastric mucus-secreting cells: 6.6;Glandular and luminal cells: 10.5;Theca cells: 4.2"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in single"		"medulla oblongata: 1.2"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	15	"Hep G2: 31.7;OE19: 21.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA036279, HPA036543, HPA070297"			Supported	Nucleoplasm,Cytosol	"Intracellular and membrane"	NA	NA				"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 30: Mammary glandular cells - Lactation"	Nucleoplasm	Cytosol	"HPA036279: , HPA036543: AB_10669797, HPA070297: "	"unprognostic (2.34e-2)"	"unprognostic (2.43e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.75e-1)"		"unprognostic (3.34e-3)"	"unprognostic (1.06e-1)"	"unprognostic (1.88e-2)"		"unprognostic (3.47e-1)"	"unprognostic (3.08e-1)"	"unprognostic (3.03e-1)"		"unprognostic (2.72e-1)"		"unprognostic (1.86e-2)"	"unprognostic (2.50e-2)"	0.0	0.8	0.0	2.9	0.0	0.0	0.7	0.0	0.0	0.3	0.1	3.6	1.0	0.1	0.6	0.2	0.1	0.5	0.0	0.0	0.8	1.2	0.0	2.4	0.3	1.2	0.7	0.0	0.5	3.6	0.5	0.3	0.0	1.8	0.8	0.0	371.5	1.4	0.0	0.0	0.7	7.3	0.0	0.0	9.8	0.0	0.2	0.0	4.1	0.0	1.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	31.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.6	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.4	0.0	0.0	0.0	0.1	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	1.2	0.7	0.0	0.0	0.2	0.0	0.1	3.2	4.2	0.0	0.0	0.0	1.5	0.0	0.0	0.0	10.3	0.4	0.0	1.5	1.3	1.8	0.0	0.4	0.0	0.0	0.0	6.5	0.0	2.3	0.9	0.1	0.0	0.0	0.0	8.2	0.0	0.0	6.6	10.5	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	4.2	0.5	0.4
ODF2	"CT134, ODF84"	ENSG00000136811	"Outer dense fiber of sperm tails 2"	Q5BJF6	9	128455186-128501292	"Predicted intracellular proteins"	"Differentiation, Spermatogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	8	"testis: 317.6"	"Cell type enriched"	"Detected in all"	4	"Late spermatids: 8228.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001874, HPA048841"	Enhanced		Supported	Vesicles,Centrosome		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 83: Testis - Spermatogenesis"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 31: Spermatids - Spermatogenesis"	Centrosome	Vesicles	"HPA001874: AB_1079522, HPA048841: AB_2680536"	"unprognostic (4.54e-3)"	"unprognostic (9.91e-2)"	"unprognostic (4.02e-2)"	"unprognostic (1.57e-3)"	"unprognostic (6.11e-2)"	"unprognostic (2.25e-2)"	"prognostic unfavorable (1.58e-4)"	"unprognostic (1.88e-1)"	"unprognostic (1.79e-2)"	"unprognostic (2.60e-1)"	"unprognostic (6.28e-2)"	"prognostic unfavorable (1.72e-4)"	"unprognostic (1.93e-2)"	"unprognostic (9.23e-3)"	"unprognostic (1.47e-1)"	"unprognostic (1.62e-1)"	"unprognostic (7.65e-2)"	14.3	11.8	9.6	22.1	9.8	31.1	14.2	17.9	13.5	20.4	40.1	15.7	10.3	21.9	11.0	12.4	22.6	13.2	14.4	11.1	10.7	14.1	16.4	14.4	25.6	13.4	16.1	15.1	13.2	15.3	30.8	15.9	11.6	16.1	15.1	14.9	12.9	14.7	8.9	19.3	13.7	20.5	9.7	20.5	13.7	317.6	11.7	34.8	13.2	5.3	26.6	17.0	14.4	9.9	44.2	52.2	85.3	97.7	33.3	39.6	68.6	72.3	33.7	58.9	30.8	51.8	31.6	78.6	26.7	59.2	45.7	112.7	62.9	43.1	59.4	52.2	29.3	69.8	84.9	43.8	19.3	76.2	84.5	32.8	26.9	62.6	43.9	36.5	52.0	58.8	83.9	42.9	56.3	134.9	81.5	92.7	33.4	89.7	37.2	73.6	82.0	60.9	30.7	33.6	51.2	43.6	67.8	64.0	22.9	38.3	59.8	54.8	49.9	73.1	44.6	84.9	71.7	79.6	123.9	55.9	33.4	68.4	64.8	21.6	9.2	10.3	11.4	13.4	13.6	8.2	10.2	12.2	8.8	7.0	7.2	9.3	3.0	12.0	17.8	8.3	8.1	10.1	9.6	9.8	17.9	13.5	11.1	10.7	13.4	16.1	11.6	9.7	11.7	9.9	14.2	6.4	6.8	9.8	14.4	16.7	16.7	7.4	19.9	9.8	11.2	9.5	10.6	11.5	8.5	7.3	10.4	13.1	13.7	4.6	11.7	10.6	1914.4	39.4	16.3	18.3	3.6	29.8	18.5	9.0	16.8	14.0	10.2	13.4	19.6	10.1	8.2	9.6	12.4	8.4	16.6	10.9	12.2	10.2	14.9	8228.0	42.6	12.9	10.6	12.2	11.1	8.6	9.2	14.1	9.8	7.4	3.2	33.8	16.1	16.1	3.0	6.9	46.6	8.9	13.1	11.1	16.7	268.1	58.3	13.8	13.2	33.2	16.8	11.4	7.6	12.9
OFD1	"71-7A, CXorf5, JBTS10, RP23"	ENSG00000046651	"OFD1 centriole and centriolar satellite protein"	O75665	X	13734745-13769357	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cilium biogenesis/degradation"		"Ciliopathy, Disease variant, Joubert syndrome, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in all"	4	"plasmacytoid DC: 64.2"	"Lineage enriched"	"Detected in all"	4	"dendritic cells: 64.2"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031102, HPA031103, HPA031104"	Approved		Supported	Microtubules		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 44: Endometrium - Transcription"	Microtubules		"HPA031102: AB_10670836, HPA031103: AB_10602188, HPA031104: AB_10669655"	"unprognostic (3.10e-3)"	"prognostic favorable (9.62e-4)"	"unprognostic (2.83e-1)"	"unprognostic (2.68e-2)"	"unprognostic (1.10e-1)"	"unprognostic (7.42e-3)"	"unprognostic (2.20e-3)"	"unprognostic (3.03e-3)"	"unprognostic (1.82e-2)"	"unprognostic (1.43e-3)"	"unprognostic (2.82e-1)"	"unprognostic (1.50e-2)"	"prognostic unfavorable (1.63e-4)"	"unprognostic (3.32e-2)"	"unprognostic (3.90e-2)"	"unprognostic (1.04e-2)"	"prognostic favorable (2.76e-7)"	5.8	5.9	8.3	11.7	8.7	15.6	14.6	10.8	9.8	11.2	10.1	9.4	10.2	10.5	11.5	9.9	9.6	7.3	5.9	8.2	9.4	9.6	7.2	9.2	19.1	9.7	8.3	11.2	11.2	15.3	10.9	5.3	8.9	11.7	8.2	11.2	15.6	6.5	5.2	11.8	12.8	7.6	8.2	13.9	12.2	9.9	8.4	10.1	12.9	4.1	16.8	8.5	10.4	10.0	16.0	7.1	10.3	18.4	8.4	13.0	7.7	4.9	11.3	5.7	7.3	12.8	17.7	23.2	12.5	5.9	10.6	15.3	7.5	13.7	9.2	11.6	18.9	10.8	22.3	10.8	6.4	14.4	19.1	10.4	9.1	12.9	12.7	10.6	6.4	4.2	16.5	20.4	6.4	12.6	9.9	17.3	10.8	5.8	10.2	24.9	11.9	46.6	8.9	13.5	10.5	16.6	23.2	18.5	11.6	22.7	17.5	13.0	5.8	10.0	5.2	12.1	6.3	15.1	15.1	26.9	8.3	6.4	8.3	4.3	1.7	6.2	11.6	2.2	13.4	13.7	10.1	14.2	3.8	15.4	8.3	12.5	4.7	14.1	3.1	64.2	8.6	4.4	8.3	8.7	10.8	9.8	8.2	9.4	9.7	8.3	8.9	8.2	8.4	10.0	40.2	70.5	64.1	60.4	90.8	22.4	89.3	51.8	38.1	47.9	65.9	64.1	17.8	35.8	66.7	31.3	89.6	34.5	219.8	82.3	7.9	60.2	178.6	232.2	33.0	39.5	48.6	30.1	43.3	59.3	23.4	31.2	58.1	180.8	27.3	41.1	24.7	13.3	25.2	37.0	50.2	60.3	42.7	19.8	43.0	187.4	52.2	35.1	17.8	32.8	38.2	41.3	145.2	76.9	64.5	60.7	72.9	33.8	50.5	84.4	83.8	15.3	81.3	107.2	39.5	42.4	25.2	72.7	59.9	32.6	27.3	87.0	102.2	30.7	52.2	82.8
OGA	"MEA5, MGEA5, NCOAT"	ENSG00000198408	O-GlcNAcase	O60502	10	101784443-101818465	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Host-virus interaction"	"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Collecting duct cells: 86.5;dendritic cells: 89.3;Glandular and luminal cells: 83.7;Granulosa cells: 69.4;Pancreatic endocrine cells: 82.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036141, HPA076501"	Approved		Supported	Cytosol		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 6: Brain - Smell perception"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 7: Non-specific - Mitochondria"	Cytosol		"HPA036141: AB_10672079, HPA076501: AB_2686802"	"unprognostic (4.34e-1)"	"unprognostic (1.57e-1)"	"prognostic unfavorable (8.69e-5)"	"unprognostic (4.63e-1)"	"unprognostic (2.06e-1)"	"unprognostic (2.57e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.79e-2)"	"unprognostic (2.44e-1)"	"unprognostic (1.21e-3)"	"unprognostic (6.00e-2)"	"unprognostic (7.81e-2)"	"unprognostic (1.68e-1)"	"unprognostic (3.01e-1)"	"unprognostic (3.21e-2)"	"unprognostic (1.90e-1)"	"unprognostic (9.23e-3)"	65.3	34.1	77.3	46.7	80.3	89.0	59.2	99.3	82.8	62.2	54.3	64.8	28.1	50.0	55.5	57.4	52.9	29.8	60.7	82.2	74.0	45.6	46.0	52.9	69.8	66.8	70.3	66.8	42.9	60.6	44.9	41.0	67.7	52.7	40.7	99.8	50.5	38.9	56.6	72.7	62.8	35.4	68.6	74.4	46.4	38.6	84.3	67.6	51.7	29.5	64.8	57.0	58.6	77.6	89.8	44.7	63.7	124.6	40.0	96.6	44.4	61.7	61.8	28.1	48.0	33.1	56.0	59.6	43.7	73.7	48.2	62.9	60.3	77.5	59.2	87.9	41.2	59.6	65.0	26.0	43.1	44.4	32.3	93.9	85.1	48.1	113.7	80.0	53.0	53.1	42.8	107.3	48.3	45.6	47.2	46.1	35.4	19.4	44.8	64.8	70.5	44.0	47.2	80.0	27.7	48.8	55.2	29.4	78.2	58.0	77.9	47.7	80.9	43.0	41.6	63.0	71.6	53.1	91.0	47.2	54.0	74.6	24.0	14.4	2.1	7.2	6.4	2.0	5.1	6.6	4.5	5.8	1.3	7.5	6.1	5.2	14.1	6.6	6.3	3.3	4.6	1.5	77.3	80.3	99.3	82.8	82.2	74.0	66.8	70.3	67.7	68.6	84.3	77.6	66.3	0.0	0.0	0.0	40.2	0.0	0.0	0.0	0.0	0.0	66.5	47.0	0.0	0.0	0.0	86.5	0.0	41.9	89.3	0.0	13.7	38.0	0.0	61.6	68.3	18.1	0.0	0.0	0.0	40.9	34.3	20.3	0.0	83.7	0.0	69.4	0.0	0.0	39.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.5	0.0	0.0	48.6	0.0	0.0	0.0	0.0	82.4	0.0	0.0	44.3	0.0	0.0	34.0	0.0	0.0	0.0	0.0	28.3	0.0	0.0	0.0	0.0	50.9	34.6	44.8	0.0	0.0
OGFOD1	"FLJ10826, KIAA1612, TPA1"	ENSG00000087263	"2-oxoglutarate and iron dependent oxygenase domain containing 1"	Q8N543	16	56451521-56479104	"Predicted intracellular proteins"		"Dioxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003215, HPA003722"	Approved	Approved	Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 52: Non-specific - Ribosome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 60: Granulocytes - Receptor signaling"	Nucleoplasm	Cytosol	"HPA003215: AB_1078881, HPA003722: "	"unprognostic (1.13e-1)"	"unprognostic (4.52e-2)"	"unprognostic (3.80e-3)"	"unprognostic (2.86e-2)"	"unprognostic (2.48e-3)"	"prognostic unfavorable (6.65e-4)"	"prognostic unfavorable (7.02e-4)"	"unprognostic (5.51e-2)"	"unprognostic (6.87e-2)"	"unprognostic (3.36e-2)"	"unprognostic (1.58e-2)"	"unprognostic (4.59e-2)"	"unprognostic (7.49e-2)"	"unprognostic (7.20e-2)"	"unprognostic (6.11e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.84e-2)"	9.6	12.3	5.2	8.8	6.5	3.9	9.5	5.5	7.3	10.4	4.1	7.7	8.8	9.8	7.6	19.4	10.6	6.7	14.5	5.3	7.2	9.3	9.1	8.0	8.9	6.5	6.3	8.1	5.7	12.0	6.1	9.2	6.5	8.4	9.6	9.6	6.4	9.5	31.5	6.3	5.1	16.7	5.1	7.5	6.1	9.5	6.3	10.5	10.2	23.5	14.5	9.1	5.7	9.0	25.4	27.4	25.7	32.5	28.6	34.5	26.0	39.1	29.9	52.4	38.5	34.5	16.5	44.7	19.0	29.3	21.7	34.9	57.2	25.5	57.3	14.1	29.6	32.4	21.6	32.8	21.4	34.9	36.2	23.2	29.0	38.7	31.2	23.1	45.3	29.3	44.3	8.2	46.2	15.6	27.4	19.2	45.0	19.8	47.2	51.2	41.0	51.9	22.9	16.7	20.4	24.1	46.3	29.0	25.2	26.9	26.4	30.1	28.9	28.1	23.2	22.9	36.7	18.0	37.1	67.5	22.9	26.5	22.7	13.4	4.6	4.5	7.7	6.4	10.1	7.1	9.5	9.4	6.4	5.6	10.7	8.4	1.5	8.5	8.6	6.8	9.0	5.9	5.2	6.5	5.5	7.3	5.3	7.2	6.5	6.3	6.5	5.1	6.3	9.0	8.9	3.2	16.0	9.8	14.1	17.7	13.8	11.2	17.6	11.3	13.1	10.7	21.4	20.0	15.0	9.2	10.4	18.3	11.7	5.8	25.4	13.7	22.2	11.6	20.0	12.2	2.4	19.6	14.4	14.1	20.5	22.3	12.2	19.1	45.7	13.0	9.7	17.6	12.0	13.5	16.6	7.9	4.1	6.9	10.2	15.6	12.2	10.9	10.6	4.7	16.1	13.6	10.3	9.0	14.5	17.4	5.5	15.8	16.1	11.0	4.6	13.8	8.0	15.2	13.1	16.7	19.0	26.0	29.6	21.2	18.9	11.6	18.4	19.1	10.6	9.0
OGFOD2	"FLJ13491, FLJ37501"	ENSG00000111325	"2-oxoglutarate and iron dependent oxygenase domain containing 2"	Q6N063	12	122974580-122980043	"Predicted intracellular proteins"		"Dioxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	4	"Late spermatids: 431.0"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039448, HPA040306"	Approved		Supported	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 22: Non-specific - Unknown function"	"Cluster 6: T47d - Mammary gland"	"Cluster 25: Spermatids - Spermatogenesis"	Nucleoplasm	"Nuclear bodies"	"HPA039448: AB_10795035, HPA040306: AB_10794026"	"unprognostic (2.14e-1)"	"unprognostic (2.47e-1)"	"unprognostic (6.86e-2)"	"unprognostic (3.36e-1)"	"unprognostic (3.09e-2)"	"unprognostic (1.57e-2)"	"unprognostic (6.12e-3)"	"unprognostic (1.14e-1)"	"unprognostic (8.44e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.07e-3)"	"unprognostic (2.48e-3)"	"unprognostic (1.13e-3)"	"unprognostic (1.88e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.60e-2)"	"unprognostic (1.13e-1)"	6.5	15.0	10.8	7.7	11.1	8.4	7.5	10.9	14.0	9.1	12.4	9.9	13.8	6.8	5.9	10.7	10.2	4.8	10.3	10.6	10.9	14.1	21.2	7.7	11.0	12.3	11.4	9.4	20.9	6.5	13.2	5.6	11.5	12.0	5.5	4.9	14.7	7.8	10.9	11.9	12.7	3.3	10.8	14.4	13.0	29.1	11.6	9.3	11.8	4.5	6.6	7.8	8.3	13.5	11.7	18.6	7.6	12.4	5.2	5.5	20.4	6.9	7.1	9.5	8.6	17.6	10.2	13.0	14.1	6.0	5.6	16.5	5.5	9.5	3.6	9.1	12.0	20.6	17.8	18.3	11.1	20.7	15.5	8.1	14.0	8.8	7.8	13.7	10.1	24.7	24.4	9.3	4.8	22.4	17.6	39.0	4.6	8.0	23.5	19.2	7.3	23.2	7.2	10.4	9.7	8.8	9.4	13.4	13.8	5.0	34.0	17.6	6.5	13.0	13.2	15.5	7.3	23.4	15.1	12.4	17.9	10.7	12.8	18.7	11.7	18.9	9.1	12.9	7.8	15.9	7.5	9.0	13.1	11.3	8.1	7.7	9.6	9.7	18.2	7.8	16.0	9.0	10.8	11.1	10.9	14.0	10.6	10.9	12.3	11.4	11.5	10.8	11.6	13.5	4.1	0.0	7.0	4.6	10.0	2.9	6.5	10.3	8.0	3.6	9.2	8.6	0.4	10.0	8.6	12.9	2.1	25.9	5.6	9.2	9.8	11.8	97.3	13.0	5.2	5.9	2.4	17.2	3.2	15.0	14.0	5.4	8.6	5.3	0.0	8.6	7.9	21.1	12.5	11.8	3.6	8.0	16.2	11.9	3.4	431.0	8.7	6.4	7.2	1.0	7.7	7.8	10.3	3.0	2.6	12.7	7.8	4.5	18.4	4.6	32.4	34.1	30.5	6.4	13.1	4.1	5.7	36.8	16.2	7.3	4.5	16.4	7.2	11.5	10.1	4.3
OGN	"mimecan, OIF, SLRR3A"	ENSG00000106809	Osteoglycin	P20774	9	92383268-92404696	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Growth factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix: 216.0"	"Group enriched"	"Detected in many"	8	"Endometrial stromal cells: 104.1;Fibroblasts: 326.2;Leydig cells: 166.2;Peritubular cells: 212.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	9	"T-reg: 1.7"	"Lineage enriched"	"Detected in single"	9	"T-cells: 1.7"	"Group enriched"	"Detected in some"	4	"ASC TERT1: 22.2;HSkMC: 9.7;JURKAT: 15.7;MOLT-4: 32.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA013132	Approved		Supported	"Endoplasmic reticulum"	"Secreted in other tissues"	NA	NA		170000000	"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 33: Fibroblasts - ECM organization"	"Endoplasmic reticulum"		"HPA013132: AB_1854825"	"unprognostic (2.31e-1)"	"unprognostic (3.94e-3)"	"unprognostic (1.74e-1)"	"unprognostic (2.08e-2)"	"unprognostic (2.60e-1)"	"unprognostic (2.70e-1)"	"unprognostic (1.44e-4)"	"unprognostic (4.42e-2)"	"unprognostic (1.01e-2)"	"prognostic unfavorable (4.04e-4)"	"unprognostic (2.47e-1)"	"unprognostic (1.06e-1)"	"prognostic unfavorable (1.92e-4)"	"unprognostic (3.37e-3)"	"unprognostic (3.86e-2)"	"unprognostic (2.20e-3)"	"prognostic unfavorable (2.03e-4)"	100.1	22.5	1.4	6.0	3.0	0.2	53.8	4.7	6.8	216.0	11.0	43.0	10.6	130.5	44.9	30.8	67.1	164.7	79.8	1.7	2.3	6.4	4.1	18.6	2.1	1.8	1.8	91.8	11.1	117.3	19.1	22.7	2.0	57.9	32.2	0.0	3.2	19.3	2.6	3.8	23.6	118.0	2.3	2.4	22.0	13.3	2.2	4.5	14.7	22.0	5.6	54.0	23.3	2.1	0.0	0.0	0.0	0.0	4.4	22.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.2	0.0	9.7	0.0	0.0	0.0	0.0	0.0	15.7	0.0	0.0	0.0	0.1	32.2	0.3	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	1.7	0.0	1.4	3.0	4.7	6.8	1.7	2.3	1.8	1.8	2.0	2.3	2.2	2.1	10.3	6.4	1.5	1.0	0.4	4.2	0.1	0.0	1.2	0.6	0.7	0.4	2.6	10.0	7.4	3.7	0.0	2.0	0.6	0.1	0.0	0.0	1.2	2.9	104.1	5.2	0.0	0.0	1.9	0.0	1.7	326.2	7.7	1.7	1.3	0.0	20.0	0.1	4.6	0.0	1.8	0.0	0.0	0.3	11.1	4.2	166.2	2.3	1.8	16.9	0.2	0.1	0.0	2.0	1.6	0.0	0.0	212.1	0.7	0.4	0.0	0.0	2.9	0.2	6.6	4.7	22.7	0.6	0.6	0.7	4.5	5.7	2.1	1.6	0.0	0.2
OGT	"FLJ23071, HRNT1, MGC22921, O-GLCNAC, OGT1"	ENSG00000147162	"O-linked N-acetylglucosamine (GlcNAc) transferase"	O15294	X	71533104-71575892	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Apoptosis, Biological rhythms, Host-virus interaction, Ubl conjugation pathway"	"Chromatin regulator, Glycosyltransferase, Transferase"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030751, HPA030752, HPA030753, HPA030754, CAB034099"	Approved		Supported	"Nucleoplasm,Plasma membrane"		Yes	No			"Cluster 39: Non-specific - mRNA processing"	"Cluster 50: Non-specific - Ribosome"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 65: Plasmacytoid DCs - Unknown function"	Nucleoplasm	"Plasma membrane"	"CAB034099: AB_2157067, HPA030751: AB_10600217, HPA030752: AB_10601445, HPA030753: AB_2673594, HPA030754: AB_2673595"	"unprognostic (1.37e-1)"	"unprognostic (2.20e-1)"	"unprognostic (2.32e-2)"	"prognostic unfavorable (8.33e-4)"	"unprognostic (3.40e-2)"	"prognostic favorable (1.97e-4)"	"unprognostic (9.56e-3)"	"unprognostic (1.96e-3)"	"unprognostic (5.58e-2)"	"unprognostic (2.29e-1)"	"unprognostic (1.06e-1)"	"unprognostic (9.74e-3)"	"prognostic unfavorable (2.36e-6)"	"unprognostic (2.99e-3)"	"unprognostic (2.28e-1)"	"unprognostic (8.03e-3)"	"prognostic favorable (6.85e-7)"	59.3	55.9	39.7	38.3	42.4	61.5	62.7	43.3	51.6	72.7	40.1	62.5	30.6	56.0	62.2	52.8	76.4	26.4	55.5	43.9	35.5	61.6	45.8	70.7	71.9	36.1	35.8	85.5	102.4	24.3	46.9	26.4	37.9	75.4	39.6	36.9	64.1	27.1	62.8	68.6	86.4	24.5	36.1	122.8	67.4	19.0	36.2	57.2	70.7	39.2	57.8	55.7	67.4	44.3	40.5	37.0	47.1	41.5	49.6	45.6	31.6	30.3	54.3	32.1	49.1	39.3	45.4	47.9	20.7	37.3	33.3	49.1	52.0	29.5	39.4	41.1	53.4	30.4	98.6	28.5	37.6	62.9	48.1	43.6	59.2	35.1	65.7	55.5	30.5	100.7	31.1	160.4	31.1	34.3	48.9	75.2	31.6	35.5	49.8	47.8	52.7	62.1	50.0	45.9	24.1	21.2	46.9	30.9	30.2	35.5	22.8	42.4	35.5	34.6	27.9	36.6	17.9	43.5	33.5	56.5	24.4	65.0	21.6	2.8	4.6	2.0	7.5	5.7	6.8	7.4	6.3	6.2	6.1	6.2	7.2	7.4	1.9	10.4	5.7	6.2	6.2	5.6	39.7	42.4	43.3	51.6	43.9	35.5	36.1	35.8	37.9	36.1	36.2	44.3	31.1	35.3	85.2	52.9	67.2	88.1	37.9	23.5	58.6	26.5	49.6	34.0	42.8	20.0	31.1	49.7	8.4	15.8	130.7	31.1	9.8	14.4	2.4	32.1	49.8	39.8	34.9	51.3	110.7	14.4	8.5	47.5	54.6	53.3	27.8	26.4	45.7	27.5	16.1	40.4	94.6	37.3	22.4	60.9	69.7	4.8	53.4	45.8	35.6	71.2	51.6	11.3	51.5	92.0	97.9	17.6	34.9	29.7	147.2	53.8	34.8	15.1	28.0	21.8	32.9	44.8	42.2	2.5	6.1	63.3	84.1	10.9	82.1	62.0	34.0	50.8
OIP5	"CT86, hMIS18beta, MIS18B"	ENSG00000104147	"Opa interacting protein 5"	O43482	15	41309273-41332591	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 10.3;skeletal muscle: 10.3;testis: 20.9"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 45.9;Extravillous trophoblasts: 24.0;Spermatocytes: 110.6;Spermatogonia: 56.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA052271, HPA059602"	Enhanced		Supported	"Nuclear speckles,Vesicles"		NA	Yes			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Nuclear speckles"	Vesicles	"HPA052271: AB_2681780, HPA059602: AB_2684079"	"unprognostic (5.17e-2)"	"unprognostic (7.26e-2)"	"unprognostic (3.07e-1)"	"unprognostic (1.59e-2)"	"unprognostic (6.94e-2)"	"unprognostic (6.58e-2)"	"prognostic unfavorable (1.79e-4)"	"prognostic unfavorable (2.26e-4)"	"unprognostic (2.71e-2)"	"unprognostic (1.21e-1)"	"prognostic unfavorable (9.34e-5)"	"unprognostic (5.51e-2)"	"unprognostic (0.00e+0)"	"unprognostic (3.84e-2)"	"unprognostic (2.02e-1)"	"unprognostic (5.75e-2)"	"unprognostic (2.86e-2)"	0.6	1.7	0.1	3.3	0.2	10.3	1.2	1.2	0.4	0.9	0.2	4.1	3.5	0.8	0.3	3.8	0.4	0.6	1.5	0.2	0.2	0.3	1.2	0.5	5.8	0.2	0.4	1.5	0.3	0.1	0.1	2.3	0.4	0.5	3.9	0.7	0.8	0.6	10.3	3.3	3.9	1.1	0.1	1.7	1.5	20.9	0.2	9.1	0.4	0.8	5.2	0.7	1.3	0.5	33.7	17.8	34.3	24.9	1.7	2.1	32.4	20.0	9.3	24.5	26.1	31.8	16.2	19.8	17.0	7.7	37.8	51.0	35.7	16.1	19.2	42.4	40.1	42.4	49.8	33.6	0.4	46.5	22.1	0.7	3.2	13.8	14.5	5.2	21.1	40.8	59.4	37.3	16.5	16.3	27.1	34.8	30.9	50.4	37.9	32.9	28.4	30.5	11.1	15.4	53.7	17.5	33.7	34.3	9.6	13.7	33.7	26.3	10.0	24.5	37.3	24.6	36.6	17.0	83.2	71.1	7.1	56.5	35.9	0.0	0.4	0.5	0.2	0.7	0.8	1.0	0.7	0.8	0.7	1.2	1.3	0.8	0.0	1.2	0.4	4.1	3.1	0.8	0.1	0.2	1.2	0.4	0.2	0.2	0.2	0.4	0.4	0.1	0.2	0.5	0.2	0.0	0.5	1.0	2.7	4.1	0.9	3.6	1.2	0.0	1.1	2.2	0.2	0.0	1.8	0.0	0.0	15.0	1.7	2.3	0.0	0.4	12.0	1.9	0.6	0.9	0.0	45.9	2.2	0.4	24.0	1.7	5.1	1.1	1.3	5.2	0.0	0.8	7.5	0.0	2.1	3.0	8.2	2.2	1.8	10.8	0.9	1.2	0.0	0.0	0.6	1.1	2.1	1.5	2.5	0.2	0.5	1.2	10.9	0.4	0.9	0.3	0.0	0.3	6.6	1.0	1.1	110.6	56.8	8.3	2.4	3.8	1.2	2.1	7.6	0.9
OLFM4	"GC1, GW112, OlfD"	ENSG00000102837	"Olfactomedin 4"	Q6UX06	13	53028813-53052057	"Predicted secreted proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 1296.1;pancreas: 671.4"	"Cell type enhanced"	"Detected in many"		"Ductal cells: 497.1;Exocrine glandular cells: 900.9;Intestinal goblet cells: 791.9;Pancreatic endocrine cells: 933.7;Paneth cells: 556.9;Undifferentiated cells: 2419.9;Urothelial cells: 1989.0"	"Group enriched"	"Detected in many"	14	"colorectal cancer: 711.4;pancreatic cancer: 594.7;stomach cancer: 724.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 5.4;BJ hTERT+: 18.8;HaCaT: 26.4;OE19: 10.4;RPMI-8226: 6.2"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA077718	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cytokinetic bridge,Cytosol"	"Secreted to digestive system"	Yes	NA		9300		"Cluster 56: Intestine - Transmembrane transport"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Nucleoplasm, Plasma membrane"	"Cytokinetic bridge, Cytosol"	"HPA077718: AB_2732358"	"prognostic favorable (8.77e-4)"	"unprognostic (4.84e-2)"	"unprognostic (1.65e-3)"	"unprognostic (2.33e-1)"	"unprognostic (7.24e-2)"	"unprognostic (1.34e-1)"	"unprognostic (3.74e-2)"	"unprognostic (5.16e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.22e-1)"	"unprognostic (4.78e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.29e-2)"	"unprognostic (1.33e-1)"	"unprognostic (4.37e-2)"	"unprognostic (4.84e-3)"	1.9	0.1	0.2	195.4	0.5	126.0	6.8	0.1	0.5	7.9	0.2	451.6	1211.9	5.5	3.5	0.8	8.3	10.4	0.8	0.2	0.4	26.9	0.9	3.8	1.4	0.1	0.2	0.2	671.4	0.0	0.5	0.6	0.2	92.4	568.7	0.4	16.2	0.9	0.6	0.4	1296.1	52.6	0.2	18.0	16.1	0.3	0.2	4.2	0.4	2.1	0.2	127.0	285.6	0.2	0.0	0.0	0.1	0.0	0.0	0.0	5.4	2.4	18.8	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	26.4	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.0	0.0	10.4	0.0	0.0	0.8	6.2	0.2	0.0	1.1	1.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.6	0.9	0.0	0.4	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.5	0.1	0.5	0.2	0.4	0.1	0.2	0.2	0.2	0.2	0.2	0.2	0.0	0.0	0.3	3.8	0.1	168.5	0.3	0.0	0.0	9.8	2.5	0.5	0.0	11.9	139.8	0.0	0.0	0.0	98.7	1.9	497.1	0.2	13.5	0.5	1.4	92.3	0.8	1.0	900.9	0.0	1.5	0.0	17.6	0.0	0.0	0.0	0.0	0.1	0.0	0.3	791.9	2.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	10.3	4.0	0.0	0.0	0.2	933.7	556.9	0.0	0.4	209.4	300.6	0.0	0.5	0.2	0.0	2.1	9.2	0.0	0.1	0.0	0.0	0.0	3.1	0.2	2419.9	1989.0
OLFML3	"HNOEL-iso, OLF44"	ENSG00000116774	"Olfactomedin like 3"	Q9NRN5	1	113979391-114035572	"Predicted intracellular proteins, Predicted secreted proteins"		"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 136.6;Fibroblasts: 246.9;Leydig cells: 73.3;Theca cells: 126.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	8	"myeloid DC: 2.1"	"Lineage enriched"	"Detected in single"	12	"dendritic cells: 2.1"	"Cell line enhanced"	"Detected in many"		"ASC diff: 577.3;ASC TERT1: 312.6;BJ hTERT+: 374.8;HSkMC: 581.6;LHCN-M2: 602.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027991			Supported	Vesicles	"Secreted to extracellular matrix"	NA	NA		3000000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 33: Fibroblasts - ECM organization"	Vesicles		"HPA027991: AB_2732440"	"unprognostic (1.04e-1)"	"unprognostic (8.06e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.50e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.02e-1)"	"unprognostic (3.72e-1)"	"unprognostic (1.67e-1)"	"unprognostic (3.04e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.77e-1)"	"prognostic unfavorable (3.45e-5)"	"unprognostic (6.80e-3)"	"unprognostic (1.88e-1)"	"unprognostic (2.61e-1)"	"unprognostic (4.41e-3)"	85.6	42.6	5.7	24.9	7.4	0.9	89.7	7.2	12.4	170.6	8.2	71.9	15.1	124.7	42.6	26.6	96.3	95.0	56.6	5.4	6.7	34.1	36.3	55.4	12.0	9.8	7.7	177.4	35.2	9.9	17.9	111.8	8.6	42.9	34.5	0.2	16.7	73.8	10.3	37.6	32.3	94.6	9.2	9.9	48.4	9.3	9.7	8.9	21.8	38.2	14.9	71.1	98.8	11.2	0.0	19.7	9.7	0.1	577.3	312.6	0.6	77.1	374.8	26.5	85.3	25.2	0.2	0.0	4.1	222.4	0.2	0.0	3.2	0.3	4.0	0.0	0.0	0.0	0.1	19.3	149.6	0.2	0.0	581.6	0.0	37.2	0.5	10.7	2.1	0.0	0.0	0.1	602.3	0.3	0.2	0.4	45.8	0.0	0.7	0.1	142.6	0.3	0.0	0.0	0.3	5.4	0.1	0.2	10.5	143.3	224.6	0.9	1.8	14.9	27.6	5.9	0.0	0.2	0.1	0.0	7.3	0.0	94.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	5.7	7.4	7.2	12.4	5.4	6.7	9.8	7.7	8.6	9.2	9.7	11.2	13.6	0.0	3.7	0.0	0.4	13.0	0.2	0.0	0.6	0.0	2.1	2.9	1.4	4.3	0.8	1.8	0.0	6.8	1.1	0.2	0.0	0.8	2.9	6.2	136.6	9.5	6.0	0.0	0.0	0.0	4.9	246.9	5.6	3.5	1.3	0.3	45.7	0.5	33.3	0.0	0.0	0.6	0.0	5.9	22.7	1.7	73.3	15.5	12.4	16.9	0.6	0.0	0.0	0.0	0.1	0.3	0.1	33.1	0.2	0.7	0.0	0.5	0.0	0.1	0.0	44.8	28.0	0.3	0.4	1.2	11.5	12.4	2.6	126.1	0.2	0.2
OLR1	"CLEC8A, LOX-1, SCARE1"	ENSG00000173391	"Oxidized low density lipoprotein receptor 1"	P78380	12	10158301-10172138	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion, Immunity, Inflammatory response"	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 52.6;lung: 100.2;placenta: 114.5"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 399.0;Hofbauer cells: 202.1;Macrophages: 202.6;Syncytiotrophoblasts: 463.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"myeloid DC: 2.8"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"CACO-2: 125.4;HaCaT: 64.9;HHSteC: 125.1;hTCEpi: 58.4;SiHa: 248.8;SK-BR-3: 96.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA050798			Approved	"Nucleoplasm,Vesicles,Plasma membrane"	"Intracellular and membrane"	NA	NA	1060000		"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Nucleoplasm, Plasma membrane"	Vesicles	"HPA050798: AB_2756318"	"unprognostic (2.30e-1)"	"unprognostic (3.16e-2)"	"unprognostic (1.58e-2)"	"unprognostic (1.32e-1)"	"unprognostic (7.81e-2)"	"prognostic unfavorable (8.24e-5)"	"unprognostic (6.34e-2)"	"unprognostic (6.07e-3)"	"unprognostic (5.40e-2)"	"unprognostic (2.64e-1)"	"unprognostic (1.97e-2)"	"unprognostic (3.51e-1)"	"unprognostic (1.08e-1)"	"unprognostic (4.94e-3)"	"unprognostic (3.47e-2)"	"unprognostic (1.48e-2)"	"unprognostic (1.42e-1)"	3.0	3.3	9.0	29.1	13.1	23.8	3.6	18.9	16.9	3.3	8.8	0.7	1.3	1.6	1.3	0.5	2.1	7.4	1.5	9.4	13.3	8.2	3.1	100.2	0.7	25.5	15.6	0.3	2.2	4.1	2.7	114.5	26.0	2.3	1.0	5.1	3.8	1.0	0.5	0.6	1.2	2.1	27.6	0.8	2.3	4.7	24.0	2.8	2.5	0.0	0.8	6.0	0.3	52.6	7.3	0.5	0.1	0.3	0.3	0.0	16.8	12.1	2.2	7.3	2.6	125.4	0.1	1.6	0.0	15.8	0.5	64.9	0.0	0.7	4.9	0.0	0.0	0.0	6.1	0.0	125.1	0.1	0.3	1.0	58.4	0.3	0.0	0.0	0.3	0.1	0.1	0.7	0.0	0.1	0.3	0.2	0.2	0.0	0.0	0.0	0.2	0.3	0.2	13.3	0.4	0.2	248.8	96.9	0.0	17.4	27.1	0.0	0.1	0.2	1.4	0.0	0.0	0.4	0.3	0.4	0.1	0.1	0.1	0.6	0.6	1.3	0.1	0.1	0.1	0.1	0.1	0.0	2.8	0.2	0.1	0.1	1.4	0.1	0.1	0.3	0.1	0.6	9.0	13.1	18.9	16.9	9.4	13.3	25.5	15.6	26.0	27.6	24.0	52.6	1.9	28.9	27.4	0.0	4.0	1.5	0.4	0.5	0.0	0.4	1.1	4.6	0.1	1.5	4.4	0.0	0.0	399.0	0.3	0.0	0.0	0.1	13.4	0.1	0.0	10.8	0.0	0.4	2.3	0.0	14.6	10.9	0.5	0.1	15.2	0.0	0.0	0.5	202.1	0.0	0.2	0.0	0.0	18.9	79.5	11.6	0.3	202.6	0.0	40.3	21.3	0.1	0.0	0.5	0.5	0.0	0.0	0.0	1.3	0.0	0.0	0.2	6.6	0.2	0.0	0.2	0.4	0.1	0.2	0.8	0.6	463.1	1.6	0.1	0.0	0.3
ONECUT2	OC-2	ENSG00000119547	"One cut homeobox 2"	O95948	18	57435374-57491298	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 9.1;gallbladder: 10.1;intestine: 10.1;liver: 8.5;retina: 5.4"	"Cell type enriched"	"Detected in many"	5	"Horizontal cells: 964.0"	"Group enriched"	"Detected in many"	7	"liver cancer: 4.3;pancreatic cancer: 4.3;stomach cancer: 5.4"	"Group enriched"	"Detected in many"	5	"basal ganglia: 9.1;cerebral cortex: 2.3;hypothalamus: 4.2"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 20.3;HeLa: 14.1;RT4: 6.7;SCLC-21H: 10.1"	"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in many"	5	"basal ganglia: 8.7;cerebellum: 4.7;cerebral cortex: 5.6;hippocampal formation: 3.2;hypothalamus: 2.5"	HPA057058	Enhanced		Supported	"Nucleoplasm,Actin filaments"		NA	NA				"Cluster 56: Intestine - Transmembrane transport"	"Cluster 20: HeLa - Mitochondria"	"Cluster 62: Horizontal cells - Visual perception"	Nucleoplasm	"Actin filaments"	"HPA057058: AB_2683323"	"unprognostic (3.02e-2)"	"unprognostic (5.36e-2)"	"unprognostic (9.06e-3)"	"unprognostic (3.79e-5)"	"unprognostic (1.13e-2)"	"unprognostic (4.48e-4)"	"unprognostic (2.10e-2)"	"unprognostic (1.81e-1)"	"unprognostic (3.75e-1)"	"unprognostic (4.56e-3)"	"unprognostic (8.66e-3)"	"unprognostic (1.16e-2)"	"unprognostic (5.34e-4)"	"unprognostic (3.83e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.13e-1)"	"unprognostic (3.21e-1)"	0.0	0.1	0.4	0.0	9.1	0.0	0.0	0.8	2.3	0.0	0.0	0.0	10.1	0.0	0.0	0.0	0.0	10.1	0.0	0.3	4.2	0.1	8.5	0.0	0.0	0.6	0.3	0.0	2.3	0.8	0.8	0.0	0.8	0.0	0.0	5.4	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.1	0.1	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.5	1.0	1.2	3.1	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.8	0.0	1.4	0.0	3.4	0.0	0.1	20.3	3.1	0.7	14.1	3.0	0.0	0.0	0.5	0.0	0.0	0.0	0.2	0.0	0.0	2.3	4.0	0.7	0.0	0.5	1.9	0.0	0.1	1.6	0.7	0.0	1.2	0.0	1.6	6.7	10.1	1.7	0.1	0.0	0.2	0.1	0.5	0.7	0.0	1.0	1.3	0.2	0.2	0.3	3.0	0.0	0.0	0.8	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	9.1	0.8	2.3	0.3	4.2	0.6	0.3	0.8	0.0	1.0	0.2	0.3	0.0	0.0	2.3	0.0	0.1	0.2	0.0	0.0	4.5	0.4	1.1	2.8	184.5	0.0	7.3	14.6	0.0	0.0	2.0	0.0	79.7	4.9	0.2	0.1	0.5	8.9	0.0	38.7	8.8	0.1	0.3	0.0	0.3	0.0	0.5	5.3	47.0	1.0	964.0	1.8	0.6	0.0	1.3	0.0	3.2	0.3	0.1	0.0	1.0	0.0	3.0	0.0	3.5	1.0	38.7	3.3	0.0	0.0	0.4	0.1	0.1	0.0	5.6	0.0	0.9	0.7	1.9	2.0	0.0	0.1	0.0	0.1	0.2	0.5	0.0
ONECUT3		ENSG00000205922	"One cut homeobox 3"	O60422	19	1753506-1780988	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"retina: 2.1;stomach 1: 4.3"	"Group enriched"	"Detected in some"	28	"Cardiomyocytes: 89.7;Horizontal cells: 312.9"	"Group enriched"	"Detected in some"	7	"pancreatic cancer: 3.5;stomach cancer: 3.9"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"HaCaT: 8.1;OE19: 10.9;PC-3: 18.1"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			HPA059936			Supported	Nucleoplasm		NA	NA				"Cluster 77: Retina - Visual perception"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 62: Horizontal cells - Visual perception"	Nucleoplasm		"HPA059936: AB_2684172"	"unprognostic (9.43e-2)"	"unprognostic (1.36e-1)"	"unprognostic (6.28e-2)"	"unprognostic (1.36e-3)"	"unprognostic (2.27e-1)"	"unprognostic (1.09e-2)"	"unprognostic (2.21e-1)"	"unprognostic (3.61e-3)"	"unprognostic (2.02e-1)"	"unprognostic (1.84e-1)"	"unprognostic (3.87e-2)"	"unprognostic (3.64e-1)"	"unprognostic (3.08e-10)"	"unprognostic (1.18e-1)"	"unprognostic (9.86e-2)"	"unprognostic (4.62e-1)"	"unprognostic (1.21e-2)"	0.0	0.0	0.5	0.1	0.2	0.2	0.0	0.2	0.2	0.0	0.3	0.0	0.6	0.0	0.1	0.0	0.0	0.7	0.1	0.2	1.1	0.0	0.0	0.0	0.0	0.7	0.5	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	2.1	0.0	0.0	0.1	0.1	0.2	0.0	0.2	0.1	4.3	0.9	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.1	0.2	0.0	0.0	8.1	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	10.9	18.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.2	0.2	0.2	1.1	0.7	0.5	0.6	0.2	0.2	0.5	0.1	0.0	0.0	0.0	0.0	0.3	0.4	0.0	0.0	1.0	0.2	0.5	89.7	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	1.9	0.2	0.4	2.9	0.0	0.0	0.1	0.2	0.0	1.3	7.1	0.8	0.0	0.0	0.0	0.1	0.1	312.9	0.1	1.3	0.0	0.0	0.8	1.5	0.0	0.3	0.0	0.0	0.1	0.3	0.0	0.0	0.0	6.4	0.0	0.4	0.0	0.4	0.2	0.0	0.0	2.6	0.0	0.4	2.1	3.2	2.9	0.0	0.3	0.0	0.2	0.0	0.2	0.5
OPA1	"FLJ12460, KIAA0567, MGM1, NPG, NTG"	ENSG00000198836	"OPA1 mitochondrial dynamin like GTPase"	O60313	3	193593144-193697811	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Apoptosis, Sensory transduction, Vision"	Hydrolase	"Cardiomyopathy, Deafness, Disease variant, Neurodegeneration, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 135.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036926, HPA036927"	Supported		Supported	Nucleoplasm,Mitochondria		NA	NA		10000	"Cluster 14: Monocytes - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 6: Erythroid cells - Oxygen transport"	"Nucleoplasm, Mitochondria"		"HPA036926: AB_10671247, HPA036927: AB_2675388"	"unprognostic (2.10e-2)"	"unprognostic (9.23e-3)"	"unprognostic (7.98e-2)"	"prognostic unfavorable (8.61e-4)"	"unprognostic (1.62e-2)"	"unprognostic (4.59e-2)"	"unprognostic (2.24e-1)"	"unprognostic (1.86e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.08e-1)"	"prognostic unfavorable (8.44e-5)"	"unprognostic (3.48e-2)"	"prognostic favorable (1.84e-4)"	"unprognostic (2.92e-1)"	"unprognostic (4.75e-1)"	"unprognostic (4.50e-3)"	"unprognostic (3.21e-1)"	15.0	12.0	14.3	7.6	17.4	25.6	12.8	15.2	19.5	10.4	9.4	18.9	16.8	10.9	9.1	14.6	8.1	10.2	39.3	18.6	17.4	18.3	20.9	8.5	11.8	16.4	15.4	8.4	10.1	23.1	3.8	11.7	16.8	12.3	16.6	9.6	11.7	13.3	24.2	11.9	13.8	13.5	12.4	9.3	14.6	6.3	15.2	12.7	13.9	44.5	12.4	13.0	5.1	13.7	58.9	18.8	18.2	20.2	15.8	25.0	19.3	27.5	26.2	30.0	29.0	45.2	19.3	38.6	58.1	27.0	27.3	37.3	32.7	31.7	53.5	46.5	25.7	67.9	16.7	23.1	24.9	55.8	29.8	28.4	27.6	30.0	40.9	18.5	26.2	15.7	28.4	37.0	30.2	46.5	21.9	30.9	25.8	33.9	59.9	27.8	40.1	41.6	22.7	36.1	39.8	24.2	41.8	46.3	29.5	14.1	60.3	43.5	26.3	27.7	20.8	29.3	58.7	33.1	41.3	74.0	30.5	43.7	28.4	9.7	7.3	7.1	5.8	8.2	5.5	6.8	5.5	5.6	7.8	5.1	5.6	6.0	2.7	4.7	17.3	4.0	6.6	5.2	14.3	17.4	15.2	19.5	18.6	17.4	16.4	15.4	16.8	12.4	15.2	13.7	24.8	16.0	24.0	72.1	27.5	15.9	16.4	17.4	24.5	19.5	20.9	13.5	135.2	22.8	20.1	18.4	31.3	19.0	24.6	31.4	17.6	19.3	7.7	20.3	25.2	23.8	23.4	86.3	106.8	24.0	14.9	24.6	31.1	26.1	19.6	25.6	14.3	39.1	17.9	21.9	106.7	20.6	10.2	25.6	14.7	13.5	15.8	28.1	21.4	58.1	22.9	14.6	11.3	87.4	98.1	28.9	12.1	14.7	29.3	18.7	24.6	34.1	19.6	23.4	6.6	21.3	26.2	15.1	16.6	34.3	22.4	17.9	22.3	28.2	26.7	22.1
OPRK1	"KOR, OPRK"	ENSG00000082556	"Opioid receptor kappa 1"	P41145	8	53225724-53251637	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters"	Behavior	"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	9	"brain: 14.5"	"Group enriched"	"Detected in some"	5	"Endometrial ciliated cells: 4.5;Excitatory neurons: 6.7;Extravillous trophoblasts: 8.0;Glandular and luminal cells: 9.8;Inhibitory neurons: 10.1;Leydig cells: 4.7"	"Cancer enhanced"	"Detected in some"		"prostate cancer: 1.8"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"U-937: 21.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA067549	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 32: U-937 - Innate immune response"	"Cluster 44: Endometrium - Transcription"	"Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA067549: AB_2732770"	"unprognostic (1.01e-1)"	"unprognostic (1.17e-2)"		"unprognostic (8.70e-3)"	"unprognostic (3.73e-2)"	"unprognostic (6.74e-2)"		"unprognostic (2.22e-3)"		"unprognostic (8.09e-2)"	"unprognostic (9.71e-2)"	"unprognostic (4.28e-3)"		"unprognostic (3.29e-1)"	"unprognostic (3.35e-2)"	"unprognostic (9.54e-4)"	"unprognostic (1.61e-1)"	0.1	0.1	7.3	0.0	14.5	0.0	0.0	1.3	8.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	3.9	5.4	0.0	0.0	0.1	0.0	5.8	1.7	0.0	0.0	0.0	0.0	0.2	5.1	1.6	0.0	0.6	0.0	0.0	1.1	0.0	0.0	0.0	0.3	0.0	0.0	0.7	6.9	0.1	0.1	0.0	0.0	0.0	0.0	2.6	0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	1.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.3	21.6	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.3	14.5	1.3	8.3	3.9	5.4	5.8	1.7	5.1	0.3	6.9	2.6	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.6	1.3	0.0	0.0	0.0	0.2	4.5	0.6	0.1	0.0	0.0	6.7	0.0	8.0	0.1	0.0	9.8	0.0	0.0	0.0	0.0	0.2	0.0	10.1	0.0	0.0	0.0	0.0	0.3	4.7	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.4	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.0	1.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0
OR10P1	"OR10P1P, OR10P2P, OR10P3P, OST701"	ENSG00000175398	"Olfactory receptor family 10 subfamily P member 1"	Q8NGE3	12	55636860-55637854	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			HPA074114			Supported	"Plasma membrane"		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"			"Cluster 54: Cardiomyocytes - Muscle contraction"	"Plasma membrane"		"HPA074114: "																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OR13C2		ENSG00000276119	"Olfactory receptor family 13 subfamily C member 2"	Q8NGS9	9	104604671-104605627	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA078297			Supported	"Nucleoplasm,Plasma membrane"		NA	NA							"Plasma membrane"	Nucleoplasm	"HPA078297: "																		0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.8	0.3	0.0	0.0	0.0	0.4	0.0	0.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.2	0.1	0.2	0.8	0.3	0.9	0.2	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OR13C5		ENSG00000277556	"Olfactory receptor family 13 subfamily C member 5"	Q8NGS8	9	104598457-104599413	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA078297			Supported	"Nucleoplasm,Plasma membrane"		NA	NA							"Plasma membrane"	Nucleoplasm	"HPA078297: "																"unprognostic (4.88e-2)"		0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.5	0.0	0.0	0.0	0.0	0.5	0.4	0.0	0.1	0.0	0.2	0.0	0.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.3	0.2	0.5	0.5	0.4	0.8	0.0	0.5	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OR13C9		ENSG00000136839	"Olfactory receptor family 13 subfamily C member 9"	Q8NGT0	9	104617248-104618204	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA078297			Uncertain	"Nucleoplasm,Plasma membrane"		NA	NA							"Plasma membrane"	Nucleoplasm	"HPA078297: "																		0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.3	0.4	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.2	0.2	0.1	0.3	0.4	0.5	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OR6C6		ENSG00000188324	"Olfactory receptor family 6 subfamily C member 6"	A6NF89	12	55293988-55296569	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in many"			HPA051090	Uncertain		Approved	"Lipid droplets,Plasma membrane"		NA	NA						"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Lipid droplets, Plasma membrane"		"HPA051090: AB_2681341"																		0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.2	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OR8S1		ENSG00000284723	"Olfactory receptor family 8 subfamily S member 1"	Q8NH09	12	48525632-48528103	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"Spermatocytes: 4.0;Spermatogonia: 1.8"					"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA045595	Uncertain		Supported	"Plasma membrane"		NA	NA						"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	"Plasma membrane"		"HPA045595: AB_10964447"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0		0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.3	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	4.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ORC1	"HSORC1, ORC1L, PARC1"	ENSG00000085840	"Origin recognition complex subunit 1"	Q13415	1	52372829-52404423	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"DNA replication"	DNA-binding	"Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 29.0;lymphoid tissue: 11.6"	"Cell type enhanced"	"Detected in some"		"Cytotrophoblasts: 5.5;Early spermatids: 5.6;Erythroid cells: 14.1;Extravillous trophoblasts: 9.9;Plasma cells: 6.3;Spermatogonia: 6.5"	"Cancer enhanced"	"Detected in many"		"testis cancer: 15.7"	"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in some"		"NK-cell: 3.4"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA027439, HPA027450"	Approved		Supported	Nucleoplasm		NA	Yes			"Cluster 15: NK-cells - Transcription"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"HPA027439: , HPA027450: AB_10602041"	"unprognostic (3.28e-1)"	"unprognostic (4.42e-3)"	"prognostic favorable (1.74e-5)"	"unprognostic (1.29e-2)"	"unprognostic (7.29e-2)"	"unprognostic (2.34e-3)"	"prognostic unfavorable (3.22e-5)"	"unprognostic (3.77e-3)"	"prognostic unfavorable (3.69e-4)"	"unprognostic (3.86e-2)"	"unprognostic (2.70e-3)"	"unprognostic (8.39e-2)"	"unprognostic (1.25e-10)"	"unprognostic (4.56e-3)"	"unprognostic (1.05e-1)"	"unprognostic (2.45e-1)"	"unprognostic (1.57e-2)"	0.4	0.6	0.2	3.5	0.1	29.0	1.1	0.6	0.2	0.6	0.0	3.4	1.7	0.6	0.1	2.7	0.3	0.4	0.2	0.1	0.2	0.5	0.6	0.6	6.7	0.3	0.0	0.5	0.3	0.3	0.3	1.9	0.2	0.4	4.0	1.0	0.6	0.1	0.5	2.0	2.3	0.9	0.0	2.0	1.0	5.2	0.2	11.6	0.3	0.1	7.7	0.9	1.0	0.3	19.3	20.8	33.0	21.7	0.8	2.7	31.8	13.5	12.2	38.9	40.0	25.8	10.7	44.2	11.6	8.5	17.8	25.9	48.9	16.9	33.8	19.0	28.1	53.2	30.2	25.8	0.2	71.9	29.2	1.4	0.8	38.1	4.3	2.7	11.7	27.6	63.0	20.9	12.8	14.4	56.9	34.0	73.1	11.7	29.5	60.2	51.3	43.1	6.8	25.0	18.5	15.6	31.0	18.8	10.3	30.5	10.2	28.7	5.4	15.8	22.5	24.9	34.0	10.9	31.1	54.4	15.6	52.6	19.5	0.0	0.1	0.0	0.2	0.1	0.2	0.2	0.4	0.4	0.6	0.8	0.1	0.3	0.4	3.4	0.2	0.0	1.2	0.3	0.2	0.1	0.6	0.2	0.1	0.2	0.3	0.0	0.2	0.0	0.2	0.3	0.6	0.0	0.0	0.3	1.7	0.9	0.3	0.4	1.2	0.7	0.7	1.1	0.5	0.0	0.1	0.0	0.0	5.5	0.7	1.2	0.0	0.3	5.6	0.5	0.6	0.5	0.0	14.1	0.7	0.2	9.9	0.7	0.5	0.6	0.0	2.8	0.0	0.2	2.9	0.0	0.7	1.3	0.0	0.3	0.4	3.8	0.6	0.6	0.0	1.0	0.3	0.2	0.0	0.5	0.5	0.2	0.8	0.4	6.3	0.2	0.2	3.9	0.1	0.9	0.0	0.6	0.7	4.1	6.5	2.5	1.1	1.8	1.1	0.9	3.7	0.4
ORC2	ORC2L	ENSG00000115942	"Origin recognition complex subunit 2"	Q13416	2	200908977-200963680	"Predicted intracellular proteins"	"DNA replication"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 107.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003693, HPA073881"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 29: Plasmacytoid DCs - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm	Cytosol	"CAB003693: AB_425574, HPA073881: AB_2686640"	"unprognostic (3.04e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.89e-1)"	"unprognostic (8.12e-3)"	"unprognostic (3.40e-2)"	"unprognostic (1.52e-2)"	"unprognostic (2.37e-3)"	"unprognostic (3.28e-1)"	"prognostic unfavorable (8.42e-4)"	"unprognostic (6.18e-2)"	"unprognostic (4.56e-2)"	"unprognostic (4.63e-3)"	"prognostic unfavorable (1.97e-4)"	"unprognostic (9.67e-2)"	"unprognostic (3.74e-1)"	"unprognostic (1.42e-1)"	"unprognostic (5.31e-3)"	5.9	4.9	2.8	6.7	3.1	5.7	8.0	7.6	4.6	5.8	4.6	7.2	9.1	6.0	6.0	5.8	5.1	4.3	8.8	2.7	3.3	5.6	5.2	4.9	8.5	2.4	2.6	6.8	6.9	7.2	5.1	5.6	2.6	6.4	6.8	7.8	7.1	5.8	6.7	8.4	7.7	4.8	1.4	6.5	7.0	20.8	2.6	9.4	8.3	6.0	8.4	5.4	5.8	5.0	17.8	12.3	13.9	13.9	5.6	9.5	23.4	18.1	11.4	16.3	16.1	26.3	14.2	11.2	12.6	10.7	18.3	14.3	30.6	20.6	24.7	24.9	28.2	26.1	22.1	32.4	11.0	20.7	17.7	8.9	12.0	16.7	20.4	12.8	19.1	18.3	42.5	13.3	14.6	16.9	29.1	19.5	33.6	17.2	29.6	20.6	14.1	16.3	17.2	14.1	22.0	16.5	15.9	14.0	10.4	27.2	10.0	10.2	14.7	14.2	14.6	12.3	18.3	9.4	24.1	17.9	11.3	19.9	13.6	0.3	2.5	3.9	3.2	1.0	4.3	5.5	4.5	3.2	2.1	4.6	5.7	4.1	1.2	3.2	1.9	4.9	3.3	1.6	2.8	3.1	7.6	4.6	2.7	3.3	2.4	2.6	2.6	1.4	2.6	5.0	12.9	9.6	18.5	30.7	16.5	19.1	9.0	7.7	23.9	14.6	12.3	7.6	18.0	14.3	14.8	9.2	25.0	20.6	17.5	12.8	7.9	10.0	56.0	11.5	14.1	12.7	4.2	26.7	54.6	12.3	18.5	10.0	14.8	13.3	10.8	27.5	13.2	10.9	8.9	6.7	61.4	13.1	4.1	7.0	7.1	11.6	12.2	7.0	10.6	24.4	11.4	7.0	20.6	41.7	55.9	10.5	9.0	8.2	16.3	9.7	15.2	9.1	12.1	14.9	19.7	13.1	9.1	107.2	22.1	16.1	15.5	10.8	14.7	6.9	14.7	8.4
ORC3	"IMAGE50150, LATHEO, ORC3L"	ENSG00000135336	"Origin recognition complex subunit 3"	Q9UBD5	6	87590067-87667453	"Predicted intracellular proteins, Predicted membrane proteins"	"DNA replication"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039553, HPA053748"	Enhanced		Supported	Nucleoplasm		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 21: Non-specific - Transcription"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 45: Enterocytes - Digestion"	Nucleoplasm		"HPA039553: AB_2676566, HPA053748: AB_2682247"	"unprognostic (9.38e-3)"	"unprognostic (2.38e-1)"	"unprognostic (3.74e-2)"	"prognostic unfavorable (2.89e-5)"	"unprognostic (8.63e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.39e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.26e-3)"	"unprognostic (1.21e-1)"	"unprognostic (9.07e-2)"	"prognostic unfavorable (7.23e-4)"	"unprognostic (1.33e-1)"	"unprognostic (2.92e-2)"	"unprognostic (3.38e-3)"	"unprognostic (1.09e-1)"	11.8	17.9	13.5	9.8	14.0	8.8	15.8	18.3	17.9	11.1	11.1	10.0	6.8	13.6	16.3	9.0	15.3	9.5	20.3	14.0	13.6	14.5	15.8	10.8	13.8	14.2	12.7	20.1	9.6	19.4	13.2	12.7	13.9	12.3	10.6	33.8	9.0	11.5	21.7	10.6	8.8	10.9	14.3	10.8	8.4	25.8	13.5	20.5	16.1	20.5	13.2	10.8	9.5	17.0	16.5	22.9	39.1	30.6	31.0	32.2	29.4	32.9	30.4	38.5	53.0	31.6	20.0	32.3	44.6	22.9	33.0	28.5	45.1	27.3	52.4	40.6	31.3	30.8	30.5	33.3	16.9	34.6	9.7	29.6	20.1	43.5	38.6	21.4	23.7	34.2	71.5	33.8	37.5	22.2	13.7	18.4	28.5	24.3	24.3	33.5	53.5	20.4	30.8	24.6	27.8	20.4	25.9	15.7	26.2	41.4	20.9	29.9	19.6	19.1	18.5	39.1	39.7	16.1	38.0	22.4	25.3	34.7	29.9	22.5	10.1	11.5	12.6	17.1	18.7	17.7	17.7	15.7	8.6	15.2	21.9	18.5	7.0	19.4	22.4	11.0	18.8	12.7	13.5	14.0	18.3	17.9	14.0	13.6	14.2	12.7	13.9	14.3	13.5	17.0	17.8	12.8	13.4	36.2	21.6	5.0	11.0	16.0	5.7	18.7	9.2	11.0	36.3	11.5	15.7	7.3	12.5	23.4	13.6	14.2	21.5	10.8	61.2	21.2	19.8	10.9	10.3	12.0	56.2	10.3	24.5	17.5	11.7	15.1	12.0	23.7	12.1	9.5	20.0	6.7	68.0	12.5	10.2	8.8	3.9	26.7	18.6	13.1	8.8	37.5	12.4	20.2	10.3	41.7	44.8	10.5	12.1	15.4	23.9	10.0	58.3	31.4	21.4	28.1	13.1	21.6	17.1	67.8	34.6	8.7	4.4	14.6	17.0	20.0	14.2	8.3
ORC4	"HsORC4, ORC4L, Orc4p"	ENSG00000115947	"Origin recognition complex subunit 4"	O43929	2	147930396-148021604	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"DNA replication"	DNA-binding	"Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB015124, HPA064562"	Approved		Supported	Nucleoplasm,Nucleoli		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 11: Alveolar cells - Smell perception"	"Nucleoplasm, Nucleoli"		"CAB015124: AB_2157883, HPA064562: AB_2685287"	"unprognostic (5.04e-2)"	"unprognostic (6.56e-2)"	"unprognostic (4.51e-2)"	"prognostic unfavorable (7.27e-4)"	"unprognostic (8.28e-2)"	"unprognostic (6.45e-2)"	"prognostic unfavorable (4.98e-8)"	"unprognostic (5.55e-2)"	"unprognostic (8.00e-2)"	"unprognostic (1.81e-2)"	"unprognostic (4.92e-2)"	"unprognostic (1.19e-1)"	"prognostic favorable (4.10e-6)"	"unprognostic (2.49e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.95e-3)"	9.7	11.2	11.5	10.1	13.1	19.3	14.6	21.6	16.3	9.0	8.7	12.6	12.0	12.0	11.0	10.6	14.2	9.7	11.6	12.8	10.8	20.5	12.8	9.3	10.9	9.6	7.9	16.7	8.2	16.2	7.6	10.1	10.0	12.1	13.8	19.7	13.4	10.3	15.0	9.3	11.4	11.5	7.6	8.9	9.4	15.5	10.9	15.7	15.6	10.9	11.9	10.2	6.6	14.4	22.8	19.3	37.2	20.4	14.2	13.9	39.9	25.2	21.3	31.3	31.0	47.9	22.6	29.3	26.8	15.1	27.7	22.4	43.4	25.2	32.4	20.6	36.1	40.2	19.0	32.8	18.8	25.9	14.5	11.9	29.4	34.0	13.9	23.3	21.4	27.5	38.8	14.9	21.2	23.8	20.1	20.9	42.3	18.9	28.0	21.6	24.9	26.5	34.5	46.3	35.0	27.4	22.6	24.7	30.1	33.6	18.9	12.2	15.5	23.5	23.2	17.3	23.4	14.7	37.9	27.5	19.1	20.0	14.6	24.1	13.1	18.3	13.6	17.5	13.9	14.1	12.9	13.9	16.4	14.5	13.4	13.5	18.8	19.3	14.0	8.3	15.1	11.7	11.5	13.1	21.6	16.3	12.8	10.8	9.6	7.9	10.0	7.6	10.9	14.4	21.5	83.3	62.5	53.5	26.0	26.0	21.8	47.1	27.3	48.7	20.3	24.0	25.9	11.5	66.1	12.9	39.6	40.3	27.3	21.7	45.0	31.6	34.0	47.9	17.6	23.8	22.9	46.5	88.4	17.2	48.2	27.7	14.3	26.1	45.5	28.3	19.2	17.1	23.8	53.8	91.4	18.9	28.5	18.8	20.7	15.7	22.4	19.7	21.4	34.7	22.0	33.8	24.7	69.9	71.3	18.3	15.4	21.4	12.8	24.4	23.2	55.4	85.8	37.5	32.9	23.2	31.5	61.2	26.8	22.6	24.9	32.7	25.6	16.9	21.8	20.6
ORC5	"ORC5L, Orc5p, ORC5T, PPP1R117"	ENSG00000164815	"Origin recognition complex subunit 5"	O43913	7	104126341-104208047	"Predicted intracellular proteins"	"DNA replication"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 54.4;Inhibitory neurons: 48.8;Oligodendrocytes: 55.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019730	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 68: Epididymis - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm	Cytosol	"HPA019730: AB_10696205"	"unprognostic (1.82e-1)"	"unprognostic (1.49e-1)"	"unprognostic (6.72e-2)"	"unprognostic (4.77e-2)"	"unprognostic (7.42e-2)"	"unprognostic (3.11e-2)"	"unprognostic (2.53e-3)"	"unprognostic (3.47e-2)"	"unprognostic (9.26e-2)"	"unprognostic (2.33e-1)"	"unprognostic (1.77e-1)"	"unprognostic (2.00e-2)"	"unprognostic (3.83e-2)"	"unprognostic (6.52e-2)"	"unprognostic (9.71e-2)"	"unprognostic (2.53e-2)"	"unprognostic (7.73e-2)"	9.7	9.8	10.5	7.8	11.5	5.8	13.2	14.3	12.5	10.2	7.8	12.0	8.4	10.8	13.7	10.6	8.9	6.6	6.3	11.2	10.5	10.4	17.4	6.4	12.2	10.3	10.0	10.7	14.5	10.1	7.5	9.5	9.7	16.9	12.8	14.1	8.9	10.6	9.0	11.6	7.5	10.9	9.3	9.0	10.3	19.3	11.6	13.3	10.2	7.9	13.4	11.0	10.0	11.2	37.1	39.2	21.2	38.1	21.8	21.5	18.8	31.0	30.8	34.2	28.5	25.9	23.7	55.4	26.9	19.5	37.9	33.1	42.4	29.9	40.8	32.3	30.5	20.2	19.1	24.8	30.8	37.9	16.5	22.3	27.9	39.4	36.2	14.4	32.8	30.1	65.0	29.3	30.8	52.6	52.4	38.7	23.2	48.6	37.9	21.6	38.0	53.4	26.4	26.4	28.9	23.5	30.2	58.7	41.3	16.5	19.7	28.4	19.2	32.8	36.0	51.8	41.6	33.7	75.8	69.3	22.2	49.7	39.8	14.2	10.6	8.4	20.2	12.7	26.5	24.0	21.6	23.9	12.3	18.7	25.7	28.9	1.4	20.6	10.9	11.4	18.4	13.7	10.5	11.5	14.3	12.5	11.2	10.5	10.3	10.0	9.7	9.3	11.6	11.2	6.7	3.2	7.2	22.2	11.2	4.5	3.6	11.4	10.8	6.6	6.6	5.7	6.2	8.6	9.8	3.7	0.0	22.1	2.6	4.4	1.9	10.3	5.7	3.8	9.8	9.1	5.4	12.8	54.4	9.0	14.3	8.6	9.7	4.5	5.1	11.6	4.6	9.7	8.8	3.3	48.8	8.9	6.1	4.8	4.2	5.7	6.2	6.0	1.8	35.6	7.8	3.4	7.2	31.2	55.9	7.4	5.4	7.9	13.9	4.9	5.9	7.2	12.9	12.5	0.0	4.1	10.9	40.1	24.6	12.6	8.5	10.5	9.5	10.3	8.1	2.0
ORMDL1		ENSG00000128699	"ORMDL sphingolipid biosynthesis regulator 1"	Q9P0S3	2	189770267-189784364	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA065643			Supported	"Endoplasmic reticulum"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 51: Non-specific - Unknown function"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 52: Non-specific - Transcription"	"Endoplasmic reticulum"		"HPA065643: AB_2685525"	"unprognostic (1.45e-1)"	"unprognostic (5.34e-3)"	"unprognostic (1.05e-1)"	"unprognostic (1.08e-1)"	"unprognostic (2.56e-1)"	"unprognostic (1.80e-1)"	"unprognostic (4.85e-3)"	"unprognostic (1.86e-2)"	"unprognostic (6.70e-3)"	"prognostic favorable (3.04e-5)"	"unprognostic (5.90e-3)"	"unprognostic (2.16e-2)"	"prognostic unfavorable (5.84e-9)"	"unprognostic (2.62e-1)"	"unprognostic (1.14e-1)"	"unprognostic (2.87e-2)"	"prognostic favorable (1.49e-5)"	60.0	66.2	27.0	50.3	28.6	51.7	54.9	34.2	33.2	67.9	36.2	60.7	41.1	56.5	99.5	46.1	55.3	47.4	37.8	28.4	33.1	55.2	68.7	66.9	75.2	27.3	27.7	50.8	84.5	42.3	79.3	63.1	28.2	62.2	50.1	82.0	66.1	47.3	41.5	84.3	84.9	43.9	30.4	131.2	64.0	58.8	28.8	44.2	62.9	23.9	69.4	50.3	51.7	32.8	31.4	20.5	68.0	54.8	88.2	100.4	70.3	64.9	61.7	71.0	71.5	41.9	51.7	57.8	44.7	49.9	36.7	52.1	43.4	42.0	77.5	65.6	55.2	82.3	106.2	61.9	102.6	65.8	63.8	113.1	51.6	61.8	70.6	99.0	58.4	57.9	48.3	85.9	72.9	28.6	58.6	127.0	60.7	32.4	86.4	46.4	50.2	78.7	87.4	49.3	43.6	51.4	33.8	32.0	74.3	78.3	38.7	73.3	61.6	70.1	48.1	44.9	65.7	82.9	66.6	55.4	76.4	68.7	38.6	49.4	32.7	39.8	35.8	39.5	33.7	37.9	39.3	36.5	26.7	35.4	45.0	40.9	13.3	29.4	48.3	46.1	46.1	33.5	27.0	28.6	34.2	33.2	28.4	33.1	27.3	27.7	28.2	30.4	28.8	32.8	80.4	80.1	50.2	41.4	90.9	56.3	55.1	95.6	26.7	138.3	69.8	76.7	34.4	41.5	65.5	36.8	175.2	212.4	141.2	36.0	33.2	58.7	42.8	58.0	63.9	61.8	42.4	38.7	53.6	67.3	73.0	58.1	24.5	47.3	45.6	84.3	47.5	37.4	86.9	65.6	60.1	37.2	101.7	126.8	60.9	18.9	74.3	83.3	39.2	33.7	96.4	107.7	117.4	57.8	49.4	66.5	48.3	48.5	83.5	79.1	62.8	45.9	66.3	217.2	52.6	55.4	63.8	186.8	145.0	32.5	60.7	218.1	104.5	117.4	46.3	51.5
ORMDL2	"adoplin-2, HSPC160, MST095, MSTP095"	ENSG00000123353	"ORMDL sphingolipid biosynthesis regulator 2"	Q53FV1	12	55818041-55821879	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA065643			Supported	"Endoplasmic reticulum"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 15: RT4 - Unknown function"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	"Endoplasmic reticulum"		"HPA065643: AB_2685525"	"unprognostic (1.12e-1)"	"unprognostic (2.59e-2)"	"unprognostic (2.41e-1)"	"prognostic favorable (3.30e-5)"	"unprognostic (6.92e-2)"	"unprognostic (1.52e-3)"	"prognostic unfavorable (9.75e-4)"	"unprognostic (1.45e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.88e-2)"	"unprognostic (1.84e-3)"	"unprognostic (1.49e-1)"	"unprognostic (2.75e-3)"	"unprognostic (1.25e-1)"	"unprognostic (2.20e-1)"	"unprognostic (3.04e-2)"	"unprognostic (5.68e-2)"	37.5	38.1	14.6	24.2	17.0	20.4	31.3	18.3	20.5	30.0	24.7	44.5	27.2	28.4	51.3	75.9	26.3	20.6	30.1	14.8	18.4	40.7	47.5	35.5	23.0	19.0	18.0	16.8	32.9	44.5	29.7	22.3	18.5	30.8	48.4	14.8	40.2	23.2	19.7	36.4	30.2	26.4	17.2	33.2	32.9	42.7	18.3	27.6	27.4	11.1	38.5	41.7	36.8	20.2	55.9	103.5	43.1	22.4	81.2	40.4	47.7	66.5	66.0	57.0	49.9	116.6	133.8	34.5	69.3	80.7	58.5	100.3	34.6	138.7	56.6	35.9	51.4	46.7	89.7	65.9	85.8	56.7	47.4	50.9	125.2	99.9	103.3	73.3	81.0	38.2	25.0	91.1	73.7	89.3	34.8	25.3	20.9	87.8	82.0	22.8	34.5	88.4	149.8	159.1	37.4	23.8	84.9	99.9	38.4	64.8	120.0	40.1	59.4	30.5	42.6	36.4	42.7	43.6	39.1	28.1	48.9	22.4	43.1	50.4	73.0	107.1	86.5	92.8	76.8	93.2	82.1	92.1	73.4	76.1	67.8	81.5	91.8	74.1	108.7	119.9	107.8	72.1	14.6	17.0	18.3	20.5	14.8	18.4	19.0	18.0	18.5	17.2	18.3	20.2	43.1	73.7	38.3	1.3	39.8	23.3	71.9	132.9	15.4	9.9	43.1	30.0	3.9	45.8	99.4	53.3	12.5	74.7	49.6	125.7	29.4	133.7	171.0	77.9	25.7	42.0	46.1	26.5	0.7	168.1	117.5	22.0	28.1	86.0	51.9	14.0	35.3	82.2	125.3	8.4	0.8	66.7	69.2	42.5	49.1	68.0	25.4	57.4	56.9	2.8	111.4	24.8	77.2	1.0	4.0	197.4	133.5	23.3	50.8	95.7	89.7	76.0	149.2	18.4	19.7	13.5	32.9	107.0	61.7	50.6	33.4	151.6	44.6	30.5	56.2	91.3
ORMDL3		ENSG00000172057	"ORMDL sphingolipid biosynthesis regulator 3"	Q8N138	17	39921041-39927601	"Disease related genes, Predicted membrane proteins"			Asthma	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 234.5"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 251.6;Late spermatids: 328.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HDLM-2: 427.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA065643			Supported	"Endoplasmic reticulum"		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 85: Liver - Metabolism"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 34: Spermatids - Unknown function"	"Endoplasmic reticulum"		"HPA065643: AB_2685525"	"unprognostic (2.28e-1)"	"unprognostic (1.06e-1)"	"unprognostic (3.31e-2)"	"unprognostic (6.49e-2)"	"unprognostic (4.11e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.96e-1)"	"prognostic favorable (9.29e-4)"	"unprognostic (1.26e-1)"	"unprognostic (3.67e-1)"	"unprognostic (5.68e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.31e-1)"	"unprognostic (2.37e-1)"	"unprognostic (4.55e-1)"	"unprognostic (1.09e-3)"	"prognostic favorable (5.18e-4)"	149.0	29.6	39.6	33.9	39.5	39.7	70.8	37.2	45.8	40.1	55.9	41.9	50.0	36.1	64.7	28.4	28.0	32.4	63.0	41.7	40.2	38.0	234.5	49.0	55.9	40.9	38.6	39.9	109.6	51.1	50.2	35.5	38.3	46.9	38.6	25.1	70.4	41.6	44.2	41.4	47.8	36.6	40.1	38.3	50.0	50.8	41.6	79.4	57.7	29.5	56.4	46.9	26.3	39.1	33.5	40.2	41.8	34.8	106.1	40.2	37.9	48.0	55.4	50.5	48.4	46.1	36.3	24.7	44.6	59.4	34.5	56.0	29.8	38.6	46.9	427.6	53.2	24.1	22.5	113.0	41.5	28.5	40.6	44.2	39.7	34.9	19.7	57.2	22.8	68.5	30.9	194.8	28.0	30.1	85.1	31.9	23.4	44.2	20.1	71.2	37.7	78.4	28.2	80.1	36.6	37.2	31.8	196.6	32.9	46.3	70.8	30.8	18.7	27.4	34.0	23.6	36.8	104.2	95.3	34.5	28.2	27.6	20.6	9.3	4.7	61.1	39.4	7.7	28.3	26.4	39.3	43.3	4.2	23.1	44.2	53.7	7.7	18.4	11.6	21.1	27.7	36.6	39.6	39.5	37.2	45.8	41.7	40.2	40.9	38.6	38.3	40.1	41.6	39.1	7.6	51.3	37.2	2.9	28.7	16.4	13.7	13.1	21.6	18.5	25.9	14.5	28.9	17.2	15.3	42.3	0.0	25.9	18.4	27.3	3.9	18.4	251.6	7.2	12.6	10.3	25.9	34.1	3.4	29.2	17.9	13.9	11.2	13.8	18.4	10.5	7.5	97.8	8.3	13.5	3.8	26.8	18.3	7.5	13.0	328.9	18.6	6.0	16.0	1.9	22.1	44.9	57.7	3.5	3.2	38.8	20.8	28.6	41.2	15.2	29.2	11.9	8.0	11.2	26.3	8.5	16.5	5.8	7.6	11.5	14.3	9.3	35.6	21.0	17.7	12.4
OS9	"ERLEC2, OS-9"	ENSG00000135506	"OS9 endoplasmic reticulum lectin"	Q13438	12	57693955-57721557	"Predicted intracellular proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in all"	7	"RH-30: 3551.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011518, HPA013694"	Supported		Supported	"Endoplasmic reticulum"	"Intracellular and membrane"	NA	NA		10000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 55: Plasma cells - Humoral immune response"	"Endoplasmic reticulum"		"CAB011518: AB_776918, HPA013694: AB_1854812"	"unprognostic (1.67e-2)"	"unprognostic (4.20e-1)"	"unprognostic (3.93e-2)"	"unprognostic (1.50e-1)"	"unprognostic (9.79e-3)"	"unprognostic (1.32e-3)"	"unprognostic (4.78e-2)"	"unprognostic (8.54e-2)"	"unprognostic (2.67e-1)"	"unprognostic (1.64e-1)"	"unprognostic (5.67e-3)"	"unprognostic (2.23e-1)"	"unprognostic (1.83e-2)"	"unprognostic (2.78e-1)"	"unprognostic (1.67e-2)"	"unprognostic (4.81e-2)"	"unprognostic (2.21e-2)"	151.0	93.0	61.1	118.6	59.3	149.0	113.4	60.7	60.8	135.6	94.3	158.1	149.9	101.2	141.4	105.2	109.6	106.2	111.0	58.4	71.5	114.8	264.5	130.0	89.7	64.5	62.8	124.6	270.0	171.6	71.5	141.3	63.5	116.4	132.6	75.5	189.0	102.1	59.6	119.8	143.2	110.2	60.8	106.0	137.2	38.9	66.7	72.6	129.4	65.5	94.2	119.7	103.5	63.7	86.8	170.8	86.2	214.4	440.4	295.6	190.5	211.9	268.4	153.4	154.6	180.2	274.5	110.0	345.3	255.2	118.5	152.9	81.3	137.5	121.2	142.0	97.6	124.0	115.3	164.8	287.1	196.9	307.3	273.7	217.6	150.7	152.6	529.4	258.6	71.7	96.0	427.9	162.2	149.5	53.7	239.7	97.7	172.0	121.2	69.8	3551.9	281.5	116.5	210.6	88.4	116.4	300.3	205.5	176.6	158.1	245.4	381.0	238.9	206.0	122.3	140.4	136.4	253.4	234.6	112.9	173.8	141.6	290.4	175.7	241.2	274.6	72.9	213.0	68.5	50.5	61.1	65.0	172.6	54.3	46.8	54.1	246.4	58.8	182.4	149.0	74.4	218.9	61.1	59.3	60.7	60.8	58.4	71.5	64.5	62.8	63.5	60.8	66.7	63.7	83.3	86.6	116.7	22.2	65.8	57.7	85.4	103.3	43.9	44.1	61.2	46.6	14.1	80.1	111.8	73.5	77.2	142.4	64.5	153.0	9.8	144.8	6.7	34.0	73.3	90.2	103.6	53.4	19.5	110.1	124.6	113.6	65.7	60.0	91.1	61.6	81.4	161.1	144.8	50.5	27.0	167.3	107.8	121.1	99.1	10.7	113.4	106.1	119.2	29.0	125.0	87.2	53.5	23.6	24.4	94.7	155.4	79.0	141.1	56.5	154.0	53.9	74.0	50.9	92.1	68.3	66.9	38.1	46.4	51.3	51.6	197.7	59.5	64.9	102.4	65.0
OSBP	OSBP1	ENSG00000110048	"Oxysterol binding protein"	P22059	11	59574398-59615774	"Predicted intracellular proteins"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039227, HPA043625"	Enhanced		Supported	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA		70000	"Cluster 29: Plasmacytoid DCs - Unknown function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 10: Non-specific - Unknown function"	"Golgi apparatus"	"Nucleoplasm, Cytosol"	"HPA039227: AB_2676401, HPA043625: AB_2678587"	"unprognostic (3.09e-2)"	"unprognostic (3.76e-2)"	"prognostic favorable (2.08e-5)"	"unprognostic (7.80e-3)"	"unprognostic (7.32e-2)"	"unprognostic (2.79e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.49e-2)"	"unprognostic (3.34e-1)"	"unprognostic (7.42e-2)"	"unprognostic (1.42e-3)"	"unprognostic (1.22e-1)"	"prognostic favorable (3.08e-7)"	"unprognostic (1.25e-1)"	"unprognostic (9.00e-2)"	"unprognostic (1.93e-1)"	"unprognostic (2.67e-1)"	19.6	41.7	14.1	15.5	15.2	27.2	27.4	15.3	18.9	24.7	18.4	26.8	29.4	20.0	31.6	19.6	22.4	19.5	25.5	15.0	15.6	42.8	57.6	18.5	17.8	15.4	16.7	22.4	37.3	44.9	16.1	22.9	16.7	25.9	28.3	15.9	30.1	27.0	57.7	26.6	25.5	21.2	14.0	15.6	27.8	18.0	15.7	24.0	32.3	43.8	23.7	19.6	17.1	15.1	40.9	33.6	24.7	33.2	56.5	52.4	26.8	32.9	42.3	38.4	34.4	38.1	40.2	41.1	42.7	37.9	47.2	41.4	45.4	43.5	43.0	40.0	20.9	28.1	25.1	25.8	60.2	36.2	52.9	40.4	52.8	36.2	94.4	40.0	41.7	38.3	48.6	37.3	34.5	19.0	34.0	26.2	28.0	59.5	32.7	32.5	39.8	28.6	45.6	47.0	28.5	20.3	38.6	47.7	46.0	33.6	66.9	22.7	45.8	32.7	22.8	49.5	22.3	51.9	45.2	41.4	37.0	25.6	26.8	1.7	1.6	1.5	2.8	1.4	2.6	2.2	2.9	2.3	1.6	1.6	2.6	2.1	1.5	2.2	1.3	4.0	1.3	1.1	14.1	15.2	15.3	18.9	15.0	15.6	15.4	16.7	16.7	14.0	15.7	15.1	29.2	25.6	9.0	14.7	18.9	39.6	16.4	13.7	29.6	23.8	38.0	27.1	34.1	32.9	19.0	27.6	22.9	14.2	31.1	34.0	7.9	14.0	8.8	37.9	52.7	21.8	30.0	10.5	25.6	18.6	14.7	21.1	22.4	43.8	27.9	21.8	15.4	67.1	16.0	26.9	22.9	40.0	8.2	12.9	16.9	14.5	15.8	17.9	14.2	12.2	9.6	15.7	18.6	18.1	23.3	20.2	20.5	19.9	32.2	31.2	34.6	21.0	27.8	21.7	6.6	28.4	19.3	25.1	14.5	27.0	47.3	30.8	20.0	43.5	28.4	26.4
OSBPL3	"KIAA0704, ORP-3, ORP3, OSBP3"	ENSG00000070882	"Oxysterol binding protein like 3"	Q9H4L5	7	24796540-24981634	"Plasma proteins, Predicted intracellular proteins"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 123.1;Excitatory neurons: 176.1;Inhibitory neurons: 272.2;Microglial cells: 94.6;Plasma cells: 91.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HMC-1: 113.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000691, HPA048401"	Enhanced		Supported	Nucleoli,Cytosol		NA	Yes			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Cytosol	Nucleoli	"HPA000691: AB_1854814, HPA048401: AB_2680386"	"unprognostic (3.57e-1)"	"unprognostic (1.14e-1)"	"unprognostic (6.11e-3)"	"unprognostic (3.89e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.57e-3)"	"unprognostic (4.51e-2)"	"unprognostic (2.26e-1)"	"unprognostic (2.05e-2)"	"prognostic unfavorable (7.88e-4)"	"unprognostic (2.34e-1)"	"unprognostic (7.95e-3)"	"unprognostic (3.38e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.20e-2)"	"unprognostic (2.06e-2)"	2.6	1.2	3.6	6.8	4.2	4.1	3.9	2.8	5.9	10.2	3.8	5.9	9.3	2.2	0.8	7.6	5.1	5.0	2.6	3.9	4.4	16.0	1.2	8.6	11.3	3.8	3.7	5.2	1.9	14.1	2.0	3.9	3.5	2.2	6.0	1.3	3.7	2.5	3.3	10.3	7.6	3.7	3.1	6.8	8.5	2.8	4.5	8.3	9.8	2.0	14.4	13.3	6.5	5.1	40.2	10.7	7.8	14.4	17.3	34.5	17.5	44.5	49.3	20.4	32.1	27.0	52.0	22.2	6.2	47.8	26.9	34.6	23.6	33.4	31.4	13.5	9.8	5.3	16.4	20.4	24.5	15.3	113.8	17.0	27.2	26.7	31.8	26.0	31.0	19.0	28.4	30.1	34.9	0.0	9.4	18.7	15.3	38.1	13.7	7.5	21.6	9.1	20.4	28.2	1.6	16.1	30.3	21.5	6.7	23.0	11.1	1.5	37.1	9.1	17.9	49.4	33.7	20.7	32.8	55.6	19.5	24.7	102.0	5.8	1.9	1.5	8.5	1.7	7.3	3.3	5.3	5.6	3.3	1.6	1.8	3.5	0.4	7.7	1.2	2.3	9.5	2.5	3.6	4.2	2.8	5.9	3.9	4.4	3.8	3.7	3.5	3.1	4.5	5.1	2.2	0.0	26.1	123.1	18.3	12.1	8.0	8.8	21.6	0.3	3.8	4.4	5.5	5.7	22.2	25.8	0.0	8.4	13.2	3.8	3.9	3.5	0.3	24.6	2.3	3.6	1.8	11.1	176.1	3.9	2.1	3.1	19.4	31.9	0.0	0.4	3.6	0.5	10.8	0.0	272.2	1.7	20.3	12.7	9.3	0.3	0.6	13.2	16.0	94.6	7.8	4.8	14.4	44.2	3.6	24.4	4.5	0.0	91.7	5.2	3.3	0.5	53.1	0.2	0.0	3.4	4.6	0.5	5.0	16.5	8.0	4.0	18.5	20.3	4.5	16.5
OSBPL7	"MGC71150, ORP7"	ENSG00000006025	"Oxysterol binding protein like 7"	Q9BZF2	17	47807372-47821834	"Predicted intracellular proteins"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 29.5;Gastric mucus-secreting cells: 118.7;Paneth cells: 29.9;Proximal enterocytes: 34.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HaCaT: 43.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036076, HPA053083, HPA073967"	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 27: Mucus-secreting cells - Mucin production"	"Nucleoplasm, Cytosol"	"Plasma membrane"	"HPA036076: AB_10601042, HPA053083: AB_2682038, HPA073967: "	"unprognostic (3.88e-2)"	"unprognostic (2.01e-1)"	"unprognostic (2.25e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.13e-1)"	"unprognostic (6.55e-3)"	"unprognostic (2.05e-3)"	"unprognostic (1.19e-1)"	"unprognostic (3.95e-2)"	"unprognostic (3.33e-1)"	"unprognostic (1.97e-1)"	"unprognostic (6.78e-2)"	"prognostic unfavorable (8.30e-4)"	"unprognostic (2.17e-1)"	"unprognostic (1.36e-1)"	"unprognostic (3.08e-1)"	"prognostic favorable (1.19e-5)"	5.0	3.7	10.6	4.9	10.4	7.2	5.4	9.5	14.0	11.1	7.3	22.7	22.3	8.6	1.6	3.4	7.6	5.3	6.5	10.3	9.9	9.9	2.2	8.5	7.5	10.6	10.2	9.6	17.3	2.6	10.1	2.3	10.7	14.3	8.7	3.1	9.0	6.1	20.2	1.7	22.7	3.5	9.2	17.2	34.0	1.4	10.5	4.9	11.3	3.5	3.8	9.1	7.0	10.9	6.0	6.9	3.0	3.4	3.3	4.6	2.5	2.2	3.2	3.7	4.2	7.1	17.8	6.0	8.7	3.2	1.3	43.2	1.7	4.8	1.2	20.8	2.4	4.4	15.0	4.8	3.0	9.4	0.1	7.4	0.9	2.4	1.7	11.5	7.7	10.5	4.4	8.1	5.8	7.8	9.5	10.0	1.8	23.8	8.9	8.6	4.7	8.3	5.0	4.5	3.1	7.0	3.7	1.2	3.3	3.7	6.4	5.9	8.9	5.6	4.9	0.0	1.8	14.6	5.8	5.8	6.1	7.9	2.2	0.0	0.6	0.6	1.8	0.4	0.8	1.0	0.7	1.1	0.6	0.4	0.5	0.8	0.3	0.4	0.0	1.0	0.9	0.9	10.6	10.4	9.5	14.0	10.3	9.9	10.6	10.2	10.7	9.2	10.5	10.9	5.5	0.0	3.9	10.4	4.5	0.1	1.1	2.5	1.2	6.1	2.9	2.5	2.7	1.5	7.4	3.7	6.2	0.2	15.4	29.5	0.0	2.7	0.1	2.1	2.7	4.3	6.0	3.2	7.3	14.7	0.1	2.0	118.7	1.7	2.5	7.1	5.3	0.5	2.7	11.8	6.3	25.8	4.1	3.4	0.8	0.3	2.8	2.3	1.8	1.0	2.7	7.1	8.2	3.5	9.3	9.3	29.9	2.6	11.4	1.7	34.5	1.2	3.4	8.2	0.0	2.5	1.9	0.0	0.3	1.3	0.1	0.5	10.0	3.3	17.6	1.3
OSBPL9		ENSG00000117859	"Oxysterol binding protein like 9"	Q96SU4	1	51577179-51798427	"Plasma proteins, Predicted intracellular proteins"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 216.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027378, HPA027397"	Supported	Approved	Supported	"Golgi apparatus,Vesicles"		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Golgi apparatus"	Vesicles	"HPA027378: AB_1854816, HPA027397: AB_1854817"	"unprognostic (5.99e-2)"	"unprognostic (1.93e-2)"	"unprognostic (1.22e-2)"	"unprognostic (2.43e-3)"	"unprognostic (3.11e-1)"	"unprognostic (6.72e-2)"	"unprognostic (2.85e-2)"	"unprognostic (2.47e-1)"	"unprognostic (4.17e-3)"	"unprognostic (1.58e-1)"	"unprognostic (8.36e-3)"	"unprognostic (8.61e-2)"	"unprognostic (3.64e-2)"	"unprognostic (7.53e-3)"	"unprognostic (2.55e-1)"	"unprognostic (4.95e-2)"	"unprognostic (3.37e-1)"	27.5	38.1	17.9	18.1	23.8	30.1	32.6	26.3	23.5	25.5	28.3	20.8	17.4	31.1	31.0	17.7	23.3	17.6	37.0	17.6	23.9	42.8	60.8	27.5	25.9	25.0	21.8	30.5	33.3	60.0	21.1	21.8	26.6	27.8	19.1	53.5	22.0	22.4	70.0	19.6	21.7	24.2	23.0	27.2	34.3	28.4	22.2	21.8	24.7	35.2	33.0	23.7	24.7	32.2	66.3	31.7	69.0	11.2	38.1	17.9	90.7	30.1	50.8	54.9	60.0	53.0	46.6	105.8	54.4	34.1	120.9	26.9	59.2	57.4	76.9	71.9	41.9	77.4	62.7	104.7	36.9	81.7	35.5	44.7	55.0	56.8	31.4	66.8	68.9	52.1	154.4	31.1	26.7	45.4	20.3	92.5	97.0	26.8	15.1	58.2	102.8	110.5	74.0	47.4	31.8	45.2	22.4	79.6	93.7	154.7	38.0	82.8	22.9	11.6	51.2	17.2	58.1	80.2	52.5	120.4	39.3	32.8	23.0	52.7	12.2	30.5	20.1	9.9	28.9	32.6	19.7	20.8	25.0	23.9	21.0	22.2	16.9	16.3	9.4	23.2	20.5	16.4	17.9	23.8	26.3	23.5	17.6	23.9	25.0	21.8	26.6	23.0	22.2	32.2	32.5	80.1	56.8	75.4	39.2	17.7	33.8	25.7	34.1	102.0	34.2	33.0	47.9	38.6	50.5	46.0	41.7	89.2	30.4	20.5	125.2	47.6	40.7	36.3	46.3	30.1	29.8	35.7	64.8	47.8	50.2	48.6	54.0	52.9	33.6	75.7	18.2	61.7	40.1	26.9	113.0	18.3	38.7	22.7	16.0	38.3	62.4	25.3	65.8	63.7	50.1	43.8	29.9	62.8	216.4	41.9	14.3	50.0	81.4	38.5	26.4	59.7	32.1	35.3	46.0	36.9	62.9	32.3	18.9	26.9	18.9	75.5	32.0	52.2	21.2	27.4
OSGEP	"GCPL1, KAE1, OSGEP1, PRSMG1, TCS3"	ENSG00000092094	"O-sialoglycoprotein endopeptidase"	Q9NPF4	14	20446401-20455089	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"tRNA processing"	"Acyltransferase, Transferase"	"Disease variant, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039751	Uncertain		Supported	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 52: Non-specific - Ribosome"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 57: B-cells - Immune response"	Nucleoplasm	"Plasma membrane"	"HPA039751: AB_10794754"	"prognostic favorable (1.48e-4)"	"unprognostic (4.15e-3)"	"unprognostic (1.29e-1)"	"unprognostic (4.33e-3)"	"unprognostic (1.54e-2)"	"unprognostic (3.95e-2)"	"unprognostic (5.54e-3)"	"unprognostic (2.80e-3)"	"unprognostic (2.98e-1)"	"unprognostic (1.05e-1)"	"unprognostic (3.35e-3)"	"unprognostic (1.22e-1)"	"prognostic unfavorable (4.64e-6)"	"unprognostic (4.83e-2)"	"unprognostic (1.86e-2)"	"unprognostic (2.53e-2)"	"unprognostic (9.91e-2)"	5.7	6.3	6.1	3.8	6.2	6.1	7.0	6.4	7.3	6.8	6.8	7.6	3.8	6.4	8.5	6.0	6.1	6.6	8.1	6.0	6.3	5.8	11.1	6.2	9.3	6.4	6.1	5.3	5.6	7.4	5.2	6.7	6.4	4.9	7.0	4.1	5.3	8.3	10.5	4.7	6.2	5.6	6.5	8.4	6.4	2.4	6.3	9.9	7.6	9.9	10.1	8.2	4.9	6.9	10.3	17.2	5.6	16.2	9.9	6.6	17.6	8.0	11.3	21.1	20.1	21.5	12.3	21.1	10.3	11.0	9.0	8.6	17.9	17.6	14.1	16.8	19.1	14.8	12.2	32.1	7.4	24.3	19.7	5.3	5.2	26.1	14.0	4.6	14.3	18.8	14.0	12.1	17.6	21.0	25.0	11.8	9.1	31.5	31.8	35.3	10.3	12.4	12.8	11.7	21.3	4.2	15.4	16.0	11.9	3.3	9.7	23.7	6.1	8.7	21.2	11.3	10.7	3.4	18.0	31.7	5.0	36.1	11.0	9.3	29.2	38.5	18.8	27.9	17.4	28.7	19.7	17.2	44.5	38.1	15.9	17.4	13.8	20.9	23.3	16.9	19.2	24.6	6.1	6.2	6.4	7.3	6.0	6.3	6.4	6.1	6.4	6.5	6.3	6.9	27.1	35.3	34.9	16.3	46.0	11.5	20.9	26.2	14.2	37.8	24.0	25.1	17.2	15.7	29.1	23.9	37.5	66.3	31.8	22.5	35.2	24.7	3.1	19.2	18.3	24.1	26.9	19.6	23.0	29.8	47.0	23.4	28.1	16.3	25.9	24.6	25.7	19.3	65.8	10.1	24.1	24.2	22.4	30.7	32.8	3.0	19.3	34.2	21.4	7.5	28.4	31.0	32.0	16.6	17.0	20.0	30.6	21.4	26.2	10.9	42.2	39.7	25.5	51.5	13.1	24.6	23.9	7.8	16.9	22.0	11.5	46.1	26.8	37.3	31.6	17.4
OSGEPL1	"OSGEPL, Qri7"	ENSG00000128694	"O-sialoglycoprotein endopeptidase like 1"	Q9H4B0	2	189746660-189763227	"Enzymes, Predicted intracellular proteins"	"tRNA processing"	"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Sertoli cells: 26.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030693	Uncertain		Supported	Mitochondria		NA	NA			"Cluster 30: Non-specific - Translation"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 52: Non-specific - Transcription"	Mitochondria		"HPA030693: AB_10601978"	"unprognostic (1.10e-1)"	"unprognostic (8.72e-2)"	"unprognostic (8.19e-2)"	"unprognostic (6.70e-2)"	"unprognostic (6.07e-2)"	"unprognostic (6.38e-2)"	"prognostic unfavorable (3.71e-4)"	"unprognostic (4.18e-3)"	"unprognostic (1.06e-3)"	"prognostic favorable (3.19e-4)"	"unprognostic (2.33e-1)"	"unprognostic (1.80e-2)"	"unprognostic (3.34e-2)"	"unprognostic (2.68e-1)"	"unprognostic (1.51e-2)"	"unprognostic (6.39e-2)"	"unprognostic (1.55e-3)"	3.9	8.2	3.6	3.5	5.0	1.9	7.2	6.1	5.0	4.5	3.0	3.5	3.3	5.7	5.6	4.0	5.2	3.2	8.9	3.4	4.0	8.4	7.9	3.9	6.5	4.3	4.5	8.7	3.1	4.7	2.7	4.0	4.5	4.1	3.9	9.8	4.7	3.7	12.3	6.1	3.5	5.0	4.3	5.4	3.1	6.4	3.9	5.6	5.2	11.0	6.3	3.6	3.0	6.1	7.1	3.8	16.7	12.7	12.9	7.1	9.8	10.8	7.5	14.9	15.9	4.5	7.1	4.7	11.7	4.5	8.2	10.1	15.0	12.7	16.9	12.3	11.5	15.3	9.0	5.9	6.7	8.8	7.6	7.8	10.6	11.5	5.5	10.2	11.3	11.8	5.6	7.2	9.8	3.9	6.8	9.9	8.1	9.5	17.4	7.5	13.4	8.1	9.7	3.8	10.1	11.2	7.3	12.8	23.9	20.6	10.1	9.9	4.7	9.6	8.5	14.3	6.8	7.3	6.6	7.4	12.7	11.0	10.7	0.5	2.7	2.3	7.5	2.7	10.6	7.7	7.7	8.6	3.8	9.8	11.3	10.5	0.4	7.6	2.4	6.6	6.6	3.1	3.6	5.0	6.1	5.0	3.4	4.0	4.3	4.5	4.5	4.3	3.9	6.1	3.6	6.4	3.6	6.8	8.4	1.9	2.8	5.9	5.2	8.9	4.0	4.8	8.6	8.6	2.8	0.0	12.5	10.6	7.3	0.4	7.9	3.0	1.4	3.5	5.5	4.1	0.0	5.2	6.6	2.3	7.3	4.5	1.5	2.3	3.8	6.8	3.6	2.9	4.4	10.1	10.0	1.1	2.0	2.4	1.7	0.8	11.1	4.1	1.8	5.6	1.8	12.0	13.4	10.1	17.0	2.0	1.0	8.2	1.9	1.1	1.7	10.2	6.0	11.8	26.3	5.8	8.4	9.6	13.7	4.4	2.0	2.2	6.0	11.8	2.2	1.0
OSTF1	"bA235O14.1, OSF, SH3P2"	ENSG00000134996	"Osteoclast stimulating factor 1"	Q92882	9	75088514-75147265	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"monocytes: 329.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 302.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020514	Approved		Supported	Cytosol		NA	NA		580000	"Cluster 49: Eosinophils - Unknown function"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 3: Monocytes - Immune response regulation"	Cytosol		"HPA020514: AB_2670461"	"unprognostic (1.41e-1)"	"unprognostic (3.69e-2)"	"unprognostic (7.54e-2)"	"prognostic favorable (3.67e-5)"	"unprognostic (1.36e-1)"	"unprognostic (2.43e-1)"	"unprognostic (9.73e-2)"	"unprognostic (1.48e-2)"	"unprognostic (2.40e-1)"	"unprognostic (1.91e-1)"	"unprognostic (5.68e-3)"	"unprognostic (3.76e-1)"	"unprognostic (7.89e-2)"	"unprognostic (6.36e-3)"	"unprognostic (9.87e-2)"	"unprognostic (3.42e-2)"	"unprognostic (1.53e-1)"	44.3	36.9	27.8	65.7	35.0	56.3	34.9	32.0	37.2	34.1	25.4	42.5	38.2	22.7	38.2	104.8	20.0	42.8	32.0	28.3	33.2	34.6	57.7	56.4	74.9	31.0	32.5	16.0	19.4	72.1	19.1	69.9	33.1	22.7	45.8	12.3	38.5	19.6	9.5	63.1	47.8	28.8	30.8	87.0	40.6	18.0	31.0	47.8	29.0	16.0	85.0	55.3	53.9	35.1	69.1	16.0	7.7	11.2	45.4	41.7	81.3	71.9	46.9	26.9	24.4	8.2	50.8	70.9	35.3	59.2	34.6	111.8	12.9	51.9	77.0	302.0	16.0	39.3	24.8	42.5	36.7	71.5	141.6	29.1	49.2	31.6	21.8	23.7	91.2	59.4	13.4	158.4	65.4	35.9	107.5	44.8	14.5	161.5	30.8	20.1	52.3	63.0	57.0	97.1	6.5	0.6	53.1	74.1	36.2	58.2	97.4	79.9	86.4	55.8	19.4	108.3	30.8	30.1	52.5	26.7	67.1	81.9	46.4	359.5	177.7	464.8	158.6	199.3	169.6	101.2	110.5	131.5	148.7	87.4	62.1	109.8	495.2	168.4	256.8	110.6	163.0	283.0	27.8	35.0	32.0	37.2	28.3	33.2	31.0	32.5	33.1	30.8	31.0	35.1	113.4	22.4	24.4	8.1	90.8	82.2	61.2	78.2	61.5	2.9	38.6	23.2	7.8	28.6	51.2	33.1	6.2	125.5	162.1	64.8	76.3	49.7	11.9	42.8	59.4	60.5	27.2	23.3	32.0	52.3	252.9	42.1	31.1	51.1	137.6	4.2	71.7	32.2	233.1	10.1	12.6	31.9	69.2	167.4	181.5	6.0	23.9	155.7	76.5	43.1	329.9	6.0	268.8	30.2	67.3	60.5	97.7	15.4	83.2	34.1	64.1	63.0	27.3	8.6	19.7	15.9	45.0	6.7	17.8	141.4	114.5	133.9	163.8	37.6	38.2	91.6
OSTM1	"GL, HSPC019"	ENSG00000081087	"Osteoclastogenesis associated transmembrane protein 1"	Q86WC4	6	108041409-108165854	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"			Osteopetrosis	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Melanocytes: 151.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA010851	Uncertain		Approved	Nucleoplasm,Vesicles,Cytosol		No	No		210000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 18: U-2197 - ECM organization"	"Cluster 4: Macrophages - Innate immune response"	Cytosol	"Nucleoplasm, Vesicles"	"HPA010851: AB_1079533"	"prognostic unfavorable (4.36e-4)"	"unprognostic (4.03e-2)"	"unprognostic (2.81e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.72e-3)"	"prognostic unfavorable (4.26e-4)"	"unprognostic (9.40e-2)"	"unprognostic (2.56e-1)"	"unprognostic (2.25e-1)"	"unprognostic (4.06e-2)"	"unprognostic (2.65e-1)"	"prognostic unfavorable (1.34e-6)"	"prognostic unfavorable (1.20e-4)"	"unprognostic (2.32e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.77e-1)"	26.1	19.1	4.7	17.9	5.2	5.7	9.8	5.1	5.8	10.4	33.1	12.2	7.9	13.7	9.0	12.7	9.5	12.5	19.2	5.3	9.2	15.6	13.1	16.2	14.7	6.0	7.6	7.5	5.8	15.3	8.3	14.1	7.9	13.8	11.1	17.6	8.9	16.7	11.8	9.8	9.0	23.3	5.3	18.3	8.5	10.1	7.4	13.7	10.7	11.5	13.5	16.9	7.0	8.3	6.0	17.2	20.1	29.4	59.0	19.0	28.6	42.8	42.7	30.7	50.4	10.0	9.8	13.7	34.4	30.0	82.5	11.1	20.2	14.6	47.0	31.6	15.7	28.9	10.9	12.8	45.6	32.1	64.6	28.1	35.7	37.7	30.0	28.2	15.8	15.2	23.3	48.7	50.3	8.4	7.1	7.3	8.0	7.1	13.0	11.4	29.1	7.5	22.0	15.7	2.2	11.8	34.7	8.7	79.9	26.6	10.0	45.8	19.3	26.7	9.8	59.7	61.4	18.6	34.4	11.9	78.9	21.3	60.3	31.4	20.2	22.8	20.3	29.4	21.5	14.7	16.9	22.3	17.8	8.6	15.6	19.8	29.8	22.0	43.5	12.9	22.6	27.0	4.7	5.2	5.1	5.8	5.3	9.2	6.0	7.6	7.9	5.3	7.4	8.3	28.5	9.6	19.0	26.4	26.0	46.7	19.8	11.7	21.6	28.3	10.0	7.0	24.8	12.8	9.4	12.9	10.4	21.7	32.3	21.9	1.9	12.4	12.0	7.5	15.7	20.7	4.2	4.6	36.6	22.9	33.9	24.4	15.8	9.6	24.1	6.9	26.7	13.2	52.8	28.6	40.1	5.8	6.1	46.5	29.5	5.4	14.3	43.1	151.2	20.6	25.6	23.7	40.2	21.1	36.6	16.8	17.0	28.6	25.0	17.9	7.6	25.5	9.8	17.5	26.3	18.5	29.6	28.0	18.7	12.4	31.1	61.2	29.5	23.7	3.3	16.0
OTC	OTCase	ENSG00000036473	"Ornithine carbamoyltransferase"	P00480	X	38352586-38421446	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Amino-acid biosynthesis, Arginine biosynthesis, Urea cycle"	Transferase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	124	"intestine: 112.4;liver: 377.8"	"Group enriched"	"Detected in some"	5	"Hepatic stellate cells: 38.9;Hepatocytes: 99.6;Proximal enterocytes: 82.0;Undifferentiated cells: 25.3"	"Cancer enriched"	"Detected in some"	20	"liver cancer: 59.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA000243, HPA000570"	Enhanced		Supported	Mitochondria		NA	NA		2200000		"Cluster 85: Liver - Metabolism"		"Cluster 2: Hepatocytes - Metabolism"	Mitochondria		"HPA000243: AB_1079535, HPA000570: AB_1079534"			"unprognostic (6.93e-2)"		"unprognostic (2.48e-1)"		"unprognostic (1.89e-3)"	"unprognostic (4.38e-2)"	"unprognostic (3.15e-1)"	"unprognostic (1.33e-1)"	"unprognostic (4.19e-2)"			"unprognostic (7.70e-3)"	"unprognostic (5.61e-2)"			1.2	0.0	0.2	0.5	0.3	0.0	0.2	0.3	0.4	0.4	0.1	5.0	112.4	0.7	0.0	0.4	0.5	0.4	0.3	0.2	0.3	0.1	377.8	0.9	0.1	0.3	0.3	0.1	1.7	0.0	0.0	0.0	0.4	0.0	2.5	0.1	0.1	0.1	0.0	0.0	87.4	0.5	0.3	0.0	1.9	0.4	0.3	0.0	0.3	0.0	0.0	0.1	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.3	0.4	0.2	0.3	0.3	0.3	0.4	0.3	0.3	0.4	0.3	0.0	0.0	1.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	2.8	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.1	7.4	0.1	0.0	1.7	1.2	0.0	0.5	0.2	0.0	0.2	0.0	0.0	0.0	0.0	38.9	99.6	0.0	0.0	0.5	8.3	0.0	3.5	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	10.9	0.0	0.0	0.0	82.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	1.0	0.0	0.0	0.0	0.3	0.0	25.3	0.0
OTUD4	"DUBA6, HSHIN1, KIAA1046"	ENSG00000164164	"OTU deubiquitinase 4"	Q01804	4	145110838-145180589	"Enzymes, Predicted intracellular proteins"	"Immunity, Innate immunity, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 185.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036623	Uncertain		Supported	Cytosol		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 44: Endometrium - Transcription"	Cytosol		"HPA036623: AB_10696780"	"unprognostic (1.67e-1)"	"unprognostic (4.18e-2)"	"unprognostic (3.41e-2)"	"unprognostic (1.95e-1)"	"unprognostic (2.80e-1)"	"unprognostic (4.06e-2)"	"unprognostic (3.42e-2)"	"unprognostic (2.66e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.74e-2)"	"unprognostic (5.21e-3)"	"unprognostic (2.03e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.90e-1)"	"unprognostic (3.01e-1)"	"unprognostic (2.62e-1)"	14.0	12.8	9.6	13.8	12.3	32.0	12.6	13.0	12.5	12.2	11.0	11.6	11.5	13.6	14.2	13.4	16.1	12.3	11.8	9.9	8.7	11.9	20.2	15.3	16.2	9.1	9.1	14.5	12.2	17.1	9.7	15.1	9.5	10.2	12.1	17.0	11.0	11.4	40.4	15.4	11.2	13.7	8.7	16.2	10.8	31.9	9.4	16.4	13.6	40.4	14.3	18.7	12.1	14.9	28.2	15.7	18.3	17.1	21.3	25.8	24.5	24.0	26.9	30.2	23.9	16.9	33.8	51.2	10.6	33.8	18.5	16.6	31.9	33.6	39.3	22.0	15.0	24.7	20.1	15.8	24.9	52.3	17.7	20.3	33.5	36.9	48.3	25.4	27.1	22.0	41.5	37.3	30.1	16.8	32.4	22.7	20.5	27.0	17.7	26.3	20.0	12.1	29.4	20.1	17.7	14.6	22.2	33.0	24.3	24.1	11.0	21.2	33.1	33.8	21.5	17.7	32.2	27.2	28.7	33.0	23.4	36.5	33.4	0.0	0.4	0.8	0.9	0.6	0.6	0.8	0.6	0.7	0.4	0.6	0.6	0.6	0.1	0.5	0.8	0.7	0.5	0.3	9.6	12.3	13.0	12.5	9.9	8.7	9.1	9.1	9.5	8.7	9.4	14.9	24.8	64.1	23.5	27.7	19.6	63.2	55.3	13.9	18.2	16.1	20.3	11.8	20.2	22.8	20.5	27.6	25.0	21.5	28.2	16.3	9.8	12.7	185.2	52.8	29.1	44.7	15.1	21.4	36.4	14.7	21.4	30.3	14.8	45.7	20.3	19.6	21.0	24.0	12.7	6.7	30.8	15.2	20.3	20.8	42.4	82.4	20.2	23.6	32.0	30.0	17.7	8.3	11.3	40.2	53.7	23.9	11.7	30.1	20.1	64.7	13.1	7.7	45.3	20.9	0.0	39.4	24.2	27.9	48.5	27.4	54.4	16.0	22.9	20.7	15.6	60.4
OTX2		ENSG00000165588	"Orthodenticle homeobox 2"	P32243	14	56799905-56816693	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"		"Developmental protein, DNA-binding"	"Disease variant, Microphthalmia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	15	"choroid plexus: 108.8;retina: 279.9"	"Group enriched"	"Detected in some"	11	"Bipolar cells: 170.6;Cone photoreceptor cells: 168.9;Rod photoreceptor cells: 202.5"	"Cancer enriched"	"Detected in single"	27	"testis cancer: 11.6"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HAP1: 249.6;hTERT-RPE1: 57.0;NTERA-2: 199.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA000633, HPA001123"	Uncertain		Supported	Nucleoplasm,Vesicles		NA	NA				"Cluster 77: Retina - Visual perception"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 9: Photoreceptor cells - Phototransduction"	Nucleoplasm	Vesicles	"HPA000633: AB_1079538, HPA001123: "					"unprognostic (3.82e-1)"			"unprognostic (2.56e-2)"							"unprognostic (9.28e-2)"			0.0	0.0	4.1	0.0	1.3	0.0	0.0	8.5	0.5	0.0	108.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	5.9	2.6	0.0	0.0	0.0	0.0	0.2	8.7	0.0	0.0	0.0	2.5	0.0	2.0	0.0	0.0	279.9	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	12.8	0.0	0.0	0.8	0.0	0.0	0.0	5.6	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	249.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	57.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	199.7	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	1.3	8.5	0.5	5.9	2.6	0.2	8.7	2.0	0.1	12.8	5.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	170.6	0.0	0.0	0.3	0.0	0.0	0.0	168.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	5.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	202.5	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OVCA2		ENSG00000262664	"OVCA2 serine hydrolase domain containing"	Q8WZ82	17	2042022-2043425	"Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"B-cells: 10.3;Basal squamous epithelial cells: 19.9;Erythroid cells: 11.3;Gastric mucus-secreting cells: 21.9;Macrophages: 8.4;Plasma cells: 31.0;Squamous epithelial cells: 32.2;T-cells: 10.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA059002			Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm	Cytosol	"HPA059002: AB_2683875"																		27.0	39.4	35.9	20.8	35.9	32.2	23.6	36.5	42.0	16.7	36.9	26.1	26.1	18.1	22.3	36.4	17.6	22.3	30.2	36.3	36.7	36.4	42.0	21.0	30.9	36.3	36.2	16.6	37.8	23.4	33.0	17.9	36.5	24.7	21.5	18.2	26.8	16.4	33.0	32.1	26.5	16.6	36.1	30.0	31.3	29.6	37.4	22.5	21.6	26.6	24.6	30.2	21.1	36.8	57.7	64.6	24.1	49.5	30.2	40.5	39.3	39.2	49.1	51.1	44.7	70.1	39.6	19.3	41.4	63.9	32.7	44.5	36.2	62.8	35.7	28.5	74.1	28.9	34.4	31.2	79.1	20.6	54.5	54.9	59.0	48.8	34.6	27.1	68.9	28.7	21.8	60.3	62.4	47.1	32.7	33.5	20.3	48.7	38.5	27.6	22.3	26.9	62.7	39.6	17.2	55.9	26.9	44.0	57.1	23.9	55.3	37.3	53.3	66.2	20.8	49.2	75.4	36.6	39.9	13.0	58.5	44.9	56.7	21.7	84.6	35.7	71.5	77.5	72.3	75.6	69.5	75.9	75.8	66.0	49.3	47.3	23.9	89.9	59.7	87.8	124.7	87.7	35.9	35.9	36.5	42.0	36.3	36.7	36.3	36.2	36.5	36.1	37.4	36.8	0.0	0.0	0.0	0.0	10.3	0.0	0.0	0.0	19.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	1.3	0.0	11.3	0.0	0.0	0.0	3.8	21.9	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	31.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	32.2	0.0	0.0	10.4	0.1	0.0	0.0
OVGP1	"CHIT5, MUC9"	ENSG00000085465	"Oviductal glycoprotein 1"	Q12889	1	111414319-111427735	"Plasma proteins, Predicted secreted proteins"	Fertilization			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	134	"fallopian tube: 2071.7"	"Cell type enhanced"	"Detected in many"		"Endometrial ciliated cells: 9.7;Excitatory neurons: 10.4;Glandular and luminal cells: 12.0;Inhibitory neurons: 8.5;Syncytiotrophoblasts: 17.4"	"Group enriched"	"Detected in many"	13	"endometrial cancer: 58.7;ovarian cancer: 27.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HEK 293: 4.9;OE19: 6.4;SK-BR-3: 5.0"	"Region enhanced"	"Detected in many"		"cerebellum: 5.9"	"Not detected"	"Not detected"			"HPA031666, HPA062205"	Enhanced		Supported	Vesicles,Microtubules	"Secreted in female reproductive system"	NA	NA				"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 21: OE19 - Mitochondria"	"Cluster 44: Endometrium - Transcription"	Vesicles	Microtubules	"HPA031666: , HPA062205: AB_2684710"	"unprognostic (1.52e-1)"	"unprognostic (2.06e-2)"	"unprognostic (3.35e-2)"	"prognostic favorable (1.36e-4)"	"unprognostic (8.39e-2)"	"unprognostic (3.58e-2)"	"unprognostic (2.33e-2)"	"unprognostic (3.34e-2)"	"unprognostic (5.44e-2)"	"unprognostic (3.82e-2)"	"unprognostic (7.68e-3)"	"unprognostic (2.58e-1)"	"unprognostic (5.35e-3)"	"unprognostic (2.39e-1)"	"unprognostic (1.38e-1)"	"unprognostic (3.86e-3)"	"prognostic favorable (3.93e-5)"	4.1	1.6	7.6	1.1	7.8	1.9	3.5	8.0	10.6	3.8	5.8	3.4	1.1	15.4	5.1	3.0	2071.7	1.1	2.3	7.7	7.0	5.0	8.0	3.9	2.2	7.3	6.9	6.7	1.5	6.8	2.4	2.0	7.2	5.5	2.2	4.3	4.2	1.5	2.6	7.6	5.2	1.4	6.5	4.6	2.8	9.2	6.9	1.2	2.4	1.0	2.0	4.6	3.8	8.2	0.4	0.4	0.9	0.5	1.8	2.0	1.7	0.2	1.4	0.3	0.7	0.6	0.0	0.8	1.7	0.6	0.0	0.5	0.3	0.3	0.5	2.0	4.9	0.3	0.8	2.4	0.6	0.9	2.2	1.8	2.9	0.0	1.0	1.4	0.4	3.2	0.3	1.5	0.1	0.5	0.6	1.2	0.2	6.4	1.7	0.6	0.2	0.7	1.4	3.7	0.6	0.6	0.1	5.0	0.7	2.4	0.3	0.8	0.8	0.1	0.2	2.5	0.7	1.8	0.5	0.4	0.2	1.6	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	7.6	7.8	8.0	10.6	7.7	7.0	7.3	6.9	7.2	6.5	6.9	8.2	1.2	0.0	1.1	3.3	0.6	3.1	1.1	0.3	0.0	2.1	1.7	1.9	0.6	0.0	0.5	0.0	0.0	5.6	0.2	1.1	1.9	0.2	4.0	9.7	0.7	1.6	0.0	0.0	10.4	0.0	2.6	0.6	0.0	12.0	0.0	1.0	1.4	2.9	0.6	0.0	8.5	1.5	2.0	0.6	1.4	6.1	1.5	0.5	0.0	3.7	0.0	0.4	0.0	1.5	2.4	0.2	0.5	1.9	0.1	1.6	0.6	2.8	1.3	0.6	0.0	0.7	1.1	3.8	0.7	1.0	3.1	17.4	0.8	0.2	1.6	1.6
OXA1L	"MGC133129, OXA1"	ENSG00000155463	"OXA1L mitochondrial inner membrane protein"	Q15070	14	22766522-22773042	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003531	Approved		Supported	Mitochondria		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 32: Non-specific - Translation"	Mitochondria		"HPA003531: AB_1079539"	"unprognostic (4.04e-3)"	"unprognostic (2.41e-2)"	"unprognostic (3.39e-1)"	"unprognostic (2.24e-2)"	"unprognostic (7.25e-2)"	"unprognostic (1.42e-2)"	"unprognostic (1.08e-2)"	"unprognostic (1.06e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.78e-1)"	"prognostic favorable (4.82e-4)"	"unprognostic (8.35e-2)"	"unprognostic (1.62e-1)"	"unprognostic (4.37e-2)"	"unprognostic (1.15e-3)"	77.7	90.7	27.6	40.8	28.5	71.9	67.6	31.4	28.8	59.4	47.1	72.9	66.3	55.0	48.1	76.6	55.8	49.6	147.2	27.5	29.6	70.8	108.6	54.8	70.0	31.3	29.1	71.2	98.0	105.3	27.5	38.0	31.1	45.0	57.7	41.9	64.2	44.8	234.9	69.3	58.9	46.1	29.1	62.3	83.9	25.0	31.6	63.6	54.9	272.5	75.5	61.3	60.4	31.1	89.3	121.3	48.8	82.1	146.7	217.4	94.4	64.0	138.1	94.3	107.9	91.1	96.4	167.0	86.4	75.0	73.0	121.0	103.0	126.3	90.0	67.6	65.4	79.1	73.2	329.7	165.5	150.9	88.4	211.0	137.6	75.4	114.9	114.7	273.3	93.8	62.2	124.0	103.4	130.0	91.8	51.3	53.2	118.5	150.0	92.9	87.2	128.3	117.9	103.4	35.1	67.0	94.6	205.7	129.7	58.4	89.2	122.7	86.2	52.7	62.2	98.5	75.4	94.0	84.7	78.1	41.6	83.6	60.0	11.9	68.1	18.5	29.5	71.6	36.0	51.0	42.5	37.4	95.1	54.4	47.4	35.6	15.1	41.7	58.5	26.9	55.8	53.7	27.6	28.5	31.4	28.8	27.5	29.6	31.3	29.1	31.1	29.1	31.6	31.1	30.6	48.1	44.0	7.8	83.7	69.5	61.1	89.0	92.8	31.0	52.1	46.5	118.0	72.9	62.1	29.5	10.4	72.8	32.5	48.9	74.3	85.2	10.2	20.4	40.3	58.6	40.7	64.3	6.8	161.3	113.0	47.6	66.8	23.1	80.4	56.5	64.2	102.9	143.4	18.5	7.5	75.3	38.7	148.1	76.8	13.3	57.2	85.6	51.6	3.7	133.4	22.9	74.2	4.5	8.0	86.3	69.7	36.9	84.2	45.6	101.4	116.0	42.6	38.3	39.5	39.4	43.0	31.8	28.4	112.9	67.3	57.2	57.9	70.6	112.1	74.9
OXGR1	"aKGR, GPR80, GPR99, P2RY15, P2Y15"	ENSG00000165621	"Oxoglutarate receptor 1"	Q96P68	13	96985719-96994730	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Low tissue specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	13	"Extravillous trophoblasts: 49.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	6	"myeloid DC: 1.2;plasmacytoid DC: 2.1"	"Lineage enriched"	"Detected in single"	7	"dendritic cells: 2.1"	"Cell line enhanced"	"Detected in some"		"RT4: 3.3;SK-BR-3: 1.4;U-2 OS: 1.6"	"Not detected"	"Not detected"							HPA067673			Supported	"Plasma membrane"		NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 15: RT4 - Unknown function"	"Cluster 38: Extravillous trophoblasts - Unknown function"	"Plasma membrane"		"HPA067673: AB_2685883"	"unprognostic (1.83e-1)"	"unprognostic (1.01e-2)"	"unprognostic (1.33e-1)"	"unprognostic (6.97e-4)"	"unprognostic (7.23e-2)"	"unprognostic (1.52e-1)"		"unprognostic (8.38e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.22e-2)"	"unprognostic (4.14e-2)"	"unprognostic (3.88e-2)"	"unprognostic (1.89e-1)"	"unprognostic (2.75e-1)"	"unprognostic (1.54e-1)"	"unprognostic (9.68e-2)"	1.3	0.0	1.0	1.3	0.8	0.1	4.2	0.5	1.5	1.0	0.5	2.0	0.2	0.5	2.5	2.1	1.6	0.1	0.2	0.8	2.1	4.0	0.0	0.4	0.1	1.2	1.3	0.1	0.5	0.3	0.3	0.9	1.0	0.5	1.6	0.0	3.0	0.4	0.2	2.6	0.4	0.5	0.7	0.4	0.2	0.1	2.6	0.3	0.5	0.3	0.8	1.7	0.6	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	3.3	0.0	0.1	0.0	1.4	0.0	0.0	0.7	0.0	0.0	0.0	1.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.1	1.0	0.8	0.5	1.5	0.8	2.1	1.2	1.3	1.0	0.7	2.6	1.3	0.8	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.6	0.0	1.7	1.4	0.2	0.0	0.0	0.0	0.0	2.4	0.1	0.2	1.9	0.0	0.2	0.7	0.1	0.8	1.2	0.0	0.6	0.0	49.7	0.1	0.0	0.1	0.0	0.0	0.0	0.0	1.8	0.0	0.6	0.5	0.0	0.0	0.4	0.1	0.0	0.3	3.6	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.0	0.9	0.0	0.0	2.2	0.0	3.7	0.0	0.0	1.2	0.0
OXSM	"CEM1, FASN2D, FLJ20604, KS"	ENSG00000151093	"3-oxoacyl-ACP synthase, mitochondrial"	Q9NWU1	3	25782917-25794534	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism"	"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 59.5;Spermatocytes: 48.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021293, HPA021300, HPA021337"	Enhanced		Approved	Mitochondria,Cytosol		No	No			"Cluster 24: B-cells - Unknown function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Mitochondria, Cytosol"		"HPA021293: AB_1848772, HPA021300: AB_1848774, HPA021337: AB_1848776"	"unprognostic (2.20e-2)"	"unprognostic (3.28e-1)"	"prognostic favorable (1.35e-4)"	"prognostic favorable (5.51e-4)"	"unprognostic (1.01e-1)"	"unprognostic (8.17e-2)"	"unprognostic (2.15e-3)"	"unprognostic (1.41e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.83e-2)"	"unprognostic (3.06e-2)"	"unprognostic (1.20e-1)"	"prognostic favorable (4.18e-9)"	"unprognostic (1.79e-2)"	"unprognostic (2.42e-1)"	"unprognostic (3.10e-1)"	"unprognostic (1.73e-2)"	6.1	11.0	3.1	5.5	3.4	4.0	9.3	3.5	4.6	4.9	5.3	11.1	9.4	4.6	13.9	8.5	6.8	3.9	12.9	3.3	3.6	13.7	22.0	4.9	7.9	3.3	3.3	4.9	10.5	10.0	5.8	5.9	3.4	5.9	12.3	10.2	10.1	5.9	14.6	7.7	7.8	5.2	3.5	7.9	8.2	11.7	3.5	7.1	8.6	15.6	8.8	5.5	5.3	3.4	11.0	18.1	3.8	10.5	10.7	11.6	10.9	8.6	12.4	15.8	11.2	13.8	12.9	20.4	11.5	8.0	9.2	11.3	15.7	16.6	14.9	12.3	16.0	22.5	15.2	16.9	13.1	18.4	13.7	11.0	20.4	12.7	13.3	10.3	13.8	18.9	23.5	16.0	13.7	16.6	13.6	14.4	0.7	8.8	20.6	17.8	9.9	33.7	23.3	6.8	5.4	9.7	13.8	23.6	18.3	6.0	25.5	16.9	8.5	10.0	11.9	13.1	12.7	15.1	18.8	6.6	13.9	16.0	10.4	2.1	5.1	3.7	8.6	6.0	10.1	7.9	8.8	10.8	8.4	8.9	10.2	10.7	0.8	11.4	6.8	8.8	6.0	6.3	3.1	3.4	3.5	4.6	3.3	3.6	3.3	3.3	3.4	3.5	3.5	3.4	5.9	0.0	9.4	3.9	9.3	3.1	5.9	23.0	4.0	6.5	8.7	13.2	13.3	10.0	12.0	11.0	4.2	19.5	7.1	5.4	11.7	13.5	59.5	7.8	7.2	4.9	2.4	2.1	4.5	6.8	16.9	5.9	4.6	6.4	10.1	13.0	7.5	17.4	8.5	5.0	5.1	9.8	14.2	3.8	3.2	15.1	7.2	6.8	5.4	1.0	5.2	9.1	6.2	3.5	3.8	7.5	8.9	4.1	7.8	6.5	10.6	18.4	9.2	7.4	0.0	5.3	5.8	48.0	12.6	7.2	4.4	14.1	5.9	19.2	8.8	3.6
P2RX5	"LRH-1, P2X5"	ENSG00000083454	"Purinergic receptor P2X 5"	Q93086	17	3672199-3696240	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel, Ligand-gated ion channel, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 24.7;lymphoid tissue: 78.2"	"Group enriched"	"Detected in some"	4	"B-cells: 94.6;Plasma cells: 29.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	19	"memory B-cell: 76.4;naive B-cell: 84.8"	"Lineage enriched"	"Detected in many"	20	"B-cells: 84.8"	"Cell line enhanced"	"Detected in many"		"Daudi: 53.2;Karpas-707: 32.7;RPMI-8226: 59.5;U-698: 47.1"									"HPA021948, HPA067827"	Supported		Supported	Cytosol		NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 57: B-cells - Immune response"	Cytosol		"HPA021948: AB_1854878, HPA067827: AB_2685908"	"unprognostic (1.08e-3)"	"unprognostic (9.16e-2)"	"unprognostic (1.40e-2)"	"unprognostic (5.81e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.06e-1)"	"unprognostic (8.33e-2)"	"unprognostic (4.34e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.14e-1)"	"unprognostic (2.15e-1)"	"unprognostic (2.42e-2)"	"unprognostic (1.99e-8)"	"unprognostic (1.60e-1)"	"unprognostic (1.00e-1)"	"unprognostic (3.50e-2)"	"unprognostic (3.63e-2)"	0.8	0.3	1.8	30.4	2.2	9.4	0.8	0.2	2.7	0.3	0.0	2.4	1.5	0.1	0.0	0.7	0.3	1.3	8.0	2.1	0.9	0.7	0.5	1.4	78.2	0.6	0.5	0.0	0.2	0.2	1.2	0.2	0.7	0.5	1.9	0.4	1.8	0.0	17.5	0.0	24.7	0.5	0.1	54.4	3.4	0.7	1.1	12.1	0.9	4.0	53.9	2.7	0.3	1.4	8.3	6.7	0.0	0.0	0.2	1.3	0.0	8.4	3.9	0.9	2.6	5.5	9.8	53.2	4.9	4.2	2.9	4.3	18.8	0.0	1.7	0.9	3.2	2.7	17.5	6.3	1.2	3.6	4.2	2.1	1.8	0.2	12.4	6.5	0.0	12.2	0.5	32.7	18.2	0.0	23.4	8.1	4.9	4.4	20.5	0.8	0.0	59.5	0.2	6.3	4.3	0.0	7.5	2.5	3.9	0.0	2.0	3.3	0.1	0.0	4.5	0.2	1.5	11.0	25.2	47.1	0.0	5.1	0.5	0.0	0.1	2.0	3.1	0.0	4.2	76.4	2.8	2.2	0.4	84.8	0.3	0.3	0.0	0.0	0.0	0.1	1.9	4.5	1.8	2.2	0.2	2.7	2.1	0.9	0.6	0.5	0.7	0.1	1.1	1.4	0.1	0.0	0.6	0.0	94.6	0.4	0.1	0.0	0.0	0.8	0.1	0.1	2.7	0.0	0.0	1.8	0.0	0.0	13.4	0.0	0.0	0.2	4.8	0.2	0.2	0.7	0.0	11.1	0.0	0.2	0.0	0.3	0.5	0.3	4.5	0.0	1.4	0.4	0.2	0.0	0.0	0.1	0.0	1.2	0.0	3.1	1.5	1.6	3.6	0.0	1.1	0.0	2.1	0.0	0.0	1.5	0.0	0.0	29.7	0.0	0.0	0.1	0.0	0.2	0.0	0.5	0.9	1.0	0.8	0.0	0.0	0.0	11.0	0.0	0.1	0.1
P3H2	"FLJ10718, LEPREL1, MLAT4"	ENSG00000090530	"Prolyl 3-hydroxylase 2"	Q8IVL5	3	189956728-190122437	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"		"Dioxygenase, Oxidoreductase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 80.3;Granulosa cells: 124.1;Microglial cells: 91.8;Theca cells: 74.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	22	"plasmacytoid DC: 28.9"	"Lineage enriched"	"Detected in single"	90	"dendritic cells: 28.9"	"Cell line enhanced"	"Detected in many"		"GAMG: 120.2;HaCaT: 109.9;RPTEC TERT1: 109.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA007890, HPA013355, HPA013611"	Approved		Supported	"Nucleoplasm,Golgi apparatus,Vesicles,Cytosol"	"Intracellular and membrane"	NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 64: Macrophages - Immune response"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 40: Granulosa cells - Unknown function"	"Golgi apparatus"	"Nucleoplasm, Vesicles, Cytosol"	"HPA007890: AB_1852796, HPA013355: AB_1852798, HPA013611: "	"unprognostic (4.90e-2)"	"unprognostic (1.57e-1)"	"unprognostic (3.76e-1)"	"unprognostic (4.32e-3)"	"unprognostic (1.97e-2)"	"unprognostic (7.75e-2)"	"unprognostic (9.68e-2)"	"unprognostic (2.17e-1)"	"unprognostic (3.15e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.03e-3)"	"unprognostic (1.60e-1)"	"unprognostic (1.15e-2)"	"unprognostic (1.80e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.10e-1)"	"unprognostic (4.01e-2)"	4.9	41.6	2.8	4.9	3.1	1.0	6.5	3.0	3.1	17.0	1.8	24.0	2.7	17.6	18.5	11.0	8.0	4.8	8.8	3.3	4.8	51.3	7.0	28.7	2.4	7.6	4.7	16.1	3.6	2.3	8.2	9.2	6.7	37.6	10.4	19.3	4.9	26.5	1.2	17.8	6.7	32.4	5.2	54.8	23.9	4.2	4.9	5.2	3.0	1.7	2.0	11.9	19.9	8.3	46.9	18.2	35.1	0.2	0.6	1.4	42.1	48.7	19.3	7.8	12.6	15.0	18.0	0.1	27.1	8.6	120.2	109.9	0.1	65.3	16.3	0.4	6.2	0.1	12.1	0.3	35.4	0.2	0.3	16.9	21.4	15.2	5.4	73.5	1.4	0.1	0.1	0.4	12.3	1.1	0.1	0.4	11.0	31.3	3.7	0.1	7.1	2.8	109.8	77.5	2.5	0.3	66.1	3.7	29.3	51.1	0.1	0.7	24.4	45.9	16.8	0.4	8.9	3.4	0.2	0.5	10.6	0.2	60.2	0.3	0.2	0.1	0.0	0.1	0.0	0.1	0.0	0.0	1.2	0.0	0.0	0.0	0.2	0.1	0.0	28.9	0.0	0.2	2.8	3.1	3.0	3.1	3.3	4.8	7.6	4.7	6.7	5.2	4.9	8.3	5.7	48.1	80.3	19.2	1.0	0.0	7.7	0.0	13.6	2.3	1.6	9.9	1.0	2.8	3.1	44.1	4.2	42.0	9.5	19.8	5.9	4.7	19.6	2.0	27.3	10.5	0.0	2.7	55.6	0.8	14.7	10.3	8.6	1.5	1.3	124.1	32.5	0.8	11.4	10.1	60.4	0.5	0.0	3.2	0.0	14.9	4.7	5.6	0.0	91.8	0.8	44.5	0.0	43.7	4.4	30.6	1.9	0.0	0.2	15.1	0.0	26.2	0.0	1.2	0.0	10.9	45.2	0.5	0.9	13.5	0.0	38.6	0.7	74.3	2.1	3.9
P3H4	"LEPREL4, NO55, SC65"	ENSG00000141696	"Prolyl 3-hydroxylase family member 4 (inactive)"	Q92791	17	41801947-41812604	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"gdT-cell: 3.9;MAIT T-cell: 5.0;memory CD4 T-cell: 2.5;memory CD8 T-cell: 2.7;naive CD4 T-cell: 3.0;naive CD8 T-cell: 3.9;NK-cell: 8.5"	"Group enriched"	"Detected in many"	10	"NK-cells: 8.5;T-cells: 5.0"	"Cell line enriched"	"Detected in many"	13	"OE19: 1032.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA022520			Supported	"Endoplasmic reticulum,Vesicles"	"Intracellular and membrane"	NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 21: OE19 - Mitochondria"	"Cluster 33: Fibroblasts - ECM organization"	"Endoplasmic reticulum, Vesicles"		"HPA022520: "	"unprognostic (9.11e-2)"	"unprognostic (3.72e-3)"	"unprognostic (3.66e-2)"	"unprognostic (3.72e-2)"	"unprognostic (8.69e-3)"	"unprognostic (4.32e-2)"	"unprognostic (2.16e-3)"	"unprognostic (1.94e-1)"	"unprognostic (2.47e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.19e-1)"	"unprognostic (4.03e-2)"	"prognostic unfavorable (4.48e-6)"	"unprognostic (1.47e-1)"	"unprognostic (1.23e-1)"	"unprognostic (8.96e-2)"	"unprognostic (1.96e-3)"	5.1	11.6	5.4	5.5	5.6	0.5	4.9	7.3	6.6	10.0	7.5	6.2	7.6	10.7	4.9	2.8	7.7	6.8	8.8	4.6	6.8	7.8	2.3	6.0	2.7	5.2	4.9	7.9	12.9	11.5	10.5	12.1	4.9	7.3	4.2	1.3	10.4	7.2	4.8	7.4	6.5	10.1	4.5	3.3	5.2	2.3	6.6	1.3	12.2	2.0	1.6	7.2	6.4	4.5	9.2	45.0	27.4	70.8	29.1	28.1	26.9	75.5	33.6	25.6	35.0	22.3	12.4	1.4	30.6	58.7	19.5	16.4	23.6	32.3	10.1	21.0	35.5	11.4	44.1	30.3	35.4	2.3	3.6	29.5	9.5	22.3	20.3	61.0	32.6	3.2	2.2	11.6	16.7	31.6	0.6	6.8	17.1	1032.2	25.2	25.3	30.1	31.4	16.5	2.7	13.2	29.0	13.3	81.2	28.9	18.1	46.8	7.4	34.3	24.5	35.7	46.2	34.1	10.7	2.6	0.2	37.7	11.1	38.5	0.0	0.2	0.0	3.9	0.0	5.0	0.6	2.5	2.7	0.2	0.6	3.0	3.9	0.0	8.5	0.0	0.0	0.7	1.5	5.4	5.6	7.3	6.6	4.6	6.8	5.2	4.9	4.9	4.5	6.6	4.5	7.3	0.0	7.8	12.1	1.5	0.0	5.4	0.0	6.2	3.6	11.6	10.8	10.7	11.5	1.8	5.5	8.4	10.8	3.6	7.2	7.9	21.6	0.5	2.7	25.3	11.0	2.4	7.0	6.4	6.5	27.3	26.6	16.8	7.7	1.3	17.7	11.0	1.9	2.8	26.9	4.4	13.0	0.0	1.2	0.0	0.8	21.1	1.0	0.0	4.7	1.2	9.6	13.4	6.0	1.5	7.1	9.5	20.7	2.8	9.6	26.8	5.9	0.7	2.7	19.7	13.1	16.7	2.7	10.0	1.9	0.0	5.3	3.2	19.1	9.8	2.0
P4HA1	"C-P4Halpha(I), P4HA"	ENSG00000122884	"Prolyl 4-hydroxylase subunit alpha 1"	P13674	10	73007217-73096974	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Dioxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"hTERT-RPE1: 494.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007599, HPA026593"	Enhanced		Supported	"Endoplasmic reticulum,Vesicles,Mitochondria"	"Intracellular and membrane"	Yes	No		60000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Endoplasmic reticulum"	"Vesicles, Mitochondria"	"HPA007599: AB_1854891, HPA026593: AB_1854892"	"prognostic unfavorable (9.01e-4)"	"prognostic unfavorable (3.19e-5)"	"unprognostic (2.76e-3)"	"unprognostic (3.04e-1)"	"unprognostic (1.69e-2)"	"prognostic unfavorable (1.19e-5)"	"unprognostic (2.30e-1)"	"prognostic unfavorable (5.10e-4)"	"unprognostic (1.28e-1)"	"unprognostic (2.29e-1)"	"prognostic unfavorable (2.85e-4)"	"unprognostic (9.15e-2)"	"prognostic unfavorable (9.40e-9)"	"unprognostic (3.14e-1)"	"unprognostic (4.22e-2)"	"unprognostic (1.02e-2)"	"unprognostic (5.75e-2)"	28.1	26.0	25.7	20.8	26.4	15.5	26.3	29.6	58.5	31.9	34.7	16.3	11.0	27.0	18.9	10.1	41.1	26.3	38.7	26.5	27.1	35.8	72.8	27.8	16.2	32.9	30.0	34.9	17.5	17.0	11.6	65.3	33.0	20.0	17.4	33.3	13.0	18.4	110.9	17.4	14.4	28.5	30.2	19.6	19.8	19.3	30.1	12.9	13.9	54.0	14.6	29.6	18.2	39.0	84.0	21.2	60.1	117.6	181.2	138.3	50.1	239.9	215.8	90.8	215.8	35.6	63.6	28.4	89.7	239.0	55.1	92.5	38.3	87.7	197.1	36.5	14.5	24.4	18.6	42.5	75.3	45.1	16.4	84.5	50.3	77.7	101.6	494.2	43.5	23.8	38.3	14.7	79.3	22.4	17.9	42.9	21.6	38.9	92.3	16.4	40.2	52.4	51.0	35.6	5.5	33.7	49.2	143.2	58.3	135.0	21.9	41.9	41.9	110.5	44.8	31.3	56.9	81.8	31.3	13.7	198.1	64.5	54.9	1.1	18.8	14.9	6.7	23.5	8.7	8.2	8.1	7.9	20.7	9.2	5.9	6.1	10.4	5.2	25.7	16.6	10.7	9.1	25.7	26.4	29.6	58.5	26.5	27.1	32.9	30.0	33.0	30.2	30.1	39.0	29.0	6.4	28.4	87.1	31.7	36.3	33.0	138.0	22.2	13.5	23.8	15.7	42.0	7.2	69.2	23.9	27.1	31.5	24.9	25.1	0.0	33.1	16.8	85.6	89.2	25.9	10.3	7.2	48.8	19.5	116.4	67.7	14.3	131.4	40.5	16.9	20.0	29.8	43.9	11.8	41.6	9.5	46.8	54.1	75.7	8.1	51.9	51.5	44.4	62.8	39.0	34.0	6.2	86.5	44.8	36.6	27.1	47.0	32.9	24.9	13.5	25.1	94.6	17.2	39.5	37.0	44.7	61.7	34.0	9.8	23.9	33.2	27.7	31.1	7.0	17.6
P4HB	"DSI, ERBA2L, GIT, P4Hbeta, PDI, PDIA1, PO4DB, PO4HB, PROHB"	ENSG00000185624	"Prolyl 4-hydroxylase subunit beta"	P07237	17	81843159-81860856	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Chaperone, Isomerase"	"Craniosynostosis, Disease variant, Osteogenesis imperfecta"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 1856.8;pancreas: 2446.9"	"Cell type enhanced"	"Detected in all"		"Exocrine glandular cells: 1077.9;Extravillous trophoblasts: 1349.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012463, HPA018884"	Enhanced		Supported	"Endoplasmic reticulum"	"Intracellular and membrane"	No	No		110000000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 55: Plasma cells - Humoral immune response"	"Endoplasmic reticulum"		"CAB012463: , HPA018884: AB_1854896"	"unprognostic (9.47e-3)"	"unprognostic (1.09e-2)"	"unprognostic (2.99e-2)"	"unprognostic (7.14e-3)"	"unprognostic (7.75e-3)"	"unprognostic (1.05e-2)"	"unprognostic (1.30e-1)"	"unprognostic (5.26e-2)"	"unprognostic (1.22e-1)"	"unprognostic (4.73e-3)"	"unprognostic (1.43e-1)"	"unprognostic (3.93e-2)"	"prognostic unfavorable (2.30e-11)"	"unprognostic (1.18e-1)"	"unprognostic (1.04e-2)"	"unprognostic (4.99e-3)"	"unprognostic (3.19e-3)"	266.5	507.8	34.6	209.8	35.7	517.1	225.5	39.1	35.7	272.0	59.6	258.4	640.2	206.5	133.0	618.7	183.4	202.0	318.4	31.7	50.2	270.7	1856.8	301.3	104.0	48.9	37.1	187.8	2446.9	144.3	330.0	334.3	40.8	335.8	173.6	23.3	948.1	184.2	328.5	370.4	554.7	179.8	39.8	428.6	539.2	68.8	58.7	89.3	244.8	150.8	137.9	233.7	322.9	43.7	690.3	580.7	236.8	687.5	813.4	726.7	593.6	1038.5	1081.1	741.9	934.5	550.4	576.9	264.4	501.8	1120.2	407.5	464.1	248.8	647.4	254.1	145.8	320.5	355.2	362.9	953.6	1010.8	1146.4	613.4	618.8	494.8	478.2	596.7	843.0	1250.1	182.1	273.6	978.2	559.5	566.4	260.5	723.2	157.7	791.0	463.8	261.8	342.5	614.0	453.2	492.8	248.7	301.1	586.1	1693.1	808.1	289.6	855.3	1601.2	644.1	980.5	503.1	574.3	586.6	743.5	407.9	204.8	1372.0	591.3	825.4	198.3	268.1	163.0	202.6	154.4	209.8	83.9	138.9	165.7	174.7	68.1	74.9	114.6	72.9	157.0	115.3	311.5	105.6	372.4	34.6	35.7	39.1	35.7	31.7	50.2	48.9	37.1	40.8	39.8	58.7	43.7	122.3	102.5	162.1	23.2	151.4	120.1	163.6	371.0	140.6	59.2	283.0	170.8	24.1	247.4	211.7	112.2	33.3	790.2	208.9	420.7	41.1	671.9	43.5	78.4	196.8	153.9	199.9	140.9	15.3	1077.9	1349.1	272.5	388.9	209.1	99.1	210.4	190.2	840.7	435.9	62.2	16.2	610.9	189.2	186.9	125.5	64.9	141.4	180.3	136.9	20.6	263.3	122.7	230.7	13.6	19.6	575.2	465.6	112.1	664.3	310.6	914.2	105.0	91.3	54.3	157.8	103.4	226.7	83.4	94.1	302.3	144.6	1001.2	138.8	378.4	475.4	220.8
PABPC1	"PAB1, PABP1, PABPC2, PABPL1"	ENSG00000070756	"Poly(A) binding protein cytoplasmic 1"	P11940	8	100685816-100722809	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing, Nonsense-mediated mRNA decay"	RNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB011536, HPA045423, HPA067156"	Supported		Supported	Cytosol		NA	NA		3900000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 32: Non-specific - Translation"	Cytosol		"CAB011536: AB_777008, HPA045423: AB_2679320, HPA067156: AB_2685793"	"unprognostic (5.00e-2)"	"unprognostic (2.64e-2)"	"unprognostic (3.18e-1)"	"unprognostic (4.50e-1)"	"prognostic favorable (2.51e-4)"	"unprognostic (1.93e-2)"	"prognostic unfavorable (5.80e-4)"	"unprognostic (2.51e-3)"	"unprognostic (5.70e-2)"	"unprognostic (1.50e-2)"	"unprognostic (3.21e-3)"	"unprognostic (7.24e-2)"	"prognostic unfavorable (5.70e-12)"	"unprognostic (6.22e-2)"	"unprognostic (2.55e-1)"	"unprognostic (6.98e-3)"	"unprognostic (1.40e-2)"	627.6	341.5	48.8	490.8	73.4	364.0	575.7	54.9	58.6	700.3	86.2	524.3	450.2	453.5	68.3	1353.3	437.0	227.1	233.8	35.3	80.2	296.4	347.7	490.3	542.4	104.1	58.7	724.0	728.0	126.7	167.7	214.5	92.2	473.9	270.3	80.2	1287.6	172.7	197.7	732.4	502.0	226.5	64.1	483.1	524.7	507.9	92.7	421.0	303.4	75.8	532.3	630.5	853.3	81.6	2069.1	644.4	372.2	842.0	585.0	1050.0	793.4	504.4	593.5	451.8	468.7	791.5	1107.8	3230.4	1609.1	809.5	291.3	792.4	554.6	1092.3	459.5	758.2	555.4	1713.1	302.2	562.6	835.7	673.3	891.0	1338.6	1050.2	554.8	2126.1	950.7	690.8	1071.8	1339.4	1120.1	477.5	857.3	2617.8	949.5	882.3	1487.3	929.6	967.5	541.7	1074.2	301.8	953.1	629.2	650.1	415.8	548.6	1200.7	513.2	1031.7	949.5	1005.1	512.4	809.4	723.9	897.9	753.6	606.1	1523.2	609.7	1378.1	538.8	122.8	401.3	131.2	159.3	405.2	348.9	297.4	333.0	264.3	421.4	263.0	437.4	370.4	112.5	306.9	468.5	277.2	301.5	568.0	48.8	73.4	54.9	58.6	35.3	80.2	104.1	58.7	92.2	64.1	92.7	81.6	348.4	371.8	939.1	28.7	1089.1	787.4	1075.3	735.0	1067.7	66.5	1036.1	641.2	139.7	459.0	1020.8	110.3	50.1	454.2	872.8	457.0	264.1	467.0	1727.8	352.1	628.4	523.0	477.1	999.1	42.4	769.0	860.8	458.8	530.1	436.1	1054.1	357.3	570.8	308.3	615.5	72.3	34.1	853.8	360.1	1520.8	1162.9	306.0	498.9	1144.3	370.0	53.4	1583.7	167.7	679.7	29.7	41.1	626.9	698.0	424.3	674.4	655.3	446.1	388.4	473.5	88.4	499.6	530.4	876.7	1433.1	476.0	929.6	765.3	777.9	1041.1	408.3	1061.2	1296.9
PACSIN2	SDPII	ENSG00000100266	"Protein kinase C and casein kinase substrate in neurons 2"	Q9UNF0	22	42835412-43015149	"Predicted intracellular proteins"	Endocytosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 95.7"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049854, HPA056520"	Enhanced		Supported	"Nuclear speckles,Vesicles,Plasma membrane,Cytosol"		NA	NA		2400000	"Cluster 52: Eosinophils - Transcription"	"Cluster 25: Pancreas - Digestion"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Nuclear speckles, Vesicles, Cytosol"	"Plasma membrane"	"HPA049854: AB_2680915, HPA056520: AB_2683163"	"unprognostic (5.62e-3)"	"unprognostic (1.22e-1)"	"unprognostic (1.71e-2)"	"unprognostic (1.64e-3)"	"unprognostic (1.63e-2)"	"unprognostic (3.96e-1)"	"prognostic unfavorable (7.33e-4)"	"unprognostic (4.48e-2)"	"unprognostic (3.40e-2)"	"unprognostic (2.82e-3)"	"unprognostic (3.09e-2)"	"unprognostic (1.00e-1)"	"prognostic favorable (1.09e-13)"	"unprognostic (2.87e-1)"	"unprognostic (1.11e-1)"	"unprognostic (6.20e-2)"	"unprognostic (2.95e-1)"	40.8	74.3	25.7	37.1	29.1	29.3	40.7	34.2	27.3	37.5	32.3	61.7	40.8	39.1	21.2	34.1	35.3	45.3	55.7	27.7	39.2	47.1	41.1	50.9	34.2	40.5	36.8	31.4	162.4	29.4	39.9	34.2	40.8	47.0	41.6	28.2	43.5	27.4	49.8	39.5	38.1	30.4	30.7	35.9	51.5	19.5	32.5	28.7	43.9	42.4	26.4	36.5	34.5	31.1	76.3	78.3	64.6	41.5	32.6	34.6	52.9	67.8	40.7	59.9	49.7	82.1	43.8	35.2	56.1	50.6	40.8	52.8	42.5	72.1	39.3	36.1	42.4	56.8	39.4	117.8	46.1	40.5	118.1	33.4	69.8	79.1	34.3	48.7	49.9	32.1	49.9	24.9	52.2	49.7	43.1	63.3	35.6	110.4	32.7	52.3	96.5	23.8	68.9	44.4	41.9	18.7	81.1	55.2	155.8	41.5	40.1	53.1	74.3	44.5	56.4	50.0	40.5	18.4	27.2	38.4	42.7	35.4	99.1	26.1	18.5	47.4	6.8	32.2	7.3	11.3	7.8	5.8	21.5	11.6	7.6	5.8	95.7	16.8	33.9	7.9	12.1	14.1	25.7	29.1	34.2	27.3	27.7	39.2	40.5	36.8	40.8	30.7	32.5	31.1	31.7	70.5	60.6	20.2	20.6	23.2	43.4	23.9	21.1	15.7	37.4	31.1	26.3	24.3	37.2	46.0	39.6	34.4	19.9	142.6	45.0	80.2	3.6	51.6	31.3	28.6	24.7	12.6	22.7	65.4	29.6	20.9	36.7	57.4	71.0	14.7	16.1	22.3	42.7	6.7	41.0	49.5	30.5	38.5	50.0	6.2	21.8	44.9	83.6	54.4	51.3	8.4	7.2	29.1	19.5	70.9	62.3	23.3	13.1	50.6	32.0	55.0	30.7	24.9	92.1	23.5	82.9	22.6	27.6	22.5	16.9	48.2	19.1	13.8	42.2	30.3
PACSIN3	SDPIII	ENSG00000165912	"Protein kinase C and casein kinase substrate in neurons 3"	Q9UKS6	11	47177522-47186443	"Plasma proteins, Predicted intracellular proteins"	Endocytosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"heart muscle: 161.8;skeletal muscle: 480.9;tongue: 279.4"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 112.0;Extravillous trophoblasts: 60.6;Muller glia cells: 63.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"T-47d: 127.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039480, HPA043904"	Approved	Approved	Supported	"Plasma membrane,Cytosol"		NA	NA				"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 20: HeLa - Mitochondria"	"Cluster 54: Cardiomyocytes - Muscle contraction"	Cytosol	"Plasma membrane"	"HPA039480: AB_2676531, HPA043904: AB_2678725"	"unprognostic (1.75e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.73e-2)"	"unprognostic (3.10e-2)"	"unprognostic (1.21e-1)"	"unprognostic (6.89e-2)"	"unprognostic (4.66e-2)"	"unprognostic (8.17e-2)"	"unprognostic (2.85e-1)"	"prognostic favorable (2.09e-4)"	"unprognostic (3.86e-3)"	"unprognostic (1.26e-1)"	"unprognostic (2.75e-2)"	"unprognostic (9.72e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.29e-1)"	"unprognostic (4.76e-2)"	14.4	66.5	19.6	4.5	28.2	0.4	18.4	24.5	20.9	33.3	18.8	50.2	4.7	33.5	11.4	52.6	29.1	7.2	161.8	18.0	19.4	14.8	43.6	15.9	2.0	33.8	27.5	23.2	33.1	11.0	6.2	16.1	32.1	35.2	2.7	4.5	40.8	20.6	480.9	41.4	11.3	21.2	25.0	4.5	33.5	4.5	25.4	2.0	24.5	279.4	5.2	21.5	31.8	39.0	56.4	27.1	12.5	51.5	10.3	10.2	59.8	19.4	24.6	33.9	19.1	40.8	7.3	0.3	5.9	9.2	23.0	90.0	23.7	40.2	13.0	8.7	44.8	8.4	105.5	91.7	19.9	2.0	8.4	28.2	52.3	17.9	28.3	27.2	15.3	15.2	18.4	0.7	13.9	106.7	0.7	40.8	15.5	43.7	58.7	33.1	48.0	9.0	14.3	49.3	0.3	42.6	28.2	17.9	24.6	24.6	127.3	6.9	6.9	57.6	62.5	7.5	47.1	10.1	4.4	5.3	18.6	19.2	30.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	19.6	28.2	24.5	20.9	18.0	19.4	33.8	27.5	32.1	25.0	25.4	39.0	6.1	0.0	8.1	4.9	0.3	35.9	29.1	25.1	30.7	0.7	32.2	24.3	112.0	38.6	18.1	5.5	0.0	31.0	0.6	0.2	9.8	37.7	0.0	3.1	8.4	7.8	0.0	2.7	0.8	15.5	60.6	12.6	9.7	6.2	0.0	3.0	8.6	33.1	6.0	0.0	1.1	0.2	14.2	1.6	4.6	0.4	16.1	1.0	17.8	2.8	0.0	63.6	0.0	0.0	9.5	41.0	0.0	12.4	2.6	56.8	1.5	24.3	5.0	3.2	32.9	18.5	25.4	0.2	7.5	39.7	29.8	18.3	0.7	4.8	1.4	29.8
PADI1	"HPAD10, PAD1, PDI, PDI1"	ENSG00000142623	"Peptidyl arginine deiminase 1"	Q9ULC6	1	17205128-17246007	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"esophagus: 109.5"	"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 14.8;Extravillous trophoblasts: 14.0;Squamous epithelial cells: 5.6;Urothelial cells: 22.5"	"Cancer enhanced"	"Detected in many"		"pancreatic cancer: 13.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 4.2;EFO-21: 2.1;HaCaT: 1.5;RPTEC TERT1: 1.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA062294	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA				"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 22: Epithelial cell types - Mixed function"	Cytosol	Nucleoplasm	"HPA062294: AB_2684741"	"unprognostic (9.30e-2)"	"unprognostic (2.44e-1)"	"unprognostic (6.15e-2)"	"unprognostic (1.40e-1)"	"unprognostic (5.22e-2)"	"unprognostic (7.27e-2)"	"unprognostic (3.84e-1)"	"unprognostic (3.37e-2)"	"unprognostic (1.41e-1)"	"unprognostic (7.75e-2)"	"unprognostic (1.01e-3)"	"unprognostic (3.64e-2)"	"prognostic unfavorable (8.34e-11)"	"unprognostic (2.00e-1)"	"unprognostic (3.12e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.15e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.2	0.0	0.0	0.0	0.1	0.0	109.5	0.0	0.0	0.0	0.0	0.1	0.1	1.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	1.0	0.1	0.2	0.0	0.0	11.5	0.0	0.0	4.1	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	4.4	1.4	18.0	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	4.2	0.0	2.1	0.1	0.1	1.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.6	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.7	0.6	0.9	0.0	0.0	14.8	0.0	3.9	0.0	0.0	0.2	0.0	0.6	0.0	0.6	0.0	0.1	0.1	0.5	0.0	0.0	0.0	0.0	14.0	0.3	0.0	0.4	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.4	2.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.8	0.5	0.0	0.0	0.8	0.0	0.0	0.6	0.3	0.0	0.0	0.3	0.2	0.1	5.6	0.0	0.7	0.0	0.1	0.6	22.5
PAF1	"F23149_1, FLJ11123, PD2"	ENSG00000006712	"PAF1 homolog, Paf1/RNA polymerase II complex component"	Q8N7H5	19	39385629-39391154	"Predicted intracellular proteins"	"Transcription, Transcription regulation, Wnt signaling pathway"		"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041875, HPA043637"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 71: Testis - DNA repair"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm		"HPA041875: AB_2677720, HPA043637: AB_2678592"	"unprognostic (5.33e-3)"	"unprognostic (3.57e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.92e-1)"	"unprognostic (2.99e-1)"	"prognostic unfavorable (8.68e-4)"	"unprognostic (6.65e-2)"	"unprognostic (4.21e-1)"	"unprognostic (8.37e-2)"	"prognostic favorable (8.66e-4)"	"unprognostic (2.28e-1)"	"unprognostic (2.35e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.32e-1)"	"unprognostic (4.60e-1)"	"unprognostic (2.73e-1)"	36.9	45.4	32.3	26.1	36.4	36.9	37.5	35.1	36.3	40.7	32.4	41.4	22.9	36.9	28.0	44.8	38.9	23.6	45.2	32.8	38.8	35.4	49.5	33.5	29.3	36.4	34.9	50.1	31.9	38.3	48.5	21.0	35.6	40.6	20.2	26.5	38.2	27.7	62.3	34.3	37.3	23.2	33.0	46.9	39.4	68.5	35.7	31.0	41.4	30.9	31.5	37.9	37.4	40.0	92.1	114.9	74.9	40.3	46.7	39.5	30.5	75.0	69.4	86.1	82.7	95.3	48.3	72.6	51.0	61.6	51.3	31.4	81.3	62.1	70.2	82.4	95.2	71.6	77.0	62.6	50.4	61.5	65.6	39.9	42.0	72.0	46.4	54.3	63.8	63.0	56.7	59.0	71.5	103.3	70.7	40.5	26.5	76.2	38.7	70.8	73.4	51.7	64.7	102.3	63.2	42.6	80.5	52.8	41.6	37.1	50.4	52.5	60.8	51.6	68.1	54.5	84.0	63.2	61.2	61.9	51.6	53.0	49.0	32.3	20.0	33.7	29.4	28.0	30.9	40.1	24.4	29.4	21.8	36.6	27.3	25.3	31.3	30.5	26.6	20.4	26.0	21.6	32.3	36.4	35.1	36.3	32.8	38.8	36.4	34.9	35.6	33.0	35.7	40.0	26.6	22.4	46.2	9.4	49.9	53.5	63.0	29.9	63.2	14.1	28.9	27.1	37.5	21.5	35.9	22.0	8.4	38.4	33.2	26.0	13.7	27.3	40.4	48.4	25.3	24.4	26.4	16.4	3.8	27.3	30.0	33.0	43.3	62.8	50.7	19.0	18.2	24.1	24.8	8.4	4.8	22.4	26.4	12.9	62.4	30.6	35.1	28.1	23.2	1.9	20.4	23.4	12.3	6.6	8.8	23.3	22.1	27.8	54.2	24.5	22.9	25.9	64.0	16.8	13.1	22.5	29.8	96.0	26.8	41.0	49.2	64.0	48.7	24.6	21.9	34.8
PAFAH1B1	"LIS1, MDCR, MDS, NudF, PAFAH"	ENSG00000007168	"Platelet activating factor acetylhydrolase 1b regulatory subunit 1"	P43034	17	2593210-2685615	"Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Differentiation, Lipid degradation, Lipid metabolism, Mitosis, Neurogenesis, Transport"	"Developmental protein"	"Disease variant, Lissencephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"Early spermatids: 640.0;Late spermatids: 1864.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004489, HPA020036"	Approved		Supported	Centrosome		NA	NA		860000	"Cluster 26: Non-specific - Mitochondria"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 25: Spermatids - Spermatogenesis"	Centrosome		"CAB004489: AB_627889, HPA020036: AB_1854925"	"unprognostic (1.54e-3)"	"unprognostic (6.84e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.51e-1)"	"unprognostic (2.13e-1)"	"unprognostic (3.19e-3)"	"unprognostic (3.17e-2)"	"unprognostic (6.36e-2)"	"unprognostic (2.27e-1)"	"unprognostic (6.62e-2)"	"unprognostic (3.89e-3)"	"unprognostic (5.80e-2)"	"prognostic favorable (3.16e-4)"	"unprognostic (3.31e-1)"	"unprognostic (3.51e-1)"	"unprognostic (7.45e-2)"	"unprognostic (5.58e-2)"	34.8	32.2	35.5	27.2	43.1	4.0	32.6	31.5	46.5	38.3	6.7	46.4	30.5	43.9	26.9	38.0	36.7	31.8	51.1	46.2	47.4	41.4	30.0	37.3	30.9	41.3	38.4	35.4	26.3	56.4	38.4	32.4	48.1	32.6	32.8	47.2	32.4	38.6	87.7	42.1	36.5	44.4	30.2	31.0	34.6	55.7	36.7	41.5	43.9	73.2	38.8	35.7	37.8	38.0	51.3	53.3	81.8	28.4	66.9	74.1	27.3	76.5	67.1	56.3	53.0	69.7	18.7	64.5	63.5	100.3	27.4	53.5	74.4	59.8	80.6	50.9	48.4	56.4	48.8	27.3	69.3	37.5	66.4	68.8	73.5	58.8	58.1	71.7	58.1	51.8	38.8	32.7	84.8	21.1	58.3	28.6	36.7	30.5	27.0	39.5	67.6	30.0	62.5	30.5	37.4	62.0	63.0	34.5	65.5	51.8	36.5	30.1	84.9	71.5	17.1	57.1	61.0	24.7	32.1	28.8	60.4	33.7	66.2	2.6	1.7	3.4	4.7	2.5	5.2	2.9	4.1	3.3	2.5	2.4	4.9	3.8	2.6	3.6	3.8	1.5	5.1	2.4	35.5	43.1	31.5	46.5	46.2	47.4	41.3	38.4	48.1	30.2	36.7	38.0	73.7	121.8	92.2	90.8	82.7	118.7	114.8	74.3	63.2	102.4	52.1	42.9	136.3	30.0	101.6	35.0	50.1	56.4	117.2	77.4	35.2	77.2	640.0	82.2	95.5	77.2	34.1	45.9	178.1	56.3	76.7	74.7	87.7	100.9	93.7	45.1	43.2	32.3	60.2	102.6	161.8	43.7	57.0	46.3	77.0	1864.4	64.0	77.6	56.9	104.9	90.3	60.7	97.9	115.1	193.5	100.8	61.5	56.8	91.7	91.6	76.9	55.0	80.7	65.8	46.0	84.5	133.0	256.8	78.1	69.7	132.6	129.6	92.7	54.7	39.2	122.4
PAFAH1B2		ENSG00000168092	"Platelet activating factor acetylhydrolase 1b catalytic subunit 2"	P68402	11	117144284-117176894	"Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Lipid degradation, Lipid metabolism"	Hydrolase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051836	Approved		Supported	"Nucleoli,Plasma membrane,Cytosol"		NA	NA		250000	"Cluster 49: Eosinophils - Unknown function"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 65: Plasmacytoid DCs - Unknown function"	Cytosol	"Nucleoli, Plasma membrane"	"HPA051836: AB_2681630"	"unprognostic (1.08e-2)"	"unprognostic (3.14e-2)"	"unprognostic (2.07e-2)"	"unprognostic (3.88e-2)"	"unprognostic (9.94e-2)"	"unprognostic (1.21e-3)"	"prognostic unfavorable (9.44e-4)"	"prognostic unfavorable (3.07e-4)"	"unprognostic (1.01e-1)"	"prognostic favorable (4.25e-4)"	"prognostic unfavorable (7.79e-5)"	"unprognostic (8.18e-2)"	"unprognostic (1.11e-2)"	"unprognostic (9.97e-2)"	"unprognostic (3.25e-1)"	"unprognostic (2.46e-1)"	"unprognostic (1.34e-1)"	23.1	34.3	35.1	21.2	42.2	41.2	20.6	43.9	45.0	20.8	28.4	21.7	22.4	23.8	22.7	23.9	20.9	19.9	28.2	33.9	45.4	25.3	23.8	21.7	20.7	47.6	45.0	23.3	20.3	21.9	24.5	25.4	51.0	22.3	20.0	23.2	17.4	16.1	15.7	22.0	19.4	20.4	48.7	20.4	23.0	30.0	43.6	21.5	31.9	20.3	22.2	26.9	20.9	51.6	43.4	48.5	54.9	79.7	60.1	41.7	42.6	71.0	61.7	38.8	35.2	89.2	92.9	46.6	99.4	85.8	38.7	67.7	80.6	92.0	50.9	41.8	31.1	120.0	41.3	57.9	53.8	42.1	44.0	46.6	71.7	77.4	96.7	42.4	64.8	25.6	65.0	34.6	60.3	27.7	40.8	61.7	50.4	60.0	37.8	44.9	62.2	51.2	59.8	66.7	60.9	80.5	82.2	61.6	28.1	46.6	68.4	35.6	103.8	70.4	46.3	34.8	51.4	10.8	17.9	61.5	28.3	78.8	60.4	63.4	51.4	48.6	39.0	58.7	46.4	43.8	44.7	41.0	37.4	41.2	45.8	49.2	63.7	33.1	66.3	27.4	35.1	53.1	35.1	42.2	43.9	45.0	33.9	45.4	47.6	45.0	51.0	48.7	43.6	51.6	48.5	28.9	34.8	17.9	41.4	122.4	44.5	45.9	54.7	38.6	55.4	32.1	37.6	58.6	32.8	66.2	47.9	40.4	44.4	48.0	46.9	61.3	13.1	63.6	54.8	64.8	82.6	39.4	29.2	39.5	86.7	40.8	33.6	78.4	19.0	36.8	79.6	47.0	43.0	47.1	32.5	41.8	36.7	65.4	175.9	13.7	45.4	52.1	49.8	20.6	59.3	36.2	21.6	13.0	61.2	99.0	50.5	34.3	28.9	67.0	33.7	54.8	32.9	38.3	13.1	42.8	40.0	54.7	84.7	53.2	115.9	54.6	41.6	35.2	45.4	50.6
PAIP2	PAIP2A	ENSG00000120727	"Poly(A) binding protein interacting protein 2"	Q9BPZ3	5	139341587-139369720	"Predicted intracellular proteins"	"Translation regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 834.4;Late spermatids: 2779.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035945, CAB037212, HPA056766"	Approved		Supported	Vesicles		NA	NA		21000	"Cluster 5: Granulocytes - Unknown function"	"Cluster 43: Testis - Unknown function"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 31: Spermatids - Spermatogenesis"	Vesicles		"CAB037212: AB_1841072, HPA035945: AB_10672996, HPA056766: AB_2683231"	"unprognostic (1.07e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.19e-1)"	"unprognostic (5.86e-2)"	"unprognostic (7.40e-2)"	"unprognostic (3.80e-3)"	"unprognostic (7.70e-3)"	"unprognostic (8.91e-2)"	"unprognostic (4.64e-2)"	"unprognostic (2.36e-2)"	"unprognostic (2.67e-2)"	"unprognostic (3.27e-1)"	"unprognostic (2.01e-3)"	"unprognostic (2.01e-1)"	"unprognostic (2.21e-1)"	"unprognostic (3.36e-1)"	"unprognostic (6.92e-2)"	103.3	148.6	107.9	77.2	107.9	115.7	90.3	120.0	149.6	77.3	119.9	79.1	44.2	94.1	85.6	68.8	91.6	66.5	173.1	107.8	118.9	104.7	114.2	73.1	109.0	119.5	114.0	112.3	64.2	88.9	96.2	93.7	123.8	84.3	53.9	168.9	92.1	82.4	169.6	48.2	50.0	83.1	119.1	92.1	58.1	169.0	110.0	147.4	74.6	161.9	107.7	81.4	54.3	138.9	91.9	102.7	196.2	118.5	144.0	81.3	95.6	81.9	113.6	104.7	163.6	138.5	86.7	160.7	170.8	62.3	120.1	88.9	173.5	112.5	137.4	155.7	136.4	148.5	145.7	125.8	93.0	92.8	105.4	93.2	92.4	78.5	88.8	112.9	108.7	173.3	143.7	138.6	95.8	121.1	254.3	227.3	118.9	130.5	74.6	140.0	248.1	177.2	84.0	163.2	90.9	165.2	121.2	110.7	251.2	245.4	214.4	192.6	66.9	55.9	67.9	61.3	67.3	200.0	262.6	167.8	98.2	161.6	58.9	569.5	292.2	735.8	286.2	329.3	317.0	378.7	314.7	330.4	292.0	337.7	364.4	356.5	800.5	347.5	380.6	298.7	449.5	577.2	107.9	107.9	120.0	149.6	107.8	118.9	119.5	114.0	123.8	119.1	110.0	138.9	154.8	73.7	87.5	26.4	173.8	159.8	164.3	168.2	79.1	102.4	108.2	98.0	59.7	97.2	100.9	99.3	58.4	198.6	253.1	74.0	170.2	126.4	834.4	228.6	109.2	126.9	97.0	190.0	40.6	115.1	134.1	129.5	38.7	109.0	109.0	108.2	123.1	103.8	142.3	97.6	46.6	57.7	120.1	142.2	196.1	2779.9	160.9	170.6	135.2	29.0	239.2	158.5	247.2	29.7	59.9	122.5	64.7	155.3	146.8	232.8	62.1	256.2	149.4	93.6	170.9	87.7	180.3	432.3	238.1	57.0	208.3	479.7	191.3	145.8	59.5	178.3
PAK1		ENSG00000149269	"P21 (RAC1) activated kinase 1"	Q13153	11	77322017-77474635	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins"	"Apoptosis, Exocytosis"	"Allosteric enzyme, Kinase, Serine/threonine-protein kinase, Transferase"	"Disease variant, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 219.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in all"	9	"classical monocyte: 182.2;eosinophil: 292.7;intermediate monocyte: 177.7;myeloid DC: 264.3;neutrophil: 431.8;non-classical monocyte: 202.6"	"Group enriched"	"Detected in all"	11	"dendritic cells: 264.3;granulocytes: 431.8;monocytes: 202.6"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003565, CAB005312"	Enhanced	Supported	Supported	"Plasma membrane,Cytosol"		NA	NA		560000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Plasma membrane, Cytosol"		"CAB005312: AB_2160720, HPA003565: AB_1854935"	"unprognostic (1.15e-2)"	"unprognostic (3.23e-2)"	"prognostic favorable (5.87e-4)"	"unprognostic (1.30e-1)"	"prognostic unfavorable (1.15e-4)"	"unprognostic (6.62e-2)"	"unprognostic (8.19e-3)"	"unprognostic (4.84e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.22e-3)"	"unprognostic (1.86e-2)"	"unprognostic (2.76e-1)"	"unprognostic (1.02e-1)"	"unprognostic (6.91e-2)"	"unprognostic (1.57e-1)"	"unprognostic (4.00e-3)"	"unprognostic (1.52e-2)"	12.7	13.4	32.4	33.9	44.5	59.0	18.2	13.9	57.7	21.1	0.0	43.2	43.1	20.9	29.8	21.4	21.9	30.9	9.4	58.3	8.0	26.1	14.5	16.8	20.4	19.2	12.2	21.1	17.5	20.5	20.7	14.7	19.4	19.1	46.5	25.1	19.9	19.7	87.0	16.2	45.7	27.0	0.9	29.3	41.2	25.7	17.1	29.1	40.6	18.8	23.1	27.7	20.7	30.0	39.9	26.7	56.7	25.5	22.8	37.6	45.9	44.6	32.1	42.0	48.7	38.7	52.8	36.3	16.0	39.4	54.4	20.2	40.2	47.8	65.5	41.4	32.6	38.2	17.6	2.3	15.3	64.3	53.5	28.2	28.8	49.2	73.1	36.6	10.1	41.3	25.5	61.2	77.6	2.9	42.3	30.2	84.5	166.2	22.5	62.6	72.3	1.4	10.6	32.9	24.6	23.9	23.6	9.7	19.5	55.0	45.4	29.0	0.9	27.3	47.5	148.9	37.9	165.7	92.4	23.4	23.0	42.5	30.6	2.5	182.2	292.7	11.2	177.7	9.4	16.8	8.4	10.7	264.3	12.9	7.4	14.5	431.8	28.4	202.6	22.9	7.3	92.3	32.4	44.5	13.9	57.7	58.3	8.0	19.2	12.2	19.4	0.9	17.1	30.0	3.1	3.2	20.5	24.2	23.9	11.9	33.3	28.2	23.9	51.6	25.1	19.7	6.2	35.8	30.8	25.8	8.4	25.4	10.2	78.6	45.0	32.4	38.8	37.3	13.5	3.2	37.8	30.5	219.1	56.3	53.5	24.0	45.9	39.7	132.2	35.2	3.6	11.4	49.8	1.7	118.5	50.8	28.5	59.6	152.9	28.3	14.3	80.0	30.2	54.4	121.7	14.9	10.3	53.3	70.7	50.9	57.9	13.2	28.6	28.7	47.9	55.7	39.0	6.4	13.1	13.8	25.2	50.4	53.8	23.6	10.4	95.0	19.3	10.3	52.8	33.2
PAK1IP1	"bA421M1.5, FLJ20624, hPIP1, MAK11, PIP1, WDR84"	ENSG00000111845	"PAK1 interacting protein 1"	Q9NWT1	6	10694972-10709782	"Predicted intracellular proteins"	"Ribosome biogenesis"	"Signal transduction inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030111, HPA030112"	Supported		Supported	Nucleoli		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoli		"HPA030111: AB_2732454, HPA030112: AB_10603125"	"unprognostic (9.41e-2)"	"unprognostic (3.79e-1)"	"unprognostic (1.67e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.17e-2)"	"prognostic unfavorable (1.35e-6)"	"unprognostic (7.23e-2)"	"unprognostic (9.29e-3)"	"unprognostic (1.06e-3)"	"unprognostic (2.14e-2)"	"unprognostic (2.12e-1)"	"prognostic unfavorable (7.02e-8)"	"unprognostic (8.14e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.11e-1)"	"unprognostic (2.10e-1)"	13.5	10.3	5.6	7.6	5.7	10.6	12.4	5.7	8.1	9.3	5.5	8.4	4.2	10.3	7.2	16.3	8.4	5.2	9.6	5.7	6.2	9.3	11.3	7.3	7.8	5.7	6.0	8.0	9.6	5.7	6.7	7.0	5.9	37.8	7.3	4.9	9.2	5.7	15.2	8.8	7.1	8.1	5.8	8.2	7.8	5.7	5.9	7.0	7.5	9.7	9.6	11.5	9.9	6.9	35.3	13.7	17.2	29.9	21.3	19.4	24.9	22.4	18.7	33.7	32.9	30.2	15.4	35.6	54.9	19.4	41.4	18.4	35.8	29.2	48.1	20.9	23.3	19.4	12.4	35.2	31.1	54.5	24.3	17.9	25.2	32.6	55.3	11.1	22.9	19.2	60.2	10.0	28.3	21.2	27.4	49.5	37.4	32.7	24.1	27.9	22.4	55.0	24.4	21.0	25.7	22.4	16.8	42.7	51.1	28.9	18.9	19.6	19.6	26.9	19.5	29.2	56.4	23.3	68.7	38.9	11.0	36.3	51.7	2.0	8.1	2.9	9.4	12.4	9.6	10.0	8.3	9.4	11.7	7.2	11.1	13.5	0.4	9.9	10.3	13.7	5.9	6.8	5.6	5.7	5.7	8.1	5.7	6.2	5.7	6.0	5.9	5.8	5.9	6.9	22.6	19.2	12.3	8.8	18.5	66.4	54.2	47.3	30.1	13.2	18.6	28.3	18.6	17.2	35.0	11.0	4.2	24.9	24.8	10.3	19.6	43.3	12.4	26.0	35.0	24.1	5.4	31.1	9.9	26.9	32.0	32.0	14.8	34.3	35.5	16.6	15.0	21.7	36.6	13.5	10.9	12.7	42.7	16.1	12.6	8.4	21.5	18.2	12.4	6.5	22.1	12.0	12.3	9.5	12.5	31.3	7.7	20.7	18.2	56.5	5.1	27.0	17.7	11.8	6.6	40.9	31.4	27.3	44.2	29.3	49.9	17.5	16.3	23.1	24.0	28.6
PAK4		ENSG00000130669	"P21 (RAC1) activated kinase 4"	O96013	19	39125770-39182816	"Enzymes, Metabolic proteins, Predicted intracellular proteins, RAS pathway related proteins"	"Apoptosis, Cell cycle"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"A549: 154.7;MCF7: 172.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB025747, CAB044670, HPA070175, HPA072220"	Uncertain		Supported	"Plasma membrane,Cell Junctions"		NA	Yes			"Cluster 26: Non-specific - Mitochondria"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 17: Intestinal endocrine cells - Hormone signaling"	"Plasma membrane, Cell Junctions"		"CAB025747: , CAB044670: AB_1854940, HPA070175: AB_2686232, HPA072220: AB_2686497"	"unprognostic (1.71e-1)"	"unprognostic (2.84e-1)"	"unprognostic (5.86e-2)"	"unprognostic (2.84e-2)"	"unprognostic (1.93e-1)"	"unprognostic (8.51e-2)"	"unprognostic (3.56e-3)"	"unprognostic (1.13e-3)"	"unprognostic (3.90e-2)"	"unprognostic (4.04e-2)"	"unprognostic (7.29e-2)"	"prognostic unfavorable (9.85e-4)"	"prognostic favorable (5.29e-5)"	"unprognostic (2.39e-1)"	"unprognostic (7.05e-2)"	"unprognostic (2.02e-1)"	"unprognostic (4.85e-2)"	11.6	20.0	16.7	8.1	18.2	5.3	22.1	14.2	18.4	27.2	14.0	30.2	27.4	20.6	9.4	43.9	23.4	7.5	15.5	13.9	13.4	37.2	26.2	39.6	4.5	17.1	17.2	24.2	31.8	16.2	30.5	16.3	15.8	40.7	8.0	5.8	42.4	11.0	14.0	40.4	25.1	5.7	12.0	13.8	25.3	35.0	15.7	5.4	29.3	4.3	5.4	20.2	30.4	17.0	62.8	154.7	22.7	34.8	7.1	7.5	68.1	29.3	11.7	19.3	19.4	102.1	51.9	14.3	43.3	18.7	25.2	22.7	12.6	23.2	7.2	38.0	35.4	16.9	27.5	50.4	11.3	17.5	23.6	9.0	10.2	18.1	12.9	12.6	25.5	21.4	34.3	11.0	11.8	172.7	18.6	18.9	41.4	55.2	36.7	18.5	17.9	10.9	19.0	67.9	72.2	49.9	29.8	130.6	33.6	11.7	58.1	28.4	42.8	32.6	55.6	37.8	53.0	12.3	12.9	11.9	39.9	10.3	39.9	0.3	0.7	1.2	0.6	0.3	0.8	0.5	0.7	1.1	0.9	0.6	0.5	0.5	0.5	0.9	0.6	0.8	0.9	0.7	16.7	18.2	14.2	18.4	13.9	13.4	17.1	17.2	15.8	12.0	15.7	17.0	5.1	0.0	1.5	9.4	3.9	14.4	15.9	13.8	9.6	18.8	34.2	21.7	2.0	20.0	9.1	18.4	25.0	42.6	4.4	47.5	31.3	20.5	4.1	19.5	8.5	15.0	44.9	5.0	3.9	19.7	67.4	8.8	23.9	23.3	5.7	21.6	10.0	13.3	9.6	21.9	4.2	33.8	28.5	5.3	4.1	6.4	11.8	3.6	7.2	8.4	11.2	13.6	8.2	9.5	13.5	21.8	44.2	10.5	5.8	21.7	39.5	14.4	13.7	13.4	0.0	8.5	7.5	10.4	24.0	20.1	18.8	65.4	6.0	22.3	33.9	24.3
PAK6	PAK5	ENSG00000137843	"P21 (RAC1) activated kinase 6"	Q9NQU5	15	40217428-40277487	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 25.6;skin 1: 28.2"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 52.7;NK-cells: 16.5;Suprabasal keratinocytes: 19.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CACO-2: 26.5;HaCaT: 32.2;hTCEpi: 19.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA031124	Approved		Approved	"Nucleoplasm,Nucleoli fibrillar center,Cell Junctions"		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Nucleoplasm, Nucleoli fibrillar center"	"Cell Junctions"	"HPA031124: AB_10601044"	"unprognostic (1.85e-3)"	"unprognostic (2.15e-1)"	"unprognostic (3.33e-3)"	"unprognostic (7.79e-3)"	"unprognostic (7.08e-3)"	"unprognostic (9.57e-2)"		"unprognostic (2.71e-1)"	"unprognostic (7.73e-2)"	"unprognostic (1.34e-2)"	"unprognostic (7.13e-3)"	"unprognostic (4.04e-2)"	"unprognostic (8.87e-3)"	"unprognostic (1.72e-1)"	"unprognostic (1.79e-1)"	"unprognostic (7.37e-3)"	"unprognostic (3.34e-2)"	0.2	8.2	11.6	0.4	15.9	0.9	2.1	8.5	16.6	4.5	0.0	1.3	1.5	0.9	1.0	25.6	4.3	1.1	8.3	17.6	3.0	4.7	0.3	2.5	0.9	1.4	1.1	0.6	8.0	8.0	12.1	7.6	1.9	4.4	1.1	0.8	6.1	3.8	4.5	28.2	1.5	0.3	1.8	0.9	3.9	17.7	3.0	0.5	7.5	1.3	1.9	3.5	9.4	5.4	3.9	0.0	0.2	0.0	0.0	0.0	6.0	0.0	0.2	0.7	0.7	26.5	2.9	0.1	3.6	0.0	1.3	32.2	4.5	6.9	0.3	0.2	1.0	0.0	3.0	0.2	0.0	0.1	0.3	0.0	19.4	0.3	4.5	0.2	0.0	5.5	1.8	0.3	0.0	4.5	0.0	0.5	0.5	3.9	2.9	0.2	0.2	2.9	1.5	8.4	7.3	2.0	2.6	10.9	0.3	1.7	1.7	10.3	0.0	0.3	0.6	0.0	0.3	0.1	0.3	0.1	0.7	0.6	0.2	1.2	0.1	1.2	2.3	0.1	0.8	0.6	0.1	1.9	0.3	0.1	0.1	0.4	0.5	0.9	0.1	0.1	0.0	0.6	11.6	15.9	8.5	16.6	17.6	3.0	1.4	1.1	1.9	1.8	3.0	5.4	0.0	0.0	4.2	0.7	0.3	9.8	9.6	4.8	8.6	3.5	2.8	2.9	0.0	4.3	5.4	5.5	0.0	52.7	2.1	0.3	13.7	4.4	8.6	3.3	0.4	0.3	4.9	0.0	8.9	4.3	3.0	0.7	0.5	5.1	0.0	0.7	0.0	0.0	4.1	0.0	7.3	1.1	2.0	0.6	0.9	5.8	1.8	0.3	1.8	1.0	0.0	1.3	16.5	0.5	0.3	2.5	1.0	1.9	0.1	5.2	0.2	0.2	3.9	0.2	0.0	0.3	0.4	1.9	3.3	13.9	19.0	9.0	1.0	0.8	2.0	11.3
PALB2	"FANCN, FLJ21816"	ENSG00000083093	"Partner and localizer of BRCA2"	Q86YC2	16	23603160-23641310	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins"	"DNA damage, DNA recombination, DNA repair"	DNA-binding	"Cancer-related genes, Disease variant, Fanconi anemia, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Spermatocytes: 30.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB014895, HPA057000"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 71: Testis - DNA repair"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	Nucleoplasm		"CAB014895: , HPA057000: AB_2683307"	"unprognostic (1.11e-1)"	"unprognostic (5.67e-3)"	"prognostic favorable (2.83e-5)"	"unprognostic (1.43e-2)"	"unprognostic (6.22e-2)"	"unprognostic (1.61e-2)"	"unprognostic (2.00e-3)"	"unprognostic (5.18e-2)"	"unprognostic (2.46e-2)"	"unprognostic (2.00e-2)"	"prognostic unfavorable (2.35e-5)"	"unprognostic (2.05e-2)"	"unprognostic (1.04e-2)"	"unprognostic (2.72e-1)"	"unprognostic (1.25e-1)"	"unprognostic (7.20e-2)"	"unprognostic (3.21e-1)"	5.8	5.6	6.2	4.4	6.5	3.5	6.4	9.8	10.7	7.1	6.2	6.1	6.5	5.6	5.6	10.1	5.4	3.3	4.7	6.2	6.1	7.9	9.9	4.8	6.3	6.0	6.2	6.2	6.0	5.8	5.1	3.8	6.2	5.3	5.3	8.6	6.0	4.0	5.4	9.0	7.0	4.0	5.7	7.8	5.7	9.8	6.6	6.4	5.3	4.8	6.9	6.6	7.2	7.0	17.3	13.1	15.4	10.8	12.6	9.4	13.9	12.0	18.4	19.7	23.6	11.2	17.3	18.2	8.7	8.6	15.0	15.2	13.9	19.8	23.4	10.8	8.1	11.2	18.2	31.8	11.7	20.5	17.3	11.2	20.3	18.7	20.7	10.9	10.6	17.1	23.4	9.4	17.2	17.4	21.2	21.3	34.3	12.5	7.6	24.2	18.9	24.7	15.2	15.2	11.2	11.3	12.5	13.5	16.7	13.4	12.9	13.9	7.7	23.1	8.7	11.2	13.2	11.2	19.0	18.3	15.4	14.8	14.3	6.4	1.8	1.8	2.1	2.3	2.6	1.8	2.4	2.7	2.0	1.4	2.6	2.1	0.1	2.1	4.5	1.5	1.7	1.1	6.2	6.5	9.8	10.7	6.2	6.1	6.0	6.2	6.2	5.7	6.6	7.0	4.7	12.8	4.2	8.5	5.1	0.9	3.5	5.4	2.2	4.8	4.0	3.7	4.8	2.8	8.2	3.7	4.2	2.9	3.8	2.4	3.9	5.8	6.8	2.3	5.1	4.8	1.2	4.6	7.4	5.0	2.0	4.4	4.1	2.6	5.1	7.7	3.3	4.7	3.7	1.7	8.0	3.4	2.0	5.0	1.5	3.6	4.7	5.1	1.8	5.6	8.4	4.8	5.2	7.1	5.9	8.6	2.5	6.4	4.2	5.3	4.6	5.4	8.3	7.5	6.6	4.7	3.0	30.0	17.7	5.4	2.7	1.2	3.7	6.9	4.8	4.1
PALLD	"CGI-151, KIAA0992, SIH002"	ENSG00000129116	"Palladin, cytoskeletal associated protein"	Q8WX93	4	168497052-168928457	"Disease related genes, Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 527.9;Cardiomyocytes: 591.7;Peritubular cells: 399.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 13.7"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"LHCN-M2: 304.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035905, CAB070159"	Enhanced		Supported	"Plasma membrane,Actin filaments,Mitochondria,Cytosol"		No	No		27000	"Cluster 10: Basophils - Unknown function"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 22: Epithelial cell types - Mixed function"	"Actin filaments"	"Plasma membrane, Mitochondria, Cytosol"	"CAB070159: AB_1726016, HPA035905: AB_2674854"	"unprognostic (3.59e-2)"	"unprognostic (3.99e-1)"	"unprognostic (2.55e-2)"	"unprognostic (5.03e-3)"	"unprognostic (2.51e-1)"	"unprognostic (7.03e-2)"	"unprognostic (2.60e-1)"	"unprognostic (2.40e-2)"	"unprognostic (3.57e-2)"	"unprognostic (4.21e-2)"	"unprognostic (2.38e-1)"	"unprognostic (3.86e-1)"	"unprognostic (8.54e-2)"	"unprognostic (1.39e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.50e-1)"	"prognostic unfavorable (3.28e-4)"	65.0	35.5	31.7	49.7	27.3	0.9	43.6	11.1	19.9	146.1	0.0	303.3	29.0	301.5	21.9	122.6	118.4	71.0	180.4	27.9	36.2	42.1	12.4	71.7	16.9	29.8	25.9	62.1	13.2	55.6	11.3	62.1	25.1	137.0	74.9	12.8	40.8	205.7	127.7	34.7	64.1	303.1	21.4	60.5	94.8	35.1	24.7	23.3	38.7	47.3	16.6	280.2	85.3	22.7	82.1	39.6	87.9	53.4	77.2	83.9	123.6	53.7	137.6	47.2	66.7	1.1	4.6	36.6	14.4	23.7	29.0	17.0	54.1	138.8	60.5	73.9	16.6	0.8	112.5	10.4	135.5	0.4	1.0	132.8	84.4	85.5	125.4	115.0	20.8	19.7	0.1	0.5	304.5	3.8	23.8	1.4	24.9	20.8	24.1	8.3	81.4	0.8	5.3	16.4	9.0	46.4	102.8	8.1	7.3	151.2	48.6	0.5	64.4	50.3	192.1	20.7	90.1	47.8	0.7	1.7	41.6	1.0	14.2	13.7	3.1	0.0	4.6	1.8	0.2	0.1	0.5	2.4	2.1	0.1	0.6	1.6	0.7	0.6	1.2	0.2	0.8	1.8	31.7	27.3	11.1	19.9	27.9	36.2	29.8	25.9	25.1	21.4	24.7	22.7	22.7	32.1	9.4	167.8	1.5	93.6	527.9	56.8	76.8	6.0	46.0	107.9	591.7	20.0	58.7	44.1	18.8	52.1	8.1	20.9	1.9	27.6	133.1	52.8	181.2	27.7	44.8	0.8	27.8	51.3	115.6	130.5	59.7	51.0	52.6	21.0	47.8	11.2	24.5	26.9	108.4	30.7	18.3	28.9	23.8	146.4	130.1	36.7	23.2	16.9	52.9	55.1	17.5	182.4	6.5	83.0	18.6	399.4	2.6	167.6	9.8	23.4	85.2	4.0	177.5	115.4	227.8	81.0	7.6	34.1	49.3	22.3	9.2	13.4	29.3	113.0
PALMD	"C1orf11, FLJ20271, PALML"	ENSG00000099260	Palmdelphin	Q9NP74	1	99646113-99694541	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 130.8"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 537.2;Cardiomyocytes: 157.6;Endothelial cells: 219.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HUVEC TERT2: 155.2;LHCN-M2: 49.5;TIME: 220.5;U-87 MG: 92.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017959, HPA030549"	Supported		Supported	"Plasma membrane,Actin filaments,Focal adhesion sites"		NA	NA				"Cluster 82: Adipose tissue - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Actin filaments"	"Plasma membrane, Focal adhesion sites"	"HPA017959: AB_1854949, HPA030549: AB_2673518"	"unprognostic (1.48e-2)"	"unprognostic (1.15e-2)"	"unprognostic (2.05e-2)"	"prognostic favorable (9.42e-4)"	"unprognostic (7.67e-2)"	"prognostic favorable (5.90e-5)"	"unprognostic (1.54e-2)"	"unprognostic (2.10e-1)"	"unprognostic (3.93e-2)"	"unprognostic (1.64e-1)"	"unprognostic (8.32e-2)"	"unprognostic (6.18e-2)"	"unprognostic (5.19e-2)"	"unprognostic (1.63e-2)"	"unprognostic (1.88e-1)"	"unprognostic (2.70e-1)"	"unprognostic (8.08e-2)"	130.8	43.0	14.6	7.1	11.7	0.0	77.6	10.5	15.3	27.4	45.8	9.5	3.4	33.0	6.1	38.2	22.8	14.6	91.2	13.7	12.7	11.0	57.1	28.4	3.9	12.0	11.8	18.8	4.9	9.2	10.5	43.2	11.5	18.0	6.5	7.5	71.0	7.9	112.6	48.9	8.6	31.4	11.1	6.3	6.1	11.0	14.1	8.0	7.2	66.2	8.6	14.5	15.9	10.4	0.0	0.3	0.4	0.2	7.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.2	39.2	2.5	0.6	10.8	0.0	0.5	0.1	0.1	0.1	0.0	18.6	26.4	0.0	0.0	0.1	3.9	2.0	0.0	0.0	4.3	155.2	0.0	22.7	0.0	49.5	0.6	0.0	0.0	0.0	1.6	6.8	0.0	38.2	0.1	0.0	8.0	0.9	0.5	0.0	9.9	0.0	1.0	2.3	0.0	220.5	0.0	0.4	16.8	0.0	0.0	0.0	0.1	92.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.6	11.7	10.5	15.3	13.7	12.7	12.0	11.8	11.5	11.1	14.1	10.4	537.2	6.4	5.6	0.3	0.5	38.5	11.4	49.6	22.2	2.0	20.0	31.8	157.6	32.9	35.9	3.7	0.0	0.4	1.6	0.1	5.9	8.1	74.9	78.7	71.9	219.4	1.8	2.7	1.4	0.2	0.3	19.2	2.0	17.7	1.3	0.0	96.0	57.3	0.6	3.3	1.8	0.0	14.2	2.2	5.5	12.2	9.3	1.7	24.9	73.1	0.0	55.0	0.0	0.5	0.2	4.1	0.0	24.0	0.0	5.9	0.0	0.4	111.5	3.3	0.0	91.3	12.7	0.5	0.6	27.5	46.5	0.3	1.4	110.1	0.1	3.3
PAM16	"Magmas, Tim16, TIMM16"	ENSG00000217930	"Presequence translocase associated motor 16"	Q9Y3D7	16	4331549-4355607	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Protein transport, Translocation, Transport"		"Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 109.3"	"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 67.2;Gastric mucus-secreting cells: 36.2;Plasma cells: 39.5;Squamous epithelial cells: 81.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-2197: 184.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA062721			Approved	Nucleoplasm,Microtubules,Mitochondria		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 18: U-2197 - ECM organization"	"Cluster 59: Non-specific - Transcription"	"Nucleoplasm, Mitochondria"	Microtubules	"HPA062721: AB_2684849"	"unprognostic (2.69e-2)"	"unprognostic (1.64e-1)"	"unprognostic (4.06e-1)"	"unprognostic (6.81e-2)"	"unprognostic (6.98e-2)"	"unprognostic (9.68e-2)"	"unprognostic (1.83e-1)"	"unprognostic (6.32e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.39e-1)"	"unprognostic (4.79e-2)"	"unprognostic (2.18e-2)"	"prognostic unfavorable (5.73e-5)"	"unprognostic (7.25e-2)"	"unprognostic (2.22e-1)"	"unprognostic (3.56e-1)"	"prognostic favorable (1.33e-4)"	26.2	44.3	16.2	6.4	16.9	14.4	24.5	14.8	29.0	21.8	15.6	23.8	14.9	20.5	7.0	25.9	22.3	3.9	70.7	16.4	16.2	28.7	66.4	22.4	7.6	15.5	15.9	20.0	39.2	7.4	27.7	6.2	15.6	20.6	4.8	4.7	19.1	8.2	109.3	21.5	19.6	5.1	14.9	22.4	26.8	34.5	15.9	5.8	17.9	17.6	6.1	26.2	20.7	16.2	20.7	41.2	13.8	41.1	5.2	15.2	44.1	34.3	9.8	23.3	15.5	39.0	28.5	49.4	43.7	10.6	22.6	28.5	12.0	16.3	5.5	56.1	87.8	44.8	26.0	20.4	23.4	33.0	34.6	17.7	27.6	17.2	13.0	12.5	13.2	44.1	68.9	24.8	13.2	57.1	40.1	92.8	41.6	16.2	71.5	54.5	18.6	61.5	10.0	12.8	61.8	49.6	32.7	31.7	52.4	8.3	25.7	54.0	13.2	26.0	41.9	184.8	49.7	34.0	46.7	71.1	15.3	30.3	34.8	0.3	25.0	3.2	17.9	16.2	17.0	26.0	16.3	16.4	17.5	23.2	20.0	20.7	14.3	18.3	18.1	33.2	21.7	18.9	16.2	16.9	14.8	29.0	16.4	16.2	15.5	15.9	15.6	14.9	15.9	16.2	2.6	3.2	4.8	0.0	12.8	4.0	1.4	6.9	67.2	0.8	9.8	7.7	0.5	10.0	5.0	0.0	0.0	2.3	3.7	1.8	7.9	4.0	3.3	14.3	11.9	4.4	0.0	18.5	0.0	3.1	2.8	7.0	36.2	10.0	1.3	12.0	3.3	14.6	1.6	1.7	0.0	2.6	2.0	4.3	1.5	2.2	5.0	6.9	1.8	0.0	4.5	0.4	0.0	0.0	0.0	4.8	2.5	3.8	39.5	1.2	5.5	7.3	5.1	0.6	6.6	2.0	5.1	9.7	13.7	81.3	5.8	1.2	8.8	1.7	3.5	1.3
PANK2	"C20orf48, FLJ11729, HARP, HSS, NBIA1, PKAN"	ENSG00000125779	"Pantothenate kinase 2"	Q9BZ23	20	3888839-3929887	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Angiogenesis, Coenzyme A biosynthesis"	"Kinase, Transferase"	"Disease variant, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008440	Approved		Supported	Cytosol		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 66: Spermatocytes - Spermatogenesis"	Cytosol		"HPA008440: AB_1079559"	"unprognostic (4.50e-2)"	"unprognostic (7.96e-3)"	"unprognostic (2.26e-1)"	"unprognostic (1.39e-2)"	"unprognostic (1.68e-1)"	"unprognostic (6.00e-2)"	"prognostic unfavorable (1.20e-5)"	"unprognostic (2.75e-1)"	"unprognostic (3.39e-1)"	"unprognostic (2.52e-1)"	"unprognostic (3.02e-2)"	"unprognostic (1.65e-1)"	"unprognostic (6.01e-3)"	"unprognostic (1.73e-2)"	"unprognostic (2.18e-3)"	"unprognostic (2.63e-1)"	"unprognostic (1.81e-1)"	13.0	12.3	14.5	16.8	13.7	20.9	12.2	15.3	15.9	11.9	14.1	11.4	8.4	11.0	11.3	20.0	16.3	12.1	8.7	15.5	13.5	15.7	18.3	14.1	18.5	12.7	14.1	12.9	10.3	10.9	8.9	15.3	13.3	12.0	14.2	10.3	11.9	10.7	9.6	11.7	11.6	13.7	12.7	14.9	9.1	25.9	13.9	16.8	15.4	11.2	22.0	15.6	9.9	12.4	39.3	29.4	33.7	18.6	39.3	32.6	15.0	25.6	34.2	38.3	48.3	40.8	25.4	34.6	10.6	34.9	70.2	34.9	34.7	57.3	49.3	8.8	9.8	47.4	22.7	80.2	33.3	33.6	15.9	28.7	26.4	39.7	28.7	17.0	36.0	23.3	34.7	30.5	42.5	11.7	30.0	30.3	28.8	22.9	19.5	20.3	46.0	22.4	26.2	45.7	36.2	16.7	30.0	44.3	78.1	32.6	23.6	28.1	24.6	47.7	17.8	60.7	43.3	14.0	50.8	23.3	15.0	30.7	34.2	3.0	10.5	3.4	3.6	11.1	3.5	3.8	3.7	3.4	8.5	4.5	4.1	3.4	5.9	6.8	9.4	3.0	5.9	4.0	14.5	13.7	15.3	15.9	15.5	13.5	12.7	14.1	13.3	12.7	13.9	12.4	23.8	19.2	11.7	23.8	29.2	25.5	17.5	12.0	41.5	22.0	15.8	17.3	9.8	7.2	13.4	14.7	25.0	29.4	38.6	14.4	23.5	19.4	83.1	24.1	20.6	26.7	20.3	42.7	28.6	17.8	36.0	21.1	24.5	24.1	7.6	20.1	26.0	14.0	33.8	35.3	25.3	12.7	10.2	52.8	37.9	17.3	21.1	34.3	19.6	29.0	55.0	14.1	35.0	23.1	17.7	15.9	12.8	22.6	33.2	20.9	15.1	20.6	20.2	21.1	6.6	14.1	23.1	54.6	25.9	37.7	24.3	18.6	31.6	21.2	15.0	20.0
PANX2	"hPANX2, PX2"	ENSG00000073150	"Pannexin 2"	Q96RD6	22	50170731-50180295	"Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 51.0"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 11.4;Excitatory neurons: 13.3;Hepatocytes: 10.7;Inhibitory neurons: 15.8;Muller glia cells: 29.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"neutrophil: 1.9"	"Lineage enhanced"	"Detected in single"		"granulocytes: 1.9"	"Cell line enhanced"	"Detected in many"		"EFO-21: 10.3;HDLM-2: 16.7;Hep G2: 19.6;MCF7: 10.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004624, HPA039117"	Enhanced		Supported	"Plasma membrane"		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 5: Muller glia cells - Visual perception"	"Plasma membrane"		"HPA004624: , HPA039117: AB_10805354"	"unprognostic (1.00e-1)"	"unprognostic (7.25e-2)"	"unprognostic (2.72e-2)"	"unprognostic (1.05e-1)"	"unprognostic (3.01e-3)"	"unprognostic (2.11e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.56e-1)"	"unprognostic (4.43e-2)"	"unprognostic (3.08e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.65e-9)"	"unprognostic (2.23e-1)"	"unprognostic (1.78e-1)"	"unprognostic (3.00e-1)"	"unprognostic (4.08e-1)"	1.0	0.8	4.4	0.5	4.4	1.6	1.0	8.4	40.1	1.7	0.0	0.3	0.0	1.2	0.5	5.2	2.2	0.4	0.7	8.0	13.1	3.0	9.6	2.1	0.0	51.0	8.8	3.4	1.4	0.3	7.9	0.1	48.4	3.9	0.0	1.6	5.0	1.4	0.7	1.1	0.2	0.0	7.9	1.9	0.4	1.7	14.1	0.0	7.3	0.1	0.1	1.4	1.9	16.4	0.9	2.1	0.4	2.3	0.0	0.2	4.9	2.6	2.5	0.5	0.4	0.5	8.0	0.0	10.3	0.3	1.4	0.5	1.3	1.0	0.1	16.7	1.4	0.4	3.5	19.6	0.7	0.1	1.2	0.2	1.0	0.7	0.0	1.1	0.6	0.0	1.4	0.0	0.2	10.8	0.0	1.0	3.9	0.0	4.2	1.0	0.0	4.0	0.0	1.6	9.8	0.9	1.6	0.2	6.5	0.5	0.7	0.8	4.5	0.5	4.1	6.7	4.9	1.8	0.1	0.6	0.3	0.0	7.4	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.6	0.0	0.0	4.4	4.4	8.4	40.1	8.0	13.1	51.0	8.8	48.4	7.9	14.1	16.4	0.0	0.0	1.1	7.2	0.3	0.5	3.1	0.6	0.0	11.4	2.5	2.4	0.8	1.5	2.6	0.0	0.0	0.0	1.5	0.0	5.9	2.3	0.3	5.9	1.5	0.7	0.0	0.4	13.3	2.8	0.2	0.8	0.0	7.0	0.0	2.1	0.0	10.7	0.1	0.0	15.8	0.0	0.0	0.9	1.5	0.2	0.0	1.1	0.0	1.9	1.8	29.7	0.0	6.6	1.2	1.8	0.0	1.2	0.5	6.0	0.0	3.0	3.0	3.6	0.0	0.1	0.9	0.0	1.8	0.3	0.3	0.0	0.2	0.1	0.0	4.5
PAPOLA	PAP	ENSG00000090060	"Poly(A) polymerase alpha"	P51003	14	96501433-96567111	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"mRNA processing"	"RNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Syncytiotrophoblasts: 1036.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001788	Supported		Supported	Nucleoplasm		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"HPA001788: AB_1079564"	"unprognostic (3.18e-1)"	"unprognostic (1.30e-1)"	"unprognostic (9.69e-2)"	"unprognostic (7.26e-2)"	"unprognostic (9.10e-2)"	"unprognostic (5.10e-3)"	"prognostic unfavorable (2.41e-5)"	"unprognostic (2.12e-2)"	"unprognostic (2.82e-2)"	"unprognostic (1.38e-3)"	"unprognostic (3.13e-1)"	"unprognostic (1.22e-3)"	"unprognostic (3.37e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.08e-2)"	"unprognostic (4.05e-1)"	52.6	60.5	62.7	66.6	65.1	96.9	62.7	71.7	87.4	61.7	70.1	70.5	57.1	68.5	72.5	59.6	57.9	56.1	61.0	59.9	64.4	60.7	81.6	50.0	77.8	63.0	61.7	76.1	71.6	73.2	53.0	85.3	64.3	54.2	71.8	92.4	63.8	54.0	46.7	57.9	67.6	61.6	62.8	69.3	65.9	75.8	62.1	93.0	68.9	56.4	82.8	66.4	53.5	80.7	126.6	119.4	150.5	152.6	107.2	119.4	331.6	112.9	120.4	132.1	125.8	132.9	125.6	170.9	125.3	134.1	115.2	104.4	50.1	156.9	235.0	141.1	81.1	131.9	88.9	138.5	110.6	166.2	133.4	110.6	134.1	148.0	131.1	127.8	150.5	79.5	128.2	146.5	128.9	184.6	140.5	91.1	102.9	205.0	135.3	146.7	183.5	98.7	132.0	192.7	154.0	102.0	151.4	115.8	111.6	167.9	165.3	158.3	119.0	91.3	72.6	104.1	140.7	114.3	186.7	138.6	144.5	137.5	158.9	73.5	32.0	56.1	23.8	39.3	29.0	38.9	30.2	34.2	38.8	42.7	35.3	33.9	41.3	41.3	37.7	25.1	32.7	36.6	62.7	65.1	71.7	87.4	59.9	64.4	63.0	61.7	64.3	62.8	62.1	80.7	126.3	80.1	122.4	64.6	171.4	229.7	406.3	196.6	126.9	78.2	140.0	101.6	157.2	88.6	160.1	84.6	95.9	346.2	139.6	124.1	183.9	121.4	634.7	326.1	145.4	150.7	117.2	126.8	87.9	137.0	440.7	129.9	95.3	371.7	136.4	113.8	85.6	112.3	155.6	63.9	111.5	154.9	168.9	141.3	239.4	275.3	96.3	153.2	168.9	104.9	171.8	93.4	135.9	105.1	115.2	129.6	118.9	80.5	197.4	373.0	122.5	136.5	253.1	107.2	105.2	131.6	185.0	256.8	203.0	146.0	247.6	1036.0	167.8	131.2	166.1	540.3
PAQR8	"C6orf33, LMPB1, MPRB"	ENSG00000170915	"Progestin and adipoQ receptor family member 8"	Q8TEZ7	6	52361421-52407777	"Predicted membrane proteins, Transporters"	"Differentiation, Oogenesis"	"Developmental protein, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 144.9"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 168.5;Distal enterocytes: 154.3;Microglial cells: 74.0;Oligodendrocytes: 298.2;Paneth cells: 80.7;Proximal enterocytes: 100.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Hep G2: 41.8;OE19: 87.9;SuSa: 34.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA064625			Supported	"Golgi apparatus,Plasma membrane"		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 21: OE19 - Mitochondria"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Plasma membrane"	"Golgi apparatus"	"HPA064625: AB_2685304"	"prognostic favorable (4.61e-4)"	"unprognostic (7.39e-3)"	"unprognostic (2.77e-3)"	"unprognostic (8.23e-2)"	"unprognostic (4.33e-1)"	"unprognostic (4.08e-3)"	"unprognostic (2.66e-2)"	"unprognostic (5.67e-2)"	"unprognostic (6.37e-2)"	"unprognostic (4.30e-3)"	"unprognostic (2.10e-1)"	"unprognostic (5.55e-2)"	"unprognostic (8.82e-3)"	"unprognostic (1.04e-1)"	"unprognostic (2.12e-1)"	"unprognostic (3.14e-2)"	"prognostic favorable (6.40e-4)"	2.7	4.0	83.7	9.2	113.9	1.2	2.3	122.9	86.7	4.7	42.0	38.9	19.3	5.1	8.0	17.6	6.3	6.0	3.5	74.4	89.7	8.0	1.5	7.3	10.3	133.8	110.7	24.3	2.8	5.2	2.2	7.0	123.1	4.3	36.7	2.9	2.2	23.3	0.9	3.1	33.7	6.3	102.8	6.2	32.3	3.7	106.4	9.2	2.8	1.5	7.6	9.7	5.5	144.9	0.9	1.0	10.7	4.6	6.3	10.2	7.3	3.2	12.1	2.0	4.4	4.1	3.8	1.1	1.2	2.2	4.7	0.4	1.4	5.3	3.2	14.8	1.7	6.6	1.0	41.8	1.7	1.8	0.9	2.9	0.7	1.4	7.5	7.4	11.5	12.9	1.5	6.4	8.3	1.5	4.4	6.1	5.4	87.9	0.5	11.5	1.7	2.8	12.4	3.1	4.0	8.7	0.8	0.3	12.4	34.4	0.3	14.7	4.8	4.0	1.6	1.2	1.9	1.9	2.6	1.6	3.7	16.9	21.5	3.0	3.2	1.4	2.8	0.6	4.2	1.1	8.3	5.7	7.0	1.0	17.8	8.3	0.6	8.5	0.6	3.5	6.2	4.2	83.7	113.9	122.9	86.7	74.4	89.7	133.8	110.7	123.1	102.8	106.4	144.9	4.9	3.2	10.6	168.5	3.6	2.0	3.7	3.1	0.6	2.1	0.7	1.3	4.4	14.3	3.5	3.7	8.4	1.7	7.6	154.3	0.0	4.4	0.5	12.2	3.9	7.4	22.9	4.2	21.1	1.1	3.1	6.8	18.8	7.5	4.5	23.7	4.2	0.2	8.8	0.0	19.4	45.5	6.1	19.8	3.5	1.6	5.6	7.3	14.2	74.0	11.4	4.2	3.1	19.1	298.2	4.9	80.7	10.1	0.6	6.6	100.5	0.1	8.9	3.3	0.0	1.0	3.6	12.1	3.3	5.3	1.0	0.8	9.2	10.0	42.5	7.3
PARD3	"ASIP, Baz, Bazooka, PAR3, PARD3A, PPP1R118"	ENSG00000148498	"Par-3 family cell polarity regulator"	Q8TEW0	10	34109560-34815325	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Differentiation"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"Astrocytes: 455.4;Inhibitory neurons: 147.0;Microglial cells: 193.0;Oligodendrocyte precursor cells: 367.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	50	"basophil: 9.6"	"Lineage enriched"	"Detected in single"	97	"granulocytes: 9.6"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030443	Approved		Supported	"Plasma membrane,Cell Junctions"		NA	NA		21000	"Cluster 34: Basophils - Unknown function"	"Cluster 31: Skin - Epidermis development"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Plasma membrane, Cell Junctions"		"HPA030443: AB_10600926"	"unprognostic (9.49e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.83e-2)"	"unprognostic (1.81e-2)"	"unprognostic (3.52e-2)"	"prognostic unfavorable (1.73e-5)"	"unprognostic (3.48e-1)"	"unprognostic (3.49e-1)"	"unprognostic (8.07e-2)"	"unprognostic (5.82e-3)"	"unprognostic (1.28e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.20e-2)"	"unprognostic (3.54e-1)"	"unprognostic (9.20e-2)"	"prognostic unfavorable (4.41e-4)"	13.1	15.9	19.6	4.8	17.0	0.5	21.5	10.9	12.4	25.9	16.0	30.4	10.6	20.7	12.2	47.8	20.6	14.9	14.6	17.8	20.6	25.1	22.1	15.2	2.6	15.7	22.1	38.5	34.2	20.7	7.3	21.7	15.9	17.0	21.7	13.6	20.1	23.9	40.5	52.1	13.4	21.8	16.0	4.2	17.7	14.0	24.0	13.5	15.2	30.9	12.4	21.3	30.8	13.9	50.6	121.1	40.1	28.6	28.5	24.2	59.1	22.2	25.4	37.3	40.0	44.3	43.3	0.3	31.4	44.6	30.4	35.8	34.7	56.7	46.1	0.4	26.8	0.0	14.9	44.1	36.2	5.7	0.1	28.7	54.9	50.9	38.1	35.9	23.3	32.4	34.7	14.9	44.8	35.4	59.3	4.2	18.0	32.7	41.4	44.9	39.0	21.9	80.9	38.4	20.1	20.9	26.8	37.3	42.9	49.6	21.1	6.7	28.4	18.7	56.1	35.5	24.2	13.2	17.1	0.1	21.0	0.2	22.3	9.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.2	19.6	17.0	10.9	12.4	17.8	20.6	15.7	22.1	15.9	16.0	24.0	13.9	6.4	35.3	35.3	455.4	0.2	34.0	42.3	19.8	19.9	8.7	17.1	24.9	39.0	21.5	24.3	14.7	29.2	24.9	0.2	25.6	0.0	34.1	19.9	22.3	29.9	9.4	24.0	2.7	5.4	36.4	25.0	22.3	13.3	33.4	1.3	33.1	8.9	24.8	3.4	11.8	147.0	30.1	14.2	0.6	4.7	20.3	30.4	7.7	5.4	193.0	0.8	28.8	1.0	367.9	13.9	38.8	23.8	38.4	1.4	31.4	13.7	25.6	29.3	19.7	26.3	23.4	26.1	6.2	27.6	40.4	61.5	40.1	1.5	32.1	22.0	47.2
PARD3B	"ALS2CR19, PAR3beta, Par3L"	ENSG00000116117	"Par-3 family cell polarity regulator beta"	Q8TEW8	2	204545475-205620162	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 490.7;Microglial cells: 183.6;Oligodendrocyte precursor cells: 159.3;Oligodendrocytes: 104.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 17.8;BJ hTERT+: 12.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035283	Approved		Supported	"Cell Junctions"		NA	NA				"Cluster 57: Non-specific - Angiogenesis"	"Cluster 36: HEL - Hemostasis"	"Cluster 64: Astrocytes - Nervous system maintenance"	"Cell Junctions"		"HPA035283: AB_10671102"	"unprognostic (6.18e-2)"	"unprognostic (3.86e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.41e-2)"	"unprognostic (3.61e-2)"	"unprognostic (1.73e-1)"	"unprognostic (2.69e-1)"	"unprognostic (1.67e-2)"	"unprognostic (1.57e-1)"	"unprognostic (2.38e-1)"	"unprognostic (2.20e-1)"	"unprognostic (1.43e-1)"	"prognostic favorable (2.67e-10)"	"unprognostic (1.74e-1)"	"unprognostic (8.13e-2)"	"unprognostic (1.23e-1)"	"unprognostic (8.09e-2)"	9.1	2.8	6.0	1.7	7.3	0.0	5.5	5.3	5.3	4.9	9.3	12.6	3.6	5.1	3.7	4.0	6.5	4.5	4.0	4.6	9.2	6.9	3.4	5.4	2.1	9.3	12.2	7.3	4.9	9.2	1.9	4.4	8.3	4.8	5.5	2.5	3.0	5.2	2.7	4.5	4.2	5.2	8.4	3.1	4.5	3.8	8.0	1.4	5.6	3.6	2.5	5.9	4.0	7.4	2.5	2.1	6.3	2.3	17.8	8.9	3.4	3.8	12.5	3.5	3.8	6.2	1.7	0.0	4.3	7.8	2.8	0.3	0.8	1.0	3.6	0.2	2.9	8.8	5.2	0.0	1.8	0.0	0.5	3.4	1.7	1.2	5.2	5.3	5.2	0.8	0.2	0.1	4.5	1.0	0.0	0.0	0.8	0.9	0.5	0.0	2.7	2.1	3.7	2.5	0.7	2.0	2.0	1.9	1.7	6.2	3.1	0.0	10.9	2.7	1.7	5.5	1.8	0.0	0.0	0.0	2.6	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.0	7.3	5.3	5.3	4.6	9.2	9.3	12.2	8.3	8.4	8.0	7.4	9.5	9.6	8.6	490.7	0.5	11.0	3.3	2.4	6.8	0.5	5.6	5.8	10.8	15.7	14.5	29.5	0.0	3.2	0.2	12.4	0.0	8.7	76.6	8.5	4.0	6.8	6.0	0.8	5.6	2.4	0.2	16.2	11.7	7.4	1.3	14.1	8.2	4.5	0.5	5.0	50.8	9.2	2.0	1.0	4.3	26.0	31.1	0.6	7.2	183.6	0.1	9.7	0.0	159.3	104.2	6.5	15.9	57.9	1.4	5.0	9.4	4.8	17.0	0.3	19.7	23.5	9.6	1.4	2.9	3.5	4.7	1.1	1.0	2.3	8.0	5.3
PARD6A	"PAR-6, PAR-6A, PAR6alpha, TAX40, TIP-40"	ENSG00000102981	"Par-6 family cell polarity regulator alpha"	Q9NPB6	16	67660946-67662774	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 38.5;testis: 42.9"	"Cell type enriched"	"Detected in many"	4	"Late spermatids: 266.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"REH: 27.9;RPMI-8226: 24.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009733, HPA041551"	Approved		Supported	"Cell Junctions,Actin filaments,Cytosol"		No	No			"Cluster 24: B-cells - Unknown function"	"Cluster 22: Non-specific - Unknown function"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 25: Spermatids - Spermatogenesis"	"Cell Junctions, Actin filaments"	Cytosol	"CAB009733: AB_2159676, HPA041551: AB_2677545"	"prognostic favorable (5.40e-4)"	"unprognostic (6.18e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.33e-2)"	"unprognostic (7.63e-2)"	"unprognostic (4.08e-3)"	"unprognostic (1.23e-2)"	"unprognostic (1.27e-1)"	"unprognostic (6.59e-2)"	"unprognostic (2.09e-1)"	"unprognostic (1.98e-3)"	"unprognostic (9.13e-2)"	"prognostic favorable (3.08e-7)"	"unprognostic (9.22e-3)"	"unprognostic (6.69e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.39e-2)"	3.2	8.0	25.1	2.4	24.8	1.3	2.8	32.4	38.5	2.1	19.3	7.7	1.1	2.6	2.1	2.0	2.7	1.9	4.2	28.1	22.3	8.8	6.5	3.1	3.1	25.3	22.8	3.9	27.9	6.6	30.2	0.7	26.8	3.6	1.0	2.7	2.7	2.7	8.7	1.8	4.1	1.6	21.9	4.8	5.9	42.9	25.8	3.4	2.4	5.3	2.2	3.7	1.7	25.4	8.9	9.4	2.6	23.5	1.7	0.4	4.7	0.2	1.1	3.4	3.2	4.7	3.6	14.8	4.3	0.3	1.2	7.0	5.2	1.1	0.7	6.9	5.0	6.0	4.1	5.5	2.4	2.5	13.5	0.1	0.5	3.2	1.3	2.1	1.7	21.7	0.6	3.4	0.6	8.7	15.6	3.2	3.3	12.0	6.0	27.9	1.7	24.5	8.8	5.1	21.8	11.7	1.4	3.2	3.7	0.7	19.9	0.9	1.4	0.3	0.8	2.1	4.6	3.5	12.1	13.5	2.6	5.3	1.0	2.1	0.9	0.4	4.3	0.6	7.8	10.9	5.9	5.4	1.1	8.3	2.8	2.2	3.4	1.3	0.1	5.1	6.3	2.0	25.1	24.8	32.4	38.5	28.1	22.3	25.3	22.8	26.8	21.9	25.8	25.4	4.4	3.2	5.8	2.0	17.0	0.9	2.2	1.6	1.2	11.1	7.7	6.7	1.7	10.0	2.6	20.2	4.2	5.7	8.2	3.5	33.2	7.2	61.0	4.1	0.5	3.2	34.0	4.0	7.2	15.0	0.4	3.3	6.1	2.7	5.7	5.2	3.9	4.6	4.3	32.0	7.3	3.3	0.0	4.1	5.7	266.5	3.7	4.7	5.4	3.7	2.2	19.1	1.0	2.0	2.2	6.0	2.1	1.5	12.1	2.1	2.9	16.3	3.4	10.1	0.0	8.0	9.7	5.5	3.9	1.4	1.6	2.9	15.0	1.9	4.7	2.4
PARD6B	PAR-6B	ENSG00000124171	"Par-6 family cell polarity regulator beta"	Q9BYG5	20	50731580-50756795	"Predicted intracellular proteins"	"Cell cycle, Cell division"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 16.1"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 189.1;Glandular and luminal cells: 179.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CACO-2: 29.0;MCF7: 51.7;T-47d: 48.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA013376	Uncertain		Supported	Cytosol		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 6: T47d - Mammary gland"	"Cluster 44: Endometrium - Transcription"	Cytosol		"HPA013376: AB_1854972"	"unprognostic (1.13e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.39e-3)"	"unprognostic (2.56e-1)"	"unprognostic (1.27e-1)"	"prognostic unfavorable (1.02e-5)"	"unprognostic (2.12e-1)"	"unprognostic (1.37e-1)"	"unprognostic (9.33e-2)"	"prognostic unfavorable (8.38e-4)"	"unprognostic (2.27e-1)"	"prognostic favorable (6.38e-5)"	"unprognostic (1.84e-2)"	"unprognostic (1.97e-1)"	"unprognostic (4.18e-2)"	"unprognostic (1.07e-2)"	1.9	1.1	1.6	0.8	2.0	2.3	3.5	3.7	1.8	1.7	8.4	2.5	3.6	1.4	8.2	3.1	3.8	2.5	0.8	2.7	1.8	16.1	4.4	5.4	1.0	1.8	2.1	1.1	4.6	4.3	1.4	3.9	1.6	1.2	2.3	8.9	1.8	1.7	3.9	2.9	3.2	0.8	1.8	1.1	5.7	2.7	2.0	0.9	3.7	0.9	2.1	1.7	1.5	2.4	5.4	6.2	1.7	3.7	1.1	0.4	8.0	0.4	0.6	0.9	0.7	29.0	12.7	2.4	5.4	0.1	3.8	4.3	2.6	3.9	1.5	1.2	1.5	1.3	2.1	11.5	1.2	0.9	1.3	0.1	1.9	0.5	1.6	1.7	0.1	2.3	3.1	1.6	0.1	51.7	2.5	2.3	3.0	9.0	2.3	1.4	1.7	2.3	12.9	5.9	1.1	1.6	4.1	9.6	3.0	7.2	48.8	1.3	0.2	0.5	3.2	0.5	1.0	1.9	1.3	2.0	1.3	0.9	1.1	1.6	0.2	1.5	1.4	0.3	1.5	1.1	1.4	1.4	0.3	1.3	2.2	1.4	1.1	1.6	0.6	1.3	0.9	0.4	1.6	2.0	3.7	1.8	2.7	1.8	1.8	2.1	1.6	1.8	2.0	2.4	0.4	189.1	50.4	2.9	4.5	63.0	58.9	17.0	30.7	14.4	60.3	15.0	4.3	37.1	31.1	90.1	54.2	35.5	4.0	68.6	41.1	26.2	4.0	110.1	14.4	1.7	14.9	0.4	11.5	24.4	15.0	4.7	55.5	179.2	1.3	1.8	1.8	20.1	3.7	5.0	10.6	26.7	22.4	0.8	4.2	2.5	1.8	3.5	16.0	1.9	1.2	12.3	2.1	1.5	4.6	57.5	39.7	0.7	6.3	43.6	29.3	102.0	30.0	62.7	6.6	1.2	4.8	16.6	9.4	34.7	68.3	48.4	6.3	1.5	27.3	102.7
PARG		ENSG00000227345	"Poly(ADP-ribose) glycohydrolase"	Q86W56	10	49818279-49970203	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"DNA damage"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021819, HPA053007"	Enhanced		Supported	Nucleoplasm,Vesicles,Cytosol		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Nucleoplasm	"Vesicles, Cytosol"	"HPA021819: AB_1854974, HPA053007: AB_2682014"	"unprognostic (5.77e-3)"	"unprognostic (6.74e-2)"	"unprognostic (3.06e-2)"	"unprognostic (9.90e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.33e-1)"	"prognostic unfavorable (5.57e-5)"	"unprognostic (1.21e-1)"	"unprognostic (3.97e-1)"	"unprognostic (8.34e-2)"	"unprognostic (1.47e-1)"	"unprognostic (4.06e-2)"	"unprognostic (5.20e-3)"	"unprognostic (1.14e-1)"	"unprognostic (1.77e-1)"	"unprognostic (8.54e-2)"	"unprognostic (1.13e-1)"	5.3	6.5	3.7	6.2	3.8	3.2	7.1	7.5	4.8	6.1	1.4	7.3	8.8	6.1	4.7	7.0	5.8	5.4	8.5	4.0	4.3	12.7	6.9	5.2	9.1	3.6	3.2	5.4	4.0	8.9	4.3	7.7	4.0	6.7	7.8	5.8	5.3	6.3	12.0	7.3	7.0	6.3	3.0	6.9	6.4	7.8	3.7	9.1	6.7	9.0	9.0	6.2	5.2	4.3	15.3	9.5	20.0	17.8	11.2	13.6	14.9	13.6	17.2	17.0	16.1	9.8	15.2	10.5	10.7	13.3	7.8	17.7	17.3	10.2	19.8	15.5	16.6	11.6	7.7	13.2	13.8	16.5	8.9	8.4	21.0	12.3	22.4	13.4	10.6	14.0	18.8	11.1	14.9	9.2	18.0	20.0	22.4	10.5	26.8	21.1	20.7	13.9	16.1	8.4	16.0	19.7	10.6	21.6	17.1	21.2	23.8	10.9	10.0	11.5	12.4	11.8	15.9	10.4	16.2	21.9	18.9	18.8	8.8	6.1	2.5	1.4	2.3	2.2	3.2	3.0	3.0	2.8	2.7	2.9	3.7	3.5	1.3	3.9	3.5	2.9	2.8	2.3	3.7	3.8	7.5	4.8	4.0	4.3	3.6	3.2	4.0	3.0	3.7	4.3	8.2	9.6	15.3	22.2	12.2	6.1	5.2	4.3	12.0	13.9	9.5	7.4	28.6	14.3	9.2	12.9	27.1	7.7	8.9	10.4	9.8	7.3	6.1	17.7	14.8	11.1	6.6	12.8	42.5	6.5	6.2	12.0	11.2	11.8	14.5	17.0	6.8	13.6	9.7	5.0	37.9	10.0	2.0	12.0	4.3	4.6	7.5	11.6	3.6	35.6	12.4	7.3	24.7	26.7	41.4	8.1	3.7	8.2	9.9	5.3	8.7	40.3	21.5	20.7	0.0	11.3	12.0	17.1	13.3	13.8	6.0	4.7	12.0	20.0	11.2	4.4
PARK7	"DJ-1, DJ1, GATD2"	ENSG00000116288	"Parkinsonism associated deglycase"	Q99497	1	7954291-7985505	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Autophagy, DNA damage, DNA repair, Fertilization, Inflammatory response, Stress response"	"Chaperone, Hydrolase, Protease, RNA-binding"	"Disease variant, Neurodegeneration, Parkinson disease, Parkinsonism, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004190, CAB005870"	Supported		Supported	Nucleoplasm,Cytosol		NA	NA		35000000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoplasm, Cytosol"		"CAB005870: AB_444361, HPA004190: AB_1079566"	"unprognostic (6.88e-3)"	"unprognostic (7.50e-2)"	"unprognostic (3.48e-2)"	"unprognostic (1.16e-2)"	"unprognostic (4.08e-2)"	"unprognostic (5.68e-2)"	"unprognostic (7.45e-2)"	"unprognostic (9.63e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.66e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.02e-1)"	"unprognostic (1.96e-3)"	"unprognostic (8.17e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.30e-1)"	"unprognostic (7.43e-2)"	249.4	373.6	283.5	213.7	290.0	205.0	235.7	292.9	403.4	201.1	327.7	252.5	145.8	212.2	278.0	161.0	203.2	162.9	388.0	285.5	296.6	311.0	397.6	181.6	269.2	289.6	286.0	234.2	308.5	387.6	283.6	174.1	291.7	234.9	194.9	273.8	240.9	185.6	771.4	127.1	170.5	199.1	295.2	188.2	234.2	139.6	288.1	217.9	286.3	541.8	249.7	226.5	171.2	299.7	537.0	452.5	467.1	523.2	459.8	442.6	218.4	476.7	434.4	450.4	360.3	419.9	549.4	633.1	534.2	505.1	328.6	367.1	483.2	625.3	579.3	574.5	526.2	683.0	678.6	674.5	403.8	662.9	418.6	421.3	262.4	459.8	547.4	359.2	478.2	340.1	676.8	471.7	633.0	485.0	474.3	868.7	376.1	653.6	465.4	366.7	598.0	888.7	714.7	269.7	527.7	447.4	470.4	728.0	798.4	370.1	414.9	503.7	459.3	412.8	344.6	395.5	539.5	452.8	788.4	938.8	551.5	1002.9	606.4	298.4	590.2	394.0	484.7	553.7	459.2	483.6	478.2	577.3	717.4	374.6	406.8	466.8	202.5	551.1	456.9	1378.2	874.4	1060.8	283.5	290.0	292.9	403.4	285.5	296.6	289.6	286.0	291.7	295.2	288.1	299.7	243.6	131.4	157.1	23.2	211.8	208.9	402.4	677.7	200.9	196.2	342.0	381.8	453.3	257.4	318.5	248.3	79.2	553.0	382.3	131.1	851.0	504.3	32.1	272.1	263.9	241.7	238.0	177.1	19.5	478.4	612.1	302.3	146.3	195.9	206.5	291.2	183.1	368.1	435.1	186.7	22.9	279.6	484.2	204.5	304.5	53.6	358.2	258.9	359.3	21.5	605.4	816.4	327.5	18.1	36.0	378.9	186.9	378.7	269.7	523.4	227.1	941.5	327.8	235.5	276.1	277.8	342.6	288.2	302.2	220.4	143.8	469.6	244.4	535.3	312.2	433.1
PARM1	"Cipar1, DKFZP564O0823, WSC4"	ENSG00000169116	"Prostate androgen-regulated mucin-like protein 1"	Q6UWI2	4	74933095-75050115	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 181.9;Distal enterocytes: 398.3;Intestinal goblet cells: 109.7;Paneth cells: 132.1"	"Cancer enhanced"	"Detected in all"		"thyroid cancer: 56.3"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	15	"memory B-cell: 8.1;myeloid DC: 4.0;naive B-cell: 5.6"	"Group enriched"	"Detected in many"	15	"B-cells: 8.1;dendritic cells: 4.0"	"Cell line enhanced"	"Detected in many"		"ASC diff: 44.6;Karpas-707: 44.9;U-266/70: 49.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038236	Approved		Approved	Nucleoplasm,Vesicles,Cytosol		NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Nucleoplasm, Vesicles, Cytosol"		"HPA038236: AB_10675789"	"unprognostic (2.57e-2)"	"unprognostic (5.20e-2)"	"unprognostic (1.26e-3)"	"unprognostic (8.61e-2)"	"unprognostic (1.44e-1)"	"unprognostic (8.49e-3)"	"unprognostic (3.08e-1)"	"unprognostic (2.42e-2)"	"unprognostic (2.73e-1)"	"unprognostic (9.74e-2)"	"unprognostic (9.44e-2)"	"unprognostic (3.51e-2)"	"unprognostic (5.21e-2)"	"unprognostic (1.96e-1)"	"unprognostic (2.16e-1)"	"prognostic unfavorable (1.78e-4)"	"unprognostic (2.23e-1)"	45.1	51.8	4.1	27.7	5.4	0.4	29.3	0.0	19.3	43.3	2.1	91.3	7.0	34.7	14.0	13.5	23.3	28.6	103.6	10.4	26.0	55.9	1.3	33.7	18.2	1.3	3.9	19.6	34.1	73.1	41.0	40.7	21.2	83.8	113.4	6.0	39.4	64.5	21.0	11.1	15.7	48.2	0.0	15.3	13.4	12.0	4.1	17.3	123.7	18.1	20.9	44.9	25.0	0.0	1.1	1.9	1.7	0.0	44.6	0.3	0.2	0.0	0.2	0.0	0.0	3.9	0.3	0.0	0.2	0.0	0.1	0.1	15.1	0.0	0.0	0.2	3.3	0.0	0.0	0.0	7.4	0.0	1.3	1.0	0.0	0.0	0.0	0.1	0.0	3.8	0.0	44.9	0.8	0.5	5.2	0.2	4.3	0.0	2.7	0.0	4.1	11.8	0.2	9.5	2.8	0.1	0.1	0.3	0.0	1.8	0.0	0.0	0.0	2.7	2.9	0.3	4.2	49.8	5.1	12.9	4.7	0.0	0.7	0.0	0.1	0.0	0.0	0.3	0.0	8.1	0.0	0.0	4.0	5.6	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.5	4.1	5.4	0.0	19.3	10.4	26.0	1.3	3.9	21.2	0.0	4.1	0.0	44.8	16.0	84.1	2.9	11.6	3.2	27.2	6.5	4.0	7.0	4.0	3.4	181.9	31.5	10.4	0.0	0.0	0.3	0.1	398.3	3.9	0.5	10.1	3.0	73.5	6.4	19.9	2.7	51.3	49.2	0.7	13.2	2.0	2.8	1.3	61.9	2.9	0.0	1.5	0.0	77.8	109.7	14.2	0.3	34.7	28.6	36.7	4.9	8.8	1.0	0.7	0.1	0.0	6.0	3.6	23.5	132.1	74.4	42.9	32.6	2.5	27.7	7.2	1.7	46.0	5.4	61.5	1.6	3.2	0.3	1.8	0.8	1.9	14.9	81.6	9.1
PARN	DAN	ENSG00000140694	"Poly(A)-specific ribonuclease"	O95453	16	14435700-14632728	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"Nonsense-mediated mRNA decay"	"Exonuclease, Hydrolase, Nuclease, RNA-binding"	"Disease variant, Dyskeratosis congenita"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006314, CAB011673, HPA012010"	Supported		Supported	"Nuclear speckles"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	"Nuclear speckles"		"CAB011673: AB_778216, HPA006314: AB_1079567, HPA012010: AB_1854976"	"unprognostic (2.54e-1)"	"unprognostic (3.43e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.23e-1)"	"unprognostic (2.28e-1)"	"prognostic unfavorable (4.64e-4)"	"unprognostic (2.99e-3)"	"unprognostic (5.07e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.94e-1)"	"unprognostic (2.16e-3)"	"unprognostic (1.75e-1)"	"unprognostic (1.52e-1)"	"unprognostic (3.25e-2)"	"unprognostic (2.46e-1)"	"unprognostic (3.10e-3)"	"unprognostic (1.09e-2)"	16.6	20.2	10.8	13.9	12.1	9.2	15.9	11.7	11.4	17.2	12.0	19.3	11.8	19.1	24.7	15.6	16.0	13.4	14.8	10.6	14.0	12.7	16.4	14.2	21.2	11.7	11.9	16.4	16.5	21.1	16.3	15.6	11.9	16.1	16.8	7.0	15.3	17.1	16.8	17.9	16.1	18.0	11.3	15.7	16.2	18.1	12.6	21.6	20.6	9.7	23.4	19.3	16.0	13.5	28.0	39.9	17.6	22.9	32.9	33.2	20.3	24.4	32.4	29.8	28.3	21.9	28.7	56.2	63.1	32.3	25.3	30.4	46.7	32.3	41.0	42.9	29.4	28.8	24.2	53.2	35.5	46.0	36.2	32.5	38.5	32.0	43.1	25.5	22.5	32.6	28.5	29.9	32.5	44.9	36.7	33.1	26.0	28.2	16.7	56.2	36.1	57.1	23.1	17.1	18.7	16.9	53.4	29.6	36.3	28.6	31.6	28.0	21.2	31.5	15.8	16.4	26.9	32.5	31.0	63.5	34.6	30.8	35.8	8.9	8.0	15.8	8.6	13.2	7.7	16.0	10.4	12.4	13.6	9.4	14.2	14.4	6.2	15.0	15.6	8.3	19.1	7.1	10.8	12.1	11.7	11.4	10.6	14.0	11.7	11.9	11.9	11.3	12.6	13.5	18.0	32.1	39.1	37.9	26.2	7.1	7.8	9.7	21.6	13.0	13.4	14.0	22.3	7.2	11.8	11.0	8.4	29.2	24.7	13.6	11.7	14.2	14.1	15.2	20.5	15.2	14.9	20.4	48.0	12.9	23.2	19.5	21.9	21.7	2.5	19.2	11.7	15.6	14.8	8.4	48.2	14.3	6.1	14.2	5.8	6.3	21.1	18.2	10.6	54.4	35.8	10.3	52.5	38.2	72.4	15.2	10.6	17.7	23.0	7.1	12.2	10.8	19.2	10.8	19.7	13.1	15.0	70.5	70.5	20.0	8.2	22.4	21.5	20.1	13.4	4.8
PARP10	"ARTD10, FLJ14464"	ENSG00000178685	"Poly(ADP-ribose) polymerase family member 10"	Q53GL7	8	143977153-144012772	"Metabolic proteins, Predicted intracellular proteins"	"DNA damage, DNA repair"	"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"plasmacytoid DC: 16.5"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"							"HPA028122, HPA052427"	Approved		Supported	"Nucleoli rim,Golgi apparatus,Cytosol"		No	No			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Nucleoli rim"	"Golgi apparatus, Cytosol"	"HPA028122: AB_10601979, HPA052427: AB_2681828"	"unprognostic (9.80e-3)"	"unprognostic (5.89e-2)"	"unprognostic (2.63e-3)"	"unprognostic (9.10e-2)"	"unprognostic (1.74e-2)"	"unprognostic (1.46e-2)"	"unprognostic (7.37e-2)"	"unprognostic (3.61e-1)"	"unprognostic (9.05e-2)"	"unprognostic (7.17e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.05e-1)"	"unprognostic (4.69e-3)"	"unprognostic (1.09e-3)"	"unprognostic (4.17e-2)"	"unprognostic (8.69e-2)"	"unprognostic (5.30e-3)"	25.2	34.9	10.0	36.3	10.6	23.7	24.6	9.8	13.2	31.8	10.4	33.2	28.4	29.1	3.7	21.5	35.7	9.9	13.8	9.0	10.4	38.4	39.7	34.7	35.8	16.0	11.0	40.6	21.7	6.2	26.0	10.2	12.5	35.7	4.9	6.4	38.3	16.6	18.3	23.1	35.4	7.3	13.3	61.2	25.6	35.4	12.3	34.2	29.4	4.5	10.6	17.8	25.1	11.9	17.8	1.8	1.2	3.3	8.4	7.3	9.3	3.0	3.7	18.7	21.0	0.9	29.6	21.9	39.8	9.2	21.4	6.7	0.4	10.1	0.8	49.5	0.1	24.1	10.8	11.0	7.8	9.5	27.7	4.7	9.9	9.3	3.8	2.1	2.9	30.6	0.4	16.9	3.7	21.4	33.4	16.5	1.0	0.2	13.9	30.8	3.5	29.4	7.7	21.6	1.0	1.1	19.8	2.0	38.8	0.4	22.0	13.9	13.1	9.6	14.2	16.4	10.9	28.4	18.3	5.1	13.9	31.6	5.3	0.0	2.4	3.6	4.4	2.8	2.7	1.1	2.1	3.6	2.3	2.0	1.5	2.4	1.0	1.8	2.8	16.5	1.5	3.5	10.0	10.6	9.8	13.2	9.0	10.4	16.0	11.0	12.5	13.3	12.3	11.9	22.3	3.2	5.2	10.4	19.1	7.6	8.2	10.7	17.6	5.7	12.3	16.0	3.2	7.2	6.3	9.2	14.6	2.2	42.2	20.5	1.9	9.2	6.2	12.0	12.7	10.7	19.2	5.7	0.4	5.6	4.0	12.7	23.9	13.3	19.1	25.9	9.3	21.1	12.0	0.0	0.6	17.3	6.1	16.6	6.8	7.9	15.8	21.4	7.2	12.2	25.8	13.4	34.0	4.5	1.0	6.5	13.8	11.3	15.2	4.5	22.0	25.1	6.7	20.4	6.6	11.7	13.4	19.6	9.1	10.4	4.7	1.4	27.0	17.7	16.4	4.0
PARP11	"ARTD11, C12orf6"	ENSG00000111224	"Poly(ADP-ribose) polymerase family member 11"	Q9NR21	12	3791047-3873448	"Metabolic proteins, Predicted intracellular proteins"	"Differentiation, mRNA transport, Protein transport, Spermatogenesis, Translocation, Transport"	"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 61.5;Granulosa cells: 72.0;Late spermatids: 45.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026895	Uncertain		Supported	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 40: Granulosa cells - Unknown function"	"Nuclear bodies"	"Nucleoplasm, Cytosol"	"HPA026895: AB_1854980"	"unprognostic (9.58e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.88e-1)"	"unprognostic (4.12e-2)"	"unprognostic (6.14e-2)"	"unprognostic (1.49e-2)"	"unprognostic (2.53e-1)"	"unprognostic (2.61e-1)"	"unprognostic (3.58e-2)"	"unprognostic (2.32e-2)"	"unprognostic (2.50e-1)"	"unprognostic (2.11e-1)"	"unprognostic (7.52e-2)"	"unprognostic (3.81e-2)"	"unprognostic (2.87e-2)"	3.4	5.0	2.7	5.0	2.9	3.2	5.3	2.0	2.9	4.2	2.0	3.6	3.7	6.5	5.4	3.1	4.1	4.0	2.3	2.5	3.4	3.9	4.5	3.8	10.2	3.4	3.2	8.2	2.5	7.8	1.8	3.2	3.3	8.6	4.1	3.3	4.0	4.2	1.8	2.2	3.7	5.2	2.8	6.2	3.3	9.4	3.5	10.4	9.1	2.9	9.4	5.0	1.9	3.5	2.7	2.3	14.0	2.3	4.4	7.2	4.1	3.3	5.5	5.6	5.7	8.7	2.2	8.0	2.0	6.4	6.6	2.2	4.8	4.8	9.0	16.1	4.9	12.0	0.0	6.5	5.1	8.1	4.4	5.9	3.8	4.4	12.4	0.0	4.4	15.3	3.1	6.5	8.1	4.0	4.2	3.1	5.2	2.9	0.3	8.3	9.8	1.8	2.6	6.3	0.9	2.9	3.1	2.8	4.2	15.1	0.5	7.1	8.5	4.9	4.8	7.3	4.4	3.1	7.3	11.7	4.6	4.4	1.2	20.3	8.9	9.2	7.4	7.4	10.0	10.0	8.3	5.5	8.9	8.8	9.2	7.5	8.5	7.7	6.1	7.8	3.7	6.2	2.7	2.9	2.0	2.9	2.5	3.4	3.4	3.2	3.3	2.8	3.5	3.5	8.6	9.6	9.5	16.0	18.3	1.9	4.4	6.7	7.4	10.6	5.7	4.1	3.8	2.8	4.5	1.8	2.1	4.2	17.7	2.6	0.0	3.4	61.5	2.1	9.6	5.3	3.6	12.0	30.8	3.1	1.6	8.4	1.1	1.9	14.7	72.0	6.8	4.1	7.1	3.3	30.8	4.7	2.0	9.8	5.8	45.1	10.5	9.7	1.8	18.7	10.3	5.4	17.5	32.6	18.8	3.3	7.6	8.6	3.7	6.6	2.6	4.1	6.0	6.4	6.6	7.0	9.8	9.9	10.9	3.6	1.8	2.6	15.0	8.9	5.0	3.4
PARP14	"ARTD8, KIAA1268, pART8"	ENSG00000173193	"Poly(ADP-ribose) polymerase family member 14"	Q460N5	3	122680839-122730840	"Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Immunity, Innate immunity, Transcription, Transcription regulation"	"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 246.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+: 74.7;BJ hTERT+ SV40 Large T+ RasG12V: 113.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA008846, HPA012063"	Supported		Supported	Cytosol		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 64: Macrophages - Immune response"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 44: Endometrium - Transcription"	Cytosol		"HPA008846: AB_1854982, HPA012063: AB_1854981"	"unprognostic (4.38e-2)"	"unprognostic (1.07e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.95e-2)"	"unprognostic (2.56e-1)"	"unprognostic (2.50e-3)"	"unprognostic (1.87e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.44e-1)"	"unprognostic (4.20e-2)"	"unprognostic (1.74e-3)"	"unprognostic (1.62e-2)"	"prognostic unfavorable (1.79e-4)"	"unprognostic (7.87e-2)"	"unprognostic (3.82e-2)"	"unprognostic (1.58e-3)"	"unprognostic (1.71e-2)"	14.0	12.6	4.3	24.3	5.1	20.1	11.3	3.6	2.7	11.4	5.5	11.5	15.3	8.2	2.4	9.0	10.7	15.2	11.1	2.8	5.1	14.9	24.5	33.5	24.0	15.1	5.9	9.2	7.8	7.3	7.6	17.8	8.6	13.0	8.7	1.1	11.7	7.2	5.0	5.3	17.5	10.2	10.9	37.4	11.7	2.2	8.9	15.4	14.7	8.3	26.8	13.7	9.4	7.8	15.6	13.0	8.0	8.3	9.1	26.2	0.0	6.1	40.1	74.7	113.1	6.9	28.7	0.0	24.2	13.4	41.8	11.5	11.9	11.6	15.0	24.0	1.5	14.6	5.8	8.7	20.4	6.4	6.8	14.7	4.7	13.0	4.8	16.4	32.2	12.3	7.0	22.7	2.1	7.9	24.8	1.5	1.1	2.1	11.1	34.2	8.3	4.3	9.5	16.2	0.6	0.0	15.3	3.1	14.1	0.8	5.7	9.3	22.0	4.0	9.4	2.3	5.5	8.7	1.6	2.7	12.0	13.8	7.2	13.1	10.8	5.8	8.6	13.7	7.2	12.8	4.5	5.6	5.6	20.3	3.6	4.1	29.5	9.5	14.7	0.7	9.9	4.3	4.3	5.1	3.6	2.7	2.8	5.1	15.1	5.9	8.6	10.9	8.9	7.8	111.5	246.8	98.4	17.3	115.3	16.8	17.0	35.9	13.1	2.1	19.6	15.6	14.6	24.3	65.9	25.8	4.2	14.1	64.9	43.0	3.9	36.0	0.3	118.8	59.8	94.7	10.7	18.5	0.5	41.2	28.4	37.2	24.5	149.8	32.2	69.6	67.1	32.5	36.5	0.0	3.0	18.2	26.4	61.6	39.9	2.1	28.0	83.9	16.0	124.6	132.2	15.1	58.7	47.3	1.1	44.0	20.2	17.3	50.9	31.8	29.5	11.5	73.0	1.0	13.1	32.7	30.3	1.9	1.1	13.7	10.5	4.8	51.4	42.8	16.0	25.9
PARP2	"ADPRTL2, ARTD2"	ENSG00000129484	"Poly(ADP-ribose) polymerase 2"	Q9UGN5	14	20343615-20357904	"Enzymes, FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins"	"DNA damage, DNA repair"	"DNA-binding, Glycosyltransferase, Transferase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052003	Approved		Supported	Nucleoplasm,Nucleoli		NA	Yes			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 54: Non-specific - Microtubule organization"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm	Nucleoli	"HPA052003: AB_2681689"	"unprognostic (3.93e-1)"	"unprognostic (7.92e-2)"	"unprognostic (4.12e-1)"	"unprognostic (1.24e-1)"	"unprognostic (3.40e-2)"	"unprognostic (7.30e-2)"	"prognostic unfavorable (6.48e-4)"	"unprognostic (1.97e-2)"	"unprognostic (4.43e-2)"	"unprognostic (9.35e-3)"	"unprognostic (1.44e-2)"	"unprognostic (1.42e-2)"	"unprognostic (3.37e-3)"	"unprognostic (2.83e-1)"	"unprognostic (9.19e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.89e-2)"	17.7	21.1	21.1	10.7	22.0	26.8	17.5	21.4	31.4	18.1	16.4	19.3	12.8	20.9	17.8	14.6	17.5	10.0	17.1	22.5	21.0	15.5	17.2	13.5	14.5	19.5	18.9	22.9	17.9	11.1	21.0	12.9	19.8	13.9	14.0	26.4	14.2	13.4	32.4	19.2	14.2	15.8	19.0	16.5	16.3	23.8	19.8	11.9	16.7	27.1	17.9	13.8	15.3	22.1	55.5	39.5	59.7	45.3	19.4	18.4	43.4	60.2	32.5	74.8	91.8	36.8	51.3	40.4	26.5	19.0	64.8	50.1	78.3	27.5	87.8	32.4	38.3	37.2	46.6	63.3	17.3	77.9	20.4	12.5	23.0	45.5	51.1	20.5	38.5	48.0	39.2	53.4	52.3	33.5	40.1	33.0	33.0	62.8	60.0	49.7	79.7	26.5	30.0	28.2	41.3	28.3	65.3	36.8	17.9	37.4	34.2	25.8	26.6	45.3	68.1	31.5	48.1	49.3	67.7	53.4	19.0	33.3	51.4	1.9	5.0	0.5	8.9	4.8	11.7	6.8	8.4	7.9	5.5	4.1	9.0	8.6	0.1	7.6	2.6	5.6	5.3	4.8	21.1	22.0	21.4	31.4	22.5	21.0	19.5	18.9	19.8	19.0	19.8	22.1	12.1	25.6	6.5	7.2	9.5	6.5	10.5	16.1	18.8	29.2	7.4	10.0	14.0	5.7	19.9	7.3	12.5	25.8	10.2	4.5	7.9	12.8	9.3	9.9	13.3	11.0	4.8	30.3	17.6	8.7	22.2	11.6	7.7	11.3	8.2	18.4	6.8	10.1	11.9	30.3	15.5	5.0	14.2	4.6	5.1	9.8	11.5	6.6	8.8	9.4	4.2	20.7	6.2	6.0	9.3	10.1	4.5	17.0	19.1	4.5	5.3	7.4	28.0	23.2	6.6	9.8	18.5	20.9	41.5	11.3	4.8	14.9	6.2	16.7	7.4	7.0
PARP3	"ADPRT3, ADPRTL3, ARTD3, hPARP-3, IRT1, pADPRT-3"	ENSG00000041880	"Poly(ADP-ribose) polymerase family member 3"	Q9Y6F1	3	51942345-51948867	"FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins"	"DNA damage, DNA repair"	"Glycosyltransferase, Transferase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Proximal enterocytes: 33.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020984, HPA067657"	Supported		Supported	"Nucleoplasm,Nuclear bodies"		Yes	No			"Cluster 15: NK-cells - Transcription"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 45: Enterocytes - Digestion"	"Nucleoplasm, Nuclear bodies"		"HPA020984: , HPA067657: AB_2685881"	"prognostic favorable (6.39e-5)"	"unprognostic (1.25e-1)"	"unprognostic (1.54e-2)"	"unprognostic (2.85e-2)"	"unprognostic (7.31e-2)"	"unprognostic (1.56e-1)"	"unprognostic (4.13e-1)"	"unprognostic (3.53e-2)"	"unprognostic (2.26e-1)"	"unprognostic (2.01e-1)"	"unprognostic (7.44e-3)"	"unprognostic (4.30e-1)"	"prognostic favorable (1.25e-8)"	"unprognostic (5.63e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.40e-2)"	"unprognostic (4.65e-3)"	16.0	33.4	12.7	9.9	13.5	3.1	15.3	12.9	14.6	9.6	14.4	17.1	28.1	11.4	5.9	10.4	11.2	11.3	13.6	11.6	14.2	21.2	29.2	13.4	10.9	13.8	14.9	8.9	4.4	35.8	10.9	5.9	13.7	14.6	10.2	4.7	14.5	15.5	15.8	7.5	25.2	9.3	12.9	14.8	16.4	5.4	14.9	8.2	19.6	17.6	8.0	15.4	10.8	12.4	10.0	6.6	2.0	17.3	17.8	30.0	4.8	15.4	29.0	23.1	24.9	3.9	28.1	14.1	4.5	29.4	12.6	1.6	5.0	14.5	9.1	34.8	1.2	7.8	15.1	13.2	18.8	5.3	10.9	24.4	12.4	16.2	9.1	35.7	10.8	10.2	3.5	14.7	19.9	3.4	4.6	12.5	2.4	4.2	16.4	7.3	2.8	13.9	14.0	13.5	2.0	6.4	16.3	4.8	10.7	1.4	6.5	5.9	24.0	42.5	9.9	7.4	10.4	22.5	26.0	6.0	27.2	14.4	13.6	0.0	1.6	1.2	2.4	3.0	2.2	6.3	2.6	1.8	2.6	2.5	3.6	3.5	0.1	5.7	1.6	0.9	3.2	1.8	12.7	13.5	12.9	14.6	11.6	14.2	13.8	14.9	13.7	12.9	14.9	12.4	5.3	6.4	10.0	6.2	8.1	2.7	10.6	15.9	21.1	2.0	8.6	8.9	7.4	8.6	8.6	0.0	0.0	0.6	2.1	13.1	7.9	9.7	7.8	2.4	3.8	5.3	3.0	1.7	2.6	6.3	0.4	4.7	17.3	2.7	4.5	0.8	2.5	9.5	3.7	0.0	3.0	11.3	6.1	3.2	2.2	15.3	4.7	3.7	7.2	3.7	5.0	3.8	0.0	1.0	1.8	11.5	6.5	1.5	4.9	4.3	33.4	20.6	9.5	2.1	6.6	4.1	5.7	3.4	3.3	7.8	1.4	0.5	5.9	1.6	13.8	9.3
PARP4	"ADPRTL1, ARTD4, p193, VAULT3, VPARP, VWA5C"	ENSG00000102699	"Poly(ADP-ribose) polymerase family member 4"	Q9UKK3	13	24420931-24512778	"Metabolic proteins, Predicted intracellular proteins"		"Glycosyltransferase, Ribonucleoprotein, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"granulocytes: 99.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA011739	Approved		Supported	Nucleoplasm,Cytosol		Yes	No			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 9: Intestine - Unknown function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 11: Alveolar cells - Smell perception"	Nucleoplasm	Cytosol	"HPA011739: AB_1854986"	"unprognostic (1.61e-1)"	"unprognostic (2.34e-2)"	"unprognostic (1.62e-2)"	"unprognostic (4.35e-2)"	"unprognostic (2.46e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.20e-1)"	"unprognostic (2.52e-1)"	"unprognostic (2.45e-1)"	"unprognostic (2.02e-2)"	"unprognostic (4.12e-3)"	"unprognostic (2.97e-2)"	"prognostic favorable (1.21e-5)"	"unprognostic (3.23e-2)"	"unprognostic (1.71e-1)"	"unprognostic (3.80e-2)"	"unprognostic (2.84e-3)"	18.6	22.8	8.4	24.2	11.9	22.1	16.7	11.2	8.2	24.3	12.1	38.7	38.9	17.9	18.0	22.0	21.1	29.5	12.7	7.5	10.4	26.9	24.9	28.7	23.6	15.6	11.3	18.6	14.8	18.5	5.8	15.9	15.2	13.1	39.5	8.3	16.8	18.6	6.4	11.0	39.1	19.5	11.3	26.3	34.4	9.0	11.8	21.6	21.2	11.3	25.2	28.3	14.0	15.6	42.9	37.7	18.1	32.7	48.7	68.8	15.3	48.7	63.5	41.8	37.1	15.5	108.5	32.0	47.3	44.5	46.3	48.5	27.2	49.4	34.1	73.7	19.0	45.9	33.0	35.9	27.8	59.3	43.3	39.9	16.3	34.6	18.3	81.4	69.7	24.5	13.2	13.8	50.2	19.9	37.6	28.5	20.5	100.6	45.9	35.0	33.8	45.0	77.6	86.7	16.4	20.9	35.7	14.2	33.5	23.4	7.1	48.2	99.7	18.9	19.8	24.4	50.4	15.6	19.3	41.4	34.3	30.6	42.1	50.0	21.1	45.9	20.4	25.7	20.4	14.2	16.8	20.5	27.9	8.0	12.2	14.8	24.0	21.1	34.6	10.4	21.9	20.1	8.4	11.9	11.2	8.2	7.5	10.4	15.6	11.3	15.2	11.3	11.8	15.6	20.5	51.3	51.8	21.2	20.5	2.8	6.9	29.2	6.2	6.3	10.2	5.8	17.6	17.2	52.6	25.8	2.1	5.0	33.8	74.2	5.9	26.1	5.4	35.9	19.4	19.8	4.9	13.9	1.5	22.5	8.9	18.3	42.8	50.9	99.2	30.7	31.1	16.0	17.7	1.7	2.1	27.0	18.3	23.4	6.9	4.7	11.8	35.3	8.8	36.5	37.1	6.7	36.0	21.1	40.8	30.9	53.8	8.2	27.0	10.6	59.7	18.2	69.7	7.4	6.6	12.2	10.4	2.5	8.9	13.5	3.8	1.9	28.9	24.1	30.8	20.5
PARP9	"ARTD9, BAL, BAL1"	ENSG00000138496	"Poly(ADP-ribose) polymerase family member 9"	Q8IXQ6	3	122527924-122564577	"Disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Antiviral defense, DNA damage, DNA repair, Immunity, Innate immunity"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+: 95.8;BJ hTERT+ SV40 Large T+ RasG12V: 113.4;SK-MEL-30: 93.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA066708			Supported	Nucleoplasm,Mitochondria,Cytosol		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 64: Macrophages - Immune response"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Nucleoplasm, Cytosol"	Mitochondria	"HPA066708: AB_2685707"	"unprognostic (3.06e-2)"	"unprognostic (4.80e-2)"	"unprognostic (1.55e-3)"	"unprognostic (6.70e-3)"	"unprognostic (1.11e-1)"	"unprognostic (6.38e-2)"	"unprognostic (4.73e-3)"	"unprognostic (3.39e-3)"	"unprognostic (1.31e-1)"	"prognostic favorable (6.65e-4)"	"unprognostic (1.00e-3)"	"unprognostic (5.63e-3)"	"unprognostic (1.56e-3)"	"unprognostic (3.06e-2)"	"unprognostic (3.70e-2)"	"unprognostic (9.65e-3)"	"unprognostic (1.56e-2)"	20.1	29.4	14.0	35.8	15.1	20.8	17.6	13.8	17.4	20.3	14.8	22.5	21.2	19.6	19.1	24.8	20.1	28.8	18.3	13.5	15.1	22.0	68.3	36.5	30.5	21.3	15.5	12.9	22.0	23.7	18.5	20.1	16.8	18.9	19.5	5.8	39.9	12.6	13.6	11.6	21.4	29.1	17.6	44.3	20.0	6.4	17.4	30.6	16.8	17.3	25.9	26.0	16.5	16.1	23.1	7.7	2.8	1.9	16.9	34.6	2.6	7.6	41.0	95.8	113.4	12.0	24.9	5.2	16.4	15.3	60.2	24.8	6.6	13.4	19.9	40.3	4.5	24.9	7.6	6.4	18.0	8.1	15.9	28.4	12.9	13.6	3.4	19.1	20.8	15.7	2.3	20.7	3.9	10.2	26.0	10.1	1.1	4.7	21.1	27.3	27.2	1.7	37.0	13.1	1.7	6.6	20.2	3.3	93.8	1.5	10.7	9.0	12.6	4.1	11.8	0.9	4.7	12.8	7.1	9.5	14.1	8.7	7.7	41.9	29.9	36.9	19.8	41.1	18.5	15.9	20.6	22.3	27.5	11.4	15.6	19.3	87.5	30.2	45.2	3.3	24.9	23.3	14.0	15.1	13.8	17.4	13.5	15.1	21.3	15.5	16.8	17.6	17.4	16.1	37.0	41.7	44.2	13.4	18.9	7.1	10.8	13.8	12.5	0.8	10.5	6.3	5.8	10.0	35.1	20.2	0.0	5.2	14.0	32.5	1.9	30.4	1.6	23.6	28.1	37.4	10.7	19.0	0.3	39.9	19.3	19.9	22.4	23.2	10.1	19.5	21.8	50.1	42.0	0.0	1.3	11.5	10.2	32.3	9.2	4.5	18.3	41.2	7.2	45.0	50.2	12.1	32.0	17.1	3.9	36.8	11.7	24.0	13.6	8.9	17.5	19.3	48.8	1.0	19.7	18.9	16.3	0.9	1.9	15.7	6.7	1.6	23.5	17.0	8.6	14.4
PARPBP	"C12orf48, FLJ20641, PARI"	ENSG00000185480	"PARP1 binding protein"	Q9NWS1	12	102120183-102197520	"Predicted intracellular proteins"	"DNA damage, DNA repair"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 9.3;lymphoid tissue: 7.5"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 20.0;Spermatogonia: 17.7"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA039677	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"HPA039677: AB_10673426"	"unprognostic (7.84e-3)"	"unprognostic (1.34e-2)"	"unprognostic (4.54e-3)"	"unprognostic (3.03e-2)"	"unprognostic (1.84e-1)"	"unprognostic (3.03e-1)"	"unprognostic (1.30e-5)"	"unprognostic (2.52e-3)"	"prognostic unfavorable (3.17e-4)"	"unprognostic (2.38e-1)"	"unprognostic (3.95e-3)"	"unprognostic (2.83e-1)"	"unprognostic (5.61e-8)"	"unprognostic (3.50e-3)"	"unprognostic (2.34e-1)"	"unprognostic (9.16e-3)"	"unprognostic (6.14e-2)"	0.8	0.6	0.2	3.1	0.2	9.3	1.8	0.3	0.4	1.2	0.1	3.0	2.3	1.2	0.5	3.6	0.6	1.1	0.4	0.3	0.4	0.8	0.6	0.6	4.2	0.3	0.4	0.7	0.2	0.3	0.2	2.3	0.3	1.0	3.8	0.2	0.9	0.9	0.4	1.9	2.7	1.7	0.3	1.2	1.8	3.9	0.3	7.5	0.5	0.3	5.1	1.9	1.1	0.3	13.5	27.2	23.6	13.7	3.8	3.4	16.7	19.9	11.0	32.0	27.9	14.8	10.4	25.4	11.4	7.8	16.2	14.5	38.5	11.7	34.2	25.7	22.6	31.9	15.7	13.9	1.1	33.5	9.1	3.3	2.8	22.3	14.4	8.3	21.6	18.9	31.0	15.3	21.1	10.7	30.5	31.1	31.7	17.8	26.6	20.4	38.9	16.7	10.3	21.1	15.9	14.7	13.8	16.6	11.8	24.0	27.1	12.1	8.5	16.5	15.7	20.2	25.3	11.3	24.8	22.8	11.4	33.7	22.4	2.6	0.4	1.0	0.5	0.6	0.1	1.1	0.9	0.8	0.7	0.7	0.5	0.6	0.0	0.5	0.4	0.7	1.8	0.7	0.2	0.2	0.3	0.4	0.3	0.4	0.3	0.4	0.3	0.3	0.3	0.3	1.1	0.0	0.0	2.9	4.3	3.7	1.5	3.6	0.6	1.9	2.4	2.4	0.7	1.5	2.5	1.8	0.0	11.3	2.3	1.5	5.9	1.6	2.5	3.0	11.6	2.5	1.8	20.0	4.1	1.3	13.9	4.8	6.1	3.0	5.7	15.0	2.2	0.1	6.5	3.3	5.3	3.1	10.2	5.7	4.3	2.6	1.2	3.1	0.0	3.7	1.7	0.2	2.1	3.5	4.1	1.2	0.8	0.4	14.2	0.7	1.3	1.8	1.4	0.9	0.0	1.1	2.8	16.0	17.7	9.8	1.6	3.6	4.1	9.3	7.8	1.6
PARVA	"FLJ10793, FLJ12254, MXRA2"	ENSG00000197702	"Parvin alpha"	Q9NVD7	11	12377563-12535356	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Angiogenesis, Cell adhesion, Cell shape, Chemotaxis, Cilium biogenesis/degradation"	Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"MAIT T-cell: 1.0"	"Lineage enriched"	"Detected in single"	11	"T-cells: 1.0"	"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 229.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005964	Approved		Supported	"Actin filaments,Focal adhesion sites,Cytosol"		NA	NA		7300000	"Cluster 16: MAIT-cells - Unknown function"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 33: Fibroblasts - ECM organization"	"Actin filaments, Focal adhesion sites"	Cytosol	"HPA005964: AB_1079569"	"unprognostic (3.87e-2)"	"unprognostic (7.38e-2)"	"unprognostic (3.30e-2)"	"prognostic favorable (1.76e-4)"	"unprognostic (7.37e-3)"	"unprognostic (1.38e-2)"	"unprognostic (6.78e-2)"	"prognostic unfavorable (8.19e-4)"	"unprognostic (1.76e-2)"	"unprognostic (2.80e-2)"	"unprognostic (1.70e-2)"	"unprognostic (9.82e-2)"	"unprognostic (6.73e-2)"	"unprognostic (6.58e-3)"	"unprognostic (1.35e-1)"	"unprognostic (1.50e-1)"	"unprognostic (3.82e-2)"	61.8	17.6	9.3	22.7	9.0	0.1	40.9	7.2	10.1	53.9	16.5	92.4	17.5	71.8	16.7	42.8	38.8	31.9	34.3	9.8	11.6	23.0	16.9	28.8	6.4	11.0	7.3	31.9	36.0	16.9	11.7	35.9	8.4	50.6	38.4	8.9	20.9	68.9	8.1	14.0	26.1	95.5	11.3	11.3	42.5	6.8	8.6	4.6	17.9	11.7	9.1	55.0	28.2	11.0	34.0	33.1	30.2	39.4	147.8	110.6	69.1	126.5	130.1	87.7	81.6	24.7	51.8	0.0	41.1	229.5	9.9	20.7	0.4	66.4	104.0	0.6	14.9	0.1	42.4	18.7	114.7	0.1	0.9	91.3	22.3	37.1	57.4	107.5	110.9	0.0	0.1	0.3	131.8	20.4	0.0	0.2	14.2	20.2	26.4	0.0	75.2	0.2	44.9	32.8	4.8	0.1	97.6	39.1	65.5	66.9	18.4	0.9	138.2	105.1	43.8	57.2	35.4	0.1	0.1	0.2	58.5	0.1	118.3	0.0	0.0	0.0	0.1	0.0	1.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.3	9.0	7.2	10.1	9.8	11.6	11.0	7.3	8.4	11.3	8.6	11.0	37.0	99.3	33.0	47.3	1.1	13.8	25.0	29.3	20.5	4.3	24.4	24.8	45.1	18.6	27.0	27.6	0.0	39.9	0.7	39.6	39.2	56.1	0.9	26.9	62.5	33.3	27.1	0.0	31.4	67.1	92.2	59.1	24.5	35.9	5.1	34.8	39.7	19.1	6.5	0.0	34.9	26.2	18.3	1.8	8.8	2.5	41.0	2.0	46.2	36.5	1.0	25.3	0.0	30.7	1.0	51.7	25.4	51.9	0.2	33.5	23.1	38.1	54.8	2.5	52.6	32.6	60.6	1.1	3.4	20.2	8.9	19.0	2.3	25.1	32.4	25.1
PASK	"KIAA0135, PASKIN, STK37"	ENSG00000115687	"PAS domain containing serine/threonine kinase"	Q96RG2	2	241106099-241150264	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 19.8;lymphoid tissue: 22.9"	"Cell type enhanced"	"Detected in many"		"Peritubular cells: 24.5;Theca cells: 26.5"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in many"		"basal ganglia: 19.8"	"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA016450, HPA021079"	Uncertain		Supported	Cytosol		NA	Yes			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 14: REH - Unknown function"	"Cluster 63: NK-cells & T-cells - Immune response"	Cytosol		"HPA016450: AB_1854992, HPA021079: AB_1854993"	"unprognostic (1.76e-2)"	"unprognostic (1.29e-2)"	"unprognostic (2.84e-1)"	"unprognostic (1.41e-2)"	"unprognostic (1.14e-1)"	"unprognostic (8.99e-6)"	"unprognostic (1.80e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.60e-3)"	"unprognostic (1.58e-2)"	"unprognostic (1.02e-2)"	"unprognostic (6.35e-2)"	"unprognostic (7.12e-2)"	"unprognostic (1.52e-3)"	"unprognostic (1.68e-1)"	"unprognostic (6.44e-2)"	"unprognostic (4.38e-3)"	1.6	1.1	3.7	7.1	19.8	8.8	2.1	1.0	5.3	2.5	3.1	2.4	3.4	2.1	3.9	3.3	6.1	2.0	1.1	2.7	1.7	3.7	1.4	3.2	13.7	1.9	1.9	1.9	3.6	2.4	4.6	1.0	1.8	10.0	2.3	11.9	2.9	1.4	0.8	4.1	4.5	1.2	0.3	4.1	3.0	16.1	3.2	22.9	5.1	0.2	7.8	2.1	2.2	5.2	7.4	9.9	12.9	16.7	1.1	1.9	17.4	7.0	2.2	6.3	8.8	8.1	7.4	3.8	1.4	1.5	13.8	17.9	15.1	6.1	4.6	15.6	13.8	10.6	19.1	14.4	0.8	14.7	16.0	0.9	4.7	6.5	1.9	2.6	4.6	16.2	14.0	5.2	4.5	8.0	17.5	15.4	14.6	8.8	5.9	27.5	13.3	4.7	2.5	16.0	23.1	7.0	3.9	8.0	3.2	6.8	6.7	10.5	6.1	8.8	7.7	11.1	9.6	6.8	7.4	18.1	5.4	10.9	8.2	4.4	0.6	0.5	1.0	0.4	0.9	4.5	3.9	3.5	0.8	3.9	2.3	2.6	0.8	1.9	0.7	0.4	4.1	2.2	3.7	19.8	1.0	5.3	2.7	1.7	1.9	1.9	1.8	0.3	3.2	5.2	2.3	3.2	7.9	2.6	8.5	2.7	1.2	1.6	2.2	2.6	3.5	4.3	3.1	2.8	1.9	3.7	4.2	0.9	2.2	3.1	0.0	1.5	14.9	13.9	1.6	8.5	0.0	13.3	12.5	2.0	1.7	2.7	3.6	4.4	3.8	11.7	17.5	1.5	2.0	1.7	6.1	3.5	0.0	4.7	2.0	3.5	5.9	2.1	12.4	3.7	2.7	2.1	7.2	0.5	2.6	0.9	1.0	24.5	4.7	1.7	1.9	1.4	12.3	18.7	0.0	2.1	2.1	16.1	12.7	2.6	1.4	0.3	19.1	26.5	3.9	0.9
PATJ	"Cipp, INADL"	ENSG00000132849	"PATJ crumbs cell polarity complex component"	Q8NI35	1	61742477-62178675	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 75.0"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 86.6;Alveolar cells type 2: 60.6;Club cells: 39.0;Collecting duct cells: 57.0;Endometrial ciliated cells: 55.7;Glandular and luminal cells: 98.3;Pancreatic endocrine cells: 47.9"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	5	"cerebellum: 75.0"	"Immune cell enhanced"	"Detected in many"		"eosinophil: 7.2"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"A-431: 36.3;RPTEC TERT1: 30.3;RT4: 33.4"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"cerebellum: 72.3"	"HPA066352, HPA066960, HPA069079"	Approved		Supported	"Cell Junctions,Centriolar satellite,Cytosol"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 54: Non-specific - Microtubule organization"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 44: Endometrium - Transcription"	"Cell Junctions"	"Centriolar satellite, Cytosol"	"HPA066352: AB_2685663, HPA066960: AB_2685755, HPA069079: AB_2686079"	"unprognostic (1.81e-1)"	"unprognostic (5.70e-3)"	"unprognostic (1.75e-2)"	"unprognostic (2.32e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.35e-1)"	"unprognostic (7.96e-2)"	"unprognostic (7.60e-2)"	"unprognostic (1.88e-1)"	"unprognostic (9.90e-2)"	"unprognostic (3.39e-3)"	"unprognostic (2.99e-2)"	"prognostic favorable (1.47e-5)"	"unprognostic (3.05e-3)"	"unprognostic (6.72e-3)"	"unprognostic (2.21e-2)"	"unprognostic (2.43e-1)"	3.4	7.2	6.8	3.6	5.4	3.5	18.1	75.0	5.3	8.4	25.3	12.2	8.9	5.8	26.5	19.3	8.3	7.1	45.2	3.8	9.2	27.5	12.4	10.0	2.9	12.8	9.0	6.8	12.4	20.0	10.9	3.5	14.2	12.3	11.1	15.8	20.0	7.9	45.4	22.4	9.3	3.5	11.5	3.1	10.2	5.1	9.1	4.0	13.1	16.1	6.2	7.9	13.2	9.5	36.3	7.0	2.3	3.2	1.3	3.3	29.5	2.1	2.8	2.2	3.0	12.5	13.2	0.2	9.1	4.4	18.7	21.1	5.1	18.9	3.8	3.5	8.8	0.2	10.4	11.3	2.9	0.1	0.2	1.2	19.7	3.7	8.0	5.3	1.2	0.0	0.0	0.0	1.9	12.6	0.1	0.1	12.0	16.4	1.9	0.1	2.8	5.2	30.3	33.4	6.1	2.0	8.8	29.4	7.7	23.7	23.7	0.3	0.3	1.8	4.3	0.2	4.2	1.4	2.7	4.8	1.7	0.0	0.5	0.4	0.0	7.2	1.2	0.1	2.3	1.2	2.0	1.7	0.0	1.1	2.6	1.7	0.6	2.6	0.1	0.2	1.9	0.6	6.8	5.4	75.0	5.3	3.8	9.2	12.8	9.0	14.2	11.5	9.1	9.5	6.4	86.6	60.6	0.0	4.5	0.0	0.0	0.0	0.0	0.0	35.0	29.8	0.0	0.0	39.0	57.0	0.0	4.3	3.8	0.0	5.9	37.6	0.0	55.7	8.6	1.6	0.0	0.0	0.0	26.4	0.7	5.5	0.0	98.3	1.3	14.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	47.9	0.0	0.0	2.7	0.0	0.0	35.7	27.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	26.4	10.3	1.7	0.0	0.0
PATL1	"FLJ36874, Pat1b"	ENSG00000166889	"PAT1 homolog 1, processing body mRNA decay factor"	Q86TB9	11	59636716-59669037	"Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039030, HPA074680"	Approved		Supported	"Cytoplasmic bodies"		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 44: Endometrium - Transcription"	"Cytoplasmic bodies"		"HPA039030: AB_10673232, HPA074680: "	"unprognostic (3.00e-2)"	"unprognostic (1.17e-1)"	"prognostic favorable (4.56e-4)"	"unprognostic (3.93e-3)"	"unprognostic (3.03e-2)"	"unprognostic (5.26e-2)"	"unprognostic (6.37e-3)"	"unprognostic (6.74e-3)"	"unprognostic (2.16e-1)"	"unprognostic (7.34e-3)"	"prognostic unfavorable (2.04e-4)"	"unprognostic (3.86e-2)"	"unprognostic (4.54e-2)"	"unprognostic (3.64e-2)"	"unprognostic (3.04e-2)"	"unprognostic (6.99e-2)"	"unprognostic (2.18e-1)"	18.6	17.3	10.1	18.9	11.7	56.6	16.5	11.9	11.8	19.0	12.4	17.5	22.4	18.7	11.6	19.1	14.5	14.6	15.7	9.5	11.3	16.5	33.1	21.4	20.3	12.0	11.1	19.2	11.1	14.2	8.6	21.9	12.4	12.0	20.8	23.5	15.8	12.1	40.8	19.0	19.1	18.5	10.7	18.8	16.8	12.5	11.9	20.3	14.6	32.9	23.7	20.0	18.1	14.0	57.7	44.2	31.9	31.4	30.7	34.3	27.6	37.4	63.8	66.1	66.1	28.7	49.4	56.3	35.6	40.4	64.0	42.1	46.6	45.0	70.4	49.4	21.4	32.4	21.3	28.6	110.1	43.0	69.2	38.9	33.9	56.7	77.3	31.8	32.1	34.2	40.5	44.5	37.9	26.7	41.7	39.1	32.5	41.8	28.9	33.6	53.2	24.2	41.1	52.9	22.8	22.0	52.7	39.1	64.9	26.7	55.6	31.5	31.3	43.0	39.4	75.5	33.5	45.4	53.8	47.6	51.8	35.5	36.1	1.9	2.4	3.4	2.7	2.8	2.2	2.0	2.1	2.4	2.3	1.4	2.0	2.0	3.4	1.6	2.9	1.4	1.9	1.5	10.1	11.7	11.9	11.8	9.5	11.3	12.0	11.1	12.4	10.7	11.9	14.0	13.8	3.2	15.9	10.4	24.1	27.0	18.9	15.8	27.3	10.5	12.7	9.8	13.0	18.6	17.6	11.0	0.0	11.1	16.2	21.7	13.7	14.0	11.8	16.9	21.8	17.6	13.7	12.6	10.7	18.2	14.0	13.2	13.7	28.6	23.4	10.8	10.4	34.5	24.0	6.7	11.2	16.3	2.0	30.8	36.3	4.2	10.8	24.6	10.6	13.1	29.6	7.9	15.5	16.1	18.1	22.8	13.7	9.4	17.4	21.3	16.4	9.4	13.8	10.8	6.6	13.4	12.1	12.0	9.1	25.0	34.1	12.7	18.8	10.1	16.1	19.3
PATZ1	"dJ400N23, MAZR, PATZ, RIAZ, ZBTB19, ZNF278, ZSG"	ENSG00000100105	"POZ/BTB and AT hook containing zinc finger 1"	Q9HBE1	22	31325804-31346346	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047893, HPA048315"	Approved		Supported	Nucleoplasm		No	No			"Cluster 13: T-cells - Unknown function"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 35: Glandular cells - Unknown function"	Nucleoplasm		"HPA047893: AB_2680201, HPA048315: AB_2680353"	"unprognostic (3.25e-1)"	"unprognostic (8.72e-2)"	"unprognostic (1.77e-1)"	"unprognostic (2.88e-3)"	"prognostic favorable (1.06e-4)"	"unprognostic (1.77e-1)"	"unprognostic (8.34e-3)"	"prognostic favorable (8.71e-5)"	"unprognostic (1.14e-1)"	"unprognostic (1.41e-2)"	"unprognostic (1.99e-3)"	"unprognostic (1.76e-1)"	"prognostic favorable (8.54e-8)"	"unprognostic (9.22e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.51e-1)"	"prognostic favorable (7.79e-6)"	10.2	10.5	16.0	11.4	18.1	15.8	12.1	16.4	16.1	14.5	11.1	14.8	9.9	18.7	14.2	6.1	22.2	9.3	10.8	14.7	16.0	11.6	11.8	11.2	20.3	18.4	16.7	27.3	13.5	21.0	10.5	9.3	17.6	13.1	6.9	14.9	18.7	17.0	10.5	7.9	12.7	12.2	17.1	15.7	11.1	8.1	16.4	24.0	19.3	8.5	14.8	15.7	9.7	20.4	19.0	23.3	46.7	27.7	12.1	11.1	24.5	5.7	14.2	22.6	20.6	16.5	17.7	40.1	20.1	10.6	7.9	14.5	32.0	17.3	11.5	23.7	29.5	16.9	16.7	33.8	19.7	57.4	21.9	17.4	20.5	14.4	16.0	17.8	18.0	19.4	7.3	15.7	14.6	57.7	37.1	39.3	31.4	34.4	27.1	61.9	19.9	13.3	15.3	39.4	60.8	48.7	14.2	17.1	31.4	15.4	33.8	36.2	12.8	15.1	28.3	9.5	19.5	20.3	14.4	36.5	6.3	7.5	26.3	0.0	1.0	2.8	1.8	0.6	1.8	2.5	1.3	2.3	1.4	1.8	2.9	2.2	0.4	2.1	0.3	4.0	2.2	1.2	16.0	18.1	16.4	16.1	14.7	16.0	18.4	16.7	17.6	17.1	16.4	20.4	6.6	3.2	14.9	11.4	12.8	1.7	7.1	7.6	8.0	16.8	22.0	16.0	13.7	17.2	11.7	20.2	8.4	5.2	17.0	3.3	19.6	14.3	0.6	14.9	8.8	7.6	20.4	8.0	2.4	6.2	2.0	6.4	5.6	16.7	6.3	19.3	7.1	16.2	9.4	21.9	5.0	9.7	20.3	8.1	2.6	1.7	9.6	6.6	3.6	7.5	7.7	14.4	12.3	11.1	8.8	6.4	6.0	8.6	5.5	7.4	5.0	7.1	10.5	14.3	6.6	7.1	8.5	0.7	8.1	2.3	1.6	0.8	10.4	8.4	11.8	7.3
PAWR	"par-4, PAR4"	ENSG00000177425	"Pro-apoptotic WT1 regulator"	Q96IZ0	12	79574979-79690964	"Predicted intracellular proteins"	"Apoptosis, Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Prostatic glandular cells: 273.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"memory B-cell: 2.7;naive B-cell: 2.8;NK-cell: 1.4"	"Group enriched"	"Detected in many"	5	"B-cells: 2.8;NK-cells: 1.4"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012640, CAB020779"	Approved		Approved	"Plasma membrane,Actin filaments"		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 22: Epithelial cell types - Mixed function"	"Plasma membrane, Actin filaments"		"CAB020779: , HPA012640: AB_1855748"	"unprognostic (2.42e-1)"	"unprognostic (5.58e-2)"	"unprognostic (9.77e-3)"	"unprognostic (5.39e-2)"	"unprognostic (9.44e-3)"	"unprognostic (4.21e-3)"	"unprognostic (9.21e-2)"	"unprognostic (1.37e-1)"	"unprognostic (4.78e-1)"	"unprognostic (3.03e-1)"	"unprognostic (2.42e-3)"	"unprognostic (4.97e-3)"	"unprognostic (2.22e-2)"	"unprognostic (2.58e-2)"	"unprognostic (4.64e-1)"	"unprognostic (2.22e-1)"	"unprognostic (4.23e-2)"	11.0	6.1	6.8	9.0	8.0	3.1	13.4	4.8	3.6	20.9	21.6	16.7	11.7	28.0	15.9	14.3	24.7	8.5	5.2	4.7	7.6	12.6	13.3	11.6	6.9	7.7	13.4	20.4	11.6	13.3	8.7	6.2	5.5	14.9	15.3	0.7	14.3	21.8	1.7	16.5	12.1	16.7	5.5	6.2	13.6	10.9	12.4	4.3	16.2	1.8	6.6	16.1	16.4	5.5	54.5	49.1	8.8	0.3	4.4	1.9	58.6	34.1	9.9	17.0	10.3	61.5	20.2	36.2	61.2	19.0	12.2	59.2	31.0	25.7	24.3	14.7	42.2	0.0	28.7	27.1	23.6	0.5	1.0	4.1	53.4	13.4	76.0	63.0	28.7	14.8	2.1	4.9	18.8	41.0	8.8	0.2	42.6	15.7	27.7	0.0	20.2	23.5	32.4	40.4	25.4	0.1	60.8	31.8	5.7	29.4	28.5	0.3	43.2	25.4	22.8	0.9	23.1	15.3	21.6	26.8	4.2	0.1	11.2	0.4	0.0	0.0	0.0	0.0	0.0	2.7	0.1	0.1	0.2	2.8	0.2	0.2	0.2	1.4	0.0	0.1	0.0	0.0	6.8	8.0	4.8	3.6	4.7	7.6	7.7	13.4	5.5	5.5	12.4	5.5	51.3	80.1	40.7	16.6	33.1	200.1	170.3	42.0	63.2	6.4	93.6	77.3	21.0	60.1	59.2	66.2	0.0	57.1	4.6	103.9	17.6	57.3	62.6	75.7	50.9	31.0	68.8	4.6	1.5	38.5	81.4	41.7	32.1	157.5	1.3	87.4	13.6	54.5	6.5	16.8	50.9	120.9	32.6	1.6	19.2	96.3	84.8	5.3	17.8	23.4	0.4	2.5	4.1	30.7	0.9	83.2	72.0	91.0	11.4	273.4	44.3	47.2	49.9	1.4	85.5	18.3	109.7	98.4	62.1	76.6	179.6	76.9	6.7	62.9	92.7	169.5
PAX2		ENSG00000075891	"Paired box 2"	Q02962	10	100735396-100829944	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"epididymis: 29.6;kidney: 85.3"	"Cell type enhanced"	"Detected in some"		"Collecting duct cells: 145.3;Distal tubular cells: 49.0;Endometrial ciliated cells: 129.5;Glandular and luminal cells: 246.0"	"Group enriched"	"Detected in some"	19	"endometrial cancer: 6.7;ovarian cancer: 7.0;renal cancer: 14.5"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	14	"AN3-CA: 14.4;EFO-21: 22.6;RPTEC TERT1: 16.0"	"Group enriched"	"Detected in some"	9	"cerebellum: 1.3;pons and medulla: 3.4"	"Group enriched"	"Detected in some"	7	"cerebellum: 3.6;medulla oblongata: 5.6;spinal cord: 4.9"	"CAB013024, HPA047704, HPA070751"	Enhanced		Supported	Nucleoplasm	"Intracellular and membrane"	NA	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm		"CAB013024: AB_2533990, HPA047704: AB_2636861, HPA070751: AB_2686305"	"unprognostic (3.98e-2)"	"unprognostic (9.55e-2)"	"unprognostic (1.48e-2)"	"prognostic unfavorable (4.56e-4)"	"unprognostic (4.85e-2)"	"unprognostic (5.54e-1)"	"unprognostic (1.91e-1)"	"unprognostic (2.05e-1)"		"unprognostic (1.24e-2)"	"unprognostic (6.59e-2)"	"unprognostic (9.18e-2)"	"unprognostic (3.30e-3)"	"unprognostic (3.67e-1)"	"unprognostic (1.97e-1)"	"unprognostic (6.34e-2)"	"unprognostic (8.26e-2)"	0.0	0.0	0.9	0.0	0.0	0.0	0.0	2.2	0.4	5.4	0.2	0.0	0.0	1.8	29.6	0.0	8.4	0.0	0.0	0.5	0.4	85.3	0.1	0.0	0.0	6.8	1.6	0.2	0.4	5.9	0.8	0.0	3.3	0.2	0.0	1.2	0.0	11.5	0.0	0.0	0.0	0.0	6.3	0.0	0.0	0.4	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	14.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	22.6	0.0	0.1	0.0	1.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.1	16.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	2.2	0.4	0.5	0.4	6.8	1.6	3.3	6.3	0.1	0.9	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.8	0.4	5.9	0.0	0.0	145.3	0.0	0.0	0.0	0.0	49.0	0.0	9.4	129.5	14.8	0.6	0.0	0.0	0.5	0.2	0.0	0.2	0.0	246.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.0	0.0	1.5	0.0	1.1	0.0	0.0	0.0	3.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.0	27.6	0.0	0.5	0.0	0.0	0.6	1.1	1.2	0.0	0.0	0.0	1.2	0.0	0.1	0.0
PAX5	BSAP	ENSG00000196092	"Paired box 5"	Q02548	9	36833269-37034268	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Spermatogenesis, Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Cancer-related genes, Disease variant, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"lymphoid tissue: 39.7"	"Cell type enriched"	"Detected in some"	29	"B-cells: 91.3"	"Low cancer specificity"	"Detected in some"			"Region enhanced"	"Detected in many"		"midbrain: 6.5"	"Group enriched"	"Detected in some"	43	"memory B-cell: 39.0;naive B-cell: 26.0"	"Lineage enriched"	"Detected in single"	52	"B-cells: 39.0"	"Group enriched"	"Detected in some"	9	"Daudi: 66.6;REH: 194.1;U-698: 87.1"	"Region enriched"	"Detected in single"	11	"midbrain: 3.9"	"Low region specificity"	"Detected in all"			"CAB026269, CAB026869, HPA056394, HPA068498"	Enhanced	Supported	Supported	"Nucleoplasm,Nucleoli fibrillar center,Vesicles,Cytosol"		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 16: Immune cells - Immune response"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 57: B-cells - Immune response"	Nucleoplasm	"Nucleoli fibrillar center, Vesicles, Cytosol"	"CAB026269: , CAB026869: , HPA056394: AB_2683116, HPA068498: AB_2685997"	"unprognostic (4.69e-4)"	"unprognostic (3.83e-1)"	"unprognostic (9.13e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.65e-2)"	"unprognostic (1.15e-1)"	"unprognostic (2.09e-2)"	"unprognostic (2.95e-2)"	"unprognostic (2.48e-1)"	"unprognostic (2.00e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.46e-2)"	"unprognostic (1.11e-3)"	"unprognostic (3.15e-1)"	"unprognostic (8.96e-2)"	"unprognostic (6.03e-2)"	"unprognostic (1.01e-1)"	0.3	0.1	0.4	14.9	0.3	9.4	0.1	0.5	0.5	0.0	0.2	0.8	0.5	0.2	0.1	0.2	0.0	0.8	0.2	0.3	0.6	0.1	0.2	0.3	39.7	1.1	6.5	0.0	0.0	0.0	0.2	0.1	4.1	0.3	0.8	0.5	1.0	0.0	3.1	0.0	6.6	0.0	0.8	18.7	1.6	0.6	1.9	2.8	0.2	0.0	36.2	1.1	0.0	0.3	0.1	0.3	5.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	66.6	0.1	0.0	0.1	0.2	0.1	0.0	0.0	3.5	0.1	0.0	0.0	0.0	0.0	2.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	1.5	0.1	0.3	1.9	0.3	0.4	194.1	0.4	0.3	0.0	0.0	13.2	2.9	0.1	0.7	0.0	0.0	0.0	7.5	0.2	0.0	0.2	0.1	0.0	0.2	0.1	87.1	0.0	1.5	0.1	0.7	0.0	0.1	0.0	0.1	0.1	39.0	0.0	0.0	0.1	26.0	0.1	0.1	0.1	0.2	0.2	0.1	0.1	0.7	0.4	0.3	0.5	0.5	0.3	0.6	1.1	6.5	4.1	0.8	1.9	0.3	0.0	0.0	0.0	0.7	91.3	0.0	0.3	0.0	0.0	0.1	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.9	0.0	0.0	0.3	0.0	0.4	0.6	0.0	0.0	0.4	0.0	0.0	1.3	0.0	0.0	0.4	0.0	0.0	0.5	0.1	0.0	0.3	0.0	3.1	0.0	0.9	0.0	0.0	0.2	0.5	0.0	0.0	0.3	0.0	0.1	0.0	2.7	0.4	0.0	0.1	0.0	0.1	0.0	0.8	0.1	0.6	0.2	0.2	0.0	0.0	2.0	0.0	0.0	0.3
PAX9		ENSG00000198807	"Paired box 9"	P55771	14	36657568-36679362	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"esophagus: 81.0;lymphoid tissue: 20.5;parathyroid gland: 43.0;salivary gland: 51.8"	"Cell type enhanced"	"Detected in some"		"Basal respiratory cells: 45.3;Basal squamous epithelial cells: 174.8;Ionocytes: 40.7;Squamous epithelial cells: 172.0"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 12.3;HDLM-2: 58.3;PC-3: 18.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA001572, CAB016239"	Enhanced		Supported	Nucleoplasm,Nucleoli		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 61: Squamous epithelial cells - Keratinization"	Nucleoli	Nucleoplasm	"CAB016239: AB_2159984, HPA001572: "	"unprognostic (3.09e-1)"	"prognostic favorable (5.38e-4)"	"unprognostic (1.56e-2)"	"unprognostic (2.80e-2)"	"unprognostic (1.40e-2)"	"unprognostic (1.43e-2)"	"unprognostic (5.93e-3)"	"unprognostic (2.71e-3)"	"unprognostic (2.96e-1)"	"unprognostic (5.58e-2)"	"unprognostic (2.41e-2)"	"unprognostic (9.44e-2)"	"unprognostic (2.31e-4)"	"unprognostic (1.43e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.17e-1)"	0.1	0.1	0.0	0.1	0.0	0.3	0.6	0.0	0.0	7.3	0.1	0.7	0.0	0.2	0.3	81.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.1	0.0	0.0	0.1	0.1	43.0	2.2	0.0	0.0	3.7	0.1	0.0	51.8	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.3	0.2	0.0	20.5	0.7	0.0	8.5	0.7	7.1	0.0	5.3	2.3	0.0	2.5	2.1	3.8	2.0	0.0	0.3	0.0	0.0	1.6	1.8	1.6	0.8	0.0	0.5	11.4	2.1	12.3	0.0	58.3	7.3	0.9	1.2	0.0	0.0	0.0	4.2	0.7	6.0	0.0	1.9	0.0	0.0	5.3	2.3	0.3	0.2	7.3	0.9	0.0	0.1	1.9	18.9	0.0	0.0	0.0	0.0	6.9	3.4	0.0	1.3	7.0	1.4	0.9	5.1	0.0	0.0	0.0	0.6	2.2	1.0	0.0	0.1	4.4	0.7	0.5	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	8.4	45.3	174.8	0.0	1.6	1.3	0.4	0.0	25.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.2	0.2	0.0	0.6	0.0	0.4	0.0	0.2	0.2	0.7	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	40.7	0.0	0.3	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.1	0.0	0.0	20.9	0.0	0.0	26.8	0.0	0.0	0.1	2.0	2.4	0.9	172.0	0.3	0.1	0.1	0.0	0.6	12.1
PAXX	"C9orf142, XLS"	ENSG00000148362	"PAXX non-homologous end joining factor"	Q9BUH6	9	136992422-136993984	"Predicted intracellular proteins"	"DNA damage, DNA repair"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 147.1;dendritic cells: 198.4;Distal tubular cells: 131.0;Extravillous trophoblasts: 216.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045268	Uncertain		Supported	Nucleoplasm		NA	NA		95000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm		"HPA045268: AB_10963079"	"unprognostic (1.85e-1)"	"prognostic favorable (2.06e-4)"	"unprognostic (1.14e-3)"	"unprognostic (9.88e-3)"	"unprognostic (1.95e-1)"	"unprognostic (2.15e-1)"	"unprognostic (2.13e-3)"	"unprognostic (3.22e-1)"	"unprognostic (3.10e-1)"	"unprognostic (1.00e-2)"	"prognostic favorable (6.71e-4)"	"unprognostic (3.54e-2)"	"unprognostic (1.75e-2)"	"unprognostic (9.64e-3)"	"unprognostic (3.66e-1)"	"unprognostic (9.31e-2)"	"unprognostic (8.97e-3)"	24.1	24.9	15.9	8.1	16.3	17.6	23.6	18.0	27.3	27.9	9.6	25.5	11.8	23.5	1.7	29.5	24.7	4.3	29.3	13.9	15.0	37.3	44.7	28.4	11.8	21.9	18.8	21.5	37.7	5.5	37.4	7.5	19.1	34.5	2.0	1.2	20.2	7.4	14.9	34.7	28.8	1.9	19.4	48.3	31.2	14.8	17.1	10.1	32.4	2.1	4.0	25.7	25.5	21.8	27.6	30.3	4.8	18.4	8.5	7.6	70.5	20.7	12.3	13.7	7.4	13.5	19.8	24.6	35.3	5.4	5.4	43.5	1.7	15.6	1.1	63.3	42.7	19.3	16.2	11.4	12.7	27.6	41.2	5.6	14.6	4.7	6.3	2.4	12.5	44.1	29.4	7.1	3.1	61.2	29.0	45.6	28.7	32.6	91.5	37.7	9.8	70.4	9.5	14.2	22.6	28.2	17.8	44.0	24.9	0.8	52.5	23.4	16.6	6.5	19.9	31.2	25.1	13.1	12.5	16.9	11.6	31.6	24.8	25.9	44.3	18.7	142.3	54.9	122.5	33.8	78.3	123.9	46.2	30.5	42.4	99.1	14.9	87.7	29.0	238.2	66.0	62.2	15.9	16.3	18.0	27.3	13.9	15.0	21.9	18.8	19.1	19.4	17.1	21.8	65.5	16.0	27.6	0.0	20.2	0.0	0.0	0.0	0.0	0.0	76.8	95.0	0.0	0.0	7.4	40.5	0.0	147.1	198.4	0.0	131.0	54.3	0.0	45.3	34.0	22.6	0.0	0.0	0.0	43.4	216.7	25.0	0.0	44.4	12.6	66.5	0.0	0.0	77.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	36.9	0.0	0.0	35.2	0.0	0.0	0.0	0.0	40.0	0.0	0.0	21.5	0.0	0.0	82.4	11.7	0.0	0.0	0.0	24.1	0.0	0.0	0.0	0.0	88.7	72.3	59.1	0.0	0.0
PBOV1	"UC28, UROC28"	ENSG00000254440	"Prostate and breast cancer overexpressed 1"	Q9GZY1	6	138215986-138218491	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enriched"	"Detected in single"	12	"brain: 3.1"	"Cell type enhanced"	"Detected in single"		"Bipolar cells: 1.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA063021, HPA069649"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 69: Cerebellum - Gene expression regulation"		"Cluster 50: Fibroblasts - ECM organization"	Nucleoplasm	Cytosol	"HPA063021: AB_2684923, HPA069649: "	"unprognostic (3.32e-3)"							"unprognostic (8.23e-2)"		"unprognostic (9.35e-2)"	"unprognostic (1.22e-1)"	"unprognostic (4.77e-2)"		"unprognostic (2.51e-1)"			"unprognostic (1.35e-4)"	0.0	0.0	0.7	0.0	1.1	0.2	0.0	2.7	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.7	0.1	0.0	0.0	0.0	0.9	0.6	0.0	0.1	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.7	1.1	2.7	0.9	1.2	0.7	0.9	0.6	0.7	0.3	0.8	3.1	0.0	0.0	0.5	0.3	0.0	0.0	0.3	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.7	0.3	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.2
PCBP2	"hnRNP-E2, HNRNPE2, HNRPE2"	ENSG00000197111	"Poly(rC) binding protein 2"	Q15366	12	53452102-53481162	"Plasma proteins, Predicted intracellular proteins"	"Antiviral defense, Host-virus interaction, Immunity, Innate immunity, Viral RNA replication"	"DNA-binding, Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038356, HPA073145"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA		970000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm	Cytosol	"HPA038356: AB_10697248, HPA073145: "	"unprognostic (1.44e-1)"	"unprognostic (2.08e-1)"	"unprognostic (9.89e-2)"	"unprognostic (2.92e-3)"	"unprognostic (4.34e-3)"	"unprognostic (2.69e-2)"	"prognostic unfavorable (1.82e-5)"	"unprognostic (2.52e-1)"	"unprognostic (2.05e-2)"	"prognostic favorable (8.23e-4)"	"unprognostic (3.53e-2)"	"unprognostic (2.12e-1)"	"unprognostic (2.04e-1)"	"unprognostic (9.84e-2)"	"unprognostic (3.35e-1)"	"unprognostic (1.99e-1)"	"unprognostic (8.20e-2)"	467.6	429.4	213.6	263.0	232.5	863.1	396.1	260.1	240.3	385.9	238.8	318.2	334.8	345.0	366.4	314.4	407.8	301.5	340.3	197.9	232.9	534.9	509.0	350.9	380.4	228.2	223.5	507.3	501.5	437.3	220.7	299.7	232.8	265.5	325.5	665.2	322.1	264.5	481.1	416.6	324.5	333.8	227.4	323.8	390.4	363.6	228.8	543.6	414.9	401.7	455.6	313.3	323.5	263.2	527.6	809.2	755.8	614.7	1068.5	809.3	582.3	547.0	722.3	844.6	605.4	951.9	760.5	916.9	518.6	796.7	398.6	501.2	830.1	720.1	830.0	579.1	617.4	917.3	597.0	946.0	1071.1	922.5	592.1	937.8	593.9	719.6	1147.1	1451.3	819.3	583.5	810.8	1621.9	762.9	1444.3	856.8	1030.1	975.1	447.8	559.7	690.0	686.4	1098.4	667.5	814.6	742.4	655.6	736.2	656.2	553.9	767.2	918.2	791.8	615.9	443.9	614.0	412.7	561.7	908.2	666.0	840.7	523.9	572.6	494.4	19.1	34.5	25.9	27.7	34.0	44.6	38.1	42.3	35.7	41.6	34.3	48.1	41.8	30.8	23.9	33.3	57.2	52.3	30.1	213.6	232.5	260.1	240.3	197.9	232.9	228.2	223.5	232.8	227.4	228.8	263.2	306.1	115.4	179.2	64.9	433.6	390.7	302.9	352.6	569.1	88.0	361.5	389.9	73.7	253.1	193.0	296.1	110.5	329.2	313.6	242.9	493.1	233.0	68.3	264.2	289.3	285.1	206.5	525.1	54.6	240.0	365.1	285.8	326.2	298.1	155.0	360.3	283.4	302.2	368.2	102.6	58.1	279.1	223.8	437.6	473.8	65.6	309.1	376.0	233.1	74.0	476.5	152.9	292.5	58.8	101.4	250.8	266.5	229.0	483.8	256.3	446.8	714.4	159.5	188.3	190.7	346.6	435.1	292.8	183.4	511.3	382.3	443.3	341.6	240.4	325.7	345.0
PCBP4	"LIP4, MCG10"	ENSG00000090097	"Poly(rC) binding protein 4"	P57723	3	51957454-51974016	"Predicted intracellular proteins"		"DNA-binding, Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"retina: 391.4"	"Group enriched"	"Detected in many"	5	"Bipolar cells: 374.5;Cone photoreceptor cells: 654.7;Rod photoreceptor cells: 592.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	22	"B-cells: 5.2;granulocytes: 7.0;T-cells: 12.0"	"Cell line enhanced"	"Detected in all"		"SH-SY5Y: 160.4;SK-MEL-30: 140.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA057754			Supported	Cytosol		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 54: Non-specific - Microtubule organization"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 9: Photoreceptor cells - Phototransduction"	Cytosol		"HPA057754: AB_2683517"	"unprognostic (7.17e-2)"	"unprognostic (8.16e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.34e-2)"	"unprognostic (4.94e-3)"	"unprognostic (1.94e-2)"	"unprognostic (4.97e-3)"	"unprognostic (4.46e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.09e-1)"	"unprognostic (5.45e-2)"	"unprognostic (1.62e-1)"	"unprognostic (3.13e-2)"	"unprognostic (6.79e-2)"	"unprognostic (1.89e-1)"	"unprognostic (3.59e-1)"	"unprognostic (4.72e-2)"	25.7	26.9	86.3	9.2	111.6	2.6	27.7	100.8	106.8	41.6	75.1	40.2	18.3	39.3	13.4	16.0	31.9	13.0	68.4	87.7	92.1	30.1	20.0	31.2	8.3	116.1	106.6	33.8	20.1	24.1	48.7	8.6	101.9	55.5	9.3	391.4	24.7	22.1	154.1	21.7	24.1	16.8	91.3	22.3	33.3	24.4	106.5	5.7	35.0	96.3	6.5	38.2	30.4	139.9	35.1	11.8	46.3	67.8	20.6	36.6	7.9	78.7	38.1	46.4	29.8	44.2	12.4	1.1	11.5	62.6	41.0	8.1	43.4	27.5	21.7	55.4	7.0	4.4	41.3	46.1	33.2	4.5	32.7	49.8	50.6	29.6	12.9	57.5	23.5	20.1	2.2	15.2	75.3	16.5	1.9	5.4	22.5	22.2	31.5	24.5	22.4	6.2	16.5	24.7	90.3	160.4	21.5	11.6	140.2	12.2	21.5	17.0	47.2	49.3	92.6	15.7	42.8	10.1	7.0	7.2	57.2	9.9	73.5	7.0	0.1	3.8	11.1	0.0	7.8	5.2	10.6	10.9	0.3	2.6	4.8	3.7	0.0	0.1	0.0	0.1	12.0	3.4	86.3	111.6	100.8	106.8	87.7	92.1	116.1	106.6	101.9	91.3	106.5	139.9	14.9	3.2	3.2	27.7	3.8	8.7	16.2	14.2	9.1	374.5	12.4	15.7	7.3	1.5	5.6	9.2	654.7	1.5	6.3	7.7	17.6	31.4	49.8	2.2	15.8	17.3	62.0	0.4	15.0	23.4	1.2	13.0	6.6	4.2	1.3	7.8	15.7	3.6	1.1	42.1	20.8	9.4	16.2	1.0	5.1	101.2	22.4	1.5	23.2	5.6	0.9	88.8	9.2	40.7	65.0	42.3	16.6	16.1	5.3	19.8	21.2	10.7	1.5	592.7	6.6	11.6	17.9	1.4	6.0	4.4	11.8	0.5	9.6	3.6	6.1	11.1
PCCA		ENSG00000175198	"Propionyl-CoA carboxylase subunit alpha"	P05165	13	100089015-100530437	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Lipid degradation, Lipid metabolism"	Ligase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"epididymis: 218.2"	"Cell type enhanced"	"Detected in all"		"Astrocytes: 152.8;Excitatory neurons: 152.8;Inhibitory neurons: 166.5;Microglial cells: 217.4;Oligodendrocyte precursor cells: 200.6;Oligodendrocytes: 182.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"RPTEC TERT1: 167.0;SCLC-21H: 91.1;U-937: 131.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041716, HPA047792"	Enhanced		Supported	Mitochondria		NA	NA		290000	"Cluster 27: Non-specific - Gene expression"	"Cluster 68: Epididymis - Unknown function"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 68: Oligodendrocytes - Mixed function"	Mitochondria		"HPA041716: AB_2677635, HPA047792: AB_2680156"	"unprognostic (1.18e-1)"	"unprognostic (2.13e-1)"	"unprognostic (1.97e-2)"	"unprognostic (4.71e-2)"	"unprognostic (1.11e-2)"	"unprognostic (1.71e-2)"	"unprognostic (1.55e-1)"	"unprognostic (5.90e-3)"	"unprognostic (2.41e-1)"	"unprognostic (1.55e-1)"	"unprognostic (6.14e-2)"	"unprognostic (1.42e-1)"	"prognostic favorable (0.00e+0)"	"unprognostic (7.08e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.18e-1)"	"unprognostic (9.32e-2)"	35.4	56.3	29.0	12.4	29.8	6.2	25.8	55.5	34.6	22.3	44.4	37.5	13.2	14.9	218.2	19.4	17.4	11.6	35.4	28.6	26.3	111.7	104.3	12.0	8.0	28.9	27.4	19.9	27.6	25.7	12.3	21.3	31.1	25.9	27.6	25.2	26.9	16.9	17.6	18.6	18.0	13.7	30.3	17.2	40.9	9.2	33.9	11.4	20.4	27.2	6.4	21.3	17.5	38.7	10.6	18.5	29.8	9.9	27.9	24.2	16.6	10.2	15.4	9.5	9.0	23.0	13.9	0.8	15.2	10.1	12.0	11.8	9.1	14.1	15.6	17.5	10.1	24.6	12.7	49.7	15.4	1.2	11.3	22.4	15.2	8.8	14.6	23.0	19.6	13.0	9.8	13.4	17.1	11.6	2.6	54.8	18.6	37.2	8.1	21.4	12.9	17.3	167.0	20.5	91.1	10.9	7.0	38.4	17.9	31.9	27.9	43.1	14.3	9.6	8.0	6.7	7.3	13.1	12.9	0.4	18.4	131.6	6.9	1.6	9.1	1.7	4.5	11.2	5.9	3.6	2.8	4.2	13.5	2.3	3.9	4.9	1.1	8.7	12.3	1.1	6.5	5.2	29.0	29.8	55.5	34.6	28.6	26.3	28.9	27.4	31.1	30.3	33.9	38.7	11.3	3.2	8.7	152.8	6.6	1.9	29.1	12.7	8.6	15.5	13.5	8.8	10.5	52.9	14.8	20.2	29.2	25.7	4.3	20.7	99.7	19.7	17.6	76.5	22.4	12.0	3.6	3.4	152.8	8.4	6.9	12.9	12.2	72.9	14.0	20.7	12.1	48.8	11.8	28.6	166.5	12.4	12.2	14.2	2.2	12.0	8.7	8.2	5.4	217.4	6.0	11.5	10.3	200.6	182.5	5.8	17.5	13.5	9.4	11.2	13.2	86.9	13.2	31.7	13.1	12.3	10.1	7.2	6.2	10.6	3.8	30.2	6.4	17.6	27.6	19.2
PCDH1	pc42	ENSG00000156453	"Protocadherin 1"	Q08174	5	141853090-141879246	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 61.5;Distal enterocytes: 66.4;Exocrine glandular cells: 46.3;Pancreatic endocrine cells: 65.2;Urothelial cells: 54.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 86.1;HaCaT: 108.0;HUVEC TERT2: 56.2;OE19: 77.8;RT4: 74.2;TIME: 74.5;WM-115: 52.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047720, HPA050538"	Enhanced		Approved	"Nucleoplasm,Nucleoli,Cell Junctions"		NA	NA		2500000		"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Nucleoplasm, Cell Junctions"	Nucleoli	"HPA047720: AB_2680130, HPA050538: AB_2681162"	"unprognostic (4.67e-2)"	"unprognostic (1.79e-1)"	"unprognostic (5.30e-2)"	"unprognostic (4.61e-3)"	"unprognostic (5.03e-2)"	"unprognostic (4.16e-2)"	"prognostic unfavorable (4.96e-5)"	"unprognostic (1.98e-2)"	"unprognostic (4.87e-2)"	"unprognostic (1.31e-1)"	"prognostic unfavorable (3.61e-4)"	"unprognostic (2.43e-1)"	"prognostic favorable (7.55e-5)"	"unprognostic (2.05e-1)"	"unprognostic (4.16e-2)"	"unprognostic (3.13e-2)"	"unprognostic (1.91e-1)"	24.0	4.0	11.7	7.7	15.9	1.2	22.8	3.3	15.1	11.6	0.0	23.1	21.4	9.2	6.4	41.7	9.1	6.6	19.3	17.0	2.3	21.3	19.3	27.7	2.0	0.0	0.8	2.5	13.8	3.8	6.5	19.2	0.0	10.8	14.3	3.4	28.8	11.2	8.2	27.4	17.1	7.2	1.1	1.8	23.6	1.1	2.7	1.0	12.6	11.1	9.1	9.8	19.2	5.7	18.9	1.0	7.7	8.5	0.3	0.0	5.5	0.2	0.2	0.1	0.0	4.5	86.1	0.1	43.7	0.6	1.0	108.0	9.9	7.9	0.0	0.1	0.3	0.0	0.4	0.1	6.9	0.0	0.3	0.0	17.8	0.1	1.2	18.1	56.2	0.0	0.1	9.2	0.0	15.1	0.3	0.0	32.5	77.8	14.6	0.3	0.1	13.2	6.3	74.2	0.9	1.8	0.5	23.3	20.0	21.6	18.8	0.4	74.5	0.1	0.7	0.1	6.9	0.0	0.1	0.2	0.5	0.0	52.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	11.7	15.9	3.3	15.1	17.0	2.3	0.0	0.8	0.0	1.1	2.7	5.7	61.5	0.0	5.3	3.6	0.2	1.0	12.0	4.6	0.0	9.6	9.5	4.7	4.4	20.0	8.6	12.9	0.0	0.7	2.0	66.4	3.9	15.3	1.3	10.1	2.1	34.2	7.7	2.7	12.3	46.3	0.3	2.6	21.9	21.3	0.0	0.0	7.5	30.1	0.2	26.9	6.1	21.3	12.2	1.4	2.3	2.5	0.6	0.5	0.0	6.5	0.0	4.8	7.2	5.5	7.2	65.2	30.3	0.4	1.4	25.8	36.4	5.2	7.1	0.5	13.1	0.9	18.5	0.3	0.2	7.4	2.6	20.1	0.9	0.5	18.9	54.5
PCDHA4	"CNR1, CNRN1, CRNR1, PCDH-ALPHA4"	ENSG00000204967	"Protocadherin alpha 4"	Q9UN74	5	140806929-141012347	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 2.9"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 3.2;Alveolar cells type 2: 2.0;granulocytes: 3.8;Respiratory ciliated cells: 2.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 6.6;AF22: 5.6;EFO-21: 5.1;T-47d: 5.4"	"Not detected"	"Not detected"							"HPA043180, HPA073478"	Approved		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA				"Cluster 6: Brain - Smell perception"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 60: Granulocytes - Receptor signaling"	"Nucleoplasm, Plasma membrane"	Cytosol	"HPA043180: AB_10806381, HPA073478: AB_2686608"	"unprognostic (2.71e-3)"	"unprognostic (1.16e-1)"	"unprognostic (2.85e-1)"	"unprognostic (5.32e-2)"	"unprognostic (1.93e-1)"	"unprognostic (3.14e-2)"	"unprognostic (2.56e-1)"	"unprognostic (7.90e-3)"	"unprognostic (7.14e-3)"	"unprognostic (7.00e-2)"	"unprognostic (5.06e-3)"	"unprognostic (6.94e-5)"	"unprognostic (5.01e-3)"	"unprognostic (6.21e-2)"	"unprognostic (3.98e-1)"	"unprognostic (6.29e-3)"	"unprognostic (4.79e-2)"	0.2	0.2	0.9	0.2	1.2	0.9	0.4	2.9	1.1	0.5	0.0	0.3	0.3	0.6	0.4	0.1	0.3	1.3	0.1	0.9	0.5	0.4	0.1	0.4	0.3	0.6	0.5	0.2	1.2	0.1	0.4	0.1	0.6	0.4	0.2	0.9	0.2	0.3	0.3	0.5	0.2	0.3	0.3	0.3	0.3	0.4	0.4	0.1	0.3	0.1	0.2	0.2	0.1	1.5	0.1	6.6	5.6	0.2	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.1	1.1	0.1	5.1	0.1	0.3	0.2	0.0	0.0	0.1	0.1	0.1	0.2	0.4	0.2	0.1	0.2	0.3	0.3	1.1	0.1	0.1	0.3	0.3	0.2	0.1	0.7	0.1	0.1	0.1	0.2	1.7	1.2	0.9	0.1	0.1	0.2	0.1	0.2	0.2	2.3	0.0	1.4	0.5	0.8	5.4	0.1	0.6	1.2	0.8	0.5	0.1	0.3	0.1	0.1	0.2	0.2	0.5	0.3	0.0	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.0	0.0	0.9	1.2	2.9	1.1	0.9	0.5	0.6	0.5	0.6	0.3	0.4	1.5	0.1	3.2	2.0	0.0	0.0	0.0	0.6	0.0	0.0	1.1	0.2	0.0	0.8	0.0	0.7	0.0	0.0	0.0	0.0	0.1	0.0	0.6	1.3	0.6	0.7	0.4	0.0	0.0	0.0	0.2	0.0	0.5	0.0	0.3	3.8	0.1	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.2	0.0	0.2	2.9	1.1	0.0	0.4	0.5	1.0	0.5	0.0	0.0	0.0	0.2	0.1	0.1	0.4
PCDHB3	PCDH-BETA3	ENSG00000113205	"Protocadherin beta 3"	Q9Y5E6	5	141100473-141103827	"Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Adipocytes: 2.8;Cone photoreceptor cells: 2.1;Endometrial stromal cells: 2.6;Horizontal cells: 8.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 11.3;HAP1: 3.5;SH-SY5Y: 15.2;U-138 MG: 5.3"	"Low region specificity"	"Detected in all"							HPA050296	Uncertain		Supported	Vesicles		NA	NA				"Cluster 68: Epididymis - Unknown function"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 50: Fibroblasts - ECM organization"	Vesicles		"HPA050296: AB_2681078"	"unprognostic (2.72e-2)"	"unprognostic (7.47e-4)"	"unprognostic (1.22e-1)"	"unprognostic (1.95e-4)"	"unprognostic (9.34e-3)"	"unprognostic (3.42e-2)"	"unprognostic (2.29e-2)"	"unprognostic (3.17e-1)"	"unprognostic (1.37e-1)"	"unprognostic (3.34e-1)"	"unprognostic (8.52e-3)"	"unprognostic (3.45e-2)"	"unprognostic (1.82e-2)"	"unprognostic (2.37e-3)"	"unprognostic (1.24e-1)"	"unprognostic (1.82e-2)"	"unprognostic (5.18e-4)"	1.8	1.2	0.4	0.7	1.1	0.0	1.7	0.6	1.5	1.2	0.0	0.9	0.3	1.5	0.7	0.3	0.9	0.8	1.1	1.0	0.2	1.1	0.1	1.1	0.1	0.3	0.5	1.6	1.2	1.7	1.8	0.4	0.1	1.4	0.5	1.0	0.7	0.5	0.7	0.7	0.5	1.0	0.2	0.4	0.5	3.6	0.6	0.0	0.7	0.9	0.1	0.8	0.9	0.8	0.0	0.0	1.1	3.1	1.9	0.3	0.4	0.4	0.0	0.0	0.0	0.0	0.0	0.0	11.3	0.2	1.7	0.0	3.5	0.1	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.7	1.3	0.0	0.5	0.0	0.2	0.0	0.0	0.1	0.6	0.0	0.0	0.0	0.6	15.2	0.0	0.1	0.0	0.5	1.9	0.1	0.0	5.3	0.7	0.5	0.3	0.3	0.0	0.0	0.3	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1.1	0.6	1.5	1.0	0.2	0.3	0.5	0.1	0.2	0.6	0.8	2.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.5	0.9	0.8	0.3	0.0	0.0	0.0	2.1	0.0	0.0	0.0	1.9	0.3	0.8	0.4	2.6	1.1	0.0	0.0	0.0	0.2	0.0	1.4	0.0	0.2	0.0	0.0	1.8	0.0	0.0	8.4	0.0	0.2	0.0	0.0	0.3	0.0	0.6	0.0	1.8	0.0	0.0	0.9	0.0	0.0	0.0	0.3	0.0	0.7	0.0	0.5	0.0	0.1	0.0	0.3	0.0	1.7	1.1	1.8	0.7	0.1	0.3	0.0	0.0	0.4	0.0	0.3
PCDHGB2	PCDH-GAMMA-B2	ENSG00000253910	"Protocadherin gamma subfamily B, 2"	Q9Y5G2	5	141360042-141512979	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 6.3"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 2.2;Cardiomyocytes: 1.4;Endometrial stromal cells: 1.0;Fibroblasts: 1.2"	"Cancer enriched"	"Detected in many"	5	"glioma: 6.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 13.5;ASC TERT1: 9.8;LHCN-M2: 8.2;REH: 7.8"	"Low region specificity"	"Detected in all"							"HPA008755, HPA010580, HPA077526"	Uncertain		Supported	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"		NA	NA				"Cluster 70: Brain - Nervous system development"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Vesicles, Plasma membrane, Cytosol"	Nucleoplasm	"HPA008755: AB_1079577, HPA010580: AB_2732401, HPA077526: AB_2732350"	"unprognostic (7.14e-3)"	"unprognostic (8.79e-3)"	"unprognostic (3.21e-2)"	"unprognostic (2.17e-1)"	"prognostic unfavorable (8.67e-4)"	"unprognostic (1.10e-2)"	"unprognostic (2.19e-4)"	"unprognostic (2.68e-1)"	"unprognostic (2.64e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.05e-1)"	"unprognostic (8.46e-3)"	"unprognostic (4.59e-2)"	"unprognostic (2.57e-1)"	"unprognostic (3.06e-2)"	"unprognostic (1.29e-1)"	"unprognostic (3.36e-4)"	1.5	1.0	2.6	0.6	3.6	0.1	1.1	6.3	2.8	2.1	0.0	1.1	0.2	3.0	0.9	0.9	1.6	1.9	1.8	3.1	3.2	0.7	0.7	1.7	0.3	3.7	3.3	2.8	0.8	1.2	0.9	1.1	3.6	1.3	0.8	1.6	0.8	1.2	0.8	0.8	0.5	1.5	3.0	0.6	0.6	0.5	2.2	0.4	0.7	0.9	0.3	0.9	1.1	5.5	0.1	0.3	2.0	0.2	13.5	9.8	0.1	2.1	2.9	0.6	3.2	0.0	0.3	3.7	1.0	1.7	7.1	0.5	0.4	0.3	1.0	0.0	0.2	0.0	0.3	0.4	0.5	0.2	0.2	2.5	0.5	0.2	0.1	4.7	1.7	0.1	0.2	1.2	8.2	0.5	2.9	0.7	0.1	0.9	0.9	7.8	2.6	0.2	0.2	0.3	1.5	1.6	0.2	0.4	0.4	1.5	3.0	0.2	5.9	2.9	0.6	4.4	3.9	0.2	2.2	0.6	3.1	1.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	3.6	6.3	2.8	3.1	3.2	3.7	3.3	3.6	3.0	2.2	5.5	0.1	0.0	0.5	0.0	0.3	0.0	0.0	0.0	0.6	2.2	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	1.0	0.1	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.6	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0
PCF11	KIAA0824	ENSG00000165494	"PCF11 cleavage and polyadenylation factor subunit"	O94913	11	83156988-83187451	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Skeletal myocytes: 227.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-698: 124.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040779			Supported	Nucleoplasm,Mitochondria		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 34: Non-specific - Transcription"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm	Mitochondria	"HPA040779: AB_2677133"	"unprognostic (1.53e-1)"	"unprognostic (7.24e-2)"	"unprognostic (3.99e-2)"	"unprognostic (1.18e-1)"	"unprognostic (3.24e-3)"	"prognostic favorable (1.34e-4)"	"unprognostic (3.74e-2)"	"unprognostic (4.89e-3)"	"unprognostic (1.12e-3)"	"unprognostic (9.53e-2)"	"unprognostic (6.07e-2)"	"unprognostic (5.63e-2)"	"unprognostic (1.55e-1)"	"unprognostic (3.91e-3)"	"unprognostic (1.15e-1)"	"unprognostic (1.07e-1)"	"prognostic favorable (2.03e-5)"	20.1	13.9	9.8	23.5	15.0	42.5	23.7	29.1	13.6	19.2	6.0	19.6	16.3	22.4	15.2	19.5	17.7	17.2	13.5	9.3	10.9	14.9	16.9	22.8	32.4	13.1	12.7	28.3	17.0	16.6	10.4	16.7	14.0	18.7	19.9	26.6	15.4	16.2	26.3	27.8	20.8	23.8	10.9	28.7	16.4	24.7	12.1	33.4	24.3	19.5	29.6	17.0	13.5	17.9	26.3	18.4	29.4	25.3	34.4	33.4	23.5	24.7	18.2	23.2	17.7	31.5	25.7	58.9	18.1	18.0	21.9	25.8	43.2	17.0	22.3	42.1	14.8	34.5	26.3	22.4	19.4	40.9	36.8	23.9	32.1	17.7	25.6	31.2	23.8	38.8	40.9	27.9	21.9	27.9	38.7	45.2	30.7	44.6	20.5	36.4	37.1	35.2	20.2	38.4	24.4	27.0	30.1	23.7	24.3	26.9	23.7	28.0	24.6	33.0	16.9	24.5	16.6	25.0	45.2	124.6	14.5	26.8	26.0	14.8	7.2	14.9	10.1	6.8	8.5	10.9	6.9	7.3	6.9	9.9	7.8	8.2	17.1	13.5	5.5	7.1	5.5	5.8	9.8	15.0	29.1	13.6	9.3	10.9	13.1	12.7	14.0	10.9	12.1	17.9	96.4	41.7	63.5	58.1	90.6	53.7	79.8	30.7	101.9	48.4	84.4	81.0	42.7	35.8	43.4	46.0	33.3	30.2	90.1	49.8	25.4	22.9	203.3	55.5	70.8	66.8	31.8	62.5	32.0	18.1	26.9	58.8	40.2	83.6	37.2	48.0	56.7	21.7	37.6	55.5	37.9	51.0	26.4	57.8	41.0	40.3	60.3	87.4	28.4	45.0	52.5	34.5	58.7	40.7	72.0	19.2	46.2	45.1	69.0	71.6	83.4	14.2	29.0	55.3	39.5	227.3	66.8	46.7	17.9	100.4	62.7	39.4	81.7	42.7	50.3	71.1
PCGF2	"MEL-18, RNF110, ZNF144"	ENSG00000277258	"Polycomb group ring finger 2"	P35227	17	38733898-38749817	"Disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047732, HPA063531"	Uncertain		Supported	Nucleoplasm		NA	NA				"Cluster 72: Non-specific - Transcription"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Nucleoplasm		"HPA047732: AB_2680138, HPA063531: AB_2685031"	"unprognostic (1.56e-1)"	"unprognostic (1.46e-2)"	"prognostic unfavorable (4.55e-4)"	"unprognostic (2.45e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.31e-3)"	"unprognostic (2.47e-2)"	"unprognostic (7.78e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.09e-1)"	"unprognostic (5.10e-3)"	"unprognostic (8.18e-2)"	"unprognostic (6.12e-2)"	"unprognostic (7.66e-2)"	"unprognostic (2.42e-1)"	"unprognostic (1.00e-2)"	"unprognostic (1.79e-1)"	33.6	38.3	3.3	4.6	3.2	0.0	33.0	7.7	5.5	44.7	4.3	24.4	3.7	40.6	2.4	21.4	35.9	6.1	37.3	3.2	5.2	56.5	12.9	33.4	2.1	2.6	3.0	40.5	22.9	2.9	55.6	6.8	2.9	37.5	1.6	7.2	22.6	2.7	9.3	21.6	22.7	2.1	1.2	28.3	25.3	13.3	4.1	0.2	41.7	0.9	0.8	27.3	30.8	3.1	16.9	38.2	9.2	34.5	7.2	2.3	11.7	13.1	6.2	6.2	7.4	21.1	17.6	1.3	14.3	4.2	16.3	26.2	3.4	6.1	2.5	10.4	20.1	7.9	20.7	52.4	2.3	1.2	9.4	2.5	2.8	9.0	6.1	9.6	7.5	7.9	14.9	21.2	3.9	37.8	1.5	0.2	11.7	7.4	15.3	12.6	14.7	3.3	3.2	22.5	16.4	26.8	12.6	9.0	20.8	9.0	35.4	1.6	22.0	24.8	27.1	24.8	23.2	12.5	4.1	4.3	13.3	2.0	22.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	3.2	7.7	5.5	3.2	5.2	2.6	3.0	2.9	1.2	4.1	3.1	49.6	3.2	16.0	2.0	1.1	14.1	11.2	19.7	23.9	59.9	20.6	17.0	2.1	15.7	10.1	20.2	10.4	13.3	0.8	23.7	52.8	24.9	15.1	8.0	22.1	46.4	13.2	0.0	6.5	13.7	26.7	21.9	12.8	12.8	1.3	14.0	51.0	2.9	4.8	35.3	7.0	12.5	22.4	2.9	5.5	5.0	37.0	2.9	14.2	6.5	3.2	26.4	2.1	9.5	2.4	18.9	10.3	29.3	3.8	15.4	22.3	59.6	5.0	16.5	0.0	16.8	16.7	6.1	15.7	9.6	16.9	22.2	0.9	13.3	13.2	11.1
PCGF3	"DONG1, FLJ36550, MGC40413, RNF3, RNF3A"	ENSG00000185619	"Polycomb group ring finger 3"	Q3KNV8	4	705748-770640	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA061879	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 24: NB-4 - Immune response"	"Cluster 34: Spermatids - Unknown function"	Nucleoplasm		"HPA061879: AB_2684631"	"unprognostic (1.24e-1)"	"unprognostic (2.77e-1)"	"unprognostic (2.62e-1)"	"unprognostic (1.06e-2)"	"unprognostic (1.66e-1)"	"prognostic favorable (3.73e-4)"	"unprognostic (2.76e-2)"	"unprognostic (4.21e-2)"	"unprognostic (9.52e-2)"	"unprognostic (1.47e-2)"	"prognostic favorable (1.44e-4)"	"unprognostic (2.36e-2)"	"unprognostic (6.84e-3)"	"unprognostic (2.53e-1)"	"unprognostic (2.20e-1)"	"unprognostic (1.96e-1)"	"prognostic favorable (5.25e-4)"	32.7	45.1	17.9	15.5	18.5	30.1	34.7	30.6	19.5	41.9	16.7	31.7	22.6	35.3	8.7	35.5	33.6	14.0	27.2	18.9	17.0	31.7	29.7	34.7	18.3	18.1	17.2	50.4	27.8	7.8	31.4	19.8	17.5	38.3	10.3	13.3	37.4	9.7	18.4	53.3	36.2	10.7	16.2	51.0	32.1	23.3	17.9	18.6	34.6	11.4	11.8	27.2	39.4	24.1	22.1	19.6	35.3	40.4	15.8	16.2	43.3	29.2	15.9	23.5	23.7	21.5	23.8	15.7	19.1	28.3	23.8	14.9	16.5	23.7	17.8	20.8	17.9	22.6	24.2	38.4	19.3	15.5	28.9	20.5	31.0	20.5	9.3	15.4	30.5	28.2	31.5	12.6	23.3	24.6	41.8	54.6	23.4	14.9	35.0	41.0	22.4	10.1	14.1	35.6	50.2	37.9	15.2	16.1	16.1	22.7	31.5	21.8	36.9	22.8	18.4	19.2	38.1	30.1	27.6	24.6	18.0	24.5	43.0	3.4	7.1	3.1	3.3	5.1	2.8	4.2	2.0	2.1	3.2	5.0	2.5	1.7	4.5	4.7	2.2	4.6	3.3	2.3	17.9	18.5	30.6	19.5	18.9	17.0	18.1	17.2	17.5	16.2	17.9	24.1	29.5	12.8	28.8	19.6	12.5	25.4	17.3	17.2	25.0	12.3	28.3	21.3	21.7	17.2	21.8	9.2	12.5	13.4	13.5	21.4	3.9	20.6	52.0	17.7	28.7	27.8	19.2	9.1	18.1	19.8	30.0	17.8	35.2	21.2	16.5	22.4	25.4	15.3	12.2	6.7	18.6	21.7	20.3	15.1	21.0	54.4	16.4	20.1	23.2	23.4	14.3	9.1	16.5	27.2	22.8	32.7	19.3	15.4	22.9	24.0	19.1	9.4	14.0	8.5	6.6	18.8	18.8	19.0	25.6	22.5	28.7	23.7	13.3	20.8	20.2	38.2
PCGF5	"MGC16202, RNF159"	ENSG00000180628	"Polycomb group ring finger 5"	Q86SE9	10	91163012-91284337	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 345.7;Oligodendrocytes: 252.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038349, HPA059071"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 25: Spermatids - Spermatogenesis"	Nucleoplasm		"HPA038349: AB_10669523, HPA059071: "	"unprognostic (1.34e-2)"	"unprognostic (8.22e-2)"	"unprognostic (1.25e-2)"	"unprognostic (7.41e-2)"	"unprognostic (1.15e-1)"	"unprognostic (8.35e-2)"	"unprognostic (6.53e-2)"	"unprognostic (6.43e-2)"	"unprognostic (3.89e-1)"	"unprognostic (3.24e-2)"	"unprognostic (3.75e-2)"	"unprognostic (1.49e-1)"	"prognostic favorable (4.98e-4)"	"unprognostic (2.43e-1)"	"unprognostic (2.00e-1)"	"unprognostic (2.56e-2)"	"prognostic favorable (6.90e-4)"	13.7	21.8	17.8	13.1	18.9	5.8	11.9	17.4	20.0	12.0	10.9	15.3	17.6	12.5	10.7	12.8	12.1	12.7	28.3	14.2	25.2	23.4	26.2	13.1	16.9	21.8	21.2	14.9	16.2	19.9	7.2	15.9	17.7	13.7	14.1	16.3	17.6	14.0	15.2	11.2	21.0	11.9	17.6	17.8	14.7	11.4	21.1	19.4	24.2	16.7	15.7	12.2	8.5	23.0	32.9	14.2	11.6	5.0	16.5	25.7	8.3	18.2	37.3	16.2	22.5	2.2	18.7	43.2	8.3	22.9	13.3	6.3	12.6	12.5	28.4	50.1	9.5	20.4	9.0	22.2	21.8	16.0	31.0	11.7	22.6	12.1	16.8	33.2	13.7	19.0	11.1	23.5	25.4	6.1	36.2	4.1	1.7	7.5	8.1	17.8	21.5	11.7	29.6	5.1	5.5	7.8	8.9	9.4	15.6	4.1	7.6	7.1	35.9	19.0	13.4	11.8	21.8	40.8	26.9	38.2	26.7	11.4	6.0	6.4	1.6	2.7	2.6	4.0	4.7	4.0	3.9	2.7	2.1	3.9	3.9	3.9	2.1	5.1	7.7	0.5	2.4	2.6	17.8	18.9	17.4	20.0	14.2	25.2	21.8	21.2	17.7	17.6	21.1	23.0	35.8	6.4	24.0	135.8	60.1	34.4	48.7	34.8	38.7	20.2	26.8	30.6	81.2	28.6	28.3	29.5	16.7	16.5	49.7	82.8	49.0	33.9	127.8	25.2	38.7	33.8	21.6	124.8	99.0	63.9	5.0	32.7	33.1	29.0	23.4	14.0	35.3	58.6	50.5	50.5	159.5	65.4	20.3	73.1	64.9	345.7	19.6	65.9	42.7	56.2	74.0	79.9	40.2	107.1	252.6	54.3	55.1	29.7	72.3	61.2	83.7	59.0	27.9	19.3	13.1	59.1	39.4	78.2	14.4	34.4	31.3	5.6	55.9	10.9	49.0	67.2
PCID2	FLJ11305	ENSG00000126226	"PCI domain containing 2"	Q5JVF3	13	113177536-113208715	"Predicted intracellular proteins"	"mRNA transport, Protein transport, Translocation, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 204.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA069107, HPA073074"	Uncertain		Approved	Nucleoplasm,Nucleoli		NA	Yes			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Nucleoplasm, Nucleoli"		"HPA069107: AB_2686088, HPA073074: AB_2686568"	"unprognostic (2.53e-2)"	"unprognostic (2.94e-2)"	"unprognostic (4.02e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.26e-1)"	"prognostic unfavorable (7.80e-5)"	"unprognostic (1.73e-3)"	"unprognostic (1.50e-1)"	"unprognostic (1.89e-1)"	"unprognostic (1.47e-1)"	"unprognostic (3.02e-2)"	"unprognostic (1.49e-2)"	"prognostic unfavorable (4.24e-6)"	"unprognostic (1.41e-2)"	"unprognostic (5.41e-3)"	"unprognostic (1.45e-1)"	"unprognostic (6.28e-2)"	22.2	29.0	16.6	15.8	17.4	15.5	22.9	19.0	18.8	27.0	18.3	25.2	12.1	23.0	23.0	19.3	25.9	17.1	37.7	16.8	17.3	20.1	23.8	18.6	25.8	16.4	16.6	33.7	23.9	19.1	22.6	15.5	16.4	24.7	18.5	10.7	23.8	19.2	29.1	18.9	20.2	21.8	16.5	24.7	24.4	45.3	17.6	24.4	20.8	24.4	23.0	23.9	22.4	18.8	62.9	26.3	39.1	34.7	70.2	52.3	27.4	47.2	70.7	64.4	59.1	51.9	57.7	50.2	30.7	64.5	81.6	38.8	62.9	42.8	71.2	44.3	62.1	64.8	68.1	45.9	70.0	110.4	25.5	43.3	46.6	40.4	71.1	51.4	51.3	68.5	50.4	19.9	73.6	30.3	59.4	77.9	38.9	115.1	33.2	53.4	43.4	48.0	58.8	31.3	52.0	31.9	29.5	72.2	55.9	39.3	39.9	133.4	33.5	19.0	68.7	27.9	36.2	30.4	30.4	70.4	65.3	74.1	44.2	28.2	25.5	20.0	68.9	34.4	81.6	39.7	58.0	72.5	26.0	39.5	52.2	54.6	3.9	22.6	33.2	24.8	64.7	54.7	16.6	17.4	19.0	18.8	16.8	17.3	16.4	16.6	16.4	16.5	17.6	18.8	26.5	19.2	16.7	16.3	28.4	21.5	29.1	37.8	17.6	23.6	25.5	32.3	27.8	21.5	23.7	14.7	16.7	30.2	38.5	7.8	27.4	22.8	52.8	26.8	35.7	26.2	7.8	32.8	43.6	13.8	24.7	33.8	18.8	21.7	10.8	39.0	18.9	18.4	20.2	37.0	33.7	15.6	16.2	18.2	14.0	18.1	41.3	17.2	16.0	26.2	24.0	19.0	38.1	25.1	40.4	18.1	15.8	40.6	16.8	46.3	13.6	23.6	30.4	23.8	19.7	37.4	30.9	204.4	72.7	17.6	24.7	31.1	43.7	33.0	20.1	25.3
PCIF1	"bA465L10.1, C20orf67, CAPAM, PPP1R121"	ENSG00000100982	"Phosphorylated CTD interacting factor 1"	Q9H4Z3	20	45934683-45948023	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049517	Enhanced		Supported	"Nucleoplasm,Microtubules,Cytokinetic bridge"		Yes	No			"Cluster 5: Granulocytes - Unknown function"	"Cluster 59: Non-specific - Translation"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm	"Microtubules, Cytokinetic bridge"	"HPA049517: AB_2680801"	"unprognostic (5.42e-3)"	"unprognostic (7.76e-2)"	"unprognostic (7.69e-2)"	"prognostic unfavorable (8.86e-4)"	"unprognostic (1.39e-2)"	"unprognostic (4.20e-2)"	"unprognostic (1.89e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.72e-1)"	"unprognostic (7.57e-2)"	"unprognostic (1.29e-1)"	"prognostic favorable (1.50e-6)"	"unprognostic (1.01e-1)"	"unprognostic (4.44e-2)"	"unprognostic (9.14e-3)"	"unprognostic (1.24e-1)"	28.7	28.0	20.7	18.6	23.0	33.9	28.7	30.2	24.2	36.1	17.6	30.7	16.5	39.7	10.8	24.4	35.3	16.3	31.9	20.4	20.2	23.4	19.5	28.2	27.3	22.7	21.6	41.7	29.5	22.8	26.0	17.0	22.1	26.2	11.7	15.9	23.6	21.3	41.7	36.7	27.2	21.3	20.9	34.7	25.4	18.1	21.7	34.4	32.0	27.6	19.6	28.6	29.3	24.9	21.2	29.0	22.0	27.2	15.3	18.2	24.2	8.3	25.1	24.9	24.2	49.3	27.7	22.7	27.4	22.6	28.7	23.4	15.8	29.0	10.8	14.1	11.4	29.1	23.1	33.4	28.2	26.4	28.1	25.5	29.9	15.3	24.5	22.3	21.0	37.1	20.8	30.9	17.9	44.6	52.3	48.3	7.8	25.5	24.9	32.2	20.4	28.0	20.1	21.8	30.2	30.0	31.5	29.5	16.1	11.6	31.0	30.7	18.1	30.7	24.1	27.3	16.8	35.4	22.1	21.0	37.7	23.8	18.2	75.5	47.5	80.2	54.5	47.2	43.0	51.6	47.3	50.2	50.3	56.2	48.6	43.0	74.6	74.3	48.0	40.4	54.4	64.0	20.7	23.0	30.2	24.2	20.4	20.2	22.7	21.6	22.1	20.9	21.7	24.9	19.7	3.2	14.2	4.6	33.7	8.7	26.4	7.9	26.2	9.9	17.0	19.7	21.9	20.0	7.1	11.0	2.1	19.5	32.4	14.6	15.6	21.4	9.6	13.3	10.7	16.1	26.5	25.4	2.5	38.6	22.6	15.4	17.3	13.5	14.5	14.9	9.7	12.4	16.9	13.5	3.6	14.0	4.1	16.0	8.7	8.1	11.5	21.5	17.8	1.0	24.9	12.0	33.0	3.0	3.9	28.3	13.1	12.8	35.5	25.4	14.8	23.2	11.0	13.4	0.0	20.2	19.3	14.4	11.9	23.8	10.7	27.8	30.8	15.1	12.0	38.8
PCLAF	"KIAA0101, NS5ATP9, OEATC-1, p15(PAF), PAF15"	ENSG00000166803	"PCNA clamp associated factor"	Q15004	15	64364304-64387687	"Predicted intracellular proteins"	"DNA damage, DNA repair"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"bone marrow: 128.6;lymphoid tissue: 73.8"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 82.2;Extravillous trophoblasts: 160.2;Granulosa cells: 48.8;Hofbauer cells: 110.2;Syncytiotrophoblasts: 42.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in many"	4	"T-reg: 23.6"	"Lineage enriched"	"Detected in many"	4	"T-cells: 23.6"	"Low cell line specificity"	"Detected in all"											HPA047929			Supported	Centrosome		NA	Yes			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 24: NB-4 - Immune response"	"Cluster 12: Non-specific - Cell cycle regulation"	Centrosome		"HPA047929: AB_2680215"	"unprognostic (5.34e-2)"	"unprognostic (1.36e-3)"	"unprognostic (9.39e-2)"	"unprognostic (1.28e-1)"	"unprognostic (4.16e-1)"	"unprognostic (2.22e-1)"	"prognostic unfavorable (3.26e-5)"	"unprognostic (4.38e-3)"	"unprognostic (1.91e-3)"	"unprognostic (7.26e-2)"	"unprognostic (2.56e-3)"	"unprognostic (9.65e-2)"	"prognostic unfavorable (9.77e-15)"	"unprognostic (5.59e-2)"	"unprognostic (2.05e-1)"	"unprognostic (8.65e-2)"	"unprognostic (3.22e-1)"	2.1	1.4	0.9	22.9	1.0	128.6	3.9	1.4	1.1	1.7	0.8	19.0	14.7	4.5	1.2	15.2	1.3	2.5	0.4	0.9	0.6	1.2	3.6	2.5	49.5	1.0	0.8	0.4	1.9	0.8	0.5	8.7	0.9	2.0	22.6	0.3	2.3	0.3	0.4	6.7	15.8	5.0	0.5	7.4	8.1	1.1	1.0	73.8	2.2	0.1	47.1	7.9	4.9	1.9	212.6	165.8	154.4	140.8	15.9	60.9	134.4	146.2	84.8	185.4	276.4	198.4	202.1	343.7	46.4	57.4	64.8	153.6	340.7	83.1	235.3	192.5	124.8	352.5	202.5	209.8	1.5	285.3	153.8	20.0	7.9	156.4	31.9	52.3	168.9	175.9	201.3	104.4	248.1	187.8	268.0	605.5	73.9	179.9	73.4	416.6	353.8	247.1	115.9	200.2	19.1	86.7	112.8	105.2	69.3	78.9	153.8	365.3	36.3	158.4	308.6	177.8	386.7	65.5	223.4	229.0	67.7	512.9	108.5	2.4	0.3	0.9	1.4	0.2	0.2	2.0	4.4	4.2	2.8	0.6	0.5	1.0	2.7	5.7	0.4	0.3	23.6	2.3	0.9	1.0	1.4	1.1	0.9	0.6	1.0	0.8	0.9	0.5	1.0	1.9	0.5	9.6	11.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	27.5	25.5	0.0	0.0	5.0	1.8	0.0	82.2	8.3	0.0	1.9	6.5	0.0	18.6	10.4	8.5	0.0	0.0	0.0	3.0	160.2	25.4	0.0	13.8	3.8	48.8	0.0	0.0	110.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.7	0.0	0.0	1.0	0.0	0.0	0.0	0.0	4.0	0.0	0.0	4.3	0.0	0.0	3.0	3.6	0.0	0.0	0.0	20.6	0.0	0.0	0.0	0.0	42.1	5.8	7.6	0.0	0.0
PCM1	PTC4	ENSG00000078674	"Pericentriolar material 1"	Q15154	8	17922840-18027975	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Cilium biogenesis/degradation"		"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 528.5;Spermatocytes: 569.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023370, HPA023374, CAB058695"	Enhanced		Supported	"Centriolar satellite,Cytosol"		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Centriolar satellite"	Cytosol	"CAB058695: AB_2665588, HPA023370: AB_1855072, HPA023374: AB_1855073"	"unprognostic (1.52e-2)"	"unprognostic (1.77e-2)"	"unprognostic (6.54e-3)"	"unprognostic (3.35e-2)"	"unprognostic (9.52e-2)"	"unprognostic (1.62e-2)"	"unprognostic (1.40e-1)"	"unprognostic (7.74e-3)"	"unprognostic (1.09e-1)"	"unprognostic (2.26e-1)"	"unprognostic (2.84e-1)"	"unprognostic (2.83e-1)"	"unprognostic (1.76e-2)"	"unprognostic (2.16e-1)"	"unprognostic (4.60e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.45e-1)"	29.5	31.3	32.9	28.1	39.7	52.2	43.1	42.7	37.0	39.3	39.9	37.3	21.8	39.3	41.6	28.1	44.1	30.7	38.6	31.7	35.0	33.0	39.2	33.6	41.5	35.5	34.2	47.0	39.9	52.6	31.0	35.2	37.2	33.5	27.4	76.6	35.1	32.2	105.3	30.4	29.5	30.6	32.8	33.4	27.9	154.2	35.8	56.9	49.0	84.9	37.3	31.0	26.2	47.0	64.0	66.8	100.5	133.4	55.2	57.0	51.7	52.6	64.4	54.9	61.3	45.4	37.0	83.0	35.3	52.8	47.2	45.0	64.8	48.3	93.0	27.6	25.1	142.7	46.2	93.1	61.6	63.7	35.1	50.3	50.6	63.9	70.3	47.9	64.1	84.9	98.4	62.6	67.9	32.0	136.8	103.3	82.7	52.8	19.1	81.0	90.1	30.0	45.3	87.1	76.6	57.6	56.5	30.5	82.1	42.8	48.2	91.0	57.8	49.6	40.5	61.3	45.0	26.6	62.9	72.5	41.8	68.3	52.0	31.5	7.2	18.7	13.0	4.6	13.5	13.0	11.6	15.1	7.3	13.1	12.9	13.2	7.6	13.9	10.0	17.8	13.1	5.6	32.9	39.7	42.7	37.0	31.7	35.0	35.5	34.2	37.2	32.8	35.8	47.0	91.6	128.2	154.9	187.7	109.3	33.8	66.3	44.4	75.7	196.1	74.1	72.0	249.4	62.9	117.2	86.5	350.3	50.9	145.9	33.6	29.4	73.0	528.5	275.2	130.4	86.5	71.2	115.5	219.9	59.0	33.6	100.4	55.0	132.5	142.1	103.9	64.6	50.8	43.3	129.5	211.8	45.7	61.1	61.3	39.7	301.3	92.2	83.6	55.2	162.1	82.8	145.8	132.8	208.6	243.1	58.9	36.0	97.8	84.7	45.8	45.6	25.9	282.1	234.9	124.9	173.8	92.7	569.3	177.1	65.4	38.2	60.5	122.5	92.1	50.6	47.2
PCMT1		ENSG00000120265	"Protein-L-isoaspartate (D-aspartate) O-methyltransferase"	P22061	6	149749443-149811420	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 1022.2;Late spermatids: 428.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003239	Approved		Supported	Cytosol		No	No		4100000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 47: Non-specific - Unknown function"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 29: Early spermatids - Spermatogenesis"	Cytosol		"HPA003239: AB_1079580"	"prognostic unfavorable (4.02e-7)"	"prognostic unfavorable (9.58e-4)"	"unprognostic (1.35e-2)"	"prognostic unfavorable (4.27e-4)"	"unprognostic (1.02e-1)"	"prognostic unfavorable (1.88e-4)"	"prognostic unfavorable (2.58e-4)"	"unprognostic (1.91e-2)"	"unprognostic (1.58e-2)"	"unprognostic (9.02e-2)"	"unprognostic (6.45e-2)"	"unprognostic (6.77e-2)"	"unprognostic (6.14e-2)"	"unprognostic (4.38e-1)"	"unprognostic (1.70e-1)"	"unprognostic (2.17e-2)"	"prognostic unfavorable (6.38e-4)"	48.7	43.2	77.5	32.8	85.1	75.9	46.2	70.2	107.1	46.4	56.4	45.5	36.6	38.8	48.5	45.3	39.2	28.4	121.7	87.5	84.8	51.1	73.8	37.9	41.4	80.3	73.0	39.3	38.1	46.3	43.3	42.9	86.2	52.1	43.1	55.8	39.8	50.1	211.9	44.6	34.6	48.9	71.1	34.5	37.8	76.7	72.3	57.4	49.0	163.3	46.7	40.7	38.0	79.2	87.3	68.4	70.4	88.6	152.1	125.9	77.6	140.7	82.9	114.7	143.4	200.1	65.4	117.9	113.0	127.5	126.5	106.6	123.9	143.6	159.9	79.2	180.0	175.5	122.2	192.1	99.2	203.7	197.7	62.8	105.2	128.5	138.5	80.7	107.6	89.8	256.5	107.7	142.3	258.9	98.5	150.4	56.5	84.7	78.6	83.4	89.7	82.6	108.9	62.4	137.5	52.4	111.2	173.9	97.7	82.5	107.8	146.1	83.3	67.2	80.7	124.7	151.2	64.1	109.9	115.4	103.6	135.8	137.7	162.9	193.2	178.0	93.0	182.4	94.7	105.0	93.7	102.8	176.0	81.5	86.5	98.0	101.6	108.5	185.7	79.9	129.2	204.1	77.5	85.1	70.2	107.1	87.5	84.8	80.3	73.0	86.2	71.1	72.3	79.2	57.0	54.5	41.4	21.2	62.6	175.1	74.4	204.4	56.3	72.6	48.0	40.6	154.1	60.1	96.4	79.1	37.5	169.3	66.8	56.6	78.2	113.5	1022.2	51.9	58.4	69.8	55.2	170.1	77.0	110.7	214.0	79.2	26.0	48.8	107.7	38.8	53.9	115.6	119.1	65.6	52.8	72.9	187.2	78.7	127.5	428.1	71.7	78.2	138.7	31.9	143.7	121.2	74.2	30.7	72.2	106.6	57.9	73.7	71.8	67.8	65.1	89.3	106.2	66.3	111.7	64.0	110.4	224.9	96.3	60.7	157.6	148.3	83.0	55.0	58.7	59.1
PCNT	"KEN, KIAA0402, PCN, PCNT2, PCNTB, SCKL4"	ENSG00000160299	Pericentrin	O95613	21	46324141-46445769	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"		Calmodulin-binding	Dwarfism	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"skeletal muscle: 239.2"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	6	"dendritic cells: 4.6;granulocytes: 6.0;T-cells: 8.8"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016820, HPA019887, HPA032101"	Uncertain		Supported	"Centriolar satellite,Centrosome,Cytosol"		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 33: Striated muscle - Muscle contraction"	"Cluster 36: HEL - Hemostasis"	"Cluster 37: Myocytes - Muscle contraction"	Centrosome	"Centriolar satellite, Cytosol"	"HPA016820: AB_1855079, HPA019887: AB_1855080, HPA032101: AB_2674151"	"unprognostic (9.07e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.65e-2)"	"unprognostic (1.30e-2)"	"unprognostic (5.35e-2)"	"unprognostic (3.40e-3)"	"unprognostic (1.27e-2)"	"unprognostic (2.59e-1)"	"unprognostic (9.29e-2)"	"unprognostic (1.35e-2)"	"unprognostic (1.59e-3)"	"unprognostic (3.86e-2)"	"unprognostic (1.95e-2)"	"unprognostic (5.83e-2)"	"unprognostic (2.90e-1)"	"unprognostic (3.36e-1)"	"unprognostic (5.86e-2)"	9.7	11.1	7.6	5.9	10.5	17.7	8.9	4.2	11.9	8.6	5.3	10.7	4.1	8.2	4.3	11.7	8.5	3.6	28.3	6.0	5.4	7.7	10.9	8.2	8.2	9.0	3.9	9.6	7.8	4.3	20.3	3.5	9.5	8.2	4.3	4.6	9.7	4.2	239.2	12.3	10.1	4.4	2.6	11.5	9.5	25.6	4.7	12.5	8.4	52.0	5.5	9.6	9.2	7.4	15.4	11.6	18.0	11.1	8.9	8.8	11.3	11.6	8.0	11.3	10.0	14.2	9.7	15.2	7.3	13.4	15.3	10.8	14.6	9.9	7.8	44.9	20.4	40.2	24.1	11.3	3.1	20.6	16.1	4.8	7.5	15.2	7.6	5.5	8.8	15.8	20.9	22.4	15.8	25.4	20.6	21.3	18.0	13.9	8.0	25.3	7.2	13.5	8.7	16.3	22.1	9.8	25.4	15.7	8.0	4.4	14.8	16.0	12.1	20.4	10.2	11.7	18.9	19.3	17.2	16.4	12.6	19.9	11.1	6.0	0.6	1.2	1.5	0.5	4.6	0.3	0.7	4.8	2.0	0.1	0.5	8.8	0.4	0.4	1.0	4.6	0.8	2.0	7.6	10.5	4.2	11.9	6.0	5.4	9.0	3.9	9.5	2.6	4.7	7.4	10.5	28.9	32.0	19.9	8.6	8.3	5.7	7.0	13.6	15.0	8.9	8.6	35.7	10.0	15.3	0.0	6.2	6.4	36.7	14.0	0.0	7.1	20.4	17.0	19.9	10.1	15.6	36.2	38.1	7.6	7.4	13.1	25.0	17.8	16.4	25.4	7.1	9.0	23.3	23.5	39.0	11.2	4.1	6.9	5.5	25.6	12.8	12.7	0.0	17.8	14.7	6.8	25.7	10.6	21.9	5.7	5.7	12.0	31.4	4.2	5.7	4.1	13.0	11.1	26.3	61.3	14.2	40.5	39.8	25.0	7.1	6.4	18.8	15.1	10.4	5.1
PCSK5	"PC5, PC6, SPC6"	ENSG00000099139	"Proprotein convertase subtilisin/kexin type 5"	Q92824	9	75890644-76362975	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	Pregnancy	"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 189.7;Inhibitory neurons: 81.9;NK-cells: 82.4;Oligodendrocyte precursor cells: 149.3;Proximal enterocytes: 99.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	8	"basophil: 2447.1;neutrophil: 626.3"	"Lineage enriched"	"Detected in all"	18	"granulocytes: 2447.1"	"Cell line enhanced"	"Detected in many"		"BEWO: 32.6;HaCaT: 46.9;RH-30: 30.4;RPTEC TERT1: 42.5;U-2 OS: 66.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA031072	Approved		Supported	"Golgi apparatus"	"Secreted to blood"	NA	NA		290000	"Cluster 41: Basophils - Cellular respiration"	"Cluster 45: Intestine - Brush border"	"Cluster 9: U-2 OS - Unknown function"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Golgi apparatus"		"HPA031072: AB_10602190"	"unprognostic (3.28e-2)"	"unprognostic (1.44e-1)"	"unprognostic (4.13e-4)"	"unprognostic (4.08e-2)"	"unprognostic (7.43e-3)"	"unprognostic (3.17e-1)"	"unprognostic (2.07e-3)"	"unprognostic (9.39e-2)"	"unprognostic (1.15e-1)"	"unprognostic (5.92e-2)"	"unprognostic (2.81e-2)"	"unprognostic (6.80e-2)"	"prognostic unfavorable (9.61e-5)"	"unprognostic (2.99e-1)"	"unprognostic (3.21e-2)"	"unprognostic (3.22e-2)"	"unprognostic (1.77e-5)"	17.6	4.2	6.6	5.9	6.6	2.3	6.9	22.2	23.8	9.0	0.0	10.2	25.0	7.1	9.6	8.5	6.9	8.6	5.3	7.4	7.8	3.8	1.7	6.1	2.7	21.7	17.3	13.5	3.0	5.9	2.3	9.4	20.0	3.3	8.4	6.0	3.5	3.0	3.0	3.6	26.4	6.6	23.0	3.3	3.3	6.3	5.3	9.1	4.8	5.4	2.5	5.3	8.8	2.4	2.5	1.8	5.1	3.4	3.2	1.0	32.6	4.7	0.4	0.3	0.0	18.7	2.0	0.8	1.3	0.6	0.1	46.9	2.4	1.4	0.3	0.6	4.1	6.3	4.5	1.6	0.8	1.9	2.8	6.0	0.4	1.0	0.5	0.3	9.6	3.1	7.5	2.4	3.3	11.5	7.4	11.1	22.8	4.3	1.9	1.3	30.4	1.9	42.5	2.9	0.7	0.5	7.1	1.5	0.5	9.5	2.6	8.0	7.6	1.5	66.5	3.8	2.0	0.7	0.3	1.0	5.1	2.7	25.7	2447.1	43.1	192.4	100.0	25.9	85.2	92.3	100.8	93.7	21.8	116.5	98.2	125.2	626.3	135.5	51.6	135.0	96.9	10.1	6.6	6.6	22.2	23.8	7.4	7.8	21.7	17.3	20.0	23.0	5.3	2.4	41.1	6.4	7.2	189.7	0.1	6.5	3.5	8.6	13.6	4.8	0.7	2.0	5.8	11.5	14.3	5.5	0.0	2.1	9.6	47.3	0.0	8.2	19.0	6.0	35.1	19.5	1.2	0.0	33.5	6.1	34.3	26.6	9.7	10.6	0.0	32.1	15.0	0.9	2.9	55.5	81.9	10.2	6.1	4.1	3.9	39.4	20.5	7.5	1.8	70.3	11.4	30.3	82.4	149.3	5.8	10.1	18.5	25.2	0.4	2.9	99.2	4.2	23.4	1.4	19.7	9.1	11.4	1.0	1.9	6.2	3.0	2.5	6.2	5.6	23.9	0.9
PDCD11	"ALG-4, KIAA0185, NFBP, RRP5"	ENSG00000148843	"Programmed cell death 11"	Q14690	10	103396626-103446294	"Plasma proteins, Predicted intracellular proteins"	"rRNA processing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 61.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017924, CAB026472"	Approved		Supported	"Nucleoli rim,Vesicles"		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 29: Early spermatids - Spermatogenesis"	"Nucleoli rim"	Vesicles	"CAB026472: , HPA017924: AB_10601045"	"unprognostic (1.34e-1)"	"unprognostic (6.84e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.31e-2)"	"unprognostic (1.80e-1)"	"unprognostic (8.94e-2)"	"prognostic unfavorable (2.79e-4)"	"unprognostic (2.11e-1)"	"unprognostic (1.89e-1)"	"unprognostic (1.16e-1)"	"unprognostic (6.49e-2)"	"unprognostic (3.25e-2)"	"unprognostic (9.29e-2)"	"unprognostic (1.01e-2)"	"unprognostic (1.77e-1)"	"unprognostic (6.28e-2)"	"unprognostic (5.59e-2)"	8.1	7.8	4.1	10.0	4.8	7.5	9.4	4.5	4.6	8.7	4.5	7.7	5.9	9.9	5.9	11.7	9.0	4.4	7.5	4.4	4.7	9.8	9.1	7.3	11.0	4.4	4.5	10.4	11.6	8.5	6.4	7.5	4.6	8.0	7.9	6.1	7.2	6.2	15.8	15.5	7.7	9.1	4.1	9.5	7.3	14.8	5.1	11.9	6.9	8.1	11.8	9.9	8.4	5.0	27.4	39.8	27.2	77.0	23.3	20.9	30.5	29.6	20.7	29.2	23.7	54.7	26.3	74.9	20.5	21.4	18.0	48.0	70.6	37.1	32.5	34.8	47.5	43.7	26.0	44.2	27.7	88.0	28.7	21.8	33.3	44.8	101.3	21.0	31.6	19.4	71.5	32.7	28.4	30.9	44.5	49.9	55.9	21.7	37.9	44.3	39.0	34.1	18.1	26.6	18.2	34.1	19.9	23.2	32.6	26.4	22.8	24.8	34.5	21.5	27.0	29.0	55.9	41.2	61.8	69.5	19.0	83.3	16.2	0.1	2.8	0.9	3.2	2.6	5.2	3.4	3.1	2.7	2.8	2.2	2.7	3.2	0.3	2.1	2.3	3.3	2.3	2.5	4.1	4.8	4.5	4.6	4.4	4.7	4.4	4.5	4.6	4.1	5.1	5.0	8.8	12.8	14.1	5.9	13.6	16.4	9.3	10.8	8.0	15.0	18.6	15.6	14.6	20.0	17.4	9.2	29.2	12.8	18.1	9.6	13.7	23.6	61.2	12.6	25.4	14.4	9.5	14.9	11.8	15.8	15.8	14.0	5.6	11.7	18.9	18.5	8.9	24.5	10.9	6.7	9.3	12.9	4.1	7.7	5.2	19.6	11.1	10.7	10.6	8.4	9.8	4.9	9.2	7.5	7.6	29.1	4.9	10.1	9.6	17.9	4.4	8.2	20.2	13.8	6.6	16.8	11.0	27.5	30.7	14.0	16.9	8.2	11.6	19.0	19.9	8.7
PDCD6	"ALG-2, PEF1B"	ENSG00000249915	"Programmed cell death 6"	O75340	5	271621-314974	"Plasma proteins, Predicted intracellular proteins, Transporters"	"Angiogenesis, Apoptosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047221			Supported	Nucleoplasm,Cytosol		No	No		1800000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 20: HeLa - Mitochondria"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Cytosol	Nucleoplasm	"HPA047221: "	"unprognostic (1.32e-1)"	"unprognostic (5.01e-2)"	"unprognostic (2.10e-2)"	"unprognostic (4.41e-3)"	"unprognostic (4.94e-2)"	"unprognostic (1.01e-1)"	"prognostic unfavorable (5.47e-5)"	"unprognostic (1.56e-1)"	"unprognostic (1.27e-2)"	"unprognostic (4.37e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.46e-2)"	"prognostic unfavorable (5.16e-6)"	"unprognostic (7.97e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.67e-1)"	"prognostic favorable (2.19e-4)"	63.3	108.3	89.0	48.7	90.4	42.1	74.8	95.4	102.6	73.4	88.1	83.0	71.6	63.4	98.2	134.8	64.8	48.4	53.5	91.1	92.9	114.6	85.0	53.1	59.9	92.2	88.9	61.7	65.5	77.3	76.4	61.4	90.5	64.3	85.4	29.6	73.9	54.4	42.3	72.7	71.8	52.8	94.9	77.0	69.0	50.3	90.3	81.2	72.8	27.3	74.5	72.7	86.9	100.1	151.8	208.6	88.4	133.5	156.1	141.9	185.6	115.5	151.9	144.2	134.6	147.3	186.4	119.6	283.2	155.4	187.2	112.9	137.3	288.2	116.0	409.9	170.9	105.9	508.7	194.0	193.3	155.7	129.5	128.1	175.0	117.4	208.9	148.3	137.9	81.2	136.8	90.3	130.7	237.7	125.7	270.1	95.6	183.8	295.1	102.0	83.8	171.5	344.7	192.6	86.3	117.5	297.2	309.4	224.7	91.9	215.1	210.7	108.5	94.0	76.9	82.8	100.0	121.4	163.4	141.8	138.9	198.9	128.9	172.8	209.7	284.4	158.2	206.0	199.7	251.9	196.4	179.6	229.3	224.6	217.8	175.5	231.0	260.7	206.6	183.2	236.7	356.2	89.0	90.4	95.4	102.6	91.1	92.9	92.2	88.9	90.5	94.9	90.3	100.1	134.6	64.1	57.4	9.4	99.5	82.1	129.6	250.6	85.4	47.9	140.1	182.1	50.4	78.6	146.7	103.0	37.5	239.1	104.4	146.4	252.4	172.0	55.4	130.9	91.6	110.7	79.7	83.9	10.7	129.1	321.6	104.3	68.8	99.9	82.5	101.3	69.9	77.7	140.4	63.9	11.3	187.5	219.7	84.1	75.5	55.5	117.4	90.0	124.5	10.3	175.3	136.8	137.0	5.5	11.0	164.0	136.7	116.6	57.7	170.7	175.6	205.1	181.9	42.0	85.5	85.3	109.5	100.8	137.8	123.8	92.5	356.7	92.6	173.3	192.3	176.6
PDCD6IP	"AIP1, Alix, Hp95"	ENSG00000170248	"Programmed cell death 6 interacting protein"	Q8WUM4	3	33798571-33869707	"Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Cell cycle, Cell division, Host-virus interaction, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal enterocytes: 299.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA011905, CAB016212, HPA051604"	Approved		Approved	Vesicles,Centrosome	"Intracellular and membrane"	NA	NA		4100000	"Cluster 27: Non-specific - Gene expression"	"Cluster 37: Intestine - Unknown function"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Vesicles	Centrosome	"CAB016212: AB_673819, HPA011905: AB_1855111, HPA051604: "	"unprognostic (1.53e-1)"	"unprognostic (2.63e-1)"	"prognostic favorable (1.16e-4)"	"unprognostic (2.17e-1)"	"unprognostic (2.75e-1)"	"unprognostic (5.12e-2)"	"unprognostic (7.76e-3)"	"unprognostic (1.23e-2)"	"unprognostic (3.29e-1)"	"unprognostic (2.86e-1)"	"unprognostic (3.88e-3)"	"unprognostic (4.49e-2)"	"prognostic favorable (3.90e-9)"	"unprognostic (9.61e-2)"	"unprognostic (1.89e-1)"	"unprognostic (4.78e-1)"	"unprognostic (1.11e-1)"	33.1	27.6	16.3	24.5	17.9	21.2	32.9	18.4	23.3	35.0	23.0	46.4	36.2	35.1	26.4	46.0	30.9	25.9	30.5	17.6	19.7	35.0	33.2	35.2	26.1	25.2	18.1	34.3	25.0	40.6	22.8	31.2	26.4	30.0	41.5	30.5	29.7	23.7	33.9	39.8	38.8	31.8	18.6	27.5	37.2	23.8	18.8	24.4	34.2	22.1	30.1	26.9	35.9	21.4	47.2	46.4	30.2	25.1	78.5	80.6	34.3	67.2	56.2	50.9	52.2	33.3	43.8	75.9	33.8	77.7	32.2	45.5	47.8	61.4	57.8	27.4	39.5	56.7	37.4	28.2	50.8	56.5	57.6	62.2	69.5	57.6	67.8	60.5	77.1	32.4	50.3	26.2	74.4	27.0	36.3	31.8	29.9	43.5	57.8	32.8	36.5	43.8	64.6	39.2	14.7	26.8	61.6	67.8	30.7	48.9	62.0	51.4	101.1	59.5	28.2	50.1	46.9	26.6	37.6	55.6	56.7	62.6	28.8	6.8	13.5	11.0	8.0	18.1	8.7	12.0	8.9	8.1	12.4	10.8	7.7	7.5	6.8	12.1	18.0	5.0	9.4	10.0	16.3	17.9	18.4	23.3	17.6	19.7	25.2	18.1	26.4	18.6	18.8	21.4	78.5	86.6	84.8	85.8	76.1	41.7	62.6	62.7	51.8	28.6	42.5	34.0	53.4	62.9	80.6	64.4	52.1	53.0	58.5	299.9	37.2	67.2	85.3	121.6	84.0	68.8	36.1	40.6	83.5	78.3	52.8	54.3	96.8	77.8	53.7	53.0	54.3	57.3	60.6	25.2	69.2	97.1	63.1	93.0	44.7	50.4	74.0	85.0	28.4	75.9	71.0	23.1	42.2	96.0	161.7	122.5	127.1	80.5	46.9	56.5	130.2	61.0	130.9	49.9	46.0	42.3	50.4	93.0	48.4	61.5	43.2	96.6	55.2	47.7	86.7	70.3
PDE2A		ENSG00000186642	"Phosphodiesterase 2A"	O00408	11	72576141-72674591	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 197.0"	"Group enriched"	"Detected in many"	6	"Adipocytes: 114.9;Endothelial cells: 58.5;Enteroendocrine cells: 34.4;Excitatory neurons: 70.1;Hepatic stellate cells: 118.2;Inhibitory neurons: 35.6"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"amygdala: 75.1;basal ganglia: 84.7;cerebral cortex: 102.1;hippocampal formation: 84.4;white matter: 48.3"	"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"B-cells: 2.8;T-cells: 7.3"	"Cell line enriched"	"Detected in some"	8	"HeLa: 513.6"	"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in all"	5	"amygdala: 83.5;basal ganglia: 146.9;cerebral cortex: 90.5;hippocampal formation: 94.0"	"CAB009752, HPA031192"	Enhanced		Supported	Cytosol		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 64: Macrophages - Immune response"	"Cluster 20: HeLa - Mitochondria"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Cytosol		"CAB009752: AB_2268159, HPA031192: AB_2673781"	"unprognostic (1.92e-1)"	"unprognostic (1.52e-3)"	"unprognostic (4.58e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.26e-1)"	"unprognostic (2.50e-1)"	"prognostic favorable (1.76e-6)"	"unprognostic (3.06e-2)"	"unprognostic (1.35e-1)"	"unprognostic (3.01e-3)"	"unprognostic (3.13e-3)"	"unprognostic (1.50e-2)"	"unprognostic (1.77e-2)"	"unprognostic (2.85e-3)"	"unprognostic (6.31e-2)"	"unprognostic (7.72e-2)"	"unprognostic (7.96e-4)"	89.2	44.1	75.1	5.1	84.7	4.7	83.6	0.0	102.1	38.1	0.0	34.6	6.0	27.2	8.3	18.6	39.3	22.7	41.1	84.4	7.0	32.5	19.4	12.6	6.7	6.4	5.1	11.6	6.9	5.5	11.8	12.0	10.1	20.7	8.9	3.0	9.2	10.7	16.8	18.1	18.7	18.5	0.0	197.0	17.1	7.4	17.9	3.8	24.1	28.9	3.5	28.8	27.1	48.3	0.3	0.2	0.7	0.2	0.2	0.1	0.3	0.1	0.2	0.2	0.4	0.4	2.5	0.8	12.2	0.2	1.9	0.2	0.9	0.1	0.1	0.1	0.1	0.0	513.6	0.8	0.9	0.0	7.8	0.1	1.1	2.7	20.5	1.1	11.3	0.5	0.8	0.9	0.1	0.0	0.2	0.2	7.4	0.2	14.0	0.0	0.2	1.4	0.1	0.3	44.5	2.4	0.4	0.2	2.2	0.7	0.3	0.1	65.2	0.1	9.4	3.5	0.4	0.4	0.2	0.1	3.9	0.1	0.6	0.0	0.6	0.0	7.3	0.8	4.2	2.8	4.3	4.3	1.0	1.8	2.7	2.3	0.1	0.0	0.4	0.0	1.8	1.5	75.1	84.7	0.0	102.1	84.4	7.0	6.4	5.1	10.1	0.0	17.9	48.3	114.9	0.0	0.5	2.0	0.7	2.5	0.1	0.0	0.0	4.9	0.6	1.0	7.8	0.0	0.0	0.0	0.0	0.0	1.6	0.2	0.0	0.0	0.6	0.0	0.1	58.5	34.4	5.3	70.1	0.0	0.3	2.1	0.0	0.1	1.3	0.1	118.2	2.1	0.5	1.7	35.6	1.2	0.0	9.4	8.2	2.5	0.3	4.9	1.8	11.2	0.0	0.0	0.0	9.0	5.7	0.1	0.0	0.4	1.5	0.1	0.0	0.1	0.0	0.4	0.0	1.8	6.6	4.8	2.5	0.5	2.8	0.0	0.6	0.2	0.1	0.3
PDE4A	DPDE2	ENSG00000065989	"Phosphodiesterase 4A"	P27815	19	10416773-10469630	"Enzymes, FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins"		Hydrolase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Langerhans cells: 190.8;Late spermatids: 197.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HMC-1: 36.5;NB-4: 43.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017632, HPA043310, HPA076091"	Uncertain		Supported	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 47: Non-specific - Unknown function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 25: Spermatids - Spermatogenesis"	"Plasma membrane"	Nucleoplasm	"CAB017632: AB_1127109, HPA043310: AB_2678419, HPA076091: AB_2686775"	"unprognostic (1.29e-2)"	"unprognostic (3.98e-2)"	"unprognostic (8.91e-2)"	"unprognostic (1.82e-1)"	"unprognostic (7.00e-2)"	"unprognostic (6.84e-2)"	"unprognostic (1.54e-2)"	"unprognostic (4.39e-2)"	"unprognostic (7.91e-2)"	"unprognostic (1.52e-2)"	"unprognostic (6.90e-2)"	"unprognostic (2.41e-1)"	"unprognostic (2.27e-2)"	"unprognostic (1.64e-2)"	"unprognostic (2.57e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.15e-1)"	13.7	5.6	10.9	5.9	12.5	5.4	9.7	3.0	32.3	12.4	0.0	11.0	2.7	9.8	1.4	4.1	7.5	6.6	12.5	11.8	7.9	7.0	2.5	13.0	3.2	21.9	7.1	1.5	12.7	22.2	3.9	6.5	20.8	8.4	4.0	5.3	9.8	4.8	37.9	5.4	6.5	6.2	1.1	8.2	12.9	24.5	13.0	1.6	11.0	16.9	2.6	8.2	8.2	15.7	0.1	2.5	0.5	6.7	18.7	11.1	3.7	5.6	11.1	0.7	1.9	6.0	5.4	2.6	16.1	14.6	0.4	0.6	3.9	0.7	0.4	6.7	5.5	23.7	8.1	6.7	12.3	3.9	36.5	8.3	0.8	6.2	0.0	0.7	5.3	2.1	18.9	5.5	4.0	1.7	2.3	43.3	2.9	6.7	4.7	15.6	3.7	20.3	0.9	1.4	4.2	1.5	0.4	0.2	6.2	1.0	0.8	7.8	11.2	8.3	10.5	5.7	3.7	10.9	0.9	12.4	3.5	0.3	6.7	4.1	1.7	3.4	0.8	2.5	0.4	0.1	0.3	1.1	2.0	0.0	0.0	0.4	0.1	3.0	2.7	0.1	0.7	1.1	10.9	12.5	3.0	32.3	11.8	7.9	21.9	7.1	20.8	1.1	13.0	15.7	9.4	3.2	11.6	6.2	10.8	10.1	2.6	2.5	1.8	25.6	6.4	4.3	7.7	8.6	5.5	9.2	0.0	0.5	58.9	7.1	0.0	3.1	48.9	2.1	20.7	8.6	0.0	1.7	39.4	12.9	4.8	12.1	7.1	3.6	31.8	0.3	10.4	0.9	10.2	55.5	43.5	5.1	6.1	22.1	190.8	197.0	17.4	53.9	14.2	12.2	15.4	1.2	22.6	12.5	1.5	12.3	3.8	18.0	27.0	3.0	0.1	0.2	6.9	3.6	6.6	9.0	10.2	8.6	8.5	0.5	8.1	0.4	37.0	1.0	6.8	1.3
PDE4D	DPDE3	ENSG00000113448	"Phosphodiesterase 4D"	Q08499	5	58969038-60522120	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"		Hydrolase	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 74.9;skeletal muscle: 70.4"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 619.3;Excitatory neurons: 2969.7;Inhibitory neurons: 1116.9;Oligodendrocyte precursor cells: 848.0;Oligodendrocytes: 443.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in many"	5	"eosinophil: 57.9"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 57.9"	"Cell line enhanced"	"Detected in many"		"A549: 62.2;AN3-CA: 70.4;HeLa: 104.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045895	Uncertain		Supported	"Plasma membrane,Cytosol"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 59: Non-specific - Translation"	"Cluster 20: HeLa - Mitochondria"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Plasma membrane"	Cytosol	"HPA045895: AB_10960275"	"unprognostic (1.14e-1)"	"unprognostic (8.73e-3)"	"unprognostic (4.35e-2)"	"unprognostic (7.87e-2)"	"unprognostic (5.97e-2)"	"unprognostic (2.03e-1)"	"unprognostic (8.10e-4)"	"unprognostic (1.17e-1)"	"unprognostic (6.59e-2)"	"unprognostic (1.84e-1)"	"unprognostic (2.71e-1)"	"unprognostic (2.65e-1)"	"prognostic favorable (4.00e-5)"	"unprognostic (1.51e-1)"	"unprognostic (8.20e-2)"	"unprognostic (1.77e-2)"	"unprognostic (2.56e-2)"	8.9	1.3	3.3	9.8	9.9	74.9	4.6	0.0	11.3	5.3	0.0	21.0	5.5	7.4	18.4	13.7	7.3	9.1	15.7	4.4	4.2	17.2	2.8	13.3	5.3	7.0	2.0	3.0	3.7	5.5	6.7	16.6	1.2	19.9	15.0	21.4	7.4	21.2	70.4	4.5	7.0	15.3	0.8	4.0	10.3	3.4	3.8	8.6	7.4	34.4	5.6	22.0	8.2	5.7	0.1	62.2	12.8	70.4	2.3	4.4	10.1	1.6	1.8	3.4	4.9	24.5	2.0	4.8	0.2	0.5	10.3	10.6	0.0	2.8	5.9	2.9	7.0	9.2	104.6	5.3	9.1	4.4	0.7	9.3	2.3	9.6	1.7	1.1	7.3	0.3	0.0	1.6	5.9	4.5	3.6	10.3	2.4	1.8	3.2	1.2	16.0	10.5	15.9	23.5	2.3	8.0	16.4	27.1	14.2	11.4	1.9	9.3	8.5	0.9	0.2	12.0	3.3	3.5	0.1	0.5	10.3	17.3	2.7	4.2	2.0	57.9	1.5	0.1	1.5	11.0	1.4	0.7	1.4	11.3	0.9	0.7	3.1	0.4	0.2	0.0	0.8	1.1	3.3	9.9	0.0	11.3	4.4	4.2	7.0	2.0	1.2	0.8	3.8	5.7	22.5	32.1	110.0	619.3	32.3	10.6	30.1	6.6	35.3	20.2	5.1	2.7	35.7	8.6	30.2	42.3	73.0	11.3	118.6	28.1	11.7	0.6	21.4	19.0	8.6	16.9	33.4	2.1	2969.7	1.8	25.7	27.5	40.2	21.9	22.2	0.3	17.2	0.8	5.2	1.7	1116.9	18.2	6.1	4.8	11.1	36.6	1.5	29.5	10.6	407.5	6.0	12.0	29.9	848.0	443.3	8.2	11.9	4.9	44.4	43.3	8.9	27.5	19.4	52.8	0.0	64.0	6.3	1.1	7.7	40.6	8.8	3.1	94.3	1.1	11.7	26.5
PDE4DIP	"CMYA2, KIAA0454, KIAA0477, MMGL"	ENSG00000178104	"Phosphodiesterase 4D interacting protein"	Q5VU43	1	148808181-149048286	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	8	"heart muscle: 729.5;skeletal muscle: 2164.0;tongue: 1379.7"	"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 702.6;Rod photoreceptor cells: 272.3;Syncytiotrophoblasts: 309.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"ASC diff: 289.6;ASC TERT1: 233.8;K-562: 222.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA012678			Supported	"Golgi apparatus"		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 54: Cardiomyocytes - Muscle contraction"	"Golgi apparatus"		"HPA012678: AB_1855123"	"unprognostic (2.14e-1)"	"unprognostic (3.27e-1)"	"unprognostic (5.31e-2)"	"unprognostic (6.73e-2)"	"unprognostic (7.82e-2)"	"unprognostic (1.16e-2)"	"unprognostic (2.17e-1)"	"unprognostic (9.72e-2)"	"unprognostic (7.65e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.23e-2)"	"unprognostic (5.08e-2)"	"unprognostic (1.70e-3)"	"unprognostic (1.82e-1)"	"unprognostic (4.14e-2)"	"unprognostic (9.13e-2)"	"unprognostic (2.28e-1)"	32.9	16.9	103.0	20.9	82.9	15.8	22.3	142.7	106.1	28.0	32.4	22.5	24.2	17.4	73.5	37.9	19.8	19.5	729.5	115.5	118.5	42.0	63.5	36.1	21.7	102.2	95.6	8.6	21.4	84.6	53.1	68.5	109.7	29.2	25.4	173.3	34.9	22.9	2164.0	26.1	29.4	18.8	96.8	17.2	29.7	9.2	139.9	12.1	16.9	1379.7	23.2	24.0	17.1	114.9	39.2	7.5	10.6	11.6	289.6	233.8	60.7	45.2	42.3	42.7	55.7	35.5	24.1	19.8	13.7	64.5	121.3	19.8	25.7	31.5	72.1	14.7	36.8	10.0	16.2	14.2	76.2	8.8	10.2	167.5	61.9	181.7	97.8	96.9	17.1	16.3	222.1	45.0	76.8	66.2	6.9	5.4	37.1	32.3	15.9	14.6	26.5	7.7	25.4	39.9	50.1	4.7	44.1	123.4	36.1	44.7	37.5	11.7	22.9	49.3	11.2	124.7	100.9	19.9	29.6	29.1	200.6	8.0	30.2	10.6	5.7	4.5	5.3	6.1	5.5	12.0	10.6	7.1	7.0	11.0	8.1	4.5	1.3	4.9	2.1	3.0	14.4	4.8	103.0	82.9	142.7	106.1	115.5	118.5	102.2	95.6	109.7	96.8	139.9	114.9	5.7	51.3	45.1	81.3	24.0	28.8	9.9	19.8	23.3	71.0	16.1	11.3	702.6	24.3	45.4	69.9	114.7	184.6	9.5	24.0	62.6	13.1	38.9	41.1	14.2	15.7	43.2	7.4	85.8	7.1	148.3	54.2	20.4	27.0	13.9	6.1	5.3	80.8	45.0	33.7	81.1	32.0	20.3	46.1	90.4	50.0	10.5	68.7	55.2	6.5	21.5	45.7	14.4	65.9	41.5	4.5	25.1	9.8	37.5	4.1	48.8	20.7	88.0	272.3	32.9	131.2	40.1	8.7	15.9	14.6	16.3	309.2	24.0	4.2	24.2	4.3
PDE9A		ENSG00000160191	"Phosphodiesterase 9A"	O76083	21	42653621-42775509	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 74.7"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 90.8;Paneth cells: 105.3;Proximal enterocytes: 233.5"	"Cancer enriched"	"Detected in all"	5	"prostate cancer: 31.5"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"naive CD4 T-cell: 3.1"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"AF22: 29.7;EFO-21: 30.0;MCF7: 23.2;NB-4: 34.7;NTERA-2: 41.2;SCLC-21H: 22.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011380, HPA011978"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 37: Intestine - Unknown function"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 45: Enterocytes - Digestion"	Cytosol	"Nucleoplasm, Plasma membrane"	"HPA011380: AB_1855132, HPA011978: "	"unprognostic (5.75e-2)"	"unprognostic (9.92e-3)"	"unprognostic (3.50e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.40e-1)"	"unprognostic (5.06e-2)"	"unprognostic (3.99e-2)"	"unprognostic (6.02e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.25e-2)"	"unprognostic (5.01e-2)"	"unprognostic (1.90e-2)"	"unprognostic (4.01e-3)"	"unprognostic (1.97e-1)"	"unprognostic (6.55e-2)"	"unprognostic (1.79e-1)"	9.4	11.1	12.3	3.9	15.1	0.5	10.8	14.0	12.9	7.2	8.6	74.7	2.9	5.1	19.4	3.7	10.6	6.8	4.3	10.6	12.6	29.8	4.2	4.9	4.8	12.4	14.4	3.5	4.1	6.5	9.9	10.3	12.7	38.5	16.4	10.7	12.7	15.8	2.4	7.0	47.3	8.8	11.0	18.3	13.4	1.9	15.0	7.8	6.5	4.8	3.1	18.9	6.2	12.0	0.0	2.8	29.7	3.7	0.0	0.8	0.5	0.0	0.0	0.0	0.0	3.2	18.2	0.0	30.0	0.0	2.2	0.0	2.7	9.8	0.0	0.0	10.4	0.0	0.0	6.4	2.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.5	0.0	0.0	23.2	1.5	34.7	41.2	14.6	0.0	0.0	0.0	1.2	20.4	7.6	22.5	13.5	5.2	0.0	0.5	7.0	0.2	19.1	0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.0	0.0	12.4	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.9	0.2	0.1	0.2	3.1	0.6	0.4	0.9	0.0	0.4	1.0	0.3	12.3	15.1	14.0	12.9	10.6	12.6	12.4	14.4	12.7	11.0	15.0	12.0	18.6	3.2	5.0	43.4	1.6	1.0	10.9	4.2	6.2	26.4	13.4	12.6	1.6	5.7	2.4	18.4	0.0	0.0	1.0	90.8	29.4	7.3	0.6	18.1	8.5	11.9	13.1	3.2	5.6	2.4	0.1	5.9	1.5	26.8	1.3	6.1	5.7	0.9	7.5	35.3	10.8	25.8	8.2	1.3	0.8	2.2	11.8	1.6	28.4	31.9	1.1	11.0	0.0	29.1	16.6	5.3	105.3	6.0	0.2	28.1	233.5	8.9	1.3	2.8	13.1	0.5	6.4	0.4	2.3	0.5	0.6	0.4	3.8	16.9	24.4	15.0
PDGFC	"fallotein, SCDGF"	ENSG00000145431	"Platelet derived growth factor C"	Q9NRA1	4	156760454-156971799	"Predicted secreted proteins, RAS pathway related proteins"		"Developmental protein, Growth factor, Mitogen"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"parathyroid gland: 20.3"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 98.6;Granulosa cells: 124.1;Microglial cells: 85.3;Oligodendrocyte precursor cells: 233.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 60.0;hTERT-RPE1: 56.8;U-138 MG: 41.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA009134	Approved		Supported	"Plasma membrane,Cytosol"	"Secreted to blood"	NA	NA		37000		"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 40: Granulosa cells - Unknown function"	"Plasma membrane, Cytosol"		"HPA009134: AB_10601981"	"unprognostic (3.12e-1)"	"unprognostic (1.91e-2)"	"unprognostic (5.79e-2)"	"unprognostic (3.67e-2)"	"unprognostic (3.97e-1)"	"unprognostic (3.41e-2)"	"unprognostic (8.78e-2)"	"unprognostic (1.60e-2)"	"unprognostic (1.36e-1)"	"unprognostic (8.12e-2)"	"unprognostic (2.43e-3)"	"unprognostic (1.14e-1)"	"prognostic favorable (1.35e-5)"	"prognostic unfavorable (3.05e-4)"	"unprognostic (1.25e-1)"	"unprognostic (1.19e-2)"	"prognostic unfavorable (3.17e-4)"	4.8	4.0	0.9	1.3	1.0	0.6	7.5	0.4	1.0	9.2	0.7	2.3	2.0	9.9	2.1	3.3	6.7	4.8	2.6	1.0	0.8	5.5	5.1	3.1	1.1	0.8	0.7	7.7	4.3	20.3	0.4	4.5	0.7	8.7	2.0	0.7	8.4	7.0	1.2	1.6	2.8	9.4	0.9	1.3	2.8	0.9	1.1	2.0	6.5	1.2	1.0	3.2	1.2	1.0	2.5	3.7	38.6	25.4	7.0	13.4	1.0	21.5	21.5	12.0	16.1	2.2	9.4	0.0	3.8	60.0	9.2	2.6	10.8	13.4	16.5	0.0	5.0	25.5	3.2	2.4	18.3	3.9	0.3	14.2	6.6	30.6	21.7	56.8	6.0	0.1	0.1	0.1	30.2	0.1	0.0	0.0	0.4	0.0	1.7	0.0	8.1	0.0	22.5	0.9	0.0	0.0	0.0	0.2	0.4	6.0	3.1	1.3	28.3	41.7	0.4	10.9	17.3	0.0	0.0	0.0	16.1	0.0	1.6	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.9	1.0	0.4	1.0	1.0	0.8	0.8	0.7	0.7	0.9	1.1	1.0	2.4	6.4	14.2	98.6	0.7	49.6	22.7	12.4	25.0	2.0	14.7	13.6	16.8	58.6	7.8	12.9	0.0	0.6	3.4	0.5	0.0	15.4	30.5	6.9	15.0	7.3	0.0	5.5	64.4	7.1	0.3	18.6	8.2	11.4	1.3	124.1	10.0	15.9	13.0	0.0	32.1	2.1	4.1	34.4	21.6	23.8	5.3	32.1	10.6	85.3	14.2	6.3	0.0	233.2	3.0	18.0	0.5	23.0	1.4	8.7	2.4	18.6	3.5	0.5	6.6	34.8	18.2	0.7	2.9	3.4	13.5	0.5	0.9	13.8	2.1	4.8
PDGFRA	"CD140a, GAS9, PDGFR2"	ENSG00000134853	"Platelet derived growth factor receptor alpha"	P16234	4	54229280-54298245	"Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins"	"Chemotaxis, Host-virus interaction"	"Developmental protein, Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease variant, FDA approved drug targets, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"ovary: 190.2"	"Group enriched"	"Detected in many"	8	"Endometrial stromal cells: 423.9;Fibroblasts: 256.4;Leydig cells: 449.8;Oligodendrocyte precursor cells: 499.6;Peritubular cells: 408.9"	"Cancer enhanced"	"Detected in all"		"glioma: 30.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 468.1;ASC TERT1: 216.1;BJ hTERT+: 279.4;fHDF/TERT166: 195.9;HHSteC: 156.3;HSkMC: 392.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004947, CAB018143"	Supported		Approved	"Nucleoplasm,Plasma membrane,Cell Junctions"	"Intracellular and membrane"	NA	NA		300000	"Cluster 34: Basophils - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 36: Stromal cells - Cell proliferation"	"Nucleoplasm, Plasma membrane, Cell Junctions"		"CAB018143: AB_2162351, HPA004947: AB_2732399"	"unprognostic (1.67e-1)"	"unprognostic (9.35e-2)"	"unprognostic (4.59e-3)"	"unprognostic (1.60e-1)"	"unprognostic (8.92e-2)"	"prognostic favorable (9.33e-4)"	"unprognostic (1.24e-1)"	"unprognostic (2.00e-2)"	"unprognostic (1.46e-1)"	"unprognostic (2.18e-2)"	"unprognostic (2.18e-1)"	"unprognostic (7.01e-2)"	"prognostic unfavorable (9.79e-6)"	"unprognostic (9.58e-3)"	"unprognostic (9.87e-2)"	"unprognostic (2.16e-2)"	"unprognostic (1.72e-3)"	46.0	28.9	13.9	40.4	13.7	1.6	40.1	8.1	12.8	50.8	18.1	37.7	22.4	44.3	21.8	22.5	50.9	38.5	32.1	11.9	11.0	26.5	16.0	37.9	8.5	16.7	11.9	190.2	13.4	3.0	3.7	62.7	15.1	15.0	35.2	5.3	16.6	18.9	9.6	14.8	31.3	48.1	12.1	46.2	29.4	13.6	8.9	7.6	16.5	41.9	7.2	63.9	38.0	20.0	0.1	0.0	1.0	0.8	468.1	216.1	0.5	25.4	279.4	0.1	0.7	67.6	0.5	0.5	0.5	195.9	0.8	0.6	19.6	0.2	0.1	2.6	1.0	0.7	0.7	1.2	156.3	0.3	0.4	392.0	0.0	31.4	0.0	5.4	0.0	0.7	0.6	0.9	1.1	0.1	0.4	1.2	3.5	0.3	1.1	0.5	0.1	0.1	0.0	0.4	0.6	37.9	0.0	0.5	0.2	2.0	0.7	0.1	0.8	84.9	3.2	93.9	0.2	0.4	0.1	0.8	2.6	0.1	2.2	0.7	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	13.9	13.7	8.1	12.8	11.9	11.0	16.7	11.9	15.1	12.1	8.9	20.0	11.1	0.0	0.5	0.3	0.6	17.1	0.6	2.4	1.2	5.5	4.3	3.2	4.8	0.0	0.8	0.0	0.0	1.4	0.9	0.1	1.9	4.2	2.2	11.7	423.9	5.7	0.0	0.0	1.1	6.7	2.0	256.4	5.1	9.0	0.0	2.6	26.0	1.0	3.1	0.0	19.5	0.2	10.2	0.6	27.3	17.2	449.8	5.4	23.2	39.4	4.7	17.5	0.0	499.6	0.4	20.0	0.0	408.9	0.2	0.9	0.0	0.1	0.5	0.6	0.0	25.7	13.9	1.0	3.4	8.1	15.8	1.4	2.5	49.6	0.0	1.0
PDGFRB	"CD140b, JTK12, PDGFR, PDGFR1"	ENSG00000113721	"Platelet derived growth factor receptor beta"	P09619	5	150113839-150155872	"Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins"	Chemotaxis	"Developmental protein, Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease variant, FDA approved drug targets, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enriched"	"Detected in many"	4	"Sertoli cells: 1288.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"non-classical monocyte: 1.6"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in many"	4	"ASC diff: 1350.1;ASC TERT1: 462.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003842, CAB018144, HPA028499"	Enhanced		Supported	"Golgi apparatus,Vesicles"		NA	NA		39000000	"Cluster 14: Monocytes - Unknown function"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 48: Smooth muscle cells - ECM organization"	Vesicles	"Golgi apparatus"	"CAB003842: AB_562328, CAB018144: AB_2162497, HPA028499: AB_10602018"	"unprognostic (4.75e-2)"	"unprognostic (2.48e-1)"	"unprognostic (5.21e-2)"	"unprognostic (3.60e-2)"	"unprognostic (3.27e-1)"	"unprognostic (5.61e-2)"	"unprognostic (1.02e-1)"	"unprognostic (3.36e-2)"	"unprognostic (2.12e-2)"	"unprognostic (2.57e-3)"	"unprognostic (6.72e-2)"	"unprognostic (1.25e-1)"	"prognostic unfavorable (5.87e-8)"	"unprognostic (3.13e-3)"	"unprognostic (1.25e-2)"	"unprognostic (5.47e-2)"	"prognostic unfavorable (8.11e-4)"	171.2	25.1	25.4	27.5	27.2	0.7	106.3	20.5	33.3	155.9	43.5	41.6	11.9	101.1	24.2	24.1	89.6	124.5	75.7	22.1	23.2	49.7	13.4	98.3	27.5	22.1	24.6	105.5	20.8	21.9	23.0	113.3	22.8	56.2	14.1	6.3	34.5	43.3	38.1	65.0	37.9	68.9	19.4	41.4	27.9	18.4	27.7	8.7	66.5	44.1	13.8	58.3	98.6	21.6	0.1	0.3	8.3	0.4	1350.1	462.7	3.0	48.9	202.3	33.5	56.4	5.4	0.0	0.0	6.4	142.0	19.0	0.1	0.1	0.4	15.8	0.0	0.0	0.1	3.3	3.5	190.7	0.0	0.4	210.0	0.0	46.3	0.6	106.6	0.1	0.1	0.1	5.5	5.5	0.0	0.1	0.6	9.0	0.2	0.2	3.7	2.5	0.2	0.0	0.0	0.1	24.8	0.5	0.1	0.0	38.2	0.1	0.6	0.4	53.7	17.2	23.1	2.8	0.4	0.0	0.3	33.4	0.1	1.5	0.0	0.0	0.0	0.9	0.2	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	1.6	0.0	0.0	0.2	25.4	27.2	20.5	33.3	22.1	23.2	22.1	24.6	22.8	19.4	27.7	21.6	50.8	0.0	1.1	81.9	0.5	24.0	0.5	0.0	2.2	6.6	1.4	3.3	17.3	1.5	0.0	1.8	4.2	0.6	6.0	0.3	0.0	0.8	1.6	2.8	99.5	32.2	0.0	0.0	7.9	0.0	1.1	123.5	2.0	2.3	0.0	2.5	6.4	1.9	1.5	0.0	1.3	0.7	0.0	0.0	35.6	10.9	165.3	3.1	24.9	45.0	0.7	50.7	23.7	10.1	3.3	0.1	0.1	203.8	2.3	0.7	0.3	0.1	0.7	2.9	1288.5	6.6	288.3	1.9	1.6	0.8	15.3	0.8	4.8	4.0	0.4	1.1
PDHA1	PDHA	ENSG00000131828	"Pyruvate dehydrogenase E1 subunit alpha 1"	P08559	X	19343893-19361718	"Citric acid cycle related proteins, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Carbohydrate metabolism, Glucose metabolism, Tricarboxylic acid cycle"	Oxidoreductase	"Disease variant, Leigh syndrome, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 508.8;tongue: 770.2"	"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 479.9;Distal tubular cells: 354.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047487, HPA047864, HPA063053"	Approved		Supported	Mitochondria	"Intracellular and membrane"	NA	NA		100000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 18: U-2197 - ECM organization"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"HPA047487: AB_2680066, HPA047864: AB_2680190, HPA063053: AB_2684931"	"unprognostic (5.71e-3)"	"unprognostic (2.46e-3)"	"unprognostic (5.71e-2)"	"unprognostic (3.36e-3)"	"unprognostic (3.12e-2)"	"unprognostic (2.27e-2)"	"unprognostic (1.37e-2)"	"unprognostic (4.28e-1)"	"unprognostic (1.01e-1)"	"unprognostic (7.01e-3)"	"unprognostic (6.90e-2)"	"unprognostic (8.68e-2)"	"prognostic favorable (1.13e-7)"	"unprognostic (3.72e-2)"	"unprognostic (3.03e-1)"	"unprognostic (1.92e-2)"	"unprognostic (9.06e-2)"	93.0	69.0	62.1	37.9	66.9	88.1	63.1	66.2	91.5	55.9	84.4	112.6	87.0	53.1	78.9	76.8	49.1	29.3	508.8	68.2	67.0	174.1	118.3	47.2	36.6	64.5	62.7	50.6	83.4	161.0	48.7	43.1	65.0	48.4	104.4	90.1	109.7	63.4	459.0	60.9	82.1	51.8	59.6	49.3	121.8	24.0	67.4	52.3	64.5	770.2	59.1	61.7	56.1	71.1	124.9	151.4	107.9	114.2	102.3	77.7	131.6	83.8	74.6	170.2	130.7	216.6	78.2	212.2	60.6	102.0	226.7	159.0	334.2	145.8	178.1	70.1	186.1	104.8	264.0	194.2	107.8	170.3	82.8	100.9	132.8	157.3	154.4	85.6	105.3	129.8	94.2	87.2	120.7	164.5	142.7	173.5	110.0	227.4	261.7	145.2	180.9	260.3	298.0	125.1	59.7	62.6	134.1	167.8	158.1	229.8	177.1	118.1	65.4	87.6	78.6	240.9	108.6	73.3	82.0	140.5	82.4	117.2	77.4	99.9	87.4	65.3	72.3	119.9	88.9	103.4	69.4	79.5	115.7	82.1	67.7	72.0	15.5	98.1	109.1	76.9	84.4	89.6	62.1	66.9	66.2	91.5	68.2	67.0	64.5	62.7	65.0	59.6	67.4	71.1	34.1	44.8	44.4	18.6	30.7	29.8	59.7	135.4	25.0	59.0	37.0	29.3	479.9	87.2	74.8	152.6	33.3	105.0	32.5	73.0	354.1	88.8	2.5	41.2	33.7	36.8	41.9	55.8	21.2	59.8	120.7	49.2	49.5	36.9	42.6	39.7	18.2	76.3	73.2	25.2	24.6	64.4	71.2	26.8	30.5	4.1	35.4	32.5	56.9	9.4	40.8	49.0	26.8	13.0	11.5	47.4	52.5	40.6	43.3	47.1	88.6	213.7	33.1	69.1	32.9	37.5	51.7	51.1	25.3	45.2	33.4	133.4	31.6	25.4	130.3	55.8
PDHA2	PDHAL	ENSG00000163114	"Pyruvate dehydrogenase E1 subunit alpha 2"	P29803	4	95840093-95841464	"Citric acid cycle related proteins, Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Carbohydrate metabolism, Glucose metabolism, Tricarboxylic acid cycle"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	602	"testis: 60.2"	"Group enriched"	"Detected in some"	71	"Early spermatids: 426.6;Late spermatids: 288.3;Spermatocytes: 229.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"HPA047487, HPA047864, HPA063053"	Approved		Supported	Mitochondria		NA	NA				"Cluster 36: Testis - Spermatogenesis"		"Cluster 66: Spermatocytes - Spermatogenesis"	Mitochondria		"HPA047487: AB_2680066, HPA047864: AB_2680190, HPA063053: AB_2684931"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	60.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	426.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	288.3	4.4	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	229.6	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PDHB	PDHE1B	ENSG00000168291	"Pyruvate dehydrogenase E1 subunit beta"	P11177	3	58427630-58433857	"Citric acid cycle related proteins, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Carbohydrate metabolism, Glucose metabolism, Tricarboxylic acid cycle"	Oxidoreductase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"tongue: 299.4"	"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 300.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB033794, HPA036744, HPA036745"	Enhanced		Supported	Nucleoplasm,Mitochondria		No	No		61000	"Cluster 27: Non-specific - Gene expression"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria	Nucleoplasm	"CAB033794: AB_2162946, HPA036744: AB_10670921, HPA036745: AB_2675285"	"unprognostic (2.06e-2)"	"unprognostic (1.79e-1)"	"unprognostic (6.04e-3)"	"unprognostic (1.22e-1)"	"unprognostic (7.22e-2)"	"unprognostic (1.42e-1)"	"unprognostic (3.20e-2)"	"unprognostic (6.13e-2)"	"unprognostic (9.62e-2)"	"unprognostic (5.94e-2)"	"unprognostic (3.98e-1)"	"unprognostic (2.35e-1)"	"prognostic favorable (2.79e-8)"	"unprognostic (2.67e-1)"	"unprognostic (8.37e-2)"	"unprognostic (1.06e-2)"	"unprognostic (9.85e-2)"	59.9	76.5	48.7	42.2	50.2	25.7	42.9	53.9	62.7	43.3	63.6	56.8	42.5	38.5	44.6	57.4	37.7	35.9	175.0	49.7	52.3	100.8	110.7	36.4	53.1	51.7	49.4	26.5	36.4	88.8	44.1	57.0	51.5	48.5	60.4	30.7	45.9	52.1	272.6	36.8	37.6	63.8	51.6	42.8	53.9	42.3	53.1	53.1	40.8	299.4	56.0	49.7	35.9	54.3	66.5	90.9	92.3	69.8	91.7	111.1	110.4	81.6	101.3	117.9	120.6	165.1	62.6	140.3	44.9	103.8	109.0	37.6	113.2	74.9	90.0	81.7	83.0	125.4	163.7	126.0	92.5	103.0	67.9	97.9	67.7	95.5	55.8	137.5	103.1	114.2	65.9	61.5	129.5	63.1	98.2	107.8	127.2	69.2	101.3	46.3	71.8	136.1	188.1	89.1	63.7	70.2	75.6	107.2	85.4	131.3	159.0	108.7	76.3	62.9	83.7	66.8	94.2	85.2	129.9	99.2	96.2	120.8	60.7	57.8	98.9	98.7	83.2	115.1	87.9	102.2	81.7	80.5	141.1	103.4	90.9	82.4	19.6	129.4	109.7	94.7	113.2	124.1	48.7	50.2	53.9	62.7	49.7	52.3	51.7	49.4	51.5	51.6	53.1	54.3	57.8	60.9	34.5	5.9	45.3	27.9	40.7	142.0	26.7	31.8	29.4	31.6	300.6	48.6	96.0	35.0	25.0	174.1	35.3	41.0	230.9	95.9	76.3	37.0	37.3	58.0	58.0	22.5	10.9	72.2	101.6	54.1	29.6	34.2	39.3	48.5	46.1	76.1	84.6	57.2	13.3	50.4	162.8	37.9	26.6	16.9	60.3	37.2	56.9	9.4	76.5	61.7	70.0	9.0	13.6	55.9	43.0	51.1	38.8	19.1	45.8	146.8	70.7	45.9	65.7	30.8	72.3	98.2	88.3	42.8	29.8	157.2	44.7	224.4	53.0	37.7
PDIA4	"ERP70, ERP72"	ENSG00000155660	"Protein disulfide isomerase family A member 4"	P13667	7	149003062-149028662	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Isomerase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 386.7;Hepatocytes: 595.4;Plasma cells: 556.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006139, HPA006140, CAB017368"	Supported		Supported	"Endoplasmic reticulum"	"Intracellular and membrane"	NA	NA		15000000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 55: Plasma cells - Humoral immune response"	"Endoplasmic reticulum"		"CAB017368: AB_10621725, HPA006139: AB_1848256, HPA006140: AB_1848257"	"unprognostic (1.98e-1)"	"unprognostic (1.62e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.87e-2)"	"prognostic unfavorable (9.69e-4)"	"unprognostic (1.97e-2)"	"unprognostic (1.81e-1)"	"unprognostic (2.11e-2)"	"unprognostic (5.11e-2)"	"unprognostic (3.24e-3)"	"unprognostic (6.08e-3)"	"unprognostic (3.20e-2)"	"prognostic unfavorable (5.20e-9)"	"unprognostic (1.03e-1)"	"unprognostic (1.53e-1)"	"unprognostic (6.76e-2)"	"unprognostic (2.51e-1)"	50.3	30.0	22.8	91.5	27.5	35.7	38.2	31.1	24.1	92.8	33.6	84.8	74.1	58.6	163.5	38.9	81.6	53.5	40.4	22.1	31.2	49.5	241.7	48.5	59.0	35.3	29.3	47.3	112.6	26.4	44.6	92.0	34.2	69.3	85.5	8.4	56.1	47.4	9.3	30.0	66.3	71.9	29.6	63.6	95.6	30.8	33.8	46.7	234.1	10.1	72.4	65.6	33.3	49.8	251.3	236.0	249.8	703.3	223.2	158.2	358.2	343.5	230.5	194.8	314.5	196.6	661.5	179.4	748.2	287.0	532.2	160.1	170.6	329.1	168.9	129.0	99.0	86.6	62.7	436.6	298.4	198.5	233.9	156.4	145.1	213.6	169.8	251.7	401.0	90.6	143.6	476.1	173.4	276.4	190.9	226.0	371.1	510.9	134.0	123.6	192.5	440.5	228.2	194.9	79.1	207.6	313.0	223.7	124.1	295.7	127.4	151.9	220.6	152.1	84.5	372.0	247.5	357.5	173.7	125.5	354.2	231.1	528.9	74.4	80.5	51.0	130.4	85.6	135.4	99.1	83.7	100.8	77.6	58.2	77.4	82.7	11.0	91.9	91.4	251.8	68.7	160.6	22.8	27.5	31.1	24.1	22.1	31.2	35.3	29.3	34.2	29.6	33.8	49.8	43.3	28.9	36.2	6.8	87.9	34.7	88.0	142.5	29.0	4.2	50.8	31.5	31.0	95.8	92.4	42.3	4.2	177.8	86.9	135.4	15.6	129.0	3.1	91.1	93.1	57.0	61.6	41.2	3.2	91.0	386.7	102.8	119.8	107.1	57.8	72.0	81.4	595.4	147.9	0.0	5.7	282.9	61.1	84.7	49.6	5.5	59.0	55.3	87.2	9.4	51.8	15.6	68.0	4.5	11.9	94.5	88.6	42.9	556.7	108.1	71.3	66.3	114.8	6.7	32.9	35.2	66.0	47.6	86.1	29.2	28.6	230.4	46.7	52.4	155.6	72.4
PDIA5	"FLJ30401, PDIR"	ENSG00000065485	"Protein disulfide isomerase family A member 5"	Q14554	3	123067025-123225227	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Isomerase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 80.2"	"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 133.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Immune cell enhanced"	"Detected in many"		"plasmacytoid DC: 12.8"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030353, HPA030355"	Enhanced		Supported	"Nucleoplasm,Nucleoli fibrillar center,Golgi apparatus"	"Intracellular and membrane"	NA	NA		4700000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 85: Liver - Metabolism"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 38: Extravillous trophoblasts - Unknown function"	"Nucleoplasm, Golgi apparatus"	"Nucleoli fibrillar center"	"HPA030353: AB_10599734, HPA030355: AB_10602200"	"unprognostic (8.81e-2)"	"unprognostic (2.25e-2)"	"unprognostic (8.93e-2)"	"prognostic favorable (4.55e-4)"	"unprognostic (4.34e-2)"	"unprognostic (2.10e-2)"	"unprognostic (7.38e-2)"	"unprognostic (2.41e-1)"	"unprognostic (3.21e-2)"	"unprognostic (4.02e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.26e-3)"	"prognostic unfavorable (8.09e-11)"	"unprognostic (1.57e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.06e-2)"	"unprognostic (4.06e-3)"	17.9	23.6	0.3	15.2	0.3	17.9	13.8	0.2	1.4	14.5	2.7	20.1	13.9	12.4	30.2	6.1	14.0	19.6	9.9	0.6	0.8	14.5	80.2	17.7	11.1	0.5	0.6	11.5	26.6	10.7	12.7	47.4	0.4	32.3	25.0	4.2	13.7	7.9	4.2	8.8	12.8	17.0	0.3	10.1	33.4	15.3	0.9	4.5	30.8	4.3	12.0	17.9	9.5	0.7	24.0	14.6	17.7	21.5	80.3	71.9	95.0	44.9	74.5	24.5	66.9	47.8	21.6	0.0	57.6	69.9	15.7	12.5	7.8	27.4	25.7	1.1	8.8	10.4	3.9	56.7	33.2	26.5	1.4	62.3	40.2	16.6	34.5	26.1	84.0	10.1	13.6	60.4	16.9	29.6	7.2	31.3	13.1	54.5	15.6	6.7	13.0	67.5	20.7	13.9	19.3	11.4	22.0	24.0	40.4	28.7	21.4	32.3	47.2	6.2	19.5	29.4	12.3	18.1	5.0	10.8	20.2	21.0	21.5	0.0	9.3	0.3	1.4	2.4	2.3	3.5	1.0	0.8	5.5	1.1	0.6	0.6	0.2	0.5	0.5	12.8	0.0	2.3	0.3	0.3	0.2	1.4	0.6	0.8	0.5	0.6	0.4	0.3	0.9	0.7	17.2	19.2	30.7	2.6	5.6	5.0	6.0	6.4	3.4	13.1	6.9	4.7	2.7	35.8	11.3	5.5	39.6	41.8	3.1	5.4	0.0	32.2	1.6	5.4	13.1	24.3	8.4	5.5	9.6	28.6	133.6	20.7	30.5	21.1	3.8	7.3	37.5	50.1	12.1	0.0	7.1	36.9	0.0	7.8	5.5	2.0	24.2	4.4	8.8	5.6	5.0	2.3	0.0	1.0	2.5	11.9	7.6	22.2	40.1	18.1	3.5	5.3	6.4	28.4	13.1	3.6	17.6	1.3	1.5	3.4	4.1	50.2	3.1	23.3	15.1	4.5
PDIA6	"ERp5, P5, TXNDC7"	ENSG00000143870	"Protein disulfide isomerase family A member 6"	Q15084	2	10783391-10837977	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Chaperone, Isomerase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Extravillous trophoblasts: 1202.1;Plasma cells: 883.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034347, HPA034652, HPA034653"	Enhanced		Supported	"Endoplasmic reticulum,Cytosol"	"Intracellular and membrane"	NA	NA		15000000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 55: Plasma cells - Humoral immune response"	"Endoplasmic reticulum, Cytosol"		"CAB034347: AB_2299360, HPA034652: AB_2674263, HPA034653: AB_10601982"	"unprognostic (8.16e-2)"	"prognostic unfavorable (1.80e-4)"	"unprognostic (1.03e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.31e-1)"	"prognostic unfavorable (1.20e-4)"	"prognostic unfavorable (3.63e-5)"	"unprognostic (3.17e-2)"	"unprognostic (1.02e-2)"	"unprognostic (5.25e-3)"	"unprognostic (6.03e-3)"	"unprognostic (1.68e-1)"	"prognostic unfavorable (2.51e-6)"	"unprognostic (6.59e-2)"	"unprognostic (2.34e-1)"	"unprognostic (1.38e-2)"	"unprognostic (3.69e-3)"	118.3	112.3	54.5	155.8	64.6	140.8	124.9	57.1	66.7	178.8	71.2	156.0	122.4	131.6	418.5	98.2	133.5	96.7	113.4	55.9	60.8	130.3	260.5	103.8	118.1	61.1	55.4	99.8	252.1	149.7	74.0	171.3	60.7	127.4	171.6	48.0	184.1	135.5	59.3	64.3	121.5	155.5	60.9	107.4	155.4	55.1	62.6	86.6	363.3	59.4	153.7	130.9	75.7	66.4	287.0	304.6	425.7	672.6	535.6	459.4	753.4	677.8	625.9	348.3	465.1	435.1	548.5	460.9	464.7	668.9	674.1	228.0	324.1	568.3	371.1	363.2	253.4	374.2	228.4	713.2	577.5	387.9	268.9	334.2	428.4	338.1	603.3	642.1	798.0	171.8	328.0	963.6	348.7	338.8	150.5	400.8	356.6	923.4	236.4	355.7	433.0	846.4	498.3	339.9	272.0	543.2	267.6	387.0	396.2	547.8	136.8	648.5	395.0	324.4	409.8	296.3	399.1	900.0	596.6	297.1	438.5	479.6	464.8	276.1	200.0	95.5	198.4	210.9	219.0	197.6	154.2	187.6	215.0	161.0	74.3	125.1	35.0	241.6	161.4	268.9	174.4	319.2	54.5	64.6	57.1	66.7	55.9	60.8	61.1	55.4	60.7	60.9	62.6	66.4	217.1	57.7	124.2	17.6	193.9	103.0	294.2	552.8	61.5	69.1	121.1	91.7	35.9	148.7	264.6	196.8	29.2	456.3	164.6	125.8	43.0	338.6	8.2	146.5	382.9	176.2	157.7	89.2	47.4	240.6	1202.1	228.2	138.1	255.0	131.3	210.6	211.3	355.6	413.1	42.1	30.5	276.3	170.9	155.7	149.8	16.2	121.2	145.9	199.3	15.0	132.1	106.5	142.2	32.6	25.3	175.4	131.2	135.1	883.2	385.4	99.9	149.6	145.8	60.1	85.5	96.9	225.3	98.5	117.9	95.4	102.6	554.1	125.7	254.3	248.3	265.3
PDIK1L	CLIK1L	ENSG00000175087	"PDLIM1 interacting kinase 1 like"	Q8N165	1	26111165-26125555	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA064157			Supported	Nucleoplasm		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 62: Horizontal cells - Visual perception"	Nucleoplasm		"HPA064157: "	"unprognostic (1.09e-1)"	"unprognostic (1.81e-3)"	"unprognostic (2.99e-3)"	"unprognostic (2.52e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.34e-3)"	"unprognostic (3.93e-2)"	"unprognostic (1.72e-3)"	"unprognostic (7.29e-3)"	"unprognostic (1.08e-1)"	"unprognostic (2.42e-2)"	"unprognostic (3.59e-1)"	"unprognostic (1.34e-2)"	"unprognostic (4.24e-3)"	"unprognostic (2.94e-1)"	"unprognostic (4.47e-1)"	"unprognostic (1.78e-2)"	3.2	3.4	4.4	4.5	4.0	16.6	8.2	6.6	5.1	5.9	2.7	6.9	7.1	4.4	4.6	4.9	5.4	3.9	3.3	4.1	5.2	6.0	8.1	4.6	6.5	3.9	4.0	6.5	7.8	7.0	2.6	3.4	4.8	4.7	7.3	8.3	6.3	5.0	4.8	5.5	5.6	3.6	3.8	4.6	7.3	5.0	4.9	8.6	15.4	5.2	6.3	4.6	3.2	4.9	7.9	2.9	7.5	9.8	2.7	3.8	2.6	2.3	2.7	5.2	3.3	2.0	11.2	17.8	6.3	2.6	4.0	5.6	11.2	4.0	4.4	6.1	7.7	15.3	4.3	2.2	4.7	15.6	9.0	2.2	5.9	4.6	8.5	3.5	4.8	15.3	18.0	16.8	1.8	4.8	23.5	7.4	3.5	9.5	4.7	12.7	7.3	19.2	3.7	6.1	13.3	10.8	8.2	10.0	10.5	2.0	5.4	5.4	4.4	5.5	5.2	7.0	6.9	23.8	26.5	12.0	5.9	19.2	5.0	10.5	3.8	3.3	4.8	3.6	4.5	4.9	6.6	5.3	7.3	4.2	7.0	5.6	0.3	4.4	5.1	2.8	7.9	4.0	4.4	4.0	6.6	5.1	4.1	5.2	3.9	4.0	4.8	3.8	4.9	4.9	6.4	9.6	4.2	5.9	6.2	3.2	1.7	3.5	7.4	18.6	8.6	3.9	2.3	7.2	7.0	1.8	0.0	3.9	2.7	6.5	0.0	3.7	1.3	3.2	5.7	5.0	13.1	6.3	13.7	4.0	0.7	3.8	7.1	4.9	7.0	6.3	5.0	11.1	4.1	23.5	15.4	8.0	4.1	6.3	5.9	0.5	2.5	4.6	3.6	5.6	3.1	11.0	0.0	10.1	12.1	2.9	3.3	3.0	14.0	3.5	4.5	7.5	8.4	11.7	0.0	2.9	3.6	14.0	11.7	14.5	7.4	1.6	5.4	3.0	8.7	3.0
PDK2	PDHK2	ENSG00000005882	"Pyruvate dehydrogenase kinase 2"	Q15119	17	50094737-50112152	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Carbohydrate metabolism, Glucose metabolism"	"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 216.2;tongue: 285.0"	"Cell type enhanced"	"Detected in all"		"Proximal enterocytes: 123.0;Proximal tubular cells: 131.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008287	Supported		Approved	Nucleoplasm,Mitochondria		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 18: U-2197 - ECM organization"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Nucleoplasm, Mitochondria"		"HPA008287: AB_1079589"	"unprognostic (2.74e-2)"	"prognostic favorable (5.87e-4)"	"unprognostic (1.16e-1)"	"unprognostic (2.43e-3)"	"unprognostic (1.22e-1)"	"unprognostic (9.63e-3)"	"unprognostic (9.80e-3)"	"unprognostic (8.39e-3)"	"unprognostic (3.19e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.17e-2)"	"unprognostic (2.21e-1)"	"prognostic favorable (9.59e-5)"	"unprognostic (3.81e-1)"	"unprognostic (2.54e-1)"	"unprognostic (5.33e-1)"	"unprognostic (1.55e-1)"	40.8	63.8	49.9	8.7	51.2	5.0	26.4	65.7	58.2	30.5	37.1	42.7	28.1	29.4	124.4	21.8	24.3	18.0	116.6	50.6	41.8	62.7	50.8	15.3	10.1	40.8	44.0	48.2	44.3	40.7	17.0	14.7	41.8	23.5	21.5	14.7	25.7	27.4	216.2	26.0	32.5	25.7	40.8	18.4	33.7	13.7	44.6	12.6	27.3	285.0	9.2	30.9	22.2	44.6	12.4	17.5	20.6	18.5	21.2	16.5	2.2	13.2	19.3	19.3	18.5	1.7	13.2	15.5	21.7	37.0	13.0	6.4	13.7	5.3	18.8	30.6	19.3	14.0	17.1	13.2	11.3	0.0	15.0	33.6	19.6	12.5	0.9	33.7	17.2	20.0	5.7	15.0	11.0	15.8	11.8	0.0	4.5	37.2	17.1	17.5	45.8	21.1	10.4	10.4	13.8	20.7	18.7	5.9	9.0	25.0	35.0	13.7	8.8	22.5	18.4	16.0	10.1	29.4	29.9	8.2	33.3	4.9	15.4	14.3	16.2	8.9	16.2	12.9	12.8	12.9	14.8	18.0	18.4	13.8	17.2	18.0	2.6	22.9	14.1	25.8	22.4	17.4	49.9	51.2	65.7	58.2	50.6	41.8	40.8	44.0	41.8	40.8	44.6	44.6	17.9	9.6	10.3	18.3	12.1	15.2	12.3	12.4	17.6	19.0	16.0	26.8	5.4	12.8	11.7	20.2	6.2	19.6	16.7	38.6	58.7	11.7	8.8	6.5	12.1	11.8	13.8	10.8	18.6	9.1	3.6	17.7	13.7	7.8	1.3	19.0	18.2	52.0	19.9	43.7	15.6	50.2	16.2	13.6	9.1	18.9	24.2	12.0	24.9	8.4	14.5	37.3	7.2	6.0	11.3	6.2	55.2	52.6	25.9	6.7	123.0	131.9	6.5	11.0	19.7	15.0	20.5	3.3	11.7	14.6	18.8	7.9	12.9	29.0	36.9	11.3
PDK3		ENSG00000067992	"Pyruvate dehydrogenase kinase 3"	Q15120	X	24465270-24550466	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Carbohydrate metabolism, Glucose metabolism"	"Kinase, Transferase"	"Charcot-Marie-Tooth disease, Disease variant, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 71.6;Excitatory neurons: 92.8;Inhibitory neurons: 78.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046583, HPA072492"	Approved		Supported	Nucleoli,Mitochondria		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 6: T47d - Mammary gland"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Mitochondria	Nucleoli	"HPA046583: AB_2679707, HPA072492: AB_2686526"	"unprognostic (5.41e-3)"	"unprognostic (5.43e-3)"	"unprognostic (5.35e-3)"	"unprognostic (3.40e-1)"	"unprognostic (4.05e-3)"	"unprognostic (5.38e-2)"	"prognostic unfavorable (2.76e-4)"	"unprognostic (1.51e-1)"	"unprognostic (5.57e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.39e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.02e-1)"	"unprognostic (2.92e-1)"	"unprognostic (2.28e-2)"	"unprognostic (9.43e-3)"	4.4	2.0	4.4	5.6	6.2	8.9	8.8	1.4	7.5	3.5	2.5	6.1	8.2	2.8	10.9	3.9	5.9	3.2	7.4	13.2	4.7	8.8	4.7	5.0	7.9	2.6	4.2	4.8	2.9	6.7	5.8	4.1	2.4	4.6	5.3	6.0	11.1	2.9	1.4	6.8	8.3	4.5	0.9	7.7	6.9	11.6	9.1	6.3	2.3	1.8	8.0	4.2	4.1	4.2	11.5	5.2	4.2	8.0	0.2	0.0	5.0	3.4	2.4	4.1	6.9	0.5	13.9	10.4	2.3	0.8	11.6	2.1	12.3	8.4	10.4	9.7	6.0	5.3	6.1	3.3	1.4	4.6	5.8	0.9	3.6	1.1	1.2	0.5	6.8	10.9	0.9	16.5	0.5	20.9	9.4	6.0	8.1	12.2	5.6	5.0	8.0	17.3	4.1	21.4	2.6	4.0	17.9	8.0	5.5	7.3	9.6	1.9	0.1	3.3	3.6	5.8	4.2	11.0	8.9	12.9	8.7	7.7	6.4	13.3	15.4	37.9	11.8	19.6	16.5	7.5	9.1	10.3	12.2	7.3	7.6	8.6	57.6	13.3	18.8	3.5	8.3	12.4	4.4	6.2	1.4	7.5	13.2	4.7	2.6	4.2	2.4	0.9	9.1	4.2	3.9	3.2	2.0	19.6	15.2	4.6	9.5	13.5	30.1	3.5	11.1	8.1	6.6	1.5	5.2	1.8	0.0	5.5	16.6	4.2	3.9	4.3	71.6	2.1	2.9	3.8	4.2	14.3	92.8	5.1	32.1	4.9	5.6	2.8	5.7	4.9	5.3	5.3	15.0	8.4	78.0	2.9	10.2	19.8	7.4	35.9	3.7	17.4	16.0	35.6	10.3	3.7	25.7	19.6	14.0	2.1	0.3	5.7	19.0	5.9	13.3	14.2	2.4	3.5	0.0	2.0	10.6	10.2	8.3	6.8	4.4	17.8	18.2	9.7	4.1	8.4
PDLIM1	"CLIM1, CLP-36, CLP36, hCLIM1"	ENSG00000107438	"PDZ and LIM domain 1"	O00151	10	95237572-95291012	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 675.1"	"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 805.9;Basal respiratory cells: 763.8;Paneth cells: 769.2;Proximal enterocytes: 1059.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	7	"eosinophil: 189.7;memory B-cell: 223.8;naive B-cell: 213.0"	"Group enriched"	"Detected in all"	7	"B-cells: 223.8;granulocytes: 189.7"	"Cell line enhanced"	"Detected in many"		"HaCaT: 766.3;Hep G2: 635.3;HHSteC: 731.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017010, CAB072838, CAB072840"	Approved		Supported	"Plasma membrane,Cell Junctions,Actin filaments"		NA	NA		93000000	"Cluster 43: B-cells - Humoral immune response"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Actin filaments"	"Plasma membrane, Cell Junctions"	"CAB072838: , CAB072840: , HPA017010: AB_1855147"	"unprognostic (1.61e-1)"	"unprognostic (2.87e-2)"	"unprognostic (2.58e-2)"	"prognostic favorable (1.14e-5)"	"unprognostic (3.18e-2)"	"unprognostic (7.54e-2)"	"unprognostic (2.07e-1)"	"unprognostic (8.99e-2)"	"unprognostic (2.26e-1)"	"unprognostic (2.82e-3)"	"unprognostic (5.77e-2)"	"unprognostic (6.56e-2)"	"unprognostic (1.27e-2)"	"unprognostic (2.00e-1)"	"unprognostic (1.97e-1)"	"unprognostic (4.21e-3)"	"unprognostic (1.11e-1)"	301.7	32.4	10.7	91.5	10.8	25.0	236.0	10.2	18.5	133.1	30.2	220.0	179.4	115.0	91.8	182.3	155.3	114.9	393.2	11.7	10.9	82.8	160.3	337.2	104.5	20.4	12.7	35.6	98.3	65.9	29.5	141.1	14.1	116.9	218.5	36.9	166.1	114.7	675.1	136.8	249.0	146.0	14.0	148.3	148.3	13.7	13.8	105.9	194.7	290.0	123.7	276.3	165.3	11.2	274.4	181.8	12.4	0.4	64.1	43.3	277.1	82.6	266.4	218.8	356.5	387.0	429.8	0.3	21.9	233.8	110.4	766.3	91.5	498.1	220.6	0.2	132.0	277.9	50.1	635.3	731.0	0.1	13.2	125.5	257.0	111.9	400.6	233.2	396.8	24.2	60.0	70.3	52.7	51.4	0.8	4.9	24.6	137.7	137.2	234.1	10.0	98.4	114.4	268.9	48.3	18.9	91.2	84.6	0.9	293.8	68.2	125.7	345.1	84.5	19.7	0.7	0.7	31.2	0.1	91.6	92.5	0.2	41.0	0.4	2.4	189.7	11.9	0.8	0.1	223.8	2.3	14.1	31.0	213.0	0.5	8.1	7.5	8.9	1.5	3.2	2.2	44.5	10.7	10.8	10.2	18.5	11.7	10.9	20.4	12.7	14.1	14.0	13.8	11.2	435.0	76.9	123.5	0.0	145.6	366.3	805.9	763.8	244.7	10.1	100.6	131.4	266.2	223.1	250.2	51.5	29.2	538.2	20.5	657.0	15.6	420.1	8.4	218.6	319.3	359.3	101.3	41.6	0.9	172.5	116.7	149.2	100.9	113.0	12.6	47.2	459.7	100.4	50.0	1.7	0.4	488.9	152.5	19.4	105.2	8.0	5.0	88.8	40.9	2.8	8.8	11.6	32.0	0.0	0.0	227.0	769.2	0.7	103.5	256.5	1059.7	109.0	316.4	59.5	315.5	21.0	213.1	4.3	35.7	170.4	197.9	117.0	25.8	1.9	419.2	554.3
PDLIM2		ENSG00000120913	"PDZ and LIM domain 2"	Q96JY6	8	22578279-22598025	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Syncytiotrophoblasts: 793.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Region enhanced"	"Detected in all"		"white matter: 429.2"	"Low region specificity"	"Detected in many"			HPA003880	Approved		Supported	"Actin filaments,Focal adhesion sites"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 59: Non-specific - Translation"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	"Actin filaments, Focal adhesion sites"		"HPA003880: AB_1855149"	"unprognostic (1.04e-1)"	"unprognostic (3.53e-2)"	"unprognostic (1.80e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.45e-3)"	"unprognostic (9.33e-2)"	"unprognostic (3.69e-2)"	"unprognostic (4.55e-2)"	"unprognostic (1.79e-2)"	"unprognostic (1.22e-3)"	"unprognostic (1.52e-1)"	"unprognostic (3.37e-1)"	"prognostic unfavorable (1.37e-7)"	"unprognostic (6.14e-2)"	"unprognostic (8.17e-2)"	"unprognostic (3.47e-2)"	"unprognostic (3.08e-3)"	66.0	31.6	40.6	31.9	42.2	23.7	51.0	51.0	56.6	85.1	42.6	86.9	60.9	80.2	9.8	131.4	56.0	52.8	51.4	36.9	43.9	77.7	59.4	88.8	54.4	56.6	52.9	49.6	53.7	9.8	35.3	40.5	59.4	45.5	11.2	2.0	48.6	30.9	201.9	153.1	64.3	23.2	49.9	232.0	38.8	12.2	49.9	20.4	27.4	60.9	24.4	57.5	91.7	54.8	90.3	54.5	36.2	63.9	69.9	118.5	40.9	139.1	102.4	97.6	98.5	62.4	14.7	36.9	38.4	126.4	18.1	44.7	20.5	95.0	19.0	0.1	14.1	11.6	35.2	46.1	88.2	13.0	85.9	127.2	11.6	48.2	13.2	76.8	54.2	20.2	3.3	23.4	67.4	46.5	16.7	15.4	29.8	37.8	5.5	13.3	6.9	3.9	17.3	18.3	11.3	26.9	29.1	78.1	128.7	21.3	27.5	25.8	68.2	105.7	108.6	127.9	64.8	0.4	0.8	12.5	109.0	51.3	79.6	78.2	48.0	162.3	47.0	64.4	42.2	25.0	35.5	46.9	38.4	27.6	23.8	35.4	101.6	28.1	63.8	24.7	40.7	34.6	40.6	42.2	51.0	56.6	36.9	43.9	56.6	52.9	59.4	49.9	49.9	54.8	85.8	76.9	13.1	5.5	45.0	95.1	12.9	48.1	39.9	3.0	34.0	42.5	10.2	18.6	34.2	18.4	0.0	73.1	70.9	92.0	15.6	24.9	1.0	8.8	94.0	48.7	1.2	10.5	3.2	26.1	115.1	98.9	7.7	13.8	27.3	25.7	86.4	49.4	59.0	3.3	2.3	12.6	20.3	59.1	73.8	3.4	132.0	37.9	48.0	8.4	42.5	33.1	122.6	7.1	3.9	93.2	126.1	218.2	6.8	52.7	217.6	146.3	5.2	3.6	59.2	27.1	108.3	0.7	6.3	39.7	100.7	793.0	71.6	21.0	15.0	30.6
PDLIM3	ALP	ENSG00000154553	"PDZ and LIM domain 3"	Q53GG5	4	185500660-185535507	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	10	"skeletal muscle: 4781.7;tongue: 1519.6"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 228.9;Ductal cells: 332.7;Melanocytes: 124.5;Peritubular cells: 196.0;Skeletal myocytes: 428.3;Smooth muscle cells: 131.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"LHCN-M2: 115.6;RH-30: 26.9;U-266/70: 111.2;U-266/84: 34.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004749	Enhanced		Supported	Cytosol		NA	NA		240000		"Cluster 33: Striated muscle - Muscle contraction"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 37: Myocytes - Muscle contraction"	Cytosol		"HPA004749: AB_1855150"	"unprognostic (2.75e-1)"	"unprognostic (3.85e-2)"	"unprognostic (3.20e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.08e-2)"	"unprognostic (1.11e-2)"	"prognostic unfavorable (7.22e-4)"	"unprognostic (3.15e-2)"	"unprognostic (3.64e-1)"	"unprognostic (1.62e-1)"	"unprognostic (9.46e-2)"	"unprognostic (3.77e-1)"	"prognostic unfavorable (4.97e-7)"	"unprognostic (1.64e-3)"	"unprognostic (7.77e-2)"	"prognostic unfavorable (2.13e-6)"	"unprognostic (2.78e-3)"	36.3	11.5	12.7	25.7	13.3	0.0	34.5	16.8	14.8	22.7	10.9	201.2	20.8	235.3	59.1	216.2	97.5	40.1	314.0	12.0	15.7	13.9	7.7	55.2	10.7	19.9	14.2	38.1	18.7	0.8	20.7	18.8	13.8	87.0	32.5	11.2	56.3	148.1	4781.7	12.1	69.0	127.6	17.9	24.5	95.8	8.2	14.6	4.1	32.7	1519.6	26.2	141.1	40.8	14.2	0.0	0.0	0.9	0.0	0.3	0.0	0.8	0.0	0.0	0.3	1.0	1.2	0.4	0.0	0.0	0.0	6.0	0.0	0.0	0.2	0.0	0.0	15.1	0.0	0.8	4.7	13.5	0.0	0.0	8.7	0.0	2.6	0.0	12.3	9.1	0.0	0.0	0.0	115.6	0.0	0.0	0.1	2.4	0.0	1.0	0.0	26.9	0.3	0.0	0.0	17.6	13.3	0.0	0.0	7.3	2.8	0.6	0.0	7.9	0.0	7.6	0.1	7.1	111.2	34.8	0.0	0.4	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.7	13.3	16.8	14.8	12.0	15.7	19.9	14.2	13.8	17.9	14.6	14.2	22.4	9.6	6.0	37.2	2.6	8.9	11.4	0.7	12.5	12.1	72.8	105.7	228.9	5.7	2.2	0.0	12.5	2.5	0.6	0.2	0.0	332.7	0.4	1.4	0.8	39.0	3.5	0.0	2.5	16.7	2.7	82.9	1.1	1.1	0.0	1.3	67.5	0.9	1.6	5.0	0.5	0.5	2.0	1.8	11.7	2.6	19.6	2.3	124.5	1.0	3.2	36.4	0.0	6.6	2.6	31.2	0.0	196.0	7.3	12.2	0.0	0.2	3.2	44.3	105.2	428.3	131.4	4.0	12.6	2.4	7.1	12.2	2.5	2.4	0.3	3.9
PDPK1	PDK1	ENSG00000140992	"3-phosphoinositide dependent protein kinase 1"	O15530	16	2537979-2603188	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004272, HPA035199"	Supported		Supported	Cytosol		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 41: Macrophages - Immune response"	Cytosol		"CAB004272: AB_626657, HPA035199: AB_2674514"	"unprognostic (2.67e-2)"	"unprognostic (1.63e-1)"	"unprognostic (3.12e-3)"	"unprognostic (4.21e-2)"	"unprognostic (1.34e-1)"	"unprognostic (4.69e-3)"	"unprognostic (8.37e-2)"	"unprognostic (3.18e-2)"	"unprognostic (8.17e-2)"	"unprognostic (3.70e-2)"	"unprognostic (1.52e-2)"	"unprognostic (3.28e-2)"	"prognostic favorable (1.29e-14)"	"unprognostic (2.04e-2)"	"unprognostic (5.96e-2)"	"unprognostic (1.95e-1)"	"unprognostic (2.16e-1)"	11.6	13.5	15.1	12.4	25.2	16.1	11.1	10.2	20.6	10.9	1.5	15.8	17.3	11.8	13.2	13.3	14.7	9.5	15.1	19.2	5.2	17.0	12.4	13.6	15.0	10.8	6.1	14.0	19.4	27.1	11.2	12.1	11.3	13.0	14.9	15.5	17.8	12.2	18.9	14.2	19.6	12.3	3.7	13.9	13.6	14.7	7.7	16.8	15.8	19.2	14.1	11.1	10.4	12.5	13.1	16.5	20.1	13.5	20.3	16.9	21.5	21.7	13.6	18.7	15.6	16.6	15.2	21.4	14.5	20.7	15.9	20.2	24.3	15.3	17.6	39.6	17.1	11.4	23.0	27.7	17.7	19.2	29.0	15.4	27.5	20.1	13.3	17.9	17.3	19.1	22.2	17.0	22.1	27.7	19.2	13.3	12.8	24.3	15.1	39.0	20.2	19.5	18.0	11.5	31.7	16.3	27.9	31.3	11.5	12.8	29.0	23.5	21.6	20.2	20.2	20.0	18.8	22.6	23.4	33.3	9.7	13.1	17.9	5.4	7.1	8.4	4.1	8.3	3.9	4.2	3.8	5.0	5.8	3.4	4.3	4.0	12.5	5.2	8.9	8.0	1.9	4.7	15.1	25.2	10.2	20.6	19.2	5.2	10.8	6.1	11.3	3.7	7.7	12.5	17.6	16.0	19.1	45.1	32.9	26.6	20.8	25.7	26.7	60.2	30.0	22.0	33.8	40.0	23.0	11.0	54.2	47.0	35.2	41.1	13.7	23.1	14.4	35.6	23.8	19.1	21.6	28.0	46.7	23.6	27.9	23.2	23.0	45.3	7.6	18.1	22.5	46.1	26.0	74.0	41.7	29.9	10.2	55.7	51.1	30.4	31.7	37.1	21.4	31.9	43.3	42.3	25.7	37.7	44.2	31.6	24.0	44.4	27.1	30.3	50.2	44.8	41.1	44.9	46.0	30.5	30.0	46.8	36.8	38.5	34.1	104.7	25.7	24.2	31.4	27.1
PDPN	"aggrus, Gp38, GP40, PA2.26, T1A-2"	ENSG00000162493	Podoplanin	Q86YL7	1	13583465-13617957	"Predicted membrane proteins"	"Cell shape"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 135.6"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 105.8;Basal respiratory cells: 98.5;Fibroblasts: 123.1;monocytes: 116.3;Muller glia cells: 97.7;Peritubular cells: 62.8"	"Group enriched"	"Detected in many"	4	"glioma: 83.2;head and neck cancer: 40.2;testis cancer: 102.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 149.5;EFO-21: 356.4;HAP1: 253.3;HHSteC: 216.0;NTERA-2: 116.0;SuSa: 119.0;TIME: 242.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007534, HPA007949, CAB008376"	Enhanced		Supported	"Plasma membrane,Cell Junctions,Mitochondria"		NA	NA				"Cluster 28: Placenta - Pregnancy"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 33: Fibroblasts - ECM organization"	"Plasma membrane"	"Cell Junctions, Mitochondria"	"CAB008376: AB_592530, HPA007534: AB_1857718, HPA007949: "	"unprognostic (1.75e-1)"	"unprognostic (3.19e-2)"	"unprognostic (6.03e-2)"	"unprognostic (3.61e-2)"	"unprognostic (2.73e-2)"	"unprognostic (1.05e-2)"	"unprognostic (3.85e-2)"	"unprognostic (5.23e-2)"	"unprognostic (9.21e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.13e-2)"	"unprognostic (1.92e-2)"	"unprognostic (5.62e-3)"	"unprognostic (9.20e-3)"	"unprognostic (1.21e-1)"	"unprognostic (3.29e-2)"	"unprognostic (2.78e-2)"	61.5	3.3	8.9	55.9	9.3	0.0	20.9	13.7	8.1	43.1	23.5	16.6	3.8	25.9	11.3	15.8	33.4	42.1	20.3	8.0	14.6	3.4	0.6	32.4	9.8	24.9	15.6	29.4	6.4	1.1	3.3	135.6	19.1	14.0	10.6	22.7	9.1	14.1	30.0	20.0	15.9	34.5	16.4	0.3	24.7	4.5	22.5	10.3	6.2	11.3	18.5	96.1	25.2	21.2	0.1	0.0	149.5	0.1	0.5	0.0	0.1	2.4	0.1	0.0	0.0	0.0	0.1	0.2	356.4	9.0	0.1	0.7	253.3	44.7	0.0	1.0	46.1	0.1	0.0	0.0	216.0	0.0	0.2	29.5	82.9	18.6	21.8	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.1	116.0	0.0	0.6	0.3	0.2	0.1	0.0	4.0	0.1	0.1	0.2	0.0	0.3	119.0	0.1	0.6	242.2	41.8	34.6	0.6	0.1	0.1	0.3	1.0	88.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	8.9	9.3	13.7	8.1	8.0	14.6	24.9	15.6	19.1	16.4	22.5	21.2	2.4	105.8	11.2	3.9	0.2	14.5	30.4	98.5	14.8	1.4	0.5	19.9	8.4	2.8	18.8	0.0	4.2	2.0	0.1	0.0	0.0	0.5	0.7	1.6	37.6	22.4	0.0	0.0	2.6	0.0	2.1	123.1	0.0	2.8	1.3	3.4	6.4	0.0	6.5	0.0	3.5	0.0	8.2	0.0	14.0	1.8	20.2	5.3	7.2	5.6	116.3	97.7	0.0	19.6	0.2	0.4	0.0	62.8	0.0	15.8	0.0	0.0	5.4	3.4	0.0	17.0	8.4	1.0	8.2	3.9	7.0	2.9	1.3	0.9	0.0	3.4
PDSS2	"bA59I9.3, C6orf210, COQ1B"	ENSG00000164494	"Decaprenyl diphosphate synthase subunit 2"	Q86YH6	6	107152562-107459564	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Isoprene biosynthesis, Ubiquinone biosynthesis"	Transferase	"Cancer-related genes, Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Microglial cells: 82.4;Oligodendrocyte precursor cells: 72.9;Oligodendrocytes: 74.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029685, HPA029686"	Approved		Supported	Cytosol		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 32: U-937 - Innate immune response"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Cytosol		"HPA029685: AB_10600219, HPA029686: AB_10602309"	"prognostic unfavorable (1.34e-5)"	"unprognostic (1.44e-1)"	"prognostic favorable (5.74e-5)"	"unprognostic (5.76e-2)"	"unprognostic (1.42e-1)"	"unprognostic (3.30e-2)"	"unprognostic (3.26e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.18e-1)"	"unprognostic (9.38e-2)"	"unprognostic (2.19e-1)"	"prognostic favorable (3.75e-7)"	"unprognostic (2.25e-1)"	"unprognostic (2.86e-1)"	"unprognostic (1.29e-1)"	"unprognostic (2.11e-2)"	7.9	17.9	4.6	6.3	5.2	9.0	8.1	6.1	5.7	9.2	6.8	12.4	9.3	6.8	6.5	8.6	8.6	8.7	13.9	4.6	5.2	21.6	27.1	8.0	7.6	4.9	4.7	9.1	8.4	13.2	8.5	6.8	5.0	14.6	13.2	6.0	15.3	7.4	12.5	6.3	9.6	8.5	4.7	6.7	9.6	7.7	5.3	8.1	13.3	13.7	7.1	7.6	6.1	6.1	7.6	10.0	8.3	13.2	14.2	18.0	19.2	13.1	16.5	12.4	11.8	10.0	10.8	14.4	11.7	14.7	13.1	10.2	20.3	16.5	16.7	9.1	9.8	14.4	11.4	16.9	15.0	18.5	11.1	13.5	19.1	19.5	15.3	10.8	13.1	16.5	20.7	19.0	12.2	9.3	5.4	19.7	5.3	17.3	12.7	9.7	7.4	11.7	15.2	10.2	8.2	7.1	9.0	15.4	19.7	9.0	12.7	22.3	8.3	8.8	5.2	12.4	11.4	5.3	6.8	11.3	16.3	27.4	16.3	3.2	5.1	2.8	3.7	5.9	5.9	4.7	3.8	4.7	7.0	5.5	5.0	4.8	0.6	3.6	9.9	3.3	5.5	3.4	4.6	5.2	6.1	5.7	4.6	5.2	4.9	4.7	5.0	4.7	5.3	6.1	11.4	16.0	19.1	64.9	12.3	4.2	13.8	11.7	13.6	8.2	9.7	8.3	17.4	12.8	13.9	14.7	2.1	26.9	8.3	15.1	35.2	12.7	37.3	16.3	9.3	8.4	10.3	8.0	53.5	14.5	17.3	9.5	8.2	10.9	14.0	11.9	7.5	32.6	11.8	6.7	67.3	15.3	14.2	9.8	5.1	12.7	5.3	10.2	7.2	82.4	8.5	11.8	6.2	72.9	74.5	13.7	14.4	9.4	13.0	12.2	14.2	40.8	21.0	11.5	26.3	8.7	7.9	21.7	11.5	14.3	5.8	11.9	9.8	13.4	17.0	12.5
PDX1	"IDX-1, IPF1, MODY4, PDX-1, STF-1"	ENSG00000139515	"Pancreatic and duodenal homeobox 1"	P52945	13	27920000-27926313	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"	"Diabetes mellitus, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"intestine: 41.8;pancreas: 13.3"	"Cell type enhanced"	"Detected in some"		"Cholangiocytes: 15.7;Ductal cells: 13.3;Enteroendocrine cells: 13.8;Exocrine glandular cells: 9.8;Gastric mucus-secreting cells: 4.6"	"Group enriched"	"Detected in many"	4	"colorectal cancer: 8.4;pancreatic cancer: 8.6;stomach cancer: 7.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 4.0;HEK 293: 2.3;HeLa: 5.9;OE19: 6.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB025873, HPA059146"	Enhanced		Supported	Nucleoplasm		NA	NA				"Cluster 56: Intestine - Transmembrane transport"	"Cluster 21: OE19 - Mitochondria"	"Cluster 1: Pancreatic cells - Digestion"	Nucleoplasm		"CAB025873: , HPA059146: AB_2683927"		"unprognostic (2.79e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.92e-1)"	"unprognostic (2.65e-1)"	"unprognostic (6.84e-2)"	"unprognostic (3.89e-2)"	"unprognostic (6.75e-3)"			"unprognostic (7.10e-3)"			"unprognostic (3.83e-2)"	"unprognostic (1.65e-1)"		"unprognostic (1.04e-1)"	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.3	41.8	0.0	0.0	0.0	0.0	1.8	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	13.3	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	5.4	0.0	0.0	0.0	5.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	1.3	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	4.0	2.3	0.0	5.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.2	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	15.7	0.0	0.0	0.0	0.0	0.0	0.5	0.0	13.3	0.0	0.0	0.0	0.0	13.8	0.0	0.0	9.8	0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0
PDZD2	"KIAA0300, PDZK3"	ENSG00000133401	"PDZ domain containing 2"	O15018	5	31639131-32110932	"Predicted intracellular proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 24.8"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 232.9;Excitatory neurons: 313.2;Oligodendrocyte precursor cells: 745.0"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"basal ganglia: 24.8;cerebral cortex: 15.7"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 8.1;EFO-21: 4.5;SiHa: 11.6;SK-BR-3: 10.6;T-47d: 5.5"	"Low region specificity"	"Detected in all"							"CAB020784, HPA036503, HPA036504, HPA064387, HPA076072"	Uncertain		Supported	"Plasma membrane,Cytosol"	"Intracellular and membrane"	NA	NA				"Cluster 82: Adipose tissue - ECM organization"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Plasma membrane, Cytosol"		"CAB020784: , HPA036503: AB_2675161, HPA036504: , HPA064387: AB_2685252, HPA076072: "	"unprognostic (3.65e-2)"	"unprognostic (4.06e-2)"	"unprognostic (6.63e-2)"	"unprognostic (5.42e-5)"	"unprognostic (2.39e-1)"	"unprognostic (9.67e-3)"	"unprognostic (2.55e-1)"	"unprognostic (6.49e-2)"	"unprognostic (3.38e-2)"	"unprognostic (2.45e-2)"	"unprognostic (1.71e-2)"	"unprognostic (1.93e-1)"	"unprognostic (2.33e-3)"	"unprognostic (4.13e-2)"	"unprognostic (6.92e-2)"	"unprognostic (7.67e-2)"	"unprognostic (1.79e-1)"	16.5	0.9	4.5	0.7	24.8	0.1	5.0	0.7	15.7	2.2	10.6	1.4	0.5	2.5	1.9	5.3	2.2	0.9	18.8	4.7	0.3	8.2	0.1	9.0	0.3	4.5	4.3	14.4	1.2	0.6	1.8	10.9	1.0	1.5	0.7	14.8	1.6	1.9	2.5	10.1	0.6	2.4	0.3	0.2	1.7	5.6	4.1	2.6	1.0	4.8	1.7	0.6	2.1	0.0	0.1	0.0	3.1	0.1	0.0	0.0	8.1	0.0	0.0	0.6	0.5	0.0	0.0	0.0	4.5	0.0	1.2	4.3	1.7	0.9	0.0	0.0	0.2	0.0	2.6	0.0	0.0	0.0	2.2	0.2	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.9	0.0	0.7	0.0	0.0	0.0	3.5	0.0	0.1	0.7	11.6	10.6	0.0	2.6	5.5	0.0	0.0	0.0	2.2	0.0	0.5	0.0	0.0	2.7	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	24.8	0.7	15.7	4.7	0.3	4.5	4.3	1.0	0.3	4.1	0.0	26.2	44.8	38.6	39.2	0.2	16.8	4.4	14.0	13.6	7.0	10.6	6.9	53.9	0.0	9.3	5.5	98.0	25.5	1.9	0.1	0.0	0.2	232.9	9.7	16.9	14.7	0.0	1.3	313.2	0.2	3.4	8.6	7.7	33.2	1.3	18.7	5.7	0.2	2.2	15.2	113.2	0.0	4.1	0.3	3.1	55.2	7.5	1.0	7.2	87.1	0.2	6.4	0.0	745.0	104.7	3.5	0.0	10.5	0.1	3.5	0.0	8.2	2.8	62.1	46.0	7.3	13.4	12.3	3.8	15.1	18.5	21.1	1.3	46.8	0.0	1.8
PDZD7	"bA108L7.8, DFNB57, FLJ23209, PDZK7"	ENSG00000186862	"PDZ domain containing 7"	Q9H5P4	10	101007679-101032295	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Deafness, Disease variant, Non-syndromic deafness, Retinitis pigmentosa, Usher syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"brain: 21.5;intestine: 20.0;pituitary gland: 6.0"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 15.9;Cone photoreceptor cells: 22.9;Excitatory neurons: 32.3;Inhibitory neurons: 16.5;Proximal enterocytes: 56.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"A-431: 7.5;SCLC-21H: 11.7;THP-1: 18.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA074542			Supported	Nucleoplasm		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 45: Intestine - Brush border"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 45: Enterocytes - Digestion"	Nucleoplasm		"HPA074542: "	"unprognostic (1.46e-1)"	"unprognostic (2.85e-3)"	"unprognostic (3.96e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.15e-2)"	"unprognostic (2.83e-2)"	"unprognostic (1.38e-2)"	"unprognostic (5.31e-2)"	"unprognostic (2.52e-2)"	"unprognostic (2.95e-2)"	"unprognostic (2.45e-1)"	"unprognostic (1.87e-3)"	"unprognostic (3.54e-3)"	"unprognostic (3.89e-1)"	"unprognostic (1.79e-1)"	"unprognostic (3.51e-2)"	"unprognostic (2.80e-1)"	1.5	1.3	5.8	1.0	8.0	1.3	0.5	10.2	15.4	0.7	0.7	0.4	12.8	1.4	0.9	0.3	0.4	1.9	0.6	5.7	4.5	1.5	0.1	1.0	0.9	21.5	7.7	0.6	0.9	1.1	6.0	1.0	21.0	0.7	0.2	2.3	1.1	0.5	0.9	2.4	20.0	1.0	2.7	1.6	1.0	1.2	8.8	0.7	1.2	0.2	0.1	0.4	0.8	9.9	7.5	0.9	0.5	0.7	0.9	0.1	2.3	1.2	0.6	0.0	0.3	1.5	1.7	3.7	3.5	0.3	1.0	2.2	0.2	0.7	0.0	1.0	2.5	0.2	3.8	2.3	0.6	0.5	3.1	0.3	0.1	0.2	0.1	4.2	0.2	3.3	0.6	0.7	0.1	1.8	0.5	1.2	0.6	1.5	2.4	1.6	1.0	0.4	1.8	0.6	11.7	5.4	0.8	0.3	1.2	1.0	2.4	18.2	0.5	1.1	2.4	1.4	1.0	1.5	0.1	0.2	6.4	1.2	0.6	0.6	0.4	0.5	0.3	0.4	0.3	0.3	0.2	0.4	0.1	0.3	0.4	0.2	1.6	0.8	0.3	0.1	0.1	0.3	5.8	8.0	10.2	15.4	5.7	4.5	21.5	7.7	21.0	2.7	8.8	9.9	0.8	0.0	0.0	1.3	0.1	0.5	0.5	0.2	0.0	15.9	0.5	0.9	1.4	2.8	0.2	1.8	22.9	0.2	0.1	0.2	1.9	0.7	1.7	2.1	0.3	0.7	0.0	0.0	32.3	0.4	5.2	0.8	1.1	0.3	0.0	1.6	0.7	0.0	2.1	1.7	16.5	1.5	0.0	1.3	2.7	2.6	0.3	1.0	0.0	5.6	0.3	0.9	1.0	0.5	6.9	1.3	1.2	1.2	0.3	0.4	56.7	1.6	1.3	8.3	0.0	1.4	1.7	2.9	3.7	0.2	0.4	1.9	0.8	0.1	1.0	0.2
PDZRN3	"KIAA1095, LNX3, SEMACAP3, SEMCAP3"	ENSG00000121440	"PDZ domain containing ring finger 3"	Q9UPQ7	3	73382431-73624941	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 256.0;Excitatory neurons: 183.1;Inhibitory neurons: 258.3;Microglial cells: 329.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	19	"plasmacytoid DC: 1.9"	"Lineage enriched"	"Detected in single"	19	"dendritic cells: 1.9"	"Cell line enhanced"	"Detected in many"		"AF22: 32.1;ASC diff: 57.0;ASC TERT1: 29.6;BJ hTERT+: 42.0;HSkMC: 41.4;U-87 MG: 30.4"	"Group enriched"	"Detected in many"	4	"amygdala: 15.1;basal ganglia: 8.1;cerebral cortex: 19.5;hippocampal formation: 16.1;white matter: 7.2"	"Low region specificity"	"Detected in many"			"HPA038822, HPA061420"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Cytosol	Nucleoplasm	"HPA038822: AB_10675952, HPA061420: AB_2684512"	"unprognostic (3.22e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.00e-2)"	"prognostic favorable (3.35e-5)"	"unprognostic (1.09e-1)"	"unprognostic (5.54e-2)"	"unprognostic (8.47e-2)"	"unprognostic (3.67e-1)"	"unprognostic (1.60e-1)"	"unprognostic (7.51e-2)"	"prognostic favorable (4.93e-4)"	"unprognostic (8.38e-2)"	"prognostic favorable (3.65e-7)"	"unprognostic (8.63e-3)"	"unprognostic (1.63e-1)"	"unprognostic (3.72e-2)"	"unprognostic (2.86e-3)"	29.9	35.7	14.9	10.2	16.3	0.0	24.0	8.5	20.9	45.2	58.0	84.0	9.2	64.1	24.5	27.8	26.7	27.4	48.0	16.7	10.6	10.7	2.1	14.9	4.5	13.0	11.8	69.4	6.9	0.8	4.6	17.5	11.0	31.7	13.9	6.3	20.9	29.0	91.8	17.3	24.4	38.4	13.1	2.4	38.7	6.4	17.1	2.9	3.6	22.4	1.4	46.7	32.0	13.2	0.0	0.0	32.1	0.1	57.0	29.6	0.1	16.9	42.0	5.0	3.2	16.2	0.0	0.1	0.1	22.8	0.8	0.0	0.0	0.0	4.8	0.0	2.2	0.0	0.0	0.0	9.5	0.0	0.1	41.4	0.0	13.8	0.1	6.0	0.0	0.0	0.0	0.0	4.9	2.1	0.0	0.2	4.6	0.0	0.2	0.0	8.4	0.1	0.0	0.0	3.7	10.5	0.0	7.8	12.7	9.2	4.5	0.0	0.0	20.6	1.5	23.6	2.2	0.7	0.0	0.2	30.4	0.0	16.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	14.9	16.3	8.5	20.9	16.7	10.6	13.0	11.8	11.0	13.1	17.1	13.2	5.9	0.0	0.0	256.0	0.5	2.4	9.7	0.0	1.8	19.3	7.5	7.6	65.0	0.0	0.0	5.5	6.2	0.5	2.7	1.0	1.9	0.0	0.4	2.1	45.2	2.3	21.1	0.0	183.1	0.4	0.5	25.2	2.0	3.3	0.0	35.0	0.0	0.0	0.8	0.0	258.3	9.1	0.0	0.0	2.9	1.3	23.3	0.7	16.0	329.8	0.0	22.5	0.0	21.6	5.5	0.3	0.9	28.2	0.1	10.9	0.1	7.1	0.0	1.9	0.0	4.6	19.6	0.5	6.2	2.9	1.8	0.8	0.5	12.4	3.9	6.3
PEA15	"HMAT1, HUMMAT1H, MAT1, MAT1H, PEA-15, PED, PED-PEA15, PED/PEA15"	ENSG00000162734	"Proliferation and apoptosis adaptor protein 15"	Q15121	1	160205380-160215376	"Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Sugar transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 1106.4"	"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 246.3;monocytes: 267.6;Muller glia cells: 315.8"	"Cancer enhanced"	"Detected in all"		"glioma: 466.1"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"intermediate monocyte: 78.2"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028356, HPA070820"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA		300000	"Cluster 7: Monocytes - Unknown function"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 3: Monocytes - Immune response regulation"	Cytosol	Nucleoplasm	"HPA028356: AB_10602814, HPA070820: AB_2732166"	"unprognostic (1.29e-1)"	"unprognostic (4.78e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.57e-1)"	"unprognostic (2.53e-1)"	"unprognostic (1.64e-2)"	"unprognostic (1.99e-3)"	"unprognostic (6.10e-2)"	"unprognostic (4.57e-1)"	"unprognostic (1.25e-1)"	"unprognostic (6.31e-2)"	"unprognostic (4.07e-2)"	"prognostic unfavorable (6.53e-7)"	"unprognostic (2.60e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.82e-3)"	"unprognostic (1.24e-1)"	190.2	82.2	863.3	121.7	900.6	16.6	142.7	908.1	949.4	110.1	612.5	146.5	31.7	124.5	83.4	119.2	104.2	88.2	241.9	884.6	939.2	112.0	41.2	147.9	75.5	1028.2	1010.2	80.4	39.6	85.4	80.0	102.3	981.5	112.2	58.5	461.4	80.8	119.4	61.1	105.6	64.8	194.6	933.0	103.2	75.8	80.5	915.2	40.7	83.5	84.5	96.9	133.4	110.2	1106.4	139.2	46.8	190.5	82.5	344.5	191.5	63.6	593.2	503.3	471.6	328.5	103.7	72.3	63.4	210.9	729.4	226.6	146.4	71.5	181.7	365.3	34.4	40.2	52.4	32.5	26.7	423.9	17.8	62.0	161.8	100.7	260.2	328.5	259.6	360.7	45.7	55.1	111.8	640.6	68.3	21.0	41.1	127.0	160.9	134.3	34.4	200.6	43.8	173.0	71.0	38.0	100.0	310.4	207.6	179.9	409.4	128.1	122.6	487.7	311.3	246.4	234.4	254.5	88.1	59.5	118.7	287.1	33.2	450.8	1.3	39.3	5.2	8.4	78.2	6.5	18.9	6.2	6.9	56.7	13.5	3.8	4.2	1.8	7.9	38.7	25.0	7.9	14.9	863.3	900.6	908.1	949.4	884.6	939.2	1028.2	1010.2	981.5	933.0	915.2	1106.4	137.8	16.0	29.9	40.5	38.6	80.2	124.2	21.8	33.6	172.1	76.9	60.2	246.3	11.5	24.7	5.5	73.0	21.8	13.7	12.7	29.4	74.7	65.4	36.4	33.7	125.1	12.0	7.4	24.8	46.3	61.1	81.5	17.9	85.9	31.1	17.2	89.3	6.5	63.3	92.5	19.1	12.0	8.2	42.6	234.6	55.4	66.8	68.9	74.7	14.0	267.6	315.8	8.2	12.1	48.3	102.5	4.7	109.9	14.8	119.4	5.4	18.3	13.8	129.2	46.0	69.4	78.3	16.5	4.1	42.7	73.3	45.3	19.4	18.5	12.8	178.8
PEAR1	"FLJ00193, JEDI, MEGF12"	ENSG00000187800	"Platelet endothelial aggregation receptor 1"	Q5VY43	1	156893698-156916434	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 44.6;Endothelial cells: 30.6;Hepatic stellate cells: 40.0;Leydig cells: 44.4;Peritubular cells: 35.7;Sertoli cells: 26.3;Smooth muscle cells: 34.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 19.5;HBEC3-KT: 29.9;HHSteC: 21.6;HUVEC TERT2: 52.2;TIME: 85.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035217	Approved		Approved	"Nucleoplasm,Cell Junctions,Centrosome"		NA	NA		62000000		"Cluster 82: Adipose tissue - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 48: Smooth muscle cells - ECM organization"	"Nucleoplasm, Cell Junctions"	Centrosome	"HPA035217: AB_10669902"	"unprognostic (1.02e-1)"	"unprognostic (1.84e-5)"	"unprognostic (4.77e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.48e-1)"	"unprognostic (5.62e-2)"	"unprognostic (5.93e-2)"	"unprognostic (1.04e-2)"	"unprognostic (3.99e-1)"	"unprognostic (2.17e-1)"	"unprognostic (5.04e-1)"	"prognostic unfavorable (4.31e-4)"	"unprognostic (1.20e-2)"	"unprognostic (3.37e-3)"	"unprognostic (8.51e-2)"	"unprognostic (2.64e-2)"	19.0	5.0	2.5	2.3	3.0	2.3	12.9	1.2	4.1	12.3	2.0	4.5	1.6	10.0	1.1	2.6	9.1	7.4	8.7	1.2	1.7	4.8	2.1	11.8	3.8	2.0	2.3	9.1	2.3	1.7	3.4	11.7	2.3	4.7	0.9	0.4	2.9	3.7	5.7	4.2	4.1	4.6	1.1	7.0	3.7	3.0	2.9	1.4	9.7	7.6	1.1	6.0	7.3	1.4	0.5	2.9	0.8	0.0	0.0	3.7	0.1	11.7	19.5	4.8	2.8	0.3	0.5	0.0	0.6	8.7	0.4	0.2	0.0	29.9	1.3	0.2	0.0	14.8	0.7	0.8	21.6	0.1	0.0	11.3	0.1	6.5	1.5	1.0	52.2	0.5	0.0	0.0	0.2	0.0	0.0	0.0	0.7	0.0	11.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.1	0.0	6.9	0.0	0.0	85.2	0.1	6.4	2.6	0.5	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	2.5	3.0	1.2	4.1	1.2	1.7	2.0	2.3	2.3	1.1	2.9	1.4	44.6	0.0	3.2	0.0	0.4	0.9	0.1	0.7	1.2	2.4	0.6	1.3	7.5	1.5	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.5	1.2	0.2	2.5	30.6	1.8	5.7	0.0	0.4	0.1	10.1	1.5	0.4	1.3	0.1	40.0	0.4	0.5	0.0	0.0	2.3	0.0	1.6	1.5	3.5	44.4	3.0	5.4	12.2	0.4	0.2	0.0	0.0	0.0	1.2	0.0	35.7	0.0	0.2	0.0	0.1	0.2	0.2	26.3	1.7	34.2	1.5	1.5	0.2	1.1	0.3	0.3	1.1	0.3	0.2
PECR	"HSA250303, SDR29C1, TERP"	ENSG00000115425	"Peroxisomal trans-2-enoyl-CoA reductase"	Q9BY49	2	215996329-216082955	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"liver: 160.2"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 91.0;Proximal enterocytes: 49.5;Proximal tubular cells: 79.1"	"Cancer enhanced"	"Detected in all"		"liver cancer: 30.4"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Hep G2: 38.3;RPTEC TERT1: 35.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021593, HPA022539"	Enhanced		Supported	Peroxisomes		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 85: Liver - Metabolism"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Peroxisomes		"HPA021593: AB_1855177, HPA022539: AB_1855178"	"unprognostic (7.97e-2)"	"unprognostic (1.08e-1)"	"unprognostic (5.72e-2)"	"unprognostic (1.32e-3)"	"unprognostic (2.90e-1)"	"unprognostic (6.40e-2)"	"unprognostic (1.16e-3)"	"unprognostic (3.56e-2)"	"unprognostic (4.03e-2)"	"unprognostic (1.11e-1)"	"unprognostic (5.01e-3)"	"unprognostic (5.61e-2)"	"prognostic favorable (1.36e-5)"	"unprognostic (6.63e-2)"	"unprognostic (1.84e-2)"	"unprognostic (7.75e-2)"	"unprognostic (6.64e-2)"	25.4	5.4	2.7	2.9	3.1	7.1	10.2	3.8	2.9	4.5	6.0	8.7	26.0	3.3	4.1	3.1	8.1	9.7	2.4	2.7	2.8	33.9	160.2	6.4	3.9	3.2	3.1	4.1	4.8	7.2	3.2	1.0	3.3	5.0	7.5	2.2	5.6	3.4	6.8	4.2	20.1	3.2	2.6	3.0	3.9	0.5	3.0	3.4	16.1	5.2	3.8	2.3	2.3	3.7	6.0	6.6	2.6	0.1	15.7	5.7	3.1	1.4	3.3	3.7	6.3	7.6	17.1	0.1	11.9	3.5	9.2	1.4	7.5	8.7	6.5	9.5	7.7	7.8	3.6	38.3	15.7	2.0	5.1	5.0	6.1	3.9	5.5	5.6	3.8	4.6	3.3	8.6	8.2	4.4	2.4	2.2	4.8	0.1	4.9	5.3	5.0	0.9	35.9	1.0	3.6	5.2	3.6	7.4	15.6	6.2	8.6	6.5	0.0	2.4	2.5	6.0	4.3	9.8	8.9	3.1	5.3	2.8	5.6	1.2	4.2	1.5	6.5	1.6	7.7	4.3	8.8	7.5	1.5	5.7	9.2	6.1	4.5	9.9	2.3	0.2	16.6	4.1	2.7	3.1	3.8	2.9	2.7	2.8	3.2	3.1	3.3	2.6	3.0	3.7	4.3	6.4	13.6	6.5	7.0	3.7	4.7	4.0	3.4	10.8	2.4	2.9	3.7	35.8	3.4	29.5	14.6	3.9	5.9	11.5	13.7	13.2	0.1	10.1	2.7	3.9	7.2	9.4	15.4	3.8	7.3	5.0	7.7	6.3	1.3	2.0	6.8	91.0	9.6	3.3	18.4	8.0	6.1	4.7	3.7	0.3	5.6	5.5	10.6	8.4	27.4	10.1	9.2	8.5	10.6	5.0	17.7	8.2	5.9	2.0	49.5	79.1	13.1	6.4	0.0	6.6	4.4	0.1	1.6	4.9	2.8	1.6	11.4	1.9	14.6	2.7
PEDS1	"CarF, Kua, TMEM189"	ENSG00000240849	"Plasmanylethanolamine desaturase 1"	A5PLL7	20	50118254-50153734	"Enzymes, Predicted membrane proteins"	"Fatty acid metabolism, Lipid metabolism"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Cytotrophoblasts: 86.8;Extravillous trophoblasts: 167.6;Hofbauer cells: 38.6;Syncytiotrophoblasts: 50.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059549	Approved		Supported	"Endoplasmic reticulum"		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 38: Extravillous trophoblasts - Unknown function"	"Endoplasmic reticulum"		"HPA059549: AB_2684059"	"unprognostic (3.11e-2)"	"unprognostic (7.04e-3)"	"unprognostic (1.56e-2)"	"prognostic unfavorable (7.51e-4)"	"unprognostic (1.71e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.03e-3)"	"unprognostic (7.00e-2)"	"unprognostic (2.19e-2)"	"unprognostic (1.35e-1)"	"unprognostic (8.63e-2)"	"unprognostic (5.79e-2)"	"prognostic unfavorable (5.79e-11)"	"unprognostic (1.85e-1)"	"unprognostic (1.20e-1)"	"unprognostic (9.46e-2)"	"unprognostic (4.42e-2)"	13.2	14.0	19.6	7.3	24.0	5.7	10.4	25.3	24.3	12.7	15.8	18.4	8.7	13.8	10.7	26.0	9.1	7.2	20.8	19.6	20.8	9.3	17.8	13.7	6.0	25.8	24.4	5.5	9.3	12.8	5.8	17.6	24.1	11.6	7.1	2.2	12.4	13.5	16.9	22.9	9.8	21.8	21.0	10.0	15.1	6.3	23.3	7.8	7.7	16.3	7.4	15.4	15.1	29.1	19.6	17.7	20.7	16.3	30.7	23.0	34.6	13.6	12.6	27.8	15.6	48.6	30.5	7.2	21.2	12.8	39.7	52.8	10.4	27.4	10.0	3.8	8.0	9.3	24.5	41.6	17.3	15.1	24.2	19.7	62.7	15.6	16.4	13.4	33.6	12.2	9.8	10.2	9.5	17.3	12.0	38.1	10.1	50.1	18.3	9.7	15.9	7.8	53.7	28.4	10.8	7.1	15.4	52.2	32.4	20.3	8.3	21.2	26.8	23.1	12.1	15.1	13.5	7.5	13.6	2.9	19.9	11.1	19.1	4.9	5.3	6.2	3.1	10.2	2.6	1.8	3.5	2.6	5.6	1.5	2.9	3.4	2.0	4.0	14.0	3.6	5.6	3.8	19.6	24.0	25.3	24.3	19.6	20.8	25.8	24.4	24.1	21.0	23.3	29.1	8.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.8	0.0	0.0	0.0	0.0	86.8	6.3	0.0	0.0	0.0	0.0	0.0	0.0	4.9	0.0	0.0	0.0	0.0	167.6	6.3	0.0	0.0	0.0	0.0	0.0	0.0	38.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	50.1	1.2	0.0	0.0	0.0
PEDS1-UBE2V1	"CROC-1B, Kua-UEV, TMEM189-UBE2V1"	ENSG00000124208	"PEDS1-UBE2V1 readthrough"		20	50081124-50153637	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"			"Tissue enhanced"	"Detected in many"		"brain: 12.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Region enhanced"	"Detected in single"		"cerebral cortex: 1.2"					"HPA052535, HPA053186"			Supported	Nucleoplasm		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 70: Brain - Nervous system development"	"Cluster 39: CACO-2 - Unknown function"		Nucleoplasm		"HPA052535: AB_2681863, HPA053186: AB_2682073"	"unprognostic (3.69e-1)"	"unprognostic (1.27e-1)"			"unprognostic (2.41e-3)"	"unprognostic (2.71e-2)"		"unprognostic (1.52e-1)"	"unprognostic (6.05e-3)"					"unprognostic (2.40e-1)"			"unprognostic (8.19e-2)"	2.1	1.6	3.0	1.7	8.4	0.0	1.5	11.3	5.7	2.3	1.3	1.1	0.2	1.7	0.0	4.1	0.9	0.4	1.6	3.6	6.7	0.7	1.2	1.8	0.7	9.2	7.0	0.8	2.1	2.9	1.0	3.5	10.9	0.7	0.1	0.1	1.7	0.5	2.9	2.9	0.9	0.9	8.0	0.9	1.5	2.7	6.1	1.1	1.0	1.3	0.2	1.6	2.5	12.3	3.8	6.9	2.2	6.5	9.7	6.4	6.8	6.8	4.5	9.1	5.1	15.7	8.3	2.0	8.5	3.7	8.0	16.3	3.6	7.5	1.5	1.0	1.3	2.8	12.2	9.3	4.4	5.2	5.0	6.6	13.6	6.7	2.4	0.6	9.2	0.8	4.9	6.1	4.2	5.3	3.9	0.7	1.8	1.4	1.6	3.5	1.9	3.4	2.5	10.9	3.5	1.4	3.0	13.5	2.3	0.0	3.1	4.5	13.7	10.6	3.8	3.0	4.2	1.5	2.1	0.8	4.6	1.3	7.1	7.7	8.7	11.0	7.6	12.5	6.6	3.6	6.8	7.4	8.4	6.0	6.1	6.6	1.2	7.8	15.2	5.0	7.8	10.8	3.0	8.4	11.3	5.7	3.6	6.7	9.2	7.0	10.9	8.0	6.1	12.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PEF1	PEF1A	ENSG00000162517	"Penta-EF-hand domain containing 1"	Q9UBV8	1	31629866-31644896	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Syncytiotrophoblasts: 182.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA061608			Supported	Nucleoplasm,Vesicles,Cytosol		NA	NA		570000	"Cluster 2: Granulocytes - Unknown function"	"Cluster 68: Epididymis - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Nucleoplasm, Vesicles, Cytosol"		"HPA061608: AB_2684567"	"unprognostic (2.92e-2)"	"prognostic favorable (3.95e-4)"	"unprognostic (1.59e-1)"	"unprognostic (2.30e-2)"	"unprognostic (1.11e-1)"	"unprognostic (8.40e-2)"	"prognostic unfavorable (2.88e-4)"	"unprognostic (5.22e-3)"	"unprognostic (1.04e-1)"	"unprognostic (2.79e-2)"	"unprognostic (1.60e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.35e-1)"	"unprognostic (8.85e-3)"	"unprognostic (2.38e-1)"	"unprognostic (1.60e-1)"	"unprognostic (2.89e-3)"	57.3	67.1	76.4	28.5	78.6	37.9	56.4	80.1	81.3	56.3	77.8	59.0	31.3	63.3	84.4	62.1	54.6	38.6	63.8	77.9	81.6	69.4	71.3	61.3	38.5	81.9	78.6	50.2	40.9	69.1	52.1	61.4	84.7	59.4	45.1	26.6	39.9	59.1	42.5	85.7	44.0	60.0	79.9	55.9	51.3	40.1	78.9	56.6	110.9	39.3	61.6	61.9	52.2	81.4	56.9	65.0	53.1	41.3	61.2	63.8	51.0	52.8	89.8	124.4	109.0	38.7	83.2	60.2	71.9	118.3	63.9	58.1	103.9	134.5	100.1	76.0	112.6	49.9	49.4	78.6	107.9	49.0	45.3	66.3	152.6	122.0	113.2	79.2	122.2	72.6	52.4	60.6	90.4	67.1	75.6	47.5	74.3	69.7	72.9	72.5	51.7	66.2	98.6	60.8	75.8	43.9	60.2	56.1	81.0	82.9	50.0	35.5	65.7	54.0	46.0	92.7	71.3	38.7	42.2	65.4	67.7	71.8	65.9	147.3	75.6	93.0	90.2	69.4	86.8	70.9	75.5	81.4	77.5	76.4	70.2	70.6	76.2	87.4	67.2	71.4	84.0	104.8	76.4	78.6	80.1	81.3	77.9	81.6	81.9	78.6	84.7	79.9	78.9	81.4	58.2	41.7	37.7	5.9	31.6	36.2	66.6	70.8	29.6	41.2	34.7	36.2	20.4	21.5	35.3	69.9	12.5	160.0	33.9	36.6	113.5	72.0	81.3	17.4	20.0	60.3	44.3	40.0	8.0	61.9	106.1	34.0	21.9	19.8	72.9	34.3	35.3	24.4	61.9	53.8	7.4	49.8	50.8	18.5	21.8	87.5	45.1	27.8	49.8	7.5	81.6	59.6	46.4	6.0	13.8	59.1	44.0	58.6	23.6	65.4	48.9	57.8	23.5	26.5	19.7	25.8	38.8	44.1	44.2	24.6	51.4	182.8	33.6	50.9	39.5	58.3
PEMT	"PEMPT, PEMT2"	ENSG00000133027	"Phosphatidylethanolamine N-methyltransferase"	Q9UBM1	17	17505563-17591708	"Enzymes, Metabolic proteins, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"epididymis: 166.2;liver: 267.4"	"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 122.9;Hepatocytes: 220.1;Peritubular cells: 346.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042375, HPA073930"	Approved		Supported	"Endoplasmic reticulum,Vesicles,Mitochondria,Cytosol"		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 36: Stromal cells - Cell proliferation"	"Endoplasmic reticulum, Mitochondria"	"Vesicles, Cytosol"	"HPA042375: AB_10796905, HPA073930: "	"unprognostic (1.39e-2)"	"unprognostic (3.43e-1)"	"unprognostic (2.43e-2)"	"prognostic favorable (6.77e-6)"	"unprognostic (2.85e-1)"	"unprognostic (7.14e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.28e-1)"	"unprognostic (3.89e-1)"	"unprognostic (3.41e-2)"	"unprognostic (5.47e-3)"	"unprognostic (2.67e-1)"	"unprognostic (8.63e-3)"	"unprognostic (2.08e-1)"	"unprognostic (2.10e-1)"	"unprognostic (6.66e-2)"	"unprognostic (7.60e-2)"	71.6	33.9	13.2	5.2	13.6	9.2	92.7	16.3	20.0	47.4	12.7	13.6	15.0	36.9	166.2	26.8	26.5	5.4	24.5	13.0	15.2	30.2	267.4	25.8	5.2	14.9	15.3	27.9	32.2	13.3	24.7	7.3	16.8	30.8	3.4	2.8	27.1	24.0	29.5	34.3	13.7	6.8	15.1	12.8	19.5	40.8	14.2	5.6	33.5	10.7	4.5	21.1	24.2	17.2	34.3	64.7	16.5	43.4	34.6	23.8	25.1	21.6	19.0	28.5	22.4	38.2	22.6	29.8	38.1	21.9	21.6	39.9	24.6	12.8	7.2	22.2	86.9	14.8	33.2	55.4	38.4	13.5	21.4	24.9	26.7	19.2	29.1	9.7	15.7	41.3	14.6	12.3	12.9	66.0	23.9	24.2	23.2	65.5	52.4	22.2	26.7	27.5	24.1	12.5	16.7	39.5	15.3	10.1	39.2	31.5	15.6	5.1	13.9	28.1	28.2	47.4	18.9	17.0	12.1	5.5	25.9	18.5	23.6	1.9	41.1	2.1	16.9	39.0	24.8	23.5	22.2	21.5	30.5	28.3	17.2	19.4	3.1	29.3	28.0	27.7	22.4	21.3	13.2	13.6	16.3	20.0	13.0	15.2	14.9	15.3	16.8	15.1	14.2	17.2	38.1	16.0	17.5	4.9	12.4	18.2	21.0	27.9	39.3	4.5	33.0	45.1	15.5	11.5	24.9	27.6	0.0	19.5	5.9	9.3	17.6	33.3	2.9	21.8	122.9	18.5	68.8	17.1	5.4	38.5	21.6	30.4	8.2	23.8	12.7	52.4	10.4	220.1	23.5	5.0	6.8	30.9	24.4	13.7	12.2	14.9	94.8	11.2	21.4	3.7	5.7	34.7	2.1	9.5	4.0	25.7	10.8	346.8	15.3	35.1	21.7	32.3	14.2	6.1	6.6	20.0	23.6	21.0	24.9	39.5	18.2	14.6	12.5	49.3	24.1	23.8
PER1	"PER, RIGUI"	ENSG00000179094	"Period circadian regulator 1"	O15534	17	8140472-8156506	"Cancer-related genes, Predicted intracellular proteins"	"Biological rhythms, Transcription, Transcription regulation"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"HBEC3-KT: 49.8;hTCEpi: 56.6;hTERT-HME1: 54.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047947, HPA067064"			Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 50: Non-specific - Ribosome"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 24: Non-specific - Transcription regulation"	Cytosol	Nucleoplasm	"HPA047947: AB_2680219, HPA067064: AB_2685774"	"unprognostic (7.64e-2)"	"prognostic favorable (3.89e-4)"	"unprognostic (5.54e-2)"	"unprognostic (1.20e-1)"	"unprognostic (2.59e-1)"	"unprognostic (9.44e-2)"	"prognostic favorable (2.56e-4)"	"unprognostic (5.28e-2)"	"unprognostic (6.67e-2)"	"unprognostic (6.21e-3)"	"unprognostic (6.87e-2)"	"unprognostic (4.68e-2)"	"unprognostic (7.09e-3)"	"prognostic unfavorable (1.94e-4)"	"unprognostic (2.08e-1)"	"unprognostic (1.37e-1)"	"unprognostic (3.34e-2)"	128.3	73.3	17.6	36.6	19.1	53.3	113.2	25.5	27.3	85.1	25.9	99.2	10.4	63.9	6.2	61.9	101.8	36.6	88.2	18.9	21.4	56.2	73.5	95.5	18.3	19.4	20.6	168.5	103.7	49.5	103.3	20.5	17.7	83.9	11.7	22.0	62.5	27.9	211.8	182.2	58.0	30.6	16.1	54.6	82.5	35.8	18.0	12.8	100.1	67.3	11.5	81.0	90.6	25.7	2.2	8.2	9.4	13.4	29.8	21.7	5.2	3.4	5.9	4.1	4.8	8.3	5.4	15.6	2.5	4.7	4.4	6.7	9.4	49.8	2.9	4.9	11.7	8.4	18.5	2.6	40.7	3.3	11.9	33.8	56.6	7.0	54.9	5.4	9.0	11.9	10.9	21.0	7.5	7.6	9.6	6.8	7.9	2.6	5.4	13.2	5.3	8.3	9.7	1.8	4.0	9.9	6.9	7.9	6.6	3.8	5.8	2.5	15.5	4.7	8.7	1.8	2.8	12.7	5.1	5.3	6.3	4.1	3.3	0.0	1.2	0.6	0.6	0.9	0.7	0.3	0.5	0.4	1.8	0.6	0.5	0.3	1.2	0.2	0.4	0.2	0.4	0.5	17.6	19.1	25.5	27.3	18.9	21.4	19.4	20.6	17.7	16.1	18.0	25.7	88.8	54.5	78.5	24.8	47.6	53.2	38.9	31.5	118.9	37.7	39.2	37.5	24.4	51.5	37.7	27.6	98.0	5.9	63.9	16.8	5.9	6.5	28.2	48.3	23.6	39.4	50.2	50.9	18.7	4.0	4.0	50.5	60.1	54.4	70.2	11.9	40.7	48.8	19.7	20.2	9.9	22.9	16.2	59.2	70.1	52.4	41.0	91.5	48.0	15.0	12.1	40.0	3.1	8.0	5.6	8.5	21.7	33.8	55.4	34.4	38.9	6.3	48.7	49.2	32.9	89.3	47.1	6.6	10.0	63.0	59.8	13.5	84.4	12.8	16.4	19.9
PER2	KIAA0347	ENSG00000132326	"Period circadian regulator 2"	O15055	2	238244044-238290102	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Biological rhythms, Transcription, Transcription regulation"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Skeletal myocytes: 110.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA053136, HPA060510"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 50: Non-specific - Ribosome"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 50: Fibroblasts - ECM organization"	Nucleoplasm	Cytosol	"HPA053136: , HPA060510: AB_2684298"	"unprognostic (1.96e-2)"	"unprognostic (4.41e-2)"	"unprognostic (1.88e-2)"	"unprognostic (9.28e-2)"	"unprognostic (2.52e-1)"	"prognostic favorable (2.29e-4)"	"unprognostic (2.47e-2)"	"unprognostic (2.17e-2)"	"unprognostic (3.59e-3)"	"unprognostic (3.59e-2)"	"unprognostic (1.76e-2)"	"unprognostic (2.13e-1)"	"unprognostic (6.81e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.27e-1)"	"unprognostic (2.58e-1)"	"unprognostic (5.22e-2)"	12.2	3.3	4.7	5.0	5.2	8.4	14.2	7.2	5.8	11.9	2.4	7.6	5.1	10.2	5.7	13.6	7.9	12.3	5.7	5.7	5.1	3.9	12.4	7.1	4.7	5.2	5.7	7.8	14.4	4.2	9.0	2.9	4.4	9.3	6.2	5.1	14.1	8.9	11.4	17.0	8.0	4.9	5.4	4.8	13.4	11.8	4.7	4.1	8.8	7.6	6.2	8.7	8.2	4.7	1.6	11.7	2.4	4.2	0.1	1.2	8.2	1.1	4.1	1.5	1.4	1.8	5.8	10.3	1.2	2.7	1.5	8.6	2.4	3.5	2.2	2.9	1.7	9.1	6.2	8.2	2.0	13.8	9.2	1.6	8.3	1.8	6.1	1.5	0.8	4.2	4.5	6.3	1.3	7.7	6.9	15.2	3.5	7.6	2.3	16.5	5.5	3.3	1.5	3.3	9.7	1.2	2.9	6.3	1.8	0.7	5.9	8.5	2.1	3.6	4.2	2.8	4.1	7.1	1.8	12.3	6.7	5.9	4.5	2.1	1.2	0.3	1.0	2.2	1.6	1.5	1.6	1.2	1.4	1.5	1.5	1.6	1.0	1.2	2.1	1.8	1.2	0.3	4.7	5.2	7.2	5.8	5.7	5.1	5.2	5.7	4.4	5.4	4.7	4.7	24.9	16.0	30.1	18.6	9.9	73.9	61.7	21.3	38.1	20.6	67.8	33.8	5.7	31.5	46.9	27.6	2.1	9.2	27.0	22.5	7.9	7.5	9.6	69.7	30.1	15.6	24.6	6.9	20.9	10.4	6.3	39.8	52.5	86.1	9.5	3.3	11.4	35.8	3.9	11.8	13.9	35.1	18.3	10.1	25.3	4.7	11.1	12.4	24.9	5.6	5.3	13.5	2.1	9.0	7.2	7.6	35.3	18.4	10.9	15.0	10.9	5.5	44.2	7.8	6.6	110.1	32.2	31.3	17.0	38.4	85.4	13.0	13.6	3.7	36.9	33.9
PER3		ENSG00000049246	"Period circadian regulator 3"	P56645	1	7784320-7845177	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Biological rhythms, Transcription, Transcription regulation"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 137.8;Bipolar cells: 241.0;Horizontal cells: 124.5;Rod photoreceptor cells: 138.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"U-937: 36.0"	"Low region specificity"	"Detected in all"							HPA019530	Approved		Supported	Cytosol		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 54: Non-specific - Microtubule organization"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 56: Bipolar cells - Visual perception"	Cytosol		"HPA019530: AB_1855201"	"unprognostic (5.11e-2)"	"prognostic favorable (7.14e-4)"	"unprognostic (2.45e-2)"	"unprognostic (2.97e-3)"	"unprognostic (1.74e-1)"	"prognostic favorable (1.34e-4)"	"unprognostic (3.87e-1)"	"unprognostic (5.53e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.77e-1)"	"unprognostic (4.11e-2)"	"unprognostic (8.96e-2)"	"prognostic favorable (2.20e-5)"	"unprognostic (1.16e-1)"	"unprognostic (1.20e-1)"	"unprognostic (3.46e-1)"	"unprognostic (1.62e-1)"	13.9	11.1	10.1	4.6	14.1	0.7	12.6	46.1	15.9	12.4	3.1	18.4	6.4	19.0	10.6	17.0	12.6	12.2	22.3	9.6	9.9	12.5	25.6	12.0	4.7	12.7	13.9	18.5	17.0	19.8	16.9	2.7	14.4	15.6	6.6	55.9	25.4	20.5	28.7	13.4	9.4	10.7	11.8	9.0	17.4	8.8	14.4	4.6	23.3	24.3	7.2	10.3	10.4	26.0	7.2	2.1	6.1	1.8	1.1	0.6	1.8	3.0	5.5	5.5	7.6	8.6	27.7	3.2	1.6	12.4	9.4	3.3	22.1	1.4	8.3	0.2	1.2	22.7	8.3	1.3	6.8	0.7	7.6	3.0	2.4	6.0	6.1	11.4	2.0	1.6	18.7	5.8	2.4	5.7	12.7	10.2	3.3	16.0	5.9	11.0	2.2	0.2	3.1	1.3	7.9	8.5	26.3	0.1	11.0	6.1	6.6	1.0	4.2	14.9	21.4	4.6	4.0	0.8	0.5	2.7	10.5	36.0	21.2	0.3	0.6	0.4	1.5	0.7	1.8	0.6	0.7	1.4	0.7	0.2	0.6	0.7	0.0	0.3	1.3	0.5	1.3	0.6	10.1	14.1	46.1	15.9	9.6	9.9	12.7	13.9	14.4	11.8	14.4	26.0	45.0	19.2	12.1	137.8	3.9	30.1	13.1	4.3	40.5	241.0	14.3	17.3	17.0	8.6	9.9	9.2	81.3	1.7	3.0	5.0	9.8	3.2	16.5	4.4	19.6	17.5	6.6	0.0	42.8	4.8	0.5	33.6	20.4	4.3	26.0	6.9	10.8	28.1	9.4	124.5	64.1	4.0	12.2	8.5	14.8	5.8	12.5	11.2	12.4	40.3	3.4	91.2	2.1	62.4	91.6	5.7	1.6	27.4	3.3	9.7	5.0	5.2	9.7	138.5	6.6	39.2	25.4	22.2	23.2	32.9	25.6	0.5	5.9	11.5	1.7	8.6
PEX1	"ZWS, ZWS1"	ENSG00000127980	"Peroxisomal biogenesis factor 1"	O43933	7	92487020-92528520	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Peroxisome biogenesis, Protein transport, Transport"		"Amelogenesis imperfecta, Deafness, Disease variant, Peroxisome biogenesis disorder, Zellweger syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020235	Approved		Supported	Peroxisomes		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 52: Non-specific - Transcription"	Peroxisomes		"HPA020235: AB_1855224"	"unprognostic (4.67e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.55e-2)"	"unprognostic (1.53e-2)"	"unprognostic (4.85e-1)"	"unprognostic (2.41e-2)"	"unprognostic (7.81e-2)"	"unprognostic (9.79e-3)"	"unprognostic (2.17e-2)"	"unprognostic (6.39e-2)"	"unprognostic (1.68e-2)"	"unprognostic (3.61e-2)"	"unprognostic (2.95e-3)"	"unprognostic (1.59e-1)"	"unprognostic (2.49e-1)"	"unprognostic (5.35e-3)"	"unprognostic (4.90e-2)"	5.8	6.9	2.6	6.0	4.7	4.1	8.7	4.6	4.3	6.4	2.5	8.6	6.6	6.7	11.2	6.1	5.6	4.7	8.9	2.4	3.1	14.2	13.0	5.3	6.9	3.5	3.5	6.8	8.8	11.7	6.3	4.2	4.1	7.8	9.5	13.2	9.1	7.0	9.1	7.9	8.1	5.4	2.8	6.0	8.2	6.7	3.0	7.9	8.6	9.9	6.7	5.6	5.8	6.3	8.3	8.9	14.4	24.6	8.9	7.6	13.0	5.4	7.1	6.3	9.1	5.5	8.7	12.2	12.0	6.3	9.6	8.4	11.0	9.9	10.0	12.7	9.7	5.8	9.5	7.0	6.2	10.6	6.4	8.2	8.6	9.4	12.7	8.0	9.9	12.6	21.9	17.2	10.1	15.5	21.3	10.4	10.0	12.3	8.3	15.0	16.0	15.3	8.8	12.0	10.6	17.1	12.4	34.3	10.8	20.2	7.1	4.4	8.1	6.0	8.1	23.0	5.7	18.9	15.9	16.7	5.7	6.2	9.8	0.8	1.1	1.8	2.5	1.8	2.5	3.0	2.6	2.8	1.2	2.8	2.9	3.3	0.9	4.7	2.2	0.7	2.8	1.1	2.6	4.7	4.6	4.3	2.4	3.1	3.5	3.5	4.1	2.8	3.0	6.3	14.2	28.9	18.4	26.1	14.1	5.9	8.4	8.1	10.8	43.5	11.7	12.6	29.7	5.7	13.1	5.5	35.5	9.0	13.6	17.2	9.8	6.6	7.3	22.6	14.7	11.6	13.9	12.4	30.0	7.5	3.9	11.6	21.9	14.2	8.8	20.5	8.2	14.2	5.4	40.4	45.7	12.0	8.2	7.6	3.1	4.8	14.3	8.4	7.2	13.1	12.7	14.2	14.4	23.6	55.2	6.0	11.3	15.1	11.6	9.6	16.5	19.2	32.4	42.9	6.6	15.5	12.6	36.6	14.4	11.2	7.7	8.3	12.0	11.8	15.2	7.7
PEX11B		ENSG00000131779	"Peroxisomal biogenesis factor 11 beta"	O96011	1	145911350-145918717	"Disease related genes, Predicted membrane proteins"	"Peroxisome biogenesis"		"Peroxisome biogenesis disorder"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA017150, HPA050104"	Supported		Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 47: Cytotrophoblasts - Unknown function"	Vesicles	Nucleoplasm	"HPA017150: , HPA050104: AB_2681017"	"unprognostic (4.59e-2)"	"unprognostic (3.13e-2)"	"unprognostic (1.80e-1)"	"unprognostic (2.29e-1)"	"unprognostic (3.62e-1)"	"unprognostic (1.18e-1)"	"prognostic unfavorable (2.67e-4)"	"prognostic favorable (6.85e-4)"	"unprognostic (1.19e-1)"	"unprognostic (4.08e-2)"	"unprognostic (2.10e-1)"	"unprognostic (8.48e-2)"	"unprognostic (6.96e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.84e-1)"	"unprognostic (7.62e-3)"	"unprognostic (4.28e-1)"	17.5	25.1	34.7	19.0	35.8	13.3	31.2	32.5	42.5	24.6	33.3	24.9	24.6	23.4	33.1	34.3	25.7	17.0	28.0	36.3	38.1	32.4	27.1	20.1	27.4	33.3	33.0	24.6	27.2	33.5	24.5	23.1	35.1	24.3	27.6	20.2	28.7	25.6	39.8	28.1	25.9	21.0	31.6	27.7	28.3	30.8	34.1	30.2	26.4	34.9	34.7	23.2	22.2	34.2	27.1	24.4	21.0	21.1	48.6	37.9	21.9	26.8	35.3	34.4	26.5	11.3	30.7	25.2	28.1	38.3	16.6	31.9	18.6	40.0	24.0	28.4	14.1	15.6	14.8	29.2	68.3	46.9	27.5	49.9	49.3	23.3	22.8	43.9	44.5	34.8	28.7	40.5	54.7	43.1	35.8	43.5	7.5	57.4	29.5	33.0	31.5	55.5	58.8	19.1	14.7	24.0	20.2	38.4	24.7	20.5	53.2	72.0	39.7	23.1	18.2	30.3	19.8	43.1	54.0	35.1	38.5	26.3	16.0	89.6	64.7	47.3	58.5	60.9	64.8	93.2	67.5	65.4	70.8	84.1	74.7	67.9	32.4	71.1	60.5	94.9	79.6	82.7	34.7	35.8	32.5	42.5	36.3	38.1	33.3	33.0	35.1	31.6	34.1	34.2	5.0	16.0	10.3	9.8	17.0	19.4	9.2	41.3	26.7	8.0	16.8	17.0	12.8	17.2	20.7	40.5	0.0	37.9	19.6	20.2	45.0	13.7	12.2	8.2	7.0	12.3	12.7	14.1	13.0	13.8	13.9	11.1	19.4	7.4	3.8	9.3	18.2	32.9	23.0	5.0	13.5	16.0	20.3	18.3	10.7	21.1	14.0	12.9	21.4	4.7	27.1	12.6	25.7	9.5	12.9	16.0	11.4	19.9	17.4	10.1	20.1	34.5	22.9	5.1	6.6	5.8	10.3	41.1	24.3	34.0	22.0	20.0	13.8	11.6	15.8	9.4
PEX13		ENSG00000162928	"Peroxisomal biogenesis factor 13"	Q92968	2	61017225-61051990	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Protein transport, Transport"		"Disease variant, Peroxisome biogenesis disorder, Zellweger syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 125.8;Urothelial cells: 112.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA032141, HPA032142, CAB032689"	Enhanced		Supported	Peroxisomes		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 85: Liver - Metabolism"	"Cluster 15: RT4 - Unknown function"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Peroxisomes		"CAB032689: AB_2162137, HPA032141: AB_2674176, HPA032142: AB_10669676"	"unprognostic (2.44e-3)"	"unprognostic (4.10e-2)"	"unprognostic (7.84e-3)"	"unprognostic (2.73e-2)"	"unprognostic (1.28e-1)"	"unprognostic (5.08e-2)"	"unprognostic (2.05e-2)"	"unprognostic (1.78e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.86e-2)"	"prognostic unfavorable (8.07e-5)"	"unprognostic (5.42e-2)"	"unprognostic (4.44e-2)"	"unprognostic (1.93e-1)"	"unprognostic (2.84e-1)"	"unprognostic (1.41e-1)"	"unprognostic (2.63e-2)"	9.5	8.0	6.6	6.7	7.1	7.4	11.1	9.7	9.2	10.2	10.2	10.2	10.2	9.2	7.5	10.2	6.6	8.8	11.9	6.8	7.4	13.6	25.0	9.3	6.8	6.7	7.1	11.0	11.8	9.6	7.4	9.3	6.8	14.6	10.7	8.8	8.7	5.8	14.6	7.9	9.8	8.1	6.6	6.7	10.1	14.9	7.1	7.3	13.7	13.6	6.7	13.8	9.1	7.7	15.5	11.3	15.7	20.3	14.8	11.5	24.2	15.9	12.3	10.6	10.8	16.9	22.9	10.0	16.7	15.6	19.9	22.8	14.1	19.2	20.0	9.9	9.7	9.2	15.1	28.0	17.5	13.9	10.8	14.2	28.9	14.5	22.3	16.2	19.4	11.3	22.8	8.7	16.3	14.1	10.4	16.6	17.2	28.6	11.2	11.1	17.4	12.7	20.3	38.2	17.7	12.2	17.7	23.7	14.9	18.5	15.8	7.1	15.3	20.2	27.0	11.8	13.6	14.2	11.6	25.0	12.7	14.0	14.5	12.4	3.9	5.9	5.0	3.9	4.7	5.4	5.8	5.5	5.1	4.1	6.1	4.6	3.7	5.5	5.0	4.5	5.4	3.9	6.6	7.1	9.7	9.2	6.8	7.4	6.7	7.1	6.8	6.6	7.1	7.7	12.9	19.2	19.1	14.0	13.8	51.2	35.1	61.9	25.6	11.9	23.0	13.2	21.9	28.6	53.0	22.0	8.4	36.9	13.4	27.6	25.4	28.8	125.8	24.5	16.1	15.1	2.4	9.9	18.8	28.5	43.1	14.5	12.8	28.8	8.2	15.6	13.6	49.3	20.9	16.8	16.8	14.5	36.7	14.6	25.9	28.7	9.6	14.8	16.0	25.3	19.3	12.6	18.6	14.1	19.4	23.2	13.2	11.7	9.9	43.9	28.8	33.2	38.7	15.0	6.6	11.6	18.8	66.8	26.4	21.8	50.3	68.7	15.0	11.4	18.1	112.0
PEX19	"D1S2223E, HK33, PMP1, PMPI, PXF, PXMP1"	ENSG00000162735	"Peroxisomal biogenesis factor 19"	P40855	1	160276807-160286348	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	"Peroxisome biogenesis"		"Peroxisome biogenesis disorder, Zellweger syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA044837, HPA051966"	Supported		Supported	Peroxisomes		NA	NA		7900	"Cluster 34: Basophils - Unknown function"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 38: Extravillous trophoblasts - Unknown function"	Peroxisomes		"HPA044837: AB_10962496, HPA051966: AB_2681677"	"unprognostic (1.49e-2)"	"unprognostic (2.26e-1)"	"unprognostic (3.42e-1)"	"unprognostic (4.80e-3)"	"unprognostic (3.89e-2)"	"unprognostic (3.88e-2)"	"unprognostic (3.79e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.32e-1)"	"unprognostic (1.53e-2)"	"unprognostic (8.06e-2)"	"unprognostic (1.00e-1)"	"prognostic favorable (2.92e-5)"	"unprognostic (3.46e-2)"	"unprognostic (2.25e-1)"	"unprognostic (2.19e-2)"	"unprognostic (1.24e-2)"	79.3	25.7	21.1	14.5	22.5	12.3	36.5	22.2	23.5	20.3	15.6	22.6	19.4	18.2	25.0	24.9	22.9	19.6	39.4	21.5	22.7	33.1	109.1	21.6	16.6	22.3	23.5	23.6	17.2	40.4	15.0	21.9	23.5	28.0	23.2	30.9	21.3	26.6	66.2	18.2	18.8	16.7	22.1	16.7	20.0	16.8	22.7	21.0	34.3	84.8	20.5	23.9	15.2	24.5	31.2	18.9	69.8	22.4	59.8	57.8	53.0	25.3	51.3	44.6	35.3	35.1	37.2	37.8	40.9	37.3	26.3	29.7	34.2	44.0	35.3	32.3	17.3	26.6	26.5	36.3	46.9	48.6	32.6	84.7	51.0	60.0	38.6	35.8	32.2	51.4	40.8	27.9	50.0	17.8	37.0	15.8	50.3	38.6	48.2	45.7	34.4	45.5	45.8	61.8	23.2	38.3	98.3	49.5	37.4	71.3	48.1	48.2	24.8	26.5	31.1	29.9	30.1	42.5	57.9	68.6	43.1	20.9	38.9	9.1	5.5	5.0	5.8	8.9	4.2	5.0	2.8	3.5	5.5	1.9	4.0	3.7	2.2	4.7	6.6	3.4	4.2	2.3	21.1	22.5	22.2	23.5	21.5	22.7	22.3	23.5	23.5	22.1	22.7	24.5	16.4	9.6	20.6	9.1	12.7	9.9	21.0	15.4	13.1	18.8	18.9	16.4	45.6	20.0	11.3	16.5	10.4	30.0	6.9	25.4	49.0	22.6	6.6	12.0	13.7	13.6	11.4	15.6	8.6	14.8	51.2	18.4	13.3	12.0	16.5	15.6	20.0	60.1	30.1	25.2	9.0	11.5	0.0	15.7	7.0	3.1	21.8	15.0	21.4	6.5	24.9	39.0	12.3	6.0	11.5	20.2	17.2	29.3	9.5	18.5	29.8	40.7	11.8	12.7	32.9	14.6	16.2	17.8	25.3	15.0	9.9	38.7	12.5	18.2	15.7	25.2
PEX2	"PAF-1, PMP35, PXMP3, RNF72, ZWS3"	ENSG00000164751	"Peroxisomal biogenesis factor 2"	P28328	8	76980258-77001044	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Peroxisome biogenesis"		"Disease variant, Peroxisome biogenesis disorder, Zellweger syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal tubular cells: 133.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010983, HPA011410, HPA027729"	Approved		Supported	Vesicles		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 39: Non-specific - Basic cellular processes"	Vesicles		"HPA010983: , HPA011410: AB_1854922, HPA027729: AB_10610416"	"unprognostic (6.42e-2)"	"unprognostic (2.90e-2)"	"unprognostic (4.64e-2)"	"unprognostic (2.35e-1)"	"unprognostic (9.91e-2)"	"unprognostic (2.33e-1)"	"unprognostic (6.19e-2)"	"unprognostic (2.22e-1)"	"unprognostic (3.16e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.85e-2)"	"unprognostic (2.07e-2)"	"unprognostic (9.57e-3)"	"unprognostic (2.48e-1)"	"unprognostic (9.49e-2)"	"unprognostic (3.06e-2)"	"unprognostic (1.09e-3)"	39.8	45.9	33.1	33.5	36.6	35.8	53.9	34.2	45.6	40.7	38.6	43.1	39.8	33.3	42.4	32.9	41.8	31.9	39.7	32.1	35.1	53.6	43.7	36.5	39.4	37.3	34.5	33.3	39.0	57.7	27.2	24.7	37.6	44.2	39.6	66.5	50.9	83.4	61.8	24.5	41.0	35.3	37.3	36.5	48.3	22.1	34.5	48.8	53.2	44.6	35.7	35.7	31.3	43.3	88.2	29.3	46.9	47.9	50.7	63.2	24.5	64.4	75.3	49.9	55.2	18.4	76.9	50.2	93.6	59.9	39.7	33.3	33.1	50.1	61.2	93.3	28.5	61.1	26.0	28.3	33.9	51.5	46.5	70.9	43.5	37.8	45.6	77.0	55.3	79.3	34.4	46.7	53.9	26.4	90.4	30.1	27.2	126.4	26.3	16.5	37.4	42.1	59.9	61.6	16.7	43.0	41.9	192.0	36.9	39.8	58.7	36.1	54.7	44.4	58.1	57.7	32.4	86.0	53.8	87.9	56.5	26.7	50.2	179.9	55.6	102.6	57.2	58.0	51.2	46.1	39.6	46.5	46.3	50.5	51.6	49.3	38.6	83.1	67.8	46.8	48.6	71.7	33.1	36.6	34.2	45.6	32.1	35.1	37.3	34.5	37.6	37.3	34.5	43.3	28.0	48.1	25.2	32.3	29.7	18.1	31.0	57.8	28.5	28.9	38.9	33.1	27.2	28.6	38.4	27.6	12.5	42.8	38.3	30.2	133.1	52.3	5.6	36.5	19.9	20.7	28.9	25.6	11.9	49.1	24.8	29.8	20.4	22.2	18.3	20.2	25.7	36.7	26.6	13.5	15.2	37.5	48.8	39.1	22.4	7.3	29.5	26.8	28.4	16.9	36.3	68.4	53.5	31.7	45.9	42.0	28.2	35.7	41.7	36.3	43.3	61.4	36.6	34.4	6.6	34.9	24.6	13.7	20.8	28.6	21.0	34.8	37.6	27.7	30.0	43.0
PEX3		ENSG00000034693	"Peroxisomal biogenesis factor 3"	P56589	6	143450805-143490616	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Peroxisome biogenesis"		"Disease variant, Peroxisome biogenesis disorder, Zellweger syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 80.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042830, HPA058006"	Supported		Approved	Nucleoplasm,Peroxisomes		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Nucleoplasm, Peroxisomes"		"HPA042830: AB_10794918, HPA058006: AB_2683576"	"unprognostic (3.52e-3)"	"unprognostic (6.28e-2)"	"unprognostic (1.81e-2)"	"unprognostic (1.51e-2)"	"unprognostic (1.21e-1)"	"unprognostic (4.16e-1)"	"unprognostic (8.45e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.56e-2)"	"unprognostic (2.50e-2)"	"unprognostic (2.16e-1)"	"prognostic favorable (3.80e-4)"	"unprognostic (1.87e-1)"	"unprognostic (7.30e-2)"	"unprognostic (3.80e-2)"	"unprognostic (2.12e-1)"	8.7	38.4	4.4	7.6	4.8	3.2	11.8	4.5	5.6	11.7	7.3	7.5	6.0	9.8	12.5	17.8	9.6	7.3	12.6	4.2	5.3	18.3	24.4	7.9	8.8	3.6	3.4	10.7	6.7	24.4	9.0	9.4	3.9	11.7	6.2	10.0	10.6	11.2	11.6	12.8	7.4	8.9	3.9	7.2	9.7	12.2	3.6	8.3	15.5	9.6	9.5	8.9	13.4	7.5	21.4	4.6	11.0	21.1	17.8	15.6	12.2	17.8	13.8	23.7	28.3	31.5	12.8	31.7	21.1	17.4	27.8	17.3	14.4	23.9	30.8	19.4	16.5	22.8	10.2	20.0	15.0	38.7	9.6	18.1	16.6	22.4	17.2	10.3	13.0	18.5	21.1	15.7	24.0	14.1	20.2	15.3	6.1	12.6	18.2	15.3	22.2	14.0	28.0	9.2	15.3	5.3	23.0	19.3	14.7	9.5	10.2	12.7	10.3	16.7	15.9	26.9	20.9	10.7	16.4	36.1	21.1	26.0	13.3	12.9	6.3	6.4	15.5	10.1	17.2	23.2	16.3	15.5	9.9	18.6	21.1	20.7	1.0	15.6	13.4	10.6	21.2	9.8	4.4	4.8	4.5	5.6	4.2	5.3	3.6	3.4	3.9	3.9	3.6	7.5	13.1	16.0	14.4	23.8	19.7	26.6	12.7	19.2	14.8	14.5	9.9	11.8	14.8	5.7	19.0	9.2	4.2	41.7	9.0	4.1	19.6	12.3	12.6	15.2	10.4	12.0	6.0	5.9	61.0	9.5	11.6	13.5	10.2	13.1	25.3	9.6	13.6	20.5	11.5	16.8	67.4	5.4	16.2	7.6	6.6	4.9	13.7	6.0	8.8	28.1	8.0	15.4	10.3	40.7	59.6	9.6	2.3	11.3	18.1	6.6	8.2	28.8	27.2	12.1	6.6	12.2	13.6	80.0	18.5	20.2	34.8	58.7	13.7	20.9	7.6	8.5
PEX5	"PTS1R, PXR1"	ENSG00000139197	"Peroxisomal biogenesis factor 5"	P50542	12	7188685-7218574	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Protein transport, Transport"		"Disease variant, Peroxisome biogenesis disorder, Rhizomelic chondrodysplasia punctata, Zellweger syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	6	"Early spermatids: 277.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Daudi: 156.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039259, HPA039260"	Enhanced		Supported	"Golgi apparatus,Cytosol"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 29: Early spermatids - Spermatogenesis"	"Golgi apparatus, Cytosol"		"HPA039259: AB_10673419, HPA039260: AB_2676417"	"unprognostic (7.44e-2)"	"unprognostic (2.54e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.86e-1)"	"unprognostic (1.27e-1)"	"unprognostic (4.46e-1)"	"unprognostic (1.48e-1)"	"unprognostic (2.20e-2)"	"unprognostic (5.14e-2)"	"unprognostic (3.72e-2)"	"unprognostic (1.63e-2)"	"unprognostic (2.92e-1)"	"unprognostic (5.70e-2)"	"unprognostic (7.31e-3)"	"unprognostic (1.96e-1)"	"unprognostic (2.13e-2)"	"unprognostic (1.13e-1)"	33.1	27.8	43.7	13.2	42.8	8.8	34.2	38.0	43.3	25.0	33.5	25.3	12.1	26.0	10.9	18.8	23.2	13.6	22.0	39.1	38.5	24.5	37.8	22.1	18.6	40.9	41.2	29.2	30.4	18.9	44.1	10.0	41.2	19.7	11.8	13.6	22.2	13.6	74.1	26.2	20.3	15.2	43.1	16.0	22.2	50.9	45.4	39.3	20.0	28.4	20.8	21.7	21.2	40.9	14.7	24.7	13.0	34.2	29.1	19.9	24.3	14.0	16.6	16.2	17.2	36.9	21.8	156.1	8.3	16.2	23.6	18.2	22.1	19.5	16.8	20.8	18.2	13.8	19.0	25.7	15.4	21.3	13.6	22.2	35.2	11.1	34.5	22.0	14.2	75.0	28.2	5.3	14.7	20.0	49.7	18.5	38.6	28.0	13.1	23.7	28.1	21.4	13.0	21.4	10.9	22.6	20.9	45.4	20.1	26.2	10.2	12.5	12.7	18.2	29.9	15.8	17.2	9.5	11.6	53.4	18.0	22.8	12.2	0.0	1.6	2.1	2.9	1.4	3.6	1.9	2.0	2.9	2.6	1.4	2.6	2.6	1.2	2.8	4.1	4.6	0.9	2.2	43.7	42.8	38.0	43.3	39.1	38.5	40.9	41.2	41.2	43.1	45.4	40.9	8.6	12.8	20.1	11.4	5.6	14.5	7.2	5.2	8.0	7.8	9.2	8.5	13.7	14.3	5.6	7.3	8.4	11.3	5.1	9.9	9.8	10.1	277.8	7.0	13.6	10.3	7.2	4.6	31.5	14.9	6.4	7.8	4.1	5.2	3.8	7.2	5.7	17.6	4.7	13.5	22.1	7.2	4.1	5.4	5.0	43.7	14.3	5.2	5.4	1.0	4.6	12.7	5.2	16.1	13.3	10.2	14.2	13.9	2.9	14.1	9.9	19.3	9.8	7.0	19.7	12.0	10.2	32.2	16.6	7.4	15.3	7.7	5.8	9.6	10.4	5.7
PEX6	"PAF-2, PXAAA1"	ENSG00000124587	"Peroxisomal biogenesis factor 6"	Q13608	6	42963865-42979181	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	"Peroxisome biogenesis"		"Amelogenesis imperfecta, Deafness, Disease variant, Peroxisome biogenesis disorder, Zellweger syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 76.2"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"OE19: 78.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA025924, HPA074179"	Supported		Supported	"Nucleoplasm,Nuclear bodies,Vesicles"		NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 22: Non-specific - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 52: Non-specific - Transcription"	"Nucleoplasm, Vesicles"	"Nuclear bodies"	"HPA025924: AB_1855230, HPA074179: "	"unprognostic (7.32e-3)"	"unprognostic (2.43e-1)"	"unprognostic (1.38e-1)"	"unprognostic (9.16e-2)"	"unprognostic (9.18e-2)"	"unprognostic (3.27e-1)"	"unprognostic (8.88e-2)"	"unprognostic (5.92e-2)"	"unprognostic (3.36e-1)"	"unprognostic (7.12e-2)"	"unprognostic (7.24e-3)"	"unprognostic (5.31e-2)"	"unprognostic (3.79e-3)"	"unprognostic (1.86e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.55e-1)"	11.6	20.5	24.9	9.2	25.2	9.5	12.1	23.9	27.7	19.1	25.5	16.3	9.3	15.5	7.7	16.4	22.7	9.6	18.7	25.1	25.5	16.5	27.7	10.0	14.5	27.2	25.5	26.1	76.2	15.2	24.3	9.6	24.2	21.6	7.8	9.9	14.8	11.4	23.4	14.0	16.3	9.6	23.9	17.5	16.3	16.2	25.1	14.7	19.8	15.0	10.4	17.3	15.7	25.2	35.0	16.4	8.1	30.6	29.6	28.3	8.4	6.0	9.4	4.8	10.0	10.5	10.1	14.1	8.2	14.3	20.5	32.2	28.7	31.1	5.0	27.6	15.2	4.7	24.4	6.2	20.0	4.8	9.4	35.5	35.5	19.9	5.5	39.1	24.7	18.9	25.2	14.1	10.7	3.9	12.7	15.8	10.0	78.8	14.3	26.8	14.3	5.8	12.3	10.0	25.4	11.1	5.6	21.9	32.7	13.1	43.2	21.2	14.0	15.2	2.9	7.5	14.0	21.0	19.8	19.7	5.2	24.6	12.4	1.3	1.3	2.1	1.2	1.1	2.1	1.0	1.8	2.5	1.9	1.9	2.2	2.1	0.8	2.0	0.7	1.0	0.9	1.1	24.9	25.2	23.9	27.7	25.1	25.5	27.2	25.5	24.2	23.9	25.1	25.2	5.6	6.4	2.6	19.9	5.6	5.0	10.2	6.2	10.8	15.2	11.8	12.7	4.1	10.0	5.6	7.3	2.1	11.4	5.4	10.2	13.7	2.8	2.5	17.6	10.6	5.8	5.4	1.7	24.6	1.5	6.7	9.2	11.2	9.1	0.0	19.8	8.6	14.1	5.8	21.9	22.4	8.5	6.1	9.7	3.2	3.6	14.6	5.4	8.8	9.4	4.5	11.8	9.2	13.0	16.6	1.9	10.4	9.4	3.1	6.3	15.1	13.9	14.3	7.0	0.0	13.0	6.6	7.3	2.6	6.3	5.5	7.4	7.8	26.1	10.5	6.6
PEX7	"PTS2R, RD"	ENSG00000112357	"Peroxisomal biogenesis factor 7"	O00628	6	136822564-136913934	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	"Protein transport, Transport"		"Cataract, Deafness, Disease variant, Ichthyosis, Peroxisome biogenesis disorder, Retinitis pigmentosa, Rhizomelic chondrodysplasia punctata"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 60.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049202	Uncertain		Supported	Nucleoplasm,Vesicles		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoplasm, Vesicles"		"HPA049202: AB_2680674"	"unprognostic (1.36e-2)"	"unprognostic (2.07e-2)"	"prognostic favorable (1.61e-4)"	"unprognostic (4.01e-3)"	"unprognostic (2.50e-2)"	"unprognostic (6.38e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.71e-2)"	"unprognostic (4.87e-2)"	"unprognostic (1.23e-1)"	"unprognostic (2.49e-1)"	"unprognostic (6.88e-2)"	"prognostic favorable (1.85e-10)"	"unprognostic (3.57e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.52e-2)"	"unprognostic (2.65e-1)"	5.2	14.8	4.6	2.0	4.8	3.8	11.9	6.0	5.2	6.8	5.1	7.9	5.3	4.2	17.2	7.3	8.7	4.5	11.7	4.2	4.2	15.6	9.1	4.9	3.2	4.3	4.4	5.0	26.9	17.1	6.0	4.1	4.5	10.4	8.4	6.9	10.6	6.4	10.7	11.2	4.7	3.3	4.4	3.3	15.6	10.0	4.7	3.7	11.0	9.8	3.3	5.4	6.7	5.5	4.4	4.3	4.4	6.2	6.6	9.8	2.4	6.1	8.9	7.5	7.4	4.9	6.0	1.5	11.3	8.3	8.5	5.3	3.3	13.8	9.8	5.7	7.5	6.4	4.3	0.9	13.9	8.1	5.3	9.6	13.1	5.4	7.9	8.7	5.4	12.0	13.0	5.2	10.6	13.4	3.5	7.9	5.0	13.9	8.3	4.8	3.4	5.7	17.4	6.4	8.3	10.6	6.5	9.0	8.4	4.9	5.8	7.7	2.5	4.8	1.7	7.3	5.3	6.9	5.1	0.0	4.2	6.4	4.9	2.9	1.3	2.2	0.7	1.0	0.7	1.5	1.3	1.6	2.3	1.0	2.4	1.5	0.9	1.6	1.9	1.8	2.3	0.9	4.6	4.8	6.0	5.2	4.2	4.2	4.3	4.4	4.5	4.4	4.7	5.5	4.9	3.2	9.4	10.7	6.3	12.1	14.9	16.5	9.1	9.1	19.5	13.8	18.7	11.5	14.7	11.0	8.4	19.6	2.3	11.6	60.7	16.5	12.5	18.7	6.4	5.6	10.3	15.8	12.4	22.7	21.0	6.8	10.2	11.1	14.0	7.9	6.1	7.0	12.4	0.0	14.7	21.8	30.5	5.7	6.2	10.2	9.0	6.4	14.2	5.6	11.9	20.8	4.1	17.6	19.9	16.7	13.2	9.8	3.7	16.0	15.0	38.3	16.1	9.9	6.6	5.7	8.2	30.6	16.7	15.4	18.2	17.1	6.6	24.3	17.2	17.4
PFDN5	"MM-1, PFD5"	ENSG00000123349	"Prefoldin subunit 5"	Q99471	12	53295291-53299452	"Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 3559.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			HPA008587	Approved		Supported	"Intermediate filaments,Cytosol"		NA	NA		110000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 35: Non-specific - Unknown function"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 32: Non-specific - Translation"	"Intermediate filaments, Cytosol"		"HPA008587: AB_1079597"	"unprognostic (3.56e-3)"	"unprognostic (2.31e-2)"	"unprognostic (2.87e-2)"	"unprognostic (4.02e-3)"	"unprognostic (1.59e-1)"	"unprognostic (3.44e-1)"	"unprognostic (3.44e-2)"	"unprognostic (1.99e-2)"	"unprognostic (2.65e-2)"	"unprognostic (2.12e-1)"	"prognostic favorable (5.45e-4)"	"unprognostic (1.27e-1)"	"prognostic unfavorable (1.54e-6)"	"unprognostic (5.34e-2)"	"unprognostic (9.48e-2)"	"unprognostic (2.30e-2)"	"unprognostic (2.01e-3)"	719.5	656.4	903.9	307.4	919.3	863.9	819.2	894.2	1279.0	907.5	890.8	684.3	238.6	555.3	867.4	520.1	654.0	366.1	633.1	880.3	907.3	677.4	505.6	539.2	610.5	907.4	899.1	1007.6	724.5	606.1	688.1	399.6	910.7	671.6	371.8	371.8	557.5	394.2	723.2	684.8	514.0	357.2	935.9	712.7	591.9	388.0	927.2	547.7	634.5	615.5	625.9	614.7	651.4	928.1	333.3	492.3	472.8	426.6	889.1	1220.7	347.2	814.5	1081.9	730.8	489.3	456.0	496.9	449.2	479.3	871.1	285.7	299.0	416.7	575.0	702.6	425.4	575.7	410.6	639.1	634.6	574.3	676.8	425.6	1174.9	823.4	522.7	398.6	1269.3	658.4	539.4	485.7	589.1	735.3	1150.9	478.1	993.0	447.7	359.1	757.4	381.1	514.6	530.8	842.9	477.8	396.5	454.1	525.6	450.1	612.1	481.8	588.1	843.6	585.6	408.2	319.1	198.7	372.6	444.5	500.8	670.7	450.3	528.5	386.0	1641.6	2761.6	989.6	1636.2	2095.6	2283.3	3705.2	2468.1	2003.4	2060.9	3368.6	3147.1	2533.0	740.8	1645.0	2221.2	1921.0	2149.1	8653.7	903.9	919.3	894.2	1279.0	880.3	907.3	907.4	899.1	910.7	935.9	927.2	928.1	711.6	262.8	501.5	27.7	1274.1	1505.2	1217.7	1648.8	900.3	184.0	1219.6	1850.4	598.0	684.9	778.6	566.4	102.2	899.8	862.2	593.0	1412.6	561.2	902.9	629.9	703.6	734.7	659.9	587.9	25.3	961.0	973.4	708.4	362.9	440.2	655.9	647.4	782.8	584.8	1830.1	72.3	25.0	892.0	734.5	1977.7	2549.4	3559.9	948.7	1235.9	1538.5	15.9	1663.4	619.2	905.3	21.6	27.6	705.6	990.6	655.2	582.9	971.9	1053.0	2024.3	862.7	321.5	552.2	713.6	902.4	469.7	234.3	762.4	1526.5	876.0	1147.0	658.2	849.4	1114.8
PFKP	"PFK-C, PFKF"	ENSG00000067057	"Phosphofructokinase, platelet"	Q01813	10	3066333-3137718	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	Glycolysis	"Allosteric enzyme, Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"retina: 277.0"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 459.8;Late spermatids: 516.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018257, HPA056484"	Uncertain		Supported	Cytosol		No	No		1900000	"Cluster 10: Basophils - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 34: Spermatids - Unknown function"	Cytosol		"HPA018257: AB_10960391, HPA056484: AB_2683147"	"unprognostic (1.16e-1)"	"unprognostic (2.41e-3)"	"unprognostic (5.79e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.40e-1)"	"prognostic unfavorable (1.55e-4)"	"prognostic unfavorable (8.72e-6)"	"unprognostic (1.36e-3)"	"unprognostic (2.38e-1)"	"unprognostic (8.51e-2)"	"unprognostic (2.37e-2)"	"unprognostic (8.82e-2)"	"unprognostic (6.02e-3)"	"unprognostic (2.60e-2)"	"unprognostic (9.74e-2)"	"unprognostic (2.06e-1)"	"unprognostic (4.54e-3)"	35.0	11.5	41.6	41.5	39.3	14.4	23.5	13.8	49.9	26.3	61.7	43.8	48.8	55.5	5.6	67.1	34.9	34.1	128.6	60.4	65.0	44.6	4.7	19.1	32.5	30.7	50.9	19.1	15.9	15.2	29.9	15.5	58.0	35.6	30.7	277.0	39.8	62.0	70.4	40.3	59.6	44.1	8.3	19.1	36.8	141.1	47.0	29.7	38.5	21.0	21.2	64.7	42.8	31.7	314.8	420.2	25.9	0.6	26.8	56.9	336.9	187.2	66.6	186.2	222.8	444.5	320.4	37.0	147.8	134.9	174.9	243.0	141.7	292.3	173.1	102.1	111.0	132.0	189.1	24.2	65.2	53.7	203.4	27.0	61.2	190.0	96.0	273.7	367.8	153.7	37.0	1.3	195.7	239.8	182.5	44.4	42.9	133.9	149.3	138.8	46.9	150.1	185.7	115.9	69.5	64.7	133.7	111.0	172.0	307.8	93.7	80.3	449.2	124.6	65.3	380.5	199.3	195.4	200.1	135.7	331.0	98.0	78.5	30.8	8.5	2.9	26.8	4.2	21.2	13.7	26.2	25.0	14.5	15.3	9.6	15.4	1.3	26.7	1.6	22.5	37.6	16.5	41.6	39.3	13.8	49.9	60.4	65.0	30.7	50.9	58.0	8.3	47.0	31.7	30.5	3.2	7.0	128.6	14.8	28.7	58.5	96.8	14.8	40.4	10.3	7.7	147.4	8.6	57.9	64.4	54.2	7.8	16.3	72.6	43.0	115.7	459.8	41.2	9.0	36.0	37.2	10.3	49.4	10.8	205.8	25.9	35.7	63.8	55.9	25.8	14.6	0.7	33.9	42.1	25.9	23.1	124.1	7.6	31.4	516.3	7.5	14.3	19.6	15.0	15.4	113.1	16.5	16.1	6.7	116.8	57.2	6.8	14.2	80.9	53.2	5.9	62.6	133.4	13.1	43.2	34.6	149.4	3.5	25.1	22.6	26.5	28.8	11.2	28.9	64.2
PGAM1	"PGAM-B, PGAMA"	ENSG00000171314	"Phosphoglycerate mutase 1"	P18669	10	97426191-97433444	"Candidate cardiovascular disease genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	Glycolysis	"Hydrolase, Isomerase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Extravillous trophoblasts: 791.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042528, HPA060483"	Approved		Supported	Nucleoplasm		NA	NA		120000000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	Nucleoplasm		"HPA042528: AB_2678039, HPA060483: AB_2684292"	"prognostic unfavorable (2.04e-4)"	"prognostic unfavorable (3.86e-4)"	"unprognostic (3.64e-1)"	"unprognostic (5.64e-2)"	"unprognostic (1.16e-1)"	"unprognostic (9.47e-3)"	"unprognostic (7.60e-3)"	"unprognostic (1.74e-3)"	"unprognostic (3.22e-1)"	"unprognostic (1.05e-1)"	"unprognostic (4.37e-3)"	"unprognostic (2.48e-2)"	"unprognostic (1.48e-1)"	"unprognostic (5.74e-2)"	"unprognostic (4.94e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.61e-3)"	149.0	294.7	228.7	153.6	249.7	180.0	122.1	252.9	265.0	184.3	275.1	162.9	151.5	153.7	98.6	436.7	117.2	106.6	275.7	256.1	266.0	167.6	182.5	121.7	165.7	241.7	242.7	133.3	81.8	191.3	150.8	156.6	280.9	107.3	141.9	420.7	164.7	156.5	56.5	206.9	141.4	177.9	228.3	139.6	133.2	87.5	278.8	124.9	86.9	70.2	229.7	186.6	233.3	224.7	1160.6	538.9	364.0	697.9	336.7	307.7	494.1	722.4	938.4	830.2	1148.3	589.4	335.4	609.1	482.7	619.2	333.4	706.8	639.8	1051.4	998.1	567.2	611.7	393.6	386.4	667.5	248.4	570.0	503.9	303.2	422.5	552.7	408.7	1118.9	610.8	447.2	262.0	334.0	884.8	478.3	514.7	697.8	559.0	331.8	637.8	384.2	333.6	484.0	646.0	431.1	79.1	370.1	388.6	229.2	381.2	564.9	625.0	472.9	463.8	441.5	385.2	394.8	844.0	499.0	593.1	556.1	1023.3	937.5	209.3	242.5	433.5	572.7	217.0	366.6	192.3	134.8	183.8	216.9	309.7	114.7	117.5	164.9	312.6	149.4	422.7	110.5	265.6	580.2	228.7	249.7	252.9	265.0	256.1	266.0	241.7	242.7	280.9	228.3	278.8	224.7	92.9	44.8	44.4	23.8	122.2	187.0	173.1	394.2	124.1	403.5	77.8	76.7	22.9	85.8	140.8	106.7	77.2	495.8	122.3	233.9	358.1	321.8	15.1	50.2	113.7	145.9	48.1	71.1	29.4	205.8	791.9	146.0	68.8	72.0	103.4	109.5	96.8	193.7	395.1	387.0	35.7	116.7	152.5	170.0	129.1	27.0	149.5	174.6	131.6	16.9	376.9	404.4	174.0	14.1	19.9	295.7	132.9	234.3	254.9	175.2	283.0	274.8	72.1	300.5	203.8	73.1	199.9	38.0	114.7	253.3	204.7	372.6	138.0	257.8	176.4	269.6
PGAM5	"BXLBv68, MGC5352"	ENSG00000247077	"PGAM family member 5, mitochondrial serine/threonine protein phosphatase"	Q96HS1	12	132710819-132722734	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	Necrosis	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036978, HPA036979, CAB068215"	Enhanced		Supported	Mitochondria	"Intracellular and membrane"	NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"CAB068215: AB_2665674, HPA036978: AB_10964347, HPA036979: AB_10960559"	"unprognostic (9.57e-2)"	"unprognostic (2.00e-2)"	"unprognostic (3.83e-2)"	"unprognostic (3.11e-2)"	"unprognostic (3.46e-1)"	"unprognostic (1.39e-1)"	"prognostic unfavorable (1.13e-6)"	"unprognostic (3.32e-2)"	"unprognostic (1.47e-1)"	"unprognostic (5.67e-2)"	"unprognostic (1.23e-1)"	"unprognostic (6.92e-2)"	"unprognostic (6.42e-3)"	"unprognostic (1.63e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.19e-1)"	"unprognostic (5.53e-2)"	10.5	17.7	13.0	17.0	12.7	16.3	9.7	12.7	17.0	9.8	10.1	16.1	15.2	10.9	6.6	23.9	12.4	8.7	20.0	19.0	12.5	14.3	28.9	9.3	21.2	9.3	9.7	7.2	25.8	10.7	9.9	10.7	10.1	9.4	11.3	6.0	15.5	11.5	33.2	17.1	13.2	11.3	7.9	12.8	13.3	16.5	10.8	14.8	11.6	19.0	16.1	15.6	11.8	11.3	72.2	134.3	28.2	79.5	19.4	15.6	66.1	37.4	22.0	59.1	33.0	168.6	40.2	92.3	67.2	31.2	30.4	61.2	132.9	67.5	24.1	47.3	106.7	110.7	61.6	89.2	44.0	105.8	61.8	19.4	48.8	69.0	73.6	19.3	43.6	73.4	143.3	36.9	23.5	128.5	144.5	105.7	108.0	61.8	94.4	109.4	31.2	73.3	38.4	97.4	102.8	58.0	62.2	86.1	38.9	22.2	108.9	57.5	38.2	29.9	65.5	60.6	89.9	77.2	124.8	133.5	38.8	85.3	51.1	4.9	1.1	0.3	1.1	1.2	1.8	1.7	1.3	1.3	1.0	1.7	1.3	1.7	0.9	1.6	1.7	3.3	1.1	0.8	13.0	12.7	12.7	17.0	19.0	12.5	9.3	9.7	10.1	7.9	10.8	11.3	6.6	3.2	6.1	3.9	8.9	11.5	16.7	2.6	2.2	9.5	7.8	5.5	15.1	15.7	1.5	5.5	14.6	7.6	11.9	11.7	5.9	5.8	14.5	6.3	6.3	7.0	13.1	5.0	5.1	7.9	14.4	4.9	4.1	9.3	0.0	7.1	5.7	22.4	7.3	6.7	3.9	8.9	2.0	6.9	5.8	20.6	5.9	4.7	3.6	1.9	5.3	4.4	3.1	2.0	2.3	7.5	6.9	6.8	9.7	19.5	5.2	11.5	4.5	12.9	6.6	8.0	6.4	15.1	10.1	10.8	17.3	6.2	7.4	9.2	15.7	16.1
PGAP6	"M83, TMEM6, TMEM8, TMEM8A"	ENSG00000129925	"Post-glycosylphosphatidylinositol attachment to proteins 6"	Q9HCN3	16	370788-387113	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"Cytotrophoblasts: 63.7;Hofbauer cells: 29.2;Syncytiotrophoblasts: 100.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 36.0"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"CACO-2: 129.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA051281, HPA064673"	Approved		Supported	"Nucleoplasm,Cytokinetic bridge"		Yes	No			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	Nucleoplasm	"Cytokinetic bridge"	"HPA051281: AB_2681418, HPA064673: AB_2685317"	"unprognostic (5.84e-2)"	"unprognostic (6.13e-2)"	"unprognostic (3.85e-2)"	"unprognostic (3.21e-2)"	"unprognostic (5.77e-2)"	"unprognostic (3.19e-2)"	"unprognostic (1.13e-3)"	"unprognostic (1.56e-2)"	"unprognostic (8.89e-2)"	"unprognostic (7.73e-2)"	"unprognostic (3.43e-1)"	"unprognostic (1.38e-2)"	"prognostic favorable (1.29e-5)"	"unprognostic (4.20e-3)"	"unprognostic (3.19e-2)"	"unprognostic (4.93e-2)"	"unprognostic (2.48e-1)"	23.5	25.5	13.5	18.0	15.1	30.0	20.1	11.8	17.7	17.7	14.5	39.6	31.4	19.2	24.8	31.9	17.7	16.4	37.7	12.8	11.0	59.4	57.6	36.2	17.0	14.6	12.6	12.2	102.8	19.3	28.8	34.8	13.5	30.3	10.3	5.6	40.8	12.5	36.1	11.3	38.5	8.8	11.9	36.0	53.9	63.3	16.0	11.7	28.0	10.1	7.9	23.4	14.3	14.6	12.7	32.8	18.4	33.9	24.7	22.1	36.7	35.5	36.6	17.7	25.3	129.2	57.9	13.4	47.1	34.5	27.3	17.8	8.4	39.2	4.9	38.5	31.1	22.1	23.1	74.8	56.9	16.9	40.4	25.7	11.6	27.4	7.9	18.0	41.4	14.8	36.2	20.1	22.6	78.2	23.9	33.2	29.2	20.1	12.9	51.0	21.0	31.2	28.8	32.0	21.9	25.2	19.8	19.7	106.3	9.6	35.7	33.4	61.1	50.2	53.6	35.2	19.2	40.3	21.6	27.0	25.5	17.8	32.5	7.1	7.6	10.1	10.7	8.6	8.3	2.5	8.1	8.3	3.9	2.6	10.7	8.0	36.0	1.5	6.1	4.2	6.6	5.7	13.5	15.1	11.8	17.7	12.8	11.0	14.6	12.6	13.5	11.9	16.0	14.6	11.7	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.9	0.0	0.0	0.0	0.0	63.7	8.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	7.4	2.9	0.0	0.0	0.0	0.0	0.0	0.0	29.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	100.2	1.4	0.0	0.0	0.0
PGBD5	"DKFZp761A0620, FLJ11413"	ENSG00000177614	"PiggyBac transposable element derived 5"	Q8N414	1	230314490-230426332	"Disease related genes, Predicted intracellular proteins"	Transposition	"Endonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 41.8;pancreas: 20.3"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 26.6;Excitatory neurons: 83.3;Inhibitory neurons: 78.4;Oligodendrocytes: 48.0"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"amygdala: 17.7;basal ganglia: 18.5;cerebral cortex: 35.9;hippocampal formation: 41.8"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"Daudi: 30.7;GAMG: 15.0;NTERA-2: 30.3;RH-30: 16.4;SCLC-21H: 41.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA065010			Supported	Nucleoplasm		NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Nucleoplasm		"HPA065010: AB_2685402"	"unprognostic (2.00e-2)"	"unprognostic (4.25e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.61e-2)"	"prognostic unfavorable (8.78e-5)"	"unprognostic (1.44e-2)"	"unprognostic (4.66e-2)"	"unprognostic (4.91e-2)"	"unprognostic (3.97e-1)"	"unprognostic (1.15e-1)"	"unprognostic (7.48e-3)"	"unprognostic (2.57e-1)"	"unprognostic (3.29e-2)"	"unprognostic (6.69e-2)"	"unprognostic (2.12e-1)"	"unprognostic (3.13e-3)"	"unprognostic (2.51e-1)"	0.4	9.4	17.7	0.4	18.5	0.1	0.4	1.1	35.9	18.1	0.0	1.0	0.5	4.6	0.0	1.2	4.9	1.7	13.1	41.8	0.0	1.0	3.1	1.3	0.5	0.9	0.0	0.3	20.3	1.3	5.8	2.1	1.4	0.8	0.7	6.9	5.2	0.7	2.6	0.7	0.5	2.4	0.0	2.2	1.1	5.2	0.1	3.0	5.2	5.1	4.6	0.9	2.6	6.6	0.0	0.0	7.6	0.1	0.1	0.0	0.6	0.5	0.0	0.2	0.0	6.8	0.0	30.7	2.8	0.1	15.0	5.7	2.4	0.0	0.0	0.1	2.6	0.1	0.2	0.1	0.0	0.1	0.1	0.1	0.3	0.0	0.0	0.0	0.0	1.5	0.3	0.0	0.2	1.5	0.3	6.2	30.3	0.0	0.2	0.0	16.4	4.9	3.5	0.0	41.4	7.7	1.0	0.1	0.4	0.6	0.4	10.5	0.0	0.0	2.5	0.0	2.5	12.7	10.3	0.0	0.1	2.6	0.5	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	17.7	18.5	1.1	35.9	41.8	0.0	0.9	0.0	1.4	0.0	0.1	6.6	0.3	0.0	1.9	18.9	0.3	0.1	0.7	0.1	0.0	26.6	1.3	0.6	9.0	4.3	0.4	0.0	20.9	0.1	0.3	0.4	0.0	10.3	0.9	1.4	3.0	0.3	9.1	0.0	83.3	5.8	0.2	0.8	0.0	2.9	10.8	1.9	0.4	4.1	11.5	21.9	78.4	0.4	0.0	3.8	0.3	0.9	0.0	0.9	1.8	4.7	0.1	2.8	0.0	16.1	48.0	5.5	0.3	0.0	0.0	2.1	0.0	0.8	0.9	10.8	0.0	6.4	0.8	0.7	1.8	0.0	0.0	0.3	0.5	2.8	0.6	1.9
PGLS	6PGL	ENSG00000130313	6-phosphogluconolactonase	O95336	19	17511636-17521288	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"PC-3: 244.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040744, HPA042032"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA		7200000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	Nucleoplasm	Cytosol	"HPA040744: AB_2677111, HPA042032: AB_2677809"	"unprognostic (3.68e-2)"	"unprognostic (8.98e-3)"	"unprognostic (1.25e-1)"	"unprognostic (9.64e-3)"	"unprognostic (1.35e-1)"	"unprognostic (1.04e-1)"	"unprognostic (3.55e-3)"	"unprognostic (2.95e-1)"	"unprognostic (1.44e-1)"	"unprognostic (7.55e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.30e-1)"	"unprognostic (4.75e-3)"	"unprognostic (2.39e-1)"	"unprognostic (1.99e-1)"	"unprognostic (5.05e-2)"	"unprognostic (9.26e-3)"	65.0	85.9	31.6	20.0	33.8	40.6	60.9	33.8	41.8	53.2	33.9	53.9	26.2	42.6	13.2	107.4	44.6	16.9	32.1	30.1	33.3	64.7	75.6	46.5	27.2	36.5	32.4	59.7	88.2	28.5	43.0	17.1	35.2	57.3	16.1	3.7	66.1	19.0	18.0	83.6	49.0	15.9	34.5	73.6	54.7	23.2	34.6	26.2	58.3	11.6	20.6	50.1	62.6	38.5	68.7	62.2	38.7	26.3	57.6	94.8	70.6	45.4	76.5	46.4	59.5	29.7	104.0	74.4	50.0	74.9	33.1	46.6	21.9	73.6	14.5	37.3	80.9	35.3	28.0	54.1	97.8	38.7	38.6	111.8	100.5	27.9	83.9	48.3	63.3	29.4	40.7	18.7	58.5	77.2	84.6	108.6	50.6	72.9	244.0	57.3	23.3	49.9	64.3	56.3	47.3	56.0	28.3	33.2	70.3	21.1	47.9	69.7	57.2	47.9	12.9	96.0	26.6	31.4	23.9	32.2	68.2	97.5	48.0	73.0	163.5	194.6	55.3	185.4	44.9	61.5	49.5	50.1	185.0	71.4	45.4	46.1	158.8	72.5	180.2	137.2	57.3	102.7	31.6	33.8	33.8	41.8	30.1	33.3	36.5	32.4	35.2	34.5	34.6	38.5	93.7	28.9	38.3	7.2	84.8	64.5	94.5	132.5	100.2	22.2	128.9	177.8	8.9	110.1	89.4	47.8	16.7	122.4	98.8	194.0	111.6	177.5	35.5	89.4	99.7	72.0	133.0	48.4	3.5	208.8	169.6	94.2	82.0	90.9	25.4	163.7	99.2	94.0	263.4	26.9	4.9	147.0	75.3	306.5	142.4	70.8	90.7	208.2	74.7	8.4	325.3	79.4	139.0	8.0	11.8	175.7	211.6	69.2	40.4	107.6	263.1	211.1	66.7	28.1	52.6	51.4	103.9	28.7	25.8	210.7	96.2	105.2	85.2	178.3	173.4	143.5
PGM1		ENSG00000079739	"Phosphoglucomutase 1"	P36871	1	63593411-63660245	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Carbohydrate metabolism, Glucose metabolism"	Isomerase	"Congenital disorder of glycosylation, Disease variant, Glycogen storage disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"skeletal muscle: 1559.1;tongue: 788.0"	"Cell type enhanced"	"Detected in many"		"Exocrine glandular cells: 238.4;Extravillous trophoblasts: 185.9;Hepatocytes: 214.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004666, HPA024190, HPA024637, HPA046329"	Enhanced		Supported	Cytosol		NA	NA		21000000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 33: Striated muscle - Muscle contraction"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 54: Cardiomyocytes - Muscle contraction"	Cytosol		"CAB004666: AB_425590, HPA024190: AB_1855266, HPA024637: AB_1855267, HPA046329: AB_2679625"	"unprognostic (2.50e-1)"	"unprognostic (2.26e-3)"	"unprognostic (1.74e-2)"	"unprognostic (5.90e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.28e-2)"	"unprognostic (1.86e-3)"	"unprognostic (2.42e-3)"	"unprognostic (2.20e-1)"	"prognostic unfavorable (8.74e-5)"	"unprognostic (7.07e-2)"	"unprognostic (1.55e-2)"	"unprognostic (6.58e-3)"	"unprognostic (1.37e-1)"	"unprognostic (2.46e-1)"	"unprognostic (9.74e-3)"	113.7	70.8	31.6	20.7	34.7	21.5	57.4	34.3	38.4	33.9	53.1	58.9	60.8	22.9	19.2	49.3	17.0	30.3	178.9	31.4	34.0	52.2	279.8	42.6	14.7	44.7	34.1	51.0	112.2	65.3	31.8	26.9	32.7	46.6	49.9	22.6	41.8	49.7	1559.1	30.6	55.1	41.4	31.9	14.7	30.6	11.1	36.5	14.3	27.5	788.0	19.4	38.4	22.1	30.2	113.4	47.0	17.3	57.0	111.0	81.4	138.6	45.7	61.8	48.9	79.0	38.8	51.3	35.8	93.2	71.2	107.4	26.5	24.0	96.3	55.9	44.0	32.1	75.3	72.6	40.3	91.6	66.8	4.3	103.4	60.7	57.1	88.5	129.8	29.6	36.3	0.1	46.3	78.8	6.9	19.6	36.7	78.3	3.4	73.9	26.8	80.0	11.8	70.0	35.3	10.4	66.7	100.0	103.0	157.4	78.6	32.4	25.2	3.1	71.6	36.0	64.0	39.4	29.1	45.5	57.8	117.0	58.0	31.5	46.0	33.2	49.2	40.5	22.4	32.7	22.4	23.5	31.0	48.4	11.8	21.0	24.7	38.7	43.9	21.2	13.9	20.4	35.4	31.6	34.7	34.3	38.4	31.4	34.0	44.7	34.1	32.7	31.9	36.5	30.2	8.4	93.0	29.4	48.3	16.9	17.8	29.0	58.8	47.8	9.2	33.8	21.8	139.2	48.6	24.2	16.5	10.4	76.6	14.2	81.8	88.0	55.9	32.0	8.2	12.1	12.7	13.1	5.7	17.9	238.4	185.9	37.0	27.0	13.5	5.1	134.3	15.0	214.4	24.6	0.0	26.3	47.5	20.3	17.0	10.8	8.5	22.1	13.5	26.6	4.7	32.8	75.8	29.9	32.2	9.8	70.5	31.6	38.0	40.4	29.2	90.2	74.8	17.0	11.4	13.1	53.4	25.5	5.6	10.1	57.3	18.2	58.8	19.0	20.2	81.5	19.0
PGRMC1	HPR6.6	ENSG00000101856	"Progesterone receptor membrane component 1"	O00264	X	119236245-119244466	"Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 677.4"	"Cell type enhanced"	"Detected in all"		"Hepatocytes: 520.4;Theca cells: 907.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002877, HPA064724"	Enhanced		Supported	"Nucleoli,Endoplasmic reticulum"		NA	NA		1200000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 85: Liver - Metabolism"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 52: Non-specific - Transcription"	"Endoplasmic reticulum"	Nucleoli	"HPA002877: AB_1079602, HPA064724: "	"unprognostic (6.97e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.72e-1)"	"unprognostic (4.35e-1)"	"unprognostic (6.51e-2)"	"prognostic unfavorable (3.02e-4)"	"unprognostic (1.58e-3)"	"unprognostic (9.28e-2)"	"unprognostic (4.66e-2)"	"unprognostic (6.20e-2)"	"unprognostic (3.08e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.14e-1)"	"unprognostic (3.06e-3)"	"unprognostic (2.08e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.11e-1)"	108.0	171.3	97.9	37.5	102.5	25.1	106.0	83.8	115.5	135.4	96.3	98.2	109.3	154.5	273.3	57.0	149.0	56.9	38.6	102.3	127.0	235.4	677.4	62.1	27.6	97.2	109.3	93.3	40.2	113.9	59.1	44.9	126.1	127.6	87.3	80.5	71.4	200.4	15.7	53.2	131.9	85.2	106.1	41.4	77.1	46.5	112.8	33.4	89.0	27.0	29.3	77.3	65.0	116.9	165.6	102.4	196.3	227.7	414.2	196.9	127.1	243.0	281.0	126.1	155.7	124.5	196.6	47.3	259.5	253.8	147.3	128.3	216.5	102.1	168.8	50.8	248.7	53.7	88.5	141.0	69.0	88.4	27.5	204.7	56.5	153.8	79.2	93.5	82.6	55.7	57.2	28.8	150.3	176.5	66.9	64.7	515.8	179.4	170.3	78.5	123.1	68.5	168.7	123.9	182.9	81.7	178.1	291.7	98.9	188.2	67.4	56.2	64.2	87.6	127.7	312.6	233.6	29.9	59.2	51.0	238.8	138.6	170.6	21.0	20.1	20.4	8.7	19.9	11.8	5.8	12.0	12.9	17.0	5.5	12.0	10.1	9.1	8.8	18.4	12.0	13.4	50.2	97.9	102.5	83.8	115.5	102.3	127.0	97.2	109.3	126.1	106.1	112.8	116.9	109.1	125.0	91.4	16.0	19.0	94.1	131.3	67.4	81.4	199.1	110.8	95.1	17.1	120.1	76.7	73.5	68.8	88.2	25.8	170.5	68.4	93.0	4.2	119.7	264.2	81.9	57.7	37.6	36.5	73.0	138.6	153.1	50.4	122.4	40.5	197.0	66.4	520.4	51.8	65.6	58.5	85.0	81.4	35.0	51.2	9.0	172.1	111.1	103.2	15.0	26.5	109.8	18.6	108.6	91.3	68.9	144.7	181.7	22.6	118.8	375.5	295.1	105.4	92.4	105.2	99.2	111.1	68.2	77.2	69.3	87.7	62.1	32.1	907.9	137.6	127.9
PHB	PHB1	ENSG00000167085	Prohibitin	P35232	17	49404052-49414901	"Plasma proteins, Predicted intracellular proteins"	"DNA synthesis, Host-virus interaction"		Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Proximal tubular cells: 473.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"CACO-2: 749.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003280	Supported		Supported	Mitochondria	"Intracellular and membrane"	NA	NA		360000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 10: Non-specific - Unknown function"	Mitochondria		"HPA003280: AB_1855732"	"unprognostic (2.31e-2)"	"unprognostic (5.70e-2)"	"unprognostic (1.19e-2)"	"unprognostic (7.88e-3)"	"unprognostic (8.33e-2)"	"prognostic unfavorable (1.58e-4)"	"prognostic unfavorable (9.91e-4)"	"unprognostic (5.81e-2)"	"unprognostic (4.40e-2)"	"unprognostic (3.53e-2)"	"unprognostic (1.67e-1)"	"unprognostic (7.36e-2)"	"prognostic favorable (3.77e-4)"	"unprognostic (5.10e-2)"	"unprognostic (1.77e-1)"	"unprognostic (2.71e-2)"	"unprognostic (3.09e-3)"	81.6	88.4	39.2	23.3	42.2	19.8	77.4	44.2	49.8	55.3	54.0	104.5	52.6	68.0	34.1	88.6	55.7	26.9	147.0	40.6	44.4	143.4	120.4	59.0	27.0	43.9	42.5	59.7	62.5	70.1	51.1	33.1	44.1	67.2	60.0	12.1	135.9	44.7	138.1	67.5	68.0	35.7	40.9	61.1	79.7	33.5	41.9	26.2	61.5	98.5	26.8	75.2	59.4	46.0	86.0	339.1	46.4	96.9	81.9	48.3	111.8	69.8	72.3	175.1	122.4	749.5	80.2	119.2	88.1	60.0	67.3	63.4	151.7	135.3	128.4	72.9	327.1	77.7	122.8	361.8	53.0	109.6	58.1	54.9	125.9	130.9	41.6	45.7	87.6	68.6	112.7	27.6	77.5	224.0	106.0	118.5	99.9	135.9	311.1	74.9	144.0	103.8	144.0	116.1	122.1	75.9	35.4	59.1	113.7	71.7	112.2	33.4	58.9	96.3	124.7	78.4	98.4	35.3	65.7	59.1	58.0	125.6	110.7	11.7	45.9	13.4	61.6	53.4	80.5	61.2	56.6	56.3	62.3	46.7	59.4	59.7	8.9	69.0	59.5	155.1	61.4	79.8	39.2	42.2	44.2	49.8	40.6	44.4	43.9	42.5	44.1	40.9	41.9	46.0	88.5	48.1	46.8	8.8	78.3	117.5	147.5	182.6	70.0	44.8	135.7	180.0	8.4	100.1	101.9	84.6	37.5	230.2	144.4	220.8	406.9	233.1	14.0	93.4	85.5	92.6	131.9	77.2	7.8	158.6	278.7	87.8	74.9	131.0	73.0	124.6	61.4	101.8	228.1	21.9	10.0	281.7	223.8	51.9	87.9	24.7	89.5	70.9	158.3	1.9	120.3	83.1	88.6	11.1	15.3	162.8	139.8	115.1	93.0	242.8	151.4	473.6	68.0	42.1	52.6	72.8	306.5	18.0	47.3	107.6	124.0	152.4	75.9	159.9	337.2	161.9
PHC1	"EDR1, HPH1, RAE28"	ENSG00000111752	"Polyhomeotic homolog 1"	P78364	12	8913896-8941467	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		"Developmental protein, DNA-binding"	"Disease variant, Primary microcephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 48.3"	"Cancer enriched"	"Detected in many"	7	"testis cancer: 32.8"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"BEWO: 141.8;NTERA-2: 492.6;SuSa: 178.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006973	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 9: Photoreceptor cells - Phototransduction"	Nucleoplasm		"HPA006973: AB_1855278"	"unprognostic (4.00e-2)"	"unprognostic (1.79e-1)"	"unprognostic (2.57e-1)"	"unprognostic (1.73e-1)"	"unprognostic (4.21e-3)"	"unprognostic (7.46e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.59e-1)"	"unprognostic (2.52e-1)"	"unprognostic (1.47e-1)"	"unprognostic (4.79e-3)"	"unprognostic (1.69e-1)"	"unprognostic (1.34e-2)"	"unprognostic (7.55e-2)"	"unprognostic (2.47e-1)"	"unprognostic (9.27e-2)"	"unprognostic (3.63e-2)"	20.1	18.1	22.9	17.7	21.1	7.5	23.1	26.1	21.8	46.8	31.3	32.1	6.9	42.0	13.3	20.7	44.6	15.7	20.4	21.7	21.4	24.9	6.9	21.4	16.1	20.5	22.9	47.2	25.5	26.4	75.7	14.1	19.3	31.7	9.4	40.0	23.6	20.2	16.1	10.7	21.0	22.4	19.2	22.2	22.3	43.3	20.8	28.1	44.3	10.3	14.6	28.0	26.9	19.8	6.6	11.1	46.5	43.0	13.8	14.5	141.8	6.6	13.7	11.3	14.7	7.4	10.5	17.4	5.7	11.3	17.4	5.8	12.9	15.4	15.2	60.8	7.5	22.8	14.5	7.5	15.0	12.4	38.5	18.0	8.0	18.1	18.1	36.2	13.7	19.8	4.6	6.4	11.5	8.2	15.8	22.1	492.6	2.5	3.7	25.1	31.3	0.9	12.3	29.0	9.0	32.1	10.4	23.4	17.4	178.3	3.4	12.4	7.8	20.8	34.5	13.2	9.6	12.8	8.9	24.9	9.3	6.7	14.4	0.6	0.2	0.0	0.8	1.1	0.5	1.1	1.2	1.5	0.1	0.9	1.2	0.9	0.0	0.8	2.8	1.2	0.8	0.8	22.9	21.1	26.1	21.8	21.7	21.4	20.5	22.9	19.3	19.2	20.8	19.8	11.9	16.0	19.8	48.3	7.7	2.4	5.5	4.6	9.1	24.2	10.8	11.2	0.5	11.5	13.1	9.2	27.1	5.9	10.1	0.8	1.9	5.4	26.4	20.0	17.4	11.0	11.4	9.5	36.4	5.2	11.5	11.8	5.1	10.6	19.0	15.5	8.6	2.0	4.4	16.8	44.0	2.7	4.1	5.4	3.9	17.6	14.3	6.0	7.2	12.2	3.2	17.7	7.2	23.1	13.0	4.6	1.9	12.0	3.0	4.5	0.7	5.3	19.2	36.8	0.0	15.8	12.2	17.7	25.1	10.2	2.4	5.1	11.2	8.7	2.0	4.9
PHC2	"EDR2, HPH2"	ENSG00000134686	"Polyhomeotic homolog 2"	Q8IXK0	1	33323623-33431052	"Predicted intracellular proteins"		"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in all"	9	"neutrophil: 93.4"	"Lineage enriched"	"Detected in all"	11	"granulocytes: 93.4"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047403	Supported		Supported	Nucleoplasm		NA	NA			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 59: Non-specific - Translation"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm		"HPA047403: AB_10964220"	"unprognostic (8.58e-3)"	"unprognostic (2.10e-1)"	"unprognostic (9.51e-2)"	"unprognostic (3.69e-1)"	"unprognostic (2.00e-1)"	"unprognostic (2.77e-1)"	"prognostic unfavorable (2.28e-6)"	"unprognostic (1.04e-1)"	"unprognostic (2.40e-1)"	"unprognostic (7.91e-2)"	"unprognostic (3.08e-1)"	"unprognostic (1.85e-1)"	"prognostic unfavorable (2.35e-4)"	"unprognostic (2.16e-1)"	"unprognostic (1.57e-1)"	"unprognostic (3.65e-2)"	"unprognostic (1.72e-1)"	114.4	87.1	57.1	52.1	66.9	50.6	103.8	62.5	64.3	87.1	73.5	104.3	26.0	86.3	27.9	50.7	86.2	49.2	113.1	56.0	63.6	141.7	124.9	135.0	31.3	79.7	67.7	66.9	54.8	33.4	70.5	46.2	68.9	79.9	27.9	51.1	68.8	44.6	260.0	68.2	64.2	60.2	64.5	118.9	92.7	62.2	67.1	40.4	81.7	74.7	23.9	97.2	63.5	72.5	53.0	34.0	145.3	56.0	149.3	169.9	43.2	51.4	111.1	70.0	76.5	21.5	115.2	47.2	42.4	81.3	56.7	27.4	29.2	88.0	67.2	22.9	26.6	31.5	15.7	54.9	229.2	38.8	29.1	279.3	53.4	126.3	99.0	133.2	93.9	44.9	28.3	35.1	185.1	21.8	84.8	39.7	33.1	89.4	97.8	95.0	60.4	26.3	128.4	39.5	88.3	81.0	40.2	39.9	204.7	60.7	19.9	49.5	93.8	69.5	35.0	59.9	98.1	24.3	18.0	35.6	165.5	40.7	195.3	10.5	6.6	3.4	2.0	6.7	1.6	1.4	2.2	1.8	3.4	1.2	2.6	1.4	93.4	2.1	8.3	3.9	1.6	2.2	57.1	66.9	62.5	64.3	56.0	63.6	79.7	67.7	68.9	64.5	67.1	72.5	89.3	16.0	13.9	24.2	5.6	14.1	28.9	16.2	4.6	75.9	24.1	30.9	31.8	25.8	13.2	35.0	68.8	11.3	17.4	19.5	17.6	34.4	58.2	18.7	40.2	43.0	37.7	17.4	60.7	44.4	9.2	32.9	14.8	28.5	6.3	39.4	47.8	55.6	21.4	62.2	82.0	21.9	18.3	75.7	14.1	72.9	29.2	55.3	21.4	61.8	18.4	58.5	8.2	91.0	117.2	85.8	11.0	29.7	2.5	23.8	11.2	31.7	14.8	78.5	13.1	24.2	48.7	14.2	8.6	7.9	10.9	11.5	11.4	30.0	20.0	30.9
PHC3	"EDR3, FLJ12729, FLJ12967, HPH3"	ENSG00000173889	"Polyhomeotic homolog 3"	Q8NDX5	3	170086732-170181749	"Predicted intracellular proteins"		"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Oligodendrocytes: 156.5;Rod photoreceptor cells: 126.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039162, HPA062031"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 20: HeLa - Mitochondria"	"Cluster 46: Photoreceptor cells - Phototransduction"	Nucleoplasm		"HPA039162: AB_10671038, HPA062031: AB_2684666"	"unprognostic (4.57e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.60e-1)"	"unprognostic (4.85e-3)"	"unprognostic (2.48e-1)"	"unprognostic (1.18e-1)"	"unprognostic (5.04e-2)"	"unprognostic (1.19e-2)"	"unprognostic (8.71e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.34e-3)"	"unprognostic (3.26e-2)"	"unprognostic (3.70e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.92e-1)"	"unprognostic (9.58e-3)"	"unprognostic (2.76e-2)"	9.1	7.4	3.7	12.7	9.1	50.8	10.5	29.3	8.9	9.0	6.3	10.5	11.2	12.2	8.1	12.4	10.2	12.9	8.1	2.0	14.3	9.7	8.7	9.7	18.1	6.5	2.9	14.9	11.3	15.1	5.4	8.4	7.8	11.6	11.3	42.0	8.9	8.6	8.7	8.5	12.3	13.5	0.0	13.9	11.8	11.5	5.5	16.8	16.6	14.0	14.1	11.8	7.4	14.0	35.0	32.3	6.9	11.6	19.2	19.4	12.8	14.6	16.5	14.8	18.2	21.6	17.0	16.5	34.8	20.5	19.7	17.1	15.3	14.1	26.6	38.3	14.2	28.5	30.2	10.0	11.3	35.4	14.8	14.0	8.1	22.1	31.0	10.9	11.1	12.7	6.9	45.0	14.6	32.3	16.2	7.4	7.2	11.3	11.9	12.0	29.5	24.0	7.4	38.7	7.5	4.6	48.1	29.8	9.8	4.5	34.6	27.0	22.3	20.5	12.1	17.1	25.4	43.0	37.6	48.1	12.8	13.1	12.6	9.5	7.0	25.7	16.2	11.2	13.8	16.8	15.2	14.1	7.8	21.6	15.6	13.8	10.2	13.3	7.3	26.0	20.2	7.5	3.7	9.1	29.3	8.9	2.0	14.3	6.5	2.9	7.8	0.0	5.5	14.0	26.8	22.4	31.9	77.4	46.2	14.1	16.9	16.1	19.9	36.3	16.4	12.1	22.7	18.6	18.7	27.6	60.5	15.5	45.9	11.1	0.0	8.9	5.5	18.7	34.5	21.3	7.8	28.8	108.2	7.5	9.6	25.1	25.0	19.0	12.7	35.9	19.6	17.8	11.1	53.8	103.2	14.1	16.2	21.6	22.6	3.8	29.5	22.5	19.6	105.9	25.5	21.9	32.0	103.0	156.5	10.4	16.7	27.8	45.6	22.8	16.4	10.7	24.1	126.2	6.6	29.8	26.4	21.0	19.3	17.8	15.9	18.3	40.4	25.7	14.4	19.6
PHF10	"BAF45a, FLJ10975, XAP135"	ENSG00000130024	"PHD finger protein 10"	Q8WUB8	6	169703902-169725566	"Predicted intracellular proteins"	"Neurogenesis, Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA055649	Supported		Supported	Nucleoplasm		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"HPA055649: AB_2682875"	"unprognostic (1.74e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.40e-2)"	"unprognostic (4.25e-2)"	"unprognostic (4.45e-2)"	"unprognostic (6.76e-3)"	"prognostic unfavorable (3.42e-4)"	"unprognostic (1.28e-1)"	"unprognostic (1.11e-1)"	"unprognostic (2.48e-1)"	"prognostic favorable (1.12e-5)"	"unprognostic (5.92e-2)"	"prognostic unfavorable (1.56e-5)"	"unprognostic (2.63e-1)"	"unprognostic (6.82e-2)"	"unprognostic (2.43e-1)"	"unprognostic (2.76e-2)"	41.9	78.5	49.1	39.0	55.4	53.4	40.9	52.2	53.9	43.1	46.3	49.2	32.3	40.0	39.2	46.7	39.7	34.6	46.5	43.0	54.2	38.4	52.4	40.4	61.7	52.5	56.2	80.7	41.0	47.7	36.3	43.7	54.8	48.4	34.6	59.1	44.5	44.7	81.3	50.9	40.7	33.4	56.6	49.8	42.7	41.7	55.0	53.2	48.6	63.7	61.3	42.3	41.9	57.4	31.2	30.7	119.2	125.5	40.7	24.5	49.0	41.2	37.3	49.8	54.3	88.9	31.4	91.1	24.4	29.2	31.7	38.4	92.5	45.3	72.0	73.3	82.1	91.1	54.8	116.9	41.5	134.2	5.4	18.5	46.7	32.1	29.4	82.3	80.2	64.4	102.7	57.5	36.0	53.4	25.6	115.0	37.6	68.3	18.9	121.0	84.4	73.7	62.1	32.5	56.7	75.9	56.4	18.4	41.5	49.7	36.3	158.6	54.0	28.1	46.6	36.3	53.2	50.7	46.1	112.3	36.7	88.6	45.6	1.6	1.4	3.2	1.5	1.5	1.4	2.6	2.7	2.1	1.4	1.7	2.6	2.8	0.2	1.2	1.6	1.2	1.8	0.8	49.1	55.4	52.2	53.9	43.0	54.2	52.5	56.2	54.8	56.6	55.0	57.4	42.5	25.6	30.1	17.9	24.5	29.8	22.7	13.3	13.1	12.1	38.1	31.8	59.3	35.8	23.7	11.0	41.7	14.8	25.9	11.0	13.7	12.5	15.3	32.1	27.4	28.2	25.9	7.4	14.9	12.6	8.9	27.6	12.8	42.1	6.3	38.1	29.3	27.5	11.6	11.8	19.0	22.8	18.3	13.9	28.7	9.7	22.4	21.5	19.6	28.1	11.8	33.4	10.3	17.6	33.6	17.1	19.4	21.1	16.4	27.6	18.6	12.4	22.7	26.8	19.7	27.9	53.1	18.9	22.0	21.2	23.4	17.4	21.2	33.2	20.0	27.4
PHF11	"BCAP, IGER, NY-REN-34"	ENSG00000136147	"PHD finger protein 11"	Q9UIL8	13	49495610-49528981	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA016566			Supported	"Nucleoplasm,Nuclear membrane"		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 64: Macrophages - Immune response"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	Nucleoplasm	"Nuclear membrane"	"HPA016566: AB_2669387"	"unprognostic (1.65e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.29e-1)"	"prognostic favorable (7.98e-6)"	"unprognostic (3.49e-3)"	"unprognostic (6.29e-2)"	"unprognostic (5.50e-2)"	"unprognostic (6.91e-2)"	"unprognostic (3.05e-2)"	"unprognostic (1.64e-1)"	"unprognostic (2.37e-1)"	"unprognostic (8.48e-2)"	"prognostic unfavorable (4.46e-7)"	"unprognostic (9.81e-2)"	"unprognostic (5.36e-3)"	"unprognostic (1.05e-1)"	"prognostic favorable (3.46e-4)"	28.3	39.5	17.2	33.4	18.8	37.0	32.3	17.6	23.6	29.1	18.2	28.9	25.3	24.0	28.5	23.2	23.0	26.4	21.3	16.4	19.6	33.1	22.4	28.9	43.4	21.2	19.9	22.6	25.1	16.5	16.1	23.9	20.3	26.3	22.0	9.1	39.7	24.6	13.4	27.2	27.6	27.3	20.5	39.3	28.9	13.4	19.4	31.6	34.3	11.3	39.4	28.4	27.4	20.5	12.0	4.9	1.7	0.0	23.5	44.4	14.7	28.5	32.5	40.0	42.1	0.0	28.3	29.2	7.7	32.1	26.5	8.2	10.4	9.8	23.6	59.2	8.8	14.5	9.5	12.8	29.1	10.5	21.5	27.0	15.4	16.2	9.0	16.4	26.0	23.6	3.1	12.4	30.3	9.8	33.7	24.8	5.6	7.8	3.3	32.2	0.0	8.9	36.5	21.8	1.0	0.2	7.6	15.9	0.4	2.1	9.3	23.6	23.2	9.7	3.8	14.0	8.2	8.9	4.9	18.1	20.0	14.9	14.9	26.3	42.4	31.0	42.3	54.1	49.1	40.7	53.6	50.6	39.9	35.0	43.1	48.5	51.3	30.0	51.4	34.8	78.0	42.6	17.2	18.8	17.6	23.6	16.4	19.6	21.2	19.9	20.3	20.5	19.4	20.5	48.0	16.0	28.7	15.7	48.2	22.6	35.1	41.0	29.0	4.4	26.8	25.4	19.5	27.1	40.3	36.8	0.0	26.1	54.6	15.2	35.2	41.1	35.9	38.3	48.9	35.0	4.2	18.5	11.1	42.3	46.4	32.6	23.0	34.9	24.0	30.3	31.1	22.3	41.9	11.8	11.7	15.6	26.4	40.9	31.5	56.3	32.0	46.6	12.4	27.2	66.8	17.0	58.7	16.1	23.9	38.5	8.5	31.6	35.7	35.4	21.4	29.2	63.4	5.0	46.0	26.5	28.7	24.2	6.0	27.1	20.2	21.1	60.4	23.1	15.8	35.8
PHF2	"CENP-35, JHDM1E, KDM7C, KIAA0662"	ENSG00000197724	"PHD finger protein 2"	O75151	9	93576584-93679587	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, Chromatin regulator, Dioxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	12	"Early spermatids: 155.2;Late spermatids: 575.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA010831	Approved		Supported	"Nucleoplasm,Nucleoli rim"		NA	No			"Cluster 49: Eosinophils - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 14: REH - Unknown function"	"Cluster 25: Spermatids - Spermatogenesis"	"Nucleoli rim"	Nucleoplasm	"HPA010831: AB_1855294"	"unprognostic (9.42e-2)"	"unprognostic (1.23e-1)"	"prognostic unfavorable (9.34e-4)"	"unprognostic (1.30e-1)"	"unprognostic (2.79e-1)"	"unprognostic (1.40e-1)"	"unprognostic (2.44e-1)"	"unprognostic (8.48e-2)"	"unprognostic (1.07e-1)"	"unprognostic (5.89e-2)"	"unprognostic (7.63e-2)"	"unprognostic (1.49e-1)"	"prognostic favorable (1.12e-5)"	"unprognostic (1.11e-1)"	"unprognostic (2.20e-1)"	"unprognostic (2.17e-1)"	"unprognostic (4.19e-2)"	22.6	15.8	27.6	11.6	30.7	17.3	23.5	32.1	28.1	31.1	23.2	28.8	10.1	29.6	13.2	19.4	27.4	11.9	28.1	25.9	28.2	16.5	14.3	24.0	13.5	30.4	30.0	34.2	21.7	17.2	29.7	15.9	29.2	24.9	9.3	13.8	21.1	17.8	28.7	23.2	18.7	14.6	27.5	23.9	22.9	15.1	28.6	18.6	25.7	21.2	10.0	24.5	26.3	34.4	16.1	13.6	27.9	22.6	17.4	13.5	14.0	12.8	17.0	18.2	12.9	6.4	9.3	11.7	9.0	16.7	16.3	30.6	17.7	12.3	9.6	31.8	11.5	9.6	15.9	9.7	15.0	18.8	31.3	13.7	20.2	8.6	14.4	17.7	14.6	17.7	14.2	19.6	12.5	36.1	35.9	20.3	7.2	28.3	11.5	40.4	21.4	4.6	11.4	20.5	36.4	17.6	13.4	21.1	11.7	8.0	14.4	31.9	17.2	16.9	14.3	18.6	18.3	15.3	2.7	8.6	9.3	11.3	19.6	0.4	0.8	0.8	0.9	0.4	0.9	0.5	1.0	0.6	0.8	0.8	1.0	1.2	1.6	0.3	0.6	1.2	0.6	0.7	27.6	30.7	32.1	28.1	25.9	28.2	30.4	30.0	29.2	27.5	28.6	34.4	18.4	16.0	13.7	13.7	7.5	7.6	6.6	7.1	4.6	14.4	13.3	11.0	15.5	4.3	16.0	5.5	8.4	7.3	9.8	7.5	0.0	5.6	155.2	13.2	14.0	15.0	16.3	9.9	11.9	5.6	3.5	13.3	10.2	13.3	17.1	8.4	13.2	7.6	5.8	10.1	16.0	7.3	8.2	12.4	10.0	575.3	19.9	10.2	3.6	12.2	9.0	9.6	5.2	20.1	28.8	6.1	3.8	20.3	3.9	8.7	4.1	3.2	16.4	7.9	19.7	15.0	13.4	1.8	3.4	7.8	8.0	6.0	9.6	4.9	7.6	8.2
PHF20	"C20orf104, dJ1121G12.1, TDRD20A"	ENSG00000025293	"PHD finger protein 20"	Q9BVI0	20	35771974-35950370	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 452.5;Late spermatids: 661.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA029619, HPA029620, HPA029621"	Approved		Supported	"Nucleoplasm,Nuclear membrane,Cytosol"		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 36: HEL - Hemostasis"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm	"Nuclear membrane, Cytosol"	"HPA029619: AB_10600090, HPA029620: AB_10601110, HPA029621: AB_10602201"	"unprognostic (1.21e-3)"	"unprognostic (7.30e-2)"	"unprognostic (3.20e-2)"	"unprognostic (2.35e-3)"	"unprognostic (1.36e-1)"	"unprognostic (1.95e-1)"	"prognostic unfavorable (2.49e-4)"	"unprognostic (2.76e-1)"	"unprognostic (2.17e-1)"	"unprognostic (2.64e-2)"	"unprognostic (4.59e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.92e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.07e-1)"	"unprognostic (7.23e-2)"	"unprognostic (1.01e-2)"	12.9	8.2	10.4	12.0	11.5	11.8	12.5	15.4	13.0	10.8	9.4	10.9	6.0	11.8	7.3	11.9	9.2	10.8	11.5	11.2	10.4	7.8	8.2	10.0	14.2	11.6	11.1	13.2	6.8	12.1	5.4	11.7	11.1	10.3	8.4	14.4	9.5	10.8	32.3	8.1	7.8	11.6	9.5	14.7	8.2	11.8	11.8	14.7	10.2	17.6	13.9	10.5	8.5	14.7	18.1	14.2	24.4	36.0	17.3	19.7	22.5	20.2	19.1	19.8	17.2	41.4	13.1	30.1	17.9	27.1	24.4	10.7	22.6	28.2	24.1	13.7	9.6	55.8	26.3	15.6	17.3	27.2	20.8	15.6	38.8	21.0	32.2	23.5	22.1	21.0	23.3	18.8	23.1	10.8	27.6	15.9	12.0	11.9	17.5	20.0	35.9	17.9	15.9	12.4	21.9	17.9	36.0	41.0	18.4	21.8	32.6	20.0	31.1	43.7	9.9	23.0	21.0	17.2	22.0	21.5	32.2	19.5	22.9	17.3	11.2	33.1	12.4	11.5	13.6	15.0	12.5	14.6	10.6	11.1	14.0	14.7	25.9	16.0	16.9	9.9	7.2	9.0	10.4	11.5	15.4	13.0	11.2	10.4	11.6	11.1	11.1	9.5	11.8	14.7	51.2	38.5	41.8	28.4	131.1	34.8	76.6	52.5	31.3	77.4	49.8	53.5	62.2	31.5	43.5	38.6	98.0	106.7	191.0	16.3	37.2	29.8	452.5	39.8	41.6	46.3	36.0	37.6	49.7	19.9	52.5	53.6	23.0	34.7	142.4	41.2	47.2	18.2	54.5	114.4	49.5	27.9	30.5	62.7	84.3	661.6	35.8	87.1	39.2	62.8	62.6	50.0	105.0	34.2	55.2	24.1	26.5	53.4	76.9	60.0	14.0	24.8	50.2	80.7	19.7	65.5	50.6	60.4	47.0	29.8	28.3	22.3	127.8	30.1	28.8	55.4
PHF6	"BFLS, BORJ, CENP-31, KIAA1823, MGC14797"	ENSG00000156531	"PHD finger protein 6"	Q8IWS0	X	134373312-134428791	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding	"Cancer-related genes, Disease variant, Epilepsy, Hypotrichosis, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Granulosa cells: 149.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001023	Enhanced		Supported	Nucleoplasm,Nucleoli		NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 40: Granulosa cells - Unknown function"	"Nucleoplasm, Nucleoli"		"HPA001023: AB_1079606"	"unprognostic (2.38e-3)"	"unprognostic (8.21e-2)"	"unprognostic (1.99e-1)"	"unprognostic (3.04e-3)"	"unprognostic (6.03e-3)"	"unprognostic (5.20e-3)"	"prognostic unfavorable (3.38e-4)"	"unprognostic (1.81e-1)"	"unprognostic (4.85e-2)"	"unprognostic (1.08e-1)"	"prognostic unfavorable (9.96e-4)"	"unprognostic (1.09e-1)"	"unprognostic (5.96e-2)"	"unprognostic (4.84e-2)"	"unprognostic (7.45e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.29e-2)"	6.7	18.0	6.6	14.2	7.9	8.4	10.8	10.3	9.3	8.3	6.2	9.1	8.9	9.7	32.7	8.2	7.9	6.6	6.7	7.1	8.4	10.2	7.7	6.8	25.3	8.3	7.8	33.3	9.5	16.3	6.2	9.3	8.4	9.2	10.3	12.0	13.2	11.0	5.0	8.3	8.8	8.1	8.6	13.3	9.3	9.2	7.7	20.8	13.2	6.8	29.8	8.6	7.1	11.5	28.2	22.9	98.7	40.8	17.9	22.9	18.7	27.6	22.1	29.1	35.6	13.9	28.5	45.1	61.8	16.9	28.3	24.6	69.4	31.3	48.6	37.2	32.1	44.3	37.7	16.1	19.2	44.2	23.3	15.3	23.2	31.7	39.2	29.1	41.1	43.1	32.6	21.8	35.8	18.7	71.3	21.8	30.1	38.3	31.0	69.6	36.0	34.5	30.7	33.8	34.1	39.9	21.2	19.3	29.5	29.0	18.0	24.0	31.5	26.8	19.2	34.0	42.9	11.1	27.3	60.5	17.7	51.4	34.3	5.9	6.3	4.1	8.0	6.6	8.7	18.7	8.2	7.3	9.5	12.4	9.6	8.2	2.6	11.0	8.4	11.7	9.1	5.5	6.6	7.9	10.3	9.3	7.1	8.4	8.3	7.8	8.4	8.6	7.7	11.5	25.5	22.4	18.4	13.1	42.7	13.0	14.3	28.7	22.2	22.4	17.5	20.3	16.3	11.5	17.8	16.5	18.8	11.8	27.1	9.9	23.5	14.2	3.7	13.0	29.1	18.7	11.4	31.3	27.8	13.8	7.6	17.2	14.8	18.7	24.6	149.5	20.0	15.2	15.1	18.5	23.4	12.5	10.2	15.5	10.2	3.1	20.8	20.2	7.2	29.0	25.3	27.9	21.6	33.2	46.7	14.4	18.7	15.4	23.1	12.3	9.5	19.8	16.5	19.7	26.3	21.0	21.9	10.3	22.0	25.7	11.5	4.7	22.6	69.3	17.7	11.5
PHF7	"HSPC226, NYD-SP6"	ENSG00000010318	"PHD finger protein 7"	Q9BWX1	3	52410660-52423641	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	212	"testis: 1216.7"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 2630.6;Late spermatids: 8698.5;Spermatocytes: 1456.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 14.8;U-266/70: 17.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"HPA036283, HPA070305"	Enhanced		Supported	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 83: Testis - Spermatogenesis"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 31: Spermatids - Spermatogenesis"	Nucleoplasm	"Golgi apparatus"	"HPA036283: AB_10795026, HPA070305: AB_2686248"	"prognostic favorable (7.38e-5)"	"unprognostic (4.57e-2)"	"unprognostic (6.97e-3)"	"prognostic favorable (9.44e-5)"	"unprognostic (3.63e-1)"	"unprognostic (2.61e-3)"	"unprognostic (7.44e-2)"	"unprognostic (5.78e-2)"	"unprognostic (2.98e-1)"	"unprognostic (6.38e-3)"	"unprognostic (1.55e-3)"	"unprognostic (1.12e-1)"	"prognostic favorable (1.05e-6)"	"unprognostic (2.07e-2)"	"unprognostic (1.82e-1)"	"unprognostic (2.34e-2)"	"unprognostic (6.79e-2)"	4.8	2.8	0.6	1.3	0.6	4.1	5.0	0.9	1.3	2.1	0.6	4.3	2.7	1.6	3.3	2.6	2.0	1.1	1.9	0.6	0.7	2.9	4.7	2.4	2.1	0.8	0.8	1.4	4.4	5.7	1.7	2.0	0.8	4.3	4.6	0.6	3.5	1.7	2.3	5.0	4.2	1.4	0.7	3.2	2.5	1216.7	0.7	2.8	2.2	0.9	2.2	2.4	2.3	0.8	2.2	0.6	1.6	6.8	1.1	1.6	2.8	2.1	2.2	1.7	2.1	1.1	0.9	3.6	0.2	1.6	1.0	1.2	1.2	3.4	2.9	4.5	1.6	4.1	0.6	2.5	1.1	4.6	7.5	1.0	3.7	1.6	3.5	0.5	2.5	8.3	2.5	14.8	1.3	1.0	5.4	1.7	0.7	0.7	4.6	2.4	1.5	4.5	1.8	0.9	1.1	1.3	2.0	0.1	1.6	2.0	1.0	2.3	1.8	2.8	1.9	3.0	4.5	17.4	9.0	2.1	1.2	10.4	1.7	0.3	1.1	1.8	0.9	1.2	1.1	3.4	1.0	1.6	0.5	1.8	0.7	1.5	0.2	1.1	0.6	1.1	2.5	0.9	0.6	0.6	0.9	1.3	0.6	0.7	0.8	0.8	0.8	0.7	0.7	0.8	4.3	3.2	4.6	15.7	7.8	4.6	4.8	3.5	13.6	11.2	6.2	5.0	9.7	4.3	1.3	7.3	8.4	3.5	5.8	7.7	13.7	3.6	2630.6	5.3	3.1	6.7	11.5	14.7	10.9	2.8	2.0	5.7	6.1	2.1	7.0	3.7	3.3	4.5	4.2	13.5	12.4	4.2	2.0	4.1	2.3	8698.5	77.0	7.9	8.8	1.9	4.4	8.1	7.2	5.5	16.3	3.7	2.4	63.2	7.6	1.7	12.7	7.3	6.0	15.3	52.6	6.0	4.5	1456.7	71.6	7.6	3.0	0.5	5.5	7.2	10.2	2.2
PHF8	"JHDM1F, KDM7B, KIAA1111, ZNF422"	ENSG00000172943	"PHD finger protein 8"	Q9UPP1	X	53936676-54048958	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, Transcription, Transcription regulation"	"Activator, Chromatin regulator, Dioxygenase, Oxidoreductase"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"epididymis: 70.6"	"Cell type enhanced"	"Detected in many"		"Spermatocytes: 57.9;Spermatogonia: 58.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038779, HPA062015"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 68: Epididymis - Unknown function"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	Nucleoplasm		"HPA038779: AB_10675950, HPA062015: AB_2684658"	"unprognostic (6.35e-2)"	"unprognostic (2.16e-2)"	"unprognostic (1.70e-2)"	"unprognostic (1.04e-1)"	"unprognostic (8.76e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.40e-1)"	"unprognostic (2.66e-3)"	"unprognostic (1.97e-3)"	"unprognostic (1.22e-1)"	"unprognostic (5.64e-2)"	"unprognostic (1.02e-1)"	"unprognostic (5.17e-2)"	"unprognostic (1.22e-1)"	"unprognostic (9.94e-2)"	"unprognostic (1.85e-2)"	"prognostic favorable (3.74e-5)"	11.6	8.1	8.3	13.3	11.1	16.2	13.8	9.5	10.3	13.9	20.0	11.6	10.3	14.1	70.6	13.4	14.1	9.2	9.8	7.8	11.2	9.7	28.7	13.5	16.3	10.1	9.4	19.3	17.8	10.8	13.9	13.2	11.2	16.0	9.6	14.6	12.8	18.3	11.0	13.1	14.2	9.4	8.1	13.9	12.7	40.1	10.2	18.6	13.2	7.8	15.8	14.1	13.5	13.3	16.1	14.0	20.4	19.9	12.2	9.6	33.3	12.0	10.4	12.9	11.4	15.7	12.8	23.4	6.9	10.8	13.9	16.5	51.1	10.3	13.7	36.4	23.8	14.2	18.1	15.8	9.6	22.4	25.6	10.9	14.0	15.0	20.2	9.7	12.0	24.3	18.7	33.2	7.6	16.1	30.6	16.9	37.2	11.0	19.6	29.7	22.5	22.9	8.9	19.2	29.2	14.5	31.6	20.5	10.5	31.2	20.5	15.5	14.3	10.3	14.5	19.2	10.0	25.1	25.4	28.3	12.2	27.9	11.3	6.1	2.7	4.4	3.2	4.8	5.1	2.3	3.3	3.9	2.9	3.1	2.5	2.8	4.4	3.5	3.2	2.3	5.3	3.4	8.3	11.1	9.5	10.3	7.8	11.2	10.1	9.4	11.2	8.1	10.2	13.3	9.5	9.6	10.3	17.3	11.2	8.9	9.4	4.5	15.4	13.7	13.9	8.1	7.8	5.7	5.4	9.2	12.5	13.9	14.1	8.3	0.0	5.1	54.9	34.5	11.3	11.3	5.4	5.2	19.7	4.6	4.7	6.9	10.7	40.2	14.0	15.0	7.9	39.4	6.8	8.4	22.0	8.8	10.2	11.8	6.4	31.4	9.3	11.6	3.6	20.6	9.2	6.1	9.2	27.2	30.0	4.4	9.4	6.4	14.4	10.9	9.2	3.7	16.5	15.3	6.6	11.6	9.2	57.9	58.7	15.2	9.8	12.2	13.5	6.3	8.3	14.7
PHIP	"BRWD2, DCAF14, FLJ20705, ndrp, WDR11"	ENSG00000146247	"Pleckstrin homology domain interacting protein"	Q8WWQ0	6	78934419-79078254	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019140, HPA019838"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 34: Non-specific - Transcription"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA019140: AB_2670073, HPA019838: AB_2670287"	"unprognostic (1.58e-1)"	"unprognostic (1.60e-1)"	"unprognostic (9.43e-2)"	"unprognostic (8.47e-3)"	"unprognostic (1.05e-1)"	"unprognostic (2.01e-3)"	"unprognostic (3.50e-3)"	"unprognostic (5.03e-2)"	"unprognostic (4.03e-2)"	"unprognostic (6.40e-3)"	"unprognostic (1.72e-1)"	"unprognostic (1.05e-1)"	"prognostic unfavorable (1.71e-5)"	"unprognostic (2.76e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.55e-2)"	8.5	5.7	7.6	8.4	9.9	29.4	12.0	18.8	9.3	11.0	6.0	8.5	5.8	11.1	8.4	6.2	9.8	6.3	6.6	6.6	9.0	6.1	4.8	8.8	11.0	8.8	8.7	11.7	8.4	8.5	9.4	7.9	9.2	8.7	7.7	20.5	8.5	7.0	9.7	8.9	7.9	7.1	8.3	9.9	8.1	6.4	8.5	13.1	7.8	8.4	9.1	8.4	9.2	14.0	13.6	10.8	25.2	24.6	9.6	13.7	14.6	14.3	11.3	12.0	15.1	13.4	8.2	22.3	11.1	9.0	10.1	12.2	19.1	9.1	20.1	32.2	13.9	25.0	20.7	10.0	4.4	28.2	15.4	8.4	7.9	14.4	14.3	10.1	12.9	14.0	25.5	20.8	11.7	9.1	11.0	21.0	15.9	7.0	11.8	18.9	32.3	9.7	12.9	18.0	24.7	15.8	19.0	14.4	9.2	16.0	11.2	37.6	15.2	13.9	9.8	6.8	23.8	14.2	14.9	12.3	5.9	17.9	21.2	10.0	4.2	7.7	4.4	3.0	4.7	6.1	5.3	5.0	2.9	6.6	5.8	4.6	14.4	4.6	5.7	5.3	4.8	2.1	7.6	9.9	18.8	9.3	6.6	9.0	8.8	8.7	9.2	8.3	8.5	14.0	64.4	70.5	109.9	181.8	92.5	63.2	88.9	56.7	48.9	183.4	53.7	52.2	58.6	54.3	95.9	55.2	152.2	85.4	95.3	52.1	1.9	71.6	33.8	94.6	75.1	74.5	72.7	80.4	168.9	47.2	91.0	77.3	59.7	58.4	115.2	76.6	71.0	21.3	51.0	181.7	196.4	58.2	71.2	83.8	75.6	17.2	101.2	83.3	49.8	154.6	134.7	84.4	83.4	154.3	346.1	58.1	49.1	87.6	124.8	81.5	46.7	19.0	148.4	174.1	52.6	97.9	87.4	127.3	53.6	50.1	56.4	102.1	92.9	50.5	62.1	104.5
PHKG2		ENSG00000156873	"Phosphorylase kinase catalytic subunit gamma 2"	P15735	16	30748293-30761176	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Carbohydrate metabolism, Glycogen metabolism"	"Calmodulin-binding, Kinase, Serine/threonine-protein kinase, Transferase"	"Disease variant, Glycogen storage disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"testis: 130.1"	"Group enriched"	"Detected in many"	5	"Early spermatids: 397.0;Late spermatids: 1576.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA065618, HPA068751"			Supported	Cytosol		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 25: Spermatids - Spermatogenesis"	Cytosol		"HPA065618: AB_2685520, HPA068751: AB_2686025"	"unprognostic (7.63e-3)"	"prognostic favorable (7.90e-4)"	"prognostic unfavorable (9.92e-4)"	"unprognostic (1.08e-1)"	"unprognostic (1.25e-1)"	"unprognostic (5.81e-2)"	"unprognostic (3.72e-2)"	"prognostic favorable (1.90e-4)"	"unprognostic (6.45e-2)"	"unprognostic (1.25e-2)"	"prognostic favorable (8.02e-4)"	"unprognostic (6.15e-2)"	"unprognostic (5.27e-2)"	"unprognostic (1.36e-2)"	"unprognostic (2.41e-1)"	"unprognostic (2.18e-2)"	"unprognostic (3.03e-2)"	9.0	15.8	17.5	11.5	16.9	30.0	9.9	17.1	18.7	10.0	15.9	12.9	11.0	10.1	9.5	10.2	11.7	8.2	12.1	18.9	16.4	14.7	19.1	10.0	12.5	17.7	17.2	8.3	9.7	18.9	15.9	7.8	18.8	14.7	12.0	8.9	11.5	12.0	13.2	14.6	12.0	9.9	16.0	12.9	13.8	130.1	17.5	11.6	13.6	8.8	12.7	10.1	9.2	16.2	24.7	16.3	13.1	16.2	11.8	9.4	29.8	17.2	24.6	22.1	25.1	13.5	12.6	21.0	19.3	17.1	11.5	24.0	13.5	21.5	17.6	11.4	38.2	11.9	28.8	38.7	18.1	18.1	16.9	12.9	11.2	21.4	9.9	10.7	22.8	15.3	16.1	11.7	16.3	55.5	22.3	27.1	18.0	17.6	18.0	29.4	20.0	28.2	25.7	27.2	17.5	11.9	13.5	38.1	16.6	11.8	30.1	15.5	13.6	14.4	15.1	17.2	16.0	24.1	14.4	14.8	27.3	35.2	11.4	44.0	55.8	114.9	37.8	56.5	30.9	21.1	27.1	38.8	52.0	21.5	24.2	27.7	44.7	63.8	42.3	46.1	43.3	49.0	17.5	16.9	17.1	18.7	18.9	16.4	17.7	17.2	18.8	16.0	17.5	16.2	10.4	12.8	21.7	13.7	18.5	21.0	15.2	28.7	22.8	8.8	21.8	17.1	15.9	10.0	32.0	18.4	10.4	29.6	32.2	32.1	27.4	11.9	397.0	35.8	13.0	10.0	16.3	20.2	14.7	24.4	41.5	11.8	44.4	38.8	13.3	16.1	10.4	24.1	28.2	20.2	14.5	21.4	26.4	19.1	27.2	1576.6	17.4	26.4	12.4	11.2	40.3	13.7	39.1	9.0	8.1	19.6	18.5	23.3	20.5	31.5	27.8	47.3	33.0	9.9	0.0	8.9	14.8	180.5	22.9	20.5	23.0	75.5	25.9	20.8	27.0	16.9
PHLDA1	"DT1P1B11, PHRIP, TDAG51"	ENSG00000139289	"Pleckstrin homology like domain family A member 1"	Q8WV24	12	76025447-76031776	"Cancer-related genes, Predicted intracellular proteins"	Apoptosis		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"salivary gland: 159.1"	"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 1438.7;Basal squamous epithelial cells: 582.8;Urothelial cells: 760.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Group enriched"	"Detected in many"	6	"monocytes: 1.1;T-cells: 1.6"	"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 296.3;RPTEC TERT1: 233.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016160, HPA019000, HPA063520"	Enhanced		Supported	"Nucleoplasm,Nucleoli,Nucleoli rim"		NA	NA			"Cluster 13: T-cells - Unknown function"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 22: Epithelial cell types - Mixed function"	"Nucleoli, Nucleoli rim"	Nucleoplasm	"CAB016160: AB_628117, HPA019000: AB_1855309, HPA063520: AB_2685028"	"unprognostic (9.09e-2)"	"unprognostic (2.27e-2)"	"unprognostic (2.03e-1)"	"unprognostic (4.51e-3)"	"unprognostic (2.33e-1)"	"unprognostic (2.60e-3)"	"unprognostic (1.40e-1)"	"unprognostic (4.18e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.16e-1)"	"unprognostic (5.21e-3)"	"unprognostic (5.03e-2)"	"unprognostic (1.21e-1)"	"unprognostic (3.34e-2)"	"unprognostic (2.32e-1)"	"unprognostic (1.29e-1)"	"unprognostic (4.55e-3)"	21.3	31.0	9.9	17.3	10.1	21.8	28.1	8.9	11.0	23.1	6.2	8.9	6.5	13.4	4.4	59.8	7.8	39.3	20.6	10.3	11.3	14.8	67.6	27.1	5.9	10.8	16.9	19.2	17.9	5.3	8.2	14.3	11.3	8.9	10.2	13.8	159.1	8.2	5.8	11.5	8.6	14.8	9.6	19.5	22.5	3.1	11.5	7.4	27.2	1.5	7.5	60.9	33.7	11.3	60.9	71.5	54.9	30.4	25.0	51.6	3.9	50.5	134.7	22.4	30.8	39.7	72.2	0.3	14.8	21.2	73.8	30.7	1.5	84.2	47.9	9.3	1.2	1.5	3.8	68.2	36.3	1.4	15.1	16.2	60.6	93.2	182.6	296.3	54.4	0.1	5.0	1.7	115.8	7.8	0.2	7.9	20.1	36.3	108.7	0.2	14.3	1.8	233.7	135.1	4.0	10.4	8.8	0.8	169.5	67.8	35.5	0.7	50.8	75.8	7.2	89.3	50.4	0.8	0.3	0.2	127.9	0.8	96.7	0.2	0.0	0.0	0.9	0.1	1.5	0.0	0.9	1.0	0.0	0.0	0.1	0.2	0.2	0.0	1.1	0.0	1.6	0.2	9.9	10.1	8.9	11.0	10.3	11.3	10.8	16.9	11.3	9.6	11.5	11.3	98.5	12.8	12.4	7.2	13.0	195.3	1438.7	249.6	582.8	5.2	136.2	140.3	34.8	11.5	44.4	31.3	2.1	4.7	42.9	11.6	84.1	74.8	2.2	11.5	111.2	162.5	117.7	0.0	7.8	43.1	11.5	203.2	55.0	20.4	79.5	7.1	21.4	127.8	94.7	1.7	14.6	41.0	384.5	14.0	123.4	2.1	9.3	110.8	286.4	8.4	24.0	97.8	0.0	142.2	2.7	208.4	27.7	15.4	19.0	116.1	0.2	39.3	12.4	5.2	269.5	59.8	276.3	0.7	3.2	66.3	75.6	7.4	132.8	20.7	18.0	760.3
PHLDB1	"FLJ00141, KIAA0638, LL5a"	ENSG00000019144	"Pleckstrin homology like domain family B member 1"	Q86UU1	11	118606440-118658031	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 133.7"	"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 87.2;Late spermatids: 87.7;Oligodendrocytes: 244.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 105.2;ASC TERT1: 105.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037959, HPA038448"	Approved		Supported	"Vesicles,Plasma membrane,Cytosol"		NA	No				"Cluster 57: Non-specific - Angiogenesis"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 36: Stromal cells - Cell proliferation"	"Vesicles, Cytosol"	"Plasma membrane"	"HPA037959: AB_10673651, HPA038448: AB_10697390"	"unprognostic (7.81e-2)"	"unprognostic (8.32e-3)"	"unprognostic (1.13e-1)"	"unprognostic (9.36e-3)"	"unprognostic (8.28e-2)"	"unprognostic (1.55e-1)"	"unprognostic (4.37e-3)"	"unprognostic (1.22e-1)"	"unprognostic (3.21e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.44e-2)"	"unprognostic (1.57e-1)"	"prognostic unfavorable (6.36e-6)"	"unprognostic (7.09e-2)"	"unprognostic (2.42e-2)"	"unprognostic (3.69e-2)"	"unprognostic (1.44e-1)"	52.6	8.1	39.2	11.5	79.7	0.5	38.9	42.5	66.0	39.1	3.8	23.8	9.2	38.4	2.6	9.1	30.2	21.6	33.0	42.3	49.2	15.8	3.2	26.8	4.6	64.3	64.6	31.9	22.2	4.5	8.8	24.6	56.0	16.7	6.4	1.6	11.1	15.8	13.3	15.1	15.3	18.6	33.4	12.5	14.3	12.0	75.3	3.1	20.3	13.6	2.3	21.9	22.9	133.7	4.8	7.5	28.9	14.2	105.2	105.9	10.1	21.9	26.6	12.7	7.4	11.2	31.8	0.0	40.2	44.3	17.2	18.6	6.6	44.8	2.0	0.7	4.2	8.6	5.7	5.5	27.2	0.0	15.8	55.8	9.6	17.8	12.5	28.3	36.6	0.7	7.5	0.3	16.7	3.4	0.1	0.5	10.2	0.4	3.8	1.1	7.5	0.7	12.5	6.8	6.5	14.5	55.8	4.7	15.6	11.3	20.1	2.7	45.4	25.9	22.9	13.2	18.3	0.2	0.0	0.1	7.5	1.5	29.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.3	0.3	0.0	0.0	0.0	0.0	39.2	79.7	42.5	66.0	42.3	49.2	64.3	64.6	56.0	33.4	75.3	133.7	34.4	6.4	13.7	53.2	1.6	18.4	9.2	13.7	14.2	4.0	7.2	19.6	5.6	1.5	6.3	31.3	0.0	1.0	2.5	34.2	0.0	9.4	78.3	11.6	87.2	32.1	8.4	0.0	4.1	4.4	1.5	54.9	11.7	8.6	1.3	25.6	26.4	0.9	5.9	3.3	8.3	20.4	0.0	2.5	34.4	87.7	67.1	8.2	12.4	23.4	2.2	7.6	0.0	67.3	244.5	24.3	29.8	44.4	0.7	4.2	10.7	7.8	0.5	2.3	39.5	42.9	53.8	21.9	10.1	1.9	9.1	1.5	5.4	11.0	16.8	2.4
PHLDB2	"FLJ21791, LL5b, LL5beta"	ENSG00000144824	"Pleckstrin homology like domain family B member 2"	Q86SQ0	3	111732497-111976517	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 249.9;Basal prostatic cells: 189.9;Suprabasal keratinocytes: 114.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"A-431: 103.8;HaCaT: 105.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035146, HPA035147"	Approved		Supported	"Plasma membrane,Cytosol"		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 22: Epithelial cell types - Mixed function"	"Plasma membrane, Cytosol"		"HPA035146: AB_10600927, HPA035147: AB_2674492"	"unprognostic (2.83e-2)"	"unprognostic (4.93e-3)"	"unprognostic (2.15e-2)"	"unprognostic (8.01e-2)"	"unprognostic (1.00e-2)"	"prognostic unfavorable (2.59e-4)"	"unprognostic (5.14e-2)"	"unprognostic (2.20e-2)"	"unprognostic (1.43e-1)"	"unprognostic (9.03e-2)"	"unprognostic (2.00e-2)"	"unprognostic (3.53e-1)"	"prognostic favorable (7.03e-8)"	"unprognostic (3.24e-3)"	"unprognostic (3.47e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.83e-1)"	25.6	7.2	2.2	15.7	2.3	1.5	11.3	0.9	4.0	10.6	10.3	29.0	6.0	20.4	7.4	11.1	13.3	15.3	42.7	0.9	0.5	31.5	35.6	17.6	5.1	1.2	1.8	8.9	10.0	1.8	5.7	40.8	1.6	16.4	8.6	0.5	10.6	25.7	4.8	7.0	7.7	24.3	1.6	16.5	11.7	2.8	3.9	5.0	6.2	8.7	3.2	26.5	10.5	2.0	103.8	11.2	62.2	0.1	19.8	32.3	25.5	58.3	28.5	37.8	44.5	32.1	7.5	0.0	59.6	22.6	38.2	105.2	0.9	37.5	68.6	1.6	1.5	0.0	26.1	10.6	21.3	0.2	0.3	38.1	21.9	26.1	48.1	42.5	61.8	1.0	0.1	0.4	11.5	0.2	4.2	0.1	25.3	1.0	19.3	9.0	80.1	0.0	22.2	24.5	1.6	4.7	57.6	1.1	5.9	34.1	2.1	0.3	54.4	10.2	85.2	27.4	14.3	5.4	0.2	0.2	10.4	0.1	19.9	0.1	0.0	0.0	2.6	0.0	1.8	0.2	1.8	2.9	0.0	0.4	0.0	1.1	0.2	1.0	0.0	0.5	0.4	0.8	2.2	2.3	0.9	4.0	0.9	0.5	1.2	1.8	1.6	1.6	3.9	2.0	30.9	80.1	7.5	2.6	1.6	249.9	189.9	33.3	33.0	0.2	11.6	9.8	95.8	25.8	16.8	33.1	2.1	27.0	13.0	0.6	23.5	62.6	12.9	3.7	15.3	44.8	10.8	2.7	51.7	20.5	51.5	40.3	14.3	26.2	7.0	1.2	35.3	35.2	3.5	0.0	9.5	3.4	8.2	2.5	20.6	5.3	14.3	2.9	23.2	39.4	1.0	0.1	23.7	4.5	1.8	45.4	0.5	22.6	2.8	60.1	0.0	30.9	6.8	0.3	13.1	21.0	95.9	0.5	3.3	17.7	114.7	66.8	6.7	2.7	1.9	84.0
PHLPP2	"KIAA0931, PHLPPL, PPM3B"	ENSG00000040199	"PH domain and leucine rich repeat protein phosphatase 2"	Q6ZVD8	16	71637835-71724701	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 22.0;retina: 32.2"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 104.3;Distal enterocytes: 75.5;Excitatory neurons: 69.5;Proximal enterocytes: 73.7;Rod photoreceptor cells: 68.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040761, HPA041837, HPA048598"	Approved		Supported	"Nucleoplasm,Cytokinetic bridge,Mitotic spindle,Cytosol"		Yes	No			"Cluster 15: NK-cells - Transcription"	"Cluster 45: Intestine - Brush border"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 45: Enterocytes - Digestion"	Cytosol	"Nucleoplasm, Cytokinetic bridge, Mitotic spindle"	"HPA040761: , HPA041837: , HPA048598: AB_2680459"	"unprognostic (5.67e-2)"	"unprognostic (2.00e-1)"	"unprognostic (2.29e-2)"	"unprognostic (2.44e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.17e-1)"	"unprognostic (3.27e-1)"	"unprognostic (1.22e-1)"	"unprognostic (3.43e-1)"	"unprognostic (1.97e-4)"	"unprognostic (3.08e-2)"	"unprognostic (8.85e-3)"	"unprognostic (6.41e-2)"	"unprognostic (4.92e-2)"	"unprognostic (8.46e-3)"	"unprognostic (8.27e-2)"	4.2	2.8	6.6	2.8	7.5	6.5	2.7	5.8	7.4	3.5	0.1	11.7	11.1	3.7	2.9	1.4	3.2	2.4	2.8	7.8	4.8	3.4	3.0	3.1	3.5	4.6	3.9	4.2	3.1	4.5	4.0	2.7	4.7	2.7	12.2	32.2	1.7	3.4	1.9	1.8	22.0	4.5	0.6	2.5	2.4	6.8	5.3	1.9	6.6	2.6	3.2	3.3	2.4	5.1	6.0	7.8	8.3	9.3	6.5	7.8	4.8	8.8	8.0	12.5	10.1	7.2	1.9	11.8	3.4	14.6	9.0	12.4	12.1	4.5	16.1	4.2	6.5	3.3	7.3	4.8	5.1	2.9	5.0	5.8	2.5	17.7	5.7	5.2	4.7	4.1	3.0	3.2	8.7	12.7	3.9	2.3	6.5	1.9	2.1	6.3	7.3	3.9	5.9	4.5	7.2	3.8	18.9	5.1	3.1	6.4	6.3	1.6	6.5	12.5	9.0	5.3	7.4	7.1	5.4	11.9	7.7	2.3	2.8	0.2	0.1	0.0	0.2	0.1	0.2	0.5	0.1	0.3	0.1	0.3	0.2	0.2	0.2	0.7	0.1	0.5	0.3	0.1	6.6	7.5	5.8	7.4	7.8	4.8	4.6	3.9	4.7	0.6	5.3	5.1	4.0	9.6	2.2	26.1	7.4	9.3	5.1	3.5	7.4	20.6	6.9	5.6	3.3	0.0	3.6	3.7	104.3	4.3	3.8	75.5	0.0	2.7	12.0	2.9	6.1	5.3	6.0	22.9	69.5	2.3	0.4	7.7	1.1	5.1	10.2	11.3	2.9	4.1	1.5	23.5	45.9	6.7	4.1	7.0	12.7	6.3	5.3	2.7	14.2	10.3	3.2	6.5	1.0	30.7	32.7	2.5	31.4	5.3	4.0	8.2	73.7	5.1	3.1	68.6	6.6	7.8	7.9	31.6	20.4	1.9	9.1	1.4	4.9	1.7	9.2	2.2
PHOX2A	"ARIX, CFEOM2, FEOM2, PMX2A"	ENSG00000165462	"Paired like homeobox 2A"	O14813	11	72239077-72245664	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"adrenal gland: 19.9;brain: 18.3"	"Cell type enriched"	"Detected in single"	4	"Spermatogonia: 2.9"	"Cancer enriched"	"Detected in some"	9	"ovarian cancer: 9.3"	"Region enriched"	"Detected in some"	9	"pons: 18.3"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	226	"SH-SY5Y: 569.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"HPA053810, HPA065621, HPA078004"	Enhanced		Supported	Nucleoplasm		No	NA				"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	Nucleoplasm		"HPA053810: , HPA065621: AB_2685522, HPA078004: AB_2732367"			"unprognostic (5.84e-2)"		"unprognostic (8.51e-2)"					"unprognostic (5.07e-2)"	"unprognostic (2.19e-1)"		"unprognostic (2.13e-1)"	"unprognostic (9.92e-4)"	"unprognostic (3.03e-2)"			0.3	19.9	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	2.6	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	1.9	0.0	0.2	0.0	0.5	0.0	18.3	0.1	0.5	0.0	0.0	0.0	0.0	0.0	1.0	0.2	0.3	0.0	1.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	569.5	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	1.9	18.3	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PHYHIP	"DYRK1AP3, KIAA0273, PAHX-AP"	ENSG00000168490	"Phytanoyl-CoA 2-hydroxylase interacting protein"	Q92561	8	22219703-22232101	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 217.1"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 18.9;Basal squamous epithelial cells: 14.8;Excitatory neurons: 48.5;Inhibitory neurons: 15.4"	"Cancer enhanced"	"Detected in many"		"glioma: 6.3;thyroid cancer: 6.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"RPMI-8226: 9.3;SH-SY5Y: 3.5"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"amygdala: 101.1;basal ganglia: 300.5;cerebellum: 251.7;cerebral cortex: 256.5;hippocampal formation: 296.8"	"HPA068030, HPA069318"	Approved		Supported	Nucleoplasm,Mitochondria		NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Mitochondria	Nucleoplasm	"HPA068030: AB_2685944, HPA069318: AB_2686117"	"unprognostic (1.19e-2)"	"unprognostic (2.33e-2)"	"unprognostic (3.06e-2)"	"unprognostic (9.22e-3)"	"unprognostic (2.07e-3)"	"unprognostic (2.35e-1)"	"unprognostic (1.59e-1)"	"unprognostic (2.80e-1)"	"unprognostic (3.01e-2)"	"unprognostic (7.44e-3)"	"unprognostic (2.36e-1)"	"unprognostic (4.05e-2)"	"unprognostic (4.44e-5)"	"unprognostic (8.62e-4)"	"unprognostic (1.36e-1)"	"unprognostic (1.35e-2)"	"unprognostic (4.09e-3)"	11.3	33.1	106.0	1.5	183.9	0.0	9.3	98.1	217.1	11.6	0.0	14.1	1.3	14.5	2.8	9.8	25.6	6.7	5.2	210.3	21.9	9.4	0.7	2.5	0.2	63.7	11.5	7.1	1.6	0.2	35.7	2.5	58.1	11.9	0.6	2.2	1.8	5.9	0.9	55.8	5.1	8.1	2.0	11.5	3.7	10.7	30.7	0.2	3.9	0.3	0.2	12.1	15.1	137.4	0.6	1.6	0.3	0.0	0.2	0.5	0.8	0.2	0.9	0.2	0.2	0.1	1.4	0.0	1.5	0.5	1.0	2.6	0.0	0.4	0.0	0.0	0.1	0.0	3.0	1.0	1.1	0.0	0.0	0.6	0.0	0.6	0.0	2.5	1.7	0.1	0.1	0.9	0.0	0.0	0.0	0.0	0.6	0.5	0.2	0.0	0.2	9.3	0.0	0.0	2.9	3.5	2.0	0.0	2.4	0.2	0.0	0.2	0.7	0.0	1.4	1.1	0.5	0.6	0.1	0.0	1.4	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	106.0	183.9	98.1	217.1	210.3	21.9	63.7	11.5	58.1	2.0	30.7	137.4	1.1	0.0	0.0	7.2	0.0	18.9	5.5	5.6	14.8	1.5	0.7	1.3	1.4	1.5	1.9	3.7	0.0	0.1	0.1	0.2	0.0	0.2	0.8	0.4	3.6	1.5	0.0	0.0	48.5	2.1	0.4	5.6	0.5	0.2	0.0	0.0	1.4	1.0	0.2	0.0	15.4	0.7	0.0	0.0	1.4	1.8	3.1	0.1	1.8	5.6	0.0	0.6	0.0	7.5	5.8	0.8	0.0	3.8	0.0	1.3	2.6	3.5	0.3	1.1	0.0	0.2	8.0	0.4	0.4	8.2	10.9	2.2	0.2	0.1	0.1	5.0
PI4K2B	"FLJ11105, PI4KIIB, PIK42B"	ENSG00000038210	"Phosphatidylinositol 4-kinase type 2 beta"	Q8TCG2	4	25160663-25279204	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 57.9"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004099	Enhanced		Supported	Cytosol		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 55: Plasma cells - Humoral immune response"	Cytosol		"HPA004099: AB_1855353"	"unprognostic (1.02e-1)"	"unprognostic (6.34e-3)"	"prognostic favorable (9.64e-5)"	"unprognostic (2.75e-2)"	"unprognostic (1.98e-2)"	"unprognostic (2.68e-2)"	"unprognostic (7.54e-2)"	"unprognostic (7.75e-2)"	"unprognostic (5.06e-1)"	"unprognostic (6.39e-3)"	"unprognostic (1.71e-1)"	"unprognostic (1.32e-1)"	"unprognostic (9.07e-2)"	"unprognostic (9.61e-2)"	"unprognostic (2.39e-2)"	"unprognostic (2.02e-2)"	"unprognostic (4.47e-2)"	7.9	8.9	3.4	14.0	3.9	14.1	16.5	3.6	4.5	11.4	5.8	18.7	39.0	8.0	5.8	16.7	8.7	8.3	4.5	3.2	4.1	12.9	57.9	16.5	18.1	4.3	3.6	5.2	9.5	7.7	3.4	12.0	4.5	11.4	20.4	4.9	23.5	7.9	2.4	13.1	31.6	9.1	4.5	13.5	22.7	12.1	3.7	19.7	24.1	4.8	18.9	14.3	8.1	5.3	33.8	9.9	16.7	14.6	18.2	33.9	31.3	50.8	48.6	48.4	58.1	14.0	37.7	86.3	11.5	45.3	37.5	14.7	37.3	24.6	41.7	28.9	12.2	30.4	23.3	26.1	14.2	61.9	21.0	21.6	17.9	18.6	19.2	12.9	28.0	27.0	20.7	76.2	37.0	18.8	58.3	39.7	23.6	40.5	13.6	34.4	58.1	47.5	32.2	32.2	28.9	6.2	24.5	17.1	12.0	17.0	25.7	27.3	33.8	31.8	8.4	18.3	32.5	76.3	49.5	77.4	34.5	45.4	30.6	5.3	1.1	3.4	1.5	1.2	1.0	1.4	1.5	1.5	0.8	1.2	1.2	1.4	1.7	0.9	0.9	1.5	3.5	0.6	3.4	3.9	3.6	4.5	3.2	4.1	4.3	3.6	4.5	4.5	3.7	5.3	5.6	6.4	18.5	21.5	14.9	15.0	15.8	9.9	8.0	2.1	8.4	5.3	0.0	5.7	12.2	9.2	0.0	21.6	6.7	20.2	5.9	5.5	1.0	10.0	3.4	7.1	8.4	25.7	8.7	7.1	12.6	6.1	16.3	8.5	0.0	3.5	6.8	40.4	10.3	1.7	13.7	13.7	8.2	15.4	13.9	1.0	4.4	8.6	5.4	11.2	10.3	0.7	4.1	30.2	20.1	5.8	8.2	4.5	27.4	14.1	16.8	20.3	10.4	3.4	0.0	5.3	7.2	9.6	10.3	18.3	15.6	13.5	10.3	4.4	13.9	18.2
PI4KB	"PI4K-BETA, pi4K92, PIK4CB"	ENSG00000143393	"Phosphatidylinositol 4-kinase beta"	Q9UBF8	1	151291797-151327715	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Host-virus interaction"	"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006280, HPA006281, CAB022071"	Approved		Supported	"Golgi apparatus"		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 59: Non-specific - Transcription"	"Golgi apparatus"		"CAB022071: , HPA006280: AB_1079613, HPA006281: AB_1079614"	"unprognostic (1.17e-1)"	"unprognostic (1.57e-1)"	"unprognostic (5.42e-3)"	"unprognostic (5.23e-3)"	"unprognostic (7.32e-2)"	"unprognostic (1.36e-2)"	"prognostic unfavorable (2.97e-4)"	"unprognostic (1.87e-1)"	"unprognostic (3.94e-1)"	"unprognostic (1.58e-1)"	"prognostic favorable (1.25e-5)"	"unprognostic (8.51e-2)"	"prognostic unfavorable (3.23e-4)"	"unprognostic (2.53e-1)"	"unprognostic (2.16e-1)"	"prognostic unfavorable (6.78e-4)"	"unprognostic (7.08e-2)"	45.6	45.0	57.3	33.1	61.4	78.0	47.6	64.4	63.2	62.6	53.2	50.9	35.8	58.8	54.8	48.0	58.6	40.2	45.8	59.2	62.3	50.4	40.5	47.2	46.8	57.9	60.7	60.2	46.1	56.0	56.5	39.6	60.4	57.6	44.0	46.4	45.8	42.6	68.5	60.5	47.0	62.2	54.4	59.8	48.0	46.0	61.0	45.7	67.8	58.6	47.5	48.9	51.3	68.2	49.2	40.1	34.2	53.9	92.8	68.1	28.9	50.9	88.3	65.3	53.8	51.7	43.4	46.1	57.1	78.5	41.1	44.9	57.3	52.5	50.1	63.0	50.9	33.0	48.8	26.6	64.8	38.5	60.9	71.7	62.4	72.3	51.3	56.3	63.7	46.3	57.5	67.9	56.0	91.2	41.0	30.9	27.6	69.5	60.3	36.2	28.8	54.4	45.2	61.2	41.3	35.4	35.5	71.1	46.7	53.9	60.1	71.9	50.3	46.5	36.3	37.3	55.1	71.6	50.4	89.8	52.9	39.7	82.3	41.3	22.7	36.0	17.8	24.7	19.9	20.4	18.5	23.6	24.3	16.7	15.1	14.3	21.0	19.3	26.3	13.9	20.0	23.9	57.3	61.4	64.4	63.2	59.2	62.3	57.9	60.7	60.4	54.4	61.0	68.2	16.8	16.0	24.3	19.2	26.4	22.3	18.2	17.7	28.5	33.5	24.3	24.6	7.0	21.5	17.7	12.9	20.9	30.1	16.0	28.7	19.6	20.9	12.2	21.5	19.9	19.3	18.5	26.9	17.8	24.9	20.5	25.9	23.0	24.6	19.0	30.0	15.4	12.4	29.2	35.3	19.0	16.4	10.2	20.1	20.5	15.5	23.3	21.3	14.2	15.9	29.3	23.1	21.6	18.1	25.8	23.5	17.3	24.8	24.4	17.7	25.7	15.2	17.1	28.4	13.1	24.2	23.2	28.9	25.1	24.8	31.1	48.7	23.8	44.7	20.2	28.1
PIAS2	"ARIP3, miz, PIASX-ALPHA, PIASX-BETA, ZMIZ4"	ENSG00000078043	"Protein inhibitor of activated STAT 2"	O75928	18	46803218-46920160	"Predicted intracellular proteins, Predicted membrane proteins"	"Transcription, Transcription regulation, Ubl conjugation pathway"	"DNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 67.2"	"Cell type enhanced"	"Detected in all"		"Early spermatids: 521.4;Late spermatids: 519.5;Spermatocytes: 238.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA068792	Enhanced		Supported	Nucleoplasm		Yes	No			"Cluster 26: Non-specific - Mitochondria"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm		"HPA068792: AB_2686037"	"unprognostic (9.59e-3)"	"unprognostic (2.14e-1)"	"unprognostic (1.63e-1)"	"unprognostic (2.75e-2)"	"unprognostic (1.25e-1)"	"unprognostic (6.39e-2)"	"unprognostic (1.05e-3)"	"unprognostic (3.67e-2)"	"unprognostic (1.05e-1)"	"unprognostic (3.71e-3)"	"unprognostic (1.77e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.58e-1)"	"unprognostic (6.92e-2)"	"prognostic unfavorable (1.27e-4)"	"unprognostic (1.71e-1)"	4.8	5.4	7.3	4.1	8.1	7.4	5.1	16.9	9.8	4.9	6.4	4.9	2.8	5.0	7.5	3.7	4.5	4.6	6.8	8.7	6.2	6.4	5.9	4.3	6.2	4.7	6.9	5.0	4.2	11.8	5.6	3.9	5.4	6.5	7.0	10.9	5.5	4.4	16.1	7.7	4.2	4.7	3.7	6.0	4.5	67.2	7.9	4.6	8.2	10.2	5.2	4.1	4.4	8.0	13.7	5.5	6.1	8.7	6.0	7.5	2.9	7.0	5.6	6.0	5.5	6.5	5.1	13.7	3.7	5.3	6.1	4.5	12.3	7.5	8.5	6.6	4.6	8.5	5.4	7.7	5.9	14.3	5.8	7.7	4.5	5.3	5.6	9.7	5.5	11.9	6.4	3.5	12.0	7.4	8.2	8.3	6.7	2.5	3.5	15.0	13.1	0.1	5.5	10.4	11.7	9.0	6.4	4.1	4.7	6.8	6.1	6.3	6.9	12.8	5.5	4.5	5.3	10.1	5.4	17.7	9.5	15.1	12.8	0.7	1.7	1.2	2.0	1.3	1.3	1.6	1.8	2.4	2.0	3.0	2.5	2.1	1.0	1.9	1.3	2.1	1.9	0.8	7.3	8.1	16.9	9.8	8.7	6.2	4.7	6.9	5.4	3.7	7.9	8.0	26.3	19.2	21.9	60.4	25.0	20.6	19.9	15.2	23.9	57.7	21.8	13.2	30.7	12.8	12.6	25.8	89.6	2.6	32.8	18.1	19.6	13.5	521.4	16.6	25.4	26.0	28.5	16.6	137.9	8.9	2.3	20.6	19.4	15.9	14.5	48.4	34.2	22.3	28.1	32.0	134.9	18.0	16.2	50.3	15.7	519.5	33.5	24.2	12.4	73.1	34.7	21.9	40.2	133.7	94.0	7.9	17.1	35.0	30.3	28.4	11.8	23.1	13.9	36.0	6.6	42.5	18.2	238.7	72.4	24.7	15.3	1.4	19.2	35.6	25.5	18.0
PIAS3	"FLJ14651, ZMIZ5"	ENSG00000131788	"Protein inhibitor of activated STAT 3"	Q9Y6X2	1	145848522-145859836	"Predicted intracellular proteins"	"Transcription, Transcription regulation, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006389, HPA067383"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 49: Ciliated cells - Cilium organization"	Nucleoplasm		"HPA006389: AB_2667576, HPA067383: AB_2685828"	"unprognostic (1.23e-1)"	"unprognostic (2.21e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.79e-2)"	"unprognostic (1.37e-1)"	"prognostic unfavorable (6.12e-4)"	"unprognostic (2.30e-2)"	"unprognostic (5.92e-2)"	"unprognostic (2.50e-1)"	"unprognostic (2.77e-3)"	"unprognostic (5.06e-1)"	"prognostic unfavorable (1.21e-7)"	"unprognostic (5.14e-2)"	"unprognostic (4.98e-2)"	"unprognostic (5.66e-2)"	"unprognostic (2.11e-2)"	21.9	11.5	11.3	12.8	10.8	4.9	23.3	10.2	12.2	35.2	13.5	24.5	7.6	32.0	7.9	37.3	37.2	12.1	18.1	10.9	12.8	13.7	7.2	17.9	9.1	11.7	12.2	23.4	13.1	14.4	15.4	10.7	11.7	21.6	8.0	9.8	29.2	21.1	25.8	34.4	14.6	23.6	11.3	13.3	21.7	11.1	13.9	13.5	14.9	14.5	17.9	29.1	34.9	10.7	34.6	23.5	23.8	21.1	35.9	67.3	14.5	31.8	43.6	35.5	39.3	19.3	22.2	17.8	33.6	54.8	15.0	35.0	12.4	50.4	29.9	19.4	18.3	8.2	15.9	10.4	35.8	14.7	38.8	55.2	32.3	32.9	18.6	45.6	52.0	15.8	13.2	24.0	74.7	57.6	15.8	7.8	37.0	97.3	37.7	24.6	16.2	11.7	28.2	20.5	8.1	37.9	30.7	16.9	15.5	27.0	78.0	22.1	80.7	47.2	34.8	31.7	20.9	32.6	15.7	11.5	45.8	10.9	23.9	8.9	9.1	10.7	10.6	8.7	11.4	5.4	6.7	11.6	6.8	3.6	6.2	6.0	2.2	15.2	12.5	8.4	8.1	7.0	11.3	10.8	10.2	12.2	10.9	12.8	11.7	12.2	11.7	11.3	13.9	10.7	14.7	22.4	11.5	8.5	8.6	10.7	7.9	15.4	19.4	10.2	16.2	16.5	0.9	4.3	22.8	16.5	12.5	3.7	10.0	2.1	1.9	7.9	2.3	29.4	14.8	12.3	4.2	2.1	4.2	7.7	7.3	11.9	13.3	19.1	10.8	4.9	13.2	3.8	5.2	10.1	3.9	6.2	12.2	4.4	7.0	3.9	14.3	4.1	5.4	7.5	13.1	4.2	8.2	6.6	7.4	12.7	2.0	13.2	4.8	9.2	2.1	1.8	37.6	11.8	26.3	7.0	13.6	4.0	11.4	19.9	16.3	4.0	8.6	6.0	2.8	10.4
PIAS4	"FLJ12419, Piasg, PIASY, ZMIZ6"	ENSG00000105229	"Protein inhibitor of activated STAT 4"	Q8N2W9	19	4007736-4039386	"Enzymes, Predicted intracellular proteins"	"Transcription, Transcription regulation, Ubl conjugation pathway, Wnt signaling pathway"	"DNA-binding, Repressor, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 103.7;Late spermatids: 264.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010598, HPA076008"	Enhanced		Supported	Nucleoplasm,Centrosome		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 31: Spermatids - Spermatogenesis"	Nucleoplasm	Centrosome	"HPA010598: AB_1079616, HPA076008: "	"unprognostic (1.23e-1)"	"unprognostic (8.94e-3)"	"unprognostic (3.50e-2)"	"prognostic favorable (1.18e-5)"	"unprognostic (2.45e-1)"	"unprognostic (4.77e-3)"	"unprognostic (4.01e-3)"	"unprognostic (9.79e-2)"	"unprognostic (6.89e-2)"	"unprognostic (6.22e-2)"	"prognostic favorable (7.04e-4)"	"unprognostic (1.33e-2)"	"unprognostic (5.98e-2)"	"unprognostic (4.52e-3)"	"unprognostic (5.76e-2)"	"unprognostic (1.25e-1)"	"unprognostic (4.67e-3)"	8.0	10.7	9.2	6.0	11.8	4.7	9.0	11.6	11.4	11.0	3.8	15.4	6.6	10.5	2.3	11.1	8.8	2.9	10.1	8.5	7.4	8.7	15.5	7.9	5.6	12.2	11.5	10.6	13.9	3.5	10.4	5.3	10.3	11.4	2.4	3.7	9.8	3.9	10.6	12.7	9.9	3.8	8.5	11.6	12.1	37.2	10.4	5.9	7.5	4.8	4.0	10.4	9.7	17.4	15.1	10.6	9.7	9.3	4.7	4.2	15.4	9.0	4.9	9.2	8.4	16.7	6.8	11.4	7.9	4.8	10.1	15.5	10.0	7.1	4.0	18.5	15.8	8.2	7.8	13.1	9.6	12.0	13.8	4.9	7.8	8.3	5.1	5.1	11.1	11.6	15.5	15.2	4.5	15.5	21.9	13.9	21.6	7.3	9.7	19.3	9.9	15.0	6.1	8.3	17.8	19.8	12.8	12.4	10.3	7.3	11.5	11.0	8.2	9.2	13.2	19.4	14.2	28.3	22.8	14.4	7.7	14.6	11.5	10.5	13.2	19.8	15.2	15.3	10.8	16.1	10.8	14.0	11.0	14.6	9.3	10.6	15.8	17.1	19.5	11.0	13.0	10.3	9.2	11.8	11.6	11.4	8.5	7.4	12.2	11.5	10.3	8.5	10.4	17.4	12.8	3.2	15.0	15.0	10.1	18.4	8.4	15.8	7.4	18.8	14.5	11.2	3.6	11.5	11.5	9.2	12.5	24.3	12.3	13.2	7.9	17.1	103.7	13.9	10.7	12.3	22.1	9.9	7.3	17.6	16.9	9.1	11.7	12.4	7.0	15.2	11.4	12.3	14.6	26.9	5.7	15.6	20.3	8.3	9.2	264.3	14.0	10.6	7.2	2.8	12.8	11.3	10.3	6.6	18.0	13.5	7.8	18.4	12.0	11.9	14.0	12.5	15.6	23.1	6.6	8.1	9.3	69.1	42.1	7.4	15.5	36.4	10.1	13.3	12.4	9.0
PIBF1	"C13orf24, CEP90"	ENSG00000083535	"Progesterone immunomodulatory binding factor 1"	Q8WXW3	13	72782133-73016461	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	Immunity		"Ciliopathy, Disease variant, Joubert syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 334.5;Oligodendrocyte precursor cells: 143.7;Oligodendrocytes: 138.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA052269, HPA066120"	Approved		Supported	"Centriolar satellite"	"Secreted to blood"	NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 29: Early spermatids - Spermatogenesis"	"Centriolar satellite"		"HPA052269: AB_2681779, HPA066120: AB_2685621"	"unprognostic (1.54e-1)"	"unprognostic (4.17e-1)"	"unprognostic (6.73e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.06e-1)"	"unprognostic (3.80e-2)"	"unprognostic (3.79e-2)"	"unprognostic (3.87e-2)"	"unprognostic (4.08e-2)"	"unprognostic (2.62e-2)"	"unprognostic (2.26e-3)"	"unprognostic (1.39e-1)"	"unprognostic (6.85e-3)"	"unprognostic (8.31e-2)"	"unprognostic (2.78e-2)"	"unprognostic (1.89e-2)"	"unprognostic (2.45e-1)"	7.6	9.1	5.2	6.7	5.5	10.2	12.2	7.4	7.3	11.5	9.8	7.4	7.0	11.5	10.7	7.1	11.0	8.4	7.5	4.6	4.8	8.3	9.8	8.7	9.9	5.1	5.0	12.6	5.5	8.5	7.5	9.7	4.7	9.8	8.8	10.2	7.4	8.2	6.6	8.5	6.9	8.5	4.7	8.4	8.7	14.3	5.0	13.0	15.5	7.4	8.4	10.1	8.0	6.0	13.1	4.2	16.8	9.8	14.4	25.3	6.5	11.9	15.9	11.8	14.4	5.8	22.1	12.0	13.7	13.2	6.2	11.1	9.1	12.0	18.9	12.2	8.7	8.2	10.9	6.7	18.4	31.0	7.5	16.4	9.4	12.7	30.7	15.1	15.5	8.2	11.7	6.1	15.9	3.7	15.2	18.6	8.9	23.3	3.9	12.0	12.4	12.4	24.5	7.0	9.6	15.4	9.2	6.3	16.3	13.5	10.6	21.8	11.8	6.0	6.3	9.5	7.2	9.7	7.5	6.0	18.0	17.3	13.3	8.4	3.4	6.1	6.0	3.7	6.4	5.9	6.4	6.5	3.0	5.6	8.7	7.3	3.3	8.6	3.6	5.1	5.3	2.5	5.2	5.5	7.4	7.3	4.6	4.8	5.1	5.0	4.7	4.7	5.0	6.0	33.8	32.1	30.8	101.2	21.6	10.3	16.3	10.5	16.5	17.1	15.5	17.8	28.1	14.3	27.7	5.5	16.7	9.4	19.3	6.6	13.7	11.6	334.5	41.5	33.6	20.0	7.2	15.2	115.1	11.1	10.2	20.4	21.4	18.5	24.1	21.8	9.7	5.6	7.1	18.5	119.3	9.7	12.2	8.6	3.5	50.4	19.3	10.3	8.8	92.8	9.8	11.9	17.5	143.7	138.6	12.0	8.5	15.4	11.6	11.8	7.1	6.5	46.3	31.3	13.1	28.9	17.9	59.4	39.2	11.8	8.9	6.0	23.1	25.6	10.0	13.7
PICK1	"dJ1039K5, MGC15204, PRKCABP"	ENSG00000100151	"Protein interacting with PRKCA 1"	Q9NRD5	22	38056311-38075701	"Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 116.1;Late spermatids: 85.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000819, HPA072674"	Approved		Supported	Cytosol		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 35: Non-specific - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 29: Early spermatids - Spermatogenesis"	Cytosol		"HPA000819: , HPA072674: AB_2686547"	"unprognostic (1.97e-2)"	"unprognostic (4.61e-3)"	"unprognostic (7.79e-2)"	"unprognostic (9.26e-2)"	"unprognostic (1.29e-2)"	"unprognostic (1.81e-1)"	"unprognostic (6.04e-2)"	"unprognostic (1.65e-2)"	"unprognostic (4.62e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.68e-3)"	"unprognostic (1.20e-1)"	"unprognostic (8.56e-2)"	"prognostic favorable (5.26e-5)"	"unprognostic (1.36e-1)"	"unprognostic (2.74e-1)"	"unprognostic (4.61e-3)"	8.8	14.9	12.4	4.8	15.2	5.4	13.5	12.8	20.3	9.9	12.9	11.9	10.1	11.7	13.8	15.9	16.3	8.9	18.2	14.5	13.5	15.1	17.5	10.8	5.4	14.5	13.6	15.4	18.5	29.3	28.8	6.7	16.7	25.6	12.2	5.9	18.6	12.6	26.3	16.9	11.3	11.3	11.6	10.1	16.2	27.4	15.6	5.9	14.6	16.2	8.2	9.3	12.0	23.0	19.5	13.7	7.6	10.0	5.3	4.1	11.3	10.7	12.8	22.5	22.7	14.6	12.0	8.6	11.6	13.0	17.0	20.8	21.0	43.2	19.3	5.3	33.6	3.1	16.8	17.1	19.3	10.1	20.4	13.3	24.9	14.8	21.9	22.8	8.8	11.1	6.4	6.2	4.7	12.4	6.0	0.9	12.1	44.3	14.9	5.1	0.3	7.8	25.8	31.1	31.5	16.0	12.0	28.8	11.1	11.1	16.8	7.3	2.4	6.4	12.0	8.6	6.4	13.9	3.4	2.7	13.8	3.4	9.4	0.0	0.9	0.0	0.5	0.4	0.2	0.3	0.5	1.0	1.6	1.1	1.0	0.5	0.6	0.4	0.5	0.3	0.7	0.6	12.4	15.2	12.8	20.3	14.5	13.5	14.5	13.6	16.7	11.6	15.6	23.0	8.1	9.6	10.6	11.1	8.1	8.0	14.2	15.6	12.0	12.7	18.7	16.1	10.2	11.5	12.1	7.3	8.4	26.1	6.0	25.4	11.7	18.8	116.1	15.4	3.6	7.8	10.3	1.7	26.8	15.7	14.8	6.8	29.6	17.3	8.9	36.3	5.7	9.7	15.1	20.2	19.4	20.1	18.3	31.5	13.3	85.5	11.1	16.3	7.2	6.5	16.0	13.6	8.2	8.5	29.0	21.4	18.5	17.0	5.8	22.1	18.3	16.0	12.8	12.5	13.1	6.0	9.5	17.2	6.7	12.0	9.7	38.4	6.8	15.5	18.5	14.7
PIDD1	"DKFZp434D229, LRDD, MGC16925, PIDD"	ENSG00000177595	"P53-induced death domain protein 1"	Q9HB75	11	799179-809753	"Predicted intracellular proteins"	Apoptosis	Hydrolase	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 29.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BEWO: 26.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB012647, HPA055473, HPA066948"	Supported		Approved	"Golgi apparatus,Cytosol"		NA	Yes			"Cluster 39: Non-specific - mRNA processing"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Golgi apparatus, Cytosol"		"CAB012647: , HPA055473: AB_2682827, HPA066948: "	"unprognostic (1.38e-1)"	"prognostic favorable (8.19e-5)"	"unprognostic (5.07e-3)"	"prognostic favorable (3.32e-5)"	"unprognostic (7.25e-2)"	"prognostic favorable (3.91e-4)"	"unprognostic (8.17e-3)"	"unprognostic (5.97e-2)"	"unprognostic (3.10e-1)"	"unprognostic (1.03e-1)"	"unprognostic (3.37e-3)"	"unprognostic (2.17e-2)"	"prognostic unfavorable (1.52e-4)"	"unprognostic (2.84e-3)"	"unprognostic (8.46e-2)"	"unprognostic (2.24e-1)"	"unprognostic (2.22e-2)"	3.3	3.1	2.3	2.3	2.8	7.4	3.3	2.5	4.1	3.6	2.8	3.9	3.0	3.0	0.1	4.0	3.3	1.1	2.9	2.1	2.2	3.1	5.5	2.7	3.2	3.6	2.6	2.8	3.7	0.9	2.8	1.9	3.5	4.3	0.6	0.2	3.2	1.0	6.5	5.5	4.5	0.7	2.5	5.0	4.0	2.4	3.0	3.2	3.8	0.8	1.0	3.2	3.1	4.6	5.4	6.2	2.9	6.2	0.6	2.2	26.6	7.5	2.0	2.7	3.6	5.7	10.2	4.4	2.3	1.1	2.5	7.9	2.1	3.0	0.5	9.0	12.3	3.8	5.0	12.0	6.8	4.3	9.4	8.4	5.3	1.4	0.3	0.5	5.0	10.3	4.5	3.3	1.1	2.6	12.0	7.2	4.0	5.8	4.3	19.4	4.2	8.6	1.1	1.9	5.1	6.8	3.1	8.2	2.0	1.6	6.0	7.3	2.7	3.4	7.6	2.5	4.9	10.5	6.4	8.5	4.4	3.5	5.6	0.0	0.5	0.0	0.4	0.4	0.4	0.3	0.3	0.4	0.8	0.4	0.4	0.4	0.0	0.1	0.4	0.2	0.9	0.4	2.3	2.8	2.5	4.1	2.1	2.2	3.6	2.6	3.5	2.5	3.0	4.6	4.9	3.2	8.8	25.8	7.2	0.0	3.6	0.0	6.2	14.9	7.3	8.1	4.2	5.7	5.6	3.7	10.4	29.2	8.9	12.0	1.9	2.5	1.4	6.7	4.2	3.7	9.0	5.7	12.8	4.6	7.5	4.4	10.7	4.2	1.3	14.0	2.2	10.3	5.5	1.7	14.2	8.1	0.0	3.5	0.0	1.9	7.2	3.8	0.0	7.5	4.1	7.0	2.1	6.6	26.9	3.5	9.9	4.1	6.0	4.4	10.0	3.8	0.0	15.4	0.0	5.7	3.5	25.2	20.8	6.7	0.0	9.7	6.3	7.5	10.5	3.6
PIF1	"C15orf20, FLJ22692"	ENSG00000140451	"PIF1 5'-to-3' DNA helicase"	Q9H611	15	64815632-64825668	"Enzymes, Predicted intracellular proteins"	"DNA damage, DNA recombination, DNA repair"	"DNA-binding, Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 4.8"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 21.3;Erythroid cells: 17.7;Granulosa cells: 15.1;NK-cells: 15.5;Theca cells: 18.3"	"Cancer enhanced"	"Detected in many"		"testis cancer: 10.2"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			CAB018701	Supported		Supported	Nucleoplasm		NA	Yes			"Cluster 35: T-regs - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 20: HeLa - Mitochondria"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"CAB018701: AB_2164654"	"unprognostic (1.99e-1)"	"unprognostic (6.11e-2)"	"unprognostic (1.34e-1)"	"unprognostic (3.12e-2)"	"unprognostic (1.62e-1)"	"unprognostic (8.33e-3)"	"unprognostic (8.66e-4)"	"unprognostic (1.47e-1)"	"prognostic unfavorable (5.22e-4)"	"unprognostic (6.68e-2)"	"unprognostic (2.38e-2)"	"unprognostic (3.27e-2)"	"unprognostic (0.00e+0)"	"unprognostic (2.96e-3)"	"unprognostic (1.78e-1)"	"unprognostic (9.61e-2)"	"unprognostic (5.95e-2)"	0.7	1.0	0.8	2.6	0.8	3.8	0.4	0.7	1.3	0.9	0.7	2.4	1.9	0.8	0.1	3.1	0.7	0.8	0.9	0.7	1.2	0.6	0.6	1.0	4.6	1.4	1.0	0.4	0.2	0.2	0.5	0.9	1.1	1.7	1.0	0.1	0.6	0.7	0.3	1.0	2.6	1.2	0.9	4.8	1.8	2.5	1.2	3.6	0.5	0.1	3.3	1.5	1.4	0.8	7.7	8.7	21.1	8.6	3.7	4.3	7.8	7.4	3.9	7.3	5.6	14.0	12.6	9.3	3.0	3.6	6.8	20.9	21.8	6.2	2.7	14.8	8.0	10.8	28.5	10.2	1.9	4.3	8.4	2.5	0.0	3.2	2.6	1.8	7.5	13.6	7.2	18.0	7.0	6.7	4.7	17.9	17.2	9.7	6.0	9.7	7.0	13.0	4.1	4.3	8.7	5.6	5.7	6.3	3.3	9.2	7.0	4.7	5.2	4.4	22.6	7.0	14.0	14.3	14.3	9.0	4.2	18.8	6.4	0.0	0.0	0.0	0.3	0.0	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.9	0.1	0.8	0.8	0.7	1.3	0.7	1.2	1.4	1.0	1.1	0.9	1.2	0.8	1.2	0.0	1.1	3.6	6.5	1.9	0.8	0.6	0.0	0.5	0.6	0.6	1.9	0.0	0.1	0.0	0.0	5.1	7.5	3.2	0.0	0.0	21.3	0.4	4.4	2.3	0.0	17.7	2.6	0.0	6.5	5.6	3.6	0.7	0.0	15.1	5.3	0.5	5.8	0.0	1.0	2.4	0.0	5.1	2.0	2.3	1.5	4.5	0.0	1.9	0.1	0.8	15.5	3.5	0.1	0.2	0.1	2.2	9.7	1.1	0.2	0.1	0.1	1.2	6.6	4.2	3.5	0.8	2.0	1.6	1.0	1.1	7.5	18.3	6.2	1.3
PIGV	FLJ20477	ENSG00000060642	"Phosphatidylinositol glycan anchor biosynthesis class V"	Q9NUD9	1	26787054-26800659	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted membrane proteins"	"GPI-anchor biosynthesis"	"Glycosyltransferase, Transferase"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 50.8;Late spermatids: 96.0;Spermatocytes: 80.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"hTCEpi: 43.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054181			Approved	"Endoplasmic reticulum,Cytosol"		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 25: Spermatids - Spermatogenesis"	Cytosol	"Endoplasmic reticulum"	"HPA054181: "	"unprognostic (2.08e-1)"	"unprognostic (6.53e-2)"	"unprognostic (1.32e-3)"	"unprognostic (1.96e-2)"	"unprognostic (2.02e-2)"	"unprognostic (5.76e-2)"	"unprognostic (2.00e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.56e-1)"	"unprognostic (8.40e-2)"	"unprognostic (4.44e-2)"	"prognostic favorable (7.60e-7)"	"unprognostic (1.71e-1)"	"unprognostic (4.24e-1)"	"unprognostic (8.92e-2)"	"unprognostic (5.96e-3)"	6.6	13.9	4.6	3.4	5.3	3.0	7.6	5.1	4.8	9.5	4.1	8.1	6.5	8.1	13.8	9.0	10.2	6.2	4.4	4.2	4.7	10.9	24.1	6.2	4.2	6.1	5.2	7.9	10.3	13.9	10.0	6.2	5.5	8.4	8.4	3.7	10.0	8.0	4.4	11.3	7.3	6.7	5.2	6.9	8.9	30.0	5.1	6.7	10.6	4.8	6.4	8.5	8.3	5.4	10.6	4.4	4.1	4.7	7.3	10.8	5.8	6.7	14.0	7.6	7.9	2.3	25.9	6.7	7.3	7.7	8.2	20.3	4.2	8.6	8.6	11.5	2.5	5.6	5.1	5.1	10.3	7.7	10.0	11.8	43.8	9.8	12.2	12.0	5.1	9.4	10.0	12.2	14.0	3.9	3.7	3.0	9.9	20.9	3.0	3.8	6.2	15.0	11.0	1.0	7.6	3.9	9.2	4.3	8.7	9.8	14.1	6.5	8.1	10.8	6.5	6.0	1.8	3.8	2.2	2.9	10.7	10.0	8.2	33.1	14.1	11.0	14.0	13.0	21.1	8.8	9.9	14.4	12.5	8.8	10.2	12.4	14.2	21.5	18.5	4.5	9.7	10.8	4.6	5.3	5.1	4.8	4.2	4.7	6.1	5.2	5.5	5.2	5.1	5.4	5.2	3.2	6.0	7.5	6.0	4.2	11.0	27.5	6.2	3.3	10.0	7.6	1.9	4.3	12.7	7.3	8.4	27.4	10.6	5.0	7.9	7.2	50.8	6.7	4.7	4.6	3.5	13.5	2.8	4.6	14.8	8.8	6.1	6.4	0.0	6.8	6.4	16.6	9.2	8.4	3.2	6.5	12.2	5.2	3.2	96.0	7.2	4.2	7.2	2.8	8.2	11.1	7.2	0.0	5.5	4.9	4.8	9.8	6.5	7.6	12.1	10.2	16.3	2.7	0.0	5.7	4.9	80.8	15.1	7.3	4.1	14.1	8.2	12.1	9.2	8.4
PIK3C2A	PI3K-C2alpha	ENSG00000011405	"Phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 alpha"	O00443	11	17077730-17207983	"Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Endocytosis, Exocytosis"	"Kinase, Transferase"	"Cataract, Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Astrocytes: 217.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037641, HPA037642"	Uncertain		Supported	Nucleoplasm,Vesicles,Cytosol		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 43: Cardiomyocytes - Nuclear processes"	Nucleoplasm	"Vesicles, Cytosol"	"HPA037641: AB_10671878, HPA037642: AB_10697081"	"unprognostic (2.35e-1)"	"unprognostic (2.16e-2)"	"unprognostic (3.71e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.63e-1)"	"unprognostic (6.63e-2)"	"unprognostic (2.47e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.29e-2)"	"unprognostic (1.86e-2)"	"unprognostic (4.74e-2)"	"unprognostic (1.84e-1)"	"prognostic favorable (1.66e-4)"	"unprognostic (3.20e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.37e-1)"	22.5	13.7	16.3	12.3	25.9	9.4	15.9	22.5	14.6	16.1	17.4	13.2	14.9	18.0	15.7	15.4	14.5	19.0	12.4	10.5	14.0	23.5	15.5	16.6	11.3	16.6	16.1	14.1	12.3	43.6	10.3	23.1	17.0	16.4	13.0	22.4	11.8	14.8	6.4	12.3	11.8	18.3	13.8	13.0	18.0	19.3	19.6	9.4	30.7	12.1	10.9	14.9	12.0	15.8	53.8	24.1	39.6	24.8	28.0	28.3	35.3	33.2	35.7	23.9	33.2	58.9	6.0	15.6	16.2	28.6	39.1	34.8	31.9	25.4	42.1	13.5	27.6	9.8	28.4	23.3	30.6	12.3	14.9	22.2	17.5	23.6	45.8	22.2	57.7	9.9	23.4	14.7	18.6	16.6	6.6	7.7	22.6	30.1	18.5	6.9	41.1	11.0	29.6	47.0	23.2	20.5	50.6	21.4	23.2	33.0	12.7	12.3	72.5	19.1	27.4	50.1	20.4	5.9	14.1	12.8	22.8	11.3	22.6	1.7	1.5	1.1	1.7	1.0	1.1	1.4	1.3	1.3	2.1	1.5	1.7	1.0	2.3	1.8	3.2	1.4	0.9	0.6	16.3	25.9	22.5	14.6	10.5	14.0	16.6	16.1	17.0	13.8	19.6	15.8	93.2	76.9	62.0	217.4	25.0	35.3	26.1	18.7	24.5	49.1	34.7	25.0	29.7	25.8	33.1	36.8	70.9	29.6	29.5	22.6	19.6	19.8	35.9	51.8	35.1	87.6	28.7	11.2	57.0	25.1	17.9	28.6	45.3	72.4	32.2	22.8	106.7	32.4	19.2	35.3	81.1	23.5	18.3	46.3	33.1	18.6	25.7	27.0	19.6	69.3	19.6	73.0	17.5	62.8	79.4	26.1	13.1	31.2	29.9	42.7	15.2	22.4	26.4	40.4	39.5	33.7	35.1	52.6	26.8	23.5	34.0	143.5	25.3	25.1	20.7	37.3
PIK3CA	PI3K	ENSG00000121879	"Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha"	P42336	3	179148114-179240093	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, RAS pathway related proteins"	"Angiogenesis, Lipid metabolism, Phagocytosis"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Disease variant, FDA approved drug targets, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 126.7;Inhibitory neurons: 122.0;Oligodendrocyte precursor cells: 130.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA009985, CAB017804"	Approved		Supported	Mitochondria,Cytosol		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Cytosol	Mitochondria	"CAB017804: , HPA009985: AB_1079610"	"unprognostic (1.81e-1)"	"unprognostic (2.77e-1)"	"unprognostic (2.18e-1)"	"unprognostic (2.69e-3)"	"unprognostic (6.49e-3)"	"unprognostic (1.43e-1)"	"unprognostic (2.65e-2)"	"unprognostic (1.00e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.37e-1)"	"unprognostic (2.57e-3)"	"unprognostic (5.21e-2)"	"unprognostic (4.50e-2)"	"unprognostic (1.16e-2)"	"unprognostic (2.48e-1)"	"unprognostic (9.74e-2)"	"unprognostic (3.82e-2)"	14.7	7.9	3.1	8.1	3.7	12.4	8.5	9.7	8.3	8.7	0.3	6.7	4.2	8.3	4.8	7.9	5.7	8.4	9.5	3.7	3.6	8.2	7.1	7.9	9.2	5.1	4.2	10.3	4.3	11.5	3.4	11.1	5.1	7.3	5.8	12.4	4.5	7.1	7.1	5.5	5.3	8.9	2.3	8.8	5.8	6.1	3.7	13.7	7.9	13.0	9.2	8.6	5.8	6.4	19.9	6.5	9.6	9.2	22.7	27.7	6.5	10.8	16.5	10.9	16.0	5.1	13.0	16.1	21.7	10.8	14.1	5.9	8.4	9.8	16.5	32.0	6.2	22.4	5.2	4.4	10.7	13.1	12.6	16.8	10.6	12.4	15.0	13.4	15.8	12.9	10.6	17.3	18.9	6.9	10.9	8.5	8.0	8.8	7.8	13.9	10.0	16.7	8.5	10.0	5.2	9.9	13.1	10.8	16.1	9.1	19.0	11.1	21.1	10.4	6.5	18.1	13.3	9.3	13.8	29.0	11.3	9.6	5.4	1.3	1.2	0.4	1.2	1.0	0.8	1.5	0.8	0.6	0.8	1.6	1.0	0.8	2.2	0.7	0.9	0.9	0.8	0.3	3.1	3.7	9.7	8.3	3.7	3.6	5.1	4.2	5.1	2.3	3.7	6.4	31.3	32.1	26.8	60.7	28.3	14.7	17.9	11.2	2.2	27.9	14.4	15.2	18.5	5.7	15.9	7.3	31.3	10.2	17.9	8.7	1.9	10.7	2.0	14.1	21.7	25.6	2.4	9.2	126.7	13.9	6.1	23.5	8.6	21.6	31.6	19.9	33.5	21.9	11.1	38.7	122.0	10.3	14.2	23.5	24.3	3.4	32.6	20.9	14.2	75.9	24.5	17.4	18.6	130.2	84.2	16.9	10.8	39.5	15.1	34.6	9.5	14.8	20.1	27.1	26.3	25.7	28.6	11.8	10.2	9.8	14.9	8.8	19.9	19.6	9.2	32.0
PIK3CB	PIK3C1	ENSG00000051382	"Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta"	P42338	3	138652698-138834928	"Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"	"Autophagy, Cell adhesion, Endocytosis"	"Kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 96.5;Inhibitory neurons: 92.4;Oligodendrocytes: 88.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"HEL: 115.2;HMC-1: 185.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB031938, HPA042288, HPA064207"	Approved		Supported	Nucleoplasm,Nucleoli,Vesicles,Midbody		Yes	No			"Cluster 52: Eosinophils - Transcription"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 38: Extravillous trophoblasts - Unknown function"	Nucleoplasm	"Nucleoli, Vesicles, Midbody"	"CAB031938: AB_2165408, HPA042288: , HPA064207: AB_2685212"	"unprognostic (4.89e-2)"	"unprognostic (1.42e-2)"	"unprognostic (5.97e-2)"	"unprognostic (7.85e-2)"	"unprognostic (4.89e-2)"	"unprognostic (6.01e-2)"	"prognostic unfavorable (6.42e-4)"	"unprognostic (3.98e-2)"	"unprognostic (1.35e-1)"	"unprognostic (2.28e-1)"	"prognostic unfavorable (3.99e-5)"	"unprognostic (2.15e-1)"	"unprognostic (6.18e-3)"	"unprognostic (9.33e-2)"	"unprognostic (7.82e-2)"	"unprognostic (2.79e-1)"	"unprognostic (4.59e-2)"	11.6	7.4	4.3	12.4	5.0	23.7	11.9	8.6	8.6	12.4	14.4	17.8	17.8	8.2	7.0	18.0	12.1	10.3	15.8	5.4	4.4	26.4	11.0	11.2	12.3	5.1	3.3	9.2	22.3	19.3	2.7	18.6	6.1	15.0	18.1	23.0	19.8	12.0	19.5	23.7	17.9	9.1	3.5	10.8	13.0	8.0	4.0	17.0	43.2	13.2	13.2	9.9	5.4	7.9	64.1	21.9	11.7	9.4	10.6	13.0	79.2	14.2	14.5	15.1	16.7	26.0	25.2	25.0	38.0	13.7	29.1	27.5	15.1	24.1	27.3	31.8	12.5	115.2	14.8	17.3	11.8	30.1	185.1	12.4	17.6	10.2	21.9	26.4	21.5	12.3	43.0	19.0	18.1	28.6	17.8	20.7	16.6	49.2	19.5	11.5	12.2	19.6	24.5	35.5	9.8	7.4	37.6	18.0	56.2	34.7	44.8	73.0	20.3	8.4	11.7	21.2	21.1	30.3	22.1	23.7	22.8	27.7	14.0	4.4	5.1	6.9	2.4	2.8	1.6	2.8	2.8	1.8	5.9	2.6	3.5	2.4	6.4	0.8	2.8	1.0	1.5	2.0	4.3	5.0	8.6	8.6	5.4	4.4	5.1	3.3	6.1	3.5	4.0	7.9	19.7	9.6	21.3	40.1	12.1	19.1	18.7	12.5	14.2	16.2	13.1	7.7	37.3	12.8	18.3	18.4	25.0	35.5	6.9	30.3	5.9	11.1	1.1	18.3	4.0	13.9	16.3	8.0	96.5	19.4	61.1	7.3	21.4	18.8	14.5	6.7	9.7	19.1	14.4	21.9	92.4	17.1	4.1	33.3	23.1	1.7	3.7	28.1	7.2	37.5	29.5	8.9	11.3	48.2	88.2	20.0	25.9	6.8	10.2	25.8	21.9	23.4	17.4	19.5	6.6	8.6	5.9	16.0	19.9	22.1	23.3	47.9	11.6	4.2	15.1	17.5
PIK3CG		ENSG00000105851	"Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma"	P48736	7	106865278-106908980	"Cancer-related genes, Enzymes, FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins"	"Angiogenesis, Chemotaxis, Endocytosis, Immunity, Inflammatory response"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"bone marrow: 43.6;lymphoid tissue: 19.7"	"Cell type enhanced"	"Detected in some"		"B-cells: 24.9;dendritic cells: 26.5;Early spermatids: 28.9;granulocytes: 20.8;monocytes: 23.8;NK-cells: 25.7;Plasma cells: 88.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"Daudi: 29.4;HL-60: 28.8;HMC-1: 34.9;Karpas-707: 29.1;MOLT-4: 56.0;U-266/70: 71.4;U-937: 52.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA069976	Enhanced		Supported	"Plasma membrane,Cytosol"		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 55: Plasma cells - Humoral immune response"	"Plasma membrane"	Cytosol	"HPA069976: AB_2686224"	"unprognostic (8.34e-2)"	"unprognostic (2.01e-2)"	"unprognostic (1.44e-2)"	"unprognostic (1.71e-2)"	"unprognostic (3.20e-2)"	"unprognostic (3.82e-3)"	"unprognostic (3.02e-1)"	"unprognostic (6.77e-2)"	"unprognostic (1.16e-1)"	"unprognostic (7.06e-3)"	"unprognostic (1.15e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.77e-2)"	"unprognostic (9.08e-2)"	"unprognostic (1.23e-1)"	"unprognostic (5.38e-1)"	"unprognostic (5.24e-2)"	3.1	1.8	0.5	11.5	0.6	43.6	1.9	0.8	1.3	1.9	1.3	4.2	4.1	1.3	0.5	1.7	1.4	3.2	1.6	0.5	1.0	1.0	2.0	4.9	19.0	2.5	1.3	1.6	0.3	0.7	0.2	2.9	2.7	1.0	3.8	0.1	1.3	0.9	0.3	0.8	4.3	2.7	1.8	11.0	4.0	5.2	2.0	16.4	1.1	1.0	19.7	4.3	0.2	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	29.4	2.7	0.0	0.1	0.1	0.0	0.0	0.0	0.3	0.0	17.9	0.0	0.0	0.0	28.8	34.9	0.0	0.0	0.0	0.0	0.0	11.0	16.9	20.6	29.1	0.0	0.0	56.0	17.6	0.0	0.0	0.0	14.6	0.0	19.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	20.6	2.9	0.1	0.2	0.1	0.0	71.4	0.0	27.3	0.1	52.1	6.7	10.8	6.0	24.3	8.8	17.8	8.1	7.3	4.1	6.7	9.4	10.2	4.2	5.9	22.7	9.8	43.7	8.6	4.4	6.8	0.5	0.6	0.8	1.3	0.5	1.0	2.5	1.3	2.7	1.8	2.0	3.9	1.5	0.0	1.8	0.3	24.9	0.8	0.0	0.0	0.6	0.0	0.1	0.1	0.5	0.0	0.6	0.0	0.0	0.0	26.5	0.2	0.0	0.0	28.9	0.1	0.2	1.7	0.0	7.8	5.5	0.0	0.0	0.1	3.6	0.1	20.8	0.4	2.5	0.5	6.8	0.0	0.3	0.0	0.0	11.9	8.3	18.8	0.6	18.9	7.2	15.0	23.8	0.0	25.7	0.0	0.2	0.0	0.0	0.0	88.4	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.2	6.6	3.7	0.2	0.3	0.1	18.1	0.6	0.6	0.1
PIK3R5	"p101, P101-PI3K"	ENSG00000141506	"Phosphoinositide-3-kinase regulatory subunit 5"	Q8WYR1	17	8878911-8965712	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"			"Disease variant, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 87.4"	"Cell type enhanced"	"Detected in some"		"dendritic cells: 29.9;Kupffer cells: 35.7;Langerhans cells: 40.5;Macrophages: 36.8;Microglial cells: 79.6;NK-cells: 32.0;Plasma cells: 24.7;T-cells: 25.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 39.2;HMC-1: 5.7;JURKAT: 13.7;U-937: 11.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA044505, HPA052247, HPA052412"	Uncertain		Supported	"Centriolar satellite,Cytosol"		No	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	Cytosol	"Centriolar satellite"	"HPA044505: AB_2678964, HPA052247: AB_2681772, HPA052412: AB_2681823"	"unprognostic (2.81e-1)"	"unprognostic (1.31e-2)"	"unprognostic (3.10e-2)"	"unprognostic (2.37e-2)"	"unprognostic (3.44e-2)"	"unprognostic (9.89e-3)"	"unprognostic (1.42e-1)"	"unprognostic (5.70e-2)"	"unprognostic (1.38e-1)"	"unprognostic (7.95e-2)"	"unprognostic (1.33e-2)"	"unprognostic (2.66e-1)"	"unprognostic (7.59e-3)"	"unprognostic (6.89e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.24e-1)"	6.5	3.6	1.4	19.7	1.3	87.4	2.7	1.3	7.5	2.1	1.6	3.3	3.3	1.4	0.8	2.5	3.0	6.6	1.8	1.3	1.7	1.4	2.9	14.1	13.7	4.0	2.7	0.8	1.3	0.8	0.8	3.1	3.6	1.5	2.6	0.0	2.1	1.0	0.7	1.5	9.5	3.9	2.8	22.4	3.6	2.2	6.8	12.3	1.7	0.9	8.9	6.5	1.4	5.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	39.2	0.4	1.5	0.0	0.0	0.0	0.5	5.7	0.0	0.0	0.0	0.0	0.0	0.0	13.7	0.0	0.0	0.0	0.3	1.5	2.5	0.6	0.0	0.0	4.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.2	0.0	9.5	16.1	5.7	18.1	14.3	11.8	4.3	10.1	15.6	11.5	5.7	7.5	12.0	34.4	8.6	19.0	9.0	13.2	16.2	1.4	1.3	1.3	7.5	1.3	1.7	4.0	2.7	3.6	2.8	6.8	5.4	0.2	0.0	6.1	0.7	11.7	1.0	0.0	0.0	0.0	0.0	0.2	0.3	2.1	1.5	0.0	0.0	0.0	0.1	29.9	0.0	0.0	0.1	4.5	0.1	0.1	0.7	0.0	4.0	0.3	0.0	0.3	0.5	1.5	0.1	5.1	0.0	1.4	0.4	18.3	0.0	0.5	0.0	0.0	35.7	40.5	12.2	0.3	36.8	1.8	79.6	19.8	0.0	32.0	1.0	0.3	0.0	0.0	0.0	24.7	0.1	0.0	0.2	0.0	0.0	0.0	0.4	1.4	0.6	0.4	0.1	0.9	0.4	25.7	0.0	0.0	0.0
PIM1	PIM	ENSG00000137193	"Pim-1 proto-oncogene, serine/threonine kinase"	P11309	6	37170152-37175428	"Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Apoptosis, Cell cycle"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 219.0"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 368.2;Suprabasal keratinocytes: 228.6;Urothelial cells: 455.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 321.3"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 321.3"	"Cell line enhanced"	"Detected in all"		"HEL: 219.9;HMC-1: 391.5;K-562: 192.7;U-698: 735.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003941, CAB017040"	Uncertain		Supported	Nucleoplasm,Nucleoli,Cytosol		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 55: Plasma cells - Humoral immune response"	Cytosol	"Nucleoplasm, Nucleoli"	"CAB017040: , HPA003941: AB_1079618"	"unprognostic (1.25e-2)"	"unprognostic (4.77e-1)"	"unprognostic (3.61e-2)"	"prognostic unfavorable (9.73e-4)"	"unprognostic (1.91e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.75e-1)"	"unprognostic (4.64e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.65e-2)"	"unprognostic (7.32e-2)"	"unprognostic (2.14e-3)"	"unprognostic (8.16e-3)"	"unprognostic (1.04e-1)"	"unprognostic (5.26e-3)"	"unprognostic (2.90e-1)"	152.8	14.4	8.5	42.3	8.6	219.0	46.2	10.5	10.7	82.9	10.0	45.8	39.2	46.3	2.6	201.5	66.4	52.6	65.4	7.9	11.6	27.0	58.0	49.8	38.5	15.1	12.2	60.4	20.4	3.4	14.8	28.9	12.8	22.5	17.8	8.2	41.1	7.5	36.3	109.8	44.4	38.1	12.3	61.7	40.3	10.7	11.6	26.6	22.7	5.8	26.8	101.6	113.3	12.1	19.1	7.9	12.1	6.7	27.2	14.5	141.9	6.7	20.3	13.5	21.5	28.3	26.2	38.3	10.4	8.0	30.2	21.7	12.7	20.1	12.3	174.4	8.4	219.9	8.7	37.0	27.9	3.8	391.5	49.0	24.5	12.4	8.3	14.9	4.0	9.2	192.7	59.7	2.2	5.0	12.3	19.9	22.7	35.4	12.1	29.7	22.0	45.7	3.9	114.4	58.8	11.9	14.7	1.7	3.8	27.9	3.2	6.5	7.4	7.8	23.3	35.6	8.5	28.0	15.9	735.7	3.4	55.3	8.1	321.3	8.0	113.5	60.3	7.3	77.7	7.1	53.4	53.8	6.3	5.2	47.1	36.9	61.7	39.8	4.2	1.9	41.3	42.1	8.5	8.6	10.5	10.7	7.9	11.6	15.1	12.2	12.8	12.3	11.6	12.1	41.1	22.4	16.0	2.9	35.1	127.8	166.5	63.3	26.7	4.9	9.6	5.3	36.0	18.6	37.6	9.2	0.0	36.5	55.0	50.4	5.9	40.6	4.8	40.3	125.8	33.3	37.1	368.2	2.4	17.2	121.8	67.4	26.0	92.0	49.3	27.5	11.0	33.8	53.6	15.2	2.2	12.4	44.7	44.3	47.4	12.4	8.1	53.9	44.4	4.7	72.3	7.6	112.3	1.0	0.9	60.7	34.2	3.0	190.1	109.6	51.1	17.2	12.9	1.7	0.0	34.2	41.3	14.5	33.9	92.8	228.6	80.7	118.0	1.1	7.8	455.2
PIM3		ENSG00000198355	"Pim-3 proto-oncogene, serine/threonine kinase"	Q86V86	22	49960768-49964072	"Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Cell cycle"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Langerhans cells: 408.4;Syncytiotrophoblasts: 389.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 20.7"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Karpas-707: 163.3;SK-BR-3: 144.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA068758			Supported	Cytosol		NA	Yes			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 72: Non-specific - Transcription"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 41: Macrophages - Immune response"	Cytosol		"HPA068758: AB_2686026"	"unprognostic (3.67e-2)"	"unprognostic (7.69e-3)"	"unprognostic (1.07e-1)"	"unprognostic (1.11e-1)"	"unprognostic (3.67e-2)"	"unprognostic (5.83e-2)"	"unprognostic (1.48e-2)"	"unprognostic (1.13e-2)"	"unprognostic (2.71e-2)"	"prognostic unfavorable (9.68e-4)"	"unprognostic (2.00e-2)"	"unprognostic (1.00e-1)"	"prognostic favorable (8.09e-4)"	"unprognostic (5.59e-3)"	"unprognostic (1.71e-1)"	"unprognostic (3.92e-3)"	"unprognostic (7.27e-3)"	97.8	48.4	25.9	31.3	31.3	114.3	80.2	32.8	38.1	49.2	26.9	55.1	23.8	40.8	12.7	80.8	54.0	25.8	68.7	25.2	32.6	113.3	92.9	107.1	28.2	40.6	36.1	35.7	73.1	21.6	51.3	21.3	38.0	87.3	10.4	3.1	93.5	22.6	112.0	116.4	51.6	9.9	30.3	80.7	118.1	33.9	35.2	19.0	54.9	35.0	13.0	71.0	68.6	39.9	26.8	17.7	11.6	21.9	9.0	6.7	65.5	16.5	26.7	19.4	14.0	29.5	22.3	47.3	20.1	4.6	39.1	22.5	22.3	12.6	6.9	35.8	92.1	19.5	46.3	36.0	41.8	42.5	36.0	12.8	41.0	11.9	20.2	10.5	63.5	31.7	27.0	163.3	5.9	60.6	21.7	76.4	24.2	28.1	27.8	100.3	19.2	57.6	10.6	20.3	41.1	28.6	32.2	144.7	109.2	10.7	19.0	56.4	16.8	12.1	51.5	19.8	27.1	82.2	56.9	41.4	30.1	24.1	33.2	0.0	4.0	0.1	2.2	4.1	2.5	4.3	5.0	4.4	3.1	7.5	4.8	1.9	20.7	1.7	5.2	7.0	5.8	2.7	25.9	31.3	32.8	38.1	25.2	32.6	40.6	36.1	38.0	30.3	35.2	39.9	120.2	64.1	85.9	6.5	107.7	227.3	236.8	79.1	96.8	31.5	99.2	67.3	32.8	121.5	72.8	80.9	2.1	56.9	79.5	57.9	84.1	50.9	5.1	114.2	76.3	167.7	97.7	10.8	10.2	54.5	346.5	69.0	202.3	170.5	69.3	16.8	98.6	45.9	69.7	62.2	6.7	101.7	81.4	41.1	408.4	4.8	32.3	134.8	108.5	6.5	35.8	14.0	11.3	6.6	20.5	71.0	94.6	11.3	95.1	298.4	58.1	88.5	40.9	16.5	26.3	39.4	57.3	26.1	37.7	95.3	204.7	389.9	90.4	11.6	79.0	266.0
PIN4	"EPVH, PAR14, PAR17"	ENSG00000102309	"Peptidylprolyl cis/trans isomerase, NIMA-interacting 4"	Q9Y237	X	72181353-72302926	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"DNA-binding, Isomerase, Rotamase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054483, HPA064504"	Approved		Supported	"Nucleoplasm,Nucleoli,Mitotic chromosome"		Yes	No			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoplasm, Nucleoli"	"Mitotic chromosome"	"HPA054483: AB_2682503, HPA064504: AB_2685274"	"unprognostic (2.47e-1)"	"unprognostic (6.97e-3)"	"unprognostic (1.65e-1)"	"unprognostic (3.77e-2)"	"unprognostic (8.42e-2)"	"unprognostic (1.30e-2)"	"unprognostic (1.14e-2)"	"prognostic favorable (6.37e-4)"	"unprognostic (1.56e-1)"	"unprognostic (2.13e-2)"	"unprognostic (2.49e-1)"	"unprognostic (9.54e-2)"	"unprognostic (2.09e-3)"	"unprognostic (1.92e-1)"	"prognostic favorable (2.58e-4)"	"unprognostic (3.34e-3)"	"prognostic favorable (2.66e-4)"	14.1	14.8	23.5	10.4	24.0	8.7	16.9	25.2	36.3	15.2	24.0	16.2	11.5	14.7	21.5	14.4	12.9	7.3	19.0	23.6	24.8	19.7	28.6	10.6	10.5	24.4	24.2	16.1	13.1	20.4	13.9	11.8	24.2	15.6	12.7	18.3	16.1	10.1	19.4	10.6	12.7	10.8	24.0	13.9	15.8	5.7	23.8	17.5	16.5	20.4	11.1	13.2	14.9	25.4	36.8	41.2	42.5	29.9	28.1	23.4	23.1	24.6	26.8	28.7	29.1	20.8	26.4	11.2	68.6	25.2	39.2	25.8	38.6	43.0	35.6	26.9	83.3	18.8	51.1	55.3	14.9	29.9	14.8	15.7	22.5	32.0	11.1	32.4	29.1	32.5	32.1	46.6	20.4	43.4	25.3	49.9	30.3	42.4	36.7	25.8	34.7	32.3	37.1	24.7	27.0	48.1	28.5	13.3	27.0	32.0	20.3	25.9	30.7	13.4	19.9	36.8	17.7	15.4	18.5	17.9	38.5	28.3	14.7	42.7	37.1	40.6	41.8	41.1	41.7	49.2	43.7	40.3	38.0	45.6	44.1	44.8	15.7	41.1	39.4	44.6	58.1	39.6	23.5	24.0	25.2	36.3	23.6	24.8	24.4	24.2	24.2	24.0	23.8	25.4	68.3	67.3	48.2	14.0	44.4	43.2	63.3	167.9	36.5	26.7	67.2	94.5	84.9	78.6	89.4	119.5	8.4	162.8	44.5	99.2	181.9	125.0	13.5	78.6	66.7	71.5	92.7	71.7	17.8	117.9	89.0	59.9	45.3	56.6	57.6	46.3	92.4	288.5	110.3	28.6	17.8	93.7	128.1	72.9	44.9	9.3	74.6	50.7	60.5	7.5	69.6	90.7	80.3	16.6	27.3	136.3	114.9	81.3	38.7	51.5	162.0	296.1	95.9	42.9	85.5	65.9	94.6	19.6	42.6	51.3	46.9	120.7	44.8	53.9	88.5	54.8
PINX1	"FLJ20565, Gno1, LPTL, LPTS, MGC8850, Pxr1"	ENSG00000254093	"PIN2 (TERF1) interacting telomerase inhibitor 1"	Q96BK5	8	10764961-10839884	"Predicted intracellular proteins"			"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"Cytotrophoblasts: 20.0;Extravillous trophoblasts: 13.0;Hofbauer cells: 16.1;Syncytiotrophoblasts: 48.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023139, HPA023146"	Uncertain		Supported	Nucleoplasm,Nucleoli,Mitochondria		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	Nucleoli	"Nucleoplasm, Mitochondria"	"HPA023139: AB_1855384, HPA023146: "	"unprognostic (4.01e-1)"	"prognostic favorable (2.45e-5)"	"unprognostic (7.80e-3)"	"unprognostic (3.35e-2)"	"unprognostic (4.10e-1)"	"unprognostic (4.61e-2)"	"unprognostic (1.83e-2)"	"unprognostic (3.40e-2)"	"unprognostic (9.73e-3)"	"unprognostic (2.49e-1)"	"unprognostic (1.40e-1)"	"unprognostic (4.37e-1)"	"unprognostic (2.59e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.45e-1)"	"unprognostic (2.08e-2)"	9.9	7.7	7.2	8.9	8.4	9.1	9.9	8.9	8.9	9.7	6.1	9.9	6.2	9.3	4.5	12.1	8.8	4.0	8.2	7.4	7.1	11.6	11.7	8.0	11.5	7.2	7.1	9.8	9.0	6.1	6.4	7.2	7.4	8.1	6.1	12.0	7.3	4.2	13.5	14.4	7.7	8.5	7.0	9.3	8.2	9.7	7.4	13.0	8.2	9.3	11.1	10.2	10.5	7.7	14.5	18.9	20.1	19.2	16.6	13.5	23.1	21.5	9.7	23.2	15.6	20.0	12.4	38.5	7.4	11.7	28.3	28.6	51.4	39.9	29.8	15.7	15.3	16.2	13.3	22.0	18.8	17.4	9.7	11.3	24.9	18.3	34.0	8.2	32.7	25.8	52.3	23.1	22.9	17.1	57.7	21.8	46.3	62.6	21.0	46.5	24.5	35.2	17.5	17.5	16.6	17.3	14.5	17.0	48.3	24.3	18.1	21.7	20.0	13.9	30.3	18.0	28.1	10.3	29.0	71.2	14.4	32.6	32.1	1.9	8.4	6.1	14.6	10.7	18.9	12.9	12.8	15.6	11.1	10.8	17.1	13.5	0.5	12.5	9.9	8.6	16.1	10.4	7.2	8.4	8.9	8.9	7.4	7.1	7.2	7.1	7.4	7.0	7.4	7.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	20.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	13.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	16.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	48.2	0.0	0.0	0.0	0.0
PIP4K2A	"PIP5K2A, PIP5KIIA, PIP5KIIalpha"	ENSG00000150867	"Phosphatidylinositol-5-phosphate 4-kinase type 2 alpha"	P48426	10	22534854-22714578	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	6	"brain: 498.1"	"Cell type enriched"	"Detected in many"	6	"Oligodendrocytes: 1585.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA065440, HPA068771"	Supported		Approved	"Golgi apparatus,Plasma membrane,Cytosol"		NA	NA		4900000	"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 70: Brain - Nervous system development"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Golgi apparatus"	"Plasma membrane, Cytosol"	"HPA065440: AB_2685490, HPA068771: AB_2686030"	"unprognostic (1.11e-1)"	"unprognostic (2.71e-3)"	"unprognostic (1.57e-3)"	"unprognostic (4.20e-3)"	"unprognostic (1.55e-1)"	"unprognostic (8.80e-3)"	"unprognostic (1.56e-3)"	"unprognostic (7.32e-2)"	"unprognostic (1.68e-1)"	"unprognostic (7.08e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.21e-1)"	"prognostic unfavorable (1.46e-4)"	"unprognostic (1.52e-3)"	"unprognostic (2.51e-1)"	"unprognostic (1.38e-1)"	"unprognostic (7.92e-3)"	28.4	15.5	162.5	47.8	329.4	44.8	15.0	239.0	239.9	26.5	49.8	17.8	13.2	21.1	11.8	19.8	15.2	32.9	13.5	169.7	193.6	16.5	18.6	25.9	81.2	260.6	273.4	8.8	10.9	24.8	8.5	23.7	271.7	9.3	19.1	15.3	7.8	13.0	5.1	8.3	20.6	31.5	171.8	62.6	19.3	12.5	233.3	60.4	12.8	10.9	88.5	24.1	10.5	498.1	30.2	29.2	33.4	10.8	52.3	70.6	25.3	55.0	58.1	29.1	35.7	27.6	47.2	63.2	19.4	111.0	63.7	10.4	29.2	15.4	29.2	140.5	30.4	118.7	21.6	60.9	92.5	23.1	89.1	35.6	13.7	39.7	38.2	44.6	43.7	83.5	67.4	119.1	54.5	12.5	92.3	20.5	13.7	14.5	20.7	36.9	47.8	86.3	43.0	5.8	6.1	13.9	17.7	9.0	86.4	37.6	7.6	39.1	53.0	22.3	32.8	41.7	33.9	75.1	46.3	45.0	60.5	68.3	17.6	72.6	32.6	104.0	119.5	57.9	164.0	52.1	94.2	139.9	43.7	33.1	62.8	118.2	40.5	144.2	67.3	44.8	75.9	183.4	162.5	329.4	239.0	239.9	169.7	193.6	260.6	273.4	271.7	171.8	233.3	498.1	22.5	3.2	6.7	84.9	43.2	17.6	4.0	2.0	3.4	5.7	12.9	5.5	8.1	14.3	5.6	18.4	2.1	8.6	196.9	3.4	11.7	9.7	22.9	7.4	15.7	29.2	4.9	236.9	65.6	10.7	5.4	19.6	6.6	24.8	22.8	13.4	62.4	8.7	31.8	13.5	62.0	2.9	0.0	98.6	80.0	34.5	16.8	82.8	104.9	142.4	81.3	5.0	159.6	167.9	1585.0	22.1	3.7	10.1	36.4	7.1	1.0	15.6	2.2	9.1	19.7	14.1	30.6	6.1	7.9	3.3	16.9	12.4	130.7	8.5	2.8	6.6
PIP4K2B	"PIP5K2B, PIP5KIIB, PIP5KIIbeta"	ENSG00000276293	"Phosphatidylinositol-5-phosphate 4-kinase type 2 beta"	P78356	17	38765691-38800126	"Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA062220			Supported	Nucleoplasm		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 12: NES - Nervous system development"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA062220: AB_2684715"	"unprognostic (7.77e-2)"	"unprognostic (8.37e-2)"	"unprognostic (3.74e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.67e-1)"	"unprognostic (1.91e-1)"	"prognostic unfavorable (4.54e-4)"	"unprognostic (2.64e-1)"	"unprognostic (2.33e-1)"	"unprognostic (1.50e-2)"	"unprognostic (6.10e-3)"	"unprognostic (3.79e-1)"	"unprognostic (4.82e-3)"	"unprognostic (3.38e-2)"	"unprognostic (3.22e-1)"	"prognostic favorable (1.36e-4)"	"unprognostic (2.48e-1)"	19.9	27.0	82.5	15.5	85.6	7.3	20.8	62.3	93.9	30.1	43.3	24.2	10.3	28.8	23.3	15.4	29.1	16.3	30.2	90.7	75.2	20.1	14.4	21.4	20.5	65.9	65.7	49.8	16.4	16.6	25.2	22.8	67.1	22.2	14.0	36.0	16.9	25.3	99.0	24.6	17.3	29.5	63.2	23.2	16.4	13.0	80.4	23.4	20.3	75.6	20.4	22.9	20.9	81.4	18.1	40.2	66.0	69.9	56.7	45.5	12.2	31.6	38.2	43.1	35.0	28.2	18.4	44.8	17.2	59.8	36.3	35.9	44.9	28.7	41.4	27.8	17.2	38.4	27.3	40.7	26.2	43.7	23.5	40.0	34.2	33.7	24.2	59.2	36.3	48.6	34.2	22.3	46.8	14.2	44.0	34.0	32.0	20.7	15.8	44.6	63.7	25.6	31.3	22.3	34.0	46.1	30.9	13.9	34.5	68.5	43.6	44.5	33.4	35.8	21.6	29.4	28.9	27.4	36.5	19.7	42.0	36.8	32.9	1.3	1.9	0.6	3.4	1.6	3.5	2.3	2.9	3.3	2.4	2.3	3.2	2.9	1.8	2.8	1.4	2.2	3.0	3.3	82.5	85.6	62.3	93.9	90.7	75.2	65.9	65.7	67.1	63.2	80.4	81.4	15.8	19.2	11.4	21.5	6.7	6.1	3.5	4.6	7.4	31.6	11.5	13.3	23.4	4.3	7.5	5.5	10.4	7.0	14.8	3.7	1.9	5.3	9.2	10.8	17.7	17.3	11.5	9.0	33.5	4.9	5.0	13.8	5.6	9.0	1.3	22.6	18.2	12.7	8.8	43.7	29.1	7.4	2.0	11.3	4.9	21.1	15.2	8.6	1.8	18.7	6.9	14.8	10.3	22.1	24.0	6.0	4.1	16.6	6.2	4.9	5.4	7.7	6.4	14.0	6.6	13.8	13.2	4.6	7.4	9.9	4.4	2.5	8.1	17.3	7.2	2.7
PIP4K2C	"FLJ22055, PIP5K2C"	ENSG00000166908	"Phosphatidylinositol-5-phosphate 4-kinase type 2 gamma"	Q8TBX8	12	57591174-57603418	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 121.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"RH-30: 130.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028658	Approved		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 68: Epididymis - Unknown function"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 43: Cardiomyocytes - Nuclear processes"	Cytosol	"Nucleoplasm, Plasma membrane"	"HPA028658: AB_10601245"	"unprognostic (7.84e-3)"	"unprognostic (1.51e-1)"	"unprognostic (2.42e-1)"	"unprognostic (2.77e-2)"	"unprognostic (2.49e-2)"	"unprognostic (3.37e-2)"	"prognostic unfavorable (7.98e-4)"	"unprognostic (3.17e-2)"	"unprognostic (6.00e-2)"	"unprognostic (5.51e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.88e-1)"	"prognostic favorable (2.06e-6)"	"unprognostic (1.87e-1)"	"unprognostic (2.16e-1)"	"unprognostic (3.27e-1)"	"unprognostic (3.42e-1)"	13.6	17.2	18.4	11.6	24.0	26.5	20.0	13.4	32.8	18.4	20.7	24.1	16.0	18.5	81.6	28.2	26.6	16.1	15.0	22.3	11.5	36.0	14.8	19.7	13.5	14.9	13.0	16.0	21.0	39.1	18.7	12.1	16.0	21.6	26.3	29.1	25.6	18.4	14.0	27.1	19.2	15.9	11.9	14.6	39.8	28.1	15.7	11.4	22.4	10.5	18.8	18.2	20.5	20.9	52.0	36.4	14.8	17.6	0.0	0.1	47.0	21.4	40.6	38.7	35.1	46.7	73.4	11.3	44.1	25.6	47.4	46.1	24.2	42.2	30.3	15.9	26.1	20.0	17.5	33.7	32.8	19.3	35.0	12.9	70.0	14.7	26.9	46.4	19.6	12.1	26.8	33.3	20.0	52.6	16.5	16.7	28.1	32.1	31.2	0.5	130.9	17.2	39.6	91.1	23.7	30.0	45.8	30.4	29.7	49.3	83.2	17.8	4.2	18.5	26.1	27.7	22.8	25.1	31.5	25.6	36.0	16.0	32.1	58.8	8.2	25.8	24.3	10.5	16.1	8.7	14.8	18.4	8.6	11.0	13.8	16.7	16.3	16.2	14.6	3.8	19.9	11.0	18.4	24.0	13.4	32.8	22.3	11.5	14.9	13.0	16.0	11.9	15.7	20.9	4.1	9.6	8.6	4.9	6.9	12.4	6.2	11.7	10.8	14.3	13.2	8.0	121.7	12.8	11.9	35.0	18.8	11.3	7.4	33.7	21.5	17.7	25.7	14.2	4.2	8.8	22.2	5.2	28.0	19.7	15.2	5.4	26.0	20.3	3.8	4.0	9.3	12.6	8.9	8.4	11.8	18.4	10.2	6.0	2.2	47.9	6.8	5.7	12.4	2.8	5.9	7.5	5.2	5.0	11.5	40.5	12.8	5.3	9.4	10.1	14.2	13.3	15.3	8.1	19.7	3.8	13.1	12.0	9.0	14.3	12.8	17.4	11.9	5.5	10.4	9.2
PIP5K1A		ENSG00000143398	"Phosphatidylinositol-4-phosphate 5-kinase type 1 alpha"	Q99755	1	151197949-151249536	"Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029366	Approved		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 44: Endometrium - Transcription"	"Plasma membrane, Cytosol"	Nucleoplasm	"HPA029366: AB_10602116"	"unprognostic (1.05e-1)"	"unprognostic (2.36e-2)"	"unprognostic (8.64e-2)"	"unprognostic (7.94e-3)"	"unprognostic (1.17e-1)"	"unprognostic (3.28e-2)"	"unprognostic (1.26e-2)"	"unprognostic (3.01e-1)"	"unprognostic (8.79e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.04e-1)"	"prognostic unfavorable (4.16e-7)"	"unprognostic (1.44e-1)"	"unprognostic (8.14e-2)"	"unprognostic (2.93e-1)"	"unprognostic (1.59e-1)"	20.1	19.1	16.0	16.1	17.3	9.7	19.5	17.8	19.2	18.9	20.8	17.2	16.2	18.8	21.1	20.4	18.9	19.7	19.8	16.8	17.3	21.9	18.6	21.8	18.7	15.1	15.7	18.7	13.6	23.0	21.5	25.9	14.7	16.7	15.1	30.1	16.9	14.1	29.2	21.0	16.9	20.3	14.2	19.0	16.6	35.1	16.9	24.7	18.4	25.4	20.1	20.5	17.4	18.4	49.3	37.4	57.7	67.6	37.5	38.8	56.7	63.5	89.3	116.6	103.7	68.7	46.8	43.9	66.8	67.9	52.7	42.0	75.7	42.6	101.2	68.8	54.0	36.0	48.4	33.9	70.1	64.9	43.8	51.1	40.3	72.7	90.7	52.1	48.8	69.4	35.6	36.7	60.4	69.9	63.6	32.4	86.0	38.2	58.3	60.5	50.7	34.1	61.2	27.1	38.6	49.4	87.1	66.6	57.4	96.4	69.2	59.4	47.4	46.6	64.7	42.6	77.0	50.5	93.6	99.3	44.7	18.6	56.6	0.1	3.9	5.7	3.7	4.7	2.8	6.6	3.3	4.1	6.4	3.0	3.7	2.9	8.9	3.9	3.8	6.7	3.1	4.7	16.0	17.3	17.8	19.2	16.8	17.3	15.1	15.7	14.7	14.2	16.9	18.4	11.6	32.1	12.2	43.8	21.3	66.2	23.2	17.0	39.9	34.1	31.3	22.0	18.4	17.2	15.3	31.3	98.0	25.9	18.3	12.7	9.8	13.5	4.9	64.0	26.2	15.6	6.0	12.4	59.6	8.7	29.3	19.8	19.4	71.0	12.0	19.9	14.3	14.3	12.8	26.9	51.2	9.7	18.3	10.7	29.5	4.8	13.4	14.9	12.4	44.0	12.2	12.5	9.2	54.8	64.0	19.4	8.9	10.9	16.8	20.9	21.0	10.1	18.4	43.0	13.1	17.4	20.9	52.1	24.6	38.4	50.0	63.5	15.9	18.4	10.7	39.4
PIP5KL1	"bA203J24.5, MGC46424"	ENSG00000167103	"Phosphatidylinositol-4-phosphate 5-kinase like 1"	Q5T9C9	9	127920881-127930785	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 22.6;Late spermatids: 24.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"Karpas-707: 45.5;RPMI-8226: 31.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			HPA056240	Uncertain		Supported	Cytosol		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 71: Testis - DNA repair"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 34: Spermatids - Unknown function"	Cytosol		"HPA056240: AB_2683075"	"unprognostic (2.15e-2)"	"unprognostic (3.06e-1)"	"unprognostic (1.23e-3)"	"unprognostic (8.51e-5)"	"unprognostic (1.44e-2)"	"unprognostic (4.62e-2)"	"unprognostic (1.19e-1)"	"unprognostic (6.29e-2)"	"unprognostic (5.20e-2)"	"unprognostic (5.50e-2)"	"unprognostic (2.49e-2)"	"unprognostic (1.57e-3)"	"unprognostic (9.95e-8)"	"unprognostic (1.87e-1)"	"unprognostic (7.21e-2)"	"unprognostic (6.05e-2)"	"unprognostic (1.59e-1)"	0.6	0.2	1.0	0.0	1.0	0.6	1.7	1.6	1.8	2.3	0.2	1.0	0.1	1.3	0.2	3.2	1.7	0.3	0.2	0.9	1.0	1.3	0.2	1.9	0.1	2.1	0.8	0.9	1.3	2.9	3.8	0.6	2.4	3.1	0.0	0.2	3.2	1.4	0.1	3.9	0.5	0.3	0.7	0.6	1.4	2.5	1.3	0.1	1.7	0.0	0.2	1.0	3.6	1.0	0.0	0.7	0.7	0.8	0.8	1.9	4.1	0.8	0.8	0.2	0.2	0.3	5.5	0.5	1.6	3.7	1.6	1.7	0.0	4.1	0.2	0.3	2.7	0.0	1.4	0.1	1.3	0.0	0.2	2.1	2.6	0.6	0.0	1.3	0.0	3.7	0.0	45.5	0.0	4.0	0.0	1.6	0.4	1.7	0.6	0.4	0.1	31.5	0.0	0.1	1.4	2.7	0.3	1.0	0.0	0.4	1.7	2.2	0.6	0.5	1.3	0.9	0.1	4.0	2.8	1.0	8.0	0.6	0.5	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.0	1.0	1.6	1.8	0.9	1.0	2.1	0.8	2.4	0.7	1.3	1.0	0.5	0.0	9.3	0.3	1.1	2.2	4.7	5.1	8.6	0.7	3.2	4.7	0.5	0.0	2.0	5.5	0.0	0.9	1.5	0.6	1.9	1.4	22.6	2.3	3.5	0.8	0.0	3.2	0.9	1.5	4.4	0.9	7.7	4.1	0.0	1.7	0.4	0.3	0.3	5.0	1.7	0.4	2.0	0.3	0.6	24.6	0.9	0.3	0.0	0.0	0.2	1.9	0.0	0.0	0.1	1.2	0.1	0.4	2.0	2.9	0.1	0.1	7.4	0.8	0.0	1.0	1.3	1.8	2.2	2.3	1.1	3.1	0.9	1.2	0.7	2.1
PIR		ENSG00000087842	Pirin	O00625	X	15384799-15493564	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Dioxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 96.1;Syncytiotrophoblasts: 85.6"	"Cancer enhanced"	"Detected in all"		"melanoma: 48.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"GAMG: 292.4;HUVEC TERT2: 683.9;SK-MEL-30: 267.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000697	Approved		Supported	Cytosol		NA	NA		35000	"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 47: Cytotrophoblasts - Unknown function"	Cytosol		"HPA000697: AB_1079621"	"unprognostic (3.46e-3)"	"prognostic favorable (2.78e-4)"	"unprognostic (4.26e-2)"	"unprognostic (5.62e-3)"	"unprognostic (4.16e-3)"	"unprognostic (2.09e-2)"	"unprognostic (6.70e-3)"	"unprognostic (1.65e-1)"	"unprognostic (1.08e-1)"	"prognostic favorable (4.94e-4)"	"unprognostic (3.78e-2)"	"unprognostic (1.92e-1)"	"prognostic unfavorable (6.11e-7)"	"unprognostic (1.99e-2)"	"unprognostic (8.90e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.44e-1)"	19.1	19.9	20.2	5.2	23.7	5.7	15.4	23.5	24.3	12.4	21.2	10.0	6.5	11.7	15.3	29.6	13.3	11.4	17.3	18.7	22.9	11.4	21.0	15.4	2.7	23.0	22.6	13.1	3.3	4.9	11.3	10.5	22.8	10.1	6.7	7.9	10.3	14.2	14.7	11.9	8.6	10.4	22.5	20.1	11.9	6.2	22.5	6.2	15.7	6.4	7.1	30.4	17.4	25.7	14.3	76.6	45.0	66.3	26.1	29.0	14.4	4.2	26.5	11.0	24.5	21.5	118.9	0.0	147.2	12.3	292.4	96.7	52.8	21.3	4.0	0.0	11.6	8.4	80.7	63.9	33.4	4.4	29.8	8.3	72.3	41.9	14.4	19.2	683.9	0.0	6.4	19.2	9.4	29.8	3.3	4.1	48.4	62.1	47.7	0.0	8.9	37.9	22.2	136.0	17.2	47.5	36.7	20.5	267.9	76.8	42.4	26.7	43.2	5.9	11.0	28.5	8.7	9.1	39.6	0.3	28.6	15.8	59.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	20.2	23.7	23.5	24.3	18.7	22.9	23.0	22.6	22.8	22.5	22.5	25.7	24.5	0.0	4.1	0.0	1.1	8.7	24.3	48.4	10.8	2.8	4.2	4.8	5.8	10.0	19.4	1.8	0.0	96.1	0.0	4.8	9.8	5.9	0.6	59.6	3.8	40.3	11.3	11.6	0.2	2.5	12.8	15.6	15.8	20.0	0.0	21.7	22.9	24.0	22.0	20.2	0.2	3.4	38.7	6.4	3.4	4.0	37.6	4.1	40.9	0.0	11.9	30.8	0.0	0.0	0.0	3.4	1.7	28.6	3.6	18.1	5.9	12.0	38.0	4.8	13.1	8.4	11.3	0.6	3.5	34.5	12.6	85.6	0.6	56.2	4.3	50.9
PITPNM1	"DRES9, NIR2, PITPNM, Rd9, RDGB, RDGB1, RDGBA1"	ENSG00000110697	"Phosphatidylinositol transfer protein membrane associated 1"	O00562	11	67491768-67506263	"Predicted intracellular proteins, Transporters"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 64.6;Distal enterocytes: 69.9;Endometrial ciliated cells: 63.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"HDLM-2: 91.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA060227	Approved		Supported	Vesicles,Cytosol		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 20: Retina & Lymphoid tissues - Unknown function"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Cytosol	Vesicles	"HPA060227: AB_2684226"	"unprognostic (1.13e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.69e-2)"	"unprognostic (1.71e-1)"	"unprognostic (2.83e-2)"	"unprognostic (8.68e-2)"	"unprognostic (8.16e-2)"	"unprognostic (4.55e-2)"	"unprognostic (1.77e-1)"	"unprognostic (2.26e-2)"	"unprognostic (4.61e-1)"	"unprognostic (3.27e-2)"	"unprognostic (2.32e-2)"	"unprognostic (1.14e-2)"	"unprognostic (1.58e-1)"	"unprognostic (4.62e-2)"	"unprognostic (5.69e-2)"	10.6	24.5	19.6	24.3	12.6	26.8	6.4	6.1	23.2	10.7	13.9	14.4	18.7	9.3	2.4	19.5	23.1	9.0	22.3	13.3	23.8	37.8	11.0	16.3	27.6	14.2	31.0	4.0	9.8	10.3	26.7	8.0	13.5	10.4	7.5	40.7	8.7	10.3	6.9	5.0	21.1	5.9	2.3	21.6	16.0	8.8	51.5	17.4	15.7	18.4	17.2	16.2	9.3	5.5	12.7	31.2	18.8	13.9	20.3	12.1	30.5	12.2	21.5	14.8	8.4	28.5	22.6	12.5	28.7	17.5	28.4	32.4	14.5	27.0	4.8	91.0	6.0	17.0	55.8	10.8	16.0	19.4	35.3	15.0	17.0	22.4	14.7	27.4	17.9	18.7	13.2	11.0	12.5	19.1	33.2	45.6	19.3	35.9	13.5	23.7	6.0	17.3	24.4	25.1	18.1	11.5	27.3	37.6	29.6	9.0	7.4	16.9	17.7	26.5	20.1	16.9	8.9	16.0	8.3	11.2	37.1	22.7	10.6	0.0	1.4	0.9	1.1	3.3	1.0	0.7	0.8	1.0	1.0	0.5	0.3	0.8	1.4	0.1	2.7	0.4	0.7	1.1	19.6	12.6	6.1	23.2	13.3	23.8	14.2	31.0	13.5	2.3	51.5	5.5	7.5	3.2	5.8	2.0	10.8	8.2	6.3	9.3	13.6	45.7	5.4	5.2	8.4	5.7	9.7	20.2	64.6	4.6	10.6	69.9	3.9	11.3	6.1	63.3	16.5	4.9	11.4	0.4	5.1	9.3	8.9	4.2	34.7	24.6	2.5	7.1	3.3	3.4	8.4	38.7	6.6	16.8	10.2	13.2	14.0	17.0	2.1	15.2	3.6	10.3	13.5	20.7	3.1	0.5	0.5	15.9	32.7	1.2	7.5	9.8	39.0	18.9	37.8	53.7	0.0	6.3	9.8	1.4	5.5	11.2	3.3	15.2	14.9	1.4	24.0	19.4
PITPNM2	"NIR3, RDGB2, RDGBA2"	ENSG00000090975	"Phosphatidylinositol transfer protein membrane associated 2"	Q9BZ72	12	122983480-123150015	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"lymphoid tissue: 87.3"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 33.6;Cone photoreceptor cells: 54.2;Excitatory neurons: 51.3;Horizontal cells: 40.4;Inhibitory neurons: 41.3;Late spermatids: 87.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in single"		"NK-cell: 1.9"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"HEL: 29.5;JURKAT: 35.6;MOLT-4: 55.0;WM-115: 25.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003414, HPA003978"	Approved		Supported	Vesicles		NA	NA			"Cluster 22: NK-cells - Unknown function"	"Cluster 63: T-cells - Adaptive immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 25: Spermatids - Spermatogenesis"	Vesicles		"HPA003414: AB_1855410, HPA003978: AB_1855411"	"unprognostic (2.43e-1)"	"unprognostic (9.29e-2)"	"unprognostic (2.00e-1)"	"unprognostic (5.39e-2)"	"unprognostic (2.14e-1)"	"unprognostic (6.76e-2)"	"unprognostic (2.26e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.55e-1)"	"unprognostic (6.44e-2)"	"unprognostic (1.03e-1)"	"unprognostic (9.28e-2)"	"unprognostic (1.50e-3)"	"unprognostic (7.66e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.19e-2)"	"unprognostic (9.99e-2)"	4.6	9.0	11.4	4.6	12.3	5.2	3.7	6.7	15.6	6.1	18.7	5.7	4.7	4.6	3.7	4.7	3.7	2.6	4.9	13.1	1.8	8.7	11.0	6.8	3.2	4.9	3.6	15.3	3.5	6.6	8.4	3.6	1.6	3.5	2.5	15.2	2.4	3.8	5.0	4.1	4.9	5.7	0.4	4.4	4.6	7.3	4.9	87.3	3.7	3.3	1.9	7.0	4.9	3.8	4.6	8.7	2.8	4.1	1.9	3.7	16.8	0.7	1.1	2.3	1.2	3.8	3.7	0.0	3.7	1.5	4.8	12.8	2.3	2.2	0.8	0.3	2.8	29.5	5.7	10.5	1.3	1.1	6.0	1.8	3.8	3.0	2.3	10.8	4.5	35.6	6.8	0.3	2.9	2.9	55.0	6.1	3.2	1.4	3.9	15.7	0.2	11.4	4.1	4.7	2.5	0.9	6.3	5.2	4.1	1.6	1.1	3.1	13.3	3.3	3.7	5.4	5.1	0.8	1.0	20.4	8.2	2.2	25.4	0.0	0.0	0.0	0.7	0.0	0.0	0.1	0.2	0.6	0.0	0.2	0.5	0.4	0.0	1.9	0.0	0.0	0.3	0.7	11.4	12.3	6.7	15.6	13.1	1.8	4.9	3.6	1.6	0.4	4.9	3.8	16.2	0.0	5.0	33.6	2.8	3.6	0.7	0.7	2.2	19.6	1.5	1.5	7.3	2.8	1.6	9.2	54.2	1.3	6.3	6.3	1.9	3.3	33.0	3.7	3.6	9.3	0.0	1.7	51.3	4.5	6.5	3.8	2.0	5.2	1.3	0.8	6.4	16.3	0.5	40.4	41.3	3.7	0.0	0.6	1.1	87.7	1.8	3.6	1.8	10.3	1.3	3.7	10.3	22.1	1.8	3.9	0.3	4.9	2.2	1.1	6.1	2.6	0.1	15.8	0.0	2.1	2.5	8.2	4.7	3.6	1.6	3.7	4.8	0.4	2.6	0.6
PITRM1	"hMP1, KIAA1104, MP1, PreP"	ENSG00000107959	"Pitrilysin metallopeptidase 1"	Q5JRX3	10	3137728-3172841	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 186.1;Late spermatids: 98.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006753, HPA006754"	Enhanced		Supported	Mitochondria		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 59: Non-specific - Translation"	"Cluster 18: U-2197 - ECM organization"	"Cluster 34: Spermatids - Unknown function"	Mitochondria		"HPA006753: AB_1079624, HPA006754: AB_1079623"	"unprognostic (1.83e-3)"	"unprognostic (7.01e-3)"	"unprognostic (2.19e-1)"	"unprognostic (1.69e-1)"	"unprognostic (3.20e-2)"	"unprognostic (6.67e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.78e-1)"	"unprognostic (6.31e-2)"	"unprognostic (3.41e-1)"	"unprognostic (1.00e-2)"	"unprognostic (3.32e-1)"	"unprognostic (7.10e-2)"	"unprognostic (3.99e-1)"	"unprognostic (5.80e-2)"	"unprognostic (4.76e-3)"	"unprognostic (2.08e-2)"	40.8	64.9	22.7	19.1	24.9	26.0	36.9	23.8	34.2	40.9	22.9	40.9	19.6	40.5	23.8	38.4	38.0	18.3	60.2	25.2	24.5	50.5	44.9	40.4	21.0	25.3	26.0	54.4	41.1	33.3	42.3	17.0	26.0	42.6	22.1	49.6	41.3	22.1	94.9	39.2	32.7	25.8	21.0	30.4	37.0	43.6	26.1	42.4	41.7	59.6	21.7	43.6	38.4	28.5	81.8	67.2	21.7	31.7	62.1	67.6	22.3	125.9	51.0	92.5	49.1	55.5	45.5	38.5	39.5	70.7	33.2	55.8	37.8	82.4	74.3	72.3	55.0	61.1	42.9	39.2	36.2	21.8	62.3	50.4	57.0	103.5	55.8	55.4	81.2	56.3	60.1	44.5	115.7	67.1	59.6	14.0	15.0	97.9	71.0	27.5	34.1	54.0	67.9	54.8	29.4	16.4	95.9	57.5	46.6	35.8	67.2	23.9	114.5	63.7	17.2	160.5	47.8	36.1	48.6	41.7	108.8	38.2	31.5	3.1	6.9	1.5	10.3	8.8	10.5	10.4	9.5	10.9	13.3	5.3	9.7	11.1	0.3	13.7	11.9	5.3	12.6	8.5	22.7	24.9	23.8	34.2	25.2	24.5	25.3	26.0	26.0	21.0	26.1	28.5	12.2	28.9	29.0	13.4	9.3	6.8	17.6	11.1	6.2	13.1	10.7	12.2	44.9	8.6	23.5	3.7	20.9	13.4	7.9	12.4	7.9	18.2	186.1	14.5	14.6	14.0	18.0	10.7	18.4	29.2	20.0	14.7	16.8	23.1	14.5	18.0	7.1	16.3	14.8	6.7	17.9	12.7	20.3	10.1	6.3	98.7	17.1	10.0	19.6	6.5	9.9	7.1	4.1	11.1	14.7	34.8	10.0	14.7	13.7	23.9	10.6	8.5	19.1	19.7	6.6	16.9	15.3	28.1	21.6	17.0	5.7	13.5	10.1	30.4	12.9	17.7
PIWIL4	"FLJ36156, HIWI2, Miwi2"	ENSG00000134627	"Piwi like RNA-mediated gene silencing 4"	Q7Z3Z4	11	94543840-94621421	"Predicted intracellular proteins"	"Differentiation, Meiosis, RNA-mediated gene silencing, Spermatogenesis, Translation regulation"	"Developmental protein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 24.3"	"Cell type enhanced"	"Detected in many"		"Intestinal goblet cells: 8.7;Spermatogonia: 12.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"NB-4: 93.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA036587, HPA036588, HPA057508"	Enhanced		Supported	Nucleoplasm,Mitochondria		NA	NA				"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 24: NB-4 - Immune response"	"Cluster 27: Mucus-secreting cells - Mucin production"	"Nucleoplasm, Mitochondria"		"HPA036587: AB_2732473, HPA036588: AB_10673502, HPA057508: AB_2683452"	"unprognostic (1.43e-1)"	"unprognostic (9.46e-2)"	"unprognostic (2.59e-3)"	"unprognostic (2.22e-3)"	"unprognostic (3.16e-2)"	"unprognostic (1.07e-3)"	"unprognostic (1.96e-2)"	"unprognostic (5.18e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.70e-1)"	"unprognostic (6.17e-2)"	"unprognostic (2.68e-1)"	"unprognostic (1.21e-4)"	"unprognostic (6.89e-2)"	"unprognostic (1.68e-1)"	"unprognostic (2.50e-1)"	"unprognostic (2.80e-2)"	3.3	1.1	5.5	2.8	5.3	24.3	3.6	4.9	5.0	4.4	3.4	5.8	5.8	3.7	2.3	1.6	3.6	4.6	2.8	5.6	4.7	3.2	1.3	2.7	3.9	4.5	4.4	3.4	11.3	0.4	2.2	2.0	4.5	2.5	6.0	6.7	8.8	2.6	1.0	1.7	6.3	2.0	4.5	3.7	5.1	13.3	4.9	3.0	2.0	1.0	2.7	3.3	3.0	5.4	0.2	0.1	0.4	0.0	6.6	4.3	0.5	0.5	0.3	0.2	0.9	0.7	0.6	0.0	0.4	2.8	0.2	0.0	0.9	0.0	0.2	2.7	0.3	0.2	0.6	0.0	2.5	6.5	0.1	1.5	0.0	0.5	0.0	0.1	0.1	0.5	0.3	0.0	1.1	0.4	0.3	93.2	0.1	9.2	0.6	0.4	0.0	0.0	2.1	0.0	0.4	0.3	0.4	0.9	0.4	0.3	0.0	20.7	1.2	0.4	0.1	0.1	0.1	0.1	0.0	0.0	0.1	9.9	0.0	0.0	0.4	0.1	0.1	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.2	5.5	5.3	4.9	5.0	5.6	4.7	4.5	4.4	4.5	4.5	4.9	5.4	1.1	0.0	0.5	3.3	0.2	1.3	0.2	0.4	0.0	0.6	1.3	1.3	3.5	7.2	1.4	0.0	0.0	4.0	0.2	4.1	1.9	6.2	4.7	0.7	0.7	0.6	0.0	0.4	5.4	2.0	0.5	1.6	7.7	1.3	0.0	0.9	0.7	0.0	1.7	0.0	4.9	8.7	0.0	3.0	1.7	2.1	0.3	1.7	0.0	3.7	2.0	0.7	1.0	5.0	6.0	3.0	4.9	1.2	0.1	0.5	4.4	0.6	1.7	3.3	0.0	2.2	1.3	1.2	12.0	0.6	0.1	1.0	0.3	0.3	5.3	0.1
PKD2	"Pc-2, PC2, PKD4, TRPP2"	ENSG00000118762	"Polycystin 2, transient receptor potential cation channel"	Q13563	4	88007635-88077777	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Calcium transport, Ion transport, Potassium transport, Transport, Wnt signaling pathway"	"Calcium channel, Ion channel, Potassium channel, Voltage-gated channel"	"Ciliopathy, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 129.1;Inhibitory neurons: 148.6;Microglial cells: 95.5;Oligodendrocyte precursor cells: 178.9;Oligodendrocytes: 219.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"basophil: 1.4"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"BJ: 137.2;BJ hTERT+: 207.1;fHDF/TERT166: 166.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004544, HPA015794, HPA055297"	Approved		Supported	"Endoplasmic reticulum,Cytosol"		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Endoplasmic reticulum"	Cytosol	"CAB004544: AB_672377, HPA015794: AB_1855437, HPA055297: "	"unprognostic (2.01e-1)"	"unprognostic (3.57e-2)"	"unprognostic (1.22e-1)"	"unprognostic (6.83e-2)"	"unprognostic (9.71e-2)"	"unprognostic (1.97e-1)"	"unprognostic (3.17e-2)"	"unprognostic (1.88e-1)"	"unprognostic (8.64e-2)"	"unprognostic (1.08e-1)"	"unprognostic (6.59e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.17e-3)"	"unprognostic (3.54e-3)"	"unprognostic (1.07e-1)"	"unprognostic (1.12e-2)"	"unprognostic (2.51e-1)"	30.7	24.2	9.6	13.9	12.2	10.7	18.6	10.0	12.0	40.0	7.3	32.5	10.7	61.1	14.7	12.7	39.3	26.9	19.7	9.0	8.9	48.6	15.0	22.2	11.5	10.4	11.2	47.7	14.8	27.9	9.0	24.5	10.0	23.3	13.2	14.0	9.7	39.2	5.8	10.3	14.8	53.7	9.1	10.9	20.0	10.3	11.9	7.6	16.4	11.7	8.7	20.6	18.4	14.6	7.4	40.8	44.9	23.2	101.8	67.6	13.3	137.2	207.1	62.9	62.2	2.0	12.8	4.0	29.3	166.4	24.0	9.1	8.1	20.4	54.5	21.2	7.1	6.6	21.8	4.3	56.5	16.2	12.9	56.4	9.1	49.4	26.4	85.6	28.8	7.6	0.9	10.9	55.5	14.4	11.4	7.7	23.4	5.3	6.7	21.5	26.8	6.0	55.6	17.2	9.0	20.1	25.5	1.2	32.5	45.0	9.7	12.1	44.7	59.1	12.9	16.8	18.8	8.7	2.9	4.4	35.2	2.5	55.3	1.4	0.1	0.2	0.2	0.2	0.4	0.1	0.2	0.1	0.0	0.1	0.2	0.1	0.2	0.3	0.1	0.4	0.1	0.1	9.6	12.2	10.0	12.0	9.0	8.9	10.4	11.2	10.0	9.1	11.9	14.6	14.8	3.2	6.3	59.4	3.5	7.4	5.3	7.4	23.3	16.7	7.4	11.3	7.1	18.6	7.2	69.9	10.4	10.4	2.7	0.6	0.0	14.0	0.3	10.3	41.7	19.2	6.7	13.5	129.1	3.8	3.4	42.0	2.0	11.1	1.3	12.7	21.4	10.6	12.2	26.9	148.6	3.4	4.1	5.0	6.8	1.1	23.0	9.8	23.2	95.5	9.5	17.3	4.1	178.9	219.4	2.2	4.6	50.8	3.1	6.5	3.9	17.0	12.3	1.9	26.3	53.0	31.5	0.8	3.8	13.3	6.7	2.7	6.1	11.5	2.8	3.4
PKD2L1	"PCL, PKD2L, PKDL, TRPP3"	ENSG00000107593	"Polycystin 2 like 1, transient receptor potential cation channel"	Q9P0L9	10	100288149-100330264	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 10.8;lymphoid tissue: 7.9;retina: 13.3"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 14.6;Hofbauer cells: 13.6;Horizontal cells: 60.6;Kupffer cells: 14.4;Late spermatids: 20.1"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"CAB022621, HPA070002"	Uncertain		Approved	"Plasma membrane,Actin filaments,Cytosol"		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 77: Retina - Visual perception"		"Cluster 62: Horizontal cells - Visual perception"	"Plasma membrane"	"Actin filaments, Cytosol"	"CAB022621: , HPA070002: "	"unprognostic (2.67e-1)"	"unprognostic (3.66e-7)"	"unprognostic (8.07e-3)"	"unprognostic (4.38e-2)"	"unprognostic (4.70e-2)"	"unprognostic (5.31e-2)"	"unprognostic (2.19e-1)"	"unprognostic (2.85e-2)"	"unprognostic (2.01e-1)"	"unprognostic (9.25e-2)"	"unprognostic (1.55e-1)"	"unprognostic (9.37e-2)"	"unprognostic (1.49e-4)"	"unprognostic (3.00e-1)"	"unprognostic (2.05e-2)"	"unprognostic (7.94e-2)"	"unprognostic (2.25e-1)"	0.2	0.1	5.4	0.4	5.6	0.9	0.7	4.8	10.8	0.1	4.8	0.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	5.4	4.9	0.3	1.6	2.3	1.5	4.9	5.2	0.1	0.1	0.0	0.1	0.5	5.1	0.3	1.2	13.3	0.1	0.0	0.1	0.0	0.6	0.0	5.0	7.9	0.0	2.3	5.0	0.9	0.0	0.0	1.7	0.2	0.0	5.5	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.3	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.6	0.0	0.0	0.3	0.0	0.0	0.8	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.8	0.0	0.0	0.1	5.4	5.6	4.8	10.8	5.4	4.9	4.9	5.2	5.1	5.0	5.0	5.5	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	14.6	0.0	0.0	0.1	0.0	0.0	2.3	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.1	13.6	60.6	0.4	0.0	0.0	14.4	0.0	20.1	0.3	3.2	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.9	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0
PKMYT1	"MYT1, PPP1R126"	ENSG00000127564	"Protein kinase, membrane associated tyrosine/threonine 1"	Q99640	16	2968024-2980479	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell cycle"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 27.6;testis: 56.9"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 29.0;Extravillous trophoblasts: 52.0;Plasma cells: 22.9;Spermatocytes: 114.7;Spermatogonia: 46.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Immune cell enriched"	"Detected in single"	6	"T-reg: 1.3"	"Lineage enriched"	"Detected in single"	6	"T-cells: 1.3"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA068860			Supported	"Nucleoplasm,Nucleoli,Golgi apparatus"		NA	Yes			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 12: Non-specific - Cell cycle regulation"	"Golgi apparatus"	"Nucleoplasm, Nucleoli"	"HPA068860: AB_2686050"	"unprognostic (7.82e-2)"	"unprognostic (8.70e-2)"	"unprognostic (5.93e-2)"	"unprognostic (2.04e-2)"	"unprognostic (4.54e-2)"	"unprognostic (1.44e-1)"	"prognostic unfavorable (8.33e-4)"	"prognostic unfavorable (3.37e-4)"	"unprognostic (4.52e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.61e-2)"	"unprognostic (7.95e-3)"	"unprognostic (0.00e+0)"	"unprognostic (1.09e-3)"	"unprognostic (9.13e-2)"	"unprognostic (1.96e-1)"	"unprognostic (5.91e-2)"	1.1	1.0	0.4	6.8	0.5	27.6	0.6	1.6	1.4	2.2	0.2	3.9	2.8	0.6	0.3	11.5	0.4	0.6	0.9	0.5	0.2	0.9	1.6	2.0	8.0	0.7	0.6	0.3	1.8	0.1	1.0	3.1	0.8	1.0	1.3	17.4	1.9	0.1	2.4	4.4	4.0	1.0	0.5	5.6	3.3	56.9	0.7	9.6	0.5	0.0	4.5	0.7	3.3	0.8	84.2	57.0	22.0	31.2	0.3	0.9	64.0	65.5	15.1	40.0	38.4	45.0	49.3	54.2	29.2	7.9	24.2	106.7	15.7	20.7	7.2	71.7	56.7	27.9	52.7	40.0	0.0	31.2	73.6	0.7	1.8	24.0	6.5	5.0	8.4	57.6	80.6	87.0	13.5	127.5	83.6	88.0	37.9	39.3	34.4	93.7	51.2	100.7	7.8	17.7	42.6	46.7	31.9	77.7	23.9	12.1	44.7	56.9	7.7	53.2	69.7	77.3	68.0	67.6	54.2	94.0	19.4	40.0	61.2	0.0	0.1	0.1	0.0	0.1	0.0	0.2	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	1.3	0.3	0.4	0.5	1.6	1.4	0.5	0.2	0.7	0.6	0.8	0.5	0.7	0.8	0.0	0.0	1.1	0.0	1.9	2.5	1.3	2.1	0.6	0.4	1.5	1.3	0.6	1.5	1.6	1.8	6.2	16.0	1.3	5.0	0.0	0.8	20.0	0.6	0.8	0.8	1.8	29.0	0.4	0.6	52.0	2.5	3.1	1.9	0.0	4.5	0.0	0.4	11.8	0.0	0.2	3.6	6.1	2.1	1.8	8.6	0.3	1.9	0.0	0.0	0.7	0.2	0.0	0.0	0.3	0.6	0.3	0.4	22.9	0.7	0.3	0.1	0.2	7.1	0.0	0.1	2.6	114.7	46.1	11.2	0.6	7.4	4.2	0.5	8.6	2.0
PKNOX1	PREP1	ENSG00000160199	"PBX/knotted 1 homeobox 1"	P55347	21	42974510-43033931	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Basal prostatic cells: 106.8;Early spermatids: 121.1;Spermatocytes: 99.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004285, HPA057215, HPA065017"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 22: Epithelial cell types - Mixed function"	Nucleoplasm		"CAB004285: AB_2164128, HPA057215: AB_2683372, HPA065017: AB_2685405"	"unprognostic (1.68e-2)"	"unprognostic (2.64e-1)"	"unprognostic (1.59e-1)"	"unprognostic (8.39e-2)"	"unprognostic (1.90e-2)"	"unprognostic (4.81e-2)"	"prognostic unfavorable (4.54e-8)"	"unprognostic (2.03e-1)"	"unprognostic (8.03e-2)"	"unprognostic (3.67e-2)"	"prognostic favorable (6.71e-4)"	"unprognostic (9.45e-2)"	"unprognostic (3.94e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.21e-2)"	"unprognostic (6.16e-2)"	"unprognostic (4.31e-3)"	4.8	4.2	6.6	4.0	6.6	2.5	3.9	9.6	6.9	8.1	5.5	6.5	2.8	8.3	5.4	4.1	6.5	4.7	3.5	6.7	6.7	6.7	4.4	4.5	5.0	6.9	6.6	8.6	3.9	3.4	4.6	5.3	6.6	5.0	3.8	4.7	4.2	6.6	7.6	5.4	4.3	6.0	7.5	4.7	4.4	8.2	7.3	5.2	11.5	5.9	4.5	7.0	4.6	7.6	8.8	3.0	3.9	3.8	7.3	11.0	4.8	11.0	7.6	6.5	5.6	5.2	6.6	12.2	8.9	9.7	5.1	4.6	9.1	7.0	8.6	8.4	7.3	7.2	5.7	4.9	7.5	6.6	5.4	8.3	11.3	8.1	6.6	6.8	6.3	4.1	5.8	8.8	15.1	5.2	6.2	7.3	6.1	12.4	6.5	9.8	17.7	6.7	13.0	6.9	12.6	7.5	7.8	5.6	7.6	4.5	4.7	8.4	7.5	10.2	5.0	5.7	7.1	5.1	6.1	6.2	12.9	11.6	5.5	0.3	2.1	1.7	3.9	2.9	4.1	2.8	2.8	3.2	1.9	2.2	3.3	3.0	5.7	2.3	1.9	1.7	3.3	2.4	6.6	6.6	9.6	6.9	6.7	6.7	6.9	6.6	6.6	7.5	7.3	7.6	18.4	6.4	15.7	28.1	12.5	17.5	106.8	13.7	17.1	23.7	12.4	11.7	7.4	12.8	18.2	16.5	4.2	14.9	11.1	12.3	9.8	17.1	121.1	15.1	37.7	16.0	14.9	11.0	30.3	12.6	28.8	22.3	3.6	23.8	6.3	17.3	10.0	8.4	12.6	13.5	27.2	11.8	14.2	8.4	22.5	40.8	18.6	15.3	14.2	16.9	20.8	9.5	11.3	27.6	40.8	14.5	7.0	29.3	8.6	32.2	8.5	7.5	16.3	11.5	32.9	27.3	20.8	99.7	26.4	17.1	13.8	29.0	17.1	24.2	10.8	45.2
PKP2		ENSG00000057294	"Plakophilin 2"	Q99959	12	32790755-32896777	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell adhesion"		"Cardiomyopathy, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 188.2"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 393.9;Distal enterocytes: 105.5;Extravillous trophoblasts: 185.9;Undifferentiated cells: 135.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"eosinophil: 8.1"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CACO-2: 198.8;OE19: 72.7;SuSa: 149.0"	"Region enriched"	"Detected in many"	4	"hippocampal formation: 20.2"	"Low region specificity"	"Detected in all"			"HPA014314, CAB037336, HPA056908"	Enhanced		Enhanced	"Nucleoplasm,Cell Junctions"		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 54: Cardiomyocytes - Muscle contraction"	"Cell Junctions"	Nucleoplasm	"CAB037336: , HPA014314: AB_1855451, HPA056908: AB_2683272"	"unprognostic (1.89e-1)"	"unprognostic (1.70e-2)"	"prognostic favorable (8.55e-4)"	"unprognostic (2.55e-1)"	"unprognostic (1.13e-1)"	"unprognostic (3.88e-2)"	"unprognostic (1.35e-1)"	"prognostic unfavorable (6.79e-4)"	"unprognostic (2.90e-1)"	"unprognostic (1.83e-2)"	"unprognostic (5.94e-3)"	"unprognostic (2.22e-1)"	"unprognostic (4.94e-2)"	"unprognostic (1.21e-2)"	"unprognostic (1.35e-1)"	"unprognostic (2.41e-2)"	"unprognostic (3.76e-2)"	5.5	2.6	1.6	6.5	2.0	5.8	11.2	3.1	3.8	20.3	8.2	49.8	23.6	5.0	3.9	5.3	73.0	7.4	188.2	8.7	1.0	7.8	25.9	1.3	4.5	1.4	0.3	15.1	16.4	33.6	9.9	20.5	0.6	9.1	45.2	2.6	58.5	6.9	6.0	2.9	26.5	5.5	0.7	2.0	17.8	6.4	1.6	12.4	0.3	1.7	10.6	5.3	3.4	1.6	56.5	10.8	0.4	0.3	0.2	0.0	0.5	0.0	0.0	0.2	0.1	198.8	49.6	0.0	32.9	0.0	7.1	48.8	6.8	43.3	0.0	0.2	15.7	0.3	2.3	52.6	29.5	3.1	0.6	0.2	40.2	0.1	46.2	21.4	1.8	0.1	10.4	15.3	4.8	14.9	0.2	0.4	29.7	72.7	9.5	0.0	23.6	16.8	14.3	26.3	5.9	5.3	2.3	11.4	0.1	149.0	24.7	0.7	0.3	0.1	21.1	0.0	13.5	12.6	0.2	0.4	0.1	0.2	2.6	5.8	0.9	8.1	0.2	1.1	0.6	0.1	0.4	0.3	2.9	0.3	0.5	0.3	0.6	1.0	1.7	0.5	0.4	0.4	1.6	2.0	3.1	3.8	8.7	1.0	1.4	0.3	0.6	0.7	1.6	1.6	0.4	0.0	0.0	0.3	2.2	7.0	48.1	20.7	32.5	3.2	22.1	13.1	393.9	21.5	17.7	1.8	4.2	57.9	0.9	105.5	3.9	12.7	4.0	61.2	11.6	3.7	27.1	2.1	1.3	10.1	185.9	12.9	43.3	52.1	4.5	23.2	5.0	46.0	8.6	1.7	58.8	67.0	26.4	17.0	20.4	1.8	11.8	28.6	10.6	4.7	1.4	14.3	0.0	2.0	1.0	23.6	65.5	2.2	1.6	32.8	30.8	11.0	14.2	1.1	0.0	13.0	9.8	6.9	5.7	12.1	3.3	41.5	2.7	1.0	135.6	28.2
PKP3		ENSG00000184363	"Plakophilin 3"	Q9Y446	11	392614-404908	"Plasma proteins, Predicted intracellular proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 294.4;skin 1: 223.0"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 345.0;Extravillous trophoblasts: 176.8;Paneth cells: 248.9;Proximal enterocytes: 195.6;Undifferentiated cells: 142.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A-431: 151.3;CAPAN-2: 102.6;HaCaT: 199.1;hTCEpi: 126.9;MCF7: 94.9;SK-BR-3: 148.0"	"Region enriched"	"Detected in single"	37	"cerebellum: 8.9"	"Low region specificity"	"Detected in all"			"CAB012993, HPA062937"	Enhanced		Enhanced	"Nucleoplasm,Cell Junctions"		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Cell Junctions"	Nucleoplasm	"CAB012993: AB_2533221, HPA062937: AB_2684908"	"unprognostic (4.74e-2)"	"unprognostic (5.28e-2)"	"unprognostic (4.45e-2)"	"unprognostic (2.25e-2)"	"unprognostic (1.58e-2)"	"unprognostic (1.57e-1)"	"unprognostic (8.88e-3)"	"prognostic unfavorable (2.89e-5)"	"unprognostic (1.25e-1)"	"unprognostic (6.73e-3)"	"prognostic unfavorable (3.93e-4)"	"unprognostic (3.55e-2)"	"prognostic unfavorable (1.08e-4)"	"unprognostic (2.16e-2)"	"unprognostic (3.41e-1)"	"unprognostic (2.60e-1)"	"unprognostic (3.15e-2)"	1.1	0.1	0.3	3.7	0.2	0.0	9.1	0.2	0.6	50.2	0.1	34.3	31.1	1.4	4.7	294.4	7.5	4.9	0.8	0.3	0.3	4.2	0.8	9.7	0.1	0.6	0.2	0.3	27.4	9.1	15.8	10.9	0.6	19.8	10.2	0.0	52.8	5.0	1.0	223.0	28.6	0.5	0.2	0.2	29.1	0.7	0.3	2.5	12.8	0.1	8.8	9.2	104.3	0.3	151.3	28.8	0.0	0.6	0.1	0.2	60.3	1.2	1.0	3.1	1.6	59.2	102.6	0.1	6.0	1.1	6.4	199.1	0.0	75.1	0.5	0.1	36.9	0.1	18.0	41.7	0.6	0.0	0.3	0.5	126.9	0.5	30.8	0.5	0.5	0.0	45.3	0.9	0.4	94.9	0.5	0.2	0.3	75.6	49.1	0.8	0.3	0.6	1.6	29.9	41.1	0.7	42.7	148.0	0.2	1.8	53.8	0.4	5.4	1.0	5.2	2.7	0.8	0.2	0.4	0.1	1.2	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.3	0.2	0.2	0.6	0.3	0.3	0.6	0.2	0.6	0.2	0.3	0.3	0.2	16.0	13.0	0.0	1.1	72.1	52.0	56.1	54.7	0.2	27.7	26.5	1.1	11.5	36.8	12.9	0.0	133.8	0.4	345.0	0.0	83.8	0.0	16.1	1.8	1.8	21.7	0.0	0.2	62.9	176.8	2.3	91.3	27.4	13.4	0.4	0.0	0.3	13.2	0.0	0.0	95.1	36.7	0.3	6.5	0.4	0.9	0.9	1.8	0.0	2.0	0.6	0.0	0.0	0.0	140.2	248.9	0.0	0.2	63.5	195.6	0.9	17.9	0.2	0.0	0.0	2.8	0.2	1.7	114.1	88.7	109.7	1.6	0.0	142.9	60.4
PKP4	p0071	ENSG00000144283	"Plakophilin 4"	Q99569	2	158456952-158682879	"Plasma proteins, Predicted intracellular proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 256.9"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 261.0;Inhibitory neurons: 260.9;Oligodendrocyte precursor cells: 235.3;Oligodendrocytes: 864.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"non-classical monocyte: 2.0"	"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB037334, HPA066647, HPA070648"	Approved		Enhanced	"Plasma membrane,Cell Junctions"		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Cell Junctions"	"Plasma membrane"	"CAB037334: , HPA066647: AB_2685696, HPA070648: AB_2686291"	"unprognostic (2.76e-1)"	"unprognostic (5.26e-2)"	"unprognostic (1.48e-2)"	"prognostic favorable (5.80e-4)"	"unprognostic (2.34e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.02e-3)"	"unprognostic (2.43e-1)"	"unprognostic (1.04e-2)"	"unprognostic (9.53e-2)"	"unprognostic (1.82e-2)"	"unprognostic (9.69e-2)"	"prognostic favorable (3.29e-7)"	"unprognostic (2.23e-1)"	"unprognostic (9.80e-2)"	"unprognostic (1.33e-3)"	"unprognostic (2.28e-3)"	13.4	6.5	165.2	6.7	229.0	8.3	26.2	186.6	212.7	31.9	89.3	12.6	12.4	14.0	14.2	17.8	19.6	15.3	22.1	130.2	179.5	57.0	16.8	12.6	6.0	256.9	217.1	13.3	15.1	18.1	9.6	6.2	213.7	12.9	13.4	18.5	34.0	20.9	8.2	16.1	11.3	14.3	222.9	6.1	13.8	10.3	194.1	16.1	30.4	9.8	10.1	16.5	12.4	239.5	36.9	21.8	26.7	30.4	12.1	13.4	25.7	29.1	15.9	44.5	38.4	72.4	32.5	23.4	21.5	35.4	16.0	29.0	35.2	29.8	74.1	35.4	19.2	21.2	23.5	56.3	20.9	34.4	4.6	5.7	28.1	30.0	46.3	26.7	23.0	28.9	30.1	33.3	34.7	42.6	15.2	14.3	28.8	51.4	15.9	20.6	40.2	19.3	64.6	26.6	46.2	8.2	20.3	30.4	24.5	24.9	34.7	31.3	10.6	25.9	29.2	19.3	38.2	19.8	18.0	17.0	14.8	19.2	25.4	0.0	0.3	0.0	0.1	0.1	0.2	0.0	0.5	0.2	0.1	0.0	0.4	0.1	0.4	0.0	2.0	0.2	0.7	0.2	165.2	229.0	186.6	212.7	130.2	179.5	256.9	217.1	213.7	222.9	194.1	239.5	59.8	41.7	18.9	28.7	3.1	27.0	21.3	23.5	34.1	44.5	44.3	35.9	49.7	38.6	28.7	47.8	29.2	0.2	3.5	17.7	23.5	21.3	14.6	21.0	12.2	71.1	9.0	24.6	261.0	18.1	0.3	15.3	26.0	38.5	10.1	11.8	23.2	28.6	3.1	5.0	260.9	16.6	16.2	7.6	10.0	9.2	10.8	6.2	7.2	163.9	4.5	8.6	2.1	235.3	864.7	17.4	16.7	17.0	5.2	44.6	12.4	33.1	29.0	19.2	13.1	11.4	13.9	15.4	6.3	30.4	30.4	0.3	5.0	15.5	19.4	26.8
PLA2G15	"GXVPLA2, LLPL, LYPLA3"	ENSG00000103066	"Phospholipase A2 group XV"	Q8NCC3	16	68245304-68261058	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Fatty acid metabolism, Lipid degradation, Lipid metabolism"	"Acyltransferase, Hydrolase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 58.3"	"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 116.0;Horizontal cells: 38.7;Kupffer cells: 37.1;Syncytiotrophoblasts: 50.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA041702, HPA041727"	Enhanced		Supported	Nucleoplasm,Vesicles	"Intracellular and membrane"	NA	NA		38000000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 4: Macrophages - Innate immune response"	"Nucleoplasm, Vesicles"		"HPA041702: AB_10794486, HPA041727: AB_10793931"	"unprognostic (3.47e-2)"	"unprognostic (9.99e-2)"	"unprognostic (1.54e-3)"	"unprognostic (6.84e-3)"	"unprognostic (1.38e-2)"	"unprognostic (1.65e-2)"	"unprognostic (4.12e-3)"	"unprognostic (3.16e-1)"	"unprognostic (2.12e-2)"	"unprognostic (1.84e-2)"	"unprognostic (2.56e-1)"	"unprognostic (9.29e-2)"	"unprognostic (2.45e-3)"	"unprognostic (2.98e-2)"	"unprognostic (5.40e-3)"	"unprognostic (6.28e-2)"	"unprognostic (3.47e-2)"	15.1	11.5	12.9	7.6	12.5	7.0	9.8	12.8	18.1	6.6	9.2	8.0	6.9	6.2	8.7	6.2	7.4	9.3	35.5	13.1	14.2	33.4	17.3	17.5	13.6	13.1	14.1	7.7	7.4	11.4	11.4	27.3	14.6	8.1	5.9	4.4	9.1	5.7	58.3	13.9	6.5	8.8	12.4	20.3	8.4	10.8	15.9	11.7	13.2	22.4	5.1	8.8	6.4	16.1	10.0	10.0	7.9	25.5	36.7	26.8	19.0	24.6	31.6	35.7	30.2	26.1	18.6	17.4	31.2	34.1	28.5	15.2	8.5	10.4	15.9	6.0	16.4	5.0	10.4	19.0	19.6	4.6	25.0	19.0	11.2	35.2	5.5	44.6	22.5	8.9	7.9	9.8	23.0	21.3	7.2	14.5	5.1	9.4	12.1	9.9	11.3	55.3	17.7	8.7	3.0	5.1	31.2	9.6	19.2	6.6	25.2	23.7	18.8	31.5	15.0	41.1	16.5	34.6	33.5	22.1	28.6	13.8	12.0	19.6	24.1	16.0	4.7	27.5	4.8	5.0	5.2	7.0	14.1	5.3	6.5	5.5	1.0	2.3	32.4	12.2	5.1	14.6	12.9	12.5	12.8	18.1	13.1	14.2	13.1	14.1	14.6	12.4	15.9	16.1	4.4	6.4	3.3	3.6	3.0	4.8	2.4	6.8	2.8	12.1	7.0	6.0	22.5	1.5	5.1	9.2	8.4	20.9	4.9	8.1	5.9	10.1	1.9	4.3	4.8	5.9	0.0	1.7	7.0	7.2	7.6	8.2	8.6	9.0	15.2	6.6	9.3	13.7	116.0	38.7	6.7	8.5	2.0	37.1	6.8	6.1	2.1	21.4	12.4	10.3	7.7	4.4	3.1	5.5	3.9	6.3	5.0	1.5	2.6	2.6	3.0	19.5	2.7	6.1	0.0	5.5	6.7	3.4	2.8	4.1	3.4	50.8	3.9	3.1	4.1	2.0
PLA2G4A	"cPLA2-alpha, PLA2G4"	ENSG00000116711	"Phospholipase A2 group IVA"	P47712	1	186828949-186988981	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Glycerol metabolism, Leukotriene biosynthesis, Lipid biosynthesis, Lipid degradation, Lipid metabolism, Phospholipid degradation, Phospholipid metabolism, Prostaglandin biosynthesis, Prostaglandin metabolism"	Hydrolase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"parathyroid gland: 87.2;seminal vesicle: 48.3"	"Cell type enhanced"	"Detected in many"		"Endometrial ciliated cells: 33.4;Glandular and luminal cells: 28.1;Microglial cells: 115.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"classical monocyte: 6.8;eosinophil: 7.8;intermediate monocyte: 8.4;myeloid DC: 7.7;non-classical monocyte: 4.0;plasmacytoid DC: 3.1"	"Group enriched"	"Detected in many"	7	"dendritic cells: 7.7;granulocytes: 7.8;monocytes: 8.4"	"Cell line enhanced"	"Detected in many"		"HeLa: 52.4;OE19: 84.4;RPMI-8226: 73.4;U-2197: 66.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB010050, HPA050062, HPA054206"	Approved		Supported	Vesicles,Cytosol		NA	NA		35000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 21: OE19 - Mitochondria"	"Cluster 44: Endometrium - Transcription"	Cytosol	Vesicles	"CAB010050: AB_631312, HPA050062: AB_2681002, HPA054206: AB_2682417"	"prognostic favorable (9.07e-4)"	"unprognostic (1.18e-1)"	"unprognostic (2.03e-1)"	"prognostic favorable (2.85e-4)"	"unprognostic (5.55e-2)"	"unprognostic (1.51e-3)"	"unprognostic (2.67e-2)"	"unprognostic (2.43e-1)"	"unprognostic (2.63e-1)"	"unprognostic (7.14e-3)"	"unprognostic (1.50e-1)"	"unprognostic (1.68e-1)"	"unprognostic (2.96e-2)"	"unprognostic (8.07e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.90e-2)"	"unprognostic (4.26e-2)"	9.9	12.7	2.4	6.3	3.4	4.8	6.5	2.8	3.7	14.5	3.2	11.9	11.1	10.2	11.7	7.5	24.9	6.2	6.3	2.4	3.3	10.8	2.1	5.9	5.3	4.4	3.5	6.4	7.6	87.2	2.0	5.8	4.0	8.8	8.1	0.8	6.3	48.3	0.5	9.5	8.2	10.5	4.1	6.6	5.3	2.8	3.1	1.5	2.6	2.1	2.9	29.1	8.4	3.9	0.0	39.7	0.2	0.0	23.8	9.5	0.0	1.5	15.1	1.8	3.2	0.3	15.5	0.0	0.0	0.0	6.8	2.8	24.6	7.4	0.8	12.5	0.6	7.6	52.4	0.0	14.7	11.1	3.8	5.4	5.0	19.5	4.0	2.4	16.5	3.4	16.7	5.9	0.0	0.0	0.0	0.0	2.1	84.4	5.1	0.0	0.0	73.4	0.1	5.4	0.2	0.0	5.9	2.0	7.3	0.7	0.8	15.0	3.3	14.3	1.9	66.3	3.2	2.3	0.0	0.0	5.3	32.4	20.7	0.2	6.8	7.8	0.0	8.4	0.2	0.0	0.0	0.0	7.7	0.0	0.0	0.0	0.6	1.1	4.0	3.1	0.0	1.7	2.4	3.4	2.8	3.7	2.4	3.3	4.4	3.5	4.0	4.1	3.1	3.9	0.6	0.0	1.1	0.3	0.2	21.4	4.3	4.6	10.2	0.2	2.9	2.9	2.3	0.0	4.9	0.0	0.0	0.1	3.2	1.6	1.9	2.1	0.9	33.4	1.7	6.6	1.2	3.0	8.1	0.0	0.1	11.2	7.1	28.1	10.8	3.3	1.1	0.2	6.6	0.0	5.8	2.6	2.0	7.9	8.3	1.3	10.5	11.5	5.4	115.2	3.7	0.0	1.0	2.0	0.4	1.7	7.3	14.7	0.0	2.3	2.0	0.3	2.3	0.5	0.0	1.2	5.0	0.6	0.3	5.2	8.9	0.0	1.0	1.2	4.8	13.4
PLAA	"DOA1, FLJ11281, FLJ12699, PLA2P, PLAP"	ENSG00000137055	"Phospholipase A2 activating protein"	Q9Y263	9	26903372-26947242	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	Neurogenesis	"Developmental protein"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005035, HPA020994, HPA020996"	Approved		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA		12000000	"Cluster 14: Monocytes - Unknown function"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 10: Non-specific - Unknown function"	"Plasma membrane, Cytosol"	Nucleoplasm	"CAB005035: AB_562036, HPA020994: AB_1855444, HPA020996: AB_1855445"	"unprognostic (5.48e-2)"	"unprognostic (1.39e-1)"	"unprognostic (4.00e-3)"	"unprognostic (5.00e-1)"	"unprognostic (1.61e-1)"	"unprognostic (4.06e-2)"	"unprognostic (4.50e-3)"	"unprognostic (2.48e-1)"	"unprognostic (5.54e-2)"	"prognostic favorable (7.87e-4)"	"unprognostic (3.24e-2)"	"unprognostic (1.44e-1)"	"unprognostic (9.29e-3)"	"unprognostic (1.86e-2)"	"unprognostic (6.68e-2)"	"unprognostic (1.39e-2)"	"unprognostic (5.10e-1)"	16.0	16.9	8.5	16.2	9.0	42.0	12.6	9.3	11.2	11.3	9.6	15.2	13.6	17.5	13.4	18.8	9.8	13.0	18.8	9.5	9.7	15.4	21.5	12.8	15.0	8.1	8.3	11.0	12.0	16.9	8.0	16.0	9.0	12.9	15.9	14.1	10.9	12.5	50.3	12.1	12.6	19.3	8.3	13.3	12.7	20.4	8.1	18.0	15.9	29.1	18.1	14.7	11.2	10.2	64.6	37.0	46.1	46.3	30.4	38.2	34.6	58.4	33.1	43.9	42.2	13.1	29.8	56.9	48.0	45.0	30.6	25.1	45.8	46.0	47.7	75.7	19.1	35.2	57.9	25.5	30.9	28.8	46.3	34.4	27.0	53.2	38.8	33.0	44.3	41.7	22.1	56.6	47.6	26.6	56.3	28.1	66.8	33.2	31.6	39.4	28.7	34.4	33.5	37.6	29.2	49.9	31.3	36.5	19.1	44.8	25.5	22.5	54.3	0.2	53.8	28.5	48.3	18.4	43.7	59.5	30.8	40.4	23.4	21.9	12.7	21.0	11.0	18.2	12.6	14.3	11.5	11.4	13.1	11.9	10.3	12.0	11.4	14.9	21.2	6.6	18.0	9.6	8.5	9.0	9.3	11.2	9.5	9.7	8.1	8.3	9.0	8.3	8.1	10.2	10.8	16.0	11.2	18.3	18.8	11.0	11.3	14.6	17.1	9.1	7.5	6.6	23.8	5.7	16.1	9.2	0.0	24.9	14.9	11.9	9.8	17.6	27.7	10.2	12.3	17.1	9.6	25.9	31.9	16.2	26.6	11.5	15.8	14.7	40.6	13.2	12.5	10.7	20.7	5.0	30.8	8.6	14.2	15.8	8.2	6.6	8.7	17.5	1.8	21.5	15.9	9.5	16.5	24.6	32.1	15.2	8.7	8.2	23.1	10.6	11.0	12.3	12.7	6.7	19.7	13.0	34.1	28.1	24.9	20.9	9.5	49.3	18.3	21.5	12.6	11.6
PLAAT3	"AdPLA, H-REV107-1, HRASLS3, HREV107, HREV107-3, MGC118754., PLA2G16, PLAAT-3"	ENSG00000176485	"Phospholipase A and acyltransferase 3"	P53816	11	63573195-63616883	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins"	"Host-virus interaction, Lipid degradation, Lipid metabolism"	"Hydrolase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adipose tissue: 318.7;brain: 394.8"	"Cell type enhanced"	"Detected in some"		"Adipocytes: 80.5;Cardiomyocytes: 151.9;Cytotrophoblasts: 137.4;Extravillous trophoblasts: 365.5;Hofbauer cells: 71.0;Syncytiotrophoblasts: 290.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"plasmacytoid DC: 187.8"	"Group enriched"	"Detected in all"	6	"dendritic cells: 187.8;T-cells: 55.0"	"Cell line enhanced"	"Detected in many"		"A549: 135.1;ASC diff: 148.2;CAPAN-2: 247.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011749, HPA058997"	Approved		Supported	Mitochondria		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 38: Extravillous trophoblasts - Unknown function"	Mitochondria		"HPA011749: , HPA058997: AB_2683874"	"unprognostic (5.18e-2)"	"unprognostic (3.67e-2)"	"unprognostic (7.92e-2)"	"unprognostic (3.89e-2)"	"unprognostic (1.94e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.13e-1)"	"unprognostic (3.06e-2)"	"unprognostic (6.97e-2)"	"unprognostic (1.14e-1)"	"prognostic unfavorable (5.58e-6)"	"unprognostic (6.38e-2)"	"unprognostic (1.93e-3)"	"unprognostic (1.62e-1)"	"unprognostic (1.75e-1)"	"prognostic favorable (2.54e-5)"	"unprognostic (2.35e-1)"	318.7	36.2	208.5	10.2	287.0	3.1	166.8	234.7	261.6	13.3	142.8	32.8	8.7	17.6	26.6	13.2	33.0	29.1	103.0	197.7	215.3	65.0	76.5	37.6	11.6	283.0	250.7	73.4	32.4	28.6	33.4	40.3	279.8	16.4	7.6	26.6	28.9	29.9	108.9	10.7	21.8	15.8	241.2	15.9	31.9	54.7	237.1	7.1	41.2	118.7	4.4	26.7	9.6	394.8	87.7	135.1	3.7	0.2	148.2	25.1	24.1	3.2	26.9	22.3	11.2	30.8	247.1	0.0	55.3	6.9	72.4	4.4	127.4	6.8	16.9	108.0	5.0	1.3	33.3	5.4	87.8	0.0	1.3	15.2	0.7	55.4	2.2	88.1	35.4	0.0	1.6	9.6	24.0	15.3	0.2	0.6	10.8	55.0	43.0	0.0	0.0	8.7	71.2	12.3	1.7	9.7	18.0	51.5	28.7	54.6	111.6	4.5	52.2	10.0	0.7	34.0	7.7	39.6	28.0	0.3	40.1	0.0	1.0	0.1	21.1	0.1	55.0	9.1	30.3	7.4	12.1	40.5	6.4	1.2	3.9	30.0	1.3	21.0	0.6	187.8	9.3	27.2	208.5	287.0	234.7	261.6	197.7	215.3	283.0	250.7	279.8	241.2	237.1	394.8	80.5	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	151.9	0.0	0.0	0.0	0.0	137.4	18.6	0.0	0.0	0.0	0.0	0.0	0.0	12.0	0.0	0.0	0.0	0.0	365.5	14.7	0.0	0.0	0.0	0.0	0.0	0.0	71.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.0	0.0	0.0	0.0	0.0	290.6	2.0	0.0	0.0	0.0
PLAG1	ZNF912	ENSG00000181690	"PLAG1 zinc finger"	Q6DJT9	8	56160909-56211324	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes, Dwarfism, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Horizontal cells: 32.0;Microglial cells: 28.1;Rod photoreceptor cells: 27.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 16.0;ASC TERT1: 20.9;hTERT-HME1: 15.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA072290			Supported	"Nucleoplasm,Nuclear speckles,Centrosome,Cytosol"		NA	NA			"Cluster 30: Non-specific - Translation"	"Cluster 77: Retina - Visual perception"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 52: Non-specific - Transcription"	"Nucleoplasm, Nuclear speckles"	"Centrosome, Cytosol"	"HPA072290: AB_2686508"	"unprognostic (1.89e-2)"	"unprognostic (1.93e-2)"	"unprognostic (1.22e-3)"	"unprognostic (1.63e-4)"	"unprognostic (6.81e-2)"	"unprognostic (1.07e-1)"	"unprognostic (5.63e-3)"	"unprognostic (8.56e-2)"	"unprognostic (1.18e-1)"	"unprognostic (7.99e-2)"	"unprognostic (3.42e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.32e-3)"	"unprognostic (2.83e-2)"	"unprognostic (3.94e-1)"	"unprognostic (1.21e-2)"	"unprognostic (6.14e-2)"	0.7	1.4	0.8	1.0	1.2	0.9	0.9	2.5	1.1	3.0	0.6	0.8	1.4	1.4	4.1	0.7	3.1	0.7	3.1	0.7	1.0	1.3	0.3	1.9	1.8	1.5	1.4	4.9	0.8	1.2	3.8	1.6	1.8	1.3	0.6	7.7	3.0	1.8	0.4	1.4	2.3	0.4	1.2	2.6	1.3	2.4	1.3	2.8	1.3	1.4	2.3	1.3	3.0	2.0	2.0	0.0	11.9	0.1	16.0	20.9	3.7	5.4	6.9	2.5	1.1	0.8	6.2	0.2	5.1	2.9	0.7	0.4	3.4	7.1	2.5	0.2	7.4	8.0	0.8	1.8	3.3	2.5	2.3	14.9	3.9	1.4	15.6	6.9	4.7	5.3	3.4	0.1	5.3	0.1	0.7	4.7	3.4	0.5	1.8	6.1	0.8	4.9	3.2	0.7	0.1	0.0	0.1	0.1	0.4	8.0	0.1	2.4	7.2	3.6	4.6	5.9	1.4	1.8	1.5	2.9	4.1	0.9	1.0	0.6	0.0	0.4	0.1	0.0	0.1	1.3	0.4	0.2	0.0	0.7	1.8	1.8	0.4	0.3	0.2	0.1	0.1	0.4	0.8	1.2	2.5	1.1	0.7	1.0	1.5	1.4	1.8	1.2	1.3	2.0	2.6	6.4	3.2	2.9	13.0	1.0	2.5	6.2	1.8	23.6	1.6	0.6	12.2	4.3	6.7	5.5	25.0	8.3	2.0	1.0	0.0	0.7	6.2	3.0	2.3	3.7	5.4	5.0	16.8	1.3	4.2	4.0	2.6	4.2	1.3	0.4	15.7	0.7	5.8	32.0	12.3	3.6	6.1	2.9	2.2	6.7	15.2	2.8	16.0	28.1	1.2	16.3	4.1	2.0	19.2	1.4	4.1	10.1	6.3	5.0	5.1	0.8	9.1	27.8	0.0	2.4	1.4	9.0	8.8	1.1	0.9	7.1	4.5	0.9	3.6	12.9
PLAGL1	"LOT1, ZAC"	ENSG00000118495	"PLAG1 like zinc finger 1"	Q9UM63	6	143940300-144064599	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Diabetes mellitus"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 252.3"	"Cell type enhanced"	"Detected in many"		"Fibroblasts: 143.6;Leydig cells: 138.5;Theca cells: 205.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"AF22: 99.0;RH-30: 94.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA055706			Supported	"Nuclear bodies,Golgi apparatus,Vesicles"		No	No			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 28: Placenta - Pregnancy"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 33: Fibroblasts - ECM organization"	"Nuclear bodies"	"Golgi apparatus, Vesicles"	"HPA055706: AB_2682893"	"unprognostic (4.74e-3)"	"unprognostic (8.35e-3)"	"unprognostic (5.43e-2)"	"unprognostic (1.74e-3)"	"unprognostic (5.09e-2)"	"unprognostic (1.95e-1)"	"unprognostic (9.32e-2)"	"unprognostic (6.17e-2)"	"unprognostic (3.49e-2)"	"unprognostic (5.02e-2)"	"unprognostic (1.78e-3)"	"unprognostic (2.07e-1)"	"prognostic unfavorable (4.94e-6)"	"prognostic unfavorable (6.61e-4)"	"unprognostic (4.69e-2)"	"unprognostic (5.17e-3)"	"unprognostic (4.93e-3)"	37.7	74.8	4.1	18.5	5.2	21.7	29.6	1.9	7.0	31.4	5.8	28.8	9.6	29.5	9.0	32.9	20.8	26.9	26.4	3.8	2.9	17.0	3.6	26.7	12.1	3.6	4.1	36.5	27.7	9.5	81.6	252.3	3.9	26.0	21.3	1.6	30.1	12.1	12.2	61.9	20.6	19.7	3.2	15.6	26.9	8.7	6.0	6.6	13.8	22.3	12.1	39.6	34.4	4.0	0.2	5.0	99.0	0.1	39.4	78.0	0.3	32.9	21.6	16.1	33.5	0.3	6.0	2.7	16.0	30.4	4.0	0.0	0.8	12.0	32.2	3.1	4.4	45.2	58.7	0.9	13.9	40.9	8.9	60.5	4.6	15.8	13.8	23.4	33.5	16.1	4.4	0.8	18.0	6.2	16.9	19.8	17.2	0.0	3.7	20.7	94.1	0.1	33.1	1.1	8.7	10.3	51.0	0.1	0.1	29.6	0.1	50.1	19.8	0.2	35.2	77.7	36.4	9.1	9.0	0.6	25.3	16.6	2.0	4.9	12.0	25.1	1.4	9.1	1.4	3.7	1.3	1.9	14.9	5.8	0.9	1.5	21.7	2.2	2.9	6.7	2.0	3.8	4.1	5.2	1.9	7.0	3.8	2.9	3.6	4.1	3.9	3.2	6.0	4.0	19.5	51.3	51.0	28.4	15.2	21.7	14.6	5.3	34.1	2.1	16.8	14.0	8.4	5.7	12.6	5.5	0.0	4.6	19.0	16.1	7.9	11.8	1.8	8.6	91.9	23.8	16.7	19.3	60.3	11.3	15.0	143.6	11.7	13.0	18.4	38.7	8.6	0.2	20.3	8.4	76.6	33.6	18.3	26.8	27.8	5.5	138.5	26.8	8.8	49.6	37.6	0.9	2.1	10.6	5.5	13.0	22.5	97.0	5.7	52.0	4.3	15.3	4.4	0.4	13.1	61.7	31.1	0.9	1.0	24.1	43.3	9.9	10.0	205.8	28.5	19.7
PLAUR	"CD87, UPAR, URKR"	ENSG00000011422	"Plasminogen activator, urokinase receptor"	Q03405	19	43646095-43670547	"Cancer-related genes, CD markers, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"		Receptor	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	6	"bone marrow: 688.4"	"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 820.7;Langerhans cells: 1833.9;Macrophages: 864.3;Urothelial cells: 2274.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 1172.3"	"Group enriched"	"Detected in all"	4	"granulocytes: 1172.3;monocytes: 550.7"	"Cell line enhanced"	"Detected in many"		"hTEC/SVTERT24-B: 311.7;U-251 MG: 413.1;U-87 MG: 346.9;WM-115: 346.5"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA050843, CAB073533"	Uncertain		Supported	"Plasma membrane"	"Intracellular and membrane"	NA	NA		4100000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 41: Macrophages - Immune response"	"Plasma membrane"		"CAB073533: , HPA050843: AB_2681255"	"unprognostic (9.28e-2)"	"unprognostic (9.65e-3)"	"unprognostic (1.39e-1)"	"unprognostic (1.29e-3)"	"unprognostic (3.59e-3)"	"unprognostic (1.50e-2)"	"unprognostic (2.18e-3)"	"prognostic unfavorable (2.33e-5)"	"unprognostic (8.08e-3)"	"unprognostic (4.30e-2)"	"unprognostic (2.29e-3)"	"unprognostic (5.30e-2)"	"prognostic unfavorable (7.83e-9)"	"unprognostic (4.99e-2)"	"unprognostic (1.66e-1)"	"unprognostic (5.45e-2)"	"unprognostic (9.33e-2)"	52.1	10.4	7.5	81.7	9.8	688.4	14.5	11.2	32.4	30.9	10.3	26.7	10.0	30.2	4.8	11.6	22.8	78.1	23.0	8.1	10.4	18.2	19.8	69.5	10.6	12.2	9.8	14.9	13.6	5.4	9.1	35.9	13.3	11.5	20.1	2.8	21.7	5.8	3.6	7.8	10.6	26.2	9.7	20.4	28.4	3.1	24.8	10.2	9.5	4.7	8.6	109.7	15.8	13.8	83.9	31.0	26.1	1.9	23.4	83.3	16.2	180.7	189.6	114.6	141.4	2.4	95.1	2.4	43.0	116.9	66.8	35.2	7.0	46.4	127.9	5.3	5.3	15.8	44.7	3.9	30.6	18.8	195.2	87.4	9.0	311.7	46.5	160.6	129.0	19.1	16.4	2.2	107.7	6.1	21.0	55.3	8.7	156.1	64.7	24.0	17.4	5.6	35.9	3.8	1.3	22.2	82.0	17.4	25.0	12.6	3.2	59.4	129.7	230.0	121.1	109.8	413.1	3.0	9.0	0.6	346.9	36.0	346.5	87.7	476.5	745.5	6.8	427.9	8.3	2.7	8.9	5.7	213.6	1.4	3.2	4.0	1172.3	6.7	550.7	69.3	3.6	253.9	7.5	9.8	11.2	32.4	8.1	10.4	12.2	9.8	13.3	9.7	24.8	13.8	23.1	73.7	76.6	2.3	15.5	105.2	820.7	274.2	72.3	0.7	45.8	22.5	4.5	24.3	151.9	20.2	0.0	6.5	17.4	314.5	1.9	219.3	0.9	188.1	68.0	64.9	14.8	5.2	2.5	106.5	58.8	145.4	156.0	519.1	305.2	4.2	19.2	1.7	428.9	10.1	3.3	85.3	22.4	155.4	1833.9	2.0	6.8	864.3	72.9	5.6	52.1	1.2	4.1	1.5	0.9	558.8	435.5	4.1	14.5	479.4	12.7	2.7	52.7	0.7	6.6	38.5	90.0	1.2	4.7	202.6	63.1	13.1	33.2	3.1	29.3	2274.4
PLCD4		ENSG00000115556	"Phospholipase C delta 4"	Q9BRC7	2	218607855-218637184	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Lipid degradation, Lipid metabolism"	"Guanine-nucleotide releasing factor, Hydrolase, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"retina: 166.0;skeletal muscle: 114.0"	"Group enriched"	"Detected in some"	5	"Bipolar cells: 139.9;Cone photoreceptor cells: 246.0;Rod photoreceptor cells: 176.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"SH-SY5Y: 20.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009914, HPA038139, HPA038140"	Enhanced		Supported	"Endoplasmic reticulum,Plasma membrane,Cytosol"		NA	NA				"Cluster 54: Non-specific - Microtubule organization"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 9: Photoreceptor cells - Phototransduction"	Cytosol	"Endoplasmic reticulum, Plasma membrane"	"CAB009914: AB_2252306, HPA038139: AB_2675855, HPA038140: AB_2675856"	"unprognostic (2.11e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.76e-2)"	"unprognostic (5.65e-5)"	"unprognostic (7.77e-2)"	"unprognostic (1.45e-2)"	"unprognostic (7.06e-3)"	"unprognostic (2.86e-2)"	"unprognostic (3.15e-1)"	"unprognostic (8.87e-3)"	"unprognostic (7.54e-5)"	"unprognostic (3.28e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.86e-1)"	"unprognostic (6.32e-2)"	"unprognostic (8.46e-3)"	"unprognostic (3.09e-1)"	1.5	2.7	4.5	0.2	4.4	0.0	1.3	4.5	7.2	1.4	3.5	15.6	0.6	0.6	0.3	4.8	0.6	0.4	1.1	4.5	4.6	10.7	0.6	0.6	0.1	5.6	5.1	0.7	0.5	1.7	9.6	0.2	4.9	4.4	1.7	166.0	2.3	0.3	114.0	1.0	3.3	1.3	4.2	0.3	6.9	9.8	5.0	0.1	1.6	30.4	0.1	20.5	2.0	4.7	0.0	0.9	1.2	0.0	0.3	1.2	1.1	0.0	2.5	0.4	1.3	0.0	0.1	0.0	1.5	0.4	0.4	0.1	0.0	1.5	0.3	0.0	0.0	0.0	2.1	0.0	0.2	0.0	0.0	2.8	0.1	1.9	0.5	4.2	2.8	0.1	0.0	0.0	2.3	0.0	0.0	0.0	0.1	0.0	2.1	0.0	0.0	0.1	4.3	0.0	1.8	20.2	0.3	0.1	0.1	0.2	2.1	0.0	4.5	0.1	0.0	0.2	0.2	0.0	0.0	0.0	4.3	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	4.5	4.4	4.5	7.2	4.5	4.6	5.6	5.1	4.9	4.2	5.0	4.7	0.3	0.0	1.1	7.8	0.1	0.5	0.3	0.9	3.4	139.9	1.5	0.9	1.0	0.0	0.1	0.0	246.0	0.1	0.1	0.0	0.0	0.1	21.4	0.6	0.4	1.5	0.0	0.0	6.7	0.0	13.5	0.7	0.0	1.0	0.0	0.1	0.7	0.0	0.6	8.4	4.9	0.1	0.0	0.0	0.4	33.8	0.3	0.2	0.0	0.0	0.1	9.1	0.0	2.0	2.3	0.7	0.0	0.0	0.0	0.1	0.0	2.2	0.2	176.9	0.0	6.1	1.8	3.6	1.2	0.6	0.1	0.8	0.1	0.0	0.1	0.2
PLCE1	"KIAA1516, NPHS3, PLCE"	ENSG00000138193	"Phospholipase C epsilon 1"	Q9P212	10	93993931-94332823	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins"	"Lipid degradation, Lipid metabolism"	"Guanine-nucleotide releasing factor, Hydrolase, Transducer"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 70.5;Astrocytes: 69.5;Distal enterocytes: 79.6;Inhibitory neurons: 83.9;Muller glia cells: 82.7;Oligodendrocyte precursor cells: 123.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"RT4: 10.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA015597, HPA015598"	Enhanced		Supported	Cytosol		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 21: OE19 - Mitochondria"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Cytosol		"HPA015597: AB_1855321, HPA015598: AB_1855322"	"unprognostic (4.73e-2)"	"unprognostic (1.16e-1)"	"unprognostic (4.03e-2)"	"unprognostic (3.59e-3)"	"unprognostic (3.01e-1)"	"unprognostic (2.96e-1)"	"unprognostic (1.73e-2)"	"unprognostic (4.76e-3)"	"unprognostic (1.58e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.23e-1)"	"unprognostic (3.26e-3)"	"unprognostic (3.56e-1)"	"unprognostic (3.92e-2)"	"unprognostic (3.54e-2)"	"unprognostic (4.30e-2)"	3.8	2.6	4.5	2.8	4.1	0.2	2.7	3.1	5.6	8.0	7.0	12.6	4.0	9.0	5.3	1.7	4.4	2.5	12.4	3.9	4.7	8.4	0.7	7.3	0.7	3.9	4.8	3.9	14.7	0.8	4.4	2.9	4.0	3.8	7.5	7.3	2.3	5.4	4.1	1.1	5.2	4.2	3.2	6.2	8.3	2.0	5.4	0.5	9.8	6.3	0.6	5.6	5.6	4.2	4.0	6.7	1.8	1.1	0.7	3.2	1.9	2.8	0.6	0.3	0.4	5.3	1.3	0.8	1.3	2.3	1.3	2.6	2.2	0.4	0.6	0.4	2.3	0.5	4.0	0.5	0.0	0.9	0.3	1.8	0.0	1.1	0.0	6.8	0.0	0.4	0.5	0.3	4.2	0.3	0.8	0.9	0.7	7.9	5.0	0.1	3.9	0.2	0.2	10.3	0.9	1.5	3.3	3.6	0.7	4.1	3.5	0.6	0.6	3.0	5.9	2.0	4.4	0.6	0.3	0.4	3.5	1.1	2.2	0.1	0.1	0.0	0.3	0.2	0.2	0.5	0.3	0.2	0.1	0.7	0.5	0.4	0.1	0.2	0.2	0.2	0.1	0.1	4.5	4.1	3.1	5.6	3.9	4.7	3.9	4.8	4.0	3.2	5.4	4.2	8.2	70.5	5.4	69.5	7.0	8.2	9.7	6.8	2.2	12.2	3.6	3.6	34.7	4.3	12.3	0.0	0.0	3.7	2.9	79.6	1.9	1.1	20.7	26.7	18.4	9.7	1.8	0.0	3.1	6.4	2.5	15.3	29.6	10.6	0.0	7.2	4.2	1.6	0.7	6.7	83.9	9.7	4.1	2.4	5.2	5.3	12.2	1.3	7.2	5.6	1.2	82.7	4.1	123.1	2.4	4.2	54.8	23.3	0.9	7.5	11.0	2.5	10.6	18.7	6.6	30.8	37.7	3.7	8.0	1.7	7.4	1.9	4.3	3.7	41.1	10.5
PLD3	HU-K4	ENSG00000105223	"Phospholipase D family member 3"	Q8IV08	19	40348456-40380439	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Immunity, Inflammatory response"	"Exonuclease, Hydrolase, Nuclease"	"Disease variant, Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pituitary gland: 711.9"	"Cell type enhanced"	"Detected in all"		"Hofbauer cells: 688.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in all"	5	"basophil: 1727.4"	"Lineage enriched"	"Detected in all"	7	"granulocytes: 1727.4"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012800, CAB020812"	Approved		Approved	"Nucleoplasm,Endoplasmic reticulum,Cytosol"		NA	NA		450000	"Cluster 10: Basophils - Unknown function"	"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 4: Macrophages - Innate immune response"	"Endoplasmic reticulum, Cytosol"	Nucleoplasm	"CAB020812: , HPA012800: AB_1855330"	"unprognostic (1.11e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.64e-3)"	"unprognostic (2.56e-3)"	"unprognostic (2.06e-3)"	"unprognostic (2.68e-1)"	"unprognostic (4.52e-2)"	"unprognostic (3.89e-2)"	"unprognostic (1.09e-1)"	"unprognostic (4.60e-2)"	"prognostic favorable (6.44e-4)"	"unprognostic (4.34e-2)"	"prognostic favorable (2.21e-4)"	"unprognostic (3.49e-2)"	"unprognostic (2.10e-1)"	"unprognostic (1.38e-2)"	"unprognostic (6.42e-2)"	169.3	200.0	143.3	78.4	159.7	48.3	138.4	46.0	229.7	139.4	54.0	131.4	71.7	155.7	84.7	84.9	133.5	96.7	206.1	202.5	294.4	130.2	121.3	181.5	98.1	132.4	128.5	199.0	151.0	105.9	711.9	123.4	137.9	133.4	49.2	51.4	138.7	106.2	105.1	120.5	105.3	79.1	63.8	197.0	126.5	77.7	197.7	44.3	120.8	82.3	41.4	126.2	126.0	129.6	85.6	257.8	163.7	259.1	444.2	210.2	124.5	206.5	208.6	146.4	166.6	49.4	93.8	36.9	211.0	180.9	47.8	39.3	39.9	81.2	63.5	138.4	145.3	39.9	82.1	63.2	302.7	16.8	435.1	402.5	167.0	112.1	76.6	244.2	125.0	59.3	142.5	144.5	106.7	111.5	29.5	79.6	107.4	138.7	52.8	37.0	124.5	154.2	75.2	63.2	116.7	193.9	99.0	60.6	113.8	169.5	83.6	283.2	222.3	122.8	58.5	105.6	47.0	148.9	173.3	38.8	197.7	66.2	77.9	1727.4	256.7	378.7	75.0	129.5	62.0	34.4	59.5	67.7	235.0	28.1	60.8	61.3	25.7	102.3	64.2	34.7	64.5	208.6	143.3	159.7	46.0	229.7	202.5	294.4	132.4	128.5	137.9	63.8	197.7	129.6	66.7	32.1	69.6	59.4	27.0	35.4	93.6	263.1	39.9	101.5	45.9	61.2	22.0	45.8	90.4	57.0	33.3	158.2	27.2	42.5	21.5	52.5	8.7	32.0	49.8	53.9	72.8	18.7	99.1	58.3	107.2	158.8	38.2	31.5	60.3	134.7	88.2	43.1	688.4	121.1	113.4	41.3	126.1	280.9	59.1	15.7	151.6	261.3	92.5	50.6	54.2	94.1	35.0	53.3	70.2	54.3	42.6	143.7	85.8	57.9	78.8	37.1	35.2	47.6	19.7	73.1	59.7	24.2	67.9	32.4	33.4	195.9	28.8	114.1	41.6	68.2
PLEC	"EBS1, PCN, PLEC1, PLTN"	ENSG00000178209	Plectin	Q15149	8	143915153-143976734	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"		Actin-binding	"Cancer-related genes, Disease variant, Epidermolysis bullosa, Limb-girdle muscular dystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 256.5"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 257.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"PC-3: 384.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003847, HPA025967, HPA029906"	Enhanced		Supported	"Intermediate filaments,Focal adhesion sites,Cytosol"		NA	NA		7400000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 59: Non-specific - Translation"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Intermediate filaments, Cytosol"	"Focal adhesion sites"	"CAB003847: AB_562198, HPA025967: AB_10601671, HPA029906: AB_10602279"	"unprognostic (1.02e-1)"	"unprognostic (1.37e-3)"	"prognostic unfavorable (4.29e-4)"	"unprognostic (2.09e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.05e-2)"	"unprognostic (1.76e-3)"	"prognostic unfavorable (5.33e-4)"	"unprognostic (1.72e-3)"	"unprognostic (1.13e-2)"	"unprognostic (2.85e-3)"	"unprognostic (5.48e-2)"	"prognostic unfavorable (7.98e-6)"	"unprognostic (2.30e-1)"	"unprognostic (4.04e-2)"	"unprognostic (6.58e-2)"	"unprognostic (5.58e-3)"	41.8	30.9	44.2	22.6	25.4	43.2	37.9	20.4	39.7	57.4	6.7	58.0	21.1	55.2	8.5	59.7	47.9	22.8	78.9	42.2	31.0	30.0	31.3	49.2	22.1	48.5	28.6	47.1	27.6	8.1	33.0	18.3	30.8	49.5	13.0	3.9	42.9	19.8	256.5	83.1	53.8	27.7	28.8	46.1	49.1	15.3	43.2	14.4	25.7	74.7	15.8	56.5	55.7	25.9	92.6	247.3	15.1	20.3	31.6	66.9	62.8	125.9	49.3	32.3	18.7	39.2	88.5	8.9	82.9	179.7	54.6	98.9	10.3	162.6	13.3	58.7	10.0	24.9	268.0	34.0	54.0	9.6	26.1	71.8	40.7	84.6	164.2	28.3	43.0	7.6	16.2	25.9	39.7	175.3	5.1	19.8	12.2	29.4	384.8	1.8	46.2	24.6	67.7	147.7	16.6	16.8	217.4	50.0	21.1	21.7	55.7	12.4	125.7	117.8	217.3	110.6	155.1	4.7	3.7	6.3	106.9	15.2	176.2	0.0	2.0	0.1	0.6	1.7	1.3	0.6	1.2	0.9	1.6	0.6	0.8	0.5	0.4	0.3	1.2	1.3	1.4	2.0	44.2	25.4	20.4	39.7	42.2	31.0	48.5	28.6	30.8	28.8	43.2	25.9	83.8	28.9	15.6	78.0	27.0	108.0	53.1	62.9	50.7	15.8	29.4	27.9	39.3	31.5	42.9	40.5	25.0	34.4	27.1	257.8	0.0	39.3	1.4	39.4	52.6	68.2	32.2	11.8	47.3	20.2	32.1	45.7	170.2	57.3	8.2	14.4	63.1	69.0	35.2	30.3	36.5	79.9	10.2	67.5	100.4	5.0	44.4	61.2	33.8	27.2	54.9	11.2	15.5	14.6	3.4	157.8	194.1	74.9	39.3	144.9	124.9	4.6	50.3	10.8	6.6	42.1	61.5	1.2	7.1	72.2	76.7	69.0	35.0	18.8	61.6	121.0
PLEKHA1	TAPP1	ENSG00000107679	"Pleckstrin homology domain containing A1"	Q9HB21	10	122374696-122442602	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 336.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in all"	6	"B-cells: 10.3;NK-cells: 21.3;T-cells: 27.1"	"Cell line enhanced"	"Detected in many"		"RPTEC TERT1: 203.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002043, HPA064795"	Approved		Enhanced	Nucleoplasm,Cytosol		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 25: Spermatids - Spermatogenesis"	Nucleoplasm	Cytosol	"HPA002043: AB_1079632, HPA064795: AB_2685354"	"unprognostic (1.79e-2)"	"unprognostic (3.18e-2)"	"unprognostic (2.70e-1)"	"unprognostic (5.44e-3)"	"unprognostic (7.41e-2)"	"unprognostic (1.69e-1)"	"unprognostic (5.50e-2)"	"unprognostic (4.07e-2)"	"unprognostic (3.88e-1)"	"unprognostic (2.69e-1)"	"unprognostic (7.98e-2)"	"unprognostic (7.63e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.46e-1)"	"unprognostic (7.42e-2)"	"unprognostic (4.31e-2)"	"unprognostic (5.23e-2)"	18.0	10.4	21.2	13.9	25.5	4.4	19.6	10.7	42.0	18.6	5.0	21.4	25.9	25.9	20.5	39.4	12.7	24.0	29.2	25.9	14.8	39.1	38.7	36.6	14.9	12.4	14.9	19.2	27.3	27.6	21.8	37.3	13.3	17.9	20.1	19.8	25.2	18.8	31.8	66.5	25.1	23.6	13.2	13.7	21.2	40.7	13.7	15.6	27.3	57.4	18.0	24.9	21.7	36.9	25.9	23.5	23.3	16.1	33.1	37.5	28.0	28.2	49.1	16.8	18.0	20.0	31.8	16.1	13.3	25.6	17.0	55.4	22.3	86.1	15.4	11.4	21.8	0.0	22.6	23.6	21.8	2.9	7.3	20.5	69.7	13.9	58.3	27.5	56.8	33.2	24.3	0.1	15.6	9.9	14.8	2.5	18.1	39.3	15.5	4.0	33.1	3.2	203.2	28.3	31.6	15.5	36.4	26.8	28.9	32.7	14.9	0.3	54.6	14.1	11.5	15.4	14.3	0.1	0.0	5.4	21.6	0.1	8.8	0.3	2.7	2.3	27.1	2.4	17.5	5.1	16.3	21.9	3.2	10.3	25.4	21.9	0.8	21.3	2.9	1.6	11.9	11.6	21.2	25.5	10.7	42.0	25.9	14.8	12.4	14.9	13.3	13.2	13.7	36.9	48.6	144.2	42.0	19.9	28.0	72.8	54.7	51.6	97.9	46.5	25.6	19.2	55.9	55.8	46.0	57.0	75.0	58.4	47.6	39.1	41.1	63.1	202.0	50.2	30.6	70.8	22.3	6.9	133.8	85.3	53.9	34.3	28.1	83.7	5.1	20.8	32.5	45.1	37.2	26.9	92.9	19.6	22.4	23.7	23.6	336.5	44.1	20.4	24.9	35.6	28.5	20.2	147.2	35.2	161.9	71.4	26.9	36.1	7.4	91.4	64.4	118.1	29.1	49.5	26.3	32.2	28.9	119.4	86.1	71.6	84.8	39.7	39.7	14.7	27.5	83.5
PLEKHA5	"FLJ10667, KIAA1686, PEPP2"	ENSG00000052126	"Pleckstrin homology domain containing A5"	Q9HAU0	12	19129733-19376400	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 555.7;Inhibitory neurons: 506.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"basophil: 22.6;MAIT T-cell: 5.7"	"Group enriched"	"Detected in many"	6	"granulocytes: 22.6;T-cells: 5.7"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 65.5;NTERA-2: 64.4;SuSa: 61.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035923, HPA035924, HPA041455"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Nucleoplasm, Cytosol"		"HPA035923: AB_10673491, HPA035924: AB_10672994, HPA041455: AB_2677490"	"unprognostic (3.16e-1)"	"unprognostic (8.35e-3)"	"unprognostic (1.30e-1)"	"unprognostic (4.85e-3)"	"unprognostic (6.14e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.32e-1)"	"unprognostic (2.35e-2)"	"unprognostic (3.62e-1)"	"unprognostic (2.55e-1)"	"prognostic unfavorable (5.41e-5)"	"unprognostic (3.71e-1)"	"prognostic unfavorable (7.42e-5)"	"unprognostic (1.27e-1)"	"unprognostic (2.43e-1)"	"unprognostic (4.03e-2)"	"unprognostic (1.07e-2)"	10.5	61.3	7.2	5.2	15.7	3.7	15.3	3.9	15.8	30.7	1.3	12.1	13.0	29.8	32.3	20.7	20.0	18.5	35.2	12.6	7.7	42.7	16.2	12.8	3.1	13.6	16.1	32.7	14.9	21.9	12.6	12.7	11.5	17.3	13.6	35.1	15.5	28.0	2.4	17.7	13.3	15.3	11.8	3.4	18.6	20.5	10.4	8.6	14.6	5.1	4.9	23.5	25.0	14.7	25.8	12.5	45.2	0.4	14.9	20.1	15.8	10.8	23.7	6.5	10.2	19.1	22.8	0.5	3.5	12.1	13.2	10.9	30.8	20.3	13.5	65.5	10.8	15.4	28.1	9.1	14.0	0.3	2.0	11.8	20.4	18.6	35.2	35.5	7.1	12.9	6.7	0.7	7.0	8.0	10.2	1.8	64.4	21.1	6.5	0.2	21.0	0.2	45.6	30.5	4.1	9.1	10.6	5.9	40.3	61.0	7.4	3.5	10.8	4.0	17.3	0.9	0.4	0.6	0.5	0.3	9.8	0.2	8.3	22.6	0.3	0.3	2.4	0.4	5.7	0.2	2.2	2.1	1.8	0.3	0.3	1.6	0.8	1.6	0.2	2.5	2.1	0.4	7.2	15.7	3.9	15.8	12.6	7.7	13.6	16.1	11.5	11.8	10.4	14.7	19.9	25.6	28.2	145.9	3.2	20.5	46.6	42.2	25.0	86.2	27.8	49.7	157.9	57.2	49.5	46.0	137.6	26.8	9.0	25.6	35.2	33.7	25.8	84.2	187.3	17.2	32.4	7.8	555.7	33.1	38.7	79.8	37.8	98.8	3.8	11.3	20.3	38.9	6.6	126.2	506.4	17.9	22.4	10.5	94.1	15.3	40.4	11.4	117.4	178.0	168.2	97.5	0.0	158.8	82.0	52.6	30.9	28.2	4.9	33.4	30.4	115.3	60.6	139.7	32.9	24.7	38.1	45.5	48.8	39.4	25.7	26.4	12.0	75.3	36.9	47.2
PLEKHA7	DKFZp686M22243	ENSG00000166689	"Pleckstrin homology domain containing A7"	Q6IQ23	11	16777297-17014414	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 111.0;Gastric mucus-secreting cells: 40.8;Microglial cells: 48.7;Oligodendrocytes: 37.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"eosinophil: 3.7;MAIT T-cell: 2.0"	"Group enriched"	"Detected in many"	6	"granulocytes: 3.7;T-cells: 2.0"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 116.4;HaCaT: 75.2;OE19: 58.6;RT4: 109.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038610, HPA066103"	Approved		Enhanced	"Nucleoplasm,Cell Junctions,Cytosol"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 77: Retina - Visual perception"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 64: Astrocytes - Nervous system maintenance"	"Nucleoplasm, Cell Junctions"	Cytosol	"HPA038610: AB_10671746, HPA066103: AB_2732738"	"unprognostic (1.05e-1)"	"unprognostic (1.33e-1)"	"unprognostic (3.81e-2)"	"unprognostic (4.30e-2)"	"unprognostic (2.51e-2)"	"unprognostic (6.95e-3)"	"unprognostic (2.81e-2)"	"unprognostic (1.85e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.73e-1)"	"unprognostic (2.65e-3)"	"unprognostic (3.13e-2)"	"prognostic favorable (1.89e-15)"	"unprognostic (9.74e-2)"	"unprognostic (1.17e-2)"	"unprognostic (4.81e-1)"	"unprognostic (2.65e-2)"	10.3	1.7	10.0	5.5	11.9	0.6	13.3	9.6	7.0	11.2	26.5	18.3	27.3	4.1	3.8	46.0	9.1	7.3	24.0	7.5	14.3	26.4	16.7	8.0	2.3	11.5	17.9	12.7	15.2	17.6	4.2	9.0	11.8	7.0	16.9	27.4	21.5	5.3	2.2	14.1	25.4	3.6	7.3	1.8	23.7	10.1	21.2	4.0	10.9	2.2	6.6	14.0	18.3	10.3	14.2	12.7	11.9	5.5	0.7	0.0	20.7	0.1	0.4	4.9	9.0	22.6	116.4	0.2	5.4	1.9	0.7	75.2	16.9	0.2	3.5	4.2	16.2	39.7	11.2	13.5	0.3	0.1	0.5	0.6	6.4	0.0	0.4	10.7	0.0	14.3	1.7	0.4	2.0	8.7	8.8	0.3	6.1	58.6	12.4	11.5	0.0	3.0	10.9	109.9	8.3	0.9	16.7	44.3	0.6	22.3	11.3	4.1	3.3	0.2	4.1	3.2	2.8	7.6	2.4	16.2	0.1	0.8	0.1	0.1	0.1	3.7	0.3	0.0	2.0	0.1	0.3	0.2	0.1	0.0	0.1	0.2	0.3	0.1	0.0	0.4	0.0	0.2	10.0	11.9	9.6	7.0	7.5	14.3	11.5	17.9	11.8	7.3	21.2	10.3	8.2	3.2	17.0	111.0	0.6	0.6	1.1	1.4	0.6	2.3	6.9	6.1	8.7	7.2	8.6	11.0	25.0	6.7	0.2	12.0	3.9	6.1	16.3	20.5	2.3	4.7	0.0	1.3	19.3	6.0	0.9	1.0	40.8	22.9	2.5	16.1	2.2	2.9	1.8	0.0	26.2	6.5	0.0	1.0	1.4	6.1	0.6	2.7	0.0	48.7	0.8	4.3	1.0	15.6	37.9	10.7	4.1	0.4	1.8	0.8	9.2	10.6	8.0	9.7	0.0	1.0	1.2	0.5	0.5	12.3	0.4	6.0	1.2	2.1	3.1	6.4
PLEKHA8	"FAPP2, MGC3358"	ENSG00000106086	"Pleckstrin homology domain containing A8"	Q96JA3	7	30027404-30130483	"Predicted intracellular proteins"	"Lipid transport, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA072314			Supported	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 12: NES - Nervous system development"	"Cluster 44: Endometrium - Transcription"	"Golgi apparatus"	Nucleoplasm	"HPA072314: AB_2686511"	"unprognostic (5.49e-3)"	"unprognostic (8.62e-3)"	"unprognostic (2.39e-1)"	"unprognostic (5.14e-2)"	"unprognostic (1.22e-1)"	"unprognostic (2.71e-1)"	"unprognostic (1.70e-4)"	"unprognostic (5.96e-2)"	"unprognostic (2.86e-1)"	"unprognostic (3.21e-2)"	"unprognostic (1.41e-1)"	"unprognostic (2.31e-2)"	"unprognostic (2.96e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.82e-1)"	"unprognostic (2.19e-2)"	"unprognostic (3.07e-2)"	3.6	2.4	3.7	3.2	3.7	1.5	3.6	5.2	4.4	5.0	3.6	4.0	3.7	3.7	4.2	4.1	3.1	3.0	2.8	4.0	3.1	6.1	3.0	3.5	4.3	4.2	3.5	4.1	3.6	4.2	3.2	8.0	3.3	3.6	3.6	11.8	4.0	3.7	2.4	3.9	4.2	3.8	3.2	2.4	3.4	3.5	4.0	2.8	2.8	2.4	4.7	3.8	4.3	4.3	11.4	7.8	34.5	35.3	9.4	7.3	23.2	8.2	6.6	6.3	8.3	14.1	4.9	25.8	10.5	7.4	16.4	8.2	18.2	9.1	8.9	5.0	12.5	15.1	12.8	13.4	7.9	6.9	5.2	3.8	7.3	8.6	12.4	7.8	13.6	12.3	14.3	9.3	9.1	7.2	13.2	4.6	22.7	5.5	8.6	0.0	9.4	18.2	7.1	9.0	4.4	25.2	8.8	28.9	11.5	30.5	10.2	7.0	11.5	5.7	22.8	5.6	9.4	18.9	35.6	15.4	10.8	4.4	12.8	0.3	0.1	0.5	0.3	0.1	0.1	0.2	0.1	0.2	0.1	0.1	0.2	0.3	0.0	0.2	0.1	0.0	0.1	0.0	3.7	3.7	5.2	4.4	4.0	3.1	4.2	3.5	3.3	3.2	4.0	4.3	8.9	3.2	2.6	32.7	6.6	11.2	6.3	2.3	10.8	14.8	7.0	4.7	3.7	1.5	2.8	12.9	25.0	21.6	4.4	7.2	3.9	11.7	2.0	11.4	10.3	5.8	2.4	3.8	36.0	7.1	19.6	6.0	2.6	14.8	4.5	10.0	3.9	4.6	6.7	10.1	30.2	5.0	8.2	3.4	4.6	1.1	3.4	4.7	10.6	14.0	6.5	6.3	10.3	33.7	24.2	10.2	23.9	4.9	15.8	8.7	9.6	12.2	4.4	18.7	6.6	4.9	10.3	14.0	12.4	7.6	12.6	20.2	4.7	4.9	4.8	10.2
PLEKHG3	"ARHGEF43, KIAA0599"	ENSG00000126822	"Pleckstrin homology and RhoGEF domain containing G3"	A1L390	14	64704102-64750249	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 179.2"	"Cell type enhanced"	"Detected in many"		"Oligodendrocytes: 90.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	6	"granulocytes: 24.0;NK-cells: 9.4;T-cells: 16.2"	"Cell line enhanced"	"Detected in many"		"A-431: 78.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA063455, HPA065323, HPA073702, HPA074734"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cytokinetic bridge,Centrosome,Cytosol"		Yes	No			"Cluster 5: Granulocytes - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Plasma membrane, Cytosol"	"Nucleoplasm, Cytokinetic bridge, Centrosome"	"HPA063455: AB_2685015, HPA065323: AB_2685467, HPA073702: AB_2732238, HPA074734: AB_2732265"	"unprognostic (8.71e-2)"	"unprognostic (1.69e-1)"	"unprognostic (4.38e-2)"	"unprognostic (4.04e-2)"	"unprognostic (2.18e-1)"	"unprognostic (7.22e-2)"	"unprognostic (7.21e-2)"	"unprognostic (5.53e-3)"	"unprognostic (1.49e-1)"	"unprognostic (3.34e-3)"	"unprognostic (3.63e-1)"	"unprognostic (3.54e-2)"	"prognostic favorable (7.39e-8)"	"unprognostic (2.29e-1)"	"unprognostic (2.67e-1)"	"unprognostic (4.24e-2)"	"unprognostic (2.67e-3)"	25.2	3.5	44.0	10.7	92.5	16.3	23.4	47.2	74.1	33.9	53.0	39.0	13.0	67.5	5.0	45.8	38.1	22.6	17.2	44.5	46.7	36.0	36.3	14.3	5.6	65.8	66.3	33.8	33.0	17.0	6.8	29.3	60.9	24.2	15.5	2.9	29.2	37.5	9.7	44.9	13.2	26.4	37.9	26.6	22.3	5.7	74.1	4.6	23.7	7.4	4.9	32.2	39.1	179.2	78.4	36.5	29.8	45.3	3.1	0.0	49.0	8.7	10.4	13.8	11.0	38.9	34.3	0.0	15.3	8.6	4.8	74.6	20.3	69.7	4.7	0.2	16.7	35.1	48.3	9.2	4.0	1.3	16.1	3.9	39.6	2.9	24.4	22.9	9.1	0.3	0.0	0.4	4.6	37.5	0.1	32.0	10.0	21.2	37.0	0.4	14.7	5.5	37.0	58.0	9.9	18.0	17.7	26.7	25.1	27.5	29.0	8.0	16.6	6.0	59.8	0.3	12.3	0.1	0.2	0.1	0.6	3.7	10.7	9.0	3.0	18.2	16.2	1.5	11.1	0.0	5.0	7.3	1.0	0.0	0.5	3.6	24.0	9.4	1.0	0.0	1.7	5.3	44.0	92.5	47.2	74.1	44.5	46.7	65.8	66.3	60.9	37.9	74.1	179.2	3.1	3.2	6.2	15.0	0.7	19.4	19.4	15.1	21.6	5.5	16.0	9.8	7.8	12.8	6.0	47.8	0.0	7.9	14.5	24.7	11.7	26.7	0.9	18.6	18.5	4.0	34.7	0.4	1.0	20.6	9.5	7.4	14.3	23.6	1.3	1.9	3.6	10.1	5.5	0.0	3.2	26.9	18.3	6.5	8.0	1.5	7.5	2.7	5.4	6.5	4.6	9.1	45.3	10.6	90.9	35.3	16.7	25.6	2.8	16.1	2.3	9.5	4.0	0.8	26.3	5.1	25.3	0.2	1.6	25.6	21.5	2.6	9.0	10.5	13.2	32.2
PLEKHG6	"FLJ10665, MYOGEF"	ENSG00000008323	"Pleckstrin homology and RhoGEF domain containing G6"	Q3KR16	12	6310436-6328506	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 33.9;intestine: 43.4"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 117.9;Extravillous trophoblasts: 56.2;Paneth cells: 67.5;Proximal enterocytes: 62.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in single"		"plasmacytoid DC: 1.1"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"BEWO: 153.2;CACO-2: 50.1;CAPAN-2: 27.3;OE19: 48.0;RT4: 53.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA041459, HPA058230"	Uncertain		Supported	"Cell Junctions,Centrosome"		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 37: Intestine - Unknown function"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Cell Junctions"	Centrosome	"HPA041459: AB_10794518, HPA058230: AB_2683645"	"unprognostic (1.67e-1)"	"unprognostic (9.93e-3)"	"unprognostic (1.44e-1)"	"unprognostic (8.03e-3)"	"unprognostic (5.84e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.30e-1)"	"unprognostic (9.20e-2)"	"unprognostic (1.22e-1)"	"unprognostic (3.13e-1)"	"unprognostic (3.68e-2)"	"unprognostic (1.72e-1)"	"unprognostic (6.95e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.44e-1)"	"unprognostic (4.18e-2)"	"unprognostic (5.73e-2)"	15.1	0.3	1.3	4.3	1.2	2.7	12.8	1.5	2.0	7.5	2.1	31.0	36.5	0.5	0.5	33.9	1.0	5.0	0.3	1.0	0.9	2.7	4.5	1.3	0.6	1.4	1.4	0.2	5.6	7.9	5.2	8.5	1.0	3.0	17.9	0.2	13.3	1.3	0.4	12.1	43.4	1.1	0.7	0.5	11.0	0.8	1.3	0.7	3.9	0.2	2.5	15.7	15.0	1.5	0.7	6.0	0.8	0.1	2.9	0.2	153.2	0.3	0.0	0.4	0.3	50.1	27.3	0.3	0.4	0.0	0.2	13.0	0.0	0.4	0.2	0.1	0.1	0.2	1.5	10.2	0.5	0.5	0.4	0.0	0.7	0.2	0.0	0.5	0.1	0.2	0.4	0.3	0.0	7.9	0.0	0.7	12.7	48.0	1.0	0.2	0.2	0.3	0.1	53.2	0.3	0.2	1.2	23.1	0.3	10.9	7.5	0.0	1.2	0.2	0.5	0.6	0.2	0.0	0.1	0.1	0.8	0.7	0.7	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.7	0.0	0.0	1.1	0.0	0.0	1.3	1.2	1.5	2.0	1.0	0.9	1.4	1.4	1.0	0.7	1.3	1.5	0.6	0.0	0.0	0.0	0.2	5.0	7.0	2.8	20.5	0.0	4.6	2.9	0.4	8.6	2.5	1.8	0.0	17.6	0.4	117.9	0.0	12.1	1.4	2.9	1.1	0.8	8.4	0.0	0.2	1.8	56.2	1.5	16.3	4.2	0.0	0.5	0.4	2.3	2.7	0.0	0.2	19.3	0.0	0.0	0.7	2.0	2.5	0.3	0.0	0.0	0.2	0.8	2.1	0.0	0.1	2.2	67.5	0.7	0.2	8.4	62.6	0.8	3.0	0.1	0.0	4.7	3.1	0.2	0.5	14.2	7.0	23.9	0.3	0.0	27.9	21.6
PLEKHM1	KIAA0356	ENSG00000225190	"Pleckstrin homology and RUN domain containing M1"	Q9Y4G2	17	45435900-45490749	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Autophagy, Protein transport, Transport"		"Disease variant, Osteopetrosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 31.7"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"neutrophil: 6.5"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 6.5"	"Cell line enhanced"	"Detected in many"		"OE19: 26.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA025018, HPA039473"	Approved		Supported	Nucleoli,Vesicles		NA	NA			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 44: Endometrium - Transcription"	Vesicles	Nucleoli	"HPA025018: AB_1855465, HPA039473: AB_2676526"	"unprognostic (1.52e-1)"	"unprognostic (3.13e-2)"	"unprognostic (4.29e-2)"	"prognostic favorable (1.28e-6)"	"unprognostic (8.71e-2)"	"unprognostic (3.06e-2)"	"prognostic unfavorable (3.25e-4)"	"unprognostic (2.20e-2)"	"unprognostic (1.88e-1)"	"unprognostic (2.93e-2)"	"unprognostic (4.02e-1)"	"unprognostic (3.93e-2)"	"unprognostic (4.31e-2)"	"unprognostic (2.27e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.76e-1)"	7.0	6.4	2.9	5.5	2.9	9.7	6.2	3.5	3.8	12.9	3.2	6.5	3.5	5.7	1.0	31.7	5.9	5.3	6.2	2.8	3.1	3.6	3.6	8.8	4.8	3.7	3.1	4.9	6.1	4.4	5.7	2.9	3.2	5.1	3.6	1.6	14.4	0.9	12.3	11.8	6.2	2.0	2.8	6.8	5.6	3.4	3.4	5.4	6.5	7.2	4.8	6.8	13.6	3.7	7.3	11.0	1.7	5.4	8.4	4.8	0.1	3.3	4.9	1.9	2.6	4.2	6.0	5.2	3.4	3.9	14.1	1.7	4.1	1.9	1.6	13.7	3.5	0.0	5.6	6.9	2.0	0.0	4.3	2.2	4.9	0.9	8.0	3.8	10.0	0.0	5.2	6.2	9.1	6.0	5.2	1.1	1.7	26.6	9.0	2.8	5.6	5.3	6.0	16.8	3.2	2.1	3.2	4.5	5.2	4.8	10.1	5.3	19.1	12.7	3.6	5.2	5.9	0.6	6.2	1.8	7.7	2.8	5.8	2.8	1.2	1.0	0.2	0.3	0.0	1.2	0.6	0.2	0.3	0.3	0.2	0.0	6.5	0.7	0.4	0.2	0.5	0.2	2.9	2.9	3.5	3.8	2.8	3.1	3.7	3.1	3.2	2.8	3.4	3.7	12.6	12.8	18.1	7.8	17.5	18.0	18.1	10.3	6.8	10.4	11.7	8.4	8.7	15.7	12.7	12.9	16.7	4.8	24.3	25.6	5.9	8.1	4.3	24.9	11.1	12.1	13.8	10.8	13.5	8.2	4.7	12.1	19.9	27.9	1.3	5.4	12.8	8.1	9.1	16.8	13.3	13.0	4.1	27.9	15.2	2.0	7.2	21.1	7.2	9.4	13.7	7.3	14.4	7.5	20.8	18.3	17.7	7.9	22.9	27.2	8.6	10.5	11.9	8.2	0.0	17.7	7.6	7.6	3.7	10.0	16.3	8.6	18.5	9.3	12.2	43.1
PLEKHO1	"CKIP-1, OC120"	ENSG00000023902	"Pleckstrin homology domain containing O1"	Q53GL0	1	150149183-150164720	"Predicted intracellular proteins"			"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 202.3"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 245.9;Langerhans cells: 159.2;Late spermatids: 390.5;Macrophages: 147.9;monocytes: 151.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA061018			Supported	Mitochondria		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 10: Non-specific - Unknown function"	Mitochondria		"HPA061018: AB_2684416"	"unprognostic (1.41e-2)"	"unprognostic (7.04e-3)"	"unprognostic (2.01e-2)"	"unprognostic (1.78e-2)"	"unprognostic (3.23e-2)"	"unprognostic (4.77e-2)"	"unprognostic (1.62e-2)"	"unprognostic (8.33e-2)"	"unprognostic (3.84e-2)"	"unprognostic (3.18e-2)"	"unprognostic (8.71e-2)"	"unprognostic (3.21e-1)"	"prognostic unfavorable (6.47e-11)"	"unprognostic (9.30e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.87e-1)"	"unprognostic (6.52e-2)"	27.7	43.2	49.9	53.9	50.1	17.9	22.6	52.8	61.6	32.3	45.5	202.3	17.8	50.7	5.2	17.5	43.5	20.6	59.3	49.5	47.9	15.9	8.7	34.9	49.5	49.8	48.1	28.1	5.1	4.1	14.9	15.1	48.0	45.5	11.5	4.2	11.0	16.2	39.6	11.2	58.4	40.4	48.9	59.9	55.8	83.2	48.0	33.9	13.0	15.2	26.0	97.5	23.6	48.9	14.3	3.4	46.3	36.0	14.4	12.7	3.8	24.8	32.9	31.8	28.1	1.0	0.4	0.4	4.7	28.5	23.9	1.2	23.3	1.1	10.3	86.7	12.1	2.8	1.9	8.9	27.1	20.0	77.7	18.5	1.0	39.8	6.2	30.6	30.6	38.5	5.4	35.9	43.9	6.7	76.0	40.0	43.7	0.0	6.4	68.1	25.2	16.2	5.6	4.1	28.8	46.9	2.0	0.2	18.7	22.1	2.4	19.4	43.4	20.8	24.1	21.9	30.1	14.0	0.4	9.2	83.4	0.2	8.2	2.6	25.9	0.5	5.6	24.8	6.0	20.0	8.2	5.9	20.1	17.2	5.6	4.7	30.9	4.1	23.4	27.3	6.7	9.2	49.9	50.1	52.8	61.6	49.5	47.9	49.8	48.1	48.0	48.9	48.0	48.9	23.5	35.3	8.9	32.3	65.1	21.5	92.7	2.9	4.6	7.9	11.8	17.9	36.4	2.8	2.9	0.0	0.0	1.7	97.5	0.5	1.9	8.8	245.9	17.9	50.2	58.9	17.8	4.2	13.5	7.8	3.3	29.4	4.6	22.0	5.7	24.5	42.5	1.8	107.1	8.4	24.3	0.9	10.2	85.5	159.2	390.5	17.4	147.9	24.9	21.5	151.1	34.0	23.7	9.0	1.6	10.7	0.0	24.5	23.7	50.1	0.2	0.5	1.3	6.2	72.3	7.5	105.0	122.5	17.5	2.9	14.2	1.5	45.6	8.6	0.4	23.0
PLIN2	"ADFP, ADRP"	ENSG00000147872	"Perilipin 2"	Q99541	9	19108375-19149290	"Metabolic proteins, Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adipose tissue: 621.3;liver: 905.1"	"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 743.3;Hepatocytes: 527.0;Syncytiotrophoblasts: 1815.2"	"Group enriched"	"Detected in all"	5	"liver cancer: 63.0;renal cancer: 136.9"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"basophil: 776.5;eosinophil: 581.9"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 776.5"	"Group enriched"	"Detected in many"	5	"ASC diff: 2345.1;HHSteC: 2025.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016607, CAB037331"	Supported		Supported	"Lipid droplets"		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	"Lipid droplets"		"CAB037331: , HPA016607: AB_2669403"	"unprognostic (2.02e-1)"	"unprognostic (4.30e-2)"	"unprognostic (3.47e-1)"	"unprognostic (2.55e-2)"	"unprognostic (2.41e-2)"	"unprognostic (3.08e-2)"	"unprognostic (3.02e-2)"	"unprognostic (3.28e-3)"	"unprognostic (4.92e-2)"	"unprognostic (4.66e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.20e-1)"	"prognostic unfavorable (3.32e-4)"	"unprognostic (3.14e-3)"	"unprognostic (7.89e-2)"	"prognostic favorable (2.16e-4)"	"unprognostic (1.77e-1)"	621.3	127.5	15.4	44.8	18.1	119.3	460.1	15.9	47.2	96.4	17.4	51.5	186.1	56.1	13.6	20.5	60.0	71.2	215.5	15.8	16.2	169.4	905.1	126.3	38.4	18.9	17.9	44.2	29.6	18.8	34.4	155.9	20.2	30.5	23.2	13.1	47.3	27.9	435.5	103.1	164.3	35.4	15.6	43.9	44.3	24.3	54.5	33.8	32.4	127.4	32.4	107.6	61.9	21.5	0.5	35.0	39.3	28.9	2345.1	318.3	434.8	113.5	87.6	67.7	76.5	54.1	8.3	0.4	2.0	232.9	432.1	4.7	39.1	0.3	115.1	146.9	0.8	191.8	5.4	205.2	2025.0	23.3	336.2	338.2	39.7	165.7	0.4	54.4	84.8	0.1	35.3	40.6	266.2	10.0	53.5	79.4	52.6	1.1	69.5	127.0	18.4	1.3	0.2	133.2	3.0	64.7	52.8	13.2	113.6	49.6	27.0	50.8	134.1	0.1	20.6	105.6	0.5	24.4	26.7	76.2	0.6	39.0	10.9	776.5	111.0	581.9	80.7	149.5	69.9	23.6	69.8	57.9	63.8	25.8	67.3	57.6	6.7	17.2	169.0	7.9	74.7	106.5	15.4	18.1	15.9	47.2	15.8	16.2	18.9	17.9	20.2	15.6	54.5	21.5	280.4	19.2	51.4	7.5	43.9	206.2	507.2	69.5	42.1	2.4	213.3	24.1	62.3	91.5	62.1	12.9	0.0	173.6	77.5	43.3	27.4	105.6	3.6	83.5	188.1	91.2	14.9	78.5	0.6	16.0	743.3	182.0	24.5	232.5	422.1	8.1	94.9	527.0	410.7	11.8	0.8	26.1	26.4	214.1	81.1	12.3	39.7	277.1	87.2	10.3	50.2	44.4	30.9	3.5	2.6	37.4	45.7	69.2	45.3	109.0	382.5	267.9	16.9	4.8	13.1	36.1	68.8	8.0	25.9	12.3	108.5	1815.2	123.3	21.4	44.3	263.3
PLIN3	"M6PRBP1, PP17, TIP47"	ENSG00000105355	"Perilipin 3"	O60664	19	4838341-4867694	"FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	Transport		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Proximal enterocytes: 268.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006427, HPA066538"	Uncertain		Supported	"Lipid droplets"		NA	Yes		11000000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 59: Non-specific - Translation"	"Cluster 18: U-2197 - ECM organization"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Lipid droplets"		"HPA006427: AB_1079289, HPA066538: AB_2685687"	"unprognostic (1.18e-1)"	"unprognostic (4.86e-2)"	"unprognostic (1.55e-2)"	"prognostic favorable (2.62e-4)"	"unprognostic (2.94e-1)"	"unprognostic (1.56e-1)"	"prognostic unfavorable (3.27e-5)"	"prognostic unfavorable (7.67e-6)"	"unprognostic (2.27e-1)"	"unprognostic (1.28e-1)"	"unprognostic (4.34e-2)"	"unprognostic (8.24e-2)"	"prognostic unfavorable (9.15e-7)"	"unprognostic (2.62e-1)"	"unprognostic (2.14e-1)"	"unprognostic (1.95e-1)"	"unprognostic (2.39e-2)"	30.8	69.9	23.3	41.4	39.6	70.8	29.5	44.2	27.5	50.4	25.9	37.6	70.8	22.6	14.4	124.7	22.9	34.5	25.3	22.1	28.6	38.0	26.5	25.7	29.1	51.1	36.1	40.0	20.3	9.8	9.3	33.3	48.9	28.0	20.9	1.7	45.9	21.0	112.0	87.5	73.9	23.9	36.2	32.3	28.5	34.3	39.1	28.0	24.8	36.4	33.0	37.5	55.4	66.0	138.2	79.1	53.6	50.5	59.8	189.8	24.1	196.8	178.9	152.0	142.9	52.6	124.9	72.5	43.3	242.2	82.1	61.3	25.1	108.2	88.2	82.7	35.4	79.1	43.0	97.8	41.4	56.7	112.9	147.1	46.2	107.4	23.6	90.5	81.2	23.5	122.4	31.3	192.1	57.1	78.3	72.9	42.5	63.3	127.7	136.2	74.9	40.2	133.8	31.7	2.3	26.3	62.5	55.5	49.5	43.2	70.4	125.9	125.1	83.3	80.5	333.8	102.9	44.1	58.9	50.8	250.7	79.6	97.3	128.3	141.7	64.8	13.8	100.4	14.6	46.3	24.7	15.9	109.1	36.3	19.4	12.4	173.9	39.5	76.7	82.8	34.1	86.4	23.3	39.6	44.2	27.5	22.1	28.6	51.1	36.1	48.9	36.2	39.1	66.0	19.2	19.2	25.6	5.5	28.5	142.2	62.9	58.8	90.0	0.4	108.0	43.1	2.3	14.3	51.3	11.0	2.1	152.2	34.4	169.7	37.2	114.7	9.7	65.2	50.9	27.7	40.7	18.5	0.8	86.8	77.3	62.9	33.1	78.4	55.8	112.9	26.0	18.2	101.2	0.0	1.1	67.0	28.5	57.8	103.4	14.0	35.8	74.7	55.2	2.8	62.3	23.9	15.5	5.0	17.1	243.4	223.0	53.0	37.1	39.3	268.8	38.8	65.2	0.7	52.6	37.8	66.2	75.1	14.6	109.0	229.3	194.8	20.3	193.4	54.8	69.2
PLIN5	"LSDA5, LSDP5, MLDP, OXPAT"	ENSG00000214456	"Perilipin 5"	Q00G26	19	4522531-4535224	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 202.0;skeletal muscle: 149.2"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 47.1;Astrocytes: 53.8;Cardiomyocytes: 39.8;Hepatic stellate cells: 42.1;Hepatocytes: 140.5"	"Cancer enhanced"	"Detected in many"		"liver cancer: 9.7"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	7	"neutrophil: 13.9"	"Lineage enriched"	"Detected in single"	20	"granulocytes: 13.9"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 2.3;BEWO: 3.2;RT4: 3.1;SH-SY5Y: 2.8;T-47d: 6.3"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA077050			Supported	"Vesicles,Lipid droplets"		NA	NA			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 6: T47d - Mammary gland"	"Cluster 15: Hepatocytes - Hemostasis"	"Vesicles, Lipid droplets"		"HPA077050: "	"prognostic favorable (7.68e-4)"	"unprognostic (1.01e-1)"	"unprognostic (4.22e-2)"	"prognostic unfavorable (8.56e-4)"	"unprognostic (1.24e-2)"	"unprognostic (6.06e-3)"	"prognostic favorable (2.81e-4)"	"unprognostic (1.11e-2)"	"unprognostic (4.67e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.54e-1)"	"prognostic favorable (1.97e-4)"	"unprognostic (3.18e-1)"	"unprognostic (1.40e-1)"	"unprognostic (8.28e-3)"	"prognostic favorable (2.16e-4)"	41.9	6.4	10.8	3.5	11.2	5.2	29.3	6.9	9.6	7.5	12.8	5.4	1.5	2.7	3.9	3.4	12.6	2.0	62.7	8.5	8.1	30.1	202.0	9.3	0.5	8.4	9.2	90.8	112.2	1.5	18.9	0.2	6.9	17.6	0.6	0.9	61.0	3.9	149.2	8.0	5.3	0.5	6.8	8.2	58.9	3.3	9.4	0.4	9.8	24.7	1.0	11.2	2.7	6.4	0.2	0.1	0.5	2.3	1.7	0.1	3.2	0.1	0.1	0.1	0.0	0.2	0.5	0.1	0.7	0.1	0.1	0.2	0.0	0.0	0.0	0.3	0.1	0.1	0.8	1.1	0.4	0.3	0.4	0.4	0.0	0.0	0.0	0.2	0.2	0.1	0.7	0.2	0.1	0.6	0.1	0.4	0.4	0.3	0.3	0.1	0.1	2.1	0.2	3.1	0.3	2.8	0.2	0.4	0.0	0.2	6.3	0.4	0.3	0.3	0.3	0.2	0.2	0.3	0.1	0.1	0.2	0.6	0.1	1.9	0.4	0.8	0.3	0.3	0.2	0.3	0.2	0.2	0.1	0.4	0.3	0.3	13.9	0.6	0.3	0.3	0.1	0.1	10.8	11.2	6.9	9.6	8.5	8.1	8.4	9.2	6.9	6.8	9.4	6.4	6.0	9.6	47.1	53.8	1.6	0.5	18.4	2.3	4.0	1.2	9.2	1.9	39.8	35.8	11.5	1.8	0.0	0.4	0.1	11.9	9.8	8.7	1.5	20.8	1.4	7.4	0.0	2.7	1.1	12.3	0.5	1.3	16.3	5.1	3.8	18.7	42.1	140.5	0.5	0.0	1.8	6.9	4.1	6.9	0.5	0.3	0.3	2.5	0.0	5.6	0.1	8.1	0.0	11.1	2.0	4.8	1.3	2.6	0.5	6.6	0.5	11.1	10.4	1.2	13.1	25.8	1.8	6.2	6.6	0.5	1.0	1.4	1.1	20.5	8.8	11.5
PLK4	"Sak, STK18"	ENSG00000142731	"Polo like kinase 4"	O00444	4	127880893-127899224	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	Dwarfism	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"bone marrow: 22.6;lymphoid tissue: 14.4;testis: 22.6"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 65.9;Late spermatids: 87.5;Spermatocytes: 53.5"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017327, HPA035026, HPA043198"	Approved		Supported	Centrosome,Cytosol		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Centrosome, Cytosol"		"HPA017327: AB_2669584, HPA035026: AB_10602080, HPA043198: AB_2732504"	"unprognostic (2.44e-1)"	"unprognostic (4.24e-2)"	"prognostic favorable (7.46e-5)"	"unprognostic (2.18e-1)"	"unprognostic (3.79e-1)"	"unprognostic (9.20e-2)"	"unprognostic (1.06e-5)"	"prognostic unfavorable (5.13e-4)"	"unprognostic (1.44e-3)"	"unprognostic (5.66e-2)"	"prognostic unfavorable (5.14e-4)"	"unprognostic (1.27e-1)"	"unprognostic (2.22e-11)"	"unprognostic (2.29e-2)"	"unprognostic (3.58e-1)"	"unprognostic (4.75e-2)"	"unprognostic (7.93e-2)"	1.0	1.1	0.4	4.9	0.5	22.6	2.0	0.2	0.7	0.9	0.1	3.5	2.8	1.5	0.6	3.2	1.3	1.1	0.5	0.5	0.6	0.6	0.8	0.9	7.4	0.5	0.5	1.0	0.4	0.6	0.2	3.6	0.4	0.9	4.3	2.1	0.9	0.9	0.1	2.3	2.9	1.8	0.4	1.6	2.0	22.6	0.6	14.4	0.9	0.7	7.3	1.3	1.4	0.4	26.1	12.1	44.3	22.9	1.5	4.2	20.1	24.9	17.6	32.4	33.3	17.0	26.1	34.9	9.0	13.9	26.3	16.7	31.6	19.9	49.6	27.4	13.1	31.6	20.0	16.0	0.5	45.2	35.9	1.4	2.0	29.7	13.6	5.9	25.3	26.3	37.5	45.2	27.6	18.2	69.9	20.1	20.7	26.3	13.6	36.0	30.9	12.1	10.8	16.4	24.4	20.0	15.8	14.2	7.6	18.7	11.5	19.3	11.0	25.3	24.4	17.4	31.4	23.1	27.4	49.0	13.0	33.7	28.7	0.0	0.1	0.4	0.4	0.2	0.3	0.1	0.5	0.5	0.2	0.2	0.1	0.6	0.0	0.4	0.1	0.1	1.2	0.2	0.4	0.5	0.2	0.7	0.5	0.6	0.5	0.5	0.4	0.4	0.6	0.4	1.6	0.0	0.6	0.0	1.6	1.7	0.9	1.7	1.2	1.8	1.0	0.9	0.9	0.0	0.6	1.8	0.0	6.0	1.9	2.0	0.0	0.6	65.9	4.7	1.0	1.0	2.4	19.6	0.8	0.4	12.9	1.6	4.1	2.0	1.3	7.5	0.4	0.5	3.7	0.0	0.8	3.3	6.1	1.3	0.6	87.5	2.8	1.5	0.0	1.0	1.2	1.1	1.0	1.0	1.2	0.1	0.5	0.4	8.7	0.7	0.5	0.6	3.7	0.8	0.0	0.4	3.6	53.5	13.4	6.8	0.9	3.8	2.1	0.8	4.5	1.7
PLPP1	"LPP1, PAP-2a, PPAP2A"	ENSG00000067113	"Phospholipid phosphatase 1"	O14494	5	55424854-55534969	"Enzymes, Metabolic proteins, Predicted membrane proteins"	"Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 359.1;Endometrial stromal cells: 206.7;Hepatic stellate cells: 267.0;Leydig cells: 219.3;Prostatic glandular cells: 182.0"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 200.4"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 445.7;fHDF/TERT166: 142.8;HMC-1: 235.8;HSkMC: 171.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB033331, HPA047815"	Enhanced		Supported	"Plasma membrane"		NA	NA			"Cluster 29: Plasmacytoid DCs - Unknown function"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Plasma membrane"		"CAB033331: AB_2168044, HPA047815: AB_2680164"	"unprognostic (1.22e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.55e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.36e-1)"	"prognostic favorable (6.06e-4)"	"unprognostic (2.81e-1)"	"unprognostic (2.20e-1)"	"unprognostic (4.05e-3)"	"unprognostic (2.43e-2)"	"unprognostic (1.05e-1)"	"unprognostic (4.37e-3)"	"prognostic unfavorable (5.77e-4)"	"unprognostic (3.94e-2)"	"unprognostic (1.66e-1)"	"unprognostic (3.11e-2)"	172.3	78.1	51.5	42.3	59.9	0.9	140.7	63.7	59.4	88.7	59.6	118.3	47.4	119.5	39.8	42.4	73.4	167.5	117.1	49.9	56.8	104.0	67.7	56.2	32.2	62.1	56.2	29.4	35.6	49.0	27.8	37.6	64.2	254.1	65.8	9.7	32.9	61.3	70.0	57.9	79.1	108.9	62.5	31.1	70.9	21.0	58.6	15.8	112.9	81.5	24.2	128.8	63.8	72.9	9.8	24.4	7.0	14.2	445.7	51.8	9.6	21.8	61.4	11.9	27.9	16.7	17.7	10.2	20.0	142.8	31.9	6.5	25.2	12.6	13.5	6.8	20.1	1.1	9.6	21.3	70.5	2.5	235.8	171.3	25.7	17.6	10.9	23.3	19.9	9.1	0.2	27.0	24.1	6.0	6.8	5.5	15.5	1.1	20.0	2.0	11.7	0.9	46.3	79.8	8.4	5.8	21.5	4.2	13.4	28.8	15.6	1.6	24.0	4.0	6.9	17.8	15.5	16.6	7.4	11.8	15.7	1.3	19.5	0.0	0.4	4.0	1.6	0.5	1.7	6.7	5.3	3.4	2.0	3.3	9.5	7.7	0.3	3.0	0.9	15.0	2.6	1.8	51.5	59.9	63.7	59.4	49.9	56.8	62.1	56.2	64.2	62.5	58.6	72.9	359.1	6.4	9.4	0.0	9.8	0.0	51.0	0.0	10.2	4.0	8.4	45.7	0.0	21.5	5.6	29.5	2.1	3.3	5.4	61.0	5.9	25.2	44.4	10.7	206.7	112.3	1.2	5.7	0.0	28.5	11.1	115.5	11.2	18.5	27.8	4.0	267.0	48.3	12.8	1.7	0.0	20.2	0.0	12.0	0.0	21.0	219.3	8.1	0.0	0.0	4.5	16.6	1.0	0.0	0.0	30.0	24.6	88.4	13.0	182.0	49.4	29.3	2.2	5.6	59.2	89.7	49.7	54.4	17.7	10.0	0.0	4.9	11.3	3.1	12.1	42.8
PLPP2	"LPP2, PAP-2c, PPAP2C"	ENSG00000141934	"Phospholipid phosphatase 2"	O43688	19	281040-291403	"Enzymes, Metabolic proteins, Predicted membrane proteins"	"Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 204.5;Ductal cells: 352.1;Proximal enterocytes: 209.8;Rod photoreceptor cells: 234.9;Urothelial cells: 205.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"gdT-cell: 3.2;MAIT T-cell: 6.6"	"Lineage enriched"	"Detected in single"	41	"T-cells: 6.6"	"Cell line enhanced"	"Detected in many"		"A549: 144.1;CAPAN-2: 154.6;OE19: 255.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055540, HPA058428"	Uncertain		Supported	"Plasma membrane"		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 22: Non-specific - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 22: Epithelial cell types - Mixed function"	"Plasma membrane"		"HPA055540: AB_2682839, HPA058428: "	"prognostic unfavorable (4.55e-4)"	"unprognostic (8.91e-3)"	"unprognostic (1.06e-1)"	"prognostic favorable (3.21e-8)"	"unprognostic (2.95e-1)"	"unprognostic (1.36e-1)"	"unprognostic (3.83e-3)"	"unprognostic (5.48e-2)"	"unprognostic (1.59e-1)"	"unprognostic (5.67e-2)"	"unprognostic (1.18e-3)"	"unprognostic (3.85e-1)"	"unprognostic (3.53e-3)"	"unprognostic (1.06e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.30e-3)"	"unprognostic (1.36e-3)"	4.8	13.2	37.7	8.5	61.6	0.0	36.9	57.1	50.0	63.4	26.2	40.5	62.7	16.8	8.4	27.2	81.8	52.4	1.7	38.8	43.5	11.5	3.7	8.3	1.4	57.3	53.6	2.7	37.3	19.5	11.8	3.6	56.2	31.7	32.1	29.6	105.7	32.9	0.6	53.2	51.0	6.4	44.8	4.7	50.3	7.6	49.2	5.2	5.7	0.5	6.0	36.5	14.2	83.9	85.5	144.1	2.1	0.1	0.0	0.3	0.2	8.2	0.0	25.3	18.9	41.7	154.6	0.0	88.3	11.9	0.1	45.3	0.0	17.6	11.1	0.8	2.6	0.0	55.9	0.0	28.6	0.0	5.5	5.2	7.6	12.7	16.7	53.4	4.2	0.0	0.7	0.1	0.0	98.5	0.4	0.1	61.5	255.8	0.0	0.0	0.0	2.4	62.1	13.7	17.4	40.9	23.3	38.3	60.3	5.8	50.0	2.5	4.5	55.7	36.5	0.5	61.9	0.8	101.7	70.4	15.5	0.0	46.9	0.0	0.0	0.0	3.2	0.0	6.6	0.0	1.3	1.6	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.3	37.7	61.6	57.1	50.0	38.8	43.5	57.3	53.6	56.2	44.8	49.2	83.9	17.0	6.4	7.5	0.0	1.5	0.0	134.2	0.0	8.0	19.7	137.1	149.9	0.0	204.5	35.3	22.0	10.4	0.5	2.7	77.0	3.9	352.1	0.3	115.2	9.2	15.2	8.5	0.0	0.0	139.5	15.1	3.0	91.3	90.1	1.3	0.0	0.0	0.5	0.9	16.8	0.0	38.8	0.0	1.0	0.0	1.6	0.0	1.9	0.0	0.0	2.6	21.7	0.0	0.0	0.0	128.8	85.2	0.0	1.6	97.4	209.8	1.4	91.1	234.9	0.0	0.8	2.7	0.6	35.1	20.3	0.0	0.8	3.5	0.1	87.2	205.8
PLPP3	"LPP3, PAP-2b, PPAP2B"	ENSG00000162407	"Phospholipid phosphatase 3"	O14495	1	56494761-56645301	"Enzymes, Metabolic proteins, Plasma proteins, Predicted membrane proteins"	"Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Fibroblasts: 392.7;Hepatic stellate cells: 779.6;Leydig cells: 1092.6;Peritubular cells: 398.7"	"Cancer enhanced"	"Detected in all"		"thyroid cancer: 168.2"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"memory B-cell: 2.4;naive B-cell: 2.3"	"Lineage enriched"	"Detected in single"	6	"B-cells: 2.4"	"Cell line enhanced"	"Detected in many"		"ASC diff: 710.0;ASC TERT1: 351.8;HSkMC: 438.1;U-2197: 660.4"					"Low region specificity"	"Detected in all"			HPA072751	Approved		Supported	"Golgi apparatus"		NA	Yes			"Cluster 19: B-cells - Humoral immune response"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 18: U-2197 - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Golgi apparatus"		"HPA072751: AB_2686555"	"unprognostic (2.50e-2)"	"unprognostic (3.94e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.65e-1)"	"unprognostic (2.71e-1)"	"unprognostic (2.22e-3)"	"unprognostic (5.86e-3)"	"unprognostic (7.25e-2)"	"unprognostic (1.59e-1)"	"unprognostic (3.75e-2)"	"unprognostic (3.91e-2)"	"unprognostic (3.08e-1)"	"prognostic favorable (4.59e-4)"	"unprognostic (3.16e-2)"	"unprognostic (1.74e-1)"	"unprognostic (3.54e-2)"	"unprognostic (2.09e-1)"	168.4	53.0	93.9	33.6	94.2	13.1	139.8	87.3	105.9	294.6	50.7	56.7	24.0	107.2	56.2	51.3	122.5	66.3	84.6	88.3	90.6	91.4	182.0	87.0	22.4	107.5	108.1	81.9	36.8	130.2	23.1	225.5	87.7	102.8	41.8	19.0	76.2	169.7	50.9	82.1	45.8	65.6	86.8	23.3	66.0	37.3	113.2	29.8	327.6	63.0	19.9	139.2	142.8	88.6	3.3	10.8	14.1	1.5	710.0	351.8	34.5	39.3	39.7	35.5	17.4	31.8	6.2	5.2	4.6	59.3	39.4	5.9	2.1	0.8	7.4	0.0	9.4	1.3	4.4	44.5	17.3	0.1	0.0	438.1	3.0	34.2	28.6	25.1	34.1	0.4	2.9	0.1	39.0	3.2	0.1	0.5	43.3	9.2	42.6	0.1	0.1	1.7	6.1	32.6	0.4	28.1	12.4	16.1	4.2	42.6	5.2	0.0	21.6	176.2	14.4	660.4	1.8	0.0	0.0	0.0	31.0	1.7	12.7	0.0	0.1	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	2.3	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.1	93.9	94.2	87.3	105.9	88.3	90.6	107.5	108.1	87.7	86.8	113.2	88.6	148.5	25.6	18.9	0.0	7.2	0.0	19.8	0.0	35.3	3.9	12.2	31.2	0.0	44.3	13.0	22.0	0.0	127.0	1.1	8.1	21.5	21.5	7.9	13.9	139.4	148.3	2.4	8.0	0.0	9.2	9.8	392.7	5.6	16.3	3.8	8.1	779.6	132.6	38.8	0.0	0.0	8.5	0.0	35.2	0.0	28.3	1092.6	14.9	0.0	0.0	0.9	136.0	0.0	0.0	0.0	7.9	5.9	398.7	7.1	20.8	15.5	21.3	4.4	4.1	138.1	179.7	107.2	4.5	3.4	16.4	0.0	214.9	5.0	22.4	7.2	20.1
PLPP7	"C9orf67, FLJ14662, MGC12921, NET39, PPAPDC3"	ENSG00000160539	"Phospholipid phosphatase 7 (inactive)"	Q8NBV4	9	131289459-131359022	"Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	8	"heart muscle: 91.2;skeletal muscle: 210.1;tongue: 74.4"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 18.8;Horizontal cells: 8.4;Leydig cells: 5.0;Skeletal myocytes: 7.0"	"Cancer enhanced"	"Detected in many"		"glioma: 5.4"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 11.1;ASC diff: 11.4;ASC TERT1: 8.6;SCLC-21H: 11.3;SH-SY5Y: 8.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA070252	Uncertain		Approved	Nucleoplasm,Vesicles		No	No			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 37: Myocytes - Muscle contraction"	Vesicles	Nucleoplasm	"HPA070252: AB_2686242"	"unprognostic (2.19e-1)"	"unprognostic (3.07e-1)"	"unprognostic (3.07e-2)"	"unprognostic (2.71e-1)"	"unprognostic (8.78e-2)"	"unprognostic (7.03e-2)"	"unprognostic (1.23e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.65e-1)"	"unprognostic (3.96e-3)"	"unprognostic (1.47e-1)"	"unprognostic (1.71e-3)"	"unprognostic (3.69e-2)"	"unprognostic (1.10e-2)"	"unprognostic (7.85e-2)"	"unprognostic (9.72e-3)"	4.8	9.7	10.0	1.1	11.5	0.4	4.9	16.4	13.9	6.3	1.4	9.6	0.7	6.4	0.6	2.5	5.1	2.1	91.2	10.6	9.1	4.2	0.3	2.1	0.5	11.0	10.7	8.7	2.3	1.2	4.7	0.5	11.1	4.9	0.5	4.0	3.4	2.5	210.1	1.4	3.1	2.7	8.8	2.4	3.1	5.0	11.7	0.4	1.8	74.4	0.3	6.7	4.0	11.0	0.0	0.0	2.2	11.1	11.4	8.6	2.3	1.7	1.2	0.3	0.0	0.0	0.0	0.0	0.3	4.5	2.4	0.0	0.2	0.0	0.1	0.0	1.9	0.0	0.1	3.6	2.8	0.0	0.0	2.9	0.0	3.1	0.0	0.0	0.0	0.0	0.2	0.0	5.2	0.1	0.0	0.1	2.6	0.0	0.0	0.0	0.0	0.0	2.5	0.0	11.3	8.7	0.0	0.1	0.0	0.3	0.3	2.8	0.1	0.1	0.7	0.5	0.0	0.0	0.4	0.0	1.9	0.0	1.8	0.0	2.6	0.0	0.0	1.7	0.0	0.4	0.0	0.0	2.3	0.5	0.2	0.2	0.0	1.3	1.5	1.0	0.0	0.9	10.0	11.5	16.4	13.9	10.6	9.1	11.0	10.7	11.1	8.8	11.7	11.0	1.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	18.8	0.1	0.0	0.0	0.0	0.0	1.8	2.1	0.1	0.1	0.0	1.9	0.0	1.4	0.1	1.7	1.4	0.0	1.3	0.0	0.6	0.7	4.1	0.0	0.1	0.0	0.8	1.1	0.0	0.5	8.4	0.0	0.0	0.0	0.3	0.0	1.7	5.0	2.2	0.0	0.0	0.1	2.6	0.0	0.0	0.0	0.3	0.0	3.8	0.7	0.0	0.0	2.3	0.0	3.7	0.0	7.0	3.0	0.0	0.1	0.0	0.0	0.0	0.2	1.5	0.0	0.0
PLPPR1	"FLJ20300, LPPR1, MGC26189, PRG-3"	ENSG00000148123	"Phospholipid phosphatase related 1"	Q8TBJ4	9	101028727-101325135	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 12.8;kidney: 15.6"	"Group enriched"	"Detected in some"	4	"Distal tubular cells: 37.2;Early spermatids: 12.3;Proximal tubular cells: 39.0"	"Group enriched"	"Detected in some"	5	"glioma: 11.1;liver cancer: 5.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"Hep G2: 3.7;SCLC-21H: 9.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA014760, HPA014968, HPA014979"	Supported		Supported	Nucleoplasm		NA	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Nucleoplasm		"HPA014760: AB_2669084, HPA014968: AB_1855702, HPA014979: AB_2669130"	"unprognostic (1.08e-2)"	"unprognostic (2.79e-1)"	"unprognostic (2.98e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.14e-1)"	"unprognostic (7.33e-2)"	"unprognostic (3.41e-1)"	"prognostic favorable (1.37e-4)"	"unprognostic (2.09e-1)"	"unprognostic (1.14e-1)"	"unprognostic (9.86e-4)"	"unprognostic (1.44e-1)"	"unprognostic (1.65e-6)"	"unprognostic (3.68e-2)"	"unprognostic (1.46e-1)"	"unprognostic (2.85e-1)"	"unprognostic (4.83e-2)"	0.0	0.1	9.7	0.0	12.8	0.0	0.7	7.1	12.7	0.1	5.2	0.2	0.0	0.0	2.8	0.0	0.2	0.0	0.0	10.4	9.3	15.6	3.6	1.4	0.0	10.2	9.1	0.0	0.3	0.0	0.1	0.0	9.8	0.2	0.1	1.5	0.3	0.0	0.0	0.1	0.0	0.0	9.6	0.0	0.1	0.6	10.9	0.4	0.0	0.0	0.0	0.0	0.0	11.5	0.0	0.1	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.6	0.0	0.0	0.0	0.0	0.0	0.7	9.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.7	12.8	7.1	12.7	10.4	9.3	10.2	9.1	9.8	9.6	10.9	11.5	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.3	2.3	0.0	1.5	0.6	0.0	0.0	0.0	0.1	0.0	37.2	0.0	12.3	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.7	0.1	0.0	0.0	0.1	0.0	0.0	0.0	4.3	0.0	0.1	0.0	0.0	0.0	6.2	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.2	0.0	39.0	0.0	1.0	0.0	0.2	0.0	0.0	1.3	0.0	0.0	0.0	0.2	0.0	0.2	0.0
PLRG1	"Cwc1, PRL1, Prp46, PRPF46, TANGO4"	ENSG00000171566	"Pleiotropic regulator 1"	O43660	4	154535005-154550400	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA035931, HPA035932, HPA061486"	Supported		Enhanced	"Nuclear membrane,Nuclear speckles"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 52: Non-specific - Ribosome"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Nuclear speckles"	"Nuclear membrane"	"HPA035931: AB_2674868, HPA035932: AB_10673224, HPA061486: AB_2684536"	"unprognostic (6.51e-2)"	"unprognostic (5.66e-3)"	"unprognostic (6.10e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.61e-2)"	"unprognostic (2.17e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.85e-2)"	"unprognostic (2.88e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.74e-2)"	"prognostic favorable (8.20e-5)"	"unprognostic (2.92e-1)"	"unprognostic (9.84e-3)"	"unprognostic (1.64e-2)"	"unprognostic (1.97e-1)"	29.4	21.9	22.8	24.9	26.3	31.1	38.7	26.0	24.3	32.8	20.8	30.9	24.8	34.0	28.6	33.9	34.2	24.8	25.9	22.6	32.6	38.1	43.8	27.3	35.2	30.5	26.8	34.0	19.6	41.1	16.0	28.3	30.7	27.4	34.2	26.4	25.8	33.7	31.7	26.4	25.8	44.6	33.5	27.7	26.4	21.4	25.3	40.4	38.0	39.5	51.2	34.8	22.7	39.2	73.2	58.6	73.7	79.4	85.1	73.5	62.3	91.6	111.2	121.9	98.9	69.3	62.7	79.1	45.7	109.1	80.3	52.4	97.2	122.1	134.5	80.2	48.7	95.1	45.1	67.8	87.0	96.0	76.4	79.7	110.8	144.6	112.6	73.0	106.1	85.3	98.9	98.2	107.2	52.3	73.9	45.7	56.1	57.5	62.7	72.2	38.5	48.2	84.8	46.1	43.0	48.6	55.9	59.3	91.7	69.4	57.1	66.4	69.3	72.4	81.9	64.6	82.9	50.9	72.0	100.6	68.1	45.6	98.8	53.0	37.0	29.7	41.6	43.3	49.9	47.0	43.5	45.7	47.6	36.2	45.9	43.2	9.4	67.6	63.9	46.4	55.7	49.4	22.8	26.3	26.0	24.3	22.6	32.6	30.5	26.8	30.7	33.5	25.3	39.2	26.9	25.6	18.1	29.0	26.9	16.3	31.2	98.7	18.2	26.2	19.6	22.9	24.7	20.0	50.7	22.0	12.5	49.1	23.6	18.0	15.6	48.0	31.7	22.7	33.0	27.5	27.1	30.5	23.6	34.7	37.9	30.9	17.9	20.3	45.7	27.0	16.1	26.8	34.2	62.2	21.7	15.9	73.2	19.3	12.0	5.8	28.0	17.2	14.2	17.8	36.8	31.2	28.8	14.1	25.0	32.6	20.9	35.0	21.8	14.9	33.7	35.0	45.2	21.4	19.7	31.2	40.8	36.4	30.2	25.0	17.3	44.3	26.9	36.8	22.3	20.6
PLS3	T-plastin	ENSG00000102024	"Plastin 3"	P13797	X	115561174-115650861	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"		Actin-binding	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 209.3;Alveolar cells type 1: 211.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"NK-cell: 3.7;plasmacytoid DC: 12.2"	"Group enriched"	"Detected in many"	6	"dendritic cells: 12.2;NK-cells: 3.7"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020433, HPA076083"	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA		120000000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Plasma membrane, Cytosol"		"HPA020433: AB_2670440, HPA076083: AB_2686773"	"unprognostic (1.32e-1)"	"unprognostic (1.85e-2)"	"unprognostic (6.10e-2)"	"unprognostic (4.37e-2)"	"unprognostic (9.63e-2)"	"prognostic unfavorable (6.07e-5)"	"unprognostic (2.40e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.83e-2)"	"unprognostic (1.31e-1)"	"prognostic unfavorable (4.59e-4)"	"unprognostic (2.23e-1)"	"prognostic unfavorable (1.01e-4)"	"unprognostic (5.15e-2)"	"unprognostic (1.54e-1)"	"prognostic favorable (3.72e-4)"	"prognostic unfavorable (7.04e-4)"	120.8	32.4	33.2	36.3	40.6	1.4	71.4	44.3	43.6	83.7	22.1	46.4	21.8	120.5	76.2	117.8	68.3	83.1	57.9	30.7	34.9	113.2	202.0	139.8	24.2	43.5	40.1	101.5	31.4	12.7	11.7	78.4	42.2	43.6	31.8	11.9	46.8	103.2	31.4	119.5	25.0	119.4	38.4	99.8	37.7	22.3	39.5	27.2	175.0	48.8	41.9	75.4	88.5	47.9	206.2	207.1	176.8	51.5	174.3	161.7	269.3	208.2	233.1	194.5	233.9	225.0	167.2	0.8	590.0	171.9	140.6	256.7	190.5	339.1	314.2	2.9	235.8	19.4	234.6	95.0	157.5	0.1	9.6	103.1	159.5	302.7	211.1	315.3	429.5	16.8	0.5	0.3	188.9	59.7	0.4	2.3	234.6	88.0	243.2	0.4	117.8	4.9	233.1	109.1	0.6	36.9	436.8	107.9	89.7	253.7	60.2	3.0	474.3	314.5	53.9	324.6	422.8	7.8	30.5	4.2	137.6	0.8	133.4	0.7	0.0	0.0	0.1	0.1	0.0	0.0	0.4	0.1	0.4	0.0	0.1	0.0	0.1	3.7	0.0	12.2	1.4	0.2	33.2	40.6	44.3	43.6	30.7	34.9	43.5	40.1	42.2	38.4	39.5	47.9	209.3	211.5	88.6	26.8	2.0	124.9	121.4	79.6	48.9	0.2	5.6	25.4	17.9	24.3	79.4	99.3	0.0	4.0	1.6	3.5	13.7	59.0	8.4	33.0	39.4	130.5	13.2	4.4	12.3	53.8	105.3	74.3	31.1	64.1	0.0	60.5	64.2	92.1	3.9	0.0	47.6	6.9	38.7	5.0	21.7	8.0	51.9	3.0	56.9	40.3	0.6	26.4	0.0	1.5	97.9	68.6	6.5	82.8	1.6	80.7	2.2	22.0	31.2	1.5	52.6	19.8	132.3	1.2	17.7	65.5	134.1	4.5	3.6	131.1	11.1	100.6
PLSCR1	MMTRA1B	ENSG00000188313	"Phospholipid scramblase 1"	O15162	3	146515180-146544856	"Predicted intracellular proteins, Transporters"	"Antiviral defense, Host-virus interaction"	"DNA-binding, Host cell receptor for virus entry, Hydrolase, Nuclease, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Ductal cells: 291.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+: 319.8;BJ hTERT+ SV40 Large T+ RasG12V: 418.6;HHSteC: 292.9;SK-MEL-30: 569.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA068923, CAB070421"	Approved		Supported	"Nucleoplasm,Golgi apparatus,Plasma membrane"		NA	Yes			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 1: Pancreatic cells - Digestion"	"Nucleoplasm, Plasma membrane"	"Golgi apparatus"	"CAB070421: AB_11153452, HPA068923: AB_2686059"	"unprognostic (7.88e-2)"	"unprognostic (1.10e-1)"	"unprognostic (5.34e-2)"	"prognostic unfavorable (1.35e-4)"	"unprognostic (1.12e-1)"	"unprognostic (3.35e-1)"	"unprognostic (5.22e-2)"	"unprognostic (7.73e-3)"	"unprognostic (9.19e-3)"	"unprognostic (6.93e-3)"	"unprognostic (3.07e-3)"	"unprognostic (1.10e-1)"	"unprognostic (1.09e-3)"	"unprognostic (5.26e-2)"	"unprognostic (1.64e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.63e-1)"	60.6	23.0	11.4	86.7	12.5	64.4	45.9	12.7	17.6	25.9	11.9	65.0	39.8	28.2	31.0	47.9	40.0	66.1	24.3	12.1	13.5	71.9	49.2	49.3	40.6	17.4	14.2	34.9	38.3	16.8	15.4	56.3	15.3	23.7	59.5	9.8	49.1	49.6	10.8	13.6	45.4	41.9	16.2	64.5	44.0	17.1	14.7	30.0	27.8	17.6	39.4	68.1	29.5	14.0	106.2	41.5	26.4	12.1	40.9	65.0	40.5	32.6	88.4	319.8	418.6	34.0	88.1	8.4	75.6	20.6	245.9	86.2	21.2	32.7	56.6	32.9	21.6	66.1	12.5	25.2	292.9	40.3	35.4	106.3	53.3	36.6	182.3	52.6	49.4	19.1	44.7	104.0	66.9	41.0	30.6	16.1	25.8	71.6	37.6	27.4	28.1	2.9	95.9	29.6	16.3	0.0	42.6	20.9	569.9	35.8	20.7	46.8	30.6	26.9	22.7	59.1	55.8	79.2	15.6	0.4	27.0	29.0	23.3	41.1	157.6	44.3	20.8	159.6	30.0	25.2	13.5	18.5	105.8	19.7	9.3	13.9	100.0	57.8	94.8	28.5	8.3	79.3	11.4	12.5	12.7	17.6	12.1	13.5	17.4	14.2	15.3	16.2	14.7	14.0	191.4	35.3	43.0	12.7	28.2	37.0	106.5	92.1	26.2	0.7	36.0	22.6	7.3	124.4	110.4	95.6	0.0	53.7	25.4	134.2	74.3	291.6	2.0	56.1	24.5	135.2	33.1	18.3	7.1	217.4	114.1	74.8	47.9	58.2	28.4	60.5	100.6	29.7	139.9	0.0	9.0	71.5	79.3	86.2	162.9	6.8	114.9	185.5	48.0	35.6	72.3	64.3	32.0	7.1	0.3	157.6	110.3	45.9	18.2	79.6	40.7	75.0	133.5	1.6	39.5	63.4	59.2	1.5	2.4	21.8	28.6	44.5	25.9	42.6	69.4	211.9
PLSCR3		ENSG00000187838	"Phospholipid scramblase 3"	Q9NRY6	17	7389727-7394842	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 3.2;Alveolar cells type 2: 3.0;Ductal cells: 5.8;Exocrine glandular cells: 3.6;monocytes: 2.0;Pancreatic endocrine cells: 8.6"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA048387, HPA068609"	Supported		Supported	Mitochondria		NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 72: Non-specific - Transcription"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	Mitochondria		"HPA048387: AB_2680381, HPA068609: AB_2686011"	"unprognostic (1.86e-2)"	"unprognostic (5.29e-2)"	"unprognostic (2.29e-2)"	"unprognostic (1.56e-2)"	"unprognostic (4.36e-2)"	"unprognostic (5.02e-2)"	"unprognostic (2.27e-2)"	"unprognostic (9.71e-2)"	"unprognostic (1.75e-3)"	"unprognostic (1.91e-1)"	"unprognostic (1.11e-2)"	"unprognostic (1.77e-2)"	"unprognostic (2.11e-5)"	"unprognostic (1.24e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.97e-1)"	"unprognostic (2.55e-2)"	39.5	21.1	7.4	11.0	7.5	3.3	35.0	7.0	8.5	46.2	7.2	27.1	3.1	44.5	5.9	37.4	29.4	6.5	32.0	6.8	7.4	23.5	14.4	32.8	10.5	8.5	7.3	30.5	16.7	5.6	16.4	7.0	7.6	24.7	3.4	1.2	22.9	8.0	21.2	35.2	21.9	12.3	7.4	40.7	21.9	6.1	8.1	6.4	22.8	11.1	10.5	34.8	38.1	7.7	26.7	6.6	5.7	17.2	19.4	32.8	6.8	24.1	22.1	21.3	19.3	9.8	6.6	7.3	19.4	35.1	9.0	37.6	7.0	41.4	10.9	19.0	4.0	6.7	9.2	6.0	23.6	2.5	8.2	22.6	25.4	20.7	30.1	32.0	32.3	14.5	4.1	5.6	27.1	14.3	7.7	2.0	5.1	7.1	18.3	15.1	4.3	8.3	20.1	17.7	4.7	15.6	13.9	8.8	5.9	5.0	16.0	1.3	53.2	13.9	14.5	15.7	10.3	6.2	7.4	3.0	22.4	8.4	15.9	7.0	24.5	2.8	39.5	34.1	40.8	32.2	72.8	40.7	24.1	32.5	59.2	36.1	2.6	18.0	30.2	2.8	83.5	33.3	7.4	7.5	7.0	8.5	6.8	7.4	8.5	7.3	7.6	7.4	8.1	7.7	1.0	3.2	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	5.8	0.0	0.1	1.0	1.0	0.0	0.0	0.0	3.6	0.3	1.0	0.0	0.1	1.3	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	2.0	0.0	0.0	0.0	0.0	8.6	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.3	0.6	0.1	0.0	0.0
PLXDC2	"FLJ14623, TEM7R"	ENSG00000120594	"Plexin domain containing 2"	Q6UX71	10	19816239-20289856	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"Microglial cells: 1508.4;Oligodendrocytes: 470.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"classical monocyte: 57.5;intermediate monocyte: 33.4;myeloid DC: 36.0;neutrophil: 81.6;non-classical monocyte: 37.3"	"Group enriched"	"Detected in many"	13	"dendritic cells: 36.0;granulocytes: 81.6;monocytes: 57.5"	"Cell line enhanced"	"Detected in some"		"HHSteC: 19.4;U-2197: 45.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017268, HPA070793"	Approved		Supported	"Nuclear bodies"		No	No		720000000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 18: U-2197 - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Nuclear bodies"		"HPA017268: AB_10965928, HPA070793: AB_2686313"	"unprognostic (1.75e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.15e-1)"	"unprognostic (3.05e-1)"	"unprognostic (3.31e-2)"	"unprognostic (2.99e-1)"	"unprognostic (1.94e-2)"	"unprognostic (1.57e-1)"	"unprognostic (5.32e-2)"	"unprognostic (7.52e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.35e-1)"	"unprognostic (5.44e-2)"	"unprognostic (3.91e-3)"	"unprognostic (8.71e-2)"	"unprognostic (3.35e-1)"	"unprognostic (2.66e-2)"	12.4	9.4	13.3	7.3	14.1	5.2	11.5	9.6	13.3	12.7	16.8	5.3	4.2	10.7	3.5	7.5	10.1	17.4	10.2	11.3	25.6	10.7	3.1	17.1	2.4	18.0	17.3	9.4	3.6	16.2	3.3	4.7	19.2	7.6	4.6	18.2	6.2	7.7	5.0	15.5	7.1	16.2	16.2	9.4	3.8	5.9	22.3	2.5	6.8	10.0	2.8	8.5	8.9	29.1	0.0	0.0	5.8	0.0	0.0	0.0	6.7	0.2	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	7.7	2.2	1.8	0.0	0.0	0.7	2.8	8.6	0.4	19.4	0.0	0.0	7.7	0.6	0.0	2.3	8.9	0.0	0.0	0.1	1.7	0.9	1.1	0.6	0.1	3.4	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.4	0.2	2.4	0.4	0.0	1.8	0.8	0.9	0.0	7.6	3.9	45.9	0.0	0.1	0.0	0.0	3.5	0.1	0.0	10.7	57.5	11.8	1.3	33.4	2.7	0.0	0.0	0.3	36.0	0.0	0.0	0.0	81.6	4.4	37.3	1.6	0.0	17.7	13.3	14.1	9.6	13.3	11.3	25.6	18.0	17.3	19.2	16.2	22.3	29.1	101.4	16.0	8.9	131.9	2.6	36.8	23.8	12.3	41.5	44.2	14.4	45.3	10.9	15.7	10.9	5.5	8.4	0.9	2.9	7.1	0.0	6.9	2.9	16.5	7.6	45.3	3.0	10.5	190.9	0.0	8.1	97.2	1.1	19.4	31.6	80.9	82.1	4.2	94.3	1.7	59.9	27.3	8.2	91.3	46.3	2.1	19.3	147.7	7.2	1508.4	94.5	25.5	5.2	158.3	470.2	1.0	16.6	57.2	3.8	5.5	16.0	22.2	3.0	73.6	19.7	110.1	12.7	1.6	1.2	35.5	38.1	1.2	4.2	71.4	8.8	11.7
PLXNA1	"NOV, PLXN1"	ENSG00000114554	"Plexin A1"	Q9UIW2	3	126988594-127037392	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 48.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007499, CAB012483"	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA		10000000		"Cluster 17: Adrenal gland - Steroid metabolism"	"Cluster 15: RT4 - Unknown function"	"Cluster 50: Fibroblasts - ECM organization"	Nucleoplasm	Cytosol	"CAB012483: , HPA007499: AB_1079637"	"unprognostic (1.87e-1)"	"unprognostic (1.11e-1)"	"unprognostic (4.38e-2)"	"unprognostic (1.19e-2)"	"unprognostic (1.66e-2)"	"unprognostic (4.17e-2)"	"prognostic unfavorable (4.13e-6)"	"unprognostic (1.79e-2)"	"unprognostic (9.06e-2)"	"prognostic unfavorable (1.35e-4)"	"unprognostic (3.77e-2)"	"unprognostic (7.45e-2)"	"prognostic unfavorable (5.64e-5)"	"unprognostic (4.50e-3)"	"unprognostic (7.62e-3)"	"unprognostic (1.37e-3)"	"unprognostic (1.73e-1)"	11.2	7.6	13.9	7.0	13.0	1.0	9.6	0.6	16.4	11.6	0.5	9.1	3.4	10.9	2.3	11.3	10.2	4.8	15.8	14.0	7.9	8.6	3.2	14.7	6.3	5.5	5.6	13.8	9.3	24.0	5.5	8.2	5.6	9.3	1.9	1.7	12.9	6.3	10.9	15.1	7.9	5.2	1.3	13.2	7.9	9.0	14.8	6.3	9.6	6.1	4.2	9.8	10.0	5.5	45.3	21.1	22.8	18.1	29.3	32.7	36.3	26.3	22.2	14.8	14.7	70.2	20.6	5.0	38.6	28.4	20.0	68.2	11.7	51.6	6.1	7.2	18.6	0.7	13.4	18.3	19.2	5.4	3.6	32.8	35.4	27.4	21.2	14.9	7.5	14.7	26.3	9.1	16.1	26.3	10.6	9.9	22.0	14.2	18.5	14.0	58.0	14.1	12.9	89.4	20.2	22.1	19.1	17.9	24.7	14.7	28.8	33.9	28.0	23.6	30.0	43.4	28.1	5.5	3.9	9.8	33.9	10.2	25.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	13.9	13.0	0.6	16.4	14.0	7.9	5.5	5.6	5.6	1.3	14.8	5.5	1.9	48.1	4.1	8.8	1.8	15.8	5.6	23.4	6.2	6.7	6.6	7.4	13.0	1.5	18.6	12.9	4.2	21.8	0.8	3.6	0.0	8.9	4.4	5.0	10.0	3.8	9.6	0.4	22.1	6.9	2.5	13.8	7.1	5.6	0.0	20.8	2.2	0.9	13.1	20.2	11.3	4.0	0.0	7.4	12.8	1.0	7.8	7.4	8.8	5.6	1.0	2.5	1.0	13.6	3.6	17.0	2.3	6.4	3.1	21.3	7.4	1.5	11.2	3.3	6.6	6.4	9.9	5.3	9.5	6.7	16.1	7.3	2.2	4.7	5.1	9.5
PMEL	"D12S53E, gp100, Pmel17, SI, SIL, SILV"	ENSG00000185664	"Premelanosome protein"	P40967	12	55954105-55973317	"Predicted intracellular proteins, Predicted membrane proteins"	"Melanin biosynthesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	9	"cervix: 80.5;endometrium 1: 32.2;skin 1: 115.2"	"Cell type enriched"	"Detected in many"	32	"Melanocytes: 1472.7"	"Cancer enriched"	"Detected in many"	500	"melanoma: 2481.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in many"	68	"SK-MEL-30: 8590.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			HPA031649	Enhanced		Supported	"Endoplasmic reticulum,Golgi apparatus"	"Intracellular and membrane"	NA	NA		11000000	"Cluster 6: Non-specific - Transcription"	"Cluster 31: Skin - Epidermis development"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 48: Smooth muscle cells - ECM organization"	"Endoplasmic reticulum"	"Golgi apparatus"	"HPA031649: AB_2673976"	"unprognostic (4.63e-1)"	"unprognostic (8.93e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.60e-1)"	"unprognostic (5.90e-2)"	"unprognostic (6.46e-2)"	"unprognostic (1.94e-1)"	"unprognostic (1.46e-3)"	"unprognostic (6.44e-2)"	"unprognostic (1.21e-1)"	"unprognostic (5.12e-2)"	"unprognostic (3.98e-1)"	"prognostic favorable (3.70e-4)"	"unprognostic (2.86e-2)"	"unprognostic (1.54e-1)"	"unprognostic (7.60e-2)"	"unprognostic (1.04e-1)"	3.3	0.8	0.2	0.8	0.2	1.8	8.3	0.7	0.5	80.5	0.3	1.3	1.6	32.2	1.5	0.7	1.2	1.6	0.6	0.3	0.0	2.1	5.0	0.9	5.6	0.0	0.4	4.3	2.3	1.7	0.7	2.8	0.1	0.9	1.2	0.4	3.5	0.8	0.3	115.2	2.1	3.5	0.0	0.5	1.1	4.8	0.0	0.7	1.1	0.2	2.2	1.3	4.0	0.3	14.8	1.1	5.6	0.2	83.6	0.6	126.2	0.9	0.8	1.9	2.0	12.8	6.0	2.6	6.1	0.8	0.3	2.5	0.6	1.0	1.6	3.0	2.1	2.4	2.5	0.7	0.3	1.0	1.4	0.5	1.0	1.2	0.6	1.3	1.0	1.1	0.5	1.8	0.5	2.7	0.4	1.0	17.1	2.8	0.3	1.6	3.5	1.5	1.4	2.7	0.5	2.6	0.3	2.5	8590.9	4.6	4.4	8.8	1.4	0.9	6.5	0.7	7.9	2.1	10.4	3.2	1.0	2.7	0.3	0.0	0.3	0.1	0.0	0.0	0.4	0.3	0.1	0.0	0.0	0.1	0.2	0.0	0.4	0.0	0.0	0.4	0.0	0.1	0.2	0.2	0.7	0.5	0.3	0.0	0.0	0.4	0.1	0.0	0.0	0.3	0.8	0.0	0.5	0.0	0.1	45.9	0.8	1.1	2.8	0.0	1.0	0.9	0.4	1.5	2.2	0.0	0.0	12.1	0.0	1.5	0.0	2.1	8.0	0.7	0.2	1.2	0.0	0.8	0.1	2.3	12.4	1.6	1.1	0.5	0.0	11.1	0.0	2.9	1.7	0.0	0.1	1.6	0.0	0.3	14.6	5.3	12.2	0.6	1472.7	1.0	0.6	0.2	0.0	0.0	0.1	1.0	0.6	0.7	1.2	0.5	2.4	2.8	1.0	0.0	0.0	0.2	1.7	3.9	2.6	1.0	10.2	24.9	0.4	1.3	1.6	0.4
PMEPA1	"STAG1, TMEPAI"	ENSG00000124225	"Prostate transmembrane protein, androgen induced 1"	Q969W9	20	57648392-57711536	"Cancer-related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Ubl conjugation pathway"	"Signal transduction inhibitor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"prostate: 110.8"	"Cell type enhanced"	"Detected in many"		"Ductal cells: 339.6;Muller glia cells: 325.9;Pancreatic endocrine cells: 827.5"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 157.4"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"naive B-cell: 6.3;plasmacytoid DC: 23.9"	"Group enriched"	"Detected in many"	8	"B-cells: 6.3;dendritic cells: 23.9"	"Cell line enhanced"	"Detected in many"		"SiHa: 206.1;U-2 OS: 129.9;U-251 MG: 481.8;WM-115: 237.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA072291			Supported	Vesicles	"Intracellular and membrane"	NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 1: Pancreatic cells - Digestion"	Vesicles		"HPA072291: AB_2686509"	"unprognostic (2.72e-3)"	"prognostic unfavorable (2.45e-4)"	"unprognostic (5.77e-2)"	"unprognostic (1.73e-1)"	"unprognostic (6.61e-2)"	"unprognostic (2.11e-3)"	"unprognostic (3.13e-2)"	"prognostic unfavorable (4.73e-5)"	"unprognostic (5.53e-1)"	"unprognostic (1.32e-3)"	"unprognostic (7.83e-3)"	"unprognostic (2.02e-1)"	"prognostic unfavorable (2.87e-7)"	"unprognostic (1.16e-1)"	"unprognostic (2.35e-1)"	"unprognostic (9.87e-3)"	"prognostic unfavorable (7.60e-4)"	50.5	14.5	24.2	14.2	75.5	1.3	25.1	38.8	29.9	94.8	1.8	30.7	6.5	48.4	7.1	7.6	19.9	26.0	29.2	24.0	28.3	16.2	3.8	21.8	7.4	32.9	34.1	14.9	31.3	5.0	13.5	3.9	38.8	110.8	8.4	23.6	30.5	20.6	33.2	18.1	12.6	28.8	27.0	6.6	12.2	5.3	36.1	2.4	13.6	13.6	8.9	13.1	29.6	26.2	32.2	75.4	2.3	3.9	2.4	0.0	0.8	4.9	0.2	1.7	0.8	1.5	97.4	0.2	17.7	7.4	51.8	121.1	1.6	100.8	1.3	1.0	4.1	0.0	23.2	0.1	1.5	0.3	0.8	1.2	55.8	4.4	12.1	16.5	13.0	67.8	0.8	1.2	6.2	66.1	3.8	0.7	9.4	15.0	9.6	0.3	36.0	11.3	24.2	0.0	17.7	13.7	206.1	120.3	15.1	5.6	18.8	4.1	33.1	17.9	129.9	1.9	481.8	5.9	0.8	0.5	8.1	1.1	237.1	0.0	0.4	0.0	0.0	0.0	0.0	2.6	0.8	0.2	0.1	6.3	1.8	1.2	0.1	0.0	0.1	23.9	0.5	0.6	24.2	75.5	38.8	29.9	24.0	28.3	32.9	34.1	38.8	27.0	36.1	26.2	59.4	57.7	32.3	4.9	32.7	167.0	143.1	120.6	30.7	59.0	38.0	23.0	23.2	125.8	31.7	11.0	2.1	0.2	27.8	57.3	3.9	339.6	1.2	33.4	88.8	55.6	10.1	0.0	19.1	62.5	4.1	40.5	5.1	80.2	59.8	17.5	24.7	0.5	6.1	1.7	32.7	16.9	14.2	3.5	68.0	2.7	3.1	13.4	32.0	31.9	5.8	325.9	0.0	17.6	9.0	827.5	54.2	21.8	25.3	203.1	6.2	2.7	10.1	11.5	72.3	43.8	155.2	0.2	8.8	10.0	178.4	0.1	17.8	9.1	19.3	87.5
PMM1	Sec53	ENSG00000100417	"Phosphomannomutase 1"	Q92871	22	41576900-41589871	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Isomerase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Proximal enterocytes: 176.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030712, HPA074950"	Uncertain		Supported	Cytosol		NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 45: Intestine - Brush border"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 45: Enterocytes - Digestion"	Cytosol		"HPA030712: AB_10669600, HPA074950: "	"unprognostic (2.66e-1)"	"prognostic favorable (5.92e-4)"	"unprognostic (3.25e-2)"	"prognostic favorable (6.09e-6)"	"unprognostic (1.25e-1)"	"unprognostic (2.85e-2)"	"unprognostic (1.01e-2)"	"unprognostic (1.95e-2)"	"unprognostic (2.24e-3)"	"unprognostic (1.78e-1)"	"prognostic favorable (2.05e-4)"	"unprognostic (6.56e-3)"	"unprognostic (5.76e-3)"	"unprognostic (2.78e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.40e-2)"	"unprognostic (2.70e-1)"	47.0	51.7	49.0	12.0	50.4	26.2	39.0	47.0	65.0	34.4	41.2	33.6	37.7	26.9	19.2	73.7	34.7	18.8	26.5	49.5	52.1	59.4	64.2	33.8	17.5	46.9	47.2	48.1	45.0	15.4	19.5	14.2	51.2	26.5	20.3	13.6	23.3	20.2	16.2	33.2	33.8	19.9	47.8	13.7	65.7	32.6	49.8	14.3	13.8	11.4	16.8	31.7	28.0	49.7	16.0	29.0	19.6	42.5	54.3	84.0	23.0	61.7	69.8	56.0	61.0	23.0	15.3	14.9	20.3	74.4	40.0	23.4	25.8	40.0	31.1	31.2	38.6	3.8	34.8	49.2	85.8	22.6	23.8	70.4	38.2	58.3	24.2	61.9	9.3	23.8	16.9	51.9	76.5	42.0	17.1	32.5	6.2	75.1	38.2	13.1	20.7	30.7	24.0	17.1	5.8	11.2	50.5	18.1	75.2	15.2	20.3	24.4	7.5	63.2	34.3	59.4	32.8	33.2	34.0	24.3	70.3	18.8	38.7	21.0	22.0	44.8	27.7	18.5	22.3	17.8	27.6	22.8	23.2	20.5	29.4	21.1	28.8	13.4	22.9	9.2	49.4	18.8	49.0	50.4	47.0	65.0	49.5	52.1	46.9	47.2	51.2	47.8	49.8	49.7	7.8	35.3	106.4	16.3	15.0	14.8	10.2	22.5	20.5	16.7	22.8	29.3	12.4	82.9	25.8	35.0	6.2	57.1	10.0	104.8	107.6	31.8	17.1	77.7	34.2	6.9	48.7	19.3	14.9	11.0	91.1	33.3	36.2	51.4	3.8	60.9	8.9	83.5	34.5	28.6	10.9	58.1	14.2	14.4	13.5	15.3	28.0	16.3	44.4	3.7	21.9	67.1	16.5	4.0	7.1	10.8	117.0	30.5	17.7	8.5	176.1	138.5	34.8	22.6	39.5	18.9	36.9	72.6	10.9	23.1	14.1	65.3	21.0	37.9	55.3	8.2
PMS1	"MLH2, PMSL1"	ENSG00000064933	"PMS1 homolog 1, mismatch repair system component"	P54277	2	189784085-189877629	"Predicted intracellular proteins"	"DNA damage, DNA repair"	DNA-binding	"Hereditary nonpolyposis colorectal cancer, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 48.4"	"Group enriched"	"Detected in many"	6	"Early spermatids: 474.4;Late spermatids: 570.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031013			Supported	"Nucleoplasm,Nuclear bodies"		No	No			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 21: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 34: Spermatids - Unknown function"	"Nucleoplasm, Nuclear bodies"		"HPA031013: AB_2673696"	"unprognostic (1.03e-1)"	"unprognostic (1.58e-2)"	"unprognostic (9.31e-2)"	"unprognostic (2.14e-1)"	"unprognostic (3.16e-3)"	"unprognostic (1.49e-2)"	"prognostic unfavorable (2.38e-6)"	"unprognostic (5.31e-2)"	"unprognostic (1.60e-2)"	"unprognostic (7.29e-3)"	"unprognostic (3.55e-1)"	"unprognostic (2.30e-1)"	"prognostic unfavorable (1.86e-6)"	"unprognostic (1.29e-1)"	"unprognostic (3.77e-2)"	"unprognostic (1.92e-2)"	"prognostic favorable (3.73e-4)"	9.2	9.0	9.6	12.0	8.2	12.1	11.6	14.7	9.7	10.8	7.6	7.7	7.4	13.3	15.7	6.3	9.7	8.3	7.0	7.8	10.0	6.3	7.7	8.0	13.7	7.5	8.2	11.9	8.3	7.3	9.8	8.7	8.7	9.5	9.1	18.4	9.9	10.2	9.4	11.5	8.4	10.2	7.2	13.2	13.0	48.4	9.5	8.0	10.6	6.6	10.7	7.4	7.5	11.4	13.8	11.8	29.9	23.8	16.1	24.3	26.6	25.3	12.3	21.2	25.4	19.6	18.1	39.7	14.0	10.6	15.1	19.2	29.9	18.7	29.5	30.3	17.4	39.5	24.1	30.3	22.5	23.3	17.3	15.6	18.4	19.3	39.7	18.8	22.4	27.6	34.0	20.8	26.1	9.7	27.6	32.2	31.6	14.1	27.6	31.9	19.5	38.8	20.9	19.6	27.8	19.3	18.5	12.5	19.6	36.2	13.4	20.1	17.3	22.8	15.4	14.7	23.2	16.6	21.9	34.4	13.1	20.4	14.7	2.9	6.4	3.7	13.6	4.2	13.3	14.4	10.1	15.5	6.4	15.9	10.6	13.0	3.0	12.0	5.2	10.0	10.8	4.8	9.6	8.2	14.7	9.7	7.8	10.0	7.5	8.2	8.7	7.2	9.5	11.4	18.5	16.0	14.4	45.1	22.7	6.9	8.9	12.9	21.6	30.8	13.7	14.6	16.3	10.0	15.8	5.5	8.4	16.4	18.7	3.6	0.0	7.6	474.4	17.3	26.6	14.8	12.0	10.9	68.6	8.0	11.7	18.5	13.7	11.7	13.3	27.7	8.2	9.6	9.2	10.1	80.2	7.3	16.2	16.0	5.1	570.1	21.8	14.9	7.2	43.1	9.8	11.2	22.6	80.9	64.8	6.4	4.3	19.5	30.1	7.5	4.9	6.1	27.0	28.0	13.1	16.3	15.0	25.3	25.9	19.3	7.0	5.2	20.9	22.2	11.1	4.3
PNISR	"bA98I9.2, C6orf111, DKFZp564B0769, FLJ14752, SFRS18, SRrp130"	ENSG00000132424	"PNN interacting serine and arginine rich protein"	Q8TF01	6	99397629-99425331	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038796, HPA075076"	Approved		Supported	"Nuclear speckles,Plasma membrane,Cytosol"		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 51: Non-specific - Unknown function"	"Cluster 20: HeLa - Mitochondria"	"Cluster 52: Non-specific - Transcription"	"Nuclear speckles"	"Plasma membrane, Cytosol"	"HPA038796: AB_10672652, HPA075076: "	"unprognostic (2.95e-1)"	"unprognostic (2.29e-1)"	"unprognostic (2.11e-1)"	"unprognostic (9.72e-3)"	"unprognostic (1.68e-2)"	"unprognostic (8.55e-3)"	"unprognostic (4.41e-2)"	"unprognostic (1.58e-3)"	"unprognostic (5.82e-2)"	"unprognostic (4.32e-3)"	"prognostic favorable (5.27e-4)"	"unprognostic (1.47e-2)"	"prognostic unfavorable (1.41e-4)"	"unprognostic (3.43e-2)"	"unprognostic (2.59e-1)"	"unprognostic (8.89e-2)"	"prognostic favorable (1.09e-4)"	68.2	68.8	56.9	52.0	55.4	106.8	75.3	78.4	89.8	103.1	67.5	114.5	51.4	79.7	93.6	51.8	93.2	38.2	84.6	54.3	56.4	67.1	62.2	74.4	78.7	56.7	54.7	123.0	66.0	38.4	112.0	36.4	52.9	91.2	49.4	102.1	76.6	48.1	89.4	64.1	94.1	49.4	49.3	90.6	77.1	39.4	56.9	51.4	114.5	31.2	54.9	81.6	80.3	60.1	26.7	19.5	98.8	72.0	35.3	46.8	45.8	44.1	22.8	25.6	29.9	33.3	49.2	85.8	26.6	25.3	28.7	41.9	49.3	33.3	45.2	75.0	48.8	52.6	105.0	30.6	22.2	73.0	67.9	51.8	50.0	27.4	37.5	95.7	34.2	44.8	59.3	52.5	31.3	25.2	31.8	71.2	55.2	24.5	15.3	62.1	29.6	32.4	47.1	47.1	43.4	51.9	21.7	23.6	35.3	75.4	32.8	58.6	45.0	25.2	28.9	25.7	37.2	35.9	24.3	70.5	37.5	68.3	27.0	12.3	10.8	11.9	12.5	6.4	13.0	19.3	12.0	10.4	5.0	25.8	17.9	16.6	30.0	23.5	7.7	19.6	12.4	3.7	56.9	55.4	78.4	89.8	54.3	56.4	56.7	54.7	52.9	49.3	56.9	60.1	175.8	185.9	237.6	356.2	375.8	195.3	357.3	250.5	165.6	546.2	143.9	192.5	121.2	137.2	215.7	178.4	446.2	158.3	336.4	152.4	74.3	130.8	17.0	132.2	185.7	210.7	247.8	194.4	241.5	104.5	102.1	240.1	100.9	140.5	190.5	344.5	135.7	109.4	99.7	498.0	257.4	129.6	199.4	128.0	236.8	47.9	593.3	152.1	167.2	193.9	261.6	223.6	375.9	270.4	252.6	133.1	176.2	441.2	209.8	293.6	205.8	58.6	179.6	419.9	249.8	288.7	236.3	342.6	181.3	115.5	173.6	180.9	283.8	363.3	151.3	352.4
PNKP	PNK	ENSG00000039650	"Polynucleotide kinase 3'-phosphatase"	Q96T60	19	49859882-49878351	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair"	"Hydrolase, Kinase, Multifunctional enzyme, Transferase"	"Disease variant, Epilepsy, Mental retardation, Neurodegeneration, Primary microcephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006782	Supported		Supported	Nucleoplasm,Nucleoli		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 15: RT4 - Unknown function"	"Cluster 52: Non-specific - Transcription"	"Nucleoplasm, Nucleoli"		"HPA006782: AB_1855496"	"prognostic favorable (9.18e-4)"	"unprognostic (1.87e-1)"	"unprognostic (4.31e-2)"	"unprognostic (4.23e-1)"	"unprognostic (1.00e-1)"	"unprognostic (4.40e-2)"	"unprognostic (1.08e-2)"	"unprognostic (1.24e-1)"	"unprognostic (3.36e-1)"	"unprognostic (1.58e-1)"	"unprognostic (3.71e-2)"	"unprognostic (1.70e-1)"	"unprognostic (4.55e-2)"	"unprognostic (3.00e-2)"	"unprognostic (2.82e-1)"	"unprognostic (7.24e-2)"	"unprognostic (3.68e-3)"	18.9	45.1	12.0	21.0	12.9	26.4	21.2	12.8	16.2	21.1	24.2	21.6	16.0	21.3	13.5	19.4	22.9	10.6	23.9	14.4	11.9	27.3	22.4	22.2	17.5	14.0	14.0	23.7	28.6	16.7	36.8	11.1	14.3	25.3	13.1	10.1	21.6	12.4	18.5	17.8	22.8	11.5	12.8	37.2	25.0	21.2	13.3	12.3	31.9	7.8	15.3	19.4	18.0	14.1	27.5	17.4	19.1	27.2	15.8	13.4	28.6	43.4	21.2	18.7	17.7	17.5	34.2	18.4	13.6	13.6	11.3	23.5	6.1	25.9	10.9	22.3	27.2	30.0	36.7	14.8	12.2	25.8	36.3	13.2	13.0	17.9	11.0	16.9	26.3	23.4	14.9	34.3	24.7	18.8	28.7	23.5	16.0	28.3	37.4	24.3	15.9	34.7	21.0	68.5	20.6	33.4	19.3	52.5	9.2	14.5	10.2	14.8	36.0	37.6	24.9	9.6	35.8	38.7	16.5	13.0	33.8	12.3	30.8	1.8	12.3	16.7	9.2	11.5	7.9	9.1	7.8	7.3	9.8	12.2	5.7	5.0	23.4	3.9	18.1	5.5	9.1	5.8	12.0	12.9	12.8	16.2	14.4	11.9	14.0	14.0	14.3	12.8	13.3	14.1	23.6	16.0	23.6	5.9	47.2	13.4	35.4	29.9	25.6	40.9	28.1	23.7	11.1	21.5	19.1	20.2	81.3	44.5	37.7	40.0	23.5	42.5	15.0	25.2	28.5	26.6	30.5	17.1	6.0	39.9	35.1	19.1	31.6	28.0	29.1	54.6	35.0	20.1	39.5	33.7	6.0	31.7	24.4	27.7	19.0	32.9	59.4	26.8	14.2	8.4	46.1	18.4	96.8	6.0	5.7	44.6	22.3	44.8	40.4	33.6	27.1	36.1	33.8	73.9	19.7	17.9	20.1	19.4	28.9	23.3	13.1	49.3	39.2	83.0	34.1	35.6
PNMA1	MA1	ENSG00000176903	"PNMA family member 1"	Q8ND90	14	73711783-73714384	"Predicted intracellular proteins"		"Tumor antigen"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 84.2;Peritubular cells: 84.7;Spermatocytes: 87.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"							"HPA003817, HPA015007"	Enhanced		Supported	"Nucleoplasm,Focal adhesion sites,Cytosol"		NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 66: Spermatocytes - Spermatogenesis"	Cytosol	"Nucleoplasm, Focal adhesion sites"	"HPA003817: AB_1079646, HPA015007: AB_1855502"	"unprognostic (2.82e-2)"	"unprognostic (3.26e-1)"	"unprognostic (9.50e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.96e-1)"	"prognostic unfavorable (7.49e-5)"	"prognostic unfavorable (3.00e-5)"	"unprognostic (2.90e-1)"	"unprognostic (5.35e-2)"	"unprognostic (3.63e-1)"	"unprognostic (5.58e-2)"	"unprognostic (4.58e-2)"	"unprognostic (1.67e-3)"	"unprognostic (2.04e-3)"	"unprognostic (4.17e-2)"	"unprognostic (2.23e-3)"	"prognostic unfavorable (4.51e-5)"	35.5	30.2	75.0	20.3	80.5	8.8	20.6	55.5	85.6	37.6	34.7	56.7	13.9	46.3	54.6	23.4	38.1	24.6	23.3	77.3	90.0	27.8	4.9	15.5	16.4	62.1	62.5	53.4	9.2	8.0	53.1	21.4	62.9	48.8	16.5	59.9	10.9	89.3	12.0	9.8	24.9	52.3	66.9	19.2	26.0	71.0	78.4	19.0	18.5	10.4	12.5	41.7	26.6	70.3	48.2	42.8	72.3	54.1	53.1	56.0	29.9	49.8	27.8	44.5	32.5	40.6	29.2	1.1	33.8	60.7	42.4	31.6	56.0	29.4	45.7	45.7	34.7	27.2	35.8	30.7	56.8	15.3	41.6	49.8	35.1	53.4	33.5	87.4	68.1	28.7	23.9	29.3	61.2	117.6	30.5	37.1	21.8	24.6	149.0	47.5	45.0	1.1	58.8	1.5	85.4	65.5	87.5	19.9	40.4	43.6	97.0	25.6	66.5	89.3	71.7	54.9	41.1	25.7	42.9	14.2	88.3	21.4	30.3	2.9	1.8	4.7	8.5	3.5	5.8	2.8	10.9	8.7	3.9	3.1	10.4	10.0	1.6	5.6	5.3	0.6	14.2	7.3	75.0	80.5	55.5	85.6	77.3	90.0	62.1	62.5	62.9	66.9	78.4	70.3	13.1	6.4	3.0	21.9	8.8	3.8	6.8	5.0	6.2	48.6	7.0	7.5	19.9	2.8	4.1	14.7	12.5	7.5	10.4	6.7	15.6	10.1	84.2	32.2	30.6	13.5	18.7	3.0	31.4	6.7	11.3	20.5	14.3	10.2	16.5	16.6	20.0	1.6	15.6	58.9	28.9	5.4	14.2	6.8	25.9	57.6	32.6	18.8	19.6	12.2	14.1	65.2	10.3	17.1	21.7	30.2	1.4	84.7	10.9	7.4	1.6	26.6	23.1	49.1	72.3	31.2	44.1	87.2	44.4	4.7	3.8	6.0	20.0	43.8	2.5	3.7
PNN	memA	ENSG00000100941	"Pinin, desmosome associated protein"	Q9H307	14	39175183-39183220	"Predicted intracellular proteins, Transporters"	"mRNA processing, mRNA splicing, Transcription, Transcription regulation"	"Activator, DNA-binding"	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001378	Supported		Supported	"Nuclear speckles"		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 20: HeLa - Mitochondria"	"Cluster 52: Non-specific - Transcription"	"Nuclear speckles"		"HPA001378: AB_1079648"	"unprognostic (9.28e-3)"	"unprognostic (5.07e-2)"	"unprognostic (5.46e-2)"	"unprognostic (3.91e-1)"	"unprognostic (7.38e-3)"	"unprognostic (7.40e-2)"	"prognostic unfavorable (5.79e-4)"	"unprognostic (1.65e-2)"	"unprognostic (1.67e-3)"	"unprognostic (3.75e-2)"	"unprognostic (3.70e-2)"	"prognostic unfavorable (2.44e-4)"	"unprognostic (1.51e-3)"	"unprognostic (1.25e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.00e-1)"	"unprognostic (4.30e-2)"	57.8	60.6	42.7	68.0	46.6	135.9	60.2	50.6	48.1	82.2	77.8	83.1	56.5	81.5	129.5	74.0	77.0	41.8	54.9	42.9	51.4	87.6	124.8	61.4	87.6	47.5	45.1	84.5	78.5	40.8	90.7	53.8	47.2	83.8	63.1	76.0	65.6	48.4	59.9	67.7	90.5	48.0	43.9	103.6	70.7	58.5	47.1	65.6	88.4	27.0	69.5	69.2	73.3	50.9	152.4	72.0	193.2	94.0	45.5	37.4	141.4	116.6	35.4	82.4	81.2	112.3	232.6	229.1	72.7	53.2	69.7	156.4	153.3	85.5	138.5	105.1	109.0	158.6	243.7	246.0	39.1	201.0	107.6	55.8	73.5	80.1	65.1	115.5	57.3	119.0	149.1	128.2	65.8	122.6	145.5	170.3	126.6	76.2	114.3	188.4	137.0	64.2	65.6	219.3	93.8	50.5	126.2	90.5	69.1	133.2	114.4	117.5	92.7	115.9	90.9	52.7	142.2	102.5	87.8	194.0	59.5	167.3	70.6	9.2	13.7	22.0	17.0	11.4	16.1	22.2	12.1	10.9	11.8	25.5	17.2	16.6	27.6	15.4	16.4	22.1	14.2	6.1	42.7	46.6	50.6	48.1	42.9	51.4	47.5	45.1	47.2	43.9	47.1	50.9	105.6	192.3	125.0	40.8	170.5	126.2	244.5	84.4	153.1	203.1	77.5	87.5	63.4	61.5	164.8	60.7	56.3	113.2	230.9	129.3	35.2	89.4	59.0	155.0	178.9	127.9	136.2	121.1	33.1	58.3	100.0	117.1	101.9	289.4	142.5	273.5	69.3	67.8	62.3	153.1	35.6	96.6	71.2	69.3	72.5	53.7	156.3	93.9	49.8	25.3	89.2	138.0	193.6	41.2	54.6	76.7	126.3	151.6	116.7	172.1	82.9	28.9	111.7	172.4	151.2	166.2	161.3	212.8	149.3	145.0	112.0	99.6	170.6	211.8	123.7	245.4
PNO1	"KHRBP1, RRP20"	ENSG00000115946	"Partner of NOB1 homolog"	Q9NRX1	2	68157888-68176238	"Plasma proteins, Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA056928			Supported	Nucleoplasm,Nucleoli		NA	Yes			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoli	Nucleoplasm	"HPA056928: "	"unprognostic (1.81e-3)"	"unprognostic (4.83e-1)"	"unprognostic (5.93e-2)"	"prognostic unfavorable (1.12e-4)"	"unprognostic (5.88e-2)"	"unprognostic (1.66e-3)"	"prognostic unfavorable (3.04e-8)"	"unprognostic (5.82e-2)"	"unprognostic (2.59e-2)"	"unprognostic (1.16e-1)"	"unprognostic (9.13e-3)"	"unprognostic (3.33e-2)"	"unprognostic (1.46e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.58e-1)"	"unprognostic (3.74e-2)"	"unprognostic (7.66e-2)"	15.1	14.2	6.4	12.1	8.0	19.5	11.6	7.0	11.8	7.6	6.9	9.7	7.6	9.8	11.2	11.1	8.8	9.9	10.2	12.0	7.3	14.1	12.6	8.6	12.6	6.7	6.9	7.0	12.7	12.5	7.1	12.7	6.8	10.0	9.1	19.0	7.1	10.8	20.1	9.1	6.7	11.5	6.7	8.2	8.8	8.9	6.9	8.1	12.5	12.6	12.2	19.8	7.6	7.4	37.8	40.1	18.5	30.5	22.5	18.3	46.0	34.7	23.0	39.1	27.8	77.9	21.9	51.4	28.5	23.6	54.0	31.6	60.6	41.9	61.3	35.2	40.6	49.7	17.4	58.2	34.6	40.2	22.4	24.1	30.2	39.4	45.0	11.3	29.1	32.7	69.7	27.3	35.7	27.4	39.9	38.1	52.0	68.7	43.1	33.3	45.2	54.8	29.8	31.7	32.7	24.0	26.1	32.4	57.8	29.7	22.9	22.4	21.2	44.2	48.0	40.1	97.9	21.6	33.1	78.1	36.3	59.1	62.1	0.9	12.6	2.8	12.2	18.1	19.1	19.2	13.8	14.4	16.8	14.5	16.0	14.6	2.4	15.0	13.0	11.8	16.0	21.3	6.4	8.0	7.0	11.8	12.0	7.3	6.7	6.9	6.8	6.7	6.9	7.4	23.7	16.0	13.2	3.3	29.9	83.2	62.8	29.5	25.6	22.7	18.6	18.4	11.9	18.6	36.2	7.3	12.5	39.5	20.2	7.9	19.6	36.7	33.5	28.7	37.7	25.5	17.3	21.4	10.6	29.8	43.5	28.3	9.7	20.9	31.6	13.6	12.5	15.8	26.0	18.5	9.0	12.1	30.5	10.4	38.7	7.7	12.5	20.7	12.4	4.7	18.9	21.0	14.4	7.1	10.4	29.1	5.8	16.6	27.8	56.6	4.6	34.7	28.6	51.3	6.6	40.4	29.6	28.9	41.7	21.0	56.1	47.6	25.7	20.5	20.2	37.6
PNP	"NP, PUNP"	ENSG00000198805	"Purine nucleoside phosphorylase"	P00491	14	20468954-20477089	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Purine salvage"	"Glycosyltransferase, Transferase"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 333.9;epididymis: 594.8"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 360.6;Erythroid cells: 227.3;Syncytiotrophoblasts: 646.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HL-60: 531.3;U-937: 593.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA001625	Enhanced		Supported	Cytosol		NA	NA		58000000	"Cluster 16: MAIT-cells - Unknown function"	"Cluster 68: Epididymis - Unknown function"	"Cluster 32: U-937 - Innate immune response"	"Cluster 47: Cytotrophoblasts - Unknown function"	Cytosol		"HPA001625: AB_1854577"	"unprognostic (1.20e-3)"	"unprognostic (2.68e-2)"	"unprognostic (1.04e-2)"	"unprognostic (1.70e-1)"	"unprognostic (3.10e-1)"	"unprognostic (7.06e-2)"	"prognostic unfavorable (4.43e-4)"	"unprognostic (4.94e-3)"	"unprognostic (3.87e-2)"	"unprognostic (7.45e-2)"	"unprognostic (1.85e-2)"	"unprognostic (2.21e-1)"	"prognostic favorable (2.24e-4)"	"unprognostic (1.69e-1)"	"unprognostic (7.54e-2)"	"unprognostic (2.46e-1)"	"unprognostic (1.64e-3)"	78.6	24.8	16.1	46.8	16.6	333.9	34.6	22.6	22.7	25.3	18.9	52.2	120.3	14.2	594.8	87.4	18.2	56.8	29.0	17.7	19.6	206.8	98.0	48.6	46.7	20.3	18.1	5.0	23.2	32.0	19.8	132.6	20.1	15.0	61.8	27.1	22.6	27.4	7.3	29.6	60.3	38.7	23.1	44.5	50.6	7.4	21.1	33.5	17.8	10.0	64.4	100.4	41.5	20.1	86.1	113.4	24.0	53.9	26.0	21.0	71.8	85.2	40.3	68.2	67.0	66.1	76.5	227.1	96.8	45.5	81.5	89.9	125.2	159.8	89.5	75.0	109.6	189.1	89.9	109.3	24.2	531.3	94.7	14.4	57.4	206.0	91.0	37.8	295.9	141.0	95.4	137.4	86.7	79.1	157.6	311.3	67.5	215.7	186.1	130.2	35.9	88.3	243.7	79.6	101.9	22.6	163.4	205.0	13.2	32.6	75.5	92.5	240.0	46.1	62.6	105.1	148.4	63.1	113.3	258.9	39.3	593.0	4.6	12.0	30.6	10.3	39.8	27.3	73.6	25.7	44.2	45.0	48.1	28.8	27.6	35.9	3.7	38.5	26.6	27.3	16.7	31.1	16.1	16.6	22.6	22.7	17.7	19.6	20.3	18.1	20.1	23.1	21.1	20.1	149.6	0.0	23.5	5.9	50.3	84.6	67.4	12.6	112.7	4.7	56.3	62.6	3.5	27.1	13.4	82.8	14.6	360.6	45.2	61.1	39.2	43.2	1.3	36.0	12.7	139.4	46.4	227.3	0.6	51.5	41.8	32.4	106.5	65.3	57.7	5.0	24.3	30.6	70.9	16.8	1.1	51.3	18.3	18.1	58.4	0.8	0.3	83.3	30.2	3.7	13.2	78.8	29.9	3.0	0.9	130.8	83.9	0.7	88.6	27.5	41.2	118.9	10.5	18.1	0.0	23.9	41.3	0.4	0.7	114.7	63.9	646.2	62.3	3.1	51.4	77.1
PNPT1	"DFNB70, old-35, OLD35, PNPase"	ENSG00000138035	"Polyribonucleotide nucleotidyltransferase 1"	Q8TCS8	2	55634061-55693863	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"mRNA processing, Transport"	"Exonuclease, Hydrolase, Nuclease, Nucleotidyltransferase, RNA-binding, Transferase"	"Deafness, Disease variant, Non-syndromic deafness, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB033424, HPA034602, HPA034603"	Supported		Supported	Mitochondria,Cytosol		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 11: Alveolar cells - Smell perception"	Mitochondria	Cytosol	"CAB033424: AB_2299801, HPA034602: AB_2674243, HPA034603: AB_10603130"	"unprognostic (9.09e-2)"	"unprognostic (7.40e-2)"	"unprognostic (2.30e-1)"	"prognostic unfavorable (5.57e-4)"	"unprognostic (3.40e-2)"	"unprognostic (1.03e-2)"	"prognostic unfavorable (1.95e-7)"	"unprognostic (1.88e-1)"	"unprognostic (5.93e-3)"	"unprognostic (5.23e-2)"	"prognostic unfavorable (5.44e-5)"	"unprognostic (2.19e-2)"	"unprognostic (2.11e-2)"	"unprognostic (6.92e-2)"	"unprognostic (1.94e-1)"	"unprognostic (2.41e-1)"	"unprognostic (1.21e-1)"	6.7	5.9	5.4	4.0	7.0	7.4	5.7	6.4	7.7	5.2	6.4	5.7	3.3	6.4	4.5	4.6	5.7	3.0	6.6	4.8	6.5	5.6	5.2	5.0	4.3	6.9	6.0	4.8	7.8	4.9	5.0	2.9	7.1	4.4	5.2	5.5	5.0	3.2	11.5	5.9	5.3	4.2	5.7	6.2	5.8	3.2	6.3	3.4	5.2	5.9	3.3	5.6	4.5	9.0	9.0	4.3	6.5	2.9	4.7	7.8	8.4	12.2	7.7	19.8	13.1	13.5	4.2	17.9	5.4	5.8	6.2	7.1	8.3	10.1	9.5	6.3	16.3	10.2	5.9	7.0	11.8	25.0	6.4	8.6	6.9	8.4	7.0	4.7	6.4	7.3	11.5	4.2	8.0	4.4	15.4	17.9	15.5	9.3	8.1	15.2	10.9	16.6	8.6	5.2	15.2	9.6	4.4	14.3	17.0	5.6	3.8	11.4	6.4	4.6	3.9	4.2	13.5	18.9	1.3	3.8	9.2	21.1	8.3	3.3	3.4	4.0	4.2	2.8	2.4	3.1	1.7	4.1	1.3	5.6	3.4	3.9	3.4	2.2	2.7	4.1	1.4	2.9	5.4	7.0	6.4	7.7	4.8	6.5	6.9	6.0	7.1	5.7	6.3	9.0	25.1	48.1	57.0	23.8	21.6	24.2	23.1	17.5	29.0	41.3	12.6	11.2	25.6	15.7	46.8	20.2	58.4	19.9	14.2	7.7	9.8	18.6	25.6	27.9	28.9	24.4	10.2	17.4	48.4	16.0	23.3	25.3	14.8	14.3	58.7	21.8	11.7	14.7	15.4	30.3	48.1	12.8	26.4	12.2	17.7	4.8	17.4	26.7	16.0	17.8	16.5	23.9	13.4	34.2	97.7	15.8	11.4	18.4	23.1	26.0	7.6	19.8	38.5	58.6	26.3	31.7	22.3	43.4	20.7	25.7	20.2	12.3	24.7	58.2	18.6	17.6
PNRC2		ENSG00000189266	"Proline rich nuclear receptor coactivator 2"	Q9NPJ4	1	23956839-23963462	"Predicted intracellular proteins"	"Nonsense-mediated mRNA decay, Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027820, HPA045837"	Uncertain		Supported	"Nucleoplasm,Golgi apparatus"		No	No			"Cluster 46: Basophils - DNA binding"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 22: Epithelial cell types - Mixed function"	Nucleoplasm	"Golgi apparatus"	"HPA027820: AB_10602147, HPA045837: AB_2679467"	"prognostic favorable (6.02e-4)"	"unprognostic (5.99e-2)"	"unprognostic (3.15e-3)"	"unprognostic (2.10e-2)"	"unprognostic (3.58e-1)"	"unprognostic (4.45e-3)"	"prognostic unfavorable (7.97e-5)"	"unprognostic (4.05e-2)"	"prognostic unfavorable (1.41e-4)"	"unprognostic (1.22e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.92e-3)"	"unprognostic (1.81e-2)"	"unprognostic (1.49e-1)"	"unprognostic (2.18e-1)"	"unprognostic (4.44e-2)"	"prognostic favorable (4.05e-4)"	82.7	82.5	49.5	80.6	52.1	141.0	78.5	53.4	62.0	69.6	56.1	98.1	99.5	87.4	68.6	62.8	58.3	80.5	75.2	49.6	51.9	99.6	66.8	76.0	137.0	52.6	50.7	79.3	52.2	94.3	34.8	103.3	54.4	70.5	92.2	56.2	55.0	56.9	49.8	46.1	84.2	71.8	50.9	87.5	81.9	33.7	51.9	133.5	122.2	63.6	109.5	100.1	51.4	57.8	107.8	42.0	179.5	124.9	121.5	110.7	68.6	116.7	103.7	132.7	106.1	122.7	132.5	291.7	111.5	74.8	49.9	93.5	121.6	101.8	146.7	208.6	78.7	277.5	131.8	130.2	103.3	272.1	122.3	83.9	125.8	109.2	101.0	86.8	130.3	148.4	239.6	159.5	79.0	87.5	169.4	103.3	243.8	101.7	76.5	189.7	116.7	125.0	134.8	113.8	107.4	93.5	101.0	85.7	123.7	130.9	93.6	168.6	105.3	85.6	82.2	84.6	75.4	133.7	164.8	197.6	58.0	259.0	89.8	230.8	112.7	126.8	103.5	115.0	108.8	129.1	112.5	112.2	109.1	131.1	124.9	106.8	74.2	108.6	112.2	77.4	129.4	178.3	49.5	52.1	53.4	62.0	49.6	51.9	52.6	50.7	54.4	50.9	51.9	57.8	119.0	185.9	109.2	11.4	122.5	13.3	231.7	2.0	99.0	33.6	110.5	109.6	84.8	58.6	62.2	62.5	18.8	129.8	104.7	160.5	238.7	90.5	6.9	86.0	96.1	97.3	100.4	157.0	7.9	127.8	101.4	128.7	66.3	130.9	76.5	84.1	86.7	30.0	68.6	20.2	6.4	109.3	0.0	82.3	10.9	14.2	78.9	109.0	1.8	13.1	81.8	66.9	127.7	6.0	11.8	119.2	157.7	81.3	48.8	187.6	90.3	112.0	56.1	28.7	46.0	104.3	104.5	21.2	24.4	97.8	12.6	141.7	104.0	203.9	110.2	314.0
PODXL	"Gp200, PC, PCLP"	ENSG00000128567	"Podocalyxin like"	O00592	7	131500262-131558217	"Plasma proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 96.2"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 165.8;Cone photoreceptor cells: 87.6;Endothelial cells: 181.1;Glandular and luminal cells: 121.3;Microglial cells: 92.8;Rod photoreceptor cells: 188.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 295.8;NTERA-2: 509.7;SuSa: 640.8;TIME: 474.0;U-251 MG: 226.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002110, CAB016169, HPA045507, CAB062558, CAB068219, CAB068220"	Enhanced		Supported	"Vesicles,Plasma membrane,Centriolar satellite"		NA	NA		33000000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 44: Endometrium - Transcription"	"Plasma membrane, Centriolar satellite"	Vesicles	"CAB016169: AB_628165, CAB062558: AB_2665627, CAB068219: AB_2665618, CAB068220: AB_2665619, HPA002110: AB_1855512, HPA045507: AB_2679356"	"unprognostic (1.26e-1)"	"unprognostic (7.68e-2)"	"unprognostic (8.28e-3)"	"unprognostic (6.46e-3)"	"unprognostic (5.16e-3)"	"unprognostic (5.85e-2)"	"unprognostic (1.63e-2)"	"unprognostic (1.05e-1)"	"unprognostic (7.95e-3)"	"unprognostic (3.52e-1)"	"unprognostic (9.20e-3)"	"unprognostic (3.40e-1)"	"prognostic favorable (2.89e-4)"	"unprognostic (2.56e-1)"	"unprognostic (8.78e-3)"	"unprognostic (3.55e-2)"	"unprognostic (1.03e-1)"	20.8	6.8	27.7	8.9	26.5	0.3	21.9	25.2	34.4	26.0	19.0	8.4	5.1	27.5	5.6	8.1	49.0	14.5	29.1	25.2	25.3	96.2	3.0	31.8	5.6	29.2	28.1	6.1	26.0	18.9	1.1	29.3	29.5	8.7	8.6	67.8	16.1	18.9	15.3	4.8	6.2	28.9	22.0	5.6	5.6	2.4	42.0	3.7	28.5	26.1	6.1	9.6	1.0	22.0	50.9	18.9	42.6	16.3	0.5	0.0	2.6	5.4	4.2	16.9	6.1	121.4	83.1	0.3	109.7	295.8	57.1	34.9	34.3	0.7	15.3	5.4	17.3	0.2	115.0	2.7	1.1	4.2	4.0	0.2	0.4	50.5	0.8	9.4	146.3	1.5	10.5	1.8	16.9	18.0	0.5	1.3	509.7	10.0	43.6	16.2	73.1	15.8	1.6	16.6	34.3	8.9	34.7	7.0	0.2	640.8	4.1	2.2	474.0	6.8	26.6	72.5	226.1	2.5	4.5	1.2	27.1	20.1	48.4	0.0	0.0	0.3	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	27.7	26.5	25.2	34.4	25.2	25.3	29.2	28.1	29.5	22.0	42.0	22.0	165.8	6.4	9.9	3.6	2.4	5.2	0.9	14.0	0.6	9.7	33.3	20.7	22.9	4.3	25.4	27.6	87.6	0.8	1.0	1.0	0.0	4.6	0.8	44.8	13.0	181.1	2.4	2.7	9.4	18.3	0.4	9.2	1.1	121.3	2.5	2.2	65.0	1.0	0.4	5.0	3.3	12.9	4.1	0.9	9.6	1.3	4.7	2.6	5.4	92.8	0.7	10.6	0.0	7.1	3.1	42.7	0.8	0.4	4.3	3.6	0.7	0.8	10.3	188.4	0.0	6.3	8.4	0.3	1.1	1.3	3.1	0.7	3.3	1.9	2.7	5.8
POF1B	"FLJ22792, POF"	ENSG00000124429	"POF1B actin binding protein"	Q8WVV4	X	85277396-85379717	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		Actin-binding	"Disease variant, Premature ovarian failure"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 54.2;skin 1: 123.9"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 129.8;Gastric mucus-secreting cells: 48.9;Intestinal goblet cells: 61.1;Paneth cells: 62.5;Proximal enterocytes: 73.6;Squamous epithelial cells: 39.2;Undifferentiated cells: 51.1"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 44.7"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"memory B-cell: 2.9;naive B-cell: 2.1"	"Lineage enriched"	"Detected in single"	7	"B-cells: 2.9"	"Group enriched"	"Detected in some"	5	"OE19: 179.0;RT4: 78.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA002033, HPA050027"	Approved		Supported	"Nucleoplasm,Golgi apparatus"		NA	NA		200000	"Cluster 19: B-cells - Humoral immune response"	"Cluster 31: Skin - Epidermis development"	"Cluster 21: OE19 - Mitochondria"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Golgi apparatus"	Nucleoplasm	"HPA002033: AB_1079650, HPA050027: "	"unprognostic (2.23e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.54e-3)"	"prognostic unfavorable (3.08e-4)"	"unprognostic (1.97e-1)"	"unprognostic (3.39e-2)"	"prognostic unfavorable (2.03e-4)"	"unprognostic (1.86e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.17e-2)"	"unprognostic (2.50e-1)"	"unprognostic (4.42e-2)"	"unprognostic (1.07e-2)"	"unprognostic (1.81e-1)"	"unprognostic (5.57e-4)"	"unprognostic (1.01e-2)"	0.7	0.3	0.1	6.1	0.1	0.2	11.0	0.8	0.3	6.4	0.0	54.2	34.4	0.2	0.5	33.1	6.2	9.0	10.6	0.1	0.0	1.4	0.4	1.8	0.5	0.0	0.0	0.1	6.9	0.0	0.3	1.0	0.0	2.9	50.9	0.4	8.5	1.3	0.8	123.9	43.4	2.0	0.0	3.5	23.7	0.2	0.0	0.5	0.5	0.0	12.0	14.3	14.7	0.0	3.7	22.9	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	12.5	23.9	12.0	3.3	0.0	0.1	23.7	5.1	0.4	0.0	2.4	0.1	4.4	0.1	0.1	0.0	0.1	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.3	0.7	3.9	0.0	9.6	0.1	0.2	0.0	179.0	0.0	0.2	1.0	0.1	0.0	78.2	0.1	0.1	0.0	6.0	0.0	1.8	2.4	1.0	0.2	0.1	0.1	0.2	0.3	2.0	4.8	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.2	0.0	0.0	2.1	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.1	0.8	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.7	1.2	9.1	4.9	7.9	12.0	0.0	2.5	0.8	24.2	8.6	10.2	5.5	0.0	3.2	0.0	129.8	0.0	13.8	0.0	0.3	0.0	1.7	22.8	0.0	0.4	15.6	0.6	3.4	48.9	0.2	0.0	0.0	0.4	0.2	0.3	0.0	0.4	61.1	6.1	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.5	0.4	24.8	62.5	0.0	0.2	3.9	73.6	0.1	9.5	0.0	0.0	0.1	0.9	0.0	0.1	39.2	28.6	5.3	0.3	0.0	51.1	17.1
POGLUT1	"9630046K23Rik, C3orf9, hCLP46, KDELCL1, KTELC1, MDS010, MDSRP, MGC32995, Rumi"	ENSG00000163389	"Protein O-glucosyltransferase 1"	Q8NBL1	3	119468963-119494708	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	Gastrulation	"Developmental protein, Glycosyltransferase, Transferase"	"Disease variant, Limb-girdle muscular dystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Langerhans cells: 81.2;monocytes: 151.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037855, HPA037856"	Approved		Supported	"Endoplasmic reticulum"	"Intracellular and membrane"	NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 3: Monocytes - Immune response regulation"	"Endoplasmic reticulum"		"HPA037855: AB_10672728, HPA037856: AB_2732477"	"unprognostic (2.43e-1)"	"unprognostic (5.94e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.83e-2)"	"unprognostic (5.62e-2)"	"unprognostic (2.00e-2)"	"unprognostic (3.38e-1)"	"unprognostic (2.81e-2)"	"unprognostic (1.84e-2)"	"unprognostic (1.03e-1)"	"unprognostic (6.52e-3)"	"unprognostic (1.31e-2)"	"prognostic unfavorable (7.02e-7)"	"unprognostic (3.08e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.23e-3)"	"prognostic favorable (2.23e-4)"	6.8	7.2	5.9	7.8	6.1	3.1	7.7	6.0	8.2	7.1	6.9	6.8	4.2	9.0	7.8	5.6	6.0	4.7	5.9	5.9	7.2	5.7	6.6	5.6	10.8	6.6	6.5	5.5	7.9	9.5	4.9	8.2	6.6	5.4	7.2	4.2	4.6	11.6	3.2	10.0	7.8	10.4	6.1	9.0	5.4	2.5	7.2	9.7	5.6	3.4	10.8	8.5	6.3	6.7	10.8	7.1	11.7	13.1	29.5	16.8	8.6	16.7	16.7	12.3	18.4	11.5	6.9	16.5	22.2	21.4	10.6	11.9	15.9	16.8	20.4	14.4	10.6	19.3	11.1	12.9	19.1	21.3	21.7	17.5	9.6	13.3	18.0	15.7	15.5	11.2	10.5	19.7	13.9	10.9	12.5	20.7	12.4	18.6	13.8	12.2	12.2	24.0	11.6	13.9	12.7	20.0	8.1	4.9	13.4	11.7	13.2	17.8	19.7	13.1	8.0	3.8	8.9	27.1	25.2	21.7	11.1	20.6	18.8	2.9	16.4	13.9	16.2	15.7	18.7	13.9	18.2	17.0	20.7	10.1	21.1	20.0	1.2	29.5	10.8	11.5	22.3	15.0	5.9	6.1	6.0	8.2	5.9	7.2	6.6	6.5	6.6	6.1	7.2	6.7	19.1	0.0	6.2	11.4	15.7	16.8	7.3	17.4	16.5	13.6	9.7	8.5	5.2	14.3	10.1	20.2	6.2	10.6	17.1	5.2	0.0	6.9	0.7	5.5	19.3	16.1	9.5	8.4	32.7	5.3	14.7	14.5	9.2	7.0	17.7	11.3	13.6	12.5	8.4	5.0	31.6	11.7	22.4	11.9	81.2	0.2	8.7	16.6	12.4	6.5	151.4	10.3	21.6	23.6	25.8	5.0	8.3	17.0	14.1	8.0	8.5	6.0	6.5	13.0	13.1	16.7	13.4	1.5	1.5	13.9	14.9	6.6	15.5	17.4	13.9	5.9
POGLUT2	"EP58, KDELC1, MGC5302"	ENSG00000134901	"Protein O-glucosyltransferase 2"	Q6UW63	13	102784281-102798976	"Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Cytotrophoblasts: 6.0;Extravillous trophoblasts: 23.3;Fibroblasts: 3.8;Hofbauer cells: 3.3;Syncytiotrophoblasts: 3.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"NK-cell: 3.9"	"Group enriched"	"Detected in many"	5	"NK-cells: 3.9;T-cells: 2.4"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB020780, HPA043946, HPA064398"	Approved		Supported	Nucleoplasm	"Intracellular and membrane"	NA	NA		44000	"Cluster 40: NK-cells - Unknown function"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm		"CAB020780: , HPA043946: AB_2678743, HPA064398: AB_2685256"	"unprognostic (1.97e-2)"	"unprognostic (2.34e-1)"	"unprognostic (3.21e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.55e-1)"	"prognostic unfavorable (2.24e-4)"	"unprognostic (6.68e-3)"	"prognostic unfavorable (4.81e-4)"	"unprognostic (4.34e-3)"	"unprognostic (2.75e-2)"	"unprognostic (7.26e-2)"	"unprognostic (1.50e-2)"	"prognostic unfavorable (4.73e-4)"	"unprognostic (1.11e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.46e-1)"	"unprognostic (2.60e-3)"	4.6	2.3	1.5	3.1	2.2	1.6	3.3	2.2	2.4	5.6	1.6	3.5	1.3	11.1	4.3	2.6	4.3	8.1	4.8	1.5	1.5	4.6	7.7	3.4	2.4	1.8	1.7	6.5	1.6	2.8	2.1	12.2	1.9	2.7	2.7	3.4	1.8	4.2	0.8	2.3	2.1	12.5	1.7	3.6	2.4	1.5	1.9	1.9	2.9	2.5	1.9	6.0	3.2	2.7	8.1	6.0	36.8	35.5	37.0	28.5	9.0	21.4	16.4	19.5	33.5	17.1	11.5	0.0	16.7	17.6	10.0	13.3	26.6	10.9	19.5	3.4	22.1	9.8	16.3	18.8	32.1	25.4	34.5	27.0	12.3	14.8	14.2	29.1	43.0	12.3	16.3	0.0	10.5	9.0	11.4	20.8	23.5	11.5	17.9	0.0	26.3	9.5	53.7	0.7	5.5	33.7	21.0	5.6	12.3	30.5	16.1	10.9	13.3	12.8	9.3	14.7	21.6	7.4	14.4	0.0	25.2	0.0	22.6	0.0	0.0	0.0	1.4	0.0	2.4	0.2	0.7	1.1	0.6	0.0	0.2	0.7	0.0	3.9	0.0	0.0	0.9	0.2	1.5	2.2	2.2	2.4	1.5	1.5	1.8	1.7	1.9	1.7	1.9	2.7	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	6.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	23.3	3.8	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0
POLA1	"NSX, p180, POLA"	ENSG00000101868	"DNA polymerase alpha 1, catalytic subunit"	P09884	X	24693873-24996986	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"	"DNA replication, Host-virus interaction"	"DNA-binding, DNA-directed DNA polymerase, Nucleotidyltransferase, Transferase"	"Disease variant, Dwarfism, FDA approved drug targets, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 38.5;Excitatory neurons: 42.3;Inhibitory neurons: 65.7;Microglial cells: 57.1;Oligodendrocyte precursor cells: 59.3;Oligodendrocytes: 97.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002947, CAB012274"	Supported		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm	Cytosol	"CAB012274: , HPA002947: AB_1079652"	"unprognostic (6.92e-2)"	"unprognostic (4.43e-3)"	"unprognostic (3.27e-3)"	"unprognostic (1.53e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.49e-1)"	"prognostic unfavorable (4.80e-5)"	"unprognostic (1.87e-1)"	"unprognostic (9.25e-3)"	"unprognostic (2.48e-2)"	"unprognostic (8.41e-2)"	"unprognostic (7.42e-2)"	"unprognostic (2.09e-1)"	"unprognostic (1.44e-1)"	"unprognostic (3.66e-2)"	"unprognostic (3.48e-2)"	"unprognostic (3.08e-1)"	3.7	2.0	1.9	4.8	2.5	7.3	5.1	2.2	1.8	4.3	0.8	4.1	2.4	4.2	1.4	3.9	3.7	2.1	3.5	1.3	1.9	2.9	2.0	3.1	6.8	2.3	2.3	5.8	2.8	3.4	1.8	5.6	2.4	3.1	5.2	3.7	3.0	3.5	4.9	4.0	3.5	4.8	2.2	3.5	3.7	2.6	2.1	11.9	3.1	3.1	7.7	3.7	3.8	2.6	32.7	24.6	30.3	24.1	5.2	6.5	6.9	23.6	12.7	25.0	28.3	20.4	17.0	41.1	7.7	9.6	23.4	26.0	59.7	18.7	33.6	21.1	24.8	31.0	42.8	13.5	2.4	41.6	15.5	4.1	3.6	31.2	8.4	5.8	13.0	20.8	28.7	20.0	16.8	22.4	45.2	7.2	30.7	20.3	19.1	39.0	81.5	30.7	7.1	21.1	27.9	16.7	28.1	11.2	11.6	33.0	25.7	11.5	10.1	21.3	14.9	42.4	22.6	11.6	18.1	32.7	12.4	18.3	24.9	0.0	0.2	0.2	0.6	1.4	0.8	1.0	0.8	1.0	0.7	0.4	0.4	0.5	0.0	0.8	0.2	0.2	0.9	0.5	1.9	2.5	2.2	1.8	1.3	1.9	2.3	2.3	2.4	2.2	2.1	2.6	5.8	9.6	6.5	38.5	5.2	2.8	4.6	1.8	5.7	3.9	4.7	4.3	11.8	0.0	7.2	1.8	2.1	6.1	3.2	2.5	3.9	3.2	0.2	3.2	4.7	6.3	4.2	24.2	42.3	3.0	4.9	4.6	4.6	3.8	9.5	8.3	3.3	3.4	4.4	1.7	65.7	4.2	4.1	4.4	1.5	1.7	6.2	4.5	0.0	57.1	3.7	4.8	5.2	59.3	97.7	1.4	1.2	3.4	8.6	2.0	2.3	1.6	6.1	7.4	6.6	9.2	6.0	6.4	4.5	5.5	2.3	2.3	4.9	5.0	4.2	2.4
POLA2	FLJ21662	ENSG00000014138	"DNA polymerase alpha 2, accessory subunit"	Q14181	11	65261920-65305589	"Metabolic proteins, Predicted intracellular proteins"	"DNA replication"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Erythroid cells: 23.2;Spermatocytes: 23.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											HPA037570	Supported		Supported	Nucleoplasm,Cytosol		NA	Yes			"Cluster 44: Non-specific - Transcription"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	Cytosol	"HPA037570: AB_10672280"	"unprognostic (2.28e-1)"	"prognostic favorable (4.61e-4)"	"unprognostic (1.67e-2)"	"unprognostic (7.44e-2)"	"unprognostic (5.20e-2)"	"unprognostic (3.18e-2)"	"prognostic unfavorable (2.11e-6)"	"unprognostic (1.14e-1)"	"unprognostic (2.87e-2)"	"unprognostic (1.15e-2)"	"unprognostic (4.05e-2)"	"unprognostic (1.83e-1)"	"prognostic unfavorable (4.09e-8)"	"unprognostic (1.60e-3)"	"unprognostic (8.26e-2)"	"unprognostic (8.16e-2)"	"unprognostic (6.25e-3)"	3.3	2.6	1.9	5.3	2.9	6.9	3.5	4.8	3.3	4.5	1.7	5.3	3.6	5.0	3.3	4.5	3.8	1.8	2.9	1.9	1.5	3.5	3.7	3.5	10.0	4.5	2.8	5.1	3.3	3.2	1.9	2.1	3.7	3.0	4.9	3.6	4.2	3.1	3.1	5.1	4.2	4.1	3.1	5.7	3.8	5.2	2.6	15.9	3.3	3.4	13.2	3.2	3.2	7.0	32.6	21.9	47.3	20.4	3.7	3.6	19.5	25.6	15.9	64.4	43.3	6.9	24.0	48.1	20.4	11.0	35.5	18.9	38.8	25.1	61.1	21.3	14.7	32.4	39.4	10.4	0.9	33.5	25.6	3.7	2.9	47.4	8.5	10.3	14.6	20.2	30.2	25.3	44.4	34.9	62.6	13.2	38.6	16.1	16.2	33.4	29.9	40.7	14.1	21.8	32.5	18.1	14.9	15.9	7.9	29.7	28.6	14.1	3.9	25.4	18.7	19.8	16.0	12.0	14.7	45.0	14.9	18.8	33.7	10.0	5.2	2.3	3.8	3.2	4.5	3.9	4.2	4.2	7.4	3.9	3.5	3.1	1.4	3.8	1.7	5.9	4.6	5.3	1.9	2.9	4.8	3.3	1.9	1.5	4.5	2.8	3.7	3.1	2.6	7.0	2.6	0.0	3.4	1.0	5.1	1.7	4.2	5.7	2.2	2.2	3.0	2.3	2.9	7.2	3.7	5.5	2.1	15.6	4.3	3.0	3.9	5.3	2.7	1.8	2.9	3.7	3.0	23.2	4.3	3.4	19.0	7.7	5.6	2.5	0.0	11.0	5.3	2.1	9.7	3.3	3.6	3.5	2.0	2.8	3.7	4.0	7.5	5.3	0.0	12.2	8.0	2.2	5.2	1.5	8.7	4.9	2.2	7.5	10.4	3.4	1.7	2.0	3.2	5.4	6.6	19.6	5.0	23.7	17.7	4.3	1.4	7.3	5.5	4.0	6.3	3.7
POLD1	"CDC2, POLD"	ENSG00000062822	"DNA polymerase delta 1, catalytic subunit"	P28340	19	50384204-50418018	"Cancer-related genes, Disease related genes, Enzymes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA excision, DNA repair, DNA replication"	"DNA-binding, DNA-directed DNA polymerase, Exonuclease, Hydrolase, Nuclease, Nucleotidyltransferase, Transferase"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Paneth cells: 51.3;Spermatogonia: 25.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004375, HPA046524"	Supported		Supported	Nucleoplasm		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"CAB004375: AB_675487, HPA046524: AB_2679684"	"unprognostic (2.45e-1)"	"unprognostic (7.02e-3)"	"unprognostic (1.59e-1)"	"unprognostic (4.35e-2)"	"unprognostic (2.55e-1)"	"unprognostic (1.85e-2)"	"prognostic unfavorable (2.87e-6)"	"unprognostic (4.12e-2)"	"unprognostic (1.16e-2)"	"unprognostic (2.83e-1)"	"unprognostic (5.08e-1)"	"unprognostic (3.92e-3)"	"unprognostic (4.01e-3)"	"unprognostic (1.28e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.89e-1)"	"unprognostic (3.70e-2)"	5.6	5.1	3.2	9.2	3.7	26.3	6.3	4.5	3.8	7.6	2.5	8.9	5.4	8.4	0.4	10.7	6.5	2.1	5.8	2.7	2.7	6.5	6.4	9.5	11.2	5.1	3.7	7.1	7.9	2.3	4.7	5.9	4.1	6.1	2.2	1.9	7.4	2.6	5.6	9.2	10.1	2.3	3.5	12.8	6.2	13.3	4.1	11.0	9.8	1.5	5.2	5.9	7.7	4.4	52.1	77.9	27.9	22.4	3.0	2.8	45.6	34.0	9.6	30.0	34.9	42.4	39.2	84.6	19.4	7.1	13.9	45.1	27.4	25.1	6.8	64.4	145.0	66.1	73.0	54.6	3.7	67.0	57.7	6.4	7.1	26.1	6.5	6.0	14.2	58.2	77.4	54.3	9.1	40.6	92.2	110.6	48.7	25.3	55.4	105.4	62.2	67.7	7.4	44.9	39.3	38.6	33.0	35.9	8.8	10.1	21.1	50.7	17.4	21.4	70.7	22.0	56.5	60.0	91.3	76.3	21.2	66.9	20.8	1.3	4.3	1.5	4.3	5.6	4.0	6.0	4.0	3.5	3.9	5.4	4.0	3.9	0.6	4.2	6.9	7.1	3.1	4.0	3.2	3.7	4.5	3.8	2.7	2.7	5.1	3.7	4.1	3.5	4.1	4.4	3.5	3.2	3.9	0.7	8.7	6.4	2.3	3.5	3.4	4.0	4.3	5.3	3.4	2.8	3.8	3.7	6.2	19.2	3.8	12.2	0.0	4.8	1.9	2.8	1.6	3.4	7.2	15.2	1.2	4.0	15.0	4.1	3.1	3.0	0.0	9.5	1.1	2.2	15.1	0.0	0.9	7.4	0.0	5.7	5.3	1.9	3.1	5.8	5.4	1.0	4.8	1.2	6.2	1.5	2.2	4.7	51.3	5.3	10.6	2.8	6.3	2.8	3.0	4.3	0.0	3.5	4.0	11.5	25.6	5.5	5.3	7.7	5.4	3.4	14.3	1.3
POLD3	"KIAA0039, P66, P68, PPP1R128"	ENSG00000077514	"DNA polymerase delta 3, accessory subunit"	Q15054	11	74493851-74669117	"Metabolic proteins, Predicted intracellular proteins"	"DNA damage, DNA excision, DNA repair, DNA replication"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA058846	Enhanced		Supported	Nucleoplasm		NA	Yes			"Cluster 14: Monocytes - Unknown function"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm		"HPA058846: AB_2683833"	"unprognostic (3.68e-1)"	"unprognostic (3.22e-2)"	"unprognostic (2.05e-3)"	"unprognostic (3.28e-1)"	"unprognostic (1.74e-1)"	"unprognostic (3.49e-1)"	"prognostic unfavorable (9.17e-4)"	"unprognostic (1.08e-1)"	"prognostic unfavorable (5.48e-4)"	"unprognostic (3.99e-3)"	"unprognostic (1.54e-3)"	"unprognostic (9.21e-3)"	"prognostic unfavorable (7.90e-6)"	"unprognostic (7.92e-3)"	"unprognostic (2.65e-1)"	"unprognostic (9.11e-2)"	"unprognostic (1.23e-1)"	7.9	6.2	6.1	14.6	6.0	10.1	11.1	6.0	7.3	10.6	7.6	17.2	15.7	16.5	12.0	12.9	16.3	14.9	8.9	5.9	6.1	44.5	7.1	11.5	14.5	4.9	5.6	16.0	11.4	7.8	4.6	11.5	5.6	8.3	17.9	14.9	6.8	10.1	7.7	11.6	14.4	15.3	5.1	11.4	15.4	19.6	5.5	15.7	15.0	12.5	15.2	12.7	7.5	7.4	32.2	28.6	43.6	29.8	13.2	22.5	30.9	42.7	23.9	43.7	37.0	37.8	40.8	45.7	30.9	20.5	25.3	41.2	36.3	28.0	54.6	34.5	23.3	29.1	44.3	12.8	9.5	56.4	25.3	10.0	17.3	51.1	27.3	13.8	17.1	39.8	26.7	35.5	25.6	25.3	63.4	25.3	26.4	95.3	29.1	60.0	109.4	37.9	20.2	30.6	29.0	19.5	50.7	25.3	49.7	26.2	29.5	35.7	16.4	42.9	30.8	48.8	34.2	24.8	56.6	102.4	24.5	35.1	33.2	7.3	22.6	15.9	9.2	18.5	9.1	10.1	11.7	8.2	17.7	8.0	11.6	9.6	19.4	10.8	19.0	5.2	13.7	13.0	6.1	6.0	6.0	7.3	5.9	6.1	4.9	5.6	5.6	5.1	5.5	7.4	14.8	12.8	20.0	13.1	9.7	5.9	7.0	11.4	12.5	12.3	10.5	12.8	7.8	7.2	17.7	9.2	8.4	19.7	11.1	17.9	5.9	17.2	28.3	24.8	17.1	14.2	5.4	24.2	20.1	32.1	26.7	13.1	16.8	14.4	19.0	20.9	8.2	4.9	15.6	23.5	15.3	12.7	12.2	12.9	7.2	23.1	12.5	16.9	3.6	15.0	25.3	15.3	9.2	6.6	18.7	17.4	13.4	8.6	11.4	11.4	10.7	39.1	45.2	19.1	6.6	13.7	12.4	60.3	37.7	11.2	5.4	13.0	11.8	10.0	19.9	10.5
POLDIP3	"KIAA1649, PDIP3, PDIP46, SKAR"	ENSG00000100227	"DNA polymerase delta interacting protein 3"	Q9BY77	22	42583721-42614962	"Predicted intracellular proteins"	"mRNA transport, Translation regulation, Transport"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"Early spermatids: 129.3;Late spermatids: 469.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018419, HPA048790"	Approved		Enhanced	"Nuclear speckles,Cytoplasmic bodies"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 31: Spermatids - Spermatogenesis"	"Nuclear speckles"	"Cytoplasmic bodies"	"HPA018419: AB_1856928, HPA048790: AB_2680522"	"unprognostic (2.00e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.32e-1)"	"unprognostic (7.05e-3)"	"prognostic favorable (7.79e-4)"	"unprognostic (2.82e-1)"	"unprognostic (1.17e-2)"	"unprognostic (5.44e-2)"	"unprognostic (8.16e-2)"	"unprognostic (4.49e-3)"	"unprognostic (2.48e-1)"	"unprognostic (5.96e-2)"	"prognostic favorable (3.36e-4)"	"unprognostic (3.73e-2)"	"unprognostic (3.11e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.19e-1)"	25.9	36.5	51.7	26.3	56.0	68.2	33.3	52.5	54.9	43.2	45.5	36.7	25.8	40.5	34.7	42.6	53.2	24.0	34.4	50.2	51.1	40.6	33.2	36.3	36.2	59.2	54.1	91.1	35.9	34.4	35.6	32.6	53.3	41.3	29.3	30.1	37.7	33.4	34.9	39.1	31.8	35.4	50.6	38.6	44.4	30.8	54.1	48.6	37.6	34.5	46.4	34.8	34.3	58.1	43.7	43.7	96.3	45.4	42.7	48.7	61.7	49.0	41.1	73.6	54.6	51.6	29.5	73.3	30.8	58.2	34.9	49.5	101.0	55.8	57.1	35.6	74.9	58.4	50.8	53.6	39.5	91.9	57.5	33.8	62.5	54.1	56.0	61.4	52.5	54.1	63.7	47.0	58.8	48.5	76.3	65.3	53.5	56.4	40.5	96.5	87.7	49.5	61.4	27.9	31.5	27.2	59.6	51.1	53.0	56.2	47.4	67.4	48.3	46.7	56.0	31.8	50.1	45.3	59.5	67.1	37.8	56.0	67.4	23.3	36.9	29.8	30.9	34.8	32.0	26.9	27.3	26.3	41.9	26.2	29.7	27.1	21.2	28.6	30.9	21.5	31.0	38.7	51.7	56.0	52.5	54.9	50.2	51.1	59.2	54.1	53.3	50.6	54.1	58.1	15.8	19.2	15.1	10.4	28.6	19.6	23.7	13.1	22.2	30.1	23.0	20.6	13.3	17.2	16.0	20.2	20.9	36.5	23.1	22.9	21.5	29.1	129.3	22.9	20.7	18.9	19.2	25.6	7.1	24.9	39.7	23.2	21.4	23.4	24.1	18.8	16.1	19.0	22.2	25.2	8.8	15.8	16.2	25.7	17.9	469.0	21.8	19.9	19.6	18.7	40.3	23.6	22.6	11.6	17.4	26.4	21.2	24.8	24.5	37.2	19.2	20.3	19.5	17.1	46.0	19.3	18.5	33.0	34.5	22.9	17.6	52.1	23.0	22.6	19.0	28.6
POLE	POLE1	ENSG00000177084	"DNA polymerase epsilon, catalytic subunit"	Q07864	12	132623753-132687376	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, DNA replication"	"DNA-binding, DNA-directed DNA polymerase, Hydrolase, Nucleotidyltransferase, Transferase"	"Cancer-related genes, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Spermatocytes: 46.6"	"Low cancer specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"cerebellum: 4.1;cerebral cortex: 1.1;hippocampal formation: 1.6"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"HPA058210, HPA067385"			Supported	"Nucleoplasm,Plasma membrane"		NA	NA				"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 24: NB-4 - Immune response"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	"Plasma membrane"	"HPA058210: AB_2683639, HPA067385: AB_2685830"	"unprognostic (1.60e-1)"	"unprognostic (1.77e-3)"	"unprognostic (2.00e-1)"	"unprognostic (9.17e-2)"	"unprognostic (1.68e-1)"	"unprognostic (2.01e-2)"	"unprognostic (3.96e-3)"	"unprognostic (2.23e-1)"	"prognostic unfavorable (1.44e-4)"	"unprognostic (7.12e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.67e-1)"	"prognostic unfavorable (3.19e-8)"	"unprognostic (8.60e-2)"	"unprognostic (3.18e-1)"	"unprognostic (1.28e-1)"	"unprognostic (9.95e-2)"	6.0	2.9	0.2	6.1	0.2	24.7	6.0	4.1	1.1	6.4	0.3	7.3	6.5	5.4	2.1	7.0	6.2	3.1	4.3	1.6	0.0	3.0	8.6	5.0	7.2	0.3	0.1	7.8	6.5	2.6	2.7	5.3	0.3	6.4	6.3	2.4	6.1	3.3	7.5	13.2	8.5	3.7	0.1	16.2	8.0	16.2	0.5	15.7	4.7	3.0	7.1	6.1	6.2	0.3	25.3	33.3	48.7	22.0	10.2	7.6	39.9	26.0	11.7	30.3	21.8	38.3	14.5	28.7	10.2	14.1	11.6	33.6	35.4	16.7	18.8	13.3	41.2	45.4	45.7	15.2	1.9	37.2	24.9	5.5	6.0	31.8	10.5	8.1	10.8	35.1	53.4	15.7	14.9	33.3	61.8	46.8	36.9	9.3	18.5	48.0	27.6	13.0	6.9	40.8	40.6	22.0	30.0	22.7	4.7	23.4	35.0	19.1	9.9	26.5	24.7	20.6	25.9	20.3	14.5	44.8	14.7	26.3	19.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.2	0.2	4.1	1.1	1.6	0.0	0.3	0.1	0.3	0.1	0.5	0.3	3.2	0.0	6.7	7.5	4.0	5.7	3.8	3.0	4.0	8.7	7.8	6.7	6.9	1.5	1.6	1.8	0.0	8.8	5.6	18.8	0.0	2.3	8.2	3.2	3.8	4.9	7.2	14.9	13.6	3.3	10.8	5.1	11.2	6.8	2.5	16.2	8.9	10.5	13.2	0.0	7.6	9.1	2.0	6.9	5.4	9.7	6.8	2.9	5.4	4.7	1.6	2.6	2.1	3.5	2.9	2.6	6.0	3.4	6.3	4.0	4.1	1.0	1.9	6.1	26.3	7.0	6.1	46.6	18.2	5.8	7.7	4.0	5.8	2.9	10.9	2.8
POLE2	DPE2	ENSG00000100479	"DNA polymerase epsilon 2, accessory subunit"	P56282	14	49643555-49688422	"FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins"	"DNA replication"	DNA-binding	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 18.2"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 21.0;Spermatogonia: 24.4"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in some"							HPA027555	Uncertain		Supported	"Nucleoplasm,Nuclear bodies,Vesicles"		No	No			"Cluster 48: NK-cells - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	"Nucleoplasm, Nuclear bodies"	Vesicles	"HPA027555: AB_10610282"	"unprognostic (1.42e-1)"	"unprognostic (6.57e-3)"	"unprognostic (3.53e-2)"	"unprognostic (7.44e-2)"	"unprognostic (2.04e-2)"	"unprognostic (4.99e-3)"	"unprognostic (7.60e-3)"	"unprognostic (2.32e-3)"	"unprognostic (1.10e-3)"	"unprognostic (2.69e-2)"	"unprognostic (1.88e-2)"	"unprognostic (1.37e-3)"	"unprognostic (5.13e-11)"	"unprognostic (9.97e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.50e-3)"	0.9	0.9	0.5	5.1	0.3	18.2	3.0	0.5	0.6	2.1	0.0	3.8	2.5	2.5	0.7	3.7	1.0	0.9	0.6	0.2	0.2	0.7	3.1	1.2	5.1	0.2	0.4	1.0	0.8	0.7	0.5	3.0	0.2	1.4	4.5	3.0	1.0	0.7	0.5	3.5	3.6	2.3	0.3	1.5	2.1	4.1	0.2	5.5	0.9	0.9	6.2	1.4	1.9	0.6	37.2	18.6	34.3	16.3	1.7	9.9	18.2	20.4	10.4	31.9	36.7	19.3	27.5	23.6	11.6	11.6	17.5	22.3	35.3	12.8	36.9	27.4	19.6	35.4	20.6	23.9	0.8	41.2	14.6	2.8	0.8	18.5	2.9	4.1	19.0	30.5	30.9	14.3	31.6	32.7	43.6	28.4	20.2	30.9	42.6	35.9	31.7	21.0	11.6	20.6	24.8	14.3	20.5	11.9	6.7	16.5	24.5	15.8	6.7	5.3	38.5	21.4	16.9	10.7	22.7	52.7	9.8	30.1	20.9	0.0	0.0	0.2	0.2	0.0	0.1	0.3	0.2	0.4	0.1	0.2	0.0	0.2	0.0	0.9	0.0	0.2	0.7	0.1	0.5	0.3	0.5	0.6	0.2	0.2	0.2	0.4	0.2	0.3	0.2	0.6	2.0	3.2	0.5	4.2	2.4	4.8	2.1	1.9	2.2	0.8	1.5	1.1	1.2	1.5	1.3	0.0	0.0	9.1	1.0	2.2	0.0	1.3	1.2	0.8	2.6	1.5	1.2	21.0	9.5	1.5	10.6	2.7	1.1	1.5	0.0	4.3	5.0	5.5	5.5	0.0	11.9	2.8	0.0	1.9	1.6	0.8	1.5	1.1	1.8	7.5	1.0	2.0	4.1	12.1	11.5	0.8	0.5	3.0	5.7	1.9	1.1	1.2	0.9	3.1	0.0	2.1	7.4	5.3	24.4	6.0	3.7	3.4	1.7	1.8	4.7	1.5
POLG	"POLG1, POLGA"	ENSG00000140521	"DNA polymerase gamma, catalytic subunit"	P54098	15	89305198-89334861	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"DNA replication"	"DNA-binding, DNA-directed DNA polymerase, Nucleotidyltransferase, Transferase"	"Disease variant, Epilepsy, Leigh syndrome, Neurodegeneration, Neuropathy, Primary mitochondrial disease, Progressive external ophthalmoplegia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA056821, HPA078482"	Approved		Supported	Mitochondria		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 72: Non-specific - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 65: Plasmacytoid DCs - Unknown function"	Mitochondria		"HPA056821: AB_2683247, HPA078482: "	"unprognostic (1.87e-1)"	"unprognostic (4.71e-2)"	"unprognostic (2.61e-2)"	"unprognostic (3.64e-1)"	"unprognostic (1.62e-1)"	"unprognostic (3.19e-1)"	"unprognostic (2.22e-1)"	"unprognostic (1.13e-1)"	"unprognostic (8.41e-2)"	"unprognostic (2.63e-1)"	"unprognostic (1.41e-1)"	"prognostic unfavorable (5.73e-4)"	"unprognostic (2.65e-3)"	"unprognostic (1.58e-2)"	"unprognostic (4.29e-2)"	"unprognostic (2.07e-1)"	"unprognostic (3.45e-1)"	13.3	11.1	6.8	4.0	5.0	2.6	12.0	4.8	6.3	12.0	4.5	13.3	5.5	12.9	0.4	14.6	11.2	0.9	13.8	6.1	3.5	10.1	12.9	13.8	3.0	9.0	5.8	10.8	10.7	2.9	8.4	2.5	6.5	10.5	0.9	1.4	12.3	2.2	25.0	16.0	14.5	1.3	5.4	16.2	11.9	5.4	5.7	7.3	10.5	10.9	2.4	12.2	12.7	6.3	8.0	17.0	6.7	10.0	7.7	1.6	16.4	16.4	2.7	7.9	5.9	28.0	10.9	14.4	33.6	5.9	16.9	11.8	14.3	4.8	0.9	35.8	31.3	19.4	19.5	11.1	10.8	21.3	33.6	2.4	8.7	7.0	3.0	8.3	12.2	26.8	19.5	5.4	6.1	22.8	16.3	16.5	8.7	13.7	8.2	18.2	13.7	17.4	3.2	19.2	24.5	6.9	26.8	9.6	16.8	6.0	7.7	10.8	17.3	12.8	15.6	28.5	14.2	17.0	9.4	18.6	9.5	14.3	11.6	3.3	4.3	6.1	5.5	4.0	4.3	2.0	4.6	6.8	6.0	3.0	3.7	4.4	1.8	5.0	3.5	4.1	3.3	5.3	6.8	5.0	4.8	6.3	6.1	3.5	9.0	5.8	6.5	5.4	5.7	6.3	15.7	12.8	11.9	11.4	17.2	12.2	11.0	10.7	9.1	7.6	12.0	10.3	19.0	11.5	9.5	11.0	2.1	15.0	33.8	17.2	9.8	10.4	1.3	8.4	9.4	12.4	5.4	9.0	12.9	10.9	15.8	11.9	21.4	11.3	8.2	14.8	14.6	17.8	12.7	3.3	9.9	24.9	4.1	18.5	14.7	1.5	14.3	17.2	19.6	8.4	21.8	6.1	30.9	9.5	11.9	11.4	15.9	10.5	16.8	17.7	10.5	7.5	7.8	6.4	6.6	13.3	12.9	9.2	11.1	11.8	11.9	21.8	21.7	14.8	17.6	15.5
POLG2	"HP55, MTPOLB"	ENSG00000256525	"DNA polymerase gamma 2, accessory subunit"	Q9UHN1	17	64477785-64497054	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"	"DNA replication"	DNA-binding	"Disease variant, Primary mitochondrial disease, Progressive external ophthalmoplegia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Skeletal myocytes: 92.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"CAB017030, HPA023202, HPA078396"	Approved		Supported	"Nuclear bodies,Mitochondria"		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 71: Testis - DNA repair"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 7: Non-specific - Mitochondria"	Mitochondria	"Nuclear bodies"	"CAB017030: , HPA023202: AB_1855523, HPA078396: "	"unprognostic (1.76e-1)"	"unprognostic (2.20e-1)"	"unprognostic (1.59e-1)"	"unprognostic (7.02e-2)"	"unprognostic (6.01e-2)"	"unprognostic (2.91e-2)"	"prognostic unfavorable (1.39e-6)"	"unprognostic (4.38e-2)"	"unprognostic (8.46e-2)"	"unprognostic (3.14e-1)"	"unprognostic (5.17e-3)"	"prognostic unfavorable (6.59e-4)"	"prognostic unfavorable (1.17e-5)"	"unprognostic (5.17e-2)"	"unprognostic (1.58e-1)"	"unprognostic (2.88e-2)"	"unprognostic (4.82e-2)"	4.5	5.8	2.7	4.4	3.0	3.6	4.5	3.9	4.5	6.8	3.0	4.7	3.5	4.7	2.0	4.0	5.6	2.4	5.0	2.8	3.6	5.7	5.3	3.9	5.4	3.2	3.0	7.9	4.7	2.4	4.0	2.9	3.1	5.1	1.9	2.6	3.9	2.9	6.8	4.2	5.6	2.0	2.9	7.5	4.0	12.8	3.1	6.3	5.8	4.2	4.0	4.8	5.3	3.9	8.1	10.4	6.7	7.6	7.2	4.7	8.4	4.6	4.6	7.0	5.9	10.1	6.2	15.7	5.4	2.8	6.5	5.3	9.3	3.9	8.8	4.6	11.0	9.9	12.2	10.5	7.0	14.2	10.6	4.5	4.7	5.3	7.2	8.4	4.7	7.6	18.3	4.7	6.5	10.0	15.3	15.4	7.3	8.6	11.2	13.3	23.8	14.2	6.4	2.4	9.3	10.0	4.4	7.1	8.0	8.7	7.4	12.0	6.1	7.0	9.9	5.8	12.3	8.4	7.2	11.3	5.9	13.4	4.8	7.2	5.2	6.0	6.5	3.2	6.6	10.7	7.5	6.2	9.7	11.9	9.7	9.7	0.9	5.8	8.4	4.4	8.1	4.0	2.7	3.0	3.9	4.5	2.8	3.6	3.2	3.0	3.1	2.9	3.1	3.9	24.6	12.8	21.2	7.8	19.6	8.2	13.7	7.8	16.5	5.0	30.1	37.5	18.4	12.8	13.3	3.7	0.0	13.0	22.7	31.7	0.0	5.4	14.7	16.5	26.7	16.0	10.9	20.4	9.1	3.8	14.4	19.2	14.8	29.2	13.3	9.9	14.6	4.7	9.2	6.7	7.4	13.9	6.1	6.9	7.1	7.3	6.5	17.7	7.2	11.2	8.0	4.5	18.6	13.0	14.1	2.9	21.8	3.0	6.3	9.8	8.9	5.2	7.1	9.2	6.6	92.0	18.4	49.7	9.2	10.8	8.7	4.0	16.2	15.2	19.8	5.2
POLI	"RAD30B, RAD3OB"	ENSG00000101751	"DNA polymerase iota"	Q9UNA4	18	54269517-54321266	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, DNA replication, DNA synthesis"	"DNA-binding, DNA-directed DNA polymerase, Mutator protein, Nucleotidyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 117.4;Spermatocytes: 80.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012000, HPA064696"	Enhanced		Supported	"Nuclear speckles,Cytoplasmic bodies"		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 12: NES - Nervous system development"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Nuclear speckles"	"Cytoplasmic bodies"	"HPA012000: AB_1847786, HPA064696: AB_2685325"	"unprognostic (1.64e-1)"	"unprognostic (5.79e-3)"	"unprognostic (9.72e-3)"	"unprognostic (4.92e-2)"	"unprognostic (3.04e-1)"	"unprognostic (4.46e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.05e-2)"	"unprognostic (4.04e-3)"	"unprognostic (2.22e-2)"	"unprognostic (2.07e-3)"	"unprognostic (1.30e-3)"	"unprognostic (1.55e-1)"	"unprognostic (4.05e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.52e-2)"	"unprognostic (6.99e-2)"	21.2	9.2	7.6	7.2	10.6	7.0	18.2	7.4	9.2	13.8	4.8	9.5	7.8	15.0	14.4	7.2	11.3	9.6	10.7	5.7	8.5	14.4	7.5	10.0	9.6	9.5	8.0	16.7	13.4	15.8	11.5	14.8	8.3	14.1	8.6	25.4	8.2	14.6	6.3	7.5	6.6	11.5	8.6	9.4	9.7	38.0	8.5	14.6	31.4	5.6	8.4	9.4	8.7	12.9	12.0	4.3	31.4	19.1	10.3	20.1	10.2	9.7	20.6	10.9	18.0	3.2	11.1	5.6	3.1	14.2	11.1	9.6	7.4	11.1	12.2	13.7	3.7	7.1	5.2	8.3	16.9	11.4	5.5	21.9	16.4	9.5	19.6	24.5	23.4	9.1	4.9	15.6	18.3	9.6	8.2	9.9	10.8	3.0	4.7	5.1	6.4	14.1	12.3	15.9	14.6	14.9	6.9	6.0	10.1	20.2	22.1	5.1	11.3	20.4	5.5	3.1	8.2	12.6	3.0	7.9	14.5	10.0	15.1	4.0	6.3	6.7	4.6	3.5	4.3	5.1	4.8	4.8	6.1	6.5	7.0	4.0	3.9	4.9	3.7	4.8	6.1	3.9	7.6	10.6	7.4	9.2	5.7	8.5	9.5	8.0	8.3	8.6	8.5	12.9	8.7	25.6	16.4	24.5	5.0	2.5	8.0	9.1	10.8	15.3	12.1	10.0	10.5	2.8	9.6	5.5	10.4	33.5	4.7	1.8	9.8	9.0	117.4	14.4	12.3	8.0	6.1	5.0	16.5	6.2	16.6	11.0	9.2	10.3	13.3	13.9	8.9	6.1	9.2	3.3	20.3	4.7	8.2	5.9	2.5	25.4	19.9	6.2	7.2	26.2	8.2	18.7	7.2	28.6	43.5	6.2	2.6	18.0	3.3	4.7	3.7	15.6	20.6	23.6	32.9	13.9	9.6	80.1	31.4	4.9	2.6	27.9	6.4	11.7	4.3	3.1
POLL		ENSG00000166169	"DNA polymerase lambda"	Q9UGP5	10	101578882-101588270	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, DNA replication, DNA synthesis"	"DNA-binding, DNA-directed DNA polymerase, Lyase, Nucleotidyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA076828			Supported	Nucleoplasm	"Intracellular and membrane"	NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 22: Non-specific - Unknown function"	"Cluster 6: T47d - Mammary gland"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm		"HPA076828: "	"unprognostic (3.71e-3)"	"unprognostic (6.93e-3)"	"unprognostic (1.73e-2)"	"unprognostic (2.47e-2)"	"unprognostic (9.52e-2)"	"unprognostic (1.80e-2)"	"unprognostic (2.11e-2)"	"unprognostic (1.24e-1)"	"unprognostic (8.11e-2)"	"unprognostic (1.71e-2)"	"unprognostic (1.12e-2)"	"unprognostic (7.19e-2)"	"unprognostic (4.74e-2)"	"unprognostic (1.06e-2)"	"unprognostic (1.94e-1)"	"unprognostic (3.86e-1)"	"unprognostic (1.64e-3)"	17.4	22.4	17.3	12.4	18.0	12.8	19.6	15.9	19.0	21.1	18.2	21.8	16.8	19.4	22.6	18.1	22.1	15.6	19.9	17.5	16.0	24.8	26.9	15.6	17.0	16.3	16.3	26.3	45.6	21.3	28.5	13.7	17.2	26.0	17.1	17.4	20.8	15.4	34.4	16.1	18.7	14.2	14.1	22.7	27.6	41.4	17.1	7.4	26.1	18.2	17.1	20.9	17.7	17.4	23.5	21.0	16.2	23.0	16.2	30.0	22.7	15.3	26.4	22.9	23.9	15.5	27.8	5.7	23.5	13.9	12.6	28.8	18.4	22.6	18.4	20.8	24.8	18.1	23.1	17.7	29.8	19.0	16.2	27.5	30.3	25.0	51.8	64.1	24.7	11.1	20.4	19.2	14.7	18.8	0.0	20.8	8.6	13.0	12.4	0.1	14.6	9.9	19.2	14.1	11.2	16.6	9.4	15.7	26.5	23.8	47.3	11.0	13.5	8.1	16.4	9.8	16.8	28.4	15.3	8.9	17.5	16.6	6.3	0.6	9.2	1.3	6.5	6.6	10.6	8.4	7.4	6.8	11.6	6.8	11.7	8.0	1.0	9.5	6.7	0.2	10.2	7.6	17.3	18.0	15.9	19.0	17.5	16.0	16.3	16.3	17.2	14.1	17.1	17.4	7.5	6.4	12.9	13.7	11.4	3.7	6.7	9.7	7.4	16.9	14.7	19.0	8.6	11.5	7.4	7.3	47.9	16.9	7.5	9.1	5.9	9.6	25.2	7.3	7.5	7.6	13.1	25.9	10.4	21.5	9.8	9.6	20.9	6.6	14.0	20.9	8.6	10.9	11.2	21.9	7.9	13.6	18.3	17.7	6.0	51.6	14.0	9.6	10.6	2.8	18.0	10.1	13.4	8.5	9.9	13.7	9.2	11.3	10.9	6.5	13.7	11.6	7.2	24.0	13.1	10.8	9.6	35.5	11.0	8.4	2.0	11.5	9.4	14.4	15.6	5.6
POLQ	POLH	ENSG00000051341	"DNA polymerase theta"	O75417	3	121431427-121546641	"Cancer-related genes, Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair"	"DNA-directed DNA polymerase, Nucleotidyltransferase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 6.0;lymphoid tissue: 4.5"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 16.4;Excitatory neurons: 9.5;Granulosa cells: 12.6;Inhibitory neurons: 7.8;Plasma cells: 12.2"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in single"		"cerebellum: 1.0"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"cerebellum: 2.5"	HPA053359			Supported	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	Yes				"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	"Golgi apparatus, Cytosol"	"HPA053359: "	"unprognostic (1.59e-1)"	"unprognostic (4.18e-2)"	"unprognostic (2.66e-2)"	"prognostic unfavorable (5.46e-5)"	"unprognostic (2.70e-1)"	"unprognostic (6.23e-3)"	"unprognostic (3.09e-5)"	"unprognostic (8.55e-3)"	"unprognostic (1.09e-4)"	"unprognostic (2.86e-1)"	"unprognostic (5.59e-5)"	"unprognostic (2.06e-3)"	"unprognostic (0.00e+0)"	"prognostic favorable (1.04e-4)"	"unprognostic (1.76e-1)"	"unprognostic (6.01e-2)"	"unprognostic (5.76e-2)"	0.1	0.2	0.0	1.6	0.1	6.0	0.4	1.0	0.2	0.2	0.0	1.2	1.2	0.2	0.0	2.0	0.0	0.1	0.2	0.2	0.0	0.0	0.1	0.2	2.8	0.0	0.0	0.0	0.0	0.1	0.0	1.0	0.0	0.1	2.0	0.0	0.3	0.0	0.0	1.4	0.9	0.4	0.0	0.8	0.5	2.2	0.0	4.5	0.0	0.0	2.3	0.3	0.5	0.0	18.2	12.1	10.2	7.2	0.9	1.2	9.2	8.5	3.2	9.7	12.9	9.8	6.6	21.5	3.7	4.6	11.7	14.0	12.2	5.4	16.4	6.3	6.7	13.8	8.0	6.1	0.1	15.1	12.1	0.2	0.4	8.9	5.4	1.7	4.9	7.9	9.3	15.9	10.3	7.1	13.7	8.8	9.7	5.5	5.9	11.4	12.2	7.6	3.1	10.3	5.5	5.0	9.8	5.2	3.4	8.8	4.8	14.8	3.8	8.6	11.2	3.4	11.1	8.0	6.9	21.8	4.1	11.0	6.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	1.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.5	1.6	0.7	0.9	0.5	0.6	0.0	0.9	0.6	0.6	1.6	0.0	2.0	0.0	0.0	3.1	0.6	1.6	0.0	0.1	0.4	0.9	1.0	0.5	0.0	16.4	9.5	0.0	3.3	1.2	4.6	1.0	0.0	12.6	0.0	0.2	2.3	0.0	7.8	1.6	2.0	1.3	1.2	0.7	0.3	1.7	0.0	1.0	0.6	0.4	0.0	1.5	1.3	0.2	1.2	0.0	12.2	0.5	0.2	0.1	2.4	0.2	0.0	0.1	1.0	6.8	3.4	4.9	0.1	0.3	1.8	0.9	3.2	0.8
POLR1B	"FLJ10816, FLJ21921, RPA135, RPA2, Rpo1-2"	ENSG00000125630	"RNA polymerase I subunit B"	Q9H9Y6	2	112541915-112579818	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, RNA polymerase related proteins"	Transcription	"Nucleotidyltransferase, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	4	"Early spermatids: 181.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037528			Supported	"Nucleoli fibrillar center,Cytosol"		NA	NA			"Cluster 22: NK-cells - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	"Nucleoli fibrillar center"	Cytosol	"HPA037528: AB_10671627"	"unprognostic (1.66e-1)"	"unprognostic (3.17e-2)"	"unprognostic (2.55e-1)"	"prognostic unfavorable (2.71e-5)"	"unprognostic (2.07e-1)"	"unprognostic (1.16e-2)"	"unprognostic (1.98e-3)"	"unprognostic (1.98e-1)"	"unprognostic (2.05e-1)"	"unprognostic (1.13e-1)"	"prognostic unfavorable (5.52e-4)"	"unprognostic (6.12e-2)"	"unprognostic (1.29e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.19e-1)"	"unprognostic (1.08e-1)"	"unprognostic (3.56e-2)"	5.7	4.6	2.9	5.6	3.0	4.1	8.2	3.5	3.1	5.3	3.8	5.5	4.4	4.7	4.4	8.1	6.7	3.7	4.1	2.8	3.5	8.1	10.7	4.1	9.3	2.6	2.7	6.3	8.1	11.9	4.4	5.6	2.5	5.0	6.2	5.2	3.8	4.7	7.5	5.2	3.8	5.3	2.6	6.7	4.3	8.4	3.1	7.2	10.7	6.4	10.8	7.9	3.6	3.4	21.1	21.6	11.2	28.2	13.9	13.2	24.0	15.1	11.9	24.0	21.5	48.8	12.5	46.1	22.9	9.8	18.8	29.5	56.1	30.6	28.4	22.3	30.9	26.5	21.4	37.1	14.2	43.6	18.1	12.7	21.6	25.4	39.6	9.8	19.9	10.2	55.0	16.8	13.2	17.5	20.5	29.7	66.3	29.5	42.8	30.9	21.3	54.1	17.2	19.2	34.3	29.1	12.1	34.7	19.7	13.8	16.3	15.6	15.9	14.6	23.2	13.7	21.8	24.3	44.4	40.9	11.0	28.8	13.1	0.4	8.0	3.3	10.0	8.3	21.5	11.4	9.9	10.7	14.2	11.6	12.4	12.5	0.8	15.3	6.5	3.5	15.2	9.6	2.9	3.0	3.5	3.1	2.8	3.5	2.6	2.7	2.5	2.6	3.1	3.4	4.8	16.0	5.9	4.6	8.5	15.0	4.7	4.1	9.6	3.6	4.2	3.7	6.4	7.2	5.8	9.2	2.1	3.4	6.5	2.0	5.9	3.9	181.9	3.5	7.6	5.8	3.6	5.9	8.8	4.6	2.8	3.5	8.6	4.2	5.1	6.5	1.4	9.4	3.8	1.7	9.2	3.8	0.0	4.3	3.7	40.9	3.1	3.8	1.8	3.7	4.5	4.3	8.2	7.5	8.1	3.8	5.8	3.0	6.4	6.2	1.2	5.1	3.2	2.9	0.0	5.1	3.5	10.3	7.9	12.7	17.2	0.5	6.2	6.8	5.5	3.9
POLR1C	"AC40, RPA39, RPA40, RPA5, RPAC1, RPC40"	ENSG00000171453	"RNA polymerase I and III subunit C"	O15160	6	43509702-43562419	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, RNA polymerase related proteins"	Transcription		"Disease variant, Leukodystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"OE19: 306.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031010			Supported	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 10: Non-specific - Unknown function"	"Nucleoplasm, Nucleoli fibrillar center"		"HPA031010: AB_10603131"	"unprognostic (2.84e-1)"	"unprognostic (1.67e-1)"	"unprognostic (3.15e-1)"	"unprognostic (6.57e-2)"	"unprognostic (7.01e-2)"	"unprognostic (3.59e-1)"	"unprognostic (6.69e-3)"	"unprognostic (1.09e-3)"	"unprognostic (2.00e-3)"	"unprognostic (1.90e-2)"	"unprognostic (2.05e-1)"	"unprognostic (7.32e-2)"	"prognostic unfavorable (4.17e-4)"	"unprognostic (1.20e-2)"	"unprognostic (4.69e-2)"	"unprognostic (3.01e-1)"	"unprognostic (6.41e-2)"	15.5	19.2	16.0	12.3	16.0	7.7	20.3	15.7	20.9	15.3	19.8	18.4	13.1	15.1	15.7	21.3	21.0	9.5	13.3	16.0	16.4	17.6	17.7	11.0	13.9	15.9	15.9	14.4	15.5	17.1	13.8	12.2	16.2	14.4	15.5	6.6	15.8	12.0	15.3	20.5	10.9	14.8	16.0	12.7	14.6	20.1	16.3	12.5	16.1	13.4	20.8	23.4	15.5	17.1	76.0	61.7	26.6	72.3	40.0	43.0	42.1	45.3	33.5	49.7	42.2	82.5	25.2	85.2	48.3	44.2	42.5	45.2	64.7	57.6	57.6	45.4	67.7	58.3	57.2	115.7	50.1	90.0	39.1	38.7	54.8	67.9	85.4	29.4	39.6	35.4	136.9	24.5	44.0	106.4	47.4	65.0	49.2	306.8	52.9	31.9	41.8	57.6	60.7	104.1	49.0	32.8	39.6	34.1	62.2	19.4	36.9	77.9	47.6	35.3	48.1	38.4	72.3	35.1	85.0	146.0	24.1	60.9	40.0	5.7	30.0	4.6	34.1	24.0	46.5	51.1	40.4	34.1	42.4	55.0	55.1	49.6	2.7	41.7	20.5	38.6	32.7	34.0	16.0	16.0	15.7	20.9	16.0	16.4	15.9	15.9	16.2	16.0	16.3	17.1	13.0	12.8	17.7	9.8	24.9	61.8	50.6	34.3	42.1	8.2	24.0	23.6	5.2	17.2	30.4	5.5	6.2	29.7	15.3	11.3	15.6	26.7	13.5	23.4	15.9	18.6	13.1	12.8	13.6	24.4	18.9	21.5	25.0	14.2	14.0	14.4	15.7	11.9	13.3	5.0	12.3	17.4	28.5	5.2	17.0	8.3	11.5	8.5	21.4	11.2	8.3	7.1	14.4	14.1	10.2	21.0	11.5	11.7	13.1	29.2	5.0	27.5	48.5	15.4	6.6	29.1	45.6	34.4	43.3	26.4	40.9	13.5	17.4	21.5	19.9	37.0
POLR1E	"FLJ13390, FLJ13970, PAF53, PRAF1, RPA49"	ENSG00000137054	"RNA polymerase I subunit E"	Q9GZS1	9	37485948-37503697	"Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, RNA polymerase related proteins"	Transcription			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022527, HPA052400"	Supported		Supported	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 32: Non-specific - Translation"	"Nucleoplasm, Nucleoli fibrillar center"		"HPA022527: AB_1854924, HPA052400: AB_2681815"	"prognostic favorable (2.27e-4)"	"unprognostic (2.09e-1)"	"unprognostic (9.90e-3)"	"unprognostic (1.10e-2)"	"unprognostic (7.16e-3)"	"unprognostic (2.07e-1)"	"unprognostic (1.09e-2)"	"unprognostic (7.14e-2)"	"unprognostic (1.04e-1)"	"unprognostic (2.48e-1)"	"unprognostic (2.80e-1)"	"unprognostic (2.48e-1)"	"unprognostic (1.07e-1)"	"unprognostic (4.96e-2)"	"unprognostic (5.23e-1)"	"unprognostic (1.58e-1)"	"unprognostic (4.24e-2)"	20.8	15.3	9.4	14.6	9.7	13.1	24.0	9.7	9.0	22.7	7.0	17.9	8.5	24.3	14.8	13.9	20.0	12.6	18.4	8.8	10.6	8.4	29.7	11.9	19.3	9.0	9.5	42.4	27.9	11.5	9.4	8.3	9.4	14.0	10.9	8.9	18.0	17.4	19.1	15.7	10.9	22.5	10.2	10.9	15.0	9.1	9.6	17.0	13.7	10.5	21.6	17.9	17.0	10.4	58.5	53.7	29.0	46.2	53.2	67.8	18.9	50.6	19.5	51.2	45.0	46.4	18.9	84.1	23.8	58.5	34.9	23.8	71.5	60.0	64.2	81.9	33.6	40.4	68.0	33.3	39.7	78.2	27.5	72.7	20.9	100.4	85.7	32.2	26.5	46.0	107.5	36.0	45.6	28.0	54.5	26.8	51.7	39.7	43.5	47.8	26.7	40.5	26.7	21.4	41.3	33.9	33.7	26.7	43.8	23.8	26.0	51.4	18.3	60.3	91.9	52.3	102.2	19.5	29.6	87.7	20.8	48.8	51.2	0.0	3.5	2.2	14.2	6.0	22.7	10.1	13.5	14.5	5.6	11.5	16.6	14.7	1.1	13.1	5.2	3.9	8.0	7.5	9.4	9.7	9.7	9.0	8.8	10.6	9.0	9.5	9.4	10.2	9.6	10.4	7.2	0.0	8.4	1.6	20.4	28.3	23.7	10.9	21.1	7.0	13.2	15.2	8.6	14.3	7.4	0.0	4.2	15.6	20.0	4.3	7.9	13.8	5.6	5.4	20.1	7.1	1.8	15.4	1.8	21.6	21.4	16.1	8.6	6.7	8.8	14.0	3.9	18.7	7.4	3.3	2.4	7.7	6.1	10.3	8.0	10.7	14.9	8.1	5.4	3.7	9.2	9.2	12.3	1.5	2.1	14.1	3.0	15.1	28.3	23.6	3.1	5.9	4.1	6.9	0.0	22.1	15.9	20.6	23.5	14.0	17.8	8.3	23.7	31.9	11.9	12.7
POLR1H	"A12.2, HTEX-6, hZR14, RPA12, tctex-6, ZNRD1"	ENSG00000066379	"RNA polymerase I subunit H"	Q9P1U0	6	30058899-30064909	"Metabolic proteins, Predicted intracellular proteins, RNA polymerase related proteins"	Transcription			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Adipocytes: 14.6;B-cells: 17.6;Cardiomyocytes: 15.2;Cytotrophoblasts: 28.2;dendritic cells: 20.5;Extravillous trophoblasts: 43.0;Hofbauer cells: 35.3;Syncytiotrophoblasts: 17.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055074, HPA077979"	Supported		Supported	"Nucleoli fibrillar center"		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 72: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 24: Non-specific - Transcription regulation"	"Nucleoli fibrillar center"		"HPA055074: AB_2682690, HPA077979: AB_2732366"	"unprognostic (4.94e-2)"	"unprognostic (2.93e-2)"	"unprognostic (2.54e-1)"	"unprognostic (3.81e-1)"	"unprognostic (3.88e-2)"	"unprognostic (8.55e-2)"	"unprognostic (5.36e-2)"	"unprognostic (2.82e-3)"	"unprognostic (1.96e-1)"	"unprognostic (9.52e-3)"	"unprognostic (5.18e-1)"	"unprognostic (3.28e-1)"	"prognostic unfavorable (2.17e-7)"	"unprognostic (2.57e-1)"	"unprognostic (1.51e-1)"	"unprognostic (9.97e-2)"	"prognostic favorable (2.75e-5)"	26.0	26.2	5.0	4.3	5.0	2.6	22.4	4.7	9.6	24.4	5.1	22.4	16.8	22.7	4.7	29.3	21.7	1.1	23.7	5.2	6.2	32.3	24.4	19.7	2.9	5.5	5.6	25.4	30.0	2.4	18.0	5.8	5.4	21.1	14.2	4.3	16.8	2.7	25.4	23.0	24.7	4.0	5.4	33.2	26.3	30.5	5.3	13.1	17.5	7.7	3.3	23.0	22.1	5.2	17.9	5.4	20.5	40.9	5.7	5.9	6.9	7.2	19.4	19.9	18.7	23.0	9.3	16.2	7.3	8.1	10.4	10.8	37.4	27.7	25.4	2.0	43.1	24.6	13.7	31.0	36.4	33.8	8.1	22.5	13.1	20.4	49.0	6.4	32.3	25.1	60.8	8.3	15.5	29.9	22.9	67.5	0.0	29.9	28.1	18.1	26.5	30.2	11.5	23.7	12.5	20.0	10.0	19.5	10.4	9.8	19.1	30.4	7.3	19.5	8.0	0.0	23.1	9.7	10.7	20.4	3.4	33.1	25.4	22.1	5.3	4.4	6.5	3.9	6.7	4.9	6.0	6.1	6.3	4.3	6.6	5.1	4.0	5.1	3.9	4.9	7.8	4.0	5.0	5.0	4.7	9.6	5.2	6.2	5.5	5.6	5.4	5.4	5.3	5.2	14.6	0.0	0.0	0.0	17.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.2	0.0	0.0	0.0	0.0	28.2	20.5	0.0	0.0	0.0	0.0	0.0	0.0	5.0	0.0	0.0	0.0	0.0	43.0	10.0	0.0	0.0	0.0	0.0	0.0	0.0	35.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.7	0.0	0.0	0.0	0.0	17.6	4.4	0.0	0.0	0.0
POLR2A	"POLR2, POLRA, RPB1"	ENSG00000181222	"RNA polymerase II subunit A"		17	7484366-7514616	"Human disease related genes, Metabolic proteins, Predicted intracellular proteins, RNA polymerase related proteins"				"Evidence at protein level"	"Evidence at protein level"			"Tissue enhanced"	"Detected in some"		"brain: 2.4;lymphoid tissue: 1.6"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"SCLC-21H: 3.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012226, CAB016388, HPA021563, HPA053012"			Enhanced	Nucleoplasm,Cytosol		NA	Yes			"Cluster 27: Non-specific - Gene expression"		"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm	Cytosol	"CAB012226: AB_304749, CAB016388: AB_677353, HPA021563: AB_1855526, HPA053012: AB_2682017"	"unprognostic (2.03e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.58e-1)"	"unprognostic (2.40e-1)"	"unprognostic (1.71e-1)"	"unprognostic (5.43e-2)"	"unprognostic (8.77e-3)"	"unprognostic (1.48e-1)"	"unprognostic (5.19e-3)"	"unprognostic (1.81e-1)"	"unprognostic (1.52e-1)"	"unprognostic (3.70e-2)"	"unprognostic (1.01e-3)"	"unprognostic (1.25e-1)"	"unprognostic (2.30e-2)"	"unprognostic (1.49e-1)"	"unprognostic (4.70e-2)"	0.1	0.7	0.4	1.6	0.2	0.2	0.1	0.3	1.9	0.0	0.8	0.1	0.5	0.1	0.0	0.0	0.2	0.1	0.1	0.7	0.4	0.1	0.0	0.2	0.2	2.4	0.7	0.1	0.0	0.1		0.2	1.1	0.2	0.2	0.3	0.0	0.0	0.5	0.1	0.4	0.0	0.4	0.2	0.0	0.7	1.1	0.2	0.0	0.1	0.0	0.0		1.6	1.0	1.7	0.5	1.5	0.4	0.0	0.9	0.0	0.0	0.0	0.2	0.0	0.6	0.4	0.4	0.0	0.6	1.0	2.1	0.0	0.0	0.3	0.0	0.5	0.0	0.9	0.0	1.6	2.9	0.3	0.0	1.3	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.3	1.0	0.4	2.1	0.0	0.0	2.5	2.3	1.0	0.0	2.7	3.5	2.8	1.2	0.8	0.0	0.0	0.8	1.6	0.0	1.0	0.5	1.1	2.0	0.4	0.2	1.6	1.1	0.8	1.0	0.0	2.2	0.8	2.0	0.9	2.5	1.1	0.3	0.8	2.2	0.5	1.3	1.0	0.0	2.0	4.2	0.0	3.2	10.1	0.4	0.2	0.3	1.9	0.7	0.4	2.4	0.7	1.1	0.4	1.1	1.6	124.2	22.4	41.6	13.4	68.0	42.8	40.7	33.8	64.3	90.4	56.5	187.1	26.9	38.6	30.3	23.9	110.5	35.9	153.5	55.0	3.9	27.0	25.0	74.9	64.4	57.7	76.7	43.3	18.1	30.2	28.7	53.3	103.0	67.3	42.5	46.0	40.4	29.9	45.4	55.5	14.9	43.9	26.4	42.1	38.3	7.4	37.0	65.7	37.4	19.7	38.2	27.3	26.8	17.6	17.8	32.0	35.9	41.8	62.0	27.9	42.5	13.2	38.4	90.5	6.6	94.4	53.9	58.5	120.2	73.8	41.2	53.8	89.2	49.8	32.6	30.8
POLR2B	RPB2	ENSG00000047315	"RNA polymerase II subunit B"	P30876	4	56977722-57031158	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, RNA polymerase related proteins"	Transcription	"Nucleotidyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037506	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA037506: AB_10672597"	"unprognostic (9.88e-3)"	"unprognostic (4.38e-2)"	"unprognostic (1.83e-3)"	"unprognostic (7.51e-2)"	"unprognostic (2.30e-2)"	"unprognostic (4.21e-3)"	"unprognostic (1.24e-3)"	"unprognostic (3.51e-1)"	"unprognostic (6.39e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.95e-1)"	"prognostic favorable (7.17e-4)"	"unprognostic (1.91e-1)"	"unprognostic (1.51e-1)"	"unprognostic (3.43e-1)"	"unprognostic (7.35e-2)"	28.2	29.1	11.8	38.3	14.0	34.1	34.1	21.0	17.6	32.9	16.9	34.7	32.6	34.9	26.5	30.0	32.9	30.2	48.1	14.2	16.0	35.7	30.0	27.7	49.9	14.1	11.8	31.6	28.3	50.3	17.8	32.9	15.4	32.5	36.3	36.8	30.6	32.4	64.7	28.0	30.9	38.3	12.8	36.5	31.1	39.8	12.8	61.2	37.6	56.7	51.3	42.4	19.8	17.6	78.9	64.3	110.5	98.2	89.3	80.3	61.2	94.6	101.3	98.3	91.1	82.9	80.1	126.5	86.1	94.3	71.4	52.2	140.5	77.2	139.8	54.2	66.3	96.9	70.0	71.5	102.2	156.0	100.6	86.8	76.1	114.3	68.5	81.0	119.5	95.0	145.4	100.0	115.9	56.8	142.3	60.5	92.0	101.5	77.9	105.9	75.7	68.4	66.8	90.7	95.3	106.8	67.5	120.3	89.6	90.7	65.8	88.3	91.2	74.4	95.2	75.8	132.2	77.3	75.5	172.8	82.4	83.1	92.4	51.9	17.0	22.8	27.7	17.0	29.5	27.9	26.6	28.8	22.2	18.9	25.9	30.8	14.4	26.5	19.8	17.6	30.9	19.8	11.8	14.0	21.0	17.6	14.2	16.0	14.1	11.8	15.4	12.8	12.8	17.6	39.5	28.9	52.0	26.8	61.5	41.3	60.9	60.3	39.9	45.5	31.5	26.5	35.7	35.8	56.3	36.8	43.8	49.2	77.1	36.9	19.6	60.9	5.9	53.4	52.7	39.5	29.9	50.5	31.1	55.0	30.7	42.8	59.1	45.8	58.2	36.8	30.7	30.8	29.1	45.4	32.0	36.9	50.8	45.8	36.8	8.8	57.5	42.5	44.4	33.7	74.3	26.7	115.4	23.6	40.4	54.0	36.2	38.0	50.5	59.4	36.6	32.7	80.6	49.0	72.3	46.5	45.7	74.0	63.6	32.7	39.9	41.0	75.2	46.2	35.4	74.6
POLR2C	RPB3	ENSG00000102978	"RNA polymerase II subunit C"	P19387	16	57462660-57472009	"Metabolic proteins, Predicted intracellular proteins, RNA polymerase related proteins"	Transcription			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040919, HPA041826"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm	Cytosol	"HPA040919: AB_10795483, HPA041826: AB_10793935"	"unprognostic (2.10e-2)"	"unprognostic (4.42e-2)"	"unprognostic (7.52e-3)"	"unprognostic (1.82e-2)"	"unprognostic (1.34e-1)"	"prognostic unfavorable (1.48e-4)"	"unprognostic (2.90e-1)"	"unprognostic (9.54e-2)"	"unprognostic (1.95e-1)"	"unprognostic (2.48e-2)"	"unprognostic (2.60e-2)"	"unprognostic (6.63e-2)"	"prognostic favorable (3.03e-6)"	"unprognostic (2.29e-1)"	"unprognostic (2.31e-2)"	"unprognostic (1.20e-1)"	"unprognostic (5.43e-3)"	35.1	41.6	49.9	30.4	51.2	43.9	39.6	52.3	60.3	36.8	49.4	36.0	33.1	39.2	67.1	31.2	47.0	31.3	52.1	51.0	52.0	59.8	62.3	47.7	38.7	50.5	51.0	54.3	45.1	55.1	46.9	39.5	51.8	40.4	40.0	59.3	39.0	45.9	74.2	34.5	31.8	40.6	52.4	30.8	36.4	25.4	50.4	47.7	40.8	61.4	44.9	39.1	31.2	54.5	59.3	94.0	81.2	72.7	72.7	62.9	67.6	75.4	84.9	126.0	82.3	121.7	74.7	65.8	86.4	89.3	75.6	60.5	111.9	83.5	134.2	30.2	77.0	51.1	53.5	142.0	81.8	95.0	94.4	57.8	66.4	96.7	88.7	66.6	74.8	90.0	90.2	37.3	81.6	78.6	106.9	98.6	118.4	72.1	138.0	151.4	94.4	120.5	99.7	56.7	102.5	117.4	122.9	69.8	81.4	74.0	51.6	85.2	54.4	76.3	76.3	56.8	89.0	82.2	76.2	135.0	75.3	79.5	102.5	79.8	38.3	70.3	44.6	37.8	49.2	52.4	50.6	42.8	38.1	48.4	60.4	57.4	96.9	64.6	49.5	31.2	54.9	60.5	49.9	51.2	52.3	60.3	51.0	52.0	50.5	51.0	51.8	52.4	50.4	54.5	49.5	25.6	43.0	11.1	49.2	31.0	46.0	51.3	30.1	81.6	39.4	52.5	11.0	41.5	31.9	27.6	56.3	78.8	49.8	38.2	92.0	62.9	5.6	25.0	25.4	39.0	38.2	35.6	13.3	65.8	80.8	40.5	15.8	22.3	61.0	46.1	23.2	25.1	41.2	52.2	13.9	34.5	48.8	22.9	30.3	8.4	51.6	22.7	40.9	8.4	49.1	102.7	58.7	8.0	9.6	59.5	44.6	51.9	40.0	43.9	63.8	120.4	29.4	93.9	46.0	30.0	49.1	50.4	66.4	30.0	30.0	92.9	52.9	49.0	38.4	43.5
POLR2D	RPB4	ENSG00000144231	"RNA polymerase II subunit D"	O15514	2	127843553-127858155	"Metabolic proteins, Plasma proteins, Predicted intracellular proteins, RNA polymerase related proteins"	Transcription			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 74.3"	"Cell type enhanced"	"Detected in all"		"Late spermatids: 170.2;Spermatocytes: 86.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034694, HPA046092"	Approved		Supported	"Nucleoplasm,Nuclear speckles"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 25: Spermatids - Spermatogenesis"	"Nucleoplasm, Nuclear speckles"		"HPA034694: AB_2674284, HPA046092: AB_10963049"	"unprognostic (3.57e-2)"	"unprognostic (3.76e-2)"	"unprognostic (2.59e-1)"	"unprognostic (2.54e-2)"	"unprognostic (2.77e-1)"	"unprognostic (1.27e-1)"	"prognostic unfavorable (8.91e-4)"	"unprognostic (2.51e-1)"	"unprognostic (7.95e-3)"	"unprognostic (2.64e-3)"	"unprognostic (1.97e-1)"	"unprognostic (2.51e-1)"	"prognostic unfavorable (2.79e-4)"	"unprognostic (3.66e-2)"	"unprognostic (6.57e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.38e-1)"	12.3	10.4	7.2	14.4	9.8	32.4	11.9	9.6	8.3	9.4	7.3	12.0	9.7	10.3	8.0	12.3	10.6	8.4	10.0	7.5	8.7	8.8	19.2	10.2	19.7	8.0	8.9	15.0	14.7	10.4	8.3	15.9	8.3	9.5	14.7	8.1	8.4	9.2	29.3	11.3	9.3	15.0	8.4	12.8	9.4	74.3	8.1	28.3	9.1	27.1	26.9	15.3	8.4	11.0	63.4	40.6	73.9	51.9	26.8	29.2	59.0	59.1	27.9	69.6	61.9	92.0	50.9	97.7	49.6	40.0	39.8	32.7	107.0	51.2	107.3	57.7	58.3	96.6	37.9	85.4	31.4	104.9	51.6	20.8	37.8	93.3	53.2	19.3	46.1	70.4	137.1	84.8	40.4	50.1	105.0	47.5	103.6	65.9	46.4	99.3	77.8	88.0	23.1	42.6	45.7	60.9	39.9	48.9	50.7	54.7	54.6	71.4	47.0	60.1	84.4	34.4	69.0	99.4	173.4	173.0	52.4	51.2	60.5	9.9	22.8	17.3	26.3	31.7	25.0	22.8	21.0	23.2	29.9	20.2	27.6	23.7	7.3	25.8	35.0	19.5	20.6	21.3	7.2	9.8	9.6	8.3	7.5	8.7	8.0	8.9	8.3	8.4	8.1	11.0	10.9	3.2	11.7	2.6	22.0	10.8	22.0	7.6	15.9	15.1	9.8	6.2	10.4	11.5	10.1	12.9	8.4	33.0	23.4	7.6	11.7	20.3	70.8	13.2	16.1	12.5	8.4	31.1	4.7	17.5	31.0	15.2	9.7	10.4	18.4	23.1	11.4	17.0	21.7	33.7	5.2	11.9	8.2	11.1	14.1	170.2	17.7	13.3	8.8	2.8	23.4	13.2	16.5	2.5	7.5	18.4	8.4	18.4	46.6	26.2	10.2	11.1	6.8	13.7	13.1	18.5	15.5	86.1	48.9	19.3	10.1	26.7	17.1	31.5	14.0	18.9
POLR2E	"hRPB25, hsRPB5, RPABC1, RPB5, XAP4"	ENSG00000099817	"RNA polymerase II, I and III subunit E"	P19388	19	1086574-1095380	"Metabolic proteins, Predicted intracellular proteins, RNA polymerase related proteins"	"Host-virus interaction, Transcription"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA063030, HPA068992"	Supported		Supported	Nucleoplasm		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 3: Monocytes - Immune response regulation"	Nucleoplasm		"HPA063030: AB_2684926, HPA068992: AB_2686065"	"unprognostic (2.52e-1)"	"unprognostic (3.73e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.51e-2)"	"unprognostic (2.14e-1)"	"unprognostic (6.42e-2)"	"unprognostic (2.59e-3)"	"unprognostic (1.60e-1)"	"unprognostic (2.08e-1)"	"unprognostic (2.05e-1)"	"unprognostic (2.03e-3)"	"unprognostic (3.03e-2)"	"prognostic favorable (3.21e-6)"	"unprognostic (3.22e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.72e-3)"	"unprognostic (4.77e-2)"	30.8	16.7	25.5	16.3	22.9	15.4	18.1	23.0	28.9	13.0	16.0	18.7	13.7	12.8	14.4	22.8	17.3	7.9	14.6	25.9	23.5	23.6	41.1	17.0	18.6	28.1	24.7	14.0	13.2	20.3	12.2	10.3	28.6	12.5	19.5	17.5	14.8	12.1	16.4	16.2	17.0	16.7	23.4	19.3	15.9	13.0	26.6	13.8	17.0	22.6	26.6	14.0	11.2	24.1	33.6	30.8	41.6	33.4	55.6	34.5	19.5	24.2	34.1	39.5	23.1	36.1	11.9	27.5	10.7	72.1	6.1	26.5	79.1	26.9	73.1	29.2	23.9	36.3	36.2	33.9	22.3	54.3	26.4	25.5	17.5	27.7	51.0	40.6	36.7	14.7	42.3	31.0	44.3	27.6	30.0	17.1	33.6	23.9	23.1	31.9	40.7	27.0	39.5	38.3	21.0	23.9	40.2	27.8	17.5	37.2	29.5	24.7	49.9	19.6	21.7	36.0	28.4	47.6	70.9	50.9	32.3	34.6	23.2	24.2	50.2	29.5	25.5	33.7	26.5	18.2	23.2	26.0	44.3	19.6	18.5	18.4	25.2	28.7	38.7	31.2	24.5	38.4	25.5	22.9	23.0	28.9	25.9	23.5	28.1	24.7	28.6	23.4	26.6	24.1	67.7	32.1	63.0	8.1	80.1	104.3	83.9	152.1	59.7	55.7	80.9	82.9	78.2	60.1	79.9	55.2	41.7	234.3	67.4	103.1	174.1	156.7	21.0	64.0	64.4	77.8	70.6	77.4	13.0	141.1	264.1	95.1	66.3	57.2	71.0	74.9	68.9	96.6	259.7	55.5	13.9	91.8	107.8	93.6	221.7	37.8	69.3	103.7	99.6	6.5	361.7	78.1	103.0	4.5	10.6	162.5	84.6	62.1	93.8	111.7	163.1	188.4	72.3	48.9	26.3	50.5	96.9	125.4	82.5	104.1	109.7	234.6	73.4	110.6	130.5	106.9
POLR2F	"HRBP14.4, RPB6"	ENSG00000100142	"RNA polymerase II, I and III subunit F"	P61218	22	37952607-38041915	"Metabolic proteins, Predicted intracellular proteins, RNA polymerase related proteins"	Transcription			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Cancer enriched"	"Detected in single"	4	"melanoma: 1.5"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000827, CAB009882"	Supported		Supported	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	"Nucleoplasm, Nucleoli fibrillar center"		"CAB009882: AB_2299942, HPA000827: AB_1079834"	"unprognostic (8.27e-2)"	"unprognostic (7.50e-2)"	"unprognostic (1.51e-3)"	"unprognostic (1.43e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.35e-1)"	"unprognostic (2.09e-1)"	"unprognostic (2.73e-3)"	"unprognostic (2.85e-1)"	"unprognostic (5.87e-2)"	"unprognostic (4.06e-1)"	"unprognostic (1.40e-3)"	"unprognostic (1.11e-4)"	"unprognostic (9.08e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.90e-1)"	"unprognostic (7.86e-2)"	52.5	61.1	73.4	34.6	92.3	38.9	50.8	77.5	90.2	59.5	56.9	64.9	37.7	53.2	24.8	58.7	50.2	19.5	91.8	74.2	91.2	58.2	118.6	41.6	31.0	87.9	83.9	60.9	47.5	76.5	62.7	30.2	82.6	47.7	28.7	16.8	56.1	39.6	111.0	45.8	42.3	28.8	75.3	36.4	57.6	48.8	86.8	36.7	54.7	68.4	26.3	53.1	52.7	123.7	150.7	176.2	120.6	128.7	141.1	81.7	109.4	138.0	81.0	141.4	130.5	210.0	51.8	117.4	99.1	120.3	138.3	106.4	166.9	135.7	67.1	143.0	303.7	107.3	181.3	289.1	125.9	213.6	67.0	112.4	99.8	186.3	72.1	71.2	118.7	130.4	208.9	93.7	101.9	220.2	168.4	258.2	174.3	175.4	134.7	162.3	110.4	134.5	77.4	94.8	180.6	67.2	129.5	88.9	215.3	69.6	62.9	144.3	110.5	119.8	173.9	150.4	158.1	106.0	178.0	247.9	122.4	107.9	138.4	118.9	92.9	140.8	83.8	90.4	78.5	95.8	71.9	81.8	86.3	71.3	63.1	63.7	122.8	113.7	78.5	123.3	103.4	85.3	73.4	92.3	77.5	90.2	74.2	91.2	87.9	83.9	82.6	75.3	86.8	123.7	82.6	38.5	85.9	9.4	73.2	204.3	113.9	205.4	63.7	26.7	133.8	168.7	0.3	101.5	122.5	121.4	25.0	243.5	70.5	148.7	193.7	160.0	117.0	96.0	117.2	94.8	117.2	109.6	9.9	159.5	303.4	97.4	58.1	82.4	90.0	90.0	98.6	304.4	178.5	28.6	10.7	143.1	116.0	94.2	102.9	42.0	159.7	65.9	225.9	2.8	102.3	99.4	111.2	9.5	99.0	182.4	152.9	151.2	65.7	137.3	196.6	306.5	114.3	33.3	157.8	90.1	197.1	237.0	241.0	106.0	224.3	211.9	82.4	82.7	145.7	121.2
POLR2G	"hRPB19, hsRPB7, RPB7"	ENSG00000168002	"RNA polymerase II subunit G"	P62487	11	62761565-62766710	"Metabolic proteins, Predicted intracellular proteins, RNA polymerase related proteins"	Transcription	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053000	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Nucleoplasm		"HPA053000: AB_2682010"	"unprognostic (7.58e-3)"	"unprognostic (2.75e-1)"	"unprognostic (2.37e-2)"	"prognostic favorable (8.23e-4)"	"unprognostic (1.39e-1)"	"unprognostic (2.16e-2)"	"prognostic unfavorable (6.02e-5)"	"unprognostic (8.50e-2)"	"unprognostic (6.01e-2)"	"unprognostic (6.26e-3)"	"unprognostic (9.41e-2)"	"unprognostic (1.85e-1)"	"prognostic unfavorable (1.11e-4)"	"unprognostic (1.53e-1)"	"unprognostic (1.64e-1)"	"unprognostic (2.46e-1)"	"unprognostic (2.21e-1)"	63.1	69.5	75.5	48.3	79.7	70.6	75.3	82.0	101.1	54.8	72.3	53.9	37.3	52.5	85.8	59.2	64.3	41.5	53.5	75.1	80.7	67.7	67.9	49.1	89.1	85.0	76.6	54.6	41.1	57.9	41.1	60.7	84.5	55.2	66.1	76.0	41.9	51.8	45.4	60.9	44.1	66.2	83.8	62.7	49.9	32.6	79.2	112.2	53.6	47.3	106.2	53.1	50.1	90.1	124.4	212.7	225.1	142.9	114.0	111.7	56.7	85.7	107.8	199.8	159.9	129.3	141.4	173.9	192.5	129.8	86.2	118.9	103.6	159.8	176.4	342.3	129.7	116.6	157.2	156.5	159.6	159.7	103.2	108.8	161.2	93.0	185.9	105.6	157.9	160.5	148.5	115.4	143.4	389.4	230.6	209.4	142.3	130.7	218.2	185.6	207.0	234.8	150.8	103.8	95.7	162.1	143.8	112.8	226.2	84.6	318.6	132.6	62.7	101.7	109.0	199.1	101.0	89.0	177.6	192.8	103.7	99.8	139.1	169.9	147.5	164.1	127.2	160.7	124.2	150.4	109.0	126.0	174.9	146.7	103.5	129.6	64.0	154.6	175.3	184.5	151.0	230.5	75.5	79.7	82.0	101.1	75.1	80.7	85.0	76.6	84.5	83.8	79.2	90.1	50.9	38.5	60.7	3.3	69.1	44.9	46.6	209.0	43.3	43.5	47.0	56.3	46.4	55.8	102.3	77.3	8.4	222.1	79.3	27.5	140.8	120.3	7.4	51.3	66.4	73.3	58.6	59.3	1.9	111.3	138.4	69.5	30.5	61.2	90.0	69.6	73.5	73.8	191.6	38.7	2.2	55.1	148.5	74.5	80.7	14.9	70.8	86.4	88.9	2.8	149.2	147.2	118.4	2.5	8.5	93.1	48.3	62.1	39.3	35.1	44.1	150.4	58.0	55.9	78.9	51.8	65.7	36.4	38.9	62.9	60.4	139.0	79.7	91.7	77.6	41.4
POLR2H	RPB8	ENSG00000163882	"RNA polymerase II, I and III subunit H"	P52434	3	184361718-184368596	"Metabolic proteins, Predicted intracellular proteins, RNA polymerase related proteins"	Transcription	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037745, HPA055813"	Supported		Supported	Nucleoplasm		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm		"HPA037745: AB_10672914, HPA055813: AB_2797254"	"unprognostic (3.21e-1)"	"unprognostic (4.96e-3)"	"unprognostic (3.61e-3)"	"unprognostic (7.15e-2)"	"unprognostic (1.17e-2)"	"unprognostic (6.72e-2)"	"prognostic unfavorable (2.01e-4)"	"unprognostic (8.82e-3)"	"unprognostic (2.84e-1)"	"unprognostic (4.02e-3)"	"unprognostic (4.24e-2)"	"unprognostic (1.27e-3)"	"prognostic unfavorable (1.65e-10)"	"unprognostic (1.34e-1)"	"unprognostic (4.01e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.93e-3)"	41.6	60.6	50.4	32.5	51.0	31.1	42.2	53.5	60.1	48.8	51.8	54.4	57.6	36.3	39.7	52.1	39.8	30.0	34.8	50.7	49.9	77.5	63.8	37.6	41.1	50.8	50.6	40.2	52.1	35.5	32.9	34.9	50.9	42.9	57.8	14.6	44.2	26.3	37.3	37.8	55.5	35.0	49.8	41.9	51.2	32.3	51.3	39.8	48.3	30.0	40.8	43.4	41.5	52.9	225.2	77.3	81.7	121.4	89.0	62.8	101.2	82.8	86.3	110.8	141.6	199.6	104.6	126.0	201.7	65.0	168.4	88.8	147.4	148.7	98.1	124.4	194.7	121.4	89.8	126.2	80.1	129.3	67.9	81.6	83.3	72.6	129.8	99.4	116.3	124.6	95.3	81.0	89.0	265.6	128.7	172.3	89.0	279.0	159.3	74.3	74.9	171.2	133.9	100.3	122.8	87.3	69.7	214.0	126.9	78.6	267.9	102.4	61.5	52.5	82.9	70.9	224.3	161.7	181.3	237.3	83.4	136.2	71.5	8.3	17.6	15.9	26.8	30.7	32.9	32.9	31.6	29.1	34.0	33.9	45.8	34.8	1.3	29.8	19.2	34.7	36.7	21.6	50.4	51.0	53.5	60.1	50.7	49.9	50.8	50.6	50.9	49.8	51.3	52.9	45.1	38.5	43.8	23.8	39.4	113.4	74.1	113.7	61.5	22.0	70.1	77.0	17.4	47.1	70.2	44.1	16.7	103.2	45.8	132.8	140.8	73.0	21.0	62.3	62.3	57.9	55.7	53.8	12.9	91.2	146.0	52.8	53.5	83.7	31.1	50.4	43.2	58.5	61.4	25.2	15.8	80.2	93.6	21.4	57.5	14.3	46.0	29.9	51.6	9.4	29.0	26.7	32.0	8.5	11.5	97.6	90.9	27.8	52.1	139.7	94.5	150.5	55.1	24.9	39.5	48.0	69.6	92.9	111.0	66.0	74.2	122.3	38.0	71.6	83.1	92.5
POLR2K	"RPB10alpha, RPB12"	ENSG00000147669	"RNA polymerase II, I and III subunit K"	P53803	8	100150623-100154003	"Metabolic proteins, Predicted intracellular proteins, RNA polymerase related proteins"	Transcription			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA047477			Supported	"Nucleoli fibrillar center"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoli fibrillar center"		"HPA047477: "	"unprognostic (3.13e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.15e-3)"	"unprognostic (2.75e-2)"	"unprognostic (4.68e-2)"	"unprognostic (1.58e-2)"	"unprognostic (1.62e-1)"	"unprognostic (2.45e-1)"	"unprognostic (1.57e-2)"	"unprognostic (9.75e-3)"	"unprognostic (5.73e-2)"	"unprognostic (5.65e-2)"	"unprognostic (3.46e-2)"	"unprognostic (3.07e-2)"	"unprognostic (9.16e-2)"	"unprognostic (3.43e-2)"	55.2	73.7	65.1	40.9	67.7	66.8	70.4	70.2	110.9	55.3	62.9	51.4	37.7	49.6	71.2	45.0	39.8	41.6	63.8	67.3	72.1	74.5	69.9	48.6	57.9	68.9	67.8	43.4	33.9	80.8	48.4	48.1	69.1	52.1	54.0	61.3	47.5	54.2	45.5	37.3	38.8	47.0	69.0	42.7	47.2	33.2	67.8	64.1	63.3	58.7	58.2	61.4	36.0	70.7	152.7	75.8	95.3	67.3	100.3	91.0	63.9	109.9	90.5	110.1	132.6	46.7	101.5	100.7	214.7	87.8	64.1	67.8	103.4	91.1	144.3	164.8	114.5	138.3	88.8	100.4	79.1	90.3	95.2	74.6	119.0	87.3	88.7	71.1	101.4	116.6	109.7	96.0	108.6	96.5	228.0	132.5	98.9	216.5	148.1	88.7	55.1	146.5	138.4	84.5	199.3	130.1	75.6	65.9	169.9	92.1	134.7	136.0	78.7	64.1	92.3	100.4	119.0	98.1	169.2	160.6	121.8	156.3	102.4	72.5	33.3	50.4	47.8	44.6	58.3	65.6	61.5	60.5	43.1	46.7	54.1	57.9	12.6	58.0	42.5	67.4	70.3	55.7	65.1	67.7	70.2	110.9	67.3	72.1	68.9	67.8	69.1	69.0	67.8	70.7	120.5	67.3	57.8	8.8	101.3	162.6	162.9	263.8	82.6	57.5	115.9	123.3	93.4	82.9	152.2	147.1	16.7	134.7	126.5	75.0	440.3	146.0	6.3	113.1	80.9	101.5	122.1	95.9	18.2	130.1	197.0	105.2	60.1	95.2	109.2	52.1	79.2	122.7	154.1	48.8	17.9	116.9	213.6	72.2	103.9	17.6	117.1	78.6	136.9	8.4	144.3	115.7	122.6	12.1	17.4	141.3	72.0	121.5	127.2	224.7	108.1	388.5	127.8	64.9	72.3	96.8	148.0	139.1	166.6	103.0	170.1	137.6	127.9	92.9	98.8	261.3
POLR2L	"hRPB7.6, hsRPB10b, RBP10, RPABC5, RPB10beta, RPB7.6"	ENSG00000177700	"RNA polymerase II, I and III subunit L"	P62875	11	837356-842529	"Metabolic proteins, Plasma proteins, Predicted intracellular proteins, RNA polymerase related proteins"	Transcription			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Hepatocytes: 1813.6;Proximal tubular cells: 1989.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"A549: 569.0;PC-3: 706.8"	"Low region specificity"	"Detected in all"							HPA073614			Supported	Nucleoplasm		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 35: Non-specific - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm		"HPA073614: "	"unprognostic (2.65e-2)"	"unprognostic (6.56e-3)"	"unprognostic (1.40e-1)"	"unprognostic (5.71e-2)"	"unprognostic (3.49e-2)"	"unprognostic (3.46e-2)"	"prognostic unfavorable (2.37e-4)"	"unprognostic (6.17e-3)"	"unprognostic (1.34e-1)"	"unprognostic (7.51e-3)"	"unprognostic (2.37e-2)"	"unprognostic (6.77e-2)"	"prognostic favorable (5.56e-4)"	"unprognostic (3.60e-2)"	"unprognostic (1.32e-1)"	"unprognostic (4.03e-3)"	"unprognostic (1.73e-1)"	112.1	101.2	68.2	21.5	69.9	27.2	91.0	69.0	98.3	48.0	90.5	63.5	26.1	48.9	16.5	87.1	43.3	16.4	161.8	72.9	75.3	112.7	107.6	68.3	20.4	68.3	71.0	37.3	111.5	30.4	71.7	21.1	70.1	67.9	15.4	11.9	62.6	31.3	101.0	65.3	46.2	24.9	67.9	68.4	63.3	34.3	70.1	21.0	72.5	43.1	17.6	63.3	54.1	69.7	106.4	569.0	52.9	66.5	150.1	107.8	45.6	134.5	94.1	129.6	86.5	166.2	97.6	64.4	35.6	166.6	110.4	69.5	79.7	160.8	39.9	59.9	381.6	63.4	160.7	216.6	88.3	62.3	49.3	178.9	71.6	74.2	36.6	79.2	101.7	63.9	67.0	71.3	156.1	268.4	59.7	63.1	82.6	124.7	706.8	58.8	41.9	99.3	160.7	81.1	104.1	32.1	133.3	135.2	107.3	28.2	81.2	36.7	117.9	87.5	69.1	48.3	83.8	40.0	50.0	62.3	130.8	58.3	78.2	93.3	119.5	121.7	92.9	109.0	100.1	75.5	86.0	92.0	114.0	73.6	71.8	89.3	32.1	123.7	76.6	141.1	92.5	134.7	68.2	69.9	69.0	98.3	72.9	75.3	68.3	71.0	70.1	67.9	70.1	69.7	364.4	410.3	390.2	9.8	265.9	611.8	245.0	767.6	279.4	68.1	491.1	412.0	500.6	584.8	415.4	526.0	25.0	625.4	305.0	669.3	1287.4	444.0	84.2	388.4	377.2	400.3	501.7	363.4	5.0	684.1	467.7	392.3	283.4	301.7	266.2	194.4	649.6	1813.6	700.2	50.5	5.3	641.6	323.5	434.5	582.0	235.7	305.7	307.3	658.1	11.2	493.6	368.5	389.3	3.5	9.0	751.1	589.2	255.1	382.8	300.0	813.6	1989.1	329.9	82.5	157.8	195.2	340.8	182.6	268.6	459.8	696.6	449.6	286.1	284.9	553.1	289.7
POLR3A	"C160, hRPC155, RPC1, RPC155"	ENSG00000148606	"RNA polymerase III subunit A"	O14802	10	77969251-78029515	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, RNA polymerase related proteins"	"Antiviral defense, Immunity, Innate immunity, Transcription"	"Nucleotidyltransferase, Transferase"	"Disease variant, Leukodystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 64.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"PC-3: 75.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037926	Uncertain		Supported	Nucleoplasm		NA	NA			"Cluster 42: Non-specific - Transcription"	"Cluster 58: Brain - Synaptic function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 9: Photoreceptor cells - Phototransduction"	Nucleoplasm		"HPA037926: AB_10672400"	"unprognostic (6.83e-2)"	"unprognostic (3.41e-2)"	"unprognostic (4.54e-2)"	"unprognostic (2.76e-2)"	"unprognostic (6.41e-2)"	"unprognostic (1.75e-1)"	"prognostic unfavorable (3.64e-6)"	"unprognostic (3.25e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.73e-1)"	"unprognostic (6.64e-2)"	"unprognostic (2.09e-2)"	"unprognostic (1.51e-2)"	"unprognostic (1.34e-1)"	"unprognostic (3.19e-1)"	"unprognostic (1.30e-1)"	"unprognostic (4.11e-2)"	4.3	6.0	6.6	5.2	7.1	3.9	6.2	6.7	7.9	5.1	4.7	4.8	5.1	5.5	7.5	5.0	4.8	3.7	4.9	8.1	3.7	5.2	5.6	4.0	5.7	5.5	3.4	6.5	5.4	6.8	10.4	6.1	5.5	5.8	5.7	12.8	5.0	4.5	11.5	6.7	4.7	5.6	2.2	5.1	4.7	6.0	4.0	7.6	5.6	8.7	6.3	5.0	4.8	6.5	14.2	16.3	17.4	28.8	11.2	14.2	11.6	16.0	20.7	20.2	19.8	22.1	10.0	17.6	9.7	14.0	11.5	15.7	30.3	17.5	24.4	13.0	22.2	14.2	13.6	26.6	10.5	24.6	11.5	12.2	12.3	35.9	33.0	19.4	18.0	14.1	26.8	10.6	19.9	10.6	18.7	15.6	19.0	11.0	75.1	17.5	11.0	11.5	10.0	8.6	15.5	20.0	15.4	28.3	16.6	15.5	21.0	12.7	19.8	12.9	12.5	14.2	32.0	16.4	18.6	21.0	23.0	25.4	6.4	5.4	2.6	1.5	3.5	3.1	3.5	2.6	2.8	3.4	2.4	3.2	2.5	3.0	1.5	3.4	2.9	2.6	4.6	1.9	6.6	7.1	6.7	7.9	8.1	3.7	5.5	3.4	5.5	2.2	4.0	6.5	8.5	0.0	9.1	17.0	8.7	9.9	5.1	5.3	11.4	28.3	9.6	8.3	11.7	8.6	9.5	0.0	64.6	8.0	12.6	6.1	1.9	7.0	1.6	8.3	14.4	8.1	7.2	11.6	26.4	6.2	6.9	8.2	8.2	8.9	6.3	15.7	5.3	9.5	5.5	15.2	26.3	10.2	0.0	6.9	3.7	1.2	13.1	5.9	1.8	10.3	7.8	13.0	12.3	16.1	18.7	8.1	8.3	8.2	11.2	4.7	8.0	5.0	10.4	31.5	6.6	13.6	8.3	12.5	18.0	10.1	9.1	4.1	7.8	13.7	8.6	3.6
POLR3G	"C31, RPC32, RPC7"	ENSG00000113356	"RNA polymerase III subunit G"	O15318	5	90471748-90514557	"Metabolic proteins, Predicted intracellular proteins, RNA polymerase related proteins"	"Antiviral defense, Immunity, Innate immunity, Transcription"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 24.8;Inhibitory neurons: 21.2;Oligodendrocytes: 70.8;Spermatogonia: 26.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"WM-115: 84.5"									"CAB010109, HPA052658, HPA074330"	Enhanced		Supported	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 6: Brain - Smell perception"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Nucleoplasm	"Nuclear bodies, Cytosol"	"CAB010109: AB_2165718, HPA052658: AB_2681904, HPA074330: "	"unprognostic (4.31e-1)"	"unprognostic (5.35e-2)"	"unprognostic (2.62e-2)"	"unprognostic (3.55e-3)"	"unprognostic (1.18e-1)"	"unprognostic (3.42e-2)"	"unprognostic (4.19e-6)"	"unprognostic (2.17e-3)"	"unprognostic (1.91e-1)"	"unprognostic (1.93e-2)"	"unprognostic (3.52e-2)"	"unprognostic (9.71e-2)"	"unprognostic (1.21e-14)"	"unprognostic (3.86e-2)"	"unprognostic (3.19e-2)"	"unprognostic (1.53e-2)"	"unprognostic (8.17e-5)"	1.8	0.6	3.5	2.4	4.5	3.0	2.0	6.3	5.9	1.3	0.7	1.6	1.8	1.5	4.7	4.3	1.2	1.3	1.8	3.6	6.0	0.9	2.2	1.6	4.7	5.7	4.4	1.9	2.4	2.0	0.9	1.8	6.8	1.7	1.5	3.3	2.3	0.5	3.0	4.3	1.4	0.8	1.9	1.8	1.2	4.5	4.2	0.8	3.2	0.8	1.9	2.0	1.7	6.3	24.1	13.0	18.8	5.3	5.9	8.2	7.7	11.9	4.3	19.8	16.8	9.0	18.8	63.7	4.2	5.3	20.0	11.6	20.8	23.2	69.2	29.6	19.6	26.2	8.1	15.1	9.5	19.4	6.2	6.7	8.1	32.7	25.8	4.6	27.2	26.5	35.8	6.4	8.3	13.2	19.1	14.1	78.1	4.0	63.2	16.5	7.4	40.2	5.9	3.2	22.0	6.4	3.7	9.6	35.1	7.7	5.4	6.2	29.1	10.3	21.2	13.2	48.3	13.5	36.7	50.0	22.1	23.7	84.5	3.3	0.2	0.2	1.5	0.4	0.7	1.7	0.5	0.9	0.4	0.9	1.1	1.2	0.7	2.9	1.5	1.0	0.2	0.3	3.5	4.5	6.3	5.9	3.6	6.0	5.7	4.4	6.8	1.9	4.2	6.3	3.2	6.4	2.2	11.8	2.8	3.6	1.6	1.5	1.8	3.0	2.8	3.7	5.2	0.0	0.7	1.8	8.4	0.8	0.7	0.9	3.9	2.4	4.5	1.6	2.3	2.0	6.7	8.8	24.8	4.4	5.4	3.8	0.5	1.2	7.0	1.6	4.6	2.6	1.7	3.3	21.2	1.4	0.0	0.3	0.3	1.0	0.3	1.2	1.8	5.6	0.0	1.1	1.0	14.6	70.8	4.1	3.0	1.2	5.4	6.1	0.4	1.5	3.0	0.8	0.0	1.1	1.8	7.2	26.6	6.3	8.5	0.8	1.7	6.5	2.0	0.8
POLR3H	"C25, KIAA1665, RPC8"	ENSG00000100413	"RNA polymerase III subunit H"	Q9Y535	22	41525799-41544606	"Metabolic proteins, Predicted intracellular proteins, RNA polymerase related proteins"	"Antiviral defense, Immunity, Innate immunity, Transcription"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Late spermatids: 163.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046787	Approved		Supported	Nucleoplasm,Vesicles,Centrosome		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 25: Spermatids - Spermatogenesis"	Nucleoplasm	"Vesicles, Centrosome"	"HPA046787: AB_2679806"	"unprognostic (1.55e-1)"	"unprognostic (6.74e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.87e-3)"	"unprognostic (9.57e-2)"	"unprognostic (1.26e-1)"	"prognostic unfavorable (2.04e-4)"	"unprognostic (2.05e-2)"	"unprognostic (1.33e-2)"	"unprognostic (5.43e-2)"	"prognostic favorable (5.41e-4)"	"unprognostic (6.40e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.94e-2)"	"unprognostic (1.49e-1)"	"unprognostic (4.00e-2)"	"unprognostic (1.70e-1)"	16.6	21.0	40.4	8.5	38.9	5.4	15.1	38.0	49.5	11.0	33.3	13.4	4.8	14.0	9.0	16.4	15.8	7.9	18.3	39.5	38.6	13.5	26.7	14.2	10.0	41.1	41.7	18.5	12.2	11.9	18.2	6.5	38.1	15.4	5.2	7.0	11.5	10.7	13.8	12.1	9.7	11.7	40.1	10.9	13.4	16.2	41.3	8.0	14.1	9.0	7.7	14.2	9.8	39.4	36.4	23.8	21.4	32.7	23.0	20.9	14.8	30.5	27.3	49.0	39.3	47.9	12.0	30.8	21.9	49.9	27.8	17.8	39.8	48.1	30.6	26.3	50.1	18.4	37.1	23.7	23.9	75.3	30.8	26.3	30.8	64.9	17.4	18.8	23.5	29.3	39.5	19.9	28.0	34.4	19.3	20.1	15.6	49.8	28.1	30.0	16.9	32.6	22.9	21.7	21.2	12.5	37.0	39.7	19.3	13.7	15.6	21.1	22.7	29.8	30.7	49.8	39.8	16.7	28.6	46.6	49.5	26.8	28.9	0.1	12.5	0.2	8.8	18.3	12.6	16.6	8.7	10.4	14.2	13.9	11.6	9.7	0.6	5.4	18.6	13.3	5.8	9.9	40.4	38.9	38.0	49.5	39.5	38.6	41.1	41.7	38.1	40.1	41.3	39.4	6.1	0.0	32.0	15.7	14.8	17.7	12.0	19.0	13.6	18.8	24.9	23.4	6.4	14.3	19.8	16.5	16.7	32.9	7.9	5.0	46.9	30.4	42.6	12.7	15.4	10.3	14.3	19.1	10.0	29.6	30.9	14.8	13.3	8.9	11.4	13.1	9.7	33.3	30.5	21.9	7.1	4.8	14.2	9.5	11.0	163.9	16.8	10.2	24.9	1.9	19.6	24.1	18.6	2.0	6.7	27.6	6.6	20.3	21.8	16.8	4.1	40.7	12.7	20.9	0.0	17.9	16.8	51.6	50.9	21.2	25.6	17.9	10.3	21.2	9.5	11.8
POLRMT	"APOLMT, h-mtRPOL, MTRNAP, MTRPOL"	ENSG00000099821	"RNA polymerase mitochondrial"	O00411	19	617221-633537	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	Transcription	"Nucleotidyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 84.0;Spermatogonia: 84.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006366	Uncertain		Supported	Mitochondria		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 21: Non-specific - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	Mitochondria		"HPA006366: AB_1079654"	"unprognostic (3.24e-1)"	"unprognostic (4.31e-2)"	"unprognostic (7.96e-2)"	"prognostic favorable (4.50e-4)"	"unprognostic (9.46e-2)"	"unprognostic (2.94e-2)"	"unprognostic (3.04e-2)"	"unprognostic (9.41e-2)"	"unprognostic (1.45e-1)"	"unprognostic (3.48e-1)"	"unprognostic (7.64e-3)"	"unprognostic (1.81e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.28e-3)"	"unprognostic (1.66e-1)"	"unprognostic (2.92e-1)"	"unprognostic (1.01e-1)"	17.2	23.9	19.5	9.1	20.5	6.8	18.1	20.7	28.5	19.3	16.9	22.3	14.5	19.7	10.0	21.0	19.2	5.3	38.0	20.1	17.5	26.2	41.3	16.0	9.6	24.4	20.4	20.7	26.3	11.4	22.7	5.0	21.3	20.7	7.2	5.7	17.2	9.2	69.2	27.9	23.9	6.6	17.8	22.5	21.8	66.6	20.9	11.0	20.1	14.9	7.5	21.5	17.7	24.4	24.5	43.6	9.7	42.1	19.7	11.0	35.7	11.1	12.9	15.7	14.5	44.2	15.9	24.9	22.0	10.2	7.9	24.5	35.5	21.0	11.8	28.3	86.8	19.3	26.4	56.9	20.5	32.6	34.7	10.7	29.3	16.4	19.7	11.3	22.9	34.0	37.3	23.6	14.8	34.3	43.7	44.7	38.4	31.1	30.2	42.0	13.3	42.4	21.4	20.7	30.7	22.1	10.2	26.7	28.4	10.3	15.4	29.9	14.1	17.2	22.0	26.9	33.3	57.4	51.0	38.7	36.9	27.3	21.8	0.0	2.9	2.5	6.2	3.8	5.0	5.6	4.6	4.6	5.5	6.3	3.9	4.5	0.5	6.0	4.2	5.4	3.1	4.6	19.5	20.5	20.7	28.5	20.1	17.5	24.4	20.4	21.3	17.8	20.9	24.4	10.3	12.8	11.5	2.6	14.2	8.0	6.1	5.8	10.2	18.3	9.1	8.0	18.0	15.7	7.9	16.5	18.8	15.5	13.3	31.5	7.9	6.7	39.8	7.7	6.1	9.7	13.1	9.4	2.7	8.0	8.7	8.9	14.3	8.6	12.7	15.1	8.2	21.9	10.4	11.8	2.7	12.7	4.1	8.3	7.4	84.0	12.5	8.0	10.6	3.7	7.4	8.4	18.6	1.5	4.6	6.5	12.4	13.2	7.8	10.3	26.0	15.1	6.4	18.1	6.6	8.9	10.0	31.6	84.9	10.6	7.2	7.7	12.7	15.6	24.4	6.2
POMP	"C13orf12, HSPC014, UMP1"	ENSG00000132963	"Proteasome maturation protein"	Q9Y244	13	28659104-28678959	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		Chaperone	"Ichthyosis, Palmoplantar keratoderma"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026995	Approved		Supported	"Nuclear speckles"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Nuclear speckles"		"HPA026995: AB_1845546"	"unprognostic (2.00e-1)"	"unprognostic (3.56e-2)"	"unprognostic (2.26e-1)"	"unprognostic (3.15e-1)"	"unprognostic (8.58e-2)"	"prognostic unfavorable (2.05e-5)"	"unprognostic (2.71e-3)"	"unprognostic (2.50e-2)"	"unprognostic (9.90e-2)"	"unprognostic (4.35e-2)"	"unprognostic (4.83e-2)"	"unprognostic (4.93e-1)"	"unprognostic (1.39e-3)"	"unprognostic (1.70e-2)"	"unprognostic (9.41e-2)"	"unprognostic (1.03e-2)"	"unprognostic (9.81e-2)"	78.9	71.6	77.5	62.9	78.5	66.4	66.7	82.1	101.1	45.1	77.8	66.6	57.0	44.4	78.9	68.7	43.4	46.2	126.3	78.1	83.6	94.1	110.9	65.6	65.4	82.2	83.4	32.9	46.6	51.7	41.7	100.3	83.2	46.6	66.3	56.2	45.1	50.7	175.6	48.5	58.4	57.2	83.6	61.2	54.9	70.0	81.0	64.6	51.4	114.6	70.1	74.0	46.9	86.3	103.4	124.9	129.9	153.1	145.3	161.3	120.3	232.1	203.8	225.5	179.5	245.7	228.7	181.7	136.3	178.6	241.7	150.3	170.7	179.3	307.5	137.7	131.9	171.7	130.1	191.1	203.0	209.6	136.0	131.2	181.9	162.5	149.5	122.3	181.6	139.7	222.2	72.5	291.5	182.5	178.4	295.6	226.1	319.0	146.1	169.6	199.3	122.2	259.6	160.7	152.1	117.1	104.0	147.4	162.2	161.5	103.1	238.5	166.2	108.7	111.2	172.3	195.5	61.5	118.5	255.3	129.2	139.8	243.6	146.4	155.3	101.7	99.9	210.8	88.7	136.4	101.6	113.2	190.8	137.6	71.8	101.9	135.1	95.3	213.9	223.4	132.3	165.2	77.5	78.5	82.1	101.1	78.1	83.6	82.2	83.4	83.2	83.6	81.0	86.3	527.4	131.4	114.2	17.3	218.5	409.8	345.1	1106.2	124.1	110.1	194.3	229.9	806.2	204.5	523.9	239.1	54.2	660.4	255.5	410.0	600.7	566.3	1156.6	266.7	235.8	486.2	228.7	271.5	23.4	699.5	974.0	281.8	128.9	293.0	207.3	181.6	434.1	538.7	780.7	97.6	22.4	315.0	585.9	431.0	673.7	533.7	201.0	407.1	300.6	29.0	612.6	294.7	228.6	13.6	26.1	755.1	414.0	233.6	228.1	443.5	491.8	922.5	472.8	121.8	322.1	193.8	494.6	625.5	240.3	230.1	416.3	972.4	202.7	234.7	335.5	494.3
POP1		ENSG00000104356	"POP1 homolog, ribonuclease P/MRP subunit"	Q99575	8	98117293-98159835	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"tRNA processing"	"Hydrolase, RNA-binding"	"Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA066194			Supported	Nucleoli		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoli		"HPA066194: AB_2732742"	"prognostic unfavorable (2.54e-4)"	"unprognostic (9.42e-2)"	"unprognostic (5.96e-3)"	"unprognostic (3.31e-2)"	"unprognostic (1.46e-1)"	"unprognostic (7.46e-2)"	"prognostic unfavorable (1.26e-6)"	"prognostic unfavorable (9.88e-4)"	"unprognostic (4.85e-1)"	"unprognostic (1.47e-1)"	"unprognostic (3.79e-1)"	"unprognostic (1.39e-2)"	"prognostic unfavorable (5.97e-4)"	"unprognostic (1.81e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.96e-1)"	2.1	1.6	1.7	3.5	1.5	1.5	2.1	3.4	2.3	1.4	1.2	1.9	1.5	1.7	1.4	3.0	1.8	1.3	1.6	1.3	1.2	2.0	1.9	1.6	3.6	1.1	1.4	2.9	1.7	1.7	1.5	1.2	1.1	1.5	4.8	2.4	1.4	1.3	1.7	3.0	1.6	1.8	0.8	2.1	1.9	3.1	1.6	2.6	1.5	1.2	4.4	2.5	1.5	1.8	21.9	12.9	13.8	12.8	4.8	3.3	9.1	18.3	15.2	18.7	13.8	13.4	13.8	15.3	25.6	12.9	9.0	14.3	40.3	18.2	18.9	11.1	17.0	30.0	10.2	9.2	2.1	16.4	18.4	2.8	3.3	20.8	8.2	5.7	14.8	7.2	17.0	13.5	17.7	17.4	23.8	8.3	10.4	25.1	17.6	19.4	7.5	11.0	13.5	11.5	32.8	7.7	8.4	14.2	6.4	7.9	19.2	6.0	18.4	16.3	11.6	20.8	36.5	13.3	13.6	32.7	12.8	17.3	14.6	9.4	5.1	3.9	7.4	5.7	6.0	4.9	5.4	5.0	5.0	8.1	6.8	6.5	0.8	3.8	2.9	6.2	4.9	2.1	1.7	1.5	3.4	2.3	1.3	1.2	1.1	1.4	1.1	0.8	1.6	1.8	2.3	3.2	3.9	10.7	4.7	3.7	8.2	3.8	4.0	7.0	2.5	2.3	3.9	0.0	3.8	5.5	0.0	4.1	4.1	2.7	5.9	8.8	13.8	2.4	6.4	4.2	0.0	5.0	17.7	5.9	3.4	5.8	6.6	2.9	1.3	5.9	1.8	5.4	3.4	1.7	19.0	1.7	2.0	2.4	0.8	3.0	5.3	3.3	0.0	3.7	7.9	2.7	10.3	8.5	11.0	7.8	1.0	4.5	5.2	4.8	1.1	8.5	2.6	9.5	6.6	4.0	6.1	7.7	19.1	9.8	2.4	3.0	4.4	6.1	3.9	5.1
POP4	RPP29	ENSG00000105171	"POP4 homolog, ribonuclease P/MRP subunit"	O95707	19	29606283-29617237	"Enzymes, Predicted intracellular proteins"	"tRNA processing"	"Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042748, HPA064577"	Approved		Approved	Nucleoplasm,Nucleoli		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 35: Non-specific - Unknown function"	"Cluster 9: U-2 OS - Unknown function"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoplasm, Nucleoli"		"HPA042748: AB_10964774, HPA064577: "	"unprognostic (5.88e-2)"	"unprognostic (2.78e-2)"	"unprognostic (7.21e-2)"	"unprognostic (4.00e-3)"	"unprognostic (4.50e-2)"	"unprognostic (5.73e-2)"	"prognostic unfavorable (3.31e-4)"	"unprognostic (8.35e-2)"	"unprognostic (2.37e-2)"	"unprognostic (1.26e-1)"	"unprognostic (2.20e-2)"	"unprognostic (9.47e-2)"	"unprognostic (5.84e-2)"	"unprognostic (4.21e-1)"	"unprognostic (1.77e-2)"	"unprognostic (5.23e-3)"	"unprognostic (8.08e-3)"	11.3	13.6	8.9	5.2	9.4	6.3	10.6	10.0	9.5	8.8	8.5	11.1	4.7	9.7	3.8	13.3	7.7	2.5	14.1	9.1	9.6	13.4	14.4	8.1	5.9	10.1	9.5	7.8	9.5	3.9	8.3	3.7	9.8	8.8	2.9	3.6	10.5	3.2	18.8	11.6	10.5	3.5	9.7	11.4	11.6	12.8	9.8	5.0	9.2	4.0	4.7	9.6	9.3	10.5	44.5	61.9	5.3	5.4	7.8	3.9	26.5	42.1	4.9	9.3	9.3	28.6	10.5	35.2	72.1	7.3	10.1	20.6	10.8	10.0	5.3	79.9	65.1	42.0	19.4	18.2	7.5	51.4	21.6	4.4	8.0	7.9	4.8	5.0	8.2	18.5	34.8	8.0	8.2	36.9	29.7	8.6	10.3	13.6	39.5	19.0	44.7	18.0	5.6	17.1	15.1	16.6	44.4	15.4	18.5	5.0	15.5	12.5	30.0	13.4	40.5	23.1	37.1	30.3	59.7	44.1	17.1	24.8	13.5	73.1	39.7	40.3	35.5	52.1	26.1	48.1	34.2	37.5	39.9	36.4	27.1	32.4	23.3	36.5	43.0	33.2	53.0	45.8	8.9	9.4	10.0	9.5	9.1	9.6	10.1	9.5	9.8	9.7	9.8	10.5	26.4	22.4	20.0	4.9	29.8	12.6	20.0	61.0	15.9	16.6	18.5	21.0	26.1	27.1	29.6	33.1	8.4	53.4	25.8	29.5	80.3	59.5	18.2	29.8	21.5	27.1	17.4	21.4	4.6	78.3	45.0	22.8	17.3	22.6	26.0	22.1	25.4	40.2	62.1	11.8	4.3	27.5	46.8	26.2	18.3	15.3	16.4	27.3	24.9	0.0	57.4	34.1	52.5	4.0	5.8	66.2	26.6	28.2	33.6	20.3	39.4	72.4	38.0	15.5	26.3	18.6	27.8	71.0	15.4	21.4	16.1	47.3	27.4	31.7	26.2	19.5
POP5		ENSG00000167272	"POP5 homolog, ribonuclease P/MRP subunit"	Q969H6	12	120578764-120581402	"Enzymes, Predicted intracellular proteins"	"rRNA processing, tRNA processing"	"Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal tubular cells: 154.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047598, HPA069204"	Approved		Supported	Nucleoplasm,Nucleoli		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm	Nucleoli	"HPA047598: AB_2680096, HPA069204: "	"unprognostic (1.50e-2)"	"prognostic favorable (2.68e-5)"	"unprognostic (1.55e-1)"	"unprognostic (3.61e-3)"	"unprognostic (3.81e-1)"	"unprognostic (1.50e-1)"	"unprognostic (4.80e-3)"	"unprognostic (1.28e-1)"	"unprognostic (7.34e-2)"	"unprognostic (5.75e-2)"	"unprognostic (4.13e-2)"	"unprognostic (1.33e-1)"	"prognostic unfavorable (4.85e-4)"	"unprognostic (3.07e-1)"	"unprognostic (6.21e-2)"	"unprognostic (2.68e-1)"	"unprognostic (5.68e-2)"	27.0	51.3	5.2	5.6	6.1	9.5	25.6	6.0	8.9	20.7	6.1	24.6	6.0	21.8	2.4	25.9	20.1	5.1	42.5	5.5	5.9	38.3	40.5	19.0	10.8	6.1	5.7	17.2	25.2	7.3	26.2	2.1	6.4	24.3	2.8	1.2	25.2	4.8	22.9	22.4	24.6	3.5	6.2	31.8	25.4	10.2	5.8	7.9	27.4	3.6	4.3	24.3	21.0	6.4	22.2	43.4	3.8	8.7	10.1	4.5	14.7	14.2	5.7	13.6	11.2	36.6	6.6	13.4	26.9	7.8	6.1	15.7	8.0	30.1	1.1	41.4	42.1	13.5	20.3	26.5	12.1	11.7	11.3	14.1	11.2	13.5	2.4	3.4	8.9	30.2	18.2	5.6	7.5	45.0	18.9	11.2	8.0	14.6	36.5	20.5	9.8	28.5	11.5	18.5	7.4	8.7	27.7	6.5	15.7	2.8	27.5	20.7	11.8	8.1	13.2	13.6	19.8	16.1	35.8	16.7	20.5	21.6	13.3	4.5	12.7	3.1	17.7	14.9	16.4	25.2	14.2	16.2	16.8	18.0	17.6	16.3	0.9	16.0	14.1	26.6	15.8	20.8	5.2	6.1	6.0	8.9	5.5	5.9	6.1	5.7	6.4	6.2	5.8	6.4	24.2	12.8	27.6	10.1	47.8	19.6	38.6	83.7	34.1	22.0	37.5	50.4	60.5	37.1	59.3	77.3	14.6	51.7	49.3	21.6	154.6	44.9	1.7	39.9	30.5	25.4	22.1	30.1	6.4	44.9	42.9	33.8	32.6	24.8	54.6	24.0	24.3	58.3	53.2	18.5	6.9	30.5	54.9	19.8	21.7	5.0	36.1	35.7	49.8	7.5	33.4	79.3	52.5	10.6	8.2	40.0	21.9	37.6	56.8	23.6	31.2	136.2	45.2	34.4	19.7	27.5	39.4	22.7	43.8	53.3	24.7	17.6	46.1	106.3	44.2	33.5
POP7	"RPP2, RPP20"	ENSG00000172336	"POP7 homolog, ribonuclease P/MRP subunit"	O75817	7	100706121-100707486	"Enzymes, Predicted intracellular proteins"	"rRNA processing, tRNA processing"	"Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021007	Uncertain		Supported	Nucleoli,Vesicles		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 38: Extravillous trophoblasts - Unknown function"	"Nucleoli, Vesicles"		"HPA021007: AB_10963575"	"unprognostic (3.19e-1)"	"unprognostic (2.45e-2)"	"unprognostic (2.72e-2)"	"unprognostic (1.80e-3)"	"unprognostic (6.47e-2)"	"unprognostic (1.04e-1)"	"prognostic unfavorable (4.99e-5)"	"unprognostic (2.98e-2)"	"unprognostic (2.28e-1)"	"unprognostic (3.12e-2)"	"unprognostic (9.50e-2)"	"unprognostic (3.88e-1)"	"prognostic unfavorable (6.02e-4)"	"unprognostic (1.05e-2)"	"unprognostic (1.44e-1)"	"unprognostic (6.21e-2)"	"unprognostic (6.73e-2)"	25.6	31.7	30.1	18.1	31.6	33.9	26.6	33.4	38.6	24.2	23.8	27.9	19.3	27.7	11.0	34.0	21.3	9.8	37.6	32.3	30.8	25.8	67.1	18.2	17.3	30.1	27.8	18.1	31.3	16.6	22.8	16.6	30.8	22.6	9.2	9.6	29.0	13.5	69.0	50.2	22.3	12.1	29.4	22.7	26.4	12.5	29.1	15.6	16.8	31.9	12.0	25.4	24.9	33.9	115.7	115.3	47.2	78.4	25.1	23.9	92.0	65.6	32.4	73.7	73.1	159.8	71.0	97.5	105.1	30.0	81.4	70.4	70.1	79.5	36.8	82.7	212.4	44.9	75.0	166.5	42.1	69.2	49.8	27.6	30.2	76.2	74.8	20.9	41.6	68.9	157.4	77.8	39.8	330.4	158.0	232.9	135.2	77.8	164.4	123.6	50.0	159.4	45.3	65.2	90.4	92.3	54.5	156.2	78.7	42.0	50.0	66.2	41.3	92.0	117.7	191.0	127.6	34.0	99.4	175.8	61.0	115.1	104.6	106.3	63.2	72.4	54.7	64.7	50.7	60.3	54.6	54.3	55.3	47.7	49.5	52.0	39.0	78.9	70.3	51.2	69.8	62.5	30.1	31.6	33.4	38.6	32.3	30.8	30.1	27.8	30.8	29.4	29.1	33.9	30.5	19.2	17.0	2.9	29.7	105.0	32.0	57.2	56.3	26.1	61.6	64.1	27.9	37.1	31.5	35.0	6.2	148.2	25.8	51.8	93.9	75.4	2.1	31.2	32.3	37.2	40.2	50.1	5.2	87.4	181.3	37.3	25.0	35.1	17.7	32.4	33.5	99.0	66.1	32.0	6.0	61.7	67.1	27.3	40.7	7.9	42.0	22.4	56.9	2.8	38.7	41.8	41.2	4.0	5.8	92.2	47.6	37.2	55.1	75.6	69.8	86.1	27.8	21.3	46.0	29.8	52.2	9.2	45.5	74.7	119.2	139.3	27.2	39.9	55.8	43.5
POSTN	"OSF-2, periostin, PN"	ENSG00000133110	Periostin	Q15063	13	37562583-37598844	"Cancer-related genes, Plasma proteins, Predicted secreted proteins"	"Cell adhesion"	Heparin-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skin 1: 207.2;stomach 1: 174.6"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 295.7;Breast myoepithelial cells: 158.1;Endothelial cells: 134.6;Fibroblasts: 191.5;Smooth muscle cells: 151.5"	"Cancer enhanced"	"Detected in all"		"breast cancer: 231.9"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"hTEC/SVTERT24-B: 490.2;SuSa: 440.5;U-138 MG: 619.3;U-2197: 427.2"	"Low region specificity"	"Detected in many"			"Region enriched"	"Detected in all"	6	"spinal cord: 87.9"	HPA012306	Enhanced		Approved	"Nucleoplasm,Golgi apparatus"	"Secreted to extracellular matrix"	NA	NA		660000000		"Cluster 31: Skin - Epidermis development"	"Cluster 18: U-2197 - ECM organization"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Golgi apparatus"	Nucleoplasm	"HPA012306: AB_1854827"	"unprognostic (7.73e-2)"	"unprognostic (1.44e-3)"	"unprognostic (2.19e-2)"	"unprognostic (2.57e-2)"	"unprognostic (4.73e-2)"	"unprognostic (2.22e-2)"	"unprognostic (4.19e-3)"	"prognostic unfavorable (2.93e-4)"	"unprognostic (3.05e-3)"	"unprognostic (7.10e-2)"	"unprognostic (1.32e-2)"	"unprognostic (5.93e-2)"	"prognostic unfavorable (1.83e-7)"	"prognostic unfavorable (4.86e-4)"	"unprognostic (1.15e-1)"	"unprognostic (1.20e-1)"	"unprognostic (8.32e-3)"	71.4	5.2	4.5	23.8	0.1	0.3	84.0	0.0	4.4	20.3	2.9	61.3	5.1	53.2	13.0	20.5	83.5	64.3	83.2	3.0	0.0	28.1	13.0	45.1	12.8	0.9	0.0	3.6	2.2	21.6	2.4	60.9	2.0	16.1	84.9	0.0	17.7	44.8	10.6	207.2	15.0	66.6	0.0	1.1	174.6	3.4	0.1	5.8	19.1	29.9	3.9	91.4	10.7	0.4	0.0	0.0	71.0	1.6	85.0	51.0	0.2	23.1	0.0	5.5	0.7	0.0	1.4	0.1	0.0	18.7	0.1	0.0	0.7	0.0	2.6	0.0	0.0	0.0	0.0	0.0	14.2	0.2	0.1	90.8	0.0	490.2	1.9	15.9	0.7	0.0	0.0	0.0	11.8	0.0	0.3	0.4	4.1	0.0	0.0	0.2	0.1	0.2	0.0	0.0	0.4	0.2	0.1	0.6	0.0	440.5	0.9	0.0	0.0	619.3	0.3	427.2	3.4	0.1	0.0	0.0	0.0	0.0	6.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.1	0.0	4.4	3.0	0.0	0.9	0.0	2.0	0.0	0.1	0.4	46.7	6.4	10.6	0.7	0.3	295.7	1.3	51.5	0.0	0.0	2.9	158.1	22.8	0.0	18.7	0.0	0.0	2.5	1.0	0.0	0.0	0.0	0.5	0.5	9.8	134.6	0.0	0.0	1.5	0.0	0.2	191.5	0.0	0.3	3.8	0.0	22.5	0.6	3.7	0.0	36.8	0.0	24.4	0.0	27.0	1.1	6.5	0.8	30.2	0.0	0.0	0.0	0.0	0.0	0.8	0.1	0.0	0.7	0.4	0.4	0.0	0.0	5.6	0.0	0.0	0.7	151.5	1.3	0.9	0.2	48.4	3.4	2.3	49.3	0.0	0.3
POT1	"DKFZp586D211, hPot1"	ENSG00000128513	"Protection of telomeres 1"	Q9NUX5	7	124822386-124929983	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"		DNA-binding	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Inhibitory neurons: 41.5;Oligodendrocytes: 66.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA068538			Supported	Nucleoplasm		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm		"HPA068538: AB_2686001"	"unprognostic (1.39e-3)"	"unprognostic (1.34e-1)"	"unprognostic (2.04e-1)"	"unprognostic (5.71e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.38e-3)"	"unprognostic (7.88e-2)"	"unprognostic (2.26e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.48e-2)"	"unprognostic (9.89e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.92e-1)"	"unprognostic (1.75e-2)"	"unprognostic (4.77e-3)"	"unprognostic (7.42e-2)"	5.6	5.7	3.2	5.7	3.8	4.1	10.4	3.7	3.6	7.9	4.0	5.6	4.5	9.5	6.1	4.5	8.1	6.0	6.2	3.2	4.2	9.7	9.9	6.1	8.8	3.9	3.4	10.1	5.3	9.8	6.4	6.9	4.1	7.1	6.4	9.9	3.9	6.7	3.2	4.1	4.2	7.2	3.8	8.1	5.8	13.8	3.2	13.0	12.9	4.4	9.6	7.7	4.5	6.1	24.0	6.9	14.0	9.9	9.2	16.2	10.3	12.1	14.9	14.3	19.7	7.3	25.9	24.4	8.5	11.1	23.6	9.5	14.8	15.0	21.7	21.4	17.5	18.9	10.3	3.2	15.4	22.6	12.4	13.1	13.6	12.8	21.8	14.5	16.6	10.1	38.1	51.9	15.0	4.1	29.8	12.5	17.4	13.2	14.1	19.1	14.0	27.5	9.9	9.8	13.9	16.6	18.7	19.8	15.6	20.3	8.0	12.3	8.4	14.3	5.5	19.1	17.1	23.2	27.0	39.8	20.4	23.6	22.7	0.6	2.2	1.0	2.3	2.3	4.3	3.2	2.6	3.0	2.5	2.5	4.3	3.0	0.4	3.7	1.8	2.2	2.8	1.9	3.2	3.8	3.7	3.6	3.2	4.2	3.9	3.4	4.1	3.8	3.2	6.1	9.7	6.4	4.1	36.9	10.1	4.6	6.7	5.5	13.1	9.2	7.1	7.1	8.8	8.6	3.6	12.9	10.4	7.0	8.0	1.5	19.6	5.0	19.3	4.3	6.9	7.1	9.0	16.0	34.7	4.5	8.0	6.9	8.2	4.2	3.8	9.4	7.1	10.5	6.3	8.4	41.5	4.0	2.0	10.9	7.0	8.3	8.7	8.7	16.0	24.4	5.6	12.6	4.1	37.2	66.8	3.8	1.7	4.5	7.6	2.8	0.8	11.2	4.9	10.0	0.0	5.4	6.3	35.2	14.4	7.6	2.6	4.5	8.5	4.8	4.9	3.5
POU1F1	"GHF-1, PIT-1, PIT1, POU1F1a"	ENSG00000064835	"POU class 1 homeobox 1"	P28069	3	87259404-87276584	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	137	"pituitary gland: 59.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA041646, HPA050624"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA				"Cluster 26: Pituitary gland - Hormone signaling"			"Nucleoplasm, Cytosol"		"HPA041646: AB_10794672, HPA050624: AB_2681192"	"unprognostic (1.88e-1)"	"unprognostic (2.06e-1)"	"unprognostic (4.27e-1)"	"unprognostic (1.44e-1)"	"unprognostic (3.60e-1)"	"unprognostic (2.93e-1)"	"unprognostic (1.87e-2)"	"unprognostic (7.63e-3)"	"unprognostic (3.21e-1)"	"unprognostic (1.50e-1)"	"unprognostic (4.69e-3)"	"unprognostic (1.55e-1)"	"unprognostic (1.52e-2)"	"unprognostic (1.87e-2)"		"unprognostic (1.22e-1)"	"unprognostic (1.05e-4)"	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	59.7	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1
POU2F1	"OCT1, OTF1"	ENSG00000143190	"POU class 2 homeobox 1"	P14859	1	167220876-167427345	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Astrocytes: 270.6;Excitatory neurons: 187.6;Inhibitory neurons: 184.0;Oligodendrocyte precursor cells: 186.0;Oligodendrocytes: 202.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"basophil: 4.6"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002608, HPA058559, HPA064323"	Supported		Supported	"Nucleoplasm,Endoplasmic reticulum,Vesicles"		No	No			"Cluster 34: Basophils - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 12: NES - Nervous system development"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Nucleoplasm, Vesicles"	"Endoplasmic reticulum"	"CAB002608: , HPA058559: AB_2683756, HPA064323: AB_2685245"	"unprognostic (1.74e-1)"	"unprognostic (9.33e-2)"	"unprognostic (1.28e-2)"	"unprognostic (1.40e-3)"	"unprognostic (5.78e-3)"	"unprognostic (4.26e-2)"	"unprognostic (5.67e-6)"	"unprognostic (4.47e-2)"	"unprognostic (5.14e-1)"	"unprognostic (7.94e-3)"	"unprognostic (1.95e-2)"	"unprognostic (1.28e-1)"	"prognostic unfavorable (2.98e-5)"	"unprognostic (1.89e-1)"	"unprognostic (4.02e-1)"	"unprognostic (3.42e-1)"	"unprognostic (1.17e-2)"	4.0	2.5	5.0	2.2	5.8	3.9	3.4	7.3	5.2	3.6	2.9	3.7	1.3	4.0	2.6	2.7	3.4	1.4	2.6	4.8	3.8	2.9	2.3	3.5	3.0	4.1	4.2	4.1	2.4	3.4	3.6	2.4	3.9	3.2	2.1	12.9	3.0	2.0	4.1	3.5	3.6	1.4	3.8	4.2	2.6	4.3	5.0	3.8	3.3	2.6	3.4	3.4	3.2	4.4	7.4	4.0	14.8	4.5	1.7	1.7	6.1	0.9	1.6	1.7	1.7	8.1	4.2	8.3	3.8	1.5	1.7	5.6	8.8	2.7	2.6	3.3	3.5	5.9	3.9	7.1	1.1	6.5	3.8	1.2	1.6	2.0	3.6	2.1	2.3	5.7	6.4	4.3	2.3	3.7	6.0	4.3	17.4	4.0	2.3	8.7	5.4	3.7	3.1	4.0	9.0	6.9	5.6	4.1	3.7	7.4	4.6	7.9	3.8	3.4	5.3	2.0	3.5	4.4	2.1	18.3	1.6	3.9	4.4	4.6	0.3	0.3	0.2	0.3	0.3	2.0	0.2	0.0	0.4	0.7	0.3	0.2	0.4	0.2	0.3	0.9	0.2	0.4	5.0	5.8	7.3	5.2	4.8	3.8	4.1	4.2	3.9	3.8	5.0	4.4	19.9	12.8	17.2	270.6	25.2	13.4	11.3	9.7	9.6	58.7	12.5	11.8	15.8	14.3	11.6	20.2	102.2	17.8	20.2	12.3	5.9	10.5	26.2	17.7	18.7	19.8	24.1	14.5	187.6	11.6	18.5	17.5	10.2	18.9	19.7	18.7	15.0	13.3	13.3	47.1	184.0	14.3	8.2	52.5	12.4	44.1	25.7	19.9	7.2	114.3	21.7	43.8	14.4	186.0	202.1	16.5	8.0	20.7	33.5	16.1	5.3	8.3	11.5	101.7	26.3	28.4	16.4	17.6	35.7	12.7	11.1	51.7	14.1	11.0	14.5	21.0
POU3F2	"BRN2, OCT7, OTF7, POUF3"	ENSG00000184486	"POU class 3 homeobox 2"	P20265	6	98834574-98839458	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	15	"brain: 17.3"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 77.4;Excitatory neurons: 8.8;Muller glia cells: 11.1;Oligodendrocyte precursor cells: 27.2;Oligodendrocytes: 13.4"	"Cancer enriched"	"Detected in some"	11	"glioma: 16.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 125.4;SK-MEL-30: 18.3;U-251 MG: 39.9;WM-115: 33.8"	"Low region specificity"	"Detected in all"							"HPA047081, HPA056261"		Approved	Supported	Nucleoplasm		NA	NA				"Cluster 70: Brain - Nervous system development"	"Cluster 12: NES - Nervous system development"	"Cluster 64: Astrocytes - Nervous system maintenance"	Nucleoplasm		"HPA047081: , HPA056261: AB_2683081"	"unprognostic (5.94e-4)"	"unprognostic (7.80e-2)"	"unprognostic (3.07e-3)"	"unprognostic (1.83e-1)"	"unprognostic (3.57e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.17e-3)"	"unprognostic (1.84e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.63e-3)"	"unprognostic (4.77e-1)"	"unprognostic (9.38e-11)"	"unprognostic (4.77e-2)"	"unprognostic (2.84e-2)"	"unprognostic (8.47e-3)"	"unprognostic (4.04e-1)"	0.0	0.0	9.7	0.0	9.6	0.0	0.0	11.4	15.5	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.6	13.0	0.0	0.0	0.0	0.0	9.8	17.3	0.0	0.0	0.0	0.0	0.0	9.3	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	10.5	0.0	0.0	0.1	10.6	0.0	0.0	0.0	0.0	0.0	0.0	12.2	0.0	0.0	125.4	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	5.6	0.0	0.0	0.2	7.6	0.1	0.1	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	1.6	5.0	0.0	0.1	0.0	1.0	0.0	0.6	0.0	5.5	4.3	1.0	0.0	0.0	0.0	6.9	3.6	0.0	0.0	18.3	0.1	1.0	0.1	0.0	0.7	0.0	0.2	39.9	0.1	0.0	0.0	0.2	0.0	33.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.7	9.6	11.4	15.5	7.6	13.0	9.8	17.3	9.3	10.5	10.6	12.2	0.1	0.0	0.0	77.4	0.0	0.1	0.4	0.0	0.0	0.2	0.1	0.3	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.1	0.2	0.0	0.0	8.8	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	2.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	2.8	0.0	11.1	0.0	27.2	13.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.8	0.4	0.3	1.4	0.0	0.1	0.0	0.4	0.0	0.1	0.3
POU3F4	"BRN4, DFN3, DFNX2, OTF9"	ENSG00000196767	"POU class 3 homeobox 4"		X	83508290-83512127	"Human disease related genes, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Tissue enriched"	"Detected in some"	7	"brain: 11.9"	"Cell type enriched"	"Detected in some"	6	"Collecting duct cells: 11.0"	"Cancer enriched"	"Detected in single"	21	"glioma: 5.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	99	"AF22: 9.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA062295			Supported	Nucleoplasm		NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 12: NES - Nervous system development"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"HPA062295: AB_2732681"					"unprognostic (5.73e-2)"										"unprognostic (2.00e-1)"			0.0	0.0	2.3	0.0	11.9	0.0	0.0	2.6	4.5	0.0	0.6	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.5	2.5	1.6	0.0	0.0	0.0	2.9	5.5	0.1	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	9.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	11.9	2.6	4.5	1.5	2.5	2.9	5.5	2.5	2.6	3.4	1.6	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	11.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
POU4F3	"BRN3C, DFNA15, DFNA42, DFNA52"	ENSG00000091010	"POU class 4 homeobox 3"	Q15319	5	146338839-146341728	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	"Activator, DNA-binding"	"Deafness, Disease variant, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in single"		"urothelial cancer: 0.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA038215	Uncertain		Supported	Nucleoplasm		NA	NA							Nucleoplasm		"HPA038215: AB_10697245"	"unprognostic (8.41e-3)"	"unprognostic (9.46e-2)"	"unprognostic (1.84e-1)"	"unprognostic (6.26e-4)"	"unprognostic (1.86e-1)"	"unprognostic (1.12e-1)"		"unprognostic (1.03e-1)"	"unprognostic (9.54e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.09e-3)"	"unprognostic (1.20e-3)"	"unprognostic (1.24e-3)"	"unprognostic (1.38e-1)"	"unprognostic (1.87e-1)"	"unprognostic (8.84e-2)"	"unprognostic (7.82e-2)"	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.5	0.1	0.1	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
POU5F1	"MGC22487, OCT3, Oct4, OTF3"	ENSG00000204531	"POU class 5 homeobox 1"	Q01860	6	31164337-31180731	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 16.5"	"Cell type enhanced"	"Detected in many"		"Endometrial ciliated cells: 27.9;Glandular and luminal cells: 67.8"	"Cancer enriched"	"Detected in many"	34	"testis cancer: 355.9"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	51	"SuSa: 287.4"	"Not detected"	"Not detected"							"CAB025600, CAB026380, HPA058267, CAB079773"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 12: NES - Nervous system development"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm	Cytosol	"CAB025600: , CAB026380: , CAB079773: AB_2687916, HPA058267: AB_2683659"	"unprognostic (3.25e-2)"	"unprognostic (3.12e-1)"	"unprognostic (2.87e-1)"	"unprognostic (1.06e-2)"	"unprognostic (3.02e-2)"	"unprognostic (2.11e-2)"	"unprognostic (2.62e-2)"	"unprognostic (2.27e-1)"	"unprognostic (2.59e-1)"	"unprognostic (9.27e-2)"	"unprognostic (2.27e-2)"	"unprognostic (4.79e-2)"	"unprognostic (1.19e-3)"	"unprognostic (1.38e-1)"	"unprognostic (1.35e-1)"	"unprognostic (3.86e-2)"	"prognostic favorable (2.04e-5)"	1.1	0.3	1.2	1.0	1.0	1.5	1.2	1.5	1.2	6.3	0.4	4.9	4.3	2.3	2.4	1.8	7.1	2.1	3.3	1.0	0.7	16.5	8.0	3.7	1.0	1.3	0.8	0.5	13.0	0.0	0.3	0.2	1.1	7.6	1.1	0.7	0.8	2.4	1.0	2.2	8.0	0.3	0.2	2.0	10.1	1.3	1.3	0.2	0.9	0.3	0.3	10.2	2.0	1.9	3.6	1.8	0.4	0.7	0.0	0.0	0.8	0.5	0.0	0.0	0.0	0.0	1.3	0.3	5.6	0.1	0.4	2.9	0.7	3.1	0.0	0.6	1.4	0.6	3.3	2.5	0.2	0.9	0.8	0.3	0.6	0.3	0.9	0.2	0.0	0.7	0.1	1.0	1.0	0.2	0.3	1.0	2.9	0.6	0.1	0.8	0.6	0.7	4.8	3.8	0.6	0.1	1.0	0.2	0.3	287.4	0.6	0.4	0.0	0.7	0.5	1.8	0.3	1.3	1.3	1.6	0.5	1.3	0.5	0.4	0.1	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.5	0.1	0.0	0.3	0.2	0.1	0.3	0.0	0.1	1.2	1.0	1.5	1.2	1.0	0.7	1.3	0.8	1.1	0.2	1.3	1.9	1.0	0.0	1.1	0.0	0.9	5.2	2.7	5.3	2.8	0.5	0.7	0.8	0.4	10.0	2.3	9.2	2.1	0.0	0.1	9.2	0.0	6.7	0.0	27.9	5.9	1.2	1.2	0.0	0.2	6.6	0.1	0.7	11.2	67.8	0.0	0.1	0.4	2.4	0.1	0.0	0.1	6.4	2.0	0.0	1.5	0.2	0.0	0.7	1.8	1.0	0.7	0.1	1.0	0.5	0.1	12.6	12.5	0.7	0.2	5.6	10.1	2.0	1.6	1.0	0.0	1.4	1.2	0.1	0.8	0.8	3.8	0.1	0.8	0.0	4.1	4.3
POU5F1B	"OTF3C, OTF3P1, POU5F1P1"	ENSG00000212993	"POU class 5 homeobox 1B"	Q06416	8	127322183-127420066	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"			"Tissue enhanced"	"Detected in some"		"choroid plexus: 3.1"	"Cell type enhanced"	"Detected in some"		"Cone photoreceptor cells: 4.2;Distal enterocytes: 3.2;Endometrial ciliated cells: 5.5;Glandular and luminal cells: 10.6"	"Cancer enhanced"	"Detected in some"		"colorectal cancer: 1.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CACO-2: 1.1;EFO-21: 1.5;hTERT-HME1: 3.7;NTERA-2: 1.9"									HPA058267			Supported	Nucleoplasm		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm		"HPA058267: AB_2683659"	"unprognostic (1.74e-2)"	"unprognostic (2.27e-2)"	"unprognostic (2.58e-2)"	"unprognostic (8.22e-3)"	"unprognostic (1.65e-1)"	"unprognostic (5.85e-2)"	"unprognostic (9.31e-4)"	"unprognostic (2.21e-3)"	"unprognostic (1.13e-1)"	"unprognostic (3.25e-1)"	"unprognostic (6.56e-2)"	"unprognostic (5.11e-2)"	"unprognostic (5.60e-10)"	"unprognostic (1.21e-1)"	"unprognostic (7.05e-3)"	"unprognostic (1.37e-1)"	"unprognostic (7.33e-3)"	0.2	0.1	0.2	0.1	0.2	0.2	0.7	0.7	0.3	0.3	3.1	0.4	0.1	0.5	0.6	0.2	0.5	0.2	0.0	0.5	0.2	0.5	0.2	0.2	0.3	0.3	0.5	0.2	0.2	0.4	0.1	0.2	0.3	0.6	0.5	0.2	1.7	0.3	0.1	0.6	0.1	0.1	0.0	0.2	0.3	0.2	0.2	0.2	0.5	0.0	0.2	0.1	0.2	0.2	0.2	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.1	0.5	0.0	1.5	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.1	0.0	3.7	0.1	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	1.9	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.5	0.0	0.0	0.2	0.1	0.5	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.1	0.0	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.2	0.7	0.3	0.5	0.2	0.3	0.5	0.3	0.0	0.2	0.2	1.0	0.0	0.5	0.0	0.2	0.3	0.3	0.3	0.0	0.0	1.0	0.9	0.7	0.0	0.4	0.0	4.2	0.0	0.1	3.2	1.9	1.5	0.3	5.5	0.9	1.4	0.0	0.0	0.0	1.8	0.0	0.4	0.0	10.6	0.0	0.0	0.4	0.1	0.0	1.7	0.0	1.4	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	2.0	2.3	0.0	0.1	0.2	2.7	0.4	0.9	0.1	0.0	0.1	0.2	0.2	0.0	0.0	0.6	0.0	0.4	0.0	1.3	0.4
POU6F1	"BRN5, MPOU, TCFB1"	ENSG00000184271	"POU class 6 homeobox 1"		12	51186936-51217708	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 20.9;Excitatory neurons: 22.2;Inhibitory neurons: 29.4;Oligodendrocyte precursor cells: 21.1;Oligodendrocytes: 23.6"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in many"		"cerebral cortex: 6.0"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 4.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047021, HPA050411"	Enhanced		Supported	"Nuclear bodies,Actin filaments"		NA	NA				"Cluster 72: Non-specific - Transcription"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Nuclear bodies"	"Actin filaments"	"HPA047021: AB_2679905, HPA050411: AB_2681119"	"unprognostic (4.96e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.48e-3)"	"unprognostic (1.45e-2)"	"unprognostic (2.72e-1)"	"unprognostic (6.58e-2)"	"unprognostic (9.70e-2)"	"unprognostic (7.11e-3)"	"unprognostic (4.45e-1)"	"unprognostic (2.05e-1)"	"prognostic favorable (6.61e-4)"	"unprognostic (2.48e-2)"	"unprognostic (9.36e-2)"	"unprognostic (2.09e-3)"	"unprognostic (1.74e-1)"	"unprognostic (2.02e-1)"	"unprognostic (2.33e-1)"	2.0	1.5	0.3	1.2	1.3	0.4	1.7	3.6	6.0	3.1	0.0	2.4	0.6	2.5	0.1	0.7	2.2	1.2	1.1	1.4	0.0	1.2	0.5	1.8	0.8	0.0	0.0	3.2	1.3	0.8	2.6	0.6	0.0	2.1	0.2	1.3	2.1	1.4	4.0	1.4	1.5	1.5	0.0	1.5	1.3	0.3	0.3	0.2	2.3	1.3	0.5	1.7	1.7	0.0	0.3	0.8	1.0	1.4	0.3	1.2	0.5	0.5	0.6	0.6	0.7	0.1	0.5	1.8	0.2	0.4	0.3	0.0	1.2	0.0	0.0	2.8	1.8	0.5	1.1	0.0	1.0	0.4	2.4	0.6	0.5	1.0	0.1	1.4	2.0	0.7	0.7	4.9	0.3	0.0	0.2	0.7	1.8	0.0	0.0	0.5	0.6	0.0	0.3	0.0	1.3	2.2	1.2	0.0	2.3	0.5	0.5	1.7	1.5	1.1	0.9	0.3	1.3	3.2	2.8	0.2	1.0	0.4	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.3	3.6	6.0	1.4	0.0	0.0	0.0	0.0	0.0	0.3	0.0	4.5	6.4	2.8	20.9	2.1	3.1	1.3	0.4	0.0	10.0	2.3	1.3	3.1	1.5	1.7	7.3	4.2	0.6	1.1	0.1	1.9	0.8	5.3	0.9	1.7	4.8	0.0	2.7	22.2	2.0	0.2	3.2	0.5	1.6	5.1	2.4	3.6	1.2	0.3	1.7	29.4	0.3	4.1	2.2	3.9	3.7	5.9	1.1	1.8	8.4	1.7	3.7	0.0	21.1	23.6	1.6	0.2	6.8	0.7	1.8	0.0	0.7	2.7	7.9	0.0	3.8	4.1	0.1	0.7	0.5	2.8	0.4	1.8	0.2	0.6	0.7
PPA1	"IOPPP, PP, PP1, Ppase, SID6-8061"	ENSG00000180817	"Inorganic pyrophosphatase 1"	Q15181	10	70202835-70233911	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Muller glia cells: 1239.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019878, HPA020096"	Supported		Supported	Vesicles		NA	NA		1000000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 5: Muller glia cells - Visual perception"	Vesicles		"HPA019878: AB_1855601, HPA020096: AB_1855600"	"unprognostic (1.50e-1)"	"unprognostic (2.85e-1)"	"unprognostic (4.71e-2)"	"unprognostic (2.85e-1)"	"unprognostic (1.42e-1)"	"unprognostic (4.47e-2)"	"unprognostic (2.86e-2)"	"unprognostic (9.43e-2)"	"unprognostic (3.34e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.13e-2)"	"unprognostic (3.60e-2)"	"unprognostic (1.82e-3)"	"unprognostic (5.36e-2)"	"unprognostic (2.37e-1)"	"unprognostic (3.53e-2)"	"unprognostic (2.74e-1)"	176.7	198.5	124.3	116.0	138.8	85.0	186.7	166.7	163.0	96.5	123.0	137.3	99.4	85.8	166.7	157.7	110.2	90.3	100.1	125.8	148.5	123.2	150.2	129.0	132.6	153.1	142.3	56.5	188.5	68.5	92.1	103.7	165.4	68.7	152.5	332.0	116.1	78.7	133.0	85.9	125.1	96.8	159.3	64.2	97.5	73.5	141.6	103.5	126.3	137.3	137.3	167.1	140.0	167.0	446.9	181.2	158.8	471.2	421.6	368.8	148.2	163.5	305.3	250.1	261.8	556.7	230.6	641.0	144.5	164.0	162.8	351.2	470.7	318.4	253.8	599.1	443.5	176.1	169.1	321.7	265.8	439.0	106.9	244.2	372.9	201.3	530.7	273.8	307.9	319.2	416.9	336.4	239.4	262.3	426.5	408.7	165.9	614.2	494.8	256.9	181.7	378.2	527.0	276.3	474.4	159.6	179.3	694.5	148.0	110.8	174.3	194.2	141.0	69.0	262.2	229.4	315.2	110.1	259.2	469.8	106.7	605.2	62.0	0.4	68.8	1.7	48.9	55.2	131.1	83.6	112.3	85.6	190.0	59.4	122.7	106.8	4.1	65.8	63.1	44.4	120.4	105.3	124.3	138.8	166.7	163.0	125.8	148.5	153.1	142.3	165.4	159.3	141.6	167.0	207.0	224.4	165.9	17.0	122.7	267.9	366.2	427.3	158.2	184.9	347.8	363.7	93.3	218.8	275.7	108.5	173.0	313.2	63.4	203.3	201.5	540.1	31.7	278.8	196.1	182.1	162.7	88.4	36.8	776.1	298.3	156.9	114.2	512.1	36.8	208.2	38.2	141.8	96.5	85.8	41.2	254.9	160.7	80.1	148.1	31.7	109.6	120.3	181.5	29.0	612.7	1239.0	65.9	21.6	98.4	532.9	213.5	117.4	161.2	512.4	444.5	551.2	92.1	278.4	65.7	97.2	136.8	173.7	170.7	245.8	257.1	245.7	120.9	203.0	347.6	613.9
PPARGC1A	"PGC-1alpha, PGC1, PGC1A, PPARGC1"	ENSG00000109819	"PPARG coactivator 1 alpha"	Q9UBK2	4	23755041-23904089	"Cancer-related genes, Predicted intracellular proteins"	"Biological rhythms, Transcription, Transcription regulation"	"Activator, RNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 44.6"	"Group enriched"	"Detected in many"	5	"Excitatory neurons: 1098.2;Inhibitory neurons: 1704.4;Oligodendrocyte precursor cells: 890.2"	"Cancer enhanced"	"Detected in many"		"renal cancer: 7.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	7	"A-431: 88.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA063136			Supported	Nucleoplasm		NA	NA				"Cluster 8: Non-specific - Mitochondria"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm		"HPA063136: AB_2684948"	"unprognostic (1.08e-1)"	"unprognostic (7.47e-2)"	"unprognostic (6.85e-3)"	"unprognostic (2.28e-6)"	"unprognostic (5.00e-2)"	"unprognostic (1.15e-1)"	"prognostic favorable (3.35e-6)"	"unprognostic (3.04e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.69e-1)"	"unprognostic (6.77e-2)"	"unprognostic (4.58e-2)"	"prognostic favorable (1.49e-14)"	"unprognostic (3.62e-2)"	"unprognostic (2.31e-1)"	"prognostic unfavorable (5.80e-4)"	"unprognostic (3.07e-3)"	2.3	2.9	4.2	0.6	3.2	0.0	1.6	7.6	13.0	3.3	33.9	7.4	7.6	0.9	1.5	3.3	1.5	2.6	36.3	3.1	10.7	29.0	44.6	3.1	0.2	4.1	4.1	1.2	3.8	38.5	4.8	0.1	2.6	3.3	9.1	4.2	29.3	3.0	29.5	8.2	6.6	1.9	2.4	0.8	4.3	4.5	7.2	2.3	17.7	37.2	0.4	1.1	1.0	4.1	88.6	0.0	1.6	0.0	2.6	0.0	0.0	0.0	1.9	0.2	0.2	0.0	0.0	0.2	0.0	0.0	0.2	0.1	0.3	0.0	0.0	0.0	0.8	0.0	4.5	10.7	0.0	0.1	0.0	8.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.2	0.0	0.0	0.0	0.4	7.6	0.0	0.0	0.7	0.0	12.3	0.1	4.0	0.2	2.8	0.0	3.5	4.2	0.5	1.4	0.0	0.7	0.7	0.0	1.6	8.1	0.1	0.1	1.6	1.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.2	3.2	7.6	13.0	3.1	10.7	4.1	4.1	2.6	2.4	7.2	4.1	2.5	19.2	2.6	240.6	0.9	0.9	4.1	7.4	1.2	7.0	2.7	1.5	90.9	47.1	6.3	36.8	39.6	0.0	0.0	36.0	52.8	12.0	78.3	7.2	1.3	0.8	26.7	0.0	1098.2	0.0	0.0	2.4	4.1	9.7	1.3	0.2	1.1	88.8	0.0	0.0	1704.4	17.0	38.7	2.5	0.3	69.7	0.9	0.6	7.2	24.4	0.1	6.4	0.0	890.2	28.8	0.6	7.3	2.2	1.8	1.4	32.0	26.8	4.8	1.9	0.0	37.1	5.1	0.8	0.6	2.6	1.1	0.0	1.0	1.9	21.9	1.5
PPARGC1B	"PERC, PGC1B"	ENSG00000155846	"PPARG coactivator 1 beta"	Q86YN6	5	149730298-149855022	"Human disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 12.4"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 111.8;Cone photoreceptor cells: 135.5;Rod photoreceptor cells: 72.0"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"cerebellum: 9.7"	"Immune cell enhanced"	"Detected in some"		"non-classical monocyte: 3.1"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA050543			Supported	Nucleoplasm,Cytosol		NA	Yes			"Cluster 14: Monocytes - Unknown function"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 15: RT4 - Unknown function"	"Cluster 56: Bipolar cells - Visual perception"	Nucleoplasm	Cytosol	"HPA050543: AB_2681165"	"unprognostic (2.86e-1)"	"unprognostic (1.07e-2)"	"unprognostic (5.09e-3)"	"unprognostic (1.13e-3)"	"unprognostic (2.63e-1)"	"unprognostic (2.00e-3)"	"unprognostic (4.51e-3)"	"unprognostic (6.55e-2)"	"unprognostic (9.14e-3)"	"unprognostic (2.65e-2)"	"unprognostic (1.83e-1)"	"unprognostic (1.21e-1)"	"unprognostic (9.01e-6)"	"unprognostic (8.45e-2)"	"unprognostic (5.09e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.77e-3)"	2.2	0.9	2.1	2.4	2.2	2.0	1.4	9.7	3.1	1.4	0.0	7.0	7.0	2.1	1.1	4.1	2.2	1.2	6.3	1.6	0.4	0.8	1.6	3.6	1.4	1.9	0.2	1.3	1.0	4.4	0.6	1.5	2.0	1.8	6.0	12.4	1.4	3.3	6.2	3.3	6.4	2.8	0.4	2.1	3.8	0.8	0.3	0.9	0.4	2.5	1.8	3.7	2.6	0.5	0.5	1.9	0.7	4.5	1.8	0.6	7.3	0.3	0.0	0.5	0.7	8.5	1.8	9.2	1.3	0.0	2.1	5.5	6.9	3.5	0.6	0.5	5.9	8.6	3.6	1.8	0.5	12.0	3.2	0.9	4.6	1.8	3.0	0.2	1.0	4.0	6.0	2.9	0.4	2.3	4.4	5.4	2.9	2.6	4.8	8.3	5.0	5.1	1.4	11.2	2.4	0.5	1.2	9.8	1.5	1.3	2.5	3.9	1.3	1.0	1.6	3.6	1.8	3.6	2.8	5.3	2.2	7.4	0.9	0.5	0.9	0.1	0.1	1.7	0.3	0.8	0.1	0.1	1.1	0.3	0.2	0.2	0.6	0.3	3.1	0.1	0.1	0.3	2.1	2.2	9.7	3.1	1.6	0.4	1.9	0.2	2.0	0.4	0.3	0.5	6.1	0.0	1.1	1.6	3.0	5.1	3.9	17.9	12.0	111.8	2.5	3.2	22.3	1.5	7.4	1.8	135.5	1.8	0.7	15.4	1.9	0.5	0.3	1.7	4.1	5.4	5.4	5.7	29.2	0.8	1.6	2.7	18.8	2.5	1.3	2.1	4.2	3.5	7.6	8.4	26.2	10.3	0.0	12.5	4.7	0.2	1.5	12.1	3.6	12.2	6.1	4.0	2.1	12.1	0.9	0.5	6.7	0.4	5.5	5.1	19.6	3.0	2.9	72.0	6.6	3.0	8.9	0.2	3.2	23.1	10.7	4.9	2.0	2.1	24.9	6.1
PPFIA1	"LIP.1, LIPRIN"	ENSG00000131626	"PTPRF interacting protein alpha 1"	Q13136	11	70270690-70385312	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 190.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"A-431: 261.2;SK-MEL-30: 156.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017032, HPA042271"	Uncertain		Supported	"Focal adhesion sites,Cytosol"		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 29: Early spermatids - Spermatogenesis"	Cytosol	"Focal adhesion sites"	"CAB017032: , HPA042271: AB_2677923"	"unprognostic (1.89e-1)"	"unprognostic (1.28e-2)"	"unprognostic (6.27e-2)"	"unprognostic (9.92e-2)"	"unprognostic (1.18e-1)"	"prognostic unfavorable (5.58e-4)"	"unprognostic (7.20e-3)"	"unprognostic (2.20e-1)"	"unprognostic (3.02e-2)"	"unprognostic (5.45e-3)"	"prognostic unfavorable (8.26e-4)"	"unprognostic (1.14e-1)"	"prognostic favorable (3.76e-4)"	"unprognostic (1.09e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.80e-1)"	"unprognostic (2.14e-2)"	26.6	14.6	17.5	16.1	18.2	20.6	17.6	16.0	19.2	13.1	22.1	18.2	14.0	17.9	13.7	16.4	12.1	22.1	14.5	15.6	15.8	16.4	15.0	19.8	15.7	25.9	21.0	15.1	15.9	18.0	13.2	24.1	20.6	12.4	15.8	14.9	13.4	14.0	31.6	18.0	16.2	17.4	17.6	15.3	13.5	26.3	20.1	15.7	23.3	26.8	14.0	17.0	12.1	25.1	261.2	30.4	31.8	22.5	33.1	20.3	34.9	30.0	24.4	40.8	26.0	66.8	22.8	25.8	39.6	27.3	39.4	38.3	30.7	28.3	35.9	15.5	21.5	19.7	34.3	24.7	33.4	26.2	22.1	24.9	46.8	53.1	44.6	31.4	27.9	21.3	33.1	19.9	37.3	30.8	19.3	17.7	19.7	59.5	34.3	20.6	80.2	22.2	20.6	32.9	31.9	21.5	45.2	59.1	156.6	36.0	37.5	31.2	30.0	38.0	29.8	54.3	32.4	24.7	15.8	37.3	28.2	20.1	43.0	0.0	1.6	1.1	0.8	1.2	1.2	1.5	1.2	1.1	1.3	1.0	0.9	0.6	5.0	0.4	3.5	1.7	1.2	0.6	17.5	18.2	16.0	19.2	15.6	15.8	25.9	21.0	20.6	17.6	20.1	25.1	33.0	25.6	53.5	114.6	19.3	27.4	26.4	14.2	30.1	39.1	32.8	24.1	27.2	20.0	25.1	18.4	31.3	44.2	14.2	39.3	11.7	21.8	190.4	28.7	44.4	31.4	26.9	24.8	57.8	20.3	13.7	33.3	25.5	45.4	8.8	94.3	20.7	25.2	25.2	33.7	52.8	19.8	16.2	35.5	28.8	97.7	27.7	40.4	21.4	38.4	28.8	71.8	17.5	47.7	56.4	36.2	24.7	25.6	23.6	36.7	19.2	22.7	27.1	45.8	19.7	45.4	30.0	60.7	61.9	36.1	33.1	74.3	22.2	42.2	25.1	37.2
PPIB	"B, CYP-S1, CYPB, OI9, PPIase, SCYLP"	ENSG00000166794	"Peptidylprolyl isomerase B"	P23284	15	64155740-64163134	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"		"Isomerase, Rotamase"	"Disease variant, Dwarfism, Osteogenesis imperfecta"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 1473.7;Plasma cells: 2242.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011487, HPA012720"	Enhanced		Supported	"Nucleoplasm,Endoplasmic reticulum"	"Secreted to blood"	No	No		33000000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 55: Plasma cells - Humoral immune response"	"Endoplasmic reticulum"	Nucleoplasm	"CAB011487: AB_443295, HPA012720: AB_1847399"	"unprognostic (3.00e-3)"	"unprognostic (5.65e-3)"	"unprognostic (2.81e-1)"	"prognostic favorable (1.56e-5)"	"unprognostic (1.65e-1)"	"unprognostic (1.07e-3)"	"unprognostic (3.69e-2)"	"unprognostic (1.27e-2)"	"unprognostic (7.19e-2)"	"unprognostic (8.80e-3)"	"unprognostic (2.87e-1)"	"unprognostic (2.79e-2)"	"prognostic unfavorable (2.02e-11)"	"unprognostic (7.05e-2)"	"unprognostic (3.77e-2)"	"unprognostic (1.82e-1)"	"unprognostic (3.90e-2)"	375.5	377.5	230.7	449.5	240.3	571.9	361.9	247.9	259.2	611.5	257.2	401.0	365.0	383.9	899.0	298.8	401.5	379.2	262.0	229.7	256.9	312.3	737.4	351.1	344.5	258.1	241.4	386.2	644.2	345.4	416.8	515.2	255.1	375.7	411.3	72.3	513.1	488.6	62.2	205.5	334.3	482.4	247.0	360.5	375.0	110.0	254.9	315.6	672.8	91.1	346.4	510.9	295.6	262.6	675.6	847.9	736.7	1666.7	2577.0	1492.3	641.9	1570.3	2108.3	1248.7	1472.3	1242.6	1223.1	653.6	1227.4	2513.0	1235.3	1067.7	1384.6	1080.4	641.1	406.2	491.0	914.5	915.3	1643.7	2682.9	915.0	778.1	1374.2	1149.4	725.9	1751.3	1516.7	1539.2	301.1	645.9	2174.7	966.0	1102.6	280.6	1404.9	625.1	1879.0	529.5	520.6	784.1	3347.9	1312.7	1062.6	410.5	647.7	726.0	1224.5	1194.2	1086.0	727.6	2767.0	927.6	1213.7	975.8	679.2	1079.4	1152.5	1269.5	693.4	1129.0	1478.0	1238.2	716.7	712.5	491.7	929.6	547.3	931.8	827.8	645.0	762.4	930.9	541.4	411.3	558.0	347.5	668.1	369.3	2643.5	569.3	1512.3	230.7	240.3	247.9	259.2	229.7	256.9	258.1	241.4	255.1	247.0	254.9	262.6	389.3	125.0	209.0	16.6	375.3	160.2	426.2	614.6	234.5	34.5	264.3	303.8	0.8	270.2	328.7	272.2	31.3	625.9	560.0	271.0	90.1	665.1	19.0	295.8	910.1	285.0	297.0	172.6	10.2	566.4	1473.7	627.8	441.4	494.2	181.2	540.4	322.7	473.2	630.1	45.4	15.8	603.9	205.4	216.9	333.4	29.5	456.3	316.6	281.1	19.7	299.1	149.1	368.7	35.2	37.0	435.1	338.9	393.1	2242.6	569.3	338.6	287.4	168.2	43.7	230.1	204.3	445.6	38.4	76.6	337.0	144.8	1118.9	352.3	674.0	477.2	422.3
PPID	CYP-40	ENSG00000171497	"Peptidylprolyl isomerase D"	Q08752	4	158709127-158723396	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Host-virus interaction, Protein transport, Transport"	"Chaperone, Isomerase, Rotamase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019520, HPA019692"	Approved		Supported	"Nucleoplasm,Nucleoli,Nucleoli rim,Cytosol"		NA	NA		480000	"Cluster 2: Granulocytes - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 10: Non-specific - Unknown function"	Cytosol	"Nucleoplasm, Nucleoli, Nucleoli rim"	"HPA019520: AB_1847400, HPA019692: AB_1847401"	"unprognostic (4.26e-2)"	"unprognostic (2.03e-2)"	"unprognostic (8.91e-3)"	"unprognostic (8.17e-3)"	"unprognostic (1.50e-1)"	"unprognostic (2.04e-3)"	"unprognostic (4.72e-2)"	"unprognostic (1.62e-2)"	"unprognostic (4.72e-2)"	"unprognostic (5.92e-2)"	"unprognostic (4.54e-2)"	"unprognostic (1.46e-2)"	"unprognostic (2.66e-3)"	"unprognostic (8.78e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.09e-1)"	26.8	38.3	38.0	24.4	40.2	25.1	22.8	40.4	77.6	25.4	46.4	33.9	50.6	24.2	19.0	27.7	24.1	18.8	49.6	40.1	44.2	39.5	87.6	19.8	28.6	39.0	39.4	24.2	31.7	17.0	28.6	21.6	40.2	23.5	20.3	36.2	23.3	18.7	88.9	36.1	45.3	18.9	39.6	29.1	29.0	24.1	42.2	24.3	23.9	45.5	25.8	27.4	24.0	46.9	46.7	42.3	41.8	57.7	60.7	45.2	63.1	44.9	24.3	40.3	30.4	55.4	30.9	48.9	19.7	42.0	63.4	35.1	127.9	51.5	48.8	162.9	44.4	87.5	36.5	76.9	46.8	55.6	63.0	28.9	41.2	34.6	51.5	52.0	44.6	81.9	111.0	84.4	45.5	44.6	80.0	49.9	57.9	75.5	55.8	35.9	20.7	41.7	44.6	23.0	70.2	47.1	33.8	69.2	65.6	60.0	31.9	52.2	43.7	40.1	45.3	44.7	60.2	48.3	107.2	62.0	51.1	59.4	41.1	68.8	23.9	55.2	31.1	35.4	36.0	22.3	30.2	29.1	26.4	25.4	30.9	32.0	32.9	40.5	37.7	26.9	37.0	28.0	38.0	40.2	40.4	77.6	40.1	44.2	39.0	39.4	40.2	39.6	42.2	46.9	29.2	6.4	13.4	13.1	24.8	10.1	29.7	17.5	9.1	30.2	19.1	20.8	59.7	25.8	27.9	27.6	22.9	41.5	38.7	17.1	37.2	39.2	39.0	66.1	39.9	25.1	19.6	17.4	24.3	23.0	49.5	24.3	14.3	28.5	32.3	24.4	17.2	18.5	41.9	75.7	28.6	28.3	22.4	17.0	14.7	23.1	20.5	26.0	14.2	9.4	51.6	23.3	48.4	15.1	28.3	29.5	27.4	22.6	22.3	31.6	39.7	33.7	62.3	32.3	6.6	17.7	58.2	96.0	77.5	16.9	11.8	47.6	33.7	33.7	32.0	20.2
PPIE	"CyP-33, MGC111222, MGC3736"	ENSG00000084072	"Peptidylprolyl isomerase E"	Q9UNP9	1	39692182-39763914	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Isomerase, RNA-binding, Rotamase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"HPA019357, HPA020131"	Approved		Supported	"Nuclear speckles"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 72: Non-specific - Transcription"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 31: Spermatids - Spermatogenesis"	"Nuclear speckles"		"HPA019357: AB_2670131, HPA020131: AB_1847405"	"unprognostic (2.94e-1)"	"unprognostic (4.32e-2)"	"unprognostic (6.34e-2)"	"unprognostic (6.97e-2)"	"unprognostic (5.99e-2)"	"unprognostic (8.41e-2)"	"prognostic unfavorable (1.76e-4)"	"unprognostic (3.52e-2)"	"unprognostic (2.69e-1)"	"unprognostic (3.88e-3)"	"unprognostic (1.25e-1)"	"unprognostic (9.29e-2)"	"prognostic unfavorable (5.05e-5)"	"unprognostic (5.86e-2)"	"unprognostic (3.95e-1)"	"unprognostic (9.06e-2)"	"unprognostic (1.00e-1)"	26.0	27.9	22.3	16.1	22.9	18.5	26.8	22.7	26.5	31.4	20.2	41.1	18.3	33.8	24.9	31.8	35.0	18.1	33.3	22.3	22.8	33.0	33.7	23.3	27.2	22.6	22.0	36.7	40.2	23.8	27.7	20.7	22.9	32.3	22.5	20.9	26.2	23.6	43.1	29.5	29.2	25.4	23.7	32.7	31.7	41.8	22.3	20.6	29.1	30.3	28.2	36.4	29.5	24.6	24.5	34.4	37.2	25.7	40.9	36.9	14.3	40.8	42.7	58.7	56.4	32.8	64.8	68.4	52.2	47.9	34.5	32.8	57.1	52.3	68.8	41.1	38.4	75.6	37.4	9.7	50.9	68.4	36.3	32.8	47.2	53.9	21.0	42.0	54.5	52.8	74.8	39.5	46.6	24.7	34.2	42.1	39.9	49.7	31.5	41.4	28.4	38.4	37.8	37.2	47.7	42.3	43.8	31.5	28.4	49.7	40.9	155.8	35.8	36.3	35.3	48.4	57.1	55.8	66.4	52.5	27.0	86.4	52.3	38.3	62.8	32.6	83.9	64.8	82.8	107.5	89.4	83.8	74.1	109.2	103.5	82.4	6.0	123.2	70.0	63.8	101.3	122.5	22.3	22.9	22.7	26.5	22.3	22.8	22.6	22.0	22.9	23.7	22.3	24.6	28.2	32.1	36.7	10.7	37.0	24.9	43.1	69.8	23.9	25.9	30.3	47.5	31.8	21.5	62.1	33.1	14.6	62.5	39.3	22.8	66.5	57.5	29.2	34.6	27.7	28.7	28.8	38.3	7.7	48.4	59.3	34.0	16.3	23.4	55.2	44.1	37.9	31.1	56.1	23.5	8.8	32.9	40.7	33.4	26.9	76.3	29.8	30.0	39.2	8.4	46.8	34.0	58.7	8.0	13.6	40.0	24.1	45.1	31.7	32.0	39.3	69.8	63.4	29.7	59.2	23.3	40.1	76.1	51.4	24.5	26.3	34.8	36.6	36.3	35.9	32.9
PPIF	"Cyp-D, hCyP3"	ENSG00000108179	"Peptidylprolyl isomerase F"	P30405	10	79347469-79355334	"Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Necrosis"	"Isomerase, Rotamase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Langerhans cells: 370.9;Macrophages: 160.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 75.0"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA077416			Supported	Mitochondria		NA	NA		320000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 41: Macrophages - Immune response"	Mitochondria		"HPA077416: AB_2686840"	"unprognostic (2.21e-1)"	"unprognostic (5.48e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.72e-3)"	"unprognostic (1.69e-1)"	"unprognostic (3.16e-3)"	"unprognostic (3.45e-1)"	"unprognostic (4.33e-3)"	"unprognostic (1.66e-1)"	"unprognostic (1.97e-1)"	"unprognostic (2.82e-1)"	"unprognostic (9.37e-3)"	"unprognostic (1.02e-3)"	"unprognostic (1.23e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.69e-3)"	"unprognostic (4.88e-2)"	62.7	227.7	42.7	42.8	48.4	168.8	42.4	57.9	69.6	27.6	63.7	50.0	36.3	14.0	7.2	66.0	22.9	19.5	119.1	38.1	45.2	63.3	174.9	29.1	32.3	49.0	56.2	19.3	86.9	77.6	18.3	27.1	48.8	18.8	52.4	8.9	39.5	45.5	99.5	71.9	31.3	21.0	50.6	58.7	98.2	35.0	57.1	28.3	26.0	133.6	55.5	60.0	35.1	60.8	220.4	90.6	62.3	123.5	57.0	73.6	79.8	124.2	161.2	265.7	249.6	213.5	102.7	224.8	68.0	87.4	188.6	127.8	195.3	115.4	410.5	72.2	186.4	352.8	87.5	380.7	96.4	245.7	80.4	173.2	81.3	264.5	262.3	86.5	47.5	86.4	351.6	268.3	91.6	111.7	64.1	204.2	53.0	99.6	500.6	109.8	96.4	114.7	103.9	200.0	124.1	92.0	63.6	253.8	97.9	40.5	111.4	187.2	43.5	116.1	106.3	137.9	242.0	124.7	137.7	181.9	114.5	313.9	32.0	15.2	34.3	18.0	10.4	27.5	10.9	19.1	9.1	9.6	43.3	7.7	8.1	7.9	75.0	9.0	10.4	5.4	10.0	16.6	42.7	48.4	57.9	69.6	38.1	45.2	49.0	56.2	48.8	50.6	57.1	60.8	8.4	6.4	6.8	7.2	32.7	42.6	30.2	23.8	31.3	4.0	41.8	40.8	124.6	14.3	14.4	12.9	6.2	99.4	26.4	39.9	92.0	42.1	14.5	12.4	24.0	10.1	21.6	37.0	4.1	28.0	127.1	25.1	78.0	15.5	13.4	73.4	6.1	98.5	91.1	8.4	5.7	69.5	18.3	40.3	370.9	14.1	6.2	160.8	35.6	4.7	32.0	13.0	5.2	5.5	15.0	39.8	26.6	6.0	48.7	41.4	21.3	41.2	12.6	5.2	19.7	18.2	28.6	14.8	22.5	52.9	37.6	142.3	23.9	60.2	81.1	34.2
PPIG	"CARS-Cyp, SCAF10, SRCyp"	ENSG00000138398	"Peptidylprolyl isomerase G"	Q13427	2	169584342-169641406	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Isomerase, Rotamase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021788, HPA057469"	Supported		Supported	"Nuclear speckles,Cytosol"		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 10: Non-specific - Unknown function"	"Nuclear speckles"	Cytosol	"HPA021788: AB_1847408, HPA057469: AB_2683445"	"unprognostic (2.70e-1)"	"unprognostic (2.17e-1)"	"unprognostic (2.40e-1)"	"unprognostic (2.04e-3)"	"unprognostic (4.17e-2)"	"unprognostic (3.49e-2)"	"unprognostic (1.55e-3)"	"unprognostic (3.66e-2)"	"unprognostic (2.15e-3)"	"unprognostic (3.15e-3)"	"unprognostic (2.47e-2)"	"unprognostic (2.28e-1)"	"prognostic unfavorable (4.56e-4)"	"unprognostic (5.23e-2)"	"unprognostic (3.29e-1)"	"unprognostic (3.41e-2)"	"unprognostic (3.39e-2)"	26.0	23.2	23.1	28.4	22.1	54.2	27.5	28.8	58.6	27.6	22.9	26.3	26.6	28.8	31.5	27.5	23.6	22.0	25.6	21.5	29.9	29.2	47.1	24.7	36.9	24.6	25.6	26.5	21.2	32.6	25.8	28.0	24.3	27.9	26.0	29.3	26.5	22.9	27.6	25.4	29.7	21.7	22.9	32.3	27.4	20.1	23.7	36.1	29.9	26.2	35.4	26.3	26.5	25.9	56.4	25.5	70.8	35.9	35.4	42.5	63.7	58.9	42.3	45.0	45.9	66.3	58.9	94.8	52.5	44.1	55.5	50.5	56.6	48.4	65.6	68.0	45.7	129.9	36.7	88.3	34.4	136.8	58.9	36.6	54.0	58.5	64.6	40.6	50.4	53.5	142.7	76.2	49.5	43.5	101.0	81.9	100.8	45.3	25.1	90.7	71.7	90.5	53.9	81.2	60.5	41.2	63.4	47.2	68.9	52.9	44.2	78.7	52.7	53.9	43.7	38.4	52.6	41.1	65.3	126.8	38.5	68.1	54.1	31.9	22.5	36.7	22.8	25.1	26.7	32.9	30.9	29.2	18.2	38.4	33.4	27.6	40.4	21.1	31.4	30.0	26.8	17.0	23.1	22.1	28.8	58.6	21.5	29.9	24.6	25.6	24.3	22.9	23.7	25.9	159.7	221.2	175.1	53.5	188.8	151.4	191.4	185.9	101.3	204.6	120.8	156.1	148.4	107.2	169.5	93.8	54.2	170.0	160.1	91.6	80.3	103.1	11.0	104.6	142.3	141.1	104.8	163.5	82.4	103.3	177.0	142.4	66.8	126.3	179.1	115.8	121.7	181.2	151.7	220.4	81.8	135.8	116.0	130.3	126.5	15.6	142.0	129.6	110.3	46.9	152.4	137.6	133.9	53.8	69.7	93.9	118.0	146.7	130.1	161.8	121.1	113.8	132.2	109.1	164.3	150.2	193.9	276.4	183.8	108.3	172.8	205.5	166.7	147.1	149.9	167.7
PPIL1	CYPL1	ENSG00000137168	"Peptidylprolyl isomerase like 1"	Q9Y3C6	6	36854827-36874803	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Isomerase, Rotamase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cytotrophoblasts: 58.7;Extravillous trophoblasts: 72.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA062916			Supported	Nucleoli		NA	NA		21000	"Cluster 16: MAIT-cells - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 38: Extravillous trophoblasts - Unknown function"	Nucleoli		"HPA062916: AB_2684904"	"unprognostic (3.51e-2)"	"unprognostic (2.33e-1)"	"unprognostic (2.64e-3)"	"unprognostic (1.11e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.81e-2)"	"prognostic unfavorable (1.28e-5)"	"unprognostic (2.01e-1)"	"unprognostic (3.37e-2)"	"prognostic favorable (4.90e-4)"	"unprognostic (6.58e-2)"	"unprognostic (5.49e-2)"	"unprognostic (8.99e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.30e-1)"	"unprognostic (3.39e-2)"	"unprognostic (2.15e-2)"	12.4	21.7	20.3	19.1	21.9	11.4	18.4	22.6	27.3	15.0	23.8	14.7	13.2	15.7	19.1	17.0	23.0	10.7	42.8	20.0	25.2	18.9	21.5	10.5	21.9	22.0	22.0	17.7	14.3	21.7	12.0	22.3	23.3	16.8	17.6	29.1	19.5	17.6	18.5	9.5	11.3	22.9	24.1	9.5	12.9	23.2	22.2	18.6	33.2	20.7	24.6	20.5	8.0	22.8	69.2	50.0	111.2	78.5	19.7	31.5	77.5	60.9	41.0	82.7	70.0	89.7	39.7	87.7	75.5	41.9	105.5	55.4	135.1	92.7	96.2	81.3	114.6	102.7	33.6	147.7	53.5	89.3	40.8	24.7	48.7	62.3	118.9	31.8	75.5	79.1	202.4	48.0	63.3	71.2	101.9	69.8	92.3	108.5	57.9	79.4	100.2	92.0	63.2	53.5	140.0	68.5	41.8	51.4	102.5	83.5	76.3	100.2	44.0	66.7	69.0	58.5	98.8	57.0	145.2	153.0	23.7	183.7	139.4	1.6	4.8	1.3	14.7	6.2	19.7	10.3	12.1	13.9	9.2	7.4	13.4	15.9	1.2	7.3	3.4	7.8	10.2	9.8	20.3	21.9	22.6	27.3	20.0	25.2	22.0	22.0	23.3	24.1	22.2	22.8	5.7	6.4	7.5	2.9	10.8	3.1	18.6	12.2	5.7	16.9	9.0	10.5	45.8	8.6	8.3	5.5	4.2	58.7	6.6	3.3	23.5	25.7	32.0	10.3	14.2	12.3	3.6	22.7	6.5	20.3	72.3	12.2	7.7	7.7	10.8	16.3	5.0	8.2	30.1	16.8	8.6	11.4	4.1	3.3	3.6	11.7	6.8	6.4	7.2	1.9	9.2	41.0	11.3	7.5	5.4	22.1	5.5	12.4	15.0	13.5	3.3	17.1	13.5	15.5	6.6	6.1	12.8	25.7	51.0	10.6	4.5	25.3	9.2	21.1	11.9	8.6
PPIP5K1	"HISPPD2A, IPS1, KIAA0377, VIP1"	ENSG00000168781	"Diphosphoinositol pentakisphosphate kinase 1"	Q6PFW1	15	43533462-43590253	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 41.7;Excitatory neurons: 46.6;Inhibitory neurons: 37.6;Rod photoreceptor cells: 44.2"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in many"		"cerebellum: 45.4"	"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039380	Approved		Supported	"Plasma membrane,Cytosol"		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 21: Non-specific - Transcription"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 9: Photoreceptor cells - Phototransduction"	"Plasma membrane, Cytosol"		"HPA039380: AB_10673528"	"unprognostic (8.72e-2)"	"unprognostic (6.49e-2)"	"unprognostic (1.90e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.38e-1)"	"unprognostic (2.78e-1)"	"unprognostic (8.18e-2)"	"unprognostic (5.78e-2)"	"unprognostic (2.59e-3)"	"prognostic unfavorable (8.57e-4)"	"unprognostic (6.67e-2)"	"unprognostic (2.85e-3)"	"prognostic favorable (7.14e-8)"	"unprognostic (2.67e-2)"	"unprognostic (3.35e-2)"	"unprognostic (5.92e-3)"	"unprognostic (7.95e-3)"	6.6	14.8	5.7	7.3	9.8	5.9	10.3	45.4	21.0	8.3	1.1	17.6	24.7	7.4	15.1	11.6	9.4	8.3	7.5	8.0	1.8	8.5	5.6	5.8	7.8	6.0	0.6	9.2	9.4	33.7	21.6	4.5	8.8	10.0	17.6	53.7	13.8	8.3	20.0	20.0	24.3	7.7	0.0	8.6	15.5	15.5	2.8	5.4	14.3	21.2	10.0	9.0	9.9	9.2	14.5	9.3	8.1	15.0	4.8	3.0	13.8	7.1	9.0	10.0	14.6	11.0	13.5	13.5	10.5	9.8	14.9	38.6	15.8	30.6	10.1	13.3	12.5	20.3	29.9	5.9	11.0	23.4	20.2	5.4	26.6	12.2	18.6	13.5	10.7	31.0	15.0	19.4	7.4	11.3	7.8	13.2	3.9	27.0	10.0	16.7	8.2	6.8	10.7	25.9	24.1	7.6	18.3	17.2	6.7	11.4	31.7	19.4	4.7	8.7	10.2	11.1	17.4	4.3	5.7	16.4	16.3	26.5	8.5	2.4	0.5	0.0	1.0	1.1	1.3	2.0	1.2	1.3	1.2	1.2	0.9	0.9	0.3	1.5	0.8	0.9	0.3	1.3	5.7	9.8	45.4	21.0	8.0	1.8	6.0	0.6	8.8	0.0	2.8	9.2	2.3	0.0	2.2	11.4	5.2	4.0	1.5	3.2	7.4	16.5	3.2	3.3	5.4	2.8	3.4	7.3	41.7	3.3	2.9	9.2	0.0	2.1	2.7	2.1	1.4	2.9	2.4	5.5	46.6	1.5	0.9	1.8	20.9	2.8	0.0	9.5	3.3	1.8	1.9	10.1	37.6	5.9	0.0	2.8	1.8	2.4	1.8	2.1	0.0	15.0	1.8	3.9	0.0	11.6	11.0	1.9	5.2	7.2	3.1	1.2	12.2	1.5	2.3	44.2	6.6	2.3	3.2	8.1	3.3	7.3	3.3	2.2	3.1	3.5	8.2	3.2
PPL		ENSG00000118898	Periplakin	O60437	16	4882507-4960741	"Plasma proteins, Predicted intracellular proteins"	Keratinization			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 728.1;vagina: 288.6"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 73.7;Squamous epithelial cells: 138.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 86.5;HaCaT: 191.1;MCF7: 71.5;SiHa: 102.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA042550, HPA059859"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA		80000		"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 61: Squamous epithelial cells - Keratinization"	"Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA042550: AB_2678048, HPA059859: AB_2684145"	"unprognostic (2.12e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.16e-1)"	"unprognostic (3.90e-2)"	"unprognostic (2.84e-2)"	"unprognostic (1.40e-1)"	"unprognostic (3.70e-3)"	"unprognostic (5.58e-2)"	"unprognostic (2.41e-1)"	"prognostic unfavorable (2.76e-4)"	"unprognostic (2.41e-2)"	"unprognostic (1.31e-1)"	"unprognostic (4.13e-3)"	"unprognostic (2.43e-2)"	"unprognostic (2.25e-1)"	"unprognostic (1.19e-1)"	"unprognostic (7.86e-2)"	56.3	4.9	2.5	1.0	3.2	0.2	39.8	0.3	4.2	163.0	3.3	10.4	6.5	5.7	7.3	728.1	11.5	7.1	5.7	3.6	0.0	13.2	13.3	18.6	0.4	0.0	2.8	5.9	10.6	4.1	14.3	6.4	1.1	17.3	3.4	2.4	149.5	11.5	12.0	188.4	12.3	1.7	0.0	0.3	11.1	1.9	0.0	3.5	22.1	5.3	57.0	22.0	288.6	0.5	24.0	8.6	0.1	0.1	60.0	86.5	29.6	0.1	1.6	0.2	0.6	39.5	59.5	0.4	13.5	1.2	3.4	191.1	1.3	23.0	0.0	0.0	1.3	0.1	46.3	7.1	3.8	0.1	0.1	4.2	20.7	0.2	7.1	4.6	0.1	0.2	0.2	0.2	0.1	71.5	0.1	0.2	6.0	31.3	18.1	0.1	0.1	30.0	44.6	37.5	30.9	0.3	102.5	33.8	0.3	8.9	17.4	0.5	0.3	0.2	0.3	0.3	0.1	0.4	1.1	0.1	12.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	2.5	3.2	0.3	4.2	3.6	0.0	0.0	2.8	1.1	0.0	0.0	0.5	4.1	73.7	29.1	1.6	1.2	35.1	32.5	30.5	35.9	8.4	18.8	13.8	5.1	35.8	42.6	57.0	6.2	2.1	2.0	3.6	1.9	18.4	0.7	31.6	4.1	8.0	39.4	0.0	6.6	4.5	1.6	38.0	9.2	28.0	0.0	0.8	2.9	12.7	0.7	1.7	2.5	3.8	18.3	0.9	9.0	1.3	55.3	1.4	17.8	1.0	1.2	3.7	2.1	1.0	1.7	23.4	8.3	4.1	0.2	35.1	13.5	1.2	32.5	12.5	0.0	28.7	4.3	3.9	3.1	138.0	51.3	1.4	2.7	0.4	4.8	53.2
PPM1A	"MGC9201, PP2CA, PP2Calpha"	ENSG00000100614	"Protein phosphatase, Mg2+/Mn2+ dependent 1A"	P35813	14	60245752-60299087	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 142.9"	"Cell type enhanced"	"Detected in all"		"Early spermatids: 446.2;Late spermatids: 565.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029209	Approved		Supported	"Plasma membrane,Cytosol"		NA	NA		380000	"Cluster 34: Basophils - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 51: Myeloid cells - Hemostasis"	Cytosol	"Plasma membrane"	"HPA029209: AB_2672951"	"unprognostic (3.14e-1)"	"unprognostic (2.14e-1)"	"unprognostic (5.64e-2)"	"unprognostic (1.85e-1)"	"unprognostic (4.00e-2)"	"unprognostic (2.30e-2)"	"unprognostic (4.50e-2)"	"unprognostic (1.11e-1)"	"unprognostic (3.43e-1)"	"unprognostic (2.89e-2)"	"unprognostic (7.96e-2)"	"unprognostic (1.29e-1)"	"prognostic favorable (1.57e-9)"	"unprognostic (1.58e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.57e-2)"	"unprognostic (1.37e-1)"	22.7	19.2	14.0	22.2	16.5	142.9	23.5	27.0	22.4	22.4	3.3	36.6	36.8	28.0	19.3	25.7	17.3	20.1	36.8	16.7	24.4	42.5	51.2	20.3	24.4	18.2	16.3	16.2	25.5	36.8	14.3	22.1	20.0	29.9	36.0	51.0	31.5	23.0	78.9	21.9	37.3	26.5	15.3	20.4	23.2	54.5	16.4	31.1	24.3	76.6	26.2	21.4	17.8	23.1	129.7	28.6	24.4	20.9	36.5	33.6	31.1	34.8	40.7	25.3	23.8	16.3	37.2	77.1	32.4	39.6	18.7	28.1	25.5	35.9	44.0	70.1	14.4	47.6	19.5	25.7	30.6	54.7	32.6	28.6	42.1	29.7	40.4	29.5	25.1	38.7	26.9	59.6	31.3	56.5	71.5	12.8	23.0	25.8	23.9	25.3	56.5	25.0	30.4	61.2	41.2	31.0	36.1	41.7	30.1	22.2	42.0	23.5	35.1	52.4	52.0	23.3	25.0	46.1	28.1	89.9	24.0	21.2	27.1	5.4	1.0	3.0	1.8	1.0	1.9	0.9	1.4	1.6	1.5	3.0	1.1	1.0	4.4	2.9	1.2	0.9	2.6	0.9	14.0	16.5	27.0	22.4	16.7	24.4	18.2	16.3	20.0	15.3	16.4	23.1	25.9	16.0	22.6	43.8	34.2	77.4	41.3	17.6	34.7	42.2	41.6	22.7	95.0	44.3	20.0	38.6	64.6	31.9	49.1	111.2	33.2	24.6	446.2	31.3	34.6	31.5	60.9	93.5	77.8	24.4	24.0	36.6	25.5	38.8	26.6	20.7	22.9	73.3	28.2	58.9	71.6	60.2	22.4	33.5	51.0	565.6	42.3	58.6	60.5	25.3	26.8	40.1	45.3	66.4	53.4	34.6	87.8	52.3	45.4	86.5	128.5	90.0	17.8	66.8	39.5	36.2	35.9	69.8	25.3	32.9	82.3	73.5	40.8	19.4	42.1	69.6
PPM1B	"PP2CB, PP2CBETA, PPC2BETAX"	ENSG00000138032	"Protein phosphatase, Mg2+/Mn2+ dependent 1B"	O75688	2	44167969-44244384	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 218.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA016745	Approved		Approved	Nucleoli,Cytosol		NA	NA		75000	"Cluster 52: Eosinophils - Transcription"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 46: Photoreceptor cells - Phototransduction"	"Nucleoli, Cytosol"		"HPA016745: AB_1855622"	"unprognostic (5.49e-2)"	"unprognostic (2.67e-2)"	"unprognostic (1.11e-2)"	"unprognostic (2.96e-3)"	"unprognostic (1.92e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.50e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.94e-1)"	"unprognostic (2.25e-1)"	"unprognostic (6.71e-2)"	"unprognostic (1.70e-2)"	"unprognostic (3.81e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.75e-2)"	40.2	20.4	41.2	19.5	48.0	44.0	23.9	45.1	61.8	23.0	43.1	28.6	20.3	23.9	30.0	22.5	21.2	21.8	33.3	38.6	42.1	29.0	44.0	21.9	28.7	41.4	44.1	22.9	32.4	35.8	18.9	18.8	42.1	30.6	28.7	49.9	27.0	23.3	129.4	20.5	21.7	22.8	40.2	26.4	23.1	21.4	42.7	36.0	22.8	86.5	27.0	24.7	21.4	50.9	37.1	32.8	41.8	31.2	51.3	23.8	47.6	27.9	32.0	28.2	24.8	43.8	23.3	40.7	42.4	32.4	23.0	19.6	47.6	18.2	41.6	41.7	18.4	42.9	19.9	30.8	41.4	38.6	34.1	23.0	31.5	22.5	37.9	22.2	23.5	18.4	31.7	41.5	25.7	30.6	38.6	61.5	52.4	33.4	11.0	40.5	46.6	27.1	66.3	36.9	33.7	42.5	25.3	37.4	33.5	62.3	20.2	26.7	21.6	24.7	35.5	20.6	27.8	36.2	25.5	37.7	13.4	63.2	18.3	6.9	2.2	8.1	4.6	3.0	3.9	4.2	4.3	3.9	3.7	4.5	5.8	4.0	6.1	3.2	3.6	3.6	4.3	1.1	41.2	48.0	45.1	61.8	38.6	42.1	41.4	44.1	42.1	40.2	42.7	50.9	17.4	19.2	20.8	78.4	49.3	60.5	40.3	14.4	35.3	51.9	31.8	19.9	55.4	38.6	24.0	40.5	64.6	31.5	68.6	64.5	46.9	42.5	68.5	44.1	33.3	22.0	40.2	32.8	95.9	46.4	29.7	33.7	35.2	62.4	26.6	27.4	20.3	55.0	26.8	107.7	91.8	31.5	30.5	55.2	63.0	43.0	35.8	45.0	56.9	38.4	46.7	57.5	51.5	112.6	218.0	44.7	46.6	33.8	51.9	71.2	26.8	41.0	16.9	147.5	26.3	33.5	32.4	48.5	27.7	36.6	62.4	64.6	63.8	29.5	37.3	88.7
PPM1D	"PP2C-DELTA, Wip1"	ENSG00000170836	"Protein phosphatase, Mg2+/Mn2+ dependent 1D"	O15297	17	60600183-60666280	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Cell cycle"	"Hydrolase, Protein phosphatase"	"Autism spectrum disorder, Cancer-related genes, Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 68.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"MCF7: 34.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022277, HPA061848"	Approved		Supported	Nucleoplasm,Nucleoli		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm	Nucleoli	"HPA022277: AB_1858839, HPA061848: "	"unprognostic (1.48e-1)"	"unprognostic (1.36e-2)"	"prognostic favorable (3.52e-4)"	"unprognostic (1.76e-1)"	"unprognostic (1.02e-1)"	"unprognostic (5.12e-2)"	"prognostic unfavorable (4.27e-4)"	"unprognostic (5.50e-2)"	"unprognostic (1.70e-2)"	"unprognostic (6.07e-2)"	"unprognostic (2.52e-3)"	"unprognostic (3.46e-2)"	"unprognostic (1.95e-3)"	"unprognostic (7.33e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.71e-2)"	"unprognostic (1.98e-1)"	4.4	2.4	2.7	2.2	5.2	5.9	3.9	14.8	4.6	4.5	5.0	3.1	2.9	4.3	2.9	3.5	3.7	3.1	2.9	3.3	3.4	2.8	2.8	3.6	2.7	4.0	3.5	6.3	3.3	2.3	2.4	5.9	4.7	3.1	3.5	6.4	3.1	2.2	4.0	2.9	2.7	3.0	3.4	3.8	2.7	5.5	3.7	4.4	2.9	3.1	2.3	2.8	4.0	9.1	3.8	6.9	7.5	6.4	5.0	3.1	10.7	5.8	3.6	3.4	4.9	7.1	2.0	9.9	4.5	3.7	1.3	3.4	4.9	2.2	4.6	1.9	11.1	7.4	6.7	8.1	4.2	2.9	5.3	2.7	3.6	5.1	3.0	2.8	7.9	4.1	5.4	4.0	3.7	34.4	8.1	4.4	3.5	3.4	5.2	9.5	9.6	6.6	3.1	4.2	10.5	7.4	7.1	2.4	1.6	8.0	2.8	3.9	5.7	4.7	12.5	3.5	3.3	6.7	7.7	7.3	1.7	2.9	3.8	9.9	16.1	18.0	7.6	12.5	6.8	8.9	6.3	7.0	16.0	6.2	6.8	7.0	24.7	8.6	8.1	7.0	10.6	9.8	2.7	5.2	14.8	4.6	3.3	3.4	4.0	3.5	4.7	3.4	3.7	9.1	40.9	32.1	7.7	15.0	23.1	21.0	6.2	3.3	52.3	13.1	14.2	9.8	6.3	8.6	4.6	5.5	4.2	17.6	19.4	15.0	3.9	6.6	68.9	14.0	15.5	25.2	14.4	14.1	19.6	6.6	6.4	14.7	10.2	15.6	1.3	7.2	23.6	4.2	8.8	3.3	20.8	11.4	6.1	21.4	19.2	12.8	13.7	16.1	3.6	28.1	12.3	7.0	6.2	20.6	38.6	5.4	10.2	7.5	24.5	7.8	8.7	5.1	3.6	10.4	0.0	12.1	14.0	43.8	15.0	34.4	18.0	38.6	18.1	6.0	11.5	7.7
PPM1H	"ARHCL1, FLJ13253, KIAA1157, NERPP-2C"	ENSG00000111110	"Protein phosphatase, Mg2+/Mn2+ dependent 1H"	Q9ULR3	12	62643994-62935150	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 30.0;parathyroid gland: 42.4"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 123.5;Glandular and luminal cells: 81.6;Inhibitory neurons: 162.1;Microglial cells: 89.9;Oligodendrocytes: 341.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"basophil: 2.9"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"CACO-2: 80.6;HMC-1: 62.7;SK-BR-3: 35.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB020694, HPA044244, HPA058777"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Nucleoplasm		"CAB020694: , HPA044244: AB_2678871, HPA058777: AB_2683816"	"unprognostic (3.41e-2)"	"unprognostic (1.94e-1)"	"unprognostic (9.51e-2)"	"unprognostic (8.61e-3)"	"unprognostic (1.44e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.86e-2)"	"unprognostic (5.85e-2)"	"unprognostic (3.17e-1)"	"unprognostic (1.78e-2)"	"unprognostic (5.53e-3)"	"unprognostic (2.19e-1)"	"prognostic favorable (2.72e-5)"	"unprognostic (3.90e-2)"	"unprognostic (1.73e-1)"	"unprognostic (8.04e-3)"	"unprognostic (1.14e-1)"	2.2	1.5	12.0	1.2	12.7	3.1	4.9	30.0	16.0	7.5	5.7	2.4	3.1	6.2	6.7	0.6	6.5	6.7	2.4	13.3	15.7	10.6	3.4	2.7	1.2	11.1	11.3	9.6	3.9	42.4	8.2	6.5	14.9	13.4	3.0	26.7	11.4	6.0	1.1	0.8	1.7	1.5	7.8	0.9	5.7	0.9	16.5	4.3	3.2	1.3	1.7	2.1	0.3	16.2	1.2	12.4	2.2	0.2	0.5	0.0	26.5	2.9	2.9	1.8	0.6	80.6	5.7	0.0	2.7	1.4	1.8	1.6	8.7	0.2	1.1	0.2	4.3	15.2	2.4	18.4	0.1	4.6	62.7	0.1	0.3	0.0	0.7	1.9	0.3	2.7	4.0	0.0	1.3	9.5	1.5	2.2	15.9	4.1	5.9	2.1	5.6	23.0	18.1	28.3	6.9	0.0	5.0	35.6	12.1	8.5	19.6	2.7	0.2	0.5	1.5	0.2	0.9	3.3	21.4	4.1	0.2	0.1	1.2	2.9	0.7	1.4	0.0	0.6	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.5	0.1	0.6	0.0	0.0	0.1	12.0	12.7	30.0	16.0	13.3	15.7	11.1	11.3	14.9	7.8	16.5	16.2	4.6	6.4	4.7	25.5	1.0	0.1	0.3	3.0	0.0	9.4	9.5	3.4	2.4	12.8	5.9	16.5	27.1	22.2	0.0	0.7	3.9	4.2	8.5	27.6	25.3	6.5	9.0	3.8	123.5	6.3	2.1	1.3	7.7	81.6	14.5	0.3	9.7	6.1	6.1	11.8	162.1	2.0	6.1	1.6	2.1	10.1	0.9	2.1	3.6	89.9	2.1	6.4	0.0	41.7	341.4	4.5	2.1	1.5	0.5	4.3	0.1	8.5	14.0	10.9	0.0	0.6	1.7	0.0	0.5	0.5	0.1	6.8	1.3	2.8	2.4	0.5
PPM1K	"BDP, DKFZp761G058, hPTMP, PP2Ckappa, PP2Cm"	ENSG00000163644	"Protein phosphatase, Mg2+/Mn2+ dependent 1K"	Q8N3J5	4	88257620-88284769	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 92.5"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 512.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 58.0;Karpas-707: 48.6;U-698: 48.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020066, HPA020862, HPA023891"	Approved		Supported	Mitochondria		No	No			"Cluster 24: B-cells - Unknown function"	"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 54: Cardiomyocytes - Muscle contraction"	Mitochondria		"HPA020066: AB_1855628, HPA020862: AB_1855629, HPA023891: AB_1855630"	"unprognostic (2.38e-2)"	"unprognostic (5.86e-2)"	"unprognostic (7.42e-3)"	"unprognostic (6.70e-3)"	"unprognostic (1.18e-1)"	"unprognostic (1.17e-3)"	"unprognostic (1.87e-1)"	"unprognostic (5.88e-2)"	"unprognostic (5.50e-2)"	"unprognostic (1.41e-2)"	"unprognostic (9.25e-3)"	"unprognostic (6.56e-2)"	"unprognostic (9.82e-2)"	"unprognostic (5.57e-2)"	"unprognostic (1.34e-1)"	"unprognostic (2.11e-1)"	"unprognostic (2.28e-1)"	5.3	8.5	23.3	14.9	26.3	9.9	14.5	22.5	31.2	19.4	22.0	5.9	4.4	32.7	7.6	11.2	21.5	8.9	92.5	26.5	23.9	17.8	7.6	9.7	25.6	19.9	22.3	32.5	11.1	12.5	9.9	9.7	22.9	16.2	6.0	14.2	11.8	7.1	14.2	2.6	10.4	26.6	22.1	18.9	8.0	19.9	27.7	15.2	7.9	11.5	25.8	8.9	11.7	33.2	4.6	1.5	5.7	10.1	8.3	10.9	2.3	7.2	13.0	23.3	27.4	11.6	1.1	58.0	7.7	4.6	11.5	0.5	17.0	5.4	9.1	44.9	7.1	10.8	5.0	10.8	6.6	14.6	5.3	7.2	2.7	14.5	12.5	4.9	4.2	25.4	15.5	48.6	7.0	6.5	20.3	7.9	3.4	3.5	2.3	10.8	9.3	21.9	8.1	2.0	4.4	3.9	4.6	0.5	5.4	9.6	23.2	3.9	0.8	8.3	4.2	2.8	4.1	15.6	15.0	48.3	9.1	11.7	14.0	24.7	9.9	8.1	39.4	12.0	51.4	102.9	37.1	39.9	18.6	113.5	36.3	44.2	3.2	27.6	3.6	131.3	46.9	24.5	23.3	26.3	22.5	31.2	26.5	23.9	19.9	22.3	22.9	22.1	27.7	33.2	20.7	48.1	12.4	105.4	124.8	9.8	15.8	5.7	29.6	109.5	42.8	25.7	512.1	8.6	13.7	49.7	18.8	11.5	153.0	0.8	156.5	7.0	7.9	9.7	37.2	27.2	9.6	34.3	89.5	6.2	3.2	42.9	8.2	20.0	19.0	32.2	24.7	30.2	28.9	85.8	145.6	16.5	4.1	14.5	16.4	10.5	23.9	27.5	21.4	40.3	75.6	21.8	80.3	100.0	54.7	4.6	9.2	31.6	82.7	32.1	8.2	47.6	19.5	14.8	26.3	38.5	36.4	38.2	22.9	71.4	5.4	2.9	70.1	45.4	4.1	6.7
PPM1N	FLJ40125	ENSG00000213889	"Protein phosphatase, Mg2+/Mn2+ dependent 1N (putative)"	Q8N819	19	45488777-45502510	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enriched"	"Detected in many"	8	"skeletal muscle: 213.3"	"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 123.1;Rod photoreceptor cells: 74.3"	"Cancer enhanced"	"Detected in many"		"testis cancer: 11.3"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in all"	6	"non-classical monocyte: 142.4"	"Lineage enriched"	"Detected in all"	11	"monocytes: 142.4"	"Cell line enhanced"	"Detected in many"		"OE19: 24.1;RT4: 29.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA043577			Supported	Vesicles		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 38: Extravillous trophoblasts - Unknown function"	Vesicles		"HPA043577: "	"unprognostic (2.38e-2)"	"unprognostic (1.11e-2)"	"unprognostic (8.53e-2)"	"unprognostic (6.59e-2)"	"unprognostic (4.71e-1)"	"unprognostic (2.64e-2)"	"unprognostic (1.98e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.25e-1)"	"unprognostic (4.45e-2)"	"unprognostic (9.27e-2)"	"unprognostic (2.48e-2)"	"unprognostic (1.11e-16)"	"unprognostic (3.42e-2)"	"unprognostic (1.79e-1)"	"unprognostic (3.92e-2)"	"unprognostic (1.86e-3)"	2.0	0.8	15.5	2.0	14.7	2.6	3.3	14.5	19.9	2.0	14.5	2.6	0.6	0.7	1.3	2.6	0.9	1.4	1.3	15.1	15.0	1.4	2.6	2.5	3.0	14.7	14.7	0.6	0.5	2.1	1.1	4.7	15.1	1.2	1.3	25.8	0.9	2.0	213.3	3.1	1.6	1.2	13.7	9.2	2.8	5.3	14.3	2.3	1.1	0.2	3.4	2.4	1.6	16.2	2.6	7.1	1.2	5.1	5.9	7.8	14.7	1.9	3.0	0.6	2.3	1.7	15.8	11.1	3.2	1.8	4.1	7.6	3.0	2.2	0.9	10.9	4.5	9.0	2.7	1.9	1.4	0.8	18.1	3.2	3.6	3.1	1.9	4.0	1.0	4.4	10.3	9.6	1.0	1.9	3.1	4.6	4.0	24.1	1.4	2.0	1.5	3.0	3.4	29.9	5.8	6.8	1.0	11.1	9.2	8.8	3.8	2.7	1.5	8.2	4.7	4.3	1.4	1.7	4.5	2.3	6.1	2.3	7.2	6.7	4.4	3.2	6.4	22.5	5.5	6.3	3.9	6.2	12.8	3.6	4.3	7.9	6.5	3.1	142.4	2.4	4.5	5.7	15.5	14.7	14.5	19.9	15.1	15.0	14.7	14.7	15.1	13.7	14.3	16.2	6.4	0.0	2.7	1.0	7.5	3.4	14.7	6.2	17.6	14.1	5.9	32.5	2.3	17.2	2.5	3.7	31.3	3.2	6.0	5.5	0.0	2.9	12.5	2.0	3.9	3.5	3.0	0.8	1.1	1.8	123.1	6.5	3.1	7.4	7.0	1.0	5.3	1.3	20.1	1.7	1.4	4.2	0.0	15.5	15.7	4.9	0.9	15.2	1.8	1.0	6.1	7.3	20.6	0.0	0.3	3.1	4.7	0.7	1.7	6.7	6.9	0.6	0.8	74.3	0.0	25.6	5.5	2.9	9.1	3.4	4.1	8.5	7.5	0.3	3.1	8.4
PPME1	"ABDH19, PME-1"	ENSG00000214517	"Protein phosphatase methylesterase 1"	Q9Y570	11	74171267-74254703	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Serine esterase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Erythroid cells: 96.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RH-30: 432.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004541, HPA043900, HPA064396"	Enhanced		Supported	"Nucleoplasm,Nuclear bodies"		NA	NA		45000	"Cluster 27: Non-specific - Gene expression"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 6: Erythroid cells - Oxygen transport"	Nucleoplasm	"Nuclear bodies"	"CAB004541: AB_628161, HPA043900: AB_2678722, HPA064396: AB_2685254"	"unprognostic (2.99e-2)"	"unprognostic (1.27e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.98e-1)"	"unprognostic (9.26e-2)"	"unprognostic (5.77e-3)"	"prognostic unfavorable (4.45e-6)"	"unprognostic (2.31e-2)"	"unprognostic (7.92e-2)"	"unprognostic (9.76e-2)"	"unprognostic (1.57e-1)"	"unprognostic (2.06e-1)"	"prognostic unfavorable (2.76e-4)"	"unprognostic (1.84e-1)"	"unprognostic (1.54e-1)"	"unprognostic (4.14e-3)"	"unprognostic (1.33e-3)"	14.7	25.1	16.8	10.0	18.1	16.9	14.9	8.5	21.3	17.3	7.8	15.2	11.0	16.8	29.1	20.8	24.1	14.0	21.4	18.8	19.4	18.6	10.1	13.0	9.3	12.7	14.5	18.3	15.4	62.5	14.5	14.9	17.5	23.8	15.7	23.8	20.1	24.9	29.7	28.7	11.5	21.4	9.8	8.1	13.4	31.9	13.4	18.8	23.1	24.1	14.7	22.3	13.9	14.0	50.5	62.3	42.4	45.9	45.4	36.0	41.3	71.8	48.4	134.8	103.6	139.1	32.3	26.3	47.7	55.1	73.6	79.9	63.4	50.3	123.1	36.4	23.8	38.7	66.6	64.1	96.7	28.9	33.2	34.6	41.8	69.7	32.7	54.8	39.1	37.5	93.0	22.5	236.6	34.1	38.0	36.1	34.4	71.2	50.3	39.9	432.4	39.9	56.7	33.9	57.2	49.2	85.1	38.7	108.4	46.2	72.7	29.1	23.5	52.1	67.6	51.5	55.2	41.4	54.6	46.9	39.2	26.7	43.4	1.4	8.7	11.3	10.4	10.5	13.2	7.2	13.4	12.6	11.2	8.3	13.3	10.9	4.9	13.7	9.5	11.8	10.9	9.2	16.8	18.1	8.5	21.3	18.8	19.4	12.7	14.5	17.5	9.8	13.4	14.0	16.1	28.9	12.8	28.7	10.8	20.3	24.4	30.5	23.3	31.3	18.5	17.7	18.0	7.2	28.5	35.0	37.5	14.1	11.2	15.4	17.6	16.9	51.4	44.9	32.8	15.0	25.7	96.4	65.3	13.4	38.9	19.1	23.9	24.2	8.2	21.2	10.8	9.7	13.6	33.7	59.3	13.5	34.6	6.7	14.8	13.4	13.7	11.1	3.6	20.6	10.8	15.2	16.5	35.7	40.5	16.6	12.0	25.2	8.2	19.2	10.3	11.6	40.9	18.8	6.6	19.0	33.0	61.9	45.6	21.5	24.9	15.5	12.4	18.8	13.4	17.3
PPP1CA	"PP-1A, PP1A, PP1alpha, PPP1A"	ENSG00000172531	"Protein phosphatase 1 catalytic subunit alpha"	P62136	11	67398181-67421183	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Carbohydrate metabolism, Cell cycle, Cell division, Glycogen metabolism, Host-virus interaction"	"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004545, HPA046833"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA		3600000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 52: Non-specific - Ribosome"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Nucleoplasm, Plasma membrane, Cytosol"		"CAB004545: AB_628177, HPA046833: AB_2679829"	"unprognostic (1.03e-1)"	"unprognostic (5.82e-3)"	"unprognostic (1.10e-1)"	"unprognostic (2.67e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.51e-2)"	"unprognostic (3.15e-3)"	"unprognostic (3.93e-2)"	"unprognostic (2.07e-1)"	"unprognostic (3.89e-2)"	"unprognostic (5.05e-3)"	"unprognostic (8.00e-2)"	"unprognostic (1.66e-1)"	"unprognostic (9.96e-2)"	"unprognostic (7.69e-2)"	"prognostic favorable (1.17e-4)"	"unprognostic (7.60e-2)"	70.0	102.4	61.2	102.6	70.8	127.8	63.5	64.0	70.7	62.1	61.2	110.8	95.9	50.5	66.8	184.0	61.1	51.2	122.0	63.5	63.6	121.8	128.2	78.9	147.8	68.3	62.4	33.1	105.1	64.2	59.8	83.5	63.8	81.1	89.6	21.6	100.4	51.0	123.2	105.8	107.1	56.1	63.9	148.7	102.7	34.6	65.8	113.7	88.7	81.3	155.6	74.9	80.6	68.2	283.1	305.6	181.1	270.3	88.4	108.9	185.6	136.1	158.4	267.4	202.3	445.8	328.5	237.2	227.3	208.1	198.4	238.7	213.9	280.2	169.6	256.3	139.9	227.5	129.3	232.7	195.2	295.2	281.1	123.3	181.1	225.7	130.7	125.4	272.2	226.0	217.4	191.1	220.5	619.4	378.2	562.2	303.5	526.7	241.1	262.7	254.0	209.8	262.2	220.7	142.5	236.7	159.2	283.0	439.8	135.3	338.5	201.2	196.4	208.5	208.9	245.3	179.0	190.1	193.2	271.8	244.6	199.9	224.3	921.6	735.9	1234.1	779.2	962.9	604.3	733.4	679.9	792.5	705.3	779.6	412.6	584.2	853.8	688.8	1186.1	500.4	1098.7	2042.5	61.2	70.8	64.0	70.7	63.5	63.6	68.3	62.4	63.8	63.9	65.8	68.2	49.2	76.9	92.2	8.8	165.8	99.9	143.5	305.9	64.3	35.5	81.7	79.1	8.4	102.9	157.8	86.5	10.4	360.4	151.2	377.5	213.2	265.6	2.5	63.1	67.2	101.6	96.9	108.8	8.8	311.1	507.0	68.8	132.0	107.1	109.6	87.1	89.3	113.9	377.1	43.7	7.7	241.3	181.0	219.8	138.5	7.7	49.0	186.5	136.9	9.4	353.0	53.8	408.8	6.0	13.1	318.4	308.4	28.6	206.5	139.0	341.3	297.4	70.5	30.5	98.6	67.1	100.7	13.6	94.6	142.0	121.6	427.3	176.3	100.1	231.7	205.4
PPP1CB	"MP, PP-1B, PP1B, PP1beta, PP1c, PPP1beta"	ENSG00000213639	"Protein phosphatase 1 catalytic subunit beta"	P62140	2	28751640-28802940	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Biological rhythms, Carbohydrate metabolism, Cell cycle, Cell division, Glycogen metabolism"	"Hydrolase, Protein phosphatase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Langerhans cells: 985.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022558, HPA065425, CAB069426"	Supported		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA		3800000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 24: Non-specific - Transcription regulation"	"Nucleoplasm, Cytosol"	"Plasma membrane"	"CAB022558: , CAB069426: , HPA065425: AB_2685489"	"unprognostic (2.90e-1)"	"unprognostic (5.03e-2)"	"unprognostic (5.49e-2)"	"unprognostic (2.00e-1)"	"unprognostic (7.08e-2)"	"unprognostic (1.39e-1)"	"prognostic unfavorable (6.52e-6)"	"unprognostic (3.47e-2)"	"unprognostic (2.44e-1)"	"unprognostic (3.15e-2)"	"unprognostic (1.54e-3)"	"unprognostic (3.95e-1)"	"unprognostic (1.68e-1)"	"unprognostic (3.66e-1)"	"unprognostic (1.89e-1)"	"unprognostic (4.56e-1)"	"unprognostic (2.26e-2)"	90.9	75.2	55.8	74.7	73.5	119.1	110.5	55.6	74.9	148.6	67.8	109.2	84.8	138.4	104.0	245.7	113.5	103.1	185.2	54.3	73.8	84.4	70.5	73.3	60.4	73.9	61.2	92.7	76.2	126.9	45.9	74.8	74.5	149.1	92.9	70.8	114.6	123.4	386.0	73.7	76.0	159.7	71.8	65.8	81.7	47.6	63.5	71.3	78.8	262.8	91.1	118.0	104.1	88.2	186.0	114.6	391.1	121.7	130.8	121.0	227.0	97.7	110.6	92.2	91.0	102.6	106.9	147.5	119.2	101.5	102.7	111.4	112.6	129.9	109.8	235.9	58.2	111.3	130.1	111.5	284.3	127.8	50.5	93.5	181.3	100.1	207.8	97.4	113.8	77.0	103.6	140.4	123.3	93.2	136.9	110.3	128.3	141.8	89.8	132.2	344.9	112.7	304.3	220.6	106.7	131.3	151.4	166.2	136.2	111.4	80.4	70.6	137.6	122.6	134.6	89.3	119.0	100.4	171.0	299.8	130.1	135.0	93.5	72.4	59.4	84.9	39.8	96.7	50.8	38.6	59.3	46.8	65.4	31.6	51.8	58.8	103.6	61.4	115.2	49.8	74.3	52.8	55.8	73.5	55.6	74.9	54.3	73.8	73.9	61.2	74.5	71.8	63.5	88.2	172.2	93.0	80.6	59.4	147.8	492.1	176.7	101.5	64.9	62.4	208.0	117.0	352.1	112.9	124.1	310.8	27.1	129.6	210.4	324.5	244.6	297.0	514.0	330.2	245.7	129.3	283.0	200.2	68.5	210.5	202.1	147.8	78.5	258.9	146.6	91.2	137.8	108.7	114.7	163.2	71.8	144.2	111.9	182.6	985.1	406.2	196.7	238.1	336.2	59.0	137.9	116.6	55.6	64.3	68.4	236.8	181.3	302.0	100.9	364.9	106.6	227.4	213.3	65.2	631.1	225.8	264.8	55.2	66.6	135.6	458.0	392.9	237.7	65.8	154.4	498.9
PPP1R10	"CAT53, FB19, p99, PNUTS"	ENSG00000204569	"Protein phosphatase 1 regulatory subunit 10"	Q96QC0	6	30600413-30618612	"Predicted intracellular proteins"		"DNA-binding, Protein phosphatase inhibitor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Immune cell enhanced"	"Detected in many"		"basophil: 7.9"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB025501, HPA047248, HPA056756"	Enhanced		Enhanced	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm	"Nuclear bodies"	"CAB025501: , HPA047248: AB_2679996, HPA056756: AB_2683227"	"unprognostic (1.68e-1)"	"prognostic favorable (4.84e-4)"	"unprognostic (1.21e-1)"	"unprognostic (9.31e-3)"	"unprognostic (6.31e-2)"	"unprognostic (9.57e-3)"	"unprognostic (2.02e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.62e-2)"	"unprognostic (1.25e-1)"	"prognostic favorable (9.74e-5)"	"unprognostic (2.72e-1)"	"unprognostic (8.02e-3)"	"unprognostic (5.90e-2)"	"unprognostic (1.76e-1)"	"unprognostic (2.89e-1)"	"unprognostic (3.74e-2)"	20.9	27.5	0.2	12.0	0.1	1.0	15.8	0.2	1.3	23.3	0.1	21.8	8.9	21.2	1.1	23.1	22.0	10.7	14.6	0.5	0.4	22.8	33.6	17.4	5.0	1.2	1.3	22.8	28.0	4.8	26.3	5.0	0.6	22.8	6.4	5.2	20.1	7.9	23.0	21.1	21.0	7.0	0.3	25.1	25.2	21.7	0.3	10.1	22.9	1.2	5.6	22.5	21.8	0.2	9.1	20.0	30.9	16.8	17.0	2.2	8.9	15.9	7.0	5.6	23.3	5.0	9.7	11.5	9.6	16.0	10.5	23.6	24.3	35.7	9.7	13.1	0.0	19.8	14.1	0.2	7.6	16.3	27.3	14.2	4.0	28.0	30.9	13.2	9.7	3.9	18.4	3.7	14.4	5.4	5.5	2.4	9.1	1.9	2.3	25.4	39.3	19.8	1.4	8.0	19.3	9.1	29.5	28.3	8.8	13.0	13.8	21.8	2.6	12.7	9.0	18.5	10.7	26.9	5.1	11.3	15.8	19.9	15.8	7.9	1.2	2.0	0.9	2.1	1.6	2.9	0.4	1.7	3.3	0.7	0.5	1.1	1.0	1.0	0.8	1.2	1.9	0.4	0.2	0.1	0.2	1.3	0.5	0.4	1.2	1.3	0.6	0.3	0.3	0.2	243.9	32.1	40.3	20.5	152.7	69.8	64.9	41.1	167.9	72.7	165.1	163.8	59.1	28.6	34.2	27.6	131.3	44.0	178.9	120.5	35.2	27.2	32.0	138.2	103.8	102.6	71.3	30.5	26.1	23.0	21.8	103.2	107.0	151.4	44.9	143.0	38.2	33.6	33.1	35.3	27.0	102.2	54.9	35.5	70.6	11.3	46.3	123.4	37.4	30.0	46.4	59.0	72.1	21.1	29.7	29.8	58.3	30.1	140.1	51.9	88.1	40.3	46.9	102.2	32.9	211.5	114.9	45.9	23.4	125.7	77.9	88.5	144.1	99.9	77.0	34.5
PPP1R12A	"M130, MBS, MYPT1"	ENSG00000058272	"Protein phosphatase 1 regulatory subunit 12A"	O14974	12	79773563-79935460	"Disease related genes, Predicted intracellular proteins"			"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocyte precursor cells: 353.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041296, HPA071956"	Approved		Supported	"Actin filaments,Cytosol"		NA	NA		270000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 48: Smooth muscle cells - ECM organization"	"Actin filaments, Cytosol"		"HPA041296: AB_2677394, HPA071956: AB_2732192"	"unprognostic (3.34e-1)"	"unprognostic (1.73e-1)"	"unprognostic (2.54e-1)"	"unprognostic (1.72e-1)"	"unprognostic (5.60e-3)"	"unprognostic (6.19e-2)"	"prognostic unfavorable (1.72e-4)"	"unprognostic (1.61e-1)"	"unprognostic (9.69e-3)"	"unprognostic (1.85e-1)"	"unprognostic (2.04e-2)"	"unprognostic (1.04e-1)"	"unprognostic (2.44e-3)"	"unprognostic (5.50e-2)"	"unprognostic (1.95e-1)"	"unprognostic (2.45e-1)"	"unprognostic (1.38e-1)"	31.5	18.6	21.2	32.3	26.6	57.5	21.7	25.3	65.3	34.1	15.0	73.3	22.8	66.2	31.1	71.2	40.9	36.6	28.0	27.7	20.3	18.2	14.2	24.6	31.9	14.3	14.5	27.4	11.0	18.5	11.2	41.6	14.2	67.6	35.4	14.6	19.0	84.8	20.5	17.6	27.6	83.7	14.1	30.8	29.2	23.5	20.7	34.3	24.9	27.2	27.8	64.5	27.7	27.0	42.9	36.5	49.3	28.5	36.8	36.2	45.8	84.0	46.5	53.1	35.2	34.9	20.7	36.9	33.4	113.8	21.4	33.4	38.6	32.9	63.8	51.3	24.3	98.2	40.5	24.1	29.1	64.8	59.5	30.7	24.3	53.6	49.1	60.1	37.2	36.7	41.1	43.0	57.0	27.7	71.4	34.3	39.1	18.8	25.2	57.9	54.4	27.8	31.4	66.6	23.8	17.9	66.3	23.2	28.5	45.1	32.4	30.9	56.8	56.3	29.9	40.1	48.2	28.3	27.8	48.6	19.2	36.3	49.3	155.1	44.4	197.4	62.8	47.5	56.5	56.8	59.7	66.8	41.8	52.8	47.3	61.3	187.2	98.2	70.4	35.3	69.6	46.3	21.2	26.6	25.3	65.3	27.7	20.3	14.3	14.5	14.2	14.1	20.7	27.0	108.4	76.9	65.9	168.5	79.7	84.5	69.0	59.1	57.5	82.2	30.7	69.0	127.4	32.9	61.5	53.3	35.5	66.7	113.4	44.9	15.6	50.9	111.3	47.5	113.6	93.6	44.9	66.3	240.4	40.0	82.0	82.4	42.8	81.2	121.4	66.6	55.0	27.5	78.0	102.6	135.4	37.7	44.7	57.5	100.8	64.2	86.3	92.8	60.5	132.1	112.0	52.2	120.5	353.9	132.9	55.9	42.7	147.4	60.7	52.0	34.3	26.3	41.0	61.4	210.4	74.6	332.7	133.4	89.8	50.9	81.1	83.7	119.7	81.5	41.3	63.6
PPP1R13B	"ASPP1, KIAA0771, p53BP2-like, p85"	ENSG00000088808	"Protein phosphatase 1 regulatory subunit 13B"	Q96KQ4	14	103733195-103847575	"Plasma proteins, Predicted intracellular proteins"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 106.1;Granulosa cells: 83.4;Inhibitory neurons: 105.9;Late spermatids: 78.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"MCF7: 20.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006394, CAB015454"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 71: Testis - DNA repair"	"Cluster 14: REH - Unknown function"	"Cluster 40: Granulosa cells - Unknown function"	Nucleoplasm	Cytosol	"CAB015454: AB_2252775, HPA006394: AB_1079668"	"unprognostic (1.20e-1)"	"unprognostic (8.61e-2)"	"unprognostic (6.65e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.12e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.25e-2)"	"prognostic favorable (1.41e-4)"	"unprognostic (3.22e-3)"	"unprognostic (5.13e-2)"	"unprognostic (5.39e-2)"	"unprognostic (1.62e-3)"	"prognostic favorable (3.28e-11)"	"unprognostic (1.68e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.97e-2)"	"unprognostic (2.23e-1)"	7.0	4.7	3.4	3.2	4.2	0.7	7.4	6.6	8.5	6.8	4.0	7.7	7.1	7.6	2.1	11.6	9.8	4.7	21.2	7.6	3.9	6.9	5.0	9.9	2.7	1.2	2.0	10.9	8.3	7.8	6.5	6.0	1.7	10.7	5.6	8.0	10.2	5.3	7.5	12.5	7.6	5.2	0.3	11.3	10.1	19.1	3.8	2.0	23.4	6.2	5.1	8.0	7.1	4.2	4.9	4.2	0.5	5.4	0.9	0.4	1.9	3.2	2.3	4.0	1.8	3.3	4.4	1.1	11.7	2.2	4.9	9.8	5.8	3.7	3.5	2.2	4.0	0.0	1.3	5.7	3.6	0.5	4.4	1.0	4.4	0.3	4.7	1.7	7.9	2.8	0.7	1.7	2.7	20.3	0.0	0.5	1.0	12.3	5.1	11.3	3.2	2.7	7.8	12.7	6.6	16.9	9.9	7.3	2.5	2.6	18.4	0.7	7.1	2.9	4.0	2.4	3.0	4.0	5.8	8.4	1.8	2.9	1.4	0.0	0.0	0.0	0.2	0.0	0.3	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	3.4	4.2	6.6	8.5	7.6	3.9	1.2	2.0	1.7	0.3	3.8	4.2	35.1	19.2	39.5	31.0	7.1	13.5	16.6	6.9	18.8	15.8	31.3	20.6	45.4	14.3	11.8	7.3	12.5	2.9	11.9	26.9	3.9	7.9	58.0	37.9	7.9	30.3	15.6	2.7	106.1	6.4	1.0	7.7	37.8	48.5	0.0	83.4	14.3	9.0	2.9	15.2	105.9	14.2	6.1	1.6	5.7	78.4	4.4	3.0	3.6	49.6	0.4	5.8	1.0	31.7	33.2	6.8	18.7	20.3	6.3	13.1	14.6	7.8	8.3	12.9	6.6	10.9	6.7	17.8	15.1	24.1	12.9	2.2	9.0	8.7	15.8	13.7
PPP1R14A	"CPI-17, PPP1INL"	ENSG00000167641	"Protein phosphatase 1 regulatory inhibitor subunit 14A"	Q96A00	19	38251237-38256532	"Plasma proteins, Predicted intracellular proteins"		"Protein phosphatase inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 492.0;intestine: 450.3"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 332.5;Granulosa cells: 435.0;Leydig cells: 341.1;Peritubular cells: 656.0;Sertoli cells: 979.5;Smooth muscle cells: 465.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"memory B-cell: 299.4;naive B-cell: 283.9;plasmacytoid DC: 246.9"	"Group enriched"	"Detected in many"	24	"B-cells: 299.4;dendritic cells: 246.9"	"Group enriched"	"Detected in some"	4	"A549: 164.1;EFO-21: 112.2;K-562: 64.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005044, CAB009803, HPA042097, HPA054534"	Enhanced		Supported	"Nucleoplasm,Nuclear bodies"		NA	NA		880000	"Cluster 37: B-cells - Transcription"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 48: Smooth muscle cells - ECM organization"	Nucleoplasm	"Nuclear bodies"	"CAB005044: AB_562091, CAB009803: AB_2168720, HPA042097: AB_2677846, HPA054534: AB_2682518"	"unprognostic (5.40e-2)"	"unprognostic (4.00e-3)"	"unprognostic (4.02e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.74e-1)"	"unprognostic (8.92e-3)"	"unprognostic (2.18e-3)"	"unprognostic (1.30e-1)"	"unprognostic (2.28e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.66e-1)"	"prognostic unfavorable (1.25e-5)"	"prognostic unfavorable (7.12e-4)"	"unprognostic (4.13e-1)"	"unprognostic (5.81e-2)"	"unprognostic (2.22e-2)"	134.0	144.2	175.2	22.1	347.5	2.9	111.9	321.5	226.5	149.7	63.2	450.3	18.6	273.5	5.2	47.6	153.7	14.8	94.6	175.2	219.6	53.3	17.9	163.1	2.6	402.3	322.9	125.1	31.1	2.8	12.6	34.1	336.3	142.0	12.6	0.3	19.0	86.1	27.5	28.6	82.1	57.2	222.0	101.2	140.3	77.6	365.3	1.7	25.8	12.3	1.4	301.6	106.1	492.0	0.0	164.1	0.4	0.0	1.0	0.0	6.1	10.8	0.0	0.1	0.0	12.8	0.2	0.0	112.2	1.0	0.0	0.5	13.6	0.2	0.0	1.4	0.0	25.5	0.0	0.0	4.6	0.0	0.0	0.3	0.0	1.4	0.0	0.0	0.1	0.0	64.5	0.3	0.0	0.8	0.0	0.3	4.9	0.0	0.0	0.2	2.4	0.4	0.4	0.0	3.5	0.2	0.0	0.0	0.1	9.2	0.0	0.4	0.4	0.0	0.8	0.4	0.0	0.4	0.0	0.5	0.2	0.0	0.1	11.3	0.6	1.2	0.1	0.7	0.2	299.4	0.2	0.4	44.3	283.9	0.6	0.1	1.7	8.7	0.2	246.9	0.2	21.6	175.2	347.5	321.5	226.5	175.2	219.6	402.3	322.9	336.3	222.0	365.3	492.0	332.5	0.0	1.1	1.3	29.9	9.6	3.0	1.2	3.4	0.4	8.8	209.8	19.6	2.8	0.7	0.0	0.0	48.3	48.7	32.7	0.0	0.7	14.1	15.4	239.5	108.5	1.8	34.7	0.5	10.9	7.4	66.8	2.0	10.8	3.8	435.0	224.5	2.3	9.5	0.0	0.6	0.4	0.0	5.6	24.6	42.1	341.1	41.4	8.8	14.0	66.1	0.5	4.1	3.5	155.6	2.2	2.6	656.0	4.8	2.4	3.8	0.3	0.0	1.6	979.5	8.7	465.2	9.9	46.2	0.6	8.0	26.4	3.7	66.0	0.4	1.2
PPP1R16B	"ANKRD4, KIAA0823, TIMAP"	ENSG00000101445	"Protein phosphatase 1 regulatory subunit 16B"	Q96T49	20	38805697-38923024	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 71.6;lymphoid tissue: 41.9"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 119.4;Inhibitory neurons: 46.8;Oligodendrocyte precursor cells: 49.8;Oligodendrocytes: 238.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"Daudi: 57.3;HMC-1: 59.2;HUVEC TERT2: 35.6;U-266/70: 96.7;U-266/84: 41.8;U-698: 38.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049571, HPA079512"	Approved		Supported	"Nuclear speckles,Plasma membrane"		NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 59: Non-specific - Transcription"	"Plasma membrane"	"Nuclear speckles"	"HPA049571: , HPA079512: "	"unprognostic (2.62e-2)"	"prognostic favorable (2.11e-4)"	"unprognostic (2.67e-3)"	"unprognostic (3.35e-3)"	"unprognostic (2.19e-1)"	"prognostic favorable (7.87e-5)"	"unprognostic (1.13e-1)"	"unprognostic (4.17e-2)"	"unprognostic (4.31e-2)"	"unprognostic (6.28e-2)"	"unprognostic (4.09e-3)"	"unprognostic (4.77e-2)"	"unprognostic (3.45e-2)"	"unprognostic (8.53e-2)"	"unprognostic (3.75e-2)"	"unprognostic (1.73e-1)"	"unprognostic (7.90e-2)"	13.2	2.9	36.5	19.3	71.6	17.7	8.2	26.1	61.1	3.2	5.1	4.6	3.6	3.4	1.5	3.1	5.8	5.3	5.2	49.3	22.3	27.7	2.4	7.9	37.7	27.8	34.7	1.1	1.5	0.8	2.2	3.7	27.1	1.6	5.1	3.7	2.0	1.9	3.6	1.5	18.0	7.2	24.3	18.1	5.6	0.7	35.7	18.2	3.4	5.7	41.9	6.0	1.6	52.1	0.1	0.7	9.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	57.3	0.8	0.0	0.9	0.1	1.0	0.1	0.0	1.4	0.2	4.4	0.0	0.0	0.0	0.2	59.2	0.0	0.1	0.0	0.0	0.0	35.6	7.6	1.0	11.9	0.0	0.0	7.4	9.7	7.9	0.1	0.0	5.0	0.0	0.0	0.0	0.0	17.7	19.7	0.0	0.0	0.0	0.7	0.0	3.1	5.5	0.0	0.9	0.0	0.0	96.7	41.8	38.3	0.0	0.0	0.1	0.0	0.2	2.5	3.4	0.5	1.8	5.3	2.3	3.3	0.7	3.3	1.3	1.8	0.0	2.9	0.9	3.3	2.6	1.1	36.5	71.6	26.1	61.1	49.3	22.3	27.8	34.7	27.1	24.3	35.7	52.1	29.3	3.2	3.0	1.3	33.6	1.0	0.0	0.8	0.6	2.3	0.5	0.5	23.5	1.5	4.0	0.0	0.0	0.0	34.0	0.3	0.0	0.0	1.9	0.2	0.2	18.7	0.0	2.7	119.4	0.0	0.0	1.6	4.1	0.3	3.8	0.0	38.6	0.3	0.1	37.0	46.8	0.1	0.0	3.1	3.6	1.5	0.0	3.8	8.8	23.4	20.5	0.3	11.3	49.8	238.0	0.0	0.1	0.0	29.3	0.0	0.0	17.4	3.6	0.3	0.0	0.3	1.0	0.0	0.3	0.3	1.3	0.0	37.4	0.0	0.2	0.3
PPP2CB	PP2Abeta	ENSG00000104695	"Protein phosphatase 2 catalytic subunit beta"	P62714	8	30774457-30814314	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Peritubular cells: 264.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB018600, HPA043236"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 68: Epididymis - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm		"CAB018600: AB_675841, HPA043236: AB_2678379"	"unprognostic (9.77e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.51e-2)"	"unprognostic (3.82e-1)"	"unprognostic (6.70e-2)"	"unprognostic (7.79e-2)"	"unprognostic (1.13e-2)"	"unprognostic (3.51e-1)"	"unprognostic (2.28e-1)"	"unprognostic (2.86e-2)"	"unprognostic (4.50e-2)"	"unprognostic (1.89e-2)"	"prognostic favorable (5.82e-7)"	"unprognostic (9.24e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.65e-3)"	89.9	66.6	190.2	42.2	196.1	10.5	68.4	189.1	220.1	84.0	147.9	79.3	72.9	112.1	117.1	95.1	87.8	74.2	94.7	191.6	190.7	131.9	118.6	90.6	32.5	199.7	184.1	147.4	75.7	93.3	52.5	91.0	190.4	74.9	76.2	77.9	68.6	87.1	105.7	63.7	87.0	122.3	195.1	52.9	71.2	64.7	204.4	41.4	126.7	122.7	47.4	76.8	70.0	200.1	96.5	82.7	136.4	54.4	134.6	120.0	78.0	124.0	114.0	123.1	129.5	86.6	68.3	45.6	118.7	165.4	117.9	56.5	84.4	142.1	167.3	28.5	44.2	61.8	52.7	86.9	157.3	28.1	34.2	108.6	157.4	105.2	115.9	124.2	152.5	73.6	97.7	47.6	212.4	48.4	77.1	34.9	102.6	139.3	47.0	53.9	55.7	34.5	168.5	73.6	134.3	55.0	57.8	61.1	127.0	150.5	34.1	47.8	164.0	109.1	81.7	36.1	105.5	24.0	33.6	53.7	93.4	26.0	141.4	3.4	2.5	1.7	1.8	3.1	2.3	2.9	1.7	1.9	1.7	1.1	1.7	2.1	2.3	3.8	1.5	3.8	1.3	0.8	190.2	196.1	189.1	220.1	191.6	190.7	199.7	184.1	190.4	195.1	204.4	200.1	81.0	70.5	60.7	68.6	13.0	104.1	115.9	44.4	44.9	36.6	64.9	51.8	80.2	45.8	54.3	86.5	31.3	41.1	23.6	186.1	46.9	40.6	21.8	98.5	109.8	60.9	32.3	16.6	41.0	48.9	52.8	79.0	34.7	89.2	17.7	95.4	87.8	95.5	58.4	47.1	59.1	65.3	28.5	55.4	60.4	20.3	73.3	36.0	40.9	52.5	27.4	127.2	17.5	37.7	60.4	81.1	78.9	264.0	15.8	125.4	115.6	95.9	68.2	26.5	46.0	93.1	73.0	37.2	40.4	50.3	95.6	70.6	17.4	75.3	41.2	149.9
PPP2R3B	"PPP2R3L, PPP2R3LY, PR48, PR70"	ENSG00000167393	"Protein phosphatase 2 regulatory subunit B''beta"	Q9Y5P8	X	333933-386955	"Metabolic proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"heart muscle: 73.0;skeletal muscle: 103.4"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 72.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"PC-3: 18.5;U-698: 29.9"									HPA026606			Supported	Nucleoplasm,Cytosol		NA	NA				"Cluster 59: Non-specific - Translation"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 54: Cardiomyocytes - Muscle contraction"	Nucleoplasm	Cytosol	"HPA026606: "	"unprognostic (1.25e-1)"	"unprognostic (4.35e-3)"	"unprognostic (5.10e-2)"	"unprognostic (1.16e-1)"	"unprognostic (6.03e-2)"	"unprognostic (2.46e-3)"	"unprognostic (1.56e-2)"	"unprognostic (2.73e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.79e-2)"	"prognostic favorable (2.92e-5)"	"unprognostic (4.65e-2)"	"unprognostic (2.29e-8)"	"unprognostic (1.15e-1)"	"unprognostic (4.97e-2)"	"unprognostic (3.17e-1)"	"prognostic favorable (1.90e-5)"	4.4	4.7	1.2	0.2	1.2	1.9	4.9	0.8	1.6	8.3	0.8	4.0	0.5	6.9	0.0	9.5	9.3	0.3	73.0	1.0	1.6	4.0	3.7	3.9	0.6	1.5	1.7	7.6	4.5	0.2	10.3	0.6	1.5	9.1	0.0	0.1	7.1	0.3	103.4	16.5	4.7	0.3	1.2	7.2	4.6	16.3	1.4	1.3	5.0	2.6	0.0	11.8	7.7	1.8	1.0	5.0	0.6	1.9	0.1	0.1	8.1	7.6	1.3	4.7	6.0	5.4	0.0	1.8	4.0	5.4	0.7	0.0	0.1	0.0	1.0	5.6	6.3	1.1	1.8	0.3	0.0	2.3	3.1	0.2	0.1	0.0	3.7	0.4	0.1	3.3	1.6	0.2	0.7	3.1	11.8	8.6	3.1	0.1	18.5	5.3	3.7	0.4	1.0	1.4	0.0	11.1	0.0	0.6	5.3	4.0	0.0	1.7	0.4	2.5	3.6	0.0	2.0	0.2	0.4	29.9	0.0	2.6	4.8	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	1.2	0.8	1.6	1.0	1.6	1.5	1.7	1.5	1.2	1.4	1.8	6.7	0.0	1.7	11.4	3.8	6.8	8.6	1.7	4.6	13.5	8.5	10.7	72.3	4.3	2.1	0.0	27.1	5.2	5.7	3.8	0.0	2.5	0.6	12.1	4.6	5.4	4.8	4.8	2.8	4.0	7.3	8.0	4.6	7.4	0.0	25.6	2.9	1.8	3.7	6.7	3.7	3.9	0.0	2.8	4.5	2.0	4.1	5.8	5.4	5.6	3.1	8.6	6.2	17.6	10.4	2.4	0.6	3.0	3.3	3.7	1.8	1.7	4.3	19.0	0.0	12.2	6.5	16.7	27.1	6.1	7.5	4.0	5.0	7.8	3.6	4.5
PPP2R3C	"C14orf10, FLJ20644, G4-1, G5PR"	ENSG00000092020	"Protein phosphatase 2 regulatory subunit B''gamma"	Q969Q6	14	35085467-35122517	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Cone-rod dystrophy, Deafness, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"Early spermatids: 489.7;Late spermatids: 233.5;Spermatocytes: 239.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040835, HPA058834"	Approved		Supported	"Nucleoplasm,Golgi apparatus,Cytosol"		No	No			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm	"Golgi apparatus, Cytosol"	"HPA040835: AB_10794152, HPA058834: AB_2683831"	"unprognostic (1.41e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.15e-1)"	"unprognostic (7.32e-3)"	"unprognostic (5.33e-2)"	"unprognostic (9.73e-2)"	"unprognostic (1.10e-3)"	"unprognostic (3.05e-1)"	"unprognostic (7.85e-2)"	"unprognostic (9.48e-3)"	"unprognostic (1.17e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.18e-1)"	"unprognostic (3.04e-2)"	"unprognostic (3.15e-3)"	"unprognostic (8.55e-2)"	"unprognostic (8.29e-2)"	19.9	15.5	23.5	23.9	25.0	42.8	17.1	24.4	41.6	18.1	23.3	18.6	21.0	16.2	16.4	12.5	14.0	18.6	22.9	23.8	25.6	14.4	16.1	17.7	31.0	25.3	24.4	15.9	10.2	17.0	17.6	18.8	25.6	17.1	20.3	15.4	13.5	14.1	24.9	7.1	22.5	21.0	24.9	24.4	16.2	71.6	24.4	26.4	12.4	25.7	25.9	22.3	10.4	27.5	41.2	21.8	41.7	33.9	32.4	54.5	29.6	33.0	32.0	41.0	48.0	18.1	32.2	47.2	13.4	33.9	15.5	17.6	20.0	13.8	60.5	47.8	19.3	26.2	11.9	65.2	43.3	51.2	51.7	41.9	14.4	29.0	19.7	24.0	55.7	26.2	25.7	46.3	57.4	28.4	46.4	43.1	37.1	27.4	24.3	50.2	27.1	32.8	15.8	24.1	39.9	37.5	41.7	27.6	57.8	19.9	17.9	57.0	47.9	41.3	17.3	36.0	34.9	44.8	52.4	92.8	22.8	47.9	48.1	66.5	41.6	86.9	23.4	52.5	27.0	31.0	24.8	29.5	36.1	33.1	22.0	26.9	76.9	33.1	42.7	16.3	40.8	34.0	23.5	25.0	24.4	41.6	23.8	25.6	25.3	24.4	25.6	24.9	24.4	27.5	35.5	16.0	24.7	32.7	40.2	11.5	23.3	31.7	9.6	15.9	18.8	14.7	26.3	17.2	25.8	20.2	4.2	19.4	48.1	29.1	33.2	31.2	489.7	23.1	28.1	33.8	31.2	69.7	28.3	36.1	26.2	26.5	19.9	21.7	33.7	31.3	34.6	22.8	61.3	8.4	30.4	26.8	32.6	49.7	36.3	233.5	28.3	42.6	28.4	24.4	71.5	28.7	46.4	36.2	58.8	49.2	22.3	30.5	37.4	24.8	37.8	43.2	25.1	21.5	32.9	24.0	43.1	239.2	58.6	19.6	13.5	34.8	45.2	36.2	24.6	30.5
PPP2R5A	"B56A, B56alpha, PR61A"	ENSG00000066027	"Protein phosphatase 2 regulatory subunit B'alpha"	Q15172	1	212285410-212361853	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 252.7;Late spermatids: 547.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA059288, HPA078841"	Approved		Supported	Cytosol		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 25: Spermatids - Spermatogenesis"	Cytosol		"HPA059288: AB_2683966, HPA078841: "	"unprognostic (3.56e-1)"	"unprognostic (2.71e-1)"	"unprognostic (8.48e-2)"	"unprognostic (2.54e-1)"	"unprognostic (9.21e-2)"	"unprognostic (1.01e-1)"	"unprognostic (5.01e-2)"	"unprognostic (1.12e-2)"	"unprognostic (8.07e-2)"	"unprognostic (1.84e-2)"	"unprognostic (3.04e-1)"	"unprognostic (5.63e-2)"	"unprognostic (1.40e-3)"	"unprognostic (8.33e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.17e-1)"	"unprognostic (1.39e-1)"	60.2	12.0	35.5	20.0	40.6	86.5	38.3	34.4	34.9	24.7	27.4	34.2	25.7	20.1	18.4	51.3	19.2	27.7	50.4	31.0	35.6	35.6	51.6	57.7	31.0	36.3	40.8	15.3	36.9	23.5	13.2	35.9	36.1	22.6	37.0	23.9	36.3	22.2	36.7	30.8	33.4	22.2	35.0	49.5	44.5	17.4	42.6	36.3	41.8	56.6	31.3	34.7	30.2	39.6	45.4	19.1	9.5	19.1	102.5	62.2	76.1	19.6	38.3	21.9	20.6	57.1	45.7	31.9	14.5	31.5	22.9	32.0	18.3	27.9	22.8	27.5	23.1	20.7	19.9	20.8	33.1	43.3	30.7	25.7	36.4	20.1	29.0	27.7	53.3	28.0	29.6	33.4	12.1	19.7	17.1	28.5	16.0	40.6	39.5	22.0	15.2	40.6	38.5	20.9	13.6	9.1	27.3	84.7	65.0	40.0	52.7	38.0	11.4	15.3	15.6	24.2	21.2	50.9	42.7	42.1	18.4	32.6	11.5	18.0	2.0	10.1	4.4	2.3	3.0	1.4	3.4	4.0	1.4	2.2	2.0	4.0	9.8	3.3	3.3	1.5	5.2	1.4	35.5	40.6	34.4	34.9	31.0	35.6	36.3	40.8	36.1	35.0	42.6	39.6	66.7	99.3	104.4	71.5	34.2	68.6	22.1	9.0	40.9	24.6	30.1	18.5	65.8	47.1	17.4	14.7	2.1	10.9	56.2	51.2	97.8	25.9	252.7	25.5	17.7	53.3	16.2	22.9	21.3	34.8	26.9	18.7	43.8	53.5	40.0	6.6	38.6	52.2	22.1	52.2	13.8	33.9	8.2	34.8	20.6	547.2	19.3	34.1	17.8	45.0	35.1	37.4	53.5	32.6	115.2	27.8	32.5	14.3	29.6	31.0	30.8	20.9	21.3	11.1	32.9	14.8	36.5	18.4	10.9	66.2	81.3	8.2	54.1	58.3	30.8	45.7
PPP2R5C	"B56G, B56gamma, PR61G"	ENSG00000078304	"Protein phosphatase 2 regulatory subunit B'gamma"	Q13362	14	101761798-101927989	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"dendritic cells: 525.3;T-cells: 323.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027553	Approved		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 24: Non-specific - Transcription regulation"	"Nucleoplasm, Cytosol"	"Golgi apparatus"	"HPA027553: AB_10602081"	"unprognostic (3.28e-1)"	"unprognostic (1.66e-1)"	"unprognostic (2.19e-1)"	"unprognostic (3.24e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.78e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.99e-1)"	"unprognostic (1.31e-3)"	"unprognostic (2.08e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.33e-3)"	"unprognostic (1.17e-1)"	"unprognostic (3.09e-1)"	"unprognostic (4.49e-1)"	"unprognostic (1.72e-1)"	54.7	58.4	72.7	77.6	75.1	129.2	62.0	67.3	81.2	59.2	55.1	70.7	52.4	53.8	63.5	73.8	49.2	57.7	112.6	89.3	72.5	58.6	89.3	66.8	136.9	73.1	71.1	61.2	59.6	64.1	43.2	45.6	72.4	50.5	74.4	56.2	69.2	55.8	79.2	67.3	57.3	60.8	74.2	72.0	53.8	66.5	71.9	114.4	66.5	73.0	124.6	67.3	44.1	72.8	100.6	67.4	111.8	108.6	99.5	138.8	107.9	92.7	121.5	113.5	107.9	68.2	169.8	272.1	86.9	120.8	79.7	102.7	103.6	98.2	146.6	123.2	48.3	79.0	74.8	66.7	73.3	122.7	162.4	91.9	124.4	78.2	72.1	100.7	103.3	145.3	167.5	111.7	109.7	153.2	124.1	135.1	65.0	200.7	111.2	103.7	125.8	67.8	109.3	112.1	87.2	163.3	125.6	82.2	161.1	78.0	150.2	92.9	103.0	71.1	67.3	276.4	93.0	154.8	249.3	449.4	106.6	89.5	81.0	97.5	72.7	72.6	217.2	94.3	140.0	74.8	139.8	172.3	65.4	68.8	98.4	153.5	133.7	68.2	104.6	95.8	156.2	91.3	72.7	75.1	67.3	81.2	89.3	72.5	73.1	71.1	72.4	74.2	71.9	72.8	51.0	83.3	93.9	61.4	94.4	58.6	45.7	35.0	26.2	30.8	51.7	35.8	133.9	47.1	52.4	36.8	58.4	49.8	525.3	69.3	46.9	38.3	79.6	104.2	39.2	45.9	47.4	45.3	124.6	46.9	46.6	43.4	33.6	54.9	69.6	38.7	59.3	78.5	73.2	26.9	92.2	78.9	38.7	122.9	84.5	69.5	52.5	78.4	85.4	84.3	128.2	49.9	280.2	71.4	89.8	50.6	69.7	45.5	193.9	48.9	51.0	62.8	76.5	43.3	39.5	34.3	54.1	47.1	27.5	36.2	70.3	52.4	323.4	42.7	62.6	71.6
PPP2R5E	"B56E, B56epsilon"	ENSG00000154001	"Protein phosphatase 2 regulatory subunit B'epsilon"	Q16537	14	63371364-63543377	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 283.4;Horizontal cells: 262.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006034, CAB072342"	Approved		Supported	Cytosol		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 29: Early spermatids - Spermatogenesis"	Cytosol		"CAB072342: , HPA006034: AB_1079670"	"unprognostic (1.58e-1)"	"unprognostic (1.65e-1)"	"unprognostic (3.11e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.06e-1)"	"unprognostic (2.17e-1)"	"prognostic unfavorable (1.95e-4)"	"unprognostic (2.26e-1)"	"unprognostic (2.91e-1)"	"unprognostic (1.57e-2)"	"unprognostic (1.70e-2)"	"unprognostic (4.62e-2)"	"prognostic favorable (4.16e-4)"	"unprognostic (1.23e-1)"	"unprognostic (9.51e-2)"	"unprognostic (1.92e-1)"	"unprognostic (8.22e-2)"	12.7	12.5	9.5	13.5	11.0	14.5	12.5	10.3	11.1	14.6	7.2	17.0	10.7	14.9	10.2	19.8	11.7	12.0	15.7	11.4	11.1	14.7	15.8	12.7	15.4	7.4	7.6	12.6	10.9	17.5	6.6	16.0	7.9	12.7	20.0	26.7	9.2	12.6	17.8	11.8	12.3	15.0	7.6	14.3	12.0	14.3	10.4	19.2	20.2	16.5	17.0	17.1	9.8	7.8	90.5	26.0	46.7	22.1	31.6	37.0	44.5	37.1	30.4	39.5	39.1	33.1	35.4	39.6	22.1	38.1	29.3	36.2	48.1	34.4	67.8	36.2	11.8	25.7	18.1	27.7	33.7	41.7	30.4	27.1	37.7	38.8	42.7	28.8	40.2	39.8	33.3	41.9	43.8	60.2	41.8	18.7	35.3	37.7	46.8	41.9	47.8	30.1	38.2	68.1	26.5	51.6	47.7	39.1	25.0	40.1	57.4	20.8	37.8	61.7	68.6	31.7	33.0	15.2	24.4	50.9	28.4	26.3	42.7	1.4	1.3	1.3	2.0	1.4	1.9	1.1	2.2	2.5	1.2	1.7	1.7	1.9	1.0	4.5	1.9	1.9	1.4	0.6	9.5	11.0	10.3	11.1	11.4	11.1	7.4	7.6	7.9	7.6	10.4	7.8	52.1	89.8	55.5	54.2	52.8	80.4	56.9	34.0	60.3	65.0	49.3	27.8	61.7	44.3	35.3	22.0	64.6	27.2	54.8	55.0	29.4	46.4	283.4	65.1	57.2	52.5	27.1	41.2	110.4	47.7	41.5	44.8	33.1	74.6	24.1	48.6	41.0	45.1	29.8	262.5	131.6	51.6	28.5	38.7	49.0	46.6	43.8	42.3	37.4	59.0	49.7	38.4	61.8	93.5	91.8	41.4	48.1	43.2	55.9	58.5	24.9	41.2	41.6	81.2	26.3	51.5	71.1	74.9	22.5	63.1	91.6	30.6	57.0	47.8	70.2	46.9
PPP3R1	"CALNB1, CNB, CNB1"	ENSG00000221823	"Protein phosphatase 3 regulatory subunit B, alpha"	P63098	2	68178857-68256237	"Metabolic proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 189.9"	"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 151.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"neutrophil: 2.7"	"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"CAB005610, HPA047157"	Approved		Supported	"Plasma membrane,Cytosol"		NA	NA		42000	"Cluster 46: Basophils - DNA binding"	"Cluster 58: Brain - Synaptic function"	"Cluster 36: HEL - Hemostasis"	"Cluster 59: Non-specific - Transcription"	"Plasma membrane"	Cytosol	"CAB005610: AB_325975, HPA047157: AB_2679960"	"unprognostic (2.12e-1)"	"unprognostic (2.09e-2)"	"unprognostic (1.55e-1)"	"prognostic unfavorable (9.08e-6)"	"unprognostic (5.90e-2)"	"unprognostic (1.86e-1)"	"prognostic unfavorable (5.37e-4)"	"unprognostic (3.59e-1)"	"unprognostic (3.96e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.13e-2)"	"unprognostic (1.74e-1)"	"prognostic unfavorable (1.70e-5)"	"unprognostic (5.24e-3)"	"unprognostic (5.35e-1)"	"unprognostic (8.70e-2)"	"unprognostic (1.24e-1)"	53.7	37.7	56.1	32.4	92.9	73.6	27.1	38.0	127.3	27.3	0.0	27.6	25.7	31.0	26.1	30.0	23.3	28.0	20.6	99.0	24.2	21.4	58.2	27.7	40.2	23.5	18.4	24.9	20.7	17.0	18.3	36.6	24.9	26.3	27.8	189.9	24.9	30.1	88.8	33.6	23.9	35.3	14.4	34.2	24.8	20.6	30.0	42.6	23.8	31.0	40.5	32.9	28.6	64.5	61.5	51.7	69.7	48.4	47.4	54.3	70.5	86.3	75.9	98.8	86.8	75.9	55.4	85.7	28.7	61.4	69.5	41.8	74.4	64.8	120.0	59.4	52.9	284.0	38.3	71.1	93.1	111.9	92.2	55.1	57.6	76.9	78.0	55.9	67.2	72.2	67.8	96.8	73.2	53.8	96.1	99.4	81.9	52.0	44.4	69.1	90.6	139.9	61.7	66.1	91.4	64.2	50.4	72.3	65.9	45.0	33.9	51.8	69.5	84.6	76.5	64.2	75.1	53.8	62.6	124.7	61.3	115.2	54.0	1.5	0.5	1.3	0.2	0.3	0.5	0.2	0.3	0.1	0.5	0.3	0.3	0.5	2.7	0.3	0.6	0.7	0.3	0.4	56.1	92.9	38.0	127.3	99.0	24.2	23.5	18.4	24.9	14.4	30.0	64.5	37.0	9.6	12.7	81.6	40.4	74.8	11.6	7.0	72.8	22.2	21.0	13.1	17.9	10.0	7.7	16.5	52.1	11.7	34.0	20.5	11.7	7.1	20.0	19.9	23.0	34.0	15.1	52.8	151.2	8.7	17.2	24.2	18.8	29.1	19.7	11.2	15.4	19.2	24.7	11.8	93.1	15.6	4.1	40.0	105.1	7.7	9.9	54.7	35.6	105.9	21.2	27.8	18.6	72.9	77.5	12.9	10.6	8.6	39.2	17.3	12.6	20.1	5.8	92.7	13.1	14.4	29.8	2.9	6.1	64.0	70.5	12.0	39.9	14.2	13.2	21.3
PPP4C	"PP4, PPX"	ENSG00000149923	"Protein phosphatase 4 catalytic subunit"	P60510	16	30075978-30085376	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043837	Supported		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm	"Plasma membrane, Cytosol"	"HPA043837: AB_2678695"	"unprognostic (1.20e-1)"	"unprognostic (1.33e-2)"	"unprognostic (2.68e-1)"	"unprognostic (4.74e-2)"	"unprognostic (2.16e-1)"	"unprognostic (5.79e-3)"	"unprognostic (3.28e-3)"	"unprognostic (2.60e-3)"	"unprognostic (3.82e-1)"	"unprognostic (1.29e-1)"	"unprognostic (2.52e-1)"	"unprognostic (3.17e-2)"	"unprognostic (1.98e-2)"	"unprognostic (3.78e-2)"	"unprognostic (9.36e-2)"	"unprognostic (9.96e-2)"	"unprognostic (1.88e-1)"	44.3	57.9	34.8	43.2	34.7	63.2	42.5	35.9	38.7	42.8	41.0	49.8	47.0	39.6	47.1	88.3	35.9	32.5	45.6	34.0	35.7	49.9	83.2	46.2	58.6	35.5	34.9	29.4	41.0	46.4	33.5	49.6	35.3	37.8	35.2	18.1	44.0	28.5	60.8	60.8	49.0	32.8	35.6	62.5	49.2	65.4	38.4	61.2	35.4	30.2	63.7	56.3	48.9	36.4	132.7	145.9	95.5	134.0	88.4	73.8	148.5	115.8	127.7	148.7	163.8	129.5	167.9	102.7	145.2	137.0	95.5	105.9	119.3	143.2	87.0	130.1	213.0	70.5	86.0	290.4	133.5	100.1	126.8	107.9	124.7	135.9	85.5	88.4	174.9	130.5	139.6	91.0	115.1	382.2	174.4	180.7	182.2	104.7	77.1	190.9	99.4	180.4	142.5	134.5	91.9	136.8	57.1	169.1	101.8	79.4	156.0	166.0	113.3	86.4	90.4	70.6	90.8	155.4	183.8	122.4	123.1	126.9	107.0	100.6	103.5	236.1	66.5	113.2	47.7	68.5	69.6	74.2	115.8	88.3	62.0	54.1	215.2	51.7	100.1	90.6	95.1	48.3	34.8	34.7	35.9	38.7	34.0	35.7	35.5	34.9	35.3	35.6	38.4	36.4	87.8	51.3	33.4	10.7	85.8	147.2	121.7	206.9	71.2	23.3	94.2	82.8	11.1	82.9	133.5	77.3	29.2	313.7	106.0	217.0	158.5	226.9	156.9	80.5	55.5	91.7	125.6	89.2	8.0	193.3	335.3	66.7	106.0	85.2	69.2	66.7	74.6	94.2	239.3	35.3	8.6	159.3	193.3	105.4	138.4	143.8	62.7	124.4	80.0	9.4	221.1	61.1	118.4	8.0	12.9	345.5	220.8	52.3	97.6	161.3	191.0	198.6	119.7	29.5	72.3	43.4	85.9	228.5	157.8	113.2	172.5	421.0	93.0	61.7	175.9	227.2
PPP4R3A	"FLFL1, FLJ20707, KIAA2010, MSTP033, PP4R3, SMEK1, smk-1, smk1"	ENSG00000100796	"Protein phosphatase 4 regulatory subunit 3A"	Q6IN85	14	91457508-91510554	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002568, HPA063917"	Approved		Supported	"Nucleoplasm,Nuclear speckles,Cytosol"		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm	"Nuclear speckles, Cytosol"	"HPA002568: AB_1079207, HPA063917: AB_2685153"	"unprognostic (5.51e-2)"	"unprognostic (2.93e-2)"	"unprognostic (3.26e-1)"	"unprognostic (1.40e-1)"	"unprognostic (4.40e-2)"	"unprognostic (9.95e-3)"	"unprognostic (4.10e-2)"	"unprognostic (5.71e-3)"	"unprognostic (1.05e-1)"	"unprognostic (8.34e-3)"	"unprognostic (1.33e-1)"	"unprognostic (3.85e-2)"	"unprognostic (3.07e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.57e-1)"	"unprognostic (1.57e-1)"	"unprognostic (4.53e-2)"	19.3	13.5	14.4	18.2	14.5	50.0	19.6	16.6	15.2	19.1	16.2	21.2	17.2	20.0	15.9	21.4	20.4	12.3	16.2	12.6	13.3	18.3	23.7	20.2	28.3	13.6	14.2	22.0	19.8	16.8	14.8	17.5	13.7	18.4	18.5	10.9	20.8	13.1	24.5	25.4	24.4	15.0	12.7	24.1	20.6	22.3	14.5	27.4	17.7	16.7	25.4	19.5	19.4	16.9	24.5	41.4	34.1	27.1	22.5	20.9	60.9	23.2	21.4	24.5	24.6	35.2	32.1	63.1	30.2	19.2	15.0	27.8	36.6	28.9	39.8	52.0	19.7	32.5	25.7	24.5	26.3	59.1	33.1	15.1	50.4	19.7	31.1	20.1	26.7	29.4	33.5	36.2	33.1	52.1	42.8	38.0	31.2	46.5	29.8	54.0	40.6	26.5	30.3	41.5	41.6	25.4	35.3	77.0	32.5	33.6	39.4	37.8	28.0	19.2	20.6	21.1	26.8	36.0	67.0	69.3	25.2	31.8	34.7	6.2	1.9	2.9	4.9	2.6	6.6	4.6	4.5	4.4	2.1	7.4	5.6	4.8	2.5	9.0	3.7	5.0	6.9	2.6	14.4	14.5	16.6	15.2	12.6	13.3	13.6	14.2	13.7	12.7	14.5	16.9	44.1	32.1	48.3	0.0	83.0	0.0	46.7	0.0	58.1	27.9	35.9	23.5	0.0	32.9	30.3	46.0	20.9	33.9	91.8	21.1	29.4	21.2	13.0	86.9	46.5	33.3	13.3	47.5	0.0	25.1	29.0	27.3	45.3	70.7	20.2	39.8	28.9	51.8	25.8	32.0	0.0	28.2	0.0	48.7	0.0	8.5	37.6	70.7	0.0	0.0	41.8	21.0	44.3	0.0	0.0	27.8	25.7	42.5	75.8	56.6	37.3	23.5	16.8	27.3	26.3	45.9	27.1	91.0	59.9	58.0	0.0	44.3	80.1	33.0	25.8	75.2
PPP4R3B	"FLFL2, FLJ31474, KIAA1387, PSY2, SMEK2"	ENSG00000275052	"Protein phosphatase 4 regulatory subunit 3B"	Q5MIZ7	2	55547292-55618880	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001233, CAB017185"	Approved		Supported	"Nucleoplasm,Nuclear speckles,Centrosome"		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 59: Non-specific - Transcription"	"Nucleoplasm, Nuclear speckles"	Centrosome	"CAB017185: , HPA001233: AB_1080033"	"unprognostic (9.60e-2)"	"unprognostic (2.47e-2)"	"unprognostic (5.77e-2)"	"unprognostic (1.87e-2)"	"unprognostic (6.34e-2)"	"unprognostic (3.56e-1)"	"unprognostic (2.66e-2)"	"unprognostic (3.27e-2)"	"unprognostic (8.27e-3)"	"unprognostic (7.62e-2)"	"unprognostic (1.07e-2)"	"unprognostic (3.69e-1)"	"prognostic unfavorable (6.03e-4)"	"unprognostic (9.73e-2)"	"unprognostic (1.45e-1)"	"unprognostic (6.28e-2)"	"unprognostic (2.77e-1)"	29.0	27.4	14.8	28.2	15.1	25.8	29.1	20.9	16.9	26.8	20.0	28.1	31.6	23.7	19.3	31.7	32.3	24.7	14.3	13.8	16.9	33.4	48.0	23.4	38.1	15.0	16.3	25.7	32.1	27.4	12.5	24.5	16.2	24.9	27.7	35.3	28.1	23.2	14.7	29.6	32.1	21.8	15.9	28.7	30.8	23.7	15.1	42.2	33.0	20.3	38.7	26.7	16.9	18.7	42.8	33.0	35.6	30.0	37.2	38.9	49.1	34.0	35.9	28.2	24.0	39.5	40.9	57.7	67.5	32.7	44.8	36.4	39.9	27.5	41.4	84.6	16.7	56.7	30.0	52.9	60.3	66.0	45.6	29.8	64.9	34.1	60.1	36.9	45.0	31.6	55.2	57.4	37.7	50.9	42.8	43.7	35.1	55.9	25.3	40.1	53.6	44.6	39.3	43.8	43.4	26.9	36.8	49.9	54.8	23.5	31.6	52.0	36.3	43.3	56.8	21.6	47.2	59.1	47.3	22.3	40.8	61.3	47.2	25.6	16.5	26.9	20.4	20.9	23.2	18.1	21.2	21.6	18.4	18.6	24.5	21.5	19.6	22.5	23.0	9.9	24.0	23.9	14.8	15.1	20.9	16.9	13.8	16.9	15.0	16.3	16.2	15.9	15.1	18.7	46.8	44.8	41.3	0.0	61.8	0.0	48.9	0.0	44.3	44.1	42.7	27.9	0.0	31.5	29.1	16.5	33.3	30.6	51.4	25.3	39.2	32.4	9.5	85.1	43.2	32.9	18.2	46.7	0.0	41.0	28.5	33.9	43.8	39.6	30.3	39.0	26.0	52.5	26.2	53.8	0.0	29.4	0.0	37.7	0.0	7.6	28.0	44.9	0.0	0.0	47.9	53.1	49.4	0.0	0.0	35.4	24.1	36.1	57.2	57.4	46.1	52.9	62.7	38.5	6.6	54.9	28.4	39.1	25.7	53.3	0.0	47.7	56.3	44.6	29.0	57.2
PPP4R4	"CFAP14, KIAA1622, PP4R4"	ENSG00000119698	"Protein phosphatase 4 regulatory subunit 4"	Q6NUP7	14	94146128-94279734	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"testis: 7.9"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 44.4;Cone photoreceptor cells: 75.0;Excitatory neurons: 63.1;Inhibitory neurons: 63.0;Spermatocytes: 33.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"hTERT-HME1: 6.7;RH-30: 19.4;T-47d: 23.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041866, HPA050321"	Approved		Supported	Cytosol		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 15: Liver - Metabolism"	"Cluster 6: T47d - Mammary gland"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Cytosol		"HPA041866: AB_10804120, HPA050321: AB_2681086"	"unprognostic (2.65e-3)"	"unprognostic (3.06e-1)"	"unprognostic (9.07e-2)"	"unprognostic (9.49e-3)"	"unprognostic (2.48e-2)"	"unprognostic (1.59e-1)"	"unprognostic (3.88e-2)"	"unprognostic (2.45e-1)"	"unprognostic (1.25e-1)"	"unprognostic (8.85e-2)"	"unprognostic (6.91e-3)"	"unprognostic (1.72e-2)"	"unprognostic (8.95e-2)"	"unprognostic (7.53e-2)"	"unprognostic (3.35e-2)"	"unprognostic (1.77e-1)"	"unprognostic (6.24e-2)"	0.2	0.4	2.7	0.3	3.0	0.1	0.5	2.2	4.0	4.3	1.0	0.1	0.0	0.8	0.0	0.3	1.6	0.3	0.2	3.3	3.6	0.3	3.0	1.5	0.2	2.8	2.7	5.1	0.4	0.9	2.6	0.5	2.4	0.4	0.1	5.4	0.3	0.6	0.1	0.6	0.1	0.3	1.8	0.0	0.7	7.9	3.4	0.1	0.2	0.0	0.6	0.2	1.2	4.2	0.8	0.1	3.5	0.9	0.8	0.0	0.9	0.4	3.1	1.0	0.9	0.2	0.9	0.0	0.0	0.0	2.5	0.1	4.5	4.7	0.6	0.3	0.7	0.0	0.0	1.9	0.3	0.0	0.6	0.0	0.9	0.1	6.7	0.0	0.0	2.1	0.0	0.3	0.6	1.0	0.0	0.1	1.8	0.0	0.1	0.2	19.4	0.1	0.2	0.9	0.4	0.1	0.1	0.1	0.1	1.3	23.6	0.0	0.0	3.0	2.9	0.2	0.3	0.9	0.1	0.6	1.8	1.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.7	3.0	2.2	4.0	3.3	3.6	2.8	2.7	2.4	1.8	3.4	4.2	0.1	3.2	9.5	44.4	0.1	4.8	4.9	4.9	5.7	1.4	3.6	0.8	0.4	0.0	2.9	0.0	75.0	0.0	0.0	0.0	0.0	2.4	17.9	3.5	0.2	0.6	0.0	0.0	63.1	0.4	0.2	0.5	2.0	3.1	0.0	19.5	6.4	1.0	0.1	1.7	63.0	0.0	2.0	1.3	0.7	18.0	5.9	0.2	0.0	1.9	0.0	6.0	0.0	17.6	3.7	0.2	0.0	5.7	0.1	17.8	0.0	0.2	14.5	0.8	0.0	0.6	1.6	33.7	9.2	1.6	2.6	0.0	0.4	1.2	0.0	7.2
PPP5C	"PP5, PPP5"	ENSG00000011485	"Protein phosphatase 5 catalytic subunit"	P53041	19	46347087-46392981	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"DNA damage, DNA repair"	"Hydrolase, Protein phosphatase"	"Alzheimer disease, Amyloidosis, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022641, HPA029065, HPA056933"	Approved		Supported	Vesicles,Cytosol		NA	NA		120000	"Cluster 27: Non-specific - Gene expression"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 24: NB-4 - Immune response"	"Cluster 59: Non-specific - Transcription"	"Vesicles, Cytosol"		"CAB022641: , HPA029065: AB_10610284, HPA056933: AB_2683278"	"unprognostic (8.25e-2)"	"unprognostic (7.90e-2)"	"unprognostic (1.44e-1)"	"unprognostic (6.30e-2)"	"unprognostic (5.92e-2)"	"unprognostic (2.62e-2)"	"prognostic unfavorable (3.45e-6)"	"unprognostic (1.29e-1)"	"unprognostic (1.04e-2)"	"unprognostic (8.25e-2)"	"unprognostic (5.56e-2)"	"unprognostic (2.20e-2)"	"unprognostic (3.24e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.35e-1)"	"unprognostic (5.92e-3)"	"unprognostic (1.37e-1)"	27.4	37.5	27.7	17.7	29.3	14.2	26.3	28.4	36.5	28.0	27.7	31.3	16.8	34.9	9.8	30.4	31.7	13.3	56.4	29.8	28.6	29.1	32.7	28.0	19.7	32.3	28.2	24.7	23.7	32.5	36.6	15.8	33.3	23.7	15.4	14.4	23.0	18.2	58.9	27.5	25.9	20.8	26.2	33.5	33.6	16.9	30.3	20.5	26.2	45.7	15.0	27.7	26.3	28.5	61.9	114.9	66.0	50.1	48.3	50.9	30.6	75.4	59.6	88.2	78.2	82.4	47.9	94.3	39.9	54.0	48.4	49.9	86.2	88.5	24.7	65.9	120.5	76.4	80.9	59.4	54.5	106.6	52.8	47.8	40.9	62.1	45.9	34.2	77.2	79.3	76.0	47.3	49.4	67.5	59.5	203.4	50.2	109.6	61.7	89.0	56.6	76.5	52.8	81.8	93.1	69.7	62.6	78.8	26.9	28.6	49.7	67.8	65.5	38.3	64.3	29.1	79.1	38.0	93.0	111.5	41.7	89.4	65.9	0.0	10.3	3.0	27.8	18.0	17.8	15.1	12.8	22.0	16.8	11.7	12.2	16.8	0.2	22.0	23.4	11.7	14.3	15.4	27.7	29.3	28.4	36.5	29.8	28.6	32.3	28.2	33.3	26.2	30.3	28.5	28.1	6.4	12.5	22.9	16.5	9.4	16.6	20.9	19.9	19.7	13.1	13.5	5.6	44.3	14.2	16.5	16.7	26.4	12.3	25.2	33.2	29.9	1.2	31.3	25.2	19.6	14.9	11.6	18.5	19.5	36.2	17.6	26.0	19.6	4.5	18.6	24.3	24.9	21.6	16.8	23.2	17.0	22.4	12.3	8.2	3.2	17.4	11.9	16.0	11.2	12.1	21.0	17.5	17.6	14.5	26.4	17.0	18.4	25.5	12.1	16.3	21.4	14.6	17.9	39.5	14.6	19.9	26.6	32.0	20.8	13.2	25.7	20.4	23.1	25.0	11.7
PPP6R2	"dJ579N16.1, KIAA0685, SAP190, SAPS2"	ENSG00000100239	"Protein phosphatase 6 regulatory subunit 2"	O75170	22	50343304-50445090	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030656, CAB034919"	Uncertain		Supported	Vesicles,Cytosol		NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Basic cellular processes"	"Vesicles, Cytosol"		"CAB034919: AB_2183817, HPA030656: AB_10602926"	"unprognostic (1.24e-1)"	"unprognostic (1.82e-3)"	"unprognostic (1.03e-1)"	"prognostic favorable (1.70e-5)"	"unprognostic (2.17e-1)"	"unprognostic (3.79e-3)"	"unprognostic (2.32e-1)"	"unprognostic (1.30e-2)"	"unprognostic (2.82e-1)"	"unprognostic (1.82e-2)"	"prognostic favorable (7.51e-4)"	"unprognostic (6.89e-2)"	"unprognostic (1.42e-2)"	"unprognostic (1.20e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.02e-1)"	"unprognostic (7.77e-3)"	21.9	35.6	23.5	20.9	27.3	21.4	23.2	24.3	32.2	23.7	19.2	28.5	24.5	25.4	11.5	28.3	23.8	18.0	36.7	25.4	19.7	29.6	72.4	25.2	27.3	26.9	22.2	24.8	29.0	21.4	41.0	14.8	21.8	31.4	11.8	12.6	27.9	17.1	65.8	27.6	28.7	14.0	18.2	32.4	30.1	62.7	26.0	25.8	30.8	31.7	16.5	23.9	22.3	25.8	30.9	17.8	27.3	34.8	19.7	21.0	24.4	30.1	31.9	31.5	31.7	15.0	18.7	36.9	14.5	30.0	17.4	24.6	16.9	22.4	11.8	19.3	30.9	19.8	37.7	37.7	25.6	46.9	52.1	31.2	23.8	19.0	10.1	24.8	27.8	30.8	20.5	31.5	23.2	50.0	32.3	33.9	11.3	19.5	21.9	44.8	20.9	24.3	23.1	36.1	17.0	23.1	31.0	47.6	25.0	10.1	17.2	35.2	32.5	29.3	26.4	24.6	20.3	33.6	8.7	32.7	30.6	22.6	41.2	4.0	8.6	5.8	9.0	9.4	10.4	7.9	6.2	9.6	8.8	8.4	5.9	7.9	13.7	5.9	6.8	11.0	13.3	8.5	23.5	27.3	24.3	32.2	25.4	19.7	26.9	22.2	21.8	18.2	26.0	25.8	28.5	22.4	20.6	79.0	32.0	8.8	14.4	12.9	22.8	43.7	25.5	21.8	19.2	37.1	17.1	27.6	56.3	17.3	39.9	39.8	31.3	19.3	84.0	30.8	39.0	18.1	26.9	19.8	83.0	32.5	11.8	15.3	35.2	34.8	31.8	23.9	18.9	65.1	16.0	65.6	80.8	23.0	16.2	25.3	8.8	48.6	19.6	23.4	10.6	61.8	32.1	25.0	50.4	52.8	59.9	33.3	29.0	19.9	42.0	19.4	27.0	23.6	17.9	43.2	26.3	16.9	18.7	78.5	47.1	17.9	8.5	28.5	28.4	17.8	25.2	17.5
PPT1	"CLN1, INCL, PPT"	ENSG00000131238	"Palmitoyl-protein thioesterase 1"	P50897	1	40072710-40097260	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Sensory transduction, Vision"	Hydrolase	"Disease variant, Neurodegeneration, Neuronal ceroid lipofuscinosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Hofbauer cells: 251.9;Kupffer cells: 315.8;Langerhans cells: 328.8;Macrophages: 271.3;monocytes: 227.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"classical monocyte: 1254.3;eosinophil: 624.2;intermediate monocyte: 1006.3;myeloid DC: 1091.1;neutrophil: 683.9;non-classical monocyte: 815.7"	"Group enriched"	"Detected in all"	4	"dendritic cells: 1091.1;granulocytes: 683.9;monocytes: 1254.3"	"Cell line enhanced"	"Detected in all"		"SK-BR-3: 1082.7;THP-1: 1449.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021546	Supported		Supported	"Golgi apparatus,Vesicles"	"Intracellular and membrane"	NA	NA		240000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 4: Macrophages - Innate immune response"	"Golgi apparatus, Vesicles"		"HPA021546: AB_1855667"	"unprognostic (5.02e-2)"	"unprognostic (2.73e-1)"	"unprognostic (1.64e-1)"	"unprognostic (2.06e-3)"	"unprognostic (6.68e-2)"	"unprognostic (2.83e-2)"	"prognostic unfavorable (6.98e-8)"	"unprognostic (1.39e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.23e-1)"	"unprognostic (8.16e-2)"	"unprognostic (2.39e-1)"	"unprognostic (5.20e-3)"	"unprognostic (1.75e-1)"	"unprognostic (2.30e-1)"	"unprognostic (2.93e-2)"	"unprognostic (2.08e-2)"	69.8	59.4	92.9	92.7	95.6	117.5	95.7	100.4	135.9	70.1	106.1	50.5	32.1	72.7	60.1	45.1	55.4	57.1	45.3	93.6	101.2	75.8	54.1	128.5	93.9	97.0	96.7	68.6	42.6	79.2	39.0	74.8	99.6	73.4	58.8	89.4	56.8	63.2	21.3	40.3	39.2	95.3	101.6	177.0	45.1	37.6	99.1	78.0	60.0	37.1	75.1	79.1	34.7	113.5	115.6	62.5	93.7	81.0	106.5	92.1	209.8	68.4	127.9	153.0	183.3	350.1	270.5	140.1	118.1	65.2	112.2	209.5	154.9	112.7	163.6	186.4	151.4	100.3	127.2	155.5	137.5	233.7	158.9	103.1	107.5	108.7	126.4	79.7	190.9	108.8	167.7	247.0	80.6	168.1	109.8	88.3	258.3	163.9	93.8	116.0	263.7	226.1	89.2	152.0	114.1	96.9	247.9	1082.7	298.6	111.7	199.3	1449.6	85.2	100.7	147.1	70.7	174.9	161.2	383.8	133.9	109.4	408.7	155.5	85.7	1254.3	624.2	122.2	1006.3	137.9	118.8	171.5	131.3	1091.1	118.6	227.0	168.3	683.9	100.3	815.7	101.8	204.1	1586.9	92.9	95.6	100.4	135.9	93.6	101.2	97.0	96.7	99.6	101.6	99.1	113.5	45.2	28.9	47.7	19.9	33.3	39.6	77.1	30.8	34.7	46.6	55.3	37.5	15.7	41.5	40.0	38.6	16.7	51.7	28.9	4.7	5.9	59.0	64.8	13.8	46.4	49.6	19.9	40.1	28.4	42.1	66.5	56.6	14.8	18.2	84.9	34.6	47.5	9.3	251.9	25.2	39.2	8.1	20.3	315.8	328.8	87.6	31.4	271.3	67.6	31.9	227.2	120.3	28.8	27.6	22.7	22.2	6.0	39.5	34.2	42.4	3.2	18.5	32.3	37.0	19.7	30.5	49.3	17.5	33.0	19.1	27.3	41.2	43.5	39.4	11.4	35.6
PPT2		ENSG00000221988	"Palmitoyl-protein thioesterase 2"	Q9UMR5	6	32153441-32163678	"Metabolic proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Granulosa cells: 33.6;Smooth muscle cells: 27.8;Syncytiotrophoblasts: 23.3"	"Cancer enhanced"	"Detected in all"		"melanoma: 21.5"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"naive CD8 T-cell: 1.0"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"ASC diff: 21.3;HEK 293: 27.9;SK-MEL-30: 29.4"									HPA000414			Supported	Vesicles	"Intracellular and membrane"	NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 10: Non-specific - Unknown function"	Vesicles		"HPA000414: "	"unprognostic (1.90e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.95e-1)"	"prognostic unfavorable (5.03e-5)"	"unprognostic (1.62e-1)"	"unprognostic (6.75e-3)"	"unprognostic (2.92e-3)"	"unprognostic (6.41e-3)"	"unprognostic (7.12e-2)"	"unprognostic (2.56e-3)"	"unprognostic (5.28e-3)"	"unprognostic (1.12e-2)"	"unprognostic (2.75e-3)"	"unprognostic (5.09e-2)"	"unprognostic (2.94e-1)"	"unprognostic (4.89e-2)"	"unprognostic (1.24e-3)"	19.0	18.0	1.1	2.1	1.1	0.1	18.7	1.1	4.8	26.5	1.0	23.7	1.6	22.0	2.6	28.2	21.7	0.0	24.5	1.1	1.1	22.1	13.9	14.3	1.7	1.1	1.2	46.2	14.3	0.0	13.7	3.9	1.1	17.2	1.5	6.2	14.9	0.0	19.0	29.4	14.9	1.3	1.1	13.3	21.0	8.3	1.1	1.9	14.6	0.2	1.0	18.1	24.2	1.3	0.0	0.0	0.0	0.4	21.3	7.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	16.2	1.6	0.7	5.3	2.6	5.0	0.0	0.0	27.9	4.0	0.0	0.0	0.0	3.5	1.8	4.0	1.6	0.0	7.3	3.8	0.0	14.9	0.0	1.8	1.7	13.0	4.6	0.0	0.0	0.9	0.0	6.3	5.8	0.0	14.3	0.0	1.6	5.4	8.7	5.2	29.4	15.2	0.0	3.7	0.8	0.0	11.4	0.0	0.0	0.8	12.6	3.0	5.8	2.2	3.5	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.2	0.0	0.0	0.0	0.1	1.0	0.0	0.1	0.0	0.7	0.0	0.1	1.1	1.1	1.1	4.8	1.1	1.1	1.1	1.2	1.1	1.1	1.1	1.3	9.4	0.0	0.5	0.0	0.7	3.3	2.9	2.6	5.7	12.4	4.2	2.9	6.8	2.8	2.8	3.7	16.7	14.5	4.4	2.4	1.9	1.8	0.3	4.5	4.3	7.6	4.9	17.4	0.0	3.0	9.2	6.3	1.5	5.0	0.0	33.6	6.4	4.4	3.0	3.3	0.0	2.6	2.0	1.3	1.3	1.1	4.1	1.1	7.2	0.0	0.2	9.5	3.1	0.0	0.0	1.8	3.8	3.0	1.7	1.4	1.4	3.1	0.6	6.1	0.0	3.6	27.8	4.0	6.7	4.4	2.3	23.3	1.4	5.0	3.0	1.5
PPWD1	KIAA0073	ENSG00000113593	"Peptidylprolyl isomerase domain and WD repeat containing 1"	Q96BP3	5	65563236-65587549	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Isomerase, Rotamase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019353, HPA019360"	Enhanced		Supported	"Nuclear bodies"		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 34: Spermatids - Unknown function"	"Nuclear bodies"		"HPA019353: AB_1855668, HPA019360: AB_1855669"	"unprognostic (3.31e-2)"	"unprognostic (2.07e-2)"	"unprognostic (6.78e-2)"	"unprognostic (2.85e-1)"	"unprognostic (9.61e-2)"	"unprognostic (1.22e-2)"	"prognostic unfavorable (2.19e-4)"	"unprognostic (1.37e-1)"	"unprognostic (4.97e-2)"	"unprognostic (1.09e-1)"	"unprognostic (7.84e-3)"	"unprognostic (5.72e-2)"	"prognostic unfavorable (6.72e-4)"	"unprognostic (2.40e-1)"	"unprognostic (1.18e-1)"	"unprognostic (2.15e-1)"	"unprognostic (1.30e-2)"	15.0	12.1	12.3	18.2	14.6	27.6	17.2	16.5	16.4	17.3	13.4	14.7	13.4	19.0	17.8	13.5	16.1	15.7	13.5	12.4	13.2	13.0	15.5	14.9	30.0	13.6	12.8	22.9	14.0	15.5	14.7	19.6	13.4	15.0	19.2	14.7	12.7	13.7	13.2	22.2	17.1	13.2	12.9	22.6	14.4	18.1	13.0	32.9	16.3	15.6	26.0	13.7	15.2	18.5	36.5	23.6	35.1	35.2	30.6	36.9	38.8	34.5	25.3	36.5	45.5	37.8	35.4	41.5	28.5	24.3	49.1	32.3	38.4	35.5	49.8	35.7	32.3	26.0	40.0	31.1	25.9	23.9	26.4	29.2	15.3	35.5	25.5	27.0	32.3	31.6	35.3	28.8	28.8	35.8	40.0	31.6	24.7	15.2	13.3	35.4	46.7	35.1	21.2	29.5	18.1	14.8	34.8	14.5	33.1	26.8	21.5	30.8	24.9	20.2	29.2	22.4	52.9	17.1	26.3	45.5	22.3	35.8	21.4	35.0	15.1	31.6	26.1	19.3	32.0	25.8	29.1	29.9	21.2	19.1	36.1	31.0	14.3	26.5	24.0	11.8	38.1	23.4	12.3	14.6	16.5	16.4	12.4	13.2	13.6	12.8	13.4	12.9	13.0	18.5	25.1	28.9	22.4	28.1	36.0	12.4	14.9	15.4	18.2	14.2	9.1	12.8	19.8	7.2	22.1	11.0	8.4	27.7	27.0	6.9	9.8	8.7	76.8	16.4	28.7	20.7	9.6	21.5	37.2	7.7	14.4	21.1	15.8	13.8	11.4	32.6	18.9	6.0	11.8	6.7	46.8	14.9	8.2	16.4	11.9	41.7	20.2	15.2	14.2	23.4	22.6	11.8	23.7	42.3	67.1	8.9	14.7	18.8	29.4	6.6	10.0	7.9	17.8	20.9	6.6	19.9	17.8	32.5	33.7	13.2	11.8	25.2	35.4	15.8	11.4	9.0
PRAC1	"C17orf92, PRAC"	ENSG00000159182	"PRAC1 small nuclear protein"	Q96KF2	17	48721719-48722518	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Group enriched"	"Detected in some"	12	"intestine: 206.4;prostate: 109.0"	"Group enriched"	"Detected in some"	5	"Distal enterocytes: 326.1;Enteroendocrine cells: 908.1;Intestinal goblet cells: 717.3;Paneth cells: 328.7;Undifferentiated cells: 624.3"	"Cancer enriched"	"Detected in many"	5	"prostate cancer: 291.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	32	"PC-3: 379.0"									HPA047871	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA				"Cluster 37: Intestine - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm	Cytosol	"HPA047871: AB_2680195"			"unprognostic (7.59e-2)"									"unprognostic (2.43e-2)"			"unprognostic (2.04e-1)"			0.0	0.1	0.2	0.0	0.2	0.0	0.4	0.2	0.3	4.4	0.1	106.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.2	0.1	0.2	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.2	109.0	206.4	0.0	0.0	0.6	0.1	0.1	0.0	0.0	0.0	0.0	1.0	0.1	0.2	0.0	0.0	0.0	0.0	12.4	12.8	0.4	0.0	0.0	0.0	0.4	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.4	0.0	0.0	0.4	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	379.0	11.8	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.5	0.8	0.0	0.1	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.3	0.2	0.1	0.4	0.1	0.2	0.0	0.2	0.4	0.0	0.0	0.0	0.0	1.0	0.0	110.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	326.1	0.0	0.0	0.7	0.0	0.0	0.4	908.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	717.3	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	328.7	0.0	0.0	101.9	0.2	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.1	0.9	0.0	624.3	63.1
PRAG1	"DKFZp761P0423, NACK, PEAK2, PRAGMIN, SgK223"	ENSG00000275342	"PEAK1 related, kinase-activating pseudokinase 1"	Q86YV5	8	8317736-8386439	"Enzymes, Metabolic proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 35.0;thyroid gland: 23.2"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 45.9;Breast glandular cells: 14.1;Breast myoepithelial cells: 11.0;Hofbauer cells: 18.3"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in many"		"cerebellum: 35.0"	"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"A549: 50.2;NTERA-2: 32.1;SuSa: 32.1"	"Low region specificity"	"Detected in all"							"HPA011776, HPA012066"	Uncertain		Uncertain	"Nucleoli,Focal adhesion sites"		NA	NA			"Cluster 29: Plasmacytoid DCs - Unknown function"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 7: Non-specific - Mitochondria"	Nucleoli	"Focal adhesion sites"	"HPA011776: , HPA012066: AB_1847706"	"unprognostic (7.04e-3)"	"unprognostic (7.90e-2)"	"unprognostic (2.32e-1)"	"unprognostic (2.95e-2)"	"unprognostic (1.60e-1)"	"unprognostic (2.92e-1)"	"unprognostic (1.05e-1)"	"unprognostic (4.78e-3)"	"unprognostic (2.64e-3)"	"unprognostic (5.19e-2)"	"unprognostic (4.95e-2)"	"unprognostic (1.78e-1)"	"prognostic favorable (4.81e-4)"	"unprognostic (5.27e-2)"	"unprognostic (1.23e-1)"	"unprognostic (5.04e-2)"	"unprognostic (5.22e-3)"	8.7	1.0	9.2	5.2	12.0	0.6	9.4	35.0	5.8	2.8	0.0	5.3	11.3	1.7	0.2	5.5	5.6	2.3	6.1	5.3	1.4	3.7	2.7	5.2	8.1	1.2	3.0	3.8	3.3	2.2	1.5	5.7	1.8	2.5	4.1	0.2	5.0	1.5	7.4	7.5	11.6	1.4	0.1	8.4	4.8	2.2	4.6	3.0	23.2	3.4	6.1	2.3	2.8	1.8	6.2	50.2	5.6	0.7	0.0	0.3	14.1	12.8	2.7	4.9	2.0	25.0	14.4	10.2	8.6	6.1	13.5	21.9	1.0	15.3	1.0	0.5	1.6	0.0	6.2	14.2	5.3	1.5	15.4	1.2	9.8	0.8	2.2	2.9	10.2	1.5	0.0	0.1	3.8	8.5	1.4	4.8	32.1	19.5	12.9	6.6	6.0	2.5	7.2	17.5	2.8	1.9	4.9	13.9	5.0	32.1	10.8	6.3	13.7	0.5	12.9	0.0	3.2	0.8	1.1	13.9	3.1	3.4	7.4	0.0	0.2	0.9	0.4	0.0	0.3	1.2	0.6	0.2	0.3	0.9	1.6	1.3	0.0	0.5	0.8	1.9	0.0	0.2	9.2	12.0	35.0	5.8	5.3	1.4	1.2	3.0	1.8	0.1	4.6	1.8	45.9	9.6	6.5	0.0	1.9	0.0	0.0	0.0	0.0	0.0	14.1	11.0	0.0	0.0	0.0	0.0	0.0	7.5	5.3	0.0	0.0	9.0	0.0	3.0	1.4	5.6	0.0	0.0	0.0	3.1	7.2	2.5	0.0	1.7	2.5	1.7	0.0	0.0	18.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	1.0	0.0	0.0	0.0	0.0	6.9	0.0	0.0	0.9	0.0	0.0	2.7	1.5	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.8	2.3	7.4	0.0	0.0
PRAME	"CT130, MAPE"	ENSG00000185686	"PRAME nuclear receptor transcriptional regulator"	P78395	22	22547701-22559361	"Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Differentiation, Growth regulation, Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	10	"testis: 105.1"	"Cell type enriched"	"Detected in some"	4	"Spermatogonia: 249.0"	"Cancer enhanced"	"Detected in many"		"melanoma: 139.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in many"	5	"K-562: 834.1"					"Not detected"	"Not detected"			"HPA045153, HPA068562"	Enhanced		Approved	"Nucleoplasm,Plasma membrane"		NA	NA				"Cluster 83: Testis - Spermatogenesis"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	Nucleoplasm	"Plasma membrane"	"HPA045153: AB_10797259, HPA068562: "	"unprognostic (9.36e-3)"	"unprognostic (9.74e-2)"	"unprognostic (1.02e-1)"	"unprognostic (3.87e-2)"	"unprognostic (5.20e-2)"	"prognostic unfavorable (3.41e-4)"	"unprognostic (3.43e-2)"	"unprognostic (4.00e-2)"	"unprognostic (1.33e-1)"	"unprognostic (6.52e-3)"	"unprognostic (9.68e-3)"	"unprognostic (2.06e-1)"	"prognostic unfavorable (7.48e-9)"	"unprognostic (1.95e-1)"	"unprognostic (2.21e-1)"	"unprognostic (8.87e-2)"	"unprognostic (1.26e-1)"	0.2	3.7	0.0	0.2	0.0	0.0	0.1	0.0	0.0	1.4	0.0	0.2	0.0	3.4	10.0	0.0	0.5	0.0	0.3	0.0	0.1	1.8	0.1	0.2	0.1	0.1	0.0	4.7	0.1	0.0	0.3	0.0	0.1	0.1	0.0	0.2	0.1	0.1	0.2	0.2	0.3	0.2	0.0	0.1	0.1	105.1	0.0	0.2	0.1	0.0	0.1	0.0	0.2	0.2	0.9	53.3	0.0	126.0	0.0	0.0	33.4	0.0	0.0	0.0	0.0	0.4	0.7	3.5	88.8	0.0	0.5	0.1	4.3	0.0	0.0	61.5	14.8	36.0	21.7	0.6	0.0	2.9	172.6	0.0	0.0	0.0	0.0	0.0	0.0	14.9	834.1	15.6	0.0	8.1	0.3	0.2	0.0	27.2	3.5	5.0	0.0	0.2	0.0	0.2	1.1	185.0	0.0	0.6	0.2	0.0	27.8	24.3	5.0	0.1	159.6	0.0	0.2	3.0	14.6	1.3	0.2	0.8	19.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	37.8	22.3	1.1	0.3	0.0	0.0	0.0	0.0	0.9	2.0	0.0	13.0	0.0	60.9	0.0	0.0	0.1	10.1	0.0	0.0	0.0	0.0	0.0	41.4	5.6	0.4	0.0	0.0	3.1	0.2	0.0	0.0	0.0	0.1	0.0	3.4	0.0	0.0	0.0	1.8	0.0	0.4	6.6	0.0	2.7	41.8	249.0	0.0	0.0	0.0	0.1	14.2	0.1	0.0
PRC1	ASE1	ENSG00000198901	"Protein regulator of cytokinesis 1"	O43663	15	90966040-90995629	"Predicted intracellular proteins"	"Cell cycle, Cell division"		Oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 89.9;testis: 55.0"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 142.9;Extravillous trophoblasts: 68.3;Spermatocytes: 136.4;Spermatogonia: 74.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	4	"basophil: 34.4"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 34.4"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA034521, HPA048816"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Microtubules,Cytokinetic bridge,Midbody"		Yes	Yes			"Cluster 38: Basophils - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Plasma membrane, Microtubules, Cytokinetic bridge, Midbody"	Nucleoplasm	"HPA034521: AB_10670169, HPA048816: "	"unprognostic (1.14e-1)"	"unprognostic (3.98e-2)"	"unprognostic (9.21e-2)"	"unprognostic (1.75e-3)"	"unprognostic (2.39e-1)"	"unprognostic (3.43e-2)"	"prognostic unfavorable (2.11e-4)"	"unprognostic (1.24e-3)"	"unprognostic (3.86e-3)"	"unprognostic (1.65e-2)"	"prognostic unfavorable (2.76e-5)"	"unprognostic (2.49e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (3.09e-2)"	"unprognostic (1.79e-1)"	"unprognostic (7.90e-2)"	"unprognostic (3.92e-2)"	7.4	6.2	6.4	10.0	6.1	89.9	6.4	10.3	8.4	8.1	5.0	16.3	10.6	5.7	2.3	37.6	6.0	3.0	6.9	5.6	4.9	5.6	4.8	9.0	16.9	4.8	5.2	8.1	8.9	2.6	3.6	15.3	5.2	4.9	16.5	4.9	9.5	1.5	4.1	20.1	13.0	9.4	4.9	12.5	11.7	55.0	4.2	43.0	4.3	2.3	24.9	4.8	13.7	5.6	167.9	199.9	164.8	113.6	16.8	28.7	87.5	237.8	139.3	257.2	195.3	134.6	158.5	65.5	91.4	151.9	156.9	220.9	188.8	101.2	240.6	118.7	206.4	135.6	263.5	123.5	4.1	71.4	109.0	7.7	12.8	145.8	146.9	56.6	146.4	100.5	114.0	132.4	241.1	144.4	66.9	98.5	66.6	216.4	84.9	69.7	205.1	86.3	115.3	123.6	151.2	118.9	225.4	121.9	82.7	112.3	149.1	127.1	91.2	168.2	146.0	140.5	345.1	43.5	127.7	80.0	74.5	162.0	265.3	34.4	0.6	2.9	0.6	0.1	0.4	1.1	1.3	1.3	2.4	0.5	1.2	0.4	0.4	3.0	0.3	2.6	8.0	1.0	6.4	6.1	10.3	8.4	5.6	4.9	4.8	5.2	5.2	4.9	4.2	5.6	2.5	0.0	3.1	1.3	6.8	16.6	6.6	8.0	2.2	6.4	3.4	4.3	3.2	0.0	7.6	3.7	0.0	45.5	2.8	16.5	0.0	3.2	41.5	4.5	4.0	4.7	5.4	142.9	5.0	2.9	68.3	7.2	16.3	6.8	8.9	13.2	9.3	2.1	21.5	3.3	5.2	17.0	10.2	8.7	15.0	15.4	3.7	5.2	3.6	1.9	5.5	3.8	4.1	2.0	1.7	2.3	3.2	1.9	17.5	5.9	2.0	0.1	3.2	4.6	6.6	7.4	10.9	136.4	74.2	38.0	14.2	14.6	6.8	0.4	24.1	6.7
PRCP	"HUMPCP, PCP"	ENSG00000137509	Prolylcarboxypeptidase	P42785	11	82822936-82970584	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Carboxypeptidase, Hydrolase, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Hepatic stellate cells: 348.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"ASC diff: 463.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017065, HPA071115"	Approved		Supported	Vesicles	"Intracellular and membrane"	NA	NA		42000000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 68: Epididymis - Unknown function"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Vesicles		"HPA017065: AB_1855676, HPA071115: "	"unprognostic (3.24e-1)"	"unprognostic (2.25e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.54e-1)"	"unprognostic (1.33e-2)"	"unprognostic (9.22e-2)"	"unprognostic (1.42e-1)"	"unprognostic (7.97e-2)"	"unprognostic (2.61e-1)"	"unprognostic (2.70e-1)"	"unprognostic (1.88e-2)"	"prognostic favorable (2.65e-6)"	"unprognostic (7.16e-2)"	"unprognostic (1.73e-2)"	"unprognostic (3.49e-1)"	"unprognostic (4.07e-1)"	74.8	87.3	81.1	57.8	82.1	37.7	70.0	84.3	109.1	91.9	95.0	49.3	28.6	62.9	81.4	62.1	57.0	64.3	70.0	76.6	85.6	144.7	151.9	58.1	92.1	84.4	82.1	53.5	37.9	78.4	34.5	152.8	80.9	52.5	46.6	21.9	85.6	55.5	15.9	54.1	31.8	80.8	89.0	54.0	32.0	41.8	86.0	33.7	63.7	28.5	85.0	100.2	57.5	86.7	34.9	41.8	49.6	121.0	463.5	146.7	67.1	67.5	131.9	70.9	97.0	103.5	70.7	55.9	100.7	117.9	72.6	53.2	53.7	45.2	72.0	43.9	38.3	37.7	56.5	76.7	86.2	31.0	124.7	122.0	39.3	72.7	68.6	166.5	224.0	26.3	39.1	69.8	72.7	19.5	4.9	171.7	33.9	90.3	31.1	27.1	97.0	65.1	118.0	71.2	24.0	51.9	101.9	60.2	41.5	80.6	66.6	49.6	65.0	78.8	77.4	71.1	33.5	64.2	113.6	46.3	32.9	41.7	44.5	53.5	76.9	50.9	13.7	79.0	16.1	31.7	14.0	15.9	140.2	34.2	12.0	17.4	89.0	34.7	64.8	27.9	14.8	49.6	81.1	82.1	84.3	109.1	76.6	85.6	84.4	82.1	80.9	89.0	86.0	86.7	86.9	19.2	12.9	58.8	45.5	31.4	41.5	53.4	25.0	11.7	26.2	25.1	26.6	37.1	25.2	62.5	2.1	65.1	29.0	9.8	29.4	32.9	44.9	17.4	37.7	180.4	19.7	13.7	42.2	12.0	120.1	73.6	23.9	29.9	12.7	18.2	348.7	65.4	80.7	16.8	38.5	19.1	14.2	152.9	118.9	47.6	44.1	88.0	71.2	33.7	79.5	53.5	28.8	34.7	10.5	8.2	10.2	46.3	62.2	23.3	3.9	83.8	9.1	5.3	65.7	25.5	25.6	60.8	6.3	54.3	34.9	52.9	22.3	27.7	20.9	39.2
PRDM10	"KIAA1231, MGC131802, PFM7"	ENSG00000170325	"PR/SET domain 10"	Q9NQV6	11	129899706-130002835	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 22.5;Excitatory neurons: 21.3;Inhibitory neurons: 21.2;Oligodendrocytes: 21.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HMC-1: 44.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026997, HPA061749"	Approved		Supported	"Nucleoplasm,Nucleoli fibrillar center,Vesicles"		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm	"Nucleoli fibrillar center, Vesicles"	"HPA026997: AB_1855681, HPA061749: "	"unprognostic (4.40e-2)"	"unprognostic (2.17e-1)"	"unprognostic (5.32e-3)"	"unprognostic (2.03e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.52e-3)"	"unprognostic (2.19e-2)"	"unprognostic (2.48e-1)"	"unprognostic (1.87e-3)"	"unprognostic (3.33e-2)"	"unprognostic (4.45e-2)"	"unprognostic (3.57e-2)"	"unprognostic (1.87e-1)"	"unprognostic (5.69e-2)"	"unprognostic (4.88e-1)"	"unprognostic (6.23e-2)"	"unprognostic (1.51e-1)"	2.8	2.4	2.5	3.1	2.5	7.9	4.2	7.4	3.3	3.2	2.8	3.4	3.4	3.0	3.3	4.0	2.6	2.8	2.0	2.9	3.4	2.2	3.5	3.0	3.9	1.8	1.8	3.4	3.1	3.4	4.6	2.6	1.9	3.4	3.9	4.7	3.1	2.5	6.7	6.2	3.7	2.5	0.9	3.1	4.0	2.4	3.3	6.7	3.0	3.8	4.0	2.6	3.4	4.0	4.7	6.1	7.7	5.1	3.4	4.1	5.1	3.9	5.0	3.2	4.1	6.2	4.8	17.8	4.5	4.6	4.4	6.1	6.4	3.2	5.2	6.6	5.5	12.3	7.5	5.0	2.2	10.9	44.8	2.9	7.1	4.8	3.1	4.9	5.7	5.0	7.0	6.6	4.7	5.2	6.7	5.7	5.9	6.3	4.4	6.5	4.8	2.9	4.7	8.0	8.3	4.3	5.7	6.4	1.7	4.3	4.5	4.8	5.7	7.2	3.4	3.8	5.1	1.7	3.0	25.1	3.2	6.1	5.9	2.4	2.2	6.0	2.6	2.5	2.6	6.8	2.1	2.2	2.1	3.6	3.1	1.4	6.3	4.4	2.7	2.1	2.9	1.4	2.5	2.5	7.4	3.3	2.9	3.4	1.8	1.8	1.9	0.9	3.3	4.0	2.7	3.2	2.7	22.5	3.2	6.1	2.6	1.8	6.8	3.7	3.5	2.2	2.7	1.5	2.0	0.0	0.0	1.5	2.5	6.3	0.0	1.2	3.0	2.9	2.7	1.8	1.8	8.6	21.3	1.1	1.2	2.7	4.6	3.2	1.3	2.7	1.1	2.3	1.6	1.7	21.2	3.1	2.0	3.1	2.9	4.1	2.5	2.8	0.0	13.1	2.1	1.0	1.0	13.6	21.6	0.9	3.2	1.9	2.4	4.6	3.1	1.0	2.3	2.7	0.0	3.9	3.4	0.8	0.8	7.2	5.1	0.5	3.5	1.7	2.7	5.8
PRDM15	"C21orf83, ZNF298"	ENSG00000141956	"PR/SET domain 15"	P57071	21	41798225-41879482	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding, Methyltransferase, Repressor, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 12.5;Plasma cells: 15.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in all"		"Daudi: 31.1;U-266/70: 32.2;U-698: 76.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024268, HPA029255, HPA029256"	Uncertain		Supported	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 55: Plasma cells - Humoral immune response"	"Nuclear bodies"	Nucleoplasm	"HPA024268: AB_1855688, HPA029255: AB_2672970, HPA029256: AB_2672971"	"unprognostic (8.73e-2)"	"unprognostic (1.32e-2)"	"unprognostic (2.43e-2)"	"unprognostic (6.93e-2)"	"unprognostic (2.44e-1)"	"unprognostic (1.85e-4)"	"unprognostic (4.22e-4)"	"unprognostic (6.50e-2)"	"unprognostic (4.88e-2)"	"unprognostic (1.91e-2)"	"unprognostic (5.52e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.30e-8)"	"unprognostic (1.34e-1)"	"unprognostic (2.70e-1)"	"unprognostic (9.72e-2)"	"unprognostic (4.86e-3)"	2.0	1.8	1.8	4.5	1.7	1.7	2.1	1.3	1.9	2.2	1.2	2.3	2.8	2.2	1.6	2.5	2.4	1.4	1.7	1.7	1.4	1.5	2.1	1.9	8.3	1.4	1.4	2.4	2.3	1.8	2.1	1.2	1.4	2.4	1.8	1.6	2.3	1.5	4.5	3.9	2.9	1.4	1.0	3.7	2.2	2.0	1.3	3.2	2.2	1.7	7.4	1.9	2.2	1.6	2.8	6.0	4.4	5.8	1.9	2.4	4.4	2.2	1.8	2.2	1.6	4.1	3.0	31.1	2.5	2.7	2.1	4.1	3.9	2.9	2.1	3.3	5.5	6.5	15.1	5.0	1.3	5.6	3.9	1.1	3.9	2.7	1.8	2.4	3.3	3.4	5.6	2.0	3.0	6.4	5.5	3.7	5.1	3.1	3.1	8.5	3.5	2.5	2.3	4.8	7.5	4.3	10.1	5.1	1.5	1.7	3.8	2.7	3.3	3.8	2.1	2.9	4.3	32.2	3.5	76.0	3.6	6.5	5.3	0.0	0.4	0.5	0.2	0.8	0.2	0.6	0.1	0.3	0.4	0.2	0.2	0.3	0.0	0.1	0.1	0.1	0.2	0.4	1.8	1.7	1.3	1.9	1.7	1.4	1.4	1.4	1.4	1.0	1.3	1.6	2.4	3.2	12.5	6.2	5.1	2.9	1.8	1.6	2.2	3.4	2.8	2.4	4.4	1.5	7.8	1.8	6.2	1.4	2.0	2.3	0.0	1.3	2.2	2.6	2.5	2.5	0.0	2.5	9.0	2.6	0.9	2.6	3.1	2.0	3.8	3.3	1.1	2.2	1.9	3.3	6.4	1.3	2.0	2.8	2.2	4.3	1.2	3.3	1.8	6.5	2.9	1.1	4.1	3.5	8.0	1.7	0.8	0.4	15.9	2.3	1.1	0.8	5.3	3.1	0.0	3.1	2.3	2.3	2.9	3.2	3.4	0.7	2.7	1.3	2.2	1.8
PRDM16	"KIAA1675, KMT8F, MEL1, MGC166915, PFM13"	ENSG00000142611	"PR/SET domain 16"	Q9HAZ2	1	3069168-3438621	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	"Activator, DNA-binding, Methyltransferase, Repressor, Transferase"	"Cancer-related genes, Cardiomyopathy, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"choroid plexus: 16.2"	"Cell type enriched"	"Detected in many"	4	"Astrocytes: 173.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in single"	16	"NK-cell: 2.4"	"Lineage enriched"	"Detected in single"	16	"NK-cells: 2.4"	"Cell line enhanced"	"Detected in some"		"HEK 293: 1.8;HHSteC: 2.0;hTERT-RPE1: 6.7;MCF7: 1.6;OE19: 3.5"	"Region enriched"	"Detected in many"	5	"basal ganglia: 15.7"	"Low region specificity"	"Detected in many"			"HPA050343, HPA060467"			Supported	Nucleoplasm		NA	NA			"Cluster 22: NK-cells - Unknown function"	"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 21: OE19 - Mitochondria"	"Cluster 64: Astrocytes - Nervous system maintenance"	Nucleoplasm		"HPA050343: AB_2681099, HPA060467: AB_2684287"	"unprognostic (2.44e-1)"	"unprognostic (1.44e-1)"	"unprognostic (5.31e-4)"	"unprognostic (1.27e-1)"	"unprognostic (1.14e-1)"	"unprognostic (3.95e-2)"	"unprognostic (9.15e-3)"	"unprognostic (5.68e-4)"	"unprognostic (2.58e-1)"	"unprognostic (2.07e-2)"	"unprognostic (5.21e-2)"	"unprognostic (1.71e-1)"	"unprognostic (7.80e-6)"	"unprognostic (2.14e-1)"	"unprognostic (1.73e-1)"	"prognostic unfavorable (4.70e-5)"	"unprognostic (4.06e-2)"	1.6	0.2	3.7	0.5	4.8	0.0	1.1	0.1	4.1	1.3	16.2	1.1	7.4	1.0	2.1	0.3	1.4	1.1	5.4	2.8	0.6	6.8	0.2	2.5	0.5	0.5	1.7	1.5	5.8	0.9	0.6	0.1	0.9	0.7	0.2	0.0	0.4	2.2	0.4	0.5	2.6	0.2	0.0	2.1	9.3	0.7	4.1	0.1	8.0	0.6	0.3	0.9	1.1	1.5	0.0	0.0	0.5	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.4	0.3	0.0	0.2	0.0	0.2	0.0	1.3	0.0	0.0	0.1	1.8	0.0	0.0	0.3	2.0	0.0	0.7	0.0	0.0	0.0	0.0	6.7	0.0	0.1	0.0	0.0	0.0	1.6	0.1	0.0	0.1	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.4	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	2.4	0.0	0.0	0.0	0.0	3.7	4.8	0.1	4.1	2.8	0.6	0.5	1.7	0.9	0.0	4.1	1.5	4.5	35.3	10.5	173.7	0.1	0.6	0.3	2.1	0.6	0.1	0.2	0.3	5.2	22.8	6.3	7.3	0.0	0.0	0.1	0.2	5.9	10.0	0.3	0.2	0.0	2.1	5.4	0.8	1.2	4.9	4.2	0.6	30.5	0.4	0.0	0.3	0.0	0.0	0.0	1.7	1.0	0.9	0.0	0.0	0.4	0.2	1.5	0.1	0.0	14.0	0.0	1.4	0.0	6.6	1.8	7.1	0.8	1.9	0.1	0.8	0.5	0.2	1.9	0.3	0.0	3.3	9.0	0.3	1.8	0.2	0.0	0.0	0.4	0.0	1.5	0.2
PRDM2	"HUMHOXY1, KMT8, KMT8A, MTB-ZF, RIZ, RIZ1, RIZ2"	ENSG00000116731	"PR/SET domain 2"	Q13029	1	13700198-13825079	"Enzymes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"B-cells: 182.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005809	Approved		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 57: B-cells - Immune response"	"Nucleoplasm, Golgi apparatus"		"HPA005809: AB_1079673"	"unprognostic (2.22e-1)"	"unprognostic (3.28e-1)"	"unprognostic (5.34e-2)"	"unprognostic (1.28e-2)"	"unprognostic (6.70e-2)"	"unprognostic (2.72e-3)"	"unprognostic (1.94e-2)"	"unprognostic (1.12e-2)"	"unprognostic (3.20e-2)"	"unprognostic (2.53e-2)"	"unprognostic (2.30e-1)"	"unprognostic (1.35e-1)"	"unprognostic (9.63e-3)"	"unprognostic (3.81e-1)"	"unprognostic (2.45e-1)"	"unprognostic (1.85e-1)"	"unprognostic (5.85e-3)"	21.7	15.2	19.4	19.3	21.2	79.4	21.9	27.5	38.7	27.8	7.6	27.1	13.0	24.2	16.4	21.9	20.9	17.0	19.9	21.5	18.2	14.2	13.1	21.4	27.3	18.5	16.6	34.3	14.9	14.7	16.3	16.7	18.7	24.3	13.8	18.1	21.2	17.6	43.8	27.2	23.6	15.0	12.9	20.2	19.2	18.7	16.9	22.6	24.3	30.0	25.0	27.0	26.8	34.7	15.3	8.5	30.3	11.8	23.5	18.0	14.6	19.5	11.8	13.0	14.5	13.5	16.9	46.4	16.7	18.9	11.0	18.5	22.8	11.4	14.4	28.9	16.3	31.2	10.6	6.4	12.9	10.5	25.8	19.1	19.7	13.8	11.4	12.4	13.0	18.0	28.2	52.0	16.5	7.7	16.9	16.6	9.0	12.1	11.4	23.3	16.4	13.9	7.4	17.0	26.3	17.0	15.7	9.8	21.4	18.0	13.9	16.8	23.2	16.7	18.1	15.3	10.9	75.8	55.4	65.5	14.8	24.1	21.9	4.7	4.9	7.5	5.5	3.2	3.5	18.5	4.4	5.2	3.0	13.4	4.9	4.4	9.9	6.2	6.0	5.6	4.4	2.8	19.4	21.2	27.5	38.7	21.5	18.2	18.5	16.6	18.7	12.9	16.9	34.7	41.3	38.5	39.7	34.3	182.9	62.1	54.8	17.1	61.5	49.5	43.8	33.8	41.3	27.1	33.0	23.9	45.9	25.6	77.7	26.9	17.6	17.3	21.7	84.5	62.5	35.1	37.8	21.7	114.5	13.8	16.2	47.6	25.5	121.2	40.5	50.0	26.0	18.8	16.6	70.7	97.0	24.1	14.2	45.6	39.9	15.6	44.1	42.1	30.2	75.9	41.5	21.2	59.8	70.4	122.5	15.5	25.7	45.1	71.7	54.5	34.2	9.0	43.8	39.7	26.3	86.3	34.4	52.7	49.4	65.4	52.1	18.3	74.4	25.8	19.6	64.5
PRDM4	PFM1	ENSG00000110851	"PR/SET domain 4"	Q9UKN5	12	107732871-107761272	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024322, HPA067437"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 57: B-cells - Immune response"	Nucleoplasm		"HPA024322: AB_1855691, HPA067437: AB_2685839"	"unprognostic (4.64e-2)"	"unprognostic (3.16e-3)"	"unprognostic (1.73e-3)"	"unprognostic (2.35e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.19e-1)"	"prognostic unfavorable (1.86e-4)"	"unprognostic (1.11e-3)"	"prognostic unfavorable (7.66e-4)"	"unprognostic (9.64e-2)"	"unprognostic (9.06e-3)"	"unprognostic (5.31e-2)"	"prognostic favorable (3.15e-7)"	"unprognostic (9.24e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.59e-1)"	"unprognostic (2.62e-3)"	12.8	8.6	12.8	11.9	13.3	16.9	11.7	14.5	13.5	12.0	13.1	15.0	13.2	15.2	13.4	15.6	11.8	11.2	8.9	12.3	12.8	21.0	7.0	12.9	12.4	13.2	12.8	15.0	10.2	44.5	8.1	12.5	13.5	11.5	16.4	20.9	11.5	12.1	12.5	12.3	13.8	13.9	11.1	12.3	12.7	11.6	14.7	11.4	12.6	12.8	14.0	11.5	13.2	14.3	19.2	20.9	22.4	23.4	23.7	24.3	17.1	25.6	33.2	25.4	19.2	14.7	8.1	24.6	10.6	27.2	23.7	13.4	23.5	18.7	27.4	18.1	24.1	19.5	15.5	15.8	30.5	28.1	19.3	29.8	35.3	28.7	49.1	27.6	33.5	22.7	24.0	29.0	30.6	20.1	15.9	24.9	11.7	12.4	28.2	12.8	22.4	24.2	26.2	29.0	27.6	25.8	19.3	13.5	23.5	15.2	16.5	14.1	34.1	19.4	14.0	26.1	21.7	20.3	21.5	17.2	14.2	13.1	14.7	1.1	0.8	1.4	1.9	3.0	1.3	2.6	1.0	1.7	2.3	2.1	1.6	2.0	0.3	1.2	4.2	1.2	2.2	0.8	12.8	13.3	14.5	13.5	12.3	12.8	13.2	12.8	13.5	11.1	14.7	14.3	10.6	9.6	6.4	4.9	38.3	14.5	9.0	4.2	8.0	13.6	7.6	6.7	7.3	4.3	6.3	12.9	14.6	6.3	9.8	13.3	9.8	14.8	23.4	12.3	19.8	11.2	12.6	6.9	12.0	11.4	7.5	9.7	10.2	21.8	3.8	11.0	11.0	4.6	11.4	33.7	12.2	10.3	2.0	10.3	7.2	28.4	6.2	9.0	8.8	15.0	12.1	7.5	12.3	9.5	12.9	16.6	8.1	4.9	8.2	12.4	14.6	9.7	7.2	11.7	6.6	12.4	10.6	6.3	12.5	12.5	16.9	4.8	11.1	6.4	12.0	10.2
PRDM5	PFM2	ENSG00000138738	"PR/SET domain 5"	Q9NQX1	4	120684919-120922870	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Chromatin regulator, DNA-binding, Methyltransferase, Repressor, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 51.2;Early spermatids: 75.6;Inhibitory neurons: 31.9;Late spermatids: 31.0;Oligodendrocyte precursor cells: 52.8"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	27	"eosinophil: 7.5;neutrophil: 5.4"	"Lineage enriched"	"Detected in single"	32	"granulocytes: 7.5"	"Cell line enhanced"	"Detected in many"		"U-266/84: 19.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051406	Enhanced		Supported	"Nucleoplasm,Nucleoli,Nuclear bodies"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	"Nucleoplasm, Nuclear bodies"	Nucleoli	"HPA051406: AB_2681472"	"unprognostic (7.74e-2)"	"unprognostic (8.45e-3)"	"unprognostic (3.15e-3)"	"unprognostic (1.09e-1)"	"unprognostic (7.20e-2)"	"unprognostic (9.30e-2)"	"unprognostic (3.28e-2)"	"unprognostic (4.52e-2)"	"unprognostic (5.09e-2)"	"unprognostic (8.71e-2)"	"unprognostic (6.29e-2)"	"unprognostic (4.13e-1)"	"unprognostic (3.00e-2)"	"unprognostic (4.91e-4)"	"unprognostic (2.34e-1)"	"unprognostic (1.29e-1)"	"unprognostic (5.56e-3)"	3.0	4.0	1.8	1.6	2.0	3.5	3.0	3.2	2.0	5.2	4.2	3.2	1.3	6.0	2.8	2.2	4.6	2.4	3.0	1.6	3.2	1.9	0.4	4.2	0.9	4.1	4.0	10.3	4.8	8.6	3.9	3.5	4.0	4.1	2.9	4.7	1.8	4.3	1.6	1.5	1.8	4.4	4.7	2.4	2.1	3.6	2.9	1.4	5.8	3.0	0.8	2.9	3.3	4.4	2.2	3.4	7.8	0.1	4.5	9.3	9.2	4.7	9.9	4.7	4.2	4.4	1.2	0.4	1.2	6.2	4.5	0.1	0.0	1.0	6.0	0.0	1.4	2.9	3.1	0.3	4.9	10.0	0.1	6.6	2.9	3.3	4.1	4.3	3.4	1.2	0.0	14.2	5.7	0.4	1.5	0.1	5.7	0.8	2.7	0.0	9.3	6.1	1.6	0.0	1.4	6.2	0.0	0.1	0.9	4.0	6.4	4.1	1.4	0.2	2.7	4.8	4.6	13.0	19.7	0.1	3.6	0.1	3.6	0.1	0.0	7.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	5.4	0.0	0.0	0.0	0.0	0.0	1.8	2.0	3.2	2.0	1.6	3.2	4.1	4.0	4.0	4.7	2.9	4.4	7.1	12.8	5.6	51.2	0.5	1.7	2.7	2.4	9.1	9.1	1.1	2.4	8.2	2.8	3.8	1.8	8.4	1.0	0.2	1.5	1.9	2.3	75.6	1.4	9.4	6.3	3.6	0.0	25.0	2.5	2.6	9.6	2.6	1.4	2.5	15.5	3.6	0.0	0.8	0.0	31.9	3.6	4.1	0.3	0.7	31.0	8.7	0.6	1.8	23.4	0.2	7.6	0.0	52.8	8.0	1.5	0.8	9.4	0.7	2.6	0.1	0.2	1.8	7.5	6.6	10.1	6.6	8.2	3.5	4.6	1.7	0.5	1.2	14.9	3.0	0.7
PRDM8	KMT8D	ENSG00000152784	"PR/SET domain 8"	Q9NQV8	4	80183879-80204329	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Neurogenesis, Transcription, Transcription regulation"	"DNA-binding, Methyltransferase, Transferase"	"Disease variant, Epilepsy, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"prostate: 26.1;seminal vesicle: 27.2"	"Cell type enriched"	"Detected in many"	9	"Bipolar cells: 271.5"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 4.6"	"Region enhanced"	"Detected in many"		"cerebral cortex: 17.0"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 27.3;LHCN-M2: 41.7;NB-4: 48.2;SCLC-21H: 99.3"	"Region enhanced"	"Detected in many"		"hippocampal formation: 28.7"	"Low region specificity"	"Detected in all"			HPA057253			Supported	"Nucleoplasm,Nuclear bodies"		No	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 56: Bipolar cells - Visual perception"	"Nuclear bodies"	Nucleoplasm	"HPA057253: AB_2683382"	"unprognostic (2.33e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.23e-1)"	"unprognostic (2.67e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.68e-1)"	"unprognostic (1.65e-1)"	"unprognostic (7.95e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.34e-1)"	"unprognostic (2.80e-2)"	"unprognostic (1.89e-11)"	"unprognostic (4.64e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.56e-1)"	4.8	2.3	5.1	5.0	10.2	4.0	4.0	0.0	17.0	11.7	0.0	11.4	1.1	9.3	1.9	1.7	5.2	1.7	1.7	13.7	0.0	1.3	0.3	1.6	5.1	0.0	0.0	5.2	0.9	0.0	5.4	4.3	0.0	26.1	1.5	24.1	1.4	27.2	2.2	2.7	5.7	3.8	0.6	1.8	5.0	1.1	0.1	0.7	1.2	0.9	2.4	10.2	9.8	3.2	2.3	0.2	0.7	0.0	2.1	7.2	0.1	5.8	20.5	2.8	3.2	0.0	2.2	0.0	0.0	7.2	1.8	0.7	0.1	2.4	12.1	8.8	1.8	0.8	0.0	0.0	4.1	9.1	2.5	4.4	0.2	11.1	3.2	27.3	0.4	2.4	0.0	3.7	41.7	0.0	4.2	48.2	0.0	0.2	17.0	1.6	0.0	0.2	1.2	0.3	99.3	13.8	0.3	0.0	0.1	0.1	0.0	4.5	8.8	7.1	1.0	5.2	0.4	1.7	0.0	0.0	17.8	4.2	1.0	0.0	0.0	0.0	0.4	0.0	0.6	0.1	0.5	0.5	0.1	0.7	0.3	0.1	0.5	0.2	0.0	0.1	0.2	0.1	5.1	10.2	0.0	17.0	13.7	0.0	0.0	0.0	0.0	0.6	0.1	3.2	0.9	0.0	0.5	2.3	8.2	0.6	3.4	0.4	0.0	271.5	0.1	0.4	1.8	0.0	5.2	1.8	2.1	0.0	2.5	0.0	0.0	0.0	1.5	0.3	6.5	2.2	0.0	2.5	29.9	0.2	0.2	8.8	0.0	0.5	0.0	0.1	0.0	0.0	0.5	3.3	2.0	0.2	2.0	1.2	6.2	6.7	3.1	5.9	1.8	3.7	0.9	6.1	2.1	7.1	17.0	0.7	0.0	3.4	2.7	3.7	0.0	0.2	5.0	11.6	0.0	4.2	2.9	0.3	0.4	0.0	0.1	0.1	5.0	0.1	0.0	0.6
PRDX3	"AOP-1, AOP1, MER5, SP-22"	ENSG00000165672	"Peroxiredoxin 3"	P30048	10	119167720-119178812	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Antioxidant, Oxidoreductase, Peroxidase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal tubular cells: 1060.4;Proximal tubular cells: 937.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB008656, HPA041488, CAB079909"	Enhanced		Supported	Mitochondria		NA	NA		1600000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"CAB008656: AB_1620979, CAB079909: AB_2809998, HPA041488: AB_2677508"	"unprognostic (8.29e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.26e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.72e-3)"	"unprognostic (4.62e-3)"	"unprognostic (2.40e-1)"	"unprognostic (2.06e-1)"	"unprognostic (3.65e-2)"	"unprognostic (1.29e-2)"	"unprognostic (9.48e-2)"	"unprognostic (6.03e-3)"	"unprognostic (2.77e-1)"	"unprognostic (2.77e-1)"	"unprognostic (2.27e-1)"	"unprognostic (1.21e-1)"	165.7	335.3	92.4	96.0	92.6	82.3	138.3	101.3	116.0	103.4	139.2	133.3	137.8	87.0	120.8	83.3	116.7	88.0	278.2	95.2	104.5	385.7	571.2	74.9	108.4	97.2	97.1	74.9	96.2	223.8	60.0	126.3	99.0	126.7	139.8	52.5	132.1	131.7	376.0	38.0	132.1	130.0	100.4	76.3	97.5	48.3	98.6	98.3	176.7	402.7	104.0	112.8	65.1	102.7	350.6	392.2	234.1	267.3	241.7	259.8	145.9	244.8	414.8	364.5	380.7	303.4	339.9	407.2	208.8	290.8	173.4	155.5	391.5	296.1	408.8	401.5	411.4	183.7	149.7	542.4	252.5	347.8	212.7	306.8	186.4	292.1	269.7	261.2	268.6	245.2	230.0	82.5	338.7	140.2	265.1	292.7	218.9	264.0	229.3	276.5	339.7	281.5	623.8	164.6	103.0	149.2	259.8	346.1	332.2	201.0	179.6	411.5	190.5	118.3	178.1	170.9	323.1	128.0	200.7	327.0	185.7	507.4	107.3	144.4	429.1	246.9	110.5	369.5	142.7	179.9	145.6	134.6	382.1	149.8	149.5	134.0	239.9	132.8	333.9	214.8	205.7	510.2	92.4	92.6	101.3	116.0	95.2	104.5	97.2	97.1	99.0	100.4	98.6	102.7	61.4	48.1	74.5	14.4	65.1	69.8	117.8	274.0	81.4	27.5	145.2	105.2	236.5	131.5	119.0	147.1	10.4	328.4	50.6	84.5	1060.4	124.5	5.0	105.1	76.0	78.3	110.9	132.8	15.4	75.1	212.0	100.8	116.7	77.3	52.6	131.0	73.2	390.0	247.6	40.4	15.4	132.5	221.8	164.2	96.0	10.5	77.3	127.9	133.4	10.3	158.4	76.9	39.1	12.5	18.8	63.8	99.3	101.2	153.7	95.1	176.1	937.8	163.4	24.8	72.3	63.1	105.3	11.2	23.2	146.4	52.6	155.0	56.1	440.0	207.0	119.6
PRDX4	AOE37-2	ENSG00000123131	"Peroxiredoxin 4"	Q13162	X	23664262-23686397	"Cancer-related genes, Enzymes, Predicted intracellular proteins"		"Antioxidant, Oxidoreductase, Peroxidase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"pancreas: 1212.0"	"Cell type enhanced"	"Detected in all"		"Late spermatids: 1007.4;Plasma cells: 810.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB008659, CAB027389, CAB047362, HPA067039"	Enhanced		Supported	"Endoplasmic reticulum,Cytosol"	"Intracellular and membrane"	NA	NA		4400000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 25: Pancreas - Digestion"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 55: Plasma cells - Humoral immune response"	"Endoplasmic reticulum"	Cytosol	"CAB008659: AB_1620984, CAB027389: , CAB047362: , HPA067039: "	"unprognostic (3.82e-2)"	"unprognostic (6.05e-2)"	"unprognostic (1.09e-1)"	"unprognostic (6.06e-3)"	"unprognostic (1.64e-1)"	"unprognostic (1.65e-2)"	"unprognostic (1.29e-3)"	"unprognostic (1.08e-1)"	"unprognostic (8.32e-2)"	"unprognostic (3.75e-2)"	"unprognostic (2.97e-1)"	"unprognostic (1.79e-1)"	"prognostic unfavorable (1.33e-6)"	"unprognostic (7.44e-2)"	"unprognostic (1.29e-1)"	"unprognostic (3.56e-1)"	"unprognostic (4.10e-2)"	85.7	84.6	25.2	53.9	27.4	34.3	74.9	28.7	36.6	82.3	40.2	72.7	64.0	68.1	19.5	62.5	66.1	64.7	108.6	24.7	28.7	41.8	277.2	47.1	58.7	30.6	26.8	81.2	1212.0	69.2	93.8	96.2	29.6	59.9	78.8	30.2	124.9	63.2	43.7	47.8	51.3	62.9	29.7	71.9	93.5	121.4	27.5	26.5	49.5	25.4	67.1	68.9	55.7	36.8	176.4	238.2	94.5	191.1	523.9	266.6	138.0	229.6	249.2	204.9	297.5	251.4	214.3	150.0	106.1	299.0	233.6	206.5	279.8	142.6	193.8	92.5	551.5	105.8	187.8	322.1	215.9	138.4	96.9	283.6	182.6	197.7	193.5	213.8	262.0	48.4	209.7	535.4	192.8	262.3	70.3	214.5	339.8	329.5	344.9	97.2	244.3	861.2	181.0	60.5	143.8	121.7	212.6	248.6	174.9	504.1	263.1	174.4	172.7	145.1	95.1	378.4	176.1	173.8	228.6	161.5	259.9	177.0	211.9	5.9	65.6	6.9	53.8	107.8	67.4	89.9	68.1	57.1	101.6	56.0	48.4	49.7	4.8	83.8	137.8	71.3	74.6	69.8	25.2	27.4	28.7	36.6	24.7	28.7	30.6	26.8	29.6	29.7	27.5	36.8	143.8	57.7	68.2	5.5	132.8	59.8	88.6	277.2	62.0	16.7	98.8	119.0	50.7	107.2	124.0	49.7	8.4	328.7	17.9	34.0	9.8	270.4	402.0	66.5	117.4	96.2	58.7	60.6	2.4	358.8	531.6	162.1	65.2	117.6	43.1	206.7	92.1	539.5	173.4	11.8	3.3	151.6	187.2	54.2	55.1	1007.4	252.5	47.1	199.3	1.9	75.2	55.0	27.8	8.5	7.3	241.4	44.1	144.0	810.1	174.6	61.2	54.2	89.9	21.7	144.7	79.2	185.3	258.2	251.7	83.3	52.1	258.6	42.0	311.8	115.7	73.1
PRDX5	"ACR1, AOEB166, B166, MGC117264, MGC142283, MGC142285, PLP, PMP20, PRDX6, PRXV, SBBI10"	ENSG00000126432	"Peroxiredoxin 5"	P30044	11	64318121-64321811	"Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Antioxidant, Oxidoreductase, Peroxidase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Respiratory ciliated cells: 2430.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB008661, HPA037915, HPA037916"	Enhanced		Supported	Mitochondria		NA	NA		6900000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Mitochondria		"CAB008661: AB_1620988, HPA037915: AB_2675735, HPA037916: AB_2675736"	"unprognostic (2.75e-1)"	"unprognostic (4.08e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.46e-1)"	"unprognostic (9.43e-2)"	"unprognostic (6.71e-3)"	"unprognostic (1.08e-3)"	"unprognostic (3.11e-1)"	"unprognostic (9.30e-2)"	"unprognostic (1.07e-3)"	"unprognostic (1.57e-2)"	"unprognostic (2.20e-1)"	"prognostic favorable (1.24e-5)"	"unprognostic (8.19e-2)"	"unprognostic (2.30e-1)"	"unprognostic (9.63e-2)"	"unprognostic (5.03e-2)"	181.8	400.3	346.0	112.7	342.6	285.7	170.1	375.9	429.4	227.2	480.2	346.6	213.3	153.7	176.6	448.5	400.3	120.7	467.4	340.4	384.6	377.1	280.3	217.2	110.1	382.8	373.3	246.0	224.9	254.5	313.3	164.1	387.0	165.5	299.6	109.0	286.2	164.4	504.0	181.1	226.1	97.1	365.2	162.9	313.9	150.1	377.8	167.7	354.5	439.6	137.8	192.5	244.8	346.4	225.3	453.4	267.9	444.5	284.3	424.4	308.5	274.9	442.3	199.8	247.4	332.9	451.8	329.2	467.0	447.4	712.6	503.5	253.3	589.4	125.8	456.6	200.8	333.3	728.8	386.3	581.0	127.8	271.3	432.4	757.2	334.9	337.8	387.6	308.4	380.6	191.5	755.6	285.5	572.0	220.9	547.8	402.6	356.5	573.9	210.9	274.5	1178.8	760.1	442.9	224.7	424.9	230.8	506.8	818.8	254.3	370.5	283.3	298.3	281.8	258.6	326.7	123.1	383.1	490.8	392.4	340.7	253.7	223.6	703.9	465.4	630.7	251.0	432.9	218.3	393.5	229.0	205.1	369.8	409.0	224.5	225.9	802.3	368.5	399.0	487.9	297.1	639.6	346.0	342.6	375.9	429.4	340.4	384.6	382.8	373.3	387.0	365.2	377.8	346.4	213.7	266.0	463.4	17.6	182.1	326.5	760.2	1591.9	405.2	159.0	266.2	435.9	617.6	371.8	931.2	450.6	70.9	1122.2	185.8	846.1	1612.1	788.4	79.6	865.2	221.3	204.7	801.9	200.6	12.4	1039.2	1144.0	296.1	365.4	285.9	104.7	299.8	205.6	405.2	476.9	92.5	14.0	1041.6	1072.1	206.5	261.0	294.9	279.0	210.8	435.8	8.4	339.7	309.6	278.1	14.1	15.3	1487.3	641.3	226.8	288.9	401.3	922.4	1468.5	2430.7	150.3	197.2	176.2	433.1	150.2	333.9	482.8	257.7	978.9	165.2	713.3	1231.7	1077.1
PRDX6	"1-Cys, aiPLA2, AOP2, KIAA0106, MGC46173, NSGPx, p29, PRX"	ENSG00000117592	"Peroxiredoxin 6"	P30041	1	173477330-173488815	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Lipid degradation, Lipid metabolism"	"Antioxidant, Hydrolase, Multifunctional enzyme, Oxidoreductase, Peroxidase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal enterocytes: 1315.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006983, CAB008663"	Supported		Supported	"Plasma membrane,Cytosol"		NA	NA		120000000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Plasma membrane, Cytosol"		"CAB008663: AB_1620994, HPA006983: AB_1079595"	"unprognostic (9.92e-2)"	"unprognostic (1.50e-1)"	"unprognostic (3.67e-1)"	"unprognostic (2.99e-3)"	"unprognostic (1.96e-1)"	"prognostic unfavorable (1.23e-5)"	"unprognostic (5.71e-3)"	"unprognostic (2.80e-2)"	"unprognostic (5.27e-3)"	"unprognostic (3.96e-3)"	"unprognostic (3.19e-3)"	"unprognostic (1.59e-1)"	"prognostic unfavorable (9.51e-4)"	"unprognostic (2.50e-1)"	"unprognostic (7.12e-2)"	"unprognostic (1.15e-1)"	"unprognostic (4.73e-3)"	340.7	157.5	169.5	68.3	181.3	100.1	211.2	197.6	210.1	112.3	164.8	189.1	46.4	108.8	206.3	127.9	149.8	71.9	261.8	184.1	196.6	184.4	482.5	116.7	72.2	181.0	198.3	115.5	114.4	217.5	67.4	70.7	187.5	152.1	221.6	53.9	85.6	99.0	563.5	106.6	59.8	160.2	175.8	70.7	135.2	119.1	176.7	70.7	106.0	382.4	79.0	99.5	109.8	185.5	420.3	127.7	204.7	230.9	778.5	372.7	169.5	843.9	284.3	342.7	241.8	243.9	276.4	272.4	256.4	694.2	120.4	239.8	272.0	259.9	279.0	234.0	243.6	179.5	200.0	277.7	425.7	191.3	56.1	301.0	262.6	181.3	256.6	210.8	339.5	106.7	405.4	52.8	392.9	86.3	131.7	249.1	456.2	219.8	760.5	154.5	236.6	277.0	518.1	95.4	94.9	173.4	285.0	334.0	199.2	296.3	283.8	262.9	228.2	132.5	149.9	201.8	229.5	76.4	123.2	220.7	159.4	162.3	124.3	36.2	42.5	24.8	29.8	39.8	32.8	32.6	29.8	38.4	53.5	24.4	39.8	47.9	25.2	25.7	36.5	79.7	36.1	58.1	169.5	181.3	197.6	210.1	184.1	196.6	181.0	198.3	187.5	175.8	176.7	185.5	278.1	176.3	170.8	127.3	127.4	235.4	404.1	382.8	209.5	31.9	186.1	250.7	528.6	301.7	228.6	277.7	29.2	714.3	158.6	1315.9	860.8	178.6	237.5	206.9	226.8	191.8	142.1	449.5	13.8	202.3	939.1	307.0	111.6	200.0	348.6	216.6	214.2	1120.2	345.0	45.4	13.2	257.4	205.4	164.3	161.0	667.5	340.5	227.1	183.2	17.8	212.9	462.5	83.4	12.5	15.4	147.2	663.4	416.8	176.4	427.1	264.4	827.3	209.1	52.0	184.1	185.7	253.8	123.5	76.8	305.9	264.1	963.5	157.7	512.5	303.6	308.9
PRELID1	"CGI-106, PRELI, PX19"	ENSG00000169230	"PRELI domain containing 1"	Q9Y255	5	177303799-177306949	"Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Lipid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005701	Approved		Supported	Nucleoplasm,Mitochondria		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	Mitochondria	Nucleoplasm	"HPA005701: AB_1079721"	"unprognostic (1.27e-1)"	"unprognostic (8.99e-2)"	"unprognostic (3.18e-2)"	"unprognostic (2.09e-3)"	"unprognostic (2.19e-1)"	"unprognostic (8.07e-2)"	"prognostic unfavorable (5.46e-5)"	"unprognostic (7.63e-3)"	"unprognostic (1.49e-1)"	"unprognostic (8.90e-3)"	"unprognostic (1.71e-1)"	"unprognostic (6.97e-2)"	"prognostic unfavorable (2.89e-7)"	"unprognostic (3.59e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.89e-1)"	"unprognostic (2.21e-1)"	89.1	106.5	63.6	89.2	63.5	90.7	78.9	64.0	70.5	69.9	64.6	121.8	109.3	69.3	37.5	146.9	61.4	37.1	70.6	63.8	65.2	140.1	182.3	76.0	79.0	64.3	65.8	64.0	262.3	48.1	67.4	58.6	66.2	74.9	85.8	24.4	95.7	29.8	32.2	108.3	121.8	47.2	66.6	117.4	103.2	43.0	69.0	30.9	65.9	13.7	87.4	81.5	78.7	62.8	221.4	193.8	116.1	307.1	103.3	111.0	400.6	154.5	106.6	214.6	206.1	443.2	232.5	181.4	181.6	143.7	236.0	118.1	212.5	400.0	145.8	826.0	291.9	154.9	195.7	291.1	109.6	243.6	215.1	102.7	142.2	170.6	144.9	89.1	269.0	129.2	181.4	247.7	210.5	556.7	160.5	362.5	242.1	251.6	319.7	52.7	232.1	324.5	140.0	171.5	186.3	237.7	136.8	266.9	267.5	144.4	172.5	293.4	148.5	189.3	174.9	157.4	365.5	155.4	270.9	267.4	162.2	328.0	200.4	411.1	764.6	1198.6	248.0	988.0	238.5	276.0	202.6	245.4	775.1	238.7	175.7	195.7	553.7	327.4	989.8	281.9	246.6	614.3	63.6	63.5	64.0	70.5	63.8	65.2	64.3	65.8	66.2	66.6	69.0	62.8	174.4	22.4	23.4	8.1	198.3	348.3	297.0	331.8	152.5	60.8	339.3	415.4	0.4	168.7	159.0	104.8	22.9	756.9	231.4	572.7	303.3	382.9	6.6	114.1	111.2	171.5	157.5	128.9	9.7	563.3	552.7	134.0	110.6	129.9	108.1	145.9	120.3	247.5	352.2	60.6	10.0	311.3	219.7	271.0	337.1	24.6	114.0	293.8	256.1	7.5	410.1	117.1	325.4	4.0	12.2	752.9	664.0	109.1	393.9	612.4	853.7	567.0	60.5	68.9	46.0	126.6	177.3	81.5	218.6	246.7	420.8	883.6	169.7	221.0	433.6	480.2
PREP		ENSG00000085377	"Prolyl endopeptidase"	P48147	6	105273218-105454062	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 84.8"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 79.7;Syncytiotrophoblasts: 67.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB025414, HPA031388, HPA031389, HPA031390"	Supported		Supported	Cytosol		NA	NA		1700000	"Cluster 27: Non-specific - Gene expression"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Cytosol		"CAB025414: , HPA031388: AB_2673855, HPA031389: AB_2673856, HPA031390: AB_2673857"	"unprognostic (3.05e-2)"	"unprognostic (9.09e-3)"	"unprognostic (2.85e-2)"	"unprognostic (5.46e-2)"	"unprognostic (3.36e-1)"	"prognostic unfavorable (3.33e-4)"	"unprognostic (2.63e-3)"	"unprognostic (2.39e-1)"	"unprognostic (6.78e-2)"	"unprognostic (5.81e-2)"	"unprognostic (2.66e-2)"	"unprognostic (1.15e-1)"	"unprognostic (4.47e-3)"	"unprognostic (2.74e-2)"	"unprognostic (8.98e-2)"	"unprognostic (6.59e-2)"	"unprognostic (2.33e-1)"	17.3	17.4	7.2	14.6	8.1	14.3	17.7	7.4	12.0	15.2	7.8	32.1	23.6	15.8	12.1	21.1	13.0	8.7	22.5	8.8	7.3	11.3	19.0	16.2	13.6	6.7	7.7	16.0	19.2	20.5	13.0	17.8	6.8	11.6	37.5	15.4	18.6	9.0	84.8	33.4	25.6	15.3	6.6	14.3	18.7	21.4	8.8	16.4	12.3	46.9	16.2	21.4	17.5	8.5	22.3	26.9	27.9	32.1	63.1	37.1	27.7	28.6	27.0	37.2	39.0	35.9	14.2	28.5	26.8	33.9	35.0	33.3	41.8	86.5	42.7	41.8	37.4	38.1	21.7	40.0	25.3	40.5	26.2	35.8	53.4	27.6	71.7	28.0	35.4	50.1	67.4	49.8	45.5	38.8	25.8	41.4	27.9	44.2	25.0	41.1	48.4	18.3	28.2	53.8	36.0	51.8	25.3	42.0	21.7	35.3	17.9	61.9	36.1	17.3	23.9	21.6	36.2	14.2	9.7	38.5	30.4	42.6	56.6	5.5	15.2	8.4	16.3	16.8	16.8	9.3	14.2	17.1	16.5	6.9	12.9	15.5	0.8	19.9	22.7	7.0	13.6	13.5	7.2	8.1	7.4	12.0	8.8	7.3	6.7	7.7	6.8	6.6	8.8	8.5	6.3	3.2	6.7	22.9	10.1	10.8	6.8	12.0	5.7	5.1	6.0	5.5	14.8	7.2	13.6	7.3	14.6	28.2	14.5	19.3	5.9	10.4	1.4	6.6	15.1	10.1	19.3	11.2	79.7	11.7	35.9	10.6	24.5	11.6	13.4	11.2	7.5	15.1	15.0	13.5	48.3	29.4	10.2	14.2	10.8	3.2	10.8	13.3	5.4	27.2	19.1	3.3	5.2	28.6	18.7	18.0	29.1	9.1	11.0	5.3	18.5	8.8	4.8	10.4	0.0	8.3	10.3	3.9	18.8	12.9	8.5	67.9	16.1	14.4	38.2	8.5
PREX1	"KIAA1415, P-REX1"	ENSG00000124126	"Phosphatidylinositol-3,4,5-trisphosphate dependent Rac exchange factor 1"	Q8TCU6	20	48624252-48827999	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 52.5;brain: 78.1"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 87.1;dendritic cells: 84.0;Kupffer cells: 104.7;Macrophages: 76.5;Microglial cells: 95.5;NK-cells: 90.6;Oligodendrocytes: 190.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"MCF7: 157.9;SK-BR-3: 162.2;T-47d: 145.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001927	Supported		Supported	Vesicles,Cytosol		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 41: Macrophages - Immune response"	"Vesicles, Cytosol"		"HPA001927: AB_1079674"	"unprognostic (8.07e-2)"	"unprognostic (3.16e-2)"	"unprognostic (2.15e-2)"	"unprognostic (2.55e-1)"	"unprognostic (7.47e-2)"	"prognostic favorable (8.56e-4)"	"unprognostic (2.16e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.31e-1)"	"unprognostic (5.21e-2)"	"unprognostic (1.13e-2)"	"unprognostic (2.70e-2)"	"unprognostic (5.86e-3)"	"unprognostic (6.84e-2)"	"unprognostic (2.31e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.01e-2)"	14.8	10.6	32.8	37.4	56.4	52.5	15.0	43.2	47.2	12.3	1.2	7.0	6.3	4.0	1.4	6.4	4.7	13.0	6.7	32.1	42.0	4.8	5.2	26.8	36.6	52.1	52.0	2.5	5.3	6.9	7.6	11.7	53.8	4.8	6.0	3.9	5.3	3.4	6.6	3.5	12.7	7.7	43.5	42.9	8.8	6.0	45.3	9.8	9.4	8.6	21.8	12.3	3.2	78.1	2.3	6.1	78.4	0.0	1.3	5.7	27.2	2.7	3.5	11.2	2.8	0.4	0.3	16.4	49.5	7.2	21.4	1.0	4.1	0.2	7.5	3.7	2.0	2.4	8.8	0.0	4.6	9.0	51.1	6.3	0.0	25.7	0.0	7.6	68.4	7.2	0.2	0.6	14.8	157.9	0.2	24.7	3.1	8.1	6.4	24.1	22.8	9.8	0.5	0.0	16.5	2.4	14.7	162.2	17.8	4.4	145.0	67.4	77.2	4.5	15.6	0.2	4.6	0.9	3.5	20.1	72.4	17.8	24.3	4.5	1.9	2.2	3.7	2.2	2.2	1.5	2.0	3.2	1.6	1.4	0.3	1.1	9.2	1.8	2.0	1.3	7.3	2.0	32.8	56.4	43.2	47.2	32.1	42.0	52.1	52.0	53.8	43.5	45.3	78.1	43.2	3.2	6.6	87.1	35.4	2.5	0.3	0.4	1.2	0.3	40.0	21.5	3.7	2.8	2.6	1.8	8.4	0.7	84.0	0.9	0.0	0.2	3.5	3.5	4.7	24.5	1.2	14.1	13.3	1.2	4.4	10.3	4.1	6.2	1.3	0.7	20.7	1.9	32.1	0.0	4.6	1.8	0.0	104.7	28.2	2.9	0.9	76.5	8.8	95.5	47.1	19.4	90.6	49.3	190.2	0.1	1.0	0.4	23.3	0.7	0.3	0.2	4.5	0.7	0.0	18.1	3.3	2.2	11.6	0.4	2.4	9.3	63.9	41.2	4.5	0.7
PRIM2	PRIM2A	ENSG00000146143	"DNA primase subunit 2"	P49643	6	57314805-57646850	"Plasma proteins, Predicted intracellular proteins"	"DNA replication"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"prostate: 30.6"	"Cell type enhanced"	"Detected in many"		"Microglial cells: 70.3;Oligodendrocyte precursor cells: 56.8;Oligodendrocytes: 54.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046566			Supported	Nucleoplasm		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 34: Non-specific - Transcription"	"Cluster 18: U-2197 - ECM organization"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Nucleoplasm		"HPA046566: AB_2679701"	"unprognostic (1.24e-1)"	"unprognostic (1.55e-2)"	"unprognostic (2.66e-2)"	"prognostic unfavorable (6.98e-4)"	"unprognostic (3.08e-1)"	"unprognostic (6.24e-2)"	"prognostic unfavorable (3.44e-5)"	"unprognostic (2.31e-1)"	"unprognostic (1.00e-2)"	"prognostic favorable (3.00e-5)"	"prognostic unfavorable (5.25e-4)"	"unprognostic (3.89e-1)"	"prognostic unfavorable (7.34e-6)"	"unprognostic (2.04e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.08e-1)"	4.3	3.3	3.9	6.6	4.6	15.0	6.9	6.0	4.3	5.6	6.9	6.9	6.0	7.2	6.9	4.3	6.2	4.3	3.3	3.9	5.6	3.9	5.0	4.8	10.6	4.2	4.7	7.2	4.0	3.9	1.9	7.5	4.4	30.6	8.4	4.0	4.2	5.6	2.3	5.8	5.2	8.0	2.8	5.5	4.8	6.5	4.5	15.3	4.4	2.4	11.8	5.8	4.1	7.1	44.8	17.7	34.1	37.6	16.8	29.5	27.3	53.1	48.8	57.0	74.7	26.6	21.1	39.4	27.7	66.6	39.6	27.9	30.2	29.2	71.6	35.1	24.2	47.6	22.7	43.0	7.3	43.5	27.4	12.1	12.0	61.0	20.3	14.2	26.9	44.1	46.2	38.9	48.3	28.2	49.8	37.6	22.0	37.1	17.2	34.7	46.9	31.2	21.0	20.7	24.5	19.2	31.5	15.9	21.3	38.9	33.3	47.4	17.9	54.7	55.5	106.2	44.2	14.4	29.3	47.2	26.6	50.5	30.4	0.7	1.9	1.8	4.1	3.7	4.3	3.5	3.5	5.4	3.0	4.0	2.8	5.7	1.4	5.2	4.2	5.1	4.7	2.1	3.9	4.6	6.0	4.3	3.9	5.6	4.2	4.7	4.4	2.8	4.5	7.1	5.9	0.0	2.7	30.0	11.2	4.0	6.7	4.1	11.4	5.6	6.2	4.2	1.1	2.8	4.6	3.7	12.5	17.0	15.1	4.3	3.9	5.1	10.3	4.9	7.1	5.0	1.2	26.5	38.0	5.2	22.0	6.9	4.1	6.0	12.0	13.7	4.2	3.5	9.3	6.7	32.6	6.5	10.2	6.6	6.4	3.7	6.5	7.0	0.0	70.3	7.3	4.8	17.5	56.8	54.5	4.9	5.3	6.8	12.7	7.1	4.4	1.8	4.1	5.6	19.7	4.9	6.8	10.1	11.2	8.7	3.0	5.7	13.6	8.0	8.6	5.3
PRIMPOL	"CCDC111, FLJ33167"	ENSG00000164306	"Primase and DNA directed polymerase"	Q96LW4	4	184649667-184694963	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"DNA damage, DNA repair, Transcription"	"DNA-directed DNA polymerase, Nucleotidyltransferase, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Intestinal goblet cells: 58.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"eosinophil: 24.0"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 24.0"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054372	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 27: Mucus-secreting cells - Mucin production"	Cytosol	Nucleoplasm	"HPA054372: AB_2682466"	"unprognostic (1.68e-1)"	"unprognostic (1.27e-3)"	"unprognostic (1.67e-1)"	"unprognostic (1.18e-1)"	"unprognostic (2.67e-2)"	"unprognostic (4.75e-2)"	"unprognostic (2.02e-2)"	"unprognostic (3.34e-2)"	"unprognostic (3.32e-3)"	"unprognostic (5.86e-2)"	"unprognostic (2.52e-2)"	"unprognostic (5.02e-1)"	"unprognostic (3.04e-1)"	"unprognostic (3.04e-2)"	"unprognostic (3.81e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.05e-1)"	7.2	8.0	4.0	6.0	4.9	5.5	8.9	7.6	4.2	8.5	4.4	7.9	4.7	10.7	8.2	7.0	8.9	6.9	7.0	3.6	4.1	5.7	6.8	7.5	7.9	4.3	4.1	12.1	4.8	6.8	4.6	6.6	4.3	7.1	8.6	7.2	4.7	8.2	4.7	6.6	6.7	9.2	4.2	8.6	5.9	5.5	4.3	8.6	7.6	5.3	6.4	6.4	5.3	5.6	13.1	5.7	13.2	15.0	17.5	23.2	8.9	13.8	21.8	22.9	19.9	4.4	13.3	7.5	5.0	10.6	12.6	7.9	11.3	14.6	24.0	15.9	5.3	7.8	7.8	5.3	11.4	6.4	11.5	14.5	11.4	21.2	13.7	13.4	12.6	20.7	16.5	24.0	16.5	4.4	13.3	5.4	4.3	5.8	4.6	12.3	9.4	9.0	11.8	7.8	9.4	11.9	8.3	2.1	15.2	10.4	6.6	12.3	6.8	7.5	9.7	5.9	8.9	13.4	10.2	3.8	11.1	8.5	18.6	11.2	2.5	24.0	3.8	2.4	5.6	3.6	3.6	3.9	3.2	3.7	3.0	3.0	1.2	4.7	5.6	2.7	4.6	3.1	4.0	4.9	7.6	4.2	3.6	4.1	4.3	4.1	4.3	4.2	4.3	5.6	7.7	6.4	8.6	23.5	6.7	9.6	9.5	10.0	9.1	6.2	10.1	6.3	2.6	7.2	10.4	5.5	0.0	14.3	8.1	5.9	5.9	7.7	5.5	9.0	11.1	7.3	6.7	17.5	13.9	5.2	10.0	9.7	8.2	6.3	15.2	12.0	8.9	7.5	9.7	8.4	26.9	58.8	6.1	14.8	6.4	5.7	12.5	9.5	8.8	19.7	6.5	11.1	6.2	27.2	28.1	3.7	10.4	9.1	8.6	4.0	7.2	5.7	15.4	8.2	13.1	11.1	9.0	18.8	13.1	6.9	9.8	4.9	8.9	5.7	8.0	5.4
PRKAA1	AMPKa1	ENSG00000132356	"Protein kinase AMP-activated catalytic subunit alpha 1"	Q13131	5	40759379-40798374	"Enzymes, FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins"	"Autophagy, Biological rhythms, Cholesterol biosynthesis, Cholesterol metabolism, Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism, Transcription, Transcription regulation, Wnt signaling pathway"	"Chromatin regulator, Kinase, Serine/threonine-protein kinase, Transferase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"Early spermatids: 292.5;Late spermatids: 478.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005050, HPA035409, HPA064946"	Supported		Supported	"Nuclear speckles,Cytosol"		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 34: Non-specific - Transcription"	"Cluster 20: HeLa - Mitochondria"	"Cluster 31: Spermatids - Spermatogenesis"	"Nuclear speckles"	Cytosol	"CAB005050: AB_562037, HPA035409: AB_2674613, HPA064946: AB_2685390"	"unprognostic (2.07e-1)"	"unprognostic (1.41e-2)"	"unprognostic (2.51e-2)"	"unprognostic (3.57e-2)"	"unprognostic (3.97e-1)"	"unprognostic (1.05e-1)"	"unprognostic (3.51e-2)"	"unprognostic (7.53e-2)"	"unprognostic (1.66e-2)"	"unprognostic (2.88e-1)"	"unprognostic (3.34e-3)"	"unprognostic (2.63e-1)"	"unprognostic (2.82e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.27e-2)"	"unprognostic (1.10e-2)"	33.3	21.0	7.9	27.2	9.6	52.6	30.2	10.3	11.0	26.7	12.3	30.0	35.4	26.3	18.6	20.6	21.0	33.5	20.2	6.9	11.3	32.0	49.9	27.4	29.2	11.8	9.9	19.1	23.1	32.0	9.2	21.2	12.2	31.9	34.7	19.0	27.4	24.7	16.9	23.1	30.9	26.4	10.2	27.8	33.7	41.1	10.0	21.8	32.3	19.9	23.9	28.8	17.8	10.3	28.4	28.9	22.8	30.2	55.0	57.0	21.6	47.3	48.1	34.7	30.8	27.6	35.9	16.6	21.4	48.8	45.3	22.4	21.3	43.1	64.9	49.2	19.2	33.1	66.1	22.1	45.3	31.9	33.5	52.8	20.6	46.5	47.5	38.4	52.1	21.0	15.9	46.7	52.4	13.6	29.7	24.9	9.9	28.9	34.6	24.5	48.7	24.6	53.3	47.5	19.6	19.7	83.0	54.3	28.8	12.3	28.4	26.0	56.0	62.1	33.5	36.2	39.2	18.5	15.4	19.6	38.9	67.9	33.9	17.0	6.5	12.8	8.9	7.9	11.5	8.2	8.4	8.6	6.4	7.9	10.1	9.0	15.4	10.9	9.3	1.9	11.6	6.5	7.9	9.6	10.3	11.0	6.9	11.3	11.8	9.9	12.2	10.2	10.0	10.3	47.3	41.7	26.5	19.2	34.1	24.1	24.7	40.5	15.4	20.3	36.1	17.9	18.3	42.9	43.4	47.8	35.5	13.8	45.8	44.1	7.9	27.9	292.5	19.7	35.8	42.4	21.1	25.4	24.5	44.9	13.7	36.2	36.7	20.7	18.3	17.8	37.1	83.4	20.0	15.2	30.3	28.8	42.7	25.3	28.5	478.5	30.4	24.1	35.6	24.4	40.9	15.4	44.3	30.7	43.8	36.0	32.8	25.9	23.4	33.4	33.7	35.4	42.9	27.9	0.0	22.7	43.1	82.8	17.6	19.9	32.7	18.6	44.0	19.2	36.9	35.0
PRKAA2	"AMPK, AMPKa2, PRKAA"	ENSG00000162409	"Protein kinase AMP-activated catalytic subunit alpha 2"	P54646	1	56645314-56715335	"Enzymes, FDA approved drug targets, Metabolic proteins, Predicted membrane proteins, Transporters"	"Autophagy, Biological rhythms, Cholesterol biosynthesis, Cholesterol metabolism, Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism, Transcription, Transcription regulation, Wnt signaling pathway"	"Chromatin regulator, Kinase, Serine/threonine-protein kinase, Transferase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 40.8;skeletal muscle: 38.7;tongue: 36.4"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 328.5;Excitatory neurons: 109.4;Inhibitory neurons: 119.0;Oligodendrocyte precursor cells: 84.9;Rod photoreceptor cells: 115.5"	"Cancer enhanced"	"Detected in many"		"renal cancer: 5.8"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"RPTEC TERT1: 14.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044540	Approved		Supported	"Nuclear speckles,Golgi apparatus"		NA	NA				"Cluster 38: Heart - Muscle contraction"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 54: Cardiomyocytes - Muscle contraction"	"Nuclear speckles"	"Golgi apparatus"	"HPA044540: AB_2678977"	"unprognostic (4.17e-3)"	"unprognostic (1.62e-2)"	"unprognostic (4.17e-1)"	"prognostic unfavorable (4.80e-4)"	"unprognostic (9.35e-2)"	"unprognostic (1.92e-3)"	"prognostic unfavorable (5.30e-4)"	"unprognostic (7.30e-2)"	"unprognostic (3.94e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.97e-1)"	"unprognostic (8.64e-2)"	"prognostic favorable (4.95e-5)"	"unprognostic (1.30e-2)"	"unprognostic (4.52e-2)"	"unprognostic (1.57e-2)"	"unprognostic (1.85e-1)"	1.4	1.4	2.0	0.5	3.5	0.0	3.3	3.0	3.5	1.4	4.1	5.0	0.5	1.8	1.1	4.7	2.7	1.9	40.8	3.9	2.1	13.6	0.7	1.4	0.1	0.9	1.3	1.5	1.8	8.3	1.3	0.5	0.9	3.8	1.4	13.5	4.3	2.6	38.7	0.7	1.3	3.1	0.3	1.3	2.2	1.1	1.3	0.4	3.3	36.4	0.1	1.8	1.3	1.5	0.0	3.8	2.1	0.0	0.7	0.5	2.3	1.9	1.5	2.5	4.3	3.9	4.9	0.0	0.6	0.6	7.5	0.1	8.0	0.0	7.1	0.0	8.8	0.0	7.0	5.5	0.0	0.0	0.1	0.6	0.0	3.5	0.3	5.8	0.8	2.0	0.0	0.0	1.1	0.1	0.0	0.0	5.6	0.0	5.5	0.0	0.0	0.0	14.1	1.3	2.0	5.5	6.0	0.1	0.0	6.0	3.3	0.0	0.0	1.5	2.3	2.8	6.6	0.0	0.0	0.0	4.5	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	3.5	3.0	3.5	3.9	2.1	0.9	1.3	0.9	0.3	1.3	1.5	1.1	9.6	4.8	30.7	2.0	0.9	8.0	6.7	2.2	42.0	19.4	9.5	328.5	24.3	14.3	49.7	50.1	1.0	0.2	6.1	54.8	9.5	3.9	14.4	2.9	10.3	14.4	0.0	109.4	4.8	0.4	15.3	5.1	17.4	2.5	11.7	9.7	8.1	0.1	26.9	119.0	6.3	8.2	0.0	1.6	4.8	6.8	1.4	5.4	18.7	0.0	18.6	0.0	84.9	20.4	6.2	3.0	29.3	0.0	21.2	0.2	82.4	10.7	115.5	6.6	24.5	17.2	7.2	3.7	17.7	0.4	0.4	1.2	5.3	6.1	13.4
PRKCB	"PKCβ, PKCB, PRKCB1, PRKCB2"	ENSG00000166501	"Protein kinase C beta"	P05771	16	23835983-24220611	"Cancer-related genes, Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins, Transporters"	"Adaptive immunity, Apoptosis, Immunity, Transcription, Transcription regulation"	"Chromatin regulator, Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 84.0;lymphoid tissue: 47.2"	"Cell type enhanced"	"Detected in many"		"B-cells: 185.1;Bipolar cells: 208.6;Excitatory neurons: 877.7;Inhibitory neurons: 320.2;Kupffer cells: 221.9"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	95	"amygdala: 28.9;basal ganglia: 53.9;cerebral cortex: 84.0;hippocampal formation: 35.3;white matter: 36.6"	"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"HEL: 161.8;HMC-1: 154.8;K-562: 234.9;THP-1: 72.7;U-937: 64.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003843, HPA048321, HPA054203"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA		380000	"Cluster 6: Non-specific - Transcription"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Nucleoplasm	Cytosol	"CAB003843: AB_562197, HPA048321: AB_2680357, HPA054203: AB_2682416"	"unprognostic (1.53e-3)"	"unprognostic (4.53e-4)"	"unprognostic (2.52e-3)"	"unprognostic (3.07e-2)"	"unprognostic (1.72e-1)"	"unprognostic (7.13e-3)"	"unprognostic (2.06e-1)"	"unprognostic (1.67e-3)"	"unprognostic (3.19e-2)"	"unprognostic (1.79e-1)"	"unprognostic (7.38e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.17e-3)"	"unprognostic (2.08e-1)"	"unprognostic (2.12e-2)"	"unprognostic (3.28e-1)"	"unprognostic (4.95e-2)"	4.4	1.6	28.9	30.8	53.9	32.1	1.5	0.5	84.0	4.2	0.0	9.7	5.9	3.8	0.6	3.5	3.8	4.4	1.1	35.3	0.0	2.8	4.2	7.8	47.1	0.0	0.0	0.6	1.0	0.2	1.4	2.7	0.0	7.3	5.1	18.2	1.5	10.2	0.8	5.5	19.4	7.2	0.0	46.2	5.7	8.4	0.0	47.2	4.5	1.0	40.0	8.7	1.7	36.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	30.5	1.0	0.0	0.3	0.5	0.5	0.0	0.0	0.0	3.2	161.8	7.5	0.0	0.0	23.6	154.8	0.0	0.7	0.0	0.0	0.0	0.0	27.3	234.9	0.6	0.0	0.0	52.1	51.4	1.5	0.0	0.0	49.0	0.4	9.5	0.5	14.1	27.2	0.0	0.2	0.2	2.4	0.8	0.0	72.7	1.1	0.0	0.3	0.1	0.0	4.1	0.0	1.4	0.2	64.4	0.3	39.3	13.3	27.8	24.8	20.0	11.5	44.2	15.9	29.9	11.3	40.0	13.0	32.0	39.1	39.9	28.6	33.8	12.7	15.5	28.9	53.9	0.5	84.0	35.3	0.0	0.0	0.0	0.0	0.0	0.0	36.6	1.1	3.2	4.9	21.5	185.1	6.0	4.1	0.1	0.6	208.6	0.9	0.8	2.0	2.8	1.8	1.8	2.1	0.2	166.3	1.4	0.0	0.0	26.5	0.1	0.1	4.1	0.0	26.3	877.7	0.2	0.3	1.7	1.5	0.1	71.5	1.9	11.4	3.1	50.5	79.1	320.2	1.5	0.0	221.9	20.5	11.7	0.0	100.9	3.6	110.5	154.4	10.8	120.5	102.1	132.5	0.0	9.6	0.4	61.8	1.0	6.7	0.8	1.6	9.9	0.0	4.4	1.6	3.4	3.6	0.5	14.3	0.8	68.1	0.2	3.8	4.5
PRKCD		ENSG00000163932	"Protein kinase C delta"	Q05655	3	53156009-53192717	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"	"Apoptosis, Cell cycle"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, FDA approved drug targets, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Late spermatids: 75.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Group enriched"	"Detected in all"	7	"dendritic cells: 57.0;granulocytes: 52.9;monocytes: 73.7"	"Cell line enhanced"	"Detected in all"		"SK-BR-3: 267.7;THP-1: 194.0"	"Group enriched"	"Detected in all"	5	"basal ganglia: 121.4;thalamus: 334.6"	"Low region specificity"	"Detected in all"			"HPA001863, HPA001890, CAB010469, CAB013225"	Enhanced		Enhanced	"Endoplasmic reticulum,Golgi apparatus,Cytosol"		NA	NA		30000	"Cluster 52: Eosinophils - Transcription"	"Cluster 64: Macrophages - Immune response"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Cytosol	"Endoplasmic reticulum, Golgi apparatus"	"CAB010469: AB_632229, CAB013225: , HPA001863: AB_1079627, HPA001890: AB_1079628"	"unprognostic (3.59e-1)"	"unprognostic (4.85e-2)"	"unprognostic (2.66e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.17e-1)"	"unprognostic (6.97e-2)"	"prognostic unfavorable (2.24e-4)"	"prognostic favorable (9.01e-4)"	"unprognostic (1.95e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.79e-1)"	"unprognostic (2.89e-1)"	"unprognostic (2.05e-1)"	"unprognostic (1.73e-1)"	"unprognostic (2.48e-2)"	"unprognostic (2.06e-3)"	"unprognostic (2.95e-3)"	46.1	59.7	10.4	45.4	11.1	90.3	28.9	4.4	11.7	25.9	7.3	43.5	54.8	9.1	39.1	32.7	42.3	32.8	19.6	12.8	11.0	25.6	8.8	44.3	46.8	9.9	8.5	13.6	33.2	20.7	8.2	20.5	7.5	39.3	41.5	2.2	25.9	31.9	6.8	34.0	55.7	16.2	9.5	54.2	65.1	20.8	9.0	16.3	41.8	9.2	62.1	44.2	23.2	12.3	33.5	14.4	5.2	8.7	35.9	21.6	46.2	20.4	25.7	24.5	23.7	34.4	31.9	86.5	8.3	45.6	42.9	14.5	34.1	49.8	20.6	75.2	23.6	50.1	18.3	32.0	23.6	64.8	103.4	17.1	35.8	25.6	23.2	21.8	22.4	9.3	9.7	11.8	36.1	85.0	7.0	81.0	13.0	51.5	23.0	7.6	13.6	20.6	25.5	72.8	8.3	6.5	15.4	267.7	39.6	24.0	22.6	194.0	31.5	11.7	14.4	15.4	19.2	18.1	33.6	45.9	27.6	116.4	22.6	51.8	73.7	50.1	3.6	71.3	2.2	6.2	2.1	2.5	57.0	8.2	2.2	2.0	52.9	6.9	47.7	16.3	2.6	24.1	10.4	11.1	4.4	11.7	12.8	11.0	9.9	8.5	7.5	9.5	9.0	12.3	4.3	3.2	23.5	2.0	25.7	29.2	26.3	8.0	23.9	0.3	11.8	4.3	6.4	14.3	16.1	14.7	0.0	3.1	24.7	61.8	3.9	8.9	34.5	18.5	4.4	2.7	26.5	5.2	3.4	10.7	16.0	6.7	54.0	17.8	5.7	8.9	3.3	2.3	44.8	1.7	4.2	37.1	4.1	47.4	43.0	75.6	9.0	41.5	10.6	20.6	44.9	2.0	8.2	1.0	0.5	13.2	55.4	6.8	25.8	19.7	64.5	13.1	16.5	0.2	6.6	6.5	12.1	23.1	3.7	23.9	27.8	8.8	10.0	10.4	23.0	34.6
PRKCE		ENSG00000171132	"Protein kinase C epsilon"	Q02156	2	45651345-46187990	"Cancer-related genes, Enzymes, FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins"	"Cell adhesion, Cell cycle, Cell division, Immunity"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 34.5"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 206.5;Excitatory neurons: 394.4;Inhibitory neurons: 531.9;Late spermatids: 456.4;Oligodendrocyte precursor cells: 147.8"	"Low cancer specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"amygdala: 18.5;basal ganglia: 20.0;cerebral cortex: 34.5;hippocampal formation: 33.1;white matter: 17.1"	"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"REH: 27.0;TIME: 26.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB001948, HPA008236, HPA044496"	Enhanced	Supported	Supported	"Vesicles,Plasma membrane,Intermediate filaments,Cytosol"		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 58: Brain - Synaptic function"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Intermediate filaments, Cytosol"	"Vesicles, Plasma membrane"	"CAB001948: , HPA008236: , HPA044496: AB_2678959"	"unprognostic (1.10e-1)"	"unprognostic (1.78e-1)"	"unprognostic (2.27e-1)"	"prognostic unfavorable (2.42e-4)"	"unprognostic (9.61e-2)"	"unprognostic (5.70e-2)"	"unprognostic (1.51e-1)"	"prognostic favorable (9.62e-4)"	"unprognostic (3.05e-1)"	"unprognostic (6.72e-2)"	"unprognostic (7.49e-3)"	"unprognostic (9.99e-2)"	"prognostic favorable (2.63e-7)"	"unprognostic (1.21e-1)"	"unprognostic (7.11e-2)"	"unprognostic (6.43e-3)"	"unprognostic (2.23e-2)"	4.4	5.6	18.5	3.7	20.0	8.0	4.2	5.5	34.5	4.6	0.0	5.7	2.6	4.4	2.3	4.1	5.7	3.0	6.2	33.1	0.0	10.0	12.5	20.1	5.7	6.0	0.2	2.8	3.3	9.4	5.2	8.3	4.4	2.9	3.3	15.4	2.7	3.0	7.6	2.7	3.5	4.1	0.0	3.9	4.1	7.6	1.1	3.1	4.9	5.3	4.2	4.9	3.4	17.1	7.7	2.7	3.8	3.8	5.8	6.7	3.1	4.9	9.5	4.3	4.5	0.7	7.0	11.3	4.8	5.5	6.1	1.8	2.5	2.8	6.1	6.9	4.4	0.1	1.8	1.5	6.5	0.9	3.8	5.8	3.0	6.5	4.7	3.6	16.0	2.4	1.6	2.6	5.0	3.8	3.8	0.5	1.3	4.2	1.4	27.0	18.3	12.4	3.9	5.1	2.6	5.7	2.4	7.6	17.1	1.4	6.1	2.6	26.8	8.2	8.5	6.1	5.1	0.0	0.0	9.3	6.7	6.3	8.4	0.0	0.5	0.7	0.3	0.1	0.4	1.5	0.2	0.2	0.8	1.8	0.5	0.1	0.1	0.4	0.6	0.3	0.0	0.3	18.5	20.0	5.5	34.5	33.1	0.0	6.0	0.2	4.4	0.0	1.1	17.1	12.6	6.4	9.2	90.4	20.7	5.0	8.4	5.0	9.1	55.3	6.4	5.7	11.9	8.6	17.2	11.0	14.6	0.5	9.3	6.1	3.9	3.7	206.5	6.8	7.0	13.8	7.7	0.4	394.4	3.8	7.2	8.7	11.2	6.9	7.0	2.9	13.2	12.5	2.8	11.8	531.9	5.8	0.0	19.0	10.7	456.4	5.3	11.5	14.2	70.3	9.4	6.5	1.0	147.8	96.0	3.6	2.9	6.0	4.2	5.3	4.1	30.2	19.3	7.6	13.1	2.9	6.4	2.8	2.3	9.0	4.8	2.9	6.8	1.2	6.2	8.8
PRKCI	"DXS1179E, PKCI"	ENSG00000163558	"Protein kinase C iota"	P41743	3	170222424-170305977	"Cancer-related genes, Enzymes, FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, FDA approved drug targets, Proto-oncogene, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026574, HPA038635"	Approved		Supported	"Microtubules,Cytokinetic bridge,Cytosol"		Yes	No			"Cluster 15: NK-cells - Transcription"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 44: Endometrium - Transcription"	Cytosol	"Microtubules, Cytokinetic bridge"	"HPA026574: AB_1855428, HPA038635: AB_2676124"	"unprognostic (2.26e-1)"	"unprognostic (6.75e-2)"	"unprognostic (4.57e-2)"	"prognostic unfavorable (3.93e-6)"	"unprognostic (1.59e-1)"	"unprognostic (1.84e-2)"	"prognostic unfavorable (3.02e-4)"	"unprognostic (2.52e-1)"	"unprognostic (7.10e-2)"	"unprognostic (1.73e-2)"	"prognostic unfavorable (1.22e-4)"	"unprognostic (5.32e-3)"	"prognostic favorable (3.10e-4)"	"unprognostic (1.16e-1)"	"unprognostic (2.65e-1)"	"unprognostic (1.06e-1)"	"unprognostic (9.73e-2)"	6.7	5.0	2.0	6.9	2.4	2.6	10.4	2.0	3.2	12.7	0.3	12.4	11.6	11.0	8.2	15.1	15.9	11.4	6.9	3.4	1.1	13.5	7.3	16.6	4.6	0.4	0.2	13.6	7.0	13.0	3.1	10.9	0.5	17.3	13.1	6.2	17.5	12.7	6.2	6.9	10.8	11.0	0.2	5.2	34.5	12.5	0.9	10.9	24.5	9.8	10.4	16.1	6.2	1.1	81.6	20.2	20.0	21.6	17.3	23.9	32.2	20.4	29.9	26.4	28.3	29.7	38.6	24.7	65.3	28.8	36.4	37.3	37.9	40.0	44.8	18.2	23.5	22.9	24.3	16.6	27.9	20.9	10.0	21.8	27.5	22.6	35.1	42.8	20.9	13.3	25.8	19.8	27.4	28.0	30.5	8.5	42.3	86.4	22.1	21.8	30.7	41.2	42.3	24.4	31.5	25.8	44.1	57.7	20.0	29.5	63.0	14.5	22.4	27.5	21.1	26.0	34.3	33.9	34.9	35.2	19.8	16.4	11.0	0.0	0.6	0.4	1.1	0.6	1.7	0.9	1.5	2.0	0.8	1.2	1.6	0.9	0.3	2.6	0.5	0.8	1.1	0.7	2.0	2.4	2.0	3.2	3.4	1.1	0.4	0.2	0.5	0.2	0.9	1.1	17.6	73.7	82.1	23.2	5.8	57.1	49.5	39.8	30.7	16.4	29.0	19.7	16.2	24.3	45.3	49.7	14.6	30.2	15.0	29.0	25.4	16.5	8.4	42.0	29.7	20.5	29.3	10.5	77.2	22.0	26.6	32.2	59.7	72.3	8.8	20.4	17.5	17.7	10.0	15.2	55.2	28.3	50.8	18.6	26.8	6.8	23.3	11.6	17.8	22.5	12.7	8.8	6.2	33.2	33.5	55.2	18.6	28.6	29.4	99.4	18.7	20.4	31.9	9.4	19.7	23.7	18.7	15.8	20.6	38.5	63.6	20.7	14.8	14.3	28.5	80.1
PRKCSH	"G19P1, GIIB, PCLD, PLD1, VASAP-60"	ENSG00000130175	"Protein kinase C substrate 80K-H"	P14314	19	11435284-11450968	"Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"			"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004465, HPA041940, HPA043560"	Supported		Supported	"Endoplasmic reticulum"	"Intracellular and membrane"	NA	NA		55000000	"Cluster 41: Basophils - Cellular respiration"	"Cluster 50: Non-specific - Ribosome"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 32: Non-specific - Translation"	"Endoplasmic reticulum"		"CAB004465: AB_626622, HPA041940: AB_2677758, HPA043560: AB_2678553"	"unprognostic (2.75e-1)"	"unprognostic (1.67e-1)"	"unprognostic (2.45e-2)"	"unprognostic (2.14e-1)"	"unprognostic (5.65e-2)"	"unprognostic (2.63e-2)"	"unprognostic (2.52e-2)"	"unprognostic (5.52e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.07e-3)"	"unprognostic (1.28e-2)"	"unprognostic (3.15e-2)"	"prognostic unfavorable (7.69e-4)"	"unprognostic (1.63e-3)"	"unprognostic (2.10e-1)"	"unprognostic (3.44e-1)"	"unprognostic (1.18e-1)"	115.3	107.6	76.4	81.2	86.7	169.6	117.6	85.1	97.6	144.0	91.4	119.7	120.0	123.0	113.0	106.5	126.2	92.0	90.4	76.4	82.0	108.8	159.9	105.5	93.3	89.9	83.9	196.9	186.2	116.3	118.3	108.8	85.9	108.5	98.9	46.6	145.9	97.8	74.8	129.3	121.7	78.5	79.6	111.2	124.9	88.5	83.3	83.9	135.5	44.9	86.2	109.9	122.6	88.8	274.8	216.7	211.6	391.5	351.2	426.4	241.5	305.5	387.6	331.5	302.7	328.3	327.5	204.4	478.1	409.2	165.4	283.4	226.3	309.6	292.1	193.3	173.5	178.0	269.4	268.8	258.0	263.0	236.4	404.5	228.6	312.5	261.4	425.6	232.8	210.1	204.8	422.4	289.0	470.1	187.9	322.1	485.0	129.7	283.3	201.8	215.3	505.6	223.2	260.1	146.9	291.5	282.3	280.4	280.5	200.8	292.5	296.7	263.6	437.1	198.2	416.0	361.0	471.9	575.3	132.3	330.1	276.8	306.5	38.8	47.2	45.1	37.9	36.2	42.6	35.9	31.8	36.4	36.1	38.7	30.2	33.1	56.3	32.8	41.2	75.7	37.5	39.5	76.4	86.7	85.1	97.6	76.4	82.0	89.9	83.9	85.9	79.6	83.3	88.8	45.2	12.8	16.9	15.3	65.1	41.8	72.2	90.0	39.9	18.2	56.9	47.5	10.5	71.4	44.9	64.4	33.3	174.9	54.6	152.0	33.2	88.7	18.1	47.4	65.0	52.0	58.8	40.6	12.3	127.5	189.1	62.6	70.3	67.2	41.9	104.5	60.3	86.4	93.4	10.1	12.5	123.2	65.1	80.0	43.4	55.9	78.6	59.3	53.4	14.0	81.4	59.8	61.8	6.0	39.0	89.0	132.8	72.6	91.4	45.9	187.8	62.7	32.7	30.2	39.5	39.8	52.0	36.8	55.2	49.5	37.8	143.5	55.5	84.2	128.2	66.6
PRKCZ	PKC2	ENSG00000067606	"Protein kinase C zeta"	Q05513	1	2050411-2185395	"Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Inflammatory response"	"Kinase, Serine/threonine-protein kinase, Transferase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 58.0"	"Group enriched"	"Detected in many"	4	"Late spermatids: 708.3;Syncytiotrophoblasts: 1107.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	6	"eosinophil: 16.3"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 16.3"	"Cell line enhanced"	"Detected in many"		"BEWO: 44.5;OE19: 41.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021851	Enhanced		Supported	"Plasma membrane,Cytosol"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 6: Brain - Smell perception"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	Cytosol	"Plasma membrane"	"HPA021851: AB_1855433"	"unprognostic (1.25e-2)"	"unprognostic (2.61e-1)"	"unprognostic (5.10e-2)"	"unprognostic (1.14e-2)"	"unprognostic (2.08e-1)"	"unprognostic (3.61e-2)"	"unprognostic (1.73e-2)"	"unprognostic (5.13e-2)"	"unprognostic (1.18e-1)"	"unprognostic (3.10e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.86e-1)"	"prognostic favorable (1.64e-9)"	"unprognostic (3.57e-2)"	"unprognostic (3.27e-2)"	"unprognostic (1.39e-1)"	"unprognostic (7.85e-2)"	1.7	11.1	23.6	4.6	25.7	2.1	5.6	58.0	41.3	4.3	0.0	13.2	29.3	2.2	7.8	16.0	9.5	4.4	9.7	23.7	10.2	16.0	11.0	31.6	8.0	18.6	8.3	2.7	12.5	14.7	17.6	43.8	19.0	8.4	11.3	14.8	10.8	3.9	0.3	13.8	28.0	1.6	5.6	10.5	8.9	31.9	7.2	3.7	21.8	0.6	7.8	5.8	8.0	24.8	14.7	9.7	3.4	17.2	0.0	0.0	44.5	1.2	0.5	11.1	0.7	23.8	31.0	0.1	27.4	3.9	9.4	25.4	20.5	25.5	7.9	1.0	21.8	0.0	15.2	33.5	3.2	0.1	11.0	0.6	14.9	0.0	8.6	0.0	0.0	4.0	6.6	0.2	0.2	17.9	0.9	0.0	6.4	41.9	22.5	0.0	0.0	5.1	18.6	16.0	24.1	18.7	11.6	27.5	5.2	28.7	17.7	4.0	0.0	0.1	13.1	0.1	0.1	6.8	1.3	0.3	1.2	0.3	16.8	0.3	0.0	16.3	0.5	0.3	2.5	0.3	0.9	0.6	0.0	0.4	0.8	0.3	1.1	0.9	0.0	0.3	0.9	0.3	23.6	25.7	58.0	41.3	23.7	10.2	18.6	8.3	19.0	5.6	7.2	24.8	0.9	121.8	72.2	2.3	6.5	13.0	11.8	11.0	10.2	27.1	11.3	11.0	1.4	5.7	21.1	7.3	4.2	118.7	7.5	48.9	7.9	12.3	224.4	14.0	4.7	6.3	10.2	6.6	39.5	10.7	66.3	3.1	17.9	11.7	8.2	12.5	10.0	16.5	14.5	62.2	35.2	25.5	10.2	0.8	2.9	708.3	9.6	4.4	7.2	2.8	4.5	19.1	8.2	13.0	41.3	14.2	45.7	8.6	7.4	19.5	78.4	24.7	22.1	25.9	0.0	0.3	4.1	28.3	28.4	13.4	13.4	1107.9	9.8	2.6	31.3	14.3
PRKD1	"PKC-mu, PKCM, PKD, PRKCM"	ENSG00000184304	"Protein kinase D1"	Q15139	14	29576479-30191898	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Angiogenesis, Apoptosis, Differentiation, Immunity, Inflammatory response, Innate immunity, Neurogenesis"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Disease variant, Ectodermal dysplasia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 362.1;Excitatory neurons: 147.4;Inhibitory neurons: 171.1;Microglial cells: 89.0;Oligodendrocyte precursor cells: 390.6"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 10.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 21.6;fHDF/TERT166: 19.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB018367, HPA029834"	Uncertain		Supported	"Plasma membrane,Cytosol"	"Intracellular and membrane"	NA	NA				"Cluster 21: Non-specific - Transcription"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 68: Oligodendrocytes - Mixed function"	"Plasma membrane"	Cytosol	"CAB018367: AB_2253119, HPA029834: AB_10602821"	"unprognostic (5.35e-2)"	"unprognostic (3.20e-1)"	"unprognostic (2.27e-2)"	"unprognostic (6.70e-2)"	"unprognostic (2.37e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.08e-3)"	"unprognostic (8.88e-2)"	"unprognostic (2.37e-2)"	"unprognostic (5.29e-2)"	"unprognostic (7.08e-2)"	"unprognostic (1.56e-1)"	"prognostic favorable (2.44e-5)"	"unprognostic (9.45e-4)"	"unprognostic (1.99e-1)"	"prognostic unfavorable (2.91e-4)"	"unprognostic (3.89e-1)"	8.0	9.6	5.6	2.2	8.0	0.0	7.7	6.5	6.7	6.4	3.7	9.5	1.0	7.9	3.5	2.1	6.5	4.4	6.1	7.5	7.5	17.5	1.6	7.5	0.3	8.6	8.6	11.2	5.4	10.6	5.6	1.9	8.7	14.7	1.3	4.7	2.9	9.3	1.6	2.8	3.6	6.3	8.9	2.3	4.6	11.7	8.1	2.4	5.9	2.6	0.5	13.1	4.6	10.3	0.0	4.4	4.8	3.1	21.6	16.5	0.1	14.1	10.4	16.7	7.3	0.0	0.3	0.0	1.9	19.4	4.0	0.1	7.9	2.1	6.8	0.0	6.2	0.0	0.0	0.5	8.8	0.0	0.1	18.4	0.3	1.4	1.5	6.1	2.6	0.0	1.4	0.4	17.4	1.8	0.0	0.0	2.6	0.0	9.6	0.0	6.3	5.2	9.7	6.6	4.3	13.0	2.6	0.0	4.5	4.6	0.0	0.1	5.6	13.6	6.7	1.0	3.7	0.0	0.0	0.0	3.5	0.0	14.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.6	8.0	6.5	6.7	7.5	7.5	8.6	8.6	8.7	8.9	8.1	10.3	4.6	0.0	7.4	362.1	0.2	0.5	4.8	0.4	0.6	1.4	1.4	1.5	1.2	10.0	0.0	12.9	6.2	0.0	0.0	0.1	29.4	2.4	39.5	2.8	9.2	6.1	3.0	2.7	147.4	4.2	0.1	6.4	0.5	8.4	0.0	18.7	10.8	2.5	0.2	1.7	171.1	0.2	0.0	1.6	0.9	16.9	7.5	0.7	7.2	89.0	0.0	16.7	0.0	390.6	76.6	2.0	0.1	12.8	0.4	12.4	0.2	4.5	0.1	2.9	0.0	13.3	4.5	3.2	7.8	0.0	0.9	0.3	0.6	29.6	0.1	1.3
PRKD2	"DKFZP586E0820, HSPC187, PKD2"	ENSG00000105287	"Protein kinase D2"	Q9BZL6	19	46674275-46717127	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Adaptive immunity, Angiogenesis, Cell adhesion, Immunity"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"U-266/84: 149.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021490, HPA056727"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 64: Macrophages - Immune response"	"Cluster 16: U-266 - Nucleosome"	"Cluster 57: B-cells - Immune response"	Nucleoplasm	Cytosol	"HPA021490: AB_1855708, HPA056727: AB_2683217"	"unprognostic (3.01e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.23e-3)"	"unprognostic (7.06e-2)"	"unprognostic (8.91e-2)"	"unprognostic (1.99e-2)"	"unprognostic (8.79e-3)"	"unprognostic (2.61e-1)"	"unprognostic (6.22e-2)"	"unprognostic (4.21e-3)"	"unprognostic (8.89e-2)"	"unprognostic (2.74e-1)"	"unprognostic (3.45e-3)"	"unprognostic (1.04e-2)"	"unprognostic (7.19e-2)"	"unprognostic (4.34e-2)"	"prognostic favorable (9.15e-4)"	29.0	11.5	7.2	23.6	7.3	29.4	29.3	5.4	7.7	26.6	12.5	20.3	17.1	21.8	4.7	27.5	24.1	11.2	13.8	6.1	6.0	19.2	13.8	34.3	31.1	10.0	6.3	21.8	19.1	8.3	24.0	11.1	6.8	23.9	7.1	4.4	24.7	10.0	8.0	46.8	29.9	6.0	6.0	54.3	20.3	6.6	7.7	25.6	28.9	4.8	21.2	19.5	26.9	6.6	19.6	34.5	12.8	16.6	7.3	6.4	15.1	11.5	13.2	19.6	19.7	19.7	21.0	22.3	16.3	13.2	13.2	27.5	9.5	26.0	5.9	19.8	17.5	25.9	11.5	10.2	12.8	21.2	34.7	11.0	15.8	12.7	9.8	12.8	30.1	21.5	14.6	35.4	7.0	23.8	32.7	53.1	9.7	27.4	17.4	25.8	5.8	37.5	11.4	32.7	7.7	22.4	18.8	18.8	4.6	10.6	11.6	7.5	17.6	8.7	18.8	7.1	10.0	31.8	149.1	13.5	8.5	17.7	11.0	0.6	0.7	2.6	3.9	0.7	3.3	4.3	3.9	4.3	0.3	4.1	3.3	3.3	5.3	2.2	0.5	0.0	2.9	1.5	7.2	7.3	5.4	7.7	6.1	6.0	10.0	6.3	6.8	6.0	7.7	6.6	37.8	9.6	9.9	5.9	46.5	22.0	32.0	13.2	22.8	6.4	13.9	11.3	17.2	12.8	13.0	9.2	0.0	13.8	17.5	43.6	7.9	18.6	1.2	15.3	6.7	37.2	21.6	4.0	6.5	28.2	13.8	9.6	23.4	15.0	14.5	14.1	37.1	8.5	9.0	1.7	2.8	21.7	4.1	12.3	11.4	3.1	11.8	8.3	12.4	11.2	9.3	6.5	42.2	4.0	3.1	29.5	35.1	6.8	47.0	22.9	34.1	9.3	15.6	4.4	13.1	6.1	7.6	2.9	17.9	21.2	26.7	29.7	31.9	6.6	15.3	30.2
PRKD3	"EPK2, PRKCN"	ENSG00000115825	"Protein kinase D3"	O94806	2	37250502-37324833	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"SK-MEL-30: 152.1;U-266/84: 159.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029529	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 20: Retina & Lymphoid tissues - Unknown function"	"Cluster 16: U-266 - Nucleosome"	"Cluster 46: Photoreceptor cells - Phototransduction"	"Nucleoplasm, Cytosol"		"HPA029529: AB_10602082"	"unprognostic (1.39e-1)"	"unprognostic (7.34e-2)"	"prognostic favorable (4.84e-4)"	"unprognostic (1.23e-2)"	"unprognostic (5.61e-2)"	"unprognostic (2.08e-1)"	"prognostic unfavorable (3.47e-4)"	"unprognostic (1.10e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.52e-2)"	"unprognostic (2.93e-1)"	"unprognostic (1.81e-1)"	"unprognostic (7.62e-3)"	"unprognostic (2.49e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.35e-1)"	15.1	19.9	6.1	18.1	6.8	8.7	14.4	7.8	7.3	19.3	3.9	16.4	8.2	18.9	13.8	10.7	9.9	13.3	9.8	6.0	7.5	12.0	10.1	14.7	29.1	7.2	7.1	18.0	9.1	11.7	6.5	14.9	7.8	11.7	11.0	41.6	10.5	12.5	14.9	12.2	10.3	16.2	7.6	23.4	12.4	23.3	8.1	20.7	13.4	12.1	28.9	15.5	9.5	7.1	38.8	14.3	44.4	36.1	33.2	55.1	31.5	25.0	48.8	29.1	28.7	23.4	14.0	58.5	20.1	39.6	43.2	15.0	31.1	31.9	39.0	72.3	38.7	39.2	24.4	17.8	13.8	26.2	21.5	26.0	16.2	46.2	29.7	26.6	52.6	19.9	32.3	70.9	33.8	6.1	11.6	21.6	45.4	0.4	14.2	40.8	67.9	51.8	18.9	42.1	32.5	81.0	24.6	13.9	152.1	22.8	15.1	25.1	47.7	80.0	40.5	31.5	28.5	78.1	159.7	68.2	27.8	11.2	48.7	6.9	7.7	6.1	9.5	6.7	8.1	10.6	8.5	8.1	7.7	14.6	9.6	10.8	1.4	6.9	3.6	8.1	4.4	3.6	6.1	6.8	7.8	7.3	6.0	7.5	7.2	7.1	7.8	7.6	8.1	7.1	41.4	41.7	17.8	21.9	60.2	37.9	32.1	24.1	14.8	47.6	14.7	15.5	9.1	27.1	16.6	18.4	68.8	11.2	37.7	7.3	3.9	13.1	57.1	8.3	38.5	48.0	18.8	12.0	24.8	10.6	37.0	33.0	20.4	14.1	76.9	26.8	44.3	12.2	12.8	43.7	18.7	6.9	22.4	31.2	91.2	100.6	33.5	24.4	49.8	68.4	32.7	15.9	27.8	37.7	12.6	16.1	4.3	30.9	60.2	34.3	6.6	8.6	10.3	118.8	26.3	27.5	24.0	54.7	39.9	10.6	23.9	9.7	33.5	29.1	12.3	34.1
PRKN	"AR-JP, PARK2, parkin, PDJ"	ENSG00000185345	"Parkin RBR E3 ubiquitin protein ligase"	O60260	6	161347417-162727775	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Autophagy, Transcription, Transcription regulation, Ubl conjugation pathway"	Transferase	"Disease variant, Neurodegeneration, Parkinson disease, Parkinsonism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 28.3;tongue: 15.9"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 9.6;Alveolar cells type 2: 4.8;Distal tubular cells: 19.6;Proximal tubular cells: 6.8"	"Cancer enhanced"	"Detected in many"		"renal cancer: 3.3"	"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 2.0;HEL: 4.1;HSkMC: 1.7;Karpas-707: 2.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB016257, HPA036012"	Enhanced		Supported	"Nuclear speckles,Cytosol"		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 47: Non-specific - Unknown function"	"Cluster 36: HEL - Hemostasis"	"Cluster 39: Non-specific - Basic cellular processes"	"Nuclear speckles"	Cytosol	"CAB016257: AB_628104, HPA036012: AB_2732471"	"unprognostic (9.23e-2)"	"unprognostic (3.29e-2)"	"unprognostic (6.48e-2)"	"unprognostic (2.69e-3)"	"unprognostic (9.85e-2)"	"unprognostic (5.85e-2)"	"unprognostic (7.07e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.68e-2)"	"unprognostic (1.03e-3)"	"unprognostic (8.16e-2)"	"prognostic favorable (6.75e-12)"	"unprognostic (9.93e-2)"	"unprognostic (1.51e-1)"	"unprognostic (5.24e-2)"	"unprognostic (2.50e-1)"	3.4	3.3	4.1	0.1	3.6	0.3	1.9	0.4	5.7	1.3	0.6	2.7	1.2	1.6	1.2	3.2	1.2	1.5	9.1	4.6	1.8	5.2	1.2	1.0	0.5	1.0	1.9	2.8	1.2	2.3	1.8	0.4	1.6	1.2	0.6	1.5	1.3	1.4	28.3	2.0	1.0	1.2	1.0	1.0	1.9	5.3	1.9	0.5	1.3	15.9	0.3	2.5	1.0	2.4	0.0	0.0	0.3	2.0	0.4	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.5	0.0	0.3	0.0	0.1	0.0	0.0	0.1	0.5	4.1	0.1	0.6	0.3	0.0	0.0	1.7	0.0	0.0	0.2	0.3	0.0	0.2	0.2	2.2	0.0	0.2	0.0	0.0	0.0	0.2	0.8	0.0	0.0	0.7	0.0	0.0	0.5	1.0	0.0	0.2	0.2	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.7	1.7	0.3	2.2	0.8	0.1	1.3	0.6	0.8	0.9	0.7	1.6	1.8	1.8	0.5	0.6	0.4	0.0	0.1	0.8	4.1	3.6	0.4	5.7	4.6	1.8	1.0	1.9	1.6	1.0	1.9	2.4	2.3	9.6	4.8	0.0	0.6	0.0	0.0	0.0	0.0	0.0	2.1	1.5	0.0	0.0	1.8	1.8	0.0	0.5	0.4	0.0	19.6	1.1	0.0	3.4	1.8	0.7	0.0	0.0	0.0	2.2	0.1	1.8	0.0	3.2	2.5	3.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	6.8	1.5	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.3	0.4	3.7	0.0	0.0
PRKRA	"DYT16, HSD14, PACT, RAX"	ENSG00000180228	"Protein activator of interferon induced protein kinase EIF2AK2"	O75569	2	178431292-178451512	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Host-virus interaction, RNA-mediated gene silencing"	RNA-binding	"Disease variant, Dystonia, Parkinsonism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 307.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004648, HPA034996, HPA034997"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 25: Spermatids - Spermatogenesis"	Cytosol	Nucleoplasm	"CAB004648: AB_425767, HPA034996: AB_2674402, HPA034997: AB_2674403"	"unprognostic (2.53e-1)"	"unprognostic (9.18e-2)"	"unprognostic (5.38e-2)"	"unprognostic (4.02e-3)"	"unprognostic (1.22e-1)"	"unprognostic (1.04e-1)"	"prognostic unfavorable (8.33e-5)"	"unprognostic (9.66e-2)"	"unprognostic (7.10e-3)"	"unprognostic (2.32e-3)"	"unprognostic (4.79e-2)"	"unprognostic (1.29e-1)"	"unprognostic (2.16e-3)"	"unprognostic (8.99e-2)"	"prognostic favorable (5.45e-4)"	"unprognostic (1.38e-1)"	"unprognostic (6.78e-2)"	28.7	21.9	22.1	13.8	22.6	18.2	26.4	24.6	31.3	23.6	25.3	36.4	13.7	28.7	25.7	22.8	23.4	17.5	37.2	22.8	24.9	29.7	20.2	21.2	16.9	25.0	22.5	23.4	25.4	26.2	22.5	11.5	24.2	23.4	20.1	30.9	22.6	24.3	100.7	31.2	19.7	29.4	25.2	15.9	26.0	24.3	23.1	20.4	22.1	72.7	20.4	32.1	22.0	27.1	24.6	18.4	48.2	20.8	49.2	56.7	39.6	35.4	37.7	46.4	50.8	50.9	33.8	51.0	39.8	43.6	30.9	21.0	42.0	28.5	50.9	43.9	25.0	29.2	17.0	46.7	58.6	21.2	16.1	32.2	69.3	44.0	49.7	46.0	46.8	32.8	26.7	34.9	62.9	25.3	46.3	52.2	46.7	42.3	33.5	38.5	89.0	46.6	52.4	25.5	30.2	39.4	21.9	20.2	48.3	36.3	30.6	27.4	20.8	32.0	42.6	33.8	29.9	52.5	33.7	62.6	40.8	35.1	20.7	5.4	24.7	25.9	18.1	25.5	26.2	34.3	28.4	22.7	37.2	26.4	31.4	25.8	5.1	25.2	26.3	49.7	38.3	30.9	22.1	22.6	24.6	31.3	22.8	24.9	25.0	22.5	24.2	25.2	23.1	27.1	35.1	16.0	33.4	23.2	37.7	63.1	90.0	89.3	30.1	53.6	48.1	40.3	43.5	20.0	39.9	25.8	43.8	37.7	49.3	16.9	125.2	51.4	149.5	43.6	36.2	34.5	47.9	19.1	39.5	41.6	53.2	42.7	19.4	27.0	28.5	40.5	21.8	18.5	30.4	10.1	46.4	35.5	93.6	19.8	69.4	307.9	39.4	26.4	69.4	21.5	38.6	49.2	9.2	30.7	47.1	36.0	25.1	37.2	42.5	94.7	30.8	89.0	30.6	86.2	46.0	45.6	66.7	78.7	57.6	43.7	78.4	43.4	33.6	47.0	39.6	73.0
PRKRIP1	"C114, FLJ13902, KRBOX3"	ENSG00000128563	"PRKR interacting protein 1"	Q9H875	7	102363872-102426676	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051146	Uncertain		Supported	"Actin filaments,Cytosol"		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 43: Testis - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Actin filaments"	Cytosol	"HPA051146: AB_2681361"	"unprognostic (4.78e-3)"	"unprognostic (7.23e-3)"	"prognostic unfavorable (3.65e-4)"	"unprognostic (8.25e-2)"	"unprognostic (2.99e-3)"	"unprognostic (3.15e-2)"	"unprognostic (1.99e-2)"	"unprognostic (4.38e-3)"	"unprognostic (1.57e-3)"	"unprognostic (1.50e-2)"	"unprognostic (2.61e-3)"	"unprognostic (9.79e-3)"	"prognostic unfavorable (4.39e-4)"	"unprognostic (1.82e-1)"	"unprognostic (1.01e-1)"	"unprognostic (4.88e-1)"	"prognostic favorable (1.94e-4)"	12.6	16.2	15.1	7.2	15.2	16.5	12.8	18.4	17.9	15.4	14.3	14.1	8.6	13.7	3.5	11.7	14.2	5.7	10.1	15.1	17.0	16.1	12.1	9.7	12.5	16.0	15.4	14.7	11.6	11.6	15.4	7.0	15.5	15.5	3.7	4.2	12.1	6.8	12.2	18.6	12.4	5.0	14.8	18.3	13.5	19.0	15.4	12.1	14.5	7.4	7.7	13.6	13.1	16.0	17.0	12.4	11.8	17.3	5.4	7.7	17.6	13.1	9.0	21.1	17.8	20.3	14.7	17.6	20.3	11.2	15.0	19.2	9.0	12.9	10.7	20.1	19.1	7.3	12.3	11.9	13.3	10.3	10.3	5.5	12.4	16.2	10.9	11.3	10.7	19.9	21.1	26.3	13.1	33.7	34.4	46.7	18.3	15.1	14.7	24.8	11.5	27.5	11.3	7.2	13.5	25.9	19.5	29.2	20.1	11.8	15.1	20.0	12.7	21.6	26.0	23.3	20.5	36.0	26.7	31.6	18.3	18.4	29.4	3.8	10.1	18.3	11.5	10.0	10.7	14.0	11.5	12.9	7.8	13.0	14.2	12.4	20.7	12.9	13.6	14.1	9.6	10.0	15.1	15.2	18.4	17.9	15.1	17.0	16.0	15.4	15.5	14.8	15.4	16.0	23.4	32.1	21.8	0.0	31.4	13.4	19.0	14.8	20.5	23.1	21.1	19.3	23.8	14.3	23.0	16.5	31.3	27.5	31.7	13.7	31.3	24.8	77.8	29.6	26.0	21.4	16.3	21.8	0.0	25.1	26.7	21.3	16.3	32.0	22.8	27.1	15.0	14.1	27.6	23.5	0.0	13.8	8.2	13.8	16.9	92.5	17.1	19.2	12.4	0.0	22.1	25.3	20.6	0.0	0.0	29.5	9.8	16.6	28.6	22.4	14.6	26.6	27.1	21.5	32.9	29.2	27.0	88.4	47.6	20.8	17.6	41.9	30.4	24.2	12.0	19.4
PRKX	PKX1	ENSG00000183943	"Protein kinase X-linked"	P51817	X	3604340-3713649	"Disease related genes, Enzymes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Angiogenesis, Differentiation"	"Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"thyroid gland: 33.8"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 108.3;Endometrial ciliated cells: 164.0;Glandular and luminal cells: 179.5;NK-cells: 139.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 11.0"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HMC-1: 74.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015324	Supported		Supported	Nucleoplasm		No	No			"Cluster 41: Basophils - Cellular respiration"	"Cluster 21: Non-specific - Transcription"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm		"HPA015324: AB_1855715"	"unprognostic (1.07e-1)"	"unprognostic (1.23e-2)"	"unprognostic (1.57e-1)"	"unprognostic (3.63e-1)"	"unprognostic (2.45e-1)"	"unprognostic (3.33e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.33e-2)"	"unprognostic (4.14e-1)"	"unprognostic (1.68e-1)"	"unprognostic (2.68e-1)"	"unprognostic (2.92e-1)"	"unprognostic (1.07e-3)"	"unprognostic (2.15e-2)"	"unprognostic (9.91e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.70e-2)"	5.5	1.6	10.0	9.8	12.9	7.7	7.9	12.6	8.8	7.8	12.7	6.5	5.1	4.6	9.6	13.9	19.4	4.4	3.7	8.3	14.3	15.6	1.8	9.0	12.8	18.1	13.8	4.0	4.4	3.1	2.0	5.3	15.8	3.8	6.1	1.7	6.1	5.9	2.2	12.0	6.3	3.7	14.5	12.4	4.0	6.8	15.3	15.4	33.8	3.2	9.9	4.5	12.4	17.1	9.1	8.3	22.4	16.7	4.2	5.6	20.5	5.3	2.1	2.6	3.5	12.4	6.1	0.7	5.3	4.3	5.4	6.2	21.1	16.1	4.5	10.2	14.7	10.0	6.7	0.2	4.4	13.0	74.7	3.8	16.8	2.8	10.3	7.1	25.7	12.3	11.8	12.7	8.6	8.0	15.0	11.7	15.0	7.0	9.4	27.7	21.5	17.2	20.6	7.6	14.9	9.6	5.6	3.6	5.5	35.1	2.8	10.3	14.2	2.2	3.8	3.7	3.6	0.3	0.7	11.6	1.3	11.6	5.8	11.0	2.0	1.2	2.3	2.4	2.4	1.6	2.4	2.2	1.6	1.5	1.9	2.1	0.5	2.4	3.2	1.9	1.8	1.2	10.0	12.9	12.6	8.8	8.3	14.3	18.1	13.8	15.8	14.5	15.3	17.1	32.0	3.2	9.4	7.8	35.5	21.4	22.3	9.7	21.6	1.8	14.4	9.1	1.6	30.0	10.1	5.5	0.0	30.8	108.3	8.8	13.7	10.8	11.9	164.0	23.8	19.7	4.8	7.2	1.3	3.1	5.8	10.4	6.1	179.5	85.1	11.8	13.2	2.3	16.9	1.7	20.2	13.5	24.4	19.4	24.1	49.2	19.9	29.0	5.4	39.4	53.4	2.2	139.0	11.1	7.0	5.6	13.1	21.8	38.2	29.0	10.7	6.1	18.0	0.6	32.9	46.4	12.4	1.3	21.6	34.1	26.9	7.8	63.5	10.6	23.6	20.4
PRM1	CT94.1	ENSG00000175646	"Protamine 1"	P04553	16	11280841-11281330	"Predicted intracellular proteins"	"Differentiation, DNA condensation, Spermatogenesis"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	1099	"testis: 14115.0"	"Cell type enriched"	"Detected in some"	6	"Late spermatids: 776887.9"	"Cancer enriched"	"Detected in single"	161	"testis cancer: 11.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"NB-4: 2.4;U-2197: 1.7"					"Not detected"	"Not detected"			"HPA055150, HPA059371"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA				"Cluster 36: Testis - Spermatogenesis"	"Cluster 24: NB-4 - Immune response"	"Cluster 31: Spermatids - Spermatogenesis"	Nucleoplasm	Cytosol	"HPA055150: AB_2682718, HPA059371: "															"unprognostic (2.10e-2)"			2.3	2.2	0.0	0.5	0.0	0.0	9.9	0.0	0.0	2.1	0.0	2.1	1.5	1.0	0.0	1.9	1.2	0.0	2.2	0.0	0.2	2.7	4.4	1.3	0.4	0.1	0.0	1.6	3.0	0.0	1.9	0.0	0.1	12.8	0.0	0.0	2.1	1.3	5.8	3.7	4.0	0.0	0.0	1.4	2.4	14115.0	0.0	0.0	4.3	0.0	0.1	1.4	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	126844.3	0.0	0.0	80.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	776887.9	1855.9	161.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1689.6	0.0	0.0	0.0	0.0	0.0	0.0	1157.0	0.0	0.0	2054.0	1211.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PRMT1	"ANM1, HCP1, HRMT1L2"	ENSG00000126457	"Protein arginine methyltransferase 1"	Q99873	19	49675786-49689029	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Basal respiratory cells: 444.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022550, HPA069769, HPA072136"	Supported		Supported	Nucleoplasm		NA	NA		8500	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"CAB022550: , HPA069769: AB_2686193, HPA072136: AB_2686490"	"unprognostic (1.88e-2)"	"unprognostic (1.28e-2)"	"unprognostic (3.00e-2)"	"unprognostic (3.84e-1)"	"unprognostic (4.13e-2)"	"unprognostic (3.33e-2)"	"prognostic unfavorable (8.04e-5)"	"unprognostic (3.43e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.77e-1)"	"unprognostic (3.59e-2)"	"unprognostic (1.05e-1)"	"unprognostic (7.19e-3)"	"unprognostic (2.21e-1)"	"unprognostic (3.66e-2)"	"unprognostic (4.73e-2)"	"unprognostic (1.10e-2)"	79.7	102.2	62.5	76.2	63.2	65.0	76.7	68.1	74.7	107.0	59.4	87.2	55.1	115.4	44.5	90.7	109.7	49.8	149.2	65.7	71.1	77.9	61.8	76.5	94.0	66.5	65.2	106.7	66.3	65.6	101.1	65.3	68.8	77.1	45.5	71.3	67.6	73.9	242.6	74.8	71.8	74.0	66.3	91.6	69.4	78.4	71.3	79.6	70.9	163.2	84.5	92.6	81.6	68.7	262.5	584.9	396.5	481.7	105.4	118.7	208.4	163.7	283.1	461.8	394.0	439.5	202.2	425.9	119.0	193.4	181.1	188.0	337.3	345.8	200.1	333.7	580.5	311.5	156.4	484.6	256.8	378.7	214.2	166.7	169.3	259.2	369.0	154.8	277.1	338.3	334.0	293.2	182.5	394.1	493.2	467.0	420.5	324.9	375.6	344.8	319.9	388.8	264.0	540.9	440.0	342.4	188.9	193.2	103.4	126.9	146.8	220.6	173.9	269.9	262.5	125.4	398.6	280.0	457.4	429.3	165.7	271.0	289.8	25.0	76.8	37.5	104.0	93.8	129.6	198.9	95.4	111.0	131.5	171.6	105.2	103.3	14.8	162.3	71.9	158.9	97.7	132.5	62.5	63.2	68.1	74.7	65.7	71.1	66.5	65.2	68.8	66.3	71.3	68.7	169.7	3.2	10.3	15.7	112.4	207.0	228.7	444.9	123.5	228.9	71.3	96.8	17.2	40.0	117.3	44.1	106.3	195.6	74.4	45.1	127.2	204.0	5.4	88.9	124.5	167.8	115.2	38.3	9.8	135.2	177.5	101.7	51.5	87.5	54.7	154.2	109.6	22.1	104.1	129.5	15.8	74.5	227.9	27.0	125.7	19.4	104.1	52.9	112.1	15.9	149.4	119.3	57.7	14.6	20.2	125.6	45.6	89.1	117.8	263.0	35.2	87.5	62.8	168.7	92.1	89.7	236.3	66.8	121.8	94.9	158.8	235.2	76.8	200.7	105.0	183.2
PRMT2	"HRMT1L1, MGC111373"	ENSG00000160310	"Protein arginine methyltransferase 2"	P55345	21	46635595-46665124	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"NK-cells: 451.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018976, HPA029591"	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 70: Brain - Nervous system development"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 63: NK-cells & T-cells - Immune response"	"Nucleoplasm, Cytosol"		"HPA018976: AB_1855719, HPA029591: AB_10601250"	"unprognostic (1.82e-1)"	"unprognostic (2.96e-1)"	"unprognostic (8.61e-3)"	"unprognostic (1.74e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.58e-2)"	"unprognostic (1.29e-3)"	"unprognostic (1.34e-1)"	"unprognostic (2.23e-1)"	"unprognostic (6.78e-2)"	"unprognostic (4.34e-3)"	"unprognostic (1.72e-1)"	"unprognostic (4.62e-3)"	"unprognostic (8.76e-3)"	"unprognostic (2.86e-2)"	"unprognostic (1.91e-3)"	"unprognostic (2.23e-1)"	37.4	25.4	84.3	42.3	88.4	37.3	39.0	90.1	84.0	43.5	79.6	50.2	27.0	43.2	26.8	55.2	47.0	42.5	56.3	81.4	105.6	36.8	14.4	40.7	57.1	100.7	123.9	82.6	27.4	29.9	27.9	49.3	104.7	38.1	30.4	23.1	38.6	48.3	20.4	51.1	36.7	50.4	91.8	49.8	32.1	16.4	100.0	45.2	36.0	21.8	52.7	44.4	38.2	106.5	75.7	63.4	130.2	48.1	94.0	90.1	31.1	70.6	79.0	77.4	70.2	88.8	60.4	44.5	85.6	126.9	104.3	22.0	59.3	87.4	44.7	110.1	57.2	115.8	55.0	67.4	43.3	34.9	51.7	56.1	85.0	93.4	66.6	87.6	114.5	61.2	74.5	80.4	121.0	84.1	50.3	63.9	69.3	47.5	73.6	63.2	33.2	29.6	61.1	63.3	89.4	56.6	73.8	33.0	135.0	18.5	44.1	35.2	104.8	75.2	50.5	40.4	47.4	21.2	21.0	28.6	70.4	92.4	115.3	256.5	91.9	314.2	261.8	128.4	192.0	93.6	176.3	227.2	131.5	82.7	215.9	248.8	122.3	262.0	135.3	112.7	142.3	223.2	84.3	88.4	90.1	84.0	81.4	105.6	100.7	123.9	104.7	91.8	100.0	106.5	71.5	93.0	36.2	54.5	74.4	46.1	69.8	79.1	66.6	47.7	93.2	103.5	69.5	67.2	61.8	75.4	29.2	64.3	192.9	49.4	90.1	79.1	3.5	51.9	60.2	82.9	35.8	27.3	39.2	52.9	43.5	68.0	48.9	46.1	117.0	132.0	142.8	42.1	107.2	37.0	42.6	32.6	52.9	133.7	102.1	9.0	55.6	109.3	87.2	74.0	182.9	61.1	451.1	69.4	160.6	74.9	40.0	62.1	64.6	94.0	44.0	113.5	71.4	57.7	65.7	53.2	77.2	22.0	39.0	75.0	45.0	69.2	167.1	55.0	38.3	72.9
PRMT5	"HRMT1L5, SKB1, SKB1Hs"	ENSG00000100462	"Protein arginine methyltransferase 5"	O14744	14	22920525-22929408	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Biological rhythms, Transcription, Transcription regulation"	"Chromatin regulator, Methyltransferase, Repressor, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Pancreatic endocrine cells: 92.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005525, CAB012459, HPA064708"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA		45000	"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 52: Non-specific - Ribosome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	"Nucleoplasm, Cytosol"		"CAB012459: , HPA005525: AB_1079679, HPA064708: AB_2685330"	"unprognostic (8.34e-2)"	"unprognostic (5.14e-3)"	"unprognostic (1.19e-2)"	"unprognostic (2.19e-1)"	"unprognostic (4.56e-3)"	"prognostic unfavorable (1.82e-4)"	"prognostic unfavorable (4.77e-5)"	"unprognostic (3.64e-2)"	"unprognostic (6.80e-2)"	"unprognostic (1.48e-1)"	"prognostic unfavorable (2.61e-4)"	"unprognostic (4.69e-2)"	"unprognostic (1.99e-3)"	"unprognostic (1.21e-1)"	"unprognostic (7.04e-2)"	"unprognostic (6.28e-2)"	"prognostic unfavorable (1.04e-4)"	27.6	31.0	19.9	27.9	21.6	21.7	34.9	21.0	25.9	33.3	24.4	38.4	24.0	36.9	30.6	49.0	44.6	19.4	35.1	20.9	21.8	37.0	28.3	23.2	26.6	20.2	22.2	45.3	32.9	47.3	24.5	30.6	22.0	27.9	35.6	30.8	27.7	33.3	65.8	34.4	23.3	35.5	20.4	26.3	29.2	30.3	21.6	33.1	37.9	42.1	34.3	31.4	33.5	22.8	161.7	169.2	114.2	112.9	62.3	67.7	125.6	104.1	91.6	192.7	156.6	159.2	160.1	171.3	83.2	88.5	108.3	135.8	246.4	212.8	213.9	98.5	119.3	104.5	108.3	256.3	111.4	221.7	85.7	69.3	113.2	143.1	264.8	72.7	91.0	128.5	160.0	91.7	108.5	171.4	151.3	102.9	103.1	160.8	221.8	176.0	140.3	122.7	98.8	110.7	126.0	79.8	125.7	132.3	65.5	94.3	91.3	82.6	70.9	75.1	103.1	103.0	145.9	116.6	246.0	207.2	46.1	109.2	116.0	3.0	31.3	0.4	14.2	31.7	22.9	30.6	19.0	23.0	42.8	27.9	24.4	20.4	7.7	19.8	25.1	25.9	17.6	29.1	19.9	21.6	21.0	25.9	20.9	21.8	20.2	22.2	22.0	20.4	21.6	22.8	8.5	19.2	15.1	5.5	11.4	26.5	26.5	33.8	15.4	10.8	13.9	15.4	1.1	28.6	19.4	7.3	8.4	41.7	8.6	11.1	23.5	32.0	2.3	18.5	21.4	12.3	6.1	24.4	6.1	27.0	33.4	16.7	12.8	12.6	7.0	21.9	10.4	15.1	19.6	16.8	5.8	17.5	20.3	4.4	11.7	3.7	16.4	8.0	26.6	0.0	11.8	18.2	3.1	5.5	4.0	92.8	12.7	21.1	12.4	23.6	7.4	24.6	31.1	11.2	6.6	25.9	19.5	43.1	47.3	20.3	27.8	33.4	8.2	27.5	21.1	17.9
PRMT6	"FLJ10559, HRMT1L6"	ENSG00000198890	"Protein arginine methyltransferase 6"	Q96LA8	1	107056674-107067636	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, Host-virus interaction, Transcription, Transcription regulation"	"Chromatin regulator, Methyltransferase, Repressor, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in many"	5	"MCF7: 308.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059424	Approved		Supported	Nucleoplasm,Nucleoli		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 34: Non-specific - Transcription"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoplasm, Nucleoli"		"HPA059424: AB_2684012"	"unprognostic (5.17e-3)"	"unprognostic (1.48e-1)"	"unprognostic (1.47e-2)"	"prognostic unfavorable (3.05e-4)"	"unprognostic (2.68e-1)"	"unprognostic (2.55e-1)"	"unprognostic (1.36e-3)"	"unprognostic (2.13e-2)"	"unprognostic (9.72e-2)"	"unprognostic (2.53e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.63e-1)"	"unprognostic (3.15e-2)"	"unprognostic (1.03e-1)"	"unprognostic (8.34e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.73e-3)"	4.9	10.0	5.7	7.2	5.6	4.2	8.0	5.6	5.7	6.1	13.8	7.9	6.1	7.0	8.0	6.8	8.8	6.0	3.9	5.2	6.9	12.0	7.1	4.6	9.6	6.1	6.5	8.6	10.9	9.6	8.4	7.3	5.3	8.5	7.2	6.4	6.5	7.8	1.8	5.6	7.2	5.9	5.5	8.3	7.4	6.6	8.2	10.3	7.0	3.1	8.7	7.9	5.0	6.0	13.6	0.2	25.7	11.3	16.6	18.4	7.0	17.8	13.2	16.9	17.2	17.2	9.2	33.1	24.1	16.5	9.2	18.9	23.9	26.2	13.3	0.0	25.4	20.0	35.6	25.0	16.5	41.6	11.9	17.4	14.2	15.2	15.5	11.4	14.8	18.5	27.1	5.0	15.4	308.1	24.5	14.6	11.1	10.6	24.6	30.8	56.0	12.6	41.3	27.1	47.8	58.3	24.2	34.5	12.1	15.5	24.0	30.7	17.2	12.5	25.5	26.3	26.8	5.4	4.0	5.7	18.4	19.3	10.2	2.1	10.4	1.9	7.9	11.9	9.5	7.4	8.3	7.6	14.1	10.3	11.5	11.9	0.6	17.4	12.0	17.2	9.2	9.3	5.7	5.6	5.6	5.7	5.2	6.9	6.1	6.5	5.3	5.5	8.2	6.0	3.0	0.0	4.4	1.3	6.2	4.5	6.9	9.7	8.6	14.2	8.9	5.0	2.6	5.7	5.8	14.7	0.0	18.3	8.5	3.3	27.4	10.3	1.2	5.2	6.2	4.7	17.5	15.8	1.5	7.4	14.6	6.7	4.6	4.9	1.3	9.4	7.5	2.4	10.0	15.2	2.2	7.4	8.2	7.0	1.6	3.0	8.7	3.8	1.8	3.7	3.9	6.9	3.1	2.0	2.2	4.7	8.5	9.1	2.0	5.1	4.1	18.4	7.4	5.1	13.1	5.9	6.3	9.1	8.1	8.9	6.1	7.1	5.0	13.7	10.3	5.4
PRORP	"KIAA0391, MRPP3"	ENSG00000100890	"Protein only RNase P catalytic subunit"	O15091	14	35121846-35277622	"Enzymes, Predicted intracellular proteins"	"tRNA processing"	"Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 1.8;dendritic cells: 1.1;Hofbauer cells: 1.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA020459	Approved		Supported	Nucleoplasm,Mitochondria		NA	NA			"Cluster 13: T-cells - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 24: Non-specific - Transcription regulation"	Mitochondria	Nucleoplasm	"HPA020459: AB_2670449"	"unprognostic (6.44e-3)"	"unprognostic (8.10e-2)"	"unprognostic (7.71e-3)"	"unprognostic (4.90e-2)"	"unprognostic (3.42e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.76e-2)"	"unprognostic (8.67e-2)"	"unprognostic (1.94e-2)"	"unprognostic (3.25e-4)"	"unprognostic (1.75e-1)"	"unprognostic (1.80e-1)"	"unprognostic (9.67e-5)"	"unprognostic (2.56e-1)"	"unprognostic (1.67e-1)"	"unprognostic (2.10e-2)"	"unprognostic (6.65e-2)"	11.3	17.0	11.0	17.0	12.2	12.2	13.9	12.4	16.1	13.6	16.6	19.9	15.3	8.4	16.7	19.2	11.8	10.4	13.7	11.4	12.1	25.0	24.9	12.5	21.2	13.2	12.5	7.0	10.6	19.3	9.7	11.0	12.8	10.6	20.8	6.2	13.1	9.6	15.1	17.3	14.5	11.9	11.6	13.6	13.6	12.1	13.1	31.1	15.6	17.1	22.5	15.4	11.9	14.4	47.5	34.9	23.6	33.1	25.1	21.0	22.7	31.1	25.3	35.9	26.1	35.8	26.3	53.0	39.0	27.2	9.9	33.9	43.8	47.3	36.5	39.2	12.9	22.6	24.9	77.9	25.2	27.2	23.0	28.3	37.7	33.9	31.6	30.2	50.0	41.3	38.4	13.6	42.5	54.9	46.0	33.3	26.8	30.4	33.4	42.9	40.4	28.1	52.6	44.6	24.0	25.0	40.0	43.3	26.8	29.0	55.4	23.9	44.5	30.7	25.7	22.1	25.8	15.5	40.4	53.9	14.5	32.0	32.5	30.9	10.3	7.2	30.3	9.6	43.9	20.1	47.3	32.8	13.8	14.4	41.6	30.1	14.4	24.7	8.2	20.4	56.1	24.3	11.0	12.2	12.4	16.1	11.4	12.1	13.2	12.5	12.8	11.6	13.1	14.4	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.9	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.6	0.9	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.7	0.5	0.0	0.0	0.0
PRPF31	"hPrp31, NY-BR-99, PRP31, RP11, SNRNP61"	ENSG00000105618	"Pre-mRNA processing factor 31"	Q8WWY3	19	54115410-54131719	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Ribonucleoprotein, RNA-binding"	"Disease variant, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041939, HPA061873"	Supported		Supported	Nucleoplasm		NA	NA		13000	"Cluster 27: Non-specific - Gene expression"	"Cluster 72: Non-specific - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	Nucleoplasm		"HPA041939: AB_10793938, HPA061873: AB_2684630"	"unprognostic (1.32e-1)"	"unprognostic (1.73e-2)"	"unprognostic (1.26e-2)"	"unprognostic (7.98e-2)"	"unprognostic (1.28e-1)"	"unprognostic (3.28e-2)"	"prognostic unfavorable (7.33e-4)"	"unprognostic (9.55e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.66e-1)"	"unprognostic (5.26e-3)"	"unprognostic (1.81e-2)"	"unprognostic (2.06e-1)"	"unprognostic (2.16e-1)"	"unprognostic (5.94e-2)"	"unprognostic (2.53e-1)"	"unprognostic (7.04e-2)"	35.1	36.0	26.1	24.3	27.5	33.2	35.1	26.6	31.3	39.6	26.9	42.3	23.1	39.7	12.5	37.8	35.3	18.9	38.8	26.7	26.1	34.2	44.5	29.7	33.2	27.0	26.3	39.0	29.3	28.6	33.7	23.1	26.7	37.6	13.9	8.1	33.9	23.6	48.2	40.2	34.6	19.0	25.5	39.7	35.7	33.0	27.2	26.3	36.5	23.7	23.4	38.3	35.6	28.5	83.7	169.4	55.0	89.8	34.6	33.0	59.4	68.3	53.1	74.6	72.5	82.4	63.8	89.1	54.2	49.9	36.0	49.8	64.6	78.6	46.4	82.4	298.4	66.6	108.3	97.0	51.7	120.9	59.7	54.2	36.0	62.3	43.1	39.4	79.4	74.4	96.8	46.2	49.9	82.8	103.3	64.1	53.4	78.5	187.1	89.2	71.7	81.5	51.8	120.8	61.6	72.8	88.0	83.2	44.7	24.5	52.3	62.5	81.2	100.4	84.7	43.6	109.0	58.6	97.7	98.5	75.7	81.9	71.0	25.0	44.3	30.1	47.9	53.1	51.8	43.5	47.2	51.4	52.9	44.5	39.7	40.5	9.1	54.4	48.6	45.6	61.0	51.1	26.1	27.5	26.6	31.3	26.7	26.1	27.0	26.3	26.7	25.5	27.2	28.5	38.7	35.3	26.7	17.0	35.0	42.7	38.9	96.1	46.7	31.4	31.3	37.6	35.9	32.9	54.2	25.8	14.6	95.0	40.2	29.3	60.7	74.6	5.9	34.9	34.9	47.3	34.8	32.4	13.4	62.9	90.8	42.0	33.6	31.0	31.7	53.5	27.8	27.3	66.4	30.3	12.4	38.9	57.0	22.2	43.2	7.4	38.2	33.7	40.9	9.4	61.2	51.1	48.4	13.6	14.9	63.2	30.1	48.9	34.0	37.6	46.9	62.0	43.6	32.2	39.5	36.1	53.4	125.2	77.9	33.9	42.1	76.2	41.5	54.3	46.3	32.8
PRPF40B	HYPC	ENSG00000110844	"Pre-mRNA processing factor 40 homolog B"	Q6NWY9	12	49568218-49644666	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 61.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038426, HPA038599"	Enhanced		Approved	"Nucleoplasm,Nuclear bodies,Aggresome,Cytosol"		NA	NA			"Cluster 22: NK-cells - Unknown function"	"Cluster 43: Testis - Unknown function"	"Cluster 6: T47d - Mammary gland"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	"Nuclear bodies"	"Nucleoplasm, Aggresome, Cytosol"	"HPA038426: AB_10674684, HPA038599: AB_10674689"	"unprognostic (1.03e-1)"	"unprognostic (2.32e-2)"	"unprognostic (2.44e-3)"	"unprognostic (2.36e-2)"	"unprognostic (1.83e-1)"	"unprognostic (2.47e-1)"	"unprognostic (7.50e-6)"	"unprognostic (1.02e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.45e-1)"	"unprognostic (5.06e-3)"	"unprognostic (3.31e-1)"	"unprognostic (3.29e-3)"	"unprognostic (3.23e-2)"	"unprognostic (2.05e-1)"	"unprognostic (3.01e-1)"	"unprognostic (2.80e-2)"	8.3	16.3	16.3	3.2	15.6	0.7	11.5	13.3	18.8	23.9	13.7	15.6	4.0	17.9	10.4	10.4	19.1	6.4	15.6	16.6	16.5	23.9	9.2	7.4	3.1	16.4	14.5	25.4	16.0	20.3	26.2	6.5	15.9	17.5	3.4	12.3	13.3	11.7	25.2	11.4	7.6	7.8	13.3	9.5	14.5	33.7	14.7	3.5	29.2	13.5	3.4	14.6	14.6	15.3	7.2	10.5	10.3	10.0	8.4	5.4	9.5	5.8	8.1	6.1	3.0	12.2	15.8	5.8	12.0	7.7	8.6	4.2	6.3	20.1	3.1	4.4	2.5	6.1	4.2	4.4	10.6	2.0	7.8	7.7	16.8	6.1	22.0	13.2	4.9	11.7	3.0	3.0	7.3	6.7	1.4	4.2	4.4	8.2	3.9	5.1	1.6	4.8	13.0	6.6	10.9	13.1	4.7	12.8	7.2	9.4	24.5	5.7	2.0	3.7	14.9	4.9	2.5	7.1	4.3	2.4	11.2	1.5	3.5	0.0	0.1	0.0	0.8	0.1	1.1	0.3	0.8	0.3	0.2	0.6	0.8	0.9	0.0	1.3	0.0	0.5	0.3	0.3	16.3	15.6	13.3	18.8	16.6	16.5	16.4	14.5	15.9	13.3	14.7	15.3	5.3	12.8	20.3	15.7	4.1	3.6	8.7	10.2	11.4	19.1	6.6	9.7	1.2	5.7	17.5	18.4	10.4	21.9	1.2	1.5	7.9	13.8	28.9	8.6	7.5	5.2	7.7	3.0	19.3	11.1	7.4	7.2	4.1	5.6	2.5	15.6	8.2	3.1	5.4	11.8	22.9	3.2	12.2	1.6	2.1	23.1	11.8	1.5	3.6	6.5	4.9	8.3	2.1	20.6	17.2	6.8	1.1	12.0	1.1	6.7	1.4	5.6	24.5	19.8	13.1	9.8	9.7	61.3	26.6	8.0	6.0	26.4	3.1	9.2	5.2	5.0
PRPF4B	"KIAA0536, PR4H, Prp4"	ENSG00000112739	"Pre-mRNA processing factor 4B"	Q13523	6	4021267-4064983	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020638	Approved		Supported	"Nuclear speckles"		NA	NA				"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 20: HeLa - Mitochondria"	"Cluster 52: Non-specific - Transcription"	"Nuclear speckles"		"HPA020638: AB_1855774"	"unprognostic (1.03e-1)"	"unprognostic (2.66e-1)"	"unprognostic (4.95e-2)"	"unprognostic (2.20e-1)"	"unprognostic (3.59e-3)"	"unprognostic (1.21e-2)"	"prognostic unfavorable (2.27e-4)"	"unprognostic (8.68e-3)"	"unprognostic (3.41e-2)"	"unprognostic (4.45e-3)"	"unprognostic (2.17e-1)"	"unprognostic (1.07e-1)"	"unprognostic (9.50e-3)"	"unprognostic (8.90e-2)"	"unprognostic (2.34e-1)"	"unprognostic (7.63e-3)"	"prognostic favorable (6.82e-5)"	9.1	7.2	4.8	11.3	5.4	27.3	8.1	7.5	6.7	5.8	5.2	8.6	10.2	9.9	10.1	8.4	4.4	6.1	5.0	4.7	5.1	4.2	4.3	6.8	14.2	5.4	5.5	8.4	6.8	4.2	3.3	7.6	5.3	6.3	8.6	15.9	8.4	5.5	16.3	13.3	9.0	5.6	4.9	11.2	8.1	3.8	5.5	8.8	6.5	4.5	10.0	6.7	7.0	6.9	6.0	3.9	14.4	12.1	8.3	7.3	12.3	7.7	3.4	4.7	5.2	6.9	7.1	8.1	5.7	5.1	4.8	12.8	10.1	6.8	7.1	4.4	11.1	6.7	19.1	11.5	3.6	11.2	10.6	5.7	6.9	5.4	6.6	11.0	5.1	6.5	11.6	3.1	7.4	2.7	7.2	26.3	6.0	3.8	4.3	9.9	6.1	11.2	8.4	10.2	7.9	7.3	4.7	3.9	5.5	16.9	9.6	7.9	7.3	11.2	6.5	4.3	8.2	7.5	7.9	6.9	3.2	7.6	7.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.8	5.4	7.5	6.7	4.7	5.1	5.4	5.5	5.3	4.9	5.5	6.9	122.4	109.0	103.2	35.6	110.5	83.5	64.0	43.1	69.4	88.6	80.4	49.5	79.1	61.5	75.1	97.5	89.6	61.8	151.3	94.9	72.4	64.4	15.6	115.9	143.5	85.8	75.3	79.1	42.8	56.8	49.9	78.7	88.2	113.4	90.5	96.2	61.1	85.8	41.1	106.0	49.8	88.8	50.8	71.6	49.4	20.6	98.8	71.4	35.6	49.6	97.4	81.2	118.4	50.8	68.1	62.8	61.5	89.1	101.9	62.8	55.5	89.5	71.7	184.0	59.2	105.3	85.8	66.1	76.5	66.7	91.4	63.6	106.2	93.1	87.7	65.2
PRPF6	"ANT-1, bB152O15.1, C20orf14, hPrp6, Prp6, RP60, SNRNP102, TOM, U5-102K"	ENSG00000101161	"Pre-mRNA processing factor 6"	O94906	20	63981132-64033100	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"		"Disease variant, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047106	Supported		Supported	"Nuclear speckles"		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 59: Non-specific - Translation"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 52: Non-specific - Transcription"	"Nuclear speckles"		"HPA047106: AB_10963084"	"unprognostic (1.29e-1)"	"unprognostic (9.96e-3)"	"unprognostic (7.02e-2)"	"unprognostic (9.36e-3)"	"unprognostic (1.80e-1)"	"unprognostic (2.34e-1)"	"unprognostic (1.66e-3)"	"unprognostic (3.37e-2)"	"unprognostic (1.44e-2)"	"unprognostic (1.14e-1)"	"unprognostic (5.76e-3)"	"unprognostic (2.18e-1)"	"unprognostic (3.16e-3)"	"unprognostic (6.16e-2)"	"unprognostic (8.04e-2)"	"unprognostic (7.19e-2)"	"unprognostic (5.39e-3)"	44.0	32.2	33.6	30.8	37.4	33.3	40.1	44.9	37.1	38.5	34.5	39.9	30.0	43.5	27.9	38.9	49.3	27.2	39.0	32.9	34.7	35.3	29.8	32.1	40.9	37.7	35.5	50.6	44.2	37.2	36.7	30.9	37.1	34.5	25.9	36.4	38.3	36.4	64.6	58.3	38.1	29.7	34.6	40.9	37.3	41.0	35.5	44.4	36.2	37.1	40.5	40.5	36.2	46.8	72.8	86.5	62.3	66.3	69.5	48.6	81.5	56.1	62.8	167.9	74.6	233.6	86.2	90.9	133.4	74.5	107.1	110.0	101.2	116.1	88.7	44.0	59.0	76.8	112.7	213.3	76.7	105.3	102.3	55.2	81.4	77.5	89.2	59.9	63.3	83.7	76.2	76.6	56.8	89.2	106.8	131.0	55.4	114.4	106.7	116.0	53.0	87.3	64.4	71.9	61.8	72.4	108.6	110.0	74.1	43.2	108.0	135.5	90.1	96.2	55.1	77.4	104.6	63.7	66.5	94.6	70.3	62.5	76.3	90.8	59.7	73.7	67.0	62.7	93.3	67.1	82.3	72.5	58.6	58.4	95.8	80.9	50.3	130.5	77.8	54.5	79.7	92.3	33.6	37.4	44.9	37.1	32.9	34.7	37.7	35.5	37.1	34.6	35.5	46.8	60.7	60.9	62.6	19.2	69.3	38.4	45.3	50.7	63.2	81.6	54.2	59.8	70.5	34.3	71.6	62.5	37.5	72.5	53.2	43.8	82.2	59.3	49.1	70.3	66.8	55.7	52.7	43.5	12.5	56.7	47.6	51.2	38.7	62.0	91.2	49.0	63.9	55.2	46.3	42.1	14.8	60.6	57.0	44.8	34.1	28.7	58.1	49.9	48.0	5.6	79.7	86.5	57.7	12.5	17.8	65.9	43.9	52.6	67.8	33.5	58.0	65.8	87.7	112.7	59.2	68.2	61.9	120.6	118.9	59.8	46.3	94.5	60.0	32.6	47.7	34.3
PRR13	"DKFZP564J157, FLJ23818"	ENSG00000205352	"Proline rich 13"	Q9NZ81	12	53441678-53446645	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal enterocytes: 884.9;Distal tubular cells: 1365.6;Paneth cells: 858.1;Proximal enterocytes: 1642.7;Proximal tubular cells: 1097.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA039396, HPA046219"	Uncertain		Supported	Nucleoplasm		NA	Yes			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 45: Enterocytes - Digestion"	Nucleoplasm		"HPA039396: AB_2676484, HPA046219: AB_10963936"	"unprognostic (1.09e-1)"	"prognostic favorable (9.08e-4)"	"unprognostic (1.15e-1)"	"unprognostic (3.26e-1)"	"unprognostic (8.97e-3)"	"unprognostic (4.88e-3)"	"unprognostic (1.86e-3)"	"unprognostic (7.23e-2)"	"unprognostic (1.23e-1)"	"unprognostic (3.49e-1)"	"unprognostic (1.41e-2)"	"unprognostic (5.41e-2)"	"unprognostic (6.81e-3)"	"unprognostic (1.81e-1)"	"unprognostic (1.08e-1)"	"unprognostic (2.34e-1)"	"prognostic favorable (7.55e-4)"	143.8	207.8	110.8	159.2	110.1	279.1	139.2	112.6	147.7	118.9	109.7	316.1	451.6	104.6	110.8	143.4	139.2	147.1	110.6	105.8	147.8	457.9	192.8	164.3	185.3	126.6	132.1	118.8	133.3	76.0	114.6	95.2	126.3	139.6	265.7	44.0	115.5	86.6	131.6	108.7	432.6	91.4	114.3	230.2	247.8	46.4	118.4	139.0	131.8	59.6	190.4	143.7	111.7	117.1	171.7	339.6	82.6	89.4	135.3	185.3	178.4	142.5	213.0	185.6	179.4	623.1	373.6	265.1	453.5	206.8	225.4	146.6	167.8	225.0	217.9	263.1	124.6	382.4	166.4	294.6	340.7	573.2	489.5	232.6	221.2	326.5	223.6	192.6	195.3	166.1	340.1	254.6	285.1	472.5	325.8	563.8	127.5	229.2	230.7	287.6	67.8	273.9	406.2	283.8	72.3	56.5	202.5	276.7	237.2	169.5	394.0	436.2	196.3	117.2	114.0	201.3	138.0	190.7	241.6	386.4	153.3	345.1	220.2	851.3	824.0	1620.1	511.1	941.9	503.0	888.2	563.7	545.8	649.3	855.6	520.6	557.7	2095.7	584.5	1014.6	539.0	824.8	1573.1	110.8	110.1	112.6	147.7	105.8	147.8	126.6	132.1	126.3	114.3	118.4	117.1	66.8	83.3	110.4	6.8	219.1	47.5	147.8	204.8	82.6	11.1	114.3	95.2	26.4	198.8	145.1	187.6	29.2	225.3	159.1	884.9	1365.6	228.0	12.6	182.7	67.1	80.3	169.8	99.2	6.3	253.9	337.7	76.6	263.0	127.4	186.7	53.4	78.1	152.8	355.2	18.5	7.1	346.9	193.3	345.0	174.4	8.7	58.1	266.8	108.5	9.4	384.7	85.3	297.6	4.5	12.9	332.3	858.1	45.9	120.9	174.7	1642.7	1097.6	215.9	20.9	78.9	33.6	67.1	29.7	22.8	107.1	56.0	291.0	212.7	88.4	340.0	193.1
PRR7	MGC10772	ENSG00000131188	"Proline rich 7, synaptic"	Q8TB68	5	177446445-177456286	"Predicted intracellular proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 18.7"	"Cell type enhanced"	"Detected in many"		"Suprabasal keratinocytes: 66.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"PC-3: 24.7;SK-MEL-30: 26.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA046636	Uncertain		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 51: Myeloid cells - Hemostasis"	"Nucleoplasm, Plasma membrane, Cytosol"		"HPA046636: AB_2679730"	"unprognostic (3.69e-1)"	"unprognostic (9.07e-2)"	"unprognostic (1.16e-1)"	"unprognostic (3.48e-2)"	"unprognostic (4.08e-2)"	"unprognostic (7.94e-3)"	"prognostic unfavorable (1.50e-4)"	"unprognostic (1.55e-1)"	"unprognostic (1.01e-1)"	"unprognostic (4.75e-2)"	"unprognostic (5.86e-2)"	"unprognostic (2.76e-2)"	"prognostic unfavorable (1.98e-4)"	"unprognostic (8.84e-3)"	"unprognostic (2.22e-1)"	"unprognostic (3.76e-2)"	"unprognostic (1.69e-1)"	1.3	4.0	10.7	0.8	11.9	5.8	1.6	1.2	18.7	1.8	6.3	1.3	0.7	2.5	0.0	3.7	4.8	0.1	1.8	17.9	6.7	2.3	2.3	2.0	1.0	2.7	2.1	0.7	2.9	0.4	10.4	0.1	0.7	1.8	0.1	0.3	2.7	0.2	1.2	6.0	1.8	0.1	1.9	3.1	1.3	4.4	7.4	0.5	1.2	0.0	0.5	1.0	2.0	2.8	10.7	4.1	1.1	8.1	0.0	0.6	3.5	4.9	0.9	1.3	1.8	0.9	5.6	10.2	12.6	0.7	4.1	8.8	0.7	4.5	0.5	9.0	12.8	3.1	4.3	3.1	0.9	6.2	7.2	0.9	1.8	0.6	0.3	1.2	0.6	3.9	1.6	7.1	1.3	14.3	5.2	15.8	1.9	1.6	24.7	14.5	3.6	10.5	1.7	0.8	19.8	14.1	1.9	4.8	26.2	0.0	4.3	1.0	3.8	8.0	13.5	7.1	12.0	3.9	2.3	5.1	7.7	9.8	5.9	1.9	0.1	9.7	2.3	0.4	5.5	1.5	2.5	3.9	0.1	2.8	2.4	3.1	3.7	1.7	0.5	2.4	2.0	1.2	10.7	11.9	1.2	18.7	17.9	6.7	2.7	2.1	0.7	1.9	7.4	2.8	11.8	3.2	0.0	4.9	27.9	43.3	28.0	6.8	46.7	13.6	17.2	20.3	1.6	17.2	3.7	7.3	0.0	0.8	55.9	7.4	9.8	10.6	10.6	50.2	12.3	9.2	43.0	3.4	8.6	10.8	0.9	4.8	14.3	22.3	26.7	1.0	4.6	3.1	1.5	6.7	7.0	12.3	16.2	1.9	36.5	13.8	0.9	16.7	28.4	1.0	2.3	19.7	22.6	4.0	5.7	8.6	9.8	2.2	27.3	26.7	11.6	14.2	7.0	16.6	0.0	7.8	8.1	3.3	10.7	33.2	66.9	1.4	37.0	1.5	12.3	17.3
PRRC2A	"BAT2, D6S51E, G2"	ENSG00000204469	"Proline rich coiled-coil 2A"	P48634	6	31620715-31637771	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 81.9;HEK 293: 148.3;U-266/70: 75.3;U-266/84: 86.8;U-698: 78.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB026383, HPA046791, HPA066501"	Uncertain		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA		5600		"Cluster 71: Testis - DNA repair"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 59: Non-specific - Transcription"	Cytosol	"Nucleoplasm, Plasma membrane"	"CAB026383: , HPA046791: AB_2679809, HPA066501: AB_2732747"	"unprognostic (2.07e-1)"	"unprognostic (6.84e-2)"	"unprognostic (3.82e-1)"	"unprognostic (2.25e-3)"	"unprognostic (5.04e-2)"	"unprognostic (4.63e-1)"	"unprognostic (2.42e-3)"	"unprognostic (2.09e-1)"	"unprognostic (3.07e-1)"	"unprognostic (1.14e-1)"	"unprognostic (8.29e-3)"	"unprognostic (2.38e-1)"	"unprognostic (2.75e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.57e-1)"	"unprognostic (5.40e-2)"	"unprognostic (3.10e-1)"	37.2	36.5	0.2	6.8	0.2	0.1	36.3	0.2	0.4	48.8	0.0	47.9	0.5	53.7	12.2	42.0	47.3	0.0	41.5	0.6	0.2	37.4	23.0	36.4	3.4	0.6	1.0	55.7	35.1	0.0	50.4	0.8	0.1	47.5	0.6	2.9	31.8	0.3	54.9	37.6	37.3	0.1	0.2	41.7	37.1	84.3	0.2	4.3	41.9	0.0	0.0	44.1	40.3	0.2	4.4	19.3	0.2	0.7	35.5	33.6	3.3	2.0	0.0	0.0	0.2	0.9	0.2	4.2	24.5	41.8	0.0	1.8	0.0	81.9	0.0	8.1	148.3	4.6	0.2	0.3	0.1	2.0	1.4	14.9	0.0	0.2	0.0	0.0	0.0	30.7	2.0	0.0	0.2	0.7	0.9	0.2	0.4	0.1	1.7	2.2	0.6	0.9	6.9	0.5	2.6	1.3	1.5	0.1	0.7	0.0	0.3	1.5	0.7	0.5	17.6	1.3	0.9	75.3	86.8	78.7	25.7	2.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.4	0.6	0.2	0.6	1.0	0.1	0.2	0.2	0.2	39.3	0.0	5.5	25.5	39.2	32.9	28.4	26.1	67.7	36.1	41.6	39.0	6.7	18.6	14.5	40.5	60.5	26.9	38.0	48.4	5.9	24.8	58.7	33.3	37.1	33.4	38.9	47.9	19.2	25.6	22.2	32.9	52.0	35.9	10.8	55.5	33.5	22.5	34.6	37.0	19.7	39.1	26.4	28.2	30.9	23.7	49.0	31.4	19.6	15.9	28.7	20.9	39.1	23.1	15.3	34.5	37.8	44.8	47.2	39.1	27.0	16.0	20.1	35.9	19.7	57.0	44.8	58.0	43.2	64.1	28.4	18.3	38.2	45.3	48.0	28.4
PRRT2	"DKFZp547J199, DSPB3, DYT10, EKD1, FICCA, FLJ25513, ICCA, IFITMD1, PKC"	ENSG00000167371	"Proline rich transmembrane protein 2"	Q7Z6L0	16	29811382-29815892	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"			"Disease variant, Dystonia, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ovary: 124.3"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 82.3;Cone photoreceptor cells: 31.3;Leydig cells: 36.1;Peritubular cells: 40.3;Rod photoreceptor cells: 37.1"	"Cancer enhanced"	"Detected in many"		"glioma: 5.8"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	7	"NK-cell: 3.2"	"Lineage enriched"	"Detected in single"	7	"NK-cells: 3.2"	"Cell line enhanced"	"Detected in many"		"AF22: 24.1;HeLa: 13.8;hTERT-RPE1: 14.0;REH: 17.6;U-138 MG: 14.5"									"HPA014447, HPA019203, HPA048045"	Enhanced		Supported	"Plasma membrane"		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 35: Non-specific - Unknown function"	"Cluster 12: NES - Nervous system development"	"Cluster 56: Bipolar cells - Visual perception"	"Plasma membrane"		"HPA014447: AB_1855786, HPA019203: AB_2670097, HPA048045: "	"unprognostic (7.60e-3)"	"unprognostic (3.00e-1)"	"unprognostic (8.32e-3)"	"unprognostic (4.34e-2)"	"unprognostic (3.72e-2)"	"unprognostic (1.19e-3)"	"unprognostic (2.85e-1)"	"unprognostic (1.23e-1)"	"unprognostic (9.30e-2)"	"unprognostic (1.93e-1)"	"unprognostic (4.45e-2)"	"unprognostic (3.26e-2)"	"unprognostic (3.43e-8)"	"unprognostic (1.22e-1)"	"unprognostic (1.17e-1)"	"unprognostic (5.12e-2)"	"unprognostic (2.44e-2)"	13.4	10.5	32.9	2.4	40.4	0.3	10.8	70.7	70.5	79.4	0.0	33.9	5.3	39.5	8.6	6.7	47.0	10.9	15.6	46.0	20.1	8.7	2.4	12.9	3.3	15.6	8.0	124.3	4.7	4.3	85.6	7.0	16.2	39.1	2.3	19.8	5.4	13.9	4.5	5.0	14.5	10.4	24.5	1.7	12.4	14.6	29.2	0.5	10.6	1.8	1.0	34.1	51.0	34.0	0.1	1.5	24.1	8.6	1.2	4.2	0.5	2.5	4.1	1.0	0.8	1.1	1.5	0.2	0.3	4.4	0.5	1.6	3.4	0.2	0.4	4.1	1.4	1.7	13.8	1.6	0.3	0.0	0.3	4.1	0.1	1.9	0.1	14.0	1.0	0.7	0.2	1.5	0.2	3.1	0.6	0.5	5.0	0.1	1.1	17.6	0.9	0.4	0.2	0.8	4.1	4.3	0.2	2.1	0.5	3.5	7.6	0.0	1.3	14.5	5.2	0.7	1.4	3.7	0.5	0.2	5.3	0.2	0.5	0.4	0.0	0.1	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.0	0.1	0.1	0.1	3.2	0.1	0.0	0.0	0.1	32.9	40.4	70.7	70.5	46.0	20.1	15.6	8.0	16.2	24.5	29.2	34.0	2.3	3.2	0.0	22.9	0.9	1.1	1.4	1.7	0.6	82.3	1.6	1.7	0.8	1.5	1.2	0.0	31.3	1.9	1.9	9.5	1.9	1.1	2.0	4.4	10.4	5.0	6.1	0.0	24.4	1.5	0.8	11.4	2.0	1.6	0.0	1.7	3.3	0.1	0.4	20.2	19.5	4.2	2.0	0.0	2.4	9.8	36.1	0.5	0.0	5.6	0.6	5.7	1.0	8.5	1.6	3.0	9.0	40.3	0.7	1.8	15.2	1.0	5.6	37.1	6.6	2.9	11.7	2.4	3.1	0.4	0.4	2.6	2.7	0.6	2.5	1.3
PRRX1	"PHOX1, PMX1"	ENSG00000116132	"Paired related homeobox 1"	P54821	1	170662728-170739421	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"		"Developmental protein, DNA-binding"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 351.7;Endometrial stromal cells: 158.6;Fibroblasts: 180.2;Late spermatids: 390.0;Leydig cells: 256.3;Oligodendrocyte precursor cells: 288.5;Smooth muscle cells: 206.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 367.0;ASC TERT1: 290.5;BJ: 109.7;BJ hTERT+: 213.2;HSkMC: 150.6;U-138 MG: 146.0;U-2197: 140.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051084, HPA063566"	Uncertain		Supported	Nucleoplasm		NA	NA				"Cluster 46: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	Nucleoplasm		"HPA051084: AB_2681338, HPA063566: AB_2732702"	"unprognostic (2.03e-1)"	"unprognostic (2.00e-1)"	"unprognostic (1.09e-1)"	"unprognostic (7.00e-2)"	"unprognostic (1.24e-1)"	"unprognostic (4.97e-2)"	"unprognostic (2.52e-2)"	"unprognostic (1.88e-2)"	"unprognostic (2.94e-3)"	"unprognostic (1.13e-1)"	"unprognostic (1.98e-2)"	"unprognostic (3.29e-1)"	"prognostic unfavorable (6.60e-10)"	"unprognostic (4.23e-3)"	"unprognostic (4.48e-2)"	"unprognostic (2.68e-3)"	"unprognostic (1.69e-3)"	96.3	10.2	14.5	17.7	15.2	0.0	42.9	15.4	13.4	92.0	5.4	5.6	1.1	68.6	20.3	20.1	42.3	34.1	44.2	12.6	26.2	2.3	0.4	21.7	34.6	17.4	18.5	28.2	3.8	7.5	4.9	6.3	16.8	33.5	5.7	0.1	38.5	75.6	51.7	24.1	3.6	52.4	7.9	1.9	3.4	14.2	16.5	18.7	41.6	73.9	36.3	33.0	58.8	15.0	0.0	0.0	2.1	0.0	367.0	290.5	0.1	109.7	213.2	15.0	14.8	0.0	0.1	0.1	0.0	90.2	0.0	0.0	18.5	0.0	4.7	0.0	0.2	0.0	1.6	0.0	1.2	0.0	0.0	150.6	0.0	73.4	0.4	25.7	0.0	0.0	0.0	0.1	2.2	0.0	0.0	0.2	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.8	0.0	0.0	0.1	146.0	2.6	140.4	16.9	0.0	0.0	0.0	77.3	0.0	30.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.5	15.2	15.4	13.4	12.6	26.2	17.4	18.5	16.8	7.9	16.5	15.0	49.8	0.0	0.5	114.3	0.3	16.3	0.6	0.1	4.0	0.0	1.3	10.2	29.8	0.0	0.7	0.0	0.0	0.1	0.2	0.0	0.0	1.2	351.7	4.9	158.6	11.4	0.0	0.0	17.4	0.2	0.1	180.2	0.5	3.5	0.0	0.6	0.0	0.0	0.8	0.0	5.5	0.0	0.0	0.0	27.9	390.0	256.3	2.8	14.2	124.6	0.0	0.5	0.0	288.5	0.9	0.7	0.0	104.6	0.4	1.7	0.0	0.1	0.0	0.2	52.6	59.1	206.5	15.4	1.9	1.2	11.8	0.1	2.3	0.6	0.0	1.2
PRUNE1	"DRES-17, H-PRUNE, HTCD37, PRUNE"	ENSG00000143363	"Prune exopolyphosphatase 1"	Q86TP1	1	151008420-151035713	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		Hydrolase	"Disease variant, Mental retardation, Neurodegeneration, Primary microcephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 13.0;Breast glandular cells: 9.8;Breast myoepithelial cells: 8.9;Collecting duct cells: 11.0;Granulosa cells: 8.9;Proximal tubular cells: 8.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-698: 169.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028411	Uncertain		Supported	Cytosol		NA	NA		41000	"Cluster 5: Granulocytes - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 7: Non-specific - Mitochondria"	Cytosol		"HPA028411: AB_10603229"	"unprognostic (6.24e-2)"	"unprognostic (2.24e-1)"	"unprognostic (4.17e-2)"	"prognostic unfavorable (3.86e-4)"	"unprognostic (6.91e-2)"	"unprognostic (2.02e-1)"	"unprognostic (2.12e-3)"	"unprognostic (7.05e-2)"	"unprognostic (4.08e-2)"	"unprognostic (5.92e-2)"	"unprognostic (1.73e-1)"	"unprognostic (2.65e-1)"	"prognostic unfavorable (3.48e-4)"	"unprognostic (2.18e-1)"	"unprognostic (3.21e-2)"	"unprognostic (2.42e-2)"	"unprognostic (1.36e-1)"	10.1	9.5	12.2	7.7	12.1	4.4	14.9	16.1	15.1	15.0	12.4	14.8	12.5	14.8	15.6	12.4	16.0	9.2	33.4	12.4	12.6	18.8	14.3	10.8	10.8	12.0	12.5	17.2	10.7	20.9	12.6	7.1	11.9	12.2	14.5	10.8	13.2	14.4	29.4	11.5	12.0	14.1	11.9	11.2	11.2	18.3	12.8	16.2	32.5	21.4	12.6	13.7	11.9	13.5	11.0	11.6	20.2	19.3	24.3	6.6	10.9	5.1	11.2	18.7	16.4	14.1	13.0	22.2	21.7	6.9	5.5	15.5	19.9	13.4	14.6	24.5	22.6	26.6	11.8	20.4	13.5	17.5	13.0	8.4	24.7	10.2	9.5	15.4	9.2	29.4	21.1	18.3	8.9	26.2	27.2	14.1	18.7	39.7	15.0	24.2	12.8	21.5	13.4	14.9	28.7	23.5	17.5	23.5	16.1	28.3	32.6	25.7	6.3	6.6	7.8	7.5	8.1	44.1	40.0	169.1	6.5	13.0	16.9	19.1	8.1	17.8	16.4	7.8	19.8	14.4	18.1	18.6	11.9	15.4	21.7	17.5	18.6	18.8	12.2	6.4	18.5	22.3	12.2	12.1	16.1	15.1	12.4	12.6	12.0	12.5	11.9	11.9	12.8	13.5	4.5	6.4	13.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	9.8	8.9	0.0	0.0	3.1	11.0	0.0	4.1	3.2	0.0	0.0	6.0	0.0	4.3	7.8	2.1	0.0	0.0	0.0	5.7	4.8	2.5	0.0	6.4	0.0	8.9	0.0	0.0	5.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	1.6	0.0	0.0	0.0	0.0	5.6	0.0	0.0	1.0	0.0	0.0	8.9	2.9	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	5.1	2.8	4.8	0.0	0.0
PRUNE2	"A214N16.3, bA214N16.3, BMCC1, BNIPXL, C9orf65, KIAA0367"	ENSG00000106772	"Prune homolog 2 with BCH domain"	Q8WUY3	9	76611376-76906114	"Predicted intracellular proteins, Predicted membrane proteins"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 120.6;intestine: 110.9"	"Cell type enriched"	"Detected in many"	6	"Oligodendrocytes: 918.7"	"Cancer enhanced"	"Detected in many"		"renal cancer: 15.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 51.1;LHCN-M2: 83.2;RH-30: 71.5;RPTEC TERT1: 40.1"	"Low region specificity"	"Detected in all"							"HPA022470, HPA031079"	Uncertain		Approved	"Nucleoplasm,Nucleoli,Golgi apparatus,Cytosol"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Golgi apparatus, Cytosol"	"Nucleoplasm, Nucleoli"	"HPA022470: AB_1845832, HPA031079: AB_10603230"	"unprognostic (1.21e-1)"	"unprognostic (3.65e-2)"	"unprognostic (6.06e-2)"	"unprognostic (2.13e-2)"	"unprognostic (3.23e-1)"	"unprognostic (2.43e-3)"	"unprognostic (8.56e-2)"	"unprognostic (1.15e-2)"	"unprognostic (3.60e-1)"	"unprognostic (8.69e-2)"	"unprognostic (2.11e-2)"	"unprognostic (9.79e-2)"	"prognostic favorable (1.37e-6)"	"unprognostic (7.75e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.25e-3)"	"unprognostic (3.80e-4)"	11.3	23.2	26.9	11.9	82.9	2.9	5.2	49.5	54.7	16.6	0.0	110.9	7.1	50.6	18.5	34.0	29.4	16.4	8.9	26.9	48.4	15.4	1.9	5.1	2.8	90.0	52.8	4.7	4.3	4.0	30.9	4.0	76.4	47.6	18.5	39.0	14.6	64.8	16.7	5.4	27.7	55.3	31.7	4.4	37.1	4.9	53.1	0.9	2.6	56.8	2.5	69.2	14.4	120.6	0.0	0.0	1.5	0.0	51.1	25.8	0.2	1.8	3.6	6.6	14.7	0.4	0.0	0.3	3.9	4.5	13.6	0.0	0.1	0.0	18.0	0.4	2.9	6.3	3.7	0.0	8.5	0.1	0.3	28.7	0.1	26.7	0.7	15.1	14.4	0.4	0.0	20.8	83.2	0.1	4.6	1.8	4.0	0.0	0.0	0.5	71.5	0.3	40.1	0.0	17.4	0.0	0.0	0.3	4.9	2.8	0.1	0.7	11.9	14.2	0.7	34.9	1.2	22.2	3.2	0.0	11.5	0.3	0.0	0.3	0.5	0.1	0.0	0.6	0.1	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.4	0.3	0.2	0.1	0.0	0.2	26.9	82.9	49.5	54.7	26.9	48.4	90.0	52.8	76.4	31.7	53.1	120.6	0.4	0.0	1.1	27.7	0.0	2.3	0.4	0.5	0.0	47.5	1.2	3.4	11.1	0.0	1.0	11.0	0.0	0.0	1.6	3.5	1.9	0.0	12.6	37.7	4.7	3.7	54.3	0.0	152.4	0.5	0.2	2.9	3.1	34.7	0.0	0.1	21.8	0.2	3.2	15.2	65.4	36.4	4.1	3.1	3.1	30.0	0.9	2.3	5.4	13.1	1.7	9.9	2.1	134.7	918.7	0.4	8.8	1.5	0.1	5.1	9.9	20.3	17.0	6.5	0.0	27.2	9.6	4.3	4.2	0.0	1.4	0.0	0.7	0.5	5.2	0.6
PSAP	"GLBA, SAP1, SAP2"	ENSG00000197746	Prosaposin	P07602	10	71816298-71851325	"Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Lipid metabolism, Sphingolipid metabolism"		"Disease variant, Gangliosidosis, Gaucher disease, Leukodystrophy, Metachromatic leukodystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Hofbauer cells: 2792.8;Kupffer cells: 2427.0;Macrophages: 1916.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"intermediate monocyte: 11615.6"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"ASC diff: 5104.0;hTERT-RPE1: 6978.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004426, CAB004647"	Supported		Supported	Vesicles	"Intracellular and membrane"	NA	NA		88000000	"Cluster 7: Monocytes - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 4: Macrophages - Innate immune response"	Vesicles		"CAB004647: AB_425625, HPA004426: AB_1079701"	"unprognostic (4.43e-3)"	"unprognostic (2.69e-1)"	"unprognostic (1.64e-2)"	"unprognostic (8.00e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.67e-1)"	"unprognostic (8.36e-3)"	"unprognostic (2.79e-1)"	"unprognostic (3.31e-2)"	"unprognostic (3.25e-2)"	"unprognostic (2.30e-3)"	"unprognostic (2.00e-2)"	"unprognostic (3.62e-3)"	"unprognostic (6.47e-2)"	"unprognostic (4.42e-2)"	"unprognostic (2.34e-1)"	"unprognostic (2.06e-1)"	1068.6	1192.2	831.4	874.2	946.7	834.2	683.8	873.7	831.7	1073.9	1023.0	667.1	475.6	879.3	951.2	605.5	724.7	1115.6	1413.3	830.5	1081.8	860.4	906.4	1118.6	956.1	957.6	894.0	1106.9	544.7	1167.5	563.5	869.3	885.3	773.9	625.5	665.2	580.9	936.8	1409.5	544.4	487.7	1138.6	1025.9	1045.9	664.0	489.1	1048.8	672.3	875.9	987.5	560.4	941.2	578.3	1325.1	455.9	847.4	540.4	1121.0	5104.0	2910.1	1900.2	799.9	2368.3	620.8	735.9	795.4	1131.9	245.6	1608.1	1321.6	1038.9	964.1	207.5	659.1	434.8	481.4	381.8	288.9	352.3	459.6	1970.7	188.8	1596.0	1871.8	1479.1	625.7	1177.6	6978.9	1128.1	345.8	420.5	1158.1	777.0	294.9	843.8	290.1	249.5	575.4	404.0	172.9	301.3	696.7	730.3	764.4	584.4	515.8	751.1	2248.3	3122.2	700.4	454.4	431.1	1467.0	861.8	610.0	587.1	670.5	1289.0	1038.7	435.4	1375.5	374.4	650.0	863.2	10095.9	1127.5	424.2	11615.6	349.8	466.7	342.9	368.8	3481.1	425.5	370.1	350.6	2890.4	365.8	10148.2	1758.2	422.8	15009.0	831.4	946.7	873.7	831.7	830.5	1081.8	957.6	894.0	885.3	1025.9	1048.8	1325.1	263.2	253.2	339.0	136.8	173.9	228.3	253.4	487.0	108.1	193.8	254.6	158.7	664.1	253.1	318.9	476.3	127.2	891.6	260.2	434.8	70.5	1043.6	19.3	147.0	246.6	311.4	261.9	160.5	86.1	456.1	872.6	623.8	187.6	195.2	398.1	210.8	426.9	509.2	2792.8	333.1	93.7	242.2	343.8	2427.0	779.7	54.1	458.6	1916.9	663.5	105.9	1528.9	495.6	182.3	92.5	117.6	357.7	298.3	551.8	503.0	244.8	370.6	311.6	297.2	164.3	276.1	273.6	263.8	55.2	126.3	137.2	198.0	1073.2	138.9	624.1	228.3	223.9
PSCA		ENSG00000167653	"Prostate stem cell antigen"	O43653	8	142670308-142682725	"Cancer-related genes, Predicted intracellular proteins, Predicted membrane proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"stomach 1: 3019.3"	"Cell type enriched"	"Detected in many"	4	"Gastric mucus-secreting cells: 5332.3"	"Cancer enriched"	"Detected in many"	6	"urothelial cancer: 785.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 22.4;HeLa: 45.7;OE19: 17.6;RT4: 61.7"	"Not detected"	"Not detected"			"Region enriched"	"Detected in many"	8	"spinal cord: 38.2"	"HPA030783, HPA056418"	Approved		Supported	"Plasma membrane"		NA	NA		18000		"Cluster 4: Stomach - Digestion"	"Cluster 15: RT4 - Unknown function"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Plasma membrane"		"HPA030783: AB_2673611, HPA056418: AB_2683123"	"unprognostic (1.21e-3)"	"unprognostic (1.76e-3)"	"unprognostic (3.20e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.77e-2)"	"unprognostic (7.57e-2)"	"unprognostic (1.93e-2)"	"unprognostic (7.81e-3)"	"unprognostic (8.25e-3)"	"unprognostic (2.13e-1)"	"prognostic unfavorable (5.60e-5)"	"unprognostic (6.82e-2)"	"unprognostic (2.38e-3)"	"unprognostic (4.93e-2)"	"unprognostic (2.68e-1)"	"unprognostic (3.07e-1)"	"unprognostic (1.06e-3)"	4.8	0.4	0.5	0.5	0.6	0.2	1.9	0.3	0.9	67.8	0.2	7.8	4.0	0.4	0.6	334.0	7.9	10.0	0.4	0.6	0.2	5.8	0.7	6.3	0.1	0.5	0.3	0.6	3.2	0.0	0.6	2.4	0.4	230.6	4.8	0.0	23.5	1.9	0.3	11.1	2.5	0.1	0.2	0.4	3019.3	1.4	0.5	0.4	0.4	0.0	15.0	629.0	167.7	0.5	10.7	0.7	0.0	0.0	2.1	6.8	10.6	4.9	1.1	2.1	1.8	0.1	22.4	0.0	0.4	0.4	8.1	2.1	0.0	0.4	1.3	0.6	0.0	0.0	45.7	0.0	0.1	0.0	1.5	6.0	7.8	4.6	0.0	0.6	0.0	0.0	0.0	0.0	1.7	5.8	1.7	0.6	1.2	17.6	1.2	0.7	0.0	0.9	1.0	61.7	0.2	0.5	5.1	15.6	3.5	0.3	0.2	0.2	1.0	1.5	1.7	2.7	0.0	1.9	0.1	0.0	2.9	0.8	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.6	0.3	0.9	0.6	0.2	0.5	0.3	0.4	0.2	0.5	0.5	0.2	3.2	1.5	1.6	7.7	0.9	26.0	120.0	0.0	0.0	3.9	2.7	1.2	71.4	894.2	1.8	0.0	2.3	0.0	1.9	7.9	3.2	0.3	1.3	0.1	1.1	275.1	0.0	0.3	1.2	5.0	3.3	5332.3	0.3	0.0	0.3	0.0	0.0	0.6	0.0	0.2	12.9	179.0	0.6	1.0	0.4	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.2	57.1	0.2	0.0	13.4	238.7	0.3	0.4	994.9	0.0	0.0	0.0	48.9	0.0	0.5	13.1	1.3	28.5	4.6	0.0	0.9	1241.5
PSEN1	"AD3, FAD, PS1, S182"	ENSG00000080815	"Presenilin 1"	P49768	14	73136418-73223691	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Apoptosis, Cell adhesion, Notch signaling pathway"	"Hydrolase, Protease"	"Alzheimer disease, Amyloidosis, Cancer-related genes, Cardiomyopathy, Disease variant, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	5	"Oligodendrocytes: 395.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB006844, HPA030760, HPA067496"	Approved		Supported	"Nucleoplasm,Golgi apparatus,Cell Junctions"		Yes	No			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 45: Intestine - Brush border"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Golgi apparatus"	"Nucleoplasm, Cell Junctions"	"CAB006844: , HPA030760: AB_10696211, HPA067496: AB_2685853"	"unprognostic (1.67e-1)"	"unprognostic (4.79e-2)"	"unprognostic (7.39e-2)"	"unprognostic (8.68e-3)"	"unprognostic (3.84e-1)"	"unprognostic (5.48e-3)"	"prognostic unfavorable (1.99e-5)"	"unprognostic (1.65e-1)"	"unprognostic (8.99e-2)"	"unprognostic (8.45e-2)"	"unprognostic (1.76e-3)"	"unprognostic (2.74e-1)"	"prognostic favorable (1.52e-8)"	"unprognostic (2.29e-1)"	"unprognostic (2.32e-1)"	"unprognostic (7.12e-3)"	"unprognostic (1.85e-1)"	25.1	22.6	44.3	26.5	80.7	39.6	28.2	62.4	56.0	28.1	48.9	49.5	50.2	25.3	26.9	35.2	22.9	31.7	18.0	47.4	51.6	35.5	31.9	32.1	22.4	73.0	63.8	22.0	22.9	35.1	11.6	43.1	71.5	24.3	46.3	23.4	22.9	23.4	18.4	38.2	49.0	27.1	55.7	22.6	31.0	32.5	60.8	26.2	36.9	23.3	30.7	35.0	19.2	119.1	37.1	55.9	50.6	20.0	68.9	49.9	46.7	52.5	60.1	52.6	66.7	69.9	88.9	23.7	34.1	50.5	43.0	94.9	43.2	40.1	57.3	54.6	26.7	27.1	35.1	34.4	63.8	27.7	50.7	50.4	71.9	44.3	54.4	48.5	43.2	26.2	31.0	46.6	50.0	72.8	21.0	35.7	22.0	64.5	40.4	26.4	42.7	30.2	73.7	76.5	28.1	38.3	57.4	53.0	47.1	45.4	66.3	60.7	45.7	53.1	43.5	44.1	25.3	30.3	47.9	23.7	44.9	32.8	33.3	126.8	94.5	96.3	23.1	106.0	22.6	23.1	22.3	19.0	83.4	31.8	20.7	20.1	129.3	42.8	125.0	43.6	37.0	70.3	44.3	80.7	62.4	56.0	47.4	51.6	73.0	63.8	71.5	55.7	60.8	119.1	22.2	28.9	30.5	35.9	25.8	28.6	24.6	24.7	12.0	17.1	25.0	17.7	12.5	15.7	30.2	23.9	39.6	27.1	30.7	79.1	5.9	27.1	22.9	26.3	26.4	22.3	16.2	12.0	38.9	26.7	29.2	23.7	32.1	47.4	18.3	29.6	15.7	24.6	30.5	13.5	40.2	39.5	24.4	50.5	40.8	12.9	16.4	52.3	16.0	39.4	51.8	13.8	14.4	48.7	395.8	38.2	58.8	15.4	23.6	38.8	76.2	13.0	29.0	28.0	26.3	20.0	19.0	40.2	14.4	20.4	33.0	49.9	21.6	18.6	41.3	51.5
PSKH1		ENSG00000159792	"Protein serine kinase H1"	P11801	16	67893254-67929676	"Enzymes, Metabolic proteins, Predicted membrane proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA053927, HPA062763"	Approved		Supported	"Nuclear speckles,Cytosol"		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 40: Granulosa cells - Unknown function"	"Nuclear speckles, Cytosol"		"HPA053927: AB_2682312, HPA062763: "	"unprognostic (2.57e-2)"	"unprognostic (8.91e-3)"	"unprognostic (1.88e-1)"	"unprognostic (5.79e-2)"	"unprognostic (3.26e-1)"	"unprognostic (3.89e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.29e-2)"	"unprognostic (3.03e-1)"	"unprognostic (1.66e-2)"	"unprognostic (9.85e-3)"	"unprognostic (8.32e-2)"	"prognostic favorable (4.28e-10)"	"unprognostic (1.46e-1)"	"unprognostic (1.99e-1)"	"unprognostic (4.15e-2)"	"unprognostic (3.90e-3)"	14.3	18.6	12.8	9.6	14.5	5.2	14.0	12.2	13.5	13.5	19.5	18.2	13.7	19.3	10.0	16.9	18.7	10.1	17.6	11.2	11.5	20.5	16.5	12.7	10.6	15.0	14.9	19.4	26.3	32.9	13.2	7.6	13.4	15.1	10.8	4.0	18.1	12.7	15.3	13.8	15.7	15.7	13.2	12.8	21.4	21.8	13.6	12.0	15.0	13.5	8.5	16.5	9.5	14.9	13.0	22.7	25.2	28.1	38.4	19.3	16.3	15.2	23.0	15.8	14.0	17.2	18.2	12.2	22.7	25.7	12.7	19.2	14.7	15.6	5.3	4.8	16.4	13.9	16.8	22.0	26.3	13.4	8.0	35.7	26.7	18.8	19.6	21.3	23.3	22.5	21.6	5.1	16.7	28.7	18.3	8.6	24.2	14.0	13.9	27.7	9.7	25.3	18.6	16.0	21.8	26.0	47.3	12.8	15.8	9.9	23.5	23.9	20.8	17.7	6.2	15.0	7.7	15.3	8.7	26.2	21.4	8.8	19.9	0.0	2.0	1.9	2.0	2.2	1.4	1.5	1.5	2.0	2.1	1.2	1.2	1.7	1.0	2.1	1.5	1.5	0.8	1.7	12.8	14.5	12.2	13.5	11.2	11.5	15.0	14.9	13.4	13.2	13.6	14.9	5.5	0.0	3.6	4.6	2.9	1.1	3.1	5.2	2.2	11.1	5.3	4.6	2.3	7.2	3.8	5.5	6.2	6.2	3.0	11.5	11.7	6.0	14.4	5.8	6.5	5.2	10.8	3.0	4.6	7.4	4.8	5.4	5.1	4.8	6.3	13.0	5.3	10.3	4.8	6.7	6.1	6.2	10.2	6.3	1.6	22.1	4.7	2.9	5.4	3.7	4.8	11.0	3.1	5.5	9.2	7.6	4.5	7.9	3.0	3.6	10.0	8.1	4.9	6.9	13.1	6.3	6.1	6.7	6.1	5.4	1.6	5.9	3.8	10.7	7.4	2.2
PSMA1	"HC2, MGC14542, MGC14575, MGC14751, MGC1667, MGC21459, MGC22853, MGC23915, NU, PROS30"	ENSG00000129084	"Proteasome 20S subunit alpha 1"	P25786	11	14504874-14643635	"Enzymes, Predicted intracellular proteins"	Immunity			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Syncytiotrophoblasts: 627.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB033765, HPA037646, HPA043891, CAB079995"	Supported		Supported	"Nucleoplasm,Nuclear bodies,Centrosome"		NA	NA		20000000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 47: Cytotrophoblasts - Unknown function"	Nucleoplasm	"Nuclear bodies, Centrosome"	"CAB033765: AB_2253026, CAB079995: , HPA037646: AB_10670386, HPA043891: AB_2678718"	"unprognostic (1.72e-2)"	"unprognostic (4.97e-2)"	"unprognostic (7.33e-2)"	"unprognostic (4.74e-2)"	"unprognostic (7.52e-2)"	"unprognostic (6.66e-3)"	"prognostic unfavorable (3.79e-5)"	"unprognostic (3.28e-3)"	"unprognostic (7.44e-2)"	"unprognostic (3.43e-3)"	"unprognostic (8.27e-3)"	"unprognostic (8.77e-2)"	"prognostic unfavorable (4.03e-11)"	"unprognostic (1.93e-1)"	"unprognostic (1.69e-1)"	"unprognostic (4.66e-2)"	"unprognostic (1.23e-2)"	87.2	85.5	55.1	94.9	57.8	135.8	96.2	55.4	68.2	76.8	58.7	92.5	96.4	80.7	108.0	94.7	79.4	79.6	140.5	59.4	64.4	98.4	139.2	77.5	114.9	55.8	56.6	79.4	54.6	78.5	50.4	113.0	58.8	81.7	101.9	63.2	74.4	85.8	168.7	80.5	86.1	96.1	56.6	75.6	75.7	56.2	60.2	122.2	88.4	152.6	109.9	111.2	56.0	58.6	408.8	279.8	227.8	275.7	223.7	225.5	193.3	232.9	305.2	348.3	283.9	244.2	500.1	349.5	262.1	248.6	315.4	303.1	259.3	290.1	328.3	344.0	389.6	220.4	190.5	326.1	291.0	355.3	277.5	217.8	171.6	188.9	390.7	252.7	347.0	271.6	398.9	283.4	315.2	277.8	334.0	319.5	191.6	340.5	414.1	223.3	336.1	217.5	313.0	304.7	188.2	119.3	246.6	273.9	229.0	233.8	164.4	222.9	272.0	226.2	222.9	402.7	295.4	123.3	366.1	319.9	334.8	291.1	296.6	115.5	191.2	47.5	97.7	139.8	128.0	104.1	110.8	109.7	243.3	95.3	98.5	94.4	36.3	145.1	137.5	138.7	154.9	235.8	55.1	57.8	55.4	68.2	59.4	64.4	55.8	56.6	58.8	56.6	60.2	58.6	119.0	83.3	90.2	64.3	101.7	142.9	231.2	365.7	76.2	50.3	105.7	125.9	0.0	82.9	176.1	88.3	18.8	469.5	135.3	49.2	256.3	228.5	75.5	84.0	94.0	135.5	40.1	163.9	56.8	233.1	370.6	128.5	66.8	79.8	78.2	134.7	95.3	127.9	292.9	57.2	66.3	63.6	231.9	161.8	170.5	36.3	116.5	153.6	144.1	122.7	263.7	111.6	168.9	64.8	35.3	223.2	88.6	127.5	112.1	209.1	135.0	257.1	115.1	54.8	85.5	99.2	129.8	174.9	80.1	114.3	151.9	627.3	130.7	137.2	97.1	248.1
PSMA4	"HC9, HsT17706"	ENSG00000041357	"Proteasome 20S subunit alpha 4"	P25789	15	78540405-78552417	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004973, HPA055466, HPA060613"	Supported		Supported	Nucleoplasm,Vesicles,Cytosol		No	No		13000000	"Cluster 7: Monocytes - Unknown function"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 32: U-937 - Innate immune response"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Nucleoplasm, Cytosol"	Vesicles	"CAB004973: AB_425627, HPA055466: AB_2682824, HPA060613: AB_2684332"	"unprognostic (1.80e-1)"	"unprognostic (7.08e-3)"	"unprognostic (1.31e-1)"	"unprognostic (1.62e-1)"	"unprognostic (4.71e-2)"	"unprognostic (5.35e-2)"	"unprognostic (6.26e-3)"	"unprognostic (1.09e-1)"	"unprognostic (3.28e-2)"	"unprognostic (2.08e-3)"	"unprognostic (2.75e-3)"	"unprognostic (1.26e-1)"	"prognostic unfavorable (6.74e-10)"	"unprognostic (1.68e-1)"	"unprognostic (1.56e-1)"	"unprognostic (3.78e-3)"	"unprognostic (6.32e-3)"	92.9	105.0	62.5	106.3	64.4	107.6	87.5	66.2	98.8	78.9	65.6	105.1	108.9	89.6	74.5	118.2	71.6	66.0	108.4	64.7	69.1	98.1	152.1	87.9	136.9	67.6	65.5	64.6	67.3	73.4	54.4	85.8	67.5	97.2	109.6	50.3	70.3	64.2	180.6	78.3	101.3	99.3	69.3	115.3	88.5	109.9	65.6	156.5	70.6	121.6	128.7	118.8	81.2	69.9	274.2	386.9	327.7	290.8	202.1	189.5	256.3	250.2	199.9	301.4	320.6	404.9	386.9	590.8	359.7	232.5	337.4	363.9	669.1	271.8	289.1	244.2	465.7	497.6	271.6	330.1	326.9	512.6	294.5	154.6	166.8	255.0	250.9	185.4	330.7	319.1	544.2	225.0	249.6	392.3	347.5	477.4	309.7	315.3	224.5	297.7	432.9	198.9	309.5	469.4	287.6	209.9	401.3	289.5	327.5	402.2	267.8	414.7	265.8	223.7	298.6	249.3	434.2	204.0	517.9	556.2	209.9	756.7	252.6	126.0	251.9	172.9	136.2	403.9	140.3	156.0	142.0	144.7	327.4	119.9	111.7	137.0	112.8	209.4	394.8	185.4	216.8	405.6	62.5	64.4	66.2	98.8	64.7	69.1	67.6	65.5	67.5	69.3	65.6	69.9	119.0	128.2	118.5	17.3	124.1	231.6	269.6	765.7	84.2	57.8	88.5	95.8	163.7	105.8	327.0	121.4	10.4	478.9	128.4	145.3	311.0	296.2	689.4	158.0	183.6	162.5	146.2	153.2	18.0	292.7	450.6	159.9	78.0	126.0	174.2	152.9	114.9	178.9	320.4	72.3	19.6	216.2	506.6	143.2	201.7	399.0	151.0	176.9	133.4	23.4	308.6	63.5	149.3	11.1	21.5	256.0	165.7	147.4	108.0	249.3	195.8	367.2	280.0	39.8	151.2	95.4	241.1	417.1	181.0	106.4	212.8	447.1	128.6	166.7	234.7	258.4
PSMA5	ZETA	ENSG00000143106	"Proteasome 20S subunit alpha 5"	P28066	1	109399042-109426448	"Enzymes, Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"MOLT-4: 54.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028392, HPA028398, HPA028441"	Approved		Supported	Cytosol		NA	NA		20000000	"Cluster 44: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 10: Non-specific - Unknown function"	Cytosol		"HPA028392: AB_10600115, HPA028398: AB_10602310, HPA028441: AB_10602003"	"unprognostic (3.82e-2)"	"unprognostic (3.09e-3)"	"prognostic favorable (1.45e-5)"	"unprognostic (1.57e-1)"	"unprognostic (2.71e-1)"	"unprognostic (1.52e-2)"	"prognostic unfavorable (2.28e-4)"	"unprognostic (5.95e-2)"	"unprognostic (1.71e-2)"	"unprognostic (1.13e-3)"	"unprognostic (4.20e-3)"	"unprognostic (3.05e-1)"	"unprognostic (1.07e-3)"	"unprognostic (3.99e-2)"	"unprognostic (2.34e-1)"	"unprognostic (8.81e-3)"	"unprognostic (1.05e-1)"	3.5	4.7	5.1	4.3	6.2	3.8	6.8	4.0	7.7	5.8	2.7	7.4	7.5	5.5	8.6	6.8	9.1	5.4	7.7	6.8	6.7	10.9	20.2	5.9	12.7	5.0	4.7	5.2	3.2	5.9	1.4	6.9	4.5	5.4	8.5	4.8	5.0	6.2	6.1	6.2	6.7	6.5	4.1	4.8	5.2	3.5	5.3	6.4	10.2	5.1	9.3	6.1	0.9	6.6	10.1	11.7	6.2	5.7	17.6	16.9	12.6	4.9	29.8	23.2	17.9	15.0	5.5	28.1	7.8	21.2	4.2	5.7	13.8	13.7	16.1	10.7	13.1	13.4	7.7	12.4	14.0	15.2	5.3	8.5	12.3	12.7	14.3	6.2	15.0	8.2	17.1	6.5	12.4	18.6	54.4	10.3	5.7	7.0	16.5	4.4	16.9	7.4	19.0	11.5	7.3	5.2	10.5	16.2	8.9	5.0	5.9	14.1	11.7	4.6	4.6	7.9	10.3	3.6	11.6	19.7	20.0	26.0	7.4	11.0	4.3	3.1	7.7	6.3	8.4	5.7	9.0	8.3	5.9	4.7	9.7	9.7	1.4	7.2	6.1	4.2	11.4	7.0	5.1	6.2	4.0	7.7	6.8	6.7	5.0	4.7	4.5	4.1	5.3	6.6	68.9	41.7	56.8	9.4	77.4	63.6	73.5	231.0	38.1	32.6	59.5	75.7	89.5	75.8	120.9	42.3	6.2	227.0	114.5	82.1	140.8	164.9	82.0	157.6	74.1	71.6	56.3	85.0	21.7	183.0	181.4	60.4	74.9	81.9	82.4	77.7	51.4	117.4	166.9	13.5	18.4	144.1	168.9	57.8	73.6	23.4	67.7	86.3	58.7	15.0	184.8	50.2	114.4	13.0	20.2	191.6	103.5	62.1	113.1	122.2	138.0	205.6	172.4	31.7	46.0	56.1	182.6	120.3	89.1	70.4	65.9	241.2	106.1	121.4	135.3	104.2
PSMA6	"IOTA, MGC22756, MGC2333, MGC23846, p27K, PROS27"	ENSG00000100902	"Proteasome 20S subunit alpha 6"	P60900	14	35278633-35317493	"Enzymes, Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 156.3;Late spermatids: 474.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA003049	Approved		Supported	Nucleoplasm		NA	NA		18000000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 25: Spermatids - Spermatogenesis"	Nucleoplasm		"HPA003049: AB_1079703"	"unprognostic (9.68e-3)"	"unprognostic (5.91e-2)"	"unprognostic (1.90e-2)"	"unprognostic (8.07e-2)"	"unprognostic (3.42e-2)"	"unprognostic (4.11e-3)"	"unprognostic (7.48e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.16e-1)"	"prognostic favorable (3.27e-4)"	"unprognostic (1.29e-3)"	"unprognostic (2.63e-1)"	"unprognostic (1.52e-2)"	"unprognostic (2.05e-1)"	"unprognostic (5.45e-2)"	"unprognostic (3.49e-1)"	"unprognostic (5.08e-2)"	118.4	141.3	88.3	117.3	92.4	155.5	131.1	88.9	140.7	81.3	86.6	128.6	115.1	82.4	98.7	126.0	84.0	69.7	169.1	92.2	97.6	98.0	172.8	123.6	137.6	92.6	90.5	71.3	91.9	82.8	83.2	120.7	96.0	74.7	130.0	63.9	87.8	81.1	350.1	107.5	114.8	94.4	92.8	114.4	95.9	247.9	94.7	290.1	82.3	203.9	139.7	132.6	85.7	92.4	502.2	367.2	257.6	264.9	209.8	214.5	523.1	252.2	300.3	368.2	329.0	338.8	341.7	322.9	492.1	244.4	220.4	337.5	306.6	280.0	434.5	337.9	170.1	257.6	233.6	1011.6	235.8	542.0	225.8	166.7	229.4	256.6	324.7	178.2	312.2	548.1	284.2	220.4	298.7	522.9	838.2	458.2	249.3	391.0	407.0	1249.4	261.3	256.9	312.8	634.9	275.1	230.8	285.5	402.2	274.7	211.9	473.8	351.4	267.1	235.8	231.8	245.7	283.6	234.0	576.3	605.9	192.4	335.7	272.0	232.1	364.6	242.2	241.0	344.8	243.0	212.8	230.9	248.9	373.6	171.5	182.5	217.5	131.9	300.6	343.7	385.3	317.0	711.5	88.3	92.4	88.9	140.7	92.2	97.6	92.6	90.5	96.0	92.8	94.7	92.4	20.8	44.8	40.7	20.2	37.7	33.3	14.9	37.2	69.4	13.7	16.5	15.0	1.4	22.8	45.7	14.7	25.0	32.2	24.8	22.4	21.5	34.2	156.3	21.2	14.9	30.5	18.0	56.8	32.7	36.7	26.0	28.4	46.4	28.2	54.5	10.1	29.6	20.0	22.6	25.2	31.2	18.3	22.4	36.7	89.5	474.9	22.7	62.2	24.9	22.5	34.1	8.6	34.0	20.6	29.4	32.8	19.5	17.3	114.6	15.9	43.1	25.4	59.5	19.4	13.1	17.8	31.3	35.1	20.0	89.8	33.1	41.3	53.7	9.2	22.2	17.1
PSMB1	"HC5, PMSB1"	ENSG00000008018	"Proteasome 20S subunit beta 1"	P20618	6	170535120-170553307	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Syncytiotrophoblasts: 1197.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029635, HPA029637, CAB033911"	Enhanced		Supported	Nucleoplasm		NA	NA		15000000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"CAB033911: AB_2268890, HPA029635: AB_10599738, HPA029637: AB_10601793"	"unprognostic (2.78e-2)"	"unprognostic (3.10e-2)"	"unprognostic (6.73e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.20e-1)"	"unprognostic (5.41e-3)"	"unprognostic (2.36e-2)"	"unprognostic (3.32e-2)"	"unprognostic (8.39e-2)"	"unprognostic (4.28e-2)"	"unprognostic (3.07e-1)"	"unprognostic (1.09e-1)"	"prognostic unfavorable (3.76e-6)"	"unprognostic (3.63e-1)"	"unprognostic (7.50e-2)"	"unprognostic (1.45e-3)"	"unprognostic (9.62e-2)"	214.3	191.2	127.8	138.1	131.9	206.8	186.4	129.8	150.7	146.1	131.9	175.9	147.4	174.9	279.4	175.2	157.1	114.5	222.3	127.7	139.0	179.7	308.6	158.3	175.8	129.2	127.5	136.6	153.1	169.2	151.8	173.8	133.2	130.9	166.9	98.5	141.7	151.3	355.2	192.2	149.1	164.3	137.6	165.7	156.8	114.3	132.9	180.5	142.4	239.2	206.8	168.8	143.4	143.0	309.8	284.9	396.2	514.9	347.3	271.2	421.6	288.3	422.7	471.6	478.5	628.9	259.3	449.1	366.2	390.0	430.8	303.7	446.0	459.8	488.7	460.2	502.1	384.4	277.6	799.6	406.3	455.8	327.1	311.5	277.6	455.6	293.1	322.4	409.9	278.1	774.3	373.2	436.9	835.1	343.5	633.0	362.7	558.1	387.9	326.9	314.1	571.6	495.1	183.6	394.5	321.6	277.1	424.5	231.5	351.1	290.9	648.4	313.3	190.4	304.8	466.9	543.2	315.8	454.8	565.8	443.7	510.9	417.5	258.4	431.9	290.2	265.2	416.1	313.5	386.4	306.0	290.7	523.1	305.7	288.1	279.8	249.3	408.2	384.4	297.4	442.6	652.5	127.8	131.9	129.8	150.7	127.7	139.0	129.2	127.5	133.2	137.6	132.9	143.0	242.7	112.2	148.5	19.9	182.1	217.2	351.4	750.7	117.8	120.2	168.2	236.3	232.3	208.8	335.5	141.6	41.7	876.6	175.0	222.0	401.1	498.3	332.4	224.6	190.2	243.8	165.3	223.9	23.5	651.4	790.8	245.5	109.6	215.1	189.5	226.1	168.8	349.8	394.3	119.5	25.1	251.6	417.1	165.3	222.3	81.9	256.3	207.3	231.3	20.6	364.5	237.8	206.0	19.6	43.3	525.5	240.1	235.9	253.4	334.9	327.6	537.0	310.0	135.9	190.7	181.2	500.2	247.8	196.3	153.3	215.8	1197.8	182.1	283.7	276.7	365.4
PSMB4	"HN3, PROS26"	ENSG00000159377	"Proteasome 20S subunit beta 4"	P28070	1	151399560-151401937	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Host-virus interaction"		"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006700, HPA073499"	Approved		Uncertain	Nucleoplasm,Mitochondria		NA	NA		12000000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm	Mitochondria	"HPA006700: AB_1079704, HPA073499: "	"unprognostic (1.11e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.69e-1)"	"unprognostic (2.52e-1)"	"unprognostic (1.63e-1)"	"unprognostic (5.74e-2)"	"prognostic unfavorable (7.45e-4)"	"unprognostic (2.27e-1)"	"unprognostic (1.69e-1)"	"unprognostic (4.37e-3)"	"unprognostic (3.73e-1)"	"unprognostic (3.77e-1)"	"prognostic unfavorable (2.90e-10)"	"unprognostic (5.33e-2)"	"unprognostic (2.46e-2)"	"unprognostic (3.82e-2)"	"unprognostic (5.85e-2)"	189.5	242.7	200.2	156.7	202.1	172.9	174.2	210.6	212.4	167.0	201.9	194.3	150.0	195.5	225.6	170.4	178.3	139.1	241.8	201.7	212.9	196.6	269.5	143.2	214.0	206.8	203.9	179.5	164.0	218.6	168.0	187.1	211.7	162.4	166.4	94.3	169.6	190.6	299.1	186.6	152.8	191.7	210.5	173.8	171.8	69.0	205.8	233.5	156.1	237.5	235.4	196.7	151.3	218.4	428.3	451.9	373.0	447.8	412.9	392.3	507.8	247.6	549.2	719.3	503.1	608.6	569.5	384.1	730.7	424.3	379.1	419.7	383.2	472.7	407.6	535.6	391.1	268.6	320.8	463.3	444.4	377.0	355.7	431.7	444.8	672.5	276.2	364.8	506.1	419.1	434.3	740.0	512.7	1174.2	463.5	452.0	952.8	638.6	576.2	433.8	266.9	688.2	594.4	354.2	408.6	488.0	283.6	626.5	879.8	459.1	564.1	594.6	320.7	310.4	326.1	333.8	557.0	726.9	902.5	769.1	459.5	337.8	667.8	291.8	343.4	227.0	265.0	342.2	314.8	293.6	303.7	301.0	421.7	257.5	260.4	272.8	251.5	347.3	270.5	468.1	405.1	395.2	200.2	202.1	210.6	212.4	201.7	212.9	206.8	203.9	211.7	210.5	205.8	218.4	72.2	153.8	127.4	10.1	82.2	76.6	81.9	131.5	82.0	56.3	62.0	71.6	128.0	68.6	123.2	71.7	16.7	209.8	79.7	87.8	103.7	127.9	16.0	118.1	107.5	97.7	66.4	87.1	10.4	195.8	146.7	91.9	47.4	110.0	111.1	81.1	92.8	151.7	125.0	48.8	11.5	80.5	89.5	108.1	88.8	15.6	104.4	89.4	96.0	12.2	186.2	89.5	64.9	6.6	14.7	131.7	75.0	105.3	89.1	75.5	117.5	148.9	141.5	62.8	65.7	86.0	127.5	54.5	49.7	80.0	75.9	267.3	80.2	124.5	96.0	89.1
PSMB5	MB1	ENSG00000100804	"Proteasome 20S subunit beta 5"	P28074	14	23016543-23035230	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction"	"Hydrolase, Protease, Threonine protease"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Hep G2: 1146.8"	"Low region specificity"	"Detected in all"							"HPA049518, HPA061796"	Approved		Supported	Nucleoplasm,Centrosome		NA	NA		6200000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 10: Non-specific - Unknown function"	"Nucleoplasm, Centrosome"		"HPA049518: AB_2680802, HPA061796: AB_2684612"	"unprognostic (3.03e-1)"	"unprognostic (1.99e-2)"	"unprognostic (8.35e-2)"	"unprognostic (6.13e-2)"	"unprognostic (1.24e-1)"	"prognostic unfavorable (2.85e-4)"	"prognostic unfavorable (2.90e-5)"	"unprognostic (2.55e-2)"	"unprognostic (9.95e-2)"	"prognostic favorable (1.08e-4)"	"unprognostic (2.06e-1)"	"unprognostic (1.19e-1)"	"unprognostic (5.30e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.95e-1)"	"unprognostic (4.95e-2)"	"prognostic unfavorable (4.73e-4)"	84.0	116.0	129.1	58.7	134.2	32.0	81.0	141.4	134.3	71.3	141.1	80.8	61.1	71.0	129.5	102.3	93.3	61.0	136.8	136.4	141.1	98.5	119.1	64.7	49.0	137.9	138.4	61.6	80.9	143.5	80.1	90.1	145.2	76.8	88.7	59.7	73.5	78.6	332.4	76.0	53.0	103.4	141.3	50.3	81.0	57.8	136.5	79.5	72.3	274.1	68.6	92.1	68.4	146.5	181.0	398.9	250.6	245.5	360.4	318.9	261.8	252.0	307.3	446.1	376.1	329.2	282.2	228.0	228.1	352.1	298.4	239.7	428.4	320.2	401.9	139.9	311.4	146.9	260.3	1146.8	287.3	170.2	162.1	354.2	292.0	331.8	264.1	289.7	475.5	190.5	218.6	121.5	376.0	557.2	97.6	218.4	285.7	341.6	631.4	133.8	197.7	150.7	349.9	256.6	336.0	251.0	179.9	354.8	245.4	322.2	175.0	217.7	254.1	212.4	210.1	197.3	247.8	99.7	218.4	158.8	164.9	140.8	274.6	97.8	127.6	58.0	89.4	125.6	103.5	103.8	101.1	85.1	137.6	99.7	135.0	102.5	48.1	67.4	92.7	172.4	91.3	147.8	129.1	134.2	141.4	134.3	136.4	141.1	137.9	138.4	145.2	141.3	136.5	146.5	94.2	76.9	69.2	16.0	47.3	140.2	174.1	461.5	100.7	61.0	130.4	135.5	157.6	112.9	240.4	95.6	29.2	400.1	40.2	75.0	275.9	277.7	93.0	149.0	109.5	150.0	154.6	82.5	17.6	231.3	435.2	139.9	73.9	88.0	31.0	162.6	89.6	171.6	221.6	70.7	18.0	109.2	329.6	57.5	80.9	106.4	118.7	64.0	115.6	15.9	138.2	170.8	25.7	11.6	29.4	285.7	88.0	122.2	78.2	185.1	81.2	437.8	268.9	71.8	98.6	87.1	355.1	174.4	81.6	144.7	157.1	430.2	43.4	215.7	148.9	215.3
PSMB6	"DELTA, Y"	ENSG00000142507	"Proteasome 20S subunit beta 6"	P28072	17	4796144-4798502	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction"	"Hydrolase, Protease, Threonine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023312, HPA063656"	Supported		Supported	Nucleoplasm,Cytosol		NA	NA		1400000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm	Cytosol	"HPA023312: AB_1855828, HPA063656: AB_2685078"	"unprognostic (2.71e-1)"	"unprognostic (1.86e-2)"	"unprognostic (2.75e-1)"	"unprognostic (3.32e-3)"	"unprognostic (8.80e-2)"	"unprognostic (1.44e-1)"	"unprognostic (2.73e-1)"	"unprognostic (2.22e-2)"	"unprognostic (2.37e-1)"	"unprognostic (2.64e-2)"	"unprognostic (1.98e-2)"	"unprognostic (7.47e-2)"	"prognostic unfavorable (5.93e-4)"	"unprognostic (1.81e-1)"	"unprognostic (2.34e-1)"	"unprognostic (5.27e-2)"	"unprognostic (5.66e-2)"	92.7	107.8	130.1	82.2	133.7	126.9	107.0	138.1	141.2	92.6	137.4	116.3	76.9	101.9	150.9	140.6	99.2	68.3	201.6	132.8	138.1	134.8	184.6	86.2	90.1	135.7	134.1	63.7	99.3	173.3	82.5	119.8	138.7	84.8	118.3	62.6	100.0	114.2	358.6	114.9	77.0	135.3	136.0	90.4	103.8	76.6	133.5	147.4	88.7	339.5	140.5	110.6	89.2	140.3	279.8	478.2	251.6	216.4	209.9	188.1	289.7	144.1	300.1	431.3	336.0	358.7	220.5	215.0	277.9	348.1	246.5	273.8	388.0	404.4	418.0	281.9	409.7	128.0	315.3	422.7	242.0	133.5	194.4	178.3	305.1	377.4	355.7	241.5	426.5	335.8	199.4	316.6	336.1	331.8	237.4	221.8	214.1	356.2	328.2	261.9	178.7	284.6	326.6	185.3	146.9	179.9	206.6	158.9	148.6	261.4	194.5	147.2	205.1	210.8	158.9	286.4	355.2	130.8	191.8	132.9	301.3	242.1	259.3	410.6	603.3	343.2	347.5	589.9	355.9	668.6	373.1	384.0	624.9	640.8	319.8	329.3	210.5	424.4	549.4	585.5	556.2	817.2	130.1	133.7	138.1	141.2	132.8	138.1	135.7	134.1	138.7	136.0	133.5	140.3	156.3	134.6	113.3	8.5	118.3	229.2	184.1	410.8	112.1	65.5	124.6	153.4	454.8	141.5	253.9	134.3	16.7	587.3	142.8	178.0	358.1	321.6	245.2	110.9	108.1	164.7	148.4	183.7	7.6	349.9	418.2	171.5	105.5	116.0	105.2	156.1	99.6	235.4	346.3	32.0	7.2	173.0	311.3	111.7	272.1	52.9	109.6	159.8	236.5	4.7	298.9	183.4	109.2	9.0	16.9	351.3	163.4	123.0	244.7	191.7	188.6	564.6	193.3	81.3	111.7	119.8	486.8	175.1	84.7	178.6	277.2	664.5	125.9	172.6	177.7	217.3
PSMB9	"beta1i, LMP2, PSMB6i, RING12"	ENSG00000240065	"Proteasome 20S subunit beta 9"	P28065	6	32844136-32859851	"Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, Immunity"	"Hydrolase, Protease, Threonine protease"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 160.9"	"Cell type enhanced"	"Detected in many"		"monocytes: 323.0;NK-cells: 495.4;Proximal enterocytes: 318.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+ RasG12V: 27.7;Daudi: 40.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB015180, HPA042818, HPA053280"	Enhanced		Supported	Cytosol		NA	NA		340000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 64: Macrophages - Immune response"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 63: NK-cells & T-cells - Immune response"	Cytosol		"CAB015180: AB_2172368, HPA042818: AB_2678186, HPA053280: AB_2682098"	"unprognostic (1.09e-2)"	"unprognostic (1.68e-2)"	"unprognostic (1.26e-2)"	"unprognostic (2.18e-3)"	"unprognostic (7.84e-2)"	"unprognostic (1.89e-1)"	"unprognostic (5.68e-2)"	"unprognostic (6.67e-2)"	"unprognostic (1.56e-2)"	"unprognostic (6.50e-3)"	"unprognostic (1.87e-3)"	"unprognostic (1.84e-1)"	"prognostic unfavorable (1.33e-4)"	"unprognostic (2.65e-1)"	"unprognostic (1.09e-1)"	"unprognostic (4.96e-3)"	"unprognostic (5.99e-2)"	47.0	31.1	4.8	18.4	4.9	6.9	41.4	4.3	5.5	28.8	2.6	38.4	10.2	26.8	2.3	25.7	25.9	4.7	31.6	4.8	5.6	36.3	37.4	60.2	26.2	7.6	4.9	18.1	12.1	1.5	14.0	3.4	5.9	26.5	8.7	1.3	20.3	5.0	11.9	27.7	78.1	5.7	5.7	160.9	26.5	4.9	5.1	15.0	28.7	3.8	22.2	23.6	30.8	5.8	5.5	0.3	0.0	0.2	3.4	8.5	3.0	0.7	11.5	17.3	27.7	0.0	3.1	40.8	1.3	2.9	14.3	10.0	0.2	5.8	2.6	9.3	0.1	17.6	0.7	0.8	17.3	1.8	2.2	2.1	0.3	7.0	1.0	3.3	2.7	10.1	1.4	12.8	1.9	1.0	16.1	8.0	0.0	0.0	0.8	19.0	1.2	7.4	2.1	2.5	0.0	0.0	1.0	2.1	10.7	0.0	4.4	10.3	0.0	2.5	1.6	14.7	1.2	11.3	23.9	9.3	7.5	6.8	4.0	92.7	30.3	75.6	56.1	55.8	45.9	59.7	45.1	55.9	26.6	45.3	41.0	49.6	96.3	61.5	60.9	20.5	61.0	46.2	4.8	4.9	4.3	5.5	4.8	5.6	7.6	4.9	5.9	5.7	5.1	5.8	258.6	41.7	51.1	1.3	197.2	72.5	37.4	155.6	30.1	2.4	25.3	47.0	7.3	50.1	64.8	25.8	0.0	1.5	216.2	88.0	19.6	116.6	1.3	28.9	47.5	146.5	33.5	29.9	0.0	115.6	6.6	45.1	34.1	42.6	77.3	20.0	119.6	26.6	117.2	0.0	0.1	148.0	99.7	126.8	155.7	2.1	29.2	145.2	35.6	8.4	323.0	22.7	495.4	0.5	8.3	67.8	150.3	15.8	136.1	40.4	318.5	40.5	133.7	1.7	32.9	23.1	50.8	1.5	7.4	21.0	58.7	1.4	241.8	45.3	110.6	39.1
PSMC2	"MSS1, Nbla10058, S7"	ENSG00000161057	"Proteasome 26S subunit, ATPase 2"	P35998	7	103328570-103370346	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Syncytiotrophoblasts: 231.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019238, HPA049621"	Supported		Supported	"Cytosol,Cytoplasmic bodies"		NA	NA		190000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	"Cytosol, Cytoplasmic bodies"		"HPA019238: AB_1855834, HPA049621: AB_2680833"	"unprognostic (4.00e-2)"	"unprognostic (6.66e-2)"	"unprognostic (2.55e-1)"	"unprognostic (3.58e-1)"	"unprognostic (1.57e-3)"	"unprognostic (3.55e-2)"	"unprognostic (2.08e-2)"	"unprognostic (6.08e-2)"	"unprognostic (7.73e-2)"	"unprognostic (1.49e-2)"	"unprognostic (1.07e-1)"	"unprognostic (4.71e-1)"	"unprognostic (5.09e-3)"	"unprognostic (1.30e-1)"	"unprognostic (2.18e-1)"	"unprognostic (9.76e-2)"	"unprognostic (1.41e-1)"	34.1	33.6	19.6	31.7	21.6	32.0	25.6	23.7	29.5	26.2	24.3	26.2	25.2	23.5	27.8	27.2	23.1	22.0	35.9	20.5	22.9	39.9	54.2	23.5	29.6	22.5	21.0	21.2	16.5	41.4	16.1	30.9	22.3	27.1	22.8	22.3	23.8	26.4	87.2	27.6	24.5	29.6	24.3	22.4	29.5	25.8	21.7	42.4	29.2	77.1	33.5	34.3	17.7	24.8	133.5	78.3	84.4	98.2	93.0	69.7	58.5	102.5	97.9	123.7	122.7	92.7	97.3	100.1	199.2	94.7	168.1	71.0	109.2	76.6	128.7	153.3	68.0	90.5	57.9	57.8	65.2	149.0	84.9	55.3	50.2	122.5	38.9	60.9	89.8	70.4	190.1	98.2	104.2	135.8	165.0	74.2	98.7	109.6	95.2	73.8	108.4	93.8	80.6	64.2	65.3	64.9	97.6	123.9	89.6	92.9	56.6	73.3	91.5	80.9	106.6	174.6	153.8	98.9	274.8	191.3	118.1	143.7	138.5	140.0	53.4	52.7	44.7	81.6	51.5	47.5	51.1	47.9	75.3	40.6	46.3	47.3	7.3	58.4	98.2	42.3	93.3	74.2	19.6	21.6	23.7	29.5	20.5	22.9	22.5	21.0	22.3	24.3	21.7	24.8	36.2	48.1	29.5	18.3	33.8	39.8	41.4	131.8	24.5	36.0	23.5	27.2	61.8	40.0	73.9	27.6	14.6	172.2	34.4	22.5	66.5	113.9	118.9	32.3	33.9	48.5	8.4	64.6	27.9	96.4	110.6	49.7	27.5	24.9	56.4	35.5	34.2	48.5	134.6	26.9	25.1	36.9	93.6	48.5	40.4	33.2	58.4	46.1	32.0	15.9	62.4	69.5	40.2	21.1	32.8	87.3	38.5	64.3	45.0	34.7	36.9	88.8	52.5	49.1	59.2	43.7	105.2	96.3	47.2	23.6	42.9	231.8	39.5	49.1	32.0	42.9
PSMC3IP	"GT198, Hop2, HUMGT198A, TBPIP"	ENSG00000131470	"PSMC3 interacting protein"	Q9P2W1	17	42572310-42577831	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"DNA recombination, Meiosis"	DNA-binding	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 23.7"	"Cell type enhanced"	"Detected in many"		"Spermatocytes: 113.3;Spermatogonia: 44.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"plasmacytoid DC: 2.8"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			HPA044439	Enhanced		Supported	Nucleoplasm		NA	Yes			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"HPA044439: AB_10964210"	"unprognostic (2.98e-1)"	"unprognostic (3.66e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.87e-1)"	"unprognostic (6.59e-2)"	"unprognostic (2.39e-2)"	"unprognostic (1.28e-7)"	"unprognostic (6.22e-2)"	"unprognostic (6.14e-2)"	"unprognostic (2.47e-1)"	"unprognostic (7.26e-2)"	"unprognostic (1.21e-2)"	"prognostic unfavorable (9.41e-4)"	"unprognostic (6.03e-2)"	"unprognostic (3.68e-1)"	"unprognostic (1.39e-2)"	"unprognostic (1.82e-1)"	3.3	1.4	8.3	2.5	8.9	8.2	3.8	8.7	10.3	3.5	7.9	4.2	1.3	3.7	3.8	3.0	6.2	1.4	1.8	7.8	8.5	2.8	0.8	2.3	3.9	9.4	8.9	3.4	2.1	7.6	1.5	4.2	9.2	3.6	3.0	7.3	1.5	3.9	1.5	3.1	1.6	5.2	9.0	1.9	2.4	23.7	8.8	7.4	1.8	2.3	5.5	2.9	2.9	8.9	21.1	29.0	48.3	34.9	11.0	15.0	11.0	80.4	23.7	63.4	78.3	28.6	12.9	21.1	17.6	22.2	27.6	29.9	36.9	28.8	73.0	31.0	30.0	13.5	66.1	35.0	1.6	46.3	14.4	5.3	6.4	101.5	34.2	9.4	18.8	28.3	44.5	38.2	56.6	21.8	33.3	28.0	30.0	23.9	26.8	32.3	50.7	20.6	14.8	16.6	65.1	40.6	32.1	11.8	34.7	24.3	28.3	20.3	8.8	70.5	41.1	55.2	128.6	30.0	54.1	30.8	32.8	21.2	79.7	0.0	0.0	0.9	0.7	0.2	0.9	1.1	0.4	0.7	0.0	0.3	0.1	0.4	0.9	0.1	0.3	2.8	0.7	0.1	8.3	8.9	8.7	10.3	7.8	8.5	9.4	8.9	9.2	9.0	8.8	8.9	6.0	3.2	3.7	2.3	6.4	5.4	2.7	3.7	0.0	5.9	4.8	5.2	0.9	4.3	2.8	3.7	10.4	15.6	3.7	1.4	0.0	4.5	12.8	11.1	5.8	4.4	0.0	19.8	1.1	3.3	19.1	5.5	1.5	5.0	1.3	7.7	2.9	2.2	7.4	0.0	1.2	1.2	4.1	3.0	2.6	13.1	5.3	2.4	5.4	2.8	5.8	4.6	3.1	1.0	1.5	2.0	0.3	8.6	6.5	2.0	0.2	2.2	14.9	13.9	19.7	8.6	16.0	113.3	44.6	3.2	4.1	5.2	2.7	2.5	2.5	1.7
PSMC4	"MGC13687, MGC23214, MGC8570, MIP224, S6, TBP-7, TBP7"	ENSG00000013275	"Proteasome 26S subunit, ATPase 4"	P43686	19	39971165-39981764	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Syncytiotrophoblasts: 399.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002044, HPA005471"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA		200000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 10: Non-specific - Unknown function"	"Nucleoplasm, Cytosol"		"HPA002044: AB_1079707, HPA005471: AB_1855838"	"unprognostic (1.66e-1)"	"unprognostic (9.08e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.83e-2)"	"unprognostic (7.46e-2)"	"unprognostic (2.27e-2)"	"unprognostic (1.29e-3)"	"unprognostic (1.53e-2)"	"unprognostic (4.45e-1)"	"unprognostic (4.42e-2)"	"unprognostic (9.90e-2)"	"unprognostic (8.45e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.34e-1)"	"unprognostic (2.02e-1)"	"unprognostic (2.81e-1)"	"unprognostic (2.32e-1)"	41.3	54.8	21.8	21.0	22.5	14.5	38.2	24.1	24.8	38.0	21.3	41.6	20.4	50.9	26.9	54.8	38.2	16.7	58.9	22.9	25.4	48.4	69.1	35.9	18.2	24.1	23.5	32.0	32.5	30.9	37.1	19.3	25.8	35.2	19.0	13.8	36.5	20.3	112.7	48.1	39.0	20.8	24.6	40.3	43.6	43.2	22.7	22.3	41.1	30.2	23.1	41.6	38.0	26.1	68.7	221.3	43.8	53.5	38.0	31.3	47.0	38.6	50.4	87.0	66.4	129.0	46.8	33.0	72.7	49.2	50.5	35.6	61.6	52.7	72.1	60.6	63.0	46.9	39.2	110.4	52.5	52.2	54.7	31.3	46.0	69.1	48.6	25.8	60.5	42.3	63.0	48.5	57.2	108.3	62.4	32.1	80.5	88.3	66.8	54.6	49.7	48.2	64.3	105.7	56.9	74.8	42.3	69.3	38.9	41.9	47.8	45.5	36.2	53.2	54.9	52.2	97.1	62.2	114.6	51.9	69.7	54.0	62.8	38.0	41.5	33.5	44.8	64.8	39.0	35.8	39.8	46.6	66.9	34.7	32.6	32.8	22.3	43.8	89.8	34.8	59.8	61.9	21.8	22.5	24.1	24.8	22.9	25.4	24.1	23.5	25.8	24.6	22.7	26.1	52.5	32.1	19.8	8.1	53.6	64.0	84.8	191.9	40.9	50.1	31.2	31.9	38.1	52.9	96.2	44.1	14.6	174.7	53.7	119.7	92.0	143.3	203.9	70.3	46.3	63.2	59.2	48.8	8.5	110.9	118.9	55.8	53.5	57.1	41.2	41.9	29.6	50.9	163.7	42.1	8.5	41.7	126.1	42.7	66.3	120.0	55.0	57.4	44.4	12.2	91.6	59.5	63.8	6.6	10.7	127.0	103.1	70.0	58.3	65.4	95.2	179.2	88.0	49.9	92.1	49.0	152.1	114.6	45.7	44.7	58.2	399.5	57.5	69.5	69.1	79.8
PSMC5	"p45, p45/SUG, S8, SUG-1, SUG1, TBP10, TRIP1"	ENSG00000087191	"Proteasome 26S subunit, ATPase 5"	P62195	17	63827152-63832026	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 596.6;Late spermatids: 1350.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017871, HPA064293"	Enhanced		Supported	"Plasma membrane,Cytosol"		NA	NA		120000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 10: Non-specific - Unknown function"	"Plasma membrane, Cytosol"		"HPA017871: AB_1857638, HPA064293: AB_2685234"	"unprognostic (9.65e-2)"	"unprognostic (1.63e-2)"	"unprognostic (4.44e-1)"	"unprognostic (2.91e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.35e-1)"	"unprognostic (8.29e-3)"	"unprognostic (1.24e-2)"	"unprognostic (3.38e-1)"	"unprognostic (2.85e-1)"	"unprognostic (2.17e-2)"	"unprognostic (1.25e-1)"	"prognostic unfavorable (3.13e-6)"	"unprognostic (9.54e-2)"	"unprognostic (8.57e-2)"	"unprognostic (1.15e-1)"	"unprognostic (2.32e-1)"	90.4	99.0	134.8	80.9	137.5	82.4	80.6	141.3	159.0	79.6	130.2	106.1	68.0	80.1	112.3	104.9	83.2	59.4	107.5	136.2	139.3	120.9	112.7	68.1	93.0	140.5	140.2	63.3	71.0	161.1	82.5	75.5	141.2	81.4	84.4	85.3	73.4	86.7	236.2	121.5	70.6	90.3	137.7	82.4	84.5	73.3	139.6	93.3	86.4	168.7	108.0	93.4	79.6	138.9	240.1	369.1	233.9	172.9	171.4	174.7	202.8	225.3	197.0	327.1	243.8	390.3	154.7	158.7	154.7	241.6	246.0	182.8	239.1	228.5	383.5	136.8	289.7	330.3	288.9	362.4	180.1	336.0	230.4	177.5	171.4	291.9	266.6	139.1	263.7	180.9	258.4	210.2	284.9	450.7	279.4	237.4	215.6	266.3	330.0	248.9	445.5	244.3	249.0	270.9	203.2	274.1	158.6	313.9	152.3	254.4	306.8	197.8	238.8	360.3	329.9	161.5	482.6	220.5	335.2	250.4	225.8	255.7	241.5	105.1	120.4	149.4	164.1	176.3	222.8	142.7	191.6	179.3	140.0	122.0	161.3	183.1	37.7	167.4	206.3	108.6	272.1	216.1	134.8	137.5	141.3	159.0	136.2	139.3	140.5	140.2	141.2	137.7	139.6	138.9	97.9	51.3	78.6	8.5	82.7	94.6	145.0	206.3	71.7	84.9	71.1	79.1	156.0	110.1	139.6	68.0	18.8	250.4	85.1	98.8	246.5	195.2	596.6	75.4	69.4	104.7	90.9	107.7	7.9	214.5	187.2	101.4	69.3	68.1	90.2	53.3	86.4	130.9	162.9	72.3	7.9	92.7	197.4	89.8	85.0	1350.2	133.0	93.4	99.6	5.6	148.0	221.4	109.2	7.5	10.5	167.5	96.3	153.4	88.0	125.6	163.7	330.3	95.1	108.4	111.7	113.0	228.7	151.6	150.2	95.0	102.9	369.0	102.9	124.7	97.9	137.9
PSMD10	p28	ENSG00000101843	"Proteasome 26S subunit, non-ATPase 10"	O75832	X	108084207-108091549	"Predicted intracellular proteins"	Apoptosis	Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002920, CAB010434"	Approved		Supported	"Intermediate filaments,Cytosol"		NA	NA		250000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 68: Epididymis - Unknown function"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 10: Non-specific - Unknown function"	Cytosol	"Intermediate filaments"	"CAB010434: AB_640866, HPA002920: AB_1079708"	"unprognostic (1.59e-3)"	"unprognostic (4.12e-3)"	"unprognostic (3.83e-1)"	"unprognostic (3.00e-1)"	"unprognostic (4.65e-2)"	"unprognostic (1.50e-2)"	"unprognostic (3.85e-3)"	"unprognostic (2.35e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.06e-2)"	"unprognostic (4.95e-2)"	"unprognostic (7.37e-3)"	"unprognostic (1.64e-2)"	"unprognostic (1.42e-2)"	"unprognostic (2.09e-1)"	"unprognostic (5.07e-2)"	"unprognostic (1.09e-1)"	28.2	38.6	49.4	26.2	52.3	28.7	35.1	54.5	68.3	34.3	47.4	32.7	25.3	36.4	48.3	34.5	44.9	25.8	26.0	49.9	58.9	34.6	33.4	28.6	34.8	55.4	58.6	31.7	18.6	41.4	33.1	40.4	61.4	31.6	33.2	44.6	26.2	30.4	24.8	26.8	27.0	36.2	56.4	27.1	27.8	27.5	57.5	41.9	38.1	23.9	39.1	33.4	27.7	59.4	101.3	100.5	68.9	62.6	102.6	77.3	61.8	81.6	69.2	73.9	64.0	60.7	64.4	86.0	119.7	80.2	107.6	54.0	109.8	80.3	113.4	91.3	94.8	50.5	91.0	78.2	51.8	79.2	54.8	58.2	85.9	67.2	82.2	73.2	186.4	83.2	99.9	114.3	94.0	133.0	75.3	70.9	124.1	96.9	138.3	74.2	97.5	92.7	80.7	64.8	44.2	42.1	124.8	52.4	86.0	87.4	56.5	66.9	130.5	58.1	33.1	98.3	61.4	88.5	128.5	90.5	80.4	109.2	69.7	83.6	46.8	72.3	45.9	58.1	49.0	47.9	45.8	49.2	52.2	48.0	45.6	51.4	22.0	58.3	71.4	53.0	57.8	69.9	49.4	52.3	54.5	68.3	49.9	58.9	55.4	58.6	61.4	56.4	57.5	59.4	14.2	19.2	19.8	3.3	23.4	22.6	25.9	31.8	23.9	15.1	20.4	20.6	11.2	8.6	35.4	11.0	2.1	28.3	12.8	16.5	31.3	19.9	4.1	38.3	26.9	22.8	14.4	35.7	3.4	18.7	35.3	22.6	11.7	21.6	34.1	17.9	22.1	25.6	31.3	13.5	4.5	16.8	16.2	29.5	19.0	4.4	25.7	20.2	17.8	0.0	26.1	18.3	20.6	5.5	9.6	24.5	14.1	21.1	34.7	26.6	14.9	34.8	69.9	7.7	0.0	13.8	32.1	46.2	40.3	32.4	29.1	25.0	20.2	24.6	19.2	33.7
PSMD14	"pad1, POH1, Rpn11"	ENSG00000115233	"Proteasome 26S subunit, non-ATPase 14"	O00487	2	161308425-161411717	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, Ubl conjugation pathway"	"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002114, HPA003828"	Approved		Supported	Nucleoplasm		NA	NA		26000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"HPA002114: AB_1855850, HPA003828: AB_2667057"	"unprognostic (3.50e-3)"	"unprognostic (1.48e-1)"	"unprognostic (9.61e-2)"	"unprognostic (6.63e-2)"	"unprognostic (2.57e-1)"	"unprognostic (7.61e-3)"	"prognostic unfavorable (2.66e-8)"	"unprognostic (3.11e-2)"	"unprognostic (4.04e-2)"	"unprognostic (3.90e-3)"	"unprognostic (9.84e-3)"	"unprognostic (3.02e-1)"	"prognostic unfavorable (3.10e-6)"	"unprognostic (2.86e-2)"	"unprognostic (4.70e-2)"	"unprognostic (3.54e-1)"	"unprognostic (1.66e-1)"	35.2	38.3	38.6	39.7	40.0	38.8	36.4	42.5	47.5	26.2	36.7	35.2	29.1	24.7	30.1	40.7	27.3	23.7	44.6	40.7	43.3	44.4	48.4	26.9	37.8	42.1	41.7	14.5	25.6	51.1	21.4	42.0	43.7	31.0	41.0	37.9	20.8	29.9	98.0	33.2	26.4	39.6	43.8	22.9	27.2	38.7	41.1	49.7	34.7	76.0	52.0	42.5	19.6	46.6	170.3	145.8	158.8	140.8	113.9	97.0	194.2	173.6	168.2	246.1	198.6	216.2	140.2	200.2	258.0	128.7	144.3	126.5	176.8	185.6	244.6	210.3	133.1	200.8	110.8	245.9	139.7	196.7	113.8	74.4	138.8	277.4	256.8	94.0	185.5	117.1	222.1	139.6	207.7	164.1	145.0	148.0	220.5	124.3	218.2	123.6	154.4	196.0	218.6	145.0	138.4	101.3	117.8	131.7	167.5	131.4	90.2	124.3	147.2	162.7	152.4	111.6	193.8	82.5	242.7	186.7	174.1	129.6	182.2	47.4	48.2	25.2	65.3	69.6	68.7	64.2	69.4	71.0	75.4	57.4	55.4	66.5	4.9	70.2	56.2	74.5	83.7	73.3	38.6	40.0	42.5	47.5	40.7	43.3	42.1	41.7	43.7	43.8	41.1	46.6	40.1	51.3	38.2	35.3	49.4	49.5	48.1	146.8	25.0	43.7	40.2	36.2	89.8	52.9	80.3	23.9	18.8	159.5	60.4	47.7	90.1	124.3	82.5	52.4	51.8	49.9	52.5	56.2	64.0	118.3	154.6	48.1	29.6	58.4	51.2	59.0	31.8	125.3	104.7	47.1	56.1	53.5	118.0	41.1	40.0	36.0	27.7	46.1	48.0	25.3	61.1	87.7	44.3	50.3	64.6	155.0	48.0	34.3	60.2	57.0	36.5	106.1	55.4	60.6	32.9	36.6	64.5	137.0	77.7	34.3	56.0	220.3	47.8	63.6	64.5	50.8
PSMD4	"AF, AF-1, Rpn10, S5A"	ENSG00000159352	"Proteasome 26S subunit, non-ATPase 4"	P55036	1	151254709-151267479	"Cancer-related genes, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038807, HPA039252, CAB047300"	Enhanced		Enhanced	Nucleoplasm,Cytosol		NA	NA		69000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm	Cytosol	"CAB047300: , HPA038807: AB_2676217, HPA039252: AB_10673418"	"unprognostic (3.83e-2)"	"unprognostic (7.89e-2)"	"unprognostic (6.86e-3)"	"unprognostic (1.70e-1)"	"unprognostic (2.63e-1)"	"unprognostic (2.89e-2)"	"unprognostic (1.79e-3)"	"unprognostic (2.16e-1)"	"unprognostic (2.81e-1)"	"unprognostic (2.61e-2)"	"unprognostic (7.57e-2)"	"unprognostic (2.11e-1)"	"prognostic unfavorable (6.66e-10)"	"unprognostic (9.80e-2)"	"unprognostic (6.60e-2)"	"unprognostic (2.03e-2)"	"unprognostic (3.91e-1)"	108.8	118.0	198.8	77.8	203.8	89.4	97.9	203.0	288.1	88.7	195.2	136.9	68.9	99.5	114.3	115.5	91.0	58.2	191.2	202.8	205.8	110.2	170.5	81.7	95.7	208.5	215.3	85.8	114.0	91.6	79.4	91.1	209.3	91.3	82.1	64.5	83.9	86.4	404.1	103.3	91.3	91.0	204.2	109.6	115.4	152.0	203.7	114.3	76.7	188.0	114.0	118.6	88.2	203.4	251.4	294.8	213.4	175.2	227.4	167.0	231.9	166.0	202.1	258.6	205.1	388.3	278.2	202.2	396.2	235.4	178.7	255.4	277.1	250.6	219.6	331.9	236.6	197.8	256.2	396.6	250.8	234.7	220.5	182.5	204.2	296.3	271.4	193.3	229.5	222.4	313.6	247.9	220.2	723.5	217.4	276.7	406.0	384.3	293.4	181.6	207.7	364.7	252.7	210.6	166.7	283.8	184.5	266.3	222.7	313.0	278.9	452.3	203.4	128.1	201.2	159.2	288.2	295.1	397.7	430.3	212.6	218.1	238.7	439.4	439.0	713.9	247.3	478.1	281.2	399.0	287.4	274.4	398.4	426.1	261.0	258.1	580.2	351.2	502.3	240.3	476.6	651.0	198.8	203.8	203.0	288.1	202.8	205.8	208.5	215.3	209.3	204.2	203.7	203.4	90.1	57.7	62.9	15.7	78.5	88.6	111.9	249.0	58.1	50.9	60.9	69.3	245.2	82.9	125.0	60.7	27.1	328.6	74.0	104.1	168.3	177.3	279.1	91.5	63.0	95.8	84.2	107.3	25.3	186.9	234.1	88.5	46.9	59.1	83.6	88.8	83.2	116.0	184.5	33.7	24.2	94.1	156.6	104.0	98.0	243.2	105.3	90.3	104.9	11.2	256.6	91.9	115.4	16.1	23.2	172.2	129.1	98.6	67.0	121.4	168.6	206.6	148.3	54.6	118.3	79.0	221.1	234.8	83.5	66.7	86.5	414.6	77.7	105.6	114.5	107.2
PSMD9	"p27, Rpn4"	ENSG00000110801	"Proteasome 26S subunit, non-ATPase 9"	O00233	12	121888732-121918297	"Plasma proteins, Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040512, HPA044220"	Enhanced		Supported	"Plasma membrane,Cytosol"		NA	NA		500000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 59: Non-specific - Transcription"	Cytosol	"Plasma membrane"	"HPA040512: AB_2677014, HPA044220: AB_2678860"	"unprognostic (2.24e-1)"	"unprognostic (2.48e-3)"	"unprognostic (2.12e-1)"	"unprognostic (3.36e-1)"	"unprognostic (1.20e-2)"	"unprognostic (1.51e-1)"	"prognostic unfavorable (1.32e-5)"	"unprognostic (1.86e-1)"	"unprognostic (6.80e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.30e-1)"	"unprognostic (9.64e-3)"	"unprognostic (3.17e-2)"	"unprognostic (5.73e-2)"	"unprognostic (6.19e-2)"	"unprognostic (8.63e-2)"	16.5	4.6	7.5	2.3	8.1	19.2	4.8	8.0	10.0	5.8	11.8	13.8	11.5	7.1	2.2	6.2	6.4	3.8	5.5	7.9	8.1	10.8	4.6	6.0	5.7	9.0	8.9	5.9	10.6	4.8	3.5	3.9	8.3	4.6	2.2	3.6	8.8	6.7	18.5	5.9	6.2	3.3	8.3	8.9	14.9	5.1	8.7	6.6	5.1	6.0	3.2	4.1	5.5	9.4	54.8	81.8	6.7	12.2	11.2	11.6	13.9	54.5	17.8	27.3	15.5	60.0	6.3	40.5	45.0	28.6	9.2	22.1	20.0	29.1	16.3	78.5	41.6	33.3	40.9	30.5	27.5	23.3	22.7	20.4	14.0	30.4	11.7	9.9	16.6	24.7	30.1	5.3	17.6	63.2	47.1	17.8	14.0	7.1	63.4	35.6	18.3	24.9	13.4	53.9	14.1	19.3	54.4	7.7	29.3	5.8	23.3	11.3	43.3	25.4	29.0	50.1	38.4	30.4	73.0	62.1	45.5	30.1	23.8	41.8	43.6	53.0	33.9	46.2	27.3	47.6	32.6	31.0	38.5	38.5	25.0	21.2	41.3	29.3	41.7	63.7	48.1	51.6	7.5	8.1	8.0	10.0	7.9	8.1	9.0	8.9	8.3	8.3	8.7	9.4	22.8	48.1	33.7	10.1	32.6	60.5	11.4	64.1	67.2	7.3	40.9	34.8	8.0	34.3	40.0	35.0	18.8	30.3	45.8	66.6	52.8	116.9	34.9	32.6	28.7	29.7	46.6	121.4	12.9	121.4	30.7	30.5	42.8	27.4	44.4	11.0	33.9	26.8	39.8	15.2	10.7	66.5	54.9	37.9	55.3	11.4	37.9	43.6	55.2	7.5	93.9	17.2	35.0	7.1	18.7	138.2	64.2	38.7	73.2	9.5	146.8	100.7	36.6	14.8	39.5	19.5	46.8	33.9	37.5	69.4	71.6	37.8	44.9	12.9	67.7	12.8
PSME3IP1	"C16orf94, FAM192A, NIP30, PIP30"	ENSG00000172775	"Proteasome activator subunit 3 interacting protein 1"	Q9GZU8	16	57152466-57186116	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 82.3;Cytotrophoblasts: 56.7;Extravillous trophoblasts: 59.5;Hofbauer cells: 64.6;Syncytiotrophoblasts: 53.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054382, HPA059652"	Uncertain		Supported	Nucleoplasm,Vesicles		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm	Vesicles	"HPA054382: AB_2682469, HPA059652: AB_2684095"	"unprognostic (1.69e-2)"	"unprognostic (5.20e-2)"	"unprognostic (1.36e-1)"	"unprognostic (9.20e-3)"	"unprognostic (4.69e-3)"	"unprognostic (2.45e-2)"	"unprognostic (1.01e-2)"	"unprognostic (2.22e-1)"	"unprognostic (6.09e-2)"	"unprognostic (1.52e-2)"	"unprognostic (1.41e-1)"	"unprognostic (4.19e-1)"	"unprognostic (3.00e-1)"	"unprognostic (3.87e-3)"	"unprognostic (4.14e-2)"	"unprognostic (1.58e-1)"	"unprognostic (2.56e-3)"	48.8	50.2	80.5	72.9	93.9	151.0	66.7	85.8	99.0	52.4	83.8	75.4	67.6	54.1	64.7	63.5	54.1	47.3	59.2	78.4	89.7	66.3	62.6	57.6	94.8	91.7	87.3	54.6	55.3	76.7	65.3	56.0	87.3	64.7	87.5	75.2	55.2	50.3	79.0	90.3	76.1	52.3	87.9	93.3	62.6	96.8	85.8	85.0	71.5	66.0	96.5	53.3	56.1	103.7	119.3	148.6	163.6	109.8	70.3	86.2	153.4	138.3	102.3	166.3	107.1	141.3	122.5	179.2	150.6	105.8	84.2	155.9	114.4	137.9	167.1	80.3	92.1	125.0	141.6	148.3	101.0	154.8	170.8	86.6	134.8	158.2	127.4	101.8	121.0	134.4	170.1	56.5	110.8	88.2	169.4	143.2	105.1	88.0	111.3	205.6	236.9	174.5	113.1	96.4	116.3	133.9	250.2	105.2	92.7	113.0	87.1	105.9	120.2	122.0	102.3	90.2	103.7	133.2	113.1	228.6	125.0	109.7	119.6	170.3	78.3	124.1	47.6	93.0	46.8	83.1	45.8	44.7	90.0	77.8	47.0	49.1	107.6	57.1	123.4	62.4	69.2	68.1	80.5	93.9	85.8	99.0	78.4	89.7	91.7	87.3	87.3	87.9	85.8	103.7	16.9	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	82.3	0.0	0.0	0.0	0.0	56.7	10.2	0.0	0.0	0.0	0.0	0.0	0.0	7.3	0.0	0.0	0.0	0.0	59.5	16.8	0.0	0.0	0.0	0.0	0.0	0.0	64.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.6	0.0	0.0	0.0	0.0	53.1	1.5	0.0	0.0	0.0
PSME4	"KIAA0077, PA200"	ENSG00000068878	"Proteasome activator subunit 4"	Q14997	2	53864069-53970993	"Predicted intracellular proteins"	"Differentiation, DNA damage, DNA repair, Spermatogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 59.8"	"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 238.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA060922	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm		"HPA060922: AB_2684386"	"unprognostic (2.77e-2)"	"unprognostic (1.57e-1)"	"unprognostic (5.00e-2)"	"prognostic unfavorable (8.99e-4)"	"unprognostic (7.26e-2)"	"unprognostic (2.27e-1)"	"prognostic unfavorable (4.84e-4)"	"unprognostic (4.76e-2)"	"unprognostic (6.67e-2)"	"unprognostic (5.65e-2)"	"unprognostic (3.72e-3)"	"unprognostic (1.38e-1)"	"unprognostic (1.80e-3)"	"unprognostic (1.73e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.60e-1)"	"unprognostic (2.89e-1)"	7.4	8.6	5.3	8.1	8.8	16.1	12.1	5.7	7.4	15.4	11.1	9.8	5.9	16.1	6.2	8.8	8.0	11.9	16.9	6.4	7.1	7.0	16.6	8.0	11.1	7.1	7.0	6.7	7.9	8.3	6.8	8.5	6.4	10.0	8.4	8.9	14.5	7.4	59.8	7.2	7.1	15.0	5.0	9.5	10.6	33.6	8.1	10.7	14.4	45.2	12.2	13.2	8.1	12.6	28.0	18.3	27.6	8.5	9.1	19.4	18.1	29.1	25.6	29.3	23.6	28.3	10.6	38.7	26.1	29.4	14.1	18.1	32.1	23.5	52.7	29.4	18.8	59.8	18.3	38.5	11.7	32.1	17.1	14.8	14.2	33.1	26.6	12.1	30.4	10.1	48.1	24.0	26.3	10.9	19.5	15.4	26.7	13.7	15.4	22.8	41.9	25.3	15.7	27.1	20.6	23.1	18.2	23.9	14.8	17.4	18.1	12.7	39.6	25.5	21.4	19.7	27.0	17.1	16.6	24.9	20.1	26.4	16.1	0.5	0.1	0.5	0.7	0.3	0.4	0.6	0.4	0.4	0.3	0.9	0.5	0.7	0.4	0.6	0.2	0.4	0.3	0.1	5.3	8.8	5.7	7.4	6.4	7.1	7.1	7.0	6.4	5.0	8.1	12.6	20.0	16.0	35.0	58.1	33.1	75.8	72.4	37.4	60.9	20.6	40.0	19.6	63.5	20.0	45.4	22.0	45.9	16.1	51.0	20.1	3.9	20.8	99.7	60.0	49.6	27.3	40.6	28.8	100.3	37.1	12.8	27.2	41.3	97.0	28.5	34.9	18.5	34.3	19.5	25.2	83.5	19.5	30.5	28.7	47.7	92.5	21.1	35.1	28.4	71.2	28.0	15.7	36.0	64.3	238.5	43.6	9.3	10.5	61.3	92.5	8.7	10.3	39.0	27.8	13.1	48.9	26.5	36.0	18.0	79.3	66.1	29.7	42.6	14.0	18.8	107.3
PSRC1	DDA3	ENSG00000134222	"Proline and serine rich coiled-coil 1"	Q6PGN9	1	109279556-109283186	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 101.5;choroid plexus: 47.9;retina: 41.6"	"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 30.1;Oligodendrocytes: 95.2;Peritubular cells: 44.8;Rod photoreceptor cells: 71.0"	"Cancer enriched"	"Detected in all"	4	"glioma: 50.2"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"classical monocyte: 12.0"	"Group enriched"	"Detected in many"	11	"dendritic cells: 5.4;granulocytes: 7.1;monocytes: 12.0"	"Low cell line specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"amygdala: 3.5;cerebral cortex: 7.7;hippocampal formation: 5.7;white matter: 3.4"	"Low region specificity"	"Detected in all"			HPA056561			Supported	Nucleoplasm,Cytosol		NA	Yes			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 77: Retina - Visual perception"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 46: Photoreceptor cells - Phototransduction"	Cytosol	Nucleoplasm	"HPA056561: AB_2683175"	"unprognostic (1.14e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.42e-3)"	"unprognostic (6.78e-3)"	"unprognostic (2.17e-1)"	"unprognostic (4.76e-2)"	"prognostic unfavorable (1.36e-9)"	"unprognostic (3.51e-2)"	"unprognostic (6.21e-2)"	"unprognostic (4.88e-3)"	"unprognostic (1.76e-2)"	"unprognostic (1.92e-1)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (9.43e-2)"	"unprognostic (2.08e-1)"	"unprognostic (1.90e-1)"	"unprognostic (2.12e-1)"	2.0	1.9	64.7	3.8	84.0	7.9	2.4	76.5	84.1	5.1	47.9	3.9	4.3	3.1	2.6	7.6	3.5	3.0	3.0	69.7	71.2	2.7	4.5	5.3	3.6	78.0	79.9	3.3	1.5	3.2	4.2	4.0	83.0	5.5	2.7	41.6	2.4	4.5	0.9	5.2	4.5	3.9	67.9	3.9	3.4	13.3	74.1	14.2	2.3	0.9	4.3	3.2	5.8	101.5	56.0	28.2	112.9	55.1	4.4	8.7	31.0	43.1	34.7	57.6	55.1	43.7	22.7	28.2	15.4	21.4	27.1	38.9	61.4	35.4	48.1	11.0	29.6	17.7	40.5	36.2	5.0	19.0	19.3	10.0	3.3	22.8	16.2	21.5	28.7	32.9	40.9	12.5	46.8	50.5	29.2	12.9	46.9	25.4	31.8	44.4	108.7	9.5	19.6	14.4	47.2	27.3	24.3	36.8	43.6	40.8	22.3	18.0	14.9	35.4	57.9	25.1	72.5	9.7	6.9	9.8	28.6	44.9	100.9	0.0	12.0	1.9	0.6	4.8	0.4	0.0	0.7	0.2	5.4	0.0	0.4	0.3	7.1	0.3	2.7	0.0	0.7	3.4	64.7	84.0	76.5	84.1	69.7	71.2	78.0	79.9	83.0	67.9	74.1	101.5	0.7	0.0	3.9	9.8	0.5	2.0	1.8	2.3	0.6	6.7	2.1	5.6	1.3	1.5	0.5	1.8	25.0	17.6	1.0	2.0	0.0	0.9	1.1	0.5	3.2	2.3	0.0	0.8	19.3	0.9	30.1	4.4	0.5	1.1	1.3	12.9	2.9	1.2	10.9	3.3	3.8	3.9	4.1	4.4	1.8	2.6	5.9	4.9	1.8	2.8	2.2	10.0	0.0	18.1	95.2	0.5	0.6	44.8	0.6	1.0	0.6	2.9	0.9	71.0	0.0	5.5	4.7	5.0	1.5	6.5	1.1	2.9	1.5	1.1	5.4	1.3
PSTPIP1	"CD2BP1, CD2BP1L, CD2BP1S, H-PIP, PAPAS, PSTPIP"	ENSG00000140368	"Proline-serine-threonine phosphatase interacting protein 1"	O43586	15	76993359-77037475	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cell adhesion, Endocytosis, Immunity, Inflammatory response, Innate immunity"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"bone marrow: 56.6;lymphoid tissue: 33.9"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 60.0;Enteroendocrine cells: 60.0;Hofbauer cells: 42.5;Kupffer cells: 41.8;Macrophages: 41.8;monocytes: 51.1;NK-cells: 91.6;T-cells: 68.4;Theca cells: 78.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 55.1;HL-60: 14.4;NB-4: 20.9;THP-1: 14.7;U-937: 59.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA010116, HPA010600, HPA072744"	Enhanced		Supported	"Plasma membrane,Cytosol"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 32: U-937 - Innate immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Plasma membrane, Cytosol"		"HPA010116: , HPA010600: AB_1855870, HPA072744: "	"unprognostic (4.42e-3)"	"unprognostic (1.31e-3)"	"unprognostic (3.56e-2)"	"prognostic favorable (4.74e-5)"	"unprognostic (3.79e-2)"	"unprognostic (1.12e-3)"	"unprognostic (2.16e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.16e-1)"	"unprognostic (9.85e-2)"	"unprognostic (2.96e-2)"	"unprognostic (3.18e-1)"	"prognostic unfavorable (7.36e-9)"	"unprognostic (1.39e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.91e-1)"	"unprognostic (5.42e-2)"	6.0	2.6	2.8	11.7	2.7	56.6	2.3	2.7	3.1	2.0	3.4	3.3	2.5	1.6	0.1	2.0	3.1	2.9	2.4	2.7	2.8	3.4	3.4	10.4	13.5	3.1	3.1	1.0	1.3	0.2	1.6	1.8	3.0	2.9	0.8	0.1	2.4	1.0	1.5	1.8	9.4	1.4	3.1	33.9	2.9	0.7	3.6	4.2	2.9	1.0	5.5	4.3	2.7	3.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.2	0.0	0.1	0.0	55.1	0.0	0.0	0.0	3.3	0.0	14.4	0.1	0.2	0.1	0.0	0.1	0.0	0.0	3.0	0.0	0.0	0.0	0.0	2.4	20.9	0.1	0.0	0.0	0.8	0.0	0.1	0.0	0.1	4.0	0.6	0.0	0.1	0.0	0.0	0.0	14.7	0.0	0.0	0.1	0.1	0.0	0.0	1.3	2.4	0.1	59.8	0.0	4.8	71.5	71.4	39.9	33.5	30.8	13.3	27.2	32.7	59.0	18.5	14.3	22.3	85.3	41.6	38.3	5.2	27.0	42.2	2.8	2.7	2.7	3.1	2.7	2.8	3.1	3.1	3.0	3.1	3.6	3.1	1.1	0.0	5.1	1.0	19.2	9.3	1.2	0.4	0.0	1.1	0.9	1.1	1.9	0.0	2.5	0.0	0.0	0.3	60.0	3.1	0.0	0.0	9.6	0.3	0.3	0.8	60.0	4.8	0.4	0.2	0.7	1.9	0.0	0.3	2.5	0.1	2.2	0.9	42.5	0.0	0.1	6.1	2.0	41.8	36.5	18.6	0.9	41.8	7.2	0.0	51.1	0.2	91.6	5.5	1.0	0.1	2.5	2.6	8.5	0.3	0.3	0.4	0.0	0.4	0.0	0.8	3.1	0.2	1.2	0.2	4.8	0.5	68.4	78.1	0.3	1.2
PTAFR		ENSG00000169403	"Platelet activating factor receptor"	P25105	1	28147166-28193936	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters"	Chemotaxis	"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 41.1;lymphoid tissue: 30.8"	"Cell type enhanced"	"Detected in many"		"granulocytes: 75.4;Hofbauer cells: 71.7;Kupffer cells: 93.0;Langerhans cells: 67.8;Macrophages: 64.5;monocytes: 52.8;Pancreatic endocrine cells: 89.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"classical monocyte: 256.7;eosinophil: 906.5;neutrophil: 747.1"	"Group enriched"	"Detected in many"	5	"granulocytes: 906.5;monocytes: 256.7"	"Group enriched"	"Detected in some"	4	"HBEC3-KT: 36.6;HMC-1: 131.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA027543	Approved		Uncertain	"Nucleoplasm,Vesicles,Plasma membrane"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 4: Macrophages - Innate immune response"	"Nucleoplasm, Vesicles"	"Plasma membrane"	"HPA027543: AB_10610287"	"unprognostic (2.22e-2)"	"unprognostic (2.59e-2)"	"unprognostic (6.73e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.75e-1)"	"unprognostic (3.74e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.72e-1)"	"unprognostic (3.35e-1)"	"unprognostic (1.23e-1)"	"unprognostic (2.39e-1)"	"unprognostic (1.60e-1)"	"unprognostic (2.79e-2)"	"unprognostic (3.52e-1)"	"unprognostic (2.59e-2)"	"unprognostic (5.48e-2)"	"unprognostic (1.38e-2)"	10.4	2.4	4.3	30.8	4.7	41.1	3.4	4.7	5.6	3.4	4.1	5.5	4.1	1.7	1.2	7.2	2.6	7.2	2.0	3.8	5.1	2.7	4.1	17.8	13.5	8.9	6.6	1.3	2.0	1.6	0.6	7.3	7.7	1.5	6.7	0.5	2.3	1.5	0.7	5.4	6.3	7.9	8.1	14.4	3.8	1.3	7.2	3.6	1.9	2.6	18.0	14.4	1.9	11.8	20.1	0.2	0.1	0.4	0.2	0.0	0.5	0.0	0.0	0.7	0.2	0.2	5.7	1.3	0.1	0.1	0.3	13.5	0.5	36.6	0.8	0.4	0.6	7.7	0.2	0.9	0.1	1.9	131.3	0.0	6.0	0.4	0.4	0.0	0.2	0.1	0.5	0.4	0.0	1.3	0.2	19.3	0.6	0.5	0.2	0.3	0.1	0.1	8.7	2.1	0.3	0.1	0.1	18.1	0.2	0.4	0.4	5.4	0.1	0.2	0.7	0.0	0.2	1.2	1.1	5.6	0.1	2.4	0.6	61.7	256.7	906.5	0.6	77.9	1.2	12.5	0.4	0.4	116.1	6.7	0.5	0.7	747.1	0.7	34.1	1.3	1.2	112.4	4.3	4.7	4.7	5.6	3.8	5.1	8.9	6.6	7.7	8.1	7.2	11.8	2.1	6.4	6.7	0.0	4.1	6.5	2.0	37.9	5.2	1.5	0.8	0.5	2.2	1.5	20.9	1.8	2.1	0.6	2.9	0.4	0.0	18.1	0.4	0.5	0.2	7.3	0.0	4.0	0.9	5.1	0.5	1.3	1.1	0.5	75.4	2.0	2.9	1.0	71.7	0.0	0.7	0.0	18.3	93.0	67.8	0.2	0.6	64.5	0.0	15.0	52.8	0.2	0.0	1.5	6.6	89.8	0.6	0.0	0.5	0.6	0.3	0.2	20.2	0.9	0.0	0.6	1.0	2.3	0.7	3.2	2.8	1.5	2.0	0.0	0.4	9.4
PTBP1	"HNRNP-I, HNRPI, pPTB, PTB, PTB-1, PTB2, PTB3, PTB4"	ENSG00000011304	"Polypyrimidine tract binding protein 1"	P26599	19	797075-812327	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Activator, Repressor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB013507	Supported		Supported	Nucleoplasm		NA	NA		4500000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm		"CAB013507: AB_2533082"	"unprognostic (2.82e-1)"	"unprognostic (2.75e-1)"	"unprognostic (1.22e-2)"	"unprognostic (1.24e-1)"	"unprognostic (6.01e-2)"	"unprognostic (6.22e-2)"	"prognostic unfavorable (2.71e-4)"	"unprognostic (4.06e-3)"	"unprognostic (2.08e-2)"	"unprognostic (1.92e-2)"	"unprognostic (5.47e-2)"	"unprognostic (4.62e-3)"	"unprognostic (2.41e-2)"	"unprognostic (7.91e-3)"	"unprognostic (4.28e-2)"	"unprognostic (8.31e-2)"	"unprognostic (3.72e-2)"	101.5	84.7	29.9	104.7	33.4	138.2	94.9	33.5	34.9	92.7	51.7	95.9	91.4	90.5	48.9	137.7	86.9	54.0	64.7	29.9	33.6	111.8	123.5	102.3	90.1	38.1	35.5	99.5	100.8	66.4	80.9	79.0	36.7	86.3	56.0	11.8	90.7	45.6	35.2	123.8	96.6	49.7	34.4	117.2	86.0	45.5	36.2	91.9	98.0	19.7	79.2	80.3	101.5	34.8	517.8	377.1	242.8	224.3	70.1	90.3	385.1	299.7	128.8	230.2	169.2	394.1	243.6	428.0	192.5	188.9	88.0	299.8	342.7	260.0	239.3	433.8	361.2	352.9	362.6	429.8	141.8	479.4	355.1	83.5	179.0	265.5	164.2	84.4	232.2	201.3	523.0	223.0	385.6	434.8	610.4	258.5	446.4	190.2	245.2	648.8	182.0	254.2	140.4	467.5	272.9	317.4	358.4	213.4	174.8	168.5	228.9	286.4	335.4	247.5	286.9	306.0	557.4	238.0	500.7	591.2	153.2	357.7	307.9	12.9	32.5	23.1	31.8	38.6	32.3	23.7	26.3	30.0	36.0	23.7	25.1	26.2	13.4	33.5	36.7	22.3	29.1	38.3	29.9	33.4	33.5	34.9	29.9	33.6	38.1	35.5	36.7	34.4	36.2	34.8	99.8	41.7	66.9	11.8	88.7	76.7	91.8	47.0	84.8	19.6	114.5	91.9	39.1	82.9	44.3	47.8	35.5	116.5	96.1	134.3	35.2	73.3	22.3	62.2	62.2	92.1	101.1	87.7	12.4	87.5	172.7	70.4	70.3	80.5	90.8	92.0	74.6	87.9	78.7	33.7	12.1	145.0	36.7	60.6	62.7	20.6	79.9	75.1	39.2	20.6	59.8	29.9	59.8	10.1	12.9	99.4	107.5	65.8	90.0	90.5	89.9	46.9	49.9	21.3	59.2	74.8	71.1	40.5	54.3	97.2	82.0	133.4	89.7	68.7	144.9	100.7
PTCH2		ENSG00000117425	"Patched 2"	Q9Y6C5	1	44819844-44843253	"Cancer-related genes, Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		Receptor	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"ovary: 24.6;parathyroid gland: 59.1;salivary gland: 75.2;testis: 25.6"	"Cell type enhanced"	"Detected in many"		"Leydig cells: 107.8;Peritubular cells: 68.1;Plasma cells: 67.1;Theca cells: 138.7"	"Cancer enhanced"	"Detected in many"		"testis cancer: 9.3"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"U-266/84: 11.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA046839			Supported	"Nucleoli,Plasma membrane"		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 16: U-266 - Nucleosome"	"Cluster 52: Non-specific - Transcription"	"Plasma membrane"	Nucleoli	"HPA046839: "	"unprognostic (6.54e-5)"	"unprognostic (1.05e-1)"	"unprognostic (7.29e-3)"	"unprognostic (3.65e-3)"	"unprognostic (3.89e-1)"	"unprognostic (7.42e-3)"	"unprognostic (3.01e-1)"	"unprognostic (2.94e-2)"	"unprognostic (1.51e-1)"	"unprognostic (8.67e-2)"	"prognostic favorable (5.74e-5)"	"unprognostic (2.92e-1)"	"unprognostic (5.74e-6)"	"unprognostic (1.55e-2)"	"unprognostic (4.86e-2)"	"unprognostic (6.31e-2)"	"unprognostic (6.81e-2)"	4.2	3.1	6.1	0.8	3.5	9.4	3.4	6.8	6.8	5.1	3.6	3.6	1.0	6.4	1.6	0.9	4.3	2.5	1.3	3.1	4.4	1.3	1.3	1.0	2.3	2.9	4.8	24.6	1.0	59.1	9.9	0.3	2.0	3.0	0.9	3.6	75.2	1.3	2.0	3.6	1.8	1.2	1.6	2.4	2.0	25.6	6.5	0.8	4.6	0.8	0.7	3.1	3.4	4.8	0.2	0.3	1.0	2.5	0.8	0.9	1.0	0.8	1.6	0.5	0.4	0.2	0.4	1.1	0.4	0.4	0.5	0.0	1.1	0.0	0.2	2.1	1.9	0.6	1.0	0.8	0.3	0.7	1.1	0.3	0.4	1.0	0.1	1.7	0.1	1.0	0.7	1.1	0.0	0.5	1.4	2.1	0.3	0.1	0.4	1.0	0.2	0.5	0.2	0.0	1.5	0.6	0.3	0.4	0.8	0.5	0.2	1.2	0.1	0.2	0.5	1.3	0.5	1.9	11.6	3.2	0.6	3.0	0.4	2.5	1.9	0.1	0.5	0.9	1.0	1.0	0.6	0.6	1.2	1.4	0.7	0.6	0.6	0.9	0.9	3.6	0.3	0.2	6.1	3.5	6.8	6.8	3.1	4.4	2.9	4.8	2.0	1.6	6.5	4.8	2.8	0.0	1.1	14.0	13.4	0.5	0.7	1.0	0.6	0.8	4.8	8.0	1.0	7.2	1.0	1.8	2.1	2.4	6.8	7.8	0.0	5.5	2.3	9.3	13.5	2.7	11.5	1.3	23.7	1.8	1.6	14.3	28.1	8.5	0.0	4.4	0.7	7.9	6.7	8.4	27.3	4.9	2.0	24.5	2.2	8.0	107.8	17.3	0.0	5.6	3.9	2.4	2.1	9.5	2.6	2.1	2.5	68.1	67.1	0.8	13.6	0.2	1.7	1.2	13.1	5.4	5.6	5.0	3.6	0.6	1.6	2.3	7.5	138.7	5.5	0.2
PTEN	"BZS, MHAM, MMAC1, PTEN1, TEP1"	ENSG00000171862	"Phosphatase and tensin homolog"	P60484	10	87863625-87971930	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Apoptosis, Lipid metabolism, Neurogenesis"	"Hydrolase, Protein phosphatase"	"Autism spectrum disorder, Cancer-related genes, Disease variant, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 60.5"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							"CAB004076, HPA031335"	Approved		Supported	Nucleoplasm,Cytosol	"Intracellular and membrane"	NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 24: NB-4 - Immune response"	"Cluster 48: Smooth muscle cells - ECM organization"	Nucleoplasm	Cytosol	"CAB004076: AB_390810, HPA031335: AB_2797221"	"unprognostic (8.72e-2)"	"unprognostic (2.45e-1)"	"unprognostic (5.43e-1)"	"unprognostic (1.50e-2)"	"unprognostic (3.71e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.18e-1)"	"unprognostic (2.08e-1)"	"unprognostic (2.07e-1)"	"unprognostic (6.87e-2)"	"unprognostic (9.77e-2)"	"unprognostic (2.71e-1)"	"prognostic unfavorable (7.35e-4)"	"unprognostic (1.57e-1)"	"unprognostic (2.73e-1)"	"unprognostic (6.54e-3)"	"unprognostic (2.41e-1)"	64.0	25.4	17.8	18.6	19.3	12.9	47.6	34.5	23.4	54.8	15.6	28.1	12.9	27.4	18.6	28.3	35.2	15.6	29.7	20.4	18.4	22.6	39.2	39.5	21.4	16.6	17.8	28.0	33.2	11.9	17.3	30.5	16.4	26.3	14.6	30.0	19.6	16.5	23.7	25.9	24.5	22.2	14.5	40.0	25.6	28.2	19.7	31.8	26.1	14.0	16.5	28.1	38.4	17.6	23.5	10.8	12.3	11.2	28.5	19.7	10.9	12.5	28.0	14.5	20.4	10.9	28.0	28.1	8.0	20.9	8.3	14.1	16.6	14.3	22.8	14.1	4.7	9.3	28.5	13.8	30.1	31.9	15.3	13.5	38.7	18.0	23.7	60.3	20.8	17.7	7.0	72.6	13.5	18.1	17.8	56.3	4.6	19.9	0.0	27.6	6.4	20.8	22.9	13.4	4.5	19.9	16.6	7.9	23.0	9.7	21.9	45.2	17.9	44.6	10.8	18.3	10.1	23.9	32.9	30.7	14.6	29.2	2.9	21.3	14.2	25.8	6.8	21.8	7.2	7.9	7.2	6.6	10.3	6.8	8.3	8.3	60.5	8.9	15.6	8.2	7.0	4.5	17.8	19.3	34.5	23.4	20.4	18.4	16.6	17.8	16.4	14.5	19.7	17.6	67.2	35.3	63.3	83.6	48.3	56.1	57.4	31.5	47.3	113.0	49.4	41.9	46.5	57.2	31.2	29.5	39.6	25.8	64.4	57.7	33.2	24.7	70.1	40.0	114.5	56.0	31.2	52.0	141.0	30.0	62.2	79.3	39.8	33.6	25.4	39.6	53.9	64.1	35.0	45.4	132.4	44.7	12.2	206.1	97.2	92.1	56.8	105.2	62.2	196.8	101.5	61.6	44.3	139.2	95.7	30.6	39.7	54.5	39.3	45.1	50.1	38.0	31.2	61.2	92.1	66.4	170.7	33.5	25.4	45.2	60.1	57.3	46.3	44.7	46.1	64.0
PTGES	"MGST-IV, MGST1-L1, MGST1L1, PIG12, TP53I12"	ENSG00000148344	"Prostaglandin E synthase"	O14684	9	129738331-129753042	"Enzymes, Metabolic proteins, Predicted membrane proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Prostaglandin biosynthesis, Prostaglandin metabolism"	"Isomerase, Oxidoreductase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"seminal vesicle: 84.2;urinary bladder: 78.6"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 101.2;Cytotrophoblasts: 146.0;Extravillous trophoblasts: 293.1;Syncytiotrophoblasts: 276.2"	"Cancer enhanced"	"Detected in all"		"urothelial cancer: 69.6"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	7	"basophil: 28.9"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 28.9"	"Cell line enhanced"	"Detected in many"		"ASC diff: 147.7;BEWO: 162.7;GAMG: 292.8;HaCaT: 216.3;SK-BR-3: 157.6;U-2197: 404.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045064	Enhanced		Supported	"Endoplasmic reticulum"		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 28: Placenta - Pregnancy"	"Cluster 18: U-2197 - ECM organization"	"Cluster 38: Extravillous trophoblasts - Unknown function"	"Endoplasmic reticulum"		"HPA045064: AB_10795889"	"unprognostic (2.92e-3)"	"unprognostic (1.09e-1)"	"prognostic unfavorable (2.32e-4)"	"unprognostic (2.54e-2)"	"unprognostic (1.94e-3)"	"unprognostic (1.25e-1)"	"unprognostic (5.38e-3)"	"unprognostic (1.24e-3)"	"unprognostic (2.92e-1)"	"unprognostic (1.61e-1)"	"prognostic unfavorable (7.97e-5)"	"unprognostic (2.22e-1)"	"unprognostic (4.66e-2)"	"unprognostic (9.78e-3)"	"unprognostic (3.19e-2)"	"unprognostic (1.30e-1)"	"unprognostic (5.20e-2)"	36.7	1.4	4.1	13.9	3.6	7.8	25.5	3.9	4.5	26.1	3.5	9.2	2.8	3.7	19.0	17.8	5.4	9.0	8.5	4.5	5.1	8.1	0.7	7.8	7.6	6.1	5.8	2.2	1.6	42.1	1.9	58.4	7.1	13.7	4.2	0.0	30.8	84.2	1.3	42.3	9.1	4.1	4.1	2.5	7.1	16.9	4.7	4.2	3.7	1.1	30.7	78.6	20.0	3.5	1.5	94.9	0.1	46.6	147.7	51.9	162.7	7.4	64.2	1.1	1.7	5.6	71.7	0.1	2.7	18.0	292.8	216.3	0.7	7.2	0.6	0.3	0.5	0.0	62.5	0.4	3.5	0.0	0.0	30.9	49.0	0.9	0.3	1.4	0.0	0.9	0.0	0.1	0.7	1.7	0.2	0.0	1.2	46.7	8.2	0.2	0.0	0.3	5.3	102.2	0.8	3.6	87.1	157.6	0.8	6.3	83.3	0.0	0.5	0.1	0.4	404.8	0.0	0.0	0.0	0.0	78.8	0.1	0.7	28.9	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	4.0	0.0	0.0	0.3	4.1	3.6	3.9	4.5	4.5	5.1	6.1	5.8	7.1	4.1	4.7	3.5	3.4	0.0	0.0	0.3	0.3	17.8	8.9	101.2	10.8	0.0	29.7	19.7	0.1	0.0	53.2	3.7	0.0	146.0	0.6	0.0	1.9	13.4	0.6	1.6	2.3	4.0	7.3	0.0	1.0	1.1	293.1	70.7	0.0	5.0	1.3	61.5	0.0	0.0	17.5	0.0	2.8	6.6	30.5	0.0	21.6	0.4	0.3	13.2	14.2	7.5	7.2	0.0	0.0	0.0	0.2	8.1	0.2	0.0	0.3	8.2	0.3	0.5	6.7	0.0	0.0	0.8	13.5	0.3	0.0	5.5	43.0	276.2	0.8	0.2	0.4	49.2
PTGS1	"COX1, PGHS-1, PTGHS"	ENSG00000095303	"Prostaglandin-endoperoxide synthase 1"	P23219	9	122370530-122395703	"Cancer-related genes, Enzymes, FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Prostaglandin biosynthesis, Prostaglandin metabolism"	"Dioxygenase, Oxidoreductase, Peroxidase"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 108.3;skin 1: 152.5;urinary bladder: 175.0"	"Cell type enhanced"	"Detected in many"		"Endometrial ciliated cells: 109.9;Glandular and luminal cells: 191.9;granulocytes: 208.0;Hepatic stellate cells: 61.8;Macrophages: 55.3;Suprabasal keratinocytes: 58.7"	"Cancer enhanced"	"Detected in all"		"ovarian cancer: 53.4"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 28.9"	"Group enriched"	"Detected in many"	6	"dendritic cells: 20.0;granulocytes: 28.9;monocytes: 13.1"	"Cell line enhanced"	"Detected in many"		"ASC diff: 113.7;ASC TERT1: 89.5;BJ: 115.2;BJ hTERT+: 156.0;HEL: 73.6;HMC-1: 298.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA002834, CAB020315"	Enhanced		Supported	"Golgi apparatus,Vesicles"	"Intracellular and membrane"	NA	NA		2100000	"Cluster 2: Granulocytes - Unknown function"	"Cluster 31: Skin - Epidermis development"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 44: Endometrium - Transcription"	"Golgi apparatus"	Vesicles	"CAB020315: , HPA002834: AB_1079711"	"unprognostic (4.20e-1)"	"unprognostic (6.23e-2)"	"unprognostic (1.08e-2)"	"unprognostic (2.27e-2)"	"unprognostic (5.88e-2)"	"unprognostic (2.00e-2)"	"unprognostic (1.22e-3)"	"unprognostic (3.32e-1)"	"unprognostic (2.24e-1)"	"unprognostic (3.16e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.46e-1)"	"prognostic unfavorable (8.68e-4)"	"unprognostic (4.03e-2)"	"unprognostic (1.78e-2)"	"unprognostic (2.08e-1)"	"prognostic unfavorable (9.35e-4)"	12.8	2.9	3.1	10.5	3.2	9.0	6.7	4.2	4.8	5.8	5.5	108.3	10.8	6.1	2.2	67.3	43.2	9.6	12.6	7.4	5.5	9.3	3.0	11.3	4.6	6.5	5.2	2.0	1.8	2.0	4.8	2.2	6.3	21.1	24.2	0.7	4.3	6.1	2.1	152.5	17.7	16.1	6.7	8.0	20.5	0.9	7.0	2.2	3.2	4.0	11.6	175.0	15.9	11.9	0.3	0.5	0.4	0.0	113.7	89.5	0.0	115.2	156.0	1.0	1.1	0.0	0.2	4.2	5.4	19.7	0.3	7.1	0.4	10.5	0.9	0.0	0.2	73.6	0.6	0.0	32.9	5.2	298.4	46.1	1.2	5.7	0.3	0.0	42.3	0.1	0.1	0.3	2.3	0.0	0.2	6.6	1.6	0.0	0.5	0.3	1.4	8.6	14.7	0.0	0.5	0.6	0.6	9.5	0.2	0.5	0.3	8.4	1.0	0.7	0.6	1.7	0.1	0.3	0.2	0.0	0.4	31.6	0.3	28.9	12.1	23.3	0.0	13.1	0.0	2.4	0.0	0.0	20.0	3.5	0.1	0.0	5.2	2.8	10.2	1.4	0.2	21.9	3.1	3.2	4.2	4.8	7.4	5.5	6.5	5.2	6.3	6.7	7.0	11.9	0.9	0.0	6.6	0.0	5.9	9.9	2.6	7.7	0.0	0.1	1.1	1.4	1.6	4.3	2.2	42.3	0.0	0.1	0.2	0.1	0.0	0.6	0.1	109.9	10.4	24.7	1.8	18.7	0.8	0.5	0.3	10.7	2.0	191.9	208.0	0.1	61.8	0.8	26.1	0.0	0.5	0.6	4.1	15.5	20.7	0.3	1.5	55.3	3.6	16.9	11.7	0.0	7.2	1.0	0.1	0.6	0.6	0.0	0.3	2.8	0.0	0.0	0.8	0.1	0.0	1.4	3.6	0.0	0.2	18.2	58.7	0.4	3.4	0.1	1.0	0.8
PTGS2	COX2	ENSG00000073756	"Prostaglandin-endoperoxide synthase 2"	P35354	1	186671791-186680922	"Cancer-related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Prostaglandin biosynthesis, Prostaglandin metabolism"	"Dioxygenase, Oxidoreductase, Peroxidase"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 116.7;seminal vesicle: 127.4;urinary bladder: 162.5"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 342.9;Fibroblasts: 270.7;granulocytes: 347.6;Langerhans cells: 305.6;Macrophages: 173.1;Urothelial cells: 151.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	16	"neutrophil: 11.7"	"Lineage enriched"	"Detected in single"	16	"granulocytes: 11.7"	"Cell line enriched"	"Detected in many"	4	"BJ hTERT+: 405.5"	"Region enhanced"	"Detected in many"		"hippocampal formation: 15.1"	"Low region specificity"	"Detected in many"			"CAB000113, HPA001335"	Enhanced		Approved	"Endoplasmic reticulum,Vesicles"	"Intracellular and membrane"	NA	NA			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 41: Macrophages - Immune response"	"Endoplasmic reticulum, Vesicles"		"CAB000113: , HPA001335: AB_1079712"	"unprognostic (1.36e-3)"	"unprognostic (9.97e-3)"	"unprognostic (3.97e-2)"	"unprognostic (3.31e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.11e-1)"	"unprognostic (5.96e-2)"	"unprognostic (9.50e-2)"	"unprognostic (9.03e-3)"	"unprognostic (2.81e-1)"	"unprognostic (3.24e-2)"	"unprognostic (3.07e-2)"	"prognostic unfavorable (9.79e-4)"	"unprognostic (8.04e-3)"	"unprognostic (4.38e-2)"	"unprognostic (8.89e-2)"	"unprognostic (3.74e-2)"	17.0	7.9	1.4	13.9	2.5	116.7	3.0	1.1	4.1	62.2	2.7	14.9	2.6	8.9	0.7	6.9	5.1	31.6	11.7	1.9	1.4	10.2	8.0	34.3	8.9	2.0	1.6	2.6	2.2	5.6	3.1	8.4	1.5	25.0	9.9	0.3	1.2	127.4	0.4	1.6	3.6	12.2	1.9	2.8	14.8	0.2	1.8	5.2	3.2	6.5	0.6	162.5	2.2	2.6	0.0	21.8	0.1	0.0	2.5	2.1	0.0	93.4	405.5	0.6	3.6	15.0	17.2	0.0	0.0	0.1	2.5	12.2	0.0	7.6	1.3	0.0	0.0	0.8	2.2	0.0	13.2	0.0	0.2	0.8	2.7	11.3	28.7	1.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	3.8	0.0	0.0	0.0	0.0	0.0	5.5	1.5	0.0	1.0	0.0	0.9	2.7	0.0	0.1	1.5	19.3	0.6	13.5	0.6	0.2	0.0	0.0	27.7	0.4	2.3	0.0	0.3	0.2	0.0	0.7	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	11.7	0.0	0.4	0.0	0.0	0.0	1.4	2.5	1.1	4.1	1.9	1.4	2.0	1.6	1.5	1.9	1.8	2.6	5.2	342.9	77.7	0.0	7.4	118.8	59.1	72.8	12.5	0.0	2.6	12.8	2.5	0.0	79.7	0.0	0.0	0.2	4.2	0.3	0.0	0.8	0.2	50.0	9.9	31.1	1.2	3.6	3.8	0.2	0.3	270.7	2.0	98.9	347.6	3.8	13.6	0.2	12.1	0.0	1.0	1.0	8.2	21.0	305.6	0.0	0.0	173.1	35.6	3.7	3.4	0.1	0.0	0.0	0.1	4.9	0.1	0.0	2.0	122.6	0.2	0.3	13.1	0.3	0.0	1.8	12.8	0.1	0.4	3.3	28.4	0.5	10.8	3.7	1.2	151.6
PTHLH	"HHM, PLP, PTHR, PTHRP"	ENSG00000087494	"Parathyroid hormone like hormone"	P12272	12	27958084-27972733	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted secreted proteins"		Hormone	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"parathyroid gland: 22.8"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 254.0;Basal squamous epithelial cells: 93.9;Breast glandular cells: 105.4;Breast myoepithelial cells: 56.3;Club cells: 77.5"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 64.0"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	4	"HaCaT: 291.3;HBEC3-KT: 359.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA035982	Approved	Approved	Supported	"Nucleoplasm,Golgi apparatus,Cytosol"	"Secreted in other tissues"	NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Nucleoplasm, Cytosol"	"Golgi apparatus"	"HPA035982: AB_10794631"	"unprognostic (1.67e-1)"	"unprognostic (5.26e-3)"	"unprognostic (1.31e-1)"	"unprognostic (4.41e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.13e-1)"	"prognostic unfavorable (3.37e-4)"	"unprognostic (1.60e-2)"	"unprognostic (1.18e-1)"	"unprognostic (5.16e-2)"	"unprognostic (4.09e-3)"	"unprognostic (3.84e-1)"	"prognostic unfavorable (1.82e-9)"	"unprognostic (2.01e-2)"	"unprognostic (1.34e-1)"	"unprognostic (5.23e-3)"	"unprognostic (7.87e-3)"	3.1	0.8	1.8	1.2	2.3	0.0	20.1	0.6	3.2	13.6	10.2	3.3	2.3	10.7	1.1	16.2	1.5	7.5	4.2	4.1	3.2	0.4	0.2	1.2	1.1	4.0	8.1	1.8	1.7	22.8	2.9	3.0	0.4	5.2	1.6	0.2	8.5	2.4	0.7	2.0	1.6	3.0	0.2	3.6	1.8	1.3	8.6	0.4	1.8	1.7	1.0	9.2	15.2	0.8	1.7	9.9	0.0	0.0	2.9	2.8	0.1	0.3	1.0	0.5	1.3	0.3	7.9	0.0	0.5	2.6	9.1	291.3	1.3	359.8	0.1	7.4	1.7	0.5	1.8	0.1	0.8	0.1	0.4	0.2	19.7	9.1	34.4	0.9	11.2	0.1	0.0	0.4	0.2	0.1	0.1	0.0	1.4	0.4	16.7	0.1	1.5	0.6	34.3	0.3	0.2	0.1	16.4	0.1	2.1	11.5	0.5	0.1	5.6	1.6	8.9	5.1	77.8	4.7	0.1	12.1	7.5	0.2	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	1.8	2.3	0.6	3.2	4.1	3.2	4.0	8.1	0.4	0.2	8.6	0.8	1.4	0.0	0.0	0.7	0.4	4.6	1.9	254.0	93.9	0.3	105.4	56.3	0.4	0.0	77.5	0.0	0.0	0.0	0.5	0.0	0.0	3.5	5.9	0.9	4.7	4.5	0.0	0.0	0.6	8.9	0.0	13.6	0.0	0.8	0.0	2.6	0.4	0.2	0.0	0.0	11.2	0.0	4.1	0.3	1.3	2.7	0.9	0.6	23.2	1.0	0.6	1.8	0.0	0.0	0.2	8.6	0.0	0.0	6.2	0.5	0.0	0.3	14.8	0.5	6.6	8.0	6.7	3.6	0.2	7.9	1.4	0.0	0.5	0.2	0.0	0.2
PTK2	"FADK, FAK, FAK1, PPP1R71"	ENSG00000169398	"Protein tyrosine kinase 2"	Q05397	8	140657900-141002216	"Cancer-related genes, Disease related genes, Enzymes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	Angiogenesis	"Developmental protein, Kinase, Transferase, Tyrosine-protein kinase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 295.2;Excitatory neurons: 584.9;Oligodendrocyte precursor cells: 353.9;Oligodendrocytes: 791.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001842, CAB004036, HPA029671"	Approved		Supported	"Vesicles,Focal adhesion sites,Cytosol"		NA	Yes		25000	"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Focal adhesion sites"	"Vesicles, Cytosol"	"CAB004036: AB_2269034, HPA001842: AB_1855891, HPA029671: AB_10610288"	"prognostic unfavorable (3.21e-4)"	"unprognostic (3.86e-2)"	"unprognostic (1.95e-1)"	"prognostic unfavorable (9.11e-4)"	"unprognostic (1.93e-1)"	"unprognostic (2.28e-1)"	"unprognostic (3.02e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.97e-1)"	"unprognostic (2.96e-2)"	"unprognostic (1.06e-2)"	"unprognostic (2.38e-1)"	"unprognostic (2.80e-2)"	"unprognostic (2.94e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.53e-1)"	"unprognostic (2.90e-2)"	51.0	40.4	83.8	19.5	115.1	6.7	42.1	62.4	99.9	40.3	51.0	37.2	25.8	37.3	49.7	25.6	34.0	32.1	36.9	84.5	77.3	42.6	30.1	39.4	25.3	79.1	87.6	33.7	32.1	53.1	21.3	74.2	81.0	34.0	35.3	35.5	39.9	41.6	38.7	29.6	29.5	37.6	67.6	22.8	32.8	38.9	86.7	11.9	38.7	39.4	25.8	43.9	34.0	154.5	52.6	81.9	111.0	40.3	45.8	48.8	71.6	50.8	70.0	46.3	45.3	35.9	42.1	31.7	111.7	65.3	65.0	60.3	66.1	116.0	69.6	0.3	30.8	70.1	44.3	50.0	62.5	0.1	31.8	33.4	55.8	58.0	81.0	121.5	139.0	44.0	72.0	0.8	62.9	91.0	0.9	0.7	43.2	113.2	90.3	46.8	60.9	1.5	97.7	117.3	43.9	54.8	79.0	25.0	52.0	97.2	59.2	1.2	84.9	45.2	85.5	54.0	58.1	0.0	0.6	3.4	58.7	0.6	62.9	1.6	3.3	0.0	0.2	1.4	0.0	5.3	0.6	0.0	4.5	6.3	4.4	1.6	1.3	4.7	0.8	6.1	0.2	3.9	83.8	115.1	62.4	99.9	84.5	77.3	79.1	87.6	81.0	67.6	86.7	154.5	71.3	32.1	33.1	295.2	20.6	33.3	70.1	36.3	64.9	55.2	29.3	23.5	29.6	32.9	32.1	55.2	60.5	37.0	8.0	23.1	23.5	27.2	68.4	29.3	43.3	54.3	25.8	8.4	584.9	23.3	53.7	37.2	37.8	46.5	9.5	84.7	37.5	15.7	8.1	67.3	263.6	23.0	30.5	15.2	15.9	38.8	23.9	19.4	24.9	159.3	3.9	40.9	0.0	353.9	791.4	43.1	23.5	21.8	1.7	82.4	29.3	25.6	33.7	55.0	98.6	32.7	128.4	88.9	65.5	42.8	25.9	33.2	3.4	67.0	24.1	87.3
PTK2B	"CADTK, CAKB, FAK2, PTK, PYK2, RAFTK"	ENSG00000120899	"Protein tyrosine kinase 2 beta"	Q14289	8	27311482-27459391	"Disease related genes, Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Adaptive immunity, Angiogenesis, Immunity"	"Kinase, Transferase, Tyrosine-protein kinase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 106.3;brain: 102.9"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 109.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 127.4;REH: 141.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003850, HPA026091, HPA026276"	Approved		Supported	"Plasma membrane,Cytosol"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 14: REH - Unknown function"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Plasma membrane, Cytosol"		"CAB003850: AB_562205, HPA026091: AB_10599739, HPA026276: AB_10601234"	"unprognostic (2.36e-2)"	"prognostic favorable (3.32e-4)"	"unprognostic (1.06e-1)"	"unprognostic (7.36e-3)"	"unprognostic (3.72e-2)"	"unprognostic (3.11e-2)"	"unprognostic (2.70e-2)"	"unprognostic (2.13e-2)"	"unprognostic (3.23e-1)"	"unprognostic (1.45e-1)"	"unprognostic (5.74e-2)"	"unprognostic (3.32e-1)"	"unprognostic (2.40e-3)"	"unprognostic (1.44e-1)"	"unprognostic (1.38e-1)"	"prognostic favorable (5.11e-4)"	"unprognostic (3.33e-3)"	19.7	10.8	46.9	52.6	54.4	106.3	11.5	22.8	102.9	11.5	38.3	29.8	34.1	9.9	8.9	19.2	15.6	12.7	10.6	96.3	8.5	15.9	15.2	28.6	78.3	0.0	26.0	4.7	12.6	7.1	13.7	8.0	0.0	25.5	23.5	4.4	26.6	12.3	5.0	45.2	48.8	10.7	0.2	78.3	22.2	9.5	27.0	86.0	12.5	5.4	73.6	21.0	15.1	37.0	38.2	10.4	2.8	3.0	76.6	5.5	21.5	2.9	1.9	1.9	2.7	9.9	21.5	127.4	4.0	5.8	3.1	34.3	1.1	31.3	1.1	8.7	0.8	26.4	10.6	2.0	15.7	28.5	45.5	41.6	46.0	2.6	17.3	13.0	1.0	36.0	31.7	85.6	2.1	4.0	49.1	57.0	2.2	33.0	2.6	141.2	0.7	88.3	8.5	29.5	19.2	3.5	13.4	9.3	5.0	6.5	11.5	72.1	17.5	1.3	2.8	2.5	1.0	68.0	32.0	68.9	5.2	60.6	2.4	47.3	48.4	36.9	33.9	43.0	22.2	46.0	17.0	24.3	36.1	46.6	20.8	25.9	45.8	29.0	53.5	11.7	18.2	50.1	46.9	54.4	22.8	102.9	96.3	8.5	0.0	26.0	0.0	0.2	27.0	37.0	6.9	3.2	29.8	16.6	64.3	37.7	38.7	19.7	6.8	5.4	5.9	7.7	3.7	8.6	13.0	14.7	0.0	2.9	33.4	65.5	0.0	8.0	1.2	7.1	1.8	9.6	7.8	20.2	109.2	8.3	26.5	3.5	22.4	5.3	28.5	1.1	5.0	24.1	23.1	8.4	9.2	21.9	10.2	68.4	32.1	1.0	1.5	55.3	8.8	22.5	62.5	2.8	70.0	7.5	15.1	13.3	42.0	0.7	68.1	18.6	44.6	16.1	13.9	3.9	0.0	3.3	3.3	4.2	6.4	4.8	30.1	1.9	46.6	1.0	18.1	17.9
PTK6	BRK	ENSG00000101213	"Protein tyrosine kinase 6"	Q13882	20	63528001-63537376	"Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Transferase, Tyrosine-protein kinase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 109.4;skin 1: 53.9;vagina: 43.2"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 132.1;Gastric mucus-secreting cells: 59.1;Intestinal goblet cells: 42.5;Paneth cells: 97.6;Proximal enterocytes: 80.2;Squamous epithelial cells: 48.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"A-431: 22.1;CAPAN-2: 41.4;HaCaT: 33.9;hTCEpi: 45.0;OE19: 57.0;RT4: 26.4;T-47d: 25.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB032952, HPA036070, HPA036071"	Approved		Supported	"Nucleoplasm,Nuclear bodies,Plasma membrane,Cytosol"		NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm	"Nuclear bodies, Plasma membrane, Cytosol"	"CAB032952: AB_634461, HPA036070: AB_10602292, HPA036071: AB_10669982"	"unprognostic (2.32e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.42e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.29e-1)"	"unprognostic (3.03e-1)"	"unprognostic (3.72e-2)"	"prognostic unfavorable (1.96e-4)"	"unprognostic (1.28e-1)"	"prognostic unfavorable (1.26e-9)"	"unprognostic (4.19e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.73e-1)"	"unprognostic (4.24e-2)"	0.5	0.1	0.6	3.6	1.7	0.8	3.8	2.9	1.7	19.8	0.0	26.5	28.9	0.4	0.1	109.4	0.4	3.5	0.2	0.6	0.9	0.8	5.2	2.6	0.6	1.6	1.0	0.3	3.6	0.0	0.2	0.3	1.7	3.1	15.7	0.8	19.1	0.6	0.6	53.9	22.2	0.8	0.6	0.8	26.2	0.3	1.1	0.3	0.2	0.0	6.4	9.8	43.2	5.4	22.1	2.6	0.3	0.3	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.5	41.4	0.1	7.2	0.0	0.1	33.9	0.0	0.1	0.0	5.4	0.4	0.0	10.2	0.1	0.1	0.0	6.7	0.0	45.0	0.0	0.2	0.2	0.0	0.1	0.2	2.5	0.2	12.5	0.0	0.2	0.2	57.0	15.5	0.1	1.2	0.5	0.0	26.4	0.3	2.2	2.6	8.1	0.0	0.1	25.2	1.6	0.2	0.3	0.4	0.8	0.3	0.5	0.1	0.1	0.4	0.5	1.1	0.4	0.7	0.1	0.1	0.5	0.5	0.3	0.1	0.0	1.3	0.3	0.1	0.1	0.3	0.0	0.4	0.1	0.1	0.3	0.6	1.7	2.9	1.7	0.6	0.9	1.6	1.0	1.7	0.6	1.1	5.4	0.3	12.8	25.6	0.3	1.4	5.9	2.6	7.7	5.2	2.2	7.0	4.3	0.4	12.8	14.9	0.0	2.1	0.2	0.2	132.1	0.0	1.4	0.2	0.4	0.5	3.2	5.4	0.0	0.1	1.6	0.2	1.4	59.1	1.3	9.5	0.2	0.4	1.7	0.6	0.0	0.1	42.5	2.0	2.2	2.0	0.0	0.3	2.6	0.0	0.0	1.0	1.6	1.0	0.0	0.8	17.6	97.6	0.0	0.1	1.5	80.2	0.2	8.9	3.7	0.0	2.3	1.1	0.2	0.3	48.0	15.5	0.1	2.0	0.2	32.1	15.9
PTMA	TMSA	ENSG00000187514	"Prothymosin alpha"	P06454	2	231706895-231713551	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA047183	Approved		Enhanced	Nucleoplasm,Cytosol		No	No		1200000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 24: NB-4 - Immune response"	"Cluster 32: Non-specific - Translation"	Nucleoplasm	Cytosol	"HPA047183: AB_2679972"	"unprognostic (1.49e-3)"	"prognostic favorable (6.56e-4)"	"unprognostic (3.73e-1)"	"unprognostic (1.91e-1)"	"unprognostic (2.05e-1)"	"unprognostic (2.52e-2)"	"prognostic unfavorable (3.61e-4)"	"unprognostic (5.99e-2)"	"unprognostic (1.56e-2)"	"unprognostic (3.72e-3)"	"unprognostic (2.35e-3)"	"unprognostic (9.24e-2)"	"prognostic unfavorable (1.99e-7)"	"unprognostic (5.54e-2)"	"unprognostic (6.07e-2)"	"unprognostic (3.81e-3)"	"unprognostic (8.64e-3)"	1203.7	522.8	832.1	1028.5	1020.8	2322.6	1026.6	865.2	1035.4	1185.1	644.5	1045.1	703.0	1110.9	698.4	1186.1	1022.9	565.9	541.0	779.9	898.4	1203.7	652.1	933.2	1396.2	952.9	933.7	1078.5	1090.3	481.3	398.6	688.1	919.2	722.6	985.0	437.1	765.6	604.7	305.9	1425.4	935.1	699.4	875.4	896.2	873.2	237.1	929.1	2059.3	1002.8	246.4	1523.2	896.5	999.1	1137.2	2436.8	1416.4	1990.8	1788.7	592.5	783.4	2037.5	1614.2	1346.2	1379.8	1436.6	1380.8	2759.6	3811.5	1795.4	1271.0	948.1	1252.2	2830.6	1992.5	1738.6	3027.0	2228.9	4906.7	1096.2	2266.8	732.6	5621.1	2018.0	1143.7	733.1	1226.2	1002.6	1307.0	2286.8	3049.7	2910.9	1573.5	1222.0	3433.7	7998.5	7671.0	3004.9	2381.4	1180.4	5426.1	1408.4	2601.9	1719.2	2116.3	4041.8	2483.3	1851.0	1833.5	1507.1	1552.9	1383.9	4430.2	1704.1	1154.2	2052.5	1429.4	1769.7	1887.9	999.3	7614.4	790.8	3401.9	1897.3	2067.1	1713.8	1146.7	1346.2	1695.8	1945.2	2776.6	1928.5	1640.8	1828.0	2438.2	2109.4	1808.0	321.7	1782.3	1957.1	1944.4	2506.6	4661.6	832.1	1020.8	865.2	1035.4	779.9	898.4	952.9	933.7	919.2	875.4	929.1	1137.2	3907.5	971.2	1529.2	49.6	4518.0	7745.0	3851.3	5347.3	5459.5	703.1	3534.0	3673.7	259.7	1974.5	2483.8	2273.2	294.0	2599.4	4054.7	1741.3	3785.9	3474.2	103.3	2713.9	3364.3	4186.4	1695.3	3942.3	37.4	4190.1	5153.9	2404.0	2340.5	3092.6	2928.1	2349.3	1940.1	1347.6	3134.5	812.6	40.9	3178.6	3733.2	3492.4	8474.1	201.4	1306.3	3470.5	3689.1	78.7	3334.5	2195.9	2988.7	40.7	282.0	3669.3	2492.8	1404.5	3523.3	4524.2	1624.2	3136.2	1925.7	934.2	1926.2	2766.5	4571.8	1157.6	2467.8	5778.6	7944.4	2734.1	4276.7	1312.4	3381.3	4052.2
PTN	"HBGF8, HBNF, NEGF1"	ENSG00000105894	Pleiotrophin	P21246	7	137227341-137343774	"Cancer-related genes, Predicted secreted proteins"		"Growth factor, Heparin-binding, Mitogen"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 280.4;parathyroid gland: 383.5"	"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 672.0;Extravillous trophoblasts: 416.0;Horizontal cells: 526.6;Muller glia cells: 548.5;Oligodendrocyte precursor cells: 322.7;Squamous epithelial cells: 439.9"	"Cancer enriched"	"Detected in all"	11	"glioma: 514.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in many"	12	"AF22: 1717.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017685, HPA073913"	Enhanced		Supported	"Endoplasmic reticulum"	"Secreted to blood"	NA	NA	167000	1400000		"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 12: NES - Nervous system development"	"Cluster 36: Stromal cells - Cell proliferation"	"Endoplasmic reticulum"		"CAB017685: AB_1128556, HPA073913: "	"unprognostic (1.51e-2)"	"unprognostic (7.87e-2)"	"unprognostic (5.44e-2)"	"unprognostic (4.23e-2)"	"unprognostic (1.92e-1)"	"unprognostic (7.19e-2)"	"unprognostic (2.81e-2)"	"unprognostic (7.29e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.09e-2)"	"unprognostic (3.86e-1)"	"unprognostic (1.22e-2)"	"prognostic favorable (1.35e-4)"	"unprognostic (2.34e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.16e-2)"	26.2	18.2	212.9	4.1	206.4	0.1	82.3	217.0	280.4	100.0	182.0	31.4	5.4	76.8	55.3	78.2	19.2	55.9	87.7	209.6	205.2	38.4	8.5	18.4	7.4	220.3	200.5	19.0	8.4	383.5	126.1	36.2	196.3	116.1	21.6	63.4	37.4	52.5	2.2	9.1	10.1	54.0	204.2	40.4	15.7	53.8	207.6	21.4	18.9	18.8	11.4	24.8	65.1	209.1	1.2	0.0	1717.6	21.2	0.4	0.9	140.6	45.3	134.3	25.1	34.3	0.4	0.2	0.0	0.2	60.0	15.6	1.0	0.0	0.0	18.9	0.0	1.4	0.0	0.0	0.0	7.7	0.0	0.5	1.9	0.0	16.6	0.2	24.6	0.0	0.0	0.0	8.2	7.0	0.0	0.0	0.6	133.5	0.0	1.1	0.1	2.8	0.4	0.7	0.0	8.0	116.5	0.0	0.0	0.2	24.1	0.2	0.2	0.0	37.4	32.9	1.8	99.4	0.7	0.0	0.0	119.7	0.0	6.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	212.9	206.4	217.0	280.4	209.6	205.2	220.3	200.5	196.3	204.2	207.6	209.1	10.1	0.0	0.0	303.3	1.3	23.2	1.7	85.0	209.5	27.7	244.6	117.3	14.6	2.8	20.9	1.8	6.2	220.0	2.2	0.0	9.8	1.1	24.5	53.4	672.0	32.0	0.0	0.0	4.9	0.0	416.0	248.8	0.5	24.6	0.0	1.1	7.1	0.3	20.4	526.6	18.1	0.0	0.0	0.3	20.6	14.0	172.7	4.0	44.4	102.1	0.0	548.5	0.0	322.7	218.4	0.3	0.0	185.5	2.5	18.6	0.0	7.5	7.2	32.3	59.2	3.0	91.4	4.0	2.4	439.9	13.9	193.3	4.4	144.7	0.0	2.2
PTOV1		ENSG00000104960	"PTOV1 extended AT-hook containing adaptor protein"	Q86YD1	19	49850735-49860744	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 326.5;Late spermatids: 631.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051812, HPA075125"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 35: Non-specific - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 25: Spermatids - Spermatogenesis"	Nucleoplasm		"HPA051812: , HPA075125: AB_2732280"	"unprognostic (2.70e-1)"	"unprognostic (1.36e-2)"	"prognostic unfavorable (6.64e-4)"	"unprognostic (4.68e-2)"	"unprognostic (1.37e-1)"	"unprognostic (6.31e-2)"	"unprognostic (1.94e-2)"	"unprognostic (1.40e-1)"	"unprognostic (2.70e-1)"	"unprognostic (9.08e-2)"	"prognostic favorable (9.20e-4)"	"unprognostic (4.65e-2)"	"unprognostic (3.22e-2)"	"unprognostic (2.47e-1)"	"unprognostic (1.26e-2)"	"unprognostic (5.27e-2)"	"unprognostic (6.70e-2)"	46.1	107.3	123.8	24.1	122.9	29.8	46.8	122.4	161.5	76.3	129.3	65.8	23.7	65.8	15.0	43.7	62.1	17.8	65.6	124.4	132.6	69.5	67.8	40.0	23.6	133.8	126.5	91.0	61.5	27.5	106.0	23.1	125.7	73.5	5.8	19.0	55.0	23.2	106.6	51.2	43.0	11.5	131.5	47.6	58.7	66.4	126.0	18.7	62.4	16.6	8.7	53.9	52.2	136.4	43.5	88.0	87.5	94.4	12.1	19.7	53.7	52.3	45.7	47.8	50.1	48.1	73.1	46.7	49.0	26.4	32.8	47.1	32.5	40.6	11.5	122.5	218.8	30.3	72.2	76.1	31.0	25.1	59.2	37.6	25.7	20.2	8.2	32.2	40.2	64.9	71.9	54.9	22.5	53.2	113.3	113.1	56.6	31.2	79.6	135.8	35.5	65.8	42.2	75.1	113.1	123.4	44.8	51.6	23.9	21.9	50.5	27.3	58.6	56.6	93.5	34.1	43.3	57.5	37.4	63.7	58.5	35.2	73.7	8.8	2.6	4.3	2.7	2.4	3.6	7.1	3.0	2.4	1.9	6.3	3.8	3.5	7.4	4.7	1.4	7.7	1.3	1.1	123.8	122.9	122.4	161.5	124.4	132.6	133.8	126.5	125.7	131.5	126.0	136.4	42.9	38.5	25.7	18.3	43.3	36.6	82.3	21.5	55.2	50.5	56.2	60.1	32.6	65.8	26.4	44.1	18.8	110.6	29.9	69.8	90.1	28.9	326.5	87.4	68.5	37.4	99.8	46.3	14.7	26.8	91.4	62.7	56.6	78.9	15.2	92.7	38.2	57.2	52.1	35.3	17.1	72.7	20.3	28.9	39.1	631.4	64.3	28.8	44.4	10.3	18.6	75.0	18.6	17.1	23.7	35.8	61.2	80.5	72.0	74.8	68.4	141.0	38.4	44.1	59.2	44.2	56.2	30.3	93.3	40.1	36.2	153.6	34.0	88.0	55.3	70.2
PTPN11	"BPTP3, NS1, PTP2C, SH-PTP2, SHP-2, SHP2"	ENSG00000179295	"Protein tyrosine phosphatase non-receptor type 11"	Q06124	12	112418351-112509918	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins"		"Hydrolase, Protein phosphatase"	"Cancer-related genes, Deafness, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB005377	Approved		Supported	"Nucleoplasm,Nucleoli rim,Actin filaments,Cytosol"		NA	NA		74000	"Cluster 6: Non-specific - Transcription"	"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 54: Cardiomyocytes - Muscle contraction"	"Nucleoplasm, Nucleoli rim"	"Actin filaments, Cytosol"	"CAB005377: AB_632401"	"unprognostic (2.18e-3)"	"unprognostic (1.73e-3)"	"unprognostic (5.62e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.63e-2)"	"unprognostic (2.27e-1)"	"unprognostic (6.05e-2)"	"unprognostic (4.25e-2)"	"unprognostic (3.55e-2)"	"unprognostic (1.88e-1)"	"unprognostic (2.22e-2)"	"unprognostic (8.85e-2)"	"unprognostic (3.75e-3)"	"unprognostic (1.66e-1)"	"unprognostic (2.46e-1)"	"unprognostic (3.62e-2)"	"unprognostic (1.80e-2)"	62.9	36.6	74.6	34.7	91.7	46.3	37.6	72.7	115.7	37.9	38.4	32.5	27.6	37.8	28.7	38.9	24.3	29.4	68.7	66.1	85.6	39.7	53.0	34.4	35.6	79.0	84.1	26.2	31.6	53.4	16.1	38.0	85.7	35.2	30.6	51.8	25.9	42.4	75.1	32.1	26.1	45.7	83.4	26.7	30.4	18.2	81.7	35.5	46.8	64.0	32.5	40.1	23.5	106.3	116.9	107.6	77.0	73.4	109.7	106.1	92.7	136.4	148.2	105.5	78.5	107.7	43.4	124.5	69.4	127.4	66.7	68.1	100.1	121.6	173.8	93.1	85.0	181.5	102.6	59.8	109.2	145.8	108.0	86.6	119.6	113.6	159.8	101.3	88.7	92.0	140.2	41.3	103.3	83.2	101.0	69.7	94.1	112.3	73.4	102.4	114.6	70.5	97.3	126.7	53.3	66.1	133.7	99.8	85.2	77.6	114.8	97.8	108.1	122.9	110.0	74.2	121.8	79.4	141.6	120.2	102.2	99.7	117.7	32.2	11.7	16.8	14.8	10.2	14.0	18.1	13.3	12.4	13.6	20.8	15.3	11.9	10.7	12.6	13.7	18.3	10.9	7.2	74.6	91.7	72.7	115.7	66.1	85.6	79.0	84.1	85.7	83.4	81.7	106.3	49.0	60.9	68.2	27.7	25.8	25.6	39.9	25.3	20.5	29.9	40.5	32.4	131.6	24.3	41.8	36.8	16.7	23.5	34.2	25.4	33.2	37.5	63.1	31.3	92.6	46.2	13.1	21.7	67.6	42.8	25.3	35.8	21.9	40.9	28.4	33.1	26.0	101.5	26.8	13.5	54.7	22.0	18.3	33.3	21.6	28.5	51.6	31.8	14.2	40.3	31.1	59.8	29.9	32.6	73.0	59.3	19.6	79.7	37.0	73.4	16.6	39.8	23.5	22.2	32.9	58.2	49.2	7.1	6.6	37.5	27.4	35.2	31.7	30.5	22.2	66.8
PTPN13	"PTP-BAS, PTP-BL, PTP1E, PTPL1"	ENSG00000163629	"Protein tyrosine phosphatase non-receptor type 13"	Q12923	4	86594315-86815171	"Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 124.3"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 223.1;Astrocytes: 165.2;Oligodendrocytes: 200.2;Rod photoreceptor cells: 179.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"non-classical monocyte: 2.0"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"AF22: 117.6;RT4: 57.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002213, HPA063119"	Approved		Supported	"Nucleoplasm,Nucleoli fibrillar center,Cytosol"		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 12: NES - Nervous system development"	"Cluster 46: Photoreceptor cells - Phototransduction"	Nucleoplasm	"Nucleoli fibrillar center, Cytosol"	"CAB002213: AB_564089, HPA063119: "	"unprognostic (5.36e-2)"	"unprognostic (4.46e-1)"	"unprognostic (1.11e-1)"	"unprognostic (2.54e-3)"	"unprognostic (4.02e-1)"	"unprognostic (9.03e-3)"	"unprognostic (4.43e-2)"	"unprognostic (4.38e-2)"	"unprognostic (2.46e-1)"	"unprognostic (7.05e-2)"	"unprognostic (3.69e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.28e-3)"	"unprognostic (3.95e-3)"	"unprognostic (2.26e-1)"	"unprognostic (2.66e-1)"	"unprognostic (2.85e-2)"	14.0	6.7	9.9	3.0	16.6	0.3	11.7	8.1	10.8	18.8	22.4	5.2	0.8	13.1	25.5	22.2	13.0	7.7	6.1	14.2	10.6	26.6	1.4	22.9	5.2	16.7	13.1	28.7	4.9	17.5	16.8	3.3	10.5	11.0	2.4	124.3	6.6	10.6	1.0	55.9	2.6	7.9	8.2	4.0	4.1	15.8	13.8	7.6	20.8	5.0	11.5	20.7	22.7	20.4	13.8	6.8	117.6	11.5	48.2	41.9	0.0	25.0	51.0	9.4	11.7	0.1	6.8	0.0	5.3	28.0	3.3	44.4	20.6	37.9	18.0	0.3	15.1	11.4	14.6	0.0	5.9	20.5	0.1	27.2	11.8	6.8	22.4	19.7	0.0	0.0	0.0	19.2	0.0	6.2	1.8	7.4	26.5	0.0	5.1	4.1	0.0	0.0	35.6	57.2	6.8	9.8	7.4	16.4	13.3	18.8	9.6	0.7	0.0	9.1	6.9	0.2	3.3	19.8	0.0	0.0	9.5	0.0	4.0	0.0	0.1	0.0	0.1	1.3	0.9	0.0	0.8	0.1	0.2	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	9.9	16.6	8.1	10.8	14.2	10.6	16.7	13.1	10.5	8.2	13.8	20.4	5.3	48.1	223.1	165.2	0.6	109.4	25.6	26.3	79.1	11.6	11.2	8.9	1.8	11.5	52.0	47.8	91.8	0.2	0.3	0.1	3.9	5.0	23.2	16.9	49.4	3.7	4.8	0.8	67.0	3.7	0.1	28.8	4.1	7.7	5.1	7.5	3.6	0.1	0.3	1.7	39.3	1.1	8.2	1.4	10.6	20.8	45.7	4.5	19.6	51.5	0.5	20.3	0.0	75.4	200.2	6.2	2.7	32.7	3.0	16.0	0.1	10.9	27.3	179.0	13.1	10.1	20.8	25.4	20.5	97.8	99.4	0.3	6.6	14.0	0.7	52.5
PTPN14	PEZ	ENSG00000152104	"Protein tyrosine phosphatase non-receptor type 14"	Q15678	1	214348700-214552449	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Microglial cells: 91.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB011469, HPA053864, CAB069441"	Uncertain		Supported	Nucleoplasm		NA	NA				"Cluster 59: Non-specific - Translation"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Nucleoplasm		"CAB011469: AB_299202, CAB069441: , HPA053864: AB_2682281"	"unprognostic (1.54e-1)"	"unprognostic (8.19e-2)"	"unprognostic (5.42e-5)"	"unprognostic (1.42e-1)"	"unprognostic (2.91e-1)"	"unprognostic (5.97e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.58e-1)"	"unprognostic (2.84e-1)"	"unprognostic (1.31e-1)"	"prognostic unfavorable (2.29e-4)"	"unprognostic (7.43e-2)"	"unprognostic (8.34e-3)"	"prognostic unfavorable (5.16e-4)"	"unprognostic (1.16e-1)"	"unprognostic (2.21e-1)"	"unprognostic (4.81e-3)"	7.5	8.0	3.7	1.8	1.5	0.2	10.6	1.5	3.7	5.2	13.4	7.6	0.9	8.2	2.5	6.0	7.3	3.3	6.0	3.3	0.8	8.2	0.7	4.6	1.3	2.4	2.4	6.6	4.3	3.3	1.8	7.8	2.1	6.7	2.3	0.6	6.5	6.6	19.8	16.2	2.8	7.9	1.4	3.5	4.5	3.9	4.2	2.1	5.3	10.2	1.8	5.6	5.6	1.9	21.1	9.2	7.2	10.6	12.3	20.9	21.6	23.2	21.3	17.3	14.4	18.8	10.7	0.1	25.3	53.6	10.0	18.1	10.0	25.7	29.0	0.2	7.7	1.9	26.6	3.5	22.2	0.2	1.0	15.6	26.1	30.0	47.4	28.1	33.8	0.6	0.1	0.2	41.8	2.3	0.2	0.2	16.2	3.7	9.9	0.3	36.3	0.1	30.6	10.5	0.1	1.7	28.7	18.4	11.6	25.1	18.4	0.7	61.4	40.3	15.9	14.6	33.3	1.2	0.1	0.2	21.6	0.3	34.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	3.7	1.5	1.5	3.7	3.3	0.8	2.4	2.4	2.1	1.4	4.2	1.9	60.3	73.7	12.6	47.3	1.3	56.5	32.1	39.4	45.5	0.6	20.3	29.8	20.5	14.3	32.7	29.5	0.0	38.8	1.3	1.0	7.9	12.9	8.8	42.5	25.9	53.5	3.5	0.0	47.9	11.0	14.2	20.8	9.2	55.2	1.3	13.5	40.0	0.9	4.5	0.0	6.0	4.1	4.1	1.5	7.7	4.4	26.1	2.4	10.6	91.8	0.3	3.9	3.1	39.2	2.1	31.2	0.3	29.3	1.6	30.6	0.3	14.4	18.5	1.3	19.7	38.0	20.1	1.2	10.6	18.3	36.1	24.2	3.7	46.3	2.9	28.9
PTPN2	"PTPT, TC-PTP, TCELLPTP, TCPTP"	ENSG00000175354	"Protein tyrosine phosphatase non-receptor type 2"	P17706	18	12785478-12929643	"Enzymes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 99.8"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015004, HPA046176"	Enhanced		Supported	Nucleoplasm		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 21: OE19 - Mitochondria"	"Cluster 22: Epithelial cell types - Mixed function"	Nucleoplasm		"HPA015004: AB_2669131, HPA046176: AB_2679569"	"unprognostic (5.83e-3)"	"unprognostic (8.50e-2)"	"unprognostic (5.85e-2)"	"unprognostic (7.21e-3)"	"unprognostic (8.94e-3)"	"unprognostic (2.31e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.68e-1)"	"unprognostic (2.37e-3)"	"prognostic favorable (1.37e-4)"	"unprognostic (1.06e-2)"	"unprognostic (1.75e-2)"	"prognostic unfavorable (1.20e-8)"	"unprognostic (3.19e-1)"	"unprognostic (6.84e-3)"	"unprognostic (2.17e-1)"	"unprognostic (4.61e-3)"	23.4	15.2	10.0	32.8	10.8	57.2	23.7	21.0	17.1	19.9	15.6	22.2	18.9	16.0	20.4	20.0	17.4	22.4	14.7	11.0	10.4	17.3	25.8	26.3	44.4	12.3	10.4	26.8	33.1	14.1	18.3	19.5	11.8	17.6	24.1	20.2	29.4	13.5	16.7	21.0	19.5	16.9	10.7	28.5	18.0	13.6	10.0	99.8	17.5	11.9	43.5	37.2	19.9	14.3	34.8	20.7	23.7	7.9	26.5	47.4	23.0	22.7	50.2	47.5	42.2	45.4	48.8	54.3	37.2	23.6	53.2	20.4	39.0	62.2	62.1	21.2	23.5	38.4	17.7	47.6	36.4	91.1	35.1	40.2	57.6	43.3	85.1	29.2	24.6	58.1	37.9	71.6	38.6	39.9	91.3	74.5	28.5	141.7	24.0	30.4	37.3	61.9	40.2	54.6	42.3	22.0	46.0	26.7	41.8	25.1	22.4	51.5	18.8	59.8	58.0	45.1	49.8	22.6	24.5	77.8	28.3	49.3	25.7	23.7	52.6	39.2	37.0	47.7	50.4	54.4	43.7	41.4	62.5	39.5	31.6	34.9	19.0	64.1	46.7	53.0	57.3	40.7	10.0	10.8	21.0	17.1	11.0	10.4	12.3	10.4	11.8	10.7	10.0	14.3	25.8	35.3	77.0	38.5	82.4	59.9	106.0	88.0	61.5	44.1	37.0	50.5	15.0	47.1	84.4	14.7	104.3	54.1	130.4	32.2	13.7	55.1	24.3	51.0	44.8	32.0	32.3	40.8	81.1	68.8	52.5	38.1	24.5	78.7	56.4	53.1	20.3	27.9	51.3	15.2	60.5	35.0	69.2	99.2	92.5	23.2	29.2	93.4	23.2	44.0	137.0	17.6	128.8	22.6	55.0	40.0	45.1	25.6	120.2	126.4	29.9	23.1	55.4	84.5	19.7	35.4	33.8	23.3	61.3	40.0	50.2	81.1	84.2	65.2	39.5	152.4
PTPN20	"bA142I17.1, bA42B19.1, CT126, DKFZP566K0524, PTPN20A, PTPN20B"	ENSG00000204179	"Protein tyrosine phosphatase non-receptor type 20"	Q4JDL3	10	46911396-47002488	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 19.6"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 16.3;Distal tubular cells: 21.5;Early spermatids: 44.2;Late spermatids: 34.9;Proximal tubular cells: 17.7;Spermatocytes: 24.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	6	"HDLM-2: 50.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA043337, HPA046896, HPA048310, HPA069148"	Enhanced		Supported	"Centriolar satellite"		NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 39: Non-specific - Basic cellular processes"	"Centriolar satellite"		"HPA043337: AB_2678436, HPA046896: , HPA048310: AB_2680350, HPA069148: "	"unprognostic (1.08e-1)"	"unprognostic (1.30e-1)"	"unprognostic (3.04e-2)"	"unprognostic (2.82e-3)"	"unprognostic (6.78e-2)"	"unprognostic (1.85e-1)"	"unprognostic (8.44e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.53e-1)"	"unprognostic (2.22e-2)"	"unprognostic (2.83e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.48e-2)"	"unprognostic (1.75e-1)"	"unprognostic (8.34e-2)"	1.6	9.1	3.4	0.2	4.4	0.2	3.5	9.2	5.1	0.8	8.9	0.9	1.3	0.9	0.3	3.4	1.4	0.7	9.1	3.9	5.2	4.4	0.8	0.8	0.4	18.5	9.0	1.9	4.1	0.0	3.1	0.2	19.6	1.2	1.6	2.9	2.4	1.4	12.3	5.7	0.6	0.8	4.6	1.2	1.1	14.0	5.3	0.3	2.0	14.7	0.6	0.9	1.1	4.8	0.0	6.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.5	0.0	0.0	2.9	0.0	3.7	0.0	0.0	0.0	50.2	0.1	0.1	0.0	0.0	2.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.4	0.0	2.2	1.3	9.0	5.5	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	2.9	7.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.5	0.1	0.3	0.1	0.6	0.9	0.0	0.8	0.0	0.7	0.4	0.2	3.4	4.4	9.2	5.1	3.9	5.2	18.5	9.0	19.6	4.6	5.3	4.8	0.5	0.0	1.5	0.0	0.7	0.0	2.0	0.0	5.7	6.0	5.9	3.7	16.3	0.0	2.5	9.2	6.2	0.1	0.3	0.7	21.5	1.8	44.2	5.0	0.1	0.5	1.2	1.7	0.0	0.9	0.2	1.9	3.1	0.2	0.0	4.9	1.4	0.9	0.4	11.8	0.0	0.4	0.0	0.0	0.0	34.9	0.0	0.4	0.0	0.0	0.7	7.3	0.0	0.0	0.0	2.2	0.2	7.2	1.5	0.9	0.2	17.7	3.6	3.1	0.0	2.7	0.8	24.8	12.2	5.2	0.0	0.1	0.4	8.4	0.8	0.9
PTPN23	"DKFZP564F0923, HD-PTP, KIAA1471"	ENSG00000076201	"Protein tyrosine phosphatase non-receptor type 23"	Q9H3S7	3	47381011-47413435	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Cilium biogenesis/degradation, Protein transport, Transport"	"Hydrolase, Protein phosphatase"	"Disease variant, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA016845	Approved		Supported	"Nucleoplasm,Nuclear bodies,Vesicles"		Yes	No			"Cluster 10: Basophils - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 15: RT4 - Unknown function"	"Cluster 44: Endometrium - Transcription"	"Nucleoplasm, Nuclear bodies"	Vesicles	"HPA016845: AB_1855926"	"unprognostic (1.17e-3)"	"unprognostic (8.68e-2)"	"unprognostic (2.56e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.63e-1)"	"unprognostic (6.24e-2)"	"unprognostic (1.07e-3)"	"unprognostic (2.07e-2)"	"unprognostic (9.55e-2)"	"unprognostic (7.12e-2)"	"unprognostic (5.67e-2)"	"unprognostic (4.34e-2)"	"prognostic favorable (1.82e-4)"	"unprognostic (3.05e-2)"	"unprognostic (4.40e-1)"	"unprognostic (9.53e-2)"	"unprognostic (4.68e-2)"	18.5	19.1	6.2	12.6	9.2	14.7	17.4	5.8	10.5	23.3	5.1	16.3	14.3	20.9	7.5	19.0	19.2	8.4	13.2	7.1	7.2	17.5	14.0	18.7	9.1	8.8	7.2	23.5	20.2	23.5	30.9	11.6	8.5	18.7	6.5	8.5	20.0	11.4	30.0	26.4	18.4	8.8	5.5	20.0	16.1	15.6	7.7	8.0	27.1	8.9	7.3	18.5	20.4	14.4	21.5	29.9	16.4	21.4	21.0	16.0	15.8	19.2	18.9	17.5	14.8	25.0	20.7	15.1	17.2	21.9	31.2	19.0	14.3	20.8	8.5	14.3	15.1	21.0	22.2	24.0	23.0	12.3	27.5	21.4	20.9	22.9	23.2	12.4	21.7	12.5	15.9	20.3	19.0	30.2	11.5	10.4	17.5	14.9	20.1	7.2	7.9	18.5	13.2	40.9	8.6	20.6	17.1	35.6	13.6	9.8	20.3	12.0	22.4	26.7	22.2	37.7	27.5	28.8	20.4	8.7	29.0	11.6	19.5	0.8	0.2	0.0	0.1	0.1	0.0	0.2	0.1	0.2	0.0	0.1	0.1	0.1	0.2	0.2	0.0	0.2	0.3	0.3	6.2	9.2	5.8	10.5	7.1	7.2	8.8	7.2	8.5	5.5	7.7	14.4	11.1	9.6	7.0	17.0	8.2	8.0	5.2	6.9	13.6	11.7	9.5	8.0	8.7	8.6	9.5	5.5	14.6	10.6	11.0	15.7	1.9	10.5	2.1	10.3	13.7	12.4	7.3	2.5	9.8	8.9	7.9	9.1	26.5	21.1	2.5	14.9	11.4	12.7	13.9	16.8	12.0	16.3	20.3	10.4	5.5	3.1	19.3	9.5	12.4	7.5	8.7	8.8	6.2	9.5	14.3	13.5	10.4	13.5	15.4	9.3	14.6	9.4	12.6	14.2	6.6	10.2	8.8	13.6	13.3	13.2	10.9	9.3	8.9	9.4	12.8	8.2
PTPN6	"HCP, HCPH, PTP-1C, SHP-1, SHP1"	ENSG00000111679	"Protein tyrosine phosphatase non-receptor type 6"	P29350	12	6946468-6961316	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 131.8;lymphoid tissue: 153.5"	"Cell type enhanced"	"Detected in many"		"B-cells: 214.6;granulocytes: 137.3;Hofbauer cells: 191.6;Kupffer cells: 146.5;Langerhans cells: 118.2;Macrophages: 152.1;NK-cells: 154.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEL: 170.9;HL-60: 154.3;HMC-1: 648.7;THP-1: 259.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001466, CAB004572, CAB072845"	Enhanced		Supported	Nucleoplasm,Nucleoli		NA	NA		6000000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 57: B-cells - Immune response"	Nucleoplasm	Nucleoli	"CAB004572: AB_628251, CAB072845: , HPA001466: AB_1855930"	"unprognostic (4.28e-3)"	"prognostic favorable (1.87e-4)"	"prognostic unfavorable (5.42e-4)"	"prognostic favorable (6.65e-4)"	"unprognostic (6.54e-2)"	"unprognostic (7.92e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.44e-2)"	"unprognostic (6.93e-3)"	"unprognostic (3.57e-1)"	"unprognostic (1.41e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.60e-3)"	"unprognostic (1.98e-3)"	"unprognostic (2.60e-2)"	"unprognostic (5.91e-2)"	"prognostic favorable (2.64e-8)"	14.4	15.6	3.7	102.5	3.9	131.8	11.0	4.3	4.2	11.1	6.0	21.9	30.4	6.2	10.2	12.8	13.9	20.3	4.9	3.6	5.2	12.2	19.3	49.7	153.5	7.0	4.6	2.9	11.9	13.7	10.0	19.8	6.3	11.7	21.3	0.7	17.0	9.0	2.0	18.8	42.0	12.3	5.9	128.0	28.0	3.1	6.3	71.3	12.6	4.5	127.3	27.0	7.5	10.6	16.4	30.8	0.2	0.1	0.1	0.0	28.5	0.0	0.0	0.0	0.0	16.5	36.0	11.9	8.4	0.0	0.0	18.3	0.3	21.6	0.0	7.3	6.5	170.9	3.4	13.9	0.0	154.3	648.7	0.1	15.4	0.0	6.5	0.0	0.0	60.0	0.3	1.3	0.0	34.5	55.4	92.2	8.3	38.0	5.1	50.4	0.2	86.5	16.7	30.2	2.7	0.0	5.2	24.9	0.2	20.9	7.7	259.8	0.4	0.0	0.2	0.1	0.2	0.4	0.2	5.5	0.4	66.3	0.5	676.7	368.3	1112.5	263.4	728.6	169.3	595.0	125.3	195.9	377.0	650.0	142.7	182.6	674.8	238.6	1117.7	98.7	146.8	789.3	3.7	3.9	4.3	4.2	3.6	5.2	7.0	4.6	6.3	5.9	6.3	10.6	10.5	6.4	13.8	0.7	214.6	9.1	8.2	18.8	29.6	0.0	8.6	10.0	2.1	11.5	15.3	5.5	0.0	25.6	77.7	16.0	15.6	15.8	50.4	12.1	1.5	7.5	24.7	22.9	0.9	15.4	18.3	3.0	25.0	11.8	137.3	10.9	8.9	11.6	191.6	0.0	0.9	13.2	18.3	146.5	118.2	10.5	0.9	152.1	14.2	3.7	99.7	0.5	154.5	2.0	0.1	12.6	16.9	0.0	53.5	3.9	22.8	14.3	17.2	0.5	6.6	1.6	4.0	0.3	1.3	14.6	8.7	18.5	86.2	24.5	15.6	7.8
PTPN7	"HEPTP, LC-PTP"	ENSG00000143851	"Protein tyrosine phosphatase non-receptor type 7"	P35236	1	202147013-202161588	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 39.7;lymphoid tissue: 31.1"	"Cell type enhanced"	"Detected in many"		"B-cells: 46.8;dendritic cells: 112.7;granulocytes: 140.7;NK-cells: 99.9;Plasma cells: 63.9;T-cells: 127.2;Theca cells: 54.6"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in many"		"basal ganglia: 9.8"	"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in all"	5	"granulocytes: 24.9;NK-cells: 14.9;T-cells: 14.0"	"Cell line enhanced"	"Detected in some"		"HEL: 54.1;HL-60: 118.6;HMC-1: 150.8;NB-4: 51.4;THP-1: 53.7;U-937: 84.0"	"Region enriched"	"Detected in single"	9	"basal ganglia: 6.1"	"Region enriched"	"Detected in many"	8	"basal ganglia: 13.3"	"CAB009530, HPA019118"	Approved		Supported	"Microtubules,Mitotic spindle,Cytosol"		Yes	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	Cytosol	"Microtubules, Mitotic spindle"	"CAB009530: AB_2173845, HPA019118: AB_1855755"	"unprognostic (4.19e-3)"	"unprognostic (1.08e-3)"	"unprognostic (3.09e-2)"	"prognostic favorable (1.52e-4)"	"unprognostic (2.91e-2)"	"prognostic favorable (1.84e-4)"	"unprognostic (3.01e-2)"	"unprognostic (3.16e-2)"	"unprognostic (1.43e-2)"	"unprognostic (4.84e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.45e-1)"	"prognostic unfavorable (2.42e-8)"	"unprognostic (1.46e-1)"	"unprognostic (4.51e-2)"	"unprognostic (2.70e-1)"	"unprognostic (2.39e-2)"	1.3	4.2	0.6	10.2	9.8	39.7	0.7	1.0	1.8	0.8	0.5	2.2	4.5	1.1	0.0	1.5	0.6	3.2	0.5	0.6	1.2	1.3	1.1	2.5	20.8	2.3	1.5	0.3	0.4	0.1	0.3	0.5	1.8	0.8	2.7	0.0	1.3	0.6	0.1	1.2	5.6	1.5	1.4	9.9	2.4	8.3	2.9	31.1	0.8	0.5	20.8	3.2	0.6	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	41.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	12.6	0.0	54.1	0.0	0.0	0.0	118.6	150.8	0.0	0.0	0.0	0.0	0.0	0.1	40.0	2.3	5.0	0.0	0.0	16.3	51.4	0.0	0.0	0.0	2.4	0.0	39.8	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	53.7	0.3	0.0	0.5	0.0	0.1	22.8	6.3	33.7	0.1	84.0	0.1	17.9	1.5	24.9	13.7	1.5	12.5	2.6	9.2	14.0	2.9	3.2	6.7	8.2	9.9	14.9	0.6	3.8	12.8	4.5	0.6	9.8	1.0	1.8	0.6	1.2	2.3	1.5	1.8	1.4	2.9	2.5	3.2	3.2	5.1	3.3	46.8	2.3	1.3	0.1	0.0	2.7	1.5	1.8	0.7	1.5	0.7	0.0	0.0	0.5	112.7	0.5	0.0	0.5	0.6	0.9	0.8	5.6	0.0	35.5	0.7	0.0	0.2	2.2	1.5	0.7	140.7	6.7	3.6	0.4	15.4	0.0	0.7	0.1	0.0	11.2	31.2	2.4	5.3	21.3	8.8	1.0	10.4	3.8	99.9	1.0	4.6	0.1	0.1	2.2	63.9	0.6	0.2	0.7	0.1	3.7	0.0	0.9	1.1	0.8	0.7	0.5	2.4	0.8	127.2	54.6	0.5	0.6
PTPRK	R-PTP-kappa	ENSG00000152894	"Protein tyrosine phosphatase receptor type K"	Q15262	6	127968785-128520616	"Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Protein phosphatase, Receptor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 889.9;Oligodendrocyte precursor cells: 313.1;Oligodendrocytes: 1278.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"memory B-cell: 1.6;naive B-cell: 2.9"	"Lineage enriched"	"Detected in single"	7	"B-cells: 2.9"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054056, HPA054822"	Uncertain		Supported	"Vesicles,Plasma membrane,Cell Junctions"		NA	NA		13000000	"Cluster 21: B-cells - Adaptive immune response"	"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Cell Junctions"	"Vesicles, Plasma membrane"	"HPA054056: AB_2682359, HPA054822: AB_2682614"	"unprognostic (3.15e-2)"	"unprognostic (1.07e-2)"	"unprognostic (5.79e-3)"	"unprognostic (4.95e-3)"	"unprognostic (1.89e-2)"	"unprognostic (7.26e-2)"	"unprognostic (3.27e-1)"	"unprognostic (6.06e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.08e-1)"	"prognostic unfavorable (1.99e-4)"	"unprognostic (1.46e-1)"	"prognostic favorable (9.33e-5)"	"unprognostic (2.10e-1)"	"unprognostic (1.55e-1)"	"unprognostic (2.59e-1)"	"unprognostic (9.32e-2)"	10.7	4.2	13.4	9.7	20.6	0.2	25.6	16.7	18.6	13.5	8.6	27.3	32.8	12.1	8.2	9.7	14.9	32.5	12.4	15.9	14.5	14.9	29.6	19.4	6.9	16.8	16.7	15.1	26.2	10.2	7.0	21.8	17.8	18.9	27.6	4.6	15.3	19.0	5.9	12.2	28.5	15.9	14.5	7.9	30.5	2.2	16.4	10.2	11.7	9.9	8.7	20.9	12.3	29.8	17.3	16.7	10.9	1.0	24.9	31.9	11.0	43.6	86.3	18.4	16.6	28.8	15.0	0.1	13.4	40.7	50.8	49.0	10.2	35.9	26.7	50.3	19.4	0.3	23.6	45.7	29.7	0.0	1.7	23.9	35.4	35.9	49.6	50.8	54.0	14.7	0.0	1.1	49.3	33.6	26.6	0.1	11.9	34.5	22.6	94.8	21.7	3.1	51.1	33.4	43.8	0.1	45.2	55.6	2.7	12.4	14.6	1.1	86.9	30.0	18.4	54.8	42.2	0.7	6.0	0.0	38.1	0.0	31.1	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	2.9	0.1	0.3	0.0	0.2	0.0	0.0	0.1	0.1	13.4	20.6	16.7	18.6	15.9	14.5	16.8	16.7	17.8	14.5	16.4	29.8	39.2	25.6	33.5	155.7	17.5	63.5	88.1	45.2	60.3	7.3	56.6	26.5	22.2	101.5	44.1	18.4	4.2	24.8	0.8	75.2	0.0	63.2	4.6	30.6	11.5	46.6	43.9	0.0	889.9	61.3	4.1	28.6	77.5	77.5	1.3	13.4	11.4	40.9	6.4	10.1	55.3	44.2	8.2	1.6	8.8	2.7	17.1	2.2	17.8	200.5	1.7	5.1	0.0	313.1	1278.1	124.2	53.8	18.0	1.0	115.8	68.7	13.4	25.9	0.7	59.2	20.1	41.5	11.3	8.9	27.0	38.1	26.8	3.4	14.1	56.6	157.0
PTPRR	"EC-PTP, PCPTP1, PTP-SL, PTPBR7, PTPRQ"	ENSG00000153233	"Protein tyrosine phosphatase receptor type R"	Q15256	12	70638073-70920738	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Protein phosphatase, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 14.4;endometrium 1: 5.5;intestine: 7.6"	"Group enriched"	"Detected in some"	4	"Excitatory neurons: 199.5;Inhibitory neurons: 160.7"	"Cancer enhanced"	"Detected in many"		"urothelial cancer: 3.6"	"Group enriched"	"Detected in many"	5	"amygdala: 3.7;basal ganglia: 5.7;cerebellum: 14.4;cerebral cortex: 6.5;hippocampal formation: 7.2"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"HDLM-2: 20.0;RT4: 37.4"	"Region enriched"	"Detected in all"	5	"cerebellum: 89.6"					"CAB011461, HPA011851, HPA071067"	Uncertain		Supported	"Plasma membrane,Cell Junctions,Cytosol"		NA	NA				"Cluster 45: Intestine - Brush border"	"Cluster 15: RT4 - Unknown function"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Plasma membrane, Cell Junctions, Cytosol"		"CAB011461: AB_298890, HPA011851: AB_1855939, HPA071067: AB_2686340"	"unprognostic (4.98e-2)"	"unprognostic (1.91e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.04e-1)"	"unprognostic (3.63e-3)"	"unprognostic (3.48e-5)"	"unprognostic (5.44e-3)"	"unprognostic (1.77e-3)"	"unprognostic (1.13e-1)"	"unprognostic (9.01e-2)"	"unprognostic (1.37e-3)"	"unprognostic (8.06e-2)"	"unprognostic (1.10e-2)"	"unprognostic (1.92e-2)"	"unprognostic (4.78e-2)"	"unprognostic (2.72e-1)"	"prognostic favorable (1.40e-5)"	0.0	2.2	3.7	1.0	5.7	0.0	0.0	14.4	6.5	0.3	0.0	7.4	3.2	5.5	0.0	0.0	0.1	1.0	0.0	7.2	0.5	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.3	0.2	0.1	0.0	5.0	2.5	0.0	1.1	0.0	0.0	7.6	2.9	1.5	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.2	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1.9	0.0	0.4	0.0	0.0	0.7	0.0	0.0	0.0	20.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.2	37.4	0.1	5.8	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	5.7	14.4	6.5	7.2	0.5	0.2	0.0	0.1	1.5	0.0	1.5	1.7	0.0	0.0	3.9	0.2	0.5	0.1	0.5	0.0	16.5	0.2	0.1	3.5	0.0	3.4	0.0	0.0	0.0	0.7	43.2	0.0	2.6	1.7	2.2	1.3	4.0	0.0	0.0	199.5	0.2	0.3	0.3	10.2	14.6	0.0	0.0	0.7	0.0	0.0	16.8	160.7	1.8	0.0	0.0	0.3	0.4	0.0	0.2	0.0	3.7	0.0	0.2	1.0	2.0	4.0	2.8	23.0	0.0	0.0	0.4	17.3	0.0	0.1	0.8	0.0	0.1	0.8	0.0	0.1	0.0	0.1	0.8	0.4	0.0	0.7	0.4
PTPRS		ENSG00000105426	"Protein tyrosine phosphatase receptor type S"	Q13332	19	5158495-5340803	"Enzymes, Metabolic proteins, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"	"Cell adhesion"	"Heparin-binding, Hydrolase, Protein phosphatase, Receptor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 76.8;Inhibitory neurons: 104.2;Melanocytes: 80.0;Oligodendrocytes: 90.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	89	"plasmacytoid DC: 12.5"	"Lineage enriched"	"Detected in single"	89	"dendritic cells: 12.5"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 121.8;HaCaT: 124.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054747			Approved	"Plasma membrane,Cytosol"	"Secreted - unknown location"	NA	NA		150000000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 50: Fibroblasts - ECM organization"	"Plasma membrane, Cytosol"		"HPA054747: AB_2682591"	"unprognostic (8.14e-2)"	"unprognostic (4.59e-3)"	"unprognostic (2.57e-2)"	"unprognostic (9.20e-2)"	"unprognostic (2.15e-1)"	"unprognostic (6.96e-3)"	"unprognostic (6.85e-2)"	"unprognostic (2.36e-1)"	"unprognostic (3.12e-3)"	"unprognostic (1.86e-1)"	"prognostic favorable (1.07e-4)"	"unprognostic (1.25e-1)"	"prognostic unfavorable (1.70e-4)"	"unprognostic (2.80e-1)"	"unprognostic (1.45e-1)"	"unprognostic (4.05e-1)"	"unprognostic (3.46e-2)"	54.7	21.2	34.4	5.0	25.5	1.5	36.2	3.2	30.9	40.2	0.0	25.2	2.6	30.5	2.2	16.5	41.1	13.7	37.0	34.3	10.0	11.2	6.0	26.9	5.5	16.4	16.4	35.8	32.4	9.7	29.1	2.3	17.6	30.5	1.6	5.7	18.6	14.6	14.4	20.6	13.6	8.6	1.6	9.0	23.2	9.9	27.3	4.2	29.4	7.4	4.4	32.0	31.8	34.9	11.3	64.0	56.2	121.8	25.3	20.5	7.4	19.4	22.5	22.8	18.5	0.7	6.2	0.2	44.5	32.2	18.0	124.6	15.1	0.2	10.0	1.5	24.3	0.0	27.2	40.5	11.7	0.0	14.1	21.8	5.4	4.8	0.9	29.4	0.6	7.9	18.5	0.2	9.1	48.0	5.2	12.3	31.7	0.4	27.0	0.0	12.4	0.0	4.7	22.5	43.1	58.9	18.3	3.4	34.6	10.7	22.0	4.8	2.8	20.2	34.3	46.9	23.6	6.2	0.1	36.9	10.5	0.0	44.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.5	0.0	0.0	34.4	25.5	3.2	30.9	34.3	10.0	16.4	16.4	17.6	1.6	27.3	34.9	1.1	6.4	1.1	53.8	3.2	60.9	42.4	16.1	22.2	49.6	3.3	5.5	14.1	27.1	4.9	12.9	2.1	0.7	56.4	0.1	9.8	1.4	3.4	5.4	11.4	9.7	3.0	0.0	76.8	0.9	32.2	51.2	5.1	5.3	0.0	4.0	25.4	20.2	1.7	11.8	104.2	0.0	10.2	0.3	20.0	5.4	46.6	3.4	80.0	15.9	0.8	46.6	0.0	71.9	90.2	0.5	0.0	36.1	6.3	35.0	0.0	2.9	1.7	10.1	13.1	46.4	22.6	7.4	14.8	16.8	36.7	1.0	2.0	2.7	0.4	30.0
PTRH2	"BIT1, CFAP37, CGI-147, PTH2"	ENSG00000141378	"Peptidyl-tRNA hydrolase 2"	Q9Y3E5	17	59674636-59707626	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins"	Apoptosis	Hydrolase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA012897	Supported		Supported	Mitochondria		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 68: Epididymis - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Mitochondria		"HPA012897: AB_1855949"	"unprognostic (2.26e-1)"	"unprognostic (2.80e-2)"	"unprognostic (1.02e-2)"	"unprognostic (3.89e-2)"	"unprognostic (1.31e-2)"	"unprognostic (3.38e-2)"	"prognostic unfavorable (1.50e-4)"	"unprognostic (6.38e-2)"	"unprognostic (2.02e-1)"	"unprognostic (9.59e-3)"	"unprognostic (2.72e-1)"	"unprognostic (1.40e-1)"	"prognostic unfavorable (1.01e-8)"	"unprognostic (5.43e-3)"	"unprognostic (6.82e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.49e-2)"	20.8	25.9	24.3	17.3	25.1	14.5	27.6	25.0	31.9	19.7	23.6	24.1	15.3	18.8	48.5	18.1	18.4	18.2	14.5	25.1	26.1	18.5	45.7	14.7	19.0	25.9	26.1	16.9	19.5	18.6	14.1	18.6	26.7	20.7	27.5	10.2	15.9	18.6	25.0	15.7	13.2	22.9	24.8	17.5	16.1	19.5	24.9	17.3	16.2	20.9	24.1	44.0	11.8	27.4	75.9	142.9	44.3	40.8	84.8	72.6	47.4	70.6	63.8	60.7	89.0	94.1	57.7	54.1	105.0	60.9	101.1	73.3	98.4	93.8	89.4	104.2	133.2	96.7	72.3	176.2	129.4	86.0	52.5	82.0	120.9	93.9	108.5	42.8	102.5	37.4	111.3	58.2	92.4	187.9	74.2	71.2	38.0	194.5	113.4	39.1	74.8	80.7	103.7	109.2	57.9	74.2	36.7	39.6	91.5	50.7	93.1	61.1	67.2	77.8	77.8	47.1	77.9	73.6	91.9	82.3	50.7	54.4	60.4	6.1	69.0	2.9	22.7	67.4	30.9	43.1	26.3	25.7	50.0	33.1	37.4	27.0	29.0	34.8	86.0	59.4	34.0	37.9	24.3	25.1	25.0	31.9	25.1	26.1	25.9	26.1	26.7	24.8	24.9	27.4	21.4	16.0	13.6	5.5	18.7	36.7	50.1	48.1	27.9	4.1	17.1	22.4	15.4	11.5	51.6	11.0	4.2	26.8	13.0	8.9	11.7	27.2	22.1	23.4	33.1	22.5	6.7	17.9	9.8	25.6	25.0	29.7	17.3	24.1	22.8	12.8	12.8	31.5	16.9	8.4	9.1	10.3	22.4	9.7	17.2	12.0	17.4	14.6	14.2	2.8	11.4	7.2	13.4	7.5	11.5	28.8	12.3	9.8	24.8	35.1	10.0	16.5	33.3	3.4	13.1	25.4	32.2	33.4	13.3	21.3	35.7	31.7	12.6	22.4	16.7	37.5
PTTG1	"EAP1, HPTTG, PTTG, securin, TUTR1"	ENSG00000164611	"PTTG1 regulator of sister chromatid separation, securin"	O95997	5	160421855-160428739	"Cancer-related genes, Predicted intracellular proteins"	"Cell cycle, Cell division, Chromosome partition, DNA damage, DNA repair, Mitosis"		"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 160.1;lymphoid tissue: 144.9;testis: 175.6"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 770.5;Erythroid cells: 415.9;Langerhans cells: 412.3;Spermatocytes: 708.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"T-reg: 218.0"	"Lineage enriched"	"Detected in all"	7	"T-cells: 218.0"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB008373, HPA008890, HPA045034"	Enhanced		Supported	Nucleoli,Cytosol		NA	Yes			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 12: Non-specific - Cell cycle regulation"	Cytosol	Nucleoli	"CAB008373: AB_592493, HPA008890: AB_1079717, HPA045034: AB_2679192"	"unprognostic (6.48e-2)"	"unprognostic (1.03e-2)"	"unprognostic (1.40e-3)"	"unprognostic (4.46e-3)"	"unprognostic (5.81e-2)"	"unprognostic (1.29e-1)"	"prognostic unfavorable (1.62e-6)"	"unprognostic (7.50e-3)"	"unprognostic (5.24e-2)"	"unprognostic (3.47e-2)"	"unprognostic (2.13e-3)"	"unprognostic (6.70e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (7.17e-2)"	"unprognostic (1.72e-1)"	"unprognostic (4.23e-2)"	"unprognostic (3.35e-2)"	3.7	3.5	4.2	25.2	5.3	160.1	10.9	4.1	11.5	9.6	4.0	33.9	24.6	4.8	9.6	59.7	5.0	6.1	3.5	8.1	6.6	3.0	5.3	8.7	81.5	3.9	4.8	1.8	1.5	2.3	4.3	21.2	4.2	3.1	44.1	2.4	10.3	2.7	2.5	36.0	24.1	19.2	4.0	18.6	11.8	175.6	5.3	127.0	79.3	1.3	144.9	12.5	19.9	4.7	345.4	178.2	385.8	279.5	64.4	63.3	120.8	177.5	406.1	463.4	503.5	341.1	294.9	373.3	154.7	204.2	527.5	176.1	243.5	496.1	661.2	428.3	220.3	196.7	241.8	208.6	13.0	181.5	165.6	29.6	81.5	315.4	189.5	139.9	333.4	243.3	160.7	282.3	485.4	162.3	220.7	446.1	197.5	279.3	251.4	199.4	452.4	320.7	239.6	82.6	241.0	151.3	258.6	156.3	535.6	309.3	319.9	195.7	144.8	208.3	275.9	164.9	531.3	239.2	235.6	432.3	225.9	310.4	379.6	9.7	3.2	10.3	25.5	8.7	9.6	30.9	52.3	60.6	23.9	23.5	12.7	31.4	3.0	14.6	5.8	22.6	218.0	19.8	4.2	5.3	4.1	11.5	8.1	6.6	3.9	4.8	4.2	4.0	5.3	4.7	11.8	6.4	21.5	0.0	40.0	247.9	64.5	163.6	142.3	3.4	15.8	40.5	4.0	4.3	31.1	5.5	0.0	125.4	38.3	17.7	3.9	5.8	770.5	22.7	9.3	20.6	6.0	415.9	1.3	5.3	196.2	35.6	28.1	16.7	37.5	66.2	18.5	7.1	87.5	0.0	1.6	39.2	126.1	36.3	412.3	105.1	11.1	39.1	87.2	0.0	24.7	3.5	6.2	0.0	0.6	3.0	10.7	7.9	91.4	54.1	9.0	2.0	17.1	1.0	6.6	18.6	43.2	708.0	57.3	232.0	156.1	31.9	73.7	16.8	70.3	50.3
PTTG1IP	"C21orf1, C21orf3, PBF"	ENSG00000183255	"PTTG1 interacting protein"	P53801	21	44849585-44873903	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034146, HPA061827"	Uncertain		Supported	Nucleoplasm		NA	Yes		26000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm		"CAB034146: AB_1568894, HPA061827: AB_2684620"	"unprognostic (1.78e-2)"	"prognostic unfavorable (8.61e-4)"	"unprognostic (5.24e-3)"	"unprognostic (3.18e-2)"	"unprognostic (1.68e-2)"	"unprognostic (2.03e-2)"	"unprognostic (3.59e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.98e-2)"	"unprognostic (3.77e-2)"	"prognostic unfavorable (2.28e-4)"	"unprognostic (9.30e-2)"	"unprognostic (3.17e-2)"	"prognostic unfavorable (5.40e-4)"	"unprognostic (1.38e-2)"	"unprognostic (8.88e-2)"	"unprognostic (1.90e-1)"	127.8	131.8	147.6	98.4	158.9	92.0	114.0	150.8	146.8	131.1	131.1	132.7	123.2	132.4	118.5	89.1	109.4	141.8	164.3	138.1	168.7	157.6	130.5	160.5	75.3	178.8	152.9	110.7	85.6	84.1	68.8	180.1	169.9	108.5	111.5	29.7	118.3	151.4	70.7	88.9	127.3	145.0	152.0	97.7	169.9	66.9	175.3	57.9	127.4	63.2	62.0	139.6	93.3	157.5	245.3	134.6	155.3	148.2	300.6	174.8	127.0	212.9	309.8	174.1	166.6	290.0	323.9	32.9	789.8	344.4	417.0	109.8	73.0	140.2	161.1	56.3	81.0	254.3	80.0	260.1	293.8	97.6	83.5	269.9	225.1	189.1	130.8	346.3	376.6	88.6	131.7	83.1	539.5	106.0	71.0	99.5	166.8	352.9	169.8	70.4	158.4	162.0	735.6	82.7	117.2	182.0	240.0	262.5	482.0	188.7	203.7	163.7	511.8	216.9	126.5	170.6	340.0	78.5	79.4	42.2	146.7	220.6	199.8	336.2	181.2	109.1	48.4	146.7	79.5	25.5	62.7	51.3	203.3	23.6	59.7	41.0	248.8	67.3	167.0	92.5	87.3	223.7	147.6	158.9	150.8	146.8	138.1	168.7	178.8	152.9	169.9	152.0	175.3	157.5	140.9	394.2	169.6	39.8	28.0	50.7	84.1	181.3	61.5	14.6	102.0	96.8	173.0	75.8	248.9	145.3	6.2	218.6	56.8	321.4	49.0	323.0	51.5	115.0	115.0	191.6	79.3	37.8	8.5	120.6	72.7	117.1	140.6	187.7	81.5	181.3	124.2	102.2	109.3	11.8	10.7	89.1	130.2	88.0	69.6	98.7	72.1	136.3	87.2	22.5	91.1	78.8	51.5	20.1	31.9	294.3	255.2	98.9	36.4	112.8	268.1	71.2	192.3	15.2	65.7	61.1	127.9	73.7	43.4	92.4	42.9	366.7	45.6	54.6	100.3	169.9
PUM1	"KIAA0099, PUMH1"	ENSG00000134644	"Pumilio RNA binding family member 1"	Q14671	1	30931506-31065991	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Differentiation, Spermatogenesis, Translation regulation"	RNA-binding	"Disease variant, Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027424, HPA027449"	Approved		Enhanced	Nucleoplasm,Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 44: Endometrium - Transcription"	Cytosol	Nucleoplasm	"HPA027424: AB_10602918, HPA027449: AB_2672281"	"unprognostic (1.26e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.44e-3)"	"unprognostic (1.10e-1)"	"unprognostic (1.31e-2)"	"unprognostic (1.29e-1)"	"prognostic unfavorable (3.73e-4)"	"unprognostic (1.02e-1)"	"unprognostic (2.11e-2)"	"unprognostic (2.44e-2)"	"unprognostic (3.19e-3)"	"unprognostic (4.42e-2)"	"prognostic favorable (7.62e-8)"	"unprognostic (1.57e-1)"	"unprognostic (5.41e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.74e-1)"	27.8	26.0	33.4	22.5	34.3	52.0	31.9	37.5	37.8	28.0	28.5	26.7	22.5	32.2	29.3	25.7	35.0	22.7	28.6	33.7	42.5	28.7	25.9	25.6	26.2	27.0	30.0	40.3	27.5	39.3	19.2	32.4	28.0	27.3	29.4	38.4	30.3	28.0	46.1	32.7	22.6	31.6	27.8	25.7	26.3	18.4	45.5	35.1	34.9	38.3	26.1	27.1	26.0	31.5	33.7	43.7	70.4	44.7	54.1	46.5	48.2	39.3	47.9	40.3	45.5	46.0	56.6	39.3	40.2	53.8	25.2	48.2	58.3	43.4	51.4	33.2	50.8	42.8	50.7	56.0	37.9	52.6	39.2	50.0	53.3	53.5	56.1	52.8	55.6	36.9	60.0	36.1	46.5	28.1	51.6	37.8	72.2	42.0	30.2	53.1	48.0	42.3	58.7	50.0	58.0	44.0	54.5	41.7	47.6	77.6	42.1	39.3	58.5	33.2	29.8	44.7	39.7	28.8	28.3	42.5	29.7	38.3	43.0	44.1	31.3	24.8	31.0	30.3	31.7	23.9	27.5	30.3	32.0	21.1	31.0	32.0	19.6	37.9	34.5	18.5	35.9	31.0	33.4	34.3	37.5	37.8	33.7	42.5	27.0	30.0	28.0	27.8	45.5	31.5	66.6	73.7	58.8	85.2	56.9	90.2	53.8	41.2	56.3	54.6	63.2	58.7	80.7	61.5	46.3	36.8	79.2	52.6	66.4	56.4	23.5	44.0	32.2	139.8	98.0	61.5	104.7	34.3	87.0	36.4	42.4	56.8	55.0	154.6	18.3	105.1	43.2	61.0	34.0	33.7	87.5	65.6	24.4	78.3	49.8	21.5	72.1	50.4	17.8	102.1	56.6	41.6	69.0	111.6	101.7	58.1	45.0	80.5	41.7	84.6	28.8	49.2	42.7	59.2	32.9	81.6	65.5	36.4	24.4	62.9	93.6	78.0	50.5	63.6	75.8	95.5
PUM3	"HA-8, hPUF-A, KIAA0020, PEN, Puf-A, PUF6, XTP5"	ENSG00000080608	"Pumilio RNA binding family member 3"	Q15397	9	2720469-2844095	"Predicted intracellular proteins"		"DNA-binding, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Proximal tubular cells: 108.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HDLM-2: 338.4;HEL: 327.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002353	Approved		Supported	Nucleoli		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 36: HEL - Hemostasis"	"Cluster 36: Stromal cells - Cell proliferation"	Nucleoli		"HPA002353: AB_1852266"	"unprognostic (1.39e-2)"	"unprognostic (1.32e-2)"	"unprognostic (7.54e-2)"	"unprognostic (2.50e-1)"	"unprognostic (2.06e-2)"	"unprognostic (1.56e-1)"	"prognostic unfavorable (4.89e-5)"	"unprognostic (2.02e-1)"	"unprognostic (6.92e-2)"	"unprognostic (1.56e-2)"	"unprognostic (1.30e-2)"	"prognostic unfavorable (1.74e-4)"	"unprognostic (2.44e-3)"	"unprognostic (8.44e-2)"	"unprognostic (1.46e-1)"	"unprognostic (7.11e-2)"	"unprognostic (8.43e-2)"	19.5	16.7	6.2	22.3	5.9	19.0	24.7	8.1	5.6	13.8	4.9	15.8	12.8	14.7	9.8	24.8	13.5	11.7	12.0	5.5	5.7	21.8	15.2	15.4	23.2	5.0	4.7	18.3	14.8	12.2	10.1	18.0	5.3	12.5	18.7	7.4	16.8	10.6	11.1	16.6	11.7	13.6	4.2	14.7	13.2	15.4	5.2	17.1	11.9	9.4	22.0	30.7	16.0	6.7	78.9	56.7	47.0	48.2	38.6	40.8	53.5	71.7	37.6	72.3	67.3	43.6	36.0	86.4	16.1	49.5	43.2	38.8	85.8	62.0	93.5	338.4	30.7	327.8	59.3	52.9	51.0	146.2	58.7	33.3	26.8	58.8	83.5	33.0	54.3	55.6	35.0	38.1	63.8	36.0	74.6	119.9	120.4	59.9	25.1	86.7	36.8	37.3	48.8	52.7	48.4	46.4	43.2	39.8	40.3	52.0	25.2	78.4	52.1	48.6	40.2	46.8	97.1	17.7	31.0	120.5	36.8	52.4	36.1	7.7	13.7	4.1	18.8	19.9	26.3	23.4	19.3	18.9	18.5	22.4	21.2	20.7	1.9	25.2	17.1	20.8	15.7	11.8	6.2	5.9	8.1	5.6	5.5	5.7	5.0	4.7	5.3	4.2	5.2	6.7	27.7	48.1	41.4	0.0	35.8	0.0	59.6	0.0	62.6	28.0	27.5	26.7	0.0	14.3	41.5	23.9	10.4	34.7	25.5	1.9	46.9	41.2	4.8	36.7	79.1	28.3	8.5	23.8	0.0	26.5	45.4	30.9	35.2	54.9	17.7	39.8	20.0	22.1	21.6	26.9	0.0	9.2	0.0	15.8	0.0	4.9	47.2	20.6	0.0	0.0	29.4	14.2	25.7	0.0	0.0	29.1	8.0	23.0	29.2	57.7	7.6	108.3	32.1	24.0	0.0	50.2	26.8	43.7	45.3	54.3	0.0	35.0	26.5	44.5	12.7	38.2
PURB	PURBETA	ENSG00000146676	"Purine rich element binding protein B"	Q96QR8	7	44876299-44885530	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048766			Supported	Nucleoplasm		NA	NA		150000	"Cluster 18: Basophils - Vesicular transport"	"Cluster 34: Non-specific - Transcription"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"HPA048766: "	"unprognostic (1.16e-1)"	"unprognostic (1.46e-1)"	"unprognostic (3.21e-2)"	"unprognostic (9.49e-2)"	"unprognostic (4.96e-2)"	"unprognostic (2.18e-1)"	"unprognostic (8.44e-3)"	"unprognostic (1.53e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.88e-3)"	"unprognostic (2.01e-1)"	"unprognostic (4.12e-1)"	"unprognostic (5.66e-2)"	"unprognostic (4.29e-2)"	"unprognostic (7.96e-2)"	"unprognostic (1.41e-1)"	"unprognostic (3.22e-2)"	10.6	7.8	8.2	10.7	9.5	13.5	11.7	17.4	10.7	10.4	7.4	12.7	7.5	10.7	7.5	11.3	9.3	7.8	8.1	9.7	7.0	9.2	8.6	10.4	10.2	6.9	8.1	9.9	8.4	10.9	7.5	13.1	6.9	10.3	7.4	25.0	9.0	9.1	12.2	14.1	8.9	9.7	7.3	9.8	8.9	5.9	7.9	13.4	11.5	9.2	10.4	9.7	9.3	11.1	16.4	9.0	15.9	30.0	14.5	22.9	10.6	22.1	17.3	16.3	15.7	13.6	12.4	24.4	18.9	25.7	38.6	29.6	15.0	19.6	32.1	20.0	12.2	12.2	23.2	7.7	14.5	19.4	18.7	18.9	24.6	31.2	22.7	17.3	17.5	19.8	21.8	22.2	34.6	22.7	16.2	24.2	24.7	11.0	15.7	13.2	48.0	16.0	13.5	27.7	15.7	22.2	22.1	45.5	14.0	19.0	30.5	21.9	29.7	28.4	31.2	18.6	37.7	38.8	36.6	7.7	21.2	22.3	38.5	0.4	0.2	0.3	0.3	0.1	0.3	0.1	0.2	0.2	0.1	0.2	0.2	0.2	0.5	0.2	0.1	0.2	0.2	0.1	8.2	9.5	17.4	10.7	9.7	7.0	6.9	8.1	6.9	7.3	7.9	11.1	50.1	38.5	40.9	17.0	20.1	69.8	39.5	21.5	35.9	65.3	40.1	29.6	19.8	27.1	28.1	18.4	33.3	19.0	38.9	19.1	9.8	19.6	21.3	45.4	59.1	41.7	20.4	9.2	24.0	22.5	12.0	26.9	23.9	53.7	36.8	33.0	36.0	14.6	16.4	53.8	23.9	18.1	30.5	25.7	108.3	16.9	20.8	53.8	17.8	20.6	21.9	40.2	21.6	18.6	42.4	28.9	12.3	19.9	16.0	46.0	13.5	12.0	28.3	57.0	46.0	61.0	44.6	25.6	11.8	43.4	86.1	18.9	23.8	21.6	23.3	44.1
PUS1		ENSG00000177192	"Pseudouridine synthase 1"	Q9Y606	12	131929200-131945896	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"tRNA processing"	Isomerase	"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051636, HPA057593"	Approved		Supported	Nucleoplasm,Mitochondria		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoplasm, Mitochondria"		"HPA051636: AB_2681560, HPA057593: AB_2683479"	"unprognostic (2.72e-1)"	"unprognostic (9.13e-2)"	"unprognostic (1.81e-1)"	"unprognostic (2.69e-2)"	"unprognostic (8.12e-3)"	"unprognostic (8.07e-2)"	"unprognostic (4.57e-3)"	"unprognostic (7.34e-2)"	"unprognostic (1.01e-1)"	"unprognostic (3.34e-1)"	"unprognostic (2.06e-1)"	"unprognostic (5.30e-2)"	"prognostic unfavorable (3.49e-8)"	"unprognostic (1.80e-3)"	"unprognostic (8.06e-2)"	"unprognostic (8.59e-2)"	"unprognostic (1.56e-2)"	12.5	14.9	10.1	14.9	8.4	23.0	10.4	8.2	10.2	9.7	7.6	11.9	9.7	12.5	14.0	16.5	11.2	7.1	8.7	8.9	5.9	13.0	21.6	9.0	18.5	7.1	5.1	8.6	14.8	5.4	8.7	6.4	6.2	10.9	7.9	5.0	9.3	6.8	14.2	14.4	14.0	7.4	4.4	15.8	12.7	13.0	6.9	8.6	9.5	4.8	10.6	14.2	10.7	9.2	45.3	58.1	13.7	24.0	13.0	21.5	82.2	34.5	14.2	25.4	16.3	64.5	28.7	53.2	38.3	18.6	19.9	56.0	44.4	32.2	16.3	24.0	90.6	54.0	30.9	56.9	34.0	93.5	47.4	21.7	25.6	28.9	24.8	12.3	25.0	36.8	68.0	15.6	14.9	77.9	61.9	83.4	71.5	36.7	87.3	57.8	19.2	55.4	20.8	61.7	37.5	20.8	28.6	38.9	32.5	13.1	42.5	99.3	22.7	20.2	43.3	43.1	50.0	43.5	35.5	64.5	20.7	73.6	28.4	1.0	1.3	0.2	2.0	1.0	1.5	4.6	1.7	2.1	1.1	4.2	2.4	1.3	1.1	5.6	0.9	3.0	1.8	0.9	10.1	8.4	8.2	10.2	8.9	5.9	7.1	5.1	6.2	4.4	6.9	9.2	7.0	0.0	6.1	9.8	10.7	29.6	22.3	8.4	6.2	6.2	10.7	10.5	5.3	8.6	6.2	5.5	22.9	13.9	11.7	10.9	5.9	12.3	0.9	6.6	10.1	11.1	14.4	13.2	11.9	9.6	19.1	8.3	15.3	7.7	16.5	11.7	6.1	12.9	15.2	0.0	8.4	20.1	10.2	7.3	8.1	3.0	7.8	7.2	7.2	9.4	8.8	4.4	6.2	5.0	7.1	16.3	6.9	9.4	8.8	35.4	4.0	13.7	4.9	10.0	6.6	15.9	9.3	18.5	19.7	14.7	22.7	8.6	9.5	14.3	18.8	21.4
PVR	"CD155, HVED, Necl-5, NECL5, PVS, Tage4"	ENSG00000073008	"PVR cell adhesion molecule"	P15151	19	44643798-44666162	"CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Cell adhesion, Host-virus interaction"	"Host cell receptor for virus entry, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Pancreatic endocrine cells: 69.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"classical monocyte: 4.5;intermediate monocyte: 4.5;myeloid DC: 3.8;non-classical monocyte: 5.5"	"Group enriched"	"Detected in many"	4	"dendritic cells: 3.8;monocytes: 5.5"	"Cell line enhanced"	"Detected in many"		"TIME: 175.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012568, HPA064739"	Approved		Supported	"Nucleoplasm,Vesicles,Plasma membrane"	"Secreted - unknown location"	NA	NA		720000000	"Cluster 7: Monocytes - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 1: Pancreatic cells - Digestion"	"Nucleoplasm, Vesicles, Plasma membrane"		"HPA012568: AB_1846248, HPA064739: "	"unprognostic (2.90e-3)"	"prognostic unfavorable (1.29e-4)"	"unprognostic (3.36e-1)"	"unprognostic (2.34e-1)"	"unprognostic (7.89e-2)"	"unprognostic (2.45e-3)"	"unprognostic (3.06e-2)"	"prognostic unfavorable (9.30e-4)"	"unprognostic (9.05e-3)"	"unprognostic (1.69e-1)"	"unprognostic (2.09e-3)"	"unprognostic (2.64e-3)"	"unprognostic (1.69e-1)"	"unprognostic (4.97e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.04e-3)"	"prognostic unfavorable (2.75e-4)"	13.9	17.5	10.2	7.1	9.1	5.1	9.6	9.0	10.0	8.7	9.3	10.3	12.5	13.9	5.2	8.4	11.8	6.2	28.5	9.0	16.6	13.6	30.7	19.4	2.7	9.7	11.0	12.5	14.0	10.3	17.3	12.5	12.4	9.7	8.8	5.4	9.9	6.4	19.0	7.1	11.1	10.5	7.4	4.6	12.3	5.8	14.9	2.5	10.6	6.2	2.8	9.1	8.5	7.9	58.8	52.1	5.6	25.0	8.6	9.7	7.4	96.7	38.8	40.7	45.8	31.9	28.2	0.1	50.6	43.7	60.2	44.4	24.3	51.1	31.7	7.8	27.1	8.8	40.3	23.3	43.7	4.1	22.2	10.6	28.0	40.9	82.5	49.7	50.7	6.6	4.3	0.5	23.4	7.8	4.2	5.8	12.5	30.1	31.7	0.1	23.2	5.0	111.8	25.5	21.2	22.9	66.3	54.3	14.7	7.2	22.8	12.5	175.3	39.0	52.8	33.7	78.2	0.3	6.3	0.2	35.3	23.4	24.6	0.2	4.5	0.0	0.1	4.5	0.0	0.0	0.0	0.2	3.8	0.0	0.2	0.1	1.1	0.7	5.5	0.5	0.0	1.7	10.2	9.1	9.0	10.0	9.0	16.6	9.7	11.0	12.4	7.4	14.9	7.9	11.1	16.0	25.2	2.3	1.6	3.6	16.0	6.9	4.0	5.7	4.7	3.4	14.4	14.3	12.2	1.8	2.1	2.9	0.2	18.5	3.9	37.9	10.5	5.4	6.3	20.4	13.1	2.1	11.4	35.3	34.8	7.7	13.7	11.6	1.3	6.5	7.9	41.1	8.4	1.7	13.7	11.3	2.0	8.9	7.5	14.3	5.6	6.8	1.8	5.6	17.2	1.8	2.1	6.0	4.6	69.6	18.0	15.8	0.2	14.4	10.8	5.7	2.8	3.4	0.0	23.8	10.4	10.4	1.5	5.8	5.5	1.0	0.9	10.8	12.7	7.4
PWP2	"EHOC-17, PWP2H, UTP1"	ENSG00000241945	"PWP2 small subunit processome component"	Q15269	21	44107373-44131181	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 10.7;Basal respiratory cells: 9.6;Suprabasal keratinocytes: 8.5"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CACO-2: 82.9;Daudi: 84.3;U-266/84: 66.6"									HPA024573	Uncertain		Supported	Nucleoli,Cytosol		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 48: Smooth muscle cells - ECM organization"	Nucleoli	Cytosol	"HPA024573: AB_1855963"	"unprognostic (1.85e-1)"	"unprognostic (4.73e-2)"	"unprognostic (2.67e-1)"	"unprognostic (6.81e-2)"	"unprognostic (2.06e-1)"	"unprognostic (8.39e-2)"	"unprognostic (3.02e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.76e-1)"	"unprognostic (3.31e-3)"	"unprognostic (9.48e-2)"	"unprognostic (1.50e-1)"	"unprognostic (6.36e-4)"	"unprognostic (6.37e-5)"	"unprognostic (6.12e-2)"	"unprognostic (5.62e-2)"	"unprognostic (1.55e-1)"	4.0	3.2	3.3	3.2	4.4	0.9	3.3	3.6	4.4	4.2	2.4	3.6	1.5	3.3	2.6	3.5	5.7	0.5	3.7	3.5	3.2	2.6	3.0	3.2	3.0	3.5	3.5	2.9	4.1	1.9	2.2	2.5	4.2	3.0	0.3	1.2	3.4	1.4	5.0	4.9	3.7	0.5	3.2	4.5	4.6	3.1	3.4	5.6	2.9	7.2	6.9	4.1	3.2	5.7	4.7	0.5	1.5	3.6	10.4	11.4	28.5	39.2	16.9	44.3	29.5	82.9	1.4	84.3	1.4	0.0	4.5	4.2	1.5	26.4	24.7	24.4	59.5	10.8	15.6	19.2	6.2	6.8	2.9	0.7	0.0	27.1	0.0	10.1	1.7	39.2	32.5	33.8	17.1	1.1	0.2	2.1	1.5	4.1	3.3	4.8	0.2	44.1	0.0	1.2	26.8	5.4	2.2	3.0	24.2	14.6	0.9	3.2	20.9	19.6	3.1	42.4	4.3	47.6	66.6	3.7	1.8	10.6	28.4	0.5	2.2	2.5	4.7	2.7	5.8	5.1	4.0	5.1	1.8	3.4	3.7	4.6	1.1	2.7	3.7	2.2	3.3	3.0	3.3	4.4	3.6	4.4	3.5	3.2	3.5	3.5	4.2	3.2	3.4	5.7	0.4	0.0	2.0	0.3	3.2	10.7	0.1	9.6	3.4	0.7	1.1	0.3	4.5	0.0	5.4	0.0	0.0	0.1	2.3	4.6	1.9	0.0	0.1	0.2	0.2	2.0	2.4	4.8	0.0	0.0	2.0	1.8	1.1	0.4	0.0	0.3	2.2	0.3	1.9	0.0	0.0	3.8	6.1	5.4	4.9	0.0	1.2	0.4	1.8	0.0	0.6	0.5	3.1	0.0	0.0	0.0	2.4	0.0	1.5	1.2	1.8	0.3	4.6	0.3	0.0	1.4	3.7	1.4	1.7	0.8	8.5	0.7	2.6	0.5	4.6	0.3
PWWP2A	KIAA1935	ENSG00000170234	"PWWP domain containing 2A"	Q96N64	5	160061801-160119450	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 228.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046733, HPA058233"			Supported	"Nucleoplasm,Focal adhesion sites"		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Nucleoplasm	"Focal adhesion sites"	"HPA046733: AB_2679777, HPA058233: AB_2683647"	"unprognostic (1.03e-1)"	"unprognostic (2.67e-1)"	"unprognostic (5.13e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.18e-2)"	"unprognostic (7.86e-3)"	"unprognostic (1.40e-3)"	"unprognostic (6.24e-2)"	"unprognostic (2.42e-2)"	"unprognostic (7.08e-2)"	"unprognostic (7.25e-2)"	"unprognostic (8.24e-3)"	"prognostic unfavorable (3.70e-4)"	"unprognostic (2.23e-1)"	"unprognostic (3.88e-2)"	"unprognostic (1.08e-1)"	"prognostic favorable (3.51e-4)"	6.7	7.0	9.6	7.4	14.8	10.3	6.8	22.8	10.9	10.3	8.2	10.5	7.5	7.9	5.3	6.6	7.6	6.2	5.9	7.8	8.6	8.5	7.1	7.6	10.1	12.2	12.2	7.6	8.0	5.9	8.1	8.7	11.9	8.6	10.8	14.2	7.1	6.0	6.1	11.3	8.5	7.0	9.5	9.4	9.3	5.1	11.6	12.4	7.2	6.0	9.0	8.2	7.9	24.2	13.4	6.3	16.1	13.7	17.5	13.6	22.5	10.4	8.4	9.1	9.1	20.5	25.3	21.4	15.6	8.0	14.9	9.4	14.1	16.2	14.8	22.3	15.6	15.4	11.9	10.6	13.3	15.6	11.2	9.7	7.9	18.3	13.8	20.4	14.8	11.9	12.0	13.5	15.5	11.1	13.5	15.1	19.0	11.3	8.1	20.9	14.3	13.7	11.2	9.4	18.8	13.1	17.6	17.3	19.4	12.9	13.4	17.1	19.9	15.7	10.9	11.9	20.6	15.4	14.7	18.9	10.4	15.6	15.9	3.2	2.0	1.1	1.1	0.9	0.9	3.3	1.2	1.4	1.3	1.6	2.0	1.1	2.1	0.4	1.2	1.2	1.2	0.4	9.6	14.8	22.8	10.9	7.8	8.6	12.2	12.2	11.9	9.5	11.6	24.2	16.8	9.6	22.7	42.7	25.0	31.9	13.0	10.8	27.3	102.0	15.8	13.2	13.9	11.5	15.6	20.2	73.0	12.3	22.0	30.2	17.6	13.7	2.1	18.2	33.8	18.7	32.9	30.3	47.2	11.0	12.4	20.4	20.9	17.3	23.5	29.0	18.2	8.8	9.2	94.2	61.8	25.9	20.3	13.7	17.6	3.8	55.9	16.9	10.6	52.5	25.7	28.8	22.6	92.0	228.5	16.5	17.8	38.4	19.5	19.4	11.2	7.2	14.4	57.6	26.3	23.5	25.1	20.4	22.0	18.3	25.9	9.3	23.8	34.0	25.2	11.2
PWWP3A	"EXPAND1, MUM-1, MUM1"	ENSG00000160953	"PWWP domain containing 3A, DNA repair factor"	Q2TAK8	19	1354711-1378431	"Predicted intracellular proteins"	"DNA damage, DNA repair"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Adipocytes: 20.7;Cardiomyocytes: 31.4;Cytotrophoblasts: 18.8;Extravillous trophoblasts: 24.5;Fibroblasts: 14.5;Hofbauer cells: 16.9;Smooth muscle cells: 13.0;Syncytiotrophoblasts: 14.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA048063, HPA054491"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 43: Testis - Unknown function"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 24: Non-specific - Transcription regulation"	"Nucleoplasm, Cytosol"		"HPA048063: AB_2680243, HPA054491: "	"unprognostic (2.50e-2)"	"unprognostic (4.67e-1)"	"unprognostic (1.72e-1)"	"prognostic favorable (4.82e-4)"	"unprognostic (1.14e-1)"	"unprognostic (4.21e-3)"	"unprognostic (4.84e-2)"	"unprognostic (2.77e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.24e-2)"	"prognostic favorable (2.25e-6)"	"unprognostic (1.60e-1)"	"unprognostic (6.05e-3)"	"unprognostic (5.34e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.79e-1)"	"unprognostic (7.29e-3)"	16.3	13.8	28.2	5.2	26.2	3.1	16.2	21.4	27.3	20.5	14.9	17.7	4.9	23.1	5.8	10.0	22.6	5.4	13.0	24.9	28.4	14.0	22.6	12.1	5.1	31.5	29.6	29.4	11.8	6.3	30.4	6.6	27.7	15.8	4.8	8.0	13.2	9.1	13.1	13.1	14.6	10.1	23.7	16.6	13.3	36.4	30.8	4.9	15.5	5.9	4.4	16.3	13.8	26.4	7.9	12.3	11.4	15.8	7.7	10.2	18.5	11.1	6.9	8.8	7.7	8.2	5.5	14.9	5.3	13.4	3.1	9.1	9.4	7.2	7.5	17.2	10.3	6.9	12.9	12.4	9.1	5.8	20.5	7.8	5.0	5.2	2.9	12.6	9.3	9.7	14.4	7.5	8.9	9.6	10.1	8.7	16.4	6.7	5.9	18.4	11.6	6.6	6.9	12.3	9.9	24.6	8.7	14.8	8.7	10.0	7.7	16.8	11.4	12.2	16.2	9.5	13.0	15.8	11.5	5.2	14.8	10.6	17.2	9.6	0.8	4.8	2.9	1.8	2.5	2.8	1.7	2.1	1.4	2.5	2.3	2.4	1.4	3.1	1.6	2.6	0.8	0.9	28.2	26.2	21.4	27.3	24.9	28.4	31.5	29.6	27.7	23.7	30.8	26.4	20.7	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	31.4	0.0	0.0	0.0	0.0	18.8	6.2	0.0	0.0	0.0	0.0	0.0	0.0	6.0	0.0	0.0	0.0	0.0	24.5	14.5	0.0	0.0	0.0	0.0	0.0	0.0	16.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.0	0.0	0.0	0.0	0.0	14.2	0.8	0.0	0.0	0.0
PXDNL	"FLJ25471, PMR1"	ENSG00000147485	"Peroxidasin like"	A1KZ92	8	51319577-51809445	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Hydrogen peroxide"	"Endonuclease, Hydrolase, Nuclease, Oxidoreductase, Peroxidase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"heart muscle: 45.3"	"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 42.2;Early spermatids: 43.8;Excitatory neurons: 25.2;Inhibitory neurons: 68.8;Microglial cells: 16.9;Muller glia cells: 18.6;Spermatocytes: 24.2"	"Group enriched"	"Detected in some"	4	"breast cancer: 1.7;glioma: 0.7;renal cancer: 0.8;testis cancer: 1.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"AF22: 7.7;Daudi: 5.9;SH-SY5Y: 6.1"									HPA007919			Approved	Nucleoplasm,Cytosol	"Intracellular and membrane"	NA	NA				"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Nucleoplasm, Cytosol"		"HPA007919: AB_1855966"	"prognostic unfavorable (3.27e-5)"	"unprognostic (4.59e-4)"	"unprognostic (5.57e-3)"	"unprognostic (2.83e-3)"	"unprognostic (2.71e-1)"	"unprognostic (5.14e-2)"	"unprognostic (1.18e-1)"	"unprognostic (7.18e-3)"	"unprognostic (1.85e-1)"	"unprognostic (1.15e-1)"	"unprognostic (7.07e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.60e-4)"	"unprognostic (2.28e-2)"	"unprognostic (3.35e-2)"	"unprognostic (2.42e-2)"	"unprognostic (2.97e-4)"	1.6	0.1	0.2	0.2	0.1	0.0	0.2	0.2	0.6	0.1	0.0	0.1	0.0	0.1	9.4	0.2	0.0	0.1	45.3	0.2	0.3	1.6	0.0	0.2	0.3	0.5	0.6	0.1	0.0	0.2	0.0	0.0	0.8	0.2	0.1	2.9	0.3	0.0	1.4	0.2	0.2	0.0	0.1	0.4	0.0	5.0	0.2	0.5	0.3	2.1	0.5	0.0	0.0	0.4	0.5	0.0	7.7	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	6.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.2	0.6	0.2	0.3	0.5	0.6	0.8	0.1	0.2	0.4	0.3	0.0	0.0	10.7	0.0	0.1	0.1	0.0	0.0	1.2	3.7	0.1	42.2	0.0	0.0	0.0	0.0	0.0	1.5	0.0	1.9	0.0	43.8	0.0	0.0	0.3	0.0	0.0	25.2	0.0	0.0	5.3	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	68.8	0.0	0.0	0.0	0.0	6.3	0.0	0.1	0.0	16.9	0.0	18.6	0.0	14.1	14.9	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.6	0.0	0.2	0.8	24.2	1.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0
PXK	"FLJ20335, Slob"	ENSG00000168297	"PX domain containing serine/threonine kinase like"	Q7Z7A4	3	58332880-58426127	"Enzymes, Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"brain: 320.5"	"Cell type enriched"	"Detected in all"	9	"Oligodendrocytes: 732.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-937: 159.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024068	Supported		Supported	"Plasma membrane,Centriolar satellite,Cytosol"		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 32: U-937 - Innate immune response"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Cytosol	"Plasma membrane, Centriolar satellite"	"HPA024068: AB_1855967"	"unprognostic (2.98e-2)"	"unprognostic (3.29e-1)"	"unprognostic (2.71e-3)"	"unprognostic (1.61e-1)"	"unprognostic (2.40e-1)"	"unprognostic (6.62e-3)"	"unprognostic (5.03e-3)"	"prognostic favorable (5.68e-4)"	"unprognostic (3.90e-1)"	"unprognostic (8.09e-2)"	"unprognostic (3.48e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.38e-3)"	"unprognostic (2.14e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.86e-2)"	19.9	16.7	71.6	31.5	161.3	73.1	15.8	112.3	109.2	46.7	20.4	23.3	10.6	23.5	8.4	11.3	17.5	15.5	17.8	84.1	115.0	18.2	11.6	20.6	43.0	158.2	131.3	18.3	15.7	21.2	13.4	29.7	154.1	12.8	10.5	35.6	14.8	11.7	18.8	14.3	19.3	18.7	82.1	25.2	16.3	12.4	119.0	13.7	63.1	14.3	44.9	19.5	30.2	320.5	13.7	6.9	6.8	12.0	79.7	70.0	17.8	22.6	42.5	19.7	27.3	4.0	3.1	74.7	5.1	33.6	28.4	4.2	18.7	13.2	21.8	18.5	12.5	13.1	11.3	5.8	87.5	112.8	22.5	57.4	31.6	24.6	42.0	72.5	17.8	49.1	15.7	26.1	35.7	5.3	26.2	122.2	7.8	4.1	19.7	40.7	9.4	13.4	12.6	8.0	6.0	4.0	14.2	11.0	19.0	10.7	34.8	122.9	17.9	24.9	11.0	48.5	23.9	19.4	21.6	73.7	36.2	159.3	10.7	39.5	44.6	69.1	23.8	37.2	20.7	62.6	17.1	20.3	41.8	69.6	15.3	17.5	73.5	21.6	57.1	32.1	21.1	32.0	71.6	161.3	112.3	109.2	84.1	115.0	158.2	131.3	154.1	82.1	119.0	320.5	20.1	9.6	6.3	28.4	59.8	14.1	5.8	5.6	7.4	31.0	5.9	7.1	13.1	7.2	6.0	23.9	20.9	19.7	31.7	8.3	33.2	7.1	69.7	9.1	33.0	14.2	7.8	19.3	33.8	5.7	6.8	41.5	6.1	16.0	19.7	15.2	16.4	7.5	13.6	20.2	53.7	5.0	2.0	24.5	31.1	38.3	30.7	25.2	17.8	30.0	28.6	32.7	30.9	79.4	732.6	3.0	5.5	25.2	17.6	6.0	8.7	12.2	6.4	22.2	19.7	18.7	18.2	16.8	21.9	10.1	13.1	35.2	16.9	18.3	5.0	3.9
PYCARD	"ASC, CARD5, TMS-1"	ENSG00000103490	"PYD and CARD domain containing"	Q9ULZ3	16	31201486-31203450	"Predicted intracellular proteins"	"Apoptosis, Immunity, Inflammatory response, Innate immunity"		"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 84.7;skin 1: 90.5"	"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 425.8;Kupffer cells: 555.8;Macrophages: 344.2;Paneth cells: 360.0;Proximal enterocytes: 504.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"basophil: 585.7;classical monocyte: 1098.3;eosinophil: 948.1;intermediate monocyte: 1138.3;myeloid DC: 829.2;neutrophil: 1638.4;non-classical monocyte: 1152.8;plasmacytoid DC: 769.2"	"Group enriched"	"Detected in all"	6	"dendritic cells: 829.2;granulocytes: 1638.4;monocytes: 1152.8"	"Cell line enhanced"	"Detected in many"		"MCF7: 148.9;NB-4: 237.0;THP-1: 186.9;U-937: 112.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB006853, CAB015948, HPA049074, HPA054496"	Enhanced		Supported	Nucleoplasm,Nucleoli,Cytosol		NA	NA		640000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 31: Skin - Epidermis development"	"Cluster 24: NB-4 - Immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	Nucleoplasm	"Nucleoli, Cytosol"	"CAB006853: , CAB015948: , HPA049074: AB_2680621, HPA054496: AB_2682506"	"unprognostic (1.00e-3)"	"unprognostic (2.62e-2)"	"unprognostic (2.40e-1)"	"unprognostic (4.67e-3)"	"unprognostic (3.34e-1)"	"unprognostic (1.87e-1)"	"unprognostic (5.29e-2)"	"unprognostic (2.88e-2)"	"unprognostic (3.12e-1)"	"unprognostic (2.33e-1)"	"unprognostic (6.52e-3)"	"unprognostic (3.88e-2)"	"prognostic unfavorable (6.09e-7)"	"unprognostic (4.45e-3)"	"unprognostic (2.51e-1)"	"unprognostic (3.61e-2)"	"unprognostic (6.97e-2)"	25.6	11.4	4.1	32.9	4.0	43.4	20.4	4.6	8.6	22.1	5.0	48.1	63.9	10.7	0.0	56.1	17.4	4.9	9.7	3.7	5.2	10.9	10.4	32.8	19.1	7.8	5.1	14.9	11.3	1.7	7.7	6.1	6.7	19.9	9.5	0.1	24.6	8.7	3.4	90.5	48.5	5.8	7.6	84.7	22.1	2.3	6.7	9.5	9.1	1.2	12.7	19.8	33.1	11.3	23.9	54.8	0.5	0.2	9.2	18.9	0.6	12.6	22.6	8.8	6.5	0.1	31.7	10.6	0.1	17.6	0.0	69.7	2.9	57.4	0.3	73.0	0.0	9.3	7.9	18.3	25.6	86.9	65.7	24.7	30.3	4.0	1.2	0.2	18.4	0.1	42.9	17.5	2.9	148.9	0.2	237.0	15.7	13.2	0.1	75.5	0.0	35.2	1.3	22.3	0.7	0.2	10.4	0.0	12.4	0.3	15.5	186.9	11.8	0.4	0.7	9.9	0.3	0.6	0.1	0.2	6.4	112.1	0.1	585.7	1098.3	948.1	178.4	1138.3	112.2	213.7	146.5	183.3	829.2	210.7	102.1	139.6	1638.4	219.2	1152.8	769.2	206.4	814.2	4.1	4.0	4.6	8.6	3.7	5.2	7.8	5.1	6.7	7.6	6.7	11.3	35.7	22.4	28.9	0.0	58.5	74.1	66.3	237.0	100.7	0.2	92.2	131.7	2.5	41.5	84.3	25.8	0.0	62.5	158.8	184.5	5.9	90.5	0.8	18.6	16.8	39.2	58.9	42.9	0.1	56.5	11.3	39.3	50.4	7.3	110.9	60.2	48.9	3.3	425.8	0.0	0.1	144.6	75.3	555.8	280.2	2.9	47.2	344.2	97.8	13.1	277.8	0.0	132.8	0.0	0.1	60.4	360.0	22.6	54.1	22.6	504.8	3.6	88.2	0.7	26.3	10.5	28.5	0.3	1.4	83.9	163.7	17.8	70.8	119.9	287.1	70.6
PYCR3	"FLJ13852, PYCRL"	ENSG00000104524	"Pyrroline-5-carboxylate reductase 3"	Q53H96	8	143603210-143609773	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Amino-acid biosynthesis, Proline biosynthesis"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Collecting duct cells: 14.7;Ductal cells: 10.2;Exocrine glandular cells: 9.1;Extravillous trophoblasts: 11.8;Proximal tubular cells: 12.4;Theca cells: 14.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"naive B-cell: 4.7"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA053776, HPA063416, HPA069706"	Uncertain		Supported	"Cytokinetic bridge,Mitotic spindle,Cytosol"		Yes	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 7: Non-specific - Mitochondria"	Cytosol	"Cytokinetic bridge, Mitotic spindle"	"HPA053776: , HPA063416: AB_2685010, HPA069706: AB_2686178"	"unprognostic (2.12e-2)"	"unprognostic (3.16e-2)"	"unprognostic (2.74e-1)"	"unprognostic (2.44e-1)"	"unprognostic (1.06e-2)"	"unprognostic (2.30e-1)"	"unprognostic (7.68e-3)"	"unprognostic (1.79e-1)"	"unprognostic (1.96e-1)"	"unprognostic (2.26e-2)"	"unprognostic (5.85e-2)"	"unprognostic (5.44e-2)"	"unprognostic (1.82e-2)"	"unprognostic (3.64e-2)"	"unprognostic (2.96e-1)"	"unprognostic (3.54e-2)"	"unprognostic (2.54e-1)"	5.0	9.7	2.8	0.4	2.9	0.6	5.2	2.7	3.3	5.1	1.0	4.2	0.5	5.2	1.1	7.1	6.0	0.8	3.9	2.9	1.6	9.7	17.2	3.8	0.9	2.3	2.2	5.1	9.2	0.6	10.0	0.4	2.7	8.7	0.6	0.7	5.8	0.5	3.0	4.0	4.1	0.4	1.5	5.9	5.5	7.0	2.7	0.4	8.4	0.3	0.7	4.4	3.8	2.1	3.2	4.0	1.6	2.5	1.8	0.6	2.0	3.0	1.4	2.9	1.9	2.9	2.6	6.2	2.1	2.0	1.1	2.6	2.0	4.0	1.1	3.0	5.3	3.7	2.2	2.0	0.6	1.9	1.0	0.8	1.9	3.1	1.9	1.2	0.7	3.7	4.3	3.1	1.9	7.2	3.0	1.7	2.1	4.5	10.4	2.8	1.8	4.3	3.4	2.2	5.3	1.4	3.6	4.9	1.6	0.8	6.4	2.0	0.9	2.9	4.0	3.4	3.1	2.5	0.8	4.2	2.6	2.0	1.9	0.2	0.9	0.0	1.1	0.6	1.2	1.3	0.8	0.8	0.6	4.7	1.1	1.0	0.1	1.3	0.7	3.0	0.9	0.6	2.8	2.9	2.7	3.3	2.9	1.6	2.3	2.2	2.7	1.5	2.7	2.1	2.9	3.2	3.6	0.0	1.8	0.0	0.0	0.0	0.0	0.0	8.8	7.7	0.0	0.0	0.6	14.7	0.0	5.1	1.6	0.0	3.9	10.2	0.0	6.8	6.6	1.9	0.0	0.0	0.0	9.1	11.8	2.9	0.0	5.2	0.0	5.5	0.0	0.0	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	1.6	0.0	0.0	0.0	0.0	7.4	0.0	0.0	0.8	0.0	0.0	12.4	4.4	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	2.5	1.2	14.7	0.0	0.0
PYGL	GSD6	ENSG00000100504	"Glycogen phosphorylase L"	P06737	14	50857891-50944483	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Carbohydrate metabolism, Glycogen metabolism"	"Allosteric enzyme, Glycosyltransferase, Transferase"	"Disease variant, Glycogen storage disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 145.6"	"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 151.2;Hofbauer cells: 177.6;Muller glia cells: 265.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"eosinophil: 141.1;neutrophil: 153.7"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HaCaT: 279.1;HMC-1: 304.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA000962, HPA004119"	Enhanced		Supported	"Plasma membrane,Cytosol"		NA	NA		16000000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 85: Liver - Metabolism"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 5: Muller glia cells - Visual perception"	"Plasma membrane, Cytosol"		"HPA000962: AB_1079722, HPA004119: AB_1079723"	"unprognostic (2.70e-2)"	"unprognostic (8.64e-3)"	"unprognostic (1.46e-2)"	"unprognostic (8.55e-2)"	"unprognostic (9.41e-2)"	"prognostic unfavorable (5.97e-4)"	"unprognostic (1.66e-1)"	"unprognostic (1.34e-2)"	"unprognostic (3.34e-1)"	"unprognostic (1.94e-2)"	"prognostic unfavorable (2.63e-4)"	"unprognostic (4.45e-3)"	"unprognostic (3.15e-3)"	"unprognostic (1.95e-2)"	"unprognostic (1.76e-1)"	"unprognostic (9.72e-2)"	"unprognostic (1.12e-3)"	110.1	21.0	5.9	24.1	6.6	108.9	36.4	5.0	8.4	33.6	10.4	19.0	3.7	20.7	6.4	55.8	19.1	13.0	14.9	5.2	6.2	10.2	145.6	26.1	6.3	10.7	17.6	18.2	5.7	21.1	7.5	49.3	8.7	13.0	24.0	78.2	26.8	29.7	5.1	37.0	8.4	26.7	8.6	49.4	9.6	5.2	9.0	4.8	10.2	5.8	6.8	41.7	38.1	10.3	145.7	40.8	10.1	64.3	47.0	56.2	114.5	28.6	24.1	77.4	117.3	107.4	18.3	0.1	54.4	171.7	91.2	279.1	107.0	144.8	132.0	0.5	46.8	28.0	60.5	82.4	83.8	106.9	304.4	119.4	56.8	104.1	43.6	75.4	69.3	0.8	11.6	0.5	55.4	144.7	0.4	141.7	39.3	12.8	152.0	2.7	36.2	6.1	104.7	95.1	4.5	4.4	131.0	43.3	1.7	38.6	20.6	200.4	3.2	29.7	49.6	56.0	92.9	1.2	0.3	0.5	27.3	107.7	15.9	50.2	55.9	141.1	0.0	24.2	0.0	0.0	0.0	0.0	27.3	0.0	0.0	0.0	153.7	0.6	15.7	1.2	0.2	24.8	5.9	6.6	5.0	8.4	5.2	6.2	10.7	17.6	8.7	8.6	9.0	10.3	6.7	22.4	6.3	1.3	1.8	30.7	10.5	40.5	6.8	4.6	7.0	3.8	3.4	5.7	35.4	7.3	0.0	28.9	0.2	11.2	3.9	10.9	1.0	35.4	18.9	7.8	1.2	9.0	1.8	2.1	151.2	18.8	6.6	62.6	6.3	9.3	8.2	65.4	177.6	1.7	2.2	7.1	14.2	56.7	7.9	1.5	14.3	54.6	19.6	15.9	52.4	265.1	2.1	14.1	0.6	7.4	5.2	21.8	1.8	9.7	0.0	6.4	24.5	11.9	6.6	15.4	8.8	0.7	1.4	22.4	22.3	21.1	2.3	4.0	14.0	9.2
PYGO2		ENSG00000163348	"Pygopus family PHD finger 2"	Q9BRQ0	1	154957026-154963853	"Predicted intracellular proteins"	"Wnt signaling pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA023689, HPA074813"	Supported		Supported	"Nucleoplasm,Plasma membrane"		No	No			"Cluster 26: Non-specific - Mitochondria"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 63: NK-cells & T-cells - Immune response"	Nucleoplasm	"Plasma membrane"	"HPA023689: AB_1855974, HPA074813: "	"unprognostic (1.49e-2)"	"unprognostic (1.33e-1)"	"unprognostic (6.96e-3)"	"unprognostic (2.58e-2)"	"unprognostic (5.85e-2)"	"unprognostic (4.32e-3)"	"prognostic unfavorable (3.88e-6)"	"unprognostic (2.45e-1)"	"unprognostic (2.07e-1)"	"unprognostic (2.00e-2)"	"unprognostic (1.51e-1)"	"unprognostic (3.74e-1)"	"unprognostic (7.40e-3)"	"unprognostic (1.63e-2)"	"unprognostic (2.81e-2)"	"unprognostic (2.17e-1)"	"prognostic favorable (1.76e-4)"	14.6	30.6	30.0	16.7	30.3	6.5	15.3	29.3	29.8	21.4	21.1	23.5	19.0	19.1	23.5	24.2	20.3	12.7	15.5	29.9	34.0	24.7	20.1	15.7	26.5	30.5	30.8	27.2	18.1	27.5	32.4	16.3	29.1	23.5	15.3	12.7	23.2	23.3	18.9	22.4	24.4	15.7	29.8	28.2	21.6	16.1	35.3	22.5	26.2	15.9	27.8	21.2	20.0	32.3	28.1	19.4	40.4	36.0	39.8	19.5	37.0	17.1	23.0	26.5	22.7	26.1	34.2	34.9	26.4	19.9	28.7	37.2	35.6	23.7	17.4	34.7	25.1	27.9	32.7	23.6	18.5	25.8	23.9	16.2	33.8	23.9	20.0	30.0	16.5	52.5	37.1	57.6	25.2	42.8	36.0	30.0	43.3	55.7	34.2	40.2	25.7	55.6	27.1	26.1	48.4	71.8	27.0	48.5	34.9	39.1	59.7	45.9	14.1	23.5	35.1	25.6	25.1	56.8	54.3	37.1	19.6	32.4	31.8	2.3	3.9	10.9	8.0	6.5	10.0	6.9	10.3	10.7	4.1	7.5	11.0	8.7	3.8	6.3	8.4	3.9	5.8	6.2	30.0	30.3	29.3	29.8	29.9	34.0	30.5	30.8	29.1	29.8	35.3	32.3	7.0	9.6	4.9	5.5	12.6	5.5	3.8	5.8	7.4	11.8	14.3	10.0	5.3	5.7	7.4	12.9	2.1	15.5	14.1	10.3	19.6	6.2	3.4	5.7	7.5	6.8	5.4	12.4	6.3	5.9	12.6	5.8	9.7	7.4	0.0	9.3	7.1	9.4	6.5	21.9	4.3	10.6	6.1	6.6	3.5	2.2	9.0	5.6	5.4	6.5	6.4	10.6	8.2	5.5	4.7	9.7	9.1	9.1	11.5	4.9	12.0	9.8	4.0	6.0	6.6	5.4	6.9	5.9	12.2	9.8	5.3	11.6	11.7	9.3	8.4	3.7
PYHIN1	"IFIX, MGC23885"	ENSG00000163564	"Pyrin and HIN domain family member 1"	Q6K0P9	1	158930796-158977059	"Predicted intracellular proteins"	"Cell cycle"		"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"lymphoid tissue: 23.1"	"Group enriched"	"Detected in many"	5	"dendritic cells: 165.9;NK-cells: 324.4;T-cells: 104.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in many"	4	"gdT-cell: 97.3;MAIT T-cell: 56.3;memory CD4 T-cell: 40.8;memory CD8 T-cell: 74.7;naive CD8 T-cell: 45.1;NK-cell: 36.8;T-reg: 67.3"	"Group enriched"	"Detected in many"	5	"NK-cells: 36.8;T-cells: 97.3"	"Cell line enriched"	"Detected in some"	6	"U-698: 49.1"									"HPA051224, HPA055373"	Enhanced		Approved	Nucleoplasm,Nucleoli		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	Nucleoli	Nucleoplasm	"HPA051224: AB_2681394, HPA055373: "	"unprognostic (1.64e-3)"	"unprognostic (1.75e-3)"	"unprognostic (2.93e-3)"	"unprognostic (2.64e-3)"	"unprognostic (3.99e-2)"	"unprognostic (3.57e-3)"	"unprognostic (2.44e-3)"	"unprognostic (2.10e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.47e-3)"	"unprognostic (3.94e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.70e-6)"	"unprognostic (1.83e-1)"	"unprognostic (2.31e-1)"	"unprognostic (2.76e-2)"	"unprognostic (4.45e-3)"	2.3	0.6	0.2	8.3	0.3	5.5	1.2	0.2	0.4	1.0	0.4	1.7	1.6	1.1	0.8	0.8	0.9	3.8	0.6	0.3	0.4	0.7	3.2	3.7	23.1	0.7	0.3	0.8	0.3	0.2	0.3	0.9	0.6	1.0	2.1	0.1	1.6	0.5	0.3	0.5	5.4	0.7	0.2	13.9	2.7	0.4	0.5	3.7	1.4	0.6	12.5	3.3	0.8	1.2	0.0	0.0	0.0	0.0	0.7	0.4	0.6	0.0	0.2	0.0	0.1	0.0	0.0	6.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.4	0.9	0.0	0.2	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	2.8	0.0	0.1	0.1	0.0	0.0	0.9	0.0	49.1	0.0	7.7	0.0	1.5	0.3	0.4	97.3	0.4	56.3	14.8	40.8	74.7	0.3	8.7	13.5	45.1	3.5	36.8	0.5	0.6	67.3	21.0	0.2	0.3	0.2	0.4	0.3	0.4	0.7	0.3	0.6	0.2	0.5	1.2	1.3	12.8	2.8	1.0	17.0	0.4	0.6	0.0	0.0	0.5	1.2	0.9	0.6	0.0	2.0	3.7	0.0	0.1	165.9	0.1	0.0	0.1	0.3	0.5	0.3	1.2	0.0	7.4	0.5	0.0	0.0	2.7	2.6	0.2	2.5	0.1	3.9	1.2	2.7	0.0	0.5	0.0	0.0	5.0	1.5	0.3	0.0	3.5	1.8	6.5	2.3	0.5	324.4	0.0	0.2	0.0	0.0	0.0	37.9	0.6	0.0	0.6	5.3	1.1	0.0	0.7	0.7	0.1	0.2	0.1	0.6	0.1	104.7	0.0	0.2	0.4
PYM1	"PYM, WIBG"	ENSG00000170473	"PYM homolog 1, exon junction complex associated factor"	Q9BRP8	12	55901413-55932618	"Predicted intracellular proteins"	"Nonsense-mediated mRNA decay, Translation regulation"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"monocytes: 110.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012803, HPA039717, HPA046200"	Supported		Supported	"Nucleoplasm,Nucleoli,Cell Junctions,Cytosol"		No	No		27000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoplasm, Nucleoli, Cytosol"	"Cell Junctions"	"CAB012803: AB_2269494, HPA039717: AB_2676644, HPA046200: AB_10965556"	"unprognostic (3.03e-2)"	"unprognostic (1.00e-1)"	"unprognostic (5.65e-2)"	"unprognostic (8.82e-2)"	"unprognostic (1.97e-1)"	"unprognostic (2.28e-1)"	"prognostic unfavorable (3.05e-4)"	"unprognostic (3.29e-1)"	"unprognostic (2.17e-3)"	"unprognostic (2.44e-2)"	"unprognostic (3.94e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.32e-2)"	"unprognostic (1.59e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.29e-1)"	"prognostic favorable (1.34e-4)"	24.5	30.8	19.8	24.0	20.2	22.5	27.9	21.5	24.8	26.1	22.9	31.1	31.6	22.1	41.5	72.3	22.7	19.8	21.8	19.5	20.7	26.3	43.0	20.8	35.4	20.5	20.6	17.1	28.0	26.3	22.3	22.8	20.5	31.2	30.0	17.4	34.0	15.9	29.8	41.9	29.5	19.8	20.1	31.1	24.1	25.9	20.1	33.2	27.0	29.0	42.1	24.8	31.4	20.2	50.3	39.1	56.1	31.4	33.4	43.2	92.6	36.1	43.1	33.3	28.0	57.7	57.9	62.9	53.6	35.1	15.4	38.6	43.6	77.1	26.7	48.6	32.7	51.0	35.1	71.8	40.7	59.7	44.7	39.2	48.8	37.7	56.0	42.2	35.9	27.3	44.5	67.4	39.7	75.3	38.6	105.7	98.3	56.7	20.2	34.3	22.3	72.5	69.5	69.8	37.7	43.4	46.2	61.1	33.1	51.8	74.5	124.0	28.2	20.0	28.3	31.5	26.6	35.5	58.2	97.2	34.2	40.9	31.9	17.5	79.8	75.8	58.5	92.2	72.3	98.1	105.4	82.2	120.2	88.2	68.7	69.5	19.1	53.1	66.5	65.6	186.0	87.2	19.8	20.2	21.5	24.8	19.5	20.7	20.5	20.6	20.5	20.1	20.1	20.2	16.2	19.2	17.3	0.0	28.6	0.0	29.4	0.0	21.1	12.7	41.7	38.4	0.0	25.8	14.2	23.9	8.4	84.3	21.1	29.8	78.2	40.6	15.2	21.1	17.0	16.3	7.3	32.2	0.0	50.6	76.3	17.6	22.4	21.1	18.9	14.5	22.9	44.3	55.2	6.7	0.0	32.1	0.0	47.7	0.0	11.7	23.3	42.8	0.0	0.0	110.4	55.7	48.4	0.0	0.0	54.1	33.7	23.7	21.9	34.7	66.8	61.3	16.8	13.6	13.1	18.0	15.7	23.8	25.6	63.1	0.0	62.0	29.6	16.5	29.3	34.3
QKI	QK3	ENSG00000112531	"QKI, KH domain containing RNA binding"	Q96PU8	6	163414000-163578592	"Cancer-related genes, Predicted intracellular proteins"	"Differentiation, mRNA processing, mRNA splicing, mRNA transport, Translation regulation, Transport"	"Developmental protein, RNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 628.6"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 1140.0;Microglial cells: 713.0;Oligodendrocyte precursor cells: 1421.0;Oligodendrocytes: 4573.8"	"Cancer enriched"	"Detected in all"	6	"glioma: 42.0"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"AF22: 250.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019123, CAB022602"	Enhanced	Supported	Supported	Nucleoplasm		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 70: Brain - Nervous system development"	"Cluster 12: NES - Nervous system development"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Nucleoplasm		"CAB022602: , HPA019123: AB_1855980"	"unprognostic (2.42e-1)"	"unprognostic (5.81e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.06e-2)"	"unprognostic (8.57e-2)"	"unprognostic (1.65e-1)"	"prognostic unfavorable (1.27e-4)"	"unprognostic (1.34e-1)"	"unprognostic (7.06e-2)"	"unprognostic (1.76e-3)"	"unprognostic (1.08e-1)"	"unprognostic (5.15e-2)"	"prognostic unfavorable (2.31e-5)"	"prognostic unfavorable (3.69e-4)"	"unprognostic (1.16e-1)"	"unprognostic (3.86e-1)"	"unprognostic (4.09e-2)"	76.3	24.2	208.2	36.8	437.7	69.7	27.8	355.8	207.9	29.2	2.5	22.2	7.9	28.4	8.7	34.4	25.3	33.8	149.3	211.1	301.1	22.7	41.1	55.9	27.4	431.2	367.9	38.2	16.0	15.0	6.9	53.0	451.4	15.3	16.7	26.9	15.3	22.3	157.0	18.6	11.9	46.3	304.5	39.8	12.1	47.3	365.7	28.5	22.1	222.1	25.3	38.2	16.4	628.6	17.8	72.0	250.8	83.7	74.3	81.9	58.4	46.8	109.0	74.5	89.4	49.3	15.8	21.3	38.6	117.2	50.8	25.9	134.4	48.4	120.2	43.7	43.3	83.4	38.4	55.3	90.4	44.8	24.9	96.8	19.5	80.0	125.8	72.4	104.4	30.9	124.3	48.2	48.6	32.8	30.1	9.5	32.4	17.3	36.0	45.9	156.5	42.3	40.5	54.4	5.2	28.7	49.9	26.7	19.2	101.2	10.5	71.8	107.2	51.3	42.7	55.9	86.1	30.9	40.9	26.3	44.2	38.7	122.8	3.6	7.1	3.4	1.8	4.7	3.0	1.2	1.3	1.6	3.7	1.2	1.1	2.0	9.2	6.3	5.1	6.2	1.0	1.1	208.2	437.7	355.8	207.9	211.1	301.1	431.2	367.9	451.4	304.5	365.7	628.6	180.6	150.6	51.5	1140.0	35.4	153.7	34.1	25.3	43.9	60.4	42.8	47.2	355.5	37.1	30.5	20.2	58.4	51.1	77.7	0.2	21.5	21.8	53.0	60.7	156.7	130.0	0.0	40.4	58.4	12.0	51.3	92.2	10.2	71.1	60.9	64.8	131.0	72.9	86.8	32.0	471.4	0.0	14.2	221.9	188.0	102.5	86.6	165.7	113.8	713.0	107.9	113.5	32.0	1421.0	4573.8	19.8	0.1	98.6	34.4	46.5	0.0	33.2	23.7	31.5	46.0	197.7	83.5	46.1	19.7	47.4	136.1	55.1	32.2	69.9	0.2	46.4
QPCTL	FLJ20084	ENSG00000011478	"Glutaminyl-peptide cyclotransferase like"	Q9NXS2	19	45692403-45703989	"Enzymes, Predicted intracellular proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 5.5;granulocytes: 5.7;Inhibitory neurons: 6.5;Plasma cells: 9.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040797	Approved		Supported	"Golgi apparatus"		NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 55: Plasma cells - Humoral immune response"	"Golgi apparatus"		"HPA040797: AB_10794148"	"unprognostic (6.50e-2)"	"unprognostic (4.14e-2)"	"unprognostic (2.09e-1)"	"unprognostic (7.50e-2)"	"unprognostic (1.90e-1)"	"unprognostic (2.26e-1)"	"unprognostic (8.41e-3)"	"unprognostic (2.30e-2)"	"unprognostic (9.46e-2)"	"unprognostic (1.69e-1)"	"unprognostic (3.14e-2)"	"unprognostic (6.05e-2)"	"prognostic unfavorable (2.15e-8)"	"unprognostic (1.07e-1)"	"unprognostic (1.75e-1)"	"unprognostic (4.02e-2)"	"unprognostic (5.71e-2)"	4.1	7.8	3.9	3.1	3.9	4.1	4.9	3.6	4.8	4.9	4.1	5.9	4.7	4.8	3.7	4.7	4.8	2.5	3.4	4.2	4.0	5.3	9.2	6.2	4.7	4.5	3.8	6.6	7.5	4.4	7.0	3.7	4.5	6.5	3.9	2.1	6.7	3.4	1.5	5.2	5.5	2.5	3.2	8.5	6.1	4.4	4.2	2.4	6.7	0.8	3.5	4.6	4.4	3.9	16.7	10.8	8.5	36.9	8.6	4.1	6.4	10.3	15.7	15.0	24.7	11.2	12.3	19.7	11.1	11.5	15.4	9.5	10.0	11.9	8.9	5.0	12.7	6.7	10.9	24.6	14.6	7.5	12.0	7.6	14.9	12.6	17.3	10.7	13.6	10.8	9.7	32.1	9.5	13.0	7.0	7.7	5.5	14.2	5.4	7.8	6.4	16.5	16.2	8.0	7.6	4.7	10.6	8.8	18.2	3.7	6.4	10.6	8.4	7.4	12.4	7.3	10.4	28.6	20.2	18.2	26.0	17.2	5.8	1.4	0.3	0.2	1.4	0.5	0.9	0.9	0.6	0.3	0.8	0.6	0.5	0.7	1.3	1.4	0.3	1.0	0.3	0.2	3.9	3.9	3.6	4.8	4.2	4.0	4.5	3.8	4.5	3.2	4.2	3.9	0.5	0.0	1.5	2.3	3.3	1.3	1.2	1.1	0.6	1.1	0.7	0.6	0.8	1.5	1.2	0.0	0.0	0.8	2.1	1.2	0.0	0.6	5.4	0.9	1.4	0.7	0.0	1.3	5.5	0.4	1.4	0.7	1.5	1.4	5.7	0.7	0.0	1.3	0.9	1.7	6.5	0.4	0.0	0.6	1.8	1.3	0.0	1.6	1.8	0.0	0.7	0.3	1.0	3.5	1.6	0.6	0.1	0.0	9.8	1.2	0.7	0.1	2.2	2.4	0.0	0.6	1.1	1.0	0.3	1.4	1.1	0.8	2.4	1.5	1.0	0.5
QSOX1	QSCN6	ENSG00000116260	"Quiescin sulfhydryl oxidase 1"	O00391	1	180154869-180204030	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	6	"Extravillous trophoblasts: 1616.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HHSteC: 1918.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA056243			Supported	"Golgi apparatus,Vesicles"	"Secreted to extracellular matrix"	NA	NA		2600000000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 38: Extravillous trophoblasts - Unknown function"	"Golgi apparatus"	Vesicles	"HPA056243: AB_2683077"	"unprognostic (1.13e-1)"	"unprognostic (2.62e-3)"	"unprognostic (2.46e-1)"	"unprognostic (2.49e-2)"	"unprognostic (2.00e-2)"	"unprognostic (2.73e-1)"	"unprognostic (5.47e-2)"	"unprognostic (2.22e-1)"	"unprognostic (3.94e-1)"	"unprognostic (3.12e-2)"	"unprognostic (5.07e-2)"	"unprognostic (2.80e-3)"	"prognostic unfavorable (1.86e-5)"	"unprognostic (3.25e-1)"	"unprognostic (2.14e-1)"	"unprognostic (3.53e-2)"	"unprognostic (1.40e-1)"	84.8	84.9	35.8	52.1	39.4	115.5	53.2	42.7	47.3	81.7	41.1	100.1	67.5	75.2	70.2	178.4	82.3	150.3	244.9	41.5	43.4	73.8	81.7	200.0	16.3	50.0	40.7	196.1	136.3	21.0	60.2	158.9	43.2	92.3	80.9	15.2	105.6	57.5	91.2	58.6	85.7	60.0	44.0	61.9	178.3	172.9	42.6	12.1	31.9	46.0	19.6	174.1	108.7	57.7	441.4	62.0	14.8	181.0	179.1	367.8	712.5	456.5	456.6	381.6	267.1	7.3	137.7	6.8	276.7	367.8	52.6	93.7	17.6	123.5	185.0	26.4	28.0	14.1	33.6	19.4	1918.6	48.6	129.2	197.9	55.5	408.0	484.3	499.9	569.4	32.1	20.2	66.3	255.3	76.4	10.4	89.7	49.4	302.6	174.6	19.7	33.0	11.8	63.1	123.6	51.9	52.6	133.8	179.8	91.9	32.2	33.0	226.3	678.3	473.8	187.5	322.0	392.9	48.3	84.4	12.2	180.9	153.9	146.0	16.2	53.1	20.6	14.0	29.9	10.2	5.4	9.1	9.6	39.2	3.2	8.1	8.0	40.2	16.9	28.6	8.0	11.5	28.6	35.8	39.4	42.7	47.3	41.5	43.4	50.0	40.7	43.2	44.0	42.6	57.7	36.6	57.7	101.6	8.5	7.7	13.8	27.4	81.2	7.4	11.5	86.2	47.9	48.3	51.5	112.5	71.7	25.0	19.5	10.7	138.1	0.0	230.4	49.2	49.2	19.4	41.7	46.2	6.9	17.2	130.1	1616.7	78.0	136.6	80.4	25.4	27.1	89.3	4.3	68.6	6.7	17.0	185.7	132.2	45.2	35.3	20.1	177.7	48.9	44.4	8.4	49.7	53.5	10.3	24.6	23.9	249.8	165.6	71.1	12.8	35.7	9.0	9.1	47.8	6.7	32.9	13.6	31.3	30.2	32.7	10.2	9.9	154.3	13.9	13.9	89.9	68.0
RAB11FIP2	"KIAA0941, nRip11, Rab11-FIP2"	ENSG00000107560	"RAB11 family interacting protein 2"	Q7L804	10	118004916-118046941	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 82.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037726	Approved		Supported	Nucleoplasm,Vesicles		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 68: Epididymis - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 50: Fibroblasts - ECM organization"	Vesicles	Nucleoplasm	"HPA037726: AB_10672390"	"unprognostic (1.97e-1)"	"unprognostic (1.68e-2)"	"unprognostic (3.61e-1)"	"unprognostic (4.45e-2)"	"unprognostic (1.30e-1)"	"unprognostic (5.58e-2)"	"unprognostic (2.17e-2)"	"unprognostic (3.34e-2)"	"unprognostic (1.83e-2)"	"unprognostic (2.15e-1)"	"unprognostic (2.06e-1)"	"unprognostic (1.47e-1)"	"prognostic favorable (9.69e-5)"	"unprognostic (1.17e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.90e-1)"	"unprognostic (2.17e-1)"	8.6	6.6	5.2	6.6	7.0	13.8	6.9	4.8	8.5	10.2	2.4	8.2	3.6	18.8	28.5	6.3	11.8	8.3	6.1	7.1	3.4	12.2	5.4	7.6	6.9	2.8	4.6	9.9	5.6	6.3	4.3	8.2	2.2	10.8	4.9	10.3	4.8	24.7	5.0	5.9	5.5	19.5	3.7	6.6	17.2	7.8	5.3	6.2	11.4	7.5	5.5	7.6	6.2	6.1	7.1	8.8	7.3	9.3	11.9	15.0	7.8	13.8	15.8	8.3	8.6	7.4	7.4	14.5	10.8	14.0	6.1	4.8	10.1	6.1	12.8	3.8	10.9	5.1	9.1	5.1	17.2	9.7	5.5	14.8	11.3	11.6	25.4	11.0	5.1	9.3	3.9	12.1	10.9	2.5	7.5	7.3	6.2	3.1	6.2	6.4	26.0	4.9	12.4	5.6	1.7	13.5	9.8	3.9	17.3	8.7	3.0	8.9	7.7	11.2	8.9	13.3	13.8	8.9	7.8	9.4	11.5	16.4	7.0	0.2	0.2	0.2	0.2	0.1	0.2	0.3	0.2	0.2	0.1	0.4	0.4	0.2	0.3	0.1	0.1	0.5	0.1	0.0	5.2	7.0	4.8	8.5	7.1	3.4	2.8	4.6	2.2	3.7	5.3	6.1	16.7	57.7	31.5	79.7	17.7	10.3	8.8	4.4	12.5	28.1	10.1	10.7	25.8	24.3	6.0	42.3	29.2	11.6	15.1	5.5	7.9	12.6	16.5	13.1	31.0	14.1	14.5	17.4	63.8	18.7	7.9	29.1	14.8	15.7	3.8	28.0	11.4	8.6	11.4	38.7	57.9	6.6	4.1	23.0	12.2	6.6	33.5	16.2	23.2	34.7	19.4	26.0	15.5	53.8	82.9	16.6	4.7	28.6	17.0	11.1	5.4	18.1	7.3	31.4	26.3	34.0	25.8	14.9	21.2	9.2	9.5	5.2	12.9	19.2	6.5	6.4
RAB11FIP3	"eferin, KIAA0665, Rab11-FIP3"	ENSG00000090565	"RAB11 family interacting protein 3"	O75154	16	425649-523011	"Cancer-related genes, Predicted intracellular proteins"	"Cell cycle, Cell division, Transport"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 151.1"	"Cell type enriched"	"Detected in many"	5	"Proximal tubular cells: 384.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028088, HPA028631, HPA030086"	Enhanced		Enhanced	"Nucleoplasm,Vesicles,Cytokinetic bridge,Centriolar satellite,Mitochondria"		Yes	No				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Vesicles, Centriolar satellite"	"Nucleoplasm, Cytokinetic bridge, Mitochondria"	"HPA028088: AB_10601672, HPA028631: AB_10601853, HPA030086: AB_10669596"	"unprognostic (6.65e-2)"	"unprognostic (1.84e-2)"	"unprognostic (1.51e-1)"	"prognostic favorable (1.22e-4)"	"unprognostic (2.87e-2)"	"unprognostic (1.85e-1)"	"prognostic unfavorable (9.87e-5)"	"unprognostic (6.71e-2)"	"unprognostic (4.74e-1)"	"unprognostic (9.66e-2)"	"prognostic favorable (3.16e-5)"	"unprognostic (1.12e-1)"	"prognostic favorable (7.99e-4)"	"unprognostic (1.39e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.44e-1)"	27.9	32.3	18.0	5.3	18.9	7.0	19.5	21.3	22.6	29.6	7.6	35.1	9.0	31.3	5.5	12.3	27.5	7.4	31.4	21.7	14.0	151.1	37.3	25.2	5.8	14.4	15.8	33.8	47.4	15.9	41.5	6.5	15.2	29.9	3.1	6.1	19.3	7.8	52.2	19.5	27.5	7.1	12.7	26.4	22.2	34.6	16.8	5.3	24.8	15.8	3.2	31.7	19.9	19.0	5.9	14.9	14.6	11.9	20.2	13.2	10.0	10.6	11.6	10.7	7.6	11.5	3.0	15.3	11.0	18.7	8.9	5.5	8.9	13.4	3.9	10.8	14.9	7.9	14.8	31.7	20.9	9.5	8.6	12.7	8.8	11.6	9.9	11.7	17.3	10.7	3.5	6.0	14.4	22.5	10.2	15.9	11.7	5.0	6.8	22.8	10.8	4.6	11.3	4.0	13.8	12.0	11.5	13.6	7.5	5.0	7.6	13.9	29.9	14.8	8.8	13.6	7.0	6.9	6.7	18.8	6.5	5.8	11.7	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	18.0	18.9	21.3	22.6	21.7	14.0	14.4	15.8	15.2	12.7	16.8	19.0	9.4	3.2	1.7	36.9	3.8	3.7	0.7	1.1	2.2	7.7	3.5	4.3	12.4	7.2	4.3	5.5	6.2	1.0	5.7	5.9	27.4	1.6	1.2	6.4	8.7	7.1	3.0	1.7	73.5	1.2	0.2	5.5	2.0	13.1	1.3	8.4	17.9	15.9	0.8	21.9	60.3	3.0	0.0	3.7	1.6	2.6	0.6	4.7	0.0	19.7	0.6	7.2	2.1	46.8	40.7	1.4	3.9	1.9	3.4	0.9	8.1	384.2	3.1	7.6	6.6	5.3	5.4	4.0	2.8	0.3	2.3	0.8	4.4	6.1	5.9	0.3
RAB13		ENSG00000143545	"RAB13, member RAS oncogene family"	P51153	1	153981617-153986358	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	10	"classical monocyte: 7.0;myeloid DC: 10.5;plasmacytoid DC: 12.9"	"Group enriched"	"Detected in many"	11	"dendritic cells: 12.9;monocytes: 7.0"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 846.1"									HPA003996	Approved		Supported	"Plasma membrane,Cytosol"		NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Plasma membrane, Cytosol"		"HPA003996: AB_1079728"	"unprognostic (4.39e-3)"	"unprognostic (1.20e-1)"	"unprognostic (2.51e-2)"	"unprognostic (4.11e-2)"	"unprognostic (4.28e-3)"	"unprognostic (3.20e-2)"	"unprognostic (1.18e-3)"	"unprognostic (2.80e-1)"	"unprognostic (3.53e-2)"	"unprognostic (2.11e-2)"	"unprognostic (2.10e-1)"	"unprognostic (5.93e-2)"	"unprognostic (1.06e-3)"	"unprognostic (2.45e-1)"	"unprognostic (1.03e-1)"	"unprognostic (9.51e-3)"	"unprognostic (1.28e-2)"	151.4	132.8	78.8	91.0	80.1	104.3	124.1	79.4	112.4	114.1	89.2	123.6	54.1	92.2	111.3	102.0	96.0	83.3	90.1	77.3	88.6	164.6	111.1	116.8	42.5	92.5	85.3	111.1	115.1	97.9	35.4	64.3	89.7	123.5	73.6	10.5	96.3	73.5	45.9	92.1	79.0	67.5	84.7	97.5	123.3	61.7	84.0	19.2	112.8	49.5	47.7	123.2	107.7	83.7	133.4	162.5	143.7	152.8	478.2	846.1	43.2	157.9	381.1	142.6	144.6	165.4	111.9	0.1	230.7	194.4	72.7	88.4	86.9	146.7	198.0	78.6	62.3	110.1	100.5	94.3	199.5	0.4	70.9	620.1	125.3	246.6	109.1	401.0	253.4	0.0	20.6	0.5	246.6	280.0	0.5	55.4	231.8	183.9	151.2	28.9	186.1	0.1	327.0	140.5	7.2	112.6	208.7	179.8	337.0	215.4	294.2	87.0	469.6	256.0	149.5	161.1	174.7	0.4	0.1	0.9	399.6	17.4	399.7	0.0	7.0	0.1	0.0	1.0	0.1	0.7	0.1	0.0	10.5	0.6	0.1	0.4	0.8	0.0	0.1	12.9	0.0	1.9	78.8	80.1	79.4	112.4	77.3	88.6	92.5	85.3	89.7	84.7	84.0	83.7	230.1	41.7	83.4	1.0	9.0	92.0	181.3	196.3	110.4	1.2	126.9	149.2	75.2	120.1	105.3	108.5	2.1	116.3	2.8	81.5	135.0	234.4	119.9	91.9	163.2	239.8	89.1	116.4	0.0	149.2	181.2	100.8	76.5	111.4	40.6	111.9	192.4	136.2	249.1	0.0	0.0	184.2	83.4	111.1	104.5	232.1	106.2	116.0	99.6	7.5	247.4	71.5	2.1	0.0	0.1	158.1	110.6	124.1	10.6	197.0	135.7	206.5	72.2	3.8	151.2	46.9	151.4	103.6	18.4	124.8	98.2	92.9	8.9	141.6	146.1	195.9
RAB14	"FBP, RAB-14"	ENSG00000119396	"RAB14, member RAS oncogene family"	P61106	9	121178133-121223014	"Plasma proteins, Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026419, CAB037066"	Approved		Supported	Vesicles		NA	NA		2700000	"Cluster 14: Monocytes - Unknown function"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Vesicles		"CAB037066: AB_1841128, HPA026419: AB_1855996"	"unprognostic (1.30e-3)"	"unprognostic (3.12e-2)"	"unprognostic (9.01e-2)"	"unprognostic (7.18e-2)"	"unprognostic (6.53e-2)"	"unprognostic (3.00e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.18e-1)"	"unprognostic (2.52e-1)"	"unprognostic (6.90e-2)"	"unprognostic (3.05e-2)"	"unprognostic (9.71e-3)"	"prognostic favorable (1.79e-8)"	"unprognostic (1.38e-1)"	"unprognostic (3.17e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.09e-1)"	39.0	38.7	37.5	35.6	39.7	66.5	42.1	40.3	47.7	37.8	32.6	42.8	39.9	35.6	34.2	63.2	34.0	30.7	32.4	38.4	40.9	50.0	82.8	49.2	41.1	39.6	39.9	35.9	27.6	45.8	28.9	43.1	40.5	38.8	42.4	45.5	34.6	38.1	39.4	56.4	38.9	33.4	40.8	38.3	44.3	33.8	40.2	35.2	43.8	38.9	49.5	43.9	40.8	46.8	53.8	53.7	66.9	56.3	76.2	82.5	52.6	74.8	59.6	56.6	44.7	42.6	57.0	51.2	42.5	72.0	49.2	100.1	48.1	55.8	63.6	44.4	31.7	55.7	69.0	43.9	52.6	60.1	63.8	53.0	98.5	58.2	63.4	62.5	81.2	47.1	42.8	45.6	85.6	50.8	58.5	48.1	39.7	104.8	59.9	45.8	72.3	60.4	62.3	76.0	58.9	34.4	89.0	78.0	53.8	47.1	82.1	46.8	76.0	60.1	43.9	75.3	53.0	40.8	82.6	52.3	56.6	51.9	80.7	34.4	29.4	33.5	22.4	41.5	22.4	24.6	20.9	24.7	31.4	23.4	24.6	25.0	31.8	26.5	43.7	19.0	29.3	24.0	37.5	39.7	40.3	47.7	38.4	40.9	39.6	39.9	40.5	40.8	40.2	46.8	102.6	160.3	103.9	23.5	64.4	157.9	78.2	84.8	97.3	93.8	70.7	58.8	39.2	62.9	96.2	62.5	37.5	85.2	79.6	95.1	86.1	81.3	41.9	80.7	89.8	84.5	60.3	44.4	42.5	64.4	83.0	68.7	64.7	94.4	77.2	58.1	61.1	113.6	91.0	94.2	38.0	59.8	95.6	89.9	105.4	36.2	51.9	80.7	110.3	44.0	84.8	100.5	49.4	38.2	59.0	80.7	52.9	56.4	50.2	81.0	63.2	103.3	86.8	62.0	59.2	64.0	105.6	112.9	113.6	120.0	202.4	116.2	74.3	82.5	64.0	106.0
RAB1A	"RAB1, YPT1"	ENSG00000138069	"RAB1A, member RAS oncogene family"	P62820	2	65070696-65130331	"Plasma proteins, Predicted intracellular proteins"	"Autophagy, ER-Golgi transport, Protein transport, Transport"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 911.4;Syncytiotrophoblasts: 703.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005331, HPA056141"	Approved		Supported	"Endoplasmic reticulum,Cytosol"		NA	NA		3000000	"Cluster 10: Basophils - Unknown function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 25: Spermatids - Spermatogenesis"	"Endoplasmic reticulum, Cytosol"		"CAB005331: AB_632290, HPA056141: AB_2683051"	"unprognostic (4.78e-3)"	"unprognostic (1.36e-3)"	"unprognostic (4.68e-3)"	"unprognostic (2.08e-1)"	"unprognostic (1.79e-2)"	"prognostic unfavorable (4.19e-4)"	"unprognostic (1.55e-3)"	"unprognostic (2.61e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.35e-1)"	"unprognostic (4.30e-3)"	"unprognostic (2.79e-1)"	"unprognostic (4.81e-2)"	"unprognostic (2.77e-1)"	"unprognostic (7.80e-2)"	"unprognostic (1.83e-2)"	"unprognostic (8.63e-2)"	142.5	142.9	84.2	90.6	86.8	232.4	119.1	85.2	105.2	122.6	103.7	128.1	133.6	109.7	179.9	155.0	103.5	100.1	127.3	89.0	91.9	194.1	194.9	141.9	70.5	86.0	88.4	94.4	133.9	113.1	117.2	148.3	91.3	96.6	126.8	89.4	131.8	93.8	100.3	101.3	127.6	117.4	87.7	88.6	135.9	86.2	90.4	59.0	129.6	80.4	91.1	119.2	120.5	91.3	211.3	150.7	186.2	110.5	445.5	261.2	287.5	299.9	212.3	134.8	142.8	270.1	137.5	85.8	167.9	311.2	221.4	130.6	173.7	277.6	214.1	96.3	100.6	108.3	119.2	403.8	281.9	115.4	93.7	232.0	279.6	176.9	158.5	213.3	271.2	67.7	157.2	96.6	271.1	190.6	67.3	138.6	148.6	329.1	134.6	68.3	177.3	137.3	266.1	236.0	133.9	118.5	139.2	230.6	282.4	218.7	143.3	106.9	253.4	172.5	214.6	183.2	171.8	147.6	95.3	205.6	230.2	173.9	170.4	96.8	84.6	78.7	41.9	86.3	46.7	42.6	45.4	45.8	76.0	29.3	43.2	45.1	102.1	56.4	80.9	63.1	59.0	54.3	84.2	86.8	85.2	105.2	89.0	91.9	86.0	88.4	91.3	87.7	90.4	91.3	84.8	83.3	89.1	51.2	64.6	297.2	322.0	384.6	74.0	48.5	117.1	71.8	120.7	87.2	218.6	125.0	6.2	309.5	70.3	182.0	328.7	216.5	350.3	102.8	110.9	133.0	133.4	45.0	50.7	219.5	366.9	171.6	105.0	162.8	50.7	67.1	102.4	183.7	375.3	58.9	53.4	200.4	262.4	122.9	221.6	911.4	145.7	153.3	197.5	83.4	110.5	144.7	41.2	50.3	71.7	234.0	148.2	212.9	107.1	323.2	168.4	441.7	162.4	45.6	72.3	103.8	210.9	193.8	106.7	90.7	293.8	703.8	70.5	76.5	168.4	477.9
RAB1B		ENSG00000174903	"RAB1B, member RAS oncogene family"	Q9H0U4	11	66268590-66277492	"Plasma proteins, Predicted intracellular proteins"	"Autophagy, Protein transport, Transport"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB010225, HPA056141"	Approved		Supported	"Endoplasmic reticulum,Golgi apparatus"		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 59: Non-specific - Translation"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Golgi apparatus"	"Endoplasmic reticulum"	"CAB010225: AB_2284660, HPA056141: AB_2683051"	"unprognostic (6.07e-2)"	"unprognostic (2.75e-1)"	"unprognostic (1.44e-2)"	"unprognostic (1.77e-1)"	"unprognostic (2.90e-1)"	"unprognostic (9.91e-2)"	"unprognostic (2.61e-2)"	"unprognostic (2.04e-3)"	"unprognostic (2.10e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.43e-2)"	"unprognostic (2.00e-1)"	"prognostic favorable (1.09e-5)"	"unprognostic (2.41e-2)"	"unprognostic (9.45e-2)"	"unprognostic (9.42e-2)"	"unprognostic (5.85e-2)"	127.1	129.7	121.7	84.0	117.4	91.1	120.9	117.7	137.7	113.7	106.2	129.3	112.5	111.2	82.3	180.9	105.7	83.0	146.7	117.5	116.8	127.2	126.4	116.5	90.3	122.7	121.0	103.5	96.1	132.9	112.6	88.4	119.3	140.6	90.3	46.5	128.0	105.1	233.2	147.6	112.9	86.9	119.3	125.3	125.5	79.9	124.2	105.5	111.5	152.8	86.1	113.6	119.2	118.9	226.5	248.0	126.2	166.1	205.6	150.9	113.8	182.7	212.8	232.2	163.4	141.4	223.7	91.7	235.7	263.1	172.1	209.0	140.7	253.9	125.9	190.3	128.0	144.7	156.0	124.2	135.0	124.3	258.2	158.7	212.4	199.6	102.4	163.2	221.1	144.9	153.1	158.8	223.6	434.5	219.1	197.1	131.5	196.1	230.8	133.0	101.8	237.2	234.7	204.5	122.9	137.1	132.7	319.2	133.7	91.4	487.5	141.6	228.1	221.4	152.9	267.9	164.9	89.9	77.9	121.5	251.2	104.3	207.8	173.1	199.8	329.3	227.5	211.9	171.7	109.8	135.5	188.1	163.0	130.2	115.3	140.6	420.5	203.5	243.9	188.3	165.5	375.6	121.7	117.4	117.7	137.7	117.5	116.8	122.7	121.0	119.3	119.3	124.2	118.9	56.3	38.5	59.6	7.8	41.7	33.6	31.4	42.4	53.5	22.0	55.0	53.1	1.1	40.0	47.9	36.8	29.2	56.2	50.8	137.1	50.9	49.3	13.4	41.3	38.6	50.6	54.0	27.1	7.2	71.3	84.2	36.5	58.1	44.9	53.8	24.6	48.9	47.8	54.2	16.8	8.0	85.0	36.7	55.2	26.4	27.2	35.8	51.4	24.9	5.6	47.7	37.8	43.3	5.5	13.1	71.6	80.6	42.2	61.0	41.4	79.6	49.5	36.0	18.2	39.5	36.2	39.7	23.8	17.4	64.5	42.1	80.2	57.4	28.1	64.9	43.5
RAB20	FLJ20429	ENSG00000139832	"RAB20, member RAS oncogene family"	Q9NX57	13	110523066-110561722	"Plasma proteins, Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 91.3;Hofbauer cells: 105.0;Kupffer cells: 92.1;Macrophages: 100.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"OE19: 60.9;SK-BR-3: 85.7;T-47d: 54.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA002882, HPA052111, HPA068647"	Uncertain		Supported	"Golgi apparatus,Vesicles"		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 4: Macrophages - Innate immune response"	"Golgi apparatus, Vesicles"		"HPA002882: , HPA052111: AB_2681732, HPA068647: AB_2686013"	"unprognostic (5.59e-3)"	"unprognostic (1.30e-1)"	"unprognostic (3.48e-1)"	"unprognostic (1.42e-3)"	"unprognostic (1.30e-1)"	"unprognostic (3.82e-2)"	"unprognostic (1.14e-2)"	"unprognostic (5.99e-2)"	"unprognostic (9.43e-2)"	"unprognostic (2.06e-2)"	"unprognostic (9.41e-2)"	"unprognostic (2.65e-1)"	"prognostic favorable (8.57e-4)"	"unprognostic (6.96e-2)"	"unprognostic (4.32e-2)"	"unprognostic (2.28e-2)"	"prognostic favorable (4.48e-4)"	31.1	55.4	5.7	21.7	5.5	25.3	23.4	5.6	7.9	11.7	9.6	20.7	27.6	6.9	4.8	4.6	11.5	18.0	21.4	5.2	7.0	26.1	51.4	30.7	16.4	7.0	6.0	20.5	24.2	6.2	9.7	22.8	6.8	12.1	14.3	2.6	10.7	5.0	5.8	4.6	25.3	7.6	6.6	44.5	28.6	10.6	7.4	3.9	22.0	2.3	5.1	20.6	6.7	8.4	20.1	2.9	1.9	3.8	12.4	3.3	31.3	1.7	6.2	8.1	12.5	47.9	39.9	0.0	13.9	1.7	10.8	7.5	3.8	12.3	4.2	22.5	3.0	19.8	3.6	22.6	7.8	2.8	5.7	6.9	2.0	4.2	1.2	6.3	3.1	3.3	3.8	0.0	1.8	24.0	0.1	29.0	4.0	60.9	8.5	1.9	0.1	9.0	14.2	26.3	0.5	2.1	3.8	85.7	27.4	6.2	54.4	30.5	2.3	2.0	4.2	0.2	2.7	0.1	0.0	0.2	27.7	38.9	4.2	7.8	35.5	7.1	1.0	33.3	1.3	3.5	2.8	0.9	15.8	2.8	6.5	2.3	26.3	0.0	26.6	0.8	0.9	11.2	5.7	5.5	5.6	7.9	5.2	7.0	7.0	6.0	6.8	6.6	7.4	8.4	18.6	19.2	20.4	4.2	10.6	4.5	10.9	14.1	10.8	0.2	12.8	13.0	5.0	48.6	16.2	25.8	0.0	34.6	1.8	31.1	31.3	60.3	1.6	20.7	2.6	10.3	18.0	0.0	0.4	67.9	91.3	11.5	15.3	23.2	21.0	41.1	53.6	34.5	105.0	0.0	0.4	23.9	28.5	92.1	19.9	1.6	3.7	100.5	7.2	8.4	16.2	7.4	0.0	4.5	0.1	36.4	17.2	6.4	0.4	8.0	48.1	68.9	20.4	2.0	13.1	6.2	26.2	1.0	13.2	1.9	3.0	20.0	3.6	7.2	24.0	11.1
RAB27B		ENSG00000041353	"RAB27B, member RAS oncogene family"	O00194	18	54717860-54895516	"Enzymes, Plasma proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"stomach 1: 44.1"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 259.3;Gastric mucus-secreting cells: 178.4;granulocytes: 246.6;Late spermatids: 209.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"gdT-cell: 2.2;NK-cell: 2.6"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HEL: 63.3;hTCEpi: 46.6;hTERT-HME1: 56.0;U-87 MG: 165.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017712, HPA019849"	Enhanced		Approved	"Golgi apparatus,Plasma membrane,Cytosol"		NA	NA		6500000	"Cluster 48: NK-cells - Unknown function"	"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 51: Myeloid cells - Hemostasis"	"Golgi apparatus, Plasma membrane"	Cytosol	"CAB017712: , HPA019849: AB_1856000"	"unprognostic (1.59e-1)"	"unprognostic (5.20e-2)"	"unprognostic (9.89e-3)"	"unprognostic (7.51e-2)"	"unprognostic (8.89e-2)"	"unprognostic (1.84e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.73e-3)"	"unprognostic (6.82e-2)"	"unprognostic (8.12e-2)"	"prognostic unfavorable (2.13e-4)"	"unprognostic (1.39e-2)"	"unprognostic (1.20e-3)"	"unprognostic (1.42e-1)"	"unprognostic (1.84e-2)"	"unprognostic (5.75e-1)"	"unprognostic (1.29e-1)"	0.3	2.6	7.9	1.1	10.2	1.0	11.9	0.0	11.9	3.0	0.0	4.9	5.1	0.8	0.4	14.0	1.1	3.8	0.1	13.3	5.2	0.3	1.3	7.2	0.5	0.0	0.1	0.2	4.1	2.3	1.0	1.1	0.6	20.5	5.3	1.0	14.0	1.0	0.2	15.6	4.9	0.9	0.1	1.7	44.1	4.5	2.6	1.4	0.3	0.5	5.2	6.2	5.2	3.3	7.8	22.4	0.8	0.0	1.5	19.3	0.0	1.7	13.5	1.8	1.3	0.0	8.6	1.3	0.1	3.9	16.7	14.5	0.2	9.0	0.5	0.0	0.5	63.3	5.0	0.0	2.6	3.4	7.0	15.3	46.6	25.5	56.0	21.1	1.2	0.3	0.0	3.9	16.1	7.9	0.2	7.4	0.2	14.0	14.7	0.0	0.0	0.3	4.1	28.9	0.2	10.3	2.2	13.4	0.0	0.1	8.3	0.3	0.3	18.8	0.6	9.8	2.0	0.4	0.0	0.0	165.2	35.6	0.9	0.6	0.0	0.1	2.2	0.0	0.5	0.0	0.7	1.1	0.0	0.0	0.2	1.0	0.2	2.6	0.0	0.0	0.0	1.6	7.9	10.2	0.0	11.9	13.3	5.2	0.0	0.1	0.6	0.1	2.6	3.3	0.3	48.1	37.6	3.3	0.9	25.6	8.6	18.2	8.0	2.4	59.8	25.3	0.5	8.6	36.9	5.5	2.1	6.5	15.0	5.7	1.9	7.2	259.3	30.9	4.4	1.9	4.2	3.4	101.0	41.0	4.5	2.0	178.4	64.0	246.6	0.4	2.5	0.9	0.6	6.7	75.8	31.3	20.3	0.6	2.7	209.9	2.1	38.1	7.2	2.8	2.1	1.4	29.9	98.5	2.6	34.0	18.6	0.4	3.2	78.9	3.0	0.0	15.8	0.4	6.6	0.3	2.2	7.9	1.4	79.2	49.2	2.9	13.9	0.5	7.9	42.2
RAB29	"RAB7L, RAB7L1"	ENSG00000117280	"RAB29, member RAS oncogene family"	O14966	1	205767986-205775482	"Predicted intracellular proteins"	"Differentiation, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 73.1"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 82.3;monocytes: 76.4;NK-cells: 129.8;Proximal tubular cells: 187.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB020822, HPA026303"	Approved		Supported	Vesicles,Cytosol		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Vesicles, Cytosol"		"CAB020822: , HPA026303: AB_1856016"	"unprognostic (5.38e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.45e-1)"	"prognostic unfavorable (1.82e-5)"	"unprognostic (9.50e-2)"	"unprognostic (1.56e-1)"	"prognostic unfavorable (1.61e-4)"	"unprognostic (2.60e-2)"	"unprognostic (3.14e-1)"	"unprognostic (5.50e-2)"	"unprognostic (2.45e-1)"	"unprognostic (3.05e-2)"	"unprognostic (1.06e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.53e-1)"	"unprognostic (8.20e-3)"	"unprognostic (1.42e-1)"	13.5	14.4	12.5	20.4	14.1	7.1	14.1	14.3	12.1	8.7	10.5	12.6	10.6	8.3	23.8	7.8	6.2	16.9	13.1	12.3	14.3	73.1	19.4	13.5	35.1	15.9	12.9	7.9	9.2	25.5	5.9	7.2	15.8	13.8	10.1	6.8	19.8	13.9	6.4	5.5	12.4	14.8	14.3	24.3	10.4	4.6	15.3	12.1	33.4	6.0	28.0	15.7	5.7	17.0	20.4	18.6	2.8	13.1	52.5	29.8	9.7	14.1	43.2	28.9	34.4	5.6	28.7	21.6	13.6	24.3	34.6	11.2	32.8	37.3	26.4	88.3	15.3	16.4	7.3	9.5	25.4	16.1	23.2	29.0	24.6	23.3	32.8	24.0	37.2	19.8	16.2	24.2	41.2	7.6	17.7	8.3	13.1	25.4	14.0	3.7	43.1	17.5	33.6	27.7	4.4	12.5	10.0	45.0	37.8	10.3	22.0	13.2	38.7	29.7	15.0	43.5	20.6	39.4	87.0	11.5	30.1	26.3	22.5	92.4	22.6	62.3	92.2	43.8	86.9	50.8	51.0	79.5	33.4	45.8	37.2	63.5	8.8	94.1	53.9	10.4	53.3	51.3	12.5	14.1	14.3	12.1	12.3	14.3	15.9	12.9	15.8	14.3	15.3	17.0	16.3	19.2	17.7	11.1	61.2	0.0	6.3	0.0	13.6	2.1	19.5	16.0	19.3	21.5	6.2	31.3	0.0	12.0	82.3	1.9	29.4	18.7	5.1	2.0	6.3	18.6	4.9	10.8	7.8	10.1	6.4	11.2	10.7	3.5	13.3	9.2	14.6	33.7	32.8	0.0	10.2	3.7	0.0	30.1	0.0	4.1	14.3	34.0	0.0	10.3	76.4	26.5	129.8	10.6	9.8	8.3	4.8	20.7	34.8	10.7	9.5	187.7	2.9	2.0	6.6	10.0	6.7	3.8	11.8	9.3	0.0	2.9	51.7	19.7	5.5	6.9
RAB3GAP2	"DKFZP434D245, KIAA0839, RAB3-GAP150, SPG69"	ENSG00000118873	"RAB3 GTPase activating non-catalytic protein subunit 2"	Q9H2M9	1	220148293-220272453	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		"GTPase activation"	"Cataract, Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026273, HPA027299"	Approved		Supported	"Plasma membrane,Cytosol"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	Cytosol	"Plasma membrane"	"HPA026273: AB_1856007, HPA027299: AB_1856008"	"prognostic unfavorable (3.05e-4)"	"unprognostic (2.80e-3)"	"unprognostic (1.76e-2)"	"unprognostic (6.07e-2)"	"unprognostic (5.20e-2)"	"unprognostic (1.69e-1)"	"unprognostic (2.40e-2)"	"unprognostic (7.00e-2)"	"unprognostic (4.61e-2)"	"unprognostic (1.75e-1)"	"unprognostic (4.63e-2)"	"unprognostic (2.13e-1)"	"unprognostic (7.75e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.17e-1)"	"unprognostic (3.99e-2)"	"unprognostic (1.56e-1)"	10.1	9.0	6.3	9.6	6.7	10.2	11.2	11.4	7.8	8.7	23.5	8.8	7.8	9.4	8.4	9.0	7.0	7.9	9.3	7.3	9.3	11.7	10.0	8.6	12.6	6.7	6.9	9.6	8.6	18.6	6.2	11.5	9.0	8.5	8.3	18.1	9.2	7.9	8.7	7.9	7.8	9.3	5.7	9.2	9.4	6.6	7.5	13.1	12.8	12.2	14.4	9.1	6.0	9.1	21.3	15.8	18.9	14.3	21.2	25.1	21.4	21.4	20.3	18.9	22.2	14.7	17.3	26.4	14.8	20.9	14.3	19.9	19.8	16.4	21.8	22.1	12.9	20.6	21.5	13.8	27.9	29.8	20.3	20.0	18.4	18.5	28.5	21.2	17.6	11.4	36.2	16.6	21.6	6.0	23.0	10.5	40.8	11.4	9.3	12.5	26.0	23.7	16.1	17.3	18.8	22.7	22.2	21.4	35.3	20.3	22.4	28.0	25.7	20.6	9.6	14.4	23.2	14.6	19.2	22.8	17.7	24.6	24.8	10.0	2.8	5.6	4.8	3.6	5.9	4.8	4.7	6.2	3.8	3.8	4.1	4.9	1.8	2.8	3.9	2.4	6.0	3.3	6.3	6.7	11.4	7.8	7.3	9.3	6.7	6.9	9.0	5.7	7.5	9.1	28.5	41.7	21.9	60.7	30.4	11.6	13.6	15.8	17.6	57.9	18.9	16.3	34.8	32.9	23.4	25.8	68.8	18.5	30.6	23.8	5.9	17.4	4.3	21.4	27.7	22.3	35.4	18.7	106.8	16.7	13.5	23.4	20.4	28.5	19.6	40.8	28.9	24.2	25.4	42.1	105.1	22.1	16.2	29.0	9.4	2.8	18.0	22.2	14.2	68.4	25.2	39.8	26.8	82.0	81.5	21.7	14.2	25.9	24.7	21.0	19.4	14.9	17.2	50.5	6.6	24.1	20.4	17.7	13.6	17.5	9.8	23.1	27.1	23.6	19.3	13.2
RAB41		ENSG00000147127	"RAB41, member RAS oncogene family"	Q5JT25	X	70282093-70285002	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	16	"retina: 65.5"	"Cell type enriched"	"Detected in some"	19	"Cone photoreceptor cells: 533.8"	"Cancer enhanced"	"Detected in some"		"glioma: 2.5"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"U-2197: 3.7;U-87 MG: 4.6"									"HPA001510, HPA065289"	Uncertain		Supported	"Vesicles,Plasma membrane,Cytosol"		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 79: Retina - Phototransduction"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 9: Photoreceptor cells - Phototransduction"	Cytosol	"Vesicles, Plasma membrane"	"HPA001510: AB_1079733, HPA065289: "	"unprognostic (1.32e-1)"	"unprognostic (1.39e-1)"	"unprognostic (3.36e-3)"	"unprognostic (4.25e-3)"	"unprognostic (1.18e-1)"	"unprognostic (3.46e-2)"	"unprognostic (6.33e-3)"	"unprognostic (1.85e-3)"	"unprognostic (1.38e-1)"	"unprognostic (2.68e-2)"	"unprognostic (2.20e-2)"	"unprognostic (1.04e-3)"	"unprognostic (7.63e-2)"	"unprognostic (2.39e-1)"	"unprognostic (9.78e-3)"	"unprognostic (8.42e-2)"	"unprognostic (9.89e-2)"	0.2	0.8	0.5	0.5	0.6	0.4	0.1	0.3	0.9	0.1	0.0	0.3	0.4	0.2	0.0	0.3	0.2	0.5	0.6	0.3	0.4	0.3	0.1	0.3	0.5	0.5	0.5	0.8	0.1	0.0	0.2	0.2	0.4	0.2	0.0	65.5	1.0	0.0	0.5	1.3	0.7	0.0	0.4	0.5	0.2	4.0	1.0	0.0	0.8	0.0	0.0	0.3	0.1	0.5	0.5	0.5	1.3	0.5	0.0	0.0	0.5	0.5	0.0	0.0	0.0	0.6	0.5	0.6	1.1	0.0	1.1	0.6	0.0	0.0	0.0	0.8	1.3	0.1	1.4	0.0	0.0	0.2	0.6	0.0	0.0	0.0	0.0	1.7	0.0	0.8	0.5	1.2	0.0	0.3	0.8	0.5	0.8	1.7	1.7	0.3	0.9	0.9	0.0	0.4	0.8	1.5	0.5	0.3	1.5	0.6	0.3	1.4	1.6	0.6	0.7	3.7	0.8	0.7	1.1	0.8	4.6	1.1	1.1	0.0	0.0	0.0	0.1	0.2	0.3	0.2	0.1	0.1	0.3	0.4	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.5	0.6	0.3	0.9	0.3	0.4	0.5	0.5	0.4	0.4	1.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.3	0.0	0.0	0.0	533.8	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.6	0.6	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.5	0.0	0.0	0.0	28.0	8.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0
RAB5B		ENSG00000111540	"RAB5B, member RAS oncogene family"	P61020	12	55973913-55996683	"Predicted intracellular proteins, RAS pathway related proteins"	"Protein transport, Transport"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB010224, HPA068337"	Approved		Supported	Vesicles		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 22: Epithelial cell types - Mixed function"	Vesicles		"CAB010224: AB_2175453, HPA068337: AB_2685974"	"prognostic unfavorable (2.24e-5)"	"unprognostic (1.86e-1)"	"unprognostic (1.91e-1)"	"unprognostic (7.66e-3)"	"unprognostic (2.09e-1)"	"unprognostic (8.42e-2)"	"unprognostic (9.16e-3)"	"unprognostic (3.09e-1)"	"unprognostic (3.13e-1)"	"unprognostic (8.31e-3)"	"unprognostic (8.64e-2)"	"unprognostic (2.26e-1)"	"unprognostic (2.27e-2)"	"unprognostic (2.46e-2)"	"unprognostic (2.74e-1)"	"unprognostic (2.85e-1)"	"unprognostic (2.49e-1)"	50.9	54.4	95.4	39.4	102.3	35.0	68.2	106.2	96.8	76.8	76.5	72.2	52.4	73.8	92.4	99.8	75.7	55.8	87.2	93.1	99.5	70.1	68.8	72.9	44.5	103.5	105.6	85.4	47.9	112.1	31.4	63.4	106.0	74.6	80.6	72.9	61.7	94.6	100.6	92.4	50.4	79.9	103.6	48.1	67.0	57.1	99.9	64.0	64.6	127.6	76.0	65.6	69.6	112.9	62.3	39.1	80.2	59.4	128.5	115.9	72.1	56.1	102.3	68.3	57.5	67.5	76.7	34.7	65.5	107.6	50.3	44.8	51.4	77.8	63.3	44.1	39.5	39.3	53.1	38.6	94.5	33.2	61.6	94.9	142.7	64.2	54.2	153.0	87.0	42.2	36.2	99.3	87.3	42.3	42.6	51.9	35.8	51.5	35.2	36.5	49.9	45.1	128.2	100.7	40.0	35.6	73.1	72.4	89.0	88.3	104.6	102.5	72.3	44.5	32.5	32.8	22.2	56.4	46.9	21.8	71.5	30.7	38.4	18.5	10.1	32.6	11.1	9.3	10.3	8.9	9.0	9.9	8.0	6.9	10.2	8.0	27.4	7.6	10.6	8.0	7.6	8.9	95.4	102.3	106.2	96.8	93.1	99.5	103.5	105.6	106.0	103.6	99.9	112.9	24.4	57.7	37.1	13.1	26.7	51.7	26.5	34.0	35.3	33.3	54.4	38.2	53.2	55.8	34.0	42.3	52.1	44.0	29.1	88.1	35.2	49.4	11.1	24.1	22.8	30.8	38.9	29.8	21.4	37.1	42.8	33.1	37.2	33.9	19.7	34.1	42.1	86.0	31.1	16.8	23.4	51.1	16.2	46.4	52.3	27.7	53.4	25.4	35.6	11.2	64.7	41.6	32.0	11.1	26.3	71.3	44.4	59.5	27.1	57.0	44.7	35.9	23.9	31.6	59.2	31.9	33.2	36.8	25.6	64.7	89.2	88.0	25.0	23.4	42.7	65.8
RAB7A	"CMT2B, RAB7"	ENSG00000075785	"RAB7A, member RAS oncogene family"	P51149	3	128693669-128825942	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Autophagy, Host-virus interaction, Lipid degradation, Lipid metabolism, Protein transport, Transport"	Hydrolase	"Charcot-Marie-Tooth disease, Disease variant, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006964, CAB037131"	Supported		Supported	Lysosomes		NA	NA		5700000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 59: Non-specific - Translation"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	Lysosomes		"CAB037131: AB_477460, HPA006964: AB_1856015"	"unprognostic (1.99e-2)"	"unprognostic (9.03e-2)"	"unprognostic (1.41e-2)"	"prognostic unfavorable (1.52e-4)"	"unprognostic (1.45e-1)"	"unprognostic (7.82e-2)"	"prognostic unfavorable (9.89e-6)"	"unprognostic (2.15e-2)"	"unprognostic (2.38e-1)"	"unprognostic (3.50e-1)"	"prognostic unfavorable (4.63e-4)"	"unprognostic (4.69e-1)"	"unprognostic (6.73e-3)"	"unprognostic (1.88e-1)"	"unprognostic (1.97e-1)"	"unprognostic (3.03e-3)"	"unprognostic (5.64e-3)"	170.6	157.1	120.1	101.4	132.2	99.9	149.5	133.4	159.4	138.3	123.7	128.9	108.3	137.4	143.0	188.2	110.1	109.7	186.8	128.9	138.4	131.8	145.2	152.9	108.8	138.8	142.0	122.7	88.6	155.9	101.5	117.5	139.4	101.3	126.0	103.8	133.3	63.9	332.4	164.9	116.8	124.0	135.9	123.0	114.9	61.5	140.3	124.6	122.5	249.7	136.6	144.4	143.4	159.0	280.2	95.5	146.0	78.3	300.6	94.0	126.0	252.8	183.9	164.4	158.8	170.1	179.2	134.2	163.2	236.2	289.9	163.4	175.2	248.6	99.2	149.4	111.7	294.3	83.6	165.8	303.0	269.4	182.5	243.7	104.0	176.7	204.4	220.7	89.2	114.4	143.4	148.0	108.1	213.1	176.8	294.6	121.4	294.8	144.8	140.2	130.7	170.4	85.7	205.4	105.8	138.5	142.1	194.7	405.4	174.9	180.3	254.8	202.9	192.7	98.0	325.7	125.9	184.4	187.0	192.0	312.7	212.1	235.5	194.9	176.8	213.6	92.1	192.3	92.3	93.2	97.4	94.5	200.0	85.8	94.8	93.6	374.2	128.8	204.0	81.8	120.7	201.3	120.1	132.2	133.4	159.4	128.9	138.4	138.8	142.0	139.4	135.9	140.3	159.0	154.4	89.8	81.8	66.9	109.9	296.7	331.2	218.1	104.7	66.0	112.8	73.0	110.7	90.1	129.4	132.4	18.8	230.0	92.3	222.1	240.7	259.6	11.2	90.8	90.8	165.3	96.9	111.3	83.9	198.9	283.4	172.5	79.0	142.4	146.2	46.5	142.8	127.9	403.9	74.0	82.5	122.8	219.7	208.6	379.9	19.6	133.6	242.8	339.7	99.3	220.9	154.6	121.5	80.9	111.4	303.7	185.0	157.2	79.9	279.2	172.7	332.3	118.7	37.6	138.1	107.7	160.5	116.4	100.4	122.8	308.0	497.9	107.7	109.6	103.5	324.6
RAB8A	"MEL, RAB8"	ENSG00000167461	"RAB8A, member RAS oncogene family"	P61006	19	16111889-16134234	"Predicted intracellular proteins"	"Autophagy, Cilium biogenesis/degradation, Protein transport, Transport"		Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041945			Approved	"Nucleoplasm,Plasma membrane"		No	No		4800000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 9: Intestine - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 51: Myeloid cells - Hemostasis"	"Nucleoplasm, Plasma membrane"		"HPA041945: "	"unprognostic (1.10e-1)"	"unprognostic (3.95e-3)"	"unprognostic (1.98e-2)"	"unprognostic (2.59e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.11e-1)"	"unprognostic (2.57e-1)"	"unprognostic (1.14e-2)"	"unprognostic (2.52e-3)"	"unprognostic (1.29e-2)"	"prognostic unfavorable (6.56e-5)"	"unprognostic (6.60e-2)"	"unprognostic (7.25e-2)"	"prognostic favorable (1.71e-4)"	"unprognostic (9.99e-2)"	21.3	24.5	17.4	40.4	17.5	61.3	18.7	19.5	17.6	24.6	20.7	37.4	58.5	18.5	18.9	25.9	27.8	22.0	11.5	17.2	19.1	20.8	51.5	28.6	44.3	21.1	19.5	21.5	23.4	17.7	15.3	25.0	21.6	21.7	32.8	8.7	30.7	21.2	7.0	27.5	58.7	22.8	20.3	40.4	32.4	15.4	19.0	34.3	16.3	8.1	45.1	25.9	21.2	23.3	94.2	62.6	50.5	43.0	42.7	36.7	77.9	56.0	48.8	74.2	76.8	76.1	105.7	66.1	61.9	58.6	63.5	60.6	71.2	69.1	50.9	132.6	39.9	135.9	57.1	75.6	46.7	119.4	129.3	36.6	37.6	69.5	32.1	38.9	63.5	65.0	64.4	97.0	63.4	111.6	100.1	113.7	63.3	114.3	100.5	111.6	56.2	115.6	58.2	71.9	46.9	45.3	56.6	68.0	35.9	34.2	53.8	44.2	61.7	61.4	39.2	119.2	96.6	51.4	113.4	97.3	58.7	121.5	67.0	244.5	278.6	315.0	164.3	387.5	145.7	190.5	143.3	147.5	247.5	190.0	112.5	131.7	292.2	225.9	485.1	177.8	150.9	514.1	17.4	17.5	19.5	17.6	17.2	19.1	21.1	19.5	21.6	20.3	19.0	23.3	47.2	25.6	29.1	2.3	70.2	47.7	47.4	53.5	31.3	15.2	37.0	34.7	3.0	17.2	35.7	31.3	14.6	95.7	97.9	115.9	82.2	70.7	31.0	33.7	29.7	37.3	30.4	47.5	4.2	51.5	98.6	36.3	29.6	45.0	48.7	36.2	26.0	50.3	88.9	6.7	3.5	55.3	48.8	50.6	81.5	19.0	27.7	100.9	33.8	2.8	124.8	34.9	131.8	3.0	8.8	76.8	90.0	24.8	96.5	30.7	130.7	62.6	35.4	13.9	32.9	22.0	38.1	33.3	23.4	30.4	52.6	79.6	64.8	43.4	52.0	38.4
RABEP1	"neurocrescin, RAB5EP, rabaptin-5, RABPT5"	ENSG00000029725	"Rabaptin, RAB GTPase binding effector protein 1"	Q15276	17	5282265-5386340	"Cancer-related genes, Predicted intracellular proteins"	"Apoptosis, Endocytosis, Protein transport, Transport"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004549, HPA019669, HPA024235, HPA024691"	Supported		Supported	Vesicles		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Vesicles		"CAB004549: AB_628192, HPA019669: AB_1856019, HPA024235: AB_1856020, HPA024691: AB_1856021"	"unprognostic (3.22e-1)"	"unprognostic (2.90e-2)"	"unprognostic (2.45e-1)"	"unprognostic (8.75e-3)"	"unprognostic (1.64e-1)"	"unprognostic (8.25e-2)"	"unprognostic (3.71e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.60e-2)"	"unprognostic (7.73e-2)"	"prognostic favorable (6.43e-4)"	"unprognostic (1.14e-1)"	"unprognostic (6.09e-3)"	"unprognostic (7.67e-2)"	"unprognostic (2.60e-1)"	"unprognostic (1.00e-1)"	"unprognostic (9.00e-3)"	30.1	23.6	39.1	23.2	45.8	17.1	43.9	41.0	49.3	22.2	32.0	21.1	16.5	26.8	25.1	18.5	16.7	21.7	32.4	37.9	46.7	23.5	32.8	19.5	33.5	43.1	44.8	21.7	18.0	48.0	19.7	30.8	44.2	31.0	20.7	58.2	22.7	21.8	68.5	16.3	18.9	27.5	43.5	28.3	24.0	18.8	43.7	37.3	25.8	52.4	40.3	23.1	15.2	50.7	45.5	57.5	59.6	33.3	60.9	60.5	31.2	58.3	44.5	61.8	58.5	51.4	19.7	98.3	46.0	61.2	35.0	35.9	87.8	50.0	86.4	60.7	75.0	60.9	73.1	39.4	56.4	41.3	37.9	47.2	33.3	59.6	76.5	37.7	54.4	49.9	52.3	48.3	54.2	32.7	66.1	30.4	26.8	25.8	24.9	61.2	70.8	32.4	30.6	43.1	25.3	39.4	52.4	52.8	49.5	52.3	95.9	17.2	46.9	53.1	24.2	52.6	69.6	26.9	31.0	52.4	41.2	62.3	37.5	14.9	21.1	22.4	25.0	22.7	21.9	80.4	19.5	24.0	22.6	96.7	24.6	21.5	30.4	22.6	50.9	35.0	20.0	16.6	39.1	45.8	41.0	49.3	37.9	46.7	43.1	44.8	44.2	43.5	43.7	50.7	36.4	35.3	45.1	57.5	53.8	24.0	30.1	17.0	25.6	51.5	87.3	46.0	91.1	14.3	32.9	18.4	39.6	39.7	47.2	18.6	41.1	30.4	7.6	19.8	55.5	37.9	16.3	58.3	123.7	23.8	35.0	38.5	23.4	25.3	12.6	47.0	34.2	31.7	89.8	35.3	115.9	17.1	30.5	32.1	38.2	6.0	33.8	36.5	30.2	90.9	32.8	89.7	63.8	78.4	114.1	28.3	65.5	28.2	28.2	52.8	16.5	38.1	19.0	52.5	26.3	34.3	47.7	82.2	75.7	25.5	20.3	25.9	34.4	61.2	18.9	33.6
RABEP2	"FLJ23282, FRA"	ENSG00000177548	"Rabaptin, RAB GTPase binding effector protein 2"	Q9H5N1	16	28904421-28936526	"Predicted intracellular proteins"	"Cilium biogenesis/degradation, Endocytosis, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047641	Approved		Supported	Vesicles,Cytosol		NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 64: Macrophages - Immune response"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 57: B-cells - Immune response"	"Vesicles, Cytosol"		"HPA047641: AB_2680111"	"unprognostic (4.93e-2)"	"unprognostic (1.21e-2)"	"unprognostic (2.13e-2)"	"unprognostic (7.06e-2)"	"unprognostic (1.44e-1)"	"prognostic favorable (5.84e-4)"	"unprognostic (2.46e-1)"	"unprognostic (1.42e-1)"	"unprognostic (8.41e-2)"	"unprognostic (6.13e-2)"	"unprognostic (1.26e-3)"	"unprognostic (5.86e-2)"	"prognostic favorable (1.24e-6)"	"unprognostic (7.50e-2)"	"unprognostic (8.20e-2)"	"unprognostic (1.08e-1)"	"unprognostic (5.92e-3)"	7.3	21.5	7.3	25.1	8.8	11.5	9.3	8.2	9.2	11.0	10.7	15.0	16.8	8.4	2.7	18.7	7.0	6.6	16.8	6.5	7.9	19.2	10.6	10.1	46.7	10.7	8.5	6.3	17.9	11.5	16.4	5.3	8.4	28.6	4.6	3.5	17.5	7.0	6.5	23.6	28.3	3.4	7.9	47.9	14.4	6.2	8.2	5.3	13.9	3.2	9.4	12.5	12.3	8.5	13.5	21.1	5.6	10.5	3.3	4.7	10.1	15.5	9.2	10.9	10.7	15.9	12.0	27.7	23.7	6.5	4.4	17.8	2.2	9.9	2.1	9.5	9.9	10.5	17.0	21.7	6.5	7.7	32.1	7.9	8.0	13.5	2.4	6.3	15.5	7.4	4.9	9.7	8.5	31.9	9.5	17.8	7.3	5.4	11.4	33.6	5.1	17.4	7.5	17.5	8.6	11.1	7.6	34.8	7.0	1.2	27.6	15.9	27.5	16.4	8.4	12.1	15.6	15.3	5.0	20.7	17.3	18.2	12.6	0.9	2.8	2.4	3.5	2.9	2.4	12.1	2.5	3.2	3.7	15.0	2.2	2.1	0.7	5.5	3.3	2.2	2.2	2.8	7.3	8.8	8.2	9.2	6.5	7.9	10.7	8.5	8.4	7.9	8.2	8.5	11.5	3.2	10.0	4.9	42.4	5.1	14.7	14.6	17.6	11.1	13.3	11.0	1.9	11.5	12.9	20.2	35.5	26.1	21.0	35.0	17.6	16.0	0.7	9.2	8.2	14.2	17.3	6.5	4.8	20.9	7.1	9.0	23.0	10.0	18.4	12.1	7.9	4.2	12.4	15.2	6.5	33.7	18.3	8.4	11.3	1.3	4.1	10.5	10.6	9.4	11.6	8.6	22.6	5.0	8.4	20.0	44.1	6.4	21.4	15.4	32.3	11.6	8.0	43.4	13.1	7.9	9.6	4.3	6.0	16.6	8.4	22.0	14.5	22.6	26.7	19.0
RABGEF1	"rabex-5, RABEX5"	ENSG00000154710	"RAB guanine nucleotide exchange factor 1"	Q9UJ41	7	66682164-66811464	"Predicted intracellular proteins, Transporters"	"Endocytosis, Protein transport, Transport, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 76.7"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 91.4;Excitatory neurons: 124.5;Inhibitory neurons: 151.1;Oligodendrocyte precursor cells: 100.5;Oligodendrocytes: 244.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001407			Supported	Nucleoli,Cytosol		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Cytosol	Nucleoli	"HPA001407: AB_1856024"	"unprognostic (6.65e-2)"	"unprognostic (6.44e-4)"	"unprognostic (7.32e-2)"	"unprognostic (1.61e-1)"	"prognostic unfavorable (4.06e-5)"	"unprognostic (3.77e-1)"	"unprognostic (2.08e-2)"	"unprognostic (1.41e-1)"	"unprognostic (8.51e-2)"	"unprognostic (3.32e-1)"	"unprognostic (4.64e-4)"	"unprognostic (6.45e-2)"	"prognostic favorable (1.27e-4)"	"unprognostic (1.43e-1)"	"unprognostic (5.55e-1)"	"unprognostic (2.83e-1)"	"unprognostic (1.39e-1)"	16.2	14.1	15.0	11.2	14.9	76.7	13.0	14.9	18.8	13.1	15.6	10.7	8.0	11.5	10.0	19.6	8.8	14.2	9.8	15.2	16.1	11.5	14.8	10.5	11.5	15.6	14.7	12.0	9.7	14.8	4.4	13.2	15.3	12.0	11.9	49.8	8.6	17.3	13.0	23.9	9.2	12.4	14.3	9.4	10.5	25.1	15.5	13.2	15.9	13.3	16.9	19.1	14.1	17.6	47.5	10.2	10.0	16.9	32.1	45.2	10.4	40.9	52.8	42.6	40.2	12.2	28.5	22.4	13.9	60.7	28.2	17.7	16.8	22.3	59.0	14.9	11.2	12.5	14.6	11.8	25.5	21.5	16.9	22.2	28.5	54.9	60.4	33.2	11.3	13.7	21.6	13.9	42.9	19.2	13.2	27.7	15.0	20.2	19.3	12.2	20.1	14.7	37.4	19.5	12.2	17.8	16.8	37.5	19.6	15.6	19.4	12.3	14.0	65.8	12.2	42.4	32.0	19.8	28.7	25.1	31.6	23.0	18.6	18.3	6.5	7.8	7.4	5.7	8.1	9.1	6.3	8.9	6.1	12.5	6.3	6.3	11.8	13.8	12.9	8.1	5.1	6.4	15.0	14.9	14.9	18.8	15.2	16.1	15.6	14.7	15.3	14.3	15.5	17.6	7.3	12.8	12.8	91.4	11.5	4.1	11.4	3.2	10.2	9.9	11.5	7.7	4.8	4.3	10.9	5.5	16.7	3.8	13.2	10.0	11.7	5.4	5.4	13.6	12.5	5.7	18.0	3.0	124.5	5.5	3.8	14.6	8.6	22.0	14.0	8.8	5.7	8.0	4.8	8.4	151.1	4.3	2.0	15.2	5.0	2.8	5.9	19.9	1.8	60.9	6.2	5.5	7.2	100.5	244.1	18.1	13.4	9.4	15.2	13.4	4.4	5.5	11.9	18.9	0.0	10.6	8.5	8.4	6.5	8.3	6.7	13.5	9.5	7.0	5.5	12.3
RABL6	"bA216L13.9, C9orf86, FLJ10101, FLJ13045, Parf, pp8875, RBEL1"	ENSG00000196642	"RAB, member RAS oncogene family like 6"	Q3YEC7	9	136807943-136841187	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 172.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044037	Uncertain		Approved	Centrosome,Cytosol		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Cytosol	Centrosome	"HPA044037: AB_10966437"	"unprognostic (3.10e-3)"	"unprognostic (8.52e-3)"	"unprognostic (1.20e-1)"	"prognostic favorable (4.00e-4)"	"unprognostic (9.23e-2)"	"unprognostic (2.44e-2)"	"unprognostic (1.90e-3)"	"unprognostic (7.55e-3)"	"unprognostic (1.65e-1)"	"unprognostic (4.92e-2)"	"prognostic favorable (1.46e-4)"	"unprognostic (5.23e-2)"	"unprognostic (1.03e-3)"	"prognostic favorable (9.14e-4)"	"unprognostic (4.08e-1)"	"unprognostic (3.03e-2)"	"unprognostic (2.15e-1)"	37.5	45.5	49.9	29.8	67.2	51.9	35.9	43.7	69.2	33.5	30.2	59.9	39.8	38.5	10.7	57.4	36.4	15.3	86.3	47.6	35.6	55.3	24.3	41.7	26.9	47.8	41.0	39.5	101.5	22.7	69.9	21.0	41.8	67.4	21.2	15.3	42.8	20.1	154.5	45.7	51.6	16.2	35.6	50.3	61.7	50.0	47.2	28.2	42.1	60.9	18.2	43.7	35.0	45.9	75.2	97.9	68.4	80.3	27.5	30.7	178.5	65.8	42.2	63.1	45.9	109.7	77.2	104.7	40.5	52.0	66.4	159.9	76.8	58.6	21.5	110.1	97.5	64.5	127.2	129.9	49.4	120.6	79.4	34.2	59.6	39.0	42.8	38.3	66.4	88.8	142.0	50.0	43.9	149.5	130.2	82.9	128.0	91.3	82.4	167.4	81.6	103.1	41.5	65.7	223.5	92.5	117.2	135.6	83.5	36.1	116.8	120.1	81.1	80.9	69.8	86.5	109.1	42.3	51.8	85.5	68.2	57.8	77.5	0.5	1.8	1.2	1.4	2.4	1.5	2.2	1.5	1.4	1.3	2.0	1.2	1.5	0.9	2.3	0.8	1.7	2.3	0.6	49.9	67.2	43.7	69.2	47.6	35.6	47.8	41.0	41.8	35.6	47.2	45.9	36.2	28.9	41.2	24.5	25.5	18.0	17.7	12.6	38.7	39.5	38.7	33.4	35.3	0.0	13.8	25.8	20.9	25.2	35.3	172.7	31.3	34.9	13.4	42.6	40.6	25.7	52.0	25.6	37.7	58.2	33.2	28.1	43.3	43.8	15.2	85.2	0.0	0.0	31.0	38.7	34.3	78.5	20.3	0.0	26.5	18.5	19.6	37.0	40.9	8.4	27.5	22.2	24.7	18.1	26.9	62.5	80.9	26.7	67.7	36.6	59.4	55.8	18.3	38.3	0.0	19.0	33.3	18.1	28.0	55.3	19.5	28.3	29.6	41.0	94.9	26.5
RAC1	"p21-Rac1, Rac-1, TC-25"	ENSG00000136238	"Rac family small GTPase 1"	P63000	7	6374527-6403967	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins"		Hydrolase	"Cancer-related genes, Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Urothelial cells: 1980.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB035994, HPA047820"	Approved		Approved	Nucleoplasm,Nucleoli,Cytosol		NA	NA		3900000	"Cluster 26: Non-specific - Mitochondria"	"Cluster 70: Brain - Nervous system development"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 22: Epithelial cell types - Mixed function"	"Nucleoplasm, Cytosol"	Nucleoli	"CAB035994: , HPA047820: AB_2680167"	"unprognostic (8.66e-3)"	"unprognostic (2.47e-1)"	"unprognostic (4.00e-1)"	"unprognostic (2.40e-2)"	"unprognostic (1.88e-3)"	"unprognostic (4.06e-2)"	"prognostic unfavorable (1.74e-5)"	"prognostic unfavorable (4.59e-4)"	"unprognostic (1.59e-1)"	"unprognostic (2.04e-1)"	"prognostic unfavorable (4.57e-5)"	"unprognostic (3.63e-1)"	"prognostic unfavorable (2.11e-4)"	"unprognostic (1.95e-1)"	"unprognostic (2.11e-2)"	"unprognostic (4.13e-2)"	"unprognostic (8.72e-3)"	157.4	108.0	237.0	96.8	250.4	94.5	146.4	242.4	290.7	154.8	206.5	190.5	167.4	150.7	149.9	316.9	145.1	125.9	129.4	240.2	240.6	150.5	136.2	147.5	96.4	249.4	244.8	135.8	92.2	151.1	77.5	180.2	249.2	122.8	199.6	52.2	137.9	145.0	179.5	189.2	161.9	179.3	260.2	96.6	160.6	51.6	241.1	115.3	127.2	141.1	169.6	205.3	188.6	262.9	519.9	230.9	233.0	255.1	270.1	341.8	138.6	284.9	348.0	371.6	375.8	227.3	474.8	145.5	179.7	400.9	384.2	359.4	251.5	345.9	471.9	68.3	207.8	146.6	171.7	166.5	323.7	134.0	114.6	229.7	302.8	268.4	297.6	281.7	333.4	141.3	266.2	111.7	406.4	377.3	74.0	312.4	419.1	261.9	272.3	129.2	236.9	214.6	481.7	322.7	175.8	295.9	201.7	726.1	241.4	264.7	409.6	396.3	341.8	242.4	364.3	300.7	334.5	84.1	99.5	135.4	223.9	250.9	470.6	31.0	117.3	63.0	23.8	83.0	15.1	46.8	26.8	30.9	112.8	49.9	33.0	21.8	168.6	26.1	83.5	64.5	46.1	47.0	237.0	250.4	242.4	290.7	240.2	240.6	249.4	244.8	249.2	260.2	241.1	262.9	755.4	147.4	123.6	28.7	155.9	934.1	981.6	232.1	429.2	90.4	485.3	593.8	200.6	484.7	164.8	356.8	25.0	802.8	224.1	920.9	536.1	183.5	77.6	388.7	362.9	641.2	336.7	313.3	43.3	174.2	1064.1	415.9	305.3	422.8	130.9	325.4	580.8	367.1	832.0	146.4	35.3	632.9	179.0	811.3	1066.7	58.8	476.3	705.7	458.9	66.5	607.2	341.1	191.6	23.1	56.7	299.1	754.4	472.8	212.2	1495.5	816.4	832.0	214.1	64.2	479.9	346.6	466.6	216.6	373.1	774.5	1148.6	845.4	180.0	353.6	573.7	1980.7
RACK1	"Gnb2-rs1, GNB2L1, H12.3"	ENSG00000204628	"Receptor for activated C kinase 1"	P63244	5	181236897-181248096	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins, Transporters"	"Apoptosis, Biological rhythms, Cell cycle, Gastrulation, Growth regulation, Host-virus interaction, Translation regulation"	"Developmental protein, Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Breast glandular cells: 3642.0;Breast myoepithelial cells: 3742.9;Cytotrophoblasts: 3252.2;Exocrine glandular cells: 3361.4;Extravillous trophoblasts: 4389.3;Syncytiotrophoblasts: 3206.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004288, HPA021676"	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA		630000	"Cluster 30: Non-specific - Translation"	"Cluster 50: Non-specific - Ribosome"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm	Cytosol	"CAB004288: AB_2247471, HPA021676: AB_1849868"	"unprognostic (4.02e-2)"	"unprognostic (2.94e-1)"	"unprognostic (2.58e-1)"	"unprognostic (2.03e-2)"	"unprognostic (1.07e-2)"	"unprognostic (7.43e-2)"	"prognostic unfavorable (2.98e-6)"	"unprognostic (4.19e-1)"	"unprognostic (3.04e-1)"	"unprognostic (2.00e-1)"	"unprognostic (2.07e-1)"	"unprognostic (3.81e-1)"	"unprognostic (1.05e-3)"	"unprognostic (3.67e-1)"	"unprognostic (1.78e-1)"	"unprognostic (3.50e-1)"	"unprognostic (2.62e-1)"	873.7	718.9	473.2	701.4	488.1	1590.2	1435.8	482.6	527.4	1091.1	505.6	1033.5	747.7	884.8	989.4	1154.9	1366.8	732.8	676.4	457.2	487.8	641.2	817.0	631.4	1358.7	519.6	485.3	2527.6	1504.7	721.7	582.6	763.8	514.8	716.2	922.6	286.5	1204.1	638.1	1167.2	1242.9	788.2	823.6	514.0	821.7	753.6	230.4	490.2	1703.2	820.4	1152.2	1590.1	1026.2	896.4	532.7	1606.0	1783.0	1498.7	2930.0	2671.8	4139.8	2576.4	1409.8	2832.1	2364.7	2463.4	3845.9	1671.3	3592.6	1735.5	2068.5	1668.5	1216.3	1867.9	6501.5	1729.1	3457.2	3068.4	1205.2	1939.5	2508.6	3610.1	3145.0	1193.1	4375.7	3664.7	1935.6	3427.8	2880.2	2705.8	2328.3	1610.6	2717.9	2117.6	3742.7	2435.7	2703.6	1535.1	1487.1	1504.9	2218.3	1536.5	3279.6	2733.5	2152.4	1969.8	2163.4	865.3	2682.2	4446.4	1015.6	1882.1	2802.9	2089.8	1297.4	1032.1	1029.1	2315.5	1767.8	2293.6	2063.5	1242.5	2470.7	1440.5	577.1	1163.9	290.3	829.2	908.1	1333.4	1732.3	1391.2	1062.0	1405.6	1689.0	1597.5	1348.6	138.6	1092.2	861.8	1037.0	1465.0	3377.9	473.2	488.1	482.6	527.4	457.2	487.8	519.6	485.3	514.8	514.0	490.2	532.7	896.6	576.9	935.7	0.0	698.1	0.0	0.0	0.0	0.0	0.0	3642.0	3742.9	0.0	0.0	452.5	498.4	0.0	3252.2	821.7	0.0	1749.1	1773.1	0.0	590.9	1560.3	523.7	0.0	0.0	0.0	3361.4	4389.3	783.3	0.0	818.8	671.1	1822.8	0.0	0.0	1964.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	669.4	0.0	0.0	1169.6	0.0	0.0	0.0	0.0	2097.2	0.0	0.0	200.2	0.0	0.0	2538.2	253.6	0.0	0.0	0.0	689.9	0.0	0.0	0.0	0.0	3206.0	503.5	2464.9	0.0	0.0
RAD1	"HRAD1, REC1"	ENSG00000113456	"RAD1 checkpoint DNA exonuclease"	O60671	5	34905260-34918989	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"DNA damage, DNA repair"	"Exonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006692	Approved		Approved	Nucleoplasm,Vesicles		NA	Yes			"Cluster 6: Non-specific - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 20: HeLa - Mitochondria"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Nucleoplasm, Vesicles"		"HPA006692: AB_2667645"	"prognostic unfavorable (6.30e-4)"	"unprognostic (1.85e-2)"	"unprognostic (9.40e-2)"	"unprognostic (1.98e-3)"	"unprognostic (2.00e-1)"	"unprognostic (2.38e-2)"	"prognostic unfavorable (1.06e-5)"	"unprognostic (1.22e-2)"	"unprognostic (2.25e-3)"	"unprognostic (1.61e-3)"	"unprognostic (2.57e-1)"	"unprognostic (2.57e-1)"	"unprognostic (2.22e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.72e-1)"	"unprognostic (2.11e-1)"	"unprognostic (3.12e-3)"	3.5	8.1	3.2	4.8	3.5	8.4	5.8	3.9	4.6	6.8	5.3	4.1	4.9	5.6	5.4	4.9	3.9	4.6	8.9	3.8	4.6	5.1	4.3	7.5	8.9	3.5	2.7	5.7	4.4	5.1	3.5	8.1	3.2	6.8	4.3	8.7	4.9	4.8	10.9	6.7	4.8	4.6	1.9	4.9	4.8	7.9	3.4	6.3	6.3	8.6	6.2	5.2	4.7	3.8	8.5	10.2	12.3	20.5	7.9	9.4	17.2	15.1	12.0	13.0	10.6	12.2	12.3	25.0	5.2	11.2	15.7	8.4	12.6	7.6	14.4	10.1	12.7	12.9	34.0	8.0	11.9	16.5	11.9	7.8	7.3	13.9	9.3	6.1	6.2	11.0	22.7	13.2	11.2	10.2	19.6	13.9	15.4	6.0	15.7	17.1	24.0	8.6	6.7	9.0	12.4	13.3	30.0	19.9	13.3	7.6	12.5	14.8	6.2	17.9	13.3	9.7	14.4	7.9	13.8	20.3	11.1	28.6	12.5	7.4	2.9	6.5	5.3	2.8	6.9	8.6	5.8	7.6	3.1	9.1	8.2	6.8	1.6	4.5	2.8	6.9	4.9	2.6	3.2	3.5	3.9	4.6	3.8	4.6	3.5	2.7	3.2	1.9	3.4	3.8	11.5	22.4	43.2	5.9	18.3	29.2	20.2	29.3	13.1	25.3	23.9	18.4	25.7	14.3	21.3	20.2	27.1	82.3	20.4	11.9	19.6	18.1	22.0	13.1	16.6	14.1	13.1	28.2	6.6	22.5	54.4	18.7	6.1	12.0	21.5	39.1	10.0	14.8	23.4	23.5	9.0	12.7	30.5	12.0	19.3	16.8	25.1	13.1	17.8	6.5	12.7	23.9	9.2	7.5	9.1	17.8	13.8	21.8	18.0	21.9	13.4	16.4	14.6	35.6	13.1	19.6	19.4	72.5	58.6	15.6	28.6	80.6	22.3	27.4	13.0	25.8
RAD23A	"HHR23A, MGC111083"	ENSG00000179262	"RAD23 homolog A, nucleotide excision repair protein"	P54725	19	12945855-12953642	"Cancer-related genes, Predicted intracellular proteins"	"DNA damage, DNA repair, Host-virus interaction"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"skeletal muscle: 984.0;tongue: 447.9"	"Cell type enhanced"	"Detected in all"		"Erythroid cells: 901.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026418, HPA053901, HPA057003, HPA065599"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA		3400000	"Cluster 27: Non-specific - Gene expression"	"Cluster 33: Striated muscle - Muscle contraction"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 6: Erythroid cells - Oxygen transport"	Nucleoplasm	Cytosol	"HPA026418: AB_2732430, HPA053901: AB_2682300, HPA057003: AB_2683309, HPA065599: AB_2685516"	"unprognostic (2.09e-1)"	"unprognostic (1.58e-3)"	"unprognostic (1.23e-3)"	"unprognostic (7.90e-3)"	"unprognostic (1.45e-1)"	"unprognostic (1.48e-1)"	"unprognostic (3.78e-3)"	"unprognostic (3.57e-3)"	"unprognostic (3.13e-1)"	"unprognostic (3.12e-3)"	"unprognostic (1.09e-1)"	"unprognostic (4.08e-2)"	"unprognostic (2.09e-3)"	"unprognostic (2.32e-3)"	"unprognostic (9.99e-2)"	"unprognostic (8.56e-2)"	"unprognostic (6.59e-3)"	79.2	63.4	77.8	49.4	79.8	85.8	71.0	78.1	95.7	59.2	71.0	91.6	48.4	65.0	31.2	70.0	64.1	38.2	132.4	80.5	79.8	54.1	70.4	66.4	55.9	80.5	76.7	56.2	76.7	66.1	47.7	55.5	80.1	57.5	35.8	24.5	68.0	52.5	984.0	72.6	52.8	54.8	77.0	54.5	66.4	48.7	79.4	53.0	54.9	447.9	44.0	78.5	57.1	82.0	138.0	52.6	55.7	57.4	91.5	104.1	94.7	66.1	130.2	152.6	137.2	59.8	95.3	117.3	150.0	99.4	104.4	102.7	78.0	137.7	55.9	170.0	109.8	47.2	57.3	58.3	181.7	102.1	130.7	107.9	199.6	110.1	208.9	89.7	105.4	188.0	124.1	102.1	138.2	139.8	126.6	124.2	76.5	124.6	135.6	65.4	59.4	189.6	118.9	53.8	104.3	81.8	75.4	129.1	145.8	40.2	100.4	173.7	82.5	214.9	57.4	263.3	203.9	148.2	133.8	86.0	177.9	193.3	183.2	31.3	76.3	64.9	81.1	102.4	87.3	77.5	66.8	69.1	68.3	73.5	63.3	73.4	9.2	79.1	105.3	86.0	82.0	69.1	77.8	79.8	78.1	95.7	80.5	79.8	80.5	76.7	80.1	77.0	79.4	82.0	120.2	86.6	56.2	11.8	127.6	120.4	176.8	165.2	122.3	51.7	110.3	121.3	59.5	108.7	108.4	55.2	20.9	212.0	99.6	95.7	166.3	179.5	193.1	74.3	76.9	120.4	87.3	901.4	22.0	191.0	240.1	101.4	101.9	74.1	111.5	77.7	86.4	96.2	175.3	52.2	22.9	138.5	136.3	88.3	170.3	44.1	118.4	119.6	142.3	12.2	182.5	73.9	94.7	15.6	25.8	184.1	119.0	114.0	159.0	351.3	139.9	163.3	91.1	56.1	111.7	138.3	129.3	263.6	179.6	153.3	146.5	244.8	113.0	117.8	154.8	211.1
RAD23B	"HHR23B, HR23B, P58"	ENSG00000119318	"RAD23 homolog B, nucleotide excision repair protein"	P54727	9	107283137-107332192	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, Ubl conjugation pathway"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 420.5;Late spermatids: 1201.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029718, HPA029720, CAB033868"	Enhanced		Supported	Nucleoplasm,Cytosol		No	No		5900000	"Cluster 1: Neutrophils - Mixed function"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 25: Spermatids - Spermatogenesis"	"Nucleoplasm, Cytosol"		"CAB033868: AB_1128418, HPA029718: AB_10600116, HPA029720: AB_10601008"	"unprognostic (3.95e-3)"	"unprognostic (1.01e-2)"	"unprognostic (2.28e-2)"	"unprognostic (8.14e-2)"	"unprognostic (4.71e-2)"	"prognostic unfavorable (2.58e-4)"	"unprognostic (2.94e-1)"	"prognostic unfavorable (6.71e-4)"	"unprognostic (1.34e-1)"	"unprognostic (3.72e-1)"	"unprognostic (3.31e-2)"	"unprognostic (1.20e-1)"	"unprognostic (2.94e-3)"	"unprognostic (2.69e-2)"	"unprognostic (2.43e-1)"	"unprognostic (7.49e-3)"	"unprognostic (1.04e-1)"	73.8	47.8	26.6	44.4	27.0	82.8	48.5	40.4	37.4	42.8	22.0	47.7	41.9	41.9	68.8	63.6	40.9	34.1	48.7	29.0	29.2	44.4	140.8	39.3	39.4	26.9	27.0	37.8	64.5	50.4	30.5	77.7	26.3	48.2	47.7	42.1	38.4	43.5	153.0	64.7	40.6	55.0	22.5	36.2	41.5	59.4	27.7	58.4	42.6	123.5	49.9	67.5	42.8	30.7	132.9	114.9	158.6	102.9	107.5	166.6	179.9	200.6	162.3	172.8	116.9	190.1	140.5	184.8	79.3	218.6	156.4	181.2	221.0	175.9	172.9	126.4	73.0	96.2	112.0	147.6	140.3	174.2	79.3	141.1	161.3	165.3	248.0	136.0	124.3	79.6	158.3	133.6	159.5	215.0	169.6	88.3	170.5	231.2	133.0	125.3	209.6	87.8	149.8	122.1	144.9	98.2	138.8	193.1	125.8	237.5	197.7	70.5	114.3	129.0	127.0	161.6	152.5	91.9	181.2	98.5	138.0	101.7	138.0	0.9	1.1	1.1	1.9	1.2	2.1	1.8	1.1	1.6	1.0	2.1	1.7	1.5	2.9	2.3	0.8	1.1	2.2	0.6	26.6	27.0	40.4	37.4	29.0	29.2	26.9	27.0	26.3	22.5	27.7	30.7	49.7	44.8	40.4	32.3	54.7	195.5	148.1	40.5	79.1	40.5	65.3	36.6	117.4	68.6	42.2	35.0	27.1	269.7	37.1	82.9	50.9	89.2	420.5	69.8	80.8	68.7	101.0	76.1	54.9	77.4	259.7	79.3	60.6	90.8	36.2	83.0	55.6	209.9	99.5	50.5	47.2	83.8	38.7	65.6	131.1	1201.4	75.5	70.7	74.7	38.4	83.7	40.4	39.1	50.3	54.1	81.0	50.5	87.3	89.3	146.0	51.2	95.9	47.6	43.9	78.9	71.6	88.5	45.3	74.7	126.9	240.9	291.8	50.5	91.1	74.9	141.2
RAD50	"hRad50, RAD50-2"	ENSG00000113522	"RAD50 double strand break repair protein"	Q92878	5	132556019-132646349	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, DNA damage, DNA repair, Host-virus interaction, Meiosis"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB022103, CAB024979, HPA052291"	Supported		Supported	Nucleoplasm		NA	NA		12000	"Cluster 15: NK-cells - Transcription"	"Cluster 72: Non-specific - Transcription"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 50: Fibroblasts - ECM organization"	Nucleoplasm		"CAB022103: , CAB024979: , HPA052291: AB_2681786"	"unprognostic (3.46e-3)"	"prognostic unfavorable (3.77e-4)"	"unprognostic (7.50e-3)"	"unprognostic (4.22e-3)"	"unprognostic (6.71e-2)"	"unprognostic (5.98e-2)"	"unprognostic (2.76e-2)"	"unprognostic (1.06e-1)"	"unprognostic (6.84e-2)"	"unprognostic (2.55e-1)"	"unprognostic (5.40e-3)"	"unprognostic (1.62e-1)"	"prognostic favorable (1.95e-4)"	"unprognostic (1.86e-1)"	"unprognostic (1.36e-1)"	"unprognostic (2.49e-2)"	"unprognostic (2.40e-1)"	6.3	8.0	5.8	2.8	6.9	5.9	6.6	7.6	8.6	6.9	4.0	8.7	2.5	8.1	10.3	7.6	7.3	3.5	7.1	6.8	4.9	6.1	6.2	5.0	2.5	5.0	4.4	9.2	9.2	8.8	8.1	3.6	5.7	6.2	4.6	8.5	7.1	4.2	11.3	10.4	8.0	3.8	3.4	5.4	8.6	5.5	5.4	4.0	6.0	4.7	3.5	7.9	6.9	8.6	9.1	22.8	2.1	12.1	13.3	20.0	9.8	6.3	11.2	11.0	12.8	20.4	14.8	20.6	3.7	10.3	19.7	8.8	17.6	14.2	16.5	11.7	13.4	9.5	13.3	12.5	10.8	10.2	7.6	10.8	24.1	13.4	36.7	7.2	5.4	6.5	17.9	3.2	10.1	8.6	7.7	13.9	11.7	9.0	6.8	7.2	3.7	10.1	8.8	16.9	11.5	14.9	11.7	4.7	2.8	5.6	11.5	7.0	9.5	4.7	5.5	14.5	8.3	5.7	7.7	24.2	8.4	12.5	6.7	7.0	3.3	1.1	4.1	3.8	5.6	7.0	5.4	5.4	3.6	5.8	4.9	4.5	0.3	9.3	4.8	2.5	4.0	2.7	5.8	6.9	7.6	8.6	6.8	4.9	5.0	4.4	5.7	3.4	5.4	8.6	3.5	38.5	27.1	65.6	34.6	26.0	37.3	33.7	31.9	56.8	6.6	4.8	130.0	44.3	31.6	7.3	89.6	69.6	22.9	31.0	1.9	6.3	26.4	8.2	15.8	16.6	37.1	38.5	65.9	6.0	49.2	37.6	37.2	7.6	30.4	8.5	22.1	38.5	37.4	37.0	79.7	44.1	18.3	27.2	12.2	12.6	60.6	16.5	16.0	49.6	22.4	38.0	48.4	65.9	92.4	4.8	35.6	53.4	33.0	32.1	53.7	4.4	40.8	60.8	32.9	50.9	39.9	108.4	87.2	39.2	26.7	33.1	25.2	11.5	52.3	25.1
RAD51	"BRCC5, FANCR, HsRad51, HsT16930, RAD51A, RECA"	ENSG00000051180	"RAD51 recombinase"	Q06609	15	40694774-40732340	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins"	"DNA damage, DNA recombination, DNA repair"	DNA-binding	"Cancer-related genes, Disease variant, Fanconi anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 15.7;testis: 24.3"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 35.3;Extravillous trophoblasts: 67.2;Spermatocytes: 53.6;Spermatogonia: 24.8;Syncytiotrophoblasts: 25.3"	"Cancer enhanced"	"Detected in all"		"testis cancer: 19.9"	"Low region specificity"	"Detected in single"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB010381, HPA039310"	Enhanced		Supported	"Nucleoli rim,Cytosol"		NA	Yes			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Nucleoli rim"	Cytosol	"CAB010381: AB_2253533, HPA039310: AB_2676434"	"prognostic unfavorable (7.94e-4)"	"unprognostic (7.20e-3)"	"unprognostic (1.22e-1)"	"unprognostic (2.72e-2)"	"unprognostic (8.23e-2)"	"unprognostic (1.37e-1)"	"prognostic unfavorable (9.33e-4)"	"unprognostic (3.40e-3)"	"unprognostic (2.53e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.41e-3)"	"unprognostic (2.53e-3)"	"unprognostic (0.00e+0)"	"unprognostic (2.26e-2)"	"unprognostic (2.34e-1)"	"unprognostic (9.59e-2)"	"unprognostic (1.94e-2)"	0.9	0.6	0.4	5.5	0.5	10.5	1.9	1.7	0.7	1.0	0.6	8.3	3.2	1.2	0.4	4.2	0.7	1.3	0.6	0.4	0.5	0.5	1.3	1.1	11.0	0.4	0.3	0.6	1.4	0.5	0.2	6.8	0.5	0.8	9.1	0.3	1.0	0.3	1.0	3.1	4.1	2.4	0.1	2.4	1.8	24.3	0.3	15.7	0.6	0.5	13.3	1.7	1.5	0.5	33.8	16.1	33.4	16.3	4.4	7.8	31.1	54.9	16.5	43.3	43.8	35.4	22.1	20.4	26.8	20.9	18.9	67.7	56.6	22.1	42.3	39.0	22.2	47.7	28.2	30.4	0.4	37.9	28.5	1.7	2.9	30.0	13.5	6.4	22.5	48.5	59.6	55.8	36.6	28.5	54.4	43.6	35.2	69.2	19.0	61.0	49.0	30.7	15.4	45.3	15.4	27.0	23.6	41.4	8.5	39.2	27.0	39.4	9.9	32.8	22.2	48.7	27.2	12.0	65.1	59.8	16.3	78.0	33.5	1.3	0.6	1.7	2.4	1.3	0.6	1.7	2.5	3.2	1.0	1.1	0.6	1.2	1.2	1.8	1.4	0.9	5.9	1.2	0.4	0.5	1.7	0.7	0.4	0.5	0.4	0.3	0.5	0.1	0.3	0.5	0.0	0.0	0.0	0.3	1.9	3.6	1.5	2.0	0.0	0.8	0.1	0.0	0.9	0.0	1.0	0.0	0.0	35.3	1.4	3.0	0.0	0.0	5.7	0.2	0.2	1.0	0.0	16.0	1.6	0.0	67.2	1.3	2.0	0.2	0.0	0.6	2.2	0.2	12.7	0.0	1.2	5.3	2.0	1.6	1.7	5.3	0.6	0.5	0.0	1.0	0.3	0.3	2.1	0.5	0.6	0.1	5.0	0.7	8.2	0.9	1.0	0.0	0.1	0.0	0.0	0.5	0.9	53.6	24.8	3.9	1.6	25.3	1.2	0.1	8.0	2.1
RAD51C	"FANCO, RAD51L2"	ENSG00000108384	"RAD51 paralog C"	O43502	17	58692573-58735611	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"DNA damage, DNA recombination, DNA repair"	DNA-binding	"Disease variant, Fanconi anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 117.7;Spermatocytes: 140.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"MCF7: 319.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA045198			Supported	"Nucleoplasm,Vesicles,Cell Junctions,Mitochondria,Cytosol"		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 12: Non-specific - Cell cycle regulation"	"Nucleoplasm, Mitochondria, Cytosol"	"Vesicles, Cell Junctions"	"HPA045198: AB_2679250"	"unprognostic (5.39e-3)"	"unprognostic (2.39e-2)"	"unprognostic (1.23e-2)"	"unprognostic (6.20e-2)"	"unprognostic (1.83e-1)"	"unprognostic (4.59e-2)"	"prognostic unfavorable (8.68e-5)"	"unprognostic (3.65e-2)"	"unprognostic (2.91e-2)"	"unprognostic (1.03e-2)"	"prognostic favorable (5.33e-4)"	"unprognostic (2.55e-1)"	"unprognostic (2.62e-2)"	"unprognostic (7.62e-2)"	"unprognostic (2.41e-1)"	"unprognostic (9.52e-2)"	"unprognostic (2.42e-2)"	10.8	20.2	15.5	10.0	15.7	23.1	15.3	19.0	18.4	10.8	13.4	12.4	7.5	12.6	22.0	13.0	11.2	11.0	25.7	16.4	15.0	12.8	13.3	8.8	22.0	14.9	13.8	12.5	10.6	20.1	10.5	15.1	16.0	17.4	14.5	13.5	10.7	12.0	18.3	10.6	8.7	13.8	13.2	12.2	11.6	20.2	14.6	21.2	12.3	17.3	19.1	10.9	8.6	18.2	63.7	72.1	43.3	48.5	22.9	19.6	100.1	34.2	14.5	43.5	55.3	31.0	39.3	37.4	48.9	23.5	58.8	23.3	59.5	46.6	81.7	91.6	123.0	53.0	84.6	119.4	23.3	69.1	45.0	12.1	42.2	47.8	38.6	24.0	50.0	60.9	83.6	48.5	37.0	319.1	96.8	95.3	12.1	42.5	66.5	62.1	69.5	69.8	26.9	39.6	54.3	49.6	27.3	12.0	53.5	11.1	39.2	71.6	16.5	37.6	100.1	34.3	42.4	44.1	187.2	111.5	38.3	67.1	42.0	27.6	9.2	12.5	15.6	14.3	15.2	18.0	16.9	17.2	15.9	17.3	18.2	17.4	5.1	15.0	12.5	14.3	27.1	11.0	15.5	15.7	19.0	18.4	16.4	15.0	14.9	13.8	16.0	13.2	14.6	18.2	20.5	19.2	13.9	10.1	20.5	11.9	18.7	42.9	15.9	15.0	25.1	34.0	63.7	7.2	20.9	16.5	6.2	67.8	15.0	7.1	58.7	25.7	117.7	17.3	13.0	19.3	6.7	43.8	21.5	18.6	94.1	19.8	7.1	13.0	22.9	23.3	15.7	15.7	33.4	16.8	17.7	11.7	32.6	16.1	47.7	65.4	17.4	21.8	24.9	13.1	18.7	31.3	21.6	23.1	22.8	13.0	10.4	15.4	28.5	17.2	5.7	24.6	14.1	26.9	32.9	14.7	23.9	140.7	98.3	15.9	10.7	36.3	20.5	28.2	15.3	13.9
RAD9A	RAD9	ENSG00000172613	"RAD9 checkpoint clamp component A"	Q99638	11	67317871-67398410	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"DNA damage"	"Exonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006725, HPA048155, CAB079979"	Enhanced		Enhanced	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 71: Testis - DNA repair"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm	"Nuclear bodies"	"CAB079979: , HPA006725: AB_1856041, HPA048155: AB_2680290"	"unprognostic (7.64e-2)"	"prognostic favorable (6.95e-4)"	"unprognostic (8.83e-3)"	"unprognostic (1.13e-1)"	"unprognostic (2.68e-1)"	"unprognostic (2.12e-3)"	"unprognostic (9.64e-3)"	"unprognostic (1.05e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.97e-1)"	"unprognostic (9.19e-2)"	"unprognostic (2.50e-2)"	"prognostic unfavorable (2.82e-5)"	"unprognostic (6.16e-2)"	"unprognostic (3.72e-3)"	"unprognostic (2.19e-1)"	"prognostic favorable (7.52e-6)"	5.8	5.0	3.3	6.9	3.6	10.2	6.9	2.1	6.0	9.2	2.9	7.3	10.9	7.4	2.1	9.0	10.9	5.7	4.2	3.8	2.4	7.1	6.6	6.7	8.3	2.9	3.6	8.0	8.0	3.4	10.1	4.4	2.2	10.8	3.0	1.8	9.8	6.1	5.2	11.4	11.1	2.4	2.2	9.4	8.4	8.6	2.5	6.1	9.7	2.1	3.7	6.5	8.5	2.2	10.8	15.8	9.5	13.8	2.8	1.1	12.0	5.7	4.9	8.0	7.1	23.2	20.9	11.1	12.4	1.8	13.0	18.7	6.0	5.5	0.9	13.0	16.3	16.8	8.5	10.4	3.8	12.3	20.3	3.2	5.3	7.2	3.5	6.1	5.5	23.2	14.7	15.6	2.3	33.2	21.9	21.8	13.2	15.9	12.1	18.8	12.5	13.6	2.2	9.0	9.8	10.6	9.9	27.2	21.1	2.4	19.1	10.9	4.2	11.7	14.3	23.3	8.7	14.6	14.2	11.5	7.5	11.6	9.6	5.3	1.8	6.0	5.2	2.3	3.8	4.3	4.1	4.3	1.2	3.1	2.9	3.2	2.8	3.1	2.5	3.4	2.4	1.5	3.3	3.6	2.1	6.0	3.8	2.4	2.9	3.6	2.2	2.2	2.5	2.2	16.0	22.4	17.1	10.1	31.0	17.1	17.7	17.9	23.3	19.6	19.7	18.4	1.1	12.8	22.2	20.2	70.9	27.9	31.3	54.2	13.7	11.3	27.3	32.1	13.4	16.3	14.3	17.7	8.5	13.1	22.4	13.8	27.0	14.9	20.3	26.0	11.0	6.6	15.1	21.9	6.0	48.9	10.2	10.3	31.4	13.2	10.5	14.0	19.6	11.2	8.9	15.0	56.7	2.5	5.3	11.6	31.6	12.4	38.5	16.6	61.8	10.9	44.0	32.1	13.1	10.5	14.5	32.0	17.6	18.3	17.3	40.6	30.3	15.3	38.7	18.0
RADX	"CXorf57, FLJ10178, FLJ14191"	ENSG00000147231	"RPA1 related single stranded DNA binding protein, X-linked"	Q6NSI4	X	106611930-106679439	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 27.3;pituitary gland: 20.3"	"Cell type enhanced"	"Detected in some"		"Cytotrophoblasts: 12.3;Extravillous trophoblasts: 4.7;Syncytiotrophoblasts: 22.6"	"Cancer enhanced"	"Detected in many"		"urothelial cancer: 4.5"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	10	"B-cells: 1.8;NK-cells: 1.0;T-cells: 1.6"	"Cell line enhanced"	"Detected in many"		"HEK 293: 37.2;RT4: 39.9"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"HPA000896, HPA001010, HPA001374"	Uncertain		Supported	"Nuclear speckles"		NA	No			"Cluster 40: NK-cells - Unknown function"	"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	"Nuclear speckles"		"HPA000896: AB_1078880, HPA001010: , HPA001374: AB_2666288"	"unprognostic (3.30e-2)"	"unprognostic (5.59e-3)"	"unprognostic (2.67e-2)"	"unprognostic (1.46e-3)"	"unprognostic (4.85e-2)"	"unprognostic (8.26e-2)"	"unprognostic (1.24e-2)"	"unprognostic (1.89e-1)"	"unprognostic (3.02e-1)"	"unprognostic (5.49e-2)"	"unprognostic (3.81e-3)"	"unprognostic (1.17e-1)"	"unprognostic (4.20e-3)"	"unprognostic (1.63e-1)"	"unprognostic (2.70e-1)"	"unprognostic (2.21e-2)"	"unprognostic (1.23e-3)"	1.0	7.2	6.1	1.4	5.6	0.6	1.4	2.5	4.5	3.7	1.7	1.2	1.1	3.2	2.1	1.0	3.8	0.6	1.1	3.4	27.3	2.5	1.4	2.4	3.3	4.5	4.9	6.7	1.9	0.8	20.3	3.6	6.1	0.8	0.8	1.8	0.8	1.2	1.8	2.5	1.8	0.9	3.6	2.3	2.6	3.9	20.6	2.3	3.0	1.0	2.1	2.5	1.9	5.3	7.2	0.0	7.2	10.1	4.0	3.4	10.8	0.3	1.4	0.0	0.1	1.6	1.5	15.0	0.0	0.8	7.7	2.0	18.6	3.2	0.0	0.0	37.2	5.0	0.0	0.4	0.2	0.0	3.2	2.0	2.2	0.5	1.3	1.9	0.0	13.1	0.2	19.1	1.6	0.0	14.0	0.0	6.5	4.8	1.1	0.0	6.7	0.0	3.1	39.9	11.8	0.0	0.7	0.2	4.3	5.5	1.8	0.2	0.0	3.1	2.6	0.0	4.5	6.8	3.1	18.5	5.5	0.0	5.3	0.0	0.0	0.0	1.5	0.0	1.1	1.8	1.3	1.0	0.0	1.3	1.6	1.3	0.1	1.0	0.0	0.1	0.5	0.4	6.1	5.6	2.5	4.5	3.4	27.3	4.5	4.9	6.1	3.6	20.6	5.3	0.8	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	12.3	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	4.7	0.4	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	22.6	1.0	0.0	0.0	0.0
RAE1	"Gle2, Mnrp41"	ENSG00000101146	"Ribonucleic acid export 1"	P78406	20	57351223-57379211	"Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Transporters"	"Cell cycle, Cell division, Mitosis, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 103.0"	"Cell type enhanced"	"Detected in all"		"Early spermatids: 113.6;Spermatocytes: 256.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048795			Supported	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Nucleoplasm, Nucleoli fibrillar center"		"HPA048795: AB_2680523"	"unprognostic (1.20e-1)"	"unprognostic (5.98e-2)"	"unprognostic (4.55e-2)"	"prognostic unfavorable (2.44e-4)"	"unprognostic (3.23e-1)"	"unprognostic (2.04e-1)"	"prognostic unfavorable (2.12e-7)"	"unprognostic (1.88e-1)"	"unprognostic (8.26e-2)"	"unprognostic (1.22e-1)"	"unprognostic (5.50e-3)"	"unprognostic (3.88e-2)"	"unprognostic (7.48e-2)"	"unprognostic (3.55e-1)"	"unprognostic (9.49e-2)"	"unprognostic (2.89e-1)"	"unprognostic (2.01e-1)"	14.0	13.9	18.6	13.5	19.1	50.5	17.0	18.5	19.1	15.5	17.6	14.2	11.9	16.6	18.2	20.5	17.4	9.0	13.3	18.3	19.9	14.1	16.5	10.0	20.8	16.3	15.9	16.3	10.8	19.1	13.3	14.6	17.0	12.4	16.2	20.1	12.8	15.0	15.0	22.9	13.6	16.3	17.2	17.0	12.8	103.0	21.4	29.2	12.1	15.8	26.5	14.5	16.0	19.6	43.5	52.6	52.8	29.3	30.1	29.0	46.1	33.9	47.2	172.2	70.3	166.1	33.8	69.2	46.8	52.8	63.8	56.6	101.6	88.3	142.1	20.8	45.2	47.0	46.0	74.9	59.0	57.1	41.3	41.3	74.0	75.8	83.1	29.1	49.9	47.2	84.8	32.5	53.0	114.8	88.3	53.2	32.9	86.3	93.3	47.6	49.4	46.0	37.3	45.5	55.2	47.6	58.4	129.4	61.0	41.2	71.5	54.0	29.7	70.6	63.0	41.7	57.7	34.9	83.9	81.8	48.3	36.1	35.6	21.2	42.0	77.0	27.0	36.8	32.9	31.2	26.0	26.8	32.3	28.1	33.9	30.7	36.2	24.7	37.9	23.8	24.6	40.4	18.6	19.1	18.5	19.1	18.3	19.9	16.3	15.9	17.0	17.2	21.4	19.6	17.5	19.2	16.7	8.5	21.0	17.2	16.3	42.0	15.9	15.9	12.6	19.3	10.4	11.5	24.1	18.4	14.6	52.8	20.8	11.6	27.4	30.3	113.6	16.5	16.7	17.9	6.6	18.7	10.2	14.3	39.3	18.6	12.2	15.3	38.0	25.6	11.0	13.5	38.3	3.3	9.5	15.2	18.3	59.5	14.5	63.9	21.8	33.5	10.6	14.0	40.0	19.9	27.8	5.5	13.1	22.2	24.3	22.6	15.9	14.0	10.1	20.6	24.1	17.9	19.7	11.6	19.9	256.9	83.1	19.2	21.0	70.5	24.2	34.9	20.1	16.2
RAET1E	"bA350J20.7, LETAL, ULBP4"	ENSG00000164520	"Retinoic acid early transcript 1E"	Q8TD07	6	149883375-149898102	"Predicted intracellular proteins, Predicted membrane proteins"	Immunity			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix: 21.9;esophagus: 62.8;skin 1: 21.6;vagina: 27.5"	"Cell type enhanced"	"Detected in some"		"Basal respiratory cells: 12.4;Early spermatids: 10.0;Late spermatids: 5.6;Respiratory ciliated cells: 14.6;Squamous epithelial cells: 17.2;Suprabasal keratinocytes: 6.5"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 3.9"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HBEC3-KT: 19.6;HeLa: 24.4;hTCEpi: 19.1;SiHa: 9.9;U-87 MG: 7.7"									HPA054022			Supported	"Focal adhesion sites,Cytosol"	"Intracellular and membrane"	NA	NA				"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 20: HeLa - Mitochondria"	"Cluster 61: Squamous epithelial cells - Keratinization"	"Focal adhesion sites"	Cytosol	"HPA054022: AB_2797250"	"unprognostic (1.67e-2)"	"unprognostic (2.10e-1)"	"unprognostic (3.49e-3)"	"unprognostic (1.26e-1)"	"unprognostic (1.36e-1)"	"unprognostic (2.71e-2)"	"unprognostic (1.36e-3)"	"unprognostic (4.80e-4)"	"unprognostic (1.11e-1)"	"unprognostic (3.39e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.69e-1)"	"unprognostic (7.47e-5)"	"unprognostic (2.41e-2)"	"unprognostic (3.18e-2)"	"unprognostic (3.17e-2)"	"unprognostic (1.06e-1)"	3.7	0.8	0.6	0.1	0.4	0.1	1.9	1.0	0.7	21.9	0.8	0.2	0.1	0.3	0.0	62.8	0.8	0.1	0.5	0.5	0.5	2.2	0.1	0.3	0.1	0.4	0.3	0.1	0.1	0.0	0.2	0.5	0.5	0.3	0.3	0.1	12.9	0.3	1.6	21.6	0.1	0.5	0.1	0.9	0.3	0.4	0.4	0.1	0.3	0.2	11.6	1.9	27.5	0.5	1.8	1.0	0.0	0.0	0.2	1.3	0.0	0.1	0.9	0.1	0.3	0.0	4.3	0.0	2.6	4.4	1.4	1.7	0.0	19.6	0.2	0.3	0.0	0.1	24.4	0.0	0.0	0.0	0.0	0.4	19.1	1.0	3.9	0.4	0.1	0.1	0.0	1.3	0.8	0.0	0.0	0.0	0.1	0.3	0.8	0.0	0.0	0.3	0.4	0.9	0.2	0.0	9.9	1.5	0.0	0.0	1.2	0.0	1.8	0.8	0.3	0.2	0.9	0.0	0.0	0.0	7.7	0.4	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.6	0.4	1.0	0.7	0.5	0.5	0.4	0.3	0.5	0.1	0.4	0.5	1.0	0.0	0.0	0.3	0.0	2.2	1.1	12.4	1.8	0.6	0.3	0.6	0.3	1.5	3.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	10.0	2.5	0.1	1.0	0.0	0.0	0.9	0.0	0.0	2.0	0.0	0.1	0.0	0.0	0.7	0.0	0.1	0.0	1.1	0.1	0.0	0.0	0.3	5.6	0.0	0.0	0.0	1.9	0.0	0.2	0.0	0.5	1.1	0.4	0.0	0.0	0.0	0.2	0.0	0.0	14.6	0.4	0.0	0.3	0.4	0.0	0.2	17.2	6.5	0.0	0.2	0.1	0.2	1.6
RAET1G	ULBP5	ENSG00000203722	"Retinoic acid early transcript 1G"	Q6H3X3	6	149916878-149923121	"Predicted membrane proteins, Predicted secreted proteins"	"Host-virus interaction, Immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"adrenal gland: 8.4;esophagus: 15.1"	"Cell type enhanced"	"Detected in some"		"Basal respiratory cells: 42.9;Club cells: 14.8;Ionocytes: 12.2;Respiratory ciliated cells: 23.3;Squamous epithelial cells: 8.9;Urothelial cells: 8.1"	"Group enriched"	"Detected in many"	4	"cervical cancer: 4.5;head and neck cancer: 4.7;lung cancer: 1.2;thyroid cancer: 1.5;urothelial cancer: 4.2"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HeLa: 29.5;hTCEpi: 22.6;SiHa: 11.9;U-87 MG: 9.3"									"HPA062673, HPA066741"			Supported	"Vesicles,Plasma membrane"	"Secreted - unknown location"	NA	NA				"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 20: HeLa - Mitochondria"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Vesicles, Plasma membrane"		"HPA062673: , HPA066741: "	"unprognostic (4.46e-3)"	"unprognostic (4.92e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.21e-1)"	"unprognostic (2.87e-3)"	"unprognostic (1.49e-1)"	"unprognostic (4.61e-3)"	"prognostic unfavorable (5.35e-4)"	"unprognostic (3.05e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.38e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.49e-2)"	"unprognostic (2.48e-1)"	"unprognostic (8.85e-2)"	"unprognostic (9.11e-2)"	2.8	8.4	0.4	0.4	0.3	0.0	0.6	0.0	0.4	4.1	0.0	0.2	0.1	0.3	0.7	15.1	0.6	0.7	0.6	0.4	0.3	0.9	0.1	0.5	0.1	0.3	0.6	0.7	0.1	0.2	0.3	0.1	0.1	0.7	0.1	0.1	3.7	1.0	0.2	2.7	0.2	0.6	0.0	0.1	0.4	0.3	0.7	0.0	0.4	0.1	1.1	1.8	6.0	0.0	1.0	1.4	0.0	1.7	2.3	1.7	0.0	0.8	3.0	1.3	1.9	0.0	1.5	0.0	0.6	1.7	1.4	2.7	0.9	5.3	1.1	0.3	1.6	0.5	29.5	0.0	0.7	0.0	0.0	3.3	22.6	3.5	1.7	1.5	0.3	0.7	0.3	0.2	0.6	1.3	0.0	0.0	0.0	0.3	2.3	0.0	0.0	0.0	1.0	3.2	0.3	0.3	11.9	0.5	0.0	0.1	0.4	0.4	1.6	0.6	0.5	1.6	0.8	0.0	0.0	0.0	9.3	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.4	0.4	0.3	0.3	0.6	0.1	0.0	0.7	0.0	1.4	0.0	0.0	0.0	0.0	3.1	5.1	42.9	2.8	0.0	0.4	0.4	0.1	1.5	14.8	0.0	0.0	0.0	0.2	0.1	0.0	0.2	0.1	0.4	0.1	1.3	0.0	0.0	0.0	1.3	0.0	1.9	0.0	0.1	0.0	0.0	0.7	0.0	0.1	0.0	0.0	0.0	12.2	0.0	0.7	0.1	0.9	0.0	3.6	0.0	0.0	0.8	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.4	0.0	0.0	23.3	0.0	0.0	0.2	1.1	0.0	0.3	8.9	1.7	0.1	0.3	0.5	0.0	8.1
RAET1L		ENSG00000155918	"Retinoic acid early transcript 1L"	Q5VY80	6	150018334-150025532	"Predicted membrane proteins"	"Host-virus interaction, Immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"esophagus: 58.1;vagina: 17.3"	"Cell type enhanced"	"Detected in some"		"Basal keratinocytes: 6.4;Basal prostatic cells: 11.3;Basal respiratory cells: 6.4;Prostatic glandular cells: 7.1;Squamous epithelial cells: 7.2;Suprabasal keratinocytes: 17.0;Urothelial cells: 8.1"	"Group enriched"	"Detected in many"	4	"cervical cancer: 4.8;head and neck cancer: 10.1;lung cancer: 4.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"HaCaT: 14.3"									HPA066741			Supported	"Vesicles,Plasma membrane"		NA	NA				"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 22: Epithelial cell types - Mixed function"	"Vesicles, Plasma membrane"		"HPA066741: "	"unprognostic (1.80e-1)"	"unprognostic (1.63e-1)"	"unprognostic (2.15e-1)"	"unprognostic (1.84e-1)"	"unprognostic (4.24e-3)"	"unprognostic (1.51e-1)"		"prognostic unfavorable (4.09e-4)"	"unprognostic (8.34e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.26e-2)"	"unprognostic (7.48e-2)"	"unprognostic (1.46e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.29e-1)"	"unprognostic (5.14e-2)"	"unprognostic (7.43e-3)"	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.1	8.1	0.0	0.0	0.0	0.0	0.0	58.1	0.0	0.1	0.0	0.2	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.7	0.0	0.1	5.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	5.2	0.3	17.3	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.8	0.0	1.2	0.0	0.7	14.3	0.3	0.4	0.0	0.5	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	2.4	0.0	0.0	0.0	2.6	0.7	0.0	0.0	1.1	0.2	0.0	0.0	0.0	0.0	0.1	0.0	1.7	0.2	0.4	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.4	11.3	6.4	1.2	0.0	0.4	0.3	0.0	0.0	2.9	0.0	0.0	0.0	0.0	1.0	0.0	2.8	0.8	0.5	0.1	0.2	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	7.1	0.0	0.2	0.9	0.0	0.0	0.0	0.4	0.0	0.1	7.2	17.0	0.0	0.0	0.0	0.1	8.1
RAF1	"c-Raf, CRAF, Raf-1"	ENSG00000132155	"Raf-1 proto-oncogene, serine/threonine kinase"	P04049	3	12583601-12664125	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, RAS pathway related proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Cardiomyopathy, Deafness, Disease variant, FDA approved drug targets, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 175.1"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 175.1"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002639, HPA002640, CAB019291"	Approved		Supported	"Plasma membrane,Cytosol"		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 59: Non-specific - Translation"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 40: Granulosa cells - Unknown function"	"Plasma membrane, Cytosol"		"CAB019291: , HPA002639: , HPA002640: AB_1856047"	"unprognostic (6.33e-2)"	"unprognostic (1.29e-1)"	"unprognostic (5.92e-2)"	"unprognostic (2.17e-3)"	"unprognostic (6.51e-3)"	"unprognostic (7.66e-3)"	"unprognostic (2.66e-3)"	"unprognostic (1.53e-2)"	"unprognostic (2.72e-1)"	"unprognostic (7.66e-2)"	"unprognostic (2.92e-2)"	"unprognostic (1.29e-2)"	"unprognostic (2.79e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.64e-2)"	"unprognostic (2.36e-2)"	42.4	34.2	36.7	33.8	37.9	77.4	39.2	42.6	37.4	47.6	40.4	46.8	40.5	45.6	34.0	55.5	43.2	31.0	89.6	36.9	35.8	46.7	68.9	44.7	36.3	38.3	36.9	52.0	50.6	63.6	28.3	39.1	37.0	41.9	42.0	37.4	39.6	38.0	194.9	56.0	43.4	45.5	36.7	48.3	55.5	26.8	38.1	52.8	48.8	122.5	47.7	46.1	46.2	39.8	49.9	57.9	85.5	66.6	74.3	59.6	168.0	73.9	129.1	100.1	112.5	46.6	41.3	52.7	34.6	120.1	51.6	31.9	93.4	67.5	103.8	91.4	70.2	72.0	69.4	42.9	74.2	70.1	64.7	55.3	67.8	102.3	82.0	67.6	73.1	78.2	52.6	136.0	98.3	88.6	91.1	47.8	86.5	64.0	76.4	72.6	75.7	66.4	60.9	76.9	26.1	56.2	61.1	59.8	40.9	66.1	99.1	91.5	51.1	65.6	62.5	55.7	85.0	103.3	178.4	112.3	57.2	80.4	73.9	40.4	32.7	62.5	22.3	32.6	22.5	19.5	21.9	22.3	30.3	20.4	21.9	22.8	175.1	29.8	34.2	13.5	28.3	28.2	36.7	37.9	42.6	37.4	36.9	35.8	38.3	36.9	37.0	36.7	38.1	39.8	28.5	22.4	37.6	47.7	36.1	34.4	35.2	22.1	27.9	56.7	27.5	22.6	29.0	35.8	25.7	27.6	66.7	40.0	41.5	31.3	13.7	25.6	8.8	33.2	37.1	32.7	29.3	46.7	46.1	37.0	46.8	32.3	27.5	43.8	34.2	78.7	36.0	41.2	28.6	43.7	52.9	31.0	30.5	39.3	43.4	4.6	39.1	34.7	26.6	44.0	49.5	31.9	51.5	65.4	64.0	35.5	29.9	41.3	43.3	46.9	47.3	20.1	31.2	81.9	32.9	56.2	39.1	28.3	33.6	31.8	43.5	62.3	40.8	35.6	31.2	47.1
RAG1	"MGC43321, RNF74"	ENSG00000166349	"Recombination activating 1"	P15918	11	36510709-36593156	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"DNA recombination, Ubl conjugation pathway"	"Chromatin regulator, DNA-binding, Endonuclease, Hydrolase, Multifunctional enzyme, Nuclease, Transferase"	"Disease variant, SCID"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	92	"lymphoid tissue: 395.0"	"Cell type enhanced"	"Detected in some"		"Distal tubular cells: 3.9;Hepatic stellate cells: 8.2"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"MOLT-4: 283.5;REH: 266.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			HPA043939			Supported	Nucleoplasm		NA	NA				"Cluster 63: T-cells - Adaptive immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm		"HPA043939: AB_2732512"	"unprognostic (7.35e-2)"	"unprognostic (1.57e-3)"	"unprognostic (8.75e-2)"	"unprognostic (3.44e-1)"	"unprognostic (2.14e-1)"	"unprognostic (1.46e-2)"	"unprognostic (2.30e-1)"	"unprognostic (1.70e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.54e-2)"	"unprognostic (5.98e-3)"	"unprognostic (1.28e-1)"	"unprognostic (1.16e-9)"	"unprognostic (2.16e-2)"	"unprognostic (1.04e-1)"	"unprognostic (2.53e-4)"	"unprognostic (1.53e-1)"	0.4	0.5	0.1	0.2	0.1	4.3	0.2	0.1	0.2	0.4	0.2	0.4	0.8	0.2	0.8	0.1	0.3	0.4	0.3	0.1	0.1	1.3	0.8	0.6	0.1	0.1	0.1	0.3	0.3	0.6	0.1	0.6	0.1	0.3	0.3	0.6	0.4	0.3	0.1	0.1	1.0	0.1	0.1	2.6	0.5	0.3	0.1	395.0	2.4	0.3	0.6	0.3	0.1	0.1	0.4	0.0	0.5	0.1	0.2	0.6	0.0	0.3	0.3	0.1	0.5	0.0	0.4	0.5	0.0	0.0	0.1	0.2	0.0	0.4	0.4	0.1	0.0	0.2	0.0	0.0	0.1	0.0	0.1	0.3	0.4	0.0	0.3	0.2	0.5	54.0	0.2	0.0	0.5	0.0	283.5	0.0	2.2	0.2	0.0	266.4	0.0	1.3	0.9	0.0	0.1	0.3	0.1	0.7	0.1	1.2	1.0	0.1	1.0	0.2	0.2	0.2	0.1	2.3	1.9	0.0	0.0	0.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	1.5	0.0	0.0	0.0	0.1	0.1	1.4	0.7	0.0	1.0	1.0	0.8	0.9	0.0	0.4	1.8	0.0	0.2	0.5	1.3	3.9	0.8	2.3	0.3	0.3	1.6	0.0	0.4	1.8	0.5	0.1	0.7	0.0	0.4	0.0	0.3	8.2	2.1	0.4	0.0	1.7	0.8	0.0	0.6	0.7	1.7	0.0	0.1	0.0	1.0	1.1	0.5	2.1	1.0	1.3	1.1	0.4	0.0	0.0	0.5	3.0	2.9	0.4	0.9	0.0	0.2	0.7	1.0	1.0	0.2	0.4	0.4	0.4	0.5	0.6	0.6
RAI14	"DKFZp564G013, KIAA1334, NORPEG, RAI13"	ENSG00000039560	"Retinoic acid induced 14"	Q9P0K7	5	34656328-34832612	"Predicted intracellular proteins"	"Differentiation, Spermatogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 208.2;Early spermatids: 210.1;Late spermatids: 364.3;Syncytiotrophoblasts: 156.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 267.4"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in many"		"spinal cord: 23.8"	"HPA036949, HPA036950"	Supported		Supported	"Nucleoplasm,Actin filaments,Cytosol"		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 28: Placenta - Pregnancy"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 11: Alveolar cells - Smell perception"	Nucleoplasm	"Actin filaments, Cytosol"	"HPA036949: AB_10670568, HPA036950: AB_10669721"	"unprognostic (7.63e-2)"	"unprognostic (9.86e-2)"	"unprognostic (4.87e-2)"	"unprognostic (1.40e-1)"	"unprognostic (3.38e-2)"	"unprognostic (4.75e-2)"	"unprognostic (5.49e-2)"	"unprognostic (6.18e-2)"	"unprognostic (6.28e-2)"	"unprognostic (2.62e-1)"	"unprognostic (8.18e-2)"	"unprognostic (4.58e-2)"	"prognostic unfavorable (9.75e-4)"	"prognostic unfavorable (2.05e-4)"	"unprognostic (1.33e-1)"	"unprognostic (4.81e-2)"	"unprognostic (4.34e-2)"	10.6	9.0	10.1	21.6	14.5	2.4	9.8	13.3	9.8	51.2	17.5	22.1	7.0	53.6	6.2	10.0	13.8	18.7	6.8	8.0	9.4	18.9	27.5	26.2	14.7	18.1	13.9	9.5	7.9	10.8	4.9	34.6	17.1	11.4	10.3	10.2	16.5	25.4	1.9	19.5	7.5	58.0	15.6	39.4	10.8	39.2	12.7	6.3	10.1	2.3	10.2	43.0	14.3	20.0	12.5	48.5	55.2	37.1	29.0	100.9	70.3	147.0	118.3	83.3	83.0	36.7	15.6	2.9	57.0	72.5	90.5	8.2	64.0	109.0	179.2	0.2	30.5	20.6	43.3	22.9	90.0	0.5	1.9	94.8	34.0	149.4	118.1	136.7	267.4	4.6	29.4	1.0	110.1	10.0	2.3	0.7	43.3	7.8	47.0	18.2	84.1	0.6	97.4	70.1	14.4	7.9	86.8	12.8	39.5	80.5	14.9	2.3	173.2	134.1	71.7	33.5	65.1	3.1	0.1	0.4	113.5	0.4	53.5	0.9	0.2	0.1	0.9	0.0	0.1	0.1	0.2	0.0	0.0	0.2	0.0	0.1	0.4	0.8	0.0	0.1	0.0	0.0	10.1	14.5	13.3	9.8	8.0	9.4	18.1	13.9	17.1	15.6	12.7	20.0	16.2	105.8	208.2	33.3	0.9	12.0	32.2	46.7	23.9	3.2	27.8	9.9	5.2	7.2	81.8	35.0	68.8	32.3	0.6	17.9	7.9	36.1	210.1	35.7	36.1	96.1	1.8	2.7	6.6	28.5	75.3	25.0	11.2	36.1	3.8	22.7	17.2	23.0	7.2	15.2	6.0	1.1	16.2	1.6	4.3	364.3	72.1	4.6	5.4	15.0	1.0	19.3	0.0	31.2	60.1	53.3	5.1	31.6	0.1	26.6	6.3	25.3	24.8	5.1	0.0	6.0	33.4	9.0	9.2	6.4	15.8	156.1	3.4	11.4	2.6	61.5
RALA	RAL	ENSG00000006451	"RAS like proto-oncogene A"	P11233	7	39623565-39708120	"Enzymes, Predicted intracellular proteins, RAS pathway related proteins"	"Cell cycle, Cell division, Exocytosis"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Langerhans cells: 292.4;Pancreatic endocrine cells: 411.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HUVEC TERT2: 302.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047037, HPA065232"	Approved		Supported	"Plasma membrane,Focal adhesion sites"		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 70: Brain - Nervous system development"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 10: Non-specific - Unknown function"	"Plasma membrane"	"Focal adhesion sites"	"HPA047037: , HPA065232: AB_2685440"	"unprognostic (1.20e-3)"	"unprognostic (1.03e-2)"	"unprognostic (2.91e-1)"	"unprognostic (7.73e-3)"	"unprognostic (1.98e-2)"	"unprognostic (9.14e-2)"	"prognostic unfavorable (5.32e-5)"	"unprognostic (7.71e-2)"	"unprognostic (2.17e-1)"	"prognostic favorable (7.46e-4)"	"prognostic unfavorable (6.30e-4)"	"unprognostic (3.32e-1)"	"unprognostic (4.95e-3)"	"unprognostic (5.38e-2)"	"unprognostic (7.15e-2)"	"unprognostic (2.79e-1)"	"unprognostic (2.95e-2)"	27.8	32.1	32.4	20.7	35.5	7.4	23.8	35.8	37.3	23.0	30.2	30.9	32.6	20.4	20.1	54.0	19.6	26.8	17.6	33.7	34.3	20.6	21.4	41.8	21.4	37.0	35.7	22.2	16.0	22.6	10.5	32.5	36.4	15.4	31.6	13.0	19.8	15.8	25.8	26.9	30.9	21.1	37.7	18.8	33.8	12.7	34.9	25.5	17.4	19.1	35.2	23.5	22.0	39.8	81.0	18.3	44.1	38.6	81.7	67.6	30.0	69.7	99.7	61.8	67.9	46.1	39.0	41.5	25.5	54.1	58.1	81.5	62.5	45.0	105.5	40.2	29.6	32.4	28.1	34.1	132.1	56.9	43.8	53.7	54.0	110.0	155.4	76.7	302.4	39.7	65.9	27.0	63.2	26.3	40.3	66.7	123.0	88.0	35.9	49.4	40.2	36.3	63.1	37.3	78.0	75.6	42.8	67.7	49.4	78.7	63.5	60.9	98.0	36.4	32.4	46.3	50.7	47.6	39.1	50.3	40.5	58.0	67.2	38.3	13.5	15.7	12.5	15.6	15.7	15.8	20.1	16.2	22.6	18.0	25.6	22.9	6.1	23.2	12.6	14.5	28.1	15.9	32.4	35.5	35.8	37.3	33.7	34.3	37.0	35.7	36.4	37.7	34.9	39.8	66.5	83.3	38.1	25.5	40.5	90.1	37.3	75.1	41.5	14.6	41.3	63.5	37.3	40.0	50.3	23.9	6.2	52.1	28.4	80.1	21.5	165.4	98.2	56.5	64.8	121.5	47.8	35.1	47.6	122.0	92.5	52.4	42.3	99.9	31.7	41.8	75.0	27.8	101.9	11.8	48.4	53.1	144.5	33.0	292.4	17.4	47.8	73.0	30.2	44.0	97.0	37.3	23.7	39.2	37.0	411.0	73.8	69.6	48.6	61.0	70.8	38.6	36.6	16.6	32.9	26.5	131.9	59.1	71.6	113.4	109.4	62.0	37.0	53.9	58.7	64.5
RALGAPA2	"AS250, C20orf74, dJ1049G11.4, KIAA1272, RapGAPalpha2"	ENSG00000188559	"Ral GTPase activating protein catalytic subunit alpha 2"	Q2PPJ7	20	20389530-20712644	"Predicted intracellular proteins, Predicted membrane proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Astrocytes: 212.2;Microglial cells: 145.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RT4: 91.5;SCLC-21H: 51.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042707, HPA043622"	Uncertain		Supported	"Plasma membrane,Cytosol"		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 15: RT4 - Unknown function"	"Cluster 44: Endometrium - Transcription"	"Plasma membrane, Cytosol"		"HPA042707: AB_2678124, HPA043622: AB_2678585"	"unprognostic (7.40e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.69e-2)"	"unprognostic (1.09e-2)"	"unprognostic (2.36e-1)"	"unprognostic (3.34e-2)"	"unprognostic (3.36e-1)"	"unprognostic (3.29e-2)"	"unprognostic (1.95e-1)"	"unprognostic (3.56e-2)"	"unprognostic (1.74e-1)"	"unprognostic (8.23e-2)"	"prognostic favorable (3.77e-5)"	"unprognostic (6.52e-2)"	"unprognostic (1.54e-1)"	"unprognostic (3.48e-1)"	"unprognostic (5.33e-2)"	16.7	6.5	4.6	6.1	6.2	20.6	15.0	10.8	7.6	9.6	5.7	12.2	10.3	8.7	3.7	8.8	10.8	11.3	7.9	4.3	4.8	10.2	27.3	25.2	6.4	6.9	8.0	7.4	17.0	13.1	14.5	17.6	7.5	13.1	12.6	13.4	15.1	5.5	34.4	16.9	10.5	7.0	2.8	7.5	18.3	10.1	13.1	8.0	21.1	21.0	5.4	12.6	8.4	9.5	7.0	4.4	9.2	4.7	5.1	3.6	10.1	1.8	2.0	2.1	3.0	3.8	9.5	3.2	6.1	3.0	10.6	7.1	9.4	8.6	4.0	16.1	4.6	11.1	2.5	6.7	1.8	14.0	6.4	3.1	6.4	3.5	1.7	3.9	13.1	14.9	2.2	6.0	3.8	4.9	5.6	18.5	3.8	22.8	3.9	7.6	6.2	4.5	7.4	91.5	51.4	4.5	6.9	5.2	6.1	8.9	3.6	13.7	3.3	3.7	3.6	2.7	2.6	3.5	2.6	1.8	3.1	9.1	5.4	4.4	1.1	3.6	0.8	0.4	1.2	1.1	0.5	0.8	0.5	0.8	1.0	1.1	4.4	2.7	1.0	1.2	1.0	0.3	4.6	6.2	10.8	7.6	4.3	4.8	6.9	8.0	7.5	2.8	13.1	9.5	90.7	6.4	42.5	212.2	9.7	10.6	10.1	25.9	6.8	47.8	13.5	7.7	9.1	41.5	27.0	14.7	27.1	10.6	14.6	24.7	1.9	23.9	28.9	61.0	16.4	80.1	24.6	10.7	87.3	24.9	4.9	7.6	51.5	123.0	8.2	97.3	67.1	47.4	12.8	52.2	122.0	20.7	40.7	18.3	10.3	7.3	1.8	13.0	8.8	145.2	18.2	8.8	10.3	122.2	111.1	19.5	21.0	6.8	4.8	20.5	20.6	12.5	43.1	13.5	13.1	16.4	9.7	12.3	11.1	15.3	16.6	11.2	14.3	19.7	30.6	25.0
RAMAC	"C15orf18, FAM103A1, HsT19360, MGC2560, RAM, RAMMET"	ENSG00000169612	"RNA guanine-7 methyltransferase activating subunit"	Q9BTL3	15	82986210-82991057	"Predicted intracellular proteins"	"mRNA capping, mRNA processing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"Cytotrophoblasts: 108.2;Extravillous trophoblasts: 82.2;Hofbauer cells: 69.4;Syncytiotrophoblasts: 92.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA041923, HPA041948"	Supported		Supported	Nucleoplasm		No	No			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 34: Non-specific - Transcription"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm		"HPA041923: AB_10796467, HPA041948: AB_10797270"	"unprognostic (1.51e-1)"	"unprognostic (1.16e-2)"	"unprognostic (5.30e-2)"	"unprognostic (1.03e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.96e-1)"	"unprognostic (2.58e-1)"	"unprognostic (2.32e-2)"	"unprognostic (3.63e-3)"	"unprognostic (2.09e-2)"	"unprognostic (4.72e-2)"	"unprognostic (7.46e-3)"	"unprognostic (9.57e-2)"	"unprognostic (2.72e-2)"	"unprognostic (9.47e-2)"	"unprognostic (2.45e-1)"	12.9	14.8	10.9	16.4	11.4	30.1	26.1	12.9	14.8	16.6	11.6	18.4	14.5	18.2	30.1	24.1	19.5	13.4	14.8	11.6	12.2	16.8	24.2	13.0	23.0	11.6	11.3	20.6	16.4	18.8	12.9	25.9	11.3	18.0	19.3	19.9	18.2	15.2	29.1	21.5	13.4	16.8	11.6	14.1	19.0	15.6	11.1	23.3	18.2	20.2	28.9	20.8	15.6	11.6	34.1	44.7	44.3	27.1	23.5	15.9	32.7	33.7	33.5	37.6	30.4	49.4	42.9	16.8	45.8	29.2	45.4	37.9	77.1	32.4	40.6	42.0	49.7	52.7	22.7	58.7	33.3	38.0	44.9	34.9	61.4	30.6	38.5	28.7	23.6	28.5	62.8	33.9	39.8	35.7	29.5	48.3	52.0	45.0	21.1	33.4	38.2	26.0	49.0	64.6	41.1	42.0	34.6	36.7	87.0	71.5	58.6	47.9	16.8	27.5	34.9	26.1	48.8	53.1	104.0	41.8	25.2	50.7	34.5	138.6	59.2	98.2	47.9	57.0	51.8	64.8	54.1	52.3	56.1	61.1	53.9	53.4	117.4	70.4	62.8	51.6	69.9	65.9	10.9	11.4	12.9	14.8	11.6	12.2	11.6	11.3	11.3	11.6	11.1	11.6	18.3	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	108.2	19.1	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	82.2	10.0	0.0	0.0	0.0	0.0	0.0	0.0	69.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	92.9	2.7	0.0	0.0	0.0
RAMP3		ENSG00000122679	"Receptor activity modifying protein 3"	O60896	7	45157791-45186302	"FDA approved drug targets, Predicted membrane proteins, Transporters"	Transport	Receptor	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 144.6"	"Group enriched"	"Detected in many"	12	"Adipocytes: 287.8;Endothelial cells: 366.0;Hepatic stellate cells: 555.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	7	"Karpas-707: 2.5"	"Group enriched"	"Detected in all"	4	"cerebellum: 62.2;cerebral cortex: 49.2;thalamus: 174.9;white matter: 60.0"	"Low region specificity"	"Detected in all"			HPA075527			Supported	"Plasma membrane"		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Plasma membrane"		"HPA075527: "	"unprognostic (1.62e-3)"	"prognostic favorable (2.89e-4)"	"unprognostic (4.85e-2)"	"unprognostic (6.88e-3)"	"unprognostic (3.68e-2)"	"unprognostic (1.44e-3)"	"prognostic favorable (2.50e-6)"	"unprognostic (1.14e-1)"	"unprognostic (2.35e-1)"	"unprognostic (3.19e-1)"	"unprognostic (2.79e-2)"	"unprognostic (9.49e-2)"	"unprognostic (1.09e-2)"	"unprognostic (1.20e-2)"	"unprognostic (2.43e-1)"	"unprognostic (1.91e-1)"	"unprognostic (9.21e-2)"	86.9	32.6	17.7	23.0	19.7	0.2	71.7	26.9	22.7	33.5	21.3	24.4	10.2	25.9	3.9	18.9	22.8	28.7	91.3	19.2	25.8	84.1	23.9	144.6	55.0	37.3	25.7	7.4	19.7	28.1	22.3	8.6	34.2	29.7	8.6	1.1	22.1	12.9	19.3	22.8	30.0	24.4	31.6	11.4	25.7	6.3	23.5	7.3	71.9	26.9	30.3	28.5	30.5	42.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.1	0.2	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.3	17.7	19.7	26.9	22.7	19.2	25.8	37.3	25.7	34.2	31.6	23.5	42.4	287.8	0.0	1.9	0.3	3.6	16.3	0.3	0.0	2.2	0.6	5.9	2.8	8.7	1.5	0.0	0.0	0.0	0.1	1.2	0.0	0.0	0.1	20.8	0.4	7.3	366.0	0.0	13.5	3.5	0.7	0.1	10.7	0.0	0.2	0.0	0.0	555.4	7.3	0.5	0.0	0.2	0.0	0.0	31.2	19.1	6.7	1.2	1.3	26.6	5.6	0.0	0.2	0.0	0.0	6.5	0.0	0.0	1.2	1.3	0.6	0.0	0.0	0.0	0.5	0.0	2.8	4.9	0.3	0.9	0.9	14.5	0.0	1.7	1.5	0.0	0.5
RANBP2	"ADANE, ANE1, NUP358"	ENSG00000153201	"RAN binding protein 2"	P49792	2	108719482-108785809	"Cancer-related genes, Disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"mRNA transport, Protein transport, Translocation, Transport, Ubl conjugation pathway"	"RNA-binding, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018437, HPA023960, CAB034063, HPA049497, HPA051675, HPA067564"	Supported		Supported	"Nucleoplasm,Nuclear membrane,Vesicles"		NA	NA		160000	"Cluster 38: Basophils - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 65: Plasmacytoid DCs - Unknown function"	"Nuclear membrane"	"Nucleoplasm, Vesicles"	"CAB034063: AB_2176784, HPA018437: AB_2620151, HPA023960: AB_2671385, HPA049497: AB_2680794, HPA051675: AB_2681570, HPA067564: AB_2685862"	"unprognostic (2.51e-1)"	"unprognostic (3.99e-2)"	"unprognostic (1.22e-1)"	"unprognostic (4.37e-2)"	"unprognostic (1.28e-2)"	"unprognostic (9.30e-2)"	"unprognostic (5.47e-2)"	"unprognostic (2.91e-1)"	"unprognostic (4.02e-2)"	"unprognostic (2.54e-1)"	"unprognostic (4.23e-1)"	"unprognostic (5.23e-2)"	"unprognostic (1.62e-2)"	"unprognostic (8.74e-2)"	"unprognostic (3.08e-1)"	"unprognostic (3.40e-2)"	"unprognostic (2.53e-1)"	20.3	24.3	8.6	16.3	11.6	42.1	19.7	14.4	17.1	18.1	20.3	15.6	13.4	17.7	20.5	14.3	14.6	13.7	14.9	11.8	9.4	18.1	17.4	14.0	18.6	9.2	8.1	24.4	20.2	30.1	21.5	16.5	9.5	20.9	15.2	26.5	16.4	17.2	30.3	17.2	13.4	15.2	8.6	15.0	17.6	21.3	8.2	23.3	28.4	23.6	18.0	16.9	12.1	12.2	40.5	24.2	34.1	31.0	38.7	34.5	32.9	35.5	28.0	28.7	25.1	60.7	18.9	63.2	26.8	37.2	35.3	33.1	58.9	36.9	41.5	38.9	28.5	65.9	30.3	43.2	22.5	77.9	21.3	29.1	27.5	44.9	34.7	28.3	44.5	27.1	71.9	34.0	38.4	22.3	34.8	31.6	43.0	20.3	28.7	32.3	52.3	30.7	25.3	49.6	49.4	22.6	31.5	26.7	34.7	20.4	17.2	35.4	53.5	29.8	39.6	21.2	40.2	27.9	44.4	55.8	23.1	34.4	23.5	5.4	2.6	2.7	3.7	1.7	4.1	2.7	3.0	3.4	2.2	2.7	2.9	3.3	3.9	2.2	3.6	2.6	2.7	1.4	8.6	11.6	14.4	17.1	11.8	9.4	9.2	8.1	9.5	8.6	8.2	12.2	54.5	76.9	85.3	48.6	91.5	55.7	34.5	39.1	61.5	51.2	34.1	25.8	103.9	38.6	63.0	58.8	73.0	28.8	96.1	28.9	1.9	34.7	77.3	83.6	65.3	55.7	106.4	50.5	125.5	50.9	17.5	56.5	68.3	142.1	84.9	52.2	31.4	56.6	47.9	32.0	92.2	59.5	44.7	44.9	80.7	32.9	38.5	114.0	48.0	55.3	57.0	20.0	34.0	44.2	80.0	41.5	29.9	56.1	118.4	44.1	28.8	15.6	67.0	40.5	46.0	56.9	59.0	78.3	65.4	53.3	67.8	40.6	104.8	25.3	38.3	38.7
RANBP6		ENSG00000137040	"RAN binding protein 6"	O60518	9	6011025-6015625	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043748, HPA052684"	Approved		Supported	Vesicles		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 36: HEL - Hemostasis"	"Cluster 52: Non-specific - Transcription"	Vesicles		"HPA043748: AB_10796796, HPA052684: AB_2681913"	"unprognostic (1.47e-2)"	"unprognostic (8.86e-2)"	"unprognostic (1.70e-1)"	"unprognostic (6.01e-2)"	"unprognostic (3.63e-2)"	"unprognostic (1.30e-1)"	"unprognostic (3.37e-1)"	"unprognostic (3.21e-2)"	"unprognostic (1.34e-1)"	"unprognostic (8.22e-2)"	"unprognostic (3.81e-2)"	"unprognostic (1.89e-2)"	"prognostic favorable (1.34e-7)"	"unprognostic (2.42e-1)"	"unprognostic (1.91e-1)"	"unprognostic (3.04e-1)"	"unprognostic (2.61e-1)"	8.6	11.4	8.3	12.9	8.8	31.0	11.4	11.5	12.4	7.7	18.4	7.1	7.5	8.8	7.0	7.9	7.3	7.6	12.4	9.3	10.8	13.4	15.2	8.4	17.0	11.2	9.7	9.6	7.8	13.6	5.0	8.9	11.9	9.7	7.1	21.6	8.6	8.5	16.3	9.9	8.6	10.3	9.2	13.1	11.1	5.9	10.0	19.6	12.0	16.1	16.2	8.7	5.6	10.3	25.1	13.6	27.2	23.4	23.6	18.6	14.6	30.9	21.9	26.8	21.6	7.5	7.7	33.5	8.4	24.7	13.1	14.0	24.2	28.2	29.7	80.1	13.9	88.3	53.0	15.6	13.9	34.2	17.9	20.2	15.2	16.5	16.3	21.1	31.3	30.1	6.9	27.3	25.8	8.4	24.3	54.8	12.3	9.0	11.0	25.6	16.7	15.7	28.1	17.6	13.2	19.9	14.7	11.0	8.7	22.3	17.7	23.0	37.6	25.1	14.9	12.4	29.4	16.3	27.8	31.5	14.4	19.8	9.3	5.1	4.5	3.7	2.6	6.3	2.5	2.5	3.8	2.8	2.7	1.9	4.4	4.2	1.3	2.8	5.2	3.1	5.2	2.9	8.3	8.8	11.5	12.4	9.3	10.8	11.2	9.7	11.9	9.2	10.0	10.3	11.3	9.6	8.1	8.8	11.5	10.3	6.6	10.1	13.1	18.0	8.1	5.6	24.4	8.6	16.3	11.0	2.1	8.8	12.0	4.1	7.9	8.6	1.6	12.2	16.5	13.1	9.5	8.6	15.9	10.9	4.1	8.3	16.8	17.7	10.8	10.1	10.0	13.7	4.4	11.8	19.0	3.2	2.0	10.5	6.0	1.2	6.5	7.2	1.8	8.4	7.2	15.9	9.2	3.0	20.5	7.5	3.8	6.8	11.8	5.7	1.8	12.5	8.7	23.1	0.0	11.6	10.2	10.1	9.3	9.8	9.5	6.6	13.3	12.7	4.8	7.3
RANBP9	RanBPM	ENSG00000010017	"RAN binding protein 9"	Q96S59	6	13621498-13711835	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 113.6;Excitatory neurons: 132.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB033767, HPA050007, HPA076784"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Nucleoplasm	Cytosol	"CAB033767: AB_2176959, HPA050007: AB_2680990, HPA076784: "	"unprognostic (3.59e-2)"	"unprognostic (6.57e-2)"	"unprognostic (4.37e-2)"	"unprognostic (2.67e-1)"	"unprognostic (1.78e-1)"	"prognostic favorable (9.97e-4)"	"unprognostic (1.30e-1)"	"unprognostic (4.61e-2)"	"unprognostic (5.87e-3)"	"prognostic favorable (2.47e-4)"	"unprognostic (1.61e-1)"	"unprognostic (6.74e-2)"	"unprognostic (3.51e-1)"	"unprognostic (7.19e-3)"	"unprognostic (1.52e-1)"	"unprognostic (3.49e-1)"	"unprognostic (3.09e-1)"	21.8	20.3	23.3	16.7	25.2	57.3	18.3	22.2	32.4	28.3	21.5	27.5	13.2	20.6	22.2	69.1	15.3	24.6	20.0	25.5	22.6	18.7	26.4	17.9	18.5	20.3	24.3	19.7	17.4	24.1	16.7	20.0	22.7	21.3	18.0	21.0	24.3	17.2	60.5	27.7	15.5	23.5	22.0	15.1	17.9	106.4	21.7	29.7	16.5	39.5	30.8	21.6	38.2	25.4	38.1	16.3	38.7	39.3	51.9	47.8	41.0	45.6	51.6	47.2	49.5	24.8	21.9	33.4	73.0	54.0	35.7	20.3	30.5	26.8	64.6	58.0	27.5	33.6	29.9	45.9	71.7	53.0	24.5	48.7	33.8	56.0	45.9	37.4	39.0	58.3	73.3	26.2	53.1	38.5	62.1	42.0	17.1	36.2	22.6	49.1	30.2	47.1	37.7	43.2	47.9	33.7	36.9	66.3	67.0	73.4	35.6	44.6	38.3	42.3	30.2	34.7	47.4	63.5	82.3	44.9	19.4	32.8	80.1	0.3	0.5	1.8	0.7	0.7	1.4	0.7	1.5	0.7	0.5	0.7	1.3	0.9	0.8	1.2	0.8	0.8	3.6	0.4	23.3	25.2	22.2	32.4	25.5	22.6	20.3	24.3	22.7	22.0	21.7	25.4	17.2	19.2	30.5	58.1	12.5	24.9	7.8	13.5	13.1	25.1	23.3	15.0	40.1	12.8	19.2	18.4	14.6	17.9	22.3	21.7	1.9	8.2	113.6	23.5	21.8	24.0	13.2	11.6	132.9	10.8	9.1	19.8	10.2	29.6	10.1	19.5	16.8	18.3	18.0	6.7	78.3	14.5	12.2	28.0	32.3	99.9	15.8	21.8	17.8	73.1	14.9	22.8	15.5	74.9	75.6	16.6	7.3	24.8	18.3	15.5	12.2	11.4	19.8	17.5	6.6	16.5	18.5	85.4	41.9	19.3	26.1	28.5	22.9	14.3	12.0	17.7
RANGRF	"HSPC165, HSPC236, MOG1, RANGNRF"	ENSG00000108961	"RAN guanine nucleotide release factor"	Q9HD47	17	8288654-8290092	"Predicted intracellular proteins"	"Protein transport, Transport"	"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"Early spermatids: 435.1;Late spermatids: 1448.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA057280, HPA057888"	Approved		Supported	Nucleoplasm,Cytosol		Yes	No			"Cluster 35: T-regs - Unknown function"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 31: Spermatids - Spermatogenesis"	Nucleoplasm	Cytosol	"HPA057280: AB_2683393, HPA057888: AB_2683549"	"unprognostic (2.87e-2)"	"unprognostic (2.93e-2)"	"unprognostic (7.41e-2)"	"prognostic favorable (1.65e-4)"	"unprognostic (1.47e-2)"	"unprognostic (2.51e-1)"	"unprognostic (1.90e-3)"	"unprognostic (2.26e-2)"	"unprognostic (2.45e-1)"	"unprognostic (2.01e-2)"	"prognostic favorable (4.39e-4)"	"unprognostic (1.43e-1)"	"unprognostic (6.34e-2)"	"unprognostic (3.11e-1)"	"unprognostic (1.01e-1)"	"unprognostic (2.14e-1)"	"unprognostic (1.13e-2)"	28.3	27.6	40.9	18.8	42.4	20.5	29.2	39.9	43.8	47.4	40.6	38.1	15.8	36.9	31.9	15.7	35.1	16.9	41.6	40.6	42.5	44.2	18.6	25.3	33.0	40.6	41.3	36.3	15.1	43.8	32.7	22.7	41.1	35.5	15.9	34.8	13.1	27.6	24.1	19.4	28.1	27.1	41.4	33.3	39.0	78.4	43.1	34.0	25.1	26.0	32.3	34.7	23.3	41.0	52.8	59.5	41.0	42.7	30.0	41.0	35.4	29.7	59.9	75.3	72.7	30.4	20.3	98.4	31.7	35.9	29.7	58.0	77.7	39.3	53.7	71.2	97.6	46.6	45.0	46.6	72.9	30.7	66.2	39.6	75.1	66.4	66.4	38.9	65.5	93.4	21.2	27.1	48.9	1.3	91.7	98.4	29.7	29.8	22.7	81.1	32.0	61.8	44.4	21.3	15.7	45.2	23.5	36.2	65.0	25.9	2.8	28.3	36.3	16.4	29.5	33.0	58.4	47.5	40.0	121.4	35.1	60.8	24.1	17.2	47.6	81.5	68.2	50.7	64.4	74.7	82.8	78.1	51.5	82.0	72.3	61.6	5.9	70.1	41.0	67.8	129.9	57.5	40.9	42.4	39.9	43.8	40.6	42.5	40.6	41.3	41.1	41.4	43.1	41.0	21.2	9.6	26.1	6.2	35.8	18.1	24.3	23.5	25.0	26.2	31.4	36.2	4.7	12.8	17.5	25.8	12.5	93.2	25.4	9.4	68.4	25.5	435.1	19.0	18.8	26.0	19.8	15.4	6.2	18.3	46.4	25.3	14.8	19.3	27.8	19.0	23.9	17.3	49.3	20.2	9.0	17.4	26.4	16.4	19.2	1448.8	28.3	18.9	17.8	1.9	29.5	33.6	58.7	3.0	9.5	21.1	21.2	31.6	37.5	22.9	14.3	66.7	14.3	38.4	19.7	16.3	34.0	180.6	23.0	10.6	19.6	112.9	35.6	28.1	21.8	16.1
RAP1GAP2	"GARNL4, KIAA1039"	ENSG00000132359	"RAP1 GTPase activating protein 2"	Q684P5	17	2755705-3037741	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 27.7;pancreas: 37.3"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 132.8;Inhibitory neurons: 67.9"	"Low cancer specificity"	"Detected in all"			"Group enriched"	"Detected in many"	12	"amygdala: 10.6;basal ganglia: 13.6;cerebral cortex: 11.0;hippocampal formation: 17.9;white matter: 11.9"	"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"SH-SY5Y: 52.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022148, HPA022896"	Approved		Supported	"Nuclear membrane,Cytosol"		NA	NA		21000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Nuclear membrane, Cytosol"		"HPA022148: AB_1849474, HPA022896: AB_1849476"	"unprognostic (1.85e-3)"	"unprognostic (1.02e-2)"	"unprognostic (8.92e-2)"	"unprognostic (5.39e-1)"	"unprognostic (4.04e-2)"	"unprognostic (3.92e-1)"	"unprognostic (6.52e-5)"	"unprognostic (1.18e-2)"	"unprognostic (2.91e-1)"	"unprognostic (2.22e-1)"	"unprognostic (1.66e-2)"	"unprognostic (9.64e-2)"	"prognostic favorable (1.36e-6)"	"unprognostic (3.44e-2)"	"unprognostic (6.38e-2)"	"unprognostic (9.33e-2)"	"unprognostic (7.50e-2)"	1.8	6.4	10.6	4.1	13.6	27.7	4.4	0.9	11.0	3.9	0.0	7.9	8.7	4.1	1.1	3.1	8.1	4.0	14.5	17.9	1.1	5.2	0.6	3.5	2.9	0.0	0.0	4.6	37.3	4.2	5.1	4.9	0.0	3.8	8.1	7.2	10.9	4.7	0.8	3.3	8.2	3.3	0.0	3.9	22.4	3.2	0.0	2.8	2.5	2.0	2.5	2.0	2.5	11.9	8.1	9.9	1.9	8.1	0.0	0.0	15.9	10.7	5.0	1.3	1.2	21.9	3.5	3.0	2.9	1.4	13.5	11.0	6.4	20.0	0.4	0.0	6.9	3.7	14.1	9.9	1.9	0.8	3.9	0.5	17.0	5.5	13.9	7.2	0.2	3.7	21.4	1.4	0.0	9.1	3.1	2.0	11.7	3.9	9.5	13.4	6.9	7.8	5.9	4.1	21.6	52.3	15.5	15.8	6.9	7.4	7.8	2.3	2.4	9.1	14.3	1.6	9.1	0.0	0.0	1.2	0.5	6.9	15.1	0.9	1.4	2.1	2.8	2.7	1.1	0.2	0.9	2.1	1.0	0.2	0.1	1.0	4.2	1.9	3.9	1.7	1.0	1.4	10.6	13.6	0.9	11.0	17.9	1.1	0.0	0.0	0.0	0.0	0.0	11.9	1.5	6.4	2.5	13.7	5.6	2.0	6.6	1.8	1.2	23.6	9.9	7.6	20.2	11.5	2.8	12.9	33.3	7.5	27.2	15.2	9.8	6.0	6.1	9.2	6.8	1.6	48.1	0.8	132.8	12.0	6.0	2.2	18.8	9.2	6.3	3.0	3.6	0.8	3.4	37.0	67.9	21.7	8.2	11.1	4.3	8.3	1.8	11.0	3.6	47.8	12.0	2.1	35.0	8.0	4.2	12.4	24.1	1.5	6.4	16.5	5.7	0.8	4.2	4.6	0.0	7.9	2.5	0.4	3.4	2.8	0.4	3.4	8.2	1.5	14.0	11.3
RAP1GDS1	SmgGDS	ENSG00000138698	"Rap1 GTPase-GDP dissociation stimulator 1"	P52306	4	98261384-98443858	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"		"GTPase activation"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 72.4"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 434.9;Inhibitory neurons: 176.3;Late spermatids: 245.3;Oligodendrocytes: 357.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019060	Approved		Supported	Cytosol		NA	NA		62000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 77: Retina - Visual perception"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Cytosol		"HPA019060: AB_1856068"	"unprognostic (8.12e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.69e-3)"	"unprognostic (1.66e-1)"	"unprognostic (9.11e-2)"	"unprognostic (1.35e-2)"	"unprognostic (1.57e-3)"	"unprognostic (3.44e-1)"	"unprognostic (6.31e-2)"	"unprognostic (1.27e-1)"	"unprognostic (3.15e-1)"	"unprognostic (4.60e-1)"	"prognostic favorable (2.00e-4)"	"unprognostic (7.11e-2)"	"unprognostic (3.09e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.76e-1)"	15.6	12.6	49.3	18.8	54.9	14.3	17.4	56.3	56.7	11.7	25.2	16.5	10.0	12.2	11.2	18.5	9.6	11.6	9.6	48.3	54.1	16.5	21.1	14.0	23.4	59.5	62.6	10.8	19.1	10.3	16.1	13.2	67.6	10.3	18.6	65.7	12.5	15.1	5.8	14.4	14.3	22.1	51.9	18.0	11.2	22.6	64.4	32.4	17.6	5.7	24.4	19.0	12.9	72.4	50.8	30.4	37.8	32.8	47.6	56.4	14.2	86.7	48.6	51.1	40.0	22.7	66.5	61.0	26.3	65.9	24.3	27.8	47.0	80.5	68.7	60.4	17.1	37.0	35.6	29.6	93.8	64.1	25.2	65.7	47.8	45.3	69.5	42.3	67.9	61.9	25.7	51.6	128.3	27.7	104.9	31.3	13.9	43.0	19.0	41.5	22.4	20.8	51.7	40.8	55.0	32.5	36.2	81.2	48.9	20.6	18.5	41.5	67.2	52.7	36.8	23.9	51.7	16.5	30.1	51.1	43.9	47.3	69.7	32.8	17.4	10.4	23.3	24.9	24.2	23.9	24.4	23.5	27.9	17.1	12.3	19.5	2.5	37.0	28.5	60.6	41.2	14.8	49.3	54.9	56.3	56.7	48.3	54.1	59.5	62.6	67.6	51.9	64.4	72.4	17.6	16.0	12.2	88.8	34.7	13.9	10.8	11.7	22.8	48.2	17.1	12.2	11.1	14.3	14.7	16.5	50.1	6.8	45.7	9.7	23.5	17.7	434.9	7.4	16.2	15.7	20.9	19.8	146.4	20.9	16.5	11.5	16.8	11.2	15.2	19.8	13.9	18.5	23.8	15.2	176.3	13.0	12.2	33.4	27.6	245.3	9.3	24.7	17.8	89.0	32.6	16.9	34.0	110.6	357.6	23.4	14.6	10.9	30.4	16.3	14.5	20.4	7.6	77.5	0.0	12.7	17.2	16.7	36.5	26.8	16.8	4.5	34.3	19.8	18.4	15.1
RAPGEF1	"C3G, GRF2"	ENSG00000107263	"Rap guanine nucleotide exchange factor 1"	Q13905	9	131576770-131740074	"Plasma proteins, Predicted intracellular proteins"	Neurogenesis	"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 228.6"	"Cell type enhanced"	"Detected in all"		"Horizontal cells: 131.2;Langerhans cells: 108.6;Microglial cells: 123.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006426, HPA075984"	Enhanced		Supported	Vesicles		NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 41: Macrophages - Immune response"	Vesicles		"HPA006426: AB_1856070, HPA075984: AB_2686771"	"unprognostic (1.00e-1)"	"unprognostic (8.19e-2)"	"unprognostic (2.12e-2)"	"unprognostic (2.43e-2)"	"unprognostic (2.34e-1)"	"unprognostic (2.38e-1)"	"unprognostic (4.11e-2)"	"unprognostic (1.74e-1)"	"unprognostic (5.50e-2)"	"unprognostic (6.04e-2)"	"unprognostic (1.94e-2)"	"unprognostic (1.62e-1)"	"prognostic favorable (1.18e-5)"	"unprognostic (5.66e-2)"	"unprognostic (1.99e-2)"	"unprognostic (1.49e-1)"	"unprognostic (3.73e-2)"	37.3	24.0	41.4	53.9	72.6	53.2	26.8	27.0	37.1	20.4	37.9	31.9	23.9	25.6	8.0	23.6	25.5	23.7	57.8	40.8	40.2	23.0	23.0	43.3	56.1	35.8	36.9	16.3	47.8	20.1	16.4	56.4	32.3	21.5	23.4	27.5	20.2	21.4	228.6	21.9	35.3	30.4	25.6	41.9	29.1	15.9	43.8	35.1	22.7	104.8	63.1	25.8	18.2	20.2	34.5	39.4	39.1	39.6	39.1	42.0	149.2	29.0	59.0	33.0	23.6	49.0	22.1	61.9	35.6	58.8	70.7	61.4	45.1	40.5	16.4	144.6	18.6	18.3	67.2	26.2	32.8	76.1	80.4	32.2	73.0	43.3	51.0	33.1	60.4	70.8	49.7	119.1	43.4	35.7	54.0	27.0	39.6	34.1	35.2	53.0	91.0	86.8	14.9	41.1	33.0	32.9	42.5	39.8	42.3	39.0	38.1	63.1	64.4	88.1	36.7	56.4	44.7	39.8	37.3	122.0	41.9	32.0	21.6	3.1	1.2	1.6	3.4	2.2	2.0	4.9	2.3	2.3	1.4	2.9	0.5	1.5	1.3	1.3	2.4	1.6	1.8	1.6	41.4	72.6	27.0	37.1	40.8	40.2	35.8	36.9	32.3	25.6	43.8	20.2	73.5	6.4	13.8	27.1	35.6	18.7	9.3	10.9	5.2	19.5	10.8	13.5	16.2	14.3	12.3	5.5	14.6	22.7	49.7	23.3	5.9	8.2	2.6	13.0	9.4	43.0	12.1	1.7	47.5	18.6	35.3	11.8	17.9	17.8	20.3	14.0	22.5	17.4	26.4	131.2	66.6	14.9	8.2	23.9	108.6	2.5	8.7	51.6	32.0	123.7	59.8	19.7	27.8	61.3	24.7	17.1	19.1	12.0	88.0	11.7	16.8	9.2	16.7	13.4	6.6	13.4	10.3	5.1	11.8	5.6	11.4	51.7	31.0	5.8	14.0	10.8
RAPGEF2	"DKFZP586O1422, KIAA0313, PDZ-GEF1, PDZGEF1, RA-GEF"	ENSG00000109756	"Rap guanine nucleotide exchange factor 2"	Q9Y4G8	4	159103013-159360174	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Differentiation, Neurogenesis"	"Developmental protein, GTPase activation, Guanine-nucleotide releasing factor"	Epilepsy	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 456.2;Inhibitory neurons: 264.1;Microglial cells: 238.9;Oligodendrocyte precursor cells: 199.0;Oligodendrocytes: 236.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 5.9"	"Group enriched"	"Detected in many"	5	"granulocytes: 5.9;NK-cells: 3.3"	"Cell line enhanced"	"Detected in many"		"HMC-1: 104.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA068798			Supported	"Plasma membrane,Cytosol"		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Plasma membrane, Cytosol"		"HPA068798: "	"unprognostic (4.88e-2)"	"unprognostic (7.42e-2)"	"unprognostic (1.67e-2)"	"unprognostic (7.79e-3)"	"unprognostic (8.16e-2)"	"unprognostic (4.71e-3)"	"unprognostic (4.20e-3)"	"unprognostic (2.33e-1)"	"unprognostic (2.17e-1)"	"unprognostic (2.65e-2)"	"unprognostic (9.71e-2)"	"unprognostic (1.07e-1)"	"prognostic favorable (1.76e-7)"	"unprognostic (2.29e-1)"	"unprognostic (2.07e-1)"	"unprognostic (2.01e-2)"	"unprognostic (1.78e-1)"	22.7	9.4	8.7	13.4	19.8	87.5	24.1	4.1	32.1	16.7	0.0	21.8	15.9	16.1	9.8	13.8	14.0	20.1	23.2	27.4	0.3	22.7	30.5	26.6	11.9	0.0	0.7	13.5	19.5	23.5	15.3	38.5	0.3	12.2	20.8	35.1	25.3	12.6	21.7	17.5	17.0	19.7	0.6	29.7	19.3	9.8	6.0	17.5	39.5	31.4	11.5	14.8	11.8	18.6	8.9	11.9	55.4	17.2	21.4	23.9	84.9	17.0	21.3	15.2	10.9	36.7	19.4	50.7	6.1	17.0	22.0	8.0	19.1	21.8	18.0	8.6	13.2	79.0	25.3	21.4	15.5	9.7	104.5	14.1	12.1	36.5	12.9	32.0	44.1	20.7	17.6	46.0	19.0	15.6	24.1	1.5	23.7	10.4	11.8	19.7	14.0	2.0	13.6	20.2	15.7	21.0	24.9	12.1	20.0	26.5	6.0	6.3	47.0	23.9	25.2	30.7	14.2	51.0	32.9	0.8	28.3	4.1	14.8	2.2	1.0	0.7	0.5	0.5	0.6	0.2	0.4	0.3	0.5	0.2	0.6	0.3	5.9	3.3	0.6	1.0	1.0	0.3	8.7	19.8	4.1	32.1	27.4	0.3	0.0	0.7	0.3	0.6	6.0	18.6	66.7	57.7	30.1	110.7	12.9	20.4	11.2	7.5	9.6	19.7	23.5	11.9	39.0	11.5	13.8	7.3	41.7	11.1	20.2	24.8	0.0	9.2	5.3	43.5	19.5	49.2	14.4	38.9	456.2	12.6	9.6	16.9	7.7	59.2	51.8	22.9	32.2	30.5	10.8	33.7	264.1	12.0	2.0	24.6	20.1	5.3	7.8	29.5	33.8	238.9	15.6	30.2	2.1	199.0	236.2	22.1	17.7	8.6	40.5	17.6	7.1	8.7	18.7	22.4	52.6	28.1	37.2	3.5	8.9	10.7	20.0	5.9	12.9	7.2	7.9	15.1
RAPGEF3	"bcm910, cAMP-GEFI, EPAC"	ENSG00000079337	"Rap guanine nucleotide exchange factor 3"	O95398	12	47734363-47771040	"Predicted intracellular proteins"	Angiogenesis	"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 130.6;Astrocytes: 143.0;Collecting duct cells: 69.9;Endothelial cells: 53.0;Oligodendrocytes: 45.7"	"Cancer enhanced"	"Detected in all"		"thyroid cancer: 13.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"EFO-21: 26.9;HUVEC TERT2: 12.1;NB-4: 14.3;RPTEC TERT1: 13.3;TIME: 12.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004386, HPA040365, HPA043518"	Approved		Uncertain	"Endoplasmic reticulum,Cytosol"		NA	NA				"Cluster 57: Non-specific - Angiogenesis"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Cytosol	"Endoplasmic reticulum"	"CAB004386: AB_627521, HPA040365: AB_2676941, HPA043518: AB_2678524"	"unprognostic (2.12e-1)"	"unprognostic (2.88e-2)"	"unprognostic (2.99e-2)"	"unprognostic (1.81e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.82e-2)"	"unprognostic (1.23e-4)"	"unprognostic (9.35e-2)"	"unprognostic (1.25e-2)"	"unprognostic (5.32e-3)"	"unprognostic (4.67e-2)"	"unprognostic (4.37e-2)"	"prognostic favorable (6.67e-7)"	"unprognostic (9.16e-2)"	"unprognostic (2.92e-1)"	"unprognostic (2.61e-3)"	"unprognostic (3.38e-2)"	44.6	2.8	29.2	2.6	35.0	1.4	44.0	30.3	29.2	26.0	12.5	9.9	4.0	16.4	6.9	13.2	24.1	13.2	21.1	31.4	21.3	40.0	1.9	11.9	4.4	33.6	29.6	38.2	4.7	5.8	6.4	8.9	28.0	13.5	2.4	0.9	21.2	11.0	11.4	9.8	8.8	5.1	22.4	16.2	11.5	3.5	28.9	1.6	32.4	9.0	2.1	14.9	21.3	39.7	2.3	0.6	0.7	2.4	0.3	2.3	0.9	1.7	1.5	0.7	0.4	0.3	6.1	0.1	26.9	3.0	1.1	2.4	0.8	4.5	0.3	3.0	0.4	0.2	2.6	0.2	0.2	0.4	0.3	0.9	0.3	1.3	0.8	3.4	12.1	0.6	0.1	2.9	0.5	1.5	0.0	14.3	0.6	1.0	3.7	0.4	0.1	1.0	13.3	2.5	0.2	0.3	0.2	1.7	0.4	0.8	6.7	0.6	12.0	6.6	1.1	1.5	0.6	1.0	0.4	0.2	4.1	3.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	29.2	35.0	30.3	29.2	31.4	21.3	33.6	29.6	28.0	22.4	28.9	39.7	130.6	0.0	11.7	143.0	0.7	2.7	5.8	2.6	13.1	0.5	4.5	4.8	15.7	2.8	3.6	69.9	0.0	0.2	1.4	1.7	7.9	1.1	1.6	11.8	2.4	53.0	0.0	0.0	1.5	0.7	0.4	6.3	18.3	21.2	3.8	1.5	20.7	0.2	0.9	0.0	2.9	6.6	4.1	0.6	2.6	3.7	24.2	1.5	5.4	12.2	0.0	1.5	2.1	10.6	45.7	5.8	6.3	8.6	4.4	11.6	0.8	41.3	1.9	0.5	6.6	2.7	5.1	1.2	1.6	1.4	3.3	0.3	1.3	6.6	0.8	17.2
RAPGEF5	"GFR, KIAA0277, MR-GEF"	ENSG00000136237	"Rap guanine nucleotide exchange factor 5"	Q92565	7	22118236-22357154	"Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 152.1;parathyroid gland: 387.8"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 504.6;Inhibitory neurons: 193.4;Microglial cells: 138.7;Oligodendrocytes: 640.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"Daudi: 21.1;HUVEC TERT2: 45.0;SCLC-21H: 34.1;TIME: 25.8;U-698: 37.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA057821, HPA076772"	Uncertain		Supported	"Nucleoplasm,Nuclear bodies"	"Intracellular and membrane"	NA	NA				"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Nucleoplasm	"Nuclear bodies"	"HPA057821: AB_2683538, HPA076772: AB_2686814"	"unprognostic (1.00e-1)"	"unprognostic (1.57e-1)"	"unprognostic (3.17e-2)"	"prognostic unfavorable (9.44e-4)"	"unprognostic (5.22e-2)"	"prognostic favorable (3.52e-5)"	"unprognostic (1.16e-1)"	"unprognostic (2.10e-2)"	"unprognostic (1.64e-1)"	"unprognostic (2.10e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.31e-1)"	"unprognostic (3.76e-2)"	"unprognostic (6.36e-3)"	"unprognostic (6.57e-2)"	"unprognostic (2.55e-1)"	"unprognostic (8.26e-3)"	21.0	12.7	30.7	7.0	82.9	0.9	16.4	76.1	58.5	8.9	2.9	9.5	7.5	8.8	4.8	13.9	8.3	16.8	16.8	45.7	46.9	16.7	21.8	37.5	14.3	115.3	71.8	6.5	20.1	387.8	7.4	67.2	107.1	5.1	11.0	4.2	7.6	5.7	5.1	9.2	8.3	12.1	82.0	50.9	7.0	6.4	59.8	15.7	11.7	11.1	10.7	9.3	11.9	152.1	2.8	0.0	4.6	0.0	0.2	0.2	0.0	0.0	0.3	0.0	0.0	5.5	1.4	21.1	1.1	0.3	0.7	13.0	2.8	1.9	0.0	0.0	4.2	0.3	0.0	5.4	0.1	0.0	0.1	0.5	2.4	1.3	0.7	0.7	45.0	5.9	4.8	0.1	0.0	1.2	3.0	0.1	3.6	5.4	4.0	5.2	0.0	7.4	4.2	1.9	34.1	9.0	0.5	6.0	0.1	0.7	3.0	0.1	25.8	0.0	1.0	0.4	1.1	10.9	2.5	37.4	0.5	0.0	10.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	30.7	82.9	76.1	58.5	45.7	46.9	115.3	71.8	107.1	82.0	59.8	152.1	125.5	9.6	16.5	13.4	3.1	11.0	4.2	2.4	86.0	30.6	8.8	5.5	10.0	15.7	3.8	0.0	0.0	0.3	0.6	16.0	1.9	6.5	61.5	3.3	1.2	70.1	7.2	0.4	504.6	7.0	0.1	5.3	16.3	10.8	8.2	0.1	86.0	6.3	0.2	23.5	193.4	18.3	2.0	3.1	2.0	65.2	1.8	0.9	7.2	138.7	0.0	0.6	0.0	28.1	640.8	5.0	20.3	4.9	12.9	3.0	18.1	0.3	0.5	1.6	85.5	1.4	21.5	1.2	1.6	19.8	11.2	0.3	2.4	1.9	10.1	4.4
RAPGEF6	"PDZ-GEF2, PDZGEF2, RA-GEF-2"	ENSG00000158987	"Rap guanine nucleotide exchange factor 6"	Q8TEU7	5	131423921-131635231	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 35.5"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 119.1;Excitatory neurons: 243.0;Inhibitory neurons: 253.7;Microglial cells: 182.7;Oligodendrocyte precursor cells: 189.0;Oligodendrocytes: 479.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA037982, HPA037983"	Approved		Approved	Centrosome,Cytosol		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Cytosol	Centrosome	"HPA037982: AB_10670535, HPA037983: AB_2675769"	"unprognostic (1.86e-1)"	"unprognostic (5.16e-2)"	"unprognostic (5.64e-2)"	"unprognostic (2.69e-1)"	"unprognostic (3.54e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.41e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.86e-3)"	"unprognostic (3.72e-3)"	"prognostic unfavorable (3.87e-4)"	"unprognostic (3.57e-1)"	"unprognostic (4.10e-2)"	"unprognostic (6.31e-2)"	"unprognostic (2.81e-4)"	3.9	5.0	8.4	12.7	8.3	12.6	7.4	35.5	12.3	4.7	0.4	5.0	3.8	4.7	4.8	4.0	3.9	5.7	3.1	10.1	11.4	4.2	6.5	6.9	21.2	17.4	8.4	6.0	4.2	6.7	2.9	5.9	19.3	4.9	5.6	8.1	4.0	3.4	3.5	4.6	4.1	4.1	4.3	8.8	4.7	12.1	12.7	15.0	4.9	3.4	18.1	5.6	3.5	17.4	9.6	6.6	9.8	9.4	5.1	5.6	9.4	10.5	8.4	8.6	13.1	13.0	6.6	22.2	6.7	7.4	14.1	8.5	13.1	11.9	17.8	11.1	7.6	13.8	9.6	7.6	4.3	9.9	14.3	4.3	6.4	12.8	12.9	6.2	7.9	12.6	8.0	13.2	8.0	5.1	10.3	9.2	4.6	5.5	5.2	15.0	13.5	12.2	6.8	7.5	34.5	7.5	11.3	5.3	13.4	10.9	6.8	8.7	7.8	11.6	8.1	9.5	11.9	7.7	9.7	23.9	6.7	13.2	10.0	2.3	2.1	7.8	6.8	2.4	11.6	5.0	9.2	7.5	1.6	5.8	15.4	11.2	9.9	6.4	1.9	1.9	11.7	7.1	8.4	8.3	35.5	12.3	10.1	11.4	17.4	8.4	19.3	4.3	12.7	17.4	5.8	12.8	15.5	119.1	29.1	15.8	5.2	3.7	14.8	11.7	7.2	5.5	4.1	1.5	6.6	7.3	20.9	6.1	7.7	6.0	1.9	4.7	36.4	5.8	5.1	7.0	13.8	13.3	243.0	2.8	3.2	7.0	8.2	9.9	2.5	9.7	7.9	6.0	7.8	1.7	253.7	7.9	0.0	11.4	23.1	16.4	4.4	12.0	14.2	182.7	10.2	3.0	13.4	189.0	479.5	4.1	5.8	5.3	19.1	7.1	3.4	2.3	7.8	8.5	0.0	6.2	6.1	12.7	9.7	10.9	17.5	7.0	28.4	4.0	6.2	6.2
RAPH1	"ALS2CR18, ALS2CR9, KIAA1681"	ENSG00000173166	"Ras association (RalGDS/AF-6) and pleckstrin homology domains 1"	Q70E73	2	203394345-203535335	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 61.6"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 84.0;Hepatic stellate cells: 103.5;Microglial cells: 92.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016744, HPA020027"	Approved		Approved	"Nuclear bodies,Plasma membrane,Cytosol"		NA	NA		69000000	"Cluster 7: Monocytes - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 44: Endometrium - Transcription"	"Nuclear bodies, Plasma membrane"	Cytosol	"HPA016744: AB_1844781, HPA020027: AB_1844782"	"unprognostic (9.78e-2)"	"unprognostic (9.05e-2)"	"unprognostic (7.17e-4)"	"unprognostic (1.04e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.83e-1)"	"unprognostic (8.32e-2)"	"unprognostic (6.31e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.24e-4)"	"unprognostic (1.92e-1)"	"unprognostic (1.40e-2)"	"unprognostic (5.11e-2)"	"unprognostic (2.30e-1)"	"unprognostic (1.19e-2)"	"unprognostic (2.79e-1)"	11.1	6.5	1.5	5.2	4.6	3.1	13.3	1.3	7.9	9.4	0.3	7.0	7.8	5.6	4.6	8.8	5.1	8.9	5.9	5.0	8.5	7.2	61.6	14.3	3.7	2.4	7.0	2.0	6.4	5.6	3.6	13.0	4.1	6.6	7.3	7.3	8.6	4.3	6.6	8.9	7.9	7.8	0.1	16.9	8.8	9.4	2.7	2.6	30.0	6.2	4.9	7.7	6.6	2.2	11.1	7.5	15.6	9.0	12.0	15.4	14.7	15.1	11.0	15.3	19.1	35.0	11.4	0.0	3.7	23.1	11.2	5.8	8.2	12.9	31.7	2.2	4.6	0.0	17.9	6.2	30.0	0.1	0.2	21.5	10.7	28.1	29.4	16.8	24.2	1.7	0.8	8.2	31.0	6.2	0.1	0.0	9.2	5.7	10.0	0.2	22.0	6.9	11.2	34.9	5.5	7.5	10.3	9.8	12.5	20.4	5.5	0.5	29.0	37.5	12.5	18.2	16.1	3.8	7.7	0.1	30.9	0.2	8.4	0.0	0.2	0.0	0.0	0.7	0.1	0.0	0.1	0.0	0.3	0.0	0.1	0.0	0.0	0.2	0.7	0.0	0.1	0.0	1.5	4.6	1.3	7.9	5.0	8.5	2.4	7.0	4.1	0.1	2.7	2.2	36.3	16.0	8.4	12.7	1.2	49.1	20.7	10.3	16.5	11.3	21.6	9.4	1.1	15.7	9.7	14.7	14.6	8.9	0.8	32.9	7.9	6.3	14.4	24.4	17.7	29.0	2.4	3.2	84.0	9.3	7.6	23.4	47.9	65.7	1.3	6.2	103.5	79.6	18.1	10.1	56.7	8.6	4.1	17.8	51.1	4.9	4.7	28.8	12.4	92.8	3.3	18.6	0.0	41.2	9.1	20.5	21.3	4.9	0.1	19.0	22.4	2.8	5.2	4.4	19.7	26.8	33.4	29.3	19.6	26.9	40.9	10.9	2.8	0.9	13.3	28.4
RARA	"NR1B1, RAR"	ENSG00000131759	"Retinoic acid receptor alpha"	P10276	17	40309180-40357643	"Cancer-related genes, Disease related genes, FDA approved drug targets, Nuclear receptors, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Receptor"	"Cancer-related genes, FDA approved drug targets, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 52.6"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"MCF7: 221.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA058282, HPA071548"			Supported	"Nucleoplasm,Nucleoli,Actin filaments,Cytosol"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 59: Non-specific - Translation"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 41: Macrophages - Immune response"	Nucleoplasm	"Nucleoli, Actin filaments, Cytosol"	"HPA058282: AB_2683666, HPA071548: "	"unprognostic (8.05e-3)"	"unprognostic (1.89e-1)"	"unprognostic (9.48e-3)"	"prognostic favorable (2.60e-4)"	"unprognostic (8.67e-3)"	"unprognostic (4.87e-3)"	"unprognostic (2.77e-1)"	"unprognostic (5.73e-2)"	"unprognostic (1.45e-1)"	"unprognostic (3.54e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.79e-1)"	"unprognostic (2.29e-3)"	"unprognostic (1.59e-2)"	"unprognostic (5.60e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.09e-2)"	47.6	21.1	3.2	28.3	4.4	59.6	37.2	7.2	16.5	43.7	5.1	31.0	28.4	32.2	10.7	14.9	40.7	41.3	40.8	7.0	5.7	24.1	42.3	58.4	16.4	5.3	2.7	40.8	14.7	11.3	30.6	25.7	2.8	29.8	13.2	18.3	20.6	21.3	62.6	24.8	32.2	28.6	1.8	41.7	22.9	28.8	4.9	10.0	26.9	17.4	11.8	30.3	30.2	4.3	18.0	41.9	11.8	20.5	23.4	35.9	12.5	14.9	21.8	21.5	13.6	28.6	15.1	9.6	22.7	33.2	18.9	51.1	14.2	33.9	12.0	77.5	21.4	26.6	21.2	29.8	37.0	9.4	81.3	48.2	10.0	22.7	29.2	75.8	30.9	8.4	17.6	20.2	23.7	221.5	6.4	34.2	10.7	16.2	13.3	12.9	71.3	37.0	12.2	14.4	5.4	40.5	31.0	124.8	42.1	11.7	119.1	36.6	35.8	25.3	45.3	44.2	15.4	48.7	16.9	8.3	38.4	18.7	77.1	26.3	8.9	34.6	3.2	14.6	5.1	2.0	3.6	3.8	12.4	1.7	1.5	2.8	52.6	5.9	19.5	3.8	3.1	5.0	3.2	4.4	7.2	16.5	7.0	5.7	5.3	2.7	2.8	1.8	4.9	4.3	35.6	3.2	7.0	2.3	43.4	19.5	25.6	8.4	18.8	23.2	35.4	17.5	3.8	10.0	5.5	7.3	6.2	2.2	36.9	41.2	13.7	16.7	60.5	20.7	22.0	28.4	9.6	5.7	5.4	19.2	5.8	28.5	10.7	18.4	35.5	13.9	26.0	28.8	12.3	3.3	2.6	13.1	6.1	45.4	65.5	66.2	41.7	56.9	28.4	2.8	26.1	11.8	6.2	4.0	0.3	22.0	33.1	23.0	21.0	13.4	70.9	17.7	4.9	10.2	32.9	42.1	26.7	3.6	7.6	7.1	18.9	5.2	31.7	6.5	16.5	19.3
RARG	"NR1B3, RARC"	ENSG00000172819	"Retinoic acid receptor gamma"	P13631	12	53210567-53232980	"Cancer-related genes, FDA approved drug targets, Nuclear receptors, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Receptor"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 141.6;skin 1: 121.4"	"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 42.7;Squamous epithelial cells: 69.9;Suprabasal keratinocytes: 55.8;Urothelial cells: 45.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"MAIT T-cell: 18.8"	"Group enriched"	"Detected in all"	4	"dendritic cells: 6.7;T-cells: 18.8"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 101.0;MCF7: 110.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053883	Supported		Supported	Nucleoplasm		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 61: Squamous epithelial cells - Keratinization"	Nucleoplasm		"HPA053883: AB_2682292"	"unprognostic (7.29e-2)"	"unprognostic (1.95e-2)"	"unprognostic (6.11e-2)"	"prognostic unfavorable (3.68e-6)"	"unprognostic (2.53e-1)"	"unprognostic (5.43e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.08e-2)"	"unprognostic (3.54e-3)"	"unprognostic (7.21e-3)"	"unprognostic (3.78e-3)"	"unprognostic (4.44e-2)"	"prognostic unfavorable (3.08e-6)"	"unprognostic (5.41e-3)"	"unprognostic (1.98e-2)"	"unprognostic (5.94e-3)"	"unprognostic (7.41e-2)"	17.4	16.2	10.2	5.7	9.7	3.7	19.4	13.0	10.9	55.0	10.8	22.7	2.5	23.3	6.0	141.6	27.2	15.7	17.3	9.7	9.5	12.5	3.2	15.2	5.9	10.3	10.0	20.5	8.5	7.2	8.7	9.5	9.3	26.9	7.8	3.9	30.6	16.2	6.9	121.4	10.4	13.0	10.0	10.2	14.5	4.8	9.5	5.1	22.6	10.6	22.5	26.2	69.3	10.0	22.8	24.7	5.5	50.9	55.0	46.8	1.7	23.2	50.0	29.7	23.3	8.3	101.0	0.5	12.5	93.6	16.2	74.3	18.4	44.6	7.4	5.7	9.4	3.3	18.6	7.4	23.2	0.0	9.1	34.8	63.9	28.5	6.4	74.7	12.7	4.6	0.8	9.8	11.9	110.3	1.3	1.1	16.3	30.4	42.7	7.3	1.9	18.1	8.9	37.1	4.4	22.9	47.0	50.6	32.1	6.8	43.9	1.4	13.8	35.4	16.5	23.6	1.5	4.2	2.6	1.8	43.4	3.8	51.3	1.8	3.1	0.9	7.4	0.9	18.8	2.0	6.5	5.4	6.7	0.6	5.2	4.7	0.0	2.3	0.0	0.6	1.8	4.0	10.2	9.7	13.0	10.9	9.7	9.5	10.3	10.0	9.3	10.0	9.5	10.0	10.7	3.2	7.0	21.2	2.5	34.2	24.1	21.6	42.7	0.5	18.0	15.6	3.7	11.5	11.1	3.7	2.1	7.5	6.2	3.2	0.0	10.5	0.1	3.6	14.4	11.0	1.8	0.8	2.5	5.1	1.2	19.6	13.7	3.4	1.3	0.3	20.3	0.1	2.7	0.0	3.0	2.1	12.2	4.1	13.3	0.5	5.3	4.9	8.8	6.5	1.8	3.6	5.2	7.1	0.7	14.3	4.4	5.3	3.0	19.2	0.2	0.5	3.9	5.2	6.6	9.5	22.0	0.8	5.6	69.9	55.8	1.8	7.2	0.4	5.5	45.7
RARS1	"DALRD1, RARS"	ENSG00000113643	"Arginyl-tRNA synthetase 1"	P54136	5	168486451-168519301	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase"	"Disease variant, Leukodystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"Cardiomyocytes: 50.8;Cytotrophoblasts: 104.2;Extravillous trophoblasts: 96.8;Hofbauer cells: 57.2;Syncytiotrophoblasts: 84.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003979, HPA004130"	Approved		Supported	Nucleoplasm,Nucleoli,Cytosol		NA	NA		74000	"Cluster 27: Non-specific - Gene expression"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 24: Non-specific - Transcription regulation"	Cytosol	"Nucleoplasm, Nucleoli"	"HPA003979: AB_1856083, HPA004130: AB_1856084"	"unprognostic (1.06e-2)"	"unprognostic (1.92e-2)"	"unprognostic (2.74e-3)"	"unprognostic (2.82e-2)"	"unprognostic (2.50e-1)"	"prognostic unfavorable (7.59e-5)"	"prognostic unfavorable (1.10e-8)"	"unprognostic (3.26e-3)"	"unprognostic (5.16e-1)"	"unprognostic (4.22e-2)"	"unprognostic (2.92e-2)"	"unprognostic (4.27e-2)"	"unprognostic (5.43e-2)"	"unprognostic (6.43e-2)"	"unprognostic (2.35e-1)"	"unprognostic (2.39e-1)"	"unprognostic (1.33e-2)"	27.5	25.6	12.7	31.5	12.3	12.8	36.3	19.6	15.6	22.9	9.4	37.6	54.8	26.7	33.5	38.2	25.8	23.4	29.5	12.8	11.2	33.2	43.5	22.0	31.0	9.0	10.7	23.0	34.4	32.7	16.6	36.5	9.8	27.9	43.0	17.2	32.9	23.5	31.1	41.8	48.7	32.8	5.4	21.8	32.8	23.2	12.1	23.5	30.2	34.6	40.6	41.1	25.2	21.4	100.2	115.6	82.5	94.2	113.4	128.9	143.9	143.4	122.3	145.7	168.7	198.4	105.6	104.3	114.2	137.2	149.3	93.9	111.0	192.7	188.5	110.1	76.5	71.2	103.1	126.5	96.8	169.2	72.6	99.7	100.8	159.0	76.0	89.3	118.5	56.4	107.7	51.9	158.1	92.4	70.7	68.7	138.1	86.7	77.8	30.3	122.0	99.7	129.7	110.8	79.6	97.7	109.1	124.7	152.7	101.1	113.4	69.9	118.7	104.7	96.3	81.9	169.4	51.8	100.3	105.7	114.3	118.0	101.9	5.2	21.5	8.2	17.4	27.3	20.2	15.5	17.2	18.8	32.1	9.5	21.2	22.6	5.8	26.6	26.7	14.7	19.3	18.2	12.7	12.3	19.6	15.6	12.8	11.2	9.0	10.7	9.8	5.4	12.1	21.4	10.8	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	50.8	0.0	0.0	0.0	0.0	104.2	7.4	0.0	0.0	0.0	0.0	0.0	0.0	5.4	0.0	0.0	0.0	0.0	96.8	12.8	0.0	0.0	0.0	0.0	0.0	0.0	57.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.4	0.0	0.0	0.0	0.0	84.3	1.4	0.0	0.0	0.0
RASAL3	FLJ21438	ENSG00000105122	"RAS protein activator like 3"	Q86YV0	19	15451624-15464544	"Predicted intracellular proteins, RAS pathway related proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"bone marrow: 23.5;intestine: 19.8;lung: 10.6;lymphoid tissue: 39.4"	"Cell type enhanced"	"Detected in many"		"B-cells: 39.4;dendritic cells: 70.9;granulocytes: 39.3;NK-cells: 139.0;T-cells: 76.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 30.6;HEL: 25.5;HMC-1: 46.7;Karpas-707: 52.5;NB-4: 27.8;RPMI-8226: 23.5;TIME: 35.5;U-937: 34.1"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			HPA043417	Enhanced		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 16: Immune cells - Immune response"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Nucleoplasm, Plasma membrane"		"HPA043417: AB_2678473"	"unprognostic (2.72e-2)"	"prognostic favorable (8.75e-4)"	"unprognostic (3.27e-2)"	"prognostic favorable (3.58e-5)"	"unprognostic (2.31e-1)"	"prognostic favorable (3.07e-4)"	"unprognostic (1.82e-2)"	"unprognostic (6.21e-3)"	"unprognostic (7.40e-3)"	"unprognostic (1.02e-1)"	"unprognostic (3.49e-2)"	"unprognostic (3.32e-1)"	"prognostic unfavorable (1.16e-6)"	"unprognostic (2.98e-1)"	"unprognostic (1.90e-2)"	"unprognostic (1.24e-2)"	"unprognostic (1.69e-2)"	3.7	2.6	2.8	17.3	2.9	23.5	1.9	3.1	3.6	1.8	2.9	4.2	4.5	1.5	0.7	2.8	2.2	3.6	1.4	2.9	3.2	3.7	3.6	10.6	32.8	4.2	3.3	0.9	1.4	1.2	1.5	1.0	3.9	2.8	2.3	0.1	3.5	0.9	0.7	1.5	19.8	1.2	4.1	39.4	5.4	0.5	4.2	23.8	3.8	0.4	19.4	4.2	2.3	5.2	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.0	6.3	0.2	0.0	0.0	0.1	0.0	0.0	0.0	30.6	0.0	25.5	0.0	0.0	0.4	20.4	46.7	0.1	0.0	0.0	0.0	0.0	0.2	8.0	0.0	52.5	0.0	0.4	10.9	27.8	0.0	0.0	0.0	3.0	0.0	23.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	8.7	35.5	0.0	0.0	0.0	0.0	0.4	10.1	15.1	0.0	34.1	0.1	6.4	2.3	12.9	18.4	4.7	10.7	3.1	11.7	20.4	3.4	3.5	9.7	11.8	3.4	12.4	12.8	4.2	9.2	5.5	2.8	2.9	3.1	3.6	2.9	3.2	4.2	3.3	3.9	4.1	4.2	5.2	4.1	3.2	5.6	0.0	39.4	0.3	0.0	0.3	0.0	0.0	2.0	2.2	2.5	2.8	1.4	0.0	0.0	0.2	70.9	0.0	0.0	0.2	0.7	5.4	0.4	5.4	0.0	7.4	0.1	0.6	0.2	1.0	2.6	0.4	39.3	0.0	3.9	4.6	11.3	0.0	0.1	0.0	0.0	11.6	3.5	1.7	0.0	17.2	0.0	13.1	14.2	0.1	139.0	0.5	0.1	0.2	0.0	1.2	23.7	0.2	0.0	1.5	5.7	0.1	0.0	0.5	1.5	0.4	0.6	0.3	0.6	0.4	76.7	1.0	0.2	0.1
RASGRF1	"CDC25, CDC25L, GNRP, GRF1, GRF55, H-GRF55, PP13187"	ENSG00000058335	"Ras protein specific guanine nucleotide releasing factor 1"	Q13972	15	78959906-79090780	"Predicted intracellular proteins, RAS pathway related proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"brain: 26.5;lung: 7.5;retina: 7.4"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 2: 80.6;Excitatory neurons: 80.9;Inhibitory neurons: 91.2;Oligodendrocytes: 121.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 8.5;BEWO: 7.7;Karpas-707: 10.4;RPMI-8226: 13.0;U-2 OS: 15.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010413, HPA041965"	Approved		Supported	"Golgi apparatus"		NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Golgi apparatus"		"CAB010413: AB_2238127, HPA041965: AB_10793939"	"unprognostic (2.57e-3)"	"unprognostic (3.08e-2)"	"unprognostic (3.14e-2)"	"prognostic favorable (6.14e-6)"	"unprognostic (1.90e-1)"	"unprognostic (1.15e-3)"	"unprognostic (5.37e-2)"	"unprognostic (6.16e-2)"	"unprognostic (7.58e-2)"	"unprognostic (3.25e-2)"	"unprognostic (1.00e-1)"	"unprognostic (2.03e-1)"	"unprognostic (4.02e-6)"	"unprognostic (2.35e-1)"	"unprognostic (8.02e-2)"	"unprognostic (3.81e-2)"	"unprognostic (8.81e-2)"	0.1	0.1	4.2	1.0	4.1	0.0	0.1	24.4	24.4	0.6	0.0	0.2	0.2	0.4	0.1	0.1	0.4	0.1	0.0	12.2	6.4	0.7	0.0	7.5	1.3	13.9	10.2	0.8	2.3	0.6	1.1	0.2	16.4	0.5	0.2	7.4	0.1	0.2	0.0	0.0	1.4	0.1	8.7	0.6	0.2	0.3	14.9	0.5	0.0	0.0	1.4	0.3	0.1	26.5	8.5	0.1	0.1	0.0	0.0	0.0	7.7	0.0	0.4	0.5	1.2	0.0	1.5	0.4	0.2	0.0	0.6	0.7	0.0	0.2	0.9	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.4	0.1	0.0	0.1	0.1	0.3	0.0	0.0	0.0	10.4	1.1	0.0	0.0	1.4	0.0	0.0	0.0	0.0	1.9	13.0	0.1	0.3	0.8	0.0	0.0	0.1	1.6	0.7	0.0	1.7	0.0	0.0	15.1	0.0	0.3	0.0	3.8	2.9	0.0	0.2	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.2	4.1	24.4	24.4	12.2	6.4	13.9	10.2	16.4	8.7	14.9	26.5	0.2	3.2	80.6	8.5	4.5	0.6	0.6	0.2	0.0	13.7	0.2	0.1	1.0	0.0	1.9	0.0	0.0	0.9	0.0	0.0	0.0	0.1	0.2	0.6	0.4	0.5	0.0	0.0	80.9	0.0	2.7	0.3	0.0	1.8	0.0	0.0	0.0	0.0	2.0	25.2	91.2	0.0	0.0	0.3	16.1	0.0	0.0	1.8	3.6	5.6	0.6	1.1	0.0	1.5	121.5	0.3	0.0	0.4	2.1	0.2	0.0	6.8	2.0	2.5	0.0	0.0	0.1	0.0	0.5	0.0	0.3	0.8	0.1	1.6	0.0	0.4
RASGRF2	"GRF2, Ras-GRF2"	ENSG00000113319	"Ras protein specific guanine nucleotide releasing factor 2"	O14827	5	80960363-81230162	"Predicted intracellular proteins, RAS pathway related proteins"		"Calmodulin-binding, Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 22.9"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 220.6;Inhibitory neurons: 407.6;Microglial cells: 89.0;Oligodendrocytes: 395.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"gdT-cell: 1.9;MAIT T-cell: 5.2;memory CD4 T-cell: 2.6;memory CD8 T-cell: 1.5;naive CD4 T-cell: 4.2;naive CD8 T-cell: 3.0"	"Lineage enriched"	"Detected in single"	52	"T-cells: 5.2"	"Cell line enhanced"	"Detected in some"		"BEWO: 37.8;CACO-2: 23.3;Hep G2: 31.8;HHSteC: 20.8;hTERT-RPE1: 15.3;SuSa: 16.2"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in all"	4	"amygdala: 24.5;cerebral cortex: 77.3;hippocampal formation: 46.6;olfactory bulb: 27.0"	HPA018679	Uncertain		Supported	"Endoplasmic reticulum"		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 58: Brain - Synaptic function"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Endoplasmic reticulum"		"HPA018679: AB_1856089"	"unprognostic (1.32e-1)"	"unprognostic (6.96e-2)"	"unprognostic (7.27e-2)"	"unprognostic (7.80e-2)"	"unprognostic (3.62e-1)"	"unprognostic (1.00e-1)"	"unprognostic (5.76e-3)"	"unprognostic (2.58e-1)"	"unprognostic (4.02e-1)"	"unprognostic (8.51e-2)"	"unprognostic (8.13e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.47e-3)"	"unprognostic (1.37e-3)"	"unprognostic (2.13e-2)"	"unprognostic (5.01e-2)"	"unprognostic (1.12e-1)"	11.2	0.9	10.5	3.4	9.4	1.0	7.3	1.2	14.9	3.4	16.1	2.9	1.8	2.4	0.8	1.3	2.2	5.2	5.4	11.6	4.8	4.8	0.5	3.3	3.5	3.4	2.2	17.6	1.0	2.3	4.1	10.2	2.5	3.6	1.4	22.9	1.5	1.5	2.7	1.1	2.4	2.6	5.1	2.2	1.8	2.0	13.8	1.5	4.7	6.8	2.8	3.4	2.4	10.0	0.0	2.1	0.5	0.3	0.0	0.0	37.8	0.7	9.3	0.4	0.4	23.3	0.0	0.4	11.9	0.0	0.2	0.6	0.0	0.0	1.2	0.6	4.0	0.2	0.3	31.8	20.8	0.0	0.0	1.0	0.1	8.8	0.1	15.3	0.2	0.5	0.0	0.1	0.0	0.3	0.3	0.2	4.5	0.0	0.1	0.2	4.5	0.1	1.4	0.0	0.4	0.5	0.1	0.0	0.3	16.2	0.0	0.1	0.1	0.0	0.2	0.2	0.1	0.1	0.1	0.3	0.2	0.1	0.4	0.0	0.0	0.0	1.9	0.0	5.2	0.0	2.6	1.5	0.0	0.0	4.2	3.0	0.0	0.0	0.0	0.0	0.7	1.0	10.5	9.4	1.2	14.9	11.6	4.8	3.4	2.2	2.5	5.1	13.8	10.0	45.3	0.0	1.1	10.1	0.6	1.7	0.3	0.1	0.0	15.9	0.2	0.3	5.2	0.0	0.6	9.2	58.4	1.1	2.2	0.2	0.0	0.4	10.2	1.3	0.3	23.7	0.0	0.0	220.6	0.0	26.9	2.5	0.5	1.1	0.0	0.2	5.3	0.1	1.1	1.7	407.6	0.5	0.0	0.3	0.8	3.0	0.9	0.5	1.8	89.0	0.2	3.7	6.2	8.5	395.6	0.7	1.2	9.1	0.9	0.3	1.0	2.1	0.0	42.1	0.0	1.5	0.9	6.7	1.6	0.3	0.6	0.8	7.5	4.1	1.3	0.5
RASGRP1	"CalDAG-GEFII, RASGRP"	ENSG00000172575	"RAS guanyl releasing protein 1"	O95267	15	38488103-38565575	"Disease related genes, Predicted intracellular proteins, RAS pathway related proteins"	Differentiation	"Guanine-nucleotide releasing factor"	"Disease variant, Systemic lupus erythematosus"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 23.7;lymphoid tissue: 45.7;retina: 29.7"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 71.4;Excitatory neurons: 54.1;Muller glia cells: 86.9;Plasma cells: 43.0;T-cells: 84.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"T-reg: 10.3"	"Lineage enriched"	"Detected in many"	4	"T-cells: 10.3"	"Group enriched"	"Detected in many"	4	"HDLM-2: 54.5;JURKAT: 70.2;MOLT-4: 52.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039389			Supported	"Plasma membrane,Cytosol"		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 20: Retina & Lymphoid tissues - Unknown function"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 24: Non-specific - Transcription regulation"	Cytosol	"Plasma membrane"	"HPA039389: AB_2732481"	"unprognostic (3.44e-3)"	"unprognostic (1.86e-2)"	"unprognostic (1.17e-2)"	"unprognostic (3.43e-3)"	"unprognostic (1.82e-2)"	"unprognostic (3.33e-3)"	"unprognostic (9.63e-2)"	"unprognostic (4.23e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.21e-1)"	"unprognostic (4.50e-1)"	"unprognostic (3.01e-2)"	"unprognostic (2.54e-1)"	"unprognostic (2.55e-1)"	"unprognostic (1.51e-1)"	"unprognostic (3.40e-1)"	"unprognostic (9.30e-2)"	1.1	0.8	6.7	10.5	16.8	8.5	1.7	23.7	13.2	0.8	0.0	1.4	2.4	1.4	0.4	5.9	4.4	2.5	1.2	11.6	3.3	5.5	1.1	4.1	21.4	15.3	2.5	0.4	1.8	0.5	0.5	0.9	17.9	0.7	2.1	29.7	1.7	0.7	0.4	6.9	3.6	0.6	0.0	8.9	4.5	2.0	8.8	45.7	0.6	0.7	16.4	3.4	2.0	9.2	0.0	0.4	1.0	0.3	0.0	0.0	0.1	4.1	1.2	2.0	1.7	4.5	0.0	11.6	0.9	0.1	0.2	0.2	2.4	0.0	1.9	54.5	2.2	0.9	0.5	0.0	0.6	0.5	0.8	0.0	0.1	1.1	0.0	0.0	0.0	70.2	0.5	3.6	0.0	1.7	52.3	0.1	0.7	0.0	0.0	14.4	0.3	0.0	2.0	0.1	4.7	1.7	2.6	0.1	0.2	1.5	1.2	0.0	0.2	0.4	1.6	5.6	0.8	8.7	4.6	13.6	0.2	0.1	0.6	0.0	0.0	0.9	5.2	0.0	3.7	1.1	5.7	5.2	0.0	0.6	5.2	5.3	0.2	2.4	0.0	0.0	10.3	1.4	6.7	16.8	23.7	13.2	11.6	3.3	15.3	2.5	17.9	0.0	8.8	9.2	0.9	6.4	10.7	6.5	26.5	2.4	0.4	6.8	4.6	9.6	3.4	2.0	4.5	5.7	2.7	33.1	10.4	0.3	71.4	0.1	3.9	18.4	1.5	7.6	1.6	0.8	0.0	0.0	54.1	10.0	0.2	1.2	1.1	6.6	3.8	0.4	1.1	0.5	0.7	6.7	16.5	1.3	0.0	0.8	6.1	0.7	0.0	3.0	7.2	9.4	3.0	86.9	34.0	2.5	3.9	34.1	0.0	0.0	43.0	0.7	0.3	7.8	0.4	21.3	0.0	1.9	1.3	1.2	3.8	4.0	8.2	0.0	84.7	0.3	0.9	0.5
RASGRP2	CALDAG-GEFI	ENSG00000068831	"RAS guanyl releasing protein 2"	Q7LDG7	11	64726911-64745456	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"		"Guanine-nucleotide releasing factor"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 147.3;lymphoid tissue: 140.5"	"Cell type enhanced"	"Detected in many"		"B-cells: 125.5;dendritic cells: 86.1;Kupffer cells: 77.3;Macrophages: 72.2;NK-cells: 98.9;Sertoli cells: 131.5"	"Cancer enhanced"	"Detected in many"		"testis cancer: 5.8"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEL: 103.4;HL-60: 192.8;NB-4: 347.1;REH: 105.0;THP-1: 108.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015635, HPA015667"	Approved		Supported	"Plasma membrane"		NA	NA		1900000	"Cluster 37: B-cells - Transcription"	"Cluster 2: Immune cells - Immune response"	"Cluster 24: NB-4 - Immune response"	"Cluster 57: B-cells - Immune response"	"Plasma membrane"		"HPA015635: , HPA015667: AB_1856090"	"unprognostic (5.96e-2)"	"unprognostic (3.24e-3)"	"unprognostic (5.55e-2)"	"unprognostic (1.50e-2)"	"unprognostic (3.52e-2)"	"unprognostic (4.74e-5)"	"unprognostic (1.11e-2)"	"unprognostic (7.36e-3)"	"unprognostic (2.02e-1)"	"unprognostic (3.33e-1)"	"unprognostic (4.91e-3)"	"unprognostic (1.97e-1)"	"prognostic unfavorable (1.38e-4)"	"unprognostic (1.08e-1)"	"unprognostic (5.40e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.23e-1)"	23.8	10.1	16.1	52.9	35.5	147.3	16.8	9.6	22.4	20.1	7.1	37.5	6.6	28.3	4.6	9.1	29.2	8.7	51.7	13.4	13.4	15.8	10.1	29.5	106.0	12.4	16.3	9.1	4.1	1.0	5.5	10.9	11.9	23.2	5.3	1.3	4.6	18.6	12.2	6.1	86.4	15.0	9.5	140.5	17.5	11.9	20.7	34.6	10.6	10.2	62.0	26.7	15.5	9.8	0.1	0.1	3.0	0.1	0.0	0.3	8.7	1.3	0.2	1.2	0.8	1.5	0.2	62.8	2.7	0.2	0.8	0.7	5.4	0.9	0.3	0.3	1.7	103.4	0.0	0.4	0.3	192.8	35.9	0.0	0.0	0.5	0.0	0.0	0.1	25.9	4.1	1.1	0.0	1.4	45.4	347.1	2.5	0.4	0.0	105.0	0.2	4.4	0.0	0.0	0.5	2.3	0.1	0.1	0.0	2.2	0.6	108.5	0.6	0.0	2.0	1.5	0.1	0.5	0.1	58.9	0.0	58.2	0.0	64.4	34.1	59.9	70.4	88.0	37.3	170.7	72.9	57.2	34.5	100.2	92.7	83.1	70.9	55.3	105.8	85.9	93.8	67.5	16.1	35.5	9.6	22.4	13.4	13.4	12.4	16.3	11.9	9.5	20.7	9.8	27.4	3.2	1.8	2.6	125.5	2.3	0.1	0.0	0.0	2.6	1.6	3.7	53.1	2.8	0.0	0.0	0.0	1.7	86.1	0.1	0.0	0.0	6.6	1.9	27.1	13.5	0.0	24.2	6.0	0.0	1.3	6.6	2.6	1.2	3.8	5.7	31.4	1.7	6.1	0.0	12.2	0.1	0.0	77.3	19.7	19.5	18.0	72.2	0.0	6.5	55.8	0.7	98.9	2.5	0.9	0.0	0.0	47.8	28.6	0.1	0.4	0.9	0.7	2.5	131.5	5.4	56.8	18.0	43.9	0.9	1.3	11.8	61.0	0.8	0.3	0.2
RASGRP4		ENSG00000171777	"RAS guanyl releasing protein 4"	Q8TDF6	19	38409051-38426305	"Predicted intracellular proteins, RAS pathway related proteins"	Differentiation	"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"bone marrow: 20.8;lymphoid tissue: 8.9"	"Group enriched"	"Detected in some"	11	"Cardiomyocytes: 18.1;granulocytes: 26.6;Hofbauer cells: 15.1;Kupffer cells: 32.9;Langerhans cells: 11.6;Macrophages: 19.1;monocytes: 25.7"	"Cancer enhanced"	"Detected in many"		"testis cancer: 3.2"	"Low region specificity"	"Detected in some"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 39.4"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HEL: 25.7;HMC-1: 24.0;U-937: 6.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA041929			Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	"Nucleoplasm, Cytosol"	"Plasma membrane"	"HPA041929: AB_10961405"	"unprognostic (1.22e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.39e-2)"	"unprognostic (1.39e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.00e-1)"	"unprognostic (5.23e-4)"	"unprognostic (6.54e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.30e-3)"	"unprognostic (2.19e-2)"	"unprognostic (1.05e-1)"	"unprognostic (4.56e-1)"	"unprognostic (2.66e-2)"	3.2	0.8	0.3	6.7	0.3	20.8	0.7	0.3	0.9	1.1	0.4	1.2	1.2	0.5	0.1	1.0	1.0	1.9	0.6	0.2	0.3	0.3	0.7	3.3	1.1	0.9	0.4	0.4	1.1	0.3	0.2	2.3	0.6	0.5	0.8	0.0	0.4	0.5	0.8	0.5	1.8	2.0	0.7	8.9	0.9	0.2	1.1	1.1	0.2	1.4	0.7	2.5	0.4	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	25.7	0.0	0.0	0.0	0.1	24.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.4	0.0	12.5	13.5	20.1	0.0	15.4	0.0	0.1	0.3	0.0	9.4	0.1	0.0	0.0	39.4	0.0	17.9	0.7	1.4	4.4	0.3	0.3	0.3	0.9	0.2	0.3	0.9	0.4	0.6	0.7	1.1	1.0	0.2	0.0	0.6	0.0	0.2	0.8	0.0	0.0	0.0	0.1	0.0	0.3	18.1	0.0	1.3	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.8	0.7	0.0	0.2	0.4	0.0	0.0	26.6	0.0	1.4	0.0	15.1	0.0	0.4	0.0	0.0	32.9	11.6	0.0	0.0	19.1	1.8	0.0	25.7	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.7	0.0	0.4	0.4	0.0	0.1	0.0	0.0	0.3	1.5	0.0	0.0	0.1
RASSF10		ENSG00000189431	"Ras association domain family member 10"	A6NK89	11	13009316-13012119	"Predicted intracellular proteins"	Neurogenesis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 6.0;skin 1: 6.6"	"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 64.3;Distal tubular cells: 25.4;Gastric mucus-secreting cells: 17.9;Squamous epithelial cells: 60.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"A549: 8.9;CAPAN-2: 7.8;HaCaT: 12.6;HMC-1: 6.2;RPTEC TERT1: 11.9"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA040406			Approved	Vesicles,Cytosol		NA	NA				"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 61: Squamous epithelial cells - Keratinization"	Vesicles	Cytosol	"HPA040406: AB_2732485"	"unprognostic (6.71e-2)"	"unprognostic (5.12e-2)"	"unprognostic (5.06e-2)"	"unprognostic (2.41e-3)"	"unprognostic (6.25e-3)"	"prognostic favorable (2.76e-4)"		"unprognostic (3.43e-3)"	"unprognostic (8.04e-2)"	"unprognostic (5.89e-2)"	"unprognostic (2.10e-1)"	"unprognostic (1.56e-1)"	"prognostic favorable (4.12e-5)"	"unprognostic (4.45e-2)"	"unprognostic (1.73e-1)"	"unprognostic (2.88e-1)"	"unprognostic (1.65e-2)"	0.3	0.0	0.4	0.0	0.8	0.0	1.3	0.2	0.5	0.6	0.3	0.4	1.2	0.1	0.1	6.0	3.0	0.3	0.3	0.2	0.3	3.4	0.0	1.2	0.0	0.7	1.0	0.0	0.0	2.1	0.1	0.0	0.7	0.6	0.4	0.0	4.6	0.2	0.7	6.6	0.5	0.0	1.0	0.0	3.6	0.5	0.1	0.5	0.1	0.2	0.5	1.1	1.5	0.5	0.4	8.9	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	7.8	0.0	0.5	0.0	0.3	12.6	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	6.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.8	2.2	0.0	1.3	0.0	0.0	11.9	1.3	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.8	0.2	0.5	0.2	0.3	0.7	1.0	0.7	1.0	0.1	0.5	2.0	0.0	5.1	0.7	0.1	0.0	6.3	0.0	64.3	0.0	5.8	8.0	0.9	0.0	2.5	1.8	0.0	0.2	0.0	0.9	25.4	0.6	0.0	6.0	1.1	1.4	2.4	0.0	0.0	0.2	0.0	0.2	17.9	11.1	1.3	0.0	3.9	0.0	0.1	0.0	0.0	1.5	0.0	0.0	0.0	0.3	0.3	0.5	0.0	1.9	0.0	0.9	0.0	0.0	0.0	11.5	1.2	0.0	0.0	1.9	0.0	4.5	7.3	0.0	0.0	0.5	0.3	0.0	0.8	60.0	0.0	0.0	0.2	0.0	5.5	3.5
RASSF2	"CENP-34, KIAA0168"	ENSG00000101265	"Ras association domain family member 2"	P50749	20	4780023-4823608	"Predicted intracellular proteins"	"Cell cycle"		"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 217.0;retina: 162.8"	"Cell type enhanced"	"Detected in many"		"Kupffer cells: 87.1;Langerhans cells: 75.8;monocytes: 148.5;Oligodendrocytes: 106.7;Peritubular cells: 149.7;Rod photoreceptor cells: 160.3"	"Cancer enriched"	"Detected in all"	5	"glioma: 48.9"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 56.8;BEWO: 59.2;Daudi: 62.7;HL-60: 74.7;NB-4: 96.3;U-937: 116.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051200	Uncertain		Supported	"Nucleoplasm,Golgi apparatus,Plasma membrane,Cytosol"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 77: Retina - Visual perception"	"Cluster 32: U-937 - Innate immune response"	"Cluster 41: Macrophages - Immune response"	Nucleoplasm	"Golgi apparatus, Plasma membrane, Cytosol"	"HPA051200: AB_2681386"	"unprognostic (6.51e-2)"	"unprognostic (3.67e-3)"	"unprognostic (5.31e-2)"	"unprognostic (1.47e-2)"	"unprognostic (3.15e-1)"	"unprognostic (1.46e-3)"	"unprognostic (2.80e-1)"	"unprognostic (7.01e-2)"	"unprognostic (1.38e-2)"	"unprognostic (2.41e-2)"	"unprognostic (4.93e-2)"	"unprognostic (3.90e-1)"	"prognostic unfavorable (7.82e-4)"	"unprognostic (3.51e-2)"	"unprognostic (1.35e-1)"	"unprognostic (3.49e-1)"	"unprognostic (6.46e-2)"	16.4	9.7	76.1	47.1	135.2	91.2	6.9	155.5	113.5	27.9	40.0	8.4	5.3	25.4	22.5	10.0	22.1	15.6	4.2	68.9	94.7	4.0	5.9	25.4	58.6	217.0	148.8	7.0	3.1	1.5	5.0	9.1	186.4	7.3	9.6	162.8	3.0	9.3	1.2	4.2	14.5	38.7	135.8	32.7	7.0	20.6	120.0	19.5	4.7	5.0	73.6	20.7	4.9	197.0	0.1	14.5	34.9	56.8	0.4	0.0	59.2	3.5	10.0	0.6	0.2	3.4	0.1	62.7	5.6	3.1	1.4	0.2	5.1	0.0	0.8	22.7	2.1	41.1	0.0	0.7	0.0	74.7	40.1	0.1	0.0	1.3	0.0	1.3	23.4	7.0	0.2	24.0	0.0	0.1	11.0	96.3	7.8	0.0	1.1	17.1	3.9	23.8	0.0	29.0	0.4	2.8	0.0	1.0	1.7	7.4	0.0	47.0	0.7	1.5	7.4	0.7	4.6	0.3	5.9	37.8	0.3	116.8	0.4	85.6	61.5	101.3	7.7	50.1	14.6	24.3	12.0	10.4	46.8	16.4	7.8	6.5	139.5	8.5	59.9	30.7	11.8	42.1	76.1	135.2	155.5	113.5	68.9	94.7	217.0	148.8	186.4	135.8	120.0	197.0	5.5	0.0	8.7	7.5	49.3	4.7	0.0	0.1	0.0	39.2	4.1	1.7	1.9	1.5	1.9	0.0	27.1	3.0	43.0	0.1	1.9	1.2	6.0	3.2	19.6	18.6	0.0	6.1	1.5	0.9	5.1	10.9	1.1	1.0	54.3	4.5	11.4	1.2	27.1	6.7	1.3	0.7	0.0	87.1	75.8	25.1	33.2	64.6	8.8	26.2	148.5	19.3	7.2	33.7	106.7	0.6	0.0	149.7	14.3	1.2	0.0	0.3	0.1	160.3	0.0	9.4	3.5	0.7	1.0	0.3	2.6	1.4	20.8	0.8	0.0	2.3
RASSF3		ENSG00000153179	"Ras association domain family member 3"	Q86WH2	12	64507001-64697564	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Langerhans cells: 149.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in all"	6	"neutrophil: 124.1"	"Lineage enriched"	"Detected in all"	6	"granulocytes: 124.1"	"Cell line enhanced"	"Detected in all"		"SK-MEL-30: 145.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022664, CAB034035, HPA038469"	Supported		Supported	"Plasma membrane,Cytosol"		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 41: Macrophages - Immune response"	"Plasma membrane, Cytosol"		"CAB022664: , CAB034035: AB_2176848, HPA038469: AB_10671743"	"unprognostic (1.63e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.55e-1)"	"unprognostic (2.37e-2)"	"unprognostic (2.55e-3)"	"unprognostic (3.73e-1)"	"unprognostic (2.37e-1)"	"unprognostic (6.21e-2)"	"unprognostic (3.66e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.45e-3)"	"unprognostic (7.16e-2)"	"unprognostic (2.01e-1)"	"unprognostic (6.98e-2)"	"unprognostic (1.59e-2)"	33.1	22.9	13.8	43.3	9.3	17.3	14.9	7.1	9.5	19.4	33.0	106.6	21.1	23.9	15.1	36.8	13.2	29.3	44.3	7.6	9.2	6.9	10.9	32.5	37.0	11.4	20.5	19.6	13.1	3.3	4.6	39.6	13.6	33.0	42.0	1.5	35.6	48.7	45.0	6.8	26.3	60.1	11.4	47.6	34.5	13.5	22.1	15.4	6.5	13.1	33.2	50.3	14.1	13.4	28.1	30.9	9.6	18.6	10.2	14.7	58.3	11.9	61.8	15.8	18.6	22.3	28.9	43.6	24.8	8.6	19.0	12.1	29.6	12.5	19.0	35.5	11.3	28.6	13.0	25.5	27.9	30.5	19.3	10.0	10.7	36.2	26.7	46.1	68.0	20.7	15.4	21.0	18.7	26.5	20.2	19.9	21.4	65.8	18.8	32.5	30.9	18.4	20.8	33.6	21.7	22.7	20.0	3.8	145.5	23.0	17.3	19.0	98.7	12.8	15.6	13.5	13.1	19.5	22.0	28.0	15.4	26.2	37.8	19.6	16.6	12.5	13.2	17.7	11.1	14.1	19.4	14.9	9.1	10.1	19.1	20.3	124.1	12.0	17.7	8.4	22.1	2.8	13.8	9.3	7.1	9.5	7.6	9.2	11.4	20.5	13.6	11.4	22.1	13.4	30.7	3.2	15.4	4.2	32.7	16.3	15.0	5.5	2.8	0.0	12.4	13.7	56.5	30.0	8.9	5.5	0.0	35.5	39.0	67.4	0.0	12.4	0.3	14.4	4.1	31.2	26.4	16.4	8.7	21.2	19.1	14.5	20.9	28.3	6.3	4.7	20.7	4.6	24.1	0.0	16.2	15.8	2.0	69.9	149.3	0.8	2.5	55.7	48.0	49.6	72.7	2.8	32.0	3.5	4.8	24.0	14.5	14.3	9.8	25.5	13.3	1.7	3.9	0.2	13.1	9.2	27.0	0.6	19.3	5.9	11.9	19.7	30.7	1.6	20.7	21.1
RASSF7	"C11orf13, CFAP88, FAP88, HRAS1, HRC1"	ENSG00000099849	"Ras association domain family member 7"	Q02833	11	560404-564025	"Plasma proteins, Predicted intracellular proteins"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 127.5"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 224.6;Intestinal goblet cells: 179.2;Paneth cells: 194.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 85.5;HaCaT: 86.4;SK-BR-3: 75.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA078015			Supported	"Centriolar satellite"		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Centriolar satellite"		"HPA078015: AB_2686875"	"unprognostic (1.11e-2)"	"unprognostic (5.10e-2)"	"unprognostic (1.75e-2)"	"unprognostic (2.24e-2)"	"prognostic unfavorable (6.09e-4)"	"unprognostic (1.13e-1)"	"unprognostic (2.46e-3)"	"unprognostic (1.01e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.60e-1)"	"unprognostic (2.55e-1)"	"unprognostic (5.05e-2)"	"unprognostic (3.49e-2)"	"unprognostic (2.30e-1)"	"unprognostic (1.99e-1)"	"unprognostic (2.83e-1)"	"unprognostic (3.58e-3)"	15.6	5.0	7.1	8.5	9.4	6.5	13.8	10.1	10.4	23.4	6.8	50.5	33.6	6.3	15.8	49.2	50.9	10.8	4.9	7.3	7.1	127.5	92.8	44.6	10.7	9.3	6.5	6.6	67.5	6.4	27.4	5.0	9.9	42.6	8.5	1.6	42.5	11.5	1.6	53.5	43.5	1.0	6.4	17.7	63.5	13.2	7.1	8.7	23.3	0.6	5.6	18.6	23.7	6.3	51.7	49.9	2.3	12.8	0.0	0.0	35.2	7.7	5.9	8.0	5.9	52.6	85.5	6.6	34.6	4.2	14.0	86.4	7.3	26.5	1.2	8.9	25.6	4.6	28.0	25.9	5.3	10.8	7.4	0.1	25.5	2.7	2.4	11.0	4.8	13.4	11.7	2.5	0.7	51.7	12.2	23.1	7.1	58.2	28.1	19.2	3.7	14.8	39.2	24.8	10.9	8.4	5.4	75.7	6.6	4.0	34.0	6.9	6.6	1.6	23.5	3.1	15.0	8.6	9.9	5.3	12.8	15.1	6.9	5.2	6.0	23.0	17.7	5.2	16.1	13.6	18.3	15.9	10.5	14.8	14.8	13.2	7.3	8.3	5.7	18.7	21.9	8.9	7.1	9.4	10.1	10.4	7.3	7.1	9.3	6.5	9.9	6.4	7.1	6.3	6.5	86.6	70.0	3.3	19.1	25.4	23.4	118.1	14.2	2.7	39.2	30.6	4.7	92.9	90.4	86.5	0.0	38.9	20.9	224.6	52.8	90.7	17.2	28.8	3.9	8.5	51.0	14.5	5.5	90.5	111.7	5.9	124.4	35.2	15.2	15.5	7.9	73.3	19.9	11.8	2.6	179.2	46.8	11.2	15.7	23.0	2.5	11.5	5.4	1.0	28.7	7.9	21.6	1.5	0.6	148.1	194.4	0.4	12.3	61.8	110.0	44.7	73.4	3.2	0.0	0.3	6.7	4.6	9.7	21.2	25.7	40.5	29.7	4.3	113.1	60.3
RAVER1	KIAA1978	ENSG00000161847	"Ribonucleoprotein, PTB binding 1"	Q8IY67	19	10316212-10333638	"Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 15.2;Enteroendocrine cells: 16.3;Plasma cells: 15.3;Proximal enterocytes: 14.0;Undifferentiated cells: 14.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"NB-4: 255.5"					"Low region specificity"	"Detected in all"			"HPA043575, HPA049457"	Enhanced		Supported	Nucleoplasm		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 72: Non-specific - Transcription"	"Cluster 24: NB-4 - Immune response"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm		"HPA043575: AB_2678562, HPA049457: AB_2680774"	"unprognostic (2.04e-1)"	"unprognostic (3.15e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.34e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.80e-2)"	"unprognostic (1.59e-1)"	"unprognostic (4.22e-2)"	"unprognostic (2.01e-2)"	"unprognostic (7.20e-2)"	"unprognostic (2.64e-2)"	"unprognostic (3.22e-2)"	"unprognostic (3.40e-2)"	"unprognostic (1.14e-2)"	"unprognostic (1.53e-1)"	"unprognostic (8.98e-2)"	"unprognostic (2.97e-1)"	12.4	12.9	4.1	11.8	4.9	19.0	12.6	3.9	5.5	17.9	6.2	20.4	17.7	22.8	0.7	15.1	19.8	3.3	9.7	3.7	4.4	12.0	8.3	13.1	11.1	6.9	5.0	19.3	11.7	4.4	17.5	6.0	4.4	15.2	3.2	1.1	13.1	7.5	8.5	11.8	22.6	4.0	3.8	21.7	13.9	11.5	5.0	11.4	14.3	2.2	5.2	16.8	14.0	4.5	62.0	38.9	14.1	21.6	5.6	7.0	31.0	31.9	14.0	24.7	21.8	42.7	17.3	65.0	43.7	10.4	19.9	31.5	15.8	21.1	4.9	55.2	93.5	100.3	25.7	48.6	12.6	63.5	62.4	8.2	7.2	16.6	6.2	8.2	16.2	48.6	80.9	56.2	7.6	57.8	85.6	255.5	55.1	13.1	73.9	78.3	20.5	57.2	6.9	24.4	40.3	46.7	34.7	22.3	18.3	4.8	32.0	30.5	22.5	63.7	32.4	56.7	54.5	122.1	109.0	54.9	42.1	44.2	42.5	0.2	1.3	1.8	3.3	1.5	1.7	1.4	2.8	4.6	2.1	2.0	1.9	1.7	1.2	1.9	3.3	0.9	1.1	2.2	4.1	4.9	3.9	5.5	3.7	4.4	6.9	5.0	4.4	3.8	5.0	4.5	1.2	0.0	1.1	6.5	7.8	0.8	0.3	0.5	10.2	0.8	2.0	1.1	0.7	0.0	0.4	0.0	0.0	2.0	2.3	15.2	0.0	4.5	0.4	1.6	2.2	1.1	16.3	12.0	4.8	4.3	1.9	1.6	6.1	1.2	4.5	0.6	0.4	0.3	1.3	0.0	4.5	9.3	0.0	0.0	0.8	0.0	0.0	2.0	0.0	6.5	6.8	0.3	0.0	4.0	4.2	5.4	10.2	0.7	15.3	0.3	14.0	0.6	1.1	1.0	0.0	0.8	2.4	0.7	0.3	6.1	0.1	1.5	5.5	0.6	14.3	0.2
RB1	"OSRC, PPP1R130, RB"	ENSG00000139687	"RB transcriptional corepressor 1"	P06400	13	48303744-48599436	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Host-virus interaction, Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding, Repressor"	"Cancer-related genes, Disease variant, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Langerhans cells: 198.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"MOLT-4: 187.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000095, CAB016687, HPA050082"	Supported		Supported	Nucleoplasm		NA	NA			"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 16: Immune cells - Immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 41: Macrophages - Immune response"	Nucleoplasm		"CAB000095: , CAB016687: AB_1622010, HPA050082: AB_2681008"	"unprognostic (4.24e-3)"	"unprognostic (1.00e-1)"	"unprognostic (3.62e-2)"	"unprognostic (4.67e-2)"	"unprognostic (2.04e-2)"	"unprognostic (3.86e-1)"	"unprognostic (4.69e-2)"	"unprognostic (7.08e-2)"	"unprognostic (1.59e-1)"	"prognostic unfavorable (6.92e-4)"	"unprognostic (4.06e-2)"	"unprognostic (9.40e-2)"	"unprognostic (4.67e-2)"	"unprognostic (1.79e-1)"	"unprognostic (9.99e-2)"	"unprognostic (2.31e-1)"	"unprognostic (1.70e-1)"	20.7	18.7	8.9	22.8	9.7	19.3	17.8	12.0	13.0	18.8	10.9	15.1	14.6	15.7	21.2	21.9	13.1	17.3	17.8	8.5	10.9	18.4	14.5	18.1	30.7	13.9	10.3	11.5	9.2	20.5	6.5	24.9	13.4	15.1	17.1	12.5	16.9	15.9	19.0	23.6	15.6	18.3	11.6	24.8	16.3	12.9	9.3	34.2	22.4	21.2	30.1	19.8	10.6	15.1	29.1	15.8	40.9	44.2	19.8	22.8	18.5	56.6	45.9	57.4	48.3	13.4	49.8	37.3	12.8	37.4	31.7	39.6	53.7	44.8	86.6	53.0	20.8	68.5	29.4	22.7	21.1	59.5	62.0	12.9	27.0	37.3	47.1	47.8	40.1	90.1	23.4	29.6	66.4	13.7	187.2	29.8	20.0	65.6	17.3	79.8	41.1	43.0	59.6	27.6	2.0	41.8	55.1	27.3	46.2	36.2	29.8	76.3	32.1	35.3	23.3	43.7	51.2	13.1	3.9	0.4	18.8	36.7	48.9	23.8	14.9	8.8	6.9	19.9	5.6	30.2	5.7	6.9	15.2	29.4	4.8	5.6	20.6	5.9	20.9	16.9	7.4	7.1	8.9	9.7	12.0	13.0	8.5	10.9	13.9	10.3	13.4	11.6	9.3	15.1	59.2	3.2	19.6	75.4	97.3	28.4	23.3	27.6	63.2	17.3	26.9	21.0	18.3	14.3	19.2	31.3	29.2	7.1	50.1	17.8	15.6	19.3	28.1	40.1	36.2	46.4	17.5	50.7	99.5	11.9	9.6	22.2	29.0	40.4	12.0	25.9	35.7	17.3	77.4	18.5	98.9	20.0	8.2	105.3	198.9	13.9	26.1	104.2	26.6	152.7	93.7	20.4	22.6	101.0	98.3	17.4	10.7	28.6	69.9	24.0	15.7	23.6	25.3	19.6	19.7	28.5	32.3	33.0	21.3	72.1	38.2	4.4	38.3	21.2	16.6	18.0
RB1CC1	"ATG17, Cc1, DRAGOU14, FIP200, KIAA0203, PPP1R131"	ENSG00000023287	"RB1 inducible coiled-coil 1"	Q8TDY2	8	52622458-52745843	"Predicted intracellular proteins"	"Autophagy, Cell cycle, Transcription, Transcription regulation"		"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024391, HPA053049"	Approved		Supported	"Nuclear membrane,Cytosol"		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 44: Endometrium - Transcription"	Cytosol	"Nuclear membrane"	"HPA024391: AB_2671554, HPA053049: AB_2682025"	"unprognostic (1.58e-2)"	"unprognostic (7.51e-2)"	"unprognostic (9.49e-2)"	"prognostic unfavorable (1.61e-4)"	"unprognostic (3.22e-1)"	"unprognostic (4.21e-2)"	"unprognostic (7.39e-2)"	"unprognostic (1.38e-2)"	"unprognostic (9.34e-2)"	"unprognostic (1.21e-1)"	"unprognostic (8.77e-3)"	"unprognostic (2.07e-1)"	"unprognostic (9.56e-3)"	"unprognostic (7.67e-2)"	"unprognostic (4.41e-1)"	"unprognostic (8.00e-2)"	"unprognostic (2.42e-1)"	17.6	15.0	37.2	11.8	30.4	52.3	17.0	26.5	40.2	15.2	16.4	13.7	12.9	17.4	13.0	16.9	12.1	13.8	24.1	27.2	23.9	17.1	21.5	14.9	13.3	29.9	25.6	20.1	16.8	22.2	8.0	15.5	24.1	15.5	11.3	20.3	16.2	12.2	38.9	15.0	14.2	15.0	23.0	14.3	14.5	34.7	33.1	22.2	17.7	32.1	12.9	14.3	11.1	43.5	23.8	20.8	25.2	22.1	27.4	31.0	14.4	17.7	36.1	18.4	22.8	14.6	26.3	17.4	29.0	26.2	46.4	31.0	31.4	16.5	34.5	13.1	27.4	29.7	20.8	20.2	33.7	10.7	16.0	29.1	33.4	18.3	49.6	38.2	25.2	26.8	35.8	27.4	22.6	15.6	27.2	15.7	24.9	22.4	10.3	13.7	12.1	17.7	16.9	18.5	24.0	25.0	18.4	20.9	39.8	29.3	23.8	19.3	29.9	17.5	24.2	27.8	15.7	26.8	24.8	17.0	27.6	18.2	20.0	47.9	12.9	24.6	11.6	12.2	11.8	12.3	9.7	11.9	12.6	9.5	11.9	11.0	40.3	14.2	17.1	6.3	14.1	11.9	37.2	30.4	26.5	40.2	27.2	23.9	29.9	25.6	24.1	23.0	33.1	43.5	83.8	195.5	121.7	73.8	66.3	88.3	60.2	32.0	51.2	82.0	45.5	39.5	163.8	20.0	57.4	18.4	68.8	27.0	74.2	45.4	9.8	52.4	61.9	103.6	112.7	66.0	44.2	117.7	104.0	49.3	26.3	78.2	36.2	143.5	25.9	78.1	36.8	44.5	23.6	87.5	123.2	31.9	30.5	44.5	41.4	49.8	77.3	60.5	42.7	76.8	67.6	33.0	64.9	106.1	104.2	63.5	43.3	73.4	86.1	99.0	47.2	27.0	115.3	57.3	46.0	132.2	76.9	238.8	132.7	59.4	91.9	60.5	66.2	68.6	27.7	88.2
RBAK	ZNF769	ENSG00000146587	"RB associated KRAB zinc finger"	Q9NYW8	7	5045821-5069487	"Metabolic proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA071231			Supported	Nucleoplasm		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA071231: AB_2686370"	"unprognostic (2.82e-2)"	"unprognostic (1.98e-2)"	"unprognostic (7.40e-2)"	"unprognostic (1.85e-2)"	"unprognostic (5.04e-1)"	"unprognostic (4.32e-1)"	"unprognostic (2.62e-1)"	"unprognostic (2.32e-1)"	"unprognostic (4.67e-2)"	"unprognostic (5.91e-2)"	"unprognostic (6.84e-2)"	"unprognostic (5.10e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.50e-1)"	"unprognostic (3.66e-2)"	"unprognostic (6.12e-3)"	"unprognostic (5.75e-2)"	4.3	3.8	4.1	4.4	4.0	3.7	5.8	6.7	5.4	4.7	3.7	4.6	4.5	5.2	4.7	5.8	4.4	3.7	4.3	3.8	4.5	4.4	6.5	4.0	6.4	4.5	5.0	4.8	5.5	6.9	3.9	4.5	4.4	4.7	4.9	8.4	4.6	4.7	4.2	6.0	5.1	4.4	4.2	5.1	5.0	2.9	4.8	5.6	5.5	6.1	6.7	4.1	4.6	4.8	8.9	6.7	9.2	17.0	6.6	6.1	7.5	5.5	4.3	5.3	6.3	8.3	5.4	10.5	4.5	6.4	10.0	10.8	10.4	8.5	8.2	2.3	7.4	7.7	9.2	6.9	7.0	12.9	8.9	5.9	9.9	5.3	11.8	7.7	5.3	6.1	16.2	3.7	6.7	15.7	3.2	11.9	14.5	3.0	7.0	5.3	14.9	7.7	6.1	11.3	9.4	15.4	7.7	12.6	11.5	11.7	7.7	15.3	4.5	6.3	10.0	7.3	9.1	11.4	9.7	9.2	6.3	9.5	8.2	0.0	0.2	0.4	0.5	0.4	0.7	0.3	0.4	0.3	0.3	0.3	0.5	0.4	0.0	0.5	0.1	0.4	0.3	0.1	4.1	4.0	6.7	5.4	3.8	4.5	4.5	5.0	4.4	4.2	4.8	4.8	7.4	0.0	8.2	0.0	6.5	4.2	3.4	4.7	5.2	8.2	6.1	3.9	13.4	7.2	7.3	0.0	10.4	2.8	7.9	5.1	1.9	5.9	1.1	7.5	10.1	6.1	4.9	11.6	0.0	5.8	2.2	6.7	8.6	6.9	5.7	11.7	7.9	5.3	3.7	21.9	0.0	5.6	2.0	8.2	4.0	1.4	8.1	5.2	3.6	0.0	5.7	6.0	5.2	0.0	0.0	6.0	3.8	8.6	6.7	5.9	5.6	3.7	8.8	8.2	0.0	8.8	7.0	5.0	3.2	7.5	7.0	1.9	6.4	9.1	6.1	4.2
RBBP5	"RBQ3, SWD1"	ENSG00000117222	"RB binding protein 5, histone lysine methyltransferase complex subunit"	Q15291	1	205086142-205122015	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049042, HPA058085"	Uncertain		Supported	Nucleoplasm,Nucleoli		No	No			"Cluster 38: Basophils - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 57: B-cells - Immune response"	"Nucleoplasm, Nucleoli"		"HPA049042: AB_2680610, HPA058085: AB_2683600"	"unprognostic (8.72e-2)"	"unprognostic (6.35e-2)"	"unprognostic (2.14e-2)"	"unprognostic (1.36e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.17e-1)"	"unprognostic (4.61e-3)"	"unprognostic (1.24e-1)"	"unprognostic (3.07e-2)"	"unprognostic (2.88e-1)"	"unprognostic (2.75e-1)"	"unprognostic (4.98e-2)"	"unprognostic (6.90e-2)"	"unprognostic (3.78e-3)"	"unprognostic (4.95e-2)"	"unprognostic (1.28e-1)"	"unprognostic (4.88e-2)"	6.3	8.2	4.7	7.2	5.3	9.5	7.9	6.4	6.4	7.8	2.7	7.0	7.1	8.1	7.5	7.0	7.5	6.1	6.4	5.7	5.3	12.4	11.0	6.6	11.3	3.4	3.8	9.5	8.2	9.4	6.1	6.5	3.8	6.9	8.0	9.8	7.6	6.9	8.7	8.5	6.7	7.1	4.3	9.3	6.7	6.1	4.5	13.2	9.8	9.9	12.8	7.5	5.2	6.4	16.3	16.9	16.0	19.0	21.8	12.5	17.3	15.2	12.9	19.0	18.8	17.9	19.1	25.3	11.3	11.1	15.5	18.2	26.9	10.1	22.4	21.6	14.5	21.2	16.4	14.6	14.1	26.9	16.6	10.1	12.9	17.6	15.0	12.7	15.4	17.9	41.6	25.2	16.0	15.0	26.1	11.3	26.1	14.2	27.9	22.9	33.9	31.6	13.2	11.7	25.0	20.1	21.3	22.3	19.2	19.0	24.2	14.9	11.8	15.6	16.6	23.1	20.2	12.2	18.3	30.6	13.9	16.5	24.5	22.0	4.9	7.9	8.0	6.4	8.5	7.8	7.4	8.1	5.4	6.2	7.1	8.7	11.6	8.2	8.3	6.0	8.1	3.5	4.7	5.3	6.4	6.4	5.7	5.3	3.4	3.8	3.8	4.3	4.5	6.4	14.7	19.2	12.2	11.4	31.0	26.9	9.7	5.9	15.9	14.5	18.9	14.6	7.1	8.6	13.4	22.0	29.2	9.1	25.2	15.8	9.8	12.1	7.3	13.1	14.0	13.2	12.1	23.1	19.9	11.6	10.7	13.5	9.7	21.0	13.9	25.6	17.2	21.8	10.9	16.8	15.7	14.0	10.2	15.6	25.9	3.2	12.8	17.9	19.6	8.4	15.6	12.6	15.5	14.6	21.2	13.6	9.8	16.1	25.9	13.5	14.7	28.8	13.2	18.3	19.7	21.9	14.1	10.2	20.4	14.6	33.8	10.8	27.9	12.6	15.8	13.4
RBBP8	"COM1, CtIP, RIM, SCKL2"	ENSG00000101773	"RB binding protein 8, endonuclease"	Q99708	18	22798261-23026488	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, DNA damage, DNA repair, Meiosis, Mitosis"	"DNA-binding, Endonuclease, Hydrolase, Nuclease"	"Disease variant, Dwarfism, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 125.9;Spermatocytes: 116.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"non-classical monocyte: 36.7"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039890, HPA052946"	Approved		Supported	Nucleoplasm		NA	Yes			"Cluster 51: Monocytes - Innate immune response"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 41: Macrophages - Immune response"	Nucleoplasm		"HPA039890: AB_10794756, HPA052946: AB_2681996"	"unprognostic (1.55e-3)"	"unprognostic (4.10e-3)"	"unprognostic (7.89e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.44e-1)"	"unprognostic (7.28e-2)"	"unprognostic (3.60e-3)"	"unprognostic (1.87e-1)"	"prognostic unfavorable (7.21e-4)"	"unprognostic (2.29e-2)"	"unprognostic (1.58e-3)"	"unprognostic (1.04e-2)"	"prognostic favorable (1.71e-5)"	"unprognostic (3.91e-3)"	"unprognostic (2.42e-2)"	"unprognostic (1.01e-2)"	"unprognostic (4.48e-1)"	10.1	8.7	6.8	10.0	6.8	18.2	29.4	9.2	11.3	20.9	41.6	14.5	9.3	20.1	23.4	22.1	28.0	12.7	7.0	7.4	9.2	42.2	14.4	13.5	14.0	6.3	7.3	6.4	18.5	22.1	17.5	8.5	6.4	10.8	12.9	6.2	19.5	23.3	2.3	28.5	12.9	16.4	6.2	7.6	13.1	28.7	8.5	32.4	18.2	3.5	17.3	18.3	18.0	7.3	32.9	24.8	36.0	41.9	18.2	19.4	28.2	44.2	31.1	40.3	56.5	45.7	36.3	95.4	19.9	27.9	38.5	67.3	41.2	89.9	78.5	68.3	33.2	41.8	32.0	44.0	22.2	151.5	43.7	13.9	86.0	61.0	105.3	23.6	16.6	65.7	25.0	69.2	41.6	49.1	112.8	50.6	34.2	60.1	41.5	57.6	65.9	58.9	117.4	34.7	84.1	39.8	74.1	22.4	39.0	20.5	129.1	39.4	12.0	107.2	49.3	52.4	78.0	92.9	108.4	105.3	49.1	72.2	58.8	17.0	6.5	3.9	1.2	24.0	0.5	6.6	1.7	2.1	8.2	5.3	0.9	1.5	2.4	7.9	36.7	8.1	4.7	3.8	6.8	6.8	9.2	11.3	7.4	9.2	6.3	7.3	6.4	6.2	8.5	7.3	13.1	35.3	42.8	10.1	22.9	27.4	44.7	125.9	76.8	4.3	22.6	72.6	10.4	35.8	41.9	29.5	4.2	12.7	25.0	14.5	43.0	30.5	17.7	56.0	19.5	14.2	7.7	37.0	20.3	33.0	9.4	13.2	23.0	67.3	66.1	22.3	5.7	16.4	11.7	1.7	15.5	9.3	16.2	11.4	23.5	14.5	6.5	27.5	23.2	8.4	9.0	2.1	4.1	9.5	2.7	44.9	8.6	5.3	53.8	37.5	17.5	26.1	28.2	7.9	0.0	20.4	14.0	116.6	83.4	36.2	19.7	15.2	13.6	9.8	14.9	45.5
RBBP9	Bog	ENSG00000089050	"RB binding protein 9, serine hydrolase"	O75884	20	18486540-18497225	"Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 9.3"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015830, HPA049005"	Approved		Supported	Nucleoplasm		NA	NA		40000	"Cluster 38: Basophils - Unknown function"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 11: Alveolar cells - Smell perception"	Nucleoplasm		"HPA015830: AB_1845410, HPA049005: AB_2680597"	"unprognostic (1.17e-2)"	"unprognostic (2.51e-2)"	"unprognostic (2.37e-2)"	"unprognostic (1.32e-1)"	"unprognostic (4.27e-2)"	"unprognostic (1.26e-3)"	"unprognostic (2.14e-1)"	"unprognostic (7.63e-2)"	"unprognostic (1.52e-1)"	"unprognostic (4.71e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.14e-2)"	"unprognostic (3.93e-3)"	"unprognostic (1.08e-1)"	"unprognostic (2.21e-1)"	"unprognostic (6.21e-2)"	7.2	10.3	5.3	6.6	5.8	3.3	9.5	6.2	5.9	13.4	8.2	6.3	6.7	7.6	6.6	7.7	5.8	9.5	5.4	4.5	5.8	17.7	25.7	8.5	7.1	5.7	5.9	6.9	5.4	15.9	5.4	5.5	5.7	8.6	7.5	8.1	8.8	8.8	3.5	11.0	6.5	7.9	5.6	5.6	7.2	3.8	6.6	7.3	24.3	3.9	9.1	8.3	4.6	6.6	12.2	14.1	12.8	18.2	8.9	14.6	13.0	13.7	13.3	17.4	17.7	10.2	10.8	15.2	5.5	9.6	12.1	13.5	10.2	22.5	20.7	4.6	12.5	8.0	4.3	31.4	5.6	11.8	4.7	7.6	8.7	14.3	8.4	8.7	22.2	12.5	5.1	11.6	15.2	6.9	12.2	8.1	8.5	16.9	26.4	11.9	38.0	9.6	15.7	13.2	10.9	18.7	18.2	21.8	9.7	8.7	17.6	3.2	12.8	29.0	9.5	18.5	12.3	13.1	34.5	10.4	11.4	5.5	9.5	9.3	2.0	0.6	1.9	2.5	2.9	2.2	2.3	1.4	2.1	1.7	2.0	1.6	0.3	1.8	2.0	0.4	3.0	2.0	5.3	5.8	6.2	5.9	4.5	5.8	5.7	5.9	5.7	5.6	6.6	6.6	6.7	22.4	18.3	3.9	5.5	7.4	3.4	7.7	10.2	4.3	7.8	4.6	8.1	4.3	9.3	11.0	0.0	3.3	5.8	5.1	15.6	5.9	5.1	4.9	6.5	6.6	5.4	2.5	3.4	2.8	4.0	5.5	6.6	6.2	0.0	6.2	6.1	17.9	5.7	3.3	4.9	3.6	4.1	6.8	5.2	1.6	5.3	4.4	5.4	1.0	5.9	8.6	3.1	5.0	4.7	4.7	2.5	7.2	4.3	3.3	9.2	21.3	10.5	6.8	0.0	5.7	5.7	1.3	4.1	8.5	6.1	2.5	6.1	7.3	6.4	3.8
RBFOX2	"FOX-2, HNRBP2, HRNBP2, RBM9"	ENSG00000100320	"RNA binding fox-1 homolog 2"	O43251	22	35738736-36028824	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 378.7;Inhibitory neurons: 418.1;Oligodendrocyte precursor cells: 237.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006240, HPA006455, HPA075862"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm		"HPA006240: AB_1079750, HPA006455: , HPA075862: "	"unprognostic (3.17e-1)"	"unprognostic (4.80e-2)"	"unprognostic (9.30e-2)"	"unprognostic (3.21e-3)"	"unprognostic (3.42e-1)"	"unprognostic (2.74e-2)"	"unprognostic (2.28e-1)"	"unprognostic (2.14e-1)"	"unprognostic (1.42e-2)"	"unprognostic (1.63e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.02e-1)"	"unprognostic (5.78e-3)"	"unprognostic (2.13e-2)"	"unprognostic (1.53e-2)"	"unprognostic (6.08e-2)"	28.4	21.9	16.4	12.3	21.7	0.2	27.0	38.8	41.9	49.0	0.0	59.2	11.7	67.5	21.6	34.7	40.4	25.2	37.0	24.3	11.7	18.7	25.8	25.6	5.9	6.9	3.3	63.0	18.7	26.2	27.5	32.6	5.2	31.4	21.4	15.5	23.7	29.7	77.1	23.7	23.4	52.7	1.1	9.9	28.9	25.7	7.3	10.0	28.5	44.3	8.5	43.1	36.5	17.8	46.2	27.4	110.3	64.8	62.4	111.2	36.8	89.9	123.6	67.1	72.0	60.1	21.3	28.2	41.2	108.9	41.9	46.5	40.2	41.7	95.9	19.2	36.6	16.7	26.5	22.3	18.8	4.4	11.6	77.3	53.1	59.6	73.3	64.8	86.8	7.0	13.7	3.9	80.3	14.0	4.5	2.7	40.5	19.7	42.0	7.6	92.0	7.9	50.1	47.5	34.1	106.0	110.3	15.5	31.0	57.0	16.9	6.8	105.5	96.4	54.4	54.7	41.2	2.8	9.4	38.3	42.7	6.8	51.1	0.0	0.0	0.0	0.2	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	16.4	21.7	38.8	41.9	24.3	11.7	6.9	3.3	5.2	1.1	7.3	17.8	34.3	67.3	38.5	189.4	1.0	37.1	50.6	57.3	57.5	20.8	31.4	34.5	62.2	31.5	40.4	27.6	0.0	69.9	0.9	17.9	35.2	53.0	24.8	17.8	60.8	45.9	57.0	0.8	378.7	32.1	89.1	67.8	15.8	25.0	2.5	30.6	40.7	26.0	10.5	117.8	418.1	24.7	18.3	1.3	14.7	9.4	79.6	1.8	16.0	183.6	2.6	16.9	0.0	237.2	130.0	77.4	10.7	93.3	1.4	57.4	22.5	18.7	20.9	6.7	52.6	74.5	93.3	42.2	25.6	31.0	33.8	29.0	2.5	48.2	23.8	61.1
RBFOX3	"FOX-3, HRNBP3, NeuN"	ENSG00000167281	"RNA binding fox-1 homolog 3"	A6NFN3	17	79089345-79516148	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 217.2;intestine: 97.4;urinary bladder: 80.5"	"Group enriched"	"Detected in many"	7	"Excitatory neurons: 320.4;Inhibitory neurons: 163.9;Skeletal myocytes: 124.4"	"Cancer enhanced"	"Detected in some"		"prostate cancer: 1.1"	"Group enriched"	"Detected in many"	4	"cerebellum: 217.2;cerebral cortex: 118.3"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"A549: 16.1;NTERA-2: 14.2;SCLC-21H: 22.4;U-2 OS: 11.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030790, HPA075862, CAB078782"	Enhanced	Supported	Supported	Nucleoplasm		NA	NA				"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Nucleoplasm		"CAB078782: , HPA030790: AB_10602305, HPA075862: "	"unprognostic (2.84e-1)"	"unprognostic (1.88e-1)"	"unprognostic (4.10e-2)"	"unprognostic (9.23e-3)"	"unprognostic (8.85e-2)"	"unprognostic (2.34e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.09e-1)"	"unprognostic (7.72e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.19e-1)"	"unprognostic (1.04e-1)"	"unprognostic (3.22e-15)"	"unprognostic (8.92e-3)"	"unprognostic (1.92e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.88e-1)"	0.5	0.9	11.8	0.4	29.7	0.6	0.3	217.2	118.3	3.0	0.0	97.4	1.5	39.9	3.1	9.6	3.6	0.0	0.3	23.6	0.0	0.3	0.2	0.6	0.1	12.3	1.1	1.3	0.5	0.9	7.5	0.0	13.4	22.3	2.4	3.4	0.2	24.4	0.5	0.5	9.1	9.5	0.0	0.5	4.2	7.5	0.0	0.0	0.3	0.0	0.0	80.5	8.2	40.2	0.0	16.1	0.2	0.2	0.0	0.0	0.4	0.5	0.0	0.1	0.0	0.3	0.1	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.7	0.0	0.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.1	14.2	0.0	0.2	0.3	0.7	0.1	0.0	0.0	22.4	0.4	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	11.1	0.6	0.0	0.9	0.0	0.4	0.5	0.4	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	11.8	29.7	217.2	118.3	23.6	0.0	12.3	1.1	13.4	0.0	0.0	40.2	0.5	0.0	0.0	5.9	0.2	2.0	8.1	0.0	0.0	11.5	0.2	0.0	2.3	0.0	0.0	0.0	0.0	0.1	2.3	0.0	0.0	0.0	5.7	0.3	0.4	7.5	0.0	0.0	320.4	0.0	0.1	11.8	0.0	0.7	0.0	0.1	0.0	0.2	0.1	5.0	163.9	0.0	0.0	0.6	5.5	10.1	0.3	7.6	5.4	10.3	0.0	1.2	2.1	11.1	4.8	0.0	0.0	10.5	0.0	15.2	0.0	0.1	0.0	3.1	0.0	124.4	7.5	2.4	26.4	0.0	1.4	0.1	2.3	0.1	0.0	2.8
RBL2	"p130, Rb2"	ENSG00000103479	"RB transcriptional corepressor like 2"	Q08999	16	53433977-53491648	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding, Repressor"	"Cancer-related genes, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 468.3;Late spermatids: 209.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016547, HPA019703"	Supported		Supported	"Nucleoplasm,Nucleoli rim,Mitotic chromosome,Cytosol"		Yes	No			"Cluster 48: NK-cells - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 58: T-cells - T-cell receptor"	"Nucleoplasm, Nucleoli rim, Mitotic chromosome"	Cytosol	"CAB016547: AB_785011, HPA019703: AB_1856106"	"unprognostic (1.51e-1)"	"unprognostic (4.38e-2)"	"unprognostic (4.00e-2)"	"unprognostic (1.26e-1)"	"unprognostic (6.88e-2)"	"unprognostic (6.43e-2)"	"unprognostic (5.03e-2)"	"unprognostic (2.46e-2)"	"unprognostic (1.04e-1)"	"unprognostic (2.11e-1)"	"unprognostic (4.70e-1)"	"unprognostic (8.12e-2)"	"prognostic favorable (3.57e-5)"	"unprognostic (9.57e-3)"	"unprognostic (1.02e-1)"	"unprognostic (8.70e-2)"	"unprognostic (7.51e-2)"	32.5	25.4	11.1	32.3	13.6	19.1	31.7	12.5	10.4	33.5	14.8	26.6	23.3	32.2	20.2	25.0	31.8	27.7	25.6	8.7	10.5	39.2	59.5	38.9	49.7	12.3	12.0	37.8	39.0	62.7	17.7	19.3	13.0	42.9	29.3	23.1	34.2	39.9	32.4	26.3	26.1	30.7	11.7	41.0	32.6	48.4	11.4	66.6	40.2	37.7	51.2	30.9	28.9	16.9	25.9	18.1	20.7	20.6	61.2	57.9	9.4	17.8	26.4	23.1	7.9	10.1	30.9	39.0	28.4	32.8	22.3	29.6	17.9	30.1	36.0	12.5	22.4	15.9	14.7	22.0	27.3	23.4	49.0	35.6	34.0	15.3	22.4	43.0	36.3	39.6	12.7	23.2	26.6	7.1	48.6	22.0	7.8	30.8	15.0	33.6	41.8	46.1	25.4	25.3	16.9	14.3	42.2	17.2	19.1	16.8	22.7	30.0	28.3	27.5	14.3	24.1	13.7	35.7	22.9	42.4	34.4	28.2	19.0	53.9	22.5	56.5	53.4	16.2	60.5	22.5	59.7	62.8	21.7	22.0	85.5	75.3	41.8	74.4	28.8	13.1	48.2	76.2	11.1	13.6	12.5	10.4	8.7	10.5	12.3	12.0	13.0	11.7	11.4	16.9	37.9	41.7	101.1	51.2	49.5	23.1	30.1	15.3	40.9	27.8	27.0	15.5	13.5	45.8	32.5	27.6	20.9	6.0	77.0	26.3	17.6	13.4	468.3	38.9	25.8	31.4	19.8	26.5	55.1	10.2	13.0	35.8	24.5	45.9	55.1	27.9	40.7	46.1	11.2	35.3	54.1	30.0	34.6	43.6	23.7	209.1	42.0	35.4	10.6	58.1	44.9	38.3	79.3	63.3	85.7	10.8	19.0	42.9	48.7	31.4	29.2	25.3	38.3	22.5	39.5	36.2	26.1	161.4	61.3	33.7	27.6	4.1	118.9	25.2	21.7	35.6
RBM11		ENSG00000185272	"RNA binding motif protein 11"	P57052	21	14216130-14228372	"Predicted intracellular proteins"	"Differentiation, mRNA processing, mRNA splicing"	"Developmental protein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	15	"epididymis: 45.2"	"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 15.6;Excitatory neurons: 13.0;Inhibitory neurons: 14.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"naive CD4 T-cell: 1.2"	"Lineage enriched"	"Detected in single"	10	"T-cells: 1.2"	"Cell line enhanced"	"Detected in some"		"HEL: 1.4;REH: 1.0;SuSa: 1.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA045885			Supported	Nucleoplasm		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 68: Epididymis - Unknown function"	"Cluster 36: HEL - Hemostasis"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm		"HPA045885: AB_10963937"	"unprognostic (1.95e-2)"	"unprognostic (1.35e-1)"	"unprognostic (3.57e-1)"	"unprognostic (5.44e-4)"	"unprognostic (2.18e-1)"	"unprognostic (7.97e-2)"	"unprognostic (3.89e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.41e-1)"	"unprognostic (3.23e-2)"	"unprognostic (9.92e-4)"	"unprognostic (5.74e-2)"	"unprognostic (1.16e-4)"	"unprognostic (3.45e-2)"	"unprognostic (4.81e-2)"	"unprognostic (2.69e-1)"	"unprognostic (9.24e-3)"	0.2	0.7	2.4	0.3	2.1	0.5	0.4	1.8	2.9	0.3	1.5	0.3	0.2	0.7	45.2	0.6	0.9	0.2	0.6	2.2	2.2	1.2	0.0	0.3	0.3	2.2	2.4	2.0	0.3	1.2	1.6	0.1	2.5	0.5	0.1	2.4	0.4	1.1	0.0	0.1	0.3	0.4	2.2	0.4	0.3	1.5	2.3	0.6	1.1	0.0	0.2	0.4	0.4	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.1	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.4	1.4	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.5	0.3	0.0	0.9	0.0	0.0	1.0	0.0	0.0	0.2	0.4	0.1	0.0	0.1	0.9	0.0	1.0	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.8	0.0	0.1	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	1.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	2.4	2.1	1.8	2.9	2.2	2.2	2.2	2.4	2.5	2.2	2.3	2.5	0.3	3.2	2.7	2.0	2.9	1.8	6.5	0.7	1.8	7.0	2.8	3.7	0.1	0.0	0.8	1.8	0.0	2.3	1.5	0.2	15.6	2.5	9.3	0.7	0.7	0.8	7.7	0.8	13.0	1.2	0.8	1.5	2.6	0.6	2.5	1.3	0.0	0.0	0.8	5.0	14.7	0.9	2.0	0.0	0.4	5.2	0.6	0.3	0.0	0.0	0.8	9.4	2.1	4.0	6.3	0.8	0.4	0.7	0.3	5.1	0.0	0.8	0.8	4.4	0.0	2.1	2.4	7.2	9.8	2.8	1.1	1.2	1.6	1.8	0.4	5.6
RBM14	"COAA, DKFZp779J0927, SIP, SYTIP1"	ENSG00000239306	"RNA binding motif protein 14"	Q96PK6	11	66616626-66629934	"Predicted intracellular proteins"	"Immunity, Innate immunity, Transcription, Transcription regulation"	"Repressor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006628	Supported		Supported	"Nuclear speckles"		NA	NA		31000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 43: Testis - Unknown function"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 39: Non-specific - Basic cellular processes"	"Nuclear speckles"		"HPA006628: AB_1078546"	"unprognostic (6.96e-2)"	"unprognostic (4.79e-2)"	"unprognostic (4.34e-3)"	"unprognostic (4.45e-2)"	"unprognostic (2.15e-1)"	"unprognostic (9.56e-3)"	"prognostic unfavorable (2.02e-7)"	"unprognostic (4.21e-2)"	"unprognostic (1.54e-3)"	"unprognostic (1.08e-2)"	"prognostic favorable (1.04e-4)"	"unprognostic (9.38e-3)"	"unprognostic (8.59e-3)"	"unprognostic (1.29e-2)"	"unprognostic (3.32e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.94e-1)"	26.9	32.0	39.9	25.0	40.2	32.6	24.1	52.6	48.0	37.2	48.5	29.4	15.7	30.8	19.1	33.9	37.6	10.7	33.2	40.1	38.9	50.6	40.4	27.3	28.3	39.4	40.6	45.1	34.1	17.5	34.5	19.6	39.4	36.3	18.2	35.8	25.3	14.6	29.7	28.4	29.1	15.6	37.1	40.4	30.1	44.0	39.6	25.7	28.4	11.6	29.2	30.4	28.6	48.6	83.0	77.9	55.9	43.2	25.3	16.8	97.0	45.0	16.4	40.8	24.0	79.2	60.6	130.9	49.2	21.9	45.0	69.0	63.4	36.5	43.3	63.9	68.7	81.7	67.1	71.2	14.1	71.5	70.0	11.8	13.3	41.9	23.3	24.1	31.0	38.2	98.6	83.9	40.2	70.3	122.4	79.4	107.2	69.0	85.7	125.3	65.4	67.3	34.2	71.5	67.0	61.9	78.0	55.9	33.9	45.9	77.3	63.5	50.5	49.4	97.9	40.5	72.6	49.8	75.2	109.0	41.8	68.9	120.1	19.7	24.3	27.3	27.9	26.1	27.2	21.3	24.1	26.8	33.6	21.8	24.3	28.2	9.0	21.7	27.2	21.3	23.1	34.0	39.9	40.2	52.6	48.0	40.1	38.9	39.4	40.6	39.4	37.1	39.6	48.6	12.6	9.6	17.0	0.0	27.4	38.1	45.7	20.7	15.4	24.8	19.1	16.3	16.3	18.6	17.2	14.7	29.2	56.3	32.7	17.7	17.6	26.5	37.3	18.1	16.5	21.3	21.6	23.1	0.0	18.4	54.4	20.1	9.7	17.5	19.7	20.4	22.5	24.5	29.0	11.8	0.0	20.9	24.4	16.0	30.2	27.0	17.1	20.1	12.4	0.0	25.4	18.1	34.0	0.0	0.0	19.3	21.7	16.1	20.7	26.9	19.0	12.2	23.2	49.4	6.6	15.1	21.5	53.9	40.1	20.9	31.1	69.2	29.0	13.7	25.2	32.6
RBM17	"MGC14439, SPF45"	ENSG00000134453	"RNA binding motif protein 17"	Q96I25	10	6089034-6117457	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037477, HPA037478"	Supported		Supported	Nucleoplasm		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"HPA037477: AB_10671372, HPA037478: AB_2675494"	"unprognostic (8.55e-2)"	"unprognostic (2.41e-1)"	"unprognostic (3.11e-3)"	"unprognostic (6.23e-2)"	"unprognostic (1.05e-2)"	"unprognostic (3.33e-2)"	"prognostic unfavorable (4.57e-8)"	"unprognostic (3.78e-2)"	"unprognostic (6.39e-2)"	"unprognostic (3.47e-3)"	"unprognostic (1.44e-1)"	"unprognostic (8.32e-2)"	"prognostic unfavorable (4.31e-5)"	"unprognostic (1.82e-1)"	"unprognostic (5.53e-2)"	"unprognostic (1.26e-2)"	"unprognostic (3.01e-2)"	72.4	47.0	46.3	75.3	51.6	139.5	64.4	47.2	53.5	50.2	40.1	57.6	63.8	63.5	38.7	51.9	55.3	52.6	60.8	46.9	52.3	54.6	44.6	78.0	87.4	53.5	49.5	54.7	62.9	45.5	35.8	75.7	52.7	41.5	65.2	41.6	49.9	39.4	95.4	47.0	70.5	60.4	47.3	77.6	51.6	61.9	52.5	87.7	63.3	72.1	85.4	63.5	49.4	52.4	195.9	113.0	141.1	122.7	76.5	69.4	175.5	128.4	58.0	130.2	139.8	184.7	151.2	234.1	89.3	94.4	48.5	188.1	130.3	136.4	138.6	233.7	132.1	199.3	120.4	158.5	96.7	110.0	93.6	71.7	104.0	132.4	72.4	67.9	159.6	168.1	219.0	112.1	84.1	223.6	198.8	66.2	90.3	227.8	81.3	211.4	79.9	120.8	93.5	117.3	60.5	78.9	124.1	110.1	99.0	119.5	146.3	111.3	97.3	76.9	153.4	169.0	138.1	110.2	135.6	386.7	72.0	140.3	51.7	79.7	78.2	102.6	71.6	79.0	75.2	101.8	71.8	73.4	69.9	110.2	71.8	68.1	38.7	77.8	62.3	77.0	101.1	59.8	46.3	51.6	47.2	53.5	46.9	52.3	53.5	49.5	52.7	47.3	52.5	52.4	152.3	89.8	56.0	24.8	107.7	129.2	97.4	72.7	108.7	71.3	68.5	85.3	86.0	65.8	68.1	66.2	50.1	125.6	83.3	80.8	90.1	92.0	90.2	74.7	99.5	123.9	72.7	100.5	42.2	70.9	188.5	89.5	58.6	83.9	96.8	79.7	69.7	65.3	98.8	92.5	41.4	87.1	63.1	73.6	128.6	26.3	66.2	93.9	51.6	38.4	161.5	77.9	96.8	23.6	40.7	88.0	86.4	60.5	153.8	122.3	79.8	75.7	41.3	62.2	72.3	115.6	117.4	266.4	233.3	114.4	108.7	97.0	97.4	78.9	106.5	112.6
RBM19	"DKFZp586F1023, KIAA0682, Mrd1"	ENSG00000122965	"RNA binding motif protein 19"	Q9Y4C8	12	113816738-113966325	"Plasma proteins, Predicted intracellular proteins"		"Developmental protein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038860, HPA058732"	Supported		Supported	Nucleoli		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 72: Non-specific - Transcription"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 59: Non-specific - Transcription"	Nucleoli		"HPA038860: AB_10697400, HPA058732: AB_2683801"	"unprognostic (2.10e-1)"	"unprognostic (1.54e-1)"	"unprognostic (3.61e-2)"	"unprognostic (4.83e-3)"	"unprognostic (1.50e-1)"	"unprognostic (9.14e-2)"	"prognostic unfavorable (5.87e-7)"	"unprognostic (9.32e-3)"	"unprognostic (2.61e-1)"	"unprognostic (5.14e-2)"	"unprognostic (4.43e-2)"	"unprognostic (3.53e-3)"	"unprognostic (8.37e-2)"	"unprognostic (3.18e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.28e-1)"	"unprognostic (2.06e-2)"	11.5	14.1	7.4	12.5	8.5	16.4	13.5	5.7	8.8	13.8	7.9	13.8	8.7	13.1	8.3	12.5	12.9	6.4	11.6	6.5	7.1	13.4	12.3	12.2	14.0	8.7	7.9	18.9	14.2	10.1	12.7	9.9	8.8	15.1	8.9	7.7	12.6	8.4	16.7	12.5	13.5	9.0	5.1	13.3	13.3	11.9	10.3	10.4	20.8	9.3	12.9	14.4	12.4	11.1	13.0	25.6	15.0	29.3	14.7	11.7	22.7	22.9	17.9	25.3	18.5	34.4	17.7	23.1	13.9	19.5	18.5	18.1	35.4	22.1	19.8	42.0	20.8	49.6	28.0	33.4	11.1	37.9	22.7	14.6	14.3	31.0	11.2	16.2	18.6	17.8	54.3	9.3	15.9	19.4	21.4	28.6	32.8	12.9	21.6	28.2	14.4	20.1	17.3	24.9	17.9	14.4	20.5	29.3	14.2	12.4	32.3	10.9	21.3	16.6	20.3	14.4	14.3	16.7	13.5	22.7	22.3	26.7	21.5	0.1	4.4	1.3	7.7	7.7	6.0	7.3	5.5	6.4	6.1	5.9	4.4	6.0	0.2	7.6	12.4	4.2	5.4	4.8	7.4	8.5	5.7	8.8	6.5	7.1	8.7	7.9	8.8	5.1	10.3	11.1	8.1	16.0	9.6	18.9	15.6	13.8	14.6	5.1	10.8	11.8	10.3	8.3	20.4	7.2	9.2	11.0	8.4	10.6	13.2	6.5	1.9	11.7	7.2	9.1	11.7	11.2	9.0	12.4	13.8	13.3	9.2	13.6	10.2	9.8	15.2	15.5	4.6	6.9	12.3	6.7	13.1	8.4	6.1	7.6	8.7	9.5	10.8	9.8	3.6	24.4	16.8	5.4	8.2	11.1	15.5	14.5	5.6	7.2	15.1	15.3	6.4	9.8	12.8	13.5	0.0	14.1	12.9	16.6	15.1	11.8	11.5	11.4	15.1	10.4	7.8	11.4
RBM34	KIAA0117	ENSG00000188739	"RNA binding motif protein 34"	P42696	1	235131183-235161283	"Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA028606	Approved		Supported	"Nucleoplasm,Nucleoli,Mitotic chromosome"		Yes	No			"Cluster 44: Non-specific - Transcription"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 11: Alveolar cells - Smell perception"	Nucleoli	"Nucleoplasm, Mitotic chromosome"	"HPA028606: AB_10601494"	"unprognostic (4.53e-2)"	"unprognostic (3.64e-2)"	"unprognostic (7.30e-2)"	"unprognostic (3.68e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.32e-2)"	"unprognostic (6.57e-4)"	"unprognostic (2.98e-2)"	"unprognostic (5.65e-3)"	"unprognostic (2.02e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.69e-8)"	"unprognostic (8.50e-2)"	"unprognostic (1.85e-1)"	"unprognostic (8.73e-2)"	"unprognostic (7.09e-4)"	12.2	10.3	11.7	15.0	12.5	35.5	17.0	12.1	13.7	10.0	12.3	12.4	17.9	11.5	15.6	13.9	10.9	12.2	15.5	11.8	12.6	17.1	14.8	11.9	23.2	13.3	12.5	12.8	13.1	9.2	8.7	13.2	13.1	12.0	14.1	6.3	19.9	7.4	19.7	18.2	15.8	11.6	13.1	12.7	14.3	21.3	12.5	16.3	15.6	12.3	20.6	15.7	9.6	13.5	28.6	20.9	23.8	28.8	17.9	33.3	52.8	29.3	24.6	29.4	30.1	26.9	33.7	49.4	29.9	21.0	22.1	40.5	29.0	28.9	28.2	44.4	47.8	35.7	17.0	20.1	35.1	60.4	34.5	28.0	33.2	26.5	19.6	26.5	26.8	50.5	54.5	23.7	38.7	18.0	49.9	48.3	65.3	43.8	15.8	48.0	23.2	57.3	29.5	22.7	26.2	47.1	39.2	27.0	66.4	17.0	55.2	63.5	21.0	26.2	23.0	36.1	59.9	27.8	47.5	47.4	30.8	38.0	40.8	113.9	36.0	44.1	46.1	42.5	55.6	74.1	53.0	59.8	37.2	54.5	49.0	57.4	18.3	58.2	46.4	59.5	77.5	51.5	11.7	12.5	12.1	13.7	11.8	12.6	13.3	12.5	13.1	13.1	12.5	13.5	4.3	19.2	12.8	12.1	11.9	3.2	10.0	7.3	10.2	2.6	6.3	3.7	3.4	7.2	9.1	3.7	10.4	6.2	19.3	4.1	5.9	6.6	7.2	3.2	5.1	6.9	7.8	3.8	10.6	6.2	4.5	10.3	4.6	6.0	23.4	8.0	6.1	3.6	3.3	0.0	11.5	2.7	8.2	5.4	3.2	7.9	4.1	7.1	3.6	15.9	9.4	4.0	23.7	10.1	11.9	8.6	9.6	5.7	10.2	5.3	5.3	12.8	10.7	5.7	0.0	5.0	4.4	7.1	5.3	8.0	3.8	6.2	16.2	3.3	4.5	7.7
RBM38	"dJ800J21.2, HSRNASEB, RNPC1, seb4B, SEB4D"	ENSG00000132819	"RNA binding motif protein 38"	Q9H0Z9	20	57391396-57409333	"Predicted intracellular proteins"	"Cell cycle, Differentiation, Host-virus interaction, mRNA processing, mRNA splicing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 136.4;skeletal muscle: 221.7"	"Cell type enhanced"	"Detected in many"		"B-cells: 110.9;dendritic cells: 156.9;Erythroid cells: 280.4"	"Cancer enhanced"	"Detected in all"		"ovarian cancer: 95.9"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 140.6;U-698: 150.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			CAB017036	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 22: NK-cells - Unknown function"	"Cluster 59: Non-specific - Translation"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 24: Non-specific - Transcription regulation"	"Nucleoplasm, Cytosol"		"CAB017036: "	"unprognostic (1.03e-1)"	"prognostic favorable (3.64e-7)"	"unprognostic (3.71e-2)"	"unprognostic (7.73e-3)"	"unprognostic (4.16e-2)"	"unprognostic (4.85e-2)"	"unprognostic (1.53e-2)"	"unprognostic (4.37e-3)"	"unprognostic (3.04e-1)"	"unprognostic (9.04e-3)"	"unprognostic (3.90e-2)"	"unprognostic (2.29e-1)"	"prognostic unfavorable (1.05e-5)"	"unprognostic (2.13e-2)"	"unprognostic (2.29e-1)"	"prognostic favorable (1.63e-4)"	"unprognostic (1.83e-1)"	11.7	10.7	6.7	26.6	9.4	136.4	12.8	13.3	10.3	18.8	15.1	96.6	8.7	38.4	0.9	16.8	28.9	5.1	72.6	5.9	6.4	16.3	16.4	21.0	43.4	8.6	11.5	27.8	10.8	1.9	12.2	5.5	8.0	27.0	4.1	0.6	19.7	11.9	221.7	9.1	39.8	8.7	6.6	65.8	23.0	38.1	9.4	26.6	9.4	32.7	12.2	42.9	13.6	7.9	20.1	20.4	9.7	25.1	0.0	1.6	56.3	6.5	1.6	13.5	3.5	84.2	20.6	140.6	54.1	1.9	13.2	18.3	8.0	8.0	2.1	29.0	34.5	118.0	7.6	52.6	6.0	57.8	54.2	1.9	3.8	5.7	1.1	1.9	9.2	52.5	100.9	24.6	1.6	87.8	42.7	58.5	36.9	10.7	25.5	82.0	23.6	114.2	10.1	9.2	40.9	26.3	15.2	50.5	24.7	8.7	28.3	79.4	17.0	4.4	42.6	6.0	27.6	60.1	86.8	150.7	1.1	40.3	4.2	0.0	0.5	2.2	3.1	1.8	1.9	3.2	2.5	2.1	1.0	3.3	3.0	2.8	0.7	3.5	1.7	1.3	4.7	2.1	6.7	9.4	13.3	10.3	5.9	6.4	8.6	11.5	8.0	6.6	9.4	7.9	13.9	3.2	5.2	10.1	110.9	9.1	28.3	7.9	13.6	1.0	15.8	21.0	42.5	8.6	6.6	1.8	0.0	1.9	156.9	41.6	9.8	6.2	4.2	54.2	5.2	11.9	62.8	280.4	2.5	5.0	5.8	8.8	12.2	21.5	8.8	31.5	10.4	6.0	9.6	0.0	1.3	56.4	12.2	8.1	18.9	4.0	4.4	27.6	1.8	2.8	5.8	12.8	54.6	4.5	4.6	5.9	35.4	6.0	52.8	18.8	2.8	16.4	22.5	1.4	6.6	20.6	7.6	2.4	13.2	9.1	8.4	2.3	81.0	13.3	34.0	18.5
RBM39	"CAPER, CAPERalpha, CC1.3, fSAP59, HCC1, RNPC2"	ENSG00000131051	"RNA binding motif protein 39"	Q14498	20	35701347-35742312	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing, Transcription, Transcription regulation"	"Activator, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001591	Supported		Supported	"Nucleoplasm,Nuclear speckles,Microtubules,Centriolar satellite"		NA	NA		19000	"Cluster 1: Neutrophils - Mixed function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	"Nucleoplasm, Nuclear speckles"	"Microtubules, Centriolar satellite"	"HPA001591: AB_1079749"	"unprognostic (1.37e-2)"	"unprognostic (4.97e-1)"	"unprognostic (2.72e-2)"	"unprognostic (9.09e-2)"	"unprognostic (3.47e-1)"	"unprognostic (4.99e-2)"	"unprognostic (3.55e-3)"	"unprognostic (4.56e-2)"	"unprognostic (7.83e-2)"	"unprognostic (2.65e-1)"	"unprognostic (2.04e-2)"	"unprognostic (7.65e-3)"	"prognostic unfavorable (2.78e-5)"	"unprognostic (1.88e-1)"	"unprognostic (2.86e-1)"	"unprognostic (2.64e-1)"	"unprognostic (2.28e-3)"	70.1	55.8	18.4	37.7	17.6	172.0	44.6	33.5	28.0	57.8	22.2	56.0	35.1	54.5	9.2	62.3	61.4	40.8	57.3	16.5	25.0	52.2	47.7	62.2	42.3	24.2	24.0	71.1	41.2	27.3	50.0	40.9	19.4	50.2	16.9	49.5	53.4	22.3	70.3	51.2	46.9	19.2	16.0	56.4	49.7	34.3	16.9	51.1	54.2	33.1	24.1	50.7	62.1	26.5	98.8	87.6	77.0	78.5	48.8	53.8	78.8	131.0	50.6	59.6	60.2	109.3	78.5	137.5	90.6	38.9	67.9	91.2	122.3	67.9	66.5	94.6	96.7	174.6	80.7	101.2	23.4	158.6	99.9	14.4	97.6	68.9	38.4	63.7	57.8	46.4	195.5	117.6	46.3	72.2	194.5	87.9	103.2	87.5	96.8	104.9	136.2	91.7	41.5	56.2	77.9	63.4	91.1	94.7	78.4	109.3	70.6	94.6	91.4	100.8	92.5	90.5	115.8	71.6	164.3	204.0	64.7	123.2	79.2	250.9	120.4	197.5	104.7	111.1	103.6	131.1	91.5	97.6	111.8	140.5	85.7	82.1	427.7	127.2	102.2	160.9	114.7	95.7	18.4	17.6	33.5	28.0	16.5	25.0	24.2	24.0	19.4	16.0	16.9	26.5	302.0	233.9	280.9	144.3	441.7	616.4	521.0	283.0	284.0	258.5	339.1	295.4	189.2	191.6	267.6	200.5	316.9	375.2	624.9	278.1	189.8	203.8	48.1	359.2	496.0	299.7	295.3	214.2	130.1	186.0	389.6	337.9	254.9	540.8	525.8	304.4	215.3	202.1	199.8	220.4	120.9	331.3	215.7	207.7	469.5	41.9	262.5	335.5	270.3	129.3	274.3	208.7	400.6	136.2	160.5	221.3	254.8	214.4	391.0	453.6	271.8	150.6	248.0	386.5	164.3	504.0	410.2	263.5	228.1	215.8	586.9	561.6	490.8	218.2	282.8	532.1
RBM45	"DRB1, FLJ44612"	ENSG00000155636	"RNA binding motif protein 45"	Q8IUH3	2	178112424-178139011	"Plasma proteins, Predicted intracellular proteins"	"Differentiation, Neurogenesis"	"Developmental protein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020448	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA020448: AB_1856133"	"unprognostic (3.11e-2)"	"unprognostic (1.91e-1)"	"unprognostic (6.56e-2)"	"unprognostic (2.79e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.62e-1)"	"prognostic unfavorable (5.74e-9)"	"unprognostic (1.66e-1)"	"unprognostic (4.25e-2)"	"unprognostic (2.71e-2)"	"unprognostic (2.42e-1)"	"unprognostic (5.79e-2)"	"prognostic unfavorable (5.34e-9)"	"unprognostic (3.26e-1)"	"unprognostic (2.68e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.94e-1)"	4.8	6.5	12.5	5.5	12.9	4.1	8.5	12.4	18.4	5.6	12.7	8.3	5.9	6.3	9.2	6.1	7.3	4.7	6.4	12.6	12.9	6.5	8.1	5.4	8.1	12.9	12.5	5.7	7.9	8.8	6.4	3.3	12.8	5.8	9.3	9.8	6.2	5.2	4.8	8.2	6.7	5.7	12.6	7.8	6.5	6.6	12.6	8.9	7.0	3.2	9.9	5.6	5.1	13.3	9.5	10.1	15.7	6.5	13.6	15.7	9.8	12.8	14.5	12.9	14.2	10.7	7.7	15.8	8.4	15.3	12.9	8.4	13.1	16.7	15.7	12.7	11.2	12.2	6.3	16.1	14.3	14.9	11.6	12.7	13.7	13.2	11.0	12.5	13.7	8.7	11.5	12.6	16.2	15.1	15.5	10.0	11.1	14.2	12.8	12.4	11.1	15.7	19.0	21.8	9.7	10.1	9.0	8.8	11.8	17.7	12.9	13.9	11.7	9.1	8.6	10.7	12.7	11.7	14.4	20.3	8.9	11.9	12.8	3.8	5.3	1.9	6.2	8.6	7.1	12.5	6.5	6.8	7.2	8.6	5.9	7.3	1.0	11.3	10.2	7.7	10.9	5.3	12.5	12.9	12.4	18.4	12.6	12.9	12.9	12.5	12.8	12.6	12.6	13.3	5.2	3.2	4.2	8.5	6.3	2.5	3.5	11.3	5.2	7.1	4.3	3.6	4.2	8.6	6.6	1.8	10.4	5.6	8.1	5.0	7.9	7.3	3.8	4.8	5.4	5.9	6.0	8.6	10.2	6.6	10.3	5.7	7.7	3.5	8.2	8.2	3.3	5.1	8.2	10.1	13.1	7.6	4.1	8.1	3.3	4.3	4.4	5.3	1.8	6.5	8.1	7.6	6.2	15.1	13.7	5.2	6.5	5.7	8.0	1.7	6.1	7.0	9.6	9.1	6.6	6.1	6.1	11.4	5.6	6.2	3.4	1.8	6.2	9.1	4.9	2.7
RBM8A	"BOV-1A, BOV-1B, BOV-1C, RBM8, RBM8B, Y14, ZNRP"	ENSG00000265241	"RNA binding motif protein 8A"	Q9Y5S9	1	145917714-145927678	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"mRNA processing, mRNA splicing, mRNA transport, Nonsense-mediated mRNA decay, Translation regulation, Transport"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Syncytiotrophoblasts: 735.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018403	Supported		Supported	"Nuclear speckles"		NA	NA		100000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Basic cellular processes"	"Nuclear speckles"		"HPA018403: AB_1858908"	"unprognostic (3.81e-1)"	"unprognostic (3.99e-3)"	"unprognostic (1.59e-1)"	"unprognostic (6.83e-2)"	"unprognostic (1.12e-1)"	"unprognostic (3.16e-1)"	"unprognostic (4.62e-3)"	"unprognostic (1.91e-1)"	"unprognostic (1.38e-1)"	"unprognostic (8.79e-3)"	"unprognostic (7.27e-3)"	"prognostic unfavorable (1.55e-4)"	"unprognostic (3.30e-3)"	"unprognostic (2.18e-1)"	"unprognostic (3.77e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.64e-3)"	86.1	74.9	37.2	105.4	39.1	214.7	82.3	38.7	43.0	69.6	35.6	70.5	70.1	67.7	49.3	163.6	62.2	58.0	73.0	36.8	41.7	81.6	77.5	72.8	126.4	39.7	39.8	72.0	59.9	78.4	65.8	85.3	40.8	66.4	56.4	45.0	79.2	48.2	214.9	92.0	69.2	57.7	42.1	81.6	67.5	71.3	40.0	120.7	68.8	100.1	123.7	112.8	80.4	43.9	377.0	300.7	268.8	215.7	94.6	92.2	330.0	224.3	150.7	315.0	230.1	400.0	277.4	342.0	344.9	155.3	166.5	252.5	289.3	245.3	257.0	305.6	275.7	264.2	229.2	299.8	133.6	446.6	222.6	102.2	180.8	283.0	300.3	137.4	238.1	291.9	405.2	314.7	246.2	1033.8	452.3	352.2	463.7	323.9	518.4	394.4	234.6	341.2	203.2	355.6	274.6	335.7	334.5	169.7	316.5	231.0	318.0	534.3	247.3	252.3	324.0	250.9	626.0	352.2	603.4	502.6	226.4	264.9	223.2	464.6	316.5	513.6	337.2	363.9	322.1	444.3	317.6	346.4	318.0	389.6	296.1	328.3	363.7	389.8	361.3	498.4	386.3	582.7	37.2	39.1	38.7	43.0	36.8	41.7	39.7	39.8	40.8	42.1	40.0	43.9	289.1	70.5	132.4	8.1	251.0	332.9	396.7	475.4	244.2	66.3	168.5	184.7	78.0	98.7	262.8	88.3	54.2	376.2	276.0	125.3	187.9	224.1	243.7	148.0	134.3	206.0	158.9	149.2	10.8	223.2	506.3	174.1	80.5	152.8	244.0	136.8	120.3	124.4	204.3	35.3	9.1	127.6	313.3	100.3	265.2	54.4	102.2	170.7	208.1	9.4	197.7	120.3	165.8	6.0	16.1	245.4	159.8	85.4	174.9	259.6	119.5	204.1	195.1	86.3	98.6	213.7	208.1	212.0	168.9	208.1	318.0	735.5	282.1	139.7	141.7	393.0
RBP1	"CRABP-I, CRBP, CRBP1, CRBPI, RBPC"	ENSG00000114115	"Retinol binding protein 1"	P09455	3	139517434-139539829	"Metabolic proteins, Predicted intracellular proteins"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"ovary: 1366.7;pancreas: 632.7"	"Group enriched"	"Detected in many"	4	"Granulosa cells: 5988.6;Theca cells: 3228.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in many"	5	"SH-SY5Y: 835.4"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"basal ganglia: 64.4"	"HPA007338, CAB018603, CAB019276"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA		41000		"Cluster 89: Fibroblasts - ECM organization"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 40: Granulosa cells - Unknown function"	Cytosol	Nucleoplasm	"CAB018603: AB_2060572, CAB019276: , HPA007338: AB_2667814"	"unprognostic (9.62e-3)"	"unprognostic (7.67e-2)"	"unprognostic (9.53e-3)"	"unprognostic (5.17e-1)"	"unprognostic (7.48e-3)"	"unprognostic (2.27e-2)"	"unprognostic (6.29e-2)"	"unprognostic (1.16e-1)"	"unprognostic (7.12e-2)"	"unprognostic (3.91e-3)"	"unprognostic (2.74e-2)"	"unprognostic (8.86e-2)"	"unprognostic (1.11e-3)"	"unprognostic (2.60e-2)"	"unprognostic (1.71e-1)"	"unprognostic (4.50e-2)"	"unprognostic (1.28e-3)"	23.7	377.1	64.6	18.4	65.2	1.3	49.5	64.9	72.7	53.8	251.4	30.3	32.3	180.2	64.2	35.4	390.2	182.9	60.1	65.5	67.8	46.9	140.8	26.8	18.6	83.1	69.0	1366.7	632.7	46.8	257.8	63.6	64.7	44.8	14.2	23.2	50.2	41.3	15.2	31.3	26.2	119.3	68.2	47.0	29.3	56.1	75.2	9.4	23.0	15.5	12.0	65.7	24.3	67.5	7.8	2.9	7.4	164.2	0.3	0.0	0.9	0.1	0.0	0.0	0.1	0.4	76.1	0.0	53.8	0.1	2.6	0.1	38.2	0.5	0.0	0.1	5.3	0.1	2.7	75.5	155.1	0.2	0.1	3.0	0.0	0.1	0.0	160.9	0.0	0.0	0.2	29.9	0.2	0.0	0.2	0.5	18.4	0.2	0.0	0.1	32.0	0.5	0.1	0.1	19.6	835.4	35.3	0.1	0.1	13.9	3.2	1.1	0.0	0.3	120.0	0.2	0.3	0.6	0.5	0.5	1.3	0.0	2.3	0.2	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	64.6	65.2	64.9	72.7	65.5	67.8	83.1	69.0	64.7	68.2	75.2	67.5	24.8	32.1	5.9	8.8	3.5	17.6	53.5	91.9	2.8	26.3	70.4	47.8	21.4	77.2	30.3	23.9	2.1	3.2	1.0	0.1	13.7	1013.0	4.8	199.6	961.4	103.8	43.1	13.5	0.5	1042.7	6.2	158.8	19.9	58.1	0.0	5988.6	343.7	6.9	16.5	3.3	0.3	2.3	42.7	10.6	3.4	16.2	27.1	25.1	8.8	5.6	13.5	159.9	0.0	4.0	16.0	563.0	0.0	4.5	2.9	56.6	2.6	4.7	10.3	7.2	26.3	220.9	534.7	11.6	4.9	6.2	34.9	3.8	10.2	3228.5	2.7	32.7
RBPJ	"CBF1, IGKJRB, IGKJRB1, KBF2, RBP-J, RBPJK, RBPSUH, SUH"	ENSG00000168214	"Recombination signal binding protein for immunoglobulin kappa J region"	Q06330	4	26163455-26435131	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Notch signaling pathway, Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Langerhans cells: 422.1;Oligodendrocytes: 378.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000251, HPA060647"	Uncertain		Supported	Nucleoplasm		NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 41: Macrophages - Immune response"	Nucleoplasm		"HPA000251: , HPA060647: AB_2684337"	"unprognostic (2.68e-1)"	"unprognostic (2.71e-3)"	"unprognostic (2.61e-1)"	"prognostic favorable (2.98e-4)"	"unprognostic (3.78e-2)"	"unprognostic (1.37e-1)"	"unprognostic (3.64e-3)"	"unprognostic (1.66e-1)"	"unprognostic (1.22e-1)"	"unprognostic (3.01e-1)"	"unprognostic (5.80e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.31e-3)"	"unprognostic (1.46e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.04e-2)"	"unprognostic (1.15e-3)"	40.9	18.3	28.1	33.0	44.2	51.3	28.4	34.2	38.5	31.9	27.7	33.2	20.2	36.4	18.0	28.5	23.6	25.5	21.8	29.0	37.6	21.4	17.9	31.3	27.5	41.7	38.5	34.2	22.3	26.2	12.9	54.4	39.0	28.0	28.1	33.1	19.3	22.5	21.7	26.0	22.7	38.0	32.2	25.7	25.4	28.7	36.4	27.8	24.8	28.9	26.5	31.8	21.7	58.9	68.2	19.1	60.0	39.0	91.5	138.8	44.9	54.4	47.0	50.9	60.1	14.5	36.4	56.0	34.1	36.2	39.5	12.2	51.9	33.4	98.1	30.4	28.4	42.5	24.2	27.9	47.9	76.9	35.9	64.0	28.5	104.9	39.7	70.3	28.5	34.3	43.0	21.5	93.2	20.1	54.5	76.4	163.5	20.3	30.3	48.0	112.4	25.4	26.8	22.4	84.5	36.5	28.0	20.6	24.3	54.4	22.0	53.3	38.5	50.5	25.2	86.3	51.9	40.2	51.9	55.7	132.3	86.3	43.4	23.8	94.6	112.9	31.4	77.8	42.6	37.2	49.8	34.1	136.4	33.4	41.4	35.9	220.5	70.9	77.1	31.5	68.1	68.6	28.1	44.2	34.2	38.5	29.0	37.6	41.7	38.5	39.0	32.2	36.4	58.9	72.5	48.1	66.8	62.0	54.6	152.8	86.2	104.6	55.8	94.6	48.9	51.2	44.2	62.9	83.3	46.0	129.3	102.7	47.3	26.6	74.3	64.3	44.4	54.5	96.3	73.2	78.4	46.9	81.7	65.4	74.4	129.0	29.0	62.8	57.0	130.7	65.3	53.1	365.2	85.8	85.9	51.0	59.0	208.5	422.1	56.7	135.5	234.2	80.0	60.9	125.1	95.0	44.3	215.1	378.1	76.5	35.1	84.2	54.9	113.7	44.9	55.4	67.5	102.9	85.5	71.7	95.8	134.7	158.4	45.9	109.3	83.9	102.8	57.0	47.0	75.7
RBPMS	HERMES	ENSG00000157110	"RNA binding protein, mRNA processing factor"	Q93062	8	30384511-30572256	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Proximal tubular cells: 242.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	5	"plasmacytoid DC: 1.0"	"Lineage enriched"	"Detected in single"	5	"dendritic cells: 1.0"	"Cell line enhanced"	"Detected in many"		"ASC diff: 324.1;RPTEC TERT1: 232.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA056999	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 48: Smooth muscle cells - ECM organization"	Nucleoplasm	Cytosol	"HPA056999: AB_2683306"	"unprognostic (1.65e-1)"	"unprognostic (7.81e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.23e-3)"	"unprognostic (8.66e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.42e-2)"	"unprognostic (3.47e-3)"	"unprognostic (4.63e-2)"	"unprognostic (2.32e-1)"	"unprognostic (4.67e-2)"	"unprognostic (2.88e-2)"	"unprognostic (1.76e-2)"	"unprognostic (4.76e-2)"	"unprognostic (2.52e-1)"	"unprognostic (4.91e-2)"	"unprognostic (2.16e-3)"	238.3	96.7	22.3	43.8	28.0	1.4	194.8	20.2	24.1	196.9	26.7	350.6	25.2	200.7	90.0	99.9	200.5	95.4	174.7	17.3	25.2	218.7	108.9	119.6	23.3	23.1	27.6	190.0	68.8	68.6	33.0	105.0	28.7	182.6	46.6	10.4	92.1	193.7	31.2	56.6	107.7	171.9	18.7	56.7	159.8	45.4	33.2	23.5	140.7	31.6	20.0	323.4	134.0	18.9	0.7	54.5	58.5	0.4	324.1	96.4	145.8	74.8	101.8	90.2	74.6	76.2	31.2	0.5	39.3	96.7	82.5	29.9	68.0	54.4	107.9	0.1	14.6	1.8	24.7	80.5	139.4	0.5	12.0	112.8	13.8	86.7	11.5	100.8	52.8	2.5	0.5	0.4	44.6	32.6	0.3	1.2	150.9	62.3	34.6	3.5	16.2	4.7	232.2	88.9	1.1	11.6	7.7	55.2	37.7	192.3	11.7	0.0	48.8	44.3	4.2	77.3	12.8	0.1	0.2	0.4	72.8	0.2	20.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	1.0	0.0	0.0	22.3	28.0	20.2	24.1	17.3	25.2	23.1	27.6	28.7	18.7	33.2	18.9	104.0	54.5	98.9	36.6	4.5	9.3	61.8	22.7	14.2	6.7	45.8	64.3	114.4	75.8	48.5	141.6	2.1	108.7	4.1	1.8	113.5	100.0	104.7	31.2	86.3	69.7	1.8	5.0	6.4	94.8	184.8	66.7	18.8	48.2	10.1	18.0	44.3	55.2	39.9	0.0	5.2	0.1	20.3	1.9	10.2	31.5	171.2	4.3	14.2	71.2	2.1	1.0	1.0	2.0	1.6	67.0	0.0	180.2	0.5	101.5	2.0	242.2	30.9	5.7	111.7	6.6	149.9	35.3	22.0	27.8	8.0	41.2	4.4	28.1	1.0	151.7
RBSN	ZFYVE20	ENSG00000131381	"Rabenosyn, RAB effector"	Q9H1K0	3	15070073-15099163	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044878	Approved		Supported	Vesicles		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 59: Non-specific - Transcription"	Vesicles		"HPA044878: AB_10967610"	"unprognostic (6.76e-2)"	"unprognostic (2.18e-1)"	"unprognostic (3.00e-3)"	"unprognostic (1.00e-1)"	"unprognostic (8.06e-2)"	"unprognostic (3.79e-3)"	"unprognostic (1.09e-3)"	"unprognostic (1.72e-2)"	"unprognostic (3.57e-1)"	"unprognostic (1.90e-2)"	"unprognostic (2.00e-2)"	"unprognostic (9.34e-2)"	"unprognostic (2.38e-3)"	"unprognostic (4.45e-2)"	"unprognostic (1.41e-1)"	"unprognostic (2.72e-1)"	"unprognostic (1.78e-1)"	9.0	7.0	12.5	6.7	12.5	18.2	7.7	10.2	13.0	9.1	1.1	10.7	4.7	9.3	7.1	8.9	8.7	5.4	9.8	13.4	11.4	5.4	8.4	8.4	6.6	12.1	12.5	12.7	5.9	9.7	6.1	7.9	11.1	7.4	5.3	13.6	5.9	9.0	13.1	10.2	7.1	9.0	12.8	7.7	7.8	6.6	13.0	5.5	11.2	9.9	6.1	9.1	7.5	11.8	11.2	16.0	12.8	16.6	13.8	10.2	33.9	12.0	11.5	14.1	12.7	9.7	6.5	7.8	6.8	15.9	8.2	7.0	16.5	14.5	12.4	9.9	14.6	8.9	19.7	8.0	9.5	9.0	9.4	11.1	16.1	18.1	12.0	8.3	11.6	8.7	13.5	8.9	10.8	14.7	4.9	4.5	11.0	7.1	12.7	6.4	14.6	8.6	7.3	12.6	3.4	12.0	14.7	8.9	10.7	9.4	22.8	6.5	14.2	12.7	13.3	12.5	17.1	7.9	12.6	9.2	12.2	10.0	12.2	8.1	4.6	11.1	4.4	6.4	3.9	4.4	6.1	5.5	3.8	7.4	7.7	5.2	11.7	3.1	5.6	3.6	4.3	2.7	12.5	12.5	10.2	13.0	13.4	11.4	12.1	12.5	11.1	12.8	13.0	11.8	10.4	16.0	19.0	19.6	9.2	0.0	6.7	0.0	6.8	21.6	7.6	7.0	20.4	8.6	9.9	3.7	22.9	10.4	8.4	6.0	5.9	8.4	17.4	6.4	11.1	12.4	1.2	9.5	21.8	9.6	9.6	14.6	10.2	8.8	10.1	16.4	14.6	14.0	10.7	21.9	23.9	6.9	0.0	15.8	0.0	18.0	19.0	12.1	0.0	8.4	10.5	15.5	7.2	16.1	25.2	9.6	5.1	14.7	12.1	12.6	8.1	6.9	8.0	23.1	6.6	17.5	10.4	12.4	14.0	11.0	0.0	12.9	9.9	10.6	5.4	10.0
RBX1	"BA554C12.1, RNF75, ROC1"	ENSG00000100387	"Ring-box 1"	P62877	22	40951347-40973309	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, Host-virus interaction, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003038			Supported	Nucleoplasm		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 6: Erythroid cells - Oxygen transport"	Nucleoplasm		"HPA003038: AB_1079827"	"unprognostic (2.34e-1)"	"unprognostic (1.54e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.60e-3)"	"unprognostic (2.30e-1)"	"unprognostic (2.92e-2)"	"unprognostic (1.82e-3)"	"unprognostic (1.74e-1)"	"unprognostic (6.61e-2)"	"prognostic favorable (6.63e-4)"	"unprognostic (5.01e-3)"	"unprognostic (2.19e-1)"	"unprognostic (4.99e-3)"	"unprognostic (2.22e-2)"	"unprognostic (1.34e-1)"	"unprognostic (4.57e-2)"	"unprognostic (3.05e-2)"	37.8	46.8	82.3	33.4	85.6	63.4	45.1	88.4	105.1	38.5	79.7	36.6	26.3	34.3	59.2	53.5	31.4	22.3	72.7	82.9	86.5	49.4	38.9	37.5	44.5	88.2	84.1	26.9	24.7	38.3	34.5	40.9	87.3	32.8	32.8	45.3	33.1	26.9	83.2	43.3	33.1	32.7	89.7	39.8	37.5	24.8	84.1	59.3	35.8	100.5	51.6	36.4	37.7	93.6	111.1	62.2	114.4	57.9	79.9	94.9	64.3	86.6	80.0	128.2	112.9	101.4	52.5	96.7	57.3	86.3	50.8	62.3	110.6	100.2	135.1	113.9	174.7	60.4	84.0	126.1	68.2	148.3	74.8	79.1	79.1	93.0	66.6	73.3	110.5	57.8	72.2	95.6	115.1	136.7	90.2	170.1	63.7	216.3	64.8	116.8	80.0	122.5	149.3	71.0	54.1	34.9	76.5	76.3	82.7	63.8	65.8	99.5	74.8	77.9	81.1	66.4	84.5	80.0	78.9	146.5	98.0	74.7	88.6	151.8	128.1	108.7	79.9	133.9	76.0	114.7	99.2	85.7	129.7	102.4	85.5	93.8	42.3	89.2	154.6	211.1	137.6	250.2	82.3	85.6	88.4	105.1	82.9	86.5	88.2	84.1	87.3	89.7	84.1	93.6	224.9	230.8	144.8	23.5	173.6	300.9	207.2	567.7	129.1	90.4	189.6	237.9	515.4	171.6	300.0	224.3	25.0	507.3	238.6	181.8	508.7	346.8	41.1	227.4	170.6	222.1	162.1	638.3	29.9	333.6	637.9	211.2	107.6	180.4	129.8	140.0	167.4	254.8	431.3	89.2	29.7	205.1	349.9	236.7	334.2	79.4	185.8	270.7	341.5	15.0	532.3	264.5	228.6	18.6	49.6	377.7	229.8	177.1	180.8	269.5	300.5	586.5	314.3	163.7	118.3	160.0	256.3	220.2	242.9	237.5	370.7	675.9	175.3	185.7	207.1	248.8
RC3H1	"KIAA2025, RNF198, roquin, RP5-1198E17.5"	ENSG00000135870	"Ring finger and CCCH-type domains 1"	Q5TC82	1	173931084-174022357	"Enzymes, Predicted intracellular proteins"		"RNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027428, HPA027434, HPA027448"	Approved		Supported	"Golgi apparatus,Plasma membrane,Cytosol"		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 44: Endometrium - Transcription"	Cytosol	"Golgi apparatus, Plasma membrane"	"HPA027428: AB_10600324, HPA027434: AB_10601235, HPA027448: AB_10601683"	"unprognostic (6.91e-2)"	"unprognostic (7.76e-2)"	"unprognostic (2.23e-2)"	"unprognostic (2.33e-2)"	"unprognostic (7.73e-2)"	"unprognostic (1.61e-2)"	"unprognostic (5.74e-2)"	"unprognostic (1.99e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.13e-2)"	"unprognostic (2.04e-2)"	"unprognostic (1.90e-2)"	"prognostic unfavorable (7.96e-4)"	"unprognostic (5.25e-2)"	"unprognostic (2.15e-1)"	"unprognostic (3.43e-3)"	"unprognostic (6.83e-3)"	4.8	3.8	2.6	4.2	4.7	19.6	5.2	16.0	5.1	4.9	11.4	5.2	3.4	4.5	4.0	6.1	4.8	4.0	4.6	3.1	5.8	3.9	5.8	5.9	4.9	3.5	3.5	5.1	4.8	3.9	4.6	4.3	4.0	4.2	4.2	8.0	4.4	3.5	10.6	7.4	5.5	3.7	2.0	6.7	4.6	5.3	4.1	5.0	5.0	10.3	5.6	4.5	5.1	7.2	6.6	9.1	4.9	7.7	9.2	7.1	6.8	4.4	6.3	5.0	4.4	8.4	7.3	9.4	7.7	7.2	3.9	6.2	7.5	6.3	7.0	6.6	1.8	8.1	6.8	7.0	5.6	10.7	9.1	6.8	4.8	7.3	4.9	4.6	7.9	4.5	9.4	5.6	6.2	5.0	6.5	9.6	8.5	6.1	1.0	7.0	8.8	6.9	8.9	12.7	5.9	5.3	8.4	10.7	4.3	8.2	7.2	10.7	11.4	6.5	6.5	5.6	5.8	6.9	7.5	11.8	4.4	4.8	6.7	3.4	1.9	2.7	1.1	1.9	1.2	1.5	1.1	1.3	1.0	1.8	1.5	1.3	6.4	1.4	2.6	0.8	0.9	0.7	2.6	4.7	16.0	5.1	3.1	5.8	3.5	3.5	4.0	2.0	4.1	7.2	39.8	41.7	34.5	32.0	49.4	34.4	17.3	14.1	60.9	35.6	53.6	28.3	25.7	25.8	20.0	23.9	81.3	10.6	70.2	37.4	9.8	25.4	13.3	77.5	45.9	32.0	34.2	30.7	46.8	18.9	8.2	34.9	68.8	82.9	15.8	20.3	34.2	36.3	11.5	38.7	43.5	28.9	16.2	37.2	48.2	8.1	15.8	38.5	30.2	40.3	33.0	22.7	30.9	42.3	68.2	24.8	22.1	10.5	52.2	38.3	25.1	9.8	30.2	47.3	19.7	39.0	31.5	35.8	14.0	66.8	40.9	11.6	41.4	16.1	25.9	38.5
RCC1	CHC1	ENSG00000180198	"Regulator of chromosome condensation 1"	P18754	1	28505943-28539300	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	"DNA-binding, Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	4	"Late spermatids: 789.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB015413, HPA027573, HPA027574"	Enhanced		Supported	"Nucleoplasm,Nuclear membrane"		NA	NA		47000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 32: U-937 - Innate immune response"	"Cluster 25: Spermatids - Spermatogenesis"	Nucleoplasm	"Nuclear membrane"	"CAB015413: AB_831160, HPA027573: AB_10599303, HPA027574: AB_10601236"	"unprognostic (6.23e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.53e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.69e-2)"	"prognostic unfavorable (1.91e-5)"	"unprognostic (3.93e-2)"	"unprognostic (2.03e-3)"	"unprognostic (1.53e-1)"	"unprognostic (5.79e-3)"	"unprognostic (8.50e-2)"	"prognostic unfavorable (2.43e-11)"	"unprognostic (1.04e-2)"	"unprognostic (2.78e-1)"	"unprognostic (3.02e-1)"	"unprognostic (6.23e-2)"	14.2	12.1	5.5	31.0	6.1	58.5	17.2	7.3	7.6	14.7	6.5	24.4	27.2	14.2	10.3	32.2	18.9	12.9	6.6	5.8	6.1	9.0	23.9	12.3	37.4	6.8	6.2	16.1	16.1	5.8	3.8	17.7	6.8	10.9	28.1	6.1	20.6	9.2	13.3	14.6	23.4	19.3	6.1	16.1	18.6	57.9	7.6	44.3	11.7	8.0	38.0	23.6	15.8	6.9	263.2	109.7	94.8	112.9	68.4	86.5	106.2	100.2	60.2	158.5	122.9	111.9	206.2	331.0	60.0	99.2	65.3	155.0	306.6	158.1	125.1	133.7	185.0	295.0	140.0	147.2	51.6	329.0	171.5	111.6	106.0	150.0	125.6	100.7	110.6	194.5	222.8	101.1	66.0	140.8	260.5	118.0	205.3	117.8	106.4	252.9	163.3	164.0	60.5	119.9	150.6	76.7	105.3	171.5	87.6	52.7	72.6	99.8	84.5	81.6	162.5	102.0	198.2	60.9	91.2	248.8	80.5	469.7	89.5	5.1	7.7	3.3	5.0	7.9	9.4	7.1	7.8	8.2	14.0	7.2	6.8	7.6	1.8	5.9	5.7	7.7	7.6	6.3	5.5	6.1	7.3	7.6	5.8	6.1	6.8	6.2	6.8	6.1	7.6	6.9	8.9	0.0	10.3	2.0	57.4	36.7	12.4	13.6	92.2	0.8	18.9	15.4	4.6	5.7	16.2	7.3	2.1	25.6	10.7	10.7	3.9	34.0	176.5	12.7	21.1	16.6	5.4	118.1	4.5	23.7	43.5	17.4	68.8	17.4	1.3	14.8	2.9	6.6	20.8	13.5	5.0	16.0	12.2	11.3	20.0	789.4	17.1	21.3	14.2	1.9	16.6	0.5	15.5	2.0	2.9	39.5	7.0	10.5	75.5	21.6	9.6	5.7	14.1	0.3	6.6	15.0	16.6	19.2	18.4	185.3	33.8	24.5	31.7	12.5	25.0	18.4
RCHY1	"ARNIP, CHIMP, DKFZp586C1620, PIRH2, PRO1996, RNF199, ZCHY, ZNF363"	ENSG00000163743	"Ring finger and CHY zinc finger domain containing 1"	Q96PM5	4	75479037-75514764	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030338, HPA030339"	Approved		Supported	Nucleoplasm,Vesicles,Cytosol		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Cytosol	"Nucleoplasm, Vesicles"	"HPA030338: , HPA030339: AB_10603232"	"unprognostic (1.53e-1)"	"unprognostic (1.57e-1)"	"prognostic favorable (9.09e-4)"	"unprognostic (1.90e-1)"	"unprognostic (3.45e-3)"	"unprognostic (1.19e-2)"	"unprognostic (7.87e-3)"	"unprognostic (5.82e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.98e-1)"	"unprognostic (7.45e-3)"	"unprognostic (4.60e-2)"	"prognostic favorable (3.62e-5)"	"unprognostic (1.69e-1)"	"unprognostic (2.07e-1)"	"unprognostic (1.83e-1)"	"prognostic favorable (7.89e-5)"	8.6	7.0	9.5	7.9	10.2	17.0	16.8	12.6	13.0	9.0	7.7	12.1	8.7	9.6	6.9	7.2	11.9	6.8	16.8	9.4	10.6	16.2	12.3	10.0	9.5	8.9	10.4	14.5	8.3	12.6	5.8	10.0	9.9	10.9	13.2	14.8	12.9	10.1	16.5	5.6	8.6	11.6	9.9	11.5	8.9	13.6	10.7	12.7	18.9	23.6	12.6	7.6	4.7	10.7	9.8	5.0	14.6	13.8	15.1	13.1	8.4	6.5	15.1	13.2	15.4	13.8	11.9	16.2	12.0	9.4	13.1	5.8	37.6	11.5	19.9	13.4	12.3	21.2	9.2	17.9	13.0	28.9	11.2	12.2	14.1	15.2	14.2	15.9	27.0	20.8	19.9	16.2	30.9	15.8	26.7	11.5	24.5	26.9	8.7	14.2	34.4	13.9	20.4	16.7	22.6	12.4	10.7	24.8	28.2	15.9	14.0	12.9	10.8	8.6	8.5	7.8	11.1	17.0	13.0	22.8	10.5	20.2	14.0	27.5	9.2	9.7	4.3	5.7	7.6	4.6	5.4	5.2	8.0	2.1	3.9	5.5	4.0	5.5	5.6	4.1	5.7	4.7	9.5	10.2	12.6	13.0	9.4	10.6	8.9	10.4	9.9	9.9	10.7	10.7	22.2	19.2	10.3	28.4	25.4	40.7	32.3	47.1	39.3	35.0	38.5	25.9	56.8	24.3	23.5	23.9	20.9	31.6	31.2	21.9	68.4	30.3	37.3	11.9	17.1	22.3	13.8	21.8	31.2	22.5	23.2	24.6	21.9	17.3	5.1	23.8	25.4	23.0	19.0	23.5	32.3	23.4	38.7	37.5	26.8	59.8	22.4	27.4	28.4	22.5	23.9	32.0	24.7	31.7	41.0	26.5	22.6	25.2	19.7	36.6	24.6	69.4	13.5	21.7	32.9	20.9	27.3	72.8	41.7	28.1	31.0	33.8	32.9	35.2	27.6	26.3
RCN1	"FLJ37041, PIG20, Rcal, RCN"	ENSG00000049449	"Reticulocalbin 1"	Q15293	11	32091074-32105722	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"epididymis: 660.2"	"Cell type enhanced"	"Detected in all"		"Extravillous trophoblasts: 288.2;Muller glia cells: 327.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							"HPA038474, HPA062104"	Approved		Supported	"Endoplasmic reticulum"	"Intracellular and membrane"	NA	NA		9400000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 68: Epididymis - Unknown function"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 33: Fibroblasts - ECM organization"	"Endoplasmic reticulum"		"HPA038474: AB_10672595, HPA062104: AB_2684683"	"unprognostic (1.65e-1)"	"unprognostic (7.69e-3)"	"unprognostic (1.24e-1)"	"unprognostic (2.03e-2)"	"unprognostic (7.20e-3)"	"unprognostic (1.70e-2)"	"unprognostic (6.92e-3)"	"prognostic unfavorable (7.13e-6)"	"unprognostic (8.85e-2)"	"unprognostic (1.30e-2)"	"unprognostic (2.12e-1)"	"unprognostic (9.32e-2)"	"prognostic unfavorable (2.70e-13)"	"unprognostic (1.78e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.14e-1)"	"unprognostic (6.93e-3)"	81.8	54.4	26.7	58.3	39.6	8.1	64.6	24.0	28.2	73.9	37.2	54.7	43.4	79.7	660.2	25.7	69.5	50.1	46.0	26.4	37.2	39.2	100.7	50.6	29.2	29.9	27.6	83.6	21.9	62.2	67.3	129.0	29.0	85.6	53.7	48.7	89.9	82.5	32.7	26.8	41.5	79.5	31.8	35.9	40.7	22.5	36.7	19.0	63.4	28.8	23.1	113.1	41.1	31.3	130.0	143.7	335.9	217.4	720.2	548.1	340.4	425.5	501.5	286.6	515.6	123.6	157.2	0.4	293.3	718.4	380.4	157.6	118.0	135.2	450.2	63.9	231.9	28.2	104.7	58.4	519.7	21.7	42.0	780.1	154.8	197.1	215.4	333.7	647.7	60.6	17.4	25.8	342.1	116.0	61.4	50.2	137.2	2.7	143.9	45.1	393.5	39.2	270.1	355.8	82.1	42.6	117.1	26.2	333.1	227.2	171.0	77.5	350.8	417.0	215.8	338.5	364.6	1.0	0.9	1.7	514.2	28.3	224.9	0.3	13.6	0.5	14.9	16.2	11.8	6.2	6.9	12.3	15.2	4.8	5.1	9.5	0.6	10.9	10.3	8.2	2.7	9.3	26.7	39.6	24.0	28.2	26.4	37.2	29.9	27.6	29.0	31.8	36.7	31.3	131.3	54.5	34.8	9.8	11.8	41.6	80.8	78.2	34.1	40.4	47.9	37.5	9.0	42.9	55.1	47.8	12.5	172.6	10.5	14.3	7.9	143.4	210.4	60.7	154.9	112.1	53.2	16.4	8.0	45.7	288.2	152.1	23.0	110.2	12.7	100.3	85.3	61.7	44.2	15.2	5.9	80.9	38.7	17.8	33.9	173.8	80.5	19.9	32.0	8.4	50.3	327.4	19.6	16.6	1.3	39.7	30.8	73.0	38.6	184.9	6.7	14.1	30.4	17.0	26.3	80.8	91.7	17.0	7.2	33.2	28.3	217.0	13.6	55.8	75.3	99.8
RCN3	RLP49	ENSG00000142552	"Reticulocalbin 3"	Q96D15	19	49528003-49546962	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Protein transport, Transport"	Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 54.7;Fibroblasts: 105.1;Leydig cells: 38.2;Peritubular cells: 44.8;Smooth muscle cells: 66.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"naive CD4 T-cell: 6.8"	"Group enriched"	"Detected in many"	9	"granulocytes: 2.5;NK-cells: 1.8;T-cells: 6.8"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 166.6;ASC diff: 283.3;ASC TERT1: 175.4;BJ: 353.8;BJ hTERT+ SV40 Large T+ RasG12V: 179.6;fHDF/TERT166: 304.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043134, HPA050402"	Uncertain		Supported	"Endoplasmic reticulum,Vesicles"	"Intracellular and membrane"	No	No		1600000	"Cluster 32: T-cells - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 33: Fibroblasts - ECM organization"	"Endoplasmic reticulum"	Vesicles	"HPA043134: AB_2678332, HPA050402: AB_2681114"	"unprognostic (7.10e-2)"	"unprognostic (1.19e-1)"	"unprognostic (3.77e-3)"	"unprognostic (8.87e-2)"	"unprognostic (3.36e-3)"	"unprognostic (1.27e-1)"	"unprognostic (2.30e-3)"	"unprognostic (1.16e-1)"	"unprognostic (7.47e-2)"	"unprognostic (9.75e-2)"	"unprognostic (2.85e-1)"	"unprognostic (3.86e-2)"	"prognostic unfavorable (5.80e-12)"	"unprognostic (5.26e-2)"	"unprognostic (3.90e-2)"	"unprognostic (1.56e-2)"	"unprognostic (4.20e-3)"	67.9	35.3	15.8	33.6	17.2	6.8	48.2	15.5	24.1	78.8	23.5	43.5	39.9	47.4	4.4	11.4	41.4	25.2	56.7	16.0	19.1	41.2	62.3	40.8	8.7	17.4	17.0	50.0	16.4	3.9	20.7	31.1	19.0	32.4	11.4	1.4	19.1	12.1	11.7	25.3	43.2	25.7	16.8	65.9	23.4	17.2	24.5	4.0	26.4	7.5	4.1	43.2	46.3	18.8	3.2	4.3	2.7	166.6	283.3	175.4	1.9	353.8	86.5	122.0	179.6	4.2	1.3	1.3	19.5	304.0	1.3	0.3	6.8	0.5	49.2	0.1	2.5	19.5	1.5	9.1	105.7	0.1	43.0	119.5	0.2	93.2	0.4	3.2	43.8	2.3	8.7	1.0	87.8	2.9	0.1	2.0	1.4	8.8	24.5	0.5	3.9	4.0	1.4	0.0	1.7	10.5	0.3	1.1	0.3	2.8	1.3	11.5	121.4	1.7	52.4	135.3	0.1	14.9	44.5	2.6	7.9	9.6	13.4	0.0	0.2	1.6	0.7	0.0	0.7	0.4	1.7	0.6	0.4	0.2	6.8	2.3	2.5	1.8	0.3	0.2	1.6	1.1	15.8	17.2	15.5	24.1	16.0	19.1	17.4	17.0	19.0	16.8	24.5	18.8	12.0	0.0	6.1	4.6	2.8	18.6	0.6	2.9	3.4	0.8	1.7	3.3	2.1	1.5	0.8	1.8	0.0	2.5	1.4	10.5	1.9	1.6	2.2	1.5	54.7	10.6	1.2	0.0	1.0	0.5	5.0	105.1	6.6	1.6	1.3	7.0	27.1	3.7	22.6	1.7	1.1	7.6	0.0	11.4	23.2	3.0	38.2	11.9	10.6	10.3	3.1	0.6	0.0	1.5	0.8	1.5	7.9	44.8	4.8	0.9	13.1	0.6	0.9	0.8	13.1	37.5	66.5	6.5	6.8	2.8	13.9	6.2	2.2	17.2	8.0	0.4
RDH10	SDR16C4	ENSG00000121039	"Retinol dehydrogenase 10"	Q8IZV5	8	73294602-73325281	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Club cells: 131.7;Collecting duct cells: 204.1;Muller glia cells: 342.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"basophil: 1.2"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in all"		"ASC diff: 143.6;BJ: 107.4;CACO-2: 97.0;HDLM-2: 110.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049199			Supported	"Lipid droplets"		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 77: Retina - Visual perception"	"Cluster 21: OE19 - Mitochondria"	"Cluster 5: Muller glia cells - Visual perception"	"Lipid droplets"		"HPA049199: AB_2680673"	"unprognostic (1.78e-1)"	"unprognostic (1.23e-1)"	"unprognostic (8.86e-2)"	"unprognostic (2.52e-1)"	"unprognostic (2.45e-2)"	"unprognostic (1.13e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.80e-2)"	"unprognostic (7.87e-2)"	"unprognostic (7.98e-2)"	"unprognostic (1.18e-3)"	"unprognostic (8.88e-3)"	"unprognostic (1.13e-2)"	"unprognostic (4.38e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.98e-3)"	"unprognostic (6.23e-2)"	43.3	6.2	4.2	23.4	5.3	3.3	10.5	4.1	4.1	18.2	16.0	16.6	32.4	14.1	3.9	19.8	7.8	30.2	11.6	4.9	5.9	43.8	41.0	13.6	11.0	11.5	6.8	5.0	34.5	8.4	26.8	36.3	6.4	21.5	15.2	86.3	39.2	13.1	6.9	8.3	30.7	14.9	5.8	7.2	24.8	16.6	20.4	6.1	6.5	8.2	8.8	69.2	11.3	6.7	13.8	39.2	4.3	17.9	143.6	10.5	39.0	107.4	17.4	4.1	6.8	97.0	38.6	9.6	13.9	60.4	6.3	35.6	19.6	15.5	8.4	110.7	49.0	17.0	37.6	30.1	5.6	8.2	18.0	6.3	19.6	16.5	15.3	18.3	15.6	9.4	20.0	13.7	7.0	6.1	8.5	3.4	5.2	84.0	19.0	7.4	4.4	5.8	28.2	19.4	2.6	3.4	9.1	66.3	5.5	5.4	13.1	4.2	24.0	6.3	10.6	28.9	8.3	8.8	10.0	7.8	5.0	7.3	14.7	1.2	0.1	0.2	0.3	0.1	0.2	0.1	0.3	0.4	0.2	0.0	0.6	0.3	0.1	0.0	0.1	0.0	0.2	0.1	4.2	5.3	4.1	4.1	4.9	5.9	11.5	6.8	6.4	5.8	20.4	6.7	14.5	12.8	29.8	3.6	2.5	13.5	9.7	75.6	16.5	3.2	29.1	25.5	9.1	25.8	131.7	204.1	22.9	19.1	11.2	25.5	3.9	16.3	80.6	38.3	50.0	9.7	4.2	1.3	1.4	17.6	23.8	44.6	49.5	71.5	2.5	1.2	3.3	49.2	20.9	3.3	1.0	16.8	40.7	5.4	7.8	9.9	2.8	10.0	17.8	6.5	1.9	342.1	3.1	4.5	2.0	56.9	31.5	3.8	6.4	41.2	47.7	22.6	44.2	16.2	0.0	11.4	20.5	11.0	8.0	24.7	13.9	42.0	7.1	1.6	24.2	17.7
RDH13	SDR7C3	ENSG00000160439	"Retinol dehydrogenase 13"	Q8NBN7	19	55039108-55071291	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in all"		"Syncytiotrophoblasts: 209.7;Urothelial cells: 110.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEK 293: 60.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042006	Approved		Supported	Mitochondria,Cytosol	"Intracellular and membrane"	NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 31: Skin - Epidermis development"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	"Mitochondria, Cytosol"		"HPA042006: AB_10960270"	"unprognostic (9.26e-2)"	"unprognostic (1.14e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.15e-2)"	"unprognostic (8.74e-2)"	"unprognostic (1.08e-2)"	"unprognostic (2.48e-1)"	"unprognostic (3.60e-2)"	"unprognostic (1.82e-1)"	"unprognostic (9.42e-3)"	"unprognostic (1.61e-1)"	"unprognostic (2.45e-3)"	"prognostic favorable (2.09e-4)"	"unprognostic (2.19e-2)"	"unprognostic (2.23e-1)"	"unprognostic (2.12e-2)"	"unprognostic (1.66e-3)"	4.5	4.8	2.5	3.4	2.6	2.2	4.5	3.9	3.6	9.4	3.9	8.6	6.7	4.2	0.7	19.8	4.8	3.0	13.0	2.4	3.5	9.2	8.2	4.4	3.5	3.5	4.2	3.7	8.6	12.4	6.4	10.1	3.7	6.3	3.8	2.1	9.6	3.7	9.7	21.0	6.1	2.0	1.6	6.2	10.5	5.3	3.8	2.2	7.5	4.8	2.7	5.1	12.2	2.3	10.9	12.3	2.9	10.3	1.5	3.0	17.9	3.4	2.1	3.7	6.4	23.3	15.7	9.4	5.3	1.2	2.7	14.1	7.8	7.2	1.7	7.3	60.0	12.2	9.8	14.6	2.9	12.4	8.0	2.6	6.3	3.0	2.9	3.7	3.0	5.2	27.2	2.9	2.3	13.4	6.1	9.6	2.5	17.7	25.7	15.7	6.7	27.6	8.2	37.3	8.8	6.2	8.9	31.3	7.0	2.7	12.0	9.3	3.0	0.3	3.7	0.1	8.2	7.8	11.0	9.6	9.1	10.6	6.6	3.8	4.1	4.1	8.2	6.3	7.7	5.4	6.3	7.6	4.2	5.8	8.4	6.1	1.9	7.8	5.0	6.4	5.5	3.0	2.5	2.6	3.9	3.6	2.4	3.5	3.5	4.2	3.7	1.6	3.8	2.3	8.9	16.0	13.1	3.9	6.6	10.7	31.7	11.1	7.4	21.0	12.2	9.9	27.5	20.0	19.3	14.7	41.7	41.3	9.4	47.2	11.7	13.5	24.3	18.3	8.8	9.1	12.0	4.2	9.4	6.5	29.0	7.1	46.4	31.8	8.2	24.4	18.5	7.3	11.5	25.2	10.0	27.5	12.2	4.9	5.0	13.2	3.7	4.2	7.2	4.7	5.0	9.0	6.2	5.0	2.9	14.5	35.7	3.4	8.7	30.6	20.3	4.8	12.8	25.3	6.6	5.1	6.5	3.2	8.9	11.1	17.5	209.7	9.2	11.1	28.1	110.1
RDM1	"MGC33977, RAD52B"	ENSG00000278023	"RAD52 motif containing 1"	Q8NG50	17	35918066-35930773	"Predicted intracellular proteins, Predicted membrane proteins"		"DNA-binding, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"testis: 11.9"	"Group enriched"	"Detected in some"	15	"Early spermatids: 59.4;Late spermatids: 81.9;Spermatocytes: 25.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Immune cell enhanced"	"Detected in some"		"memory CD8 T-cell: 2.6"	"Lineage enhanced"	"Detected in single"		"T-cells: 2.6"	"Cell line enhanced"	"Detected in many"		"HEK 293: 11.5;JURKAT: 17.7"	"Low region specificity"	"Detected in all"							"HPA024794, HPA067546"	Enhanced		Supported	Nucleoli,Cytosol		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 21: OE19 - Mitochondria"	"Cluster 31: Spermatids - Spermatogenesis"	Nucleoli	Cytosol	"HPA024794: AB_1856039, HPA067546: AB_2732769"	"unprognostic (9.36e-2)"	"unprognostic (2.40e-2)"	"unprognostic (8.00e-2)"	"unprognostic (4.57e-3)"	"unprognostic (1.91e-2)"	"unprognostic (1.26e-1)"	"unprognostic (2.06e-4)"	"unprognostic (5.95e-2)"	"unprognostic (1.83e-2)"	"unprognostic (1.71e-2)"	"unprognostic (2.58e-2)"	"unprognostic (3.24e-2)"	"unprognostic (1.06e-8)"	"unprognostic (1.58e-1)"	"unprognostic (1.96e-1)"	"unprognostic (7.00e-3)"	"unprognostic (1.53e-1)"	0.1	0.1	0.6	0.5	0.4	0.5	0.3	1.2	0.6	0.2	0.1	0.5	0.8	0.0	0.5	0.3	0.2	0.1	0.0	0.6	0.5	0.1	0.2	0.1	1.1	0.2	0.3	0.0	0.0	0.0	0.3	0.4	0.4	0.1	0.8	0.4	0.0	0.1	0.0	0.7	0.6	0.1	0.0	0.3	0.4	11.9	0.5	2.4	0.3	0.0	1.5	0.1	0.1	0.3	4.8	4.2	1.8	2.4	0.1	0.0	1.9	0.9	0.1	1.1	2.1	7.0	6.6	5.6	2.2	0.4	5.1	0.9	3.6	2.9	3.6	2.6	11.5	2.9	2.0	0.0	0.0	0.3	1.5	0.0	0.4	0.3	0.6	1.5	0.1	17.7	2.1	0.0	0.4	4.3	1.5	3.0	0.7	9.0	3.1	1.1	0.0	0.0	1.3	2.4	2.8	1.1	0.4	1.4	3.7	5.1	8.9	0.7	0.0	0.1	2.6	0.0	0.6	5.5	1.5	2.2	2.9	1.7	1.0	0.0	0.0	0.0	0.7	0.0	1.3	0.0	0.8	2.6	0.1	0.0	0.0	0.3	0.0	0.6	0.0	0.0	0.5	0.2	0.6	0.4	1.2	0.6	0.6	0.5	0.2	0.3	0.4	0.0	0.5	0.3	0.0	0.0	0.0	0.0	0.2	0.3	0.2	0.5	0.0	0.0	0.4	0.6	0.6	0.0	0.1	0.0	0.0	3.7	0.4	0.1	0.0	0.1	59.4	0.9	0.2	0.1	1.2	0.4	0.6	0.0	1.0	0.3	0.5	0.3	0.0	1.5	0.4	0.6	1.8	0.0	0.3	0.7	0.0	0.0	0.3	81.9	0.6	0.4	0.0	0.0	0.0	0.0	2.1	0.0	0.4	0.0	0.0	0.4	0.1	0.2	0.1	0.2	0.2	0.0	0.0	0.3	0.2	25.6	2.7	0.4	0.0	0.7	0.6	0.1	1.6	0.7
RDX	DFNB24	ENSG00000137710	Radixin	P35241	11	109864295-110296712	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		"Actin capping, Actin-binding"	"Deafness, Disease variant, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 155.0"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 484.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000263, HPA000763, CAB037312"	Enhanced		Supported	"Nucleoplasm,Plasma membrane"		NA	NA		38000000	"Cluster 2: Granulocytes - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 1: Pancreatic cells - Digestion"	"Plasma membrane"	Nucleoplasm	"CAB037312: AB_261933, HPA000263: AB_1856043, HPA000763: AB_1856042"	"unprognostic (2.23e-3)"	"unprognostic (2.56e-2)"	"unprognostic (3.85e-1)"	"unprognostic (2.74e-2)"	"unprognostic (6.93e-2)"	"unprognostic (9.82e-2)"	"unprognostic (2.01e-2)"	"unprognostic (1.44e-2)"	"unprognostic (3.91e-2)"	"unprognostic (6.91e-2)"	"unprognostic (1.32e-3)"	"unprognostic (6.47e-2)"	"unprognostic (4.14e-3)"	"unprognostic (5.43e-2)"	"unprognostic (4.40e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.08e-3)"	40.3	155.0	38.0	17.4	57.7	12.0	16.4	50.0	42.7	32.1	32.8	15.2	6.8	28.8	12.9	27.4	19.7	27.2	41.0	35.1	44.7	50.2	68.5	48.8	11.4	52.7	48.2	52.8	52.7	33.2	7.6	35.3	54.3	25.4	11.1	19.2	20.8	26.0	82.1	11.9	7.4	35.0	45.1	26.6	15.0	33.7	47.7	14.3	45.7	59.7	14.6	27.1	10.1	77.6	69.6	35.3	137.3	54.8	78.8	87.4	79.3	85.8	47.6	54.3	59.2	99.7	115.4	0.1	127.4	104.7	84.9	61.5	77.3	80.4	80.5	41.9	44.2	51.5	107.7	74.1	73.6	19.0	33.2	89.7	45.6	68.0	120.1	89.3	149.8	11.1	73.5	29.5	127.0	120.0	11.0	15.6	44.0	4.0	58.4	31.2	96.8	30.1	68.1	33.5	37.2	40.5	148.5	65.9	52.7	102.5	85.0	29.9	92.6	89.5	66.8	43.9	67.4	9.5	17.3	65.9	34.2	11.3	210.9	29.5	14.8	22.0	11.6	12.5	15.5	11.5	10.2	8.8	12.8	8.3	6.8	5.8	2.0	17.6	9.9	10.3	22.0	8.4	38.0	57.7	50.0	42.7	35.1	44.7	52.7	48.2	54.3	45.1	47.7	77.6	248.8	484.0	98.8	53.5	30.0	56.1	51.8	124.6	56.9	85.9	47.4	45.7	159.3	70.1	77.9	75.4	43.8	122.1	21.6	17.7	109.5	128.1	15.5	109.1	117.2	289.2	22.2	104.8	27.1	423.4	189.8	88.4	19.9	135.3	67.2	132.0	319.2	260.1	85.1	101.0	57.6	7.3	61.1	103.2	59.9	43.6	275.2	71.6	72.9	42.2	135.4	77.0	36.0	68.3	229.4	134.3	22.1	266.7	36.1	65.9	0.1	236.9	52.2	94.8	124.9	74.0	143.8	73.9	257.4	52.8	40.5	227.3	29.2	229.9	11.8	45.9
RECK	"hRECK, ST15"	ENSG00000122707	"Reversion inducing cysteine rich protein with kazal motifs"	O95980	9	36036913-36124455	"Plasma proteins, Predicted membrane proteins"	"Wnt signaling pathway"	"Protease inhibitor, Serine protease inhibitor"	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 63.1;Inhibitory neurons: 71.1;Oligodendrocyte precursor cells: 80.4;Oligodendrocytes: 119.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 199.5;ASC TERT1: 158.5;BJ: 65.1;BJ hTERT+: 93.0;fHDF/TERT166: 57.8;HSkMC: 71.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB025109, HPA071729"	Supported		Supported	"Plasma membrane"		NA	NA		64000000	"Cluster 27: Non-specific - Gene expression"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Plasma membrane"		"CAB025109: , HPA071729: AB_2686438"	"unprognostic (3.42e-1)"	"unprognostic (4.01e-3)"	"unprognostic (5.50e-2)"	"unprognostic (5.05e-4)"	"unprognostic (8.87e-2)"	"unprognostic (8.47e-2)"	"unprognostic (2.24e-1)"	"unprognostic (2.23e-1)"	"unprognostic (3.75e-2)"	"unprognostic (1.51e-2)"	"unprognostic (9.06e-2)"	"unprognostic (8.48e-2)"	"unprognostic (7.45e-2)"	"prognostic unfavorable (7.31e-4)"	"unprognostic (2.68e-2)"	"unprognostic (1.50e-2)"	"unprognostic (3.60e-2)"	14.7	7.4	3.0	4.6	3.3	1.2	13.7	3.4	4.3	15.2	2.7	6.8	3.7	14.4	6.1	11.7	8.0	13.7	8.5	4.6	3.3	5.7	5.8	12.7	5.8	3.4	3.1	14.3	3.2	3.7	3.1	11.3	3.5	8.3	6.3	4.7	4.7	7.3	3.7	7.6	5.1	14.7	3.1	7.3	5.7	3.2	3.4	6.6	6.2	16.0	4.4	12.1	7.5	4.0	1.4	2.4	8.0	4.4	199.5	158.5	0.1	65.1	93.0	4.7	11.0	0.0	0.0	2.5	6.0	57.8	3.7	0.4	1.8	1.2	6.4	4.1	3.7	2.6	2.8	0.2	16.2	0.3	11.1	71.3	1.6	7.1	2.7	18.4	14.6	4.8	0.0	2.1	12.2	0.3	6.6	1.0	2.7	0.0	2.0	6.9	6.2	0.0	3.2	0.2	0.7	4.5	1.5	0.8	2.7	8.3	0.0	8.9	44.4	9.0	3.3	5.9	3.6	2.9	3.4	2.7	5.5	8.7	5.8	1.0	2.6	0.7	3.9	2.8	4.4	1.2	5.2	4.2	2.9	2.7	6.3	4.6	0.3	3.0	4.8	1.6	2.6	2.3	3.0	3.3	3.4	4.3	4.6	3.3	3.4	3.1	3.5	3.1	3.4	4.0	12.8	3.2	5.4	40.1	11.7	7.1	4.0	5.0	4.6	12.5	4.2	5.6	3.6	1.5	2.5	3.7	14.6	0.9	9.3	0.2	0.0	6.6	38.3	0.9	11.6	19.6	6.1	5.7	63.1	1.5	7.7	53.4	3.6	0.6	9.5	9.2	25.4	1.1	15.6	8.4	71.1	1.3	4.1	15.7	15.9	35.5	18.6	8.3	3.6	41.2	8.8	14.3	2.1	80.4	119.8	1.3	0.4	17.7	5.9	4.3	0.3	1.6	4.1	7.8	0.0	14.2	15.3	41.2	27.4	1.3	7.5	0.8	10.2	7.8	0.8	1.2
RECQL5	"FLJ90603, RecQ5"	ENSG00000108469	"RecQ like helicase 5"	O94762	17	75626845-75667189	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, DNA damage, DNA repair, DNA replication"	"Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Gastric mucus-secreting cells: 42.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029971			Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 71: Testis - DNA repair"	"Cluster 20: HeLa - Mitochondria"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm	Cytosol	"HPA029971: AB_10611389"	"unprognostic (2.19e-1)"	"unprognostic (6.16e-3)"	"unprognostic (2.26e-2)"	"prognostic unfavorable (1.73e-6)"	"unprognostic (8.39e-2)"	"unprognostic (2.34e-2)"	"unprognostic (3.57e-3)"	"unprognostic (5.83e-2)"	"unprognostic (3.15e-1)"	"unprognostic (5.84e-2)"	"prognostic favorable (4.34e-4)"	"unprognostic (4.07e-2)"	"unprognostic (7.01e-2)"	"unprognostic (6.37e-2)"	"unprognostic (1.42e-1)"	"unprognostic (4.78e-1)"	"unprognostic (1.81e-2)"	7.8	12.0	8.4	12.8	10.3	10.9	9.5	8.1	11.5	11.0	8.2	10.8	22.4	10.4	10.0	20.6	11.4	12.2	7.3	8.1	8.0	18.4	16.4	8.1	18.2	9.9	9.2	13.0	10.9	16.3	20.7	10.2	9.0	12.3	9.6	8.9	14.9	8.7	7.5	21.7	22.9	7.1	7.5	16.1	23.4	19.1	10.9	12.7	20.6	6.4	14.4	10.3	13.4	15.1	19.1	34.6	14.0	19.3	19.1	13.7	31.5	14.1	12.0	18.2	16.1	15.1	19.7	22.8	14.8	12.5	23.7	17.8	14.4	17.2	16.6	12.2	26.7	40.4	46.7	22.0	20.0	13.7	19.5	19.7	20.7	17.9	23.9	21.0	23.4	25.9	21.7	19.4	13.3	16.8	27.5	18.1	8.8	18.6	26.4	21.8	32.3	22.7	15.3	22.0	16.3	16.1	14.9	26.2	19.6	19.3	47.2	10.5	12.1	22.0	25.2	12.5	14.8	27.6	16.8	22.6	18.4	13.0	16.3	6.0	3.3	4.5	3.9	4.1	2.4	3.3	2.5	2.9	3.9	4.3	3.7	2.7	1.9	4.0	2.0	15.7	2.2	3.6	8.4	10.3	8.1	11.5	8.1	8.0	9.9	9.2	9.0	7.5	10.9	15.1	4.9	0.0	11.3	9.1	8.3	1.0	3.3	4.4	3.4	8.3	4.9	5.8	7.3	7.2	6.1	27.6	18.8	8.6	16.2	12.5	5.9	6.1	4.6	13.1	8.1	5.6	4.8	13.0	6.9	3.3	5.2	4.5	42.8	23.9	1.3	11.9	5.7	7.2	5.1	10.1	5.8	9.6	10.2	6.0	0.8	2.2	4.1	9.0	3.6	4.7	3.6	5.1	5.2	8.0	13.3	6.7	9.7	2.6	9.2	3.2	15.0	4.9	14.2	12.9	0.0	4.5	3.8	13.2	11.6	5.4	2.0	11.6	4.0	10.2	6.7	10.0
REEP4	"C8orf20, FLJ22246, FLJ22277, PP432, Yip2c"	ENSG00000168476	"Receptor accessory protein 4"	Q9H6H4	8	22138020-22141951	"Predicted membrane proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 89.3;skin 1: 91.0"	"Cell type enhanced"	"Detected in many"		"Syncytiotrophoblasts: 94.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042683	Approved		Supported	"Endoplasmic reticulum"		No	Yes			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 12: Non-specific - Cell cycle regulation"	"Endoplasmic reticulum"		"HPA042683: AB_2571730"	"unprognostic (2.38e-1)"	"unprognostic (9.96e-3)"	"unprognostic (3.35e-2)"	"unprognostic (2.38e-2)"	"unprognostic (3.41e-2)"	"unprognostic (7.75e-2)"	"prognostic unfavorable (4.14e-5)"	"unprognostic (1.83e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.91e-1)"	"unprognostic (7.15e-2)"	"unprognostic (1.37e-1)"	"prognostic unfavorable (2.88e-5)"	"unprognostic (5.72e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.25e-1)"	"unprognostic (6.65e-2)"	13.0	8.4	7.0	12.5	8.7	28.4	11.6	8.7	9.7	27.9	7.6	23.8	11.0	9.4	2.1	89.3	11.1	5.6	8.0	6.8	8.2	9.2	12.3	18.0	11.2	10.8	8.5	7.4	12.9	5.0	10.9	14.6	10.5	13.6	10.8	2.1	21.8	6.5	4.1	91.0	16.9	5.9	9.0	33.2	18.0	42.7	9.5	9.9	14.8	2.6	10.2	19.6	49.0	11.5	42.2	79.7	24.9	39.7	10.5	10.6	47.9	36.7	19.2	44.6	40.2	46.7	38.8	53.0	46.8	18.4	38.5	100.3	29.6	59.3	21.9	28.2	37.4	57.4	41.2	46.9	11.8	25.8	77.9	9.8	110.3	33.3	27.5	13.9	27.1	58.1	44.5	158.7	22.6	60.6	63.7	88.9	37.4	58.0	53.3	37.0	22.5	101.8	19.9	40.0	21.7	40.1	30.0	31.7	52.7	16.5	64.3	35.9	30.5	29.2	50.1	66.6	50.3	40.0	33.5	34.6	32.6	54.7	59.1	49.8	54.8	64.1	24.3	53.6	19.6	10.5	21.1	21.1	42.7	4.9	9.7	13.1	15.5	26.3	37.0	16.9	15.4	27.6	7.0	8.7	8.7	9.7	6.8	8.2	10.8	8.5	10.5	9.0	9.5	11.5	6.8	3.2	9.2	4.9	7.9	28.0	15.1	45.5	15.4	6.5	5.8	5.7	1.8	7.2	21.9	12.9	2.1	54.0	13.8	27.3	0.0	21.9	16.0	3.8	4.9	9.2	17.4	48.2	0.7	15.0	50.4	8.1	21.9	5.9	10.2	14.0	15.4	6.6	55.4	0.0	0.6	33.0	22.4	38.8	21.5	9.4	9.0	26.1	3.6	10.3	16.5	1.8	10.3	1.0	2.6	25.6	34.7	8.2	19.3	19.0	19.2	1.9	8.1	1.5	13.1	2.3	9.7	61.0	17.9	41.1	39.2	94.1	13.5	8.9	31.1	24.5
REEP5	"C5orf18, D5S346, DP1, POB16, TB2, Yip2e"	ENSG00000129625	"Receptor accessory protein 5"	Q00765	5	112876385-112922289	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003895, HPA069960"	Approved		Supported	"Endoplasmic reticulum"		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 6: T47d - Mammary gland"	"Cluster 10: Non-specific - Unknown function"	"Endoplasmic reticulum"		"HPA003895: AB_1845723, HPA069960: AB_2686221"	"unprognostic (3.26e-3)"	"unprognostic (2.60e-1)"	"unprognostic (2.71e-1)"	"prognostic favorable (5.23e-6)"	"unprognostic (8.29e-2)"	"unprognostic (1.44e-2)"	"unprognostic (1.13e-1)"	"unprognostic (8.41e-2)"	"unprognostic (2.85e-1)"	"unprognostic (3.75e-2)"	"unprognostic (7.75e-2)"	"unprognostic (5.90e-2)"	"prognostic favorable (2.05e-5)"	"unprognostic (2.88e-2)"	"unprognostic (4.14e-2)"	"unprognostic (1.83e-1)"	"unprognostic (3.24e-2)"	76.9	105.4	97.1	50.5	100.2	27.3	130.6	92.7	120.7	87.1	76.8	66.6	56.8	58.4	120.0	52.1	64.7	60.8	133.2	107.3	110.5	148.0	124.3	80.4	48.2	112.2	104.8	72.2	123.0	140.7	41.5	66.6	115.2	98.9	58.1	81.5	147.7	84.2	114.3	59.1	58.1	55.0	96.4	54.3	70.2	28.3	120.0	32.1	239.4	99.6	56.7	73.2	49.1	98.3	101.7	90.9	29.7	72.5	136.0	115.9	104.7	102.2	92.6	96.4	103.4	74.9	138.1	42.5	179.6	105.1	112.5	107.5	66.8	138.9	88.5	190.6	116.4	42.8	56.3	63.5	126.8	36.9	77.4	81.3	136.0	82.2	78.0	94.5	113.7	38.7	26.0	84.5	121.3	100.0	15.7	60.7	43.4	73.5	75.3	22.4	84.3	116.6	229.1	108.4	56.9	43.1	148.5	244.6	99.8	75.5	287.3	58.9	142.4	83.4	32.0	126.5	126.4	97.6	126.2	33.8	142.6	65.4	47.8	224.4	222.9	234.3	140.1	249.5	149.4	175.7	112.7	133.9	189.0	149.2	52.5	94.6	253.0	112.7	316.2	133.6	177.9	236.4	97.1	100.2	92.7	120.7	107.3	110.5	112.2	104.8	115.2	96.4	120.0	98.3	141.2	166.7	102.3	30.0	131.1	93.0	177.7	291.6	89.4	83.5	225.3	188.1	217.3	145.8	213.7	195.0	89.6	296.0	138.4	77.0	82.2	275.1	231.5	111.8	97.0	130.5	118.0	34.9	78.6	414.1	352.8	182.3	65.7	141.6	108.9	76.0	118.2	197.0	267.1	87.5	95.0	127.5	256.3	135.0	159.9	42.0	116.2	168.8	206.3	36.5	188.6	97.2	101.0	44.7	71.5	316.5	141.1	133.9	271.6	225.3	134.1	146.1	170.6	80.0	111.7	92.6	253.0	162.8	63.9	118.1	101.6	489.8	123.7	100.3	104.5	214.8
REEP6	"C19orf32, DP1L1, FLJ25383, Yip2f"	ENSG00000115255	"Receptor accessory protein 6"	Q96HR9	19	1491166-1497927	"Disease related genes, Human disease related genes, Predicted membrane proteins"			"Disease variant, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 217.5;liver: 398.0;testis: 283.9"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 559.1;Late spermatids: 3135.0;Proximal enterocytes: 898.7"	"Cancer enhanced"	"Detected in all"		"liver cancer: 114.0"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CACO-2: 57.9;Hep G2: 56.2;K-562: 155.7;T-47d: 121.4"									"HPA003895, HPA048015"	Enhanced		Supported	"Endoplasmic reticulum"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 45: Intestine - Brush border"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 25: Spermatids - Spermatogenesis"	"Endoplasmic reticulum"		"HPA003895: AB_1845723, HPA048015: AB_2680233"	"unprognostic (1.21e-1)"	"unprognostic (1.56e-1)"	"unprognostic (7.76e-2)"	"unprognostic (1.63e-3)"	"unprognostic (3.24e-1)"	"unprognostic (2.43e-2)"	"unprognostic (1.92e-1)"	"unprognostic (6.85e-2)"	"unprognostic (7.38e-2)"	"unprognostic (4.56e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.93e-1)"	"unprognostic (1.40e-2)"	"unprognostic (2.17e-1)"	"unprognostic (8.08e-2)"	"unprognostic (2.83e-1)"	"unprognostic (5.38e-2)"	8.4	86.5	11.1	1.3	12.4	1.2	17.5	10.1	18.0	5.6	7.7	3.0	217.5	3.5	14.6	14.3	4.6	7.0	3.9	12.7	8.8	22.1	398.0	1.6	1.3	9.7	10.1	7.7	28.5	2.0	9.8	1.6	9.9	20.1	1.7	94.0	17.9	6.8	2.0	9.3	199.6	0.9	8.4	1.7	4.2	283.9	12.1	0.7	6.0	0.7	1.0	9.2	7.0	10.9	7.3	9.2	2.6	34.3	5.6	2.0	39.5	1.8	0.7	1.9	1.9	57.9	22.5	3.9	12.2	1.1	2.3	7.3	9.8	0.6	1.0	1.9	4.1	21.3	1.3	56.2	4.2	1.6	6.6	4.7	4.1	0.4	1.4	3.2	1.1	4.9	155.7	5.0	0.3	29.6	1.8	4.7	12.8	21.1	19.5	4.9	1.1	10.0	10.9	2.7	0.7	17.2	9.8	14.2	6.3	1.9	121.4	5.7	3.4	2.8	5.4	8.7	1.2	16.4	5.3	0.8	11.2	9.4	8.2	0.0	1.1	0.0	5.5	1.2	2.8	0.1	1.4	1.2	1.9	0.6	2.0	2.2	0.0	4.9	4.3	3.3	1.6	1.6	11.1	12.4	10.1	18.0	12.7	8.8	9.7	10.1	9.9	8.4	12.1	10.9	1.5	3.2	3.2	2.6	2.7	6.8	7.9	6.8	10.8	30.4	47.4	20.3	1.8	91.5	10.5	5.5	33.3	69.4	2.5	7.8	7.9	34.5	559.1	4.5	7.1	4.2	6.0	10.1	1.5	69.2	12.8	4.7	2.6	3.0	10.2	132.9	5.0	267.4	9.6	23.5	1.2	51.9	4.1	6.3	4.3	3135.0	34.2	4.1	30.2	0.0	1.7	44.2	2.1	0.0	1.5	25.0	53.6	16.6	1.9	13.1	898.7	52.0	8.3	292.8	19.7	0.8	3.3	29.9	36.5	17.5	6.7	36.0	4.3	50.1	70.7	14.7
RELB	REL-B	ENSG00000104856	"RELB proto-oncogene, NF-kB subunit"	Q01201	19	45001449-45038198	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 108.5;monocytes: 112.5;Plasma cells: 108.8;Prostatic glandular cells: 145.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 15.2"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 61.9;HDLM-2: 79.5;U-698: 67.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB007753, HPA040506"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 2: Immune cells - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 22: Epithelial cell types - Mixed function"	Nucleoplasm	Cytosol	"CAB007753: AB_562340, HPA040506: AB_2677011"	"prognostic favorable (1.55e-4)"	"unprognostic (1.20e-1)"	"unprognostic (7.13e-2)"	"unprognostic (5.52e-2)"	"unprognostic (1.12e-2)"	"unprognostic (3.41e-2)"	"unprognostic (1.71e-2)"	"unprognostic (4.30e-2)"	"unprognostic (5.81e-3)"	"unprognostic (1.02e-3)"	"unprognostic (6.01e-2)"	"unprognostic (6.48e-2)"	"prognostic unfavorable (2.99e-6)"	"unprognostic (2.68e-2)"	"unprognostic (4.69e-2)"	"unprognostic (2.09e-1)"	"unprognostic (2.20e-2)"	17.2	13.1	3.5	18.7	2.9	40.1	12.6	2.9	4.4	9.1	3.1	13.3	10.8	14.1	0.8	8.7	9.2	7.4	12.7	3.1	3.4	21.3	13.0	23.0	19.2	4.9	3.5	6.4	16.5	2.1	4.0	4.8	4.1	15.3	3.9	0.2	12.1	5.2	14.0	16.5	17.7	4.9	3.6	29.1	12.0	4.3	4.6	9.2	10.0	1.4	15.6	13.8	8.1	4.1	22.2	13.0	1.3	5.7	2.8	9.1	4.5	3.9	27.5	5.9	9.6	4.5	23.6	61.9	11.0	6.4	20.8	9.8	0.5	9.0	5.1	79.5	2.0	2.2	0.8	2.5	23.8	4.9	35.3	15.0	3.7	12.3	14.4	5.4	3.9	1.7	0.5	39.2	2.1	5.3	1.1	14.9	2.0	6.3	2.4	4.8	3.2	7.7	10.0	33.7	0.1	2.0	4.1	11.4	11.6	1.4	4.0	11.8	12.6	14.4	7.1	5.3	14.4	49.0	31.2	67.0	15.6	1.7	8.1	0.0	5.1	2.5	1.4	3.4	2.0	9.2	2.2	1.9	3.8	8.0	1.7	0.8	15.2	2.1	2.8	4.1	1.1	2.0	3.5	2.9	2.9	4.4	3.1	3.4	4.9	3.5	4.1	3.6	4.6	4.1	16.4	6.4	12.4	2.3	64.4	37.9	108.5	20.3	40.9	0.0	17.6	11.3	1.8	24.3	15.7	3.7	0.0	4.2	35.0	53.0	9.8	33.1	5.2	15.1	15.2	30.8	22.8	22.5	3.0	31.5	7.3	35.4	65.2	29.1	50.9	3.8	5.0	3.5	18.4	3.3	1.7	33.3	8.2	15.1	74.9	3.4	4.7	44.7	24.9	3.7	112.5	0.8	7.2	1.5	2.5	37.4	90.3	2.6	108.8	145.3	48.0	19.4	7.4	0.3	6.6	28.9	27.3	1.1	1.7	27.7	31.8	9.9	53.8	4.1	16.8	89.7
RELL1		ENSG00000181826	"RELT like 1"	Q8IUW5	4	37590800-37686376	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 39.7"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 30.5;Microglial cells: 36.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 59.3"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"RH-30: 45.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA013377	Approved		Supported	"Plasma membrane,Microtubules"		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 65: Plasmacytoid DCs - Unknown function"	"Plasma membrane, Microtubules"		"HPA013377: AB_1844403"	"unprognostic (1.70e-1)"	"unprognostic (1.70e-1)"	"unprognostic (4.78e-2)"	"unprognostic (5.30e-2)"	"unprognostic (6.80e-2)"	"unprognostic (7.28e-2)"	"unprognostic (7.35e-2)"	"unprognostic (2.67e-2)"	"unprognostic (2.19e-1)"	"unprognostic (2.86e-2)"	"unprognostic (1.46e-1)"	"unprognostic (3.41e-1)"	"unprognostic (7.88e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.08e-1)"	"unprognostic (6.15e-2)"	"unprognostic (1.71e-2)"	13.5	2.4	10.6	4.9	15.5	25.6	7.8	20.1	14.9	5.1	9.3	8.3	6.2	5.5	2.7	6.4	5.1	6.1	6.0	8.0	13.3	3.9	4.8	6.6	4.7	29.7	19.3	3.5	2.3	1.5	1.4	6.1	27.7	3.0	6.6	3.1	3.5	3.8	15.8	12.4	5.5	6.0	24.4	7.3	12.3	1.6	20.1	3.7	12.5	4.3	4.8	7.8	4.1	39.7	4.8	5.1	12.9	11.1	10.8	6.2	10.8	8.0	6.9	5.5	7.2	16.8	5.7	1.3	5.7	6.9	9.8	4.3	4.1	7.2	9.6	0.2	2.1	1.8	4.7	18.2	8.1	6.0	4.5	10.6	10.2	7.5	8.2	3.4	24.9	3.3	3.1	5.0	6.4	4.4	7.5	8.3	3.2	6.9	1.5	2.5	45.0	2.2	13.2	5.9	2.9	8.5	6.1	6.6	10.6	3.2	18.0	3.2	29.6	13.8	8.7	10.1	9.5	2.5	2.6	7.3	11.7	12.8	11.4	0.8	15.2	27.4	5.1	5.7	6.3	0.7	6.2	4.9	8.5	0.2	5.3	7.0	59.3	7.7	5.5	9.8	5.5	5.1	10.6	15.5	20.1	14.9	8.0	13.3	29.7	19.3	27.7	24.4	20.1	39.7	30.5	9.6	3.1	16.3	2.9	3.3	2.5	1.7	10.8	0.4	8.1	9.5	2.1	5.7	3.9	0.0	0.0	1.4	9.8	8.4	0.0	3.1	6.5	5.5	9.9	14.4	1.2	3.4	3.3	8.6	3.6	10.7	22.4	2.4	2.5	0.5	6.4	0.9	2.6	3.3	2.4	1.6	0.0	3.2	2.7	8.1	3.7	9.2	1.8	36.5	4.1	4.0	0.0	22.6	12.5	10.3	2.9	6.0	15.5	2.7	6.7	0.2	3.3	1.4	13.1	18.8	16.4	0.8	0.3	5.5	4.7	5.2	10.6	5.1	1.1	3.8
RELT	"FLJ14993, TNFRSF19L"	ENSG00000054967	"RELT TNF receptor"	Q969Z4	11	73376399-73397474	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	Apoptosis	Receptor	"Amelogenesis imperfecta, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"bone marrow: 154.7"	"Cell type enhanced"	"Detected in many"		"Langerhans cells: 43.9;Macrophages: 43.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA062824, HPA071518"			Supported	Nucleoplasm		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 41: Macrophages - Immune response"	Nucleoplasm		"HPA062824: AB_2684875, HPA071518: AB_2686408"	"unprognostic (3.49e-1)"	"unprognostic (2.43e-1)"	"unprognostic (2.25e-1)"	"unprognostic (1.67e-2)"	"unprognostic (1.80e-3)"	"unprognostic (9.92e-3)"	"unprognostic (1.67e-3)"	"unprognostic (1.17e-1)"	"unprognostic (1.21e-1)"	"unprognostic (2.87e-1)"	"unprognostic (8.42e-2)"	"unprognostic (4.13e-2)"	"prognostic unfavorable (4.07e-11)"	"unprognostic (1.64e-1)"	"unprognostic (3.07e-3)"	"unprognostic (2.01e-2)"	"unprognostic (1.69e-1)"	4.9	2.2	3.4	12.9	6.5	154.7	2.5	6.7	7.7	1.4	0.4	2.3	2.3	1.4	0.5	3.9	1.9	4.5	6.2	3.6	7.0	3.7	2.1	10.9	11.9	8.9	6.8	1.8	0.8	1.1	3.5	4.6	8.1	2.1	1.4	2.2	1.9	0.4	24.3	3.2	7.1	2.6	7.0	20.8	2.2	3.2	6.9	4.6	2.2	6.4	6.9	4.8	2.3	12.6	9.1	8.9	7.0	6.8	0.8	1.0	7.5	9.6	6.2	11.1	6.7	8.5	3.9	16.4	30.9	6.4	8.8	13.1	4.4	4.7	4.3	9.9	8.3	15.4	12.4	3.1	1.8	15.6	26.3	1.1	2.0	11.9	3.5	2.6	4.1	8.4	11.8	21.0	3.1	8.5	11.5	16.5	6.1	6.9	11.0	21.9	11.7	14.2	2.3	3.9	8.9	8.5	8.3	7.5	10.0	1.7	4.1	13.9	5.4	13.8	9.7	23.1	17.6	7.5	6.1	18.2	8.5	15.5	14.8	0.7	12.5	22.2	0.9	25.4	2.0	7.6	1.0	1.7	11.8	5.8	1.3	0.6	19.9	0.4	35.3	11.7	0.5	6.3	3.4	6.5	6.7	7.7	3.6	7.0	8.9	6.8	8.1	7.0	6.9	12.6	5.7	6.4	2.2	3.6	24.2	26.5	15.4	2.8	2.8	3.5	6.1	5.5	2.7	1.5	3.4	0.0	12.5	1.6	33.0	4.7	0.0	3.6	0.9	5.4	5.2	7.2	3.5	5.7	3.1	0.9	10.7	10.1	11.2	10.8	24.8	6.8	1.8	0.2	23.0	30.3	4.5	2.8	6.1	24.2	43.9	1.2	0.0	43.9	5.4	2.8	32.8	8.9	3.1	1.5	4.8	6.7	2.4	0.0	19.2	9.9	1.0	0.5	1.4	2.8	6.6	7.2	14.5	11.7	10.5	4.6	18.3	21.1	16.1	0.6	3.1	17.8
REPIN1	"AP4, H_DJ0584D14.12, RIP60, Zfp464, ZNF464"	ENSG00000214022	"Replication initiator 1"	Q9BWE0	7	150368189-150374044	"Predicted intracellular proteins"	"DNA replication"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"plasmacytoid DC: 7.8"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RPMI-8226: 246.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036022	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm		"HPA036022: AB_10610417"	"unprognostic (2.73e-1)"	"unprognostic (2.21e-2)"	"unprognostic (1.54e-1)"	"unprognostic (7.50e-3)"	"unprognostic (5.42e-2)"	"unprognostic (7.00e-3)"	"unprognostic (1.52e-2)"	"unprognostic (6.88e-3)"	"unprognostic (6.68e-2)"	"unprognostic (6.59e-2)"	"prognostic favorable (1.12e-4)"	"unprognostic (3.40e-2)"	"prognostic favorable (5.56e-4)"	"prognostic favorable (1.61e-4)"	"unprognostic (1.79e-1)"	"unprognostic (2.02e-3)"	"prognostic favorable (6.41e-4)"	28.7	77.2	45.1	25.2	43.6	44.1	35.1	43.1	46.4	31.7	54.6	68.4	42.2	37.5	31.8	37.4	40.9	14.6	65.3	37.9	40.0	51.5	86.6	31.7	35.7	52.3	46.7	37.3	67.7	35.5	69.7	12.1	45.5	49.2	28.3	23.7	41.7	23.9	134.5	31.8	56.5	15.4	41.1	56.2	53.1	18.2	49.5	41.0	45.0	66.2	24.8	42.5	25.0	42.1	59.4	71.3	66.1	81.5	15.8	11.3	40.2	28.7	35.2	27.6	23.8	55.5	37.6	65.5	70.9	20.6	48.0	43.4	36.4	11.4	13.9	72.0	54.8	38.4	40.3	70.4	52.3	68.4	60.1	14.7	34.1	15.2	3.5	26.1	39.4	39.1	93.5	39.9	23.1	76.7	95.1	77.4	69.5	39.7	69.9	51.8	76.4	246.3	29.4	103.7	96.9	123.7	43.3	107.5	75.8	27.2	52.8	54.2	42.1	21.2	17.4	23.6	58.7	115.4	46.1	59.8	37.1	59.9	53.3	0.0	1.4	2.7	0.8	0.7	1.3	2.5	1.8	1.5	2.2	2.4	2.3	1.1	1.4	1.8	0.3	7.8	0.8	0.9	45.1	43.6	43.1	46.4	37.9	40.0	52.3	46.7	45.5	41.1	49.5	42.1	21.1	35.3	18.6	17.9	26.9	9.4	18.3	11.5	14.8	57.9	39.3	33.1	46.5	45.8	15.0	14.7	41.7	28.0	49.5	53.7	62.6	37.3	7.8	53.4	14.3	24.3	68.1	14.5	13.0	50.3	12.9	16.1	23.4	35.8	24.7	56.3	26.0	69.7	32.0	80.8	15.8	68.6	32.6	14.8	23.9	9.8	22.1	21.8	16.0	9.4	88.4	101.3	40.2	17.6	16.6	34.3	37.1	19.9	26.4	31.6	47.0	32.8	36.2	55.8	6.6	28.0	20.1	10.2	3.1	17.6	17.8	25.6	16.0	33.5	109.7	19.9
RER1		ENSG00000157916	"Retention in endoplasmic reticulum sorting receptor 1"	O15258	1	2391775-2405442	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB037240, HPA051400"	Supported		Supported	"Golgi apparatus"		No	No			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 37: Intestine - Unknown function"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 10: Non-specific - Unknown function"	"Golgi apparatus"		"CAB037240: AB_2179604, HPA051400: AB_2681469"	"unprognostic (2.90e-2)"	"unprognostic (3.35e-2)"	"unprognostic (3.17e-2)"	"unprognostic (2.59e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.53e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.28e-1)"	"unprognostic (2.72e-1)"	"unprognostic (1.14e-2)"	"unprognostic (1.50e-1)"	"prognostic unfavorable (8.23e-8)"	"unprognostic (1.01e-1)"	"unprognostic (5.41e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.27e-2)"	100.4	154.2	60.0	89.3	67.6	81.6	97.1	67.0	62.8	93.6	78.3	137.4	114.8	74.4	122.7	176.4	86.1	86.9	75.7	61.1	64.1	106.3	224.8	79.6	94.6	67.0	65.1	92.9	122.3	100.9	82.9	99.0	66.9	94.3	151.4	73.8	101.1	104.2	105.2	101.7	120.0	104.6	65.6	102.2	118.6	107.1	68.5	94.5	85.9	85.1	143.5	101.0	106.5	76.1	203.1	111.0	131.1	146.8	233.7	275.7	100.9	297.1	261.1	254.3	253.2	157.6	299.3	143.9	242.7	297.7	205.1	213.3	152.2	176.7	322.2	180.8	156.1	163.9	247.2	153.0	252.5	181.3	188.6	225.0	176.1	264.3	233.1	175.4	235.8	160.3	197.8	232.6	299.8	141.5	127.2	127.3	87.5	314.1	279.0	146.0	131.9	183.7	227.5	94.3	109.9	126.2	167.9	376.9	242.9	143.7	149.6	127.4	171.8	197.3	114.1	355.9	219.5	223.0	270.2	255.3	209.6	254.8	102.8	239.1	235.5	284.5	195.9	268.2	180.0	169.0	169.8	210.0	221.2	151.7	127.0	155.9	351.3	164.8	275.9	256.1	244.5	309.0	60.0	67.6	67.0	62.8	61.1	64.1	67.0	65.1	66.9	65.6	68.5	76.1	88.7	64.1	50.0	23.5	73.1	53.2	84.4	214.2	50.1	33.6	111.9	123.6	41.6	118.7	131.4	104.8	33.3	233.8	97.5	218.9	66.5	213.4	475.6	89.5	93.5	68.2	36.5	57.2	16.7	258.4	321.8	94.3	71.9	118.8	44.3	76.5	82.1	233.5	217.9	37.0	16.8	158.6	122.1	104.3	73.2	464.0	82.6	99.9	62.2	15.9	126.1	97.0	114.4	19.1	25.8	256.4	195.4	76.0	145.1	142.5	238.7	119.6	136.3	62.6	111.7	60.9	141.6	291.4	145.2	103.4	67.1	467.9	74.3	159.0	162.0	141.0
RERG	MGC15754	ENSG00000134533	"RAS like estrogen regulated growth inhibitor"	Q96A58	12	15107783-15348675	"Enzymes, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"endometrium 1: 104.7"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 202.7;Breast glandular cells: 80.1;Inhibitory neurons: 94.3;Sertoli cells: 92.1;Smooth muscle cells: 80.2"	"Cancer enhanced"	"Detected in all"		"breast cancer: 19.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 15.2;BEWO: 34.1;T-47d: 66.0;U-2 OS: 21.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041387	Approved		Approved	"Nucleoplasm,Nucleoli fibrillar center,Cytosol"		NA	NA				"Cluster 89: Fibroblasts - ECM organization"	"Cluster 6: T47d - Mammary gland"	"Cluster 48: Smooth muscle cells - ECM organization"	"Nucleoplasm, Cytosol"	"Nucleoli fibrillar center"	"HPA041387: AB_10796669"	"unprognostic (5.33e-2)"	"unprognostic (1.05e-1)"	"unprognostic (7.72e-2)"	"prognostic unfavorable (7.56e-4)"	"unprognostic (8.72e-2)"	"unprognostic (9.42e-3)"	"unprognostic (2.47e-1)"	"unprognostic (2.38e-2)"	"unprognostic (1.85e-3)"	"unprognostic (2.76e-2)"	"unprognostic (5.07e-2)"	"unprognostic (2.69e-1)"	"unprognostic (7.16e-3)"	"unprognostic (2.61e-3)"	"unprognostic (3.30e-2)"	"unprognostic (3.50e-1)"	"unprognostic (2.58e-2)"	30.7	45.4	8.9	6.8	21.0	0.0	42.5	5.9	16.3	32.0	3.5	37.0	4.1	104.7	50.3	15.1	72.7	11.2	14.0	10.2	12.3	37.0	2.5	16.5	4.3	20.7	12.8	29.0	9.8	4.8	1.4	33.3	21.2	17.0	9.3	0.8	10.2	77.5	5.4	10.2	18.0	83.9	7.7	31.4	20.1	9.0	12.8	2.6	5.8	5.8	2.7	17.4	20.0	9.0	0.0	1.6	0.3	15.2	6.0	0.3	34.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	6.9	0.0	0.1	0.0	0.2	0.2	0.0	0.0	4.3	0.1	5.9	0.0	4.7	0.0	1.9	0.8	1.0	0.0	2.3	0.0	0.0	0.0	0.6	0.0	1.4	0.7	0.2	0.3	1.7	0.0	0.9	0.1	0.0	0.2	5.8	0.3	0.1	2.2	2.5	2.6	0.0	1.0	66.0	0.0	0.0	0.9	21.5	0.4	0.0	0.1	5.7	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.9	21.0	5.9	16.3	10.2	12.3	20.7	12.8	21.2	7.7	12.8	9.0	10.7	0.0	2.2	202.7	0.4	3.8	8.6	0.9	6.2	1.3	80.1	36.2	1.0	5.7	4.0	7.3	0.0	12.0	0.7	0.0	15.6	9.8	20.9	6.5	9.8	6.0	1.8	0.0	20.2	9.8	14.6	28.7	2.6	1.0	0.0	0.1	2.2	0.0	2.1	3.3	94.3	0.0	18.3	0.0	2.3	16.1	22.1	1.1	7.2	41.2	0.0	5.0	0.0	3.0	1.1	2.2	0.0	32.0	0.0	3.5	0.0	33.7	0.1	0.5	92.1	8.2	80.2	8.3	15.0	12.6	5.5	14.0	1.2	16.1	0.0	5.8
RESF1	"C12orf35, FLJ10652, FLJ20696, GET, KIAA1551, UTA2-1"	ENSG00000174718	"Retroelement silencing factor 1"	Q9HCM1	12	31959370-31993107	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"ovary: 73.9"	"Cell type enhanced"	"Detected in some"		"Adipocytes: 35.8;B-cells: 43.7;dendritic cells: 88.1;Hofbauer cells: 34.1;Plasma cells: 66.6;T-cells: 21.5"	"Cancer enhanced"	"Detected in all"		"testis cancer: 65.6"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 212.8"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 212.8"	"Cell line enhanced"	"Detected in all"		"SuSa: 112.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA013816, HPA015622"	Approved		Supported	"Nucleoli,Nucleoli rim,Intermediate filaments,Cytosol"		NA	NA			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 34: Non-specific - Transcription"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 24: Non-specific - Transcription regulation"	"Nucleoli, Nucleoli rim"	"Intermediate filaments, Cytosol"	"HPA013816: AB_1848661, HPA015622: AB_1848663"	"unprognostic (7.97e-3)"	"unprognostic (1.69e-1)"	"unprognostic (1.76e-1)"	"unprognostic (8.49e-2)"	"unprognostic (3.21e-1)"	"unprognostic (3.09e-3)"	"unprognostic (2.24e-1)"	"unprognostic (2.19e-1)"	"unprognostic (8.87e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.90e-2)"	"prognostic unfavorable (5.04e-9)"	"unprognostic (3.83e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.61e-1)"	"unprognostic (7.26e-3)"	14.3	7.1	2.5	50.7	3.1	21.8	13.9	7.5	10.9	28.9	2.2	14.0	23.8	23.2	9.1	10.6	38.1	19.3	8.1	1.8	3.3	9.1	24.9	17.1	70.2	4.1	2.8	73.9	6.7	9.8	4.0	37.9	5.0	9.2	13.8	7.0	8.2	11.2	4.1	9.1	27.3	16.0	2.0	45.3	20.5	13.2	3.6	60.7	12.6	11.9	62.5	17.7	8.6	5.1	7.6	13.3	22.5	8.6	10.1	12.0	33.6	9.1	9.0	6.0	6.9	50.6	48.9	36.4	21.9	7.6	21.5	9.6	31.3	6.0	8.4	27.1	4.4	51.1	6.7	6.7	19.7	37.0	79.2	6.5	9.0	7.1	11.6	25.4	50.3	24.0	29.5	56.1	6.8	3.7	52.6	15.6	48.3	28.4	5.5	24.1	21.4	16.0	6.3	14.0	9.0	8.1	11.7	6.0	6.0	112.9	20.8	40.5	32.0	6.7	10.4	11.5	9.6	33.9	38.1	44.8	3.6	20.6	7.4	55.5	14.7	15.4	42.2	16.1	40.3	33.6	38.0	40.7	12.3	26.8	44.1	43.8	212.8	30.6	18.1	7.7	38.9	20.4	2.5	3.1	7.5	10.9	1.8	3.3	4.1	2.8	5.0	2.0	3.6	5.1	35.8	0.0	0.0	0.0	43.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.3	0.0	0.0	0.0	0.0	15.0	88.1	0.0	0.0	0.0	0.0	0.0	0.0	12.8	0.0	0.0	0.0	0.0	2.2	7.4	0.0	0.0	0.0	0.0	0.0	0.0	34.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	66.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.0	0.0	0.0	0.0	0.0	5.1	21.5	0.0	0.0	0.0
REST	"DFNA27, NRSF, XBR"	ENSG00000084093	"RE1 silencing transcription factor"	Q13127	4	56907876-56966808	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	Repressor	"Deafness, Disease variant, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006079, CAB068222"	Supported		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 34: Non-specific - Transcription"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 44: Endometrium - Transcription"	"Nucleoplasm, Cytosol"		"CAB068222: AB_2665651, HPA006079: AB_1079801"	"unprognostic (7.49e-3)"	"unprognostic (3.36e-2)"	"unprognostic (2.50e-2)"	"unprognostic (2.03e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.39e-1)"	"unprognostic (7.47e-3)"	"unprognostic (2.30e-1)"	"unprognostic (4.65e-2)"	"unprognostic (1.70e-2)"	"unprognostic (4.32e-3)"	"unprognostic (1.73e-1)"	"prognostic favorable (9.50e-5)"	"unprognostic (1.49e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.24e-1)"	"unprognostic (4.79e-2)"	6.9	5.5	5.7	9.4	6.5	24.8	9.8	6.3	7.5	8.8	9.4	6.9	6.4	9.3	8.9	8.2	7.8	7.9	7.6	5.0	5.2	10.9	11.5	8.0	13.4	8.0	6.6	11.2	7.7	13.8	0.5	9.9	7.8	10.0	7.0	7.5	7.8	8.1	5.2	8.9	6.3	8.0	6.6	10.7	8.2	12.3	6.8	18.1	10.9	6.5	13.6	8.7	2.1	7.4	10.8	13.0	17.4	18.2	13.2	16.0	22.7	15.6	13.8	16.0	14.7	11.5	16.5	24.5	23.5	16.8	10.7	9.8	13.2	16.3	24.4	12.6	8.1	22.0	9.4	12.5	16.2	29.0	13.5	16.5	14.6	15.1	16.0	20.5	20.1	19.0	14.3	26.3	19.0	17.3	31.5	21.3	15.2	12.3	8.9	30.0	14.5	8.1	19.0	18.3	0.3	8.1	17.8	18.8	14.6	24.8	19.3	20.3	28.7	20.4	18.1	12.4	14.2	10.8	7.8	15.1	13.2	16.7	10.8	7.4	2.5	7.2	6.2	3.9	6.2	11.6	6.9	5.9	5.2	21.1	10.8	4.4	2.8	6.1	7.9	6.0	9.4	2.5	5.7	6.5	6.3	7.5	5.0	5.2	8.0	6.6	7.8	6.6	6.8	7.4	38.1	70.5	60.2	18.6	51.1	57.1	51.9	33.3	99.6	1.6	42.6	35.2	50.2	42.9	43.3	29.5	81.3	58.0	65.2	21.4	23.5	58.4	9.7	67.3	64.3	50.5	3.6	54.7	0.1	38.2	57.1	40.8	23.9	63.4	51.4	56.3	47.2	31.0	32.2	0.0	0.2	23.5	44.7	36.2	37.9	11.9	39.4	44.0	21.4	12.2	78.0	45.1	71.1	11.1	21.1	45.8	29.0	36.9	44.3	44.3	22.1	24.4	43.3	36.1	32.9	56.5	56.0	58.3	53.8	55.0	45.7	66.4	66.6	62.3	26.1	48.7
RET	"CDHF12, CDHR16, HSCR1, MEN2A, MEN2B, MTC1, PTC, RET51"	ENSG00000165731	"Ret proto-oncogene"	P07949	10	43077064-43130351	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"	"Kinase, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease variant, FDA approved drug targets, Hirschsprung disease, Proto-oncogene"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"adrenal gland: 20.8;brain: 27.3;parathyroid gland: 31.8"	"Group enriched"	"Detected in some"	4	"Horizontal cells: 79.1;Ionocytes: 26.4;Skeletal myocytes: 23.1"	"Cancer enhanced"	"Detected in many"		"breast cancer: 11.0"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"MCF7: 74.6;NB-4: 42.2;SH-SY5Y: 329.3;THP-1: 95.9"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"midbrain: 53.3;spinal cord: 19.4"	"CAB002581, HPA008356, HPA008495"	Approved	Supported	Approved	"Golgi apparatus,Plasma membrane,Cytosol"		No	NA		2100000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 50: Fibroblasts - ECM organization"	"Golgi apparatus, Cytosol"	"Plasma membrane"	"CAB002581: AB_563673, HPA008356: AB_1847232, HPA008495: "	"unprognostic (7.94e-2)"	"unprognostic (3.68e-2)"	"unprognostic (4.49e-1)"	"prognostic unfavorable (5.02e-4)"	"unprognostic (1.15e-1)"	"unprognostic (9.13e-4)"	"unprognostic (1.27e-2)"	"unprognostic (3.62e-2)"	"unprognostic (2.86e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.54e-3)"	"unprognostic (4.43e-1)"	"unprognostic (9.35e-5)"	"unprognostic (1.64e-3)"	"unprognostic (8.28e-2)"	"unprognostic (3.67e-3)"	"unprognostic (2.02e-2)"	1.8	20.8	1.0	1.3	0.9	0.4	1.1	5.1	5.6	1.0	0.2	3.4	1.4	0.6	0.3	0.4	0.5	0.6	2.2	0.3	5.5	0.9	3.0	0.4	0.6	14.4	27.3	0.4	1.3	31.8	5.3	0.5	12.0	1.8	1.4	4.7	5.1	2.0	5.9	0.9	1.4	1.0	4.8	0.2	2.2	2.7	7.6	1.6	0.8	3.1	0.2	0.6	1.4	5.8	0.1	0.4	0.1	1.7	0.0	0.0	0.1	0.7	0.2	0.4	0.1	0.0	0.0	0.0	0.1	0.0	0.6	0.0	5.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	7.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	74.6	0.0	42.2	7.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	4.7	329.3	0.1	0.0	0.1	0.5	4.1	95.9	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.9	0.7	0.1	0.0	1.0	0.9	5.1	5.6	0.3	5.5	14.4	27.3	12.0	4.8	7.6	5.8	0.4	0.0	0.5	1.6	0.0	0.3	0.8	0.0	0.0	1.7	6.0	0.5	2.1	0.0	0.0	0.0	0.0	0.0	2.1	0.2	0.0	0.0	1.5	0.0	0.3	1.1	0.0	0.0	4.2	0.2	2.3	6.8	0.0	0.0	1.3	0.5	0.0	1.2	0.1	79.1	8.6	1.9	26.4	0.0	0.6	1.5	0.3	0.5	0.0	1.0	0.0	0.8	0.0	1.0	0.6	0.0	0.0	0.0	0.0	0.9	0.0	0.1	0.8	1.7	0.0	23.1	1.2	1.1	4.7	0.0	0.6	0.0	0.2	0.3	0.2	0.1
RETREG1	"FAM134B, FLJ20152, JK1"	ENSG00000154153	"Reticulophagy regulator 1"	Q9H6L5	5	16473038-16617038	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	Autophagy		"Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 91.4;skeletal muscle: 141.8"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 73.7;Cytotrophoblasts: 53.7;Exocrine glandular cells: 59.3;Glandular and luminal cells: 197.7;Pancreatic endocrine cells: 51.5;Proximal tubular cells: 152.8"	"Cancer enhanced"	"Detected in all"		"renal cancer: 28.3"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"basophil: 2.3"	"Group enriched"	"Detected in many"	6	"granulocytes: 2.3;T-cells: 1.7"	"Cell line enhanced"	"Detected in many"		"ASC diff: 26.0;GAMG: 20.3;HSkMC: 28.8;MOLT-4: 20.4;RPTEC TERT1: 26.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA012077			Supported	"Endoplasmic reticulum"		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 44: Endometrium - Transcription"	"Endoplasmic reticulum"		"HPA012077: AB_2668621"	"unprognostic (1.63e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.80e-2)"	"unprognostic (1.84e-2)"	"unprognostic (4.96e-2)"	"unprognostic (9.17e-3)"	"unprognostic (2.66e-2)"	"unprognostic (1.90e-1)"	"unprognostic (4.35e-2)"	"unprognostic (4.41e-2)"	"unprognostic (1.37e-2)"	"unprognostic (1.48e-1)"	"prognostic favorable (5.25e-10)"	"unprognostic (3.75e-1)"	"unprognostic (9.96e-2)"	"unprognostic (5.62e-2)"	"unprognostic (2.58e-1)"	15.6	3.5	20.6	6.6	26.4	2.0	13.6	23.9	33.2	13.2	21.6	24.6	12.6	4.0	5.2	3.6	7.5	13.4	91.4	19.4	22.1	61.0	44.2	9.3	6.4	27.2	25.2	2.1	37.7	30.1	9.9	13.2	27.8	11.1	32.4	7.5	5.2	5.0	141.8	10.0	25.6	2.6	23.6	2.3	10.9	12.3	25.0	20.6	6.7	81.9	4.3	2.3	5.2	37.6	1.3	0.5	0.1	3.5	26.0	3.2	15.1	0.1	3.5	3.1	4.1	2.3	0.1	0.3	2.4	0.0	20.3	3.9	7.8	0.8	1.0	4.1	3.4	0.0	10.6	0.0	0.1	5.3	0.0	28.8	11.7	0.6	3.1	7.5	0.0	15.4	0.0	0.1	1.2	1.0	20.4	0.1	0.8	3.4	0.6	3.2	0.0	1.2	26.2	0.9	17.4	2.0	1.0	1.1	13.1	1.9	5.9	2.4	0.0	2.4	0.2	6.4	3.1	0.7	0.0	0.0	14.9	18.0	6.5	2.3	0.1	0.0	0.2	0.0	0.6	0.0	0.6	0.3	0.0	0.3	1.7	1.0	0.9	0.0	0.0	0.0	0.8	0.2	20.6	26.4	23.9	33.2	19.4	22.1	27.2	25.2	27.8	23.6	25.0	37.6	4.2	73.7	8.6	0.0	3.4	0.0	0.0	0.0	0.0	0.0	33.3	19.0	0.0	0.0	9.9	44.1	0.0	53.7	2.2	0.0	17.6	31.1	0.0	33.5	45.2	1.2	0.0	0.0	0.0	59.3	2.0	7.8	0.0	197.7	1.3	3.3	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.7	0.0	0.0	1.0	0.0	0.0	0.0	0.0	51.5	0.0	0.0	0.8	0.0	0.0	152.8	19.0	0.0	0.0	0.0	5.1	0.0	0.0	0.0	0.0	10.9	8.1	0.3	0.0	0.0
REXO1	"EloA-BP1, KIAA1138, TCEB3BP1"	ENSG00000079313	"RNA exonuclease 1 homolog"	Q8N1G1	19	1815248-1848483	"Predicted intracellular proteins"		"Exonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 161.2;Late spermatids: 214.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042155, HPA042552"	Approved		Supported	"Nucleoplasm,Nuclear bodies"		NA	NA				"Cluster 71: Testis - DNA repair"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 34: Spermatids - Unknown function"	Nucleoplasm	"Nuclear bodies"	"HPA042155: AB_10806233, HPA042552: AB_10794280"	"unprognostic (1.36e-1)"	"unprognostic (3.86e-3)"	"unprognostic (7.52e-2)"	"unprognostic (3.70e-3)"	"unprognostic (4.21e-2)"	"unprognostic (2.38e-3)"	"unprognostic (7.15e-2)"	"unprognostic (5.10e-2)"	"unprognostic (1.88e-1)"	"unprognostic (2.39e-2)"	"unprognostic (6.12e-3)"	"unprognostic (3.75e-2)"	"unprognostic (2.87e-2)"	"unprognostic (1.10e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.96e-1)"	"unprognostic (2.42e-2)"	13.3	27.8	15.0	10.4	21.3	18.9	12.7	2.2	18.5	10.5	0.0	14.5	9.9	14.0	2.5	12.8	11.7	6.2	12.7	16.8	1.6	12.2	16.4	12.5	13.1	3.7	2.3	13.5	13.3	5.6	9.5	10.0	2.0	11.7	4.2	4.8	10.5	5.2	16.2	18.6	14.0	4.5	0.3	23.6	12.2	30.1	7.2	9.2	11.4	6.2	5.6	12.3	10.9	8.4	20.8	13.1	11.8	18.4	4.6	6.0	23.7	14.7	7.8	10.5	9.4	17.1	11.2	17.6	9.7	10.3	6.8	17.9	9.0	16.5	4.6	28.2	13.8	18.6	15.3	10.1	10.4	16.5	29.3	10.6	9.3	13.9	9.2	6.0	9.7	24.8	28.4	29.8	5.5	13.0	27.5	18.6	26.6	8.3	12.8	24.3	9.8	16.7	7.0	11.6	17.3	19.0	9.2	15.3	19.3	7.8	13.4	24.1	16.9	16.6	14.3	27.9	24.8	47.9	24.8	15.1	13.3	19.7	21.7	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.2	0.0	0.0	0.1	0.0	0.1	15.0	21.3	2.2	18.5	16.8	1.6	3.7	2.3	2.0	0.3	7.2	8.4	17.1	0.0	5.9	7.2	12.6	15.9	8.0	6.9	14.2	19.5	11.3	9.1	1.3	5.7	7.3	18.4	8.4	21.9	20.8	27.9	1.9	7.3	161.2	14.2	13.8	13.2	18.4	10.8	7.9	8.5	10.6	9.7	23.4	23.8	5.7	20.1	13.2	14.2	11.0	47.1	6.2	16.4	2.0	8.8	10.5	214.3	7.5	12.7	7.2	10.3	7.3	7.3	11.3	6.6	6.9	14.0	17.2	7.5	15.9	11.8	11.4	8.7	3.9	20.0	0.0	15.1	10.2	14.8	18.3	17.9	16.8	20.5	14.6	33.7	18.9	12.0
REXO2	"CGI-114, DKFZP566E144, SFN"	ENSG00000076043	"RNA exonuclease 2"	Q9Y3B8	11	114439435-114450279	"Predicted intracellular proteins"		"Exonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038450, HPA038451"	Enhanced		Supported	"Nucleoli,Focal adhesion sites,Mitochondria"		NA	NA		340000	"Cluster 6: Non-specific - Transcription"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 50: Fibroblasts - ECM organization"	Mitochondria	"Nucleoli, Focal adhesion sites"	"HPA038450: AB_10672516, HPA038451: AB_10697391"	"unprognostic (3.26e-3)"	"unprognostic (2.36e-2)"	"prognostic favorable (6.51e-4)"	"unprognostic (6.84e-3)"	"unprognostic (5.80e-3)"	"unprognostic (1.06e-1)"	"unprognostic (1.40e-3)"	"unprognostic (1.78e-1)"	"unprognostic (8.18e-3)"	"unprognostic (2.49e-2)"	"unprognostic (2.17e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.73e-2)"	"unprognostic (6.75e-2)"	"unprognostic (1.23e-1)"	"unprognostic (7.69e-2)"	"prognostic unfavorable (6.70e-4)"	51.1	57.2	23.5	40.3	25.9	55.0	57.1	26.3	31.5	73.4	28.6	80.4	24.3	71.5	46.5	65.8	38.1	47.8	140.3	24.0	29.5	102.5	50.2	42.0	32.5	30.3	28.1	69.0	45.5	154.5	32.5	56.9	29.7	72.5	47.2	9.2	115.3	58.0	40.8	50.5	33.1	106.7	26.6	44.8	65.4	53.5	25.7	30.4	36.5	40.5	37.1	68.3	64.4	29.9	159.3	92.7	32.1	88.4	254.6	268.7	81.9	266.3	192.9	122.6	155.4	244.9	261.2	88.8	258.2	220.8	185.4	97.4	74.1	219.5	201.5	86.9	61.3	98.1	136.0	144.7	339.2	72.3	29.5	190.8	206.0	157.4	163.7	214.1	223.1	84.7	183.9	48.6	278.5	38.7	49.4	84.0	102.3	119.1	160.3	45.7	112.1	317.1	177.0	126.9	59.8	38.5	122.7	86.7	110.8	134.8	184.9	35.6	231.4	162.5	194.2	124.0	161.6	39.7	52.4	146.3	111.3	165.2	89.7	64.3	14.0	21.3	32.2	19.2	37.2	37.6	47.9	41.1	18.8	29.2	43.0	35.1	3.5	45.2	20.6	70.1	75.3	29.1	23.5	25.9	26.3	31.5	24.0	29.5	30.3	28.1	29.7	26.6	25.7	29.9	82.9	105.8	56.4	20.9	42.3	138.9	146.5	189.1	88.2	14.9	99.2	100.6	370.0	47.1	126.5	95.6	2.1	171.6	55.3	27.2	277.8	126.6	83.6	75.3	110.8	98.4	80.9	315.2	20.0	70.7	188.5	176.8	48.4	85.2	31.8	40.1	89.6	80.0	98.2	5.0	17.4	82.9	89.5	21.0	56.7	48.1	210.6	33.9	241.9	15.9	41.9	36.5	29.9	25.1	33.5	110.0	33.7	176.8	103.8	199.6	26.7	371.4	126.5	8.3	52.6	90.6	177.0	237.3	82.1	119.9	162.7	269.1	47.5	120.6	72.4	130.4
REXO4	"hPMC2, XPMC2H"	ENSG00000148300	"REX4 homolog, 3'-5' exonuclease"	Q9GZR2	9	133406059-133418096	"Predicted intracellular proteins"		"Exonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047006	Uncertain		Supported	Nucleoplasm,Nucleoli		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoplasm, Nucleoli"		"HPA047006: AB_2679900"	"unprognostic (2.69e-2)"	"unprognostic (3.76e-1)"	"unprognostic (8.13e-2)"	"unprognostic (1.30e-1)"	"unprognostic (6.77e-2)"	"unprognostic (6.52e-2)"	"prognostic unfavorable (4.76e-6)"	"unprognostic (2.15e-3)"	"unprognostic (2.17e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.14e-3)"	"unprognostic (1.55e-2)"	"prognostic favorable (2.65e-4)"	"unprognostic (2.25e-2)"	"unprognostic (2.86e-2)"	"unprognostic (9.20e-2)"	"unprognostic (1.20e-1)"	12.6	15.7	8.6	6.7	8.9	5.1	12.3	9.0	9.4	16.0	8.1	14.8	5.7	12.7	3.8	18.2	12.2	4.5	16.3	8.7	8.6	15.6	22.6	10.5	8.7	8.7	8.7	18.0	21.4	5.1	13.0	5.8	8.9	15.7	3.9	3.5	13.1	4.7	35.4	17.0	14.3	3.9	8.7	18.8	14.1	18.2	8.8	8.3	12.8	9.7	6.6	16.2	15.1	9.2	9.8	22.2	10.3	15.1	10.5	10.7	18.2	16.4	9.3	17.0	11.2	26.8	12.3	31.5	11.0	9.0	13.9	26.0	21.5	17.2	9.7	20.5	19.8	17.2	23.7	21.1	13.0	39.4	16.1	10.1	14.4	17.9	24.4	13.0	12.6	16.8	38.3	13.5	11.0	28.1	27.9	23.7	20.8	35.0	32.2	19.7	16.7	31.5	10.8	9.1	29.1	15.9	17.4	20.2	19.4	10.1	24.7	15.7	11.1	30.9	16.1	14.7	20.3	8.8	11.5	21.6	11.5	22.5	18.7	0.4	1.3	2.0	1.9	1.3	2.2	2.4	2.0	2.0	1.1	2.8	2.5	2.7	0.1	3.9	1.1	1.8	2.0	1.0	8.6	8.9	9.0	9.4	8.7	8.6	8.7	8.7	8.9	8.7	8.8	9.2	16.8	22.4	15.0	4.9	29.7	25.0	22.3	12.9	10.2	26.6	27.0	23.5	9.9	21.5	8.5	25.8	22.9	37.5	27.8	24.2	19.6	29.2	38.2	36.6	34.5	17.4	13.2	7.6	4.4	28.7	36.2	14.7	7.1	32.7	17.7	24.2	19.6	26.8	21.3	16.8	4.6	22.2	4.1	22.4	11.5	83.3	28.9	13.2	7.2	1.9	37.9	17.6	51.5	1.5	5.0	30.6	21.7	24.0	18.4	25.3	30.8	28.2	10.4	34.1	19.7	13.1	16.9	51.6	65.9	10.7	27.6	31.5	24.9	16.4	35.8	13.7
RFC2	"A1, RFC40"	ENSG00000049541	"Replication factor C subunit 2"	P35250	7	74231499-74254458	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"DNA replication"		"Williams-Beuren syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cytotrophoblasts: 68.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029493	Approved		Supported	"Nucleoplasm,Golgi apparatus"		NA	Yes			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	"Golgi apparatus"	"HPA029493: AB_10603991"	"unprognostic (1.25e-1)"	"prognostic favorable (9.91e-4)"	"unprognostic (1.44e-1)"	"unprognostic (7.66e-3)"	"unprognostic (1.17e-2)"	"unprognostic (1.93e-1)"	"prognostic unfavorable (6.35e-4)"	"unprognostic (2.08e-2)"	"unprognostic (5.74e-2)"	"unprognostic (2.35e-2)"	"unprognostic (5.57e-2)"	"unprognostic (2.79e-2)"	"prognostic unfavorable (2.09e-7)"	"unprognostic (2.22e-1)"	"unprognostic (6.65e-2)"	"unprognostic (3.61e-2)"	"unprognostic (2.59e-1)"	12.2	9.5	10.6	13.4	10.9	27.4	15.5	11.4	11.5	12.6	11.1	13.4	9.0	9.6	8.4	18.6	10.1	8.6	10.1	10.5	10.9	14.7	21.2	11.3	23.5	11.7	11.3	11.3	13.3	11.8	7.9	18.4	11.4	11.5	15.0	8.8	12.2	7.6	18.8	20.3	11.2	12.6	11.5	14.2	13.6	10.0	10.7	20.2	9.2	12.2	30.8	11.5	12.6	11.8	74.3	55.6	65.2	64.6	13.1	15.2	29.4	42.5	46.7	85.2	101.4	62.6	67.3	69.2	11.5	30.7	78.7	49.7	53.3	69.2	87.5	49.6	91.5	42.9	76.4	46.7	10.1	64.6	25.3	15.4	15.9	79.8	55.0	18.5	46.0	63.9	89.4	41.9	66.4	87.2	65.1	124.7	74.1	116.3	47.4	95.0	72.0	85.8	45.7	58.1	52.4	65.5	50.7	94.8	34.7	79.2	68.7	58.0	17.4	83.4	54.9	64.6	96.3	25.1	35.1	120.6	42.4	98.4	89.3	33.4	36.7	27.3	18.0	42.3	18.1	31.6	15.5	16.5	31.9	36.8	19.5	14.3	46.4	42.9	40.1	17.1	23.9	29.1	10.6	10.9	11.4	11.5	10.5	10.9	11.7	11.3	11.4	11.5	10.7	11.8	15.4	12.8	11.1	2.6	19.0	23.8	24.3	24.3	19.9	13.2	12.6	17.4	6.1	5.7	16.5	5.5	2.1	68.6	17.5	12.4	5.9	21.0	2.8	8.1	13.3	13.5	4.8	38.3	3.0	19.0	65.0	17.4	10.7	11.5	23.4	25.1	13.6	14.0	37.7	3.3	2.6	13.1	20.3	14.4	28.2	2.5	8.7	18.2	21.4	1.9	26.3	16.1	23.7	1.5	2.2	13.8	6.9	10.9	17.5	11.0	13.2	13.8	8.8	9.5	6.6	14.6	17.5	33.8	44.6	20.1	17.0	46.1	16.9	12.9	19.1	15.3
RFC3	"MGC5276, RFC38"	ENSG00000133119	"Replication factor C subunit 3"	P40938	13	33818069-33966558	"Predicted intracellular proteins"	"DNA replication"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 52.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-698: 285.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030149	Approved		Supported	Nucleoplasm,Vesicles		No	Yes			"Cluster 27: Non-specific - Gene expression"	"Cluster 63: T-cells - Adaptive immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 10: Non-specific - Unknown function"	"Nucleoplasm, Vesicles"		"HPA030149: AB_10602921"	"unprognostic (3.86e-2)"	"unprognostic (5.27e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.16e-2)"	"unprognostic (5.76e-2)"	"unprognostic (3.07e-3)"	"unprognostic (3.32e-2)"	"unprognostic (4.93e-2)"	"unprognostic (9.02e-3)"	"unprognostic (4.49e-1)"	"unprognostic (6.46e-2)"	"unprognostic (4.05e-2)"	"unprognostic (5.24e-3)"	"unprognostic (4.05e-2)"	"unprognostic (1.79e-1)"	"unprognostic (5.08e-2)"	"unprognostic (2.86e-1)"	5.3	13.8	2.6	12.9	2.4	19.5	12.8	8.7	2.6	5.7	1.7	9.0	8.5	10.6	4.3	6.7	8.3	4.6	6.1	2.7	2.5	5.1	7.4	5.4	24.3	2.7	2.2	7.8	4.8	5.1	2.6	10.8	2.8	6.3	11.6	5.9	5.5	4.1	3.5	7.5	7.9	7.6	3.7	6.6	6.5	12.8	2.6	24.1	6.5	4.4	23.4	5.7	4.6	2.5	49.0	51.1	86.4	69.5	6.5	10.0	47.5	66.6	29.2	85.5	73.7	63.0	72.2	179.8	26.8	25.3	53.2	72.5	111.6	45.9	112.0	71.5	68.9	105.0	54.4	68.0	7.5	127.2	48.3	9.8	5.8	74.5	49.9	14.1	28.9	63.7	75.1	44.2	51.4	56.1	108.8	58.1	104.2	101.2	42.1	40.3	103.4	41.1	25.4	42.7	45.1	79.2	49.4	65.3	33.4	45.7	52.2	66.8	15.5	45.1	49.7	57.1	70.9	24.9	36.7	285.3	32.4	73.7	86.6	1.5	4.4	7.2	3.2	6.1	3.7	5.8	3.9	3.3	6.1	5.5	5.0	4.5	0.9	2.5	5.3	2.5	6.3	3.1	2.6	2.4	8.7	2.6	2.7	2.5	2.7	2.2	2.8	3.7	2.6	2.5	9.3	9.6	6.2	5.9	11.2	12.2	6.9	6.9	7.4	16.5	8.9	10.5	7.5	1.5	8.6	3.7	8.4	29.6	5.1	3.0	3.9	7.3	8.4	7.0	7.9	9.4	6.1	43.8	30.2	8.9	39.3	7.5	3.1	7.7	1.3	17.8	8.9	7.2	11.9	8.4	20.3	4.3	4.1	6.7	4.0	7.9	6.2	6.5	8.8	34.7	6.4	5.4	1.0	33.7	18.0	5.4	1.5	4.5	21.0	2.7	1.1	5.4	3.8	12.2	6.6	7.9	29.8	52.6	43.2	9.2	7.0	16.4	6.6	9.2	10.1	3.3
RFLNB	"Cfm1, FAM101B, MGC45871, RefilinB"	ENSG00000183688	"Refilin B"	Q8N5W9	17	439978-445939	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 77.9"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 101.3;Endothelial cells: 51.1;Hofbauer cells: 38.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 201.5"	"Lineage enriched"	"Detected in many"	21	"granulocytes: 201.5"	"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 95.5;HMC-1: 222.1;NB-4: 74.8;U-937: 64.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030879, HPA060388"	Enhanced		Approved	"Plasma membrane,Actin filaments,Cytosol"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Actin filaments"	"Plasma membrane, Cytosol"	"HPA030879: AB_2673643, HPA060388: AB_2732649"	"unprognostic (1.52e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.87e-1)"	"unprognostic (3.14e-1)"	"unprognostic (3.52e-2)"	"unprognostic (2.34e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.94e-1)"	"unprognostic (2.87e-2)"	"unprognostic (2.48e-2)"	"unprognostic (1.31e-1)"	"prognostic unfavorable (1.54e-4)"	"unprognostic (3.45e-2)"	"unprognostic (9.22e-2)"	"unprognostic (1.43e-1)"	"unprognostic (9.03e-3)"	19.8	5.9	2.4	7.4	2.5	77.9	15.6	2.3	2.8	8.7	10.1	13.7	3.2	10.1	3.5	3.1	7.1	4.6	12.8	3.3	2.2	8.6	3.5	13.3	5.4	2.5	2.4	5.7	3.5	3.9	4.3	10.4	2.2	9.5	1.9	1.5	4.1	2.8	7.9	6.3	9.6	6.1	2.7	10.5	8.6	3.7	2.4	16.7	8.2	3.9	4.8	11.8	5.4	2.1	30.5	8.0	4.0	18.9	13.0	9.4	20.8	48.8	21.4	15.8	7.7	0.5	1.1	0.0	1.2	95.5	7.0	3.0	11.2	1.1	14.5	0.2	6.5	1.3	1.5	2.2	19.0	11.4	222.1	5.2	0.3	5.0	1.9	6.1	16.0	4.8	4.7	0.3	18.1	0.4	0.6	74.8	8.6	0.8	0.3	3.2	8.6	0.0	2.9	0.1	0.3	43.6	19.8	0.0	17.6	14.9	0.4	34.7	3.2	12.4	11.0	7.5	0.1	7.1	7.7	0.0	0.2	64.1	19.5	201.5	6.9	80.7	6.1	5.4	6.2	0.1	6.1	5.2	2.1	0.1	9.7	8.7	35.5	2.2	7.3	9.1	4.3	3.8	2.4	2.5	2.3	2.8	3.3	2.2	2.5	2.4	2.2	2.7	2.4	2.1	101.3	0.0	4.1	0.0	1.0	0.0	0.0	0.0	0.0	0.0	3.1	7.4	0.0	0.0	1.8	1.8	0.0	0.8	16.5	0.0	0.0	1.1	0.0	2.3	1.9	51.1	0.0	0.0	0.0	0.9	1.2	9.2	0.0	6.0	1.3	12.5	0.0	0.0	38.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.4	0.0	0.0	5.7	0.0	0.0	0.0	0.0	1.9	0.0	0.0	5.9	0.0	0.0	0.5	1.5	0.0	0.0	0.0	16.2	0.0	0.0	0.0	0.0	0.5	10.7	4.2	0.0	0.0
RFWD3	"FANCW, FLJ10520, RNF201"	ENSG00000168411	"Ring finger and WD repeat domain 3"	Q6PCD5	16	74621399-74666877	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair, Ubl conjugation pathway"	Transferase	"Disease variant, Fanconi anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 47.7"	"Cell type enhanced"	"Detected in many"		"Spermatocytes: 48.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA048258, HPA075649"	Approved		Enhanced	Nucleoplasm,Cytosol		No	No			"Cluster 42: Non-specific - Transcription"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	Cytosol	"HPA048258: AB_2680332, HPA075649: AB_2686761"	"unprognostic (4.79e-2)"	"unprognostic (6.45e-3)"	"unprognostic (6.35e-2)"	"unprognostic (6.61e-2)"	"unprognostic (2.73e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.11e-3)"	"unprognostic (5.04e-2)"	"unprognostic (3.64e-2)"	"unprognostic (1.01e-1)"	"unprognostic (4.03e-3)"	"unprognostic (2.53e-3)"	"unprognostic (1.73e-3)"	"unprognostic (2.84e-1)"	"unprognostic (4.31e-1)"	"unprognostic (5.74e-2)"	"unprognostic (3.29e-1)"	5.2	3.9	2.5	9.9	3.5	47.7	7.6	4.0	3.2	6.4	4.4	8.0	6.5	6.2	5.3	9.4	6.8	6.5	2.9	2.3	2.9	6.7	5.8	6.1	15.4	3.3	3.1	7.0	10.2	6.8	3.8	8.0	3.2	4.9	9.3	6.2	5.8	5.1	3.3	12.6	6.1	6.1	2.8	8.1	6.2	25.2	3.4	27.1	6.6	2.7	16.7	7.2	6.8	4.7	46.1	57.5	42.6	31.2	8.8	11.9	47.8	40.5	30.9	63.0	54.5	75.4	46.8	63.6	32.1	31.8	31.6	53.9	70.3	42.1	76.9	20.0	42.1	56.3	46.0	43.0	7.6	57.3	56.3	8.6	13.2	79.6	48.7	16.3	27.3	53.2	86.7	27.7	48.1	72.8	84.0	52.2	84.0	26.8	27.7	128.7	28.8	55.9	22.7	47.8	31.5	33.6	65.2	22.8	28.8	38.2	41.7	48.4	26.7	46.0	43.9	26.2	51.4	37.4	75.1	188.3	32.8	43.5	57.0	12.1	4.4	6.5	5.5	4.1	6.1	4.9	4.5	5.1	4.6	5.4	6.7	4.8	4.9	6.2	7.7	3.5	7.2	4.4	2.5	3.5	4.0	3.2	2.3	2.9	3.3	3.1	3.2	2.8	3.4	4.7	6.0	0.0	5.9	4.2	13.2	10.8	6.8	4.0	10.2	6.6	8.4	8.3	3.9	2.8	5.4	1.8	10.4	12.1	15.3	7.6	11.7	6.2	5.4	6.9	5.7	7.2	9.5	22.5	8.9	7.6	8.3	5.9	5.1	6.6	4.5	13.5	11.7	7.4	8.9	3.3	7.1	9.7	2.0	12.2	6.0	6.3	3.7	7.8	16.0	15.0	7.6	3.0	10.3	6.6	15.2	10.0	2.7	4.1	11.6	12.7	4.3	4.6	5.9	6.7	6.6	6.4	5.6	48.5	31.7	9.5	9.2	7.5	10.6	3.6	9.5	11.4
RFX5		ENSG00000143390	"Regulatory factor X5"	P48382	1	151340640-151347326	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Disease variant, SCID"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"monocytes: 40.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018519, HPA079241"	Supported		Supported	Nucleoplasm,Vesicles		NA	NA			"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 16: Immune cells - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 57: B-cells - Immune response"	Nucleoplasm	Vesicles	"HPA018519: AB_1856209, HPA079241: "	"unprognostic (1.17e-3)"	"unprognostic (1.62e-1)"	"unprognostic (2.61e-1)"	"unprognostic (3.21e-2)"	"unprognostic (2.68e-2)"	"unprognostic (2.49e-2)"	"unprognostic (3.73e-2)"	"unprognostic (2.09e-3)"	"unprognostic (2.99e-2)"	"unprognostic (1.96e-1)"	"unprognostic (8.29e-2)"	"unprognostic (4.42e-2)"	"unprognostic (5.66e-3)"	"unprognostic (2.00e-3)"	"unprognostic (3.43e-2)"	"unprognostic (4.03e-2)"	"unprognostic (3.05e-2)"	18.4	25.6	13.3	43.3	13.7	24.0	14.9	17.8	13.2	18.2	11.7	22.7	31.6	22.0	13.1	18.3	18.4	23.4	18.3	12.3	16.8	18.3	13.1	27.9	67.7	17.1	17.6	10.1	9.6	22.1	18.1	12.4	18.5	20.4	28.1	14.6	16.0	25.1	17.0	13.1	26.1	31.8	15.4	50.7	19.6	15.5	15.7	50.5	23.7	23.8	71.8	26.5	11.4	13.3	37.7	41.8	57.6	32.8	27.6	24.0	12.6	17.8	30.0	43.6	57.7	13.7	50.9	145.2	63.9	21.5	42.6	59.5	24.9	34.4	31.9	177.4	39.7	54.8	89.4	23.0	17.7	48.9	59.4	25.2	18.8	28.8	13.2	35.7	39.9	92.0	26.8	88.3	33.8	34.2	78.7	36.2	41.9	30.5	21.2	97.1	32.3	80.1	42.0	49.1	20.4	60.0	35.7	55.0	52.8	69.2	51.6	114.3	39.9	23.8	25.1	11.8	33.7	110.9	118.2	168.6	37.8	26.4	31.3	5.6	22.6	11.5	17.4	28.2	15.3	47.9	13.9	17.4	47.4	53.3	10.9	12.2	3.1	31.4	30.8	25.1	28.5	21.5	13.3	13.7	17.8	13.2	12.3	16.8	17.1	17.6	18.5	15.4	15.7	13.3	8.4	9.6	7.5	4.9	32.0	6.6	12.5	11.4	14.2	7.6	9.4	6.5	5.1	8.6	12.1	7.3	0.0	8.8	16.9	3.8	9.8	15.7	8.4	7.5	6.3	9.9	4.2	16.6	3.2	9.2	3.4	6.1	5.6	12.8	24.1	9.4	10.8	7.3	12.4	1.7	7.0	5.1	10.2	18.5	15.7	17.9	5.0	13.3	5.4	8.4	40.8	7.2	21.6	3.0	2.4	8.6	2.7	9.8	9.5	14.1	11.2	10.7	7.4	2.7	6.6	5.3	5.7	15.5	7.5	14.2	6.1	3.4	13.7	15.7	7.3	14.6
RGCC	"bA157L14.2, C13orf15, RGC-32, RGC32"	ENSG00000102760	"Regulator of cell cycle"	Q9H4X1	13	41457550-41470871	"Predicted intracellular proteins"	"Cell cycle"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 415.4;lung: 694.9"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 1286.2;Basal prostatic cells: 676.2;Langerhans cells: 590.1;Prostatic glandular cells: 1415.5;T-cells: 532.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"naive CD4 T-cell: 159.9;T-reg: 90.9"	"Lineage enriched"	"Detected in many"	15	"T-cells: 159.9"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 57.5;BJ hTERT+: 316.0;Daudi: 105.1;U-698: 111.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035638, HPA063701"	Enhanced		Supported	Nucleoplasm,Nucleoli	"Intracellular and membrane"	No	No		910000	"Cluster 20: T-cells - T-cell receptor"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm	Nucleoli	"HPA035638: AB_10670152, HPA063701: AB_2685096"	"unprognostic (1.39e-3)"	"unprognostic (4.61e-2)"	"prognostic unfavorable (5.60e-4)"	"unprognostic (2.28e-1)"	"unprognostic (4.27e-2)"	"unprognostic (2.85e-1)"	"unprognostic (1.49e-3)"	"unprognostic (1.49e-2)"	"unprognostic (3.99e-2)"	"unprognostic (1.57e-3)"	"unprognostic (1.19e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.81e-2)"	"unprognostic (3.04e-3)"	"unprognostic (1.48e-1)"	"unprognostic (2.30e-1)"	"unprognostic (1.42e-3)"	197.6	21.5	186.3	27.7	226.9	415.4	132.6	218.8	236.7	36.1	148.2	34.7	16.9	43.6	7.6	18.6	31.1	42.2	145.9	195.8	196.6	56.9	25.0	694.9	38.1	209.1	204.8	9.1	41.3	48.1	35.3	150.7	205.3	61.5	9.2	5.7	111.5	19.0	47.3	58.0	29.1	33.5	186.7	37.0	37.8	24.8	198.2	70.5	144.0	61.8	21.0	47.5	39.6	241.0	1.1	0.5	34.9	0.0	6.7	57.5	1.4	0.8	316.0	0.2	1.2	44.8	0.7	105.1	0.9	4.0	0.1	1.0	1.2	2.1	0.4	11.1	5.1	0.0	7.9	3.5	3.3	3.7	1.2	4.5	6.7	1.2	43.1	0.6	36.1	24.0	8.3	0.1	1.0	0.3	24.0	2.3	0.5	4.7	0.8	0.1	0.0	0.1	0.3	0.0	1.3	0.4	0.3	0.0	0.7	3.0	0.9	20.1	24.6	0.2	3.8	2.2	0.4	0.2	0.1	111.9	0.3	2.4	0.8	0.0	0.8	0.1	5.6	0.5	5.6	5.3	46.5	14.7	6.1	10.7	159.9	35.0	0.6	0.4	0.1	1.8	90.9	10.2	186.3	226.9	218.8	236.7	195.8	196.6	209.1	204.8	205.3	186.7	198.2	241.0	1286.2	246.8	39.8	57.5	131.8	86.5	676.2	15.2	14.2	1.0	269.9	314.7	25.8	1.5	37.5	3.7	2.1	6.4	249.2	3.0	35.2	0.6	42.3	103.0	47.2	474.6	84.8	322.7	2.5	0.0	9.3	205.1	65.2	69.0	48.9	0.3	31.8	2.5	349.1	0.0	1.2	22.1	14.2	32.0	590.1	13.2	8.1	315.9	193.9	36.5	6.4	1.5	4.1	51.8	115.3	0.3	4.5	2.2	371.2	1415.5	0.1	0.8	33.7	3.1	124.9	45.4	116.0	155.3	5.0	11.2	65.1	11.1	532.4	43.8	7.8	159.7
RGP1	KIAA0258	ENSG00000107185	"RGP1 homolog, RAB6A GEF complex partner 1"	Q92546	9	35749287-35758585	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020414, HPA021085"	Approved		Supported	"Plasma membrane,Cytosol"		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 20: HeLa - Mitochondria"	"Cluster 40: Granulosa cells - Unknown function"	Cytosol	"Plasma membrane"	"HPA020414: AB_1852289, HPA021085: AB_1852291"	"unprognostic (2.10e-1)"	"unprognostic (3.22e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.01e-2)"	"unprognostic (3.35e-2)"	"unprognostic (1.47e-1)"	"prognostic unfavorable (7.09e-4)"	"unprognostic (2.22e-1)"	"unprognostic (5.42e-2)"	"unprognostic (1.51e-3)"	"unprognostic (1.81e-3)"	"unprognostic (9.77e-2)"	"prognostic favorable (8.55e-13)"	"unprognostic (2.46e-2)"	"unprognostic (1.68e-1)"	"unprognostic (3.03e-3)"	"unprognostic (1.18e-1)"	9.8	10.4	7.5	8.7	6.9	5.6	8.5	6.6	6.7	7.9	3.4	12.9	10.7	8.8	7.8	8.6	8.3	6.0	12.9	7.3	7.8	11.5	7.4	9.1	7.5	5.8	6.3	10.1	10.7	19.1	10.5	9.3	6.0	8.7	13.4	7.8	11.0	11.4	17.3	9.4	11.6	9.8	5.6	7.4	10.3	6.4	8.0	8.9	12.2	18.6	9.6	8.0	6.5	5.9	18.0	16.6	18.9	15.8	17.3	18.6	11.1	13.9	20.1	18.9	17.4	14.2	6.7	13.9	9.7	17.8	34.9	9.9	18.3	26.2	15.5	18.6	10.7	11.9	32.9	10.7	16.3	13.0	16.1	18.8	32.8	19.9	24.0	27.0	22.7	10.6	8.2	7.5	17.3	8.5	4.0	4.7	7.9	14.7	19.2	13.2	13.5	9.9	16.5	12.4	13.8	14.9	12.3	17.0	11.2	16.6	14.2	6.2	29.0	15.1	18.9	10.5	11.8	11.1	16.5	14.3	21.5	5.4	19.7	1.1	0.2	0.4	0.7	0.4	1.1	0.8	0.5	0.8	0.1	1.0	0.6	0.7	0.7	1.1	0.6	0.6	0.5	0.2	7.5	6.9	6.6	6.7	7.3	7.8	5.8	6.3	6.0	5.6	8.0	5.9	13.9	6.4	12.6	0.0	23.4	5.7	24.5	14.8	9.1	40.8	15.0	10.0	16.6	18.6	15.8	27.6	20.9	10.9	19.1	46.1	13.7	20.1	17.5	9.8	8.3	14.9	43.3	8.6	0.2	17.6	10.6	7.5	18.8	14.9	5.7	33.4	16.1	16.4	7.5	16.8	0.1	26.0	22.4	7.7	6.1	36.8	8.4	5.7	1.8	0.0	11.1	18.8	25.7	0.0	0.1	20.6	38.3	10.9	15.2	25.3	36.3	14.2	17.7	22.3	6.6	11.8	9.3	16.6	6.1	8.1	5.3	10.3	16.4	7.1	28.9	28.8
RGS10		ENSG00000148908	"Regulator of G protein signaling 10"	O43665	10	119499817-119542719	"Predicted intracellular proteins"		"GTPase activation, Signal transduction inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 222.9"	"Cell type enhanced"	"Detected in many"		"granulocytes: 291.2;Hofbauer cells: 528.1;Kupffer cells: 297.2;Langerhans cells: 358.3;Macrophages: 529.3;monocytes: 294.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HMC-1: 474.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004559, HPA021305, HPA058485"	Enhanced	Supported	Supported	"Nucleoplasm,Plasma membrane"		NA	NA		840000	"Cluster 32: T-cells - Unknown function"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 51: Myeloid cells - Hemostasis"	"Nucleoplasm, Plasma membrane"		"CAB004559: AB_628216, HPA021305: AB_1856225, HPA058485: AB_2683732"	"unprognostic (1.64e-2)"	"prognostic favorable (6.81e-4)"	"unprognostic (7.98e-2)"	"prognostic favorable (6.32e-4)"	"unprognostic (5.21e-2)"	"unprognostic (6.19e-2)"	"unprognostic (4.32e-3)"	"unprognostic (6.35e-2)"	"unprognostic (9.90e-3)"	"unprognostic (1.10e-1)"	"unprognostic (1.42e-2)"	"unprognostic (1.30e-1)"	"prognostic unfavorable (4.20e-10)"	"unprognostic (2.50e-1)"	"unprognostic (9.20e-2)"	"unprognostic (7.70e-2)"	"unprognostic (7.92e-3)"	25.1	20.6	20.0	59.3	20.2	74.5	40.7	22.3	30.4	63.9	22.3	114.3	34.2	38.5	15.8	51.5	28.5	38.3	13.4	20.7	24.5	18.8	11.4	28.1	119.0	28.6	24.5	22.5	7.0	6.9	13.8	45.6	28.9	43.2	49.7	2.6	41.0	20.3	31.5	22.9	58.3	42.8	26.1	48.7	30.0	4.9	26.1	222.9	33.0	11.6	96.5	50.3	45.8	37.2	165.2	31.2	2.4	294.7	41.4	262.6	25.9	74.9	118.1	45.3	73.5	9.8	38.7	66.8	38.1	60.9	45.7	35.4	44.3	48.2	123.8	32.0	42.8	183.1	8.9	24.2	63.1	40.0	474.0	100.7	63.1	88.3	84.4	159.4	88.2	65.4	47.6	58.5	55.0	79.2	221.9	134.8	13.5	21.2	71.1	43.8	0.3	26.1	24.7	40.4	10.8	9.3	14.4	192.6	285.3	36.3	35.1	71.7	108.3	25.4	21.9	36.1	67.8	2.7	46.0	27.0	7.6	166.5	11.4	184.8	116.0	1.4	77.9	151.4	82.9	36.0	169.6	134.9	224.3	21.7	397.5	303.3	52.5	44.3	130.4	133.2	202.3	372.5	20.0	20.2	22.3	30.4	20.7	24.5	28.6	24.5	28.9	26.1	26.1	37.2	10.4	0.0	13.1	2.6	60.3	36.8	25.7	104.5	27.9	0.2	68.9	96.6	1.1	1.5	39.7	1.8	0.0	14.0	70.1	7.1	60.7	0.8	2.1	89.8	25.1	12.7	18.7	156.6	0.2	6.4	34.8	68.6	11.2	53.6	291.2	101.2	13.2	1.5	528.1	0.0	1.8	85.7	32.6	297.2	358.3	5.1	50.1	529.3	94.3	67.5	294.5	1.8	50.4	0.5	0.2	9.9	10.0	9.4	32.1	88.8	3.3	5.2	24.6	0.8	13.1	14.4	31.8	0.3	9.3	39.6	28.1	10.1	164.7	3.5	19.3	41.4
RGS12		ENSG00000159788	"Regulator of G protein signaling 12"	O14924	4	3293028-3439913	"Plasma proteins, Predicted intracellular proteins"	Transcription	"GTPase activation, Repressor, Signal transduction inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 46.6"	"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 142.0;Inhibitory neurons: 170.1;Suprabasal keratinocytes: 110.0;Urothelial cells: 153.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054646, HPA067421"			Supported	Nucleoplasm,Nucleoli,Cytosol		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 24: NB-4 - Immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Nucleoplasm, Nucleoli"	Cytosol	"HPA054646: AB_2682555, HPA067421: AB_2685836"	"unprognostic (2.08e-1)"	"unprognostic (1.71e-3)"	"unprognostic (7.50e-2)"	"unprognostic (4.18e-2)"	"unprognostic (1.65e-1)"	"prognostic favorable (7.03e-4)"	"unprognostic (3.43e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.76e-1)"	"unprognostic (9.02e-2)"	"unprognostic (1.70e-2)"	"unprognostic (2.13e-1)"	"prognostic favorable (8.43e-4)"	"unprognostic (2.54e-1)"	"unprognostic (2.60e-1)"	"unprognostic (5.92e-2)"	"unprognostic (1.11e-2)"	8.4	6.5	13.6	2.9	46.6	2.3	8.7	10.2	20.5	16.1	10.5	8.3	4.8	8.6	4.7	30.4	9.9	3.9	6.7	12.9	8.5	11.1	17.3	10.6	3.5	9.5	8.5	12.5	4.9	3.3	13.8	3.7	8.2	16.6	1.9	3.8	9.4	4.7	12.3	20.7	6.2	2.6	7.8	6.0	6.7	10.3	8.7	3.6	8.0	4.6	3.3	10.4	20.2	10.5	4.8	6.0	11.9	8.6	3.9	3.1	4.9	5.1	4.1	5.2	3.8	4.9	2.8	1.1	3.1	4.5	7.6	4.6	2.3	16.3	1.7	0.1	1.9	0.5	3.6	12.0	3.5	0.3	6.5	2.6	10.9	2.7	3.6	4.6	11.5	4.2	5.6	0.2	4.8	4.1	0.8	13.1	5.6	2.7	5.7	12.3	4.6	4.0	2.7	14.1	13.3	13.8	3.2	2.2	11.4	2.9	5.4	8.2	8.7	10.0	6.5	2.0	5.5	5.9	4.9	2.7	5.9	7.2	7.3	0.4	0.3	0.0	0.2	1.1	0.0	0.0	0.2	0.1	0.4	0.2	0.3	0.1	0.4	0.0	1.1	0.2	0.2	0.2	13.6	46.6	10.2	20.5	12.9	8.5	9.5	8.5	8.2	7.8	8.7	10.5	16.1	6.4	6.4	66.9	2.6	84.4	142.0	69.3	71.2	17.3	11.0	14.9	8.6	8.6	28.6	5.5	29.2	6.2	1.3	6.4	3.9	10.4	5.0	22.8	13.3	26.6	14.9	4.8	44.3	10.4	1.3	14.6	7.7	11.8	14.0	57.7	27.8	28.8	20.8	10.1	170.1	10.8	8.2	12.4	11.3	5.5	14.9	21.7	17.8	47.8	7.8	29.3	2.1	71.4	25.5	14.7	2.7	7.9	0.8	53.9	6.0	23.9	34.6	18.9	0.0	12.5	12.7	24.0	15.3	84.4	110.0	6.7	4.3	11.8	9.0	153.8
RGS19	"GAIP, RGSGAIP"	ENSG00000171700	"Regulator of G protein signaling 19"	P49795	20	64073181-64079988	"Predicted intracellular proteins"	Autophagy	"Signal transduction inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 57.2;lymphoid tissue: 77.5"	"Cell type enhanced"	"Detected in many"		"B-cells: 97.8;dendritic cells: 82.0;Hofbauer cells: 135.0;Kupffer cells: 104.6;Macrophages: 101.6;monocytes: 86.3;NK-cells: 140.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HMC-1: 154.2;NB-4: 128.1;THP-1: 107.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA056384, HPA069984"	Enhanced		Supported	"Nucleoli fibrillar center,Cell Junctions"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 2: Immune cells - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 57: B-cells - Immune response"	"Cell Junctions"	"Nucleoli fibrillar center"	"HPA056384: AB_2732602, HPA069984: AB_2732145"	"unprognostic (3.98e-2)"	"unprognostic (2.32e-1)"	"unprognostic (4.26e-3)"	"unprognostic (8.42e-2)"	"unprognostic (2.03e-1)"	"unprognostic (9.94e-2)"	"prognostic unfavorable (2.75e-4)"	"unprognostic (1.25e-2)"	"unprognostic (2.41e-2)"	"unprognostic (3.91e-1)"	"unprognostic (3.22e-1)"	"unprognostic (2.88e-1)"	"prognostic unfavorable (2.06e-9)"	"unprognostic (1.35e-1)"	"unprognostic (2.68e-2)"	"unprognostic (6.77e-2)"	"unprognostic (4.66e-3)"	12.5	8.8	7.1	28.5	6.8	57.2	9.0	7.3	7.8	5.9	6.3	6.7	7.5	5.1	2.0	8.1	6.9	6.0	6.4	6.7	7.3	7.6	5.9	19.6	35.2	12.3	8.8	2.3	7.0	2.7	4.3	7.2	10.0	7.3	2.2	0.3	8.5	2.5	2.5	8.4	21.1	4.3	11.4	77.5	8.2	1.8	11.8	13.9	6.8	2.2	17.3	8.3	6.9	12.2	16.1	24.1	6.8	12.2	3.0	4.9	11.5	10.0	6.9	20.2	8.4	36.0	21.8	28.1	27.0	6.2	21.6	15.4	7.0	12.8	4.8	14.0	13.2	40.3	12.3	14.8	4.0	83.0	154.2	3.3	7.7	8.6	3.0	4.0	13.3	18.4	15.5	14.5	6.2	28.6	61.6	128.1	7.0	13.8	30.3	51.1	4.0	20.4	5.7	7.8	12.9	12.1	10.3	6.3	13.6	3.4	8.3	107.3	14.0	18.9	9.5	3.3	9.8	9.1	7.6	34.7	10.5	62.6	12.8	289.5	273.2	760.9	96.6	396.0	99.2	125.7	91.1	92.6	228.8	125.7	62.4	64.9	606.5	75.1	458.3	130.8	107.1	204.7	7.1	6.8	7.3	7.8	6.7	7.3	12.3	8.8	10.0	11.4	11.8	12.2	19.0	3.2	4.1	2.0	97.8	9.7	6.4	8.0	4.0	0.1	10.4	13.3	3.9	2.8	5.7	1.8	0.0	3.0	82.0	0.5	0.0	12.0	0.5	2.8	8.3	17.2	0.0	14.7	1.4	14.3	8.1	6.5	4.6	2.2	48.8	4.5	15.0	0.8	135.0	0.0	1.0	0.5	4.1	104.6	50.0	1.1	4.4	101.6	5.4	17.8	86.3	0.3	140.1	2.5	0.2	16.9	3.8	1.2	25.0	14.5	0.1	2.4	3.3	0.2	13.1	2.4	8.8	0.3	7.0	5.2	8.9	1.8	57.1	3.7	0.9	8.8
RGS2	G0S8	ENSG00000116741	"Regulator of G protein signaling 2"	P41220	1	192809039-192812275	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Translation regulation"	"GTPase activation, Signal transduction inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"granulocytes: 1871.8;Langerhans cells: 637.8;Macrophages: 621.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"basophil: 3268.4;neutrophil: 4374.2"	"Lineage enriched"	"Detected in all"	8	"granulocytes: 4374.2"	"Cell line enhanced"	"Detected in many"		"hTCEpi: 141.8;hTERT-HME1: 96.8;Karpas-707: 94.0;PC-3: 226.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA013385			Supported	Cytosol		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 60: Granulocytes - Receptor signaling"	Cytosol		"HPA013385: AB_2668827"	"prognostic favorable (2.43e-4)"	"unprognostic (9.75e-2)"	"unprognostic (1.28e-3)"	"unprognostic (4.43e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.93e-1)"	"unprognostic (2.09e-3)"	"unprognostic (1.29e-2)"	"unprognostic (2.59e-1)"	"unprognostic (2.79e-2)"	"unprognostic (1.36e-1)"	"unprognostic (6.49e-2)"	"prognostic unfavorable (2.90e-5)"	"prognostic unfavorable (3.56e-4)"	"unprognostic (1.16e-1)"	"unprognostic (4.34e-3)"	"unprognostic (1.01e-3)"	129.3	353.8	36.4	241.4	40.7	565.0	126.8	41.8	82.6	67.2	56.7	328.5	142.7	217.4	96.0	256.2	149.2	189.5	73.0	43.6	47.7	53.6	66.3	123.6	37.1	50.3	43.9	137.4	513.3	12.5	198.7	100.1	46.0	182.2	110.1	36.9	27.5	222.4	10.0	37.3	104.9	505.9	41.0	192.1	113.4	18.8	47.5	47.3	22.8	63.7	17.3	259.8	71.7	42.1	0.0	20.1	25.4	2.4	48.9	7.7	1.5	9.9	12.4	3.2	3.4	17.9	11.8	1.7	2.8	9.3	2.5	9.7	16.7	17.5	2.9	2.6	12.3	4.8	12.9	0.4	21.5	12.1	2.8	8.1	141.8	6.5	96.8	18.1	23.9	9.1	4.4	94.0	10.0	0.3	6.6	16.8	34.0	1.9	226.6	6.7	5.9	5.4	16.9	16.3	9.4	47.4	7.1	0.5	11.8	26.0	0.7	6.0	6.7	4.8	4.5	5.2	5.2	55.4	1.7	5.3	67.3	2.4	17.8	3268.4	517.9	754.6	14.3	200.8	32.1	6.4	10.2	10.4	118.8	3.3	5.2	6.6	4374.2	2.3	362.7	16.0	6.7	310.2	36.4	40.7	41.8	82.6	43.6	47.7	50.3	43.9	46.0	41.0	47.5	42.1	22.3	51.3	195.9	6.8	187.2	42.3	47.3	45.0	6.2	18.7	138.5	44.1	69.4	7.2	46.1	136.1	18.8	227.6	145.1	27.0	0.0	33.5	24.6	6.9	51.5	38.6	349.2	3.2	6.6	30.3	24.5	125.8	38.7	7.5	1871.8	2.3	18.5	3.1	374.4	21.9	8.4	96.9	42.7	345.0	637.8	18.3	16.4	621.2	88.9	8.4	305.0	41.5	25.7	3.5	2.4	14.8	60.3	62.8	135.9	36.3	141.5	2.5	20.4	39.0	0.0	61.4	55.5	4.2	16.9	6.1	31.1	124.2	346.1	16.6	32.3	11.3
RGS22	"CT145, DKFZP434I092, PRTD-NY2"	ENSG00000132554	"Regulator of G protein signaling 22"	Q8NE09	8	99960936-100131268	"Predicted intracellular proteins"		"Signal transduction inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"testis: 61.3"	"Group enriched"	"Detected in many"	8	"Early spermatids: 619.6;Late spermatids: 1623.3"	"Cancer enhanced"	"Detected in some"		"breast cancer: 1.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"RPMI-8226: 1.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA053026			Supported	"Nucleoli fibrillar center,Actin filaments,Cytosol"		NA	NA				"Cluster 49: Ciliated cells - Cilium organization"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 25: Spermatids - Spermatogenesis"	"Nucleoli fibrillar center"	"Actin filaments, Cytosol"	"HPA053026: "	"unprognostic (3.04e-2)"	"unprognostic (2.62e-2)"	"unprognostic (4.61e-2)"	"unprognostic (3.97e-1)"	"unprognostic (3.47e-5)"	"unprognostic (1.61e-1)"	"unprognostic (2.32e-1)"	"unprognostic (3.19e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.14e-2)"	"unprognostic (1.05e-2)"	"unprognostic (7.96e-3)"	"unprognostic (1.98e-5)"	"unprognostic (3.71e-2)"	"unprognostic (1.31e-2)"	"unprognostic (3.25e-3)"	"unprognostic (8.36e-4)"	2.7	0.9	1.7	0.0	2.4	0.0	0.6	1.0	1.5	1.4	10.4	0.3	0.0	2.9	1.1	0.3	10.6	1.2	0.3	1.1	3.9	0.2	0.1	1.7	0.3	5.9	7.4	7.3	0.5	0.0	1.1	0.5	3.7	1.3	0.1	1.0	0.1	2.3	0.1	0.6	0.1	1.5	3.7	0.0	0.1	61.3	5.3	0.1	0.3	0.1	0.3	0.4	0.5	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.9	0.6	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.2	0.1	0.0	0.1	0.0	0.3	1.3	0.1	0.1	0.5	0.0	0.0	0.0	0.0	0.2	0.1	0.2	0.0	0.0	0.8	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	2.4	1.0	1.5	1.1	3.9	5.9	7.4	3.7	3.7	5.3	2.9	0.1	0.0	0.0	14.4	0.0	2.2	0.0	1.6	0.6	1.2	1.2	0.8	0.8	0.0	12.9	0.0	0.0	0.2	0.0	0.0	0.0	0.0	619.6	58.1	14.2	0.7	0.0	0.0	2.3	0.0	0.2	8.6	0.5	0.8	0.0	1.3	0.0	0.0	0.2	0.0	1.6	0.0	4.1	0.0	2.9	1623.3	131.4	0.4	0.0	6.5	0.0	10.9	0.0	20.1	2.5	0.0	0.0	62.8	0.0	0.0	0.0	0.0	77.2	0.2	0.0	0.4	1.6	70.9	11.1	0.1	2.0	0.8	0.4	8.3	0.0	0.1
RGS3	"C2PA, FLJ20370, PDZ-RGS3"	ENSG00000138835	"Regulator of G protein signaling 3"	P49796	9	113444731-113597743	"Plasma proteins, Predicted intracellular proteins"		"Signal transduction inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Endothelial cells: 111.6;Horizontal cells: 158.2;Proximal tubular cells: 195.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 248.4;HDLM-2: 413.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044234			Supported	"Plasma membrane"		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Plasma membrane"		"HPA044234: "	"prognostic unfavorable (9.93e-4)"	"unprognostic (4.04e-2)"	"unprognostic (5.33e-3)"	"unprognostic (6.71e-3)"	"unprognostic (1.49e-2)"	"unprognostic (1.69e-2)"	"prognostic unfavorable (6.62e-4)"	"unprognostic (6.79e-2)"	"unprognostic (9.17e-2)"	"unprognostic (2.24e-1)"	"unprognostic (8.59e-3)"	"unprognostic (3.04e-1)"	"unprognostic (2.51e-3)"	"unprognostic (1.52e-2)"	"unprognostic (1.45e-1)"	"unprognostic (8.53e-2)"	"unprognostic (2.90e-1)"	60.5	31.5	32.0	18.1	37.3	9.3	43.7	33.7	29.7	17.9	49.7	30.4	16.9	20.8	11.4	10.8	15.2	42.4	95.0	24.0	31.5	70.9	54.5	64.2	23.9	32.2	44.3	10.3	23.9	12.3	16.6	32.3	32.5	26.3	15.8	10.3	10.8	10.2	48.2	15.2	20.0	18.0	28.2	31.9	27.6	31.2	58.0	7.9	24.5	19.2	11.4	26.5	15.4	34.0	4.5	16.6	40.1	37.0	12.2	18.1	2.9	41.2	248.4	32.9	27.9	40.8	14.7	17.9	29.7	33.6	32.8	10.6	0.6	16.0	19.2	413.2	0.1	1.7	13.0	24.8	24.8	0.4	5.5	32.4	16.6	91.4	13.2	72.6	125.4	1.0	0.3	17.1	60.5	18.7	1.2	1.9	10.6	28.6	13.7	1.3	19.8	2.9	67.7	8.1	31.3	4.2	3.9	31.3	24.7	19.6	21.5	3.8	61.2	109.7	11.8	5.1	79.1	8.6	1.5	2.7	126.2	3.8	51.6	10.2	6.8	3.7	24.7	7.1	16.7	2.4	5.7	20.3	6.6	2.4	2.4	10.8	18.5	42.3	6.0	0.3	3.8	15.6	32.0	37.3	33.7	29.7	24.0	31.5	32.2	44.3	32.5	28.2	58.0	34.0	49.5	16.0	13.9	14.4	5.6	12.0	9.9	7.4	4.6	1.4	9.1	10.7	55.8	72.9	8.4	22.0	6.2	4.6	23.5	28.0	82.2	65.1	38.8	9.9	14.9	111.6	0.0	6.1	2.4	30.4	3.7	29.3	27.0	4.0	47.7	12.8	66.0	35.2	15.6	158.2	3.4	7.4	4.1	14.3	13.8	17.4	4.7	14.6	55.2	21.5	10.3	3.5	50.4	3.5	24.4	31.0	23.4	13.9	4.5	5.0	20.5	195.7	7.5	6.4	6.6	8.4	35.4	9.9	1.8	4.1	11.4	3.0	18.4	55.5	11.5	12.9
RGS5		ENSG00000143248	"Regulator of G protein signaling 5"	O15539	1	163111121-163321791	"Predicted intracellular proteins"		"Signal transduction inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	7	"Sertoli cells: 5114.5;Smooth muscle cells: 1592.3"	"Cancer enhanced"	"Detected in all"		"renal cancer: 226.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 1303.0;OE19: 692.4;SH-SY5Y: 4234.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001821		Supported	Supported	Vesicles,Cytosol		NA	NA			"Cluster 30: Non-specific - Translation"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 48: Smooth muscle cells - ECM organization"	Cytosol	Vesicles	"HPA001821: AB_1079806"	"unprognostic (3.75e-1)"	"unprognostic (3.93e-3)"	"unprognostic (2.31e-1)"	"unprognostic (6.91e-2)"	"unprognostic (2.50e-2)"	"unprognostic (1.32e-3)"	"unprognostic (1.65e-2)"	"unprognostic (7.38e-2)"	"unprognostic (3.54e-3)"	"unprognostic (2.19e-1)"	"unprognostic (1.53e-2)"	"unprognostic (1.48e-1)"	"prognostic unfavorable (9.17e-4)"	"unprognostic (3.81e-3)"	"unprognostic (7.05e-2)"	"unprognostic (6.08e-2)"	"unprognostic (1.41e-1)"	138.1	312.4	75.5	29.7	87.2	0.1	58.4	84.2	136.5	160.5	73.1	95.7	64.5	73.7	63.1	71.8	65.5	142.7	238.2	65.9	90.7	88.1	34.1	55.5	33.8	95.6	89.1	19.5	30.6	83.3	45.4	19.9	108.2	75.1	42.9	15.3	27.8	190.0	116.5	21.8	75.8	278.0	68.8	16.7	93.5	40.5	99.6	21.2	164.7	236.8	39.4	136.1	60.5	83.7	0.4	0.0	62.9	8.0	1.3	3.0	2.6	1.1	4.4	2.0	1.3	5.3	1.6	0.5	9.2	1.1	0.7	0.4	0.8	0.8	3.3	3.0	1.0	1.3	0.9	0.1	2.6	0.8	0.7	2.0	1.9	2.1	2.6	14.3	1303.0	0.3	0.2	1.2	4.7	0.0	0.9	2.2	38.7	692.4	1.4	0.4	0.1	3.6	0.7	0.0	5.2	4234.9	0.9	0.0	1.5	185.8	0.0	1.3	5.3	1.0	2.3	0.9	2.0	1.5	1.2	0.4	1.4	0.2	2.9	0.0	0.0	0.0	0.0	0.1	0.5	0.5	0.5	0.2	0.1	0.2	0.4	0.4	0.1	0.2	0.1	0.0	0.2	0.1	75.5	87.2	84.2	136.5	65.9	90.7	95.6	89.1	108.2	68.8	99.6	83.7	458.3	3.2	5.6	61.4	1.7	17.1	6.0	1.0	0.6	1.8	9.8	12.1	0.0	0.0	7.3	1.8	4.2	1.5	2.4	0.3	1.9	1.0	32.7	3.4	11.6	353.7	0.0	0.0	24.4	1.1	0.8	43.0	223.3	8.1	1.3	0.9	0.0	0.0	1.2	0.0	60.5	0.2	0.0	0.0	26.3	17.0	6.8	11.9	23.2	80.6	0.6	2.6	0.0	25.1	69.7	3.9	0.2	2.6	0.4	12.7	0.2	2.5	5.9	5.8	5114.5	44.9	1592.3	5.7	1.7	5.2	12.6	1.2	5.8	5.5	0.2	7.0
RGS6		ENSG00000182732	"Regulator of G protein signaling 6"	P49758	14	71932429-72566530	"Predicted intracellular proteins"		"GTPase activation, Signal transduction inhibitor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 20.2"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 97.3;Early spermatids: 173.5;Excitatory neurons: 652.7;Inhibitory neurons: 256.1;Late spermatids: 298.0"	"Group enriched"	"Detected in some"	7	"glioma: 3.1;thyroid cancer: 1.1"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"HEL: 11.5;Karpas-707: 40.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003067	Uncertain		Approved	Nucleoplasm,Nucleoli,Vesicles		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 21: Non-specific - Transcription"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Nucleoplasm	"Nucleoli, Vesicles"	"HPA003067: AB_1079807"	"unprognostic (7.18e-2)"	"unprognostic (7.78e-2)"	"unprognostic (1.00e-1)"	"unprognostic (6.85e-2)"	"unprognostic (5.61e-2)"	"unprognostic (3.80e-2)"	"unprognostic (1.24e-4)"	"unprognostic (7.83e-2)"	"unprognostic (2.03e-1)"	"unprognostic (8.17e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.06e-2)"	"unprognostic (8.64e-2)"	"unprognostic (5.11e-2)"	"unprognostic (8.06e-3)"	"unprognostic (2.10e-1)"	"unprognostic (3.68e-2)"	4.7	0.2	1.1	0.6	2.2	1.4	4.0	0.6	8.6	4.9	0.0	1.0	0.3	1.4	2.6	0.4	2.2	1.2	11.2	3.5	2.8	2.6	0.1	0.9	0.1	19.2	16.0	1.2	0.2	8.1	1.7	3.0	20.2	0.4	1.0	1.7	0.8	1.4	1.1	0.9	0.8	1.3	5.4	0.9	0.4	10.6	6.4	0.3	5.7	0.8	0.5	0.7	0.9	3.4	0.0	0.0	1.4	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	11.5	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	40.1	0.0	0.7	0.0	0.0	0.1	0.2	0.0	0.0	0.0	1.5	0.1	0.5	0.1	0.0	0.0	0.0	0.0	0.6	1.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.2	0.0	0.1	0.3	1.2	1.1	2.2	0.6	8.6	3.5	2.8	19.2	16.0	20.2	5.4	6.4	3.4	5.8	0.0	0.0	97.3	0.2	0.3	0.0	0.0	0.0	2.2	2.1	2.4	22.6	0.0	0.0	0.0	0.0	1.9	0.1	0.0	0.0	0.0	173.5	2.8	0.9	2.6	0.0	5.3	652.7	0.2	0.1	3.1	0.0	7.1	0.0	0.4	0.0	0.0	0.2	0.0	256.1	0.0	0.0	0.0	0.0	298.0	1.8	8.3	0.0	44.0	5.1	0.0	0.0	36.2	8.9	0.0	0.0	7.5	0.2	0.0	0.0	0.4	0.0	0.4	13.1	0.4	18.6	2.3	1.3	0.2	0.1	0.8	0.5	0.1	0.0	0.7
RGS7		ENSG00000182901	"Regulator of G protein signaling 7"	P49802	1	240775514-241357230	"Plasma proteins, Predicted intracellular proteins"		"GTPase activation, Signal transduction inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"adrenal gland: 8.0;brain: 28.1;retina: 12.8"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 288.3;Excitatory neurons: 1353.2;Inhibitory neurons: 1095.0;Oligodendrocyte precursor cells: 615.8"	"Cancer enhanced"	"Detected in some"		"glioma: 1.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+ SV40 Large T+: 6.2;HaCaT: 5.3;hTERT-HME1: 7.2;RH-30: 6.4;SH-SY5Y: 5.6;U-2 OS: 5.9;U-251 MG: 7.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB017561	Enhanced		Supported	Mitochondria,Cytosol		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 6: Brain - Smell perception"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Cytosol	Mitochondria	"CAB017561: AB_2285043"	"unprognostic (6.48e-2)"	"unprognostic (4.30e-2)"	"unprognostic (4.67e-2)"	"unprognostic (6.65e-2)"	"unprognostic (7.84e-3)"	"unprognostic (4.09e-2)"		"unprognostic (1.49e-2)"	"unprognostic (3.61e-1)"	"unprognostic (1.42e-2)"	"unprognostic (2.51e-4)"	"unprognostic (3.54e-1)"	"unprognostic (2.19e-2)"	"unprognostic (2.23e-1)"	"unprognostic (2.64e-2)"		"unprognostic (2.28e-1)"	0.0	8.0	11.6	0.0	13.5	0.0	0.1	18.9	28.1	0.1	0.0	0.2	0.2	0.2	0.0	0.1	0.0	0.4	0.0	15.9	8.6	2.4	0.4	0.1	0.3	2.5	3.8	0.4	0.5	0.2	2.8	0.0	6.8	0.1	0.1	12.8	0.0	0.5	0.0	0.1	0.1	0.0	2.6	0.2	2.9	5.3	6.4	0.0	0.0	0.0	0.2	0.0	0.0	13.9	0.9	0.0	0.0	0.0	0.2	0.7	0.0	2.5	4.8	6.2	0.4	0.0	0.0	0.0	0.3	3.3	3.4	5.3	0.0	0.0	3.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	7.2	0.5	0.4	0.0	0.0	0.0	1.9	0.0	0.0	0.0	3.3	0.3	0.2	0.0	6.4	0.0	0.0	0.0	5.3	5.6	0.3	0.2	0.2	0.2	0.0	0.0	2.6	0.0	5.9	0.3	7.2	0.0	4.1	0.0	0.9	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	11.6	13.5	18.9	28.1	15.9	8.6	2.5	3.8	6.8	2.6	6.4	13.9	0.0	0.0	0.0	288.3	2.8	0.0	0.1	0.0	0.0	29.3	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	8.1	0.0	0.0	0.1	2.3	0.0	3.5	0.2	7.2	0.0	1353.2	0.0	0.0	0.5	1.5	0.1	0.0	10.0	0.4	0.4	0.1	62.2	1095.0	0.4	0.0	0.0	0.3	4.1	0.0	0.1	0.0	29.0	0.0	1.0	0.0	615.8	86.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.1	0.7	6.3	10.8	0.0	0.0	0.0	0.0	0.1	0.1	0.1
RHBDD1	DKFZp547E052	ENSG00000144468	"Rhomboid domain containing 1"	Q8TEB9	2	226835581-226999215	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Apoptosis, Differentiation, Spermatogenesis"	"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 66.9;Microglial cells: 57.1;Oligodendrocyte precursor cells: 55.8;Oligodendrocytes: 109.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-698: 73.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA013972, HPA057125"	Approved		Supported	"Endoplasmic reticulum"		NA	NA			"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 57: B-cells - Immune response"	"Endoplasmic reticulum"		"HPA013972: AB_2178629, HPA057125: AB_2683343"	"unprognostic (1.42e-1)"	"unprognostic (5.37e-2)"	"unprognostic (3.26e-1)"	"unprognostic (5.23e-2)"	"unprognostic (2.57e-1)"	"unprognostic (2.91e-1)"	"unprognostic (1.17e-2)"	"unprognostic (2.07e-2)"	"unprognostic (1.18e-1)"	"unprognostic (9.40e-2)"	"unprognostic (4.74e-3)"	"unprognostic (4.97e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.09e-1)"	"unprognostic (9.77e-2)"	"unprognostic (3.04e-2)"	10.3	8.9	11.2	13.6	20.9	11.9	11.5	12.2	13.6	11.6	1.8	11.5	10.3	13.6	12.5	11.5	12.9	10.9	10.3	8.8	15.2	12.0	15.1	9.9	16.1	15.6	15.0	13.6	13.9	16.5	4.4	9.9	17.1	13.1	11.2	7.4	9.6	13.3	8.9	8.8	11.8	14.3	15.7	14.2	11.4	17.4	16.8	37.5	15.6	8.6	16.9	11.5	7.0	22.8	10.7	9.3	9.9	15.1	28.6	28.8	0.0	24.1	20.9	12.6	14.6	8.3	18.7	10.1	19.8	25.2	18.0	11.9	0.1	26.8	23.9	25.1	9.9	15.3	5.9	6.7	31.5	15.2	8.0	25.6	38.2	23.8	51.4	14.3	9.8	26.7	41.7	25.6	13.4	18.9	27.8	8.5	0.0	12.2	10.3	12.0	0.1	14.9	10.3	13.3	9.7	7.3	13.6	5.1	18.8	17.6	14.1	18.9	13.1	5.6	12.2	22.0	7.5	28.8	14.9	73.9	17.8	19.6	16.2	10.4	13.7	12.8	7.3	20.0	11.8	22.1	11.0	8.9	17.2	24.5	12.6	10.6	3.3	11.8	13.8	21.1	16.2	10.8	11.2	20.9	12.2	13.6	8.8	15.2	15.6	15.0	17.1	15.7	16.8	22.8	6.6	12.8	6.4	66.9	28.4	5.2	8.5	7.2	8.0	8.0	7.6	4.2	16.6	4.3	8.1	11.0	16.7	7.6	9.3	6.6	3.9	7.0	16.7	8.3	8.6	6.8	1.8	15.2	28.4	9.3	4.1	9.3	8.2	7.8	8.2	22.7	3.3	14.0	5.2	11.8	41.5	6.1	6.1	8.2	4.4	24.4	5.6	7.6	12.4	57.1	6.2	6.3	9.2	55.8	109.0	8.3	1.9	6.8	48.8	13.2	6.8	3.4	7.1	6.3	0.0	5.6	6.6	15.2	9.5	7.3	5.5	5.6	8.6	25.7	5.7	8.9
RHEX	"C1orf186, FLJ16052"	ENSG00000263961	"Regulator of hemoglobinization and erythroid cell expansion"	Q6ZWK4	1	206053173-206102449	"Predicted membrane proteins"	"Differentiation, Erythrocyte maturation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix: 24.4"	"Group enriched"	"Detected in some"	14	"Endometrial ciliated cells: 202.9;Glandular and luminal cells: 337.5;granulocytes: 334.3"	"Group enriched"	"Detected in many"	5	"endometrial cancer: 42.8;ovarian cancer: 41.1;renal cancer: 27.7"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in some"	152	"basophil: 1312.1"	"Lineage enriched"	"Detected in single"	1544	"granulocytes: 1312.1"	"Cell line enriched"	"Detected in some"	5	"HMC-1: 1562.9"					"Low region specificity"	"Detected in all"			HPA037859			Supported	"Plasma membrane"		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 44: Endometrium - Transcription"	"Plasma membrane"		"HPA037859: AB_10697084"	"unprognostic (9.26e-3)"	"unprognostic (1.91e-2)"	"unprognostic (9.66e-2)"	"unprognostic (1.65e-2)"	"unprognostic (2.06e-2)"	"unprognostic (5.27e-3)"	"unprognostic (9.55e-2)"	"unprognostic (3.04e-3)"	"unprognostic (2.36e-1)"	"unprognostic (1.31e-2)"	"unprognostic (1.35e-1)"	"unprognostic (7.20e-3)"	"unprognostic (1.89e-2)"	"unprognostic (3.02e-2)"	"unprognostic (1.35e-1)"	"unprognostic (3.77e-2)"	"unprognostic (2.80e-3)"	4.1	0.4	0.0	2.9	0.0	1.3	4.7	0.0	0.0	24.4	0.0	7.5	3.3	12.8	16.3	7.7	5.3	16.3	0.9	0.0	0.0	14.3	0.9	10.7	4.1	0.0	0.0	0.2	1.4	0.3	0.4	0.6	0.0	2.8	7.4	0.0	2.8	20.0	1.0	4.5	6.7	7.3	0.0	3.0	6.4	1.0	0.1	3.1	2.0	2.5	4.6	7.7	2.6	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.7	13.9	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	143.8	0.0	0.9	0.0	75.2	1562.9	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	1.5	0.0	0.0	5.9	330.8	0.0	0.0	0.0	0.1	0.2	0.7	20.0	2.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	8.5	0.0	0.0	0.5	0.2	0.0	0.1	0.0	0.6	0.9	1.1	0.8	1312.1	0.0	8.6	0.0	0.1	0.1	0.5	0.2	0.0	0.6	0.2	0.1	0.2	0.5	0.0	0.2	0.8	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	13.6	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.8	20.2	0.0	2.3	0.7	0.0	1.9	3.6	0.0	202.9	17.6	1.3	0.0	0.0	0.0	0.2	0.2	0.4	0.0	337.5	334.3	1.3	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	5.0	0.0	0.0	13.2	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.3	3.0	0.0	0.0	0.0
RHOA	"ARH12, ARHA, Rho12, RHOH12"	ENSG00000067560	"Ras homolog family member A"	P61586	3	49359139-49412998	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins"	"Cell cycle, Cell division, Host-virus interaction"	Hydrolase	"Cancer-related genes, Disease variant, Ectodermal dysplasia, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB005052	Approved		Supported	"Plasma membrane,Cytosol"		NA	NA		1500000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 52: Non-specific - Ribosome"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 10: Non-specific - Unknown function"	"Plasma membrane, Cytosol"		"CAB005052: AB_562216"	"unprognostic (1.50e-1)"	"unprognostic (3.38e-1)"	"prognostic favorable (3.08e-4)"	"unprognostic (8.75e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.24e-1)"	"prognostic unfavorable (9.15e-4)"	"unprognostic (1.39e-1)"	"unprognostic (8.83e-2)"	"unprognostic (9.44e-3)"	"unprognostic (2.21e-2)"	"unprognostic (4.29e-2)"	"prognostic favorable (3.21e-6)"	"unprognostic (5.14e-2)"	"unprognostic (7.50e-2)"	"unprognostic (1.57e-1)"	"unprognostic (4.52e-2)"	452.4	315.0	234.6	357.9	258.6	473.4	360.0	257.1	274.1	310.4	237.4	351.9	274.6	293.8	298.6	362.6	269.2	267.1	269.6	220.8	271.2	286.9	274.5	430.9	396.3	282.9	245.8	297.2	225.3	269.4	164.3	396.8	287.2	244.5	369.3	113.3	238.0	315.6	331.0	281.3	281.0	416.9	259.3	329.1	292.1	154.1	257.5	387.7	326.3	298.5	454.9	358.2	273.6	292.5	470.4	406.1	500.9	512.7	569.9	858.9	370.8	930.1	735.7	790.3	722.4	347.6	527.4	721.8	251.6	1404.1	448.8	259.5	560.4	630.6	817.6	505.7	323.3	678.8	488.0	416.0	604.2	647.9	472.8	668.2	437.8	643.2	508.1	799.7	1038.0	391.9	361.1	437.9	967.5	254.3	717.3	739.0	441.4	548.2	497.1	325.5	451.4	610.5	701.9	559.6	167.7	387.3	599.0	464.5	495.4	499.4	301.7	819.6	972.1	558.4	483.2	737.2	725.7	388.0	775.6	754.8	567.9	691.6	678.3	716.9	1105.5	1160.5	480.1	1358.8	423.8	432.7	415.6	479.6	806.9	379.3	314.5	397.1	1282.7	440.9	1398.1	645.5	554.9	1884.8	234.6	258.6	257.1	274.1	220.8	271.2	282.9	245.8	287.2	259.3	257.5	292.5	502.8	387.8	265.2	20.5	374.6	270.9	260.0	236.1	251.6	47.1	239.4	223.1	141.1	178.7	220.9	180.3	6.2	355.8	373.1	447.2	340.4	339.5	48.2	174.2	243.7	413.8	234.4	319.3	26.1	347.8	709.8	386.2	313.9	201.0	257.3	141.6	312.7	173.2	760.0	82.4	27.0	344.9	191.2	771.9	495.8	55.6	335.2	683.7	327.3	52.5	710.0	219.9	389.3	24.6	51.4	398.0	354.6	407.7	375.7	334.1	341.3	350.8	201.1	40.8	276.1	354.1	450.1	264.4	253.6	390.8	279.6	525.2	359.5	299.1	347.7	371.4
RHOT2	"ARHT2, C16orf39, MIRO-2"	ENSG00000140983	"Ras homolog family member T2"	Q8IXI1	16	668105-674174	"Predicted intracellular proteins, Predicted membrane proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cone photoreceptor cells: 264.8;Rod photoreceptor cells: 284.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA012624, HPA012895"	Approved		Supported	Mitochondria		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 9: Photoreceptor cells - Phototransduction"	Mitochondria		"HPA012624: AB_1856272, HPA012895: AB_1856271"	"unprognostic (1.59e-1)"	"unprognostic (8.24e-2)"	"unprognostic (1.03e-1)"	"unprognostic (4.50e-2)"	"unprognostic (1.09e-1)"	"prognostic favorable (5.01e-4)"	"unprognostic (4.68e-3)"	"unprognostic (4.66e-2)"	"unprognostic (3.41e-2)"	"unprognostic (7.55e-2)"	"unprognostic (7.87e-3)"	"unprognostic (3.25e-1)"	"prognostic favorable (5.43e-4)"	"unprognostic (1.51e-2)"	"unprognostic (2.38e-1)"	"unprognostic (1.24e-1)"	"unprognostic (2.17e-2)"	32.3	48.6	28.9	20.4	28.4	28.1	34.9	27.9	36.4	38.7	32.8	42.8	29.1	32.8	7.8	37.7	38.2	12.8	53.6	29.2	27.4	46.6	44.9	34.4	26.0	29.1	28.1	34.5	34.2	20.4	51.5	14.7	28.0	50.3	8.1	36.4	35.9	17.3	33.5	38.7	45.1	9.2	27.0	57.1	41.4	36.7	28.8	20.3	45.7	15.5	11.6	37.5	35.6	28.1	25.0	52.4	25.6	39.7	13.1	13.7	44.7	41.7	19.2	33.9	26.2	70.3	37.1	29.5	28.8	16.6	11.8	47.3	17.7	39.6	8.7	41.9	77.2	32.5	65.5	52.2	24.7	29.9	44.2	21.3	29.5	25.0	14.2	17.9	24.5	35.9	62.6	22.1	17.3	108.2	33.1	32.5	67.3	21.5	33.5	72.6	30.5	59.1	20.6	48.8	57.7	70.1	39.2	50.6	22.8	11.0	49.6	46.4	38.9	25.4	41.7	23.5	30.8	56.0	40.0	38.6	17.9	28.3	39.6	5.5	19.5	21.8	22.9	23.0	13.9	11.6	18.3	18.4	19.4	12.1	13.7	11.7	16.8	12.0	18.4	20.3	23.0	17.6	28.9	28.4	27.9	36.4	29.2	27.4	29.1	28.1	28.0	27.0	28.8	28.1	30.1	32.1	27.5	53.2	37.1	33.8	26.8	80.0	25.6	98.6	29.6	25.8	25.7	30.0	38.3	29.5	264.8	63.2	46.7	63.3	21.5	40.2	6.3	16.5	21.7	26.6	43.0	17.1	46.5	35.8	52.1	26.5	51.0	21.9	51.4	40.6	20.0	34.7	35.8	85.8	36.2	52.2	61.1	30.3	29.8	7.5	27.1	26.0	28.4	20.6	45.2	40.1	46.4	17.1	27.3	43.8	46.8	25.6	23.7	25.0	47.3	24.3	27.9	284.9	52.6	19.9	31.5	44.5	51.4	19.3	31.7	67.0	42.1	45.5	54.2	23.3
RIC8B	"FLJ10620, hSyn, RIC8"	ENSG00000111785	"RIC8 guanine nucleotide exchange factor B"	Q9NVN3	12	106774621-106889316	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 96.4;Inhibitory neurons: 93.9;Microglial cells: 58.1;Oligodendrocyte precursor cells: 76.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039970, HPA042746"	Approved		Supported	"Plasma membrane,Cytosol"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Cytosol	"Plasma membrane"	"HPA039970: , HPA042746: AB_2678143"	"unprognostic (1.18e-1)"	"unprognostic (1.61e-1)"	"unprognostic (9.87e-3)"	"unprognostic (5.43e-2)"	"unprognostic (3.28e-2)"	"unprognostic (8.09e-2)"	"unprognostic (5.74e-2)"	"unprognostic (2.60e-1)"	"unprognostic (1.99e-2)"	"unprognostic (3.83e-1)"	"unprognostic (1.10e-3)"	"unprognostic (5.13e-2)"	"unprognostic (3.65e-3)"	"unprognostic (2.21e-1)"	"unprognostic (3.18e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.01e-2)"	5.5	5.3	7.7	3.2	26.1	1.3	4.9	7.9	9.7	5.5	6.6	6.4	3.1	7.0	4.3	3.1	6.3	5.6	8.7	6.8	8.7	7.2	5.8	3.7	2.5	6.6	11.5	5.8	6.2	11.5	7.8	3.7	6.5	4.5	3.9	12.6	3.5	8.2	7.3	2.7	4.1	6.4	5.4	4.7	4.1	4.4	9.3	6.5	9.3	8.2	2.4	5.9	4.3	8.4	3.6	11.0	20.7	8.3	9.7	11.7	2.5	11.7	9.3	10.3	9.6	3.7	3.1	2.2	8.0	6.7	4.1	6.2	7.5	4.1	12.3	25.0	10.0	7.5	5.2	4.7	7.5	7.2	4.9	6.8	5.2	6.7	3.4	12.2	9.6	7.7	4.7	0.1	9.4	2.9	8.2	7.8	10.4	5.6	11.0	7.1	12.0	7.2	8.7	3.2	15.1	9.7	8.5	5.3	5.9	7.8	4.7	4.9	9.3	8.3	4.6	5.6	8.5	6.1	13.7	0.1	4.0	4.9	12.4	0.9	1.4	1.2	1.9	0.8	2.2	0.4	1.0	0.9	1.3	0.2	0.8	0.8	0.6	0.9	0.7	0.8	1.1	1.0	7.7	26.1	7.9	9.7	6.8	8.7	6.6	11.5	6.5	5.4	9.3	8.4	10.0	6.4	7.8	47.7	5.9	3.3	3.9	5.5	5.2	14.4	8.5	7.4	33.9	25.8	5.8	3.7	10.4	7.1	5.0	10.9	7.9	21.7	5.7	12.7	17.5	11.2	18.6	5.5	96.4	4.0	3.7	10.5	7.7	7.3	8.2	10.4	15.0	9.2	3.6	6.7	93.9	7.8	8.2	6.6	3.9	5.0	12.8	4.6	7.2	58.1	3.8	5.5	14.4	76.9	52.9	6.6	4.8	19.2	2.6	1.7	7.2	6.7	10.8	45.0	13.1	18.6	9.3	18.4	8.8	2.6	2.8	1.4	7.6	10.6	6.7	1.5
RIF1	"FLJ10599, FLJ12870"	ENSG00000080345	"Replication timing regulatory factor 1"	Q5UIP0	2	151409883-151508013	"Predicted intracellular proteins"	"Cell cycle, DNA damage, DNA repair"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036887, HPA036888"	Supported		Uncertain	"Nucleoplasm,Nuclear bodies,Plasma membrane"		No	No			"Cluster 27: Non-specific - Gene expression"	"Cluster 34: Non-specific - Transcription"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 52: Non-specific - Transcription"	"Nucleoplasm, Nuclear bodies, Plasma membrane"		"HPA036887: AB_2675361, HPA036888: AB_2675362"	"unprognostic (1.09e-1)"	"unprognostic (2.20e-1)"	"unprognostic (2.71e-1)"	"unprognostic (4.71e-3)"	"unprognostic (5.87e-2)"	"unprognostic (1.79e-2)"	"unprognostic (3.73e-2)"	"unprognostic (1.86e-1)"	"unprognostic (2.51e-2)"	"unprognostic (2.84e-2)"	"unprognostic (1.80e-3)"	"unprognostic (4.07e-2)"	"unprognostic (1.63e-2)"	"unprognostic (1.65e-1)"	"unprognostic (2.22e-1)"	"unprognostic (1.57e-2)"	"unprognostic (8.41e-2)"	6.1	5.0	4.4	7.4	8.4	21.7	10.0	13.8	7.0	6.5	2.6	5.6	4.3	8.2	4.0	5.6	5.6	5.6	3.5	4.6	5.1	5.5	6.7	5.1	8.5	4.4	5.1	11.2	7.0	6.8	3.5	8.0	5.4	6.0	6.1	8.2	7.7	5.0	7.5	7.2	4.6	6.2	4.9	6.5	6.1	11.0	4.5	10.7	9.1	9.5	7.9	7.3	4.6	13.8	20.8	17.4	26.8	20.5	10.7	13.8	25.9	24.8	18.0	21.6	25.5	28.9	16.4	39.2	21.7	17.3	17.9	21.3	41.2	17.1	36.1	27.8	19.8	63.4	21.4	21.0	11.2	64.7	20.2	10.3	11.3	38.8	28.7	12.3	21.3	23.5	52.2	32.6	22.1	13.8	38.3	22.9	43.2	11.2	22.9	38.4	42.1	26.1	11.6	24.9	24.2	18.8	32.0	14.6	16.5	18.8	12.9	23.1	27.0	32.9	22.8	20.3	26.7	16.0	29.6	55.4	15.3	25.5	22.5	6.3	2.5	3.0	4.3	1.7	4.9	4.0	3.6	3.2	1.8	3.1	4.8	3.7	2.8	7.7	3.5	1.6	2.8	1.7	4.4	8.4	13.8	7.0	4.6	5.1	4.4	5.1	5.4	4.9	4.5	13.8	53.1	96.1	49.7	41.1	43.5	49.3	47.5	21.9	33.0	48.2	30.4	29.8	38.2	28.6	38.0	14.7	31.3	39.2	40.3	19.6	1.9	38.5	22.6	38.0	61.7	48.0	25.0	84.3	68.5	21.9	35.9	51.3	34.7	65.0	34.1	88.6	27.1	19.7	23.0	47.1	72.4	30.9	14.2	26.4	27.0	14.0	43.8	37.6	30.2	48.7	44.1	35.8	32.0	73.9	126.3	29.9	23.5	34.3	45.1	53.2	14.9	12.9	21.3	42.8	85.5	106.5	51.2	122.8	113.1	28.9	41.6	40.9	45.3	58.9	34.6	45.4
RILPL2	"FLJ30380, FLJ32372, MGC7036"	ENSG00000150977	"Rab interacting lysosomal protein like 2"	Q969X0	12	123415039-123436684	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"bone marrow: 116.2"	"Cell type enhanced"	"Detected in many"		"B-cells: 149.8;Macrophages: 288.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEL: 103.8;NB-4: 235.2;THP-1: 149.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028958	Approved		Supported	Cytosol		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 24: NB-4 - Immune response"	"Cluster 41: Macrophages - Immune response"	Cytosol		"HPA028958: AB_10602124"	"unprognostic (1.94e-3)"	"unprognostic (3.29e-3)"	"unprognostic (1.02e-1)"	"prognostic favorable (5.24e-7)"	"unprognostic (2.62e-2)"	"unprognostic (8.89e-2)"	"unprognostic (2.18e-1)"	"unprognostic (2.69e-2)"	"unprognostic (4.08e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.97e-1)"	"unprognostic (2.10e-2)"	"unprognostic (5.90e-3)"	"unprognostic (1.11e-1)"	"unprognostic (8.57e-2)"	"unprognostic (2.10e-1)"	"unprognostic (4.74e-2)"	21.4	7.5	9.3	27.4	9.7	116.2	15.8	8.2	11.1	26.3	14.2	6.3	5.4	19.3	11.2	7.6	18.4	15.7	8.2	9.5	10.2	18.6	11.9	24.1	23.8	9.7	9.7	13.1	8.0	11.4	3.5	14.4	9.2	18.6	5.8	1.4	23.2	23.7	4.6	5.5	6.5	13.8	9.1	26.7	10.3	3.2	10.3	15.2	27.8	5.9	17.7	20.5	7.0	8.6	14.2	12.7	4.6	21.8	29.8	23.6	13.3	16.1	41.0	15.3	12.7	16.2	5.5	7.6	15.2	25.1	8.4	9.2	10.3	12.3	14.2	29.1	9.8	103.8	9.9	24.2	33.2	81.2	50.6	18.3	9.3	16.0	11.6	19.8	15.7	20.4	11.1	3.8	12.4	9.4	28.0	235.2	2.9	4.5	13.9	19.8	14.1	15.4	16.0	26.1	1.0	6.7	21.9	0.7	16.9	9.2	19.5	149.0	17.0	12.5	9.2	22.8	9.9	6.2	8.0	18.2	12.3	55.1	5.3	98.6	133.3	159.3	24.0	106.0	22.4	55.8	51.1	42.7	98.7	41.9	19.7	22.5	176.8	22.4	121.5	46.7	67.7	63.8	9.3	9.7	8.2	11.1	9.5	10.2	9.7	9.7	9.2	9.1	10.3	8.6	75.7	35.3	75.2	7.2	149.8	24.5	68.4	67.8	32.5	1.4	45.3	35.9	5.1	17.2	43.3	22.0	2.1	10.1	75.0	2.4	25.4	20.1	2.1	51.9	24.8	73.2	4.2	24.2	7.5	21.0	5.4	28.2	9.2	27.0	62.6	8.4	84.3	13.3	72.9	1.7	2.6	8.1	0.0	112.5	129.7	2.7	50.4	288.7	37.4	10.3	117.8	18.7	42.2	5.5	2.3	22.7	6.4	66.2	25.7	82.6	1.5	63.5	47.1	2.1	6.6	13.1	30.1	1.4	13.0	12.5	15.3	8.1	92.5	10.1	4.8	69.2
RIOK1	"AD034, bA288G3.1, FLJ30006, RRP10"	ENSG00000124784	"RIO kinase 1"	Q9BRS2	6	7389793-7418037	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Ribosome biogenesis"	"Hydrolase, Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017866, HPA051446"	Enhanced		Supported	Cytosol		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	Cytosol		"HPA017866: AB_2669670, HPA051446: AB_2681488"	"unprognostic (2.33e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.38e-1)"	"unprognostic (1.03e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.51e-1)"	"prognostic unfavorable (3.41e-5)"	"unprognostic (2.23e-1)"	"prognostic unfavorable (4.43e-4)"	"unprognostic (3.45e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.87e-1)"	"prognostic unfavorable (5.85e-5)"	"unprognostic (2.33e-1)"	"unprognostic (2.09e-1)"	"unprognostic (6.12e-3)"	"unprognostic (2.59e-2)"	12.1	9.3	4.1	10.8	4.1	20.6	11.0	5.0	5.3	10.0	3.7	7.9	6.5	10.5	5.2	11.4	8.2	7.5	8.0	4.2	5.1	6.4	7.9	7.1	14.0	4.7	5.1	10.9	10.2	7.3	4.7	11.4	4.6	8.0	8.6	7.3	7.0	8.1	11.5	9.1	6.3	10.8	4.2	9.4	7.0	19.9	4.5	15.7	7.3	10.3	15.9	14.9	7.6	4.7	20.4	11.7	18.3	45.8	27.0	22.6	28.7	25.6	16.6	22.1	18.5	33.1	10.0	51.8	43.3	19.7	19.4	20.3	45.7	19.5	29.0	35.8	49.6	28.3	18.3	39.4	23.0	81.5	37.5	17.2	27.2	24.1	50.4	11.5	20.1	38.6	72.1	12.3	21.0	26.7	56.8	50.2	39.6	36.3	26.1	42.9	23.3	56.6	13.8	19.9	60.8	30.4	20.8	13.3	41.6	48.4	18.9	28.4	19.9	24.4	18.9	17.5	38.3	17.1	33.0	75.7	7.7	44.0	38.7	12.0	11.5	9.0	14.9	15.6	18.0	21.5	15.4	15.9	20.5	23.0	17.8	19.2	2.3	26.7	14.0	17.3	16.2	11.3	4.1	4.1	5.0	5.3	4.2	5.1	4.7	5.1	4.6	4.2	4.5	4.7	22.2	6.4	26.4	5.5	27.5	52.8	32.3	29.5	38.1	10.0	18.9	22.0	22.8	4.3	35.2	7.3	10.4	34.1	25.3	9.9	3.9	15.9	74.8	14.9	28.4	24.8	7.2	17.9	10.2	11.7	34.7	29.8	16.8	19.1	33.6	13.4	19.2	10.2	22.6	5.0	12.0	17.4	20.3	11.2	25.1	12.5	19.9	19.7	17.8	11.2	15.1	8.9	6.2	13.0	8.4	12.2	8.2	19.9	27.0	33.7	7.1	9.3	20.9	13.7	19.7	33.8	23.9	58.9	75.4	33.7	64.8	27.9	29.0	23.9	16.9	23.8
RIOX1	"C14orf169, FLJ21802, JMJD9, MAPJD, NO66"	ENSG00000170468	"Ribosomal oxygenase 1"	Q9H6W3	14	73490933-73493394	"Enzymes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, Dioxygenase, Oxidoreductase, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 9.1;dendritic cells: 8.0;Extravillous trophoblasts: 6.9;Hofbauer cells: 8.2;monocytes: 7.2;Proximal tubular cells: 7.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003730			Supported	"Nucleoli rim"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 7: Non-specific - Mitochondria"	"Nucleoli rim"		"HPA003730: AB_2667040"	"unprognostic (4.70e-3)"	"unprognostic (1.94e-2)"	"unprognostic (2.45e-1)"	"unprognostic (2.32e-1)"	"unprognostic (1.84e-3)"	"unprognostic (1.73e-1)"	"unprognostic (2.27e-2)"	"unprognostic (1.48e-1)"	"unprognostic (6.51e-2)"	"unprognostic (5.36e-2)"	"unprognostic (1.35e-3)"	"unprognostic (4.55e-2)"	"unprognostic (2.84e-3)"	"unprognostic (1.05e-1)"	"unprognostic (1.67e-1)"	"unprognostic (7.97e-3)"	"unprognostic (8.62e-2)"	3.8	4.2	5.1	5.1	4.5	7.8	3.7	6.5	5.0	3.7	4.6	4.5	3.9	5.3	4.8	5.5	4.4	2.4	4.9	4.5	4.9	4.2	6.8	3.9	6.7	4.3	4.1	3.8	6.4	5.4	3.5	2.8	4.1	3.3	3.7	1.9	4.6	3.8	3.6	4.0	5.1	4.0	3.7	5.6	4.9	13.6	4.9	9.4	3.4	3.0	6.9	4.5	3.3	5.7	17.5	15.5	9.9	15.3	12.5	7.0	19.0	11.7	8.5	11.8	10.6	13.5	8.8	29.7	8.4	10.1	9.9	20.4	19.1	11.6	9.8	19.0	21.0	18.7	9.0	9.0	6.9	0.0	24.1	7.6	10.6	11.4	5.2	7.5	10.8	17.0	13.8	10.7	10.7	27.6	33.1	21.4	10.8	15.1	26.0	26.1	15.4	9.0	11.8	12.9	20.5	14.8	19.4	34.4	12.7	9.8	34.4	18.6	15.6	0.0	19.5	10.2	0.1	14.6	16.9	10.2	5.2	15.3	11.8	0.1	1.3	3.4	3.7	2.3	4.3	2.3	3.6	2.9	1.8	1.6	3.3	2.5	0.5	3.2	1.4	3.1	1.7	0.8	5.1	4.5	6.5	5.0	4.5	4.9	4.3	4.1	4.1	3.7	4.9	5.7	2.9	3.2	1.1	0.0	2.0	0.0	0.0	0.0	0.0	0.0	5.4	3.2	0.0	0.0	3.1	5.5	0.0	9.1	8.0	0.0	5.9	3.8	0.0	4.2	4.0	2.1	0.0	0.0	0.0	5.7	6.9	1.5	0.0	4.7	2.5	5.2	0.0	0.0	8.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	7.2	0.0	0.0	0.0	0.0	3.4	0.0	0.0	1.2	0.0	0.0	7.6	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	1.4	3.4	3.5	0.0	0.0
RIOX2	"FLJ14393, JMJD10, mdig, MINA, MINA53, NO52"	ENSG00000170854	"Ribosomal oxygenase 2"	Q8IUF8	3	97941818-97972457	"Predicted intracellular proteins"	"Ribosome biogenesis, Transcription, Transcription regulation"	"Dioxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 33.7;Distal tubular cells: 49.0;Endometrial ciliated cells: 25.7;Extravillous trophoblasts: 43.5;Syncytiotrophoblasts: 31.2;Theca cells: 24.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 109.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007603, HPA008080, CAB013458"	Supported		Supported	Nucleoplasm,Nucleoli		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 7: Non-specific - Mitochondria"	"Nucleoplasm, Nucleoli"		"CAB013458: AB_2533432, HPA007603: AB_1853957, HPA008080: AB_1853960"	"prognostic unfavorable (4.41e-4)"	"unprognostic (8.64e-2)"	"unprognostic (1.59e-3)"	"unprognostic (2.11e-2)"	"unprognostic (1.26e-1)"	"unprognostic (2.53e-3)"	"unprognostic (1.64e-3)"	"unprognostic (8.68e-2)"	"unprognostic (9.68e-2)"	"unprognostic (5.34e-2)"	"unprognostic (1.56e-3)"	"unprognostic (6.95e-2)"	"unprognostic (1.35e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.49e-1)"	"unprognostic (3.44e-3)"	"unprognostic (1.76e-1)"	14.6	9.7	9.8	14.5	11.3	2.2	13.9	9.5	11.2	11.6	8.3	12.4	6.9	10.7	10.6	22.3	10.4	7.3	10.1	9.5	12.3	14.4	14.3	11.0	14.2	12.4	12.4	10.4	18.2	10.8	10.2	15.6	12.0	10.4	12.3	16.8	19.8	9.6	32.0	17.8	10.3	10.4	12.9	8.4	12.8	6.7	10.9	6.9	46.4	11.3	15.0	16.4	15.5	13.6	42.6	27.8	9.1	17.4	20.5	30.3	22.8	20.1	14.3	22.0	18.5	18.6	22.8	59.7	21.2	25.1	34.3	24.3	28.9	28.2	32.5	109.9	13.8	19.2	13.5	19.1	33.4	37.1	7.0	24.5	38.8	17.6	44.4	13.1	23.9	26.4	26.2	23.3	22.1	11.5	29.7	14.5	19.9	47.3	34.4	0.0	32.2	58.7	21.4	24.1	49.6	17.6	25.7	28.7	34.4	10.1	24.7	15.3	16.3	22.9	24.0	13.7	39.9	37.7	18.3	55.5	29.1	37.8	23.8	1.9	13.2	0.7	10.3	11.9	15.8	15.9	14.9	12.0	16.9	13.3	15.0	12.5	0.8	10.8	15.8	26.0	15.2	10.5	9.8	11.3	9.5	11.2	9.5	12.3	12.4	12.4	12.0	12.9	10.9	13.6	18.3	9.6	14.1	0.0	4.0	0.0	0.0	0.0	0.0	0.0	14.9	11.2	0.0	0.0	10.5	7.3	0.0	33.7	5.7	0.0	49.0	16.4	0.0	25.7	14.9	5.8	0.0	0.0	0.0	13.2	43.5	7.3	0.0	12.6	2.5	20.2	0.0	0.0	12.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.3	0.0	0.0	7.2	0.0	0.0	0.0	0.0	10.9	0.0	0.0	0.5	0.0	0.0	11.6	13.8	0.0	0.0	0.0	6.5	0.0	0.0	0.0	0.0	31.2	2.2	24.8	0.0	0.0
RIT2	"RIBA, RIN"	ENSG00000152214	"Ras like without CAAX 2"	Q99578	18	42743227-43115691	"Enzymes, Predicted intracellular proteins"		"Calmodulin-binding, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"brain: 25.9"	"Group enriched"	"Detected in some"	5	"Excitatory neurons: 225.8;Oligodendrocyte precursor cells: 202.5"	"Cancer enriched"	"Detected in single"	49	"glioma: 4.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"							"HPA072174, HPA072526"	Enhanced		Supported	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA				"Cluster 69: Cerebellum - Gene expression regulation"		"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Nucleoplasm	"Golgi apparatus, Cytosol"	"HPA072174: AB_2732195, HPA072526: "					"unprognostic (1.37e-2)"							"unprognostic (4.15e-1)"			"unprognostic (2.14e-1)"			0.0	1.9	9.3	0.1	10.6	0.0	0.0	25.9	16.8	0.1	5.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.8	13.3	0.0	0.0	0.0	0.0	12.8	9.2	0.0	0.0	0.0	0.5	0.0	17.4	0.0	0.1	1.9	0.0	0.0	0.0	0.0	0.1	0.0	8.9	0.0	0.0	0.2	11.6	0.0	0.0	0.0	0.0	0.0	0.2	8.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.3	10.6	25.9	16.8	8.8	13.3	12.8	9.2	17.4	8.9	11.6	8.8	0.0	0.0	0.0	5.5	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.8	0.2	0.0	0.1	0.0	0.0	225.8	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	42.5	0.0	0.0	0.0	0.0	1.4	0.3	0.0	0.0	3.7	0.0	1.0	0.0	202.5	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.1	1.4	0.2	0.0	0.0	2.1	0.0	0.5	0.0	0.0
RITA1	"C12orf52, FLJ14827, RITA"	ENSG00000139405	"RBPJ interacting and tubulin associated 1"	Q96K30	12	113185526-113192368	"Predicted intracellular proteins"	"Neurogenesis, Notch signaling pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 49.0;Proximal enterocytes: 62.0;Proximal tubular cells: 51.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039094, HPA039095, HPA061531"	Supported		Supported	Nucleoplasm		No	No			"Cluster 10: Basophils - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Nucleoplasm		"HPA039094: AB_10671037, HPA039095: AB_2676345, HPA061531: AB_2684554"	"unprognostic (7.10e-2)"	"unprognostic (4.26e-2)"	"unprognostic (2.78e-2)"	"unprognostic (3.55e-2)"	"unprognostic (2.56e-2)"	"unprognostic (6.98e-2)"	"prognostic unfavorable (9.79e-4)"	"unprognostic (3.47e-2)"	"unprognostic (2.92e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.30e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.98e-1)"	"unprognostic (2.59e-3)"	"unprognostic (1.44e-1)"	"unprognostic (2.93e-1)"	"unprognostic (2.01e-1)"	6.8	25.4	17.0	7.1	17.4	7.1	7.7	16.0	20.2	8.7	14.6	9.7	13.1	8.1	6.4	14.3	14.0	5.9	15.0	17.5	15.7	15.9	29.6	6.9	11.1	15.1	15.3	10.6	10.6	9.5	12.6	4.7	15.2	10.1	5.9	4.4	13.7	8.3	31.7	10.8	14.2	4.6	12.6	9.5	8.8	7.4	16.9	9.7	10.4	27.2	8.2	8.5	8.1	15.3	27.0	34.3	8.7	23.0	11.5	8.8	15.6	17.2	35.3	24.9	19.8	40.7	13.0	50.8	26.0	14.6	21.4	20.0	20.0	22.3	14.4	31.3	28.4	17.4	16.6	26.6	18.7	23.4	14.0	13.6	20.2	24.6	13.8	34.5	20.7	24.7	34.0	9.2	14.9	38.6	26.1	63.1	29.2	22.9	41.8	23.2	9.3	43.2	20.3	37.8	28.9	16.6	21.7	45.2	38.2	10.6	38.2	35.5	13.7	15.7	22.3	18.2	24.7	31.6	28.6	56.0	23.4	19.4	22.5	43.7	14.6	9.9	15.3	6.6	15.3	11.0	13.5	13.9	16.5	11.8	13.2	14.6	0.3	20.7	8.6	22.5	16.1	13.5	17.0	17.4	16.0	20.2	17.5	15.7	15.1	15.3	15.2	12.6	16.9	15.3	8.1	0.0	11.3	2.9	11.1	6.4	7.1	14.0	7.4	7.4	14.7	14.7	6.6	12.8	9.1	14.7	4.2	19.3	9.8	17.0	49.0	19.2	10.8	16.7	7.3	9.3	11.4	8.8	6.5	16.4	16.9	7.0	8.2	7.3	0.0	8.7	8.6	37.5	14.2	15.2	6.7	12.5	8.2	7.8	2.4	29.6	9.9	6.3	5.4	2.8	5.9	11.0	19.6	2.0	3.7	15.2	12.9	8.2	14.7	10.1	62.0	51.9	17.1	6.0	6.6	7.7	7.5	4.5	7.8	13.8	6.5	10.1	9.0	17.2	12.7	7.5
RLBP1	CRALBP	ENSG00000140522	"Retinaldehyde binding protein 1"	P12271	15	89209869-89221614	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"	"Sensory transduction, Transport, Vision"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	13	"retina: 265.6"	"Cell type enriched"	"Detected in some"	34	"Muller glia cells: 3148.2"	"Group enriched"	"Detected in some"	30	"glioma: 3.7;melanoma: 7.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	53	"SK-MEL-30: 22.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042051, HPA044083"	Enhanced	Approved	Supported	Nucleoplasm,Centrosome,Cytosol		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 77: Retina - Visual perception"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 5: Muller glia cells - Visual perception"	Cytosol	"Nucleoplasm, Centrosome"	"HPA042051: AB_2732495, HPA044083: AB_2678802"	"unprognostic (3.19e-2)"	"unprognostic (2.66e-1)"	"unprognostic (1.86e-1)"	"unprognostic (1.25e-1)"	"unprognostic (8.68e-2)"	"unprognostic (1.76e-1)"		"unprognostic (8.24e-3)"	"unprognostic (5.21e-2)"	"unprognostic (3.17e-1)"	"unprognostic (2.63e-2)"	"unprognostic (1.76e-1)"		"unprognostic (2.78e-1)"	"unprognostic (1.13e-1)"		"unprognostic (8.42e-2)"	0.0	0.2	14.9	0.1	16.9	0.1	0.0	15.0	20.8	0.0	16.7	1.6	0.2	0.0	0.2	0.0	0.0	0.0	0.0	15.7	14.5	0.0	0.0	0.0	0.0	14.5	14.2	0.0	0.0	0.0	2.6	0.0	14.3	0.0	0.1	265.6	0.0	0.0	0.1	0.0	0.4	0.1	14.0	0.0	0.2	0.9	14.9	0.0	0.0	0.1	0.0	0.0	0.0	14.9	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	14.9	16.9	15.0	20.8	15.7	14.5	14.5	14.2	14.3	14.0	14.9	14.9	0.0	0.0	0.0	19.6	0.0	0.0	0.0	0.0	0.0	21.4	0.0	0.0	0.3	0.0	0.0	0.0	39.6	4.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	2.5	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	5.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.9	2.0	3148.2	0.0	5.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	90.9	0.0	0.0	0.0	0.2	0.2	0.0	0.0	20.0	0.0	0.0	0.0	0.0
RLIM	"MGC15161, NY-REN-43, RNF12"	ENSG00000131263	"Ring finger protein, LIM domain interacting"	Q9NVW2	X	74582976-74614624	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"Transcription, Transcription regulation, Ubl conjugation pathway"	Transferase	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018895	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 41: Macrophages - Immune response"	Nucleoplasm	Cytosol	"HPA018895: AB_1856323"	"unprognostic (1.17e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.31e-3)"	"unprognostic (1.25e-1)"	"unprognostic (1.03e-1)"	"unprognostic (8.98e-3)"	"unprognostic (1.36e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.06e-1)"	"unprognostic (1.12e-1)"	"unprognostic (4.91e-2)"	"unprognostic (2.25e-1)"	"unprognostic (3.82e-2)"	"unprognostic (1.24e-1)"	"prognostic unfavorable (6.04e-4)"	"unprognostic (1.20e-1)"	11.3	11.8	10.6	10.4	11.7	41.2	10.5	5.9	9.9	10.0	10.0	6.8	5.9	9.5	5.6	8.7	8.4	9.6	8.8	11.2	15.1	10.0	8.3	12.1	8.9	8.5	10.3	10.6	7.5	11.7	10.3	9.8	10.3	9.8	6.6	10.7	7.4	7.1	9.6	9.4	6.1	9.3	7.3	9.3	7.4	6.5	12.6	11.0	11.7	8.6	9.5	8.5	8.0	8.2	23.7	24.2	22.8	18.7	20.1	22.5	22.4	22.4	26.0	19.9	24.4	18.9	24.4	12.8	25.4	28.6	26.7	19.9	45.9	26.7	30.1	11.7	23.9	22.7	43.2	10.7	17.4	34.6	38.6	21.7	14.4	28.2	46.5	15.6	23.3	20.9	19.9	22.9	24.6	18.1	26.0	16.8	35.0	12.9	22.5	24.3	48.0	21.5	16.1	28.6	16.4	19.5	42.3	19.0	24.5	20.4	11.2	24.9	31.0	23.4	23.1	24.8	19.6	12.0	24.6	20.3	25.5	33.1	23.2	22.8	6.0	5.9	3.1	7.5	3.1	3.0	3.9	3.8	4.9	3.3	4.2	3.8	11.5	5.3	5.6	2.6	4.8	3.2	10.6	11.7	5.9	9.9	11.2	15.1	8.5	10.3	10.3	7.3	12.6	8.2	44.8	16.0	17.0	13.4	22.4	35.8	29.6	16.1	23.3	13.8	18.3	13.5	30.5	18.6	20.4	25.8	14.6	16.3	27.6	10.3	11.7	13.7	7.9	32.3	35.3	30.1	23.2	12.8	19.2	10.7	21.5	27.7	27.0	41.0	38.0	24.6	21.0	14.8	18.2	21.9	18.9	10.6	10.2	20.7	34.1	4.4	9.9	29.1	17.8	15.9	12.7	13.2	12.3	11.1	16.4	14.8	8.5	18.8	16.3	25.5	6.8	12.0	25.2	14.6	6.6	31.1	24.1	9.7	18.2	21.6	38.8	26.3	22.0	19.0	11.4	37.2
RMDN1	"CGI-90, FAM82B, FLJ20665, RMD1"	ENSG00000176623	"Regulator of microtubule dynamics 1"	Q96DB5	8	86468257-86514357	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026495	Approved		Supported	"Actin filaments,Centrosome"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 39: Non-specific - Basic cellular processes"	Centrosome	"Actin filaments"	"HPA026495: AB_1848414"	"unprognostic (1.68e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.46e-1)"	"unprognostic (3.13e-3)"	"unprognostic (1.76e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.81e-2)"	"unprognostic (1.68e-1)"	"unprognostic (3.02e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.60e-1)"	"prognostic favorable (8.51e-4)"	"unprognostic (2.08e-1)"	"unprognostic (7.15e-2)"	"unprognostic (4.71e-3)"	"unprognostic (3.47e-1)"	35.6	26.1	25.8	20.9	30.1	24.7	24.3	30.4	27.8	15.5	25.3	26.7	28.7	17.6	19.8	29.4	21.1	22.5	63.0	23.0	29.5	51.7	56.8	23.4	30.3	29.8	29.7	17.0	17.5	26.3	12.9	18.9	30.0	21.2	29.0	30.9	16.4	20.7	71.7	32.8	29.2	20.2	28.3	25.2	30.6	26.4	29.6	23.0	50.4	70.5	31.5	20.1	16.3	30.5	64.0	27.1	31.3	17.8	60.3	97.8	38.5	45.9	41.1	35.8	34.6	32.2	39.9	76.2	38.1	38.2	33.2	61.0	39.8	46.0	42.1	64.6	31.9	40.2	32.8	82.1	32.1	18.4	1.0	53.3	42.6	47.6	72.9	63.9	81.6	44.3	42.4	40.7	57.5	57.3	65.1	8.6	15.9	111.3	67.5	36.6	43.6	78.9	42.5	39.3	14.8	32.8	38.2	149.2	67.6	32.5	83.9	33.6	44.6	39.5	64.0	50.8	28.2	52.4	46.5	59.7	51.2	28.7	54.4	16.4	38.5	94.2	26.6	50.7	31.1	42.2	27.1	31.3	45.2	30.8	22.3	29.0	15.5	39.0	70.3	51.3	43.2	30.7	25.8	30.1	30.4	27.8	23.0	29.5	29.8	29.7	30.0	28.3	29.6	30.5	24.0	41.7	39.0	38.8	23.8	13.5	13.2	40.1	22.2	14.5	16.8	15.0	117.3	20.0	42.4	20.2	16.7	42.5	29.9	22.2	49.0	42.9	97.8	28.3	26.6	24.3	10.2	27.3	22.5	53.0	57.1	24.0	32.1	24.8	1.3	18.9	21.8	57.7	53.7	20.2	29.9	20.6	18.3	40.1	14.8	77.1	13.1	28.3	16.0	33.7	48.5	27.4	21.6	42.3	51.9	45.8	17.2	9.1	21.8	9.2	45.7	73.0	34.4	21.5	0.0	19.9	32.9	65.7	33.5	31.0	15.5	28.5	21.6	53.1	26.9	15.2
RMDN2	"FAM82A, FAM82A1, FLJ32954, RMD2"	ENSG00000115841	"Regulator of microtubule dynamics 2"	Q96LZ7	2	37923187-38067142	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 42.5"	"Group enriched"	"Detected in many"	4	"Early spermatids: 270.4;Late spermatids: 163.5;Theca cells: 77.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			"HPA034705, HPA034706"	Enhanced		Supported	"Golgi apparatus,Mitotic spindle,Cytosol"		Yes	No			"Cluster 27: Non-specific - Gene expression"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	"Mitotic spindle, Cytosol"	"Golgi apparatus"	"HPA034705: AB_2674292, HPA034706: AB_10696362"	"unprognostic (1.34e-1)"	"unprognostic (2.61e-1)"	"unprognostic (4.03e-2)"	"unprognostic (1.71e-3)"	"unprognostic (2.49e-2)"	"unprognostic (1.76e-1)"	"unprognostic (3.06e-2)"	"prognostic favorable (2.63e-4)"	"unprognostic (7.85e-2)"	"unprognostic (9.96e-2)"	"unprognostic (7.50e-2)"	"unprognostic (1.94e-1)"	"unprognostic (2.88e-2)"	"unprognostic (5.08e-3)"	"unprognostic (1.20e-1)"	"unprognostic (4.34e-3)"	"unprognostic (3.34e-1)"	4.6	42.5	3.8	4.1	3.5	3.4	5.3	4.8	4.5	7.7	2.9	12.4	8.4	5.1	9.2	3.4	3.9	6.2	4.4	4.1	2.6	7.8	29.2	11.3	4.6	3.9	2.6	2.8	4.1	3.2	3.0	3.9	2.6	7.2	10.6	4.2	3.7	12.8	5.1	2.9	13.9	5.8	3.0	20.0	4.4	21.7	3.6	5.9	5.4	3.2	2.9	4.3	3.5	3.7	3.3	4.7	2.6	1.8	10.4	11.4	1.5	7.0	9.3	3.6	3.2	1.1	10.9	2.2	2.8	9.9	2.2	3.5	0.8	5.1	4.9	5.0	3.0	3.6	1.6	3.1	5.3	0.0	3.8	16.2	4.6	4.5	0.7	5.4	2.0	1.8	4.4	2.1	6.8	1.3	0.9	4.5	5.1	6.5	3.8	0.0	0.8	0.6	9.0	2.7	2.1	7.5	5.7	0.7	7.3	2.2	1.1	5.9	3.8	4.4	5.1	2.5	2.6	3.8	7.7	4.6	5.4	1.1	4.6	0.0	2.8	0.7	2.0	4.6	3.1	4.1	1.0	1.3	1.8	2.3	1.0	2.2	2.7	3.7	3.5	3.4	0.1	1.4	3.8	3.5	4.8	4.5	4.1	2.6	3.9	2.6	2.6	3.0	3.6	3.7	3.4	28.9	29.6	25.1	6.5	2.4	6.8	16.3	8.6	3.5	1.9	4.2	5.3	11.5	20.0	5.5	2.1	2.1	6.0	20.9	7.9	5.4	270.4	3.7	11.8	4.6	4.8	3.0	33.8	3.8	1.0	9.2	2.6	3.1	15.8	13.1	5.3	15.5	4.7	5.0	24.5	11.4	6.1	6.3	1.7	163.5	9.3	4.8	5.4	19.7	4.4	4.7	6.2	39.2	7.1	2.5	6.1	6.0	1.8	2.2	29.6	6.7	10.2	2.6	6.6	6.4	5.1	9.4	4.8	1.7	2.4	0.8	3.9	77.6	15.2	2.3
RMI1	"BLAP75, C9orf76, FLJ12888"	ENSG00000178966	"RecQ mediated genome instability 1"	Q9H9A7	9	83980798-84004074	"Predicted intracellular proteins"	"DNA replication"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 70.0;Late spermatids: 62.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021661			Supported	"Nucleoplasm,Nuclear bodies"		NA	Yes			"Cluster 2: Granulocytes - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 34: Spermatids - Unknown function"	"Nucleoplasm, Nuclear bodies"		"HPA021661: "	"unprognostic (9.59e-2)"	"unprognostic (7.96e-2)"	"unprognostic (6.72e-3)"	"unprognostic (3.03e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.90e-2)"	"prognostic unfavorable (8.71e-4)"	"unprognostic (2.65e-1)"	"unprognostic (3.39e-3)"	"unprognostic (1.32e-1)"	"unprognostic (5.55e-2)"	"unprognostic (2.26e-1)"	"unprognostic (1.53e-1)"	"unprognostic (3.68e-3)"	"unprognostic (3.42e-1)"	"unprognostic (2.42e-1)"	"unprognostic (9.24e-2)"	2.5	8.3	2.9	6.0	3.2	3.9	4.5	4.6	3.4	3.2	6.0	6.6	6.2	3.5	5.6	4.9	5.8	2.8	3.4	2.4	5.8	4.4	5.8	3.3	10.2	3.3	3.3	4.4	5.8	7.7	3.7	3.6	3.5	4.8	7.4	7.0	6.0	3.1	3.7	5.1	6.8	3.3	3.2	6.4	6.2	8.9	3.8	10.2	6.0	3.9	9.6	3.6	2.4	3.8	25.2	14.9	33.6	12.4	5.5	7.7	33.9	24.1	13.6	20.7	19.4	7.5	17.0	55.4	8.5	12.4	21.7	36.9	22.0	12.3	25.3	29.2	6.1	23.0	12.1	11.8	7.7	42.6	23.1	7.4	7.8	17.6	12.6	6.7	11.1	28.2	16.7	26.3	23.2	18.1	54.4	17.4	31.3	31.6	15.7	47.8	33.9	21.0	10.8	10.4	30.4	19.3	21.3	18.6	9.8	15.4	19.4	20.8	6.6	22.9	14.7	23.2	20.1	11.6	25.6	20.2	14.6	19.7	26.4	14.2	4.5	8.8	1.8	5.5	2.2	2.8	2.1	1.9	7.2	2.6	2.2	2.5	7.8	2.8	6.5	2.2	3.0	2.6	2.9	3.2	4.6	3.4	2.4	5.8	3.3	3.3	3.5	3.2	3.8	3.8	5.4	9.6	5.1	10.1	5.9	2.7	3.2	4.3	4.0	4.1	4.3	3.3	8.5	2.8	9.0	1.8	4.2	7.9	2.1	6.1	5.9	5.5	70.0	13.9	6.5	3.8	6.7	24.4	7.1	3.0	16.2	3.3	8.2	10.2	4.5	9.0	5.0	13.3	8.1	10.1	11.2	9.8	0.0	10.7	4.3	62.1	2.1	7.4	12.4	8.4	8.5	7.7	5.2	26.2	12.6	2.7	5.6	2.2	7.8	4.2	8.9	4.9	11.1	5.2	0.0	3.3	3.4	34.0	22.6	6.9	4.8	4.2	4.4	7.7	10.1	2.4
RMI2	"BLAP18, C16orf75, MGC24665"	ENSG00000175643	"RecQ mediated genome instability 2"	Q96E14	16	11249619-11381662	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"DNA replication"	DNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 36.8"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 123.8;Erythroid cells: 38.5;Extravillous trophoblasts: 34.1;Peritubular cells: 42.5;Spermatocytes: 36.6;Spermatogonia: 51.8;Syncytiotrophoblasts: 47.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"memory B-cell: 4.2"	"Group enriched"	"Detected in many"	6	"B-cells: 4.2;T-cells: 1.4"	"Low cell line specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA040995	Uncertain		Supported	"Nuclear speckles,Cytosol"		NA	Yes			"Cluster 37: B-cells - Transcription"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Nuclear speckles"	Cytosol	"HPA040995: AB_10795531"	"unprognostic (2.76e-1)"	"prognostic favorable (5.69e-5)"	"unprognostic (1.17e-1)"	"unprognostic (3.09e-3)"	"unprognostic (1.69e-2)"	"unprognostic (1.80e-3)"	"prognostic unfavorable (2.77e-5)"	"unprognostic (3.98e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.83e-1)"	"unprognostic (3.44e-3)"	"unprognostic (3.89e-1)"	"unprognostic (2.18e-1)"	"unprognostic (5.50e-2)"	"unprognostic (3.68e-2)"	"unprognostic (3.60e-3)"	"unprognostic (1.03e-1)"	1.4	1.5	2.2	12.3	2.0	9.9	5.1	1.0	2.2	4.8	0.9	12.5	7.5	2.9	3.9	10.8	2.1	2.2	1.6	2.3	1.3	3.4	4.3	1.9	31.4	1.2	1.3	3.0	1.8	1.3	0.6	19.3	1.2	3.2	14.4	0.5	2.4	2.1	0.9	10.2	8.8	2.3	1.0	3.5	7.0	14.0	1.4	36.8	1.5	0.6	34.9	4.5	4.4	1.8	60.3	39.5	75.2	32.6	3.3	15.8	33.0	35.9	26.8	31.6	51.8	15.4	69.2	83.8	29.1	15.8	35.3	34.4	32.4	32.5	50.5	16.6	30.5	45.3	22.6	102.5	1.3	17.6	19.5	3.7	6.1	14.5	13.3	12.3	17.4	36.2	65.3	63.2	16.5	70.3	60.9	83.1	64.1	82.6	15.7	73.1	81.1	89.3	18.7	38.0	44.1	35.0	28.5	47.4	26.1	43.5	80.4	25.8	5.6	25.1	23.3	49.3	5.0	18.1	30.9	99.3	23.3	57.4	47.2	0.0	0.0	0.4	0.3	0.0	0.0	4.2	0.1	0.0	0.2	1.1	0.8	0.3	0.1	0.1	0.0	0.2	1.4	0.1	2.2	2.0	1.0	2.2	2.3	1.3	1.2	1.3	1.2	1.0	1.4	1.8	1.3	0.0	0.5	0.0	4.5	6.8	5.4	1.4	6.2	0.2	3.4	3.2	1.0	4.3	1.6	7.3	0.0	123.8	0.5	3.3	5.9	2.6	3.0	0.8	2.1	2.8	2.4	38.5	0.0	0.5	34.1	6.4	4.1	2.2	0.0	19.7	1.1	1.1	18.5	0.0	0.0	7.7	0.0	0.8	6.5	5.9	15.8	3.7	3.6	0.0	1.1	0.2	1.0	0.0	0.0	1.0	4.0	42.5	2.4	2.1	1.3	0.4	0.1	0.6	32.9	0.0	2.2	36.6	51.8	11.3	5.4	47.7	1.9	6.5	10.3	7.5
RMND1	"bA351K16.3, C6orf96, FLJ20627, RMD1"	ENSG00000155906	"Required for meiotic nuclear division 1 homolog"	Q9NWS8	6	151404762-151452158	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Protein biosynthesis"		"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031397, HPA031398, HPA031399"	Approved		Supported	Mitochondria		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 81: Kidney & Liver - Metabolism"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	Mitochondria		"HPA031397: AB_2673861, HPA031398: AB_2673862, HPA031399: AB_10601156"	"unprognostic (1.12e-1)"	"unprognostic (4.45e-2)"	"unprognostic (9.70e-3)"	"unprognostic (6.67e-2)"	"unprognostic (2.65e-2)"	"prognostic unfavorable (6.96e-4)"	"unprognostic (1.50e-3)"	"unprognostic (6.56e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.73e-1)"	"unprognostic (2.03e-1)"	"unprognostic (3.57e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.80e-1)"	"unprognostic (9.74e-2)"	"unprognostic (1.04e-1)"	12.6	13.9	7.7	6.4	8.1	4.4	13.6	7.8	8.9	9.9	8.2	10.3	13.4	8.9	11.7	7.5	11.9	8.0	12.1	7.8	8.6	36.9	30.5	7.5	9.2	8.2	8.1	14.6	9.5	8.9	6.3	9.6	8.4	6.8	11.3	7.1	7.1	7.7	10.9	7.7	12.1	7.5	8.0	7.3	8.0	9.1	8.6	8.1	18.6	10.0	10.1	9.2	8.1	8.2	16.0	7.2	15.1	32.3	20.6	46.7	21.3	24.6	23.4	18.6	25.4	21.5	11.7	14.9	17.4	16.1	23.1	13.5	29.3	14.9	32.1	17.7	23.8	24.1	11.0	44.5	43.4	53.9	7.2	33.4	19.5	26.9	39.7	22.8	25.0	22.6	26.3	11.5	29.0	54.1	18.6	18.1	11.1	16.8	14.3	21.0	19.7	18.2	26.7	7.2	26.1	25.5	17.9	22.2	29.5	18.6	36.6	34.8	13.8	14.6	19.0	30.6	20.0	12.1	17.5	17.6	36.7	42.3	17.5	1.9	5.6	7.1	6.4	8.2	10.4	11.6	7.6	9.1	7.0	8.9	10.1	9.3	2.8	13.3	13.3	3.2	11.8	4.5	7.7	8.1	7.8	8.9	7.8	8.6	8.2	8.1	8.4	8.0	8.6	8.2	11.6	0.0	11.2	12.1	6.9	3.8	6.4	10.2	9.1	8.9	15.4	13.7	11.9	5.7	11.9	12.9	12.5	27.0	7.4	7.6	17.6	15.6	9.4	10.9	18.4	7.8	3.0	8.0	22.4	10.7	21.7	8.8	4.1	12.4	9.5	25.0	10.8	16.7	13.7	5.0	20.6	9.7	6.1	12.5	5.7	6.4	6.8	9.8	3.6	8.4	12.3	7.7	10.3	15.6	21.7	9.9	11.2	6.4	5.8	3.6	33.8	45.1	9.3	6.9	0.0	6.7	14.9	13.0	16.8	8.3	2.7	16.8	8.4	27.3	15.3	5.3
RMND5A	"FLJ13910, GID2, GID2A, p44CTLH, RMD5"	ENSG00000153561	"Required for meiotic nuclear division 5 homolog A"	Q9H871	2	86720291-86778041	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046795, HPA060843"	Uncertain		Supported	Nucleoplasm		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 6: Erythroid cells - Oxygen transport"	Nucleoplasm		"HPA046795: AB_10963573, HPA060843: AB_2684378"	"unprognostic (4.54e-2)"	"unprognostic (9.23e-2)"	"unprognostic (3.45e-2)"	"prognostic unfavorable (3.03e-4)"	"unprognostic (2.32e-2)"	"unprognostic (4.40e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.37e-1)"	"unprognostic (3.00e-2)"	"unprognostic (1.49e-2)"	"unprognostic (1.04e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.29e-2)"	"unprognostic (8.34e-3)"	"unprognostic (1.41e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.56e-1)"	17.8	11.2	19.4	9.3	24.3	31.2	16.2	54.5	25.2	13.4	20.0	19.7	16.4	13.0	13.3	31.3	12.9	6.8	38.2	21.6	17.5	18.2	42.9	10.5	11.6	18.4	20.6	11.1	11.6	20.8	7.9	11.6	18.3	12.4	21.2	18.9	11.4	11.1	63.6	22.4	15.5	13.7	20.4	14.3	12.1	7.8	18.7	31.4	13.0	37.0	14.0	10.0	17.0	28.8	19.4	10.2	17.6	10.5	22.9	10.1	36.3	7.5	6.1	9.7	11.0	37.6	20.3	66.7	22.4	6.9	11.3	22.6	45.1	15.8	15.0	19.4	34.4	58.7	21.8	34.2	23.1	43.2	18.6	15.4	30.5	10.2	35.2	11.0	17.0	48.7	37.7	37.3	7.9	12.6	40.1	36.9	29.8	23.1	13.0	47.3	54.2	42.3	20.1	22.8	32.6	25.1	16.9	33.5	27.9	24.8	16.8	36.8	16.3	6.7	12.9	12.2	11.7	16.7	18.8	45.0	5.6	51.3	7.8	37.5	11.9	8.1	8.1	10.1	9.7	4.7	6.2	9.1	9.4	6.4	8.4	11.6	27.5	8.8	12.5	7.4	4.7	8.6	19.4	24.3	54.5	25.2	21.6	17.5	18.4	20.6	18.3	20.4	18.7	28.8	32.8	12.8	15.9	15.3	27.0	41.9	23.4	10.4	46.7	26.3	25.5	15.6	93.2	24.3	10.5	11.0	6.2	21.0	36.2	73.3	23.5	13.1	13.7	33.8	28.7	26.0	39.5	105.2	27.3	14.1	18.6	20.1	24.5	35.3	8.2	16.3	25.0	76.7	15.1	23.5	27.2	57.4	14.2	34.4	42.7	5.6	19.3	26.3	32.0	14.0	23.7	15.3	30.9	10.6	42.3	21.9	30.9	17.3	30.1	34.8	38.1	34.4	26.6	16.3	6.6	22.7	20.1	17.9	27.8	50.0	54.8	24.6	31.4	24.6	28.7	34.0
RNASEL	"PRCA1, RNS4"	ENSG00000135828	"Ribonuclease L"	Q05823	1	182573634-182589256	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Antiviral defense"	"Endonuclease, Hydrolase, Nuclease, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002633, CAB010906"	Approved		Supported	Cytosol		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 34: Non-specific - Transcription"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Cytosol		"CAB010906: AB_477444, HPA002633: AB_1856314"	"unprognostic (3.46e-2)"	"unprognostic (9.10e-2)"	"unprognostic (7.74e-2)"	"unprognostic (1.13e-1)"	"unprognostic (9.29e-2)"	"unprognostic (1.57e-1)"	"unprognostic (6.14e-2)"	"unprognostic (1.42e-1)"	"unprognostic (3.89e-2)"	"unprognostic (1.93e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.02e-1)"	"unprognostic (5.43e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.59e-1)"	"unprognostic (1.81e-1)"	5.6	6.4	3.2	8.8	3.5	3.6	5.9	3.4	3.9	6.6	3.7	8.1	7.0	6.5	9.6	6.2	5.2	6.9	3.4	2.9	3.4	6.2	3.5	6.9	9.6	3.4	3.5	11.3	3.1	7.9	5.4	6.9	3.6	7.2	9.0	5.7	5.0	8.3	2.0	5.4	8.0	7.1	2.8	8.9	7.8	2.2	3.6	8.0	9.1	4.5	9.9	6.0	6.3	3.3	2.6	3.6	1.5	0.6	7.9	13.7	2.8	4.9	6.1	4.9	4.5	2.1	5.6	5.6	8.4	5.6	2.2	4.7	3.6	5.1	1.9	4.5	3.1	6.6	1.3	0.3	4.1	12.4	12.5	9.8	11.4	2.6	0.7	3.1	2.1	8.2	2.4	4.2	4.3	3.8	3.6	5.1	1.2	8.4	1.0	5.3	1.2	2.9	5.2	3.4	0.7	0.2	4.4	5.3	4.3	3.9	5.4	13.6	2.8	2.5	2.0	2.7	2.7	3.7	1.3	0.7	4.0	7.5	3.8	41.7	14.8	53.1	9.4	15.8	12.4	10.3	11.1	10.1	12.4	7.9	17.3	12.8	55.3	10.9	30.3	14.7	10.0	10.5	3.2	3.5	3.4	3.9	2.9	3.4	3.4	3.5	3.6	2.8	3.6	3.3	4.5	6.4	4.2	5.2	6.5	1.0	2.9	4.9	1.2	4.3	2.8	2.4	1.3	1.5	9.0	3.7	4.2	4.2	8.2	14.8	7.9	6.7	0.0	2.5	9.6	5.1	2.4	4.8	4.2	1.8	3.7	6.4	7.7	3.4	5.7	5.5	3.9	1.6	6.2	1.7	6.6	9.3	8.2	9.7	1.2	0.8	2.8	5.8	0.0	1.9	7.3	8.7	5.2	6.0	3.6	2.2	3.2	6.4	2.7	3.5	7.2	7.3	9.1	6.1	19.7	5.8	5.2	0.4	0.9	4.5	1.0	2.6	7.5	12.1	4.0	4.6
RND1	"ARHS, Rho6, RHOS"	ENSG00000172602	"Rho family GTPase 1"	Q92730	12	48857145-48865870	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 131.8"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 205.5;Ductal cells: 220.6;Exocrine glandular cells: 147.1;Pancreatic endocrine cells: 350.9"	"Cancer enhanced"	"Detected in many"		"liver cancer: 16.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in many"	5	"SK-BR-3: 67.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA077800			Supported	"Vesicles,Plasma membrane,Actin filaments"		NA	NA			"Cluster 30: Non-specific - Translation"	"Cluster 15: Liver - Metabolism"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 1: Pancreatic cells - Digestion"	"Vesicles, Plasma membrane, Actin filaments"		"HPA077800: AB_2686854"	"unprognostic (5.60e-2)"	"unprognostic (3.21e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.16e-1)"	"unprognostic (6.90e-2)"	"unprognostic (1.32e-3)"	"unprognostic (3.59e-2)"	"unprognostic (7.43e-2)"	"unprognostic (2.21e-3)"	"unprognostic (2.97e-1)"	"unprognostic (1.93e-1)"	"unprognostic (1.66e-1)"	"unprognostic (3.89e-1)"	"unprognostic (8.38e-3)"	"unprognostic (6.18e-2)"	"unprognostic (6.60e-2)"	"unprognostic (3.35e-3)"	9.6	0.8	24.4	2.6	26.9	1.8	5.6	18.9	40.6	1.6	15.4	4.8	2.4	3.9	1.0	3.1	2.7	14.5	7.3	26.8	20.4	4.4	131.8	37.9	1.0	21.4	23.6	1.2	2.8	2.4	8.0	1.2	21.9	6.5	1.9	1.7	3.9	0.8	1.0	1.6	2.6	2.4	19.9	0.8	23.4	0.9	22.1	2.4	15.4	0.6	2.3	14.0	2.7	23.2	1.1	7.9	3.8	2.0	0.8	0.0	0.6	0.0	0.4	1.2	1.3	4.9	1.7	6.0	1.4	0.0	0.4	0.1	3.1	0.3	0.7	1.8	1.9	0.8	0.0	3.0	0.4	1.8	1.1	0.0	0.2	0.6	0.8	0.0	2.0	3.9	0.2	6.0	0.0	10.2	0.9	0.5	8.9	13.6	0.5	1.9	0.4	2.6	1.1	1.5	0.0	1.0	0.2	67.7	0.3	9.1	6.9	0.4	0.2	0.0	0.7	0.0	0.9	2.9	5.4	10.9	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.3	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	24.4	26.9	18.9	40.6	26.8	20.4	21.4	23.6	21.9	19.9	22.1	23.2	28.9	28.9	205.5	5.9	8.5	11.5	8.4	14.1	9.1	2.5	37.5	25.4	3.8	18.6	27.5	1.8	8.4	1.1	9.0	21.7	0.0	220.6	0.4	4.5	2.0	87.3	31.5	2.7	10.6	147.1	0.7	10.5	55.5	12.6	15.2	0.8	6.1	10.9	1.2	0.0	2.7	11.4	18.3	0.8	24.1	0.0	0.0	6.6	14.2	1.0	6.4	3.0	0.0	7.1	1.0	350.9	42.2	0.4	6.5	19.5	11.1	1.7	7.7	3.6	0.0	5.8	16.7	0.8	1.6	4.3	10.5	1.5	9.9	0.6	5.4	8.6
RNF111	"ARK, Arkadia, DKFZP761D081, FLJ38008"	ENSG00000157450	"Ring finger protein 111"	Q6ZNA4	15	58865175-59097419	"Enzymes, Predicted intracellular proteins"	"DNA damage, DNA repair, Ubl conjugation pathway"	"Developmental protein, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 81.6;Inhibitory neurons: 80.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038576, HPA038577"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 34: Non-specific - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm	Cytosol	"HPA038576: AB_10964492, HPA038577: AB_10960052"	"unprognostic (7.30e-2)"	"unprognostic (2.60e-2)"	"unprognostic (2.39e-1)"	"unprognostic (3.37e-1)"	"unprognostic (7.94e-2)"	"unprognostic (2.09e-1)"	"unprognostic (2.19e-1)"	"unprognostic (3.21e-1)"	"unprognostic (5.10e-2)"	"unprognostic (6.12e-3)"	"unprognostic (3.10e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.05e-3)"	"unprognostic (2.05e-1)"	"unprognostic (6.61e-2)"	"unprognostic (1.20e-1)"	"unprognostic (9.74e-2)"	8.2	7.5	2.0	11.8	3.1	17.3	7.8	8.7	5.3	8.6	1.4	7.2	8.4	9.0	6.7	11.4	8.7	9.3	7.3	3.5	4.7	8.8	10.5	8.4	10.8	1.4	1.7	11.4	9.2	11.9	4.3	11.4	2.1	8.7	7.2	12.5	8.1	8.3	9.5	8.2	8.0	8.3	1.2	11.0	9.0	9.4	3.2	11.5	11.6	11.8	13.3	10.3	7.2	4.3	13.8	31.3	19.6	16.8	16.6	18.5	16.7	17.6	20.6	17.2	22.0	13.9	8.9	16.8	19.4	24.8	14.7	26.3	5.3	13.1	21.3	17.6	11.1	20.9	12.6	10.7	18.0	12.3	22.6	14.7	14.0	18.6	20.4	15.6	19.5	15.4	19.7	16.4	21.5	6.7	16.3	7.9	16.1	4.3	12.0	16.2	27.9	13.8	13.1	24.2	16.0	23.3	15.8	15.5	14.7	22.7	12.2	14.9	22.6	27.4	22.8	14.5	17.1	11.8	17.3	19.9	16.7	19.5	21.1	11.4	15.0	15.7	7.0	11.0	7.1	11.8	7.2	6.5	8.3	10.9	7.9	6.3	41.0	5.6	13.0	7.9	10.0	3.4	2.0	3.1	8.7	5.3	3.5	4.7	1.4	1.7	2.1	1.2	3.2	4.3	11.7	3.2	14.4	34.6	31.9	20.1	12.3	7.3	26.7	12.2	13.0	10.2	19.7	7.2	10.6	12.9	8.4	9.0	12.8	10.0	3.9	12.6	27.6	14.4	15.1	15.3	16.2	11.6	81.6	6.9	10.5	15.0	17.3	15.8	15.8	12.3	17.9	11.2	13.4	10.1	80.4	10.0	12.2	19.8	15.7	7.5	7.8	21.2	12.4	56.2	22.7	8.4	16.5	65.4	66.2	12.9	11.4	14.7	19.5	14.5	11.6	9.9	14.9	13.6	26.3	15.1	13.6	13.8	8.9	27.3	19.9	32.0	21.4	11.8	9.2	21.2
RNF113A	"Cwc24, RNF113, ZNF183"	ENSG00000125352	"Ring finger protein 113A"	O15541	X	119870475-119871733	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair, mRNA processing, mRNA splicing, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000160, HPA076658"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 63: NK-cells & T-cells - Immune response"	Nucleoplasm		"HPA000160: AB_1079821, HPA076658: AB_2732319"	"unprognostic (2.85e-1)"	"unprognostic (4.38e-3)"	"unprognostic (5.55e-3)"	"unprognostic (2.38e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.28e-2)"	"unprognostic (3.65e-3)"	"unprognostic (2.02e-3)"	"unprognostic (6.29e-2)"	"unprognostic (2.57e-1)"	"unprognostic (6.49e-3)"	"unprognostic (1.83e-1)"	"prognostic unfavorable (7.93e-4)"	"unprognostic (7.99e-2)"	"unprognostic (3.19e-1)"	"unprognostic (3.91e-2)"	"prognostic favorable (6.23e-4)"	11.0	9.6	11.5	13.0	12.1	35.3	10.2	13.0	14.4	10.5	11.3	11.4	13.2	9.8	9.6	11.3	10.2	8.2	12.7	11.7	13.9	9.2	17.7	11.0	24.7	12.7	13.0	13.4	19.1	9.2	10.0	9.0	13.1	8.9	9.5	15.6	14.4	8.8	12.3	17.1	17.5	7.5	11.9	24.3	12.1	3.4	13.1	24.7	9.9	10.6	19.0	10.8	10.3	12.6	16.9	22.9	11.0	17.7	20.7	14.9	22.3	14.8	25.0	17.6	21.0	19.7	14.1	28.0	28.1	13.8	25.1	20.4	24.4	19.1	13.1	21.9	18.0	17.0	25.8	23.5	28.3	33.7	28.3	18.4	20.6	17.7	26.0	20.7	17.1	19.4	12.2	38.4	17.3	47.5	23.5	39.9	16.1	29.5	32.8	21.7	23.2	45.3	18.5	20.6	14.7	12.9	23.1	35.5	33.1	12.9	8.7	32.9	13.1	18.6	6.6	26.7	29.7	43.2	36.0	27.9	16.8	44.1	12.3	96.4	59.5	109.5	73.9	60.3	74.4	83.6	78.3	79.0	63.4	88.6	81.3	73.1	27.5	65.9	72.6	53.3	96.6	73.6	11.5	12.1	13.0	14.4	11.7	13.9	12.7	13.0	13.1	11.9	13.1	12.6	14.8	9.6	14.8	2.6	42.8	24.3	17.2	26.6	30.7	11.5	13.6	21.1	8.9	18.6	21.4	14.7	14.6	18.5	51.6	10.8	9.8	18.3	0.5	13.1	18.8	17.4	4.2	10.3	3.0	16.8	37.6	15.2	16.3	16.5	26.5	14.4	18.2	13.1	24.4	13.5	4.1	16.8	14.2	17.6	23.1	1.4	12.2	17.0	26.6	5.6	17.2	16.5	39.1	2.0	6.2	15.5	17.8	9.8	59.6	12.3	34.9	25.1	19.6	17.7	6.6	8.3	19.3	2.9	5.8	20.9	24.4	26.4	50.2	15.9	15.5	14.3
RNF114	"PSORS12, ZNF313"	ENSG00000124226	"Ring finger protein 114"	Q9Y508	20	49936336-49953885	"Enzymes, Predicted intracellular proteins"	"Differentiation, Spermatogenesis, Ubl conjugation pathway"	"Developmental protein, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	6	"Early spermatids: 1500.7;Late spermatids: 923.4;Spermatocytes: 558.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SK-BR-3: 561.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021184	Enhanced		Supported	"Plasma membrane,Cytosol"		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Plasma membrane, Cytosol"		"HPA021184: AB_1859185"	"unprognostic (8.38e-2)"	"unprognostic (3.56e-2)"	"unprognostic (5.62e-2)"	"prognostic unfavorable (8.10e-6)"	"unprognostic (1.56e-1)"	"unprognostic (2.96e-1)"	"prognostic unfavorable (3.11e-4)"	"unprognostic (2.50e-2)"	"unprognostic (1.03e-2)"	"unprognostic (2.12e-1)"	"unprognostic (3.99e-1)"	"unprognostic (2.70e-2)"	"unprognostic (2.54e-3)"	"unprognostic (1.33e-1)"	"unprognostic (1.76e-1)"	"prognostic favorable (3.01e-4)"	"unprognostic (1.36e-2)"	32.8	32.0	43.3	29.7	48.2	51.6	31.2	46.6	45.1	37.2	41.0	45.0	42.8	28.7	32.8	30.8	34.7	28.8	37.6	40.4	44.9	48.6	49.0	37.9	39.3	47.3	46.5	39.0	52.2	30.2	28.1	35.1	46.6	33.9	40.0	16.7	41.0	34.1	83.3	24.2	40.8	25.4	47.1	52.4	35.9	166.1	47.2	39.1	37.9	52.8	37.3	28.9	28.7	49.9	83.9	80.5	42.9	43.7	84.3	57.8	118.0	73.0	86.2	153.2	64.4	241.7	67.6	39.9	142.9	40.1	91.6	66.3	62.5	74.7	90.6	73.5	44.3	51.5	50.1	173.2	73.3	95.3	59.5	51.5	68.8	58.4	39.9	52.6	36.8	69.7	98.0	46.7	45.5	281.0	82.6	98.0	42.3	67.4	114.3	85.7	45.5	73.6	83.4	67.9	63.2	45.4	88.8	561.6	118.5	45.4	149.7	86.6	47.8	134.6	62.3	71.6	87.0	93.6	107.1	79.2	76.4	63.2	76.1	112.2	97.8	86.1	48.1	92.5	53.1	63.9	52.6	48.6	75.3	71.2	61.6	50.2	100.5	57.8	112.5	61.9	68.9	92.7	43.3	48.2	46.6	45.1	40.4	44.9	47.3	46.5	46.6	47.1	47.2	49.9	47.1	48.1	53.7	13.4	69.9	107.2	127.8	103.4	63.2	24.4	50.7	55.8	46.1	41.5	101.4	69.9	12.5	91.3	61.0	61.7	72.4	107.5	1500.7	72.2	36.3	55.3	60.4	45.4	22.8	101.1	77.4	61.9	41.3	71.4	45.0	31.9	46.1	63.7	110.6	40.4	24.4	79.5	42.7	76.6	146.5	923.4	70.5	66.0	71.2	27.2	96.3	38.0	56.7	10.6	26.2	92.1	77.9	59.8	81.9	122.5	96.4	120.9	75.8	22.6	39.5	45.5	59.2	558.0	138.4	45.8	87.1	124.8	69.2	46.5	80.4	113.3
RNF125	FLJ20456	ENSG00000101695	"Ring finger protein 125"	Q96EQ8	18	32018825-32073219	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Adaptive immunity, Immunity, Ubl conjugation pathway"	Transferase	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 18.4"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 169.6;Early spermatids: 90.7;NK-cells: 160.6;Oligodendrocytes: 64.3;T-cells: 114.8"	"Cancer enhanced"	"Detected in all"		"testis cancer: 8.6"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HMC-1: 51.5;SK-MEL-30: 13.2;U-937: 11.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041514	Uncertain		Supported	"Nucleoli,Golgi apparatus"		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 24: Non-specific - Transcription regulation"	"Golgi apparatus"	Nucleoli	"HPA041514: AB_10795596"	"unprognostic (2.13e-2)"	"unprognostic (2.05e-2)"	"unprognostic (2.88e-1)"	"unprognostic (3.93e-1)"	"unprognostic (5.03e-1)"	"unprognostic (4.50e-2)"	"unprognostic (2.30e-3)"	"unprognostic (6.15e-2)"	"unprognostic (4.21e-2)"	"unprognostic (3.24e-1)"	"unprognostic (1.68e-1)"	"unprognostic (4.35e-2)"	"prognostic unfavorable (4.06e-4)"	"unprognostic (2.99e-1)"	"unprognostic (4.12e-1)"	"unprognostic (1.82e-1)"	"unprognostic (7.07e-3)"	10.2	1.3	2.0	5.2	3.7	18.4	6.3	2.7	2.7	3.9	1.6	5.0	10.5	2.9	0.5	2.5	3.4	3.3	2.6	1.9	2.3	1.0	12.5	4.7	7.0	3.6	3.2	1.4	3.1	1.7	0.3	3.7	3.4	1.8	6.4	0.3	2.2	1.4	2.3	4.9	11.3	3.3	2.6	5.9	3.4	1.0	3.8	5.3	1.4	2.9	4.0	3.0	1.7	6.2	1.2	0.1	0.2	0.4	0.5	0.8	1.0	0.1	0.0	0.0	0.0	0.1	2.5	0.1	1.2	0.1	0.4	0.9	1.6	1.2	0.2	6.6	2.6	0.3	0.4	0.3	0.1	8.9	51.5	1.6	2.4	0.0	2.8	0.3	0.4	2.7	0.1	1.9	0.1	2.0	2.3	8.2	4.2	8.9	1.5	9.2	0.6	0.2	0.5	0.5	0.9	0.3	0.2	0.1	13.2	1.6	1.3	4.2	0.2	0.1	0.7	0.1	0.1	5.9	0.2	0.1	0.6	11.5	6.9	13.3	4.5	4.5	15.0	2.5	9.9	2.5	12.0	12.8	4.2	2.3	9.5	12.3	1.9	15.5	2.8	4.3	13.7	6.9	2.0	3.7	2.7	2.7	1.9	2.3	3.6	3.2	3.4	2.6	3.8	6.2	62.2	3.2	5.8	3.3	16.3	9.8	3.1	1.0	14.2	0.8	5.3	3.7	2.1	4.3	3.8	12.9	0.0	0.4	169.6	24.6	1.9	1.0	90.7	4.9	2.1	28.4	1.2	15.8	2.7	1.8	0.1	5.3	8.6	13.4	18.9	0.2	12.5	25.1	10.5	0.0	3.0	8.3	0.0	19.2	12.6	17.4	2.8	18.4	1.8	30.9	23.8	0.7	160.6	3.5	64.3	1.1	4.5	0.0	49.9	2.7	41.4	4.5	1.7	0.9	0.0	3.2	3.2	0.5	1.8	5.8	6.8	0.8	114.8	0.2	14.7	2.4
RNF13	RZF	ENSG00000082996	"Ring finger protein 13"	O43567	3	149812770-149962139	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Ubl conjugation pathway"	Transferase	"Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 591.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 462.3"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA064784	Approved		Supported	Nucleoplasm,Vesicles,Cytosol		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 21: Non-specific - Transcription"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 4: Macrophages - Innate immune response"	"Nucleoplasm, Vesicles"	Cytosol	"HPA064784: AB_2685350"	"unprognostic (1.27e-1)"	"unprognostic (2.32e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.93e-2)"	"unprognostic (1.80e-1)"	"unprognostic (9.64e-2)"	"unprognostic (8.49e-2)"	"unprognostic (4.36e-3)"	"unprognostic (1.72e-1)"	"unprognostic (1.25e-1)"	"unprognostic (6.94e-3)"	"unprognostic (1.13e-1)"	"prognostic favorable (2.00e-8)"	"unprognostic (2.95e-1)"	"unprognostic (4.11e-2)"	"unprognostic (2.17e-1)"	"unprognostic (1.79e-1)"	48.2	41.2	58.1	40.4	95.2	19.9	53.9	88.1	91.5	33.6	63.7	35.0	28.9	33.3	57.2	32.6	30.2	40.6	34.4	55.0	77.3	67.9	73.8	64.1	38.0	101.8	83.9	35.6	36.1	52.3	18.3	64.1	100.8	46.6	37.1	40.4	75.5	39.3	36.5	32.5	30.5	36.9	85.6	53.0	34.3	25.2	75.9	32.0	64.0	42.6	33.2	42.3	28.9	131.0	60.6	39.4	24.4	29.0	92.2	55.2	40.3	32.2	86.2	32.3	47.4	33.4	84.4	26.6	48.7	42.0	58.7	58.0	37.5	41.5	42.9	34.1	24.6	35.8	17.3	31.2	61.5	35.0	41.8	59.9	73.1	26.5	71.8	37.3	37.0	24.9	10.1	49.7	28.0	34.5	26.2	18.8	16.8	58.6	29.1	19.0	26.7	108.5	54.2	29.6	12.6	37.6	28.5	39.9	110.3	19.2	79.2	34.0	37.8	40.8	16.5	45.6	23.4	89.9	61.9	51.5	35.9	30.1	23.6	98.2	130.1	106.5	37.4	153.8	48.8	51.9	41.5	44.8	93.1	48.4	38.0	42.4	462.3	46.3	207.8	68.3	48.7	104.5	58.1	95.2	88.1	91.5	55.0	77.3	101.8	83.9	100.8	85.6	75.9	131.0	100.9	109.0	72.3	78.7	55.3	73.5	68.2	84.3	74.0	44.5	54.5	51.1	27.3	48.6	68.1	47.8	29.2	101.2	61.9	30.2	43.0	63.0	2.5	32.5	34.5	69.4	20.3	32.4	122.1	70.6	83.5	84.8	31.6	39.7	60.8	14.6	80.3	53.7	201.2	21.9	98.8	27.7	67.1	183.9	173.7	6.7	76.1	177.6	103.2	92.8	93.5	98.5	38.1	115.6	591.2	58.7	33.6	88.0	62.4	71.9	38.5	71.5	40.4	37.2	92.1	76.3	55.5	23.6	32.5	52.3	72.5	52.5	49.8	38.2	27.7	55.8
RNF14	"ARA54, HFB30, TRIAD2"	ENSG00000013561	"Ring finger protein 14"	Q9UBS8	5	141958328-141990292	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 257.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008716, HPA064746"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	Nucleoplasm	Cytosol	"HPA008716: AB_1856337, HPA064746: "	"unprognostic (7.45e-3)"	"unprognostic (1.38e-1)"	"unprognostic (8.56e-2)"	"unprognostic (1.20e-1)"	"unprognostic (3.47e-2)"	"unprognostic (7.24e-3)"	"unprognostic (2.35e-1)"	"unprognostic (4.05e-2)"	"unprognostic (5.22e-2)"	"unprognostic (7.42e-2)"	"unprognostic (7.92e-2)"	"unprognostic (1.46e-1)"	"prognostic favorable (1.71e-4)"	"unprognostic (6.89e-3)"	"unprognostic (2.82e-1)"	"prognostic unfavorable (2.21e-4)"	"unprognostic (1.06e-2)"	48.4	51.8	31.5	26.0	32.7	20.2	45.6	32.7	42.8	36.6	30.6	40.7	33.2	33.6	43.2	32.6	29.7	32.6	71.2	33.3	35.6	65.3	67.6	30.2	32.3	35.3	38.2	32.3	37.2	104.0	23.7	39.8	36.3	44.0	41.2	40.4	37.1	40.2	66.7	23.5	36.4	43.3	33.4	28.9	35.4	74.5	36.5	36.7	55.1	85.8	33.7	32.1	23.4	33.7	38.3	62.5	43.1	85.1	75.7	78.8	29.0	76.8	42.6	52.8	58.1	52.4	43.4	67.1	87.5	79.3	79.4	20.6	55.6	75.4	47.0	51.1	48.5	42.9	30.2	24.0	83.2	47.7	36.9	59.7	64.9	70.3	87.6	45.6	66.2	46.0	53.0	91.7	109.4	45.7	46.6	15.3	18.3	46.2	71.0	30.2	47.8	73.8	71.7	65.2	47.5	38.3	67.3	121.3	133.2	47.8	85.0	36.7	69.3	69.6	22.6	33.2	74.0	56.8	72.1	61.8	59.7	57.4	87.9	79.6	22.0	23.2	26.9	26.9	26.0	19.5	23.2	26.9	27.4	18.1	17.6	25.9	5.5	30.1	33.9	28.9	29.1	19.7	31.5	32.7	32.7	42.8	33.3	35.6	35.3	38.2	36.3	33.4	36.5	33.7	18.1	9.6	19.3	12.7	12.5	10.7	15.9	19.6	11.4	20.2	18.4	15.0	45.4	11.5	18.1	22.0	16.7	29.1	13.3	22.9	68.4	29.2	257.1	14.1	20.8	21.7	15.0	59.1	25.1	24.9	26.1	18.2	18.3	16.4	22.2	32.0	20.7	33.1	24.5	23.5	22.9	14.9	24.4	29.7	10.4	39.3	19.3	17.1	32.0	13.1	14.8	28.7	29.9	15.6	18.6	26.3	14.0	33.4	13.5	19.2	28.3	50.5	15.8	16.3	39.5	15.8	23.0	38.7	25.8	15.6	10.5	60.5	16.4	25.0	15.0	15.0
RNF144A	"hUIP4, KIAA0161, RNF144, UBCE7IP4"	ENSG00000151692	"Ring finger protein 144A"	P50876	2	6917412-7068286	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 73.6"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 176.6;Inhibitory neurons: 101.7;Oligodendrocyte precursor cells: 194.5;Oligodendrocytes: 330.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"eosinophil: 6.1"	"Group enriched"	"Detected in many"	7	"granulocytes: 6.1;T-cells: 2.4"	"Cell line enhanced"	"Detected in many"		"HEL: 39.7;HMC-1: 127.9;SH-SY5Y: 39.0;SK-MEL-30: 39.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049939	Approved		Supported	Vesicles		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Vesicles		"HPA049939: AB_2680960"	"unprognostic (1.78e-1)"	"unprognostic (2.53e-3)"	"unprognostic (8.37e-2)"	"prognostic unfavorable (6.00e-4)"	"unprognostic (6.57e-2)"	"prognostic favorable (6.96e-4)"	"unprognostic (7.04e-6)"	"unprognostic (1.20e-1)"	"unprognostic (2.03e-2)"	"unprognostic (5.64e-1)"	"unprognostic (9.11e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.03e-1)"	"prognostic unfavorable (7.32e-5)"	"unprognostic (1.30e-2)"	"unprognostic (3.01e-1)"	"unprognostic (1.82e-3)"	9.7	28.5	21.1	4.1	46.1	13.9	10.1	59.2	36.7	24.2	1.2	5.7	2.6	26.3	7.7	4.3	7.8	7.1	8.1	17.5	24.0	7.3	1.3	5.4	6.0	30.1	27.0	19.3	30.7	38.1	12.9	5.9	33.4	9.1	5.3	23.0	4.6	6.4	9.6	5.4	3.8	11.6	21.5	23.0	2.6	4.7	30.3	7.5	3.4	10.1	5.6	4.4	7.5	73.6	0.8	5.8	30.1	6.2	6.6	13.6	23.0	0.2	0.0	1.1	2.8	0.1	0.7	2.9	3.3	0.3	8.7	0.7	10.0	0.0	0.0	1.6	2.6	39.7	0.3	11.8	0.3	0.7	127.9	21.7	0.1	2.2	0.0	0.0	0.0	9.9	17.3	0.6	0.0	4.9	20.6	1.7	11.0	0.7	13.6	15.9	21.8	2.6	1.0	10.2	9.9	39.0	0.5	4.0	39.8	3.9	1.7	2.6	0.1	3.9	10.0	10.7	4.5	10.4	3.5	0.1	14.7	8.7	14.3	1.3	0.0	6.1	1.2	0.0	1.8	0.0	1.3	0.9	0.1	0.1	2.4	1.7	0.3	0.5	0.0	0.0	0.6	0.4	21.1	46.1	59.2	36.7	17.5	24.0	30.1	27.0	33.4	21.5	30.3	73.6	27.8	3.2	4.2	34.3	2.4	2.4	0.7	0.0	1.8	4.6	2.5	2.5	11.5	2.8	1.9	0.0	75.0	2.4	5.3	15.4	1.9	3.3	5.5	6.1	15.4	13.9	25.4	18.5	176.6	5.8	3.1	10.4	2.6	10.7	8.9	31.5	23.2	1.1	4.9	10.1	101.7	2.7	0.0	1.0	1.7	14.2	4.4	1.7	24.9	17.8	1.2	7.6	10.3	194.5	330.3	3.0	11.1	10.5	3.1	3.0	2.0	0.3	1.5	39.8	0.0	16.1	5.2	1.8	6.6	5.2	1.6	1.1	9.8	19.1	2.7	1.7
RNF144B	"bA528A10.3, IBRDC2, P53RFP"	ENSG00000137393	"Ring finger protein 144B"	Q7Z419	6	18387350-18468870	"Enzymes, Metabolic proteins, Predicted membrane proteins"	"Apoptosis, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 56.9"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 634.4;Langerhans cells: 296.9;Suprabasal keratinocytes: 1501.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"non-classical monocyte: 71.9"	"Group enriched"	"Detected in many"	9	"dendritic cells: 18.4;granulocytes: 36.7;monocytes: 71.9"	"Cell line enhanced"	"Detected in many"		"Daudi: 192.8;hTCEpi: 59.1;HUVEC TERT2: 55.6;TIME: 56.1;U-698: 160.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB046013, HPA054127, HPA072469"	Uncertain		Approved	Nucleoli,Mitochondria		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 59: Non-specific - Translation"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 41: Macrophages - Immune response"	Nucleoli	Mitochondria	"CAB046013: AB_11126028, HPA054127: AB_2682391, HPA072469: "	"unprognostic (2.24e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.56e-1)"	"unprognostic (4.07e-2)"	"unprognostic (2.55e-1)"	"unprognostic (4.48e-3)"	"unprognostic (5.89e-2)"	"unprognostic (1.18e-2)"	"unprognostic (6.55e-2)"	"unprognostic (2.87e-3)"	"unprognostic (2.44e-2)"	"unprognostic (2.60e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.39e-1)"	"unprognostic (3.91e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.21e-1)"	9.4	2.0	7.4	15.6	7.4	24.0	29.1	7.9	9.0	9.5	9.1	4.2	1.8	5.7	4.7	8.4	11.8	6.2	8.1	6.4	7.7	14.0	15.5	19.4	11.3	11.8	11.9	1.6	3.2	2.9	1.7	15.1	9.4	13.1	2.8	5.0	16.9	7.3	56.9	21.1	3.3	6.2	8.9	13.1	5.7	2.3	10.5	5.1	40.9	14.1	12.9	9.4	7.1	8.7	4.6	1.0	0.4	0.0	0.3	2.0	9.8	5.3	5.7	11.0	11.8	0.1	0.4	192.8	50.7	2.3	0.6	16.3	0.1	16.0	15.5	0.9	1.4	0.2	0.2	4.2	0.2	0.2	0.2	2.7	59.1	4.3	13.2	4.9	55.6	4.3	0.1	0.0	2.7	2.0	1.5	0.0	1.6	0.6	1.1	0.7	1.7	11.8	33.2	10.6	1.9	0.2	1.2	23.9	18.5	1.5	28.2	0.5	56.1	8.6	1.9	0.8	1.2	0.0	0.1	160.6	1.0	0.4	0.7	0.4	20.7	12.9	0.5	38.9	1.6	4.6	0.8	0.6	13.3	3.6	1.6	1.0	36.7	0.6	71.9	18.4	0.5	7.1	7.4	7.4	7.9	9.0	6.4	7.7	11.8	11.9	9.4	8.9	10.5	8.7	28.8	44.8	15.0	34.9	21.7	634.4	48.8	86.0	14.8	0.9	35.7	26.3	12.8	17.2	48.3	38.6	2.1	14.1	9.8	2.2	19.6	8.6	2.1	49.0	5.8	34.6	1.2	3.8	2.3	8.9	3.7	7.8	10.7	58.5	3.8	0.1	47.2	21.9	15.0	0.0	99.0	1.8	14.2	109.4	296.9	1.8	1.2	171.7	60.5	92.8	54.1	17.9	1.0	3.5	2.5	5.2	3.6	3.0	3.4	112.3	0.9	20.6	36.7	1.2	0.0	9.0	7.8	2.2	3.2	30.0	1501.1	1.5	4.9	0.1	2.3	42.6
RNF146	"dactylidin, dJ351K20.1, DKFZp434O1427"	ENSG00000118518	"Ring finger protein 146"	Q9NTX7	6	127266682-127288567	"Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Ubl conjugation pathway, Wnt signaling pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027158, HPA027209"	Approved		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		No	No			"Cluster 14: Monocytes - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 12: NES - Nervous system development"	"Cluster 50: Fibroblasts - ECM organization"	"Plasma membrane, Cytosol"	Nucleoplasm	"HPA027158: AB_10600772, HPA027209: AB_10602312"	"unprognostic (8.22e-2)"	"unprognostic (1.20e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.38e-2)"	"unprognostic (1.17e-2)"	"unprognostic (1.37e-1)"	"unprognostic (5.47e-3)"	"unprognostic (1.87e-1)"	"unprognostic (6.74e-2)"	"prognostic favorable (5.26e-5)"	"unprognostic (2.65e-2)"	"prognostic favorable (7.32e-4)"	"unprognostic (4.04e-2)"	"unprognostic (1.29e-1)"	"unprognostic (6.13e-2)"	"unprognostic (2.15e-2)"	52.9	37.0	49.5	32.4	56.0	10.6	42.7	79.4	61.2	48.1	36.2	40.5	21.9	57.4	60.8	25.3	42.4	38.6	46.9	50.7	51.6	37.1	31.8	38.7	35.1	53.2	52.1	49.5	23.3	40.0	33.3	51.8	56.8	31.7	30.9	48.1	31.2	34.5	114.9	29.5	31.1	45.9	55.2	47.1	29.9	31.3	52.5	24.3	47.1	91.5	33.3	36.9	34.3	61.5	13.2	16.2	60.3	53.6	54.7	54.3	22.2	43.5	69.0	22.8	32.4	21.3	19.3	23.6	30.3	35.7	36.2	16.4	18.1	20.4	32.9	27.6	16.0	30.3	21.8	30.0	54.0	18.0	20.6	47.6	42.1	26.1	51.1	52.5	40.6	23.2	33.0	22.5	50.7	25.2	17.9	32.0	22.1	8.1	17.1	22.6	15.7	12.1	32.4	14.3	36.0	36.6	17.1	23.6	27.7	35.5	16.1	60.8	48.3	39.7	13.1	41.8	31.7	32.3	22.0	15.6	30.5	31.0	38.5	27.5	30.0	26.6	14.3	32.4	14.7	17.4	12.2	16.3	22.8	17.9	11.0	15.5	37.0	19.8	40.1	11.7	15.0	16.1	49.5	56.0	79.4	61.2	50.7	51.6	53.2	52.1	56.8	55.2	52.5	61.5	24.6	35.3	29.3	35.6	23.7	17.7	14.3	15.1	18.8	34.7	16.9	14.7	38.9	31.5	16.7	9.2	4.2	29.0	14.7	13.5	41.1	28.0	52.5	15.7	29.5	30.5	20.4	12.8	53.5	15.8	27.2	50.6	7.1	11.5	22.2	28.1	31.4	30.5	26.3	30.3	54.5	12.1	38.7	68.4	24.6	45.4	69.6	29.9	46.2	42.2	31.1	41.1	28.8	56.3	76.5	18.0	17.0	66.5	9.3	26.3	15.7	51.7	23.9	20.9	32.9	36.2	31.9	41.7	24.9	15.0	20.0	38.4	20.8	36.0	10.9	25.9
RNF187	"RACO-1, RACO1"	ENSG00000168159	"Ring finger protein 187"	Q5TA31	1	228487382-228496188	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Theca cells: 217.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"eosinophil: 3.6"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"U-266/70: 189.0"					"Low region specificity"	"Detected in all"			HPA030098	Approved		Supported	Nucleoplasm,Cytosol		Yes	No			"Cluster 52: Eosinophils - Transcription"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 52: Non-specific - Transcription"	"Nucleoplasm, Cytosol"		"HPA030098: AB_10602923"	"unprognostic (4.84e-2)"	"unprognostic (1.97e-1)"	"prognostic unfavorable (2.83e-4)"	"unprognostic (4.90e-3)"	"unprognostic (1.13e-1)"	"unprognostic (2.93e-2)"	"unprognostic (3.46e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.36e-1)"	"unprognostic (5.66e-3)"	"unprognostic (1.37e-1)"	"unprognostic (1.55e-1)"	"unprognostic (2.92e-3)"	"unprognostic (1.59e-1)"	"unprognostic (9.76e-2)"	"unprognostic (1.76e-1)"	"unprognostic (2.32e-2)"	26.8	66.6	16.2	7.5	16.2	11.3	25.8	14.8	24.3	40.5	3.4	28.1	8.6	31.8	4.3	59.1	28.7	5.6	35.4	15.9	16.9	40.7	52.0	23.6	7.3	19.4	15.2	39.3	34.5	22.5	47.7	5.5	18.4	33.5	3.7	9.0	39.7	8.2	64.2	45.0	22.5	5.6	15.6	37.0	27.6	20.8	18.5	8.5	36.1	19.8	6.1	29.9	41.2	19.8	26.7	23.1	14.8	28.9	16.8	12.5	26.6	21.5	17.3	15.6	12.7	12.8	19.2	65.9	43.1	28.9	11.4	20.9	19.1	22.1	5.8	25.9	28.5	20.8	13.2	12.6	46.1	22.1	34.4	20.4	44.7	11.6	15.8	18.3	14.0	52.6	35.6	115.2	12.4	17.7	35.2	20.8	30.7	19.1	24.0	27.8	12.5	61.5	11.4	17.2	29.9	30.0	21.9	44.1	62.3	4.3	34.6	50.2	27.8	18.3	16.9	19.6	19.3	189.0	56.7	36.4	46.7	22.7	28.7	0.0	0.5	3.6	0.6	1.0	0.7	0.5	0.7	1.0	0.6	1.0	0.6	0.7	0.1	0.4	1.4	0.7	0.6	0.3	16.2	16.2	14.8	24.3	15.9	16.9	19.4	15.2	18.4	15.6	18.5	19.8	54.0	25.6	15.5	8.1	47.2	36.2	42.9	10.6	38.7	85.2	59.5	58.5	70.8	65.8	14.2	40.5	18.8	19.7	52.2	39.8	113.5	15.2	0.8	35.5	47.2	32.1	40.0	118.4	16.6	24.5	27.1	54.4	34.7	32.0	44.5	45.0	41.7	67.4	27.4	55.5	17.2	36.6	2.0	40.1	30.5	4.2	24.5	35.8	39.2	12.2	29.7	145.3	62.8	7.1	12.6	21.4	23.4	25.9	35.4	44.0	32.9	126.4	10.3	47.7	19.7	52.2	38.4	4.2	21.5	57.0	55.3	17.6	54.6	217.5	38.6	31.7
RNF2	"BAP-1, BAP1, DING, HIPI3, RING1B, RING2"	ENSG00000121481	"Ring finger protein 2"	Q99496	1	185045526-185102603	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation, Ubl conjugation pathway"	"Repressor, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Spermatogonia: 83.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026803	Uncertain		Enhanced	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 28: Placenta - Pregnancy"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	Nucleoplasm	"Nuclear bodies"	"HPA026803: AB_10602086"	"unprognostic (1.23e-1)"	"unprognostic (3.71e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.35e-3)"	"unprognostic (1.70e-2)"	"unprognostic (1.19e-1)"	"prognostic unfavorable (1.08e-5)"	"unprognostic (5.85e-2)"	"unprognostic (3.56e-3)"	"unprognostic (1.62e-2)"	"unprognostic (2.01e-2)"	"unprognostic (5.51e-2)"	"prognostic unfavorable (1.94e-7)"	"unprognostic (2.08e-1)"	"unprognostic (5.51e-2)"	"unprognostic (9.89e-3)"	"unprognostic (2.52e-1)"	9.5	8.1	5.4	10.2	6.7	13.8	12.5	6.1	7.0	10.3	3.7	9.3	8.4	10.7	8.5	8.4	8.6	9.4	7.4	7.0	7.5	9.6	8.3	8.3	11.5	4.0	4.8	9.3	9.6	8.7	5.6	21.7	4.8	8.5	9.7	11.8	9.6	10.4	8.2	6.4	6.5	10.9	4.5	10.4	9.6	21.9	7.9	12.3	10.8	9.0	12.3	16.5	8.7	5.1	34.0	18.6	62.8	25.4	17.8	30.3	65.3	24.0	28.4	35.5	28.3	29.9	53.3	10.2	29.2	29.0	24.4	11.5	43.7	32.7	41.7	31.1	28.4	54.9	10.2	25.8	27.5	56.1	29.7	29.7	19.6	29.6	36.4	27.9	36.6	34.4	44.7	22.5	25.1	21.2	48.5	17.6	86.3	27.4	11.0	55.1	41.3	9.8	25.7	23.6	18.9	33.4	17.3	9.9	46.7	67.8	19.7	27.5	28.4	25.4	33.6	25.1	29.8	39.0	26.2	36.3	16.1	25.7	28.9	31.0	22.4	27.7	17.1	27.7	24.4	20.1	15.5	15.8	25.7	21.9	15.1	15.6	9.8	24.4	29.9	13.4	17.8	16.3	5.4	6.7	6.1	7.0	7.0	7.5	4.0	4.8	4.8	4.5	7.9	5.1	22.6	3.2	6.4	11.4	23.6	23.2	27.6	10.2	26.7	10.3	18.2	11.8	8.4	7.2	6.6	9.2	4.2	25.4	24.5	11.2	23.5	11.5	6.1	11.2	10.8	20.3	29.5	29.4	23.1	12.6	53.0	17.9	12.8	10.3	12.7	16.9	23.2	8.8	20.1	6.7	20.5	9.2	8.2	21.4	55.2	5.6	9.6	22.0	21.4	20.6	25.4	13.3	10.3	18.6	15.1	11.3	16.9	11.7	15.5	30.2	4.1	16.4	8.8	7.2	0.0	11.7	13.4	35.6	83.1	15.8	20.3	28.5	20.7	15.6	11.3	38.0
RNF213	"ALO17, C17orf27, KIAA1554, KIAA1618, MYMY2, NET57"	ENSG00000173821	"Ring finger protein 213"	Q63HN8	17	80260866-80398786	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Angiogenesis, Ubl conjugation pathway"	"Hydrolase, Transferase"	"Cancer-related genes, Disease variant, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"NK-cells: 396.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HDLM-2: 90.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003347, HPA026790"	Approved		Supported	Cytosol		NA	NA		3500	"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 63: NK-cells & T-cells - Immune response"	Cytosol		"HPA003347: AB_1079204, HPA026790: AB_10602296"	"unprognostic (8.98e-2)"	"unprognostic (1.60e-1)"	"unprognostic (8.97e-3)"	"prognostic unfavorable (4.65e-5)"	"unprognostic (7.39e-2)"	"unprognostic (3.99e-2)"	"unprognostic (2.23e-2)"	"unprognostic (1.52e-1)"	"unprognostic (4.57e-2)"	"unprognostic (3.85e-1)"	"unprognostic (1.96e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.52e-3)"	"unprognostic (8.92e-2)"	"unprognostic (1.13e-2)"	"unprognostic (1.40e-1)"	"unprognostic (4.56e-2)"	7.4	9.9	6.8	18.6	12.9	25.6	7.0	9.0	11.3	8.0	13.0	9.0	8.7	7.8	8.7	7.1	8.6	10.7	6.5	5.1	6.9	10.5	6.2	13.2	17.9	23.5	11.4	9.0	7.8	34.2	6.6	10.0	18.3	7.1	7.8	12.0	10.8	6.8	6.6	8.8	10.6	9.1	13.8	18.7	11.1	3.4	16.5	20.2	11.0	7.6	14.5	11.0	7.1	17.3	40.1	69.7	6.9	4.9	24.4	37.0	5.1	9.9	21.4	43.7	37.1	7.5	18.1	2.6	8.3	20.8	46.6	22.7	9.3	12.9	14.7	90.8	4.3	6.3	29.9	13.3	10.5	6.7	6.2	20.5	8.6	24.6	10.6	13.7	34.3	28.3	11.8	14.5	16.5	9.7	26.7	2.8	5.1	7.5	16.0	18.0	15.9	3.1	12.1	34.1	6.6	9.2	24.1	50.3	17.3	15.3	11.6	8.2	44.5	24.2	19.0	14.4	10.3	6.3	6.3	7.0	18.2	7.6	8.9	19.5	20.8	10.4	26.2	18.5	17.5	15.3	18.6	21.6	5.4	15.5	14.6	18.2	84.5	26.1	17.1	32.0	15.4	4.8	6.8	12.9	9.0	11.3	5.1	6.9	23.5	11.4	18.3	13.8	16.5	17.3	76.1	89.8	56.9	56.8	89.9	35.8	37.2	39.2	43.3	21.2	59.9	41.7	32.6	75.8	50.3	101.2	50.1	21.0	240.8	117.4	13.7	120.3	1.4	58.7	58.9	90.7	46.0	30.3	23.6	162.4	31.5	50.8	158.0	93.4	46.7	140.7	74.3	56.4	98.0	23.5	15.5	68.2	32.6	136.5	94.9	3.7	60.9	128.9	30.2	87.1	194.6	26.1	396.5	32.2	70.4	166.1	76.2	51.6	167.6	100.8	116.3	92.2	66.2	68.5	65.7	52.3	53.7	1.4	8.2	43.0	34.4	21.8	211.6	84.7	54.9	66.5
RNF216	"TRIAD3, UBCE7IP1, ZIN"	ENSG00000011275	"Ring finger protein 216"	Q9NWF9	7	5620047-5781696	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Apoptosis, Host-virus interaction, Ubl conjugation pathway"	Transferase	"Disease variant, Hypogonadotropic hypogonadism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 145.5;Late spermatids: 257.6;Spermatocytes: 159.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018955, HPA021123"	Supported		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 43: Testis - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	Cytosol	Nucleoplasm	"HPA018955: AB_1858500, HPA021123: AB_1858501"	"unprognostic (3.31e-2)"	"unprognostic (4.24e-2)"	"unprognostic (1.28e-2)"	"unprognostic (1.58e-2)"	"unprognostic (1.81e-2)"	"unprognostic (1.56e-1)"	"prognostic unfavorable (2.26e-4)"	"unprognostic (2.35e-1)"	"unprognostic (2.40e-1)"	"unprognostic (1.40e-2)"	"prognostic favorable (6.24e-5)"	"unprognostic (2.88e-2)"	"unprognostic (9.01e-2)"	"unprognostic (3.49e-1)"	"unprognostic (1.73e-2)"	"unprognostic (1.06e-2)"	"unprognostic (3.69e-3)"	14.3	12.3	14.3	12.8	15.9	15.6	13.1	12.6	14.6	13.2	10.0	25.5	8.1	21.9	8.2	12.3	15.8	8.7	21.7	13.8	17.5	10.0	10.1	12.8	17.0	14.9	15.4	16.5	14.9	13.9	15.4	7.7	14.8	14.6	5.8	7.2	11.4	13.7	19.6	13.3	17.9	15.0	12.8	19.2	14.6	30.1	16.2	12.8	12.7	11.9	11.5	16.4	10.9	14.3	22.0	23.6	17.0	32.8	21.6	14.6	11.5	20.7	19.3	17.6	15.8	16.7	12.3	17.3	11.4	22.0	38.7	17.1	13.6	15.3	10.3	11.4	19.3	12.5	13.6	18.0	27.7	19.5	25.3	21.4	20.4	16.2	14.6	18.4	15.0	19.2	28.4	12.9	18.9	35.2	8.8	44.7	25.7	13.1	20.0	26.1	23.4	12.2	13.9	13.9	14.1	25.3	11.8	33.9	13.2	15.3	14.2	28.2	20.5	24.9	39.9	25.2	22.8	11.4	9.0	16.0	19.6	21.7	37.4	3.5	7.7	24.2	10.1	8.3	9.4	8.3	9.3	8.7	6.3	8.8	10.9	11.3	13.2	12.7	8.7	7.1	8.3	6.9	14.3	15.9	12.6	14.6	13.8	17.5	14.9	15.4	14.8	12.8	16.2	14.3	33.4	6.4	23.9	34.9	33.6	16.6	20.8	11.9	15.9	36.4	16.1	17.8	33.3	8.6	13.6	12.9	52.1	14.1	47.7	10.3	25.4	17.6	145.5	14.6	33.7	29.7	6.0	8.8	50.2	13.7	12.9	26.7	16.3	16.9	19.6	34.0	26.4	15.1	22.9	28.6	61.7	15.4	6.1	23.0	29.3	257.6	37.3	23.1	12.4	49.6	37.0	30.2	56.7	46.3	64.2	15.6	7.0	30.1	20.3	24.2	13.0	14.9	13.7	48.5	26.3	46.0	30.0	159.8	124.2	12.9	16.2	15.2	40.2	22.8	11.8	15.2
RNF24	G1L	ENSG00000101236	"Ring finger protein 24"	Q9Y225	20	3927309-4015558	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 51.8"	"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 112.5;Inhibitory neurons: 127.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 238.2"	"Lineage enriched"	"Detected in all"	10	"granulocytes: 238.2"	"Cell line enhanced"	"Detected in all"		"ASC TERT1: 81.7"	"Low region specificity"	"Detected in all"							HPA011900	Approved		Supported	"Golgi apparatus"		NA	NA			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 32: U-937 - Innate immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Golgi apparatus"		"HPA011900: AB_10671089"	"unprognostic (6.61e-2)"	"unprognostic (6.56e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.17e-2)"	"unprognostic (8.79e-2)"	"unprognostic (9.24e-2)"	"prognostic unfavorable (3.81e-5)"	"unprognostic (2.65e-1)"	"unprognostic (5.87e-2)"	"unprognostic (2.66e-2)"	"unprognostic (5.19e-3)"	"unprognostic (3.42e-1)"	"prognostic unfavorable (2.67e-7)"	"unprognostic (1.18e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.24e-1)"	9.0	7.8	9.5	8.0	9.7	51.8	7.0	4.9	10.9	6.6	0.0	5.7	2.5	5.7	14.9	7.5	5.3	5.9	6.5	10.7	9.5	11.3	2.7	13.9	2.3	7.4	7.6	5.1	4.8	2.5	6.2	3.4	7.6	8.7	3.5	4.7	6.9	6.9	2.1	8.8	4.5	5.3	6.6	12.5	5.7	4.1	8.9	5.4	7.3	3.7	3.8	7.9	5.9	7.2	19.8	9.0	12.9	11.2	48.8	81.7	4.6	16.4	35.4	16.5	23.6	6.0	19.3	4.1	3.5	33.7	25.3	12.9	5.2	18.7	27.4	2.8	3.9	36.4	16.2	4.7	42.1	73.8	13.8	27.6	5.7	43.8	36.8	18.3	15.5	12.6	47.1	9.6	26.9	5.2	11.8	15.1	19.5	18.2	12.6	14.0	10.9	3.3	9.3	10.5	12.1	9.8	44.4	26.3	11.6	18.8	9.6	25.3	23.3	39.8	12.9	27.1	19.7	7.5	7.9	1.4	20.2	24.7	12.7	108.9	23.5	51.3	3.7	8.5	3.0	1.4	7.0	5.4	19.3	4.6	4.2	5.4	238.2	7.5	12.7	0.5	3.4	11.5	9.5	9.7	4.9	10.9	10.7	9.5	7.4	7.6	7.6	6.6	8.9	7.2	6.2	3.2	19.1	34.0	7.8	48.8	36.9	24.1	26.2	18.1	26.9	19.3	2.7	4.3	18.6	49.7	16.7	1.9	9.1	5.7	7.9	33.6	16.3	17.2	37.4	13.9	13.1	43.3	112.5	25.6	6.7	42.4	9.7	31.4	4.5	12.6	17.2	1.2	5.7	38.7	127.2	6.6	10.2	24.7	71.6	22.6	36.7	30.9	39.2	16.9	25.2	10.4	7.2	74.4	21.1	29.2	5.8	60.2	5.9	73.8	2.2	1.8	6.8	9.6	19.7	12.4	32.3	21.4	22.4	12.8	54.4	2.9	17.0	7.4	4.8	75.1
RNF32	"FKSG33, HSD15, LMBR2"	ENSG00000105982	"Ring finger protein 32"	Q9H0A6	7	156640281-156677130	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"testis: 60.9"	"Group enriched"	"Detected in many"	9	"Early spermatids: 325.5;Late spermatids: 487.1;Spermatocytes: 243.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	5	"basophil: 12.6"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 12.6"	"Cell line enhanced"	"Detected in many"		"CACO-2: 11.8;HDLM-2: 13.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019516, HPA073560"	Enhanced		Approved	"Nuclear bodies,Cytosol"		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 83: Testis - Spermatogenesis"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 31: Spermatids - Spermatogenesis"	"Nuclear bodies, Cytosol"		"HPA019516: , HPA073560: AB_2686616"	"unprognostic (9.23e-2)"	"unprognostic (3.01e-2)"	"prognostic unfavorable (2.21e-4)"	"unprognostic (7.85e-2)"	"unprognostic (3.98e-2)"	"unprognostic (2.21e-2)"	"unprognostic (5.73e-3)"	"unprognostic (1.71e-2)"	"unprognostic (8.72e-3)"	"unprognostic (6.08e-4)"	"unprognostic (4.64e-2)"	"unprognostic (2.06e-1)"	"unprognostic (8.15e-3)"	"unprognostic (1.25e-1)"	"unprognostic (3.60e-2)"	"unprognostic (3.81e-3)"	"unprognostic (1.44e-1)"	1.9	1.3	1.6	1.5	2.3	1.7	1.1	1.3	2.2	0.9	1.0	1.9	1.6	0.9	11.0	0.9	3.2	2.4	0.6	1.7	2.3	2.2	1.1	1.6	2.1	2.1	1.7	2.6	2.0	0.7	1.7	1.4	2.1	2.1	1.6	2.7	0.9	0.9	1.1	2.2	1.3	0.3	2.0	1.4	3.0	60.9	2.7	1.1	2.5	0.1	1.2	0.7	0.9	3.5	4.5	2.3	0.5	1.2	1.0	0.6	0.8	0.7	0.2	1.1	0.9	11.8	5.0	7.2	5.5	0.7	1.2	0.1	0.0	0.2	2.2	13.2	3.0	0.9	1.1	0.5	1.0	2.1	4.1	1.7	0.8	0.6	2.3	0.7	0.5	6.3	10.7	2.0	3.5	7.8	2.9	5.2	2.5	7.6	5.6	2.9	0.1	3.4	1.6	1.5	7.2	5.4	4.3	0.4	2.3	1.1	1.3	1.5	1.9	0.0	0.2	0.9	0.6	10.2	4.8	4.2	0.8	4.8	1.7	12.6	0.4	1.4	0.4	0.2	1.5	2.6	1.5	0.4	1.0	1.6	0.3	0.5	0.0	0.4	0.5	2.6	2.0	0.6	1.6	2.3	1.3	2.2	1.7	2.3	2.1	1.7	2.1	2.0	2.7	3.5	0.9	6.4	2.6	2.3	1.9	0.3	2.2	2.8	2.8	2.3	1.7	2.2	1.1	4.3	5.4	3.7	0.0	0.0	0.3	2.4	5.9	2.0	325.5	12.7	0.9	1.1	4.2	0.4	2.0	3.2	0.5	0.7	4.6	2.9	5.7	0.6	2.5	2.9	0.4	1.7	1.9	2.5	2.0	0.0	0.9	487.1	6.5	2.1	1.8	1.0	0.1	2.5	0.0	5.0	5.3	3.1	0.5	4.1	2.4	1.3	2.8	6.4	35.4	2.2	0.0	1.4	1.1	243.4	35.6	2.0	0.6	0.1	1.1	0.2	2.1	1.5
RNF34	"FLJ21786, RIF, RIFF"	ENSG00000170633	"Ring finger protein 34"	Q969K3	12	121400041-121430623	"Enzymes, Predicted intracellular proteins"	"Apoptosis, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 134.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA074151			Supported	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	Nucleoplasm	"Nuclear bodies"	"HPA074151: AB_2686668"	"unprognostic (3.54e-1)"	"unprognostic (4.83e-2)"	"unprognostic (1.90e-1)"	"unprognostic (6.10e-2)"	"unprognostic (9.92e-2)"	"unprognostic (2.55e-2)"	"prognostic unfavorable (6.72e-8)"	"unprognostic (3.39e-1)"	"unprognostic (9.99e-2)"	"unprognostic (1.60e-2)"	"unprognostic (5.87e-3)"	"unprognostic (2.80e-2)"	"prognostic unfavorable (4.63e-4)"	"unprognostic (1.09e-1)"	"unprognostic (3.55e-1)"	"unprognostic (5.55e-3)"	"prognostic favorable (3.02e-4)"	13.7	10.8	25.5	23.6	29.7	13.4	13.4	31.6	32.2	11.6	21.8	19.2	19.5	13.7	13.5	14.9	12.5	17.3	18.4	26.8	28.6	11.3	13.0	12.9	34.3	26.0	26.6	14.7	13.8	13.3	13.7	11.5	26.7	10.5	15.6	19.0	13.9	13.5	59.5	15.7	18.3	16.7	24.7	23.3	18.4	24.6	26.6	26.8	13.9	36.8	26.4	19.0	11.9	32.7	45.4	53.8	34.7	36.3	26.8	24.5	43.2	47.5	42.2	46.3	35.3	67.3	16.9	64.9	35.3	51.3	24.6	31.8	52.6	29.8	41.0	95.3	30.8	75.4	37.7	62.5	32.1	65.7	50.4	21.9	39.6	40.2	34.7	26.4	49.3	37.9	58.0	29.3	46.0	35.7	57.5	95.7	44.5	26.6	48.4	54.0	45.1	38.1	32.0	53.2	50.7	33.0	59.4	21.8	36.6	31.6	38.0	49.1	39.5	39.5	28.4	34.6	37.8	51.2	92.8	70.5	28.2	45.4	40.6	83.7	42.1	91.2	72.4	48.4	74.1	77.1	83.2	76.8	40.4	65.0	71.1	71.1	65.2	76.2	53.3	34.3	106.3	68.3	25.5	29.7	31.6	32.2	26.8	28.6	26.0	26.6	26.7	24.7	26.6	32.7	14.5	16.0	16.2	15.3	22.9	17.5	18.7	23.4	13.6	13.9	16.5	13.2	22.0	27.1	18.9	9.2	4.2	26.1	30.9	19.0	37.2	32.7	23.5	13.7	15.3	17.3	40.8	24.8	34.3	27.3	38.8	16.1	15.8	13.9	17.7	19.0	17.2	11.2	21.2	13.5	32.7	15.8	30.5	18.0	14.9	10.7	17.1	14.0	17.8	13.1	35.0	23.6	46.4	9.5	45.5	26.2	17.2	18.0	27.9	17.0	20.5	19.9	18.7	21.4	19.7	11.1	25.0	134.0	73.9	15.3	16.1	24.2	34.3	18.5	21.2	25.7
RNF38		ENSG00000137075	"Ring finger protein 38"	Q9H0F5	9	36336396-36487548	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	11	"Early spermatids: 503.1;Late spermatids: 1314.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015853	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 12: NES - Nervous system development"	"Cluster 25: Spermatids - Spermatogenesis"	Nucleoplasm		"HPA015853: AB_1856365"	"unprognostic (2.26e-1)"	"unprognostic (2.49e-1)"	"unprognostic (1.53e-1)"	"unprognostic (8.16e-2)"	"unprognostic (6.49e-2)"	"unprognostic (3.65e-3)"	"unprognostic (3.30e-3)"	"unprognostic (1.64e-2)"	"unprognostic (1.58e-1)"	"unprognostic (9.69e-2)"	"unprognostic (2.29e-1)"	"unprognostic (4.15e-2)"	"prognostic favorable (2.90e-6)"	"unprognostic (3.88e-2)"	"unprognostic (5.94e-2)"	"unprognostic (1.46e-1)"	"unprognostic (5.39e-2)"	15.8	11.9	10.5	13.2	10.9	37.8	17.2	15.6	15.1	17.3	5.2	19.9	10.5	23.4	19.6	15.9	17.8	11.8	15.8	11.0	10.7	19.2	11.3	18.9	18.4	9.2	11.5	36.7	20.5	15.7	6.6	20.5	9.7	17.6	15.8	23.9	14.1	19.1	12.7	12.1	13.3	22.9	8.6	19.5	10.7	68.4	11.4	21.3	22.5	19.6	18.5	16.7	12.9	9.4	14.4	8.0	30.5	18.2	13.7	12.6	29.8	8.8	11.0	10.6	13.8	13.8	7.8	21.6	9.1	17.1	14.0	5.5	19.6	10.3	16.3	19.3	8.4	26.2	11.6	13.6	10.6	19.4	22.9	13.0	10.9	13.4	12.9	17.6	27.4	21.0	5.5	20.2	17.4	5.0	20.1	10.2	20.5	9.5	5.7	18.3	13.8	12.0	18.1	16.4	12.7	13.6	10.0	9.9	10.0	35.5	9.6	19.6	27.2	10.1	15.2	6.0	10.6	13.2	29.6	15.0	9.2	16.1	13.2	10.7	2.9	5.0	4.4	2.7	3.6	3.5	4.0	4.7	2.7	3.7	4.2	4.3	5.3	5.9	2.8	2.2	5.9	3.1	10.5	10.9	15.6	15.1	11.0	10.7	9.2	11.5	9.7	8.6	11.4	9.4	32.8	12.8	11.7	80.6	16.8	17.3	10.9	8.7	14.8	16.5	21.9	15.2	15.9	10.0	11.5	7.3	18.8	13.2	29.9	19.6	9.8	11.2	503.1	13.1	14.6	25.0	16.8	9.0	71.2	12.0	11.9	14.4	14.8	16.7	6.3	20.5	24.7	16.6	11.4	26.9	72.8	12.8	10.2	27.0	23.7	1314.3	32.9	19.0	19.6	82.4	19.5	19.3	20.6	53.3	81.5	14.5	6.8	39.9	18.6	23.9	10.4	16.5	10.1	23.2	13.1	19.3	20.9	40.4	20.2	14.4	14.9	14.9	23.3	13.2	14.3	17.5
RNF4	"RES4-26, SLX5, SNURF"	ENSG00000063978	"Ring finger protein 4"	P78317	4	2462220-2625320	"Enzymes, Predicted intracellular proteins"	"Transcription, Transcription regulation, Ubl conjugation pathway"	"Activator, DNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022047, HPA049356"	Approved		Supported	"Nucleoplasm,Nuclear bodies,Microtubule ends"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 16: U-266 - Nucleosome"	"Cluster 59: Non-specific - Transcription"	"Nucleoplasm, Nuclear bodies"	"Microtubule ends"	"HPA022047: , HPA049356: AB_2680726"	"unprognostic (8.38e-3)"	"unprognostic (1.69e-1)"	"unprognostic (1.29e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.45e-1)"	"unprognostic (9.31e-3)"	"unprognostic (9.03e-3)"	"prognostic unfavorable (6.38e-4)"	"unprognostic (1.34e-1)"	"unprognostic (6.79e-2)"	"unprognostic (2.58e-1)"	"unprognostic (5.64e-2)"	"unprognostic (1.93e-2)"	"unprognostic (6.40e-2)"	"unprognostic (4.70e-2)"	"unprognostic (8.67e-2)"	"unprognostic (1.54e-1)"	30.2	30.9	24.0	36.0	24.9	46.4	29.2	26.0	25.1	29.4	26.5	27.9	29.0	29.5	28.3	30.7	28.5	28.3	27.0	24.5	25.5	32.6	25.9	27.8	49.9	26.0	25.9	31.0	31.2	33.6	26.8	28.4	25.2	28.2	27.4	24.0	28.0	28.1	27.7	29.7	30.4	33.1	23.9	40.3	30.1	31.9	26.3	50.1	30.7	23.2	50.0	35.0	26.8	25.5	60.9	57.0	57.9	42.0	50.6	52.2	65.6	73.3	83.4	77.3	70.0	65.1	56.8	77.6	42.0	76.0	101.5	39.7	63.5	58.6	72.7	37.6	38.5	92.4	54.6	62.6	76.6	66.7	77.8	61.0	69.7	72.3	59.4	53.6	73.1	64.8	50.0	103.2	80.4	43.5	105.0	92.5	89.8	52.3	70.9	76.6	55.3	40.8	52.6	74.5	54.3	51.0	50.5	40.4	52.1	62.9	63.1	50.6	60.0	65.8	32.0	64.2	115.4	131.3	189.5	82.6	64.6	72.7	69.5	44.7	70.0	104.6	97.7	95.4	97.2	85.0	82.2	97.0	84.1	59.1	78.8	80.3	77.2	99.2	103.8	56.5	98.8	128.6	24.0	24.9	26.0	25.1	24.5	25.5	26.0	25.9	25.2	23.9	26.3	25.5	31.1	22.4	17.5	17.0	36.0	27.5	18.4	17.7	31.3	11.9	24.0	16.0	20.7	12.8	21.3	22.0	16.7	21.3	45.9	16.5	21.5	22.2	14.0	17.0	22.8	21.7	12.1	15.4	15.9	23.3	35.0	19.5	23.0	23.9	14.5	22.7	16.4	20.4	19.7	13.5	17.8	16.8	8.2	34.0	28.5	22.4	17.1	27.8	7.2	18.7	35.1	11.5	43.3	13.0	16.3	29.8	14.3	20.7	47.8	27.1	23.1	21.2	17.6	17.7	26.3	18.2	22.0	31.2	48.6	27.0	32.1	21.8	39.7	16.4	18.9	32.9
RNF40	"BRE1B, KIAA0661, RBP95, STARING"	ENSG00000103549	"Ring finger protein 40"	O75150	16	30761745-30776307	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Chromatin regulator, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal tubular cells: 88.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041330, HPA054227"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 14: REH - Unknown function"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm		"HPA041330: AB_10793872, HPA054227: AB_2682422"	"unprognostic (1.61e-1)"	"unprognostic (1.74e-2)"	"unprognostic (3.06e-1)"	"unprognostic (4.87e-2)"	"unprognostic (1.21e-1)"	"unprognostic (4.01e-1)"	"unprognostic (5.97e-3)"	"unprognostic (1.56e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.89e-1)"	"unprognostic (2.16e-2)"	"unprognostic (1.91e-2)"	"prognostic favorable (8.11e-8)"	"unprognostic (9.96e-2)"	"unprognostic (1.36e-1)"	"unprognostic (6.55e-3)"	"unprognostic (6.60e-3)"	24.4	28.7	23.4	26.7	25.9	55.3	21.5	25.5	24.8	26.7	26.2	26.0	24.9	29.3	15.5	31.8	25.4	26.0	16.3	25.8	22.4	19.9	20.9	22.5	26.9	25.9	24.3	35.2	29.8	35.2	21.7	21.4	23.0	22.6	17.6	18.1	33.7	22.5	17.5	27.4	24.7	21.5	22.3	24.7	23.4	38.0	26.1	24.6	29.0	16.0	22.3	21.4	22.7	28.8	58.5	87.9	53.0	52.7	41.9	43.3	58.6	58.7	47.4	66.8	52.4	72.4	53.7	46.5	82.9	50.5	45.5	62.1	99.2	55.5	53.0	66.7	120.9	45.2	99.9	77.2	53.3	79.8	54.0	41.3	43.5	83.3	48.8	44.2	57.7	40.6	101.3	46.1	42.5	98.3	76.4	74.4	55.6	47.7	55.4	149.9	58.8	91.6	29.8	52.0	89.9	65.0	45.0	58.7	41.8	27.9	88.9	88.5	60.8	74.6	37.4	53.8	67.7	66.1	87.2	93.0	62.3	70.6	77.1	6.5	13.6	17.1	13.1	14.1	13.1	8.1	7.1	10.0	13.9	5.9	5.3	8.8	16.1	11.1	17.1	6.6	6.7	16.2	23.4	25.9	25.5	24.8	25.8	22.4	25.9	24.3	23.0	22.3	26.1	28.8	13.5	12.8	24.9	18.3	17.2	13.9	12.3	10.2	16.5	12.8	18.9	15.6	3.2	28.6	11.5	22.0	4.2	16.0	20.7	27.7	88.0	15.2	23.7	24.7	20.8	14.9	13.9	37.4	10.3	13.3	16.9	14.5	26.0	29.2	4.5	19.3	10.8	22.9	21.5	5.0	11.2	23.2	10.2	23.0	12.6	22.0	18.0	16.9	17.8	4.7	16.7	16.5	11.3	13.0	8.7	16.3	15.4	17.7	21.8	15.8	24.2	26.5	12.4	13.7	13.1	15.8	13.3	27.1	11.3	20.6	19.7	22.7	16.0	22.2	25.8	11.2
RNF5	"G16, NG2, RING5, RMA1"	ENSG00000204308	"Ring finger protein 5"	Q99942	6	32178405-32180793	"Enzymes, Metabolic proteins, Predicted membrane proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Proximal tubular cells: 371.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034107, HPA065032"	Uncertain		Supported	"Endoplasmic reticulum"		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Endoplasmic reticulum"		"CAB034107: AB_2238618, HPA065032: AB_2685408"	"unprognostic (1.94e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.49e-1)"	"unprognostic (4.45e-3)"	"unprognostic (1.35e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.37e-2)"	"unprognostic (4.07e-1)"	"prognostic favorable (2.44e-4)"	"unprognostic (1.95e-1)"	"unprognostic (8.93e-3)"	"unprognostic (2.91e-3)"	"unprognostic (8.84e-2)"	"unprognostic (9.17e-2)"	"unprognostic (2.72e-1)"	"unprognostic (2.99e-2)"	38.2	75.9	60.4	29.2	63.4	40.4	44.5	64.6	66.0	44.9	59.4	59.5	61.6	44.8	45.8	37.5	54.1	46.1	81.7	59.2	60.6	115.6	126.2	38.7	43.1	65.0	60.6	60.4	41.6	55.5	17.2	30.1	62.6	44.0	62.4	42.9	43.9	31.7	89.6	44.6	76.5	30.5	62.8	38.8	55.3	29.5	61.8	60.7	48.6	76.5	43.4	45.1	38.8	67.0	51.2	66.1	43.7	167.5	46.9	31.3	34.0	20.6	26.5	44.4	48.7	89.1	42.1	65.2	70.8	47.9	62.5	41.7	80.3	45.1	45.2	41.8	107.5	53.9	69.5	184.4	55.0	0.2	101.2	32.3	60.3	73.3	53.6	77.2	89.1	115.0	136.6	67.8	63.8	71.9	66.5	151.5	0.3	71.8	28.7	44.4	48.2	88.2	124.0	32.6	44.8	92.1	39.9	42.4	46.7	39.9	87.0	183.0	40.3	48.1	44.7	0.5	79.1	38.6	63.5	79.3	33.2	116.4	29.6	64.8	45.7	75.8	64.8	65.9	55.6	64.6	52.5	57.6	64.7	56.2	57.5	58.3	22.1	79.6	46.7	264.6	58.2	75.0	60.4	63.4	64.6	66.0	59.2	60.6	65.0	60.6	62.6	62.8	61.8	67.0	38.3	19.2	41.1	2.9	52.7	95.7	70.0	146.6	52.3	23.6	61.8	56.5	62.9	87.2	79.5	92.0	0.0	78.1	70.3	151.9	283.7	110.8	21.6	47.2	31.7	50.9	73.2	126.3	3.4	91.3	101.7	44.6	28.5	31.7	56.3	41.5	47.8	131.5	68.9	33.7	3.5	83.0	132.2	51.1	171.7	22.6	59.4	43.3	85.4	1.0	69.5	91.3	65.9	1.5	10.0	78.5	173.0	72.6	45.5	58.4	270.6	371.6	73.4	27.6	65.7	50.6	63.0	55.7	37.7	44.4	84.4	84.1	53.8	42.8	100.3	56.5
RNF6	DKFZp686P0776	ENSG00000127870	"Ring finger protein 6"	Q9Y252	13	26132115-26222314	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 99.1;Late spermatids: 191.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039343, HPA040048"	Approved		Supported	"Nuclear membrane"		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 34: Non-specific - Transcription"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 31: Spermatids - Spermatogenesis"	"Nuclear membrane"		"HPA039343: AB_2676456, HPA040048: AB_10672969"	"unprognostic (3.22e-1)"	"prognostic unfavorable (3.07e-4)"	"unprognostic (1.45e-1)"	"unprognostic (1.63e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.68e-2)"	"unprognostic (1.97e-1)"	"unprognostic (4.07e-2)"	"unprognostic (7.63e-2)"	"unprognostic (6.13e-2)"	"unprognostic (1.39e-1)"	"unprognostic (4.21e-2)"	"unprognostic (2.70e-2)"	"unprognostic (8.35e-3)"	"unprognostic (1.84e-1)"	"unprognostic (7.70e-2)"	"unprognostic (8.47e-2)"	18.9	17.3	12.4	18.7	13.3	32.5	17.9	13.4	18.4	13.4	13.5	18.4	17.5	12.4	13.7	18.5	14.5	13.7	13.7	13.9	11.7	18.2	16.6	16.2	22.4	10.4	13.5	11.5	14.1	22.3	10.7	19.9	11.5	16.0	18.5	26.6	13.5	13.9	21.2	17.3	18.8	15.7	10.8	19.7	17.2	33.6	13.7	25.3	17.5	15.3	23.8	18.3	10.1	11.5	33.3	28.9	10.7	15.8	36.3	28.2	23.9	56.3	45.2	35.4	24.9	36.4	41.8	59.5	27.3	53.5	31.5	43.7	30.2	45.3	58.4	57.7	19.2	64.8	23.9	31.3	56.6	68.7	65.4	26.8	86.1	39.8	84.2	34.3	36.0	25.5	25.6	0.1	55.3	30.0	38.5	39.8	8.7	59.5	19.8	30.4	41.5	23.7	43.6	43.3	19.3	11.9	29.9	54.0	54.1	24.8	20.7	66.3	47.6	30.4	18.6	41.1	40.5	14.8	14.9	34.9	27.8	38.4	40.7	46.6	14.5	34.7	15.6	18.4	17.1	18.6	17.1	17.7	17.6	12.5	16.8	14.8	9.7	20.0	23.3	9.1	19.2	14.2	12.4	13.3	13.4	18.4	13.9	11.7	10.4	13.5	11.5	10.8	13.7	11.5	20.9	22.4	19.8	6.8	26.5	30.5	12.7	17.5	14.8	22.2	15.1	10.5	13.5	5.7	19.7	7.3	25.0	20.2	31.6	24.8	33.2	15.1	99.1	37.4	16.9	23.0	11.4	24.8	14.4	15.4	21.8	16.1	17.3	19.9	26.6	12.1	17.5	12.3	17.5	30.3	17.2	15.5	24.4	22.4	19.9	191.0	14.6	23.0	14.2	12.2	21.6	24.9	29.9	11.6	16.2	24.4	20.1	11.3	18.0	22.0	15.8	21.4	40.1	43.2	26.3	21.6	14.5	83.5	29.1	19.2	29.1	42.1	26.2	17.1	12.6	23.5
RNF7	"CKBBP1, ROC2, SAG"	ENSG00000114125	"Ring finger protein 7"	Q9UBF6	3	141738249-141747560	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 898.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA036995	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 25: Spermatids - Spermatogenesis"	Nucleoplasm	Cytosol	"HPA036995: AB_10673627"	"unprognostic (5.68e-2)"	"unprognostic (4.94e-3)"	"unprognostic (1.83e-1)"	"unprognostic (3.24e-1)"	"unprognostic (9.11e-2)"	"unprognostic (3.45e-1)"	"prognostic unfavorable (2.21e-4)"	"unprognostic (4.53e-2)"	"unprognostic (1.24e-2)"	"unprognostic (3.98e-3)"	"unprognostic (5.17e-3)"	"unprognostic (8.58e-3)"	"prognostic unfavorable (1.54e-9)"	"unprognostic (4.60e-1)"	"unprognostic (2.20e-1)"	"unprognostic (3.69e-2)"	"unprognostic (2.36e-2)"	67.1	114.5	62.7	40.8	65.6	65.0	63.5	63.4	80.0	69.5	72.2	98.2	69.7	58.7	70.8	86.5	61.0	46.1	102.8	64.2	67.2	92.3	83.9	58.4	44.5	64.4	64.8	73.8	80.3	44.0	81.5	51.2	65.7	77.6	59.8	37.6	59.8	43.8	142.0	72.0	64.1	47.8	65.1	58.7	68.3	71.2	66.3	45.4	52.6	113.1	44.1	77.9	71.9	65.9	172.6	67.4	98.1	80.0	91.6	125.7	65.5	94.6	87.5	78.2	82.6	79.4	82.5	57.7	214.5	104.7	192.7	80.8	61.5	88.1	98.3	56.0	119.1	56.6	64.8	116.4	122.6	89.7	52.9	118.2	96.9	63.4	105.5	104.3	112.3	96.1	61.6	77.0	117.2	131.0	56.6	100.1	105.1	170.7	113.3	61.1	63.1	124.0	169.2	74.0	54.8	68.1	108.7	108.8	161.4	126.4	102.4	114.8	86.2	78.1	75.6	139.2	80.5	73.7	66.5	121.2	122.4	98.4	90.3	119.0	128.2	87.7	78.0	116.4	77.7	82.6	82.8	83.2	112.9	74.1	79.6	83.7	45.5	61.8	125.7	103.4	108.8	121.6	62.7	65.6	63.4	80.0	64.2	67.2	64.4	64.8	65.7	65.1	66.3	65.9	128.7	60.9	55.2	7.5	81.4	132.4	143.0	290.5	150.2	34.3	159.7	207.3	104.1	105.8	151.1	101.2	27.1	183.8	133.2	262.0	254.3	225.1	348.9	99.3	112.0	134.9	125.7	41.4	12.9	247.3	249.1	114.2	73.9	100.0	72.9	206.4	129.9	132.0	214.4	28.6	12.6	195.2	134.3	126.7	123.5	898.4	117.8	137.6	144.1	18.7	174.1	111.7	140.1	10.6	19.6	233.2	261.4	121.9	102.0	181.8	295.1	324.1	105.7	56.7	85.5	84.3	126.2	212.2	129.1	183.7	144.6	129.8	112.7	281.4	174.5	185.9
RNF8	KIAA0646	ENSG00000112130	"Ring finger protein 8"	O76064	6	37353979-37394734	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, DNA damage, DNA repair, Host-virus interaction, Mitosis, Ubl conjugation pathway"	"Chromatin regulator, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-698: 76.0"	"Not detected"	"Not detected"							"HPA050731, HPA064925"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 51: Myeloid cells - Hemostasis"	Nucleoplasm	Cytosol	"HPA050731: AB_2681222, HPA064925: AB_2685385"	"unprognostic (1.80e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.39e-2)"	"unprognostic (8.20e-2)"	"unprognostic (5.17e-2)"	"unprognostic (3.99e-2)"	"prognostic unfavorable (3.33e-5)"	"unprognostic (2.36e-2)"	"prognostic unfavorable (1.91e-4)"	"unprognostic (2.26e-3)"	"unprognostic (3.38e-1)"	"prognostic unfavorable (4.99e-5)"	"unprognostic (7.95e-3)"	"unprognostic (1.78e-1)"	"unprognostic (3.41e-2)"	"unprognostic (3.66e-3)"	"unprognostic (1.09e-1)"	5.0	7.8	10.0	3.5	10.1	4.6	5.2	11.8	14.3	7.7	9.3	6.3	3.1	7.0	2.1	10.6	6.0	4.0	8.6	10.1	10.5	8.8	4.8	5.9	4.2	10.2	10.6	7.6	4.5	7.4	6.6	4.8	10.3	6.0	3.6	9.0	6.2	5.2	8.1	7.6	5.0	4.9	9.4	4.7	5.2	11.2	11.2	5.8	4.5	10.6	6.6	6.5	7.8	9.9	12.5	7.3	17.3	20.7	13.7	19.6	4.9	12.6	15.5	23.4	25.6	11.0	6.8	15.3	7.5	12.4	20.1	11.4	24.4	16.0	24.4	16.2	23.7	26.5	12.0	16.6	7.8	14.3	18.7	9.8	15.2	14.0	16.2	14.3	22.9	17.9	18.1	5.2	13.6	8.3	17.4	17.5	12.1	6.3	9.4	13.5	16.0	10.6	12.1	8.7	34.0	11.4	9.5	10.6	18.0	11.3	9.5	13.6	10.4	15.4	13.5	14.7	18.8	15.2	21.8	76.0	7.5	20.1	18.0	1.0	4.3	2.5	9.5	5.8	8.8	8.1	7.0	9.2	7.8	4.9	6.1	8.1	0.5	7.9	8.8	3.3	9.1	5.2	10.0	10.1	11.8	14.3	10.1	10.5	10.2	10.6	10.3	9.4	11.2	9.9	21.0	19.2	25.9	13.4	15.0	18.2	22.2	26.0	26.2	26.7	16.5	20.4	31.1	12.8	18.5	25.8	39.6	24.8	18.2	10.3	15.6	24.7	41.1	68.5	32.2	19.2	22.2	18.7	17.0	18.9	25.8	28.0	16.3	52.3	28.5	37.0	27.8	16.5	17.5	50.5	15.9	16.5	14.2	13.9	17.7	30.2	26.8	24.0	10.6	11.2	19.6	25.4	37.0	12.5	20.5	28.8	18.1	30.9	13.7	31.8	11.8	20.6	23.8	32.3	13.1	23.2	20.8	46.5	34.5	34.2	22.0	5.9	19.3	22.0	18.0	21.9
RNH1	"RAI, RNH"	ENSG00000023191	"Ribonuclease/angiogenin inhibitor 1"	P13489	11	494512-507300	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"dendritic cells: 262.3;monocytes: 299.1"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039223, HPA040781"	Enhanced		Enhanced	Nucleoplasm,Cytosol		NA	NA		22000000	"Cluster 7: Monocytes - Unknown function"	"Cluster 31: Skin - Epidermis development"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 4: Macrophages - Innate immune response"	"Nucleoplasm, Cytosol"		"HPA039223: AB_10795581, HPA040781: AB_10796227"	"unprognostic (1.87e-1)"	"unprognostic (2.44e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.59e-3)"	"unprognostic (2.48e-3)"	"unprognostic (6.09e-2)"	"unprognostic (4.82e-3)"	"unprognostic (1.35e-1)"	"unprognostic (1.96e-1)"	"unprognostic (2.20e-1)"	"unprognostic (1.55e-1)"	"unprognostic (2.44e-1)"	"prognostic favorable (2.14e-5)"	"unprognostic (3.35e-1)"	"unprognostic (1.66e-1)"	"unprognostic (4.78e-2)"	"unprognostic (4.35e-2)"	163.5	137.2	27.3	29.0	41.8	46.3	133.7	42.4	33.9	156.4	28.9	123.0	27.1	140.8	10.0	215.0	119.5	29.7	198.0	26.3	32.5	118.6	111.9	146.7	30.8	48.6	39.7	119.1	89.5	25.6	80.6	27.3	38.2	100.9	8.8	5.6	112.5	31.0	145.9	257.4	91.1	25.3	35.3	113.3	101.1	90.1	38.3	15.6	106.6	21.8	13.9	144.5	160.3	49.4	86.5	123.9	13.2	39.8	66.3	93.8	43.9	70.6	51.3	68.9	58.3	61.9	92.9	41.8	54.3	175.1	41.9	72.7	20.6	76.5	10.4	51.3	104.9	28.2	28.5	65.7	243.3	39.8	90.0	77.1	108.2	40.2	46.7	29.2	47.9	27.7	36.2	71.3	37.7	86.6	30.5	78.4	19.8	45.3	112.6	37.7	22.3	55.8	40.7	34.6	35.7	23.2	41.8	59.1	73.7	7.4	44.6	122.2	77.3	109.3	32.8	39.8	49.5	44.9	53.0	32.2	117.5	81.9	74.3	37.6	246.2	57.3	51.1	298.9	59.9	63.0	55.3	51.1	262.3	48.4	49.8	45.1	17.1	54.2	299.1	71.7	58.4	236.5	27.3	41.8	42.4	33.9	26.3	32.5	48.6	39.7	38.2	35.3	38.3	49.4	156.0	112.2	83.5	18.9	92.3	202.1	239.0	265.0	89.4	102.4	82.0	105.5	83.3	88.6	138.6	79.1	110.5	222.2	85.3	126.6	225.0	188.8	105.1	72.8	132.4	136.1	57.4	59.7	10.9	164.4	217.4	194.9	64.2	82.8	140.2	93.8	101.7	68.6	374.0	168.2	14.5	115.6	148.5	191.8	323.0	42.7	211.6	230.3	193.9	12.2	334.2	144.6	79.3	10.1	70.8	171.6	120.5	179.8	101.7	161.0	139.4	242.3	97.9	146.4	177.5	99.1	178.0	153.4	157.8	140.0	260.0	305.5	96.5	199.7	114.4	217.4
RNMT	RG7MT1	ENSG00000101654	"RNA guanine-7 methyltransferase"	O43148	18	13726660-13764556	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"mRNA capping, mRNA processing"	"Methyltransferase, RNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039409	Approved		Supported	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	"Nucleoli fibrillar center"	"HPA039409: AB_10795289"	"unprognostic (3.02e-1)"	"unprognostic (1.07e-2)"	"unprognostic (3.48e-1)"	"unprognostic (1.71e-3)"	"unprognostic (3.57e-1)"	"unprognostic (3.04e-1)"	"unprognostic (6.17e-3)"	"unprognostic (1.43e-1)"	"unprognostic (3.76e-2)"	"unprognostic (1.42e-3)"	"unprognostic (9.45e-2)"	"unprognostic (9.15e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.56e-1)"	"unprognostic (2.77e-2)"	"unprognostic (1.78e-1)"	10.9	9.6	11.8	12.6	12.1	43.3	15.3	12.2	13.0	11.3	17.2	11.6	8.5	14.0	11.5	11.3	11.2	9.0	20.3	12.1	14.2	11.6	11.2	9.5	14.4	13.6	15.2	17.2	12.1	13.0	13.9	15.2	14.8	11.6	10.4	27.4	12.1	10.5	18.4	14.2	10.5	12.5	10.9	12.1	10.6	16.7	11.7	14.9	17.5	15.6	15.2	11.4	10.7	12.6	24.9	14.4	27.4	20.9	20.0	25.1	19.2	19.9	24.7	20.3	27.4	17.3	11.7	27.7	23.9	20.6	31.6	9.8	32.7	28.6	34.0	15.4	17.6	21.0	14.8	16.4	21.9	54.9	17.1	19.4	30.5	21.4	59.9	26.6	15.9	31.1	31.8	26.9	23.3	15.4	35.2	19.7	21.0	50.1	11.2	22.7	29.0	37.9	18.6	19.2	21.1	31.7	22.5	16.4	38.1	27.8	14.3	22.6	16.5	40.6	56.8	33.3	21.5	53.8	63.6	56.9	29.9	20.8	20.6	45.1	17.6	12.8	16.7	14.6	13.6	23.9	15.8	14.2	11.8	25.7	20.5	16.2	9.8	14.1	17.3	29.5	19.0	5.6	11.8	12.1	12.2	13.0	12.1	14.2	13.6	15.2	14.8	10.9	11.7	12.6	62.5	73.7	29.9	48.6	148.5	70.4	67.3	97.9	75.1	115.6	50.7	56.1	56.5	35.8	56.5	46.0	123.0	66.3	143.4	46.5	68.4	51.0	75.4	85.2	88.3	43.7	74.8	37.4	75.3	48.0	59.2	71.6	66.3	113.9	34.9	85.6	40.7	38.5	39.8	106.0	83.9	56.3	85.5	59.4	63.6	21.1	72.7	78.8	49.8	45.0	68.0	51.0	60.8	56.8	78.9	56.1	47.0	60.9	99.7	72.3	49.0	64.8	48.0	148.3	39.5	85.6	60.0	111.4	115.1	50.7	68.3	126.4	113.1	48.8	50.0	50.3
RNPC3	"FLJ20008, KIAA1839, RBM40, SNRNP65"	ENSG00000185946	"RNA binding region (RNP1, RRM) containing 3"	Q96LT9	1	103525691-103555239	"Disease related genes, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding	"Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in all"		"Cone photoreceptor cells: 133.5;Rod photoreceptor cells: 143.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052434			Supported	Nucleoplasm		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 51: Non-specific - Unknown function"	"Cluster 20: HeLa - Mitochondria"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA052434: AB_2681832"	"unprognostic (1.87e-2)"	"unprognostic (9.61e-2)"	"unprognostic (1.04e-1)"	"unprognostic (4.31e-3)"	"unprognostic (2.92e-2)"	"unprognostic (1.34e-5)"	"unprognostic (9.00e-2)"	"prognostic favorable (1.53e-4)"	"unprognostic (1.94e-2)"	"unprognostic (7.61e-2)"	"prognostic favorable (7.82e-4)"	"prognostic unfavorable (7.70e-4)"	"unprognostic (3.65e-2)"	"unprognostic (1.59e-2)"	"unprognostic (2.28e-1)"	"unprognostic (3.19e-1)"	"prognostic favorable (5.25e-4)"	31.4	24.8	9.6	22.7	9.5	24.4	30.7	21.3	24.2	35.7	0.7	30.8	23.4	33.8	54.0	16.2	35.6	21.2	30.1	8.1	3.4	29.8	17.0	26.0	33.9	3.4	1.0	37.9	44.9	24.7	33.4	12.5	2.2	25.2	22.2	63.6	37.3	21.4	44.0	37.7	29.2	16.0	0.9	30.0	22.2	15.9	5.8	20.0	55.0	16.9	26.0	26.7	27.4	23.0	10.7	8.7	17.8	8.8	10.4	18.8	11.6	14.4	9.7	11.3	17.1	9.3	17.9	20.0	22.8	7.4	6.7	20.9	11.5	11.1	13.7	13.0	20.3	21.1	52.0	9.5	7.7	28.2	17.4	17.8	16.8	9.9	6.8	16.2	10.4	17.3	13.4	22.4	12.8	5.8	16.8	13.7	11.5	9.8	12.5	22.1	16.7	15.9	14.7	11.7	18.8	9.0	9.9	13.7	14.6	9.7	9.4	12.5	13.9	12.3	12.2	6.5	9.5	17.2	6.4	18.1	21.4	21.5	6.3	249.7	91.0	70.0	53.7	46.1	39.5	109.3	65.0	50.2	28.9	127.7	75.9	69.6	252.6	40.0	53.4	111.9	48.2	15.6	9.6	9.5	21.3	24.2	8.1	3.4	3.4	1.0	2.2	0.9	5.8	23.0	28.8	28.9	43.5	108.0	31.3	7.5	17.4	13.3	30.1	104.6	21.0	26.5	20.2	12.8	30.8	27.6	133.5	7.9	31.1	23.9	15.6	10.6	44.4	20.7	22.1	18.8	16.9	13.9	89.1	10.5	4.1	19.0	34.1	18.5	20.8	22.3	16.1	9.9	7.6	62.2	76.2	19.5	14.2	23.0	10.8	6.5	24.8	22.3	16.0	44.0	37.3	40.5	25.7	64.8	71.2	10.8	19.0	21.4	26.0	10.5	19.9	7.3	41.8	143.1	26.3	35.2	23.4	22.8	11.9	18.9	8.9	10.9	26.3	16.5	14.3	14.0
RNPEPL1		ENSG00000142327	"Arginyl aminopeptidase like 1"	Q9HAU8	2	240565804-240581372	"Enzymes, Predicted intracellular proteins"		"Aminopeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 138.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036772, HPA036773"	Uncertain		Supported	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm	"Nuclear bodies"	"HPA036772: AB_10670848, HPA036773: "	"unprognostic (3.92e-2)"	"unprognostic (7.28e-2)"	"unprognostic (1.20e-2)"	"unprognostic (2.39e-1)"	"unprognostic (5.24e-3)"	"prognostic favorable (7.43e-4)"	"prognostic unfavorable (5.06e-4)"	"unprognostic (3.72e-3)"	"unprognostic (9.10e-2)"	"unprognostic (1.66e-3)"	"unprognostic (3.10e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.98e-2)"	"unprognostic (5.33e-2)"	"unprognostic (1.57e-1)"	"unprognostic (5.31e-2)"	"unprognostic (9.86e-2)"	40.3	31.4	29.1	14.1	29.6	21.7	32.0	29.0	38.7	15.6	27.0	39.6	20.2	16.8	5.6	52.4	17.0	12.1	79.4	27.9	27.8	42.7	50.6	35.9	23.8	31.5	30.0	12.0	64.2	10.9	9.1	10.6	30.3	34.7	9.5	0.8	28.9	13.1	63.7	35.3	39.8	9.4	31.0	56.4	48.4	9.9	31.4	15.9	19.2	17.1	12.1	34.1	23.2	31.1	13.7	22.4	4.9	13.2	17.6	18.1	16.6	8.6	21.1	9.5	11.6	6.3	39.3	3.9	4.3	21.8	13.3	14.6	5.5	16.1	0.9	23.9	7.7	9.0	7.3	37.2	44.1	5.9	15.5	21.6	25.5	4.9	9.6	15.1	32.8	15.2	6.8	25.7	6.5	19.3	7.5	22.4	6.5	26.5	9.0	15.5	7.4	33.3	39.3	18.5	4.6	9.8	5.8	19.7	39.9	5.6	13.9	26.8	22.7	10.2	10.4	14.4	10.0	24.1	3.9	4.8	20.9	16.6	15.7	9.2	11.2	30.5	14.8	9.9	12.7	8.2	11.3	13.4	8.2	8.7	6.4	9.5	20.0	10.7	10.1	9.5	14.7	7.9	29.1	29.6	29.0	38.7	27.9	27.8	31.5	30.0	30.3	31.0	31.4	31.1	27.9	22.4	25.7	10.4	27.8	7.8	15.0	8.4	2.8	6.4	18.8	9.1	35.6	24.3	12.9	12.9	0.0	7.1	80.4	138.9	17.6	24.6	3.1	12.1	11.0	22.7	26.4	22.3	9.5	49.6	6.8	12.3	104.5	27.4	34.2	31.8	30.0	42.2	43.8	3.3	8.6	58.7	8.2	74.3	21.0	5.9	8.7	47.1	23.2	9.4	52.0	15.9	79.3	5.5	10.3	65.0	70.0	13.5	20.5	20.2	77.1	35.6	7.2	6.9	13.1	14.8	16.4	1.3	8.2	13.0	9.2	5.1	47.9	17.4	60.5	23.0
RNPS1		ENSG00000205937	"RNA binding protein with serine rich domain 1"	Q15287	16	2253116-2268397	"Predicted intracellular proteins, Transporters"	"mRNA processing, mRNA splicing, Nonsense-mediated mRNA decay"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044014	Approved		Supported	Nucleoplasm		NA	NA		13000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm		"HPA044014: AB_10966286"	"unprognostic (3.50e-2)"	"unprognostic (2.74e-3)"	"unprognostic (3.46e-1)"	"unprognostic (1.49e-3)"	"unprognostic (2.92e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.18e-3)"	"unprognostic (1.96e-1)"	"unprognostic (2.76e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.30e-1)"	"unprognostic (2.93e-2)"	"unprognostic (1.04e-1)"	"unprognostic (7.13e-3)"	"unprognostic (2.38e-1)"	"unprognostic (4.64e-2)"	"unprognostic (2.27e-1)"	82.8	78.7	91.9	55.1	96.1	144.9	83.4	82.6	112.6	89.0	60.5	108.8	51.3	98.8	51.1	98.0	84.6	39.9	101.0	99.1	93.0	81.4	63.8	73.5	76.5	96.0	84.5	92.6	71.8	52.5	101.4	53.5	94.9	95.0	43.9	47.4	70.0	54.9	229.7	97.3	84.0	52.4	72.5	94.9	76.8	88.4	88.5	69.8	74.2	105.2	71.3	94.1	83.6	90.7	119.6	154.5	167.7	163.9	89.0	78.6	194.2	125.2	88.4	170.6	147.0	306.1	142.8	251.1	124.0	103.2	108.6	160.0	217.3	152.5	128.9	175.2	283.2	172.8	133.9	198.3	150.2	185.5	159.0	99.3	168.3	149.1	207.1	80.8	134.8	144.6	302.1	195.3	143.3	259.7	296.2	363.6	340.1	135.2	128.4	441.4	196.6	322.3	122.5	66.6	354.8	218.3	172.3	157.6	166.4	77.1	152.7	187.7	102.2	155.4	155.2	143.0	182.1	199.7	282.5	582.9	63.3	168.0	185.6	48.1	144.0	123.2	169.5	170.5	167.7	177.9	162.2	172.9	153.8	205.5	153.3	162.0	43.4	182.9	187.8	131.6	196.1	290.2	91.9	96.1	82.6	112.6	99.1	93.0	96.0	84.5	94.9	72.5	88.5	90.7	90.6	44.8	62.7	29.7	148.2	206.6	208.7	148.9	119.5	119.7	99.5	95.9	36.3	65.8	85.5	51.5	139.7	182.3	138.5	90.8	70.5	115.5	16.3	76.5	88.9	102.1	122.0	130.4	72.1	93.2	237.4	90.7	79.0	108.4	103.4	114.9	77.1	37.5	104.7	97.6	61.1	100.6	124.1	71.3	117.0	21.4	94.1	80.1	97.8	23.4	123.9	98.0	180.2	31.7	37.3	121.7	76.5	68.8	117.2	209.5	81.1	64.3	50.2	132.8	85.5	103.9	102.3	132.9	267.4	117.6	212.4	162.0	131.7	101.7	125.7	203.5
RO60	"SSA2, TROVE2"	ENSG00000116747	"Ro60, Y RNA binding protein"	P10155	1	193059454-193091777	"Plasma proteins, Predicted intracellular proteins"	"Cilium biogenesis/degradation"	"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Adipocytes: 53.0;Cardiomyocytes: 53.0;Cytotrophoblasts: 47.1;dendritic cells: 41.3;Extravillous trophoblasts: 45.2;Hofbauer cells: 33.4;Syncytiotrophoblasts: 48.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002835	Uncertain		Supported	Cytosol		NA	NA		50000	"Cluster 34: Basophils - Unknown function"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 24: Non-specific - Transcription regulation"	Cytosol		"HPA002835: AB_1857490"	"unprognostic (1.91e-2)"	"unprognostic (5.11e-2)"	"unprognostic (3.94e-3)"	"unprognostic (7.34e-2)"	"unprognostic (2.34e-2)"	"unprognostic (1.41e-1)"	"unprognostic (3.62e-2)"	"unprognostic (1.17e-1)"	"unprognostic (3.77e-2)"	"unprognostic (1.16e-2)"	"unprognostic (8.45e-3)"	"unprognostic (1.52e-1)"	"unprognostic (1.05e-3)"	"unprognostic (6.32e-2)"	"unprognostic (1.52e-1)"	"prognostic unfavorable (3.31e-4)"	"unprognostic (5.62e-2)"	10.8	8.3	10.6	8.8	16.4	29.7	8.1	15.5	8.7	7.3	3.9	7.5	6.0	9.5	6.4	9.5	6.5	7.4	10.0	6.8	13.9	7.4	9.3	7.6	9.8	17.7	12.8	10.0	7.5	7.0	4.7	8.7	18.6	8.8	6.1	15.4	6.9	6.1	9.9	7.6	6.4	9.4	15.9	10.0	6.4	13.0	11.1	8.2	9.7	10.2	8.9	8.4	7.5	22.6	13.4	25.5	22.5	25.2	20.0	17.7	15.9	19.5	19.8	14.8	18.9	11.8	18.0	25.1	15.7	18.4	14.5	18.7	19.0	13.3	23.2	40.7	14.4	31.4	22.2	15.6	16.5	35.4	23.4	15.9	13.2	25.4	25.1	11.4	19.4	11.5	34.7	38.0	20.3	26.6	21.1	9.3	16.1	10.2	10.8	18.2	21.1	30.7	11.8	28.0	9.4	17.6	25.0	24.8	25.0	15.3	24.2	14.4	26.8	26.0	11.4	25.7	25.8	20.5	29.0	26.8	11.8	18.1	38.9	102.1	31.6	46.0	53.4	29.9	52.3	47.7	37.2	47.0	32.4	44.6	39.6	45.2	53.9	45.2	33.2	29.1	44.7	39.8	10.6	16.4	15.5	8.7	6.8	13.9	17.7	12.8	18.6	15.9	11.1	22.6	53.0	0.0	0.0	0.0	8.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	53.0	0.0	0.0	0.0	0.0	47.1	41.3	0.0	0.0	0.0	0.0	0.0	0.0	11.0	0.0	0.0	0.0	0.0	45.2	17.8	0.0	0.0	0.0	0.0	0.0	0.0	33.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.4	0.0	0.0	0.0	0.0	48.0	6.2	0.0	0.0	0.0
ROCK2		ENSG00000134318	"Rho associated coiled-coil containing protein kinase 2"	O75116	2	11179759-11348330	"Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Biological rhythms"	"Kinase, Serine/threonine-protein kinase, Transferase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 280.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007459, CAB008666, HPA044109"	Approved		Supported	Cytosol		NA	NA		710000	"Cluster 15: NK-cells - Transcription"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 48: Smooth muscle cells - ECM organization"	Cytosol		"CAB008666: AB_1622617, HPA007459: AB_1079828, HPA044109: AB_2678813"	"unprognostic (4.55e-2)"	"unprognostic (1.05e-2)"	"unprognostic (4.18e-3)"	"unprognostic (4.87e-2)"	"unprognostic (1.49e-1)"	"unprognostic (2.71e-1)"	"unprognostic (1.39e-2)"	"unprognostic (2.72e-1)"	"unprognostic (3.62e-2)"	"unprognostic (6.66e-2)"	"unprognostic (3.83e-2)"	"unprognostic (1.48e-1)"	"prognostic unfavorable (1.57e-5)"	"unprognostic (1.51e-1)"	"unprognostic (1.99e-1)"	"unprognostic (2.52e-2)"	"unprognostic (3.47e-2)"	36.4	9.3	6.7	13.5	16.3	6.8	22.3	19.1	14.3	18.7	0.8	22.6	16.7	22.0	10.3	16.2	13.6	15.6	17.0	12.1	3.5	14.5	16.5	16.9	10.1	1.7	4.4	19.0	11.7	12.8	5.9	24.9	1.4	17.4	26.2	13.5	14.6	18.1	30.4	8.5	19.2	27.9	2.0	16.4	14.1	7.8	6.4	8.4	13.9	28.9	8.8	21.1	11.0	10.4	17.5	41.7	33.8	33.2	59.7	41.6	21.6	40.4	37.7	25.8	27.1	39.8	37.2	21.9	23.4	64.5	31.3	18.9	24.7	23.4	40.6	31.2	14.7	43.8	70.6	79.7	21.4	24.7	12.1	32.6	14.6	31.9	22.6	21.0	42.0	11.9	38.6	8.6	38.8	14.8	18.2	12.7	18.8	36.9	25.3	21.7	74.2	7.0	14.0	48.8	15.9	16.9	79.6	27.4	27.4	25.5	11.3	13.6	57.3	52.9	38.2	21.2	36.0	6.8	8.9	18.8	22.8	28.2	75.4	0.9	0.4	0.4	0.6	0.4	0.7	0.3	0.4	0.4	0.3	0.5	0.4	0.4	0.6	0.8	0.4	0.6	0.4	0.2	6.7	16.3	19.1	14.3	12.1	3.5	1.7	4.4	1.4	2.0	6.4	10.4	114.5	115.4	79.1	81.3	16.0	39.9	43.0	15.3	21.1	35.7	33.5	41.1	107.0	37.1	53.1	22.0	58.4	26.3	20.4	97.7	1.9	27.1	11.0	53.6	141.2	90.3	21.2	22.5	280.4	39.5	19.1	64.0	18.3	55.3	29.0	36.9	56.0	43.1	19.6	80.8	158.1	92.2	10.2	20.3	27.0	4.9	43.8	30.4	23.2	107.7	20.6	38.4	15.5	99.0	66.9	39.1	43.6	78.6	16.2	53.5	45.3	15.7	32.7	48.5	131.5	70.0	118.5	30.3	24.6	19.9	27.8	31.5	18.5	34.2	54.8	40.7
RORA	"NR1F1, ROR1, ROR2, ROR3, RZRA"	ENSG00000069667	"RAR related orphan receptor A"	P35398	15	60488284-61229302	"Disease related genes, Human disease related genes, Metabolic proteins, Nuclear receptors, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding, Receptor"	"Disease variant, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skin 1: 82.8"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 2125.3;Excitatory neurons: 627.1;Inhibitory neurons: 1056.8;Microglial cells: 757.0;Oligodendrocyte precursor cells: 1524.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Lineage enriched"	"Detected in many"	4	"T-cells: 26.7"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 73.2;U-266/70: 41.7;U-266/84: 62.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009861, HPA074448"	Approved		Supported	Nucleoli		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 64: Astrocytes - Nervous system maintenance"	Nucleoli		"CAB009861: AB_2180141, HPA074448: "	"unprognostic (1.57e-1)"	"unprognostic (4.76e-2)"	"unprognostic (2.22e-1)"	"unprognostic (2.92e-2)"	"unprognostic (1.79e-2)"	"unprognostic (1.00e-1)"	"unprognostic (2.91e-3)"	"unprognostic (4.08e-3)"	"unprognostic (2.02e-2)"	"unprognostic (1.13e-1)"	"unprognostic (9.93e-2)"	"unprognostic (1.34e-1)"	"prognostic favorable (5.42e-6)"	"unprognostic (6.94e-2)"	"unprognostic (1.35e-1)"	"unprognostic (2.55e-1)"	"unprognostic (4.62e-2)"	8.2	38.0	19.9	6.2	11.7	17.5	13.6	51.1	13.1	10.5	10.2	6.9	2.6	6.0	4.7	17.3	6.8	9.1	7.2	3.7	12.6	12.6	28.7	11.2	6.2	7.8	36.0	9.9	14.0	10.1	7.6	2.9	5.9	5.7	3.5	37.8	8.5	5.5	41.4	82.8	6.3	5.4	4.5	9.3	6.2	13.9	49.6	4.3	12.8	20.3	7.5	5.2	9.2	4.2	0.1	0.8	2.7	0.0	3.4	1.7	0.9	1.3	1.5	1.2	1.4	1.8	0.5	0.0	0.6	3.4	3.6	0.5	6.1	2.6	2.2	2.9	5.2	0.0	0.4	2.9	1.3	0.0	0.3	7.8	0.6	3.3	0.0	1.1	11.6	11.2	0.2	73.2	5.1	0.2	0.6	0.0	2.1	1.9	1.1	0.1	2.4	1.1	2.4	0.5	1.9	4.4	0.3	0.6	0.1	7.3	0.0	0.0	0.3	10.1	4.5	4.2	0.1	41.7	62.1	0.2	17.0	0.0	1.2	0.2	0.1	0.0	23.2	0.0	26.7	1.4	17.4	16.0	0.0	0.1	5.4	11.5	0.5	6.5	0.1	0.7	16.3	4.7	19.9	11.7	51.1	13.1	3.7	12.6	7.8	36.0	5.9	4.5	49.6	4.2	32.5	41.7	31.7	2125.3	23.4	185.2	30.1	17.0	55.2	167.5	24.7	16.1	26.3	30.0	23.4	58.8	454.5	0.7	185.3	1.4	13.7	21.4	148.8	26.9	52.9	40.8	18.5	42.5	627.1	12.3	1.9	69.4	11.7	36.1	2.5	7.9	34.2	97.2	0.8	126.2	1056.8	3.3	10.2	9.1	35.8	97.1	46.6	8.3	60.5	757.0	4.7	50.4	250.3	1524.0	114.9	8.2	0.5	87.3	88.7	24.0	0.7	44.6	16.0	160.0	39.5	57.9	32.2	1.9	3.8	73.2	423.4	4.7	237.6	11.5	2.1	61.9
RORC	"NR1F3, RORG, RZRG, TOR"	ENSG00000143365	"RAR related orphan receptor C"	P51449	1	151806071-151831845	"Disease related genes, Human disease related genes, Nuclear receptors, Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding, Receptor"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 86.2;skeletal muscle: 128.0"	"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 35.2;Hepatocytes: 47.8;Proximal enterocytes: 32.9"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in some"		"cerebellum: 4.1"	"Immune cell enriched"	"Detected in many"	6	"MAIT T-cell: 50.3"	"Lineage enriched"	"Detected in many"	44	"T-cells: 50.3"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 23.8;Karpas-707: 11.5;MOLT-4: 6.3;RPMI-8226: 6.0;SK-BR-3: 5.7;T-47d: 9.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA065620			Supported	"Nuclear bodies"		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 59: Non-specific - Translation"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 30: Mammary glandular cells - Lactation"	"Nuclear bodies"		"HPA065620: AB_2685521"	"unprognostic (6.51e-2)"	"unprognostic (7.78e-2)"	"prognostic favorable (1.83e-4)"	"unprognostic (9.20e-2)"	"unprognostic (3.05e-4)"	"unprognostic (6.29e-5)"	"unprognostic (1.13e-3)"	"unprognostic (8.94e-2)"	"unprognostic (1.67e-1)"	"unprognostic (7.88e-2)"	"unprognostic (3.78e-2)"	"unprognostic (2.42e-1)"	"prognostic favorable (2.94e-5)"	"unprognostic (2.13e-1)"	"unprognostic (3.22e-1)"	"unprognostic (1.82e-2)"	"unprognostic (1.80e-2)"	2.9	4.9	0.2	1.8	0.1	0.4	7.5	4.1	0.3	6.5	5.2	9.3	11.6	1.9	4.6	5.4	21.2	3.7	11.6	0.2	0.4	18.8	86.2	12.7	0.9	0.9	1.6	0.3	59.2	33.5	18.3	0.0	0.7	15.8	9.2	0.0	41.0	11.0	128.0	24.7	13.9	0.3	0.8	1.3	19.8	10.7	0.4	52.7	26.4	58.8	2.4	3.0	3.4	0.4	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.3	0.1	0.0	0.0	0.0	23.8	0.0	0.0	2.5	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	0.0	11.5	0.0	0.3	6.3	0.0	0.0	0.0	0.0	0.0	0.1	6.0	0.1	0.0	0.0	0.2	0.1	5.7	0.0	0.0	9.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	3.4	0.0	50.3	0.0	8.0	7.5	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.4	5.8	1.2	0.2	0.1	4.1	0.3	0.2	0.4	0.9	1.6	0.7	0.8	0.4	0.4	0.1	6.4	6.0	0.3	0.8	2.0	4.4	3.1	3.4	0.0	18.4	9.8	5.9	21.5	5.3	16.5	0.0	0.0	1.8	12.0	35.2	8.3	0.4	15.3	2.6	0.7	9.6	5.3	0.1	7.0	0.0	0.3	17.3	18.9	0.0	0.3	1.8	47.8	0.1	0.0	0.0	20.0	16.2	2.7	0.3	0.9	0.6	0.6	3.6	0.0	0.2	0.0	0.0	0.0	0.0	3.2	16.0	0.4	0.3	5.0	32.9	17.1	10.5	0.0	0.0	4.2	0.5	0.2	0.0	5.0	3.0	0.0	6.8	0.1	15.3	3.5
RP2	"NM23-H10, NME10, TBCCD2"	ENSG00000102218	"RP2 activator of ARL3 GTPase"	O75695	X	46837043-46882358	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Protein transport, Transport"	"GTPase activation"	"Disease variant, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 49.5"	"Cell type enhanced"	"Detected in many"		"Kupffer cells: 62.8;Langerhans cells: 72.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000234, HPA000909"	Uncertain		Approved	"Nucleoplasm,Nuclear bodies,Plasma membrane"		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 41: Macrophages - Immune response"	"Nucleoplasm, Plasma membrane"	"Nuclear bodies"	"HPA000234: AB_1079831, HPA000909: AB_2666140"	"unprognostic (2.26e-1)"	"unprognostic (6.01e-3)"	"unprognostic (2.79e-2)"	"unprognostic (2.98e-1)"	"unprognostic (1.69e-1)"	"unprognostic (3.40e-1)"	"prognostic unfavorable (7.97e-4)"	"unprognostic (2.58e-2)"	"unprognostic (9.76e-3)"	"unprognostic (3.10e-2)"	"unprognostic (3.79e-3)"	"unprognostic (9.75e-2)"	"unprognostic (6.15e-3)"	"unprognostic (2.96e-2)"	"unprognostic (9.66e-2)"	"unprognostic (1.61e-1)"	"unprognostic (4.28e-3)"	10.9	8.9	1.9	15.6	2.3	49.5	7.2	2.6	2.3	7.9	3.6	10.1	10.6	6.9	4.0	12.9	6.8	12.7	4.8	1.7	2.7	6.7	13.2	11.8	12.9	3.3	2.8	6.5	4.6	7.4	1.7	25.2	3.5	6.7	10.5	4.2	4.4	5.3	2.0	5.3	11.0	9.0	3.5	13.2	8.1	4.0	2.3	9.8	6.1	3.6	11.2	10.4	4.2	4.6	21.8	10.3	20.4	11.0	15.7	19.4	48.0	27.4	21.5	23.8	23.9	44.6	18.2	25.8	10.7	29.3	20.1	14.0	19.8	20.0	32.1	11.5	11.5	13.9	11.7	10.7	17.9	29.2	46.4	15.1	13.0	18.8	10.1	13.3	30.5	11.4	6.2	13.1	27.0	1.9	18.1	26.8	12.5	14.8	19.5	22.9	27.9	13.8	15.3	22.0	7.4	10.0	24.4	14.9	12.4	36.2	16.8	27.1	27.1	18.3	13.6	29.1	9.8	4.9	6.8	15.4	9.5	20.4	19.5	62.6	22.6	35.5	6.1	30.8	5.0	10.3	4.9	5.3	22.6	9.6	6.0	5.7	43.5	7.6	36.3	7.6	6.1	12.2	1.9	2.3	2.6	2.3	1.7	2.7	3.3	2.8	3.5	3.5	2.3	4.6	9.6	9.6	7.4	3.9	18.9	15.8	3.2	6.1	15.4	3.1	7.8	6.1	1.7	7.2	5.1	9.2	2.1	23.2	12.0	28.6	0.0	4.7	2.8	15.8	14.5	8.6	3.6	10.3	3.1	5.3	6.4	10.3	12.8	14.9	12.0	4.0	12.5	20.1	24.3	0.0	4.0	9.4	2.0	62.8	72.9	1.7	5.6	44.7	21.4	6.5	36.6	3.6	6.2	12.1	5.9	11.6	13.4	5.7	13.2	8.2	9.8	3.6	14.5	5.5	6.6	7.7	10.5	7.8	4.6	36.4	14.9	38.2	11.4	4.7	10.5	13.6
RPA4	HSU24186	ENSG00000204086	"Replication protein A4"	Q13156	X	96883908-96885467	"Predicted intracellular proteins"	"DNA damage, DNA repair"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"choroid plexus: 1.8;testis: 1.6"	"Cell type enhanced"	"Detected in many"		"Spermatocytes: 20.6;Syncytiotrophoblasts: 9.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"HeLa: 1.0"									HPA066010	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 49: Ciliated cells - Cilium organization"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	Nucleoplasm		"HPA066010: AB_2685596"	"unprognostic (6.23e-2)"	"unprognostic (2.55e-2)"	"unprognostic (1.17e-1)"	"unprognostic (6.66e-6)"	"unprognostic (1.33e-1)"	"unprognostic (6.33e-2)"	"unprognostic (9.75e-4)"	"unprognostic (3.15e-1)"	"unprognostic (7.61e-3)"	"unprognostic (2.59e-3)"	"unprognostic (1.55e-1)"	"unprognostic (2.62e-1)"	"unprognostic (2.47e-12)"	"unprognostic (8.95e-3)"	"unprognostic (6.05e-3)"	"unprognostic (8.17e-2)"	"unprognostic (4.59e-2)"	0.4	0.1	0.3	0.0	0.5	0.2	0.2	0.0	0.4	0.5	1.8	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.3	0.6	0.2	0.1	0.4	0.3	0.0	0.1	0.0	0.2	0.1	0.0	0.0	0.2	0.1	0.1	0.1	0.0	0.1	0.0	0.2	0.1	0.1	0.0	0.1	0.1	0.1	1.6	0.2	0.0	0.1	0.0	0.0	0.2	0.3	0.2	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.1	0.2	0.4	0.1	0.4	0.0	0.1	0.7	0.0	0.7	0.0	0.2	0.0	0.3	0.0	1.0	0.0	0.0	0.9	0.2	0.0	0.0	0.5	0.2	0.0	0.0	0.3	0.0	0.7	0.6	0.1	0.3	0.4	0.3	0.0	0.3	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.2	0.4	0.1	0.1	0.1	0.0	0.0	0.3	0.1	0.5	0.3	0.0	0.5	0.7	0.4	0.2	0.4	0.2	0.1	0.0	0.1	0.2	0.0	0.1	0.3	0.0	0.4	0.3	0.3	0.0	0.3	0.5	0.0	0.4	0.6	0.2	0.1	0.0	0.1	0.1	0.2	0.2	3.3	0.0	3.3	0.0	0.7	0.8	0.3	0.7	0.6	0.3	0.4	0.5	0.1	2.8	0.8	0.0	0.0	4.6	1.6	2.1	0.0	0.8	1.1	0.9	1.5	2.0	3.6	0.0	0.0	0.6	1.1	1.3	2.6	1.7	0.0	3.4	0.4	1.9	1.9	0.0	0.0	2.5	4.1	2.2	1.1	1.0	1.5	2.0	0.0	0.0	2.4	0.3	0.0	0.0	0.0	1.4	2.9	1.5	0.3	0.4	1.1	0.1	0.1	1.6	6.6	3.5	1.0	20.6	6.7	1.1	1.3	9.9	0.8	1.1	1.7	0.2
RPAIN	"hRIP, MGC4189, RIP"	ENSG00000129197	"RPA interacting protein"	Q86UA6	17	5419641-5432877	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023924, HPA031526"	Approved		Approved	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 12: NES - Nervous system development"	"Cluster 44: Endometrium - Transcription"	"Nucleoli fibrillar center"	Nucleoplasm	"HPA023924: AB_10601890, HPA031526: AB_10601555"	"unprognostic (1.68e-1)"	"unprognostic (9.31e-3)"	"unprognostic (2.32e-1)"	"unprognostic (7.88e-2)"	"unprognostic (5.41e-2)"	"unprognostic (3.58e-2)"	"unprognostic (5.29e-2)"	"unprognostic (1.87e-3)"	"unprognostic (3.98e-2)"	"unprognostic (4.25e-3)"	"prognostic favorable (5.20e-4)"	"prognostic unfavorable (4.41e-5)"	"unprognostic (6.03e-2)"	"unprognostic (1.75e-1)"	"unprognostic (9.78e-2)"	"unprognostic (6.67e-2)"	"unprognostic (1.00e-3)"	18.1	24.5	38.4	14.7	38.6	21.0	27.8	38.5	52.6	17.5	38.0	18.7	15.9	18.8	27.1	17.1	22.2	16.7	33.2	38.8	39.7	23.3	28.6	16.0	22.2	38.6	38.3	20.9	20.9	20.8	21.7	16.5	39.3	18.7	20.1	24.4	17.1	15.8	51.1	17.1	13.6	18.4	38.5	15.4	21.1	15.1	39.0	35.9	16.8	38.0	22.3	19.6	11.4	39.7	31.5	65.5	65.1	57.0	50.2	35.8	32.0	31.9	54.9	59.8	55.3	39.9	13.9	37.7	41.9	19.4	47.3	35.5	75.1	27.6	52.2	38.3	71.1	30.4	38.0	54.0	60.6	33.2	57.6	31.7	53.5	38.7	77.6	73.6	53.2	117.1	31.7	20.9	33.9	25.1	78.8	65.9	39.4	42.7	34.0	40.3	44.7	32.7	51.2	35.1	40.9	82.6	27.3	23.7	76.0	50.8	31.9	45.3	26.8	20.2	28.0	18.5	62.7	21.7	35.5	34.7	30.8	39.8	34.4	40.9	37.3	59.2	31.6	33.4	39.3	75.3	43.5	40.4	34.2	57.3	53.2	46.0	6.4	36.1	32.1	55.6	62.4	32.4	38.4	38.6	38.5	52.6	38.8	39.7	38.6	38.3	39.3	38.5	39.0	39.7	58.0	70.5	61.7	22.9	67.2	63.2	78.4	120.4	76.2	47.9	79.6	97.3	38.2	57.2	91.7	40.5	52.1	77.8	65.1	50.3	103.7	72.1	92.1	103.7	68.6	48.6	110.2	65.6	32.7	57.6	46.5	53.8	55.0	129.3	62.0	99.3	47.8	39.8	56.0	47.1	31.2	49.8	134.3	48.1	47.1	18.2	70.8	43.4	48.0	24.4	58.9	80.9	48.4	32.6	40.7	75.2	58.8	71.8	33.0	86.9	42.1	82.0	89.2	62.1	72.3	71.2	65.1	100.4	34.1	59.2	74.9	59.7	62.4	71.9	67.0	98.9
RPAP2	"C1orf82, FLJ13150, Rtr1"	ENSG00000122484	"RNA polymerase II associated protein 2"	Q8IXW5	1	92299059-92402056	"Enzymes, Metabolic proteins, Predicted membrane proteins"	"Transcription, Transcription regulation"	"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 12.6"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046443	Approved		Supported	Nucleoli,Cytosol		No	No			"Cluster 11: Basophils - Unknown function"	"Cluster 6: Brain - Smell perception"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 52: Non-specific - Transcription"	"Nucleoli, Cytosol"		"HPA046443: AB_2679669"	"unprognostic (1.29e-1)"	"unprognostic (2.52e-1)"	"unprognostic (3.71e-2)"	"unprognostic (4.12e-2)"	"unprognostic (4.96e-3)"	"unprognostic (5.73e-2)"	"unprognostic (1.23e-3)"	"unprognostic (3.29e-2)"	"unprognostic (8.01e-3)"	"unprognostic (4.09e-2)"	"unprognostic (2.59e-1)"	"unprognostic (6.09e-2)"	"unprognostic (7.02e-4)"	"unprognostic (1.18e-2)"	"unprognostic (1.69e-1)"	"unprognostic (3.62e-3)"	"unprognostic (4.10e-2)"	1.4	1.9	3.2	2.2	4.1	3.9	2.2	12.6	8.7	1.6	0.3	1.4	1.8	2.1	3.2	1.3	1.4	1.5	1.6	3.3	0.9	2.2	3.0	1.4	2.6	1.2	0.2	2.1	2.5	2.0	1.7	1.5	1.8	2.1	1.6	9.3	2.1	1.3	3.0	3.2	1.7	1.5	0.2	2.3	1.8	2.0	1.8	2.8	2.7	2.3	1.9	1.4	1.1	8.4	4.0	2.3	4.1	3.8	3.3	4.2	3.4	3.0	2.1	2.0	1.6	1.7	1.7	5.9	5.1	2.3	2.7	2.7	3.4	1.9	3.0	4.0	2.4	3.5	4.6	2.3	1.9	6.3	3.4	2.1	2.4	2.5	2.5	2.9	2.1	3.6	3.7	3.7	3.0	2.0	5.4	3.9	3.1	2.2	2.7	3.9	5.4	2.5	2.6	3.4	3.8	2.7	4.4	4.5	2.5	3.0	2.3	4.7	3.6	2.8	3.7	3.3	4.4	3.7	4.5	3.0	2.0	3.9	1.9	1.9	0.7	0.6	1.3	0.5	1.5	1.1	1.0	1.1	0.6	1.3	1.0	1.2	1.4	1.3	0.7	1.1	1.0	0.4	3.2	4.1	12.6	8.7	3.3	0.9	1.2	0.2	1.8	0.2	1.8	8.4	23.1	64.1	78.5	66.9	20.1	9.2	16.7	15.7	23.9	63.6	16.3	16.5	24.7	10.0	44.5	7.3	110.5	21.3	31.5	6.4	11.7	19.2	68.1	18.8	48.6	23.4	12.6	13.3	97.1	13.6	14.2	24.8	13.3	17.6	62.0	37.7	9.3	8.0	9.7	35.3	91.3	13.3	14.2	8.7	4.6	9.7	19.0	15.6	1.8	43.1	16.6	31.4	42.2	68.3	78.8	13.8	13.6	21.4	28.5	15.9	11.9	15.6	45.0	95.2	26.3	44.4	20.3	27.3	20.0	16.8	9.8	23.7	35.8	42.3	12.1	10.4
RPF1	BXDC5	ENSG00000117133	"Ribosome production factor 1 homolog"	Q9H9Y2	1	84479259-84498352	"Predicted intracellular proteins"	"Ribosome biogenesis, rRNA processing"	"RNA-binding, rRNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024642	Supported		Supported	Nucleoli		No	No			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoli		"HPA024642: AB_1856428"	"unprognostic (1.56e-3)"	"unprognostic (2.65e-1)"	"unprognostic (3.63e-2)"	"unprognostic (7.95e-3)"	"unprognostic (2.16e-3)"	"unprognostic (1.73e-1)"	"prognostic unfavorable (1.60e-5)"	"unprognostic (2.86e-1)"	"unprognostic (1.04e-1)"	"unprognostic (4.81e-2)"	"unprognostic (1.73e-2)"	"unprognostic (2.45e-1)"	"unprognostic (1.45e-1)"	"unprognostic (3.90e-2)"	"unprognostic (1.53e-2)"	"unprognostic (1.42e-2)"	"unprognostic (2.71e-1)"	24.4	21.6	13.7	19.0	17.4	44.9	24.7	14.7	19.4	23.5	15.8	28.1	17.7	26.0	23.0	27.0	23.2	14.1	34.2	13.5	15.4	28.0	26.1	20.5	26.8	13.7	14.0	20.7	22.8	18.8	21.0	14.9	13.8	20.8	20.9	16.8	21.9	15.5	42.7	26.1	23.2	18.1	13.4	26.2	25.6	25.3	13.9	29.4	23.3	23.9	28.1	24.9	23.3	14.8	43.1	29.2	36.6	30.2	27.1	35.5	40.5	46.8	36.5	53.2	47.0	21.4	17.6	31.9	50.1	33.9	89.0	31.7	54.3	43.2	57.7	51.0	57.6	85.2	30.7	37.8	37.2	80.0	25.4	29.0	63.0	56.0	39.2	30.7	42.6	60.7	79.9	40.7	46.9	21.8	76.3	53.0	91.5	43.0	62.5	48.3	58.5	25.7	51.3	47.6	45.2	42.2	27.7	52.7	107.3	32.8	29.6	53.4	30.3	40.1	41.3	64.8	90.4	29.5	39.0	73.0	19.2	71.0	37.0	64.0	35.2	34.6	41.4	41.0	45.4	65.4	46.0	42.0	37.4	58.6	51.3	50.7	14.7	52.6	46.3	39.5	52.9	47.4	13.7	17.4	14.7	19.4	13.5	15.4	13.7	14.0	13.8	13.4	13.9	14.8	28.2	38.5	39.5	7.2	35.8	34.7	41.5	71.6	12.0	15.7	20.4	19.6	39.3	30.0	43.0	16.5	16.7	35.5	51.7	18.0	74.3	60.3	72.7	34.9	27.6	35.0	33.5	17.2	10.1	64.1	33.1	25.0	16.8	26.5	65.2	18.6	28.9	36.6	44.0	8.4	9.8	29.6	28.5	31.7	30.2	13.2	32.6	28.4	28.4	9.4	37.0	30.1	60.8	8.5	10.4	53.0	23.6	35.0	16.2	26.8	21.7	67.4	53.8	25.6	46.0	23.4	43.3	94.7	63.7	18.0	32.7	27.5	40.3	21.4	36.0	39.7
RPF2	"bA397G5.4, BXDC1, FLJ21087"	ENSG00000197498	"Ribosome production factor 2 homolog"	Q9H7B2	6	110982015-111028263	"Predicted intracellular proteins"	"Ribosome biogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"U-2197: 234.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035475	Supported		Supported	"Nucleoplasm,Nucleoli,Nucleoli rim,Mitotic chromosome"		Yes	No			"Cluster 15: NK-cells - Transcription"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 18: U-2197 - ECM organization"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoli, Nucleoli rim"	"Nucleoplasm, Mitotic chromosome"	"HPA035475: AB_10669861"	"unprognostic (2.85e-3)"	"unprognostic (2.19e-2)"	"unprognostic (6.00e-2)"	"unprognostic (2.90e-3)"	"unprognostic (4.45e-1)"	"prognostic unfavorable (2.04e-4)"	"prognostic unfavorable (2.25e-4)"	"unprognostic (1.14e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.99e-1)"	"unprognostic (8.43e-2)"	"unprognostic (9.16e-2)"	"prognostic unfavorable (2.07e-6)"	"unprognostic (2.39e-2)"	"unprognostic (2.35e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.86e-1)"	16.4	12.2	6.6	9.5	7.4	10.8	14.9	7.3	8.7	12.9	7.2	11.9	6.6	11.2	5.4	15.2	12.5	9.1	15.3	7.0	7.1	15.8	17.2	9.7	10.4	6.9	6.9	13.2	19.9	9.7	8.1	10.2	7.0	11.4	8.8	5.6	9.9	7.1	22.2	13.9	8.1	8.1	6.9	9.3	11.7	13.5	7.1	7.6	13.0	14.0	10.9	15.3	12.5	7.9	23.3	16.6	12.7	50.5	26.4	34.7	32.6	32.5	23.6	32.3	32.6	39.2	18.5	50.2	29.4	22.8	38.8	27.0	51.5	37.6	84.2	19.4	38.7	29.5	14.2	27.4	35.9	45.9	16.6	26.5	31.4	46.5	83.5	20.3	24.9	22.1	99.0	29.9	52.2	23.4	39.2	45.5	45.2	37.7	20.2	40.2	22.4	43.6	37.4	22.9	20.3	28.7	14.1	23.7	61.3	16.8	18.8	47.3	17.5	24.7	21.2	234.1	81.4	13.4	22.0	65.0	36.4	60.8	55.2	0.2	4.4	0.7	4.1	5.5	8.5	6.6	6.1	5.0	5.8	5.7	6.8	7.0	0.3	8.8	3.5	5.8	5.0	4.0	6.6	7.4	7.3	8.7	7.0	7.1	6.9	6.9	7.0	6.9	7.1	7.9	40.0	19.2	26.9	6.5	25.0	78.4	119.6	90.1	35.9	14.1	33.6	52.3	71.9	47.1	67.6	18.4	0.0	44.9	18.0	15.8	68.4	48.2	105.7	49.8	57.6	35.2	11.4	26.1	15.7	47.4	53.8	50.0	17.3	60.9	46.2	18.9	23.6	83.6	56.0	18.5	14.0	30.3	36.7	27.7	19.5	32.1	34.5	28.2	37.4	5.6	21.8	21.0	19.6	9.0	13.5	42.2	18.7	27.1	18.8	80.4	15.2	87.2	55.0	8.9	13.1	61.7	49.9	76.8	28.4	33.0	66.2	34.6	22.9	29.8	44.0	70.2
RPGR	"COD1, CORDX1, CRD, RP15, RP3"	ENSG00000156313	"Retinitis pigmentosa GTPase regulator"	Q92834	X	38269163-38327544	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Cilium biogenesis/degradation, Sensory transduction, Vision"	"Guanine-nucleotide releasing factor"	"Cancer-related genes, Ciliopathy, Cone-rod dystrophy, Deafness, Disease variant, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Endometrial ciliated cells: 146.1;Hepatic stellate cells: 121.7;Respiratory ciliated cells: 119.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 14.6"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 14.6"	"Cell line enhanced"	"Detected in many"		"HL-60: 31.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001593, HPA073455"	Approved		Supported	"Golgi apparatus"		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 49: Ciliated cells - Cilium organization"	"Golgi apparatus"		"HPA001593: AB_1079835, HPA073455: AB_2686603"	"unprognostic (3.22e-2)"	"unprognostic (1.16e-2)"	"unprognostic (5.04e-2)"	"unprognostic (1.08e-1)"	"unprognostic (3.20e-1)"	"unprognostic (9.94e-2)"	"unprognostic (3.46e-2)"	"unprognostic (6.32e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.96e-3)"	"unprognostic (1.42e-1)"	"unprognostic (1.03e-6)"	"unprognostic (1.93e-1)"	"unprognostic (7.59e-2)"	"unprognostic (8.96e-3)"	"unprognostic (1.61e-3)"	19.2	5.7	4.7	4.4	4.6	12.2	16.8	5.2	5.5	10.2	15.5	9.1	3.0	11.6	2.5	5.5	15.0	5.5	9.8	4.6	6.3	6.2	3.7	14.8	3.7	7.6	7.0	6.2	7.5	2.6	32.9	3.7	5.8	6.9	3.6	12.1	5.2	2.6	12.1	6.0	9.4	4.5	6.6	5.1	6.8	8.1	5.3	4.7	9.7	3.7	3.2	8.7	8.2	5.4	4.7	6.0	3.4	3.2	3.6	5.2	2.7	5.8	6.5	4.1	4.8	2.7	2.6	7.1	1.8	3.9	3.4	4.4	4.1	1.8	5.6	7.5	7.9	2.5	2.7	5.5	3.3	31.8	5.8	8.0	2.4	8.7	9.2	1.6	18.9	7.5	3.3	0.0	5.7	1.5	9.1	17.7	8.7	2.9	7.5	6.8	11.7	6.4	3.6	3.0	2.7	5.2	6.4	2.6	7.2	5.1	1.7	5.4	22.4	4.5	8.0	10.7	7.2	1.9	3.9	6.0	10.6	6.1	6.2	1.3	2.6	5.9	1.3	2.4	2.9	1.9	1.5	1.8	2.6	1.5	2.2	1.8	14.6	1.7	2.0	1.8	1.9	1.8	4.7	4.6	5.2	5.5	4.6	6.3	7.6	7.0	5.8	6.6	5.3	5.4	75.2	16.0	32.6	21.2	21.8	7.9	13.5	6.6	7.4	29.5	8.8	8.8	8.0	8.6	18.0	1.8	62.6	5.8	14.0	12.6	3.9	15.3	51.4	146.1	30.4	61.3	17.4	5.5	21.8	8.6	9.5	11.8	9.2	21.0	20.3	73.5	121.7	9.7	7.8	35.3	20.0	13.5	10.2	16.2	8.4	9.1	7.8	14.5	5.4	18.7	15.5	9.4	14.4	9.0	17.1	9.9	8.9	4.5	11.0	10.2	5.0	3.1	119.2	85.7	0.0	23.1	12.9	24.9	25.3	4.8	5.8	8.2	17.2	6.6	8.9	11.2
RPGRIP1L	"CORS3, FTM, JBTS7, KIAA1005, MKS5, NPHP8, PPP1R134"	ENSG00000103494	"RPGRIP1 like"	Q68CZ1	16	53598153-53703938	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Ciliopathy, Disease variant, Joubert syndrome, Meckel syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Endometrial ciliated cells: 40.5;Excitatory neurons: 59.8;Respiratory ciliated cells: 85.9;Spermatocytes: 43.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039405, HPA040530"	Uncertain		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 49: Ciliated cells - Cilium organization"	"Plasma membrane, Cytosol"		"HPA039405: AB_10794636, HPA040530: AB_2677023"	"prognostic unfavorable (6.93e-4)"	"unprognostic (1.52e-1)"	"unprognostic (2.19e-3)"	"unprognostic (2.26e-2)"	"unprognostic (3.43e-2)"	"unprognostic (1.46e-2)"	"unprognostic (1.26e-4)"	"unprognostic (1.24e-1)"	"unprognostic (1.05e-1)"	"unprognostic (3.63e-1)"	"unprognostic (1.05e-1)"	"unprognostic (3.31e-1)"	"prognostic unfavorable (5.95e-4)"	"unprognostic (5.22e-3)"	"unprognostic (1.52e-1)"	"unprognostic (4.92e-4)"	"unprognostic (5.95e-2)"	1.6	3.5	2.3	2.1	2.2	1.5	3.2	1.0	5.2	3.1	9.5	1.7	1.3	3.8	3.7	2.2	6.8	2.7	1.9	2.7	3.0	3.0	1.1	1.9	1.8	2.4	3.2	3.5	2.0	7.6	6.0	2.1	1.9	2.9	1.7	2.9	1.7	2.8	1.0	1.9	0.9	3.5	1.0	0.9	1.9	13.5	3.5	2.6	4.6	1.4	1.8	2.2	1.8	3.2	11.8	13.7	11.6	10.7	13.9	13.3	5.6	12.7	7.9	9.8	2.7	7.1	9.5	7.5	8.5	11.1	7.8	12.5	9.4	11.6	19.1	4.6	7.2	2.8	12.1	7.5	6.0	6.7	5.0	8.1	6.9	11.4	6.9	11.4	8.9	10.0	7.2	4.3	14.8	4.5	11.2	4.7	7.4	3.7	6.3	19.3	15.9	9.4	14.0	3.1	19.9	7.5	14.3	6.4	5.3	6.7	10.0	5.7	7.8	12.2	8.6	9.7	11.0	5.4	6.9	13.1	18.9	3.9	7.3	0.7	0.2	0.3	1.2	0.3	1.2	1.1	0.8	1.0	0.2	1.5	0.8	1.8	0.6	0.8	0.3	0.7	0.7	0.4	2.3	2.2	1.0	5.2	2.7	3.0	2.4	3.2	1.9	1.0	3.5	3.2	3.1	6.4	4.8	15.7	2.9	4.6	2.8	11.1	4.6	5.5	6.9	8.0	9.8	1.5	15.1	11.0	8.4	5.5	1.5	1.3	17.6	7.4	21.5	40.5	20.7	3.9	0.0	3.0	59.8	3.3	7.4	12.9	5.1	8.6	7.0	12.9	2.5	3.8	2.9	3.3	36.6	5.6	4.1	1.2	3.1	12.0	4.7	1.9	1.8	9.4	1.8	6.3	2.1	14.1	8.6	3.3	0.5	6.4	2.1	1.7	0.2	19.8	85.9	8.7	6.6	7.8	9.7	43.2	11.2	4.7	5.4	1.6	2.7	11.5	4.4	2.4
RPL10A	"Csa-19, L10A, NEDD6"	ENSG00000198755	"Ribosomal protein L10a"	P62906	6	35468401-35470785	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA053803	Approved		Supported	"Nucleoli,Endoplasmic reticulum,Cytosol"		NA	NA		740000	"Cluster 30: Non-specific - Translation"	"Cluster 50: Non-specific - Ribosome"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 32: Non-specific - Translation"	"Endoplasmic reticulum, Cytosol"	Nucleoli	"HPA053803: AB_2682268"	"unprognostic (5.47e-2)"	"unprognostic (8.02e-2)"	"unprognostic (1.45e-1)"	"unprognostic (3.37e-1)"	"unprognostic (3.40e-2)"	"unprognostic (1.36e-1)"	"unprognostic (3.34e-2)"	"unprognostic (4.74e-2)"	"unprognostic (1.52e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.37e-2)"	"unprognostic (9.66e-2)"	"prognostic unfavorable (3.77e-4)"	"unprognostic (2.21e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.16e-1)"	"unprognostic (9.72e-2)"	1323.4	939.9	613.7	824.8	622.4	2051.4	2092.0	591.3	764.2	1803.2	604.3	1445.1	776.4	1350.0	1255.9	1583.0	1911.2	720.6	845.6	594.7	625.1	957.2	840.9	835.2	1625.6	619.7	603.1	3180.4	1894.4	682.3	731.1	747.7	627.8	1322.3	1178.3	255.2	1271.7	1007.2	1411.5	2166.4	1075.0	1114.2	654.0	1063.9	1188.8	230.5	628.8	1585.0	1084.1	1009.5	1733.0	1434.0	1506.3	642.7	1205.5	1211.3	1349.6	1275.9	1967.9	3560.6	1522.8	1213.7	2475.5	1671.2	1320.9	1765.5	1126.2	3571.4	1089.8	1650.2	819.4	1036.0	1832.7	2764.1	1374.0	1249.1	1618.0	1375.9	1007.0	2501.0	2909.6	2031.3	1096.1	4179.2	3172.8	1225.0	4066.4	2689.3	2481.9	1760.1	1652.9	1712.2	1920.0	2112.5	2158.4	2452.2	1421.3	1879.5	1057.5	1681.9	1298.7	2801.6	2124.0	1949.5	945.6	1384.7	747.8	1688.0	3632.5	1076.1	1831.0	3628.9	1450.9	541.4	975.4	729.4	1559.5	1073.4	1889.4	2381.8	681.1	2322.7	992.7	215.5	1232.7	120.6	1478.3	1210.1	2629.7	3176.9	2436.2	1905.6	1990.0	2806.5	3252.5	2601.9	113.1	2069.4	1077.8	1875.3	2059.9	5496.8	613.7	622.4	591.3	764.2	594.7	625.1	619.7	603.1	627.8	654.0	628.8	642.7	973.2	535.2	1036.5	19.2	3101.2	5399.7	5910.9	3550.3	2636.7	221.4	4627.1	4144.2	270.8	1742.9	1828.0	597.7	73.0	4048.8	1980.0	867.3	2983.7	1701.7	243.5	992.0	2446.8	1604.3	1512.3	1533.0	23.1	3272.4	5396.6	1667.3	884.8	1150.5	917.2	2228.2	1601.0	1519.3	2201.2	109.4	23.8	2834.0	1084.4	1989.9	3307.5	430.7	2517.0	1457.1	2406.5	17.8	2486.8	530.4	1845.5	31.7	32.4	2092.1	2269.8	1479.8	1382.6	4479.8	1447.6	2791.4	790.8	252.3	769.2	3139.6	1955.7	236.4	357.1	3510.2	6623.0	4105.6	2341.0	2848.1	3482.8	5438.5
RPL14	"CTG-B33, hRL14, L14, RL14"	ENSG00000188846	"Ribosomal protein L14"	P50914	3	40457292-40468587	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA004136	Approved		Supported	"Endoplasmic reticulum,Cytosol"		NA	NA		270000	"Cluster 30: Non-specific - Translation"	"Cluster 50: Non-specific - Ribosome"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 32: Non-specific - Translation"	"Endoplasmic reticulum, Cytosol"		"HPA004136: AB_1079839"	"unprognostic (1.36e-3)"	"unprognostic (2.91e-1)"	"unprognostic (2.48e-2)"	"unprognostic (2.35e-1)"	"unprognostic (3.92e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.69e-2)"	"unprognostic (2.42e-1)"	"unprognostic (1.02e-1)"	"unprognostic (4.94e-2)"	"unprognostic (1.93e-2)"	"unprognostic (1.20e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.54e-1)"	"unprognostic (2.90e-2)"	"unprognostic (6.14e-3)"	"unprognostic (1.15e-1)"	193.3	125.9	50.3	29.2	53.0	64.2	199.2	53.9	66.4	280.8	49.7	204.9	39.0	173.8	28.5	178.6	203.5	25.3	89.8	49.2	53.3	157.1	133.0	157.7	45.3	54.0	50.7	401.6	236.4	45.5	161.1	40.7	52.9	180.5	39.8	37.0	173.9	58.2	165.5	226.7	125.3	33.5	54.0	126.1	193.3	27.8	53.7	59.1	161.1	62.9	56.0	210.4	214.5	49.9	53.1	23.4	116.6	55.7	103.6	281.6	80.4	85.8	140.4	152.1	110.9	48.9	18.5	205.9	64.9	64.6	76.4	17.2	78.1	103.7	104.9	79.7	80.6	115.3	43.1	44.7	149.4	153.1	53.2	172.9	301.8	70.6	143.1	220.9	168.3	179.7	111.7	30.1	117.1	38.1	53.4	111.8	44.8	172.9	75.7	26.9	65.6	95.4	140.3	33.2	46.3	75.2	43.2	40.2	102.6	128.0	58.5	74.5	93.3	50.8	41.5	67.4	102.5	90.9	129.3	125.0	22.9	106.1	47.5	15.4	49.1	19.2	76.5	46.0	118.9	98.6	110.8	98.1	62.1	89.8	133.6	126.9	6.5	56.9	38.0	54.4	97.1	236.2	50.3	53.0	53.9	66.4	49.2	53.3	54.0	50.7	52.9	54.0	53.7	49.9	1374.3	830.1	1146.4	29.7	2884.7	3113.4	5120.8	2595.4	3076.6	225.8	3891.2	6163.2	346.3	1634.2	1633.6	676.8	102.2	3352.5	2285.9	971.2	2529.8	2063.4	290.0	898.3	1997.2	1471.6	1228.6	2245.7	39.0	4163.8	4729.5	1652.6	1184.6	1362.2	1565.2	1640.0	1678.7	1340.0	2207.8	101.0	45.7	2528.3	805.6	2102.2	2691.6	617.6	2160.3	1804.6	1782.2	32.8	2894.7	491.4	2368.7	23.1	41.3	2772.7	2061.9	1084.8	1855.0	4343.4	2359.1	3658.8	667.3	328.8	966.3	2109.4	2212.8	265.0	405.3	4161.2	3418.2	3314.5	2819.7	1921.9	2787.9	4891.9
RPL17	"L17, rpL23"	ENSG00000265681	"Ribosomal protein L17"	P18621	18	49488453-49492523	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 2876.9;Squamous epithelial cells: 3332.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA043724, HPA046385"	Supported		Supported	"Endoplasmic reticulum,Cytosol"		NA	NA		160000	"Cluster 30: Non-specific - Translation"	"Cluster 50: Non-specific - Ribosome"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 59: Non-specific - Transcription"	"Endoplasmic reticulum, Cytosol"		"HPA043724: AB_2678637, HPA046385: AB_2679646"	"unprognostic (1.11e-1)"	"unprognostic (8.77e-2)"	"unprognostic (1.33e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.73e-1)"	"unprognostic (3.34e-3)"	"prognostic unfavorable (3.60e-5)"	"unprognostic (2.69e-1)"	"unprognostic (3.29e-3)"	"unprognostic (2.11e-1)"	"unprognostic (4.35e-3)"	"unprognostic (2.72e-2)"	"unprognostic (3.32e-1)"	"unprognostic (1.66e-1)"	"unprognostic (6.54e-2)"	"unprognostic (2.41e-1)"	"unprognostic (9.60e-3)"	1966.5	1982.7	942.7	997.8	948.6	2559.4	2698.3	978.7	1418.8	2426.3	974.0	2075.1	880.2	1747.2	1295.2	2261.4	2040.5	820.1	1417.0	919.9	975.3	1619.5	1470.2	1410.7	2009.4	955.0	944.3	4472.1	4182.0	862.3	1495.0	888.2	967.1	1829.2	1089.6	612.3	1788.1	899.7	1351.1	2405.0	1619.7	912.2	988.0	1850.3	2038.0	574.8	969.5	1637.0	1607.1	868.1	1672.5	1972.7	2087.9	978.7	2205.3	1360.2	1937.9	2315.0	3146.0	6392.2	1829.3	2400.4	2783.7	2229.8	1677.4	1860.7	1039.7	3785.8	1572.2	2399.7	1250.1	2569.5	2690.1	4329.7	2377.4	1547.4	2773.8	1999.8	1500.4	2560.9	2718.4	6578.1	1526.2	6150.1	4787.7	2333.9	5487.0	5189.2	3100.5	2538.6	1995.5	2685.2	2794.0	1781.7	2386.9	4203.2	1993.4	1327.9	1110.7	2333.6	2538.1	4932.3	3037.1	2571.4	1462.8	1741.2	882.6	1827.5	3949.5	2366.9	1726.9	4230.9	2473.3	1633.3	1389.1	815.2	2570.9	2341.0	2404.3	3520.5	1564.3	3936.3	1593.2	312.8	840.7	151.3	1081.4	743.0	2106.6	1907.9	1763.3	1442.8	1305.7	1574.1	1936.2	1697.1	104.4	1431.9	618.7	1427.3	1509.5	2477.8	942.7	948.6	978.7	1418.8	919.9	975.3	955.0	944.3	967.1	988.0	969.5	978.7	104.8	663.4	916.1	0.0	1445.5	701.8	237.9	319.7	2876.9	15.3	704.3	451.7	0.7	348.9	969.4	103.0	10.4	396.5	311.7	386.7	497.0	864.7	195.8	102.2	169.2	426.4	819.2	1193.5	0.0	1630.2	582.5	558.6	1132.5	98.5	998.9	58.9	414.1	217.3	272.3	10.1	0.0	1233.6	81.4	561.1	588.8	452.1	527.2	616.8	291.7	0.0	973.9	42.7	515.9	0.0	0.0	1268.6	909.2	272.3	1659.1	177.3	768.9	648.6	561.5	23.8	249.8	401.7	297.5	100.8	100.5	3332.8	922.5	414.8	1066.7	61.1	1437.8	216.6
RPL17-C18orf32		ENSG00000215472	"RPL17-C18orf32 readthrough"		18	49481681-49492479	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"Alveolar cells type 1: 153.8;Alveolar cells type 2: 154.3;Club cells: 96.6;granulocytes: 65.6;Respiratory ciliated cells: 117.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA043724, HPA046385"	Approved		Supported	"Endoplasmic reticulum,Cytosol"		NA	NA			"Cluster 42: Non-specific - Transcription"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 11: Alveolar cells - Smell perception"	"Endoplasmic reticulum, Cytosol"		"HPA043724: AB_2678637, HPA046385: AB_2679646"	"unprognostic (1.62e-1)"	"unprognostic (1.67e-2)"			"unprognostic (1.70e-3)"	"unprognostic (3.83e-4)"		"unprognostic (1.95e-1)"	"unprognostic (2.46e-1)"	"unprognostic (3.02e-1)"		"unprognostic (2.38e-1)"	"unprognostic (2.46e-2)"	"unprognostic (2.87e-1)"		"unprognostic (5.42e-2)"		41.7	77.7	109.4	35.7	111.6	49.1	49.6	117.5	159.2	36.5	113.7	43.7	51.3	32.2	70.3	25.7	31.1	38.6	63.6	106.0	119.4	96.0	85.0	42.2	35.1	116.3	112.8	34.4	51.8	84.3	9.4	35.3	116.2	48.7	41.6	104.7	54.5	34.4	30.1	22.2	48.3	26.7	116.2	35.9	55.7	30.5	112.3	32.8	53.4	38.2	27.2	38.1	5.2	126.1	29.4	25.0	57.3	47.1	55.7	42.3	42.7	34.6	36.6	27.9	32.9	7.7	33.8	21.8	74.0	33.5	30.5	29.6	26.2	29.7	31.1	67.7	20.2	28.0	15.7	28.3	56.6	46.3	59.2	50.5	65.0	22.5	42.3	61.4	35.2	48.6	19.2	60.9	79.2	16.8	41.4	26.8	20.1	28.0	13.0	26.2	21.2	59.4	115.2	34.7	64.5	120.0	22.0	36.8	76.1	41.4	50.3	45.4	33.0	37.4	25.7	23.4	36.8	106.2	60.1	24.9	42.0	26.0	42.7	92.6	30.2	71.3	23.0	41.1	33.4	28.3	27.1	26.5	27.9	20.3	23.3	31.2	85.1	22.3	48.5	38.4	30.9	49.2	109.4	111.6	117.5	159.2	106.0	119.4	116.3	112.8	116.2	116.2	112.3	126.1	0.5	153.8	154.3	0.3	0.4	0.3	0.7	0.3	0.6	0.4	0.5	0.5	0.0	0.0	96.6	0.0	0.0	0.1	0.2	0.2	0.0	0.2	2.8	0.3	0.7	17.8	0.0	0.0	0.1	0.2	0.1	18.5	0.5	0.4	65.6	0.2	0.4	0.3	0.3	0.0	0.1	0.0	0.0	0.6	0.0	4.3	0.0	20.9	0.0	0.0	1.2	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.3	0.2	0.3	117.3	0.3	0.0	0.2	0.4	1.0	0.5	1.0	0.1	0.3	9.1	0.5	0.1	0.5
RPL18	L18	ENSG00000063177	"Ribosomal protein L18"	Q07020	19	48615328-48619184	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"	"Diamond-Blackfan anemia, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in all"	5	"NB-4: 16079.5"					"Low region specificity"	"Detected in all"			HPA046572	Approved		Supported	"Nucleoli,Endoplasmic reticulum,Cytosol"		NA	NA		290000	"Cluster 30: Non-specific - Translation"	"Cluster 50: Non-specific - Ribosome"	"Cluster 24: NB-4 - Immune response"	"Cluster 32: Non-specific - Translation"	"Endoplasmic reticulum, Cytosol"	Nucleoli	"HPA046572: AB_2679705"	"unprognostic (2.12e-2)"	"unprognostic (1.86e-2)"	"unprognostic (7.30e-2)"	"unprognostic (2.57e-2)"	"unprognostic (3.48e-3)"	"unprognostic (4.76e-2)"	"unprognostic (3.21e-3)"	"unprognostic (2.80e-1)"	"unprognostic (2.39e-1)"	"unprognostic (9.15e-2)"	"unprognostic (6.15e-2)"	"unprognostic (1.80e-1)"	"prognostic unfavorable (1.21e-4)"	"unprognostic (2.40e-1)"	"unprognostic (3.04e-2)"	"unprognostic (6.36e-2)"	"unprognostic (1.27e-2)"	1000.7	1074.9	985.7	753.7	981.5	1976.6	1333.2	932.2	1170.2	1491.2	910.5	995.0	912.2	1051.5	782.6	1786.5	1415.0	719.4	754.8	924.1	955.5	756.7	974.7	730.6	1740.2	980.7	953.9	3084.6	2343.7	580.6	905.7	746.8	972.6	1262.1	814.4	139.0	1779.2	702.0	1056.9	1944.3	956.6	709.9	999.1	1151.6	1122.4	332.2	993.5	1091.5	880.0	643.0	1399.0	1017.9	1356.0	989.5	1874.4	2697.1	1148.7	1520.6	1267.0	2299.6	1455.1	1042.7	1489.0	1754.3	1471.6	2497.8	1407.6	3436.1	874.1	1007.2	803.9	1400.0	1211.2	2056.9	844.3	1349.6	3380.2	1286.3	1234.0	2438.1	2166.6	1793.6	1309.6	2633.8	3015.8	1031.9	1603.7	1760.0	1836.8	2149.2	1629.3	2043.5	1297.6	2236.5	1926.2	16079.5	1421.6	3171.4	1469.5	2058.1	1073.4	2438.4	1527.9	2370.7	1410.8	1739.1	850.4	2306.0	2082.3	641.1	1241.4	2618.1	1220.9	1032.3	1275.0	727.4	2119.8	1970.9	2939.2	1934.2	649.6	2246.7	1257.7	381.1	1022.8	217.6	1066.6	890.3	1889.0	2384.8	1921.2	1461.0	1380.1	2368.0	2373.9	1981.4	140.7	1357.8	681.2	1451.1	1707.2	3192.5	985.7	981.5	932.2	1170.2	924.1	955.5	980.7	953.9	972.6	999.1	993.5	989.5	1729.2	593.0	983.1	22.9	4066.2	4468.5	4767.6	3561.4	4933.7	393.5	3680.3	5354.2	264.0	1637.1	1809.1	708.1	143.9	3891.0	2534.2	1344.7	1387.2	1853.2	80.5	1067.0	2619.6	1812.4	1673.5	1713.1	21.7	4530.2	5344.1	1765.9	1597.9	1584.8	1021.6	2791.1	1810.1	1426.6	2225.3	134.6	28.2	3186.8	1253.2	2491.6	3341.9	221.3	3248.9	2059.4	2278.5	16.9	2958.8	1413.2	2345.1	22.6	51.3	3022.6	2516.1	1459.7	2801.6	4727.0	2534.3	1832.5	697.3	433.7	1032.1	2596.1	2246.5	283.4	558.4	5421.3	5559.5	4138.0	2961.3	3084.2	3163.6	5183.8
RPL21	"DKFZp686C06101, FLJ27458, L21, MGC104274, MGC104275, MGC71252"	ENSG00000122026	"Ribosomal protein L21"	P46778	13	27251309-27256691	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"	"Disease variant, Hypotrichosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA047252	Approved		Supported	"Nucleoli fibrillar center,Endoplasmic reticulum,Cytosol"		NA	NA		34000	"Cluster 30: Non-specific - Translation"	"Cluster 50: Non-specific - Ribosome"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 32: Non-specific - Translation"	"Nucleoli fibrillar center, Endoplasmic reticulum, Cytosol"		"HPA047252: AB_2680000"	"unprognostic (4.79e-2)"	"unprognostic (3.69e-2)"	"unprognostic (1.99e-1)"	"unprognostic (2.31e-1)"	"unprognostic (3.57e-1)"	"unprognostic (1.90e-3)"	"unprognostic (2.55e-2)"	"unprognostic (7.72e-2)"	"prognostic unfavorable (6.66e-4)"	"unprognostic (1.66e-2)"	"unprognostic (2.42e-2)"	"unprognostic (5.47e-2)"	"unprognostic (4.53e-2)"	"unprognostic (4.83e-3)"	"unprognostic (1.28e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.44e-1)"	1565.0	1042.6	1087.8	714.2	1108.1	2293.7	1689.3	1066.4	1946.8	2047.0	1061.5	1733.4	625.1	1329.1	725.7	1504.9	1718.1	553.6	1306.5	1047.9	1131.1	1421.7	1085.9	1181.3	1633.8	1112.2	1089.9	3100.5	2449.9	514.5	1047.0	626.6	1107.4	1381.0	803.3	419.1	1325.3	643.2	1855.2	1987.4	1471.7	594.3	1106.4	1794.1	1487.8	317.3	1103.9	1072.9	1114.9	769.6	1395.1	1631.4	1650.9	1117.2	942.9	772.1	1337.0	1086.2	1361.4	2569.1	1130.1	1664.7	1515.8	1277.2	822.1	1875.1	1700.0	3578.7	627.8	1332.5	571.7	1220.3	1552.8	1694.0	1495.8	1139.5	1410.3	2803.5	738.9	1470.3	1284.7	3871.3	1063.8	2304.6	2722.2	837.5	2112.0	1751.9	1454.0	1562.9	1181.8	865.5	1468.6	1340.3	1970.6	2398.9	1754.3	2792.4	1281.4	1446.1	2566.6	1511.2	1201.2	1111.2	1153.8	1071.6	773.3	1531.6	1390.1	1120.4	1033.9	3406.6	1619.7	563.1	731.3	895.3	1384.6	579.7	874.2	2583.3	722.1	2415.5	978.6	948.5	1201.5	493.2	1996.0	1257.2	3233.0	3717.7	2993.5	2504.4	1607.9	3347.5	4294.2	3510.3	249.1	2178.4	1308.5	2181.4	2271.1	6723.7	1087.8	1108.1	1066.4	1946.8	1047.9	1131.1	1112.2	1089.9	1107.4	1106.4	1103.9	1117.2	1464.4	1685.9	2658.5	9.4	6395.0	7645.1	5673.8	7552.7	1649.3	375.0	4496.8	3380.2	191.6	4000.5	3789.8	1565.1	143.9	5240.1	4382.0	1695.3	5290.4	3849.1	74.4	1089.9	2417.7	2670.0	2385.5	4124.1	9.0	7829.6	6183.8	2401.4	924.6	1200.5	2817.5	2227.4	4446.9	4944.4	3952.9	159.9	10.1	4869.4	2518.7	7461.4	9266.1	225.9	3957.2	3114.0	5229.4	7.5	9465.6	1525.3	6167.9	8.5	14.1	4983.3	3923.7	2403.1	2133.1	4379.8	4261.8	6230.7	1742.7	634.1	1899.8	4878.6	2645.8	650.7	1016.0	2107.5	8226.2	5507.4	5413.5	1829.5	5416.3	4837.4
RPL23	"L23, rpL17"	ENSG00000125691	"Ribosomal protein L23"	P62829	17	38847860-38853764	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003373	Approved		Supported	Cytosol		NA	NA		130000	"Cluster 30: Non-specific - Translation"	"Cluster 50: Non-specific - Ribosome"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 32: Non-specific - Translation"	Cytosol		"HPA003373: AB_1856436"	"unprognostic (1.02e-2)"	"unprognostic (1.15e-1)"	"unprognostic (9.17e-2)"	"unprognostic (5.31e-2)"	"unprognostic (5.62e-2)"	"unprognostic (2.48e-2)"	"unprognostic (9.08e-3)"	"unprognostic (9.95e-2)"	"unprognostic (1.02e-1)"	"unprognostic (7.07e-2)"	"unprognostic (8.01e-2)"	"unprognostic (1.68e-1)"	"prognostic unfavorable (4.19e-5)"	"unprognostic (1.18e-1)"	"unprognostic (9.60e-2)"	"unprognostic (6.46e-3)"	"unprognostic (4.45e-1)"	2078.9	1410.2	882.7	972.2	902.3	2444.5	2530.4	888.8	1161.1	2151.7	925.6	1577.9	805.2	1497.6	1786.7	1678.9	1807.0	820.5	1232.2	860.7	927.0	1410.9	1228.9	1247.9	1934.3	926.0	901.9	3960.2	2100.0	1007.4	906.0	1087.5	937.4	1501.3	1208.1	512.2	1409.8	893.5	1901.2	2283.1	1290.8	1029.7	943.8	1607.9	1409.4	336.7	908.6	1998.6	1268.0	1617.6	2264.0	1591.5	1782.4	943.3	1912.8	1871.0	2422.1	2063.9	4227.9	5507.5	1695.5	1866.3	2802.6	2301.3	1716.5	2721.1	1652.1	4214.1	1806.8	2066.8	1701.9	3284.2	2131.0	3622.1	2803.5	1466.9	3178.0	1553.9	2573.8	3929.6	3170.2	4326.7	1561.7	5216.3	4409.6	2003.4	4154.8	4103.3	2475.7	2891.2	2507.1	2069.3	3000.0	1705.8	3818.5	4600.5	1778.3	2488.3	1131.0	2560.7	3549.4	4180.4	3262.5	2384.2	1643.0	2433.7	1001.5	1707.3	3998.7	3317.1	2828.9	5324.1	1746.6	1052.1	1617.9	1666.2	3155.0	1327.3	2217.4	3326.8	1613.0	2551.5	1388.0	568.8	1536.7	318.0	1179.7	1207.3	1463.1	2374.0	1868.0	1451.6	2065.6	2159.5	2473.1	2142.2	227.0	1404.4	1069.0	2578.5	1498.0	3233.2	882.7	902.3	888.8	1161.1	860.7	927.0	926.0	901.9	937.4	943.8	908.6	943.3	764.4	1012.8	1606.1	8.5	1481.6	2446.7	2204.6	1828.9	747.3	147.1	1240.8	1011.2	532.6	1243.9	1379.0	472.6	68.8	1809.9	1282.7	652.1	1352.0	1390.0	309.2	1084.8	2160.4	1122.6	919.7	808.5	11.3	2090.7	2633.3	985.1	306.3	1353.6	1350.3	1137.2	1572.1	1581.2	1666.5	58.9	10.9	1609.3	594.1	2477.5	2490.5	233.0	2682.2	1456.6	1108.1	11.2	2741.1	735.2	1365.6	5.0	11.5	1909.4	1437.5	1447.7	491.4	2347.2	799.6	2260.6	650.8	223.6	749.4	1743.9	1908.2	259.2	219.9	1022.2	3164.9	1904.2	1207.9	1159.8	1854.8	2378.9
RPL28	"FLJ43307, L28"	ENSG00000108107	"Ribosomal protein L28"	P46779	19	55385932-55403250	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA050459	Approved		Supported	"Endoplasmic reticulum,Cytosol"		NA	NA		59000	"Cluster 30: Non-specific - Translation"	"Cluster 50: Non-specific - Ribosome"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 32: Non-specific - Translation"	"Endoplasmic reticulum, Cytosol"		"HPA050459: AB_2681135"	"unprognostic (4.70e-3)"	"unprognostic (1.38e-1)"	"unprognostic (6.86e-3)"	"unprognostic (6.53e-2)"	"unprognostic (9.73e-2)"	"unprognostic (3.38e-2)"	"unprognostic (2.35e-2)"	"unprognostic (1.40e-1)"	"unprognostic (3.93e-1)"	"unprognostic (3.00e-2)"	"unprognostic (4.46e-1)"	"unprognostic (1.21e-1)"	"prognostic unfavorable (6.61e-5)"	"unprognostic (4.28e-1)"	"unprognostic (2.15e-1)"	"unprognostic (1.33e-1)"	"unprognostic (8.93e-3)"	1699.3	1623.4	886.6	1036.7	911.3	1692.7	1588.2	866.7	1087.6	1691.4	831.5	1387.1	786.4	1130.4	427.2	2645.2	1324.3	653.4	1156.8	864.8	915.4	1350.2	1453.1	1333.4	1734.7	956.6	879.5	2652.0	1969.1	378.5	1116.3	552.2	916.9	1628.8	522.1	208.8	1399.3	400.8	1186.7	2587.8	1467.4	476.4	902.1	1941.7	1283.5	567.2	901.9	1193.8	1266.0	498.5	1354.2	1493.5	1855.4	933.4	2243.1	2533.7	864.1	1730.7	1508.5	2405.0	1458.3	1477.7	1395.5	1261.2	1162.7	2486.9	1155.9	3331.0	1034.2	1346.2	537.3	1368.2	990.0	1898.1	555.1	1300.1	5651.9	2060.0	1543.0	3091.3	2500.4	2420.6	1734.1	3402.5	2668.8	941.2	1887.2	1654.8	1374.4	1572.5	1626.1	2656.3	1143.0	2568.8	2720.0	2234.9	2081.9	1893.1	2751.4	2723.1	1246.5	2559.5	1626.4	4386.3	1096.5	1810.3	938.4	3055.7	2388.9	476.2	1271.7	2542.5	1684.9	1122.2	1263.5	907.5	2391.6	2167.6	3426.2	2120.9	1433.4	2921.9	969.0	496.8	1137.3	329.5	1018.8	1004.1	1587.4	1951.6	1708.1	1346.5	1318.5	1929.0	1893.1	1734.6	340.9	999.2	858.7	1243.7	1726.0	3392.3	886.6	911.3	866.7	1087.6	864.8	915.4	956.6	879.5	916.9	902.1	901.9	933.4	2277.5	314.1	560.5	22.5	7020.4	3787.2	4681.7	3181.0	5272.9	276.7	5169.2	6848.9	155.6	1921.6	1378.1	1166.0	162.6	3178.0	4378.0	2153.4	2551.3	2493.5	1487.6	1657.5	3885.3	2452.6	2284.3	3256.0	27.3	4366.2	5807.8	2324.7	2571.4	2448.5	856.5	4232.7	3114.5	2411.6	4091.1	180.0	34.4	4783.0	842.3	6210.8	5627.4	4180.3	3448.6	4457.1	2114.8	50.6	5756.7	1363.1	3267.8	27.2	73.5	4770.7	4210.6	1643.7	4445.1	5429.7	4982.5	3325.8	652.2	516.8	972.9	2174.1	2361.8	832.0	896.6	8321.4	4904.2	3384.7	6066.8	4186.4	5252.8	7113.6
RPL29	"HIP, HUMRPL29, L29, RPL29P10"	ENSG00000162244	"Ribosomal protein L29"	P47914	3	51993522-51995895	"Predicted intracellular proteins, Ribosomal proteins"		"Heparin-binding, Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA069064	Approved		Supported	"Nucleoli,Endoplasmic reticulum,Cytosol"		NA	NA		190000	"Cluster 30: Non-specific - Translation"	"Cluster 50: Non-specific - Ribosome"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 32: Non-specific - Translation"	"Nucleoli, Endoplasmic reticulum, Cytosol"		"HPA069064: AB_2686077"	"unprognostic (3.77e-3)"	"unprognostic (2.72e-1)"	"unprognostic (2.18e-1)"	"unprognostic (2.32e-3)"	"unprognostic (2.89e-3)"	"unprognostic (5.46e-2)"	"unprognostic (6.79e-3)"	"unprognostic (1.79e-1)"	"unprognostic (2.16e-1)"	"unprognostic (5.06e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.40e-1)"	"unprognostic (2.16e-2)"	"unprognostic (1.98e-1)"	"unprognostic (9.99e-2)"	"unprognostic (6.25e-2)"	"unprognostic (7.56e-2)"	1695.8	1400.7	669.4	719.9	687.1	2111.2	1659.2	668.9	816.3	1854.9	645.4	1352.4	866.4	1208.8	657.8	1772.7	1470.3	645.8	1073.9	646.1	673.9	1112.9	1155.6	972.4	1348.0	697.9	665.1	2740.8	2740.5	537.5	708.8	534.7	696.9	1307.1	624.9	229.3	1478.4	550.2	2689.5	2458.5	1155.7	567.4	721.7	1239.3	1341.7	440.2	684.7	1075.5	982.6	1287.3	991.6	1339.6	1643.6	729.6	1208.7	1467.7	1123.3	1808.9	1933.5	3007.1	1603.5	1299.2	1540.3	1693.7	1396.9	1757.3	1831.7	3226.6	553.5	1292.3	1044.1	1084.1	1622.7	2689.1	802.7	1335.2	2202.3	1689.2	1892.1	3037.1	2287.6	2548.8	1630.1	3714.1	3735.4	1254.5	2210.9	1936.9	1920.9	1420.6	1338.0	2536.8	1264.3	2629.0	2238.9	3210.8	1965.5	1755.6	2463.0	1038.1	1267.3	3258.5	2211.8	2509.3	948.0	1820.6	969.6	2279.1	2378.1	706.9	1710.1	4227.3	1745.3	1001.3	1324.5	1559.7	2006.9	1615.8	2498.1	2399.9	1326.2	2953.0	1357.6	556.4	1184.0	333.4	895.8	882.9	1488.2	1886.9	1446.6	1149.2	1356.0	1749.9	1662.7	1421.4	145.3	1115.6	724.8	1154.7	1444.1	3507.7	669.4	687.1	668.9	816.3	646.1	673.9	697.9	665.1	696.9	721.7	684.7	729.6	2092.1	189.1	415.6	35.3	3749.3	3975.7	5198.9	3485.6	4465.8	234.8	4763.1	7627.1	82.4	1611.4	1245.9	711.7	102.2	2537.2	2453.7	1497.3	2181.5	1773.3	1117.1	1158.9	3170.1	1957.3	1430.9	2176.2	28.2	4573.5	5119.4	1862.6	1826.2	1529.2	694.4	3951.5	2026.4	1661.0	2373.7	107.7	33.6	3051.9	1043.6	2693.9	3423.6	4294.3	3611.5	2216.3	2218.0	37.5	2893.8	989.3	2520.1	18.1	49.2	3180.2	2816.5	1583.5	2556.8	5203.2	3720.1	3760.6	507.1	405.3	1143.9	2535.7	2110.2	564.9	465.2	5714.8	5075.9	2455.2	2765.1	5917.8	3455.9	5933.8
RPL3	L3	ENSG00000100316	"Ribosomal protein L3"	P39023	22	39312882-39320389	"FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003365, HPA055361"	Uncertain		Supported	Nucleoli,Cytosol		NA	NA		470000	"Cluster 30: Non-specific - Translation"	"Cluster 50: Non-specific - Ribosome"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 32: Non-specific - Translation"	"Nucleoli, Cytosol"		"HPA003365: AB_1079841, HPA055361: AB_2732594"	"unprognostic (9.79e-3)"	"unprognostic (2.06e-1)"	"unprognostic (2.31e-1)"	"unprognostic (1.68e-3)"	"unprognostic (5.44e-3)"	"unprognostic (1.72e-1)"	"unprognostic (3.51e-2)"	"unprognostic (1.22e-1)"	"unprognostic (3.63e-1)"	"unprognostic (5.81e-2)"	"unprognostic (5.87e-2)"	"unprognostic (7.09e-2)"	"unprognostic (2.54e-2)"	"unprognostic (1.85e-1)"	"unprognostic (6.09e-2)"	"unprognostic (2.72e-1)"	"unprognostic (4.32e-2)"	2058.6	1934.3	965.6	1484.2	985.8	2965.1	2704.2	936.9	1071.1	2705.4	1023.2	2078.1	1515.1	2007.3	1653.7	2522.3	2423.9	1128.4	1326.4	894.6	951.2	1745.2	1894.1	1421.2	2460.9	984.1	951.1	4838.0	4514.8	1462.2	1861.5	1099.8	977.1	2180.0	1361.7	809.1	2210.1	1551.8	558.4	3337.9	1722.9	1388.1	1050.0	1824.1	1982.0	752.6	1002.9	2006.1	1709.0	417.1	2320.5	2012.9	2317.5	996.1	2010.5	1836.9	2035.9	2149.6	2535.3	5394.1	2745.1	1497.8	2703.5	1400.5	1249.7	2327.8	1425.1	8262.2	2062.9	1734.1	873.2	1246.8	2275.3	3060.5	923.2	1448.3	2207.4	2039.5	2153.8	3438.2	3887.7	2932.6	1619.9	5321.2	4063.7	1265.0	4504.5	3956.7	2765.5	2217.6	2407.8	2657.6	2135.0	2597.5	2974.5	4241.1	2054.6	2172.9	1273.8	2369.5	1924.0	4017.5	2609.2	2927.6	1823.4	2180.2	936.2	2925.4	5031.9	1242.2	2226.2	4761.3	2864.1	951.4	1534.4	1027.8	1788.2	2074.0	1741.6	3606.5	2111.3	2564.4	1093.9	638.7	1690.8	351.4	3488.7	1481.6	5383.7	5629.1	4993.5	4037.9	2821.8	5113.1	6376.7	5111.7	215.7	4472.3	1339.8	3182.6	3668.7	11623.3	965.6	985.8	936.9	1071.1	894.6	951.2	984.1	951.1	977.1	1050.0	1002.9	996.1	2118.4	984.0	2299.9	16.3	4551.5	10412.0	9836.0	9475.4	2792.1	1065.7	9967.6	10172.3	182.6	4213.6	3849.3	1441.9	425.4	5623.9	4123.0	1288.7	5893.0	2943.4	2097.6	1061.7	2644.4	3666.1	2726.6	2263.9	17.0	6539.7	7508.2	2678.8	1207.4	1390.0	1784.7	4203.6	3429.3	2085.8	3282.5	358.4	18.3	3696.8	2925.6	3062.8	6215.2	4622.8	5581.1	2203.8	5104.8	17.8	3733.3	2455.8	4243.1	9.5	25.1	3814.3	2946.3	3499.2	2308.1	8261.9	3481.6	5422.4	1350.6	1305.5	1577.7	4469.5	4329.1	1074.6	1014.8	3712.4	12290.3	5489.4	4201.1	4673.7	4830.3	9407.7
RPL34	L34	ENSG00000109475	"Ribosomal protein L34"	P49207	4	108620569-108630412	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035139	Uncertain		Supported	"Nucleoli,Endoplasmic reticulum,Cytosol"		NA	NA			"Cluster 30: Non-specific - Translation"	"Cluster 50: Non-specific - Ribosome"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 32: Non-specific - Translation"	"Nucleoli, Endoplasmic reticulum, Cytosol"		"HPA035139: AB_10602925"	"unprognostic (1.49e-2)"	"unprognostic (2.06e-1)"	"unprognostic (6.97e-2)"	"prognostic favorable (2.76e-5)"	"unprognostic (2.45e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.78e-1)"	"unprognostic (8.22e-2)"	"unprognostic (7.14e-2)"	"unprognostic (2.12e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.32e-1)"	"unprognostic (3.72e-3)"	"unprognostic (6.17e-2)"	"unprognostic (8.96e-3)"	"unprognostic (2.71e-1)"	"unprognostic (1.19e-2)"	2425.0	1591.7	1002.0	785.6	1018.3	2268.5	2730.5	987.4	1524.6	3162.1	962.2	2061.8	823.2	1963.6	1544.1	2142.7	2352.9	621.4	1521.5	956.2	997.4	1752.0	1479.4	1498.1	1670.2	1010.6	982.1	4574.1	4126.6	561.6	1616.2	716.9	1015.1	2107.6	914.8	439.0	1967.4	729.0	1791.6	2675.3	1965.7	686.3	1052.9	2223.5	2008.0	507.9	1033.0	1276.7	1700.7	739.6	1511.2	2044.7	2481.9	1055.4	825.0	541.4	1026.2	1485.8	2018.1	3044.8	1023.2	1230.1	1393.2	916.9	752.8	1358.5	1395.7	2413.4	723.7	1117.5	499.4	564.9	1064.4	1792.9	1160.3	927.5	1680.3	1034.0	1087.0	2109.6	1708.0	2628.2	1118.4	2837.7	2381.1	773.6	1701.2	1839.1	1618.7	1345.9	1731.4	1357.1	1479.3	1452.6	1625.9	3123.7	1214.4	1794.1	1095.2	1473.5	1112.4	1478.1	1929.2	1234.1	1099.4	1409.8	510.1	2915.7	1881.3	805.7	957.1	2348.2	1357.7	674.5	926.3	711.3	1121.6	1020.7	1327.3	1913.0	924.1	1533.2	859.0	1744.5	3024.8	943.1	2796.0	2242.1	4811.7	7783.4	5669.6	3854.8	3005.0	6460.3	7498.4	5716.8	610.2	3571.6	1985.1	3793.7	4557.8	12314.4	1002.0	1018.3	987.4	1524.6	956.2	997.4	1010.6	982.1	1015.1	1052.9	1033.0	1055.4	3354.3	1413.4	2496.4	19.9	8040.6	12566.5	10934.5	14134.5	6505.0	343.4	12055.8	16944.0	1156.9	4838.4	5399.5	2164.7	75.0	6443.9	5150.7	1717.5	6914.3	3577.3	1527.0	2002.3	4683.1	4313.0	2720.0	3488.0	31.4	8680.5	7464.2	3471.8	2274.2	2664.1	3308.2	3093.0	5696.3	5781.3	4151.7	154.8	29.1	6030.2	3912.2	6966.0	11139.9	2023.8	7477.3	4326.2	5839.5	43.1	7738.0	1718.3	4866.1	18.1	28.5	5645.0	4899.2	4032.5	3437.1	5962.5	5302.3	9409.4	2362.8	535.0	1913.0	6558.2	3975.1	787.2	678.5	6369.9	15308.7	6380.6	7015.5	2344.3	6469.6	8608.5
RPL36	"DKFZp566B023, L36"	ENSG00000130255	"Ribosomal protein L36"	Q9Y3U8	19	5674947-5691875	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Breast myoepithelial cells: 11665.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			HPA047153	Supported		Supported	"Endoplasmic reticulum,Cytosol"		NA	NA			"Cluster 30: Non-specific - Translation"	"Cluster 50: Non-specific - Ribosome"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 32: Non-specific - Translation"	Cytosol	"Endoplasmic reticulum"	"HPA047153: AB_2679958"	"unprognostic (2.81e-2)"	"unprognostic (5.70e-3)"	"unprognostic (8.16e-2)"	"unprognostic (6.28e-3)"	"unprognostic (2.25e-2)"	"unprognostic (1.20e-1)"	"unprognostic (3.82e-2)"	"unprognostic (5.48e-2)"	"unprognostic (1.29e-1)"	"unprognostic (2.39e-2)"	"unprognostic (2.27e-1)"	"unprognostic (4.65e-2)"	"prognostic unfavorable (2.32e-4)"	"unprognostic (7.07e-2)"	"unprognostic (4.06e-2)"	"unprognostic (4.23e-2)"	"unprognostic (3.51e-2)"	1009.1	1529.4	633.1	565.3	634.4	1235.3	1113.6	595.7	819.4	1302.6	608.6	897.6	514.0	791.6	277.7	1382.3	1064.1	279.1	713.6	609.7	641.8	787.8	824.0	679.5	784.0	618.3	610.5	2559.9	2201.5	235.6	765.2	343.8	618.4	1153.6	282.7	134.9	1110.6	274.7	800.3	1876.9	864.7	214.7	626.9	1033.9	985.2	314.7	650.9	453.3	617.6	257.5	447.0	934.9	1204.6	640.0	1624.4	856.8	563.8	1439.8	676.2	1344.8	823.6	876.3	668.8	1021.0	840.8	1615.3	852.5	1173.9	1993.7	460.6	429.9	1130.5	516.6	1284.8	273.3	856.5	3892.1	744.2	839.2	1347.5	1732.2	1494.3	939.2	1304.3	1881.9	661.5	1160.1	829.4	856.6	1550.4	977.0	3630.2	553.6	1856.8	1934.9	2131.5	1915.2	955.3	2992.0	1187.0	608.1	3086.6	902.4	1141.2	1016.4	1276.6	521.4	1536.1	2592.7	259.3	1192.0	2488.2	811.2	603.9	762.9	875.4	1932.2	1609.3	1644.9	1795.1	1144.8	2480.1	859.7	649.8	1088.5	429.3	1239.7	894.7	1916.1	2491.9	2383.9	1779.7	1355.7	2443.4	2607.7	2240.3	143.2	1263.2	776.1	1337.7	2019.7	4662.9	633.1	634.4	595.7	819.4	609.7	641.8	618.3	610.5	618.4	626.9	650.9	640.0	2057.7	580.1	876.3	15.3	4029.9	6658.4	3062.7	4422.0	4306.5	233.8	7828.9	11665.5	326.1	1947.4	1831.0	1239.6	81.3	2834.0	2054.5	1783.8	2625.6	2857.3	568.5	1386.5	2987.3	2294.5	2048.6	1929.4	11.4	8143.9	4805.4	1873.1	2019.4	2045.2	1297.2	3141.8	3392.5	2952.1	2803.1	97.6	12.3	5548.2	1243.1	3831.3	4994.8	1712.7	3252.6	2108.4	3041.6	26.2	4068.5	1058.4	1988.7	10.1	18.4	5545.1	3883.8	1542.9	2258.4	3579.6	3704.5	3521.3	847.6	346.8	927.0	2285.6	1750.6	385.0	717.0	5107.2	9200.4	2783.1	3173.4	2031.0	4778.3	3290.7
RPL36A	"L36A, RPL44"	ENSG00000241343	"Ribosomal protein L36a"	P83881	X	101390824-101396155	"Metabolic proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Exocrine glandular cells: 3019.1;Undifferentiated cells: 3021.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"MCF7: 2852.7"	"Low region specificity"	"Detected in all"							"HPA063979, HPA077586"	Uncertain		Supported	"Endoplasmic reticulum,Plasma membrane,Cytosol"		NA	NA			"Cluster 30: Non-specific - Translation"	"Cluster 50: Non-specific - Ribosome"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 32: Non-specific - Translation"	"Endoplasmic reticulum, Cytosol"	"Plasma membrane"	"HPA063979: AB_2685164, HPA077586: AB_2686846"	"unprognostic (3.38e-2)"	"unprognostic (2.11e-2)"	"unprognostic (7.04e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.02e-2)"	"unprognostic (4.19e-3)"	"unprognostic (4.15e-3)"	"unprognostic (1.28e-1)"	"unprognostic (2.86e-2)"	"unprognostic (2.77e-1)"	"unprognostic (2.19e-2)"	"unprognostic (8.17e-2)"	"prognostic unfavorable (8.81e-11)"	"unprognostic (1.87e-2)"	"unprognostic (4.50e-3)"	"unprognostic (3.57e-3)"	"unprognostic (4.06e-2)"	1674.1	1002.0	390.2	179.6	390.9	502.0	1779.0	387.0	608.7	1862.0	390.9	1384.5	163.9	1291.5	278.5	1823.7	1542.2	94.6	878.4	384.9	392.9	1127.4	829.5	1066.3	304.6	398.8	389.8	3553.5	2580.0	160.2	799.7	230.4	393.6	1347.0	290.4	94.6	1304.2	219.6	1546.0	2491.5	1369.6	209.8	398.2	1575.2	1319.0	266.3	391.9	430.4	981.5	224.1	502.0	1430.5	1751.0	405.9	508.3	1045.1	465.5	237.5	640.1	1232.0	273.6	198.9	532.7	642.1	1017.6	1196.0	360.1	571.6	367.5	318.1	399.5	350.5	727.8	641.2	651.0	309.1	1445.2	205.8	1919.5	1159.3	803.0	413.1	364.3	985.5	1395.8	436.6	895.6	931.0	576.9	563.1	486.8	660.7	546.2	2852.7	288.5	1285.4	583.8	1637.7	1118.7	367.7	384.8	863.5	633.5	811.3	314.8	508.8	116.8	506.3	608.3	459.4	238.4	806.3	187.0	206.4	369.8	477.2	350.9	330.0	475.0	470.0	223.6	749.5	240.3	130.7	562.7	109.4	608.3	591.8	1102.4	1242.0	1212.6	866.9	814.7	957.9	1322.5	1179.8	51.0	760.6	615.8	919.8	678.7	1804.2	390.2	390.9	387.0	608.7	384.9	392.9	398.8	389.8	393.6	398.2	391.9	405.9	309.5	439.1	987.0	0.0	1100.1	917.4	432.3	574.6	595.8	28.9	1600.3	970.8	16.1	885.0	946.8	174.7	14.6	762.3	615.9	641.2	434.3	1235.1	9.4	124.9	331.6	566.0	1100.8	1215.5	0.0	3019.1	1125.2	523.5	315.0	164.3	1272.4	137.9	1387.8	738.4	609.1	15.2	0.0	2744.0	183.1	2089.7	1144.3	49.3	1055.9	565.6	524.7	0.0	1620.0	187.9	710.6	0.0	0.0	2338.4	1805.5	418.6	559.4	350.6	1349.6	611.7	329.9	41.2	236.7	512.1	467.7	28.7	99.3	758.7	1122.1	751.4	875.8	153.1	3021.8	351.4
RPL38	L38	ENSG00000172809	"Ribosomal protein L38"	P63173	17	74203582-74210655	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052543	Approved		Supported	"Endoplasmic reticulum,Cytosol"		NA	NA		180000	"Cluster 30: Non-specific - Translation"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 32: Non-specific - Translation"	"Endoplasmic reticulum, Cytosol"		"HPA052543: AB_2681864"	"unprognostic (1.68e-3)"	"unprognostic (1.84e-1)"	"unprognostic (7.15e-2)"	"unprognostic (2.99e-1)"	"unprognostic (1.20e-1)"	"prognostic unfavorable (2.51e-4)"	"unprognostic (1.01e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.83e-1)"	"unprognostic (7.71e-3)"	"unprognostic (4.95e-2)"	"unprognostic (1.49e-1)"	"prognostic unfavorable (6.17e-8)"	"unprognostic (1.89e-1)"	"unprognostic (6.00e-2)"	"unprognostic (1.18e-1)"	"unprognostic (3.39e-2)"	1529.9	1174.4	1493.3	822.1	1517.9	1450.0	1568.3	1474.2	1847.8	1873.4	1400.3	1523.8	648.5	1256.8	845.0	1496.0	1435.2	271.4	1470.8	1447.8	1522.6	1124.6	1109.4	1065.7	1010.8	1521.8	1487.5	3163.1	1992.1	754.3	941.5	546.1	1528.1	1267.5	660.1	379.7	1190.0	533.6	2848.0	1967.6	1244.9	535.6	1533.5	1419.7	1231.8	784.8	1535.7	1452.5	1083.8	1900.3	1197.5	1373.2	1569.6	1604.3	1720.7	1654.5	1568.1	1609.4	2096.5	2459.6	1552.1	1818.4	1160.9	1622.8	1130.0	1870.1	1274.6	3002.4	1237.3	1565.8	1504.9	1512.7	1888.2	2361.4	1266.0	844.7	3028.3	1724.1	1374.6	2467.9	2443.9	3251.8	1474.0	4777.2	3230.5	1527.0	2469.4	2179.8	2416.1	2387.7	2155.9	1622.2	1375.7	1793.0	3170.7	3903.4	1837.0	3823.2	2488.8	2259.2	3321.0	2695.8	1971.0	1317.5	1415.6	2630.5	757.0	3129.9	4282.5	1942.0	2389.2	3316.1	1592.2	1347.1	2210.4	1254.4	2416.6	2187.4	3677.2	3159.9	1104.9	2101.7	1314.4	1192.1	1841.8	676.2	1819.2	1524.9	2176.5	2904.1	3073.8	2304.5	2001.8	2772.2	3429.7	3037.1	575.3	1491.2	1383.9	2455.1	2101.1	4458.5	1493.3	1517.9	1474.2	1847.8	1447.8	1522.6	1521.8	1487.5	1528.1	1533.5	1535.7	1604.3	863.9	451.9	901.6	12.7	2204.9	2331.7	1278.1	1084.7	961.2	186.6	2059.8	1364.6	753.8	1509.9	820.1	614.3	73.0	1330.3	1639.9	1230.1	1441.9	1518.1	1413.7	1051.3	1657.7	1158.2	1469.3	1411.7	9.9	2875.9	2467.6	981.1	490.8	1223.8	1223.7	933.3	2189.2	2371.8	1800.6	87.5	9.1	3044.0	413.0	2925.5	2553.8	3689.8	3016.5	1394.9	1213.1	7.5	2817.4	751.3	2063.9	7.1	15.2	2380.8	2171.4	1509.4	769.1	1476.4	2127.6	2377.0	565.8	266.1	959.8	1959.8	1054.6	956.0	1132.1	1084.0	2690.5	1450.3	1884.0	684.7	2643.7	1293.5
RPL41	L41	ENSG00000229117	"Ribosomal protein L41"	P62945	12	56116590-56117967	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Breast myoepithelial cells: 35670.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA053169	Approved		Supported	"Endoplasmic reticulum"		NA	NA			"Cluster 30: Non-specific - Translation"	"Cluster 50: Non-specific - Ribosome"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 32: Non-specific - Translation"	"Endoplasmic reticulum"		"HPA053169: AB_2682067"	"unprognostic (7.99e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.11e-1)"	"unprognostic (3.53e-2)"	"unprognostic (8.94e-2)"	"unprognostic (1.43e-1)"	"unprognostic (4.61e-3)"	"unprognostic (1.50e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.40e-1)"	"unprognostic (2.14e-2)"	"unprognostic (1.79e-1)"	"unprognostic (8.79e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.19e-1)"	3936.1	4294.0	3557.6	3101.7	3613.5	6945.6	7552.2	3463.0	4861.4	4729.6	3626.0	4637.2	3164.3	3213.6	5188.3	5197.9	4452.5	2395.7	3076.1	3477.3	3785.5	3342.3	4356.3	3110.7	5506.9	3599.0	3568.2	8695.6	8504.0	4160.3	3131.9	2392.0	3600.6	4113.2	4408.4	1725.9	5119.7	2985.6	6133.0	6292.8	3521.6	2870.0	3637.4	3885.7	4297.4	964.0	3697.2	5319.2	3521.9	4727.8	6456.2	4672.0	4325.6	3592.3	6313.5	7806.3	7002.4	4830.9	7462.6	11563.8	4509.5	5592.4	7268.0	6990.8	5609.0	7636.8	7281.1	11851.0	7075.7	7144.1	2202.9	5093.1	8802.0	9018.4	6003.8	4866.6	8636.4	5198.6	5743.2	7893.5	8420.9	9422.8	4324.7	12971.4	11986.3	6362.7	13815.8	13392.7	8210.7	6311.2	5234.4	11000.9	6880.6	11434.7	8612.8	13968.6	8415.8	7977.4	7366.9	6352.2	6645.3	9568.4	9027.5	8830.5	4162.2	7204.8	5240.2	7801.5	11830.4	4744.8	9323.1	11208.4	5182.2	2985.4	5510.3	3766.0	5664.5	4989.5	9471.9	9750.5	4626.0	7490.8	3249.4	5072.5	5556.2	2971.9	6805.5	4758.3	9483.2	13388.0	10983.9	8845.1	6687.5	11498.7	11453.0	10037.6	2088.9	6839.0	4546.0	8108.0	9032.3	22344.5	3557.6	3613.5	3463.0	4861.4	3477.3	3785.5	3599.0	3568.2	3600.6	3637.4	3697.2	3592.3	5593.1	2484.0	4469.3	30.3	8258.1	20641.6	3999.9	15748.5	2099.5	489.3	25242.7	35670.2	584.2	6852.9	7643.1	3948.6	218.9	5477.3	8310.1	4631.3	10318.6	6428.1	822.2	3402.2	5615.0	4720.6	5139.1	3676.0	34.1	17900.6	8796.9	4448.1	803.8	4299.0	3546.3	5173.9	6544.8	10920.0	5896.5	213.7	31.0	11437.4	4752.5	9497.7	16486.3	3378.1	6739.8	4472.1	11120.4	34.7	11045.4	2983.4	7243.1	20.1	42.9	11407.4	10209.4	2920.3	2410.0	4695.0	12534.2	12547.9	4754.9	804.3	2143.1	4895.2	5070.6	550.0	666.0	3054.1	25829.7	5993.0	7150.4	4176.6	12114.5	4014.3
RPL5	"L5, PPP1R135, uL18"	ENSG00000122406	"Ribosomal protein L5"	P46777	1	92832013-92841924	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein, RNA-binding, rRNA-binding"	"Cancer-related genes, Diamond-Blackfan anemia, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA043717, HPA054444"	Approved		Supported	"Nucleoli,Nucleoli rim,Endoplasmic reticulum,Cytosol"		NA	NA		430000	"Cluster 30: Non-specific - Translation"	"Cluster 50: Non-specific - Ribosome"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 32: Non-specific - Translation"	"Endoplasmic reticulum, Cytosol"	"Nucleoli, Nucleoli rim"	"HPA043717: AB_10964719, HPA054444: AB_2732584"	"unprognostic (5.81e-3)"	"unprognostic (3.96e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.52e-1)"	"unprognostic (9.44e-3)"	"unprognostic (1.96e-1)"	"unprognostic (1.03e-3)"	"unprognostic (9.95e-2)"	"unprognostic (8.68e-2)"	"unprognostic (1.23e-1)"	"unprognostic (3.98e-2)"	"unprognostic (3.48e-1)"	"prognostic unfavorable (6.81e-5)"	"unprognostic (2.26e-2)"	"unprognostic (3.12e-2)"	"unprognostic (1.09e-1)"	"unprognostic (3.97e-1)"	1236.3	1035.1	515.2	786.9	538.3	1743.3	1798.7	522.4	778.1	1690.1	510.7	1412.8	798.0	1295.2	1388.7	1185.6	1420.7	647.6	890.3	487.5	544.8	858.2	794.9	794.7	1435.7	527.8	511.9	3356.4	2236.0	695.4	869.5	736.1	541.3	1103.1	982.0	346.6	1189.5	847.1	1115.8	1320.8	960.1	962.1	549.0	899.0	1135.5	374.3	528.7	1351.4	1179.5	830.7	1438.8	1309.6	1274.2	552.5	2211.5	924.6	1611.4	1369.2	2045.7	4096.6	2577.6	1283.0	1703.7	1560.0	1108.9	2467.5	933.6	4112.3	2002.9	1451.6	1477.1	1370.3	1871.2	2405.7	1976.3	1314.2	2557.4	2142.3	1402.4	2303.5	2447.2	3322.0	864.6	3382.6	3711.3	1390.4	3027.2	2813.9	2191.6	2129.9	2706.3	2106.7	1814.5	1247.7	2665.7	3741.2	2497.9	1659.1	1724.1	2407.7	3118.5	2702.2	1912.0	1798.7	1367.2	1632.0	836.3	2298.6	3961.6	1316.4	1268.8	4480.6	1345.5	781.6	1429.6	1498.4	2357.4	1290.8	1314.5	2793.5	531.3	2814.4	544.2	234.9	665.6	101.3	758.7	619.1	1520.2	1320.3	1385.5	1151.0	1138.3	1105.7	1729.8	1570.9	56.7	1005.7	552.2	942.7	1140.0	2356.3	515.2	538.3	522.4	778.1	487.5	544.8	527.8	511.9	541.3	549.0	528.7	552.5	1586.8	653.9	1042.2	29.7	3056.7	2843.0	4383.1	2206.0	3168.8	339.6	3182.0	5498.6	375.2	1522.7	1266.7	412.0	89.6	2557.1	2009.8	595.2	1993.7	1697.1	1438.3	840.8	2334.8	1567.8	1236.6	1980.6	35.0	2708.5	4211.6	1464.3	978.1	1009.8	1041.9	2287.9	1546.3	1087.2	1452.5	146.4	33.8	1986.9	720.2	1758.7	2200.6	1189.4	2829.9	1536.8	1406.9	35.6	2171.5	806.3	1969.1	27.2	37.7	1851.6	1567.8	2156.4	2067.8	3935.4	1225.7	2454.6	571.0	298.8	1051.8	2546.2	2122.7	682.8	501.7	3198.9	2893.0	2613.1	2318.2	2797.0	2572.8	3991.1
RPL8	L8	ENSG00000161016	"Ribosomal protein L8"	P62917	8	144789765-144792587	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein, RNA-binding, rRNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"MCF7: 6599.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045095, HPA050165"	Enhanced		Supported	"Nucleoli,Endoplasmic reticulum,Cytosol"		NA	NA		170000000	"Cluster 30: Non-specific - Translation"	"Cluster 50: Non-specific - Ribosome"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 32: Non-specific - Translation"	"Nucleoli, Endoplasmic reticulum, Cytosol"		"HPA045095: AB_2679213, HPA050165: AB_2681038"	"unprognostic (2.52e-2)"	"unprognostic (2.13e-2)"	"unprognostic (2.09e-1)"	"unprognostic (1.04e-2)"	"unprognostic (1.67e-1)"	"unprognostic (9.84e-2)"	"prognostic unfavorable (7.22e-4)"	"unprognostic (4.48e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.54e-1)"	"unprognostic (9.28e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.19e-3)"	"unprognostic (1.79e-2)"	"unprognostic (1.77e-1)"	"unprognostic (2.31e-1)"	"unprognostic (4.13e-2)"	1100.4	864.4	197.2	397.5	201.1	1020.7	1162.7	197.3	361.6	1387.5	199.5	1138.7	688.7	1042.4	63.7	1406.6	1118.6	146.4	962.6	174.2	193.7	889.8	709.6	796.1	424.5	214.1	195.2	2192.7	2021.1	150.3	784.2	264.4	199.9	974.9	110.0	22.9	1320.1	201.8	1651.4	1800.7	885.7	115.6	222.7	918.6	1003.5	304.7	218.2	150.0	739.9	194.0	196.4	1099.7	1240.2	218.1	2486.1	2860.3	200.1	874.6	220.0	496.0	1913.2	1747.7	325.3	522.4	369.7	2518.8	1299.5	3296.6	2461.9	208.4	174.3	1470.7	263.8	609.1	95.7	1446.1	3218.7	1962.1	2166.5	1805.2	546.9	1299.9	1027.5	537.1	680.7	235.9	400.8	246.5	387.8	703.1	2695.3	742.2	226.0	6599.2	1862.9	1754.6	1865.3	674.7	3196.8	1806.5	1154.4	3160.7	280.1	1842.0	1215.9	2028.4	1677.7	899.2	2541.5	81.0	2093.2	1233.3	1573.7	689.8	2622.6	1454.9	2127.3	1344.2	1235.8	2856.3	1372.4	2117.5	968.7	534.8	1464.1	574.8	1160.0	1504.9	1934.6	2970.9	1937.9	1430.4	2051.1	2991.2	2181.6	1718.2	166.1	1469.4	1479.6	1129.7	2070.5	5473.9	197.2	201.1	197.3	361.6	174.2	193.7	214.1	195.2	199.9	222.7	218.2	218.1	2510.5	852.5	1309.5	28.7	4225.5	6439.6	7085.5	5724.6	4563.8	424.0	6122.9	9469.1	1049.0	1988.8	2513.8	1028.1	268.9	4313.8	1790.8	1780.8	4433.5	2429.1	891.2	1083.4	2465.0	2455.7	1698.3	2407.7	24.0	5851.2	6733.6	2161.3	1804.3	1452.8	1044.4	2390.5	2116.1	1309.7	3031.0	166.5	28.5	3563.5	1698.8	2811.4	5097.7	2782.3	3122.7	2281.9	3520.0	30.9	2951.5	1300.3	1607.7	16.1	32.8	3402.4	3311.1	1432.3	3168.7	6500.7	3930.7	4195.9	961.7	689.1	1078.1	2701.0	3865.8	591.8	583.4	5817.5	8224.4	4365.8	2704.6	3472.7	4291.2	7522.7
RPL9	L9	ENSG00000163682	"Ribosomal protein L9"	P32969	4	39452587-39458931	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	5	"cerebral cortex: 2512.5"	"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA003372	Approved	Approved	Supported	"Nucleoli,Endoplasmic reticulum,Cytosol"		NA	NA		180000	"Cluster 30: Non-specific - Translation"	"Cluster 50: Non-specific - Ribosome"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 32: Non-specific - Translation"	"Endoplasmic reticulum, Cytosol"	Nucleoli	"HPA003372: AB_1079843"	"unprognostic (1.08e-3)"	"unprognostic (2.14e-1)"	"unprognostic (1.24e-1)"	"unprognostic (8.06e-3)"	"unprognostic (5.59e-2)"	"unprognostic (1.27e-2)"	"unprognostic (3.16e-2)"	"unprognostic (2.14e-1)"	"unprognostic (8.58e-2)"	"unprognostic (6.68e-2)"	"unprognostic (2.50e-2)"	"unprognostic (7.85e-2)"	"prognostic unfavorable (7.34e-4)"	"unprognostic (1.34e-1)"	"unprognostic (2.10e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.06e-2)"	1868.9	1181.0	377.9	809.5	384.9	2487.2	2132.6	378.2	2512.5	2407.6	382.9	1776.6	737.5	1418.3	2338.6	1568.7	1896.6	785.0	1168.4	368.3	462.3	1318.1	1056.3	1130.2	613.9	381.0	381.1	3607.4	2794.6	510.7	1060.0	419.0	382.5	1562.6	605.5	314.2	1387.6	681.5	1550.4	2153.4	1327.8	551.1	407.5	1400.1	1484.5	386.8	388.4	43.6	1072.2	1767.5	705.8	1675.7	1773.4	395.9	52.4	41.7	2173.3	48.2	57.0	90.0	72.9	1109.3	1618.3	1306.1	981.0	131.1	1243.5	2771.5	93.8	1081.2	1040.1	1169.0	67.3	79.3	1422.3	964.2	2080.2	80.0	415.4	131.2	81.3	153.2	711.1	113.8	3249.4	56.1	1445.8	1907.5	69.6	70.4	2126.4	1196.8	60.9	69.4	1556.5	163.4	1954.7	1523.9	57.6	1417.2	2327.7	76.3	1656.7	63.7	74.3	915.0	31.6	899.8	115.5	1976.1	1864.0	98.7	63.2	51.1	72.1	1486.9	134.2	1806.3	2754.2	2483.9	1456.9	1717.2	56.6	447.2	556.1	171.7	664.4	585.3	1320.8	1566.4	1311.6	919.0	779.1	1361.8	1804.5	1436.1	94.8	927.3	456.8	1013.2	1101.2	2263.3	377.9	384.9	378.2	2512.5	368.3	462.3	381.0	381.1	382.5	407.5	388.4	395.9	1634.0	663.4	908.4	2.3	3629.4	4132.6	5621.6	3089.9	1994.2	406.0	4149.6	3833.2	428.0	2051.8	1359.8	709.9	160.6	3011.2	2723.2	1300.0	2733.2	2184.8	1549.9	1126.9	2738.2	2121.2	1850.2	1755.0	3.0	4399.8	5910.8	1698.9	828.7	1534.0	913.2	2226.7	2439.5	1991.3	2775.3	198.5	3.2	3581.7	1053.8	3282.8	3322.0	1707.8	4819.6	2242.3	1851.6	2.8	4568.2	1398.0	3045.4	3.0	3.6	3145.0	2925.6	2394.1	1420.3	4718.4	2823.2	3698.3	656.7	581.0	1512.0	3760.1	2630.9	684.0	593.6	2325.1	4675.5	3400.0	2937.1	2567.2	3793.6	5564.6
RPLP0	"L10E, LP0, P0, PRLP0, RPP0"	ENSG00000089157	"Ribosomal protein lateral stalk subunit P0"	P05388	12	120196699-120201235	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003512, HPA073501"	Enhanced		Supported	"Endoplasmic reticulum,Cytosol"		NA	NA		770000	"Cluster 30: Non-specific - Translation"	"Cluster 50: Non-specific - Ribosome"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 32: Non-specific - Translation"	"Endoplasmic reticulum, Cytosol"		"HPA003512: AB_1079844, HPA073501: "	"unprognostic (2.39e-3)"	"unprognostic (2.46e-1)"	"unprognostic (1.78e-1)"	"unprognostic (8.49e-3)"	"unprognostic (2.99e-2)"	"unprognostic (2.44e-1)"	"unprognostic (2.54e-3)"	"unprognostic (5.99e-2)"	"unprognostic (1.67e-1)"	"unprognostic (4.82e-2)"	"unprognostic (2.34e-1)"	"unprognostic (3.35e-1)"	"prognostic unfavorable (7.66e-12)"	"unprognostic (2.74e-1)"	"unprognostic (2.39e-1)"	"unprognostic (3.06e-1)"	"unprognostic (1.47e-1)"	1626.2	1344.7	561.3	1155.2	565.6	3283.8	2720.3	554.1	640.3	1534.6	616.4	1752.1	1554.5	1257.0	987.6	2694.1	2220.6	979.7	1047.9	552.7	585.8	878.9	1433.5	1081.9	1835.1	618.4	571.6	2860.3	3265.5	696.8	753.7	1202.7	602.2	1195.7	1776.6	523.0	1791.6	848.6	2407.5	2585.8	1260.0	1337.9	603.4	1135.2	1608.7	396.8	599.5	1835.9	1154.9	1590.0	2433.7	1778.7	1703.7	603.6	3354.4	3355.3	2339.0	4061.4	4653.6	7635.7	3627.8	2397.9	4274.8	3734.5	2395.4	4364.8	1919.1	7137.6	2541.5	4307.9	945.2	2583.2	4120.3	5060.1	2324.4	2764.8	3209.4	3343.3	2263.6	4630.2	5153.3	4498.4	2490.2	6817.1	8686.1	2619.4	8018.0	6670.0	4528.8	4037.2	4292.7	2014.6	3645.7	5140.3	4443.4	5661.6	4494.0	3290.9	3704.7	3321.6	3175.0	5868.8	3881.1	5170.2	2606.2	3183.0	1722.7	2593.0	5541.7	2631.2	4773.6	6518.2	3016.5	1807.3	2718.5	2322.7	3249.7	4551.6	5143.0	3549.4	3136.7	3560.7	1492.7	337.6	1714.3	136.4	1750.8	1555.9	3999.6	3712.1	3171.7	2361.5	3455.6	3456.2	3255.0	2728.7	123.0	2340.3	927.0	3805.3	2342.6	7075.7	561.3	565.6	554.1	640.3	552.7	585.8	618.4	571.6	602.2	603.4	599.5	603.6	594.8	586.5	1363.0	12.7	2571.7	3876.3	4947.2	3409.7	5507.4	208.7	3351.1	3986.1	277.8	1312.6	1946.7	562.8	154.3	4464.2	1352.3	967.9	1886.1	2150.7	448.8	811.6	1878.9	1354.0	1217.3	2826.9	12.8	4812.2	7058.4	1577.5	1782.3	1217.8	796.8	1334.4	963.1	1249.9	2014.1	94.2	19.7	2395.8	950.1	1281.9	2122.5	944.5	1740.7	1327.5	1700.4	17.8	1794.6	366.3	1030.9	19.6	28.6	2966.5	1712.5	795.1	4088.9	4142.9	1870.9	2089.5	859.3	486.4	420.7	1701.5	3223.9	309.4	759.2	7221.2	4751.9	4413.0	1892.0	2405.0	3317.6	5180.7
RPLP1	LP1	ENSG00000137818	"Ribosomal protein lateral stalk subunit P1"	P05386	15	69452814-69456205	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Suprabasal keratinocytes: 28402.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA003368			Supported	"Endoplasmic reticulum,Cytosol"		NA	NA		2000000	"Cluster 30: Non-specific - Translation"	"Cluster 59: Non-specific - Translation"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 32: Non-specific - Translation"	"Endoplasmic reticulum, Cytosol"		"HPA003368: AB_1079845"	"unprognostic (5.04e-3)"	"unprognostic (2.26e-2)"	"unprognostic (2.02e-2)"	"unprognostic (4.29e-2)"	"unprognostic (6.32e-2)"	"unprognostic (1.35e-1)"	"unprognostic (4.36e-2)"	"unprognostic (2.92e-1)"	"unprognostic (1.30e-1)"	"unprognostic (2.36e-1)"	"unprognostic (2.79e-1)"	"unprognostic (9.55e-2)"	"prognostic unfavorable (2.30e-9)"	"unprognostic (7.75e-2)"	"unprognostic (1.57e-1)"	"unprognostic (2.59e-1)"	"unprognostic (5.83e-2)"	1779.5	1664.6	852.0	893.4	872.7	2781.2	1895.2	821.7	1109.7	2465.3	920.5	2035.4	1200.3	1805.3	349.4	2773.4	1670.9	579.0	2121.7	813.6	844.4	1703.1	1566.2	1439.7	1583.3	871.6	857.5	3354.5	2003.6	264.6	924.6	565.5	866.0	1991.6	449.1	157.6	1705.8	417.0	4746.4	4498.6	1693.4	529.7	892.5	1992.0	2147.0	492.5	873.6	643.5	1140.9	761.4	1017.9	2099.9	2372.6	891.4	1890.5	1882.4	827.9	1919.4	1172.4	1394.2	1770.4	1615.7	960.9	892.0	711.8	1918.7	1861.9	2622.2	2346.4	869.5	811.2	2521.6	1296.6	1287.5	193.1	2639.9	3956.6	2208.5	2153.1	1914.5	2045.2	1976.4	1931.2	1782.1	2199.9	653.6	1219.6	1438.9	1092.7	2265.9	2127.7	2160.7	642.2	1757.0	2163.4	5781.3	3098.7	1172.2	1802.9	2192.5	2696.6	3893.7	876.0	2002.9	1319.3	2558.5	1620.5	1978.2	6979.8	742.8	1633.9	4449.5	1915.7	1273.2	2851.6	1535.0	2672.3	4382.2	7690.0	2245.6	1524.1	4968.6	1076.9	2903.3	5350.5	1819.3	3182.4	3677.4	5811.2	9096.0	6532.4	4349.4	6100.6	7551.7	6871.8	6057.1	733.9	5147.0	2138.6	6392.6	5921.8	13416.9	852.0	872.7	821.7	1109.7	813.6	844.4	871.6	857.5	866.0	892.5	873.6	891.4	3508.0	1891.0	3795.4	16.0	11229.3	24186.3	18565.6	9896.5	18630.1	626.6	14197.1	19613.8	1854.3	3877.6	5293.4	2265.9	350.3	9217.3	6668.2	2484.5	5141.7	5608.7	475.1	2702.4	5765.4	5131.7	2926.5	6423.8	19.7	7158.4	12076.7	5235.1	3541.4	4232.4	2605.7	4287.7	5261.2	6536.1	8166.9	373.5	22.5	7238.9	2396.6	8309.7	12226.0	1764.3	8447.2	6779.7	9051.8	28.1	11829.2	4015.4	6451.2	15.6	42.8	7495.3	5127.5	4732.9	10308.0	16198.4	5565.3	8039.9	2204.8	1167.3	2530.9	5356.8	5872.6	690.3	1864.1	18779.3	28402.5	9502.3	9179.6	6940.6	8549.1	17342.5
RPN2	"RIBIIR, RPN-II, RPNII, SWP1"	ENSG00000118705	"Ribophorin II"	P04844	20	37178410-37241619	"Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Extravillous trophoblasts: 599.6;Syncytiotrophoblasts: 621.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008297, CAB019277, HPA025922"	Enhanced		Supported	"Endoplasmic reticulum"		NA	NA		1300000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 55: Plasma cells - Humoral immune response"	"Endoplasmic reticulum"		"CAB019277: , HPA008297: AB_1856457, HPA025922: AB_1856458"	"unprognostic (9.59e-3)"	"unprognostic (5.22e-2)"	"unprognostic (1.66e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.99e-1)"	"unprognostic (1.20e-2)"	"prognostic unfavorable (1.38e-4)"	"unprognostic (1.82e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.58e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.14e-1)"	"prognostic unfavorable (1.44e-10)"	"unprognostic (2.83e-1)"	"unprognostic (6.99e-2)"	"unprognostic (2.03e-1)"	"prognostic unfavorable (2.44e-4)"	112.6	132.5	48.2	131.9	50.4	180.8	146.1	49.9	55.9	161.8	98.0	156.9	125.5	108.7	344.1	106.8	122.9	119.8	107.3	49.5	56.5	145.1	212.1	129.7	109.2	54.0	50.6	94.8	159.6	180.9	79.1	257.9	53.9	164.4	175.2	117.0	158.2	157.5	110.4	91.5	110.9	156.6	53.8	118.1	145.1	144.2	55.4	108.5	232.5	75.1	143.3	165.4	87.9	61.9	328.2	290.6	302.7	401.2	413.1	308.2	586.7	426.7	516.8	544.8	459.2	939.2	564.8	255.3	501.6	572.3	506.4	468.4	318.8	516.4	492.0	121.2	196.5	295.3	308.4	634.1	398.9	468.4	467.0	294.6	505.1	432.3	447.5	519.8	530.4	239.2	458.7	805.1	389.1	300.9	270.6	451.0	240.4	839.3	415.7	242.3	549.1	852.7	371.6	304.3	246.4	261.0	517.9	1231.1	489.4	353.6	606.1	765.6	338.0	600.8	358.2	317.1	371.9	474.7	608.4	259.9	583.4	314.9	493.2	424.2	427.5	285.5	365.5	410.5	417.0	291.0	336.1	363.8	481.2	232.4	298.8	308.7	78.3	398.8	357.6	591.0	338.2	676.5	48.2	50.4	49.9	55.9	49.5	56.5	54.0	50.6	53.9	53.8	55.4	61.9	85.7	118.6	158.0	22.2	107.8	61.8	134.1	264.6	62.0	72.6	90.0	74.2	81.4	133.0	197.7	80.9	45.9	461.6	109.6	113.9	23.5	278.0	37.3	73.2	103.5	98.6	63.0	91.7	18.8	241.1	599.6	127.4	84.1	151.2	105.2	109.3	100.6	206.3	233.2	63.9	18.6	168.5	162.8	150.4	75.3	24.4	105.0	117.0	90.7	20.6	122.2	136.8	65.9	24.1	20.5	160.1	109.5	110.9	392.3	121.3	64.6	82.3	98.5	100.8	85.5	65.3	122.0	335.2	288.9	67.7	57.8	621.0	81.5	213.7	138.7	117.6
RPP25	FLJ20374	ENSG00000178718	"Ribonuclease P and MRP subunit p25"	Q9BUL9	15	74954418-74956772	"Enzymes, Predicted intracellular proteins"	"rRNA processing, tRNA processing"	"Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Bipolar cells: 95.1;Hofbauer cells: 77.0;Rod photoreceptor cells: 72.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"plasmacytoid DC: 25.8"	"Group enriched"	"Detected in many"	5	"dendritic cells: 25.8;monocytes: 10.1"	"Cell line enhanced"	"Detected in many"		"HHSteC: 46.0;SCLC-21H: 42.9;SK-MEL-30: 67.4"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in many"		"olfactory bulb: 23.0"	HPA046900	Approved		Supported	"Nucleoplasm,Centriolar satellite"		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 56: Bipolar cells - Visual perception"	Nucleoplasm	"Centriolar satellite"	"HPA046900: AB_10962049"	"unprognostic (9.36e-2)"	"unprognostic (7.17e-3)"	"unprognostic (5.54e-2)"	"unprognostic (2.27e-1)"	"prognostic unfavorable (2.24e-5)"	"unprognostic (7.18e-2)"	"unprognostic (5.73e-3)"	"unprognostic (5.50e-3)"	"unprognostic (7.78e-2)"	"unprognostic (1.44e-1)"	"unprognostic (3.58e-2)"	"unprognostic (1.70e-1)"	"unprognostic (4.71e-3)"	"unprognostic (5.50e-3)"	"unprognostic (5.58e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.53e-1)"	6.0	13.2	7.4	2.7	8.9	0.4	4.5	14.6	8.5	7.1	6.5	7.9	7.2	3.7	1.8	6.9	4.4	4.5	5.5	4.9	10.8	5.1	3.1	5.8	3.9	16.5	12.7	15.4	7.6	23.0	5.2	7.2	16.4	4.2	4.8	12.8	4.6	1.7	1.4	4.9	5.7	2.5	10.8	10.8	7.1	3.0	12.8	2.4	8.9	1.5	3.4	7.7	5.4	12.7	23.6	17.5	4.4	0.1	1.5	0.9	7.4	4.3	5.2	1.3	1.2	24.1	21.0	0.0	19.4	4.4	1.2	6.9	13.7	0.8	0.3	8.9	0.7	0.1	19.9	0.5	46.0	0.0	13.3	5.9	0.6	8.5	0.0	0.9	20.4	5.5	16.1	0.0	4.6	9.1	3.8	6.3	20.8	40.9	7.0	0.1	0.0	15.8	4.2	0.4	42.9	32.1	32.6	28.8	67.4	2.2	5.7	18.7	4.6	0.0	1.4	3.8	0.2	0.4	0.1	0.1	2.3	36.6	25.1	0.0	5.2	0.0	2.3	10.1	1.3	3.4	1.5	1.8	5.1	3.7	3.8	3.0	0.4	0.5	7.7	25.8	0.7	2.5	7.4	8.9	14.6	8.5	4.9	10.8	16.5	12.7	16.4	10.8	12.8	12.7	5.3	3.2	1.1	0.3	4.9	11.0	7.5	9.1	11.4	95.1	11.8	9.9	1.6	14.3	6.4	9.2	4.2	2.3	17.0	24.4	13.7	13.7	0.3	1.6	4.7	8.9	10.2	0.8	0.7	19.3	4.3	23.9	14.8	3.6	0.0	3.4	31.8	1.6	77.0	21.9	10.0	12.5	14.2	14.8	8.6	2.6	39.4	9.3	14.2	1.0	16.1	13.4	4.1	0.0	6.3	13.8	20.5	30.1	8.2	19.1	27.5	16.6	1.3	72.3	13.1	4.3	10.4	1.4	6.5	18.2	11.5	2.3	2.1	26.6	20.7	10.5
RPP25L	"bA296L22.5, C9orf23, MGC29635"	ENSG00000164967	"Ribonuclease P/MRP subunit p25 like"	Q8N5L8	9	34610486-34612104	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 118.4"	"Cell type enhanced"	"Detected in many"		"Proximal enterocytes: 132.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA052187, HPA059698"	Uncertain		Supported	Nucleoplasm		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 45: Enterocytes - Digestion"	Nucleoplasm		"HPA052187: AB_2681755, HPA059698: AB_2684106"	"unprognostic (1.56e-1)"	"unprognostic (1.43e-2)"	"unprognostic (7.44e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.78e-1)"	"unprognostic (4.78e-2)"	"unprognostic (2.56e-1)"	"unprognostic (1.66e-1)"	"unprognostic (2.53e-2)"	"unprognostic (3.39e-2)"	"unprognostic (2.44e-1)"	"prognostic favorable (3.01e-9)"	"unprognostic (4.63e-3)"	"unprognostic (6.20e-2)"	"unprognostic (3.40e-1)"	"prognostic favorable (8.21e-4)"	17.2	23.2	30.5	13.8	31.7	9.7	18.3	32.7	36.2	20.6	28.4	26.4	27.5	19.9	12.5	28.2	20.1	14.5	46.8	30.5	31.5	30.6	51.4	11.8	20.7	31.9	30.6	19.5	23.0	24.0	17.4	12.2	32.3	24.5	14.4	4.8	23.1	15.1	118.4	17.5	26.4	10.5	30.8	26.5	21.9	16.0	33.0	22.5	18.5	103.1	13.9	20.5	18.5	30.2	42.6	54.0	21.9	21.4	21.4	20.2	21.5	18.1	18.5	28.9	33.1	24.3	28.2	32.8	27.1	11.0	13.5	28.1	33.2	44.2	10.4	66.1	44.5	19.5	37.9	36.2	46.1	20.5	28.3	35.2	42.4	24.3	55.3	25.1	30.8	44.5	31.6	34.1	22.7	45.8	42.9	76.4	20.1	43.4	48.7	37.2	23.0	33.2	31.9	22.1	14.6	8.5	32.9	36.6	21.6	10.8	33.6	35.7	14.5	9.1	26.3	22.3	15.1	16.4	30.8	38.6	27.6	41.3	44.7	71.2	55.6	56.4	38.2	48.5	47.3	57.1	44.5	40.3	47.8	67.3	51.8	49.8	51.9	56.6	57.5	39.3	68.4	39.6	30.5	31.7	32.7	36.2	30.5	31.5	31.9	30.6	32.3	30.8	33.0	30.2	12.9	0.0	15.1	6.5	20.7	11.1	50.4	61.9	24.5	7.8	30.9	39.9	34.4	22.8	30.5	20.2	2.1	61.8	14.4	55.7	99.7	31.0	3.3	10.3	21.5	17.5	33.6	12.6	3.0	19.8	38.1	18.4	17.9	13.7	10.2	16.4	27.1	77.5	32.0	0.0	3.9	44.7	38.7	33.6	10.4	6.0	22.4	18.4	12.4	3.7	33.1	25.6	51.5	2.0	3.4	18.9	61.6	15.4	14.7	40.8	132.7	82.2	21.0	12.3	6.6	18.2	18.8	50.3	24.0	30.6	14.8	41.9	17.4	47.7	50.1	44.4
RPP38		ENSG00000152464	"Ribonuclease P/MRP subunit p38"	P78345	10	15097180-15139818	"Enzymes, Predicted intracellular proteins, Ribosomal proteins"	"rRNA processing, tRNA processing"	"Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"Early spermatids: 555.3;Late spermatids: 231.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045128, HPA050398"	Approved		Supported	Nucleoli		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	Nucleoli		"HPA045128: AB_2797230, HPA050398: AB_2732560"	"unprognostic (1.75e-1)"	"unprognostic (3.91e-2)"	"unprognostic (3.76e-2)"	"unprognostic (1.51e-1)"	"unprognostic (9.93e-2)"	"unprognostic (1.17e-1)"	"prognostic unfavorable (1.46e-4)"	"unprognostic (1.41e-2)"	"unprognostic (4.86e-1)"	"unprognostic (1.57e-3)"	"unprognostic (3.42e-1)"	"unprognostic (7.21e-2)"	"prognostic unfavorable (6.25e-4)"	"unprognostic (6.13e-2)"	"unprognostic (1.95e-1)"	"unprognostic (5.11e-2)"	"prognostic favorable (2.89e-6)"	14.0	12.9	9.1	12.3	9.4	12.4	19.8	12.4	11.7	14.0	15.1	16.3	15.8	15.0	16.7	16.2	19.3	11.2	13.0	9.4	9.5	17.2	19.4	13.8	20.1	8.9	9.0	14.6	15.2	14.2	13.4	11.5	8.9	13.9	16.7	13.4	14.4	12.1	19.0	17.2	16.6	12.5	8.8	17.7	15.4	48.1	9.3	15.6	16.2	14.8	18.0	17.6	13.3	10.1	40.6	29.4	15.6	20.3	20.7	21.2	27.9	18.7	14.0	29.0	29.3	29.6	40.3	33.2	19.3	17.6	23.7	36.2	31.8	32.4	26.2	26.0	28.6	34.3	17.3	26.2	44.4	19.5	27.5	25.3	43.8	23.4	20.5	21.9	23.2	33.0	40.1	22.7	22.0	32.6	34.9	20.9	18.0	49.0	14.0	28.3	15.9	41.5	37.0	15.3	14.7	18.5	25.7	44.4	53.6	25.6	39.7	30.8	18.8	13.1	22.8	28.3	25.2	31.6	36.5	44.9	25.8	23.3	12.6	21.9	48.5	49.7	49.1	49.0	48.6	58.7	49.7	60.8	51.9	66.0	57.2	52.4	16.2	41.5	40.8	52.3	47.3	43.4	9.1	9.4	12.4	11.7	9.4	9.5	8.9	9.0	8.9	8.8	9.3	10.1	15.5	16.0	22.0	4.2	24.0	31.5	41.9	34.7	14.2	14.2	22.5	26.0	7.1	11.5	40.3	9.2	6.2	30.2	18.6	18.6	27.4	34.2	555.3	54.4	18.7	19.2	13.2	15.2	3.3	33.2	42.1	15.7	16.8	16.0	12.7	15.5	19.6	32.4	24.7	8.4	3.5	25.4	36.7	18.8	12.6	231.1	23.6	13.4	8.8	5.6	21.6	17.7	33.0	4.5	5.5	29.6	16.8	19.9	14.5	46.8	26.9	33.9	89.2	31.0	13.1	14.9	14.6	68.0	34.6	17.2	36.1	32.2	21.5	23.6	24.0	43.8
RPRD1A	"FLJ10656, HsT3101, P15RS"	ENSG00000141425	"Regulation of nuclear pre-mRNA domain containing 1A"	Q96P16	18	35984387-36067576	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 233.0;Late spermatids: 362.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040602	Supported		Supported	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 68: Epididymis - Unknown function"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 34: Spermatids - Unknown function"	"Nucleoplasm, Golgi apparatus"		"HPA040602: AB_10673137"	"unprognostic (2.06e-1)"	"unprognostic (9.14e-2)"	"unprognostic (1.41e-3)"	"unprognostic (2.22e-1)"	"unprognostic (9.92e-3)"	"unprognostic (2.69e-1)"	"unprognostic (2.93e-3)"	"unprognostic (1.68e-1)"	"unprognostic (2.80e-2)"	"unprognostic (3.94e-3)"	"unprognostic (1.13e-1)"	"unprognostic (1.89e-1)"	"unprognostic (5.50e-3)"	"unprognostic (7.95e-2)"	"unprognostic (6.78e-3)"	"unprognostic (1.49e-1)"	"unprognostic (4.30e-1)"	23.3	34.8	40.6	16.4	44.4	11.3	24.7	40.7	59.9	21.1	34.6	29.6	19.0	25.7	115.2	23.6	25.3	18.5	29.1	45.5	43.2	26.7	21.8	19.2	19.5	39.5	40.3	24.1	23.4	26.1	27.8	17.8	40.0	29.6	20.5	41.5	28.3	28.9	54.7	20.9	19.0	21.3	41.4	22.3	21.3	28.0	42.6	19.9	32.1	46.5	19.3	27.6	20.0	44.4	31.6	34.1	57.0	60.8	30.6	35.8	35.5	55.6	54.5	31.7	44.5	9.4	34.2	44.1	57.2	40.7	16.9	51.2	64.1	56.3	44.7	39.2	36.6	46.9	48.9	37.0	53.9	78.9	24.3	27.6	73.7	30.2	85.4	39.8	46.0	51.5	42.8	46.7	41.1	39.3	42.4	33.3	45.9	16.2	24.4	34.7	18.3	70.8	48.4	66.9	99.1	83.4	46.5	25.7	48.3	46.2	35.2	55.9	56.4	33.0	20.6	17.7	46.0	52.5	77.6	45.0	33.6	64.1	33.9	0.7	4.7	2.2	2.9	6.3	4.4	5.0	4.0	3.4	7.8	5.4	5.0	4.0	3.5	7.0	4.2	5.4	2.3	3.3	40.6	44.4	40.7	59.9	45.5	43.2	39.5	40.3	40.0	41.4	42.6	44.4	19.0	32.1	20.7	54.9	40.6	34.4	35.9	23.6	54.7	49.6	29.9	22.2	39.4	17.2	21.0	35.0	31.3	17.1	28.7	13.6	27.4	21.0	233.0	36.3	30.2	23.1	28.8	24.6	105.0	19.9	17.6	19.0	25.0	52.5	13.3	50.7	20.7	29.3	9.8	37.0	91.0	16.7	22.4	20.1	24.2	362.4	22.1	18.8	30.2	58.1	18.1	32.2	18.6	84.9	98.5	20.4	25.2	23.0	33.1	41.5	17.8	26.2	20.3	50.8	13.1	26.1	27.0	39.5	42.2	45.2	38.2	14.6	21.9	51.9	22.2	38.2
RPRD1B	"C20orf77, CREPT, dJ1057B20.2, DKFZp434P0735, FLJ44520, K-H, Kub5-Hera, NET60"	ENSG00000101413	"Regulation of nuclear pre-mRNA domain containing 1B"	Q9NQG5	20	38033725-38127780	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 72.5"	"Cell type enhanced"	"Detected in all"		"Hepatocytes: 87.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA066290, HPA070590, HPA072645"	Enhanced		Supported	Nucleoplasm		NA	NA		28000	"Cluster 14: Monocytes - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 35: Glandular cells - Unknown function"	Nucleoplasm		"HPA066290: AB_2685650, HPA070590: , HPA072645: "	"unprognostic (3.14e-2)"	"unprognostic (3.30e-1)"	"unprognostic (5.38e-2)"	"unprognostic (1.18e-3)"	"unprognostic (3.08e-1)"	"unprognostic (3.77e-2)"	"unprognostic (2.68e-2)"	"unprognostic (4.84e-2)"	"unprognostic (1.03e-1)"	"unprognostic (3.20e-2)"	"unprognostic (1.14e-1)"	"unprognostic (5.25e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.70e-2)"	"unprognostic (5.77e-2)"	"unprognostic (1.36e-2)"	"unprognostic (3.47e-1)"	13.3	12.4	8.9	12.3	10.7	35.2	14.1	11.8	10.4	14.5	9.1	12.3	10.2	16.3	12.4	14.5	16.5	10.8	23.6	7.6	11.7	14.5	72.5	12.0	21.7	9.5	9.0	13.7	12.8	17.3	10.9	11.9	10.1	15.1	12.8	18.1	12.2	12.1	34.8	14.4	13.3	12.7	7.4	13.8	12.4	13.3	9.4	16.3	15.0	25.9	29.8	17.5	12.5	13.6	29.6	14.4	28.4	13.0	18.8	25.2	28.3	21.3	20.4	27.9	23.7	70.7	30.8	27.0	27.5	17.0	26.1	34.2	26.3	40.3	33.3	11.1	13.3	44.1	18.6	39.0	22.6	35.0	13.9	20.1	40.0	27.9	34.0	19.0	17.3	28.8	36.9	20.4	21.6	23.0	49.3	27.5	14.1	37.0	29.6	28.3	56.7	26.7	15.0	27.5	28.0	19.7	38.0	60.0	27.8	18.1	29.7	33.7	17.0	46.0	28.8	18.5	24.8	26.8	26.9	48.1	27.8	21.1	15.3	0.6	5.8	5.8	4.6	6.6	5.7	3.4	4.4	4.1	6.0	3.2	5.5	5.1	4.6	3.9	9.0	2.9	2.9	5.0	8.9	10.7	11.8	10.4	7.6	11.7	9.5	9.0	10.1	7.4	9.4	13.6	13.6	16.0	21.9	20.5	16.2	15.8	12.0	9.8	13.1	16.4	22.7	16.9	49.3	17.2	11.8	18.4	18.8	14.7	12.8	15.7	15.6	7.6	9.4	11.9	17.9	16.2	23.4	17.4	28.6	8.6	12.4	18.0	16.8	14.8	13.3	18.5	24.3	87.9	12.3	18.5	26.3	20.7	4.1	22.7	9.5	10.3	10.5	18.4	10.6	21.5	9.7	10.3	4.1	30.7	41.1	9.8	11.6	13.2	17.4	23.7	17.1	17.4	22.4	19.1	6.6	19.1	14.7	15.2	12.3	19.1	18.6	15.6	14.8	18.3	14.5	19.8
RPS11	S11	ENSG00000142534	"Ribosomal protein S11"	P62280	19	49496365-49499708	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein, RNA-binding, rRNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049719	Uncertain		Supported	"Nucleoli,Endoplasmic reticulum,Cytosol"		NA	NA		39000	"Cluster 30: Non-specific - Translation"	"Cluster 50: Non-specific - Ribosome"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 32: Non-specific - Translation"	"Endoplasmic reticulum, Cytosol"	Nucleoli	"HPA049719: AB_2680860"	"unprognostic (1.49e-3)"	"unprognostic (3.71e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.50e-2)"	"unprognostic (5.89e-3)"	"unprognostic (3.57e-1)"	"unprognostic (1.04e-2)"	"unprognostic (4.10e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.47e-1)"	"unprognostic (5.68e-2)"	"unprognostic (1.49e-1)"	"prognostic unfavorable (3.50e-7)"	"unprognostic (5.19e-2)"	"unprognostic (1.04e-1)"	"unprognostic (2.18e-1)"	"unprognostic (1.71e-3)"	2814.3	1967.1	2353.0	1926.7	2400.8	5134.9	4378.8	2317.2	2969.3	3860.2	2321.9	2702.6	1771.3	2682.7	2738.1	2407.0	3426.0	1647.5	1778.5	2271.3	2375.3	2155.4	2117.7	1996.8	4054.9	2375.8	2309.1	6075.5	3741.4	1881.9	2119.6	1859.8	2411.6	2569.3	2712.5	1006.4	2752.4	1960.9	3200.5	3819.2	2355.1	2297.6	2434.1	2818.2	2473.8	735.7	2397.5	3791.6	1978.6	3380.1	4757.2	2689.4	2908.0	2437.6	2932.3	4522.4	3340.7	5169.4	4778.9	7228.3	2239.9	2418.7	4891.5	3444.6	3294.2	3167.0	2392.5	7154.4	1461.9	3373.2	1470.8	1926.2	4003.2	4879.0	3375.9	3065.7	6870.8	4318.3	2858.4	4634.4	4446.2	7694.0	3083.3	7191.2	7968.8	2279.2	5867.3	5774.3	5106.5	4307.3	4374.9	3709.1	3792.3	3324.7	3612.0	5845.5	3067.8	7346.6	4594.6	3450.4	4209.9	3875.7	5006.0	6932.7	3555.4	4741.2	1646.4	5505.8	3793.8	3223.4	1790.9	7907.9	2886.2	2667.3	2377.5	1302.4	3236.1	3646.3	6191.7	5179.5	1104.6	5297.2	2335.7	1161.8	2103.1	653.8	1900.0	1810.3	2537.9	4890.5	2741.7	2206.3	2979.8	4589.4	3192.9	2762.8	507.2	2120.9	1563.8	3733.9	2382.4	6125.5	2353.0	2400.8	2317.2	2969.3	2271.3	2375.3	2375.8	2309.1	2411.6	2434.1	2397.5	2437.6	820.0	836.6	1502.6	30.0	2589.7	2685.3	2499.6	1615.7	971.5	289.1	1028.9	947.2	716.6	1155.3	1344.7	474.5	143.9	1915.2	1891.9	1130.4	1216.9	1295.8	900.1	1044.9	2292.8	1236.5	1501.5	1404.7	9.6	2816.1	3575.5	1178.0	550.0	1527.0	1341.6	1228.9	1633.8	1645.8	1898.6	94.2	12.1	2720.4	612.3	2780.4	3206.1	1773.6	3212.5	1749.5	1538.5	22.5	2825.6	1123.6	2614.9	10.1	22.3	2021.0	1960.1	1538.8	1006.3	2063.5	1353.7	1873.6	857.0	493.5	874.4	2214.3	2008.7	603.1	589.5	1334.2	3413.1	2356.3	1587.9	1273.7	2434.5	2570.3
RPS12	S12	ENSG00000112306	"Ribosomal protein S12"	P25398	6	132814569-132817564	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA006124, HPA006365"	Approved		Supported	"Golgi apparatus,Vesicles,Cytosol"		NA	NA		450000	"Cluster 30: Non-specific - Translation"	"Cluster 50: Non-specific - Ribosome"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 32: Non-specific - Translation"	Cytosol	"Golgi apparatus, Vesicles"	"HPA006124: AB_1856460, HPA006365: AB_2667570"	"unprognostic (6.58e-2)"	"unprognostic (3.31e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.10e-1)"	"unprognostic (4.04e-2)"	"unprognostic (6.37e-2)"	"unprognostic (4.95e-3)"	"unprognostic (1.46e-1)"	"unprognostic (3.95e-2)"	"unprognostic (1.01e-2)"	"unprognostic (2.31e-1)"	"unprognostic (7.04e-2)"	"prognostic unfavorable (1.06e-4)"	"unprognostic (2.04e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.26e-1)"	"unprognostic (5.66e-2)"	2199.7	1325.2	1393.3	1767.2	1454.1	5388.1	3551.2	1388.1	2027.8	2357.3	1375.8	1849.3	1597.8	1747.6	1664.7	2450.9	2149.5	1415.7	1311.3	1347.6	1419.0	1576.6	1443.7	1565.4	3948.0	1445.0	1406.0	4883.9	3660.2	1000.1	871.2	1633.7	1443.1	1696.0	1905.2	608.3	2167.8	1216.4	1965.9	3365.2	1692.7	1357.1	1484.2	2110.3	1718.3	682.0	1446.6	2534.1	1959.6	1376.9	3053.4	2011.6	2108.4	1482.0	1993.8	1568.3	2260.4	3581.3	4521.2	5855.0	2728.8	2502.9	3598.4	2772.7	2665.2	3294.5	1880.3	4497.8	3443.9	3368.1	1338.8	1900.3	2613.1	4373.5	2576.9	2895.0	3346.5	3013.3	1944.0	4743.1	5047.1	8481.4	2221.0	6167.0	7332.7	2340.5	8322.4	4658.3	3754.7	3556.4	5166.0	2858.9	3487.9	4342.3	3620.8	5030.3	2772.9	3420.0	2533.0	3993.0	1799.7	2884.6	3698.6	2185.9	1991.3	1573.0	833.4	5314.3	7184.2	2173.7	2276.5	8489.5	3027.8	1121.1	3111.7	3721.2	4696.8	4153.6	4104.8	3493.8	3635.1	5063.0	1621.7	599.0	1545.5	220.8	2412.5	1426.7	3728.9	4156.1	4210.9	3131.6	1971.7	3564.5	5201.1	4454.7	151.1	2031.9	1170.8	2722.3	2519.7	7450.3	1393.3	1454.1	1388.1	2027.8	1347.6	1419.0	1445.0	1406.0	1443.1	1484.2	1446.6	1482.0	3755.5	1660.2	3063.5	22.9	9470.7	8277.4	8259.7	3758.1	8926.6	531.5	10637.2	15674.0	827.7	3777.4	2693.4	1237.8	179.3	7566.9	6150.1	1808.1	4574.3	4058.0	792.6	1406.5	4602.8	3829.0	2863.4	5499.5	18.9	8085.7	9433.9	3353.4	3537.2	2309.6	1773.2	3890.7	4755.4	5136.7	5871.9	212.0	17.7	6806.4	1116.9	6161.6	5357.0	2335.6	6075.0	4790.9	3938.0	20.6	6667.5	2216.0	5160.7	10.1	25.0	6009.9	4480.8	2990.3	4762.0	10484.3	3517.1	5647.3	792.4	713.1	1617.2	5397.5	3117.8	1035.0	3063.2	11325.5	10512.6	7894.9	7990.4	4517.7	6783.0	9815.1
RPS14	"EMTB, S14"	ENSG00000164587	"Ribosomal protein S14"	P62263	5	150442635-150449739	"Human disease related genes, Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA018504	Approved		Supported	"Endoplasmic reticulum,Cytosol"		NA	NA		810000	"Cluster 30: Non-specific - Translation"	"Cluster 50: Non-specific - Ribosome"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 32: Non-specific - Translation"	"Endoplasmic reticulum, Cytosol"		"HPA018504: AB_1856463"	"unprognostic (5.70e-3)"	"unprognostic (1.94e-1)"	"unprognostic (6.72e-2)"	"unprognostic (8.17e-3)"	"unprognostic (7.51e-2)"	"unprognostic (2.42e-1)"	"prognostic unfavorable (7.73e-4)"	"unprognostic (2.36e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.58e-1)"	"unprognostic (3.26e-1)"	"prognostic unfavorable (8.69e-4)"	"unprognostic (1.47e-1)"	"unprognostic (8.81e-2)"	"unprognostic (2.29e-1)"	"unprognostic (8.14e-2)"	1391.9	1014.8	819.9	689.6	838.3	1880.5	1567.1	800.3	929.8	1696.9	799.6	1268.2	563.9	1214.3	1001.9	1525.4	1339.5	469.2	1022.8	786.7	832.9	949.3	1027.8	936.0	1126.0	832.7	803.8	2394.3	2431.0	731.9	809.7	636.1	843.8	1228.1	796.4	300.5	1310.9	690.3	1536.8	2210.9	1198.3	684.3	868.0	1343.1	1319.3	344.8	845.6	1142.5	1013.3	1030.0	1170.9	1289.1	1444.9	851.7	1196.9	1768.7	1201.2	2749.6	1497.8	2857.8	1828.0	815.2	1278.2	1298.3	1158.5	2702.9	1799.1	2098.0	1280.9	1583.7	1411.4	1091.9	1548.1	3878.5	782.1	1066.7	2153.7	879.0	1504.7	2171.0	2252.7	2642.0	1164.7	2193.0	1297.4	1441.2	3088.3	1496.2	1933.8	1975.8	1067.3	1250.1	1720.0	2804.7	1499.8	2478.0	1323.5	1935.2	1959.3	1446.0	1134.7	3166.8	2005.3	1827.0	1339.8	1410.9	634.1	3959.4	3109.0	892.6	1703.5	3152.8	1107.3	925.5	711.0	723.0	1229.2	1511.3	1853.6	1722.2	1174.2	2578.4	634.9	2439.8	6736.3	1518.4	6807.8	4685.2	9622.7	14519.2	11377.7	8377.3	7039.4	12461.6	16778.9	11703.6	982.1	6730.0	4055.3	8079.0	8024.6	34303.5	819.9	838.3	800.3	929.8	786.7	832.9	832.7	803.8	843.8	868.0	845.6	851.7	1954.3	1336.5	2464.0	15.0	5469.0	11670.8	9205.1	9468.6	4143.2	501.8	11009.9	13334.3	1873.1	3179.9	4229.9	1478.7	185.6	7225.8	4299.3	2121.7	4527.4	3485.4	1233.0	1626.2	3782.1	3867.8	2390.3	3230.5	23.3	8687.4	8833.9	3287.4	1852.2	2336.3	2293.4	4816.8	4223.5	4186.4	4707.3	203.6	20.0	5595.6	2931.6	5536.1	9991.5	1739.5	4356.7	3703.4	6474.4	21.5	6224.3	2062.0	4655.1	13.0	31.1	5196.5	4753.4	2235.0	3173.0	7998.6	5612.4	5302.3	1902.7	691.9	1604.1	3185.0	5116.9	726.4	815.9	6399.3	15358.6	7126.8	5488.0	4091.6	6155.8	10058.0
RPS18	"D6S218E, HKE3, KE-3, KE3, S18"	ENSG00000231500	"Ribosomal protein S18"	P62269	6	33272075-33276511	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein, RNA-binding, rRNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Breast myoepithelial cells: 26385.3;Suprabasal keratinocytes: 31942.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA050159, HPA055007"	Approved		Supported	Cytosol		NA	NA		120000	"Cluster 30: Non-specific - Translation"	"Cluster 50: Non-specific - Ribosome"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 32: Non-specific - Translation"	Cytosol		"HPA050159: AB_2681035, HPA055007: AB_2682668"	"prognostic favorable (9.81e-4)"	"unprognostic (1.76e-1)"	"unprognostic (2.67e-1)"	"unprognostic (7.74e-2)"	"unprognostic (4.00e-2)"	"unprognostic (3.95e-2)"	"unprognostic (1.07e-2)"	"unprognostic (2.51e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.67e-1)"	"unprognostic (4.63e-3)"	"unprognostic (1.19e-1)"	"prognostic unfavorable (1.15e-10)"	"unprognostic (7.00e-2)"	"unprognostic (4.00e-2)"	"unprognostic (2.85e-1)"	"unprognostic (9.19e-2)"	3268.2	2353.2	1862.8	2097.6	1883.3	6071.7	6110.7	1827.2	2345.5	3989.9	1782.7	3060.6	2024.5	2386.7	2877.9	4570.6	3069.7	1608.3	1778.5	1806.3	1863.3	2052.0	2248.2	2034.3	4842.9	1889.4	1840.1	6497.6	5554.4	1294.1	1412.1	1956.1	1895.2	2780.5	2977.4	697.1	3045.6	1415.3	2861.9	6539.3	2565.0	1891.5	1948.2	3087.2	2634.1	789.9	1920.2	3097.1	2084.7	2140.2	4485.9	3011.2	3685.5	1926.5	4603.2	2645.2	3377.1	8930.5	5769.4	11474.6	5486.7	4471.1	6678.3	5939.4	4461.0	6787.2	2617.5	15106.6	4694.9	4890.5	2759.3	3293.1	5472.9	7251.7	4665.1	4722.4	8590.2	5617.0	2868.6	9108.9	11226.3	9771.0	2849.3	12386.6	14318.8	4498.5	13349.4	5436.5	5770.2	4373.8	7686.7	4590.7	5362.0	7880.9	4994.9	10924.1	4652.3	5367.0	3798.3	5853.7	5446.7	10293.5	5524.1	6007.1	3902.3	5714.2	1754.6	8884.0	14781.0	2429.4	6105.7	16713.0	4642.3	2714.4	3129.5	2894.4	5978.6	5376.3	12310.7	11828.5	1512.3	10665.4	3350.2	578.7	1878.9	236.8	2362.1	1653.6	4023.7	5634.6	4545.5	3382.7	3273.4	4515.8	4968.4	4374.8	184.7	3177.0	1265.3	2962.7	3727.6	9405.4	1862.8	1883.3	1827.2	2345.5	1806.3	1863.3	1889.4	1840.1	1895.2	1948.2	1920.2	1926.5	4065.5	1480.8	2569.4	9.4	8276.1	20537.2	16151.5	18150.8	5757.2	343.9	19342.8	26385.3	596.5	4185.0	6755.1	1841.0	231.4	8761.7	5535.7	2348.6	5106.4	4750.1	1164.5	1985.2	7580.0	5826.2	3089.9	3782.1	7.5	12662.2	14558.3	4617.6	2073.4	3457.9	3051.1	5393.6	6329.9	4513.1	6281.1	159.9	8.1	7793.0	4418.8	6115.9	12428.1	3197.4	9895.8	4296.2	8448.8	13.1	6356.1	1521.4	4753.9	5.0	11.5	8283.0	5985.7	4056.9	3499.7	14221.0	5563.4	5974.5	1936.4	683.4	2005.0	7010.5	6802.2	773.3	1827.1	8678.7	31942.8	8778.2	6742.0	7987.5	9896.2	16152.8
RPS19	"DBA, eS19, LOH19CR1, S19"	ENSG00000105372	"Ribosomal protein S19"	P39019	19	41860255-41872925	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"	"Diamond-Blackfan anemia, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA063217			Supported	Nucleoplasm		NA	NA		260000	"Cluster 30: Non-specific - Translation"	"Cluster 50: Non-specific - Ribosome"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 32: Non-specific - Translation"	Nucleoplasm		"HPA063217: AB_2732699"	"unprognostic (8.02e-3)"	"unprognostic (9.04e-2)"	"unprognostic (5.93e-2)"	"unprognostic (1.14e-1)"	"unprognostic (7.32e-3)"	"unprognostic (1.32e-1)"	"unprognostic (2.69e-2)"	"unprognostic (9.14e-2)"	"unprognostic (1.06e-1)"	"unprognostic (6.68e-2)"	"unprognostic (5.78e-2)"	"unprognostic (9.96e-2)"	"prognostic unfavorable (2.32e-8)"	"unprognostic (1.16e-1)"	"unprognostic (7.55e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.72e-2)"	1929.6	1900.6	1567.9	1417.3	1592.2	2933.3	2052.3	1529.9	2038.1	2531.8	1544.4	2004.3	1389.8	1628.2	679.3	3488.9	2151.1	766.0	1349.4	1501.4	1560.9	1424.1	2262.6	1640.4	2271.7	1631.4	1548.2	3787.9	3981.7	585.6	1015.9	818.9	1606.1	2231.8	1105.1	370.4	1748.9	760.8	1573.4	3885.1	2168.6	767.5	1626.1	2909.0	2099.7	639.3	1585.0	1825.5	1516.5	728.6	1869.1	2025.4	2512.4	1619.6	3536.2	4978.2	3109.1	2770.4	3924.8	5205.4	3456.4	2731.6	3132.5	3378.6	2982.1	3854.2	2341.3	5185.2	2985.2	2483.1	1670.6	1819.8	2701.4	4647.3	1563.5	2183.2	5098.9	2626.1	1471.5	4029.3	6775.6	4355.4	2564.0	7419.1	8959.5	2132.0	3942.4	5453.7	3421.0	4849.8	2911.6	3476.5	2845.7	4010.8	3975.9	3021.3	3619.2	9954.1	2087.6	4372.0	2503.1	2511.1	3188.1	3714.9	2216.7	2693.9	1539.3	4915.7	3951.2	4649.7	2787.7	6840.6	2694.1	2157.5	3396.5	1451.9	4383.8	3886.3	4520.6	5054.3	2348.3	3672.5	2498.9	1309.9	5303.2	586.8	9147.6	9536.3	13783.0	18138.6	13464.4	11872.3	8174.5	17813.4	15114.7	13788.0	724.9	12054.7	12053.9	11257.8	11367.1	30500.3	1567.9	1592.2	1529.9	2038.1	1501.4	1560.9	1631.4	1548.2	1606.1	1626.1	1585.0	1619.6	2154.8	1644.2	2318.8	17.6	7536.2	13338.7	9463.4	12098.6	8008.7	295.5	11387.2	17068.7	680.0	2778.1	4886.7	1430.8	127.2	6635.1	4648.2	1753.9	2641.3	4446.2	482.4	1178.2	3145.6	3665.9	2227.6	2708.0	15.4	8576.4	9609.3	2834.8	2442.4	1645.3	1825.2	4566.6	3793.4	3258.5	4591.9	136.3	20.2	4777.7	3497.2	6041.3	8631.8	1752.6	4036.7	4053.7	4557.0	52.5	5989.0	991.8	4541.7	13.6	42.4	7669.3	4181.6	1892.7	4036.1	8714.9	4183.2	3284.5	1889.5	479.3	1584.3	3428.0	5508.3	608.5	1952.5	7919.1	16952.4	6534.4	6030.8	3718.5	6131.8	8160.5
RPS19BP1	"FLJ21770, MGC52010"	ENSG00000187051	"Ribosomal protein S19 binding protein 1"	Q86WX3	22	39529093-39532761	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA042874	Uncertain		Approved	Nucleoplasm,Nucleoli,Cytosol		NA	Yes			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 35: Non-specific - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoli, Cytosol"	Nucleoplasm	"HPA042874: AB_10793988"	"unprognostic (2.44e-1)"	"unprognostic (1.67e-1)"	"unprognostic (7.79e-2)"	"unprognostic (5.07e-3)"	"unprognostic (1.65e-1)"	"unprognostic (1.94e-1)"	"prognostic unfavorable (3.71e-4)"	"unprognostic (1.65e-1)"	"unprognostic (5.68e-2)"	"unprognostic (8.31e-2)"	"unprognostic (7.00e-2)"	"unprognostic (6.73e-2)"	"unprognostic (1.04e-1)"	"unprognostic (6.11e-2)"	"unprognostic (1.65e-1)"	"unprognostic (2.34e-1)"	"unprognostic (4.32e-2)"	98.5	123.0	122.2	43.1	124.5	61.7	94.6	126.7	159.0	73.5	115.9	117.1	43.5	65.5	31.5	94.2	65.6	19.3	114.6	121.2	119.7	123.1	158.5	80.4	48.0	126.5	124.2	68.9	109.6	47.1	66.5	30.2	123.7	108.1	19.2	23.9	94.4	42.8	104.7	80.0	78.3	19.7	124.8	100.5	101.5	65.8	128.4	40.5	96.7	45.4	34.6	99.9	73.7	123.9	94.8	117.6	54.5	80.4	60.7	39.7	110.8	102.0	87.3	92.5	74.0	131.1	62.1	118.9	107.4	64.5	74.8	73.8	87.8	111.3	32.2	163.8	261.5	110.0	105.5	118.0	88.2	166.8	142.3	60.1	83.1	80.3	96.8	49.4	64.9	87.6	128.0	83.8	61.0	108.0	80.6	164.1	95.1	210.9	209.5	127.3	70.0	182.0	99.7	95.8	121.2	66.9	85.8	137.3	203.1	33.6	98.8	134.8	74.0	77.5	168.8	85.7	141.7	140.3	145.4	188.4	103.3	116.8	183.1	126.8	147.4	187.3	133.0	141.6	123.5	159.7	135.1	140.6	122.4	173.9	129.9	132.8	168.7	128.9	119.4	193.1	165.1	138.3	122.2	124.5	126.7	159.0	121.2	119.7	126.5	124.2	123.7	124.8	128.4	123.9	113.6	44.8	51.4	13.1	109.5	137.1	94.3	124.3	84.2	98.0	178.6	205.7	73.8	105.8	83.0	97.5	52.1	152.9	114.7	205.5	217.2	174.9	23.6	68.6	69.8	121.0	142.6	83.5	8.7	192.2	231.9	92.0	76.0	81.6	69.8	62.0	116.0	184.8	204.3	35.3	10.9	207.5	130.2	116.4	233.3	40.3	137.0	110.8	108.5	8.4	147.8	139.1	162.7	5.5	18.7	233.5	202.2	126.0	193.3	206.8	274.9	362.2	54.0	103.7	78.9	74.4	100.9	61.6	138.0	87.6	147.9	131.6	115.2	103.1	165.9	132.4
RPS20	"S20, uS10"	ENSG00000008988	"Ribosomal protein S20"	P60866	8	56067254-56074510	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA003570	Approved		Supported	"Endoplasmic reticulum,Cytosol"		NA	NA		210000	"Cluster 30: Non-specific - Translation"	"Cluster 50: Non-specific - Ribosome"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 32: Non-specific - Translation"	"Endoplasmic reticulum, Cytosol"		"HPA003570: AB_1856466"	"unprognostic (2.57e-2)"	"unprognostic (6.91e-2)"	"unprognostic (5.61e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.51e-1)"	"unprognostic (1.99e-1)"	"unprognostic (9.40e-2)"	"unprognostic (1.07e-1)"	"unprognostic (6.75e-2)"	"unprognostic (9.78e-2)"	"unprognostic (4.83e-2)"	"unprognostic (3.46e-1)"	"prognostic unfavorable (1.21e-8)"	"unprognostic (3.64e-2)"	"unprognostic (8.80e-3)"	"unprognostic (2.33e-3)"	"unprognostic (2.19e-2)"	2422.2	1415.6	1315.1	1437.6	1380.2	4350.7	2956.6	1314.4	2021.9	2421.6	1346.7	1883.7	1075.9	1542.4	1867.0	1732.4	1773.1	1364.6	1704.0	1265.2	1344.7	1472.6	1677.3	1532.7	3682.4	1368.1	1323.4	4823.5	2312.4	967.6	1157.1	1216.1	1376.0	1847.0	1162.5	646.1	2385.0	1153.2	2332.3	2599.0	1612.4	1057.6	1411.0	2022.1	1776.0	770.6	1360.6	2421.2	1631.2	1656.7	2569.3	1939.8	2002.2	1419.8	3154.0	2878.4	2662.3	2623.1	3875.2	4572.0	2296.1	2060.3	3243.9	2550.2	2328.3	3056.4	2994.9	4688.2	2496.8	2293.0	1686.1	1922.9	1731.7	3416.4	2167.2	2011.7	2418.6	3834.9	2434.8	3830.1	3733.9	2152.1	2396.3	4425.9	3555.4	1638.9	4725.2	3971.6	3184.3	3477.9	3210.0	2689.0	2585.6	4101.1	5915.4	4351.3	3574.7	4325.3	1233.6	3196.9	977.9	2459.6	3093.5	3500.9	896.6	2761.2	891.7	2403.8	4246.6	2210.3	3493.0	4411.0	1954.8	1824.1	3074.6	2401.4	3337.6	2829.2	2756.3	3479.1	2754.4	3895.2	1655.6	2076.5	2125.0	869.1	2514.0	1746.2	3620.8	5471.6	4594.4	3362.7	2643.7	4621.2	5940.0	4391.6	374.5	2151.7	1671.8	3772.4	3333.2	8768.9	1315.1	1380.2	1314.4	2021.9	1265.2	1344.7	1368.1	1323.4	1376.0	1411.0	1360.6	1419.8	531.6	1259.6	2162.2	18.6	2262.9	3750.0	3713.6	2367.9	409.2	140.6	956.6	590.0	1017.9	1684.3	1791.9	693.4	112.6	2885.6	1645.2	793.6	2201.1	1970.4	1979.3	746.1	1507.7	1533.9	1208.0	1268.8	13.3	4091.1	4246.0	1266.3	189.1	983.9	1670.0	570.3	2543.6	2301.4	2511.0	55.5	11.6	2235.2	679.5	3405.9	3567.2	1769.8	4496.9	1619.2	1949.5	15.0	3676.2	815.3	2747.7	10.1	16.2	3313.5	1714.9	1990.1	364.9	3196.6	1259.1	3235.5	956.0	354.6	1400.3	1958.0	1531.1	1536.1	1483.5	473.0	3924.2	3019.4	2078.3	664.6	2291.2	4097.9
RPS21	S21	ENSG00000171858	"Ribosomal protein S21"	P63220	20	62387103-62388520	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003371	Approved		Supported	"Endoplasmic reticulum,Cytosol"		NA	NA		250000	"Cluster 30: Non-specific - Translation"	"Cluster 50: Non-specific - Ribosome"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 32: Non-specific - Translation"	"Endoplasmic reticulum, Cytosol"		"HPA003371: AB_1079846"	"unprognostic (1.92e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.31e-1)"	"unprognostic (3.26e-2)"	"unprognostic (1.99e-2)"	"unprognostic (1.41e-1)"	"prognostic unfavorable (8.46e-4)"	"unprognostic (6.17e-2)"	"unprognostic (9.82e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.27e-3)"	"unprognostic (2.63e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.81e-1)"	"unprognostic (4.60e-1)"	1584.8	1416.8	1374.5	789.4	1408.7	2392.8	1877.1	1365.4	1771.9	2177.4	1327.1	1555.5	746.0	1459.7	550.8	2064.4	1803.0	465.4	989.2	1361.6	1356.9	1244.1	1088.1	1150.8	1513.8	1351.9	1347.8	3181.1	2441.5	527.1	968.9	561.5	1373.6	1408.6	629.9	210.2	1471.7	509.7	2133.5	2936.6	1592.2	420.1	1392.9	1836.6	1581.4	476.4	1420.6	1510.6	1172.3	873.8	982.5	1503.0	1900.1	1424.0	2398.5	2358.8	1184.4	2320.2	1321.3	2309.7	1609.5	1472.3	1141.8	3554.0	1348.8	7961.3	3131.7	2835.0	3019.8	1156.5	1283.3	3239.7	1343.1	4099.0	1252.7	729.2	3445.4	4723.0	3120.5	6137.2	2650.8	3692.8	2066.1	2581.1	5669.7	1370.4	2496.5	1451.4	1705.6	3116.1	2436.0	2351.9	1269.6	3506.2	4242.3	5294.5	1862.4	4129.5	7157.1	2799.7	3043.3	4437.6	1745.8	2581.8	2240.7	2206.7	1508.4	6850.0	3365.8	753.9	2935.2	4792.0	1810.4	2182.4	2852.5	1853.4	2993.0	3660.0	4580.0	3219.1	2607.4	2209.6	1179.5	379.7	1000.3	242.1	1322.7	872.6	1890.4	2692.5	2242.4	1753.8	1447.0	2532.7	2648.9	2404.8	152.8	1251.1	707.2	2013.1	1578.6	3102.5	1374.5	1408.7	1365.4	1771.9	1361.6	1356.9	1351.9	1347.8	1373.6	1392.9	1420.6	1424.0	1364.6	586.5	941.1	7.8	3935.3	2655.4	1626.1	981.0	3107.4	142.2	3889.4	5494.5	366.2	1229.6	931.4	489.2	223.1	1664.7	2299.9	1067.8	692.6	1619.1	132.9	556.3	999.9	1124.0	1212.9	2581.9	9.4	3548.5	2106.0	1019.6	1460.2	940.4	958.8	1067.6	1729.4	1728.5	1271.3	149.7	8.2	2684.6	321.4	2098.5	2590.7	133.6	1556.1	1493.7	974.7	5.6	1999.4	676.9	2139.1	4.0	6.5	2264.9	2168.9	802.3	2205.5	1561.5	1866.1	1305.7	429.3	305.3	558.8	1930.9	1036.6	265.6	853.2	3960.0	3136.3	1638.4	2731.0	645.0	3215.9	1523.2
RPS25	S25	ENSG00000118181	"Ribosomal protein S25"	P62851	11	119015712-119018691	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA031801, HPA078683"	Approved		Supported	"Nucleoli,Endoplasmic reticulum,Cytosol"		NA	NA		150000	"Cluster 30: Non-specific - Translation"	"Cluster 50: Non-specific - Ribosome"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 32: Non-specific - Translation"	"Endoplasmic reticulum, Cytosol"	Nucleoli	"HPA031801: AB_10610419, HPA078683: "	"unprognostic (1.60e-2)"	"unprognostic (1.79e-1)"	"unprognostic (2.12e-1)"	"unprognostic (1.40e-1)"	"unprognostic (8.32e-2)"	"unprognostic (1.78e-2)"	"unprognostic (1.55e-2)"	"unprognostic (8.47e-2)"	"unprognostic (5.23e-2)"	"unprognostic (1.54e-2)"	"unprognostic (2.36e-2)"	"unprognostic (7.75e-3)"	"prognostic unfavorable (3.00e-7)"	"unprognostic (1.16e-1)"	"unprognostic (1.07e-1)"	"unprognostic (8.58e-2)"	"unprognostic (2.20e-1)"	1030.5	759.2	703.6	735.1	728.1	1650.9	1487.8	698.3	1133.9	1226.7	679.4	957.6	596.1	817.3	1030.4	898.8	1058.0	573.8	771.4	675.6	730.6	879.4	830.1	672.8	1488.5	718.4	700.7	2254.5	1279.5	535.1	807.7	633.7	726.5	841.2	697.9	460.2	1068.5	606.0	1873.7	1107.6	773.8	578.5	748.0	889.7	875.5	283.5	722.1	1100.8	817.0	1278.8	1307.1	967.1	1005.4	749.3	960.2	646.9	1024.1	1063.6	1461.7	2371.7	994.2	1098.1	1159.2	724.7	635.6	1753.4	1580.0	2269.6	2031.5	853.8	782.5	1146.8	951.4	1305.8	852.5	1166.9	1278.1	3013.6	598.3	1718.0	1102.2	2122.0	924.8	2043.3	2460.8	647.0	1673.7	2154.5	1384.9	1739.3	1670.1	1288.7	1072.8	2396.1	2072.1	3727.7	1045.8	2204.6	1573.1	1447.7	1055.6	2743.5	1319.2	1228.3	830.4	1737.6	578.1	1850.5	1467.1	1175.2	1533.2	2972.9	1144.8	703.2	768.0	724.7	1198.9	1051.5	1232.2	2109.6	489.5	2563.2	806.5	997.3	1197.8	775.1	1976.3	1284.0	3220.0	3716.4	3654.3	2784.5	1945.5	3077.2	4507.9	3661.8	319.1	2123.4	1145.7	2384.0	2614.1	5186.2	703.6	728.1	698.3	1133.9	675.6	730.6	718.4	700.7	726.5	748.0	722.1	749.3	1697.5	810.9	1658.7	42.7	4105.7	3970.2	4377.8	2769.0	2486.4	284.5	3671.0	4464.2	177.0	2040.3	1857.3	932.5	114.7	3745.3	2579.2	1009.2	3273.2	1883.0	1859.4	927.5	1934.9	1947.4	1330.6	2078.2	25.4	3163.4	4115.0	1768.2	946.5	1319.1	2024.6	5691.5	2726.5	2709.6	2534.6	134.6	27.4	2786.8	895.2	3338.1	3963.7	2384.8	3824.6	2101.3	2186.0	30.9	4048.0	1305.0	2802.3	16.6	39.3	2301.3	2254.2	1713.3	1821.2	4000.4	2308.2	4494.5	909.9	475.7	1334.5	2501.7	2382.7	788.8	827.3	3140.7	4661.0	3656.0	3604.7	1427.9	2788.0	4153.7
RPS26	"eS26, S26"	ENSG00000197728	"Ribosomal protein S26"	P62854	12	56041351-56044697	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"	"Diamond-Blackfan anemia, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Cancer enhanced"	"Detected in all"		"ovarian cancer: 494.3"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA043961, HPA055803"	Uncertain		Enhanced	"Nucleoli,Endoplasmic reticulum,Cytosol"		NA	NA			"Cluster 30: Non-specific - Translation"	"Cluster 50: Non-specific - Ribosome"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 59: Non-specific - Transcription"	"Endoplasmic reticulum, Cytosol"	Nucleoli	"HPA043961: AB_10963579, HPA055803: AB_2682927"	"unprognostic (1.59e-1)"	"unprognostic (1.40e-1)"	"unprognostic (3.36e-1)"	"unprognostic (9.58e-2)"	"unprognostic (3.74e-1)"	"unprognostic (7.84e-3)"	"unprognostic (1.53e-1)"	"unprognostic (1.65e-1)"	"unprognostic (2.25e-1)"	"unprognostic (3.76e-2)"	"unprognostic (2.49e-1)"	"unprognostic (3.03e-1)"	"unprognostic (2.06e-2)"	"unprognostic (1.41e-1)"	"unprognostic (4.40e-2)"	"unprognostic (2.18e-1)"	"unprognostic (7.99e-2)"	720.5	1265.1	387.6	271.7	388.8	395.5	690.2	382.8	480.4	707.7	384.0	731.2	177.1	569.7	410.7	875.4	724.0	123.3	713.0	380.9	416.6	701.8	926.6	521.9	512.9	396.3	399.7	1120.6	1170.2	274.3	476.7	251.6	389.9	627.3	403.3	69.8	592.3	335.9	778.2	857.3	744.1	307.2	383.4	832.0	717.5	208.8	394.0	616.8	544.1	390.6	715.6	734.3	698.0	389.2	639.2	763.3	853.6	319.5	1153.3	1696.4	852.0	633.4	929.5	1027.7	596.0	1182.7	281.7	1408.3	383.5	670.6	339.5	293.2	970.5	544.0	698.1	558.9	1552.8	743.9	482.1	719.0	1062.3	490.5	392.2	1036.9	1705.6	544.3	614.0	404.0	794.3	989.6	517.2	458.1	845.1	983.2	371.8	886.0	839.7	766.7	1710.8	496.7	254.8	884.3	871.4	634.9	318.2	552.4	245.8	542.2	372.2	252.1	479.4	538.6	260.8	255.0	524.3	328.0	518.0	369.3	810.2	770.9	284.0	969.2	334.4	334.8	394.8	262.5	650.7	410.2	723.2	872.3	841.4	711.8	508.4	720.3	898.4	863.6	154.8	607.5	373.0	643.6	963.7	1264.1	387.6	388.8	382.8	480.4	380.9	416.6	396.3	399.7	389.9	383.4	394.0	389.2	1114.5	224.4	237.7	5.2	2483.4	1760.6	852.7	2533.9	3266.8	131.0	1968.1	2542.2	29.2	1425.5	985.7	430.4	62.6	1237.2	1377.0	1803.5	972.4	1031.5	85.4	862.0	876.0	992.0	860.5	1977.9	5.2	2625.0	2835.4	1006.2	1666.7	861.2	514.4	1242.7	1647.4	2125.4	1369.2	75.7	5.1	1406.6	732.4	1557.8	1925.7	57.3	295.4	1146.8	1462.1	6.5	754.7	706.4	563.4	6.6	7.1	1806.8	1756.4	221.5	2590.7	1221.2	2448.3	1503.0	557.4	193.1	309.0	719.1	935.9	305.9	304.0	4236.6	1814.2	1708.2	2103.6	1318.5	1411.0	1000.6
RPS27A	"S27A, Uba80, UBCEP80"	ENSG00000143947	"Ribosomal protein S27a"	P62979	2	55231903-55235853	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB033319, HPA041344, HPA049132, HPA054087"	Supported		Supported	"Nucleoli,Endoplasmic reticulum,Cytosol"		NA	Yes		230000000	"Cluster 30: Non-specific - Translation"	"Cluster 50: Non-specific - Ribosome"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 32: Non-specific - Translation"	"Nucleoli, Endoplasmic reticulum, Cytosol"		"CAB033319: AB_793618, HPA041344: AB_2677422, HPA049132: AB_2680646, HPA054087: AB_2682373"	"unprognostic (7.32e-2)"	"unprognostic (1.41e-2)"	"unprognostic (1.11e-1)"	"unprognostic (3.20e-3)"	"unprognostic (2.16e-1)"	"unprognostic (9.75e-2)"	"prognostic unfavorable (2.26e-4)"	"unprognostic (1.39e-1)"	"unprognostic (1.65e-2)"	"unprognostic (2.46e-1)"	"unprognostic (6.89e-2)"	"unprognostic (1.70e-1)"	"prognostic unfavorable (2.60e-6)"	"unprognostic (1.09e-1)"	"unprognostic (8.82e-2)"	"unprognostic (1.47e-1)"	"unprognostic (3.60e-1)"	1440.7	1208.5	1115.0	1077.7	1151.0	2567.0	2511.6	1098.2	1883.7	2166.1	1099.2	1563.5	823.5	1450.9	1105.1	1698.4	1726.7	572.2	943.7	1085.1	1131.6	1254.8	1162.3	1097.1	1955.6	1133.6	1117.0	3146.7	2043.5	730.2	1057.5	872.9	1131.4	1430.2	1045.0	631.9	1387.4	917.9	1089.6	1767.3	1328.6	814.7	1172.6	1719.2	1478.2	405.9	1150.4	1520.4	1201.6	793.7	1774.4	1506.3	1694.7	1157.1	2384.4	1092.2	1412.2	1842.3	1892.6	3200.3	2412.6	1824.5	1779.4	1692.3	1069.1	2073.7	1987.4	3081.3	2833.2	1698.5	1115.0	1784.3	2061.7	2465.1	1981.0	2899.1	2419.0	2693.9	1088.0	2758.1	2705.9	3674.4	1605.2	3166.1	4213.4	1280.5	3401.6	3015.5	2415.9	1959.5	2469.0	2228.9	1937.3	1509.9	2307.6	4328.7	2831.1	2690.2	1710.6	2086.4	3051.2	3173.8	1994.3	1817.4	1546.0	1319.2	1064.4	4071.8	3843.7	2065.9	1811.0	3411.1	2108.9	1351.7	2395.8	1318.7	3006.7	2322.2	1881.5	1867.9	1923.5	3226.7	1392.6	1301.5	1656.9	637.7	2924.2	1530.8	4268.2	4727.8	4504.3	3592.2	2219.0	4232.8	5675.0	4744.3	351.6	3178.7	1388.8	3292.5	3058.2	8225.2	1115.0	1151.0	1098.2	1883.7	1085.1	1131.6	1133.6	1117.0	1131.4	1172.6	1150.4	1157.1	3051.9	1272.4	2321.3	39.8	7158.8	8321.0	8963.0	6850.9	5010.5	446.4	8189.8	10987.6	438.8	3029.7	3486.3	1397.8	214.8	5340.9	5465.1	1499.3	4055.8	3640.9	1050.2	1695.4	3081.0	3385.0	2057.4	3362.1	45.8	7348.0	6754.1	3043.5	1762.0	1917.3	3014.6	3565.0	3729.5	3181.0	3498.7	218.7	47.8	3995.4	2199.2	5051.0	6045.7	1576.9	5081.5	3382.7	3639.2	59.0	6346.8	2229.4	5579.8	29.1	61.0	5045.3	3396.0	2881.2	3458.4	8189.2	3670.3	5961.1	1726.4	760.9	1643.5	5220.3	4020.2	1047.7	863.4	5750.5	8931.2	5390.3	6365.7	3721.9	4717.6	7980.9
RPS27L		ENSG00000185088	"Ribosomal protein S27 like"	Q71UM5	15	63125872-63158021	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Proximal tubular cells: 2535.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA066851			Supported	"Nucleoli,Endoplasmic reticulum,Cytosol"		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 10: Non-specific - Unknown function"	"Endoplasmic reticulum, Cytosol"	Nucleoli	"HPA066851: AB_2685737"	"unprognostic (4.62e-2)"	"unprognostic (5.81e-2)"	"unprognostic (1.38e-1)"	"prognostic favorable (9.08e-6)"	"unprognostic (1.75e-1)"	"unprognostic (7.24e-2)"	"unprognostic (1.42e-3)"	"unprognostic (2.98e-1)"	"unprognostic (6.38e-2)"	"unprognostic (1.80e-1)"	"unprognostic (2.19e-3)"	"unprognostic (2.51e-1)"	"unprognostic (1.97e-2)"	"unprognostic (5.31e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.97e-3)"	"unprognostic (5.10e-3)"	142.2	242.4	78.6	71.3	80.6	73.2	127.1	81.5	113.1	124.7	102.5	190.8	157.4	108.4	157.9	70.8	117.9	94.8	181.0	78.1	84.2	194.5	266.0	109.4	83.5	82.9	81.7	95.9	247.4	94.0	88.6	69.3	84.5	156.2	178.0	31.8	164.7	106.7	190.1	75.9	161.4	80.7	86.0	103.2	174.7	38.1	81.4	86.3	106.5	97.7	68.2	149.2	94.1	90.0	140.4	383.0	340.4	92.9	486.4	571.3	341.3	432.1	306.0	93.8	225.3	71.1	190.0	130.8	150.9	415.9	166.0	52.9	116.5	212.9	155.7	97.8	157.5	108.3	329.1	512.7	558.7	86.8	287.0	452.1	279.0	211.2	158.4	701.2	535.2	81.2	101.6	127.7	785.1	194.1	112.4	134.9	101.0	178.0	112.6	86.9	163.1	149.5	266.7	278.8	49.2	74.7	157.6	65.8	326.2	677.8	145.4	199.1	571.1	490.6	463.8	106.7	195.3	142.3	132.3	117.5	518.5	235.6	453.8	263.8	132.5	164.6	99.4	145.2	125.2	132.0	149.9	118.1	122.0	105.2	116.9	119.4	44.3	110.9	198.2	121.3	305.2	166.0	78.6	80.6	81.5	113.1	78.1	84.2	82.9	81.7	84.5	86.0	81.4	90.0	210.9	96.1	198.6	9.4	255.9	255.4	262.6	424.8	230.5	33.4	361.3	429.1	349.0	511.9	424.6	410.1	47.9	300.1	144.9	694.7	903.9	802.7	60.9	202.3	185.3	245.8	285.4	184.5	12.6	782.4	1269.2	269.2	327.8	155.5	302.6	250.8	302.0	994.8	542.1	13.5	15.6	742.3	520.8	372.1	358.1	34.4	314.7	270.3	466.0	17.8	1049.6	184.8	221.4	16.1	18.5	1019.3	745.5	297.5	495.5	324.6	1513.1	2535.3	330.9	75.2	263.0	180.5	742.6	144.7	82.1	183.6	247.6	235.2	224.7	214.3	732.5	215.2
RPS29	"S29, uS14"	ENSG00000213741	"Ribosomal protein S29"	P62273	14	49570984-49599164	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"	"Diamond-Blackfan anemia, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA004107	Enhanced		Supported	"Endoplasmic reticulum,Cytosol"		NA	NA			"Cluster 30: Non-specific - Translation"	"Cluster 50: Non-specific - Ribosome"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 32: Non-specific - Translation"	"Endoplasmic reticulum, Cytosol"		"HPA004107: AB_1079848"	"prognostic favorable (2.66e-4)"	"unprognostic (1.38e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.28e-1)"	"unprognostic (4.40e-3)"	"unprognostic (4.13e-2)"	"unprognostic (9.95e-2)"	"unprognostic (4.21e-2)"	"unprognostic (2.98e-2)"	"unprognostic (1.12e-1)"	"unprognostic (8.62e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.94e-1)"	"unprognostic (3.18e-2)"	"unprognostic (1.66e-1)"	"unprognostic (7.48e-3)"	"unprognostic (7.71e-2)"	2915.6	2346.5	1747.8	1549.0	1785.8	3286.7	3207.7	1739.1	2601.7	3116.1	1718.3	2990.1	1407.8	1886.3	910.5	3294.5	2641.4	401.1	2127.4	1719.9	1762.6	2371.4	2697.6	2200.4	2364.9	1769.5	1741.7	4756.3	4388.2	1049.0	1483.6	887.0	1779.0	2246.8	1122.6	586.1	2625.0	797.7	3625.5	4604.2	3272.8	594.9	1830.7	4088.6	2645.0	1036.8	1800.8	3083.3	1906.9	1770.0	2079.7	2435.8	2777.8	1817.5	3057.7	1984.5	2021.5	1823.8	2271.9	3830.2	2675.3	2042.2	1722.2	1821.1	1483.1	2020.7	2733.7	2772.5	2264.9	1729.0	895.7	2605.0	2373.0	2922.0	2014.3	1811.3	4267.9	2191.4	1630.4	3564.5	2776.6	5612.2	1803.4	4011.6	4623.6	1204.7	3464.6	3181.7	2623.2	4723.4	2489.2	3498.4	1791.5	4047.4	3845.0	3454.4	2484.9	5075.2	5572.2	3178.5	2521.0	3196.6	2248.6	2696.4	1527.3	1753.1	1455.4	2636.2	5088.5	1938.5	3444.4	4786.4	2459.7	1381.7	3726.2	1295.6	1836.9	4014.0	4872.1	3856.3	973.0	2256.8	1363.0	3144.8	4379.9	1967.1	6689.0	3436.4	8449.9	11659.9	12162.6	8749.3	5025.2	10334.9	13471.6	11360.1	968.3	5389.4	3185.1	6778.8	7617.0	26592.8	1747.8	1785.8	1739.1	2601.7	1719.9	1762.6	1769.5	1741.7	1779.0	1830.7	1800.8	1817.5	1348.6	1131.4	2051.0	7.8	5426.0	3418.6	1043.1	2689.6	672.1	235.2	4463.4	3147.6	609.1	2805.3	2104.4	1074.1	129.3	3390.8	4425.2	2370.0	2424.1	2731.6	1371.1	1272.1	2960.5	1727.4	2673.2	2790.5	10.7	7061.8	4966.0	1443.2	650.3	1997.1	3019.4	2592.2	4092.8	7356.4	3048.0	107.7	12.0	6874.6	769.0	5623.6	5164.4	3280.3	3747.1	2396.2	2002.8	10.3	4580.9	1122.2	5206.1	10.1	17.9	5207.4	5628.6	1617.8	1584.1	1084.2	4951.5	3523.5	985.2	355.1	1091.3	1292.9	1159.9	1090.2	994.1	1255.0	4894.6	3673.2	4742.9	954.8	6917.3	1177.5
RPS3	"FLJ26283, FLJ27450, MGC87870, S3"	ENSG00000149273	"Ribosomal protein S3"	P23396	11	75399515-75422280	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"	"Apoptosis, Cell cycle, Cell division, DNA damage, DNA repair, Mitosis, Transcription, Transcription regulation, Translation regulation"	"DNA-binding, Lyase, Ribonucleoprotein, Ribosomal protein, RNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA063339	Uncertain		Supported	"Endoplasmic reticulum,Cytosol"		NA	NA		560000	"Cluster 30: Non-specific - Translation"	"Cluster 50: Non-specific - Ribosome"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 32: Non-specific - Translation"	"Endoplasmic reticulum, Cytosol"		"HPA063339: AB_2684990"	"unprognostic (3.62e-2)"	"unprognostic (6.94e-3)"	"unprognostic (2.64e-1)"	"unprognostic (1.44e-2)"	"unprognostic (5.55e-2)"	"unprognostic (1.08e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.35e-1)"	"unprognostic (2.69e-1)"	"unprognostic (5.75e-2)"	"unprognostic (3.27e-3)"	"unprognostic (1.96e-1)"	"prognostic unfavorable (6.92e-6)"	"unprognostic (3.22e-1)"	"unprognostic (2.94e-1)"	"unprognostic (1.89e-2)"	"unprognostic (2.19e-1)"	1139.4	747.7	431.1	955.9	446.8	2080.0	1950.0	427.3	575.6	1529.6	427.4	1220.4	946.0	1060.9	708.7	1669.8	1270.5	556.5	734.1	417.1	441.6	672.3	631.7	846.0	1663.4	446.6	430.8	2914.0	1761.9	356.4	660.5	760.6	442.8	929.1	919.3	352.7	1049.9	662.1	1125.5	1783.9	1128.2	739.8	444.4	1346.4	1082.2	287.7	435.1	1403.5	717.1	749.0	1360.4	1054.9	1384.5	446.9	1899.8	1145.7	1595.6	1767.5	1970.0	3482.1	2060.8	1763.7	2256.3	2289.4	1481.2	3331.6	2196.8	6547.1	2108.6	1598.8	1261.5	2672.3	2085.6	3290.7	2093.8	1749.1	1618.9	2688.6	1042.6	1490.2	2931.1	4398.6	1690.0	4124.1	4397.7	1568.8	4323.1	2684.0	3055.0	2876.5	2736.9	1809.7	2089.7	2071.2	2660.9	2112.4	2007.4	6591.3	1342.5	2482.3	5580.2	4834.0	2275.9	1551.8	1366.7	1933.6	1299.3	3050.2	1897.1	1535.9	3123.3	3289.9	2470.7	1099.6	1822.9	1515.3	1627.3	1647.2	2198.0	7283.3	660.4	2409.4	1138.1	430.3	770.8	245.5	1405.7	515.5	1924.9	1602.2	1823.1	1489.0	1099.3	1454.0	2102.1	1633.9	174.3	1142.6	512.4	960.4	1283.7	4244.2	431.1	446.8	427.3	575.6	417.1	441.6	446.6	430.8	442.8	444.4	435.1	446.9	1993.9	932.7	1604.3	18.6	4790.5	6297.7	7369.7	5554.5	4497.7	423.9	6945.0	9521.7	418.9	2088.9	2555.7	726.4	133.5	6188.6	4009.1	1694.4	2183.4	2376.0	430.9	939.2	3054.9	2780.8	2067.1	3428.9	28.3	5373.2	9079.0	2364.6	1651.9	1363.9	1641.6	4246.7	2916.7	1369.0	3662.5	132.9	32.6	4425.4	1621.5	3089.2	4666.7	968.5	3755.0	2393.1	2835.3	38.4	3626.4	957.1	4120.5	19.6	47.5	3805.0	3535.7	1803.2	2848.0	5827.8	2969.4	2226.4	797.6	505.5	1117.5	3204.8	3221.9	449.3	618.6	5734.6	7842.8	5867.5	4904.4	4865.2	5657.1	7206.9
RPS5	S5	ENSG00000083845	"Ribosomal protein S5"	P46782	19	58386400-58394806	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HEK 293: 11301.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055878, HPA061979"	Enhanced		Supported	"Endoplasmic reticulum,Cytosol"		NA	NA		880000	"Cluster 30: Non-specific - Translation"	"Cluster 50: Non-specific - Ribosome"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 32: Non-specific - Translation"	"Endoplasmic reticulum, Cytosol"		"HPA055878: AB_2682954, HPA061979: AB_2684650"	"unprognostic (5.88e-2)"	"unprognostic (2.12e-1)"	"unprognostic (3.06e-1)"	"unprognostic (1.53e-1)"	"unprognostic (2.37e-2)"	"unprognostic (2.49e-1)"	"prognostic unfavorable (1.12e-5)"	"unprognostic (4.41e-2)"	"unprognostic (2.48e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.81e-1)"	"unprognostic (5.06e-1)"	"prognostic unfavorable (4.75e-4)"	"unprognostic (2.79e-2)"	"unprognostic (4.43e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.01e-1)"	1081.7	1079.0	621.2	604.4	637.5	1609.5	1273.6	612.1	781.7	1432.2	592.8	1109.0	590.3	1053.8	378.7	1577.3	1221.4	504.3	811.8	587.0	617.8	800.1	997.5	789.2	1269.3	637.9	617.7	2437.6	2886.2	520.6	669.0	520.1	631.9	1225.4	575.6	182.5	1064.0	484.2	1456.9	2062.5	905.6	571.2	657.5	1033.5	1075.5	331.4	642.5	1007.9	830.1	821.3	1002.1	1098.4	1304.4	641.0	1779.4	2543.8	953.2	1524.9	1812.8	2328.6	1485.9	967.6	1590.9	1162.4	737.1	1909.7	1270.7	3655.5	1185.5	1379.5	1134.2	1126.2	1529.9	2381.7	478.7	1000.1	11301.4	1451.3	1247.3	2444.6	2241.6	2459.7	1183.1	2980.8	3882.4	1210.7	2740.2	1288.9	1539.0	1662.6	1880.1	1897.8	1260.5	1432.8	2399.9	1683.0	1589.7	2782.4	3399.7	2289.6	1364.6	3236.9	1296.9	2199.0	1424.2	1776.2	677.7	1916.6	2066.3	556.4	1109.2	2923.7	980.7	1743.4	1276.4	705.7	2149.8	2527.3	4650.9	2768.7	1092.1	1817.9	980.8	322.0	652.6	131.2	739.4	621.6	1360.4	2219.4	1272.0	962.1	1196.9	2071.6	1829.6	1435.3	92.8	1022.1	467.6	1253.3	1128.4	2583.3	621.2	637.5	612.1	781.7	587.0	617.8	637.9	617.7	631.9	657.5	642.5	641.0	1118.4	679.5	1091.0	10.1	3747.2	5916.6	5060.2	3028.2	3999.8	242.5	5685.5	7711.0	243.7	1499.9	1654.2	526.0	123.0	3220.8	1739.2	1023.0	1823.4	1792.4	490.1	640.6	1967.1	1631.2	1236.3	2005.8	10.6	4571.3	4191.9	1629.9	1014.8	915.6	1003.0	2412.5	1452.8	1468.4	1973.5	163.2	15.2	2390.3	958.2	1800.2	3567.2	1482.6	2160.0	1414.9	2431.5	12.2	1874.2	700.7	1618.0	12.1	25.1	2022.9	1856.1	945.2	2346.5	4934.9	1734.6	2607.0	711.5	456.9	696.8	2096.0	3046.0	489.6	758.2	4308.1	7256.9	3174.7	2382.2	2244.1	2922.0	4637.7
RPS6KA1	"HU-1, MAPKAPK1, p90Rsk, RSK1"	ENSG00000117676	"Ribosomal protein S6 kinase A1"	Q15418	1	26529761-26575030	"Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Stress response"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 91.1;monocytes: 81.2;NK-cells: 88.6;Proximal enterocytes: 93.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HMC-1: 77.6;U-937: 86.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003852, HPA007981"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 64: Macrophages - Immune response"	"Cluster 32: U-937 - Innate immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	Cytosol	Nucleoplasm	"CAB003852: AB_289590, HPA007981: AB_1079850"	"unprognostic (1.04e-3)"	"unprognostic (1.23e-1)"	"unprognostic (1.61e-3)"	"prognostic favorable (7.20e-7)"	"unprognostic (7.35e-2)"	"unprognostic (3.69e-1)"	"unprognostic (6.93e-3)"	"unprognostic (1.12e-2)"	"unprognostic (1.09e-1)"	"unprognostic (7.51e-3)"	"unprognostic (2.37e-2)"	"unprognostic (9.64e-2)"	"prognostic favorable (1.84e-4)"	"prognostic favorable (4.58e-4)"	"unprognostic (4.77e-2)"	"unprognostic (7.61e-2)"	"prognostic favorable (8.33e-4)"	7.4	17.0	7.8	17.5	9.1	23.8	8.3	9.2	9.3	6.0	11.2	37.9	33.1	3.0	1.2	16.9	7.9	5.5	3.8	7.9	9.1	26.2	10.5	33.7	20.2	10.8	9.5	1.9	19.4	12.5	13.4	4.0	10.1	17.2	20.7	1.4	21.5	4.5	1.7	17.8	51.4	3.6	9.4	47.1	20.6	5.4	10.4	11.4	24.5	1.9	20.7	9.0	9.6	11.6	27.1	9.3	7.5	9.9	0.4	0.1	9.9	2.2	4.2	11.0	10.6	10.8	21.9	50.2	11.9	1.3	13.3	31.0	16.9	61.0	7.8	41.8	11.0	55.3	21.6	19.5	3.4	65.8	77.6	1.8	22.1	10.1	18.0	5.0	4.9	19.7	9.6	17.7	0.6	15.0	2.4	64.3	19.1	52.2	29.2	34.8	9.5	22.0	31.7	7.3	10.7	4.4	18.7	17.5	8.4	7.8	11.2	55.5	3.2	0.5	13.9	1.8	9.2	10.9	14.0	27.5	6.5	86.8	10.8	37.6	57.9	131.2	24.2	52.1	20.3	14.2	17.9	21.6	68.8	15.7	11.3	15.8	108.2	26.4	58.4	26.9	19.0	65.2	7.8	9.1	9.2	9.3	7.9	9.1	10.8	9.5	10.1	9.4	10.4	11.6	2.8	16.0	25.0	0.0	23.7	18.6	8.1	19.9	16.5	1.5	12.0	10.4	1.3	11.5	7.7	9.2	4.2	1.6	53.9	91.1	7.9	16.3	1.9	19.9	2.2	6.9	16.3	29.5	1.4	18.7	17.5	1.8	18.3	20.7	31.8	3.3	7.9	3.4	47.5	0.0	2.6	41.6	12.2	53.0	14.2	1.4	0.0	44.1	1.8	12.2	81.2	0.6	88.6	1.0	12.3	28.1	41.9	0.0	14.2	18.8	93.3	17.2	13.6	1.8	6.6	0.8	2.7	1.6	3.4	10.9	11.6	4.1	36.3	2.0	43.6	9.1
RPS6KA2	"HU-2, RSK3"	ENSG00000071242	"Ribosomal protein S6 kinase A2"	Q15349	6	166409364-166906451	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 399.6;Excitatory neurons: 204.1;Horizontal cells: 287.7;Inhibitory neurons: 552.3;Oligodendrocyte precursor cells: 244.8"	"Cancer enhanced"	"Detected in all"		"thyroid cancer: 26.9"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	5	"eosinophil: 22.4"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 22.4"	"Cell line enhanced"	"Detected in many"		"ASC diff: 214.5;ASC TERT1: 156.1;HHSteC: 158.5;HSkMC: 141.4;hTERT-HME1: 173.0;hTERT-RPE1: 316.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB026243, HPA045061, HPA054237, CAB069428"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm		"CAB026243: , CAB069428: AB_1622639, HPA045061: AB_2679203, HPA054237: AB_2682425"	"unprognostic (8.71e-2)"	"unprognostic (3.14e-3)"	"unprognostic (7.29e-2)"	"unprognostic (1.72e-1)"	"unprognostic (3.80e-1)"	"unprognostic (2.45e-1)"	"unprognostic (6.44e-3)"	"unprognostic (8.63e-2)"	"unprognostic (1.40e-1)"	"prognostic unfavorable (8.63e-5)"	"unprognostic (8.68e-2)"	"unprognostic (4.11e-2)"	"prognostic favorable (2.86e-5)"	"unprognostic (3.12e-3)"	"unprognostic (1.51e-1)"	"unprognostic (1.56e-2)"	"unprognostic (2.01e-1)"	34.2	9.0	40.3	8.0	41.0	10.5	27.8	35.0	35.2	18.1	8.6	16.6	6.1	26.0	7.1	20.1	18.7	18.2	61.8	37.8	42.1	13.6	6.6	45.1	7.5	48.3	41.7	29.2	19.4	49.6	27.2	17.9	42.0	14.9	10.3	28.9	14.7	14.2	24.1	16.4	16.5	22.7	35.3	26.0	21.4	7.7	47.3	5.9	36.3	30.5	7.3	24.5	14.9	49.3	9.1	0.0	17.9	26.0	214.5	156.1	0.4	19.3	37.4	10.6	14.6	0.0	5.8	1.1	6.2	68.2	8.4	8.2	9.4	41.8	9.4	4.2	2.3	0.1	40.2	0.4	158.5	0.6	7.2	141.4	29.4	56.6	173.0	316.2	58.0	19.2	0.2	0.2	43.6	1.9	0.8	2.1	4.5	9.1	10.5	3.0	9.2	27.3	11.1	10.1	9.8	68.8	6.7	17.9	24.8	4.4	0.5	14.3	21.7	37.3	3.7	103.8	5.6	5.2	8.4	2.6	24.8	1.2	36.0	0.2	0.6	22.4	0.6	0.8	0.3	0.3	0.6	0.3	0.8	0.5	0.7	0.3	0.5	4.4	2.2	4.7	0.5	0.4	40.3	41.0	35.0	35.2	37.8	42.1	48.3	41.7	42.0	35.3	47.3	49.3	60.9	22.4	46.2	399.6	2.7	4.7	5.4	4.6	3.4	37.1	7.1	5.0	60.0	15.7	11.6	36.8	8.4	0.2	8.0	1.9	11.7	15.2	14.8	20.6	4.6	58.2	5.4	0.0	204.1	24.0	0.3	16.3	16.8	20.3	2.5	10.5	45.3	11.9	7.2	287.7	552.3	5.3	2.0	6.0	6.7	69.3	5.3	8.0	19.6	144.3	3.5	10.1	1.0	244.8	97.7	26.8	1.7	4.5	2.4	9.9	0.3	7.0	9.4	17.1	13.1	10.0	14.5	3.5	2.3	1.2	3.4	0.3	2.0	9.5	1.4	6.6
RPS6KA3	"CLS, HU-3, MRX19, RSK2"	ENSG00000177189	"Ribosomal protein S6 kinase A3"	P51812	X	20149911-20267519	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Cell cycle, Stress response"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Hep G2: 236.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003221, CAB003853, CAB013520"	Approved		Supported	Nucleoplasm,Nucleoli,Cytosol		No	No			"Cluster 46: Basophils - DNA binding"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Nucleoplasm	"Nucleoli, Cytosol"	"CAB003853: AB_562343, CAB013520: AB_2533378, HPA003221: AB_1853553"	"unprognostic (1.87e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.80e-2)"	"unprognostic (4.26e-2)"	"unprognostic (3.53e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.15e-2)"	"unprognostic (1.61e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.57e-1)"	"unprognostic (5.04e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.04e-1)"	"unprognostic (4.49e-3)"	"unprognostic (3.91e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.22e-1)"	21.1	18.8	6.9	33.7	10.2	16.2	14.8	12.7	12.8	16.1	8.5	32.8	24.1	17.5	8.5	18.7	15.1	26.9	21.1	8.7	9.4	19.5	45.0	32.3	31.3	8.4	10.0	10.6	17.2	59.4	5.9	19.5	8.5	19.9	31.8	15.7	13.2	18.0	51.8	15.0	27.6	27.8	8.7	29.2	21.1	5.5	10.6	32.9	21.2	40.3	32.6	34.2	8.5	8.0	44.9	77.0	28.4	14.8	27.1	47.3	8.6	38.0	57.4	27.8	37.7	87.7	56.2	29.3	12.8	40.0	40.5	30.9	32.8	32.2	51.1	24.8	26.1	34.6	46.2	236.8	27.7	67.8	34.2	30.3	25.1	43.5	54.4	24.3	101.9	30.4	23.1	81.0	29.4	21.2	44.2	20.7	20.6	57.8	45.9	23.3	60.0	33.8	23.9	36.9	13.1	12.8	51.1	15.3	54.4	35.3	0.1	20.0	57.3	30.1	20.8	96.3	21.7	64.3	42.1	32.1	56.9	33.1	72.6	11.9	3.8	7.9	4.7	5.3	8.3	2.4	5.4	5.2	5.6	3.2	3.7	4.5	5.8	6.6	6.0	6.7	2.9	2.2	6.9	10.2	12.7	12.8	8.7	9.4	8.4	10.0	8.5	8.7	10.6	8.0	60.6	44.8	67.5	31.6	34.8	54.4	37.0	21.2	10.2	37.8	20.4	10.8	22.9	34.3	41.1	16.5	22.9	4.0	70.0	63.5	3.9	26.3	0.4	10.8	24.0	61.1	25.0	19.1	142.2	30.5	6.7	31.6	24.5	26.1	44.3	8.3	34.6	65.4	22.6	13.5	108.4	59.1	28.5	40.8	104.3	1.5	13.1	62.6	37.4	126.5	53.7	27.5	46.4	116.6	27.0	37.4	57.9	21.1	25.5	56.6	33.5	25.1	23.3	9.7	19.7	41.5	21.3	6.4	8.7	13.8	55.5	3.6	66.0	14.2	61.1	63.8
RPS6KA6	RSK4	ENSG00000072133	"Ribosomal protein S6 kinase A6"	Q9UK32	X	84058346-84188199	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 75.3;Inhibitory neurons: 70.7;Oligodendrocyte precursor cells: 31.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"NTERA-2: 8.1;PC-3: 7.9;RH-30: 9.9;SH-SY5Y: 9.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002852, HPA003904"	Uncertain		Supported	Nucleoplasm,Nucleoli,Mitochondria		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Nucleoplasm, Mitochondria"	Nucleoli	"HPA002852: AB_1079854, HPA003904: AB_1079853"	"unprognostic (1.17e-1)"	"unprognostic (1.02e-2)"	"unprognostic (3.44e-1)"	"unprognostic (4.93e-4)"	"unprognostic (1.71e-1)"	"unprognostic (3.04e-3)"	"unprognostic (2.09e-2)"	"unprognostic (2.50e-1)"	"unprognostic (2.86e-1)"	"unprognostic (4.88e-2)"	"unprognostic (3.38e-3)"	"unprognostic (2.88e-1)"	"unprognostic (2.12e-9)"	"unprognostic (4.44e-3)"	"unprognostic (1.30e-2)"	"unprognostic (2.34e-2)"	"unprognostic (8.49e-3)"	0.4	2.0	2.6	0.5	3.1	0.1	1.7	3.2	3.0	2.0	2.6	2.9	1.2	1.7	3.1	0.8	2.2	1.1	0.6	2.7	3.4	5.7	0.6	0.6	0.2	2.7	2.4	2.6	0.9	7.0	5.8	0.3	2.2	2.8	2.3	7.0	1.7	2.7	1.6	2.0	1.3	1.0	1.5	0.4	1.7	1.5	2.4	1.0	8.1	0.4	0.3	1.3	1.4	2.0	0.0	2.4	2.6	0.0	2.4	2.2	0.0	5.2	2.7	2.3	1.9	1.9	2.0	0.0	0.0	2.6	0.0	0.1	6.4	4.6	5.1	0.0	3.5	0.0	0.1	0.0	2.7	0.0	0.0	1.4	0.0	0.0	2.4	3.0	0.6	0.0	0.0	0.1	2.0	0.0	1.1	0.1	8.1	0.0	7.9	0.0	9.9	0.0	0.5	5.4	0.0	9.4	0.0	3.4	0.0	3.8	1.4	0.0	0.0	0.1	2.4	0.0	0.0	0.3	0.0	0.0	0.8	0.0	0.0	0.6	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.6	0.0	2.6	3.1	3.2	3.0	2.7	3.4	2.7	2.4	2.2	1.5	2.4	2.0	0.3	9.6	2.7	6.2	0.7	0.3	5.3	0.3	3.4	21.1	3.6	3.4	2.6	12.8	1.9	18.4	25.0	2.6	0.1	6.7	1.9	0.5	0.7	1.9	1.2	1.2	25.0	2.7	75.3	1.2	0.7	2.2	2.0	0.9	0.0	21.8	1.1	1.3	0.2	1.7	70.7	3.6	0.0	0.0	0.0	0.4	4.4	0.5	0.0	3.7	0.1	2.1	1.0	31.2	5.8	1.3	3.4	6.0	0.0	9.2	1.8	4.3	3.7	18.2	0.0	4.9	1.5	8.4	6.2	2.5	0.4	2.3	0.9	2.0	6.5	5.2
RPS6KB1	"p70(S6K)-alpha, PS6K, S6K, S6K1, STK14A"	ENSG00000108443	"Ribosomal protein S6 kinase B1"	P23443	17	59893046-59950574	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Cell cycle, Translation regulation"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in all"	5	"MCF7: 243.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003838, CAB018346, HPA039442"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 52: Non-specific - Ribosome"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm		"CAB003838: AB_562325, CAB018346: AB_632156, HPA039442: AB_2676510"	"unprognostic (2.25e-1)"	"unprognostic (4.52e-2)"	"unprognostic (1.91e-3)"	"unprognostic (1.35e-2)"	"unprognostic (9.81e-2)"	"unprognostic (1.13e-1)"	"unprognostic (3.72e-3)"	"unprognostic (1.70e-1)"	"unprognostic (5.86e-2)"	"unprognostic (1.66e-1)"	"unprognostic (3.67e-1)"	"unprognostic (1.76e-2)"	"prognostic unfavorable (5.09e-7)"	"unprognostic (3.45e-1)"	"unprognostic (2.09e-1)"	"unprognostic (3.98e-2)"	"unprognostic (1.52e-3)"	14.0	11.3	7.1	11.9	7.8	18.0	13.3	11.8	9.8	11.8	9.4	10.7	10.0	13.8	10.1	16.3	10.2	9.4	10.6	7.2	6.6	9.8	15.2	9.9	14.2	7.3	7.0	14.9	16.9	14.9	7.4	15.4	7.5	10.6	11.0	10.9	9.4	10.2	22.7	10.6	9.3	14.3	6.2	12.4	11.1	6.9	7.5	15.2	11.9	18.3	17.3	14.9	11.0	9.6	34.5	33.5	27.5	26.2	18.1	26.2	20.8	31.2	28.3	26.3	29.3	27.6	16.8	41.7	37.9	25.4	32.1	17.3	36.0	27.3	42.7	23.3	41.5	28.7	21.2	31.2	26.9	44.5	27.1	26.7	20.7	31.0	22.8	21.9	35.0	26.0	38.5	25.9	19.7	243.6	53.2	18.4	18.6	29.8	24.9	30.8	46.7	38.8	21.9	25.1	20.1	23.8	26.2	15.2	16.6	31.7	29.7	24.2	31.1	25.8	42.9	21.2	42.0	46.2	42.0	46.3	19.4	26.7	21.2	43.8	12.1	11.4	12.7	12.2	15.5	10.4	11.6	14.7	15.3	9.4	13.5	14.3	11.5	11.9	14.4	9.5	11.9	10.3	7.1	7.8	11.8	9.8	7.2	6.6	7.3	7.0	7.5	6.2	7.5	9.6	22.8	22.4	34.2	29.0	32.6	33.0	21.4	13.0	30.7	18.0	23.1	17.8	16.8	12.8	30.4	3.7	18.8	24.3	33.5	12.4	3.9	12.9	5.1	24.0	31.7	25.5	13.2	11.8	47.3	16.4	18.2	24.8	26.0	37.7	23.4	20.0	13.6	15.1	12.1	18.5	45.2	14.1	4.1	15.2	20.4	3.8	15.8	19.0	10.6	28.1	20.0	12.8	18.6	25.6	54.8	15.1	10.9	18.0	34.6	27.9	9.3	9.2	21.1	18.9	26.3	33.4	32.6	13.0	13.7	34.5	32.0	30.5	29.9	26.0	13.9	25.4
RPS6KB2	"KLS, P70-BETA, p70S6Kb, S6Kβ, S6KB, S6Kbeta, STK14B"	ENSG00000175634	"Ribosomal protein S6 kinase B2"	Q9UBS0	11	67428460-67435401	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010010, CAB019404"	Approved		Supported	Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 55: Plasma cells - Humoral immune response"	Cytosol		"CAB019404: AB_331355, HPA010010: AB_1856469"	"unprognostic (1.38e-1)"	"unprognostic (2.36e-3)"	"unprognostic (8.50e-2)"	"unprognostic (2.56e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.41e-1)"	"unprognostic (9.01e-3)"	"unprognostic (5.10e-2)"	"unprognostic (1.22e-1)"	"unprognostic (9.49e-3)"	"unprognostic (7.66e-2)"	"unprognostic (2.79e-2)"	"prognostic unfavorable (2.03e-7)"	"unprognostic (1.28e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.12e-1)"	"unprognostic (2.66e-1)"	16.2	28.0	9.7	13.8	10.8	28.2	17.0	9.9	12.4	23.5	13.2	22.8	26.5	17.7	6.0	71.9	20.0	10.6	22.1	9.1	9.3	21.3	50.2	19.5	18.4	10.9	10.3	16.2	35.4	17.5	20.6	13.6	10.6	31.6	12.8	4.2	31.5	9.9	37.9	81.6	25.4	10.1	10.2	33.7	35.2	9.6	9.9	24.0	20.1	26.0	20.1	19.3	31.4	11.3	58.2	42.7	22.8	39.0	10.4	20.0	30.0	27.4	33.9	49.7	34.2	67.2	37.5	21.1	46.3	26.9	31.0	41.8	25.9	41.4	19.9	36.9	70.0	34.5	54.2	55.5	35.2	43.7	40.4	25.5	42.8	26.3	26.9	12.5	37.5	54.8	55.8	54.8	25.4	88.5	68.1	68.4	24.9	83.7	54.6	50.0	31.8	100.5	23.0	32.6	34.4	37.1	28.0	76.8	59.8	13.2	90.4	35.7	15.8	25.8	27.6	63.1	31.1	48.8	43.9	34.4	42.4	27.3	33.1	18.8	37.2	28.5	23.8	42.6	24.5	23.4	22.9	23.9	44.1	21.9	16.1	17.9	24.7	29.6	49.9	30.4	34.5	37.3	9.7	10.8	9.9	12.4	9.1	9.3	10.9	10.3	10.6	10.2	9.9	11.3	22.0	9.6	20.5	6.8	48.1	49.8	28.0	48.9	19.9	25.3	32.6	27.8	1.3	28.6	31.2	7.3	10.4	71.8	45.0	66.9	43.0	44.5	14.9	16.0	16.9	17.9	46.2	65.0	7.7	64.8	89.1	21.9	48.9	19.3	27.9	23.2	18.2	57.4	61.3	33.7	7.1	67.7	34.6	45.8	29.1	29.4	20.2	36.9	19.6	3.7	56.6	28.5	73.2	5.0	12.1	46.6	70.4	17.3	82.1	43.7	115.0	42.2	16.0	27.6	19.7	16.7	26.9	15.8	16.0	52.5	63.6	103.6	41.7	27.5	58.3	39.4
RPS6KC1	"humS6PKh1, RSKL1"	ENSG00000136643	"Ribosomal protein S6 kinase C1"	Q96S38	1	213051233-213274774	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 86.2;Excitatory neurons: 273.2;Inhibitory neurons: 151.2;Microglial cells: 101.2;Oligodendrocyte precursor cells: 116.6;Oligodendrocytes: 137.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 16.8"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026531, HPA031565"	Approved		Supported	Endosomes,Lysosomes		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Endosomes, Lysosomes"		"HPA026531: AB_10601497, HPA031565: AB_2673935"	"unprognostic (3.90e-2)"	"unprognostic (5.90e-2)"	"unprognostic (3.22e-1)"	"unprognostic (4.88e-2)"	"unprognostic (2.42e-1)"	"unprognostic (9.81e-2)"	"unprognostic (1.32e-2)"	"unprognostic (1.64e-1)"	"unprognostic (4.10e-2)"	"unprognostic (3.34e-1)"	"unprognostic (4.18e-1)"	"unprognostic (5.11e-2)"	"prognostic unfavorable (2.70e-4)"	"unprognostic (8.10e-2)"	"unprognostic (5.48e-2)"	"unprognostic (2.98e-2)"	"unprognostic (4.44e-2)"	8.3	8.8	9.7	7.1	11.5	4.9	7.2	8.2	13.9	8.8	4.3	7.8	6.2	9.4	5.2	6.7	7.6	7.7	6.4	12.9	8.8	6.4	7.4	7.1	5.2	8.6	8.8	9.2	9.2	10.2	4.5	8.4	8.6	11.5	6.5	9.3	6.8	11.3	10.0	4.3	6.0	12.6	8.6	7.9	8.6	19.3	9.9	5.4	6.9	11.6	5.4	8.1	4.6	13.2	11.0	9.3	15.0	16.3	15.0	21.6	13.2	14.1	20.7	21.5	24.6	7.7	11.9	6.9	9.3	21.4	14.1	8.9	18.3	11.6	16.2	14.7	6.7	18.7	10.9	10.5	13.6	11.9	21.4	14.3	9.8	18.8	10.2	17.9	18.2	6.7	24.6	10.5	22.3	6.3	5.0	3.9	21.8	9.8	10.4	5.9	14.1	6.8	9.7	10.9	8.7	22.6	15.3	11.9	20.6	25.5	17.1	4.9	17.0	14.6	13.3	16.9	9.3	6.1	12.6	5.2	6.2	4.5	15.2	16.8	4.5	3.5	2.5	6.4	2.1	2.4	2.0	2.2	8.5	1.6	1.3	3.0	0.5	3.8	6.7	1.0	1.6	2.2	9.7	11.5	8.2	13.9	12.9	8.8	8.6	8.8	8.6	8.6	9.9	13.2	10.1	9.6	5.8	86.2	8.8	2.9	2.7	4.5	7.4	17.4	6.6	5.6	9.6	7.2	4.3	0.0	14.6	3.5	7.7	4.8	0.0	5.2	33.6	7.4	12.1	9.9	3.6	12.4	273.2	8.0	4.0	10.1	15.3	9.9	7.6	16.6	7.9	9.3	7.1	20.2	151.2	3.3	6.1	11.4	7.7	45.2	11.1	15.1	7.2	101.2	13.1	5.6	10.3	116.6	137.6	6.6	2.1	7.5	8.1	5.4	4.4	5.7	4.7	20.0	13.1	13.7	9.1	19.6	19.6	9.1	4.4	3.8	10.4	6.1	4.3	3.2
RPSA	"37LRP, LAMR1, LRP, p40, SA"	ENSG00000168028	"Ribosomal protein SA"	P08865	3	39406716-39412542	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"	"Host-virus interaction"	"Host cell receptor for virus entry, Receptor, Ribonucleoprotein, Ribosomal protein"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											CAB009561	Approved		Supported	"Plasma membrane,Cytosol"		NA	NA		1200000	"Cluster 30: Non-specific - Translation"	"Cluster 50: Non-specific - Ribosome"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 32: Non-specific - Translation"	"Plasma membrane, Cytosol"		"CAB009561: AB_2182543"	"unprognostic (3.67e-3)"	"unprognostic (2.92e-1)"	"unprognostic (3.97e-2)"	"unprognostic (3.72e-2)"	"unprognostic (5.38e-2)"	"unprognostic (5.10e-2)"	"unprognostic (5.84e-3)"	"unprognostic (2.54e-1)"	"unprognostic (1.69e-1)"	"unprognostic (2.36e-2)"	"unprognostic (8.56e-2)"	"unprognostic (7.50e-2)"	"unprognostic (2.91e-2)"	"unprognostic (3.18e-1)"	"unprognostic (2.77e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.46e-1)"	1063.0	929.1	813.4	685.7	824.8	1574.8	1068.4	782.0	979.1	1260.0	761.8	1158.4	605.8	1022.1	351.0	1922.5	1128.3	372.5	783.9	778.6	794.3	905.9	972.5	894.3	1281.4	817.8	809.6	2153.7	2616.3	605.5	813.4	468.8	812.9	1212.6	872.2	273.3	1039.7	446.9	1087.1	1529.4	1133.1	718.3	842.4	1525.8	1209.3	358.0	831.9	1259.9	862.6	730.4	1466.4	1127.5	1293.1	821.5	1800.4	1646.5	1367.5	2265.9	1203.3	2661.2	2155.0	1251.2	2005.9	2775.9	1611.8	1811.6	1513.7	3949.6	737.0	2535.3	747.6	695.4	2983.8	2945.7	2402.3	1459.6	1599.6	1783.6	1390.5	1750.2	2322.7	2546.4	1649.2	3043.3	4729.8	2147.2	3475.3	2030.8	2942.7	2343.5	1909.3	1883.8	2031.1	1282.1	3031.0	1960.4	4574.2	2756.9	2755.1	1412.2	1958.4	2974.8	2004.4	814.2	985.3	1989.0	674.8	5156.5	2202.9	1843.5	1509.0	3544.5	1156.6	845.2	1545.8	1422.3	3102.3	1440.6	2363.4	2437.5	1355.7	2481.7	1143.9	98.3	240.5	56.7	572.9	294.6	993.1	1010.3	942.1	758.8	654.2	951.8	1036.2	936.1	34.3	726.0	247.5	723.6	765.5	1499.7	813.4	824.8	782.0	979.1	778.6	794.3	817.8	809.6	812.9	842.4	831.9	821.5	532.1	519.2	800.2	10.7	2802.5	1802.5	2606.9	1585.5	2040.3	270.4	1864.7	1423.4	64.0	1095.2	906.4	325.5	95.9	2852.5	1768.9	625.4	992.0	1598.4	144.3	536.7	1178.5	891.2	1033.6	1733.9	21.3	3417.4	4473.1	927.1	821.6	747.7	778.4	1654.5	937.3	717.7	1608.4	173.3	21.5	1847.0	455.7	1304.9	1469.6	283.7	1240.5	1086.9	738.2	12.2	1605.2	621.1	1858.9	19.1	29.3	1889.5	1184.2	747.4	1501.8	2136.7	724.4	1257.1	476.2	364.4	473.3	1053.5	1002.2	352.2	1255.8	2879.8	1916.2	2420.7	2100.0	1539.2	2442.4	2884.6
RPTOR	"KIAA1303, KOG1, Mip1, raptor"	ENSG00000141564	"Regulatory associated protein of MTOR complex 1"	Q8N122	17	80544819-80966371	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Host-virus interaction"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"Astrocytes: 46.0;Excitatory neurons: 70.1;Inhibitory neurons: 66.3;Microglial cells: 32.8;Oligodendrocyte precursor cells: 50.8;Oligodendrocytes: 66.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013514, HPA064306"	Approved		Enhanced	Vesicles,Lysosomes		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Vesicles, Lysosomes"		"CAB013514: AB_2533523, HPA064306: AB_2685240"	"unprognostic (5.09e-3)"	"unprognostic (1.01e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.38e-1)"	"unprognostic (9.75e-2)"	"unprognostic (3.34e-3)"	"unprognostic (1.17e-2)"	"unprognostic (9.63e-2)"	"unprognostic (8.80e-2)"	"unprognostic (4.40e-3)"	"unprognostic (8.46e-2)"	"unprognostic (6.03e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.90e-1)"	"unprognostic (1.27e-2)"	"unprognostic (1.77e-2)"	5.9	4.6	3.5	4.4	3.3	4.1	3.6	2.0	4.4	4.3	0.1	5.7	4.8	5.6	1.8	4.5	4.5	2.9	6.1	3.8	2.6	3.1	3.4	4.2	3.3	3.3	2.8	4.8	5.5	5.3	4.0	3.6	3.3	4.5	2.4	2.6	4.6	5.0	14.1	5.1	4.5	4.6	2.0	3.8	4.4	4.0	3.5	4.4	3.6	7.0	2.7	5.4	3.6	3.2	16.2	34.7	6.8	12.9	9.5	7.0	15.5	12.7	9.5	17.9	12.4	21.5	13.8	13.3	10.1	12.9	13.8	11.6	10.5	15.7	8.9	5.6	19.6	20.8	16.8	21.2	8.9	19.8	15.3	12.3	9.9	17.3	9.1	5.9	16.6	15.7	24.9	4.6	8.6	8.8	12.4	7.8	7.4	9.2	24.0	10.2	12.9	11.2	4.6	17.8	13.4	17.4	14.4	22.9	14.9	6.6	16.3	14.5	9.6	37.1	17.8	11.6	15.7	8.9	3.9	12.6	22.4	10.1	23.6	0.0	0.1	0.0	0.5	0.3	0.3	0.2	0.2	0.3	0.4	0.1	0.2	0.2	0.0	0.1	0.2	0.0	1.0	0.4	3.5	3.3	2.0	4.4	3.8	2.6	3.3	2.8	3.3	2.0	3.5	3.2	4.3	0.0	3.9	46.0	8.5	3.2	3.0	2.4	4.6	6.8	4.2	3.3	4.5	5.7	1.6	5.5	4.2	4.4	7.2	3.8	1.9	3.6	6.7	3.9	5.4	4.3	6.0	4.8	70.1	3.8	5.9	4.8	8.2	4.9	2.5	7.5	2.2	7.5	4.7	11.8	66.3	3.1	6.1	5.7	3.2	10.9	3.1	6.7	1.8	32.8	1.7	4.3	2.1	50.8	66.2	4.7	3.5	5.3	9.4	4.5	4.6	2.7	2.0	7.0	0.0	5.5	4.1	4.5	3.5	5.1	3.0	4.4	9.3	6.0	5.6	3.8
RPUSD4	FLJ14494	ENSG00000165526	"RNA pseudouridine synthase D4"	Q96CM3	11	126202096-126211692	"Metabolic proteins, Predicted intracellular proteins"	"tRNA processing"	Isomerase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 135.5;tongue: 75.2"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039689	Approved		Supported	Nucleoplasm,Mitochondria		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 33: Striated muscle - Muscle contraction"	"Cluster 36: HEL - Hemostasis"	"Cluster 54: Cardiomyocytes - Muscle contraction"	Mitochondria	Nucleoplasm	"HPA039689: AB_10673537"	"unprognostic (2.02e-2)"	"unprognostic (3.65e-1)"	"prognostic favorable (6.14e-4)"	"unprognostic (3.16e-3)"	"unprognostic (2.90e-2)"	"unprognostic (3.75e-2)"	"prognostic unfavorable (1.24e-4)"	"unprognostic (1.32e-1)"	"unprognostic (7.64e-3)"	"unprognostic (1.07e-1)"	"unprognostic (3.03e-2)"	"unprognostic (1.20e-2)"	"unprognostic (1.56e-1)"	"unprognostic (7.11e-2)"	"unprognostic (5.44e-2)"	"unprognostic (7.33e-2)"	"unprognostic (5.47e-2)"	14.8	12.7	10.2	9.8	10.4	10.6	14.0	10.5	11.2	13.8	10.7	12.1	10.4	12.6	7.7	15.1	12.9	8.1	27.2	10.5	10.4	11.8	20.5	9.4	13.8	10.2	10.2	18.3	26.8	7.8	8.8	6.8	10.5	11.5	10.1	6.1	14.4	7.0	135.5	17.1	12.1	9.2	10.6	14.4	20.0	8.8	10.5	13.2	10.1	75.2	15.5	12.4	13.4	10.5	15.6	14.0	17.0	19.7	24.5	34.3	12.5	16.2	22.7	16.6	15.1	46.4	27.3	35.7	16.8	14.1	23.7	25.1	40.3	25.8	17.3	32.4	23.9	84.1	15.0	40.5	18.3	42.5	17.1	29.8	35.0	18.4	22.9	24.8	33.4	28.8	51.8	25.1	20.2	13.5	26.6	46.3	18.4	49.3	29.1	31.0	25.2	33.3	25.7	19.8	29.3	20.5	21.5	29.7	16.7	17.0	46.2	21.9	20.9	18.6	13.3	15.4	19.9	10.1	12.4	30.7	8.8	47.2	19.7	1.6	12.7	1.4	15.9	11.7	19.6	14.4	18.0	14.3	16.3	14.5	20.4	16.8	0.9	14.3	14.0	7.0	18.1	13.3	10.2	10.4	10.5	11.2	10.5	10.4	10.2	10.2	10.5	10.6	10.5	10.5	10.0	3.2	8.4	6.8	15.3	27.5	20.4	13.2	17.1	9.9	13.1	9.1	35.4	12.8	7.4	7.3	8.4	14.0	12.3	7.2	9.8	12.3	1.8	6.7	7.1	11.9	15.5	6.7	7.0	19.6	17.1	10.2	10.7	7.4	5.7	15.2	13.6	11.3	13.3	11.8	8.4	10.7	2.0	15.9	8.7	2.3	9.6	8.6	10.6	8.4	21.0	5.3	14.4	6.6	7.8	13.5	7.4	8.6	12.4	17.4	15.6	14.5	7.0	8.2	6.6	15.6	9.9	10.3	16.7	13.2	24.0	13.3	13.1	18.3	18.8	14.7
RRAGC	"FLJ13311, GTR2"	ENSG00000116954	"Ras related GTP binding C"	Q9HB90	1	38838198-38859772	"Disease related genes, Predicted intracellular proteins"		Hydrolase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Syncytiotrophoblasts: 224.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018247, HPA055489"	Supported		Supported	Nucleoplasm,Vesicles		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 41: Macrophages - Immune response"	"Nucleoplasm, Vesicles"		"HPA018247: AB_1856475, HPA055489: AB_2682832"	"unprognostic (2.04e-2)"	"unprognostic (1.58e-1)"	"unprognostic (2.63e-2)"	"unprognostic (1.41e-2)"	"unprognostic (3.40e-1)"	"unprognostic (1.42e-1)"	"prognostic unfavorable (9.97e-9)"	"unprognostic (2.14e-1)"	"unprognostic (3.61e-2)"	"unprognostic (4.98e-2)"	"unprognostic (2.23e-2)"	"unprognostic (1.71e-1)"	"unprognostic (5.13e-2)"	"unprognostic (6.38e-2)"	"unprognostic (2.69e-1)"	"unprognostic (2.77e-1)"	"unprognostic (3.82e-2)"	37.0	16.9	18.0	16.6	19.2	30.2	25.2	20.0	19.4	17.1	16.4	21.5	18.7	16.1	14.0	24.9	13.9	17.7	21.6	17.6	20.4	24.5	18.5	19.3	20.5	20.4	21.3	21.6	14.2	24.0	10.0	28.5	21.3	14.9	17.0	16.1	14.2	16.9	17.4	29.8	16.2	21.9	19.5	17.3	15.1	17.5	19.8	18.8	16.7	18.9	21.8	19.0	18.1	21.3	37.0	16.6	21.3	23.3	110.7	74.6	33.0	33.7	68.6	44.8	47.2	12.7	23.9	23.0	18.9	52.6	71.8	21.7	40.1	22.2	36.8	37.6	28.3	22.1	19.2	14.7	135.6	26.0	23.9	66.7	55.2	48.0	61.9	35.4	47.5	24.5	22.9	44.9	65.7	10.2	19.0	14.7	27.2	15.9	28.0	18.1	37.6	15.6	31.6	42.5	11.1	16.5	27.0	20.0	73.2	47.5	18.3	19.5	42.5	54.3	22.4	60.0	29.2	35.0	60.5	26.8	50.5	29.1	28.8	0.5	2.4	5.5	1.7	2.3	2.9	3.3	2.6	2.2	2.3	3.6	2.2	2.1	5.9	1.7	1.8	8.4	2.5	1.6	18.0	19.2	20.0	19.4	17.6	20.4	20.4	21.3	21.3	19.5	19.8	21.3	31.2	32.1	28.0	6.5	42.1	111.9	47.1	19.2	40.9	20.0	31.0	25.0	22.2	24.3	16.1	12.9	12.5	84.9	38.4	30.3	11.7	55.7	56.3	32.0	26.6	34.3	14.4	24.0	7.4	48.1	57.7	39.4	12.2	42.9	16.5	16.9	35.7	14.2	72.1	38.7	8.3	10.3	20.3	34.4	65.0	49.8	30.7	49.2	53.4	9.4	63.3	43.4	10.3	7.5	15.8	47.0	14.0	37.2	20.1	47.3	21.5	30.4	15.0	22.8	19.7	28.1	37.5	24.7	28.5	46.1	140.5	224.1	23.3	18.6	12.2	51.1
RRAGD	"bA11D8.2.1, DKFZP761H171"	ENSG00000025039	"Ras related GTP binding D"	Q9NQL2	6	89364616-89412273	"Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 84.5"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 129.1;Distal tubular cells: 117.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"neutrophil: 3.3"	"Group enriched"	"Detected in many"	7	"granulocytes: 3.3;monocytes: 2.4"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 63.9;SCLC-21H: 33.1;U-266/70: 80.0;U-266/84: 39.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA068664	Approved		Approved	Nucleoplasm,Vesicles,Centrosome		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm	"Vesicles, Centrosome"	"HPA068664: AB_2686016"	"unprognostic (3.06e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.53e-3)"	"unprognostic (1.09e-1)"	"unprognostic (2.03e-1)"	"unprognostic (2.09e-1)"	"prognostic unfavorable (7.80e-4)"	"unprognostic (3.75e-2)"	"unprognostic (1.66e-2)"	"unprognostic (4.33e-2)"	"unprognostic (1.11e-2)"	"unprognostic (1.00e-1)"	"prognostic favorable (8.47e-8)"	"unprognostic (8.41e-3)"	"unprognostic (1.23e-1)"	"unprognostic (9.46e-2)"	"unprognostic (4.40e-2)"	9.8	9.1	14.0	2.3	18.9	11.6	8.2	31.8	16.1	9.4	17.9	4.0	1.7	1.5	6.9	13.8	13.7	3.6	38.4	15.9	13.9	26.5	4.4	7.0	2.8	16.4	12.2	1.6	6.4	22.7	11.4	3.2	17.2	6.1	1.8	21.8	52.2	2.8	84.5	6.7	2.0	2.1	21.5	4.8	1.7	6.9	14.8	5.5	28.1	60.3	2.5	5.8	6.2	23.8	0.1	1.7	4.4	3.3	0.4	0.0	0.3	0.0	0.0	0.5	0.9	0.1	0.1	0.0	1.5	0.0	22.6	0.1	24.5	0.1	0.0	0.0	12.1	5.8	0.1	0.1	1.8	16.9	19.0	0.4	1.5	0.0	0.1	0.0	0.0	16.9	0.5	63.9	0.1	1.8	8.2	8.4	3.6	0.0	1.8	16.8	23.1	0.2	5.8	0.6	33.1	1.8	0.6	2.2	28.8	1.3	0.7	13.2	0.0	1.8	2.8	11.5	3.0	80.0	39.8	0.0	6.1	12.5	1.9	2.6	0.6	1.4	0.0	0.5	0.0	0.0	0.2	0.0	0.4	0.0	0.1	0.3	3.3	0.1	2.4	0.3	0.0	0.1	14.0	18.9	31.8	16.1	15.9	13.9	16.4	12.2	17.2	21.5	14.8	23.8	1.4	9.6	16.7	5.2	3.7	16.2	17.0	5.8	4.0	21.7	17.4	9.7	129.1	17.2	13.9	14.7	31.3	0.6	4.7	0.1	117.4	20.2	25.6	10.4	2.5	4.8	1.2	5.0	17.6	16.9	1.5	10.0	1.1	15.0	4.5	2.9	2.5	9.7	51.9	47.1	20.6	0.5	42.7	25.8	9.2	15.5	3.1	23.2	39.2	3.7	10.4	29.6	0.0	13.0	17.2	8.1	0.0	4.1	8.0	28.4	0.0	18.6	19.4	16.3	0.0	11.8	7.0	21.7	30.3	32.4	22.6	0.7	3.9	0.2	0.2	30.2
RREB1	HNT	ENSG00000124782	"Ras responsive element binding protein 1"	Q92766	6	7107597-7251980	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA001756, HPA034843"	Approved		Supported	"Nucleoli fibrillar center,Nuclear speckles"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 65: Plasmacytoid DCs - Unknown function"	"Nuclear speckles"	"Nucleoli fibrillar center"	"HPA001756: AB_1856477, HPA034843: AB_2674357"	"unprognostic (1.69e-1)"	"unprognostic (3.16e-2)"	"unprognostic (2.93e-1)"	"unprognostic (5.05e-2)"	"unprognostic (7.38e-2)"	"unprognostic (1.23e-3)"	"unprognostic (2.53e-1)"	"unprognostic (1.32e-2)"	"unprognostic (2.45e-2)"	"unprognostic (6.51e-2)"	"unprognostic (3.31e-2)"	"unprognostic (1.16e-1)"	"prognostic favorable (1.41e-4)"	"unprognostic (1.21e-2)"	"unprognostic (1.60e-1)"	"unprognostic (9.54e-2)"	"unprognostic (2.92e-1)"	10.9	12.1	4.3	7.8	3.6	31.6	10.8	4.4	2.2	10.2	12.5	10.8	11.9	7.8	5.6	26.2	8.7	6.4	8.3	2.7	4.2	8.2	18.3	9.1	6.5	9.1	6.6	9.8	18.1	12.2	6.3	8.1	6.5	8.1	9.8	5.7	15.0	6.2	16.6	16.2	13.1	6.2	5.4	10.7	10.7	11.6	7.6	9.2	12.0	7.9	7.9	7.9	14.2	5.5	13.1	12.3	10.3	11.9	9.5	6.3	40.1	5.2	7.3	6.2	7.6	20.3	10.0	6.6	10.9	9.9	6.9	9.3	14.7	16.5	5.9	9.2	11.3	24.8	9.6	23.5	13.1	15.0	18.5	10.5	12.7	9.3	13.8	4.2	7.5	15.2	44.6	0.1	6.5	16.5	8.8	35.2	4.9	10.6	10.0	13.1	12.4	10.4	9.0	25.1	2.8	2.6	12.4	16.0	11.1	15.3	12.3	31.0	13.0	11.4	7.1	8.8	6.4	4.1	4.7	9.0	3.3	11.4	9.3	5.5	2.7	6.6	1.5	2.1	1.3	2.2	1.0	1.0	1.7	1.0	1.6	1.3	2.0	3.3	2.4	5.7	0.5	1.7	4.3	3.6	4.4	2.2	2.7	4.2	9.1	6.6	6.5	5.4	7.6	5.5	39.3	25.6	28.7	44.4	19.0	31.5	22.4	30.1	27.9	0.9	27.0	16.9	24.2	31.5	31.4	36.8	70.9	25.8	31.9	62.7	7.9	14.7	46.2	35.5	24.7	22.5	31.8	31.1	3.9	16.3	32.8	16.3	30.1	63.0	10.1	20.7	30.7	70.4	33.4	0.0	0.7	35.7	14.2	66.1	54.9	9.0	19.9	42.1	23.2	78.7	32.6	9.5	13.4	2.0	0.9	22.3	36.3	19.2	27.7	37.1	34.5	16.8	23.9	27.5	52.6	25.5	15.2	13.7	17.4	48.9	34.7	45.8	15.7	27.4	45.0	54.3
RRM1		ENSG00000167325	"Ribonucleotide reductase catalytic subunit M1"	P23921	11	4094707-4138932	"Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"DNA replication"	"Allosteric enzyme, Oxidoreductase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 102.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022093, HPA057265, HPA064297"	Enhanced		Supported	Cytosol		NA	Yes		140000	"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Cytosol		"CAB022093: , HPA057265: AB_2683386, HPA064297: AB_2685236"	"unprognostic (4.47e-2)"	"unprognostic (1.73e-2)"	"unprognostic (1.99e-3)"	"unprognostic (3.65e-1)"	"unprognostic (2.83e-1)"	"unprognostic (2.19e-1)"	"prognostic unfavorable (1.53e-4)"	"unprognostic (1.31e-2)"	"unprognostic (3.43e-2)"	"unprognostic (6.90e-2)"	"unprognostic (1.06e-3)"	"unprognostic (4.21e-2)"	"unprognostic (6.88e-3)"	"unprognostic (9.20e-3)"	"unprognostic (6.16e-2)"	"unprognostic (8.41e-2)"	"unprognostic (9.93e-3)"	16.6	21.2	5.1	24.8	5.3	32.8	22.7	7.1	6.1	16.9	4.7	25.7	19.3	16.2	10.1	26.5	15.5	11.8	16.4	5.1	5.7	13.4	18.4	12.8	34.4	6.1	5.5	16.4	14.6	24.7	7.1	20.4	6.6	18.5	29.4	23.6	14.7	16.0	30.3	36.1	20.2	20.1	6.2	13.0	17.6	17.9	5.1	56.7	15.6	30.0	45.2	15.6	18.9	6.2	221.6	117.8	188.4	110.0	28.4	56.2	73.0	198.0	98.2	220.7	225.9	106.8	163.8	237.4	47.0	100.1	95.9	173.0	176.9	143.2	259.3	117.3	187.9	121.0	159.8	83.1	11.2	208.9	84.6	26.6	37.8	121.7	86.4	48.3	107.8	140.1	161.1	107.3	186.8	99.6	246.7	41.9	118.2	152.2	119.2	196.1	147.0	84.3	59.4	61.8	159.8	88.1	175.1	104.8	30.0	75.8	102.8	71.4	62.3	203.4	106.0	206.9	147.4	70.3	103.5	252.5	114.1	137.6	130.3	8.3	4.0	4.5	11.3	11.2	21.1	9.2	22.3	16.6	7.3	5.2	17.2	15.0	0.0	10.5	15.6	4.4	41.7	10.3	5.1	5.3	7.1	6.1	5.1	5.7	6.1	5.5	6.6	6.2	5.1	6.2	12.4	19.2	14.4	4.9	17.0	33.4	26.8	31.0	17.6	15.6	15.1	14.4	33.5	14.3	24.7	18.4	6.2	62.8	14.9	13.3	7.9	25.6	69.9	11.5	14.5	15.7	18.0	81.2	11.2	22.2	62.5	22.0	20.4	13.9	7.0	27.3	10.8	15.0	28.3	18.5	12.0	25.0	16.2	11.7	10.3	83.9	13.1	13.9	10.6	6.5	10.7	24.0	5.2	12.1	11.9	15.8	10.4	16.6	31.3	10.1	12.5	8.4	15.5	22.7	13.1	19.5	27.1	102.8	63.1	36.5	29.0	39.7	23.2	18.1	34.3	20.6
RRM2	"C2orf48, FLJ25102"	ENSG00000171848	"Ribonucleotide reductase regulatory subunit M2"	P31350	2	10120698-10211725	"Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted membrane proteins"	"DNA replication"	Oxidoreductase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"bone marrow: 44.2;esophagus: 18.4;intestine: 19.7;lymphoid tissue: 58.1"	"Group enriched"	"Detected in many"	4	"Erythroid cells: 214.0;Extravillous trophoblasts: 254.1;Plasma cells: 248.0"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA056994	Enhanced		Supported	Cytosol		Yes	Yes		13000	"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Cytosol		"HPA056994: AB_2683304"	"unprognostic (2.10e-2)"	"unprognostic (1.62e-1)"	"unprognostic (6.40e-3)"	"unprognostic (4.42e-3)"	"unprognostic (5.70e-2)"	"unprognostic (1.69e-1)"	"prognostic unfavorable (1.39e-5)"	"unprognostic (1.04e-3)"	"unprognostic (6.67e-3)"	"unprognostic (4.53e-2)"	"prognostic unfavorable (1.62e-4)"	"unprognostic (5.11e-3)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (3.05e-2)"	"unprognostic (2.24e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.09e-2)"	1.5	1.3	0.3	12.4	0.3	44.2	2.9	0.5	0.4	3.0	1.9	14.2	9.4	2.2	0.7	18.4	0.8	1.1	0.5	0.3	0.3	0.9	3.2	2.4	35.5	0.4	0.4	0.3	1.1	0.3	0.2	4.6	0.4	0.9	19.7	0.2	2.1	0.5	0.1	3.7	7.5	6.1	0.3	11.1	6.0	2.9	0.8	58.1	0.9	0.1	37.6	6.0	4.6	0.5	110.2	25.0	127.1	49.9	7.4	22.5	116.8	209.2	128.6	170.2	187.9	70.8	59.1	114.4	9.5	88.6	151.1	55.0	188.0	136.6	198.0	210.7	41.8	146.3	52.1	105.1	0.8	146.7	87.4	8.1	3.4	234.6	16.2	27.7	103.3	110.4	63.4	328.6	214.3	57.1	167.3	90.9	83.0	133.3	103.6	87.6	187.0	67.8	87.1	62.7	67.7	56.2	198.0	116.6	17.3	51.8	69.2	31.4	57.6	93.1	125.1	66.9	289.6	212.1	184.9	195.9	51.0	134.4	107.7	0.3	0.1	0.1	1.2	0.0	0.0	0.1	0.3	0.8	0.1	0.1	0.1	0.4	0.4	0.8	0.0	0.1	0.2	0.2	0.3	0.3	0.5	0.4	0.3	0.3	0.4	0.4	0.4	0.3	0.8	0.5	0.2	3.2	1.5	0.0	25.0	10.5	3.0	9.2	1.2	0.0	3.9	4.4	1.4	1.5	2.3	0.0	0.0	42.3	5.6	12.9	1.9	1.2	3.9	2.2	3.5	4.2	0.0	214.0	0.1	0.0	254.1	11.2	11.7	3.6	5.7	12.2	3.9	3.7	47.9	0.0	0.0	26.9	2.0	7.2	8.8	6.8	0.3	5.0	0.0	1.0	0.0	0.0	7.2	0.0	0.0	0.5	0.3	0.4	248.0	1.5	2.4	2.1	4.6	0.0	0.0	0.2	14.6	22.9	34.0	51.5	1.6	48.7	11.9	1.2	36.7	5.6
RRN3	"DKFZp566E104, TIF-IA"	ENSG00000085721	"RRN3 homolog, RNA polymerase I transcription factor"	Q9NYV6	16	15060033-15094311	"Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049837	Supported		Supported	"Nucleoli rim"		NA	No			"Cluster 44: Non-specific - Transcription"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 59: Non-specific - Transcription"	"Nucleoli rim"		"HPA049837: AB_2680906"	"unprognostic (1.83e-1)"	"unprognostic (6.32e-2)"	"unprognostic (1.95e-2)"	"unprognostic (1.05e-2)"	"unprognostic (2.37e-1)"	"unprognostic (5.74e-3)"	"unprognostic (3.67e-2)"	"unprognostic (4.50e-2)"	"unprognostic (7.81e-2)"	"unprognostic (1.12e-1)"	"unprognostic (5.25e-3)"	"unprognostic (1.17e-2)"	"unprognostic (7.71e-2)"	"unprognostic (2.76e-2)"	"unprognostic (2.30e-1)"	"unprognostic (1.35e-2)"	"unprognostic (1.27e-1)"	21.9	17.1	8.5	11.2	8.2	28.1	20.1	10.8	13.5	15.3	7.5	16.1	7.0	16.6	11.1	13.3	16.0	12.0	16.3	8.3	9.0	15.2	31.1	12.7	15.6	8.2	10.5	20.7	20.0	20.7	15.5	12.2	9.0	16.9	18.2	23.9	13.0	13.3	41.4	15.6	14.7	13.5	8.1	16.2	15.1	13.7	9.0	19.0	16.4	39.1	18.1	18.2	14.0	10.2	17.3	8.5	25.6	22.8	20.2	24.2	7.6	19.4	19.9	28.5	29.9	5.6	31.6	39.2	28.9	27.8	27.7	18.0	40.5	26.3	46.9	20.4	21.9	95.6	17.3	52.4	44.5	17.9	103.4	19.9	41.4	38.2	41.0	25.2	20.9	13.6	18.6	32.0	44.9	26.3	17.0	44.1	25.5	23.3	4.6	61.7	26.4	41.0	26.6	18.4	42.3	33.8	30.5	38.2	24.7	16.4	43.3	25.4	19.4	34.5	14.2	19.8	26.8	27.7	32.8	56.1	20.4	30.2	43.7	8.4	3.4	3.9	3.8	2.3	5.3	4.7	2.8	3.4	3.6	2.2	4.1	3.0	0.4	6.8	2.7	1.8	3.1	4.6	8.5	8.2	10.8	13.5	8.3	9.0	8.2	10.5	9.0	8.1	9.0	10.2	31.6	9.6	13.7	13.1	28.1	17.8	10.3	8.6	28.5	14.4	16.5	12.8	22.3	8.6	10.2	16.5	20.9	11.7	21.4	14.3	5.9	10.1	18.1	9.6	22.3	20.2	7.2	22.5	13.7	8.0	10.9	19.9	20.9	15.0	10.1	22.4	15.4	18.2	15.1	11.8	16.4	17.0	12.2	14.1	15.0	7.7	14.6	21.2	16.0	14.0	15.9	19.0	18.6	13.6	12.7	11.0	13.7	18.0	23.2	12.2	12.8	15.1	5.9	18.9	0.0	14.9	19.1	15.5	21.3	27.9	21.9	6.7	27.6	19.4	14.9	11.0
RRP12	KIAA0690	ENSG00000052749	"Ribosomal RNA processing 12 homolog"	Q5JTH9	10	97356358-97426076	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"bone marrow: 90.9;skeletal muscle: 38.5"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 26.7"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049945, HPA074403"			Supported	"Nucleoli,Vesicles,Plasma membrane,Cytosol"		No	No			"Cluster 51: Monocytes - Innate immune response"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 41: Macrophages - Immune response"	Nucleoli	"Vesicles, Plasma membrane, Cytosol"	"HPA049945: AB_2680965, HPA074403: "	"unprognostic (2.79e-1)"	"unprognostic (7.65e-2)"	"unprognostic (5.87e-3)"	"unprognostic (1.10e-1)"	"unprognostic (3.42e-1)"	"unprognostic (1.73e-1)"	"prognostic unfavorable (3.12e-8)"	"unprognostic (2.64e-1)"	"unprognostic (1.30e-2)"	"unprognostic (1.54e-1)"	"unprognostic (3.94e-2)"	"unprognostic (1.82e-1)"	"prognostic unfavorable (2.54e-5)"	"unprognostic (2.58e-2)"	"unprognostic (3.32e-1)"	"unprognostic (4.81e-2)"	"unprognostic (6.99e-3)"	8.1	10.2	2.6	9.2	3.4	90.9	5.6	1.1	7.6	5.6	2.4	4.9	6.0	7.4	3.6	8.5	7.3	7.2	11.4	3.2	2.7	6.8	5.7	6.7	6.7	4.3	4.4	6.1	16.0	9.3	10.2	4.3	4.1	6.3	3.8	3.4	8.3	4.0	38.5	10.3	4.7	6.0	0.2	7.6	6.3	10.9	3.7	4.7	5.5	9.7	6.1	9.3	5.7	4.6	38.9	50.8	13.2	28.6	10.0	11.6	28.9	24.2	14.4	24.2	18.7	55.6	35.0	42.3	30.4	15.1	21.6	48.7	36.3	28.0	16.3	23.1	44.2	32.8	19.5	43.6	16.5	51.7	41.5	12.2	38.6	59.9	54.6	27.0	13.7	23.5	47.7	27.4	14.0	50.8	35.0	33.0	57.0	20.4	34.0	38.1	18.0	42.1	16.8	21.4	17.7	37.9	19.2	18.1	24.1	10.4	43.7	26.5	18.2	16.1	27.9	36.5	76.4	55.7	52.7	48.6	23.2	64.9	17.9	0.4	11.2	6.9	2.7	13.6	3.3	3.9	1.6	2.2	6.2	4.2	2.5	2.8	26.7	1.9	16.9	5.0	1.2	6.0	2.6	3.4	1.1	7.6	3.2	2.7	4.3	4.4	4.1	0.2	3.7	4.6	8.8	35.3	31.1	5.9	18.5	23.5	14.2	5.1	25.0	5.8	12.7	9.9	11.6	7.2	21.5	14.7	41.7	5.2	7.7	10.6	0.0	8.7	7.2	17.1	10.6	10.6	21.5	7.2	15.1	8.7	7.5	13.5	27.0	20.1	41.7	12.9	3.9	8.9	11.5	5.0	9.5	13.8	4.1	12.5	7.1	4.8	3.7	30.3	7.2	2.8	12.3	1.9	3.1	5.0	4.4	8.5	6.4	2.6	31.8	17.1	3.7	6.8	24.6	12.7	0.0	19.4	6.7	10.6	20.6	22.7	19.6	9.2	11.0	13.5	11.5	13.6
RRP8	"KIAA0409, NML"	ENSG00000132275	"Ribosomal RNA processing 8"	O43159	11	6595072-6603616	"Metabolic proteins, Predicted intracellular proteins"	"rRNA processing, Transcription, Transcription regulation"	"Chromatin regulator, Methyltransferase, Repressor, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038487, HPA057562"	Approved		Supported	Nucleoplasm,Nucleoli,Cytosol		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Nucleoplasm, Nucleoli, Cytosol"		"HPA038487: AB_10672518, HPA057562: AB_2683468"	"unprognostic (9.01e-2)"	"unprognostic (5.84e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.10e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.72e-1)"	"prognostic unfavorable (3.10e-7)"	"unprognostic (4.64e-2)"	"unprognostic (2.48e-1)"	"unprognostic (2.79e-1)"	"unprognostic (1.41e-1)"	"unprognostic (6.23e-2)"	"unprognostic (3.81e-3)"	"unprognostic (2.71e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.87e-2)"	10.8	10.2	10.9	5.8	10.6	18.4	10.5	10.6	14.9	12.7	9.3	21.8	6.7	11.0	9.8	11.4	10.5	3.4	15.4	10.0	9.9	13.3	21.5	9.2	8.6	10.3	10.7	9.3	10.0	5.3	8.2	6.1	10.4	15.8	6.5	7.6	7.4	8.8	9.5	12.6	10.3	6.2	10.9	14.2	12.1	10.7	10.6	6.8	10.6	4.1	8.4	16.8	11.1	12.1	12.3	12.0	4.7	6.1	9.6	8.3	6.7	6.2	7.7	14.0	13.1	12.4	14.1	17.1	6.0	5.9	10.3	12.1	13.6	10.9	14.7	8.3	19.5	8.1	14.0	14.3	11.0	14.8	10.8	7.1	14.0	6.7	12.1	9.2	14.7	8.0	16.3	9.7	11.2	15.2	14.5	22.0	11.6	21.4	10.7	12.8	3.8	3.9	13.4	9.7	7.2	8.4	8.9	18.0	10.7	7.7	9.8	12.9	7.6	13.2	6.1	13.0	12.2	10.8	10.5	16.7	11.2	14.8	8.7	26.3	10.0	10.4	11.5	10.7	11.2	9.1	11.3	10.7	13.0	11.9	11.0	11.7	3.9	13.6	11.8	9.9	11.9	9.0	10.9	10.6	10.6	14.9	10.0	9.9	10.3	10.7	10.4	10.9	10.6	12.1	17.0	22.4	15.0	37.2	19.6	23.2	18.5	13.3	14.2	17.3	14.1	11.7	20.7	8.6	14.7	9.2	14.6	23.5	20.7	12.2	11.7	19.0	7.4	13.7	22.8	16.4	7.2	37.7	45.0	15.9	21.2	15.5	21.4	14.0	17.7	14.7	12.5	23.5	18.9	3.3	32.6	16.2	12.2	9.4	13.4	13.6	13.1	13.1	8.8	21.5	18.4	14.2	22.6	27.2	34.6	22.7	18.2	9.8	15.2	15.8	13.7	29.8	10.3	30.5	0.0	15.3	20.0	23.7	18.0	18.3	27.1	20.0	17.7	25.2	17.3	15.0
RRP9	"RNU3IP2, U3-55K"	ENSG00000114767	"Ribosomal RNA processing 9, U3 small nucleolar RNA binding protein"	O43818	3	51933429-51941904	"Predicted intracellular proteins"	"rRNA processing"	"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 66.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038798	Uncertain		Supported	Nucleoplasm		NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"HPA038798: AB_10672653"	"unprognostic (5.57e-2)"	"unprognostic (9.47e-2)"	"unprognostic (2.29e-1)"	"unprognostic (1.33e-2)"	"unprognostic (4.18e-2)"	"unprognostic (1.63e-1)"	"prognostic unfavorable (2.90e-5)"	"unprognostic (1.24e-1)"	"unprognostic (2.00e-1)"	"unprognostic (1.63e-1)"	"unprognostic (2.82e-2)"	"unprognostic (8.25e-3)"	"unprognostic (2.60e-3)"	"unprognostic (1.17e-1)"	"unprognostic (1.71e-1)"	"unprognostic (4.15e-2)"	"unprognostic (5.92e-2)"	20.5	20.1	9.8	13.7	10.7	12.4	17.3	9.9	12.1	17.1	8.2	13.2	10.9	16.4	5.3	17.7	15.8	6.8	14.5	10.4	9.8	17.7	16.2	13.9	15.7	10.1	10.0	15.8	14.2	10.4	10.5	9.1	9.5	14.6	7.6	5.6	11.6	9.0	28.9	17.8	12.5	9.1	9.3	14.6	13.1	10.8	10.5	9.2	12.6	13.2	10.5	19.1	15.5	10.6	35.8	50.0	23.5	56.2	33.8	18.8	59.5	38.4	20.9	63.7	40.3	85.5	39.6	102.7	15.9	27.3	86.5	32.3	81.9	59.4	25.5	47.1	35.8	69.5	30.6	77.5	67.9	76.6	55.6	39.0	43.0	80.1	75.3	15.5	24.9	35.8	67.0	25.2	28.5	56.7	65.3	76.2	92.6	54.7	126.9	39.7	26.7	78.6	31.4	52.1	28.9	34.1	34.8	38.5	38.8	20.0	20.1	49.2	24.1	44.3	59.4	111.0	160.8	43.0	75.6	96.2	39.5	94.2	71.4	2.1	9.1	0.5	16.4	13.2	17.5	16.4	14.1	14.5	17.0	13.5	10.9	13.2	0.6	18.8	6.5	18.0	12.5	10.0	9.8	10.7	9.9	12.1	10.4	9.8	10.1	10.0	9.5	9.3	10.5	10.6	9.2	0.0	10.5	3.6	15.2	66.8	27.1	29.7	13.1	12.9	11.2	10.3	4.1	10.0	14.0	5.5	4.2	26.8	14.8	8.3	15.6	24.3	8.1	11.2	12.7	12.7	8.4	7.2	1.9	13.4	40.5	12.6	9.7	9.3	15.2	14.4	5.0	7.0	23.4	16.8	1.3	7.2	22.4	5.3	13.4	6.6	8.7	8.7	21.4	1.0	12.9	10.6	16.5	2.0	1.6	20.0	10.3	9.1	11.6	34.2	6.2	22.2	11.9	10.7	6.6	15.6	36.7	8.0	23.8	15.0	50.4	16.7	12.5	16.4	18.9	14.6
RRS1	KIAA0112	ENSG00000179041	"Ribosome biogenesis regulator 1 homolog"	Q15050	8	66429014-66430733	"Predicted intracellular proteins"	"Ribosome biogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 70.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055549, HPA060937"	Approved		Supported	Nucleoli		NA	No			"Cluster 27: Non-specific - Gene expression"	"Cluster 59: Non-specific - Translation"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 32: Non-specific - Translation"	Nucleoli		"HPA055549: AB_2682846, HPA060937: AB_2684390"	"unprognostic (7.68e-2)"	"unprognostic (1.02e-1)"	"unprognostic (3.72e-2)"	"unprognostic (5.25e-2)"	"unprognostic (2.64e-1)"	"unprognostic (3.84e-3)"	"unprognostic (4.93e-3)"	"unprognostic (2.82e-3)"	"unprognostic (3.55e-1)"	"unprognostic (1.96e-2)"	"unprognostic (2.13e-2)"	"unprognostic (1.01e-2)"	"unprognostic (3.46e-2)"	"unprognostic (8.61e-2)"	"unprognostic (2.30e-1)"	"unprognostic (5.29e-2)"	"unprognostic (8.35e-3)"	18.6	14.6	9.8	12.0	9.9	6.5	14.4	9.1	8.9	14.3	10.3	15.5	8.2	19.2	3.8	18.3	16.6	3.6	16.7	8.1	8.5	14.0	14.9	9.8	10.2	14.5	9.9	17.2	41.0	6.0	6.2	5.9	9.9	10.9	5.2	4.4	11.4	6.9	50.0	16.9	12.0	7.4	9.7	13.1	19.0	5.1	11.4	6.5	8.4	14.5	9.5	18.6	13.8	8.6	68.2	83.7	16.9	35.7	17.8	14.3	27.2	41.7	18.3	31.6	23.3	37.7	43.8	91.3	14.2	22.1	44.6	62.5	41.7	47.5	34.7	50.6	70.2	72.8	25.4	67.8	26.3	43.6	37.2	18.9	37.7	34.9	46.1	12.9	20.8	27.5	64.7	37.6	23.3	78.6	87.3	79.2	109.5	76.0	97.2	18.4	21.6	38.3	44.8	54.9	23.0	50.6	20.4	33.4	48.9	17.4	57.6	38.5	36.0	58.5	53.4	49.5	97.5	67.1	64.7	69.8	27.2	68.0	40.4	0.0	13.1	1.0	14.1	17.5	24.8	9.3	17.6	16.5	22.7	8.8	16.1	18.8	0.4	17.3	12.1	10.6	14.2	10.2	9.8	9.9	9.1	8.9	8.1	8.5	14.5	9.9	9.9	9.7	11.4	8.6	8.6	32.1	16.2	3.6	10.0	70.0	42.9	17.9	20.5	9.7	11.8	9.9	29.6	8.6	18.3	12.9	12.5	21.2	13.1	7.1	11.7	28.7	0.2	6.9	16.4	14.6	6.7	13.2	1.5	28.3	23.1	13.6	11.7	8.9	7.6	11.5	12.5	14.8	20.3	6.7	2.8	13.4	8.2	12.2	11.9	1.0	19.0	9.8	23.2	0.0	15.6	8.6	26.8	0.5	2.0	22.1	9.5	17.3	8.7	37.9	3.4	30.0	9.6	13.1	19.7	28.9	21.6	6.2	16.8	19.6	59.8	38.6	20.1	17.9	22.1	30.6
RSAD2	"cig5, vig1, Viperin"	ENSG00000134321	"Radical S-adenosyl methionine domain containing 2"	Q8WXG1	2	6865557-6898239	"Predicted intracellular proteins"	"Antiviral defense, Host-virus interaction, Immunity, Innate immunity"	Lyase	Atherosclerosis	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"salivary gland: 21.0"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 35.6;Alveolar cells type 1: 35.3;Distal enterocytes: 72.3;Erythroid cells: 44.2;Paneth cells: 107.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"basophil: 30.7;eosinophil: 43.3;neutrophil: 25.2"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 43.3"	"Group enriched"	"Detected in some"	5	"BJ hTERT+ SV40 Large T+: 75.7;BJ hTERT+ SV40 Large T+ RasG12V: 117.6;HMC-1: 55.7"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"HPA041160, HPA049409"	Approved		Supported	"Nucleoli fibrillar center,Endoplasmic reticulum"		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Endoplasmic reticulum"	"Nucleoli fibrillar center"	"HPA041160: AB_10795489, HPA049409: AB_2680751"	"unprognostic (8.91e-2)"	"unprognostic (3.85e-2)"	"unprognostic (7.89e-2)"	"prognostic unfavorable (4.60e-4)"	"unprognostic (3.27e-1)"	"unprognostic (3.25e-1)"	"unprognostic (1.95e-1)"	"unprognostic (2.29e-1)"	"unprognostic (3.32e-2)"	"unprognostic (3.66e-3)"	"unprognostic (9.47e-3)"	"unprognostic (4.06e-2)"	"unprognostic (1.27e-2)"	"unprognostic (3.98e-2)"	"unprognostic (4.54e-3)"	"unprognostic (4.47e-2)"	"unprognostic (1.79e-1)"	4.2	2.3	2.9	4.0	3.7	13.7	3.0	2.1	3.7	6.5	4.6	5.2	3.6	2.1	2.1	1.5	2.8	5.5	5.7	2.7	2.7	2.7	3.5	8.3	2.9	5.1	3.1	2.1	1.5	1.1	3.9	6.6	4.7	1.7	3.0	1.1	21.0	1.9	5.7	0.8	2.9	4.5	11.8	10.1	6.3	2.0	3.0	7.4	1.8	7.6	1.8	2.5	1.4	3.3	0.2	0.0	0.2	0.1	0.0	0.5	0.9	0.0	1.2	75.7	117.6	0.0	2.5	1.1	0.1	0.0	11.6	1.2	0.0	0.0	0.2	0.2	0.0	17.8	0.1	0.0	0.1	0.0	55.7	0.1	0.0	5.7	0.0	0.0	0.0	2.6	1.6	1.0	0.0	0.1	7.0	1.5	0.2	0.0	0.4	0.3	0.0	0.1	0.1	1.1	0.1	0.3	0.1	0.1	3.6	0.0	0.1	0.4	0.0	0.0	0.0	0.1	0.0	1.4	1.5	0.0	0.1	1.2	0.4	30.7	4.9	43.3	2.3	7.5	2.8	0.3	2.6	2.2	2.7	0.4	3.7	3.0	25.2	2.5	7.0	0.3	1.3	2.7	2.9	3.7	2.1	3.7	2.7	2.7	5.1	3.1	4.7	11.8	3.0	3.3	35.6	35.3	3.9	3.9	1.5	0.5	3.3	2.4	1.2	0.8	1.0	0.6	5.2	2.8	3.2	0.0	2.1	0.6	1.9	72.3	0.0	3.8	1.3	19.2	3.1	21.7	9.0	44.2	12.6	6.2	0.8	3.8	34.7	16.1	23.5	8.3	8.9	0.6	9.5	0.0	13.2	2.6	6.1	1.6	2.2	1.1	1.5	8.5	0.0	21.5	7.0	6.3	6.2	17.1	0.9	7.7	107.7	2.2	1.7	4.1	1.7	0.1	13.4	0.7	0.0	2.5	2.8	0.4	0.5	1.2	0.3	2.9	3.6	1.7	1.0	7.4
RSBN1	"FLJ11220, ROSBIN"	ENSG00000081019	"Round spermatid basic protein 1"	Q5VWQ0	1	113761832-113812476	"Predicted intracellular proteins"		"Chromatin regulator, Dioxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042124, HPA049484"	Approved		Supported	"Nucleoplasm,Nuclear bodies,Vesicles"		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 14: REH - Unknown function"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm	"Nuclear bodies, Vesicles"	"HPA042124: AB_10794644, HPA049484: AB_2680787"	"unprognostic (3.26e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.15e-3)"	"unprognostic (2.13e-1)"	"unprognostic (3.66e-2)"	"unprognostic (2.30e-2)"	"unprognostic (5.06e-2)"	"unprognostic (6.60e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.97e-2)"	"unprognostic (1.56e-1)"	"unprognostic (3.96e-1)"	"unprognostic (1.51e-2)"	"unprognostic (4.67e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.15e-3)"	6.4	6.0	4.6	7.7	4.7	34.4	8.2	12.7	6.1	7.9	2.8	8.4	6.2	10.3	6.5	7.3	7.9	6.4	5.2	4.2	5.3	8.0	6.4	7.5	10.6	3.1	3.7	14.2	11.0	11.0	5.1	6.6	3.2	7.9	8.6	13.7	6.8	6.9	8.0	7.5	7.5	7.0	3.9	9.2	6.8	10.7	4.3	12.3	9.0	7.9	10.5	6.4	5.5	5.2	14.6	4.1	13.7	8.2	8.0	9.2	6.6	5.1	10.9	10.1	10.5	4.9	4.3	12.7	7.9	6.3	4.6	6.2	9.8	6.2	16.4	12.3	7.1	9.6	4.4	5.6	6.0	18.1	9.9	7.0	6.7	8.6	8.2	8.6	8.1	14.0	14.7	7.7	7.5	14.9	14.7	10.8	11.6	4.6	6.9	26.3	13.4	6.6	6.0	6.2	13.8	11.0	9.7	9.4	8.7	6.8	4.5	12.1	9.7	9.0	9.7	13.5	8.3	10.3	8.2	15.9	9.3	10.9	15.4	53.3	14.5	25.6	29.1	11.7	29.3	32.2	31.2	27.2	12.8	33.1	31.9	26.2	29.0	25.4	13.4	27.3	30.6	12.6	4.6	4.7	12.7	6.1	4.2	5.3	3.1	3.7	3.2	3.9	4.3	5.2	37.4	35.3	20.1	16.0	52.7	74.7	39.2	26.9	45.5	90.0	35.0	46.7	21.5	24.3	29.6	25.8	66.7	26.3	68.0	55.5	19.6	22.3	25.6	26.2	39.4	38.9	49.4	37.5	34.3	26.0	24.1	41.5	17.9	28.8	36.1	23.4	32.5	18.7	19.2	97.6	34.2	58.5	28.5	26.3	37.7	9.0	50.4	25.7	40.9	30.9	35.0	56.7	62.8	33.7	34.6	21.2	54.0	49.7	34.7	44.3	40.2	17.2	27.8	106.5	39.5	43.8	54.9	96.8	37.0	34.3	65.1	31.5	84.8	24.2	52.7	37.8
RSBN1L	"FLJ42526, FLJ45813, MGC71764"	ENSG00000187257	"Round spermatid basic protein 1 like"	Q6PCB5	7	77696459-77783022	"Cancer-related genes, Predicted intracellular proteins"		"Dioxygenase, Oxidoreductase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Rod photoreceptor cells: 349.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 60.6"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 60.6"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020406, HPA020413"	Approved		Supported	"Nuclear speckles,Plasma membrane"		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	"Nuclear speckles"	"Plasma membrane"	"HPA020406: AB_1856488, HPA020413: AB_2253910"	"unprognostic (2.02e-1)"	"unprognostic (2.61e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.34e-1)"	"unprognostic (3.62e-2)"	"unprognostic (2.43e-2)"	"prognostic favorable (3.74e-4)"	"unprognostic (1.27e-2)"	"unprognostic (3.78e-2)"	"unprognostic (1.25e-1)"	"unprognostic (9.02e-2)"	"unprognostic (7.30e-3)"	"unprognostic (1.93e-1)"	"unprognostic (1.46e-1)"	"unprognostic (2.25e-3)"	"unprognostic (1.53e-3)"	7.3	6.4	8.7	11.5	9.1	8.2	12.1	19.0	12.1	10.3	10.2	11.3	9.0	12.5	10.3	10.8	9.5	7.3	5.6	8.5	10.5	9.1	11.3	10.5	16.1	8.2	9.0	14.5	11.2	10.3	6.9	9.9	8.6	10.3	11.7	30.2	9.6	11.4	8.2	7.8	10.4	11.0	9.0	15.0	11.0	26.3	8.6	18.3	16.5	7.6	15.0	9.6	8.2	11.6	15.8	11.9	19.6	34.5	13.4	17.0	9.5	11.5	12.4	16.0	18.2	14.9	27.6	32.4	4.4	12.0	20.2	13.4	26.8	15.0	22.8	17.7	14.4	25.8	18.4	14.7	11.3	32.1	23.3	12.2	10.7	14.7	16.0	12.1	13.5	21.2	35.7	33.0	16.8	18.2	27.7	32.1	14.0	20.3	10.6	28.3	19.6	34.2	10.0	20.5	22.9	24.0	17.5	31.4	12.6	19.9	19.2	16.9	12.9	23.9	21.9	14.5	17.7	14.7	16.7	51.6	11.4	29.2	16.0	21.6	7.4	13.5	9.5	5.8	7.3	11.0	8.4	7.1	4.4	13.5	7.8	8.6	60.6	6.4	6.7	13.9	9.3	2.6	8.7	9.1	19.0	12.1	8.5	10.5	8.2	9.0	8.6	9.0	8.6	11.6	53.6	57.7	60.3	27.1	85.0	78.8	102.1	76.1	88.8	246.8	52.1	57.3	22.1	61.5	84.4	55.2	235.6	52.7	101.5	77.1	39.2	38.1	271.3	55.5	63.3	60.8	77.5	47.7	44.3	50.4	34.1	55.6	51.5	45.6	70.3	51.3	49.2	56.5	43.7	158.2	47.5	104.6	57.0	48.1	69.0	85.2	101.5	46.4	64.0	34.7	59.0	83.2	132.8	53.8	50.1	35.1	62.7	119.6	74.6	56.7	49.6	28.4	72.0	349.9	72.3	44.2	73.0	108.0	156.7	56.2	75.3	38.7	90.2	61.7	79.1	84.0
RSC1A1	RS1	ENSG00000215695	"Regulator of solute carriers 1"	Q92681	1	15659869-15661722	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027813, HPA028676"	Approved		Supported	"Nucleoplasm,Cell Junctions"		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Nucleoplasm	"Cell Junctions"	"HPA027813: AB_10600308, HPA028676: AB_10600895"																		3.0	1.5	0.1	2.6	0.3	4.1	1.9	0.4	1.1	1.3	1.1	1.4	0.5	1.9	0.3	4.2	1.9	1.9	3.0	0.4	0.0	4.6	8.3	2.3	2.9	0.6	0.0	1.9	1.1	2.9	0.5	3.2	0.6	2.0	2.0	2.4	0.2	1.4	0.2	0.8	1.4	3.7	0.3	0.8	1.3	2.4	0.6	2.0	2.4	4.9	4.1	2.2	1.0	1.7	4.1	4.7	5.7	3.8	6.9	4.8	7.5	3.4	5.6	9.2	8.5	7.8	6.5	9.2	3.2	7.6	4.6	2.8	14.9	4.8	11.2	6.0	3.8	8.5	9.1	8.4	1.6	12.6	4.2	3.8	0.0	15.8	8.7	2.2	5.9	6.1	23.6	8.3	6.8	4.1	6.7	0.0	6.2	2.4	2.7	5.6	8.0	3.8	2.2	7.5	4.6	1.9	6.3	2.9	4.9	4.8	4.0	1.1	5.8	4.7	8.5	4.2	2.5	2.6	5.2	15.6	1.9	3.4	3.4	0.0	0.4	0.1	0.1	0.9	0.4	0.3	0.1	0.6	0.9	0.0	0.2	0.1	0.0	0.4	0.0	0.2	0.7	0.5	0.1	0.3	0.4	1.1	0.4	0.0	0.6	0.0	0.6	0.3	0.6	1.7	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
RSPH1	"CILD24, FLJ32753, RSP44, RSPH10A, TSGA2"	ENSG00000160188	"Radial spoke head component 1"	Q8WYR4	21	42472486-42496246	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	Meiosis		"Ciliopathy, Disease variant, Primary ciliary dyskinesia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"fallopian tube: 161.5"	"Group enriched"	"Detected in many"	8	"Endometrial ciliated cells: 857.0;Respiratory ciliated cells: 1058.1"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 15.2"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	10	"plasmacytoid DC: 3.0"	"Lineage enriched"	"Detected in single"	10	"dendritic cells: 3.0"	"Group enriched"	"Detected in some"	4	"MCF7: 11.0;OE19: 39.0;RPTEC TERT1: 15.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016816, HPA017382"	Enhanced		Supported	Centrosome		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 21: OE19 - Mitochondria"	"Cluster 49: Ciliated cells - Cilium organization"	Centrosome		"HPA016816: AB_1858393, HPA017382: AB_1858392"	"unprognostic (1.76e-3)"	"unprognostic (2.34e-1)"	"unprognostic (3.02e-2)"	"unprognostic (1.12e-3)"	"unprognostic (5.48e-2)"	"unprognostic (2.43e-1)"	"unprognostic (7.59e-3)"	"unprognostic (1.97e-1)"	"unprognostic (2.53e-1)"	"unprognostic (1.46e-1)"	"unprognostic (4.37e-3)"	"unprognostic (2.77e-1)"	"unprognostic (1.10e-2)"	"unprognostic (8.41e-2)"	"unprognostic (2.58e-2)"	"unprognostic (5.22e-3)"	"unprognostic (1.99e-1)"	0.4	3.5	12.7	0.8	13.3	0.3	2.1	10.7	11.8	6.7	30.2	4.0	7.5	5.4	17.0	0.9	161.5	3.0	0.2	11.9	13.1	7.7	0.6	14.2	0.3	20.1	25.0	1.2	3.2	5.1	25.9	0.1	20.4	3.2	3.6	12.4	1.4	3.3	0.7	3.6	5.6	1.0	17.0	0.2	5.2	30.9	14.1	1.5	8.0	0.1	0.3	1.5	0.8	15.5	1.6	1.2	0.1	3.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	3.4	0.1	0.5	0.0	0.4	1.9	0.0	0.5	0.0	0.2	0.1	5.4	0.5	0.0	0.0	0.1	0.2	0.3	0.8	0.0	0.1	0.0	0.0	0.9	0.0	0.2	0.0	11.0	0.1	0.2	0.3	39.0	0.5	0.0	0.4	0.0	15.4	1.3	2.5	0.9	2.4	3.7	0.3	0.0	4.2	0.4	0.2	0.0	0.1	0.1	0.0	0.4	2.5	0.2	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.1	0.1	0.1	0.1	0.2	0.1	0.0	0.1	0.0	0.0	3.0	0.1	0.1	12.7	13.3	10.7	11.8	11.9	13.1	20.1	25.0	20.4	17.0	14.1	15.5	0.4	0.0	6.2	6.5	0.9	5.1	4.5	64.6	2.8	13.3	7.2	5.8	0.6	24.3	107.1	18.4	37.5	0.1	2.9	10.5	39.2	12.6	73.9	857.0	6.2	1.3	9.0	0.0	11.5	3.8	0.0	2.7	4.6	13.9	0.0	0.4	0.0	0.2	0.1	3.3	5.9	13.5	61.1	0.0	0.0	113.4	1.8	0.9	0.0	0.0	1.0	19.9	0.0	0.5	0.3	1.9	11.2	2.6	0.8	9.5	21.4	15.7	1058.1	28.1	0.0	0.9	23.9	79.3	16.8	0.7	4.5	0.8	1.3	2.1	10.6	6.4
RTCB	"C22orf28, FAAP, HSPC117"	ENSG00000100220	"RNA 2',3'-cyclic phosphate and 5'-OH ligase"	Q9Y3I0	22	32387582-32412248	"Enzymes, Predicted intracellular proteins"	"tRNA processing"	Ligase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000535, HPA001103"	Supported		Supported	Nucleoplasm,Vesicles,Cytosol		NA	NA		73000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Nucleoplasm	"Vesicles, Cytosol"	"HPA000535: AB_2666021, HPA001103: AB_1078351"	"unprognostic (1.84e-1)"	"unprognostic (6.48e-2)"	"unprognostic (1.07e-2)"	"unprognostic (2.71e-3)"	"unprognostic (7.21e-3)"	"unprognostic (1.43e-2)"	"unprognostic (1.75e-3)"	"unprognostic (1.49e-1)"	"unprognostic (3.01e-1)"	"unprognostic (1.52e-1)"	"unprognostic (2.40e-2)"	"unprognostic (5.07e-2)"	"prognostic favorable (4.25e-5)"	"unprognostic (6.91e-2)"	"unprognostic (5.35e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.55e-1)"	43.5	44.5	33.3	39.0	36.0	31.4	51.2	37.5	40.8	37.7	35.6	56.1	93.9	43.9	43.7	49.4	46.5	32.6	45.8	33.5	38.1	75.9	75.2	36.3	45.6	36.7	37.0	45.6	45.8	73.0	39.8	45.5	39.1	45.9	73.8	44.1	47.2	47.4	71.1	76.9	79.1	56.0	38.3	43.7	48.4	32.0	36.3	72.9	41.5	63.6	87.9	53.9	39.2	40.2	116.1	101.9	125.0	94.3	106.8	79.1	99.3	98.8	118.5	154.6	145.9	133.2	45.9	28.5	64.6	116.1	95.2	76.7	144.7	143.5	198.6	144.3	144.8	81.4	83.0	122.1	73.4	192.4	71.2	78.3	93.7	153.3	147.8	85.1	141.3	78.5	98.2	78.7	114.3	96.4	82.5	66.4	71.7	133.4	91.7	126.0	134.7	147.1	106.0	99.0	128.3	71.1	107.2	68.5	129.2	130.6	75.5	73.8	107.3	84.8	124.8	74.7	96.5	54.4	46.6	102.1	87.8	85.6	113.4	112.5	135.3	89.2	93.0	151.3	104.4	143.5	96.6	97.4	161.4	150.4	114.8	99.1	13.2	125.7	118.7	90.4	131.7	156.3	33.3	36.0	37.5	40.8	33.5	38.1	36.7	37.0	39.1	38.3	36.3	40.2	32.0	32.1	33.4	15.3	40.3	60.5	54.9	84.9	47.8	51.6	35.4	27.6	35.8	47.1	60.6	35.0	20.9	112.6	43.0	74.8	66.5	108.4	4.8	46.3	28.6	45.4	46.7	36.4	22.4	95.6	87.9	35.8	45.9	53.8	42.6	50.5	41.0	58.3	85.4	52.2	19.6	62.2	116.0	47.4	45.9	10.8	35.1	43.2	30.2	25.3	80.0	66.9	34.0	28.6	35.1	106.5	62.1	47.8	36.0	64.3	178.2	146.9	48.2	56.9	26.3	35.4	43.0	67.0	65.1	52.7	76.0	97.8	34.1	59.3	61.3	73.8
RTN3	"ASYIP, HAP, NSPL2, NSPLII, RTN3-A1"	ENSG00000133318	"Reticulon 3"	O95197	11	63681446-63759891	"Predicted intracellular proteins, Predicted membrane proteins"	"Apoptosis, ER-Golgi transport, Host-virus interaction, Stress response, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 514.5"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 1074.7"	"Group enriched"	"Detected in all"	6	"granulocytes: 1074.7;monocytes: 400.1"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015649, HPA015650"	Enhanced		Supported	"Endoplasmic reticulum"		NA	NA		130000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 65: Brain - Ion transport"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Endoplasmic reticulum"		"HPA015649: AB_1856498, HPA015650: AB_1856499"	"unprognostic (8.11e-3)"	"unprognostic (8.51e-2)"	"unprognostic (3.61e-2)"	"unprognostic (7.88e-3)"	"unprognostic (1.41e-1)"	"unprognostic (1.74e-2)"	"prognostic unfavorable (1.30e-6)"	"unprognostic (5.49e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.07e-2)"	"unprognostic (2.70e-2)"	"unprognostic (1.07e-1)"	"prognostic favorable (9.87e-4)"	"unprognostic (1.60e-2)"	"unprognostic (2.54e-1)"	"unprognostic (2.73e-2)"	"unprognostic (1.57e-2)"	207.5	81.8	361.4	54.1	412.2	108.5	93.3	338.4	514.5	87.6	190.7	88.1	54.0	62.5	81.2	55.7	88.5	56.3	57.4	428.4	378.9	92.8	87.5	77.8	36.0	404.5	309.1	48.1	91.1	109.9	81.0	62.2	417.2	53.3	79.9	194.4	138.8	76.1	70.2	103.7	65.2	80.1	329.2	51.7	57.0	46.6	334.0	53.7	175.5	43.7	48.5	55.7	54.2	384.0	157.5	113.8	134.0	128.4	242.3	170.9	53.4	139.3	147.5	120.5	128.4	99.6	338.1	184.2	231.7	210.0	115.7	157.2	194.0	68.7	157.5	149.5	103.5	236.5	151.3	70.4	201.1	212.8	182.4	113.5	199.2	146.7	162.3	200.7	165.2	158.9	136.2	290.1	107.4	129.2	113.4	235.2	156.7	127.3	127.3	148.4	93.8	342.9	239.7	87.5	282.7	164.0	226.2	245.3	271.5	95.4	271.1	172.7	155.2	71.3	95.6	251.1	108.4	183.4	169.9	145.6	274.7	173.8	77.2	441.0	400.1	487.7	41.4	187.6	44.8	28.6	41.6	41.3	130.8	19.4	30.1	32.7	1074.7	41.7	240.4	79.0	68.6	323.0	361.4	412.2	338.4	514.5	428.4	378.9	404.5	309.1	417.2	329.2	334.0	384.0	62.8	134.6	67.5	110.7	35.9	144.5	103.5	63.0	101.3	157.7	125.2	59.9	36.1	81.5	91.9	244.6	70.9	68.6	55.6	118.2	29.4	154.4	35.8	96.4	74.3	68.1	99.8	85.8	398.8	117.1	105.6	96.7	60.1	129.2	77.3	71.4	85.6	81.3	143.7	82.4	372.7	83.5	122.1	178.3	110.8	71.2	79.2	151.4	113.8	100.2	178.0	150.3	42.2	200.6	294.8	103.3	82.0	89.9	94.8	79.4	94.5	55.9	156.0	97.6	78.9	53.1	78.6	194.7	133.5	85.9	146.2	86.5	48.8	51.7	96.5	99.8
RTN4R	NOGOR	ENSG00000040608	"Reticulon 4 receptor"	Q9BZR6	22	20241415-20283246	"Disease related genes, Human disease related genes, Predicted membrane proteins"		Receptor	"Disease variant, Schizophrenia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 24.3;liver: 12.8"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 12.1;Excitatory neurons: 14.1;Muller glia cells: 11.3"	"Low cancer specificity"	"Detected in all"			"Group enriched"	"Detected in many"	10	"amygdala: 8.0;basal ganglia: 20.0;cerebellum: 20.9;cerebral cortex: 24.3;hippocampal formation: 12.7"	"Immune cell enhanced"	"Detected in many"		"MAIT T-cell: 10.8"	"Lineage enriched"	"Detected in many"	9	"T-cells: 10.8"	"Cell line enhanced"	"Detected in many"		"NB-4: 38.2;REH: 53.9;SCLC-21H: 31.3;SK-MEL-30: 25.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB012443			Supported	"Plasma membrane,Actin filaments,Focal adhesion sites"		NA	NA		1900000	"Cluster 16: MAIT-cells - Unknown function"	"Cluster 6: Brain - Smell perception"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 56: Bipolar cells - Visual perception"	"Plasma membrane, Focal adhesion sites"	"Actin filaments"	"CAB012443: "	"unprognostic (1.28e-1)"	"unprognostic (1.28e-2)"	"unprognostic (8.29e-2)"	"unprognostic (6.58e-2)"	"unprognostic (3.49e-1)"	"prognostic unfavorable (7.73e-4)"	"unprognostic (2.19e-1)"	"unprognostic (1.56e-1)"	"unprognostic (3.44e-1)"	"unprognostic (8.90e-3)"	"unprognostic (1.21e-2)"	"unprognostic (9.89e-2)"	"unprognostic (1.80e-2)"	"unprognostic (1.34e-2)"	"unprognostic (1.30e-1)"	"unprognostic (5.02e-2)"	"unprognostic (3.07e-1)"	1.6	2.6	8.0	0.5	20.0	0.6	1.0	20.9	24.3	3.6	0.0	1.6	2.2	5.1	0.0	3.5	1.9	0.1	2.7	12.7	0.0	2.1	12.8	2.2	0.4	0.5	0.0	2.4	3.7	0.4	4.9	0.4	0.3	1.5	0.1	0.6	2.0	0.4	0.6	7.9	2.1	0.2	0.0	8.5	1.8	1.9	0.4	0.8	3.5	0.2	0.2	0.5	2.8	1.8	7.9	3.8	2.3	5.5	0.0	0.0	1.2	0.8	0.0	0.6	0.3	6.0	2.2	0.4	2.5	0.1	3.7	12.8	1.4	3.2	0.0	0.2	13.4	0.1	3.2	0.9	1.3	0.3	0.4	0.0	4.1	0.0	0.3	0.0	0.0	3.7	0.4	0.3	0.0	11.0	4.1	38.2	8.7	2.3	6.7	53.9	0.0	0.4	0.5	3.3	31.3	5.0	3.7	2.7	25.9	0.5	3.1	1.1	0.0	0.5	14.2	0.1	0.2	0.1	1.0	0.9	0.4	7.8	0.1	0.0	0.0	0.0	4.6	0.0	10.8	0.0	4.0	4.6	0.2	0.1	2.4	5.1	0.0	0.8	0.0	1.2	3.0	1.7	8.0	20.0	20.9	24.3	12.7	0.0	0.5	0.0	0.3	0.0	0.4	1.8	1.4	3.2	0.0	7.5	0.2	5.1	4.0	1.6	1.8	12.1	2.9	2.4	2.2	0.0	0.6	0.0	4.2	0.2	1.9	3.0	0.0	2.9	2.0	1.2	4.8	2.0	0.0	0.4	14.1	4.3	7.6	1.6	0.0	1.6	0.0	0.4	1.1	3.0	1.3	6.7	2.6	2.6	0.0	0.0	0.7	0.5	0.3	1.7	1.8	2.8	0.7	11.3	2.1	2.5	2.4	3.4	0.4	0.0	0.1	3.9	0.6	0.0	0.0	4.9	0.0	0.2	1.0	0.1	1.2	2.0	5.5	0.0	2.5	0.1	2.1	3.5
RTN4RL1	"DKFZp547J144, NgR3, NGRH2"	ENSG00000185924	"Reticulon 4 receptor like 1"	Q86UN2	17	1934677-2025334	"Predicted intracellular proteins"		Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 12.3"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 20.6;Cone photoreceptor cells: 37.5;Excitatory neurons: 43.5;Horizontal cells: 33.7;Inhibitory neurons: 18.6"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"hippocampal formation: 12.3"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"fHDF/TERT166: 10.9;HaCaT: 10.8;hTCEpi: 10.1;T-47d: 13.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044428	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Actin filaments,Midbody"	"Intracellular and membrane"	Yes	NA		35000		"Cluster 27: Brain & Skin - Unknown function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Actin filaments"	"Nucleoplasm, Plasma membrane, Midbody"	"HPA044428: AB_10963229"	"unprognostic (5.23e-1)"	"unprognostic (3.52e-2)"	"unprognostic (2.06e-1)"	"unprognostic (2.12e-1)"	"unprognostic (2.93e-2)"	"unprognostic (7.25e-2)"	"unprognostic (2.61e-3)"	"unprognostic (1.17e-1)"	"unprognostic (8.97e-3)"	"unprognostic (6.21e-2)"	"unprognostic (2.55e-3)"	"unprognostic (6.32e-3)"	"prognostic unfavorable (7.69e-4)"	"unprognostic (3.86e-2)"	"unprognostic (1.05e-1)"	"unprognostic (7.01e-2)"	"unprognostic (3.15e-2)"	4.0	3.1	4.6	0.3	4.0	0.0	6.4	0.0	9.2	2.1	0.0	0.4	0.1	0.8	0.2	1.3	1.5	0.6	2.3	12.3	0.3	1.6	2.6	1.6	0.1	0.0	0.5	0.9	1.8	1.3	5.9	0.3	0.0	3.4	0.1	8.5	4.4	2.0	1.8	9.6	0.5	0.3	0.0	1.1	0.7	0.8	1.9	0.2	1.4	0.4	0.1	1.5	2.2	0.0	1.4	1.6	1.8	2.5	2.0	0.3	0.0	0.1	1.1	0.3	0.0	0.0	0.0	0.0	0.1	10.9	0.2	10.8	4.6	0.1	0.1	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.9	10.1	0.0	3.6	0.0	0.0	2.5	0.1	0.0	0.1	0.5	0.0	0.0	0.3	0.0	0.3	0.8	0.3	1.2	0.0	0.0	2.2	0.0	0.3	0.8	1.7	0.2	13.3	0.1	0.0	0.0	0.2	0.5	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	4.0	0.0	9.2	12.3	0.3	0.0	0.5	0.0	0.0	1.9	0.0	1.0	0.0	2.2	1.6	0.1	2.7	0.2	0.0	1.8	20.6	5.4	4.3	3.0	1.5	1.3	3.7	37.5	0.0	0.1	0.0	0.0	0.6	0.3	0.0	0.0	0.7	0.0	0.0	43.5	0.0	0.0	0.4	0.0	0.0	0.0	0.0	6.1	3.3	1.8	33.7	18.6	0.0	0.0	0.3	0.4	1.1	0.0	0.1	3.6	7.5	0.0	1.8	0.0	8.5	1.7	0.1	0.0	0.0	0.1	0.9	0.0	0.1	1.5	10.0	0.0	0.0	0.6	0.0	0.2	0.5	2.8	0.0	0.2	0.0	0.0	0.3
RTP4	"IFRG28, Z3CXXC4"	ENSG00000136514	"Receptor transporter protein 4"	Q96DX8	3	187368385-187372076	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 33.2;Ductal cells: 46.4;Urothelial cells: 52.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 10.9;GAMG: 14.2;HDLM-2: 12.3;Karpas-707: 9.7;REH: 9.9;SK-MEL-30: 19.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA064887, HPA071189"	Uncertain		Supported	Nucleoplasm		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 9: Intestine - Unknown function"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 22: Epithelial cell types - Mixed function"	Nucleoplasm		"HPA064887: AB_2685383, HPA071189: AB_2686357"	"unprognostic (1.45e-2)"	"unprognostic (2.46e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.44e-2)"	"unprognostic (6.35e-2)"	"unprognostic (3.24e-1)"	"unprognostic (2.32e-1)"	"unprognostic (3.78e-1)"	"unprognostic (1.18e-1)"	"unprognostic (6.87e-2)"	"prognostic unfavorable (6.83e-4)"	"unprognostic (1.34e-1)"	"unprognostic (5.49e-2)"	"unprognostic (3.44e-2)"	"unprognostic (2.95e-2)"	"prognostic favorable (4.35e-4)"	"prognostic favorable (1.45e-4)"	2.1	2.7	2.4	5.1	2.5	1.1	6.0	2.3	3.0	4.8	2.0	5.9	9.1	4.3	3.2	1.9	10.8	6.2	3.2	2.1	2.4	4.4	6.1	7.0	8.1	3.1	2.4	4.0	2.5	0.6	1.1	2.2	2.8	4.0	6.0	0.2	10.7	5.2	1.0	2.4	8.2	4.5	3.5	8.5	8.1	1.0	2.5	9.2	1.9	2.3	5.8	8.2	2.7	2.7	3.1	0.0	0.0	0.0	1.4	4.9	0.1	0.0	1.2	2.0	1.8	0.0	10.9	1.4	0.0	1.3	14.2	3.6	0.0	0.1	0.0	12.3	0.0	0.0	0.0	0.1	1.8	0.0	2.7	1.2	0.0	0.4	0.0	0.4	0.4	0.3	0.0	9.7	0.0	0.0	7.3	0.0	0.0	0.0	0.0	9.9	0.0	8.0	2.6	7.9	0.0	0.0	0.0	0.2	19.7	0.1	0.0	4.9	0.2	0.1	0.2	0.0	0.1	7.8	2.6	0.1	0.0	2.7	6.0	7.0	8.3	5.9	11.5	10.2	11.5	6.2	9.1	10.5	7.1	5.3	6.9	8.2	2.3	14.9	13.2	0.2	19.8	6.7	2.4	2.5	2.3	3.0	2.1	2.4	3.1	2.4	2.8	3.5	2.5	2.7	7.4	6.4	4.5	0.3	4.3	1.7	33.2	10.5	1.8	0.0	4.0	5.5	0.7	11.5	11.3	5.5	0.0	0.1	4.2	6.0	15.6	46.4	0.0	13.6	4.3	9.6	9.1	0.4	0.0	9.8	0.5	4.2	10.7	6.1	1.3	1.6	10.8	4.5	5.5	0.0	0.1	9.6	6.1	7.8	2.5	0.0	2.1	6.4	1.8	1.9	8.9	3.7	25.7	1.0	0.7	16.9	9.4	4.9	2.0	12.9	17.9	3.1	24.6	0.1	0.0	1.3	3.0	0.1	0.1	1.3	1.3	0.3	8.3	12.0	7.8	52.6
RTRAF	"C14orf166, CGI-99, CLE, CLE7, hCLE1, LCRP369, RLLM1"	ENSG00000087302	"RNA transcription, translation and transport factor"	Q9Y224	14	51989514-52010694	"Predicted intracellular proteins"	"Host-virus interaction, Transcription, Transcription regulation"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 316.0;Distal tubular cells: 309.1;Exocrine glandular cells: 289.7;Extravillous trophoblasts: 349.6;Proximal tubular cells: 303.7;Syncytiotrophoblasts: 261.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039824	Supported		Supported	Nucleoplasm		NA	NA		48000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm		"HPA039824: AB_10793922"	"unprognostic (2.99e-2)"	"unprognostic (2.90e-1)"	"unprognostic (7.89e-2)"	"unprognostic (2.28e-2)"	"unprognostic (1.53e-1)"	"unprognostic (6.08e-2)"	"unprognostic (1.66e-3)"	"unprognostic (1.46e-1)"	"unprognostic (2.23e-2)"	"unprognostic (6.50e-2)"	"unprognostic (2.80e-1)"	"unprognostic (2.07e-1)"	"unprognostic (2.31e-2)"	"unprognostic (3.34e-1)"	"unprognostic (5.03e-2)"	"unprognostic (5.74e-2)"	"unprognostic (1.99e-1)"	92.9	92.7	47.2	73.7	48.9	138.9	87.2	50.8	60.3	69.3	52.5	93.5	61.3	71.1	87.0	79.1	64.5	67.8	151.6	46.6	50.9	77.3	78.9	64.0	105.5	50.4	48.6	96.5	114.0	74.1	65.6	68.2	49.4	66.6	88.7	56.3	76.8	58.7	155.8	79.6	67.3	76.9	51.4	61.2	98.9	142.2	49.0	107.0	81.2	102.2	105.3	87.9	62.8	54.6	214.6	142.1	239.8	233.7	157.7	208.3	228.8	166.9	183.6	180.9	203.1	153.2	184.0	290.8	174.0	139.5	142.2	167.1	226.2	152.6	234.7	158.0	126.5	113.3	287.8	206.7	252.1	243.8	125.0	158.5	155.6	136.6	223.5	210.1	207.2	269.6	118.8	135.1	177.3	237.6	310.8	306.3	187.1	247.8	238.1	278.6	228.0	138.0	176.1	245.2	169.0	171.6	211.0	376.7	274.7	301.3	252.8	190.4	146.0	196.6	216.4	167.2	212.7	50.5	76.2	295.7	96.9	189.3	228.7	54.8	93.3	58.7	73.5	104.7	91.1	108.8	102.0	88.6	117.6	90.9	93.2	95.2	19.2	96.1	112.5	107.9	144.0	126.6	47.2	48.9	50.8	60.3	46.6	50.9	50.4	48.6	49.4	51.4	49.0	54.6	168.6	44.8	67.2	0.0	39.2	0.0	0.0	0.0	0.0	0.0	181.7	232.8	0.0	0.0	39.0	73.5	0.0	316.0	83.1	0.0	309.1	226.6	0.0	164.3	108.1	77.5	0.0	0.0	0.0	289.7	349.6	77.4	0.0	103.6	61.8	242.8	0.0	0.0	240.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	75.5	0.0	0.0	154.5	0.0	0.0	0.0	0.0	232.4	0.0	0.0	13.0	0.0	0.0	303.7	49.6	0.0	0.0	0.0	95.2	0.0	0.0	0.0	0.0	261.6	53.6	233.9	0.0	0.0
RTTN	DKFZP434G145	ENSG00000176225	Rotatin	Q86VV8	18	70003031-70205726	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		"Developmental protein"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Microglial cells: 69.3;Oligodendrocyte precursor cells: 48.7;Oligodendrocytes: 110.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in all"		"hTERT-HME1: 21.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA041343, HPA041967, HPA075089"	Uncertain		Approved	Centrosome,Cytosol		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 20: Retina & Lymphoid tissues - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Cytosol	Centrosome	"HPA041343: AB_10794409, HPA041967: AB_10796790, HPA075089: "	"unprognostic (1.76e-1)"	"unprognostic (2.13e-1)"	"unprognostic (1.36e-1)"	"unprognostic (4.11e-2)"	"unprognostic (3.44e-2)"	"unprognostic (6.16e-3)"	"unprognostic (4.63e-3)"	"unprognostic (2.36e-1)"	"unprognostic (1.40e-1)"	"unprognostic (4.66e-2)"	"unprognostic (1.90e-1)"	"unprognostic (8.25e-2)"	"unprognostic (6.94e-3)"	"unprognostic (1.07e-1)"	"unprognostic (3.81e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.96e-2)"	1.4	1.2	3.5	1.6	5.0	3.1	2.1	3.6	3.4	1.5	2.1	1.3	1.1	1.8	1.5	1.1	1.6	1.2	2.8	2.6	3.0	2.3	2.7	1.6	2.2	4.5	4.0	2.7	1.8	1.7	0.8	1.6	5.1	1.1	1.5	4.1	1.3	0.6	1.8	1.3	1.3	1.0	4.2	2.0	1.3	3.3	6.0	3.6	0.9	1.1	1.9	0.9	1.1	7.1	4.4	6.6	9.4	2.7	1.8	2.0	3.9	7.5	3.4	6.8	7.0	2.5	2.5	3.8	1.0	4.7	6.0	5.4	6.9	11.0	11.1	13.1	3.0	4.1	5.9	3.1	1.3	7.7	4.0	1.6	10.9	7.2	21.2	3.1	4.2	5.8	4.3	8.4	6.1	2.0	7.4	2.1	1.8	1.0	5.8	6.0	8.6	3.9	1.1	3.2	4.0	4.3	4.6	2.6	2.8	6.2	2.8	4.4	3.4	8.8	2.3	3.1	5.7	4.1	3.8	7.8	5.1	4.9	6.0	0.2	0.2	0.1	0.2	0.0	0.4	0.6	0.4	0.3	0.0	0.2	0.6	0.3	0.1	0.3	0.0	0.2	0.3	0.1	3.5	5.0	3.6	3.4	2.6	3.0	4.5	4.0	5.1	4.2	6.0	7.1	6.1	0.0	8.6	19.6	7.1	1.5	1.7	10.1	1.8	8.2	3.9	3.9	5.0	1.5	5.7	0.0	0.0	4.0	4.9	2.9	0.0	1.1	10.6	6.0	5.2	3.4	0.0	4.2	25.4	1.6	1.9	4.0	6.1	6.0	5.1	10.9	1.8	3.7	2.3	16.8	25.8	1.5	2.0	1.3	1.4	3.2	2.1	3.3	0.0	69.3	1.3	1.9	3.1	48.7	110.8	2.0	2.4	1.9	14.7	1.1	2.2	4.1	1.7	9.7	13.1	5.1	4.0	10.6	6.7	3.5	1.7	3.0	5.8	2.5	2.6	2.3
RUBCN	"KIAA0226, rubicon, rundataxin"	ENSG00000145016	"Rubicon autophagy regulator"	Q92622	3	197668867-197749727	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Autophagy, Endocytosis, Immunity, Phagocytosis"		Neurodegeneration	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"monocytes: 67.5;Plasma cells: 48.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Karpas-707: 87.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA050908, HPA054497"	Approved		Supported	Vesicles,Cytosol		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 65: Plasmacytoid DCs - Unknown function"	"Vesicles, Cytosol"		"HPA050908: , HPA054497: AB_2682507"	"unprognostic (2.91e-2)"	"unprognostic (1.61e-2)"	"prognostic unfavorable (6.65e-4)"	"unprognostic (1.34e-3)"	"unprognostic (1.46e-1)"	"unprognostic (1.20e-2)"	"prognostic unfavorable (9.91e-5)"	"unprognostic (1.99e-1)"	"unprognostic (6.71e-2)"	"unprognostic (2.86e-2)"	"unprognostic (1.71e-1)"	"prognostic unfavorable (1.62e-4)"	"unprognostic (2.22e-2)"	"unprognostic (2.92e-2)"	"unprognostic (1.75e-1)"	"unprognostic (2.43e-1)"	"unprognostic (1.23e-1)"	8.3	7.5	16.2	11.6	16.3	8.5	7.2	10.5	17.0	9.2	4.4	10.4	7.3	8.8	4.0	12.0	8.5	7.2	11.4	17.0	19.0	7.7	5.6	11.8	15.3	20.0	17.8	10.7	9.1	6.8	15.8	5.8	15.9	7.4	5.7	10.9	7.3	7.2	8.9	9.1	13.1	7.8	14.5	19.2	8.1	14.6	23.7	8.8	7.1	8.1	16.1	8.9	8.4	17.4	30.9	7.4	8.2	16.2	14.4	8.3	8.6	13.8	9.2	17.0	14.2	12.7	8.4	33.6	26.7	15.8	16.1	17.0	15.0	8.0	13.6	9.3	13.9	21.6	13.4	4.9	8.4	12.0	18.0	7.0	9.6	14.8	17.6	7.9	10.7	14.4	12.3	87.7	11.5	24.4	15.7	7.5	7.1	8.8	23.2	14.9	8.6	22.6	9.6	13.9	34.3	7.9	10.2	19.8	10.8	5.5	29.2	8.1	13.7	9.9	9.9	27.8	18.9	36.5	34.2	27.0	13.6	22.4	8.7	0.8	2.6	17.5	3.7	3.9	2.4	7.7	3.1	4.7	1.6	8.5	2.2	3.2	2.9	1.8	4.8	16.6	4.4	1.7	16.2	16.3	10.5	17.0	17.0	19.0	20.0	17.8	15.9	14.5	23.7	17.4	8.5	6.4	11.2	0.0	33.9	0.0	6.0	0.0	8.0	21.0	7.3	7.0	0.0	7.2	4.3	12.9	18.8	1.8	28.9	3.8	1.9	5.8	21.7	4.8	6.2	6.7	0.0	5.7	0.0	6.4	3.7	4.8	7.1	9.8	2.5	6.1	9.3	3.5	9.2	21.9	0.0	3.7	0.0	16.3	0.0	16.4	5.0	18.7	0.0	0.0	67.5	15.0	14.4	0.0	0.0	8.5	1.5	6.4	48.3	8.9	5.8	2.7	0.7	14.3	6.6	9.7	6.8	34.1	21.3	5.6	0.0	6.4	15.9	4.9	2.8	12.3
RUFY1	"FLJ22251, RABIP4, ZFYVE12"	ENSG00000176783	"RUN and FYVE domain containing 1"	Q96T51	5	179550554-179610012	"Plasma proteins, Predicted intracellular proteins"	"Endocytosis, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Macrophages: 137.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038804	Approved		Supported	"Nuclear speckles,Vesicles,Cytosol"		NA	NA		25000	"Cluster 41: Basophils - Cellular respiration"	"Cluster 72: Non-specific - Transcription"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 51: Myeloid cells - Hemostasis"	"Vesicles, Cytosol"	"Nuclear speckles"	"HPA038804: AB_10673290"	"unprognostic (3.17e-2)"	"unprognostic (2.82e-1)"	"unprognostic (9.24e-2)"	"unprognostic (2.50e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.96e-1)"	"unprognostic (2.04e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.21e-1)"	"unprognostic (9.74e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.73e-2)"	"unprognostic (3.60e-1)"	"unprognostic (2.08e-1)"	"unprognostic (2.55e-1)"	"unprognostic (5.85e-2)"	28.2	33.1	9.6	13.4	10.5	13.3	26.1	9.8	10.2	27.2	11.3	29.1	9.4	27.5	8.1	33.9	24.5	8.8	20.4	9.5	10.1	24.1	21.3	26.6	14.2	10.2	10.0	23.9	24.4	13.5	22.7	9.0	10.1	22.4	8.2	7.4	25.8	8.6	33.8	33.1	25.9	7.8	9.9	35.2	24.2	10.9	10.0	13.6	24.7	10.1	11.5	26.3	27.2	10.6	13.9	22.5	11.8	15.7	22.3	18.2	13.4	24.2	17.2	14.1	16.3	22.0	31.6	22.4	13.4	29.6	16.2	12.6	21.9	31.6	16.4	71.2	16.6	39.2	17.1	16.0	22.8	22.0	20.7	18.5	17.1	9.5	27.0	24.6	15.5	12.5	16.2	20.8	12.7	42.0	23.5	15.2	12.6	15.0	10.5	20.9	8.4	20.9	23.5	22.4	11.7	16.7	35.4	22.5	13.2	14.8	18.0	26.6	18.8	18.3	6.2	10.0	19.3	12.8	21.2	39.8	16.9	39.0	17.2	14.9	4.8	11.9	2.2	5.1	1.3	3.8	2.7	2.3	4.2	5.7	1.9	2.4	7.9	1.8	7.1	4.8	4.5	29.8	9.6	10.5	9.8	10.2	9.5	10.1	10.2	10.0	10.1	9.9	10.0	10.6	19.8	35.3	30.8	30.0	23.6	10.3	11.5	11.7	16.5	9.3	17.8	17.5	22.8	28.6	23.1	14.7	20.9	21.7	15.7	20.0	9.8	19.7	8.0	28.2	21.9	20.9	10.8	27.7	31.8	14.4	15.8	19.7	19.9	20.0	29.8	20.4	12.5	14.1	31.1	11.8	28.4	17.5	8.2	30.7	21.0	3.4	23.0	137.2	10.6	21.5	43.7	11.9	15.5	23.1	33.9	22.1	18.5	27.1	18.3	14.2	14.1	34.0	32.8	12.0	6.6	20.8	17.8	11.1	8.4	21.9	11.4	21.2	19.5	25.0	15.3	10.2
RUFY3	"KIAA0871, RIPx, Singar1, ZFYVE30"	ENSG00000018189	"RUN and FYVE domain containing 3"	Q7L099	4	70704204-70808619	"Predicted intracellular proteins"	"Differentiation, Neurogenesis"	"Developmental protein"	Oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"retina: 120.3"	"Cell type enhanced"	"Detected in all"		"Astrocytes: 189.4;Cone photoreceptor cells: 264.8;Excitatory neurons: 192.9;Oligodendrocytes: 197.8;Rod photoreceptor cells: 198.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022952, HPA022970"	Enhanced		Supported	Cytosol		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 77: Retina - Visual perception"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 9: Photoreceptor cells - Phototransduction"	Cytosol		"HPA022952: AB_2671005, HPA022970: AB_1856307"	"unprognostic (4.33e-2)"	"unprognostic (1.60e-2)"	"unprognostic (1.30e-1)"	"unprognostic (3.96e-3)"	"unprognostic (1.38e-1)"	"prognostic favorable (1.28e-4)"	"prognostic unfavorable (8.95e-4)"	"unprognostic (1.69e-2)"	"unprognostic (2.00e-1)"	"unprognostic (3.50e-2)"	"prognostic favorable (8.02e-5)"	"unprognostic (7.90e-3)"	"unprognostic (1.31e-3)"	"unprognostic (1.26e-1)"	"unprognostic (1.21e-2)"	"unprognostic (7.45e-3)"	"unprognostic (5.41e-1)"	19.4	34.8	57.1	18.2	63.7	11.6	18.7	63.3	77.0	28.6	27.6	18.9	12.0	29.4	23.3	24.4	18.0	17.7	16.0	63.8	72.0	22.1	22.2	21.9	21.7	77.1	63.0	35.8	19.2	8.2	41.1	17.5	81.5	19.2	16.0	120.3	18.9	15.6	25.6	46.5	15.0	20.8	61.4	25.4	19.1	39.0	63.6	32.5	45.7	11.7	17.3	19.9	25.7	99.3	8.5	5.8	67.0	15.9	30.8	35.2	26.6	26.6	10.2	8.5	9.4	9.9	20.2	33.2	10.8	22.4	19.1	8.4	10.3	11.8	13.6	18.2	13.4	7.2	8.4	11.6	18.0	8.4	4.3	24.7	18.0	11.4	13.3	39.5	18.3	35.4	20.2	32.9	18.8	10.4	52.8	9.6	16.1	14.7	7.3	12.8	21.0	15.2	16.7	8.0	61.7	30.6	9.7	17.0	16.2	25.8	11.7	4.2	15.7	28.8	20.0	8.8	6.2	37.2	18.0	35.7	29.4	6.1	6.0	0.6	3.4	0.3	1.5	4.8	1.9	3.5	1.2	1.3	4.9	2.6	1.2	1.3	0.1	2.6	4.9	6.6	0.5	0.8	57.1	63.7	63.3	77.0	63.8	72.0	77.1	63.0	81.5	61.4	63.6	99.3	31.9	35.3	82.1	189.4	18.7	19.4	23.3	9.9	15.9	126.9	22.1	11.8	19.3	12.8	30.6	23.9	264.8	15.0	19.5	7.5	7.9	14.7	70.0	32.9	63.6	32.6	15.0	7.4	192.9	21.1	7.0	43.7	23.4	36.0	21.0	53.1	32.9	25.7	10.5	139.7	175.0	8.4	14.2	37.3	36.4	122.5	47.2	31.0	42.7	72.1	67.0	43.9	13.4	136.7	197.8	19.1	5.2	50.8	17.2	40.2	11.6	19.6	28.3	198.6	26.3	53.2	35.9	14.8	27.6	36.7	28.8	7.7	11.5	40.9	10.1	19.3
RUNX1T1	"AML1T1, CBFA2T1, CDR, ETO, MTG8, ZMYND2"	ENSG00000079102	"RUNX1 partner transcriptional co-repressor 1"	Q06455	8	91954967-92103286	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	11	"brain: 93.1"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 142.1;Excitatory neurons: 196.9;Hepatic stellate cells: 124.2;Inhibitory neurons: 326.3;Oligodendrocyte precursor cells: 262.4"	"Low cancer specificity"	"Detected in some"			"Region enriched"	"Detected in all"	7	"cerebellum: 93.1"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"Daudi: 19.6;fHDF/TERT166: 16.5;HEL: 35.9;HSkMC: 13.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049852, HPA070951"	Approved		Supported	Nucleoplasm		NA	NA				"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 36: HEL - Hemostasis"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm		"HPA049852: AB_2680914, HPA070951: AB_2686326"	"unprognostic (2.37e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.90e-1)"	"unprognostic (2.35e-1)"	"unprognostic (1.62e-1)"	"unprognostic (3.37e-4)"	"unprognostic (2.29e-4)"	"unprognostic (5.56e-3)"	"unprognostic (1.24e-2)"	"unprognostic (1.62e-2)"	"unprognostic (2.11e-2)"	"unprognostic (2.37e-1)"	"unprognostic (5.70e-4)"	"unprognostic (8.98e-3)"	"unprognostic (6.78e-2)"	"unprognostic (1.51e-1)"	"unprognostic (7.80e-3)"	7.0	2.8	9.4	2.1	13.2	0.2	5.1	93.1	8.7	8.4	0.0	6.5	1.2	7.4	3.6	2.5	4.7	5.0	8.2	13.1	2.3	1.4	0.6	3.8	1.3	1.4	12.8	4.7	1.0	1.0	3.0	5.8	4.6	2.5	2.4	5.2	3.1	2.4	3.9	2.4	2.5	6.5	4.2	1.9	2.7	3.6	3.6	0.5	3.7	4.8	1.1	3.8	3.9	1.2	0.0	0.0	0.4	1.9	5.0	7.2	0.0	7.6	11.6	5.0	7.6	0.0	0.0	19.6	0.0	16.5	0.0	0.0	4.0	0.5	3.3	0.0	3.2	35.9	0.0	0.0	1.9	0.0	0.0	13.6	0.0	8.4	0.4	0.0	10.8	0.0	0.1	0.0	1.3	0.0	0.0	0.0	2.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	11.1	6.0	0.0	0.0	0.0	7.8	0.0	0.0	1.2	0.4	0.0	0.9	0.0	3.8	0.0	6.3	0.7	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.4	13.2	93.1	8.7	13.1	2.3	1.4	12.8	4.6	4.2	3.6	1.2	44.9	0.0	1.1	90.8	0.1	6.2	0.2	0.0	0.6	142.1	1.2	5.1	46.0	0.0	0.6	0.0	16.7	1.1	0.5	0.2	1.9	0.0	2.6	1.1	65.8	64.3	47.7	2.7	196.9	0.2	0.3	77.7	0.5	1.1	1.3	2.1	124.2	1.5	1.9	35.3	326.3	0.6	0.0	4.1	9.4	7.5	96.3	1.2	10.6	103.0	0.0	3.9	0.0	262.4	17.3	0.2	0.0	98.9	0.0	0.3	0.0	0.1	0.0	7.2	65.7	24.4	43.1	3.3	16.8	0.9	4.8	1.1	1.1	20.7	0.0	0.1
RUNX3	"AML2, CBFA3, PEBP2A3"	ENSG00000020633	"RUNX family transcription factor 3"	Q13761	1	24899511-24965121	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 68.8;lymphoid tissue: 35.1"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 336.4;Langerhans cells: 133.9;NK-cells: 251.3;Plasma cells: 87.1;T-cells: 215.4"	"Cancer enhanced"	"Detected in all"		"melanoma: 25.3"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 124.9;Karpas-707: 155.6;SK-MEL-30: 92.4;U-266/70: 54.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA004195, CAB025416, HPA059006"	Enhanced		Supported	Nucleoplasm,Vesicles,Cytosol		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 2: Immune cells - Immune response"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 24: Non-specific - Transcription regulation"	"Nucleoplasm, Vesicles"	Cytosol	"CAB025416: , HPA004195: , HPA059006: AB_2683877"	"unprognostic (7.75e-3)"	"unprognostic (6.51e-3)"	"prognostic unfavorable (8.71e-4)"	"unprognostic (1.42e-1)"	"unprognostic (7.60e-2)"	"unprognostic (1.81e-2)"	"unprognostic (6.51e-2)"	"unprognostic (6.95e-2)"	"unprognostic (3.39e-1)"	"unprognostic (1.28e-2)"	"unprognostic (1.01e-1)"	"unprognostic (4.71e-1)"	"prognostic unfavorable (5.59e-5)"	"unprognostic (1.10e-1)"	"unprognostic (4.42e-2)"	"unprognostic (3.08e-1)"	"unprognostic (1.62e-1)"	3.5	1.4	3.7	21.1	3.6	68.8	3.5	3.8	4.6	19.7	3.7	3.7	5.0	1.6	0.7	2.6	1.6	5.3	1.1	3.6	3.8	1.6	3.7	9.5	34.7	4.7	4.4	0.6	0.9	0.4	0.7	0.9	4.3	1.9	4.2	0.1	4.7	0.8	3.8	11.5	15.0	1.6	4.1	35.1	5.5	2.3	4.3	11.2	1.8	0.7	29.0	6.5	1.5	4.5	0.3	10.4	0.0	0.2	0.0	0.0	0.1	0.8	0.0	0.5	0.0	0.5	0.0	19.3	18.4	16.4	0.1	0.4	11.1	0.0	0.7	124.9	1.9	0.4	1.8	0.1	0.0	4.5	42.8	0.1	0.0	0.0	1.1	0.0	0.0	3.1	0.1	155.6	0.0	0.0	1.5	37.9	0.7	0.0	3.2	0.0	0.1	22.7	0.0	0.5	3.5	0.0	7.3	0.1	92.4	2.9	0.0	25.7	0.0	0.0	1.9	0.0	0.5	54.6	40.4	18.2	0.1	42.0	4.4	0.7	1.1	7.0	21.7	4.5	11.3	6.7	7.9	18.7	1.4	5.7	3.9	14.6	1.3	28.7	7.7	1.5	9.2	5.5	3.7	3.6	3.8	4.6	3.6	3.8	4.7	4.4	4.3	4.1	4.3	4.5	4.4	0.0	3.6	0.0	57.7	7.6	0.8	4.6	2.2	0.0	9.8	11.3	2.4	0.0	1.5	1.8	0.0	0.1	336.4	0.5	0.0	0.2	2.3	1.1	1.2	2.4	0.0	13.7	0.0	0.2	0.1	3.3	13.3	2.3	45.2	0.0	2.2	1.5	4.6	0.0	0.0	0.5	0.0	22.9	133.9	1.0	0.0	55.6	46.2	1.0	51.1	0.0	251.3	0.0	0.1	0.1	0.1	0.7	87.1	1.2	0.0	0.3	0.5	0.0	0.0	3.5	3.6	0.3	4.1	2.3	5.8	0.3	215.4	0.1	0.4	0.4
RUVBL1	"ECP54, INO80H, NMP238, Pontin52, RVB1, TIH1, TIP49, TIP49a"	ENSG00000175792	"RuvB like AAA ATPase 1"	Q9Y265	3	128064778-128153914	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, DNA damage, DNA recombination, DNA repair, Growth regulation, Mitosis, Transcription, Transcription regulation"	"Activator, Chromatin regulator, Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Endometrial ciliated cells: 147.0;Respiratory ciliated cells: 221.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019947, HPA019948"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA		81000	"Cluster 15: NK-cells - Transcription"	"Cluster 71: Testis - DNA repair"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 49: Ciliated cells - Cilium organization"	"Nucleoplasm, Cytosol"		"HPA019947: AB_1856516, HPA019948: AB_1856514"	"unprognostic (7.40e-2)"	"unprognostic (2.17e-1)"	"unprognostic (1.28e-1)"	"unprognostic (4.73e-2)"	"unprognostic (3.55e-1)"	"unprognostic (2.66e-2)"	"prognostic unfavorable (1.21e-8)"	"unprognostic (2.43e-2)"	"unprognostic (3.31e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.25e-2)"	"unprognostic (7.39e-2)"	"unprognostic (2.98e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.61e-1)"	"unprognostic (9.27e-2)"	20.2	18.7	6.4	10.1	6.3	8.6	18.5	6.1	7.0	17.7	9.8	16.2	5.1	23.1	5.8	26.0	27.5	5.0	25.8	6.2	6.3	24.6	17.2	17.2	13.1	7.3	8.7	15.3	13.9	14.6	17.3	12.7	7.5	13.1	8.5	7.4	14.0	6.9	19.1	17.7	15.2	10.0	6.4	22.3	14.8	29.4	6.5	15.7	15.4	6.0	16.1	19.2	18.5	6.8	75.1	66.2	40.1	65.6	30.5	29.4	52.2	35.8	30.5	67.3	45.9	69.7	43.2	105.0	34.8	34.2	52.2	58.4	107.2	75.6	77.6	43.4	52.3	87.8	36.3	47.4	31.4	82.9	27.0	30.2	39.1	56.5	72.1	25.6	45.6	39.4	72.9	24.4	38.7	105.9	89.7	64.6	101.1	83.5	55.8	72.4	48.4	73.4	40.7	27.6	66.8	60.1	39.6	32.4	55.9	36.8	58.5	61.8	29.8	30.5	37.2	46.4	55.2	24.3	41.6	103.0	37.4	50.2	39.2	1.3	7.3	2.5	15.6	11.9	20.1	15.6	18.7	19.6	11.3	15.7	15.6	17.6	0.3	15.9	11.9	12.6	30.5	11.0	6.4	6.3	6.1	7.0	6.2	6.3	7.3	8.7	7.5	6.4	6.5	6.8	26.1	22.4	15.3	12.7	22.7	20.0	23.7	61.6	25.0	17.4	17.4	21.8	20.9	21.5	37.3	22.0	2.1	53.7	31.3	7.8	46.9	40.9	21.2	147.0	50.8	27.4	16.9	20.4	12.6	30.1	65.4	22.9	17.3	23.8	26.0	35.7	12.8	14.6	29.9	23.5	14.6	14.0	28.5	8.8	8.2	67.1	15.2	14.6	10.6	4.7	13.3	28.1	11.3	9.0	10.0	27.1	11.1	18.4	27.3	34.5	4.6	59.2	221.3	19.7	13.1	16.1	32.3	94.8	75.0	27.9	16.9	24.1	29.1	84.7	23.4	15.6
RUVBL2	"ECP51, INO80J, Reptin52, RVB2, TIH2, TIP48, TIP49b"	ENSG00000183207	"RuvB like AAA ATPase 2"	Q9Y230	19	48993562-49015970	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA recombination, DNA repair, Growth regulation, Transcription, Transcription regulation"	"Activator, Chromatin regulator, Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"Early spermatids: 614.5;Late spermatids: 945.1;Respiratory ciliated cells: 253.6;Spermatocytes: 394.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012432, HPA042880, HPA067966"	Enhanced		Supported	Nucleoplasm,Centrosome,Cytosol		NA	NA		53000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 43: Testis - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 31: Spermatids - Spermatogenesis"	"Nucleoplasm, Cytosol"	Centrosome	"CAB012432: , HPA042880: AB_2678210, HPA067966: AB_2685933"	"unprognostic (1.71e-1)"	"unprognostic (9.06e-3)"	"unprognostic (3.51e-1)"	"unprognostic (3.93e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.47e-2)"	"prognostic unfavorable (9.28e-4)"	"unprognostic (7.06e-3)"	"unprognostic (6.25e-2)"	"unprognostic (3.28e-1)"	"unprognostic (8.13e-2)"	"unprognostic (7.58e-2)"	"unprognostic (2.81e-2)"	"unprognostic (2.21e-2)"	"unprognostic (7.61e-3)"	"unprognostic (1.61e-1)"	"unprognostic (2.58e-1)"	23.4	21.7	41.4	26.7	42.9	51.4	22.6	44.6	54.6	23.5	48.9	29.8	27.9	19.3	15.3	36.7	72.2	15.8	37.0	44.7	42.6	19.4	24.0	19.6	30.8	42.4	45.8	25.8	34.5	28.2	6.5	24.0	44.2	20.2	17.4	14.9	32.5	25.4	60.3	30.7	24.7	19.0	41.4	20.6	22.6	110.7	43.8	38.9	23.8	39.1	21.3	22.6	7.2	52.3	236.5	346.0	63.3	250.2	45.0	50.9	88.8	105.4	86.3	214.9	162.5	267.4	148.7	219.9	78.5	106.8	93.7	134.6	99.9	210.3	68.5	99.2	323.7	158.8	196.7	241.0	119.1	318.8	96.8	78.0	68.0	145.0	113.5	59.2	114.1	232.8	266.6	121.3	90.5	195.2	234.1	218.5	122.6	162.4	152.4	227.4	156.9	155.8	110.5	182.7	155.7	169.9	132.2	164.2	66.2	30.4	125.9	179.4	104.8	100.8	135.1	63.8	318.1	171.4	177.1	223.6	76.2	174.6	156.4	51.1	54.9	18.9	42.6	52.4	46.8	54.5	45.2	42.3	65.9	52.6	42.9	40.0	3.7	47.4	48.5	48.9	49.2	55.4	41.4	42.9	44.6	54.6	44.7	42.6	42.4	45.8	44.2	41.4	43.8	52.3	16.5	12.8	20.7	4.2	25.3	27.8	52.0	89.8	37.5	17.5	30.4	33.7	48.5	24.3	55.7	33.1	33.3	104.6	15.0	33.8	46.9	78.3	614.5	131.7	29.6	27.3	17.5	58.1	6.1	71.8	81.8	36.6	28.5	25.4	13.3	32.8	23.2	34.2	51.1	18.5	5.2	38.5	52.9	22.9	25.5	945.1	36.1	18.9	26.6	1.9	35.5	31.2	27.8	4.5	5.6	56.0	30.6	42.9	41.3	43.5	33.1	70.4	253.6	31.4	19.7	28.9	65.4	394.2	43.9	49.2	27.6	115.9	20.8	37.1	61.0	38.8
RXRA	NR2B1	ENSG00000186350	"Retinoid X receptor alpha"	P19793	9	134317098-134440585	"Cancer-related genes, FDA approved drug targets, Metabolic proteins, Nuclear receptors, Predicted intracellular proteins, Transcription factors"	"Host-virus interaction, Transcription, Transcription regulation"	"DNA-binding, Receptor"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 106.5"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 218.9;Kupffer cells: 134.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 19.5"	"Group enriched"	"Detected in many"	5	"granulocytes: 19.5;monocytes: 12.9"	"Cell line enhanced"	"Detected in many"		"HaCaT: 105.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004565, CAB005352"	Supported		Supported	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	Nucleoplasm	"Golgi apparatus"	"CAB004565: AB_2184877, CAB005352: AB_2184874"	"unprognostic (2.68e-1)"	"unprognostic (7.94e-2)"	"unprognostic (3.67e-2)"	"unprognostic (7.22e-2)"	"unprognostic (2.07e-2)"	"unprognostic (6.69e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.15e-1)"	"unprognostic (3.45e-2)"	"unprognostic (1.65e-3)"	"prognostic favorable (7.02e-4)"	"unprognostic (7.72e-2)"	"prognostic unfavorable (5.58e-4)"	"unprognostic (1.25e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.49e-2)"	"unprognostic (2.59e-1)"	40.5	22.7	33.5	14.5	36.4	18.9	11.2	25.5	29.4	12.2	16.9	16.6	25.8	13.5	8.7	28.5	16.5	13.6	19.4	27.1	30.2	16.0	32.9	18.8	8.2	32.9	31.3	21.7	25.4	45.1	3.5	14.5	30.8	15.6	10.0	5.4	21.7	17.1	106.5	88.1	28.0	11.1	30.4	25.1	14.7	7.9	42.7	6.0	17.6	51.9	7.6	16.2	8.2	22.6	19.6	36.4	14.7	21.9	42.8	19.1	66.7	14.1	16.1	9.6	6.5	20.7	28.0	0.0	25.8	22.5	15.1	105.5	7.7	32.8	2.9	26.3	7.2	0.1	47.5	30.0	20.4	18.8	4.8	29.0	52.1	11.5	10.6	12.9	12.8	1.6	26.0	1.1	8.7	61.8	1.1	59.5	17.5	63.4	16.9	7.4	30.3	36.7	12.2	64.3	17.2	10.5	37.3	46.9	10.6	7.1	44.9	78.8	16.5	16.2	23.4	17.4	9.7	1.7	0.2	0.4	11.6	33.9	12.7	1.3	8.1	6.6	1.4	12.9	0.2	0.3	0.9	1.0	3.2	0.1	0.2	1.2	19.5	2.2	11.2	0.7	1.2	3.2	33.5	36.4	25.5	29.4	27.1	30.2	32.9	31.3	30.8	30.4	42.7	22.6	32.1	32.1	22.9	36.2	4.6	34.5	16.5	21.1	12.5	6.0	16.7	14.4	38.8	72.9	26.2	9.2	25.0	30.1	11.0	72.3	1.9	13.9	4.3	19.8	16.6	28.9	9.6	30.9	9.1	14.1	29.5	23.7	17.9	17.4	1.3	21.3	71.0	218.9	31.9	33.7	17.6	21.2	10.2	134.2	30.0	18.8	32.3	50.4	12.4	10.3	80.4	36.5	14.4	29.1	6.0	15.9	32.4	21.1	7.4	17.7	55.6	19.9	34.4	19.9	19.7	34.6	30.6	0.9	9.4	34.4	46.9	23.9	12.6	15.5	27.5	32.8
RXRB	"H-2RIIBP, NR2B2, RCoR-1"	ENSG00000204231	"Retinoid X receptor beta"	P28702	6	33193588-33200665	"Cancer-related genes, FDA approved drug targets, Nuclear receptors, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Receptor"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"GAMG: 11.0;RH-30: 14.4;RT4: 12.1;T-47d: 16.1;U-266/70: 11.1;U-266/84: 11.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002003, HPA063653"	Supported		Supported	Nucleoplasm		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 72: Non-specific - Transcription"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm		"CAB002003: , HPA063653: AB_2685076"	"unprognostic (3.51e-1)"	"unprognostic (8.46e-2)"	"unprognostic (1.94e-1)"	"unprognostic (2.22e-2)"	"unprognostic (2.00e-2)"	"unprognostic (4.71e-3)"	"unprognostic (4.18e-2)"	"unprognostic (2.21e-2)"	"unprognostic (1.86e-1)"	"unprognostic (2.03e-1)"	"unprognostic (1.67e-3)"	"unprognostic (8.13e-3)"	"unprognostic (9.53e-3)"	"unprognostic (8.30e-2)"	"unprognostic (1.55e-1)"	"unprognostic (6.38e-2)"	"unprognostic (8.53e-3)"	26.8	29.1	1.5	2.0	1.5	2.3	27.1	1.6	5.7	33.9	1.4	34.4	3.9	31.9	7.4	27.0	31.4	3.3	31.4	1.5	2.6	29.5	34.4	27.2	1.4	1.5	1.7	32.9	32.3	0.0	33.0	2.5	1.5	32.8	1.6	3.2	27.0	3.3	42.5	26.3	28.6	9.6	1.6	38.3	28.3	20.0	1.6	2.8	37.7	12.3	9.1	30.6	29.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	7.1	0.0	0.0	0.0	0.0	10.0	0.0	10.4	7.1	0.0	11.0	4.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	7.5	0.0	9.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.2	0.0	8.9	0.0	0.0	0.5	3.2	0.0	0.0	0.1	14.4	0.0	8.0	12.1	0.0	7.4	0.0	0.0	0.0	0.0	16.1	0.0	0.0	0.0	4.8	0.0	0.0	11.1	11.8	9.2	0.0	0.0	0.0	2.3	0.4	1.7	1.1	0.3	0.8	1.0	1.3	1.3	0.6	0.3	1.1	0.8	0.7	0.8	0.6	0.6	1.1	0.3	1.5	1.5	1.6	5.7	1.5	2.6	1.5	1.7	1.5	1.6	1.6	1.7	21.2	41.7	13.3	14.4	19.2	17.3	14.9	8.9	18.2	25.2	22.4	18.9	16.1	15.7	14.7	5.5	20.9	23.6	26.3	21.8	25.4	19.9	2.7	10.6	14.7	18.2	22.0	8.6	14.9	16.2	17.9	18.3	23.0	11.9	10.2	22.5	14.3	15.9	15.8	18.5	12.9	21.8	16.2	14.7	9.2	8.6	16.1	12.2	16.0	10.3	18.8	16.6	33.0	14.1	15.2	13.6	20.2	16.1	12.0	16.3	23.2	14.1	10.8	20.4	26.3	19.3	20.0	17.7	12.5	16.8	18.8	28.7	19.4	18.7	24.5	12.7
RYBP	"AAP1, DEDAF, YEAF1"	ENSG00000163602	"RING1 and YY1 binding protein"	Q8N488	3	72371825-72446623	"Predicted intracellular proteins"	"Apoptosis, Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 524.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053357	Approved		Supported	Nucleoplasm		NA	No			"Cluster 1: Neutrophils - Mixed function"	"Cluster 72: Non-specific - Transcription"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Nucleoplasm		"HPA053357: AB_2682124"	"unprognostic (6.80e-2)"	"unprognostic (2.81e-1)"	"unprognostic (6.40e-2)"	"unprognostic (1.58e-1)"	"unprognostic (7.60e-2)"	"unprognostic (1.60e-3)"	"unprognostic (1.44e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.14e-2)"	"unprognostic (2.40e-2)"	"unprognostic (3.84e-1)"	"unprognostic (4.12e-2)"	"prognostic favorable (2.50e-5)"	"unprognostic (1.89e-1)"	"unprognostic (4.24e-1)"	"unprognostic (3.09e-2)"	"unprognostic (4.22e-1)"	8.6	5.4	2.0	0.8	2.0	2.7	7.8	1.4	2.3	9.4	0.9	9.5	0.8	10.0	0.6	7.1	8.5	1.2	5.7	1.8	2.2	7.6	8.6	11.5	0.8	1.5	1.6	10.9	4.7	0.8	5.9	2.2	1.4	8.7	1.0	2.1	6.7	1.2	4.4	8.3	7.4	1.4	1.4	8.6	7.0	8.1	2.0	1.5	5.8	0.8	1.0	8.8	7.9	2.0	0.9	0.9	1.7	1.6	1.5	1.5	1.1	0.9	2.0	1.7	2.1	1.6	1.2	1.0	0.9	1.5	2.0	0.4	1.9	1.4	2.1	6.0	1.0	4.7	1.2	0.7	1.1	0.9	1.1	2.3	1.7	2.2	3.5	2.2	0.5	1.1	1.4	3.1	1.4	1.4	1.3	0.9	3.1	2.7	1.1	1.4	1.5	0.6	1.3	1.0	1.3	5.2	2.4	2.3	1.2	2.7	0.7	1.1	1.3	2.2	1.6	1.3	0.8	2.5	2.7	0.9	1.1	1.6	2.4	0.0	0.1	0.4	0.1	0.2	0.0	0.0	0.1	0.1	0.1	0.0	0.2	0.0	0.8	0.1	0.2	0.2	0.1	0.1	2.0	2.0	1.4	2.3	1.8	2.2	1.5	1.6	1.4	1.4	2.0	2.0	67.4	57.7	27.6	29.4	39.1	107.2	67.8	19.2	46.1	74.7	75.5	51.4	39.2	32.9	28.9	42.3	16.7	26.9	63.1	58.7	33.2	21.1	27.3	67.5	103.7	70.9	81.2	42.7	49.5	24.0	51.7	61.5	13.7	87.5	69.0	27.1	55.0	40.5	16.5	38.7	64.2	50.5	26.4	37.6	77.3	13.4	25.7	71.3	35.6	60.9	31.9	22.4	27.8	42.7	524.1	32.8	49.0	43.6	49.0	65.0	16.8	24.7	32.3	40.8	32.9	74.9	42.1	57.9	37.0	51.7	97.0	186.9	44.3	98.5	34.9	65.1
S100A1	"S100-alpha, S100A"	ENSG00000160678	"S100 calcium binding protein A1"	P23297	1	153627926-153632039	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transporters"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 3076.8;skeletal muscle: 3060.2;tongue: 4911.5"	"Cell type enriched"	"Detected in many"	4	"Proximal tubular cells: 1848.3"	"Group enriched"	"Detected in all"	5	"melanoma: 210.5;ovarian cancer: 110.1;thyroid cancer: 123.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"Hep G2: 325.8;SK-MEL-30: 1130.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002599, HPA006462"	Enhanced		Supported	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA		290000	"Cluster 10: Basophils - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Cytosol	"Nucleoplasm, Golgi apparatus"	"CAB002599: AB_2315307, HPA006462: AB_1079857"	"unprognostic (6.13e-2)"	"unprognostic (7.60e-2)"	"unprognostic (5.96e-5)"	"prognostic unfavorable (1.12e-4)"	"unprognostic (1.19e-1)"	"unprognostic (3.24e-2)"	"unprognostic (2.36e-1)"	"unprognostic (2.34e-3)"	"unprognostic (6.83e-3)"	"unprognostic (5.22e-1)"	"unprognostic (5.04e-3)"	"unprognostic (9.62e-2)"	"prognostic unfavorable (3.08e-4)"	"unprognostic (1.68e-1)"	"unprognostic (4.56e-2)"	"unprognostic (2.70e-3)"	"unprognostic (9.74e-4)"	179.7	8.3	811.3	6.5	898.6	2.3	77.2	851.4	952.4	2.9	643.9	14.5	11.1	4.2	1.0	81.0	41.8	4.9	3076.8	779.4	813.6	194.9	4.5	3.9	5.1	907.6	894.8	2.0	16.8	160.9	54.6	18.1	871.2	29.0	1.2	36.5	622.1	9.3	3060.2	23.0	6.9	1.6	847.7	4.2	23.1	5.9	882.9	9.4	167.9	4911.5	4.0	4.3	2.9	967.6	6.0	3.4	3.9	33.7	0.5	0.2	2.9	7.7	0.2	0.6	0.2	6.6	3.4	3.7	137.7	0.6	2.7	10.3	0.3	0.4	0.0	4.2	3.3	8.2	5.4	325.8	0.4	3.0	2.3	0.7	0.0	0.0	0.1	7.9	0.0	1.5	27.2	3.7	0.1	10.6	1.2	4.9	1.8	4.3	2.6	22.5	3.3	8.0	6.0	12.1	6.1	1.9	3.5	10.6	1130.2	11.1	32.8	16.2	2.7	3.3	2.8	3.0	3.8	6.1	5.7	6.2	2.5	6.2	2.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	811.3	898.6	851.4	952.4	779.4	813.6	907.6	894.8	871.2	847.7	882.9	967.6	4.3	0.0	0.0	59.4	9.5	9.7	1.2	0.4	1.8	1.1	369.9	354.1	74.4	8.6	0.2	154.5	2.1	1.1	5.9	1.1	162.4	0.9	0.6	90.5	17.3	5.3	1.8	0.0	0.3	3.7	1.9	6.0	0.0	193.3	0.0	0.0	7.9	4.7	199.1	0.0	0.3	3.7	0.0	0.6	3.5	2.2	6.5	15.6	341.5	2.8	0.0	163.5	0.0	2.0	45.8	1.9	0.6	9.1	0.0	1.8	0.9	1848.3	0.2	2.7	0.0	67.0	4.2	3.8	2.8	1.0	2.3	3.4	8.2	2.3	1.8	0.7
S100A11	S100C	ENSG00000163191	"S100 calcium binding protein A11"	P31949	1	152032506-152047907	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 4751.5"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 5473.4;Extravillous trophoblasts: 6093.0;Pancreatic endocrine cells: 6926.5;Urothelial cells: 6250.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 17820.3"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034320, HPA042745"	Enhanced		Supported	"Nucleoplasm,Nuclear speckles,Cytosol"		NA	NA		7900000	"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	"Nucleoplasm, Cytosol"	"Nuclear speckles"	"CAB034320: AB_2183487, HPA042745: AB_2678142"	"unprognostic (1.85e-2)"	"unprognostic (9.20e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.61e-1)"	"unprognostic (3.12e-2)"	"unprognostic (7.61e-2)"	"prognostic unfavorable (3.64e-5)"	"unprognostic (3.34e-2)"	"unprognostic (8.48e-2)"	"unprognostic (1.80e-2)"	"unprognostic (1.28e-3)"	"unprognostic (5.92e-2)"	"prognostic unfavorable (3.24e-6)"	"unprognostic (2.91e-1)"	"unprognostic (2.75e-1)"	"unprognostic (2.43e-3)"	"unprognostic (8.86e-2)"	656.7	214.3	92.6	487.2	92.8	415.2	574.7	99.1	222.3	1070.5	106.8	303.0	181.6	297.7	675.4	4751.5	611.1	437.8	354.1	92.3	104.4	882.5	127.6	776.0	206.7	118.1	108.6	152.0	264.1	905.1	210.7	723.2	118.0	536.4	328.7	8.4	1247.1	544.1	91.0	894.7	239.5	468.3	110.2	713.7	482.6	68.9	124.1	303.5	325.3	150.9	959.9	1527.7	1771.1	126.8	1889.0	1483.7	70.5	542.1	1960.9	2451.3	1172.4	1796.3	2626.0	1439.7	1464.8	697.6	2066.0	2.5	1571.4	2355.4	1142.4	2595.4	73.7	3254.0	814.0	913.6	149.2	162.6	830.1	409.1	1511.3	149.6	1098.4	1867.2	3255.1	1577.8	1974.9	826.9	1116.1	0.3	340.9	352.1	2137.7	3058.8	19.8	694.0	513.9	4043.1	1491.9	2.5	757.1	1426.0	4361.1	3196.5	2.5	115.8	1367.7	1797.9	1255.3	1727.2	1378.9	1612.5	1584.8	757.0	533.1	1188.8	975.7	2.5	17.0	8.2	1713.0	490.9	915.2	7956.3	4682.6	7210.4	713.6	4560.1	939.4	354.9	1346.4	845.1	3020.5	252.7	391.5	437.0	17820.3	740.5	4871.8	1042.8	1269.9	5289.9	92.6	92.8	99.1	222.3	92.3	104.4	118.1	108.6	118.0	110.2	124.1	126.8	718.5	137.8	189.4	1.3	136.6	2210.3	3924.9	5473.4	1027.8	0.7	686.8	823.8	30.8	546.2	2673.9	2284.2	0.0	3257.0	384.0	421.7	1019.3	4344.5	277.6	1738.8	561.2	617.8	277.7	52.6	0.0	4330.2	6093.0	890.7	676.4	1503.0	437.6	251.1	372.6	11.6	3806.0	0.0	0.0	479.6	1485.2	1216.7	2054.0	634.0	320.9	1971.8	1243.3	15.9	2265.2	0.8	371.8	0.0	0.0	6926.5	690.2	258.4	153.8	4365.0	343.9	925.4	2674.2	2.4	210.4	536.2	1054.9	14.5	34.8	4207.9	2822.4	3753.1	470.4	334.8	500.2	6250.2
S100A13		ENSG00000189171	"S100 calcium binding protein A13"	Q99584	1	153618787-153631360	"Predicted intracellular proteins, Predicted secreted proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Theca cells: 3084.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"NK-cell: 28.3"	"Group enriched"	"Detected in all"	5	"dendritic cells: 11.9;NK-cells: 28.3"	"Cell line enhanced"	"Detected in many"		"RPTEC TERT1: 811.3;SuSa: 896.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019592, CAB025494"	Approved		Approved	"Nucleoplasm,Nucleoli,Plasma membrane,Cytosol"	"Secreted in other tissues"	NA	NA		36000	"Cluster 48: NK-cells - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 52: Non-specific - Transcription"	"Plasma membrane, Cytosol"	"Nucleoplasm, Nucleoli"	"CAB025494: , HPA019592: AB_10601499"	"unprognostic (1.50e-2)"	"unprognostic (9.09e-2)"	"unprognostic (2.08e-2)"	"unprognostic (1.45e-1)"	"unprognostic (7.77e-2)"	"unprognostic (9.72e-3)"	"unprognostic (1.75e-3)"	"unprognostic (9.93e-2)"	"unprognostic (6.48e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.21e-2)"	"unprognostic (4.83e-3)"	"prognostic unfavorable (1.97e-4)"	"unprognostic (3.43e-2)"	"unprognostic (8.10e-2)"	"unprognostic (1.82e-3)"	"unprognostic (1.72e-2)"	275.3	137.3	237.4	47.7	247.3	4.4	222.4	241.0	347.5	133.7	214.6	198.9	30.6	111.8	72.1	91.7	129.8	103.9	310.1	233.1	240.8	262.2	66.2	138.0	48.8	252.9	245.5	138.2	75.7	317.4	73.9	70.1	249.4	100.9	59.8	25.8	156.1	64.6	250.6	114.0	116.5	68.9	245.8	111.7	94.4	41.2	251.6	21.2	318.7	220.6	49.6	121.2	122.7	258.6	188.7	153.7	174.5	111.4	150.7	437.5	62.7	254.7	400.0	150.6	172.2	150.4	203.7	4.9	471.6	435.5	22.3	174.7	73.5	158.7	132.7	0.8	68.1	12.0	178.0	129.6	99.8	5.9	39.2	355.3	59.4	135.3	145.0	441.9	346.5	1.3	61.4	0.3	475.2	663.4	0.4	3.4	141.0	161.1	460.2	30.0	180.4	1.4	811.3	141.9	53.4	2.0	544.7	277.2	576.7	896.9	226.4	6.8	495.0	103.3	57.9	139.5	312.0	2.0	5.3	9.3	185.5	3.2	62.1	4.1	2.0	0.2	0.4	0.9	0.9	4.1	0.4	0.3	7.0	2.0	0.6	0.5	0.3	28.3	1.4	11.9	1.4	1.1	237.4	247.3	241.0	347.5	233.1	240.8	252.9	245.5	249.4	245.8	251.6	258.6	331.0	28.9	106.1	29.7	9.3	110.5	177.4	105.0	103.0	2.1	311.2	345.6	141.9	164.5	104.0	465.3	0.0	132.4	15.3	148.7	248.4	323.3	8.4	399.3	449.1	251.9	124.7	17.3	1.2	323.6	202.1	450.0	58.6	573.8	23.5	185.5	372.3	51.8	162.3	0.0	0.5	167.5	61.1	31.7	107.7	36.3	771.7	37.1	238.3	13.1	14.8	308.1	1.0	0.0	8.8	488.4	164.7	314.1	6.3	240.0	128.7	521.7	77.1	6.9	0.0	234.2	132.5	12.8	23.4	80.3	75.7	74.7	20.5	3084.7	100.6	244.3
S100A14	"BCMP84, S100A15"	ENSG00000189334	"S100 calcium binding protein A14"	Q9HCY8	1	153614255-153616986	"Plasma proteins, Predicted intracellular proteins"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"esophagus: 3719.5;vagina: 1174.2"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 2340.8;Paneth cells: 1098.9;Proximal enterocytes: 1549.1;Squamous epithelial cells: 3205.8;Suprabasal keratinocytes: 3612.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A-431: 798.6;HaCaT: 1072.9;HBEC3-KT: 1527.6;hTCEpi: 2232.0;OE19: 1675.1;SK-BR-3: 1579.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA027613	Enhanced		Approved	"Nuclear bodies,Plasma membrane,Cell Junctions,Cytosol"		NA	NA		260000		"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 61: Squamous epithelial cells - Keratinization"	"Nuclear bodies, Plasma membrane, Cell Junctions, Cytosol"		"HPA027613: AB_10602298"	"unprognostic (1.73e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.48e-1)"	"unprognostic (3.94e-2)"	"unprognostic (1.75e-2)"	"unprognostic (6.27e-2)"	"unprognostic (2.30e-2)"	"unprognostic (9.48e-2)"	"unprognostic (2.50e-1)"	"unprognostic (2.16e-1)"	"unprognostic (2.75e-3)"	"unprognostic (2.89e-1)"	"unprognostic (3.16e-3)"	"unprognostic (8.41e-2)"	"unprognostic (1.80e-1)"	"unprognostic (4.81e-2)"	"unprognostic (9.53e-2)"	2.2	0.8	1.5	24.9	1.6	0.2	78.3	1.5	2.0	530.8	1.3	241.0	265.4	5.4	14.7	3719.5	20.4	18.5	4.2	1.5	1.5	70.1	16.3	82.7	0.6	1.5	1.5	1.4	17.7	125.2	5.1	1.1	1.5	19.6	240.0	0.0	550.3	39.0	2.2	608.0	209.0	13.1	1.4	1.3	119.2	0.7	1.7	149.0	98.6	0.0	449.7	32.9	1174.2	1.5	798.6	0.2	0.1	0.2	0.2	0.3	7.4	0.2	0.1	0.2	0.1	97.6	140.1	0.6	2.3	0.2	0.5	1072.9	0.0	1527.6	0.1	0.5	0.3	0.1	10.8	7.3	0.0	0.0	0.9	0.6	2232.0	0.5	20.7	0.3	0.3	0.1	0.6	1.1	0.2	140.0	0.7	1.1	0.4	1675.1	1.9	0.6	0.6	2.8	8.1	51.2	0.7	0.7	2.2	1579.1	2.1	36.5	3.9	1.7	0.0	0.7	0.8	1.1	2.0	0.4	0.8	0.9	0.6	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	1.6	1.5	2.0	1.5	1.5	1.5	1.5	1.5	1.4	1.7	1.5	2.7	60.9	162.6	2.3	4.2	2340.8	448.6	770.5	657.9	0.0	256.2	178.3	5.3	270.2	387.7	35.0	0.0	2.7	2.2	1058.2	49.0	197.5	0.0	37.3	6.4	21.5	153.4	0.0	0.0	65.8	1.5	22.8	85.6	80.3	28.0	0.2	1.1	9.5	0.3	0.0	0.0	660.1	126.1	0.3	213.7	0.0	0.0	3.0	241.9	0.0	2.0	0.0	0.0	0.0	0.1	343.0	1098.9	0.0	7.5	619.3	1549.1	4.9	56.2	0.0	0.0	1.3	27.1	0.0	0.0	3205.8	3612.0	0.3	8.7	13.6	580.9	824.9
S100A16	"DT1P1A7, MGC17528, S100F"	ENSG00000188643	"S100 calcium binding protein A16"	Q96FQ6	1	153606886-153613145	"Predicted intracellular proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 2477.7"	"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 995.4;Pancreatic endocrine cells: 1307.3;Prostatic glandular cells: 1141.1;Squamous epithelial cells: 1028.7;Suprabasal keratinocytes: 908.8;Theca cells: 1528.4;Urothelial cells: 1522.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 1369.9;SK-BR-3: 1618.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045841	Enhanced		Approved	"Plasma membrane,Cytosol"		NA	NA		190000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	Cytosol	"Plasma membrane"	"HPA045841: AB_10966282"	"unprognostic (9.86e-3)"	"unprognostic (1.69e-1)"	"unprognostic (2.23e-2)"	"unprognostic (3.06e-1)"	"unprognostic (1.71e-1)"	"unprognostic (7.03e-2)"	"prognostic unfavorable (3.18e-4)"	"prognostic unfavorable (3.14e-5)"	"unprognostic (1.70e-1)"	"unprognostic (4.59e-1)"	"prognostic unfavorable (2.04e-4)"	"unprognostic (2.60e-1)"	"prognostic unfavorable (3.91e-5)"	"unprognostic (1.01e-1)"	"unprognostic (1.92e-1)"	"unprognostic (3.45e-2)"	"unprognostic (5.29e-3)"	166.8	79.1	81.3	61.9	79.8	0.8	159.7	78.6	98.0	333.0	70.8	139.7	121.5	78.4	19.8	2477.7	68.2	81.6	122.3	79.8	80.1	219.0	209.9	161.3	28.4	104.2	80.9	83.4	41.0	76.6	42.0	71.8	84.9	77.8	105.0	7.0	438.1	38.1	51.7	474.9	109.8	79.0	84.8	118.5	100.4	60.3	103.4	25.0	72.4	52.1	205.0	163.2	713.3	84.6	670.4	318.1	16.0	36.7	102.5	386.8	42.8	367.9	341.4	302.7	265.2	315.4	366.1	0.3	577.5	553.0	69.0	479.6	1.1	839.2	175.3	1.9	0.6	0.4	260.5	90.8	117.5	0.2	0.9	182.7	787.6	731.6	567.9	390.9	1369.9	0.0	8.5	0.8	677.3	918.7	0.9	1.4	69.0	1171.0	887.9	0.9	187.4	1.8	1150.3	236.1	0.8	1.9	267.6	1618.0	55.7	140.5	504.7	3.5	743.9	178.2	289.5	171.5	848.6	0.5	3.5	2.4	525.0	0.9	122.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	81.3	79.8	78.6	98.0	79.8	80.1	104.2	80.9	84.9	84.8	103.4	84.6	275.6	38.5	25.5	10.4	6.8	633.9	995.4	531.6	157.6	0.5	225.4	191.3	33.0	124.4	290.6	108.5	2.1	20.3	4.4	500.7	72.4	610.9	4.9	50.9	172.5	293.5	139.0	16.0	0.0	193.9	8.7	112.2	96.8	128.5	19.1	154.1	365.9	132.7	5.0	0.0	0.1	286.4	164.8	15.7	95.4	17.4	67.1	7.4	112.1	5.6	7.2	72.5	0.0	7.5	0.7	1307.3	610.0	61.3	5.6	1141.1	353.3	169.7	48.6	2.1	6.6	70.9	91.2	8.0	1.3	1028.7	908.8	8.2	12.9	1528.4	320.2	1522.5
S100A4	"18A2, 42A, CAPL, FSP1, MTS1, P9KA, PEL98"	ENSG00000196154	"S100 calcium binding protein A4"	P26447	1	153543613-153550136	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Kupffer cells: 2708.8;Langerhans cells: 5952.7;Macrophages: 2786.0;monocytes: 3172.6;NK-cells: 2130.8;Skeletal myocytes: 2034.0;T-cells: 2111.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"A549: 2614.3;ASC diff: 3300.1;BJ hTERT+: 6738.6;fHDF/TERT166: 4819.1;RPMI-8226: 2700.2"	"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in many"	4	"spinal cord: 39.6"	"CAB002618, HPA007486, HPA007973, CAB027387, CAB058698, CAB068227, CAB068228"	Enhanced		Approved	Nucleoplasm,Cytosol	"Secreted to blood"	NA	NA		9600000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	"Nucleoplasm, Cytosol"		"CAB002618: , CAB027387: , CAB058698: AB_2665603, CAB068227: AB_2665602, CAB068228: AB_2665601, HPA007486: , HPA007973: AB_1079858"	"unprognostic (1.56e-1)"	"unprognostic (6.10e-2)"	"unprognostic (2.84e-2)"	"unprognostic (8.20e-2)"	"unprognostic (6.21e-2)"	"prognostic favorable (4.03e-5)"	"unprognostic (8.35e-2)"	"unprognostic (4.81e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.20e-1)"	"unprognostic (2.78e-2)"	"unprognostic (3.39e-2)"	"prognostic unfavorable (2.90e-4)"	"unprognostic (1.05e-1)"	"unprognostic (3.05e-1)"	"unprognostic (2.76e-2)"	"unprognostic (3.16e-2)"	982.3	77.1	25.5	353.9	26.2	1090.8	561.9	27.5	53.1	566.3	32.0	301.7	91.7	177.8	124.5	224.0	217.6	167.6	268.5	24.7	27.4	247.0	64.3	874.2	221.0	31.7	26.4	51.0	53.8	18.1	24.8	182.9	29.8	223.7	331.5	10.0	245.4	155.8	163.0	371.5	234.3	297.7	27.8	443.0	133.3	32.2	33.7	112.6	191.9	424.6	315.4	391.6	455.2	34.1	11.8	2614.3	13.2	77.0	3300.1	2410.9	3.7	1664.4	6738.6	32.1	148.4	20.0	180.3	0.8	299.7	4819.1	3.5	65.3	8.8	20.9	23.6	405.2	2.3	1186.8	529.0	59.4	4.3	106.9	1924.6	364.2	21.5	62.2	13.0	4.9	2.6	0.7	9.9	4.2	2468.1	10.6	3.8	1273.9	7.2	189.7	1050.4	64.1	3.7	2700.2	103.5	71.3	108.5	11.6	24.9	1286.6	9.4	412.5	77.1	1493.7	3.1	8.5	13.7	2159.5	9.3	82.8	647.5	14.3	6.1	1367.9	127.2	2789.7	13536.2	1408.0	5800.5	9099.6	6077.0	761.6	5167.7	4700.0	9268.4	282.5	882.4	2641.3	12129.7	837.1	11862.4	1626.0	7406.7	24075.8	25.5	26.2	27.5	53.1	24.7	27.4	31.7	26.4	29.8	27.8	33.7	34.1	226.0	490.4	398.4	0.0	266.1	772.9	19.5	159.0	93.9	0.7	44.9	65.9	14.9	35.8	273.8	893.8	0.0	52.4	1345.4	8.9	111.6	21.9	7.3	53.0	473.0	209.1	4.8	730.9	0.0	23.5	255.5	1378.8	54.0	41.9	1395.8	0.6	96.4	18.6	1966.1	45.4	0.0	10.0	345.8	2708.8	5952.7	24.0	235.8	2786.0	1193.5	12.2	3172.6	3.6	2130.8	0.0	0.1	35.7	17.0	45.9	266.5	12.9	3.2	19.7	154.9	2.3	151.2	2034.0	1309.6	1.9	5.5	77.6	694.0	53.4	2111.1	32.5	11.3	73.1
S100A8	"60B8AG, CAGA, CFAG, CGLA, MRP8, P8"	ENSG00000143546	"S100 calcium binding protein A8"	P05109	1	153390032-153391073	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Apoptosis, Autophagy, Chemotaxis, Immunity, Inflammatory response, Innate immunity"	Antimicrobial	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 35382.0;esophagus: 24565.6;vagina: 11166.4"	"Group enriched"	"Detected in many"	7	"Basal respiratory cells: 4126.5;Kupffer cells: 6348.0;Macrophages: 3758.3;monocytes: 6932.6;Squamous epithelial cells: 8480.1"	"Cancer enhanced"	"Detected in all"		"cervical cancer: 2290.9;head and neck cancer: 2382.0"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	9	"classical monocyte: 26833.7;neutrophil: 52973.6"	"Group enriched"	"Detected in all"	9	"granulocytes: 52973.6;monocytes: 26833.7"	"Group enriched"	"Detected in some"	24	"hTCEpi: 241.8;SK-BR-3: 719.0;THP-1: 400.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"CAB002791, HPA024372"	Enhanced		Supported	"Intermediate filaments,Cytosol"	"Secreted to blood"	NA	NA	10900000	370000000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	"Intermediate filaments"	Cytosol	"CAB002791: , HPA024372: AB_1856536"	"unprognostic (1.98e-1)"	"unprognostic (1.13e-1)"	"unprognostic (3.79e-2)"	"unprognostic (1.58e-2)"	"unprognostic (8.60e-3)"	"unprognostic (9.26e-3)"	"unprognostic (4.92e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.83e-1)"	"unprognostic (6.13e-2)"	"unprognostic (3.77e-2)"	"unprognostic (2.24e-2)"	"prognostic unfavorable (8.94e-7)"	"unprognostic (1.17e-1)"	"unprognostic (8.90e-2)"	"unprognostic (8.27e-2)"	"unprognostic (8.94e-3)"	582.3	54.3	41.7	1245.8	45.6	35382.0	70.0	43.4	88.0	5650.6	45.5	55.2	15.4	23.1	5.5	24565.6	236.1	99.0	121.1	40.9	42.7	103.0	176.7	1061.7	29.5	47.7	44.8	25.8	52.0	9.6	41.7	205.8	50.7	43.1	14.7	5.6	3988.2	5.0	48.5	267.3	47.7	430.2	44.2	3239.5	93.8	16.2	45.5	281.3	48.8	174.8	8952.6	561.9	11166.4	46.2	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	9.0	1.3	0.0	0.3	12.4	0.0	18.7	0.0	0.1	0.0	3.5	0.0	0.0	0.0	5.6	0.1	0.0	241.8	0.0	7.5	0.0	0.0	0.0	9.6	1.2	0.0	0.9	0.4	1.5	0.3	0.0	0.0	0.4	5.8	1.0	0.0	0.0	0.4	0.5	3.6	719.0	0.0	0.0	4.7	400.6	10.6	0.0	0.2	0.9	0.1	0.2	1.3	2.7	0.3	13.9	0.0	848.0	26833.7	3023.7	33.4	1999.2	49.2	57.2	21.8	18.2	4686.1	23.5	21.6	23.3	52973.6	27.1	493.1	188.1	37.1	24979.9	41.7	45.6	43.4	88.0	40.9	42.7	47.7	44.8	50.7	44.2	45.5	46.2	1.1	224.4	489.8	0.0	77.2	19.6	3.5	4126.5	50.7	0.0	13.2	3.9	10.0	70.1	817.0	14.7	0.0	5.8	67.1	0.3	0.0	1.0	210.7	0.5	0.6	33.1	0.0	143.5	0.0	0.9	8.5	61.3	1.1	0.5	227.1	0.1	76.1	54.6	417.5	0.0	0.0	0.2	207.5	6348.0	5.1	172.4	4.1	3758.3	0.0	0.0	6932.6	0.0	289.4	0.0	0.0	1.4	0.0	1.5	26.1	0.9	0.0	25.0	162.8	0.0	0.0	7.7	32.3	2.1	1.0	8480.1	113.2	6.7	91.4	0.0	0.0	31.3
S100A9	"60B8AG, CAGB, CFAG, CGLB, LIAG, MAC387, MIF, MRP14, NIF, P14"	ENSG00000163220	"S100 calcium binding protein A9"	P06702	1	153357854-153361023	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Apoptosis, Autophagy, Chemotaxis, Immunity, Inflammatory response, Innate immunity"	"Antimicrobial, Antioxidant"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 32194.3;esophagus: 30581.7;vagina: 14027.7"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 5771.3;Kupffer cells: 7537.0;Macrophages: 3678.1;monocytes: 11103.1;Squamous epithelial cells: 3263.1"	"Cancer enhanced"	"Detected in all"		"cervical cancer: 5468.0;head and neck cancer: 6692.8"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	6	"classical monocyte: 24579.6;neutrophil: 33654.0"	"Group enriched"	"Detected in all"	6	"granulocytes: 33654.0;monocytes: 24579.6"	"Cell line enriched"	"Detected in many"	6	"SK-BR-3: 2398.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA004193, CAB009441"	Enhanced		Supported	"Nucleoplasm,Cell Junctions,Cytosol"	"Secreted to blood"	NA	NA	10600000	1200000000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	"Nucleoplasm, Cell Junctions, Cytosol"		"CAB009441: AB_2184420, HPA004193: AB_1856537"	"unprognostic (1.72e-1)"	"unprognostic (3.33e-2)"	"unprognostic (2.40e-1)"	"unprognostic (3.94e-3)"	"unprognostic (1.36e-2)"	"unprognostic (5.45e-3)"	"prognostic unfavorable (1.13e-6)"	"unprognostic (1.10e-2)"	"unprognostic (4.31e-1)"	"unprognostic (3.06e-1)"	"unprognostic (1.35e-2)"	"unprognostic (5.59e-2)"	"prognostic unfavorable (8.10e-4)"	"unprognostic (1.48e-1)"	"unprognostic (7.52e-2)"	"unprognostic (5.39e-2)"	"unprognostic (1.75e-2)"	706.4	126.1	19.7	1505.7	24.3	32194.3	189.8	21.4	67.8	7849.1	28.5	123.9	24.1	50.0	2.0	30581.7	486.1	147.4	208.5	19.4	21.9	171.7	284.0	1629.4	69.3	28.7	24.2	51.5	73.9	11.5	65.4	370.1	30.0	91.3	20.2	3.6	5790.0	9.6	92.2	416.7	120.6	480.7	22.0	5381.4	187.6	16.7	26.5	197.7	90.4	150.4	4378.8	955.1	14027.7	25.4	24.6	0.2	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	1.5	0.0	9.2	372.2	0.0	0.4	23.0	0.0	157.3	0.0	0.4	0.0	6.2	0.0	0.1	0.0	7.8	0.0	0.0	130.2	0.0	8.4	0.0	0.0	0.1	7.6	3.5	0.0	31.4	0.8	3.3	0.1	3.1	0.2	0.8	5.1	82.2	0.3	100.4	1.3	0.6	4.0	2398.2	1.7	1.2	38.1	312.3	6.8	0.0	3.3	0.4	0.4	0.7	1.6	3.3	0.5	71.7	0.0	373.8	24579.6	2626.3	30.5	1754.8	52.6	29.7	25.3	17.2	4664.8	24.8	17.7	15.4	33654.0	18.8	860.2	153.3	29.2	24461.7	19.7	24.3	21.4	67.8	19.4	21.9	28.7	24.2	30.0	22.0	26.5	25.4	1.8	230.8	392.4	0.0	92.1	20.0	123.1	5771.3	28.5	0.0	55.6	6.7	8.0	57.2	1685.0	36.8	0.0	126.1	115.1	7.7	5.9	102.6	1.7	1.2	1.9	26.9	0.0	92.8	0.0	39.4	52.9	50.9	3.6	9.4	164.0	0.2	70.6	54.5	1926.0	0.0	0.0	3.7	309.3	7537.0	13.4	4.0	5.9	3678.1	0.0	0.0	11103.1	0.0	483.0	0.0	0.0	15.3	1.4	0.0	13.1	55.6	0.8	25.2	262.8	0.3	0.0	13.3	60.4	0.3	1.2	3263.1	33.2	1236.0	79.9	0.0	12.5	551.3
S100B	S100beta	ENSG00000160307	"S100 calcium binding protein B"	P04271	21	46598604-46605208	"Cancer-related genes, Candidate cardiovascular disease genes, Predicted intracellular proteins, Transporters"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	8	"brain: 1499.3;choroid plexus: 781.0"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 126.3;Breast myoepithelial cells: 124.8;Granulosa cells: 261.7;Langerhans cells: 206.8;Melanocytes: 99.6;Oligodendrocytes: 332.1"	"Group enriched"	"Detected in all"	58	"glioma: 463.5;melanoma: 495.2"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"gdT-cell: 360.9"	"Lineage enriched"	"Detected in all"	6	"T-cells: 360.9"	"Group enriched"	"Detected in some"	7	"SK-MEL-30: 547.1;WM-115: 992.8"									"CAB000073, HPA015768, CAB078196"	Enhanced	Supported	Supported	Nucleoplasm,Vesicles,Cytosol		NA	NA		300000	"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 70: Brain - Nervous system development"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 40: Granulosa cells - Unknown function"	"Nucleoplasm, Cytosol"	Vesicles	"CAB000073: AB_10013383, CAB078196: AB_2665776, HPA015768: AB_1856538"	"unprognostic (5.67e-3)"	"unprognostic (6.39e-3)"	"unprognostic (2.08e-3)"	"unprognostic (2.08e-2)"	"unprognostic (4.54e-3)"	"unprognostic (1.10e-2)"	"unprognostic (1.01e-1)"	"unprognostic (6.68e-3)"	"unprognostic (2.03e-1)"	"unprognostic (1.37e-1)"	"unprognostic (8.57e-3)"	"unprognostic (6.70e-2)"	"unprognostic (4.41e-7)"	"unprognostic (3.55e-2)"	"unprognostic (7.56e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.74e-1)"	151.1	25.7	877.1	10.5	1072.5	2.3	87.0	1254.5	1191.2	28.6	781.0	121.0	7.4	2.4	12.1	14.6	6.9	14.3	28.1	858.4	989.0	3.6	3.2	6.4	21.4	1491.0	1054.2	5.6	5.0	0.3	44.7	0.8	1359.0	29.3	14.2	14.1	19.3	26.2	3.6	15.8	36.3	6.8	1162.2	26.2	23.6	2.4	998.8	18.4	5.2	6.4	20.3	15.9	26.9	1499.3	0.5	0.0	110.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.3	0.0	0.0	0.6	0.0	0.0	0.0	0.2	0.5	0.9	0.0	0.0	0.0	0.2	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.2	15.9	0.6	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.3	2.5	0.0	0.0	547.1	0.0	0.1	0.5	0.0	0.3	0.3	0.0	3.2	0.0	0.3	0.0	1.4	6.7	992.8	0.1	0.5	0.2	360.9	9.5	103.3	0.2	1.0	67.6	16.3	1.4	3.2	153.1	3.2	58.7	10.1	3.9	0.0	63.6	877.1	1072.5	1254.5	1191.2	858.4	989.0	1491.0	1054.2	1359.0	1162.2	998.8	1499.3	4.5	3.2	4.8	126.3	4.6	16.8	0.7	0.0	17.6	1.3	41.2	124.8	6.0	0.0	0.0	0.0	0.0	0.0	14.7	0.1	0.0	0.1	0.4	0.1	0.1	2.7	0.0	2.7	0.9	0.0	0.1	4.4	0.5	0.2	0.0	261.7	4.6	0.4	9.3	0.0	1.4	0.0	0.0	38.6	206.8	1.7	5.6	37.0	99.6	9.4	33.3	25.7	63.8	83.4	332.1	0.1	0.0	0.0	2.2	0.1	0.0	0.1	0.0	4.7	0.0	5.6	7.8	0.1	0.1	0.7	12.6	0.1	37.9	0.0	0.2	0.4
S100P		ENSG00000163993	"S100 calcium binding protein P"	P25815	4	6693878-6697170	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 1410.7;stomach 1: 1742.0;urinary bladder: 1777.0"	"Cell type enhanced"	"Detected in many"		"Club cells: 1088.3;Gastric mucus-secreting cells: 2306.9;Syncytiotrophoblasts: 2773.6;Urothelial cells: 4448.3"	"Cancer enhanced"	"Detected in many"		"urothelial cancer: 564.7"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	46	"basophil: 1789.3;eosinophil: 836.9;neutrophil: 2961.8"	"Lineage enriched"	"Detected in many"	73	"granulocytes: 2961.8"	"Cell line enhanced"	"Detected in many"		"BEWO: 879.0;Hep G2: 1283.2;hTCEpi: 1185.6;OE19: 4335.4;RT4: 2619.8;SK-BR-3: 1057.4"									"HPA019502, HPA075251"	Enhanced		Supported	Nucleoplasm		NA	NA		1600000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 21: OE19 - Mitochondria"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Nucleoplasm		"HPA019502: AB_1856530, HPA075251: "	"unprognostic (1.46e-1)"	"unprognostic (1.50e-1)"	"unprognostic (7.52e-2)"	"unprognostic (1.44e-1)"	"unprognostic (2.22e-1)"	"unprognostic (7.34e-2)"	"unprognostic (1.60e-3)"	"unprognostic (3.92e-2)"	"unprognostic (7.19e-2)"	"unprognostic (9.24e-2)"	"prognostic unfavorable (2.00e-4)"	"unprognostic (3.87e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.72e-1)"	"unprognostic (9.24e-2)"	"unprognostic (3.65e-1)"	"unprognostic (1.12e-2)"	14.0	1.7	1.0	42.4	1.4	1410.7	7.4	1.6	6.3	15.0	1.4	155.6	13.2	5.9	0.0	340.6	6.9	52.1	2.7	1.4	0.9	2.1	8.8	14.7	1.0	1.1	1.1	0.5	4.7	0.4	1.7	474.7	3.2	25.5	176.0	0.1	8.2	0.5	0.4	20.9	23.8	16.6	0.6	34.3	1742.0	1.4	1.0	10.6	0.6	12.2	96.9	1777.0	34.5	1.1	115.2	89.1	0.0	0.1	0.0	0.5	879.0	0.0	1.0	0.0	0.0	5.2	17.6	0.7	40.1	0.6	1.2	137.6	0.5	1.1	0.0	54.7	0.0	1.9	106.7	1283.2	0.0	53.4	3.2	0.6	1185.6	0.0	1.1	0.2	0.2	0.8	3.1	0.0	0.0	214.5	1.6	126.5	1.5	4335.4	149.6	0.9	0.5	0.5	0.0	2619.8	1.1	0.7	156.8	1057.4	2.4	39.9	31.0	169.6	0.5	0.0	1.4	0.2	0.9	1.2	0.7	0.8	0.1	479.1	0.2	1789.3	40.6	836.9	1.4	9.5	1.1	0.4	1.7	1.1	1.6	0.5	0.3	0.8	2961.8	0.1	5.7	0.4	1.1	16.7	1.0	1.4	1.6	6.3	1.4	0.9	1.1	1.1	3.2	0.6	1.0	1.1	0.9	9.6	48.6	0.0	6.2	1.1	318.3	568.6	4.0	0.0	3.4	3.6	1.2	27.1	1088.3	1.8	0.0	550.7	2.2	322.2	0.0	4.8	12.3	37.5	38.9	8.7	16.6	0.0	0.0	31.1	783.4	13.8	2306.9	202.5	31.6	0.0	1.4	7.4	69.2	0.0	0.0	443.7	152.5	11.8	1.0	7.4	0.0	11.0	8.8	0.0	5.6	0.0	2.1	0.0	0.1	828.1	580.9	0.0	5.9	288.4	2.2	0.5	301.5	0.0	0.0	0.1	32.1	0.5	0.6	18.6	6.3	2773.6	9.8	0.1	173.2	4448.3
S100PBP	"FLJ12903, S100PBPR"	ENSG00000116497	"S100P binding protein"	Q96BU1	1	32816767-32858875	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 78.8;Spermatocytes: 109.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027242, HPA027328"	Approved		Supported	"Nuclear speckles"		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 12: NES - Nervous system development"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	"Nuclear speckles"		"HPA027242: AB_2672174, HPA027328: AB_2672221"	"unprognostic (4.29e-2)"	"unprognostic (8.54e-2)"	"unprognostic (3.54e-1)"	"unprognostic (2.52e-3)"	"unprognostic (2.44e-2)"	"prognostic favorable (5.22e-5)"	"prognostic unfavorable (1.26e-6)"	"unprognostic (1.61e-1)"	"unprognostic (2.52e-3)"	"unprognostic (3.71e-1)"	"unprognostic (6.79e-2)"	"unprognostic (1.83e-2)"	"prognostic unfavorable (9.03e-4)"	"unprognostic (2.87e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.48e-1)"	9.5	10.9	12.1	10.0	19.4	14.2	9.6	13.3	14.1	14.3	13.9	10.8	6.1	12.2	10.1	7.2	12.5	10.0	7.0	10.7	16.1	7.9	8.8	9.2	15.7	14.2	14.1	16.9	6.9	6.5	11.1	10.9	13.7	10.0	7.6	14.0	8.9	8.5	7.0	8.4	11.3	10.9	12.0	15.6	8.2	34.5	15.1	18.7	11.6	8.1	14.9	10.0	10.2	17.6	11.7	15.0	32.2	17.8	15.0	21.0	16.6	22.3	15.7	20.5	22.7	9.5	18.6	36.5	17.2	14.8	19.7	18.3	31.7	13.1	25.2	18.6	10.6	45.7	31.1	12.1	17.6	21.1	18.0	15.2	12.3	19.5	23.9	27.9	21.8	30.8	27.5	27.2	25.0	6.8	32.6	19.0	38.2	7.9	11.7	29.7	34.5	31.3	9.3	7.6	15.0	14.6	22.9	6.6	24.9	49.2	13.8	13.0	11.4	28.3	18.9	24.3	14.7	40.2	39.2	36.5	13.8	22.2	15.9	7.5	3.6	6.5	6.6	2.0	7.9	8.7	5.2	7.1	3.8	5.4	3.6	5.2	4.6	18.7	1.7	11.3	5.5	3.8	12.1	19.4	13.3	14.1	10.7	16.1	14.2	14.1	13.7	12.0	15.1	17.6	18.3	12.8	21.0	32.3	20.0	10.5	10.4	12.5	26.2	21.2	18.0	16.1	6.0	18.6	13.6	20.2	35.5	14.8	32.6	7.7	13.7	11.0	7.8	13.0	20.6	15.4	8.4	23.1	17.9	5.0	17.0	15.5	12.8	13.1	14.5	29.1	21.4	11.5	15.2	18.5	23.9	7.8	8.2	19.3	9.6	6.9	19.0	14.5	5.4	48.7	10.6	13.1	33.0	51.8	78.8	6.6	4.4	17.7	29.2	9.7	12.6	5.9	9.8	25.0	26.3	12.5	16.6	109.9	74.4	17.6	7.1	6.2	22.0	12.3	9.9	6.5
S1PR1	"CD363, D1S3362, edg-1, EDG1"	ENSG00000170989	"Sphingosine-1-phosphate receptor 1"	P21453	1	101236865-101243713	"Cancer-related genes, CD markers, FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters"	"Angiogenesis, Chemotaxis"	"G-protein coupled receptor, Receptor, Transducer"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 236.1;Endothelial cells: 122.3;Hepatic stellate cells: 114.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 1248.4"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ: 73.0;HUVEC TERT2: 198.9;TIME: 113.3;U-251 MG: 147.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010104, HPA075568"	Supported		Supported	Vesicles		No	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Vesicles		"CAB010104: AB_2238920, HPA075568: AB_2686758"	"unprognostic (1.41e-1)"	"unprognostic (9.35e-2)"	"unprognostic (2.46e-2)"	"unprognostic (2.61e-1)"	"unprognostic (9.78e-2)"	"unprognostic (4.49e-3)"	"unprognostic (1.34e-3)"	"unprognostic (1.99e-1)"	"unprognostic (1.36e-1)"	"unprognostic (9.12e-2)"	"unprognostic (2.34e-2)"	"unprognostic (2.23e-1)"	"unprognostic (5.82e-3)"	"unprognostic (2.54e-2)"	"unprognostic (1.04e-1)"	"unprognostic (3.64e-1)"	"prognostic unfavorable (8.78e-4)"	114.7	14.4	58.8	29.8	62.7	18.5	91.9	59.8	59.0	18.5	27.8	19.5	9.4	24.7	3.9	26.8	22.9	28.0	71.8	51.3	65.1	18.0	31.3	78.3	46.3	65.2	73.0	8.2	20.3	23.3	8.7	48.1	61.3	13.7	10.1	14.6	15.0	7.8	27.9	17.9	22.3	31.2	57.6	63.1	17.1	2.6	76.5	21.4	35.9	51.5	26.9	34.3	19.2	52.6	15.6	0.2	14.2	0.0	1.4	32.7	0.1	73.0	13.5	47.9	16.6	0.1	0.7	0.0	17.8	25.2	0.4	0.0	1.8	0.8	27.0	6.1	1.2	6.8	0.3	0.0	6.6	0.0	3.5	45.0	0.3	0.1	3.7	1.7	198.9	5.8	0.2	14.4	13.5	0.0	20.6	0.0	3.9	0.4	4.8	0.0	13.4	0.5	0.1	0.0	0.0	0.1	0.7	0.0	0.2	0.9	0.0	0.2	113.3	6.8	2.9	2.0	147.1	1.3	0.0	1.0	0.7	0.0	0.4	1248.4	2.2	55.4	589.4	2.1	441.5	294.7	502.6	492.1	2.6	346.9	383.3	396.3	15.4	397.5	3.4	3.1	329.4	438.7	58.8	62.7	59.8	59.0	51.3	65.1	65.2	73.0	61.3	57.6	76.5	52.6	236.1	0.0	8.9	37.9	36.0	7.6	0.2	0.0	2.2	0.4	1.1	1.1	23.8	2.8	1.3	0.0	0.0	5.9	25.0	0.0	0.0	0.0	0.0	1.1	1.0	122.3	0.0	0.4	0.1	0.0	0.3	11.7	0.5	1.8	7.6	9.7	114.2	8.9	9.9	0.0	0.3	0.0	0.0	6.5	5.7	0.0	0.9	3.0	5.4	13.1	9.9	31.1	40.2	0.5	0.2	0.0	0.0	0.0	18.2	0.5	0.0	0.1	0.0	1.4	0.0	3.6	4.8	0.7	0.7	0.6	5.1	2.6	29.9	1.8	0.1	0.4
S1PR4	EDG6	ENSG00000125910	"Sphingosine-1-phosphate receptor 4"	O95977	19	3172346-3180332	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 19.6;lymphoid tissue: 61.1"	"Cell type enhanced"	"Detected in some"		"B-cells: 62.3;dendritic cells: 76.7;monocytes: 33.7;NK-cells: 140.1;T-cells: 64.0"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in single"		"cerebral cortex: 2.4"	"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 24.0;HL-60: 32.2;NB-4: 31.7;REH: 89.2;U-937: 30.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA060601, HPA067232"			Supported	Mitochondria		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 2: Immune cells - Immune response"	"Cluster 14: REH - Unknown function"	"Cluster 63: NK-cells & T-cells - Immune response"	Mitochondria		"HPA060601: AB_2797261, HPA067232: AB_2797271"	"prognostic favorable (3.13e-4)"	"prognostic favorable (1.33e-4)"	"unprognostic (2.58e-2)"	"prognostic favorable (2.22e-4)"	"unprognostic (2.98e-2)"	"prognostic favorable (1.45e-6)"	"unprognostic (1.27e-2)"	"unprognostic (8.73e-2)"	"unprognostic (1.21e-3)"	"unprognostic (6.64e-3)"	"unprognostic (3.59e-1)"	"unprognostic (2.20e-1)"	"prognostic unfavorable (2.87e-4)"	"unprognostic (2.97e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.06e-1)"	"unprognostic (6.15e-3)"	4.6	1.0	0.3	10.7	0.2	19.6	2.8	0.1	2.4	1.0	0.2	2.3	1.1	0.9	0.0	2.3	2.3	1.0	1.6	0.2	0.1	1.7	1.6	11.9	16.5	0.3	0.1	0.3	0.7	0.1	0.3	1.4	0.6	1.3	0.2	0.0	1.2	0.1	0.6	0.8	13.6	0.5	0.2	61.1	4.9	0.2	0.5	4.8	2.9	0.7	4.8	2.8	1.2	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	10.9	0.3	0.0	0.0	0.3	0.0	0.1	0.0	24.0	0.0	10.2	0.2	0.0	0.0	32.2	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.1	31.7	0.0	0.3	0.0	89.2	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.1	0.0	0.3	0.0	0.0	0.1	0.0	3.5	0.0	30.4	0.0	53.2	28.3	81.0	31.1	32.5	27.2	32.3	37.9	29.9	20.4	39.3	31.6	30.2	120.8	16.3	44.7	18.1	67.6	21.6	0.3	0.2	0.1	2.4	0.2	0.1	0.3	0.1	0.6	0.2	0.5	0.1	6.3	3.2	4.6	0.0	62.3	1.3	0.2	0.8	0.0	0.0	0.4	0.3	0.4	1.5	1.9	1.8	0.0	0.2	76.7	0.2	0.0	0.1	0.1	0.4	0.1	4.1	0.0	17.0	0.0	0.2	0.2	0.5	3.1	0.3	5.7	0.0	6.8	0.8	25.2	0.0	0.0	0.0	0.0	27.6	8.3	0.0	0.0	27.8	1.8	0.0	33.7	0.0	140.1	0.0	0.0	0.1	0.0	0.0	27.7	0.3	0.0	0.3	2.7	0.0	0.0	0.5	0.3	0.0	0.0	0.1	1.4	0.0	64.0	0.0	0.0	0.6
SAAL1	FLJ41463	ENSG00000166788	"Serum amyloid A like 1"	Q96ER3	11	18069935-18106087	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Spermatocytes: 41.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039003, HPA039004"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"HPA039003: AB_2676303, HPA039004: AB_10673602"	"unprognostic (1.13e-1)"	"unprognostic (3.00e-1)"	"unprognostic (4.35e-1)"	"unprognostic (2.37e-2)"	"unprognostic (1.88e-1)"	"unprognostic (5.76e-2)"	"unprognostic (4.10e-3)"	"unprognostic (1.53e-2)"	"unprognostic (4.75e-2)"	"unprognostic (7.26e-2)"	"unprognostic (3.36e-1)"	"unprognostic (1.33e-1)"	"prognostic unfavorable (5.78e-5)"	"unprognostic (2.86e-1)"	"unprognostic (1.39e-1)"	"unprognostic (3.72e-1)"	"unprognostic (1.87e-1)"	6.0	5.3	4.9	8.2	4.8	19.1	10.0	5.6	6.1	6.2	4.3	9.6	8.0	7.5	7.7	6.6	5.6	4.8	6.5	4.6	5.0	5.4	8.3	4.9	14.6	4.8	5.3	8.2	8.1	5.4	5.2	7.0	4.9	6.0	11.9	8.2	5.6	5.8	5.8	5.7	6.7	9.6	4.8	7.5	6.7	12.8	5.1	13.7	6.1	7.2	15.6	7.8	6.1	5.7	27.1	41.5	29.5	40.5	19.5	21.8	24.6	29.9	20.4	44.8	52.8	57.8	10.1	73.0	15.5	16.9	62.3	34.9	56.9	48.5	62.6	32.5	57.4	33.6	24.9	35.0	15.9	57.1	28.6	15.2	22.2	28.7	42.9	16.8	38.5	62.8	50.5	23.9	37.2	36.2	66.7	54.2	38.5	41.7	39.0	65.7	51.8	25.4	25.7	31.4	36.4	34.3	26.9	28.4	36.4	37.1	18.2	25.9	15.8	51.0	35.0	29.4	43.2	11.6	37.7	80.6	21.2	45.2	47.5	11.1	12.9	4.3	14.0	15.4	13.5	16.5	16.2	12.3	22.3	11.7	12.3	13.3	0.6	10.4	14.6	11.4	20.9	10.8	4.9	4.8	5.6	6.1	4.6	5.0	4.8	5.3	4.9	4.8	5.1	5.7	7.6	0.0	10.8	7.5	15.9	4.6	7.8	16.0	9.6	9.0	7.2	6.9	8.5	2.8	7.4	1.8	2.1	22.0	13.6	6.3	5.9	9.6	21.9	4.4	8.0	8.7	28.1	11.1	8.5	10.2	23.1	8.0	4.6	4.2	14.0	15.3	5.7	4.6	16.1	0.0	9.5	10.7	8.2	10.9	7.3	3.5	8.1	7.7	5.4	6.5	10.7	6.5	4.1	15.1	11.7	6.6	7.5	7.9	17.3	3.8	6.9	7.7	6.0	8.5	6.6	6.1	10.5	41.5	24.9	8.3	5.4	10.4	9.9	10.1	15.1	6.1
SAFB2	KIAA0138	ENSG00000130254	"Scaffold attachment factor B2"	Q14151	19	5586999-5624046	"Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"DNA-binding, Repressor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA050894	Approved		Supported	"Nucleoplasm,Nuclear bodies,Vesicles"		NA	NA		48000	"Cluster 38: Basophils - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	"Nuclear bodies, Vesicles"	"HPA050894: AB_2681266"	"unprognostic (7.46e-2)"	"unprognostic (3.09e-1)"	"unprognostic (7.69e-3)"	"prognostic favorable (7.10e-4)"	"unprognostic (7.95e-2)"	"unprognostic (6.76e-3)"	"unprognostic (4.19e-3)"	"unprognostic (5.93e-2)"	"unprognostic (2.11e-1)"	"unprognostic (5.14e-2)"	"prognostic favorable (2.53e-4)"	"unprognostic (2.23e-2)"	"unprognostic (2.82e-3)"	"unprognostic (1.17e-2)"	"unprognostic (1.55e-1)"	"unprognostic (4.11e-2)"	"prognostic favorable (2.12e-4)"	26.8	35.8	23.3	22.4	23.8	35.2	25.8	28.0	30.3	48.4	21.0	35.3	22.2	38.2	21.0	23.1	44.0	15.6	30.8	21.7	29.6	40.6	30.7	27.8	24.4	24.2	23.9	56.2	30.5	18.0	48.6	14.2	23.1	43.0	16.1	34.7	27.6	18.6	41.5	25.8	34.3	19.3	17.5	39.9	27.8	32.5	23.9	22.3	38.9	20.4	21.2	31.5	35.0	27.5	44.9	54.8	38.8	30.4	36.7	23.7	47.6	40.9	21.3	24.4	23.3	69.9	31.4	84.9	36.9	19.9	19.6	39.9	47.2	24.9	39.2	59.8	53.5	64.4	59.5	54.6	21.2	53.0	58.2	23.5	25.4	35.2	26.9	23.9	24.6	29.3	63.6	40.6	28.7	48.9	65.7	53.1	69.9	33.1	59.9	82.2	34.2	47.6	27.7	70.5	37.6	35.3	54.7	25.3	35.3	24.4	36.5	33.0	40.5	30.7	32.7	39.3	57.6	55.2	52.2	58.6	31.2	47.1	52.2	42.8	12.6	22.0	14.6	10.8	16.8	13.9	13.2	11.7	11.3	14.9	14.5	11.7	23.4	9.4	12.3	12.5	13.4	7.9	23.3	23.8	28.0	30.3	21.7	29.6	24.2	23.9	23.1	17.5	23.9	27.5	40.6	41.7	45.1	79.7	69.7	46.7	58.1	41.4	47.3	70.2	39.1	30.6	28.7	20.0	39.3	33.1	75.0	46.8	63.0	46.4	23.5	49.7	7.6	44.5	92.6	49.0	43.0	45.8	36.2	44.4	44.7	47.3	44.4	58.3	42.3	45.4	26.7	23.3	30.6	43.7	42.7	46.5	57.0	27.6	49.5	13.3	72.4	46.6	26.6	32.8	52.2	77.5	52.5	29.7	34.6	42.2	48.6	65.8	70.0	50.3	54.1	61.5	55.3	78.4	46.0	75.4	47.9	68.3	78.8	37.3	41.9	32.3	79.1	59.7	44.8	54.2
SAMD4A	"DKFZP434H0350, hSmaug1, KIAA1053, SAMD4, Smaug, SMG, SMGA"	ENSG00000020577	"Sterile alpha motif domain containing 4A"	Q9UPU9	14	54566117-54793315	"Predicted intracellular proteins"	"Translation regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 94.3;testis: 107.9"	"Group enriched"	"Detected in many"	4	"Early spermatids: 1176.0;Late spermatids: 2275.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"intermediate monocyte: 1.2;non-classical monocyte: 1.0"	"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043061, HPA065309"	Approved		Approved	"Cell Junctions,Cytosol"		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 34: Spermatids - Unknown function"	"Cell Junctions"	Cytosol	"HPA043061: AB_2678299, HPA065309: AB_2685462"	"unprognostic (1.46e-1)"	"unprognostic (8.10e-3)"	"unprognostic (9.66e-3)"	"unprognostic (1.18e-4)"	"unprognostic (2.79e-1)"	"unprognostic (6.37e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.98e-1)"	"unprognostic (7.74e-2)"	"unprognostic (1.09e-2)"	"unprognostic (2.83e-2)"	"unprognostic (8.27e-2)"	"unprognostic (5.41e-2)"	"unprognostic (1.51e-1)"	16.6	4.2	27.4	8.9	33.1	0.4	13.1	42.3	24.9	13.0	14.1	37.6	3.2	26.1	4.0	6.7	12.0	6.0	47.8	22.6	40.3	12.4	16.6	21.2	4.6	79.0	46.2	4.5	6.2	3.8	6.1	9.2	69.4	14.5	4.8	2.6	7.0	9.4	94.3	8.9	10.4	17.1	64.1	7.1	10.9	107.9	41.8	1.1	7.0	39.3	3.1	17.7	12.8	60.8	32.9	2.9	6.7	3.4	14.0	21.3	11.7	27.4	41.4	22.3	22.0	36.8	7.8	1.8	14.0	41.7	8.8	22.6	6.6	14.2	32.8	16.5	2.8	0.0	4.0	7.7	7.7	0.0	0.2	12.6	5.3	15.9	23.4	6.5	17.1	0.0	2.6	0.0	11.0	2.4	0.4	0.1	3.1	0.2	7.5	0.9	13.5	0.1	11.0	10.8	1.0	10.7	4.0	5.2	15.9	13.8	21.0	0.3	37.1	26.6	41.1	6.6	8.7	0.1	0.1	0.0	7.5	0.6	8.4	0.0	0.6	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.7	0.4	0.0	0.0	0.0	0.0	1.0	0.0	0.1	0.2	27.4	33.1	42.3	24.9	22.6	40.3	79.0	46.2	69.4	64.1	41.8	60.8	16.0	25.6	1.5	170.1	7.4	39.6	47.0	12.0	1.2	2.4	6.2	6.1	278.5	14.3	9.9	18.4	8.4	10.5	1.6	4.4	3.9	9.9	1176.0	13.7	45.3	30.9	6.0	5.7	64.6	8.0	1.8	47.3	1.5	29.3	22.8	0.8	10.8	62.6	11.6	10.1	173.7	1.5	6.1	15.3	28.9	2275.7	14.6	13.0	24.9	72.1	12.8	1.5	1.0	380.5	140.7	19.8	5.5	23.7	0.3	55.1	5.6	22.9	4.0	5.4	13.1	79.7	37.1	17.1	7.6	0.4	24.3	1.9	5.7	0.3	1.7	44.5
SAMD5	dJ875H10.1	ENSG00000203727	"Sterile alpha motif domain containing 5"	Q5TGI4	6	147508690-147737547	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"Bipolar cells: 96.0;Inhibitory neurons: 276.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"CACO-2: 16.6;Hep G2: 65.6;K-562: 44.7;RH-30: 29.0;WM-115: 20.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA067811	Uncertain		Supported	Vesicles		No	No				"Cluster 77: Retina - Visual perception"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Vesicles		"HPA067811: AB_2685901"	"unprognostic (4.16e-2)"	"unprognostic (4.52e-2)"	"unprognostic (9.65e-3)"	"unprognostic (1.41e-2)"	"unprognostic (1.82e-2)"	"unprognostic (5.88e-2)"	"prognostic unfavorable (2.23e-4)"	"unprognostic (2.31e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.61e-2)"	"unprognostic (8.55e-3)"	"unprognostic (3.09e-2)"	"unprognostic (5.40e-3)"	"unprognostic (1.72e-1)"	"unprognostic (4.51e-2)"	"unprognostic (9.82e-3)"	"unprognostic (1.50e-1)"	0.6	1.8	2.8	1.3	5.6	0.1	4.1	1.0	2.6	1.4	0.1	6.0	3.0	4.2	0.8	8.9	0.9	2.2	1.2	2.7	4.0	7.4	7.5	3.4	0.3	8.7	4.1	0.4	1.3	5.7	3.8	12.2	9.1	1.4	8.1	8.9	2.3	2.4	0.2	1.9	4.4	3.1	0.0	1.4	4.5	7.6	7.2	0.1	2.1	0.1	0.7	1.5	1.9	0.8	11.2	1.4	1.4	2.0	0.0	0.0	0.1	3.6	1.3	0.3	0.2	16.6	0.1	0.6	3.6	0.0	0.6	0.1	0.3	2.5	0.4	0.0	2.0	0.8	1.5	65.6	0.2	0.0	1.3	0.0	0.1	0.3	0.1	0.0	6.8	0.0	44.7	0.6	4.8	0.1	0.0	0.0	0.1	8.4	2.8	0.0	29.0	6.5	0.1	2.3	0.5	0.1	0.9	0.2	2.8	0.3	0.0	0.0	4.9	0.5	1.5	0.5	1.3	0.1	1.1	0.0	0.1	0.1	20.8	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.8	5.6	1.0	2.6	2.7	4.0	8.7	4.1	9.1	0.0	7.2	0.8	1.7	3.2	5.9	1.3	1.0	1.8	5.6	0.5	2.2	96.0	2.9	23.5	2.6	0.0	0.0	18.4	2.1	0.2	0.0	5.4	9.8	2.2	0.5	1.1	10.7	11.1	16.9	0.0	15.7	0.2	0.3	6.9	19.4	1.8	0.0	7.0	6.1	28.1	0.8	0.0	276.9	11.6	0.0	1.0	1.4	1.3	0.3	0.7	0.0	45.0	0.0	9.2	0.0	5.5	0.9	0.6	3.4	3.4	0.1	3.0	5.2	19.7	0.0	4.0	0.0	3.1	2.0	0.5	0.2	36.4	1.6	0.3	0.5	3.6	25.7	4.2
SAMD8	"FLJ25082, SMSr"	ENSG00000156671	"Sterile alpha motif domain containing 8"	Q96LT4	10	75099586-75182123	"Predicted membrane proteins"	"Lipid metabolism, Sphingolipid metabolism"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 19.2"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044402			Supported	"Endoplasmic reticulum"		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 52: Non-specific - Transcription"	"Endoplasmic reticulum"		"HPA044402: "	"unprognostic (4.32e-1)"	"unprognostic (3.14e-1)"	"unprognostic (3.24e-2)"	"unprognostic (7.87e-2)"	"unprognostic (3.37e-2)"	"unprognostic (2.77e-2)"	"unprognostic (1.61e-2)"	"unprognostic (1.39e-1)"	"unprognostic (5.29e-1)"	"unprognostic (3.12e-2)"	"unprognostic (2.70e-1)"	"unprognostic (4.69e-2)"	"unprognostic (4.16e-3)"	"unprognostic (3.89e-2)"	"unprognostic (3.76e-1)"	"unprognostic (2.53e-1)"	"unprognostic (9.26e-3)"	14.0	10.8	17.1	7.2	22.8	17.0	10.4	20.8	18.7	14.8	10.3	7.2	6.1	11.1	7.2	15.6	10.7	9.2	11.3	17.1	17.8	7.3	7.5	10.1	6.9	23.4	24.9	13.6	5.1	9.6	9.2	11.5	22.5	8.1	4.9	22.6	7.7	8.0	27.1	7.1	6.8	10.1	23.6	7.9	5.6	15.2	21.0	6.3	7.8	14.7	6.1	9.5	12.9	29.7	8.7	7.8	12.7	10.0	28.1	25.8	15.1	14.8	29.9	9.1	11.7	12.8	12.4	5.9	9.4	14.3	10.5	15.3	6.8	11.3	15.9	7.2	8.3	2.6	8.0	8.6	15.6	2.7	6.8	24.4	11.2	18.0	24.8	24.6	14.1	6.7	5.6	10.4	21.0	6.1	5.1	4.1	5.7	6.4	23.9	4.4	10.6	2.8	10.3	7.8	1.8	8.7	13.9	17.8	15.1	13.6	7.4	3.1	22.6	10.5	13.7	12.6	10.4	6.9	6.9	6.0	16.4	7.0	6.7	3.1	3.7	2.5	2.9	4.8	1.8	5.5	3.2	3.4	3.4	5.9	2.7	3.1	19.2	4.0	6.6	3.8	3.0	1.3	17.1	22.8	20.8	18.7	17.1	17.8	23.4	24.9	22.5	23.6	21.0	29.7	24.6	9.6	12.5	25.1	25.0	42.3	28.1	34.2	23.9	20.9	21.4	11.3	26.7	10.0	26.5	14.7	14.6	10.4	18.1	10.0	0.0	10.9	47.6	17.3	29.8	24.3	23.4	4.4	50.9	10.2	12.5	29.4	10.2	23.1	12.7	18.5	23.2	10.9	13.2	18.5	37.2	3.3	26.4	16.3	48.4	10.9	25.1	27.8	12.4	35.6	27.8	20.5	12.3	38.2	77.1	16.3	11.4	25.2	22.2	22.3	11.8	7.7	35.4	32.7	32.9	30.9	23.9	54.7	24.3	42.9	42.9	68.0	20.2	12.4	5.2	40.3
SAMD9	"C7orf5, FLJ20073, KIAA2004"	ENSG00000205413	"Sterile alpha motif domain containing 9"	Q5K651	7	93099513-93118023	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 39.1"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 92.7;Distal enterocytes: 104.6;NK-cells: 109.2;Paneth cells: 171.0"	"Cancer enhanced"	"Detected in all"		"head and neck cancer: 28.5"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+ RasG12V: 66.7;GAMG: 66.0"					"Low region specificity"	"Detected in all"			"HPA021318, HPA021319"	Approved		Supported	Vesicles,Cytosol		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Cytosol	Vesicles	"HPA021318: AB_2183383, HPA021319: AB_1856554"	"unprognostic (3.66e-2)"	"unprognostic (5.35e-1)"	"unprognostic (8.60e-2)"	"prognostic unfavorable (3.14e-4)"	"unprognostic (8.96e-2)"	"unprognostic (1.38e-1)"	"unprognostic (7.48e-2)"	"prognostic unfavorable (2.93e-4)"	"unprognostic (4.76e-2)"	"unprognostic (3.37e-2)"	"prognostic unfavorable (8.31e-5)"	"unprognostic (6.00e-2)"	"prognostic unfavorable (8.40e-7)"	"unprognostic (5.91e-2)"	"unprognostic (1.37e-2)"	"unprognostic (2.18e-2)"	"unprognostic (3.64e-1)"	4.1	3.6	1.1	13.2	1.0	9.9	3.5	1.1	1.0	8.0	1.4	11.0	7.5	3.5	2.9	39.1	3.0	7.2	2.4	1.1	1.6	3.2	3.7	7.7	15.8	2.8	1.5	5.8	1.6	1.0	0.9	7.0	2.0	2.0	11.3	0.3	4.3	2.4	0.6	1.9	7.7	4.0	2.9	17.7	10.7	1.0	2.1	20.7	2.0	2.3	15.9	7.0	8.3	2.5	28.5	3.6	1.0	0.2	12.0	15.2	0.3	10.9	45.2	51.0	66.7	0.2	30.9	11.9	16.8	27.1	66.0	32.6	0.1	10.0	17.1	40.5	1.3	17.3	18.0	0.0	5.4	19.5	23.1	6.8	14.1	16.8	4.6	2.8	7.7	13.1	1.2	28.6	10.9	0.1	29.2	15.9	0.1	0.0	7.9	9.5	9.2	13.5	0.3	3.6	4.4	0.4	8.4	3.3	9.1	0.1	1.0	9.5	33.8	11.8	4.2	36.0	6.0	16.9	3.4	10.8	12.3	11.2	12.1	21.8	4.2	15.7	8.3	8.1	7.7	5.6	6.4	7.3	3.6	5.9	6.7	6.1	17.8	8.8	12.8	2.5	8.8	3.2	1.1	1.0	1.1	1.0	1.1	1.6	2.8	1.5	2.0	2.9	2.1	2.5	43.9	9.6	3.7	0.7	53.4	2.3	8.2	40.2	4.0	1.4	4.4	5.1	1.2	5.7	33.7	14.7	0.0	1.9	92.7	104.6	0.0	23.5	0.1	21.1	18.5	29.0	3.0	19.4	0.4	12.3	7.1	14.6	37.8	7.0	43.6	21.8	12.1	1.2	11.5	6.7	1.5	34.9	20.3	29.9	9.6	0.7	15.2	32.7	3.6	21.5	41.6	2.2	109.2	2.0	2.4	50.4	171.0	12.4	35.9	7.0	12.6	2.3	37.5	0.1	13.1	14.4	12.6	0.2	0.0	21.1	1.8	0.4	69.4	25.4	5.6	34.3
SAMHD1	"AGS5, HDDC1, Mg11, MOP-5, SBBI88"	ENSG00000101347	"SAM and HD domain containing deoxynucleoside triphosphate triphosphohydrolase 1"	Q9Y3Z3	20	36890229-36951843	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Antiviral defense, DNA damage, DNA repair, DNA replication, Host-virus interaction, Immunity, Innate immunity"	"Allosteric enzyme, Hydrolase"	"Aicardi-Goutieres syndrome, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"dendritic cells: 214.2;Endometrial ciliated cells: 173.8;Kupffer cells: 280.2;Macrophages: 326.4;monocytes: 257.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 510.8;BJ hTERT+ SV40 Large T+: 165.8;BJ hTERT+ SV40 Large T+ RasG12V: 187.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047072	Enhanced		Supported	"Nucleoplasm,Plasma membrane"		NA	NA		91000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 64: Macrophages - Immune response"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	Nucleoplasm	"Plasma membrane"	"HPA047072: AB_2679921"	"unprognostic (1.09e-1)"	"unprognostic (7.30e-3)"	"unprognostic (1.65e-2)"	"unprognostic (3.85e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.91e-2)"	"unprognostic (2.15e-1)"	"unprognostic (4.07e-2)"	"unprognostic (2.03e-1)"	"unprognostic (3.63e-1)"	"unprognostic (1.88e-1)"	"unprognostic (1.04e-1)"	"prognostic unfavorable (5.12e-4)"	"unprognostic (1.44e-1)"	"unprognostic (9.06e-2)"	"unprognostic (3.18e-2)"	"unprognostic (2.72e-2)"	79.5	39.9	11.9	94.3	12.4	11.5	65.7	11.6	12.2	39.1	33.2	58.4	29.4	33.0	9.1	45.8	81.8	40.2	60.5	11.4	16.6	12.2	26.1	68.0	78.0	16.8	15.0	38.0	42.2	14.0	21.7	36.0	17.9	26.3	28.8	5.5	32.6	18.1	23.8	27.8	55.2	44.1	17.6	94.2	45.0	12.6	18.0	29.3	31.7	20.7	51.2	55.3	39.9	26.4	29.9	10.9	3.7	15.6	510.8	101.8	5.5	10.8	37.7	165.8	187.8	39.1	11.2	64.4	19.9	14.4	94.9	21.2	34.7	27.8	30.9	17.4	20.6	5.3	18.8	30.9	39.3	28.2	5.1	96.4	1.0	45.3	1.9	13.3	26.4	0.0	13.7	18.8	5.4	12.0	0.0	19.2	7.9	18.3	25.9	2.8	21.7	35.3	15.7	8.2	23.0	4.2	20.2	10.2	28.2	4.7	20.5	125.4	13.9	11.5	13.5	25.1	28.5	7.3	20.3	21.7	14.5	3.2	7.1	1.4	147.7	4.8	52.2	174.4	47.0	4.5	55.7	53.3	278.6	3.1	55.5	47.6	18.5	56.2	167.0	96.4	95.8	144.3	11.9	12.4	11.6	12.2	11.4	16.6	16.8	15.0	17.9	17.6	18.0	26.4	48.7	28.9	25.5	4.2	19.4	6.4	2.3	7.8	5.7	5.5	6.9	5.8	17.3	14.3	35.3	1.8	4.2	2.6	214.2	2.6	0.0	10.3	3.3	173.8	12.7	44.3	6.0	30.7	8.6	10.2	3.3	71.4	13.3	40.6	12.6	10.5	42.5	20.1	137.2	6.7	8.5	5.7	8.2	280.2	52.3	4.8	82.3	326.4	5.4	36.5	257.9	25.1	116.4	14.1	3.5	7.5	31.3	96.3	54.8	1.9	1.1	1.9	104.4	2.9	59.2	9.6	31.9	10.2	4.9	12.1	5.8	2.9	102.6	9.7	5.5	4.9
SAMM50	"CGI-51, OMP85, SAM50, TOB55, TRG-3, YNL026W"	ENSG00000100347	"SAMM50 sorting and assembly machinery component"	Q9Y512	22	43955442-44010531	"Predicted intracellular proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 240.4"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA034537	Enhanced		Supported	Mitochondria		NA	NA			"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"HPA034537: AB_10602794"	"unprognostic (2.92e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.95e-3)"	"prognostic favorable (2.63e-7)"	"unprognostic (2.43e-3)"	"unprognostic (2.28e-1)"	"unprognostic (5.28e-3)"	"unprognostic (1.70e-3)"	"unprognostic (3.37e-2)"	"unprognostic (1.95e-1)"	"unprognostic (2.42e-1)"	"unprognostic (3.52e-1)"	"prognostic favorable (4.43e-8)"	"unprognostic (1.08e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.41e-1)"	"unprognostic (1.60e-1)"	41.7	50.6	26.1	27.0	27.0	32.5	35.8	29.8	30.6	43.4	31.1	35.6	50.8	27.0	29.3	31.7	41.9	29.3	65.5	27.1	29.2	48.8	37.2	22.2	34.6	29.8	28.5	40.0	33.3	114.4	24.4	20.1	30.4	26.5	35.5	25.5	35.2	25.1	240.4	35.9	38.3	27.7	27.0	24.4	43.8	26.1	28.5	34.4	28.1	177.0	37.0	27.9	24.0	28.0	64.6	59.8	57.1	69.5	72.2	75.9	79.8	61.7	65.7	89.1	76.4	86.1	46.0	105.9	44.3	70.8	51.4	75.6	85.4	82.6	79.7	29.4	105.3	57.5	73.9	102.6	50.4	184.0	83.1	88.3	64.7	77.0	35.5	62.3	93.1	49.9	49.9	34.0	80.9	91.7	72.6	72.0	56.0	77.4	70.9	83.8	61.8	85.9	74.4	81.0	34.1	55.4	68.3	72.2	104.1	60.4	67.7	59.8	57.7	57.3	68.8	53.6	51.2	50.1	74.4	82.1	72.0	66.3	58.7	47.5	39.2	46.9	39.8	39.0	55.4	55.1	36.6	40.5	67.7	51.0	37.8	36.0	6.1	39.1	31.8	26.7	45.7	40.2	26.1	27.0	29.8	30.6	27.1	29.2	29.8	28.5	30.4	27.0	28.5	28.0	52.9	35.3	18.9	10.4	31.6	20.6	27.0	72.0	30.7	20.1	32.1	40.9	68.6	18.6	39.5	9.2	8.4	41.6	31.7	36.1	60.7	47.2	40.3	47.3	24.9	35.1	18.6	51.4	12.0	55.5	54.1	24.6	42.3	32.7	27.3	43.9	30.0	41.8	51.1	32.0	12.7	35.2	46.8	28.6	20.5	50.1	26.1	25.0	16.0	12.2	41.4	32.8	33.0	9.5	9.1	43.7	34.5	30.5	31.0	16.2	82.4	116.8	39.9	30.1	19.7	23.2	33.4	45.8	31.2	34.3	22.6	20.5	28.5	69.9	59.8	19.3
SAMSN1	"HACS1, NASH1, SASH2, SH3D6B, SLy2"	ENSG00000155307	"SAM domain, SH3 domain and nuclear localization signals 1"	Q9NSI8	21	14485228-14658821	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 192.9;lymphoid tissue: 80.1"	"Cell type enhanced"	"Detected in many"		"granulocytes: 1174.1;Langerhans cells: 317.9;Macrophages: 414.6;monocytes: 829.9;T-cells: 332.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 314.2"	"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"HEL: 273.7;K-562: 331.6;Karpas-707: 137.3"	"Region enriched"	"Detected in many"	6	"olfactory bulb: 20.7"	"Low region specificity"	"Detected in all"			"HPA010645, HPA017055, HPA046639"	Approved		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 41: Macrophages - Immune response"	"Plasma membrane"	Nucleoplasm	"HPA010645: AB_1856559, HPA017055: AB_1856560, HPA046639: AB_2679732"	"unprognostic (7.62e-3)"	"unprognostic (1.46e-2)"	"unprognostic (1.03e-2)"	"unprognostic (3.11e-2)"	"unprognostic (2.44e-1)"	"unprognostic (3.91e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.01e-1)"	"unprognostic (2.17e-1)"	"unprognostic (6.13e-2)"	"unprognostic (2.10e-2)"	"unprognostic (1.28e-1)"	"prognostic unfavorable (4.52e-6)"	"unprognostic (9.14e-2)"	"unprognostic (3.05e-2)"	"unprognostic (2.17e-1)"	"unprognostic (1.68e-2)"	32.3	6.7	2.4	80.1	2.8	192.9	4.7	3.3	4.9	5.7	4.2	11.0	7.0	3.4	1.9	5.3	6.3	22.7	4.5	2.5	3.5	4.2	17.5	22.9	35.4	6.2	4.5	1.3	3.1	2.0	2.1	15.5	6.1	3.9	15.3	12.7	2.8	2.2	0.7	1.5	15.1	10.8	5.1	32.0	9.3	1.2	4.6	22.4	2.2	1.2	41.0	39.7	2.5	8.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.9	0.1	0.0	0.0	0.0	0.0	1.8	0.0	14.0	0.0	273.7	0.0	0.0	0.0	32.5	12.7	0.1	0.0	0.0	37.9	10.2	3.6	4.8	331.6	137.3	0.0	0.0	15.9	39.5	0.1	0.0	0.2	26.8	0.3	20.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.8	35.0	0.0	0.0	0.0	0.0	58.2	0.5	0.3	1.4	20.7	0.0	314.2	38.7	234.6	22.1	52.3	15.4	27.3	42.8	33.3	25.0	15.4	26.8	19.1	49.4	18.0	83.0	0.9	60.3	33.6	2.4	2.8	3.3	4.9	2.5	3.5	6.2	4.5	6.1	5.1	4.6	8.9	4.8	22.4	54.9	0.7	127.5	15.6	1.1	0.0	1.8	64.9	2.7	3.0	1.2	1.5	11.2	36.8	0.0	0.5	147.9	0.7	0.0	0.6	0.0	0.8	0.2	8.0	0.0	13.7	1.0	6.5	0.7	11.3	10.7	0.6	1174.1	0.1	4.6	1.8	62.0	0.0	0.8	0.8	0.0	183.7	317.9	0.4	0.6	414.6	21.4	131.2	829.9	1.6	24.7	2.5	0.6	0.7	1.1	0.0	119.3	0.5	0.0	0.5	8.0	4.7	0.0	2.2	3.7	0.1	0.2	1.2	13.2	0.5	332.8	0.1	0.9	0.9
SAP130	FLJ12761	ENSG00000136715	"Sin3A associated protein 130"	Q9H0E3	2	127941217-128028120	"Metabolic proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 47.3"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 71.5;Late spermatids: 44.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA034664			Supported	"Nuclear speckles"		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	"Nuclear speckles"		"HPA034664: AB_10603238"	"unprognostic (2.17e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.33e-1)"	"unprognostic (5.45e-2)"	"unprognostic (1.65e-1)"	"prognostic unfavorable (7.89e-4)"	"unprognostic (2.75e-1)"	"unprognostic (1.30e-2)"	"unprognostic (1.43e-1)"	"unprognostic (3.92e-2)"	"unprognostic (6.77e-2)"	"unprognostic (3.75e-2)"	"unprognostic (5.26e-2)"	"unprognostic (4.41e-1)"	"unprognostic (2.13e-1)"	"unprognostic (1.13e-1)"	9.1	8.6	8.8	8.7	8.5	21.7	8.2	8.5	10.2	10.5	5.1	10.3	8.3	10.4	9.2	10.4	9.6	7.2	8.5	8.1	10.8	7.2	8.3	8.0	10.0	6.4	7.9	11.2	8.7	12.4	14.5	9.0	7.1	8.7	9.7	8.6	9.1	7.9	11.9	12.9	9.8	10.2	6.1	8.5	9.7	47.3	8.0	14.8	8.8	13.0	12.6	9.5	10.3	8.8	35.3	18.9	35.3	28.6	22.9	15.7	38.5	22.0	21.4	33.4	26.2	45.1	14.4	29.4	19.3	25.0	17.4	24.0	39.3	22.7	34.5	16.3	25.2	29.2	16.7	35.9	27.5	25.5	22.2	14.8	16.7	44.1	27.5	17.6	27.0	24.4	35.9	21.1	28.2	39.3	35.6	20.0	36.6	20.7	21.1	24.3	29.0	19.6	17.9	30.7	18.5	22.3	23.2	21.7	13.6	22.1	16.4	17.3	23.2	32.1	34.5	30.1	23.6	29.3	31.2	34.3	26.4	17.0	21.0	2.3	4.2	4.6	5.3	2.7	4.0	2.0	3.8	3.5	3.4	5.0	2.7	3.1	14.0	3.6	8.6	6.2	2.7	3.8	8.8	8.5	8.5	10.2	8.1	10.8	6.4	7.9	7.1	6.1	8.0	8.8	5.4	0.0	10.9	29.0	7.9	7.9	2.3	3.2	5.7	5.2	6.5	5.3	15.2	2.8	3.1	1.8	8.4	11.9	9.4	13.1	0.0	4.9	71.5	4.6	8.6	6.2	6.7	11.6	25.4	4.7	12.8	5.2	8.6	8.7	1.3	5.3	5.3	5.8	7.8	8.4	28.9	7.0	4.1	8.4	6.3	44.2	8.4	7.0	5.4	16.9	4.9	5.0	6.2	26.2	31.0	6.1	7.8	8.2	13.2	4.9	6.5	3.4	4.0	5.8	6.6	4.4	5.5	31.0	17.9	9.2	10.4	19.3	7.6	3.7	7.8	4.3
SAP18	"2HOR0202, MGC27131, SAP18p"	ENSG00000150459	"Sin3A associated protein 18"	O00422	13	21140514-21149084	"Predicted intracellular proteins, Transporters"	"mRNA processing, mRNA splicing, Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011352, CAB012273"	Supported		Supported	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 24: NB-4 - Immune response"	"Cluster 7: Non-specific - Mitochondria"	"Nucleoplasm, Nuclear bodies"	Cytosol	"CAB012273: , HPA011352: AB_1856563"	"unprognostic (5.08e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.19e-3)"	"unprognostic (2.84e-1)"	"unprognostic (5.21e-2)"	"unprognostic (3.02e-1)"	"unprognostic (3.18e-1)"	"unprognostic (8.15e-2)"	"unprognostic (3.48e-1)"	"unprognostic (1.01e-1)"	"unprognostic (4.14e-2)"	"unprognostic (2.33e-2)"	"unprognostic (7.75e-3)"	"unprognostic (4.70e-2)"	"unprognostic (3.70e-3)"	"unprognostic (2.78e-2)"	125.7	164.3	140.9	122.9	152.2	242.3	121.6	149.6	198.9	120.4	137.8	141.8	137.4	123.8	97.5	159.2	112.9	82.4	195.8	147.4	160.7	190.4	171.1	106.5	118.0	154.7	153.8	109.5	134.6	114.2	129.6	111.7	157.7	109.7	58.5	89.5	126.3	73.0	297.9	119.5	127.5	51.7	164.1	107.6	119.5	194.3	155.7	115.5	110.7	156.3	64.8	131.7	118.5	170.7	182.1	99.3	159.5	173.1	169.0	140.5	246.9	227.1	167.2	205.5	151.3	181.1	342.4	187.3	272.0	189.1	223.4	186.5	198.1	142.4	231.5	288.0	100.4	267.6	121.2	305.9	191.8	367.1	207.5	143.0	159.7	157.5	187.1	158.4	157.3	223.1	128.8	103.6	188.2	231.0	417.0	599.0	200.7	501.5	109.7	261.1	251.4	187.1	295.7	160.7	185.0	161.1	145.7	213.8	296.5	176.5	206.8	528.0	192.6	126.0	141.9	230.1	268.9	159.6	243.6	536.7	122.5	214.9	236.4	433.0	431.5	540.0	344.1	485.0	349.3	493.7	418.2	410.9	427.8	443.6	405.9	402.9	430.5	395.3	547.4	568.8	517.5	909.3	140.9	152.2	149.6	198.9	147.4	160.7	154.7	153.8	157.7	164.1	155.7	170.7	638.0	134.6	143.5	15.0	291.7	458.6	336.3	640.9	310.7	101.5	298.9	594.9	592.9	194.5	383.8	233.6	41.7	566.2	397.4	353.6	759.2	396.5	1259.5	334.1	231.1	273.1	234.5	214.4	20.8	365.6	528.0	374.0	170.2	256.2	258.6	176.6	180.2	242.0	396.0	119.5	23.4	364.5	468.0	189.5	440.9	206.0	342.3	260.4	407.4	17.8	385.0	370.8	233.8	19.6	26.2	401.9	417.6	303.6	182.3	325.9	475.0	1100.6	446.8	132.3	203.8	362.5	438.3	547.7	319.9	271.7	422.2	908.3	338.8	254.2	344.7	419.9
SAP30		ENSG00000164105	"Sin3A associated protein 30"	O75446	4	173369969-173377532	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Kupffer cells: 77.2;Macrophages: 77.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"Karpas-707: 181.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022627, HPA059012"	Enhanced		Supported	Nucleoplasm	"Intracellular and membrane"	NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 41: Macrophages - Immune response"	Nucleoplasm		"CAB022627: , HPA059012: AB_2683880"	"unprognostic (1.53e-1)"	"unprognostic (3.67e-2)"	"unprognostic (3.26e-1)"	"unprognostic (1.39e-1)"	"unprognostic (5.83e-2)"	"unprognostic (8.71e-2)"	"prognostic unfavorable (1.24e-6)"	"unprognostic (4.95e-2)"	"unprognostic (7.23e-2)"	"unprognostic (3.93e-2)"	"unprognostic (4.48e-1)"	"unprognostic (1.93e-2)"	"prognostic unfavorable (1.54e-7)"	"unprognostic (3.97e-1)"	"unprognostic (5.70e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.21e-1)"	17.4	12.9	17.4	13.3	19.7	23.4	12.8	18.4	21.6	13.9	16.1	25.6	9.5	13.2	9.6	9.9	16.9	8.6	20.4	17.0	18.2	6.2	9.0	12.8	8.0	19.3	18.2	14.6	7.3	4.5	8.1	7.1	19.2	11.4	7.0	16.3	11.6	9.7	10.5	8.5	12.5	12.4	18.7	15.7	18.4	24.7	17.6	10.3	10.6	7.4	6.6	19.5	12.6	25.3	49.0	16.3	46.3	45.2	29.0	17.9	10.1	22.5	19.3	24.7	30.4	7.0	19.4	43.9	10.3	26.3	31.1	12.0	37.8	19.1	18.9	49.6	35.9	58.7	39.6	20.0	27.5	34.0	35.9	29.8	9.2	21.1	21.2	34.7	29.3	31.5	30.8	181.4	32.2	20.9	48.4	38.0	20.5	21.7	31.3	38.9	16.5	31.6	15.1	7.8	37.5	79.1	31.8	31.9	14.9	11.8	13.5	20.0	29.1	17.6	23.9	41.4	52.8	101.5	39.1	41.8	56.8	81.6	51.2	0.4	1.3	0.0	0.6	0.7	0.2	0.1	0.3	0.4	1.0	0.2	0.0	0.2	0.5	0.0	0.4	0.0	0.4	0.2	17.4	19.7	18.4	21.6	17.0	18.2	19.3	18.2	19.2	18.7	17.6	25.3	42.1	0.0	2.3	11.1	7.2	51.7	6.6	3.9	16.5	26.2	25.5	29.3	28.9	4.3	3.7	7.3	22.9	2.1	22.5	4.8	0.0	2.2	23.1	23.6	34.3	27.3	19.7	20.2	12.5	3.5	9.3	19.9	19.4	7.4	7.0	13.5	14.6	9.0	9.3	25.2	14.6	10.5	0.0	77.2	13.8	6.2	10.2	77.0	33.8	3.7	15.2	57.7	2.1	7.1	15.4	2.4	2.7	6.4	17.6	8.6	6.4	6.2	9.9	46.3	52.6	12.5	31.7	63.7	15.2	16.1	53.0	1.2	27.0	12.3	11.1	4.1
SAP30L	"FLJ11526, NS4ATP2"	ENSG00000164576	"SAP30 like"	Q9HAJ7	5	154445997-154461053	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA048665, HPA078308"	Approved		Supported	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 10: Non-specific - Unknown function"	"Nucleoplasm, Nucleoli fibrillar center"		"HPA048665: AB_2680486, HPA078308: "	"unprognostic (3.79e-3)"	"unprognostic (1.44e-2)"	"unprognostic (1.25e-1)"	"unprognostic (7.70e-2)"	"unprognostic (1.07e-1)"	"prognostic favorable (9.09e-4)"	"unprognostic (1.33e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.32e-1)"	"unprognostic (4.33e-2)"	"prognostic favorable (2.06e-5)"	"unprognostic (3.36e-1)"	"prognostic favorable (1.71e-4)"	"unprognostic (1.62e-2)"	"unprognostic (3.34e-2)"	"unprognostic (1.45e-2)"	"prognostic favorable (2.69e-4)"	10.0	8.4	12.2	5.3	13.7	1.6	11.3	13.0	13.2	14.0	10.2	14.9	10.5	13.4	9.0	7.1	12.9	6.7	9.8	11.1	12.9	13.1	8.0	9.3	6.8	13.2	13.4	19.7	6.4	13.8	5.0	7.7	12.7	10.6	8.7	6.1	7.3	12.4	14.1	11.4	11.0	11.6	13.7	8.9	8.9	7.7	13.1	9.9	9.3	15.3	8.3	10.9	10.0	13.8	9.0	7.3	13.3	8.8	28.4	22.5	6.5	9.2	19.9	10.4	11.2	4.9	5.0	9.7	7.2	14.0	12.1	7.1	10.1	7.5	11.6	4.9	9.9	7.9	6.8	3.6	8.5	10.5	5.7	8.2	13.4	4.6	11.3	16.0	8.5	9.1	3.3	6.0	8.8	4.5	9.9	6.7	3.3	8.2	5.0	9.4	13.3	4.8	6.0	4.4	8.0	10.5	7.3	15.6	17.6	12.4	5.6	12.8	12.1	7.2	5.3	9.6	6.6	5.6	8.6	5.0	10.6	8.1	4.2	0.0	0.3	0.3	0.5	0.4	0.6	0.2	0.6	0.6	0.3	0.5	0.6	0.4	0.2	1.4	1.2	0.4	0.6	0.3	12.2	13.7	13.0	13.2	11.1	12.9	13.2	13.4	12.7	13.7	13.1	13.8	25.7	19.2	6.9	7.8	7.1	17.3	8.7	4.2	8.0	4.5	17.0	14.1	19.8	17.2	6.3	3.7	6.2	7.7	15.5	26.5	3.9	4.8	22.4	15.6	18.4	17.6	7.2	11.0	6.6	8.2	12.3	18.1	4.6	9.8	1.3	16.4	15.7	16.3	8.5	10.1	6.5	11.4	0.0	9.7	12.4	18.0	20.5	11.3	10.6	9.4	10.7	21.4	14.4	6.0	12.1	10.6	13.9	18.0	7.8	16.9	32.7	10.5	9.5	5.8	0.0	14.9	16.0	16.1	17.2	5.5	18.2	6.3	8.9	10.5	12.1	13.3
SAPCD2	"C9orf140, p42.3"	ENSG00000186193	"Suppressor APC domain containing 2"	Q86UD0	9	137062127-137070557	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 7.1;esophagus: 8.5;skin 1: 6.2"	"Cell type enhanced"	"Detected in many"		"Intestinal goblet cells: 10.8;Oligodendrocyte precursor cells: 29.7;Undifferentiated cells: 12.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"MCF7: 122.1"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			HPA044154	Approved		Supported	Nucleoplasm,Nucleoli,Cytosol		NA	Yes				"Cluster 27: Brain & Skin - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Cytosol	"Nucleoplasm, Nucleoli"	"HPA044154: AB_10959464"	"unprognostic (3.68e-2)"	"unprognostic (9.85e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.11e-1)"	"unprognostic (2.80e-2)"	"unprognostic (1.27e-1)"	"unprognostic (5.42e-8)"	"prognostic unfavorable (5.88e-4)"	"unprognostic (8.33e-2)"	"unprognostic (7.47e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.45e-1)"	"unprognostic (9.83e-7)"	"unprognostic (4.37e-3)"	"unprognostic (4.62e-1)"	"unprognostic (3.82e-2)"	"unprognostic (1.35e-2)"	0.5	0.3	6.9	2.4	5.1	2.0	1.3	4.7	5.4	1.2	1.3	3.7	4.3	0.4	0.0	8.5	0.3	0.2	0.2	5.4	4.5	1.2	0.2	0.5	2.7	7.1	6.8	0.1	0.4	0.0	0.5	0.9	5.7	3.1	1.8	0.1	4.1	0.1	0.1	6.2	4.3	0.4	5.0	2.2	2.4	0.5	6.8	2.3	0.3	0.0	2.5	0.4	2.3	7.0	52.1	27.5	10.7	32.0	0.3	0.7	57.1	8.4	5.7	8.8	4.1	52.5	23.2	53.8	26.5	4.1	8.2	72.3	33.6	9.7	2.0	37.4	38.9	23.6	32.7	59.6	0.2	27.0	39.2	0.1	1.5	3.0	5.8	2.3	14.4	27.1	33.1	23.7	2.6	122.1	7.8	72.7	19.9	119.2	61.9	82.9	40.7	60.1	10.9	14.8	55.2	32.7	32.2	89.1	12.2	2.4	71.9	51.1	9.4	7.9	26.6	24.0	41.9	8.2	25.5	26.3	18.4	31.8	25.6	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	6.9	5.1	4.7	5.4	5.4	4.5	7.1	6.8	5.7	5.0	6.8	7.0	0.5	0.0	0.0	0.7	1.9	4.2	0.7	0.5	0.6	0.2	5.0	5.2	1.3	0.0	1.1	0.0	0.0	2.8	1.6	5.4	1.9	0.3	0.0	1.6	0.8	0.9	0.0	3.6	0.2	0.0	3.5	1.1	6.1	6.0	0.0	3.3	1.4	0.0	3.1	0.0	0.2	10.8	0.0	2.8	1.5	0.1	0.0	2.2	0.0	0.0	1.5	0.5	0.0	29.7	5.6	0.6	4.0	0.0	1.8	2.1	0.5	0.0	0.1	0.6	0.0	0.2	1.0	0.0	1.4	5.8	2.7	0.5	1.3	0.6	12.1	1.1
SAR1A	"SAR1, Sara, SARA1"	ENSG00000079332	"Secretion associated Ras related GTPase 1A"	Q9NR31	10	70147289-70170523	"Plasma proteins, Predicted intracellular proteins"	"ER-Golgi transport, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006923, CAB022545, HPA048368"	Supported		Supported	"Endoplasmic reticulum"		NA	NA		660000	"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 10: Non-specific - Unknown function"	"Endoplasmic reticulum"		"CAB022545: , HPA006923: AB_1856577, HPA048368: AB_2680373"	"unprognostic (3.77e-2)"	"unprognostic (7.13e-2)"	"unprognostic (3.08e-3)"	"unprognostic (3.13e-2)"	"unprognostic (5.35e-2)"	"prognostic unfavorable (7.00e-5)"	"prognostic unfavorable (4.04e-4)"	"unprognostic (1.60e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.02e-2)"	"unprognostic (4.06e-2)"	"unprognostic (2.06e-1)"	"unprognostic (2.38e-3)"	"unprognostic (1.76e-1)"	"unprognostic (4.80e-2)"	"unprognostic (1.10e-2)"	"unprognostic (7.13e-2)"	77.1	52.8	41.8	38.4	43.5	163.2	48.1	45.1	45.7	43.1	53.3	39.1	26.6	41.0	47.0	41.4	37.3	35.0	44.8	43.8	48.3	43.3	70.2	51.4	36.7	42.8	44.9	41.0	33.9	44.2	37.9	76.0	44.0	38.9	35.5	42.0	39.9	38.9	51.1	38.5	34.5	49.7	47.3	40.7	37.9	23.5	48.4	33.2	39.8	56.3	38.4	45.8	36.2	52.1	85.8	56.3	75.7	131.9	246.1	143.1	61.1	128.3	154.4	115.6	140.0	169.7	78.2	74.4	67.1	153.7	52.8	96.6	94.5	75.9	111.6	103.9	44.3	54.1	65.8	82.5	112.4	86.7	56.6	155.9	68.4	76.4	133.2	119.0	63.8	55.9	68.7	105.9	110.0	60.0	73.8	72.6	65.2	55.6	141.3	70.8	84.4	42.5	88.7	69.7	42.6	73.8	98.0	134.6	72.2	66.8	65.8	59.7	88.6	63.7	94.3	92.2	91.3	72.3	141.3	114.0	84.9	111.7	48.7	75.5	63.5	74.0	88.0	80.9	94.8	47.7	68.5	85.9	58.5	38.6	65.7	88.7	67.9	103.3	72.9	44.8	53.2	95.9	41.8	43.5	45.1	45.7	43.8	48.3	42.8	44.9	44.0	47.3	48.4	52.1	88.4	128.2	110.2	6.8	53.5	235.7	138.0	120.2	25.0	38.6	99.2	62.4	74.7	57.2	105.3	49.7	33.3	120.6	109.8	51.6	54.8	78.4	3.0	52.3	85.8	85.2	42.7	46.1	21.2	77.3	199.0	127.8	23.9	89.7	53.2	46.3	69.7	114.1	101.0	26.9	22.2	72.1	65.1	51.2	208.9	5.6	54.7	68.1	113.8	21.5	58.4	61.9	75.2	16.1	26.4	78.8	56.2	58.6	97.7	141.4	59.1	95.9	67.1	33.4	78.9	73.7	158.8	64.1	51.8	37.2	248.8	238.9	86.3	45.2	53.2	175.2
SARAF	"MGC8721, TMEM66"	ENSG00000133872	"Store-operated calcium entry associated regulatory factor"	Q96BY9	8	30063003-30083208	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Calcium transport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040400			Supported	"Endoplasmic reticulum,Rods & Rings"		NA	NA		41000	"Cluster 20: T-cells - T-cell receptor"	"Cluster 68: Epididymis - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 24: Non-specific - Transcription regulation"	"Endoplasmic reticulum"	"Rods & Rings"	"HPA040400: AB_2676962"	"unprognostic (1.11e-1)"	"unprognostic (4.78e-2)"	"unprognostic (4.27e-3)"	"unprognostic (1.38e-3)"	"unprognostic (7.86e-3)"	"unprognostic (1.91e-1)"	"unprognostic (2.32e-1)"	"prognostic favorable (5.28e-4)"	"unprognostic (1.98e-1)"	"unprognostic (1.74e-2)"	"unprognostic (8.03e-2)"	"unprognostic (6.70e-3)"	"unprognostic (1.06e-2)"	"unprognostic (5.09e-2)"	"unprognostic (3.88e-2)"	"unprognostic (3.87e-2)"	"unprognostic (2.18e-1)"	139.9	294.5	208.6	169.1	228.0	253.0	169.9	187.2	246.6	153.8	196.2	143.0	123.9	152.1	408.6	91.0	205.9	182.1	151.8	234.6	308.8	205.2	302.3	167.5	218.9	214.0	258.8	255.7	231.4	236.5	138.9	309.2	247.6	228.2	143.5	219.1	212.9	172.7	111.1	70.8	140.5	139.1	219.5	159.0	161.1	104.3	290.5	243.4	245.4	129.0	186.5	141.0	64.0	218.5	119.9	112.4	147.9	79.9	209.3	149.8	69.7	139.2	247.0	128.5	173.7	72.2	139.9	80.9	183.5	156.0	134.7	97.7	100.8	112.4	146.9	33.6	49.5	112.2	87.3	119.2	189.6	48.8	130.6	175.2	260.0	121.6	125.5	257.4	192.0	150.7	128.4	191.2	142.9	74.2	128.4	88.8	96.0	253.6	61.3	98.7	88.4	107.4	220.3	100.4	48.6	162.5	140.6	160.5	208.2	115.7	112.2	93.3	144.0	89.6	230.5	35.0	56.5	103.4	110.6	81.0	215.8	118.4	146.5	964.6	252.9	443.1	321.2	253.2	364.8	233.1	473.0	377.9	247.0	302.4	776.2	543.6	478.1	258.8	335.3	212.0	483.8	920.3	208.6	228.0	187.2	246.6	234.6	308.8	214.0	258.8	247.6	219.5	290.5	218.5	179.8	169.9	147.6	79.0	458.5	0.0	331.6	0.0	154.8	291.5	247.8	166.2	135.4	261.7	82.3	211.5	123.0	235.9	566.8	142.2	127.2	387.5	629.8	235.9	114.8	170.8	115.3	145.4	128.0	358.9	254.5	181.7	170.7	133.6	223.3	325.7	240.2	273.4	292.0	139.7	157.8	122.0	0.0	448.6	0.0	908.1	218.7	387.9	0.0	60.9	298.5	317.2	358.4	82.9	111.7	250.1	137.0	294.2	505.1	280.7	252.6	289.7	212.1	252.5	177.5	203.7	177.1	194.7	133.9	133.4	0.0	276.9	794.4	167.8	115.9	310.6
SARM1	"KIAA0524, SAMD2, SARM"	ENSG00000004139	"Sterile alpha and TIR motif containing 1"	Q6SZW1	17	28364356-28404049	"Enzymes, Predicted intracellular proteins"	"Differentiation, Immunity, Innate immunity, Neurogenesis"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Bipolar cells: 27.8;Cone photoreceptor cells: 29.2;Inhibitory neurons: 28.9;Oligodendrocyte precursor cells: 27.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"CACO-2: 32.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024359, HPA024759"	Uncertain		Supported	Mitochondria	"Intracellular and membrane"	NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 68: Epididymis - Unknown function"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 56: Bipolar cells - Visual perception"	Mitochondria		"HPA024359: AB_1856582, HPA024759: AB_1856581"	"unprognostic (1.40e-4)"	"unprognostic (9.00e-2)"	"unprognostic (2.47e-1)"	"unprognostic (2.41e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.08e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.27e-2)"	"unprognostic (1.87e-2)"	"unprognostic (7.01e-2)"	"unprognostic (2.49e-4)"	"unprognostic (6.40e-2)"	"unprognostic (5.20e-2)"	"unprognostic (1.20e-1)"	"unprognostic (2.14e-1)"	"unprognostic (4.84e-2)"	"unprognostic (7.62e-4)"	2.2	5.9	3.9	3.3	3.6	1.4	2.1	7.3	4.2	3.1	1.6	3.3	7.5	4.0	4.0	1.4	3.6	1.5	1.8	3.9	3.1	2.7	3.4	2.0	2.0	3.3	2.7	2.8	7.1	2.6	6.1	1.2	3.2	3.5	2.2	7.0	2.6	4.2	1.5	2.3	5.2	3.5	2.4	4.4	3.3	1.3	3.6	1.1	2.8	1.0	2.1	3.8	1.9	2.8	0.2	3.0	3.8	4.8	2.7	1.9	0.6	2.1	4.1	4.4	2.9	32.2	0.5	0.6	0.2	3.0	2.6	1.3	2.7	0.1	3.7	7.0	1.8	0.0	5.5	0.8	2.0	0.1	1.9	1.3	0.2	2.1	0.6	4.2	0.2	0.9	0.1	2.4	1.2	2.8	0.4	0.0	2.6	0.6	0.2	1.1	3.2	0.8	1.4	2.2	9.9	9.2	9.2	1.3	3.5	1.6	0.4	0.7	0.4	4.0	0.4	1.4	2.9	4.0	2.9	0.6	4.2	0.3	2.0	0.1	0.1	0.0	0.2	0.2	0.2	0.1	0.3	0.3	0.2	0.2	0.2	0.3	0.1	0.3	0.5	0.0	0.4	0.1	3.9	3.6	7.3	4.2	3.9	3.1	3.3	2.7	3.2	2.4	3.6	2.8	2.7	3.2	4.2	19.6	4.0	0.9	1.8	1.2	4.6	27.8	3.1	4.2	0.8	7.2	4.8	3.7	29.2	0.6	2.9	3.0	3.9	4.4	6.6	3.8	5.4	2.9	9.5	0.4	23.5	10.7	0.8	3.5	8.2	3.7	4.5	6.1	3.6	2.3	1.5	21.9	28.9	4.1	2.0	13.8	0.3	3.5	3.4	2.8	3.6	2.8	2.4	6.1	3.1	27.6	14.8	3.4	2.3	1.5	2.6	2.3	9.9	5.9	4.3	17.2	6.6	5.9	4.0	0.3	0.4	3.1	0.6	0.5	4.7	2.0	4.9	1.4
SARNP	"CIP29, Hcc-1, THO1"	ENSG00000205323	"SAP domain containing ribonucleoprotein"	P82979	12	55752463-55817724	"Plasma proteins, Predicted intracellular proteins"	"mRNA transport, Transcription, Transcription regulation, Translation regulation, Transport"	"DNA-binding, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030902, HPA030903"	Supported		Supported	"Nuclear speckles"		NA	NA		150000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	"Nuclear speckles"		"HPA030902: AB_10669872, HPA030903: AB_10964180"	"unprognostic (1.83e-2)"	"unprognostic (1.58e-2)"	"unprognostic (2.22e-1)"	"unprognostic (2.50e-1)"	"unprognostic (3.01e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.36e-4)"	"unprognostic (2.02e-2)"	"unprognostic (4.29e-3)"	"unprognostic (1.21e-2)"	"unprognostic (5.03e-2)"	"unprognostic (6.48e-2)"	"unprognostic (2.31e-6)"	"unprognostic (8.50e-2)"	"unprognostic (1.31e-1)"	"unprognostic (5.29e-3)"	"unprognostic (1.19e-1)"	48.0	59.1	52.9	45.8	53.7	88.8	58.0	56.4	88.2	52.6	55.0	53.7	31.1	48.2	57.2	61.9	42.3	34.8	81.5	53.4	60.8	62.5	49.4	46.4	67.2	54.8	56.8	48.5	31.6	45.7	43.7	55.1	55.3	48.0	53.6	31.6	39.4	47.7	98.9	43.3	38.5	53.4	53.5	47.9	44.1	55.4	55.8	83.0	41.6	84.0	84.5	59.8	48.3	56.2	118.8	106.6	251.5	107.9	114.9	162.9	119.7	160.5	126.2	196.7	163.6	151.4	129.1	191.3	108.7	131.8	77.2	66.5	223.7	158.2	209.8	151.2	140.5	192.5	181.6	132.9	166.9	162.0	142.4	121.1	115.7	129.0	99.7	206.0	210.4	169.1	141.3	137.9	198.0	100.5	204.1	257.8	221.4	107.0	97.8	186.5	131.6	159.3	265.9	133.0	108.2	87.8	138.1	88.1	144.8	143.3	134.1	216.3	146.1	79.0	79.3	101.3	128.3	87.0	122.8	258.5	94.9	163.8	101.9	246.1	137.9	218.7	110.5	156.2	101.1	125.3	115.8	119.0	153.7	114.0	91.7	103.0	107.2	134.2	138.8	146.8	170.6	153.9	52.9	53.7	56.4	88.2	53.4	60.8	54.8	56.8	55.3	53.5	55.8	56.2	14.7	32.1	35.6	27.7	26.6	25.2	24.5	24.0	46.1	11.2	12.9	9.9	0.2	10.0	41.0	22.0	16.7	16.1	17.9	11.8	25.4	28.8	16.3	9.1	8.8	16.5	14.9	34.1	32.8	29.8	19.8	30.5	33.6	11.4	27.8	8.9	8.9	7.4	14.6	8.4	33.8	13.3	24.4	19.2	36.3	35.9	18.0	25.1	21.4	27.2	32.4	10.6	16.5	37.7	46.6	32.1	13.1	17.3	37.0	14.8	14.8	19.1	45.2	10.0	6.6	12.6	23.3	36.4	32.8	50.9	26.6	16.8	29.9	12.2	11.5	20.4
SART1	"Ara1, HAF, SNRNP110, Snu66"	ENSG00000175467	"Spliceosome associated factor 1, recruiter of U4/U6.U5 tri-snRNP"	O43290	11	65961728-65980137	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"		"Allergen, Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031188, HPA031189, HPA031190"	Supported		Enhanced	"Nuclear speckles,Golgi apparatus"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 59: Non-specific - Translation"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 10: Non-specific - Unknown function"	"Nuclear speckles"	"Golgi apparatus"	"HPA031188: AB_10600092, HPA031189: AB_10601854, HPA031190: AB_10602289"	"unprognostic (2.93e-2)"	"unprognostic (1.13e-2)"	"unprognostic (1.09e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.45e-1)"	"unprognostic (6.99e-2)"	"unprognostic (2.52e-3)"	"unprognostic (8.15e-2)"	"unprognostic (8.97e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.11e-2)"	"unprognostic (3.05e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.62e-1)"	"unprognostic (4.24e-2)"	24.6	18.3	15.5	18.3	16.8	41.6	23.1	15.4	17.4	29.2	14.7	26.0	15.6	29.1	8.0	22.7	25.6	8.6	23.2	14.9	16.1	20.4	21.8	22.9	20.3	16.6	16.2	29.2	25.8	11.7	21.4	14.0	15.9	21.7	7.7	8.0	22.2	14.4	38.1	32.0	24.3	10.9	14.6	32.7	24.8	23.5	15.7	20.9	23.5	13.0	13.3	26.2	24.6	17.9	50.4	60.8	27.2	36.8	26.1	20.7	40.8	37.5	27.2	43.8	28.6	44.2	34.3	56.9	42.4	33.8	52.9	48.7	34.6	35.6	22.0	45.8	33.5	65.6	43.6	41.4	39.0	57.4	52.7	26.2	26.4	40.8	36.3	17.4	27.6	42.3	42.2	39.8	25.6	92.6	74.0	83.5	45.7	27.3	55.9	80.8	39.0	60.7	18.4	33.7	30.5	43.0	35.6	37.2	45.5	12.6	41.7	47.0	40.6	54.5	53.0	53.9	54.1	59.6	49.4	48.3	45.0	28.8	47.0	1.4	2.8	8.1	4.3	3.5	3.6	3.9	4.8	4.4	3.6	3.5	3.5	3.9	4.1	2.8	2.0	3.2	5.4	1.8	15.5	16.8	15.4	17.4	14.9	16.1	16.6	16.2	15.9	14.6	15.7	17.9	17.5	6.4	9.1	7.8	27.8	22.7	24.0	12.2	17.6	19.2	12.2	9.1	9.4	21.5	11.3	16.5	10.4	34.1	27.2	30.5	5.9	23.7	9.0	14.2	16.3	19.8	12.5	32.8	5.1	29.3	31.9	17.6	21.9	16.8	32.4	21.8	21.0	15.6	29.4	16.8	4.8	26.5	16.2	22.5	23.6	8.7	37.0	22.9	17.8	6.5	35.7	23.8	34.0	7.1	7.8	26.3	20.1	33.1	31.2	20.5	28.3	18.5	17.5	26.0	32.9	27.6	34.9	26.7	29.7	18.3	21.7	45.3	28.4	15.5	27.5	18.2
SART3	"KIAA0156, p110, RP11-13G14, TIP110"	ENSG00000075856	"Spliceosome associated factor 3, U4/U6 recycling protein"	Q15020	12	108522214-108561400	"Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028840, HPA044322"	Approved		Supported	Nucleoplasm		No	No			"Cluster 27: Non-specific - Gene expression"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	Nucleoplasm		"HPA028840: , HPA044322: AB_2678895"	"unprognostic (1.72e-1)"	"unprognostic (1.16e-1)"	"unprognostic (7.59e-2)"	"unprognostic (1.72e-1)"	"unprognostic (2.00e-1)"	"unprognostic (1.21e-2)"	"prognostic unfavorable (6.32e-6)"	"unprognostic (2.74e-1)"	"prognostic unfavorable (8.74e-4)"	"unprognostic (1.38e-1)"	"unprognostic (7.88e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.23e-3)"	"unprognostic (7.91e-2)"	"unprognostic (1.61e-1)"	"unprognostic (6.36e-2)"	14.6	15.1	14.0	18.5	14.0	25.5	14.8	17.6	15.1	18.8	12.2	15.9	12.6	19.3	13.7	19.2	17.4	11.9	13.9	13.7	14.6	13.9	16.1	14.5	26.3	12.5	12.9	23.8	13.2	18.3	18.9	15.4	13.0	16.5	15.2	20.3	14.1	14.5	17.8	19.0	17.2	13.9	13.5	19.8	15.1	16.8	14.5	25.7	18.8	15.1	23.2	15.5	16.0	16.8	34.5	61.5	45.4	53.8	24.2	18.9	43.6	29.3	35.8	50.1	37.2	51.5	23.4	51.3	20.1	26.4	32.2	32.0	68.2	33.9	44.1	61.8	43.0	74.1	40.9	47.9	39.2	74.0	44.4	26.4	31.4	31.9	46.8	38.1	30.8	42.1	85.7	33.7	30.9	34.6	69.9	57.5	90.2	27.6	59.9	67.3	44.7	59.3	26.1	57.5	56.8	40.3	45.0	17.0	30.7	38.7	49.0	51.1	26.0	39.0	21.0	30.1	30.7	42.6	68.3	75.6	34.1	42.2	46.2	6.9	6.2	6.4	8.3	5.1	9.9	7.7	6.3	8.3	9.0	7.1	9.4	6.0	1.6	8.6	7.6	6.1	10.5	7.9	14.0	14.0	17.6	15.1	13.7	14.6	12.5	12.9	13.0	13.5	14.5	16.8	14.7	19.2	24.5	16.0	25.9	14.7	16.3	15.4	16.5	42.0	11.5	11.4	19.9	10.0	23.4	18.4	35.5	21.4	21.1	12.0	7.9	14.7	53.6	15.1	21.6	20.0	12.5	23.1	22.1	12.7	14.0	17.1	15.3	15.9	17.7	21.9	11.7	12.5	13.2	35.3	22.2	9.3	24.4	14.1	13.8	30.8	10.2	17.0	16.0	16.9	18.6	23.4	14.4	19.1	24.9	13.5	7.7	17.7	29.6	16.1	9.5	8.2	27.4	39.1	32.9	22.0	18.0	27.2	31.1	19.6	18.0	23.7	24.2	19.1	14.0	17.0
SATB1		ENSG00000182568	"SATB homeobox 1"	Q01826	3	18345377-18445588	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Host-virus interaction, Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"lymphoid tissue: 374.2"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 180.2;Inhibitory neurons: 283.4;Oligodendrocyte precursor cells: 168.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in all"		"naive CD4 T-cell: 113.7"	"Group enriched"	"Detected in all"	4	"NK-cells: 63.4;T-cells: 113.7"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 455.3;JURKAT: 213.3;MOLT-4: 107.7;REH: 126.5;THP-1: 192.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051769, CAB056144, HPA070534"	Enhanced		Supported	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 63: T-cells - Adaptive immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm	"Nuclear bodies"	"CAB056144: AB_10584780, HPA051769: AB_2681600, HPA070534: "	"unprognostic (2.16e-1)"	"unprognostic (3.99e-1)"	"unprognostic (7.13e-2)"	"unprognostic (3.58e-1)"	"unprognostic (9.15e-2)"	"unprognostic (4.22e-3)"	"unprognostic (2.16e-1)"	"unprognostic (1.62e-3)"	"unprognostic (2.90e-2)"	"unprognostic (6.14e-2)"	"prognostic favorable (8.97e-4)"	"unprognostic (1.66e-1)"	"prognostic favorable (1.96e-7)"	"unprognostic (1.92e-2)"	"unprognostic (2.18e-1)"	"unprognostic (2.79e-2)"	"unprognostic (1.47e-3)"	16.1	10.3	13.4	28.8	19.1	42.8	13.2	0.8	32.2	11.4	2.6	29.9	16.0	13.6	24.0	12.2	17.9	17.6	26.0	23.4	0.4	10.8	15.4	15.7	38.1	0.3	6.1	13.8	28.8	32.4	22.5	4.9	0.0	22.5	18.5	29.8	44.0	25.9	89.5	21.4	21.0	11.8	1.4	27.4	18.5	6.7	0.9	374.2	24.5	49.0	27.8	24.6	12.3	11.0	2.1	0.0	12.7	0.0	17.2	16.6	1.4	3.4	12.3	2.9	9.8	0.5	22.9	4.7	0.4	4.1	1.0	0.2	46.4	5.4	5.9	455.3	28.0	0.1	1.1	0.0	2.5	26.7	3.8	7.4	4.0	0.1	0.6	35.1	3.3	213.3	0.6	24.3	2.2	0.4	107.7	33.9	18.5	1.5	1.5	126.5	6.2	4.9	4.8	15.7	5.9	34.5	0.0	3.9	0.3	10.0	98.5	192.7	1.7	12.6	7.9	5.9	3.7	1.3	0.4	10.0	10.3	101.3	5.7	21.1	1.9	4.6	44.2	2.0	78.6	1.6	29.9	23.0	3.5	13.0	113.7	69.5	4.1	63.4	1.1	4.0	6.0	26.6	13.4	19.1	0.8	32.2	23.4	0.4	0.3	6.1	0.0	1.4	0.9	11.0	19.3	25.6	29.6	48.3	44.6	14.3	12.3	10.9	12.0	12.1	33.2	18.0	70.0	22.8	15.0	31.3	87.6	0.5	71.1	11.0	1.9	16.9	8.2	31.6	15.3	17.0	32.4	22.5	180.2	12.5	0.2	16.4	8.6	11.6	23.4	20.6	35.0	20.9	9.3	0.0	283.4	30.8	4.1	41.5	36.4	4.3	8.4	45.5	10.6	41.2	23.0	15.5	56.7	168.9	28.8	10.5	23.6	8.2	20.6	21.7	24.6	9.1	50.9	63.1	6.6	8.3	10.2	3.2	9.3	20.5	22.0	0.3	84.0	16.8	25.7	19.7
SATB2	"FLJ21474, KIAA1034"	ENSG00000119042	"SATB homeobox 2"	Q9UPW6	2	199269500-199471266	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Chromatin regulator, Developmental protein, DNA-binding, Repressor"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 13.9;intestine: 39.5"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 129.7;Enteroendocrine cells: 99.7;Excitatory neurons: 363.9;Intestinal goblet cells: 66.9;Paneth cells: 70.0;Undifferentiated cells: 84.7"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 10.0"	"Group enriched"	"Detected in many"	84	"basal ganglia: 10.9;cerebral cortex: 13.9;hippocampal formation: 4.6;white matter: 3.9"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HEL: 40.3;K-562: 45.1;THP-1: 59.8"	"Region enhanced"	"Detected in many"		"cerebral cortex: 29.2"	"Group enriched"	"Detected in all"	5	"cerebral cortex: 46.4;hippocampal formation: 37.1"	"HPA001042, CAB023669, HPA029543, CAB062562, CAB067751, CAB068229, CAB068230, CAB068231"	Enhanced		Supported	Nucleoplasm		NA	NA				"Cluster 37: Intestine - Unknown function"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Nucleoplasm		"CAB023669: AB_1129287, CAB062562: AB_2665615, CAB067751: AB_2665629, CAB068229: AB_2665628, CAB068230: AB_2665630, CAB068231: AB_2665631, HPA001042: AB_10601711, HPA029543: AB_10959737"	"unprognostic (1.77e-2)"	"unprognostic (1.90e-1)"	"unprognostic (8.53e-3)"	"unprognostic (4.77e-2)"	"unprognostic (1.07e-1)"	"unprognostic (9.39e-3)"	"unprognostic (1.80e-1)"	"unprognostic (5.54e-3)"	"unprognostic (8.26e-2)"	"unprognostic (3.75e-1)"	"unprognostic (2.04e-2)"	"unprognostic (1.13e-1)"	"prognostic favorable (5.37e-8)"	"unprognostic (1.14e-1)"	"unprognostic (2.84e-1)"	"unprognostic (7.95e-6)"	"unprognostic (1.08e-3)"	2.7	4.8	0.0	4.3	10.9	0.3	2.2	0.0	13.9	2.7	0.0	34.2	1.5	1.7	0.9	0.8	1.4	1.3	0.7	4.6	0.0	4.0	3.0	0.9	0.5	0.0	0.0	1.9	3.9	2.1	1.0	0.6	0.0	1.9	39.5	0.8	1.5	2.8	2.2	1.8	5.7	3.0	0.0	0.7	1.0	2.8	0.0	0.2	1.6	2.7	1.0	1.6	3.1	3.9	2.6	1.7	17.6	8.1	8.3	9.9	1.3	6.2	8.9	4.4	5.7	0.4	5.8	0.9	0.2	13.3	6.9	0.5	14.0	3.7	7.0	9.4	12.3	40.3	4.1	4.9	1.9	18.7	17.1	4.8	6.4	8.8	5.6	11.3	0.4	6.0	45.1	0.0	12.8	0.9	0.8	22.9	3.2	2.0	2.9	1.7	6.0	0.1	6.6	0.6	3.8	0.0	3.1	0.0	9.5	3.1	3.6	59.8	6.2	31.5	5.9	10.1	16.6	2.6	8.9	25.9	21.7	14.6	25.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.9	0.0	13.9	4.6	0.0	0.0	0.0	0.0	0.0	0.0	3.9	1.4	0.0	1.1	18.6	0.6	1.8	2.7	0.5	0.6	2.4	0.9	0.4	1.5	0.0	0.7	0.0	4.2	0.1	0.2	129.7	1.9	0.3	1.0	0.9	3.9	1.5	99.7	0.0	363.9	2.7	0.3	3.6	0.0	0.7	0.0	1.6	1.8	5.4	0.8	0.0	3.5	66.9	0.0	2.5	3.0	0.9	2.5	1.0	5.4	9.4	0.6	0.5	0.0	21.1	34.1	1.2	70.0	1.2	0.0	4.3	19.1	7.6	0.2	0.5	0.0	1.7	10.4	6.1	4.1	0.8	3.0	0.1	1.3	3.9	84.7	2.2
SAV1	"salvador, WW45, WWP4"	ENSG00000151748	"Salvador family WW domain containing protein 1"	Q9H4B6	14	50632058-50668306	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001808	Approved		Supported	Cytosol		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 50: Fibroblasts - ECM organization"	Cytosol		"HPA001808: AB_2666441"	"prognostic favorable (2.92e-5)"	"unprognostic (5.17e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.52e-2)"	"unprognostic (4.38e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.44e-3)"	"unprognostic (3.00e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.41e-3)"	"unprognostic (5.20e-2)"	"prognostic favorable (3.83e-6)"	"unprognostic (2.32e-1)"	"unprognostic (2.05e-1)"	"unprognostic (1.28e-2)"	"unprognostic (1.90e-3)"	32.2	16.4	14.0	12.8	16.7	7.3	35.3	15.1	16.9	24.5	22.0	17.0	15.3	23.3	18.8	15.8	21.2	26.2	24.2	12.8	15.0	22.9	17.6	20.2	15.7	16.5	15.1	37.7	34.4	27.0	8.5	17.0	16.1	27.6	12.6	17.6	45.5	19.2	23.1	17.8	13.2	17.7	14.7	18.6	18.9	30.6	16.6	10.3	34.2	27.1	14.7	16.7	18.7	19.6	96.3	10.7	17.8	12.4	43.5	39.8	22.4	26.6	87.3	34.1	43.4	16.0	47.8	14.9	63.9	26.4	17.8	42.8	25.7	28.9	62.9	45.6	20.8	16.4	16.4	11.4	21.3	17.9	14.0	24.9	36.5	15.3	33.8	25.8	24.5	15.9	27.5	7.2	42.5	17.9	15.1	11.0	33.1	21.6	17.3	17.2	49.5	6.1	21.5	13.6	22.2	16.8	47.1	27.7	41.3	28.9	20.3	18.0	17.7	16.2	55.5	22.4	16.4	11.3	15.4	9.0	11.1	7.2	22.1	0.6	0.3	0.0	0.9	0.3	0.9	3.3	0.7	0.5	0.3	3.4	0.5	0.7	0.5	0.5	0.4	1.2	1.0	0.4	14.0	16.7	15.1	16.9	12.8	15.0	16.5	15.1	16.1	14.7	16.6	19.6	76.4	35.3	44.0	9.4	35.8	65.9	37.2	19.1	24.5	19.6	76.4	60.6	39.1	15.7	35.1	18.4	25.0	19.9	14.7	11.2	17.6	40.5	92.5	39.6	47.3	76.9	5.4	27.0	10.4	47.6	23.0	59.3	11.7	58.1	2.5	46.4	59.3	14.5	10.5	5.0	10.0	10.1	10.2	13.5	61.5	26.1	66.8	34.1	30.2	12.2	11.6	26.9	2.1	12.5	27.0	66.5	14.6	42.5	7.4	81.4	12.1	16.3	33.3	26.4	6.6	41.8	45.1	41.4	38.8	14.6	59.5	23.1	9.4	17.7	9.6	34.1
SAYSD1	"C6orf64, FLJ11101"	ENSG00000112167	"SAYSVFN motif domain containing 1"	Q9NPB0	6	39104063-39115186	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 55.5"	"Group enriched"	"Detected in many"	4	"Early spermatids: 136.1;Late spermatids: 63.2;Spermatocytes: 223.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007959		Approved	Supported	Vesicles		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 66: Spermatocytes - Spermatogenesis"	Vesicles		"HPA007959: AB_1078359"	"unprognostic (2.65e-1)"	"unprognostic (1.49e-2)"	"unprognostic (2.03e-2)"	"unprognostic (2.58e-1)"	"unprognostic (3.70e-1)"	"unprognostic (2.56e-1)"	"unprognostic (9.90e-3)"	"unprognostic (1.96e-2)"	"unprognostic (6.50e-2)"	"unprognostic (1.82e-3)"	"unprognostic (5.08e-2)"	"unprognostic (9.90e-2)"	"unprognostic (2.54e-2)"	"unprognostic (1.79e-1)"	"unprognostic (9.78e-3)"	"unprognostic (2.27e-1)"	"unprognostic (2.00e-3)"	8.8	7.9	7.8	6.5	8.4	7.6	10.5	8.3	10.3	8.6	8.0	8.7	9.9	8.4	11.1	7.5	8.6	6.9	8.3	8.2	8.3	9.6	10.1	7.0	10.3	8.0	8.1	8.8	11.1	7.7	6.3	6.7	8.1	9.2	7.8	6.8	12.6	8.2	7.0	7.4	9.4	6.8	8.1	7.5	7.8	55.5	8.1	17.0	8.7	7.0	9.4	7.2	6.9	9.6	14.8	9.4	8.3	9.9	13.4	17.7	8.6	6.7	7.3	7.9	8.3	13.6	10.2	13.4	9.4	8.8	11.2	9.9	7.3	6.3	8.3	8.5	13.2	8.8	5.5	11.9	10.9	10.1	12.7	12.3	15.4	3.1	7.8	5.6	7.4	19.9	15.1	7.9	9.0	20.4	16.1	16.6	7.2	9.7	4.8	2.3	10.1	5.4	16.7	10.3	23.3	9.4	11.6	10.0	10.9	6.6	16.4	13.1	9.7	10.4	7.5	3.2	8.8	0.2	4.3	16.2	6.0	14.4	7.8	10.6	10.8	24.9	14.0	15.1	16.0	16.4	15.2	12.8	11.4	18.5	21.0	17.9	5.2	15.8	15.8	9.0	22.2	12.1	7.8	8.4	8.3	10.3	8.2	8.3	8.0	8.1	8.1	8.1	8.1	9.6	19.3	3.2	6.0	4.6	11.4	15.4	13.2	29.1	8.6	6.4	26.4	21.8	18.8	21.5	17.0	18.4	8.4	33.1	8.3	10.5	17.6	22.9	136.1	22.8	14.0	11.2	8.4	13.5	3.2	21.8	32.7	16.8	4.6	19.0	8.2	13.8	6.4	23.3	26.8	6.7	4.2	16.5	2.0	13.9	15.7	63.2	20.5	13.2	12.4	0.0	11.9	15.5	12.3	9.0	6.3	15.9	9.7	19.2	5.3	22.6	21.8	28.3	19.2	4.1	6.6	13.1	17.3	223.6	14.5	11.6	16.6	12.3	12.8	10.2	20.1	14.9
SBDS	"CGI-97, FLJ10917, SDS, SWDS"	ENSG00000126524	"SBDS ribosome maturation factor"	Q9Y3A5	7	66987680-66995587	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Ribosome biogenesis"		"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 2042.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028891	Approved		Supported	Nucleoplasm,Cytosol		NA	NA		190000	"Cluster 44: Non-specific - Transcription"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 31: Spermatids - Spermatogenesis"	"Nucleoplasm, Cytosol"		"HPA028891: AB_10601500"	"prognostic unfavorable (1.49e-4)"	"unprognostic (1.87e-2)"	"unprognostic (5.73e-2)"	"unprognostic (1.71e-3)"	"unprognostic (8.06e-3)"	"prognostic unfavorable (3.65e-4)"	"unprognostic (1.07e-1)"	"unprognostic (2.22e-2)"	"unprognostic (1.44e-1)"	"unprognostic (6.99e-2)"	"unprognostic (7.84e-3)"	"unprognostic (4.59e-1)"	"unprognostic (1.04e-2)"	"unprognostic (9.38e-3)"	"unprognostic (1.83e-1)"	"unprognostic (2.30e-1)"	"unprognostic (5.06e-3)"	139.1	107.5	136.1	57.9	152.1	157.2	113.7	151.2	168.3	97.3	115.8	143.6	127.8	117.2	83.3	128.6	99.2	84.9	238.0	133.1	148.4	117.8	126.8	113.8	43.8	156.2	142.3	90.1	89.3	145.0	87.4	106.2	155.0	107.9	111.6	90.3	80.7	122.6	374.0	92.0	114.2	128.2	152.6	57.3	104.6	60.9	143.4	38.8	107.0	263.3	52.5	113.9	90.7	169.7	168.3	68.9	59.9	54.6	212.7	157.9	67.0	281.4	225.4	206.1	157.1	143.1	83.0	62.2	209.7	253.5	136.3	80.1	101.7	164.3	219.4	59.8	136.4	31.1	125.9	86.6	188.9	78.1	40.8	144.0	215.1	157.0	269.8	105.9	129.2	39.7	227.2	65.0	324.2	100.0	41.8	112.4	67.2	227.3	165.9	31.3	132.6	129.3	218.1	73.6	91.7	63.7	142.3	235.5	194.3	131.0	176.2	64.8	176.4	276.5	96.7	142.5	205.4	40.6	51.4	141.0	95.7	125.5	157.4	75.5	33.2	61.4	64.7	37.7	81.7	62.8	82.7	75.2	33.4	59.9	104.4	85.7	13.0	51.8	35.1	45.4	80.2	62.2	136.1	152.1	151.2	168.3	133.1	148.4	156.2	142.3	155.0	152.6	143.4	169.7	169.9	304.5	128.0	10.7	101.6	464.2	466.2	213.2	145.7	73.7	118.5	154.0	286.6	108.7	160.3	92.0	12.5	130.5	98.0	270.9	262.2	177.4	583.0	93.0	131.2	153.2	101.9	51.3	12.5	165.7	232.1	197.7	96.8	128.2	150.0	29.7	138.5	102.1	107.0	58.9	15.3	221.9	142.4	47.2	238.1	2042.9	127.1	74.8	256.1	11.2	66.5	161.9	30.9	7.5	36.0	300.0	242.2	168.5	117.5	267.2	359.3	264.6	75.6	56.8	164.3	512.9	266.2	86.3	47.9	129.9	430.0	398.5	144.5	132.2	165.4	318.5
SBF1	"DENND7A, MTMR5"	ENSG00000100241	"SET binding factor 1"	O95248	22	50445000-50475035	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"	"Charcot-Marie-Tooth disease, Disease variant, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA074004			Supported	"Nuclear bodies"		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 59: Non-specific - Transcription"	"Nuclear bodies"		"HPA074004: AB_2732249"	"unprognostic (4.79e-2)"	"unprognostic (1.37e-1)"	"unprognostic (7.39e-2)"	"unprognostic (4.87e-2)"	"unprognostic (6.11e-2)"	"prognostic favorable (3.46e-5)"	"unprognostic (2.21e-3)"	"unprognostic (1.14e-1)"	"unprognostic (2.32e-2)"	"unprognostic (3.60e-3)"	"unprognostic (1.78e-1)"	"unprognostic (1.75e-2)"	"unprognostic (2.42e-2)"	"unprognostic (3.29e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.74e-2)"	"unprognostic (2.05e-1)"	26.8	32.3	50.8	22.3	57.3	20.6	24.2	31.8	72.4	25.9	9.2	32.9	14.8	29.5	3.2	43.9	27.2	10.6	38.7	70.1	28.5	30.5	23.4	26.8	28.8	52.0	39.2	30.4	48.0	7.1	28.6	8.8	46.5	28.5	4.9	6.5	26.9	11.6	75.7	42.2	38.6	8.8	32.8	35.4	30.1	111.2	44.1	32.7	62.3	14.4	14.7	28.3	27.3	63.5	34.3	28.2	24.0	32.9	24.3	18.6	65.9	23.5	20.1	21.6	17.7	39.0	23.7	78.1	16.7	27.9	23.9	31.4	19.9	28.7	5.3	28.6	76.0	17.6	59.6	50.7	41.7	54.7	26.1	25.0	44.6	28.1	21.0	17.0	14.8	41.6	28.8	20.8	15.0	42.6	54.8	52.4	10.1	26.1	31.7	71.0	45.6	48.3	12.8	27.3	19.1	46.0	36.5	35.5	47.7	10.5	20.7	25.2	25.1	33.9	49.6	24.3	29.7	38.1	13.4	37.6	38.8	22.1	32.7	0.5	1.3	2.1	4.4	1.3	2.4	2.6	3.0	3.5	1.6	1.6	2.2	3.6	1.9	1.9	2.6	5.6	2.6	2.3	50.8	57.3	31.8	72.4	70.1	28.5	52.0	39.2	46.5	32.8	44.1	63.5	5.7	6.4	11.8	10.7	13.7	13.4	4.6	9.3	6.8	15.5	11.3	9.1	7.6	4.3	9.4	3.7	10.4	4.9	21.4	19.9	1.9	7.2	32.8	10.3	8.9	5.6	3.6	8.6	11.3	12.5	7.9	10.6	24.5	11.4	1.3	20.4	5.7	9.1	6.9	11.8	10.9	13.2	10.2	6.9	10.7	21.4	6.5	9.5	5.4	5.6	10.8	6.9	21.6	11.1	31.7	19.9	8.1	6.0	15.6	11.6	16.0	7.7	11.1	10.0	6.6	12.3	11.6	25.5	23.5	21.3	14.6	11.5	19.8	12.2	12.3	10.1
SCAF11	"CASP11, SFRS2IP, SIP1, SRRP129, SRSF2IP"	ENSG00000139218	"SR-related CTD associated factor 11"	Q99590	12	45919131-45992120	"Predicted intracellular proteins, Predicted membrane proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038862, HPA045456, HPA046345"	Supported		Enhanced	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 34: Non-specific - Transcription"	"Cluster 32: U-937 - Innate immune response"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	"Nuclear bodies"	"HPA038862: AB_10672830, HPA045456: AB_2679331, HPA046345: AB_2679630"	"unprognostic (2.83e-2)"	"unprognostic (4.10e-2)"	"unprognostic (2.01e-1)"	"unprognostic (5.88e-2)"	"unprognostic (1.19e-1)"	"unprognostic (5.19e-3)"	"unprognostic (6.67e-3)"	"unprognostic (9.00e-2)"	"unprognostic (1.37e-2)"	"unprognostic (1.30e-2)"	"unprognostic (4.10e-2)"	"unprognostic (2.15e-2)"	"unprognostic (6.30e-3)"	"unprognostic (1.68e-1)"	"unprognostic (2.76e-1)"	"unprognostic (4.30e-2)"	"unprognostic (4.13e-2)"	31.1	21.2	22.3	41.7	29.6	89.6	40.1	38.7	23.7	28.0	36.5	31.6	29.4	34.5	41.2	26.7	26.6	30.9	30.0	19.7	25.2	29.9	42.4	31.0	54.7	30.2	26.5	37.7	23.5	39.8	17.2	31.5	32.5	29.4	34.9	60.8	27.0	24.9	35.2	40.3	31.7	29.2	25.9	43.0	29.6	29.0	26.3	44.4	34.7	38.6	49.8	31.8	23.6	38.3	56.4	49.4	60.6	50.7	41.0	55.7	56.0	64.7	52.6	54.8	39.3	180.3	60.1	116.7	71.0	69.3	32.3	54.0	62.4	52.2	61.9	62.1	42.1	108.8	64.5	47.0	32.3	115.6	70.4	46.4	54.7	47.2	71.1	62.9	57.1	50.0	85.1	62.3	70.3	51.9	87.2	63.4	47.0	0.6	67.4	70.2	81.7	57.9	52.4	70.5	34.2	35.0	71.9	60.8	35.0	47.6	56.4	123.4	71.6	55.9	46.3	42.5	34.9	44.4	36.0	187.9	47.0	245.0	21.8	39.4	19.6	29.5	21.7	19.9	19.9	28.6	20.6	21.3	16.0	28.2	22.2	20.0	51.5	21.3	23.5	30.2	20.8	12.9	22.3	29.6	38.7	23.7	19.7	25.2	30.2	26.5	32.5	25.9	26.3	38.3	180.2	176.3	164.0	91.4	200.4	128.5	127.6	87.4	132.1	134.9	101.8	96.8	187.4	88.6	131.7	79.1	127.2	86.3	229.6	96.1	54.8	117.8	57.7	133.3	148.7	146.2	103.3	118.4	75.3	107.9	72.5	135.3	69.3	152.4	222.7	224.7	114.5	138.9	109.8	107.7	81.7	123.3	67.1	158.0	160.9	39.2	121.8	157.3	67.6	141.5	211.7	105.2	185.3	119.6	122.4	103.4	103.4	103.8	126.4	121.6	97.2	83.5	149.6	198.4	124.9	176.3	129.7	157.6	82.5	116.4	120.5	61.0	170.6	114.2	107.5	145.0
SCAI	"C9orf126, FLJ36664, NET40"	ENSG00000173611	"Suppressor of cancer cell invasion"	Q8N9R8	9	124942608-125143528	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Repressor, Signal transduction inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 11.2"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 200.1;Excitatory neurons: 327.4;Inhibitory neurons: 171.6;Rod photoreceptor cells: 136.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020632	Approved		Supported	"Nucleoplasm,Nuclear membrane"		NA	NA			"Cluster 29: Plasmacytoid DCs - Unknown function"	"Cluster 20: Retina & Lymphoid tissues - Unknown function"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Nucleoplasm, Nuclear membrane"		"HPA020632: AB_1845804"	"unprognostic (1.93e-1)"	"unprognostic (1.88e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.93e-2)"	"unprognostic (6.90e-2)"	"unprognostic (3.34e-3)"	"unprognostic (7.75e-2)"	"unprognostic (4.54e-3)"	"unprognostic (5.69e-2)"	"unprognostic (2.78e-1)"	"unprognostic (4.72e-3)"	"unprognostic (1.47e-1)"	"unprognostic (1.87e-2)"	"unprognostic (3.57e-2)"	"unprognostic (6.40e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.26e-3)"	1.7	2.5	3.3	1.8	3.7	2.9	1.9	0.3	4.2	2.1	5.2	1.9	1.1	2.1	1.5	1.4	2.1	1.2	1.3	2.4	0.3	1.5	1.5	3.2	2.9	0.0	0.4	2.7	1.7	1.5	1.7	0.9	0.0	1.9	1.7	7.5	1.4	1.0	1.7	2.4	1.5	1.3	0.0	1.9	1.5	1.9	0.9	11.2	1.9	1.0	2.3	1.5	1.7	0.9	3.2	2.4	3.2	3.1	1.7	4.2	5.4	2.0	4.1	2.1	2.9	3.1	3.0	5.7	1.5	2.0	2.4	5.3	4.2	2.2	4.2	4.1	1.5	3.8	4.4	2.8	2.4	4.0	2.8	1.6	1.8	3.2	2.1	3.5	3.0	10.2	5.4	6.6	3.2	3.5	13.0	2.8	3.2	6.1	2.6	8.1	5.1	5.0	1.4	4.3	3.3	2.1	4.7	2.5	2.4	3.5	6.3	1.8	3.1	1.9	3.5	3.2	3.5	3.6	7.3	5.5	2.2	3.3	2.8	0.2	0.3	0.0	0.2	0.4	0.3	0.5	0.4	0.3	0.2	0.6	0.6	0.4	0.2	0.6	0.1	0.8	0.7	0.3	3.3	3.7	0.3	4.2	2.4	0.3	0.0	0.4	0.0	0.0	0.9	0.9	7.3	70.5	28.2	49.0	19.7	2.8	7.9	6.0	10.2	46.4	8.7	5.6	4.8	14.3	9.4	18.4	200.1	6.6	14.6	6.3	1.9	4.1	14.5	9.4	8.5	8.0	13.1	23.3	327.4	2.0	4.7	7.5	8.2	14.2	5.1	74.5	12.5	8.7	4.2	16.8	171.6	8.4	16.2	6.6	5.5	5.9	9.6	5.4	3.6	55.3	5.4	25.8	22.6	72.9	61.0	2.9	7.3	6.0	14.3	9.6	8.3	3.1	10.3	136.5	0.0	11.3	8.3	34.7	21.5	12.4	4.3	2.6	14.8	28.9	11.2	4.4
SCAMP2		ENSG00000140497	"Secretory carrier membrane protein 2"	O15127	15	74843730-74873365	"Predicted membrane proteins, Transporters"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014699, HPA019194"	Approved		Supported	"Golgi apparatus,Vesicles"		NA	NA		71000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 10: Non-specific - Unknown function"	"Golgi apparatus, Vesicles"		"HPA014699: AB_1856605, HPA019194: AB_1856604"	"unprognostic (1.74e-1)"	"unprognostic (1.27e-2)"	"unprognostic (2.05e-1)"	"unprognostic (5.23e-3)"	"unprognostic (2.89e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.53e-2)"	"unprognostic (7.23e-2)"	"unprognostic (9.73e-3)"	"unprognostic (7.26e-2)"	"unprognostic (8.44e-2)"	"unprognostic (1.97e-1)"	"prognostic favorable (1.12e-6)"	"unprognostic (3.40e-1)"	"unprognostic (1.79e-2)"	"unprognostic (1.19e-2)"	"unprognostic (3.10e-2)"	43.1	46.7	27.8	40.3	32.8	51.5	40.7	31.9	31.2	40.5	38.8	76.0	75.7	36.9	36.9	103.4	47.4	35.4	32.4	26.1	29.8	44.9	42.0	49.6	47.9	40.7	30.9	26.5	54.5	85.6	29.4	48.9	36.7	35.5	72.7	4.7	92.7	32.4	34.2	68.3	80.1	33.6	33.6	66.8	64.9	36.2	33.3	33.0	38.3	18.9	53.4	38.1	49.4	35.4	44.7	57.3	24.2	37.6	72.0	37.2	72.0	45.0	56.6	46.9	50.1	83.0	102.6	36.5	57.8	68.1	67.7	157.8	72.3	55.9	19.4	145.8	71.1	92.8	31.2	57.6	54.3	48.0	170.9	48.0	97.6	44.4	32.0	37.0	46.0	42.0	31.3	67.5	33.3	68.1	24.6	55.3	24.1	111.0	36.6	42.6	22.3	126.4	54.0	63.1	24.9	25.0	36.7	64.3	42.4	35.4	88.5	76.3	43.4	40.2	23.9	43.8	53.0	46.1	73.2	37.6	37.8	112.2	30.2	118.3	111.3	90.0	94.1	106.9	76.1	80.8	85.3	95.9	81.8	70.9	69.4	75.8	74.4	83.8	119.3	128.7	105.3	120.8	27.8	32.8	31.9	31.2	26.1	29.8	40.7	30.9	36.7	33.6	33.3	35.4	36.0	73.7	31.7	17.9	49.5	17.5	41.7	40.5	19.4	6.8	28.0	24.8	14.4	24.3	53.1	40.5	2.1	156.9	63.4	116.8	15.6	67.4	132.3	30.8	22.0	36.2	37.3	29.0	7.7	92.8	61.9	37.2	54.0	40.6	79.2	31.3	26.4	27.7	164.7	6.7	6.1	77.5	42.7	78.3	44.5	56.2	32.0	77.0	32.0	21.5	56.9	41.4	63.8	12.1	17.9	96.1	75.5	23.0	73.1	54.0	105.7	48.1	52.6	8.4	26.3	25.6	35.8	47.1	35.3	39.6	22.3	136.4	55.1	40.0	64.2	58.5
SCAMP3	C1orf3	ENSG00000116521	"Secretory carrier membrane protein 3"	O14828	1	155255979-155262430	"Predicted membrane proteins, Transporters"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA071167			Supported	Vesicles		NA	NA		75000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 72: Non-specific - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 55: Plasma cells - Humoral immune response"	Vesicles		"HPA071167: AB_2686352"	"unprognostic (4.31e-2)"	"unprognostic (1.30e-2)"	"unprognostic (1.07e-2)"	"unprognostic (2.17e-2)"	"unprognostic (5.33e-2)"	"unprognostic (1.04e-1)"	"prognostic unfavorable (2.92e-5)"	"unprognostic (8.78e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.65e-1)"	"unprognostic (3.74e-2)"	"unprognostic (8.46e-3)"	"unprognostic (1.60e-1)"	"unprognostic (4.79e-1)"	"unprognostic (1.07e-1)"	"unprognostic (7.18e-2)"	45.1	69.6	4.6	7.1	6.8	7.9	43.5	6.3	8.2	38.1	4.5	37.4	7.7	35.2	0.2	49.9	31.9	5.0	65.0	5.0	4.5	49.0	48.4	40.9	12.1	6.3	5.2	34.9	51.9	4.7	33.8	7.3	5.6	37.0	2.4	1.1	49.3	6.1	90.9	56.4	38.4	3.5	6.4	46.5	47.0	28.3	5.4	8.3	38.6	3.2	7.2	39.5	38.6	8.2	19.7	30.2	11.2	8.8	8.3	6.8	14.5	21.6	20.7	26.3	19.4	30.0	15.7	45.1	49.3	10.9	15.7	20.5	9.0	18.7	1.8	29.8	68.3	25.7	11.7	8.5	26.1	30.5	17.4	9.7	20.9	21.2	10.3	3.3	18.9	49.3	38.2	18.3	11.6	38.3	50.5	14.6	16.5	27.9	59.4	43.1	9.1	67.5	4.8	13.1	8.3	20.0	26.2	8.0	39.1	3.4	32.1	13.7	29.0	20.9	17.5	29.3	29.6	43.3	84.8	52.9	16.7	41.1	15.2	41.0	47.5	52.8	94.4	51.7	86.8	98.8	91.3	91.1	58.1	100.3	83.3	86.6	6.7	76.0	71.4	102.4	101.0	100.9	4.6	6.8	6.3	8.2	5.0	4.5	6.3	5.2	5.6	6.4	5.4	8.2	23.0	16.0	37.1	12.4	33.8	38.2	23.8	57.3	54.1	18.5	27.3	19.3	39.1	30.0	43.7	33.1	4.2	86.4	27.2	19.0	9.8	49.0	1.7	16.3	20.8	33.1	30.1	14.5	9.9	69.4	55.1	27.1	27.0	26.3	25.3	16.6	32.9	37.9	57.3	18.5	11.9	24.3	42.7	21.3	26.7	5.3	17.1	23.0	24.9	7.5	41.3	20.2	30.9	9.5	17.4	48.5	19.9	18.8	56.1	24.7	36.8	24.4	22.6	10.9	13.1	16.7	27.3	20.0	5.5	46.7	40.1	71.3	33.4	20.5	30.1	22.5
SCAPER	"Zfp291, ZNF291"	ENSG00000140386	"S-phase cyclin A associated protein in the ER"	Q9BY12	15	76347904-76905444	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Disease variant, Mental retardation, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"retina: 55.4"	"Cell type enhanced"	"Detected in all"		"Cone photoreceptor cells: 252.3;Oligodendrocytes: 251.5;Rod photoreceptor cells: 710.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046253, HPA048077"	Approved		Supported	"Nucleoplasm,Nuclear speckles,Cytosol"		NA	No			"Cluster 11: Basophils - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 16: U-266 - Nucleosome"	"Cluster 46: Photoreceptor cells - Phototransduction"	"Nucleoplasm, Nuclear speckles"	Cytosol	"HPA046253: AB_2679600, HPA048077: "	"unprognostic (3.67e-1)"	"unprognostic (8.60e-2)"	"unprognostic (6.08e-2)"	"unprognostic (8.37e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.37e-1)"	"unprognostic (2.76e-2)"	"unprognostic (4.94e-2)"	"unprognostic (3.74e-2)"	"unprognostic (5.40e-2)"	"unprognostic (1.02e-1)"	"prognostic favorable (2.69e-9)"	"unprognostic (2.14e-1)"	"unprognostic (3.79e-1)"	"unprognostic (1.86e-1)"	"unprognostic (2.89e-3)"	5.5	7.9	9.7	4.0	12.2	7.4	6.9	18.2	10.4	6.2	6.5	6.0	6.5	7.4	7.7	8.9	6.4	5.3	13.8	9.0	12.8	9.0	7.5	6.3	4.7	11.5	10.5	12.1	8.3	14.5	8.2	6.5	11.3	7.0	4.4	55.4	7.9	6.2	13.6	6.9	6.3	6.3	9.2	5.9	6.1	21.0	10.7	8.6	12.2	12.0	6.0	5.0	6.5	16.3	6.3	5.8	7.8	4.5	3.9	7.0	6.5	8.3	5.9	3.8	5.4	6.1	5.0	6.3	7.2	2.8	10.0	6.7	18.5	3.5	5.7	14.7	9.1	3.3	6.8	3.0	4.9	9.0	7.6	5.9	6.0	4.5	7.3	8.2	5.2	12.6	4.8	17.5	6.6	2.6	8.8	2.7	2.3	5.5	3.3	7.9	12.4	2.2	3.5	6.3	18.4	8.9	11.2	3.9	9.0	9.4	5.8	7.3	6.3	8.7	8.1	4.1	7.4	10.5	23.7	8.9	5.1	11.1	5.9	40.8	6.3	17.4	11.4	3.5	13.1	16.3	11.5	10.3	3.6	17.0	18.8	12.1	10.7	17.1	4.2	9.3	9.7	4.2	9.7	12.2	18.2	10.4	9.0	12.8	11.5	10.5	11.3	9.2	10.7	16.3	28.5	99.3	61.5	190.7	33.2	20.6	28.9	10.6	18.8	91.5	13.9	15.5	191.3	12.8	27.4	12.9	252.3	33.8	26.6	17.1	1.9	14.6	59.1	10.6	13.8	23.5	16.2	1.7	151.5	6.0	11.8	22.1	17.3	18.4	22.1	41.9	21.8	9.3	14.3	77.4	201.8	9.0	6.1	13.6	11.3	24.9	20.5	14.4	10.6	135.9	12.8	51.3	34.0	203.1	251.5	6.5	11.4	19.2	28.6	15.9	72.6	7.8	12.3	710.6	19.7	39.1	23.5	143.9	68.9	15.1	18.8	52.0	30.5	26.7	13.4	19.7
SCARA3	"APC7, CSR, CSR1, MSLR1, MSRL1"	ENSG00000168077	"Scavenger receptor class A member 3"	Q6AZY7	8	27633868-27676776	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 136.5"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 238.6;Collecting duct cells: 66.2;Cytotrophoblasts: 45.8;Muller glia cells: 52.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 179.9;HeLa: 203.2;HUVEC TERT2: 140.1;U-2 OS: 120.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029861, HPA047386"	Uncertain		Supported	"Endoplasmic reticulum"		NA	NA				"Cluster 57: Non-specific - Angiogenesis"	"Cluster 20: HeLa - Mitochondria"	"Cluster 64: Astrocytes - Nervous system maintenance"	"Endoplasmic reticulum"		"HPA029861: AB_2673225, HPA047386: AB_2680024"	"unprognostic (2.24e-1)"	"unprognostic (5.36e-3)"	"unprognostic (2.68e-3)"	"unprognostic (1.36e-1)"	"unprognostic (1.48e-2)"	"unprognostic (1.17e-1)"	"unprognostic (4.31e-1)"	"unprognostic (1.60e-1)"	"unprognostic (3.58e-2)"	"unprognostic (1.45e-1)"	"unprognostic (3.80e-1)"	"unprognostic (1.66e-1)"	"unprognostic (3.41e-2)"	"unprognostic (1.78e-2)"	"unprognostic (4.95e-2)"	"unprognostic (6.31e-3)"	"unprognostic (6.03e-3)"	23.8	7.2	53.4	15.7	58.6	0.0	17.6	55.6	57.8	58.7	29.9	34.5	5.0	87.9	9.5	23.7	86.8	30.5	13.9	50.3	68.1	11.3	3.9	15.2	13.4	136.5	89.5	13.8	4.1	1.5	9.6	19.5	79.2	25.6	8.5	8.8	35.7	66.5	2.6	17.5	15.4	68.1	80.3	2.8	14.7	3.2	79.2	15.9	51.3	8.0	23.0	31.1	20.7	71.4	1.8	61.0	9.4	0.2	49.9	179.9	40.0	23.8	38.2	25.8	19.1	22.7	15.8	0.0	52.7	50.3	21.1	44.5	0.1	44.9	12.7	0.2	5.1	17.8	203.2	0.8	5.3	0.0	0.1	75.6	2.9	40.2	2.3	35.0	140.1	4.6	0.0	0.2	15.0	11.8	0.2	0.1	12.3	0.0	22.3	0.1	0.0	0.3	8.2	27.4	0.2	5.9	5.7	32.0	0.1	4.8	31.1	0.5	49.9	20.7	120.1	77.2	12.8	0.1	0.1	0.2	35.7	0.0	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	53.4	58.6	55.6	57.8	50.3	68.1	136.5	89.5	79.2	80.3	79.2	71.4	2.3	0.0	0.5	238.6	0.0	3.6	16.2	4.8	14.8	1.0	12.6	19.8	2.2	8.6	6.0	66.2	0.0	45.8	0.6	0.1	0.0	0.4	2.9	3.8	10.1	6.4	0.0	0.0	38.4	0.8	20.4	25.1	1.5	2.0	0.0	5.3	15.4	0.4	4.7	0.0	30.4	0.1	0.0	0.3	2.1	1.3	15.8	0.5	17.8	21.5	0.6	52.4	0.0	19.1	18.1	2.2	0.1	6.4	0.0	5.4	0.0	0.0	6.5	1.5	6.6	1.8	14.7	0.2	1.5	6.2	3.8	8.2	0.3	1.9	0.3	10.3
SCEL	"FLJ21667, MGC22531"	ENSG00000136155	Sciellin	O95171	13	77535674-77645263	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 385.5;skin 1: 302.7"	"Cell type enriched"	"Detected in many"	12	"Alveolar cells type 1: 679.5"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 17.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 28.6;HaCaT: 54.6;HBEC3-KT: 25.3;OE19: 74.2;RPTEC TERT1: 107.2"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA039737, HPA040154"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		No	No				"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 11: Alveolar cells - Smell perception"	"Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA039737: AB_10805485, HPA040154: AB_10795359"	"unprognostic (1.18e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.00e-1)"	"prognostic unfavorable (4.07e-4)"	"unprognostic (5.91e-2)"	"unprognostic (4.54e-2)"		"unprognostic (6.62e-2)"	"unprognostic (3.51e-1)"	"unprognostic (8.08e-3)"	"prognostic unfavorable (1.24e-4)"	"unprognostic (4.57e-2)"	"prognostic favorable (6.87e-4)"	"unprognostic (1.81e-1)"	"unprognostic (2.82e-1)"	"unprognostic (1.75e-3)"	"prognostic unfavorable (1.73e-5)"	3.1	0.1	0.0	0.1	0.1	0.1	19.5	0.1	0.1	69.9	0.0	1.1	0.0	0.1	0.1	385.5	0.3	0.1	0.1	0.0	0.0	0.4	0.1	59.8	0.0	0.1	0.2	0.2	0.2	0.3	0.5	0.8	0.2	0.1	2.0	0.1	57.8	0.0	1.5	302.7	0.1	0.0	0.1	0.0	0.6	2.3	0.1	0.5	2.2	0.0	76.8	0.1	121.6	0.2	16.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	28.6	0.0	1.8	0.0	0.0	54.6	0.0	25.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	15.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	74.2	14.9	0.0	0.0	0.0	107.2	0.0	2.5	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.1	0.2	0.2	0.1	0.1	0.2	0.1	679.5	31.6	0.0	0.0	10.7	0.1	12.9	0.0	0.0	0.0	0.0	0.2	0.0	49.7	0.0	0.0	0.3	0.0	0.7	0.0	3.2	6.6	0.7	0.1	0.2	0.0	0.0	0.2	0.2	0.0	2.0	0.0	1.0	1.3	0.0	0.0	0.0	0.0	0.0	0.6	7.8	8.2	0.0	1.1	20.9	0.0	0.3	1.8	0.0	0.0	1.6	0.0	1.0	1.7	45.5	0.2	0.0	0.0	0.1	0.0	0.1	7.1	0.0	0.0	0.0	1.2	7.9	5.0	48.8	55.8	0.1	0.3	0.8	0.1	2.7
SCG3	"FLJ90833, SgIII"	ENSG00000104112	"Secretogranin III"	Q8WXD2	15	51681492-51721026	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"brain: 133.5;choroid plexus: 40.1;pituitary gland: 39.4;retina: 56.8"	"Group enriched"	"Detected in many"	4	"Astrocytes: 79.3;Bipolar cells: 120.4;Cone photoreceptor cells: 102.2;Enteroendocrine cells: 148.4;Excitatory neurons: 46.2;Horizontal cells: 148.0;Inhibitory neurons: 64.0;Ionocytes: 38.7;Oligodendrocyte precursor cells: 63.3;Rod photoreceptor cells: 93.3"	"Group enriched"	"Detected in many"	7	"glioma: 41.0;pancreatic cancer: 15.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"NTERA-2: 50.5;SCLC-21H: 121.2;SH-SY5Y: 57.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006880, CAB033274, HPA053715"	Enhanced	Supported	Supported	Vesicles	"Secreted in brain"	NA	NA		3100000		"Cluster 58: Brain - Synaptic function"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 62: Horizontal cells - Visual perception"	Vesicles		"CAB033274: AB_2302033, HPA006880: AB_1079898, HPA053715: AB_2682239"	"unprognostic (1.38e-2)"	"unprognostic (2.42e-1)"	"unprognostic (1.40e-1)"	"unprognostic (5.24e-5)"	"unprognostic (1.59e-2)"	"unprognostic (3.63e-2)"	"unprognostic (1.74e-1)"	"unprognostic (9.93e-2)"	"unprognostic (1.40e-1)"	"unprognostic (2.46e-1)"	"unprognostic (1.71e-2)"	"unprognostic (8.17e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.78e-1)"	"unprognostic (2.78e-1)"	"unprognostic (8.88e-2)"	"unprognostic (1.27e-1)"	0.5	16.7	71.0	1.1	87.0	0.6	0.5	85.8	133.5	0.1	40.1	1.8	2.3	0.2	0.3	0.3	0.3	0.2	0.2	88.2	112.7	0.2	0.2	0.6	0.4	68.7	75.8	0.1	15.6	0.2	39.4	0.1	68.9	0.3	2.0	56.8	0.2	0.0	0.1	0.6	2.0	0.5	71.9	0.2	9.9	2.6	79.8	0.5	1.0	0.0	0.2	0.2	0.2	71.6	0.2	0.1	4.8	0.3	0.0	0.0	0.2	0.1	0.0	0.1	0.1	0.2	0.2	0.3	0.5	0.0	0.6	0.4	0.1	0.0	0.1	0.1	0.5	0.1	0.3	0.1	0.0	0.3	3.0	0.1	0.1	0.1	0.0	0.2	0.0	0.2	0.2	0.8	0.0	0.3	0.1	0.1	50.5	0.1	0.2	0.3	0.1	0.4	0.0	0.5	121.2	57.5	0.2	0.4	0.2	15.5	0.1	3.8	0.1	0.3	0.7	0.2	0.2	0.4	0.2	0.4	0.7	0.3	11.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	71.0	87.0	85.8	133.5	88.2	112.7	68.7	75.8	68.9	71.9	79.8	71.6	0.2	0.0	0.0	79.3	0.0	0.3	0.0	0.3	0.0	120.4	0.0	0.1	0.2	0.0	0.1	0.0	102.2	0.0	0.0	0.2	1.9	0.4	20.0	0.0	0.0	4.3	148.4	0.0	46.2	1.0	0.1	4.1	0.0	0.0	0.0	0.0	1.8	0.0	0.4	148.0	64.0	3.4	38.7	0.0	0.3	11.3	0.0	0.1	1.8	7.5	6.7	19.2	0.0	63.3	8.9	5.3	0.0	0.4	0.0	0.4	0.1	0.0	0.8	93.3	0.0	0.4	0.2	13.8	5.8	0.0	0.0	0.0	0.0	0.2	0.3	0.3
SCGN	"CALBL, DJ501N12.8, SECRET, SEGN"	ENSG00000079689	"Secretagogin, EF-hand calcium binding protein"	O76038	6	25652201-25701783	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 43.5;pancreas: 67.1;pituitary gland: 38.5"	"Cell type enriched"	"Detected in some"	5	"Enteroendocrine cells: 600.1"	"Cancer enhanced"	"Detected in many"		"pancreatic cancer: 38.2;renal cancer: 22.6"	"Group enriched"	"Detected in many"	4	"cerebellum: 23.6;hippocampal formation: 14.5;hypothalamus: 43.5"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 3.4;CACO-2: 6.4;HEL: 4.6;Hep G2: 3.6;SCLC-21H: 24.7"	"Region enriched"	"Detected in many"	16	"olfactory bulb: 82.0"	"Region enriched"	"Detected in some"	9	"olfactory bulb: 137.1"	"CAB004005, HPA006641, CAB044060, CAB062563, CAB068232"	Enhanced	Supported	Supported	Cytosol	"Intracellular and membrane"	NA	NA				"Cluster 22: Non-specific - Unknown function"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 17: Intestinal endocrine cells - Hormone signaling"	Cytosol		"CAB004005: , CAB044060: , CAB062563: AB_2665612, CAB068232: AB_2665613, HPA006641: AB_1079874"	"unprognostic (8.15e-2)"		"unprognostic (4.31e-3)"		"unprognostic (1.46e-1)"		"unprognostic (1.25e-2)"	"unprognostic (4.70e-1)"			"unprognostic (1.78e-2)"	"unprognostic (2.01e-1)"	"unprognostic (5.14e-2)"	"unprognostic (5.41e-2)"	"unprognostic (9.45e-2)"	"unprognostic (1.19e-1)"		3.7	3.5	1.7	3.4	1.2	0.2	3.3	23.6	2.9	0.1	0.1	16.9	12.4	0.0	0.0	0.2	0.1	0.9	11.7	14.5	43.5	1.4	4.1	0.8	0.1	1.7	2.3	0.3	67.1	0.1	38.5	3.3	6.1	2.0	19.2	1.0	2.5	0.1	0.0	0.6	11.5	1.2	1.4	0.0	18.9	0.6	0.9	0.4	1.9	0.0	0.0	0.1	0.1	0.5	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	6.4	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	4.6	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	24.7	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.1	0.0	0.3	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	1.2	23.6	2.9	14.5	43.5	1.7	2.3	6.1	1.4	0.9	0.5	1.9	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	1.0	0.6	0.5	107.2	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.3	0.1	0.0	0.0	2.2	600.1	0.0	0.2	0.4	0.2	0.3	9.2	0.0	0.0	0.9	3.3	0.5	0.1	0.0	1.8	14.3	4.1	0.0	0.0	0.2	0.6	0.1	0.0	0.0	1.0	0.0	0.0	0.0	0.1	4.8	3.7	0.0	0.0	3.7	1.1	3.1	0.0	0.0	13.1	0.0	9.1	0.2	1.1	0.0	0.0	0.0	0.1	0.5	2.2	0.3
SCHIP1	SCHIP-1	ENSG00000151967	"Schwannomin interacting protein 1"	P0DPB3	3	159839861-159897360	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"brain: 81.0;choroid plexus: 28.9;heart muscle: 80.4;skeletal muscle: 101.3;tongue: 92.8"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 14.2;Horizontal cells: 15.2;Skeletal myocytes: 7.0"	"Cancer enriched"	"Detected in single"	7	"glioma: 2.9"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"plasmacytoid DC: 6.9"	"Group enriched"	"Detected in many"	46	"dendritic cells: 6.9;granulocytes: 2.1"	"Cell line enhanced"	"Detected in many"		"AF22: 27.0;AN3-CA: 49.2;HUVEC TERT2: 58.3;NTERA-2: 29.8;SH-SY5Y: 167.0"									"HPA003243, HPA069824"	Uncertain		Approved	"Nucleoplasm,Nuclear bodies,Plasma membrane,Cell Junctions,Cytosol"		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 37: Myocytes - Muscle contraction"	"Plasma membrane, Cell Junctions, Cytosol"	"Nucleoplasm, Nuclear bodies"	"HPA003243: AB_1079877, HPA069824: AB_2732142"	"unprognostic (1.07e-1)"	"unprognostic (3.27e-2)"	"unprognostic (1.37e-2)"	"unprognostic (2.36e-5)"	"prognostic favorable (2.80e-4)"	"unprognostic (6.25e-2)"	"unprognostic (4.56e-3)"	"unprognostic (1.11e-1)"	"unprognostic (7.81e-2)"	"unprognostic (1.38e-1)"	"unprognostic (6.45e-3)"	"unprognostic (4.67e-2)"	"unprognostic (2.12e-1)"	"unprognostic (4.66e-4)"	"unprognostic (2.30e-1)"	"unprognostic (4.52e-2)"	"unprognostic (4.96e-1)"	6.1	2.9	46.5	0.2	56.3	0.8	1.2	52.6	55.0	2.5	28.9	11.1	1.0	3.9	0.7	3.4	2.3	1.9	80.4	50.0	48.7	2.5	0.7	2.9	0.5	51.0	48.2	0.5	0.4	0.2	11.8	10.9	52.6	5.6	1.1	3.6	1.9	1.4	101.3	0.4	3.6	5.4	55.6	4.8	4.6	1.9	46.9	0.8	0.8	92.8	0.2	0.7	1.2	81.0	0.1	0.0	27.0	49.2	0.0	0.2	0.0	0.2	0.1	0.1	1.1	0.0	0.0	0.0	1.7	0.0	1.3	0.0	0.0	2.4	0.0	1.4	0.0	0.0	0.0	0.0	1.3	0.0	0.0	2.7	1.1	0.3	11.2	0.4	58.3	0.0	0.0	0.1	3.5	0.0	0.0	0.0	29.8	0.0	0.0	0.0	5.5	0.0	1.3	0.0	0.0	167.0	0.0	0.0	0.2	7.0	0.0	3.1	10.9	0.6	1.5	0.4	2.5	2.1	0.0	0.0	0.7	2.0	1.3	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	6.9	0.0	0.0	46.5	56.3	52.6	55.0	50.0	48.7	51.0	48.2	52.6	55.6	46.9	81.0	4.5	6.4	1.7	0.0	0.1	0.4	4.8	2.5	1.2	5.4	0.6	0.8	14.2	0.0	2.2	3.7	2.1	1.5	2.7	0.1	0.0	0.3	0.0	4.4	0.4	6.0	0.0	2.1	0.0	0.2	0.5	1.6	0.0	3.1	0.0	0.1	2.2	0.5	0.2	15.2	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.7	3.6	0.0	0.0	3.1	0.0	0.0	0.0	1.3	0.0	0.0	0.0	1.6	0.0	1.4	3.7	0.6	0.0	7.0	2.9	0.0	0.4	0.4	0.6	0.8	0.2	0.2	0.0	1.4
SCMH1	Scml3	ENSG00000010803	"Scm polycomb group protein homolog 1"	Q96GD3	1	41027200-41242154	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Developmental protein, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"Astrocytes: 125.4;Excitatory neurons: 161.3;Inhibitory neurons: 213.0;Microglial cells: 102.1;Oligodendrocyte precursor cells: 154.3;Oligodendrocytes: 77.9;Spermatocytes: 54.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA048898, HPA053292"			Supported	"Nucleoplasm,Nuclear bodies,Cytosol"		No	No			"Cluster 29: Plasmacytoid DCs - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm	"Nuclear bodies, Cytosol"	"HPA048898: , HPA053292: AB_2797246"	"unprognostic (6.02e-2)"	"unprognostic (1.34e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.31e-2)"	"unprognostic (2.08e-2)"	"unprognostic (1.46e-1)"	"prognostic unfavorable (3.82e-4)"	"unprognostic (1.98e-2)"	"unprognostic (8.77e-2)"	"unprognostic (8.93e-3)"	"unprognostic (2.77e-2)"	"unprognostic (1.40e-1)"	"unprognostic (7.38e-2)"	"unprognostic (9.47e-2)"	"unprognostic (1.63e-1)"	"unprognostic (8.08e-2)"	"prognostic favorable (5.80e-4)"	22.0	24.0	15.2	11.3	15.9	17.8	23.2	16.5	18.1	32.0	18.6	54.6	12.7	35.4	20.5	14.0	33.1	15.8	39.3	16.1	16.9	29.8	19.7	20.6	10.4	13.6	14.7	36.3	40.1	34.7	27.6	11.0	13.1	40.4	17.0	21.0	27.5	30.7	44.9	13.3	23.4	24.6	12.2	15.5	32.5	32.8	16.7	16.6	24.1	34.2	10.5	38.9	21.3	14.1	19.5	12.8	29.9	27.5	13.4	25.4	0.1	15.4	26.7	25.2	26.0	12.3	24.6	35.4	11.4	28.1	21.1	4.8	23.3	20.6	21.6	24.7	17.8	16.6	17.7	31.2	58.2	35.7	26.2	27.7	20.5	16.7	40.2	30.5	25.7	43.3	15.7	26.8	25.0	10.6	36.0	30.8	27.7	16.4	13.5	39.3	31.3	21.0	20.4	24.1	21.0	22.5	26.7	21.1	22.1	20.2	18.8	90.7	19.0	26.3	20.4	16.4	28.5	27.1	16.2	38.6	16.5	31.5	24.4	0.6	0.6	1.2	1.6	1.1	2.0	2.4	1.9	1.5	1.9	1.1	1.3	1.1	0.0	1.6	0.2	3.9	1.4	0.9	15.2	15.9	16.5	18.1	16.1	16.9	13.6	14.7	13.1	12.2	16.7	14.1	7.1	9.6	10.8	125.4	9.4	6.6	25.8	11.5	26.7	17.0	16.4	17.0	14.9	18.6	7.4	12.9	16.7	7.3	10.8	7.2	1.9	11.4	9.4	7.2	13.8	9.6	8.4	16.0	161.3	21.3	3.3	11.4	15.3	13.1	5.1	11.9	8.9	7.3	6.2	8.4	213.0	7.4	8.2	3.3	6.5	12.4	16.4	3.2	8.8	102.1	2.7	6.9	2.1	154.3	77.9	12.4	6.2	18.0	20.2	23.3	10.4	18.1	5.8	14.2	19.7	11.9	10.3	54.3	26.1	6.1	3.7	4.8	7.4	3.5	12.4	14.5
SCN1A	"FEB3, GEFSP2, HBSCI, NAC1, Nav1.1, SCN1, SMEI"	ENSG00000144285	"Sodium voltage-gated channel alpha subunit 1"	P35498	2	165984641-166149214	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Sodium transport, Transport"	"Ion channel, Sodium channel, Voltage-gated channel"	"Autism, Autism spectrum disorder, Disease variant, Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"brain: 24.7"	"Group enriched"	"Detected in some"	11	"Excitatory neurons: 409.9;Inhibitory neurons: 494.6;Oligodendrocyte precursor cells: 692.1"	"Cancer enriched"	"Detected in single"	8	"glioma: 1.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"ASC TERT1: 6.1;Hep G2: 3.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA078664			Supported	"Nucleoplasm,Nuclear bodies,Plasma membrane"		NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Nucleoplasm, Plasma membrane"	"Nuclear bodies"	"HPA078664: AB_2686888"	"unprognostic (9.25e-2)"	"unprognostic (3.97e-2)"		"unprognostic (6.88e-2)"	"unprognostic (7.44e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.74e-1)"	"unprognostic (4.70e-2)"	"unprognostic (2.88e-1)"	"unprognostic (1.67e-1)"	"unprognostic (9.59e-2)"	"unprognostic (1.23e-1)"	"unprognostic (5.03e-9)"	"unprognostic (6.92e-2)"	"unprognostic (3.69e-2)"	"unprognostic (5.06e-3)"	"unprognostic (6.93e-1)"	0.0	0.0	4.2	0.0	4.2	0.0	0.0	2.1	24.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.1	2.1	6.9	0.0	0.0	1.4	0.0	14.2	6.2	0.0	0.0	0.0	2.0	0.0	18.5	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.1	10.9	0.0	0.0	0.0	0.0	0.0	0.0	10.9	0.0	0.0	0.9	0.0	0.0	6.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	3.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.2	4.2	2.1	24.7	2.1	6.9	14.2	6.2	18.5	2.2	10.9	10.9	0.0	6.4	33.9	27.4	0.0	0.0	0.0	0.0	0.0	47.4	0.6	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	4.5	0.0	0.3	1.8	0.0	409.9	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.3	0.0	494.6	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	18.7	0.0	2.8	0.0	692.1	11.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.1	0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0
SCN5A	"CDCD2, CMD1E, CMPD2, HB1, HB2, HBBD, HH1, ICCD, IVF, LQT3, Nav1.5, PFHB1, SSS1"	ENSG00000183873	"Sodium voltage-gated channel alpha subunit 5"	Q14524	3	38548057-38649687	"Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Sodium transport, Transport"	"Calmodulin-binding, Ion channel, Sodium channel, Voltage-gated channel"	"Atrial fibrillation, Brugada syndrome, Cardiomyopathy, Disease variant, FDA approved drug targets, Long QT syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	16	"heart muscle: 42.8"	"Cell type enriched"	"Detected in some"	5	"Cardiomyocytes: 77.1"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"LHCN-M2: 27.6;RH-30: 22.8"	"Group enriched"	"Detected in many"	5	"amygdala: 3.1;basal ganglia: 10.1;hypothalamus: 6.0"	"Region enhanced"	"Detected in many"		"basal ganglia: 5.4"	HPA063346			Supported	"Nucleoplasm,Nucleoli,Plasma membrane"		NA	NA				"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 43: Cardiomyocytes - Nuclear processes"	"Plasma membrane"	"Nucleoplasm, Nucleoli"	"HPA063346: "	"unprognostic (9.29e-4)"	"unprognostic (4.05e-2)"	"unprognostic (9.95e-2)"	"unprognostic (1.74e-1)"	"unprognostic (9.21e-2)"	"unprognostic (1.24e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.48e-1)"	"unprognostic (7.36e-2)"	"unprognostic (8.48e-2)"	"unprognostic (7.12e-3)"	"unprognostic (5.28e-2)"	"unprognostic (1.16e-4)"	"unprognostic (4.85e-3)"	"unprognostic (1.09e-1)"	"unprognostic (5.35e-2)"	"unprognostic (4.95e-3)"	0.2	0.1	1.9	0.1	1.2	0.2	0.2	0.0	0.7	1.7	0.0	0.2	0.2	0.7	0.0	0.1	0.3	0.1	42.8	0.2	1.5	0.0	0.0	0.1	0.0	0.0	0.7	0.5	0.0	0.0	0.4	0.2	0.0	0.3	0.1	2.0	0.2	0.5	1.6	0.1	0.2	0.3	0.2	0.1	0.1	0.3	2.6	0.0	0.2	1.0	0.0	0.4	0.7	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.1	1.1	0.4	0.1	0.0	0.2	3.6	0.0	0.0	0.0	1.0	0.5	2.7	0.0	0.4	0.0	1.0	1.0	0.0	0.0	0.0	0.0	0.2	0.6	0.0	0.4	0.0	2.1	2.8	0.4	0.0	0.0	27.6	1.4	0.0	0.0	2.6	0.0	0.0	0.0	22.8	0.0	0.0	3.2	0.4	3.1	0.0	0.0	0.0	0.8	0.0	0.0	5.7	0.0	5.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	1.2	0.0	0.7	0.2	1.5	0.0	0.7	0.0	0.2	2.6	0.2	0.1	0.0	0.0	0.0	0.0	0.3	1.3	0.0	0.0	2.7	0.0	0.3	77.1	0.0	0.1	0.0	14.6	0.2	0.0	0.0	0.0	0.1	1.2	0.1	3.2	2.8	0.0	0.0	0.5	0.0	0.3	3.1	0.0	0.3	0.0	0.8	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	6.3	0.3	0.6	0.2	0.0	3.7	0.0	0.6	0.0	1.5	0.1	0.1	0.0	0.0	0.0	1.0	0.0	0.1	0.0	0.9	0.0	7.3	3.1	0.2	1.0	0.0	0.0	0.0	0.1	0.1	0.0	1.4
SCN8A	"CerIII, CIAT, MED, NaCh6, Nav1.6, PN4"	ENSG00000196876	"Sodium voltage-gated channel alpha subunit 8"	Q9UQD0	12	51590266-51812864	"Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Sodium transport, Transport"	"Ion channel, Sodium channel, Voltage-gated channel"	"Disease variant, Epilepsy, FDA approved drug targets, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"brain: 35.0"	"Group enriched"	"Detected in many"	8	"Excitatory neurons: 336.7;Inhibitory neurons: 280.1;Oligodendrocyte precursor cells: 104.5"	"Low cancer specificity"	"Detected in some"			"Region enhanced"	"Detected in many"		"cerebral cortex: 35.0"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 13.7;ASC TERT1: 13.5;WM-115: 13.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022169, HPA043937, HPA073590"			Approved	"Vesicles,Plasma membrane,Cell Junctions"		NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Plasma membrane"	"Vesicles, Cell Junctions"	"CAB022169: , HPA043937: , HPA073590: "	"unprognostic (2.96e-2)"	"unprognostic (8.49e-2)"	"unprognostic (6.93e-2)"	"unprognostic (3.52e-6)"	"unprognostic (8.13e-2)"	"unprognostic (1.51e-2)"	"unprognostic (1.16e-1)"	"unprognostic (7.77e-2)"	"unprognostic (5.44e-2)"	"unprognostic (1.16e-1)"	"unprognostic (4.73e-4)"	"unprognostic (1.69e-2)"	"unprognostic (1.29e-5)"	"unprognostic (4.38e-1)"	"unprognostic (1.56e-1)"	"unprognostic (2.37e-1)"	"unprognostic (4.75e-2)"	0.2	1.0	5.6	0.4	8.9	0.7	0.5	2.5	35.0	0.4	0.0	0.7	0.2	0.4	0.7	0.1	0.2	0.9	0.1	11.4	0.2	0.9	2.6	0.1	0.4	4.2	0.0	0.5	1.6	0.5	6.7	0.1	3.8	0.6	0.9	7.9	0.6	0.2	0.3	0.3	0.2	0.1	0.0	0.6	1.0	1.7	2.4	0.5	0.5	0.1	0.2	0.2	0.2	11.5	1.7	1.3	13.7	0.2	1.8	13.5	0.3	8.0	12.5	9.1	8.5	2.8	1.6	0.4	1.9	9.9	4.4	0.1	2.3	0.0	10.5	1.6	0.8	0.1	0.3	0.3	0.1	0.2	1.1	1.8	0.0	6.5	1.4	3.4	9.8	3.5	0.2	0.2	5.5	1.0	2.5	0.2	4.9	0.9	4.8	0.1	0.7	0.0	0.0	0.5	5.6	2.2	4.5	2.1	0.3	2.1	0.4	0.2	2.8	8.9	6.3	3.3	5.2	0.2	0.1	0.0	1.8	1.9	13.0	0.5	0.0	0.1	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.4	0.1	0.0	0.1	0.0	0.0	5.6	8.9	2.5	35.0	11.4	0.2	4.2	0.0	3.8	0.0	2.4	11.5	1.2	0.0	0.0	27.1	0.0	0.0	0.5	0.0	3.4	16.7	2.6	1.8	1.4	1.5	0.0	0.0	10.4	0.0	0.3	1.0	0.0	0.5	0.6	0.0	0.7	1.3	11.4	0.0	336.7	0.5	0.0	0.1	3.1	0.0	0.0	0.7	1.1	4.3	0.0	5.0	280.1	1.3	0.0	0.0	0.0	0.7	0.0	0.0	0.0	20.6	0.0	4.7	0.0	104.5	14.2	0.7	0.5	0.7	0.0	0.4	0.0	0.7	0.0	11.2	0.0	0.4	0.3	3.8	10.2	0.1	0.0	0.0	0.3	0.0	0.9	0.3
SCNN1D	"dNaCh, ENaCdelta"	ENSG00000162572	"Sodium channel epithelial 1 subunit delta"	P51172	1	1280436-1292029	"FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Sensory transduction, Sodium transport, Taste, Transport"	"Ion channel, Sodium channel"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 35.5"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 10.7;Early spermatids: 10.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"U-266/70: 9.3"					"Low region specificity"	"Detected in all"			HPA026884	Enhanced		Supported	"Plasma membrane,Actin filaments"		NA	NA				"Cluster 43: Testis - Unknown function"	"Cluster 20: HeLa - Mitochondria"	"Cluster 29: Early spermatids - Spermatogenesis"	"Plasma membrane, Actin filaments"		"HPA026884: AB_10601501"	"unprognostic (2.08e-2)"	"unprognostic (2.08e-1)"	"unprognostic (7.39e-4)"	"unprognostic (1.06e-2)"	"unprognostic (2.74e-1)"	"prognostic favorable (1.60e-4)"	"unprognostic (1.44e-2)"	"unprognostic (1.81e-1)"	"unprognostic (2.08e-2)"	"unprognostic (1.14e-1)"	"prognostic favorable (1.32e-4)"	"unprognostic (5.27e-2)"	"prognostic unfavorable (6.67e-5)"	"unprognostic (3.13e-1)"	"unprognostic (4.18e-2)"	"unprognostic (2.13e-1)"	"unprognostic (7.06e-2)"	5.6	7.1	10.3	1.7	10.4	3.2	6.0	11.7	18.1	11.1	5.9	9.4	5.2	8.0	0.9	4.0	14.0	1.2	6.2	9.7	7.5	7.7	13.7	3.7	2.3	10.7	8.5	14.7	4.8	0.7	18.5	1.1	10.9	9.7	0.3	1.7	5.8	1.7	3.4	4.7	7.6	0.8	6.9	8.0	6.3	35.5	9.9	0.9	6.3	1.4	0.7	5.1	7.6	11.7	0.5	4.2	1.6	4.3	1.1	0.6	0.7	2.8	0.8	1.3	1.5	0.8	2.4	3.0	1.5	1.2	2.2	0.7	0.7	0.6	0.2	5.8	2.5	0.4	5.9	1.1	1.1	0.1	2.9	1.8	0.9	2.3	0.0	1.8	0.4	5.5	2.1	7.0	0.3	1.5	1.2	2.0	0.8	0.5	3.0	8.1	0.3	0.7	0.6	0.2	2.2	3.1	1.2	1.2	1.9	0.6	5.4	1.6	1.2	2.6	2.1	4.1	0.9	9.3	0.6	2.5	2.3	5.2	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.3	10.4	11.7	18.1	9.7	7.5	10.7	8.5	10.9	6.9	9.9	11.7	1.7	3.2	2.3	10.7	1.0	0.8	0.2	1.2	1.2	3.7	2.2	3.4	4.0	0.0	1.7	0.0	4.2	0.1	0.6	1.0	0.0	0.5	10.5	0.6	2.1	0.6	1.2	2.7	5.2	0.5	0.4	1.7	4.1	1.3	2.5	3.2	0.7	3.5	0.4	5.0	6.0	0.4	0.0	0.8	0.5	4.0	0.9	1.1	0.0	1.0	0.1	1.4	0.0	4.5	5.4	2.0	3.8	1.9	0.7	0.1	3.9	0.7	1.9	2.8	0.0	1.8	1.5	2.8	2.2	0.8	1.6	0.0	1.0	0.5	0.9	0.3
SCNN1G	"ENaCgamma, SCNEG"	ENSG00000166828	"Sodium channel epithelial 1 subunit gamma"	P51170	16	23182745-23216883	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted membrane proteins, Transporters"	"Ion transport, Sensory transduction, Sodium transport, Taste, Transport"	"Ion channel, Sodium channel"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 42.4"	"Cell type enriched"	"Detected in some"	4	"Collecting duct cells: 90.1"	"Cancer enhanced"	"Detected in many"		"urothelial cancer: 15.6"	"Region enriched"	"Detected in single"	6	"cerebellum: 4.4"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"hTCEpi: 46.8;RT4: 21.7"	"Region enriched"	"Detected in single"	13	"cerebellum: 2.5"	"Not detected"	"Not detected"			HPA071194			Supported	"Nucleoplasm,Plasma membrane"		NA	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 44: Endometrium - Transcription"	"Plasma membrane"	Nucleoplasm	"HPA071194: AB_2686359"	"unprognostic (2.90e-1)"	"unprognostic (5.21e-3)"	"unprognostic (5.79e-2)"	"unprognostic (4.31e-2)"	"unprognostic (1.92e-3)"	"unprognostic (1.71e-3)"		"unprognostic (1.97e-1)"	"unprognostic (4.85e-2)"	"unprognostic (7.84e-3)"	"unprognostic (1.90e-1)"	"unprognostic (2.57e-2)"	"prognostic unfavorable (3.20e-7)"	"unprognostic (2.80e-2)"	"unprognostic (1.34e-1)"	"unprognostic (2.63e-1)"	"unprognostic (4.17e-3)"	0.7	0.2	0.4	0.0	0.3	0.3	2.3	4.4	0.2	16.0	0.2	10.3	0.0	1.8	0.7	9.9	0.4	0.0	0.0	0.8	0.2	42.4	0.0	7.4	0.0	0.2	0.2	0.0	3.2	0.0	3.8	0.5	0.4	13.8	1.2	0.2	17.7	3.4	0.0	9.7	0.4	0.1	0.0	0.0	10.1	0.1	0.1	2.0	5.7	0.0	1.2	1.4	15.3	0.3	1.1	0.0	0.0	0.0	0.0	0.0	5.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	46.8	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	2.9	0.0	0.0	0.1	0.0	21.7	1.5	0.0	0.0	0.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.3	4.4	0.2	0.8	0.2	0.2	0.2	0.4	0.0	0.1	0.3	0.4	19.2	4.2	0.0	0.0	0.4	4.7	8.8	19.9	0.0	0.8	1.3	0.8	0.0	17.4	90.1	0.0	0.2	0.0	3.4	0.0	2.0	0.0	9.8	1.1	0.1	0.0	0.0	0.2	1.7	0.0	0.4	15.3	18.6	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.2	10.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.5	1.1	0.0	0.1	5.3	0.0	0.2	1.9	0.0	0.0	0.0	0.2	0.1	0.1	4.4	0.3	0.1	0.2	0.0	0.4	1.8
SCOC	"HRIHFB2072, SCOCO, UNC-69"	ENSG00000153130	"Short coiled-coil protein"	Q9UIL1	4	140257286-140385728	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal tubular cells: 320.8;Early spermatids: 537.1;Proximal tubular cells: 311.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA061198, HPA070321"	Approved		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA		22000	"Cluster 44: Non-specific - Transcription"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 29: Early spermatids - Spermatogenesis"	"Nucleoplasm, Golgi apparatus"		"HPA061198: AB_2684449, HPA070321: AB_2686252"	"unprognostic (2.27e-2)"	"unprognostic (2.26e-2)"	"unprognostic (3.18e-2)"	"unprognostic (1.10e-2)"	"unprognostic (7.34e-3)"	"unprognostic (1.37e-3)"	"unprognostic (8.99e-3)"	"unprognostic (1.13e-1)"	"unprognostic (6.14e-2)"	"unprognostic (1.23e-2)"	"unprognostic (2.30e-1)"	"unprognostic (4.03e-1)"	"prognostic favorable (4.82e-12)"	"unprognostic (2.98e-2)"	"unprognostic (1.32e-1)"	"unprognostic (7.51e-2)"	"unprognostic (1.28e-2)"	44.8	66.8	81.8	27.7	84.5	14.7	69.4	87.4	114.6	42.6	72.0	43.9	45.4	48.0	79.5	54.1	44.7	39.7	103.6	85.1	109.1	101.6	74.3	35.9	29.7	91.3	96.8	42.6	51.3	94.1	43.2	48.3	103.1	59.9	49.8	74.5	49.2	47.1	40.8	29.9	37.1	50.9	91.4	27.9	53.7	33.8	95.2	29.3	67.4	59.3	32.8	38.9	19.4	105.6	53.9	38.1	92.6	49.9	80.6	109.3	67.4	85.5	78.0	64.6	71.8	24.4	81.0	22.0	75.5	83.9	60.6	22.6	57.3	113.6	95.7	79.1	40.4	33.5	18.8	59.7	70.1	70.2	40.5	72.5	155.9	59.0	63.1	124.1	87.1	63.8	53.0	60.0	116.3	36.5	94.7	42.5	30.2	47.6	57.1	54.0	39.1	32.1	197.1	52.9	68.4	70.4	57.0	84.5	97.0	81.7	63.4	41.9	68.0	104.4	60.5	86.9	83.1	94.4	193.4	64.9	118.2	32.2	102.3	47.8	16.5	23.0	27.5	23.0	35.1	36.8	32.3	27.3	21.4	30.3	46.8	36.4	9.7	36.9	23.1	26.7	33.2	37.0	81.8	84.5	87.4	114.6	85.1	109.1	91.3	96.8	103.1	91.4	95.2	105.6	63.2	48.1	47.2	15.3	34.4	61.1	69.7	74.1	78.6	135.0	84.9	96.0	140.3	62.9	51.8	126.9	22.9	139.9	31.3	63.4	320.8	99.2	537.1	67.5	52.4	54.4	37.8	34.7	33.8	112.8	82.2	58.3	66.8	58.4	36.8	32.0	51.4	65.0	47.6	171.6	37.1	42.7	114.0	23.0	27.9	91.2	60.0	34.5	138.7	17.8	36.7	205.6	22.6	20.6	42.9	92.9	37.0	66.2	30.8	91.7	46.8	311.1	54.9	71.0	46.0	40.8	64.5	60.7	56.1	83.8	56.7	88.9	36.3	39.6	46.1	56.0
SCP2		ENSG00000116171	"Sterol carrier protein 2"	P22307	1	52927276-53051698	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Lipid transport, Transport"	"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 1116.8"	"Cell type enhanced"	"Detected in all"		"Hepatocytes: 1240.7;Proximal enterocytes: 769.0;Proximal tubular cells: 881.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA027101, HPA027135, HPA027317"	Supported		Supported	Nucleoplasm,Peroxisomes		NA	NA		640000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 2: Hepatocytes - Metabolism"	Peroxisomes	Nucleoplasm	"HPA027101: AB_1856634, HPA027135: AB_1856633, HPA027317: AB_10610422"	"unprognostic (7.51e-2)"	"unprognostic (5.23e-2)"	"prognostic favorable (7.05e-5)"	"unprognostic (9.68e-2)"	"unprognostic (1.53e-2)"	"unprognostic (5.53e-2)"	"unprognostic (1.87e-3)"	"unprognostic (1.22e-2)"	"unprognostic (1.62e-2)"	"unprognostic (1.59e-1)"	"unprognostic (4.53e-2)"	"unprognostic (6.16e-2)"	"prognostic favorable (7.85e-8)"	"unprognostic (1.49e-2)"	"unprognostic (1.09e-1)"	"unprognostic (8.64e-2)"	"unprognostic (1.13e-2)"	203.7	125.5	68.5	92.7	71.6	111.2	196.6	74.2	90.1	153.8	79.2	256.7	336.3	94.6	165.5	140.2	119.7	144.6	162.4	65.8	76.1	319.8	1116.8	140.6	106.0	75.4	72.3	94.5	119.2	130.9	64.7	79.0	77.9	150.9	270.5	76.6	114.0	97.3	142.0	130.6	305.7	112.9	75.6	83.9	234.4	63.4	74.7	131.9	140.9	152.8	125.5	139.2	76.9	78.9	120.6	64.8	85.5	157.9	273.6	232.6	92.7	140.0	208.9	90.1	129.2	58.7	127.5	114.7	147.6	206.6	105.3	82.5	59.6	131.0	136.5	168.2	86.4	123.4	88.8	122.1	182.0	179.9	197.5	190.2	175.0	107.1	52.9	196.2	260.0	132.6	111.5	58.2	184.7	70.1	200.7	155.2	94.6	304.4	126.0	101.9	150.9	158.3	252.2	192.2	70.9	85.3	122.0	246.3	121.6	189.6	125.9	201.4	203.8	122.4	63.4	213.2	114.9	95.9	131.0	134.2	159.0	175.7	113.8	285.6	193.7	286.0	185.9	208.8	152.1	150.8	144.9	184.6	230.5	132.6	120.8	171.4	29.4	176.8	204.2	150.9	195.2	289.5	68.5	71.6	74.2	90.1	65.8	76.1	75.4	72.3	77.9	75.6	74.7	78.9	167.0	134.6	198.4	52.2	91.1	150.4	123.8	222.2	110.4	37.5	189.8	86.0	157.4	258.7	166.2	185.8	31.3	182.7	128.3	512.7	473.5	168.1	57.4	150.4	81.6	126.8	235.1	93.4	45.0	162.4	156.5	124.3	180.4	125.3	138.4	54.0	146.7	1240.7	203.5	42.1	54.4	462.7	250.3	230.1	173.1	51.4	184.2	148.8	192.1	42.2	154.6	132.0	181.3	48.2	44.3	157.4	503.4	171.9	76.6	118.1	769.0	881.0	178.2	34.1	78.9	72.0	110.6	20.4	19.4	150.0	170.8	133.9	132.9	110.3	336.4	187.8
SCRN2		ENSG00000141295	"Secernin 2"	Q96FV2	17	47837692-47841289	"Enzymes, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Proximal enterocytes: 149.7;Proximal tubular cells: 332.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022934, HPA023434"	Enhanced		Supported	"Nucleoplasm,Golgi apparatus"		NA	NA		370000	"Cluster 44: Non-specific - Transcription"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Nucleoplasm	"Golgi apparatus"	"HPA022934: AB_1856638, HPA023434: AB_1856639"	"unprognostic (2.35e-2)"	"unprognostic (1.42e-2)"	"unprognostic (2.86e-1)"	"unprognostic (6.14e-2)"	"unprognostic (2.46e-2)"	"unprognostic (1.73e-1)"	"prognostic favorable (3.86e-4)"	"unprognostic (4.63e-2)"	"unprognostic (3.25e-2)"	"unprognostic (5.77e-2)"	"unprognostic (1.28e-3)"	"unprognostic (8.72e-2)"	"unprognostic (3.43e-2)"	"unprognostic (5.28e-3)"	"unprognostic (1.64e-1)"	"unprognostic (1.20e-1)"	"prognostic favorable (5.83e-4)"	81.2	22.9	18.9	11.1	19.4	13.4	48.9	18.8	22.3	28.2	22.0	23.8	43.8	24.5	11.5	19.2	26.5	12.0	31.9	18.5	20.6	68.6	37.2	17.4	12.9	19.9	19.6	25.4	26.4	25.4	31.5	12.9	18.8	28.5	10.4	6.5	33.8	19.7	38.1	22.1	36.7	10.2	20.1	34.0	21.5	10.6	19.4	12.0	39.9	25.0	10.1	22.2	23.3	20.1	28.0	43.8	12.1	11.0	33.7	25.7	36.6	13.7	27.6	20.6	21.0	32.5	33.2	15.3	27.5	7.1	11.0	14.7	3.9	24.6	6.9	37.6	29.7	15.5	33.8	29.2	12.0	7.9	12.7	25.7	18.1	12.8	9.8	31.5	23.5	35.6	5.4	18.2	28.9	25.4	24.6	12.8	6.0	12.1	17.5	32.7	9.0	62.4	16.9	12.9	8.9	37.6	8.0	17.3	17.8	8.3	37.9	14.5	10.7	18.2	20.8	5.6	6.6	70.2	9.8	7.7	52.1	13.2	4.2	24.5	19.9	43.4	24.6	21.1	24.1	24.8	20.4	24.2	25.7	25.3	31.7	17.8	5.4	29.3	10.8	30.1	23.0	16.5	18.9	19.4	18.8	22.3	18.5	20.6	19.9	19.6	18.8	20.1	19.4	20.1	21.9	38.5	29.9	15.0	18.7	15.7	31.5	41.8	20.5	12.0	24.5	25.7	19.3	15.7	35.9	16.5	10.4	43.1	12.4	33.2	74.3	27.7	3.9	16.9	10.0	24.6	22.3	7.2	12.4	61.0	9.3	25.7	17.3	12.4	16.5	22.1	24.3	26.7	22.7	20.2	10.5	33.6	48.8	11.1	13.7	2.8	33.2	12.8	42.7	7.5	13.9	28.8	26.8	11.1	6.0	33.3	36.5	16.6	30.9	14.1	149.7	332.7	40.9	16.8	6.6	19.1	16.0	5.2	16.7	21.9	11.5	33.8	21.6	23.9	40.7	27.0
SCRT1	"DKFZp547F072, ZNF898"	ENSG00000261678	"Scratch family transcriptional repressor 1"	Q9BWW7	8	144330565-144336482	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	19	"brain: 64.2"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 41.2;Early spermatids: 55.6;Excitatory neurons: 10.6;Horizontal cells: 35.3;Inhibitory neurons: 14.2;Late spermatids: 11.2"	"Cancer enriched"	"Detected in single"	5	"glioma: 1.5"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"SCLC-21H: 4.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045265	Uncertain		Supported	"Nuclear bodies"		NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 29: Early spermatids - Spermatogenesis"	"Nuclear bodies"		"HPA045265: AB_10959521"	"unprognostic (7.70e-2)"	"unprognostic (7.97e-2)"	"unprognostic (6.96e-3)"	"unprognostic (6.88e-4)"	"unprognostic (2.43e-2)"	"unprognostic (1.52e-1)"	"unprognostic (4.05e-2)"	"unprognostic (1.97e-1)"	"unprognostic (8.02e-3)"	"unprognostic (1.30e-1)"	"unprognostic (1.83e-4)"	"unprognostic (5.02e-2)"	"unprognostic (7.05e-2)"	"unprognostic (2.78e-1)"	"unprognostic (2.35e-1)"	"unprognostic (2.66e-3)"	"unprognostic (1.04e-1)"	0.0	0.5	3.4	0.0	4.8	0.0	0.0	12.5	64.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	19.4	0.0	0.0	0.0	0.0	22.9	8.5	0.0	0.3	0.0	3.4	0.0	18.1	0.0	0.0	3.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	2.4	26.2	0.0	0.0	0.0	0.0	0.0	0.0	23.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	4.8	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	4.8	12.5	64.2	1.6	19.4	22.9	8.5	18.1	0.1	26.2	23.6	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	41.2	0.0	0.1	1.6	0.0	0.0	0.0	8.4	0.0	0.0	0.0	0.0	0.0	55.6	0.0	0.0	0.3	0.0	0.0	10.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	35.3	14.2	0.0	0.0	0.0	0.0	11.2	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.5	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.0	0.0	0.0	0.1	1.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0
SCYL1	"GKLP, HT019, MGC78454, NKTL, NTKL, P105, TAPK, TEIF, TRAP"	ENSG00000142186	"SCY1 like pseudokinase 1"	Q96KG9	11	65525077-65538704	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"ER-Golgi transport, Transcription, Transcription regulation, Transport"	"Activator, DNA-binding"	"Mental retardation, Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Syncytiotrophoblasts: 138.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015015	Uncertain		Supported	Cytosol		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 55: Plasma cells - Humoral immune response"	Cytosol		"HPA015015: AB_1856643"	"unprognostic (5.56e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.03e-1)"	"unprognostic (3.99e-1)"	"unprognostic (1.23e-2)"	"unprognostic (7.87e-2)"	"unprognostic (1.23e-2)"	"unprognostic (5.06e-2)"	"unprognostic (1.14e-1)"	"unprognostic (7.23e-2)"	"unprognostic (4.41e-1)"	"unprognostic (4.29e-1)"	"unprognostic (7.86e-3)"	"unprognostic (6.49e-3)"	"unprognostic (4.27e-1)"	"unprognostic (8.29e-2)"	"unprognostic (2.29e-3)"	43.4	69.3	36.6	26.4	37.4	32.8	41.1	33.1	53.9	46.8	37.1	46.7	28.0	49.4	32.5	40.0	44.0	26.3	59.7	39.2	34.1	45.7	83.2	42.4	30.7	36.0	35.2	52.4	61.6	35.5	44.7	34.6	35.5	47.3	17.2	12.4	48.5	33.7	104.5	44.5	39.6	27.5	30.9	46.4	50.0	50.6	37.7	23.4	48.8	51.6	21.8	47.8	39.5	39.0	55.0	45.9	36.6	50.9	65.4	56.6	50.0	66.6	89.4	77.7	60.4	66.9	32.2	39.2	65.7	86.9	66.2	49.1	38.7	50.1	27.0	46.6	49.7	46.4	50.8	78.3	92.8	30.8	64.0	79.1	48.6	66.9	49.4	54.2	51.6	39.7	49.2	53.8	49.0	118.9	41.4	70.4	35.3	36.9	63.4	41.4	28.5	72.5	48.1	48.4	33.7	35.7	41.2	89.6	74.5	22.4	88.8	38.4	51.4	61.3	41.0	100.7	40.1	73.8	55.8	41.4	71.0	25.3	43.7	2.9	21.1	28.4	20.7	20.0	16.6	14.0	19.6	20.9	23.5	14.3	15.2	15.0	41.9	18.2	13.6	17.0	14.4	19.8	36.6	37.4	33.1	53.9	39.2	34.1	36.0	35.2	35.5	30.9	37.7	39.0	22.7	19.2	16.7	11.4	25.7	21.9	29.8	30.9	25.0	25.4	29.9	20.1	5.8	21.5	26.0	20.2	12.5	64.6	18.5	47.4	37.2	37.5	25.7	17.3	22.7	23.7	30.5	22.3	14.6	43.4	70.0	34.1	38.2	25.4	25.4	34.0	22.1	35.0	38.1	16.8	12.8	39.9	28.5	19.2	24.3	25.2	45.7	24.5	30.2	11.2	34.3	26.6	21.6	6.6	10.5	36.4	31.4	45.5	53.4	44.8	50.8	37.2	15.3	22.0	13.1	24.4	33.8	39.5	21.8	27.5	23.2	138.6	23.2	44.3	36.2	38.5
SDAD1	FLJ10498	ENSG00000198301	"SDA1 domain containing 1"	Q9NVU7	4	75940950-75990962	"Human disease related genes, Predicted intracellular proteins"	"Protein transport, Ribosome biogenesis, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035949	Uncertain		Supported	Nucleoplasm,Nucleoli		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoli	Nucleoplasm	"HPA035949: AB_10673225"	"unprognostic (8.82e-3)"	"unprognostic (3.39e-3)"	"unprognostic (7.62e-3)"	"unprognostic (1.10e-1)"	"unprognostic (2.17e-1)"	"unprognostic (7.74e-2)"	"prognostic unfavorable (1.32e-4)"	"unprognostic (5.15e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.59e-1)"	"unprognostic (2.08e-2)"	"unprognostic (3.98e-2)"	"prognostic favorable (2.13e-4)"	"unprognostic (1.57e-1)"	"unprognostic (1.41e-1)"	"unprognostic (2.24e-2)"	"unprognostic (4.62e-1)"	14.6	13.5	10.5	14.8	10.8	7.2	17.9	8.4	12.3	13.6	8.5	14.3	11.9	17.6	19.0	15.3	12.7	8.7	14.3	10.9	11.0	15.0	15.8	12.6	21.2	9.6	8.9	13.7	17.7	17.7	8.9	12.9	9.3	14.2	15.1	6.8	15.0	16.2	22.9	14.8	11.1	17.1	8.5	15.5	14.0	21.3	11.1	16.4	21.2	16.4	20.2	18.8	11.7	10.2	29.8	11.8	28.5	38.9	33.1	29.8	30.6	41.3	35.9	34.0	29.1	36.6	42.0	46.7	30.2	38.1	32.4	29.7	44.5	40.5	42.3	41.2	23.0	39.9	24.4	30.6	32.7	68.5	43.9	26.4	45.0	36.3	40.4	21.1	30.0	31.2	72.7	37.8	36.4	33.1	69.6	25.1	47.4	48.3	18.1	41.8	53.5	39.3	32.7	32.6	43.3	35.6	28.1	57.0	48.9	31.1	26.4	39.6	29.1	36.6	36.7	44.4	34.8	33.9	37.6	62.0	40.7	31.1	46.0	10.4	14.5	4.1	19.1	19.1	23.8	17.8	23.0	21.1	15.3	20.1	23.0	19.5	2.3	23.4	27.5	13.0	21.5	15.9	10.5	10.8	8.4	12.3	10.9	11.0	9.6	8.9	9.3	8.5	11.1	10.2	36.2	19.2	34.7	15.0	45.7	27.5	26.8	45.1	35.3	21.1	21.3	29.1	12.3	14.3	46.0	22.0	6.2	30.6	35.7	14.5	35.2	37.7	109.0	12.1	29.9	25.2	22.8	35.3	34.0	24.9	32.2	27.4	20.9	18.7	49.4	26.3	18.9	22.1	37.9	13.5	31.8	22.6	36.7	24.3	16.3	106.7	25.4	30.0	24.9	30.9	40.3	23.7	42.2	23.6	29.9	33.4	18.3	33.1	49.0	37.1	17.1	46.6	26.1	20.0	19.7	33.2	38.7	75.6	100.7	47.5	33.1	25.0	38.1	33.2	27.9	22.4
SDCBP	"MDA-9, SYCL"	ENSG00000137575	"Syndecan binding protein"	O00560	8	58552924-58582859	"Plasma proteins, Predicted intracellular proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Langerhans cells: 959.8;Melanocytes: 889.4"	"Cancer enriched"	"Detected in all"	4	"melanoma: 244.8"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 1908.0"	"Group enriched"	"Detected in all"	5	"granulocytes: 1908.0;monocytes: 562.9"	"Cell line enhanced"	"Detected in many"		"HHSteC: 787.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012245, HPA023840"	Approved		Supported	"Nucleoplasm,Nuclear membrane,Cytosol"	"Intracellular and membrane"	NA	NA		1300000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 41: Macrophages - Immune response"	"Nucleoplasm, Cytosol"	"Nuclear membrane"	"CAB012245: , HPA023840: AB_1857712"	"unprognostic (2.39e-2)"	"unprognostic (3.34e-2)"	"unprognostic (1.84e-2)"	"unprognostic (4.45e-2)"	"unprognostic (9.15e-2)"	"unprognostic (2.60e-3)"	"unprognostic (7.14e-2)"	"unprognostic (1.04e-3)"	"unprognostic (1.11e-1)"	"unprognostic (5.68e-2)"	"unprognostic (3.05e-2)"	"unprognostic (3.01e-1)"	"unprognostic (1.53e-2)"	"unprognostic (3.14e-1)"	"unprognostic (8.02e-2)"	"unprognostic (2.82e-2)"	"unprognostic (2.92e-1)"	228.5	126.4	94.1	160.8	111.8	245.6	167.1	102.0	130.1	160.9	112.2	119.6	83.1	109.8	83.6	88.8	95.7	194.8	120.6	103.7	112.6	126.6	174.0	223.9	121.2	113.7	103.8	89.1	80.8	132.9	45.8	264.3	113.5	70.8	134.7	26.8	124.9	78.3	65.9	84.8	92.8	151.2	107.4	203.0	130.0	41.1	110.8	129.9	120.7	113.7	92.8	248.8	91.9	123.7	123.5	185.9	194.2	101.4	711.7	607.1	86.1	122.9	439.6	175.3	228.9	74.8	250.7	0.4	194.8	166.4	321.2	49.7	106.0	142.4	215.7	22.6	91.3	184.3	156.0	60.6	787.9	47.7	287.1	417.9	188.1	176.5	525.2	273.0	428.0	125.2	92.3	104.6	403.4	32.4	104.1	55.9	122.2	478.6	52.3	49.6	59.4	24.3	282.1	127.0	84.9	153.5	133.8	56.1	630.0	213.8	51.0	127.9	382.3	168.8	72.5	200.8	81.5	31.4	45.6	74.8	428.9	0.5	155.1	777.4	562.9	528.1	61.2	349.6	78.0	69.4	82.0	67.3	251.8	61.0	103.9	80.2	1908.0	42.6	329.1	69.9	103.0	453.2	94.1	111.8	102.0	130.1	103.7	112.6	113.7	103.8	113.5	107.4	110.8	123.7	382.7	211.5	115.9	26.8	170.3	338.7	321.2	312.5	108.1	10.8	86.7	54.6	70.6	88.6	181.3	206.0	16.7	284.3	220.2	192.9	225.0	392.9	7.8	110.9	87.0	412.7	112.3	116.6	18.5	291.6	756.8	308.1	162.1	120.5	396.9	62.9	378.3	101.9	782.5	15.2	23.7	180.3	248.2	552.1	959.8	15.9	233.9	626.0	889.4	71.2	312.4	94.3	51.5	21.6	16.3	297.9	152.9	159.9	65.1	307.4	78.4	211.2	169.8	11.1	98.6	82.7	177.4	14.8	8.4	73.3	173.2	483.0	256.2	117.0	129.2	457.6
SDCBP2	"SITAC18, ST-2"	ENSG00000125775	"Syndecan binding protein 2"	Q9H190	20	1309909-1329139	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 141.8;intestine: 136.9;stomach 1: 101.8"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 782.5;Pancreatic endocrine cells: 755.4;Paneth cells: 948.5;Proximal enterocytes: 470.3;Urothelial cells: 641.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 18.6;OE19: 57.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA005804, HPA064490"	Enhanced		Supported	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 37: Intestine - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	Nucleoplasm	"Golgi apparatus, Cytosol"	"HPA005804: , HPA064490: AB_2732713"	"unprognostic (1.96e-2)"	"unprognostic (5.44e-2)"	"unprognostic (2.37e-1)"	"unprognostic (5.85e-2)"	"unprognostic (2.54e-1)"	"unprognostic (2.27e-2)"	"unprognostic (2.57e-2)"	"prognostic unfavorable (2.42e-4)"	"unprognostic (1.01e-1)"	"unprognostic (3.78e-3)"	"prognostic unfavorable (3.07e-4)"	"unprognostic (3.17e-1)"	"unprognostic (1.07e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.20e-1)"	"prognostic favorable (3.37e-4)"	7.3	3.4	19.9	10.1	20.7	0.7	6.9	16.3	24.3	25.8	15.2	85.8	136.9	5.7	9.0	141.8	4.3	41.8	4.6	19.6	20.2	16.0	18.1	20.9	1.3	17.2	17.9	3.5	15.2	2.5	3.9	3.3	17.4	6.5	55.5	1.0	29.8	2.5	2.8	62.9	133.0	3.6	16.9	3.1	101.8	5.6	20.3	1.5	14.6	1.4	13.7	38.2	49.9	18.0	10.9	0.5	1.4	0.5	5.8	5.1	0.9	3.2	6.3	2.8	2.7	2.3	18.6	1.1	2.1	1.2	2.0	8.2	0.5	15.5	1.4	0.4	1.0	0.9	0.6	1.5	5.8	1.1	1.2	1.8	10.8	2.2	2.2	6.0	9.6	2.0	1.5	0.7	1.1	2.6	1.7	3.0	1.3	57.3	0.7	1.6	0.7	2.2	1.2	14.4	2.4	1.9	1.5	9.3	3.6	0.6	0.4	0.9	6.5	1.5	0.6	2.8	1.2	2.8	2.7	1.1	0.7	4.1	0.9	0.1	0.8	1.9	0.9	0.3	0.7	0.2	1.2	0.9	1.0	0.4	1.0	1.8	0.8	0.9	0.6	0.7	2.3	0.7	19.9	20.7	16.3	24.3	19.6	20.2	17.2	17.9	17.4	16.9	20.3	18.0	15.6	16.0	4.2	0.0	4.1	55.7	112.0	198.1	3.4	1.0	4.9	4.8	0.8	72.9	172.6	16.5	0.0	1.8	1.0	782.5	27.4	114.5	17.1	25.8	11.7	14.1	35.9	0.0	0.0	209.7	1.1	4.6	201.8	85.4	8.9	1.0	7.1	5.1	0.9	1.7	0.0	150.8	156.6	1.9	6.4	1.9	1.5	1.8	8.8	0.0	2.3	1.0	2.1	0.0	0.0	755.4	948.5	0.0	0.7	107.0	470.3	1.8	89.6	0.9	0.0	1.7	9.9	5.0	7.6	31.1	95.6	1.6	3.5	2.0	109.2	641.9
SDE2	"C1orf55, FLJ35382"	ENSG00000143751	"SDE2 telomere maintenance homolog"	Q6IQ49	1	225982702-225999343	"Predicted intracellular proteins"	"Cell cycle, Cell division, DNA replication, Mitosis"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 72.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028467, HPA031255, HPA031256"	Approved		Supported	"Nuclear speckles,Golgi apparatus,Plasma membrane,Cytosol"		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 41: Macrophages - Immune response"	"Nuclear speckles"	"Golgi apparatus, Plasma membrane, Cytosol"	"HPA028467: AB_10599192, HPA031255: AB_10601462, HPA031256: AB_10603568"	"unprognostic (9.69e-2)"	"unprognostic (2.69e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.36e-2)"	"unprognostic (2.12e-1)"	"unprognostic (3.10e-1)"	"unprognostic (9.59e-2)"	"unprognostic (2.68e-1)"	"unprognostic (3.63e-2)"	"unprognostic (1.84e-2)"	"unprognostic (3.34e-2)"	"unprognostic (9.01e-2)"	"unprognostic (1.41e-3)"	"unprognostic (3.90e-2)"	"unprognostic (3.51e-1)"	"unprognostic (3.98e-2)"	"unprognostic (3.84e-2)"	17.4	8.5	5.5	11.3	7.0	32.9	11.8	6.4	6.6	9.0	4.8	8.3	9.0	11.8	7.8	9.6	7.4	10.5	7.7	4.9	6.0	9.2	14.6	9.2	12.4	6.9	6.6	10.2	9.6	11.1	4.4	11.8	6.6	9.8	9.1	5.1	6.7	7.3	12.7	10.8	9.0	9.8	6.6	10.4	7.7	8.3	6.1	22.8	12.5	9.6	10.6	11.6	7.8	8.4	13.1	9.3	14.9	15.9	10.2	11.3	18.5	13.7	12.9	18.4	14.0	13.7	14.7	19.2	20.9	11.6	7.2	16.5	18.9	11.9	22.2	14.7	15.3	21.1	7.9	12.7	18.6	21.0	24.6	12.5	16.9	19.6	24.6	10.3	12.8	22.6	39.3	22.6	13.7	3.8	29.5	16.6	20.8	20.2	9.8	24.4	19.1	24.9	11.1	9.2	13.3	22.0	15.6	16.9	26.3	11.9	16.6	25.4	12.7	15.6	11.0	20.3	30.4	13.4	10.3	23.4	16.1	12.9	31.5	21.8	6.3	5.9	8.0	6.4	10.8	8.0	8.1	7.8	7.1	7.0	8.1	7.7	18.5	13.5	7.9	8.1	6.7	6.9	5.5	7.0	6.4	6.6	4.9	6.0	6.9	6.6	6.6	6.6	6.1	8.4	36.0	28.9	22.6	4.2	39.9	43.6	17.2	11.2	29.0	6.2	19.8	13.6	9.4	2.8	20.1	9.2	0.0	9.6	29.3	14.3	15.6	6.5	72.8	24.8	15.1	24.8	17.4	56.2	4.7	7.1	10.2	17.8	13.3	35.9	35.5	9.7	12.8	20.6	11.1	15.2	5.0	10.8	16.2	16.4	28.8	20.4	9.9	27.0	19.6	1.9	7.4	12.6	10.3	4.5	8.6	9.7	9.4	6.4	26.6	14.2	9.5	12.7	12.7	8.9	6.6	28.8	23.9	23.9	14.4	26.5	59.1	14.2	23.2	21.0	9.9	18.2
SDF4	Cab45	ENSG00000078808	"Stromal cell derived factor 4"	Q9BRK5	1	1216909-1232067	"Plasma proteins, Predicted intracellular proteins, Transporters"	Exocytosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Proximal enterocytes: 406.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011249, HPA011895, CAB015227"	Supported	Supported	Supported	"Golgi apparatus"	"Intracellular and membrane"	NA	NA		2600000	"Cluster 26: Non-specific - Mitochondria"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 45: Enterocytes - Digestion"	"Golgi apparatus"		"CAB015227: , HPA011249: AB_2668468, HPA011895: "	"unprognostic (1.98e-1)"	"prognostic unfavorable (5.89e-4)"	"unprognostic (3.63e-1)"	"unprognostic (2.38e-3)"	"unprognostic (5.88e-2)"	"unprognostic (7.95e-3)"	"unprognostic (3.73e-3)"	"unprognostic (1.06e-1)"	"unprognostic (2.01e-1)"	"unprognostic (8.70e-2)"	"unprognostic (1.46e-2)"	"unprognostic (1.07e-1)"	"unprognostic (8.39e-3)"	"unprognostic (1.09e-1)"	"unprognostic (2.32e-1)"	"unprognostic (1.42e-1)"	"unprognostic (3.04e-2)"	86.5	91.8	44.2	78.8	47.8	56.2	80.2	47.2	65.3	84.4	72.5	95.9	117.1	91.8	43.9	66.3	74.6	66.2	134.6	45.5	44.8	89.6	160.7	82.0	53.4	53.2	46.1	85.4	104.6	61.5	78.5	73.3	47.0	76.9	60.4	25.7	83.5	52.2	78.9	72.9	116.8	58.2	43.5	78.0	93.6	71.7	50.5	34.6	81.8	47.7	39.6	82.2	71.6	45.9	139.7	123.7	67.1	214.0	320.0	160.4	80.5	266.1	241.4	191.2	159.4	147.0	236.2	87.8	201.8	258.0	137.4	140.4	77.5	117.1	58.2	147.9	133.0	153.6	185.7	207.8	147.4	156.7	199.2	199.0	59.5	144.6	81.2	186.5	155.9	57.3	129.2	225.0	95.7	101.1	77.8	158.9	61.7	158.0	167.1	85.8	86.5	234.4	127.2	66.4	243.3	86.7	177.2	208.2	182.8	59.0	108.0	176.7	198.8	196.2	107.0	149.5	154.2	138.9	141.2	144.6	222.9	289.7	87.1	14.4	21.5	30.8	19.3	14.6	14.6	13.5	27.6	28.4	21.9	16.8	16.0	14.1	16.9	26.8	23.2	14.0	25.1	11.8	44.2	47.8	47.2	65.3	45.5	44.8	53.2	46.1	47.0	43.5	50.5	45.9	92.9	22.4	19.2	18.6	62.5	119.8	74.0	24.6	46.7	34.5	51.2	47.6	35.7	68.6	28.9	49.7	18.8	124.1	68.4	240.0	11.7	79.0	39.1	49.0	76.2	77.8	65.5	32.8	21.1	71.4	284.4	117.1	81.1	60.8	36.2	61.4	76.4	117.1	122.4	38.7	23.5	174.9	30.5	73.7	154.8	36.8	95.4	62.8	167.2	13.1	50.8	64.9	111.2	13.6	17.5	73.0	213.5	76.0	202.5	101.5	406.2	57.7	18.4	40.0	59.2	69.8	75.1	101.7	63.5	53.2	114.2	168.0	73.4	88.7	181.0	71.1
SDHAF1	LYRM8	ENSG00000205138	"Succinate dehydrogenase complex assembly factor 1"	A6NFY7	19	35995188-35996312	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		Chaperone	"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA064277, HPA074563"			Supported	Mitochondria		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 35: Non-specific - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 32: Non-specific - Translation"	Mitochondria		"HPA064277: AB_2685231, HPA074563: "	"unprognostic (2.01e-1)"	"unprognostic (3.46e-2)"	"unprognostic (2.22e-2)"	"unprognostic (3.11e-2)"	"unprognostic (1.81e-1)"	"unprognostic (4.47e-2)"	"unprognostic (5.25e-2)"	"unprognostic (2.29e-2)"	"unprognostic (1.24e-1)"	"unprognostic (3.78e-2)"	"unprognostic (6.89e-3)"	"unprognostic (1.83e-2)"	"prognostic favorable (2.11e-4)"	"unprognostic (1.38e-2)"	"unprognostic (2.59e-1)"	"unprognostic (2.24e-1)"	"unprognostic (3.59e-2)"	15.4	16.2	13.7	6.3	15.2	4.2	16.1	17.8	15.5	19.1	13.3	21.5	13.6	16.3	6.1	16.3	17.0	4.8	15.0	14.1	14.4	18.5	32.7	12.8	9.5	16.0	14.4	15.0	24.7	9.6	20.1	5.5	16.3	16.5	5.0	6.8	16.9	6.6	19.0	18.3	18.9	3.0	15.4	19.1	18.9	9.9	14.5	8.5	16.4	7.6	6.0	18.7	16.6	18.4	9.6	24.7	7.2	16.7	6.9	8.7	12.5	9.2	9.8	9.8	11.3	17.8	7.1	17.8	17.3	6.1	6.7	9.5	9.5	5.1	4.7	33.6	22.3	7.9	10.7	23.6	8.4	9.5	12.5	7.7	16.4	6.0	6.4	3.9	5.5	18.5	24.6	18.9	4.3	23.5	18.2	18.6	11.2	31.4	11.8	19.6	8.0	20.3	9.7	12.2	28.2	21.1	14.8	23.9	16.5	5.9	13.7	15.9	7.3	11.2	16.8	10.7	14.2	25.4	12.6	21.0	9.8	18.1	10.1	45.6	34.0	55.2	40.3	40.7	43.8	43.0	43.4	39.5	35.8	46.5	47.8	40.5	19.2	57.7	45.7	45.0	49.6	32.1	13.7	15.2	17.8	15.5	14.1	14.4	16.0	14.4	16.3	15.4	14.5	18.4	18.7	6.4	4.1	4.6	24.6	30.0	11.4	9.7	14.2	20.9	27.1	26.4	9.5	17.2	5.9	18.4	6.2	25.1	19.9	21.7	27.4	21.9	25.0	7.9	15.8	16.9	28.8	8.8	4.0	29.6	37.7	20.0	16.3	7.3	4.5	17.3	19.6	19.9	22.7	18.5	4.6	32.7	10.2	19.6	18.5	6.5	23.0	12.1	24.9	3.7	28.2	16.6	32.0	3.0	8.1	22.9	37.2	29.3	16.8	23.1	54.1	32.8	3.3	14.8	26.3	10.9	13.8	10.5	13.9	16.1	41.6	23.1	20.1	25.4	32.0	16.4
SDHAF2	"C11orf79, FLJ20487, PGL2, SDH5"	ENSG00000167985	"Succinate dehydrogenase complex assembly factor 2"	Q9NX18	11	61430042-61446733	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"		Chaperone	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA039464, HPA039732"	Supported		Approved	Nucleoli,Mitochondria,Cytosol		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Basic cellular processes"	"Mitochondria, Cytosol"	Nucleoli	"HPA039464: AB_10962146, HPA039732: AB_10962868"	"unprognostic (5.31e-2)"	"unprognostic (1.12e-2)"	"unprognostic (3.13e-1)"	"unprognostic (1.30e-2)"	"unprognostic (1.40e-1)"	"unprognostic (6.71e-2)"	"unprognostic (1.98e-3)"	"unprognostic (9.06e-2)"	"unprognostic (2.17e-1)"	"unprognostic (2.09e-3)"	"unprognostic (4.21e-3)"	"unprognostic (1.50e-1)"	"unprognostic (1.81e-2)"	"unprognostic (3.61e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.45e-1)"	"unprognostic (4.48e-2)"	27.5	37.1	36.2	26.4	37.4	45.6	28.9	37.9	38.2	23.8	37.4	27.2	24.7	23.8	34.8	28.8	28.7	25.5	40.4	35.9	40.2	36.5	46.4	23.8	39.9	37.9	37.6	26.9	24.0	32.9	41.0	24.9	37.9	29.0	29.1	23.4	26.3	20.9	38.9	26.3	27.0	26.9	37.7	34.7	27.6	22.1	38.0	38.0	28.6	44.7	41.6	32.8	21.7	39.2	45.0	58.4	36.5	25.1	57.2	52.2	27.0	33.3	58.0	48.9	41.8	52.8	46.8	42.3	58.4	55.6	62.8	45.4	45.4	51.4	56.6	60.4	39.7	33.2	35.5	71.9	52.8	41.4	48.1	55.6	58.7	50.2	45.8	35.3	80.8	43.5	42.2	50.9	63.5	86.0	49.2	89.3	56.1	47.0	78.6	45.9	45.9	76.6	63.7	57.9	36.9	40.6	46.9	53.5	99.0	38.5	83.0	40.2	53.3	45.0	32.7	54.3	37.5	31.2	51.2	54.7	43.4	37.3	46.0	125.3	68.8	126.6	82.5	64.5	103.1	89.7	93.0	91.7	55.9	84.8	101.5	97.5	97.9	97.9	53.3	63.3	126.7	78.6	36.2	37.4	37.9	38.2	35.9	40.2	37.9	37.6	37.9	37.7	38.0	39.2	32.8	35.3	33.2	11.1	28.9	20.6	34.6	53.7	10.2	14.0	27.9	35.1	22.3	14.3	33.5	29.5	6.2	77.0	41.9	29.5	54.8	55.3	15.8	19.3	21.7	36.5	34.2	30.3	13.2	60.3	51.4	28.4	16.8	19.0	32.3	22.2	42.5	42.3	52.7	15.2	13.3	31.4	59.0	36.5	22.8	17.8	31.4	29.7	44.4	8.4	66.4	49.4	69.0	16.6	18.1	62.9	34.9	30.9	16.3	30.8	34.0	51.9	31.5	19.7	32.9	17.3	27.2	23.1	25.8	10.9	22.4	99.6	41.5	45.1	27.6	38.8
SDHB	"SDH, SDH1"	ENSG00000117118	"Succinate dehydrogenase complex iron sulfur subunit B"	P21912	1	17018722-17054032	"Cancer-related genes, Citric acid cycle related proteins, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Electron transport, Transport, Tricarboxylic acid cycle"	Oxidoreductase	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 491.5;tongue: 580.6"	"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 405.5;Proximal tubular cells: 449.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002868, CAB009822, CAB068233, CAB068234, CAB068235"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Mitochondria"	"Intracellular and membrane"	NA	NA		7900	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria	"Nucleoplasm, Plasma membrane"	"CAB009822: AB_2183458, CAB068233: AB_2665638, CAB068234: AB_2665639, CAB068235: AB_2665640, HPA002868: AB_1079889"	"unprognostic (1.06e-1)"	"unprognostic (2.86e-2)"	"unprognostic (2.19e-2)"	"unprognostic (2.93e-2)"	"unprognostic (1.88e-1)"	"unprognostic (2.79e-3)"	"unprognostic (1.58e-1)"	"unprognostic (3.02e-1)"	"unprognostic (1.19e-1)"	"unprognostic (8.45e-2)"	"unprognostic (5.51e-2)"	"unprognostic (3.93e-2)"	"prognostic favorable (2.93e-7)"	"unprognostic (1.46e-1)"	"unprognostic (2.75e-1)"	"unprognostic (7.82e-2)"	"unprognostic (3.82e-2)"	85.8	95.7	68.0	59.0	72.2	94.6	68.7	80.6	84.3	56.8	81.1	134.3	163.0	56.0	71.0	77.4	59.8	48.0	302.8	69.9	76.9	228.0	336.1	56.1	75.3	74.8	71.4	44.4	80.3	144.3	42.8	57.6	73.8	55.7	132.4	62.9	74.0	60.5	491.5	55.6	121.9	70.4	73.9	60.5	92.8	64.4	74.9	62.7	64.3	580.6	84.2	71.3	52.0	78.9	157.3	152.7	72.2	107.8	141.6	135.2	95.9	122.4	145.2	254.3	227.7	216.8	183.1	206.8	159.3	156.4	176.1	180.1	290.7	226.8	284.8	128.7	280.6	183.4	149.2	168.2	172.8	276.0	135.6	140.4	154.9	224.5	370.1	138.7	183.6	176.5	165.2	236.9	179.6	129.5	182.4	175.1	70.4	224.6	302.6	146.1	142.5	265.4	252.4	88.7	157.5	86.0	172.3	216.3	392.3	76.4	131.1	169.1	94.9	115.8	131.0	206.4	176.0	98.9	133.3	198.6	170.4	438.5	128.3	68.7	149.8	149.5	71.4	206.5	70.7	89.9	81.0	77.5	186.8	81.1	73.5	74.8	174.3	85.3	185.7	89.3	113.8	116.1	68.0	72.2	80.6	84.3	69.9	76.9	74.8	71.4	73.8	73.9	74.9	78.9	48.2	64.1	47.4	20.9	57.4	52.1	93.3	199.8	40.5	31.5	45.2	49.4	405.5	101.5	97.0	47.8	14.6	107.1	48.3	176.1	354.1	134.3	220.3	48.7	38.2	54.7	48.6	77.3	27.7	149.2	142.2	62.0	46.9	45.5	66.6	39.9	46.8	226.0	177.4	37.0	32.1	103.1	116.0	88.7	67.9	30.5	57.8	78.4	64.0	29.0	123.1	78.3	48.4	15.6	24.6	111.5	218.3	67.7	62.2	74.4	300.5	449.0	79.8	53.8	39.5	57.1	191.6	148.9	71.5	72.9	54.6	121.8	46.8	69.3	162.0	110.9
SEC13	"D3S1231E, npp-20, SEC13L1, SEC13R"	ENSG00000157020	"SEC13 homolog, nuclear pore and COPII coat complex component"	P55735	3	10293131-10321112	"Metabolic proteins, Predicted intracellular proteins, Transporters"	"ER-Golgi transport, mRNA transport, Protein transport, Translocation, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035292, HPA057943"	Approved		Supported	Nucleoplasm,Vesicles		NA	NA		35000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 59: Non-specific - Translation"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 55: Plasma cells - Humoral immune response"	"Nucleoplasm, Vesicles"		"HPA035292: AB_10959451, HPA057943: AB_2683560"	"unprognostic (3.33e-3)"	"unprognostic (6.16e-2)"	"unprognostic (2.28e-2)"	"unprognostic (4.95e-2)"	"unprognostic (4.22e-1)"	"unprognostic (2.64e-2)"	"prognostic unfavorable (1.73e-4)"	"unprognostic (2.43e-1)"	"unprognostic (2.67e-1)"	"unprognostic (1.69e-1)"	"unprognostic (4.58e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.40e-1)"	"unprognostic (4.60e-1)"	"unprognostic (2.43e-1)"	"unprognostic (2.03e-1)"	"unprognostic (8.33e-2)"	62.1	71.5	51.0	61.8	55.6	58.4	58.9	55.9	57.6	83.7	59.2	68.8	114.7	66.4	59.4	72.6	57.4	47.5	71.1	52.2	57.2	67.4	92.1	64.3	54.6	54.6	54.6	52.6	85.2	64.6	109.2	68.5	55.2	53.8	65.7	21.2	96.2	64.9	111.5	62.7	96.6	76.6	54.3	59.4	67.3	39.4	54.2	70.3	57.6	87.3	65.4	69.9	59.2	58.2	122.6	182.1	142.9	55.2	228.0	251.6	474.4	243.8	296.1	279.3	319.8	150.3	97.6	110.7	109.6	390.1	156.8	49.0	186.4	218.3	142.4	97.8	194.5	136.2	137.3	363.7	311.8	156.7	115.5	224.7	173.1	292.6	181.5	205.6	337.0	146.2	148.4	159.8	219.5	250.2	153.8	169.9	160.9	158.0	218.7	148.1	102.4	198.2	172.4	90.2	80.3	99.4	107.3	98.7	101.3	119.3	127.5	150.8	253.6	114.2	130.2	172.6	213.3	131.7	198.4	258.6	215.5	217.5	193.0	127.3	163.2	106.6	84.4	144.9	94.6	96.5	83.6	82.1	222.5	82.6	68.0	71.2	105.8	93.9	116.4	198.3	106.1	176.5	51.0	55.6	55.9	57.6	52.2	57.2	54.6	54.6	55.2	54.3	54.2	58.2	23.9	48.1	61.9	14.0	45.8	39.4	50.4	73.6	31.3	16.2	29.5	26.4	40.2	30.0	68.3	27.6	10.4	119.9	36.5	60.1	66.5	79.3	25.6	31.8	44.0	51.0	41.4	33.0	17.3	109.2	166.6	74.1	73.9	47.1	43.1	35.5	33.9	57.3	104.9	11.8	13.7	108.2	50.8	33.0	46.7	10.2	53.4	45.0	26.6	12.2	64.2	37.4	35.0	11.6	12.6	81.8	56.1	52.6	203.2	52.4	187.5	112.0	64.5	21.1	13.1	37.7	63.6	54.9	38.9	43.7	40.2	168.6	36.5	35.8	74.2	62.3
SEC14L1	"PRELID4A, SEC14L"	ENSG00000129657	"SEC14 like lipid binding 1"	Q92503	17	77088749-77217101	"Plasma proteins, Predicted intracellular proteins"	"Immunity, Innate immunity"	"Signal transduction inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Adipocytes: 430.3;Hepatic stellate cells: 286.3;Late spermatids: 740.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in all"	7	"neutrophil: 355.0"	"Lineage enriched"	"Detected in all"	11	"granulocytes: 355.0"	"Cell line enhanced"	"Detected in all"		"HUVEC TERT2: 398.1;TIME: 251.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021463, HPA028703"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 25: Spermatids - Spermatogenesis"	"Nucleoplasm, Cytosol"		"HPA021463: AB_2670712, HPA028703: AB_10602300"	"unprognostic (1.19e-1)"	"unprognostic (8.61e-2)"	"unprognostic (1.51e-2)"	"unprognostic (4.64e-3)"	"unprognostic (1.26e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.61e-1)"	"unprognostic (7.37e-2)"	"unprognostic (1.21e-1)"	"unprognostic (7.40e-3)"	"unprognostic (1.39e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.33e-3)"	"unprognostic (3.09e-1)"	"unprognostic (4.30e-2)"	66.7	54.2	42.6	44.6	63.3	65.5	57.6	75.4	60.7	39.5	36.3	19.5	21.8	24.6	28.2	31.5	27.3	34.3	50.2	49.5	57.5	42.0	25.3	66.9	49.7	64.0	63.0	20.7	30.8	25.1	27.9	76.7	54.6	18.3	19.8	19.0	35.0	16.8	94.1	20.5	21.7	27.1	46.2	49.9	31.7	51.9	63.6	24.1	41.6	54.7	46.2	26.0	20.6	50.9	55.0	45.4	65.6	105.0	27.4	36.3	24.1	47.4	42.0	57.8	49.5	55.7	39.6	143.1	93.3	65.0	71.1	26.3	36.0	47.8	72.6	27.3	50.1	81.1	42.4	75.9	44.4	26.8	39.8	46.6	20.7	47.8	47.8	69.1	398.1	24.3	55.8	136.0	79.2	36.2	28.5	22.4	25.0	25.7	43.7	20.3	104.2	112.2	91.2	26.2	59.5	44.8	51.1	31.3	32.1	58.3	27.9	20.7	251.1	65.4	60.6	35.0	37.7	71.1	64.8	79.9	27.9	22.1	21.6	33.8	19.4	48.9	7.1	28.3	8.9	14.6	6.9	5.3	12.7	10.8	10.9	5.9	355.0	10.0	33.3	18.9	12.5	11.5	42.6	63.3	75.4	60.7	49.5	57.5	64.0	63.0	54.6	46.2	63.6	50.9	430.3	41.7	18.6	55.8	69.4	29.3	23.5	22.5	37.0	31.5	86.5	37.8	17.6	15.7	28.9	27.6	18.8	10.8	77.5	20.3	99.7	18.0	242.6	114.8	46.7	205.9	19.7	86.5	33.0	20.7	10.8	34.0	35.2	240.5	34.7	104.3	286.3	11.1	51.6	37.0	54.6	14.0	61.1	127.2	48.1	740.3	26.4	115.1	35.6	62.8	76.1	31.4	34.0	23.1	44.4	41.8	15.2	17.3	269.1	39.5	9.6	24.8	69.5	17.2	39.5	36.4	36.3	45.1	42.5	25.1	30.4	13.3	51.6	64.3	11.5	39.1
SEC14L2	"C22orf6, KIAA1186, KIAA1658, SPF, TAP, TAP1"	ENSG00000100003	"SEC14 like lipid binding 2"	O76054	22	30396941-30425303	"Predicted intracellular proteins"	"Transcription, Transcription regulation, Transport"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 86.0;liver: 243.8"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 146.3;Muller glia cells: 112.6;Pancreatic endocrine cells: 115.2;Proximal enterocytes: 52.8;Rod photoreceptor cells: 56.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"naive CD4 T-cell: 3.7;naive CD8 T-cell: 2.7"	"Lineage enriched"	"Detected in single"	7	"T-cells: 3.7"	"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 93.9;hTCEpi: 47.3;hTERT-RPE1: 55.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA064466	Approved		Supported	Nucleoplasm,Cytosol		NA	NA		580000	"Cluster 32: T-cells - Unknown function"	"Cluster 15: Liver - Metabolism"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 2: Hepatocytes - Metabolism"	Nucleoplasm	Cytosol	"HPA064466: AB_2685270"	"prognostic favorable (3.05e-4)"	"unprognostic (1.47e-1)"	"unprognostic (1.98e-1)"	"unprognostic (5.59e-3)"	"unprognostic (6.51e-2)"	"prognostic unfavorable (7.63e-6)"	"unprognostic (1.25e-3)"	"unprognostic (3.76e-3)"	"unprognostic (2.23e-1)"	"unprognostic (2.40e-1)"	"unprognostic (2.76e-2)"	"unprognostic (5.63e-3)"	"unprognostic (1.17e-3)"	"unprognostic (1.17e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.34e-3)"	"unprognostic (2.01e-1)"	2.8	1.4	33.1	2.6	43.3	4.1	44.4	35.8	37.1	6.0	35.4	3.4	21.6	3.4	86.0	20.6	3.1	7.4	2.4	34.3	39.7	8.0	243.8	2.7	3.1	45.4	39.5	2.6	2.6	11.0	11.1	1.5	33.2	52.3	1.3	64.2	9.3	13.7	0.7	7.0	24.3	3.4	30.4	1.1	5.9	1.3	41.4	4.2	9.0	0.5	4.5	3.2	7.7	32.2	24.8	5.5	5.0	6.4	6.5	16.8	0.4	18.0	15.5	12.0	13.1	1.6	15.9	0.5	5.6	22.7	20.5	20.0	3.0	93.9	13.8	2.2	4.1	0.4	5.4	8.0	9.2	0.0	7.1	11.5	47.3	11.5	20.8	55.5	29.7	4.2	0.1	0.5	22.2	4.0	3.0	0.5	0.1	13.9	7.6	1.2	8.0	0.6	20.7	7.8	2.8	3.1	13.3	3.2	11.2	0.6	14.7	0.5	41.2	15.8	10.4	6.8	12.7	0.3	0.2	0.8	32.4	0.1	12.6	0.0	0.1	0.2	0.5	0.1	0.2	0.4	1.4	0.3	0.0	0.3	3.7	2.7	0.3	0.0	0.0	0.5	0.7	0.8	33.1	43.3	35.8	37.1	34.3	39.7	45.4	39.5	33.2	30.4	41.4	32.2	1.1	3.2	5.8	33.6	1.1	4.1	18.0	25.2	6.8	9.2	36.5	21.7	1.2	12.8	10.3	0.0	16.7	4.2	3.2	0.6	5.9	22.9	8.3	2.9	2.3	2.4	1.2	17.2	9.8	18.7	0.3	5.1	5.6	5.8	5.7	0.7	7.1	146.3	0.5	13.5	6.7	2.0	4.1	4.4	0.4	10.7	1.2	2.6	7.2	1.9	0.2	112.6	0.0	21.6	13.2	115.2	0.0	0.7	2.5	15.3	52.8	8.7	3.9	56.0	0.0	2.8	4.0	0.6	1.2	5.6	2.0	3.0	7.4	0.1	2.1	7.8
SEC16A	"KIAA0310, p250, Sec16L"	ENSG00000148396	"SEC16 homolog A, endoplasmic reticulum export factor"	O15027	9	136440096-136483759	"Predicted intracellular proteins"	"ER-Golgi transport, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005684	Supported		Supported	"Endoplasmic reticulum,Golgi apparatus"		NA	NA		48000	"Cluster 27: Non-specific - Gene expression"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 27: Mucus-secreting cells - Mucin production"	"Golgi apparatus"	"Endoplasmic reticulum"	"HPA005684: AB_1079189"	"unprognostic (1.24e-3)"	"unprognostic (2.07e-1)"	"unprognostic (2.02e-1)"	"prognostic favorable (1.30e-6)"	"unprognostic (1.97e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.67e-1)"	"unprognostic (3.84e-2)"	"unprognostic (3.48e-1)"	"unprognostic (5.30e-2)"	"unprognostic (1.38e-3)"	"unprognostic (4.75e-1)"	"prognostic favorable (4.47e-4)"	"unprognostic (5.57e-3)"	"unprognostic (2.64e-1)"	"unprognostic (2.47e-2)"	"unprognostic (1.41e-1)"	16.8	18.2	6.4	16.6	6.7	35.3	17.1	8.0	9.4	16.6	19.3	17.3	14.9	17.9	9.0	17.9	16.4	12.4	14.5	7.0	5.2	14.3	37.9	19.4	16.9	4.4	4.9	16.2	29.2	14.0	24.3	10.8	3.5	18.7	10.5	9.2	25.8	13.1	23.5	19.7	19.1	10.7	2.4	20.7	27.2	17.6	5.2	17.4	15.3	11.9	12.3	15.9	14.5	5.0	26.5	57.7	28.5	47.2	29.6	30.3	33.6	32.1	27.9	23.4	17.8	41.9	22.1	26.4	22.1	39.2	28.8	71.3	31.8	46.2	12.7	56.2	20.7	26.9	55.1	33.7	28.6	46.2	45.8	32.8	32.5	32.7	38.1	18.9	32.2	34.5	34.1	35.6	25.0	114.3	31.2	24.9	25.1	79.0	40.4	44.3	35.2	45.0	23.8	35.0	40.0	26.6	41.6	62.2	19.8	13.8	63.6	35.9	47.0	37.6	28.1	30.8	25.2	16.9	27.7	33.4	29.2	20.6	38.3	1.7	2.8	1.2	2.5	3.1	2.7	2.3	2.6	3.0	1.6	1.4	1.6	2.8	2.0	1.5	3.4	2.6	1.9	2.4	6.4	6.7	8.0	9.4	7.0	5.2	4.4	4.9	3.5	2.4	5.2	5.0	20.0	25.6	41.7	16.6	16.4	24.9	15.3	18.4	10.8	20.2	38.7	30.6	11.5	12.8	23.6	12.9	25.0	8.1	17.5	30.1	7.9	14.2	5.1	26.9	19.5	18.2	40.7	12.0	27.4	16.4	11.8	16.0	46.9	38.2	23.5	25.4	17.9	62.2	16.5	33.7	19.2	65.5	20.3	23.4	19.5	6.0	13.1	22.3	14.2	17.8	19.5	13.0	11.3	9.5	14.7	22.8	14.7	16.6	25.1	26.3	22.3	10.1	34.7	17.1	13.1	20.5	16.6	24.4	16.1	17.2	26.9	15.1	17.8	15.8	22.8	22.1
SEC23B	"CDA-II, CDAII, CDAN2, HEMPAS"	ENSG00000101310	"SEC23 homolog B, COPII coat complex component"	Q15437	20	18507520-18561415	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"ER-Golgi transport, Protein transport, Transport"		"Congenital dyserythropoietic anemia, Disease variant, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008216, HPA069974"	Uncertain		Supported	Vesicles		NA	Yes		16000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 55: Plasma cells - Humoral immune response"	Vesicles		"HPA008216: AB_1079895, HPA069974: AB_2686223"	"unprognostic (4.47e-2)"	"unprognostic (2.67e-2)"	"unprognostic (3.52e-1)"	"prognostic favorable (8.25e-4)"	"unprognostic (1.24e-1)"	"unprognostic (1.33e-1)"	"unprognostic (5.44e-3)"	"unprognostic (6.01e-2)"	"unprognostic (1.39e-1)"	"unprognostic (8.75e-2)"	"unprognostic (1.97e-1)"	"unprognostic (9.97e-2)"	"unprognostic (3.91e-2)"	"unprognostic (1.72e-2)"	"unprognostic (4.26e-2)"	"unprognostic (2.81e-2)"	"unprognostic (8.21e-2)"	19.6	38.3	18.7	32.0	27.1	36.0	37.8	24.7	25.9	36.2	27.4	31.6	23.8	17.2	53.8	28.4	29.5	23.1	8.5	19.5	22.4	37.4	30.6	29.7	30.5	27.2	23.8	16.9	57.1	50.6	32.6	24.2	27.2	34.8	32.7	40.7	70.9	35.9	4.1	18.2	23.3	18.5	24.5	25.5	38.2	34.8	23.2	27.6	59.5	6.2	38.0	30.5	12.6	38.9	85.0	93.9	49.8	48.7	32.3	36.6	116.0	69.8	45.3	80.0	68.7	84.9	73.8	37.5	44.9	50.4	107.0	88.5	88.5	120.7	86.2	47.5	43.1	64.9	35.6	130.6	70.5	90.2	78.7	28.0	71.8	118.0	151.4	47.6	50.6	34.0	74.8	82.4	55.1	90.7	59.8	49.5	48.0	118.9	101.6	62.4	77.7	122.1	83.0	85.6	78.8	58.0	83.6	188.9	80.6	62.6	82.3	94.4	45.3	53.1	29.8	58.4	87.1	104.2	155.9	60.1	45.3	47.8	74.4	147.9	94.1	106.0	57.2	95.6	78.7	67.2	56.8	61.4	107.9	61.2	51.3	54.0	48.0	78.8	94.9	80.7	75.4	103.7	18.7	27.1	24.7	25.9	19.5	22.4	27.2	23.8	27.2	24.5	23.2	38.9	8.5	16.0	43.5	15.3	24.7	11.5	21.0	34.3	10.2	21.0	21.5	15.6	3.0	20.0	42.5	31.3	16.7	34.3	36.0	26.2	58.7	36.1	95.6	25.4	12.4	11.3	19.7	7.4	17.9	33.4	30.0	11.7	25.0	31.3	15.9	13.6	11.0	25.6	42.9	13.5	20.5	34.7	26.4	38.7	21.0	11.3	14.3	30.3	23.2	15.0	33.1	23.9	9.2	23.1	27.0	31.8	24.2	10.5	59.0	30.1	11.8	53.2	45.4	20.4	19.7	12.4	12.2	48.7	22.1	15.8	14.2	65.8	21.0	16.0	21.5	28.3
SEC24C	KIAA0079	ENSG00000176986	"SEC24 homolog C, COPII coat complex component"	P53992	10	73744372-73772161	"Predicted intracellular proteins"	"ER-Golgi transport, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA040196, HPA040213"	Supported		Supported	Vesicles		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 63: NK-cells & T-cells - Immune response"	Vesicles		"HPA040196: AB_10796449, HPA040213: AB_10796451"	"unprognostic (5.06e-2)"	"unprognostic (1.00e-2)"	"unprognostic (2.17e-1)"	"unprognostic (3.54e-1)"	"unprognostic (8.46e-2)"	"unprognostic (7.23e-2)"	"unprognostic (9.06e-2)"	"unprognostic (4.55e-2)"	"unprognostic (1.64e-1)"	"unprognostic (2.46e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.35e-1)"	"unprognostic (7.71e-2)"	"unprognostic (8.34e-3)"	"unprognostic (2.11e-1)"	"unprognostic (3.35e-2)"	"unprognostic (1.77e-2)"	27.8	42.9	20.1	31.6	21.2	16.2	27.4	23.1	26.8	42.5	20.7	34.2	27.4	36.4	33.2	69.0	30.7	24.0	34.5	20.4	21.2	29.8	45.8	30.5	31.4	21.4	20.1	33.2	34.9	50.5	45.4	36.4	20.9	37.7	27.6	29.1	36.9	31.1	49.7	35.8	31.7	32.1	18.3	37.1	34.1	27.7	22.7	35.2	34.0	33.9	43.3	35.5	38.8	23.0	72.7	71.8	55.6	99.9	59.2	48.3	45.6	53.6	90.4	70.4	65.7	67.2	47.9	57.3	43.3	72.0	48.1	61.4	78.3	70.7	60.4	76.6	55.6	53.1	50.5	71.2	47.0	80.7	71.1	41.5	76.8	61.8	76.4	89.2	73.6	44.6	64.1	80.8	69.9	64.7	60.4	55.3	34.8	68.3	259.2	65.2	45.0	47.0	46.5	40.8	20.0	51.7	41.9	144.6	60.1	51.7	106.3	70.6	72.7	29.5	53.1	57.7	62.5	82.0	85.9	84.0	84.0	80.8	35.0	28.2	15.8	13.6	27.4	21.4	35.5	12.6	16.2	21.6	18.1	9.4	11.7	15.8	11.5	22.4	19.1	14.8	10.9	22.7	20.1	21.2	23.1	26.8	20.4	21.2	21.4	20.1	20.9	18.3	22.7	23.0	12.1	35.3	28.6	16.3	11.6	8.7	4.7	11.5	6.2	15.1	17.0	14.9	2.3	14.3	17.6	14.7	16.7	17.8	18.6	24.7	3.9	15.1	8.8	10.9	13.0	11.0	19.2	5.9	14.6	19.4	16.4	9.7	19.9	17.0	22.2	20.1	16.4	19.9	17.1	15.2	15.7	18.4	8.2	11.7	8.4	6.0	11.8	12.4	5.4	6.5	12.3	10.3	17.5	14.1	16.8	23.8	14.4	11.7	21.9	10.8	20.0	10.4	8.2	14.7	6.6	10.0	9.7	10.3	8.3	11.5	11.4	25.2	16.9	14.7	16.1	10.9
SEC31A	"ABP125, ABP130, KIAA0905, SEC31L1"	ENSG00000138674	"SEC31 homolog A, COPII coat complex component"	O94979	4	82818509-82901166	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"ER-Golgi transport, Protein transport, Transport"		Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005457	Approved		Supported	Vesicles,Cytosol		NA	NA		40000	"Cluster 27: Non-specific - Gene expression"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 40: Granulosa cells - Unknown function"	"Vesicles, Cytosol"		"HPA005457: AB_1079896"	"unprognostic (3.50e-2)"	"unprognostic (2.28e-3)"	"unprognostic (2.55e-2)"	"unprognostic (1.58e-2)"	"unprognostic (2.93e-1)"	"unprognostic (6.52e-2)"	"prognostic unfavorable (3.32e-4)"	"unprognostic (6.14e-3)"	"unprognostic (1.54e-1)"	"unprognostic (1.17e-1)"	"unprognostic (4.21e-3)"	"unprognostic (3.62e-1)"	"unprognostic (1.64e-1)"	"unprognostic (5.53e-3)"	"unprognostic (2.92e-1)"	"unprognostic (2.85e-1)"	"prognostic unfavorable (2.69e-4)"	98.7	103.3	52.2	78.4	54.3	119.4	111.4	62.4	70.1	145.5	94.9	107.1	124.2	119.7	162.1	92.6	90.9	122.1	110.7	54.0	61.4	133.6	174.8	96.2	88.2	58.4	58.7	152.8	192.6	116.4	108.4	143.2	58.7	113.4	127.2	87.9	134.0	111.3	96.8	107.8	111.0	131.5	50.9	76.5	110.1	77.8	54.4	93.8	168.0	85.6	102.1	113.1	94.1	63.9	146.2	65.2	183.6	130.4	318.9	394.5	133.3	264.8	295.4	146.0	179.2	113.2	182.3	188.3	113.7	532.2	84.6	68.1	183.3	176.2	200.4	193.4	72.7	115.3	110.5	302.1	316.4	124.4	140.7	380.5	217.7	223.5	254.3	251.2	240.5	83.8	178.4	181.1	264.2	128.6	164.9	99.6	126.1	154.0	58.3	121.2	100.1	140.3	237.2	83.0	118.6	131.2	105.7	180.7	174.9	184.8	142.1	137.8	248.2	190.7	98.9	169.0	168.8	135.1	62.4	256.7	190.6	147.8	224.2	84.3	66.9	51.2	65.1	74.0	80.5	60.0	57.6	64.3	73.3	50.0	56.9	54.6	19.2	89.9	83.1	61.1	52.7	71.8	52.2	54.3	62.4	70.1	54.0	61.4	58.4	58.7	58.7	50.9	54.4	63.9	62.6	105.8	85.3	50.9	58.1	60.5	60.5	64.1	56.9	52.3	54.5	43.7	85.5	51.5	109.8	47.8	54.2	57.3	61.0	62.8	27.4	65.8	30.6	90.1	164.6	65.0	38.3	41.2	61.0	71.2	85.3	125.2	100.9	119.7	75.2	241.0	65.0	94.0	45.9	42.1	60.0	99.4	50.8	51.2	55.3	19.3	139.1	63.8	51.6	67.5	60.4	36.5	38.1	74.9	72.6	67.5	46.3	126.0	152.2	76.3	121.0	65.9	100.5	66.9	52.6	86.5	98.9	30.3	34.6	62.2	74.2	81.5	55.4	78.9	54.9	101.1
SEC31B	"DKFZP434M183, SEC31B-1, SEC31L2"	ENSG00000075826	"SEC31 homolog B, COPII coat complex component"	Q9NQW1	10	100486646-100519864	"Predicted intracellular proteins"	"ER-Golgi transport, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 28.7;Bipolar cells: 32.2;Cone photoreceptor cells: 39.6;Excitatory neurons: 38.1;Horizontal cells: 40.4;Inhibitory neurons: 40.7;Oligodendrocyte precursor cells: 32.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"hTERT-RPE1: 9.1;JURKAT: 8.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA035882, HPA040819, HPA060052"	Uncertain		Supported	Nucleoplasm,Vesicles,Cytosol		NA	NA				"Cluster 59: Non-specific - Translation"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 62: Horizontal cells - Visual perception"	"Nucleoplasm, Vesicles, Cytosol"		"HPA035882: AB_10795246, HPA040819: AB_10794151, HPA060052: "	"unprognostic (1.23e-1)"	"unprognostic (3.13e-3)"	"unprognostic (3.39e-3)"	"unprognostic (1.03e-2)"	"unprognostic (4.85e-2)"	"unprognostic (1.42e-3)"	"unprognostic (1.97e-3)"	"unprognostic (6.63e-2)"	"unprognostic (2.22e-1)"	"unprognostic (2.25e-2)"	"unprognostic (1.10e-4)"	"unprognostic (8.23e-3)"	"prognostic unfavorable (6.41e-7)"	"unprognostic (2.31e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.01e-4)"	2.2	1.5	2.0	1.1	2.0	2.5	2.0	2.3	2.9	2.6	1.2	2.5	0.3	2.1	1.0	0.8	2.6	0.8	2.8	1.8	1.9	2.2	2.0	1.7	1.6	1.9	1.7	2.8	0.6	1.7	3.7	0.7	1.8	2.3	0.8	1.5	1.6	0.8	5.9	1.3	2.3	0.8	1.5	3.0	1.7	2.7	1.9	2.9	2.0	8.3	1.3	1.8	1.5	2.2	0.1	0.0	2.0	0.5	0.6	1.0	0.1	0.4	0.9	0.2	0.6	0.1	0.0	0.4	0.6	0.0	0.1	0.0	1.1	0.2	0.5	2.5	0.5	1.0	1.5	0.2	0.9	0.8	0.8	1.8	1.0	0.1	1.2	9.1	0.3	8.9	0.1	1.3	0.0	0.0	1.4	2.3	0.0	0.2	0.4	2.0	0.0	0.9	0.6	0.0	0.1	0.7	0.2	0.0	0.4	1.5	0.4	0.2	0.0	0.1	0.2	0.1	0.1	0.9	0.5	0.6	0.0	2.3	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.0	2.0	2.3	2.9	1.8	1.9	1.9	1.7	1.8	1.5	1.9	2.2	2.5	6.4	4.5	28.7	2.4	1.1	0.9	1.7	1.2	32.2	2.9	2.0	8.0	4.3	2.3	11.0	39.6	1.2	4.5	3.8	0.0	0.4	2.3	1.3	3.4	2.6	5.4	0.4	38.1	0.2	0.3	2.4	3.1	1.6	1.3	7.7	2.9	6.1	2.2	40.4	40.7	3.3	0.0	4.8	1.7	1.7	3.4	3.5	1.8	7.5	5.2	3.6	1.0	32.6	21.5	0.2	2.0	4.1	2.5	1.2	2.4	1.0	2.2	5.8	0.0	1.9	2.2	7.7	3.2	1.8	1.1	0.8	4.6	4.7	4.0	1.1
SEC61A1		ENSG00000058262	"SEC61 translocon subunit alpha 1"	P61619	3	128051641-128071683	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Protein transport, Translocation, Transport"	Chaperone	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB022076			Supported	"Endoplasmic reticulum"		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Endoplasmic reticulum"		"CAB022076: "	"unprognostic (1.84e-1)"	"unprognostic (8.00e-2)"	"unprognostic (8.21e-2)"	"prognostic favorable (7.82e-4)"	"unprognostic (2.13e-1)"	"unprognostic (1.24e-1)"	"prognostic unfavorable (1.07e-6)"	"unprognostic (2.84e-2)"	"unprognostic (4.67e-1)"	"unprognostic (1.23e-1)"	"unprognostic (3.85e-2)"	"unprognostic (1.43e-1)"	"prognostic unfavorable (6.84e-9)"	"unprognostic (2.73e-2)"	"unprognostic (3.18e-2)"	"unprognostic (8.33e-2)"	"unprognostic (2.51e-2)"	82.1	100.7	31.3	88.3	33.4	79.5	75.3	33.5	34.7	144.5	52.4	90.7	81.9	88.9	128.9	88.7	78.1	81.7	74.2	32.3	39.6	64.6	134.8	93.3	60.2	40.9	37.6	67.3	272.1	111.7	93.5	112.8	36.0	90.0	90.0	37.0	176.3	97.0	70.5	66.9	75.8	110.7	36.6	73.7	105.5	38.8	46.6	61.4	104.8	59.3	80.6	97.0	68.7	35.8	272.8	136.5	132.0	240.3	367.9	317.3	256.9	426.9	470.8	349.0	371.2	259.1	186.9	184.7	259.5	534.8	266.2	232.6	209.0	291.3	334.2	168.1	126.2	213.5	143.5	273.6	542.9	264.1	225.9	348.1	345.4	329.3	422.4	265.0	314.3	122.2	136.9	415.3	412.8	237.7	135.1	87.5	184.6	231.6	202.8	144.2	125.5	349.8	181.4	229.3	155.8	162.4	216.0	193.5	270.7	152.0	184.2	215.1	327.3	278.3	164.7	333.7	201.4	386.6	210.6	265.8	456.3	166.2	369.1	160.3	88.6	67.0	89.0	79.6	120.0	43.8	62.9	78.2	82.6	26.1	38.8	46.2	22.5	65.0	84.2	114.0	45.1	116.9	31.3	33.4	33.5	34.7	32.3	39.6	40.9	37.6	36.0	36.6	46.6	35.8	31.9	32.1	33.1	18.6	46.6	37.0	25.7	44.4	30.7	17.0	63.5	41.3	15.0	37.1	43.3	49.7	35.5	64.3	59.2	107.2	3.9	81.0	42.2	28.2	72.9	45.9	73.6	19.5	12.6	154.5	136.3	57.4	77.5	68.6	26.0	55.6	49.6	118.2	75.9	26.9	18.5	150.8	38.7	34.8	32.1	25.7	41.0	38.2	33.8	26.2	32.1	22.4	28.8	19.1	17.2	104.9	50.2	43.6	192.8	69.6	63.5	26.8	31.0	15.5	32.9	25.6	47.2	12.3	18.4	42.5	29.5	127.9	32.4	52.6	100.4	44.6
SEC61B		ENSG00000106803	"SEC61 translocon subunit beta"	P60468	9	99222064-99230615	"Predicted membrane proteins, Transporters"	"Protein transport, Translocation, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"monocytes: 1573.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA049407	Approved		Supported	"Endoplasmic reticulum"		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 21: OE19 - Mitochondria"	"Cluster 65: Plasmacytoid DCs - Unknown function"	"Endoplasmic reticulum"		"HPA049407: AB_2680750"	"unprognostic (1.11e-1)"	"unprognostic (5.99e-3)"	"unprognostic (3.46e-1)"	"prognostic favorable (1.26e-5)"	"unprognostic (1.96e-1)"	"unprognostic (4.54e-2)"	"unprognostic (1.21e-3)"	"unprognostic (1.09e-1)"	"unprognostic (6.67e-2)"	"unprognostic (1.87e-2)"	"unprognostic (2.90e-2)"	"unprognostic (7.07e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.57e-1)"	"unprognostic (6.87e-2)"	"unprognostic (2.75e-1)"	173.5	235.8	101.0	154.7	104.0	255.5	153.4	104.3	120.8	179.4	105.3	139.3	155.0	167.7	259.4	169.8	155.0	129.8	106.7	104.4	110.8	213.7	465.3	169.0	184.0	104.5	102.1	158.5	546.0	145.9	209.5	98.3	105.8	168.0	102.8	48.5	347.7	124.3	61.0	122.5	132.9	106.3	106.8	173.1	186.5	76.4	103.8	188.8	179.8	44.2	146.7	148.8	139.1	111.6	226.5	213.3	244.1	243.7	234.5	296.0	293.9	327.6	335.8	299.9	259.2	307.3	172.6	305.3	244.3	298.7	328.9	272.0	171.9	259.5	143.1	325.4	238.7	160.7	200.7	440.3	509.9	278.9	198.3	268.0	389.4	237.3	210.3	268.1	369.8	246.7	255.0	581.1	285.6	407.7	255.6	404.9	196.3	533.9	497.7	244.2	207.7	398.1	332.3	158.3	252.7	179.2	183.6	421.1	441.5	190.8	163.4	378.6	265.1	215.3	260.0	363.5	277.7	312.0	226.6	200.7	359.3	176.6	145.6	875.3	460.3	453.3	354.6	387.9	480.8	356.5	389.3	360.4	481.0	257.1	242.9	267.7	388.5	325.7	350.8	1661.8	388.0	525.0	101.0	104.0	104.3	120.8	104.4	110.8	104.5	102.1	105.8	106.8	103.8	111.6	255.6	102.5	206.1	18.3	370.9	395.8	308.3	712.8	213.9	59.3	499.1	530.7	55.5	271.7	416.8	200.5	31.3	336.6	605.9	239.9	633.9	498.6	184.2	274.7	410.2	286.1	302.0	226.8	16.2	792.5	577.9	343.2	214.1	391.3	214.8	258.8	213.8	822.0	509.8	53.8	15.5	534.0	406.9	295.3	553.2	51.8	328.0	316.3	496.2	17.8	1573.9	197.3	284.2	15.6	25.9	633.4	280.0	304.3	1190.6	654.2	290.3	767.6	331.4	81.5	138.1	237.1	404.7	218.4	171.0	337.5	443.4	553.8	270.1	333.0	334.0	501.5
SEC63	"DNAJC23, ERdj2, PRO2507, SEC63L"	ENSG00000025796	"SEC63 homolog, protein translocation regulator"	Q9UGP8	6	107867756-107958208	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Protein transport, Transport"	Chaperone	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Theca cells: 354.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA053295, HPA060535"	Supported		Supported	"Endoplasmic reticulum"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 52: Non-specific - Transcription"	"Endoplasmic reticulum"		"HPA053295: AB_2682105, HPA060535: AB_2684312"	"prognostic unfavorable (3.32e-4)"	"prognostic unfavorable (4.01e-4)"	"unprognostic (4.08e-1)"	"unprognostic (1.56e-1)"	"unprognostic (4.36e-3)"	"unprognostic (1.51e-2)"	"unprognostic (8.33e-3)"	"unprognostic (1.24e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.04e-1)"	"unprognostic (3.27e-1)"	"unprognostic (1.72e-1)"	"prognostic unfavorable (6.16e-4)"	"unprognostic (2.35e-1)"	"unprognostic (1.93e-1)"	"unprognostic (1.56e-1)"	"unprognostic (4.41e-2)"	27.5	33.0	11.6	22.0	14.3	32.9	23.3	14.4	12.9	30.2	25.7	19.2	16.8	25.2	29.6	19.5	21.8	22.0	19.0	12.4	15.3	20.0	46.6	21.7	16.7	13.3	12.0	40.4	61.2	31.7	14.4	20.9	14.2	27.7	18.6	21.2	77.8	23.3	14.3	15.5	18.0	22.2	12.3	16.1	23.1	33.0	12.1	22.6	52.1	14.1	17.3	21.8	14.0	17.7	28.5	17.1	46.0	57.6	47.1	55.2	41.4	59.2	65.0	27.8	39.2	30.8	34.6	52.8	49.4	53.7	34.4	40.9	32.3	38.3	42.5	63.8	35.7	57.2	25.2	31.6	73.2	65.9	32.5	43.5	61.4	44.5	97.6	50.0	39.3	31.7	48.5	82.8	57.7	22.7	20.6	29.5	36.4	30.0	18.1	65.2	54.4	43.7	33.5	37.1	40.3	45.7	32.9	48.8	59.1	31.2	34.9	95.8	42.5	41.6	25.8	42.2	46.6	31.4	25.0	52.9	45.9	56.4	48.7	5.6	5.2	5.0	4.8	4.7	7.5	4.4	3.9	3.9	5.4	4.0	4.3	3.4	1.7	7.1	9.8	6.9	2.2	3.5	11.6	14.3	14.4	12.9	12.4	15.3	13.3	12.0	14.2	12.3	12.1	17.7	55.6	118.6	143.3	38.2	64.4	85.0	70.5	90.9	42.7	57.7	67.8	54.2	78.8	81.5	125.5	53.3	39.6	80.8	71.6	39.2	11.7	86.0	40.3	48.7	102.8	61.6	53.5	31.5	52.5	125.4	96.4	107.1	46.9	54.8	68.9	84.8	59.6	126.7	62.7	47.1	50.8	80.0	83.4	56.7	78.9	23.9	106.2	54.8	80.0	42.2	54.3	61.0	59.8	60.3	64.8	81.9	53.5	118.8	144.6	91.1	37.2	38.4	116.7	49.9	46.0	108.2	77.2	143.1	75.0	44.7	80.0	91.0	52.3	354.8	60.8	73.8
SECISBP2	SBP2	ENSG00000187742	"SECIS binding protein 2"	Q96T21	9	89318500-89359663	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Protein biosynthesis"	RNA-binding	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 332.4;Late spermatids: 440.3;Spermatocytes: 338.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044314, HPA054905"	Approved		Supported	Nucleoplasm	"Intracellular and membrane"	NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 51: Myeloid cells - Hemostasis"	Nucleoplasm		"HPA044314: AB_10964885, HPA054905: "	"unprognostic (1.07e-1)"	"unprognostic (4.24e-1)"	"unprognostic (1.64e-1)"	"unprognostic (3.54e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.21e-1)"	"unprognostic (4.00e-1)"	"unprognostic (8.80e-2)"	"unprognostic (1.35e-2)"	"unprognostic (7.18e-2)"	"unprognostic (1.92e-2)"	"unprognostic (1.16e-1)"	"prognostic favorable (8.98e-9)"	"unprognostic (5.44e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.98e-1)"	"unprognostic (4.55e-3)"	22.9	27.2	17.7	22.6	21.0	35.1	28.2	22.2	19.9	29.2	25.1	26.0	23.5	27.4	28.0	19.7	28.1	18.6	18.2	18.5	21.3	31.6	29.2	25.9	31.9	19.4	18.7	40.8	40.8	25.3	28.1	27.1	19.6	25.2	27.5	49.0	27.1	16.3	41.6	29.7	29.3	15.3	17.8	34.8	27.0	68.9	19.9	33.8	35.3	21.3	27.5	24.7	23.6	28.0	29.9	19.9	53.5	31.1	24.7	26.5	38.8	16.9	20.9	19.8	19.4	11.2	24.4	44.4	14.6	15.9	31.5	37.1	36.4	17.0	18.3	29.4	21.6	21.8	16.5	28.7	21.3	44.2	31.5	16.7	31.5	16.8	19.9	21.8	25.0	58.5	28.4	51.1	19.1	27.7	60.9	22.6	55.7	74.5	19.5	29.1	26.2	29.3	22.2	22.7	39.0	38.3	15.3	33.7	45.9	35.4	29.9	37.8	23.2	19.2	22.3	26.0	26.4	61.7	42.3	18.2	33.3	28.3	28.1	17.0	8.2	14.7	10.8	8.9	10.5	14.2	10.9	10.7	7.4	14.8	16.2	13.9	23.0	10.2	11.5	13.0	14.3	6.5	17.7	21.0	22.2	19.9	18.5	21.3	19.4	18.7	19.6	17.8	19.9	28.0	72.5	44.8	58.0	43.8	81.2	19.5	72.0	29.9	38.1	113.8	49.0	59.8	18.3	31.5	40.2	40.5	91.8	70.6	67.7	41.0	43.0	39.4	332.4	44.8	34.6	46.2	37.3	60.4	55.2	31.4	47.2	36.1	42.8	47.7	36.1	51.8	36.0	36.9	26.9	57.2	55.4	56.7	30.5	32.6	19.4	440.3	40.0	69.6	21.4	51.5	47.2	44.8	69.0	46.8	77.5	35.9	49.6	25.6	81.5	64.1	49.2	54.5	41.8	112.9	32.9	63.2	36.3	338.9	223.2	44.2	25.4	91.8	54.3	43.9	50.0	65.4
SELENBP1	"hSBP, hSP56, LPSB"	ENSG00000143416	"Selenium binding protein 1"	Q13228	1	151364304-151372707	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Protein transport, Transport"	Oxidoreductase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 509.3"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 525.6;Distal enterocytes: 1056.9;Erythroid cells: 590.9;Hepatocytes: 501.5;Paneth cells: 451.4;Undifferentiated cells: 452.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"myeloid DC: 2.4"	"Lineage enhanced"	"Detected in single"		"dendritic cells: 2.4"	"Cell line enhanced"	"Detected in many"		"ASC diff: 144.9;HEL: 120.5;HSkMC: 75.9;OE19: 92.8;SK-BR-3: 274.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005741, CAB008366, HPA011731"	Enhanced		Supported	Nucleoli		NA	NA		59000000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoli		"CAB008366: AB_592677, HPA005741: AB_1856662, HPA011731: AB_1856663"	"unprognostic (1.51e-1)"	"unprognostic (7.01e-2)"	"unprognostic (8.52e-3)"	"unprognostic (6.25e-3)"	"unprognostic (6.28e-2)"	"prognostic favorable (6.63e-4)"	"unprognostic (1.08e-2)"	"unprognostic (1.21e-2)"	"unprognostic (3.78e-3)"	"unprognostic (2.86e-1)"	"unprognostic (1.46e-1)"	"unprognostic (2.60e-1)"	"unprognostic (2.67e-2)"	"unprognostic (6.98e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.86e-2)"	"unprognostic (6.86e-3)"	128.3	18.7	49.8	24.9	53.0	95.9	76.3	45.5	54.8	57.0	47.4	509.3	74.7	31.3	43.4	31.8	132.7	52.2	69.1	47.1	48.2	77.2	261.7	181.0	10.9	47.8	51.0	49.4	29.0	11.9	15.0	20.4	46.5	44.2	471.7	3.9	61.6	48.8	72.9	25.2	94.2	49.5	46.9	51.1	126.4	6.1	51.0	7.1	115.1	138.1	6.8	58.3	29.3	45.7	0.0	17.2	31.9	1.8	144.9	59.1	8.4	5.9	2.6	3.1	6.5	18.1	5.4	0.0	30.7	10.7	0.0	0.4	0.0	0.4	2.8	0.1	14.8	120.5	53.1	28.9	30.5	0.2	0.0	75.9	1.0	5.3	0.1	0.4	19.0	0.0	12.4	0.0	8.0	13.2	0.0	0.0	26.6	92.8	32.2	0.1	1.7	0.7	7.1	0.0	0.4	0.7	0.5	274.4	0.0	25.1	49.4	1.8	1.8	0.0	1.1	16.8	0.1	0.1	0.0	0.1	0.0	0.6	0.0	0.0	0.6	0.0	0.0	0.4	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.2	49.8	53.0	45.5	54.8	47.1	48.2	47.8	51.0	46.5	46.9	51.0	45.7	36.6	294.9	525.6	38.2	4.0	10.8	27.7	56.4	30.7	0.3	73.0	59.9	135.7	75.8	123.9	5.5	0.0	2.4	1.9	1056.9	115.4	17.1	0.7	30.9	14.9	27.5	155.0	590.9	0.1	9.1	2.1	85.2	163.6	14.1	27.3	10.9	26.0	501.5	15.3	0.0	0.1	137.2	79.3	39.6	12.4	4.2	66.5	3.9	33.8	13.1	0.2	37.4	0.0	0.0	2.0	6.5	451.4	80.9	0.8	25.6	251.0	148.3	101.5	1.4	52.6	15.6	102.3	0.1	0.3	22.7	9.9	4.0	5.7	30.5	452.4	71.0
SELENOO	SELO	ENSG00000073169	"Selenoprotein O"	Q9BVL4	22	50200979-50217616	"Enzymes, Predicted intracellular proteins"		"Nucleotidyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 27.9"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 21.1;Granulosa cells: 34.7;Proximal tubular cells: 41.7;Theca cells: 29.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA071795, HPA079100"	Approved		Supported	"Mitotic chromosome,Mitochondria"	"Intracellular and membrane"	Yes	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 85: Liver - Metabolism"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 7: Non-specific - Mitochondria"	Mitochondria	"Mitotic chromosome"	"HPA071795: , HPA079100: "	"unprognostic (1.79e-1)"	"unprognostic (2.07e-3)"	"unprognostic (1.60e-1)"	"unprognostic (2.50e-3)"	"unprognostic (3.89e-1)"	"unprognostic (2.33e-2)"	"unprognostic (2.85e-2)"	"unprognostic (5.91e-2)"	"unprognostic (1.51e-1)"	"unprognostic (5.62e-2)"	"unprognostic (8.20e-3)"	"unprognostic (8.91e-2)"	"unprognostic (1.81e-2)"	"unprognostic (7.31e-2)"	"unprognostic (1.98e-1)"	"unprognostic (2.52e-1)"	"prognostic favorable (8.32e-4)"	6.7	6.7	2.3	4.5	3.4	13.9	4.8	11.7	6.8	5.6	2.5	5.3	8.0	5.9	2.8	8.2	5.7	4.1	5.3	3.0	1.1	6.6	27.9	4.7	6.4	4.6	2.7	5.0	13.1	3.0	4.1	3.0	3.7	5.6	2.0	2.9	7.7	4.1	12.3	8.2	6.5	2.4	2.3	6.5	7.0	3.7	3.1	4.4	5.1	4.1	3.9	5.1	6.1	6.0	12.0	7.7	4.2	4.7	5.6	4.1	8.6	11.8	5.6	7.0	5.5	10.6	7.5	7.9	9.2	4.7	3.9	26.2	6.5	10.7	1.4	2.3	29.9	5.7	17.4	6.4	2.8	10.6	6.9	5.4	7.2	4.5	3.5	4.5	5.8	5.3	7.8	5.6	2.9	18.6	5.7	16.4	3.7	2.8	15.6	17.6	5.9	11.8	4.3	15.3	8.4	9.3	12.8	11.3	7.5	2.1	8.7	7.5	9.5	6.0	8.3	6.5	7.1	13.8	3.6	4.7	6.8	6.9	3.5	0.0	1.1	1.3	0.2	0.4	0.5	0.0	0.2	0.5	1.1	0.2	0.1	0.4	0.5	0.0	0.4	0.4	0.2	0.3	2.3	3.4	11.7	6.8	3.0	1.1	4.6	2.7	3.7	2.3	3.1	6.0	11.8	0.0	21.1	0.0	4.1	0.0	0.0	0.0	0.0	0.0	13.3	13.2	0.0	0.0	5.6	9.2	0.0	3.1	12.2	0.0	15.6	3.6	0.0	11.8	10.9	3.0	0.0	0.0	0.0	4.6	2.4	6.0	0.0	15.2	3.8	34.7	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.5	0.0	0.0	2.0	0.0	0.0	0.0	0.0	4.7	0.0	0.0	4.5	0.0	0.0	41.7	3.6	0.0	0.0	0.0	4.8	0.0	0.0	0.0	0.0	1.9	5.5	29.6	0.0	0.0
SEMA5B	"FLJ10372, KIAA1445, SEMAG, SemG"	ENSG00000082684	"Semaphorin 5B"	Q9P283	3	122909082-123028605	"Predicted intracellular proteins, Predicted membrane proteins"	"Differentiation, Neurogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 16.2"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 9.4;Excitatory neurons: 30.8;Muller glia cells: 7.3;Oligodendrocyte precursor cells: 45.2;Smooth muscle cells: 14.3"	"Cancer enhanced"	"Detected in many"		"renal cancer: 18.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 79.7;NTERA-2: 15.7;SH-SY5Y: 21.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA066548	Enhanced		Supported	Cytosol		NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 12: NES - Nervous system development"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Cytosol		"HPA066548: AB_2685689"	"unprognostic (7.34e-2)"	"unprognostic (1.84e-3)"	"unprognostic (1.92e-4)"	"unprognostic (3.01e-2)"	"unprognostic (1.04e-1)"	"unprognostic (2.28e-1)"	"unprognostic (4.72e-2)"	"unprognostic (1.58e-2)"	"unprognostic (7.66e-3)"	"unprognostic (2.87e-2)"	"unprognostic (4.71e-2)"	"unprognostic (2.58e-1)"	"prognostic unfavorable (7.57e-4)"	"unprognostic (1.31e-3)"	"unprognostic (5.96e-2)"	"unprognostic (6.12e-2)"	"unprognostic (2.12e-1)"	1.7	1.5	12.1	0.4	11.8	0.0	1.3	7.3	15.9	1.8	6.7	1.3	0.9	1.4	2.8	0.7	3.5	2.5	9.5	16.2	8.0	9.1	0.9	1.2	0.6	8.4	8.5	1.4	1.7	0.6	2.7	2.6	9.7	1.4	0.8	7.1	0.4	1.4	0.9	1.5	1.5	1.9	7.7	0.2	0.6	0.7	7.8	0.2	2.6	0.5	0.6	1.6	1.6	10.9	0.0	0.0	79.7	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.2	0.3	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	15.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	21.3	0.0	0.2	0.0	3.2	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.1	11.8	7.3	15.9	16.2	8.0	8.4	8.5	9.7	7.7	7.8	10.9	1.2	0.0	1.1	9.4	0.0	0.0	0.0	0.1	0.0	7.2	0.1	0.0	3.5	1.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.1	0.2	0.8	0.0	0.0	30.8	0.0	0.3	0.7	0.0	0.0	0.0	0.1	1.8	0.0	0.1	0.0	6.6	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	1.9	0.6	7.3	0.0	45.2	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.1	0.0	0.1	14.3	0.2	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0
SEMA6C	KIAA1869	ENSG00000143434	"Semaphorin 6C"	Q9H3T2	1	151131685-151146664	"Predicted intracellular proteins, Predicted membrane proteins"	"Differentiation, Neurogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"skeletal muscle: 322.9;tongue: 96.9"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 12.9;Cardiomyocytes: 19.1;Cone photoreceptor cells: 20.9;Inhibitory neurons: 13.7;Skeletal myocytes: 12.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 14.1;HUVEC TERT2: 24.8;TIME: 11.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA076150, HPA077625"			Approved	"Nucleoplasm,Nucleoli fibrillar center,Plasma membrane,Cytosol"	"Intracellular and membrane"	NA	NA		1500000		"Cluster 33: Striated muscle - Muscle contraction"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 37: Myocytes - Muscle contraction"	"Nucleoplasm, Plasma membrane"	"Nucleoli fibrillar center, Cytosol"	"HPA076150: , HPA077625: "	"unprognostic (6.97e-2)"	"unprognostic (8.40e-2)"	"unprognostic (1.56e-3)"	"prognostic unfavorable (3.27e-4)"	"unprognostic (2.79e-1)"	"unprognostic (2.88e-2)"	"unprognostic (3.00e-2)"	"unprognostic (1.24e-2)"	"unprognostic (5.66e-3)"	"unprognostic (4.25e-2)"	"prognostic favorable (3.06e-5)"	"unprognostic (3.72e-2)"	"unprognostic (1.67e-2)"	"unprognostic (6.12e-2)"	"unprognostic (9.49e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.85e-1)"	8.8	2.8	7.7	1.8	6.7	1.2	7.9	21.9	9.4	12.0	1.0	7.6	13.7	10.5	1.4	5.5	10.7	3.7	38.8	7.9	5.4	12.1	12.4	5.1	1.7	5.0	5.0	14.8	3.6	2.1	13.4	1.9	4.9	8.3	1.8	5.2	8.5	2.3	322.9	8.9	10.8	6.2	2.2	3.0	5.4	32.2	7.3	2.2	4.7	96.9	0.9	8.4	8.8	5.3	0.9	1.0	14.1	5.4	5.8	1.9	1.3	1.0	0.5	0.9	1.3	0.3	0.6	0.7	4.0	3.3	2.0	1.4	1.3	0.5	0.8	1.3	4.2	7.7	0.7	1.2	0.8	0.1	2.7	3.3	1.7	1.2	0.6	2.8	24.8	4.1	0.7	0.7	2.3	0.5	1.3	1.0	6.3	0.2	1.7	9.0	3.1	0.3	0.5	0.4	7.1	9.3	1.3	0.6	1.2	3.5	1.6	1.3	11.8	2.3	3.3	3.5	0.6	5.9	1.2	6.1	0.6	0.3	0.8	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.7	6.7	21.9	9.4	7.9	5.4	5.0	5.0	4.9	2.2	7.3	5.3	12.9	0.0	2.8	3.9	1.0	1.7	0.8	0.3	0.6	5.7	1.9	3.0	19.1	1.5	0.8	0.0	20.9	0.2	0.6	0.1	0.0	0.3	0.6	0.4	2.8	10.2	0.0	0.8	6.7	0.4	0.6	4.4	0.5	0.4	0.0	9.9	6.8	5.3	0.4	6.7	13.7	0.3	0.0	2.5	0.7	3.1	5.6	0.5	1.8	4.7	0.4	1.9	1.0	5.5	1.5	0.4	0.0	2.6	1.9	0.5	3.3	2.9	0.3	7.5	0.0	12.0	2.9	3.3	1.2	0.5	1.0	0.1	0.8	0.5	0.8	0.5
SENP2	"AXAM2, DKFZp762A2316, KIAA1331, SMT3IP2"	ENSG00000163904	"SUMO specific peptidase 2"	Q9HC62	3	185582496-185633551	"Enzymes, Plasma proteins, Predicted intracellular proteins, Transporters"	"mRNA transport, Protein transport, Translocation, Transport, Ubl conjugation pathway, Wnt signaling pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 249.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029247, HPA029248"	Approved		Supported	Cytosol		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 29: Early spermatids - Spermatogenesis"	Cytosol		"HPA029247: AB_10599305, HPA029248: AB_10601855"	"unprognostic (4.57e-2)"	"unprognostic (1.84e-2)"	"unprognostic (6.80e-2)"	"prognostic unfavorable (7.98e-5)"	"unprognostic (7.85e-2)"	"unprognostic (2.90e-2)"	"unprognostic (4.41e-3)"	"unprognostic (1.45e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.85e-1)"	"unprognostic (8.41e-3)"	"unprognostic (5.12e-2)"	"unprognostic (6.92e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.56e-1)"	7.4	7.3	13.4	4.4	15.8	10.7	7.5	13.3	16.2	6.0	12.0	7.8	6.0	6.1	9.7	6.5	7.2	4.5	8.3	13.9	13.1	7.3	9.5	6.4	6.2	12.9	13.6	10.0	7.4	9.6	10.5	9.0	12.4	6.6	6.1	12.8	7.6	6.3	18.9	9.2	6.6	4.8	12.2	6.7	8.0	15.1	14.2	8.1	7.2	13.0	6.0	7.1	6.3	14.4	24.4	4.6	11.6	13.4	20.6	13.8	15.1	10.9	12.6	13.8	14.6	18.3	7.5	13.2	20.3	10.2	23.6	12.6	24.3	9.0	20.3	9.7	11.6	8.9	9.8	11.0	10.9	13.2	5.6	8.6	13.3	7.8	9.5	10.2	9.6	12.5	10.8	18.1	12.0	12.0	11.4	14.7	42.4	12.3	8.1	13.1	15.8	22.1	7.7	7.9	11.9	13.4	9.3	20.4	18.3	23.0	27.8	17.5	6.1	9.0	9.8	16.4	17.7	20.9	26.8	23.8	14.9	13.9	12.5	5.1	1.3	2.6	1.6	1.3	1.6	1.3	1.3	1.3	1.0	1.9	1.5	1.5	3.4	2.3	1.6	2.0	1.3	0.9	13.4	15.8	13.3	16.2	13.9	13.1	12.9	13.6	12.4	12.2	14.2	14.4	12.3	28.9	27.4	17.9	21.2	10.8	23.7	12.6	6.2	22.8	21.6	15.4	24.2	11.5	26.2	9.2	31.3	25.0	22.6	15.7	5.9	12.9	249.6	26.3	12.0	12.8	5.4	11.1	42.9	15.2	19.9	16.1	15.3	25.2	10.8	21.3	17.2	20.5	13.2	11.8	43.0	15.1	14.2	12.5	9.1	43.0	22.7	11.1	17.8	26.2	13.6	17.8	21.6	41.2	41.3	17.9	6.6	17.7	25.7	17.0	24.2	18.2	28.8	38.1	19.7	23.2	16.3	84.2	31.8	13.4	12.5	39.7	18.2	33.7	15.8	22.5
SENP3	"DKFZP586K0919, DKFZp762A152, SMT3IP1, SSP3, Ulp1"	ENSG00000161956	"SUMO specific peptidase 3"	Q9H4L4	17	7561919-7571969	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 22.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"											HPA060290	Supported		Supported	Nucleoplasm,Nucleoli		Yes	No				"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 9: Photoreceptor cells - Phototransduction"	"Nucleoplasm, Nucleoli"		"HPA060290: AB_2684244"	"unprognostic (5.68e-2)"	"unprognostic (2.39e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.01e-1)"	"unprognostic (3.34e-1)"	"unprognostic (3.48e-1)"	"unprognostic (1.30e-3)"	"unprognostic (2.82e-1)"	"unprognostic (7.37e-2)"	"unprognostic (3.72e-2)"	"prognostic favorable (6.22e-5)"	"unprognostic (2.71e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.37e-1)"	"unprognostic (8.21e-2)"	"unprognostic (2.56e-2)"	24.2	24.0	43.7	21.0	42.6	25.4	23.7	38.5	47.9	23.7	38.5	32.4	21.2	26.7	27.4	25.4	25.9	19.3	25.2	42.6	39.8	34.1	20.5	28.6	26.5	40.4	42.2	26.8	26.4	38.1	26.4	22.5	41.1	23.0	25.4	24.7	24.8	26.0	33.5	28.6	25.2	28.9	39.5	28.3	27.0	29.0	44.0	33.8	23.9	30.9	31.2	29.7	21.8	42.0	76.4	90.8	52.7	82.5	58.6	42.8	54.8	54.8	56.0	93.4	87.2	54.9	32.5	90.3	52.6	72.7	62.3	72.0	114.4	85.8	78.0	63.7	105.0	46.7	74.8	56.9	79.1	44.0	57.9	55.1	86.5	107.1	103.5	53.3	76.0	102.1	61.5	24.7	73.0	51.4	107.9	33.6	64.2	70.9	54.5	97.1	48.8	52.4	62.9	44.0	52.5	67.6	55.3	52.7	60.0	66.6	44.1	28.5	40.5	53.0	45.9	51.3	119.0	36.3	40.4	57.3	53.9	45.7	80.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	43.7	42.6	38.5	47.9	42.6	39.8	40.4	42.2	41.1	39.5	44.0	42.0	4.5	3.2	5.4	0.0	4.9	8.5	6.4	1.6	10.2	6.1	6.7	11.0	7.1	7.2	3.6	1.8	22.9	3.0	4.8	2.6	0.0	2.3	1.4	4.0	4.2	4.7	6.6	1.3	0.0	2.4	2.3	3.8	3.6	4.7	1.3	5.2	8.2	2.7	1.5	6.7	0.0	3.0	2.0	6.0	6.4	0.7	4.1	4.9	3.6	0.0	4.7	5.5	4.1	0.0	0.0	2.1	0.8	2.2	6.4	6.1	4.0	1.1	2.1	7.3	0.0	5.2	4.4	3.7	4.0	7.4	11.6	4.1	4.9	3.0	3.7	6.4
SENP6	"KIAA0797, SUSP1"	ENSG00000112701	"SUMO specific peptidase 6"	Q9GZR1	6	75601509-75718281	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024376	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 34: Non-specific - Transcription"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm	Cytosol	"HPA024376: AB_1856678"	"unprognostic (9.86e-2)"	"unprognostic (1.20e-2)"	"unprognostic (4.84e-2)"	"unprognostic (1.87e-2)"	"unprognostic (6.38e-3)"	"unprognostic (7.33e-2)"	"unprognostic (1.13e-2)"	"unprognostic (2.97e-1)"	"unprognostic (3.93e-2)"	"unprognostic (5.32e-3)"	"unprognostic (7.81e-2)"	"unprognostic (9.24e-2)"	"prognostic unfavorable (6.09e-4)"	"unprognostic (1.78e-1)"	"unprognostic (1.74e-1)"	"prognostic unfavorable (2.83e-5)"	"unprognostic (1.72e-1)"	25.1	22.6	12.8	24.6	16.8	37.9	31.4	47.6	15.5	28.6	7.5	26.6	20.9	33.0	22.1	25.3	26.8	26.0	22.6	9.6	14.3	28.5	28.0	26.4	28.5	11.9	11.9	40.5	27.0	39.4	22.3	33.4	12.8	29.3	26.0	31.4	21.8	28.9	25.5	25.2	20.5	31.9	12.3	28.9	24.9	33.8	12.0	32.4	41.9	30.1	30.4	29.7	21.2	22.3	23.8	24.5	54.3	39.1	41.3	54.6	40.3	41.9	46.5	34.6	43.1	33.9	22.4	40.1	38.6	48.7	40.9	29.8	51.6	28.0	53.1	59.2	44.2	60.8	28.9	31.7	57.3	53.5	42.8	42.6	45.6	32.6	71.8	41.9	58.2	32.8	74.9	43.2	43.0	29.0	21.4	28.6	33.1	31.9	20.4	39.7	28.7	59.0	36.7	35.0	47.2	48.7	35.8	31.3	36.4	43.5	28.2	50.1	49.0	30.8	33.4	15.9	43.8	48.9	52.4	31.4	15.4	49.8	33.1	7.5	8.0	20.8	7.3	8.4	10.5	9.1	7.4	9.9	8.9	10.5	10.5	9.6	14.9	10.1	14.7	11.0	6.9	6.3	12.8	16.8	47.6	15.5	9.6	14.3	11.9	11.9	12.8	12.3	12.0	22.3	76.7	67.3	128.3	158.0	74.0	46.5	65.0	27.6	78.6	58.8	53.0	59.6	76.7	31.5	70.9	29.5	91.8	33.0	73.8	43.2	17.6	33.7	40.4	62.9	78.1	57.9	27.6	50.5	152.6	33.7	29.4	69.3	51.0	62.9	65.1	74.2	42.1	32.0	29.5	60.6	177.3	35.6	24.4	43.2	41.5	35.6	70.8	57.7	35.6	149.9	68.4	56.6	50.4	218.1	228.9	32.1	29.9	63.2	62.8	63.4	32.6	26.8	47.2	65.7	26.3	98.9	73.7	107.7	61.7	61.4	48.4	41.2	67.2	66.0	46.3	66.8
SENP7		ENSG00000138468	"SUMO specific peptidase 7"	Q9BQF6	3	101324205-101513241	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Inhibitory neurons: 109.6;Oligodendrocyte precursor cells: 157.3;Oligodendrocytes: 134.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 44.1"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 44.1"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027259, HPA071998"	Approved		Supported	"Nucleoplasm,Nuclear bodies,Centrosome,Cytosol"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 34: Non-specific - Transcription"	"Cluster 12: NES - Nervous system development"	"Cluster 68: Oligodendrocytes - Mixed function"	Nucleoplasm	"Nuclear bodies, Centrosome, Cytosol"	"HPA027259: AB_1856679, HPA071998: "	"unprognostic (1.50e-1)"	"unprognostic (6.12e-2)"	"unprognostic (2.78e-2)"	"unprognostic (7.31e-2)"	"unprognostic (2.44e-2)"	"prognostic favorable (4.23e-4)"	"unprognostic (1.38e-3)"	"unprognostic (9.25e-3)"	"unprognostic (8.80e-2)"	"unprognostic (2.24e-1)"	"unprognostic (7.77e-3)"	"unprognostic (1.94e-1)"	"unprognostic (9.85e-2)"	"unprognostic (8.08e-3)"	"unprognostic (3.27e-1)"	"unprognostic (9.03e-2)"	"unprognostic (2.23e-2)"	15.1	9.7	9.7	13.7	12.7	24.7	16.9	21.8	11.8	15.8	9.7	12.5	7.3	26.8	14.7	7.8	16.1	14.2	9.5	9.3	12.3	11.4	8.7	12.8	23.1	13.9	11.7	26.3	12.8	16.9	10.2	19.4	14.0	12.7	10.8	26.0	8.9	11.5	11.2	20.8	12.4	14.7	10.1	16.9	14.1	9.1	11.5	20.5	17.5	11.2	17.7	11.8	11.4	20.3	9.2	6.1	29.4	16.4	5.6	8.2	5.3	5.2	3.8	8.5	10.4	4.0	8.3	7.0	7.9	5.1	7.8	9.1	9.4	4.8	17.0	13.0	2.7	12.7	5.1	5.5	4.5	7.4	12.2	6.4	8.5	4.3	9.6	7.6	12.2	13.4	10.5	17.6	8.1	6.1	13.7	8.6	6.0	4.8	6.3	15.2	8.0	6.4	10.1	5.2	11.3	8.8	4.8	4.8	6.5	15.0	8.0	9.8	10.2	11.8	7.1	3.9	5.2	12.2	7.8	16.4	4.1	9.7	9.8	44.1	5.9	5.9	5.8	5.4	7.3	6.4	7.8	5.8	4.8	9.0	10.3	7.1	17.3	9.3	6.3	4.1	6.9	6.1	9.7	12.7	21.8	11.8	9.3	12.3	13.9	11.7	14.0	10.1	11.5	20.3	44.5	16.0	24.9	78.4	33.0	9.1	8.4	7.4	21.1	48.3	14.4	12.2	21.6	2.8	18.4	16.5	20.9	5.8	30.8	5.4	5.9	8.1	4.1	33.1	48.5	28.4	13.1	18.7	62.4	5.2	2.7	23.4	21.4	34.1	37.2	28.6	32.9	10.3	8.2	52.2	109.6	6.5	12.2	20.5	9.5	4.0	18.3	19.1	10.6	80.6	13.6	16.7	35.0	157.3	134.4	6.9	4.1	19.5	23.5	4.8	7.0	8.5	27.5	33.8	46.0	29.7	23.3	22.8	19.9	13.4	9.9	2.5	41.0	21.1	5.9	6.1
SEPTIN10	"FLJ11619, SEPT10"	ENSG00000186522	"Septin 10"	Q9P0V9	2	109542799-109614143	"Predicted intracellular proteins"	"Cell cycle, Cell division"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Adipocytes: 56.4;Cardiomyocytes: 21.8;Cytotrophoblasts: 15.1;Extravillous trophoblasts: 59.4;Fibroblasts: 15.5;Hofbauer cells: 19.6;Smooth muscle cells: 11.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"T-reg: 3.5"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047860, HPA056304, HPA060310"	Enhanced		Supported	"Actin filaments"		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 24: Non-specific - Transcription regulation"	"Actin filaments"		"HPA047860: AB_2680187, HPA056304: AB_2683094, HPA060310: AB_2684249"	"unprognostic (1.84e-1)"	"unprognostic (4.29e-3)"	"unprognostic (1.94e-2)"	"unprognostic (3.18e-2)"	"unprognostic (6.34e-2)"	"unprognostic (3.41e-2)"	"unprognostic (2.02e-3)"	"unprognostic (1.80e-2)"	"unprognostic (9.67e-2)"	"unprognostic (8.61e-2)"	"unprognostic (1.78e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.58e-2)"	"unprognostic (3.05e-3)"	"unprognostic (2.72e-1)"	"unprognostic (2.55e-1)"	"unprognostic (9.12e-2)"	57.0	24.2	16.1	22.6	29.5	0.7	52.9	29.8	20.3	41.5	58.7	52.0	22.3	44.5	21.7	88.4	33.4	41.8	41.7	15.1	24.2	43.4	66.5	60.4	18.4	46.8	29.5	46.7	20.3	26.9	9.5	50.4	41.6	40.6	39.8	13.6	34.7	42.2	28.5	73.4	24.3	58.0	31.9	36.3	30.5	76.9	26.1	19.9	43.3	39.0	22.8	55.1	43.2	44.5	104.7	27.7	99.6	64.1	78.1	145.8	61.1	166.5	290.6	114.8	133.3	52.2	59.0	0.0	82.2	130.4	72.2	47.7	42.8	105.2	151.6	199.4	31.2	0.2	38.5	75.3	58.7	0.2	13.4	91.5	46.9	103.5	135.1	123.9	154.3	0.0	2.7	0.4	141.5	9.9	0.1	10.3	74.4	61.3	53.7	0.1	80.9	17.4	95.7	136.8	29.6	61.8	97.8	2.1	77.0	115.2	26.5	1.2	158.5	120.1	85.1	46.9	69.6	61.4	36.0	0.9	106.7	2.3	148.1	0.0	2.4	0.0	0.1	1.6	0.1	0.8	1.5	0.4	0.6	0.3	0.7	0.2	0.1	0.0	1.0	0.0	3.5	0.8	16.1	29.5	29.8	20.3	15.1	24.2	46.8	29.5	41.6	31.9	26.1	44.5	56.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.8	0.0	0.0	0.0	0.0	15.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	6.5	0.0	0.0	0.0	0.0	59.4	15.5	0.0	0.0	0.0	0.0	0.0	0.0	19.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.7	0.0	0.0	0.0	0.0	7.5	0.1	0.0	0.0	0.0
SEPTIN2	"DIFF6, hNedd5, KIAA0158, NEDD5, Pnutl3, SEPT2"	ENSG00000168385	"Septin 2"	Q15019	2	241315100-241354027	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Differentiation, Mitosis, Spermatogenesis"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Adipocytes: 89.9;Cardiomyocytes: 133.5;Cytotrophoblasts: 135.9;Extravillous trophoblasts: 190.1;Hofbauer cells: 136.8;Syncytiotrophoblasts: 139.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017190, HPA018481"	Supported		Enhanced	"Nucleoplasm,Plasma membrane,Actin filaments,Cytokinetic bridge"		Yes	No		3300000	"Cluster 27: Non-specific - Gene expression"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 24: Non-specific - Transcription regulation"	"Actin filaments"	"Nucleoplasm, Plasma membrane, Cytokinetic bridge"	"CAB017190: , HPA018481: AB_1856684"	"unprognostic (6.31e-2)"	"unprognostic (5.27e-2)"	"unprognostic (2.95e-2)"	"unprognostic (4.03e-2)"	"prognostic favorable (8.21e-4)"	"unprognostic (3.32e-1)"	"prognostic unfavorable (3.66e-4)"	"unprognostic (1.96e-3)"	"unprognostic (1.83e-2)"	"unprognostic (5.69e-2)"	"unprognostic (1.11e-3)"	"unprognostic (3.16e-1)"	"unprognostic (9.58e-3)"	"unprognostic (8.11e-2)"	"unprognostic (9.53e-2)"	"unprognostic (1.40e-1)"	"unprognostic (2.17e-2)"	246.0	155.0	192.8	159.7	216.1	125.3	177.2	208.8	220.6	233.8	183.2	179.7	140.8	209.0	176.7	161.1	168.7	193.8	211.8	180.5	209.6	212.6	117.1	184.5	157.2	227.2	203.3	221.7	214.2	220.1	112.7	217.3	232.2	186.1	188.6	114.0	163.3	218.2	160.6	119.0	154.8	253.1	224.1	164.9	152.6	145.0	198.3	141.8	224.6	163.5	180.5	221.0	116.7	245.3	245.1	207.7	561.7	370.8	511.5	555.0	289.1	517.3	508.9	329.1	417.2	118.7	258.4	96.1	119.4	599.0	176.7	209.6	377.7	347.9	535.5	241.9	262.2	388.9	200.5	444.5	311.6	374.4	228.0	495.1	224.8	275.0	259.1	369.8	576.2	240.9	357.4	138.0	491.9	171.5	226.7	227.3	412.5	215.2	152.8	216.2	707.4	204.7	483.5	359.9	401.4	270.0	363.0	245.7	353.0	397.9	146.9	333.4	555.5	399.2	166.2	392.9	320.6	267.7	251.9	340.9	344.7	225.1	571.6	172.0	165.0	98.3	101.0	184.1	125.1	87.4	97.9	104.2	183.8	77.2	84.4	89.6	58.9	191.4	144.8	138.7	108.0	241.2	192.8	216.1	208.8	220.6	180.5	209.6	227.2	203.3	232.2	224.1	198.3	245.3	89.9	0.0	0.0	0.0	9.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	133.5	0.0	0.0	0.0	0.0	135.9	39.9	0.0	0.0	0.0	0.0	0.0	0.0	25.3	0.0	0.0	0.0	0.0	190.1	50.4	0.0	0.0	0.0	0.0	0.0	0.0	136.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	44.7	0.0	0.0	0.0	0.0	139.0	6.5	0.0	0.0	0.0
SEPTIN4	"ARTS, C17orf47, CE5B3, FLJ40121, H5, hCDCREL-2, hucep-7, MART, PNUTL2, SEPT4"	ENSG00000108387	"Septin 4"	"O43236, Q8NEP4"	17	58520250-58544368	"Predicted intracellular proteins"	"Cell cycle, Cell division, Differentiation, Spermatogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 1288.2;choroid plexus: 593.0;retina: 404.5"	"Group enriched"	"Detected in some"	7	"Cardiomyocytes: 52.0;Smooth muscle cells: 38.9"	"Cancer enhanced"	"Detected in all"		"glioma: 8.9"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HHSteC: 14.0;hTERT-RPE1: 19.4;SK-MEL-30: 32.8"									"CAB006855, HPA021587, HPA022905, HPA028424"	Enhanced		Supported	Nucleoplasm		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 43: Cardiomyocytes - Nuclear processes"	Nucleoplasm		"CAB006855: , HPA021587: AB_1856686, HPA022905: AB_1856687, HPA028424: AB_10601690"	"unprognostic (1.12e-1)"	"unprognostic (5.54e-2)"	"unprognostic (8.36e-3)"	"unprognostic (8.01e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.96e-2)"	"unprognostic (6.88e-3)"	"unprognostic (2.73e-2)"	"unprognostic (2.76e-1)"	"unprognostic (8.02e-2)"	"unprognostic (1.97e-2)"	"unprognostic (2.10e-1)"	"prognostic unfavorable (3.28e-7)"	"unprognostic (6.40e-3)"	"unprognostic (1.58e-1)"	"unprognostic (8.26e-2)"	"unprognostic (8.75e-3)"	46.6	165.0	832.1	5.0	1011.1	0.5	33.5	861.9	1288.2	13.9	593.0	15.3	4.9	12.4	6.9	5.9	14.2	17.1	56.3	774.4	799.2	31.8	56.6	39.6	14.4	864.7	904.6	15.8	8.7	9.4	23.1	20.9	859.8	8.6	5.3	404.5	9.2	6.5	10.8	11.1	12.1	11.7	798.0	49.5	11.5	25.7	925.2	4.4	23.2	13.7	7.3	12.2	12.1	1080.0	0.0	0.6	1.2	3.6	1.4	0.2	0.6	0.2	0.5	2.1	2.4	0.2	0.5	0.0	5.1	0.8	3.2	0.4	1.8	1.4	0.5	0.3	0.9	1.3	0.3	7.6	14.0	0.1	0.7	7.2	2.9	0.5	2.6	19.4	0.6	1.9	0.0	3.8	0.2	0.5	0.0	0.1	0.6	0.0	0.9	0.2	0.0	1.6	0.0	0.1	3.9	2.1	0.1	0.2	32.8	1.6	0.8	0.4	0.0	0.3	1.6	0.0	1.4	1.0	0.6	0.0	1.1	0.0	0.4	0.0	3.6	0.8	4.9	0.5	1.5	1.6	1.0	1.3	3.7	0.3	1.8	1.4	1.9	1.0	0.0	0.2	0.7	3.6	832.1	1011.1	861.9	1288.2	774.4	799.2	864.7	904.6	859.8	798.0	925.2	1080.0	6.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	52.0	0.0	0.0	0.0	0.0	6.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.3	5.9	0.0	0.0	0.0	0.0	0.0	0.0	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	38.9	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0
SEPTIN7	"CDC10, CDC3, SEPT7, SEPT7A"	ENSG00000122545	"Septin 7"	Q16181	7	35800932-35907105	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Differentiation, Mitosis, Spermatogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 570.9"	"Group enriched"	"Detected in some"	4	"Adipocytes: 192.1;Cardiomyocytes: 227.0;Cytotrophoblasts: 171.4;dendritic cells: 196.6;Extravillous trophoblasts: 198.2;Fibroblasts: 153.5;Hofbauer cells: 191.0;Smooth muscle cells: 190.0;Syncytiotrophoblasts: 124.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023309, HPA029524"	Enhanced		Approved	"Nucleoli,Plasma membrane,Actin filaments,Midbody,Cytosol"		Yes	No		4300000	"Cluster 44: Non-specific - Transcription"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 24: Non-specific - Transcription regulation"	"Actin filaments"	"Nucleoli, Plasma membrane, Midbody, Cytosol"	"HPA023309: AB_10600093, HPA029524: AB_10601573"	"unprognostic (7.91e-3)"	"unprognostic (6.89e-3)"	"unprognostic (9.49e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.22e-2)"	"prognostic unfavorable (2.37e-4)"	"unprognostic (2.00e-2)"	"unprognostic (4.43e-2)"	"unprognostic (7.13e-2)"	"unprognostic (3.56e-2)"	"unprognostic (7.66e-2)"	"prognostic unfavorable (2.78e-4)"	"unprognostic (2.86e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.43e-3)"	127.1	95.1	352.6	98.8	386.1	131.0	99.5	334.3	570.9	111.5	289.5	116.4	55.7	126.5	121.5	106.6	84.1	117.5	172.1	344.1	341.6	82.9	76.9	98.6	150.9	337.4	355.9	138.2	37.0	81.1	62.6	143.5	339.1	93.9	94.8	119.5	50.3	95.5	82.9	105.0	74.9	145.2	345.1	108.3	59.4	70.3	367.7	159.0	78.2	104.3	149.7	125.0	86.9	411.9	198.1	94.3	232.0	153.2	256.7	263.1	119.3	248.6	228.6	206.7	177.0	147.7	148.9	186.2	164.2	254.9	274.9	146.3	166.3	166.4	294.0	127.8	88.4	149.8	123.4	80.8	149.4	182.7	157.7	171.7	127.1	163.8	159.4	215.6	221.0	143.3	120.1	141.9	341.6	92.8	185.6	304.3	249.7	183.1	132.6	188.3	220.9	107.6	202.6	146.1	124.3	217.4	173.5	220.1	151.8	377.1	163.1	198.7	187.3	207.2	246.7	129.9	278.5	165.9	163.4	470.2	132.4	301.2	449.3	266.8	86.0	150.1	214.8	100.1	220.7	165.6	151.5	199.6	100.8	155.5	134.4	171.2	160.9	298.7	110.5	71.0	147.4	241.7	352.6	386.1	334.3	570.9	344.1	341.6	337.4	355.9	339.1	345.1	367.7	411.9	192.1	0.0	0.0	0.0	41.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	227.0	0.0	0.0	0.0	0.0	171.4	196.6	0.0	0.0	0.0	0.0	0.0	0.0	40.1	0.0	0.0	0.0	0.0	198.2	153.5	0.0	0.0	0.0	0.0	0.0	0.0	191.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	44.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	190.0	0.0	0.0	0.0	0.0	124.2	30.4	0.0	0.0	0.0
SERINC5	"C5orf12, TPO1"	ENSG00000164300	"Serine incorporator 5"	Q86VE9	5	80111651-80256048	"Predicted membrane proteins, Transporters"	"Antiviral defense, Host-virus interaction, Immunity, Innate immunity, Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Oligodendrocyte precursor cells: 223.2;Oligodendrocytes: 222.5;Urothelial cells: 254.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 56.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037898, HPA037899"	Supported		Supported	"Vesicles,Plasma membrane,Centrosome,Cytosol"		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 15: Liver - Metabolism"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 22: Epithelial cell types - Mixed function"	"Plasma membrane, Cytosol"	"Vesicles, Centrosome"	"HPA037898: AB_10673649, HPA037899: AB_2675727"	"unprognostic (2.95e-1)"	"unprognostic (1.80e-1)"	"unprognostic (4.98e-3)"	"unprognostic (1.08e-2)"	"unprognostic (5.05e-2)"	"unprognostic (1.19e-2)"	"unprognostic (1.80e-2)"	"unprognostic (8.00e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.68e-2)"	"unprognostic (7.71e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.40e-2)"	"unprognostic (4.81e-2)"	"unprognostic (8.09e-2)"	"unprognostic (4.93e-2)"	"unprognostic (9.17e-2)"	12.9	34.8	19.2	9.8	31.0	6.3	11.8	27.2	20.7	16.4	17.4	28.3	9.2	9.2	21.1	17.6	16.2	14.2	5.3	18.0	22.7	6.2	45.4	14.1	8.2	26.5	27.6	15.1	7.6	7.1	4.1	16.5	26.8	33.7	29.4	16.3	13.3	7.0	2.7	19.1	9.7	7.6	22.2	4.8	16.6	29.2	28.0	7.9	5.8	2.9	11.4	17.8	11.3	44.4	11.3	19.7	6.6	4.2	8.9	9.5	19.6	9.0	6.0	3.9	4.0	40.0	56.7	1.7	9.0	11.7	9.2	31.7	8.9	23.9	5.6	1.6	4.8	1.4	2.2	21.7	3.3	1.3	4.1	10.8	13.1	10.2	26.0	11.0	7.3	54.0	3.6	9.4	10.4	19.4	22.8	5.5	9.3	15.8	6.8	26.9	5.8	3.0	11.5	54.4	0.4	6.3	8.0	18.5	35.4	33.5	8.2	6.9	8.0	11.3	3.2	11.6	11.3	7.1	3.5	28.1	21.0	3.9	46.9	10.4	9.1	6.7	2.1	4.9	1.6	0.8	18.7	5.7	5.8	1.1	23.3	14.1	5.2	0.6	1.5	1.4	6.6	7.5	19.2	31.0	27.2	20.7	18.0	22.7	26.5	27.6	26.8	22.2	28.0	44.4	48.5	60.9	30.2	46.0	10.5	6.4	56.8	5.6	19.9	3.6	27.7	14.1	8.2	31.5	18.3	16.5	0.0	16.1	12.9	127.4	9.8	26.5	1.7	82.0	29.6	24.5	60.1	24.8	20.9	19.5	25.7	24.9	40.2	157.0	8.2	27.6	35.3	82.7	21.8	3.3	78.3	60.0	4.1	29.2	27.8	7.6	18.3	38.4	5.4	66.5	44.8	65.1	1.0	223.2	222.5	35.4	56.4	39.9	8.7	148.2	27.7	5.1	4.3	5.3	32.9	7.5	17.4	3.1	12.8	44.4	9.8	129.2	37.7	15.2	85.9	254.2
SERPINB1	"anti-elastase, EI, ELANH2, PI2"	ENSG00000021355	"Serpin family B member 1"	P30740	6	2832332-2841959	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Protease inhibitor, Serine protease inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 466.8;esophagus: 478.3"	"Cell type enhanced"	"Detected in many"		"Exocrine glandular cells: 1424.3;Pancreatic endocrine cells: 1067.8;Urothelial cells: 984.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 125.3;OE19: 162.5;U-937: 144.9"					"Low region specificity"	"Detected in all"			"HPA018871, HPA018882, HPA052642"	Enhanced		Supported	"Cytoplasmic bodies"	"Secreted to blood"	NA	NA		24000000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	"Cytoplasmic bodies"		"HPA018871: AB_1856724, HPA018882: , HPA052642: AB_2681896"	"unprognostic (1.13e-2)"	"unprognostic (1.93e-1)"	"unprognostic (6.07e-2)"	"unprognostic (1.75e-2)"	"unprognostic (5.14e-3)"	"unprognostic (9.67e-2)"	"unprognostic (3.59e-3)"	"unprognostic (1.13e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.88e-2)"	"unprognostic (1.08e-3)"	"unprognostic (9.07e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.16e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.67e-1)"	"unprognostic (2.28e-1)"	36.6	54.4	10.7	69.7	14.4	466.8	25.0	11.1	14.0	55.6	17.3	77.7	140.4	15.6	22.2	478.3	35.8	57.4	26.8	10.7	12.7	33.2	32.1	81.7	51.3	15.1	13.0	18.1	232.1	29.8	32.9	27.0	14.6	15.9	87.5	13.4	99.6	16.9	54.2	15.8	107.3	24.9	13.6	67.4	97.9	7.1	13.7	31.9	30.7	22.9	122.8	88.6	112.4	14.8	42.9	49.7	2.7	0.3	10.6	21.8	41.2	11.8	36.1	14.5	26.1	47.1	125.3	0.3	86.6	26.6	15.6	26.8	4.8	11.4	11.1	59.4	7.5	76.6	16.0	37.0	37.2	13.5	46.2	26.8	18.4	7.3	3.3	7.2	48.7	0.0	27.1	9.9	13.4	19.9	1.7	35.4	4.5	162.5	22.1	3.9	0.5	44.4	51.0	9.3	8.8	4.8	28.8	11.2	64.2	5.9	5.6	43.2	29.1	4.6	10.4	10.2	3.6	0.1	2.2	0.5	17.4	144.9	2.4	118.0	207.1	109.4	53.3	103.7	45.8	43.5	48.1	48.4	150.4	32.3	47.4	50.6	182.3	85.1	82.8	48.6	58.5	175.8	10.7	14.4	11.1	14.0	10.7	12.7	15.1	13.0	14.6	13.6	13.7	14.8	79.9	240.4	269.9	0.7	90.7	35.1	165.1	699.1	38.1	4.2	55.0	51.2	17.6	72.9	420.9	46.0	2.1	124.5	120.8	264.1	56.7	490.3	1.7	210.6	28.7	118.9	96.3	176.3	0.9	1424.3	149.1	89.1	345.1	104.5	452.2	32.1	124.9	20.2	183.0	10.1	0.9	263.1	109.9	332.7	308.2	3.5	34.8	387.3	71.2	15.9	589.7	48.3	139.0	4.5	6.6	1067.8	308.4	27.8	65.2	147.5	333.7	81.3	343.8	17.2	13.1	109.7	67.2	2.0	11.2	461.5	38.1	99.7	112.9	59.2	242.6	984.3
SERPINB10	"bomapin, PI10"	ENSG00000242550	"Serpin family B member 10"	P48595	18	63897174-63936111	"Plasma proteins, Predicted intracellular proteins"		"Protease inhibitor, Serine protease inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	60	"bone marrow: 74.7"	"Cell type enhanced"	"Detected in some"		"Basal respiratory cells: 2.4;Club cells: 2.7;Erythroid cells: 1.3;Kupffer cells: 1.2;monocytes: 4.7;Respiratory ciliated cells: 5.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in some"		"classical monocyte: 1.3;eosinophil: 1.2"	"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	7	"U-937: 104.1"					"Not detected"	"Not detected"			"HPA015480, HPA059582"	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA		59000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 32: U-937 - Innate immune response"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Nucleoplasm	Cytosol	"HPA015480: AB_1855456, HPA059582: AB_2684072"	"unprognostic (4.66e-1)"	"unprognostic (5.11e-2)"			"unprognostic (1.33e-2)"	"unprognostic (1.19e-1)"		"unprognostic (9.56e-2)"	"unprognostic (2.56e-1)"	"unprognostic (4.59e-1)"	"unprognostic (1.10e-1)"			"unprognostic (3.64e-1)"			"unprognostic (1.25e-4)"	0.3	0.1	0.1	0.1	0.2	74.7	0.0	0.5	0.4	0.3	0.1	0.0	0.0	0.1	0.1	0.8	0.0	0.1	0.0	0.2	0.1	0.0	0.2	0.2	0.2	0.2	0.1	0.0	0.0	0.1	0.0	0.2	0.2	0.0	0.0	0.1	0.2	0.0	0.1	1.2	0.1	0.1	0.1	0.7	0.1	0.0	0.3	0.9	0.0	0.0	0.6	0.0	0.2	0.3	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.8	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	6.1	0.0	0.1	0.6	0.0	0.1	0.0	0.1	0.0	0.0	14.5	0.0	0.0	0.2	0.3	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	4.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	7.5	0.0	0.7	0.1	1.5	0.1	0.0	0.0	0.1	0.1	104.1	0.1	0.1	1.3	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.7	0.0	0.3	0.1	0.2	0.5	0.4	0.2	0.1	0.2	0.1	0.2	0.1	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	2.4	0.0	0.0	0.0	0.0	0.2	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.7	0.0	0.0	4.7	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	5.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.1	0.0	0.0	0.2
SERPINB13	"headpin, HUR7, hurpin, PI13"	ENSG00000197641	"Serpin family B member 13"	Q9UIV8	18	63586989-63604639	"Cancer-related genes, Predicted intracellular proteins, Predicted membrane proteins"		"Protease inhibitor, Serine protease inhibitor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"cervix: 56.6;esophagus: 180.4;vagina: 135.0"	"Group enriched"	"Detected in some"	4	"Basal respiratory cells: 58.8;Club cells: 54.8;Squamous epithelial cells: 148.6"	"Group enriched"	"Detected in many"	5	"cervical cancer: 45.9;head and neck cancer: 27.6;lung cancer: 12.2"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	129	"HaCaT: 198.9;hTCEpi: 74.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA052630, HPA057129"	Enhanced		Approved	"Nuclear speckles,Cytosol"		NA	NA		210000		"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 61: Squamous epithelial cells - Keratinization"	"Nuclear speckles, Cytosol"		"HPA052630: AB_2681891, HPA057129: AB_2683347"		"unprognostic (3.49e-2)"		"unprognostic (3.73e-1)"		"unprognostic (1.11e-1)"		"unprognostic (7.27e-2)"	"unprognostic (2.28e-1)"			"unprognostic (4.29e-2)"		"unprognostic (2.81e-1)"			"unprognostic (6.04e-3)"	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.1	56.6	0.0	0.0	0.0	0.0	0.0	180.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.0	35.7	0.0	0.0	13.6	0.0	0.0	0.0	0.0	0.1	0.0	0.2	1.2	0.0	0.0	22.9	3.3	135.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	198.9	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	74.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.7	0.0	1.7	1.9	58.8	13.1	0.0	0.0	0.1	0.1	0.0	54.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	6.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.8	0.0	0.0	8.5	0.0	0.0	0.0	1.0	0.0	0.0	148.6	1.3	0.5	0.0	0.0	0.0	19.9
SERPINB3	"HsT1196, SCC, SCCA1, T4-A"	ENSG00000057149	"Serpin family B member 3"	P29508	18	63655197-63661893	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"		"Protease inhibitor, Serine protease inhibitor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"cervix: 418.5;esophagus: 809.7;vagina: 669.6"	"Group enriched"	"Detected in some"	6	"Basal respiratory cells: 6903.4;Club cells: 6726.1"	"Group enriched"	"Detected in many"	4	"cervical cancer: 186.5;head and neck cancer: 69.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 1.9;HaCaT: 6.5;HBEC3-KT: 1.6;SiHa: 4.1;U-2197: 8.2"									"CAB018772, CAB036006, CAB036007, HPA048341, HPA049988, HPA055992"	Enhanced		Approved	"Plasma membrane,Cytosol"		NA	NA		9100000		"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 18: U-2197 - ECM organization"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Cytosol	"Plasma membrane"	"CAB018772: AB_2285759, CAB036006: , CAB036007: , HPA048341: AB_2680364, HPA049988: AB_2680985, HPA055992: AB_2682998"		"unprognostic (2.95e-3)"		"unprognostic (1.66e-1)"		"unprognostic (2.03e-1)"		"unprognostic (2.91e-2)"	"unprognostic (2.11e-1)"		"prognostic unfavorable (3.19e-4)"	"unprognostic (6.68e-2)"		"unprognostic (2.58e-1)"			"unprognostic (4.19e-3)"	0.1	0.1	0.0	0.3	0.0	0.0	1.1	0.0	0.0	418.5	0.0	0.1	0.0	3.2	0.0	809.7	0.2	0.2	0.4	0.0	0.0	0.1	0.2	3.1	0.0	0.0	0.0	0.1	0.2	0.0	0.9	0.0	0.0	7.6	0.0	0.0	100.0	0.0	0.1	42.9	0.1	0.0	0.0	0.1	0.5	1.9	0.0	4.8	0.1	0.0	19.6	73.8	669.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.1	0.1	6.5	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.4	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	8.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.1	0.0	0.0	0.0	35.2	6903.4	2.2	0.0	0.0	0.0	0.0	0.0	6726.1	0.0	0.0	0.0	0.0	0.0	0.0	6.2	31.4	0.1	0.2	0.5	0.0	0.0	0.0	8.9	0.0	3.0	0.0	0.9	2.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	986.7	0.0	0.0	55.4	1.2	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.8	0.0	0.4	0.0	60.2	0.0	0.2	447.6	0.0	0.0	0.0	178.1	1.0	0.3	413.5	0.0	0.3	0.8	0.0	0.0	265.9
SERPINB5	"maspin, PI5"	ENSG00000206075	"Serpin family B member 5"	P36952	18	63476958-63505085	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 216.6;skin 1: 239.7"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 964.1;Basal prostatic cells: 358.7;Basal respiratory cells: 272.9;Squamous epithelial cells: 535.4;Suprabasal keratinocytes: 1215.3;Urothelial cells: 564.9"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 124.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HaCaT: 1279.3;HBEC3-KT: 425.6;hTCEpi: 875.0;hTERT-HME1: 217.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"CAB009570, HPA019025, HPA019132, HPA020136"	Enhanced		Supported	Vesicles	"Intracellular and membrane"	NA	NA		770000		"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 61: Squamous epithelial cells - Keratinization"	Vesicles		"CAB009570: AB_2186315, HPA019025: AB_1856726, HPA019132: AB_1856727, HPA020136: AB_1856728"	"unprognostic (2.84e-3)"	"unprognostic (1.05e-1)"	"unprognostic (9.24e-2)"	"unprognostic (1.04e-3)"		"unprognostic (2.09e-2)"		"prognostic unfavorable (1.54e-4)"	"unprognostic (1.36e-1)"	"unprognostic (3.47e-3)"	"prognostic unfavorable (5.71e-6)"	"unprognostic (1.28e-1)"	"unprognostic (1.84e-6)"	"unprognostic (2.57e-1)"	"unprognostic (6.58e-2)"	"unprognostic (3.14e-1)"	"unprognostic (8.38e-2)"	0.6	0.0	0.0	4.3	0.0	0.2	37.1	0.1	0.1	38.5	0.1	4.8	16.7	0.1	0.1	216.6	1.4	2.7	0.1	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.5	0.0	9.9	4.5	0.0	37.6	1.7	1.4	239.7	22.1	0.2	0.0	0.0	9.7	2.8	0.0	13.9	0.1	0.0	39.9	90.9	78.7	0.1	80.8	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	73.4	0.1	3.8	0.0	0.1	1279.3	0.0	425.6	0.0	0.0	0.0	0.0	95.8	0.2	0.0	0.0	0.6	0.1	875.0	0.0	217.0	0.0	0.0	0.0	0.0	0.9	0.0	0.2	0.0	0.0	0.1	179.9	93.4	0.1	0.0	0.2	0.0	95.1	1.4	0.0	60.2	0.3	0.0	0.3	0.2	0.2	0.2	0.0	0.2	0.0	0.2	0.2	0.1	0.2	0.9	0.2	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.3	0.0	964.1	358.7	272.9	224.3	0.0	5.1	27.3	0.2	0.0	90.0	3.7	0.0	0.3	0.1	14.2	0.0	0.1	9.0	6.2	0.1	5.4	3.5	0.0	0.3	0.0	0.2	5.8	12.2	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	10.3	34.6	0.0	57.6	18.6	0.6	1.8	62.2	0.0	0.0	0.0	0.0	0.0	0.1	16.3	51.7	0.0	2.5	85.4	13.5	0.1	85.4	0.0	0.0	0.0	7.1	6.6	2.2	535.4	1215.3	0.1	4.0	0.1	30.6	564.9
SERPINB8	"CAP2, PI8"	ENSG00000166401	"Serpin family B member 8"	P50452	18	63970029-64019779	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"		"Protease inhibitor, Serine protease inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skin 1: 58.8"	"Cell type enhanced"	"Detected in many"		"Suprabasal keratinocytes: 48.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HL-60: 120.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			CAB034300	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA		920000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 31: Skin - Epidermis development"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 41: Macrophages - Immune response"	Nucleoplasm	Cytosol	"CAB034300: AB_2186486"	"unprognostic (8.49e-2)"	"unprognostic (4.87e-2)"	"unprognostic (4.10e-3)"	"unprognostic (2.86e-2)"	"unprognostic (1.52e-2)"	"unprognostic (7.71e-2)"	"unprognostic (4.50e-2)"	"unprognostic (2.19e-1)"	"unprognostic (2.67e-1)"	"unprognostic (2.98e-3)"	"unprognostic (6.58e-3)"	"unprognostic (1.50e-1)"	"prognostic unfavorable (3.31e-5)"	"unprognostic (8.73e-2)"	"unprognostic (3.48e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.90e-1)"	10.8	9.5	2.6	15.8	3.2	30.3	9.5	3.4	3.6	9.3	3.5	8.6	6.3	4.7	1.5	30.1	4.4	18.1	5.7	2.8	3.9	9.0	37.8	12.1	13.4	5.2	4.0	4.2	7.1	2.7	3.7	7.2	4.8	4.6	9.7	2.3	10.8	3.3	3.0	58.8	8.8	7.3	4.3	7.8	7.1	2.7	4.6	6.5	5.3	2.3	18.3	23.7	17.1	4.5	24.2	4.8	4.0	28.8	13.9	19.7	2.0	75.6	72.9	46.8	46.4	1.0	10.8	0.4	27.2	45.6	23.3	38.3	0.8	48.2	66.3	33.4	0.9	0.0	8.7	2.5	32.1	120.0	10.0	19.1	41.3	63.6	20.9	30.3	51.4	5.1	0.7	13.4	32.9	2.1	2.1	13.5	1.7	3.8	23.6	1.7	10.5	2.1	21.4	27.1	2.3	2.4	15.0	2.3	28.8	3.3	0.8	45.4	79.2	71.0	15.4	8.8	31.1	5.9	1.0	0.1	72.5	69.2	63.0	2.7	44.2	2.0	7.6	34.2	6.8	7.1	6.3	4.7	53.8	9.9	3.3	5.2	12.4	4.6	18.1	28.8	8.9	11.2	2.6	3.2	3.4	3.6	2.8	3.9	5.2	4.0	4.8	4.3	4.6	4.5	6.0	3.2	8.3	0.3	9.1	41.0	25.9	38.9	5.7	0.4	5.5	3.8	1.2	8.6	25.5	0.0	0.0	4.9	13.4	12.3	0.0	30.0	1.3	7.6	3.3	8.7	1.8	3.0	1.8	19.2	5.6	8.6	8.2	16.3	4.5	0.9	7.5	9.6	15.3	0.0	1.3	3.5	12.2	24.8	35.1	1.1	0.9	35.9	16.0	1.0	29.0	1.6	5.2	1.5	2.9	42.2	10.7	0.0	3.5	13.0	8.5	2.9	12.9	0.3	0.0	12.3	9.8	1.7	2.3	18.2	48.4	31.3	8.2	1.4	5.0	33.3
SERPINB9	"CAP3, PI9"	ENSG00000170542	"Serpin family B member 9"	P50453	6	2887270-2903309	"Predicted intracellular proteins"		"Protease inhibitor, Serine protease inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 41.1;placenta: 52.3"	"Cell type enriched"	"Detected in many"	5	"Langerhans cells: 1527.7"	"Cancer enriched"	"Detected in all"	5	"testis cancer: 46.3"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BEWO: 225.3;SuSa: 227.6;U-698: 98.8"					"Low region specificity"	"Detected in all"			HPA030067	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA		3400000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 41: Macrophages - Immune response"	Nucleoplasm	Cytosol	"HPA030067: AB_2673295"	"unprognostic (6.82e-3)"	"unprognostic (8.59e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.25e-1)"	"unprognostic (4.06e-1)"	"unprognostic (1.50e-1)"	"unprognostic (3.12e-2)"	"unprognostic (9.48e-2)"	"unprognostic (2.12e-2)"	"unprognostic (3.83e-3)"	"unprognostic (1.06e-1)"	"unprognostic (9.85e-2)"	"prognostic unfavorable (1.66e-6)"	"unprognostic (9.90e-2)"	"unprognostic (8.56e-2)"	"unprognostic (1.27e-1)"	"unprognostic (3.76e-2)"	11.6	11.0	6.4	35.4	6.7	18.9	5.3	7.5	7.9	7.8	5.9	5.3	4.4	4.4	3.1	9.2	8.3	11.3	9.1	6.3	8.0	5.2	16.3	26.4	40.9	8.8	7.8	3.0	2.4	6.7	8.8	52.3	8.7	5.2	6.5	4.7	4.3	2.8	2.4	2.7	10.8	5.9	8.4	28.2	5.0	8.7	7.2	13.8	7.6	1.8	41.1	17.0	7.4	8.2	0.2	9.8	0.3	0.1	0.7	0.3	225.3	1.9	0.5	2.3	3.4	2.9	18.8	38.2	22.8	2.1	0.1	0.1	27.6	0.0	2.0	12.4	2.7	3.8	3.3	5.5	12.9	0.0	0.1	10.1	0.1	4.1	0.0	0.2	50.2	3.4	17.8	0.3	1.9	0.9	0.0	0.3	31.7	0.1	0.1	3.7	0.1	0.4	1.6	0.1	1.5	0.5	22.7	0.1	0.0	227.6	0.1	0.6	52.5	0.0	0.4	0.1	0.1	0.2	49.5	98.8	0.0	0.1	0.1	4.7	48.6	0.3	43.6	100.8	36.3	22.4	31.3	41.7	16.1	24.9	28.7	41.4	7.6	51.3	62.7	17.0	35.7	37.9	6.4	6.7	7.5	7.9	6.3	8.0	8.8	7.8	8.7	8.4	7.2	8.2	26.2	19.2	17.6	12.1	105.1	35.3	2.2	4.2	1.8	1.5	13.8	6.7	5.3	1.5	12.1	5.5	0.0	83.1	100.8	4.7	0.0	15.8	1.0	68.0	10.8	44.1	15.5	11.6	21.4	0.2	143.7	35.6	3.6	82.2	46.3	2.2	66.4	7.1	17.9	8.4	23.1	2.7	2.0	59.6	1527.7	4.9	4.4	232.6	88.9	92.8	99.8	5.3	43.3	1.0	3.2	9.3	6.0	17.7	115.7	2.5	0.1	2.4	10.4	3.0	13.1	55.3	14.6	0.4	2.2	3.8	36.9	270.2	100.6	8.1	3.4	6.9
SERPINH1	"CBP1, CBP2, colligen, HSP47, SERPINH2"	ENSG00000149257	"Serpin family H member 1"	P50454	11	75562056-75572783	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Stress response"	Chaperone	"Osteogenesis imperfecta"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 473.6;Endometrial stromal cells: 273.3;Extravillous trophoblasts: 342.1;Fibroblasts: 287.6;Smooth muscle cells: 295.1"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	5	"cerebral cortex: 291.0"	"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CACO-2: 1018.3;fHDF/TERT166: 1215.2;HHSteC: 1029.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004441, HPA029198"	Supported		Supported	"Endoplasmic reticulum"	"Intracellular and membrane"	NA	Yes		920000	"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 33: Fibroblasts - ECM organization"	"Endoplasmic reticulum"		"CAB004441: AB_627757, HPA029198: AB_10601712"	"unprognostic (3.80e-1)"	"prognostic unfavorable (2.10e-4)"	"unprognostic (5.93e-2)"	"unprognostic (2.81e-3)"	"unprognostic (3.25e-2)"	"prognostic unfavorable (1.85e-4)"	"unprognostic (2.39e-2)"	"unprognostic (1.72e-3)"	"unprognostic (2.35e-2)"	"unprognostic (7.40e-2)"	"unprognostic (1.57e-2)"	"unprognostic (2.54e-2)"	"prognostic unfavorable (3.22e-15)"	"unprognostic (2.75e-2)"	"unprognostic (1.27e-1)"	"unprognostic (3.93e-2)"	"unprognostic (1.96e-2)"	214.1	101.9	46.2	106.5	50.4	3.7	107.1	51.1	291.0	137.7	66.7	95.2	23.2	160.7	27.6	41.7	119.4	72.1	159.3	46.1	50.5	116.9	52.5	199.3	21.1	59.9	47.3	157.4	40.1	18.1	50.8	251.3	58.3	66.1	36.7	2.0	40.7	53.2	22.2	47.6	51.3	207.3	51.6	53.9	76.9	27.7	54.0	21.6	91.2	33.2	18.2	156.8	85.9	60.1	57.7	192.9	349.5	722.0	528.8	484.2	162.2	514.3	349.6	380.4	483.5	1018.3	294.1	0.4	470.2	1215.2	3.1	337.2	242.2	163.2	182.5	27.5	47.0	42.7	174.0	216.5	1029.5	0.9	7.2	580.9	165.2	365.0	121.3	475.5	530.8	22.1	90.5	16.1	182.5	457.6	1.2	74.8	315.6	215.8	50.7	29.3	200.3	48.8	95.6	107.8	9.1	119.1	326.9	59.7	102.0	539.6	144.4	72.7	284.6	388.6	324.6	270.6	128.3	23.1	25.5	6.1	168.0	0.2	535.6	4.1	1.1	0.1	6.0	1.1	5.2	0.9	3.9	4.0	4.4	0.7	4.0	3.3	0.2	5.9	0.1	3.7	3.5	2.1	46.2	50.4	51.1	291.0	46.1	50.5	59.9	47.3	58.3	51.6	54.0	60.1	142.3	38.5	32.0	4.9	2.9	81.8	473.6	56.5	74.0	5.3	28.3	39.5	36.6	14.3	21.0	25.8	58.4	217.0	3.2	33.0	0.0	64.5	2.9	21.8	273.3	194.9	61.1	11.4	0.4	11.9	342.1	287.6	15.3	33.0	9.5	144.1	124.9	9.9	94.2	6.7	0.2	55.7	22.4	5.7	110.0	6.0	164.4	43.6	44.4	18.7	9.8	14.3	8.2	1.0	0.5	22.5	24.3	120.7	6.5	139.8	12.4	22.8	11.9	1.2	92.1	31.4	295.1	29.3	23.0	14.1	44.5	165.8	68.8	79.8	62.8	73.4
SERTAD2	"KIAA0127, Sei-2, TRIP-Br2"	ENSG00000179833	"SERTA domain containing 2"	Q14140	2	64631621-64751005	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 85.7"	"Cell type enhanced"	"Detected in all"		"Basal keratinocytes: 177.6;Basal squamous epithelial cells: 153.1;Suprabasal keratinocytes: 148.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019021, HPA020904"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm	Cytosol	"HPA019021: AB_1856740, HPA020904: AB_1856741"	"unprognostic (1.40e-2)"	"unprognostic (7.41e-2)"	"unprognostic (1.89e-2)"	"prognostic unfavorable (4.03e-4)"	"unprognostic (2.15e-2)"	"unprognostic (8.15e-2)"	"unprognostic (3.39e-3)"	"unprognostic (1.06e-1)"	"unprognostic (9.55e-2)"	"unprognostic (5.95e-3)"	"unprognostic (1.98e-3)"	"unprognostic (7.04e-2)"	"prognostic unfavorable (1.70e-4)"	"unprognostic (3.21e-3)"	"unprognostic (6.78e-2)"	"unprognostic (4.98e-2)"	"unprognostic (3.84e-1)"	14.1	6.7	4.3	13.8	5.8	85.7	9.4	5.3	5.5	12.7	3.8	8.5	6.2	8.6	7.9	22.8	6.9	9.4	10.3	5.0	4.5	7.5	14.6	9.7	19.2	6.3	5.9	13.5	6.6	10.7	3.6	12.6	5.8	9.3	8.7	15.6	11.7	8.5	8.6	18.8	9.0	8.1	5.4	19.3	9.2	7.2	5.3	35.3	8.1	9.6	27.3	15.9	16.8	7.1	30.9	9.0	16.5	16.6	13.9	35.2	18.9	24.2	23.2	14.1	13.2	23.1	23.0	26.0	13.0	39.8	19.6	12.0	10.9	14.8	29.6	2.5	16.4	17.2	8.8	16.8	3.1	15.3	8.4	24.0	19.1	32.2	20.9	21.1	8.6	12.7	10.9	14.1	33.2	7.4	16.5	16.7	9.0	16.9	23.6	14.3	28.2	10.2	19.1	28.0	19.1	7.5	17.1	11.9	31.5	15.3	7.9	12.1	26.1	75.7	39.1	44.8	19.9	24.0	9.8	29.6	28.0	27.7	30.3	1.3	1.6	2.3	0.9	1.5	0.5	2.5	0.9	1.0	1.5	2.5	2.2	1.6	2.0	1.5	1.8	4.9	0.5	0.9	4.3	5.8	5.3	5.5	5.0	4.5	6.3	5.9	5.8	5.4	5.3	7.1	25.6	6.4	23.6	22.9	40.8	177.6	40.9	22.5	153.1	24.8	28.7	28.6	26.4	32.9	25.9	9.2	18.8	38.6	33.0	31.6	1.9	12.8	51.2	57.8	18.5	35.4	11.3	26.5	27.3	10.0	42.8	35.1	17.3	97.7	8.8	4.8	25.4	24.1	23.6	10.1	19.8	17.1	18.3	39.3	84.7	35.4	17.1	43.6	39.2	38.4	27.4	20.0	14.4	19.6	35.5	20.7	45.4	10.5	28.1	43.9	11.6	9.5	24.9	24.3	13.1	26.8	31.0	10.8	6.7	135.4	148.3	60.1	25.5	3.7	13.3	71.5
SERTAD4	DJ667H12.2	ENSG00000082497	"SERTA domain containing 4"	Q9NUC0	1	210232796-210246631	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 28.5;Breast glandular cells: 23.1;Extravillous trophoblasts: 54.9;Ionocytes: 24.4;Squamous epithelial cells: 27.4"	"Cancer enhanced"	"Detected in many"		"breast cancer: 10.7"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A-431: 7.5;BEWO: 7.4;SCLC-21H: 7.4;SK-BR-3: 8.5;T-47d: 10.5;U-2 OS: 8.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027344, HPA028514"	Uncertain		Supported	Nucleoplasm		NA	NA				"Cluster 37: Intestine - Unknown function"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 38: Extravillous trophoblasts - Unknown function"	Nucleoplasm		"HPA027344: AB_10601770, HPA028514: AB_10611391"	"unprognostic (1.75e-2)"	"unprognostic (3.92e-2)"	"unprognostic (3.83e-2)"	"unprognostic (9.74e-2)"	"unprognostic (1.98e-2)"	"unprognostic (1.27e-1)"	"unprognostic (6.46e-2)"	"unprognostic (1.03e-1)"	"unprognostic (7.74e-2)"	"unprognostic (8.49e-2)"	"unprognostic (1.69e-2)"	"unprognostic (5.98e-2)"	"unprognostic (6.24e-2)"	"unprognostic (2.05e-1)"	"unprognostic (3.85e-2)"	"unprognostic (6.55e-2)"	"unprognostic (4.24e-1)"	1.1	0.3	0.6	0.3	1.6	0.0	3.6	1.0	1.1	2.0	0.2	4.8	0.4	3.8	0.6	4.2	1.7	0.7	3.0	0.6	1.0	1.9	0.0	1.5	0.1	0.9	1.4	1.0	0.1	0.6	0.9	1.0	1.0	1.8	1.4	0.1	5.9	1.4	0.2	3.3	0.8	2.7	1.2	0.1	1.4	0.2	0.8	0.6	1.4	0.7	0.7	0.6	1.8	1.1	7.5	0.1	1.6	0.0	0.8	0.7	7.4	1.8	1.8	1.4	2.4	0.3	0.8	0.0	0.2	0.4	1.1	3.6	0.2	0.6	0.7	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.7	0.2	1.7	0.2	0.0	0.0	0.0	0.3	1.8	0.0	0.0	5.2	6.0	0.3	0.0	2.4	0.0	1.2	1.3	7.4	6.3	1.2	8.5	0.1	2.9	10.5	0.0	2.3	2.0	8.7	0.1	5.6	0.0	0.0	0.0	0.0	0.0	5.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	1.6	1.0	1.1	0.6	1.0	0.9	1.4	1.0	1.2	0.8	1.1	5.0	6.4	3.9	1.6	0.0	16.7	9.6	16.0	28.5	2.5	23.1	9.3	0.7	1.5	10.9	9.2	0.0	14.2	0.0	1.5	7.9	2.1	0.5	4.8	1.2	5.2	1.2	0.0	10.1	3.9	54.9	7.5	2.6	5.8	0.0	9.3	2.5	0.0	1.4	0.0	3.7	5.6	24.4	0.0	5.0	0.6	0.6	0.3	10.6	3.7	0.0	0.5	0.0	1.0	9.4	8.1	1.3	1.5	0.0	2.5	0.0	0.4	13.9	0.3	0.0	1.8	3.7	0.1	1.7	27.4	4.7	4.4	0.3	0.1	6.5	3.4
SESN1	"PA26, SEST1"	ENSG00000080546	"Sestrin 1"	Q9Y6P5	6	108986437-109094819	"Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 137.2;Excitatory neurons: 134.9;Inhibitory neurons: 127.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"B-cells: 48.0;NK-cells: 58.9;T-cells: 74.6"	"Cell line enhanced"	"Detected in all"		"BEWO: 80.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA073659			Supported	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 4: Macrophages - Innate immune response"	"Nucleoli fibrillar center"	Nucleoplasm	"HPA073659: AB_2686622"	"unprognostic (2.22e-1)"	"unprognostic (5.97e-2)"	"unprognostic (1.02e-1)"	"unprognostic (3.52e-2)"	"unprognostic (1.17e-1)"	"prognostic favorable (6.47e-5)"	"unprognostic (2.68e-1)"	"unprognostic (6.91e-2)"	"unprognostic (1.01e-1)"	"unprognostic (8.33e-2)"	"unprognostic (1.83e-3)"	"prognostic favorable (2.07e-4)"	"unprognostic (3.54e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.08e-1)"	"unprognostic (5.72e-2)"	"unprognostic (7.95e-2)"	30.7	26.6	29.1	23.2	30.7	50.2	42.3	29.8	35.9	29.9	29.8	31.6	20.2	31.7	26.6	22.7	32.5	18.5	36.2	31.1	29.4	16.7	29.2	25.6	33.8	27.9	27.9	62.6	31.6	50.3	25.8	53.4	28.7	25.1	23.9	25.0	18.3	23.6	151.2	43.1	38.1	32.9	28.7	37.0	31.0	42.0	29.9	21.9	32.1	140.0	33.8	28.3	28.2	30.8	3.5	5.7	25.7	12.2	32.1	40.6	80.5	13.8	15.7	4.7	9.0	10.9	3.6	29.3	11.4	10.2	3.7	4.1	7.0	27.6	5.8	2.6	34.7	13.0	6.9	40.9	19.7	5.1	12.7	44.2	43.0	8.5	13.7	20.5	24.7	8.3	9.7	20.5	23.3	6.9	11.3	16.4	10.6	5.7	3.6	9.0	7.3	13.7	10.1	17.4	6.3	12.7	7.5	4.7	5.7	41.3	4.5	33.5	15.3	3.6	7.1	3.3	4.5	20.5	12.5	12.0	7.9	12.8	7.9	11.9	2.7	3.4	34.4	6.3	74.6	13.3	32.4	27.3	2.7	48.0	39.6	20.8	10.0	58.9	8.7	5.4	15.1	20.3	29.1	30.7	29.8	35.9	31.1	29.4	27.9	27.9	28.7	28.7	29.9	30.8	13.9	64.1	22.4	79.0	37.3	6.5	4.9	7.4	25.0	23.8	14.2	14.5	30.0	17.2	15.2	14.7	45.9	57.8	22.9	12.7	9.8	4.3	137.2	10.3	15.2	9.8	15.5	24.2	134.9	5.3	13.7	21.9	28.5	8.2	3.8	17.4	10.8	14.7	44.9	26.9	127.7	10.0	2.0	43.1	11.3	104.8	34.5	56.5	16.0	71.2	9.4	39.1	25.7	64.3	119.1	3.1	11.9	35.3	26.2	9.4	7.8	9.3	26.4	44.3	26.3	43.9	15.9	18.4	16.2	25.4	8.4	44.6	41.8	102.9	13.6	4.3
SETBP1	"KIAA0437, SEB"	ENSG00000152217	"SET binding protein 1"	Q9Y6X0	18	44680173-45068510	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins"		DNA-binding	"Cancer-related genes, Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"Excitatory neurons: 349.0;Inhibitory neurons: 548.3;Oligodendrocyte precursor cells: 170.4"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"cerebellum: 11.6"	"Immune cell enhanced"	"Detected in some"		"naive B-cell: 3.0;plasmacytoid DC: 2.8"	"Group enriched"	"Detected in many"	5	"B-cells: 3.0;dendritic cells: 2.8;monocytes: 1.0"	"Cell line enhanced"	"Detected in many"		"AF22: 16.1;Karpas-707: 44.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049022, HPA057259"	Uncertain		Supported	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA		66000	"Cluster 19: B-cells - Humoral immune response"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm	"Nuclear bodies, Cytosol"	"HPA049022: AB_2680602, HPA057259: AB_2683384"	"unprognostic (1.25e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.97e-2)"	"unprognostic (4.63e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.91e-1)"	"unprognostic (3.57e-2)"	"unprognostic (3.49e-1)"	"unprognostic (2.01e-2)"	"unprognostic (2.71e-3)"	"unprognostic (6.52e-2)"	"prognostic favorable (6.34e-8)"	"unprognostic (2.18e-2)"	"unprognostic (2.29e-1)"	"unprognostic (6.06e-2)"	"unprognostic (7.81e-5)"	7.3	1.9	2.0	3.7	3.7	1.8	6.3	11.6	5.7	11.6	0.0	10.9	1.7	8.3	7.2	4.5	7.2	5.0	4.3	2.6	0.2	7.4	4.7	6.6	5.3	0.0	0.1	7.7	5.8	3.7	2.7	7.2	0.1	7.8	3.5	3.0	4.3	9.2	10.7	4.4	4.6	7.4	0.0	3.7	5.6	1.8	0.0	4.4	5.1	9.7	4.7	8.1	8.5	3.8	0.0	2.4	16.1	0.0	4.1	1.2	1.0	1.3	3.0	1.5	1.3	0.2	0.0	1.0	0.5	1.8	1.0	4.8	1.8	4.9	1.0	1.4	0.8	0.0	1.8	1.2	0.0	0.0	0.0	3.8	2.0	0.0	3.0	2.7	0.5	0.0	0.1	44.7	0.4	0.8	0.0	0.1	2.0	0.0	1.1	5.6	0.0	5.5	4.9	3.9	8.2	4.2	0.0	0.0	0.9	7.1	2.2	0.0	0.0	9.5	3.3	0.0	7.7	8.6	0.5	0.0	5.8	0.2	5.5	0.1	0.0	0.0	0.4	0.6	0.0	2.0	0.0	0.2	0.0	3.0	0.0	0.1	0.0	0.0	1.0	2.8	0.0	0.1	2.0	3.7	11.6	5.7	2.6	0.2	0.0	0.1	0.1	0.0	0.0	3.8	7.6	0.0	1.8	85.5	42.4	15.4	8.6	8.3	7.4	12.5	11.0	12.6	3.9	14.3	4.2	16.5	18.8	1.5	25.5	1.6	3.9	4.5	1.3	12.9	15.6	8.3	12.0	0.8	349.0	3.5	1.4	29.3	4.1	14.8	0.0	0.7	17.9	16.5	2.0	3.3	548.3	4.4	10.2	2.4	8.7	3.7	62.7	4.6	3.6	88.1	1.5	10.7	6.2	170.4	62.9	3.7	9.1	39.9	29.6	8.1	0.4	10.5	5.8	18.2	6.6	18.4	28.6	0.3	0.8	4.0	15.2	0.8	5.9	0.1	4.7	1.5
SETD1A	"KIAA0339, KMT2F, Set1"	ENSG00000099381	"SET domain containing 1A, histone lysine methyltransferase"	O15047	16	30957754-30984664	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, Chromatin regulator, Methyltransferase, RNA-binding, Transferase"	"Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA020646, HPA058376"	Enhanced		Supported	"Nuclear speckles"		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 71: Testis - DNA repair"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	"Nuclear speckles"		"HPA020646: AB_1856752, HPA058376: AB_2683695"	"unprognostic (8.62e-2)"	"unprognostic (1.93e-2)"	"unprognostic (3.96e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.40e-2)"	"prognostic unfavorable (8.47e-4)"	"unprognostic (5.01e-2)"	"unprognostic (1.54e-1)"	"unprognostic (3.18e-1)"	"unprognostic (5.77e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.12e-1)"	"unprognostic (1.70e-2)"	"unprognostic (1.94e-1)"	10.2	10.0	6.0	7.3	5.5	20.1	10.0	8.4	8.3	11.0	3.0	13.0	6.6	13.0	2.8	9.0	10.5	4.1	8.5	5.5	5.5	8.4	10.4	8.2	8.6	5.6	5.4	12.4	10.6	8.0	11.9	5.0	5.4	10.2	3.3	3.1	9.3	6.1	15.1	12.3	10.5	6.3	4.1	11.8	10.0	20.8	6.0	10.0	11.8	7.1	5.1	10.2	9.3	6.9	13.1	24.4	15.9	19.4	8.7	6.3	18.0	13.6	10.6	11.9	10.1	20.2	12.8	34.2	15.2	13.0	12.0	16.4	15.0	14.6	9.3	18.5	56.1	16.0	47.1	23.2	8.9	26.6	26.2	11.0	11.3	17.1	10.8	9.2	9.3	19.5	32.3	19.0	6.4	27.2	32.3	27.7	23.4	9.0	15.4	48.7	15.9	21.9	7.6	13.9	17.6	18.1	18.7	15.1	10.8	8.7	16.2	22.1	12.8	17.7	17.1	11.6	14.9	28.0	36.2	32.4	14.3	22.9	13.5	0.0	0.1	0.6	0.2	0.3	0.3	0.0	0.2	0.2	0.1	0.5	0.1	0.2	0.0	0.2	0.1	0.6	0.1	0.2	6.0	5.5	8.4	8.3	5.5	5.5	5.6	5.4	5.4	4.1	6.0	6.9	7.8	3.2	9.2	9.1	8.8	15.7	5.1	3.8	15.4	8.1	9.5	8.3	3.9	5.7	4.0	7.3	6.2	4.6	11.4	6.8	0.0	4.2	3.1	6.1	8.2	9.9	10.3	6.7	6.4	4.2	3.7	7.8	6.1	8.6	3.8	9.5	7.5	9.1	6.5	13.5	6.1	7.9	2.0	4.7	7.1	2.9	9.9	5.5	8.8	6.5	4.7	4.8	7.2	2.5	5.7	5.4	4.8	11.7	7.9	8.3	5.1	2.8	4.0	5.2	6.6	10.8	7.8	17.5	23.3	15.7	12.9	2.9	8.6	10.3	6.9	4.8
SETD6	FLJ21148	ENSG00000103037	"SET domain containing 6, protein lysine methyltransferase"	Q8TBK2	16	58515479-58523842	"Metabolic proteins, Predicted intracellular proteins"		"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041481, HPA053546"	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	Nucleoplasm	Cytosol	"HPA041481: AB_10804004, HPA053546: AB_2682182"	"unprognostic (1.32e-1)"	"unprognostic (2.98e-3)"	"unprognostic (3.35e-1)"	"unprognostic (2.81e-1)"	"unprognostic (7.90e-3)"	"unprognostic (1.95e-1)"	"unprognostic (1.93e-3)"	"unprognostic (1.65e-1)"	"unprognostic (3.65e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.16e-2)"	"prognostic unfavorable (3.54e-4)"	"unprognostic (3.74e-3)"	"unprognostic (2.14e-1)"	"unprognostic (3.73e-1)"	"unprognostic (5.93e-3)"	"unprognostic (1.55e-1)"	8.6	12.4	3.8	2.9	3.6	2.6	9.1	8.9	4.6	9.4	3.9	8.4	3.8	8.4	5.4	13.4	9.7	2.7	11.3	3.9	3.8	12.5	13.5	7.0	4.6	3.8	3.5	9.1	19.6	6.5	12.5	2.5	3.9	10.9	4.3	7.9	11.1	5.9	15.0	14.6	9.2	3.3	3.5	10.6	11.4	12.7	3.8	2.8	12.2	3.9	4.4	8.3	10.8	3.8	2.5	6.1	1.3	10.7	4.3	2.8	15.9	4.0	5.4	7.1	3.8	10.1	6.1	19.9	5.4	4.6	0.9	8.1	9.0	6.3	4.9	2.2	23.6	0.9	11.0	17.2	4.3	14.4	7.8	3.8	13.2	5.6	8.8	4.8	4.5	0.2	14.7	2.6	1.5	10.1	0.3	17.7	21.0	9.7	9.6	0.4	2.5	26.7	7.3	0.4	19.6	12.6	16.8	15.9	7.8	6.2	10.0	2.0	3.7	2.5	6.0	3.1	7.3	11.7	8.1	13.7	5.3	6.9	4.6	2.5	1.1	0.2	2.0	1.5	1.4	1.5	1.6	2.2	1.8	1.5	2.0	2.2	0.7	4.4	1.6	2.0	1.6	1.3	3.8	3.6	8.9	4.6	3.9	3.8	3.8	3.5	3.9	3.5	3.8	3.8	5.2	6.4	6.9	6.8	7.1	13.9	10.5	7.5	13.6	14.3	12.0	11.0	7.6	17.2	8.5	9.2	14.6	17.5	8.6	5.3	1.9	10.1	9.2	10.8	6.9	6.8	4.8	10.3	11.5	12.2	9.9	8.4	8.2	10.0	1.3	14.9	4.2	7.9	3.5	11.8	11.3	5.0	2.0	3.5	5.6	16.9	9.0	3.4	5.4	5.6	5.6	15.0	6.2	7.5	4.7	6.1	4.2	10.1	6.8	13.8	6.5	9.4	12.0	13.4	13.1	10.1	7.4	15.0	22.9	12.1	12.1	12.6	7.1	6.1	7.4	6.2
SETD7	"KIAA1717, KMT7, SET7, SET7/9, Set9"	ENSG00000145391	"SET domain containing 7, histone lysine methyltransferase"	Q8WTS6	4	139495941-139606699	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, Chromatin regulator, Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA058111	Enhanced		Enhanced	"Nucleoli,Nucleoli rim,Mitotic chromosome"		Yes	No			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Nucleoli, Nucleoli rim"	"Mitotic chromosome"	"HPA058111: AB_2683607"	"prognostic unfavorable (8.28e-4)"	"unprognostic (7.07e-2)"	"unprognostic (4.04e-1)"	"unprognostic (2.07e-1)"	"unprognostic (2.92e-1)"	"unprognostic (4.82e-2)"	"unprognostic (1.48e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.71e-2)"	"unprognostic (9.10e-2)"	"unprognostic (6.44e-2)"	"unprognostic (7.75e-2)"	"unprognostic (1.37e-1)"	"unprognostic (6.16e-3)"	"unprognostic (1.17e-1)"	"unprognostic (6.92e-2)"	"unprognostic (6.56e-3)"	44.7	18.5	17.8	15.1	17.7	9.7	27.3	19.3	17.3	40.5	21.2	23.5	7.3	33.0	12.6	28.1	18.8	26.7	41.0	16.6	19.4	10.1	50.1	19.2	11.7	25.0	20.3	19.6	21.9	34.7	8.8	19.1	24.7	35.1	15.3	11.5	16.2	20.6	106.6	22.7	12.1	34.8	24.6	17.0	20.1	14.4	24.5	10.1	14.1	73.7	15.9	23.4	18.2	29.2	28.4	37.2	13.0	7.8	77.1	65.9	29.6	65.7	67.3	32.4	27.1	22.7	37.2	68.0	25.5	110.5	22.4	13.9	44.3	51.3	52.4	32.8	33.0	8.9	45.5	0.8	38.4	31.9	12.9	57.7	58.6	52.1	54.6	41.2	41.7	27.8	5.5	96.1	42.3	46.8	21.0	4.6	6.4	40.8	23.9	19.7	48.4	37.3	31.5	25.3	55.3	18.5	44.7	63.5	15.3	12.6	25.3	28.0	68.8	57.1	40.7	68.6	55.2	89.6	86.8	42.2	65.9	31.1	28.0	0.5	3.9	0.2	0.3	2.0	2.7	1.0	1.1	1.1	4.4	1.2	0.4	0.2	0.9	0.2	3.2	2.1	3.7	1.2	17.8	17.7	19.3	17.3	16.6	19.4	25.0	20.3	24.7	24.6	24.5	29.2	28.7	6.4	18.8	17.3	8.9	17.2	14.5	14.1	12.5	5.4	24.0	14.7	43.1	20.0	15.0	9.2	12.5	26.2	4.2	4.1	0.0	22.7	1.3	3.5	35.9	29.4	1.2	3.6	21.1	21.2	16.7	39.8	16.8	7.5	2.5	2.9	37.1	70.6	20.4	8.4	42.4	13.6	18.3	31.0	20.9	4.3	23.0	19.5	10.6	19.7	19.0	15.0	0.0	36.2	29.2	22.4	4.1	28.2	13.2	38.4	1.3	4.5	14.0	12.9	19.7	35.2	23.3	3.7	2.7	17.9	22.0	46.1	9.8	9.5	11.7	20.4
SETDB1	"ESET, KG1T, KIAA0067, KMT1E, TDRD21"	ENSG00000143379	"SET domain bifurcated histone lysine methyltransferase 1"	Q15047	1	150926263-150964744	"Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, Methyltransferase, Repressor, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in all"	6	"U-698: 341.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018142, HPA058484"	Uncertain		Supported	Nucleoplasm,Vesicles		Yes	No			"Cluster 44: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm	Vesicles	"HPA018142: AB_1856757, HPA058484: AB_2683731"	"unprognostic (1.07e-1)"	"unprognostic (4.08e-1)"	"unprognostic (8.02e-2)"	"unprognostic (2.24e-3)"	"unprognostic (1.65e-2)"	"unprognostic (9.57e-2)"	"prognostic unfavorable (8.88e-4)"	"unprognostic (6.03e-2)"	"unprognostic (9.94e-3)"	"unprognostic (7.13e-2)"	"unprognostic (1.21e-1)"	"unprognostic (6.65e-2)"	"prognostic unfavorable (4.25e-4)"	"unprognostic (1.59e-1)"	"unprognostic (3.93e-2)"	"unprognostic (3.14e-2)"	"unprognostic (1.14e-1)"	13.5	11.3	7.1	15.2	8.2	18.1	16.7	12.8	8.9	14.4	8.7	13.4	12.5	18.1	13.1	11.8	15.3	11.5	8.2	6.7	7.9	11.7	11.5	13.4	19.6	8.2	7.6	19.4	13.3	15.7	8.6	17.7	7.6	11.4	15.5	14.2	12.3	12.2	16.4	14.4	13.7	16.5	6.0	19.9	13.4	25.1	8.4	21.6	15.5	11.7	20.3	13.1	12.7	10.3	22.9	26.3	37.1	24.6	17.5	23.2	61.7	18.6	21.2	26.2	22.2	17.9	31.1	44.9	24.9	20.7	10.4	28.1	35.0	20.0	20.7	21.8	43.3	25.5	27.3	20.8	24.7	45.3	23.2	30.5	22.0	21.8	34.8	26.6	31.2	28.3	43.4	35.6	18.9	44.1	31.6	26.4	51.1	32.1	20.6	36.3	24.3	33.4	20.1	25.9	27.1	49.1	28.4	32.9	22.5	44.5	35.7	60.4	21.2	15.3	15.7	17.0	26.3	36.6	42.3	341.6	15.7	15.7	15.1	6.9	8.3	5.7	5.8	11.6	6.1	6.1	5.3	6.6	9.7	8.3	5.7	5.9	4.8	6.3	8.5	6.5	3.5	4.3	7.1	8.2	12.8	8.9	6.7	7.9	8.2	7.6	7.6	6.0	8.4	10.3	8.5	6.4	14.0	15.3	15.3	5.5	9.3	6.6	10.2	11.0	9.8	10.7	5.5	10.0	7.8	7.3	18.8	13.9	8.8	6.6	3.9	7.6	26.1	10.8	13.3	8.3	3.6	9.2	19.6	5.7	8.5	9.1	10.2	10.7	7.6	17.9	11.4	8.1	9.9	6.7	19.4	9.7	12.2	17.2	5.1	31.0	10.2	13.9	1.8	23.4	14.4	6.2	14.4	15.6	23.5	8.1	9.5	9.8	8.9	8.2	7.6	6.4	11.0	10.4	6.6	10.2	10.3	24.4	15.9	10.9	5.1	10.0	10.2	14.6	10.7	7.8
SETMAR	metnase	ENSG00000170364	"SET domain and mariner transposase fusion gene"	Q53H47	3	4303304-4317567	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"DNA damage, DNA repair"	"Chromatin regulator, DNA-binding, Endonuclease, Hydrolase, Methyltransferase, Multifunctional enzyme, Nuclease, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 25.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"											HPA057999			Supported	Nucleoli		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 47: Cytotrophoblasts - Unknown function"	Nucleoli		"HPA057999: AB_2683574"	"unprognostic (1.59e-1)"	"unprognostic (1.22e-2)"	"unprognostic (5.24e-3)"	"unprognostic (4.89e-2)"	"unprognostic (7.73e-2)"	"unprognostic (4.73e-2)"	"prognostic unfavorable (2.85e-4)"	"unprognostic (1.58e-2)"	"unprognostic (1.54e-2)"	"unprognostic (3.29e-1)"	"unprognostic (1.19e-3)"	"unprognostic (1.19e-1)"	"prognostic favorable (6.61e-6)"	"unprognostic (5.42e-1)"	"unprognostic (3.06e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.26e-3)"	6.5	3.7	2.6	2.2	4.3	2.6	8.5	4.2	3.3	8.4	1.9	3.9	2.7	10.3	4.6	4.5	8.5	5.3	3.4	3.0	2.3	6.4	3.3	2.7	2.9	3.6	2.8	12.1	5.1	3.4	3.7	3.7	3.4	7.9	4.3	2.1	5.7	6.1	3.8	4.8	3.1	10.4	2.5	2.8	3.7	4.2	4.0	6.0	7.4	5.1	2.8	5.5	5.2	6.5	3.7	3.2	9.8	2.1	23.1	7.6	9.9	4.1	1.2	3.9	3.7	3.5	2.9	9.9	4.2	2.3	7.2	3.1	8.9	6.1	4.3	6.8	7.6	12.5	6.1	5.6	2.7	5.9	5.1	9.1	4.7	3.0	0.9	3.6	5.7	11.2	8.3	3.6	6.2	5.2	8.9	3.7	9.5	2.4	5.7	10.3	9.6	4.1	3.6	5.1	7.8	11.4	4.9	6.1	5.3	6.2	5.9	3.4	3.8	5.8	8.0	4.9	5.4	4.9	12.3	24.1	2.1	6.7	4.9	0.7	0.4	0.5	0.8	1.2	0.7	1.0	1.0	1.1	0.4	1.3	1.6	2.0	0.0	0.2	0.8	0.6	0.7	0.6	2.6	4.3	4.2	3.3	3.0	2.3	3.6	2.8	3.4	2.5	4.0	6.5	4.8	0.0	5.0	4.9	2.4	2.4	8.0	12.0	10.8	5.8	6.6	13.7	6.6	2.8	10.8	0.0	0.0	25.5	1.9	2.7	13.7	11.2	0.7	3.8	6.3	5.6	3.6	5.5	6.4	13.4	12.1	8.9	5.6	4.4	1.3	13.9	4.2	2.6	5.7	0.0	6.9	2.8	10.2	2.1	1.5	1.9	9.6	2.7	0.0	4.7	4.1	4.6	2.1	7.1	11.7	6.6	4.4	13.2	1.8	4.4	2.0	6.0	6.7	2.8	6.6	7.0	8.1	7.5	6.4	6.0	0.6	16.3	2.8	16.9	5.6	3.6
SETSIP	SETP18	ENSG00000230667	"SET like protein"	P0DME0	1	92074533-92075441	"Predicted intracellular proteins"	"Differentiation, Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"Basal prostatic cells: 1.4;Cardiomyocytes: 3.5;Early spermatids: 1.7;granulocytes: 3.8;NK-cells: 3.1"	"Low cancer specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA063683	Approved		Supported	"Nucleoplasm,Lipid droplets"		NA	NA						"Cluster 60: Granulocytes - Receptor signaling"	Nucleoplasm	"Lipid droplets"	"HPA063683: AB_2685088"	"unprognostic (2.31e-2)"	"unprognostic (3.79e-3)"	"unprognostic (7.59e-2)"	"unprognostic (5.74e-2)"	"unprognostic (5.60e-2)"	"unprognostic (7.74e-2)"	"unprognostic (1.88e-8)"	"unprognostic (3.43e-1)"	"unprognostic (1.65e-2)"	"unprognostic (9.37e-2)"	"unprognostic (4.35e-4)"	"unprognostic (1.63e-2)"	"unprognostic (2.58e-1)"	"unprognostic (3.10e-2)"	"unprognostic (4.93e-2)"	"unprognostic (2.15e-2)"	"unprognostic (1.74e-1)"	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.2	0.0	0.0	0.4	0.0	0.3	0.0	0.1	0.2	0.2	0.2	0.0	0.1	0.2	0.1	0.2	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.6	0.0	0.4	0.0	1.4	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.6	0.0	0.0	0.6	0.0	0.1	0.0	0.0	1.7	0.1	0.1	0.2	0.0	0.0	0.1	0.0	0.8	0.5	0.0	0.1	3.8	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.3	0.0	0.1	0.6	0.3	0.0	0.0	0.1	0.0	3.1	0.5	0.1	0.0	0.0	0.0	0.0	1.2	0.0	0.1	0.0	0.0	0.0	0.4	0.4	0.1	0.7	0.0	0.0	0.5	0.4	0.0	0.0	0.9
SETX	"ALS4, AOA2, KIAA0625, SCAR1, Sen1"	ENSG00000107290	Senataxin	Q7Z333	9	132261356-132354986	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Biological rhythms, Differentiation, DNA damage, DNA recombination, DNA repair, Neurogenesis, Spermatogenesis"	"Helicase, Hydrolase"	"Amyotrophic lateral sclerosis, Disease variant, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024105, HPA057269"	Approved		Supported	"Nucleoplasm,Cytokinetic bridge"		Yes	No			"Cluster 6: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm	"Cytokinetic bridge"	"HPA024105: AB_2671437, HPA057269: AB_2683389"	"unprognostic (2.16e-1)"	"unprognostic (5.77e-2)"	"unprognostic (3.23e-1)"	"unprognostic (2.03e-1)"	"unprognostic (9.99e-2)"	"unprognostic (2.14e-2)"	"unprognostic (4.86e-2)"	"unprognostic (1.64e-2)"	"unprognostic (2.06e-2)"	"unprognostic (1.38e-2)"	"unprognostic (2.36e-1)"	"unprognostic (3.32e-1)"	"unprognostic (6.76e-3)"	"unprognostic (2.47e-1)"	"unprognostic (1.13e-1)"	"unprognostic (5.64e-3)"	"unprognostic (6.42e-2)"	13.7	9.5	6.2	19.9	8.8	16.8	13.9	9.8	6.3	13.2	7.7	13.1	10.6	12.7	11.1	10.6	10.9	12.7	10.5	5.1	7.8	11.9	16.7	15.4	27.4	8.7	7.0	13.0	9.2	18.3	6.0	14.3	9.6	13.0	12.8	13.2	9.0	12.7	12.9	12.3	13.2	12.8	8.0	27.6	12.9	31.9	7.7	25.4	33.0	12.8	26.3	15.7	8.5	13.2	15.1	19.9	22.5	24.4	28.3	34.1	13.5	19.6	21.9	15.6	14.6	21.1	16.8	25.6	9.4	36.9	38.3	30.2	22.8	17.0	17.0	24.6	9.9	26.9	22.7	18.4	26.5	41.8	31.2	24.0	26.2	26.6	23.6	19.1	25.4	17.8	31.7	20.0	18.3	21.8	25.9	15.8	24.2	25.4	15.4	24.2	32.6	17.2	17.1	19.5	14.0	21.4	32.4	14.2	18.2	29.7	19.7	21.2	29.3	32.5	14.0	22.1	19.0	12.2	22.0	38.6	14.9	16.3	17.8	10.5	4.4	4.7	5.3	4.1	5.6	5.5	3.9	4.1	3.3	6.9	4.2	3.7	15.1	5.2	4.9	5.0	3.2	2.3	6.2	8.8	9.8	6.3	5.1	7.8	8.7	7.0	9.6	8.0	7.7	13.2	76.2	60.9	45.7	75.1	85.6	30.2	34.6	26.6	38.7	31.2	24.1	22.7	61.3	17.2	43.9	20.2	29.2	13.7	96.8	37.6	3.9	20.0	7.6	62.7	68.0	58.7	14.5	25.5	73.7	14.7	10.6	52.9	44.4	89.7	58.2	38.3	51.4	33.0	28.8	67.3	64.8	30.6	16.2	73.1	37.6	13.8	30.7	75.5	12.4	131.2	75.8	20.7	87.6	65.9	113.0	23.2	31.9	36.1	61.8	49.3	25.6	18.5	54.4	28.7	13.1	44.9	42.5	145.2	38.5	35.1	33.5	9.4	65.9	53.7	26.9	46.4
SF1	"ZCCHC25, ZFM1, ZNF162"	ENSG00000168066	"Splicing factor 1"	Q15637	11	64764606-64778786	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing, Transcription, Transcription regulation"	"Repressor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA018883	Supported		Supported	Nucleoplasm		NA	NA		130000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 59: Non-specific - Translation"	"Cluster 14: REH - Unknown function"	"Cluster 57: B-cells - Immune response"	Nucleoplasm		"HPA018883: AB_1856763"	"unprognostic (1.24e-1)"	"unprognostic (2.42e-1)"	"unprognostic (1.18e-1)"	"unprognostic (4.01e-2)"	"unprognostic (1.50e-1)"	"unprognostic (4.35e-1)"	"prognostic unfavorable (4.85e-5)"	"unprognostic (3.72e-1)"	"unprognostic (4.51e-3)"	"unprognostic (1.39e-1)"	"unprognostic (4.62e-3)"	"unprognostic (6.20e-2)"	"unprognostic (8.00e-2)"	"unprognostic (2.18e-1)"	"unprognostic (1.42e-1)"	"unprognostic (2.62e-2)"	"unprognostic (1.78e-1)"	111.7	89.1	47.2	73.1	47.9	230.4	100.8	70.8	73.7	106.8	39.7	112.6	62.3	110.5	46.3	98.2	118.7	53.8	93.0	44.2	64.4	97.9	100.4	85.0	95.8	51.5	40.2	142.4	103.3	52.0	97.7	53.4	42.2	105.7	42.5	46.3	87.4	58.4	149.2	96.3	110.5	63.4	27.7	133.6	104.5	110.2	53.3	91.2	99.6	73.3	80.4	98.4	92.3	57.9	141.2	165.4	151.1	131.0	82.4	65.5	178.8	98.9	83.6	130.3	100.3	142.0	154.8	223.6	120.2	111.4	119.4	163.8	172.2	171.0	110.3	167.1	115.0	144.6	107.6	107.0	130.7	155.0	143.7	86.0	87.1	165.2	172.3	77.0	118.9	145.0	216.4	141.5	100.8	145.1	294.2	217.9	206.5	126.2	117.5	253.2	104.7	177.7	87.5	151.8	119.6	157.4	138.1	118.8	138.3	95.6	182.7	163.6	104.6	145.1	131.7	134.5	158.2	163.6	139.4	205.6	129.1	132.2	180.2	3.4	9.7	10.7	12.9	10.8	12.9	9.3	9.6	12.7	9.6	7.3	11.2	11.9	13.7	9.2	9.7	10.9	10.5	9.4	47.2	47.9	70.8	73.7	44.2	64.4	51.5	40.2	42.2	27.7	53.3	57.9	131.9	60.9	88.7	82.3	326.5	184.2	205.1	121.4	350.0	267.2	158.4	127.8	63.5	107.2	87.2	55.2	225.2	118.6	194.5	133.6	37.2	80.4	156.9	156.6	180.5	134.3	209.8	115.7	60.6	73.8	116.8	126.1	138.6	170.1	107.8	212.6	164.2	120.7	98.2	175.0	52.1	115.6	109.9	137.2	167.6	67.1	157.5	122.0	96.0	72.1	146.4	121.9	166.9	62.4	141.0	88.3	106.3	113.2	188.1	192.8	118.5	56.0	83.1	325.8	78.9	145.3	132.0	116.8	84.3	246.9	183.8	148.7	250.2	249.6	129.6	194.3
SF3A3	"PRP9, PRPF9, SAP61, SF3a60"	ENSG00000183431	"Splicing factor 3a subunit 3"	Q12874	1	37956975-37990075	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA032054, HPA032055"	Supported		Supported	"Nucleoplasm,Nuclear speckles"		NA	NA		57000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	"Nuclear speckles"	Nucleoplasm	"HPA032054: AB_10602184, HPA032055: AB_2674130"	"unprognostic (1.56e-1)"	"unprognostic (1.21e-1)"	"unprognostic (7.08e-3)"	"unprognostic (6.19e-3)"	"unprognostic (1.06e-1)"	"unprognostic (5.68e-2)"	"prognostic unfavorable (2.11e-8)"	"unprognostic (1.34e-1)"	"unprognostic (2.74e-2)"	"unprognostic (5.74e-3)"	"unprognostic (9.18e-2)"	"unprognostic (4.79e-1)"	"unprognostic (1.23e-2)"	"unprognostic (2.52e-3)"	"unprognostic (8.39e-2)"	"unprognostic (2.24e-1)"	"unprognostic (3.68e-2)"	24.6	23.4	22.3	29.2	22.6	57.9	31.7	24.1	29.0	25.6	23.2	25.1	20.4	30.5	33.7	23.3	27.5	19.1	18.6	22.0	22.8	26.0	27.4	22.9	39.0	22.6	22.6	32.1	20.3	30.6	16.2	25.4	22.9	24.9	30.0	29.9	23.5	28.8	49.6	29.2	21.4	31.7	22.3	27.4	20.0	27.5	23.4	43.4	26.9	27.4	44.6	28.1	18.8	24.0	84.4	57.0	108.1	90.8	63.3	57.7	129.6	82.2	69.1	131.9	106.4	97.2	84.4	165.8	68.1	73.6	51.6	71.5	136.7	108.6	162.3	74.9	125.7	206.3	92.3	86.7	57.9	261.1	93.5	54.9	75.4	135.5	88.4	58.6	89.9	112.6	176.1	60.0	95.2	53.2	131.4	123.0	268.0	80.4	89.9	156.8	197.0	110.7	59.4	83.5	95.8	69.4	104.2	47.1	83.9	95.1	54.0	90.3	82.0	70.3	79.6	64.9	157.2	57.6	89.5	166.4	65.6	215.6	92.1	37.2	41.3	28.4	56.1	53.3	55.0	54.9	65.3	56.7	53.1	68.9	69.4	58.9	4.6	56.2	61.8	32.5	75.5	61.7	22.3	22.6	24.1	29.0	22.0	22.8	22.6	22.6	22.9	22.3	23.4	24.0	37.3	51.3	35.0	11.4	42.2	47.3	38.6	46.6	55.2	37.0	21.3	27.7	22.7	20.0	42.3	22.0	22.9	59.1	40.7	12.1	39.2	44.4	37.9	23.7	42.4	35.8	15.6	53.6	15.7	38.1	69.2	41.6	15.3	25.3	42.4	43.0	25.0	23.6	51.5	26.9	14.9	23.9	34.6	28.0	39.8	14.0	39.7	34.2	39.2	6.5	82.9	45.6	44.3	11.1	11.5	35.4	13.1	54.2	41.5	28.5	19.0	29.2	27.8	38.6	39.5	47.2	68.3	120.8	55.2	36.5	41.8	33.0	42.9	53.5	31.4	24.0
SF3B3	"KIAA0017, RSE1, SAP130, SF3b130"	ENSG00000189091	"Splicing factor 3b subunit 3"	Q15393	16	70523791-70577670	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041134, HPA042986"	Supported		Supported	"Nucleoplasm,Nucleoli,Nucleoli rim"		No	No		50000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	"Nucleoplasm, Nucleoli, Nucleoli rim"		"HPA041134: AB_2677317, HPA042986: AB_10960386"	"unprognostic (3.39e-2)"	"unprognostic (1.53e-1)"	"unprognostic (7.47e-2)"	"unprognostic (1.87e-1)"	"unprognostic (2.05e-2)"	"unprognostic (3.59e-2)"	"unprognostic (1.06e-2)"	"unprognostic (7.67e-2)"	"unprognostic (2.07e-1)"	"unprognostic (2.29e-1)"	"unprognostic (6.97e-2)"	"unprognostic (2.29e-1)"	"unprognostic (3.28e-2)"	"unprognostic (1.60e-1)"	"unprognostic (8.76e-2)"	"unprognostic (7.91e-2)"	"unprognostic (1.73e-1)"	15.7	11.2	7.9	19.2	8.2	22.2	13.8	15.9	9.6	16.3	11.4	17.1	13.6	17.0	10.2	19.9	16.4	11.6	12.1	8.8	9.7	12.5	12.3	11.7	24.3	7.0	6.9	22.3	13.8	16.8	7.9	14.1	7.5	11.6	13.2	16.3	12.6	10.7	23.6	19.9	12.9	16.0	6.5	13.9	13.2	10.2	10.4	23.7	14.5	11.7	26.6	14.2	14.4	12.0	72.4	72.6	93.4	65.3	45.5	41.6	74.0	66.3	55.5	84.5	67.3	75.6	55.8	97.1	52.6	51.8	49.9	81.4	98.0	55.7	133.0	31.5	71.1	75.1	56.7	81.0	30.6	106.1	83.9	39.8	40.1	93.9	68.8	54.1	50.9	55.3	104.6	34.2	67.4	87.5	92.9	51.6	85.2	44.8	41.9	163.2	73.3	109.7	26.9	96.4	81.4	59.8	217.7	33.8	33.8	39.2	73.9	53.0	52.7	61.9	67.8	49.2	71.6	37.4	90.4	260.7	40.9	66.9	61.3	23.4	26.1	28.1	35.8	30.8	39.3	28.4	33.1	37.5	35.3	34.3	38.8	33.7	8.3	35.5	31.2	19.1	40.2	37.4	7.9	8.2	15.9	9.6	8.8	9.7	7.0	6.9	7.5	6.5	10.4	12.0	18.9	25.6	25.7	16.6	33.0	22.4	23.2	23.4	13.1	35.5	20.5	18.3	29.3	14.3	25.4	23.9	14.6	33.6	21.6	19.7	7.9	20.7	6.3	17.8	31.9	25.4	21.1	36.8	23.2	23.2	34.7	24.2	20.4	17.5	17.7	52.3	17.5	23.6	23.6	40.4	26.5	21.8	24.4	20.6	12.8	10.3	33.8	19.2	17.8	24.4	22.7	19.4	25.7	26.2	26.7	24.9	14.0	33.1	25.1	30.2	18.1	15.7	18.8	26.7	6.6	30.2	18.8	28.7	33.3	37.6	26.1	25.4	28.3	48.2	31.6	24.7
SF3B6	"CGI-110, Ht006, P14, SAP14a, SF3B14a"	ENSG00000115128	"Splicing factor 3b subunit 6"	Q9Y3B4	2	24067586-24076373	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034829, HPA034830"	Enhanced		Supported	Nucleoplasm		NA	NA		11000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 22: Epithelial cell types - Mixed function"	Nucleoplasm		"HPA034829: AB_10673104, HPA034830: AB_10669680"	"unprognostic (6.37e-2)"	"unprognostic (1.38e-1)"	"unprognostic (3.59e-1)"	"unprognostic (1.08e-2)"	"unprognostic (1.03e-1)"	"unprognostic (5.35e-3)"	"prognostic unfavorable (5.57e-5)"	"unprognostic (1.74e-2)"	"unprognostic (8.75e-2)"	"unprognostic (7.41e-2)"	"prognostic unfavorable (8.92e-4)"	"unprognostic (2.80e-2)"	"prognostic unfavorable (1.74e-4)"	"unprognostic (1.28e-1)"	"unprognostic (1.42e-2)"	"unprognostic (5.44e-2)"	"unprognostic (2.91e-1)"	79.0	86.5	82.4	65.1	84.1	211.2	137.9	86.4	125.3	99.1	82.5	106.2	91.1	84.7	141.9	123.5	89.2	78.2	89.3	82.7	85.7	111.5	132.6	67.3	102.8	85.9	84.2	93.7	63.7	103.0	62.9	88.3	86.3	81.2	108.7	64.4	71.6	84.2	74.7	76.4	84.7	89.0	88.6	65.1	70.4	66.6	82.0	138.6	104.9	106.2	123.3	117.2	85.2	92.4	307.2	152.4	231.6	207.9	182.7	292.8	139.3	233.6	253.8	279.1	284.2	329.9	197.0	236.6	117.3	213.1	265.4	187.7	245.2	293.7	345.5	218.0	263.4	256.6	197.2	299.4	324.4	314.3	151.3	268.5	342.5	281.3	319.3	286.4	288.8	199.4	290.2	181.3	294.2	250.3	234.1	486.1	194.7	362.8	264.0	170.6	327.7	239.1	334.6	189.0	214.4	320.7	123.6	268.3	570.9	195.4	122.7	309.4	173.9	159.6	213.6	157.3	384.4	171.2	239.1	655.3	215.4	515.8	224.5	225.0	118.9	185.7	96.0	133.5	108.1	153.9	122.9	117.8	138.9	114.7	118.0	130.0	173.5	133.7	124.3	129.6	179.6	143.8	82.4	84.1	86.4	125.3	82.7	85.7	85.9	84.2	86.3	88.6	82.0	92.4	207.4	70.5	91.5	11.8	125.1	0.0	280.4	0.0	208.3	50.7	194.3	320.5	120.8	133.0	55.1	138.0	16.7	296.5	149.2	217.1	389.4	206.1	195.9	226.4	208.1	149.0	180.3	164.7	9.2	167.4	413.2	153.0	85.6	210.7	100.1	185.1	142.1	167.1	232.7	18.5	10.2	253.5	0.0	129.3	0.0	49.4	210.3	132.6	0.0	10.3	227.4	175.4	149.3	11.6	19.4	205.4	314.5	180.5	134.0	327.5	381.2	423.1	78.0	68.4	118.3	155.0	158.9	272.4	173.7	257.8	0.0	271.7	126.6	344.4	242.7	438.1
SFMBT2	KIAA1617	ENSG00000198879	"Scm like with four mbt domains 2"	Q5VUG0	10	7158624-7411486	"Predicted intracellular proteins"		Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 27.7"	"Cell type enriched"	"Detected in many"	4	"Microglial cells: 618.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"non-classical monocyte: 4.6"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 23.0;REH: 21.0;RPMI-8226: 20.2;SH-SY5Y: 16.6;THP-1: 25.0;U-937: 16.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA035447, HPA035448, HPA070388"	Uncertain		Supported	"Nucleoplasm,Nuclear speckles"		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 77: Retina - Visual perception"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 64: Astrocytes - Nervous system maintenance"	"Nucleoplasm, Nuclear speckles"		"HPA035447: AB_2674628, HPA035448: AB_10669904, HPA070388: "	"unprognostic (4.36e-2)"	"unprognostic (2.29e-2)"	"unprognostic (4.36e-2)"	"unprognostic (1.42e-3)"	"unprognostic (3.23e-2)"	"unprognostic (2.05e-3)"	"unprognostic (4.65e-1)"	"unprognostic (4.56e-1)"	"unprognostic (1.03e-1)"	"unprognostic (6.51e-2)"	"unprognostic (5.57e-2)"	"unprognostic (1.38e-1)"	"unprognostic (2.41e-2)"	"unprognostic (1.26e-1)"	"unprognostic (9.17e-3)"	"unprognostic (5.37e-3)"	"unprognostic (7.29e-2)"	3.8	4.1	13.0	5.9	13.1	6.6	5.5	10.2	9.8	3.4	5.1	2.8	2.0	4.0	3.7	1.1	4.0	3.5	4.0	7.5	17.6	3.0	1.3	4.7	7.3	20.4	15.0	9.1	1.3	5.7	6.4	3.4	17.1	6.6	3.2	18.0	2.3	3.1	4.2	1.7	4.0	3.3	12.7	9.0	3.1	1.8	27.7	4.5	6.8	2.6	5.8	4.1	4.2	19.0	0.0	4.0	0.3	0.0	0.0	0.0	4.9	0.1	0.0	0.0	0.0	0.0	1.1	7.6	0.0	0.0	0.0	1.9	7.6	0.0	0.0	0.4	7.9	0.0	13.0	0.0	0.7	8.0	1.1	1.1	0.4	0.0	0.3	0.0	0.1	10.0	11.5	23.0	0.0	3.5	7.0	14.3	1.6	0.0	0.0	21.0	2.2	20.2	0.0	0.8	2.0	16.6	0.0	0.1	0.0	2.1	1.3	25.0	0.0	0.0	2.6	0.4	0.2	10.1	13.3	0.0	1.1	16.5	0.3	0.1	0.2	1.1	0.7	2.3	0.4	0.0	0.2	0.5	0.4	0.0	1.0	0.6	0.1	0.9	4.6	3.1	0.0	0.2	13.0	13.1	10.2	9.8	7.5	17.6	20.4	15.0	17.1	12.7	27.7	19.0	8.2	0.0	5.2	148.2	10.2	1.5	1.5	0.0	1.2	8.1	9.3	8.6	9.7	1.5	0.6	0.0	81.3	7.7	22.1	0.1	0.0	0.4	0.2	0.8	15.8	10.1	4.2	6.1	77.3	0.2	2.5	4.2	2.0	3.5	4.5	7.1	5.7	1.1	15.5	0.0	103.9	0.0	0.0	15.7	9.9	0.8	5.0	26.3	5.4	618.3	11.4	12.4	15.5	26.2	113.7	0.1	0.0	2.2	25.8	11.4	0.0	0.3	0.7	34.1	0.0	4.4	2.6	0.3	3.9	0.2	1.3	4.4	25.8	2.5	0.2	0.6
SFN	YWHAS	ENSG00000175793	Stratifin	P31947	1	26863149-26864456	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"esophagus: 2461.5;skin 1: 1219.1;vagina: 692.0"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 7750.0;Basal prostatic cells: 2119.7;Squamous epithelial cells: 3587.1;Suprabasal keratinocytes: 10714.0;Urothelial cells: 2780.0"	"Cancer enhanced"	"Detected in all"		"cervical cancer: 1510.8;head and neck cancer: 2526.8"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	17	"basophil: 5.9"	"Lineage enriched"	"Detected in single"	17	"granulocytes: 5.9"	"Cell line enhanced"	"Detected in many"		"A-431: 770.8;HaCaT: 1181.6;HBEC3-KT: 1819.0;hTCEpi: 1196.7"	"Low region specificity"	"Detected in many"							"CAB006268, HPA011105, CAB040552"	Enhanced		Supported	Cytosol	"Secreted in other tissues"	NA	Yes		29000000	"Cluster 34: Basophils - Unknown function"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 28: Keratinocytes - Keratinization"	Cytosol		"CAB006268: AB_425459, CAB040552: , HPA011105: AB_1844339"	"unprognostic (5.70e-2)"	"unprognostic (1.26e-1)"	"unprognostic (8.37e-2)"	"prognostic favorable (1.92e-4)"	"unprognostic (1.26e-2)"	"unprognostic (1.85e-1)"	"prognostic unfavorable (5.68e-5)"	"unprognostic (1.71e-2)"	"unprognostic (2.99e-1)"	"unprognostic (3.96e-1)"	"prognostic unfavorable (6.01e-4)"	"unprognostic (3.83e-1)"	"prognostic unfavorable (7.45e-6)"	"unprognostic (7.90e-3)"	"unprognostic (3.25e-1)"	"unprognostic (8.12e-2)"	"unprognostic (2.06e-2)"	3.1	0.8	1.9	11.6	1.8	2.0	29.1	1.8	9.5	350.2	0.4	95.4	48.8	8.0	0.7	2461.5	2.2	21.4	1.3	1.9	1.6	16.0	3.7	56.1	0.2	9.0	4.4	0.9	2.2	0.1	2.7	1.6	4.3	77.2	32.5	0.6	332.8	3.2	5.0	1219.1	40.8	3.3	1.2	0.9	66.6	0.7	5.2	22.1	2.0	0.1	147.9	167.6	692.0	2.3	770.8	126.9	0.1	1.1	0.3	0.1	37.2	0.5	0.0	0.1	0.3	46.6	393.6	6.7	32.2	0.2	0.6	1181.6	0.3	1819.0	0.0	183.4	5.4	0.9	119.6	138.4	0.1	0.4	1.4	0.4	1196.7	0.6	310.1	0.2	0.2	0.7	1.8	4.5	0.1	163.8	0.7	0.3	2.3	132.6	208.7	0.5	0.4	43.1	281.3	173.9	0.7	0.7	181.2	31.9	1.8	2.9	83.6	1.5	0.5	0.5	337.2	0.3	4.9	1.0	5.8	3.8	1.5	0.7	0.7	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	1.9	1.8	1.8	9.5	1.9	1.6	9.0	4.4	4.3	1.2	5.2	2.3	1.6	179.5	162.2	0.0	5.0	7750.0	2119.7	1374.7	1714.2	0.0	72.6	119.9	0.8	24.3	285.6	16.5	0.0	18.6	0.7	972.0	3.9	48.8	0.0	138.0	20.1	45.3	67.4	0.0	0.0	76.2	59.9	46.2	221.2	251.8	32.3	0.0	0.4	4.5	1.9	0.0	0.1	140.7	114.0	0.6	479.7	0.0	0.0	9.7	533.6	0.0	1.0	0.0	0.0	0.0	0.1	524.8	933.0	0.0	21.2	1030.2	318.5	0.6	158.2	0.0	0.0	0.7	55.2	0.0	0.6	3587.1	10714.0	6.0	23.4	0.1	292.4	2780.0
SFXN4	SLC56A4	ENSG00000183605	"Sideroflexin 4"	Q6P4A7	10	119140767-119165714	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Amino-acid transport, Transport"		"Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018028, HPA020872"	Approved		Approved	Nucleoplasm,Vesicles,Mitochondria		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoplasm, Mitochondria"	Vesicles	"HPA018028: AB_1856792, HPA020872: AB_1856793"	"unprognostic (8.13e-2)"	"unprognostic (6.11e-2)"	"unprognostic (3.61e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.27e-2)"	"unprognostic (9.49e-2)"	"unprognostic (1.59e-2)"	"unprognostic (1.72e-1)"	"unprognostic (6.84e-2)"	"unprognostic (4.56e-2)"	"unprognostic (8.58e-2)"	"unprognostic (2.94e-2)"	"unprognostic (1.70e-3)"	"unprognostic (4.22e-3)"	"unprognostic (1.43e-1)"	"unprognostic (6.21e-3)"	"unprognostic (3.07e-3)"	13.3	35.9	9.9	10.1	12.5	16.4	14.1	12.8	13.6	14.2	17.0	21.9	20.4	11.1	13.5	19.1	14.3	8.6	33.1	10.2	12.4	24.5	36.4	8.5	14.4	11.3	12.5	16.0	33.7	23.1	21.5	8.8	11.6	18.8	22.7	5.7	27.8	13.2	51.4	11.5	17.3	12.2	10.6	20.9	17.3	11.9	11.3	11.0	24.7	59.3	17.8	16.4	13.8	12.5	26.2	27.6	8.7	41.8	10.4	19.7	33.0	16.3	19.8	21.0	21.8	45.9	43.2	62.6	15.6	14.9	22.4	48.2	57.5	36.3	24.3	33.1	65.7	28.7	18.4	47.3	37.1	49.7	28.8	21.1	34.4	22.0	63.8	19.5	25.0	46.5	45.2	17.5	13.6	29.6	53.8	60.4	11.8	50.2	32.5	51.7	27.1	49.0	24.3	17.3	25.2	13.9	10.8	42.2	61.9	11.1	26.0	28.4	11.5	10.6	21.9	19.8	37.6	42.6	53.0	56.3	16.2	72.6	7.2	2.5	18.1	1.9	6.5	19.5	10.8	12.5	7.9	7.1	21.2	7.0	12.1	9.8	2.2	7.3	15.9	10.6	6.0	11.1	9.9	12.5	12.8	13.6	10.2	12.4	11.3	12.5	11.6	10.6	11.3	12.5	8.0	6.4	5.6	29.0	16.9	12.0	25.8	39.9	23.3	7.9	17.8	18.2	36.2	12.8	19.1	14.7	2.1	37.6	6.2	13.2	58.7	28.4	27.4	7.6	8.9	8.4	18.0	33.6	22.3	23.8	25.8	12.4	14.3	7.9	5.7	28.5	7.1	31.5	29.2	6.7	29.1	24.7	30.5	17.6	5.0	69.3	8.7	13.1	12.4	8.4	11.3	7.7	10.3	22.1	19.5	17.6	12.1	13.5	31.9	28.0	29.8	65.6	13.5	11.3	6.6	22.3	10.6	27.7	15.2	26.9	9.1	21.9	9.2	44.5	45.8	20.5
SGK2		ENSG00000101049	"Serum/glucocorticoid regulated kinase 2"	Q9HBY8	20	43558968-43588237	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 40.5;kidney: 53.6;liver: 63.2"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 76.5;Distal tubular cells: 76.3;Hepatocytes: 32.8;Paneth cells: 21.7;Proximal enterocytes: 23.8;Proximal tubular cells: 25.5"	"Cancer enhanced"	"Detected in many"		"liver cancer: 8.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 20.5;CAPAN-2: 14.2;Hep G2: 18.7;OE19: 61.7;RPTEC TERT1: 25.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA008859, HPA011387"	Uncertain		Supported	Nucleoplasm		NA	NA				"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 21: OE19 - Mitochondria"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm		"HPA008859: AB_2668159, HPA011387: AB_1856744"	"unprognostic (1.82e-1)"	"unprognostic (1.84e-1)"	"unprognostic (4.53e-2)"	"unprognostic (2.86e-1)"	"unprognostic (6.27e-2)"	"unprognostic (2.98e-4)"	"unprognostic (2.05e-2)"	"unprognostic (1.35e-1)"	"unprognostic (4.30e-2)"	"unprognostic (2.60e-1)"	"unprognostic (1.05e-1)"	"unprognostic (5.72e-4)"	"unprognostic (4.15e-2)"	"unprognostic (1.38e-1)"	"unprognostic (2.56e-1)"	"unprognostic (3.11e-2)"	"prognostic favorable (5.65e-4)"	23.5	1.4	4.9	1.5	14.8	0.5	6.1	12.6	10.5	3.5	0.7	37.7	31.6	1.8	33.8	1.0	3.7	10.0	1.2	6.0	7.7	53.6	63.2	1.0	0.2	18.1	13.3	6.6	16.2	0.5	3.0	0.8	14.3	2.6	40.5	5.6	1.8	2.9	0.4	6.2	20.1	1.6	11.8	1.1	22.8	1.8	13.3	0.3	1.7	0.4	0.3	4.2	3.0	24.5	0.0	20.5	0.3	0.1	0.3	0.0	0.1	0.2	0.0	0.2	0.0	0.6	14.2	0.1	8.7	0.1	0.1	0.2	0.0	0.0	0.2	0.0	0.3	0.4	0.0	18.7	0.4	0.0	0.1	0.0	0.5	0.0	0.0	0.7	0.0	0.4	0.2	0.1	0.0	0.1	0.1	0.5	0.1	61.7	0.0	0.1	0.1	0.0	25.4	4.2	0.2	1.0	0.0	1.2	0.1	0.4	0.0	0.1	0.9	0.0	0.1	0.0	0.0	0.9	0.0	0.0	0.2	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.9	14.8	12.6	10.5	6.0	7.7	18.1	13.3	14.3	11.8	13.3	24.5	0.3	0.0	0.0	4.9	0.2	0.1	0.1	0.2	0.0	0.8	0.3	0.8	4.9	8.6	0.0	11.0	0.0	5.1	0.0	76.5	76.3	6.8	0.3	0.9	0.5	0.6	1.8	0.0	0.7	6.3	1.3	0.4	11.2	2.4	0.0	0.7	0.7	32.8	0.7	6.7	1.3	4.1	0.0	1.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.2	0.0	3.5	20.7	2.5	21.7	0.4	0.0	0.1	23.8	25.5	0.2	0.8	0.0	0.2	0.4	0.1	0.1	0.0	0.1	17.1	0.2	0.0	7.7	0.3
SGK3	"SGK2, SGKL"	ENSG00000104205	"Serum/glucocorticoid regulated kinase family member 3"	Q96BR1	8	66712734-66862022	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 49.0"	"Cell type enhanced"	"Detected in many"		"Breast glandular cells: 56.0;monocytes: 53.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"T-47d: 28.4"									"HPA006699, HPA027146"	Supported		Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 6: T47d - Mammary gland"	"Cluster 35: Glandular cells - Unknown function"	Vesicles	Nucleoplasm	"HPA006699: , HPA027146: AB_1856745"	"prognostic favorable (5.52e-6)"	"prognostic favorable (8.28e-4)"	"unprognostic (8.52e-3)"	"unprognostic (1.10e-2)"	"unprognostic (3.75e-1)"	"unprognostic (1.37e-2)"	"unprognostic (2.32e-1)"	"unprognostic (1.69e-3)"	"unprognostic (9.51e-2)"	"unprognostic (8.86e-3)"	"prognostic favorable (9.65e-4)"	"unprognostic (1.94e-2)"	"unprognostic (8.95e-2)"	"unprognostic (4.55e-3)"	"unprognostic (1.77e-1)"	"unprognostic (1.01e-1)"	"unprognostic (5.29e-3)"	5.2	5.3	13.4	9.8	25.7	8.5	24.1	21.3	16.9	10.5	36.0	10.3	8.9	8.0	8.6	7.6	6.9	7.5	5.4	14.6	17.3	14.7	13.6	10.0	7.8	29.4	21.6	9.1	15.6	28.3	6.2	5.7	28.3	7.4	10.3	2.4	7.0	7.1	2.9	13.3	11.3	5.3	19.3	8.9	7.5	9.4	20.9	5.8	17.5	3.5	6.9	5.0	5.7	49.0	14.2	3.7	0.6	2.4	3.9	6.5	7.7	8.1	7.4	4.2	5.1	6.1	8.6	10.2	2.2	7.7	13.6	4.9	7.3	5.5	5.4	5.3	11.7	9.7	2.6	6.7	4.1	8.9	10.5	2.9	3.7	1.7	7.9	4.3	7.4	7.4	1.5	4.6	10.0	2.4	6.2	5.8	1.9	8.5	5.0	11.7	5.3	7.6	6.4	3.3	2.9	2.2	3.4	6.5	14.4	6.0	28.4	16.9	9.0	4.4	3.9	3.9	3.4	6.1	12.8	12.7	4.5	14.2	4.9	21.1	15.0	5.1	8.7	9.9	13.8	4.7	8.8	8.0	13.8	6.4	8.7	7.1	2.0	7.2	5.1	8.9	5.7	9.0	13.4	25.7	21.3	16.9	14.6	17.3	29.4	21.6	28.3	19.3	20.9	49.0	20.7	6.4	28.1	0.0	12.5	13.3	8.1	3.3	8.6	1.7	56.0	30.5	7.6	7.2	8.5	11.0	18.8	9.2	24.9	13.3	15.6	7.0	0.9	16.7	6.6	15.3	16.2	10.3	0.0	18.2	1.4	8.9	6.6	12.3	15.2	11.0	17.5	20.7	22.9	0.0	0.0	9.3	8.2	41.9	14.3	2.2	4.1	42.6	8.8	0.0	53.4	3.8	19.6	0.0	0.0	14.8	8.4	7.9	18.3	9.3	14.0	36.8	15.4	1.7	0.0	5.9	4.2	5.9	13.7	9.9	15.8	4.8	19.4	5.2	10.4	5.3
SGO1	"NY-BR-85, SGOL1"	ENSG00000129810	"Shugoshin 1"	Q5FBB7	3	20160593-20186206	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cell cycle, Cell division, Chromosome partition, Mitosis"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 8.7;lymphoid tissue: 13.0;testis: 6.7"	"Cell type enhanced"	"Detected in some"		"Cytotrophoblasts: 16.5;Extravillous trophoblasts: 42.6;Granulosa cells: 20.3;Hofbauer cells: 10.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in many"	5	"basophil: 10.0;memory B-cell: 8.8;naive B-cell: 8.9;plasmacytoid DC: 4.1;T-reg: 2.6"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA035501, HPA069302, HPA069857"	Enhanced		Enhanced	Nucleoplasm,Kinetochore,Cytosol		Yes	Yes			"Cluster 37: B-cells - Transcription"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	"Kinetochore, Cytosol"	"HPA035501: AB_2732469, HPA069302: , HPA069857: AB_2686214"	"unprognostic (6.87e-3)"	"unprognostic (5.01e-2)"	"unprognostic (2.25e-2)"	"unprognostic (8.93e-3)"	"unprognostic (2.51e-2)"	"unprognostic (4.10e-2)"	"unprognostic (2.55e-6)"	"unprognostic (9.49e-3)"	"unprognostic (2.45e-2)"	"unprognostic (3.69e-2)"	"unprognostic (1.65e-4)"	"unprognostic (1.52e-2)"	"unprognostic (0.00e+0)"	"unprognostic (2.29e-2)"	"unprognostic (4.95e-2)"	"unprognostic (4.14e-1)"	"unprognostic (1.64e-1)"	0.3	0.1	0.3	3.3	0.7	8.7	0.5	0.9	0.5	0.4	0.0	2.1	2.3	0.4	0.0	1.9	0.1	0.4	0.1	0.3	0.4	0.3	0.6	0.3	6.2	0.8	0.6	0.2	0.1	0.2	0.0	1.7	0.6	0.2	2.8	0.1	0.4	0.1	0.1	1.1	2.5	1.0	0.3	1.4	1.5	6.7	0.6	13.0	0.2	0.0	6.6	0.9	0.7	1.2	20.3	23.9	29.9	18.5	1.4	2.6	20.2	21.3	10.1	31.2	33.6	16.5	24.0	30.7	10.6	8.6	21.2	11.4	28.7	11.3	37.6	40.9	19.6	34.6	15.6	12.8	0.2	32.0	28.8	0.3	0.9	33.3	13.1	4.0	18.5	34.9	31.3	52.2	24.6	19.4	52.4	15.4	30.0	20.3	17.0	31.8	38.4	17.7	7.5	14.9	14.2	15.4	23.6	27.2	13.1	22.7	18.2	21.3	4.7	22.5	27.3	20.5	43.3	22.8	57.4	35.2	12.5	31.1	35.0	10.0	0.1	1.4	0.2	0.2	0.1	8.8	0.6	0.7	0.3	8.9	0.2	0.3	1.4	0.3	0.2	4.1	2.6	0.6	0.3	0.7	0.9	0.5	0.3	0.4	0.8	0.6	0.6	0.3	0.6	1.2	0.1	0.0	0.5	0.0	1.9	0.0	0.0	0.0	0.0	0.0	2.0	3.4	0.0	0.0	0.0	1.8	0.0	16.5	1.5	0.0	0.0	1.1	0.0	2.3	1.6	1.2	0.0	0.0	0.0	1.8	42.6	3.3	0.0	2.9	1.3	20.3	0.0	0.0	10.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	2.6	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.3	0.0	0.0	1.1	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	4.9	1.0	4.3	0.0	0.0
SGPL1	SPL	ENSG00000166224	"Sphingosine-1-phosphate lyase 1"	O95470	10	70815948-70881184	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Apoptosis, Lipid metabolism, Sphingolipid metabolism"	Lyase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RT4: 112.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021125, HPA023086"	Enhanced		Supported	"Endoplasmic reticulum"		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 37: Intestine - Unknown function"	"Cluster 15: RT4 - Unknown function"	"Cluster 44: Endometrium - Transcription"	"Endoplasmic reticulum"		"HPA021125: AB_1856803, HPA023086: AB_1856804"	"unprognostic (1.14e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.15e-1)"	"unprognostic (3.07e-2)"	"unprognostic (2.13e-1)"	"unprognostic (2.34e-1)"	"unprognostic (7.60e-2)"	"unprognostic (2.98e-2)"	"unprognostic (2.88e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.70e-2)"	"unprognostic (2.12e-1)"	"unprognostic (9.52e-2)"	"unprognostic (3.42e-1)"	"unprognostic (2.14e-1)"	"unprognostic (9.21e-2)"	"unprognostic (4.68e-3)"	12.0	12.7	15.8	18.0	17.4	6.8	13.0	15.2	16.3	17.6	11.0	16.7	16.0	14.4	18.8	27.9	15.3	12.6	6.4	14.7	16.4	15.5	22.9	10.7	18.1	18.6	16.7	9.0	18.5	21.0	9.4	10.0	17.4	17.5	17.9	10.8	14.3	12.4	9.6	30.4	22.8	13.9	17.4	16.1	12.3	14.0	17.7	17.9	20.1	6.0	20.1	25.0	14.7	19.8	26.9	35.2	33.2	38.1	8.9	11.5	22.1	15.5	16.4	16.5	21.4	38.4	57.8	24.2	18.0	15.8	15.9	44.1	28.8	31.0	23.5	39.1	15.6	2.5	17.5	46.2	33.6	10.6	20.9	21.8	51.4	22.1	57.6	34.6	10.4	22.3	7.2	20.4	23.6	29.6	13.2	7.1	15.0	35.4	19.5	16.6	25.2	9.1	26.3	112.1	22.6	27.5	30.9	46.6	28.5	25.9	24.3	7.5	20.3	14.8	38.7	11.6	30.1	8.4	12.6	11.0	14.7	19.3	10.7	1.1	18.2	14.0	18.0	34.6	16.5	7.2	11.5	14.7	16.2	8.7	8.5	13.5	15.0	18.8	44.9	8.9	11.8	12.4	15.8	17.4	15.2	16.3	14.7	16.4	18.6	16.7	17.4	17.4	17.7	19.8	3.8	16.0	6.4	32.3	11.0	12.2	17.8	21.4	8.0	6.3	15.8	9.8	6.3	27.1	23.2	46.0	20.9	7.3	16.0	41.5	3.9	36.2	2.9	30.2	13.3	7.3	25.1	4.4	48.7	37.6	13.8	10.1	6.6	46.1	14.7	23.1	7.1	44.5	27.6	15.2	38.8	21.2	22.4	43.1	16.1	5.2	11.5	25.7	7.2	35.6	22.7	9.8	25.7	41.7	43.8	55.6	18.8	20.3	5.9	26.0	53.5	12.0	26.6	9.7	6.6	13.3	19.0	20.0	34.0	15.9	22.7	6.3	11.1	18.2	20.9	25.3
SGPP1		ENSG00000126821	"Sphingosine-1-phosphate phosphatase 1"	Q9BX95	14	63684216-63728065	"Metabolic proteins, Predicted membrane proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Kupffer cells: 61.8;Oligodendrocytes: 60.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 6.9"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Daudi: 43.8;U-698: 57.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA053149, HPA064908"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 64: Macrophages - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 57: B-cells - Immune response"	Nucleoplasm		"HPA053149: AB_2682057, HPA064908: AB_2797270"	"unprognostic (1.57e-2)"	"unprognostic (1.04e-2)"	"unprognostic (5.40e-3)"	"unprognostic (7.82e-2)"	"unprognostic (9.09e-2)"	"unprognostic (4.30e-2)"	"unprognostic (6.49e-3)"	"unprognostic (1.35e-2)"	"unprognostic (1.64e-1)"	"unprognostic (7.41e-2)"	"unprognostic (1.51e-1)"	"unprognostic (3.27e-1)"	"unprognostic (8.59e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.31e-3)"	7.9	10.6	5.3	6.0	6.0	3.0	6.4	5.8	7.9	6.4	3.6	7.0	3.8	7.4	6.2	4.9	5.7	5.5	4.9	5.3	5.9	15.9	19.5	6.9	13.3	6.6	6.2	5.8	12.7	10.2	5.6	12.0	6.6	7.4	5.3	4.1	4.8	4.0	4.2	3.8	8.8	4.8	7.3	9.3	5.5	5.4	5.8	5.8	5.8	2.6	12.9	5.8	6.8	8.0	19.7	6.2	3.0	8.6	10.7	9.9	35.9	15.7	10.9	9.6	10.7	2.7	10.9	43.8	4.5	8.0	8.0	20.3	4.8	9.3	15.3	17.3	5.7	4.0	3.4	4.4	13.1	7.3	12.2	7.3	14.7	8.4	13.2	9.7	4.6	8.2	2.3	1.2	14.1	7.3	8.6	0.1	2.1	3.2	13.1	2.1	8.4	3.5	15.2	9.7	1.8	5.0	11.0	10.2	8.4	9.2	13.3	2.6	5.2	13.2	9.1	9.5	7.9	10.1	6.5	57.4	9.7	0.0	5.8	6.9	0.2	1.7	0.5	1.4	0.5	1.8	0.5	0.3	0.3	0.4	0.8	0.6	0.2	0.3	2.1	0.1	1.3	0.3	5.3	6.0	5.8	7.9	5.3	5.9	6.6	6.2	6.6	7.3	5.8	8.0	5.3	12.8	16.2	22.2	22.6	9.7	6.1	4.1	8.0	4.0	9.4	5.2	3.8	24.3	3.2	51.5	0.0	23.4	10.9	11.9	0.0	6.0	2.4	6.3	12.1	6.5	18.6	9.7	32.6	9.1	27.0	12.8	3.1	10.1	11.4	5.0	6.1	43.6	23.7	10.1	38.5	10.2	2.0	61.8	20.1	1.2	6.2	18.6	17.8	21.5	6.8	8.2	2.1	31.7	60.0	13.2	13.5	17.0	5.7	8.1	3.2	22.7	2.6	5.4	6.6	8.1	11.3	7.4	3.5	4.6	13.5	33.0	10.4	10.3	10.3	5.6
SGSM3	"DJ1042K10.2, RabGAP-5, RABGAP5, RUSC3, RUTBC3"	ENSG00000100359	"Small G protein signaling modulator 3"	Q96HU1	22	40370591-40410289	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Cell cycle, Growth arrest"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Gastric mucus-secreting cells: 176.4;Intestinal goblet cells: 135.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048980	Approved		Supported	"Golgi apparatus"		NA	NA			"Cluster 22: NK-cells - Unknown function"	"Cluster 25: Pancreas - Digestion"	"Cluster 21: OE19 - Mitochondria"	"Cluster 27: Mucus-secreting cells - Mucin production"	"Golgi apparatus"		"HPA048980: AB_2680585"	"unprognostic (4.63e-2)"	"unprognostic (7.51e-3)"	"unprognostic (3.02e-2)"	"prognostic favorable (4.47e-5)"	"unprognostic (1.81e-1)"	"unprognostic (6.83e-3)"	"unprognostic (5.70e-3)"	"unprognostic (7.53e-2)"	"unprognostic (3.57e-1)"	"unprognostic (5.67e-2)"	"unprognostic (1.71e-3)"	"unprognostic (1.93e-1)"	"unprognostic (2.97e-1)"	"unprognostic (4.08e-3)"	"unprognostic (2.10e-1)"	"unprognostic (1.63e-1)"	"unprognostic (5.98e-3)"	24.8	42.6	34.6	26.1	34.8	19.3	29.4	27.3	43.6	37.3	32.6	46.6	32.8	31.9	14.5	49.2	37.1	28.7	37.0	33.2	33.3	36.4	37.3	33.8	32.9	36.5	34.3	30.8	107.7	24.7	55.0	21.9	34.8	62.6	24.3	11.0	70.1	25.9	34.2	36.7	46.1	17.4	27.6	51.5	91.4	39.8	33.6	27.5	48.7	23.4	28.3	33.1	35.6	31.9	37.8	21.1	30.6	34.1	33.2	18.1	43.4	35.0	22.9	26.0	33.7	12.0	30.9	23.3	23.7	37.9	15.6	30.0	29.2	42.9	10.4	58.4	68.8	15.9	56.9	11.3	31.6	23.1	33.1	30.2	29.5	29.1	17.4	29.2	46.0	48.6	19.8	31.4	19.4	60.5	32.1	23.5	20.5	75.8	14.0	59.3	19.3	51.1	26.8	33.0	18.8	24.2	38.6	55.4	27.5	24.2	46.3	38.9	40.2	8.8	31.8	23.4	20.6	47.1	23.2	31.0	37.4	19.0	22.9	1.1	14.6	16.3	18.7	15.7	15.6	17.7	11.5	14.9	18.9	22.3	13.8	11.3	3.3	35.4	11.9	31.6	11.7	15.8	34.6	34.8	27.3	43.6	33.2	33.3	36.5	34.3	34.8	27.6	33.6	31.9	5.3	3.2	10.3	14.0	32.8	11.5	32.4	33.1	14.8	57.0	12.1	7.1	8.3	27.1	42.1	7.3	18.8	42.8	23.9	46.4	1.9	20.2	17.5	5.1	3.8	14.3	31.3	18.1	27.1	45.3	54.3	14.0	176.4	6.7	15.9	3.1	21.8	24.0	24.2	26.9	34.6	135.3	50.8	17.2	8.3	31.7	22.7	11.8	16.0	13.1	21.6	13.4	30.9	15.6	15.1	21.3	40.6	19.2	30.5	46.1	36.2	4.4	60.2	34.0	39.5	14.4	13.8	83.5	44.4	19.8	10.4	45.6	16.7	3.3	47.7	60.0
SH2D3C	NSP3	ENSG00000095370	"SH2 domain containing 3C"	Q8N5H7	9	127738317-127778710	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 52.6;dendritic cells: 29.7;Endothelial cells: 52.2;Hepatic stellate cells: 41.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HMC-1: 53.3;HUVEC TERT2: 60.0;REH: 60.7;RPMI-8226: 46.1;TIME: 50.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047586	Enhanced		Supported	Cytosol		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Cytosol		"HPA047586: AB_2680093"	"unprognostic (8.33e-2)"	"unprognostic (4.77e-3)"	"unprognostic (3.28e-2)"	"prognostic favorable (9.47e-4)"	"unprognostic (5.23e-2)"	"prognostic favorable (1.98e-4)"	"unprognostic (3.75e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.58e-3)"	"unprognostic (1.61e-1)"	"unprognostic (1.88e-3)"	"unprognostic (1.22e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.18e-1)"	"unprognostic (5.28e-2)"	27.3	7.6	11.2	15.9	10.5	11.2	24.9	11.7	13.2	12.2	2.8	7.6	4.5	15.8	1.2	5.8	12.6	9.2	44.7	10.7	9.6	19.9	4.7	52.2	25.8	8.6	7.5	5.0	4.8	3.9	7.1	15.8	8.4	8.5	1.8	0.8	6.8	3.5	14.6	7.4	15.1	7.3	8.1	47.2	7.3	5.1	8.9	27.8	22.9	11.4	10.5	10.9	9.4	8.0	0.1	0.2	0.9	0.2	0.8	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.0	19.5	1.1	0.0	1.1	0.7	0.0	0.0	0.0	15.6	0.3	7.3	0.1	0.0	0.3	5.6	53.3	0.3	0.2	0.3	0.1	0.0	60.0	11.6	0.2	20.6	0.0	0.1	5.1	16.8	0.8	0.0	0.0	60.7	0.9	46.1	0.0	0.0	14.5	4.4	0.3	0.1	0.0	1.4	0.1	9.6	50.1	0.0	1.2	0.1	0.1	20.3	22.2	20.3	0.4	4.8	0.0	34.0	29.9	37.8	32.3	94.7	26.4	26.2	18.8	30.4	32.8	29.5	16.6	17.5	82.2	34.6	124.8	59.8	21.6	34.2	11.2	10.5	11.7	13.2	10.7	9.6	8.6	7.5	8.4	8.1	8.9	8.0	52.6	3.2	5.8	0.7	15.9	1.3	0.3	1.9	0.6	3.2	1.1	1.7	10.5	2.8	0.9	0.0	0.0	0.3	29.7	0.0	0.0	0.5	13.8	2.2	2.8	52.2	4.2	3.6	10.8	0.0	0.2	3.1	2.0	0.8	11.4	0.0	41.7	0.7	6.0	3.3	10.7	0.3	0.0	6.0	3.7	16.3	1.2	10.7	1.8	23.4	13.4	3.6	21.6	3.0	0.7	0.1	0.0	0.7	7.6	0.1	0.0	0.1	0.8	2.4	6.6	1.2	12.5	1.8	1.5	0.9	0.4	0.7	15.5	2.0	0.1	0.2
SH3BGRL2		ENSG00000198478	"SH3 domain binding glutamate rich protein like 2"	Q9UJC5	6	79631329-79703655	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"salivary gland: 161.7"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 156.3;Excitatory neurons: 86.5;Intestinal goblet cells: 87.8"	"Cancer enhanced"	"Detected in all"		"thyroid cancer: 50.8"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	5	"basophil: 11.1"	"Lineage enriched"	"Detected in many"	10	"granulocytes: 11.1"	"Cell line enhanced"	"Detected in many"		"CACO-2: 81.6;HEL: 41.8;OE19: 99.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047486	Approved		Supported	Nucleoplasm		NA	NA		2000000	"Cluster 34: Basophils - Unknown function"	"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 21: OE19 - Mitochondria"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm		"HPA047486: AB_2680065"	"unprognostic (3.48e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.75e-2)"	"unprognostic (2.28e-2)"	"unprognostic (4.21e-1)"	"unprognostic (7.77e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.60e-2)"	"unprognostic (6.92e-2)"	"unprognostic (6.53e-3)"	"unprognostic (2.78e-1)"	"unprognostic (7.94e-2)"	"prognostic favorable (2.24e-4)"	"unprognostic (1.60e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.11e-2)"	"unprognostic (1.33e-1)"	26.4	6.9	18.8	7.5	18.6	1.7	21.6	15.6	27.5	22.3	15.1	50.5	35.2	9.9	24.7	55.1	17.8	23.2	6.8	21.4	21.8	15.7	53.1	12.7	5.5	26.7	22.0	4.1	23.3	31.5	16.6	24.0	28.1	26.2	47.9	26.0	161.7	11.4	4.8	11.3	35.6	15.8	24.1	6.6	68.9	2.1	24.2	4.8	59.1	10.1	10.7	12.7	19.7	22.5	8.5	1.5	7.6	1.6	6.7	5.6	18.0	0.5	5.6	1.9	4.0	81.6	16.3	0.1	11.4	0.5	1.6	3.9	7.0	9.2	6.7	0.0	10.2	41.8	1.8	15.8	2.8	1.7	1.1	3.1	7.3	5.8	3.3	2.7	23.8	0.0	16.8	0.0	0.7	1.3	0.0	0.2	6.5	99.7	2.8	0.0	2.2	0.2	2.0	27.3	20.3	22.3	0.5	2.4	0.6	10.3	0.4	3.5	13.6	5.2	3.4	0.1	4.9	12.0	6.0	0.0	0.9	0.0	1.6	11.1	0.2	0.4	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.2	1.0	2.2	0.0	0.0	0.1	0.0	8.8	18.8	18.6	15.6	27.5	21.4	21.8	26.7	22.0	28.1	24.1	24.2	22.5	83.2	6.4	24.8	20.9	0.9	2.2	4.6	3.3	2.2	13.5	14.8	9.9	6.1	52.9	21.4	22.0	8.4	40.4	1.7	156.3	0.0	14.8	18.1	14.3	3.7	33.8	12.6	7.4	86.5	13.0	3.7	4.6	81.1	21.0	0.0	2.0	44.6	69.6	4.1	13.5	38.1	87.8	4.1	2.9	2.1	20.3	0.6	21.6	16.0	11.2	4.6	8.6	0.0	33.7	24.9	15.0	76.0	4.5	1.3	19.7	48.7	11.3	24.6	12.2	0.0	3.7	4.7	2.5	1.2	21.5	0.9	52.7	1.0	1.8	67.2	29.9
SH3D19	"DKFZp434D0215, EBP, Eve-1, EVE1, Kryn, SH3P19"	ENSG00000109686	"SH3 domain containing 19"	Q5HYK7	4	151102751-151325605	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in all"		"Oligodendrocyte precursor cells: 263.9;Oligodendrocytes: 360.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 190.3;ASC TERT1: 161.0;HSkMC: 129.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016424, HPA058562"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA				"Cluster 46: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Nucleoplasm, Cytosol"		"HPA016424: AB_1856814, HPA058562: AB_2683758"	"unprognostic (1.09e-1)"	"unprognostic (6.14e-2)"	"unprognostic (1.24e-3)"	"unprognostic (1.37e-1)"	"unprognostic (1.67e-1)"	"unprognostic (2.84e-2)"	"unprognostic (1.30e-2)"	"unprognostic (5.09e-1)"	"unprognostic (7.37e-2)"	"unprognostic (1.48e-1)"	"unprognostic (6.40e-3)"	"unprognostic (1.86e-1)"	"prognostic favorable (1.38e-5)"	"unprognostic (7.90e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.64e-2)"	70.8	15.7	9.8	12.8	14.9	0.2	31.5	6.0	9.6	22.5	104.9	44.2	44.4	23.2	10.7	40.8	23.7	63.7	64.1	6.8	11.6	27.2	49.9	36.2	5.1	8.8	10.3	42.9	15.2	19.9	5.0	27.9	8.8	27.1	48.3	12.8	17.3	40.5	17.7	30.0	49.0	41.4	5.1	7.4	22.6	12.4	11.5	3.9	25.1	33.8	7.9	33.3	20.6	18.6	26.3	19.2	12.1	9.5	190.3	161.0	26.0	31.8	34.0	13.9	14.4	24.9	31.6	0.0	12.5	29.9	22.7	19.2	12.8	36.6	13.5	0.1	10.1	0.0	22.2	26.7	46.0	0.1	0.1	129.1	27.6	20.9	32.0	23.9	81.9	0.0	0.0	0.1	36.9	10.9	0.0	0.4	24.3	40.3	27.6	0.0	0.9	0.4	17.3	18.3	0.9	16.3	22.7	23.0	18.5	24.7	7.5	0.1	59.9	43.6	15.6	19.5	12.9	0.1	0.0	0.1	22.6	0.1	54.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	9.8	14.9	6.0	9.6	6.8	11.6	8.8	10.3	8.8	5.1	11.5	18.6	36.7	22.4	32.5	8.1	2.9	28.6	14.1	12.3	18.8	6.6	20.5	25.0	88.5	34.3	29.2	16.5	14.6	25.9	5.0	103.5	5.9	11.9	4.4	17.6	38.1	29.1	18.6	7.0	55.8	15.4	20.7	77.9	38.7	13.7	21.5	37.5	21.8	46.4	7.4	6.7	30.0	35.6	10.2	4.6	20.2	6.7	62.1	4.8	26.6	74.0	1.2	20.8	5.2	263.9	360.1	21.3	55.9	48.2	3.2	41.5	88.2	27.2	52.4	11.0	13.1	46.0	26.3	2.9	6.0	16.7	38.5	27.2	5.5	20.3	54.0	41.2
SH3GLB1	"Bif-1, CGI-61, KIAA0491, PPP1R70"	ENSG00000097033	"SH3 domain containing GRB2 like, endophilin B1"	Q9Y371	1	86704570-86748184	"Metabolic proteins, Predicted intracellular proteins, Transporters"	"Apoptosis, Autophagy"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 634.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 301.4"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004650, HPA015608, HPA019900"	Enhanced		Supported	Cytosol		NA	NA		28000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 66: Spermatocytes - Spermatogenesis"	Cytosol		"CAB004650: AB_425966, HPA015608: AB_1845355, HPA019900: AB_1845356"	"unprognostic (1.72e-2)"	"unprognostic (1.76e-1)"	"unprognostic (5.52e-2)"	"unprognostic (9.94e-2)"	"unprognostic (3.42e-1)"	"unprognostic (1.62e-1)"	"prognostic unfavorable (2.90e-5)"	"unprognostic (8.34e-2)"	"unprognostic (1.75e-1)"	"unprognostic (4.29e-1)"	"prognostic unfavorable (2.53e-4)"	"unprognostic (1.56e-1)"	"unprognostic (4.04e-3)"	"unprognostic (7.70e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.88e-2)"	"unprognostic (1.69e-1)"	106.5	38.1	20.5	55.3	22.5	66.2	56.1	21.0	25.4	39.2	15.7	53.7	48.4	35.9	31.0	79.4	27.9	47.0	72.8	19.2	23.7	40.4	45.0	49.0	40.9	25.3	19.7	24.2	64.0	41.3	30.3	57.5	24.4	34.3	57.9	39.0	56.4	36.1	172.0	35.8	47.0	50.3	23.4	46.5	36.3	109.5	21.0	34.1	38.6	98.4	51.9	63.8	41.8	27.4	78.1	28.1	44.2	40.4	180.1	155.1	72.2	115.1	114.5	106.8	112.3	81.4	63.3	39.7	72.0	143.5	132.9	44.5	39.4	75.0	101.2	86.1	28.1	94.7	39.2	87.1	108.7	51.5	92.4	111.8	85.5	118.3	128.7	114.5	171.4	41.7	36.0	108.5	145.1	23.1	46.7	32.7	43.0	56.8	47.6	53.1	184.6	29.7	92.3	132.2	47.9	34.7	64.8	82.4	140.8	65.2	32.7	51.8	151.4	102.2	61.9	129.3	96.5	56.8	56.3	58.6	50.8	52.1	63.5	153.0	59.0	66.5	43.0	64.5	42.4	36.8	40.2	43.8	45.5	35.3	19.1	34.3	301.4	62.4	77.0	43.8	65.4	49.5	20.5	22.5	21.0	25.4	19.2	23.7	25.3	19.7	24.4	23.4	21.0	27.4	192.0	83.3	65.6	39.2	75.0	89.6	119.5	124.1	44.3	31.2	96.9	69.1	157.0	60.1	104.0	55.2	52.1	84.3	145.7	182.0	86.1	145.2	634.6	86.3	104.5	135.4	86.6	64.4	49.9	169.8	203.4	99.7	45.9	110.0	113.5	61.0	157.1	79.4	143.7	16.8	50.5	130.3	128.1	149.2	99.4	236.9	70.2	116.0	81.8	40.3	163.7	71.9	124.6	46.8	65.2	201.7	173.4	85.0	123.9	103.4	108.8	134.0	90.2	55.4	78.9	146.7	111.7	403.5	86.3	100.6	118.1	101.9	90.4	57.1	87.4	199.8
SH3GLB2	KIAA1848	ENSG00000148341	"SH3 domain containing GRB2 like, endophilin B2"	Q9NR46	9	129007036-129028331	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cytotrophoblasts: 127.9;Syncytiotrophoblasts: 149.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RPMI-8226: 234.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021438, HPA024734"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 47: Cytotrophoblasts - Unknown function"	Cytosol	Nucleoplasm	"HPA021438: AB_1856820, HPA024734: AB_1856821"	"unprognostic (2.59e-1)"	"prognostic favorable (1.56e-6)"	"unprognostic (1.88e-1)"	"unprognostic (7.51e-2)"	"unprognostic (2.94e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.04e-1)"	"unprognostic (8.54e-2)"	"unprognostic (5.77e-2)"	"unprognostic (4.70e-2)"	"unprognostic (1.81e-2)"	"unprognostic (6.25e-2)"	"prognostic favorable (2.32e-4)"	"unprognostic (1.42e-3)"	"unprognostic (1.23e-1)"	"unprognostic (1.46e-3)"	"prognostic favorable (4.28e-4)"	32.7	49.1	86.7	19.2	93.6	59.4	46.0	69.4	127.6	60.5	63.5	56.3	42.1	47.9	17.1	101.4	52.7	22.0	32.4	95.0	74.5	63.9	25.3	35.4	24.9	81.3	71.1	45.2	71.5	69.1	88.4	37.7	82.2	71.8	16.1	11.7	60.8	50.2	50.0	116.7	47.9	18.5	68.8	42.1	71.2	24.4	78.0	37.2	45.9	19.0	22.6	72.6	66.8	93.1	49.7	41.2	19.9	27.1	11.7	14.8	59.2	17.0	37.8	33.0	30.0	25.8	83.2	51.9	13.3	30.1	25.5	119.2	6.3	36.7	9.3	34.0	27.5	13.2	70.5	22.9	24.4	11.9	30.7	10.6	41.1	16.8	14.9	36.2	28.0	66.8	17.8	67.2	16.9	121.5	68.4	31.5	17.8	83.2	28.7	136.3	37.2	234.3	36.7	59.1	62.0	50.3	24.7	62.6	26.3	16.4	90.5	17.5	25.8	15.3	26.1	39.3	37.7	65.6	34.0	33.8	35.6	14.7	8.3	2.1	1.6	3.5	1.9	0.8	2.3	3.5	2.2	1.8	1.3	2.0	1.6	1.3	1.3	2.6	2.5	3.7	2.0	1.5	86.7	93.6	69.4	127.6	95.0	74.5	81.3	71.1	82.2	68.8	78.0	93.1	36.3	16.0	28.4	28.1	20.3	20.8	27.5	11.6	9.6	26.9	59.7	62.9	10.6	18.6	19.8	47.8	8.4	127.9	29.4	58.2	15.6	14.5	11.2	36.3	19.6	15.6	25.3	29.5	24.4	26.0	19.2	23.3	84.6	63.6	6.3	29.9	12.1	9.9	20.7	47.1	14.2	35.9	12.2	11.9	11.6	24.4	19.0	14.3	14.2	17.8	6.9	36.0	6.2	23.6	95.6	24.6	50.3	20.3	25.9	23.0	39.4	7.6	21.5	20.6	13.1	32.0	39.7	8.6	6.6	27.6	53.6	149.5	16.3	18.3	34.6	58.3
SH3KBP1	CIN85	ENSG00000147010	"SH3 domain containing kinase binding protein 1"	Q96B97	X	19533977-19887600	"Disease related genes, Predicted intracellular proteins"	"Apoptosis, Endocytosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 207.8;monocytes: 289.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003351, HPA003355, CAB021892"	Enhanced		Supported	Cytosol		NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 3: Monocytes - Immune response regulation"	Cytosol		"CAB021892: , HPA003351: AB_1079956, HPA003355: AB_1079954"	"unprognostic (1.17e-2)"	"unprognostic (1.33e-1)"	"unprognostic (9.48e-2)"	"unprognostic (4.65e-3)"	"unprognostic (1.62e-1)"	"unprognostic (2.88e-2)"	"unprognostic (6.47e-2)"	"unprognostic (9.91e-2)"	"unprognostic (9.75e-2)"	"unprognostic (1.76e-3)"	"unprognostic (5.96e-3)"	"unprognostic (2.49e-1)"	"prognostic unfavorable (2.10e-6)"	"unprognostic (4.00e-1)"	"unprognostic (1.54e-1)"	"unprognostic (3.94e-2)"	"unprognostic (4.92e-2)"	45.1	11.0	17.1	45.5	16.8	68.6	26.6	14.2	20.3	18.2	47.3	37.1	13.7	10.6	11.3	8.5	11.9	21.2	24.4	16.4	20.8	13.5	15.6	26.0	68.1	19.9	22.9	8.7	6.9	14.4	11.9	32.5	20.3	6.7	35.3	5.1	10.4	7.4	13.0	24.0	18.4	14.8	18.5	37.0	18.9	5.7	26.0	55.0	20.5	32.4	68.7	17.7	11.2	27.1	52.5	54.3	8.4	19.4	41.6	80.0	44.2	46.4	67.4	23.3	37.2	37.2	105.6	97.4	47.6	67.5	67.0	5.9	19.8	18.4	37.3	32.3	13.4	21.2	13.6	30.1	27.2	134.0	160.2	47.4	18.0	48.5	141.9	64.6	35.4	67.6	8.0	114.2	59.7	23.5	80.4	135.4	14.8	63.1	71.2	49.1	82.0	9.1	27.1	10.6	6.0	6.2	43.2	5.6	65.3	53.8	5.4	155.2	113.6	40.6	34.9	52.2	51.9	165.6	119.0	86.0	86.5	109.4	183.5	49.2	104.7	171.1	180.2	77.7	140.4	55.4	174.2	187.8	132.6	50.3	143.3	142.5	210.0	76.5	96.9	148.4	224.1	195.9	17.1	16.8	14.2	20.3	16.4	20.8	19.9	22.9	20.3	18.5	26.0	27.1	40.3	16.0	54.4	5.5	75.6	12.0	3.5	7.5	5.2	5.1	5.4	6.2	78.1	11.5	25.0	9.2	16.7	26.2	174.3	207.8	1.9	8.3	0.7	6.3	28.5	26.5	50.8	23.3	72.3	18.9	39.3	56.9	23.4	8.3	96.6	5.9	27.8	17.6	55.8	8.4	126.3	34.4	10.2	87.4	102.1	1.9	52.8	113.0	33.8	108.7	289.2	0.1	175.1	87.0	145.9	48.0	153.3	38.4	63.5	3.5	26.4	40.3	20.1	2.8	59.2	12.1	72.2	24.3	22.7	1.9	10.9	22.6	138.7	26.7	59.4	7.7
SH3RF1	"KIAA1494, POSH, RNF142, SH3MD2"	ENSG00000154447	"SH3 domain containing ring finger 1"	Q7Z6J0	4	169094259-169270956	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Host-virus interaction, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 146.3;Oligodendrocytes: 213.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"intermediate monocyte: 4.2;myeloid DC: 2.5;non-classical monocyte: 6.7"	"Group enriched"	"Detected in many"	15	"dendritic cells: 2.5;monocytes: 6.7"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA074783	Approved		Supported	"Vesicles,Intermediate filaments"		No	No			"Cluster 51: Monocytes - Innate immune response"	"Cluster 45: Intestine - Brush border"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 22: Epithelial cell types - Mixed function"	Vesicles	"Intermediate filaments"	"HPA074783: AB_2732268"	"unprognostic (4.14e-1)"	"unprognostic (4.67e-2)"	"unprognostic (1.23e-1)"	"unprognostic (7.83e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.30e-2)"	"unprognostic (1.29e-1)"	"unprognostic (2.65e-1)"	"unprognostic (8.44e-2)"	"unprognostic (9.58e-2)"	"unprognostic (4.77e-3)"	"unprognostic (7.88e-2)"	"prognostic favorable (5.51e-8)"	"unprognostic (4.43e-2)"	"unprognostic (1.63e-1)"	"unprognostic (5.99e-2)"	"unprognostic (1.77e-1)"	9.8	3.7	8.7	4.4	10.0	3.4	8.2	7.6	13.1	5.7	5.9	15.1	13.8	4.3	5.7	5.9	5.6	11.9	5.7	18.2	8.6	12.2	8.0	9.4	3.3	8.8	9.7	8.5	10.4	3.7	3.7	7.4	9.4	14.3	13.6	2.4	15.8	8.4	9.4	5.1	13.1	4.0	8.2	3.9	24.7	6.1	9.5	2.0	19.9	10.0	3.2	9.3	4.4	13.0	15.2	12.2	11.0	31.9	11.5	14.3	14.1	40.5	19.7	30.0	13.8	12.5	17.8	0.0	1.9	43.1	8.1	9.8	8.9	16.2	32.4	0.1	5.2	8.7	27.4	6.5	26.0	3.1	0.3	8.5	8.6	25.7	19.9	37.3	18.7	3.3	0.1	0.0	27.8	6.0	3.1	2.9	5.6	19.2	10.5	4.5	3.6	0.6	13.6	11.8	8.3	9.9	10.4	15.7	4.2	4.7	5.2	1.3	17.1	14.2	11.0	23.6	14.7	1.1	0.0	0.1	16.0	3.0	17.3	0.0	1.0	0.0	0.0	4.2	0.0	0.3	0.0	0.0	2.5	0.1	0.0	0.0	0.0	0.2	6.7	0.2	0.0	0.6	8.7	10.0	7.6	13.1	18.2	8.6	8.8	9.7	9.4	8.2	9.5	13.0	28.0	64.1	37.7	146.3	3.4	34.3	48.3	11.9	13.6	3.5	21.1	15.6	11.2	44.3	34.4	27.6	0.0	12.7	0.4	69.3	11.7	42.2	5.5	28.5	14.2	13.0	31.3	2.1	54.9	63.7	22.1	16.5	65.7	46.5	10.2	5.6	11.4	12.4	7.4	0.0	54.9	27.1	12.2	9.3	5.3	3.5	12.2	11.1	3.6	52.5	3.9	11.3	0.0	89.5	213.0	68.4	37.2	12.0	2.4	63.2	28.9	18.4	31.7	1.2	65.7	24.1	36.9	5.4	10.7	9.4	12.6	13.1	1.7	6.5	34.4	72.0
SH3RF3	"FLJ00204, POSH2, SH3MD4"	ENSG00000172985	"SH3 domain containing ring finger 3"	Q8TEJ3	2	109129205-109504634	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	7	"Astrocytes: 47.0;Excitatory neurons: 108.3;Inhibitory neurons: 160.9;Microglial cells: 164.9;Oligodendrocyte precursor cells: 42.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HHSteC: 19.8;RPMI-8226: 20.5;TIME: 23.2;U-266/84: 28.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA044822, HPA048444"	Approved		Supported	Nucleoplasm		Yes	No				"Cluster 47: Non-specific - Unknown function"	"Cluster 16: U-266 - Nucleosome"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm		"HPA044822: AB_2679103, HPA048444: AB_2680396"	"unprognostic (1.97e-1)"	"unprognostic (8.84e-3)"	"unprognostic (8.04e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.55e-1)"	"unprognostic (1.78e-1)"	"unprognostic (8.00e-2)"	"unprognostic (1.76e-1)"	"unprognostic (2.98e-2)"	"prognostic unfavorable (2.33e-4)"	"unprognostic (4.57e-2)"	"unprognostic (1.95e-1)"	"unprognostic (3.54e-2)"	"unprognostic (4.94e-2)"	"unprognostic (2.72e-1)"	"unprognostic (2.79e-2)"	"unprognostic (1.39e-2)"	6.1	6.7	4.7	3.0	6.1	0.8	4.3	1.3	6.5	5.5	1.6	5.6	1.1	3.7	0.7	2.8	4.8	4.4	6.0	6.3	3.2	6.8	1.1	7.2	2.1	3.0	4.5	3.2	2.0	0.5	1.9	5.2	2.8	4.7	1.4	0.6	1.6	4.4	5.7	3.1	3.3	3.8	3.1	2.1	2.9	4.2	3.9	3.2	2.5	7.3	1.2	5.5	4.2	3.5	0.0	0.1	0.1	2.2	9.0	6.9	0.0	4.2	12.2	3.1	1.1	1.1	0.0	0.0	3.1	3.1	0.7	0.0	0.2	1.8	1.3	0.0	4.2	0.0	0.2	0.0	19.8	0.1	0.0	12.0	2.9	14.1	6.3	1.8	11.4	2.2	0.0	11.7	7.3	0.0	0.0	6.5	1.1	0.0	12.0	2.6	0.0	20.5	0.0	0.0	0.7	2.5	0.0	0.0	0.4	0.1	0.2	0.0	23.2	4.0	12.0	11.5	5.5	4.0	28.6	0.0	0.0	6.3	5.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	4.7	6.1	1.3	6.5	6.3	3.2	3.0	4.5	2.8	3.1	3.9	3.5	5.3	0.0	0.0	47.0	0.2	1.9	0.4	0.2	1.8	0.5	0.6	0.5	10.7	0.0	0.7	0.0	0.0	0.0	1.5	0.1	0.0	1.1	2.6	9.4	9.6	6.7	1.8	0.0	108.3	0.2	0.2	4.8	0.0	1.1	0.0	0.2	7.5	0.0	4.7	10.1	160.9	0.8	0.0	2.5	1.5	5.2	2.1	1.2	5.4	164.9	0.0	1.7	0.0	42.3	1.9	0.1	0.0	3.0	1.6	0.2	0.0	0.6	2.1	0.0	13.1	3.2	6.8	0.7	9.6	0.8	0.9	0.1	0.5	2.3	0.1	0.0
SHANK1	"SPANK-1, SSTRIP, synamon"	ENSG00000161681	"SH3 and multiple ankyrin repeat domains 1"	Q9Y566	19	50659255-50719802	"Plasma proteins, Predicted intracellular proteins"	"Differentiation, Neurogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	13	"brain: 71.1"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 5.7;Excitatory neurons: 29.6;Horizontal cells: 8.4;Inhibitory neurons: 32.9;Oligodendrocyte precursor cells: 7.1"	"Cancer enhanced"	"Detected in some"		"ovarian cancer: 2.2"	"Group enriched"	"Detected in many"	5	"amygdala: 20.6;basal ganglia: 28.8;cerebral cortex: 71.1;hippocampal formation: 36.8"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"REH: 5.2;THP-1: 2.4;U-138 MG: 2.7;U-2 OS: 7.3;U-87 MG: 2.9;U-937: 3.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA032129, HPA032130"	Uncertain		Supported	"Plasma membrane"		NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 9: U-2 OS - Unknown function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Plasma membrane"		"HPA032129: AB_10602796, HPA032130: AB_2674169"	"unprognostic (1.62e-1)"	"unprognostic (4.40e-2)"	"unprognostic (7.83e-3)"	"unprognostic (4.62e-2)"	"unprognostic (1.70e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.76e-2)"	"unprognostic (1.35e-2)"	"unprognostic (5.02e-2)"	"unprognostic (1.61e-1)"	"unprognostic (7.51e-2)"	"unprognostic (3.27e-1)"	"unprognostic (3.65e-2)"	"unprognostic (1.61e-2)"	"unprognostic (5.14e-2)"	"unprognostic (4.66e-3)"	"unprognostic (1.29e-3)"	0.0	1.2	20.6	0.0	28.8	0.3	0.1	1.5	71.1	0.5	0.0	0.1	0.0	0.4	0.1	0.0	2.4	0.2	0.1	36.8	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.2	0.0	1.6	1.1	0.1	0.0	0.1	0.0	5.3	0.1	0.1	0.1	0.3	0.1	0.2	0.0	0.1	0.0	0.5	7.5	0.3	0.1	0.0	0.0	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.1	0.3	0.0	0.8	0.8	0.0	0.1	0.0	0.0	0.0	1.1	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.7	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.4	0.5	0.0	0.0	0.5	0.1	0.1	0.5	0.8	0.0	0.0	5.2	0.0	0.5	0.0	0.0	0.0	1.8	0.0	0.0	0.8	0.0	0.0	2.4	1.6	2.7	7.3	0.0	0.0	0.0	0.0	0.0	2.9	3.6	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.6	28.8	1.5	71.1	36.8	0.0	0.0	0.2	0.0	0.0	7.5	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	5.7	0.0	0.0	4.3	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.3	0.0	0.0	29.6	0.0	0.1	0.2	0.0	0.1	0.0	0.5	0.0	0.0	0.0	8.4	32.9	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	1.9	0.0	0.1	0.0	7.1	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	1.8	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SHARPIN	"DKFZP434N1923, SIPL1"	ENSG00000179526	"SHANK associated RH domain interactor"	Q9H0F6	8	144098633-144108124	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"Early spermatids: 391.4;Late spermatids: 1255.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024825, HPA044453"	Approved		Approved	"Golgi apparatus,Plasma membrane,Cytosol"		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 43: Testis - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 25: Spermatids - Spermatogenesis"	"Plasma membrane"	"Golgi apparatus, Cytosol"	"HPA024825: , HPA044453: AB_10962490"	"unprognostic (4.91e-2)"	"unprognostic (3.47e-2)"	"unprognostic (1.35e-2)"	"unprognostic (7.88e-2)"	"unprognostic (3.32e-2)"	"unprognostic (9.54e-2)"	"unprognostic (1.31e-3)"	"unprognostic (6.58e-2)"	"unprognostic (1.74e-1)"	"unprognostic (4.13e-3)"	"unprognostic (5.44e-2)"	"unprognostic (7.91e-2)"	"unprognostic (1.84e-3)"	"unprognostic (2.87e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.00e-1)"	29.9	39.2	38.5	16.5	39.9	32.6	27.2	39.1	52.2	29.9	35.7	37.7	20.7	29.4	11.2	29.9	28.8	19.4	44.4	36.0	39.2	36.7	39.1	27.1	21.8	41.7	39.7	27.4	35.1	28.7	26.7	17.2	39.9	33.8	12.7	8.9	33.8	22.2	49.4	27.1	26.3	17.3	37.7	33.4	34.2	94.7	39.8	19.6	29.1	39.7	13.9	31.2	26.4	38.7	26.9	43.5	20.4	17.9	34.2	35.1	22.5	23.5	29.5	34.0	32.9	24.9	42.0	12.0	38.5	30.6	17.1	28.4	10.8	42.2	8.2	33.0	23.3	31.4	40.1	29.9	61.6	11.6	23.1	40.4	59.4	28.3	30.8	37.6	36.8	36.6	18.2	27.3	30.2	43.8	35.2	26.6	9.3	53.6	124.2	23.6	16.7	39.4	35.2	28.3	20.3	30.7	45.0	62.1	41.5	14.3	69.4	35.8	34.0	26.5	38.9	32.5	32.4	30.0	25.4	16.3	38.3	25.9	23.5	22.6	33.5	53.5	29.9	41.2	32.4	23.3	28.5	38.3	30.0	21.8	23.5	24.7	17.5	33.9	34.8	42.7	34.1	22.4	38.5	39.9	39.1	52.2	36.0	39.2	41.7	39.7	39.9	37.7	39.8	38.7	56.3	9.6	18.1	10.4	39.4	24.0	32.9	37.0	26.2	27.1	43.5	44.4	20.9	31.5	26.1	35.0	4.2	56.7	44.4	87.2	119.3	53.8	391.4	28.3	26.8	38.9	35.4	88.0	8.0	49.5	52.6	35.9	52.0	24.4	13.3	35.1	36.4	37.2	59.0	48.8	9.5	45.6	44.7	42.1	32.9	1255.3	49.0	33.0	46.2	15.0	57.7	45.4	59.8	9.0	14.3	95.2	81.3	43.6	31.2	36.1	83.1	86.4	20.6	28.9	52.6	26.8	44.2	181.7	67.9	33.5	32.4	43.1	38.8	37.4	59.0	33.9
SHC3	"N-Shc, NSHC, SHCC"	ENSG00000148082	"SHC adaptor protein 3"	Q92529	9	89005771-89178818	"Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 28.1"	"Group enriched"	"Detected in some"	10	"Excitatory neurons: 155.2;Inhibitory neurons: 179.2;Oligodendrocyte precursor cells: 333.8"	"Cancer enriched"	"Detected in some"	5	"glioma: 5.1"	"Group enriched"	"Detected in many"	9	"amygdala: 16.8;basal ganglia: 24.9;cerebral cortex: 28.1;hippocampal formation: 23.6;white matter: 11.4"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 20.7;hTERT-RPE1: 22.6;RT4: 7.9;SH-SY5Y: 7.6;U-87 MG: 11.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031427, HPA046656, HPA072448"	Uncertain		Supported	Nucleoplasm		NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 12: NES - Nervous system development"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm		"HPA031427: AB_2673877, HPA046656: AB_2679740, HPA072448: AB_2686521"	"unprognostic (6.22e-2)"	"unprognostic (5.86e-2)"	"unprognostic (1.26e-1)"	"unprognostic (2.43e-1)"	"unprognostic (1.04e-1)"	"unprognostic (9.07e-4)"	"unprognostic (2.70e-2)"	"unprognostic (1.54e-2)"	"unprognostic (1.51e-1)"	"unprognostic (3.09e-1)"	"unprognostic (2.72e-3)"	"unprognostic (7.39e-2)"	"unprognostic (1.53e-7)"	"unprognostic (8.33e-2)"	"unprognostic (1.05e-1)"	"unprognostic (9.01e-2)"	"unprognostic (9.84e-4)"	1.0	9.0	16.8	0.2	24.9	0.0	1.7	0.0	28.1	5.8	0.0	1.4	0.4	1.7	0.9	1.0	1.7	1.8	1.1	23.6	0.0	1.4	0.2	4.6	0.2	0.0	0.0	0.2	4.0	2.7	1.1	0.2	0.0	1.0	0.7	2.3	5.0	0.6	0.3	1.8	0.7	1.0	0.0	0.1	0.8	0.3	2.3	0.0	0.6	0.6	0.2	1.4	2.9	11.4	1.4	0.4	20.7	0.0	4.5	1.4	0.0	1.5	4.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	3.0	0.4	0.0	0.2	0.0	0.0	0.2	0.0	0.3	0.4	0.5	0.2	0.0	3.1	0.0	2.1	0.0	22.6	5.5	0.1	0.0	0.0	0.0	0.2	0.0	1.3	2.7	0.3	0.3	0.3	0.0	4.5	4.5	7.9	2.8	7.6	0.5	0.0	0.0	0.2	0.0	0.4	3.2	0.8	0.1	1.3	0.1	0.0	0.0	0.0	11.4	0.5	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.8	24.9	0.0	28.1	23.6	0.0	0.0	0.0	0.0	0.0	2.3	11.4	0.3	0.0	21.0	17.6	0.0	0.1	0.3	0.1	1.2	7.6	1.1	1.0	1.1	0.0	0.7	0.0	0.0	0.1	0.2	0.0	1.9	0.1	1.1	0.4	1.8	0.5	0.0	0.0	155.2	0.9	0.1	4.4	0.0	0.2	0.0	0.3	0.0	0.0	0.2	3.3	179.2	0.0	0.0	0.0	1.1	1.6	1.5	0.3	1.8	15.0	0.0	7.2	0.0	333.8	9.6	0.1	0.0	3.8	0.0	0.0	0.1	0.6	0.9	0.6	0.0	0.9	0.9	0.3	0.6	0.7	0.6	0.4	0.3	0.8	0.0	0.8
SHCBP1	"FLJ22009, PAL"	ENSG00000171241	"SHC binding and spindle associated 1"	Q8NEM2	16	46578591-46621379	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 17.4;lymphoid tissue: 10.6"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 36.2;Extravillous trophoblasts: 28.7;Plasma cells: 38.3;Spermatocytes: 33.7;Spermatogonia: 23.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA048876	Uncertain		Approved	"Nuclear bodies,Microtubules,Midbody,Mitotic spindle"		Yes	Yes			"Cluster 19: B-cells - Humoral immune response"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Nuclear bodies"	"Microtubules, Midbody, Mitotic spindle"	"HPA048876: AB_2680542"	"unprognostic (2.44e-3)"	"unprognostic (1.13e-1)"	"unprognostic (2.98e-2)"	"unprognostic (2.74e-1)"	"unprognostic (2.54e-2)"	"unprognostic (2.35e-2)"	"unprognostic (2.96e-4)"	"unprognostic (2.26e-3)"	"unprognostic (5.35e-2)"	"unprognostic (1.10e-1)"	"prognostic unfavorable (4.47e-5)"	"unprognostic (4.81e-2)"	"unprognostic (2.22e-16)"	"unprognostic (3.59e-2)"	"unprognostic (3.86e-2)"	"unprognostic (2.66e-1)"	"unprognostic (2.66e-1)"	0.7	0.5	0.5	5.1	0.5	17.4	0.9	1.2	0.6	0.6	0.4	1.9	1.2	0.6	0.6	3.5	0.2	0.6	1.0	0.4	0.2	5.4	0.2	1.0	9.8	0.4	0.3	0.3	0.2	0.2	0.2	2.4	0.4	0.3	2.2	0.2	0.8	0.2	1.5	3.3	1.5	1.7	0.1	4.4	0.9	5.2	0.5	8.8	0.3	0.2	10.6	1.2	1.2	0.7	33.8	30.8	11.9	15.3	3.1	6.2	16.2	60.7	24.6	59.2	26.8	14.6	20.8	28.0	30.2	28.8	26.8	21.0	29.3	21.7	73.8	17.7	17.2	28.2	25.8	30.3	0.1	28.5	35.4	1.2	1.6	45.9	18.1	5.9	33.0	14.9	12.7	28.3	69.7	21.5	24.0	23.7	10.0	17.2	31.6	45.4	89.9	44.8	13.7	9.4	5.0	7.2	46.0	23.7	11.1	11.4	13.0	23.4	16.1	43.9	28.7	43.5	54.0	24.9	36.7	46.7	21.4	31.3	45.8	0.2	0.3	0.6	0.2	0.5	0.0	1.7	0.3	0.1	0.3	1.2	0.0	0.1	0.4	0.1	2.4	0.7	1.2	1.1	0.5	0.5	1.2	0.6	0.4	0.2	0.4	0.3	0.4	0.1	0.5	0.7	0.2	0.0	1.1	1.3	7.1	1.7	0.7	1.2	0.0	0.3	0.6	1.1	1.9	1.5	1.4	0.0	0.0	11.3	0.8	1.9	0.0	0.2	8.4	0.7	1.7	1.7	0.0	36.2	2.1	0.0	28.7	3.7	4.1	1.5	0.0	7.6	1.8	0.3	12.6	0.0	0.7	2.2	2.0	4.5	3.3	2.3	0.6	4.0	1.8	2.8	2.8	0.8	0.0	1.0	0.5	0.1	0.1	0.4	38.3	0.5	0.4	0.1	0.1	0.3	0.0	0.5	6.3	33.7	23.7	3.6	0.6	3.7	2.2	0.8	3.4	1.1
SHFL	"C19orf66, FLJ11286, IRAV, RyDEN, SFL"	ENSG00000130813	"Shiftless antiviral inhibitor of ribosomal frameshifting"	Q9NUL5	19	10086122-10093252	"Predicted intracellular proteins"	"Antiviral defense"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 75.7"	"Cell type enhanced"	"Detected in some"		"Adipocytes: 23.3;dendritic cells: 21.7;Fibroblasts: 6.8;Hofbauer cells: 32.6;Plasma cells: 9.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+: 71.8;BJ hTERT+ SV40 Large T+ RasG12V: 81.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042001	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 15: Liver - Metabolism"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm	Cytosol	"HPA042001: AB_10794167"	"prognostic favorable (4.04e-4)"	"unprognostic (1.21e-2)"	"unprognostic (2.39e-3)"	"unprognostic (2.03e-1)"	"unprognostic (2.19e-2)"	"unprognostic (2.00e-2)"	"unprognostic (1.46e-1)"	"unprognostic (3.93e-1)"	"unprognostic (6.57e-2)"	"unprognostic (4.22e-3)"	"unprognostic (2.34e-1)"	"unprognostic (1.88e-1)"	"prognostic unfavorable (8.96e-11)"	"unprognostic (5.92e-2)"	"unprognostic (1.81e-1)"	"unprognostic (4.41e-3)"	"prognostic favorable (1.35e-4)"	12.8	18.5	27.1	14.2	27.4	15.7	12.2	26.3	30.1	17.0	24.4	12.8	14.8	15.8	16.5	8.6	17.6	18.1	8.2	27.2	28.5	14.0	75.7	16.8	22.8	27.3	27.0	18.9	9.9	16.7	14.1	12.7	27.2	11.9	9.9	15.0	16.3	19.1	4.4	9.5	18.4	15.4	28.8	19.9	11.0	4.3	29.5	20.4	12.2	6.9	16.6	14.7	12.3	28.1	9.4	3.8	5.0	3.9	20.3	23.6	1.4	7.6	46.3	71.8	81.2	0.4	7.4	4.8	2.1	24.0	25.7	3.9	3.9	20.7	12.0	30.4	0.4	15.5	3.0	10.6	32.6	4.7	9.7	34.3	11.7	11.5	4.1	27.1	22.9	20.6	1.8	20.2	15.0	6.5	20.1	13.3	1.1	7.0	5.5	16.2	0.0	8.0	14.8	13.0	0.7	3.5	12.9	1.3	42.2	0.9	1.2	12.9	14.8	6.0	3.0	9.6	1.6	24.1	7.2	1.2	16.8	6.0	12.1	16.4	12.8	18.2	23.3	11.7	31.1	13.0	19.5	25.4	10.2	10.1	16.3	17.7	16.4	32.7	20.3	2.0	21.7	15.5	27.1	27.4	26.3	30.1	27.2	28.5	27.3	27.0	27.2	28.8	29.5	28.1	23.3	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	5.4	21.7	0.0	0.0	0.0	0.0	0.0	0.0	4.4	0.0	0.0	0.0	0.0	6.7	6.8	0.0	0.0	0.0	0.0	0.0	0.0	32.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	2.6	3.3	0.0	0.0	0.0
SHLD3	"AC008560.1, CTC-534A2.2, FLJ26957, RINN1"	ENSG00000253251	"Shieldin complex subunit 3"	Q6ZNX1	5	65625027-65630928	"Predicted intracellular proteins"	"DNA damage, DNA repair"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 17.5"	"Cell type enhanced"	"Detected in some"		"Cytotrophoblasts: 4.0;dendritic cells: 5.9;Distal tubular cells: 3.9;Pancreatic endocrine cells: 4.6;Proximal tubular cells: 5.3;Syncytiotrophoblasts: 5.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA066071, HPA068764"	Approved		Supported	Nucleoplasm,Nucleoli		No	No			"Cluster 34: Basophils - Unknown function"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm	Nucleoli	"HPA066071: AB_2685609, HPA068764: AB_2686028"	"unprognostic (7.87e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.29e-1)"	"unprognostic (9.52e-2)"	"unprognostic (5.58e-4)"	"unprognostic (2.20e-2)"	"unprognostic (1.38e-2)"	"unprognostic (7.24e-3)"	"unprognostic (5.09e-4)"	"unprognostic (2.12e-2)"	"unprognostic (1.68e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.94e-1)"	"prognostic favorable (1.17e-4)"	2.3	2.7	2.4	2.7	2.5	17.5	4.2	2.8	3.6	1.8	1.8	2.8	2.8	2.3	3.1	1.5	1.9	2.4	1.8	2.3	2.1	2.9	2.6	2.5	4.8	2.4	2.1	1.5	3.4	2.1	2.5	2.5	2.3	4.3	3.0	3.7	2.0	2.5	1.8	2.9	2.7	1.7	2.4	2.5	2.4	3.2	2.4	3.9	2.4	1.9	3.6	2.5	1.3	3.2	2.6	3.6	5.0	10.8	2.9	3.5	6.3	3.8	3.5	5.8	7.0	5.9	8.0	4.9	4.2	4.6	6.5	3.1	5.1	4.7	8.5	6.7	6.5	4.3	10.3	8.3	2.5	5.0	7.5	2.1	6.8	6.0	6.1	1.6	3.7	7.7	6.4	11.5	4.7	6.9	6.7	7.7	4.0	1.5	2.2	4.4	4.9	7.9	4.9	6.0	6.7	5.5	3.2	3.3	11.0	3.4	3.8	4.6	3.0	5.0	6.8	4.1	6.6	7.2	14.3	10.7	3.7	6.1	4.7	15.9	3.0	6.4	3.8	2.9	4.0	3.9	4.5	4.0	2.8	3.1	6.1	5.6	3.3	4.9	3.1	3.2	6.2	2.1	2.4	2.5	2.8	3.6	2.3	2.1	2.4	2.1	2.3	2.4	2.4	3.2	3.5	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	3.8	3.6	0.0	0.0	0.0	0.0	0.0	4.0	5.9	0.0	3.9	3.1	0.0	1.9	1.8	0.8	0.0	0.0	0.0	2.9	3.8	0.9	0.0	2.1	0.0	2.1	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	3.6	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.4	0.0	0.0	5.3	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	5.1	1.8	2.1	0.0	0.0
SHMT1	"CSHMT, MGC15229, MGC24556, SHMT"	ENSG00000176974	"Serine hydroxymethyltransferase 1"	P34896	17	18327860-18363563	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"One-carbon metabolism"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 168.5;liver: 398.7"	"Group enriched"	"Detected in many"	4	"Hepatocytes: 307.7;Proximal tubular cells: 435.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA023314, HPA078682"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA		1500000	"Cluster 44: Non-specific - Transcription"	"Cluster 81: Kidney & Liver - Metabolism"	"Cluster 18: U-2197 - ECM organization"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Cytosol	Nucleoplasm	"HPA023314: AB_1856830, HPA078682: "	"unprognostic (4.76e-2)"	"unprognostic (1.98e-2)"	"unprognostic (5.46e-2)"	"unprognostic (3.76e-1)"	"unprognostic (2.45e-1)"	"unprognostic (8.44e-3)"	"prognostic favorable (2.52e-4)"	"unprognostic (7.55e-3)"	"unprognostic (4.50e-1)"	"unprognostic (2.42e-1)"	"unprognostic (2.14e-1)"	"unprognostic (1.70e-1)"	"prognostic favorable (8.54e-6)"	"unprognostic (1.70e-2)"	"unprognostic (2.66e-1)"	"unprognostic (2.57e-3)"	"unprognostic (4.04e-2)"	37.5	9.4	8.1	4.0	9.4	9.5	36.3	12.6	9.5	13.6	7.1	17.5	13.8	7.6	4.9	59.2	13.1	7.7	5.7	8.8	8.5	168.5	398.7	10.3	9.0	10.8	9.3	11.7	8.8	85.7	4.1	7.7	10.7	10.1	6.1	3.1	30.0	10.0	18.8	22.6	24.4	3.7	8.0	21.7	13.3	12.8	9.4	21.1	23.5	18.6	17.6	11.5	19.3	16.0	39.6	28.9	5.5	34.5	29.9	15.8	63.0	11.3	10.3	30.8	31.2	22.1	22.5	26.8	27.8	3.6	16.4	18.8	32.4	39.7	24.3	17.3	30.6	13.0	39.9	21.6	7.2	4.4	11.0	21.1	13.6	23.1	7.2	10.9	9.7	32.3	10.0	10.9	11.3	12.4	46.0	13.9	17.4	43.6	5.1	29.7	48.5	34.7	69.3	17.0	24.0	5.3	82.7	14.9	21.4	50.2	64.5	19.4	2.6	5.7	14.0	71.4	17.6	10.7	20.5	7.1	10.3	12.7	16.5	10.2	4.7	5.2	5.3	5.9	8.1	4.4	6.6	5.5	3.5	3.7	6.8	6.4	0.2	8.5	5.2	1.1	11.2	4.3	8.1	9.4	12.6	9.5	8.8	8.5	10.8	9.3	10.7	8.0	9.4	16.0	11.2	12.8	31.0	3.3	10.4	10.3	21.7	16.5	18.8	3.1	22.7	13.8	2.7	42.9	11.2	36.8	4.2	23.7	5.2	8.9	82.2	13.7	10.9	6.2	1.9	7.4	1.2	28.0	5.2	7.7	76.1	8.0	9.2	10.1	8.2	9.9	13.6	307.7	39.6	0.0	4.8	12.9	4.1	36.8	3.5	5.5	5.9	17.2	12.4	9.4	4.4	33.8	5.2	2.0	11.4	5.3	9.7	3.0	20.3	5.9	53.7	435.7	3.5	4.2	19.7	8.1	4.4	30.0	21.4	35.4	10.5	8.5	10.1	4.9	32.2	10.9
SHMT2	SHMT	ENSG00000182199	"Serine hydroxymethyltransferase 2"	P34897	12	57229573-57234935	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"One-carbon metabolism"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 182.3"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 182.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RH-30: 2292.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020543, HPA020549"	Enhanced		Supported	Microtubules,Mitochondria		NA	NA		390000	"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 85: Liver - Metabolism"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Mitochondria	Microtubules	"HPA020543: AB_1856833, HPA020549: AB_1856834"	"prognostic unfavorable (8.37e-5)"	"unprognostic (1.24e-1)"	"unprognostic (1.90e-1)"	"unprognostic (2.65e-2)"	"unprognostic (1.65e-1)"	"unprognostic (4.97e-2)"	"unprognostic (1.58e-2)"	"unprognostic (9.83e-2)"	"unprognostic (1.11e-2)"	"unprognostic (2.67e-2)"	"unprognostic (4.00e-2)"	"unprognostic (3.19e-2)"	"prognostic unfavorable (4.84e-8)"	"unprognostic (3.05e-1)"	"unprognostic (2.30e-1)"	"unprognostic (2.72e-1)"	"unprognostic (4.74e-2)"	25.4	25.4	18.5	43.3	18.6	41.4	23.8	20.7	22.2	22.5	18.4	32.4	35.5	19.4	18.9	46.5	23.3	20.2	24.2	21.1	20.3	32.4	182.3	23.6	52.2	20.6	20.6	25.8	62.2	15.6	15.8	33.6	21.2	13.8	27.2	13.9	30.7	11.7	36.6	36.4	27.0	27.3	20.1	34.9	32.2	5.1	21.8	36.0	34.7	30.5	58.6	26.4	23.6	23.0	246.9	137.6	123.5	368.0	101.8	152.4	238.1	140.8	237.9	197.0	176.5	200.1	120.4	499.8	217.3	186.5	80.6	167.3	229.4	250.6	108.9	265.0	201.9	199.7	79.6	180.1	680.9	333.1	181.0	191.2	351.9	163.4	538.4	176.0	175.3	283.8	223.0	472.3	141.0	210.6	271.0	217.9	123.1	111.8	223.4	181.2	2292.7	433.6	95.9	151.1	265.4	119.9	73.0	170.1	518.3	48.5	222.9	424.2	108.8	84.6	150.5	96.1	185.0	574.1	338.4	421.4	169.6	320.2	154.0	34.9	41.2	23.3	26.6	50.6	31.5	127.5	46.3	29.4	59.6	137.9	21.1	22.0	2.0	40.1	34.1	20.4	202.8	53.8	18.5	18.6	20.7	22.2	21.1	20.3	20.6	20.6	21.2	20.1	21.8	23.0	9.1	9.6	14.1	4.2	58.2	34.7	23.0	43.5	39.9	7.0	26.5	24.0	12.1	21.5	23.5	3.7	0.0	55.4	11.6	9.6	13.7	45.7	0.4	6.3	22.6	17.1	9.6	53.8	3.7	47.7	52.7	25.5	23.4	10.9	29.2	18.7	22.1	182.8	50.2	8.4	3.2	24.2	34.6	36.0	25.1	0.9	18.0	23.5	39.2	3.7	32.0	45.3	21.6	4.0	2.4	40.1	18.7	16.1	74.4	18.2	15.9	63.6	13.3	6.2	6.6	23.9	40.2	1.9	6.6	52.9	32.5	37.4	21.1	39.5	37.4	23.8
SHOC2	"KIAA0862, SOC-2, SOC2, SUR-8, SUR8"	ENSG00000108061	"SHOC2 leucine rich repeat scaffold protein"	Q9UQ13	10	110919593-111013666	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"			"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA009164, HPA048134"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 34: Non-specific - Transcription"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 65: Plasmacytoid DCs - Unknown function"	"Nucleoplasm, Cytosol"		"HPA009164: AB_1079960, HPA048134: "	"unprognostic (1.39e-1)"	"unprognostic (3.52e-2)"	"unprognostic (4.23e-3)"	"unprognostic (3.27e-2)"	"unprognostic (1.82e-2)"	"unprognostic (1.76e-2)"	"unprognostic (6.09e-2)"	"unprognostic (5.56e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.07e-1)"	"unprognostic (4.33e-2)"	"unprognostic (1.01e-1)"	"unprognostic (3.70e-3)"	"unprognostic (6.97e-3)"	"unprognostic (8.35e-2)"	"unprognostic (2.95e-2)"	"unprognostic (1.67e-1)"	25.0	16.3	16.4	22.5	17.8	45.7	19.3	19.3	22.1	20.3	12.0	20.4	16.4	20.7	21.0	21.6	16.4	20.1	19.5	19.4	22.3	21.9	23.7	17.9	29.9	16.6	21.7	19.8	20.4	30.3	14.6	20.8	22.0	18.0	21.5	19.7	14.2	17.5	21.3	15.4	18.4	23.3	16.4	22.2	17.3	36.4	18.2	26.9	25.2	26.8	31.2	25.0	14.8	15.5	29.2	17.8	22.7	38.2	50.9	51.2	14.5	35.0	51.9	31.9	38.5	16.5	25.8	63.1	17.1	62.8	19.9	24.1	27.8	25.0	46.2	34.7	16.5	28.8	25.7	16.2	37.0	49.6	49.4	57.3	38.6	36.9	69.1	43.6	32.8	22.1	18.3	43.8	45.7	15.6	24.7	38.9	14.1	15.6	18.6	34.8	45.2	18.1	33.3	19.4	11.7	23.4	30.7	15.0	34.9	25.8	77.2	41.5	33.3	25.6	22.6	32.5	24.3	40.2	44.0	100.1	30.6	50.3	18.6	52.3	22.8	33.5	12.6	26.8	15.5	30.3	14.8	15.0	22.3	24.4	15.6	15.2	65.8	19.5	27.8	15.2	19.2	23.9	16.4	17.8	19.3	22.1	19.4	22.3	16.6	21.7	22.0	16.4	18.2	15.5	73.8	54.5	48.1	35.6	95.4	55.8	35.2	37.5	27.9	27.6	51.4	39.1	83.6	45.8	42.3	31.3	16.7	22.2	77.5	80.8	64.6	48.5	44.2	65.1	54.6	63.5	26.3	67.5	59.9	59.2	23.0	50.7	49.5	54.9	73.4	20.2	53.2	69.0	29.4	30.3	53.1	36.2	46.8	78.3	67.3	89.7	65.6	76.0	49.8	57.1	116.5	31.5	57.7	46.3	61.0	64.0	51.6	80.9	53.4	37.1	51.7	67.7	57.0	32.7	72.3	59.9	58.7	108.8	69.3	38.1	69.9	60.6	65.8	17.0	30.1	49.7
SHQ1	"FLJ10539, Shq1p"	ENSG00000144736	"SHQ1, H/ACA ribonucleoprotein assembly factor"	Q6PI26	3	72749277-72861914	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Oligodendrocytes: 33.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"MOLT-4: 113.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042792	Uncertain		Supported	Nucleoplasm		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	Nucleoplasm		"HPA042792: AB_10959736"	"unprognostic (1.10e-2)"	"unprognostic (1.03e-1)"	"prognostic favorable (2.83e-4)"	"prognostic favorable (6.49e-4)"	"unprognostic (2.05e-1)"	"unprognostic (4.54e-3)"	"unprognostic (9.21e-3)"	"unprognostic (3.19e-2)"	"unprognostic (8.89e-2)"	"unprognostic (6.78e-3)"	"unprognostic (3.76e-1)"	"unprognostic (5.28e-2)"	"unprognostic (7.30e-3)"	"unprognostic (3.59e-3)"	"unprognostic (3.21e-2)"	"unprognostic (1.41e-2)"	"unprognostic (1.28e-1)"	5.9	7.0	7.3	8.1	10.1	9.2	8.1	7.1	7.6	6.7	6.1	8.8	6.7	7.1	11.4	6.4	10.7	5.6	10.1	5.1	6.6	7.4	8.0	6.2	8.9	7.1	7.0	7.6	7.0	8.5	4.6	5.3	7.4	5.7	8.7	5.5	5.7	6.0	9.1	7.5	6.1	8.0	5.2	7.0	6.4	10.0	8.0	15.3	8.2	8.6	10.0	8.4	5.1	10.4	13.5	18.1	12.0	20.3	15.7	19.2	12.1	21.8	15.8	22.4	24.6	14.5	10.7	22.4	10.2	15.2	18.2	10.9	24.9	20.5	27.5	20.1	19.6	23.3	14.1	17.3	15.9	39.7	18.8	19.2	15.4	33.1	13.6	10.4	21.2	35.8	19.0	13.5	18.5	20.2	113.4	14.1	33.9	41.5	22.7	27.1	18.8	17.3	19.7	17.6	7.6	30.4	20.3	14.3	10.6	16.0	14.7	14.9	15.1	18.0	17.5	30.1	19.5	24.9	53.8	32.7	16.1	32.0	18.3	0.9	11.9	4.3	14.2	13.5	19.1	13.7	15.8	15.4	12.3	13.3	17.7	15.4	0.5	24.2	12.3	17.6	14.4	14.5	7.3	10.1	7.1	7.6	5.1	6.6	7.1	7.0	7.4	5.2	8.0	10.4	5.9	12.8	6.9	8.8	8.3	13.3	4.3	6.9	5.7	7.5	7.2	5.3	9.5	4.3	6.5	5.5	0.0	6.1	9.9	4.3	7.9	8.6	6.9	11.5	9.6	9.1	4.2	10.3	12.1	6.1	7.9	7.1	5.6	8.0	15.2	6.6	11.4	7.6	6.9	3.3	13.5	6.8	4.1	6.6	6.2	1.9	5.9	5.7	5.4	20.6	4.1	3.2	2.1	16.1	33.9	6.5	4.3	5.7	6.1	5.1	4.7	5.7	16.2	5.4	0.0	8.0	5.9	9.1	19.5	10.8	10.2	5.7	7.6	14.8	9.3	3.9
SIAH3	FLJ39203	ENSG00000215475	"Siah E3 ubiquitin protein ligase family member 3"	Q8IW03	13	45777242-45851753	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 3.0;fallopian tube: 3.1"	"Group enriched"	"Detected in some"	5	"Endometrial ciliated cells: 28.6;Inhibitory neurons: 35.6"	"Cancer enhanced"	"Detected in some"		"endometrial cancer: 0.5;ovarian cancer: 0.7"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	6	"EFO-21: 1.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA060576	Uncertain		Supported	Nucleoplasm,Mitochondria		NA	NA				"Cluster 21: Non-specific - Transcription"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Mitochondria	Nucleoplasm	"HPA060576: AB_2684325"	"unprognostic (1.07e-3)"	"unprognostic (1.26e-1)"	"unprognostic (3.00e-2)"	"unprognostic (1.14e-1)"	"unprognostic (4.96e-2)"	"unprognostic (1.00e-2)"		"unprognostic (1.05e-1)"		"unprognostic (7.53e-2)"	"unprognostic (3.24e-4)"	"unprognostic (1.11e-1)"	"unprognostic (4.77e-3)"	"unprognostic (3.24e-3)"	"unprognostic (9.03e-4)"	"unprognostic (2.03e-1)"	"unprognostic (2.18e-1)"	0.0	0.2	0.7	0.1	0.9	0.1	0.0	2.3	0.8	0.9	0.0	0.0	0.0	0.3	0.3	0.0	3.1	0.0	0.0	0.6	0.7	0.6	0.0	0.0	0.0	0.8	3.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	1.2	0.3	0.7	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.1	0.4	0.1	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.9	2.3	0.8	0.6	0.7	0.8	3.0	0.8	0.6	0.4	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	6.2	0.0	0.0	0.5	0.0	0.0	1.8	2.1	0.0	0.0	0.0	1.9	0.0	0.0	28.6	0.5	0.0	0.0	0.0	4.7	0.0	0.0	0.0	0.0	3.5	0.0	0.1	0.0	0.0	0.0	0.0	35.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	3.6	1.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.1
SIGLEC10	"MGC126774, PRO940, SIGLEC-10, SLG2"	ENSG00000142512	"Sialic acid binding Ig like lectin 10"	Q96LC7	19	51410020-51417803	"Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Cell adhesion, Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 38.5"	"Cell type enhanced"	"Detected in some"		"B-cells: 33.0;granulocytes: 39.3;Kupffer cells: 93.9;Macrophages: 51.5"	"Cancer enhanced"	"Detected in all"		"glioma: 11.6"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"eosinophil: 765.3;intermediate monocyte: 252.0;non-classical monocyte: 539.2"	"Group enriched"	"Detected in many"	16	"granulocytes: 765.3;monocytes: 539.2"	"Cell line enhanced"	"Detected in some"		"Daudi: 28.8;HDLM-2: 9.0;HEL: 14.9;HMC-1: 10.7;NB-4: 10.4;U-698: 21.3;U-937: 12.0"	"Not detected"	"Not detected"							"CAB025807, HPA027093"	Enhanced		Supported	"Plasma membrane,Actin filaments,Cytosol"	"Intracellular and membrane"	NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 57: B-cells - Immune response"	Cytosol	"Plasma membrane, Actin filaments"	"CAB025807: , HPA027093: AB_1856858"	"unprognostic (7.18e-2)"	"unprognostic (3.90e-3)"	"unprognostic (1.11e-2)"	"unprognostic (3.67e-2)"	"unprognostic (3.95e-2)"	"unprognostic (9.41e-2)"	"unprognostic (8.18e-2)"	"unprognostic (2.11e-1)"	"unprognostic (3.16e-2)"	"unprognostic (1.83e-1)"	"unprognostic (1.63e-1)"	"unprognostic (3.12e-1)"	"prognostic unfavorable (4.74e-5)"	"unprognostic (2.73e-1)"	"unprognostic (1.69e-2)"	"unprognostic (1.39e-1)"	"unprognostic (9.05e-2)"	3.5	6.4	3.9	33.9	4.8	14.9	2.1	4.3	6.0	2.1	3.5	5.4	7.0	2.1	1.0	2.0	2.4	3.7	1.4	3.9	6.2	1.7	3.2	8.5	19.9	11.4	6.9	1.6	3.5	1.0	1.4	1.8	8.8	3.0	4.6	1.1	2.2	1.1	0.7	1.2	12.2	4.5	6.3	38.5	4.7	1.3	6.3	4.0	1.0	1.1	19.5	5.5	1.2	9.4	0.2	0.0	0.5	0.5	0.0	0.0	0.3	0.2	0.0	0.1	0.0	0.1	1.3	28.8	0.9	0.1	0.3	0.5	0.0	0.2	0.0	9.0	2.5	14.9	0.3	0.1	0.0	6.4	10.7	0.1	0.0	0.1	0.0	0.1	0.0	1.7	0.7	1.4	0.0	0.6	0.2	10.4	0.8	0.7	0.4	1.9	0.1	0.5	0.0	0.3	0.4	0.4	0.3	0.1	0.2	0.5	0.1	5.2	0.7	0.7	1.3	0.6	0.2	1.3	0.3	21.3	0.5	12.0	0.5	14.0	41.9	765.3	0.8	252.0	0.4	41.4	0.5	0.5	38.0	27.4	0.3	0.5	87.2	0.4	539.2	2.2	1.1	40.7	3.9	4.8	4.3	6.0	3.9	6.2	11.4	6.9	8.8	6.3	6.3	9.4	0.7	3.2	1.3	0.3	33.0	0.1	1.2	0.0	0.0	1.4	0.4	0.9	0.3	0.0	0.0	1.8	2.1	0.1	0.6	0.1	0.0	0.0	0.9	0.0	0.0	4.2	0.0	5.2	0.6	0.0	0.1	0.8	0.0	0.1	39.3	0.1	0.4	1.0	8.1	0.0	0.2	0.1	0.0	93.9	6.3	0.4	0.0	51.5	0.0	15.0	14.8	0.2	6.2	0.0	0.0	0.0	0.0	0.0	0.1	1.2	0.0	0.1	0.0	0.7	0.0	2.0	0.4	0.5	0.7	0.0	1.3	0.1	2.7	0.1	0.0	0.9
SIGLEC14		ENSG00000254415	"Sialic acid binding Ig like lectin 14"	Q08ET2	19	51642553-51646801	"Plasma proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"bone marrow: 28.3;lymphoid tissue: 40.3"	"Cell type enhanced"	"Detected in some"		"Hofbauer cells: 18.5;Kupffer cells: 41.5;Macrophages: 13.5;monocytes: 24.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"classical monocyte: 109.1;intermediate monocyte: 125.1;myeloid DC: 65.4;neutrophil: 200.1;non-classical monocyte: 93.3"	"Group enriched"	"Detected in many"	7	"dendritic cells: 65.4;granulocytes: 200.1;monocytes: 125.1"	"Group enriched"	"Detected in some"	11	"HMC-1: 98.7;U-937: 24.7"									"HPA014377, HPA014428"	Uncertain		Uncertain	"Vesicles,Plasma membrane"		NA	NA		24000000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 2: Immune cells - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	Vesicles	"Plasma membrane"	"HPA014377: AB_2189277, HPA014428: "	"unprognostic (3.05e-1)"	"unprognostic (1.75e-1)"	"unprognostic (6.47e-3)"	"unprognostic (1.60e-1)"	"unprognostic (3.83e-2)"	"unprognostic (1.50e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.46e-1)"	"unprognostic (9.77e-3)"	"unprognostic (9.28e-2)"	"unprognostic (6.73e-2)"	"unprognostic (1.02e-1)"	"unprognostic (4.28e-3)"	"unprognostic (8.38e-2)"	"unprognostic (4.17e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.89e-1)"	3.4	2.4	1.4	25.2	1.5	28.3	1.0	1.6	3.2	1.8	1.3	1.8	0.7	0.9	0.3	1.1	2.3	2.6	1.3	1.4	2.4	0.7	3.5	7.3	13.3	4.7	3.0	0.4	1.1	0.4	0.5	2.5	3.9	0.9	1.6	0.1	1.1	0.9	0.4	0.3	6.1	2.5	2.7	40.3	1.6	2.4	3.9	1.9	0.6	0.0	14.2	4.1	0.6	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	5.8	0.0	0.0	0.0	1.6	98.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.8	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	24.7	0.0	16.6	109.1	1.8	0.3	125.1	0.1	19.3	0.2	0.3	65.4	18.2	0.1	0.1	200.1	0.7	93.3	12.0	0.2	40.3	1.4	1.5	1.6	3.2	1.4	2.4	4.7	3.0	3.9	2.7	3.9	4.1	0.0	0.0	1.1	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.5	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	6.2	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.4	18.5	0.0	0.0	0.0	0.0	41.5	6.0	0.8	0.3	13.5	0.0	1.0	24.1	0.0	2.1	0.0	0.0	0.0	0.0	2.6	0.1	0.0	0.0	0.0	0.7	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.3	0.7	0.0	0.0	0.0
SIM2	"bHLHe15, MGC119447, SIM"	ENSG00000159263	"SIM bHLH transcription factor 2"	Q14190	21	36699115-36749917	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"esophagus: 31.1;kidney: 61.3"	"Group enriched"	"Detected in some"	4	"Basal squamous epithelial cells: 100.7;Squamous epithelial cells: 68.3"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 11.8"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 24.9;PC-3: 43.0;RPTEC TERT1: 54.3;RT4: 33.5"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"hypothalamus: 1.2"	HPA029295	Approved		Supported	"Nucleoplasm,Nuclear bodies"		No	No				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 61: Squamous epithelial cells - Keratinization"	"Nucleoplasm, Nuclear bodies"		"HPA029295: AB_10610425"	"unprognostic (1.17e-3)"	"unprognostic (6.46e-2)"	"unprognostic (5.03e-2)"	"prognostic unfavorable (2.10e-4)"	"unprognostic (8.62e-2)"	"unprognostic (1.43e-2)"	"unprognostic (8.30e-2)"	"unprognostic (5.46e-3)"	"unprognostic (1.65e-2)"	"unprognostic (1.09e-1)"	"unprognostic (5.16e-3)"	"unprognostic (9.18e-2)"	"unprognostic (9.18e-7)"	"unprognostic (2.98e-2)"	"unprognostic (3.79e-2)"	"unprognostic (1.07e-2)"	"prognostic favorable (2.88e-4)"	0.3	0.3	1.8	0.0	1.1	0.0	0.4	0.7	1.4	2.3	0.4	0.5	0.0	0.5	0.8	31.1	0.6	0.0	0.2	1.5	2.5	61.3	0.4	0.2	0.0	0.7	1.4	0.2	0.3	1.8	1.6	0.0	0.5	6.6	0.0	0.0	0.6	0.0	10.6	0.5	0.3	0.0	0.5	0.3	9.5	0.4	2.4	0.0	0.4	0.0	3.5	0.7	0.7	0.7	6.4	9.6	0.0	0.3	0.0	0.0	9.4	0.0	0.0	0.9	0.0	5.0	14.7	0.0	8.6	0.2	17.0	3.2	4.8	0.0	0.5	7.8	15.0	0.0	14.3	0.3	0.0	0.0	0.0	1.6	1.4	0.0	2.6	24.9	0.0	0.0	0.0	0.0	16.0	3.7	0.0	0.0	0.0	6.4	43.0	0.0	0.0	0.0	54.3	33.5	0.4	0.0	15.7	0.0	0.9	1.6	4.1	0.0	0.6	0.0	2.5	1.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	1.1	0.7	1.4	1.5	2.5	0.7	1.4	0.5	0.5	2.4	0.7	0.2	0.0	0.0	0.0	0.0	0.3	19.1	0.0	100.7	0.2	0.1	0.1	2.0	0.0	0.0	9.2	0.0	0.0	0.0	0.2	9.8	0.1	2.2	0.3	0.3	0.4	0.0	0.0	0.3	0.0	0.0	0.8	12.8	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.4	5.8	0.3	0.3	0.0	0.0	0.0	0.0	0.0	7.1	1.1	0.0	0.0	0.0	1.3	9.5	0.1	0.2	0.0	0.5	0.0	1.5	0.9	0.5	0.2	68.3	0.4	0.0	0.4	0.0	0.2	4.0
SIPA1L3	"KIAA0545, SPAR3"	ENSG00000105738	"Signal induced proliferation associated 1 like 3"	O60292	19	37907208-38208369	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		"GTPase activation"	Cataract	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 28.9"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 93.7;Inhibitory neurons: 87.3;Oligodendrocyte precursor cells: 99.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"A549: 59.6"	"Low region specificity"	"Detected in all"							"HPA042072, HPA045480, HPA074988"	Uncertain		Supported	"Nucleoplasm,Golgi apparatus,Plasma membrane"		NA	NA			"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 18: U-2197 - ECM organization"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Plasma membrane"	"Nucleoplasm, Golgi apparatus"	"HPA042072: AB_2677832, HPA045480: AB_2679342, HPA074988: "	"unprognostic (4.24e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.86e-1)"	"unprognostic (5.56e-2)"	"unprognostic (9.99e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.31e-2)"	"unprognostic (5.48e-2)"	"unprognostic (3.11e-1)"	"unprognostic (6.05e-2)"	"unprognostic (3.15e-1)"	"unprognostic (5.43e-2)"	"unprognostic (9.26e-3)"	"unprognostic (6.45e-2)"	"unprognostic (4.94e-2)"	"unprognostic (5.36e-2)"	"unprognostic (1.96e-2)"	2.2	3.0	6.0	6.6	3.0	2.9	5.1	10.4	16.2	4.8	2.6	10.6	18.4	3.3	1.3	4.9	4.8	3.9	6.2	28.9	2.0	6.4	3.4	5.7	6.8	4.2	4.1	2.9	9.7	3.3	3.2	1.4	3.5	5.3	7.0	5.0	8.4	3.5	6.5	11.1	18.1	1.8	1.6	7.3	9.1	4.3	5.6	3.8	10.0	7.3	5.5	4.3	3.6	5.5	34.4	59.6	7.3	9.3	4.3	4.3	4.9	14.5	12.2	9.4	8.8	20.6	19.5	19.5	12.2	12.4	7.9	7.6	6.7	27.1	10.4	6.7	3.3	5.3	5.5	6.5	8.3	3.7	5.5	3.3	14.1	17.5	37.3	13.9	10.8	5.6	3.9	4.1	16.6	10.6	5.0	5.1	6.0	27.2	15.8	10.8	5.9	2.9	20.7	29.1	17.3	9.3	16.0	27.1	2.2	3.9	18.0	3.5	23.2	15.6	5.5	48.4	22.6	5.4	10.0	6.6	20.1	4.9	20.6	0.1	0.1	0.4	0.1	0.2	0.0	1.1	0.1	0.2	0.1	1.5	0.1	0.5	0.1	0.3	1.5	0.3	0.1	0.1	6.0	3.0	10.4	16.2	28.9	2.0	4.2	4.1	3.5	1.6	5.6	5.5	4.8	6.4	10.1	41.4	24.5	12.0	5.2	10.4	6.2	21.9	22.6	12.1	5.2	22.8	10.8	23.9	14.6	2.1	9.3	93.7	3.9	7.2	4.5	19.8	4.8	5.4	25.2	10.8	61.1	15.3	1.4	3.7	40.2	16.5	2.5	4.8	6.4	23.5	3.5	33.7	87.3	46.3	20.3	5.1	13.9	9.2	2.1	8.3	5.4	50.6	7.1	3.0	5.2	99.5	58.7	13.4	38.7	1.9	12.8	6.6	50.0	21.1	19.1	5.7	6.6	4.5	3.6	1.7	5.1	8.9	16.1	0.8	5.1	1.7	30.4	5.6
SIRT1	SIR2L1	ENSG00000096717	"Sirtuin 1"	Q96EB6	10	67884656-67918390	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Apoptosis, Biological rhythms, Differentiation, Host-virus interaction, Myogenesis, Transcription, Transcription regulation"	"Developmental protein, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	5	"Early spermatids: 292.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003855, HPA006295, HPA052351"	Approved		Supported	"Nucleoplasm,Nucleoli fibrillar center,Mitochondria,Cytosol"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm	"Nucleoli fibrillar center, Mitochondria, Cytosol"	"CAB003855: AB_365497, HPA006295: AB_1079975, HPA052351: AB_2681796"	"unprognostic (1.55e-1)"	"unprognostic (2.78e-1)"	"unprognostic (9.13e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.91e-1)"	"unprognostic (2.05e-2)"	"unprognostic (2.48e-1)"	"unprognostic (4.95e-2)"	"unprognostic (1.41e-1)"	"unprognostic (4.64e-2)"	"unprognostic (1.72e-1)"	"unprognostic (9.61e-2)"	"unprognostic (2.18e-2)"	"unprognostic (2.83e-2)"	"unprognostic (9.67e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.39e-1)"	16.4	30.2	8.9	11.0	10.4	19.8	17.5	15.6	11.9	17.1	7.8	12.5	9.2	18.5	11.9	10.9	11.9	14.0	10.6	8.5	9.9	13.4	17.3	12.6	17.7	9.3	9.2	25.1	12.1	14.0	6.9	12.7	10.0	14.0	12.0	13.5	9.9	11.2	14.6	9.6	9.7	13.7	8.8	14.3	10.3	26.8	9.4	19.2	14.7	18.5	15.1	15.5	9.5	12.9	15.1	16.8	26.2	29.4	24.4	18.7	16.3	20.4	21.0	27.4	24.3	18.7	12.6	31.4	10.8	13.7	17.1	11.7	32.8	6.9	29.3	16.9	19.0	16.7	12.1	14.7	22.3	18.1	12.3	17.3	16.2	16.6	28.3	29.4	11.2	17.6	21.6	16.7	20.3	12.1	17.0	25.0	32.5	9.6	26.6	30.3	20.6	12.4	13.1	9.1	16.8	23.0	37.4	24.4	26.8	22.5	17.7	16.6	9.4	21.2	19.8	19.0	20.1	13.9	17.7	61.8	10.9	27.2	8.9	1.3	0.8	1.1	1.1	1.0	1.6	1.8	1.2	1.5	1.3	1.0	2.2	1.3	1.0	1.2	1.3	1.2	1.0	0.6	8.9	10.4	15.6	11.9	8.5	9.9	9.3	9.2	10.0	8.8	9.4	12.9	35.7	19.2	7.4	17.0	27.6	39.1	20.9	7.2	22.8	12.5	48.3	33.4	34.8	11.5	8.7	5.5	27.1	7.1	42.5	31.2	5.9	4.3	292.2	38.4	26.2	20.6	42.9	10.3	16.0	5.6	5.4	28.0	23.4	57.1	12.0	14.8	15.4	15.8	9.1	11.8	18.4	21.0	10.2	23.4	28.7	45.6	17.7	34.1	16.0	30.9	14.8	7.1	9.2	18.6	30.7	6.2	20.6	19.5	15.8	26.0	11.2	8.4	4.1	14.0	0.0	43.4	28.8	24.2	16.3	21.1	47.5	12.4	29.1	8.9	18.7	17.2
SIRT2	SIR2L	ENSG00000068903	"Sirtuin 2"	Q8IXJ6	19	38878555-38899862	"Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Autophagy, Cell cycle, Cell division, Differentiation, Immunity, Innate immunity, Meiosis, Mitosis, Neurogenesis, Transcription, Transcription regulation"	Transferase	"Cancer-related genes, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 302.1;tongue: 218.2"	"Cell type enhanced"	"Detected in all"		"Early spermatids: 173.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004573, HPA011165"	Approved		Supported	Nucleoplasm,Nucleoli,Cytosol		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 29: Early spermatids - Spermatogenesis"	"Nucleoli, Cytosol"	Nucleoplasm	"CAB004573: AB_2188600, HPA011165: AB_1856900"	"unprognostic (2.15e-2)"	"unprognostic (2.24e-2)"	"unprognostic (2.88e-1)"	"prognostic unfavorable (7.20e-7)"	"unprognostic (3.75e-3)"	"unprognostic (1.28e-2)"	"unprognostic (2.85e-2)"	"unprognostic (2.44e-3)"	"unprognostic (2.73e-1)"	"unprognostic (4.83e-2)"	"unprognostic (2.97e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.90e-1)"	"unprognostic (3.60e-2)"	"unprognostic (1.19e-1)"	"unprognostic (8.73e-2)"	"unprognostic (1.70e-1)"	43.2	44.0	101.6	11.5	137.5	17.4	39.7	141.1	123.0	41.5	79.4	49.2	12.6	37.2	10.4	42.5	37.2	15.0	76.9	100.7	111.2	35.9	51.5	38.2	13.7	151.0	129.6	49.0	33.4	18.2	31.2	10.5	144.7	32.7	10.2	11.9	41.5	14.9	302.1	48.8	32.4	18.3	121.3	40.1	41.4	43.5	127.6	13.1	34.5	218.2	13.0	41.3	37.8	173.5	16.1	9.8	8.4	20.6	46.7	31.8	5.8	11.3	20.2	17.8	22.7	17.1	10.2	5.4	23.7	21.3	13.2	8.3	14.6	25.1	10.9	25.2	15.6	10.1	10.9	10.9	33.0	7.0	22.4	33.5	29.7	14.4	16.9	21.4	31.9	17.7	10.1	42.0	28.2	8.9	15.4	6.2	1.2	27.6	13.6	19.9	22.8	15.3	14.8	14.9	20.7	9.0	12.9	17.8	13.0	7.0	8.0	19.2	28.9	24.0	5.1	37.2	17.0	16.9	8.8	12.6	18.1	19.0	22.0	48.9	54.7	59.8	44.9	69.1	28.5	24.9	21.9	31.0	42.9	28.9	14.3	23.6	42.7	36.5	56.7	44.0	33.1	51.9	101.6	137.5	141.1	123.0	100.7	111.2	151.0	129.6	144.7	121.3	127.6	173.5	39.5	16.0	19.4	26.1	21.0	51.6	30.3	35.1	35.3	29.7	28.8	29.7	42.1	14.3	27.2	12.9	35.5	36.5	90.8	28.4	37.2	29.0	173.0	24.7	15.4	31.1	17.5	27.1	31.2	17.6	15.2	30.3	44.9	26.5	25.4	29.5	28.5	19.7	66.3	30.3	27.2	24.1	97.6	38.3	51.7	74.8	31.1	37.1	46.2	11.2	20.0	22.6	85.5	76.4	110.8	26.5	23.9	41.0	39.7	14.9	54.0	38.8	30.1	28.2	19.7	113.5	27.9	15.3	7.2	30.1	60.1	42.3	45.8	31.3	18.2	21.5
SIRT5		ENSG00000124523	"Sirtuin 5"	Q9NXA8	6	13574227-13615158	"Metabolic proteins, Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 52.5;Distal tubular cells: 52.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021798, HPA022002, HPA022992"	Approved		Supported	Mitochondria		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"HPA021798: AB_1856911, HPA022002: AB_1856913, HPA022992: AB_1856915"	"unprognostic (8.53e-2)"	"unprognostic (7.79e-2)"	"unprognostic (4.71e-2)"	"unprognostic (5.26e-3)"	"unprognostic (6.19e-2)"	"unprognostic (1.63e-1)"	"unprognostic (8.72e-2)"	"unprognostic (1.38e-1)"	"unprognostic (8.54e-3)"	"unprognostic (2.77e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.65e-1)"	"prognostic favorable (8.76e-10)"	"unprognostic (2.39e-1)"	"unprognostic (6.88e-2)"	"unprognostic (6.86e-2)"	"unprognostic (2.36e-3)"	7.2	6.0	9.4	5.2	10.6	5.8	6.6	10.4	12.2	5.4	13.5	8.1	7.7	6.1	5.6	5.6	9.2	5.2	28.6	10.5	10.6	11.5	33.5	5.4	8.3	9.2	9.6	10.1	6.7	16.2	7.3	5.6	9.9	6.4	8.7	6.1	10.6	6.8	33.4	7.9	9.8	5.9	8.4	9.6	8.2	6.8	10.9	8.2	9.0	38.0	7.2	6.0	5.4	11.1	10.5	8.9	8.1	10.4	5.7	8.9	7.6	5.1	5.3	6.1	8.0	12.9	11.1	14.1	35.7	4.3	10.9	16.9	7.4	11.1	7.6	5.9	10.3	8.5	5.6	20.5	11.0	6.7	6.7	7.8	19.9	4.5	19.9	12.7	10.3	20.3	13.8	4.6	6.5	12.3	8.2	13.2	7.7	16.9	13.7	15.4	4.4	24.4	10.3	11.0	13.7	4.5	4.3	7.9	25.9	25.0	11.6	4.9	8.6	6.6	3.4	4.2	5.8	11.6	15.4	10.7	4.5	7.3	8.4	0.7	6.0	16.7	9.9	9.2	10.7	14.0	13.0	9.5	6.3	12.7	11.8	10.8	2.6	11.8	17.3	5.9	10.7	7.9	9.4	10.6	10.4	12.2	10.5	10.6	9.2	9.6	9.9	8.4	10.9	11.1	16.6	28.9	3.2	30.0	8.2	4.1	11.4	14.9	10.8	7.3	9.7	9.9	52.5	15.7	16.8	11.0	0.0	20.5	6.6	9.4	52.8	13.0	2.9	13.1	5.4	12.3	6.1	15.8	36.6	6.7	10.5	6.7	6.6	8.1	0.0	23.5	9.7	25.7	9.4	1.7	39.2	13.2	8.2	13.9	3.8	2.0	8.1	8.4	5.4	14.0	6.3	11.6	10.3	15.1	25.8	7.2	13.4	5.7	4.7	6.2	18.1	34.1	22.5	7.2	0.0	9.8	6.6	8.5	12.0	9.8	4.5	10.7	7.9	13.2	15.0	9.0
SIRT6		ENSG00000077463	"Sirtuin 6"	Q8N6T7	19	4174109-4182566	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Transferase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"Distal enterocytes: 199.2;Paneth cells: 129.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049729, HPA071776"	Supported		Supported	Nucleoplasm,Vesicles		No	No			"Cluster 52: Eosinophils - Transcription"	"Cluster 45: Intestine - Brush border"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm	Vesicles	"HPA049729: AB_2680865, HPA071776: AB_2686445"	"unprognostic (4.58e-1)"	"unprognostic (3.41e-3)"	"unprognostic (1.36e-1)"	"prognostic favorable (2.85e-4)"	"unprognostic (2.28e-1)"	"unprognostic (4.14e-2)"	"unprognostic (2.93e-3)"	"unprognostic (8.32e-2)"	"unprognostic (1.86e-1)"	"unprognostic (6.13e-2)"	"unprognostic (7.27e-3)"	"unprognostic (4.42e-2)"	"unprognostic (5.84e-2)"	"prognostic favorable (9.13e-4)"	"unprognostic (5.17e-2)"	"unprognostic (1.63e-1)"	"prognostic favorable (2.58e-4)"	8.2	12.0	10.4	7.8	10.6	10.4	8.6	10.3	15.1	10.5	8.7	23.6	10.0	10.6	2.4	12.3	9.2	3.5	10.0	10.7	10.2	13.7	11.0	8.9	7.1	11.2	10.3	7.5	14.1	5.2	13.3	4.3	10.5	12.7	7.5	1.9	9.3	5.0	8.0	11.8	14.2	2.6	9.8	15.3	9.8	6.0	12.1	4.9	10.1	2.7	3.9	9.9	9.7	10.6	25.7	16.8	8.3	10.4	6.5	6.2	12.9	12.0	8.9	10.1	8.8	11.2	9.5	16.0	12.9	8.1	9.1	15.9	4.6	12.9	1.6	30.8	10.0	6.8	9.7	10.3	14.3	17.4	25.2	7.9	10.4	10.3	6.4	7.7	8.7	15.0	15.2	35.3	5.4	19.2	23.9	18.3	14.5	9.3	15.2	18.9	7.7	18.8	9.7	11.4	11.0	18.1	11.0	10.2	24.1	3.2	10.2	23.0	12.2	10.4	10.5	36.9	17.4	45.6	25.7	18.4	20.8	28.1	12.7	5.3	13.1	12.2	10.8	16.3	6.4	9.6	7.5	8.7	14.3	10.1	6.4	6.1	11.8	5.6	13.5	11.9	12.6	8.5	10.4	10.6	10.3	15.1	10.7	10.2	11.2	10.3	10.5	9.8	12.1	10.6	9.2	12.8	7.3	5.9	13.8	10.3	10.3	32.3	9.6	12.6	6.6	6.3	3.2	7.2	18.4	5.5	18.8	24.1	7.1	199.2	13.7	32.2	1.9	6.2	7.9	11.8	26.4	9.5	8.9	26.7	24.2	9.3	19.9	9.2	5.7	5.6	13.6	6.8	24.0	13.5	10.4	29.1	18.3	11.7	10.1	2.6	11.5	15.0	5.4	1.9	27.0	15.2	14.4	3.5	6.3	32.5	129.7	8.2	10.3	9.7	28.2	14.3	11.0	13.8	0.0	7.2	11.3	7.4	9.6	13.3	12.6	25.6	10.6	7.9	30.9	11.9
SIRT7		ENSG00000187531	"Sirtuin 7"	Q9NRC8	17	81911939-81921323	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, Transcription, Transcription regulation"	"Chromatin regulator, Repressor, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Gastric mucus-secreting cells: 152.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"eosinophil: 22.2"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027284, HPA028246, CAB037261, HPA053669"	Approved		Supported	"Nucleoplasm,Nuclear speckles"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 37: Intestine - Unknown function"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm	"Nuclear speckles"	"CAB037261: AB_1079989, HPA027284: , HPA028246: , HPA053669: AB_2682224"	"unprognostic (8.15e-3)"	"unprognostic (3.24e-2)"	"unprognostic (3.26e-2)"	"unprognostic (2.41e-2)"	"unprognostic (1.46e-1)"	"unprognostic (3.36e-2)"	"prognostic unfavorable (1.97e-5)"	"unprognostic (3.03e-1)"	"unprognostic (2.10e-1)"	"unprognostic (2.46e-2)"	"unprognostic (2.79e-1)"	"unprognostic (1.71e-2)"	"prognostic unfavorable (1.69e-7)"	"unprognostic (4.34e-3)"	"unprognostic (1.20e-1)"	"unprognostic (4.77e-2)"	"unprognostic (2.16e-2)"	8.8	8.0	6.8	7.4	7.3	23.2	8.6	7.5	8.6	12.5	7.4	17.3	12.9	7.0	1.9	42.1	8.0	5.4	6.4	6.9	6.7	11.5	14.2	9.6	11.8	7.6	7.0	6.0	12.8	5.4	6.9	4.2	7.4	9.8	5.8	0.6	14.1	3.7	6.2	22.4	17.1	3.6	7.0	18.7	17.9	13.3	7.6	9.4	7.9	3.7	7.2	10.8	18.0	7.6	26.5	21.7	2.8	9.5	6.9	6.4	17.0	13.1	10.8	15.1	14.1	18.7	20.7	11.8	9.9	7.3	9.6	18.8	10.5	8.1	4.9	10.2	22.9	10.4	10.7	29.7	20.4	13.6	20.5	6.5	25.0	14.5	11.9	6.4	11.3	6.5	11.3	5.8	7.2	20.9	14.6	19.5	6.8	40.6	22.3	9.7	5.5	11.1	14.7	17.4	11.1	14.6	15.0	35.9	17.7	5.0	15.1	32.1	9.0	6.8	14.9	12.9	24.2	9.5	3.2	9.0	16.6	18.4	11.3	4.5	2.6	22.2	2.8	3.8	0.9	4.5	2.1	2.3	1.4	7.0	2.0	0.7	4.4	1.8	3.3	2.1	1.2	1.5	6.8	7.3	7.5	8.6	6.9	6.7	7.6	7.0	7.4	7.0	7.6	7.6	15.2	12.8	12.2	12.4	41.4	38.0	25.8	21.1	28.5	23.4	27.4	19.0	4.4	18.6	18.7	18.4	56.3	31.1	62.8	99.0	9.8	22.4	21.8	28.8	14.0	15.4	20.4	16.0	14.3	13.6	33.2	12.4	152.9	37.0	11.4	20.1	15.0	16.0	26.1	30.3	10.6	34.6	28.5	26.4	33.5	14.1	14.3	29.4	24.9	5.6	47.3	14.7	71.1	6.6	13.8	52.7	74.5	10.1	33.2	29.1	74.7	16.0	29.6	39.1	0.0	12.5	15.5	41.3	37.4	52.4	55.5	49.3	50.8	17.9	44.6	53.9
SIVA1	"CD27BP, SIVA, Siva-1, Siva-2"	ENSG00000184990	"SIVA1 apoptosis inducing factor"	O15304	14	104753147-104768494	"Predicted intracellular proteins"	"Apoptosis, Host-virus interaction"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"MCF7: 506.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA065398, HPA066693"			Supported	Nucleoplasm		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"HPA065398: AB_2685484, HPA066693: AB_2685703"	"unprognostic (1.86e-1)"	"prognostic favorable (5.95e-4)"	"unprognostic (1.61e-1)"	"unprognostic (1.51e-1)"	"unprognostic (6.89e-2)"	"unprognostic (2.27e-1)"	"unprognostic (4.77e-3)"	"unprognostic (2.89e-1)"	"unprognostic (2.17e-2)"	"unprognostic (7.19e-3)"	"unprognostic (5.85e-3)"	"unprognostic (3.21e-2)"	"unprognostic (4.94e-2)"	"unprognostic (3.06e-2)"	"unprognostic (4.08e-1)"	"unprognostic (3.51e-1)"	"unprognostic (7.43e-2)"	79.8	64.3	36.0	28.4	37.7	102.2	80.8	36.1	60.4	95.9	43.3	108.3	39.8	78.5	9.0	76.1	86.2	24.2	104.6	35.0	36.8	79.6	155.7	65.1	39.6	39.0	36.5	94.4	103.9	16.0	94.2	27.5	36.5	87.8	7.1	3.1	63.2	37.0	168.8	65.5	73.8	10.5	38.3	83.3	91.1	102.7	40.8	69.7	82.9	35.5	12.7	85.4	78.0	38.9	143.3	233.6	58.9	94.8	19.4	24.7	157.8	76.5	41.5	92.2	80.3	179.8	124.1	135.9	109.6	27.5	60.3	138.4	23.2	77.2	7.9	106.6	230.9	56.5	129.5	214.6	48.4	98.8	95.3	29.9	34.5	42.1	13.5	13.6	53.8	382.9	57.7	76.1	22.2	506.6	319.6	225.9	85.9	94.1	317.9	186.6	117.8	107.8	20.7	133.3	151.6	76.2	107.3	63.1	106.4	9.4	123.5	103.0	58.6	74.4	92.8	176.4	124.8	61.0	71.0	161.9	85.6	112.3	84.7	210.7	139.5	255.0	140.4	171.6	159.5	205.1	167.3	154.6	107.5	195.3	182.3	156.1	134.0	102.7	188.2	502.3	195.3	193.9	36.0	37.7	36.1	60.4	35.0	36.8	39.0	36.5	36.5	38.3	40.8	38.9	127.0	60.9	126.7	8.1	109.3	116.5	213.0	188.9	92.8	38.7	178.1	261.1	54.6	107.2	130.2	103.0	12.5	297.4	147.9	145.0	138.9	91.2	241.3	103.3	88.9	109.6	91.1	148.5	6.3	170.9	345.1	139.8	63.7	74.3	145.1	127.9	163.1	221.0	180.6	38.7	6.3	194.0	103.7	89.7	106.5	54.1	140.8	98.0	108.5	5.6	119.6	143.9	84.5	4.5	9.9	113.2	131.8	124.1	131.3	162.4	201.4	180.2	176.5	45.3	111.7	126.2	143.1	368.9	325.2	112.8	116.9	278.4	115.2	136.3	198.7	218.8
SIX1	DFNA23	ENSG00000126778	"SIX homeobox 1"	Q15475	14	60643421-60658259	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Apoptosis, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding, Repressor"	"Cancer-related genes, Deafness, Disease variant, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"parathyroid gland: 47.8;salivary gland: 51.1;skeletal muscle: 119.4;tongue: 46.3"	"Cell type enhanced"	"Detected in some"		"Basal prostatic cells: 30.7;Basal respiratory cells: 30.8;Club cells: 33.9;Ionocytes: 30.5;Prostatic glandular cells: 27.4;Respiratory ciliated cells: 67.1;Skeletal myocytes: 77.3;Spermatogonia: 25.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 36.3;LHCN-M2: 142.2;RH-30: 71.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"HPA001893, CAB058690"	Enhanced		Supported	Nucleoplasm,Nucleoli		No	No				"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 50: Fibroblasts - ECM organization"	Nucleoplasm	Nucleoli	"CAB058690: AB_2665581, HPA001893: AB_1079991"	"unprognostic (3.62e-1)"	"unprognostic (5.44e-2)"	"unprognostic (5.09e-2)"	"prognostic unfavorable (8.92e-6)"	"unprognostic (1.33e-2)"	"unprognostic (1.44e-2)"	"unprognostic (2.04e-3)"	"prognostic favorable (3.94e-4)"	"unprognostic (1.40e-1)"	"unprognostic (9.15e-2)"	"unprognostic (6.45e-2)"	"unprognostic (1.89e-1)"	"unprognostic (3.06e-8)"	"unprognostic (8.61e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.94e-1)"	"unprognostic (3.86e-1)"	5.5	0.4	0.3	0.0	0.5	0.0	1.9	0.5	1.2	15.2	1.0	0.0	0.0	0.0	0.4	1.1	0.8	0.5	0.0	0.3	0.3	0.0	0.0	1.5	0.5	0.3	0.4	0.2	0.3	47.8	19.8	0.0	0.4	13.2	0.0	0.0	51.1	0.2	119.4	0.3	0.0	0.0	0.3	0.0	0.4	1.7	0.5	9.7	1.9	46.3	0.2	1.6	0.8	0.4	15.2	3.5	0.6	28.1	17.0	20.6	0.4	4.1	10.6	4.9	4.0	0.0	8.2	0.0	2.2	0.6	2.1	4.4	10.3	6.4	2.1	0.0	17.1	2.0	1.9	6.8	0.0	0.0	0.2	15.6	4.9	2.3	0.7	36.3	0.3	1.6	5.8	0.0	142.2	2.8	0.0	0.5	0.0	0.0	8.9	0.0	71.9	0.0	5.9	16.3	2.5	0.3	5.0	0.3	6.1	0.5	3.3	0.4	13.9	6.7	5.4	7.9	6.5	0.5	0.1	0.0	1.5	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.5	0.5	1.2	0.3	0.3	0.3	0.4	0.4	0.3	0.5	0.4	0.8	3.2	1.5	0.0	0.0	0.1	30.7	30.8	0.6	0.0	1.0	0.8	0.9	0.0	33.9	1.8	0.0	0.2	0.0	0.1	1.9	0.0	0.2	1.1	0.1	1.6	0.0	0.0	0.0	0.8	0.4	5.7	0.5	1.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	30.5	0.0	0.0	0.6	0.0	0.3	0.0	1.9	0.0	0.8	0.0	1.0	0.1	0.2	0.0	1.2	0.0	27.4	0.0	0.1	67.1	0.2	0.0	77.3	5.1	0.0	25.0	0.1	0.1	0.3	0.1	0.1	0.0	18.3
SIX2		ENSG00000170577	"SIX homeobox 2"	Q9NPC8	2	45005182-45009452	"Predicted intracellular proteins, Transcription factors"		"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"salivary gland: 21.1;skeletal muscle: 33.8"	"Cell type enhanced"	"Detected in some"		"Basal respiratory cells: 6.1;Cardiomyocytes: 3.3;Fibroblasts: 3.0;Ionocytes: 8.2;Skeletal myocytes: 8.5;Smooth muscle cells: 3.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 48.8;LHCN-M2: 46.8;RH-30: 31.9;SCLC-21H: 54.3;U-2197: 35.3;U-698: 43.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			HPA056958			Supported	"Nucleoplasm,Nuclear membrane"		NA	NA				"Cluster 59: Non-specific - Translation"	"Cluster 18: U-2197 - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	Nucleoplasm	"Nuclear membrane"	"HPA056958: AB_2683287"	"unprognostic (1.14e-3)"	"unprognostic (2.73e-2)"	"unprognostic (3.09e-6)"	"unprognostic (1.28e-2)"	"unprognostic (3.28e-1)"	"unprognostic (8.77e-2)"	"unprognostic (4.06e-3)"	"unprognostic (9.17e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.02e-2)"	"unprognostic (1.07e-2)"	"unprognostic (4.53e-9)"	"unprognostic (1.53e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.56e-5)"	"unprognostic (1.05e-1)"	10.4	0.1	0.1	0.1	0.3	0.0	1.6	0.2	0.5	11.6	0.5	0.7	0.0	1.7	0.1	0.2	0.2	0.0	1.5	0.9	0.2	0.5	0.0	0.2	0.1	0.4	1.5	0.1	6.0	2.1	12.9	0.1	1.7	6.2	0.0	0.9	21.1	1.2	33.8	0.4	0.1	0.1	0.1	0.0	9.5	0.3	0.2	3.9	0.6	15.5	0.0	1.8	8.6	0.2	0.7	0.0	0.0	4.2	13.0	48.8	0.0	0.2	2.3	1.0	0.1	0.4	0.0	0.0	2.2	0.0	0.4	0.1	4.7	8.5	0.6	0.0	2.5	0.0	16.7	0.0	0.0	0.0	4.5	2.4	0.1	10.4	0.1	0.4	1.6	0.5	0.2	0.0	46.8	1.7	0.0	2.8	0.4	0.0	10.2	0.0	31.9	0.0	0.1	2.7	54.3	0.4	7.1	0.2	0.0	0.5	0.4	4.2	0.7	0.9	2.7	35.3	0.0	1.0	0.0	43.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.2	0.5	0.9	0.2	0.4	1.5	1.7	0.1	0.2	0.2	0.6	0.0	0.0	0.0	0.0	0.9	0.4	6.1	0.0	0.0	1.2	0.6	3.3	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	1.5	0.4	0.0	0.0	0.0	2.2	0.0	3.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	8.2	0.0	1.2	0.0	0.0	0.0	1.8	0.0	0.0	0.5	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.5	0.0	0.0	1.0	0.5	0.0	8.5	3.2	0.0	0.4	0.0	0.9	0.0	0.0	0.2	0.0	0.2
SKA3	"C13orf3, MGC4832, RAMA1"	ENSG00000165480	"Spindle and kinetochore associated complex subunit 3"	Q8IX90	13	21153595-21176552	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 4.7;lymphoid tissue: 12.1;testis: 6.3"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 12.8;Extravillous trophoblasts: 21.0;Spermatocytes: 21.7;Spermatogonia: 18.2"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA039272, HPA039356, HPA061534"	Approved		Supported	"Mitotic spindle,Centrosome,Cytosol"		Yes	Yes			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Mitotic spindle"	"Centrosome, Cytosol"	"HPA039272: AB_10805359, HPA039356: AB_10805475, HPA061534: "	"unprognostic (3.46e-2)"	"unprognostic (7.21e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.62e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.77e-1)"	"prognostic unfavorable (9.73e-6)"	"unprognostic (2.03e-3)"	"prognostic unfavorable (8.71e-4)"	"unprognostic (2.03e-1)"	"prognostic unfavorable (3.77e-4)"	"unprognostic (1.39e-2)"	"unprognostic (0.00e+0)"	"unprognostic (2.24e-3)"	"unprognostic (1.81e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.32e-1)"	0.2	0.1	0.2	2.5	0.2	4.7	0.8	0.1	0.3	0.2	0.0	1.7	1.0	0.5	0.0	1.9	0.2	0.4	0.0	0.5	0.2	0.1	0.2	0.2	4.3	0.2	0.2	0.0	0.0	0.0	0.0	1.6	0.2	0.0	3.0	0.0	0.2	0.0	0.0	1.8	2.1	1.1	0.2	0.7	1.0	6.3	0.3	12.1	0.1	0.1	3.7	0.4	0.5	0.2	26.1	13.0	25.8	20.5	0.9	5.1	19.1	35.0	14.8	42.1	28.7	23.4	27.8	35.6	10.0	19.3	18.5	24.4	34.4	15.2	54.7	30.3	15.9	47.3	7.7	12.7	0.0	39.5	17.7	1.5	1.0	34.9	15.4	4.2	20.7	30.6	26.3	14.2	33.9	21.0	60.7	37.8	27.9	42.8	23.8	36.5	50.3	15.8	12.2	9.9	30.1	11.1	11.8	17.1	8.1	17.9	15.3	33.5	8.7	16.0	23.8	17.0	43.9	9.0	19.7	34.5	4.4	31.1	51.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.5	0.1	0.2	0.2	0.1	0.3	0.5	0.2	0.2	0.2	0.2	0.2	0.3	0.2	0.4	0.0	0.0	0.0	2.6	2.0	0.7	2.4	0.0	0.1	0.9	0.8	0.8	0.0	1.8	0.0	0.0	8.7	1.0	2.1	0.0	1.2	6.3	2.8	0.9	1.4	0.0	12.8	0.8	1.3	21.0	2.1	1.5	1.6	0.0	5.8	1.8	0.4	5.5	0.0	0.6	1.8	2.0	1.9	2.9	7.7	1.5	1.6	0.0	1.9	0.8	0.3	3.1	0.0	0.2	1.0	1.6	1.2	8.5	0.3	0.4	0.6	2.0	0.4	0.0	0.3	2.3	21.7	18.2	5.8	2.8	2.2	1.2	0.5	5.0	0.7
SKAP2	"RA70, SAPS, SCAP2, SKAP-HOM, SKAP55R"	ENSG00000005020	"Src kinase associated phosphoprotein 2"	O75563	7	26667068-26995239	"Predicted intracellular proteins"	"B-cell activation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 313.5;Kupffer cells: 192.2;Late spermatids: 354.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 149.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005560, HPA024045"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA		1000000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 16: Immune cells - Immune response"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 57: B-cells - Immune response"	Nucleoplasm	Cytosol	"HPA005560: AB_2667360, HPA024045: AB_2671416"	"unprognostic (8.52e-2)"	"unprognostic (5.57e-2)"	"unprognostic (3.76e-1)"	"unprognostic (5.62e-2)"	"unprognostic (7.91e-3)"	"unprognostic (1.30e-1)"	"unprognostic (1.07e-3)"	"unprognostic (4.15e-3)"	"unprognostic (1.82e-1)"	"unprognostic (1.41e-2)"	"unprognostic (1.26e-2)"	"unprognostic (3.80e-2)"	"unprognostic (1.94e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.89e-1)"	"unprognostic (1.12e-1)"	"unprognostic (3.51e-2)"	32.1	24.0	6.6	30.1	7.3	21.2	16.3	5.9	7.6	9.8	4.3	23.2	15.9	5.1	17.7	13.7	13.6	14.1	4.5	7.3	8.4	27.9	11.9	25.5	32.0	16.0	8.3	18.8	6.0	26.9	4.0	8.0	15.3	9.0	21.9	4.0	5.4	11.9	6.6	10.9	21.0	13.0	19.4	36.3	12.5	15.7	9.3	11.4	7.2	3.2	30.0	25.5	9.2	26.0	38.1	19.8	2.0	48.5	9.0	7.4	12.0	15.2	22.5	7.4	18.4	15.8	149.4	29.2	65.2	28.9	54.1	20.2	26.9	15.5	15.6	16.8	43.0	32.3	5.3	20.9	11.9	60.2	109.0	32.3	14.2	21.6	29.2	1.3	45.4	0.0	17.5	14.8	29.6	7.0	0.1	30.2	1.7	33.9	19.3	38.8	4.7	2.3	90.2	29.4	23.7	0.9	27.6	14.8	20.9	10.9	20.4	31.2	67.0	12.2	0.4	41.2	15.9	23.1	31.7	50.8	29.3	76.3	48.0	28.7	33.9	55.8	9.6	42.1	13.2	26.3	5.2	7.8	26.4	21.5	1.2	7.0	100.9	23.5	53.7	33.8	10.1	20.0	6.6	7.3	5.9	7.6	7.3	8.4	16.0	8.3	15.3	19.4	9.3	26.0	93.0	19.2	28.3	9.4	98.9	26.5	38.7	9.9	42.7	12.5	29.5	27.2	5.3	2.8	12.4	23.9	12.5	13.4	101.2	51.4	64.6	8.3	313.5	20.1	1.8	50.5	43.1	54.7	76.1	23.1	22.7	34.5	9.7	19.9	53.2	11.1	110.7	10.8	91.4	5.0	36.0	65.2	34.6	192.2	58.9	354.2	9.0	149.4	19.6	119.0	115.4	12.3	63.8	3.0	15.9	19.4	37.6	10.9	29.9	18.3	54.4	103.1	20.2	12.8	0.0	11.5	33.5	26.7	45.0	38.1	43.3	18.6	36.4	41.8	48.8	35.1
SKI		ENSG00000157933	"SKI proto-oncogene"	P12755	1	2228319-2310213	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			"Craniosynostosis, Disease variant, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010449, HPA066567"	Approved		Supported	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Nucleoplasm, Nuclear bodies"		"CAB010449: AB_2187342, HPA066567: AB_2685692"	"unprognostic (3.99e-2)"	"unprognostic (3.81e-2)"	"unprognostic (1.44e-1)"	"unprognostic (5.42e-2)"	"unprognostic (4.66e-2)"	"unprognostic (7.32e-2)"	"unprognostic (1.88e-1)"	"unprognostic (9.14e-2)"	"unprognostic (1.08e-1)"	"unprognostic (4.76e-2)"	"unprognostic (4.94e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.56e-3)"	"unprognostic (1.88e-1)"	"unprognostic (7.82e-2)"	"unprognostic (9.69e-2)"	"unprognostic (5.24e-3)"	38.3	14.3	22.0	14.1	20.9	11.5	31.5	59.5	24.2	37.5	3.4	34.6	9.3	42.0	8.3	23.5	34.1	14.6	34.4	24.1	11.0	23.6	24.3	33.9	11.6	20.1	16.9	36.4	13.1	7.3	23.0	13.9	17.2	26.8	7.0	5.1	25.2	19.8	22.1	38.6	24.1	16.8	17.1	22.9	22.6	13.2	19.4	8.7	25.4	11.7	10.2	30.8	29.2	15.7	18.3	10.4	24.5	23.9	40.0	23.8	16.1	26.7	14.8	16.3	11.9	15.8	13.7	11.5	19.5	34.4	6.8	21.0	13.8	21.6	15.0	12.7	30.0	29.0	16.4	22.5	26.7	16.5	29.8	25.8	11.8	24.5	18.2	30.0	20.2	4.8	16.6	8.6	20.2	11.6	2.0	18.1	24.8	12.0	19.8	9.1	15.5	9.6	13.9	7.0	35.0	22.9	26.0	22.9	26.7	15.6	7.7	20.9	36.9	27.7	17.5	39.6	21.1	6.7	5.2	10.5	14.8	28.2	11.6	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.5	0.2	0.0	0.0	0.0	0.0	22.0	20.9	59.5	24.2	24.1	11.0	20.1	16.9	17.2	17.1	19.4	15.7	44.2	9.6	12.6	18.9	18.8	47.0	13.1	7.0	32.5	8.9	20.3	25.8	12.7	11.5	6.7	7.3	0.0	7.3	32.2	7.3	1.9	8.2	0.8	10.1	28.9	34.3	6.0	14.7	22.6	6.9	15.5	35.5	9.7	18.5	13.3	6.4	33.9	23.0	13.7	11.8	24.1	14.3	0.0	16.4	29.5	5.0	49.7	28.9	16.0	48.7	9.4	11.1	12.3	11.6	11.4	13.0	9.4	55.3	16.9	14.9	8.1	6.0	4.0	4.4	46.0	36.2	37.3	4.7	12.8	32.2	45.0	16.3	33.4	6.7	10.7	11.4
SKIL	"SNO, SnoA, SnoN"	ENSG00000136603	"SKI like proto-oncogene"	P12757	3	170357678-170396835	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008472, HPA014233"	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm	Cytosol	"HPA008472: AB_1856933, HPA014233: "	"unprognostic (5.50e-2)"	"unprognostic (1.71e-2)"	"unprognostic (3.95e-2)"	"unprognostic (3.51e-3)"	"unprognostic (7.66e-2)"	"unprognostic (6.45e-2)"	"unprognostic (2.21e-2)"	"unprognostic (1.68e-2)"	"unprognostic (2.52e-2)"	"unprognostic (7.79e-2)"	"unprognostic (2.26e-3)"	"unprognostic (3.25e-2)"	"prognostic unfavorable (1.19e-7)"	"unprognostic (2.94e-2)"	"unprognostic (7.34e-2)"	"unprognostic (8.73e-2)"	"unprognostic (3.34e-1)"	11.9	12.0	6.1	18.8	7.3	23.1	9.0	8.5	10.0	9.4	8.3	10.4	13.8	12.0	8.2	9.2	6.4	21.1	12.0	6.6	10.9	10.3	15.6	16.1	13.8	10.7	10.8	9.2	9.6	5.7	11.0	13.9	10.5	11.6	9.7	9.6	7.4	8.9	11.0	5.8	14.2	10.5	12.0	7.2	15.9	13.0	11.4	9.2	11.3	21.4	18.4	14.6	8.8	13.2	19.9	24.0	15.6	10.4	20.0	8.7	29.1	19.6	13.6	13.8	10.6	4.9	42.2	24.9	60.5	18.2	23.1	44.8	9.9	9.0	21.3	43.6	9.2	32.8	24.8	11.0	17.8	13.7	17.4	15.3	8.8	19.9	15.0	42.9	34.1	2.4	14.7	27.9	28.4	21.3	5.9	4.5	61.2	21.8	8.1	13.6	52.8	5.0	20.8	31.7	11.5	14.1	48.3	47.4	10.3	31.6	32.2	14.2	66.1	38.2	35.9	33.0	37.1	36.2	18.6	47.3	14.3	7.1	18.3	3.1	3.4	1.8	1.3	8.3	1.8	3.6	1.1	1.7	2.4	4.4	1.9	2.0	4.0	2.8	10.3	1.6	0.5	1.9	6.1	7.3	8.5	10.0	6.6	10.9	10.7	10.8	10.5	12.0	11.4	13.2	104.1	73.7	72.8	21.2	142.1	72.7	88.8	52.5	67.7	25.6	79.3	38.1	12.4	21.5	70.4	35.0	54.2	14.8	124.9	45.9	15.6	56.7	115.7	118.4	80.9	86.0	23.8	3.0	48.6	111.4	58.3	100.6	93.8	102.0	204.8	46.3	72.5	32.0	26.3	53.8	21.6	62.4	22.4	65.4	85.2	35.8	37.9	121.7	35.6	60.0	42.1	12.7	14.4	26.2	27.5	176.5	29.1	68.1	104.3	43.5	41.3	45.9	82.1	30.5	26.3	143.6	63.6	53.9	37.6	61.3	96.0	41.2	81.5	17.5	31.3	117.8
SKP1	"EMC19, MGC34403, OCP-II, OCP2, p19A, SKP1A, TCEB1L"	ENSG00000113558	"S-phase kinase associated protein 1"	P63208	5	134148935-134176964	"Predicted intracellular proteins"	"Host-virus interaction, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012982, HPA053745, HPA058134"	Approved		Supported	Nucleoplasm,Cytosol		No	No		880000	"Cluster 44: Non-specific - Transcription"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm	Cytosol	"CAB012982: AB_2533076, HPA053745: AB_2682245, HPA058134: AB_2683617"	"prognostic unfavorable (7.53e-4)"	"unprognostic (1.97e-1)"	"unprognostic (9.81e-3)"	"unprognostic (1.07e-1)"	"unprognostic (2.02e-1)"	"unprognostic (2.53e-2)"	"prognostic unfavorable (5.72e-4)"	"unprognostic (4.47e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.72e-1)"	"unprognostic (2.73e-1)"	"unprognostic (3.07e-1)"	"prognostic favorable (5.20e-4)"	"unprognostic (1.02e-2)"	"unprognostic (2.06e-1)"	"unprognostic (8.26e-2)"	"unprognostic (2.40e-1)"	430.5	566.7	442.5	194.9	463.6	363.7	559.0	471.7	648.6	455.4	486.2	529.3	230.1	441.3	490.7	401.9	437.8	330.1	650.5	470.8	492.5	588.6	442.8	346.6	305.9	465.9	457.1	525.4	266.6	776.2	501.0	394.6	474.2	420.9	350.2	484.3	366.9	550.9	1056.8	419.5	354.9	422.6	494.4	304.8	385.9	380.4	470.5	456.1	551.5	814.1	332.0	452.9	391.6	515.0	657.0	500.1	730.3	986.5	1103.6	891.8	519.2	744.6	939.1	854.0	877.1	773.0	620.0	481.9	1084.9	1009.8	974.9	356.6	738.2	1124.1	988.3	442.6	519.5	380.7	724.0	555.8	518.7	296.3	452.0	771.1	886.2	750.1	588.7	1060.4	928.4	611.2	467.4	411.8	1295.2	515.6	642.0	314.8	423.9	619.6	530.7	349.2	780.7	591.7	952.3	724.6	594.6	463.8	1010.2	254.4	726.9	942.4	738.5	454.6	705.3	547.5	338.4	578.2	766.4	254.7	459.1	717.8	762.3	555.5	608.0	1745.5	851.4	1484.9	884.6	841.7	1011.4	1202.8	1264.6	1099.9	817.8	1094.4	1495.5	1174.8	811.4	1096.1	1027.0	728.1	1416.7	2538.6	442.5	463.6	471.7	648.6	470.8	492.5	465.9	457.1	474.2	494.4	470.5	515.0	430.1	285.2	306.3	64.0	403.6	674.3	1025.7	1354.7	380.1	230.0	539.8	558.4	700.9	497.6	767.4	594.1	73.0	881.0	417.7	441.8	1696.3	644.9	593.3	511.9	405.3	410.1	356.0	617.8	66.5	376.9	749.4	561.5	270.1	439.0	336.9	433.9	340.2	376.9	471.6	223.8	65.8	402.2	1192.2	296.1	505.1	1048.6	601.4	344.8	718.6	33.7	565.4	792.8	338.8	43.7	87.0	378.1	564.0	712.8	278.2	744.7	630.0	1577.8	965.7	217.5	506.2	480.4	668.1	753.5	652.7	349.0	645.6	1347.0	511.1	500.4	410.4	837.6
SKP2	"FBL1, FBXL1, p45"	ENSG00000145604	"S-phase kinase associated protein 2"	Q13309	5	36151989-36196849	"Cancer-related genes, Predicted intracellular proteins"	"Antiviral defense, Host-virus interaction, Immunity, Innate immunity, Ubl conjugation pathway"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 37.9"	"Group enriched"	"Detected in many"	4	"Cytotrophoblasts: 134.4;Extravillous trophoblasts: 227.3;Syncytiotrophoblasts: 83.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"BEWO: 274.7;RH-30: 286.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013491, CAB013533, HPA051196, HPA054633"	Approved		Supported	Nucleoplasm,Cytosol		NA	Yes			"Cluster 46: Basophils - DNA binding"	"Cluster 28: Placenta - Pregnancy"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 38: Extravillous trophoblasts - Unknown function"	"Nucleoplasm, Cytosol"		"CAB013491: AB_2533074, CAB013533: , HPA051196: AB_2681383, HPA054633: AB_2682550"	"unprognostic (2.32e-2)"	"unprognostic (2.87e-1)"	"unprognostic (1.26e-1)"	"unprognostic (5.74e-2)"	"unprognostic (9.56e-2)"	"unprognostic (1.52e-2)"	"unprognostic (1.21e-3)"	"unprognostic (2.22e-1)"	"prognostic unfavorable (3.72e-7)"	"prognostic favorable (8.57e-4)"	"unprognostic (5.06e-2)"	"unprognostic (2.71e-1)"	"prognostic unfavorable (4.77e-15)"	"unprognostic (2.50e-2)"	"unprognostic (3.73e-1)"	"unprognostic (1.63e-1)"	"unprognostic (2.19e-1)"	4.9	4.0	3.6	5.8	3.9	11.4	4.9	4.7	4.5	5.9	3.9	6.1	6.3	4.7	4.3	8.3	5.1	2.9	2.5	3.9	3.1	2.3	9.8	4.2	7.9	3.7	3.5	5.2	3.8	2.5	4.0	37.9	3.9	4.0	6.1	4.6	4.0	3.7	2.2	5.7	6.5	4.1	3.9	5.9	4.0	2.6	3.7	12.3	3.1	1.6	8.3	4.7	5.6	5.4	25.4	14.8	35.6	54.3	15.5	20.1	274.7	31.2	25.7	89.5	48.7	83.3	22.8	43.3	10.6	20.0	13.3	28.3	53.3	46.7	71.0	19.2	46.7	23.9	51.4	47.1	6.1	44.8	11.4	18.1	12.2	16.9	8.5	7.7	24.2	40.2	37.9	9.1	31.9	16.4	58.9	26.8	51.5	23.8	24.2	53.7	286.7	28.3	7.2	28.1	45.5	46.8	94.3	27.4	14.1	32.2	22.7	33.3	8.0	31.4	36.1	13.5	24.5	12.4	13.1	50.8	15.2	61.3	21.9	9.2	6.6	13.4	4.2	6.1	6.9	5.2	4.7	4.5	14.0	6.0	6.4	4.6	1.1	6.2	3.2	3.5	4.8	4.7	3.6	3.9	4.7	4.5	3.9	3.1	3.7	3.5	3.9	3.9	3.7	5.4	4.4	22.4	8.9	11.8	8.7	3.7	2.4	7.1	12.0	8.2	3.6	4.2	1.3	1.5	1.7	1.8	10.4	134.4	7.4	2.4	1.9	2.4	0.7	5.2	6.5	6.5	3.0	14.1	22.4	2.9	227.3	11.6	7.1	2.4	2.5	20.9	1.8	11.9	35.0	0.0	13.1	6.0	4.1	9.3	3.1	0.3	4.1	5.3	1.8	12.2	7.6	2.5	9.2	11.6	29.5	2.6	3.4	6.4	10.9	1.0	3.2	1.4	6.2	6.8	0.0	11.5	4.1	1.4	6.4	19.8	4.0	83.9	5.6	11.8	9.6	1.2
SLBP	HBP	ENSG00000163950	"Stem-loop binding protein"	Q14493	4	1692731-1712344	"Predicted intracellular proteins"	"mRNA processing"	"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 263.6;Spermatogonia: 294.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA019254, HPA061670"	Supported		Supported	Nucleoplasm,Nucleoli,Cytosol		Yes	Yes			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	"Nucleoli, Cytosol"	"HPA019254: AB_1856951, HPA061670: AB_2684581"	"unprognostic (1.81e-2)"	"unprognostic (6.80e-3)"	"unprognostic (2.05e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.94e-1)"	"unprognostic (7.09e-3)"	"prognostic unfavorable (2.29e-5)"	"unprognostic (5.53e-2)"	"unprognostic (1.94e-2)"	"unprognostic (1.13e-2)"	"unprognostic (9.81e-3)"	"unprognostic (9.55e-3)"	"unprognostic (4.58e-2)"	"unprognostic (7.31e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.44e-1)"	"unprognostic (7.07e-2)"	29.9	26.4	38.6	37.6	40.2	114.2	26.7	38.0	65.7	28.4	34.4	30.6	23.9	27.3	32.9	35.9	27.6	21.9	18.4	40.9	43.6	35.1	33.9	27.2	71.7	36.4	39.1	28.0	24.4	24.0	26.7	42.0	39.3	22.8	30.6	17.1	25.6	25.3	22.6	37.7	25.6	28.8	37.7	28.3	26.9	63.1	41.8	53.5	27.3	19.2	69.5	35.0	28.0	41.1	132.7	53.9	76.6	80.7	65.3	70.0	81.9	120.1	92.5	131.4	133.8	120.3	144.7	180.6	67.4	96.0	150.9	77.8	147.0	103.0	154.1	75.4	98.5	215.9	63.3	123.6	82.6	208.3	102.8	55.0	84.7	98.1	67.3	74.4	76.5	108.8	172.7	170.3	163.2	52.8	314.6	200.6	97.4	136.7	108.6	241.1	126.3	105.3	131.0	99.5	86.1	69.3	95.4	59.6	69.5	96.8	99.0	127.7	66.3	108.0	63.8	116.1	180.4	107.4	192.2	428.3	99.6	176.0	106.0	25.7	65.4	47.5	47.1	49.7	43.3	51.6	59.7	64.8	50.6	37.8	50.6	49.6	95.8	46.3	44.8	42.2	77.9	75.4	38.6	40.2	38.0	65.7	40.9	43.6	36.4	39.1	39.3	37.7	41.8	41.1	35.2	16.0	18.8	7.2	96.3	105.2	96.3	38.8	61.5	19.4	35.9	34.0	8.2	27.1	23.6	36.8	25.0	166.3	80.5	28.8	107.6	50.6	75.9	38.8	34.9	36.1	35.9	146.0	14.6	31.3	51.8	49.1	53.5	55.5	23.5	45.9	30.0	27.0	81.3	25.2	15.1	33.6	44.7	36.8	58.6	41.6	44.1	60.3	65.8	6.5	64.4	27.4	43.3	9.0	14.4	38.7	25.3	44.0	94.2	88.6	22.5	55.4	16.3	13.6	13.1	46.3	43.8	263.6	294.0	84.1	105.8	44.7	96.6	33.2	44.1	76.5
SLC11A2	"DCT1, DMT1, NRAMP2"	ENSG00000110911	"Solute carrier family 11 member 2"	P49281	12	50979401-51028566	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Iron transport, Transport"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Respiratory ciliated cells: 109.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA032139, HPA032140"	Uncertain		Supported	Mitochondria		No	No			"Cluster 27: Non-specific - Gene expression"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Mitochondria		"HPA032139: AB_10964213, HPA032140: AB_10962932"	"unprognostic (4.40e-3)"	"unprognostic (1.41e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.07e-3)"	"unprognostic (2.35e-1)"	"unprognostic (1.92e-1)"	"unprognostic (2.09e-1)"	"prognostic favorable (3.07e-6)"	"unprognostic (1.06e-2)"	"unprognostic (1.99e-2)"	"unprognostic (1.15e-1)"	"unprognostic (7.28e-2)"	"unprognostic (2.29e-1)"	"unprognostic (3.20e-2)"	"unprognostic (2.61e-1)"	"unprognostic (2.32e-2)"	"unprognostic (2.24e-1)"	12.1	17.0	12.8	14.0	21.6	15.9	30.3	19.6	18.1	29.3	12.7	16.4	53.8	15.7	17.6	23.9	21.4	17.7	14.7	13.2	16.5	22.5	25.6	23.2	10.3	22.8	18.3	12.8	22.6	42.5	10.9	23.7	22.9	24.4	16.2	23.1	31.2	19.3	18.4	20.3	13.8	15.3	19.1	8.7	17.8	13.3	18.5	19.2	41.6	20.3	17.2	20.4	13.9	31.1	19.0	22.4	31.4	28.7	33.5	28.6	106.3	19.7	73.9	19.0	21.8	30.6	35.3	11.8	38.8	22.8	35.7	25.3	26.6	19.2	21.9	17.1	17.4	27.4	29.2	35.5	35.7	19.0	54.5	31.6	24.3	32.7	35.1	45.6	22.8	23.6	24.4	5.6	22.4	21.7	21.8	12.9	46.6	19.8	15.5	14.7	28.6	21.1	23.4	27.7	21.6	19.0	16.3	47.1	20.9	36.2	50.8	12.6	26.8	19.2	15.8	21.5	10.9	14.1	20.4	4.7	54.1	10.2	8.3	0.6	4.7	1.9	4.2	6.8	3.7	2.6	3.3	4.3	7.0	3.3	4.6	4.3	2.3	6.0	4.8	2.9	2.9	3.4	12.8	21.6	19.6	18.1	13.2	16.5	22.8	18.3	22.9	19.1	18.5	31.1	9.8	38.5	46.1	32.7	6.9	15.4	24.8	84.0	22.2	26.6	37.6	18.5	15.5	25.8	69.4	57.0	18.8	27.0	11.9	14.0	3.9	30.6	1.5	31.7	11.6	13.1	16.4	64.8	33.6	28.3	22.5	17.3	15.3	43.6	71.4	20.1	11.4	41.3	35.2	28.6	38.1	14.3	42.7	16.9	25.4	1.7	9.6	30.1	26.6	26.2	15.7	26.5	6.2	51.8	94.5	20.6	15.0	8.6	8.2	47.8	13.2	9.0	109.6	17.8	6.6	14.2	13.2	9.0	12.2	14.3	13.4	19.4	10.7	10.4	15.0	23.1
SLC13A3	"NADC3, SDCT2"	ENSG00000158296	"Solute carrier family 13 member 3"	Q8WWT9	20	46557823-46684467	"Disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Symport, Transport"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"kidney: 407.6"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 53.8;Cytotrophoblasts: 106.6;Excitatory neurons: 65.0;Oligodendrocytes: 178.1;Proximal tubular cells: 245.9;Syncytiotrophoblasts: 79.4"	"Cancer enhanced"	"Detected in many"		"liver cancer: 11.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BEWO: 16.1;EFO-21: 18.8;Hep G2: 56.1;HHSteC: 18.4;K-562: 15.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014333, HPA014353, HPA014736"	Enhanced		Supported	"Plasma membrane"		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Plasma membrane"		"HPA014333: AB_2732407, HPA014353: AB_1856968, HPA014736: AB_1856970"	"unprognostic (1.07e-2)"	"unprognostic (7.40e-2)"	"unprognostic (5.59e-2)"	"unprognostic (1.19e-2)"	"unprognostic (3.34e-1)"	"unprognostic (3.19e-2)"	"unprognostic (2.15e-1)"	"unprognostic (2.82e-2)"	"unprognostic (1.66e-2)"	"unprognostic (9.50e-2)"	"unprognostic (1.92e-2)"	"unprognostic (1.03e-1)"	"unprognostic (8.94e-2)"	"unprognostic (3.87e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.87e-1)"	"unprognostic (2.05e-2)"	1.3	2.4	12.5	0.7	22.8	0.2	1.9	16.5	16.1	2.0	4.9	0.8	0.3	1.8	1.0	0.9	2.4	1.9	1.0	10.1	16.2	407.6	21.7	1.4	0.6	18.3	19.5	4.5	9.0	0.2	2.6	43.2	19.0	6.3	0.5	1.1	4.9	0.8	1.0	2.2	0.4	1.9	12.5	0.6	4.7	8.7	19.9	1.1	1.4	0.3	0.7	1.8	1.4	37.4	0.1	0.0	1.6	5.6	8.3	7.7	16.1	3.5	2.0	1.9	1.4	0.0	0.1	0.2	18.8	0.2	0.1	2.1	0.1	2.6	4.5	0.0	0.6	6.8	0.4	56.1	18.4	0.1	4.8	10.5	7.5	10.9	5.4	5.4	0.0	0.0	15.3	0.3	0.0	0.6	0.1	0.7	10.3	0.2	0.0	0.2	0.0	0.1	1.2	0.4	0.7	0.2	0.0	4.0	0.8	1.0	2.9	0.3	0.2	0.1	4.0	8.7	0.1	0.5	1.2	0.1	0.6	0.0	0.4	0.7	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.2	0.1	0.0	0.5	0.0	0.0	12.5	22.8	16.5	16.1	10.1	16.2	18.3	19.5	19.0	12.5	19.9	37.4	0.3	0.0	2.2	53.8	3.8	1.3	1.0	0.8	6.2	0.7	1.2	1.7	1.7	0.0	0.5	7.3	0.0	106.6	0.0	0.1	15.6	0.2	23.3	0.5	2.0	0.6	0.0	0.0	65.0	0.9	7.1	2.3	3.1	0.8	0.0	3.0	0.4	17.5	9.5	0.0	40.3	0.0	0.0	0.3	0.7	27.8	3.1	2.0	0.0	11.2	0.0	0.4	0.0	24.1	178.1	0.9	0.0	0.4	1.2	3.5	0.0	245.9	6.4	0.2	0.0	0.4	1.0	6.6	1.2	1.2	0.6	79.4	1.5	2.2	0.0	0.6
SLC13A5	"INDY, NACT"	ENSG00000141485	"Solute carrier family 13 member 5"	Q86YT5	17	6684719-6713377	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Symport, Transport"		"Amelogenesis imperfecta, Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	11	"liver: 414.0"	"Cell type enriched"	"Detected in some"	15	"Hepatocytes: 381.0"	"Cancer enriched"	"Detected in some"	15	"liver cancer: 27.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	79	"Hep G2: 58.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044343	Approved		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA				"Cluster 62: Liver - Hemostasis"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 15: Hepatocytes - Hemostasis"	"Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA044343: AB_10961771"	"unprognostic (8.46e-3)"	"unprognostic (3.89e-2)"	"unprognostic (3.24e-2)"	"unprognostic (1.75e-2)"	"unprognostic (7.33e-2)"	"unprognostic (1.07e-1)"	"unprognostic (6.79e-2)"	"unprognostic (8.79e-3)"	"unprognostic (1.32e-1)"	"unprognostic (3.23e-1)"	"unprognostic (1.26e-3)"	"unprognostic (1.30e-3)"	"unprognostic (3.78e-11)"	"unprognostic (2.42e-2)"	"unprognostic (2.46e-1)"	"unprognostic (2.05e-2)"	"unprognostic (2.04e-1)"	0.3	2.7	4.8	0.0	7.0	0.0	0.3	4.8	8.0	0.3	2.7	0.0	0.0	0.3	0.0	1.1	2.1	0.0	0.1	5.3	7.9	0.7	414.0	0.0	0.2	6.8	6.1	0.6	0.3	0.0	0.8	0.0	5.4	0.0	0.0	1.7	38.0	0.0	0.0	0.1	0.0	0.0	4.8	3.3	0.0	2.3	8.4	0.0	0.0	0.0	0.0	0.0	0.2	3.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	58.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.8	7.0	4.8	8.0	5.3	7.9	6.8	6.1	5.4	4.8	8.4	3.9	0.4	0.0	0.0	24.8	4.8	0.5	0.6	0.6	1.2	0.6	0.1	0.1	0.9	7.2	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.2	0.1	0.1	1.9	0.0	24.0	0.3	0.5	0.1	0.4	0.0	0.1	0.0	0.9	16.8	381.0	0.0	0.0	0.2	0.0	0.0	23.2	1.1	0.4	0.6	0.3	0.0	1.9	0.0	7.0	0.0	1.5	0.1	16.9	0.0	0.0	0.0	0.3	0.0	0.0	0.1	1.6	0.0	0.5	0.5	2.4	2.8	1.2	0.4	0.1	1.0	7.8	0.0	0.3
SLC14A1	"HsT1341, JK, RACH1, RACH2"	ENSG00000141469	"Solute carrier family 14 member 1 (Kidd blood group)"	Q13336	18	45687025-45752520	"Blood group antigen proteins, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport	"Blood group antigen"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 133.8;prostate: 78.3;urinary bladder: 90.9"	"Group enriched"	"Detected in many"	7	"Adipocytes: 136.6;Astrocytes: 228.5;Basal prostatic cells: 313.4;Erythroid cells: 102.5;Prostatic glandular cells: 192.6;Urothelial cells: 249.9"	"Group enriched"	"Detected in many"	5	"glioma: 5.3;prostate cancer: 8.6;urothelial cancer: 16.1"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"T-reg: 4.1"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"GAMG: 273.4;RT4: 113.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA059570, HPA077233"	Approved		Supported	"Plasma membrane"		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 22: Epithelial cell types - Mixed function"	"Plasma membrane"		"HPA059570: AB_2684066, HPA077233: "	"unprognostic (2.04e-1)"	"unprognostic (2.56e-3)"	"unprognostic (5.20e-2)"	"unprognostic (1.27e-1)"	"unprognostic (6.86e-2)"	"unprognostic (1.84e-2)"	"unprognostic (1.70e-2)"	"unprognostic (7.97e-2)"	"unprognostic (8.17e-2)"	"unprognostic (9.99e-2)"	"unprognostic (2.69e-1)"	"unprognostic (1.42e-1)"	"unprognostic (3.02e-2)"	"unprognostic (2.31e-1)"	"unprognostic (1.52e-1)"	"unprognostic (9.09e-2)"	"unprognostic (6.93e-2)"	3.4	1.6	70.2	1.0	97.1	15.2	2.0	110.5	53.6	3.6	24.9	1.7	1.3	0.5	0.7	0.4	0.3	10.1	23.7	60.5	96.0	37.9	1.1	4.3	2.3	109.4	131.0	0.3	1.7	0.9	1.0	1.6	114.2	78.3	1.3	0.3	2.3	3.0	3.9	4.1	3.4	0.5	97.7	4.6	1.8	0.2	133.8	7.7	6.4	7.8	2.3	90.9	2.2	104.6	0.0	0.4	0.0	0.1	0.0	0.2	0.7	0.4	8.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	273.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.2	0.1	0.2	0.0	0.0	0.0	0.0	38.3	0.0	0.2	0.0	0.2	0.3	0.1	0.9	0.3	0.0	0.3	0.2	0.0	0.0	0.2	3.0	113.8	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.3	0.0	1.8	0.5	0.9	0.1	4.1	0.2	0.1	2.7	1.3	1.3	0.0	0.0	1.1	0.8	0.0	0.0	0.3	0.9	0.9	0.0	0.3	0.2	1.5	0.0	0.9	0.0	0.1	4.1	0.6	70.2	97.1	110.5	53.6	60.5	96.0	109.4	131.0	114.2	97.7	133.8	104.6	136.6	0.0	0.6	228.5	3.1	0.3	313.4	0.1	0.6	0.3	5.4	1.5	10.9	5.7	0.0	0.0	0.0	0.0	8.6	0.0	0.0	0.2	0.6	0.0	0.1	28.7	0.0	102.5	0.6	0.2	0.1	3.8	0.0	0.1	0.0	0.2	21.4	0.3	0.1	0.0	0.7	0.2	18.3	0.6	0.3	0.4	0.0	2.0	12.4	5.6	0.1	0.0	5.2	3.5	0.7	0.3	0.0	1.2	2.1	192.6	0.0	0.0	0.0	0.2	0.0	1.7	3.7	0.1	0.2	0.2	0.4	0.0	6.1	0.1	0.0	249.9
SLC15A3	"hPTR3, PHT2"	ENSG00000110446	"Solute carrier family 15 member 3"	Q8IY34	11	60937060-60952653	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Immunity, Innate immunity, Peptide transport, Protein transport, Symport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 90.6;Kupffer cells: 59.3;Macrophages: 65.5;monocytes: 70.9;Muller glia cells: 211.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"classical monocyte: 9.0;intermediate monocyte: 12.8;memory B-cell: 4.9;myeloid DC: 6.5;neutrophil: 13.4;non-classical monocyte: 6.4;plasmacytoid DC: 10.7"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BEWO: 23.4;BJ hTERT+ SV40 Large T+: 58.0;BJ hTERT+ SV40 Large T+ RasG12V: 74.0;HHSteC: 34.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA047880, HPA057642"	Approved		Supported	Vesicles		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 64: Macrophages - Immune response"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 5: Muller glia cells - Visual perception"	Vesicles		"HPA047880: AB_10959455, HPA057642: AB_2683487"	"unprognostic (5.61e-2)"	"prognostic favorable (4.07e-5)"	"unprognostic (8.79e-2)"	"unprognostic (1.67e-2)"	"unprognostic (8.48e-2)"	"unprognostic (9.33e-3)"	"unprognostic (1.49e-1)"	"unprognostic (2.10e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.46e-1)"	"unprognostic (9.78e-3)"	"unprognostic (6.47e-2)"	"unprognostic (4.42e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.02e-1)"	27.5	12.8	11.6	30.7	10.3	35.3	18.2	10.7	15.1	19.7	13.0	34.9	12.0	13.9	3.9	9.3	18.2	19.1	27.1	9.7	13.1	14.9	15.1	52.2	40.1	14.5	10.9	29.2	6.5	4.4	8.4	27.5	13.8	16.7	9.4	17.5	10.0	8.5	6.4	7.9	28.7	15.1	13.5	63.9	18.5	5.5	14.3	12.9	10.5	10.1	15.7	15.6	17.6	15.5	4.3	0.0	2.2	0.0	12.6	9.9	23.4	1.2	21.8	58.0	74.0	0.1	1.9	9.7	0.3	8.8	14.2	1.7	0.0	0.7	3.4	9.4	0.0	0.1	0.1	0.6	34.9	0.0	0.9	6.6	0.0	15.3	0.0	0.1	2.8	0.0	0.0	0.5	3.6	0.5	0.0	1.8	9.8	0.0	0.1	3.9	0.0	3.3	0.0	1.3	0.0	0.1	2.8	9.6	0.4	0.4	4.2	5.7	0.3	0.3	1.2	1.0	0.1	0.0	0.0	3.8	3.9	0.0	13.7	0.0	9.0	1.2	0.1	12.8	0.0	4.9	0.0	0.0	6.5	1.9	0.9	0.9	13.4	0.0	6.4	10.7	0.0	2.4	11.6	10.3	10.7	15.1	9.7	13.1	14.5	10.9	13.8	13.5	14.3	15.5	19.3	9.6	13.2	0.0	7.7	1.7	0.2	4.5	2.2	1.6	0.7	1.4	2.5	1.5	3.7	0.0	0.0	3.6	9.6	1.1	0.0	0.3	7.9	0.1	2.0	12.6	0.0	0.4	0.1	2.2	15.1	5.6	1.1	0.3	15.2	3.7	20.3	3.1	90.6	5.0	0.0	1.2	2.0	59.3	35.5	3.8	8.1	65.5	1.8	4.7	70.9	211.7	1.0	0.0	0.1	2.2	2.8	4.9	2.0	0.1	0.3	0.1	3.1	5.5	13.1	3.1	3.0	4.2	0.7	0.6	1.4	2.6	1.9	4.5	1.1	0.3
SLC16A10	"MCT10, TAT1"	ENSG00000112394	"Solute carrier family 16 member 10"	Q8TF71	6	111087503-111231194	"Metabolic proteins, Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"choroid plexus: 53.7;skeletal muscle: 41.2"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 32.8;Excitatory neurons: 33.9;Inhibitory neurons: 47.8;Macrophages: 33.8;Melanocytes: 44.4"	"Cancer enriched"	"Detected in many"	6	"testis cancer: 4.5"	"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"naive CD4 T-cell: 1.7;T-reg: 1.6"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"HAP1: 49.4;HEK 293: 20.2;RPMI-8226: 37.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA016860	Approved		Supported	"Vesicles,Cell Junctions"		NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 41: Macrophages - Immune response"	"Vesicles, Cell Junctions"		"HPA016860: AB_2189211"	"unprognostic (2.03e-1)"	"unprognostic (2.08e-1)"	"unprognostic (6.11e-2)"	"unprognostic (3.56e-4)"	"unprognostic (2.24e-1)"	"unprognostic (2.15e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.89e-1)"	"unprognostic (1.86e-3)"	"unprognostic (5.22e-1)"	"unprognostic (1.74e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.10e-3)"	"unprognostic (2.73e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.91e-1)"	2.9	5.5	1.4	3.0	8.6	0.8	0.8	4.2	3.4	0.6	53.7	1.2	8.5	0.5	1.4	0.8	0.8	1.5	2.3	2.0	1.2	10.0	13.5	4.6	0.9	1.1	5.0	0.9	29.7	7.9	1.0	23.7	2.8	1.3	1.8	0.7	3.1	0.2	41.2	15.3	5.0	0.3	0.2	1.8	5.3	4.2	9.6	10.9	2.7	6.0	1.3	1.9	1.2	1.1	0.9	1.0	0.4	2.2	0.1	0.1	3.1	0.0	0.2	0.8	1.2	9.0	0.4	5.2	1.4	0.3	2.5	0.1	49.4	0.1	1.0	0.1	20.2	8.2	0.7	7.4	0.1	7.6	7.4	0.0	0.0	0.1	0.0	0.2	0.0	10.9	1.4	0.2	0.1	3.6	9.8	0.8	14.6	0.2	3.2	5.4	6.8	37.2	0.0	0.5	10.7	3.3	0.2	0.7	1.8	3.6	1.8	0.9	0.1	0.1	1.8	0.5	2.5	2.6	0.1	1.5	0.3	5.8	0.8	0.4	0.0	0.0	0.1	0.0	0.1	0.1	0.4	0.1	0.0	0.2	1.7	1.5	0.3	0.1	0.0	0.1	1.6	0.1	1.4	8.6	4.2	3.4	2.0	1.2	1.1	5.0	2.8	0.2	9.6	1.1	0.4	9.6	32.8	2.0	1.5	9.7	10.7	0.0	4.6	6.9	2.0	1.3	9.1	0.0	3.1	5.5	2.1	1.9	0.7	2.1	1.9	0.2	9.0	0.4	0.8	1.4	6.6	1.7	33.9	12.5	1.8	8.9	3.6	1.3	1.3	2.5	4.2	25.4	21.4	1.7	47.8	4.8	0.0	12.4	12.4	8.2	0.0	33.8	44.4	0.0	0.7	1.6	0.0	16.6	0.3	2.0	0.9	0.0	4.8	3.9	10.9	17.7	0.7	0.7	0.0	18.5	1.0	11.6	11.2	1.2	14.8	1.2	5.8	9.2	8.5	1.2
SLC16A13	MCT13	ENSG00000174327	"Solute carrier family 16 member 13"	Q7RTY0	17	7036015-7040117	"Disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Symport, Transport"		"Diabetes mellitus"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 36.1"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 8.2;NK-cells: 6.2;Squamous epithelial cells: 7.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"A549: 22.8;GAMG: 26.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA065245			Supported	"Golgi apparatus,Cytosol"		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 85: Liver - Metabolism"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 59: Non-specific - Transcription"	"Golgi apparatus"	Cytosol	"HPA065245: AB_2685443"	"unprognostic (5.61e-2)"	"unprognostic (1.70e-1)"	"unprognostic (2.83e-2)"	"unprognostic (1.78e-1)"	"unprognostic (2.22e-3)"	"unprognostic (9.53e-2)"	"unprognostic (1.62e-1)"	"unprognostic (8.72e-2)"	"unprognostic (1.81e-1)"	"unprognostic (2.60e-1)"	"prognostic favorable (1.50e-4)"	"unprognostic (2.44e-2)"	"unprognostic (7.31e-3)"	"unprognostic (9.70e-3)"	"unprognostic (3.99e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.14e-1)"	1.4	1.0	1.1	2.1	0.8	0.4	1.4	1.8	1.1	1.8	1.0	2.2	9.2	0.8	1.3	5.3	1.8	3.7	1.6	0.9	1.0	6.8	36.1	2.4	2.8	1.2	1.2	0.5	1.2	2.9	0.8	1.5	1.0	1.4	1.6	0.3	3.3	0.8	0.4	5.3	5.5	0.9	0.9	3.5	1.9	0.5	1.0	1.8	3.3	0.2	2.5	1.2	2.6	0.8	13.1	22.8	5.3	3.2	3.2	1.8	2.2	1.3	3.3	2.9	6.5	7.4	14.3	8.3	2.2	2.1	26.2	20.1	4.1	7.0	1.2	10.3	2.9	3.4	1.8	18.0	3.6	1.2	7.6	2.1	7.8	4.3	3.5	3.9	11.9	7.4	4.0	2.3	3.1	6.5	5.1	2.1	2.2	6.6	1.8	2.4	1.8	1.4	2.7	3.6	0.2	1.4	4.0	2.2	1.8	7.8	6.1	1.8	4.5	1.8	4.1	3.0	1.9	4.0	8.9	0.5	5.4	3.0	0.8	0.0	0.8	1.0	1.2	0.8	0.9	1.1	1.0	1.5	0.8	2.5	1.1	1.1	0.9	1.2	0.9	1.1	1.2	0.5	1.1	0.8	1.8	1.1	0.9	1.0	1.2	1.2	1.0	0.9	1.0	0.8	2.3	0.0	1.5	0.7	5.1	0.5	0.9	1.3	4.0	0.4	1.6	0.9	0.4	1.5	0.8	5.5	0.0	1.9	2.4	1.1	0.0	1.0	0.0	0.5	0.5	2.8	0.0	0.4	1.8	0.2	0.4	0.6	4.1	0.7	3.8	1.1	2.2	8.2	0.5	3.3	1.1	1.2	2.0	0.6	3.1	0.0	0.9	1.6	0.0	1.0	1.4	0.9	6.2	0.5	0.0	0.5	0.1	0.0	2.9	0.9	2.4	1.9	1.4	0.5	0.0	0.3	1.1	0.0	0.0	7.4	1.6	2.5	4.7	0.5	1.0	1.0
SLC16A3	"MCT3, MCT4"	ENSG00000141526	"Solute carrier family 16 member 3"	O15427	17	82217934-82261129	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Symport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 198.3"	"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 1667.1;Syncytiotrophoblasts: 748.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 109.1"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB017490, HPA021451"	Approved		Supported	"Nuclear membrane,Plasma membrane"		NA	NA		260000	"Cluster 52: Eosinophils - Transcription"	"Cluster 59: Non-specific - Translation"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 38: Extravillous trophoblasts - Unknown function"	"Plasma membrane"	"Nuclear membrane"	"CAB017490: AB_2189333, HPA021451: AB_1853663"	"unprognostic (2.49e-1)"	"prognostic unfavorable (6.07e-4)"	"unprognostic (4.31e-1)"	"unprognostic (1.74e-1)"	"unprognostic (3.47e-3)"	"unprognostic (4.26e-3)"	"prognostic unfavorable (1.19e-7)"	"prognostic unfavorable (2.02e-5)"	"unprognostic (2.52e-1)"	"unprognostic (2.09e-2)"	"unprognostic (4.35e-3)"	"unprognostic (1.53e-1)"	"prognostic unfavorable (3.71e-7)"	"unprognostic (2.27e-1)"	"unprognostic (4.00e-2)"	"unprognostic (8.00e-2)"	"unprognostic (1.36e-2)"	30.4	16.9	3.8	25.3	5.8	22.7	15.7	6.6	9.7	26.2	5.0	28.9	11.6	11.6	1.3	42.4	18.5	12.8	26.0	4.5	7.3	48.2	11.3	46.4	5.7	17.3	8.5	9.1	5.8	2.5	12.1	24.7	11.9	19.6	5.7	5.7	27.5	5.9	198.3	8.4	22.9	6.0	8.4	57.5	22.0	32.0	13.8	2.9	29.1	73.2	5.2	26.3	28.5	15.1	52.8	24.4	0.6	1.3	7.8	28.8	51.7	225.6	107.7	117.4	142.2	10.1	119.1	0.7	158.0	122.5	127.9	18.9	15.6	242.0	51.8	78.1	1.2	87.4	144.0	236.4	164.1	105.2	111.5	64.8	38.2	77.0	38.5	185.8	69.1	2.2	1.0	26.6	116.1	14.0	1.4	166.3	1.9	22.1	223.5	0.9	1.6	33.2	75.9	3.0	2.9	1.7	196.7	166.9	3.2	20.4	25.4	131.4	124.0	281.7	5.1	4.5	200.9	97.3	1.9	3.9	140.2	94.7	3.0	56.6	32.6	92.1	9.6	30.4	13.4	8.1	7.7	10.5	24.1	6.2	4.2	5.3	109.1	25.3	31.4	15.2	7.3	16.0	3.8	5.8	6.6	9.7	4.5	7.3	17.3	8.5	11.9	8.4	13.8	15.1	19.2	9.6	9.8	3.6	27.9	6.5	47.5	210.1	2.8	13.4	3.2	2.5	6.1	4.3	182.3	57.0	4.2	67.6	72.4	216.7	0.0	136.1	3.0	33.7	15.4	29.9	20.9	9.1	0.3	18.0	1667.1	17.2	45.3	65.1	75.0	15.9	16.8	1.1	271.0	127.9	0.3	28.3	148.5	99.9	84.6	3.8	3.1	168.6	14.2	9.4	184.9	20.3	40.2	0.0	1.0	305.5	190.2	3.8	35.7	16.5	62.4	5.6	91.1	11.6	0.0	1.6	50.5	1.9	9.5	1.6	6.7	748.8	38.5	0.8	33.4	119.6
SLC16A7	MCT2	ENSG00000118596	"Solute carrier family 16 member 7"	O60669	12	59596029-59789855	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Symport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 34.4"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 135.4;Early spermatids: 117.3;Excitatory neurons: 150.5;Inhibitory neurons: 128.2;Late spermatids: 135.5"	"Cancer enhanced"	"Detected in many"		"renal cancer: 3.6"	"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in all"	5	"cerebellum: 22.2"	HPA005911	Approved		Supported	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 18: U-2197 - ECM organization"	"Cluster 59: Non-specific - Transcription"	"Plasma membrane"	Nucleoplasm	"HPA005911: AB_1853659"	"unprognostic (1.52e-2)"	"unprognostic (9.47e-3)"	"unprognostic (9.48e-2)"	"unprognostic (3.22e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.29e-2)"	"unprognostic (5.35e-2)"	"unprognostic (8.09e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.04e-1)"	"unprognostic (8.39e-2)"	"unprognostic (9.79e-2)"	"prognostic favorable (8.85e-5)"	"unprognostic (2.19e-3)"	"unprognostic (3.11e-1)"	"unprognostic (9.35e-2)"	"unprognostic (2.45e-2)"	20.1	6.8	1.2	3.9	1.2	4.7	4.1	5.7	3.9	2.8	3.7	2.0	1.6	3.0	1.5	6.3	2.2	5.4	34.4	1.3	0.3	11.6	3.9	4.5	4.9	2.9	0.4	2.7	9.8	1.0	1.5	1.6	2.9	1.6	2.5	1.8	2.9	1.6	1.8	7.9	2.5	3.5	0.5	6.3	10.0	2.2	1.3	4.5	1.6	3.6	4.2	4.0	3.0	4.2	0.2	3.6	0.8	0.5	10.9	18.1	0.2	8.8	8.1	4.0	3.4	0.3	6.3	5.8	2.5	16.8	3.8	0.8	1.0	1.7	6.0	2.4	0.5	10.7	12.6	0.5	5.9	14.3	0.1	8.5	3.9	1.4	10.3	7.5	1.6	7.2	0.2	13.0	6.5	3.4	5.5	3.2	0.8	1.2	3.3	0.5	0.1	2.7	9.5	16.0	3.0	1.0	0.1	0.4	6.2	0.7	0.5	2.4	0.0	8.6	3.3	15.6	0.5	11.3	0.2	10.0	10.2	0.1	1.6	0.2	1.5	0.0	4.2	3.2	5.6	1.8	3.3	3.6	1.5	4.1	3.5	5.8	0.1	3.0	8.4	2.1	3.8	2.3	1.2	1.2	5.7	3.9	1.3	0.3	2.9	0.4	2.9	0.5	1.3	4.2	15.3	28.9	21.4	13.7	28.4	10.1	7.8	9.9	16.5	24.5	1.5	3.9	135.4	90.1	16.5	46.0	10.4	0.3	29.7	0.8	23.5	53.3	117.3	2.1	25.0	22.0	0.0	2.5	150.5	67.1	0.3	36.2	7.1	9.1	10.1	4.7	9.3	14.5	3.6	8.4	128.2	27.2	6.1	32.7	6.1	135.5	6.8	24.8	3.6	14.0	14.9	1.3	37.0	63.8	82.8	28.0	1.2	10.1	26.3	8.1	1.0	0.7	14.4	6.0	6.6	14.0	18.9	4.2	4.5	61.5	12.6	0.7	35.8	80.1	1.5	3.4
SLC17A5	"AST, ISSD, NSD, SD, SIALIN, SIASD, SLD"	ENSG00000119899	"Solute carrier family 17 member 5"	Q9NRA2	6	73593379-73653992	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Amino-acid transport, Symport, Transport"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	7	"parathyroid gland: 310.5"	"Low cell type specificity"	"Detected in many"			"Cancer enhanced"	"Detected in all"		"thyroid cancer: 47.0"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"ASC diff: 99.9;ASC TERT1: 74.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044479			Supported	"Plasma membrane,Cytosol"		NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 27: Mucus-secreting cells - Mucin production"	"Plasma membrane, Cytosol"		"HPA044479: "	"unprognostic (6.48e-3)"	"unprognostic (7.95e-3)"	"unprognostic (9.23e-2)"	"unprognostic (1.45e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.08e-1)"	"unprognostic (2.59e-3)"	"unprognostic (4.44e-2)"	"unprognostic (4.18e-2)"	"unprognostic (2.60e-1)"	"unprognostic (3.14e-2)"	"unprognostic (8.29e-2)"	"unprognostic (4.59e-2)"	"unprognostic (2.50e-1)"	"unprognostic (1.40e-1)"	"prognostic favorable (3.52e-4)"	"unprognostic (1.09e-1)"	10.4	10.5	5.9	6.4	6.0	6.8	13.8	6.2	7.0	10.7	5.9	20.4	16.4	9.4	44.6	8.4	5.3	10.4	8.5	6.5	8.5	31.9	17.6	13.2	5.3	6.5	7.0	4.0	11.6	310.5	9.9	21.7	7.8	16.8	22.1	18.3	30.3	14.7	5.4	7.1	21.1	10.6	5.7	7.0	14.4	6.1	7.1	4.5	43.5	6.2	5.6	12.6	6.3	7.6	7.4	9.9	9.7	15.6	99.9	74.2	12.8	23.8	59.4	6.3	22.0	6.6	17.6	6.8	11.2	32.9	14.8	12.6	13.7	5.9	11.2	4.8	15.5	2.8	5.1	15.4	19.4	5.6	10.8	34.2	8.8	14.2	9.7	26.4	16.2	9.0	7.1	7.2	22.3	4.9	2.3	3.3	7.1	30.9	5.7	5.0	12.1	28.5	16.0	20.2	3.8	6.7	4.8	14.0	14.4	14.0	6.3	34.1	23.5	3.0	2.8	12.1	5.7	20.4	30.6	1.9	10.5	11.6	9.0	13.3	7.9	3.3	6.0	7.4	5.8	3.9	6.6	5.8	7.6	2.4	5.4	6.0	5.7	8.9	4.8	5.5	6.6	4.9	5.9	6.0	6.2	7.0	6.5	8.5	6.5	7.0	7.8	5.7	7.1	7.6	8.8	22.4	20.7	16.3	8.2	9.6	13.2	13.7	5.7	8.2	22.6	5.5	6.8	18.6	17.4	51.5	29.2	19.4	11.0	46.4	3.9	14.2	36.6	16.6	7.8	13.8	12.1	3.8	47.7	13.7	13.5	25.8	14.8	19.6	14.5	3.2	23.9	32.9	64.6	0.0	46.8	47.7	20.3	24.8	22.7	48.3	7.5	25.4	10.6	14.0	11.2	8.3	13.4	17.6	16.3	19.2	17.5	11.3	20.6	29.1	23.9	36.3	21.5	28.9	0.0	10.5	9.1	8.4	3.6	10.2	11.2	22.8	11.0	2.9	19.2	30.7
SLC18A2	"SVAT, SVMT, VMAT2"	ENSG00000165646	"Solute carrier family 18 member A2"	Q05940	10	117241093-117279430	"Disease related genes, FDA approved drug targets, Metabolic proteins, Predicted membrane proteins, Transporters"	"Neurotransmitter transport, Transport"		"Disease variant, Dystonia, FDA approved drug targets, Parkinsonism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 81.1;cervix: 30.0"	"Cell type enriched"	"Detected in many"	5	"granulocytes: 636.0"	"Low cancer specificity"	"Detected in some"			"Group enriched"	"Detected in many"	11	"hypothalamus: 20.8;midbrain: 81.1;pons: 70.5"	"Immune cell enriched"	"Detected in some"	15	"basophil: 59.5"	"Lineage enriched"	"Detected in many"	15	"granulocytes: 59.5"	"Cell line enriched"	"Detected in some"	19	"HMC-1: 351.0"	"Region enhanced"	"Detected in many"		"midbrain: 62.7"	"Region enriched"	"Detected in all"	4	"midbrain: 111.6"	HPA073224	Enhanced		Approved	Vesicles,Centrosome		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 60: Granulocytes - Receptor signaling"	"Vesicles, Centrosome"		"HPA073224: AB_2732222"	"unprognostic (1.49e-1)"	"unprognostic (2.48e-1)"	"unprognostic (2.33e-3)"	"unprognostic (9.00e-2)"	"unprognostic (2.85e-1)"	"unprognostic (5.33e-3)"	"unprognostic (2.23e-1)"	"unprognostic (1.71e-2)"	"unprognostic (1.40e-1)"	"unprognostic (4.55e-2)"	"unprognostic (2.00e-1)"	"unprognostic (6.06e-3)"	"unprognostic (7.94e-5)"	"unprognostic (2.95e-2)"	"unprognostic (2.31e-1)"	"unprognostic (2.43e-1)"	"unprognostic (3.57e-2)"	1.1	14.6	0.1	0.9	1.1	2.4	1.8	0.1	0.3	30.0	0.2	2.3	1.5	2.6	1.6	2.5	0.5	3.6	0.7	0.2	20.8	0.9	2.8	7.4	0.6	3.8	81.1	10.4	3.4	0.2	0.2	0.1	70.5	9.2	3.5	0.4	0.8	1.3	0.8	6.3	2.1	2.3	0.0	0.3	4.4	0.9	5.0	6.1	0.0	0.5	0.9	2.9	7.9	0.2	0.2	1.1	0.3	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.7	0.3	0.6	0.0	0.1	0.7	0.0	0.0	0.0	0.1	0.7	18.6	0.1	0.2	0.0	1.0	351.0	0.0	0.0	0.0	0.0	0.2	0.0	3.7	0.0	0.7	0.0	0.1	1.0	0.3	0.2	0.3	0.6	0.2	0.4	0.2	0.0	0.2	3.4	0.7	0.3	0.1	0.0	0.2	0.0	0.1	0.3	0.1	2.5	0.3	0.8	0.5	0.4	0.2	0.4	1.9	0.3	59.5	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.3	0.0	0.0	3.8	0.0	2.0	0.1	1.1	0.1	0.3	0.2	20.8	3.8	81.1	70.5	0.0	5.0	0.2	0.0	9.6	16.2	1.0	0.2	1.9	0.0	0.0	0.0	2.1	0.2	0.0	0.3	0.0	2.5	0.0	4.2	0.0	5.7	0.4	0.0	0.0	0.0	13.1	16.1	0.7	8.9	4.2	1.1	0.0	0.0	3.4	4.1	112.4	636.0	2.4	9.7	0.3	0.8	0.0	1.7	0.0	0.0	1.0	3.6	0.2	0.6	3.5	1.8	0.0	0.1	0.4	0.0	0.5	0.6	0.1	0.1	4.9	1.9	3.8	0.0	0.1	0.7	0.8	0.0	0.4	1.3	0.2	2.1	0.0	2.7	0.0	5.6	9.8	0.1	0.1
SLC1A6	EAAT4	ENSG00000105143	"Solute carrier family 1 member 6"	P48664	19	14950034-15022990	"Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Amino-acid transport, Symport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"brain: 88.2;testis: 28.0"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 17.1;Early spermatids: 35.3;Horizontal cells: 23.5;Late spermatids: 31.8;Syncytiotrophoblasts: 40.0"	"Cancer enriched"	"Detected in some"	7	"urothelial cancer: 5.2"	"Region enriched"	"Detected in all"	6	"cerebellum: 88.2"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HAP1: 7.4;NTERA-2: 6.1;U-698: 28.3"	"Region enriched"	"Detected in all"	6	"cerebellum: 136.3"	"Region enhanced"	"Detected in all"		"cerebellum: 53.8"	"HPA041505, HPA044066"	Enhanced	Supported	Supported	"Plasma membrane,Intermediate filaments"		NA	NA				"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	"Plasma membrane"	"Intermediate filaments"	"HPA041505: AB_2677520, HPA044066: AB_2678796"	"unprognostic (3.62e-2)"	"unprognostic (1.35e-1)"		"unprognostic (4.41e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.12e-1)"		"unprognostic (5.94e-3)"	"unprognostic (8.90e-2)"	"unprognostic (6.52e-4)"	"unprognostic (1.55e-1)"	"unprognostic (5.40e-3)"	"unprognostic (1.11e-2)"	"unprognostic (9.92e-2)"	"unprognostic (1.35e-1)"	"unprognostic (5.57e-2)"	"prognostic unfavorable (6.88e-6)"	0.1	0.2	9.1	0.2	10.8	0.9	0.4	88.2	14.4	0.1	0.5	0.2	0.3	0.4	1.7	0.1	0.2	0.2	0.2	14.5	5.0	0.1	0.2	0.2	0.3	3.7	7.5	0.3	0.6	0.9	0.3	0.7	8.1	0.5	0.3	2.3	0.4	0.5	0.3	8.6	0.3	0.2	3.2	0.4	0.2	28.0	6.6	0.2	0.3	0.1	0.3	0.1	0.1	5.1	0.1	0.1	0.3	0.4	0.2	0.2	0.9	0.1	0.1	0.1	0.1	0.2	0.2	0.1	0.1	0.2	0.1	1.4	7.4	0.2	0.1	0.2	0.1	0.2	0.4	0.3	0.0	0.2	0.1	0.1	0.2	0.1	0.1	0.2	0.1	0.2	0.1	0.6	0.1	0.6	0.0	0.5	6.1	0.0	0.1	0.1	0.1	0.1	0.1	0.3	0.5	0.2	0.2	2.8	0.0	1.1	0.3	0.1	0.0	0.3	1.1	0.3	0.1	0.5	0.1	28.3	0.1	0.3	0.1	0.3	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.1	0.1	0.3	0.0	0.0	0.1	0.0	0.0	9.1	10.8	88.2	14.4	14.5	5.0	3.7	7.5	8.1	3.2	6.6	5.1	0.0	0.0	0.0	0.7	0.0	3.2	0.7	0.0	0.0	17.1	0.0	0.1	2.1	0.0	0.0	1.8	0.0	1.9	0.0	0.0	0.0	0.0	35.3	0.0	0.1	0.1	0.0	0.0	8.2	0.4	9.9	0.4	0.0	0.0	0.0	5.8	0.0	0.0	0.5	23.5	8.6	0.0	0.0	0.0	0.7	31.8	0.6	0.0	0.0	1.0	0.0	0.7	0.0	4.5	0.9	0.0	0.0	0.7	0.0	0.2	0.0	0.2	0.0	0.8	0.0	0.0	0.4	2.2	6.3	0.0	6.8	40.0	0.0	0.0	0.0	0.1
SLC24A2	NCKX2	ENSG00000155886	"Solute carrier family 24 member 2"	Q9UI40	9	19507452-19786928	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Antiport, Calcium transport, Ion transport, Potassium transport, Sensory transduction, Sodium transport, Symport, Transport, Vision"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"brain: 117.1"	"Cell type enriched"	"Detected in some"	4	"Oligodendrocytes: 2710.1"	"Group enriched"	"Detected in some"	4	"breast cancer: 0.5;glioma: 1.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"K-562: 2.6;SCLC-21H: 2.2;U-87 MG: 2.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA079359			Supported	"Plasma membrane"		NA	NA			"Cluster 42: Non-specific - Transcription"	"Cluster 70: Brain - Nervous system development"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Plasma membrane"		"HPA079359: "	"unprognostic (1.30e-1)"	"unprognostic (8.57e-2)"	"unprognostic (4.20e-1)"	"unprognostic (1.05e-2)"	"unprognostic (3.33e-2)"	"unprognostic (1.48e-2)"		"unprognostic (8.46e-2)"	"unprognostic (8.37e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.50e-2)"	"unprognostic (6.51e-2)"	"unprognostic (1.57e-2)"	"unprognostic (2.08e-4)"	"unprognostic (1.58e-1)"	"unprognostic (2.11e-3)"	"unprognostic (1.51e-2)"	0.1	5.9	28.4	0.0	64.7	0.1	0.0	42.3	64.6	0.1	0.0	0.1	0.0	2.0	0.0	0.0	0.5	0.1	0.0	19.2	19.1	0.1	0.0	0.0	0.0	81.3	36.3	0.0	0.0	0.0	0.8	0.1	87.7	0.1	0.0	18.7	0.0	0.0	0.1	0.1	0.0	0.0	19.4	0.1	0.1	0.2	81.9	0.0	0.0	0.3	0.0	0.0	0.0	117.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.1	0.0	0.1	0.0	0.0	0.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.5	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.3	0.2	0.2	0.1	0.1	0.0	28.4	64.7	42.3	64.6	19.2	19.1	81.3	36.3	87.7	19.4	81.9	117.1	0.0	0.0	0.0	18.9	0.1	0.0	0.0	0.0	0.0	58.7	0.0	0.0	2.3	0.0	0.0	0.0	273.1	0.0	0.0	0.1	0.0	0.0	1.1	0.0	0.1	0.1	0.0	0.0	668.6	0.0	0.1	0.9	0.0	0.1	0.0	0.0	1.4	0.0	0.1	97.6	637.3	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	25.3	0.0	4.1	0.0	217.6	2710.1	0.0	0.1	0.4	0.0	0.0	0.0	0.1	0.0	10.4	0.0	3.2	0.2	0.2	0.7	0.0	0.1	0.3	0.0	0.0	0.1	0.0
SLC25A10	DIC	ENSG00000183048	"Solute carrier family 25 member 10"	Q9UBX3	17	81712236-81721016	"Human disease related genes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport		"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 183.3"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 42.3;Late spermatids: 76.9;Proximal enterocytes: 50.9;Proximal tubular cells: 84.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"NK-cell: 1.0"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in all"		"Hep G2: 158.9;SK-BR-3: 116.6"									HPA023048	Supported		Supported	Nucleoplasm,Mitochondria		NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Mitochondria	Nucleoplasm	"HPA023048: AB_2301950"	"unprognostic (7.17e-2)"	"unprognostic (2.38e-2)"	"unprognostic (2.36e-2)"	"unprognostic (1.36e-1)"	"unprognostic (9.50e-2)"	"prognostic favorable (2.56e-4)"	"unprognostic (5.66e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.78e-2)"	"prognostic favorable (8.14e-4)"	"unprognostic (6.73e-2)"	"unprognostic (1.33e-1)"	"unprognostic (6.02e-2)"	"unprognostic (6.32e-2)"	"unprognostic (2.76e-1)"	"unprognostic (2.05e-1)"	"prognostic favorable (1.31e-4)"	17.8	14.8	5.3	3.0	5.0	9.5	16.8	5.6	6.2	6.5	6.4	26.1	21.4	3.8	2.7	38.8	9.2	5.5	10.4	4.6	5.2	72.9	183.3	4.3	2.5	6.6	5.2	4.8	35.8	17.3	6.3	1.8	5.1	17.2	6.8	0.6	26.0	6.1	5.8	17.3	20.1	0.9	5.8	4.8	24.0	35.0	5.4	3.9	9.6	1.9	2.9	9.1	11.5	6.6	45.3	81.8	7.6	38.1	2.9	2.3	15.3	19.2	6.1	23.2	17.4	49.5	18.4	20.2	14.3	4.5	11.2	28.3	10.8	19.3	4.2	14.9	66.2	16.7	49.0	158.9	3.3	37.5	19.5	1.6	10.0	16.5	3.2	4.5	13.6	27.9	28.0	24.3	8.2	85.4	54.3	40.0	7.8	18.8	63.9	41.0	16.3	63.6	21.1	39.6	49.8	34.0	18.1	116.6	4.0	2.0	50.3	20.4	6.1	17.9	58.6	26.5	34.4	15.3	8.3	12.0	7.8	39.0	15.9	0.0	0.2	0.0	0.1	0.3	0.3	0.0	0.1	0.4	0.1	0.2	0.1	0.0	0.0	1.0	0.0	0.1	0.2	0.2	5.3	5.0	5.6	6.2	4.6	5.2	6.6	5.2	5.1	5.8	5.4	6.6	1.4	0.0	2.2	1.6	1.3	0.0	4.5	0.0	2.2	4.9	14.6	7.5	3.8	17.2	3.1	14.7	0.0	16.4	2.3	10.2	25.4	16.9	30.5	22.3	3.8	1.5	4.9	8.2	1.2	22.9	6.9	2.3	18.8	16.4	0.0	5.1	3.6	42.3	8.0	0.0	1.7	15.3	0.0	2.4	0.0	76.9	2.1	2.0	0.0	0.0	0.8	1.9	3.1	0.5	1.2	9.9	19.3	1.9	4.3	4.7	50.9	84.6	7.3	4.2	0.0	1.3	1.6	27.9	3.1	15.9	0.0	4.2	1.5	5.3	27.2	7.9
SLC25A13	"ARALAR2, CITRIN, CTLN2"	ENSG00000004864	"Solute carrier family 25 member 13"	Q9UJS0	7	96120220-96322147	"Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	Transport		"Disease variant, Intrahepatic cholestasis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"liver: 150.1"	"Cell type enhanced"	"Detected in all"		"Hepatocytes: 153.4;Oligodendrocytes: 439.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018997	Enhanced		Supported	Mitochondria		NA	NA		21000	"Cluster 14: Monocytes - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Mitochondria		"HPA018997: AB_1857023"	"unprognostic (3.61e-2)"	"unprognostic (7.99e-2)"	"unprognostic (6.99e-2)"	"unprognostic (7.19e-2)"	"unprognostic (1.14e-1)"	"unprognostic (3.44e-2)"	"unprognostic (1.42e-2)"	"unprognostic (6.67e-2)"	"unprognostic (2.31e-2)"	"unprognostic (5.46e-2)"	"unprognostic (1.01e-1)"	"unprognostic (6.99e-2)"	"prognostic favorable (9.14e-4)"	"unprognostic (1.15e-1)"	"unprognostic (1.05e-1)"	"unprognostic (3.32e-1)"	"unprognostic (7.09e-2)"	9.2	14.3	7.0	8.9	13.7	8.0	10.3	13.7	10.0	8.0	15.1	16.3	16.0	7.6	10.2	9.6	9.5	9.9	6.6	6.7	9.9	32.3	150.1	7.9	7.1	13.6	12.2	7.8	9.6	13.8	8.3	16.1	13.0	8.2	17.8	19.4	7.7	12.5	7.0	12.3	13.4	6.7	10.1	10.0	14.4	7.4	11.3	3.9	13.7	3.3	8.7	11.0	7.6	20.2	45.3	39.2	44.2	15.5	7.5	6.0	61.8	11.2	8.5	26.5	26.7	70.7	41.2	20.2	51.9	7.2	57.8	26.3	50.1	16.2	31.0	8.0	33.0	23.0	34.4	55.4	17.4	29.5	17.4	15.8	16.9	22.7	20.4	10.1	31.0	3.0	65.9	7.6	13.0	49.6	0.1	27.6	78.0	47.8	24.0	11.6	26.3	46.8	63.7	42.1	21.1	69.0	38.8	81.1	67.3	72.9	24.2	22.4	18.2	19.6	43.6	46.8	34.5	15.2	40.8	12.7	24.1	28.0	32.9	0.4	3.1	2.2	1.4	4.5	1.5	2.4	1.1	1.3	6.1	1.2	0.7	0.9	0.6	2.0	5.1	3.1	1.2	1.4	7.0	13.7	13.7	10.0	6.7	9.9	13.6	12.2	13.0	10.1	11.3	20.2	31.5	9.6	12.6	60.7	19.7	7.4	8.5	8.6	16.5	36.5	13.6	17.1	8.3	27.1	9.2	18.4	54.2	29.2	8.9	32.1	27.4	19.8	11.0	44.0	23.2	20.7	37.8	15.3	26.6	19.1	26.5	18.8	44.4	34.2	14.5	30.4	11.7	153.4	23.2	10.1	43.7	22.3	12.2	23.8	10.0	11.1	13.1	21.5	21.4	82.4	13.2	17.6	8.2	53.3	439.6	22.6	23.7	15.8	12.7	14.9	27.1	74.9	14.2	47.3	13.1	19.0	16.9	7.0	14.5	25.4	8.0	20.0	7.9	21.6	25.5	15.4
SLC25A17	PMP34	ENSG00000100372	"Solute carrier family 25 member 17"	O43808	22	40769630-40819399	"Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA052708, HPA060972"	Approved		Supported	Peroxisomes		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 68: Epididymis - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	Peroxisomes		"HPA052708: AB_2681924, HPA060972: AB_2684400"	"unprognostic (2.75e-1)"	"unprognostic (1.11e-3)"	"unprognostic (1.91e-3)"	"unprognostic (2.44e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.96e-2)"	"unprognostic (2.85e-3)"	"unprognostic (2.16e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.63e-3)"	"unprognostic (8.44e-2)"	"unprognostic (2.72e-1)"	"unprognostic (5.59e-2)"	"unprognostic (8.54e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.18e-1)"	7.4	12.3	9.4	5.3	9.2	3.3	14.3	9.9	10.7	9.3	11.5	6.3	5.4	13.2	19.6	7.1	11.4	5.7	4.3	9.2	10.2	13.6	16.9	6.6	9.4	9.9	9.6	20.6	8.8	13.6	9.2	10.0	9.7	10.7	7.3	9.2	9.8	5.9	3.9	9.6	6.0	10.5	10.1	7.3	7.8	10.0	10.0	9.3	12.7	3.6	9.7	8.1	7.2	11.2	23.5	13.5	21.0	18.5	12.8	15.9	16.8	20.7	22.7	32.5	35.7	16.5	8.8	26.7	12.2	20.4	17.7	18.6	30.6	16.6	33.4	27.0	41.3	31.1	18.4	21.1	18.3	35.8	16.2	15.3	22.8	28.6	18.4	14.7	19.4	21.4	46.5	12.9	26.5	19.2	22.0	24.2	17.7	33.2	20.6	23.8	32.4	40.3	27.6	19.7	14.2	12.5	42.8	26.6	26.7	20.3	22.0	10.7	11.8	18.5	24.4	16.1	19.2	13.9	29.6	25.7	19.7	18.4	20.4	7.0	3.3	4.2	4.9	3.9	6.9	8.4	5.8	5.5	4.2	7.6	8.2	6.7	1.5	8.3	3.3	5.4	8.6	4.7	9.4	9.2	9.9	10.7	9.2	10.2	9.9	9.6	9.7	10.1	10.0	11.2	8.4	19.2	9.5	23.2	10.9	16.6	16.8	29.8	10.8	12.1	13.6	9.3	4.0	7.2	20.7	12.9	8.4	39.8	8.0	5.8	21.5	17.9	9.6	17.9	16.5	10.4	6.1	11.6	17.3	17.7	31.9	15.9	8.2	14.2	5.1	15.5	8.2	24.8	12.9	11.8	21.5	6.5	26.4	7.9	6.0	16.0	27.1	7.4	16.0	7.5	17.6	7.9	10.3	18.1	28.0	18.1	4.4	26.7	11.9	18.1	8.2	21.1	15.0	7.0	32.9	9.3	11.6	51.0	38.0	11.7	17.2	28.6	9.7	16.4	7.5	14.9
SLC25A19	"DNC, MCPHA, MUP1, TPC"	ENSG00000125454	"Solute carrier family 25 member 19"	Q9HC21	17	75272981-75289510	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport		"Disease variant, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 82.2;Langerhans cells: 160.3;Spermatocytes: 79.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021936			Supported	Mitochondria		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 66: Spermatocytes - Spermatogenesis"	Mitochondria		"HPA021936: "	"unprognostic (2.28e-1)"	"unprognostic (7.05e-3)"	"unprognostic (8.21e-2)"	"prognostic unfavorable (8.72e-5)"	"unprognostic (2.31e-1)"	"unprognostic (1.65e-1)"	"prognostic unfavorable (1.21e-7)"	"unprognostic (6.71e-2)"	"unprognostic (2.73e-1)"	"unprognostic (2.85e-1)"	"unprognostic (7.72e-2)"	"unprognostic (1.77e-3)"	"unprognostic (2.71e-3)"	"unprognostic (3.58e-2)"	"unprognostic (4.44e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.13e-1)"	10.9	31.2	11.6	16.0	12.4	8.0	6.4	13.1	13.3	7.3	12.4	9.8	9.4	6.7	2.4	8.6	6.3	6.2	10.6	11.7	12.6	10.9	8.8	11.7	22.9	14.9	12.6	6.2	8.8	8.1	4.8	12.1	13.2	6.1	8.8	3.1	6.2	3.7	14.5	4.9	8.5	7.1	13.0	14.6	10.9	33.0	14.7	8.6	6.0	16.7	18.8	11.5	5.7	14.7	28.3	34.8	6.2	18.4	13.6	7.0	20.0	18.1	7.0	20.3	20.5	59.8	17.4	89.8	12.8	6.4	17.7	24.7	43.5	20.9	25.3	26.5	70.5	41.1	40.4	58.4	11.5	58.7	44.9	6.1	11.6	31.5	25.2	4.7	33.9	44.9	51.0	41.9	6.5	59.3	61.8	59.3	13.5	55.3	67.8	47.4	19.8	85.1	14.1	19.7	60.7	15.3	19.3	51.4	22.2	10.2	32.1	47.3	12.0	12.1	24.1	23.5	49.0	102.7	53.4	95.8	9.5	66.9	15.5	0.3	21.0	2.3	16.2	25.2	16.6	36.3	12.7	15.4	24.9	29.7	14.2	14.7	1.7	10.0	14.8	31.0	17.7	14.5	11.6	12.4	13.1	13.3	11.7	12.6	14.9	12.6	13.2	13.0	14.7	14.7	5.1	6.4	6.7	3.3	27.6	15.2	10.8	6.0	2.8	1.2	5.4	7.5	0.6	2.8	6.1	7.3	2.1	7.5	13.3	8.6	23.5	6.5	18.0	5.6	8.7	6.7	3.0	11.1	3.1	5.3	82.2	8.6	9.7	3.5	11.4	2.7	2.5	2.9	44.1	3.3	3.5	6.2	4.1	9.5	160.3	24.1	3.1	31.5	24.9	4.7	38.8	1.6	11.3	2.0	2.4	5.1	8.6	3.4	26.5	14.1	6.5	6.4	3.9	6.0	6.6	5.9	10.0	79.6	11.9	7.9	12.9	8.9	12.5	11.4	11.0	9.7
SLC25A20	"CAC, CACT"	ENSG00000178537	"Solute carrier family 25 member 20"	O43772	3	48856926-48898904	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport		"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 148.3"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 42.2;Hepatocytes: 64.2;Proximal enterocytes: 51.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 96.1;RPMI-8226: 138.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016862, HPA029863"	Approved		Approved	Mitochondria,Cytosol		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Mitochondria, Cytosol"		"HPA016862: AB_1857028, HPA029863: AB_10602893"	"unprognostic (1.02e-1)"	"unprognostic (1.84e-1)"	"unprognostic (2.20e-1)"	"unprognostic (3.46e-2)"	"unprognostic (5.18e-2)"	"unprognostic (3.97e-2)"	"unprognostic (1.03e-1)"	"unprognostic (5.96e-3)"	"unprognostic (4.06e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.36e-2)"	"unprognostic (2.51e-1)"	"unprognostic (3.71e-3)"	"unprognostic (3.34e-1)"	"unprognostic (5.12e-1)"	"unprognostic (4.22e-2)"	"unprognostic (3.49e-2)"	20.7	29.9	16.3	11.9	18.2	10.7	17.9	18.6	16.4	8.3	15.3	26.5	65.6	10.4	4.6	9.1	12.8	15.7	62.8	15.5	17.9	25.6	148.3	15.6	14.6	17.7	17.4	5.9	30.4	17.3	11.6	7.3	17.8	11.7	23.5	4.5	19.9	9.0	66.5	10.4	52.7	15.1	17.4	20.6	21.0	9.1	17.5	17.3	11.4	61.1	16.1	11.3	8.4	18.4	4.1	12.8	9.7	13.8	30.1	11.8	1.9	22.3	11.8	15.2	15.8	16.3	19.1	19.0	15.6	35.1	18.7	4.1	24.5	9.8	11.6	47.9	11.8	26.4	19.2	20.4	14.0	27.8	48.1	14.9	11.2	20.6	3.8	6.1	20.2	28.1	24.1	96.1	20.2	10.9	30.4	13.7	5.1	22.9	27.6	10.6	5.9	138.4	16.4	10.1	3.9	13.6	20.7	0.2	11.4	13.6	30.5	12.9	16.6	17.2	3.2	25.5	16.4	35.6	27.0	21.8	24.5	19.5	23.3	60.8	101.1	215.2	97.4	79.7	62.2	36.8	53.1	71.2	97.5	33.0	41.2	69.1	48.6	64.6	83.7	120.5	60.7	112.3	16.3	18.2	18.6	16.4	15.5	17.9	17.7	17.4	17.8	17.4	17.5	18.4	7.5	6.4	2.7	13.1	7.0	1.8	2.5	4.6	3.4	1.1	4.0	3.6	42.2	4.3	4.4	0.0	6.2	2.3	13.6	28.4	3.9	3.5	1.3	2.3	4.6	5.5	7.3	16.4	2.2	4.3	2.3	6.1	9.2	2.1	1.3	3.8	7.5	64.2	16.9	0.0	3.8	12.7	2.0	13.4	4.5	1.8	10.5	10.0	1.8	1.0	31.3	2.9	32.0	1.0	6.0	3.7	16.4	12.4	12.6	3.9	51.8	16.7	5.9	1.3	0.0	5.4	5.3	8.3	7.1	4.1	1.3	1.2	14.4	27.7	16.6	2.9
SLC25A23	"APC2, FLJ30339, MGC2615"	ENSG00000125648	"Solute carrier family 25 member 23"	Q9BV35	19	6436079-6465203	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 238.7"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 164.2;Proximal enterocytes: 106.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA009675, HPA050883"	Approved		Supported	Mitochondria		NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 65: Brain - Ion transport"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Mitochondria		"HPA009675: AB_2668252, HPA050883: AB_2681260"	"unprognostic (3.51e-1)"	"unprognostic (1.53e-3)"	"unprognostic (1.52e-1)"	"prognostic unfavorable (1.29e-4)"	"unprognostic (2.05e-2)"	"unprognostic (3.65e-3)"	"unprognostic (3.43e-2)"	"unprognostic (1.31e-3)"	"unprognostic (1.27e-1)"	"unprognostic (3.82e-1)"	"unprognostic (1.30e-1)"	"unprognostic (3.25e-1)"	"prognostic favorable (1.10e-12)"	"unprognostic (8.95e-2)"	"unprognostic (3.20e-1)"	"unprognostic (5.44e-2)"	"unprognostic (4.22e-1)"	28.8	38.0	144.8	12.0	238.7	0.8	18.0	77.5	200.1	32.1	72.0	94.4	39.3	41.8	24.0	64.7	36.6	21.4	79.0	206.5	95.1	45.0	38.5	24.0	9.2	108.8	98.2	33.6	24.2	58.8	22.2	4.7	109.5	35.0	49.1	41.2	68.9	40.0	90.8	33.5	40.5	65.5	82.7	11.9	41.3	9.5	101.4	7.2	60.7	78.2	31.2	55.8	31.1	115.8	58.2	22.9	32.2	101.9	42.3	18.6	14.9	17.0	26.4	31.0	37.2	58.2	37.1	32.2	40.0	41.3	34.1	48.0	66.3	39.0	24.3	0.1	58.6	23.2	46.7	46.2	39.2	1.6	52.5	53.3	33.4	27.6	12.0	62.9	32.8	34.7	68.8	39.4	6.2	41.6	20.7	32.8	23.6	61.0	71.1	10.0	8.8	49.4	83.3	10.2	2.4	31.9	11.7	70.8	30.0	34.8	37.1	50.1	11.7	9.8	41.8	2.6	11.2	7.3	10.7	28.3	4.5	54.2	15.6	0.5	0.0	0.0	2.0	0.0	0.4	1.0	1.1	0.9	0.2	0.4	1.5	1.4	0.0	0.3	0.0	0.4	1.3	0.4	144.8	238.7	77.5	200.1	206.5	95.1	108.8	98.2	109.5	82.7	101.4	115.8	6.2	9.6	20.9	11.8	7.0	10.5	8.8	11.5	12.0	13.1	18.9	15.6	39.5	47.1	10.0	46.0	8.4	1.4	4.5	164.2	19.6	54.7	15.9	8.2	6.4	8.0	13.8	1.3	24.7	28.5	1.8	10.2	12.8	17.5	7.0	17.9	16.1	38.0	2.7	8.4	17.9	34.5	10.2	3.0	2.6	71.2	19.0	1.4	17.8	12.2	1.0	28.7	4.1	17.1	12.6	55.5	57.9	29.3	17.6	13.6	106.8	28.7	6.4	22.0	13.1	12.1	12.7	0.5	4.6	34.1	23.3	0.8	5.2	39.5	34.2	30.3
SLC25A25	"KIAA1896, MCSC, PCSCL"	ENSG00000148339	"Solute carrier family 25 member 25"	Q6KCM7	9	128068201-128109245	"Predicted intracellular proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 136.5"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 127.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020381	Uncertain		Supported	Vesicles,Mitochondria	"Intracellular and membrane"	NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 16: U-266 - Nucleosome"	"Cluster 44: Endometrium - Transcription"	"Vesicles, Mitochondria"		"HPA020381: AB_1857037"	"unprognostic (4.62e-2)"	"unprognostic (2.66e-2)"	"unprognostic (2.56e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.89e-1)"	"unprognostic (1.40e-1)"	"prognostic favorable (1.01e-4)"	"unprognostic (1.20e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.60e-2)"	"unprognostic (4.96e-2)"	"unprognostic (3.70e-2)"	"prognostic favorable (4.65e-6)"	"unprognostic (1.21e-1)"	"unprognostic (1.05e-2)"	"unprognostic (1.66e-3)"	"unprognostic (1.42e-2)"	55.3	22.9	16.0	12.5	16.5	9.5	22.9	14.7	19.7	33.2	10.6	17.2	11.9	26.8	3.3	35.0	40.7	39.9	12.8	18.1	17.4	28.6	136.5	27.9	11.2	19.9	18.1	25.3	82.6	19.6	45.7	11.5	17.9	15.2	7.8	31.2	16.5	14.2	82.0	24.4	18.3	26.3	15.4	15.6	23.7	7.6	19.6	15.3	18.9	21.1	6.2	19.0	21.4	14.9	9.5	9.8	13.6	19.8	10.1	8.6	9.0	19.3	17.8	15.9	10.5	17.7	9.7	12.2	5.8	9.0	8.8	16.6	10.8	6.3	6.0	14.3	8.9	7.1	21.6	10.7	16.0	8.3	15.7	11.0	6.0	15.5	11.3	5.2	10.9	20.1	26.1	25.7	10.1	22.9	14.7	8.4	13.8	30.5	15.1	14.3	11.6	26.1	6.1	9.8	33.6	14.5	20.2	12.9	27.8	5.3	14.2	4.7	7.0	17.9	10.6	13.6	19.3	22.3	42.2	13.2	12.1	4.4	15.0	2.6	1.7	0.9	3.0	5.1	1.6	1.2	3.4	3.1	3.1	1.8	2.7	4.9	0.3	1.0	6.1	1.0	2.7	3.2	16.0	16.5	14.7	19.7	18.1	17.4	19.9	18.1	17.9	15.4	19.6	14.9	59.3	22.4	34.2	17.6	9.3	26.1	46.2	24.3	56.3	18.8	71.7	73.5	3.2	58.6	22.8	20.2	127.2	10.1	7.6	45.6	11.7	11.2	0.3	72.0	34.5	44.7	51.7	11.0	19.7	11.5	12.9	21.0	43.8	110.3	8.2	18.7	26.0	84.5	9.1	18.5	20.5	26.5	28.5	20.1	42.9	1.5	9.3	16.8	21.4	13.1	12.6	15.2	12.3	11.1	2.4	12.1	42.7	8.2	14.5	28.6	47.7	10.2	30.8	70.4	19.7	48.1	40.3	5.6	7.9	89.5	43.0	23.0	14.2	11.9	22.3	58.3
SLC25A26		ENSG00000144741	"Solute carrier family 25 member 26"	Q70HW3	3	66133610-66388116	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport		"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026887	Supported		Supported	Mitochondria		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"HPA026887: AB_2189921"	"unprognostic (1.93e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.38e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.32e-1)"	"unprognostic (7.83e-2)"	"unprognostic (7.94e-2)"	"unprognostic (5.38e-2)"	"unprognostic (1.53e-1)"	"unprognostic (3.54e-1)"	"unprognostic (9.21e-2)"	"unprognostic (8.43e-2)"	"prognostic favorable (1.73e-5)"	"unprognostic (4.73e-2)"	"unprognostic (2.59e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.07e-1)"	15.8	16.0	9.6	5.6	9.9	12.9	15.0	8.7	11.0	12.7	6.8	18.1	7.8	13.3	9.4	15.9	12.7	7.8	28.3	10.1	8.7	18.5	25.9	11.6	10.7	9.1	9.3	16.5	15.5	14.9	10.2	7.7	9.2	13.5	9.5	8.5	16.1	9.0	42.4	22.0	13.3	7.8	9.3	13.5	17.4	14.3	11.1	8.6	15.8	21.0	9.6	17.5	14.1	11.3	10.7	10.4	6.5	12.4	13.9	13.1	13.9	9.0	15.7	10.7	10.2	13.5	13.9	12.3	5.5	15.1	14.3	7.6	7.3	15.8	11.7	11.5	16.8	16.3	8.1	19.2	14.7	22.5	13.4	17.7	29.6	8.4	21.3	11.2	8.9	21.5	9.2	12.8	12.9	12.5	9.9	28.3	20.8	23.2	6.8	10.0	11.7	19.4	10.1	8.3	5.4	14.6	12.4	11.8	21.4	10.9	9.8	19.7	10.4	12.7	11.0	15.9	16.6	21.1	30.6	15.1	17.4	21.1	14.7	1.8	9.9	6.1	15.4	10.8	14.5	19.3	16.9	16.4	18.3	16.2	20.5	17.5	0.9	18.1	6.7	17.5	17.7	13.4	9.6	9.9	8.7	11.0	10.1	8.7	9.1	9.3	9.2	9.3	11.1	11.3	11.6	32.1	22.2	22.9	29.5	35.8	38.6	45.7	28.5	17.7	36.1	34.0	106.9	30.0	25.0	18.4	12.5	36.8	27.3	14.1	35.2	28.8	33.3	17.2	13.6	20.5	18.6	9.2	55.5	45.1	44.6	26.1	17.3	19.1	19.6	21.1	13.2	39.1	30.3	11.8	51.4	29.2	28.5	22.3	26.5	28.6	16.1	15.8	37.4	31.9	21.4	26.5	32.0	32.2	63.9	27.6	20.8	21.8	18.7	49.1	30.8	57.7	16.2	24.5	19.7	31.7	22.1	29.4	32.9	28.2	36.8	32.7	39.6	22.3	33.3	37.8
SLC25A27	"FLJ33552, UCP4"	ENSG00000153291	"Solute carrier family 25 member 27"	O95847	6	46652915-46678190	"Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 53.2;Excitatory neurons: 78.1;Inhibitory neurons: 78.1;Oligodendrocyte precursor cells: 127.2;Oligodendrocytes: 88.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HeLa: 53.6;hTCEpi: 24.2;U-698: 27.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA069732			Supported	Mitochondria		NA	NA				"Cluster 21: Non-specific - Transcription"	"Cluster 20: HeLa - Mitochondria"	"Cluster 68: Oligodendrocytes - Mixed function"	Mitochondria		"HPA069732: AB_2686185"	"unprognostic (2.16e-2)"	"unprognostic (2.19e-1)"	"unprognostic (9.86e-3)"	"unprognostic (4.93e-2)"	"unprognostic (1.87e-1)"	"unprognostic (2.03e-1)"	"unprognostic (2.81e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.35e-1)"	"prognostic favorable (6.16e-4)"	"unprognostic (3.82e-3)"	"unprognostic (1.01e-1)"	"unprognostic (7.53e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.74e-1)"	"unprognostic (7.47e-3)"	33.7	23.7	34.7	5.9	46.5	1.5	31.6	76.5	45.5	57.9	42.1	50.4	6.7	41.4	69.9	18.6	52.9	19.8	36.0	41.3	34.0	52.2	43.8	25.2	5.7	35.9	36.7	94.3	34.1	21.1	114.7	3.0	36.5	72.2	15.5	118.8	28.4	24.4	21.2	41.1	24.4	22.2	28.5	15.8	31.7	32.5	44.9	1.2	70.8	10.9	4.8	43.0	40.9	57.1	3.5	2.3	3.9	13.1	14.6	10.0	0.1	2.0	6.2	1.8	0.4	0.0	4.9	1.4	8.9	3.3	4.3	6.9	1.8	5.8	1.2	0.0	19.7	0.0	53.6	5.0	7.7	0.1	0.6	15.7	24.2	0.1	15.2	9.4	0.4	13.5	0.2	0.1	1.6	1.4	0.0	0.2	2.0	3.5	5.2	0.0	5.0	0.2	9.7	12.5	11.8	1.3	9.2	0.6	5.4	5.7	9.8	0.0	1.4	8.1	5.3	0.8	1.7	5.3	0.0	27.4	1.3	0.1	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	34.7	46.5	76.5	45.5	41.3	34.0	35.9	36.7	36.5	28.5	44.9	57.1	3.6	3.2	4.6	53.2	0.2	0.9	4.4	0.5	9.1	32.0	3.6	7.5	9.5	2.8	1.7	5.5	29.2	0.0	0.0	0.7	0.0	1.2	29.0	5.7	6.1	4.5	6.0	2.5	78.1	0.7	0.1	7.2	1.1	5.1	1.3	7.3	1.8	2.2	0.2	20.2	78.1	1.3	2.0	0.3	0.3	22.7	3.1	0.8	1.8	27.2	0.0	7.0	0.0	127.2	88.5	0.2	0.7	5.3	0.2	4.5	0.5	1.0	5.0	36.2	0.0	8.8	7.5	0.5	1.8	4.4	2.4	0.0	0.2	8.8	1.5	2.8
SLC25A3	PHC	ENSG00000075415	"Solute carrier family 25 member 3"	Q00325	12	98593591-98606379	"Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Symport, Transport"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 1537.4"	"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 1748.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045709			Supported	Mitochondria		NA	NA		83000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"HPA045709: AB_10965843"	"unprognostic (1.16e-2)"	"unprognostic (4.68e-1)"	"unprognostic (1.95e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.56e-2)"	"unprognostic (6.38e-2)"	"unprognostic (3.25e-3)"	"unprognostic (9.41e-2)"	"unprognostic (4.98e-2)"	"unprognostic (6.43e-2)"	"unprognostic (5.65e-2)"	"unprognostic (7.40e-2)"	"prognostic favorable (8.11e-7)"	"unprognostic (3.45e-1)"	"unprognostic (2.99e-1)"	"unprognostic (8.66e-3)"	"unprognostic (4.72e-2)"	300.9	550.7	131.2	184.7	136.0	209.2	267.5	159.3	146.5	224.3	209.3	418.9	396.4	283.5	226.1	437.7	248.9	136.2	1237.8	132.6	160.4	419.8	370.1	255.7	201.7	148.9	149.6	290.2	392.2	499.7	216.9	192.4	153.0	209.9	347.6	167.2	302.7	220.9	1537.4	275.7	321.2	257.4	150.4	235.1	423.5	90.8	159.0	205.7	225.1	1233.2	312.8	294.7	264.6	135.4	731.4	447.1	620.0	509.6	534.1	891.5	1005.3	622.8	724.1	704.3	573.4	787.6	316.4	1003.2	376.9	633.0	320.3	573.7	616.9	741.3	680.6	402.9	651.8	589.5	297.4	563.3	683.0	665.7	416.6	857.3	616.8	494.2	681.2	994.3	990.8	488.8	654.9	240.5	782.7	436.5	642.5	724.2	605.4	540.6	988.5	703.0	730.3	1075.0	858.8	559.6	355.5	506.1	740.1	565.5	1009.8	504.4	771.0	676.3	782.0	371.2	390.0	442.8	603.4	486.5	648.5	678.1	295.6	368.3	494.9	184.7	408.9	223.2	244.7	520.2	285.6	298.5	270.8	271.4	534.7	222.6	281.3	269.8	166.6	288.5	545.2	321.7	377.4	637.0	131.2	136.0	159.3	146.5	132.6	160.4	148.9	149.6	153.0	150.4	159.0	135.4	319.2	214.7	294.8	46.0	392.2	376.0	590.6	751.4	495.1	223.1	442.5	549.3	1748.6	370.3	384.5	215.2	79.2	785.9	480.8	727.5	874.6	512.1	41.7	217.9	275.3	328.6	312.4	413.5	44.9	879.5	946.2	393.1	390.4	288.7	210.4	477.9	278.1	416.3	589.4	292.7	49.7	470.7	370.2	467.9	280.7	29.0	255.1	449.1	437.6	34.7	593.5	317.3	294.5	32.2	42.2	632.9	602.7	256.5	442.7	652.4	945.5	1029.4	201.1	230.2	302.4	470.5	733.5	126.1	169.9	796.6	362.4	814.7	356.3	536.0	729.1	769.9
SLC25A4	"ANT1, PEO2, PEO3, T1"	ENSG00000151729	"Solute carrier family 25 member 4"	P12235	4	185143266-185150382	"Disease related genes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted membrane proteins, Transporters"	"Antiport, Host-virus interaction, Transport"		"Cardiomyopathy, Disease variant, FDA approved drug targets, Primary mitochondrial disease, Progressive external ophthalmoplegia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	9	"heart muscle: 245.1;skeletal muscle: 190.8;tongue: 346.6"	"Cell type enriched"	"Detected in all"	4	"Cardiomyocytes: 4722.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046835, HPA071684"	Approved		Supported	Mitochondria		NA	NA		380000	"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 38: Heart - Muscle contraction"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 54: Cardiomyocytes - Muscle contraction"	Mitochondria		"HPA046835: AB_2679831, HPA071684: AB_2686431"	"unprognostic (4.19e-2)"	"unprognostic (1.06e-2)"	"unprognostic (3.11e-1)"	"unprognostic (8.85e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.90e-3)"	"unprognostic (8.25e-2)"	"unprognostic (1.26e-2)"	"unprognostic (7.87e-2)"	"unprognostic (1.60e-1)"	"prognostic favorable (3.41e-4)"	"unprognostic (2.05e-1)"	"prognostic favorable (0.00e+0)"	"unprognostic (1.98e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.73e-1)"	"unprognostic (8.28e-3)"	4.7	5.7	14.0	1.6	15.3	0.4	4.6	22.6	30.6	3.4	6.8	21.0	3.0	5.9	3.5	10.1	5.8	3.9	245.1	16.7	11.8	10.4	7.3	4.5	1.5	11.6	10.7	4.9	5.2	7.8	9.5	1.7	11.8	8.9	3.9	19.9	9.0	12.6	190.8	3.3	6.8	8.1	9.4	3.1	15.7	4.7	12.5	1.4	5.2	346.6	1.2	9.8	3.6	18.2	0.7	3.1	2.5	5.1	2.7	0.3	4.6	2.6	0.8	3.1	3.0	6.8	1.7	2.3	1.8	3.1	2.4	2.5	9.8	2.7	2.0	3.9	8.4	1.6	4.7	8.1	5.5	1.4	1.5	2.0	6.6	4.7	1.3	7.2	2.3	4.0	3.8	1.7	1.9	5.0	1.6	3.1	4.1	2.2	6.6	2.5	1.3	3.2	6.9	4.8	8.1	6.2	3.1	1.3	12.5	4.5	2.4	1.1	1.7	0.2	1.4	1.5	3.4	7.3	3.5	2.9	2.2	0.3	2.8	0.0	0.0	0.0	1.7	0.0	1.3	1.5	0.5	1.4	0.0	1.0	0.4	1.2	0.1	0.3	0.0	1.3	0.5	0.6	14.0	15.3	22.6	30.6	16.7	11.8	11.6	10.7	11.8	9.4	12.5	18.2	37.5	86.6	76.4	22.9	37.9	44.1	159.0	119.9	30.1	180.6	42.9	53.5	4722.0	115.8	80.0	71.7	104.3	69.2	41.1	44.4	988.0	75.3	20.6	77.8	7.4	80.1	53.8	3.0	35.1	74.1	56.5	120.1	54.0	33.6	12.0	18.6	27.5	92.1	65.9	159.9	43.7	40.6	215.7	8.5	13.8	16.7	46.6	6.8	190.3	19.7	9.0	541.2	16.5	26.7	29.2	51.4	28.5	112.8	76.4	59.1	113.8	178.3	144.0	221.0	105.2	134.5	402.7	28.0	34.0	33.2	18.2	40.5	27.7	23.7	54.2	50.7
SLC25A42	MGC26694	ENSG00000181035	"Solute carrier family 25 member 42"	Q86VD7	19	19063994-19113030	"Disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	Transport		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 82.0"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 67.7;Hepatocytes: 52.1;Proximal tubular cells: 39.6;Rod photoreceptor cells: 41.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"gdT-cell: 2.7;MAIT T-cell: 1.4;memory B-cell: 3.3;memory CD4 T-cell: 1.5;memory CD8 T-cell: 2.4;naive B-cell: 3.2;naive CD4 T-cell: 1.0;naive CD8 T-cell: 1.4;NK-cell: 1.8;T-reg: 1.7"	"Group enriched"	"Detected in many"	6	"B-cells: 3.3;NK-cells: 1.8;T-cells: 2.7"	"Cell line enhanced"	"Detected in many"		"K-562: 20.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049449	Approved		Supported	Mitochondria		Yes	No			"Cluster 43: B-cells - Humoral immune response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 56: Bipolar cells - Visual perception"	Mitochondria		"HPA049449: AB_2680772"	"unprognostic (2.27e-1)"	"prognostic favorable (5.04e-4)"	"unprognostic (5.79e-2)"	"unprognostic (5.67e-2)"	"unprognostic (1.35e-1)"	"unprognostic (3.42e-3)"	"unprognostic (1.27e-3)"	"prognostic favorable (4.11e-4)"	"unprognostic (6.89e-2)"	"unprognostic (2.73e-1)"	"unprognostic (1.37e-3)"	"unprognostic (3.04e-2)"	"unprognostic (5.29e-3)"	"unprognostic (1.76e-1)"	"unprognostic (2.39e-2)"	"unprognostic (4.17e-2)"	"unprognostic (2.03e-2)"	8.5	7.5	17.2	4.3	16.9	8.3	7.9	14.5	18.3	13.1	16.7	8.4	5.1	10.1	3.7	5.2	12.5	3.5	15.8	17.9	16.9	34.1	82.0	6.6	9.0	14.9	15.2	16.9	11.3	6.0	14.4	2.6	14.7	9.9	2.4	8.4	9.2	5.2	46.5	6.7	9.3	4.9	13.9	12.7	8.3	7.0	18.0	8.1	25.6	32.6	7.5	9.6	9.1	13.9	7.3	1.0	1.8	3.2	6.8	5.6	2.8	3.5	5.2	5.3	6.0	1.4	14.3	5.2	8.0	3.3	5.3	1.3	3.7	2.9	3.0	1.3	7.0	1.8	2.0	11.8	5.4	0.8	3.6	5.6	2.0	4.0	2.4	4.3	2.4	16.8	20.9	9.2	2.8	6.6	9.0	8.4	1.0	2.0	7.4	6.8	3.2	10.2	2.1	1.3	2.0	1.5	3.7	0.1	1.6	2.4	6.5	4.1	2.2	3.9	2.2	8.2	3.4	10.7	6.2	4.1	4.1	11.2	2.0	0.0	0.1	0.1	2.7	0.3	1.4	3.3	1.5	2.4	0.2	3.2	1.0	1.4	0.0	1.8	0.3	0.4	1.7	0.9	17.2	16.9	14.5	18.3	17.9	16.9	14.9	15.2	14.7	13.9	18.0	13.9	4.6	0.0	13.1	12.4	14.2	3.2	2.8	3.3	2.8	67.7	5.9	6.6	9.7	5.7	4.1	9.2	18.8	7.7	16.5	3.1	13.7	1.5	1.2	2.5	5.4	4.1	8.4	13.7	18.6	3.1	3.8	5.1	4.1	3.6	3.8	8.3	5.3	52.1	1.8	3.3	25.0	3.8	6.1	0.6	1.9	1.6	5.0	1.4	3.6	6.5	1.3	12.5	32.0	16.1	8.6	2.5	4.6	6.4	16.4	2.4	9.2	39.6	3.0	41.4	6.6	9.6	5.8	10.6	7.6	0.9	2.8	4.7	10.9	8.0	3.1	1.7
SLC25A46		ENSG00000164209	"Solute carrier family 25 member 46"	Q96AG3	5	110738136-110765161	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport		"Charcot-Marie-Tooth disease, Disease variant, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 238.9;Late spermatids: 448.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039601, HPA071582"	Approved		Supported	Mitochondria		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 25: Spermatids - Spermatogenesis"	Mitochondria		"HPA039601: AB_2676592, HPA071582: AB_2686422"	"unprognostic (1.86e-1)"	"unprognostic (3.29e-1)"	"prognostic favorable (8.41e-4)"	"unprognostic (4.91e-2)"	"unprognostic (2.27e-2)"	"unprognostic (2.25e-1)"	"unprognostic (2.34e-1)"	"unprognostic (1.77e-2)"	"unprognostic (5.14e-2)"	"unprognostic (1.97e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.40e-1)"	"unprognostic (2.25e-2)"	"unprognostic (2.26e-1)"	"unprognostic (2.62e-1)"	"prognostic unfavorable (2.52e-4)"	"unprognostic (1.98e-1)"	22.9	15.9	10.4	19.9	11.8	17.6	16.4	12.7	16.7	18.5	7.8	22.1	23.8	14.7	10.5	21.2	10.7	15.8	31.1	12.2	12.2	29.7	30.0	16.7	22.5	12.4	10.2	11.7	15.4	20.6	4.9	17.0	13.2	15.7	21.6	18.8	13.3	16.0	55.8	14.9	20.9	20.8	10.3	15.7	20.1	21.9	11.2	24.8	19.8	60.2	26.8	19.0	6.6	14.1	36.2	27.7	25.7	20.7	65.2	60.2	9.9	44.3	55.9	47.5	59.3	37.6	28.7	96.8	44.8	50.1	61.9	29.6	41.0	71.2	54.3	61.8	20.8	40.1	35.2	25.6	53.1	37.3	40.2	49.9	25.4	55.5	39.6	29.5	31.9	37.2	31.4	56.4	54.1	27.3	54.0	17.2	18.1	25.7	24.7	26.0	57.0	71.5	35.1	39.2	46.7	33.5	37.7	29.7	49.7	23.7	30.9	35.3	42.5	43.6	21.0	40.7	54.4	111.8	76.2	68.4	48.0	43.8	24.0	29.2	16.0	13.2	12.3	19.0	12.5	14.4	13.7	12.9	17.0	14.5	14.5	14.8	6.6	20.9	17.7	11.1	18.2	17.4	10.4	11.8	12.7	16.7	12.2	12.2	12.4	10.2	13.2	10.3	11.2	14.1	21.3	22.4	24.8	40.8	26.7	22.9	9.1	16.0	31.9	16.8	15.7	10.8	63.5	11.5	12.9	20.2	22.9	21.7	18.0	34.8	19.6	18.1	238.9	10.4	20.1	18.9	23.4	29.9	73.3	25.6	18.2	22.6	34.7	12.1	19.0	16.2	26.7	43.9	27.2	18.5	63.9	28.3	32.6	26.1	21.0	448.2	21.1	23.9	30.2	31.9	28.1	21.9	17.5	49.8	91.8	18.9	22.8	22.2	73.8	8.0	26.5	41.7	14.9	14.1	19.7	18.5	22.6	23.3	14.2	30.0	26.9	20.5	23.9	22.7	24.0	6.8
SLC25A5	"2F1, ANT2, T2, T3"	ENSG00000005022	"Solute carrier family 25 member 5"	P05141	X	119468422-119471396	"FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted membrane proteins, Transporters"	"Antiport, Chromosome partition, Host-virus interaction, Transport"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal tubular cells: 2533.6;Proximal enterocytes: 2785.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046835, HPA071684"	Approved		Supported	Mitochondria		NA	NA		640000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 45: Enterocytes - Digestion"	Mitochondria		"HPA046835: AB_2679831, HPA071684: AB_2686431"	"unprognostic (1.25e-2)"	"prognostic favorable (7.35e-4)"	"prognostic favorable (7.47e-4)"	"unprognostic (1.48e-1)"	"unprognostic (4.58e-2)"	"unprognostic (1.45e-2)"	"unprognostic (2.73e-2)"	"unprognostic (1.36e-1)"	"unprognostic (6.52e-2)"	"unprognostic (2.47e-1)"	"unprognostic (1.60e-1)"	"unprognostic (2.17e-1)"	"prognostic favorable (8.06e-6)"	"unprognostic (1.41e-1)"	"unprognostic (2.65e-1)"	"unprognostic (4.36e-2)"	"unprognostic (3.03e-1)"	178.1	178.3	116.9	176.0	116.1	260.9	161.3	141.6	126.0	155.0	114.3	458.7	740.2	134.5	63.9	411.0	118.6	100.4	196.1	109.0	141.5	491.8	336.1	216.5	255.4	120.6	118.0	108.2	629.1	295.3	89.0	138.1	126.4	111.9	503.0	127.7	250.2	103.8	61.6	294.9	562.8	150.5	119.3	182.6	492.1	54.2	126.4	351.9	128.8	65.1	297.7	200.8	235.3	121.5	845.1	789.6	303.3	525.4	189.5	277.3	561.0	306.8	331.3	631.7	560.8	662.4	518.4	1059.3	400.9	296.1	456.1	576.9	752.1	640.5	572.5	281.1	711.2	357.5	418.7	477.0	239.8	984.0	566.1	303.7	705.2	652.2	412.6	240.1	660.4	535.0	292.5	425.9	350.1	1868.4	878.6	995.1	640.4	1147.6	1244.3	474.5	383.4	825.7	486.9	663.6	365.0	344.5	526.7	793.3	646.7	306.7	327.7	491.0	279.5	297.3	428.9	670.8	1122.2	494.6	656.3	847.4	329.5	987.7	492.2	113.4	603.4	170.2	170.7	1045.7	198.1	459.2	248.3	224.6	872.6	376.0	243.3	232.1	99.2	318.1	824.2	476.1	443.1	931.8	116.9	116.1	141.6	126.0	109.0	141.5	120.6	118.0	126.4	119.3	126.4	121.5	260.4	163.5	308.6	28.7	339.6	815.7	567.0	1615.3	398.9	109.8	406.2	413.5	131.2	301.7	609.2	187.6	60.5	1038.8	336.2	1379.0	2533.6	578.2	4.0	137.3	134.2	257.5	401.0	349.1	16.8	1056.4	463.1	214.4	543.3	157.6	192.9	306.0	146.7	333.6	881.7	26.9	25.5	856.4	1129.1	610.6	650.9	18.1	145.4	473.2	547.8	15.0	441.2	140.8	218.3	24.1	19.2	554.1	1061.8	110.6	419.9	522.3	2785.2	1622.3	239.5	199.0	131.5	163.9	506.7	11.5	119.2	1046.8	960.2	1589.1	291.2	626.6	1053.7	809.7
SLC25A6	"ANT3, ANT3Y, MGC17525"	ENSG00000169100	"Solute carrier family 25 member 6"	P12236	X	1386152-1392113	"FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted membrane proteins, Transporters"	"Antiport, Apoptosis, Host-virus interaction, Transport"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA046835, HPA071684"	Approved		Supported	Mitochondria		NA	NA		450000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 25: Pancreas - Digestion"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 32: Non-specific - Translation"	Mitochondria		"HPA046835: AB_2679831, HPA071684: AB_2686431"	"unprognostic (1.13e-1)"	"unprognostic (1.65e-2)"	"unprognostic (4.79e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.14e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.01e-3)"	"unprognostic (1.34e-1)"	"unprognostic (8.07e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.37e-3)"	"unprognostic (2.51e-1)"	"unprognostic (3.96e-2)"	"unprognostic (2.73e-1)"	"unprognostic (1.69e-1)"	"unprognostic (2.85e-1)"	"unprognostic (4.57e-3)"	356.6	410.1	227.8	223.3	241.4	441.5	307.3	210.8	296.7	253.7	351.6	350.9	466.0	277.9	80.6	344.8	243.4	127.2	201.5	227.9	216.1	386.8	130.0	239.4	275.0	222.6	222.8	460.8	626.9	323.5	275.8	147.1	228.0	264.1	141.5	108.3	697.7	178.8	115.5	331.3	387.7	129.4	208.3	263.7	413.9	62.2	227.4	232.7	321.5	89.2	159.3	292.0	244.6	219.2	290.4	596.8	393.8	422.6	267.5	527.4	466.2	396.8	386.1	296.8	289.2	796.7	330.6	1023.0	334.1	264.9	445.6	179.2	269.5	482.0	89.8	260.3	886.0	545.0	396.0	899.7	642.2	398.1	649.8	870.1	882.2	235.8	335.9	367.5	441.6	315.7	407.2	233.8	284.5	575.4	791.1	733.3	516.0	105.5	802.2	378.8	333.8	828.3	351.4	693.6	682.9	1096.5	271.1	817.7	1239.7	224.1	466.1	832.5	505.5	305.1	169.6	596.5	422.1	606.7	110.5	705.9	48.7	389.9	170.3	34.2	739.8	47.2	319.5	808.7	466.9	671.4	431.3	377.9	985.9	532.5	396.1	399.7	34.4	359.9	832.3	461.2	447.6	1120.7	227.8	241.4	210.8	296.7	227.9	216.1	222.6	222.8	228.0	208.3	227.4	219.2	194.2	147.4	244.3	13.7	724.4	1151.2	1447.6	1800.6	421.8	286.1	981.3	710.8	106.0	371.8	704.7	316.3	98.0	1581.2	448.5	690.4	1659.2	752.6	11.4	164.4	388.1	473.0	928.4	471.3	15.1	1473.5	1229.8	507.8	374.1	245.3	343.6	698.0	529.4	149.7	1264.7	242.3	20.4	1208.1	819.9	1553.5	1299.4	45.8	667.9	764.0	754.2	17.8	1450.5	184.6	531.4	8.0	13.7	789.8	1127.8	366.3	604.9	1452.4	1564.9	1320.8	180.3	280.0	341.8	631.7	665.6	13.3	80.7	796.7	1321.5	1744.1	494.7	847.8	1524.3	1723.2
SLC26A11		ENSG00000181045	"Solute carrier family 26 member 11"	Q86WA9	17	80219699-80253500	"Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Anion exchange, Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 58.4;Rod photoreceptor cells: 40.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029893	Approved		Supported	"Nucleoplasm,Golgi apparatus,Vesicles"		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 9: Photoreceptor cells - Phototransduction"	"Golgi apparatus, Vesicles"	Nucleoplasm	"HPA029893: AB_10600809"	"unprognostic (5.86e-2)"	"unprognostic (6.66e-2)"	"unprognostic (3.84e-2)"	"prognostic unfavorable (1.55e-5)"	"unprognostic (3.80e-2)"	"unprognostic (2.63e-3)"	"prognostic unfavorable (1.82e-6)"	"unprognostic (2.05e-2)"	"unprognostic (3.54e-2)"	"unprognostic (1.03e-1)"	"prognostic favorable (1.43e-5)"	"unprognostic (2.86e-1)"	"unprognostic (3.50e-1)"	"unprognostic (9.54e-3)"	"unprognostic (8.40e-2)"	"unprognostic (8.69e-2)"	"unprognostic (7.32e-2)"	12.2	36.5	27.4	8.9	24.8	16.4	11.8	14.1	23.2	16.3	21.9	12.1	7.2	11.6	8.9	7.5	13.5	7.6	7.1	21.1	45.5	19.1	10.2	18.8	14.1	27.8	33.3	22.5	10.6	11.8	35.1	9.0	30.1	16.8	4.1	11.6	11.3	9.2	5.9	13.0	11.2	6.0	17.7	22.6	10.0	4.8	42.2	3.4	24.8	3.6	5.6	11.6	12.1	17.4	0.7	12.4	14.3	11.1	7.1	5.2	16.1	6.7	8.4	15.6	9.4	13.6	2.5	0.1	13.1	7.4	11.3	4.4	8.0	5.2	6.1	15.7	14.4	0.0	17.5	13.5	18.6	0.0	2.2	9.5	8.4	7.5	3.4	1.4	13.3	2.7	6.4	16.8	9.3	11.6	0.6	0.3	6.5	3.5	11.7	0.5	1.6	5.7	14.2	13.6	5.4	16.9	6.8	17.0	18.3	22.0	20.4	0.3	9.9	11.8	6.9	10.4	0.9	17.8	7.4	1.8	6.2	0.0	10.1	0.0	1.0	0.0	0.7	0.4	1.1	0.2	1.2	1.0	0.6	0.1	1.9	0.8	0.0	0.0	0.1	0.0	1.7	0.9	27.4	24.8	14.1	23.2	21.1	45.5	27.8	33.3	30.1	17.7	42.2	17.4	8.8	6.4	13.4	22.2	3.9	4.6	8.9	5.0	5.2	27.2	9.6	9.9	2.5	5.7	5.6	12.9	58.4	14.5	5.6	3.2	1.9	7.5	0.6	7.1	7.0	12.4	10.2	2.7	13.4	6.0	8.8	8.1	3.6	11.6	1.3	15.4	8.2	2.2	15.2	3.3	17.2	3.2	8.2	11.4	10.5	0.7	17.1	15.1	3.6	12.2	4.2	22.8	5.2	12.1	13.3	3.4	3.9	12.4	2.2	9.0	7.0	6.0	4.4	40.8	32.9	6.4	7.7	0.2	5.3	2.4	4.7	26.0	8.2	16.4	2.6	5.3
SLC28A1	CNT1	ENSG00000156222	"Solute carrier family 28 member 1"	O00337	15	84884654-84945798	"Disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	Transport		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	21	"intestine: 49.1;kidney: 48.2;liver: 111.3"	"Group enriched"	"Detected in some"	5	"Hepatocytes: 38.6;Hofbauer cells: 54.3;Proximal enterocytes: 86.9;Proximal tubular cells: 93.4"	"Group enriched"	"Detected in some"	63	"liver cancer: 10.9;renal cancer: 33.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA019551, HPA056247"	Enhanced		Approved	"Nuclear speckles,Plasma membrane,Cytosol"		NA	NA				"Cluster 41: Intestine & Liver - Lipid metabolism"		"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Plasma membrane"	"Nuclear speckles, Cytosol"	"HPA019551: AB_2670187, HPA056247: "	"unprognostic (3.81e-2)"	"unprognostic (1.60e-1)"	"unprognostic (2.22e-1)"	"unprognostic (7.49e-2)"	"unprognostic (5.08e-2)"	"unprognostic (7.08e-2)"	"unprognostic (8.68e-3)"	"unprognostic (1.82e-1)"	"unprognostic (1.98e-1)"	"unprognostic (2.18e-2)"	"unprognostic (1.63e-1)"	"unprognostic (8.37e-2)"	"unprognostic (1.35e-1)"	"unprognostic (7.42e-2)"	"unprognostic (7.72e-3)"	"unprognostic (6.65e-2)"	"unprognostic (1.55e-1)"	0.2	0.0	0.0	0.1	0.2	0.0	0.1	0.2	0.1	0.3	0.0	0.0	37.9	0.0	0.5	0.1	0.7	0.2	1.0	0.1	0.3	48.2	111.3	0.0	0.2	0.9	0.3	0.0	0.0	0.2	0.2	1.2	0.7	0.0	0.0	0.0	0.1	0.0	1.5	0.0	49.1	0.0	0.4	0.0	0.1	0.1	0.2	0.0	0.0	3.3	0.0	0.0	0.0	0.6	0.7	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.1	0.1	0.3	0.9	0.3	0.7	0.4	0.2	0.6	0.2	0.0	0.0	0.3	0.0	0.0	0.0	1.0	0.0	0.0	0.5	0.3	2.2	4.3	0.6	7.3	0.0	0.5	0.0	0.0	11.7	3.0	0.0	0.4	0.1	0.1	0.0	0.0	0.5	0.0	0.5	0.4	0.0	0.6	0.0	0.0	0.4	38.6	54.3	0.0	0.5	2.8	0.0	0.6	0.0	0.0	0.0	0.9	0.0	0.0	0.6	0.0	0.0	0.5	1.1	0.3	2.5	0.0	0.0	0.0	86.9	93.4	1.4	0.0	0.0	2.6	0.2	0.0	0.0	0.0	0.0	0.8	0.4	0.3	1.5	0.1
SLC2A10	GLUT10	ENSG00000197496	"Solute carrier family 2 member 10"	O95528	20	46709649-46736347	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Sugar transport, Transport"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Hepatocytes: 43.6;Intestinal goblet cells: 56.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	75	"basophil: 20.9"	"Lineage enriched"	"Detected in single"	75	"granulocytes: 20.9"	"Cell line enhanced"	"Detected in many"		"ASC diff: 45.8;HSkMC: 56.6;OE19: 49.8;SK-MEL-30: 60.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA041015, HPA055673"	Approved		Supported	Cytosol		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 27: Mucus-secreting cells - Mucin production"	Cytosol		"HPA041015: AB_2677252, HPA055673: AB_2682879"	"unprognostic (8.94e-3)"	"unprognostic (2.62e-3)"	"unprognostic (2.06e-1)"	"unprognostic (1.85e-1)"	"unprognostic (6.17e-3)"	"unprognostic (1.04e-1)"	"unprognostic (7.68e-2)"	"unprognostic (2.80e-1)"	"unprognostic (1.83e-1)"	"unprognostic (8.06e-2)"	"unprognostic (4.94e-3)"	"unprognostic (1.70e-1)"	"unprognostic (3.63e-3)"	"unprognostic (1.25e-2)"	"unprognostic (1.05e-1)"	"unprognostic (3.00e-1)"	"unprognostic (5.96e-2)"	7.0	5.9	4.0	3.5	4.1	1.2	15.3	3.4	3.9	19.4	18.9	12.7	5.4	7.9	8.7	5.1	9.9	10.3	5.2	3.8	3.7	3.5	41.4	6.9	1.7	5.2	4.7	9.9	17.4	19.5	6.3	11.6	4.0	31.3	16.0	1.6	24.0	9.9	1.5	3.6	5.3	8.5	3.8	2.6	22.8	2.6	4.0	1.6	19.5	2.7	2.1	9.3	8.4	3.4	0.0	0.1	11.3	11.7	45.8	38.9	34.2	22.2	30.2	10.1	12.0	0.9	38.9	0.0	16.3	40.6	0.0	0.2	0.0	1.1	4.8	0.0	0.3	3.3	0.0	18.6	32.2	0.0	0.0	56.6	1.0	6.2	0.0	11.8	4.2	0.0	0.2	0.1	17.5	41.3	0.0	1.2	4.3	49.8	2.9	0.0	1.6	0.1	0.0	10.6	0.0	1.8	4.3	7.2	60.3	8.1	5.4	9.2	2.6	21.7	9.1	17.2	2.9	0.3	0.1	0.0	0.1	0.0	4.6	20.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	4.0	4.1	3.4	3.9	3.8	3.7	5.2	4.7	4.0	3.8	4.0	3.4	4.2	6.4	6.3	12.4	0.8	0.6	6.1	7.8	5.2	0.0	29.6	14.4	6.4	7.2	15.8	1.8	0.0	2.7	0.4	11.4	0.0	7.4	0.2	3.2	17.8	4.6	3.6	6.1	0.1	5.6	16.3	16.7	23.4	4.0	6.3	10.7	8.6	43.6	1.1	0.0	0.4	56.6	12.2	1.9	1.3	1.6	26.4	0.4	1.8	2.8	0.0	5.5	0.0	10.1	0.3	5.1	10.3	17.3	2.8	23.9	1.7	0.8	27.5	0.5	13.1	5.1	6.3	0.8	0.3	4.2	1.0	2.1	0.5	3.6	14.6	10.9
SLC2A12	"GLUT12, GLUT8"	ENSG00000146411	"Solute carrier family 2 member 12"	Q8TD20	6	133987581-134052624	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Sugar transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"choroid plexus: 87.3"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 24.8;Oligodendrocytes: 14.5;Syncytiotrophoblasts: 36.7"	"Cancer enriched"	"Detected in many"	6	"prostate cancer: 18.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 7.6;hTERT-RPE1: 14.8;SuSa: 21.7;U-2 OS: 7.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031593, HPA031594"	Approved		Supported	"Plasma membrane,Cell Junctions"		NA	NA				"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 12: NES - Nervous system development"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	"Plasma membrane"	"Cell Junctions"	"HPA031593: AB_10600810, HPA031594: AB_2673948"	"unprognostic (2.06e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.69e-2)"	"unprognostic (5.55e-3)"	"unprognostic (2.18e-1)"	"unprognostic (6.02e-2)"	"unprognostic (2.24e-3)"	"unprognostic (2.54e-2)"	"unprognostic (2.08e-2)"	"unprognostic (3.69e-2)"	"unprognostic (2.38e-1)"	"unprognostic (1.83e-1)"	"unprognostic (2.33e-3)"	"unprognostic (3.04e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.04e-2)"	"unprognostic (1.55e-3)"	0.5	1.0	3.6	0.3	4.8	0.0	1.1	7.8	4.6	3.0	87.3	2.1	7.3	8.2	2.1	6.1	2.8	2.6	10.7	5.7	2.6	5.8	6.8	3.1	0.1	2.3	3.1	1.2	1.1	2.3	1.4	1.6	2.5	22.4	1.0	2.3	5.1	9.3	3.8	2.7	9.8	3.1	1.6	0.1	14.3	0.4	3.4	1.0	0.2	4.1	1.2	3.5	1.2	3.1	2.5	0.9	2.3	0.0	1.4	0.7	0.1	1.5	5.4	0.7	2.9	0.0	7.6	0.3	1.2	0.1	5.7	5.9	0.0	0.5	1.0	0.0	5.3	0.0	0.8	0.1	0.2	0.0	0.0	1.0	0.5	0.6	0.1	14.8	0.4	0.4	0.5	0.8	0.1	0.8	0.1	0.1	2.0	0.0	0.5	0.0	1.0	2.2	1.6	0.8	0.2	0.7	0.1	2.1	0.0	21.7	0.1	0.0	0.1	0.2	7.6	0.2	0.9	3.2	2.4	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	3.6	4.8	7.8	4.6	5.7	2.6	2.3	3.1	2.5	1.6	3.4	3.1	0.2	0.0	7.7	24.8	0.1	2.0	1.0	3.3	8.6	0.4	0.5	2.2	6.3	0.0	2.2	0.0	0.0	2.0	0.1	1.2	3.9	1.5	0.1	3.4	0.4	2.3	4.2	0.0	8.0	0.2	0.6	2.2	2.6	1.6	0.0	0.4	0.0	1.1	0.3	0.0	3.2	0.2	6.1	0.0	0.3	0.0	0.0	0.1	0.0	4.7	0.1	9.8	0.0	4.5	14.5	1.1	2.4	1.5	1.6	10.5	0.5	0.5	10.4	0.5	0.0	2.1	1.3	0.0	0.0	8.6	1.8	36.7	0.2	3.5	0.4	1.3
SLC2A2	GLUT2	ENSG00000163581	"Solute carrier family 2 member 2"	P11168	3	170996347-171026743	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Sugar transport, Transport"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	13	"liver: 836.1"	"Cell type enriched"	"Detected in some"	4	"Hepatocytes: 457.6"	"Cancer enriched"	"Detected in some"	12	"liver cancer: 105.2"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	55	"CACO-2: 7.7;Hep G2: 27.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"CAB010444, HPA028997"	Enhanced		Supported	"Plasma membrane"		NA	NA				"Cluster 85: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 2: Hepatocytes - Metabolism"	"Plasma membrane"		"CAB010444: AB_641068, HPA028997: AB_2672860"			"unprognostic (9.56e-2)"		"unprognostic (1.24e-1)"		"prognostic favorable (2.63e-5)"				"unprognostic (3.10e-1)"		"unprognostic (1.02e-1)"	"unprognostic (2.95e-2)"	"unprognostic (6.31e-2)"			0.0	0.0	0.2	0.0	0.8	0.0	0.0	0.2	0.4	0.0	0.2	0.0	66.1	0.0	0.0	0.0	0.0	5.2	0.0	0.3	0.3	30.8	836.1	0.0	0.0	0.5	0.4	0.0	2.4	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	48.0	0.0	0.4	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	27.6	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.8	0.2	0.4	0.3	0.3	0.5	0.4	0.8	0.4	0.4	2.3	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	90.1	0.0	0.0	0.0	0.0	0.0	0.1	1.9	0.2	6.7	0.0	0.0	0.1	0.0	2.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.1	457.6	0.0	0.0	0.1	3.0	0.0	10.0	0.0	1.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.1	2.5	0.0	0.0	0.0	105.4	63.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	1.8	0.0
SLC30A1	"ZNT1, ZRC1"	ENSG00000170385	"Solute carrier family 30 member 1"	Q9Y6M5	1	211571568-211579161	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport, Zinc transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 86.1"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 94.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015275, HPA049000"	Uncertain		Supported	"Vesicles,Plasma membrane"		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 44: Endometrium - Transcription"	"Plasma membrane"	Vesicles	"HPA015275: AB_1857083, HPA049000: AB_2680593"	"unprognostic (1.13e-1)"	"unprognostic (2.67e-3)"	"unprognostic (6.94e-2)"	"unprognostic (1.81e-3)"	"unprognostic (3.47e-1)"	"unprognostic (1.80e-1)"	"unprognostic (2.27e-2)"	"unprognostic (1.82e-3)"	"unprognostic (4.72e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.42e-3)"	"unprognostic (4.78e-2)"	"unprognostic (2.23e-2)"	"unprognostic (3.03e-1)"	"unprognostic (2.55e-1)"	"unprognostic (1.02e-1)"	"unprognostic (4.53e-2)"	14.8	18.0	15.7	10.9	17.0	29.8	8.5	15.2	19.3	18.6	27.8	15.4	28.2	10.8	9.9	8.0	12.5	12.4	10.0	16.9	15.4	20.5	86.1	7.2	6.1	17.9	17.3	7.8	11.3	10.3	4.6	10.1	16.8	7.8	13.6	6.1	9.3	7.9	1.8	16.0	19.9	11.6	16.7	15.4	9.5	13.4	18.9	4.5	16.9	4.8	7.1	12.2	7.5	13.2	10.3	15.0	7.7	9.9	32.4	14.9	70.5	27.3	19.3	13.8	13.6	6.4	46.6	5.8	24.1	24.4	19.3	17.2	11.5	15.4	16.4	15.0	9.3	4.7	28.8	14.7	18.1	15.8	10.0	22.5	37.5	17.7	28.4	20.5	8.6	3.4	18.7	25.5	17.2	9.1	3.2	9.9	24.2	10.6	12.0	10.0	3.7	20.4	42.5	26.4	7.8	13.7	26.7	13.6	62.7	14.2	7.0	20.2	14.6	10.4	24.8	35.4	22.1	11.9	19.0	4.5	9.8	15.7	9.3	1.4	1.3	0.5	0.4	1.5	0.5	0.2	0.3	0.2	0.9	0.1	0.3	0.4	0.1	0.4	1.2	0.5	0.3	0.4	15.7	17.0	15.2	19.3	16.9	15.4	17.9	17.3	16.8	16.7	18.9	13.2	29.7	9.6	9.8	3.9	8.8	28.6	8.2	3.0	16.5	11.0	24.9	14.7	21.0	18.6	4.2	36.8	6.2	11.6	19.9	54.5	1.9	6.9	44.0	37.0	19.1	27.3	9.5	26.1	0.6	12.5	32.7	15.9	8.6	66.4	5.1	7.5	17.9	94.9	32.0	6.7	0.6	22.8	2.0	27.2	14.5	6.8	9.9	25.5	21.4	3.7	18.8	29.0	1.0	1.0	0.1	9.5	41.7	7.5	8.6	13.9	49.2	29.8	6.4	9.4	6.6	15.9	11.7	37.9	17.4	24.2	46.2	24.5	14.2	14.8	23.3	13.7
SLC30A5	"FLJ12496, FLJ12756, MGC5499, ZnT-5, ZNT5, ZNTL1, ZTL1"	ENSG00000145740	"Solute carrier family 30 member 5"	Q8TAD4	5	69093949-69131069	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport, Zinc transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035373	Approved		Supported	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 24: NB-4 - Immune response"	"Cluster 38: Extravillous trophoblasts - Unknown function"	"Golgi apparatus"	Nucleoplasm	"HPA035373: AB_10794630"	"unprognostic (9.81e-3)"	"unprognostic (3.33e-1)"	"unprognostic (2.82e-2)"	"unprognostic (8.16e-2)"	"unprognostic (1.65e-1)"	"unprognostic (3.88e-2)"	"unprognostic (1.16e-3)"	"unprognostic (2.47e-2)"	"unprognostic (4.65e-2)"	"unprognostic (5.41e-2)"	"unprognostic (3.57e-2)"	"unprognostic (2.92e-1)"	"unprognostic (1.49e-1)"	"unprognostic (2.53e-2)"	"unprognostic (2.07e-1)"	"unprognostic (2.11e-2)"	"unprognostic (1.40e-1)"	25.8	25.6	9.8	21.0	10.3	19.6	30.3	11.7	15.9	29.7	17.4	26.9	24.7	25.6	38.2	19.3	24.3	24.0	24.1	9.7	10.6	29.1	29.0	21.1	24.7	10.1	11.4	22.3	33.0	35.9	24.0	27.4	10.2	29.4	24.7	18.5	30.8	24.0	16.4	27.1	23.6	22.8	9.7	21.9	26.3	16.4	10.9	20.8	37.5	16.5	23.7	23.6	19.7	12.1	37.4	29.9	26.3	46.2	69.1	53.2	82.5	58.8	53.6	36.4	55.1	26.0	45.7	50.2	70.6	41.4	63.7	38.8	38.6	46.1	61.5	60.2	43.5	55.7	35.0	43.2	55.0	34.8	58.3	35.7	57.1	38.3	46.5	50.1	36.6	34.2	34.9	57.0	46.1	46.9	46.4	71.6	29.4	25.3	33.3	35.5	33.2	89.9	53.6	34.5	46.0	36.8	47.4	45.0	84.5	36.0	43.7	76.2	33.3	23.2	29.5	58.7	58.2	49.5	67.5	37.9	46.6	62.3	58.9	11.9	5.1	8.5	4.1	5.3	4.4	6.9	6.4	6.2	6.3	4.3	5.9	4.8	4.1	4.0	5.5	9.6	4.9	2.8	9.8	10.3	11.7	15.9	9.7	10.6	10.1	11.4	10.2	9.7	10.9	12.1	17.3	19.2	21.5	14.7	26.9	18.7	27.9	27.5	19.9	15.3	28.5	20.6	29.2	18.6	23.2	25.8	22.9	42.0	35.3	19.9	29.4	22.0	6.9	28.8	35.8	19.3	13.2	29.9	29.6	27.1	80.4	24.8	34.7	23.7	41.3	15.4	21.8	19.8	22.3	8.4	30.6	27.9	32.6	17.2	18.4	9.9	24.2	16.8	14.2	19.7	21.2	14.9	15.5	22.1	23.3	19.0	16.7	22.2	51.8	34.7	16.9	21.3	27.7	24.7	26.3	17.5	21.4	11.0	14.9	26.6	21.5	51.6	23.4	20.9	23.2	28.6
SLC30A7	"ZNT7, ZnTL2"	ENSG00000162695	"Solute carrier family 30 member 7"	Q8NEW0	1	100896076-100981757	"Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport, Zinc transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018034	Uncertain		Supported	"Golgi apparatus"		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 18: U-2197 - ECM organization"	"Cluster 55: Plasma cells - Humoral immune response"	"Golgi apparatus"		"HPA018034: AB_1857089"	"unprognostic (1.94e-1)"	"unprognostic (1.08e-1)"	"unprognostic (8.05e-3)"	"unprognostic (1.79e-1)"	"unprognostic (2.50e-1)"	"unprognostic (3.18e-1)"	"unprognostic (2.89e-3)"	"unprognostic (1.24e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.11e-3)"	"unprognostic (2.78e-2)"	"unprognostic (1.95e-1)"	"unprognostic (5.46e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.46e-1)"	"unprognostic (2.25e-1)"	"unprognostic (3.37e-1)"	6.8	6.8	2.5	7.2	3.0	6.7	6.5	3.7	3.5	7.2	6.6	5.9	6.6	4.7	7.8	5.0	4.6	6.7	4.2	2.5	3.0	5.3	10.2	9.3	7.5	2.9	3.1	4.5	8.0	6.8	5.7	8.7	3.0	5.9	7.1	4.7	8.6	3.6	2.6	6.1	6.1	4.4	2.7	7.1	7.6	3.0	3.2	7.0	6.9	2.1	7.0	7.8	5.3	3.9	11.3	5.2	6.1	12.5	16.5	14.9	16.2	8.5	17.0	7.3	9.4	5.3	7.7	5.0	17.2	14.1	4.9	10.7	6.5	11.1	12.7	6.4	4.7	8.5	8.4	11.4	19.5	11.7	7.6	17.3	8.4	12.9	18.9	10.9	15.3	8.4	4.9	15.9	12.5	4.4	9.4	8.1	7.7	5.6	5.5	4.2	10.8	5.8	10.6	10.0	3.3	7.4	11.4	15.8	12.2	5.3	6.7	8.1	17.9	18.2	6.3	19.9	13.7	14.0	5.7	4.6	23.1	11.1	5.7	8.3	5.8	4.2	5.2	6.6	4.9	2.7	5.3	4.8	3.9	2.5	5.5	5.7	2.7	3.5	8.7	3.9	4.3	3.1	2.5	3.0	3.7	3.5	2.5	3.0	2.9	3.1	3.0	2.7	3.2	3.9	28.3	32.1	21.6	32.3	26.3	57.4	19.7	22.8	21.1	10.1	25.8	13.2	6.1	20.0	22.1	23.9	6.2	32.6	24.5	24.1	1.9	24.1	0.9	14.9	27.0	34.5	22.8	11.6	44.8	26.4	24.3	29.1	29.0	29.4	37.4	16.3	33.5	44.6	22.1	5.0	39.6	38.3	14.2	37.0	39.1	1.1	17.1	28.5	32.0	34.7	29.6	6.5	28.8	52.8	59.2	36.0	27.9	16.6	48.1	46.0	20.7	15.7	23.5	13.7	6.6	30.2	20.9	11.4	9.2	19.3	63.9	41.7	28.8	34.8	24.3	32.7
SLC34A1	"NAPI-3, NPT2, NPTIIa, SLC11, SLC17A2"	ENSG00000131183	"Solute carrier family 34 member 1"	Q06495	5	177379235-177398848	"Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Symport, Transport"		"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	54	"kidney: 155.4"	"Cell type enriched"	"Detected in some"	14	"Proximal tubular cells: 143.2"	"Cancer enriched"	"Detected in single"	12	"renal cancer: 1.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	12	"HEL: 2.4;U-937: 1.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA051255, HPA077175"	Approved		Approved	"Nucleoplasm,Nuclear speckles,Plasma membrane,Mitotic spindle,Cytosol"		Yes	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 36: HEL - Hemostasis"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Nuclear speckles, Plasma membrane"	"Nucleoplasm, Mitotic spindle, Cytosol"	"HPA051255: AB_2681409, HPA077175: "	"unprognostic (1.17e-1)"	"unprognostic (3.33e-3)"	"unprognostic (1.49e-1)"	"unprognostic (3.49e-2)"		"unprognostic (1.56e-3)"	"unprognostic (2.28e-1)"	"unprognostic (4.50e-2)"	"unprognostic (4.43e-3)"	"unprognostic (1.91e-1)"	"unprognostic (1.14e-1)"	"unprognostic (5.95e-2)"	"unprognostic (1.23e-3)"	"unprognostic (1.38e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.28e-2)"	"unprognostic (4.66e-2)"	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	155.4	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	7.3	0.0	0.0	0.2	0.0	9.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	143.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.6	0.0	0.0	0.1
SLC34A2	NAPI-3B	ENSG00000157765	"Solute carrier family 34 member 2"	O95436	4	25648011-25678748	"Cancer-related genes, Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Symport, Transport"		"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"lung: 753.0"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 477.5;Alveolar cells type 2: 1315.9;Club cells: 179.9;Glandular and luminal cells: 241.3;Respiratory ciliated cells: 217.0"	"Group enriched"	"Detected in many"	4	"lung cancer: 252.6;ovarian cancer: 191.7;thyroid cancer: 585.2"	"Region enriched"	"Detected in single"	6	"cerebellum: 2.1"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	82	"BEWO: 32.2;EFO-21: 121.0;RPTEC TERT1: 86.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA037989, HPA066474"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA				"Cluster 19: Lung - Lung function"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 11: Alveolar cells - Smell perception"	"Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA037989: AB_10670536, HPA066474: "	"unprognostic (1.60e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.38e-1)"	"unprognostic (4.25e-2)"	"unprognostic (7.33e-2)"	"unprognostic (9.83e-2)"	"unprognostic (2.37e-2)"	"unprognostic (6.60e-3)"	"unprognostic (6.27e-2)"	"unprognostic (1.89e-2)"	"unprognostic (5.77e-2)"	"unprognostic (2.24e-1)"	"unprognostic (7.08e-3)"	"unprognostic (3.25e-1)"	"unprognostic (6.75e-2)"	"unprognostic (2.57e-2)"	"unprognostic (1.93e-1)"	0.4	0.8	0.0	0.3	0.0	0.0	19.1	2.1	0.2	66.6	6.9	0.1	16.4	34.6	0.1	1.5	69.8	9.0	0.2	0.1	0.0	16.7	1.2	753.0	0.1	0.0	0.0	1.3	7.3	0.0	2.1	4.8	0.1	1.0	0.0	0.5	90.2	16.8	0.1	2.6	4.3	0.2	0.0	0.7	2.5	2.7	0.3	2.1	33.6	0.0	7.4	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	32.2	0.0	0.0	0.0	0.0	0.2	0.1	0.2	121.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.7	0.4	0.1	0.0	0.2	0.1	0.1	86.8	0.0	0.1	0.1	0.0	0.0	0.1	0.5	0.1	0.0	0.0	0.0	0.7	0.9	0.0	0.5	0.4	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.2	477.5	1315.9	0.0	0.1	0.0	0.1	79.1	0.0	0.0	41.5	7.5	0.8	34.3	179.9	20.2	0.0	1.4	0.0	0.0	5.9	72.2	5.4	78.6	30.3	2.5	0.0	0.0	0.1	8.5	0.0	2.6	0.0	241.3	29.0	0.0	0.0	0.0	0.2	0.0	0.1	1.2	26.4	0.0	0.0	20.8	1.2	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.8	2.5	0.0	0.0	11.8	13.6	3.4	217.0	0.0	0.0	0.0	5.8	2.1	0.1	0.0	0.0	0.3	4.8	0.0	1.8	4.0
SLC35A2	"UGALT, UGAT, UGT, UGT1, UGT2, UGTL"	ENSG00000102100	"Solute carrier family 35 member A2"	P78381	X	48903180-48911958	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Sugar transport, Transport"		"Congenital disorder of glycosylation, Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036087	Approved		Supported	"Golgi apparatus"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 30: Mammary glandular cells - Lactation"	"Golgi apparatus"		"HPA036087: AB_10604093"	"prognostic unfavorable (3.16e-4)"	"unprognostic (3.34e-1)"	"unprognostic (4.88e-3)"	"unprognostic (1.11e-1)"	"unprognostic (8.15e-3)"	"unprognostic (4.25e-3)"	"prognostic unfavorable (9.64e-5)"	"unprognostic (3.47e-1)"	"unprognostic (2.50e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.94e-3)"	"unprognostic (9.58e-2)"	"unprognostic (3.16e-2)"	"prognostic favorable (8.23e-4)"	"unprognostic (1.38e-1)"	"unprognostic (1.61e-1)"	"unprognostic (5.13e-2)"	15.8	20.5	13.7	12.7	14.3	15.9	14.9	14.3	14.8	18.7	19.4	29.3	17.3	13.1	28.4	24.7	32.6	15.2	15.0	14.5	15.8	19.8	31.8	18.2	11.4	14.6	15.0	9.3	30.0	24.7	21.3	19.9	15.4	17.1	28.2	3.1	23.8	14.8	14.0	21.9	18.0	11.7	14.4	14.7	25.0	7.1	15.9	11.8	15.4	7.2	14.7	19.8	15.4	15.9	48.8	55.2	18.8	27.3	36.5	31.6	29.7	49.7	54.1	51.3	59.9	64.0	84.5	18.8	22.2	54.2	64.4	67.0	51.7	40.0	39.7	27.9	34.0	20.5	33.1	49.6	47.8	38.7	40.9	35.7	69.9	48.6	39.8	28.9	30.6	25.9	38.7	29.8	37.6	47.1	20.5	35.0	39.7	55.3	67.7	22.3	35.5	61.1	44.4	39.1	21.8	36.1	52.9	54.5	28.7	35.1	80.8	30.7	28.2	30.3	30.6	55.4	27.5	45.1	32.8	19.6	38.4	34.1	40.3	18.1	22.3	40.0	15.3	23.4	15.8	10.7	12.6	13.9	27.7	9.9	8.3	14.6	24.2	13.8	17.5	27.7	13.1	11.9	13.7	14.3	14.3	14.8	14.5	15.8	14.6	15.0	15.4	14.4	15.9	15.9	16.2	9.6	17.0	3.3	13.1	14.1	11.7	29.0	2.8	4.5	26.5	10.9	5.2	10.0	23.5	16.5	0.0	31.0	15.6	24.1	3.9	27.4	3.3	24.2	12.0	13.5	12.7	19.0	2.6	32.3	30.6	14.0	18.8	16.8	2.5	8.0	11.0	15.6	23.4	6.7	2.5	31.5	28.5	10.1	14.5	1.3	9.9	12.3	10.6	4.7	21.9	9.4	8.2	4.5	4.4	27.1	19.7	10.9	19.3	18.7	17.8	10.5	50.5	5.7	6.6	9.7	19.4	10.3	6.8	10.9	17.5	48.0	13.8	12.2	21.7	23.4
SLC35C1	"FLJ11320, FUCT1"	ENSG00000181830	"Solute carrier family 35 member C1"	Q96A29	11	45804072-45813016	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Sugar transport, Transport"		"Congenital disorder of glycosylation, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 84.5"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 50.6;Distal enterocytes: 54.6;Pancreatic endocrine cells: 50.6;Paneth cells: 54.0;Proximal enterocytes: 58.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA064001	Enhanced		Supported	"Golgi apparatus"		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 37: Intestine - Unknown function"	"Cluster 18: U-2197 - ECM organization"	"Cluster 27: Mucus-secreting cells - Mucin production"	"Golgi apparatus"		"HPA064001: AB_2685171"	"unprognostic (2.62e-2)"	"unprognostic (5.16e-2)"	"unprognostic (7.82e-2)"	"unprognostic (1.57e-2)"	"prognostic unfavorable (9.68e-4)"	"unprognostic (8.22e-2)"	"unprognostic (9.40e-2)"	"unprognostic (1.56e-2)"	"unprognostic (2.83e-2)"	"unprognostic (1.28e-1)"	"unprognostic (4.09e-2)"	"unprognostic (2.73e-1)"	"unprognostic (7.68e-2)"	"unprognostic (1.83e-3)"	"unprognostic (2.18e-1)"	"prognostic favorable (3.64e-4)"	"unprognostic (2.30e-2)"	28.2	7.3	6.6	10.7	6.3	2.4	19.8	7.0	7.0	9.6	6.1	19.8	24.4	8.8	2.3	41.5	7.3	12.2	9.0	6.2	7.2	7.0	84.5	10.2	6.6	8.2	7.9	6.3	13.4	5.6	10.4	15.0	7.7	9.9	14.3	1.6	26.1	5.9	6.8	5.1	24.1	9.9	6.5	8.4	18.5	5.2	8.8	4.5	6.6	6.9	10.0	13.8	14.9	6.3	10.3	25.8	6.3	16.3	19.9	19.8	19.5	22.1	20.1	13.3	14.4	10.7	15.2	10.4	9.9	27.3	19.4	26.0	13.4	13.6	6.5	24.8	14.5	5.9	20.4	20.6	42.6	11.4	16.2	23.8	16.3	9.2	11.1	16.2	17.6	10.3	13.3	13.8	14.4	21.8	5.9	9.0	27.5	39.9	34.6	7.2	10.5	21.5	15.1	25.4	6.0	8.6	16.6	16.3	9.5	6.6	13.7	6.0	25.7	25.0	14.7	46.1	15.6	9.8	26.9	4.9	18.5	14.4	14.2	9.7	11.6	12.5	11.0	11.9	12.3	5.0	18.0	14.7	9.6	3.7	9.3	8.0	1.8	5.6	8.7	8.2	13.0	10.1	6.6	6.3	7.0	7.0	6.2	7.2	8.2	7.9	7.7	6.5	8.8	6.3	5.5	0.0	11.2	2.6	6.2	3.6	8.9	12.7	3.4	1.9	11.1	3.0	50.6	22.8	26.7	5.5	2.1	13.8	6.4	54.6	0.0	18.4	4.9	7.3	6.7	10.6	9.6	3.6	2.0	41.9	14.0	10.5	23.4	11.4	2.5	5.2	6.8	42.2	14.7	3.3	2.1	40.6	4.1	9.3	4.8	6.0	6.5	6.3	1.8	2.8	9.5	2.8	7.2	1.0	2.1	50.6	54.0	5.7	13.6	11.8	58.0	4.7	11.4	1.1	0.0	3.6	9.7	4.0	4.3	12.7	2.4	15.3	6.5	5.7	26.4	20.1
SLC35C2	"bA394O2.1, C20orf5, CGI-15, OVCOV1"	ENSG00000080189	"Solute carrier family 35 member C2"	Q9NQQ7	20	46345980-46364458	"Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027011	Approved		Supported	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Golgi apparatus"	Nucleoplasm	"HPA027011: AB_2672082"	"unprognostic (7.25e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.01e-1)"	"unprognostic (2.27e-2)"	"unprognostic (1.06e-2)"	"unprognostic (2.90e-1)"	"prognostic unfavorable (1.08e-4)"	"unprognostic (1.34e-1)"	"unprognostic (1.23e-1)"	"unprognostic (2.56e-1)"	"unprognostic (4.05e-2)"	"unprognostic (1.29e-2)"	"prognostic unfavorable (8.68e-4)"	"unprognostic (9.31e-2)"	"unprognostic (7.15e-2)"	"unprognostic (1.18e-2)"	"unprognostic (3.88e-1)"	23.2	36.3	23.1	17.2	22.3	27.1	23.2	21.3	25.2	26.4	22.6	23.9	21.3	23.1	17.4	31.8	23.2	18.2	17.2	21.8	20.6	27.7	38.3	22.8	24.0	22.6	23.1	25.5	34.9	14.9	20.3	18.2	22.3	31.2	10.1	11.3	30.3	14.0	18.3	32.7	26.4	10.4	21.2	33.6	27.7	25.0	23.4	14.4	29.2	8.2	13.4	22.4	25.6	22.8	35.9	45.1	17.5	15.0	23.9	23.2	36.3	17.6	33.7	19.7	22.6	60.9	54.6	22.5	63.2	19.9	24.7	49.0	9.3	40.5	6.7	19.6	32.5	20.2	29.5	49.0	46.6	27.6	23.6	33.6	51.0	27.4	29.8	20.8	15.2	23.7	33.3	41.5	14.2	85.0	19.8	40.7	24.3	34.1	36.7	18.9	19.7	45.3	25.8	35.1	28.1	39.6	16.4	87.1	60.9	10.4	56.0	47.8	15.7	53.2	33.7	27.5	32.0	55.6	51.5	25.2	58.0	29.7	23.9	42.7	37.9	48.0	37.5	39.9	35.4	29.7	39.0	38.8	42.4	27.9	44.5	40.3	33.5	33.4	30.8	72.9	41.1	44.1	23.1	22.3	21.3	25.2	21.8	20.6	22.6	23.1	22.3	21.2	23.4	22.8	17.0	16.0	19.1	24.5	27.6	14.4	29.0	35.5	29.0	41.3	32.4	25.4	6.7	21.5	29.2	27.6	41.7	89.5	32.6	26.9	13.7	41.3	5.9	12.8	13.0	18.4	21.0	12.4	13.6	61.8	49.2	24.0	26.0	13.9	14.7	20.3	31.8	27.5	38.7	18.5	13.6	35.1	26.4	22.8	8.2	6.7	19.3	23.6	21.4	14.0	36.4	23.4	34.0	11.1	14.2	35.0	26.9	19.2	28.8	50.0	34.8	18.3	18.7	33.6	19.7	20.1	19.0	16.1	23.6	24.8	16.6	79.2	25.9	24.8	30.2	33.1
SLC35D2	"SQV7L, UGTrel8"	ENSG00000130958	"Solute carrier family 35 member D2"	Q76EJ3	9	96313444-96383711	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Sugar transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Oligodendrocytes: 117.2;Proximal enterocytes: 67.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 103.8;Hep G2: 132.3"									HPA064047	Approved		Supported	"Golgi apparatus"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Golgi apparatus"		"HPA064047: AB_2685182"	"unprognostic (3.67e-1)"	"unprognostic (5.73e-2)"	"unprognostic (2.59e-1)"	"unprognostic (1.16e-2)"	"unprognostic (3.17e-1)"	"unprognostic (8.86e-3)"	"unprognostic (4.25e-3)"	"unprognostic (2.24e-2)"	"unprognostic (4.12e-1)"	"unprognostic (5.67e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.74e-2)"	"unprognostic (1.33e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.99e-2)"	"unprognostic (1.44e-1)"	14.7	8.8	13.5	14.4	20.6	11.4	16.4	17.8	20.6	16.5	12.3	49.1	65.1	14.9	12.1	13.7	14.6	20.6	12.2	14.3	16.0	32.1	56.4	19.2	12.4	25.5	19.7	17.3	31.4	16.4	7.2	25.5	22.1	14.2	46.4	4.3	13.0	11.0	3.9	9.4	65.8	13.9	16.6	10.0	43.1	7.2	20.1	7.5	29.5	6.9	11.7	17.2	13.1	27.8	33.2	27.6	15.8	30.2	20.3	37.3	27.9	14.7	30.2	21.6	17.5	60.4	103.8	0.6	24.5	13.5	49.9	47.6	22.2	21.8	18.7	16.4	16.8	11.3	9.8	132.3	32.5	0.1	0.0	32.2	27.6	16.3	48.7	51.0	46.7	0.0	22.3	0.4	23.7	27.2	0.3	0.1	13.2	67.5	28.5	0.1	0.0	0.0	54.4	21.3	5.5	35.9	11.9	24.8	68.5	53.3	16.4	24.7	41.3	14.5	16.2	21.2	13.8	0.0	0.9	0.1	30.2	0.1	20.4	1.2	0.9	0.6	1.3	1.1	1.6	0.7	2.1	2.9	1.2	0.9	0.7	1.4	0.1	1.8	2.1	0.2	3.9	0.5	13.5	20.6	17.8	20.6	14.3	16.0	25.5	19.7	22.1	16.6	20.1	27.8	14.5	9.6	11.0	12.1	4.3	5.2	8.9	2.1	1.8	1.1	15.1	13.1	7.2	27.1	4.6	12.9	2.1	28.1	12.9	61.7	11.7	8.1	0.2	21.0	14.0	12.6	9.6	1.3	0.8	24.5	45.1	9.5	20.4	31.6	4.5	20.0	13.2	43.2	20.5	1.7	1.1	42.0	4.1	23.0	9.7	0.6	10.8	17.7	17.8	20.6	8.9	10.2	7.2	11.1	117.2	25.4	43.5	6.0	6.3	15.5	67.0	23.6	6.7	3.6	13.1	6.8	11.2	1.4	4.4	8.6	5.4	26.5	14.6	7.0	34.9	17.9
SLC35G2	"DKFZp564K2464, MGC3295, TMEM22"	ENSG00000168917	"Solute carrier family 35 member G2"	Q8TBE7	3	136818647-136855888	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 54.2;Early spermatids: 65.4;Inhibitory neurons: 42.4;Spermatocytes: 35.5"	"Cancer enhanced"	"Detected in many"		"glioma: 6.2"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"memory CD8 T-cell: 1.0"	"Lineage enriched"	"Detected in single"	10	"T-cells: 1.0"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 73.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA052054, HPA064728"	Approved		Supported	"Plasma membrane"		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Plasma membrane"		"HPA052054: AB_2681709, HPA064728: AB_2685336"	"unprognostic (1.04e-1)"	"unprognostic (1.46e-2)"	"unprognostic (6.91e-4)"	"unprognostic (2.56e-4)"	"unprognostic (5.34e-2)"	"unprognostic (6.73e-2)"	"unprognostic (1.16e-5)"	"unprognostic (1.83e-3)"	"unprognostic (1.12e-1)"	"unprognostic (6.39e-2)"	"unprognostic (1.49e-2)"	"unprognostic (3.32e-1)"	"prognostic unfavorable (1.16e-7)"	"unprognostic (1.00e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.07e-2)"	"unprognostic (2.30e-2)"	14.9	15.4	20.9	2.1	21.2	0.5	11.1	23.1	26.4	5.1	16.5	3.8	1.0	4.3	4.6	2.6	5.7	5.3	8.1	20.0	24.4	3.9	4.4	7.0	1.9	21.4	25.0	5.5	7.6	6.7	19.3	7.4	26.9	4.1	2.0	5.3	3.1	2.6	2.4	3.7	2.9	5.1	22.1	3.2	2.9	14.4	22.6	2.8	8.5	5.4	1.2	6.5	5.0	21.0	3.9	10.7	10.6	4.8	20.8	17.1	0.0	16.9	73.1	24.7	37.0	10.1	5.7	0.0	12.7	17.5	39.3	1.3	12.7	0.7	22.8	0.1	3.5	3.2	12.0	6.3	26.6	0.1	0.0	24.2	1.8	21.5	5.9	18.0	18.8	6.8	1.8	0.1	32.1	0.0	4.7	3.3	2.3	0.0	7.9	4.2	7.1	0.2	21.1	0.9	17.5	11.7	13.7	0.0	24.0	3.6	0.0	1.8	13.1	18.4	4.7	8.2	18.6	0.0	0.0	0.0	25.4	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	1.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.1	20.9	21.2	23.1	26.4	20.0	24.4	21.4	25.0	26.9	22.1	22.6	21.0	22.4	12.8	7.0	54.2	2.5	3.3	4.9	12.0	7.4	4.7	0.7	0.8	2.5	1.5	7.1	1.8	12.5	1.3	2.7	0.8	1.9	3.3	65.4	1.0	1.6	30.6	4.2	4.4	34.0	10.7	1.3	12.4	0.5	1.3	2.5	3.6	27.8	2.3	0.7	6.7	42.4	1.0	0.0	2.2	7.3	30.3	9.9	2.1	3.6	17.8	3.7	7.8	15.5	15.6	6.1	10.0	0.1	3.0	3.7	4.7	0.6	0.7	1.4	4.6	6.6	4.7	4.8	35.5	16.1	1.2	3.0	2.2	3.8	3.1	0.6	2.0
SLC38A2	"ATA2, KIAA1382, SAT2, SNAT2"	ENSG00000134294	"Solute carrier family 38 member 2"	Q96QD8	12	46358188-46372773	"FDA approved drug targets, Metabolic proteins, Predicted membrane proteins, Transporters"	"Amino-acid transport, Ion transport, Sodium transport, Symport, Transport"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Basal keratinocytes: 1118.3;Suprabasal keratinocytes: 1078.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"hTERT-HME1: 1198.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035180, HPA069672"	Approved		Supported	"Plasma membrane"		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 85: Liver - Metabolism"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 7: Non-specific - Mitochondria"	"Plasma membrane"		"HPA035180: AB_10669901, HPA069672: "	"unprognostic (6.61e-3)"	"unprognostic (2.87e-2)"	"unprognostic (4.88e-2)"	"unprognostic (2.51e-2)"	"unprognostic (2.96e-1)"	"unprognostic (1.00e-2)"	"unprognostic (7.78e-2)"	"unprognostic (5.50e-3)"	"unprognostic (1.20e-1)"	"unprognostic (3.79e-1)"	"unprognostic (9.24e-3)"	"unprognostic (1.75e-1)"	"unprognostic (1.47e-1)"	"unprognostic (5.08e-2)"	"unprognostic (3.80e-1)"	"unprognostic (1.83e-1)"	"unprognostic (8.68e-2)"	112.8	113.0	36.1	71.6	48.5	95.4	88.5	53.9	50.2	91.7	25.8	58.3	33.6	92.9	38.6	108.1	83.6	131.3	60.7	32.4	46.1	64.8	307.3	117.0	67.1	52.2	42.7	130.1	74.7	91.5	27.9	162.1	53.5	52.8	49.7	27.0	77.2	43.1	108.5	204.4	54.4	115.8	44.2	75.3	63.0	25.4	44.2	100.4	63.1	174.7	78.1	98.9	88.0	73.0	83.7	179.9	157.6	444.1	356.7	347.7	118.1	382.8	921.2	313.0	254.0	108.2	151.2	0.1	504.2	627.9	215.3	271.1	107.9	335.1	299.1	67.0	61.0	105.8	208.7	339.9	548.8	88.0	108.7	357.2	718.4	199.5	1198.9	778.5	265.7	116.3	103.8	163.1	560.4	100.0	110.3	122.8	138.2	0.1	185.1	97.5	115.5	200.9	191.6	173.4	103.9	89.8	263.5	68.5	233.7	171.0	140.5	193.8	467.3	156.7	121.8	67.8	62.2	187.8	194.3	100.6	148.0	304.5	76.8	41.1	24.9	18.9	22.7	13.1	17.4	19.2	19.0	23.0	35.2	17.8	23.5	24.8	17.5	51.6	18.4	40.6	23.7	27.6	36.1	48.5	53.9	50.2	32.4	46.1	52.2	42.7	53.5	44.2	44.2	73.0	237.7	83.3	77.4	31.3	187.7	1118.3	134.1	262.8	653.9	40.5	315.7	252.2	153.6	108.7	123.9	57.0	70.9	53.8	292.3	114.6	5.9	41.2	5.5	228.5	245.0	234.7	76.7	109.0	54.6	51.1	49.3	219.1	328.2	464.0	81.6	138.3	227.7	265.9	54.0	53.8	58.9	175.0	130.2	143.3	303.6	12.4	263.2	193.8	250.8	59.0	52.6	74.3	70.0	42.3	136.2	79.4	83.5	85.0	322.2	181.7	67.4	24.4	50.3	68.7	282.7	184.8	339.5	6.7	15.5	532.6	1078.3	38.4	252.4	84.0	110.7	150.8
SLC38A9	FLJ90709	ENSG00000177058	"Solute carrier family 38 member 9"	Q8NBW4	5	55625845-55773194	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Amino-acid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 57.8"	"Cell type enhanced"	"Detected in all"		"Cytotrophoblasts: 182.5;Early spermatids: 262.6;Syncytiotrophoblasts: 619.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"BEWO: 110.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043785, HPA061702"	Uncertain		Supported	Vesicles		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 28: Placenta - Pregnancy"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	Vesicles		"HPA043785: AB_10961859, HPA061702: "	"unprognostic (4.80e-2)"	"unprognostic (1.18e-1)"	"unprognostic (3.26e-2)"	"prognostic unfavorable (7.24e-5)"	"unprognostic (2.49e-1)"	"unprognostic (8.19e-2)"	"unprognostic (8.35e-2)"	"unprognostic (7.95e-2)"	"unprognostic (5.47e-2)"	"unprognostic (9.44e-2)"	"unprognostic (1.74e-1)"	"unprognostic (4.87e-1)"	"unprognostic (4.18e-3)"	"unprognostic (1.76e-1)"	"unprognostic (2.25e-1)"	"unprognostic (2.84e-2)"	"unprognostic (1.12e-1)"	6.1	4.8	5.4	8.8	7.3	7.1	8.2	8.1	6.3	6.5	4.1	9.4	8.1	6.6	6.6	8.4	5.0	8.3	3.8	4.3	6.6	7.4	16.6	8.0	11.2	6.3	5.9	5.4	12.1	10.7	3.3	57.8	6.6	6.1	9.8	10.0	6.4	6.0	4.4	7.6	6.6	8.5	5.5	8.4	8.1	19.2	6.3	8.8	7.7	3.8	14.5	8.4	4.8	8.9	17.9	17.3	17.1	20.0	22.0	20.4	110.0	16.5	21.3	18.3	30.4	29.5	27.2	31.6	28.6	12.7	32.1	22.5	20.2	18.2	22.8	15.4	18.4	10.8	16.4	18.7	31.1	18.9	10.8	26.3	21.0	20.2	25.7	13.7	20.0	21.3	20.9	18.6	16.5	15.0	23.6	16.4	29.4	7.2	15.6	17.6	28.6	32.2	24.7	14.0	8.1	14.5	17.3	9.3	25.4	24.0	20.1	34.4	29.6	3.6	11.7	26.8	16.6	20.5	47.6	20.8	10.9	17.4	11.4	3.3	9.3	5.5	5.2	8.7	7.5	7.4	4.5	6.1	8.4	4.2	6.2	5.3	2.0	7.7	6.9	8.0	5.9	4.9	5.4	7.3	8.1	6.3	4.3	6.6	6.3	5.9	6.6	5.5	6.3	8.9	7.3	6.4	3.1	21.9	14.2	3.2	4.2	8.5	2.8	6.6	5.7	3.9	2.8	11.5	9.8	9.2	8.4	182.5	10.4	8.9	1.9	8.9	262.6	4.4	9.2	8.1	4.2	8.4	56.2	11.4	71.5	7.2	8.6	7.3	2.5	8.0	10.4	22.1	26.3	1.7	57.3	4.3	8.2	10.0	8.0	82.4	7.5	11.7	5.4	38.4	11.0	5.6	4.1	55.8	103.2	10.9	9.7	4.9	8.4	4.6	4.4	7.2	6.3	7.4	6.6	3.3	7.0	15.8	6.5	8.1	3.4	619.9	8.7	4.0	5.2	4.7
SLC39A6	LIV-1	ENSG00000141424	"Solute carrier family 39 member 6"	Q13433	18	36108531-36129385	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport, Zinc transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Breast glandular cells: 307.0;Prostatic glandular cells: 197.9"	"Group enriched"	"Detected in all"	4	"breast cancer: 361.9;prostate cancer: 127.3"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042377	Approved		Uncertain	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 35: Glandular cells - Unknown function"	Cytosol	"Nucleoplasm, Plasma membrane"	"HPA042377: AB_2677968"	"unprognostic (7.60e-2)"	"unprognostic (2.27e-2)"	"unprognostic (5.50e-3)"	"unprognostic (2.58e-3)"	"unprognostic (1.02e-1)"	"unprognostic (4.87e-3)"	"prognostic unfavorable (5.33e-4)"	"unprognostic (1.79e-1)"	"unprognostic (2.00e-1)"	"unprognostic (1.18e-1)"	"unprognostic (3.19e-1)"	"unprognostic (4.50e-2)"	"unprognostic (7.63e-3)"	"unprognostic (2.16e-1)"	"unprognostic (4.74e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.30e-1)"	27.3	25.9	23.3	21.6	28.5	11.6	147.2	28.6	26.1	34.5	48.9	13.9	9.6	56.9	56.2	17.0	63.6	24.2	14.0	20.0	28.8	28.2	16.5	18.9	17.3	28.8	33.6	43.1	37.7	86.5	23.9	31.7	30.6	129.0	13.4	50.2	30.9	114.3	12.7	51.3	8.9	30.2	28.6	15.5	16.4	19.3	26.7	18.5	37.3	16.6	28.4	52.6	16.1	34.2	43.7	54.0	127.1	75.1	131.4	96.6	33.0	116.2	137.3	76.5	88.7	30.3	47.5	47.1	57.3	113.1	53.1	104.1	112.4	109.2	115.5	105.4	40.7	20.6	69.5	44.4	83.2	69.8	49.6	88.7	236.1	116.2	100.5	69.9	11.7	38.6	10.7	92.1	108.9	67.0	69.0	15.6	30.6	24.0	30.4	70.6	72.8	61.4	84.4	145.2	132.8	116.8	143.5	41.5	200.6	52.1	56.7	32.4	18.9	184.9	30.5	35.5	59.2	85.9	90.0	35.7	64.0	48.3	99.8	29.2	13.3	31.2	16.3	19.7	19.7	16.7	13.8	14.7	16.4	17.3	12.0	17.7	10.2	18.1	19.4	33.6	17.0	14.2	23.3	28.5	28.6	26.1	20.0	28.8	28.8	33.6	30.6	28.6	26.7	34.2	13.3	38.5	18.7	8.8	22.5	45.9	58.2	79.6	59.2	41.5	307.0	132.2	19.6	10.0	66.4	42.3	33.3	6.6	36.7	4.0	1.9	53.1	21.3	37.1	76.1	12.9	25.6	4.6	13.0	37.8	56.7	45.6	9.2	73.8	23.5	18.9	8.9	11.0	20.4	23.5	23.9	7.4	38.7	20.1	30.0	18.1	37.3	26.0	67.6	1.9	25.7	38.2	10.3	34.2	36.5	39.5	1.9	47.8	24.4	197.9	2.7	13.6	44.3	41.3	39.5	40.4	38.6	43.9	27.8	32.6	74.4	23.8	23.2	23.0	5.7	69.3
SLC39A7	"D6S2244E, H2-KE4, HKE4, KE4, RING5, ZIP7"	ENSG00000112473	"Solute carrier family 39 member 7"	Q92504	6	33200445-33204439	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport, Zinc transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Syncytiotrophoblasts: 168.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053999	Approved		Supported	"Endoplasmic reticulum"		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 27: Mucus-secreting cells - Mucin production"	"Endoplasmic reticulum"		"HPA053999: AB_2682338"	"unprognostic (3.63e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.21e-1)"	"unprognostic (3.24e-2)"	"unprognostic (8.95e-2)"	"unprognostic (2.51e-1)"	"prognostic unfavorable (3.62e-4)"	"unprognostic (4.87e-2)"	"unprognostic (9.92e-2)"	"unprognostic (7.20e-3)"	"unprognostic (3.29e-1)"	"unprognostic (2.40e-1)"	"unprognostic (1.99e-2)"	"unprognostic (4.80e-1)"	"unprognostic (1.50e-1)"	"unprognostic (8.22e-3)"	"unprognostic (1.12e-2)"	52.5	73.7	2.2	3.6	2.4	2.4	51.1	2.5	2.7	51.0	5.4	66.7	7.2	60.8	8.6	47.1	44.4	5.8	63.2	2.0	2.8	45.1	75.0	64.9	3.0	3.1	2.6	40.9	98.7	12.8	74.1	8.2	3.2	55.8	8.7	1.9	90.9	7.5	31.5	38.4	58.5	8.3	2.5	47.7	71.4	29.0	3.2	2.8	67.2	2.8	4.4	42.4	41.2	2.9	10.7	9.6	8.6	8.2	25.8	15.9	13.2	17.8	25.3	23.1	23.1	16.7	6.6	5.1	11.9	22.9	12.4	7.5	8.3	14.5	9.7	16.6	10.1	9.4	10.0	25.1	18.2	10.0	30.7	16.0	13.6	15.1	20.6	13.5	11.7	8.3	15.5	7.7	10.2	9.8	4.3	7.4	8.1	23.2	9.9	5.7	6.8	12.2	14.0	5.8	6.8	5.1	8.6	37.2	13.2	5.4	25.0	10.3	10.9	13.1	17.4	8.2	9.8	18.3	15.1	3.9	7.5	8.7	15.0	2.2	1.8	2.0	3.3	1.1	4.4	1.2	2.0	1.2	0.7	1.2	1.8	1.7	0.8	2.1	1.0	1.3	1.0	1.5	2.2	2.4	2.5	2.7	2.0	2.8	3.1	2.6	3.2	2.5	3.2	2.9	40.0	25.6	34.8	7.2	23.4	36.1	29.4	53.6	19.4	27.4	36.7	18.5	33.1	34.3	54.7	25.8	29.2	103.0	22.9	75.5	5.9	73.8	0.8	26.9	47.3	40.9	25.3	28.4	4.3	86.1	129.1	64.4	66.8	53.7	20.8	29.5	28.2	34.4	42.9	11.8	5.9	135.1	48.8	14.8	35.3	2.7	46.0	22.1	40.9	5.6	23.7	42.9	24.7	8.5	8.3	67.8	54.9	42.9	91.6	60.2	56.0	25.9	28.3	26.8	19.7	35.4	43.0	9.4	11.5	26.0	40.9	168.7	23.1	69.2	61.7	51.3
SLC3A2	"4F2, 4F2HC, 4T2HC, CD98, CD98HC, MDU1, NACAE"	ENSG00000168003	"Solute carrier family 3 member 2"	P08195	11	62856004-62888880	"Cancer-related genes, CD markers, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Amino-acid transport, Transport"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Syncytiotrophoblasts: 780.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"hTCEpi: 1441.0;SiHa: 1287.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010455, HPA017980"	Enhanced		Approved	"Nucleoplasm,Plasma membrane"		NA	NA		170000000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Nucleoplasm, Plasma membrane"		"CAB010455: AB_638288, HPA017980: AB_2669723"	"unprognostic (1.79e-1)"	"unprognostic (9.61e-3)"	"unprognostic (3.59e-1)"	"unprognostic (7.87e-3)"	"unprognostic (2.06e-1)"	"unprognostic (2.41e-3)"	"prognostic unfavorable (8.17e-4)"	"unprognostic (2.09e-3)"	"unprognostic (2.62e-1)"	"unprognostic (4.16e-2)"	"unprognostic (2.29e-2)"	"unprognostic (3.71e-1)"	"prognostic favorable (8.22e-4)"	"unprognostic (2.92e-2)"	"unprognostic (5.52e-3)"	"unprognostic (3.49e-3)"	"prognostic unfavorable (1.48e-4)"	103.3	105.6	130.5	46.7	138.0	122.0	108.9	140.1	160.4	101.6	115.6	60.6	51.5	97.2	65.3	112.9	94.0	35.8	52.0	123.1	133.3	171.2	71.9	117.8	34.9	138.4	132.6	93.0	109.7	189.7	65.3	55.4	134.0	100.8	23.1	22.8	110.6	41.9	122.3	127.1	79.7	33.8	135.8	77.4	90.2	65.1	154.5	30.1	110.2	26.0	28.8	77.7	95.1	130.6	155.5	675.7	60.2	213.2	89.7	69.7	596.7	267.5	106.2	154.0	126.3	643.3	293.0	173.9	290.5	185.4	284.5	540.0	123.1	588.9	84.3	319.3	114.0	117.5	422.4	299.2	825.7	136.0	169.4	144.9	1441.0	175.3	528.8	46.2	83.6	380.7	232.9	347.4	95.1	792.6	149.8	181.3	106.9	222.5	214.2	153.8	92.7	341.8	113.9	84.0	112.5	53.5	1287.0	499.6	948.5	121.2	161.5	182.6	146.2	138.3	200.0	204.4	195.5	436.0	556.1	561.2	135.0	225.1	418.0	37.8	149.0	49.7	117.9	147.4	157.7	58.3	107.3	122.1	88.6	72.1	90.1	97.2	31.2	90.3	123.9	304.7	112.5	186.3	130.5	138.0	140.1	160.4	123.1	133.3	138.4	132.6	134.0	135.8	154.5	130.6	97.8	48.1	37.3	91.1	78.8	218.1	244.2	321.7	399.5	58.4	124.2	120.8	13.4	30.0	141.1	49.7	66.7	222.5	136.2	109.6	33.2	161.9	31.5	122.0	96.3	149.2	84.3	117.7	16.9	151.1	143.7	102.9	71.4	179.7	84.3	43.2	99.2	27.0	202.9	53.8	25.1	60.4	223.8	54.1	140.9	28.9	30.4	141.5	224.1	29.0	104.7	188.4	40.2	21.1	11.3	130.6	58.7	30.5	140.9	156.9	120.7	227.4	63.4	61.2	6.6	71.8	114.6	21.3	31.9	160.7	150.6	780.7	118.1	52.4	60.7	194.9
SLC40A1	"FPN1, HFE4, IREG1, MTP1, SLC11A3"	ENSG00000138449	"Solute carrier family 40 member 1"	Q9NP59	2	189560590-189583758	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Iron transport, Transport"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 489.8;Kupffer cells: 1340.2;Syncytiotrophoblasts: 2463.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 326.2"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 509.0;CACO-2: 123.1;HEL: 430.0;HMC-1: 110.5;T-47d: 207.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA065634	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 36: HEL - Hemostasis"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	"Plasma membrane, Cytosol"	Nucleoplasm	"HPA065634: AB_2685524"	"unprognostic (1.28e-2)"	"unprognostic (1.73e-2)"	"unprognostic (9.41e-2)"	"unprognostic (1.83e-2)"	"unprognostic (8.00e-3)"	"unprognostic (1.36e-2)"	"unprognostic (1.66e-1)"	"unprognostic (6.22e-2)"	"unprognostic (6.65e-2)"	"unprognostic (1.84e-1)"	"unprognostic (6.43e-2)"	"unprognostic (6.44e-2)"	"prognostic favorable (8.55e-5)"	"unprognostic (4.66e-1)"	"unprognostic (1.61e-1)"	"unprognostic (8.96e-2)"	"unprognostic (4.11e-2)"	59.6	333.5	9.3	52.6	11.9	45.8	97.7	9.6	9.8	156.3	10.4	124.7	289.3	95.4	61.6	30.5	214.2	148.7	52.6	7.2	12.0	79.9	251.5	122.9	172.6	15.6	15.7	317.2	53.2	91.8	19.0	250.1	12.8	39.5	130.8	29.5	58.7	53.1	64.2	12.2	127.9	69.3	15.5	368.1	96.8	33.2	13.9	62.6	68.0	60.3	59.1	53.1	21.8	11.3	0.0	7.4	0.6	0.0	509.0	3.3	25.4	0.2	6.6	1.9	3.1	123.1	0.4	0.2	1.0	0.2	1.4	0.4	2.4	0.3	1.6	0.3	1.7	430.0	1.7	45.8	1.9	1.5	110.5	35.9	0.2	1.2	0.0	11.7	13.0	16.4	44.6	1.1	6.3	0.0	18.2	28.8	1.5	92.7	1.7	0.2	5.0	2.5	5.3	18.1	1.0	5.4	0.8	35.4	0.0	39.5	207.6	6.2	0.3	0.8	11.7	0.5	0.1	1.1	0.2	0.3	0.1	0.2	0.1	129.8	101.5	172.1	2.2	23.7	3.2	0.2	54.4	4.9	115.6	0.7	80.2	17.8	326.2	4.6	2.6	18.8	5.3	105.8	9.3	11.9	9.6	9.8	7.2	12.0	15.6	15.7	12.8	15.5	13.9	11.3	44.2	125.0	40.3	3.6	12.0	9.2	51.3	10.5	19.9	4.8	83.8	30.0	48.0	138.7	31.6	33.1	4.2	489.8	5.7	328.9	49.0	54.7	10.5	39.6	38.2	39.8	18.6	253.7	0.3	71.8	20.3	81.9	76.5	129.5	9.5	12.8	245.9	259.7	86.4	6.7	6.8	60.8	6.1	1340.2	26.8	9.2	121.2	172.7	8.8	34.7	41.7	17.5	2.1	14.6	0.2	71.5	86.2	58.6	4.1	26.2	163.0	150.0	34.4	48.4	65.7	13.7	49.1	7.4	3.9	12.5	8.1	2463.5	11.9	84.8	48.9	27.7
SLC41A3	FLJ20473	ENSG00000114544	"Solute carrier family 41 member 3"	Q96GZ6	3	126006357-126101561	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045847	Approved		Supported	"Plasma membrane"		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Plasma membrane"		"HPA045847: AB_2679472"	"unprognostic (1.77e-1)"	"unprognostic (3.35e-2)"	"unprognostic (1.11e-1)"	"unprognostic (3.37e-2)"	"unprognostic (7.68e-3)"	"unprognostic (2.20e-1)"	"prognostic unfavorable (1.49e-7)"	"unprognostic (1.36e-1)"	"unprognostic (3.23e-2)"	"unprognostic (2.82e-3)"	"unprognostic (5.74e-2)"	"unprognostic (3.57e-1)"	"prognostic favorable (6.04e-7)"	"unprognostic (1.26e-1)"	"unprognostic (5.88e-2)"	"unprognostic (2.85e-1)"	"unprognostic (7.54e-2)"	29.5	47.2	53.3	13.3	55.6	11.3	29.5	55.0	56.1	42.4	53.0	24.8	18.1	44.4	55.1	22.2	40.2	28.6	34.3	57.7	54.9	27.7	14.3	21.4	18.1	56.8	54.0	54.5	32.7	34.9	40.0	19.7	59.6	23.1	19.2	25.7	31.1	23.7	61.8	24.6	23.8	29.4	49.8	19.6	27.8	44.7	54.7	34.4	32.0	47.9	19.3	28.9	29.6	48.4	43.7	17.4	28.5	24.1	78.7	45.3	42.4	24.4	42.1	32.9	39.0	23.3	38.7	31.4	44.8	48.9	35.7	33.3	10.8	42.1	29.0	31.1	32.0	17.2	32.1	34.2	65.3	31.4	18.4	44.0	50.8	20.0	41.1	48.7	46.5	38.2	14.7	26.2	44.0	22.2	35.1	25.7	21.7	57.4	26.3	18.6	29.3	43.5	39.6	31.6	22.1	23.8	37.8	12.3	104.0	26.6	12.2	41.9	32.2	30.8	23.2	47.1	28.0	19.4	17.2	15.8	27.7	14.0	28.9	13.0	6.3	4.6	12.0	9.4	9.6	9.4	11.1	12.2	9.8	9.0	9.6	9.1	1.2	14.9	6.1	9.6	21.8	6.1	53.3	55.6	55.0	56.1	57.7	54.9	56.8	54.0	59.6	49.8	54.7	48.4	25.6	16.0	10.9	9.8	13.5	13.8	22.3	24.9	20.5	15.4	22.9	23.5	14.4	32.9	20.5	22.0	4.2	34.6	14.6	7.5	3.9	35.8	36.7	34.1	15.3	28.5	21.1	5.0	17.0	24.7	36.1	19.7	11.7	17.9	5.7	21.2	35.0	7.2	16.1	28.6	20.7	12.1	30.5	12.8	10.3	14.7	37.6	8.6	14.2	15.0	13.5	25.9	7.2	11.6	8.0	24.3	6.8	54.9	10.3	15.3	14.7	12.6	14.8	12.1	26.3	23.1	20.7	16.7	45.4	18.2	15.3	25.3	17.7	42.4	15.6	19.0
SLC44A1	"CD92, CDW92, CHTL1, CTL1"	ENSG00000070214	"Solute carrier family 44 member 1"	Q8WWI5	9	105244622-105439171	"CD markers, Disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	Transport		Neurodegeneration	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 284.9"	"Cell type enriched"	"Detected in all"	8	"Oligodendrocytes: 2444.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"ASC diff: 285.9;ASC TERT1: 224.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA064714, HPA074007"	Enhanced		Supported	Nucleoplasm,Mitochondria		NA	NA		99000	"Cluster 24: B-cells - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Mitochondria	Nucleoplasm	"HPA064714: AB_2685334, HPA074007: "	"unprognostic (3.49e-1)"	"unprognostic (2.25e-1)"	"unprognostic (1.27e-1)"	"unprognostic (6.54e-3)"	"unprognostic (4.77e-2)"	"unprognostic (1.74e-2)"	"unprognostic (2.21e-2)"	"prognostic unfavorable (4.49e-4)"	"unprognostic (2.48e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.64e-3)"	"unprognostic (6.20e-2)"	"prognostic favorable (1.85e-4)"	"unprognostic (2.13e-1)"	"unprognostic (2.07e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.07e-2)"	16.9	13.3	112.9	12.9	204.4	11.4	26.2	166.7	138.7	16.7	79.4	50.2	22.6	15.9	32.4	18.4	15.2	20.2	12.7	116.2	136.1	21.8	38.0	18.4	9.7	204.3	167.7	14.1	15.1	23.2	5.3	23.3	205.5	11.8	49.0	14.1	9.6	25.0	9.4	21.5	27.0	17.3	161.1	9.5	35.2	3.5	150.8	13.6	43.6	20.2	15.5	21.8	15.6	284.9	29.0	23.8	6.4	7.9	285.9	224.1	20.3	23.9	61.7	15.1	20.2	25.6	74.8	38.4	12.0	90.2	17.1	56.1	19.3	34.4	25.7	34.0	15.7	47.8	15.8	32.0	19.3	9.6	23.7	125.3	27.6	29.0	26.1	38.8	48.6	19.7	1.4	77.1	17.3	40.8	38.8	10.9	35.9	51.1	22.9	8.0	24.7	29.3	20.9	66.6	30.6	12.0	33.4	36.5	33.3	37.8	36.2	28.7	41.9	15.1	13.5	16.5	17.7	59.1	41.7	28.4	29.2	20.6	20.2	1.7	3.3	0.7	0.7	1.2	0.4	1.1	0.7	0.4	2.2	2.0	0.8	0.3	0.5	5.3	0.7	0.8	0.8	0.9	112.9	204.4	166.7	138.7	116.2	136.1	204.3	167.7	205.5	161.1	150.8	284.9	48.6	35.3	26.5	83.2	22.2	70.6	36.0	28.3	75.1	10.3	76.9	27.2	10.1	67.2	19.9	106.7	235.6	53.3	7.6	296.5	3.9	17.5	2.9	59.2	40.3	45.2	157.2	20.4	174.2	36.5	12.1	64.0	84.1	175.2	100.1	16.7	48.9	170.0	21.3	6.7	108.1	160.0	14.2	46.5	46.5	6.1	110.0	48.6	74.7	81.5	91.0	9.0	13.4	257.3	2444.2	36.9	161.2	79.7	162.9	23.8	95.4	27.1	31.4	53.3	39.5	43.8	34.9	2.3	4.4	86.9	74.3	70.6	20.3	12.1	199.1	34.8
SLC46A1	"HCP1, MGC9564, PCFT"	ENSG00000076351	"Solute carrier family 46 member 1"	Q96NT5	17	28394642-28407197	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	Transport		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 93.9"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 26.6;Hepatocytes: 27.8;Hofbauer cells: 25.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in many"	5	"CACO-2: 205.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB011614	Approved		Supported	"Plasma membrane,Cytosol"		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 56: Intestine - Transmembrane transport"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 4: Macrophages - Innate immune response"	"Plasma membrane, Cytosol"		"CAB011614: AB_2270597"	"unprognostic (1.10e-1)"	"unprognostic (8.62e-2)"	"unprognostic (1.40e-1)"	"unprognostic (7.59e-2)"	"prognostic unfavorable (5.62e-4)"	"unprognostic (9.11e-2)"	"unprognostic (4.05e-2)"	"unprognostic (1.36e-2)"	"unprognostic (1.94e-1)"	"unprognostic (3.80e-2)"	"unprognostic (1.04e-3)"	"unprognostic (6.15e-2)"	"unprognostic (2.10e-3)"	"unprognostic (2.16e-1)"	"unprognostic (2.94e-1)"	"unprognostic (2.15e-1)"	"unprognostic (1.04e-1)"	6.7	24.8	8.1	5.7	10.6	3.4	5.7	14.7	9.2	5.6	26.7	5.7	93.9	4.6	8.5	2.4	13.4	4.6	4.6	8.0	8.4	7.5	27.3	6.9	5.5	11.2	9.7	8.7	11.2	15.0	15.5	8.2	10.4	7.4	5.6	8.7	12.5	9.0	3.6	2.3	40.5	5.5	9.8	11.1	5.5	3.1	10.0	23.4	6.4	2.8	2.1	5.0	2.6	12.1	5.4	22.5	7.4	12.2	5.9	1.3	22.9	6.3	4.6	5.1	5.7	205.4	6.4	0.4	3.6	3.4	14.8	17.3	8.4	14.1	4.3	13.1	19.6	0.2	14.0	17.6	2.1	0.1	10.1	2.8	25.3	5.3	15.8	7.1	0.4	1.8	8.9	1.2	0.9	7.2	0.1	0.6	4.4	5.2	2.9	0.3	6.0	2.7	4.0	11.8	19.4	10.2	43.6	20.1	2.4	10.1	15.6	3.4	0.6	0.8	8.6	1.2	6.6	9.0	11.1	0.3	1.2	1.3	4.7	5.2	0.9	0.6	0.4	3.0	0.7	1.6	0.4	0.3	1.4	0.8	0.5	0.8	1.0	1.6	2.6	0.5	0.9	0.5	8.1	10.6	14.7	9.2	8.0	8.4	11.2	9.7	10.4	9.8	10.0	12.1	1.2	12.8	5.3	7.5	1.0	0.4	1.9	2.8	4.0	26.6	5.1	6.1	2.3	17.2	2.2	7.3	4.2	20.8	0.2	3.7	0.0	3.5	3.6	18.2	1.8	1.9	1.2	0.4	2.8	4.6	9.7	3.6	3.1	1.5	1.3	4.2	1.8	27.8	25.7	20.2	4.6	2.4	0.0	21.5	1.0	19.5	4.1	8.0	0.0	5.6	2.0	2.2	0.0	8.0	6.9	3.8	3.6	3.4	3.0	2.6	3.9	4.6	4.3	6.0	6.6	3.7	1.4	0.3	0.3	1.2	0.3	4.4	0.6	5.8	1.3	1.6
SLC48A1	"FLJ20489, hHRG-1, HRG1"	ENSG00000211584	"Solute carrier family 48 member 1"	Q6P1K1	12	47753916-47782751	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 135.6"	"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 100.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"EFO-21: 102.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA065396, HPA073994"	Approved		Supported	Vesicles		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 70: Brain - Nervous system development"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 6: Erythroid cells - Oxygen transport"	Vesicles		"HPA065396: , HPA073994: "	"unprognostic (9.60e-2)"	"prognostic favorable (4.27e-4)"	"unprognostic (1.13e-2)"	"unprognostic (1.18e-2)"	"unprognostic (1.22e-1)"	"unprognostic (2.79e-1)"	"prognostic unfavorable (9.39e-5)"	"unprognostic (1.12e-1)"	"unprognostic (1.83e-1)"	"unprognostic (9.88e-2)"	"unprognostic (1.54e-2)"	"unprognostic (6.63e-3)"	"prognostic favorable (1.34e-6)"	"unprognostic (1.45e-1)"	"unprognostic (5.96e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.72e-2)"	27.5	37.4	98.8	6.9	131.6	12.3	27.6	116.7	104.3	26.8	58.5	26.8	7.4	20.2	16.2	28.9	28.4	15.4	29.0	96.2	99.8	44.1	15.2	22.3	7.0	125.5	127.0	53.1	19.5	29.4	17.7	17.7	113.4	20.4	10.6	11.2	20.2	22.7	29.9	22.0	14.3	16.6	103.2	25.8	22.1	9.9	126.8	7.9	52.6	21.5	8.2	27.6	22.6	135.6	11.9	36.3	5.7	42.8	36.4	15.5	12.3	8.3	18.3	7.8	8.0	11.7	31.0	7.2	102.7	23.3	15.5	45.4	7.3	9.6	6.0	59.1	6.8	49.4	30.4	16.1	20.8	13.3	27.9	9.2	19.3	11.2	13.6	40.6	22.1	20.0	13.1	28.3	5.1	24.7	6.5	13.7	3.9	21.9	17.1	6.0	1.6	39.0	31.5	31.3	7.3	3.3	11.0	13.8	7.8	10.2	46.0	12.2	12.3	10.9	14.3	21.1	6.0	21.6	14.3	2.2	14.2	62.8	6.7	0.1	17.9	12.4	5.2	13.5	4.7	10.4	6.4	5.5	12.9	9.9	7.7	6.4	36.7	2.0	7.7	2.6	5.5	6.3	98.8	131.6	116.7	104.3	96.2	99.8	125.5	127.0	113.4	103.2	126.8	135.6	35.2	9.6	13.5	35.3	6.2	6.6	9.7	6.4	22.2	11.1	15.5	15.2	16.4	20.0	5.5	51.5	2.1	9.5	2.3	9.0	23.5	10.4	8.5	10.9	6.2	22.3	8.4	53.0	9.1	9.8	2.3	15.6	4.6	18.0	1.3	16.4	16.8	11.8	24.1	15.2	8.3	13.5	6.1	18.0	9.9	12.5	32.6	14.1	5.4	8.4	28.4	26.8	2.1	11.1	100.3	6.6	5.2	23.0	10.1	12.9	9.2	34.9	2.3	11.2	6.6	11.9	11.6	4.1	10.5	20.9	11.9	3.6	3.3	18.0	7.5	11.6
SLC49A4	"DIRC2, FLJ14784, RCC4"	ENSG00000138463	"Solute carrier family 49 member 4"	Q96SL1	3	122795069-122881139	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Cytotrophoblasts: 44.0;Extravillous trophoblasts: 61.2;Syncytiotrophoblasts: 226.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA072579			Supported	Vesicles		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	Vesicles		"HPA072579: AB_2686536"	"unprognostic (1.40e-1)"	"unprognostic (8.53e-3)"	"unprognostic (1.20e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.16e-1)"	"unprognostic (5.36e-2)"	"prognostic unfavorable (7.48e-4)"	"unprognostic (9.74e-2)"	"unprognostic (2.58e-1)"	"unprognostic (3.95e-2)"	"prognostic unfavorable (5.81e-5)"	"unprognostic (1.87e-1)"	"prognostic favorable (8.81e-11)"	"unprognostic (2.36e-1)"	"unprognostic (2.64e-1)"	"unprognostic (1.73e-1)"	"unprognostic (7.13e-2)"	4.4	5.0	4.9	2.7	5.1	5.9	3.1	4.9	5.3	3.0	6.2	4.1	1.9	2.6	3.8	5.6	3.1	3.7	6.4	5.7	5.9	4.6	3.5	5.2	2.0	4.8	5.6	2.2	6.5	12.7	2.4	7.6	5.6	4.9	4.5	5.7	3.7	3.6	15.9	6.6	2.6	2.7	5.2	2.8	3.1	2.5	5.6	1.9	5.2	14.0	2.5	4.0	2.6	5.9	7.4	6.1	5.9	3.3	7.5	6.1	19.6	3.1	6.7	4.9	5.0	14.4	8.0	1.0	3.9	3.5	10.9	10.5	4.3	5.6	4.7	1.6	3.2	1.2	3.3	6.2	5.5	0.7	0.7	5.0	15.0	3.5	5.9	7.6	5.6	2.0	0.7	1.3	6.3	3.3	0.9	0.8	5.3	2.5	9.8	2.0	13.3	1.5	7.0	8.4	6.1	4.6	9.1	4.1	8.4	3.7	4.8	1.6	8.0	7.6	2.8	4.6	2.6	1.3	1.2	0.4	3.8	1.3	4.2	0.0	0.2	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.9	0.0	0.2	0.0	0.0	0.0	4.9	5.1	4.9	5.3	5.7	5.9	4.8	5.6	5.6	5.2	5.6	5.9	3.5	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.0	0.0	0.0	0.0	0.0	44.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	61.2	2.4	0.0	0.0	0.0	0.0	0.0	0.0	12.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	226.6	0.4	0.0	0.0	0.0
SLC4A1AP	"HLC3, kanadaptin"	ENSG00000163798	"Solute carrier family 4 member 1 adaptor protein"	Q9BWU0	2	27663471-27694976	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 143.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036679	Approved		Supported	"Nucleoplasm,Vesicles,Plasma membrane"		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 21: Non-specific - Transcription"	"Cluster 16: U-266 - Nucleosome"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	Nucleoplasm	"Vesicles, Plasma membrane"	"HPA036679: AB_2675244"	"unprognostic (5.63e-2)"	"unprognostic (1.01e-1)"	"unprognostic (4.62e-2)"	"prognostic unfavorable (1.49e-4)"	"unprognostic (2.21e-1)"	"unprognostic (7.89e-3)"	"prognostic unfavorable (3.76e-7)"	"unprognostic (1.32e-1)"	"unprognostic (7.74e-2)"	"unprognostic (1.83e-2)"	"unprognostic (1.06e-1)"	"unprognostic (9.66e-2)"	"unprognostic (9.68e-2)"	"unprognostic (2.29e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.40e-2)"	"prognostic unfavorable (1.79e-4)"	13.7	16.6	15.3	16.1	16.2	15.8	14.5	17.9	20.9	11.8	12.7	12.3	12.6	13.4	12.4	15.1	12.7	10.4	20.6	16.4	16.2	16.0	16.2	13.9	17.4	15.7	15.6	15.5	14.4	21.1	12.7	15.7	15.7	12.9	12.9	19.8	12.9	12.0	30.6	16.4	13.3	13.2	13.3	15.0	13.9	33.9	15.6	17.1	15.3	22.1	16.9	12.6	12.0	16.4	44.6	25.4	25.1	23.6	25.3	23.2	36.8	36.1	24.8	37.2	30.3	37.4	31.7	28.0	32.7	29.1	39.2	31.0	40.6	28.0	33.2	39.2	33.2	32.2	26.2	41.5	30.7	46.6	29.5	20.9	34.8	37.1	34.8	31.2	38.4	27.1	47.5	29.7	34.7	27.1	31.5	45.4	25.4	29.3	24.7	25.9	54.9	32.4	38.5	20.4	27.2	26.8	28.1	37.9	36.0	25.2	23.0	30.1	39.3	34.5	31.3	24.2	42.7	48.5	73.8	88.4	37.4	36.8	28.2	104.8	33.4	48.9	31.6	32.6	31.8	26.1	28.6	28.0	25.8	36.7	34.5	29.1	31.9	43.7	37.6	20.8	34.9	28.0	15.3	16.2	17.9	20.9	16.4	16.2	15.7	15.6	15.7	13.3	15.6	16.4	17.1	32.1	28.9	14.7	17.3	11.9	12.3	27.1	14.8	19.9	13.3	11.0	30.1	11.5	29.1	18.4	18.8	24.5	21.0	11.4	5.9	28.4	47.2	22.0	20.3	21.9	16.3	11.8	25.5	36.9	20.3	17.4	13.3	20.4	38.6	18.5	15.4	13.9	24.4	25.2	23.7	11.5	16.2	13.9	8.2	7.9	17.4	18.9	17.8	8.4	31.5	21.6	19.6	12.5	18.2	30.5	9.3	19.2	22.1	8.7	11.5	16.1	24.4	21.1	32.9	23.3	21.7	143.4	82.4	15.7	11.9	24.4	21.8	21.5	10.1	10.8
SLC4A2	"AE2, BND3L, EPB3L1, HKB3, NBND3"	ENSG00000164889	"Solute carrier family 4 member 2"	P04920	7	151057210-151076526	"Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Anion exchange, Antiport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	6	"choroid plexus: 492.1"	"Cell type enhanced"	"Detected in many"		"Syncytiotrophoblasts: 91.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019339	Enhanced		Uncertain	"Nuclear speckles,Plasma membrane,Cytosol"		NA	NA			"Cluster 29: Plasmacytoid DCs - Unknown function"	"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 40: Granulosa cells - Unknown function"	"Nuclear speckles, Plasma membrane"	Cytosol	"HPA019339: AB_1844825"	"unprognostic (1.19e-1)"	"unprognostic (3.33e-3)"	"unprognostic (8.12e-3)"	"unprognostic (1.10e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.49e-1)"	"prognostic unfavorable (9.04e-6)"	"unprognostic (1.24e-1)"	"unprognostic (4.23e-1)"	"unprognostic (3.30e-1)"	"unprognostic (1.07e-1)"	"unprognostic (3.21e-1)"	"prognostic favorable (1.26e-4)"	"unprognostic (4.67e-3)"	"unprognostic (1.22e-1)"	"unprognostic (1.28e-1)"	"unprognostic (2.36e-2)"	28.4	34.8	16.9	19.2	29.4	12.7	23.7	29.1	21.9	38.9	492.1	45.0	22.5	40.3	4.9	21.0	31.1	19.7	31.3	39.4	23.2	38.6	52.3	33.2	13.1	32.8	27.9	31.9	52.5	72.4	13.8	27.0	32.0	28.2	7.1	4.7	23.1	14.0	18.8	21.7	29.3	16.5	20.2	27.0	82.2	13.7	32.7	12.4	25.4	12.3	6.3	31.9	25.8	40.2	60.9	196.9	37.8	78.9	37.6	17.9	87.1	72.9	37.0	56.9	48.0	113.0	91.6	35.8	154.1	35.0	84.6	58.2	38.2	31.4	9.8	105.3	59.1	48.5	91.9	57.5	59.6	25.2	147.0	29.0	27.4	65.6	15.7	60.9	31.3	50.6	151.8	27.1	44.3	118.0	69.2	43.3	90.4	80.7	73.2	55.2	21.2	42.2	44.6	41.0	31.5	113.9	67.0	118.4	62.0	27.3	51.2	46.7	72.0	78.1	39.1	77.5	106.5	31.2	47.7	20.5	118.7	61.4	160.6	0.0	1.6	0.4	0.8	1.6	0.7	0.9	0.7	0.7	1.0	0.3	0.7	0.8	0.2	0.1	1.0	2.1	0.2	0.9	16.9	29.4	29.1	21.9	39.4	23.2	32.8	27.9	32.0	20.2	32.7	40.2	15.6	9.6	8.2	9.8	7.2	11.1	5.9	13.6	15.4	7.7	14.5	11.9	4.0	18.6	9.6	20.2	25.0	36.1	14.2	17.6	17.6	35.7	1.0	21.9	18.9	13.6	27.6	2.5	0.4	35.8	9.4	13.6	30.1	17.0	47.1	62.1	17.9	34.6	26.0	15.2	1.4	12.1	16.2	16.1	12.0	1.6	13.7	17.0	26.6	4.7	11.6	21.6	3.1	3.0	16.8	43.8	14.0	19.9	9.9	5.9	24.9	19.1	11.4	8.2	13.1	12.8	17.6	3.1	7.9	10.6	7.0	91.5	8.5	11.2	22.1	4.5
SLC4A7	"NBC3, SBC2, SLC4A6"	ENSG00000033867	"Solute carrier family 4 member 7"	Q9Y6M7	3	27372721-27484420	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Symport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 57.6;retina: 72.9"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 733.9;Rod photoreceptor cells: 704.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"hTERT-HME1: 78.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022494, HPA035857"	Enhanced		Supported	"Plasma membrane,Focal adhesion sites,Cytosol"		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 20: Retina & Lymphoid tissues - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 9: Photoreceptor cells - Phototransduction"	"Plasma membrane"	"Focal adhesion sites, Cytosol"	"CAB022494: , HPA035857: AB_10795135"	"unprognostic (2.94e-2)"	"unprognostic (6.34e-2)"	"unprognostic (1.80e-3)"	"unprognostic (1.91e-1)"	"unprognostic (8.48e-3)"	"unprognostic (2.68e-1)"	"unprognostic (6.79e-4)"	"unprognostic (4.13e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.83e-1)"	"unprognostic (8.58e-3)"	"prognostic unfavorable (7.91e-6)"	"unprognostic (1.09e-2)"	"unprognostic (6.68e-2)"	"unprognostic (1.93e-1)"	"unprognostic (7.26e-2)"	8.6	5.1	3.2	9.0	5.2	4.0	18.7	3.4	16.9	10.5	1.6	16.2	57.6	6.4	8.2	8.6	6.0	13.7	7.8	19.3	2.5	12.7	3.9	8.3	11.2	0.5	3.2	6.8	3.4	1.7	3.4	5.8	0.6	7.9	7.4	72.9	5.8	8.7	5.0	4.6	17.4	6.6	1.8	7.0	6.0	7.1	4.4	5.8	4.9	27.2	10.3	12.1	8.8	2.6	13.0	23.8	21.0	9.8	9.6	17.2	15.0	43.3	20.0	16.3	12.6	6.5	6.6	29.4	3.6	16.8	15.7	5.5	20.2	21.1	25.7	25.1	6.6	13.5	15.4	7.1	16.5	30.9	11.3	13.7	9.0	24.8	78.9	34.2	27.1	19.0	9.1	10.1	33.8	4.7	31.1	7.2	13.8	1.6	23.4	21.0	16.7	5.9	38.1	9.2	5.3	13.1	19.7	14.4	6.9	17.9	32.9	11.8	19.0	38.2	10.6	26.7	33.7	3.8	4.3	16.6	33.3	21.4	17.8	0.0	0.2	0.0	1.0	0.2	0.7	0.4	1.3	1.4	0.5	0.5	0.5	0.9	0.0	1.0	0.3	0.7	1.2	0.3	3.2	5.2	3.4	16.9	19.3	2.5	0.5	3.2	0.6	1.8	4.4	2.6	30.0	0.0	11.2	10.7	37.5	29.3	39.5	23.4	11.4	130.2	72.4	30.4	23.1	21.5	22.8	62.5	733.9	5.8	51.8	5.5	9.8	15.5	10.2	73.6	40.7	53.6	38.2	7.2	46.2	7.1	29.3	52.2	15.8	124.1	23.5	24.6	17.5	6.2	17.0	6.7	88.7	58.5	36.7	48.4	61.6	7.6	9.0	46.5	35.6	185.5	26.7	45.7	20.6	60.8	20.9	19.1	23.4	9.8	27.8	93.1	142.5	10.2	9.6	704.2	39.5	56.4	43.7	40.0	21.7	21.7	30.7	8.1	56.1	19.0	26.7	35.2
SLC5A12	"MGC52019, SMCT2"	ENSG00000148942	"Solute carrier family 5 member 12"	Q1EHB4	11	26667020-26723427	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Symport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"epididymis: 47.7;intestine: 30.1;kidney: 171.7"	"Group enriched"	"Detected in some"	23	"Proximal enterocytes: 286.0;Proximal tubular cells: 181.0"	"Cancer enriched"	"Detected in single"	26	"renal cancer: 9.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Karpas-707: 2.3;NTERA-2: 1.7;SuSa: 3.3;T-47d: 1.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA060904	Enhanced		Supported	"Nucleoplasm,Plasma membrane"		NA	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Plasma membrane"	Nucleoplasm	"HPA060904: AB_2684385"	"unprognostic (3.69e-3)"	"unprognostic (6.92e-2)"	"unprognostic (1.79e-1)"	"unprognostic (2.86e-1)"	"unprognostic (2.01e-2)"	"unprognostic (9.35e-3)"	"unprognostic (4.21e-3)"	"unprognostic (4.49e-2)"	"unprognostic (2.36e-3)"	"unprognostic (1.71e-1)"	"unprognostic (2.03e-2)"	"unprognostic (3.43e-1)"	"unprognostic (2.91e-3)"	"unprognostic (1.34e-1)"	"unprognostic (8.53e-2)"	"unprognostic (1.42e-2)"	"unprognostic (9.40e-3)"	0.1	0.1	0.3	0.0	0.5	0.9	0.1	0.9	0.4	0.0	0.3	0.2	4.9	0.1	47.7	0.0	0.1	0.1	4.3	0.3	0.4	171.7	1.7	0.1	0.1	0.2	0.1	0.2	0.0	0.0	0.0	0.6	0.2	0.1	0.2	1.0	0.1	0.1	0.1	0.3	30.1	0.0	0.0	0.6	0.3	0.2	0.2	0.1	0.1	0.1	0.0	0.1	0.0	0.5	0.2	0.0	0.1	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.1	0.2	0.3	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	2.3	0.0	0.0	0.1	0.2	1.7	0.3	0.0	0.0	0.0	0.3	0.0	0.5	0.8	0.1	0.7	0.1	0.0	3.3	1.2	0.2	0.2	0.2	0.1	0.2	0.1	1.0	0.3	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.5	0.9	0.4	0.3	0.4	0.2	0.1	0.2	0.0	0.2	0.5	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.3	0.0	0.1	3.7	0.0	0.1	0.0	2.4	9.8	0.0	1.4	0.2	0.0	0.2	0.0	0.0	0.7	0.0	0.2	0.7	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.3	6.7	0.0	0.0	0.0	0.2	0.0	0.7	0.0	1.0	0.0	0.8	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	286.0	181.0	0.1	0.3	0.0	0.0	0.1	0.1	0.3	0.0	0.0	0.1	0.6	4.5	3.5	0.1
SLC5A3	"SMIT, SMIT1"	ENSG00000198743	"Solute carrier family 5 member 3"	P53794	21	34073578-34106260	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Symport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"choroid plexus: 96.0"	"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 129.1;Collecting duct cells: 138.0;Granulosa cells: 148.6"	"Cancer enhanced"	"Detected in all"		"thyroid cancer: 22.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029791			Supported	"Plasma membrane"		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 40: Granulosa cells - Unknown function"	"Plasma membrane"		"HPA029791: AB_10601892"	"unprognostic (9.70e-2)"	"unprognostic (4.99e-2)"	"unprognostic (2.23e-1)"	"unprognostic (7.57e-2)"	"unprognostic (1.07e-1)"	"unprognostic (4.54e-2)"	"unprognostic (4.48e-3)"	"unprognostic (1.63e-1)"	"unprognostic (3.02e-2)"	"unprognostic (2.55e-1)"	"prognostic unfavorable (1.98e-5)"	"unprognostic (1.30e-1)"	"prognostic unfavorable (4.72e-4)"	"unprognostic (1.82e-1)"	"unprognostic (1.82e-1)"	"unprognostic (2.21e-1)"	"unprognostic (8.60e-2)"	6.9	5.9	8.6	4.5	9.2	1.9	6.6	5.7	11.4	3.7	96.0	4.5	2.6	6.8	5.2	3.1	4.8	2.5	2.4	10.7	17.0	29.0	5.9	3.9	4.9	9.3	9.9	3.9	1.9	3.2	4.1	10.6	9.2	2.9	5.2	5.6	2.8	3.5	2.5	6.7	3.7	2.9	8.2	2.4	3.9	6.2	20.3	3.9	25.2	2.6	4.8	3.8	3.4	9.2	10.5	9.3	19.0	13.4	15.5	12.7	9.1	11.8	35.7	7.2	10.9	15.5	22.5	16.9	9.3	24.0	13.5	5.3	23.3	6.7	12.2	17.7	6.0	17.5	9.0	5.2	4.1	7.6	7.1	6.1	17.0	19.7	7.8	22.0	4.4	13.7	17.6	3.9	18.7	7.1	8.1	6.1	9.6	4.0	9.0	8.1	3.4	7.7	28.1	14.5	9.9	4.6	24.5	6.4	5.6	11.3	3.9	8.0	4.2	14.0	10.7	27.1	4.8	20.1	18.5	12.4	28.2	10.9	9.6	0.0	0.2	0.0	0.6	0.2	0.5	0.1	0.3	0.4	0.2	0.1	0.4	0.6	0.1	0.2	0.1	0.5	0.1	0.1	8.6	9.2	5.7	11.4	10.7	17.0	9.3	9.9	9.2	8.2	20.3	9.2	18.8	16.0	10.2	0.0	33.3	0.0	46.5	0.0	129.1	33.8	37.4	34.9	11.4	10.0	13.0	138.0	20.9	27.4	43.0	39.1	21.5	4.0	9.0	38.7	59.9	16.4	49.3	17.0	0.0	5.5	19.7	42.3	18.3	42.5	41.3	148.6	5.0	20.7	15.2	37.0	0.0	69.3	0.0	14.4	0.0	7.2	6.5	41.0	0.0	0.0	23.3	6.7	16.5	0.0	0.0	7.6	49.7	20.7	54.1	88.4	16.3	9.4	8.7	20.9	13.1	15.4	33.7	14.8	18.5	39.7	0.0	28.2	48.3	14.0	36.3	69.5
SLC66A1	"FLJ20320, LAAT-1, LAAT1, PQLC2"	ENSG00000040487	"Solute carrier family 66 member 1"	Q6ZP29	1	19312326-19329300	"Predicted membrane proteins, Transporters"	"Amino-acid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in some"	13	"Cytotrophoblasts: 26.9;Extravillous trophoblasts: 17.0;Hofbauer cells: 37.4;Syncytiotrophoblasts: 60.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA057810	Approved		Supported	Vesicles		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	Vesicles		"HPA057810: AB_2683535"	"unprognostic (7.84e-3)"	"unprognostic (6.56e-2)"	"unprognostic (6.54e-2)"	"prognostic favorable (3.50e-4)"	"unprognostic (3.77e-3)"	"unprognostic (2.19e-1)"	"prognostic unfavorable (2.64e-5)"	"unprognostic (2.61e-1)"	"unprognostic (4.47e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.42e-3)"	"unprognostic (3.82e-2)"	"unprognostic (4.70e-3)"	"unprognostic (8.64e-2)"	"unprognostic (2.07e-1)"	"unprognostic (6.56e-2)"	"unprognostic (4.46e-2)"	10.7	24.8	12.4	5.6	13.8	13.1	10.7	17.9	14.7	12.9	11.3	11.6	10.7	10.8	9.1	9.8	10.1	6.9	11.3	12.5	13.0	15.2	26.6	10.7	7.9	15.7	13.6	11.0	17.4	7.9	23.2	7.1	14.7	14.2	4.7	12.1	10.5	6.3	14.2	14.1	16.7	5.7	12.1	14.6	14.5	18.6	14.2	4.3	13.5	6.1	5.6	9.9	10.6	15.1	14.6	15.0	13.9	22.4	13.3	12.4	17.6	18.0	24.6	24.7	20.7	22.1	18.0	4.7	23.0	13.3	34.2	10.6	13.7	16.2	11.1	9.9	16.5	3.6	13.4	24.0	37.8	3.1	6.3	20.6	16.7	34.9	11.1	13.8	9.6	8.1	26.8	10.7	24.0	12.8	2.1	10.2	13.3	5.2	13.3	8.1	17.5	8.2	18.9	9.4	17.2	14.3	13.5	9.1	35.5	12.4	15.1	35.8	12.8	20.4	11.8	35.0	16.1	18.4	13.8	2.7	25.1	18.3	17.3	1.3	10.5	10.3	3.7	9.1	2.6	6.0	3.9	3.1	13.7	5.4	1.1	2.3	6.4	4.1	13.8	20.5	3.8	4.5	12.4	13.8	17.9	14.7	12.5	13.0	15.7	13.6	14.7	12.1	14.2	15.1	2.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	26.9	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	17.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	37.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	60.5	0.1	0.0	0.0	0.0
SLC6A13	GAT2	ENSG00000010379	"Solute carrier family 6 member 13"	Q9NSD5	12	220621-262873	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Neurotransmitter transport, Symport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"kidney: 153.1"	"Cell type enriched"	"Detected in some"	6	"Proximal tubular cells: 324.9"	"Cancer enriched"	"Detected in some"	18	"renal cancer: 32.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"RPTEC TERT1: 4.6;SuSa: 1.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036449, HPA052726"			Supported	Nucleoplasm,Nucleoli,Mitochondria,Cytosol		NA	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Mitochondria	"Nucleoplasm, Nucleoli, Cytosol"	"HPA036449: AB_2675130, HPA052726: AB_2681927"	"unprognostic (8.45e-3)"	"unprognostic (4.20e-1)"	"unprognostic (5.44e-2)"	"unprognostic (1.64e-5)"	"unprognostic (1.13e-1)"	"unprognostic (8.02e-2)"	"unprognostic (1.32e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.75e-1)"	"unprognostic (2.15e-1)"	"unprognostic (7.21e-4)"	"unprognostic (2.93e-1)"	"unprognostic (1.25e-3)"	"unprognostic (3.79e-2)"	"unprognostic (2.62e-1)"	"unprognostic (6.23e-2)"	"unprognostic (1.91e-1)"	0.2	0.3	13.4	0.0	16.5	0.1	0.1	11.0	20.1	0.1	13.9	0.1	2.6	0.1	0.3	0.0	7.1	0.0	2.6	12.2	11.9	153.1	36.8	0.8	0.0	11.6	12.6	0.2	0.0	0.0	3.0	0.0	11.7	0.5	0.0	1.1	0.1	0.1	0.5	0.2	0.6	0.0	12.1	0.3	0.1	3.1	13.8	0.1	6.3	0.0	0.0	0.0	0.0	11.7	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.1	0.0	0.2	0.2	0.2	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.0	0.4	1.6	0.0	0.0	0.1	0.0	0.5	0.0	0.2	0.6	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.4	16.5	11.0	20.1	12.2	11.9	11.6	12.6	11.7	12.1	13.8	11.7	0.0	0.0	0.6	1.3	1.9	0.0	0.0	0.4	0.0	0.4	0.1	0.1	1.5	0.0	0.1	18.4	2.1	0.0	0.1	0.0	49.0	0.0	1.4	0.6	0.1	0.2	0.0	5.3	3.6	0.0	0.0	0.3	0.0	0.6	0.0	0.0	1.8	27.0	0.0	0.0	1.2	0.0	2.0	1.6	0.0	0.6	0.3	1.7	0.0	17.8	0.0	0.0	0.0	1.5	1.3	0.0	0.0	0.0	0.0	0.1	0.5	324.9	0.7	0.7	0.0	0.4	0.1	0.6	0.4	0.0	0.0	0.3	0.9	0.0	0.0	0.0
SLC6A16	NTT5	ENSG00000063127	"Solute carrier family 6 member 16"	Q9GZN6	19	49289638-49325215	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Neurotransmitter transport, Symport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"testis: 94.2"	"Group enriched"	"Detected in many"	8	"Early spermatids: 125.9;Late spermatids: 46.8;Spermatocytes: 153.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"AF22: 18.2;SuSa: 9.9"	"Not detected"	"Not detected"							HPA076812			Supported	"Golgi apparatus"		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 49: Ciliated cells - Cilium organization"	"Cluster 12: NES - Nervous system development"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Golgi apparatus"		"HPA076812: AB_2686816"	"unprognostic (1.98e-1)"	"unprognostic (7.15e-3)"	"unprognostic (6.39e-3)"	"unprognostic (1.36e-1)"	"unprognostic (1.29e-1)"	"unprognostic (6.83e-3)"	"unprognostic (7.89e-2)"	"unprognostic (7.92e-2)"	"unprognostic (1.77e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.55e-3)"	"unprognostic (1.63e-1)"	"unprognostic (3.23e-2)"	"unprognostic (3.31e-1)"	"unprognostic (2.10e-1)"	"unprognostic (8.93e-2)"	"unprognostic (4.18e-2)"	4.5	2.0	2.8	2.9	2.2	4.5	3.2	1.2	2.1	4.6	17.9	3.8	1.2	4.0	2.4	1.7	5.8	2.3	2.5	2.2	1.8	8.5	10.0	4.9	7.3	5.0	4.9	7.0	6.9	0.9	1.6	3.2	4.3	5.0	1.1	5.0	1.5	2.9	1.0	2.2	3.7	1.8	2.9	4.7	3.5	94.2	2.5	2.3	3.2	0.5	5.5	3.6	3.4	2.1	0.0	7.3	18.2	6.5	0.3	2.8	3.3	0.9	1.5	0.6	2.0	0.2	0.6	8.5	1.1	0.8	0.3	0.3	2.0	0.3	2.2	1.3	2.1	0.7	0.7	1.7	1.4	0.6	3.0	2.8	1.1	1.4	1.0	5.2	1.6	1.5	1.7	1.1	2.4	1.6	0.5	0.3	6.4	0.3	0.9	0.3	4.4	1.6	1.0	0.0	0.2	0.4	2.9	0.1	0.6	9.9	2.9	0.3	9.3	1.4	6.7	4.2	0.0	4.0	4.6	7.5	0.1	2.0	0.4	0.2	0.3	2.6	1.6	1.2	1.5	4.5	0.5	1.6	0.4	2.2	1.4	0.9	1.9	1.8	2.1	1.1	0.9	1.3	2.8	2.2	1.2	2.1	2.2	1.8	5.0	4.9	4.3	2.9	2.5	2.1	4.4	0.0	1.1	3.6	5.8	1.5	0.9	0.4	2.2	8.6	1.7	1.7	1.5	2.8	0.1	1.8	2.1	0.0	1.7	0.1	11.7	0.8	125.9	2.3	1.6	3.9	0.0	0.0	4.1	0.6	0.0	1.7	0.0	1.5	1.3	0.3	2.2	5.5	0.9	0.0	8.1	0.1	0.0	1.4	1.8	46.8	3.7	0.8	5.4	12.2	1.2	0.5	5.2	2.5	1.7	0.2	0.0	3.4	1.5	0.5	0.0	0.3	11.3	1.2	0.0	1.7	4.9	153.5	8.3	0.3	1.3	0.0	1.1	1.8	0.1	0.3
SLC6A4	"5-HTT, HTT, OCD1, SERT1"	ENSG00000108576	"Solute carrier family 6 member 4"	P31645	17	30194319-30236002	"FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted membrane proteins, Transporters"	"Neurotransmitter transport, Symport, Transport"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"brain: 232.0"	"Group enriched"	"Detected in many"	6	"Cytotrophoblasts: 125.4;Proximal enterocytes: 100.9;Syncytiotrophoblasts: 106.4"	"Cancer enhanced"	"Detected in some"		"breast cancer: 2.3"	"Group enriched"	"Detected in some"	11	"midbrain: 232.0;pons: 86.1"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 1.9;CACO-2: 3.9;Hep G2: 10.4"	"Region enriched"	"Detected in some"	4	"midbrain: 58.4"	"Group enriched"	"Detected in some"	7	"midbrain: 38.9;pons: 29.1"	"HPA054723, HPA071354, HPA074728"	Supported	Supported	Supported	"Golgi apparatus,Vesicles"		NA	NA				"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Golgi apparatus, Vesicles"		"HPA054723: , HPA071354: , HPA074728: AB_2686708"	"unprognostic (7.45e-2)"	"unprognostic (7.13e-2)"	"unprognostic (2.26e-1)"	"unprognostic (3.72e-4)"	"unprognostic (2.07e-1)"	"unprognostic (8.42e-3)"	"unprognostic (2.73e-2)"	"unprognostic (3.39e-2)"	"unprognostic (3.37e-3)"	"unprognostic (1.17e-3)"	"unprognostic (2.70e-3)"	"unprognostic (1.16e-1)"	"unprognostic (8.78e-2)"	"unprognostic (4.98e-2)"	"unprognostic (1.76e-1)"	"unprognostic (4.05e-2)"	"unprognostic (7.18e-2)"	0.1	0.1	0.1	0.0	0.0	0.2	0.2	0.3	0.2	0.2	0.0	0.5	10.3	0.0	0.0	2.8	1.7	0.0	0.9	0.1	0.2	0.2	0.0	28.8	0.1	14.8	232.0	0.1	1.4	0.2	0.0	18.4	86.1	0.1	0.1	0.1	0.7	0.2	0.1	0.5	40.3	0.0	0.0	0.1	0.9	0.3	0.2	0.0	0.5	0.0	0.2	0.1	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	3.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	10.4	1.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.7	0.0	0.4	0.5	0.0	0.0	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.3	0.2	0.1	0.2	14.8	232.0	86.1	0.0	0.2	0.2	1.1	16.0	5.0	0.3	0.0	0.1	0.4	0.1	17.1	1.2	0.1	0.0	1.0	0.0	1.9	1.8	0.0	125.4	1.5	0.2	0.0	0.0	2.8	0.2	0.6	3.2	0.0	0.0	0.9	0.0	8.6	1.3	0.0	0.5	2.5	0.2	2.2	0.3	9.5	0.0	0.6	2.3	0.0	1.0	1.2	2.2	0.3	5.9	0.0	0.0	0.1	0.5	2.1	0.5	0.5	0.4	0.0	0.4	0.1	0.3	100.9	0.4	0.7	0.8	0.0	1.3	0.5	0.5	0.9	4.8	0.3	106.4	0.5	0.2	4.1	0.3
SLC7A14	"KIAA1613, PPP1R142"	ENSG00000013293	"Solute carrier family 7 member 14"	Q8TBB6	3	170459548-170586075	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Amino-acid transport, Transport"		"Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"brain: 15.9;pituitary gland: 7.3;retina: 6.1"	"Group enriched"	"Detected in some"	5	"Bipolar cells: 28.4;Excitatory neurons: 61.9;Horizontal cells: 28.6;Inhibitory neurons: 90.2;Oligodendrocytes: 67.4"	"Group enriched"	"Detected in some"	11	"glioma: 0.8;pancreatic cancer: 0.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"LHCN-M2: 3.2;SCLC-21H: 3.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045929	Approved		Approved	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"		NA	NA				"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Vesicles, Cytosol"	"Nucleoplasm, Plasma membrane"	"HPA045929: AB_2679501"	"unprognostic (1.00e-1)"		"unprognostic (9.56e-2)"	"unprognostic (1.03e-1)"	"unprognostic (4.15e-2)"	"unprognostic (1.43e-2)"	"unprognostic (7.46e-2)"	"unprognostic (9.16e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.29e-1)"	"unprognostic (6.68e-3)"	"unprognostic (6.36e-2)"	"unprognostic (3.03e-6)"	"unprognostic (1.54e-2)"	"unprognostic (8.05e-2)"	"unprognostic (1.71e-2)"	"unprognostic (3.24e-3)"	0.0	2.3	8.9	0.4	8.1	0.1	0.0	5.5	8.8	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.0	0.1	0.0	7.9	15.9	0.1	0.0	0.0	0.0	15.6	6.4	0.1	0.7	0.0	7.3	0.0	14.9	0.1	0.4	6.1	0.0	0.0	0.1	0.1	0.3	0.1	4.0	0.0	0.2	0.1	8.9	0.0	0.0	0.0	0.0	0.0	0.1	7.7	0.0	0.0	0.1	0.0	0.5	0.9	0.0	0.3	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.8	0.0	0.0	0.5	0.3	0.1	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.9	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	8.9	8.1	5.5	8.8	7.9	15.9	15.6	6.4	14.9	4.0	8.9	7.7	0.8	3.2	2.2	4.6	0.1	0.4	0.3	0.1	0.0	28.4	0.1	0.0	1.0	0.0	2.5	0.0	2.1	0.1	0.1	0.0	0.0	0.0	0.6	0.2	0.2	0.5	1.8	0.0	61.9	0.0	0.1	0.4	0.0	0.1	2.5	0.1	0.4	0.9	0.0	28.6	90.2	0.1	0.0	0.0	1.2	0.6	2.1	0.4	3.6	6.5	0.0	1.8	0.0	9.5	67.4	0.1	1.2	2.6	0.1	0.3	0.1	0.2	3.0	4.3	0.0	0.7	0.5	0.0	0.2	0.0	0.6	0.0	0.4	0.1	0.0	0.2
SLC7A2	"ATRC2, CAT-2, HCAT2"	ENSG00000003989	"Solute carrier family 7 member 2"	P52569	8	17497088-17570573	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Amino-acid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 176.7;parathyroid gland: 224.1"	"Cell type enhanced"	"Detected in many"		"Exocrine glandular cells: 93.1;Glandular and luminal cells: 139.8;Hepatocytes: 249.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HHSteC: 204.3;RT4: 55.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA009277			Supported	"Plasma membrane,Cell Junctions"		NA	NA				"Cluster 8: Non-specific - Mitochondria"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 44: Endometrium - Transcription"	"Plasma membrane"	"Cell Junctions"	"HPA009277: AB_2668229"	"unprognostic (1.31e-1)"	"unprognostic (2.28e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.13e-2)"	"unprognostic (1.06e-1)"	"unprognostic (5.20e-2)"	"unprognostic (7.24e-3)"	"unprognostic (3.11e-1)"	"unprognostic (1.76e-1)"	"unprognostic (4.49e-1)"	"unprognostic (1.34e-2)"	"unprognostic (1.11e-2)"	"prognostic unfavorable (2.65e-7)"	"prognostic unfavorable (3.08e-4)"	"unprognostic (1.46e-2)"	"unprognostic (8.98e-2)"	"unprognostic (1.79e-1)"	28.6	11.6	7.9	3.4	7.0	0.2	17.2	9.5	9.6	32.5	16.6	6.2	2.4	15.2	17.8	11.3	42.5	11.2	12.2	10.0	8.0	8.0	176.7	7.5	2.7	14.1	6.2	84.4	83.1	224.1	7.1	9.8	12.6	14.2	4.3	17.6	5.1	7.2	114.5	8.1	4.5	13.4	12.7	3.8	8.3	15.4	7.1	3.1	45.1	45.8	3.5	10.5	14.9	15.9	0.0	3.1	1.0	32.4	0.2	0.3	35.1	0.3	22.1	1.7	2.0	10.7	0.1	0.0	7.4	0.0	4.7	0.0	23.5	5.4	7.4	0.0	12.3	0.0	24.8	23.2	204.3	10.3	0.0	27.7	4.5	27.2	25.7	0.0	10.2	0.0	0.2	0.0	24.9	35.5	1.3	11.7	11.8	7.4	2.9	0.0	16.2	17.6	2.7	55.3	0.4	4.3	1.7	0.8	9.9	23.5	0.0	1.2	22.9	0.0	11.8	0.1	0.1	0.0	0.0	0.1	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.9	7.0	9.5	9.6	10.0	8.0	14.1	6.2	12.6	12.7	7.1	15.9	9.4	12.8	78.1	58.8	0.4	8.3	6.6	5.8	20.5	2.9	52.0	25.8	15.5	38.6	16.3	7.3	35.5	22.6	0.1	0.4	0.0	8.3	12.8	67.0	40.4	5.6	87.9	10.7	0.5	93.1	15.1	20.6	0.5	139.8	2.5	0.4	7.1	249.0	5.8	0.0	19.9	3.6	0.0	6.7	2.3	22.9	37.9	1.4	3.6	1.9	0.6	23.5	0.0	11.6	2.6	20.5	0.6	27.8	0.1	50.2	0.3	3.7	53.9	38.0	59.2	8.8	75.7	0.3	1.1	7.8	3.8	26.0	1.6	9.5	3.2	8.4
SLC7A5	"CD98, D16S469E, E16, LAT1, MPE16"	ENSG00000103257	"Solute carrier family 7 member 5"	Q01650	16	87830023-87869507	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Amino-acid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 110.7;brain: 121.9"	"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 178.7;Microglial cells: 109.6;Plasma cells: 135.1;Syncytiotrophoblasts: 107.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	10	"plasmacytoid DC: 17.2"	"Lineage enriched"	"Detected in many"	10	"dendritic cells: 17.2"	"Cell line enhanced"	"Detected in all"		"HBEC3-KT: 1326.5;hTCEpi: 2229.0;MCF7: 1264.6;SiHa: 1873.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA052673, HPA056077"	Approved		Supported	"Vesicles,Plasma membrane,Cytosol"		NA	NA		51000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 65: Plasmacytoid DCs - Unknown function"	"Plasma membrane, Cytosol"	Vesicles	"HPA052673: AB_2681909, HPA056077: AB_2683031"	"unprognostic (2.71e-3)"	"unprognostic (1.10e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.64e-1)"	"unprognostic (3.22e-2)"	"unprognostic (2.99e-3)"	"unprognostic (1.64e-1)"	"prognostic unfavorable (2.43e-4)"	"unprognostic (6.86e-2)"	"unprognostic (4.46e-2)"	"unprognostic (1.27e-1)"	"unprognostic (3.17e-1)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (5.93e-2)"	"unprognostic (5.52e-3)"	"unprognostic (1.64e-2)"	"unprognostic (7.19e-3)"	10.6	3.9	121.9	18.3	87.8	110.7	6.0	89.5	119.4	11.0	64.5	11.4	6.6	5.2	35.7	100.2	6.4	6.6	21.1	96.0	91.0	18.0	26.6	9.8	14.1	111.3	104.3	8.1	14.0	1.8	22.8	17.0	104.9	9.8	2.7	42.5	28.6	10.4	30.1	25.1	8.9	3.2	93.0	16.7	34.4	65.6	117.1	6.9	3.9	2.8	11.5	24.6	22.6	88.1	187.4	693.5	13.2	192.1	5.1	10.6	487.3	147.1	52.8	87.4	56.3	456.3	260.4	170.1	126.7	187.6	30.5	818.3	142.5	1326.5	61.0	179.9	71.9	140.3	618.0	331.2	199.5	131.2	246.0	35.9	2229.0	107.8	791.4	28.5	18.0	588.8	212.6	185.1	71.1	1264.6	159.2	192.7	63.3	116.7	166.0	152.0	52.4	264.1	98.3	15.7	109.2	43.5	1873.1	368.9	406.9	123.0	170.0	171.8	14.3	30.9	201.3	127.8	114.5	237.9	213.2	728.2	120.1	322.1	296.4	1.0	0.0	0.0	1.0	0.0	1.3	0.5	0.5	0.9	0.4	0.0	0.1	0.4	0.2	0.2	0.0	17.2	1.6	0.5	121.9	87.8	89.5	119.4	96.0	91.0	111.3	104.3	104.9	93.0	117.1	88.1	3.7	0.0	0.6	8.1	23.0	73.3	17.9	27.0	178.7	15.2	12.0	8.9	2.9	2.8	6.3	1.8	16.7	15.4	80.0	3.4	0.0	18.1	1.0	20.5	7.6	29.1	86.3	86.3	12.0	9.6	35.4	9.5	43.3	51.0	66.9	4.5	1.8	17.3	9.2	10.1	13.2	6.3	8.2	3.0	50.5	5.0	1.8	51.0	39.2	109.6	2.6	14.8	2.1	15.1	1.6	25.7	2.3	1.5	135.1	18.2	1.0	0.4	3.2	52.7	0.0	33.6	31.5	1.6	4.5	58.8	37.5	107.4	65.8	2.7	4.2	42.8
SLC7A6	"KIAA0245, LAT-2, LAT3, y+LAT-2"	ENSG00000103064	"Solute carrier family 7 member 6"	Q92536	16	68264516-68301823	"Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Amino-acid transport, Antiport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 75.0"	"Cell type enhanced"	"Detected in many"		"Microglial cells: 55.3;Syncytiotrophoblasts: 47.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA050713	Uncertain		Uncertain	"Vesicles,Plasma membrane"		NA	NA			"Cluster 29: Plasmacytoid DCs - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 63: NK-cells & T-cells - Immune response"	Vesicles	"Plasma membrane"	"HPA050713: AB_2681218"	"unprognostic (6.35e-2)"	"unprognostic (4.63e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.40e-2)"	"unprognostic (2.41e-1)"	"unprognostic (5.02e-2)"	"unprognostic (1.24e-3)"	"unprognostic (1.16e-1)"	"unprognostic (1.48e-1)"	"unprognostic (5.16e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.76e-2)"	"unprognostic (1.89e-3)"	"unprognostic (7.82e-2)"	"unprognostic (2.66e-1)"	"unprognostic (4.79e-3)"	"prognostic unfavorable (1.84e-4)"	35.3	8.8	1.7	15.5	1.9	8.4	26.9	6.5	3.3	5.5	17.3	8.3	3.9	5.8	11.5	4.5	8.6	4.4	18.5	3.3	2.2	5.9	2.0	10.9	18.6	1.0	1.3	2.7	3.8	2.5	9.6	18.6	1.5	6.2	11.1	5.0	7.3	5.2	75.0	10.2	12.0	7.7	1.0	10.7	6.6	5.1	2.2	37.6	16.7	26.9	21.5	6.8	4.8	1.1	22.6	22.1	16.3	16.8	46.9	27.6	42.9	24.9	18.7	36.9	30.6	97.9	16.2	43.7	19.8	33.4	10.9	33.1	32.0	32.2	39.7	9.5	22.9	23.8	47.3	31.0	7.7	28.2	20.3	19.3	26.1	27.5	13.5	11.4	25.3	21.0	35.1	7.3	20.5	11.7	36.4	19.3	12.4	14.6	8.1	45.0	10.2	36.0	12.0	19.6	23.7	13.5	75.7	20.8	6.8	13.4	30.9	13.3	38.4	24.6	19.0	20.5	32.8	16.7	33.5	50.3	15.6	20.1	17.2	3.4	3.2	2.8	4.3	1.7	5.4	6.8	6.6	4.3	3.6	6.3	11.7	6.7	6.1	7.1	1.4	16.8	3.1	1.5	1.7	1.9	6.5	3.3	3.3	2.2	1.0	1.3	1.5	1.0	2.2	1.1	8.5	41.7	18.8	12.4	18.4	19.6	9.3	8.5	13.6	6.1	5.9	4.8	19.9	2.8	4.9	18.4	37.5	25.1	23.3	7.3	0.0	3.3	5.5	10.7	16.8	12.0	2.4	2.1	39.3	4.0	2.5	12.8	4.1	3.3	4.5	1.8	6.8	1.4	14.6	10.1	40.3	10.5	4.1	8.5	12.1	18.3	5.9	9.9	10.6	55.3	10.0	1.8	14.4	13.0	10.7	5.6	5.9	3.8	16.0	8.0	2.5	0.6	10.4	2.7	0.0	10.8	7.2	17.3	10.9	6.7	21.9	47.9	23.5	4.3	7.8	2.6
SLC8A1	NCX1	ENSG00000183023	"Solute carrier family 8 member A1"	P32418	2	40097270-40611053	"FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Antiport, Calcium transport, Ion transport, Sodium transport, Transport"	Calmodulin-binding	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 117.5"	"Group enriched"	"Detected in many"	8	"Cardiomyocytes: 743.1;Excitatory neurons: 1267.5;Inhibitory neurons: 631.3;Microglial cells: 574.3;Oligodendrocyte precursor cells: 753.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"neutrophil: 44.2"	"Group enriched"	"Detected in many"	6	"granulocytes: 44.2;monocytes: 11.5"	"Cell line enhanced"	"Detected in many"		"BJ: 28.9;fHDF/TERT166: 70.4;hTERT-HME1: 19.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022694, HPA070007"	Uncertain		Supported	"Nucleoplasm,Plasma membrane"	"Intracellular and membrane"	NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Nucleoplasm, Plasma membrane"		"CAB022694: , HPA070007: AB_2686227"	"unprognostic (2.46e-1)"	"unprognostic (1.33e-2)"	"unprognostic (1.42e-2)"	"unprognostic (7.57e-6)"	"unprognostic (1.56e-1)"	"unprognostic (3.94e-1)"	"unprognostic (2.28e-2)"	"unprognostic (4.60e-2)"	"unprognostic (1.31e-1)"	"unprognostic (7.71e-2)"	"unprognostic (1.21e-2)"	"unprognostic (1.07e-1)"	"unprognostic (3.66e-2)"	"unprognostic (7.04e-3)"	"unprognostic (3.93e-2)"	"unprognostic (5.46e-2)"	"unprognostic (6.77e-2)"	6.1	4.0	25.7	7.2	25.8	2.0	1.6	0.0	28.0	4.7	0.0	9.6	5.0	19.7	5.6	5.9	5.6	6.5	117.5	30.6	11.0	17.5	3.1	5.8	3.3	1.5	19.8	2.5	1.8	0.7	0.8	11.2	0.7	18.8	4.8	5.9	1.0	27.1	0.3	1.5	5.5	23.4	2.7	7.3	3.5	0.7	19.5	2.0	0.8	0.9	1.5	8.9	2.5	24.1	3.0	2.2	2.1	0.2	3.1	6.4	0.0	28.9	11.1	9.4	6.1	0.0	4.7	0.1	2.2	70.4	10.1	1.1	0.5	4.8	9.5	0.0	3.9	0.0	0.0	0.0	0.1	0.0	0.5	3.7	0.0	10.8	19.8	4.3	0.7	0.0	0.0	0.4	12.1	0.0	0.9	0.1	1.4	0.3	4.0	7.8	14.8	0.0	3.3	0.4	3.2	0.6	0.0	0.0	0.0	9.7	0.1	0.6	9.8	8.8	0.3	0.0	3.1	1.6	0.0	0.0	1.4	1.7	1.4	0.0	8.3	0.0	0.0	9.1	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	44.2	0.0	11.5	0.3	0.0	1.1	25.7	25.8	0.0	28.0	30.6	11.0	1.5	19.8	0.7	2.7	19.5	24.1	10.3	3.2	2.8	39.5	3.6	1.3	0.0	0.2	1.2	79.1	0.5	5.8	743.1	2.8	0.6	35.0	4.2	0.5	0.3	0.0	0.0	0.0	1.1	2.3	52.8	15.1	0.0	3.0	1267.5	0.0	1.6	26.6	1.5	3.0	0.0	0.2	12.1	0.3	29.3	0.0	631.3	2.5	0.0	78.0	26.7	1.4	0.0	88.8	1.8	574.3	42.7	32.0	1.0	753.0	20.5	0.1	3.8	8.2	0.7	0.2	24.7	0.5	0.0	7.2	13.1	1.4	46.6	0.2	1.2	0.5	3.1	1.1	1.2	0.7	2.5	0.1
SLC9A1	"APNH, NHE1, PPP1R143"	ENSG00000090020	"Solute carrier family 9 member A1"	P19634	1	27098809-27166981	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Antiport, Ion transport, Sodium transport, Transport"	Calmodulin-binding	"Deafness, Disease variant, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"salivary gland: 76.5;stomach 1: 65.9"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 81.5;Gastric mucus-secreting cells: 160.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022371, HPA048532, HPA052891"	Enhanced		Supported	"Plasma membrane"		NA	NA		21000	"Cluster 16: MAIT-cells - Unknown function"	"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 15: RT4 - Unknown function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Plasma membrane"		"CAB022371: , HPA048532: AB_2680431, HPA052891: AB_2681981"	"unprognostic (6.18e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.21e-1)"	"unprognostic (8.48e-2)"	"prognostic unfavorable (7.47e-4)"	"unprognostic (2.70e-2)"	"unprognostic (4.33e-3)"	"unprognostic (3.18e-2)"	"unprognostic (9.74e-2)"	"prognostic unfavorable (7.10e-4)"	"unprognostic (3.44e-2)"	"unprognostic (6.95e-2)"	"unprognostic (2.05e-2)"	"unprognostic (1.27e-2)"	"unprognostic (1.60e-1)"	"unprognostic (3.34e-1)"	"unprognostic (1.16e-2)"	9.6	10.7	6.1	10.4	14.7	11.5	9.0	2.8	10.8	10.9	0.2	18.6	29.3	10.9	8.0	11.0	7.6	16.9	13.7	2.3	5.3	5.8	2.4	13.2	7.0	13.8	4.7	7.0	8.6	20.7	8.2	21.9	11.2	9.0	13.6	4.5	76.5	19.4	4.6	10.5	19.0	10.7	0.5	11.6	65.9	10.1	10.4	6.3	9.5	4.9	6.7	15.1	9.2	2.4	32.3	10.7	9.9	10.1	21.8	15.7	60.8	25.9	38.5	21.7	23.5	13.0	20.0	14.4	21.9	33.4	10.5	38.9	9.8	62.4	13.4	17.4	9.4	21.9	7.1	5.5	66.1	13.1	16.0	19.7	29.5	36.5	50.7	15.8	36.3	9.8	6.3	13.4	32.3	18.7	6.8	6.4	14.0	38.2	21.9	11.8	9.0	6.7	10.9	46.3	11.4	3.7	21.5	28.4	12.6	10.0	13.3	7.9	39.9	23.0	9.4	21.7	14.5	12.6	8.6	4.3	24.6	14.1	13.5	0.0	0.6	0.6	0.7	0.3	1.5	0.1	0.8	0.7	0.2	0.3	0.5	0.6	2.0	0.1	0.6	0.0	0.3	0.8	6.1	14.7	2.8	10.8	2.3	5.3	13.8	4.7	11.2	0.5	10.4	2.4	13.5	6.4	14.8	6.5	7.9	31.2	17.9	14.6	13.1	7.4	21.7	23.2	13.5	7.2	8.3	11.0	0.0	40.3	11.9	81.5	0.0	9.1	26.5	13.8	15.9	9.7	12.5	0.4	14.1	12.5	19.4	12.7	160.0	26.5	27.3	7.5	6.8	1.2	12.9	20.2	14.1	15.0	4.1	5.7	5.1	14.4	9.3	12.7	7.2	8.4	4.3	8.2	12.3	4.0	4.6	28.1	43.1	13.2	4.8	9.6	38.9	1.2	5.9	3.8	6.6	20.8	9.8	3.6	4.4	15.0	25.1	52.9	9.8	4.8	18.3	18.3
SLC9A2	NHE2	ENSG00000115616	"Solute carrier family 9 member A2"	Q9UBY0	2	102619553-102711355	"Metabolic proteins, Plasma proteins, Predicted membrane proteins, Transporters"	"Antiport, Ion transport, Sodium transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 20.7;stomach 1: 26.4"	"Cell type enhanced"	"Detected in some"		"Distal enterocytes: 41.3;Early spermatids: 46.5;Gastric mucus-secreting cells: 41.8;Intestinal goblet cells: 23.4;Late spermatids: 31.4;Paneth cells: 38.7;Undifferentiated cells: 29.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 10.0;OE19: 37.3;RT4: 16.9;SK-BR-3: 14.7;T-47d: 18.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA035121, HPA035122"	Approved		Supported	"Cell Junctions"		NA	NA				"Cluster 37: Intestine - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Cell Junctions"		"HPA035121: AB_10602894, HPA035122: AB_2674477"	"unprognostic (1.53e-2)"	"unprognostic (8.05e-3)"	"unprognostic (6.00e-2)"	"unprognostic (3.00e-3)"	"unprognostic (3.12e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.12e-1)"	"unprognostic (1.86e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.23e-1)"	"unprognostic (2.37e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.40e-3)"	"unprognostic (1.60e-1)"	"unprognostic (7.51e-2)"	"unprognostic (1.39e-2)"	"unprognostic (1.70e-1)"	0.0	0.1	1.4	2.1	0.7	0.0	1.4	0.8	1.5	1.4	0.2	20.0	6.3	0.1	3.9	0.3	0.3	1.1	0.0	1.9	0.9	5.4	0.0	0.1	0.1	1.4	0.7	0.0	0.0	5.8	1.0	0.0	1.5	5.8	20.7	0.1	4.9	2.1	6.4	0.8	3.4	0.7	0.8	0.0	26.4	5.7	1.2	0.4	1.0	6.2	4.5	1.0	0.0	0.5	10.0	6.1	0.0	1.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	6.7	0.2	0.0	3.4	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.3	3.4	2.9	0.0	0.0	0.5	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	7.7	0.0	0.1	0.2	37.3	5.0	0.0	0.1	0.0	1.1	16.9	0.1	0.0	0.0	14.7	0.0	0.0	18.5	0.0	0.0	0.0	0.7	0.0	1.4	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.7	0.8	1.5	1.9	0.9	1.4	0.7	1.5	0.8	1.2	0.5	0.0	0.0	0.0	2.0	0.3	0.4	0.2	0.1	0.0	0.0	1.1	0.1	0.8	0.0	0.3	9.2	0.0	0.5	0.0	41.3	0.0	0.2	46.5	0.5	0.2	0.3	9.7	0.0	3.0	0.0	0.0	0.0	41.8	3.1	0.0	0.0	0.0	0.0	0.1	0.0	14.6	23.4	6.1	0.0	0.4	31.4	0.6	0.0	0.0	5.6	0.0	0.5	0.0	1.0	1.0	8.5	38.7	0.0	0.2	4.1	3.2	1.4	0.1	0.1	0.0	0.5	0.1	4.5	0.2	0.0	0.6	0.3	0.2	0.0	29.6	0.8
SLC9A3	NHE3	ENSG00000066230	"Solute carrier family 9 member A3"	P48764	5	470456-524449	"Disease related genes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted membrane proteins, Transporters"	"Antiport, Ion transport, Sodium transport, Transport"		"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 45.4;intestine: 94.3;kidney: 62.5;stomach 1: 50.1"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 16.0;Collecting duct cells: 16.5;Proximal tubular cells: 40.7"	"Cancer enhanced"	"Detected in many"		"stomach cancer: 14.7"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"HDLM-2: 37.8"	"Region enriched"	"Detected in single"	14	"cerebellum: 4.1"	"Low region specificity"	"Detected in many"			"HPA036493, HPA036669"	Enhanced		Supported	"Plasma membrane"		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Plasma membrane"		"HPA036493: AB_10673353, HPA036669: AB_10670843"	"unprognostic (1.27e-1)"	"unprognostic (4.88e-1)"	"unprognostic (9.35e-3)"	"unprognostic (1.11e-1)"	"unprognostic (2.37e-1)"	"unprognostic (3.35e-1)"	"unprognostic (2.51e-1)"	"unprognostic (9.40e-2)"	"prognostic unfavorable (8.49e-4)"	"unprognostic (5.18e-2)"	"unprognostic (1.29e-1)"	"unprognostic (3.69e-2)"	"unprognostic (3.84e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.24e-2)"	"unprognostic (1.32e-1)"	2.9	4.4	3.0	10.4	2.5	1.9	3.1	6.1	5.0	3.8	1.7	94.3	46.0	2.9	4.0	8.7	4.9	45.4	3.2	4.7	2.5	62.5	2.4	2.8	3.8	3.8	2.3	4.3	6.7	6.2	0.7	2.1	3.7	7.3	10.8	1.7	9.9	3.8	6.2	19.0	68.1	3.3	1.3	3.7	50.1	5.8	3.4	3.5	4.9	3.9	3.4	2.5	2.5	2.6	6.7	5.1	10.4	10.5	2.5	3.0	7.8	5.3	3.9	8.0	5.0	11.0	7.4	14.0	7.5	3.0	5.5	10.0	6.1	4.0	3.9	37.8	10.7	6.7	23.4	5.4	3.9	5.5	8.2	4.2	8.1	3.5	5.4	3.9	2.4	6.3	9.6	7.5	2.9	9.0	6.0	24.3	4.0	17.8	8.3	8.6	9.3	8.3	2.8	4.8	11.5	5.0	19.0	5.3	4.2	4.5	12.3	4.2	2.9	8.0	7.2	5.3	3.9	12.4	5.8	8.5	5.2	21.2	5.6	0.0	0.7	0.1	2.6	0.3	2.2	0.9	3.3	2.4	0.9	1.0	3.9	3.1	0.1	2.4	0.2	1.2	2.7	1.8	3.0	2.5	6.1	5.0	4.7	2.5	3.8	2.3	3.7	1.3	3.4	2.6	3.8	16.0	5.8	0.0	1.5	0.0	0.0	0.0	0.0	0.0	7.3	8.9	0.7	0.0	5.6	16.5	0.0	0.0	3.4	0.7	5.9	9.0	0.0	3.8	3.6	2.3	0.0	0.0	0.3	8.8	0.0	2.2	0.0	2.6	2.5	5.3	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	4.6	0.0	0.0	0.0	0.1	7.7	0.0	0.0	0.7	0.0	1.1	40.7	2.9	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	2.3	5.4	0.0	0.0
SLC9A3R2	"E3KARP, NHERF-2, SIP-1, TKA-1"	ENSG00000065054	"SLC9A3 regulator 2"	Q15599	16	2025356-2039026	"Predicted intracellular proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 568.2"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 1013.8;Endothelial cells: 398.9;Hepatic stellate cells: 374.4;Hepatocytes: 227.4;Pancreatic endocrine cells: 326.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"classical monocyte: 2.2;intermediate monocyte: 1.6;myeloid DC: 3.9;plasmacytoid DC: 2.9"	"Group enriched"	"Detected in many"	5	"dendritic cells: 3.9;monocytes: 2.2"	"Cell line enhanced"	"Detected in many"		"A549: 188.6;MCF7: 306.8;PC-3: 281.2;SK-BR-3: 188.3;U-251 MG: 193.6;WM-115: 202.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001672, HPA066520"	Enhanced		Supported	"Plasma membrane"		NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Plasma membrane"		"HPA001672: AB_1080017, HPA066520: AB_2732748"	"unprognostic (6.99e-2)"	"unprognostic (4.56e-2)"	"unprognostic (2.06e-2)"	"prognostic favorable (1.03e-4)"	"unprognostic (1.41e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.94e-3)"	"unprognostic (9.17e-2)"	"unprognostic (1.68e-2)"	"unprognostic (1.56e-2)"	"unprognostic (2.17e-2)"	"unprognostic (1.70e-2)"	"unprognostic (2.20e-2)"	"unprognostic (6.20e-3)"	"unprognostic (9.10e-2)"	"unprognostic (2.40e-1)"	"unprognostic (2.80e-2)"	234.7	81.7	107.0	20.7	98.6	0.7	181.7	83.4	119.7	92.6	60.6	77.4	27.2	92.7	10.7	47.3	77.7	34.8	568.2	82.4	88.5	207.5	408.3	289.1	22.0	96.4	95.5	57.9	47.7	24.0	95.6	51.3	99.3	129.1	11.9	3.0	149.1	42.4	144.6	45.3	81.2	18.8	87.0	143.8	109.5	36.3	116.2	7.9	188.4	109.0	7.4	77.4	72.6	94.7	32.5	188.6	5.0	38.6	6.2	8.6	5.7	138.1	81.9	67.9	22.5	25.4	41.9	0.1	63.4	59.2	9.1	30.9	15.0	13.7	7.1	0.4	45.0	3.1	80.8	61.6	44.3	0.5	13.9	9.2	13.7	20.2	5.9	32.1	68.2	15.0	24.0	2.9	4.8	306.8	0.6	35.7	7.5	76.8	281.2	27.6	8.1	50.5	16.0	2.9	35.3	33.1	9.7	188.3	12.8	5.0	152.6	16.8	176.4	21.5	30.7	1.9	193.6	5.1	4.6	0.7	2.5	3.6	202.4	0.0	2.2	0.0	0.5	1.6	0.2	0.0	0.1	0.1	3.9	0.0	0.4	0.5	0.0	0.0	0.5	2.9	0.1	0.7	107.0	98.6	83.4	119.7	82.4	88.5	96.4	95.5	99.3	87.0	116.2	94.7	1013.8	3.2	10.5	4.2	7.3	15.2	19.6	17.1	7.4	2.6	79.5	65.0	25.5	88.6	47.3	12.9	0.0	1.0	11.4	13.3	5.9	36.1	16.1	37.2	36.8	398.9	21.5	17.3	3.4	8.8	0.8	53.5	33.6	67.8	0.0	5.1	374.4	227.4	2.6	3.3	5.5	77.0	22.4	30.9	35.1	35.8	82.0	7.0	33.8	31.9	2.2	17.2	7.2	4.0	3.6	326.8	9.3	44.4	4.9	51.8	1.2	14.7	27.3	5.0	26.3	22.3	69.1	7.0	15.4	3.4	11.4	1.0	8.8	9.5	18.0	66.6
SLC9A5	NHE5	ENSG00000135740	"Solute carrier family 9 member A5"	Q14940	16	67237683-67272191	"Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Antiport, Ion transport, Sodium transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 6.6;lymphoid tissue: 17.4"	"Cell type enhanced"	"Detected in some"		"Excitatory neurons: 11.1;Horizontal cells: 16.8;Inhibitory neurons: 12.2;Oligodendrocyte precursor cells: 7.1;Spermatocytes: 17.2;Theca cells: 6.8"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"U-138 MG: 6.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA041004, HPA041329"	Uncertain		Uncertain	"Plasma membrane,Cytosol"		NA	NA				"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	Cytosol	"Plasma membrane"	"HPA041004: AB_10794433, HPA041329: AB_10794373"	"unprognostic (8.90e-2)"	"unprognostic (9.70e-2)"	"unprognostic (3.39e-3)"	"unprognostic (1.37e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.24e-2)"	"unprognostic (5.17e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.50e-3)"	"unprognostic (4.84e-2)"	"unprognostic (9.85e-11)"	"unprognostic (9.21e-2)"	"unprognostic (1.95e-1)"	"unprognostic (8.12e-3)"	"unprognostic (9.07e-2)"	0.9	0.6	4.2	0.3	6.6	0.1	1.0	5.4	6.5	0.8	2.5	0.5	0.4	0.4	1.0	0.2	0.5	0.6	1.6	4.6	3.9	0.8	0.2	1.4	0.8	4.8	4.1	1.2	0.6	0.1	0.8	0.6	5.3	0.9	0.3	1.2	0.8	0.3	1.8	1.5	0.5	0.1	3.4	17.4	0.5	3.2	4.2	0.1	0.8	0.7	0.4	0.4	0.5	4.0	0.3	2.9	2.6	0.9	4.7	3.2	0.3	1.1	4.1	2.4	2.2	0.1	2.0	0.0	0.6	1.2	1.2	0.1	0.6	0.4	1.0	0.8	0.8	2.1	0.5	0.7	0.5	1.0	4.7	3.8	1.0	1.5	0.2	4.5	1.0	0.9	0.5	1.3	1.6	1.7	0.0	0.2	1.5	0.2	0.2	0.0	0.5	0.7	0.4	0.5	1.6	0.9	2.4	0.1	1.2	0.6	1.1	0.2	0.8	6.4	0.9	1.1	0.4	2.4	0.5	1.3	4.5	0.5	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	4.2	6.6	5.4	6.5	4.6	3.9	4.8	4.1	5.3	3.4	4.2	4.0	0.6	3.2	2.8	4.2	0.4	0.6	0.2	0.1	1.2	3.4	1.8	1.3	1.5	1.5	0.2	0.0	0.0	0.3	0.1	0.5	0.0	0.3	1.8	0.2	0.8	0.8	1.2	0.0	11.1	0.2	0.1	0.7	0.0	0.9	0.0	0.9	1.4	0.0	0.1	16.8	12.2	0.3	0.0	0.0	0.4	0.7	0.3	0.5	0.0	1.9	0.6	0.3	0.0	7.1	2.6	0.5	0.1	2.2	0.0	0.5	0.2	0.0	0.7	0.9	0.0	0.6	1.4	17.2	4.6	0.3	0.9	0.0	0.3	6.8	0.3	0.2
SLC9A6	"KIAA0267, NHE6"	ENSG00000198689	"Solute carrier family 9 member A6"	Q92581	X	135973841-136047269	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Antiport, Ion transport, Sodium transport, Transport"		"Disease variant, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 40.3;Horizontal cells: 48.8;Inhibitory neurons: 42.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA059445, HPA059590"	Enhanced		Supported	Vesicles		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 58: Brain - Synaptic function"	"Cluster 18: U-2197 - ECM organization"	"Cluster 62: Horizontal cells - Visual perception"	Vesicles		"HPA059445: AB_2684021, HPA059590: AB_2684075"	"unprognostic (1.35e-1)"	"unprognostic (8.28e-3)"	"unprognostic (4.36e-1)"	"unprognostic (4.93e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.60e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.72e-2)"	"unprognostic (7.43e-2)"	"unprognostic (1.29e-1)"	"unprognostic (7.07e-2)"	"unprognostic (5.30e-2)"	"unprognostic (1.75e-1)"	"unprognostic (4.49e-2)"	"unprognostic (5.06e-2)"	5.1	6.3	11.6	5.6	11.9	4.6	3.3	1.2	15.7	5.6	0.0	6.0	8.5	6.4	3.3	6.3	5.7	5.5	8.6	12.7	19.0	6.9	4.5	6.7	5.7	7.8	4.4	8.0	3.8	10.4	2.2	4.7	8.9	4.0	6.1	14.4	4.1	4.9	7.5	4.7	7.8	7.4	3.4	5.7	5.8	5.8	15.3	5.6	6.7	7.1	6.6	5.6	1.6	4.2	20.0	10.5	9.1	3.8	14.8	14.2	17.3	15.9	16.9	13.3	27.9	9.2	15.5	14.8	35.2	18.4	19.8	11.6	14.3	14.0	19.1	11.7	12.9	4.0	15.3	5.3	7.9	11.6	13.3	7.7	11.6	22.0	10.8	9.4	11.2	12.5	7.5	20.5	14.9	8.7	15.5	3.4	6.0	7.1	14.0	10.4	16.0	15.2	9.4	9.8	9.5	7.2	11.4	1.2	8.9	8.8	4.5	8.7	16.4	16.5	10.9	24.5	20.7	9.6	23.8	12.7	10.0	19.4	9.4	2.0	5.0	3.0	6.4	7.0	11.1	4.1	7.1	5.9	5.8	2.6	7.6	5.7	2.0	5.1	6.0	3.5	6.9	5.4	11.6	11.9	1.2	15.7	12.7	19.0	7.8	4.4	8.9	3.4	15.3	4.2	4.3	3.2	5.4	22.9	5.9	7.5	1.4	6.2	7.4	14.2	2.7	3.4	11.2	12.8	4.0	12.9	8.4	2.5	6.1	8.9	0.0	4.3	0.8	4.2	4.1	4.9	10.7	5.0	40.3	6.0	2.4	5.1	8.6	6.8	1.3	4.6	8.2	9.6	9.9	48.8	42.0	4.0	8.2	13.0	7.0	1.4	5.6	9.8	8.8	15.9	8.2	12.9	4.1	19.6	22.7	6.1	6.0	4.5	3.8	2.0	10.3	6.0	3.1	7.8	0.0	5.1	8.4	9.0	11.9	7.0	6.8	2.9	8.9	3.1	6.0	3.1
SLC9A7	NHE7	ENSG00000065923	"Solute carrier family 9 member A7"	Q96T83	X	46599251-46759118	"Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Antiport, Ion transport, Potassium transport, Sodium transport, Transport"		"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"brain: 41.6"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 43.3;Inhibitory neurons: 66.8;Oligodendrocyte precursor cells: 69.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"plasmacytoid DC: 2.8"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA048938, HPA075385"	Approved		Supported	Vesicles		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 65: Brain - Ion transport"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Vesicles		"HPA048938: AB_2680565, HPA075385: AB_2686747"	"unprognostic (2.77e-1)"	"unprognostic (4.68e-2)"	"unprognostic (1.37e-1)"	"prognostic unfavorable (8.58e-4)"	"prognostic unfavorable (8.14e-4)"	"unprognostic (2.16e-2)"	"unprognostic (2.73e-3)"	"unprognostic (5.26e-3)"	"unprognostic (1.28e-2)"	"unprognostic (9.25e-2)"	"unprognostic (5.30e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.08e-1)"	"unprognostic (7.20e-2)"	"unprognostic (2.62e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.13e-1)"	0.5	5.0	9.1	2.4	41.6	3.6	5.8	6.3	14.6	1.2	0.5	0.6	1.2	0.8	2.6	1.9	1.7	1.6	1.1	8.6	17.0	2.6	3.1	1.3	6.3	13.9	7.5	4.3	3.4	8.9	9.2	1.1	14.2	4.6	0.9	4.9	6.0	2.0	5.7	2.1	2.2	0.7	6.7	3.7	6.3	0.8	14.5	3.2	4.3	2.5	6.3	1.8	1.3	5.1	10.4	7.7	1.1	3.3	1.2	7.4	4.3	9.6	12.0	5.7	4.5	7.9	10.9	22.7	2.9	15.6	11.0	4.6	7.4	10.9	10.3	11.9	3.9	2.3	3.1	3.3	4.6	1.0	17.9	4.6	1.4	16.1	10.6	26.8	8.2	7.7	0.2	0.3	7.9	15.7	2.6	1.2	5.3	5.0	9.2	10.0	0.4	0.2	4.4	11.4	8.2	1.0	4.9	7.3	2.1	9.2	9.7	0.4	0.4	12.0	4.0	1.8	5.7	2.3	0.5	11.2	17.1	0.1	4.0	0.5	0.2	0.1	0.1	0.2	0.1	1.7	0.2	0.1	1.1	1.7	0.1	0.1	0.8	0.5	0.2	2.8	0.3	0.2	9.1	41.6	6.3	14.6	8.6	17.0	13.9	7.5	14.2	6.7	14.5	5.1	0.5	3.2	8.2	11.4	21.0	0.6	10.1	0.9	1.2	13.0	16.9	8.6	5.7	1.5	2.6	16.5	4.2	7.9	24.4	0.3	0.0	17.6	0.0	1.8	2.0	1.5	2.4	5.5	43.3	14.2	0.7	2.7	13.3	1.7	0.0	4.5	0.7	6.5	6.4	13.5	66.8	2.0	0.0	6.3	8.4	0.6	0.9	9.2	1.8	3.7	8.0	6.1	1.0	69.9	1.6	16.4	0.1	0.4	2.8	21.0	0.1	2.1	0.1	3.5	6.6	12.1	1.9	0.0	1.6	4.2	1.0	7.3	2.9	1.3	0.9	11.5
SLC9B1	"NHA1, NHEDC1"	ENSG00000164037	"Solute carrier family 9 member B1"	Q4ZJI4	4	102885048-103019719	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Antiport, Fertilization, Ion transport, Sodium transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	10	"testis: 40.4"	"Group enriched"	"Detected in many"	4	"Early spermatids: 177.8;Late spermatids: 106.0;Spermatocytes: 224.8"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in some"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA058971, HPA065520"			Supported	"Centriolar satellite,Mitochondria"		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 66: Spermatocytes - Spermatogenesis"	Mitochondria	"Centriolar satellite"	"HPA058971: AB_2683865, HPA065520: AB_2685502"	"unprognostic (4.87e-3)"	"unprognostic (2.38e-1)"	"unprognostic (1.18e-1)"	"unprognostic (8.26e-4)"	"unprognostic (2.53e-1)"	"unprognostic (3.39e-1)"	"unprognostic (5.06e-4)"	"unprognostic (5.85e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.07e-3)"	"unprognostic (7.68e-2)"	"unprognostic (3.03e-2)"	"unprognostic (3.33e-1)"	"unprognostic (1.85e-1)"	"unprognostic (5.66e-5)"	"unprognostic (5.78e-2)"	1.0	0.8	1.7	0.6	2.6	0.6	0.5	2.0	2.1	0.4	0.0	0.4	0.7	1.3	2.1	0.3	0.6	1.5	0.8	1.2	1.8	0.5	0.2	0.5	1.0	2.5	2.3	1.4	1.2	0.7	0.5	0.8	2.9	0.9	0.7	1.7	0.2	0.7	0.2	1.8	0.5	0.6	2.5	0.9	0.4	40.4	2.3	1.1	1.0	0.0	1.0	0.8	0.2	4.1	0.1	0.0	0.9	1.5	1.9	1.4	0.3	0.3	0.4	0.0	0.1	0.0	0.1	0.7	0.2	0.8	0.3	0.0	0.7	0.4	0.6	1.5	0.9	1.2	1.0	0.0	0.0	0.4	0.2	0.2	0.4	0.0	0.8	0.4	0.5	2.0	0.5	0.8	0.7	0.6	0.4	1.0	0.4	0.2	0.0	1.3	0.8	0.2	0.4	0.2	0.9	2.3	0.2	0.3	1.1	0.6	0.2	0.8	0.3	0.4	0.1	0.5	0.5	2.5	1.9	0.7	0.5	0.4	1.0	0.2	0.2	0.0	0.4	0.1	0.5	0.5	0.3	0.6	0.2	0.5	1.5	0.9	0.1	0.1	0.1	0.6	0.6	0.2	1.7	2.6	2.0	2.1	1.2	1.8	2.5	2.3	2.9	2.5	2.3	4.1	1.3	3.2	1.5	26.1	3.4	1.3	0.5	1.8	1.8	1.8	1.0	0.6	0.9	1.5	0.4	0.0	16.7	0.6	1.1	0.2	1.9	0.3	177.8	0.8	1.1	1.7	0.0	0.4	6.0	0.4	0.4	2.3	0.0	0.6	0.0	1.9	1.4	0.2	1.3	3.3	8.3	0.1	6.1	3.9	3.1	106.0	5.3	1.3	1.8	4.7	1.5	2.5	1.0	24.1	40.5	1.1	0.0	3.0	1.8	0.9	0.4	0.9	0.2	5.0	0.0	6.4	1.8	224.8	9.5	0.7	0.6	0.5	2.9	2.0	0.3	0.6
SLC9B2	"FLJ23984, NHA2, NHEDC2"	ENSG00000164038	"Solute carrier family 9 member B2"	Q86UD5	4	103019868-103085829	"Predicted membrane proteins, Transporters"	"Antiport, Hydrogen ion transport, Ion transport, Sodium transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 38.7"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 57.9;Exocrine glandular cells: 68.5;Inhibitory neurons: 57.2;Pancreatic endocrine cells: 94.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"NK-cell: 11.8"	"Group enriched"	"Detected in many"	5	"B-cells: 5.1;NK-cells: 11.8;T-cells: 6.4"	"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA047008	Uncertain		Approved	"Nucleoplasm,Cell Junctions"		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 15: Liver - Metabolism"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	"Nucleoplasm, Cell Junctions"		"HPA047008: AB_2679901"	"unprognostic (1.85e-1)"	"unprognostic (5.43e-2)"	"unprognostic (2.68e-1)"	"unprognostic (1.11e-1)"	"unprognostic (8.83e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.43e-2)"	"unprognostic (3.78e-2)"	"unprognostic (3.26e-1)"	"unprognostic (2.53e-2)"	"unprognostic (3.53e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.51e-5)"	"unprognostic (2.23e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.90e-2)"	"unprognostic (2.35e-5)"	7.8	6.0	11.2	5.2	11.7	4.6	5.7	10.9	12.8	6.2	3.2	6.2	1.1	6.8	2.3	3.4	5.6	7.6	6.2	12.5	11.1	2.5	38.7	3.6	5.9	11.4	9.1	6.7	2.4	0.3	8.5	3.9	12.7	4.1	2.7	12.8	2.4	5.0	3.0	3.0	3.7	7.7	7.0	3.6	4.9	3.6	10.0	3.6	2.9	3.5	5.6	6.5	4.9	11.2	4.9	2.1	5.2	10.5	26.0	20.7	0.0	22.0	7.8	3.2	3.0	2.5	3.0	29.3	3.7	24.3	5.1	1.4	12.2	9.3	4.8	24.7	7.5	30.2	7.5	21.8	13.5	22.5	8.8	18.7	10.8	7.7	27.3	11.1	15.3	8.3	10.1	22.1	10.7	1.7	15.3	10.8	4.4	0.1	6.4	0.0	6.0	12.2	9.0	2.4	17.5	14.9	10.0	2.3	6.0	1.4	2.6	13.4	17.6	7.5	4.3	11.6	6.9	16.8	14.2	21.7	8.7	17.5	3.0	0.0	0.1	0.0	4.9	0.0	6.4	5.1	5.1	4.1	0.9	3.0	3.1	3.8	0.0	11.8	0.1	1.6	2.4	1.8	11.2	11.7	10.9	12.8	12.5	11.1	11.4	9.1	12.7	7.0	10.0	11.2	13.9	0.0	0.5	15.0	15.6	4.8	3.4	2.0	6.2	9.7	3.1	2.8	2.5	8.6	1.1	0.0	27.1	0.5	6.5	0.2	0.0	14.1	12.1	1.1	8.6	17.8	3.0	17.2	57.9	68.5	2.3	13.2	22.4	0.9	1.3	10.3	6.1	39.5	1.4	8.4	57.2	1.1	4.1	1.3	5.3	6.9	5.6	3.4	10.6	5.6	3.9	0.7	0.0	32.6	17.6	94.7	0.3	5.3	12.0	4.9	0.0	1.4	1.1	2.3	6.6	16.5	11.5	5.8	4.2	5.6	3.8	0.3	7.9	4.8	0.3	1.3
SLCO1A2	"OATP, OATP-A, OATP1A2, SLC21A3"	ENSG00000084453	"Solute carrier organic anion transporter family member 1A2"	P46721	12	21264600-21419594	"Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 82.0;choroid plexus: 28.6"	"Cell type enriched"	"Detected in some"	4	"Oligodendrocytes: 487.6"	"Cancer enhanced"	"Detected in some"		"testis cancer: 2.5"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"NTERA-2: 16.7;RPMI-8226: 12.0;SuSa: 16.1;U-266/70: 23.1;U-266/84: 9.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA071152			Supported	"Plasma membrane"		No	No			"Cluster 1: Neutrophils - Mixed function"	"Cluster 70: Brain - Nervous system development"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Plasma membrane"		"HPA071152: AB_2686350"	"unprognostic (5.43e-3)"	"unprognostic (2.33e-1)"	"unprognostic (1.28e-1)"	"unprognostic (8.59e-2)"	"unprognostic (1.08e-1)"	"unprognostic (6.36e-2)"	"unprognostic (7.63e-2)"	"unprognostic (1.53e-1)"	"unprognostic (3.82e-2)"	"unprognostic (1.54e-2)"	"unprognostic (1.51e-1)"	"unprognostic (8.82e-2)"	"unprognostic (1.66e-4)"	"unprognostic (2.52e-2)"	"unprognostic (3.20e-1)"		"unprognostic (1.24e-1)"	0.0	0.1	48.9	0.1	65.9	0.1	4.0	43.5	80.2	0.0	28.6	0.1	0.0	0.1	0.2	0.1	0.3	0.2	0.9	41.3	46.4	1.2	11.5	2.8	0.7	54.0	51.9	0.2	2.4	0.2	0.4	1.2	52.6	0.7	0.0	0.6	15.8	0.0	0.4	0.5	0.1	0.0	45.2	0.5	0.3	1.9	48.3	0.6	0.2	0.0	0.4	0.2	0.0	82.0	2.1	0.6	0.8	0.1	0.0	0.0	3.4	0.0	0.0	0.1	0.0	3.8	1.4	0.1	2.1	0.2	0.0	0.3	0.3	0.2	0.5	0.7	0.9	0.0	0.5	1.5	0.0	0.4	0.3	0.0	1.7	0.2	0.2	1.5	0.1	0.4	4.0	1.2	0.0	2.6	0.4	0.1	16.7	2.0	0.2	0.2	0.2	12.0	0.0	2.2	1.9	2.9	0.0	0.2	0.2	16.1	3.2	0.9	0.0	0.1	1.7	0.8	0.4	23.1	9.8	0.2	0.1	0.3	0.0	0.2	0.1	0.1	0.4	0.1	0.6	0.4	0.6	0.4	0.0	0.2	0.6	0.4	1.3	0.3	0.0	0.2	0.5	0.1	48.9	65.9	43.5	80.2	41.3	46.4	54.0	51.9	52.6	45.2	48.3	82.0	0.0	35.3	3.1	5.9	0.0	0.0	0.0	0.0	0.0	0.2	3.5	2.8	0.5	0.0	0.0	1.8	0.0	0.2	0.0	0.0	0.0	0.0	5.0	0.0	0.0	2.8	0.0	0.0	0.7	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	1.5	0.1	0.0	0.8	0.0	0.0	0.0	0.0	4.5	0.0	0.1	0.0	102.1	0.0	0.1	0.0	2.5	487.6	0.1	0.0	0.0	0.0	0.0	0.0	0.1	1.5	0.0	0.0	0.0	0.1	0.4	1.5	0.0	0.0	0.1	0.1	0.0	0.0	0.0
SLCO1B1	"LST-1, OATP-C, OATP1B1, SLC21A6"	ENSG00000134538	"Solute carrier organic anion transporter family member 1B1"	Q9Y6L6	12	21131194-21239796	"Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	614	"liver: 537.2"	"Cell type enriched"	"Detected in some"	9	"Hepatocytes: 83.1"	"Cancer enriched"	"Detected in some"	96	"liver cancer: 52.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HeLa: 1.1;NTERA-2: 1.3;RPMI-8226: 1.8;SuSa: 2.2"									"HPA050892, HPA073093"	Supported		Supported	"Plasma membrane"		NA	NA				"Cluster 60: Liver - Hemostasis & Lipid metabolism"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 2: Hepatocytes - Metabolism"	"Plasma membrane"		"HPA050892: AB_2681265, HPA073093: "			"unprognostic (5.45e-1)"			"unprognostic (1.82e-4)"	"unprognostic (2.43e-3)"	"unprognostic (1.96e-3)"		"unprognostic (1.80e-1)"	"unprognostic (2.41e-1)"	"unprognostic (8.82e-2)"		"unprognostic (5.63e-2)"	"unprognostic (3.86e-2)"		"unprognostic (3.49e-1)"	0.0	0.0	0.0	0.0	0.2	0.0	0.8	0.1	0.1	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.1	537.2	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.7	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.1	0.0	0.2	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.3	0.0	0.1	0.0	0.2	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.0	0.1	0.2	0.1	0.2	0.1	0.2	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	83.1	0.0	0.0	0.2	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	8.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0
SLCO1B3	"OATP1B3, OATP8, SLC21A8"	ENSG00000111700	"Solute carrier organic anion transporter family member 1B3"	Q9NPD5	12	20810702-20916911	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	16	"liver: 265.1"	"Cell type enriched"	"Detected in some"	26	"Hepatocytes: 203.4"	"Cancer enriched"	"Detected in many"	4	"liver cancer: 5.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 65.3;A549: 17.5;CAPAN-2: 12.6;GAMG: 13.6;HeLa: 14.2;PC-3: 17.3;U-2 OS: 14.7"									"HPA004943, HPA050892"	Enhanced		Supported	"Plasma membrane"		NA	NA				"Cluster 62: Liver - Hemostasis"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 2: Hepatocytes - Metabolism"	"Plasma membrane"		"HPA004943: AB_1854758, HPA050892: AB_2681265"		"unprognostic (5.36e-2)"	"unprognostic (1.25e-1)"	"unprognostic (6.95e-2)"		"unprognostic (1.63e-2)"	"unprognostic (1.89e-2)"	"unprognostic (7.09e-2)"		"unprognostic (3.08e-2)"	"unprognostic (1.54e-2)"	"unprognostic (7.37e-2)"		"unprognostic (1.50e-1)"	"unprognostic (6.61e-3)"		"unprognostic (2.36e-3)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	13.0	16.2	0.3	0.2	0.1	0.4	0.3	0.0	0.3	0.0	0.5	0.0	0.0	265.1	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.8	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.1	1.2	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	65.3	17.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	12.6	0.0	4.3	0.0	13.6	0.1	0.0	0.5	0.0	0.0	0.0	0.0	14.2	0.0	0.0	0.0	0.0	0.0	0.5	0.0	2.9	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	14.7	0.0	1.3	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.5	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.1	1.5	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.2	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	203.4	0.0	0.0	0.5	0.0	0.0	1.6	0.0	7.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	1.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.1	0.0	0.2	0.2
SLCO4A1	"OATP-E, OATP4A1, SLC21A12"	ENSG00000101187	"Solute carrier organic anion transporter family member 4A1"	Q96BD0	20	62642503-62685785	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 57.2"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 61.8;Extravillous trophoblasts: 239.4;Melanocytes: 60.5"	"Cancer enhanced"	"Detected in all"		"colorectal cancer: 21.0"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"T-reg: 1.6"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"PC-3: 197.2;RPTEC TERT1: 193.9"	"Region enriched"	"Detected in some"	5	"cerebellum: 6.7"	"Low region specificity"	"Detected in some"			"HPA030669, HPA030670"	Uncertain		Supported	"Cell Junctions"		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 38: Extravillous trophoblasts - Unknown function"	"Cell Junctions"		"HPA030669: AB_10601163, HPA030670: AB_10670033"	"unprognostic (8.94e-2)"	"unprognostic (2.01e-1)"	"unprognostic (3.41e-1)"	"unprognostic (2.46e-3)"	"unprognostic (3.34e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.84e-3)"	"prognostic unfavorable (4.74e-4)"	"unprognostic (4.94e-2)"	"unprognostic (1.21e-2)"	"unprognostic (3.49e-3)"	"unprognostic (1.53e-1)"	"unprognostic (1.49e-1)"	"unprognostic (2.84e-3)"	"unprognostic (9.27e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.25e-1)"	32.4	5.6	26.2	1.8	24.0	1.3	23.4	24.2	35.7	11.1	19.6	9.8	1.2	8.7	0.3	16.7	13.1	1.8	48.6	23.9	25.4	35.8	5.0	57.2	2.4	26.5	24.8	6.5	4.9	3.8	2.9	4.7	28.0	5.9	1.8	21.5	8.5	1.0	18.8	25.6	9.2	0.8	25.7	6.6	13.5	2.1	31.6	1.1	8.6	5.6	3.2	12.0	16.8	24.9	14.8	19.1	0.8	10.8	2.5	2.1	26.5	4.7	16.6	14.1	5.4	32.0	14.9	17.8	44.2	0.5	9.6	22.0	16.4	1.0	5.4	2.1	9.6	21.7	22.1	23.8	0.1	16.6	6.7	0.0	6.5	0.3	6.2	4.2	2.5	10.7	17.1	4.6	0.0	14.8	17.2	63.9	5.4	74.1	197.2	30.6	1.1	26.2	193.9	14.2	17.4	25.1	4.1	4.4	15.7	6.5	1.0	7.5	2.8	0.4	10.5	7.0	27.2	9.2	15.9	11.1	38.1	24.0	2.6	0.0	0.0	0.0	0.0	0.1	0.0	0.8	0.1	0.0	0.9	0.7	0.2	0.1	0.0	0.0	0.0	0.0	1.6	0.2	26.2	24.0	24.2	35.7	23.9	25.4	26.5	24.8	28.0	25.7	31.6	24.9	61.8	3.2	1.3	1.3	13.1	27.3	1.4	19.8	1.2	14.1	1.2	0.8	4.4	1.5	5.9	25.8	31.3	2.1	3.7	7.5	0.0	5.9	0.3	8.7	3.6	40.3	0.0	2.1	7.9	2.5	239.4	4.3	20.9	35.6	0.0	0.0	14.6	0.6	5.5	0.0	6.6	8.4	2.0	9.7	33.5	0.7	0.3	11.9	60.5	3.7	0.0	6.1	0.0	1.5	0.3	11.8	1.9	0.7	19.1	3.5	0.8	9.6	1.3	43.2	0.0	1.9	2.9	0.2	3.0	1.1	16.1	23.5	5.6	0.1	7.5	11.0
SLCO5A1	"OATP-J, OATP5A1, OATPRP4, SLC21A15"	ENSG00000137571	"Solute carrier organic anion transporter family member 5A1"	Q9H2Y9	8	69667046-69834978	"Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 6.5;skeletal muscle: 7.6;tongue: 11.1"	"Group enriched"	"Detected in many"	4	"Bipolar cells: 10.1;Cardiomyocytes: 14.4;Enteroendocrine cells: 15.6;Excitatory neurons: 8.6;Inhibitory neurons: 30.1;monocytes: 21.2;Oligodendrocyte precursor cells: 26.2;Plasma cells: 14.3;Prostatic glandular cells: 11.8"	"Cancer enhanced"	"Detected in some"		"prostate cancer: 1.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HAP1: 5.5;NTERA-2: 3.7;RPMI-8226: 3.6;SCLC-21H: 3.9;U-266/70: 2.1"	"Group enriched"	"Detected in some"	7	"basal ganglia: 2.3;olfactory bulb: 6.7"	"Region enriched"	"Detected in some"	7	"olfactory bulb: 12.8"	HPA025062	Uncertain		Supported	"Vesicles,Plasma membrane"		NA	NA				"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Plasma membrane"	Vesicles	"HPA025062: AB_1857220"	"unprognostic (1.30e-3)"	"unprognostic (7.35e-3)"	"unprognostic (4.13e-2)"	"unprognostic (1.14e-2)"	"unprognostic (1.48e-1)"	"unprognostic (5.70e-2)"	"unprognostic (1.46e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.37e-4)"	"unprognostic (1.75e-1)"	"unprognostic (4.48e-4)"	"unprognostic (1.74e-2)"	"unprognostic (2.92e-6)"	"unprognostic (2.20e-1)"	"unprognostic (1.23e-1)"	"unprognostic (2.13e-1)"	"unprognostic (4.50e-2)"	0.1	0.0	0.3	0.9	0.4	0.9	0.1	0.0	0.4	0.2	0.0	0.2	0.2	0.2	0.0	0.5	0.3	0.2	3.7	0.2	0.6	0.0	0.0	0.1	1.0	0.2	0.0	0.0	0.4	0.0	1.5	0.0	0.2	2.3	0.4	0.7	0.3	0.0	7.6	0.1	0.3	0.1	0.0	0.5	0.2	0.3	0.1	6.5	0.0	11.1	0.9	0.6	0.0	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.5	0.0	0.0	1.5	1.8	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.7	3.7	0.0	0.6	0.6	0.6	3.6	0.0	0.0	3.9	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.7	2.1	0.3	0.0	0.2	0.0	1.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.0	0.4	0.2	0.6	0.2	0.0	0.2	0.0	0.1	0.1	0.1	3.2	0.0	3.6	3.6	0.3	1.8	0.0	0.6	10.1	0.2	0.3	14.4	0.0	0.6	0.0	2.1	0.0	0.0	0.6	0.0	1.8	0.6	0.4	1.7	2.0	15.6	0.0	8.6	1.3	0.0	4.0	0.0	1.7	0.0	0.0	0.0	0.2	0.1	1.7	30.1	2.0	0.0	0.0	3.6	0.6	0.0	0.7	0.0	3.7	21.2	0.5	0.0	26.2	2.2	2.1	0.1	0.0	14.3	11.8	0.0	0.1	0.0	0.3	0.0	3.4	2.0	1.1	2.6	0.4	0.4	0.0	0.1	0.4	1.5	1.5
SLF2	"C10orf6, FAM178A, FLJ10512, FLJ25012"	ENSG00000119906	"SMC5-SMC6 complex localization factor 2"	Q8IX21	10	100912963-100965134	"Predicted intracellular proteins, Predicted membrane proteins"	"DNA damage, DNA repair"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Leydig cells: 108.1;Peritubular cells: 105.7;Theca cells: 77.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RH-30: 145.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038499, HPA057568"	Approved		Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 68: Epididymis - Unknown function"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 52: Non-specific - Transcription"	"Nucleoplasm, Vesicles"		"HPA038499: AB_10672520, HPA057568: AB_2683471"	"unprognostic (9.05e-2)"	"unprognostic (1.18e-2)"	"unprognostic (3.89e-2)"	"unprognostic (4.54e-2)"	"unprognostic (1.13e-1)"	"unprognostic (6.19e-3)"	"unprognostic (2.16e-2)"	"unprognostic (7.87e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.30e-1)"	"unprognostic (2.66e-2)"	"unprognostic (1.54e-2)"	"unprognostic (1.16e-3)"	"unprognostic (2.85e-1)"	"unprognostic (4.90e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.41e-1)"	9.1	17.2	17.3	10.9	29.2	11.8	8.8	20.4	23.1	14.0	9.3	12.6	7.9	20.8	48.6	8.9	17.6	8.0	10.8	17.0	24.9	11.3	11.6	10.8	14.7	24.5	24.7	25.1	13.1	7.9	23.8	15.4	25.7	15.2	10.1	11.7	9.4	12.9	17.8	13.4	12.7	10.7	19.1	23.1	10.4	25.8	25.3	12.2	11.3	13.3	11.5	11.3	11.2	46.2	25.7	20.6	29.6	31.4	16.1	20.9	11.3	26.3	18.5	24.1	29.0	15.2	17.5	24.1	15.8	11.3	17.9	25.3	20.4	8.8	29.1	26.6	16.6	21.7	14.2	31.0	11.7	28.0	24.9	10.0	13.2	18.6	19.9	25.1	15.7	14.7	15.6	22.5	37.3	17.7	19.1	16.0	13.7	9.9	15.2	18.5	145.7	8.3	10.1	12.8	6.6	12.9	16.5	4.6	30.6	14.1	26.3	10.7	20.6	28.2	23.4	18.0	31.1	18.1	28.5	19.1	20.0	32.9	15.1	6.1	6.6	7.0	9.8	6.7	8.9	8.6	7.8	8.5	5.2	11.0	8.5	7.8	3.6	9.1	7.5	7.5	8.0	4.6	17.3	29.2	20.4	23.1	17.0	24.9	24.5	24.7	25.7	19.1	25.3	46.2	18.4	25.6	18.9	0.0	18.2	0.0	8.4	0.0	12.5	33.8	13.8	12.6	0.0	5.7	8.6	25.8	25.0	17.4	29.4	9.0	13.7	11.0	8.4	22.7	64.8	20.8	12.2	11.3	0.0	8.0	7.1	20.2	10.7	25.0	24.0	32.3	26.7	12.8	17.9	38.7	0.0	10.5	0.0	18.2	0.0	10.4	108.1	18.6	0.0	0.0	19.2	19.7	46.4	0.0	0.0	7.0	8.4	105.7	12.3	9.4	9.3	8.9	13.8	31.4	19.7	44.5	12.8	33.5	43.0	10.4	0.0	5.1	19.7	77.6	8.2	6.0
SLFN11	FLJ34922	ENSG00000172716	"Schlafen family member 11"	Q7Z7L1	17	35350305-35373701	"Predicted intracellular proteins"	"Antiviral defense, DNA damage, Immunity"	"Helicase, Hydrolase, RNA-binding, tRNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 70.6;dendritic cells: 39.9;Endothelial cells: 38.8;Langerhans cells: 53.0;Macrophages: 47.0;Smooth muscle cells: 38.8;T-cells: 37.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"MOLT-4: 118.2"					"Low region specificity"	"Detected in many"			"HPA023030, HPA062062"	Uncertain		Supported	Nucleoplasm,Cytosol		No	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 68: Epididymis - Unknown function"	"Cluster 14: REH - Unknown function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Nucleoplasm	Cytosol	"HPA023030: AB_1856613, HPA062062: AB_2684673"	"unprognostic (1.93e-2)"	"unprognostic (2.56e-1)"	"unprognostic (3.04e-2)"	"unprognostic (1.03e-2)"	"unprognostic (3.48e-3)"	"unprognostic (1.01e-1)"	"unprognostic (5.19e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.54e-1)"	"prognostic unfavorable (9.93e-10)"	"unprognostic (1.65e-1)"	"unprognostic (5.71e-3)"	"unprognostic (6.33e-2)"	"unprognostic (8.81e-3)"	31.7	8.2	5.6	20.0	6.1	12.8	17.1	6.4	5.2	21.1	8.2	10.2	6.2	12.1	42.2	8.4	20.6	18.3	20.0	6.0	8.0	6.4	6.8	37.7	21.2	9.5	6.3	23.1	5.4	6.1	6.5	10.5	9.7	9.1	11.1	1.4	11.8	12.3	7.3	5.2	13.9	19.1	7.6	23.3	9.0	2.7	11.0	22.9	24.1	19.0	20.9	17.9	12.6	9.4	29.3	25.6	0.1	0.0	25.4	72.0	0.4	35.3	25.2	59.9	103.9	0.0	0.0	0.2	0.6	46.4	18.8	13.9	78.8	0.0	72.1	16.6	94.2	63.0	0.3	0.0	33.0	82.4	0.1	29.5	0.9	66.5	0.2	0.0	99.4	46.8	0.1	0.3	10.1	0.0	118.2	66.4	0.6	0.0	0.1	98.9	73.3	0.2	0.7	13.8	0.2	0.1	0.0	13.0	0.1	0.0	20.7	58.6	52.1	16.3	0.4	61.9	53.7	2.3	1.0	0.2	12.2	70.3	36.0	0.5	18.2	2.1	6.1	27.6	8.4	4.6	3.8	5.5	14.0	1.5	2.8	4.1	1.4	3.1	18.2	19.4	6.3	8.7	5.6	6.1	6.4	5.2	6.0	8.0	9.5	6.3	9.7	7.6	11.0	9.4	70.6	0.0	5.2	0.3	19.5	7.5	1.1	1.1	5.7	0.4	6.7	2.8	9.2	1.5	2.7	1.8	0.0	1.4	39.9	0.1	0.0	0.0	1.4	5.9	16.0	38.8	0.0	9.9	0.3	0.6	0.5	29.2	6.6	2.2	3.8	0.3	15.0	0.4	32.8	0.0	2.6	0.1	0.0	36.5	53.0	1.7	10.2	47.0	12.4	17.8	17.2	0.3	3.1	0.0	0.1	0.1	1.2	3.0	24.7	1.3	0.1	0.2	13.3	0.1	6.6	7.9	38.8	0.0	0.2	1.9	8.5	0.8	37.3	7.7	0.1	0.7
SLIRP	"C14orf156, DC50"	ENSG00000119705	"SRA stem-loop interacting RNA binding protein"	Q9GZT3	14	77708071-77761104	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Repressor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 1099.6;Proximal tubular cells: 1027.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020291	Approved		Supported	Mitochondria		No	Yes		32000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"HPA020291: AB_1845563"	"unprognostic (9.28e-2)"	"unprognostic (4.88e-2)"	"unprognostic (1.87e-1)"	"unprognostic (3.62e-1)"	"unprognostic (1.34e-1)"	"prognostic unfavorable (4.88e-4)"	"unprognostic (1.18e-1)"	"unprognostic (8.23e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.14e-2)"	"unprognostic (1.92e-2)"	"unprognostic (1.35e-1)"	"unprognostic (9.95e-3)"	"unprognostic (1.52e-1)"	"unprognostic (2.39e-1)"	"unprognostic (3.60e-2)"	"unprognostic (1.37e-1)"	121.9	131.0	241.0	80.4	251.7	122.7	155.0	250.5	391.0	92.8	228.9	161.3	112.5	91.5	196.3	163.7	89.6	68.3	336.8	249.8	251.6	203.0	211.2	81.1	82.8	251.4	247.5	82.0	110.5	145.2	120.2	91.9	248.6	95.7	141.3	109.9	105.0	90.3	364.5	92.1	107.6	97.0	248.2	92.9	140.2	122.9	245.9	97.4	94.6	442.3	113.5	123.8	101.8	261.2	422.5	867.3	340.9	330.8	226.0	227.7	441.2	240.0	234.8	484.1	419.6	1187.1	387.1	314.2	238.9	284.7	295.6	415.7	645.4	508.0	647.3	166.5	717.2	316.3	816.1	1199.5	343.4	211.8	216.6	242.5	332.3	387.3	428.2	232.4	408.7	403.2	321.2	172.8	430.0	1442.6	325.3	562.2	525.1	938.0	1211.5	294.8	282.9	345.6	508.8	840.3	425.5	274.1	253.3	533.0	360.3	373.7	555.7	360.9	227.0	237.1	422.5	254.0	416.9	184.8	374.7	605.0	325.7	407.2	309.6	88.9	276.1	103.9	105.2	275.3	112.0	169.4	139.0	104.6	239.8	143.1	143.4	120.3	87.8	93.3	288.8	247.4	154.9	216.2	241.0	251.7	250.5	391.0	249.8	251.6	251.4	247.5	248.6	248.2	245.9	261.2	130.4	109.0	140.0	8.5	112.3	178.8	164.5	542.9	92.8	68.8	168.8	154.3	1099.6	270.2	303.9	264.8	47.9	393.0	82.7	330.9	770.9	405.1	548.5	163.7	141.9	169.0	246.8	203.2	10.8	530.1	382.3	166.0	119.3	123.7	171.5	73.1	179.2	793.4	313.6	43.7	9.6	373.1	388.6	202.8	119.5	123.0	168.0	135.2	250.8	2.8	211.4	206.4	93.7	8.5	16.7	440.6	334.4	170.0	136.9	190.5	563.3	1027.1	254.5	126.8	170.9	178.6	202.7	382.6	210.3	178.5	214.4	240.5	80.6	84.7	404.0	163.8
SLIT3	"MEGF5, SLIL2, Slit-3, SLIT1, slit2"	ENSG00000184347	"Slit guidance ligand 3"	O75094	5	168661733-169301139	"Predicted intracellular proteins, Predicted secreted proteins"	"Differentiation, Neurogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 202.3;Fibroblasts: 112.7;Sertoli cells: 85.5;Smooth muscle cells: 99.3"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 12.3"	"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in single"	8	"NK-cell: 1.2"	"Lineage enriched"	"Detected in single"	8	"NK-cells: 1.2"	"Cell line enhanced"	"Detected in many"		"ASC diff: 310.3;fHDF/TERT166: 116.0;RT4: 101.1;SH-SY5Y: 73.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051630	Approved		Supported	"Cell Junctions"	"Secreted in other tissues"	NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Cell Junctions"		"HPA051630: AB_2681557"	"unprognostic (2.86e-2)"	"unprognostic (2.64e-1)"	"unprognostic (4.43e-2)"	"unprognostic (2.92e-2)"	"unprognostic (2.50e-2)"	"unprognostic (3.53e-2)"	"unprognostic (9.21e-3)"	"unprognostic (3.06e-2)"	"unprognostic (1.71e-1)"	"unprognostic (9.50e-3)"	"unprognostic (1.57e-1)"	"unprognostic (2.08e-1)"	"prognostic unfavorable (2.45e-5)"	"unprognostic (5.90e-3)"	"unprognostic (8.56e-2)"	"unprognostic (4.27e-1)"	"unprognostic (3.53e-1)"	61.9	20.7	10.0	11.9	10.6	0.1	32.7	11.9	7.5	36.4	0.3	20.0	5.4	23.9	8.8	21.4	22.2	43.5	39.7	12.3	4.3	16.7	1.5	38.1	6.2	12.9	0.7	17.0	7.8	44.9	4.4	21.7	11.6	10.3	9.7	3.1	16.8	15.4	4.4	25.8	10.4	27.1	0.3	14.3	10.1	2.7	6.9	20.0	23.3	6.5	4.2	55.5	24.3	2.2	0.0	11.0	0.1	0.0	310.3	5.7	0.0	18.1	3.1	4.0	8.4	0.1	0.0	0.0	4.2	116.0	13.1	0.0	2.9	1.2	0.3	0.0	0.3	0.0	0.0	0.0	0.9	0.0	0.0	1.8	4.2	0.5	3.9	44.1	0.9	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.5	0.2	0.0	0.0	0.0	0.0	0.0	101.1	1.1	73.3	0.0	0.0	0.0	12.5	0.0	0.0	0.0	3.0	1.9	25.5	0.1	0.0	0.0	0.0	6.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.2	0.0	0.0	0.0	0.0	10.0	10.6	11.9	7.5	12.3	4.3	12.9	0.7	11.6	0.3	6.9	2.2	11.7	0.0	2.3	4.2	0.5	26.6	1.8	5.5	3.4	8.6	1.1	3.8	25.9	0.0	0.4	0.0	0.0	2.3	0.5	0.0	0.0	0.2	11.9	1.3	35.7	5.4	0.0	0.0	202.3	0.0	0.5	112.7	4.6	3.6	1.3	0.5	1.8	0.0	1.2	0.0	20.2	0.0	0.0	0.0	32.5	8.2	0.9	1.1	35.6	14.0	0.0	13.7	0.0	8.0	2.9	0.0	0.0	0.4	0.8	1.1	0.1	1.9	0.2	0.9	85.5	1.8	99.3	1.2	2.2	1.1	17.6	1.1	1.8	0.3	0.0	0.8
SLITRK6	FLJ22774	ENSG00000184564	"SLIT and NTRK like family member 6"	Q9H5Y7	13	85792790-85806683	"Disease related genes, Human disease related genes, Predicted membrane proteins"	"Hearing, Sensory transduction, Vision"		Deafness	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"salivary gland: 27.7;urinary bladder: 14.7"	"Cell type enhanced"	"Detected in some"		"Basal respiratory cells: 22.8;Bipolar cells: 41.7;Club cells: 27.4;Ionocytes: 16.2;Respiratory ciliated cells: 41.6"	"Cancer enhanced"	"Detected in many"		"breast cancer: 21.1;urothelial cancer: 18.5"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"hTCEpi: 28.8;OE19: 24.2;RT4: 101.4;WM-115: 23.7"	"Region enhanced"	"Detected in many"		"thalamus: 22.6"	"Low region specificity"	"Detected in many"			"HPA014491, HPA014513"	Uncertain		Supported	"Plasma membrane"		NA	NA		28000		"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 15: RT4 - Unknown function"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Plasma membrane"		"HPA014491: AB_10601603, HPA014513: AB_2669026"	"unprognostic (6.14e-2)"	"unprognostic (5.21e-3)"	"unprognostic (1.40e-1)"	"unprognostic (2.66e-2)"	"unprognostic (2.46e-2)"	"prognostic unfavorable (8.52e-4)"	"unprognostic (6.10e-2)"	"unprognostic (1.72e-2)"	"unprognostic (1.69e-1)"	"unprognostic (4.82e-2)"	"unprognostic (7.60e-2)"	"unprognostic (7.92e-2)"	"unprognostic (3.31e-5)"	"unprognostic (5.60e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.83e-1)"	"unprognostic (2.51e-2)"	0.1	0.2	1.0	0.9	4.4	0.0	3.2	2.2	1.9	1.2	0.1	5.5	3.5	1.0	2.5	1.9	0.5	1.4	1.5	0.2	2.0	0.1	0.9	3.3	0.0	0.6	2.3	0.0	0.2	0.0	0.1	0.9	0.9	7.6	6.8	4.8	27.7	2.2	0.0	5.6	5.7	0.4	0.3	0.1	1.5	0.3	5.7	0.2	0.3	0.1	0.1	14.7	1.4	0.4	0.0	2.9	0.1	0.5	0.0	0.0	0.0	2.8	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	4.9	0.0	0.0	0.0	0.0	0.7	0.0	0.7	0.0	0.0	0.0	28.8	0.0	3.3	2.7	0.0	0.0	0.0	0.1	0.0	3.3	0.0	0.0	0.0	24.2	1.9	0.2	0.0	0.0	0.0	101.4	1.0	1.2	0.5	0.1	0.1	1.7	0.5	0.0	0.0	0.3	1.0	0.0	0.1	0.0	0.0	0.0	0.9	0.0	23.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	4.4	2.2	1.9	0.2	2.0	0.6	2.3	0.9	0.3	5.7	0.4	0.1	0.0	1.8	0.0	0.0	3.8	5.0	22.8	0.0	41.7	5.3	1.5	0.4	0.0	27.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	1.2	4.3	0.3	0.0	0.0	0.1	0.0	0.0	2.0	0.0	2.7	0.0	2.2	2.2	0.0	0.2	0.0	0.4	1.7	16.2	0.0	0.6	0.0	9.6	0.1	0.0	1.0	0.0	0.6	0.0	0.0	0.0	1.8	0.0	0.4	0.0	1.5	0.0	0.1	41.6	2.0	0.0	0.0	0.8	0.0	0.1	3.8	2.4	0.0	0.2	0.1	0.5	4.5
SLU7	9G8	ENSG00000164609	"SLU7 homolog, splicing factor"	O95391	5	160401641-160421711	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035907, HPA058120"	Uncertain		Supported	"Nucleoplasm,Nuclear speckles"		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 6: Brain - Smell perception"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm	"Nuclear speckles"	"HPA035907: AB_10671717, HPA058120: AB_2683612"	"unprognostic (3.70e-2)"	"unprognostic (7.18e-2)"	"unprognostic (1.86e-2)"	"unprognostic (9.96e-3)"	"unprognostic (8.01e-2)"	"unprognostic (3.52e-1)"	"unprognostic (3.38e-3)"	"unprognostic (3.76e-2)"	"unprognostic (2.22e-2)"	"unprognostic (2.42e-1)"	"unprognostic (1.93e-1)"	"unprognostic (7.69e-2)"	"prognostic favorable (1.98e-4)"	"unprognostic (2.65e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.25e-1)"	22.1	23.2	26.2	19.5	27.2	48.6	27.4	27.7	46.6	21.1	22.3	20.8	17.0	19.9	25.9	21.9	18.0	18.7	25.8	28.3	26.7	24.4	24.4	23.3	27.3	25.6	27.2	21.3	16.4	24.6	10.9	21.1	26.0	21.2	20.9	29.4	24.7	19.7	32.6	22.6	21.5	18.2	24.6	27.9	23.4	27.2	26.6	30.4	32.2	33.0	31.3	21.5	12.1	28.9	24.5	29.6	26.0	36.2	33.4	35.1	33.1	33.9	49.3	35.9	43.8	40.1	29.1	39.5	34.2	36.6	36.9	27.0	22.9	37.7	45.2	65.1	33.0	29.4	39.0	26.2	33.7	49.8	34.9	38.1	34.3	33.8	38.1	37.7	25.7	35.3	26.7	36.0	33.2	21.5	24.7	32.1	18.6	25.2	26.5	21.4	53.4	40.4	31.6	37.8	30.9	42.7	40.1	35.6	62.2	21.6	47.7	46.4	32.7	34.5	18.2	26.1	36.3	40.1	48.8	34.9	51.2	33.1	33.4	49.9	22.2	39.2	26.7	24.9	25.5	30.0	25.2	27.2	20.2	26.1	27.2	26.7	54.2	33.9	36.5	21.6	29.4	22.8	26.2	27.2	27.7	46.6	28.3	26.7	25.6	27.2	26.0	24.6	26.6	28.9	42.7	67.3	67.8	9.8	53.7	44.7	39.9	55.5	24.5	70.2	25.7	26.3	71.4	24.3	57.1	25.8	25.0	38.1	70.9	34.1	50.9	52.2	126.2	43.0	41.6	44.1	39.5	68.8	19.8	55.8	39.7	43.0	17.9	51.3	46.3	34.7	35.3	24.6	38.4	57.2	18.3	34.7	54.9	47.3	57.3	34.3	47.8	46.9	65.8	20.6	65.8	61.6	64.9	9.0	15.2	50.5	45.3	47.4	33.1	40.0	39.8	39.5	62.0	49.4	46.0	49.6	50.1	88.9	54.6	27.4	41.5	94.1	52.0	41.9	27.8	52.5
SLX4	"BTBD12, FANCP, KIAA1784, KIAA1987"	ENSG00000188827	"SLX4 structure-specific endonuclease subunit"	Q8IY92	16	3581181-3611606	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"DNA damage, DNA recombination, DNA repair"		"Fanconi anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 10.6"	"Cell type enhanced"	"Detected in many"		"Spermatocytes: 20.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049421, HPA066238"	Approved		Supported	"Nucleoplasm,Cell Junctions,Cytosol"		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	"Cell Junctions, Cytosol"	"HPA049421: AB_2680759, HPA066238: AB_2685642"	"unprognostic (1.04e-1)"	"unprognostic (1.23e-1)"	"unprognostic (4.06e-2)"	"unprognostic (2.65e-2)"	"unprognostic (4.62e-1)"	"unprognostic (6.08e-3)"	"unprognostic (8.28e-5)"	"unprognostic (6.52e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.97e-2)"	"unprognostic (1.50e-1)"	"unprognostic (4.32e-2)"	"unprognostic (8.39e-3)"	"unprognostic (1.20e-1)"	"unprognostic (1.43e-3)"	"unprognostic (5.74e-2)"	1.8	2.1	2.1	2.9	1.9	3.0	1.6	7.1	2.7	2.1	0.4	2.3	2.2	2.1	1.3	2.4	2.0	1.1	1.9	2.3	2.1	1.9	1.9	2.1	4.1	2.3	2.0	1.6	1.7	1.1	3.9	1.1	1.8	2.3	0.9	1.7	1.6	1.0	2.7	1.8	2.8	1.2	1.1	3.4	2.2	10.6	1.9	2.7	1.8	1.3	2.9	2.1	2.0	2.1	2.7	8.4	5.3	6.7	2.0	2.1	5.6	4.3	2.2	4.9	5.4	4.2	3.3	10.0	4.2	2.2	3.8	6.0	3.6	3.0	2.9	8.4	4.6	6.8	6.5	2.7	1.8	6.7	9.3	1.5	2.2	4.6	2.6	1.2	3.6	5.6	6.7	5.3	3.9	4.7	4.2	5.9	4.5	1.7	3.1	8.2	8.9	2.8	1.9	1.9	4.5	4.1	3.8	2.6	1.3	2.8	6.5	5.2	4.3	5.6	7.8	4.9	5.1	4.8	4.0	11.4	1.8	6.7	5.7	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.1	2.1	1.9	7.1	2.7	2.3	2.1	2.3	2.0	1.8	1.1	1.9	2.1	2.7	0.0	2.3	4.6	4.5	0.8	0.8	1.1	4.0	8.7	2.0	1.4	1.7	1.5	3.2	0.0	2.1	1.7	3.4	2.0	0.0	1.5	6.5	5.5	4.2	1.8	0.0	6.5	9.5	2.4	1.6	2.4	3.6	4.6	0.0	4.8	1.1	1.4	2.9	0.0	9.3	2.4	2.0	2.9	1.6	2.3	2.1	5.1	0.0	4.7	2.2	2.7	4.1	7.1	5.5	2.0	0.3	1.9	4.0	0.4	2.3	0.6	2.3	10.1	0.0	4.9	2.5	20.0	9.1	2.3	0.6	1.0	4.4	3.0	2.1	0.6
SMAD1	"JV4-1, MADH1, MADR1"	ENSG00000170365	"SMAD family member 1"	Q15797	4	145481194-145559176	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 195.9;Endothelial cells: 76.3;Late spermatids: 80.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 46.2;non-classical monocyte: 22.2"	"Group enriched"	"Detected in many"	5	"granulocytes: 46.2;monocytes: 22.2"	"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 110.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB005389	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Nucleoplasm, Cytosol"		"CAB005389: AB_656608"	"unprognostic (8.20e-2)"	"unprognostic (1.63e-1)"	"unprognostic (2.76e-2)"	"unprognostic (1.11e-1)"	"unprognostic (3.74e-1)"	"unprognostic (6.85e-2)"	"unprognostic (1.70e-1)"	"unprognostic (6.02e-2)"	"unprognostic (2.30e-1)"	"unprognostic (8.24e-2)"	"unprognostic (5.31e-2)"	"unprognostic (4.68e-2)"	"unprognostic (1.73e-3)"	"unprognostic (1.48e-1)"	"unprognostic (5.88e-2)"	"unprognostic (1.14e-3)"	"unprognostic (3.15e-2)"	19.6	5.3	16.7	10.9	21.9	5.8	15.9	15.3	18.2	20.4	6.9	20.4	15.4	29.0	32.7	16.3	24.4	17.1	13.1	13.2	16.6	12.6	20.2	12.3	17.6	14.6	18.3	11.7	13.3	29.1	6.0	11.4	14.5	12.5	20.8	6.5	12.9	17.2	20.7	24.4	15.7	30.4	13.6	14.0	10.6	13.9	16.4	18.3	17.4	17.8	13.7	17.9	8.9	13.6	9.6	12.6	23.5	27.3	8.7	12.8	11.5	13.9	32.6	22.0	16.4	6.2	34.0	9.8	8.0	31.8	9.7	14.1	26.6	30.2	12.8	0.0	13.5	0.0	10.0	13.1	23.2	15.8	2.4	17.6	35.2	11.8	22.9	17.9	110.7	20.7	11.1	0.4	27.0	9.6	24.4	0.3	21.8	15.3	14.6	47.0	21.1	28.5	25.9	17.1	35.3	17.6	18.8	40.3	9.6	14.1	14.0	0.2	32.4	10.5	14.5	11.3	8.6	31.1	0.0	56.1	16.7	0.3	11.1	46.2	3.6	1.5	0.0	9.4	0.0	0.0	0.6	0.0	6.8	0.1	0.3	0.0	0.0	2.4	22.2	0.0	1.3	1.3	16.7	21.9	15.3	18.2	13.2	16.6	14.6	18.3	14.5	13.6	16.4	13.6	62.9	9.6	10.9	54.9	0.1	11.5	17.5	22.0	45.5	6.6	8.6	9.3	3.6	12.8	16.3	14.7	14.6	5.2	0.8	13.2	7.9	12.6	195.9	19.5	12.1	76.3	9.1	8.4	47.7	18.5	2.7	11.5	12.2	24.8	0.0	10.0	10.4	12.0	2.5	10.1	43.2	10.4	28.5	6.5	2.7	80.7	4.4	4.5	1.8	26.2	3.2	5.3	0.0	66.9	22.0	12.0	10.2	5.7	0.3	17.5	6.6	11.5	12.7	5.9	0.0	19.0	10.6	8.3	16.8	19.9	12.6	2.2	1.2	6.9	8.8	17.2
SMAD2	"JV18-1, MADH2, MADR2"	ENSG00000175387	"SMAD family member 2"	Q15796	18	47808957-47931146	"Cancer-related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB025507, HPA067203, CAB073546"	Approved		Supported	Nucleoplasm,Nucleoli,Cytosol		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 34: Non-specific - Transcription"	"Cluster 20: HeLa - Mitochondria"	"Cluster 9: Photoreceptor cells - Phototransduction"	"Nucleoplasm, Nucleoli, Cytosol"		"CAB025507: , CAB073546: , HPA067203: AB_2685803"	"unprognostic (1.55e-1)"	"unprognostic (2.49e-1)"	"unprognostic (1.43e-2)"	"unprognostic (9.82e-3)"	"unprognostic (9.88e-2)"	"unprognostic (1.06e-1)"	"prognostic unfavorable (9.44e-5)"	"unprognostic (1.91e-2)"	"unprognostic (7.59e-2)"	"unprognostic (1.41e-3)"	"unprognostic (6.46e-2)"	"unprognostic (4.91e-2)"	"unprognostic (9.20e-3)"	"unprognostic (2.68e-1)"	"unprognostic (6.13e-2)"	"unprognostic (3.20e-2)"	"unprognostic (6.28e-2)"	48.6	52.6	38.0	38.6	42.4	37.5	46.5	46.2	36.7	43.2	35.6	47.5	36.7	38.6	41.0	55.0	46.8	39.6	53.8	32.9	48.6	43.3	35.6	46.7	44.5	50.2	43.2	52.5	40.4	44.6	20.3	42.7	51.9	36.4	48.7	70.5	36.7	44.8	57.4	34.0	37.4	47.9	47.8	47.5	45.2	51.5	42.4	72.4	75.7	55.5	55.2	53.8	31.1	59.4	81.1	113.7	68.0	66.2	106.1	128.5	77.4	86.1	102.7	87.9	101.8	43.8	75.6	124.8	60.3	110.0	123.0	86.6	77.2	96.1	116.9	136.4	39.3	106.4	164.4	71.9	123.2	149.6	104.1	95.8	121.4	75.5	172.9	102.1	98.6	99.7	50.3	101.6	109.6	52.7	103.4	71.6	33.6	4.4	26.7	74.4	98.9	85.9	197.8	137.2	62.8	73.3	103.7	70.1	85.7	65.8	53.5	97.7	111.4	129.5	74.2	35.6	63.6	99.0	102.7	108.3	89.6	99.9	97.1	58.8	33.6	38.7	23.8	38.5	29.8	16.7	32.3	29.9	32.8	13.9	35.3	27.6	34.1	38.6	33.0	23.3	40.5	31.6	38.0	42.4	46.2	36.7	32.9	48.6	50.2	43.2	51.9	47.8	42.4	59.4	55.0	44.8	36.1	55.8	36.3	54.4	44.1	38.3	54.1	48.0	44.2	30.2	49.2	41.5	45.5	77.3	212.7	48.2	53.0	42.8	39.2	36.5	68.1	58.6	53.0	53.1	51.0	36.4	63.4	43.5	40.3	40.5	44.4	68.1	21.5	80.0	56.4	29.6	43.9	35.3	50.5	46.1	38.7	57.3	41.8	131.9	41.7	48.7	51.6	104.9	63.9	44.8	72.1	96.0	130.0	44.0	31.6	53.4	34.5	66.1	37.9	39.5	41.8	88.1	32.9	53.5	39.6	37.2	39.4	59.2	61.8	69.5	47.4	41.7	42.3	77.2
SMAD3	"HsT17436, JV15-2, MADH3"	ENSG00000166949	"SMAD family member 3"	P84022	15	67063763-67195173	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Host-virus interaction, Transcription, Transcription regulation"	DNA-binding	"Aortic aneurysm, Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Granulosa cells: 162.5;Prostatic glandular cells: 149.3;Urothelial cells: 276.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB008094, HPA046386, HPA067203, CAB069409"	Approved		Supported	Nucleoplasm,Cytosol		NA	Yes			"Cluster 52: Eosinophils - Transcription"	"Cluster 59: Non-specific - Translation"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 22: Epithelial cell types - Mixed function"	Nucleoplasm	Cytosol	"CAB008094: AB_2302271, CAB069409: AB_1622941, HPA046386: AB_2679647, HPA067203: AB_2685803"	"unprognostic (1.04e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.99e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.98e-2)"	"unprognostic (8.40e-3)"	"unprognostic (1.80e-2)"	"unprognostic (7.62e-2)"	"unprognostic (6.82e-2)"	"prognostic unfavorable (2.48e-4)"	"unprognostic (2.93e-1)"	"unprognostic (2.14e-2)"	"unprognostic (3.10e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.15e-1)"	"unprognostic (5.97e-2)"	30.0	6.3	17.9	15.8	22.4	18.8	22.2	6.8	16.1	32.2	31.5	15.4	17.7	20.3	13.6	51.9	23.3	21.2	28.1	16.1	9.3	35.7	19.8	21.4	16.8	17.0	9.0	30.7	18.2	10.5	14.5	16.8	9.3	24.4	12.9	6.2	17.2	13.8	55.0	29.1	21.6	21.1	10.9	15.4	22.2	3.9	12.9	19.6	30.2	39.0	25.7	43.6	31.5	8.5	49.3	157.0	30.6	13.9	50.8	115.9	22.5	27.6	114.0	37.8	30.7	33.7	125.3	16.5	36.6	79.4	169.8	111.3	31.2	116.9	38.1	13.1	11.9	1.8	43.4	26.2	38.2	6.6	2.7	106.5	26.7	33.2	27.7	83.2	128.2	5.2	40.3	40.8	47.1	24.2	1.5	26.0	17.7	26.1	50.5	1.6	9.1	5.9	25.2	149.4	0.8	10.3	36.6	19.5	32.5	59.2	5.3	30.2	109.4	50.4	47.1	36.5	31.7	16.5	5.0	21.0	45.8	7.0	45.9	0.0	1.0	2.3	3.2	0.9	3.3	1.2	3.6	3.4	1.0	2.8	1.6	1.4	0.0	0.3	0.9	1.5	1.9	1.1	17.9	22.4	6.8	16.1	16.1	9.3	17.0	9.0	9.3	10.9	12.9	8.5	18.2	48.1	19.9	28.4	33.9	89.0	90.2	70.6	53.5	10.8	13.3	10.5	12.2	17.2	49.6	36.8	6.2	1.1	19.7	48.2	3.9	61.9	1.0	23.6	30.2	26.6	3.5	9.1	63.2	50.7	4.2	42.6	28.5	75.2	24.1	162.5	11.4	12.6	10.7	0.0	6.9	13.0	24.4	6.2	40.8	5.7	26.8	18.8	21.4	67.5	9.7	8.5	20.6	140.2	1.3	99.7	49.2	20.7	10.6	149.3	34.2	14.0	52.2	0.6	26.3	28.9	27.5	0.6	2.3	70.3	48.9	1.6	21.6	18.8	16.6	276.2
SMAD4	"DPC4, MADH4"	ENSG00000141646	"SMAD family member 4"	Q13485	18	51028394-51085045	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Granulosa cells: 132.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019154	Approved		Supported	Nucleoplasm,Centrosome,Cytosol		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 52: Non-specific - Ribosome"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 40: Granulosa cells - Unknown function"	"Nucleoplasm, Cytosol"	Centrosome	"HPA019154: AB_1853480"	"unprognostic (1.58e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.25e-2)"	"unprognostic (4.83e-2)"	"unprognostic (1.17e-2)"	"unprognostic (4.05e-1)"	"unprognostic (7.29e-3)"	"unprognostic (9.00e-2)"	"unprognostic (4.01e-2)"	"unprognostic (2.51e-2)"	"unprognostic (1.03e-3)"	"unprognostic (4.40e-2)"	"prognostic favorable (1.92e-5)"	"unprognostic (2.62e-2)"	"unprognostic (4.23e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.44e-1)"	16.4	11.8	9.0	10.9	10.3	10.6	17.2	21.7	10.5	18.5	11.2	14.9	11.9	20.6	9.8	15.7	16.3	12.8	14.1	11.7	10.0	16.1	19.1	13.1	12.7	9.0	8.2	24.0	21.4	19.9	11.3	18.9	9.4	21.8	14.3	18.3	14.0	18.0	24.9	14.6	12.1	18.9	8.0	13.9	15.2	14.2	11.9	17.7	21.4	24.9	14.5	13.5	13.1	13.8	16.4	22.5	59.4	16.6	23.9	36.6	31.4	27.7	32.2	39.4	49.6	13.0	3.8	25.9	7.8	25.6	19.6	24.9	33.6	13.2	40.7	19.3	14.8	20.6	20.5	15.9	23.7	34.8	13.1	16.6	21.9	19.1	27.8	37.0	28.7	14.0	21.9	25.8	23.5	9.0	18.8	10.0	31.2	9.1	14.3	23.3	30.6	26.9	18.2	7.4	34.4	20.3	27.0	5.0	18.8	24.8	13.3	19.4	20.0	34.5	13.3	8.8	19.7	30.6	28.6	26.2	21.2	12.8	22.6	0.3	0.6	0.6	1.0	0.4	1.1	0.7	1.0	0.8	1.2	0.9	1.2	1.5	1.0	1.0	0.4	1.0	1.4	0.5	9.0	10.3	21.7	10.5	11.7	10.0	9.0	8.2	9.4	8.0	11.9	13.8	32.5	22.4	29.1	55.2	21.0	25.6	20.9	15.1	18.8	17.1	27.3	20.4	38.8	24.3	19.3	22.0	20.9	20.7	24.0	22.7	11.7	16.9	10.6	30.4	36.6	26.2	39.6	12.4	37.0	12.5	20.6	30.3	28.5	35.2	4.5	132.4	28.5	44.1	15.1	15.2	39.0	32.1	16.2	28.5	20.9	16.2	33.2	21.1	28.4	49.6	16.9	20.4	17.5	41.2	72.5	20.1	21.0	30.5	24.8	36.3	26.7	22.6	22.4	20.0	26.3	32.2	34.2	17.2	18.8	20.9	27.3	12.6	20.1	22.1	24.5	29.7
SMAD5	"Dwfc, JV5-1, MADH5"	ENSG00000113658	"SMAD family member 5"	Q99717	5	136132845-136188747	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 91.6"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 91.6"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA058931	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 21: Non-specific - Transcription"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 48: Smooth muscle cells - ECM organization"	Nucleoplasm	Cytosol	"HPA058931: AB_2683856"	"unprognostic (6.04e-2)"	"unprognostic (4.16e-2)"	"unprognostic (9.99e-3)"	"unprognostic (3.23e-1)"	"unprognostic (5.98e-2)"	"unprognostic (3.40e-1)"	"unprognostic (1.87e-2)"	"unprognostic (9.49e-2)"	"unprognostic (4.23e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.27e-1)"	"unprognostic (3.79e-2)"	"unprognostic (4.69e-2)"	"unprognostic (1.40e-3)"	"unprognostic (3.22e-1)"	"unprognostic (5.95e-2)"	"unprognostic (2.15e-1)"	18.0	13.7	11.0	10.9	17.4	10.1	17.6	33.9	15.4	18.5	10.4	14.1	12.8	25.7	14.4	16.8	16.5	14.2	15.0	7.9	14.5	15.4	20.4	13.0	11.6	13.1	13.9	29.8	13.3	21.2	7.3	24.9	12.6	17.4	16.8	15.7	13.2	16.4	14.9	27.3	11.8	20.1	13.0	14.9	14.2	11.7	15.1	11.3	17.3	21.6	13.5	14.3	15.5	18.7	36.1	30.0	35.3	31.4	37.3	57.2	37.4	48.2	34.0	32.7	48.3	134.1	25.4	39.1	39.8	38.1	33.5	32.0	42.0	56.0	51.9	16.8	26.6	25.7	32.8	24.4	31.0	15.9	26.9	43.2	32.6	50.8	34.2	32.9	40.2	19.3	25.6	26.1	35.0	14.1	13.2	16.2	21.1	12.5	14.8	27.2	68.2	23.1	18.9	37.2	31.8	33.1	42.3	11.0	41.2	42.3	24.6	19.2	46.3	48.1	30.0	35.5	48.5	29.8	37.9	48.3	31.0	19.9	37.6	91.6	12.8	29.3	14.4	8.4	11.2	14.2	8.4	9.7	13.3	14.8	2.6	8.6	2.1	20.8	10.1	15.5	2.6	5.8	11.0	17.4	33.9	15.4	7.9	14.5	13.1	13.9	12.6	13.0	15.1	18.7	95.8	41.7	32.4	34.3	24.1	46.4	38.6	31.1	79.6	29.2	36.1	46.9	38.3	42.9	36.3	31.3	20.9	19.8	25.8	19.7	23.5	24.5	25.7	32.7	80.9	57.5	99.8	17.2	27.2	26.6	12.1	63.9	41.8	38.5	8.8	62.1	53.9	61.3	14.0	52.2	36.3	36.6	22.4	33.7	21.7	24.1	70.8	21.6	21.4	52.5	20.2	50.1	25.7	45.2	57.1	31.5	21.7	72.6	40.5	48.1	10.3	43.9	32.2	27.7	46.0	87.4	58.2	23.3	23.6	66.4	50.6	11.8	18.2	68.7	30.6	35.9
SMAD6	"HsT17432, MADH6, MADH7"	ENSG00000137834	"SMAD family member 6"	O43541	15	66702236-66782849	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding	"Craniosynostosis, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 30.1;lung: 27.9"	"Cell type enhanced"	"Detected in many"		"Endothelial cells: 25.1;Hepatic stellate cells: 91.4;Microglial cells: 57.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"EFO-21: 29.8;HaCaT: 18.2;HeLa: 28.6;U-2197: 17.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA061917			Supported	"Nucleoplasm,Nuclear bodies,Golgi apparatus"		NA	NA				"Cluster 46: Fibroblasts - ECM organization"	"Cluster 20: HeLa - Mitochondria"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Nucleoplasm	"Nuclear bodies, Golgi apparatus"	"HPA061917: AB_2684637"	"unprognostic (1.20e-1)"	"unprognostic (7.43e-3)"	"unprognostic (5.62e-2)"	"unprognostic (1.26e-1)"	"unprognostic (3.02e-1)"	"unprognostic (3.50e-3)"	"unprognostic (9.59e-2)"	"unprognostic (4.50e-1)"	"unprognostic (3.47e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.10e-3)"	"unprognostic (1.68e-1)"	"unprognostic (1.67e-2)"	"unprognostic (1.55e-3)"	"unprognostic (4.30e-2)"	"unprognostic (1.33e-1)"	"prognostic favorable (5.45e-5)"	9.5	2.6	5.2	1.6	4.9	0.1	7.6	4.9	4.3	6.8	8.6	3.7	1.9	6.2	0.6	2.1	5.4	1.4	30.1	3.4	4.1	8.9	6.7	27.9	0.5	7.6	5.4	5.9	2.7	1.1	3.4	7.4	5.8	7.0	1.1	0.9	2.1	3.5	1.6	2.4	3.9	0.9	4.4	2.6	5.5	1.8	6.8	0.4	15.5	1.5	0.2	8.0	5.7	4.6	1.3	10.2	1.6	3.5	6.0	1.6	9.4	7.2	0.1	1.1	0.1	2.0	4.6	0.7	29.8	6.1	0.9	18.2	2.2	0.0	0.2	2.3	8.4	16.1	28.6	1.7	0.7	0.1	1.2	2.0	0.0	0.1	0.0	3.4	1.3	5.1	1.4	1.0	0.5	2.0	0.1	4.4	3.0	10.5	3.8	0.0	1.8	2.2	3.4	8.1	3.6	1.6	3.9	4.3	0.8	5.9	1.4	2.9	6.2	4.3	5.5	17.6	1.4	0.5	1.8	0.3	3.1	5.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.2	4.9	4.9	4.3	3.4	4.1	7.6	5.4	5.8	4.4	6.8	4.6	19.8	12.8	6.0	5.2	0.9	0.8	1.2	2.1	0.6	0.6	0.9	1.1	4.9	4.3	3.0	1.8	2.1	0.8	0.1	4.3	3.9	4.7	3.4	8.3	5.5	25.1	0.0	0.0	0.3	5.8	0.9	4.9	5.1	6.5	4.5	5.9	91.4	4.0	1.7	0.0	0.3	2.1	0.0	10.0	0.3	1.4	2.8	1.2	0.0	57.1	0.7	10.2	0.0	0.5	0.4	8.4	1.5	8.2	0.0	1.3	2.1	1.9	0.1	0.6	0.0	0.9	1.5	0.2	3.2	0.4	0.1	0.8	0.4	0.1	5.5	0.4
SMAD7	"MADH7, MADH8"	ENSG00000101665	"SMAD family member 7"	O15105	18	48919853-48952052	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 54.5;Distal enterocytes: 56.6;Hepatic stellate cells: 71.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"basophil: 4.1;eosinophil: 5.6"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 38.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB026212, HPA028897"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 24: Non-specific - Transcription regulation"	"Nucleoplasm, Cytosol"		"CAB026212: , HPA028897: AB_10600811"	"unprognostic (1.63e-1)"	"unprognostic (3.72e-2)"	"unprognostic (1.02e-1)"	"prognostic unfavorable (5.61e-4)"	"unprognostic (8.15e-2)"	"unprognostic (5.35e-1)"	"unprognostic (2.76e-1)"	"unprognostic (6.02e-2)"	"unprognostic (2.37e-1)"	"unprognostic (1.87e-2)"	"unprognostic (2.70e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.91e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.50e-2)"	"unprognostic (4.44e-1)"	17.9	5.9	7.1	8.6	7.3	17.8	14.5	12.0	7.3	17.4	9.6	12.7	10.3	11.2	2.9	4.8	8.2	10.2	46.1	5.4	5.1	11.6	8.6	21.9	5.8	10.9	8.7	7.5	5.3	12.3	6.6	18.9	8.5	11.3	11.9	3.2	6.3	8.6	10.7	8.3	15.0	9.3	10.0	5.9	12.5	1.3	7.9	3.7	16.6	6.7	5.2	13.3	12.2	8.4	3.7	2.8	2.8	8.3	14.3	5.0	21.1	18.6	7.1	6.5	3.1	1.0	5.3	0.3	32.2	13.1	6.0	19.2	6.1	5.8	3.6	38.4	9.4	0.3	10.5	6.9	2.1	6.9	18.6	5.1	4.8	7.8	7.8	32.2	1.1	0.6	6.6	25.9	9.1	1.2	0.0	1.9	17.3	27.7	1.1	2.1	2.5	9.0	9.1	4.2	4.8	10.3	8.0	3.5	6.6	21.2	3.3	5.6	17.3	18.5	9.9	5.3	16.5	13.4	7.1	2.0	8.1	4.9	3.1	4.1	0.1	5.6	0.8	0.5	0.6	0.1	0.8	0.7	0.1	0.0	0.2	0.5	0.0	1.7	0.1	0.0	1.2	0.2	7.1	7.3	12.0	7.3	5.4	5.1	10.9	8.7	8.5	10.0	7.9	8.4	30.4	54.5	9.4	3.9	7.0	12.9	3.5	7.2	14.2	6.1	14.7	10.3	9.7	1.5	11.2	11.0	6.2	9.9	43.7	56.6	9.8	14.4	0.2	43.2	30.5	25.0	12.7	0.0	6.5	13.9	3.3	15.5	8.2	45.9	18.9	4.0	71.4	3.1	8.9	0.0	5.0	19.1	2.0	23.3	8.9	1.1	1.5	14.7	0.0	19.7	8.2	1.4	11.3	5.5	16.3	31.5	17.3	3.4	13.8	3.0	28.7	7.1	3.3	2.5	6.6	11.3	14.1	0.1	0.6	14.2	11.8	12.9	25.2	1.3	12.4	2.6
SMAD9	"MADH6, MADH9, SMAD8, SMAD8/9"	ENSG00000120693	"SMAD family member 9"	O15198	13	36844831-36920765	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"thyroid gland: 38.7"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 48.0;Enteroendocrine cells: 51.6;Glandular and luminal cells: 73.4;Hepatic stellate cells: 43.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 12.9;HEK 293: 12.3;SH-SY5Y: 40.2"					"Low region specificity"	"Detected in all"			"CAB009119, HPA031162"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA				"Cluster 21: Non-specific - Transcription"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm	Cytosol	"CAB009119: AB_2286517, HPA031162: AB_2673767"	"unprognostic (2.88e-1)"	"unprognostic (1.38e-1)"	"unprognostic (9.68e-3)"	"unprognostic (3.50e-3)"	"prognostic favorable (5.99e-4)"	"unprognostic (1.30e-1)"	"unprognostic (1.34e-1)"	"unprognostic (3.71e-3)"	"unprognostic (4.23e-2)"	"unprognostic (6.62e-2)"	"unprognostic (4.07e-3)"	"unprognostic (3.74e-2)"	"unprognostic (9.70e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.16e-1)"	"prognostic unfavorable (4.92e-4)"	"unprognostic (2.47e-2)"	4.0	2.6	10.7	2.8	7.8	0.1	1.6	10.7	6.8	4.8	1.2	5.1	2.3	8.9	9.8	4.2	4.3	7.0	5.6	10.3	16.3	3.2	0.9	4.9	2.2	17.2	10.9	9.2	0.9	2.4	1.9	6.5	16.9	13.9	5.3	7.0	21.0	11.2	3.0	1.5	2.5	6.7	15.5	0.9	3.7	2.3	9.6	0.5	38.7	5.1	2.9	3.3	2.1	21.3	0.0	0.1	0.8	8.6	2.6	1.1	0.3	10.5	1.1	2.7	1.7	0.0	0.2	0.2	7.2	12.9	0.9	0.4	9.3	0.2	2.8	0.3	12.3	0.0	4.4	6.6	2.4	0.8	0.1	4.4	0.8	0.0	0.0	5.7	5.3	1.1	0.1	0.0	6.0	0.6	0.1	0.8	1.2	0.3	1.1	0.2	9.2	0.0	0.0	1.5	7.6	40.2	1.9	0.2	0.5	2.3	0.6	0.4	9.6	4.0	3.5	2.4	2.6	0.1	0.0	0.1	2.8	0.3	0.6	0.1	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.2	0.0	0.0	10.7	7.8	10.7	6.8	10.3	16.3	17.2	10.9	16.9	15.5	9.6	21.3	22.5	28.9	11.5	48.0	0.4	2.8	4.3	1.8	1.8	13.1	2.5	2.2	5.9	2.8	6.9	11.0	4.2	0.2	0.2	3.3	1.9	0.3	0.1	30.3	14.0	26.7	51.6	0.0	18.1	0.2	0.6	11.6	3.6	73.4	0.0	19.7	43.9	0.1	0.1	0.0	33.0	15.6	8.2	2.2	1.9	0.3	18.6	1.1	0.0	31.9	0.0	20.4	0.0	14.1	39.3	0.5	3.4	15.1	0.0	17.2	0.0	7.3	1.6	3.2	0.0	7.2	10.1	1.2	14.1	0.2	1.8	0.3	1.4	0.5	5.7	1.2
SMAGP	"hSMAGP, MGC149453, MGC149454"	ENSG00000170545	"Small cell adhesion glycoprotein"	Q0VAQ4	12	51244558-51270415	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 139.8;placenta: 102.1"	"Group enriched"	"Detected in many"	7	"Cytotrophoblasts: 1219.9;Syncytiotrophoblasts: 842.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BEWO: 131.2;OE19: 163.9"	"Low region specificity"	"Detected in all"							HPA039711	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cell Junctions"		NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Plasma membrane"	"Nucleoplasm, Cell Junctions"	"HPA039711: AB_10674985"	"unprognostic (2.55e-3)"	"unprognostic (2.63e-1)"	"unprognostic (3.96e-2)"	"unprognostic (3.63e-3)"	"prognostic unfavorable (5.36e-4)"	"unprognostic (3.01e-1)"	"unprognostic (1.63e-3)"	"unprognostic (6.26e-2)"	"unprognostic (7.48e-2)"	"unprognostic (9.11e-2)"	"prognostic unfavorable (4.38e-4)"	"unprognostic (1.46e-1)"	"prognostic favorable (2.24e-4)"	"unprognostic (4.32e-3)"	"unprognostic (1.60e-1)"	"unprognostic (1.99e-2)"	"unprognostic (1.52e-1)"	14.0	17.2	2.7	9.9	2.7	3.5	16.1	5.2	3.2	33.8	3.4	57.5	17.6	6.5	20.7	139.8	8.3	16.2	10.3	3.0	2.5	43.0	10.2	17.7	6.0	2.8	2.9	11.4	16.5	11.1	4.3	102.1	2.8	10.5	59.3	1.0	24.1	8.6	3.4	34.8	19.6	8.5	2.6	13.7	35.9	8.1	3.3	1.5	8.7	6.8	27.6	17.5	67.9	3.0	81.6	24.2	2.9	2.7	10.5	40.9	131.2	61.1	60.9	30.6	18.7	48.9	83.2	1.0	10.5	37.9	11.6	28.3	17.1	23.5	42.6	4.1	14.2	10.9	3.3	16.5	28.8	2.7	10.1	26.7	17.8	66.3	59.4	69.4	74.6	20.6	8.7	4.7	49.9	71.4	13.4	9.8	12.3	163.9	93.9	0.8	0.8	3.1	44.0	18.5	3.3	4.1	13.4	53.2	10.2	31.3	45.0	4.2	26.1	33.9	32.7	1.7	37.8	1.7	2.4	1.6	49.8	26.3	18.7	4.6	6.6	12.0	15.4	4.6	10.0	36.9	6.8	11.1	4.7	38.1	6.3	11.0	16.0	19.8	5.4	2.9	5.3	6.8	2.7	2.7	5.2	3.2	3.0	2.5	2.8	2.9	2.8	2.6	3.3	3.0	44.1	0.0	25.7	0.3	26.3	21.7	74.3	35.5	12.0	1.3	23.4	25.8	1.7	55.8	44.7	16.5	0.0	1219.9	21.7	85.0	49.0	43.6	11.7	4.8	2.3	60.9	20.4	8.6	0.6	108.7	108.0	11.4	47.9	8.7	12.7	19.7	51.4	6.7	96.8	1.7	0.5	121.5	26.4	6.3	11.2	3.2	13.1	6.1	14.2	6.5	7.9	4.1	38.1	0.0	0.5	142.5	88.1	9.8	5.7	73.7	35.0	22.6	17.4	1.7	26.3	4.8	11.1	6.2	31.3	80.7	29.7	842.5	13.8	9.8	121.7	105.2
SMAP2	SMAP1L	ENSG00000084070	"Small ArfGAP2"	Q8WU79	1	40344850-40423326	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 216.3"	"Cell type enhanced"	"Detected in all"		"B-cells: 338.4;dendritic cells: 258.0;Kupffer cells: 284.4;Macrophages: 256.8;monocytes: 291.7;Plasma cells: 224.4;T-cells: 199.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HDLM-2: 177.1;THP-1: 302.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021466, HPA024424"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 24: Non-specific - Transcription regulation"	Cytosol	Nucleoplasm	"HPA021466: AB_2239737, HPA024424: AB_1857259"	"unprognostic (1.65e-1)"	"prognostic favorable (6.55e-4)"	"unprognostic (7.17e-2)"	"unprognostic (1.40e-3)"	"unprognostic (4.32e-1)"	"prognostic favorable (5.34e-5)"	"prognostic unfavorable (2.53e-4)"	"unprognostic (9.05e-2)"	"unprognostic (2.27e-1)"	"unprognostic (2.24e-1)"	"unprognostic (4.00e-3)"	"unprognostic (2.65e-1)"	"unprognostic (1.02e-2)"	"unprognostic (1.88e-2)"	"unprognostic (5.45e-2)"	"unprognostic (6.23e-2)"	"unprognostic (1.24e-1)"	65.3	24.0	44.2	136.7	50.7	80.9	33.3	35.7	54.3	43.9	33.8	33.5	17.5	17.9	14.1	26.2	30.7	46.3	17.2	52.1	48.2	19.2	73.5	58.4	205.8	41.8	41.1	17.1	23.8	27.4	43.9	38.0	42.9	20.0	32.1	48.5	29.5	19.0	30.0	33.3	99.2	40.1	38.3	216.3	41.8	17.0	48.0	158.3	19.2	21.2	199.5	52.2	19.3	47.2	25.1	9.3	22.0	22.2	31.4	60.0	12.2	38.4	34.7	38.9	37.9	11.7	16.8	93.1	18.4	34.4	16.0	10.2	41.1	29.4	53.3	177.1	34.8	51.7	14.2	25.5	28.1	54.3	153.7	51.7	24.3	50.4	21.6	19.1	22.4	71.6	94.9	95.2	47.0	16.8	79.3	51.2	13.4	24.7	84.7	30.3	20.4	96.3	18.9	28.9	37.1	17.1	18.1	46.1	29.9	16.8	14.8	302.3	12.4	42.8	17.6	40.2	29.9	31.3	37.1	75.9	38.8	53.1	28.2	12.4	87.7	102.0	14.5	153.8	18.2	43.7	23.3	22.1	49.3	58.6	32.4	30.1	195.4	31.6	195.8	9.3	35.5	52.1	44.2	50.7	35.7	54.3	52.1	48.2	41.8	41.1	42.9	38.3	48.0	47.2	12.8	25.6	28.4	10.1	338.4	18.0	11.4	8.5	4.0	34.7	17.5	13.6	15.3	30.0	24.5	7.3	22.9	5.5	258.0	11.0	5.9	12.6	12.7	78.2	15.8	18.7	9.5	66.7	75.7	18.7	9.6	17.1	26.0	25.0	28.4	10.4	38.6	66.3	43.5	26.9	52.4	9.8	12.2	284.4	140.1	19.5	5.3	256.8	28.4	89.9	291.7	15.0	129.8	54.8	33.6	17.1	8.9	4.9	224.4	9.6	10.0	9.1	70.2	25.6	32.9	12.8	27.9	15.9	11.6	12.7	17.8	4.1	199.9	14.6	9.5	14.6
SMARCA1	"hSNF2L, ISWI, NURF140, SNF2L, SNF2L1, SNF2LB, SWI"	ENSG00000102038	"SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 1"	P28370	X	129446501-129523500	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Chromatin regulator, Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Leydig cells: 142.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"naive CD4 T-cell: 1.1"	"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003335, HPA064712"	Uncertain		Supported	Nucleoplasm,Vesicles		NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 68: Epididymis - Unknown function"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 36: Stromal cells - Cell proliferation"	Nucleoplasm	Vesicles	"HPA003335: AB_1080024, HPA064712: AB_2685332"	"unprognostic (1.40e-1)"	"unprognostic (8.28e-3)"	"unprognostic (2.30e-1)"	"unprognostic (5.06e-2)"	"unprognostic (6.21e-2)"	"unprognostic (2.16e-2)"	"unprognostic (5.44e-2)"	"unprognostic (7.15e-2)"	"unprognostic (3.41e-2)"	"unprognostic (1.53e-1)"	"prognostic favorable (3.03e-4)"	"unprognostic (9.26e-2)"	"prognostic favorable (5.09e-4)"	"unprognostic (1.87e-3)"	"unprognostic (1.28e-1)"	"unprognostic (6.14e-2)"	"unprognostic (2.33e-2)"	19.0	78.6	15.7	9.0	17.8	0.3	20.6	14.0	18.1	27.9	36.0	20.9	6.7	27.2	34.7	11.3	20.1	21.4	24.5	19.9	31.6	23.9	62.1	16.3	4.6	17.0	19.0	72.6	15.8	44.6	34.8	38.0	20.3	36.7	7.0	26.7	18.5	35.4	17.3	8.1	8.4	25.9	17.1	8.9	17.3	57.7	26.7	7.9	45.3	19.8	4.2	30.0	14.0	18.1	23.5	53.5	104.8	67.9	76.3	67.1	36.6	46.8	133.2	68.6	76.7	18.3	80.9	0.0	71.8	88.7	81.1	22.1	66.6	27.5	76.4	0.1	12.9	0.2	46.9	100.0	32.6	0.0	0.1	84.2	7.8	49.0	9.3	104.3	50.4	13.1	12.4	5.7	76.1	0.0	0.6	0.2	42.6	9.0	31.0	0.0	56.7	0.2	67.4	28.3	26.0	69.8	6.6	0.9	12.1	73.1	46.9	0.6	35.7	46.0	23.3	30.3	26.4	0.0	0.0	0.2	40.7	0.0	28.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.3	0.0	0.5	0.0	0.2	0.0	0.1	15.7	17.8	14.0	18.1	19.9	31.6	17.0	19.0	20.3	17.1	26.7	18.1	23.2	96.1	55.0	24.2	1.5	23.3	35.4	28.3	47.3	26.5	34.8	24.1	80.5	12.8	47.6	40.5	45.9	56.9	1.8	0.1	29.4	30.1	3.7	32.2	80.2	25.6	16.8	3.2	29.3	12.0	15.7	64.3	23.4	42.7	2.5	84.3	22.9	67.0	15.0	92.5	43.4	2.6	14.2	3.2	9.9	18.4	142.9	3.0	28.4	22.5	5.7	47.7	0.0	41.2	17.2	14.0	0.1	125.6	0.1	24.9	0.2	34.9	41.0	13.4	65.7	40.0	49.7	11.4	23.9	17.5	11.8	58.4	2.0	82.9	2.3	29.2
SMARCA2	"BAF190, BRM, hBRM, hSNF2a, SNF2, SNF2L2, SNF2LA, Sth1p, SWI2"	ENSG00000080503	"SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2"	P51531	9	1980290-2193624	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Neurogenesis, Transcription, Transcription regulation"	"Activator, DNA-binding, Helicase, Hydrolase"	"Disease variant, Hypotrichosis, Mental retardation, Schizophrenia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Astrocytes: 246.5;Inhibitory neurons: 263.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in many"	6	"HDLM-2: 1486.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029981, CAB037276"	Enhanced		Approved	"Nucleoplasm,Vesicles,Intermediate filaments"		NA	NA		19000	"Cluster 6: Non-specific - Transcription"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 24: Non-specific - Transcription regulation"	"Nucleoplasm, Vesicles"	"Intermediate filaments"	"CAB037276: AB_477083, HPA029981: AB_10602406"	"unprognostic (5.34e-2)"	"unprognostic (1.99e-2)"	"unprognostic (6.27e-2)"	"unprognostic (6.53e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.13e-2)"	"unprognostic (4.91e-2)"	"unprognostic (2.80e-2)"	"unprognostic (2.62e-1)"	"unprognostic (3.97e-1)"	"unprognostic (3.60e-3)"	"unprognostic (9.64e-2)"	"prognostic favorable (1.26e-6)"	"unprognostic (3.09e-1)"	"unprognostic (2.81e-1)"	"unprognostic (8.32e-3)"	"unprognostic (8.50e-2)"	51.9	55.9	68.9	36.1	73.9	95.7	62.0	87.4	81.7	42.1	40.2	31.0	20.2	53.2	57.3	41.7	57.4	46.0	43.8	60.3	53.7	45.9	58.3	40.3	50.9	43.2	54.4	166.0	36.8	170.3	32.7	48.2	50.6	42.5	31.7	63.6	50.7	53.2	97.7	48.2	27.7	44.2	40.3	52.3	32.0	56.3	55.7	42.2	55.7	60.1	47.8	31.8	28.8	52.9	45.7	32.9	23.7	33.8	47.2	56.6	71.7	59.4	44.6	24.9	19.5	0.5	17.7	76.2	22.0	50.7	13.5	18.8	12.9	46.5	17.6	1486.7	20.2	208.3	88.2	16.2	18.7	88.3	118.1	37.6	17.5	24.9	46.4	44.9	40.3	35.4	7.3	255.1	43.0	19.1	22.2	72.3	23.4	26.4	12.6	97.6	30.5	69.4	57.6	40.9	15.3	14.0	36.2	8.3	14.9	34.1	16.3	55.8	49.1	40.6	19.8	25.8	27.3	22.9	31.8	33.6	43.5	32.5	11.4	26.1	5.2	15.8	10.8	7.2	10.4	12.3	10.5	11.2	6.4	9.4	13.1	10.3	14.6	9.9	10.3	12.5	12.6	5.0	68.9	73.9	87.4	81.7	60.3	53.7	43.2	54.4	50.6	40.3	55.7	52.9	83.9	73.7	70.6	246.5	57.2	58.6	18.3	55.0	82.6	57.6	103.7	74.3	95.2	31.5	54.1	106.7	37.5	99.3	102.8	32.0	31.3	30.6	38.0	44.1	61.6	69.0	37.2	41.2	216.2	22.4	24.5	65.7	19.4	45.2	48.0	27.9	36.8	62.0	31.5	35.3	263.2	31.2	48.8	54.9	34.7	22.6	76.7	57.5	49.8	142.4	45.2	53.4	43.3	120.6	100.8	18.7	15.1	86.9	71.4	13.9	26.9	18.5	88.3	37.4	13.1	58.7	40.3	42.9	14.6	66.2	52.7	88.7	74.8	56.1	28.2	12.7
SMARCA4	"BAF190, BRG1, FLJ39786, hSNF2b, SNF2, SNF2-BETA, SNF2L4, SNF2LB, SWI2"	ENSG00000127616	"SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4"	P51532	19	10960932-11079426	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Neurogenesis, Transcription, Transcription regulation"	"Activator, Chromatin regulator, Helicase, Hydrolase, Repressor, RNA-binding"	"Cancer-related genes, Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 372.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004208, HPA048340"	Supported		Supported	"Nucleoplasm,Nucleoli fibrillar center,Nucleoli rim"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 14: REH - Unknown function"	"Cluster 43: Cardiomyocytes - Nuclear processes"	Nucleoplasm	"Nucleoli fibrillar center, Nucleoli rim"	"CAB004208: AB_626762, HPA048340: "	"unprognostic (2.68e-1)"	"unprognostic (4.85e-2)"	"unprognostic (1.71e-1)"	"unprognostic (3.43e-3)"	"unprognostic (1.40e-1)"	"unprognostic (6.33e-3)"	"prognostic unfavorable (1.11e-4)"	"unprognostic (7.19e-2)"	"unprognostic (7.29e-2)"	"unprognostic (1.73e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.15e-2)"	"unprognostic (6.80e-3)"	"unprognostic (6.83e-3)"	"unprognostic (5.44e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.29e-1)"	13.8	16.2	14.4	22.6	14.3	31.8	13.0	15.3	23.7	16.1	13.2	18.1	19.9	14.5	9.5	32.9	20.8	13.3	16.2	15.4	9.6	15.7	8.6	17.9	27.0	10.4	10.4	14.9	18.3	22.9	11.1	20.2	11.0	17.7	12.9	19.7	25.9	15.6	23.7	28.1	17.2	14.5	3.9	19.5	20.4	30.2	11.8	43.1	20.6	13.9	23.7	17.4	14.7	19.3	92.5	5.0	157.2	149.8	30.3	25.4	68.9	62.7	37.2	74.6	54.9	126.9	4.0	215.4	94.2	54.9	3.0	65.9	123.6	77.5	40.8	89.5	93.3	171.3	76.5	149.6	45.7	125.5	82.0	43.1	36.7	63.1	64.5	33.3	67.5	92.0	156.7	78.3	59.2	188.0	210.0	107.5	159.9	45.1	134.7	220.6	99.5	111.7	47.9	114.8	177.8	161.7	66.6	84.4	73.5	50.1	71.9	93.3	90.9	110.3	57.3	102.5	104.9	160.6	192.2	209.1	62.6	118.5	96.0	5.7	5.8	6.4	9.3	6.9	8.2	5.3	6.8	7.9	6.1	6.8	7.6	7.5	3.4	8.5	10.8	7.9	6.4	4.7	14.4	14.3	15.3	23.7	15.4	9.6	10.4	10.4	11.0	3.9	11.8	19.3	25.4	67.3	72.6	27.4	28.5	37.0	43.7	43.8	24.5	91.3	42.2	28.4	372.9	40.0	62.7	44.1	70.9	65.9	21.2	60.1	41.1	79.8	53.0	58.8	49.2	58.3	63.2	41.8	32.2	61.4	57.3	43.8	50.0	63.5	30.4	75.3	28.5	21.9	42.3	101.0	39.6	47.7	57.0	23.8	21.5	37.6	26.1	30.4	16.0	14.0	43.8	36.1	23.7	32.6	28.1	76.4	41.8	13.5	37.6	66.0	29.8	27.6	62.5	69.1	13.1	45.1	66.4	99.4	86.0	52.2	51.7	61.0	30.4	68.1	60.5	50.1
SMARCA5	"hISWI, hSNF2H, ISWI"	ENSG00000153147	"SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 5"	O60264	4	143513702-143557486	"Predicted intracellular proteins, Transcription factors"		"Chromatin regulator, Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Alveolar cells type 1: 307.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005227, HPA008751"	Supported		Supported	"Nucleoplasm,Nucleoli fibrillar center"		No	No			"Cluster 27: Non-specific - Gene expression"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 11: Alveolar cells - Smell perception"	"Nucleoplasm, Nucleoli fibrillar center"		"CAB005227: AB_2191863, HPA008751: AB_1857268"	"unprognostic (9.21e-3)"	"unprognostic (7.99e-2)"	"unprognostic (4.99e-3)"	"unprognostic (8.03e-2)"	"unprognostic (8.96e-2)"	"unprognostic (3.47e-1)"	"prognostic unfavorable (1.61e-4)"	"unprognostic (3.85e-2)"	"unprognostic (8.84e-2)"	"unprognostic (1.99e-1)"	"unprognostic (4.19e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.87e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.61e-1)"	"unprognostic (4.20e-2)"	"unprognostic (1.82e-1)"	16.9	26.0	15.1	21.1	20.1	32.7	17.6	17.6	17.3	18.1	13.5	17.2	14.9	20.4	20.5	14.1	14.6	19.3	17.1	13.0	16.6	16.7	16.8	27.9	27.0	17.9	16.8	21.2	16.4	22.6	13.5	22.8	19.1	18.1	17.9	26.4	12.4	17.0	15.3	11.1	16.4	18.4	18.3	22.8	16.2	32.6	16.0	29.9	23.1	15.3	25.7	22.7	11.0	26.0	33.4	25.8	92.5	58.5	53.4	38.4	55.5	41.5	49.4	59.5	50.0	44.3	45.8	90.0	27.9	35.7	23.7	26.0	85.9	38.9	57.1	60.2	30.2	67.7	36.9	36.7	39.3	84.2	38.3	34.0	27.8	42.1	36.0	34.5	46.9	45.1	62.0	55.4	39.2	30.1	98.7	29.4	75.7	55.6	36.6	108.2	59.1	29.4	46.6	40.4	73.6	62.2	54.0	37.9	49.5	69.2	27.4	39.1	50.0	38.9	29.7	41.0	41.2	60.0	77.4	106.8	30.6	69.5	40.3	5.8	10.7	16.0	12.7	12.8	15.3	11.4	13.1	14.2	13.3	11.2	13.4	13.6	9.4	15.8	21.5	10.0	16.7	11.5	15.1	20.1	17.6	17.3	13.0	16.6	17.9	16.8	19.1	18.3	16.0	26.0	77.3	307.7	291.0	30.7	95.7	46.4	78.9	50.6	55.2	93.9	56.4	49.0	104.1	31.5	96.9	44.1	64.6	70.6	125.6	39.8	39.2	77.9	63.2	104.5	127.1	74.3	79.9	85.4	42.5	61.4	66.4	73.8	46.4	94.2	103.1	97.3	39.3	25.4	44.8	85.8	41.7	41.3	69.2	51.9	49.4	27.9	60.3	79.2	30.2	27.2	98.6	84.7	55.6	37.7	85.2	66.0	35.3	62.1	93.9	57.7	36.6	36.8	109.6	116.4	52.6	113.9	88.3	144.4	130.8	47.4	40.9	102.1	107.9	118.7	46.2	71.2
SMARCAL1	"HARP, HHARP"	ENSG00000138375	"SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a like 1"	Q9NZC9	2	216412414-216483053	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		"Helicase, Hydrolase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Oligodendrocytes: 35.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020337	Uncertain		Supported	Nucleoplasm		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 34: Non-specific - Transcription"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Nucleoplasm		"HPA020337: AB_2670410"	"unprognostic (4.56e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.65e-1)"	"unprognostic (2.20e-2)"	"unprognostic (3.39e-2)"	"unprognostic (2.68e-2)"	"prognostic unfavorable (5.22e-4)"	"unprognostic (4.35e-3)"	"unprognostic (3.31e-2)"	"unprognostic (2.33e-1)"	"unprognostic (1.36e-1)"	"unprognostic (7.46e-2)"	"unprognostic (2.00e-2)"	"unprognostic (2.67e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.97e-1)"	"unprognostic (3.16e-1)"	9.2	9.8	7.5	8.9	10.3	9.1	8.8	8.0	9.7	10.6	7.6	8.0	6.8	10.7	7.5	9.8	11.0	9.5	8.9	8.0	9.0	7.2	6.7	7.9	13.1	10.6	9.1	16.3	8.2	10.8	9.3	9.1	10.6	8.1	7.4	5.6	8.0	8.9	10.5	10.6	7.9	10.1	8.4	9.7	8.0	10.3	10.2	15.1	10.2	10.6	11.9	8.8	9.0	14.2	16.7	16.3	22.2	12.7	21.5	25.1	21.3	22.0	22.7	23.0	26.1	26.7	20.3	15.0	21.8	27.6	28.8	12.3	19.1	24.4	30.5	45.7	18.9	42.8	12.0	19.9	22.0	11.5	23.9	16.7	25.7	24.9	24.4	24.0	27.6	23.5	42.6	15.8	26.3	12.3	22.2	26.8	16.1	14.7	8.9	24.6	14.6	9.3	18.2	11.4	18.4	11.9	12.0	9.1	18.7	38.2	12.4	18.1	21.3	28.3	13.0	13.7	13.9	18.0	18.6	13.3	28.8	15.6	20.2	25.9	9.5	14.1	12.2	10.5	11.6	9.6	11.5	14.3	14.9	9.2	9.6	11.8	1.7	21.0	18.1	18.0	14.7	8.5	7.5	10.3	8.0	9.7	8.0	9.0	10.6	9.1	10.6	8.4	10.2	14.2	6.3	6.4	6.1	20.2	8.2	0.9	3.3	4.6	8.6	5.1	4.3	3.4	5.0	7.2	3.7	0.0	0.0	10.4	6.7	3.4	5.9	7.4	14.5	10.4	7.2	7.0	3.6	11.4	20.6	3.8	12.2	8.0	5.6	5.8	17.7	11.0	4.2	3.2	9.7	8.4	30.8	3.7	2.0	8.9	3.1	13.7	6.2	6.2	1.8	12.2	10.1	4.7	10.3	24.6	35.9	4.0	13.3	8.6	7.0	1.3	4.7	5.8	4.4	4.8	13.1	6.0	6.8	7.7	4.4	5.3	1.3	7.3	6.5	7.5	5.3	2.0
SMARCB1	"BAF47, hSNFS, Ini1, PPP1R144, RDT, Sfh1p, SNF5, SNF5L1, Snr1"	ENSG00000099956	"SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily b, member 1"	Q12824	22	23786931-23838009	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Host-virus interaction, Neurogenesis, Transcription, Transcription regulation"	"Activator, Chromatin regulator, DNA-binding"	"Cancer-related genes, Disease variant, Hypotrichosis, Mental retardation, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009196, HPA018248, HPA019127"	Supported		Supported	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 72: Non-specific - Transcription"	"Cluster 12: NES - Nervous system development"	"Cluster 57: B-cells - Immune response"	Nucleoplasm	"Nucleoli fibrillar center"	"CAB009196: AB_2191983, HPA018248: AB_1851162, HPA019127: AB_1851165"	"unprognostic (2.15e-1)"	"unprognostic (5.62e-2)"	"unprognostic (6.60e-3)"	"unprognostic (1.63e-2)"	"unprognostic (4.01e-3)"	"unprognostic (2.14e-1)"	"prognostic unfavorable (6.52e-4)"	"unprognostic (4.10e-1)"	"unprognostic (1.86e-1)"	"unprognostic (1.03e-2)"	"unprognostic (2.10e-2)"	"unprognostic (4.43e-3)"	"prognostic favorable (1.14e-6)"	"unprognostic (1.24e-1)"	"unprognostic (4.58e-2)"	"unprognostic (4.57e-2)"	"unprognostic (7.04e-2)"	35.9	46.4	2.3	6.9	2.5	3.3	40.3	4.1	10.0	51.5	2.7	40.9	8.1	51.4	0.4	51.0	40.4	2.2	44.0	2.3	2.3	47.0	36.9	32.3	5.8	4.3	2.7	63.1	43.9	1.2	48.0	1.2	2.7	36.6	1.1	25.3	44.1	0.6	48.1	50.1	51.7	0.6	2.2	51.7	40.4	68.3	2.3	3.5	41.3	1.8	1.5	37.5	40.9	2.9	2.4	1.6	28.2	2.6	2.7	0.7	5.8	9.2	2.7	2.7	4.3	3.4	2.6	24.2	7.9	1.2	2.9	4.4	6.9	4.6	4.5	4.1	10.5	20.1	3.2	2.1	3.0	21.7	5.6	1.6	3.4	3.2	6.9	1.4	1.4	3.0	5.6	12.9	1.7	6.1	17.6	5.0	8.6	7.2	5.7	11.0	23.1	10.8	2.3	4.5	13.4	10.1	2.2	0.6	17.9	14.8	2.2	3.3	2.2	2.4	9.8	3.8	2.7	13.8	14.3	17.7	1.8	11.3	6.8	7.1	12.8	6.4	4.4	13.4	6.4	24.4	5.5	5.7	12.0	9.2	4.5	3.0	1.1	9.8	16.8	13.3	10.4	8.1	2.3	2.5	4.1	10.0	2.3	2.3	4.3	2.7	2.7	2.2	2.3	2.9	33.6	6.4	8.6	17.0	120.2	50.2	73.3	85.1	51.2	55.4	42.9	49.1	6.1	47.1	37.4	47.8	20.9	120.6	61.8	36.6	84.1	94.6	42.6	40.9	54.9	37.4	71.8	57.8	14.1	77.1	228.1	46.2	41.8	41.1	34.8	112.2	41.0	20.3	76.1	67.3	18.4	54.6	99.7	23.0	41.7	18.9	35.8	36.5	56.9	15.9	51.2	92.4	45.3	17.1	18.1	74.7	53.1	32.0	139.6	74.4	41.9	86.4	28.5	49.6	19.7	47.7	62.8	138.9	163.3	64.5	53.0	160.1	42.0	96.8	65.4	65.1
SMARCD1	"BAF60A, CRACD1, Rsc6p"	ENSG00000066117	"SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily d, member 1"	Q96GM5	12	50085200-50100707	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins"	Neurogenesis	"Chromatin regulator"	"Cancer-related genes, Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004101	Supported		Supported	Nucleoplasm,Vesicles		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm	Vesicles	"HPA004101: AB_1080026"	"unprognostic (1.88e-1)"	"unprognostic (1.89e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.11e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.76e-1)"	"prognostic unfavorable (2.53e-8)"	"unprognostic (3.62e-2)"	"unprognostic (1.44e-1)"	"unprognostic (4.23e-2)"	"unprognostic (1.16e-2)"	"unprognostic (2.10e-2)"	"unprognostic (1.20e-3)"	"unprognostic (2.18e-1)"	"unprognostic (3.45e-1)"	"unprognostic (1.38e-1)"	"unprognostic (5.04e-2)"	25.8	28.1	25.2	23.2	27.6	44.0	24.9	24.4	27.0	23.5	20.8	22.0	23.2	27.9	27.1	27.5	23.8	17.9	18.3	26.3	23.8	25.3	19.0	23.9	35.0	25.7	25.7	26.4	22.5	47.3	19.7	28.9	25.3	23.2	27.2	25.1	24.3	21.8	16.9	24.3	27.8	28.8	24.8	31.3	20.5	23.8	25.8	57.2	26.8	16.1	47.6	23.5	21.7	27.6	28.4	47.6	134.8	75.8	41.1	38.9	68.1	35.1	62.0	100.3	58.2	130.0	42.1	109.4	51.0	67.2	44.4	35.4	112.9	91.5	87.3	84.4	87.0	107.2	49.4	75.8	49.3	95.0	41.1	40.2	60.2	59.8	107.4	66.1	119.5	114.0	93.1	64.8	50.6	67.7	137.6	54.0	166.0	43.2	76.6	165.5	34.9	96.0	57.3	66.1	71.4	121.3	73.1	35.2	139.3	100.4	79.4	78.7	70.4	50.1	56.0	31.7	69.9	91.6	88.2	95.4	40.6	37.7	56.9	3.4	1.2	2.2	2.9	1.2	2.9	3.6	1.6	2.0	1.8	2.7	1.0	3.3	0.5	1.7	1.9	3.5	2.7	1.2	25.2	27.6	24.4	27.0	26.3	23.8	25.7	25.7	25.3	24.8	25.8	27.6	29.7	0.0	9.6	11.1	42.9	16.6	22.3	17.7	42.7	33.7	33.2	30.2	6.5	15.7	20.5	27.6	20.9	21.1	39.6	21.6	52.8	32.8	4.3	20.0	36.9	30.1	31.1	25.7	9.3	29.0	19.4	17.8	14.8	30.5	16.5	40.0	17.5	15.1	17.3	26.9	10.5	18.2	10.2	14.4	13.1	9.1	16.4	16.8	17.8	7.5	27.1	26.5	29.9	11.1	17.1	36.8	14.8	16.1	28.9	28.8	19.5	47.9	9.4	28.8	32.9	31.6	28.2	28.4	36.5	31.3	19.6	11.1	30.0	26.8	19.1	15.9
SMARCE1	BAF57	ENSG00000073584	"SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily e, member 1"	Q969G3	17	40624962-40648654	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	Neurogenesis	"Chromatin regulator, DNA-binding"	"Cancer-related genes, Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003916, CAB037318"	Supported		Supported	Nucleoplasm		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 34: Non-specific - Transcription"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm		"CAB037318: AB_476780, HPA003916: AB_1857279"	"unprognostic (7.91e-2)"	"unprognostic (2.68e-2)"	"unprognostic (2.09e-2)"	"unprognostic (8.06e-3)"	"unprognostic (1.87e-1)"	"unprognostic (2.55e-2)"	"unprognostic (4.48e-1)"	"unprognostic (1.25e-2)"	"unprognostic (2.20e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.53e-2)"	"unprognostic (2.04e-1)"	"unprognostic (9.80e-2)"	"unprognostic (5.93e-2)"	"unprognostic (7.63e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.27e-2)"	39.4	22.2	10.5	37.8	11.9	43.2	35.6	10.6	13.3	45.9	14.3	40.2	38.9	56.2	28.3	43.6	39.0	41.4	40.1	9.2	11.7	31.2	31.5	36.1	49.6	13.7	10.7	58.6	35.4	38.3	13.3	48.4	13.2	34.2	38.5	17.5	33.6	42.1	42.5	27.7	39.3	57.4	11.7	40.5	30.9	31.5	11.2	76.1	40.8	44.7	54.2	46.8	26.2	16.5	86.5	139.6	169.1	126.5	87.7	125.5	82.8	105.9	145.4	122.1	91.0	92.7	72.7	135.9	149.6	145.3	81.0	114.5	106.1	112.3	145.1	128.3	138.0	97.2	73.4	165.2	87.8	179.8	94.5	109.3	87.6	97.7	140.6	122.1	133.4	106.5	144.2	52.2	118.2	96.5	331.6	37.1	95.4	70.8	68.6	183.3	190.2	103.7	147.5	144.9	134.6	130.0	94.5	269.4	86.6	181.5	161.5	111.4	109.7	98.1	107.6	89.7	132.6	97.7	122.8	204.5	100.0	80.9	154.9	106.3	64.4	88.2	91.7	67.8	95.0	99.8	82.4	96.1	77.9	112.3	68.3	79.3	26.5	124.7	82.2	80.3	114.7	112.2	10.5	11.9	10.6	13.3	9.2	11.7	13.7	10.7	13.2	11.7	11.2	16.5	41.4	48.1	45.1	13.1	67.5	38.1	43.0	69.5	65.4	75.8	19.7	20.2	53.0	38.6	61.5	20.2	16.7	101.8	68.7	38.7	15.6	41.5	27.1	34.9	47.0	60.4	96.5	84.1	17.1	32.3	75.7	72.4	44.9	32.1	74.0	41.3	62.8	44.0	51.6	82.4	18.8	53.5	65.1	42.9	39.6	11.8	90.4	30.9	24.9	19.7	63.2	63.3	105.0	26.7	32.7	35.7	46.7	82.4	44.2	36.5	52.8	30.5	59.3	37.1	39.5	62.7	57.0	49.7	50.9	63.3	40.1	114.8	53.8	35.3	62.5	34.3
SMC1B	"bK268H5, SMC1L2"	ENSG00000077935	"Structural maintenance of chromosomes 1B"	Q8NDV3	22	45344063-45413619	"Predicted intracellular proteins"	"Cell cycle, Meiosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	98	"testis: 31.1"	"Group enriched"	"Detected in some"	6	"Spermatocytes: 897.6;Spermatogonia: 448.5"	"Cancer enriched"	"Detected in many"	6	"cervical cancer: 4.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 8.9;EFO-21: 4.0;SiHa: 18.0;U-266/70: 3.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA001500	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA				"Cluster 36: Testis - Spermatogenesis"	"Cluster 20: HeLa - Mitochondria"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	"Nucleoplasm, Cytosol"		"HPA001500: AB_1080030"	"unprognostic (1.18e-2)"	"unprognostic (6.16e-3)"	"unprognostic (2.22e-1)"	"unprognostic (3.38e-3)"	"unprognostic (1.77e-1)"	"unprognostic (3.21e-2)"	"unprognostic (6.18e-2)"	"unprognostic (1.87e-3)"	"unprognostic (3.41e-2)"	"unprognostic (3.65e-1)"	"unprognostic (4.49e-2)"	"unprognostic (3.79e-1)"	"unprognostic (3.83e-9)"	"unprognostic (2.10e-1)"	"unprognostic (1.11e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.98e-3)"	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	31.1	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	8.9	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.7	0.1	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.1	0.0	0.2	0.2	0.2	0.1	0.0	0.1	0.1	0.0	0.0	0.4	0.2	0.1	0.0	18.0	0.0	0.0	0.0	0.1	1.5	0.1	0.0	0.0	0.4	0.0	3.9	0.0	0.0	0.0	0.3	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.3	0.1	0.0	0.2	0.1	0.0	0.0	0.3	0.6	0.8	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.1	75.6	0.5	0.2	0.8	0.0	0.0	1.4	0.0	0.9	0.3	0.0	0.2	0.0	0.7	0.4	0.1	0.1	0.0	1.1	0.0	0.0	0.3	0.0	36.9	5.6	0.5	0.0	1.0	0.0	0.3	0.0	1.0	1.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.2	1.0	98.6	0.4	0.2	897.6	448.5	0.0	0.0	0.8	0.1	0.0	0.0	0.2
SMC2	"CAP-E, hCAP-E, SMC2L1"	ENSG00000136824	"Structural maintenance of chromosomes 2"	O95347	9	104094260-104141419	"Predicted intracellular proteins"	"Cell cycle, Cell division, DNA condensation, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 25.7"	"Cell type enhanced"	"Detected in all"		"Endometrial ciliated cells: 114.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA071309	Approved		Supported	Nucleoplasm,Nucleoli		Yes	No		26000	"Cluster 44: Non-specific - Transcription"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	Nucleoli	"HPA071309: AB_2686385"	"unprognostic (1.51e-1)"	"unprognostic (2.01e-3)"	"unprognostic (2.26e-2)"	"unprognostic (2.23e-2)"	"unprognostic (3.04e-1)"	"unprognostic (1.05e-1)"	"unprognostic (5.57e-3)"	"unprognostic (2.59e-3)"	"unprognostic (1.47e-2)"	"unprognostic (4.35e-1)"	"unprognostic (1.24e-2)"	"unprognostic (1.01e-1)"	"unprognostic (5.56e-3)"	"unprognostic (8.02e-3)"	"unprognostic (1.65e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.32e-2)"	5.2	4.1	2.8	11.3	4.0	18.4	6.6	4.4	3.3	7.5	1.3	8.2	7.5	6.0	2.6	7.3	4.7	4.0	7.9	2.2	4.0	6.3	4.7	4.5	16.0	4.9	3.7	4.7	3.5	5.7	1.5	6.9	4.1	4.2	8.8	5.6	3.1	4.7	2.2	7.4	7.6	5.4	3.5	7.2	6.1	12.0	3.5	25.7	7.6	5.4	15.9	4.9	3.2	5.0	59.3	45.0	49.4	45.9	10.3	14.9	46.2	53.5	25.4	46.9	39.4	39.3	44.9	112.6	25.2	27.7	40.5	97.6	72.3	34.8	63.2	71.6	30.3	67.9	68.8	25.5	2.7	41.5	65.6	9.8	7.0	63.7	25.7	15.9	33.7	71.2	55.8	89.8	43.0	28.9	109.1	21.3	42.9	47.6	34.8	72.0	141.3	42.2	20.1	21.1	46.5	35.9	63.8	29.6	15.5	20.5	59.5	28.0	27.1	56.8	59.1	79.3	67.9	32.6	118.2	64.6	36.8	59.8	70.3	15.0	2.2	2.5	4.8	5.9	5.4	7.3	4.4	4.8	2.6	7.9	5.0	5.8	0.3	7.0	7.4	4.4	6.0	2.4	2.8	4.0	4.4	3.3	2.2	4.0	4.9	3.7	4.1	3.5	3.5	5.0	19.6	25.6	11.9	6.5	19.9	27.3	16.4	27.6	11.4	39.7	16.6	19.3	45.1	7.2	17.8	16.5	8.4	54.3	15.2	13.7	35.2	18.9	40.0	114.6	21.6	21.4	4.9	95.3	10.2	20.4	93.8	20.2	13.3	16.0	22.2	40.4	21.0	7.6	44.3	28.6	15.5	14.6	26.4	19.8	19.8	24.7	18.6	22.9	7.2	7.5	19.8	15.6	22.6	5.5	18.4	15.6	6.3	12.4	40.9	7.3	10.3	15.0	12.0	19.1	13.1	25.1	37.7	84.5	93.5	27.4	23.2	25.9	18.1	28.1	35.0	14.2
SMC3	"BAM, bamacan, CSPG6, HCAP, SMC3L1"	ENSG00000108055	"Structural maintenance of chromosomes 3"	Q9UQE7	10	110567695-110606048	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, DNA damage, DNA repair, Meiosis, Mitosis"		"Cancer-related genes, Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"Spermatocytes: 994.2;Spermatogonia: 799.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043206	Approved		Supported	Nucleoplasm		NA	NA		630000	"Cluster 44: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	Nucleoplasm		"HPA043206: AB_2678362"	"unprognostic (3.40e-1)"	"unprognostic (1.73e-2)"	"unprognostic (9.05e-2)"	"unprognostic (3.00e-2)"	"unprognostic (3.73e-2)"	"unprognostic (8.89e-3)"	"unprognostic (9.74e-3)"	"unprognostic (8.06e-2)"	"unprognostic (5.31e-2)"	"unprognostic (6.32e-2)"	"unprognostic (3.53e-2)"	"unprognostic (1.17e-2)"	"unprognostic (8.73e-3)"	"unprognostic (7.22e-2)"	"unprognostic (5.18e-2)"	"unprognostic (7.95e-2)"	"unprognostic (1.32e-1)"	19.5	13.3	9.0	18.7	10.9	43.9	19.1	18.5	11.7	18.5	11.7	18.3	15.5	20.3	15.7	19.2	16.5	11.1	12.9	8.6	10.2	14.0	15.3	14.5	25.2	10.2	9.4	25.7	19.6	20.0	14.2	20.7	10.4	14.0	16.7	27.6	16.2	15.2	21.1	20.6	19.4	16.9	9.6	18.6	14.7	38.1	9.5	39.2	16.5	14.1	24.3	15.5	17.8	12.7	73.1	44.5	95.4	67.8	30.7	26.3	40.9	57.7	56.7	51.9	50.7	56.4	59.7	94.2	24.5	38.6	40.0	56.5	68.7	35.0	78.6	77.3	60.1	76.5	56.2	51.2	30.8	109.8	56.6	21.1	28.0	57.4	89.5	48.5	38.8	31.7	61.7	70.4	45.4	38.1	85.2	58.3	66.1	38.6	35.1	71.1	171.5	51.4	32.4	31.7	53.7	61.8	62.0	17.7	48.6	61.8	28.5	53.1	40.1	41.6	65.5	47.6	84.4	40.9	38.8	99.6	37.5	103.9	34.8	20.7	6.1	15.8	9.6	8.4	12.1	11.0	11.3	10.6	6.8	11.0	11.3	11.2	6.5	12.6	7.6	8.7	14.5	6.2	9.0	10.9	18.5	11.7	8.6	10.2	10.2	9.4	10.4	9.6	9.5	12.7	74.9	80.1	62.0	16.6	73.5	60.5	53.2	64.1	34.7	81.3	44.3	49.9	64.5	47.1	64.4	55.2	75.0	119.6	94.3	29.8	25.4	96.9	56.9	52.0	65.0	74.9	40.7	104.6	26.2	45.6	111.4	66.0	20.9	49.0	56.3	124.9	40.4	31.9	59.1	60.6	29.2	40.7	54.9	37.9	42.5	34.6	115.2	49.8	37.4	19.7	96.1	54.9	98.9	33.2	43.4	53.0	70.1	114.0	65.0	44.7	70.7	30.3	68.3	78.9	184.1	102.0	110.6	994.2	799.1	48.1	64.5	49.1	80.9	112.7	51.9	37.5
SMC4	"CAP-C, hCAP-C, SMC4L1"	ENSG00000113810	"Structural maintenance of chromosomes 4"	Q9NTJ3	3	160399274-160434954	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, DNA condensation, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 60.6"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 305.8;Spermatocytes: 339.8;Spermatogonia: 239.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in all"		"basophil: 74.4"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029449, CAB055509"	Approved		Supported	"Nuclear speckles,Cytosol"		NA	Yes		25000	"Cluster 18: Basophils - Vesicular transport"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Nuclear speckles, Cytosol"		"CAB055509: , HPA029449: AB_10603891"	"unprognostic (2.63e-1)"	"unprognostic (1.01e-1)"	"unprognostic (2.45e-2)"	"prognostic unfavorable (7.63e-4)"	"unprognostic (2.22e-1)"	"unprognostic (1.28e-2)"	"prognostic unfavorable (2.94e-4)"	"unprognostic (9.54e-2)"	"unprognostic (2.18e-2)"	"unprognostic (5.47e-2)"	"prognostic unfavorable (4.20e-5)"	"prognostic unfavorable (9.00e-4)"	"prognostic unfavorable (8.05e-7)"	"unprognostic (3.03e-2)"	"unprognostic (4.46e-1)"	"unprognostic (1.06e-1)"	"unprognostic (4.98e-2)"	6.8	6.5	1.0	21.2	2.0	36.3	6.8	1.2	1.7	6.3	1.5	13.2	14.0	7.4	2.3	23.5	4.5	7.6	7.3	0.9	1.9	5.9	7.8	11.8	37.1	1.7	1.4	5.9	7.8	3.8	2.0	16.2	1.6	5.8	14.9	7.7	4.6	5.0	3.6	11.0	15.4	10.1	1.3	14.7	11.8	32.5	1.9	60.6	9.0	6.8	31.6	9.6	4.3	3.2	386.3	72.8	155.0	73.0	31.5	30.9	72.1	181.2	88.8	206.0	176.8	94.4	209.7	236.6	101.9	81.1	140.0	212.5	183.0	95.0	332.4	297.9	113.8	234.7	123.3	33.6	17.3	158.3	182.6	14.6	13.3	114.4	96.5	78.5	94.8	103.2	130.3	272.2	133.9	78.3	183.2	44.4	91.8	106.7	149.3	180.1	238.8	177.3	43.4	54.8	93.7	94.0	141.4	135.1	65.5	76.6	156.9	128.6	84.8	132.2	105.2	119.9	349.8	181.1	192.2	412.0	96.7	166.9	151.9	74.4	6.0	23.6	11.5	8.9	11.4	17.2	18.2	14.3	6.6	15.0	11.4	10.2	10.8	15.3	15.9	11.7	30.3	9.5	1.0	2.0	1.2	1.7	0.9	1.9	1.7	1.4	1.6	1.3	1.9	3.2	24.6	105.8	174.0	3.9	43.7	40.8	18.2	33.1	30.7	14.9	21.5	21.0	41.3	25.8	35.0	35.0	8.4	74.6	54.4	41.4	3.9	20.9	48.6	35.2	27.0	44.8	30.1	305.8	3.5	14.7	138.1	50.7	32.6	36.1	79.1	77.3	38.2	20.4	61.3	0.0	2.9	44.5	24.4	29.7	43.5	28.3	25.1	36.4	17.8	17.8	39.3	9.3	46.4	3.5	30.1	13.5	26.5	48.2	95.9	14.1	25.9	8.6	25.4	25.8	131.5	21.7	73.2	339.8	239.4	58.1	35.7	34.1	58.4	34.6	69.7	19.1
SMC5	"KIAA0594, SMC5L1"	ENSG00000198887	"Structural maintenance of chromosomes 5"	Q8IY18	9	70258978-70354873	"Predicted intracellular proteins"	"Cell cycle, Cell division, DNA damage, DNA recombination, DNA repair, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA054900	Supported		Supported	"Nuclear speckles"		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	"Nuclear speckles"		"HPA054900: AB_2682634"	"unprognostic (2.55e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.24e-2)"	"unprognostic (1.40e-1)"	"unprognostic (2.72e-1)"	"unprognostic (8.04e-3)"	"unprognostic (2.15e-2)"	"unprognostic (1.20e-1)"	"unprognostic (3.80e-2)"	"unprognostic (2.23e-1)"	"unprognostic (3.36e-2)"	"unprognostic (7.30e-2)"	"unprognostic (1.71e-2)"	"unprognostic (2.73e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.80e-1)"	10.2	7.7	4.3	15.0	4.8	26.0	16.6	10.4	5.0	12.2	9.0	15.0	13.5	15.2	12.8	10.8	12.3	12.9	9.9	4.2	6.1	8.0	14.8	12.8	18.5	5.2	5.7	25.2	19.4	10.4	9.6	14.8	5.7	11.4	16.9	8.3	17.1	8.7	13.8	9.0	13.9	10.7	4.2	12.0	14.5	13.5	4.9	18.2	14.3	8.2	16.1	16.4	11.3	7.8	43.9	10.8	26.6	16.2	15.1	28.3	20.9	29.8	25.8	15.9	17.3	4.1	23.3	43.7	9.5	22.5	13.9	39.3	28.9	19.8	31.7	19.9	10.3	25.5	18.3	13.1	19.2	41.8	25.3	19.9	13.5	21.5	24.5	25.4	16.9	25.8	19.1	17.1	29.9	6.7	55.4	14.7	20.4	33.5	14.9	32.4	43.6	13.7	16.1	21.3	18.9	14.2	29.5	18.7	8.3	19.2	11.2	17.6	18.6	21.3	22.4	29.2	41.2	20.9	29.9	29.9	17.9	21.6	25.9	14.1	5.6	10.4	8.5	6.3	8.0	8.4	7.3	8.1	4.6	8.2	8.0	7.4	3.7	8.1	7.6	8.7	8.4	4.0	4.3	4.8	10.4	5.0	4.2	6.1	5.2	5.7	5.7	4.2	4.9	7.8	48.9	57.7	70.3	61.7	54.6	45.6	102.0	30.3	59.7	26.8	39.2	34.0	34.6	41.5	62.0	20.2	29.2	32.1	65.2	38.8	9.8	61.3	47.9	65.3	58.9	37.6	28.1	29.0	72.2	54.8	37.5	62.1	40.8	89.1	51.8	52.5	16.1	25.9	16.4	38.7	66.4	34.8	20.3	22.9	30.8	15.9	53.4	37.9	24.9	74.0	65.4	17.2	54.6	85.5	94.6	68.3	37.9	59.5	40.6	105.5	23.6	11.7	51.0	35.7	26.3	66.2	52.2	80.0	55.0	52.5	41.9	35.6	56.7	58.4	45.0	105.8
SMC6	"FLJ22116, SMC6L1"	ENSG00000163029	"Structural maintenance of chromosomes 6"	Q96SB8	2	17663812-17800242	"Predicted intracellular proteins"	"DNA damage, DNA recombination, DNA repair"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 153.4;Spermatocytes: 150.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035057, CAB037186, HPA042733"	Uncertain		Supported	Nucleoplasm		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"CAB037186: AB_1080031, HPA035057: AB_2674435, HPA042733: AB_2678134"	"unprognostic (1.75e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.50e-2)"	"unprognostic (1.33e-3)"	"unprognostic (1.70e-2)"	"unprognostic (6.57e-2)"	"unprognostic (1.38e-2)"	"unprognostic (3.91e-2)"	"unprognostic (2.03e-2)"	"unprognostic (2.94e-3)"	"unprognostic (9.33e-2)"	"unprognostic (1.38e-1)"	"prognostic unfavorable (3.15e-4)"	"unprognostic (7.02e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.25e-1)"	"unprognostic (5.25e-2)"	8.4	5.2	6.8	14.7	7.6	13.3	8.5	11.4	7.7	9.5	31.9	11.9	9.0	9.4	17.4	13.2	8.7	9.4	8.6	8.0	8.4	8.9	17.2	9.0	21.6	6.2	6.9	6.9	6.1	6.0	11.6	14.2	7.4	6.7	13.3	6.8	12.4	10.8	9.4	14.7	11.4	8.7	5.3	14.9	9.8	35.2	8.4	14.3	7.7	8.8	22.6	8.6	11.4	10.6	50.6	24.8	31.9	26.6	33.6	32.2	32.2	26.4	18.6	16.7	16.2	27.9	19.4	43.9	16.6	24.2	27.9	34.4	38.5	31.0	25.7	52.3	25.2	60.3	16.2	42.1	31.3	42.3	31.2	24.3	21.4	27.0	35.1	20.5	38.9	26.4	67.5	35.4	31.9	20.8	32.8	21.7	43.3	25.3	19.7	38.7	90.0	29.9	16.2	27.7	28.0	29.9	38.4	20.0	30.0	35.1	12.7	18.7	42.7	41.3	16.5	32.5	47.2	25.0	43.5	87.9	21.0	45.7	30.0	2.2	3.8	8.2	7.8	4.2	6.6	24.8	6.0	7.1	5.1	26.4	4.3	6.0	3.1	7.5	6.7	27.7	14.4	4.1	6.8	7.6	11.4	7.7	8.0	8.4	6.2	6.9	7.4	5.3	8.4	10.6	25.6	48.1	12.5	34.9	63.7	18.2	21.6	41.5	68.3	15.2	8.4	9.3	36.5	14.3	30.8	5.5	12.5	15.2	51.5	18.9	11.7	17.0	153.4	33.0	26.3	21.9	11.3	36.6	51.1	11.7	27.5	21.0	32.1	18.2	20.8	38.6	15.7	19.3	17.6	6.7	47.9	15.7	16.2	10.0	9.1	123.7	22.4	20.1	26.6	30.0	22.0	12.5	25.7	56.3	60.5	19.7	17.2	27.4	25.3	25.1	16.0	14.5	27.2	17.4	46.0	41.2	67.8	150.0	87.9	37.4	14.2	12.4	22.2	28.9	21.2	14.9
SMDT1	"C22orf32, DDDD, dJ186O1.1, EMRE"	ENSG00000183172	"Single-pass membrane protein with aspartate rich tail 1"	Q9H4I9	22	42079691-42084284	"Predicted membrane proteins, Transporters"	"Calcium transport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA032117, HPA060340"	Uncertain		Supported	Nucleoplasm,Mitochondria		NA	NA			"Cluster 22: NK-cells - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria	Nucleoplasm	"HPA032117: AB_10601093, HPA060340: AB_2684257"	"unprognostic (1.11e-2)"	"unprognostic (1.46e-3)"	"unprognostic (5.77e-2)"	"prognostic favorable (5.32e-8)"	"unprognostic (1.25e-1)"	"unprognostic (2.40e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.07e-2)"	"unprognostic (2.55e-1)"	"unprognostic (4.84e-2)"	"prognostic favorable (5.87e-4)"	"unprognostic (2.96e-1)"	"prognostic favorable (2.36e-9)"	"unprognostic (1.91e-1)"	"unprognostic (2.65e-1)"	"unprognostic (1.45e-1)"	"unprognostic (9.72e-3)"	12.2	13.9	21.6	6.1	22.2	17.6	19.5	25.7	27.7	14.6	21.2	14.7	10.3	12.3	19.5	12.6	15.2	7.4	20.0	22.1	22.0	18.2	15.1	9.7	16.1	21.6	21.4	22.5	21.5	18.0	14.9	7.3	22.2	16.1	11.2	16.0	22.7	13.4	35.6	14.8	13.5	8.4	21.3	12.6	17.7	6.9	21.3	12.4	18.6	37.9	12.2	12.4	11.9	22.4	5.7	3.7	7.4	8.9	13.1	9.5	5.8	2.0	10.0	12.1	10.5	7.1	5.3	7.8	2.4	10.3	3.4	6.1	9.8	10.4	7.7	3.8	15.7	4.7	8.1	10.3	16.5	8.6	5.9	7.4	17.3	4.8	9.9	6.9	12.2	5.1	7.9	12.3	8.4	11.2	12.1	13.0	2.8	14.1	2.7	10.8	6.5	20.8	15.5	6.4	9.2	6.0	5.0	11.1	12.8	3.7	9.3	9.3	4.8	5.1	5.3	4.5	3.9	8.2	9.8	16.9	7.9	8.5	4.1	4.0	5.8	2.9	3.1	3.1	5.9	5.9	8.6	4.5	8.4	7.2	9.3	6.0	0.5	5.5	4.5	6.4	5.4	5.4	21.6	22.2	25.7	27.7	22.1	22.0	21.6	21.4	22.2	21.3	21.3	22.4	161.1	83.3	109.3	11.8	295.0	166.7	202.2	157.3	191.2	71.6	400.9	477.3	350.9	237.4	160.3	204.1	20.9	308.7	127.8	285.6	573.2	160.0	114.0	156.8	81.1	138.2	345.2	135.7	10.5	199.6	190.6	127.8	150.3	127.2	91.4	55.4	161.3	380.1	256.1	55.5	12.8	356.5	262.4	164.5	200.6	131.9	189.2	187.7	211.7	5.6	125.8	196.4	124.6	7.5	13.8	193.7	314.0	149.0	275.8	238.2	486.7	623.4	223.7	109.5	124.9	133.6	202.7	256.0	55.5	271.5	274.1	308.8	186.3	151.7	308.8	272.2
SMG1	"ATX, KIAA0421, LIP"	ENSG00000157106	"SMG1 nonsense mediated mRNA decay associated PI3K related kinase"	Q96Q15	16	18804860-18926408	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, Nonsense-mediated mRNA decay"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 31.7"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 31.7"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006870, HPA031623, HPA073972"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 42: Non-specific - Transcription"	"Cluster 50: Non-specific - Ribosome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm		"HPA006870: AB_1079725, HPA031623: AB_2673962, HPA073972: AB_2686648"	"unprognostic (6.34e-2)"	"unprognostic (5.88e-2)"	"unprognostic (5.98e-2)"	"unprognostic (2.66e-1)"	"unprognostic (2.44e-2)"	"unprognostic (1.35e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.28e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.42e-1)"	"unprognostic (8.32e-3)"	"unprognostic (7.28e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.61e-2)"	"unprognostic (1.15e-1)"	"unprognostic (3.17e-2)"	"unprognostic (2.45e-2)"	12.9	8.4	11.0	16.1	11.0	39.0	19.5	42.6	12.6	13.4	11.9	14.4	11.6	14.1	15.8	14.2	12.1	10.8	13.5	12.0	7.5	14.6	17.8	11.4	21.6	7.5	6.7	18.6	13.0	15.2	10.2	11.5	9.9	12.1	15.9	20.9	12.0	10.9	53.1	42.0	13.6	13.2	1.9	15.9	12.8	14.5	12.6	29.9	18.1	35.4	19.1	15.4	13.2	16.6	42.2	27.5	25.5	18.1	28.6	29.9	18.8	19.1	18.8	20.4	22.7	24.4	15.1	57.5	26.8	26.8	21.5	23.3	29.6	16.7	32.3	37.2	18.4	26.2	25.8	31.4	23.1	35.7	19.9	17.7	27.5	42.4	50.5	20.1	29.1	30.7	41.0	31.0	22.8	22.0	24.8	20.9	27.2	15.3	15.7	28.4	34.2	19.8	17.6	32.1	23.0	17.6	29.9	19.9	20.8	20.8	15.9	22.3	37.0	30.2	20.4	19.0	28.7	15.8	21.8	37.0	20.2	27.1	18.6	31.7	2.7	4.2	6.6	3.2	3.2	4.0	4.4	4.8	2.9	7.6	5.7	5.1	8.4	2.6	7.2	5.3	4.5	1.4	11.0	11.0	42.6	12.6	12.0	7.5	7.5	6.7	9.9	1.9	12.6	16.6	83.2	76.9	85.4	58.4	98.8	193.2	73.0	26.9	112.1	52.0	71.3	40.5	48.1	32.9	67.1	27.6	75.0	21.3	97.4	65.5	3.9	21.7	20.3	88.1	81.1	66.5	39.4	44.8	81.5	23.6	19.0	57.3	90.7	140.0	39.3	66.1	37.9	46.1	24.1	42.1	75.2	41.8	36.7	48.0	112.8	24.9	29.8	82.5	39.2	68.4	61.4	20.5	72.1	48.7	87.5	34.6	76.9	26.4	82.2	94.2	43.0	15.6	45.9	44.8	46.0	118.2	63.1	49.6	32.2	107.1	204.4	30.0	97.6	37.6	46.4	95.4
SMG6	"C17orf31, EST1A, KIAA0732, SMG-6"	ENSG00000070366	"SMG6 nonsense mediated mRNA decay factor"	Q86US8	17	2059839-2303785	"Plasma proteins, Predicted intracellular proteins"	"Nonsense-mediated mRNA decay"	"DNA-binding, Endonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042932	Approved		Supported	Nucleoli,Cytosol		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 52: Non-specific - Transcription"	Nucleoli	Cytosol	"HPA042932: AB_10964261"	"unprognostic (5.22e-2)"	"unprognostic (1.20e-1)"	"unprognostic (5.30e-1)"	"unprognostic (4.41e-2)"	"unprognostic (1.33e-1)"	"unprognostic (9.33e-3)"	"unprognostic (1.62e-1)"	"unprognostic (2.08e-1)"	"unprognostic (4.75e-2)"	"unprognostic (7.63e-2)"	"unprognostic (4.78e-2)"	"unprognostic (1.31e-1)"	"prognostic favorable (1.30e-6)"	"unprognostic (1.90e-2)"	"unprognostic (2.67e-1)"	"unprognostic (2.61e-1)"	"unprognostic (3.08e-2)"	12.2	13.0	15.5	12.3	14.6	13.6	10.5	17.6	15.0	16.4	13.2	11.4	9.3	26.6	11.1	16.4	21.7	17.2	14.0	13.8	17.8	12.3	7.4	11.9	12.3	19.9	17.3	37.5	7.4	14.4	13.3	10.5	14.3	13.9	9.4	19.2	10.4	12.8	12.9	16.0	10.9	18.9	12.5	9.8	9.6	19.5	16.0	23.1	11.7	9.1	10.9	13.1	12.0	14.8	14.9	22.5	31.7	20.6	33.6	27.0	16.3	23.6	25.9	26.3	22.2	27.6	7.3	15.7	8.3	34.8	12.0	21.3	23.5	20.1	27.4	15.7	14.7	15.3	11.8	13.5	19.2	8.2	10.5	38.5	14.5	21.2	18.6	42.6	24.3	15.3	12.8	18.5	19.9	11.7	20.8	6.6	10.2	8.9	11.7	21.4	20.2	6.2	15.2	13.5	5.3	16.1	24.6	7.1	10.2	22.2	11.1	6.0	32.2	24.0	13.1	25.6	25.1	16.0	10.5	7.2	19.1	9.1	14.0	3.0	0.7	0.8	1.3	0.3	1.3	0.5	1.1	1.3	0.4	0.7	1.5	1.1	0.5	2.0	1.6	1.3	0.6	0.6	15.5	14.6	17.6	15.0	13.8	17.8	19.9	17.3	14.3	12.5	16.0	14.8	17.2	22.4	18.4	41.4	13.2	7.9	13.8	13.1	10.2	35.6	13.8	14.5	8.0	7.2	11.8	14.7	75.0	16.5	17.7	17.9	5.9	13.8	22.5	19.4	37.1	20.3	4.2	12.8	57.1	12.4	10.7	21.0	18.3	21.3	10.8	20.3	17.9	9.1	10.3	47.1	61.7	14.4	16.2	8.7	6.8	36.9	16.8	10.6	8.8	81.5	15.9	24.8	21.6	44.7	64.3	17.2	15.2	19.9	14.6	14.7	10.1	7.6	17.9	50.5	26.3	27.1	20.4	63.7	59.0	15.1	8.7	17.4	24.9	22.4	13.5	14.2
SMG7	"C1orf16, EST1C, KIAA0250, SGA56M, SMG-7"	ENSG00000116698	"SMG7 nonsense mediated mRNA decay factor"	Q92540	1	183472216-183598246	"Plasma proteins, Predicted intracellular proteins"	"Nonsense-mediated mRNA decay"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029350	Supported		Supported	"Intermediate filaments,Cytosol"		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 44: Endometrium - Transcription"	"Intermediate filaments, Cytosol"		"HPA029350: AB_10603031"	"unprognostic (6.06e-2)"	"unprognostic (1.79e-1)"	"unprognostic (3.32e-1)"	"unprognostic (2.67e-3)"	"unprognostic (1.98e-2)"	"unprognostic (1.36e-1)"	"unprognostic (5.44e-2)"	"unprognostic (6.15e-2)"	"unprognostic (1.46e-1)"	"unprognostic (9.01e-2)"	"unprognostic (6.17e-2)"	"unprognostic (2.69e-1)"	"unprognostic (6.47e-3)"	"unprognostic (7.82e-2)"	"unprognostic (3.76e-2)"	"unprognostic (2.16e-2)"	"unprognostic (4.40e-3)"	17.4	16.2	19.2	21.9	20.8	43.1	17.0	28.1	24.4	19.6	21.4	20.0	20.5	19.6	15.4	22.9	25.9	15.3	22.0	20.4	18.1	21.8	22.7	18.7	25.8	16.5	17.8	25.9	21.8	24.8	20.4	18.9	16.0	17.0	23.8	32.0	21.6	16.1	25.8	25.3	20.5	17.9	16.0	21.5	22.4	67.5	19.5	35.7	23.5	27.9	30.2	18.1	19.3	20.0	56.4	33.6	47.5	37.3	31.8	29.8	78.9	33.8	61.8	36.9	28.0	50.1	42.8	78.9	37.9	42.1	33.5	59.4	64.5	50.1	43.4	35.2	28.1	63.8	36.3	41.0	32.1	84.4	39.1	27.3	45.0	50.6	116.1	30.0	41.0	42.9	80.6	54.0	38.8	56.9	59.7	37.1	82.4	66.9	19.1	37.2	53.0	61.9	28.3	51.7	63.7	49.7	52.2	73.1	40.5	80.4	72.9	34.0	39.3	41.5	42.9	41.7	48.5	58.6	74.3	63.5	33.8	46.9	45.3	2.0	5.8	6.2	5.6	5.7	5.1	5.5	5.0	5.5	6.6	4.7	5.5	5.9	6.8	5.9	3.2	7.0	4.9	5.1	19.2	20.8	28.1	24.4	20.4	18.1	16.5	17.8	16.0	16.0	19.5	20.0	31.3	22.4	20.6	66.3	26.8	27.0	11.6	13.9	23.3	22.6	21.4	15.6	31.8	20.0	20.5	27.6	31.3	11.4	23.9	38.5	9.8	12.1	58.1	39.8	23.6	26.8	34.6	28.8	63.0	15.8	16.5	14.9	31.1	48.0	22.1	19.4	25.4	45.2	13.2	30.3	63.0	23.0	6.1	38.6	48.6	49.5	15.2	25.2	10.6	52.5	20.0	9.6	15.5	70.9	99.1	17.6	19.9	12.4	36.2	16.7	30.4	12.9	30.5	19.0	39.5	14.5	23.8	35.2	23.8	30.8	26.9	10.8	24.2	13.0	18.8	23.2
SMN1	"BCD541, GEMIN1, SMA, SMA@, SMA1, SMA2, SMA3, SMNT, TDRD16A"	ENSG00000172062	"Survival of motor neuron 1, telomeric"	Q16637	5	70925030-70953942	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins"	"mRNA processing, mRNA splicing, Neurogenesis"	RNA-binding	"Disease variant, FDA approved drug targets, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Club cells: 29.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"MOLT-4: 120.5;NB-4: 77.9;T-47d: 88.9;WM-115: 120.3"									"CAB016324, HPA045271, CAB069888, HPA073601"	Supported		Supported	"Nuclear bodies,Cytosol"		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 72: Non-specific - Transcription"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 11: Alveolar cells - Smell perception"	"Nuclear bodies, Cytosol"		"CAB016324: AB_627931, CAB069888: AB_10001257, HPA045271: AB_2679280, HPA073601: "	"unprognostic (1.32e-1)"	"unprognostic (1.59e-1)"	"unprognostic (3.18e-1)"	"unprognostic (2.09e-1)"	"unprognostic (2.85e-1)"	"unprognostic (9.52e-3)"	"unprognostic (2.10e-2)"	"unprognostic (2.43e-1)"	"unprognostic (9.91e-3)"	"unprognostic (1.13e-2)"	"unprognostic (1.01e-1)"	"unprognostic (4.41e-1)"	"prognostic unfavorable (6.62e-13)"	"unprognostic (2.04e-1)"	"unprognostic (2.17e-1)"	"unprognostic (8.06e-2)"	"unprognostic (4.14e-2)"	28.0	21.8	5.7	4.9	6.1	21.8	26.8	7.6	7.5	33.8	5.0	25.8	2.1	24.7	12.8	25.8	31.5	7.4	20.4	6.3	7.1	22.6	37.6	22.0	15.5	6.5	5.7	36.8	27.6	6.9	26.4	5.1	6.1	25.6	7.8	12.1	21.5	3.8	31.5	24.0	19.6	8.2	5.9	22.6	20.3	24.8	5.7	2.4	24.2	1.5	1.9	26.1	27.6	6.6	11.3	2.1	3.5	4.0	19.3	23.0	62.8	3.5	4.9	5.3	3.8	4.1	4.1	4.6	69.5	9.9	5.8	7.4	5.4	3.7	4.2	1.0	5.2	65.4	6.2	6.2	1.3	7.9	5.8	1.5	29.8	1.8	1.8	31.4	3.0	4.1	2.7	6.4	2.7	3.2	120.5	77.9	4.4	0.9	2.1	6.0	15.9	58.0	2.4	5.2	11.4	16.2	6.5	23.4	69.4	2.4	88.9	21.2	32.7	33.8	3.8	3.1	7.5	4.2	3.0	60.0	4.9	4.8	120.3	9.8	7.4	4.3	6.4	12.2	17.6	13.2	10.2	7.7	11.2	7.2	13.1	14.5	2.1	8.7	13.5	13.1	16.1	6.3	5.7	6.1	7.6	7.5	6.3	7.1	6.5	5.7	6.1	5.9	5.7	6.6	5.0	9.6	11.5	0.0	5.6	13.9	4.6	10.7	0.6	4.7	4.1	4.3	22.4	7.2	29.9	1.8	10.4	7.9	7.0	2.3	5.9	6.8	18.2	5.6	5.5	6.8	6.0	9.9	1.3	4.6	8.4	11.8	4.1	4.4	19.6	4.0	5.0	2.9	4.8	3.3	1.1	4.2	10.2	3.4	4.4	12.9	9.3	5.2	5.4	0.0	6.1	1.4	12.3	1.0	1.3	6.5	1.8	6.4	5.1	2.9	3.8	4.5	28.1	7.8	13.1	7.4	8.5	16.0	17.2	6.9	12.5	8.8	7.2	5.6	4.2	4.1
SMN2	"BCD541, GEMIN1, SMNC, TDRD16B"	ENSG00000205571	"Survival of motor neuron 2, centromeric"	Q16637	5	70049638-70078522	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins"	"mRNA processing, mRNA splicing, Neurogenesis"	RNA-binding	"Disease variant, FDA approved drug targets, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 41.8;Club cells: 20.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BEWO: 122.7;MOLT-4: 125.1;NB-4: 106.2"									"CAB009344, HPA045271, HPA073601"	Supported		Supported	"Nuclear bodies,Cytosol"		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 72: Non-specific - Transcription"	"Cluster 24: NB-4 - Immune response"	"Cluster 43: Cardiomyocytes - Nuclear processes"	"Nuclear bodies, Cytosol"		"CAB009344: AB_2193083, HPA045271: AB_2679280, HPA073601: "	"unprognostic (2.07e-2)"	"unprognostic (5.70e-3)"	"unprognostic (1.23e-1)"	"unprognostic (1.59e-1)"	"unprognostic (2.77e-1)"	"unprognostic (1.89e-1)"	"unprognostic (1.40e-3)"	"unprognostic (2.08e-1)"	"unprognostic (1.22e-4)"	"unprognostic (1.17e-1)"	"unprognostic (2.21e-1)"	"unprognostic (5.19e-2)"	"unprognostic (2.98e-5)"	"unprognostic (2.36e-2)"	"unprognostic (1.76e-1)"	"unprognostic (2.67e-1)"	"unprognostic (1.19e-1)"	19.7	15.6	1.6	4.5	1.8	13.8	19.4	1.0	2.3	20.3	1.0	19.2	0.5	20.0	16.9	17.1	15.2	13.6	16.0	1.1	7.2	14.4	23.2	16.4	13.8	1.7	2.0	25.9	18.3	8.4	20.5	3.8	2.0	18.8	5.6	3.0	15.1	5.8	26.0	17.0	13.6	14.0	1.3	14.7	14.5	16.5	1.6	0.1	17.3	0.0	0.1	16.0	20.9	2.3	61.3	0.6	0.6	0.4	16.1	20.9	122.7	31.7	21.1	42.0	44.0	0.4	0.4	1.2	86.6	31.8	1.1	28.8	0.9	0.0	50.1	0.8	1.2	68.6	0.0	2.1	0.0	1.1	0.0	0.3	36.0	0.0	1.1	14.3	0.7	0.0	0.0	0.6	0.0	0.6	125.1	106.2	0.5	0.0	0.5	0.0	45.8	55.3	31.5	0.3	30.5	70.7	60.2	6.7	89.7	0.0	41.4	25.2	53.4	27.2	1.3	0.4	0.7	0.6	1.1	72.4	0.4	0.0	76.2	8.0	9.9	5.2	12.1	16.5	14.6	16.8	14.4	10.1	16.6	20.0	17.0	14.8	1.8	10.9	11.4	16.3	12.7	13.4	1.6	1.8	1.0	2.3	1.1	7.2	1.7	2.0	2.0	1.3	1.6	2.3	2.0	6.4	7.8	0.0	2.7	13.6	3.4	9.7	1.8	0.3	2.7	2.8	41.8	0.0	20.2	1.8	0.0	6.9	4.0	1.1	5.9	2.7	14.1	3.3	4.0	6.6	1.8	3.4	0.0	1.0	3.3	10.1	2.6	3.2	8.2	1.2	2.5	3.1	2.6	1.7	0.0	3.1	6.1	2.6	6.8	8.9	7.2	3.3	1.8	0.0	2.9	0.6	2.1	0.0	0.0	2.3	1.6	5.3	2.5	1.7	2.7	3.8	14.0	1.1	0.0	5.3	6.4	12.0	11.4	3.1	12.6	7.1	5.0	1.0	2.5	2.8
SMNDC1	"SMNR, SPF30, TDRD16C"	ENSG00000119953	"Survival motor neuron domain containing 1"	O75940	10	110290730-110304938	"Predicted intracellular proteins"	"Apoptosis, mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA061214, HPA070666"			Enhanced	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm	"Nuclear bodies"	"HPA061214: AB_2684451, HPA070666: "	"unprognostic (4.65e-2)"	"unprognostic (1.68e-2)"	"unprognostic (2.64e-1)"	"unprognostic (3.07e-2)"	"unprognostic (3.63e-3)"	"unprognostic (5.03e-3)"	"prognostic unfavorable (8.08e-6)"	"unprognostic (3.16e-3)"	"unprognostic (1.21e-1)"	"unprognostic (1.33e-1)"	"prognostic unfavorable (7.20e-4)"	"unprognostic (2.68e-3)"	"unprognostic (6.88e-3)"	"unprognostic (1.35e-1)"	"unprognostic (2.82e-1)"	"unprognostic (1.80e-1)"	"unprognostic (2.00e-1)"	16.3	12.0	7.0	15.1	7.5	31.8	13.7	10.8	11.1	13.8	7.7	13.4	9.9	14.4	8.7	16.2	13.3	11.6	12.4	6.5	7.2	13.6	14.9	14.2	16.9	7.1	6.9	13.5	10.2	13.1	8.9	18.4	7.0	10.0	11.1	16.6	11.5	10.2	24.8	13.2	11.5	14.6	7.5	14.7	11.5	13.1	7.1	20.4	12.1	17.9	18.3	17.3	13.7	9.4	36.2	27.0	38.9	44.9	29.6	35.1	28.9	41.0	42.6	53.3	54.6	35.1	43.7	51.2	25.7	25.9	30.5	38.5	57.8	28.2	59.9	29.0	30.6	51.1	21.9	41.2	35.3	56.9	47.2	27.4	29.7	42.2	71.1	39.5	30.0	29.0	46.8	46.5	41.9	17.1	61.0	55.0	43.5	27.8	18.4	52.0	77.9	26.8	30.0	25.7	19.4	26.0	26.6	22.4	48.9	33.3	27.7	32.3	33.0	31.2	35.2	28.9	52.9	37.8	42.4	76.7	31.4	77.9	24.6	5.7	8.9	14.5	5.2	9.2	6.4	5.4	6.8	6.7	8.6	4.8	5.9	5.9	16.6	6.3	9.8	5.2	8.1	4.3	7.0	7.5	10.8	11.1	6.5	7.2	7.1	6.9	7.0	7.5	7.1	9.4	57.7	28.9	37.1	6.8	53.4	69.6	42.5	27.2	89.4	27.3	31.7	26.7	23.4	14.3	27.9	11.0	20.9	33.0	55.7	23.9	33.2	22.8	10.7	34.2	52.0	41.5	18.6	37.0	7.8	18.0	32.0	39.1	37.8	58.8	58.3	27.3	27.1	26.5	32.4	33.7	8.0	21.4	38.7	40.9	79.7	4.4	29.2	47.7	35.6	6.5	45.8	23.0	22.6	5.0	11.2	21.7	21.0	22.2	45.7	53.3	20.6	40.9	28.6	33.0	19.7	30.8	39.7	46.2	37.7	72.4	83.4	46.1	57.4	33.5	24.1	65.8
SMOX	"C20orf16, dJ779E11.1, FLJ20746, MGC1010, PAO, PAOh1, SMO"	ENSG00000088826	"Spermine oxidase"	Q9NWM0	20	4120980-4187747	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 61.3"	"Cell type enhanced"	"Detected in many"		"Ductal cells: 48.4;Erythroid cells: 89.7;Macrophages: 73.3;Pancreatic endocrine cells: 131.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"classical monocyte: 1.0;myeloid DC: 2.4;neutrophil: 3.6;plasmacytoid DC: 1.1"	"Group enriched"	"Detected in many"	6	"dendritic cells: 2.4;granulocytes: 3.6;monocytes: 1.0"	"Cell line enhanced"	"Detected in many"		"A549: 119.6;Karpas-707: 201.7;RPTEC TERT1: 91.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047117, HPA060198"	Approved		Supported	"Nucleoplasm,Nuclear membrane,Vesicles,Cytosol"		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 22: Non-specific - Unknown function"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 51: Myeloid cells - Hemostasis"	Nucleoplasm	"Nuclear membrane, Vesicles, Cytosol"	"HPA047117: AB_2679940, HPA060198: AB_2684220"	"unprognostic (1.24e-2)"	"unprognostic (6.55e-2)"	"unprognostic (7.24e-3)"	"unprognostic (2.77e-1)"	"unprognostic (1.40e-1)"	"unprognostic (2.32e-1)"	"prognostic unfavorable (3.33e-6)"	"prognostic unfavorable (1.36e-4)"	"unprognostic (4.92e-2)"	"unprognostic (3.37e-1)"	"unprognostic (7.18e-2)"	"unprognostic (7.58e-2)"	"prognostic unfavorable (1.06e-4)"	"unprognostic (4.08e-2)"	"unprognostic (2.64e-3)"	"unprognostic (1.26e-2)"	"unprognostic (3.07e-1)"	8.5	4.4	50.9	4.4	61.3	32.2	5.3	54.5	60.9	17.7	32.8	5.6	10.6	10.8	7.1	8.5	7.4	15.1	6.8	46.3	51.7	20.5	8.5	4.9	4.8	56.6	54.4	12.5	32.5	25.2	13.2	6.2	53.7	12.2	1.2	2.9	12.1	7.9	4.3	11.9	8.1	4.0	53.0	6.4	20.1	5.8	55.5	4.3	6.8	2.8	2.6	8.2	12.4	54.1	11.0	119.6	8.3	6.3	5.5	8.2	14.6	15.6	29.8	11.1	7.4	49.5	29.6	0.0	5.1	14.4	18.0	21.6	6.8	7.5	4.8	0.0	3.5	21.5	4.1	50.6	35.0	4.1	8.3	31.3	13.1	23.1	9.8	13.4	19.8	16.7	4.8	201.7	6.7	3.3	8.1	12.1	10.2	10.7	16.3	7.3	10.3	29.1	91.4	8.3	1.6	7.2	28.9	3.4	54.1	4.2	0.3	5.1	24.0	12.7	12.0	2.3	12.2	9.1	1.7	0.1	10.6	5.4	9.8	0.0	1.0	0.2	0.0	0.4	0.0	0.1	0.2	0.2	2.4	0.0	0.0	0.0	3.6	0.3	0.1	1.1	0.0	16.0	50.9	61.3	54.5	60.9	46.3	51.7	56.6	54.4	53.7	53.0	55.5	54.1	4.4	0.0	0.5	38.5	3.8	12.6	12.0	14.4	6.8	0.5	6.9	4.6	1.7	12.8	6.3	11.0	0.0	0.4	0.2	1.4	0.0	48.4	4.0	9.2	15.8	11.2	6.0	89.7	1.6	30.5	0.8	11.3	6.6	18.7	5.7	10.4	13.6	2.3	20.6	0.0	3.5	3.0	6.1	3.1	10.2	7.7	14.6	73.3	8.8	5.6	22.6	25.4	1.0	9.0	6.2	131.3	1.5	13.5	7.4	13.1	4.0	3.8	1.2	1.4	0.0	2.7	10.2	19.1	7.8	2.1	10.5	0.3	2.1	1.9	3.7	12.6
SMPD3	NSMASE2	ENSG00000103056	"Sphingomyelin phosphodiesterase 3"	Q9NY59	16	68358327-68448508	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell cycle, Lipid metabolism, Sphingolipid metabolism"	"Developmental protein, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 61.5;lymphoid tissue: 52.0"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 77.1;Gastric mucus-secreting cells: 70.8;Horizontal cells: 301.2;Proximal enterocytes: 115.1"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"amygdala: 8.0;basal ganglia: 29.7;cerebral cortex: 24.9;hippocampal formation: 25.4"	"Immune cell enriched"	"Detected in many"	7	"plasmacytoid DC: 138.9"	"Lineage enriched"	"Detected in many"	7	"dendritic cells: 138.9"	"Cell line enhanced"	"Detected in some"		"HMC-1: 9.7;MOLT-4: 14.7;RPMI-8226: 12.4;SCLC-21H: 13.4"	"Region enhanced"	"Detected in all"		"basal ganglia: 115.2"	"Region enhanced"	"Detected in all"		"basal ganglia: 67.7"	"CAB033885, HPA065535, HPA069383"	Approved		Supported	"Endoplasmic reticulum"		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 56: Intestine - Transmembrane transport"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 62: Horizontal cells - Visual perception"	"Endoplasmic reticulum"		"CAB033885: AB_1126788, HPA065535: , HPA069383: "	"unprognostic (1.21e-1)"	"prognostic favorable (7.72e-4)"	"unprognostic (5.61e-3)"	"prognostic favorable (3.86e-4)"	"unprognostic (2.46e-1)"	"unprognostic (5.85e-4)"	"unprognostic (7.87e-2)"	"unprognostic (8.12e-3)"	"unprognostic (2.77e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.04e-3)"	"unprognostic (5.02e-3)"	"unprognostic (2.49e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.93e-3)"	6.8	2.1	8.0	3.6	29.7	1.8	2.8	1.8	24.9	2.7	0.1	13.8	61.5	1.4	0.1	2.1	3.8	9.0	1.5	25.4	0.5	4.0	7.4	2.5	4.2	0.0	0.2	4.8	2.6	0.1	16.5	0.2	0.6	4.6	6.9	6.5	3.0	0.3	2.4	13.6	57.7	0.7	0.5	3.4	23.2	8.6	5.1	52.0	2.7	0.0	1.9	1.7	2.5	2.3	0.3	0.8	0.4	0.1	0.0	0.0	5.5	0.4	0.0	0.4	0.1	3.1	1.0	0.4	0.6	0.3	0.2	1.2	0.0	0.0	0.1	0.3	0.7	0.1	2.7	0.3	0.0	0.0	9.7	0.0	0.0	0.0	0.2	0.5	0.0	0.9	0.9	0.3	0.3	0.2	14.7	2.8	0.6	4.9	0.1	0.7	0.2	12.4	0.0	0.1	13.4	2.7	0.4	1.6	0.7	0.2	1.1	0.9	0.0	0.4	0.8	1.4	0.1	2.3	1.2	0.3	0.2	0.9	0.2	4.4	0.0	20.7	2.3	0.1	0.3	1.7	0.2	0.6	0.1	0.9	0.6	0.3	0.1	0.1	0.0	138.9	1.9	1.2	8.0	29.7	1.8	24.9	25.4	0.5	0.0	0.2	0.6	0.5	5.1	2.3	0.3	3.2	1.1	1.0	2.6	0.1	1.5	0.6	0.0	50.8	1.8	0.6	2.9	15.7	1.5	0.0	0.0	0.0	77.1	44.7	0.0	1.3	8.5	3.0	0.3	0.6	25.8	0.4	33.8	0.9	0.1	5.2	70.8	0.5	0.0	0.2	0.7	9.4	0.3	301.2	20.4	34.7	2.0	1.0	0.5	18.6	15.2	2.9	0.0	1.9	0.6	0.9	1.0	10.6	1.7	1.6	39.9	45.9	2.5	3.6	115.1	0.0	14.6	3.9	0.0	0.2	0.3	10.0	2.1	0.1	1.0	0.0	6.2	0.2	21.6	5.4
SMTN		ENSG00000183963	Smoothelin	P53814	22	31064105-31104757	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 887.2;urinary bladder: 450.6"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 283.5;Hepatic stellate cells: 121.3;Sertoli cells: 184.1;Smooth muscle cells: 116.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"WM-115: 200.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB001721, HPA051778, HPA058590"	Enhanced		Supported	"Nucleoplasm,Actin filaments"		No	Yes		140000	"Cluster 30: Non-specific - Translation"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 48: Smooth muscle cells - ECM organization"	Nucleoplasm	"Actin filaments"	"CAB001721: , HPA051778: AB_2681607, HPA058590: AB_2683765"	"unprognostic (1.36e-2)"	"unprognostic (4.84e-3)"	"unprognostic (5.59e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.41e-1)"	"unprognostic (2.38e-3)"	"unprognostic (1.08e-3)"	"unprognostic (2.05e-2)"	"unprognostic (4.56e-1)"	"unprognostic (2.15e-1)"	"unprognostic (7.22e-2)"	"prognostic unfavorable (2.73e-5)"	"unprognostic (2.75e-2)"	"unprognostic (1.84e-1)"	"unprognostic (8.41e-3)"	"unprognostic (6.34e-2)"	54.7	19.2	10.8	25.3	12.5	4.7	42.2	10.3	13.1	100.2	7.6	887.2	30.0	251.0	7.0	65.1	132.4	20.8	152.0	9.0	9.3	35.6	15.3	38.2	5.6	11.7	12.5	34.0	25.2	3.3	9.8	17.4	11.0	150.9	29.2	15.2	16.3	177.9	95.7	38.7	151.5	127.2	10.5	54.5	231.2	12.5	12.4	2.9	26.4	26.2	2.5	450.6	91.5	10.0	73.0	21.2	7.2	27.0	11.0	17.2	58.0	106.8	49.1	85.7	58.4	29.9	22.4	32.1	9.3	59.3	17.3	10.6	7.2	62.8	40.4	10.6	58.2	33.9	18.3	36.1	9.7	51.5	57.4	14.2	5.8	114.0	18.7	29.2	74.7	12.3	37.3	25.9	59.6	64.5	5.9	11.4	8.2	36.1	90.0	20.3	20.5	34.6	34.5	23.2	11.5	12.7	33.4	15.9	15.7	7.4	18.8	8.2	118.7	62.1	58.4	59.4	79.8	24.6	32.5	18.8	91.0	19.7	200.5	0.0	1.0	0.0	0.1	0.2	0.0	1.3	0.1	0.3	0.4	0.0	1.0	0.5	0.1	0.1	0.2	0.2	0.0	0.6	10.8	12.5	10.3	13.1	9.0	9.3	11.7	12.5	11.0	10.5	12.4	10.0	94.5	6.4	3.3	23.8	2.0	65.1	33.5	16.1	19.4	46.6	18.6	26.7	39.5	5.7	6.1	9.2	283.5	13.4	2.7	12.8	9.8	14.8	1.2	4.0	52.1	62.8	29.2	0.0	0.2	20.1	68.8	35.9	18.3	7.3	0.0	11.0	121.3	2.6	6.0	5.0	1.9	29.9	14.2	6.8	14.6	1.9	22.4	4.7	14.2	7.5	1.0	31.2	1.0	4.5	2.0	73.2	11.4	48.5	2.1	21.7	5.6	18.4	2.2	54.0	184.1	18.4	116.4	5.7	7.9	9.7	69.3	21.9	3.7	16.3	27.0	14.9
SMUG1	"FDG, HMUDG, UNG3"	ENSG00000123415	"Single-strand-selective monofunctional uracil-DNA glycosylase 1"	Q53HV7	12	54121277-54189008	"Predicted intracellular proteins"	"DNA damage, DNA repair"	"DNA-binding, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Extravillous trophoblasts: 98.9;Syncytiotrophoblasts: 100.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026804, HPA065892"			Supported	"Nucleoplasm,Nucleoli fibrillar center,Cytosol"		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 38: Extravillous trophoblasts - Unknown function"	Nucleoplasm	"Nucleoli fibrillar center, Cytosol"	"HPA026804: , HPA065892: "	"unprognostic (2.68e-1)"	"unprognostic (2.86e-1)"	"unprognostic (8.58e-2)"	"unprognostic (7.68e-2)"	"unprognostic (1.40e-1)"	"unprognostic (3.30e-2)"	"prognostic unfavorable (6.96e-4)"	"unprognostic (1.82e-1)"	"unprognostic (6.12e-2)"	"prognostic favorable (1.31e-4)"	"unprognostic (1.67e-3)"	"unprognostic (3.35e-1)"	"unprognostic (2.41e-3)"	"unprognostic (2.02e-1)"	"unprognostic (1.60e-1)"	"unprognostic (2.46e-1)"	"unprognostic (1.73e-1)"	20.5	29.2	21.9	13.9	22.4	10.7	26.3	20.7	24.2	17.3	22.6	20.8	17.1	17.1	39.9	38.6	24.5	16.9	19.4	22.3	21.1	28.9	49.6	14.7	18.9	23.7	21.4	18.8	30.0	23.9	16.9	19.1	22.1	24.0	18.7	14.3	29.7	18.1	27.4	29.4	21.3	16.3	22.1	21.8	32.2	15.9	22.7	17.8	21.9	21.8	18.6	20.3	20.1	24.8	31.9	57.5	22.2	23.2	40.4	31.3	37.7	24.2	31.4	37.2	33.8	58.0	69.5	19.0	60.4	35.1	34.8	40.3	15.7	63.7	23.5	19.7	33.3	28.6	47.4	42.3	48.2	19.3	34.0	35.7	97.7	43.9	43.2	40.4	30.2	33.3	48.2	40.3	41.4	60.8	24.3	37.2	27.7	54.3	51.7	17.5	22.6	34.3	46.6	46.2	33.1	39.2	27.6	47.3	43.5	44.9	73.7	35.9	14.3	24.7	27.5	22.5	28.1	37.3	32.1	13.1	35.8	15.0	38.4	89.6	46.2	57.1	28.5	39.5	28.4	49.7	27.3	30.7	40.3	36.6	24.6	24.6	45.5	27.1	31.5	45.5	41.0	33.9	21.9	22.4	20.7	24.2	22.3	21.1	23.7	21.4	22.1	22.1	22.7	24.8	6.6	6.4	16.0	2.9	13.3	7.5	14.4	40.2	11.4	10.5	25.5	22.5	17.7	22.8	26.4	25.8	8.4	87.5	8.8	28.4	60.7	37.1	5.2	15.3	8.9	11.0	11.5	7.4	6.8	40.2	98.9	13.6	16.3	11.0	2.5	10.1	18.2	49.4	46.1	6.7	6.1	25.8	32.6	19.2	5.8	11.8	18.6	14.0	5.4	3.7	34.0	16.3	19.6	5.0	8.1	41.4	24.6	17.7	12.6	20.7	58.4	56.6	27.1	11.9	32.9	8.5	13.8	26.2	28.0	20.8	10.4	100.0	9.5	19.4	23.7	19.6
SMURF2		ENSG00000108854	"SMAD specific E3 ubiquitin protein ligase 2"	Q9HAU4	17	64542282-64662307	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Host-virus interaction, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"BJ: 221.1;HBF TERT88: 157.4;LHCN-M2: 164.1;TIME: 207.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA071508	Enhanced		Supported	"Nuclear speckles"		NA	NA			"Cluster 22: NK-cells - Unknown function"	"Cluster 28: Placenta - Pregnancy"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Nuclear speckles"		"HPA071508: AB_2686406"	"unprognostic (1.21e-1)"	"unprognostic (2.07e-2)"	"unprognostic (1.59e-2)"	"unprognostic (3.24e-1)"	"unprognostic (6.19e-2)"	"unprognostic (7.33e-2)"	"unprognostic (2.67e-2)"	"unprognostic (1.50e-1)"	"unprognostic (7.94e-2)"	"unprognostic (1.09e-2)"	"unprognostic (5.46e-3)"	"unprognostic (2.54e-1)"	"unprognostic (5.55e-2)"	"unprognostic (1.98e-2)"	"unprognostic (7.82e-2)"	"unprognostic (2.20e-2)"	"unprognostic (1.41e-1)"	6.8	4.3	3.3	6.2	3.9	5.9	5.2	5.3	3.4	7.3	3.4	5.3	6.9	5.9	2.3	4.4	5.8	7.1	4.1	3.1	3.3	7.0	3.8	10.5	5.0	4.6	2.7	4.8	6.5	6.3	3.4	13.3	2.8	7.4	4.8	12.5	6.2	5.2	3.0	5.0	10.1	6.1	3.2	5.4	7.8	13.0	3.6	7.8	8.3	6.2	6.5	7.5	3.2	3.8	67.0	17.8	15.3	9.1	11.0	41.5	7.6	221.1	103.2	88.2	73.4	10.4	45.5	8.6	14.5	38.8	29.9	15.2	16.0	37.2	157.4	4.3	12.9	9.1	10.9	11.8	12.0	12.2	5.5	11.8	16.1	109.5	48.5	52.7	97.0	11.9	13.0	7.5	164.1	13.2	28.3	4.8	9.9	8.8	23.8	6.1	38.4	5.2	20.1	11.1	16.0	17.9	14.4	5.8	10.0	24.6	11.7	8.4	207.6	93.8	44.4	39.2	139.6	10.4	11.7	13.9	23.7	7.3	28.4	1.0	0.6	1.4	1.0	0.4	1.1	0.7	0.8	1.1	0.7	0.9	0.9	0.9	1.4	2.7	0.3	0.6	0.2	0.5	3.3	3.9	5.3	3.4	3.1	3.3	4.6	2.7	2.8	3.2	3.6	3.8	40.2	32.1	26.0	96.3	18.6	43.8	30.8	10.0	25.0	26.4	23.3	18.7	10.3	7.2	16.1	9.2	43.8	13.2	35.4	13.8	9.8	18.1	29.0	29.0	37.2	39.3	17.9	2.5	46.1	10.0	3.6	28.1	12.2	39.7	13.3	21.4	38.2	5.1	13.6	26.9	40.9	11.2	10.2	17.3	25.5	9.2	12.5	22.8	21.4	101.2	13.2	21.4	20.6	101.0	52.8	26.5	24.7	12.0	18.0	25.2	28.0	9.6	14.4	46.7	0.0	37.4	23.3	37.1	21.3	13.7	39.8	7.3	33.5	16.2	13.8	24.6
SNAI1	"SLUGH2, SNA, SNAH, SNAIL, SNAIL1"	ENSG00000124216	"Snail family transcriptional repressor 1"	O95863	20	49982980-49988886	"Predicted intracellular proteins, Transcription factors"		"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 30.3"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 191.3;Endothelial cells: 54.4;Extravillous trophoblasts: 79.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"plasmacytoid DC: 1.2"	"Lineage enriched"	"Detected in single"	6	"dendritic cells: 1.2"	"Cell line enhanced"	"Detected in many"		"SiHa: 28.1;TIME: 39.3;WM-115: 25.1"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	8	"spinal cord: 7.0"	"CAB005883, HPA056831, HPA069985, CAB078687"	Supported		Supported	Nucleoplasm		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm		"CAB005883: AB_443967, CAB078687: AB_2665847, HPA056831: AB_2732606, HPA069985: AB_2732146"	"unprognostic (4.60e-2)"	"unprognostic (2.25e-2)"	"prognostic unfavorable (4.76e-4)"	"unprognostic (2.60e-2)"	"unprognostic (1.15e-2)"	"unprognostic (4.22e-2)"	"unprognostic (2.04e-1)"	"prognostic unfavorable (1.61e-5)"	"unprognostic (3.34e-3)"	"unprognostic (9.85e-3)"	"unprognostic (1.76e-1)"	"unprognostic (1.28e-1)"	"prognostic unfavorable (2.63e-7)"	"unprognostic (3.75e-3)"	"unprognostic (1.53e-1)"	"prognostic unfavorable (8.82e-7)"	"unprognostic (1.88e-2)"	30.3	12.0	2.5	4.4	2.3	4.5	16.8	2.7	2.8	6.1	2.7	5.1	1.0	7.0	0.7	2.7	9.6	16.5	16.0	2.2	3.8	8.3	5.2	16.7	2.1	4.5	2.7	2.4	5.1	1.3	6.5	7.2	2.6	4.1	0.8	0.3	3.9	2.4	2.3	4.6	3.3	3.1	2.4	9.7	5.9	3.9	4.2	0.8	15.4	1.3	0.7	9.4	4.6	3.0	1.2	0.9	5.4	0.7	1.6	1.0	10.9	4.7	5.8	0.9	0.6	8.9	1.4	0.7	12.6	8.4	5.6	0.1	1.6	0.0	0.5	0.1	1.1	0.6	2.0	5.4	13.6	1.5	4.3	3.1	0.3	2.0	0.0	14.3	14.0	0.7	7.0	0.2	0.0	2.0	0.1	1.6	7.2	0.8	3.8	2.5	1.4	0.8	6.4	0.0	2.3	5.6	28.1	7.1	1.2	4.6	1.4	6.5	39.3	0.0	6.8	0.0	0.1	0.2	0.1	7.5	2.3	2.1	25.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	2.5	2.3	2.7	2.8	2.2	3.8	4.5	2.7	2.6	2.4	4.2	3.0	191.3	0.0	5.3	0.3	11.8	5.2	2.4	0.5	5.2	0.6	18.6	37.0	4.5	2.8	3.8	0.0	0.0	8.3	29.7	2.8	0.0	1.5	3.0	5.8	18.6	54.4	1.8	0.0	0.6	0.2	79.9	31.7	5.6	8.7	1.3	1.0	17.5	0.3	8.0	3.3	0.4	4.5	2.0	6.4	40.3	0.8	5.6	35.6	5.4	0.0	1.0	0.8	0.0	0.0	0.7	4.7	1.6	14.3	2.2	1.6	1.4	0.2	1.0	0.4	6.6	7.6	17.5	1.4	3.8	7.2	4.8	14.0	12.2	7.2	3.0	0.6
SNAP23	"HsT17016, SNAP23A, SNAP23B"	ENSG00000092531	"Synaptosome associated protein 23"	O00161	15	42491233-42545356	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 326.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"eosinophil: 675.6"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001214, CAB037083, CAB037317"	Approved		Supported	"Plasma membrane"		NA	NA		3900000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 51: Myeloid cells - Hemostasis"	"Plasma membrane"		"CAB037083: AB_477494, CAB037317: AB_261925, HPA001214: AB_1080037"	"unprognostic (1.77e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.18e-1)"	"unprognostic (3.76e-3)"	"unprognostic (2.42e-2)"	"unprognostic (1.65e-1)"	"unprognostic (9.67e-3)"	"unprognostic (1.60e-1)"	"unprognostic (2.60e-1)"	"unprognostic (2.93e-1)"	"unprognostic (7.31e-2)"	"unprognostic (1.36e-1)"	"unprognostic (2.04e-2)"	"unprognostic (1.59e-1)"	"unprognostic (8.95e-2)"	"unprognostic (1.10e-1)"	"unprognostic (3.93e-2)"	44.4	30.3	23.0	62.9	27.7	35.1	38.2	25.7	46.3	37.5	28.6	52.8	50.3	43.2	35.3	31.9	29.8	40.2	44.6	23.5	24.8	42.4	44.4	45.2	84.6	28.0	25.9	34.6	24.2	36.2	12.9	68.9	31.3	49.2	51.2	12.8	45.2	30.9	43.9	26.5	56.4	48.3	25.6	70.3	39.9	36.1	27.5	38.0	33.1	28.7	78.7	42.5	23.9	37.2	58.3	29.7	55.7	54.7	91.8	70.4	85.1	77.6	61.8	50.8	59.1	93.0	27.8	35.1	91.3	52.3	48.1	52.7	63.2	50.1	70.9	58.4	35.3	149.2	30.5	89.1	66.8	57.4	136.6	59.1	37.9	43.5	70.4	64.7	192.9	69.4	121.6	31.4	67.1	24.1	68.3	69.4	46.0	94.3	22.8	122.4	33.8	55.1	71.8	57.8	9.0	36.3	57.2	51.3	56.4	83.5	76.2	91.6	155.0	46.6	61.2	52.1	80.4	59.1	122.3	153.2	56.3	120.0	62.8	244.8	159.8	675.6	51.4	237.6	60.2	110.2	53.5	50.2	148.2	103.9	68.0	52.4	361.9	70.7	236.0	62.6	66.4	179.4	23.0	27.7	25.7	46.3	23.5	24.8	28.0	25.9	31.3	25.6	27.5	37.2	58.9	112.2	30.5	30.7	79.0	50.7	107.6	30.8	34.7	7.7	41.9	19.8	19.2	38.6	32.8	20.2	20.9	75.9	45.3	61.3	56.7	71.1	207.6	34.4	38.6	77.1	14.9	25.0	21.2	52.2	109.5	44.3	32.6	41.2	83.5	22.4	77.4	28.0	88.9	5.0	23.6	80.2	52.9	125.4	112.8	326.0	39.1	131.8	44.4	36.5	120.0	14.6	53.5	39.7	54.6	110.8	52.8	60.5	27.9	79.9	55.0	76.2	42.6	18.4	52.6	42.1	40.6	16.7	7.9	29.3	38.5	142.6	48.2	47.8	39.7	64.7
SNAP29	"CEDNIK, SNAP-29"	ENSG00000099940	"Synaptosome associated protein 29"	O95721	22	20859007-20891214	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Autophagy, Cilium biogenesis/degradation, Protein transport, Transport"		"Ichthyosis, Neuropathy, Palmoplantar keratoderma"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 524.1;Late spermatids: 191.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"K-562: 220.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031823, CAB037092, HPA056492"	Supported		Supported	Nucleoplasm,Cytosol		NA	NA		110000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	Cytosol	Nucleoplasm	"CAB037092: AB_477491, HPA031823: AB_10602407, HPA056492: AB_2683151"	"unprognostic (1.76e-1)"	"prognostic favorable (6.99e-4)"	"unprognostic (3.72e-3)"	"unprognostic (3.26e-2)"	"unprognostic (7.83e-3)"	"unprognostic (3.80e-1)"	"unprognostic (1.66e-1)"	"unprognostic (2.05e-2)"	"unprognostic (1.34e-2)"	"unprognostic (2.60e-2)"	"unprognostic (3.68e-2)"	"unprognostic (6.85e-2)"	"unprognostic (1.22e-1)"	"unprognostic (2.52e-1)"	"unprognostic (1.45e-1)"	"unprognostic (4.51e-3)"	"unprognostic (6.08e-2)"	18.3	18.0	10.8	17.1	11.5	18.9	15.9	12.8	18.0	15.3	11.7	19.9	17.4	14.5	11.1	23.1	12.8	13.7	18.9	12.0	11.4	16.8	35.8	13.9	17.0	12.6	11.7	13.6	17.3	18.7	11.0	19.1	12.4	13.5	17.8	14.4	15.8	14.1	31.2	19.0	16.6	18.1	11.2	16.8	18.6	56.5	11.0	24.1	12.3	27.4	19.7	15.6	15.7	12.5	48.4	19.4	27.1	22.3	30.0	43.5	35.0	44.8	40.3	49.5	49.5	26.8	16.7	30.1	27.9	42.2	50.0	27.8	35.8	30.4	53.2	43.5	27.3	50.0	20.9	29.2	42.7	44.6	38.8	34.6	42.2	51.9	37.2	34.0	35.1	25.5	220.8	41.5	46.2	33.1	40.7	42.9	8.9	55.9	20.2	38.9	60.6	12.1	29.1	25.5	22.0	26.2	48.0	29.9	51.0	33.3	46.8	35.3	30.7	50.1	45.5	34.6	35.6	42.4	74.0	55.3	37.5	29.8	36.7	49.0	43.7	52.4	21.7	61.5	22.7	23.7	21.2	23.7	38.0	22.6	19.3	19.8	49.0	60.0	77.9	43.6	34.5	34.6	10.8	11.5	12.8	18.0	12.0	11.4	12.6	11.7	12.4	11.2	11.0	12.5	24.4	12.8	29.0	8.8	19.0	16.7	24.5	34.7	17.6	12.4	26.4	22.5	22.5	21.5	22.9	23.9	12.5	80.1	35.9	40.0	43.0	40.3	524.1	26.3	28.2	30.1	22.1	36.4	9.6	50.0	146.0	28.4	26.5	22.3	29.2	25.0	29.6	46.5	74.4	20.2	7.2	27.6	32.6	49.4	23.1	191.7	33.2	46.7	35.6	2.8	51.4	30.6	48.4	10.6	12.1	59.4	21.4	36.5	44.1	26.7	38.8	36.8	37.4	13.2	39.5	21.9	27.9	113.5	81.1	28.2	15.5	98.2	26.5	70.3	25.3	29.7
SNAPC2	"PTFdelta, SNAP45"	ENSG00000104976	"Small nuclear RNA activating complex polypeptide 2"	Q13487	19	7920338-7923250	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049843, HPA077597"	Supported		Supported	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 71: Testis - DNA repair"	"Cluster 18: U-2197 - ECM organization"	"Cluster 48: Smooth muscle cells - ECM organization"	"Nucleoplasm, Nuclear bodies"	Cytosol	"HPA049843: AB_2680910, HPA077597: AB_2732354"	"unprognostic (4.56e-3)"	"unprognostic (1.89e-1)"	"unprognostic (7.98e-3)"	"unprognostic (8.11e-3)"	"unprognostic (2.03e-1)"	"unprognostic (6.87e-2)"	"prognostic unfavorable (4.89e-5)"	"unprognostic (1.44e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.82e-1)"	"unprognostic (5.45e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.57e-1)"	"unprognostic (3.22e-1)"	"unprognostic (5.30e-2)"	"unprognostic (9.78e-2)"	21.2	21.6	15.4	10.4	17.7	16.7	19.6	14.7	21.4	37.1	11.0	36.1	9.7	50.7	5.7	14.3	35.0	8.3	16.6	17.1	16.0	17.2	11.9	17.1	9.1	15.6	15.2	20.7	17.8	10.1	25.5	6.5	16.4	27.0	3.8	1.8	16.6	17.2	9.0	20.5	15.2	12.4	13.8	21.4	18.7	32.6	16.3	7.6	13.1	9.7	4.9	31.7	25.1	15.3	20.6	22.9	10.8	42.0	14.7	31.1	10.0	21.4	22.6	20.5	18.5	10.6	17.4	17.6	25.8	25.0	16.4	24.7	7.7	15.9	5.9	22.7	19.7	24.5	9.6	15.4	26.6	15.4	38.7	25.5	24.0	24.3	14.9	16.6	23.5	18.1	24.5	28.3	12.7	18.1	19.9	43.6	13.9	10.4	51.8	23.4	10.7	17.6	19.1	7.1	12.7	28.7	11.0	11.8	48.6	4.8	19.2	16.6	30.9	68.8	24.5	65.2	26.8	27.4	48.1	10.8	43.1	31.6	22.2	7.0	23.8	23.5	19.0	30.8	19.2	15.7	16.1	16.5	30.1	14.5	16.6	16.9	3.5	27.7	33.4	19.9	24.0	16.4	15.4	17.7	14.7	21.4	17.1	16.0	15.6	15.2	16.4	13.8	16.3	15.3	19.8	3.2	3.7	3.3	15.4	24.3	20.0	25.1	35.9	8.6	25.8	26.2	3.2	7.2	10.7	11.0	0.0	12.2	22.9	9.8	17.6	21.2	1.9	10.7	25.0	20.7	12.0	20.2	4.1	24.5	24.2	18.5	8.6	15.0	18.4	15.4	12.5	5.2	28.6	23.5	2.6	11.9	14.2	19.6	28.0	6.0	13.7	19.2	19.6	1.0	31.3	6.0	13.4	2.0	3.0	28.9	6.6	14.3	8.4	28.5	16.7	16.1	3.0	6.1	13.1	7.3	30.1	9.5	38.6	19.0	24.3	9.9	18.4	29.2	15.5	24.1
SNAPC3	"MGC132011, MGC33124, PTFbeta, SNAP50"	ENSG00000164975	"Small nuclear RNA activating complex polypeptide 3"	Q92966	9	15422704-15465953	"Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 121.7;Late spermatids: 270.7;Spermatocytes: 113.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA053145, HPA066031"			Supported	"Nucleoplasm,Nucleoli,Nuclear bodies"		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 54: Non-specific - Microtubule organization"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 31: Spermatids - Spermatogenesis"	"Nucleoplasm, Nuclear bodies"	Nucleoli	"HPA053145: AB_2682055, HPA066031: AB_2685600"	"unprognostic (2.62e-1)"	"unprognostic (4.26e-1)"	"unprognostic (5.42e-3)"	"unprognostic (2.09e-1)"	"unprognostic (4.93e-3)"	"unprognostic (6.08e-2)"	"unprognostic (5.60e-3)"	"unprognostic (4.15e-2)"	"unprognostic (1.68e-2)"	"unprognostic (1.67e-2)"	"unprognostic (1.12e-2)"	"unprognostic (2.64e-2)"	"unprognostic (1.36e-3)"	"unprognostic (3.07e-1)"	"unprognostic (2.63e-1)"	"unprognostic (4.38e-2)"	"unprognostic (2.09e-2)"	4.1	6.6	5.5	4.0	5.2	1.7	3.8	10.4	7.6	6.5	4.9	5.8	4.2	5.9	5.4	5.5	5.1	3.8	7.0	7.7	5.5	4.6	3.4	4.3	4.4	5.4	5.5	7.1	4.3	4.9	5.1	6.2	6.2	4.8	5.1	11.3	4.5	3.7	7.9	5.0	5.3	4.5	4.5	4.9	4.8	5.5	6.4	3.5	4.4	6.2	3.9	5.1	5.9	8.0	4.7	5.9	12.3	4.7	9.6	10.0	7.2	7.2	3.1	4.2	4.9	2.8	2.0	3.3	2.7	4.6	5.9	2.8	6.6	3.4	5.1	15.5	7.7	11.9	13.4	4.0	4.8	2.7	8.9	6.5	6.6	2.9	3.3	17.7	7.8	7.7	3.4	5.3	9.7	1.4	3.2	8.5	3.9	3.5	15.4	6.6	1.5	1.8	7.3	2.8	13.1	9.2	2.5	2.2	1.7	10.7	5.3	5.5	6.5	7.0	2.7	3.0	9.3	6.9	9.0	4.2	4.4	3.5	3.3	4.9	14.2	7.8	7.6	24.6	7.6	15.2	7.6	7.0	11.2	16.5	10.9	10.5	1.7	7.8	32.2	9.2	12.2	8.9	5.5	5.2	10.4	7.6	7.7	5.5	5.4	5.5	6.2	4.5	6.4	8.0	13.8	19.2	11.9	31.6	21.1	9.6	14.1	18.1	8.6	19.7	9.7	6.9	39.5	7.2	16.8	20.2	31.3	12.4	14.5	21.3	13.7	17.6	121.7	15.2	14.8	18.7	15.0	19.4	56.0	9.2	17.3	15.3	11.2	14.7	17.2	22.2	20.3	14.8	16.1	35.3	63.9	15.7	38.7	25.0	10.7	270.7	33.8	16.3	19.6	26.2	21.5	13.8	18.6	46.8	46.3	12.4	27.9	30.5	18.0	9.8	36.4	28.4	23.9	19.0	13.1	11.6	32.0	113.3	27.1	9.1	11.9	9.7	13.4	34.6	17.7	11.7
SNAPC4	"FLJ13451, PTFalpha, SNAP190"	ENSG00000165684	"Small nuclear RNA activating complex polypeptide 4"	Q5SXM2	9	136375577-136400168	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028939, HPA046627, HPA073243"	Uncertain		Supported	"Nucleoplasm,Nuclear membrane,Cytosol"		No	No			"Cluster 24: B-cells - Unknown function"	"Cluster 71: Testis - DNA repair"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 49: Ciliated cells - Cilium organization"	Nucleoplasm	"Nuclear membrane, Cytosol"	"HPA028939: , HPA046627: AB_10961152, HPA073243: AB_2686585"	"unprognostic (3.34e-2)"	"unprognostic (2.12e-1)"	"unprognostic (5.26e-2)"	"unprognostic (1.75e-2)"	"unprognostic (3.17e-2)"	"unprognostic (2.22e-2)"	"unprognostic (2.08e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.87e-1)"	"unprognostic (2.40e-1)"	"prognostic favorable (4.52e-5)"	"unprognostic (3.15e-2)"	"unprognostic (1.20e-2)"	"unprognostic (1.09e-2)"	"unprognostic (6.99e-2)"	"unprognostic (1.06e-2)"	"unprognostic (6.41e-2)"	6.3	5.3	3.5	6.0	2.9	8.5	6.6	2.0	6.3	8.0	2.7	6.2	5.7	6.7	3.0	5.8	9.8	3.9	5.8	2.9	0.5	7.6	10.8	6.5	6.9	1.7	1.1	8.0	11.3	5.9	11.2	3.7	0.9	8.0	4.1	5.4	6.6	4.6	6.3	8.2	7.2	4.5	0.1	10.1	6.0	19.7	0.9	5.2	8.6	2.4	6.0	6.7	6.4	2.2	9.2	10.5	10.6	14.8	6.7	12.9	19.4	11.7	7.8	12.0	9.5	24.3	8.2	14.0	8.2	9.3	8.3	29.0	12.9	15.0	7.1	19.9	20.3	9.5	30.3	11.6	5.9	20.2	10.8	10.3	12.4	10.4	9.8	10.4	10.8	11.3	19.8	10.1	8.4	20.6	11.7	22.7	21.9	14.5	13.7	19.0	10.7	19.9	6.9	16.4	30.4	21.2	11.7	19.1	6.2	9.1	19.7	11.6	15.4	12.3	11.2	22.3	16.9	6.3	7.9	11.2	8.6	9.3	7.3	0.0	0.5	0.4	0.7	0.3	0.3	0.5	0.3	0.3	0.1	1.5	0.2	0.1	1.0	0.7	0.1	0.5	0.2	0.1	3.5	2.9	2.0	6.3	2.9	0.5	1.7	1.1	0.9	0.1	0.9	2.2	3.6	6.4	9.0	12.1	4.8	5.4	2.8	3.9	5.7	8.2	6.0	5.0	5.9	5.7	3.8	3.7	2.1	2.6	5.9	5.4	0.0	6.2	4.1	15.1	5.6	4.1	5.3	7.0	12.2	4.5	2.0	4.1	4.6	7.1	1.3	7.0	5.7	8.1	3.2	3.3	8.5	5.0	10.2	4.2	7.7	2.5	5.0	3.4	0.0	5.6	3.2	4.4	3.1	7.1	5.5	6.8	5.8	4.9	4.6	3.7	3.6	4.3	20.3	12.2	0.0	4.2	4.4	9.5	10.0	3.0	6.8	1.4	5.7	6.2	6.1	2.9
SNAPC5	SNAP19	ENSG00000174446	"Small nuclear RNA activating complex polypeptide 5"	O75971	15	66490135-66497780	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 118.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024379	Uncertain		Supported	Nucleoplasm		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm		"HPA024379: AB_2671552"	"unprognostic (4.43e-2)"	"unprognostic (1.53e-3)"	"unprognostic (4.39e-3)"	"unprognostic (4.56e-2)"	"unprognostic (3.49e-2)"	"unprognostic (2.31e-1)"	"unprognostic (1.06e-1)"	"unprognostic (8.07e-2)"	"unprognostic (1.12e-2)"	"unprognostic (3.39e-2)"	"unprognostic (3.13e-1)"	"unprognostic (6.28e-2)"	"unprognostic (1.64e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.21e-1)"	"unprognostic (9.40e-2)"	"unprognostic (5.69e-2)"	22.4	26.0	31.5	17.3	32.0	15.0	21.8	33.3	40.5	20.4	34.9	32.9	15.7	25.1	41.1	15.8	22.9	13.9	42.3	32.4	34.2	33.0	35.1	19.4	23.8	31.8	33.2	20.9	22.3	32.9	27.4	18.2	33.0	24.4	18.7	28.6	18.5	22.1	60.1	15.1	19.7	20.2	31.3	22.8	23.2	32.6	33.3	21.3	26.9	27.5	22.3	27.3	17.8	33.6	17.3	54.2	23.4	50.4	27.8	26.5	26.3	19.4	27.1	24.5	17.2	31.1	40.3	21.2	44.6	22.6	22.4	35.5	62.6	27.0	27.3	37.7	34.6	28.5	56.2	47.0	33.0	72.8	30.2	22.4	33.2	20.2	49.9	16.5	17.0	38.6	92.8	43.3	18.2	37.7	35.0	28.5	24.3	72.2	23.0	33.8	23.0	79.5	30.2	24.9	30.1	24.3	22.1	44.0	86.5	49.4	40.5	48.7	17.8	23.0	43.2	25.1	33.3	30.2	56.5	36.3	23.7	93.2	47.9	32.5	26.7	34.7	33.6	43.3	42.3	43.8	40.4	45.2	22.6	32.7	53.5	45.3	13.0	49.2	47.0	39.1	50.7	32.3	31.5	32.0	33.3	40.5	32.4	34.2	31.8	33.2	33.0	31.3	33.3	33.6	24.2	22.4	19.2	13.1	20.1	9.4	16.2	33.0	8.6	13.7	19.1	24.5	53.1	18.6	27.9	27.6	10.4	33.4	23.9	13.9	84.1	27.1	118.4	28.4	18.1	23.3	13.9	17.9	8.6	47.6	26.6	22.5	11.7	14.0	19.6	25.1	12.5	48.2	47.2	18.5	10.2	18.1	38.7	18.2	11.8	98.3	26.8	20.3	26.6	8.4	33.2	22.2	43.3	8.5	13.6	27.9	11.1	27.8	19.2	28.7	17.1	79.7	46.4	19.7	0.0	21.3	25.5	92.3	40.7	15.7	9.7	22.3	26.0	30.0	18.6	19.2
SNCAIP	SYPH1	ENSG00000064692	"Synuclein alpha interacting protein"	Q9Y6H5	5	122311354-122464219	"Disease related genes, Predicted intracellular proteins"			"Neurodegeneration, Parkinson disease, Parkinsonism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"endometrium 1: 19.5;ovary: 37.5"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 84.5;Early spermatids: 68.1;Endometrial stromal cells: 56.9;Inhibitory neurons: 62.8;Oligodendrocyte precursor cells: 30.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	50	"basophil: 7.6"	"Lineage enriched"	"Detected in single"	50	"granulocytes: 7.6"	"Cell line enhanced"	"Detected in some"		"AF22: 5.2;BJ hTERT+: 5.1;HBF TERT88: 3.2;OE19: 3.0;RPMI-8226: 5.2"	"Low region specificity"	"Detected in all"							HPA064687	Uncertain		Supported	"Nucleoplasm,Cytoplasmic bodies"		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 12: NES - Nervous system development"	"Cluster 64: Astrocytes - Nervous system maintenance"	"Cytoplasmic bodies"	Nucleoplasm	"HPA064687: AB_2685324"	"unprognostic (7.28e-3)"	"unprognostic (1.02e-2)"	"unprognostic (3.01e-1)"	"unprognostic (6.56e-2)"	"unprognostic (2.18e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.47e-2)"	"unprognostic (4.95e-2)"	"unprognostic (1.95e-2)"	"unprognostic (3.73e-1)"	"unprognostic (3.52e-2)"	"unprognostic (3.00e-1)"	"unprognostic (5.98e-2)"	"unprognostic (1.82e-3)"	"unprognostic (5.77e-2)"	"unprognostic (2.82e-1)"	"unprognostic (2.44e-1)"	3.1	1.0	2.5	2.5	7.8	0.3	1.4	7.2	3.0	17.2	10.1	1.1	1.2	19.5	1.3	0.6	5.1	2.5	1.3	2.9	2.9	1.7	0.1	1.2	2.1	4.6	5.2	37.5	0.5	0.2	1.2	2.0	4.2	1.9	1.1	0.5	0.4	2.7	0.3	1.8	0.7	12.0	3.0	5.2	1.0	4.5	5.7	1.7	0.8	1.6	1.5	4.1	2.5	4.3	0.0	0.0	5.2	0.1	0.0	0.0	0.1	2.2	5.1	0.8	0.4	0.0	0.1	0.1	0.1	2.2	0.4	0.0	2.1	0.3	3.2	1.9	0.4	0.0	0.3	0.0	0.0	0.0	0.1	0.4	0.0	0.3	0.2	0.0	0.6	0.1	0.0	0.8	0.0	0.0	0.0	0.1	2.5	3.0	0.0	0.1	0.0	5.2	0.2	0.6	0.9	0.0	0.0	0.0	0.0	1.6	0.4	0.0	0.0	0.2	0.5	0.3	0.4	0.0	0.0	0.2	0.2	0.0	0.1	7.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	2.5	7.8	7.2	3.0	2.9	2.9	4.6	5.2	4.2	3.0	5.7	4.3	6.1	0.0	0.5	84.5	0.0	1.8	3.8	0.5	1.8	0.4	0.4	1.0	0.8	1.5	1.7	0.0	0.0	0.0	0.0	0.0	0.0	6.1	68.1	4.6	56.9	7.1	0.0	0.0	21.8	0.0	0.1	5.6	0.0	1.4	1.3	0.1	18.9	0.2	0.3	0.0	62.8	0.0	0.0	0.8	0.4	16.6	5.3	0.6	1.8	13.1	0.0	0.5	0.0	30.7	1.9	0.4	0.7	5.7	0.0	3.0	0.0	0.3	14.9	0.0	0.0	0.5	2.3	4.1	2.1	1.8	2.7	0.1	0.4	0.1	0.2	1.5
SNF8	"Dot3, EAP30, VPS22"	ENSG00000159210	"SNF8 subunit of ESCRT-II"	Q96H20	17	48929316-48944842	"Predicted intracellular proteins"	"Protein transport, Transcription, Transcription regulation, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 341.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059320	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 10: Non-specific - Unknown function"	Cytosol	Nucleoplasm	"HPA059320: AB_2683977"	"unprognostic (7.85e-3)"	"unprognostic (3.97e-3)"	"unprognostic (2.25e-2)"	"unprognostic (1.73e-1)"	"unprognostic (4.39e-1)"	"unprognostic (1.77e-1)"	"prognostic unfavorable (7.64e-4)"	"unprognostic (1.91e-1)"	"unprognostic (1.58e-1)"	"unprognostic (2.64e-1)"	"unprognostic (1.73e-2)"	"unprognostic (5.36e-2)"	"prognostic unfavorable (2.81e-7)"	"unprognostic (1.56e-2)"	"unprognostic (1.22e-1)"	"unprognostic (3.52e-1)"	"unprognostic (1.38e-1)"	28.7	31.7	24.6	26.0	26.9	35.2	26.6	25.8	27.1	21.5	24.7	28.4	27.6	21.3	32.1	26.9	20.3	20.5	42.7	23.9	25.7	33.0	33.1	21.9	24.8	25.9	25.9	18.5	29.7	26.1	18.3	22.0	26.1	20.1	30.7	18.1	29.6	21.5	48.6	23.7	24.4	25.8	25.6	22.7	30.0	18.4	25.5	27.8	25.5	48.5	32.5	26.7	20.5	29.2	60.9	119.3	73.2	93.3	73.7	42.4	114.0	49.9	68.1	95.0	84.8	294.6	61.5	55.3	85.5	94.3	106.0	39.8	68.0	70.1	105.4	80.1	110.7	61.6	158.7	126.1	64.2	83.8	66.6	52.7	68.9	91.0	69.2	70.5	90.4	71.7	61.4	54.7	98.2	120.7	90.8	71.4	35.6	139.1	101.3	58.9	132.8	65.8	57.1	67.4	48.0	96.3	60.1	28.1	73.5	125.2	70.9	101.3	77.2	103.6	81.1	65.3	95.1	79.6	97.5	66.0	92.1	45.1	81.5	0.9	4.4	9.2	2.5	5.0	1.3	4.4	3.5	2.8	5.0	5.4	2.3	1.9	1.9	1.6	5.7	6.2	4.7	1.1	24.6	26.9	25.8	27.1	23.9	25.7	25.9	25.9	26.1	25.6	25.5	29.2	77.4	44.8	34.4	14.7	60.0	59.8	76.5	46.4	26.2	67.9	75.0	80.9	49.0	68.6	34.4	64.4	14.6	119.6	71.3	126.4	148.7	147.8	111.9	48.3	57.6	63.5	70.8	71.8	21.4	218.4	175.7	62.8	52.5	41.7	43.1	87.5	61.8	75.2	149.1	25.2	22.7	93.2	48.8	84.4	96.2	341.1	62.7	82.7	85.4	8.4	137.9	95.1	80.3	12.1	17.6	166.6	78.7	62.1	88.6	100.0	125.4	210.1	33.7	86.7	46.0	51.9	123.3	68.0	76.3	58.6	72.5	95.1	57.7	75.0	98.9	95.9
SNIP1	PML1	ENSG00000163877	"Smad nuclear interacting protein 1"	Q8TAD8	1	37534449-37554293	"Disease related genes, Predicted intracellular proteins"	"mRNA processing, mRNA splicing, RNA-mediated gene silencing"		"Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Glandular and luminal cells: 58.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036896	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm	Cytosol	"HPA036896: AB_10670244"	"unprognostic (1.37e-1)"	"unprognostic (2.83e-1)"	"unprognostic (1.65e-3)"	"unprognostic (7.24e-2)"	"unprognostic (5.83e-2)"	"unprognostic (8.30e-3)"	"unprognostic (3.26e-2)"	"unprognostic (3.66e-2)"	"unprognostic (7.74e-2)"	"unprognostic (5.01e-2)"	"unprognostic (9.30e-2)"	"unprognostic (5.34e-3)"	"unprognostic (3.06e-2)"	"unprognostic (6.78e-3)"	"unprognostic (2.63e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.86e-1)"	3.2	3.8	3.5	2.8	3.5	5.5	4.3	4.4	4.4	3.5	3.6	3.3	2.5	3.7	3.2	3.9	2.7	2.3	3.1	3.7	3.9	2.8	6.3	2.7	3.7	3.5	3.5	3.5	3.4	3.9	3.1	2.4	3.5	3.8	2.5	3.9	3.4	3.1	3.1	3.4	3.5	2.8	3.2	3.9	3.6	4.4	3.8	4.1	2.9	3.2	4.2	3.1	3.0	4.0	4.9	2.6	5.2	5.1	6.2	5.9	3.5	6.2	6.9	5.7	5.0	2.6	4.1	6.6	4.6	6.5	3.7	5.0	4.9	5.6	4.7	6.0	7.0	10.3	4.4	5.3	7.0	9.6	5.5	5.6	6.5	5.7	7.2	6.2	5.6	5.0	7.3	5.7	4.1	3.5	5.7	7.3	8.5	4.0	6.1	5.0	8.8	5.6	4.3	4.6	4.1	8.4	6.4	4.1	8.3	5.4	3.6	5.1	9.2	4.3	4.9	5.6	6.0	7.0	8.8	5.3	5.3	6.7	4.1	1.5	0.9	1.3	1.5	0.8	1.5	1.0	1.0	1.5	0.8	0.9	1.4	1.2	1.4	1.0	1.2	1.3	1.3	0.6	3.5	3.5	4.4	4.4	3.7	3.9	3.5	3.5	3.5	3.2	3.8	4.0	14.4	19.2	11.9	3.9	18.5	16.2	11.8	6.9	22.8	10.6	18.0	12.1	6.1	17.2	13.9	5.5	8.4	5.4	20.7	11.8	1.9	7.3	7.5	34.4	25.8	9.2	8.4	7.2	6.5	7.1	4.7	12.4	13.7	58.1	12.0	11.0	11.7	10.9	4.6	10.1	6.1	11.0	10.2	8.8	9.2	11.7	8.1	11.4	8.8	4.7	9.5	9.9	12.3	7.1	6.8	8.4	5.8	7.9	15.7	9.7	6.0	4.4	9.7	16.6	0.0	13.6	11.1	14.4	15.1	19.5	18.0	10.1	16.9	8.0	6.5	12.6
SNRNP200	"ASCC3L1, BRR2, HELIC2, KIAA0788, RP33, U5-200KD"	ENSG00000144028	"Small nuclear ribonucleoprotein U5 subunit 200"	O75643	2	96274338-96321271	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Helicase, Hydrolase"	"Disease variant, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029321	Approved		Supported	Nucleoplasm		NA	NA		78000	"Cluster 41: Basophils - Cellular respiration"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm		"HPA029321: AB_10604096"	"unprognostic (2.63e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.44e-1)"	"prognostic unfavorable (3.89e-4)"	"unprognostic (1.50e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.48e-3)"	"unprognostic (1.01e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.74e-1)"	"unprognostic (3.10e-1)"	"unprognostic (6.46e-2)"	"unprognostic (2.61e-2)"	"unprognostic (1.82e-1)"	"unprognostic (2.69e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.03e-1)"	26.5	21.8	11.2	38.1	11.3	58.8	38.6	16.9	12.1	31.9	25.5	29.6	29.4	41.0	20.2	29.5	39.8	25.8	26.9	9.9	11.1	28.8	29.3	29.3	43.2	13.1	10.3	53.2	34.3	52.4	19.7	39.2	12.0	31.6	34.6	67.6	35.1	33.0	47.4	30.8	30.3	38.5	12.2	36.5	30.6	40.4	9.8	73.5	37.4	38.7	52.3	30.1	21.6	14.6	97.8	107.7	144.1	106.1	63.1	57.1	131.5	67.3	80.6	119.5	112.9	197.3	69.3	169.3	101.3	83.3	178.9	74.9	264.4	88.8	130.8	94.3	139.4	221.6	169.8	106.7	40.9	171.2	92.4	58.1	53.7	133.2	112.0	61.3	97.3	98.3	198.2	112.3	68.3	82.3	158.8	49.4	182.8	77.9	102.4	185.0	139.3	107.4	43.8	145.4	159.8	150.5	107.7	88.7	65.4	165.0	86.4	100.5	86.2	98.3	117.2	101.3	96.2	101.0	134.0	207.6	66.2	109.0	106.2	16.7	4.7	6.0	7.9	5.0	8.9	5.7	6.0	9.5	5.6	6.1	5.2	7.1	4.7	7.3	6.1	5.8	6.8	5.5	11.2	11.3	16.9	12.1	9.9	11.1	13.1	10.3	12.0	12.2	9.8	14.6	47.3	44.8	53.9	21.9	57.4	29.6	27.2	35.5	38.1	79.3	40.2	42.4	35.2	54.3	46.2	51.5	104.3	43.2	64.2	43.4	5.9	42.6	29.3	42.4	48.7	44.8	46.7	54.1	21.2	46.7	36.1	37.9	52.0	48.8	25.3	79.0	40.4	49.4	35.1	87.5	21.1	40.6	34.6	31.9	33.2	18.2	57.5	35.2	17.8	16.9	45.2	79.1	73.2	17.1	16.7	46.1	30.7	55.3	68.3	34.8	47.3	17.9	50.7	135.2	65.7	54.7	45.5	77.6	56.0	38.7	33.0	44.6	71.6	53.3	49.4	30.3
SNRNP25	"C16orf33, U11/U12-25K"	ENSG00000161981	"Small nuclear ribonucleoprotein U11/U12 subunit 25"	Q9BV90	16	53828-57669	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 131.6"	"Cell type enhanced"	"Detected in all"		"Distal tubular cells: 156.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"plasmacytoid DC: 219.7"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041183, HPA044248"	Uncertain		Supported	"Nucleoplasm,Cytokinetic bridge,Cytosol"		Yes	No			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	"Cytokinetic bridge, Cytosol"	"HPA041183: AB_2677353, HPA044248: AB_2678873"	"unprognostic (7.87e-2)"	"prognostic favorable (1.95e-4)"	"unprognostic (6.04e-2)"	"unprognostic (5.03e-2)"	"unprognostic (2.04e-1)"	"unprognostic (5.99e-2)"	"unprognostic (1.17e-1)"	"unprognostic (4.27e-2)"	"unprognostic (1.64e-1)"	"unprognostic (8.99e-2)"	"unprognostic (4.32e-3)"	"unprognostic (1.60e-1)"	"prognostic favorable (1.16e-5)"	"unprognostic (1.51e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.45e-1)"	"unprognostic (6.03e-3)"	15.2	29.3	80.7	20.6	81.4	32.7	16.1	95.2	98.3	14.0	74.4	27.2	12.9	15.9	16.3	20.1	16.0	10.4	85.3	81.7	81.0	25.0	39.2	10.8	32.6	86.3	82.7	19.8	19.7	24.6	30.7	8.7	87.0	19.8	17.5	12.4	22.9	13.8	131.6	10.9	16.5	15.1	81.8	19.0	27.6	11.0	88.0	22.5	17.7	84.5	31.2	17.2	11.9	80.1	50.1	111.2	60.7	70.8	21.2	24.9	29.5	41.4	26.5	90.7	76.1	150.4	47.5	157.3	48.3	34.2	48.6	50.4	111.8	76.2	69.2	57.3	87.8	91.6	155.3	152.9	22.4	168.9	103.9	32.1	27.0	80.8	22.4	19.6	49.6	93.5	139.2	36.5	52.2	236.5	89.5	70.0	72.8	88.4	54.5	141.9	64.6	186.9	48.6	34.7	66.2	42.9	93.4	119.8	20.7	59.0	77.5	80.8	39.3	40.0	49.6	51.8	67.2	37.6	96.9	248.2	21.3	89.5	62.3	15.1	25.5	93.3	14.9	40.3	17.9	74.3	15.1	17.9	49.6	75.1	15.9	16.3	17.2	22.5	35.9	219.7	26.1	23.2	80.7	81.4	95.2	98.3	81.7	81.0	86.3	82.7	87.0	81.8	88.0	80.1	16.5	12.8	14.3	6.8	53.4	18.6	27.2	39.5	14.8	17.9	48.1	51.9	113.0	18.6	29.3	33.1	4.2	54.6	62.3	30.9	156.5	41.6	3.0	27.3	23.8	18.9	44.0	58.5	9.9	51.4	63.3	29.3	30.1	36.9	4.5	62.3	16.4	67.5	114.5	11.8	9.8	34.5	69.2	26.4	59.8	6.5	21.5	36.2	62.2	5.6	94.3	89.0	32.0	4.5	6.5	31.0	44.8	29.7	65.9	31.5	24.0	87.6	53.2	14.5	6.6	29.4	35.7	33.7	44.8	35.8	21.9	26.1	22.4	105.0	53.5	27.7
SNRNP35	U1SNRNPBP	ENSG00000184209	"Small nuclear ribonucleoprotein U11/U12 subunit 35"	Q16560	12	123458088-123473154	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA059145, HPA067031"	Supported		Supported	Nucleoli		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Nucleoli		"HPA059145: AB_2683926, HPA067031: AB_2685766"	"unprognostic (3.80e-2)"	"unprognostic (1.17e-2)"	"unprognostic (6.16e-2)"	"unprognostic (1.35e-3)"	"unprognostic (6.78e-2)"	"unprognostic (1.96e-1)"	"unprognostic (7.43e-2)"	"unprognostic (2.30e-1)"	"unprognostic (1.75e-1)"	"unprognostic (6.24e-2)"	"unprognostic (2.56e-3)"	"unprognostic (7.24e-2)"	"unprognostic (3.36e-2)"	"unprognostic (1.21e-1)"	"unprognostic (7.10e-2)"	"unprognostic (2.30e-2)"	"unprognostic (1.31e-3)"	19.0	20.0	33.1	16.0	34.8	17.6	18.7	36.2	46.3	24.2	33.4	20.8	15.4	22.2	15.1	26.2	19.0	10.3	41.2	32.7	35.3	29.2	26.4	19.1	20.1	34.6	34.0	17.1	19.2	20.5	24.5	16.8	34.1	24.9	17.8	18.3	23.7	12.7	79.5	26.5	23.3	16.2	32.0	30.8	22.9	16.4	34.8	18.7	23.3	43.3	19.3	18.4	21.4	37.2	22.8	23.7	28.1	14.4	20.0	18.6	24.6	19.5	28.4	20.1	14.6	14.9	15.3	45.0	14.0	28.4	14.5	23.0	24.3	34.9	17.2	33.0	19.7	21.1	22.0	34.6	14.0	21.8	32.5	22.7	24.0	18.0	17.1	36.3	27.8	14.0	27.5	8.9	28.4	48.0	23.6	49.1	19.6	30.5	22.4	18.0	12.3	24.0	46.8	45.2	23.9	35.3	17.3	36.1	28.2	27.8	43.6	29.1	32.4	13.3	24.3	16.9	17.7	22.0	23.8	26.6	21.7	21.1	18.6	81.0	45.6	74.3	43.3	48.5	43.0	71.5	54.3	49.2	47.0	66.2	41.9	45.2	70.2	47.9	47.0	47.8	79.3	36.8	33.1	34.8	36.2	46.3	32.7	35.3	34.6	34.0	34.1	32.0	34.8	37.2	21.4	51.3	20.1	14.0	25.0	14.0	19.1	57.3	13.1	30.9	16.3	19.3	29.5	18.6	36.7	33.1	12.5	51.6	31.3	26.9	50.9	35.2	38.3	26.1	21.2	22.5	14.9	29.2	8.4	33.6	34.8	19.3	27.0	22.9	13.3	19.9	23.9	27.1	33.1	15.2	12.1	22.4	44.7	17.0	10.2	10.9	24.2	19.3	16.0	11.2	35.9	37.1	39.1	12.1	27.1	35.0	33.4	25.9	15.9	20.6	37.4	48.9	32.5	28.6	32.9	19.0	24.1	25.3	24.2	18.9	14.5	42.0	24.4	18.3	18.1	25.4
SNRNP40	"HPRP8BP, PRP8BP, PRPF8BP, SPF38, WDR57"	ENSG00000060688	"Small nuclear ribonucleoprotein U5 subunit 40"	Q96DI7	1	31259568-31296788	"Predicted intracellular proteins, Predicted membrane proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026527, HPA027345"	Supported		Supported	"Nuclear speckles"		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Nuclear speckles"		"HPA026527: AB_1858814, HPA027345: AB_2239703"	"unprognostic (2.31e-3)"	"unprognostic (5.63e-2)"	"unprognostic (5.24e-3)"	"unprognostic (1.36e-1)"	"unprognostic (1.14e-3)"	"unprognostic (1.28e-2)"	"prognostic unfavorable (4.73e-6)"	"unprognostic (2.14e-2)"	"unprognostic (2.43e-2)"	"unprognostic (2.50e-1)"	"unprognostic (1.22e-1)"	"unprognostic (8.57e-2)"	"unprognostic (2.34e-2)"	"unprognostic (1.78e-2)"	"unprognostic (5.93e-2)"	"unprognostic (4.31e-2)"	"unprognostic (6.24e-2)"	17.9	18.9	10.7	21.2	14.6	30.0	20.7	15.5	12.6	17.7	10.3	20.6	16.4	20.1	21.7	19.1	22.5	13.1	14.2	10.4	12.5	17.6	19.3	15.8	35.4	14.5	13.3	20.8	13.0	18.0	15.9	22.3	15.4	20.1	22.1	19.1	15.0	20.8	20.9	18.5	17.6	21.7	13.7	21.3	16.6	21.2	12.8	40.3	18.0	18.1	40.2	24.0	16.7	20.1	71.6	53.6	95.5	78.6	46.7	38.4	66.2	58.8	57.4	104.7	101.9	76.7	69.8	91.8	56.4	46.1	53.9	66.4	145.7	69.8	105.9	99.2	109.3	135.2	72.1	83.9	58.4	150.0	59.3	36.2	54.7	102.1	75.6	34.4	86.1	80.2	129.0	52.9	60.5	51.6	111.3	87.9	171.6	71.1	76.5	87.3	134.5	71.1	44.2	57.7	65.1	63.6	92.3	47.4	116.2	88.0	47.2	94.9	59.5	57.9	85.2	81.5	112.9	43.5	57.1	126.1	47.1	139.3	96.4	102.8	75.8	82.3	98.6	97.3	113.1	93.8	95.1	98.2	93.0	82.6	101.1	115.1	16.4	110.5	92.0	78.4	110.2	161.1	10.7	14.6	15.5	12.6	10.4	12.5	14.5	13.3	15.4	13.7	12.8	20.1	44.1	3.2	6.1	14.7	51.5	53.0	50.2	90.8	41.5	15.6	24.4	30.6	16.5	21.5	32.5	16.5	18.8	108.7	35.7	11.9	43.0	42.5	7.1	21.0	27.5	39.4	34.8	80.8	23.7	35.9	91.3	38.1	28.5	13.9	34.3	36.2	28.9	22.3	56.2	10.1	24.3	18.6	69.2	20.7	48.6	5.4	26.8	31.5	42.7	15.0	44.7	23.8	44.3	23.6	49.0	36.4	20.2	34.3	40.6	55.0	17.0	45.0	27.6	22.2	32.9	31.0	35.1	105.5	89.7	39.6	54.8	61.3	52.4	45.9	36.9	40.6
SNRNP48	"C6orf151, dJ336K20B.1, dJ512B11.2, FLJ32234"	ENSG00000168566	"Small nuclear ribonucleoprotein U11/U12 subunit 48"	Q6IEG0	6	7590198-7611967	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029234	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm	Cytosol	"HPA029234: AB_10604097"	"prognostic unfavorable (8.30e-4)"	"unprognostic (3.46e-2)"	"unprognostic (2.65e-1)"	"unprognostic (9.65e-2)"	"unprognostic (1.07e-2)"	"unprognostic (1.54e-1)"	"unprognostic (9.46e-3)"	"unprognostic (2.55e-1)"	"unprognostic (9.87e-3)"	"unprognostic (1.62e-2)"	"unprognostic (1.57e-1)"	"unprognostic (2.03e-1)"	"prognostic unfavorable (4.16e-4)"	"unprognostic (1.55e-1)"	"unprognostic (8.70e-2)"	"unprognostic (1.41e-2)"	"unprognostic (1.03e-1)"	5.4	3.8	4.8	5.5	5.1	10.4	6.9	8.5	6.7	7.0	4.4	5.4	5.7	6.4	4.6	4.7	5.7	4.0	7.2	4.6	5.0	6.0	7.3	4.5	7.3	5.7	4.9	7.7	5.7	3.7	3.6	5.3	5.9	5.8	5.5	7.3	5.3	4.4	9.7	6.3	6.7	5.4	4.7	6.1	5.4	2.7	5.1	7.1	5.8	7.1	5.9	5.6	5.8	5.9	10.0	7.9	16.2	30.3	8.5	12.5	10.9	11.2	10.4	12.0	13.1	16.9	8.1	23.6	11.8	9.4	11.5	12.6	20.2	12.1	18.2	18.2	19.8	17.0	24.1	32.7	8.9	20.5	10.9	8.8	18.3	13.5	10.2	14.2	10.5	20.8	24.1	3.6	16.8	5.7	33.7	29.6	21.9	17.1	8.8	35.8	13.9	31.6	10.8	8.7	25.0	6.8	21.8	5.6	19.6	29.7	10.9	7.2	11.8	15.8	7.1	9.5	19.6	5.8	34.6	14.5	5.3	16.1	28.9	0.1	0.7	0.4	0.7	0.5	1.2	0.6	0.8	0.9	0.9	1.1	0.7	1.3	2.3	1.1	0.3	1.0	0.7	0.6	4.8	5.1	8.5	6.7	4.6	5.0	5.7	4.9	5.9	4.7	5.1	5.9	18.6	19.2	10.3	8.1	15.7	35.7	20.2	13.6	12.0	18.7	12.6	14.6	32.1	15.7	17.3	9.2	20.9	16.3	22.7	19.2	11.7	18.0	2.5	18.0	14.8	20.5	11.4	17.7	20.4	20.1	15.6	18.0	8.2	19.6	24.1	16.8	20.3	23.4	15.9	5.0	18.8	18.2	0.0	15.1	22.1	2.5	17.7	14.9	8.8	13.1	21.7	15.5	19.6	14.6	23.8	12.1	17.9	16.6	11.5	21.4	27.1	20.1	8.5	17.8	6.6	20.9	23.2	16.1	17.0	11.5	34.0	16.3	18.5	11.2	17.1	20.1
SNRPA	"Mud1, U1-A, U1A"	ENSG00000077312	"Small nuclear ribonucleoprotein polypeptide A"	P09012	19	40750637-40765389	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004652, HPA046440, HPA054834"	Supported		Supported	Nucleoplasm		NA	NA		35000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 50: Non-specific - Ribosome"	"Cluster 14: REH - Unknown function"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"CAB004652: AB_425687, HPA046440: AB_2679668, HPA054834: AB_2682619"	"unprognostic (3.53e-2)"	"prognostic favorable (2.50e-4)"	"unprognostic (3.78e-2)"	"unprognostic (2.10e-1)"	"unprognostic (3.30e-1)"	"unprognostic (5.19e-2)"	"prognostic unfavorable (1.34e-5)"	"unprognostic (1.03e-1)"	"unprognostic (8.04e-2)"	"unprognostic (9.08e-3)"	"unprognostic (1.81e-1)"	"unprognostic (3.38e-2)"	"prognostic unfavorable (2.96e-9)"	"unprognostic (2.52e-2)"	"unprognostic (1.05e-1)"	"unprognostic (4.80e-2)"	"unprognostic (7.01e-3)"	45.3	42.1	33.3	40.8	36.6	59.9	47.0	33.8	39.6	61.7	36.1	54.4	36.4	54.8	42.6	55.1	58.4	18.2	38.6	32.7	35.7	48.2	44.9	48.5	57.1	34.5	34.5	69.2	38.0	20.5	47.7	28.7	34.4	55.0	33.8	10.8	41.1	33.0	51.0	41.2	52.7	30.2	34.5	65.2	45.9	36.5	33.9	63.5	56.2	27.6	48.2	53.8	51.7	35.0	143.4	134.6	157.2	129.4	44.2	56.8	125.9	53.8	76.8	145.5	151.9	119.4	129.8	197.2	70.1	75.6	76.2	114.2	162.0	149.6	126.7	96.7	191.5	137.0	115.2	150.0	64.9	159.8	90.0	56.1	36.6	101.4	164.6	78.2	131.7	180.1	167.5	101.2	98.5	145.4	273.7	285.1	164.1	133.1	134.8	251.6	102.0	154.5	100.8	88.4	117.8	113.4	102.4	113.4	90.6	84.3	110.1	150.8	73.8	77.4	127.8	77.5	131.2	107.4	121.6	252.9	78.0	179.3	100.0	3.2	28.0	7.5	27.6	32.2	29.2	28.1	29.2	32.4	56.5	26.4	29.6	27.9	2.5	28.0	16.2	34.7	31.8	23.0	33.3	36.6	33.8	39.6	32.7	35.7	34.5	34.5	34.4	34.5	33.9	35.0	39.3	12.8	15.2	4.9	53.0	35.9	51.6	63.7	63.7	7.2	49.8	67.2	7.2	15.7	27.0	25.8	2.1	87.1	39.6	34.9	43.0	41.6	32.7	22.7	31.1	34.2	33.0	65.4	5.4	49.4	127.0	43.7	51.0	37.6	32.4	67.0	31.4	21.9	60.1	5.0	6.5	44.9	48.8	29.9	35.0	14.6	37.3	37.5	23.2	3.7	50.4	17.8	29.9	6.0	9.5	44.6	29.4	28.2	56.6	38.9	34.6	35.2	17.5	5.1	19.7	28.2	75.7	60.7	66.2	85.1	33.1	66.4	50.9	44.3	61.2	47.7
SNRPA1	"Lea1, U2A'"	ENSG00000131876	"Small nuclear ribonucleoprotein polypeptide A'"	P09661	15	101281510-101295282	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045622, HPA048499"	Supported		Supported	"Nucleoplasm,Nuclear speckles,Nuclear bodies"		NA	NA		48000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm	"Nuclear speckles, Nuclear bodies"	"HPA045622: AB_2679394, HPA048499: AB_2680421"	"unprognostic (2.73e-1)"	"unprognostic (1.48e-1)"	"unprognostic (8.09e-2)"	"unprognostic (2.20e-1)"	"unprognostic (8.08e-2)"	"unprognostic (1.07e-1)"	"prognostic unfavorable (8.56e-5)"	"unprognostic (5.80e-2)"	"unprognostic (1.66e-3)"	"prognostic favorable (8.83e-5)"	"unprognostic (4.74e-2)"	"unprognostic (6.77e-3)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (3.06e-2)"	"unprognostic (2.84e-1)"	"unprognostic (2.43e-1)"	"unprognostic (1.37e-2)"	19.0	18.2	11.0	35.5	11.4	68.1	20.8	13.2	15.4	14.7	14.7	30.6	24.3	15.5	33.0	33.8	18.6	12.7	25.8	12.0	11.6	25.2	25.5	19.5	43.3	11.5	11.3	13.6	22.2	18.3	13.9	30.4	11.7	16.3	30.8	15.5	23.1	12.6	19.7	18.5	30.1	19.3	10.9	25.2	23.2	37.8	12.4	37.4	18.3	12.4	51.9	26.3	18.2	12.6	175.5	119.5	112.7	57.4	31.3	25.6	111.3	158.2	72.8	139.2	105.1	255.8	150.7	192.9	89.2	107.8	109.0	101.7	170.2	113.1	148.1	98.0	262.5	151.4	196.7	137.3	24.0	175.1	103.7	21.0	83.0	89.0	111.3	30.9	90.9	147.1	216.1	175.8	86.5	194.6	177.6	185.7	144.5	232.0	100.1	174.5	121.7	194.8	103.3	450.2	88.6	92.7	97.2	109.0	125.1	117.1	105.2	136.4	66.2	74.1	141.0	86.8	160.3	143.5	464.8	378.9	59.9	162.9	89.3	3.8	36.6	21.5	55.7	47.2	55.3	53.0	57.7	56.1	58.0	47.4	46.6	59.0	6.8	48.5	44.0	54.7	68.9	39.0	11.0	11.4	13.2	15.4	12.0	11.6	11.5	11.3	11.7	10.9	12.4	12.6	41.5	19.2	54.6	16.3	71.6	65.6	73.4	141.6	70.6	37.8	41.8	52.6	30.5	18.6	80.3	36.8	12.5	124.3	69.6	37.4	68.4	94.6	96.2	52.7	42.5	47.2	27.0	61.4	30.9	109.0	154.1	51.5	27.0	55.6	65.8	37.7	21.4	35.5	67.0	37.0	29.2	44.2	126.1	24.1	39.2	22.4	34.8	36.4	42.7	13.1	76.4	39.6	47.4	16.6	28.6	95.3	41.8	28.6	76.1	142.3	78.7	87.1	89.2	34.9	13.1	37.9	67.1	192.9	65.9	68.3	50.6	112.3	68.1	42.3	52.4	101.6
SNRPB	"COD, Sm-B/B', SmB/SmB', snRNP-B, SNRPB1"	ENSG00000125835	"Small nuclear ribonucleoprotein polypeptides B and B1"	P14678	20	2461634-2470853	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Ribonucleoprotein, RNA-binding"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"HPA003482, CAB009610, HPA067842"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm		"CAB009610: AB_2193859, HPA003482: AB_1857337, HPA067842: AB_2685909"	"unprognostic (2.33e-1)"	"unprognostic (3.14e-2)"	"unprognostic (5.64e-2)"	"unprognostic (2.73e-2)"	"unprognostic (9.47e-2)"	"unprognostic (2.04e-2)"	"prognostic unfavorable (1.07e-5)"	"unprognostic (5.11e-2)"	"unprognostic (3.66e-1)"	"unprognostic (4.66e-2)"	"unprognostic (7.30e-2)"	"unprognostic (4.20e-2)"	"unprognostic (2.21e-1)"	"unprognostic (2.79e-1)"	"unprognostic (1.13e-1)"	"unprognostic (9.18e-2)"	"unprognostic (9.47e-2)"	113.4	110.5	45.0	110.7	45.1	345.4	111.6	50.8	54.5	103.7	48.5	108.1	102.6	119.4	66.7	177.1	93.7	62.7	90.1	46.7	47.1	103.6	91.9	111.7	166.7	47.7	45.1	93.8	78.0	83.1	72.5	82.9	47.4	87.9	86.5	25.0	99.7	62.4	112.6	148.5	109.2	85.9	48.6	139.0	100.7	83.2	46.8	168.9	77.1	59.9	154.0	109.3	108.9	50.4	782.5	1063.7	376.7	340.4	83.8	149.1	418.7	334.6	259.8	693.8	556.2	1209.6	555.7	588.8	210.6	203.2	556.7	567.8	370.7	636.2	350.3	239.7	658.6	400.5	190.0	1148.0	290.0	560.3	236.6	171.3	237.9	564.0	252.6	132.2	389.0	491.1	561.0	414.6	288.7	543.0	897.1	916.2	825.2	405.8	520.8	531.3	379.0	711.4	266.8	407.8	405.6	442.7	414.5	554.3	503.2	162.8	524.5	612.9	266.7	404.4	340.9	360.8	764.8	345.5	938.8	877.1	137.7	623.8	419.5	167.9	166.7	133.0	202.8	210.9	170.5	210.7	178.0	179.5	226.7	210.6	144.2	167.5	87.8	166.0	221.6	237.4	241.5	266.0	45.0	45.1	50.8	54.5	46.7	47.1	47.7	45.1	47.4	48.6	46.8	50.4	197.0	44.8	69.1	4.6	206.9	478.6	335.2	309.4	150.2	46.8	156.8	151.8	17.9	112.9	167.3	93.8	12.5	365.2	251.9	163.6	144.8	347.3	17.1	98.3	143.0	202.9	142.0	170.0	6.8	295.8	647.8	155.4	89.2	128.4	144.5	215.0	83.2	60.8	294.8	30.3	6.3	239.4	203.4	102.7	308.3	20.4	159.1	158.0	190.3	6.5	189.5	68.9	265.7	6.0	8.5	404.6	171.9	123.8	176.9	421.8	119.3	143.6	98.9	57.5	157.8	169.6	228.5	329.6	308.3	181.5	423.1	373.4	210.1	306.7	293.5	433.2
SNRPB2	"Msl1, U2B''"	ENSG00000125870	"Small nuclear ribonucleoprotein polypeptide B2"	P08579	20	16729961-16742564	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Proximal tubular cells: 524.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"OE19: 381.4;SK-MEL-30: 378.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA050814, HPA076104"	Supported		Supported	"Nuclear speckles,Cytoplasmic bodies"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Nuclear speckles"	"Cytoplasmic bodies"	"HPA050814: AB_2681245, HPA076104: AB_2732301"	"unprognostic (4.73e-2)"	"unprognostic (1.78e-1)"	"unprognostic (4.02e-1)"	"prognostic unfavorable (7.57e-4)"	"unprognostic (8.45e-2)"	"unprognostic (8.36e-2)"	"prognostic unfavorable (6.03e-7)"	"unprognostic (4.23e-2)"	"unprognostic (5.94e-2)"	"unprognostic (1.65e-2)"	"unprognostic (2.73e-2)"	"unprognostic (4.06e-1)"	"prognostic unfavorable (2.79e-4)"	"unprognostic (1.21e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.14e-2)"	"unprognostic (1.77e-1)"	27.5	27.6	23.9	30.9	24.9	53.9	31.0	24.3	35.7	22.3	26.0	26.4	24.3	29.0	35.2	20.8	24.4	21.9	25.0	24.9	25.9	42.3	30.1	22.2	43.3	24.9	25.2	29.1	18.3	26.9	22.6	28.7	24.7	21.9	26.5	11.2	21.1	21.6	30.2	17.0	24.6	27.1	25.6	28.4	23.4	22.6	24.7	37.3	25.6	27.2	36.6	28.9	19.8	27.3	76.0	73.3	94.3	59.1	46.1	57.8	104.7	73.4	60.9	78.0	76.1	84.6	83.5	121.0	56.0	63.0	119.2	69.3	74.9	85.5	111.0	40.0	62.8	111.8	22.4	157.4	53.9	132.0	73.8	57.6	56.0	71.5	55.6	58.1	74.4	81.3	93.8	53.6	80.6	79.2	152.5	159.6	84.2	381.4	97.0	86.1	113.1	84.9	76.9	50.8	49.8	142.3	54.5	147.6	378.7	69.4	93.8	106.5	63.7	71.0	71.2	64.4	122.7	46.9	102.8	134.7	33.7	77.8	157.1	51.8	29.4	47.4	27.3	38.6	35.8	31.5	34.7	31.5	31.6	29.1	30.0	33.4	12.8	31.7	40.5	45.9	48.0	29.9	23.9	24.9	24.3	35.7	24.9	25.9	24.9	25.2	24.7	25.6	24.7	27.3	125.9	44.8	58.0	6.2	128.6	89.1	186.9	238.2	60.3	30.7	93.8	118.5	67.4	107.2	126.5	93.8	0.0	281.4	150.1	79.6	215.2	165.9	163.3	105.3	150.3	124.6	93.3	131.7	12.9	169.2	288.3	120.8	50.0	120.5	132.5	103.2	140.3	139.3	227.3	48.8	14.3	133.3	152.5	157.9	124.6	35.1	172.7	120.5	110.3	8.4	195.4	77.7	153.5	15.1	21.5	169.4	102.7	155.7	91.2	143.8	94.9	524.6	107.2	25.1	98.6	118.7	147.5	192.4	130.4	60.8	96.0	376.9	150.1	94.7	127.7	170.2
SNRPD2	"Sm-D2, SNRPD1"	ENSG00000125743	"Small nuclear ribonucleoprotein D2 polypeptide"	P62316	19	45687460-45692569	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	Ribonucleoprotein		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041437	Supported		Supported	Cytosol		NA	NA		76000	"Cluster 30: Non-specific - Translation"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 34: Spermatids - Unknown function"	Cytosol		"HPA041437: AB_10795119"	"unprognostic (1.48e-1)"	"unprognostic (1.11e-1)"	"unprognostic (2.18e-1)"	"unprognostic (1.94e-2)"	"unprognostic (6.63e-2)"	"unprognostic (6.84e-2)"	"unprognostic (1.23e-3)"	"unprognostic (2.08e-1)"	"unprognostic (7.71e-2)"	"unprognostic (3.50e-1)"	"unprognostic (4.79e-2)"	"unprognostic (1.78e-1)"	"prognostic unfavorable (8.58e-5)"	"unprognostic (1.95e-1)"	"unprognostic (6.57e-3)"	"unprognostic (1.53e-1)"	"unprognostic (7.12e-2)"	201.0	215.1	305.0	237.7	317.2	478.3	390.9	309.5	374.8	267.3	297.8	253.3	170.1	228.8	331.5	244.5	318.1	195.9	265.5	312.2	321.0	215.6	200.1	157.1	442.7	312.2	308.3	440.0	184.9	263.5	202.9	215.3	310.8	201.9	253.5	120.8	197.4	209.7	306.0	245.1	168.1	235.2	311.1	202.2	189.1	167.5	315.5	501.0	214.7	305.6	406.4	312.2	216.4	312.6	970.0	1429.6	863.8	905.4	843.8	797.5	475.5	630.8	777.8	933.3	974.0	814.6	582.4	1119.3	493.9	788.2	624.9	543.7	1180.4	1184.6	888.6	721.6	1428.6	1066.5	756.6	1040.6	585.1	1287.9	646.4	894.2	862.7	798.3	759.9	639.5	960.3	1111.6	996.6	713.1	765.9	1329.7	1274.7	1129.0	780.8	1758.5	776.2	848.1	890.0	896.5	782.0	1249.4	792.7	880.4	828.1	842.8	808.7	705.9	500.2	1378.5	614.2	422.3	694.7	397.5	1198.8	717.5	1949.8	1775.2	601.5	1087.8	691.3	306.6	525.1	275.0	810.3	500.5	1045.6	1309.4	1076.4	964.5	789.1	1155.8	1244.5	1083.7	62.7	885.6	393.8	876.0	1144.9	1776.3	305.0	317.2	309.5	374.8	312.2	321.0	312.2	308.3	310.8	311.1	315.5	312.6	150.6	147.4	211.1	8.1	407.6	470.5	564.5	724.2	463.9	43.1	361.2	650.5	443.3	233.1	372.3	329.2	22.9	607.0	294.3	318.8	665.2	368.8	563.3	190.9	310.2	225.3	310.2	315.9	7.9	350.7	787.7	305.2	199.8	198.2	266.0	284.4	232.3	265.4	475.4	37.0	8.3	492.0	376.4	269.9	470.6	1325.8	347.9	232.5	434.0	9.4	373.9	162.6	373.9	3.5	12.2	318.2	348.5	231.7	341.2	553.5	356.9	768.7	309.3	65.2	164.3	279.4	382.1	286.3	274.7	562.6	422.7	482.8	426.5	216.2	556.9	534.0
SNRPD3	"Sm-D3, SMD3"	ENSG00000100028	"Small nuclear ribonucleoprotein D3 polypeptide"	P62318	22	24555958-24582052	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA001170	Supported		Supported	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA		290000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm	"Nuclear bodies, Cytosol"	"HPA001170: AB_1080042"	"unprognostic (3.30e-1)"	"unprognostic (1.63e-2)"	"unprognostic (9.15e-2)"	"unprognostic (1.95e-1)"	"unprognostic (3.01e-2)"	"unprognostic (6.28e-3)"	"unprognostic (4.49e-2)"	"unprognostic (2.03e-1)"	"unprognostic (4.44e-2)"	"unprognostic (1.13e-3)"	"unprognostic (1.20e-2)"	"unprognostic (3.52e-2)"	"unprognostic (3.64e-2)"	"unprognostic (2.91e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.87e-1)"	"unprognostic (1.65e-2)"	30.5	31.1	24.7	35.2	25.7	39.2	37.5	29.6	34.8	31.8	25.7	50.5	33.2	35.5	35.5	43.5	36.7	20.2	35.3	25.0	25.8	48.0	64.9	26.9	47.7	23.7	23.9	34.3	23.7	51.2	27.0	24.7	25.5	33.8	40.7	54.1	29.7	31.9	103.7	28.8	35.7	29.5	23.6	34.3	36.5	24.7	25.0	74.4	38.9	86.2	53.3	39.5	32.3	30.7	182.5	45.7	188.6	58.5	70.1	57.7	56.1	173.1	74.8	166.1	148.1	61.4	65.8	158.7	70.1	109.2	83.0	130.7	252.1	219.3	175.5	107.9	188.8	152.4	95.4	113.9	66.2	408.0	95.7	66.5	93.8	186.3	86.6	81.8	120.6	139.8	116.2	60.5	61.5	56.8	187.0	82.6	98.9	237.8	61.9	179.5	190.7	66.6	154.5	130.0	82.2	95.6	83.4	62.7	87.7	162.7	102.3	97.5	135.5	127.0	126.3	74.3	126.2	74.3	168.2	283.7	70.1	127.1	91.4	18.5	42.9	53.9	35.6	50.2	37.6	60.5	38.4	39.2	54.2	50.7	36.6	41.3	18.6	51.1	51.1	49.7	41.1	47.4	24.7	25.7	29.6	34.8	25.0	25.8	23.7	23.9	25.5	23.6	25.0	30.7	120.0	96.1	81.8	7.5	118.2	108.6	115.3	293.1	133.1	61.1	94.2	138.8	95.9	101.5	162.9	130.6	35.5	239.5	123.1	112.6	291.6	161.9	91.0	176.6	157.7	96.8	111.0	139.4	8.1	114.8	228.8	121.0	92.2	147.9	86.2	145.3	66.0	203.3	176.4	38.7	8.7	134.2	168.9	74.5	84.8	85.1	116.2	98.1	67.6	10.3	151.0	134.3	86.5	8.0	13.4	129.4	118.2	118.5	120.7	96.8	191.7	310.5	135.2	68.9	65.7	102.8	209.6	111.1	131.4	164.9	113.7	180.3	111.9	176.2	139.0	113.3
SNTB2	"D16S2531E, EST25263, SNT2B2, SNT3, SNTL"	ENSG00000168807	"Syntrophin beta 2"	Q13425	16	69187129-69309052	"Plasma proteins, Predicted intracellular proteins"		"Actin-binding, Calmodulin-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 151.4;Muller glia cells: 214.1;Rod photoreceptor cells: 136.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"SiHa: 42.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001394			Supported	"Nucleoplasm,Golgi apparatus,Plasma membrane"	"Intracellular and membrane"	NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 77: Retina - Visual perception"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Golgi apparatus, Plasma membrane"	Nucleoplasm	"HPA001394: AB_1080170"	"unprognostic (4.86e-1)"	"unprognostic (3.26e-2)"	"unprognostic (2.77e-2)"	"unprognostic (8.07e-3)"	"unprognostic (6.46e-2)"	"unprognostic (9.68e-2)"	"unprognostic (1.89e-2)"	"unprognostic (5.50e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.63e-2)"	"unprognostic (1.65e-2)"	"unprognostic (3.64e-2)"	"unprognostic (5.77e-3)"	"unprognostic (1.71e-2)"	"unprognostic (7.43e-2)"	"unprognostic (1.73e-2)"	"unprognostic (1.88e-1)"	11.0	5.0	3.3	5.2	3.9	2.7	8.8	1.0	6.7	11.0	10.1	6.7	3.7	10.4	5.1	7.0	8.7	7.1	5.3	4.6	0.8	6.7	3.8	8.6	5.6	2.5	0.9	6.2	4.1	12.4	4.0	5.2	0.9	8.2	5.3	21.6	5.2	5.5	5.7	8.5	6.0	8.7	0.6	5.7	6.1	7.1	1.5	5.8	10.5	3.8	4.9	8.7	8.7	3.7	7.2	10.9	7.4	5.8	26.6	35.6	9.1	13.9	19.3	10.7	11.8	10.7	6.5	9.0	8.3	16.2	5.6	12.9	10.0	6.8	13.9	4.0	5.5	4.0	11.1	9.2	8.8	0.3	5.9	25.6	4.9	17.6	7.1	11.1	32.4	2.5	2.3	13.8	13.1	8.2	3.0	1.4	5.0	4.2	8.6	18.1	6.5	16.8	5.7	10.9	2.8	6.1	42.6	6.0	4.4	5.5	7.1	0.5	25.4	20.0	9.6	14.2	13.0	3.1	5.2	10.0	12.8	1.4	9.3	0.4	0.2	0.3	0.9	0.3	0.9	0.2	0.4	0.5	0.2	0.2	0.2	1.1	0.9	0.7	0.3	0.1	0.5	0.3	3.3	3.9	1.0	6.7	4.6	0.8	2.5	0.9	0.9	0.6	1.5	3.7	55.9	19.2	11.7	36.6	9.0	38.0	28.0	17.1	70.0	33.2	19.0	25.0	9.2	10.0	10.4	27.6	41.7	9.5	33.7	29.0	3.9	9.7	25.9	20.6	61.3	81.4	10.3	4.8	151.4	24.1	7.9	53.1	20.9	28.7	1.3	15.8	126.7	11.1	6.9	5.0	62.6	16.6	8.2	33.1	29.3	27.5	59.0	12.9	30.2	33.7	8.6	214.1	47.4	30.7	27.9	16.3	32.8	65.1	20.7	40.9	12.7	34.5	10.0	136.7	6.6	26.0	35.6	27.9	15.4	30.7	38.8	3.7	32.8	20.2	19.6	28.7
SNTG2	"G2SYN, SYN5"	ENSG00000172554	"Syntrophin gamma 2"	Q9NY99	2	950849-1367613	"Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Early spermatids: 68.2;Excitatory neurons: 24.4;Horizontal cells: 90.9;Late spermatids: 44.7;Spermatocytes: 22.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Daudi: 1.6;HAP1: 1.7;JURKAT: 1.6;MOLT-4: 1.1;NTERA-2: 2.0;SCLC-21H: 2.0"	"Low region specificity"	"Detected in many"							"HPA065258, HPA077904"	Approved		Supported	"Nucleoplasm,Plasma membrane"		NA	NA				"Cluster 77: Retina - Visual perception"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 29: Early spermatids - Spermatogenesis"	"Plasma membrane"	Nucleoplasm	"HPA065258: , HPA077904: "	"unprognostic (7.52e-3)"	"unprognostic (7.52e-4)"	"unprognostic (4.15e-1)"	"unprognostic (3.50e-2)"	"unprognostic (2.52e-2)"	"unprognostic (1.39e-3)"		"unprognostic (2.46e-3)"	"unprognostic (2.05e-1)"	"unprognostic (2.23e-1)"	"unprognostic (3.26e-2)"	"unprognostic (7.87e-3)"	"unprognostic (3.58e-3)"	"unprognostic (3.64e-1)"	"unprognostic (2.52e-1)"	"unprognostic (1.77e-2)"	"unprognostic (5.05e-2)"	2.0	0.3	0.6	0.0	0.7	0.0	1.8	1.0	0.6	1.0	1.1	0.5	0.1	1.2	0.2	0.5	1.2	0.2	0.4	1.7	0.7	0.1	0.0	0.3	0.0	1.7	0.9	0.2	0.9	0.0	2.9	0.0	1.3	0.6	0.2	2.1	0.5	0.0	0.4	1.1	0.6	0.7	0.4	3.2	0.3	1.8	0.7	0.2	0.7	0.9	0.1	0.8	1.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	1.6	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	1.1	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.7	1.0	0.6	1.7	0.7	1.7	0.9	1.3	0.4	0.7	0.6	6.8	0.0	0.0	0.7	0.4	0.9	0.1	0.0	0.6	0.8	0.2	0.3	0.7	0.0	0.0	1.8	0.0	0.0	0.0	0.1	0.0	0.0	68.2	0.1	0.9	7.3	0.0	0.0	24.4	0.2	0.5	0.8	0.0	0.0	0.0	3.0	0.0	0.0	0.1	90.9	10.7	0.0	0.0	0.0	1.2	44.7	0.3	0.0	1.8	9.4	0.0	0.6	0.0	1.5	1.3	0.0	0.0	4.1	0.0	0.3	0.0	0.5	0.0	4.6	0.0	0.3	0.4	22.0	5.4	0.1	0.1	0.0	0.2	0.2	0.0	0.2
SNURF		ENSG00000273173	"SNRPN upstream reading frame"	Q9Y675	15	24954986-24977850	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 62.9"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"NTERA-2: 191.3;U-698: 112.1"									HPA065733			Supported	"Nuclear speckles"		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 54: Non-specific - Microtubule organization"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 59: Non-specific - Transcription"	"Nuclear speckles"		"HPA065733: AB_2685548"	"unprognostic (2.08e-1)"	"unprognostic (2.88e-2)"	"unprognostic (6.82e-2)"	"unprognostic (4.59e-3)"	"unprognostic (4.03e-2)"	"unprognostic (1.40e-3)"	"unprognostic (4.39e-2)"	"unprognostic (6.89e-3)"	"unprognostic (1.56e-2)"	"unprognostic (6.74e-2)"	"unprognostic (8.91e-4)"	"unprognostic (3.77e-1)"	"unprognostic (1.77e-2)"	"unprognostic (6.04e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.12e-2)"	8.1	16.1	3.7	6.9	7.5	12.5	5.3	16.3	16.0	12.1	1.2	14.6	1.9	9.6	54.8	5.3	8.5	13.2	50.7	5.6	11.8	14.6	12.9	9.8	10.2	1.5	2.8	13.7	13.5	19.8	28.5	2.7	2.4	15.2	2.5	25.3	8.4	8.3	62.9	3.7	6.4	3.8	0.5	17.2	11.5	3.3	6.5	8.1	15.5	7.4	7.0	12.8	7.3	8.6	0.1	11.9	61.9	44.1	3.1	4.1	0.1	40.7	3.3	4.2	2.8	7.0	36.4	0.5	21.0	2.7	6.0	15.3	0.0	9.1	3.2	14.1	0.0	74.3	50.2	1.8	11.0	79.2	25.4	10.0	2.3	7.7	0.5	22.1	5.2	22.4	7.3	0.2	8.3	0.0	55.5	0.5	191.3	0.0	1.9	54.7	84.7	0.9	3.3	82.0	37.1	29.1	0.0	3.8	22.3	75.2	38.7	7.1	75.8	27.2	30.2	1.0	8.9	58.8	81.6	112.1	43.9	33.6	24.5	17.7	1.5	6.3	14.9	0.7	31.0	22.3	32.9	28.4	2.7	27.8	41.2	38.1	1.7	22.4	3.1	23.6	35.7	20.1	3.7	7.5	16.3	16.0	5.6	11.8	1.5	2.8	2.4	0.5	6.5	8.6	1.0	3.2	3.7	0.0	2.9	0.5	0.6	1.4	2.2	1.6	1.4	1.1	4.1	0.0	1.1	0.0	0.0	0.0	1.1	0.7	3.9	2.1	0.4	0.7	1.2	0.9	0.0	0.8	0.0	2.4	0.0	1.4	1.5	0.7	1.3	2.0	1.1	0.7	0.3	3.3	0.0	2.7	0.0	0.8	0.4	0.3	0.6	0.6	0.0	0.0	0.7	0.4	0.0	0.0	0.0	2.2	2.8	0.4	2.7	0.6	1.1	0.7	4.1	1.5	0.0	0.9	2.0	0.3	0.8	0.7	0.3	0.0	2.8	1.9	1.2	0.3
SNX1	"HsT17379, MGC8664, SNX1A, Vps5"	ENSG00000028528	"Sorting nexin 1"	Q13596	15	64094123-64146090	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 177.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"HPA047373, HPA052761"	Approved		Enhanced	Endosomes,Lysosomes		NA	NA		6100000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 68: Epididymis - Unknown function"	"Cluster 16: U-266 - Nucleosome"	"Cluster 10: Non-specific - Unknown function"	"Endosomes, Lysosomes"		"HPA047373: AB_2680018, HPA052761: AB_2681939"	"unprognostic (3.99e-2)"	"unprognostic (8.65e-3)"	"unprognostic (1.96e-1)"	"unprognostic (1.50e-2)"	"unprognostic (7.13e-2)"	"unprognostic (2.73e-1)"	"unprognostic (7.15e-2)"	"unprognostic (6.49e-3)"	"unprognostic (1.53e-1)"	"unprognostic (8.28e-2)"	"unprognostic (2.47e-2)"	"unprognostic (3.26e-1)"	"prognostic favorable (9.88e-6)"	"unprognostic (2.27e-1)"	"unprognostic (3.98e-1)"	"unprognostic (2.59e-2)"	"unprognostic (1.95e-1)"	63.4	69.0	47.1	59.0	64.1	34.8	46.2	60.9	49.8	52.8	44.5	60.2	49.8	47.6	67.7	60.6	37.5	42.9	50.4	46.2	51.4	56.8	69.3	54.7	67.1	67.5	63.6	39.0	44.3	72.1	32.0	57.8	66.4	51.9	47.6	27.0	55.4	64.4	69.1	48.5	52.4	53.0	62.5	61.0	54.8	34.2	57.2	79.5	102.9	36.8	66.8	62.1	51.2	76.8	75.4	93.5	69.1	60.8	116.4	81.3	23.0	93.5	91.5	81.4	94.5	64.6	115.6	74.4	100.5	86.7	79.7	113.8	102.6	95.2	63.5	136.1	56.0	101.2	110.4	98.2	63.6	94.7	108.0	102.9	62.6	65.2	50.2	59.7	86.1	77.0	74.0	29.2	85.1	107.8	111.4	80.2	54.5	103.2	52.1	100.0	65.3	118.1	127.1	170.5	56.3	56.4	91.4	61.1	86.3	59.5	87.0	86.6	103.0	80.1	120.2	50.8	52.5	93.4	220.5	120.1	72.9	123.5	85.8	144.1	149.1	162.1	83.4	143.1	70.9	101.1	70.4	82.2	127.3	101.9	67.0	66.6	113.7	98.1	144.2	86.1	95.8	156.0	47.1	64.1	60.9	49.8	46.2	51.4	67.5	63.6	66.4	62.5	57.2	76.8	34.4	115.4	74.2	35.6	32.9	26.5	38.1	39.3	29.0	18.9	29.7	29.2	50.6	34.3	52.8	18.4	22.9	51.5	51.6	32.1	33.2	40.9	3.7	36.4	36.7	34.2	26.5	26.5	44.2	37.2	35.1	36.2	27.5	44.9	39.2	44.9	35.3	34.2	72.2	15.2	39.3	28.3	28.5	46.8	27.4	4.0	32.3	42.7	32.0	44.0	56.3	19.7	35.0	121.7	177.7	34.6	30.3	37.6	34.0	32.7	39.2	53.6	31.9	16.5	46.0	36.0	64.0	33.3	23.4	33.8	27.1	47.7	35.0	39.3	28.8	33.9
SNX10		ENSG00000086300	"Sorting nexin 10"	Q9Y5X0	7	26291862-26374383	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cilium biogenesis/degradation, Protein transport, Transport"		"Disease variant, Osteopetrosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 69.1"	"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 285.7;Hofbauer cells: 148.7;Kupffer cells: 215.5;Macrophages: 166.5;monocytes: 152.3;Muller glia cells: 310.5;Proximal tubular cells: 204.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 336.7"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"RPTEC TERT1: 103.1;U-937: 87.3;WM-115: 297.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015605, HPA064782"	Approved		Supported	Nucleoplasm,Nucleoli,Microtubules		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 57: B-cells - Immune response"	"Nucleoplasm, Microtubules"	Nucleoli	"HPA015605: AB_1857342, HPA064782: AB_2685349"	"unprognostic (6.42e-2)"	"unprognostic (2.72e-3)"	"unprognostic (2.45e-1)"	"unprognostic (7.62e-2)"	"prognostic unfavorable (1.16e-4)"	"unprognostic (6.92e-2)"	"unprognostic (2.48e-3)"	"unprognostic (4.51e-2)"	"unprognostic (4.87e-1)"	"unprognostic (9.36e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.56e-1)"	"prognostic unfavorable (8.06e-5)"	"unprognostic (1.12e-2)"	"unprognostic (3.21e-1)"	"unprognostic (8.59e-2)"	"unprognostic (1.50e-1)"	23.7	14.5	26.4	34.7	27.8	42.1	11.0	17.6	45.9	4.5	6.1	5.6	4.1	9.0	1.1	2.9	3.0	8.8	1.8	30.2	42.2	37.8	69.1	41.2	36.9	29.1	28.2	1.1	7.8	1.3	4.7	10.9	40.3	3.5	6.4	47.1	1.7	2.1	1.0	1.4	6.2	9.5	18.6	42.1	3.9	5.1	32.0	15.8	2.9	2.7	24.8	10.9	1.6	26.8	55.8	5.0	0.2	10.1	0.1	0.0	57.8	0.0	3.9	0.1	0.0	0.5	18.4	24.0	41.4	0.0	36.2	1.7	13.5	3.6	0.0	33.3	12.4	2.5	0.4	36.3	0.1	52.2	8.9	0.6	5.4	0.0	4.2	0.1	0.8	30.7	1.5	0.3	0.0	9.7	22.2	54.3	15.3	0.9	5.1	0.1	0.1	1.3	103.1	12.0	22.5	7.1	11.7	8.5	62.7	18.1	15.2	72.6	0.3	0.1	12.2	0.2	13.7	17.9	15.5	16.4	0.5	87.3	297.4	55.9	144.7	3.7	18.6	158.5	18.2	82.3	13.2	16.4	101.2	71.7	6.9	12.0	336.7	47.7	162.5	37.0	29.6	70.0	26.4	27.8	17.6	45.9	30.2	42.2	29.1	28.2	40.3	18.6	32.0	26.8	3.3	3.2	14.7	6.8	63.4	5.4	1.2	0.7	1.8	20.3	17.6	9.5	1.8	34.3	4.4	23.9	2.1	14.9	18.6	2.5	285.7	66.0	1.3	2.1	40.7	7.6	9.5	19.1	63.1	27.1	111.8	3.4	0.0	2.3	31.1	2.9	2.2	109.8	148.7	35.3	53.4	3.3	0.0	215.5	130.3	2.1	1.2	166.5	8.8	19.7	152.3	310.5	33.0	7.1	8.5	14.1	1.5	0.0	8.0	4.4	4.5	204.9	0.8	23.2	0.0	0.7	4.7	7.1	29.5	0.8	3.0	28.7	31.6	0.9	8.7	1.3
SNX11		ENSG00000002919	"Sorting nexin 11"	Q9Y5W9	17	48103357-48123601	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"monocytes: 37.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044787, HPA054660"	Approved		Approved	"Endoplasmic reticulum,Vesicles"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 3: Monocytes - Immune response regulation"	"Endoplasmic reticulum"	Vesicles	"HPA044787: AB_10795988, HPA054660: AB_2682560"	"unprognostic (1.75e-1)"	"unprognostic (6.86e-3)"	"unprognostic (4.34e-2)"	"unprognostic (4.33e-3)"	"unprognostic (2.45e-1)"	"unprognostic (1.54e-1)"	"unprognostic (2.68e-3)"	"unprognostic (2.07e-1)"	"unprognostic (9.27e-2)"	"unprognostic (2.15e-1)"	"unprognostic (5.42e-2)"	"unprognostic (2.12e-1)"	"unprognostic (5.22e-3)"	"unprognostic (9.02e-3)"	"unprognostic (2.70e-2)"	"unprognostic (9.50e-2)"	"unprognostic (3.89e-2)"	14.3	12.0	18.0	18.1	19.1	21.5	11.1	18.2	19.4	10.5	16.4	13.8	8.7	10.5	12.5	19.9	9.6	8.9	12.5	18.3	18.4	15.8	14.5	11.4	21.7	20.1	18.9	8.8	11.7	13.4	10.7	11.3	18.8	12.1	12.5	11.9	12.2	8.7	12.8	11.6	12.4	17.0	20.1	24.0	12.4	11.4	19.8	16.1	20.0	15.3	29.1	13.3	11.6	20.7	20.6	25.4	21.9	21.1	18.1	8.3	22.8	21.8	13.9	26.5	28.8	36.0	17.7	21.6	27.3	24.1	15.5	18.6	21.2	21.0	29.2	52.4	24.5	32.5	17.5	17.5	18.4	36.0	22.7	13.8	20.8	25.1	23.7	16.5	22.4	20.4	19.8	21.7	17.4	17.0	21.8	22.8	12.2	23.6	21.3	13.5	39.7	24.8	16.1	20.1	15.7	28.6	14.2	9.7	37.7	26.6	20.1	25.4	18.8	30.6	18.2	20.3	26.3	34.0	54.1	26.0	22.1	16.4	19.6	28.7	34.6	35.6	19.0	43.3	13.1	22.1	10.5	12.9	28.2	21.2	8.6	14.7	92.9	16.8	54.5	12.9	10.1	24.0	18.0	19.1	18.2	19.4	18.3	18.4	20.1	18.9	18.8	20.1	19.8	20.7	8.7	6.4	2.0	2.9	15.4	6.0	5.0	5.9	7.4	8.9	6.4	6.2	5.3	1.5	4.3	16.5	2.1	11.7	14.2	13.3	5.9	11.4	1.9	6.2	4.6	8.0	14.9	3.6	4.1	15.3	12.2	6.0	6.6	7.1	2.5	5.4	6.1	6.9	19.9	15.2	3.9	9.0	6.1	23.2	4.6	2.1	5.3	15.9	5.4	2.8	37.5	14.2	14.4	5.0	8.8	18.1	5.6	6.8	6.3	6.9	9.9	9.9	2.9	9.3	13.1	4.6	8.8	10.3	21.2	8.9	5.1	16.4	7.5	7.7	8.0	6.4
SNX14	RGS-PX2	ENSG00000135317	"Sorting nexin 14"	Q9Y5W7	6	85505496-85594156	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Protein transport, Transport"		"Disease variant, Mental retardation, Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 173.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017639	Approved		Supported	Vesicles,Cytosol		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 68: Epididymis - Unknown function"	"Cluster 32: U-937 - Innate immune response"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Vesicles, Cytosol"		"HPA017639: AB_1857345"	"unprognostic (1.16e-2)"	"unprognostic (3.29e-2)"	"unprognostic (2.19e-2)"	"unprognostic (1.52e-2)"	"unprognostic (5.23e-2)"	"prognostic unfavorable (2.78e-4)"	"unprognostic (1.92e-2)"	"unprognostic (3.45e-2)"	"unprognostic (4.60e-1)"	"unprognostic (1.57e-2)"	"unprognostic (3.14e-2)"	"unprognostic (2.37e-2)"	"unprognostic (1.10e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.87e-3)"	"unprognostic (4.72e-3)"	27.3	39.9	39.0	23.0	40.5	31.4	41.7	44.4	61.0	30.8	49.7	39.7	29.8	23.5	57.3	24.3	28.2	28.3	24.8	40.7	47.0	54.4	69.6	39.6	32.6	40.1	40.7	26.8	43.6	47.1	36.3	36.2	43.1	33.2	35.1	47.2	27.8	30.8	16.4	28.6	31.7	22.4	40.9	37.4	45.3	87.0	42.5	18.9	40.5	12.9	28.8	35.1	24.7	44.2	46.1	27.3	44.5	64.9	98.3	71.6	46.0	58.0	78.5	44.2	67.5	49.0	75.4	60.3	69.8	74.4	85.9	60.7	30.5	58.8	69.4	53.3	18.0	66.1	36.4	75.1	80.9	62.4	65.0	63.0	43.7	52.0	51.6	81.1	79.4	23.2	67.7	50.4	96.9	52.1	4.4	117.0	18.3	72.1	31.1	26.2	90.6	29.1	107.1	82.7	19.8	44.5	35.0	76.6	56.3	57.9	47.9	108.9	71.6	35.4	21.8	44.1	60.3	50.4	87.0	22.8	71.3	72.2	71.8	36.7	21.5	33.0	19.9	33.6	14.7	13.3	13.4	18.1	26.2	14.7	12.0	15.0	9.9	22.9	40.9	7.9	16.7	15.7	39.0	40.5	44.4	61.0	40.7	47.0	40.1	40.7	43.1	40.9	42.5	44.2	28.5	93.0	47.2	76.4	25.3	14.7	18.7	32.8	15.9	36.4	23.3	15.1	16.9	15.7	39.1	22.0	56.3	50.4	32.6	30.7	5.9	31.7	87.1	37.3	22.2	26.9	31.8	13.2	115.2	41.6	31.9	23.1	37.8	32.5	31.6	36.0	26.0	28.7	35.4	15.2	124.4	26.1	65.1	37.7	22.3	21.6	19.6	33.4	28.4	63.7	43.1	26.1	41.2	85.5	91.0	34.4	22.0	29.3	23.8	15.7	31.9	25.1	58.9	40.7	19.7	26.2	33.0	173.0	14.9	15.9	14.8	56.5	26.4	26.5	28.6	17.7
SNX15		ENSG00000110025	"Sorting nexin 15"	Q9NRS6	11	65027439-65040572	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Distal enterocytes: 5.6;Enteroendocrine cells: 7.8;granulocytes: 8.2;monocytes: 7.9;Paneth cells: 8.0;Proximal enterocytes: 6.5;Undifferentiated cells: 5.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038955	Approved		Approved	"Nucleoli,Vesicles,Plasma membrane,Cytosol"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Nucleoli, Cytosol"	"Vesicles, Plasma membrane"	"HPA038955: AB_10672834"	"unprognostic (2.00e-2)"	"unprognostic (4.90e-2)"	"unprognostic (3.93e-1)"	"unprognostic (9.61e-4)"	"unprognostic (2.79e-1)"	"unprognostic (4.06e-3)"	"unprognostic (4.45e-3)"	"unprognostic (4.74e-2)"	"unprognostic (1.09e-1)"	"unprognostic (9.55e-2)"	"unprognostic (8.93e-3)"	"unprognostic (1.79e-2)"	"unprognostic (8.84e-2)"	"unprognostic (7.86e-2)"	"unprognostic (2.93e-2)"	"unprognostic (1.88e-1)"	"unprognostic (2.68e-4)"	17.1	13.3	17.3	10.2	18.5	10.5	15.3	19.4	19.2	16.6	9.0	22.5	15.3	15.8	6.4	14.9	12.9	7.4	15.0	18.4	17.1	17.0	10.1	11.9	9.3	19.3	18.2	14.8	12.7	10.7	9.4	7.3	16.1	12.9	8.8	5.8	12.3	10.9	25.7	17.5	16.8	8.9	16.1	10.8	16.4	5.3	17.8	9.4	10.6	15.5	7.4	18.0	14.9	18.5	31.1	22.3	14.7	14.2	17.3	12.4	7.9	10.0	13.6	23.3	21.3	17.6	23.7	30.7	16.7	17.4	29.3	16.8	16.8	15.2	9.8	47.0	14.0	15.8	18.2	30.2	18.3	10.7	24.5	10.6	22.2	24.7	14.5	13.0	14.1	22.6	27.0	19.6	12.5	18.8	29.2	36.8	15.5	12.0	21.9	23.7	8.4	34.0	17.6	6.7	25.6	19.2	25.3	23.0	23.2	9.7	23.4	18.6	27.5	23.5	22.9	24.1	14.7	20.9	38.3	30.3	23.2	14.5	8.4	9.2	13.6	13.6	7.6	16.2	6.2	8.9	7.8	6.8	9.4	8.7	5.6	5.1	2.1	4.3	23.6	6.4	8.3	7.3	17.3	18.5	19.4	19.2	18.4	17.1	19.3	18.2	16.1	16.1	17.8	18.5	0.3	0.0	3.3	0.0	0.8	1.0	0.1	0.4	4.0	0.0	0.5	0.3	0.4	0.0	0.2	0.0	0.0	0.4	0.1	5.6	0.0	4.8	0.0	0.1	0.2	0.9	7.8	1.3	0.0	3.1	0.6	0.4	1.1	0.1	8.2	0.4	0.7	0.1	1.0	0.0	0.0	3.3	0.0	0.0	0.3	0.0	0.0	0.5	0.0	0.0	7.9	0.2	0.0	0.0	0.0	3.9	8.0	0.4	1.1	0.0	6.5	0.6	0.7	0.4	0.0	0.7	1.0	0.0	0.0	1.5	0.4	0.4	1.1	0.2	5.6	0.1
SNX16		ENSG00000104497	"Sorting nexin 16"	P57768	8	81799581-81842866	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 82.8;Late spermatids: 137.3;Spermatocytes: 74.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024730, HPA024731, HPA024817"	Approved		Supported	Vesicles		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 71: Testis - DNA repair"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 31: Spermatids - Spermatogenesis"	Vesicles		"HPA024730: AB_10600220, HPA024731: AB_1857346, HPA024817: AB_10602313"	"unprognostic (5.50e-2)"	"unprognostic (3.20e-2)"	"unprognostic (1.40e-1)"	"unprognostic (8.41e-3)"	"unprognostic (3.21e-3)"	"unprognostic (7.54e-3)"	"unprognostic (1.24e-3)"	"unprognostic (1.33e-1)"	"unprognostic (2.12e-1)"	"unprognostic (2.18e-1)"	"unprognostic (3.94e-2)"	"unprognostic (1.43e-1)"	"unprognostic (5.73e-3)"	"unprognostic (7.60e-3)"	"unprognostic (2.30e-1)"	"unprognostic (1.35e-1)"	"unprognostic (3.65e-1)"	10.1	5.2	4.7	6.0	5.7	10.7	8.2	6.6	7.6	8.6	2.5	6.3	6.4	9.7	8.3	17.3	6.2	10.8	8.1	5.3	6.6	6.6	5.5	6.7	5.1	6.1	7.4	9.6	3.1	8.9	3.7	5.5	8.6	7.3	6.6	4.9	5.7	7.7	4.6	11.2	5.7	11.9	5.8	12.0	9.0	14.9	5.7	9.4	8.7	9.4	6.7	7.0	7.7	6.7	13.8	3.8	6.6	6.3	22.9	13.7	7.3	16.6	20.2	14.1	20.6	3.4	11.1	2.2	10.0	11.4	16.5	11.0	5.1	6.8	19.5	19.9	3.1	7.1	5.2	6.2	17.4	2.9	11.5	10.5	10.6	5.4	12.5	15.8	10.0	7.8	4.5	26.0	32.9	7.2	15.6	5.1	2.8	12.6	6.2	6.6	9.5	2.4	12.7	6.7	10.9	8.3	3.1	3.9	8.3	9.8	10.3	5.5	7.7	19.5	15.6	13.5	7.2	15.1	12.5	5.7	8.4	9.1	15.7	9.2	4.5	6.1	2.1	2.8	2.0	1.6	2.5	1.7	4.0	4.4	2.9	2.8	6.2	2.6	2.4	3.0	5.0	1.9	4.7	5.7	6.6	7.6	5.3	6.6	6.1	7.4	8.6	5.8	5.7	6.7	10.6	6.4	9.4	9.8	6.4	25.2	12.1	5.0	9.6	5.5	12.1	7.6	8.8	7.2	9.3	5.5	4.2	2.3	3.7	7.5	5.9	5.9	82.8	9.4	7.8	11.5	3.0	8.2	24.7	6.0	4.0	8.5	10.7	16.2	8.2	5.0	13.9	3.5	5.7	55.5	18.4	6.2	8.2	7.0	10.0	137.3	23.3	7.2	3.6	8.4	2.3	4.3	1.0	23.1	22.2	6.7	5.5	16.1	8.6	12.6	3.7	7.3	10.9	5.2	19.7	12.1	9.3	74.2	26.5	13.0	32.0	9.9	5.4	4.2	4.7	20.7
SNX2		ENSG00000205302	"Sorting nexin 2"	O60749	5	122775079-122834543	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Hofbauer cells: 349.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"memory B-cell: 290.2;naive B-cell: 289.1"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"BEWO: 79.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037400	Approved		Supported	Endosomes,Lysosomes		NA	NA		150000	"Cluster 37: B-cells - Transcription"	"Cluster 72: Non-specific - Transcription"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 10: Non-specific - Unknown function"	"Endosomes, Lysosomes"		"HPA037400: AB_10670381"	"unprognostic (9.26e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.86e-2)"	"unprognostic (1.97e-2)"	"unprognostic (2.74e-1)"	"unprognostic (2.91e-1)"	"prognostic unfavorable (7.90e-6)"	"unprognostic (1.03e-1)"	"unprognostic (3.86e-2)"	"unprognostic (3.27e-2)"	"unprognostic (4.41e-2)"	"unprognostic (1.60e-1)"	"prognostic favorable (8.76e-7)"	"unprognostic (8.76e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.07e-1)"	"unprognostic (8.59e-2)"	40.6	31.0	6.0	17.9	6.5	14.2	33.8	9.5	8.5	27.8	6.2	32.6	13.4	28.2	12.5	30.1	29.0	12.8	22.4	6.2	6.5	37.8	28.0	33.7	26.5	6.4	7.0	37.1	31.3	14.1	23.2	19.2	6.5	24.2	14.5	7.1	29.1	10.1	27.0	29.0	34.8	17.9	6.9	52.4	32.9	17.1	7.1	10.4	38.3	7.7	24.0	33.6	26.1	8.5	18.9	14.1	18.7	13.1	27.8	19.0	79.6	6.2	21.1	15.1	24.2	27.1	27.2	18.8	18.5	14.9	37.4	6.1	24.6	16.2	18.0	13.4	12.2	23.3	15.8	29.7	19.7	7.7	10.8	16.1	12.8	9.6	16.6	17.6	16.8	15.4	10.1	14.9	14.0	16.1	5.5	11.6	6.3	22.2	10.7	20.2	14.3	25.4	17.3	33.9	12.0	13.3	16.0	19.8	17.0	46.4	24.2	16.0	10.7	13.7	6.9	19.1	11.7	4.4	14.9	24.4	13.6	32.1	15.6	77.9	78.5	57.0	15.4	89.1	18.3	290.2	25.7	24.2	66.5	289.1	23.6	21.0	34.7	18.5	86.6	20.1	48.7	72.7	6.0	6.5	9.5	8.5	6.2	6.5	6.4	7.0	6.5	6.9	7.1	8.5	48.4	35.3	42.8	33.0	260.8	40.7	46.9	82.3	45.5	43.1	23.8	29.3	34.4	40.0	62.4	80.9	8.4	153.9	36.2	19.9	131.0	69.1	25.5	71.5	44.7	49.0	31.8	34.3	38.5	51.8	244.9	62.1	52.5	52.2	65.1	41.8	89.6	31.4	349.2	26.9	42.2	32.6	69.2	125.8	75.8	15.0	53.4	133.0	33.8	61.8	215.8	71.7	23.7	51.8	51.4	35.7	37.0	53.0	37.5	28.1	57.8	114.7	77.8	38.0	46.0	42.8	74.5	89.1	75.9	32.9	38.9	122.9	47.2	92.4	39.8	37.5
SNX25	SBBI31	ENSG00000109762	"Sorting nexin 25"	Q9H3E2	4	185204237-185370185	"Cancer-related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Protein transport, Transport"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 128.9;Astrocytes: 50.6;Excitatory neurons: 57.7;Inhibitory neurons: 60.7;Oligodendrocyte precursor cells: 55.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"naive B-cell: 1.0"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in all"		"HDLM-2: 55.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036928			Supported	Vesicles		NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 77: Retina - Visual perception"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 11: Alveolar cells - Smell perception"	Vesicles		"HPA036928: AB_10669720"	"unprognostic (9.20e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.26e-1)"	"unprognostic (4.29e-3)"	"unprognostic (8.89e-2)"	"unprognostic (5.63e-2)"	"unprognostic (1.43e-2)"	"unprognostic (6.41e-2)"	"unprognostic (5.35e-2)"	"unprognostic (2.99e-2)"	"unprognostic (4.03e-3)"	"unprognostic (1.87e-1)"	"unprognostic (3.33e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.32e-2)"	"unprognostic (8.55e-3)"	7.6	8.0	7.0	7.3	8.4	2.0	9.5	17.3	7.9	6.0	23.9	12.3	3.5	6.9	6.3	7.1	9.7	8.5	8.7	7.5	8.9	11.3	9.1	29.1	11.5	9.6	10.0	7.4	10.0	13.3	10.5	11.8	9.7	14.9	6.7	25.5	6.7	8.6	10.2	6.2	7.9	7.0	8.1	9.5	6.2	12.7	8.8	2.9	16.7	8.6	12.9	7.2	5.4	7.3	11.9	6.2	7.8	11.0	20.5	15.0	11.5	35.6	17.1	17.9	14.9	5.3	8.1	33.6	3.8	26.0	12.4	4.6	8.9	7.8	20.0	55.9	14.5	5.7	7.5	12.8	11.9	3.8	8.0	10.4	8.3	15.6	8.6	36.0	15.7	6.3	12.0	33.3	23.9	3.5	1.5	6.9	6.3	1.6	5.9	4.9	9.0	8.6	43.0	4.5	16.5	11.9	7.4	2.0	30.3	10.8	4.2	4.9	30.0	10.2	6.5	9.8	15.7	29.3	12.8	7.1	16.7	2.8	12.9	0.0	0.0	0.0	0.1	0.0	0.3	0.7	0.3	0.4	0.0	1.0	0.1	0.2	0.0	0.1	0.0	0.0	0.2	0.0	7.0	8.4	17.3	7.9	7.5	8.9	9.6	10.0	9.7	8.1	8.8	7.3	9.5	25.6	128.9	50.6	12.6	4.8	4.2	2.3	4.6	15.9	7.0	3.4	6.8	0.0	7.3	5.5	31.3	4.8	5.5	5.4	0.0	4.8	5.9	11.5	8.1	9.6	0.0	0.0	57.7	2.6	4.9	4.9	5.1	10.3	1.3	3.9	12.5	8.8	2.0	6.7	60.7	4.0	2.0	3.2	2.5	4.8	9.6	2.2	21.4	32.8	0.6	5.6	3.1	55.3	21.4	3.9	1.6	9.8	11.3	9.4	5.6	2.3	6.7	15.7	0.0	4.8	5.7	9.0	16.2	2.3	6.1	5.6	7.0	10.3	3.3	5.5
SNX5		ENSG00000089006	"Sorting nexin 5"	Q9Y5X3	20	17941597-17968980	"Predicted intracellular proteins"	"Endocytosis, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Proximal tubular cells: 271.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Hep G2: 639.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB020679, HPA051187, HPA076450"	Approved		Supported	Vesicles,Cytosol		NA	NA		8200	"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Vesicles, Cytosol"		"CAB020679: , HPA051187: AB_2681379, HPA076450: "	"unprognostic (6.00e-2)"	"unprognostic (2.35e-1)"	"unprognostic (3.08e-2)"	"unprognostic (4.00e-2)"	"unprognostic (4.47e-2)"	"unprognostic (5.71e-2)"	"prognostic unfavorable (2.30e-10)"	"unprognostic (1.67e-1)"	"unprognostic (6.19e-2)"	"unprognostic (1.69e-1)"	"unprognostic (2.62e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.77e-1)"	"unprognostic (3.15e-2)"	"unprognostic (6.50e-2)"	"unprognostic (3.48e-2)"	"unprognostic (2.99e-1)"	42.4	51.4	12.5	43.7	15.2	57.5	37.6	14.9	12.4	35.7	14.5	37.6	47.1	28.3	49.4	35.2	33.5	24.9	28.5	11.0	13.5	59.3	33.7	36.1	59.1	15.5	13.6	51.4	32.0	24.8	21.7	28.9	16.8	23.6	40.1	14.2	34.3	17.2	70.8	28.7	40.2	24.4	17.2	57.5	33.1	15.5	14.0	21.2	70.2	21.8	51.2	34.7	32.5	21.2	103.0	108.6	45.3	49.6	29.6	49.8	270.7	84.1	43.3	49.9	55.9	104.8	140.2	169.6	48.6	49.9	69.7	112.2	63.8	124.6	67.2	44.1	57.8	150.1	49.5	639.4	48.0	106.6	173.9	49.2	54.2	54.6	98.3	37.1	72.8	111.3	72.8	109.6	58.6	79.6	94.2	92.6	48.4	87.0	55.3	110.0	115.2	126.1	61.2	116.4	45.0	26.4	76.0	113.7	102.1	34.0	62.4	67.8	57.3	77.8	98.7	49.2	101.5	77.8	129.2	137.2	38.5	37.6	69.6	69.6	58.7	83.6	54.8	81.7	50.0	80.6	49.6	54.6	71.9	75.2	29.7	42.7	4.8	39.0	92.3	37.2	67.3	54.9	12.5	15.2	14.9	12.4	11.0	13.5	15.5	13.6	16.8	17.2	14.0	21.2	35.6	64.1	113.1	21.5	93.0	31.7	45.7	49.0	48.3	19.1	48.9	44.2	38.5	38.6	59.8	49.7	27.1	101.0	54.9	59.6	160.4	47.8	43.6	51.1	42.3	48.7	31.7	98.4	18.8	44.8	137.7	57.7	52.0	66.9	130.8	47.9	139.9	41.4	151.9	16.8	19.9	54.4	34.6	174.6	47.2	16.0	60.9	88.2	26.6	31.9	68.4	66.3	55.6	24.6	20.3	37.2	58.3	51.6	96.7	49.2	100.0	271.5	52.0	19.8	19.7	50.7	39.6	19.1	44.6	83.5	32.4	78.5	53.0	66.5	100.1	57.4
SNX6		ENSG00000129515	"Sorting nexin 6"	Q9UNH7	14	34561093-34630160	"Plasma proteins, Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049374	Approved		Supported	Endosomes,Lysosomes		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 10: Non-specific - Unknown function"	"Endosomes, Lysosomes"		"HPA049374: AB_2680734"	"unprognostic (1.89e-1)"	"unprognostic (6.49e-2)"	"unprognostic (1.46e-1)"	"unprognostic (3.06e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.36e-3)"	"prognostic unfavorable (1.25e-4)"	"unprognostic (1.23e-1)"	"unprognostic (6.63e-2)"	"unprognostic (1.06e-1)"	"prognostic unfavorable (4.68e-4)"	"unprognostic (1.91e-1)"	"unprognostic (3.48e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.55e-1)"	"unprognostic (8.82e-2)"	"unprognostic (2.10e-2)"	50.0	36.5	38.0	46.8	44.4	42.0	36.7	41.2	62.9	40.4	40.2	50.4	74.2	33.6	30.1	40.0	31.2	39.7	33.7	35.4	41.0	44.4	38.9	33.4	56.5	45.4	42.9	31.3	25.1	78.3	14.9	74.5	44.9	25.8	49.1	14.8	27.2	29.5	30.5	30.3	49.1	43.9	44.8	49.2	39.6	36.0	42.1	45.1	34.1	29.2	47.8	50.2	29.6	51.4	112.3	65.3	73.5	48.9	114.5	224.7	99.4	113.1	124.0	110.4	95.4	61.6	115.4	73.2	79.0	153.2	44.1	67.8	81.1	85.8	187.9	93.5	31.7	44.6	34.9	115.9	108.5	77.2	46.8	154.1	98.9	80.7	109.7	100.4	151.7	53.3	48.8	56.3	146.9	68.4	69.9	41.4	40.2	97.7	73.0	74.3	84.4	64.1	135.2	84.6	56.7	61.1	89.9	72.9	94.6	65.0	77.6	47.5	150.8	74.6	52.6	67.8	72.0	55.9	95.9	82.9	37.6	41.6	86.1	73.5	74.2	93.4	73.1	97.4	95.8	71.5	97.0	84.8	66.5	68.0	73.3	79.2	126.5	74.0	101.3	47.6	102.0	109.0	38.0	44.4	41.2	62.9	35.4	41.0	45.4	42.9	44.9	44.8	42.1	51.4	130.2	86.6	49.7	17.6	77.5	51.4	63.0	109.7	69.4	43.4	51.1	67.8	73.4	27.1	87.2	80.9	22.9	166.7	108.9	73.0	125.2	88.1	6.6	74.9	110.1	87.5	52.0	55.5	25.5	64.7	126.3	88.0	68.8	114.3	85.4	93.5	124.6	36.8	251.1	21.9	31.2	62.7	67.1	196.1	73.0	15.3	64.3	155.7	62.2	26.2	155.4	69.6	88.6	21.1	52.5	74.1	77.9	94.8	51.2	84.0	54.8	127.0	73.3	39.4	59.2	74.2	133.8	164.6	167.9	90.0	65.8	254.6	109.4	346.2	82.0	76.8
SNX8	Mvp1	ENSG00000106266	"Sorting nexin 8"	Q9Y5X2	7	2251770-2354318	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 108.9;Late spermatids: 358.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"GAMG: 100.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA057296, HPA060194"	Approved		Supported	Vesicles		NA	NA			"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 31: Spermatids - Spermatogenesis"	Vesicles		"HPA057296: AB_2683401, HPA060194: AB_2684219"	"unprognostic (2.22e-2)"	"unprognostic (3.38e-1)"	"unprognostic (9.85e-3)"	"unprognostic (1.39e-1)"	"unprognostic (2.08e-2)"	"unprognostic (9.32e-2)"	"prognostic unfavorable (8.47e-6)"	"unprognostic (5.23e-2)"	"unprognostic (1.91e-3)"	"unprognostic (1.54e-2)"	"unprognostic (3.06e-1)"	"unprognostic (6.01e-2)"	"unprognostic (1.54e-1)"	"unprognostic (5.10e-2)"	"unprognostic (4.83e-2)"	"unprognostic (1.12e-2)"	"unprognostic (1.35e-1)"	15.4	6.8	13.7	11.3	14.1	10.9	12.4	11.8	11.4	7.0	10.9	7.7	10.6	6.9	3.1	10.2	7.0	9.8	12.8	12.9	11.3	7.3	7.2	9.7	21.5	15.1	13.0	7.5	7.5	5.9	5.4	9.3	13.3	4.3	6.8	5.7	7.8	3.0	11.0	10.2	9.5	5.6	12.9	32.7	6.9	23.2	15.1	7.9	8.3	7.5	17.7	8.5	5.7	14.9	40.3	38.7	15.6	21.8	21.3	20.5	36.7	19.2	28.4	31.8	39.2	27.3	30.6	23.4	7.7	22.8	100.9	10.6	13.6	10.5	16.1	5.9	12.8	13.0	15.5	22.9	53.9	12.7	20.8	41.4	12.1	39.0	15.0	8.5	12.1	18.3	26.0	26.9	26.4	26.4	4.3	13.5	28.4	22.4	19.0	20.6	32.2	10.7	7.5	18.8	7.5	19.7	17.4	47.8	27.3	17.0	35.5	27.4	18.5	26.6	69.7	44.0	25.4	17.5	22.9	21.9	26.4	16.9	73.6	11.8	15.4	5.1	2.9	17.2	2.1	26.1	2.1	2.9	21.8	30.6	2.0	2.4	2.6	2.2	17.8	5.4	3.4	8.7	13.7	14.1	11.8	11.4	12.9	11.3	15.1	13.0	13.3	12.9	15.1	14.9	7.4	6.4	9.4	3.9	35.7	5.2	7.8	6.1	2.8	10.0	12.3	10.4	12.4	10.0	4.8	3.7	8.4	16.7	7.7	10.5	13.7	21.0	108.9	3.3	12.8	13.0	6.0	26.3	5.0	30.0	15.4	10.3	10.7	4.5	12.6	8.2	45.3	8.8	78.1	21.9	7.8	10.9	6.1	35.2	75.2	358.9	12.2	36.7	14.2	6.5	41.9	7.8	7.2	2.5	9.1	26.9	7.9	13.2	12.9	8.8	12.5	14.9	5.5	12.5	0.0	5.3	9.6	10.6	22.9	5.7	6.1	43.4	6.3	29.6	9.7	9.2
SNX9	"SDP1, SH3PX1, SH3PXD3A"	ENSG00000130340	"Sorting nexin 9"	Q9Y5X1	6	157700387-157945077	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Endocytosis, Mitosis, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Glandular and luminal cells: 251.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"plasmacytoid DC: 10.0"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 146.6;GAMG: 145.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031410, HPA057203"	Approved		Supported	"Plasma membrane,Cytosol"		No	No			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 18: U-2197 - ECM organization"	"Cluster 44: Endometrium - Transcription"	"Plasma membrane"	Cytosol	"HPA031410: AB_10603339, HPA057203: AB_2683368"	"unprognostic (1.63e-3)"	"prognostic unfavorable (5.95e-4)"	"unprognostic (1.39e-1)"	"unprognostic (8.09e-2)"	"unprognostic (8.09e-2)"	"unprognostic (1.40e-2)"	"unprognostic (4.06e-2)"	"prognostic unfavorable (3.77e-4)"	"unprognostic (7.93e-2)"	"unprognostic (4.99e-3)"	"unprognostic (4.45e-2)"	"unprognostic (2.42e-1)"	"prognostic favorable (9.95e-4)"	"unprognostic (2.14e-1)"	"unprognostic (2.46e-1)"	"unprognostic (1.13e-2)"	"unprognostic (2.57e-1)"	57.9	25.2	19.2	25.7	20.6	14.3	41.4	21.2	20.9	38.8	20.6	34.2	33.2	41.8	20.8	57.8	26.2	46.9	33.2	18.8	19.9	26.2	39.0	21.0	24.2	22.2	21.1	28.0	28.5	37.7	13.4	48.5	21.8	31.0	29.5	2.7	35.1	41.7	24.4	30.4	35.6	41.2	20.9	18.4	37.5	11.0	20.7	13.9	29.8	34.2	21.7	49.8	33.7	23.0	26.0	19.1	18.9	22.1	96.6	78.6	37.7	46.3	146.6	36.4	48.9	16.6	27.6	0.0	25.0	85.6	145.8	18.7	22.7	36.3	21.1	23.9	23.4	17.7	25.7	23.9	48.6	7.6	31.6	51.1	33.9	37.8	37.1	63.9	49.8	23.3	80.9	0.0	15.8	17.2	0.0	15.6	14.4	18.7	21.3	0.0	17.9	32.7	59.7	15.9	11.8	20.9	34.1	16.4	90.5	16.2	6.8	20.0	41.7	41.3	16.6	128.8	30.4	0.0	0.0	0.0	84.8	6.4	25.4	0.0	0.7	0.1	0.4	2.1	1.5	3.2	0.7	0.6	1.4	2.4	5.3	1.2	0.0	0.1	6.8	10.0	2.2	0.6	19.2	20.6	21.2	20.9	18.8	19.9	22.2	21.1	21.8	20.9	20.7	23.0	71.5	0.0	1.1	40.5	102.6	43.3	109.7	17.3	30.1	15.6	28.7	18.4	28.4	28.6	19.0	9.2	0.0	40.6	37.6	97.7	21.5	57.5	73.4	112.8	53.0	57.9	15.7	17.7	105.4	55.9	41.1	83.0	70.3	251.1	12.0	16.4	37.1	34.3	41.6	3.3	90.4	43.0	8.2	59.0	74.2	26.8	44.7	84.3	21.4	48.7	39.5	11.1	7.2	100.5	161.2	107.0	108.9	46.6	14.9	127.5	52.5	46.2	14.3	1.8	39.5	43.6	49.6	21.9	15.4	22.9	29.8	109.9	48.8	9.1	29.7	137.0
SOCS1	"Cish1, JAB, SOCS-1, SSI-1, TIP3"	ENSG00000185338	"Suppressor of cytokine signaling 1"	O15524	16	11254408-11256204	"Cancer-related genes, Predicted intracellular proteins"	"Growth regulation, Ubl conjugation pathway"	"Signal transduction inhibitor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 102.5;dendritic cells: 191.9;T-cells: 161.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"basophil: 13.6"	"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in many"	6	"HDLM-2: 107.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"CAB010355, HPA074108"	Approved		Supported	"Nucleoplasm,Cytoplasmic bodies"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm	"Cytoplasmic bodies"	"CAB010355: AB_2193144, HPA074108: AB_2686661"	"unprognostic (4.50e-3)"	"unprognostic (3.30e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.66e-2)"	"unprognostic (1.25e-2)"	"prognostic favorable (1.10e-4)"	"unprognostic (1.71e-2)"	"unprognostic (4.09e-3)"	"unprognostic (5.31e-3)"	"unprognostic (4.82e-2)"	"unprognostic (1.17e-1)"	"unprognostic (5.39e-2)"	"prognostic unfavorable (1.08e-6)"	"unprognostic (1.56e-1)"	"unprognostic (5.68e-2)"	"unprognostic (6.08e-2)"	"unprognostic (1.67e-1)"	10.7	4.2	0.9	14.3	1.0	9.9	6.9	5.8	1.1	15.6	0.7	5.0	2.0	5.9	1.1	5.4	4.6	2.3	5.1	0.9	1.3	23.2	26.9	9.7	13.5	2.5	1.2	9.4	3.1	0.7	14.8	3.8	2.7	6.3	0.9	0.1	4.9	1.7	2.1	7.4	12.4	1.0	1.9	18.6	8.0	7.6	2.6	9.8	4.4	0.5	10.2	6.6	7.0	1.0	2.8	0.5	1.1	0.2	3.3	0.5	4.0	2.2	15.7	1.0	1.3	0.7	0.5	6.3	4.7	1.0	2.9	1.1	0.4	0.2	0.2	107.8	0.8	1.7	0.0	8.6	1.4	0.0	18.5	1.4	0.3	2.2	0.2	0.4	0.3	0.6	14.4	1.8	0.1	2.5	7.2	4.0	11.4	0.2	1.7	0.7	0.7	0.7	1.2	0.5	1.5	0.2	0.5	3.7	1.2	3.1	0.0	0.9	0.1	1.3	6.4	0.9	1.5	0.4	0.6	10.0	2.6	0.8	1.3	13.6	0.1	10.2	2.1	0.0	1.9	1.5	2.4	2.6	0.0	5.3	2.6	2.3	0.3	6.1	0.1	1.3	2.8	0.4	0.9	1.0	5.8	1.1	0.9	1.3	2.5	1.2	2.7	1.9	2.6	1.0	102.5	0.0	4.4	1.6	67.7	12.2	17.4	1.9	8.6	1.9	33.8	55.5	10.3	2.8	0.7	51.5	6.2	24.1	191.9	30.6	23.5	18.4	64.8	18.1	19.9	14.3	26.0	8.4	0.0	8.5	4.8	61.5	26.0	36.9	52.8	4.9	8.2	3.4	4.5	0.0	0.2	17.7	8.2	5.8	25.7	24.7	7.2	33.8	30.2	1.0	14.2	6.7	24.7	0.5	0.0	5.0	20.2	41.8	89.0	7.4	19.0	9.2	2.5	4.8	0.0	30.2	34.2	0.8	8.3	10.1	6.8	57.7	161.5	23.0	11.8	11.6
SOD1	"ALS, ALS1, IPOA"	ENSG00000142168	"Superoxide dismutase 1"	P00441	21	31659666-31668931	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Antioxidant, Oxidoreductase"	"Amyotrophic lateral sclerosis, Cancer-related genes, Disease variant, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 1645.6"	"Cell type enhanced"	"Detected in all"		"Hepatocytes: 3357.9;Proximal tubular cells: 3285.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001401, CAB008670"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA	44900000	50000000	"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 15: Liver - Metabolism"	"Cluster 16: U-266 - Nucleosome"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Nucleoplasm, Plasma membrane, Cytosol"		"CAB008670: AB_1623312, HPA001401: AB_1080132"	"unprognostic (1.73e-1)"	"unprognostic (1.18e-2)"	"unprognostic (4.43e-1)"	"unprognostic (6.19e-2)"	"unprognostic (1.39e-1)"	"unprognostic (9.59e-3)"	"unprognostic (8.34e-2)"	"unprognostic (2.30e-1)"	"unprognostic (3.47e-1)"	"unprognostic (5.28e-2)"	"unprognostic (9.33e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.03e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.74e-2)"	"unprognostic (1.57e-1)"	"unprognostic (3.26e-2)"	257.6	597.1	558.0	118.4	577.4	166.4	233.5	605.2	805.1	206.6	586.6	251.0	360.3	179.5	228.4	221.1	197.1	206.0	477.3	575.1	619.9	483.2	1645.6	153.9	169.6	619.8	604.6	302.1	117.1	210.6	236.7	155.8	653.1	203.9	180.5	248.6	160.5	204.2	428.0	152.1	266.7	136.6	588.1	147.5	210.4	132.1	585.8	165.7	197.4	355.9	151.7	232.1	220.6	634.7	526.8	451.4	309.2	312.8	407.3	282.1	257.8	430.2	258.0	291.3	217.4	593.6	326.0	628.2	441.2	405.8	517.7	186.1	453.3	320.6	239.9	463.3	540.0	1008.2	579.5	866.3	267.4	451.7	363.1	294.8	240.6	406.5	225.2	327.9	331.2	469.0	704.4	773.2	357.4	860.0	489.0	454.5	466.1	830.0	475.4	413.0	622.0	981.4	579.4	320.5	335.9	281.4	805.1	419.4	438.3	279.2	484.3	393.4	387.4	222.9	489.2	304.7	322.0	583.4	1374.2	741.8	455.7	654.3	301.9	204.2	159.7	194.0	313.4	234.0	365.3	427.1	509.2	402.4	212.8	310.1	521.8	412.1	37.8	241.4	465.4	240.6	746.0	474.5	558.0	577.4	605.2	805.1	575.1	619.9	619.8	604.6	653.1	588.1	585.8	634.7	319.8	294.9	175.1	38.2	248.1	491.4	672.7	479.2	319.8	226.6	264.1	352.9	721.0	527.6	294.7	391.8	47.9	703.4	250.2	703.5	1631.7	426.3	277.0	410.7	241.2	261.0	288.4	898.8	39.7	807.3	574.9	365.8	198.8	216.3	220.0	278.9	318.1	3357.9	363.3	282.7	45.5	402.7	366.2	220.0	318.5	952.2	521.9	224.2	419.8	29.0	313.1	598.5	239.0	28.6	68.7	322.8	600.9	528.1	178.2	567.0	1158.3	3285.9	638.3	216.5	440.4	313.6	404.5	211.7	506.3	379.9	349.8	725.9	423.1	470.3	593.6	497.7
SORBS1	"CAP, FLJ12406, KIAA1296, ponsin, SH3D5, sh3p12"	ENSG00000095637	"Sorbin and SH3 domain containing 1"	Q9BX66	10	95311771-95561414	"Predicted intracellular proteins"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 800.2;Cardiomyocytes: 612.3;Excitatory neurons: 401.1;Inhibitory neurons: 295.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	5	"basophil: 6.1"	"Lineage enriched"	"Detected in single"	10	"granulocytes: 6.1"	"Cell line enhanced"	"Detected in many"		"CACO-2: 28.0;Hep G2: 19.5;HMC-1: 48.3;SK-MEL-30: 45.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027559, CAB032850, HPA043084"	Enhanced		Supported	"Plasma membrane,Focal adhesion sites,Centrosome"		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 54: Cardiomyocytes - Muscle contraction"	"Focal adhesion sites"	"Plasma membrane, Centrosome"	"CAB032850: AB_2286335, HPA027559: AB_10600812, HPA043084: AB_2678307"	"prognostic favorable (2.84e-4)"	"unprognostic (3.53e-1)"	"unprognostic (1.89e-1)"	"unprognostic (7.85e-2)"	"unprognostic (3.43e-1)"	"unprognostic (1.41e-1)"	"unprognostic (2.98e-2)"	"unprognostic (5.30e-2)"	"unprognostic (1.95e-2)"	"unprognostic (1.65e-2)"	"unprognostic (3.17e-2)"	"unprognostic (1.27e-1)"	"unprognostic (3.40e-2)"	"unprognostic (3.13e-2)"	"unprognostic (1.80e-1)"	"unprognostic (2.55e-2)"	"unprognostic (5.01e-3)"	370.8	21.6	128.5	53.3	153.3	4.7	78.3	101.7	144.1	46.0	42.6	312.8	25.6	169.4	32.1	155.5	99.2	81.3	351.6	127.0	165.4	17.6	49.3	34.4	3.1	164.0	161.5	19.0	22.0	26.4	11.5	30.3	126.7	140.6	67.0	39.0	24.5	217.4	190.5	24.5	62.7	151.0	138.9	8.1	143.1	14.4	127.0	3.7	14.8	155.9	1.5	235.3	47.1	139.9	1.6	1.2	12.4	3.1	4.2	0.2	2.4	0.4	0.1	0.4	0.1	28.0	10.9	0.0	2.2	0.2	4.2	0.6	2.4	0.6	0.4	3.2	4.5	7.2	0.4	19.5	1.5	0.0	48.3	0.9	0.4	0.5	0.3	0.2	4.9	1.9	11.7	2.3	1.3	0.8	0.1	0.8	5.7	6.2	2.6	1.0	4.0	0.4	15.1	18.3	4.9	3.7	1.8	0.6	45.2	8.9	2.1	0.4	0.3	0.1	4.0	0.1	2.4	1.8	0.5	0.2	4.8	0.5	11.7	6.1	0.1	1.2	0.4	0.6	0.5	0.0	0.1	0.2	0.0	0.0	0.1	0.0	0.1	0.4	0.1	0.0	0.3	0.1	128.5	153.3	101.7	144.1	127.0	165.4	164.0	161.5	126.7	138.9	127.0	139.9	42.2	22.4	20.9	800.2	0.8	11.6	8.7	0.0	5.2	7.5	6.5	19.3	612.3	12.8	1.3	1.8	2.1	20.2	1.0	4.0	3.9	7.2	70.4	1.4	15.8	25.7	6.0	16.0	401.1	3.1	2.4	21.4	8.6	1.6	16.4	8.2	30.4	50.5	3.1	6.7	295.1	10.9	0.0	3.8	12.0	48.6	7.5	1.1	14.2	163.9	0.7	22.1	1.0	155.3	22.6	2.3	2.8	76.8	1.1	4.7	1.2	6.1	0.1	5.5	0.0	11.8	51.6	3.4	3.7	1.9	12.5	29.6	1.6	0.1	5.1	5.9
SORCS2	KIAA1329	ENSG00000184985	"Sortilin related VPS10 domain containing receptor 2"	Q96PQ0	4	7192538-7742836	"Plasma proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 22.9"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 107.1;Bipolar cells: 70.3;Excitatory neurons: 41.4;Muller glia cells: 33.0;Oligodendrocytes: 76.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 7.6;HaCaT: 19.6;HMC-1: 14.5;RPMI-8226: 9.1;SiHa: 14.1;THP-1: 8.4;U-937: 8.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA071818			Approved	Vesicles,Cytosol		NA	NA				"Cluster 45: Intestine - Brush border"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 56: Bipolar cells - Visual perception"	"Vesicles, Cytosol"		"HPA071818: "	"unprognostic (1.38e-1)"	"unprognostic (6.32e-2)"	"unprognostic (1.91e-2)"	"unprognostic (4.37e-2)"	"unprognostic (4.91e-3)"	"unprognostic (1.82e-2)"	"unprognostic (4.60e-2)"	"unprognostic (1.14e-2)"	"unprognostic (1.49e-3)"	"prognostic unfavorable (3.55e-4)"	"unprognostic (1.52e-1)"	"unprognostic (3.56e-2)"	"prognostic unfavorable (3.09e-4)"	"unprognostic (2.17e-3)"	"unprognostic (5.37e-2)"	"unprognostic (2.09e-1)"	"unprognostic (7.27e-3)"	2.4	1.1	13.4	3.4	18.3	1.7	1.6	11.6	15.9	8.5	0.0	4.5	1.4	4.7	3.8	2.2	3.3	3.6	2.0	12.1	11.3	9.0	4.6	4.4	0.8	18.6	17.6	5.8	0.7	0.0	2.7	0.2	14.7	5.2	1.1	12.9	1.0	2.4	1.1	1.8	2.6	6.2	11.3	0.4	1.6	1.6	14.1	3.1	3.1	1.2	1.2	3.0	3.7	22.9	0.8	1.1	1.3	0.2	0.1	0.0	0.0	0.2	0.1	1.6	0.4	0.2	0.6	0.0	7.6	5.0	1.3	19.6	0.0	0.0	0.3	0.0	0.0	0.0	2.8	0.3	0.2	0.0	14.5	0.2	4.3	6.0	0.0	0.1	0.0	0.0	0.0	0.4	0.3	0.1	0.0	0.0	0.4	0.0	0.9	0.0	1.6	9.1	0.2	0.0	0.8	0.7	14.1	0.0	0.0	0.8	0.0	8.4	0.0	4.9	1.4	0.0	0.1	0.0	0.0	0.0	1.6	8.7	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.4	18.3	11.6	15.9	12.1	11.3	18.6	17.6	14.7	11.3	14.1	22.9	0.1	3.2	11.3	107.1	0.0	0.1	0.3	4.6	0.0	70.3	0.1	2.4	2.0	0.0	6.9	5.5	0.0	0.0	0.3	0.0	0.0	0.2	2.2	0.4	0.4	0.3	0.0	0.0	41.4	0.0	0.0	5.0	0.0	0.9	0.0	5.4	0.4	1.6	0.2	1.7	24.3	0.0	2.0	0.3	0.0	11.6	12.8	0.4	1.8	8.4	0.1	33.0	1.0	8.0	76.2	1.1	0.0	7.9	0.1	0.4	0.4	1.4	2.0	2.7	0.0	0.9	1.0	0.1	0.3	0.0	0.4	0.0	0.3	1.5	0.0	0.6
SORT1	"Gp95, NT3"	ENSG00000134243	"Sortilin 1"	Q99523	1	109309568-109397918	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Differentiation, Endocytosis, Osteogenesis, Transport"	"Developmental protein, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 285.6"	"Cell type enriched"	"Detected in many"	4	"Oligodendrocytes: 447.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"intermediate monocyte: 9.2;non-classical monocyte: 10.8"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006889, CAB011498"	Enhanced		Supported	"Golgi apparatus,Plasma membrane,Cytosol"		NA	NA	7170000	110000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 70: Brain - Nervous system development"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Golgi apparatus, Cytosol"	"Plasma membrane"	"CAB011498: AB_2192606, HPA006889: AB_1080056"	"unprognostic (2.10e-2)"	"unprognostic (7.46e-2)"	"prognostic favorable (7.74e-6)"	"unprognostic (4.12e-1)"	"unprognostic (9.41e-2)"	"unprognostic (1.40e-1)"	"prognostic unfavorable (1.23e-4)"	"unprognostic (3.34e-3)"	"unprognostic (4.27e-2)"	"unprognostic (9.44e-2)"	"unprognostic (2.42e-2)"	"unprognostic (1.28e-2)"	"unprognostic (1.23e-3)"	"unprognostic (1.45e-2)"	"unprognostic (2.15e-1)"	"unprognostic (3.95e-1)"	"unprognostic (4.46e-3)"	48.2	11.3	71.0	12.0	168.3	21.4	25.1	124.3	114.2	17.7	21.5	29.5	22.1	24.7	139.8	41.5	27.5	17.8	64.7	131.8	90.0	38.7	6.5	37.4	2.8	151.9	133.8	6.1	17.5	46.5	11.3	44.8	153.1	18.3	26.9	40.0	25.2	44.0	85.0	19.0	21.9	27.8	102.8	10.2	18.2	43.5	118.0	6.4	42.7	71.8	10.3	16.9	18.0	285.6	38.8	15.3	37.5	45.8	107.0	21.2	107.3	28.2	44.9	27.2	29.0	39.8	14.0	0.3	35.2	11.9	19.9	9.4	44.7	22.3	38.9	1.1	21.2	10.7	23.5	43.1	41.8	0.2	33.5	53.2	3.6	33.3	7.3	72.6	4.2	31.7	81.3	4.0	38.7	41.1	27.9	0.8	14.1	17.5	6.3	30.7	87.9	18.9	52.0	27.8	38.3	21.8	16.6	109.3	120.6	53.1	46.1	6.7	1.1	5.8	21.7	1.0	47.6	37.0	32.2	0.3	9.8	0.3	24.3	0.0	7.1	2.5	0.0	9.2	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	1.8	0.4	10.8	1.6	0.0	2.0	71.0	168.3	124.3	114.2	131.8	90.0	151.9	133.8	153.1	102.8	118.0	285.6	10.6	38.5	47.9	54.5	1.9	1.3	4.7	6.7	1.2	14.9	27.5	14.2	98.9	27.1	20.3	75.4	35.5	30.6	3.2	70.2	5.9	23.9	65.1	33.2	5.2	15.9	16.8	4.0	87.9	23.7	30.2	9.8	16.8	34.9	7.6	10.4	7.9	22.1	30.1	13.5	56.7	27.7	6.1	38.7	9.9	79.7	8.7	34.6	21.4	78.7	37.7	21.7	0.0	48.7	447.8	25.6	23.2	49.7	1.5	7.1	64.0	13.1	29.6	50.7	32.9	25.1	53.6	46.3	21.6	9.3	1.8	36.8	2.1	1.8	28.3	10.8
SOX10	"DOM, WS2E, WS4"	ENSG00000100146	"SRY-box transcription factor 10"	P56693	22	37970686-37987422	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Deafness, Disease variant, Hirschsprung disease, Kallmann syndrome, Waardenburg syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"brain: 194.9;salivary gland: 114.3"	"Group enriched"	"Detected in some"	14	"Breast glandular cells: 32.3;Breast myoepithelial cells: 47.8;Melanocytes: 35.6;Oligodendrocyte precursor cells: 61.3;Oligodendrocytes: 59.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	510	"SK-MEL-30: 313.9;WM-115: 432.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003171, HPA068898"	Enhanced		Supported	Nucleoplasm		Yes	NA				"Cluster 70: Brain - Nervous system development"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 35: Glandular cells - Unknown function"	Nucleoplasm		"CAB003171: AB_2195374, HPA068898: AB_2686054"																		2.9	2.7	76.9	2.5	133.7	0.1	21.7	103.1	102.8	11.8	24.9	26.6	1.5	0.8	1.2	2.7	2.5	2.2	8.8	82.7	89.0	0.5	0.5	0.1	0.0	134.7	114.0	1.2	0.8	0.0	1.8	0.0	123.3	6.8	2.6	0.5	114.3	5.8	0.6	17.0	7.1	1.9	87.3	0.3	6.1	2.7	114.2	0.0	0.9	1.5	0.0	8.4	9.5	194.9	0.5	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	313.9	0.0	0.1	0.4	0.0	0.2	0.2	0.0	0.2	0.0	0.3	0.1	0.7	0.0	432.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	76.9	133.7	103.1	102.8	82.7	89.0	134.7	114.0	123.3	87.3	114.2	194.9	0.3	0.0	0.0	0.0	0.1	3.2	0.1	0.0	0.0	0.0	32.3	47.8	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.4	0.0	0.0	0.3	0.0	0.0	0.8	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.4	0.4	0.9	0.1	35.6	0.0	0.0	0.0	0.0	61.3	59.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.3	0.7	0.0	0.9	0.0	0.2	0.0	0.0	0.0
SOX11		ENSG00000176887	"SRY-box transcription factor 11"	P35716	2	5692384-5701385	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"brain: 5.0"	"Cell type enhanced"	"Detected in some"		"Breast glandular cells: 6.4;Breast myoepithelial cells: 8.6;Cardiomyocytes: 13.9;Inhibitory neurons: 8.4;Oligodendrocyte precursor cells: 21.6;Skeletal myocytes: 38.8"	"Cancer enhanced"	"Detected in many"		"glioma: 8.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 47.2;NTERA-2: 23.6;REH: 17.9;RH-30: 18.2;SCLC-21H: 29.1;SH-SY5Y: 44.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA000448, HPA000536, CAB056152, CAB056153"	Approved		Supported	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 42: Non-specific - Transcription"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 50: Fibroblasts - ECM organization"	Nucleoplasm	"Plasma membrane"	"CAB056152: AB_2665567, CAB056153: AB_2665568, HPA000448: , HPA000536: AB_1080060"	"unprognostic (2.17e-2)"	"unprognostic (2.02e-2)"	"unprognostic (1.44e-2)"	"unprognostic (7.35e-6)"	"unprognostic (2.79e-1)"	"unprognostic (1.19e-1)"	"unprognostic (4.04e-8)"	"unprognostic (2.79e-2)"	"unprognostic (7.27e-2)"	"unprognostic (3.17e-1)"	"unprognostic (3.35e-3)"	"unprognostic (2.42e-1)"	"unprognostic (8.45e-8)"	"unprognostic (1.35e-1)"	"unprognostic (1.96e-1)"	"unprognostic (5.50e-3)"	"unprognostic (7.47e-2)"	0.0	0.0	2.3	0.0	2.8	0.0	0.0	1.3	1.9	0.0	0.3	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1.3	5.0	0.0	0.0	0.0	0.0	2.5	2.9	0.0	0.0	0.0	0.2	0.0	2.0	0.0	0.1	0.2	0.1	0.0	0.1	0.0	0.2	0.2	3.2	0.1	0.0	0.0	4.6	0.0	0.0	0.1	0.0	0.0	0.0	3.0	0.0	0.0	47.2	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.3	0.0	0.0	0.6	0.0	0.0	0.0	1.5	0.0	2.3	0.0	0.0	4.4	0.0	0.0	0.0	23.6	0.0	0.0	17.9	18.2	0.7	0.0	0.0	29.1	44.0	0.0	0.3	0.0	8.2	0.0	0.0	0.0	0.6	0.2	0.0	0.0	3.3	0.6	1.2	0.0	0.0	11.1	0.7	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.2	0.2	0.1	0.1	0.1	2.3	2.8	1.3	1.9	1.3	5.0	2.5	2.9	2.0	3.2	4.6	3.0	0.4	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	2.1	6.4	8.6	13.9	0.0	0.6	0.0	0.0	0.2	0.0	0.0	0.0	5.7	0.9	0.0	0.8	1.2	0.0	0.0	0.4	0.0	0.2	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	8.4	0.0	0.0	0.0	0.3	0.2	0.0	0.2	0.0	1.0	0.0	0.5	0.0	21.6	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	38.8	1.1	0.0	0.2	0.0	0.0	0.3	0.1	0.1	0.0	0.0
SOX30		ENSG00000039600	"SRY-box transcription factor 30"	O94993	5	157625679-157671480	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	85	"testis: 80.6"	"Cell type enriched"	"Detected in some"	4	"Early spermatids: 351.1"	"Cancer enhanced"	"Detected in some"		"cervical cancer: 1.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 1.9;CACO-2: 1.3;HDLM-2: 4.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA006159, CAB009382"	Enhanced		Supported	Nucleoplasm,Vesicles,Cytosol		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 36: Testis - Spermatogenesis"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 29: Early spermatids - Spermatogenesis"	"Nucleoplasm, Vesicles"	Cytosol	"CAB009382: AB_2195963, HPA006159: AB_1080062"	"unprognostic (3.51e-2)"	"unprognostic (4.72e-2)"	"unprognostic (7.31e-2)"	"unprognostic (4.70e-4)"	"unprognostic (2.53e-2)"	"unprognostic (6.12e-2)"	"unprognostic (4.47e-2)"	"unprognostic (2.22e-2)"	"unprognostic (5.33e-2)"	"unprognostic (1.36e-1)"	"unprognostic (4.73e-2)"	"unprognostic (7.85e-2)"	"unprognostic (4.64e-4)"	"unprognostic (5.88e-2)"	"unprognostic (1.64e-1)"	"unprognostic (3.72e-2)"	"unprognostic (3.45e-1)"	0.0	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.2	0.0	0.0	0.3	0.7	0.1	0.0	0.1	0.9	0.1	0.1	0.1	0.3	0.1	0.0	0.1	0.3	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.4	0.1	0.1	0.2	0.1	80.6	0.4	0.7	0.0	0.0	0.1	0.1	0.0	0.2	1.9	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.1	0.1	1.3	0.8	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.1	4.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.4	0.0	0.4	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.1	0.3	0.1	0.3	0.1	0.0	0.0	0.2	0.3	0.2	0.0	0.3	0.2	0.2	0.0	0.0	0.0	0.5	0.3	0.1	0.1	0.1	0.1	0.2	0.1	0.3	0.1	0.1	0.2	0.1	0.4	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.6	0.0	0.0	0.1	0.0	0.6	0.0	0.0	351.1	0.5	0.0	0.1	0.0	0.0	0.4	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	71.4	1.8	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.9	0.0	0.1	1.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	42.8	11.7	0.0	0.0	0.0	0.1	0.3	0.0	0.0
SOX4		ENSG00000124766	"SRY-box transcription factor 4"	Q06945	6	21593751-21598619	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 73.4"	"Cell type enhanced"	"Detected in many"		"Ductal cells: 1128.5;Granulosa cells: 1047.5;Ionocytes: 1320.3;Pancreatic endocrine cells: 1288.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"plasmacytoid DC: 45.7"	"Group enriched"	"Detected in all"	5	"dendritic cells: 45.7;granulocytes: 33.3;monocytes: 22.0"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 254.1;MOLT-4: 229.9"	"Region enhanced"	"Detected in all"		"olfactory bulb: 54.2"					HPA029901	Approved		Supported	Nucleoplasm,Mitochondria		NA	Yes			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 34: Non-specific - Transcription"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 40: Granulosa cells - Unknown function"	Nucleoplasm	Mitochondria	"HPA029901: AB_10601592"	"unprognostic (4.01e-2)"	"unprognostic (3.06e-1)"	"unprognostic (9.28e-2)"	"unprognostic (5.18e-2)"	"unprognostic (5.00e-2)"	"unprognostic (1.08e-2)"	"prognostic unfavorable (2.57e-5)"	"unprognostic (1.78e-1)"	"unprognostic (8.01e-3)"	"unprognostic (1.98e-2)"	"unprognostic (3.88e-3)"	"unprognostic (1.18e-1)"	"unprognostic (8.73e-3)"	"unprognostic (3.66e-2)"	"unprognostic (3.31e-1)"	"unprognostic (2.01e-1)"	"unprognostic (9.27e-2)"	11.8	4.3	4.7	9.2	5.0	24.0	17.9	8.8	6.7	21.5	2.8	11.9	12.5	57.8	15.0	5.4	13.5	20.4	6.4	4.2	6.5	16.8	6.4	19.3	5.8	3.5	5.0	51.7	10.2	3.6	4.1	6.1	4.1	14.5	14.4	6.4	17.5	6.8	3.5	8.8	11.6	17.4	4.0	5.4	17.5	9.9	7.1	73.4	8.6	6.1	7.4	21.1	7.7	4.2	8.5	24.4	60.5	254.1	22.0	5.5	98.7	3.8	7.8	4.6	4.1	16.7	16.5	2.9	100.2	6.2	3.5	25.1	32.0	17.9	3.3	36.6	66.8	2.7	11.5	11.2	3.5	9.0	2.1	9.6	18.1	2.1	7.3	64.1	72.3	138.8	0.6	0.2	5.2	20.6	229.9	21.6	45.3	12.7	23.1	99.7	5.3	0.4	44.1	78.3	78.9	141.2	35.9	41.1	14.0	74.9	20.1	30.9	55.7	7.1	23.1	1.7	18.6	1.5	0.1	71.8	2.4	30.6	28.5	33.3	19.3	2.1	0.5	11.7	0.1	7.0	0.3	0.3	8.7	6.6	2.2	1.6	0.8	7.4	22.0	45.7	2.1	4.7	4.7	5.0	8.8	6.7	4.2	6.5	3.5	5.0	4.1	4.0	7.1	4.2	235.0	198.7	50.4	0.7	36.2	112.5	129.2	660.7	676.7	99.7	586.1	676.5	297.4	423.2	457.3	154.5	12.5	74.8	104.4	247.6	66.5	1128.5	6.1	669.0	624.2	264.5	340.8	114.3	3.2	604.4	409.4	247.3	313.0	650.9	60.6	1047.5	119.2	6.8	35.5	48.8	4.6	263.0	1320.3	78.0	266.7	12.2	12.2	94.0	243.7	3.7	91.4	189.1	17.5	70.4	1.0	1288.2	153.8	11.3	40.9	151.1	76.7	132.5	162.1	31.6	6.6	234.2	439.9	4.9	236.8	400.7	93.1	30.2	36.6	69.6	299.4	272.5
SOX5	"L-SOX5, MGC35153"	ENSG00000134532	"SRY-box transcription factor 5"	P35711	12	23529504-24562544	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	"Activator, DNA-binding"	"Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 32.3"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 1531.5;Excitatory neurons: 615.9;Inhibitory neurons: 717.3;Oligodendrocyte precursor cells: 1437.1"	"Cancer enhanced"	"Detected in many"		"melanoma: 3.3"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"memory B-cell: 1.5;naive B-cell: 1.3"	"Lineage enriched"	"Detected in single"	5	"B-cells: 1.5"	"Cell line enhanced"	"Detected in many"		"AF22: 17.3;Daudi: 18.3;HDLM-2: 38.3;K-562: 17.0;WM-115: 14.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA060499			Supported	Nucleoplasm		NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm		"HPA060499: AB_2684294"	"unprognostic (9.11e-4)"	"unprognostic (4.64e-3)"	"unprognostic (3.23e-1)"	"unprognostic (6.83e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.03e-3)"	"unprognostic (1.36e-1)"	"unprognostic (8.40e-2)"	"unprognostic (1.70e-4)"	"unprognostic (6.95e-2)"	"unprognostic (4.53e-4)"	"unprognostic (3.12e-3)"	"unprognostic (2.37e-1)"	"unprognostic (9.59e-2)"	"unprognostic (2.75e-2)"	5.8	1.1	6.3	1.7	9.6	0.4	1.5	0.4	10.3	6.9	0.0	1.3	0.7	5.0	1.2	1.2	3.6	3.0	2.4	6.4	7.6	1.8	11.1	2.7	3.7	2.9	5.8	7.7	1.1	0.4	0.4	8.8	5.6	2.1	1.2	3.7	3.2	3.1	0.6	6.3	1.1	2.7	3.1	1.3	1.1	32.3	6.8	0.6	2.0	1.7	3.1	1.3	0.6	5.0	0.2	0.2	17.3	0.0	9.6	5.1	0.0	0.2	0.0	0.2	0.5	3.1	0.1	18.3	0.8	0.0	0.0	0.2	9.9	0.0	0.3	38.3	2.4	3.9	0.1	8.4	6.6	0.1	0.2	2.7	0.0	0.9	0.0	2.2	0.0	0.6	17.0	0.8	0.3	0.0	7.1	0.1	5.5	0.1	0.0	0.0	0.3	0.0	0.1	0.1	0.8	0.8	0.0	0.0	6.7	4.3	0.3	3.6	0.0	0.3	2.1	0.0	1.7	0.4	0.0	1.1	4.0	0.1	14.4	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.1	6.3	9.6	0.4	10.3	6.4	7.6	2.9	5.8	5.6	3.1	6.8	5.0	4.5	6.4	11.0	1531.5	3.7	13.3	0.1	0.0	1.8	11.9	1.0	1.3	4.0	1.5	3.1	3.7	0.0	0.1	0.0	0.0	0.0	0.2	198.7	18.7	55.7	4.0	5.4	0.4	615.9	0.0	0.2	11.3	1.5	21.2	1.3	13.3	3.6	22.0	0.3	0.0	717.3	0.0	0.0	0.8	1.9	208.6	10.2	0.8	12.4	279.2	5.7	17.9	0.0	1437.1	24.4	0.0	0.0	6.8	1.2	0.1	0.4	0.6	13.8	2.6	19.7	2.8	24.7	97.0	1.4	0.5	12.1	0.3	0.7	0.2	0.2	0.2
SOX6		ENSG00000110693	"SRY-box transcription factor 6"	P35712	11	15966449-16739591	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 26.9"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 308.9;Early spermatids: 256.8;Inhibitory neurons: 481.0;Oligodendrocyte precursor cells: 1687.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	20	"neutrophil: 2.0"	"Lineage enriched"	"Detected in single"	20	"granulocytes: 2.0"	"Cell line enhanced"	"Detected in some"		"CACO-2: 5.7;HAP1: 4.4;hTCEpi: 5.0;SK-MEL-30: 4.9;WM-115: 18.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001923, HPA003908"	Enhanced		Supported	Nucleoplasm		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 68: Oligodendrocytes - Mixed function"	Nucleoplasm		"HPA001923: AB_1080065, HPA003908: AB_1080063"	"unprognostic (3.40e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.68e-1)"	"unprognostic (4.17e-3)"	"unprognostic (1.05e-2)"	"unprognostic (6.47e-3)"	"unprognostic (1.25e-2)"	"unprognostic (1.31e-1)"	"unprognostic (7.89e-4)"	"unprognostic (9.08e-2)"	"unprognostic (7.37e-3)"	"prognostic favorable (6.47e-12)"	"unprognostic (9.90e-2)"	"unprognostic (5.02e-2)"	"unprognostic (1.15e-1)"	"unprognostic (3.04e-2)"	1.8	1.3	5.4	0.4	5.9	26.9	0.7	2.6	4.7	1.7	5.5	1.2	6.5	0.6	2.0	2.1	4.0	2.6	3.0	4.0	7.2	11.1	4.8	0.8	0.1	7.2	7.8	0.7	6.8	0.1	2.9	2.5	6.0	0.4	1.3	3.2	0.5	0.6	9.3	5.8	11.0	0.5	7.7	0.5	1.0	14.4	4.1	1.6	3.4	5.9	0.2	0.8	0.8	6.8	0.0	0.7	3.9	3.7	0.0	0.0	0.0	0.3	1.3	0.1	0.1	5.7	0.0	0.0	3.6	0.0	0.0	0.1	4.4	1.1	0.0	0.0	0.5	0.0	0.0	0.3	0.6	0.0	0.0	0.0	5.0	0.0	0.1	0.0	0.0	0.0	2.2	0.5	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.8	0.0	1.8	0.0	0.0	0.1	0.4	0.0	4.9	0.5	0.0	0.0	0.0	2.6	2.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	18.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	5.4	5.9	2.6	4.7	4.0	7.2	7.2	7.8	6.0	7.7	4.1	6.8	2.7	3.2	6.3	308.9	1.0	40.1	5.8	6.8	66.6	26.3	3.7	2.5	21.6	54.3	3.8	36.8	10.4	1.3	0.1	1.4	9.8	19.8	256.8	29.4	5.3	4.8	7.8	126.7	2.8	3.7	0.6	14.5	2.0	27.8	0.0	1.6	2.2	7.5	1.1	0.0	481.0	6.6	0.0	2.9	3.2	70.1	3.4	1.4	35.6	21.5	0.0	48.4	0.0	1687.9	8.9	5.5	20.3	2.2	0.1	3.2	99.8	27.1	8.3	4.3	0.0	26.2	14.6	22.1	4.5	32.7	16.1	0.5	1.1	3.0	11.8	3.7
SP100		ENSG00000067066	"SP100 nuclear antigen"	P23497	2	230415942-230545606	"Predicted intracellular proteins, Transcription factors"	"Host-virus interaction, Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 189.2"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+ RasG12V: 255.0"					"Low region specificity"	"Detected in all"			"HPA016707, HPA017384"	Enhanced		Supported	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 57: B-cells - Immune response"	"Nuclear bodies"	Nucleoplasm	"HPA016707: AB_1857398, HPA017384: AB_1857399"	"unprognostic (8.04e-3)"	"unprognostic (1.08e-2)"	"unprognostic (3.34e-2)"	"unprognostic (1.86e-3)"	"unprognostic (5.48e-2)"	"unprognostic (1.12e-2)"	"unprognostic (1.44e-1)"	"unprognostic (2.77e-2)"	"unprognostic (6.25e-3)"	"unprognostic (5.32e-3)"	"unprognostic (1.11e-2)"	"unprognostic (3.17e-1)"	"prognostic unfavorable (1.61e-4)"	"unprognostic (1.96e-2)"	"unprognostic (1.48e-2)"	"unprognostic (2.33e-2)"	"unprognostic (3.25e-2)"	66.3	53.1	11.0	65.5	12.3	189.2	53.8	11.3	17.9	42.4	20.7	46.1	46.1	35.1	30.8	29.4	34.9	55.9	52.9	10.9	14.0	46.0	60.9	72.4	94.3	19.6	14.3	44.3	41.1	10.5	18.3	54.5	16.7	34.9	36.1	2.5	72.7	33.0	24.3	35.7	60.4	38.7	16.2	78.8	47.9	9.2	16.5	54.2	41.0	32.1	81.6	56.1	37.1	17.1	56.9	16.9	0.8	7.5	80.8	123.2	13.3	70.3	151.0	162.4	255.0	10.6	67.9	22.9	57.0	77.0	103.0	25.9	0.8	66.6	120.7	55.2	1.9	41.8	27.9	24.0	120.0	47.3	51.4	105.6	38.8	79.8	71.4	120.2	125.1	18.9	23.9	37.9	61.7	15.9	32.0	57.6	2.4	25.6	25.6	24.4	40.7	18.2	45.9	45.3	0.4	0.7	30.0	9.5	130.3	2.8	9.1	48.3	140.3	78.7	21.4	49.4	41.8	50.3	16.0	59.8	71.6	54.8	38.1	149.7	84.4	115.8	116.3	74.9	93.9	152.0	113.0	102.4	64.6	160.5	107.5	95.3	284.6	119.8	106.0	67.0	116.0	110.1	11.0	12.3	11.3	17.9	10.9	14.0	19.6	14.3	16.7	16.2	16.5	17.1	171.9	153.8	56.6	0.3	236.6	70.7	71.2	96.5	49.5	0.6	31.2	36.7	72.3	42.9	74.4	33.1	2.1	32.9	150.6	50.5	43.0	102.9	4.7	61.6	58.3	122.7	9.0	66.9	0.6	105.5	69.4	77.9	46.4	58.9	56.8	39.3	73.5	34.5	81.0	0.0	0.7	32.5	63.1	72.9	70.9	4.8	46.6	104.1	71.2	140.5	114.3	0.2	128.8	4.5	4.8	89.7	56.9	52.6	95.6	74.2	72.8	45.4	68.4	0.8	39.5	61.2	65.9	0.8	1.1	28.4	68.2	16.1	151.5	74.0	25.2	73.7
SP110	"IFI41, IFI75"	ENSG00000135899	"SP110 nuclear body protein"	Q9HB58	2	230165186-230225729	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Host-virus interaction, Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 53.7"	"Cell type enhanced"	"Detected in many"		"B-cells: 141.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+ RasG12V: 99.3"					"Low region specificity"	"Detected in all"			HPA058554			Supported	Nucleoplasm		No	No			"Cluster 5: Granulocytes - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 57: B-cells - Immune response"	Nucleoplasm		"HPA058554: AB_2683754"	"unprognostic (9.72e-2)"	"unprognostic (1.15e-2)"	"unprognostic (5.02e-2)"	"unprognostic (8.33e-4)"	"unprognostic (2.93e-1)"	"unprognostic (1.80e-1)"	"unprognostic (6.65e-2)"	"unprognostic (9.44e-2)"	"unprognostic (9.68e-2)"	"unprognostic (1.46e-2)"	"unprognostic (4.11e-3)"	"unprognostic (2.55e-1)"	"prognostic unfavorable (1.17e-5)"	"unprognostic (2.38e-1)"	"unprognostic (2.66e-2)"	"unprognostic (2.99e-3)"	"unprognostic (9.50e-3)"	14.0	7.3	8.4	38.5	10.3	29.8	11.8	9.4	10.8	11.6	11.5	12.6	11.9	10.5	7.9	9.2	9.6	18.0	8.1	8.1	10.3	11.9	14.8	21.0	53.7	15.3	10.9	16.5	7.9	9.7	5.3	17.5	11.6	9.6	14.0	2.0	17.0	7.6	5.7	7.8	17.6	13.4	12.1	49.8	12.9	3.1	10.9	35.7	7.4	8.4	50.1	18.9	9.3	12.3	8.3	4.4	2.7	4.7	14.2	23.6	8.3	14.8	30.8	70.3	99.3	0.2	12.7	34.5	13.8	15.8	67.0	5.1	9.0	23.0	25.7	30.5	6.0	14.9	6.2	8.9	14.5	22.1	17.1	32.7	11.8	20.8	27.4	13.2	25.3	23.6	5.3	12.1	20.6	4.9	33.0	43.5	8.6	4.2	5.1	20.1	25.4	12.8	56.2	11.1	0.5	5.7	5.7	12.7	32.7	0.9	9.6	18.5	18.8	12.9	7.9	3.2	7.5	12.9	4.6	16.2	14.4	20.6	10.7	92.2	49.7	124.4	55.2	85.8	47.8	142.8	53.5	50.5	44.1	135.8	54.1	58.7	268.6	56.9	143.4	84.4	70.7	48.5	8.4	10.3	9.4	10.8	8.1	10.3	15.3	10.9	11.6	12.1	10.9	12.3	77.8	44.8	23.8	17.3	141.7	9.9	5.2	25.7	16.5	0.4	21.6	19.3	3.7	7.2	19.6	11.0	0.0	3.8	84.0	17.0	13.7	19.9	5.2	17.2	21.3	28.6	6.7	9.7	1.1	28.5	12.7	22.8	9.2	20.1	38.0	21.2	26.4	6.2	26.9	0.0	2.1	11.4	73.2	47.4	25.8	4.2	11.8	62.3	19.6	42.2	56.7	9.7	59.8	19.6	18.2	26.0	11.6	10.1	35.7	3.5	10.7	14.4	21.0	4.9	6.6	8.6	16.2	4.8	2.3	9.8	10.1	4.7	68.8	23.5	6.1	3.0
SP3	SPR-2	ENSG00000172845	"Sp3 transcription factor"	Q02447	2	173880850-173965702	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004580, HPA032145, HPA032146"	Supported	Supported	Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm	Cytosol	"CAB004580: AB_628274, HPA032145: , HPA032146: AB_2732465"	"unprognostic (1.94e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.85e-1)"	"unprognostic (2.39e-3)"	"unprognostic (2.50e-1)"	"unprognostic (4.92e-2)"	"unprognostic (5.54e-3)"	"unprognostic (6.36e-2)"	"unprognostic (2.76e-3)"	"unprognostic (3.27e-1)"	"unprognostic (5.01e-3)"	"unprognostic (1.68e-1)"	"prognostic unfavorable (2.46e-5)"	"unprognostic (2.78e-1)"	"unprognostic (2.07e-1)"	"unprognostic (8.02e-2)"	"unprognostic (1.69e-1)"	32.6	19.8	15.8	35.2	16.0	53.1	43.1	21.3	19.8	50.9	16.1	34.3	26.9	45.1	34.6	32.1	37.1	28.9	23.8	14.2	17.1	29.7	40.1	29.9	46.1	16.9	16.7	40.3	24.9	43.1	13.2	49.1	16.4	31.9	38.9	21.0	26.1	30.4	22.5	38.5	29.6	36.3	16.3	38.6	27.0	25.2	15.5	68.0	47.5	33.7	53.8	33.7	28.0	18.5	41.6	34.5	74.6	45.8	91.8	82.3	83.5	47.5	67.1	62.2	66.1	56.8	59.7	65.1	39.3	65.0	46.3	41.0	57.8	46.0	91.7	55.2	21.2	65.9	33.9	54.0	45.5	60.4	48.9	60.6	53.2	72.9	63.6	48.4	49.4	51.3	51.4	86.8	65.7	44.4	84.0	49.9	66.1	60.1	37.8	74.2	68.5	53.0	48.4	55.8	67.8	48.1	67.1	38.1	52.4	81.7	30.0	80.0	44.1	70.6	61.8	47.5	50.4	58.8	46.7	85.8	53.0	41.6	67.2	8.9	9.4	13.0	11.6	7.0	12.9	9.5	12.3	12.3	9.9	7.4	13.8	12.8	27.3	21.9	10.3	6.2	13.8	9.9	15.8	16.0	21.3	19.8	14.2	17.1	16.9	16.7	16.4	16.3	15.5	18.5	36.1	19.2	22.9	44.7	55.2	57.6	31.7	25.7	64.9	29.1	36.8	23.4	18.8	14.3	23.3	20.2	27.1	30.9	67.9	37.9	11.7	18.6	4.3	22.3	57.8	33.9	30.5	31.7	52.7	19.3	42.7	43.9	17.9	29.5	23.5	31.3	32.2	43.8	24.6	23.5	50.7	28.8	20.3	54.1	72.8	7.1	45.4	55.6	42.7	81.5	39.0	30.5	46.4	60.3	74.7	30.8	22.9	36.9	63.7	34.2	22.1	24.4	26.6	20.2	19.7	40.4	53.4	10.5	20.4	48.6	57.0	34.6	50.8	26.0	29.0	59.0
SP6	"Epfn, KLF14"	ENSG00000189120	"Sp6 transcription factor"	Q3SY56	17	47844908-47855874	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 22.8;skin 1: 14.6"	"Group enriched"	"Detected in some"	5	"Cytotrophoblasts: 57.5;Syncytiotrophoblasts: 98.8"	"Cancer enhanced"	"Detected in many"		"urothelial cancer: 11.8"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in many"	5	"BEWO: 92.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA024516, HPA044469"			Supported	"Nucleoplasm,Mitotic spindle,Centrosome"		Yes	No				"Cluster 31: Skin - Epidermis development"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 47: Cytotrophoblasts - Unknown function"	Nucleoplasm	"Mitotic spindle, Centrosome"	"HPA024516: AB_10960551, HPA044469: AB_10966430"	"unprognostic (3.06e-2)"	"unprognostic (4.32e-2)"	"unprognostic (1.07e-2)"	"unprognostic (7.55e-3)"	"unprognostic (6.79e-2)"	"unprognostic (4.57e-2)"	"unprognostic (2.10e-1)"	"prognostic unfavorable (2.11e-6)"	"unprognostic (1.22e-1)"	"unprognostic (8.72e-2)"	"unprognostic (3.92e-3)"	"unprognostic (1.63e-1)"	"unprognostic (9.59e-3)"	"prognostic favorable (6.39e-4)"	"unprognostic (3.33e-1)"	"unprognostic (9.93e-2)"	"prognostic favorable (5.72e-4)"	0.9	0.9	0.1	0.6	0.1	0.0	3.9	0.4	0.1	1.3	0.1	1.4	1.6	0.3	3.9	5.5	1.1	0.1	0.3	0.1	0.2	1.0	0.0	3.1	0.6	0.7	0.4	0.9	0.4	6.2	0.2	22.8	1.0	1.8	0.7	0.1	0.9	10.2	0.1	14.6	4.7	0.3	0.5	0.8	0.3	0.2	0.2	1.1	1.1	0.1	1.9	2.7	3.9	0.1	6.8	0.8	0.0	0.0	0.0	0.0	92.3	0.4	0.4	1.8	0.4	20.1	1.9	0.0	0.6	0.0	1.3	2.8	0.1	3.4	0.5	0.2	0.7	0.1	1.5	0.6	0.1	0.0	0.0	0.1	1.8	0.0	1.8	0.2	0.2	0.2	4.7	0.1	0.1	1.8	0.0	0.1	0.0	8.2	1.6	0.0	0.0	0.2	0.5	11.9	2.9	0.1	0.1	11.9	0.0	16.8	4.8	0.0	6.3	0.4	2.6	0.0	0.5	0.8	0.0	0.1	4.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.4	0.1	0.1	0.2	0.7	0.4	1.0	0.5	0.2	0.1	1.3	0.0	0.0	1.0	0.2	0.1	2.6	4.6	4.0	0.0	6.0	6.1	0.5	0.0	0.8	1.8	0.0	57.5	0.3	5.2	0.0	0.7	0.1	0.4	0.1	2.7	1.8	0.0	0.2	0.8	3.9	0.7	0.0	0.7	0.0	0.2	0.7	0.1	4.1	0.0	0.2	2.7	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.8	3.2	0.0	0.1	3.8	13.4	0.0	1.0	0.0	0.0	0.0	0.2	0.3	0.6	1.1	0.9	98.8	0.3	0.1	3.3	6.3
SPAG1	"CILD28, CT140, FLJ32920, HSD-3.8, SP75, TPIS"	ENSG00000104450	"Sperm associated antigen 1"	Q07617	8	100157906-100259278	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	Fertilization	Hydrolase	"Ciliopathy, Kartagener syndrome, Primary ciliary dyskinesia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 96.0;Endometrial ciliated cells: 190.6;Respiratory ciliated cells: 198.6;Spermatocytes: 91.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"A-431: 31.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023748, HPA053682"	Enhanced		Supported	Cytosol		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 49: Ciliated cells - Cilium organization"	Cytosol		"HPA023748: AB_2671304, HPA053682: AB_2682229"	"unprognostic (9.95e-2)"	"unprognostic (5.37e-2)"	"unprognostic (1.38e-2)"	"unprognostic (4.24e-2)"	"unprognostic (1.46e-1)"	"unprognostic (2.57e-1)"	"unprognostic (5.86e-2)"	"unprognostic (9.19e-2)"	"unprognostic (1.53e-1)"	"unprognostic (5.62e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.17e-1)"	"prognostic unfavorable (3.87e-4)"	"unprognostic (9.11e-3)"	"unprognostic (8.83e-3)"	"unprognostic (1.54e-1)"	"prognostic favorable (2.62e-4)"	1.8	1.3	3.0	3.6	3.2	10.1	3.0	4.2	3.0	5.4	14.0	12.9	2.9	2.4	1.5	7.8	10.0	3.7	1.5	3.0	4.6	3.2	4.7	5.0	2.7	7.2	9.0	1.0	2.5	9.0	5.7	1.8	6.2	3.1	18.3	1.9	4.6	3.5	0.4	7.9	2.7	1.8	6.0	2.0	6.3	19.4	4.8	2.1	3.4	0.6	4.4	5.3	3.0	5.4	31.3	8.3	0.5	1.8	1.8	1.5	4.6	5.7	3.4	6.8	7.1	8.3	13.5	1.2	20.0	1.8	10.1	16.1	5.9	11.1	6.3	18.1	6.1	5.2	9.0	3.1	2.4	1.4	4.5	1.3	5.8	8.4	6.6	5.3	5.8	5.7	0.2	16.1	1.0	11.2	3.1	1.4	0.5	15.6	9.1	0.5	1.3	4.7	26.1	14.8	4.8	3.5	7.8	6.4	7.0	2.2	9.2	5.9	5.3	6.8	9.8	3.6	14.9	10.9	8.9	0.9	6.5	5.0	3.4	0.0	0.1	0.6	0.1	0.0	0.0	0.8	0.1	0.1	0.1	0.3	0.0	0.1	0.7	1.0	0.2	0.2	0.0	0.0	3.0	3.2	4.2	3.0	3.0	4.6	7.2	9.0	6.2	6.0	4.8	5.4	7.7	48.1	22.8	18.9	7.7	5.6	9.6	18.1	2.2	2.0	13.3	7.7	5.6	22.8	37.2	18.4	0.0	1.3	19.0	32.9	5.9	19.7	96.0	190.6	7.1	6.9	22.1	0.4	30.1	8.6	8.7	5.0	22.4	39.5	10.1	7.3	4.2	8.0	2.8	8.4	21.6	14.9	6.1	2.2	5.3	32.3	5.0	3.9	1.8	6.5	4.5	11.5	5.2	4.5	4.1	14.9	17.7	3.8	15.9	10.3	2.4	10.0	198.6	2.3	0.0	4.8	6.4	91.9	4.7	2.9	5.4	2.3	12.0	1.3	20.1	23.3
SPAG5	"DEEPEST, hMAP126, MAP126"	ENSG00000076382	"Sperm associated antigen 5"	Q96R06	17	28577565-28599025	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 37.9;kidney: 37.8;testis: 74.0"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 126.0;Erythroid cells: 37.2;Spermatocytes: 72.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"basophil: 11.7;T-reg: 4.9"	"Group enriched"	"Detected in many"	6	"granulocytes: 11.7;T-cells: 4.9"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"HPA022008, HPA022479, HPA024418"	Approved		Supported	"Nuclear bodies,Mitotic spindle,Cytosol"		Yes	Yes			"Cluster 34: Basophils - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Nuclear bodies, Mitotic spindle"	Cytosol	"HPA022008: AB_1853519, HPA022479: AB_1853521, HPA024418: "	"unprognostic (4.71e-2)"	"unprognostic (1.32e-1)"	"unprognostic (5.31e-3)"	"unprognostic (2.32e-3)"	"unprognostic (3.50e-1)"	"unprognostic (1.55e-1)"	"prognostic unfavorable (5.43e-5)"	"unprognostic (3.37e-3)"	"unprognostic (4.84e-3)"	"unprognostic (5.97e-2)"	"prognostic unfavorable (3.02e-4)"	"unprognostic (3.49e-2)"	"prognostic unfavorable (5.43e-13)"	"unprognostic (2.64e-1)"	"unprognostic (1.66e-1)"	"unprognostic (2.90e-2)"	"unprognostic (2.01e-1)"	2.2	3.3	7.8	7.8	7.6	37.9	2.4	5.8	9.1	2.6	3.4	8.3	7.9	1.9	2.4	8.3	1.7	1.8	1.4	7.6	7.7	37.8	14.8	3.4	14.5	6.7	6.8	2.7	1.5	1.1	4.3	5.7	6.7	2.2	10.7	10.8	2.4	0.8	1.0	5.5	9.1	3.4	5.0	7.4	3.6	74.0	7.7	22.4	8.7	0.7	17.3	2.6	3.6	7.5	84.7	87.7	103.3	78.4	5.2	8.6	42.4	65.9	42.4	98.1	78.3	69.2	25.5	59.8	34.2	46.8	91.7	70.2	114.5	42.7	103.8	108.6	72.9	62.9	87.9	80.2	0.6	83.1	76.1	2.9	3.8	78.6	40.4	14.5	52.1	90.6	69.7	101.5	80.7	52.6	109.4	92.9	54.2	68.3	44.5	72.1	144.4	70.9	29.0	43.0	78.6	45.8	96.4	114.9	31.6	84.9	82.2	70.6	25.7	56.4	91.3	46.6	114.6	46.7	72.9	87.3	37.8	60.6	91.8	11.7	0.0	0.0	0.4	0.4	0.7	0.6	1.2	0.9	0.1	1.4	1.1	0.9	0.2	0.8	0.3	0.3	4.9	0.9	7.8	7.6	5.8	9.1	7.6	7.7	6.7	6.8	6.7	5.0	7.7	7.5	0.5	3.2	1.7	0.7	3.3	2.0	0.9	1.3	1.2	5.0	1.1	1.0	0.7	0.0	1.9	0.0	0.0	9.0	1.3	4.7	1.9	0.5	126.0	6.0	1.1	1.5	13.1	37.2	5.2	0.4	12.2	2.6	5.1	1.8	1.3	12.6	3.3	6.3	6.5	3.3	6.0	4.6	4.1	2.7	4.0	25.2	0.9	6.1	0.0	1.9	0.9	0.7	0.0	2.0	1.7	0.4	4.7	0.0	13.1	0.8	8.1	12.5	7.7	3.9	6.6	2.0	2.2	72.6	21.0	5.2	1.0	3.8	2.8	0.9	5.1	1.1
SPAG7	"ACRP, FSA-1, MGC20134"	ENSG00000091640	"Sperm associated antigen 7"	O75391	17	4959226-4967817	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 305.3"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA024032, HPA052394"	Uncertain		Supported	Nucleoplasm		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Nucleoplasm		"HPA024032: AB_1857410, HPA052394: AB_2681810"	"unprognostic (7.10e-2)"	"unprognostic (8.82e-2)"	"unprognostic (1.43e-2)"	"unprognostic (1.24e-2)"	"unprognostic (1.46e-2)"	"unprognostic (2.92e-1)"	"unprognostic (8.90e-2)"	"unprognostic (9.83e-2)"	"unprognostic (8.35e-2)"	"unprognostic (1.27e-1)"	"unprognostic (8.39e-3)"	"unprognostic (1.96e-1)"	"prognostic favorable (5.79e-5)"	"unprognostic (4.66e-3)"	"unprognostic (5.51e-2)"	"unprognostic (7.07e-3)"	"unprognostic (2.72e-2)"	51.1	56.1	55.4	37.5	56.0	46.0	48.3	58.5	63.5	50.5	56.0	67.1	37.1	67.1	41.0	52.0	68.2	38.0	156.7	56.4	57.4	84.0	69.7	46.0	44.7	58.8	56.1	42.9	45.5	69.3	38.4	52.3	59.4	45.8	38.2	47.6	48.0	40.5	305.3	48.0	45.4	50.3	56.6	51.7	56.6	35.6	58.5	47.2	56.1	215.5	41.7	54.0	47.6	58.8	41.8	90.7	116.9	65.4	79.8	115.5	67.5	80.9	91.8	77.8	59.5	53.7	53.3	52.9	116.6	100.5	54.2	58.6	59.3	123.9	35.1	77.5	52.6	57.6	74.5	75.3	111.3	32.1	82.1	127.4	87.9	66.5	123.9	118.6	99.4	66.9	39.0	53.2	96.2	66.9	58.7	71.2	66.8	58.0	29.0	61.4	74.1	38.3	135.7	52.1	32.8	64.6	68.7	27.3	68.2	59.9	59.2	50.2	96.6	52.4	34.0	26.1	67.2	46.5	40.3	32.5	101.4	45.6	69.1	96.0	88.3	82.6	82.3	72.6	89.7	97.2	77.1	77.9	103.9	81.1	95.5	84.0	23.1	67.3	73.7	105.9	95.0	91.0	55.4	56.0	58.5	63.5	56.4	57.4	58.8	56.1	59.4	56.6	58.5	58.8	40.6	57.7	52.6	11.1	54.6	55.3	103.0	252.0	52.3	62.0	62.9	66.3	135.8	77.2	125.4	99.3	45.9	183.5	61.1	82.0	324.8	161.6	23.0	63.1	49.1	64.2	57.2	33.7	7.3	144.1	183.5	66.1	40.8	48.1	73.4	68.3	70.6	72.4	139.3	92.5	8.1	73.5	156.6	64.9	88.9	21.9	46.0	65.6	104.9	2.8	221.0	89.7	97.9	7.1	12.0	128.8	82.8	42.2	39.4	98.7	116.4	239.3	127.4	69.7	72.3	53.5	70.1	55.8	50.6	52.8	50.2	230.8	52.2	89.5	74.6	105.2
SPANXA1	"CT11.1, NAP-X, SPAN-Xa, SPAN-Xb, SPANX"	ENSG00000198021	"Sperm protein associated with the nucleus, X-linked, family member A1"	Q9NS26	X	141583674-141585011	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	17	"testis: 15.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	6	"U-2 OS: 3.2"									"HPA046423, HPA073647"	Supported		Supported	Nucleoplasm,Vesicles		NA	NA				"Cluster 78: Testis - Spermatogenesis"	"Cluster 9: U-2 OS - Unknown function"		Nucleoplasm	Vesicles	"HPA046423: AB_2679660, HPA073647: AB_2732232"																		0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.8	0.2	0.2	0.2	0.1	0.3	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SPANXA2	SPANX	ENSG00000203926	"SPANX family member A2"	Q9NS26	X	141589708-141590762	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	62	"testis: 20.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 1.5;GAMG: 1.3;PC-3: 1.3;U-2197: 1.5"									"HPA046423, HPA073647"	Supported		Supported	Nucleoplasm,Vesicles		NA	NA				"Cluster 74: Testis - Spermatogenesis"	"Cluster 18: U-2197 - ECM organization"		Nucleoplasm	Vesicles	"HPA046423: AB_2679660, HPA073647: AB_2732232"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.8	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SPANXB1	"CT11.2, SPANXB2, SPANXF1, SPANXF2"	ENSG00000227234	"SPANX family member B1"	Q9NS25	X	141002594-141003706	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	81	"testis: 88.8"	"Group enriched"	"Detected in some"	160	"Early spermatids: 686.8;Late spermatids: 2015.4"	"Group enriched"	"Detected in some"	4	"breast cancer: 2.1;cervical cancer: 1.1;head and neck cancer: 2.1;lung cancer: 1.8;urothelial cancer: 3.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 81.9;GAMG: 16.6;U-2 OS: 27.4"									"HPA046423, HPA073647"	Supported		Approved	Nucleoplasm,Vesicles		NA	NA				"Cluster 74: Testis - Spermatogenesis"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 34: Spermatids - Unknown function"	Nucleoplasm	Vesicles	"HPA046423: AB_2679660, HPA073647: AB_2732232"															"unprognostic (8.55e-2)"			0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	88.8	0.1	0.0	0.0	1.0	0.0	0.0	0.0	0.3	81.9	1.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.3	0.0	16.6	0.1	0.0	0.0	0.0	0.0	0.2	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.3	0.0	0.2	0.1	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.6	0.0	0.0	0.0	0.1	27.4	1.9	0.7	0.4	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.2	0.1	0.0	0.2	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	686.8	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2015.4	6.2	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.2	0.0	0.0	0.0	0.2	0.0	0.0	6.6	0.0	0.1	8.4	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SPANXC	"CT11.3, CTp11"	ENSG00000198573	"SPANX family member C"	Q9NY87	X	141241463-141242517	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	30	"testis: 31.0"	"Group enriched"	"Detected in some"	209	"Early spermatids: 468.6;Late spermatids: 1668.9"	"Cancer enhanced"	"Detected in single"		"urothelial cancer: 0.6"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"A-431: 11.8;U-2 OS: 6.2"									"HPA046423, HPA073647"	Supported		Supported	Nucleoplasm,Vesicles		NA	NA				"Cluster 74: Testis - Spermatogenesis"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 31: Spermatids - Spermatogenesis"	Nucleoplasm	Vesicles	"HPA046423: AB_2679660, HPA073647: AB_2732232"															"unprognostic (3.56e-1)"			0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	31.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.4	11.8	0.5	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	6.2	0.0	0.3	0.0	0.0	0.1	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.3	0.1	1.0	0.2	0.1	0.3	0.1	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	468.6	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1668.9	4.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.1	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SPART	"KIAA0610, SPG20, TAHCCP1"	ENSG00000133104	Spartin	Q8N0X7	13	36301638-36370180	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Disease variant, Hereditary spastic paraplegia, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Granulosa cells: 75.0;Proximal tubular cells: 90.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in all"	5	"basophil: 172.7"	"Lineage enriched"	"Detected in all"	7	"granulocytes: 172.7"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039053, HPA039054"	Approved		Supported	"Plasma membrane,Cytosol"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 68: Epididymis - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 7: Non-specific - Mitochondria"	Cytosol	"Plasma membrane"	"HPA039053: AB_10672769, HPA039054: AB_2676323"	"unprognostic (3.73e-2)"	"unprognostic (9.39e-2)"	"unprognostic (3.06e-2)"	"unprognostic (4.60e-2)"	"unprognostic (2.21e-2)"	"unprognostic (1.10e-2)"	"unprognostic (9.18e-3)"	"unprognostic (9.58e-2)"	"unprognostic (3.36e-2)"	"unprognostic (2.22e-1)"	"unprognostic (7.62e-2)"	"unprognostic (8.14e-2)"	"unprognostic (1.54e-1)"	"unprognostic (9.26e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.54e-2)"	"unprognostic (5.79e-2)"	42.3	48.4	36.9	18.0	42.8	23.6	32.5	43.4	50.6	49.2	42.3	37.8	12.7	42.4	67.1	24.5	44.5	37.4	25.7	35.3	39.4	48.4	19.9	27.0	15.7	42.4	40.5	63.6	14.6	29.5	29.6	39.8	42.1	34.7	13.3	43.3	17.3	36.4	33.5	18.4	15.4	52.8	41.2	30.7	21.1	27.6	38.3	16.7	35.6	33.7	11.2	35.5	29.9	51.0	0.1	22.4	59.5	0.0	127.9	106.6	42.4	54.1	81.3	53.7	52.8	0.1	0.0	0.0	32.9	65.9	98.2	31.2	81.4	38.0	57.5	4.4	46.9	69.4	28.3	14.6	128.0	72.8	134.3	106.2	59.5	44.4	61.9	131.7	79.6	18.7	30.6	11.9	97.5	5.2	21.7	120.8	30.0	0.0	7.8	0.0	99.4	2.5	62.5	28.2	6.2	14.5	46.3	18.3	58.9	85.3	10.5	84.7	66.8	40.0	20.1	55.9	32.2	14.2	0.2	0.1	44.6	61.8	71.0	172.7	22.1	30.1	13.5	21.7	13.1	10.1	18.6	5.4	15.7	9.7	24.5	13.1	35.0	14.2	23.8	19.3	4.8	18.1	36.9	42.8	43.4	50.6	35.3	39.4	42.4	40.5	42.1	41.2	38.3	51.0	43.5	35.3	51.5	0.0	6.1	0.0	0.0	0.0	0.0	0.0	30.8	30.1	0.0	0.0	40.2	27.6	0.0	52.7	18.6	0.0	66.5	26.2	0.0	59.4	62.6	15.9	0.0	0.0	0.0	15.0	59.7	39.8	0.0	38.1	58.0	75.0	0.0	0.0	42.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	24.0	0.0	0.0	24.3	0.0	0.0	0.0	0.0	16.8	0.0	0.0	3.5	0.0	0.0	90.4	65.6	0.0	0.0	0.0	27.8	0.0	0.0	0.0	0.0	64.3	10.8	59.2	0.0	0.0
SPAST	"ADPSP, FSP2, KIAA1083, SPG4"	ENSG00000021574	Spastin	Q9UBP0	2	32063556-32157637	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Cell cycle, Cell division, Differentiation, Neurogenesis"	"Allosteric enzyme, Developmental protein, Isomerase"	"Disease variant, Hereditary spastic paraplegia, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Inhibitory neurons: 55.2;Oligodendrocyte precursor cells: 59.3;Oligodendrocytes: 62.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017311	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 24: NB-4 - Immune response"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm	Cytosol	"HPA017311: AB_1857415"	"unprognostic (1.89e-1)"	"unprognostic (1.59e-2)"	"unprognostic (5.33e-2)"	"unprognostic (3.90e-2)"	"unprognostic (3.75e-2)"	"unprognostic (4.00e-2)"	"prognostic unfavorable (1.62e-4)"	"unprognostic (3.26e-2)"	"unprognostic (2.35e-2)"	"unprognostic (7.39e-2)"	"unprognostic (5.98e-2)"	"unprognostic (3.52e-1)"	"prognostic unfavorable (4.15e-4)"	"unprognostic (5.71e-2)"	"unprognostic (3.04e-1)"	"unprognostic (1.53e-2)"	"unprognostic (1.13e-1)"	5.8	5.9	9.0	7.2	12.7	9.9	6.2	10.8	12.9	8.6	1.6	7.1	7.4	7.7	5.0	6.9	6.5	6.5	3.9	9.0	10.6	5.9	9.6	6.3	9.7	10.8	11.2	9.1	5.3	6.2	4.4	6.8	10.5	6.3	7.5	6.9	4.2	5.3	7.8	7.4	8.0	7.3	11.6	7.0	6.3	9.8	10.7	14.1	8.5	10.0	9.2	7.3	4.4	13.9	17.5	12.2	19.7	19.5	12.0	14.2	17.8	9.4	13.7	9.7	8.6	16.9	14.8	30.2	8.5	13.1	14.2	12.0	19.5	9.6	11.9	20.7	11.8	33.3	6.0	20.5	11.0	23.2	22.4	7.9	12.3	12.4	11.6	11.7	21.5	9.6	27.6	10.0	10.7	7.4	37.8	19.4	20.5	19.2	7.1	19.8	27.9	19.5	13.0	10.7	27.9	29.9	16.0	13.2	15.9	16.0	8.7	15.8	18.8	10.6	16.2	9.5	11.1	14.7	29.7	23.8	11.6	19.9	13.0	1.8	3.5	3.8	1.8	4.9	2.5	2.4	2.8	2.9	3.9	1.9	2.9	3.0	5.3	3.9	3.8	1.7	4.2	2.5	9.0	12.7	10.8	12.9	9.0	10.6	10.8	11.2	10.5	11.6	10.7	13.9	15.0	9.6	4.4	26.4	12.2	9.6	5.9	7.9	11.4	15.4	11.7	6.9	8.0	8.6	7.9	5.5	22.9	9.6	21.4	11.4	0.0	6.6	4.4	16.9	11.8	11.3	10.8	10.3	38.9	8.0	7.4	8.1	9.7	13.7	10.1	16.7	7.9	12.0	9.7	10.1	55.2	10.8	10.2	17.5	9.9	8.5	8.7	17.6	1.8	36.5	21.1	7.9	18.6	59.3	62.7	10.4	9.8	10.1	12.5	8.7	10.9	7.0	13.0	14.1	0.0	11.9	11.9	16.7	21.2	11.7	13.1	8.1	13.3	10.9	10.4	7.2
SPATA18	FLJ32906	ENSG00000163071	"Spermatogenesis associated 18"	Q8TC71	4	52051304-52097299	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 68.3;testis: 28.8"	"Cell type enriched"	"Detected in many"	4	"Late spermatids: 2341.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 31.5;BEWO: 24.4;BJ hTERT+: 15.9;HSkMC: 29.3;hTCEpi: 28.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA036854, HPA036855"	Enhanced		Supported	Mitochondria		NA	NA				"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 25: Spermatids - Spermatogenesis"	Mitochondria		"HPA036854: AB_10670927, HPA036855: AB_2675352"	"unprognostic (6.54e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.46e-1)"	"prognostic favorable (1.32e-5)"	"unprognostic (1.02e-2)"	"unprognostic (1.53e-2)"	"unprognostic (7.27e-2)"	"unprognostic (4.49e-2)"	"unprognostic (1.76e-1)"	"unprognostic (2.73e-1)"	"unprognostic (3.13e-1)"	"unprognostic (3.13e-2)"	"prognostic favorable (3.73e-9)"	"unprognostic (4.38e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.01e-2)"	"unprognostic (4.00e-2)"	2.1	5.0	2.4	0.7	2.2	0.0	6.3	1.3	1.0	10.7	15.6	4.1	2.1	4.2	2.0	4.6	68.3	6.7	1.8	2.5	2.7	5.3	5.4	8.0	0.3	6.8	8.3	1.8	2.0	4.5	4.9	1.9	5.5	4.2	5.6	0.1	10.1	5.6	0.8	6.6	2.2	3.1	6.0	0.6	4.9	28.8	2.6	3.2	1.2	1.3	0.9	2.8	3.4	3.8	0.0	3.8	1.8	0.0	12.7	31.5	24.4	9.3	15.9	0.6	0.7	0.0	1.5	0.0	0.0	12.3	0.2	0.3	0.1	7.1	0.3	0.0	1.1	0.0	0.0	8.0	11.2	0.0	0.0	29.3	28.7	1.0	4.5	5.1	6.9	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	1.4	1.9	2.0	1.0	0.0	0.0	9.7	0.0	0.2	9.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	2.2	1.3	1.0	2.5	2.7	6.8	8.3	5.5	6.0	2.6	3.8	0.3	9.6	3.0	0.3	0.0	5.2	8.5	9.4	8.6	0.0	6.0	6.7	2.2	8.6	15.1	0.0	0.0	1.7	0.3	1.8	1.9	1.2	561.1	124.6	1.8	1.2	1.8	0.0	1.7	2.6	1.8	4.3	11.2	4.7	2.5	1.9	1.4	3.4	0.3	0.0	0.5	1.6	6.1	0.6	1.6	2341.5	10.8	1.1	0.0	2.8	0.1	0.0	0.0	0.5	0.1	2.0	2.7	10.9	0.0	5.1	1.9	7.4	141.4	0.0	0.0	1.8	3.9	13.9	7.1	7.1	7.5	0.8	0.2	2.5	4.3	6.8
SPATA24	"CCDC161, T6441"	ENSG00000170469	"Spermatogenesis associated 24"	Q86W54	5	139396563-139404089	"Predicted intracellular proteins"	"Differentiation, Spermatogenesis, Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	6	"testis: 147.0"	"Group enriched"	"Detected in many"	26	"Early spermatids: 1073.6;Late spermatids: 2829.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HDLM-2: 85.6"									HPA044000	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 22: NK-cells - Unknown function"	"Cluster 21: Non-specific - Transcription"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 34: Spermatids - Unknown function"	"Nucleoplasm, Cytosol"		"HPA044000: AB_10959668"	"unprognostic (2.19e-3)"	"unprognostic (1.18e-1)"	"unprognostic (2.09e-1)"	"unprognostic (9.30e-2)"	"unprognostic (3.82e-1)"	"unprognostic (7.71e-2)"	"prognostic unfavorable (2.75e-4)"	"unprognostic (1.26e-2)"	"unprognostic (1.58e-1)"	"unprognostic (2.87e-2)"	"unprognostic (5.36e-3)"	"unprognostic (1.07e-1)"	"unprognostic (6.11e-2)"	"unprognostic (1.24e-1)"	"unprognostic (3.44e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.64e-1)"	2.9	7.1	6.1	2.9	5.4	1.8	4.1	5.5	7.1	3.3	5.8	4.6	6.5	4.1	21.0	3.4	15.0	3.8	20.6	5.9	6.6	15.0	5.1	3.1	7.2	7.8	8.0	4.2	5.3	12.5	12.7	3.1	7.0	4.9	2.9	6.5	6.6	4.0	23.0	2.9	7.1	2.9	7.6	4.0	4.3	147.0	6.2	3.1	7.3	19.2	5.4	3.9	3.2	6.1	13.4	8.4	11.6	6.3	3.3	6.5	9.2	3.3	6.3	7.0	12.0	18.7	17.2	21.0	9.5	6.4	23.5	7.3	8.7	14.6	7.4	85.6	10.4	6.5	15.7	14.4	12.7	1.4	11.1	5.7	7.1	10.2	12.6	7.7	8.3	13.3	6.5	36.1	9.3	7.4	13.8	10.1	8.5	5.4	7.1	31.6	7.5	28.9	16.3	7.2	8.8	8.0	12.8	24.2	6.0	28.0	7.0	14.5	15.3	4.1	5.3	7.7	9.5	8.7	8.9	19.4	7.6	10.8	3.4	0.0	2.1	1.5	3.0	1.6	4.1	3.5	3.1	3.5	2.4	1.9	3.4	4.8	0.1	2.0	0.6	1.4	1.5	1.5	6.1	5.4	5.5	7.1	5.9	6.6	7.8	8.0	7.0	7.6	6.2	6.1	2.2	0.0	4.1	2.6	3.4	1.7	6.4	6.4	2.8	0.3	3.8	3.4	24.7	7.2	3.7	5.5	8.4	6.0	2.3	3.0	13.7	4.6	1073.6	14.9	1.6	4.1	0.0	0.8	1.0	1.8	3.2	2.2	2.0	2.4	0.0	3.6	4.2	3.7	5.2	1.7	1.3	1.5	2.0	2.7	1.4	2829.6	14.3	2.4	1.8	0.0	1.5	3.3	7.2	0.5	0.9	2.6	3.1	13.5	1.7	3.3	6.8	36.5	20.8	1.4	26.3	3.7	4.1	75.0	18.2	2.4	1.8	4.5	3.2	8.5	3.1	5.4
SPC24	"FLJ90806, SPBC24"	ENSG00000161888	"SPC24 component of NDC80 kinetochore complex"	Q8NBT2	19	11131520-11155808	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 26.0;lymphoid tissue: 14.7"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 35.0;Extravillous trophoblasts: 15.5;Hofbauer cells: 14.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			HPA051234	Approved		Supported	Nucleoplasm,Nucleoli		NA	Yes			"Cluster 40: NK-cells - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	Nucleoli	"HPA051234: AB_2681397"	"unprognostic (1.57e-1)"	"prognostic favorable (3.59e-4)"	"unprognostic (6.79e-2)"	"unprognostic (1.07e-3)"	"unprognostic (4.04e-1)"	"unprognostic (2.98e-2)"	"prognostic unfavorable (1.46e-4)"	"unprognostic (1.21e-2)"	"unprognostic (1.69e-2)"	"unprognostic (1.12e-2)"	"prognostic unfavorable (1.22e-4)"	"unprognostic (6.12e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (1.62e-2)"	"unprognostic (3.52e-2)"	"unprognostic (2.25e-1)"	"unprognostic (8.82e-2)"	1.9	1.7	1.3	4.8	1.5	26.0	1.2	3.9	2.1	2.1	1.7	4.7	4.5	2.7	0.8	5.0	1.3	2.3	2.7	1.6	1.5	0.8	1.6	1.6	6.3	1.1	0.8	1.3	1.1	0.4	0.4	3.2	1.3	1.6	4.3	1.2	1.3	2.0	4.0	3.9	4.1	8.1	0.5	3.1	2.9	4.3	1.4	14.7	0.9	1.1	6.5	2.5	2.0	2.4	73.6	26.9	36.9	30.1	5.0	9.7	16.6	42.3	15.7	38.6	43.6	28.4	24.6	58.2	46.0	18.5	22.8	38.8	29.0	30.3	28.7	30.9	24.9	78.5	68.9	43.2	1.1	55.5	33.7	1.9	1.1	27.8	12.8	10.0	34.7	62.3	42.8	118.3	27.6	48.7	76.4	32.9	25.5	19.8	43.9	59.8	56.7	18.6	11.2	23.8	38.4	27.2	37.0	22.4	9.6	17.5	22.0	19.8	33.2	36.8	38.3	49.6	51.2	70.5	39.8	55.6	26.9	53.9	30.5	1.9	0.4	0.4	0.5	0.5	0.4	0.8	0.9	1.5	0.2	0.7	0.9	0.6	2.2	2.0	0.5	0.5	1.7	0.3	1.3	1.5	3.9	2.1	1.6	1.5	1.1	0.8	1.3	0.5	1.4	2.4	0.2	0.0	0.5	0.3	1.5	1.1	1.2	1.3	0.0	0.0	1.0	0.4	9.0	1.5	0.8	5.5	6.2	10.0	0.9	2.8	0.0	0.2	0.3	1.0	2.2	2.2	2.4	35.0	0.3	0.0	15.5	3.5	3.6	1.8	5.7	6.5	4.6	0.7	14.0	0.0	0.3	2.6	0.0	3.0	2.5	3.0	0.6	1.0	0.0	1.0	0.0	2.1	2.1	0.5	0.3	0.3	0.0	0.4	6.3	0.3	0.7	0.6	0.2	0.6	0.0	1.3	2.4	6.9	10.8	2.1	0.3	2.1	2.2	0.5	6.6	1.2
SPDYA	"Ringo3, SPDY1, SPY1"	ENSG00000163806	"Speedy/RINGO cell cycle regulator family member A"	Q5MJ70	2	28782517-28850611	"Predicted intracellular proteins"	"Cell cycle, DNA damage"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	18	"testis: 32.5"	"Group enriched"	"Detected in many"	4	"Early spermatids: 58.8;Spermatocytes: 225.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"NB-4: 2.6;THP-1: 2.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA035162, HPA066214"	Enhanced		Supported	Nucleoplasm		NA	NA				"Cluster 83: Testis - Spermatogenesis"	"Cluster 24: NB-4 - Immune response"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm		"HPA035162: AB_2674501, HPA066214: AB_2685636"	"unprognostic (3.41e-2)"	"unprognostic (3.20e-3)"	"unprognostic (2.45e-1)"	"unprognostic (3.53e-2)"	"unprognostic (4.21e-2)"	"unprognostic (4.04e-3)"	"unprognostic (1.10e-4)"	"unprognostic (3.04e-3)"	"unprognostic (1.95e-2)"	"unprognostic (6.54e-3)"	"unprognostic (1.45e-1)"	"unprognostic (1.99e-2)"	"unprognostic (1.66e-13)"	"unprognostic (8.56e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.85e-1)"	"unprognostic (5.55e-5)"	0.8	0.9	0.2	0.2	0.2	0.6	0.7	0.2	0.3	1.8	0.0	0.8	0.5	0.7	0.0	0.9	0.9	0.5	0.8	0.3	0.0	1.7	1.4	0.7	0.5	0.0	0.0	1.4	0.8	0.0	1.4	0.2	0.0	1.7	0.0	1.0	0.7	0.0	0.3	1.6	0.9	0.0	0.0	1.8	0.8	32.5	0.1	0.0	1.2	0.0	0.0	0.7	1.0	0.1	0.4	0.2	0.7	1.6	0.0	0.0	0.8	0.4	0.0	0.1	0.0	0.4	0.3	0.3	0.5	0.0	0.4	1.0	0.1	0.0	0.1	0.2	0.4	0.3	1.0	1.3	0.0	0.5	0.7	0.1	0.0	0.1	0.2	0.3	0.0	0.3	0.2	0.6	0.3	0.2	0.1	2.6	0.2	0.1	0.1	0.3	1.2	0.4	0.5	0.3	0.5	0.3	0.8	1.0	0.3	0.7	0.3	2.5	0.1	1.2	1.0	0.6	0.6	0.3	0.7	0.7	0.3	0.3	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.2	0.2	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.1	4.5	3.2	0.5	6.5	2.6	0.3	1.0	0.4	0.6	0.8	3.7	3.8	0.6	0.0	1.4	1.8	6.2	0.1	2.1	2.1	0.0	0.7	58.8	9.9	2.7	1.4	0.0	0.4	9.0	0.5	0.2	1.9	4.1	12.2	2.5	0.8	1.8	0.1	0.4	0.0	6.0	0.0	0.0	0.3	3.1	29.1	2.5	6.7	0.0	1.9	0.8	0.1	0.0	9.0	6.0	0.8	0.3	2.2	2.9	1.2	0.5	0.1	1.6	1.4	6.6	9.0	1.7	225.0	9.6	1.8	0.1	0.5	3.8	0.5	0.5	2.1
SPECC1	"CYTSB, FLJ36955, HCMOGT-1, NSP"	ENSG00000128487	"Sperm antigen with calponin homology and coiled-coil domains 1"	Q5M775	17	20008865-20319026	"Disease related genes, Predicted intracellular proteins"			Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 47.3"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 217.1;Inhibitory neurons: 220.8;Microglial cells: 187.4;Oligodendrocytes: 317.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 42.1"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"SiHa: 75.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021421, HPA021430, HPA061073"	Enhanced		Supported	"Nucleoplasm,Nucleoli fibrillar center,Vesicles,Cytosol"		NA	NA		9800	"Cluster 46: Basophils - DNA binding"	"Cluster 65: Brain - Ion transport"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Nucleoplasm, Vesicles"	"Nucleoli fibrillar center, Cytosol"	"HPA021421: AB_1857431, HPA021430: AB_1857432, HPA061073: "	"unprognostic (1.13e-3)"	"unprognostic (2.39e-1)"	"unprognostic (1.98e-2)"	"unprognostic (8.10e-3)"	"unprognostic (8.32e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.21e-1)"	"prognostic unfavorable (1.06e-5)"	"unprognostic (9.29e-2)"	"unprognostic (5.81e-2)"	"unprognostic (6.23e-3)"	"unprognostic (2.65e-1)"	"unprognostic (3.15e-1)"	"unprognostic (6.86e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.40e-1)"	"unprognostic (2.04e-1)"	12.5	9.6	30.8	7.3	35.1	23.6	9.2	24.1	43.7	6.1	22.3	15.1	9.8	12.8	4.7	9.2	8.3	14.8	5.0	41.4	21.4	4.7	1.2	5.7	5.3	32.8	25.8	16.6	4.8	3.3	6.4	3.6	24.5	6.1	10.0	6.1	6.2	5.0	5.1	3.6	10.5	9.5	21.0	13.5	10.3	22.8	41.1	3.0	5.2	2.8	5.2	4.6	4.3	47.3	26.2	37.3	15.7	7.2	14.7	6.9	29.1	10.0	12.4	12.4	21.4	67.6	17.1	1.5	45.3	11.4	24.3	21.1	10.7	33.4	3.7	12.8	18.5	14.5	34.4	10.5	4.9	1.3	5.6	10.6	36.9	10.2	24.9	46.8	0.0	4.4	1.0	15.1	10.4	24.0	0.3	5.3	14.5	17.0	6.3	11.8	49.5	23.6	32.2	11.4	7.1	6.9	75.7	35.6	13.9	62.2	26.3	9.1	0.3	0.5	21.1	0.9	30.8	5.4	11.7	0.9	19.1	12.6	6.5	42.1	15.8	33.0	2.2	8.4	3.2	1.8	1.5	3.4	26.6	1.4	1.0	1.4	11.1	13.0	7.9	4.6	0.6	5.5	30.8	35.1	24.1	43.7	41.4	21.4	32.8	25.8	24.5	21.0	41.1	47.3	28.7	22.4	14.7	170.4	5.7	5.5	12.5	22.0	10.8	7.4	5.8	4.7	10.3	7.2	21.1	18.4	68.8	5.5	10.2	56.8	9.8	30.9	100.0	40.1	44.1	13.1	7.7	82.5	217.1	36.3	11.5	18.6	34.1	64.1	116.4	29.5	3.9	0.2	22.0	0.0	220.8	54.8	12.2	12.4	15.9	54.5	5.0	29.0	21.4	187.4	84.7	13.6	11.3	125.2	317.8	67.7	24.7	44.8	7.0	19.7	25.2	3.6	18.1	31.4	59.2	7.3	81.3	73.8	68.9	5.9	2.6	2.2	10.0	87.8	27.4	21.5
SPECC1L	"CYTSA, KIAA0376"	ENSG00000100014	"Sperm antigen with calponin homology and coiled-coil domains 1 like"	Q69YQ0	22	24270817-24417739	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cell cycle, Cell division"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Late spermatids: 93.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA070614	Uncertain		Supported	"Actin filaments"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 21: Non-specific - Transcription"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 31: Spermatids - Spermatogenesis"	"Actin filaments"		"HPA070614: AB_2686287"	"unprognostic (3.54e-1)"	"unprognostic (4.93e-3)"	"unprognostic (1.62e-1)"	"unprognostic (5.88e-2)"	"unprognostic (3.74e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.54e-1)"	"unprognostic (7.82e-3)"	"unprognostic (4.98e-2)"	"unprognostic (1.72e-3)"	"prognostic favorable (7.92e-4)"	"unprognostic (3.15e-3)"	"unprognostic (6.20e-3)"	"unprognostic (1.40e-1)"	"unprognostic (3.71e-1)"	"unprognostic (5.79e-3)"	"unprognostic (1.41e-1)"	13.0	13.1	12.3	12.4	12.8	13.3	13.8	34.0	13.5	16.6	17.7	15.8	7.8	15.9	9.7	17.5	15.5	12.5	18.6	10.8	15.7	14.6	14.4	17.2	12.5	18.1	16.2	22.0	13.3	17.3	14.6	10.1	18.9	20.1	16.9	10.7	16.2	15.1	12.7	9.2	11.6	19.0	15.8	11.1	11.5	31.9	16.6	14.5	24.0	13.1	13.8	14.9	13.0	13.7	31.1	22.8	42.9	23.7	40.1	39.2	14.5	43.1	34.1	36.8	36.4	25.5	8.4	44.9	10.3	39.5	29.0	27.0	39.2	24.2	43.4	26.1	21.1	28.5	12.9	23.4	26.7	51.2	27.0	33.1	19.2	32.8	34.2	28.8	44.0	18.9	24.5	19.0	39.3	17.3	26.6	18.5	20.7	22.5	17.1	24.0	43.3	16.1	18.4	23.3	37.2	38.3	36.5	27.5	23.8	37.1	18.3	14.4	46.3	77.2	43.7	19.3	29.3	22.7	23.4	20.0	22.6	19.0	29.2	3.9	2.4	4.8	3.3	3.5	2.5	2.8	2.2	1.6	2.3	3.1	2.7	2.9	3.2	1.3	1.6	3.7	1.6	1.9	12.3	12.8	34.0	13.5	10.8	15.7	18.1	16.2	18.9	15.8	16.6	13.7	11.6	16.0	21.3	0.0	10.4	3.6	2.7	5.0	10.2	8.4	13.8	9.4	13.7	14.3	9.1	12.9	10.4	7.3	7.9	32.8	1.9	6.7	26.9	8.3	14.9	12.0	14.4	7.6	0.0	7.4	3.2	11.4	8.2	9.8	16.5	13.4	15.7	11.4	7.3	10.1	0.0	12.2	14.2	7.3	2.2	93.7	16.1	6.9	14.2	0.0	14.8	6.4	9.2	0.0	0.0	9.0	15.0	13.5	10.7	5.7	8.9	6.1	11.9	8.5	13.1	11.3	12.5	24.1	28.5	9.8	3.1	5.9	9.3	7.6	8.0	3.8
SPESP1	SP-ESP	ENSG00000258484	"Sperm equatorial segment protein 1"	Q6UW49	15	68818221-68946811	"Predicted secreted proteins"		"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"testis: 73.2"	"Group enriched"	"Detected in many"	4	"Early spermatids: 400.4;Spermatocytes: 455.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+ SV40 Large T+: 17.8;BJ hTERT+ SV40 Large T+ RasG12V: 18.6;HBF TERT88: 21.7;HMC-1: 13.4;OE19: 15.9;RPTEC TERT1: 26.8;SCLC-21H: 19.9;WM-115: 31.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA045936, HPA051040"	Enhanced		Approved	Nucleoplasm,Vesicles,Cytosol	"Secreted in male reproductive system"	NA	NA		52000	"Cluster 46: Basophils - DNA binding"	"Cluster 83: Testis - Spermatogenesis"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Nucleoplasm, Vesicles"	Cytosol	"HPA045936: AB_2679504, HPA051040: AB_2681322"	"unprognostic (1.14e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.73e-3)"	"unprognostic (9.82e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.42e-2)"	"unprognostic (1.06e-1)"	"unprognostic (5.96e-2)"	"unprognostic (2.79e-1)"	"unprognostic (2.40e-1)"	"unprognostic (8.99e-2)"	"unprognostic (1.10e-2)"	"unprognostic (1.16e-2)"	"unprognostic (2.68e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.75e-1)"	"unprognostic (9.67e-2)"	2.3	3.4	1.1	0.8	1.1	0.4	2.2	1.2	1.6	1.2	1.0	1.6	1.2	1.5	6.3	2.6	1.8	3.5	3.1	1.1	1.2	2.0	1.2	1.1	0.8	1.3	1.2	3.4	1.9	4.7	1.2	12.9	1.3	3.5	1.1	2.8	1.8	2.9	1.6	1.0	0.9	1.2	1.3	1.3	1.5	73.2	1.1	0.9	1.9	1.9	0.7	2.4	0.8	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.4	0.0	17.8	18.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	21.7	5.0	0.0	0.0	0.0	0.0	6.3	0.0	13.4	7.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.6	2.9	0.0	0.0	3.3	15.9	0.0	0.0	1.4	0.0	26.8	0.2	19.9	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	11.6	0.0	0.0	0.0	0.0	0.0	0.0	31.6	1.1	1.3	0.4	0.2	1.1	0.5	0.5	0.4	0.3	0.8	0.3	0.3	0.5	0.5	0.2	0.8	0.4	0.4	0.5	1.1	1.1	1.2	1.6	1.1	1.2	1.3	1.2	1.3	1.3	1.1	1.6	5.1	0.0	0.0	0.0	0.2	1.9	3.0	23.7	1.8	1.0	2.7	4.1	4.1	1.5	4.0	7.3	4.2	92.3	0.3	0.2	1.9	2.1	400.4	3.9	3.4	3.6	1.8	0.8	0.0	2.7	7.2	5.5	0.0	2.0	0.0	1.7	2.2	1.8	7.8	0.0	0.0	0.9	6.1	2.1	3.3	90.3	21.1	1.2	5.4	0.0	1.0	5.3	0.0	0.0	0.0	0.9	0.0	8.6	0.0	3.3	0.0	3.9	6.3	5.6	46.0	3.4	4.2	455.0	88.7	1.1	2.3	62.1	0.5	11.1	0.2	1.5
SPG11	"ALS5, FLJ21439, KIAA1840"	ENSG00000104133	"SPG11 vesicle trafficking associated, spatacsin"	Q96JI7	15	44562696-44663678	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"			"Amyotrophic lateral sclerosis, Charcot-Marie-Tooth disease, Hereditary spastic paraplegia, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 121.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040412, HPA040947"	Approved		Supported	"Nucleoli,Plasma membrane,Cytosol"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 52: Non-specific - Transcription"	"Plasma membrane, Cytosol"	Nucleoli	"HPA040412: AB_10795418, HPA040947: AB_10796232"	"unprognostic (1.10e-1)"	"unprognostic (1.74e-1)"	"unprognostic (2.39e-1)"	"unprognostic (1.98e-3)"	"unprognostic (1.99e-1)"	"unprognostic (9.31e-2)"	"unprognostic (2.91e-1)"	"unprognostic (2.32e-1)"	"unprognostic (6.71e-2)"	"unprognostic (2.26e-3)"	"unprognostic (2.58e-2)"	"unprognostic (9.19e-2)"	"prognostic favorable (6.28e-5)"	"unprognostic (8.73e-2)"	"unprognostic (2.48e-1)"	"unprognostic (3.72e-1)"	"unprognostic (6.06e-2)"	21.1	27.1	18.4	18.2	25.7	27.4	21.6	24.4	21.3	21.5	23.9	25.6	17.1	17.9	25.3	25.6	20.2	16.1	25.5	17.5	22.2	25.0	29.8	24.8	28.4	23.8	22.1	21.4	28.6	26.7	21.3	14.9	23.9	25.3	19.9	30.5	24.7	15.0	22.9	30.4	30.1	12.7	19.1	43.0	26.0	25.5	24.6	23.7	30.9	14.3	18.6	23.8	22.6	33.4	13.2	8.8	21.9	21.6	33.7	33.0	15.8	13.4	17.4	13.0	16.6	10.8	12.5	9.7	16.5	18.2	22.5	29.0	15.1	20.8	12.5	29.3	9.0	22.1	21.1	16.4	23.7	22.2	19.2	25.3	23.3	10.7	30.5	20.4	18.6	16.6	28.8	24.2	18.6	11.5	10.1	19.7	11.5	40.3	11.6	12.9	18.5	10.6	28.0	33.6	14.2	16.8	14.6	23.3	13.1	18.0	22.0	30.2	19.9	17.1	8.5	21.4	16.5	23.8	22.6	19.2	17.6	28.8	17.9	5.7	7.7	11.8	6.5	9.2	6.9	10.0	5.4	4.9	6.2	11.3	4.3	5.3	11.6	6.2	12.4	6.3	6.1	3.7	18.4	25.7	24.4	21.3	17.5	22.2	23.8	22.1	23.9	19.1	24.6	33.4	21.0	44.8	22.2	56.2	40.4	9.3	15.6	18.8	14.2	25.1	19.0	12.6	20.1	18.6	31.3	27.6	47.9	16.5	30.1	29.3	5.9	21.3	28.2	31.7	23.2	17.6	20.0	22.3	62.9	16.9	10.1	19.3	37.2	33.6	27.3	31.9	21.8	23.5	20.1	16.8	68.1	31.2	26.4	43.3	23.5	33.2	17.7	40.4	14.2	74.9	88.1	14.0	50.4	68.3	121.4	17.7	24.0	13.9	21.4	19.3	30.8	14.9	53.6	21.7	6.6	24.8	16.3	51.7	31.6	20.1	11.1	9.3	29.5	24.4	27.3	22.2
SPG21	"ABHD21, ACP33, BM-019, GL010, MAST"	ENSG00000090487	"SPG21 abhydrolase domain containing, maspardin"	Q9NZD8	15	64963022-64990310	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Hereditary spastic paraplegia, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 181.4"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040407, HPA040436"	Approved		Supported	Vesicles,Cytosol		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	"Vesicles, Cytosol"		"HPA040407: AB_2676965, HPA040436: AB_10796454"	"unprognostic (7.47e-2)"	"unprognostic (2.94e-2)"	"unprognostic (5.81e-2)"	"unprognostic (2.98e-1)"	"unprognostic (1.64e-1)"	"unprognostic (5.40e-3)"	"unprognostic (7.25e-2)"	"unprognostic (1.43e-1)"	"unprognostic (4.19e-2)"	"unprognostic (8.07e-2)"	"unprognostic (4.24e-3)"	"unprognostic (1.15e-1)"	"unprognostic (3.96e-1)"	"unprognostic (1.55e-1)"	"unprognostic (3.49e-1)"	"unprognostic (2.57e-1)"	"unprognostic (3.19e-1)"	56.6	61.7	48.4	50.8	54.1	69.4	68.8	51.5	52.9	60.4	66.0	61.6	52.1	60.2	150.1	46.1	73.4	54.7	54.4	47.8	50.3	85.3	113.1	61.9	56.9	52.1	50.2	55.3	54.7	72.1	47.1	66.3	52.7	49.8	59.3	38.6	45.7	59.0	74.3	58.5	46.6	64.5	51.1	52.6	60.1	35.0	52.6	57.7	83.1	42.4	58.8	61.2	47.8	59.4	87.0	127.0	62.8	119.5	158.7	155.7	78.0	52.8	179.7	103.2	119.8	57.4	131.1	99.1	80.6	124.8	153.1	113.3	182.1	124.5	97.8	41.0	58.5	85.7	81.7	104.0	200.7	82.2	72.7	107.0	139.3	82.1	154.2	100.7	125.6	112.2	72.7	78.3	127.8	124.1	75.8	71.5	69.6	193.9	66.3	78.2	67.3	174.6	107.1	103.6	76.7	68.6	62.7	131.4	124.9	123.3	89.9	140.9	61.5	87.1	90.6	125.4	80.6	55.6	101.8	58.2	112.8	215.1	75.1	9.9	138.2	15.5	14.1	84.2	13.1	39.0	13.8	14.7	76.9	37.6	19.9	10.9	181.4	15.7	69.8	25.1	17.5	52.3	48.4	54.1	51.5	52.9	47.8	50.3	52.1	50.2	52.7	51.1	52.6	59.4	29.4	9.6	56.3	11.1	67.7	74.9	81.8	70.6	66.6	16.2	62.7	39.4	32.1	61.5	51.5	71.7	37.5	202.9	33.6	42.7	137.0	97.1	6.0	32.9	36.9	56.9	64.8	54.3	13.1	74.1	92.2	67.5	46.9	34.3	28.5	37.5	38.2	121.6	153.9	20.2	13.7	58.2	61.1	158.7	145.4	13.2	86.6	128.5	80.0	16.9	123.2	24.8	64.9	5.5	19.6	62.3	93.5	89.9	66.2	145.2	121.1	202.3	57.9	18.9	39.5	93.4	39.5	35.4	51.3	75.4	82.8	186.5	46.5	35.5	69.5	123.5
SPHK1	SPHK	ENSG00000176170	"Sphingosine kinase 1"	Q9NYA1	17	76376584-76387860	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Calmodulin-binding, Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Ductal cells: 105.4;Muller glia cells: 165.1;Pancreatic endocrine cells: 101.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"plasmacytoid DC: 4.8"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Hep G2: 127.6;TIME: 108.9;U-251 MG: 142.1"	"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in some"		"olfactory bulb: 5.7"	"HPA022829, HPA028761"	Uncertain		Supported	"Plasma membrane,Cytosol"		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 1: Pancreatic cells - Digestion"	"Plasma membrane, Cytosol"		"HPA022829: AB_1857438, HPA028761: AB_10600814"	"unprognostic (1.04e-1)"	"unprognostic (6.30e-2)"	"unprognostic (1.09e-2)"	"unprognostic (8.66e-2)"	"unprognostic (2.25e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.68e-2)"	"unprognostic (9.32e-3)"	"unprognostic (3.13e-1)"	"unprognostic (7.43e-2)"	"unprognostic (8.99e-3)"	"unprognostic (2.18e-1)"	"prognostic unfavorable (5.14e-6)"	"unprognostic (1.39e-1)"	"unprognostic (4.82e-2)"	"unprognostic (8.29e-2)"	"unprognostic (1.10e-3)"	18.9	4.1	4.0	10.5	3.0	17.3	18.0	2.1	3.9	11.0	2.3	7.0	1.9	6.7	3.9	23.8	9.4	11.9	17.5	2.9	3.9	21.4	3.8	24.3	8.1	4.0	4.1	4.3	14.4	4.8	4.9	2.5	4.5	7.3	1.1	8.4	19.9	1.5	3.2	15.6	7.0	3.2	2.3	5.0	6.7	5.8	8.5	3.5	10.6	0.8	4.1	11.3	13.1	3.9	36.9	3.7	15.2	0.8	7.6	7.0	15.8	82.6	54.0	67.8	40.8	19.4	3.9	1.8	7.4	61.0	28.9	7.7	11.7	105.4	16.4	1.6	6.2	0.5	28.3	127.6	16.6	1.3	2.9	13.6	2.1	105.9	41.3	28.8	66.0	3.7	17.3	0.2	13.5	46.6	3.5	0.6	0.9	8.2	29.7	2.5	4.1	2.8	3.7	0.5	2.0	3.6	8.3	0.9	74.4	9.1	3.0	5.1	108.9	105.8	20.8	82.3	142.1	1.7	0.4	1.6	80.5	6.5	16.1	1.5	1.9	0.0	0.7	0.9	0.2	0.0	0.1	0.2	0.5	0.1	0.0	0.1	0.2	0.0	0.2	4.8	0.0	0.8	4.0	3.0	2.1	3.9	2.9	3.9	4.0	4.1	4.5	2.3	8.5	3.9	22.0	0.0	0.0	1.0	2.8	12.6	57.0	18.6	2.8	1.5	31.1	29.1	5.3	47.1	6.6	1.8	0.0	1.2	9.1	1.0	0.0	105.4	0.2	15.3	13.5	51.2	0.0	22.3	0.5	12.7	16.9	27.5	3.1	60.7	7.0	0.4	4.2	0.2	30.1	33.7	1.6	2.4	6.1	8.9	45.4	1.4	3.7	39.9	12.4	1.0	61.5	165.1	3.1	0.0	0.1	101.8	1.2	19.9	3.5	68.9	0.8	2.5	2.0	3.9	0.0	17.3	54.3	0.0	9.5	6.7	10.7	1.4	4.2	0.8	0.4	27.0
SPHK2		ENSG00000063176	"Sphingosine kinase 2"	Q9NRA0	19	48619291-48630717	"Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Bipolar cells: 68.5;Cone photoreceptor cells: 77.2;Rod photoreceptor cells: 79.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"NB-4: 64.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049062			Supported	Nucleoplasm		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 45: Intestine - Brush border"	"Cluster 24: NB-4 - Immune response"	"Cluster 9: Photoreceptor cells - Phototransduction"	Nucleoplasm		"HPA049062: "	"unprognostic (5.33e-2)"	"unprognostic (4.11e-2)"	"unprognostic (9.61e-2)"	"prognostic unfavorable (5.19e-4)"	"unprognostic (2.10e-1)"	"unprognostic (7.19e-3)"	"unprognostic (3.04e-1)"	"unprognostic (4.45e-3)"	"unprognostic (7.28e-2)"	"unprognostic (2.80e-1)"	"prognostic favorable (9.30e-4)"	"unprognostic (1.25e-1)"	"prognostic favorable (2.59e-5)"	"unprognostic (1.18e-2)"	"unprognostic (9.97e-2)"	"unprognostic (4.21e-2)"	"unprognostic (7.06e-2)"	9.4	10.5	18.9	6.8	20.6	3.4	9.6	23.5	29.3	9.4	9.1	16.5	22.1	12.0	2.1	9.2	11.6	3.1	7.3	25.9	19.4	23.1	31.8	8.5	5.9	36.0	30.5	15.5	8.9	7.4	16.5	2.2	37.2	13.3	3.6	3.2	7.6	4.4	7.8	4.8	18.9	2.6	21.2	11.4	14.8	24.1	30.6	5.3	16.0	3.1	3.1	10.7	7.3	26.1	8.4	22.3	8.2	15.3	8.5	3.6	16.3	8.5	6.8	9.3	11.1	39.8	10.4	15.0	5.9	5.3	5.6	6.4	7.5	6.9	1.3	17.5	19.4	16.9	11.5	13.7	13.5	11.1	17.3	6.5	3.6	6.5	4.4	4.4	5.2	20.9	11.7	12.5	4.7	8.3	27.2	64.7	11.2	6.0	10.7	23.3	6.5	10.0	4.3	5.3	29.3	23.1	8.3	12.7	8.3	4.5	7.1	6.9	8.5	13.6	7.7	10.9	17.1	24.5	31.0	16.4	7.9	12.2	12.6	11.7	6.2	2.9	4.3	7.1	4.0	5.0	3.4	4.2	5.5	8.6	4.8	4.8	2.4	5.6	6.2	5.4	3.7	3.5	18.9	20.6	23.5	29.3	25.9	19.4	36.0	30.5	37.2	21.2	30.6	26.1	3.7	6.4	7.7	8.5	13.3	3.3	5.7	5.6	4.6	68.5	6.8	6.5	1.5	12.8	6.2	11.0	77.2	6.8	13.6	20.6	1.9	6.2	11.0	6.2	6.1	6.5	16.2	2.1	9.1	5.0	6.3	5.3	15.3	6.9	4.5	14.5	6.4	19.8	8.3	45.4	11.2	11.3	4.1	12.3	7.3	18.4	16.4	6.5	3.6	6.5	11.4	20.8	33.0	6.0	11.9	6.8	16.7	12.8	7.1	6.2	44.2	18.6	4.9	79.9	6.6	6.3	5.4	18.1	6.3	7.3	2.8	4.5	12.3	8.9	17.3	4.3
SPI1	"OF, PU.1, SFPI1, SPI-1, SPI-A"	ENSG00000066336	"Spi-1 proto-oncogene"	P17947	11	47354860-47378547	"Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, RNA-binding"	Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	6	"bone marrow: 335.1;lung: 101.0;lymphoid tissue: 172.7"	"Group enriched"	"Detected in many"	6	"Hofbauer cells: 432.9;Kupffer cells: 411.9;Langerhans cells: 537.6;Macrophages: 453.3;monocytes: 357.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"eosinophil: 179.7"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 179.7"	"Cell line enhanced"	"Detected in some"		"HEL: 90.1;HL-60: 159.7;HMC-1: 282.2;NB-4: 267.8;THP-1: 206.7;U-698: 85.3;U-937: 117.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004079, HPA044653"	Enhanced		Supported	Nucleoplasm		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 4: Macrophages - Innate immune response"	Nucleoplasm		"CAB004079: AB_10692379, HPA044653: AB_2679036"	"unprognostic (4.45e-2)"	"unprognostic (3.31e-3)"	"unprognostic (2.92e-2)"	"unprognostic (1.66e-2)"	"unprognostic (5.97e-2)"	"unprognostic (3.33e-2)"	"unprognostic (5.28e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.35e-2)"	"unprognostic (2.79e-1)"	"unprognostic (3.36e-1)"	"unprognostic (1.78e-1)"	"prognostic unfavorable (2.07e-5)"	"unprognostic (1.20e-1)"	"unprognostic (4.95e-2)"	"unprognostic (2.40e-1)"	"unprognostic (4.92e-2)"	36.5	19.7	12.0	107.3	13.1	335.1	17.7	14.3	19.4	7.9	15.8	15.6	21.5	7.3	2.1	9.1	19.1	21.3	13.5	11.7	16.4	10.6	15.6	101.0	65.0	31.2	20.9	5.2	7.8	3.1	7.6	28.0	24.7	10.3	10.2	1.0	14.6	6.1	5.0	13.8	29.3	21.9	19.8	172.7	17.0	3.7	26.2	15.7	8.8	8.3	32.0	29.9	7.6	30.3	0.2	0.0	0.0	0.0	0.0	0.1	0.5	0.1	0.0	0.2	0.1	0.0	0.0	72.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	90.1	0.0	0.0	0.0	159.7	282.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	11.7	0.7	0.0	0.0	0.2	267.8	0.2	0.0	0.0	48.7	0.2	47.5	0.0	0.0	0.2	0.3	0.0	0.0	0.6	0.0	0.0	206.7	0.3	0.0	0.5	0.5	0.1	0.1	0.3	85.3	0.3	117.5	0.1	14.1	19.2	179.7	0.0	27.4	0.0	3.9	0.0	0.0	16.4	2.4	0.0	0.0	83.8	0.0	34.7	0.9	0.0	7.3	12.0	13.1	14.3	19.4	11.7	16.4	31.2	20.9	24.7	19.8	26.2	30.3	2.1	3.2	1.1	10.4	72.6	10.5	0.5	0.0	1.2	1.3	2.1	5.0	2.9	4.3	0.6	5.5	0.0	2.3	6.3	0.5	19.6	0.1	7.5	0.1	0.3	5.5	4.2	39.7	3.1	0.4	3.1	2.6	1.1	0.3	33.7	0.2	7.9	3.2	432.9	0.0	3.3	0.3	0.0	411.9	537.6	27.5	1.8	453.3	10.6	36.5	357.5	7.0	8.2	3.5	1.5	0.0	0.1	0.0	21.8	0.4	0.2	2.3	0.7	1.7	13.1	1.5	1.4	5.1	9.3	0.8	9.9	4.2	4.8	1.1	0.4	0.5
SPICE1	"CCDC52, SPICE"	ENSG00000163611	"Spindle and centriole associated protein 1"	Q8N0Z3	3	113442718-113515187	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA064843	Approved		Supported	Centrosome		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 71: Testis - DNA repair"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	Centrosome		"HPA064843: AB_2685367"	"unprognostic (2.66e-1)"	"unprognostic (1.27e-2)"	"unprognostic (1.12e-1)"	"unprognostic (4.95e-3)"	"unprognostic (2.69e-1)"	"unprognostic (1.01e-1)"	"unprognostic (4.99e-3)"	"unprognostic (1.17e-1)"	"unprognostic (6.30e-2)"	"unprognostic (2.24e-1)"	"unprognostic (1.17e-3)"	"unprognostic (1.89e-2)"	"unprognostic (4.75e-3)"	"unprognostic (6.53e-2)"	"unprognostic (4.47e-1)"	"unprognostic (3.64e-3)"	"unprognostic (2.95e-2)"	4.4	3.8	2.1	4.6	2.3	4.1	7.4	3.2	2.9	8.5	3.4	6.7	4.1	8.6	4.9	6.9	8.0	7.7	4.3	2.4	2.4	4.6	4.1	4.7	4.1	2.2	2.1	7.8	6.3	6.4	8.9	5.5	2.1	6.4	6.6	7.7	8.6	4.9	2.6	6.0	5.3	6.7	1.4	4.2	6.8	7.1	1.9	8.3	6.8	2.3	5.5	6.1	7.2	3.1	17.0	10.4	12.1	10.6	7.5	9.2	7.6	8.2	6.3	10.9	13.6	9.2	9.4	9.9	11.6	7.2	10.7	16.0	6.3	8.0	14.7	5.9	2.8	9.0	9.3	6.1	4.5	18.0	6.8	7.5	7.9	11.3	4.6	9.6	8.0	18.0	5.8	8.2	3.8	17.7	15.6	7.0	13.0	13.4	11.5	10.8	10.3	8.8	4.0	10.7	6.2	10.8	8.7	10.3	4.8	13.4	10.2	7.2	8.0	5.5	8.8	5.1	7.5	7.9	5.8	16.7	11.0	10.5	8.2	3.6	4.1	1.5	3.2	3.0	5.2	5.6	5.0	4.0	3.1	6.1	7.0	5.2	2.1	2.7	2.9	9.7	2.6	2.0	2.1	2.3	3.2	2.9	2.4	2.4	2.2	2.1	2.1	1.4	1.9	3.1	6.7	0.0	4.2	14.4	12.0	6.8	7.9	5.4	9.1	6.4	9.4	5.8	2.5	5.7	5.6	5.5	8.4	4.7	3.5	8.0	0.0	5.4	6.5	22.8	11.9	4.7	3.6	9.9	20.2	4.5	5.9	7.4	16.3	12.7	1.3	10.1	3.3	5.2	4.4	3.3	6.8	10.6	6.1	2.5	3.9	3.5	9.9	4.1	0.0	15.9	2.3	7.9	1.0	16.1	14.4	5.6	3.6	3.4	13.9	4.1	3.9	4.2	15.3	25.0	6.6	6.2	5.4	20.9	16.9	7.7	7.7	3.4	7.5	6.2	7.4	8.5
SPIDR	KIAA0146	ENSG00000164808	"Scaffold protein involved in DNA repair"	Q14159	8	47260878-47736306	"Predicted intracellular proteins"	"DNA damage, DNA recombination, DNA repair"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"Astrocytes: 122.4;Excitatory neurons: 255.4;Inhibitory neurons: 214.4;Microglial cells: 216.4;Oligodendrocyte precursor cells: 207.6;Oligodendrocytes: 141.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027201, HPA041582"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 64: Macrophages - Immune response"	"Cluster 15: RT4 - Unknown function"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Nucleoplasm		"HPA027201: AB_10603774, HPA041582: AB_2677563"	"unprognostic (5.58e-2)"	"unprognostic (2.24e-2)"	"unprognostic (2.71e-2)"	"unprognostic (7.45e-2)"	"unprognostic (4.72e-3)"	"unprognostic (7.99e-2)"	"unprognostic (3.17e-2)"	"unprognostic (2.15e-3)"	"unprognostic (2.93e-2)"	"prognostic unfavorable (8.91e-4)"	"unprognostic (1.74e-1)"	"unprognostic (1.92e-2)"	"prognostic unfavorable (2.04e-6)"	"unprognostic (5.30e-1)"	"unprognostic (1.97e-1)"	"unprognostic (8.43e-2)"	"unprognostic (1.35e-2)"	21.4	16.5	17.2	16.2	17.1	15.1	19.1	20.9	19.9	19.6	16.2	16.1	11.0	16.6	14.8	23.6	18.3	20.9	12.4	17.3	15.5	13.5	15.1	19.0	16.6	16.6	15.1	23.6	18.1	11.8	17.8	18.5	16.3	18.3	14.5	18.0	17.7	10.6	13.9	20.3	13.4	11.8	13.9	20.5	17.7	10.6	15.2	12.3	19.7	4.1	12.0	17.3	16.1	15.9	16.4	24.2	16.5	28.7	19.6	24.9	15.0	22.8	18.1	16.5	25.5	13.4	39.4	31.5	22.6	19.8	16.9	8.5	18.3	17.3	23.7	9.1	15.6	21.5	23.0	25.7	21.9	16.0	13.3	15.9	13.5	13.7	19.9	20.0	12.4	19.7	16.9	11.2	19.9	38.8	30.3	40.5	19.6	38.2	6.5	15.2	10.1	2.2	22.4	55.6	9.0	19.5	35.2	25.7	12.3	17.4	23.9	33.0	20.4	12.0	17.8	17.8	13.4	12.7	25.1	21.8	14.2	22.3	12.0	4.6	10.6	3.1	9.3	6.5	9.4	7.1	4.1	5.5	8.6	6.0	4.4	3.9	4.4	7.9	7.7	1.3	8.8	5.5	17.2	17.1	20.9	19.9	17.3	15.5	16.6	15.1	16.3	13.9	15.2	15.9	25.8	35.3	33.7	122.4	22.2	10.7	16.6	17.8	30.7	11.2	20.1	18.0	19.5	12.8	18.0	12.9	18.8	17.8	15.7	8.8	7.9	8.2	8.5	18.1	20.4	21.4	11.5	12.4	255.4	8.8	11.5	21.7	26.0	21.0	12.6	20.6	10.8	8.3	11.1	13.5	214.4	9.7	10.2	33.1	11.3	7.6	14.6	27.4	8.8	216.4	24.9	8.7	15.5	207.6	141.4	7.1	10.1	14.7	16.6	15.1	6.0	4.9	26.5	12.2	6.6	17.5	16.9	21.7	29.7	27.6	8.7	16.4	15.1	10.9	12.3	18.6
SPIN1	"SPIN, TDRD24"	ENSG00000106723	"Spindlin 1"	Q9Y657	9	88388430-88478694	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Meiosis, Wnt signaling pathway"	"Chromatin regulator, Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 178.2;Oligodendrocytes: 220.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000162, HPA068784"	Uncertain		Supported	Nucleoplasm		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 68: Epididymis - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 34: Spermatids - Unknown function"	Nucleoplasm		"HPA000162: AB_1080079, HPA068784: AB_2686033"	"unprognostic (1.53e-1)"	"unprognostic (2.29e-1)"	"unprognostic (2.74e-1)"	"unprognostic (1.01e-1)"	"unprognostic (2.91e-1)"	"unprognostic (1.53e-1)"	"unprognostic (6.11e-2)"	"unprognostic (1.19e-2)"	"unprognostic (2.08e-2)"	"unprognostic (8.96e-2)"	"unprognostic (8.78e-2)"	"unprognostic (8.32e-2)"	"prognostic favorable (8.69e-6)"	"unprognostic (4.73e-3)"	"unprognostic (1.20e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.56e-1)"	23.3	26.6	42.3	17.4	44.7	14.7	35.2	30.1	46.2	59.3	35.4	29.0	19.3	61.3	76.9	27.7	50.9	31.7	29.5	45.4	42.4	44.8	20.9	26.1	15.9	32.5	38.8	55.9	21.7	41.7	28.7	33.1	34.4	37.8	25.1	34.8	24.4	42.2	6.9	24.9	22.5	46.1	35.5	19.3	21.3	35.6	44.0	31.0	41.3	14.1	17.3	27.3	31.5	39.5	68.5	32.8	54.0	46.2	36.0	42.1	63.0	67.1	62.0	75.1	54.8	24.6	38.9	37.7	38.5	82.8	48.5	102.4	40.6	61.1	85.7	39.6	24.4	18.0	67.4	26.4	33.3	41.8	19.0	35.2	62.4	50.9	71.2	74.0	43.4	47.2	23.5	0.1	85.5	46.8	71.1	18.8	89.2	56.9	30.5	93.6	58.6	12.2	68.3	47.2	76.1	57.2	79.5	49.7	30.1	62.2	38.3	32.7	41.4	49.6	52.4	74.3	48.2	15.3	24.2	32.3	60.1	38.0	47.3	7.4	2.6	4.1	3.9	2.2	4.1	2.5	2.8	4.0	5.0	1.9	3.9	4.4	0.4	2.6	2.1	2.3	2.8	3.1	42.3	44.7	30.1	46.2	45.4	42.4	32.5	38.8	34.4	35.5	44.0	39.5	26.4	51.3	15.4	139.4	13.1	40.0	26.1	23.1	47.3	22.9	45.4	31.2	35.8	42.9	22.2	44.1	25.0	28.6	17.0	29.1	25.4	24.2	178.2	56.4	73.3	24.5	41.3	19.6	136.8	18.3	44.4	39.6	22.4	68.5	34.8	74.3	26.4	17.5	33.6	25.2	173.3	23.6	30.5	35.2	21.8	123.4	33.5	22.8	21.4	89.9	13.0	38.5	13.4	123.1	220.1	25.4	17.7	44.4	9.6	34.6	20.9	47.6	22.2	15.1	26.3	28.3	38.0	25.7	54.1	37.7	44.8	24.9	16.9	37.9	21.8	28.9
SPINT1	"HAI, MANSC2"	ENSG00000166145	"Serine peptidase inhibitor, Kunitz type 1"	O43278	15	40844018-40858207	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"		"Protease inhibitor, Serine protease inhibitor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 255.5"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 1254.0;Distal enterocytes: 477.6;Proximal enterocytes: 514.5;Syncytiotrophoblasts: 1673.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BEWO: 323.2;HaCaT: 377.6;hTCEpi: 264.0;RT4: 308.2;SK-BR-3: 558.8;T-47d: 267.7"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA006903, HPA031178"	Uncertain		Supported	"Nucleoplasm,Plasma membrane,Cytosol"	"Secreted to blood"	NA	NA		7400000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Plasma membrane, Cytosol"	Nucleoplasm	"HPA006903: AB_1079038, HPA031178: AB_2732463"	"prognostic unfavorable (6.97e-4)"	"unprognostic (1.00e-3)"	"unprognostic (3.00e-3)"	"unprognostic (5.03e-2)"	"unprognostic (6.06e-2)"	"unprognostic (3.19e-1)"	"unprognostic (5.94e-2)"	"unprognostic (6.04e-2)"	"unprognostic (8.24e-3)"	"unprognostic (1.46e-2)"	"unprognostic (1.09e-3)"	"unprognostic (1.01e-1)"	"prognostic favorable (1.37e-7)"	"unprognostic (5.37e-2)"	"unprognostic (2.22e-1)"	"unprognostic (6.45e-3)"	"unprognostic (2.17e-2)"	2.8	0.7	0.9	16.4	1.5	1.4	34.7	5.0	1.3	42.8	6.4	108.7	159.9	13.2	78.9	255.5	33.6	38.0	1.3	0.9	2.0	79.9	3.5	47.6	6.4	2.8	3.2	2.4	69.2	132.9	31.4	144.9	2.2	52.3	89.2	0.4	162.7	31.4	0.6	148.9	138.2	4.3	1.7	6.9	88.3	1.8	3.2	9.9	34.7	0.4	45.5	57.1	90.1	2.3	124.8	1.0	0.0	0.9	0.1	0.0	323.2	2.3	3.0	4.0	2.4	195.3	202.4	0.3	141.2	0.4	3.6	377.6	30.8	181.9	2.4	1.0	10.6	5.6	3.3	10.8	2.2	21.9	93.9	0.3	264.0	3.9	16.5	3.4	14.7	12.1	2.7	1.1	0.2	96.5	0.9	16.6	37.4	207.6	17.7	12.6	0.0	24.9	179.3	308.2	79.8	3.9	9.3	558.8	15.7	56.9	267.7	16.1	0.0	0.2	2.0	1.2	0.5	1.2	24.5	0.8	0.8	16.3	1.1	0.0	19.7	14.3	0.4	15.9	0.8	8.4	3.0	1.4	32.4	6.0	1.1	0.3	25.9	5.5	18.1	4.0	0.5	7.6	0.9	1.5	5.0	1.3	0.9	2.0	2.8	3.2	2.2	1.7	3.2	2.3	0.8	57.7	14.7	0.0	7.6	76.0	96.7	220.0	55.8	0.1	96.2	63.5	0.5	105.8	207.3	134.3	0.0	1254.0	1.4	477.6	25.4	429.4	0.8	63.3	14.2	6.9	147.3	4.8	0.5	255.1	105.1	10.4	106.5	155.6	10.2	1.9	0.4	0.5	135.4	0.0	0.5	169.4	221.8	10.0	23.8	1.1	3.7	19.8	14.2	0.0	68.6	0.0	0.0	0.0	0.0	309.8	375.2	0.0	2.1	135.7	514.5	44.2	46.6	0.3	0.0	0.1	12.6	0.6	5.9	93.2	87.9	1673.8	6.6	0.1	182.7	222.3
SPIRE1	"KIAA1135, spir-1"	ENSG00000134278	"Spire type actin nucleation factor 1"	Q08AE8	18	12446512-12658134	"Predicted intracellular proteins"	"Protein transport, Transport"	Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 151.8;Early spermatids: 167.4;Excitatory neurons: 165.2;Inhibitory neurons: 155.9;Late spermatids: 321.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"hTERT-HME1: 97.3;U-2197: 75.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040737, HPA040942"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 21: Non-specific - Transcription"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 31: Spermatids - Spermatogenesis"	"Nucleoplasm, Cytosol"		"HPA040737: AB_10960987, HPA040942: AB_10960492"	"unprognostic (3.39e-1)"	"unprognostic (4.77e-2)"	"unprognostic (9.18e-2)"	"prognostic unfavorable (2.07e-4)"	"unprognostic (2.09e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.60e-1)"	"unprognostic (9.49e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.46e-2)"	"unprognostic (4.60e-1)"	"unprognostic (3.66e-3)"	"prognostic unfavorable (7.92e-4)"	"unprognostic (1.41e-1)"	"unprognostic (2.54e-1)"	"unprognostic (1.44e-1)"	7.6	17.4	22.1	3.8	22.8	1.0	9.0	22.5	27.8	8.6	6.6	7.7	1.7	7.6	5.5	7.2	5.2	7.2	20.7	23.5	18.9	10.7	5.0	10.8	2.8	20.4	20.3	8.0	5.1	17.5	6.1	6.4	20.3	8.3	3.1	14.7	8.9	8.0	20.6	8.4	3.2	8.3	19.9	4.5	5.5	33.6	25.3	3.4	13.2	19.3	4.0	9.1	5.8	26.8	19.0	8.2	17.7	19.7	19.5	17.3	0.9	20.1	20.7	19.4	18.4	0.9	4.1	8.9	22.2	26.0	32.2	4.1	24.0	18.0	24.4	13.4	11.9	5.5	16.9	10.7	40.0	3.9	13.6	12.0	33.4	33.6	97.3	22.4	26.3	3.0	14.2	0.2	29.1	25.2	1.0	5.2	7.5	6.7	20.2	0.0	21.8	19.0	23.5	25.5	25.9	10.6	21.8	17.9	45.3	7.9	5.7	11.7	32.3	32.0	9.5	75.4	24.1	6.6	0.7	0.6	25.6	2.4	8.7	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	22.1	22.8	22.5	27.8	23.5	18.9	20.4	20.3	20.3	19.9	25.3	26.8	10.1	25.6	43.2	151.8	0.5	3.7	9.7	8.3	1.2	60.5	15.6	12.3	28.5	7.2	13.6	12.9	8.4	0.1	2.5	0.5	21.5	8.2	167.4	5.7	25.6	10.7	3.0	0.8	165.2	4.9	0.9	13.0	2.0	7.9	15.8	11.5	5.3	4.6	14.2	26.9	155.9	3.7	0.0	17.2	5.3	321.5	5.9	12.9	17.8	30.9	2.3	15.5	0.0	93.5	91.2	11.7	0.1	10.9	1.1	23.1	0.2	1.0	8.4	13.2	19.7	20.0	15.4	17.4	17.5	2.0	2.3	0.5	2.2	16.7	0.1	16.8
SPPL2A	"IMP3, PSL2"	ENSG00000138600	"Signal peptide peptidase like 2A"	Q8TCT8	15	50702266-50765709	"Enzymes, Plasma proteins, Predicted membrane proteins, Transporters"		"Hydrolase, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036062, HPA067304"	Enhanced		Supported	Vesicles		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Vesicles		"HPA036062: AB_10611670, HPA067304: AB_2685820"	"unprognostic (1.66e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.70e-1)"	"unprognostic (5.82e-3)"	"unprognostic (3.71e-1)"	"unprognostic (1.70e-1)"	"unprognostic (2.15e-1)"	"unprognostic (1.88e-1)"	"unprognostic (2.22e-2)"	"unprognostic (6.36e-2)"	"unprognostic (2.04e-2)"	"unprognostic (4.00e-2)"	"unprognostic (3.11e-2)"	"unprognostic (2.26e-2)"	"unprognostic (1.44e-2)"	"unprognostic (6.96e-2)"	"unprognostic (3.66e-1)"	41.1	34.7	8.3	57.6	10.9	54.5	32.0	11.1	8.5	36.6	48.6	93.4	79.6	27.9	21.5	26.5	26.8	39.4	37.1	6.8	12.3	57.9	107.0	43.4	40.2	15.3	12.8	13.6	63.7	158.5	13.0	54.1	12.5	29.5	82.8	12.5	44.5	32.6	109.3	25.2	67.6	41.0	11.2	37.3	41.7	18.5	12.1	39.5	35.2	81.8	41.7	51.7	20.9	14.5	57.3	96.9	37.0	49.2	142.3	84.3	58.2	89.1	149.1	80.5	114.1	113.1	64.3	35.1	65.0	176.3	120.7	83.5	45.2	54.3	89.5	72.2	27.5	67.0	61.5	58.9	117.4	42.0	104.5	73.9	98.3	66.8	106.7	59.4	80.2	37.7	51.3	134.2	107.6	131.5	20.1	16.2	15.8	90.8	22.0	24.2	57.3	77.6	109.7	130.4	29.7	33.4	54.0	102.7	63.4	74.0	73.2	81.6	98.9	128.7	51.7	83.7	106.7	54.0	100.2	38.8	58.1	69.4	90.3	48.7	52.3	48.9	27.9	48.6	17.4	18.3	22.3	25.5	37.4	19.2	12.4	20.5	37.7	23.5	56.6	33.1	30.4	50.2	8.3	10.9	11.1	8.5	6.8	12.3	15.3	12.8	12.5	11.2	12.1	14.5	66.2	48.1	35.9	20.5	51.9	43.1	79.1	76.3	37.5	14.8	36.4	21.3	77.5	52.9	44.3	68.0	20.9	136.5	72.7	215.5	23.5	87.1	18.8	107.2	56.6	59.6	38.4	30.3	32.0	167.1	88.3	74.3	52.0	57.3	45.7	20.5	46.8	124.1	85.9	8.4	31.4	86.5	36.7	68.7	55.7	7.0	44.7	83.0	32.0	23.4	134.5	27.5	64.9	25.6	26.2	131.9	127.3	36.5	49.9	92.2	143.0	46.8	41.8	17.2	26.3	88.0	51.6	31.7	15.3	39.3	38.8	204.5	60.6	30.8	76.0	94.1
SPPL2B	"IMP4, KIAA1532, PSL1"	ENSG00000005206	"Signal peptide peptidase like 2B"	Q8TCT7	19	2328615-2355095	"Enzymes, Predicted membrane proteins"		"Hydrolase, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Gastric mucus-secreting cells: 109.1;Late spermatids: 107.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005592, HPA039292"	Approved		Approved	"Nucleoplasm,Plasma membrane,Centrosome"		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 71: Testis - DNA repair"	"Cluster 20: HeLa - Mitochondria"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Nucleoplasm, Plasma membrane"	Centrosome	"CAB005592: AB_325074, HPA039292: AB_2676429"	"unprognostic (4.16e-2)"	"unprognostic (2.97e-2)"	"unprognostic (2.48e-2)"	"prognostic favorable (5.00e-5)"	"unprognostic (2.34e-1)"	"unprognostic (1.54e-3)"	"unprognostic (1.74e-1)"	"unprognostic (7.93e-3)"	"unprognostic (3.00e-1)"	"unprognostic (1.72e-1)"	"prognostic favorable (1.33e-4)"	"unprognostic (3.29e-3)"	"prognostic unfavorable (6.45e-4)"	"unprognostic (2.26e-2)"	"unprognostic (2.45e-1)"	"unprognostic (3.02e-1)"	"unprognostic (3.40e-2)"	23.1	23.2	13.7	16.7	13.6	29.1	27.4	15.5	18.6	28.4	17.4	43.4	41.6	26.4	4.4	22.5	34.0	10.7	21.6	11.8	12.1	35.9	33.0	22.2	20.7	19.2	15.6	27.2	50.7	11.0	63.8	10.4	15.5	32.5	9.2	7.1	27.2	9.8	25.3	28.9	52.6	5.9	13.2	39.1	33.9	63.5	15.1	12.0	40.5	3.1	9.9	21.9	20.9	16.4	16.6	25.9	10.9	19.5	8.8	8.9	27.8	21.1	6.1	7.6	8.1	18.2	18.4	15.7	19.4	9.9	7.1	21.7	3.6	7.3	2.3	18.4	16.0	10.4	44.7	24.9	16.5	18.6	13.1	13.1	8.2	7.2	5.2	11.9	10.7	32.2	17.3	39.0	4.7	18.4	20.2	23.6	20.4	14.7	10.5	33.4	5.8	43.9	8.3	41.0	19.4	18.3	21.2	12.8	16.7	7.1	21.3	30.8	24.3	13.8	9.7	35.3	16.9	51.0	20.1	16.7	17.3	21.4	24.5	11.5	7.7	7.4	6.2	7.7	4.4	8.2	5.6	6.0	9.4	12.5	6.9	7.7	3.3	6.4	5.4	17.0	6.0	6.4	13.7	13.6	15.5	18.6	11.8	12.1	19.2	15.6	15.5	13.2	15.1	16.4	23.6	3.2	17.2	57.1	30.8	0.0	6.5	0.0	8.0	26.1	21.6	21.5	6.0	20.0	5.0	25.8	47.9	50.6	18.8	79.5	1.9	16.6	51.4	39.3	22.2	14.4	40.7	14.5	25.3	11.5	20.8	14.2	109.1	25.5	7.0	39.9	13.2	15.1	11.8	32.0	30.3	63.2	0.0	9.4	0.0	107.7	14.9	10.8	0.0	9.4	8.0	13.2	19.6	39.7	35.2	10.4	49.9	15.8	11.5	7.3	57.8	7.9	10.9	39.4	0.0	15.0	11.7	57.0	13.5	10.8	0.0	42.8	11.0	36.4	49.8	6.0
SPPL3	"DKFZP586C1324, IMP2, MGC126674, MGC126676, MGC90402, PSL4"	ENSG00000157837	"Signal peptide peptidase like 3"	Q8TCT6	12	120762510-120904358	"Enzymes, Predicted membrane proteins"		"Hydrolase, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 192.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004194, HPA059958"	Uncertain		Supported	"Vesicles,Plasma membrane"		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 40: Granulosa cells - Unknown function"	"Vesicles, Plasma membrane"		"HPA004194: AB_2667171, HPA059958: AB_2684179"	"unprognostic (3.29e-1)"	"unprognostic (2.29e-2)"	"unprognostic (3.39e-2)"	"unprognostic (1.63e-1)"	"unprognostic (2.06e-1)"	"unprognostic (7.96e-3)"	"prognostic unfavorable (1.29e-5)"	"unprognostic (3.17e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.28e-1)"	"unprognostic (2.48e-1)"	"unprognostic (2.44e-1)"	"unprognostic (2.66e-1)"	"unprognostic (9.34e-2)"	"unprognostic (9.92e-2)"	"unprognostic (7.54e-2)"	"unprognostic (9.40e-2)"	20.9	14.9	25.3	11.9	28.1	20.9	24.2	29.0	27.5	30.0	13.1	26.7	18.2	26.3	15.7	44.3	28.6	18.7	18.1	25.4	30.6	22.8	19.3	20.4	15.9	25.0	26.0	31.4	21.3	49.6	13.9	28.4	26.1	20.6	27.2	15.5	20.2	27.0	15.7	56.5	18.8	29.6	24.1	24.3	15.2	39.0	26.4	32.7	31.2	19.6	27.8	28.6	34.2	31.4	30.0	29.2	43.4	27.4	56.2	37.7	30.5	22.5	66.6	47.4	37.9	30.5	29.9	27.4	0.1	39.4	42.0	35.6	44.8	48.4	48.9	21.9	27.5	23.6	16.2	23.4	59.2	27.4	29.3	38.1	75.9	40.7	38.1	56.0	47.1	41.5	26.5	13.4	41.2	26.3	36.7	22.0	29.2	27.8	20.6	21.6	36.6	19.7	36.8	83.8	29.7	31.9	42.8	19.6	34.7	46.1	58.9	18.7	35.4	21.9	29.5	13.6	17.1	30.9	60.3	26.4	32.5	22.3	36.9	4.8	1.2	1.1	1.3	1.2	1.8	1.3	1.6	1.7	2.1	1.6	1.5	1.7	2.2	1.3	1.1	2.7	1.4	0.7	25.3	28.1	29.0	27.5	25.4	30.6	25.0	26.0	26.1	24.1	26.4	31.4	35.2	19.2	20.8	79.3	25.3	55.1	32.3	29.4	43.3	37.8	35.2	24.1	21.2	20.0	19.8	40.5	27.1	42.0	21.2	47.2	1.9	19.3	8.6	20.9	26.9	33.0	27.1	14.5	97.2	24.7	29.0	33.2	25.0	29.7	4.5	68.7	37.5	33.1	38.3	37.0	112.6	33.7	22.4	38.1	39.3	8.0	28.6	34.5	26.6	79.6	26.6	23.0	16.5	141.3	192.3	22.8	34.9	35.0	22.0	33.4	34.0	18.1	18.1	22.4	13.1	32.3	27.4	55.6	41.1	76.9	84.7	64.6	22.4	35.0	35.4	37.6
SPR	SDR38C1	ENSG00000116096	"Sepiapterin reductase"	P35270	2	72887382-72892158	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase	"Disease variant, Dystonia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 85.3;Exocrine glandular cells: 81.1;Proximal tubular cells: 91.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	7	"classical monocyte: 8.3;intermediate monocyte: 2.4;myeloid DC: 8.9"	"Group enriched"	"Detected in many"	11	"dendritic cells: 8.9;monocytes: 8.3"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039505	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA		180000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 22: Non-specific - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 1: Pancreatic cells - Digestion"	"Nucleoplasm, Cytosol"		"HPA039505: AB_10795466"	"unprognostic (4.09e-1)"	"unprognostic (1.22e-1)"	"unprognostic (7.72e-3)"	"unprognostic (1.97e-1)"	"unprognostic (2.46e-2)"	"unprognostic (1.06e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.12e-1)"	"unprognostic (9.79e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.80e-1)"	"unprognostic (7.50e-3)"	"unprognostic (2.87e-1)"	"unprognostic (1.43e-3)"	"unprognostic (1.95e-1)"	25.9	50.8	26.0	7.6	27.2	0.6	20.0	27.2	61.4	14.5	39.6	36.4	23.4	13.4	36.9	19.7	26.3	11.9	44.4	26.8	30.0	44.2	99.8	15.9	3.2	27.9	31.5	12.2	63.5	38.4	10.9	6.8	29.8	26.2	32.5	3.1	31.2	16.7	43.9	9.1	22.0	11.5	27.9	9.6	42.1	7.3	28.5	2.4	20.5	25.4	5.1	25.2	13.7	28.0	47.5	130.9	0.6	20.0	51.2	18.5	31.8	21.4	31.8	16.0	15.0	84.0	48.0	34.5	25.4	26.1	80.6	43.9	58.1	35.1	13.3	10.0	43.7	51.7	30.8	87.4	19.1	8.2	13.6	16.7	38.7	17.6	19.7	32.7	42.6	25.4	54.0	6.8	21.4	100.5	3.3	31.1	10.9	139.9	118.7	0.0	82.8	20.3	85.8	73.4	8.0	14.6	39.6	89.7	31.0	16.9	40.4	9.9	52.8	17.4	42.2	30.5	38.7	7.2	16.9	2.3	25.0	17.6	31.0	0.0	8.3	0.7	0.3	2.4	0.3	0.0	0.1	0.1	8.9	0.0	0.1	0.3	0.0	0.0	0.9	0.9	0.0	2.4	26.0	27.2	27.2	61.4	26.8	30.0	27.9	31.5	29.8	27.9	28.5	28.0	13.8	12.8	7.3	0.3	1.1	8.4	23.0	14.8	20.5	0.7	22.2	16.5	46.2	38.6	10.8	42.3	0.0	18.1	0.4	85.3	21.5	56.9	0.3	12.5	4.2	16.7	11.4	6.6	0.7	81.1	10.6	13.9	26.0	6.7	4.5	8.4	17.2	62.9	42.1	1.7	0.4	39.6	12.2	6.0	7.4	1.5	9.3	9.7	14.2	1.9	20.8	13.8	0.0	0.0	0.3	43.3	50.4	5.7	1.4	33.9	71.0	91.6	11.2	0.7	6.6	8.3	8.6	0.4	10.2	17.8	6.5	4.4	1.9	8.7	57.8	15.6
SPRED1	"FLJ33903, PPP1R147"	ENSG00000166068	"Sprouty related EVH1 domain containing 1"	Q7Z699	15	38252836-38357249	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"			"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 173.7;Excitatory neurons: 163.4;Microglial cells: 199.5;Oligodendrocyte precursor cells: 277.9;Oligodendrocytes: 146.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"non-classical monocyte: 1.4"	"Lineage enriched"	"Detected in single"	4	"monocytes: 1.4"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042193, HPA061805"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 12: NES - Nervous system development"	"Cluster 68: Oligodendrocytes - Mixed function"	Nucleoplasm		"HPA042193: AB_10794079, HPA061805: AB_2684617"	"unprognostic (1.30e-1)"	"unprognostic (1.28e-2)"	"unprognostic (2.46e-1)"	"prognostic favorable (7.08e-4)"	"unprognostic (1.20e-1)"	"unprognostic (2.38e-1)"	"unprognostic (1.21e-3)"	"unprognostic (5.71e-2)"	"unprognostic (3.84e-2)"	"unprognostic (2.81e-3)"	"unprognostic (9.27e-3)"	"unprognostic (3.33e-1)"	"prognostic unfavorable (7.37e-5)"	"prognostic unfavorable (8.29e-5)"	"unprognostic (6.04e-2)"	"unprognostic (5.77e-2)"	"unprognostic (1.01e-1)"	12.7	8.2	16.0	8.8	20.3	0.7	10.9	14.7	20.6	11.5	7.1	11.4	8.2	10.9	5.7	6.1	6.9	12.8	7.3	16.5	16.3	9.1	5.6	17.4	7.1	18.9	19.6	7.9	4.5	6.8	4.0	14.0	16.2	7.2	10.9	7.5	5.6	8.6	2.6	6.1	8.4	9.5	15.6	9.0	10.3	8.2	17.9	4.4	31.1	8.0	4.9	13.2	6.8	18.3	11.0	8.2	59.0	11.3	21.4	39.0	4.8	25.1	24.7	13.1	16.2	7.6	8.7	0.1	9.0	21.7	9.5	8.6	6.2	17.3	26.2	1.5	2.0	13.0	5.2	7.3	26.3	7.1	34.6	25.5	8.5	25.5	23.4	33.6	10.7	6.5	11.7	12.1	32.2	2.9	2.6	5.2	12.0	37.6	22.0	0.0	13.3	7.3	21.2	16.9	2.9	13.0	7.2	3.5	26.7	9.3	2.8	1.7	18.2	32.0	15.7	19.7	15.4	10.1	7.1	16.7	22.5	2.8	52.1	0.0	0.2	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	16.0	20.3	14.7	20.6	16.5	16.3	18.9	19.6	16.2	15.6	17.9	18.3	26.4	99.3	26.9	173.7	2.5	28.3	24.6	9.4	45.5	12.6	17.2	20.8	7.2	28.6	12.6	1.8	6.2	1.3	1.5	15.7	1.9	9.5	40.3	12.0	29.4	28.2	6.7	4.6	163.4	4.9	0.9	33.0	17.3	14.8	41.8	5.4	26.7	4.1	57.8	5.0	100.0	21.2	6.1	48.2	24.6	9.6	21.8	38.7	28.4	199.5	7.3	25.4	0.0	277.9	146.9	15.1	7.8	30.5	1.6	12.7	6.6	12.8	11.4	5.2	6.6	44.4	44.1	8.0	5.0	18.1	9.7	1.4	2.4	21.4	15.3	14.7
SPRED2	"FLJ21897, FLJ31917, Spred-2"	ENSG00000198369	"Sprouty related EVH1 domain containing 2"	Q7Z698	2	65310851-65432637	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 108.7;Excitatory neurons: 138.5;Inhibitory neurons: 122.4;Oligodendrocyte precursor cells: 124.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"NK-cell: 1.9;plasmacytoid DC: 4.2"	"Group enriched"	"Detected in many"	4	"dendritic cells: 4.2;NK-cells: 1.9"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038256, HPA064394"	Approved		Uncertain	Nucleoplasm,Cytosol		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm	Cytosol	"HPA038256: , HPA064394: AB_2732712"	"unprognostic (1.49e-1)"	"unprognostic (5.95e-3)"	"unprognostic (3.46e-2)"	"unprognostic (4.40e-3)"	"unprognostic (8.94e-2)"	"unprognostic (1.63e-1)"	"unprognostic (2.90e-2)"	"unprognostic (9.94e-2)"	"unprognostic (9.07e-2)"	"unprognostic (4.25e-1)"	"unprognostic (5.05e-2)"	"unprognostic (1.92e-1)"	"unprognostic (2.37e-2)"	"unprognostic (3.82e-2)"	"unprognostic (1.58e-1)"	"unprognostic (7.21e-3)"	"unprognostic (5.43e-2)"	23.9	11.4	12.0	9.7	15.3	7.0	21.7	11.8	22.8	13.5	5.6	16.5	14.9	16.5	8.6	10.9	13.3	13.2	14.7	14.4	11.4	13.7	24.8	18.4	14.0	14.4	12.5	14.0	18.0	16.7	11.5	15.8	11.2	12.3	16.1	10.9	15.9	10.8	8.0	11.3	13.7	11.5	11.1	8.5	19.8	7.4	13.3	28.7	17.9	13.9	15.4	15.5	14.0	12.7	60.4	32.9	32.2	32.4	41.1	40.9	22.2	16.1	25.2	10.9	14.5	43.4	16.4	41.2	9.2	20.8	29.2	18.7	18.2	37.2	21.9	52.3	11.6	9.7	9.1	45.2	21.0	25.7	18.8	33.1	22.2	37.2	36.9	22.9	6.9	24.9	39.1	16.9	17.7	40.9	22.6	26.7	16.1	43.4	35.4	17.1	28.6	24.2	34.1	52.3	13.1	45.1	18.1	14.8	44.2	20.1	15.1	23.7	11.4	27.6	35.8	23.8	27.4	33.2	13.8	73.7	44.7	27.1	54.2	0.0	0.2	0.0	0.6	0.7	0.0	0.0	0.1	0.5	0.4	0.0	0.1	0.1	0.6	1.9	0.3	4.2	0.0	0.7	12.0	15.3	11.8	22.8	14.4	11.4	14.4	12.5	11.2	11.1	13.3	12.7	49.7	19.2	16.0	108.7	1.8	39.9	29.0	12.0	41.5	17.8	22.7	17.7	7.5	14.3	6.6	9.2	6.2	11.0	3.3	32.0	13.7	11.0	1.5	16.8	11.4	18.6	11.4	1.7	138.5	8.6	8.4	21.0	14.8	35.0	1.3	2.8	13.9	14.1	6.7	25.2	122.4	24.1	8.2	7.5	67.6	4.1	17.1	10.2	19.6	68.4	26.0	7.9	0.0	124.1	23.2	13.9	21.5	12.4	0.5	23.4	17.1	7.4	7.2	9.8	26.3	17.0	17.4	3.9	10.4	16.6	16.8	3.0	3.8	4.7	10.9	24.0
SPRR4		ENSG00000184148	"Small proline rich protein 4"	Q96PI1	1	152970648-152972574	"Predicted intracellular proteins"	Keratinization			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	19	"skin 1: 145.4"	"Cell type enriched"	"Detected in some"	4	"Late spermatids: 54.2"	"Cancer enriched"	"Detected in many"	5	"head and neck cancer: 17.2"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							HPA055963	Enhanced		Approved	"Nucleoplasm,Nuclear membrane,Cytosol"		NA	NA				"Cluster 61: Skin - Cornification"		"Cluster 25: Spermatids - Spermatogenesis"	"Nucleoplasm, Cytosol"	"Nuclear membrane"	"HPA055963: AB_2682988"		"unprognostic (4.40e-2)"				"unprognostic (7.38e-3)"			"unprognostic (1.45e-1)"								"unprognostic (6.75e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	6.1	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	145.4	0.0	0.0	0.0	0.0	0.0	7.4	0.0	0.9	0.0	0.0	0.1	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	54.2	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SPRTN	"C1orf124, DKFZP547N043, DVC1, Spartan"	ENSG00000010072	"SprT-like N-terminal domain"	Q9H040	1	231337104-231355023	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"DNA damage, DNA repair"	"Hydrolase, Metalloprotease, Protease"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cone photoreceptor cells: 85.5;Rod photoreceptor cells: 73.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA025073	Uncertain		Supported	Nucleoplasm		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 9: Photoreceptor cells - Phototransduction"	Nucleoplasm		"HPA025073: AB_1847695"	"unprognostic (2.63e-1)"	"unprognostic (5.41e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.56e-2)"	"unprognostic (2.00e-1)"	"unprognostic (5.69e-3)"	"unprognostic (1.72e-1)"	"unprognostic (1.33e-2)"	"unprognostic (4.75e-3)"	"unprognostic (1.26e-1)"	"unprognostic (3.25e-1)"	"unprognostic (7.51e-3)"	"unprognostic (1.19e-1)"	"unprognostic (3.21e-2)"	"unprognostic (3.60e-2)"	"unprognostic (5.35e-2)"	4.4	3.6	2.9	5.0	3.7	11.8	5.4	3.9	3.5	4.2	3.6	3.7	4.0	4.9	4.1	5.7	3.4	4.4	4.4	2.6	3.3	4.6	5.1	3.7	6.3	3.1	3.2	3.1	2.7	4.8	2.7	7.8	3.6	3.9	3.8	4.9	3.5	3.6	8.5	5.9	3.6	4.9	3.2	5.0	4.1	14.5	3.0	7.2	5.1	5.3	6.2	4.8	3.3	4.5	13.7	11.4	10.5	11.5	9.6	6.8	12.7	12.1	10.5	13.6	11.8	13.2	11.4	12.4	12.8	10.1	5.4	19.6	15.2	12.2	14.7	10.6	26.1	7.8	11.1	9.1	10.2	13.3	11.0	9.3	12.7	15.0	12.2	6.2	13.8	11.1	19.0	11.8	13.9	7.5	14.1	7.5	10.4	15.6	10.0	12.3	13.6	14.7	12.0	10.2	13.2	12.8	13.0	9.8	13.9	4.7	17.9	19.3	10.5	11.7	11.8	17.1	19.9	9.1	10.0	17.0	9.1	11.2	20.4	8.6	4.6	9.8	5.1	6.6	5.7	4.9	5.1	5.8	4.6	3.2	6.1	6.8	9.5	6.6	4.8	4.3	5.9	3.6	2.9	3.7	3.9	3.5	2.6	3.3	3.1	3.2	3.6	3.2	3.0	4.5	14.5	16.0	4.2	8.8	19.9	32.0	11.4	9.3	27.3	22.6	11.6	13.1	5.2	10.0	11.4	3.7	85.5	12.0	25.2	10.3	9.8	8.7	20.5	16.6	13.2	16.1	12.0	12.4	12.5	9.3	10.6	12.3	12.2	9.8	26.1	11.4	13.6	7.0	9.6	15.2	11.9	7.0	12.2	9.5	12.5	8.4	9.0	10.1	7.2	8.4	15.8	13.6	34.0	10.6	21.3	12.1	7.1	7.9	10.2	10.5	11.0	8.1	16.8	73.7	13.1	14.4	13.7	51.8	21.4	20.5	28.4	15.2	20.9	11.6	8.5	14.5
SPRY2	hSPRY2	ENSG00000136158	"Sprouty RTK signaling antagonist 2"	O43597	13	80335976-80341126	"Disease related genes, Plasma proteins, Predicted membrane proteins"		"Developmental protein"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"NK-cell: 4.1"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 267.9;SK-MEL-30: 156.9;WM-115: 136.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB037205, HPA042198"	Approved		Supported	"Actin filaments,Microtubules"		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 50: Fibroblasts - ECM organization"	"Actin filaments, Microtubules"		"CAB037205: AB_261923, HPA042198: AB_2677896"	"unprognostic (9.37e-3)"	"unprognostic (3.71e-2)"	"unprognostic (1.10e-1)"	"unprognostic (9.12e-3)"	"unprognostic (3.80e-2)"	"unprognostic (8.99e-2)"	"unprognostic (3.95e-3)"	"unprognostic (2.43e-2)"	"unprognostic (3.43e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.53e-1)"	"unprognostic (4.28e-2)"	"unprognostic (1.56e-2)"	"unprognostic (9.89e-2)"	"unprognostic (3.22e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.86e-2)"	69.6	24.1	37.4	11.8	38.0	29.5	66.2	57.6	42.9	31.0	27.7	40.4	17.6	29.3	15.3	20.0	46.7	30.1	50.9	38.5	36.0	21.1	27.8	31.5	8.9	50.2	40.4	16.9	27.4	10.2	17.3	13.9	40.2	26.2	27.3	34.2	34.8	18.9	39.1	26.5	25.4	23.5	42.0	30.8	25.9	4.1	39.7	11.3	27.1	41.4	4.9	27.0	30.8	43.4	1.8	7.6	84.2	267.9	108.4	70.6	5.8	69.3	31.1	15.3	18.2	34.9	10.3	0.0	11.6	28.5	10.6	6.7	4.8	13.9	17.0	0.1	15.3	12.0	4.5	8.9	24.9	63.4	4.8	31.8	14.6	26.1	63.3	95.6	29.9	13.0	4.4	0.3	35.0	1.5	8.6	28.8	33.7	23.6	19.6	25.6	112.0	0.2	28.8	11.7	1.0	46.7	5.7	3.1	156.9	32.9	6.3	56.0	44.3	14.3	5.6	30.3	13.6	0.1	0.1	0.0	97.6	23.9	136.9	0.0	0.0	2.1	0.3	0.0	0.1	0.4	0.0	0.8	0.9	0.0	0.0	0.1	0.0	4.1	0.0	0.1	0.0	0.1	37.4	38.0	57.6	42.9	38.5	36.0	50.2	40.4	40.2	42.0	39.7	43.4	48.5	25.6	29.3	59.4	2.9	43.5	38.0	12.5	53.5	5.9	12.4	21.3	20.5	18.6	6.3	1.8	6.2	8.7	12.1	33.4	5.9	11.3	0.3	25.2	17.6	22.3	12.0	8.4	22.1	8.0	2.9	65.9	11.2	41.7	16.4	7.2	32.5	17.0	10.9	8.4	15.3	36.1	4.1	27.3	10.7	1.5	29.5	12.2	14.2	15.9	0.8	68.5	3.1	39.7	17.6	18.0	33.7	5.7	1.7	23.1	7.2	8.3	4.8	23.3	26.3	57.7	67.6	0.1	1.5	16.2	29.1	9.6	11.1	8.5	27.6	11.9
SPRY4		ENSG00000187678	"Sprouty RTK signaling antagonist 4"	Q9C004	5	142310427-142326455	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"		"Developmental protein"	"Disease variant, Hypogonadotropic hypogonadism, Kallmann syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 39.5;Alveolar cells type 2: 49.0;Endothelial cells: 32.8;Hepatic stellate cells: 37.1;Oligodendrocyte precursor cells: 96.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 100.2;WM-115: 139.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB008086, HPA055471, HPA072661"	Enhanced		Approved	"Golgi apparatus,Cytosol"		NA	NA				"Cluster 82: Adipose tissue - ECM organization"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 68: Oligodendrocytes - Mixed function"	"Golgi apparatus"	Cytosol	"CAB008086: AB_2195454, HPA055471: AB_2682825, HPA072661: AB_2732207"	"unprognostic (9.54e-3)"	"prognostic unfavorable (7.12e-4)"	"unprognostic (2.18e-1)"	"unprognostic (1.16e-1)"	"unprognostic (8.70e-2)"	"unprognostic (3.23e-2)"	"unprognostic (3.98e-3)"	"unprognostic (1.08e-1)"	"unprognostic (6.89e-2)"	"unprognostic (1.44e-2)"	"unprognostic (1.48e-1)"	"unprognostic (9.89e-2)"	"prognostic unfavorable (2.20e-4)"	"unprognostic (6.29e-3)"	"unprognostic (3.63e-2)"	"unprognostic (4.59e-2)"	"unprognostic (8.21e-2)"	30.6	18.9	8.4	4.8	8.4	0.0	14.3	6.6	9.9	4.9	13.1	9.3	6.4	6.6	1.5	3.2	7.4	8.1	19.7	8.7	9.4	22.1	12.4	26.8	2.7	9.5	8.2	2.6	4.6	7.0	20.1	13.8	8.5	9.1	5.2	4.3	4.4	4.7	5.1	3.9	7.8	6.2	6.4	8.7	8.7	1.8	8.4	2.0	19.5	6.5	1.4	8.1	4.0	6.3	3.0	5.0	48.4	100.2	29.0	20.7	12.7	35.9	12.0	5.7	6.0	5.2	5.1	0.0	25.0	9.2	6.1	2.4	0.0	10.6	7.2	0.1	0.0	0.2	0.0	22.9	9.5	0.0	0.2	16.7	0.2	15.8	8.6	9.3	5.5	0.1	11.7	0.1	21.9	4.3	0.0	14.0	21.5	16.8	31.3	1.1	6.8	1.3	17.7	32.2	0.6	14.1	0.7	4.7	42.5	14.1	0.4	2.1	8.3	12.6	0.2	2.5	32.4	0.1	1.7	0.2	19.4	0.1	139.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.4	8.4	6.6	9.9	8.7	9.4	9.5	8.2	8.5	6.4	8.4	6.3	39.5	6.4	49.0	6.8	0.2	1.7	3.8	1.7	17.1	9.1	7.6	10.2	3.2	1.5	1.1	3.7	0.0	1.0	0.9	7.3	0.0	2.0	0.8	10.1	4.6	32.8	13.8	0.0	11.2	0.4	2.1	12.4	6.1	17.1	3.8	0.5	37.1	3.2	0.3	0.0	17.1	7.3	0.0	2.6	1.2	1.7	0.3	0.5	7.2	22.5	0.0	1.6	0.0	96.5	0.8	5.1	2.5	0.4	0.1	4.3	5.6	1.2	0.6	0.6	19.7	17.1	24.3	0.1	1.0	3.5	0.3	3.4	1.4	1.3	7.6	1.8
SPTAN1		ENSG00000197694	"Spectrin alpha, non-erythrocytic 1"	Q13813	9	128552558-128633662	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		"Actin capping, Actin-binding, Calmodulin-binding"	"Disease variant, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in all"		"Bipolar cells: 296.6;Cone photoreceptor cells: 310.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004581, HPA007927"	Enhanced		Approved	Vesicles,Microtubules		NA	NA		1600000	"Cluster 13: T-cells - Unknown function"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 20: HeLa - Mitochondria"	"Cluster 9: Photoreceptor cells - Phototransduction"	"Vesicles, Microtubules"		"CAB004581: AB_671135, HPA007927: AB_1857435"	"unprognostic (1.46e-2)"	"unprognostic (2.73e-2)"	"unprognostic (1.56e-1)"	"unprognostic (9.06e-2)"	"unprognostic (3.24e-1)"	"unprognostic (4.02e-2)"	"unprognostic (2.56e-3)"	"unprognostic (2.20e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.30e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.36e-1)"	"prognostic favorable (1.84e-12)"	"unprognostic (2.94e-2)"	"unprognostic (1.60e-1)"	"unprognostic (4.18e-3)"	"unprognostic (2.19e-3)"	48.8	31.4	81.7	38.6	85.0	28.1	36.6	54.4	99.7	39.4	0.4	47.3	24.7	57.1	32.9	36.8	54.0	32.5	65.7	90.9	43.5	34.6	22.8	55.1	38.5	142.7	49.6	51.6	24.0	47.1	32.5	57.1	155.0	32.7	36.3	103.1	31.9	46.5	23.9	69.4	34.9	58.8	65.6	44.3	31.1	44.9	61.5	45.4	38.4	22.3	38.0	40.0	36.4	55.3	108.1	116.9	75.2	83.4	107.6	121.0	61.5	90.2	75.2	99.4	74.1	167.3	74.6	94.3	78.3	137.0	69.8	193.3	80.7	90.4	61.1	53.2	47.9	15.9	324.4	94.4	61.3	70.9	51.0	58.3	71.6	166.3	55.8	83.9	134.4	87.2	9.1	107.6	98.6	74.6	136.3	29.5	96.1	125.9	72.1	91.0	90.2	59.7	80.2	91.1	58.1	91.1	296.1	40.3	42.9	91.8	70.0	19.8	232.5	68.5	102.2	100.0	71.2	65.3	82.6	51.8	83.5	31.5	65.9	3.3	1.6	3.9	9.7	1.3	13.5	6.3	12.4	9.2	2.4	5.8	7.6	7.9	1.5	7.1	1.2	3.0	15.3	5.8	81.7	85.0	54.4	99.7	90.9	43.5	142.7	49.6	155.0	65.6	61.5	55.3	144.9	70.5	27.5	123.7	56.3	37.3	27.8	34.3	25.6	296.6	69.8	83.2	68.5	68.6	33.9	101.2	310.6	27.5	112.6	145.4	7.9	67.6	18.0	108.2	71.4	103.8	56.9	13.7	159.5	59.2	16.0	77.8	76.5	87.5	12.0	47.9	96.8	36.2	29.2	124.5	183.8	54.1	30.5	22.2	29.4	40.5	85.1	32.8	35.6	74.9	24.4	97.7	48.4	87.4	17.4	102.2	93.0	94.8	70.5	45.9	62.4	22.8	71.3	156.5	26.3	53.0	60.0	33.0	44.5	43.7	45.5	18.2	95.4	22.0	73.6	65.7
SPTBN2	SCA5	ENSG00000173898	"Spectrin beta, non-erythrocytic 2"	O15020	11	66682497-66729226	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"		"Actin capping, Actin-binding"	"Disease variant, Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 73.6;skin 1: 85.5"	"Cell type enhanced"	"Detected in many"		"Collecting duct cells: 86.5;Cone photoreceptor cells: 104.3;Early spermatids: 30.9;Late spermatids: 77.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HeLa: 45.6;NTERA-2: 49.1;SCLC-21H: 49.9;SK-BR-3: 52.3;T-47d: 67.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009844, HPA039293, HPA043529"	Enhanced		Supported	"Vesicles,Plasma membrane,Cytosol"		NA	NA				"Cluster 27: Brain & Skin - Unknown function"	"Cluster 6: T47d - Mammary gland"	"Cluster 9: Photoreceptor cells - Phototransduction"	"Plasma membrane, Cytosol"	Vesicles	"CAB009844: AB_2194521, HPA039293: AB_2676430, HPA043529: AB_2678531"	"unprognostic (9.34e-2)"	"unprognostic (5.71e-2)"	"unprognostic (4.89e-2)"	"unprognostic (3.41e-3)"	"unprognostic (4.91e-1)"	"unprognostic (6.05e-3)"	"unprognostic (4.45e-2)"	"unprognostic (1.38e-2)"	"unprognostic (7.25e-2)"	"unprognostic (1.67e-2)"	"prognostic unfavorable (3.14e-5)"	"unprognostic (1.64e-1)"	"unprognostic (1.05e-3)"	"unprognostic (1.34e-1)"	"unprognostic (1.84e-1)"	"unprognostic (3.99e-2)"	"unprognostic (1.00e-3)"	1.3	14.4	26.8	1.0	32.6	2.3	7.7	29.7	73.6	14.3	0.0	0.9	0.9	1.7	1.2	39.8	3.7	1.7	1.4	38.8	0.3	37.5	23.3	1.1	0.2	4.8	0.9	0.9	16.7	13.1	16.4	0.4	3.2	12.4	0.7	14.7	29.6	4.7	0.5	85.5	1.0	1.1	0.0	0.9	2.9	52.8	4.6	1.0	0.3	0.1	6.7	1.6	16.5	24.2	20.5	7.4	3.4	0.3	0.1	0.0	0.6	0.3	0.1	0.1	0.0	4.8	28.2	0.2	3.7	0.0	0.7	16.9	25.2	2.4	0.0	0.1	10.4	0.1	45.6	3.0	0.8	7.3	0.6	0.2	11.5	0.0	7.4	4.2	6.3	5.2	7.3	0.1	0.1	35.2	6.3	3.5	49.1	28.7	21.1	23.8	2.8	14.7	9.6	4.8	49.9	29.4	14.0	52.3	3.2	2.7	67.2	2.4	1.4	0.1	8.6	1.3	11.5	0.7	3.0	14.7	0.1	0.1	1.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	26.8	32.6	29.7	73.6	38.8	0.3	4.8	0.9	3.2	0.0	4.6	24.2	0.7	3.2	1.1	4.9	0.3	3.7	2.7	3.2	2.8	11.0	4.7	4.6	1.8	1.5	4.6	86.5	104.3	0.9	0.0	0.6	0.0	2.6	30.9	3.6	1.8	1.1	3.0	7.2	29.3	10.0	0.3	0.8	1.5	3.6	0.0	1.4	1.4	24.7	0.1	0.0	20.7	1.6	0.0	0.3	0.7	77.6	1.8	0.1	0.0	2.8	0.6	1.6	0.0	7.5	4.6	7.5	0.2	1.5	0.8	3.2	0.2	1.3	3.5	21.3	0.0	0.2	0.5	8.5	9.4	14.6	12.5	0.3	0.2	0.1	0.8	1.7
SPTLC1	"hLCB1, HSAN1, HSN1, LCB1, SPTI"	ENSG00000090054	"Serine palmitoyltransferase long chain base subunit 1"	O15269	9	92000087-92115413	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted membrane proteins"	"Lipid metabolism, Sphingolipid metabolism"	"Acyltransferase, Transferase"	"Disease variant, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 94.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010860, CAB018747, HPA063907"	Supported		Supported	"Endoplasmic reticulum"		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 7: Non-specific - Mitochondria"	"Endoplasmic reticulum"		"CAB018747: AB_2195864, HPA010860: AB_1080086, HPA063907: AB_2685148"	"unprognostic (1.22e-1)"	"unprognostic (1.75e-2)"	"unprognostic (1.47e-1)"	"unprognostic (3.51e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.23e-2)"	"unprognostic (3.03e-2)"	"unprognostic (4.22e-3)"	"unprognostic (1.27e-1)"	"unprognostic (4.06e-1)"	"unprognostic (3.55e-3)"	"unprognostic (8.37e-2)"	"prognostic favorable (1.36e-6)"	"unprognostic (1.13e-1)"	"unprognostic (2.41e-2)"	"unprognostic (4.28e-1)"	"unprognostic (1.49e-1)"	35.6	32.6	24.0	27.3	27.0	23.3	44.1	26.0	34.2	43.1	28.6	42.3	34.7	40.4	41.3	54.3	36.7	34.1	21.5	24.3	26.6	42.8	23.4	33.6	25.7	27.8	27.5	43.8	26.5	48.0	17.3	42.4	28.0	32.9	44.1	19.8	31.3	28.1	14.2	41.3	37.9	31.4	27.9	26.3	37.1	26.5	25.6	25.9	53.0	18.6	34.4	37.2	34.7	31.6	73.0	48.8	46.8	41.6	120.0	92.0	78.4	74.7	94.2	65.3	66.3	31.5	150.7	38.6	45.1	93.9	78.3	198.4	49.7	68.1	73.0	39.8	36.1	36.7	32.7	51.7	80.5	65.5	49.9	82.6	92.6	68.0	74.8	72.3	62.5	43.5	83.8	46.6	91.1	69.6	34.7	47.6	67.5	97.4	57.9	39.4	58.7	33.3	84.1	37.9	35.0	37.2	104.4	81.1	61.3	62.4	39.2	54.2	72.3	58.8	48.0	73.9	56.8	33.2	44.4	23.9	74.2	39.3	79.4	32.4	33.1	20.2	16.7	36.1	17.0	15.4	18.0	17.4	30.6	15.5	21.4	16.6	33.3	18.5	34.2	18.4	25.7	25.5	24.0	27.0	26.0	34.2	24.3	26.6	27.8	27.5	28.0	27.9	25.6	31.6	40.7	38.5	38.3	27.7	22.1	10.6	13.6	14.5	26.2	6.9	33.2	20.6	4.1	4.3	25.9	36.8	14.6	12.7	24.4	8.0	9.8	53.4	94.8	34.7	42.5	23.1	2.4	7.2	35.3	56.4	15.6	32.3	13.7	47.4	24.6	26.9	6.1	4.3	11.0	6.7	32.5	7.2	12.2	5.7	10.3	26.1	6.2	24.6	12.4	20.6	22.0	13.7	7.2	36.7	52.1	60.8	7.1	6.0	26.2	9.8	11.7	28.5	28.0	8.7	13.1	12.1	23.5	35.3	25.9	27.6	9.1	21.8	21.9	33.2	6.9	14.5
SQOR	"CGI-44, SQR, SQRDL"	ENSG00000137767	"Sulfide quinone oxidoreductase"	Q9Y6N5	15	45631148-45691281	"Enzymes, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 210.0"	"Cell type enhanced"	"Detected in many"		"Ductal cells: 118.1;Exocrine glandular cells: 176.2;Hofbauer cells: 134.3;monocytes: 154.5;Pancreatic endocrine cells: 156.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 304.0"									"HPA017079, HPA041589"	Enhanced		Supported	Mitochondria		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 37: Intestine - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 7: Non-specific - Mitochondria"	Mitochondria		"HPA017079: AB_1857467, HPA041589: AB_2677565"	"unprognostic (6.15e-2)"	"unprognostic (3.28e-2)"	"unprognostic (2.15e-1)"	"prognostic favorable (2.57e-4)"	"unprognostic (2.75e-2)"	"unprognostic (5.51e-2)"	"unprognostic (6.68e-3)"	"prognostic unfavorable (8.80e-4)"	"unprognostic (1.81e-1)"	"unprognostic (3.77e-1)"	"unprognostic (6.65e-3)"	"unprognostic (2.37e-1)"	"unprognostic (3.14e-3)"	"unprognostic (2.29e-1)"	"unprognostic (4.92e-2)"	"unprognostic (7.44e-2)"	"unprognostic (4.38e-1)"	46.4	22.6	14.5	59.5	14.6	55.6	41.2	14.6	19.7	36.3	17.2	210.0	57.7	18.8	19.3	112.9	26.6	31.4	22.0	13.6	14.7	36.6	82.6	61.5	38.2	16.7	15.1	8.8	39.8	24.1	12.5	17.6	15.6	41.2	178.8	4.9	56.3	27.8	132.8	41.7	55.9	43.2	15.9	47.3	54.4	5.1	15.8	23.7	32.5	43.7	57.7	48.8	50.3	17.2	38.3	68.0	0.1	3.9	125.5	151.4	0.4	40.8	132.3	23.6	35.7	2.7	59.0	33.7	38.7	29.9	72.6	33.3	2.0	304.0	13.9	121.7	1.1	3.0	14.5	48.2	38.8	20.2	5.1	45.2	88.2	54.9	119.8	59.4	66.1	32.0	0.4	40.6	24.6	31.3	12.2	44.9	0.0	147.7	41.8	1.4	6.7	47.1	184.9	55.2	1.2	1.2	10.1	25.8	13.1	0.8	56.9	61.7	76.8	9.7	2.2	131.6	9.0	53.5	61.0	2.0	96.9	104.6	10.9	112.5	212.1	84.6	76.6	161.0	104.6	54.3	97.9	83.6	135.2	48.6	51.8	55.2	302.5	53.4	152.4	40.5	149.0	169.6	14.5	14.6	14.6	19.7	13.6	14.7	16.7	15.1	15.6	15.9	15.8	17.2	24.4	32.1	64.1	0.0	5.8	0.0	0.0	0.0	0.0	0.0	31.4	14.7	0.0	0.0	14.9	14.7	0.0	0.7	19.8	0.0	11.7	118.1	0.0	15.9	7.0	13.9	0.0	0.0	0.0	176.2	0.9	11.3	0.0	37.6	11.4	1.3	0.0	0.0	134.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	54.3	0.0	0.0	154.5	0.0	0.0	0.0	0.0	156.2	0.0	0.0	3.3	0.0	0.0	45.8	24.0	0.0	0.0	0.0	6.9	0.0	0.0	0.0	0.0	0.8	13.5	1.6	0.0	0.0
SRA1	"SRA, STRAA1"	ENSG00000213523	"Steroid receptor RNA activator 1"	Q9HD15	5	140537340-140558252	"Predicted intracellular proteins"	"Apoptosis, Transcription, Transcription regulation"	"Activator, Receptor, Ribonucleoprotein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA044598, HPA050153"	Approved		Supported	"Nucleoplasm,Microtubules,Cytokinetic bridge,Cytosol"		Yes	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm	"Microtubules, Cytokinetic bridge, Cytosol"	"HPA044598: AB_2679013, HPA050153: AB_2681033"	"unprognostic (1.51e-1)"	"unprognostic (1.04e-2)"	"unprognostic (8.69e-2)"	"prognostic favorable (8.01e-6)"	"unprognostic (9.32e-2)"	"unprognostic (2.56e-1)"	"unprognostic (2.90e-1)"	"unprognostic (2.43e-1)"	"unprognostic (9.38e-2)"	"unprognostic (7.41e-2)"	"unprognostic (5.58e-3)"	"unprognostic (2.61e-1)"	"unprognostic (5.34e-2)"	"unprognostic (3.10e-2)"	"unprognostic (3.01e-2)"	"unprognostic (3.71e-1)"	"unprognostic (1.04e-1)"	12.2	34.0	8.7	7.7	9.0	9.6	9.7	15.8	12.3	10.0	9.2	12.5	5.1	8.2	6.0	9.3	9.4	5.6	12.0	9.9	9.3	12.4	25.8	15.0	6.3	8.4	8.2	14.9	7.5	4.7	22.2	5.8	8.8	12.5	4.7	7.2	14.8	6.2	14.5	9.4	11.9	5.4	8.6	17.6	14.0	22.6	8.9	5.6	12.9	2.5	5.2	9.4	8.8	9.2	9.7	22.7	11.8	12.3	5.6	7.6	16.4	16.1	9.1	10.3	10.8	41.8	5.9	8.2	11.7	6.2	5.5	6.4	2.1	12.0	4.1	12.7	13.9	7.2	25.0	16.1	12.0	13.1	9.4	14.7	6.1	5.5	2.8	9.1	4.7	13.8	7.4	12.1	6.9	29.5	10.7	20.4	3.6	5.2	18.0	11.7	10.0	7.9	5.4	11.3	8.3	9.8	9.4	8.5	11.6	4.1	10.5	14.7	7.5	9.7	5.1	8.5	13.2	15.1	10.9	8.6	12.0	16.8	6.5	16.1	26.0	20.3	10.7	23.8	9.9	15.8	10.2	10.4	25.2	14.0	8.2	9.4	43.0	13.6	23.6	15.2	19.5	26.8	8.7	9.0	15.8	12.3	9.9	9.3	8.4	8.2	8.8	8.6	8.9	9.2	43.3	6.4	49.4	13.4	46.7	52.4	68.5	126.1	38.7	23.6	57.8	48.9	71.7	57.2	86.4	33.1	8.4	103.7	56.9	87.8	113.5	102.7	104.6	59.5	33.4	39.8	38.4	35.1	15.5	148.2	117.9	48.6	64.7	43.1	68.4	21.8	42.1	69.7	93.1	15.2	17.2	71.6	107.8	61.2	71.5	150.0	25.1	82.0	67.6	7.5	90.4	59.5	42.2	9.0	11.5	186.0	78.7	29.7	113.7	82.9	83.7	131.0	84.1	23.7	26.3	26.7	76.1	77.2	30.7	62.3	45.9	179.0	47.4	66.8	49.2	142.6
SRC	"ASV, c-src, SRC1"	ENSG00000197122	"SRC proto-oncogene, non-receptor tyrosine kinase"	P12931	20	37344685-37406050	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Transporters"	"Cell adhesion, Cell cycle, Host-virus interaction, Immunity"	"Kinase, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease variant, FDA approved drug targets, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 42.0;Gastric mucus-secreting cells: 43.8;Langerhans cells: 46.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"intermediate monocyte: 2.4;non-classical monocyte: 2.3"	"Group enriched"	"Detected in many"	6	"dendritic cells: 1.4;monocytes: 2.4"	"Cell line enhanced"	"Detected in many"		"A549: 110.8;HBEC3-KT: 102.6;RT4: 106.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004023, HPA030875"	Approved		Supported	"Nucleoplasm,Plasma membrane,Cell Junctions,Cytosol"		NA	NA		3200000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 71: Testis - DNA repair"	"Cluster 15: RT4 - Unknown function"	"Cluster 27: Mucus-secreting cells - Mucin production"	"Plasma membrane, Cell Junctions"	"Nucleoplasm, Cytosol"	"CAB004023: AB_2106059, HPA030875: AB_2673640"	"unprognostic (5.58e-2)"	"unprognostic (9.83e-2)"	"unprognostic (3.56e-1)"	"unprognostic (4.54e-3)"	"unprognostic (1.52e-1)"	"unprognostic (1.54e-2)"	"prognostic unfavorable (4.90e-5)"	"unprognostic (3.89e-2)"	"unprognostic (7.04e-2)"	"unprognostic (8.13e-2)"	"unprognostic (1.54e-2)"	"prognostic unfavorable (1.63e-4)"	"prognostic unfavorable (1.22e-4)"	"unprognostic (2.33e-2)"	"unprognostic (4.72e-2)"	"unprognostic (3.65e-2)"	"prognostic favorable (5.22e-5)"	9.7	25.3	5.7	13.3	5.2	8.4	10.1	0.4	6.2	25.1	1.5	30.3	39.8	31.9	3.2	26.1	23.8	27.9	8.8	6.4	5.5	21.4	4.3	16.1	6.3	2.6	3.4	23.6	30.8	11.1	15.9	8.1	2.2	30.8	17.1	5.5	11.8	27.4	2.4	13.0	38.8	17.2	1.7	14.2	39.9	25.2	5.0	6.1	9.8	1.5	8.1	35.6	24.6	3.0	24.6	110.8	24.9	22.6	9.3	14.7	51.6	22.0	18.9	26.3	16.6	41.9	21.5	0.7	13.4	40.2	29.9	43.5	15.1	102.6	10.3	0.1	13.7	6.2	3.9	65.9	22.0	0.3	9.3	15.7	34.2	17.3	22.8	29.4	24.3	14.2	0.6	0.2	4.4	16.7	6.0	0.8	11.7	67.3	98.8	26.5	6.6	0.7	11.0	106.3	23.1	83.6	25.0	34.5	27.2	19.1	31.1	9.0	35.8	31.4	20.9	11.7	20.1	0.3	0.8	0.3	22.1	0.1	24.0	0.0	1.6	0.0	0.0	2.4	0.0	0.1	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.3	2.3	1.4	0.0	1.0	5.7	5.2	0.4	6.2	6.4	5.5	2.6	3.4	2.2	1.7	5.0	3.0	1.0	3.2	1.7	3.3	4.1	8.2	12.5	9.5	10.8	6.5	6.2	7.5	2.2	18.6	4.7	12.9	2.1	2.3	4.9	42.0	1.9	12.2	1.8	6.4	10.7	1.4	16.8	0.4	9.5	18.7	8.3	7.2	43.8	12.4	0.0	14.8	1.1	1.6	5.7	3.3	9.1	29.2	8.2	9.4	46.3	3.3	10.8	22.8	1.8	9.4	9.7	4.4	1.0	9.0	0.6	39.1	19.2	17.3	4.3	18.0	36.7	9.3	5.6	5.2	13.1	1.8	6.7	0.3	1.1	11.2	9.1	2.3	1.0	2.9	16.9	36.6
SRCAP	"DOMO1, EAF1, KIAA0309, SWR1"	ENSG00000080603	"Snf2 related CREBBP activator protein"	Q6ZRS2	16	30698209-30741409	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Host-virus interaction, Transcription, Transcription regulation"	"Activator, Chromatin regulator, DNA-binding, Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 186.4;Club cells: 145.6;Ionocytes: 179.0;Respiratory ciliated cells: 118.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"											HPA028929	Approved		Supported	"Nucleoplasm,Nuclear bodies,Golgi apparatus"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Nucleoplasm	"Nuclear bodies, Golgi apparatus"	"HPA028929: AB_10601265"	"unprognostic (1.26e-1)"	"unprognostic (1.35e-1)"	"unprognostic (5.07e-1)"	"unprognostic (6.57e-2)"	"unprognostic (1.78e-1)"	"unprognostic (6.95e-2)"	"unprognostic (8.59e-2)"	"unprognostic (2.34e-2)"	"unprognostic (3.77e-1)"	"unprognostic (6.45e-2)"	"unprognostic (4.36e-2)"	"unprognostic (8.57e-2)"	"unprognostic (1.16e-2)"	"unprognostic (2.09e-1)"	"unprognostic (4.11e-2)"	"unprognostic (7.71e-2)"	"unprognostic (1.07e-1)"	15.4	11.9	3.6	18.9	4.8	30.1	10.1	7.1	4.2	12.8	1.7	13.2	15.7	15.5	6.4	13.5	14.2	10.9	12.1	2.9	3.4	9.6	7.1	11.6	15.3	5.9	4.3	16.9	19.4	20.2	9.5	12.6	3.5	12.6	11.2	12.5	18.0	13.1	24.5	16.2	16.1	15.0	0.8	18.7	16.0	20.6	7.7	20.2	14.0	19.4	13.6	11.3	9.9	6.8	29.5	60.1	36.9	35.9	28.3	19.5	37.7	24.0	21.1	26.2	20.7	27.8	21.9	65.9	29.7	30.5	16.9	27.8	37.7	27.5	21.9	42.2	88.1	42.5	56.2	24.3	11.4	49.8	48.0	20.8	13.2	40.3	29.0	12.8	27.8	21.7	65.4	36.5	19.7	34.5	42.2	17.4	37.6	10.8	27.7	57.7	28.7	36.4	7.5	34.2	34.5	36.5	26.6	31.0	8.4	12.2	35.4	26.0	44.1	37.0	26.5	21.0	31.6	39.8	36.7	45.9	29.7	23.2	28.9	0.3	0.7	2.9	0.8	1.2	0.6	0.7	0.4	0.9	0.5	1.0	0.5	0.4	2.2	0.6	0.3	0.9	0.9	0.7	3.6	4.8	7.1	4.2	2.9	3.4	5.9	4.3	3.5	0.8	7.7	6.8	3.0	3.2	3.7	8.8	9.8	24.6	1.9	186.4	13.1	7.5	3.3	1.8	2.4	4.3	145.6	1.8	8.4	2.3	5.3	54.3	0.0	1.4	1.2	4.6	3.0	3.4	11.3	7.6	8.6	3.1	1.4	4.2	19.9	4.7	2.5	3.0	2.2	3.0	2.3	8.4	8.6	17.7	179.0	1.9	14.3	0.9	2.8	3.4	10.6	8.4	3.0	1.7	6.2	4.5	10.6	1.9	39.1	1.2	11.1	3.1	3.1	0.6	118.3	5.8	0.0	5.0	14.3	5.6	6.0	7.8	58.2	2.5	8.9	2.0	25.6	3.1
SREBF1	"bHLHd1, SREBP-1c, SREBP1, SREBP1a"	ENSG00000072310	"Sterol regulatory element binding transcription factor 1"	P36956	17	17810399-17837011	"Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transcription factors"	"Cholesterol metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism, Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 219.2"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"neutrophil: 1.3"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in all"		"RPMI-8226: 202.5;SK-BR-3: 178.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005406, HPA043343, HPA043878"	Uncertain		Supported	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 30: Mammary glandular cells - Lactation"	"Nucleoplasm, Golgi apparatus, Cytosol"		"CAB005406: AB_2194226, HPA043343: AB_2678439, HPA043878: AB_2678710"	"unprognostic (9.29e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.28e-2)"	"prognostic favorable (2.66e-4)"	"unprognostic (4.50e-2)"	"unprognostic (1.05e-2)"	"unprognostic (9.85e-2)"	"unprognostic (1.15e-1)"	"unprognostic (3.14e-2)"	"unprognostic (9.02e-3)"	"prognostic favorable (9.05e-4)"	"unprognostic (3.12e-1)"	"unprognostic (9.02e-3)"	"unprognostic (1.11e-2)"	"unprognostic (1.20e-1)"	"unprognostic (7.65e-2)"	"unprognostic (2.36e-3)"	42.2	219.2	26.8	7.9	41.5	20.1	46.5	20.4	37.2	51.5	9.4	37.7	28.7	23.4	8.9	68.7	42.7	14.0	27.4	20.0	25.9	24.7	128.5	26.4	9.1	30.1	29.7	41.4	17.0	8.4	37.0	7.8	24.2	37.2	6.7	3.9	89.5	16.7	34.5	47.8	34.0	5.6	23.4	17.2	25.2	35.4	35.8	14.4	27.0	2.9	6.3	32.5	48.8	41.7	54.1	122.5	12.0	85.2	24.9	55.8	23.5	18.5	60.0	16.4	39.2	23.3	104.2	33.5	17.2	14.8	14.5	144.0	16.7	47.2	4.0	21.1	7.2	16.8	86.4	19.1	36.1	2.5	29.6	42.0	19.6	21.8	12.5	12.2	17.6	64.9	36.8	105.8	2.5	118.7	46.9	26.1	17.8	38.3	23.1	32.6	10.8	202.5	9.0	23.1	16.3	70.5	24.4	178.7	48.0	8.9	62.0	32.6	21.5	8.2	40.5	19.5	12.5	32.2	3.1	15.5	48.9	24.6	45.2	0.0	0.3	0.1	0.4	0.1	0.1	0.1	0.2	0.0	0.0	0.1	0.4	0.6	1.3	0.1	0.1	0.1	0.0	0.2	26.8	41.5	20.4	37.2	20.0	25.9	30.1	29.7	24.2	23.4	35.8	41.7	6.1	6.4	26.0	66.9	11.9	9.3	12.0	29.2	14.8	24.5	58.0	30.6	9.4	18.6	29.7	20.2	29.2	4.5	11.4	44.5	1.9	16.5	2.7	30.9	37.2	10.5	29.9	24.8	12.8	23.5	15.7	24.7	31.1	31.9	14.7	13.2	12.8	72.2	12.1	58.9	11.3	30.8	24.4	14.0	13.3	4.9	29.8	15.1	8.8	15.0	11.0	51.7	1.0	10.6	56.7	16.7	20.8	10.9	8.4	19.0	33.2	6.6	32.1	31.6	13.1	15.6	12.9	11.4	4.9	40.2	18.3	19.8	13.4	27.5	41.1	25.2
SREBF2	"bHLHd2, SREBP2"	ENSG00000198911	"Sterol regulatory element binding transcription factor 2"	Q12772	22	41833079-41907307	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transcription factors"	"Cholesterol metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism, Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031962, HPA031963"	Approved		Supported	"Nucleoplasm,Endoplasmic reticulum,Vesicles"		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 44: Endometrium - Transcription"	"Nucleoplasm, Vesicles"	"Endoplasmic reticulum"	"HPA031962: AB_10601266, HPA031963: AB_2674090"	"unprognostic (6.53e-2)"	"unprognostic (6.07e-2)"	"unprognostic (1.75e-2)"	"unprognostic (1.50e-3)"	"unprognostic (3.41e-3)"	"unprognostic (9.08e-2)"	"unprognostic (5.04e-2)"	"unprognostic (1.31e-1)"	"unprognostic (4.78e-1)"	"unprognostic (1.04e-2)"	"unprognostic (2.30e-1)"	"unprognostic (9.85e-2)"	"prognostic favorable (1.37e-4)"	"unprognostic (4.68e-2)"	"unprognostic (1.92e-2)"	"unprognostic (3.22e-1)"	"unprognostic (7.93e-3)"	22.8	80.7	50.1	31.1	58.7	32.3	24.5	22.3	60.5	26.5	2.5	47.1	40.8	34.4	60.5	82.0	27.4	25.3	53.8	51.8	32.3	33.3	36.2	43.2	35.2	38.5	37.8	35.8	45.8	51.4	30.5	24.5	38.3	33.5	31.6	21.0	49.1	22.9	34.1	58.4	35.9	30.1	16.1	26.1	53.8	20.4	37.8	25.0	23.3	33.5	36.2	29.7	39.0	45.1	65.5	45.8	119.4	111.6	68.4	90.9	66.7	21.4	71.1	24.8	50.5	54.3	84.2	115.8	29.7	52.6	91.1	109.6	68.7	141.8	17.5	32.9	75.0	58.0	79.7	54.6	113.8	85.7	37.9	85.8	78.7	65.1	80.6	56.7	49.2	64.2	60.6	135.9	26.4	83.1	62.5	64.5	75.7	81.2	34.9	71.3	68.1	189.0	103.3	67.6	48.2	36.3	49.1	89.3	91.7	69.5	56.3	150.2	53.0	33.2	61.0	15.9	25.8	98.3	54.3	91.7	32.4	64.0	51.9	0.0	4.7	1.6	4.6	3.6	3.1	7.0	2.5	3.3	5.0	4.8	2.2	2.6	0.7	1.4	3.1	6.3	1.5	4.8	50.1	58.7	22.3	60.5	51.8	32.3	38.5	37.8	38.3	16.1	37.8	45.1	14.5	44.8	43.3	100.6	35.4	16.3	13.5	52.2	30.7	41.0	36.3	23.1	30.3	37.1	38.0	58.8	10.4	25.4	23.5	67.0	3.9	20.3	15.9	25.2	10.5	16.8	49.1	14.1	72.6	44.3	22.6	16.3	42.8	59.2	12.7	43.2	8.2	34.3	14.8	57.2	75.1	39.4	52.9	10.3	14.8	7.0	31.4	16.3	7.2	67.5	18.1	18.6	20.6	90.5	129.5	38.4	30.5	27.4	29.2	27.9	26.3	4.8	30.0	18.7	19.7	13.7	20.5	8.4	13.8	55.7	28.1	36.5	19.0	43.0	40.3	30.2
SRF	MCM1	ENSG00000112658	"Serum response factor"	P11831	6	43171269-43181506	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 89.6;Enteroendocrine cells: 102.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001819, CAB005416"	Supported		Supported	Nucleoplasm		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 17: Intestinal endocrine cells - Hormone signaling"	Nucleoplasm		"CAB005416: AB_2255249, HPA001819: AB_1079928"	"unprognostic (1.44e-3)"	"unprognostic (1.09e-1)"	"unprognostic (5.39e-3)"	"unprognostic (2.66e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.47e-2)"	"unprognostic (4.60e-2)"	"unprognostic (9.84e-2)"	"unprognostic (4.28e-2)"	"unprognostic (2.21e-2)"	"unprognostic (6.72e-2)"	"unprognostic (1.78e-1)"	"prognostic unfavorable (2.01e-5)"	"unprognostic (5.31e-2)"	"unprognostic (1.59e-1)"	"unprognostic (5.10e-2)"	"unprognostic (1.97e-2)"	29.7	16.7	16.0	27.0	15.3	27.3	24.7	12.4	18.7	31.2	12.4	82.6	13.4	69.3	12.4	33.3	49.2	26.5	61.2	17.6	11.6	17.0	20.2	28.6	21.4	14.1	12.7	27.6	21.8	18.5	18.8	17.4	11.8	38.7	14.9	8.8	16.8	45.5	55.4	21.2	29.3	48.2	12.1	22.3	37.0	12.6	13.4	21.4	23.9	32.7	16.5	54.5	25.7	16.7	38.4	15.0	34.2	22.6	19.8	16.2	50.2	34.2	28.0	29.0	17.9	40.4	11.1	48.1	30.5	36.7	36.7	30.4	35.0	30.2	25.5	53.5	34.4	43.6	30.7	40.2	37.7	41.2	50.9	27.8	32.3	44.8	32.7	27.4	24.5	41.0	31.6	36.8	22.2	41.1	51.2	35.9	23.8	85.7	18.3	38.7	34.9	17.3	21.3	24.5	20.0	18.1	28.0	21.1	34.2	26.2	21.7	75.6	29.9	34.2	26.4	33.4	59.5	25.4	22.6	80.6	21.4	29.2	23.5	0.4	0.4	0.8	0.8	0.8	0.6	0.5	0.4	0.6	0.5	0.5	0.3	0.6	1.2	0.3	0.6	1.0	0.6	0.3	16.0	15.3	12.4	18.7	17.6	11.6	14.1	12.7	11.8	12.1	13.4	16.7	17.1	38.5	22.5	3.9	8.8	78.0	64.3	22.6	38.1	5.7	64.0	52.1	89.6	18.6	21.7	11.0	20.9	9.7	9.4	29.8	0.0	13.6	4.7	23.8	24.6	17.5	102.2	20.2	4.9	20.0	22.6	17.0	18.3	29.5	7.6	20.6	17.2	50.6	12.7	10.1	3.5	39.1	8.2	11.3	18.8	1.1	12.5	11.6	24.9	0.0	8.0	12.5	5.2	1.5	2.8	21.5	19.6	29.0	6.5	17.8	11.1	3.8	20.3	7.5	13.1	23.6	21.8	5.2	3.3	28.7	66.9	12.2	10.5	8.9	25.6	30.2
SRGN	"PPG, PRG, PRG1"	ENSG00000122862	Serglycin	P10124	10	69088103-69104805	"Plasma proteins, Predicted secreted proteins"	"Apoptosis, Biomineralization"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	10	"bone marrow: 8096.7"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 2922.2;granulocytes: 2343.1;Kupffer cells: 1789.9;Langerhans cells: 6618.2;Macrophages: 3639.1;monocytes: 3188.2;Plasma cells: 1740.9;T-cells: 2235.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 5714.1"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 5714.1"	"Cell line enhanced"	"Detected in many"		"HL-60: 4442.1;NB-4: 2549.7;THP-1: 4346.8;TIME: 2609.1;U-937: 3546.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000759	Enhanced		Supported	"Golgi apparatus"	"Secreted to blood"	NA	NA		100000000	"Cluster 5: Granulocytes - Unknown function"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 32: U-937 - Innate immune response"	"Cluster 41: Macrophages - Immune response"	"Golgi apparatus"		"HPA000759: AB_1079675"	"unprognostic (3.61e-2)"	"unprognostic (1.62e-2)"	"unprognostic (2.78e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.37e-1)"	"unprognostic (4.50e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.70e-2)"	"unprognostic (1.63e-1)"	"unprognostic (8.22e-2)"	"unprognostic (5.80e-2)"	"unprognostic (9.82e-2)"	"prognostic unfavorable (3.18e-5)"	"unprognostic (1.65e-1)"	"unprognostic (2.32e-2)"	"unprognostic (4.07e-2)"	"unprognostic (4.08e-2)"	404.6	114.9	48.8	799.8	50.5	8096.7	136.4	55.5	99.6	93.2	70.1	101.8	77.9	63.5	25.9	91.0	96.8	316.4	111.9	48.2	67.8	98.3	239.4	347.3	437.2	82.4	59.3	30.7	68.4	131.6	62.1	355.6	67.8	58.9	118.9	15.5	40.1	57.4	37.5	18.9	111.4	219.4	65.5	362.8	95.0	18.3	64.7	228.9	72.7	117.1	314.6	508.3	46.1	71.0	5.3	43.0	0.2	0.4	768.1	749.7	1.2	94.9	63.9	235.1	283.5	0.1	18.2	9.1	117.4	4.1	134.4	1.1	0.0	20.6	799.9	535.7	0.4	87.1	29.8	0.3	312.7	4442.1	914.9	306.8	1.1	641.5	39.2	223.8	1227.8	13.3	82.5	419.9	1239.9	0.2	18.7	2549.7	0.7	0.1	84.6	2.4	2.3	446.7	0.6	6.0	0.3	0.8	2.3	0.6	16.0	0.0	2.2	4346.8	2609.1	187.9	12.9	3.8	20.1	486.4	508.4	57.3	112.2	3546.9	1.2	2349.8	1105.3	2730.6	474.9	774.6	313.4	73.5	228.5	362.8	583.0	39.0	125.5	268.4	5714.1	962.8	693.6	631.9	392.6	1590.5	48.8	50.5	55.5	99.6	48.2	67.8	82.4	59.3	67.8	65.5	64.7	71.0	1081.4	112.2	198.1	0.7	592.0	175.9	12.5	38.3	8.6	1.1	16.0	28.2	21.2	21.5	57.5	33.1	0.0	10.2	2922.2	2.9	0.0	4.2	4.1	4.6	15.0	566.8	1.8	277.8	0.2	9.8	10.2	87.9	70.3	6.6	2343.1	0.4	636.1	22.1	847.1	0.0	0.5	1.7	0.0	1789.9	6618.2	8.4	7.5	3639.1	556.7	80.6	3188.2	1.4	1292.5	0.0	0.2	1.3	1.2	18.0	1740.9	12.2	0.3	4.7	45.6	5.0	72.3	22.8	97.5	0.9	2.2	8.7	141.8	14.2	2235.9	1.2	5.5	18.1
SRI		ENSG00000075142	Sorcin	P30626	7	88205115-88226993	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 566.0"	"Cell type enhanced"	"Detected in all"		"Distal enterocytes: 1172.0;Extravillous trophoblasts: 1475.3;Paneth cells: 1606.5;Proximal enterocytes: 1342.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019004, HPA073666"	Enhanced		Approved	Nucleoplasm,Cytosol		No	No		1100000	"Cluster 2: Granulocytes - Unknown function"	"Cluster 37: Intestine - Unknown function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Nucleoplasm, Cytosol"		"HPA019004: AB_2670006, HPA073666: AB_2686623"	"unprognostic (1.86e-2)"	"unprognostic (2.31e-3)"	"unprognostic (1.89e-2)"	"unprognostic (1.73e-2)"	"unprognostic (1.31e-1)"	"unprognostic (4.42e-3)"	"unprognostic (1.24e-3)"	"prognostic favorable (3.08e-4)"	"unprognostic (9.87e-2)"	"unprognostic (2.15e-1)"	"prognostic unfavorable (9.03e-4)"	"unprognostic (1.36e-1)"	"unprognostic (2.10e-2)"	"unprognostic (1.29e-2)"	"unprognostic (9.87e-2)"	"unprognostic (8.44e-2)"	"unprognostic (3.14e-3)"	98.7	89.5	139.1	95.9	147.8	85.2	95.9	148.0	177.1	87.0	115.0	566.0	178.0	70.4	122.4	68.3	147.8	52.3	81.3	135.9	159.7	104.6	42.3	84.2	69.3	146.6	150.6	83.2	75.8	56.7	75.3	64.5	158.3	69.9	447.2	50.3	74.4	64.6	37.6	49.2	252.2	94.2	155.5	60.3	66.3	38.9	147.3	54.6	70.5	53.0	78.2	136.8	81.3	165.7	181.7	59.5	188.5	193.8	295.0	247.0	89.3	106.5	177.5	121.5	143.3	56.2	414.0	198.9	108.3	168.0	296.6	182.8	237.6	244.5	160.2	155.9	92.2	103.4	177.6	0.1	173.8	139.0	108.5	250.5	221.2	127.0	185.1	218.2	365.4	123.7	87.8	175.8	170.4	106.3	211.7	94.5	159.4	261.2	119.3	86.1	256.8	110.9	229.2	179.0	131.5	151.5	323.0	188.0	154.7	179.7	88.0	61.4	218.1	223.4	185.6	201.5	192.9	159.6	79.2	222.4	220.7	130.5	387.8	620.5	151.3	580.6	169.8	217.3	202.4	173.0	185.9	194.9	201.0	151.9	137.7	158.5	93.3	224.3	262.2	161.1	210.4	216.7	139.1	147.8	148.0	177.1	135.9	159.7	146.6	150.6	158.3	155.5	147.3	165.7	258.8	86.6	123.7	63.6	84.4	95.1	389.6	494.2	75.1	34.9	117.2	129.5	107.1	35.8	402.0	156.3	12.5	166.0	104.7	1172.0	442.2	223.0	89.7	307.3	148.6	135.6	94.3	198.6	29.4	418.5	1475.3	175.7	80.0	172.7	135.6	131.3	106.7	40.5	147.6	47.1	22.9	471.7	276.7	79.5	117.9	34.0	172.1	103.2	104.9	15.9	172.5	195.6	113.3	40.2	34.9	380.9	1606.5	141.4	75.2	422.9	1342.4	182.2	660.4	25.9	111.7	111.9	183.9	80.8	106.3	86.9	108.3	197.4	117.9	126.8	536.9	488.1
SRP19		ENSG00000153037	"Signal recognition particle 19"	P09132	5	112861188-112898371	"Predicted intracellular proteins, Transporters"		"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029272, HPA057315"	Approved		Supported	"Nuclear bodies,Cytosol"		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	Cytosol	"Nuclear bodies"	"HPA029272: AB_10600910, HPA057315: "	"unprognostic (4.77e-2)"	"unprognostic (1.36e-1)"	"unprognostic (3.95e-1)"	"unprognostic (1.37e-1)"	"unprognostic (5.60e-3)"	"unprognostic (1.17e-1)"	"unprognostic (1.98e-3)"	"unprognostic (5.55e-2)"	"unprognostic (2.62e-2)"	"unprognostic (3.62e-1)"	"unprognostic (2.15e-1)"	"unprognostic (2.42e-1)"	"prognostic unfavorable (3.72e-10)"	"unprognostic (1.82e-1)"	"unprognostic (4.88e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.69e-3)"	30.2	32.5	18.9	29.0	19.8	79.2	29.0	19.2	25.8	21.6	17.7	25.1	24.6	25.2	38.2	29.3	22.0	23.1	25.4	20.0	21.4	27.7	48.1	24.4	38.4	18.4	19.1	17.9	41.7	25.4	40.5	28.6	19.0	32.6	27.2	14.5	29.6	18.0	33.9	23.8	23.4	30.2	17.5	30.0	25.8	20.2	20.4	36.0	39.9	23.9	39.9	28.7	22.3	20.6	60.1	40.7	49.3	78.6	45.2	52.4	118.7	82.0	51.8	69.2	82.3	68.0	45.8	62.3	55.0	53.2	110.0	39.0	54.6	84.5	82.2	66.0	88.8	55.1	80.5	80.6	72.4	44.7	58.5	61.2	80.5	64.9	95.6	45.5	64.7	67.1	41.9	72.3	59.5	70.1	72.6	79.0	51.1	60.5	61.6	45.6	44.3	94.4	68.6	75.5	56.1	49.6	66.4	42.4	40.3	56.5	64.7	63.2	52.1	57.1	48.6	57.3	98.3	85.2	111.4	107.9	55.4	75.4	60.3	66.7	34.1	43.6	49.3	37.3	60.9	54.9	55.0	52.7	39.9	45.8	46.3	52.4	48.1	50.9	41.3	86.8	72.2	36.3	18.9	19.8	19.2	25.8	20.0	21.4	18.4	19.1	19.0	17.5	20.4	20.6	64.7	80.1	49.9	17.9	60.6	86.4	74.8	102.2	9.1	15.6	75.1	85.9	52.0	41.5	87.8	44.1	20.9	80.0	120.2	29.6	103.7	96.4	38.9	76.0	85.0	53.4	119.0	52.2	26.7	103.2	125.0	55.9	16.3	80.4	73.5	54.6	35.7	65.3	84.5	13.5	24.6	67.6	79.3	53.3	53.8	24.0	38.8	56.6	51.6	21.5	87.8	30.7	90.6	21.6	41.1	130.4	38.9	39.5	65.7	107.5	33.5	117.1	74.1	24.6	26.3	40.8	58.3	157.4	44.7	22.6	87.8	148.2	71.3	54.2	41.2	112.7
SRP68		ENSG00000167881	"Signal recognition particle 68"	Q9UHB9	17	76038775-76072517	"Plasma proteins, Predicted intracellular proteins, Transporters"		"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 314.6"	"Cell type enhanced"	"Detected in many"		"Syncytiotrophoblasts: 162.3"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	4	"medulla oblongata: 314.6"	"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023303, HPA055617"	Approved		Supported	Cytosol		NA	NA		23000	"Cluster 26: Non-specific - Mitochondria"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	Cytosol		"HPA023303: AB_1857477, HPA055617: AB_2682863"	"unprognostic (1.25e-1)"	"unprognostic (8.97e-2)"	"unprognostic (3.47e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.62e-1)"	"prognostic unfavorable (2.18e-4)"	"prognostic unfavorable (4.28e-5)"	"unprognostic (3.31e-2)"	"unprognostic (8.31e-2)"	"unprognostic (1.62e-2)"	"unprognostic (1.11e-1)"	"unprognostic (4.10e-2)"	"unprognostic (4.42e-2)"	"unprognostic (8.73e-2)"	"unprognostic (4.75e-2)"	"prognostic favorable (2.65e-4)"	"unprognostic (4.02e-3)"	37.5	34.6	23.7	24.8	25.2	21.9	36.3	25.5	76.6	39.4	24.6	47.2	21.3	39.7	35.1	49.8	37.4	17.3	42.8	34.8	27.7	31.6	37.0	34.0	29.0	314.6	25.1	39.8	65.7	37.7	37.7	33.1	49.6	30.6	27.4	28.0	38.5	26.1	103.1	43.7	32.2	34.5	30.5	31.5	41.5	22.2	25.9	30.8	32.8	47.0	36.7	41.9	37.9	26.4	98.0	89.8	51.0	54.9	71.5	57.2	94.3	72.4	50.7	80.7	62.9	75.5	45.5	81.6	36.8	70.5	69.2	66.2	98.2	74.2	119.2	34.3	118.1	72.6	63.4	102.8	86.3	83.9	54.7	48.5	81.3	70.7	61.1	60.0	95.1	47.4	109.0	70.9	67.2	60.1	84.6	43.5	50.3	81.2	91.0	70.1	137.1	79.9	59.2	80.6	63.2	64.9	61.9	103.8	81.8	85.2	91.5	76.4	62.3	89.2	70.7	42.7	99.4	70.5	34.7	87.1	64.0	62.2	66.4	7.6	28.6	37.3	24.5	26.3	26.4	30.5	34.8	37.9	34.3	25.3	39.2	29.4	4.3	45.4	27.1	27.1	34.6	19.4	23.7	25.2	25.5	76.6	34.8	27.7	314.6	25.1	49.6	30.5	25.9	26.4	20.9	28.9	22.9	12.1	27.9	31.4	49.3	30.2	22.2	24.2	18.2	19.2	27.2	28.6	25.9	12.9	37.5	86.9	21.2	18.3	37.2	43.6	15.0	24.3	26.1	28.1	14.4	41.3	11.1	41.4	63.2	26.8	16.8	28.5	17.1	25.6	21.8	23.2	37.9	37.0	10.8	22.8	20.3	18.5	17.4	20.0	24.2	17.8	24.9	11.2	31.8	36.8	29.9	7.1	11.5	39.0	15.8	28.2	37.9	46.5	20.7	30.4	23.7	26.7	0.0	28.5	31.7	47.2	24.4	26.6	31.7	162.3	25.2	30.2	24.1	48.9
SRPK1	SFRSK1	ENSG00000096063	"SRSF protein kinase 1"	Q96SB4	6	35832966-35921342	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Chromosome partition, Differentiation, Host-virus interaction, mRNA processing, mRNA splicing"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 379.9;Late spermatids: 599.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 61.0"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 61.0"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016431, HPA056486"	Approved		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 31: Spermatids - Spermatogenesis"	"Nucleoplasm, Cytosol"	"Plasma membrane"	"HPA016431: AB_1857478, HPA056486: AB_2683148"	"unprognostic (4.65e-3)"	"unprognostic (6.82e-3)"	"unprognostic (2.54e-3)"	"unprognostic (1.01e-3)"	"unprognostic (7.74e-2)"	"unprognostic (3.31e-2)"	"prognostic unfavorable (7.90e-6)"	"unprognostic (1.23e-2)"	"unprognostic (2.54e-3)"	"unprognostic (2.36e-2)"	"prognostic unfavorable (6.53e-5)"	"unprognostic (7.28e-2)"	"unprognostic (2.21e-3)"	"unprognostic (9.24e-2)"	"unprognostic (4.43e-1)"	"unprognostic (1.01e-1)"	"unprognostic (7.55e-3)"	8.7	6.0	6.4	18.1	8.2	41.7	14.5	10.0	14.8	12.5	6.8	31.2	25.2	12.7	9.3	23.9	8.6	11.9	8.3	8.9	3.7	16.7	16.0	12.9	19.7	4.0	4.1	8.7	23.3	14.5	9.0	14.5	4.3	9.6	35.6	25.8	16.1	10.9	20.0	26.7	23.6	14.2	2.4	17.8	18.0	44.7	5.2	19.9	8.7	12.6	24.3	31.0	16.2	11.6	104.1	39.2	54.9	82.4	30.2	39.3	69.0	62.1	60.1	57.3	60.2	109.0	34.1	139.0	51.8	39.1	65.5	51.3	110.3	74.2	100.6	96.2	79.9	73.5	42.6	93.8	26.7	111.3	34.0	25.6	39.3	66.0	84.7	44.6	72.3	76.4	157.7	55.6	48.2	36.8	111.1	80.8	45.9	62.9	42.7	77.8	67.3	84.1	56.8	169.5	117.5	42.9	65.4	59.3	42.5	55.2	33.3	70.3	54.8	52.4	41.3	37.2	78.6	33.1	78.6	128.5	20.9	124.3	48.1	61.0	4.4	30.6	8.5	5.3	12.1	8.6	11.2	11.5	5.9	6.9	9.2	10.0	50.9	11.2	7.6	3.3	14.9	6.3	6.4	8.2	10.0	14.8	8.9	3.7	4.0	4.1	4.3	2.4	5.2	11.6	26.6	9.6	25.8	18.6	40.0	42.3	119.3	91.0	67.7	36.8	25.8	22.7	28.7	14.3	51.4	22.0	37.5	54.3	33.1	51.6	29.4	55.4	379.9	29.9	40.2	29.2	46.2	46.7	74.2	68.2	53.2	25.1	46.9	54.0	7.6	44.1	13.2	41.8	21.6	10.1	50.0	50.8	32.6	16.3	19.9	599.1	22.1	20.0	16.0	24.4	31.5	16.8	32.0	30.2	29.7	100.4	47.9	24.8	68.0	117.9	50.8	59.4	33.8	92.9	6.6	17.8	48.9	197.3	100.4	126.8	41.8	39.7	43.6	33.7	90.7	162.6
SRPK2	SFRSK2	ENSG00000135250	"SRSF protein kinase 2"	P78362	7	105110704-105399308	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Differentiation, mRNA processing, mRNA splicing"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 108.2"	"Group enriched"	"Detected in all"	4	"Early spermatids: 1275.7;Late spermatids: 2280.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 219.5"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 219.5"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015522, HPA020876"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 25: Spermatids - Spermatogenesis"	"Nucleoplasm, Cytosol"		"HPA015522: AB_1857479, HPA020876: AB_1857480"	"unprognostic (9.75e-2)"	"unprognostic (1.68e-2)"	"unprognostic (1.12e-1)"	"unprognostic (4.64e-2)"	"unprognostic (3.54e-1)"	"unprognostic (1.30e-1)"	"unprognostic (5.14e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.28e-2)"	"unprognostic (1.92e-1)"	"unprognostic (2.19e-1)"	"unprognostic (2.31e-1)"	"unprognostic (5.38e-2)"	"unprognostic (7.95e-2)"	"unprognostic (4.72e-2)"	"unprognostic (2.87e-2)"	"unprognostic (3.44e-1)"	14.3	16.2	27.2	15.0	29.7	10.7	18.3	20.1	46.8	16.3	0.0	13.3	11.4	18.1	15.8	16.4	14.6	16.0	14.7	31.0	30.0	13.8	14.2	12.8	17.9	27.9	25.5	17.3	14.7	15.1	12.9	17.1	30.4	18.8	14.8	24.2	15.1	14.4	11.3	24.4	11.4	18.3	19.3	17.8	16.3	108.2	26.7	41.4	15.5	11.8	20.6	18.2	11.6	47.1	36.9	24.0	37.3	74.5	39.3	43.8	21.0	35.4	40.8	34.5	39.9	18.9	30.5	23.4	43.7	45.8	38.5	21.6	38.3	37.3	43.7	40.5	33.2	33.1	21.8	16.5	45.1	31.8	47.1	30.6	67.5	29.2	54.6	33.0	59.8	54.4	33.0	92.2	38.5	69.3	118.3	23.9	31.1	20.8	25.9	37.9	41.3	51.1	49.5	56.1	54.8	37.8	40.1	59.0	37.7	49.1	22.1	21.8	39.7	62.9	45.9	60.8	33.4	100.6	106.6	56.5	24.8	32.3	48.1	50.3	30.2	103.3	41.4	21.0	24.8	45.0	31.1	31.6	27.3	44.0	29.3	33.6	219.5	38.7	25.1	23.6	38.6	25.2	27.2	29.7	20.1	46.8	31.0	30.0	27.9	25.5	30.4	19.3	26.7	47.1	35.8	28.9	29.5	128.9	62.9	212.9	60.6	68.1	49.5	76.9	45.2	40.0	23.3	28.6	41.5	23.9	50.1	52.4	87.1	16.6	27.4	52.9	1275.7	54.3	41.9	51.8	28.8	17.2	298.1	46.3	35.6	47.3	40.8	51.6	41.2	48.9	53.6	35.9	47.6	124.5	300.9	35.2	54.9	43.0	42.9	2280.6	76.7	39.2	58.7	168.6	57.0	73.7	103.0	172.4	399.8	36.4	24.4	95.9	54.8	100.7	15.7	25.9	54.2	67.6	46.0	40.3	59.1	198.8	66.0	36.7	103.3	64.4	58.2	61.4	26.1	67.9
SRSF1	"ASF, MGC5228, SF2, SF2p33, SFRS1, SRp30a"	ENSG00000136450	"Serine and arginine rich splicing factor 1"	Q07955	17	58000919-58007346	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing, mRNA transport, Transport"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013073, HPA061301"	Supported		Supported	Nucleoplasm		NA	NA		980000	"Cluster 27: Non-specific - Gene expression"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm		"CAB013073: AB_2533079, HPA061301: AB_2684474"	"unprognostic (9.86e-2)"	"prognostic favorable (7.00e-4)"	"prognostic favorable (4.56e-5)"	"unprognostic (8.11e-2)"	"unprognostic (2.00e-1)"	"unprognostic (3.88e-3)"	"prognostic unfavorable (1.64e-6)"	"unprognostic (8.28e-2)"	"unprognostic (2.60e-3)"	"unprognostic (3.07e-2)"	"unprognostic (1.98e-1)"	"unprognostic (5.48e-2)"	"prognostic unfavorable (2.95e-5)"	"unprognostic (1.02e-2)"	"unprognostic (1.44e-1)"	"unprognostic (4.50e-1)"	"unprognostic (1.59e-2)"	71.1	81.1	44.0	84.0	47.5	54.7	62.8	52.1	50.0	78.6	53.8	76.1	69.7	79.1	70.0	84.0	73.5	42.5	61.8	43.0	45.9	71.0	71.4	60.8	107.1	44.1	45.7	78.4	58.6	73.0	69.2	64.8	45.0	70.2	77.1	60.5	67.5	57.4	71.2	57.2	73.4	59.6	47.4	72.6	69.0	38.9	46.3	104.5	72.7	51.5	119.7	69.3	73.6	50.7	211.4	157.1	264.9	153.3	72.3	67.3	164.6	187.0	102.9	177.9	167.8	195.9	180.6	352.0	121.1	129.8	134.3	178.9	298.4	192.6	325.5	196.8	176.1	263.0	202.2	220.9	83.2	292.4	169.9	56.3	90.5	164.6	168.3	84.3	145.1	131.9	291.0	166.9	181.2	162.6	370.2	258.4	246.5	191.7	160.9	349.4	216.1	217.1	176.6	177.5	192.4	206.8	142.5	128.6	139.5	142.0	180.8	220.5	139.3	158.6	197.0	122.7	258.8	149.7	217.3	333.3	150.1	272.2	193.8	23.9	48.3	32.5	38.9	64.4	38.6	35.7	30.7	37.1	71.1	24.9	32.8	33.3	22.0	48.1	45.1	40.5	36.9	45.2	44.0	47.5	52.1	50.0	43.0	45.9	44.1	45.7	45.0	47.4	46.3	50.7	74.1	35.3	48.3	66.0	89.1	133.7	130.0	53.1	96.2	62.9	73.1	58.0	31.3	41.5	48.6	44.1	31.3	70.3	68.1	57.5	70.5	68.2	57.8	44.9	59.2	66.2	65.8	93.2	33.0	60.1	116.6	74.7	53.5	59.3	59.6	92.2	44.6	46.3	59.1	52.2	51.8	76.2	52.9	54.0	73.5	34.0	84.2	52.3	55.2	36.5	60.7	43.5	80.3	56.3	59.2	61.4	84.9	60.2	73.3	102.8	76.3	56.4	43.4	83.1	105.2	87.7	89.5	74.6	58.0	86.6	137.5	60.9	69.4	57.3	93.3	120.6
SRSF10	"FUSIP1, FUSIP2, PPP1R149, SFRS13, SFRS13A, SRp38, SRrp40, TASR1, TASR2"	ENSG00000188529	"Serine and arginine rich splicing factor 10"	O75494	1	23964347-23980927	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA053805, HPA053831"	Uncertain		Supported	Nucleoplasm		NA	Yes		49000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA053805: AB_2682269, HPA053831: AB_2682275"	"unprognostic (2.49e-1)"	"unprognostic (3.10e-1)"	"unprognostic (1.34e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.06e-2)"	"prognostic unfavorable (1.18e-6)"	"unprognostic (2.05e-2)"	"unprognostic (1.68e-3)"	"unprognostic (1.30e-1)"	"unprognostic (1.24e-1)"	"prognostic unfavorable (1.74e-4)"	"prognostic unfavorable (1.01e-5)"	"unprognostic (2.69e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.76e-1)"	"unprognostic (2.40e-2)"	57.0	59.9	22.5	46.3	23.3	119.6	46.9	26.5	30.1	51.7	29.9	48.8	38.0	49.6	40.7	43.8	56.3	29.2	40.0	23.2	24.4	56.3	56.7	49.6	61.0	23.3	23.5	61.1	50.1	37.2	43.6	42.2	24.3	47.9	45.0	46.5	45.4	32.1	37.7	40.1	50.2	41.3	25.0	49.0	47.9	34.7	23.1	55.8	61.3	24.4	57.1	43.0	45.0	28.6	110.7	89.6	142.9	92.9	88.6	68.2	98.0	133.4	53.5	116.8	102.3	83.5	112.8	239.5	82.7	63.5	73.8	99.7	163.4	89.7	140.7	140.9	122.7	134.5	160.3	115.1	62.2	164.3	107.9	44.2	68.5	74.3	72.9	66.8	89.1	92.1	187.2	83.4	99.3	77.2	167.9	118.1	196.2	139.6	84.4	162.9	99.7	127.6	102.1	86.4	104.9	85.5	98.7	88.2	100.1	97.4	94.2	129.5	89.2	94.7	99.5	89.2	126.4	94.6	134.6	189.1	83.4	185.9	112.8	112.8	67.7	74.0	51.3	84.1	65.1	80.2	58.5	60.3	58.1	68.8	62.9	55.8	43.9	74.5	82.0	69.6	75.9	72.3	22.5	23.3	26.5	30.1	23.2	24.4	23.3	23.5	24.3	25.0	23.1	28.6	115.8	112.2	112.1	39.2	188.4	42.6	115.5	23.2	183.2	159.1	104.4	103.4	59.1	97.2	85.5	79.1	160.6	116.8	150.5	85.6	78.2	94.2	115.4	96.7	138.3	109.8	122.0	154.2	54.7	89.2	164.1	111.3	93.8	106.7	93.6	181.0	86.0	63.8	82.0	99.3	50.9	92.4	36.7	51.2	41.3	118.5	127.7	83.4	26.6	44.0	101.5	131.6	111.2	54.8	67.2	78.6	85.9	110.6	169.4	122.6	67.4	74.6	94.6	287.5	105.2	121.8	125.8	188.1	150.5	140.0	45.5	63.3	142.6	335.7	106.3	100.1
SRSF11	"NET2, p54, SFRS11"	ENSG00000116754	"Serine and arginine rich splicing factor 11"	Q05519	1	70205682-70253052	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008762	Supported		Supported	"Nuclear speckles"		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 50: Non-specific - Ribosome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	"Nuclear speckles"		"HPA008762: AB_1856782"	"unprognostic (7.82e-3)"	"unprognostic (1.69e-1)"	"unprognostic (2.28e-2)"	"unprognostic (2.85e-1)"	"unprognostic (5.32e-3)"	"unprognostic (1.30e-3)"	"prognostic unfavorable (3.91e-4)"	"unprognostic (2.23e-3)"	"unprognostic (5.65e-3)"	"unprognostic (3.18e-2)"	"unprognostic (1.22e-1)"	"unprognostic (6.25e-3)"	"prognostic unfavorable (6.53e-6)"	"unprognostic (7.79e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.43e-2)"	76.4	67.0	39.4	51.4	42.6	136.8	76.9	48.1	64.6	86.6	40.0	73.7	44.7	75.9	70.0	62.1	83.7	45.1	51.9	39.4	46.5	68.8	94.1	70.1	75.8	42.0	40.7	96.3	85.7	43.0	79.8	56.1	43.7	73.7	45.0	57.7	69.5	40.8	66.3	75.9	84.9	39.3	39.7	89.8	72.9	58.4	41.4	75.4	86.2	32.9	64.7	68.5	75.0	47.9	92.8	46.2	118.4	76.2	59.5	79.7	162.4	111.6	57.5	89.0	80.3	81.6	68.0	156.6	74.7	56.5	58.4	77.4	151.5	61.4	120.7	105.9	118.1	159.0	112.4	98.5	71.1	221.0	63.3	64.2	76.0	82.5	83.5	111.3	80.4	79.0	159.1	96.1	88.7	36.4	133.3	163.1	190.9	72.3	76.9	156.1	130.9	99.9	104.3	65.7	99.3	82.1	94.5	101.1	139.8	109.1	80.9	98.1	96.0	97.8	70.4	71.3	102.3	110.4	94.5	169.9	70.2	161.3	87.7	111.7	63.5	103.6	65.7	51.6	74.9	76.3	67.0	65.2	66.1	70.7	72.2	67.8	31.7	85.8	64.6	91.7	80.4	52.7	39.4	42.6	48.1	64.6	39.4	46.5	42.0	40.7	43.7	39.7	41.4	47.9	198.6	211.5	224.9	90.4	208.6	354.0	295.5	229.6	222.5	164.8	166.9	171.7	119.6	115.8	184.5	195.0	118.9	242.0	243.4	123.8	115.4	151.0	64.4	160.0	267.9	186.8	173.8	218.5	219.0	135.3	253.1	228.9	165.6	231.0	194.1	218.1	146.3	152.6	150.4	159.9	183.0	158.3	150.5	124.9	244.4	56.9	255.7	155.4	168.9	126.5	183.1	115.5	145.2	168.9	219.8	144.9	104.7	264.4	234.9	317.8	122.1	101.4	157.8	158.1	170.9	199.1	218.3	270.0	138.0	181.4	353.6	303.7	226.2	195.5	172.9	315.0
SRSF2	"PR264, SC-35, SC35, SFRS2, SFRS2A"	ENSG00000161547	"Serine and arginine rich splicing factor 2"	Q01130	17	76734115-76737333	"Cancer-related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA049905	Supported		Approved	Nucleoplasm,Cytosol		NA	NA		180000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm	Cytosol	"HPA049905: AB_2680945"	"unprognostic (2.50e-1)"	"unprognostic (2.16e-3)"	"unprognostic (2.73e-3)"	"prognostic unfavorable (8.73e-4)"	"unprognostic (1.75e-2)"	"unprognostic (4.19e-2)"	"prognostic unfavorable (3.53e-8)"	"unprognostic (1.19e-1)"	"unprognostic (7.79e-3)"	"unprognostic (7.03e-3)"	"unprognostic (1.92e-1)"	"unprognostic (1.07e-3)"	"prognostic unfavorable (1.05e-7)"	"unprognostic (3.85e-2)"	"unprognostic (8.05e-2)"	"unprognostic (1.95e-1)"	"prognostic favorable (9.87e-4)"	106.0	106.8	27.8	95.5	29.6	184.7	92.1	29.9	34.0	83.6	37.7	100.3	86.2	88.9	64.0	129.5	89.5	42.1	78.5	29.2	32.9	83.0	115.2	95.4	111.6	30.8	28.5	85.6	88.3	48.4	81.9	66.0	30.3	78.0	71.6	53.4	90.6	52.3	91.7	96.5	113.2	49.0	31.3	121.6	94.4	49.5	30.0	94.2	102.1	36.0	100.2	80.0	94.3	36.0	318.7	239.8	289.5	207.5	70.9	58.5	300.5	197.3	146.8	225.4	207.0	257.2	216.8	478.0	143.3	188.7	164.3	279.9	293.3	229.0	230.2	202.3	489.3	357.9	246.6	311.9	79.3	404.4	210.6	65.2	51.1	186.2	54.0	91.1	179.9	212.0	373.4	209.6	183.7	251.0	460.0	440.9	339.5	186.4	340.2	455.0	310.6	360.5	156.5	225.2	247.7	350.8	227.1	196.3	120.4	154.0	238.8	301.6	187.9	206.9	271.3	139.4	330.0	278.2	219.2	552.9	187.3	318.9	177.1	2.5	40.9	10.0	26.0	53.3	26.0	23.5	17.7	26.7	67.0	19.6	20.1	19.4	4.4	35.6	33.6	49.2	24.0	33.0	27.8	29.6	29.9	34.0	29.2	32.9	30.8	28.5	30.3	31.3	30.0	36.0	271.3	118.6	105.6	57.5	396.7	460.8	439.7	205.9	540.1	151.9	291.7	277.9	86.2	148.7	141.5	88.3	91.8	339.4	548.0	233.1	156.5	199.1	203.6	176.8	181.9	204.3	266.3	366.6	51.1	157.3	579.7	233.9	196.7	257.4	218.4	241.7	116.7	125.1	251.3	99.3	55.4	246.9	132.2	143.7	480.4	162.0	159.1	273.5	282.8	63.7	226.9	153.3	196.7	55.8	87.9	189.0	288.7	127.5	492.0	384.8	250.5	128.7	97.4	188.9	118.3	286.8	242.1	272.3	296.8	489.5	443.4	316.0	469.1	185.4	329.4	459.4
SRSF3	"SFRS3, SRp20"	ENSG00000112081	"Serine and arginine rich splicing factor 3"	P84103	6	36594353-36605600	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing, mRNA transport, Transport"	RNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012986, HPA056981"	Supported		Supported	Nucleoplasm		NA	NA		1600000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm		"CAB012986: AB_2533150, HPA056981: AB_2683299"	"unprognostic (3.25e-1)"	"unprognostic (1.08e-3)"	"prognostic favorable (2.56e-4)"	"unprognostic (8.19e-2)"	"unprognostic (2.06e-2)"	"unprognostic (2.77e-2)"	"prognostic unfavorable (6.22e-5)"	"unprognostic (2.92e-2)"	"prognostic unfavorable (1.95e-4)"	"prognostic favorable (1.37e-4)"	"unprognostic (9.61e-2)"	"unprognostic (1.21e-1)"	"prognostic unfavorable (2.02e-4)"	"unprognostic (9.88e-2)"	"unprognostic (3.33e-2)"	"unprognostic (8.33e-2)"	"unprognostic (1.06e-2)"	97.2	62.5	39.2	93.5	40.9	172.3	90.2	43.6	44.0	72.6	42.4	89.6	54.0	76.1	62.5	97.8	78.0	40.5	70.2	40.1	43.8	83.3	75.3	68.8	118.9	40.0	40.6	84.0	58.0	62.3	49.2	74.6	41.6	58.6	95.2	45.2	57.8	64.6	76.0	66.4	73.2	89.9	43.1	67.2	74.9	59.9	44.0	164.3	60.7	48.5	147.9	97.7	72.0	45.5	357.2	232.3	401.4	308.9	151.9	117.9	247.2	248.4	206.5	408.6	312.2	275.1	248.2	593.4	174.3	273.3	266.8	275.1	533.1	395.4	433.2	279.3	327.3	357.0	175.5	312.3	184.9	485.2	289.6	105.8	131.6	267.4	295.6	130.3	315.2	354.4	438.7	244.1	300.8	277.4	601.0	457.0	424.5	414.5	241.5	527.3	384.2	355.9	292.2	291.1	308.7	291.8	276.1	267.4	385.4	284.9	271.2	513.1	207.9	208.1	303.9	211.0	380.1	238.6	381.4	822.9	178.4	443.7	295.5	85.6	179.0	57.9	145.8	176.6	166.0	129.0	136.8	154.7	350.7	113.5	136.1	140.8	17.1	190.5	125.1	206.8	184.2	305.6	39.2	40.9	43.6	44.0	40.1	43.8	40.0	40.6	41.6	43.1	44.0	45.5	648.3	201.9	238.6	47.3	337.6	469.6	425.1	308.4	225.9	146.2	371.3	388.4	227.9	198.8	258.0	125.0	54.2	495.6	574.3	245.3	363.9	357.3	176.1	216.0	295.7	346.9	332.9	345.9	24.0	324.9	816.9	373.6	226.8	251.1	396.8	275.2	243.8	182.7	359.3	99.3	23.8	409.9	191.2	262.9	559.3	321.2	211.9	356.5	334.4	45.9	366.3	368.8	334.8	38.2	51.1	290.1	301.9	172.3	256.3	401.7	259.2	274.7	164.8	154.5	203.8	497.3	448.2	374.2	290.8	312.2	445.8	526.1	415.2	184.1	427.4	285.1
SRSF4	"SFRS4, SRP75"	ENSG00000116350	"Serine and arginine rich splicing factor 4"	Q08170	1	29147743-29181900	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Repressor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA050975	Supported		Supported	"Nuclear speckles"		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 36: HEL - Hemostasis"	"Cluster 22: Epithelial cell types - Mixed function"	"Nuclear speckles"		"HPA050975: AB_2681296"	"unprognostic (3.26e-3)"	"unprognostic (8.08e-2)"	"unprognostic (1.29e-2)"	"unprognostic (1.57e-3)"	"unprognostic (1.37e-1)"	"unprognostic (5.89e-2)"	"unprognostic (1.89e-3)"	"unprognostic (1.63e-1)"	"prognostic unfavorable (3.27e-4)"	"unprognostic (2.36e-1)"	"unprognostic (1.75e-1)"	"prognostic unfavorable (4.26e-4)"	"prognostic unfavorable (4.30e-4)"	"unprognostic (6.25e-3)"	"unprognostic (2.80e-1)"	"unprognostic (7.75e-3)"	"unprognostic (1.60e-2)"	84.7	61.1	43.4	46.8	45.4	77.5	78.2	47.6	46.6	82.3	44.1	86.7	49.6	79.7	38.6	73.5	71.7	36.4	61.9	43.0	46.9	62.9	95.8	83.5	57.4	44.8	43.7	88.2	61.6	38.7	56.0	57.6	45.6	72.0	35.6	51.8	62.5	39.6	94.1	76.2	73.1	40.6	43.0	81.9	66.7	44.5	45.0	63.2	73.7	51.7	43.4	77.7	76.6	46.1	108.2	63.5	117.0	42.8	83.9	63.0	72.5	87.6	65.5	103.3	88.0	58.6	64.9	122.2	79.9	74.5	66.9	99.0	99.7	81.4	104.5	148.6	118.9	185.7	95.6	92.9	87.2	127.8	114.0	51.1	101.1	87.7	111.8	83.9	86.6	70.2	154.8	95.7	71.1	54.1	162.2	110.4	125.2	64.4	60.0	150.6	126.9	83.3	71.1	110.0	71.3	81.4	107.4	61.5	105.8	103.4	41.0	76.3	84.2	82.9	66.1	91.0	146.4	88.0	70.6	134.5	79.4	161.0	91.9	72.7	45.7	102.2	64.6	55.1	63.3	49.0	59.7	70.5	55.8	53.1	51.0	55.0	89.6	48.4	62.3	43.2	78.9	51.1	43.4	45.4	47.6	46.6	43.0	46.9	44.8	43.7	45.6	43.0	45.0	46.1	142.3	80.1	129.8	23.8	94.2	99.8	179.6	65.0	91.0	70.2	50.2	42.9	51.1	45.8	92.8	51.5	85.5	132.7	100.0	68.4	54.8	64.9	8.2	85.4	98.4	131.0	39.0	114.3	20.1	47.2	124.6	87.8	76.5	99.4	91.7	76.2	101.0	75.9	68.8	57.2	21.1	72.7	59.0	69.8	79.0	11.6	85.7	83.4	55.2	14.0	88.6	74.8	92.7	19.6	19.6	56.3	78.8	89.1	121.4	172.3	83.1	58.3	91.7	108.3	72.3	99.5	97.4	64.7	51.9	95.9	103.3	142.8	105.1	75.9	78.7	210.4
SRSF6	"B52, SFRS6, SRP55"	ENSG00000124193	"Serine and arginine rich splicing factor 6"	Q13247	20	43457893-43466046	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Repressor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA029005, CAB034889"	Supported		Supported	"Nuclear speckles"		NA	NA		50000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 50: Non-specific - Ribosome"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 65: Plasmacytoid DCs - Unknown function"	"Nuclear speckles"		"CAB034889: AB_785899, HPA029005: AB_10610424"	"unprognostic (1.51e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.98e-1)"	"unprognostic (3.25e-2)"	"unprognostic (6.41e-2)"	"unprognostic (3.91e-2)"	"prognostic unfavorable (3.86e-4)"	"unprognostic (3.99e-3)"	"unprognostic (4.39e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.27e-3)"	"unprognostic (6.03e-3)"	"prognostic unfavorable (2.82e-4)"	"unprognostic (1.73e-1)"	"unprognostic (2.70e-1)"	"unprognostic (4.31e-1)"	"unprognostic (1.18e-2)"	43.3	53.7	34.0	34.5	37.5	115.9	56.2	41.4	43.8	44.2	52.7	37.8	36.3	52.7	59.7	32.8	47.4	31.4	31.4	33.3	39.6	47.4	50.3	40.3	48.4	34.5	34.7	58.5	66.3	41.8	48.0	39.3	35.6	48.7	43.4	38.7	45.3	30.0	30.5	48.7	45.4	39.7	35.6	55.9	47.4	30.3	35.7	53.7	50.8	18.1	40.8	29.7	30.4	47.3	52.7	79.1	88.7	57.3	50.7	67.7	86.3	79.6	38.3	55.4	47.1	112.9	55.9	95.9	73.9	73.3	45.1	77.6	91.7	116.9	71.7	40.2	85.7	74.6	83.3	94.1	62.3	94.9	78.9	115.7	61.9	51.0	46.2	85.1	52.7	83.8	63.3	54.5	52.6	112.3	144.5	107.6	57.8	87.4	107.4	100.2	54.4	76.9	63.1	93.7	69.0	90.9	89.5	108.7	105.0	61.7	70.4	103.3	54.9	57.9	61.6	49.9	67.3	98.2	67.3	131.4	69.9	67.2	42.8	26.0	19.9	9.7	19.7	33.4	22.4	16.0	20.8	19.1	24.5	15.9	27.3	25.7	10.8	21.2	29.6	20.4	18.7	22.9	34.0	37.5	41.4	43.8	33.3	39.6	34.5	34.7	35.6	35.6	35.7	47.3	78.9	64.1	80.0	49.6	75.8	94.4	61.0	58.5	50.7	48.9	110.7	78.7	28.7	75.8	61.3	46.0	39.6	97.8	103.3	67.8	88.0	60.2	12.3	60.1	87.7	62.3	101.4	71.1	32.1	43.7	108.2	80.0	70.8	79.1	97.0	103.2	60.7	94.7	56.5	32.0	37.2	97.2	46.8	73.2	93.7	14.7	55.0	77.3	101.4	26.2	61.2	45.0	37.0	89.0	79.6	46.2	74.3	44.8	49.3	68.9	66.7	67.7	47.6	46.4	59.2	166.1	99.8	53.8	61.0	51.5	98.3	139.1	76.4	90.7	105.5	55.3
SRSF8	"SFRS2B, SRP46"	ENSG00000263465	"Serine and arginine rich splicing factor 8"	Q9BRL6	11	95066919-95071225	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											HPA049905	Supported		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 32: Non-specific - Translation"	Nucleoplasm	Cytosol	"HPA049905: AB_2680945"	"unprognostic (2.03e-2)"	"unprognostic (2.51e-1)"	"unprognostic (5.23e-2)"	"unprognostic (2.00e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.68e-1)"	"unprognostic (2.62e-1)"	"unprognostic (2.08e-2)"	"unprognostic (2.12e-1)"	"unprognostic (3.00e-1)"	"unprognostic (1.55e-2)"	"unprognostic (1.05e-1)"	"prognostic favorable (9.99e-7)"	"unprognostic (2.26e-1)"	"unprognostic (1.88e-1)"	"unprognostic (5.39e-2)"	"unprognostic (2.75e-3)"	14.8	13.5	16.3	12.1	16.0	14.7	16.7	16.5	18.0	14.7	16.8	15.1	15.7	17.3	16.0	14.5	15.3	12.0	13.4	15.8	17.0	19.3	15.1	13.5	17.4	15.0	15.5	20.7	21.9	17.9	15.7	14.3	15.3	19.0	15.6	10.4	19.9	16.8	13.2	14.9	17.4	14.7	16.2	20.0	15.8	5.3	17.5	12.3	23.2	14.1	14.7	13.2	13.6	17.7	7.6	7.7	19.1	0.0	24.9	15.5	21.7	11.1	12.2	5.1	5.5	18.4	24.2	40.3	32.2	16.9	9.4	16.3	16.2	24.1	5.9	24.4	17.8	33.8	9.0	16.6	18.3	34.3	17.7	20.3	25.1	5.4	25.3	15.0	16.2	18.1	25.9	21.5	10.1	10.3	17.9	30.4	10.2	19.8	21.7	22.1	5.8	32.1	20.1	24.8	24.2	24.7	13.8	24.1	16.7	12.0	9.6	18.7	15.3	9.9	13.3	13.5	11.6	11.6	19.1	21.4	5.1	22.5	22.1	10.1	2.1	0.7	5.4	1.2	7.9	9.2	9.4	8.1	4.0	7.1	12.0	9.1	0.6	6.2	1.1	3.7	10.9	4.1	16.3	16.0	16.5	18.0	15.8	17.0	15.0	15.5	15.3	16.2	17.5	17.7	32.5	44.8	29.3	8.8	82.8	0.0	51.4	0.0	57.5	49.3	54.4	60.3	21.4	58.6	11.8	33.1	33.3	39.2	56.5	41.1	150.6	36.7	1.8	22.1	27.6	45.8	56.9	122.9	18.3	45.7	52.7	31.4	40.2	33.8	10.2	43.2	52.5	57.8	26.1	18.5	16.6	82.6	0.0	24.2	0.0	6.0	41.0	41.9	0.0	18.7	40.2	45.7	97.9	13.6	29.6	28.9	40.8	60.9	46.8	46.4	53.4	110.1	9.5	50.9	32.9	34.6	31.0	7.2	6.4	63.5	0.0	51.2	58.4	52.1	67.5	38.0
SRSF9	"SFRS9, SRp30c"	ENSG00000111786	"Serine and arginine rich splicing factor 9"	Q13242	12	120461672-120469748	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Repressor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049849	Supported		Supported	Nucleoplasm,Nucleoli		No	No			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 24: NB-4 - Immune response"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm	Nucleoli	"HPA049849: AB_2680911"	"unprognostic (3.80e-1)"	"unprognostic (3.84e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.75e-2)"	"unprognostic (2.41e-1)"	"unprognostic (2.50e-3)"	"prognostic unfavorable (9.85e-7)"	"unprognostic (9.65e-3)"	"prognostic unfavorable (7.80e-4)"	"unprognostic (2.31e-2)"	"unprognostic (4.35e-1)"	"unprognostic (1.19e-2)"	"unprognostic (1.19e-3)"	"unprognostic (9.57e-2)"	"unprognostic (3.13e-1)"	"unprognostic (2.57e-1)"	"unprognostic (1.60e-1)"	68.2	112.1	71.2	75.5	74.3	95.0	72.0	73.9	75.2	70.3	81.0	88.7	73.0	57.5	85.5	126.6	76.1	48.7	38.8	70.6	75.1	94.7	92.0	62.1	99.3	72.7	77.2	71.2	113.8	94.2	78.2	85.2	74.0	76.9	84.2	21.8	77.1	57.4	30.0	80.6	63.5	58.9	74.4	86.7	82.6	93.3	77.6	110.2	80.6	27.5	129.1	82.9	75.6	72.1	334.7	229.2	344.3	222.7	153.6	153.7	365.3	224.3	200.7	281.5	240.2	276.9	153.1	323.6	254.7	189.4	152.7	194.9	312.0	318.9	308.5	244.7	321.9	276.3	152.8	273.5	197.7	344.7	241.8	163.4	201.8	244.6	211.0	301.2	260.4	207.0	353.6	95.3	245.9	466.8	339.7	668.7	429.6	224.8	198.2	374.2	144.1	312.9	246.4	420.4	303.9	217.3	262.5	137.3	276.2	222.4	415.9	299.4	229.1	207.8	247.0	157.8	246.3	288.6	234.5	404.9	218.8	255.7	221.5	28.7	16.9	49.3	22.5	19.8	17.5	41.2	17.4	19.9	22.5	36.7	17.3	19.1	19.7	26.5	27.7	30.7	20.1	8.7	71.2	74.3	73.9	75.2	70.6	75.1	72.7	77.2	74.0	74.4	77.6	72.1	172.6	25.6	37.2	17.3	190.1	264.9	269.7	81.2	140.0	74.5	235.6	174.4	1.7	157.3	60.4	161.8	29.2	339.2	204.5	119.5	489.1	200.6	68.5	179.1	149.9	143.8	144.7	141.9	24.1	155.1	469.4	148.9	105.5	143.9	33.7	321.3	132.8	150.0	202.9	72.3	23.6	160.5	63.1	136.3	322.0	28.5	124.5	171.3	200.9	11.2	192.7	134.4	129.8	14.1	24.1	152.4	102.2	155.0	317.8	336.8	89.8	404.3	63.6	55.3	52.6	128.1	165.5	288.5	248.8	218.2	313.4	475.4	158.1	433.1	160.6	392.2
SS18L1	"CREST, KIAA0693"	ENSG00000184402	"SS18L1 subunit of BAF chromatin remodeling complex"	O75177	20	62143769-62182514	"Cancer-related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, Chromatin regulator"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011827, HPA059046"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 15: Liver - Metabolism"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 9: Photoreceptor cells - Phototransduction"	"Nucleoplasm, Cytosol"		"CAB011827: AB_778216, HPA059046: AB_2683888"	"unprognostic (4.12e-2)"	"unprognostic (5.82e-2)"	"unprognostic (1.54e-1)"	"unprognostic (3.03e-2)"	"unprognostic (6.57e-2)"	"prognostic favorable (8.00e-5)"	"unprognostic (1.39e-1)"	"prognostic favorable (3.74e-4)"	"unprognostic (1.01e-1)"	"unprognostic (1.87e-1)"	"unprognostic (2.47e-3)"	"unprognostic (6.43e-2)"	"unprognostic (2.42e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.66e-1)"	"unprognostic (1.01e-1)"	"unprognostic (9.94e-3)"	7.7	8.8	11.3	6.6	10.1	6.6	7.8	26.1	13.9	10.3	7.5	8.2	7.7	8.0	8.4	10.9	9.2	5.0	8.3	9.7	9.7	10.5	37.8	9.7	6.4	12.2	9.5	10.6	12.1	6.4	11.9	7.1	11.6	9.0	6.1	10.7	8.5	5.4	13.3	19.8	8.4	5.6	6.7	10.1	9.2	8.9	11.1	6.5	9.1	9.4	5.8	8.5	10.1	18.9	11.1	12.5	17.7	16.3	7.6	8.8	12.9	10.3	3.9	16.6	8.0	44.1	10.2	6.6	13.3	5.8	8.6	27.9	10.5	9.8	15.2	4.5	6.9	29.6	30.9	23.5	5.7	11.2	25.6	5.5	20.5	8.4	7.0	9.7	7.5	11.3	20.3	12.8	9.6	13.2	16.7	17.2	7.3	11.0	13.7	18.5	23.1	7.8	12.5	13.9	33.4	18.6	17.7	22.4	15.6	11.3	20.8	17.6	9.3	31.8	19.0	12.0	14.6	13.8	13.2	5.6	15.9	10.6	10.9	0.0	0.4	0.1	0.3	0.3	0.2	0.1	0.2	0.3	0.3	1.2	0.6	0.2	0.6	0.4	0.7	0.2	0.2	0.1	11.3	10.1	26.1	13.9	9.7	9.7	12.2	9.5	11.6	6.7	11.1	18.9	9.7	9.6	7.0	19.6	5.2	16.4	4.8	8.9	17.1	17.9	10.8	8.8	10.3	2.8	11.4	7.3	22.9	5.6	6.7	7.1	3.9	5.0	10.8	11.9	8.1	9.7	14.3	4.8	29.5	2.7	3.3	8.9	7.7	12.8	1.3	10.8	8.6	40.4	4.8	15.2	32.8	6.6	14.2	10.4	12.7	20.8	7.5	7.4	12.4	20.6	10.0	4.4	4.1	8.5	25.5	8.2	7.3	3.4	7.4	9.5	8.3	9.1	9.0	16.5	6.6	11.1	7.7	4.6	10.2	10.6	17.5	7.7	6.0	10.6	7.1	6.9
SSBP1	"mtSSB, SSBP"	ENSG00000106028	"Single stranded DNA binding protein 1"	Q04837	7	141738334-141787922	"Human disease related genes, Predicted intracellular proteins"	"DNA replication"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002866	Supported		Supported	Mitochondria		NA	NA		150000	"Cluster 44: Non-specific - Transcription"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Mitochondria		"HPA002866: AB_1080092"	"unprognostic (2.95e-1)"	"unprognostic (2.99e-1)"	"unprognostic (2.49e-2)"	"unprognostic (3.62e-2)"	"unprognostic (7.36e-3)"	"unprognostic (2.86e-2)"	"prognostic unfavorable (4.42e-4)"	"unprognostic (3.68e-2)"	"unprognostic (6.03e-2)"	"prognostic favorable (3.40e-4)"	"unprognostic (9.23e-3)"	"unprognostic (4.02e-1)"	"unprognostic (9.65e-3)"	"unprognostic (1.62e-1)"	"unprognostic (9.38e-2)"	"unprognostic (1.25e-2)"	"unprognostic (9.58e-2)"	86.1	105.0	70.5	80.9	72.6	89.9	97.0	72.3	101.1	75.1	65.8	94.1	70.4	83.6	107.7	125.9	74.0	54.0	135.0	71.5	74.5	105.4	120.4	62.9	97.0	72.5	74.4	85.3	87.8	93.6	64.8	78.4	72.8	64.9	85.3	58.2	77.4	70.4	141.2	88.4	77.5	76.1	72.5	80.8	93.1	80.8	70.8	96.6	82.7	94.1	112.8	91.8	82.1	74.4	280.6	333.6	281.6	369.2	125.5	193.2	262.2	208.7	193.0	256.4	287.9	353.7	330.5	414.0	267.6	173.5	421.8	210.2	349.5	347.4	369.6	220.8	339.1	226.1	253.6	322.3	242.6	644.9	166.8	179.9	230.9	257.4	373.0	177.7	316.2	279.9	552.8	184.0	343.4	430.9	477.3	837.2	634.1	476.8	403.0	262.6	258.2	578.5	340.9	286.7	256.4	352.5	236.8	323.7	319.8	213.7	210.7	267.2	239.6	183.0	171.6	282.1	533.8	328.6	465.9	796.1	369.9	577.6	395.8	136.1	69.9	76.8	71.7	96.1	107.7	106.3	113.8	98.9	90.6	92.0	101.1	113.7	20.6	98.8	99.8	104.0	123.8	116.3	70.5	72.6	72.3	101.1	71.5	74.5	72.5	74.4	72.8	72.5	70.8	74.4	151.0	102.5	104.7	13.7	135.7	116.0	199.6	477.7	98.4	58.6	114.3	178.8	279.1	148.7	242.7	150.8	41.7	311.0	139.2	92.7	350.2	310.3	187.0	160.6	162.3	136.5	96.3	111.7	17.0	353.3	313.7	140.5	92.2	169.8	151.9	163.3	105.3	221.9	251.9	43.7	16.0	163.7	244.1	122.0	126.3	62.2	137.3	131.0	104.9	15.0	221.2	152.1	157.6	16.6	29.1	314.0	130.0	123.8	101.3	166.6	141.9	445.2	178.0	79.1	98.6	170.6	223.5	253.5	190.0	136.3	129.4	261.7	145.2	254.1	188.1	200.2
SSR1	TRAPA	ENSG00000124783	"Signal sequence receptor subunit 1"	P43307	6	7268306-7347446	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011276, HPA017062"	Enhanced		Supported	"Endoplasmic reticulum"		NA	NA		1600000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 55: Plasma cells - Humoral immune response"	"Endoplasmic reticulum"		"HPA011276: AB_1857503, HPA017062: AB_1857505"	"unprognostic (2.27e-1)"	"unprognostic (2.10e-1)"	"unprognostic (5.98e-3)"	"unprognostic (1.57e-2)"	"unprognostic (3.10e-2)"	"unprognostic (1.79e-1)"	"prognostic unfavorable (4.92e-4)"	"unprognostic (7.83e-2)"	"unprognostic (2.27e-2)"	"unprognostic (4.72e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.08e-1)"	"prognostic unfavorable (5.79e-6)"	"unprognostic (3.17e-1)"	"unprognostic (2.56e-2)"	"unprognostic (6.51e-3)"	"unprognostic (2.19e-2)"	64.0	64.4	20.3	89.6	24.6	101.9	70.3	25.4	24.8	88.5	35.7	65.3	65.6	62.7	74.2	71.6	50.8	64.5	41.2	19.0	28.9	58.6	95.5	56.7	68.4	27.6	25.2	67.0	67.9	49.4	25.8	71.5	27.2	59.2	76.4	36.6	79.7	56.0	28.3	42.6	62.4	76.9	23.7	62.4	68.2	38.5	27.8	55.9	84.8	29.1	84.2	74.4	32.8	34.7	122.2	121.7	92.3	171.7	244.9	173.1	144.4	274.5	225.5	183.4	219.1	167.5	98.5	162.9	472.1	282.5	168.3	107.0	112.0	156.6	251.6	172.2	94.6	174.3	130.6	350.7	253.4	325.6	189.6	154.2	169.0	210.2	429.2	140.4	205.2	80.4	199.3	191.1	204.6	146.4	89.6	86.6	78.2	136.5	137.2	120.1	116.0	615.7	161.3	171.5	124.6	57.9	167.0	91.1	263.4	276.8	147.9	141.7	183.1	196.1	149.0	153.3	238.1	195.7	312.1	130.4	95.3	180.4	367.1	146.1	169.5	114.5	82.9	121.9	105.6	73.0	91.7	93.9	199.9	56.1	86.3	86.9	93.3	85.7	110.1	139.3	109.4	214.7	20.3	24.6	25.4	24.8	19.0	28.9	27.6	25.2	27.2	23.7	27.8	34.7	54.0	28.9	48.1	32.3	106.1	77.8	62.1	120.2	69.4	75.4	85.3	46.1	48.5	84.4	93.7	130.6	100.1	78.2	118.6	65.4	15.6	96.0	16.1	48.7	96.0	69.6	62.3	80.8	38.6	103.0	208.5	95.4	68.8	74.3	47.5	64.0	78.1	148.1	130.0	70.7	41.3	130.4	81.4	157.3	251.5	12.4	78.6	129.7	94.3	35.6	131.5	64.1	87.6	49.8	47.8	71.9	47.0	73.0	302.1	111.2	61.5	67.1	57.8	104.2	26.3	57.6	71.6	53.4	58.7	96.0	75.4	121.8	83.6	61.2	93.6	70.4
SSR4	TRAPD	ENSG00000180879	"Signal sequence receptor subunit 4"	P51571	X	153793516-153798499	"Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted membrane proteins"			"Congenital disorder of glycosylation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 3119.7"	"Cell type enhanced"	"Detected in all"		"Plasma cells: 6002.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045209	Enhanced		Supported	"Endoplasmic reticulum"		NA	NA		110000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 25: Pancreas - Digestion"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 55: Plasma cells - Humoral immune response"	"Endoplasmic reticulum"		"HPA045209: AB_10961407"	"unprognostic (3.56e-2)"	"unprognostic (1.32e-2)"	"unprognostic (4.00e-3)"	"prognostic favorable (1.76e-4)"	"unprognostic (8.74e-2)"	"unprognostic (5.57e-2)"	"unprognostic (7.99e-2)"	"unprognostic (4.58e-2)"	"unprognostic (2.10e-1)"	"unprognostic (5.04e-3)"	"unprognostic (5.74e-3)"	"unprognostic (8.76e-2)"	"prognostic unfavorable (5.51e-6)"	"unprognostic (8.18e-2)"	"unprognostic (2.24e-1)"	"unprognostic (6.01e-2)"	"unprognostic (5.33e-2)"	213.5	311.6	152.0	232.1	153.6	498.9	252.7	157.1	186.5	319.0	195.6	366.6	341.6	192.4	885.6	233.5	201.7	185.2	295.2	148.9	190.3	203.4	397.6	236.5	319.0	161.8	156.3	182.8	3119.7	157.1	676.5	120.5	159.2	263.8	267.7	37.1	922.8	416.4	127.4	191.5	256.6	120.5	162.7	396.6	495.0	160.9	158.1	158.0	221.0	74.1	324.6	243.8	217.3	171.5	344.2	428.9	148.7	834.4	785.2	412.4	299.5	278.6	431.1	299.9	407.3	547.9	298.3	476.9	721.8	450.4	262.4	332.8	259.2	270.6	111.8	192.6	212.0	128.4	380.1	446.0	669.0	370.7	352.6	511.9	376.6	256.9	353.2	265.3	327.4	240.8	145.4	1027.1	239.8	616.8	222.3	578.1	90.8	941.3	685.7	247.3	178.4	922.7	394.2	413.9	285.8	228.8	159.3	301.7	333.1	161.9	188.8	821.6	263.9	174.4	189.9	324.4	377.5	1449.6	774.0	576.4	364.7	630.8	295.7	652.3	594.6	286.7	616.7	476.9	762.6	695.6	629.2	613.7	598.0	644.7	538.8	555.2	93.8	697.3	396.5	1751.9	515.9	1330.5	152.0	153.6	157.1	186.5	148.9	190.3	161.8	156.3	159.2	162.7	158.1	171.5	228.6	166.7	301.9	7.5	824.1	257.2	372.4	566.8	167.9	53.6	451.1	380.1	334.8	357.4	464.7	318.2	56.3	311.4	521.0	473.2	168.3	544.9	476.1	276.9	513.6	263.0	747.5	175.3	3.6	627.4	700.6	357.3	344.0	454.8	352.2	257.0	241.3	723.3	439.0	35.3	5.3	967.6	547.3	339.1	416.6	1753.1	336.7	344.5	1428.3	4.7	409.3	174.7	432.5	8.0	11.1	487.0	595.8	247.1	6002.3	633.3	581.0	414.8	340.6	83.4	118.3	174.3	300.7	199.4	207.9	306.1	322.2	564.6	473.4	600.1	548.8	490.0
SSTR2		ENSG00000180616	"Somatostatin receptor 2"	P30874	17	73165010-73176633	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 9.0"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 59.1;Enteroendocrine cells: 35.7;Sertoli cells: 32.9;Smooth muscle cells: 56.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"basophil: 1.4"	"Lineage enriched"	"Detected in single"	4	"granulocytes: 1.4"	"Cell line enriched"	"Detected in some"	8	"SCLC-21H: 12.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA007264	Uncertain		Supported	Cytosol		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 48: Smooth muscle cells - ECM organization"	Cytosol		"HPA007264: AB_1080053"	"unprognostic (2.13e-3)"	"unprognostic (2.61e-3)"	"unprognostic (7.43e-2)"	"unprognostic (9.37e-3)"	"unprognostic (6.25e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.29e-3)"	"unprognostic (7.46e-2)"	"unprognostic (2.96e-1)"	"unprognostic (6.55e-2)"	"prognostic favorable (6.63e-4)"	"unprognostic (1.07e-1)"	"prognostic unfavorable (9.04e-7)"	"unprognostic (1.35e-1)"	"unprognostic (1.00e-1)"	"unprognostic (3.71e-3)"	"unprognostic (2.95e-2)"	2.5	3.6	8.4	0.9	8.9	0.9	1.7	7.2	8.7	0.5	0.3	0.8	1.4	0.7	1.6	0.4	1.1	0.6	0.8	9.0	4.3	5.3	1.4	0.4	1.1	2.2	5.1	0.3	0.7	0.3	2.9	0.1	8.6	1.4	1.1	2.2	0.7	1.4	0.7	0.6	0.9	0.8	2.6	6.1	3.1	0.3	4.8	0.5	1.1	0.2	1.3	0.9	0.7	6.8	0.2	0.3	0.3	0.7	0.1	0.1	0.4	0.1	0.2	0.3	0.3	0.2	0.3	0.3	0.2	0.1	0.9	0.3	0.0	0.1	0.1	0.4	0.6	0.3	0.8	0.3	0.0	0.2	1.5	0.1	0.0	0.1	0.0	0.2	0.0	0.4	0.2	0.7	0.0	0.3	0.2	0.8	1.0	0.1	0.4	0.4	0.4	0.3	0.2	0.3	12.5	0.9	0.2	0.2	0.1	0.5	1.5	0.2	0.1	0.2	1.4	0.4	0.2	0.5	0.2	1.0	0.2	0.3	0.2	1.4	0.2	0.3	0.2	0.1	0.2	0.2	0.2	0.2	0.1	0.3	0.2	0.2	1.2	0.2	0.2	0.2	0.1	0.1	8.4	8.9	7.2	8.7	9.0	4.3	2.2	5.1	8.6	2.6	4.8	6.8	4.9	6.4	2.7	1.6	0.5	1.1	3.2	0.0	0.0	59.1	3.7	2.5	3.6	1.5	1.3	1.8	4.2	0.7	0.9	0.1	0.0	0.2	7.0	2.1	1.7	11.3	35.7	0.0	17.1	0.0	0.7	14.3	3.1	4.9	2.5	3.0	3.9	1.0	1.0	6.7	8.4	8.2	0.0	2.4	3.0	5.7	0.9	2.4	5.4	1.9	1.7	2.4	1.0	2.0	0.7	0.4	0.1	0.7	5.8	5.4	0.6	18.0	0.7	4.8	32.9	10.0	56.0	0.9	1.9	0.3	1.1	1.0	1.4	0.6	0.5	3.3
SSTR5		ENSG00000162009	"Somatostatin receptor 5"	P35346	16	1078781-1080142	"FDA approved drug targets, G-protein coupled receptors, Plasma proteins, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"heart muscle: 6.9;kidney: 2.9;pituitary gland: 7.3"	"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in single"		"hypothalamus: 1.5"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	16	"Hep G2: 15.4;PC-3: 54.7"	"Group enriched"	"Detected in some"	5	"basal ganglia: 4.1;hypothalamus: 2.3"	"Low region specificity"	"Detected in many"			HPA066503			Supported	"Plasma membrane"		NA	NA				"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 43: Cardiomyocytes - Nuclear processes"	"Plasma membrane"		"HPA066503: AB_2685679"		"unprognostic (2.16e-2)"	"unprognostic (7.31e-2)"		"unprognostic (3.69e-2)"	"unprognostic (2.39e-2)"		"unprognostic (2.14e-1)"			"unprognostic (9.89e-3)"	"unprognostic (1.72e-2)"	"unprognostic (1.72e-2)"	"unprognostic (2.06e-1)"	"unprognostic (2.05e-1)"		"unprognostic (4.09e-2)"	0.0	2.5	0.1	0.0	0.4	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	6.9	0.3	1.5	2.9	0.0	0.0	0.0	0.2	0.3	0.0	0.3	0.0	7.3	0.0	0.1	0.7	0.0	0.2	1.0	0.1	0.2	0.0	0.2	0.0	0.1	0.0	0.3	0.1	0.1	0.0	0.0	0.4	0.0	0.2	0.2	0.2	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	2.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	15.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	54.7	0.0	2.1	0.6	0.0	2.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.4	0.3	1.5	0.2	0.3	0.1	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ST7	"ETS7q, FAM4A, FAM4A1, HELG, RAY1, SEN4, TSG7"	ENSG00000004866	"Suppression of tumorigenicity 7"	Q9NRC1	7	116953238-117230176	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 184.1;Early spermatids: 131.4;Excitatory neurons: 191.5;Inhibitory neurons: 176.0;Oligodendrocyte precursor cells: 111.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"SK-BR-3: 115.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038325, HPA038326"	Approved		Supported	Nucleoplasm,Cytosol		No	No			"Cluster 15: NK-cells - Transcription"	"Cluster 68: Epididymis - Unknown function"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 64: Astrocytes - Nervous system maintenance"	Nucleoplasm	Cytosol	"HPA038325: AB_10671740, HPA038326: AB_10672644"	"unprognostic (3.40e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.33e-1)"	"unprognostic (4.70e-2)"	"unprognostic (1.09e-1)"	"unprognostic (8.18e-2)"	"unprognostic (3.32e-2)"	"unprognostic (1.74e-2)"	"unprognostic (1.02e-1)"	"unprognostic (4.45e-3)"	"unprognostic (1.46e-1)"	"unprognostic (2.48e-2)"	"prognostic favorable (3.39e-5)"	"unprognostic (1.80e-1)"	"unprognostic (1.96e-1)"	"unprognostic (8.41e-2)"	"unprognostic (3.40e-2)"	13.5	21.7	22.6	6.7	22.0	17.8	15.2	50.6	24.7	19.9	11.1	13.6	12.1	14.5	35.8	9.7	18.6	12.3	22.4	21.8	22.6	29.4	41.3	26.1	7.6	15.0	17.4	17.4	32.9	19.0	24.5	20.9	15.9	13.8	12.4	12.6	21.7	21.2	12.5	11.5	11.0	12.6	14.6	10.4	17.3	8.7	22.5	8.6	28.4	11.2	8.6	12.6	11.1	19.7	29.4	17.2	28.2	24.4	31.0	20.5	12.3	23.0	30.2	24.4	35.2	24.0	32.8	7.7	25.5	21.4	34.7	24.6	24.2	24.5	31.3	11.1	33.9	23.4	26.5	20.2	21.8	27.4	39.4	16.1	24.3	30.7	21.8	21.6	24.9	5.2	36.0	54.6	22.3	18.1	0.2	21.0	26.9	40.1	19.3	6.7	18.8	33.6	25.5	16.2	42.2	33.8	27.8	115.5	32.0	20.6	10.1	23.3	19.1	27.6	11.0	30.5	23.3	34.7	28.2	29.6	22.9	24.0	28.6	1.5	3.1	0.4	7.3	1.2	5.1	2.2	4.4	6.2	5.7	1.0	2.9	3.0	0.0	7.0	1.1	5.6	10.3	3.0	22.6	22.0	50.6	24.7	21.8	22.6	15.0	17.4	15.9	14.6	22.5	19.7	6.3	22.4	38.1	184.1	5.0	7.5	8.6	8.8	10.8	12.2	9.0	7.4	13.5	12.8	12.9	5.5	0.0	21.1	6.4	3.1	5.9	6.0	131.4	7.1	5.9	9.5	3.6	15.8	191.5	13.4	22.8	10.6	12.8	14.2	19.6	3.5	8.6	24.5	8.7	3.3	176.0	6.8	8.2	14.4	6.0	53.5	11.1	7.9	7.2	44.0	7.5	12.8	4.1	111.1	46.9	8.8	3.6	6.0	10.3	6.7	3.6	17.3	6.3	1.3	0.0	9.9	12.1	12.8	5.8	7.4	5.5	21.2	4.6	4.6	5.3	8.8
ST8SIA3	SIAT8C	ENSG00000177511	"ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 3"	O43173	18	57352557-57371731	"Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 21.7;pituitary gland: 8.1;retina: 7.5"	"Group enriched"	"Detected in some"	8	"Bipolar cells: 29.9;Excitatory neurons: 74.9;Horizontal cells: 63.9;Inhibitory neurons: 56.7;Oligodendrocyte precursor cells: 22.1"	"Group enriched"	"Detected in some"	11	"glioma: 0.9;pancreatic cancer: 1.8"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	26	"NTERA-2: 4.4;SCLC-21H: 8.6;SH-SY5Y: 9.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA063398, HPA066783"	Enhanced		Supported	"Golgi apparatus"		No	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Golgi apparatus"		"HPA063398: AB_2685004, HPA066783: AB_2685721"					"unprognostic (1.75e-1)"		"unprognostic (7.85e-2)"			"unprognostic (1.41e-2)"	"unprognostic (5.50e-2)"	"unprognostic (1.11e-1)"		"unprognostic (5.49e-2)"	"unprognostic (1.82e-1)"			0.0	4.3	8.0	0.0	21.7	0.0	0.0	6.7	15.6	0.0	0.0	0.1	0.7	0.0	0.0	0.0	0.0	0.9	0.0	12.5	14.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	3.7	0.0	8.1	0.0	0.0	0.0	0.1	7.5	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.7	2.1	0.0	0.0	0.0	0.0	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.6	9.7	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.0	21.7	6.7	15.6	12.5	14.5	0.0	0.0	0.0	0.0	2.1	4.9	0.0	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.0	29.9	0.0	0.0	1.6	5.7	0.0	0.0	2.1	0.0	0.0	0.0	0.0	1.4	2.3	0.0	0.0	0.1	0.0	0.0	74.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	63.9	56.7	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	4.7	0.0	1.2	0.0	22.1	3.8	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	3.6	0.0	0.0	0.0	2.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
STAB2	"DKFZP434E0321, FEEL-2, FELL, HARE, SCARH1, STAB-2"	ENSG00000136011	"Stabilin 2"	Q8WWQ8	12	103587273-103766719	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	Endocytosis	Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"lymphoid tissue: 65.9"	"Cell type enriched"	"Detected in some"	11	"Hepatic stellate cells: 145.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"BEWO: 11.5;HaCaT: 3.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA026871, HPA072699"	Enhanced		Supported	Cytosol		NA	NA		1200000		"Cluster 64: Macrophages - Immune response"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Cytosol		"HPA026871: AB_1857536, HPA072699: "	"unprognostic (5.66e-3)"	"unprognostic (7.51e-2)"	"unprognostic (3.31e-1)"	"unprognostic (3.84e-2)"	"unprognostic (8.47e-2)"	"unprognostic (2.15e-2)"	"unprognostic (1.23e-1)"	"unprognostic (2.81e-1)"	"unprognostic (5.72e-2)"	"unprognostic (1.92e-1)"	"unprognostic (4.24e-2)"	"unprognostic (1.05e-1)"	"unprognostic (9.72e-4)"	"unprognostic (1.37e-2)"	"unprognostic (5.00e-1)"	"unprognostic (1.26e-1)"	"unprognostic (2.06e-1)"	0.9	0.2	0.8	0.9	0.5	0.7	0.9	0.1	0.6	1.0	0.0	2.8	0.3	0.9	1.5	0.8	1.3	1.0	0.4	1.3	0.1	0.4	14.7	0.5	3.9	0.4	0.0	0.5	0.3	0.0	0.3	0.3	0.3	0.3	0.4	0.3	0.4	0.0	0.2	0.3	0.6	0.2	0.1	65.9	0.4	2.2	0.3	0.0	1.1	0.0	0.4	0.7	0.5	0.1	0.2	0.5	0.5	0.1	0.0	0.0	11.5	0.5	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	3.2	0.0	0.0	0.0	0.0	0.8	0.3	0.7	0.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.2	0.8	0.0	0.0	0.0	0.0	0.0	0.5	0.3	0.4	0.1	1.8	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.1	0.6	0.2	0.0	0.4	0.6	0.3	0.0	0.8	0.1	0.1	0.0	0.2	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.5	0.1	0.6	1.3	0.1	0.4	0.0	0.3	0.1	0.3	0.1	0.2	0.0	0.0	0.7	1.0	0.3	0.0	0.0	0.0	0.0	0.0	0.9	0.8	4.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	6.1	0.0	0.0	4.0	0.0	0.0	2.7	0.0	0.6	0.2	0.0	0.0	0.0	0.0	145.6	4.1	0.1	0.0	1.9	0.0	0.0	11.6	0.7	12.2	0.3	0.0	0.0	1.0	0.0	0.0	0.0	2.5	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.1	0.0	0.2	0.0	0.0	0.0
STAG2	"SA-2, SA2, SCC3B"	ENSG00000101972	"Stromal antigen 2"	Q8N3U4	X	123960212-124422664	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Chromosome partition, Meiosis, Mitosis"		"Cancer-related genes, Disease variant, Holoprosencephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002857	Supported		Supported	"Nucleoplasm,Nucleoli,Nucleoli fibrillar center"		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 34: Non-specific - Transcription"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 44: Endometrium - Transcription"	"Nucleoplasm, Nucleoli, Nucleoli fibrillar center"		"HPA002857: AB_1079861"	"unprognostic (1.62e-1)"	"unprognostic (1.01e-2)"	"unprognostic (6.75e-2)"	"unprognostic (2.16e-2)"	"unprognostic (1.37e-2)"	"unprognostic (2.70e-2)"	"unprognostic (3.77e-2)"	"unprognostic (9.67e-3)"	"unprognostic (4.68e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.24e-1)"	"unprognostic (3.38e-1)"	"unprognostic (1.59e-3)"	"unprognostic (2.81e-1)"	"unprognostic (2.77e-2)"	"unprognostic (1.63e-1)"	"unprognostic (3.97e-1)"	27.9	22.9	20.7	34.2	26.3	72.8	41.5	32.6	24.1	33.3	30.4	28.8	23.8	35.7	28.3	26.8	30.1	25.2	21.5	18.0	22.6	33.7	28.5	28.6	45.0	26.2	21.9	46.0	31.7	51.9	12.0	35.8	27.8	29.8	28.2	45.5	26.5	29.6	23.3	26.1	26.5	25.8	24.2	37.4	28.5	8.0	21.2	81.4	49.3	36.0	44.3	28.4	17.6	39.6	62.6	56.9	84.5	53.0	34.9	52.3	54.4	58.0	61.8	58.5	73.2	53.8	65.1	115.0	79.6	52.3	65.5	55.6	173.6	48.8	82.5	81.9	74.7	106.6	110.8	35.7	35.6	140.7	80.0	42.2	46.4	69.5	111.4	50.2	49.7	114.2	105.4	118.9	43.1	67.8	180.6	62.9	44.5	55.8	84.4	125.9	112.0	96.1	44.9	117.3	75.7	60.6	131.2	47.7	66.9	59.2	28.9	62.2	61.5	0.3	31.1	69.4	66.6	50.9	82.2	141.6	36.8	84.3	60.3	28.2	15.2	28.0	15.0	18.9	17.8	15.0	15.6	14.6	19.1	19.0	21.3	17.5	44.5	18.8	23.1	16.5	13.5	10.0	20.7	26.3	32.6	24.1	18.0	22.6	26.2	21.9	27.8	24.2	21.2	39.6	71.1	64.1	56.6	42.4	80.9	56.2	61.5	31.5	72.3	51.0	58.0	48.4	44.9	37.1	50.6	44.1	60.5	32.2	113.4	42.9	21.5	42.3	1.1	65.1	70.4	62.3	58.1	77.0	41.8	38.2	32.7	64.5	39.8	79.3	58.1	53.6	59.3	42.2	36.0	45.4	51.9	35.0	28.5	71.4	65.0	4.2	65.9	89.9	33.8	70.3	91.4	61.2	97.9	69.4	114.0	54.9	29.3	69.2	73.8	81.4	28.0	35.7	51.4	62.9	65.7	104.0	60.3	14.8	15.4	51.0	56.1	71.4	87.2	49.5	38.9	83.6
STAG3		ENSG00000066923	"Stromal antigen 3"	Q9UJ98	7	100177563-100221488	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cell cycle, Chromosome partition, Meiosis"		"Premature ovarian failure"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	66	"testis: 54.7"	"Cell type enhanced"	"Detected in many"		"B-cells: 56.5;Spermatocytes: 152.6;Spermatogonia: 60.0"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 41.7;HMC-1: 54.4;U-698: 13.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA049106, HPA058330"	Enhanced		Approved	Nucleoplasm,Nucleoli		NA	NA				"Cluster 83: Testis - Spermatogenesis"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	Nucleoli	Nucleoplasm	"HPA049106: AB_2680634, HPA058330: AB_2683681"	"unprognostic (6.56e-4)"	"prognostic favorable (8.45e-4)"	"unprognostic (1.25e-2)"	"unprognostic (7.54e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.86e-3)"	"unprognostic (3.59e-2)"	"unprognostic (4.62e-2)"	"unprognostic (1.12e-1)"	"unprognostic (3.46e-1)"	"unprognostic (3.31e-4)"	"unprognostic (4.26e-4)"	"unprognostic (7.48e-2)"	"unprognostic (6.80e-2)"	"unprognostic (2.72e-1)"	"unprognostic (3.13e-2)"	"unprognostic (5.07e-4)"	0.2	0.2	0.1	0.1	0.1	0.8	0.3	0.2	0.2	0.2	0.0	0.1	0.0	0.2	0.0	0.0	0.2	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.3	0.2	0.0	0.3	0.1	0.3	0.1	0.2	0.1	0.1	0.0	0.3	0.1	0.0	0.1	0.4	0.1	0.0	0.1	0.2	0.1	54.7	0.3	0.6	0.1	0.0	0.2	0.1	0.1	0.3	0.1	0.0	0.1	0.0	0.2	0.0	41.7	1.1	0.0	0.1	0.2	0.0	0.0	1.2	0.1	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	54.4	0.0	0.1	0.8	0.2	0.0	0.3	1.4	0.2	0.0	0.0	0.0	0.4	0.0	0.7	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.1	0.0	13.1	0.7	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.2	0.2	0.1	0.1	0.2	0.0	0.1	0.1	0.3	0.3	1.9	0.0	2.7	2.9	56.5	6.8	10.9	1.8	1.2	7.4	1.9	1.8	2.2	10.0	1.7	7.3	2.1	2.0	12.1	1.7	13.7	0.3	29.8	26.1	2.9	4.2	1.2	8.4	6.5	0.2	3.3	4.1	0.5	7.8	1.3	4.9	4.2	29.4	2.2	20.2	6.1	5.7	0.0	2.2	8.6	23.5	4.7	4.6	5.4	5.6	4.2	2.7	13.4	5.0	5.1	0.2	0.5	1.9	2.1	8.2	1.1	6.9	15.1	7.0	0.0	8.0	5.4	152.6	60.0	0.4	8.5	2.9	10.8	2.6	2.0	11.7
STAM	STAM1	ENSG00000136738	"Signal transducing adaptor molecule"	Q92783	10	17644151-17716824	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 53.1"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"T-reg: 76.5"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034399, HPA043882"	Supported		Supported	Vesicles		NA	NA		82000	"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 36: HEL - Hemostasis"	"Cluster 24: Non-specific - Transcription regulation"	Vesicles		"CAB034399: AB_2197486, HPA043882: AB_2678713"	"unprognostic (1.09e-2)"	"unprognostic (8.32e-2)"	"unprognostic (1.10e-1)"	"unprognostic (3.95e-2)"	"unprognostic (9.11e-3)"	"unprognostic (1.04e-1)"	"prognostic unfavorable (3.44e-6)"	"unprognostic (1.39e-1)"	"unprognostic (8.53e-2)"	"unprognostic (8.58e-2)"	"unprognostic (1.37e-2)"	"unprognostic (8.39e-2)"	"unprognostic (1.02e-3)"	"unprognostic (1.39e-1)"	"unprognostic (2.26e-1)"	"unprognostic (1.87e-1)"	"unprognostic (2.02e-1)"	10.8	13.3	7.7	6.9	9.7	53.1	8.9	14.0	11.8	10.7	3.4	8.0	8.2	9.0	5.8	12.2	7.8	9.1	18.0	9.2	8.7	10.2	6.9	10.9	7.5	9.8	9.5	11.4	10.4	10.3	7.4	8.5	9.8	8.7	7.7	11.2	8.5	6.1	24.5	10.0	7.3	8.5	9.6	6.8	11.4	8.1	9.1	13.1	10.8	10.1	7.5	10.9	9.0	14.7	34.8	19.8	30.8	14.2	30.1	21.9	10.3	45.1	19.8	41.0	33.1	25.9	31.7	9.1	7.2	33.9	31.7	18.2	27.6	21.1	35.0	10.9	12.7	86.3	15.3	43.1	31.8	6.5	43.7	22.7	27.0	33.6	28.3	26.6	19.8	56.3	30.1	10.5	43.8	10.4	35.7	5.6	14.7	19.7	10.2	18.0	29.0	11.9	17.5	11.2	13.0	19.2	24.6	16.7	34.6	24.1	27.5	9.4	26.6	23.9	24.5	42.7	21.1	6.6	11.5	15.6	25.6	9.6	15.6	47.5	7.5	12.5	5.9	8.2	5.6	5.4	12.8	6.2	9.6	3.1	8.8	7.1	5.9	17.3	7.5	5.5	76.5	6.4	7.7	9.7	14.0	11.8	9.2	8.7	9.8	9.5	9.8	9.6	9.1	14.7	13.2	12.8	23.4	15.7	14.1	22.9	5.3	16.2	23.9	19.7	9.4	8.9	30.0	5.7	14.0	16.5	10.4	10.2	24.3	6.4	5.9	15.1	3.5	16.3	22.3	11.0	11.4	56.8	31.7	13.4	10.5	23.5	15.8	25.9	31.6	13.0	10.4	7.8	15.5	10.1	36.9	7.8	2.0	10.4	16.3	3.5	9.6	15.6	19.6	39.4	8.4	13.7	10.3	31.7	59.4	29.9	8.0	6.0	20.8	10.1	5.7	15.6	14.0	14.5	26.3	22.3	12.6	22.1	14.6	21.8	21.0	24.6	27.6	18.4	8.1	8.5
STAM2	Hbp	ENSG00000115145	"Signal transducing adaptor molecule 2"	O75886	2	152116801-152175763	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 147.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 16.8"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035528, HPA035529"	Enhanced		Supported	Nucleoplasm,Vesicles,Cytosol		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 66: Spermatocytes - Spermatogenesis"	Vesicles	"Nucleoplasm, Cytosol"	"HPA035528: AB_10601606, HPA035529: AB_10672868"	"unprognostic (1.53e-1)"	"unprognostic (1.79e-1)"	"unprognostic (4.81e-2)"	"unprognostic (1.73e-1)"	"unprognostic (2.31e-1)"	"unprognostic (5.16e-2)"	"unprognostic (2.76e-2)"	"unprognostic (3.15e-2)"	"unprognostic (6.54e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.22e-1)"	"unprognostic (7.92e-2)"	"unprognostic (1.11e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.82e-1)"	"unprognostic (1.03e-2)"	9.7	9.9	7.3	7.9	8.3	3.1	12.5	7.5	8.9	10.9	8.0	10.3	9.3	10.9	8.7	9.1	12.8	9.3	9.6	6.3	7.7	14.6	11.0	10.8	8.7	7.5	7.9	11.0	8.8	12.8	6.5	10.3	7.9	12.9	10.9	11.1	11.9	8.9	5.8	10.8	9.3	10.1	8.0	8.3	11.7	12.6	7.4	8.5	14.3	7.7	8.9	10.7	6.6	9.7	8.3	7.9	7.2	8.8	18.5	22.0	7.7	16.8	19.4	10.7	13.6	7.8	7.8	10.8	13.1	24.2	9.4	8.3	8.0	15.6	17.1	13.3	6.3	7.8	5.1	11.8	21.2	11.5	14.6	16.9	14.6	20.0	26.8	15.5	11.7	7.2	5.1	7.5	22.2	8.1	6.1	8.9	4.5	6.1	11.2	4.9	8.9	5.9	16.7	14.1	3.8	5.9	9.3	8.2	14.1	8.0	11.1	10.5	15.3	23.7	7.6	18.8	10.3	6.1	6.7	6.8	17.9	9.2	13.2	16.8	3.4	4.6	1.7	4.6	1.6	1.7	1.8	1.9	2.7	2.0	1.5	1.9	8.6	2.6	7.1	3.2	2.2	1.6	7.3	8.3	7.5	8.9	6.3	7.7	7.5	7.9	7.9	8.0	7.4	9.7	17.6	25.6	33.5	39.2	10.9	13.8	12.0	16.4	15.9	10.6	17.9	11.6	30.5	7.2	28.9	16.5	16.7	7.4	14.7	22.1	23.5	13.9	147.8	37.2	25.5	15.1	8.3	13.5	43.8	14.2	14.6	22.7	27.0	22.2	27.1	14.8	17.5	16.0	16.7	1.7	39.7	20.2	20.3	20.0	13.0	64.4	15.8	16.9	14.2	32.8	19.6	14.7	8.2	51.8	61.0	21.2	18.2	15.4	10.9	14.3	13.9	14.8	55.6	11.6	26.3	18.0	16.1	54.1	20.1	13.5	13.2	20.2	9.3	18.2	13.5	16.1
STAMBP	AMSH	ENSG00000124356	"STAM binding protein"	O95630	2	73828916-73873659	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Metalloprotease, Protease"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in all"	12	"LHCN-M2: 1108.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035800, HPA035801"	Uncertain		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA		18000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 25: Spermatids - Spermatogenesis"	Nucleoplasm	"Plasma membrane, Cytosol"	"HPA035800: AB_10670591, HPA035801: AB_2732470"	"unprognostic (1.86e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.16e-1)"	"prognostic unfavorable (4.70e-5)"	"unprognostic (6.13e-2)"	"unprognostic (2.08e-3)"	"unprognostic (3.73e-2)"	"unprognostic (1.71e-1)"	"unprognostic (6.58e-2)"	"unprognostic (2.96e-2)"	"prognostic unfavorable (5.79e-4)"	"unprognostic (1.01e-1)"	"unprognostic (2.29e-1)"	"unprognostic (7.72e-2)"	"unprognostic (2.63e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.89e-1)"	15.6	11.6	21.7	14.6	30.6	13.3	20.2	29.7	23.8	19.3	19.3	21.5	20.7	20.6	15.5	25.4	18.3	16.9	22.3	20.6	24.5	21.9	19.0	15.7	19.3	31.3	28.0	17.7	12.2	24.3	9.3	17.3	30.4	22.1	23.2	14.6	21.5	15.6	37.4	16.7	20.4	21.3	27.9	14.9	18.2	15.8	27.1	23.2	22.6	42.8	21.6	16.8	16.0	38.6	39.0	44.0	34.0	31.6	31.1	37.2	39.1	23.3	31.7	42.1	40.3	73.7	35.9	32.2	35.8	19.8	55.7	30.0	36.6	81.7	47.6	56.6	41.3	43.3	29.1	58.1	43.4	35.8	50.0	30.1	57.6	49.6	70.7	53.5	25.1	43.7	47.9	47.8	1108.9	46.8	55.9	32.4	54.9	55.1	22.7	38.6	89.4	46.1	45.2	43.0	62.0	45.8	28.4	34.6	49.1	36.4	32.3	21.4	22.0	37.5	44.5	22.9	41.9	44.8	46.9	24.9	46.4	38.1	44.7	30.7	18.9	34.2	15.9	21.4	17.2	21.5	18.3	15.6	19.9	19.3	18.9	14.4	27.6	22.3	19.9	19.5	25.8	14.9	21.7	30.6	29.7	23.8	20.6	24.5	31.3	28.0	30.4	27.9	27.1	38.6	22.1	19.2	17.7	22.9	21.5	16.3	28.9	61.7	31.3	22.3	28.8	27.7	41.1	28.6	34.4	25.8	12.5	43.0	27.4	48.7	49.0	37.9	80.8	35.6	37.3	21.4	10.3	34.9	18.5	36.3	32.5	26.0	18.8	45.8	52.6	21.2	17.5	41.1	33.0	26.9	22.1	36.4	40.7	27.7	16.2	125.0	32.6	25.2	7.2	16.9	34.1	24.9	25.7	26.2	67.2	44.5	41.8	34.6	21.5	40.9	57.2	68.8	24.5	21.0	39.5	28.2	27.2	33.1	44.2	44.5	21.6	44.5	21.4	27.5	34.3	27.1
STARD10	"CGI-52, NY-CO-28, PCTP2, SDCCAG28"	ENSG00000214530	"StAR related lipid transfer domain containing 10"	Q9Y365	11	72754729-72794047	"Metabolic proteins, Predicted intracellular proteins"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 709.7"	"Cell type enhanced"	"Detected in all"		"Early spermatids: 520.2;Hepatocytes: 660.0;Intestinal goblet cells: 717.9;Late spermatids: 2055.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 21.7"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"MCF7: 617.7;OE19: 1316.9;SK-BR-3: 427.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026661	Uncertain		Supported	Cytosol		NA	NA		13000	"Cluster 52: Eosinophils - Transcription"	"Cluster 85: Liver - Metabolism"	"Cluster 21: OE19 - Mitochondria"	"Cluster 25: Spermatids - Spermatogenesis"	Cytosol		"HPA026661: AB_1857538"	"prognostic favorable (6.92e-4)"	"unprognostic (2.07e-1)"	"unprognostic (8.03e-2)"	"unprognostic (1.74e-3)"	"unprognostic (3.71e-2)"	"unprognostic (1.37e-2)"	"unprognostic (2.50e-2)"	"unprognostic (2.16e-1)"	"unprognostic (4.16e-1)"	"unprognostic (4.69e-2)"	"unprognostic (5.81e-2)"	"unprognostic (1.67e-1)"	"unprognostic (4.24e-3)"	"unprognostic (8.42e-2)"	"unprognostic (2.29e-1)"	"unprognostic (2.12e-2)"	"unprognostic (1.04e-1)"	11.8	178.2	35.1	17.7	37.6	10.3	62.1	39.2	41.8	71.9	40.9	180.6	48.5	27.3	102.9	52.0	26.4	59.5	72.5	33.9	34.1	50.1	709.7	37.7	14.5	38.0	33.0	31.0	212.6	73.2	36.2	40.2	38.2	86.2	188.1	18.7	94.5	30.9	66.7	62.6	66.0	26.7	29.9	20.2	266.9	184.3	34.4	15.6	47.9	157.9	21.8	24.5	41.1	35.7	51.2	15.3	7.7	28.7	9.8	9.6	98.3	5.6	26.2	17.3	17.3	209.8	36.7	4.4	16.7	19.2	42.3	31.8	23.4	46.8	20.2	28.3	9.0	5.9	11.1	217.6	35.2	1.6	10.0	6.6	127.0	19.1	26.7	47.2	17.8	10.0	12.1	21.5	3.9	617.7	4.8	11.1	3.4	1316.9	20.1	4.5	13.3	3.4	23.5	61.4	13.0	10.1	8.6	427.4	73.3	32.8	235.5	6.3	13.6	17.0	11.4	6.0	10.1	22.2	19.8	7.5	4.3	5.6	6.5	12.9	2.6	16.0	1.6	1.1	1.2	4.2	1.5	1.7	1.2	2.4	1.6	1.6	21.7	7.5	0.6	2.6	2.1	1.1	35.1	37.6	39.2	41.8	33.9	34.1	38.0	33.0	38.2	29.9	34.4	35.7	10.6	35.3	74.1	8.1	18.1	31.5	76.3	41.0	25.0	10.5	163.3	125.3	45.3	270.2	76.4	55.2	22.9	212.8	17.1	362.8	123.3	70.7	520.2	26.5	6.8	18.5	302.2	22.9	11.6	94.3	93.1	21.1	372.1	25.3	25.4	10.1	30.0	660.0	26.4	33.7	13.9	717.9	85.5	26.0	34.4	2055.8	26.1	12.3	16.0	5.6	7.7	64.4	7.2	8.0	11.8	93.9	398.9	25.2	13.3	150.9	73.5	58.0	34.5	16.6	6.6	11.3	19.6	101.2	22.7	30.2	55.0	352.2	15.6	7.7	440.7	132.7
STARD3	"es64, MLN64"	ENSG00000131748	"StAR related lipid transfer domain containing 3"	Q14849	17	39637090-39664201	"Cancer-related genes, Metabolic proteins, Predicted membrane proteins, Transporters"	"Lipid transport, Transport"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in all"	4	"SK-BR-3: 260.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017021, HPA024307, HPA073948"	Uncertain		Approved	"Nucleoplasm,Endoplasmic reticulum,Vesicles"		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 63: NK-cells & T-cells - Immune response"	"Nucleoplasm, Vesicles"	"Endoplasmic reticulum"	"CAB017021: , HPA024307: , HPA073948: "	"unprognostic (1.11e-1)"	"unprognostic (2.14e-2)"	"unprognostic (6.35e-2)"	"unprognostic (8.92e-3)"	"unprognostic (2.09e-2)"	"unprognostic (2.94e-1)"	"prognostic unfavorable (3.60e-5)"	"unprognostic (2.26e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.48e-1)"	"unprognostic (6.25e-3)"	"unprognostic (5.88e-2)"	"prognostic unfavorable (7.70e-4)"	"unprognostic (1.33e-1)"	"unprognostic (5.22e-2)"	"unprognostic (8.51e-3)"	"unprognostic (3.00e-2)"	24.8	33.4	18.3	18.8	29.1	25.4	23.4	21.6	18.9	22.3	14.9	21.5	24.1	20.4	2.7	24.1	21.5	17.2	16.3	17.9	15.4	18.9	25.8	28.8	22.3	21.1	21.3	21.3	26.5	15.2	24.0	17.1	19.0	20.1	5.2	3.2	21.2	11.3	23.9	27.0	26.7	9.2	18.7	33.1	26.5	26.2	22.5	14.8	21.4	9.5	8.8	21.0	20.1	18.5	29.3	47.6	18.6	33.5	19.9	22.9	31.2	23.1	24.9	27.1	24.3	24.0	47.6	25.2	47.7	17.8	30.8	55.4	11.3	21.0	6.3	36.2	34.5	15.2	18.8	30.1	25.9	29.6	35.5	24.5	19.0	29.8	12.6	19.0	23.4	36.4	41.0	27.4	23.5	24.7	32.2	25.6	22.2	15.3	20.6	28.5	31.4	40.1	15.0	35.7	24.9	29.1	16.1	260.8	64.0	10.8	34.1	41.7	26.3	43.2	29.5	46.5	43.6	27.5	37.8	18.7	36.2	36.8	45.1	23.7	36.3	54.4	42.7	35.5	30.7	20.8	29.6	32.7	38.3	26.1	29.1	27.8	63.6	39.6	29.3	18.7	38.5	33.8	18.3	29.1	21.6	18.9	17.9	15.4	21.1	21.3	19.0	18.7	22.5	18.5	45.8	3.2	7.5	31.0	23.2	16.6	13.0	23.4	14.2	12.6	19.9	14.6	3.4	18.6	14.8	11.0	37.5	28.5	32.9	21.0	9.8	26.5	2.7	9.7	11.7	35.8	27.5	11.1	17.3	35.4	37.2	16.2	29.6	11.0	19.0	22.2	45.0	11.9	49.8	18.5	14.8	11.6	14.2	49.0	18.5	5.3	17.1	27.7	5.4	9.4	18.5	15.8	29.9	12.1	30.2	35.9	22.9	13.2	24.3	20.2	41.5	10.3	8.3	13.2	13.1	21.8	14.4	9.3	16.2	15.9	16.9	40.0	35.2	18.6	15.1	20.1
STARD3NL	"MENTHO, MGC3251"	ENSG00000010270	"STARD3 N-terminal like"	O95772	7	38178245-38230670	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019204	Enhanced		Supported	Vesicles		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 34: Spermatids - Unknown function"	Vesicles		"HPA019204: AB_2197800"	"unprognostic (1.55e-3)"	"unprognostic (2.80e-3)"	"unprognostic (2.22e-1)"	"unprognostic (2.58e-1)"	"unprognostic (4.37e-2)"	"prognostic unfavorable (2.20e-4)"	"prognostic unfavorable (1.44e-5)"	"unprognostic (9.64e-2)"	"unprognostic (1.89e-1)"	"unprognostic (5.37e-2)"	"prognostic favorable (8.48e-4)"	"unprognostic (1.07e-1)"	"unprognostic (2.97e-1)"	"unprognostic (2.41e-2)"	"unprognostic (8.09e-3)"	"unprognostic (2.65e-1)"	"unprognostic (8.71e-2)"	26.8	21.8	35.5	23.1	37.6	37.8	22.0	39.6	41.7	31.4	29.8	21.5	18.5	32.6	27.1	12.3	27.5	22.0	27.1	35.7	44.1	34.0	17.4	32.8	21.3	42.0	46.8	24.2	16.4	17.9	25.5	49.4	48.4	40.6	23.5	26.3	14.9	21.6	17.3	6.6	20.3	33.1	40.5	27.1	17.6	32.7	41.8	22.3	32.7	17.5	15.3	29.4	14.8	42.9	40.9	42.7	92.6	60.4	62.8	62.2	32.4	65.2	67.2	63.2	82.4	34.3	63.0	31.9	64.0	59.9	192.0	42.9	51.4	49.5	95.2	29.0	45.1	64.8	22.1	47.4	55.3	71.5	72.7	58.8	24.0	67.0	53.0	72.0	116.7	86.1	75.0	53.7	98.4	25.1	40.9	115.2	65.5	33.7	33.9	49.6	85.9	14.9	89.0	37.5	36.9	86.7	22.4	58.8	64.1	127.0	40.9	93.8	80.0	43.0	61.0	67.8	93.5	57.4	62.2	12.1	87.0	125.6	142.4	33.5	46.8	56.2	52.2	43.3	23.9	30.8	21.6	39.3	42.3	28.4	18.1	35.6	53.1	71.8	47.0	30.3	24.8	47.1	35.5	37.6	39.6	41.7	35.7	44.1	42.0	46.8	48.4	40.5	41.8	42.9	45.8	19.2	47.3	15.0	33.2	20.8	57.3	43.4	20.5	8.7	26.8	15.0	18.2	14.3	25.9	31.3	12.5	48.3	67.2	15.5	31.3	31.4	125.3	37.0	42.5	45.5	21.5	28.2	21.9	34.3	91.2	34.2	19.9	33.1	23.5	36.0	51.0	12.4	65.8	5.0	24.5	20.9	32.6	63.2	77.9	115.2	18.3	56.8	26.6	17.8	24.2	34.6	114.4	27.6	26.0	34.0	21.6	25.9	34.3	55.2	19.4	50.1	22.8	13.0	13.1	23.4	38.4	48.8	37.3	12.2	16.2	42.3	47.5	24.5	19.5	46.4
STAT2	STAT113	ENSG00000170581	"Signal transducer and activator of transcription 2"	P52630	12	56341597-56360167	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Antiviral defense, Host-virus interaction, Transcription, Transcription regulation"	"Activator, DNA-binding"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 111.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003858, HPA018888"	Approved		Supported	"Plasma membrane,Cytosol"		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 64: Macrophages - Immune response"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 59: Non-specific - Transcription"	Cytosol	"Plasma membrane"	"CAB003858: AB_562227, HPA018888: AB_1857550"	"unprognostic (3.03e-1)"	"unprognostic (8.59e-2)"	"unprognostic (6.92e-3)"	"prognostic unfavorable (4.75e-4)"	"unprognostic (1.10e-1)"	"unprognostic (1.52e-1)"	"unprognostic (7.27e-2)"	"unprognostic (1.93e-1)"	"unprognostic (2.60e-1)"	"unprognostic (4.12e-3)"	"unprognostic (1.56e-1)"	"unprognostic (7.45e-3)"	"prognostic unfavorable (4.78e-13)"	"unprognostic (1.88e-1)"	"unprognostic (5.56e-2)"	"unprognostic (2.77e-1)"	"unprognostic (1.46e-3)"	17.3	6.3	2.6	19.2	2.3	7.8	10.3	2.7	3.1	18.7	2.9	10.7	10.7	11.3	5.6	11.1	12.9	20.1	8.1	3.1	2.3	8.4	20.6	22.8	19.6	4.2	2.0	17.4	9.9	12.4	8.6	15.9	3.1	10.3	12.5	5.6	18.1	9.9	4.0	7.8	13.0	21.8	5.9	25.2	10.3	4.0	4.6	19.9	10.7	8.4	20.1	18.4	5.6	6.2	15.5	8.5	11.8	12.5	98.3	58.6	26.1	19.4	94.0	92.4	93.1	8.7	16.4	17.9	22.6	38.6	24.2	14.9	21.0	15.1	18.0	13.8	4.7	27.2	7.6	9.3	58.8	5.0	20.2	86.8	13.4	19.5	22.8	70.5	25.6	14.3	15.2	44.7	35.1	9.4	7.3	3.5	5.2	15.1	9.8	6.9	22.1	17.1	21.3	18.1	4.2	10.1	31.5	18.8	43.1	22.7	16.4	17.7	11.2	22.2	10.7	8.0	3.1	32.5	32.9	9.8	30.3	7.2	9.9	14.8	17.2	11.3	7.7	22.8	7.9	5.2	7.4	7.7	11.6	7.5	5.2	5.1	6.8	4.8	18.3	10.2	9.8	13.1	2.6	2.3	2.7	3.1	3.1	2.3	4.2	2.0	3.1	5.9	4.6	6.2	36.0	12.8	41.7	40.5	24.0	14.3	10.3	13.7	17.1	17.0	17.4	15.0	11.1	15.7	24.4	18.4	20.9	11.2	28.1	23.8	1.9	14.0	13.8	20.7	36.4	26.5	15.5	8.6	29.8	10.7	24.5	27.6	19.9	26.6	10.1	24.6	27.8	64.8	25.9	3.3	28.6	16.8	6.1	50.9	25.6	43.7	19.6	45.2	32.0	24.4	42.3	10.4	18.6	27.6	111.8	11.9	21.9	17.3	24.4	11.4	24.0	10.7	24.2	21.8	26.3	20.3	22.5	3.2	5.0	12.5	14.5	11.1	20.1	13.7	14.8	13.2
STAT3	APRF	ENSG00000168610	"Signal transducer and activator of transcription 3"	P40763	17	42313324-42388540	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Host-virus interaction, Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes, Diabetes mellitus, Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001671, CAB003859, HPA058603, CAB068241, CAB068242"	Supported		Supported	Nucleoplasm,Cytosol		NA	NA		55000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 46: Photoreceptor cells - Phototransduction"	"Nucleoplasm, Cytosol"		"CAB003859: AB_347629, CAB068241: AB_2665663, CAB068242: AB_2665662, HPA001671: AB_1080102, HPA058603: AB_2683772"	"unprognostic (1.83e-2)"	"unprognostic (2.42e-1)"	"unprognostic (9.23e-3)"	"unprognostic (2.91e-1)"	"unprognostic (5.59e-3)"	"unprognostic (1.78e-2)"	"unprognostic (8.26e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.77e-1)"	"unprognostic (2.21e-1)"	"unprognostic (1.26e-1)"	"unprognostic (6.47e-3)"	"unprognostic (7.75e-3)"	"unprognostic (2.21e-2)"	"unprognostic (7.63e-2)"	"unprognostic (1.61e-1)"	105.6	68.1	32.4	78.5	34.5	63.2	84.4	38.7	30.2	62.6	32.4	76.9	45.9	71.6	28.2	81.6	74.0	71.7	101.2	28.6	44.6	77.2	143.1	106.0	55.3	48.4	40.7	65.4	67.3	35.3	53.3	55.6	43.4	62.9	46.5	29.9	63.5	48.2	123.9	66.8	68.1	72.1	43.9	68.0	62.3	24.6	43.0	50.5	61.9	92.1	65.2	88.6	64.3	43.1	61.5	116.0	47.4	48.2	103.7	97.6	35.4	66.5	89.7	59.6	58.3	30.3	55.8	18.5	68.2	71.2	90.3	89.2	45.8	72.6	47.7	160.6	31.4	131.2	60.4	62.4	77.3	31.8	79.0	152.1	69.8	47.4	68.9	62.2	81.1	33.4	80.1	56.4	40.1	43.8	118.7	31.3	28.5	63.4	0.0	26.6	133.8	28.1	91.3	77.2	45.2	29.8	81.4	184.9	29.2	57.2	100.5	49.1	68.7	88.9	44.9	54.8	56.5	82.9	75.3	16.4	56.1	32.8	41.6	121.1	78.4	100.0	79.5	79.9	64.4	40.2	57.5	62.6	54.3	36.6	58.7	56.5	262.6	58.3	80.8	29.3	47.9	124.5	32.4	34.5	38.7	30.2	28.6	44.6	48.4	40.7	43.4	43.9	43.0	43.1	216.0	93.0	173.7	46.0	111.6	129.5	105.3	76.8	138.3	92.6	147.1	113.0	59.7	54.3	103.2	134.3	281.5	25.2	115.1	148.9	17.6	83.2	33.5	129.3	187.0	164.7	124.0	54.3	24.2	96.8	38.2	154.0	109.1	153.9	142.0	86.3	115.3	115.7	69.1	25.2	35.8	97.8	69.2	71.0	121.7	13.7	71.7	111.7	72.9	51.5	94.1	131.3	78.2	30.7	41.7	82.9	94.5	60.9	104.6	147.9	206.4	46.3	88.5	406.7	65.7	189.5	169.7	31.5	15.3	93.4	160.1	31.2	170.2	102.3	117.5	90.6
STAT6	"D12S1644, IL-4-STAT"	ENSG00000166888	"Signal transducer and activator of transcription 6"	P42226	12	57095408-57132139	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001861	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 64: Macrophages - Immune response"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	Cytosol	Nucleoplasm	"HPA001861: AB_1080106"	"unprognostic (3.43e-3)"	"unprognostic (1.87e-1)"	"unprognostic (1.37e-1)"	"prognostic favorable (1.69e-4)"	"unprognostic (4.14e-2)"	"unprognostic (2.51e-1)"	"unprognostic (2.22e-1)"	"unprognostic (6.70e-2)"	"unprognostic (1.88e-2)"	"unprognostic (3.65e-1)"	"unprognostic (5.39e-2)"	"unprognostic (1.00e-2)"	"unprognostic (2.81e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.55e-1)"	"prognostic favorable (7.76e-4)"	"prognostic favorable (1.14e-4)"	76.0	84.0	22.5	68.1	24.2	40.1	67.6	19.0	25.4	85.4	29.7	91.3	79.0	81.9	49.0	93.3	82.4	66.2	50.2	22.3	21.3	68.8	75.2	83.4	78.3	22.6	20.6	93.3	48.8	52.9	18.9	45.0	22.2	81.5	71.1	3.5	70.1	68.6	14.3	108.2	99.0	80.5	21.4	111.3	78.5	15.0	24.4	81.7	57.5	20.5	91.9	96.8	81.7	22.8	60.2	55.2	13.8	24.3	153.2	138.4	39.7	53.5	103.3	49.5	37.7	26.8	78.8	145.8	78.1	106.4	0.2	82.0	18.7	89.2	38.1	70.5	4.4	32.0	57.5	32.8	93.0	39.0	97.5	213.5	75.1	67.3	55.9	145.4	91.8	45.7	23.3	19.2	69.5	21.3	44.9	41.5	20.3	81.1	12.6	50.4	1.3	49.6	95.6	92.9	0.3	1.2	46.7	35.3	45.6	19.1	53.4	90.8	68.2	0.6	30.7	51.9	0.4	0.1	1.0	35.4	48.6	39.2	67.3	12.6	19.6	11.1	6.9	19.1	6.9	8.0	6.3	6.2	14.1	6.4	5.4	5.7	34.4	6.0	15.0	6.3	6.7	26.8	22.5	24.2	19.0	25.4	22.3	21.3	22.6	20.6	22.2	21.4	24.4	22.8	27.6	48.1	60.8	5.5	45.1	29.8	44.3	33.4	31.3	1.8	23.8	21.2	15.1	27.1	43.3	49.7	0.0	2.0	38.4	80.4	15.6	38.2	8.0	35.8	33.1	32.0	33.0	26.3	13.1	36.1	10.2	36.9	80.0	51.9	58.2	27.6	38.9	41.0	36.4	0.0	1.3	40.3	24.4	73.2	51.7	17.9	59.4	54.5	21.4	26.2	66.9	3.4	42.2	0.5	1.1	45.1	63.4	50.8	10.6	49.2	80.0	27.9	53.1	1.0	26.3	20.9	31.7	1.0	1.4	37.1	32.8	6.3	31.2	29.2	42.9	62.0
STAU2	39K2	ENSG00000040341	"Staufen double-stranded RNA binding protein 2"	Q9NUL3	8	73420369-73747708	"Predicted intracellular proteins"	Transport	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 278.9;Inhibitory neurons: 298.3;Oligodendrocyte precursor cells: 157.8;Oligodendrocytes: 149.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"MOLT-4: 152.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019155, CAB020836"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm	Cytosol	"CAB020836: , HPA019155: AB_1857565"	"unprognostic (5.75e-2)"	"unprognostic (3.39e-1)"	"unprognostic (2.31e-3)"	"unprognostic (2.47e-2)"	"unprognostic (3.76e-1)"	"unprognostic (6.27e-2)"	"unprognostic (1.07e-2)"	"unprognostic (1.18e-1)"	"unprognostic (6.36e-2)"	"unprognostic (4.01e-2)"	"unprognostic (3.31e-2)"	"unprognostic (1.89e-1)"	"unprognostic (3.62e-3)"	"unprognostic (9.94e-2)"	"unprognostic (2.98e-1)"	"unprognostic (6.44e-3)"	"unprognostic (4.25e-2)"	20.2	22.7	24.8	15.8	30.5	24.6	17.8	35.0	39.6	15.3	5.5	17.6	14.9	18.2	19.0	35.1	16.6	24.2	70.6	34.8	22.8	29.5	25.7	17.3	19.3	25.3	25.6	18.2	16.1	29.6	12.5	17.6	25.0	20.9	18.6	34.6	20.5	20.8	110.6	15.0	20.8	23.4	16.2	16.7	16.3	16.8	20.7	35.0	22.9	110.0	22.0	20.8	14.2	35.3	34.7	40.7	63.5	34.5	35.5	25.2	19.3	30.4	27.5	27.1	35.4	15.6	36.0	55.1	31.5	23.9	24.3	27.2	44.5	29.2	39.1	56.1	21.2	74.7	19.4	25.5	18.6	28.4	25.8	18.1	21.6	23.2	15.1	55.8	54.8	48.2	50.5	24.2	36.8	22.6	152.7	22.5	31.4	57.5	26.8	44.9	29.6	46.3	57.6	38.1	24.0	40.2	16.4	43.1	27.4	46.8	51.2	33.3	43.4	26.3	46.0	26.2	22.7	39.4	41.7	51.8	29.3	42.3	22.1	24.4	18.0	42.8	28.6	17.9	21.5	15.7	19.0	24.3	18.4	17.9	16.6	21.7	30.8	44.4	22.8	25.1	26.0	12.8	24.8	30.5	35.0	39.6	34.8	22.8	25.3	25.6	25.0	16.2	20.7	35.3	20.4	9.6	31.1	120.8	22.5	10.6	15.4	16.7	8.6	29.1	24.6	11.8	75.7	21.5	40.7	20.2	41.7	18.4	27.1	22.5	43.0	22.7	22.0	18.6	11.6	26.2	29.9	14.7	278.9	21.7	10.0	20.2	21.4	25.5	20.3	21.8	38.2	58.0	16.1	28.6	298.3	17.6	18.3	24.1	16.8	32.2	9.0	22.5	16.0	129.3	16.9	26.9	43.3	157.8	149.9	17.6	16.5	9.4	20.2	10.9	102.1	37.6	27.6	22.2	0.0	15.8	21.8	12.5	13.8	22.1	19.2	12.2	21.6	20.5	16.1	18.5
STEAP2	"IPCA-1, PCANAP1, STAMP1, STMP"	ENSG00000157214	"STEAP2 metalloreductase"	Q8NFT2	7	90167590-90238137	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Electron transport, Ion transport, Iron transport, Transport"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"prostate: 127.7"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 68.0;Inhibitory neurons: 53.0;Prostatic glandular cells: 102.9"	"Cancer enriched"	"Detected in many"	12	"prostate cancer: 88.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A549: 22.5;CAPAN-2: 48.1;U-138 MG: 27.4"	"Low region specificity"	"Detected in all"							"HPA029115, HPA055603"	Uncertain		Supported	Vesicles		NA	NA				"Cluster 51: Non-specific - Unknown function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 35: Glandular cells - Unknown function"	Vesicles		"HPA029115: AB_10603894, HPA055603: "	"unprognostic (6.26e-3)"	"unprognostic (2.48e-1)"	"unprognostic (2.55e-1)"	"unprognostic (1.65e-1)"	"unprognostic (8.20e-4)"	"unprognostic (2.34e-1)"	"unprognostic (1.13e-1)"	"unprognostic (3.67e-3)"	"unprognostic (7.91e-2)"	"unprognostic (1.70e-1)"	"unprognostic (9.92e-2)"	"unprognostic (1.34e-1)"	"unprognostic (2.71e-2)"	"unprognostic (9.73e-2)"	"unprognostic (6.11e-2)"	"unprognostic (9.86e-5)"	"unprognostic (3.69e-2)"	20.0	3.7	7.3	11.9	10.4	0.0	13.0	8.3	18.5	9.5	6.9	15.1	6.1	7.1	2.7	6.9	14.3	10.1	15.1	11.2	6.9	6.8	4.0	20.5	0.4	3.1	5.0	17.2	8.1	10.1	19.4	0.2	3.8	127.7	7.6	3.9	11.9	6.9	1.4	4.7	9.1	10.8	5.4	2.7	11.0	1.1	6.4	3.3	7.9	1.6	1.7	15.8	9.0	5.7	3.2	22.5	0.5	6.3	11.5	11.1	0.3	2.8	5.8	0.4	0.8	4.2	48.1	0.0	0.3	7.5	8.8	1.8	4.9	3.5	0.8	0.0	4.7	0.0	0.1	1.1	1.0	0.0	0.1	8.1	0.8	11.5	2.3	9.4	6.1	0.0	0.0	0.4	6.6	0.0	0.0	0.7	9.1	0.0	2.5	0.0	0.0	0.2	10.3	6.6	0.7	2.1	3.5	0.0	0.1	1.0	16.8	0.0	5.1	27.4	6.0	3.8	2.4	0.1	0.0	0.0	11.7	0.0	1.1	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	7.3	10.4	8.3	18.5	11.2	6.9	3.1	5.0	3.8	5.4	6.4	5.7	0.6	0.0	1.1	18.6	0.2	4.8	21.6	20.6	9.1	7.5	16.1	10.3	18.0	18.6	19.4	12.9	2.1	0.0	0.1	15.9	0.0	1.1	0.5	2.8	3.7	2.2	15.7	2.7	68.0	7.4	0.0	27.6	10.7	2.9	0.0	30.4	3.6	5.8	0.0	1.7	53.0	9.8	10.2	0.0	6.2	0.8	15.5	0.7	0.0	2.8	0.0	23.1	0.0	27.6	2.6	11.4	24.0	15.4	0.0	102.9	13.1	10.8	16.0	1.3	0.0	14.7	5.8	3.1	6.2	4.1	5.4	0.0	0.5	9.8	13.8	25.3
STEAP4	"FLJ23153, SchLAH, STAMP2, TIARP, TNFAIP9"	ENSG00000127954	"STEAP4 metalloreductase"	Q687X5	7	88270892-88306894	"Enzymes, Predicted membrane proteins, Transporters"	"Electron transport, Ion transport, Iron transport, Transport"	Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adipose tissue: 113.7"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 402.5;Club cells: 152.8;Sertoli cells: 460.2;Smooth muscle cells: 255.3"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 45.9"	"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in some"	12	"neutrophil: 163.6"	"Lineage enriched"	"Detected in many"	12	"granulocytes: 163.6"	"Group enriched"	"Detected in some"	6	"HSkMC: 122.1;SiHa: 119.7;U-2197: 166.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA065201			Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 18: U-2197 - ECM organization"	"Cluster 48: Smooth muscle cells - ECM organization"	"Nucleoplasm, Plasma membrane"		"HPA065201: "	"unprognostic (3.76e-2)"	"unprognostic (2.16e-2)"	"unprognostic (8.82e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.62e-1)"	"unprognostic (9.96e-2)"	"prognostic favorable (2.97e-4)"	"unprognostic (7.40e-2)"	"unprognostic (3.12e-1)"	"unprognostic (4.66e-2)"	"unprognostic (4.21e-1)"	"unprognostic (2.98e-1)"	"unprognostic (7.51e-3)"	"prognostic unfavorable (5.77e-4)"	"unprognostic (1.72e-1)"	"unprognostic (2.00e-1)"	"unprognostic (4.53e-2)"	113.7	46.3	1.0	31.7	0.9	7.1	68.6	2.8	1.5	21.3	17.0	13.3	3.8	17.9	7.8	15.4	36.1	22.7	24.1	1.4	1.0	11.8	24.3	67.5	7.2	1.2	0.9	4.4	10.6	16.0	13.0	15.3	0.8	60.0	9.2	1.9	26.8	10.6	13.4	19.3	10.6	29.3	0.4	5.4	10.6	13.4	1.1	7.8	53.1	16.6	5.1	34.3	22.7	1.1	4.9	0.0	0.1	0.1	0.1	1.9	0.3	0.0	0.3	0.0	0.1	0.1	23.6	0.1	0.1	0.0	0.4	18.7	0.1	0.0	0.1	0.0	0.1	0.1	7.9	0.1	0.1	0.1	0.2	122.1	0.1	0.4	0.9	0.0	0.0	0.1	0.3	0.4	0.0	3.0	0.1	0.5	0.1	1.0	0.0	0.2	0.1	0.3	0.0	0.3	0.2	0.2	119.7	9.9	0.0	0.1	0.8	0.0	0.1	0.4	0.3	166.4	0.1	0.1	0.1	0.1	0.2	0.9	0.2	0.4	13.5	1.4	0.0	0.8	0.0	0.0	0.0	0.0	1.0	0.1	0.0	0.0	163.6	0.2	0.1	0.3	0.0	3.2	1.0	0.9	2.8	1.5	1.4	1.0	1.2	0.9	0.8	0.4	1.1	1.1	77.2	54.5	402.5	0.0	0.8	9.4	5.8	8.6	1.8	1.8	21.6	8.3	9.1	0.0	152.8	0.0	2.1	0.4	1.1	0.4	0.0	14.6	23.8	14.6	20.5	14.7	0.0	0.0	0.5	9.6	10.6	39.8	1.1	51.2	16.4	0.0	15.4	0.7	2.8	0.0	0.8	0.2	16.2	7.2	7.4	10.9	114.9	12.2	5.4	6.5	19.0	2.7	0.0	1.0	0.1	18.6	0.0	9.1	0.2	49.3	0.1	0.1	72.8	0.3	460.2	9.6	255.3	0.9	0.3	1.5	18.8	10.9	3.1	57.7	0.2	16.6
STING1	"ERIS, FLJ38577, MITA, MPYS, NET23, STING, TMEM173"	ENSG00000184584	"Stimulator of interferon response cGAMP interactor 1"	Q86WV6	5	139475533-139482935	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Autophagy, Host-virus interaction, Immunity, Innate immunity"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"Adipocytes: 25.3;Cardiomyocytes: 27.7;dendritic cells: 17.0;Hofbauer cells: 67.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 64.4;EFO-21: 83.8;HDLM-2: 200.5;THP-1: 73.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA038116, HPA038534"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 64: Macrophages - Immune response"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 24: Non-specific - Transcription regulation"	Cytosol	Nucleoplasm	"HPA038116: AB_2675841, HPA038534: AB_2676067"	"unprognostic (1.45e-1)"	"unprognostic (4.10e-3)"	"unprognostic (1.29e-1)"	"unprognostic (2.23e-2)"	"unprognostic (2.70e-2)"	"unprognostic (1.71e-2)"	"unprognostic (7.66e-2)"	"unprognostic (2.77e-2)"	"unprognostic (6.30e-2)"	"unprognostic (1.01e-1)"	"unprognostic (5.69e-2)"	"unprognostic (1.30e-1)"	"prognostic unfavorable (3.59e-8)"	"unprognostic (9.18e-3)"	"unprognostic (4.14e-2)"	"unprognostic (4.45e-2)"	"unprognostic (1.34e-1)"	38.9	9.3	4.6	18.4	5.0	16.9	26.2	4.4	5.4	32.6	12.8	16.6	6.7	25.0	6.8	21.5	36.2	11.9	35.7	4.3	4.9	17.3	5.5	48.1	15.0	5.5	4.9	21.9	5.4	3.3	11.8	12.9	5.1	20.7	11.6	0.3	24.5	15.5	7.5	15.5	19.0	18.7	5.3	37.8	11.6	3.1	6.0	12.4	20.2	8.5	27.1	21.7	28.4	4.8	2.9	0.7	0.2	0.0	4.0	12.0	0.2	15.3	64.4	7.6	24.4	0.0	18.8	0.0	83.8	49.0	1.9	10.8	0.4	22.9	4.8	200.5	3.3	13.5	6.6	0.8	7.5	4.1	0.8	16.2	1.2	4.6	5.7	12.8	27.8	1.4	3.9	58.3	33.6	0.0	2.2	24.1	0.1	0.8	4.7	0.7	6.1	18.0	9.4	7.0	5.8	0.0	6.5	5.3	16.0	0.6	0.7	73.3	17.2	1.9	1.3	6.8	5.6	0.0	20.0	0.1	0.3	56.2	11.3	16.6	60.9	0.1	56.9	40.0	29.3	0.6	57.4	47.8	55.6	0.3	40.3	35.0	5.0	90.6	17.5	19.2	65.3	60.6	4.6	5.0	4.4	5.4	4.3	4.9	5.5	4.9	5.1	5.3	6.0	4.8	25.3	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	27.7	0.0	0.0	0.0	0.0	0.8	17.0	0.0	0.0	0.0	0.0	0.0	0.0	8.6	0.0	0.0	0.0	0.0	0.6	8.4	0.0	0.0	0.0	0.0	0.0	0.0	67.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.4	0.0	0.0	0.0	0.0	1.8	5.8	0.0	0.0	0.0
STK11	"LKB1, PJS"	ENSG00000118046	"Serine/threonine kinase 11"	Q15831	19	1177558-1228431	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Apoptosis, Autophagy, Cell cycle, Differentiation, DNA damage, Spermatogenesis"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Disease variant, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 154.9;Late spermatids: 338.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 9.9"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016231, HPA017254, CAB022105, HPA067481"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 59: Non-specific - Translation"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 31: Spermatids - Spermatogenesis"	Nucleoplasm	Cytosol	"CAB016231: AB_627890, CAB022105: , HPA017254: AB_1852924, HPA067481: AB_2685847"	"unprognostic (8.60e-2)"	"unprognostic (1.68e-1)"	"unprognostic (5.00e-2)"	"prognostic favorable (3.69e-5)"	"unprognostic (2.04e-2)"	"prognostic favorable (1.96e-4)"	"unprognostic (9.11e-3)"	"unprognostic (3.19e-1)"	"unprognostic (9.08e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.95e-3)"	"unprognostic (7.70e-3)"	"unprognostic (3.54e-2)"	"unprognostic (3.16e-2)"	"unprognostic (1.60e-1)"	"unprognostic (3.31e-1)"	"unprognostic (3.12e-3)"	32.1	44.2	18.8	18.2	15.5	34.1	32.3	24.8	23.5	35.4	24.7	38.7	25.6	33.6	5.5	39.7	34.9	11.8	48.4	18.3	14.7	36.4	45.5	30.5	20.5	19.2	19.4	37.9	34.2	16.1	36.8	12.6	15.2	39.3	7.7	5.7	29.7	16.1	108.2	40.2	37.7	9.6	16.3	48.3	38.1	102.4	17.6	15.0	34.3	27.7	12.9	34.4	35.0	14.9	50.0	25.8	19.9	35.9	18.6	17.0	35.5	24.0	27.7	25.1	25.4	22.5	37.1	31.9	24.8	27.8	11.2	32.3	20.1	41.9	8.2	60.2	37.8	34.8	1.7	26.4	38.1	36.6	53.5	30.5	28.9	19.4	29.2	22.3	25.2	28.1	63.1	51.1	13.9	39.3	31.9	27.7	33.0	19.6	25.1	50.0	20.0	36.1	21.1	39.7	39.8	26.6	0.0	19.7	24.2	11.4	30.3	55.2	33.7	24.6	25.0	45.2	38.7	85.3	38.1	25.7	22.6	48.1	25.5	1.7	3.3	3.9	0.4	5.5	0.3	2.3	0.8	1.4	1.6	0.7	0.7	0.6	9.9	1.4	5.7	0.8	0.6	0.5	18.8	15.5	24.8	23.5	18.3	14.7	19.2	19.4	15.2	16.3	17.6	14.9	24.5	6.4	13.7	12.7	10.5	16.7	7.4	9.5	9.6	25.5	22.0	18.4	13.7	15.7	9.0	23.9	18.8	7.5	20.1	44.4	7.9	9.4	154.9	18.0	18.1	15.7	15.0	27.3	7.9	14.0	5.3	13.2	21.9	17.8	2.5	80.3	15.4	31.6	15.2	18.5	8.5	33.1	6.1	18.3	26.4	338.7	24.5	20.7	16.0	11.2	20.4	21.2	9.2	9.0	6.5	16.7	29.3	20.7	10.2	15.1	27.5	11.0	9.3	21.0	13.1	21.5	23.7	85.5	20.1	14.6	15.5	8.8	16.6	45.2	35.4	12.6
STK16	"MPSK, PKL12"	ENSG00000115661	"Serine/threonine kinase 16"	O75716	2	219245455-219250337	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029450	Approved		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 22: NK-cells - Unknown function"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 34: Spermatids - Unknown function"	Cytosol	"Nucleoplasm, Plasma membrane"	"HPA029450: AB_10603118"	"unprognostic (1.99e-1)"	"unprognostic (2.08e-1)"	"unprognostic (5.84e-2)"	"prognostic favorable (6.09e-4)"	"unprognostic (6.21e-2)"	"unprognostic (5.55e-2)"	"unprognostic (4.98e-3)"	"unprognostic (4.25e-1)"	"unprognostic (1.48e-1)"	"unprognostic (4.22e-2)"	"unprognostic (1.73e-2)"	"unprognostic (3.17e-1)"	"unprognostic (4.39e-3)"	"unprognostic (1.76e-1)"	"unprognostic (2.00e-1)"	"unprognostic (2.68e-1)"	"unprognostic (1.34e-1)"	15.2	24.9	17.6	11.8	17.5	15.0	16.2	16.3	20.5	14.0	19.5	20.0	17.3	13.8	20.8	22.8	18.1	13.0	19.0	16.5	16.8	26.5	43.2	14.3	17.6	17.9	17.5	14.8	30.9	22.7	19.8	9.2	16.9	20.3	13.5	7.9	20.0	10.9	14.4	17.3	17.8	9.9	17.4	21.2	24.2	27.7	18.6	20.5	19.3	8.2	14.5	17.8	14.8	16.5	14.1	18.8	15.7	13.2	40.0	40.0	17.9	17.8	23.6	14.3	14.7	21.2	31.0	8.3	24.4	32.0	23.4	14.5	18.5	30.0	7.8	20.0	19.8	17.7	15.4	19.1	34.9	17.6	20.1	40.1	48.1	20.8	57.4	29.8	17.9	18.7	23.1	21.5	26.8	27.1	19.4	38.0	14.5	25.7	10.3	18.1	17.5	24.9	32.2	16.1	12.3	14.6	5.8	25.5	39.0	11.2	27.4	36.4	13.7	20.6	14.0	16.4	17.4	25.9	12.1	19.5	22.9	18.4	18.3	1.6	7.0	5.3	4.9	3.8	5.5	7.2	6.0	9.2	6.8	6.0	6.1	7.9	4.1	14.5	3.1	5.8	7.3	8.7	17.6	17.5	16.3	20.5	16.5	16.8	17.9	17.5	16.9	17.4	18.6	16.5	11.8	6.4	5.6	3.6	22.4	9.8	18.1	32.6	24.5	7.9	31.8	31.8	9.5	24.3	19.7	7.3	16.7	24.0	23.6	27.6	68.4	40.3	87.2	21.4	13.3	14.0	25.8	36.0	2.2	58.5	25.0	15.8	17.3	12.9	8.2	17.9	12.5	43.7	28.4	13.5	2.7	38.7	16.2	27.1	17.6	70.3	15.2	17.8	21.4	0.0	38.4	22.1	44.3	4.0	6.8	33.3	44.3	13.5	27.6	18.6	58.9	80.2	19.6	19.1	0.0	11.9	19.2	43.1	9.6	28.2	11.2	12.9	22.1	33.6	34.2	20.8
STK17A	DRAK1	ENSG00000164543	"Serine/threonine kinase 17a"	Q9UEE5	7	43582758-43650713	"Enzymes, Metabolic proteins, Plasma proteins, Predicted membrane proteins"	Apoptosis	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 644.6;T-cells: 273.7;Urothelial cells: 326.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA018138, HPA037979"	Uncertain		Supported	"Nuclear speckles,Plasma membrane"		Yes	No			"Cluster 48: NK-cells - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 22: Epithelial cell types - Mixed function"	"Nuclear speckles"	"Plasma membrane"	"HPA018138: AB_2669784, HPA037979: AB_10795247"	"unprognostic (1.81e-3)"	"unprognostic (1.08e-2)"	"unprognostic (2.67e-1)"	"unprognostic (5.41e-2)"	"unprognostic (5.11e-2)"	"unprognostic (3.35e-2)"	"unprognostic (1.03e-2)"	"unprognostic (9.15e-3)"	"unprognostic (2.07e-1)"	"unprognostic (6.34e-2)"	"unprognostic (1.36e-2)"	"unprognostic (6.61e-2)"	"unprognostic (2.99e-3)"	"unprognostic (3.76e-2)"	"unprognostic (3.08e-1)"	"unprognostic (1.97e-3)"	"unprognostic (3.66e-1)"	6.7	8.1	3.9	7.9	4.2	4.8	5.2	6.9	4.9	4.0	4.0	6.4	3.2	3.5	1.2	7.2	3.9	5.3	10.8	4.0	4.1	6.3	4.6	9.4	14.4	3.4	4.4	6.2	9.1	0.8	4.2	3.2	3.6	4.3	2.4	5.5	5.8	2.1	9.9	4.6	11.5	3.3	3.6	12.6	9.5	9.0	4.3	9.0	3.8	2.5	13.5	5.6	5.0	3.1	5.8	8.2	9.0	5.3	7.8	8.3	1.9	12.3	15.1	6.6	5.9	7.5	3.1	7.9	20.2	15.3	17.8	8.5	3.6	17.4	10.4	16.9	7.0	9.3	8.2	8.4	4.9	21.1	5.6	6.4	26.4	8.2	8.6	36.4	12.6	11.0	16.7	15.1	9.6	3.6	18.2	8.0	17.3	4.1	18.3	8.4	6.9	14.2	15.6	6.7	6.9	11.2	8.1	8.5	6.1	13.6	6.5	10.8	16.9	20.7	8.3	14.3	17.2	13.3	11.2	13.5	18.4	14.0	31.7	0.5	0.0	2.7	2.0	0.0	1.5	2.4	2.0	3.2	0.1	2.2	3.0	3.0	1.6	4.9	0.1	0.4	1.3	0.9	3.9	4.2	6.9	4.9	4.0	4.1	3.4	4.4	3.6	3.6	4.3	3.1	44.2	121.8	33.1	29.0	237.8	181.9	644.6	64.5	99.6	2.9	17.7	37.8	28.7	7.2	69.8	20.2	10.4	54.8	222.3	54.4	33.2	153.0	47.0	129.1	17.4	35.2	7.2	54.1	9.5	95.4	23.3	39.1	78.0	88.3	38.8	17.7	17.9	9.6	16.9	0.0	5.6	34.3	38.7	20.3	65.9	14.7	5.9	60.9	35.6	34.7	42.1	7.9	221.4	39.2	3.7	89.4	73.0	2.6	81.2	192.6	23.8	13.2	42.4	26.3	6.6	39.4	51.3	75.8	36.1	42.3	136.1	66.8	273.7	27.0	18.0	326.1
STK19	"D6S60, G11, RP1"	ENSG00000204344	"Serine/threonine kinase 19"	P49842	6	31971091-31982821	"Cancer-related genes, Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enriched"	"Detected in all"	4	"Proximal tubular cells: 348.9"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 1.4;HEL: 1.5;HL-60: 1.6;REH: 1.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031511, HPA068559"	Uncertain		Supported	"Nuclear speckles"		NA	NA			"Cluster 30: Non-specific - Translation"	"Cluster 72: Non-specific - Transcription"	"Cluster 36: HEL - Hemostasis"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Nuclear speckles"		"HPA031511: AB_2673915, HPA068559: AB_2686004"	"unprognostic (1.65e-1)"	"unprognostic (2.30e-1)"	"unprognostic (3.31e-1)"	"unprognostic (1.86e-1)"	"unprognostic (2.63e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.15e-2)"	"unprognostic (4.26e-2)"	"prognostic unfavorable (1.18e-4)"	"unprognostic (3.95e-2)"	"unprognostic (2.76e-3)"	"unprognostic (2.25e-2)"	"unprognostic (1.08e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.60e-1)"	"unprognostic (2.40e-1)"	"unprognostic (4.10e-1)"	1.5	3.6	0.1	0.2	0.1	0.0	1.3	0.4	0.9	2.1	0.0	2.5	0.0	1.4	0.3	1.9	1.0	0.1	1.2	0.0	0.0	1.5	2.2	1.3	0.0	0.0	0.0	1.1	1.1	0.2	1.4	0.4	0.1	2.1	0.0	0.2	0.9	0.1	1.3	2.5	0.7	0.0	0.0	1.2	1.3	1.5	0.1	0.1	1.2	0.0	0.1	2.0	1.5	0.4	0.0	0.1	0.0	0.4	1.1	0.7	0.0	0.3	0.1	0.2	0.4	0.0	0.7	0.6	0.3	0.5	0.0	0.6	0.0	0.2	0.3	1.4	0.4	1.5	0.3	0.0	0.5	1.6	0.0	0.6	0.0	0.3	0.1	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.7	1.1	0.4	0.0	0.0	0.1	0.3	0.1	0.3	0.0	0.0	0.7	0.0	0.0	0.0	0.4	0.4	0.0	0.0	0.9	0.0	0.7	0.2	0.0	0.0	1.1	0.0	0.1	0.3	0.2	0.6	0.2	0.0	0.8	0.2	0.3	0.1	0.1	0.3	0.4	0.4	0.0	0.1	0.1	0.1	0.4	0.9	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.4	21.2	9.6	21.5	13.7	16.4	13.0	14.0	23.0	13.6	11.8	26.6	27.6	8.1	18.6	24.6	22.0	20.9	37.2	22.4	13.8	39.2	26.3	85.8	27.8	31.8	20.6	19.3	4.6	8.7	28.3	20.0	23.3	19.4	20.7	9.5	20.1	14.3	21.1	19.3	10.1	8.0	17.3	18.3	8.8	10.0	76.0	20.2	18.3	17.8	11.2	12.5	30.2	13.4	4.5	6.5	23.6	16.4	18.4	11.9	13.2	15.0	348.9	41.8	21.9	32.9	19.6	21.1	39.5	21.0	17.9	18.2	49.7	19.8	45.1	13.1	11.8
STK24	"MST-3, MST3, MST3B, STE20, STK3"	ENSG00000102572	"Serine/threonine kinase 24"	Q9Y6E0	13	98445185-98577940	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	Apoptosis	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal enterocytes: 203.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026435, HPA026502"	Enhanced		Supported	Nucleoli,Cytosol		No	No		1100000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Nucleoli, Cytosol"		"HPA026435: AB_1854151, HPA026502: AB_1854152"	"unprognostic (3.49e-2)"	"unprognostic (2.39e-2)"	"unprognostic (1.78e-1)"	"unprognostic (3.44e-2)"	"unprognostic (2.86e-1)"	"unprognostic (3.25e-2)"	"unprognostic (9.67e-3)"	"prognostic unfavorable (6.23e-6)"	"unprognostic (5.45e-2)"	"unprognostic (1.13e-1)"	"prognostic unfavorable (5.81e-4)"	"unprognostic (9.62e-2)"	"prognostic favorable (6.91e-5)"	"unprognostic (3.10e-2)"	"unprognostic (4.49e-2)"	"unprognostic (3.88e-2)"	"unprognostic (1.12e-2)"	71.4	32.4	30.9	49.0	32.6	58.0	60.9	34.3	34.4	99.1	49.4	75.1	83.0	53.9	58.4	167.9	50.7	55.8	49.1	34.2	29.0	77.0	32.4	54.1	67.0	29.0	35.5	44.2	48.0	42.4	31.1	57.5	27.2	49.6	72.3	31.7	70.4	51.2	47.1	154.4	94.4	48.2	28.5	51.5	78.3	36.9	41.3	68.2	55.0	38.8	74.1	86.6	113.9	29.2	161.8	49.4	85.6	79.8	128.6	76.4	121.3	73.8	103.0	100.9	97.7	145.7	212.6	114.1	36.6	92.8	63.1	142.1	80.2	162.3	95.5	286.3	41.2	122.0	59.8	84.2	181.0	124.4	82.8	49.8	253.7	79.3	231.6	106.2	88.2	88.0	45.2	76.6	67.0	70.3	93.5	51.1	76.9	217.3	36.6	116.5	52.5	62.3	98.1	143.2	49.8	71.4	46.7	74.2	103.0	129.7	89.6	119.1	120.0	63.8	46.3	52.8	86.5	74.1	41.7	42.5	99.3	74.0	107.4	5.7	12.7	6.3	5.5	10.9	6.6	6.1	10.2	8.0	10.9	7.9	6.9	5.6	10.9	1.5	13.5	7.1	13.7	6.7	30.9	32.6	34.3	34.4	34.2	29.0	29.0	35.5	27.2	28.5	41.3	29.2	36.2	12.8	27.4	27.7	37.4	70.9	83.6	51.2	20.5	20.3	41.5	33.5	3.0	55.8	55.8	68.0	56.3	39.2	36.9	203.8	25.4	35.8	3.5	74.2	48.7	32.5	42.6	41.4	39.2	55.0	45.9	43.2	65.7	99.6	18.4	49.1	25.0	26.6	28.0	10.1	34.2	86.0	24.4	82.2	57.9	5.9	26.8	58.4	56.9	49.6	47.6	25.5	20.6	35.7	11.1	84.4	96.5	30.5	25.5	60.4	111.8	39.2	51.6	11.0	39.5	47.7	41.0	2.9	21.2	61.9	82.1	20.0	45.5	20.4	59.1	153.3
STK26	"MASK, MST4"	ENSG00000134602	"Serine/threonine kinase 26"	Q9P289	X	132023302-132075943	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	Apoptosis	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 70.0;epididymis: 56.3"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 55.2;dendritic cells: 42.7;NK-cells: 53.5;Syncytiotrophoblasts: 59.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"MOLT-4: 140.1;U-937: 144.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA059921	Approved		Uncertain	"Nucleoplasm,Golgi apparatus,Centrosome,Cytosol"		Yes	No		360000	"Cluster 46: Basophils - DNA binding"	"Cluster 34: Non-specific - Transcription"	"Cluster 32: U-937 - Innate immune response"	"Cluster 47: Cytotrophoblasts - Unknown function"	Nucleoplasm	"Golgi apparatus, Centrosome, Cytosol"	"HPA059921: AB_2684163"	"unprognostic (6.53e-2)"	"unprognostic (7.83e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.02e-3)"	"unprognostic (4.42e-1)"	"unprognostic (1.03e-2)"	"prognostic unfavorable (6.82e-4)"	"unprognostic (1.18e-1)"	"unprognostic (1.93e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.42e-3)"	"unprognostic (2.49e-1)"	"prognostic unfavorable (6.87e-5)"	"unprognostic (4.76e-2)"	"unprognostic (1.83e-1)"	"unprognostic (1.77e-1)"	"unprognostic (2.88e-1)"	6.0	2.5	1.0	15.2	2.7	70.0	6.0	1.7	1.3	6.8	2.5	11.5	9.6	46.6	56.3	13.1	7.4	5.6	1.4	0.7	1.5	3.5	5.2	7.2	26.2	0.8	0.8	2.1	3.7	23.5	5.0	25.2	0.7	20.0	11.6	0.2	7.3	35.8	0.9	7.8	6.9	38.1	0.6	13.2	12.2	2.2	3.8	41.3	3.7	1.2	23.5	11.8	7.4	0.7	32.9	11.3	1.3	0.0	5.2	4.9	72.0	1.0	4.0	0.5	0.6	30.1	29.0	44.6	19.4	7.3	22.1	36.5	80.8	51.1	0.0	39.1	66.6	64.6	25.9	28.4	4.7	135.3	5.1	6.9	30.0	0.1	33.7	15.1	14.2	60.0	29.2	40.4	12.2	29.0	140.1	124.9	64.4	22.0	4.3	99.9	39.7	57.9	32.6	51.8	26.6	29.6	19.2	17.0	0.9	54.9	22.0	35.4	0.3	12.8	13.7	39.0	47.9	31.0	52.0	49.8	11.7	144.8	6.5	59.1	9.5	31.6	22.8	12.4	22.4	14.5	15.2	19.6	11.3	12.6	19.7	20.6	18.2	41.0	22.7	4.2	7.2	20.4	1.0	2.7	1.7	1.3	0.7	1.5	0.8	0.8	0.7	0.6	3.8	0.7	0.9	22.4	15.6	0.0	24.7	0.0	36.4	0.0	6.8	0.0	5.9	10.9	1.3	5.7	8.1	11.0	0.0	55.2	42.7	6.5	3.9	4.5	0.6	7.4	1.8	1.7	1.2	12.8	2.0	7.1	34.7	9.6	15.3	17.9	11.4	0.5	1.4	4.4	11.8	0.0	1.4	4.8	0.0	8.8	0.0	0.4	3.4	17.3	0.0	2.8	13.5	0.0	53.5	0.0	0.2	10.9	4.0	2.2	14.5	33.6	1.9	1.5	6.6	0.0	6.6	6.7	3.6	1.8	2.5	16.1	0.0	59.1	27.4	0.6	6.5	18.2
STK35	"bA550O8.2, CLIK1"	ENSG00000125834	"Serine/threonine kinase 35"	Q8TDR2	20	2101827-2177038	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	6	"retina: 118.8"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 150.1;Early spermatids: 214.3;Horizontal cells: 294.4;Late spermatids: 821.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026452, HPA051673"	Approved		Supported	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 30: Non-specific - Translation"	"Cluster 77: Retina - Visual perception"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 25: Spermatids - Spermatogenesis"	"Nucleoplasm, Nuclear bodies"		"HPA026452: AB_2671861, HPA051673: AB_2681569"	"unprognostic (2.25e-2)"	"unprognostic (2.97e-1)"	"unprognostic (2.87e-2)"	"unprognostic (1.30e-2)"	"unprognostic (3.25e-1)"	"unprognostic (2.28e-1)"	"prognostic unfavorable (9.46e-6)"	"unprognostic (6.53e-2)"	"unprognostic (1.82e-1)"	"unprognostic (3.05e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.07e-1)"	"unprognostic (4.39e-2)"	"unprognostic (1.74e-1)"	"unprognostic (4.67e-1)"	"unprognostic (1.40e-1)"	"unprognostic (4.99e-2)"	9.0	11.3	9.4	6.6	8.3	8.6	7.9	6.7	13.0	7.3	5.1	10.2	7.1	9.7	5.8	15.6	8.6	7.1	10.0	9.5	8.3	6.9	8.9	8.5	6.4	6.2	10.6	8.0	9.3	7.8	9.7	6.2	7.3	8.0	8.2	118.8	8.7	6.3	6.5	11.3	9.3	7.8	5.0	8.3	8.7	18.3	15.4	6.4	8.5	5.7	7.6	8.1	8.9	8.6	23.3	19.4	14.7	25.4	6.7	9.1	17.9	9.3	11.4	12.2	12.5	25.6	17.5	15.9	7.5	11.7	19.0	34.1	17.6	21.4	13.8	6.3	8.4	15.2	7.4	28.1	8.5	13.7	6.8	7.9	18.5	19.5	16.7	11.2	11.7	15.0	14.9	12.8	8.0	10.3	17.4	19.4	27.5	18.4	12.9	14.9	13.2	10.1	11.1	22.9	24.3	11.8	16.6	29.3	15.0	17.0	14.5	13.5	10.0	20.7	14.1	10.5	14.9	11.1	15.5	10.8	11.1	14.7	9.2	0.0	0.3	0.1	0.4	0.2	0.6	0.3	0.6	0.3	0.5	0.4	0.5	0.4	0.7	0.2	0.3	0.4	0.2	0.3	9.4	8.3	6.7	13.0	9.5	8.3	6.2	10.6	7.3	5.0	15.4	8.6	8.8	12.8	9.8	4.9	6.3	11.6	4.4	7.5	13.1	111.8	10.9	9.5	12.2	2.8	9.1	3.7	150.1	7.2	7.5	15.4	1.9	6.4	214.3	15.7	7.8	9.1	6.1	12.0	11.8	6.8	11.5	11.1	11.2	12.7	9.5	8.4	7.9	10.3	5.7	294.4	11.6	7.6	10.2	6.3	4.9	821.8	6.8	5.7	7.2	11.2	4.0	124.7	5.2	9.0	11.2	10.4	9.7	6.0	8.5	6.7	8.8	3.6	10.2	96.7	0.0	10.8	7.2	15.5	14.4	12.4	11.8	5.7	6.0	4.5	10.9	6.6
STK36	"FU, KIAA1278"	ENSG00000163482	"Serine/threonine kinase 36"	Q9NRP7	2	218672069-218702716	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cilium biogenesis/degradation"	"Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 37.5;Respiratory ciliated cells: 38.2;Spermatocytes: 28.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027409, HPA027453, HPA030058"	Approved		Supported	Cytosol		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 20: HeLa - Mitochondria"	"Cluster 49: Ciliated cells - Cilium organization"	Cytosol		"HPA027409: AB_10600223, HPA027453: AB_10601893, HPA030058: AB_10601225"	"unprognostic (8.11e-2)"	"unprognostic (3.77e-1)"	"unprognostic (3.59e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.52e-2)"	"prognostic unfavorable (5.20e-4)"	"unprognostic (1.55e-1)"	"unprognostic (5.83e-3)"	"unprognostic (9.04e-2)"	"unprognostic (1.38e-2)"	"unprognostic (1.13e-2)"	"unprognostic (3.52e-3)"	"unprognostic (1.46e-1)"	"unprognostic (2.60e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.99e-3)"	5.6	9.9	1.5	5.4	1.7	2.5	6.6	1.0	3.2	14.1	15.4	9.0	4.4	11.4	13.4	5.1	14.3	10.5	3.5	2.3	1.0	7.3	4.5	7.3	4.5	1.2	2.6	13.4	10.7	9.4	14.8	4.3	0.8	9.6	6.5	11.6	7.3	8.2	3.7	5.0	6.4	8.0	0.3	5.1	8.8	32.0	1.3	3.2	11.8	2.3	4.0	8.2	7.6	1.0	3.7	8.2	17.6	15.0	18.7	14.5	10.9	9.8	7.8	12.2	11.4	10.7	6.0	4.8	13.3	10.3	8.2	7.2	12.2	10.3	10.7	2.8	10.2	4.7	27.1	15.0	9.1	6.7	7.6	15.7	7.5	12.0	8.4	32.3	9.3	6.2	11.1	6.0	10.3	8.5	4.0	8.5	10.7	4.6	5.2	7.3	7.6	5.1	14.9	18.2	14.2	12.3	7.6	12.2	5.0	18.2	12.4	5.3	8.9	16.8	6.1	6.5	6.8	7.5	6.3	2.5	10.4	3.1	7.1	0.0	0.4	0.7	0.3	0.2	0.1	0.4	0.2	0.2	0.3	0.1	0.2	0.3	0.0	0.5	0.3	0.3	0.2	0.4	1.5	1.7	1.0	3.2	2.3	1.0	1.2	2.6	0.8	0.3	1.3	1.0	2.1	9.6	6.3	18.3	1.6	1.1	0.9	3.6	2.8	7.4	7.4	5.5	4.0	5.7	3.7	3.7	37.5	1.8	2.9	2.9	0.0	3.7	16.9	17.5	9.0	3.3	2.4	0.8	22.0	2.5	1.5	4.5	10.7	6.3	1.3	12.2	3.3	5.9	2.7	1.7	18.0	4.4	6.1	2.5	1.2	6.0	5.9	2.0	0.0	2.8	2.5	4.9	1.0	8.5	6.2	2.2	5.0	4.9	0.6	1.6	2.5	4.4	38.2	9.1	6.6	3.1	4.0	28.0	8.9	3.7	1.0	0.8	1.5	11.0	4.9	0.9
STK39	"DCHT, SPAK"	ENSG00000198648	"Serine/threonine kinase 39"	Q9UEW8	2	167954020-168247595	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 159.9;Inhibitory neurons: 142.9;Oligodendrocyte precursor cells: 153.3;Oligodendrocytes: 359.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB046022, HPA061803, HPA062802"	Enhanced		Supported	Nucleoplasm,Vesicles,Cytosol		NA	NA		80000	"Cluster 35: T-regs - Unknown function"	"Cluster 22: Non-specific - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Nucleoplasm	"Vesicles, Cytosol"	"CAB046022: AB_2196960, HPA061803: AB_2684616, HPA062802: AB_2684870"	"prognostic favorable (3.96e-4)"	"unprognostic (2.97e-2)"	"unprognostic (4.40e-2)"	"unprognostic (4.22e-2)"	"unprognostic (4.36e-1)"	"unprognostic (6.14e-2)"	"prognostic unfavorable (5.67e-5)"	"unprognostic (3.04e-2)"	"unprognostic (8.86e-2)"	"unprognostic (9.43e-2)"	"unprognostic (3.20e-2)"	"unprognostic (1.38e-1)"	"unprognostic (2.06e-1)"	"unprognostic (9.45e-2)"	"unprognostic (8.61e-3)"	"unprognostic (1.14e-1)"	"unprognostic (6.20e-3)"	19.4	6.7	20.1	14.0	25.8	5.1	8.4	25.3	25.1	12.0	52.9	26.3	32.0	7.3	14.5	36.3	6.4	18.1	15.8	16.0	18.6	9.0	1.9	7.6	22.2	28.8	25.8	6.6	25.6	13.7	8.2	2.3	31.9	28.7	32.4	27.8	67.9	11.5	2.7	6.3	18.6	11.7	20.8	8.6	31.8	48.5	25.6	29.1	6.9	7.6	23.5	24.8	9.5	37.0	19.1	10.9	40.9	12.9	28.1	37.5	4.0	45.0	33.8	29.6	27.8	0.2	59.9	51.1	12.2	30.5	25.5	46.6	26.7	34.4	37.1	16.2	16.4	21.2	11.8	42.9	52.3	30.5	2.1	29.1	52.8	35.1	36.5	38.5	21.2	41.3	0.5	0.0	67.0	11.4	51.6	13.0	30.3	41.0	24.3	72.1	16.0	4.8	27.9	47.6	65.7	27.0	15.7	2.6	21.8	20.3	8.0	25.9	20.2	36.6	11.1	26.5	32.2	0.1	0.0	41.5	29.7	28.5	25.1	0.0	0.3	0.0	1.1	0.2	0.6	0.2	0.9	1.6	0.5	0.5	0.2	0.8	0.0	1.0	0.1	0.1	1.8	0.2	20.1	25.8	25.3	25.1	16.0	18.6	28.8	25.8	31.9	20.8	25.6	37.0	6.1	3.2	14.0	64.6	6.4	3.8	34.4	6.5	5.7	14.8	5.5	6.5	26.2	18.6	15.2	5.5	16.7	0.1	30.0	47.7	21.5	10.9	29.4	11.9	11.6	5.6	22.8	5.7	159.9	23.1	0.1	9.2	28.1	18.9	0.0	5.8	2.9	0.4	3.5	20.2	142.9	17.3	14.2	6.7	6.7	16.2	10.2	6.7	17.8	64.6	5.5	28.9	12.3	153.3	359.4	36.0	20.1	11.3	9.5	74.8	14.5	7.9	17.5	30.0	6.6	7.7	18.2	25.4	8.1	7.5	4.4	0.3	19.4	15.8	22.4	50.6
STK4	"KRS2, MST1, YSK3"	ENSG00000101109	"Serine/threonine kinase 4"	Q13043	20	44966479-45080021	"Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins"	Apoptosis	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 57.7"	"Cell type enhanced"	"Detected in all"		"B-cells: 372.8;dendritic cells: 341.8;Langerhans cells: 606.9;monocytes: 367.5;Plasma cells: 336.2;T-cells: 414.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004038, HPA015270"	Approved		Supported	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA		45000	"Cluster 18: Basophils - Vesicular transport"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 24: Non-specific - Transcription regulation"	"Nuclear bodies"	"Nucleoplasm, Cytosol"	"CAB004038: AB_2144632, HPA015270: AB_1854150"	"unprognostic (2.77e-1)"	"unprognostic (1.10e-1)"	"unprognostic (8.83e-2)"	"unprognostic (8.49e-3)"	"unprognostic (2.95e-2)"	"unprognostic (1.24e-1)"	"prognostic unfavorable (8.04e-4)"	"unprognostic (1.70e-1)"	"unprognostic (2.51e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.96e-1)"	"unprognostic (2.70e-2)"	"prognostic unfavorable (1.84e-5)"	"unprognostic (1.28e-1)"	"unprognostic (5.70e-2)"	"unprognostic (3.96e-1)"	"unprognostic (1.18e-2)"	10.0	8.5	6.9	33.8	8.0	57.7	9.1	6.2	10.8	7.9	9.9	11.1	10.2	8.5	7.6	9.1	6.2	11.7	4.6	7.2	8.7	6.0	9.2	15.9	43.1	8.7	7.6	7.0	6.0	5.9	4.1	10.4	9.2	6.7	13.0	7.3	7.4	8.0	3.3	11.2	13.5	9.3	8.3	30.4	12.7	9.7	7.5	33.1	7.6	4.9	41.7	15.0	6.9	10.3	27.8	18.7	23.3	16.1	13.5	16.9	16.0	23.6	35.7	39.4	35.6	52.7	14.6	66.6	20.4	16.9	33.4	28.5	24.3	31.8	49.7	30.8	13.8	48.6	27.8	36.8	23.8	63.5	66.4	13.8	25.6	36.7	39.6	19.4	14.6	44.6	23.5	37.0	19.9	21.7	47.6	42.3	13.9	17.7	12.5	30.2	25.2	31.2	14.4	18.7	10.9	13.2	35.6	20.0	27.0	17.2	18.3	39.1	18.7	29.2	28.6	34.4	27.8	48.4	41.7	73.2	28.6	29.5	22.0	80.6	19.7	54.8	34.4	19.9	34.3	26.2	32.2	32.0	18.4	26.9	33.1	28.0	101.8	28.5	38.0	10.0	34.3	22.3	6.9	8.0	6.2	10.8	7.2	8.7	8.7	7.6	9.2	8.3	7.5	10.3	26.2	16.0	24.6	18.9	372.8	55.7	49.3	33.8	28.5	27.3	22.9	17.4	7.6	14.3	25.2	42.3	52.1	24.1	341.8	23.7	9.8	16.3	5.9	19.1	25.1	32.1	25.7	46.3	76.7	17.6	30.3	29.7	34.1	25.1	133.6	114.0	26.0	22.0	61.1	43.7	38.2	20.7	28.5	109.3	606.9	5.0	22.7	154.4	133.4	85.3	367.5	20.2	278.1	34.2	48.1	21.6	27.9	17.0	336.2	32.6	23.2	13.4	26.1	69.9	13.1	25.5	29.2	44.2	42.4	20.9	53.0	19.4	414.5	48.1	19.5	45.5
STK40	"MGC4796, SgK495"	ENSG00000196182	"Serine/threonine kinase 40"	Q8N2I9	1	36339624-36385924	"Enzymes, Predicted membrane proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 116.7;Late spermatids: 236.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 25.2"	"Group enriched"	"Detected in all"	5	"granulocytes: 25.2;monocytes: 12.0"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008026	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 59: Non-specific - Translation"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 31: Spermatids - Spermatogenesis"	Cytosol	Nucleoplasm	"HPA008026: AB_1857603"	"unprognostic (3.32e-1)"	"unprognostic (3.00e-1)"	"unprognostic (6.47e-2)"	"unprognostic (4.55e-1)"	"unprognostic (1.38e-1)"	"unprognostic (4.43e-2)"	"unprognostic (2.69e-3)"	"unprognostic (6.09e-2)"	"unprognostic (2.09e-1)"	"unprognostic (5.96e-2)"	"prognostic favorable (5.59e-4)"	"unprognostic (1.19e-1)"	"unprognostic (2.75e-2)"	"unprognostic (7.06e-2)"	"unprognostic (2.64e-1)"	"unprognostic (1.07e-2)"	"unprognostic (2.51e-2)"	33.3	15.5	17.4	23.1	17.0	15.2	24.6	16.6	19.9	24.3	14.1	44.8	13.5	23.6	8.1	43.8	24.7	20.4	42.7	17.5	17.6	33.5	45.3	36.4	24.3	24.8	19.0	40.3	45.7	21.8	30.1	13.5	20.6	28.5	12.7	7.5	32.0	23.1	125.2	38.8	23.7	20.0	19.9	35.4	35.5	52.5	20.1	15.6	25.3	39.6	21.4	41.7	26.7	19.8	17.4	7.4	36.6	38.3	25.3	14.7	20.5	17.2	23.1	20.3	21.8	41.3	24.2	73.0	13.8	16.1	21.5	17.1	33.5	7.4	14.9	32.0	26.4	47.7	7.5	53.3	25.1	28.1	60.9	13.3	27.7	15.6	8.2	10.9	12.9	55.2	59.7	25.7	12.9	27.0	29.3	37.1	23.5	31.2	10.2	33.3	24.9	49.1	12.7	19.2	44.6	22.7	13.2	20.5	58.5	23.1	13.9	32.7	21.6	12.7	26.5	37.7	38.3	26.6	16.2	61.3	66.3	24.3	42.8	1.2	3.8	6.8	3.1	8.6	3.6	2.8	2.1	2.2	3.5	2.9	1.2	1.8	25.2	2.1	12.0	3.3	1.3	3.5	17.4	17.0	16.6	19.9	17.5	17.6	24.8	19.0	20.6	19.9	20.1	19.8	10.7	12.8	15.3	11.8	22.0	61.3	54.0	9.4	16.5	11.8	28.3	15.4	25.3	8.6	11.1	11.0	4.2	6.5	15.8	34.8	17.6	21.2	116.7	23.9	11.2	15.2	23.4	7.8	24.8	31.6	10.7	19.2	33.1	36.5	13.3	4.9	14.3	23.7	24.7	10.1	17.3	15.5	12.2	23.3	69.5	236.8	23.0	32.2	30.2	21.5	19.2	4.9	18.6	7.5	12.3	28.5	16.3	33.4	17.0	57.1	6.2	14.9	25.6	10.5	26.3	20.6	18.6	14.9	11.1	28.7	75.4	57.2	17.3	17.6	15.1	51.3
STMN3	SCLIP	ENSG00000197457	"Stathmin 3"	Q9NZ72	20	63639705-63657682	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 291.7"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 108.5;Granulosa cells: 254.2;Horizontal cells: 109.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Lineage enriched"	"Detected in many"	5	"T-cells: 6.2"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 125.1;MOLT-4: 142.0;REH: 143.8;SCLC-21H: 192.5;SH-SY5Y: 146.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA012947	Enhanced		Supported	"Golgi apparatus,Cytosol"		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 65: Brain - Ion transport"	"Cluster 14: REH - Unknown function"	"Cluster 40: Granulosa cells - Unknown function"	"Golgi apparatus"	Cytosol	"HPA012947: AB_1857606"	"unprognostic (7.59e-2)"	"unprognostic (4.36e-1)"	"unprognostic (5.28e-2)"	"unprognostic (2.33e-1)"	"unprognostic (3.60e-2)"	"unprognostic (6.30e-2)"	"unprognostic (2.75e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.92e-2)"	"unprognostic (4.35e-2)"	"unprognostic (1.65e-3)"	"unprognostic (7.52e-2)"	"unprognostic (2.52e-3)"	"unprognostic (2.73e-2)"	"unprognostic (9.87e-2)"	"unprognostic (4.08e-2)"	"unprognostic (9.08e-3)"	23.4	49.7	188.4	21.3	197.6	11.4	20.0	112.5	291.7	29.2	16.6	26.5	5.5	30.0	5.0	11.6	27.9	10.9	17.1	215.0	162.0	24.8	3.7	23.6	25.8	259.6	158.1	50.5	16.4	17.5	102.2	10.0	266.1	24.3	5.2	38.8	11.7	12.7	4.3	20.2	24.8	14.7	100.8	48.2	15.1	9.0	159.3	43.5	63.9	3.7	12.4	21.9	19.0	179.9	10.4	11.6	74.4	125.1	1.9	7.3	5.1	12.0	0.4	35.8	16.8	73.6	13.7	0.5	36.3	4.6	2.0	68.6	52.2	1.3	11.1	5.2	14.0	5.1	17.0	27.6	9.9	3.9	42.0	15.3	0.3	11.5	2.9	1.5	1.3	34.4	98.8	2.2	9.6	11.7	142.0	17.7	76.5	2.4	81.7	143.8	12.1	58.0	60.9	2.0	192.5	146.6	5.7	3.4	14.9	5.9	2.1	25.9	1.9	0.8	20.4	0.8	2.6	4.9	10.4	3.6	2.1	14.3	48.8	1.1	0.0	1.1	2.5	0.1	2.7	0.2	5.2	4.5	0.1	0.6	6.2	5.3	0.1	0.0	0.1	1.1	0.9	2.0	188.4	197.6	112.5	291.7	215.0	162.0	259.6	158.1	266.1	100.8	159.3	179.9	5.8	6.4	2.5	16.3	17.1	8.2	6.9	11.9	8.6	108.5	4.7	14.7	2.3	4.3	3.2	3.7	52.1	11.7	13.4	1.1	13.7	4.0	10.0	1.6	17.9	7.8	37.2	4.6	56.9	2.5	4.0	25.4	2.0	2.7	4.5	254.2	6.8	0.0	2.3	109.4	67.1	0.6	4.1	2.2	7.6	18.8	30.1	3.5	7.2	7.5	4.6	37.2	16.5	21.1	11.3	2.2	0.1	35.7	5.3	4.5	0.1	5.0	0.8	44.5	13.1	3.0	20.9	3.3	6.7	1.6	4.3	8.8	28.6	51.0	0.6	2.7
STN1	"bA541N10.2, FLJ22559, OBFC1"	ENSG00000107960	"STN1 subunit of CST complex"	Q9H668	10	103877569-103918184	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		DNA-binding	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 37.4;Distal tubular cells: 41.1;Ductal cells: 34.6;Exocrine glandular cells: 79.2;Pancreatic endocrine cells: 62.9;Theca cells: 52.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037924, HPA037925"			Supported	Nucleoplasm		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm		"HPA037924: AB_10671636, HPA037925: AB_10672469"	"unprognostic (1.50e-1)"	"unprognostic (4.22e-2)"	"unprognostic (2.18e-2)"	"unprognostic (5.58e-3)"	"unprognostic (6.01e-2)"	"unprognostic (1.53e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.29e-1)"	"unprognostic (5.93e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.12e-3)"	"unprognostic (3.76e-1)"	"prognostic favorable (1.12e-6)"	"unprognostic (1.21e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.83e-2)"	15.7	22.2	8.8	12.2	10.1	13.5	17.1	11.3	9.4	13.3	11.5	14.5	12.0	12.0	9.8	41.0	12.2	18.3	35.0	8.2	11.1	17.9	13.1	25.2	16.0	13.1	11.0	22.2	20.9	33.6	14.9	17.1	11.5	10.2	16.4	6.4	18.7	13.3	22.4	13.3	11.0	15.4	9.9	15.3	22.2	23.4	11.5	24.5	17.6	28.9	22.8	22.5	18.5	11.2	26.8	19.7	23.8	19.6	18.6	57.6	7.6	12.6	36.5	16.4	14.6	11.4	43.6	16.7	22.2	16.1	14.7	24.8	8.7	31.0	15.3	24.1	11.9	15.3	7.0	23.5	25.6	12.7	12.9	37.2	52.1	15.9	43.9	42.9	32.0	31.2	8.5	34.9	27.3	21.7	31.5	22.0	5.5	38.7	28.5	22.7	16.4	19.2	40.5	31.3	13.7	16.1	9.3	14.9	24.4	13.4	12.5	11.0	47.1	20.4	14.1	14.5	19.4	47.3	13.1	16.6	30.4	26.4	9.0	41.7	33.2	110.3	65.1	21.3	103.4	25.5	71.9	60.4	40.2	29.6	52.3	62.6	48.8	71.3	23.7	37.1	100.2	51.5	8.8	10.1	11.3	9.4	8.2	11.1	13.1	11.0	11.5	9.9	11.5	11.2	14.7	22.4	20.9	0.0	2.3	0.0	0.0	0.0	0.0	0.0	12.7	16.9	0.0	0.0	5.0	9.2	0.0	37.4	17.2	0.0	41.1	34.6	0.0	9.2	9.9	6.4	0.0	0.0	0.0	79.2	14.0	3.9	0.0	15.4	5.1	23.8	0.0	0.0	16.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.4	0.0	0.0	13.5	0.0	0.0	0.0	0.0	62.9	0.0	0.0	1.0	0.0	0.0	12.8	7.3	0.0	0.0	0.0	6.7	0.0	0.0	0.0	0.0	27.0	13.3	52.4	0.0	0.0
STOML2	"HSPC108, SLP-2"	ENSG00000165283	"Stomatin like 2"	Q9UJZ1	9	35099776-35103195	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB015944, HPA062016"	Supported		Supported	"Plasma membrane,Cytosol"	"Intracellular and membrane"	NA	NA		44000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	"Plasma membrane, Cytosol"		"CAB015944: , HPA062016: AB_2684659"	"unprognostic (2.49e-1)"	"unprognostic (2.69e-1)"	"unprognostic (1.20e-2)"	"unprognostic (9.43e-2)"	"unprognostic (1.29e-1)"	"unprognostic (6.13e-2)"	"prognostic unfavorable (4.77e-4)"	"unprognostic (5.14e-2)"	"unprognostic (4.25e-2)"	"unprognostic (1.04e-2)"	"unprognostic (9.06e-2)"	"unprognostic (1.45e-1)"	"prognostic favorable (3.00e-5)"	"unprognostic (2.74e-2)"	"unprognostic (5.26e-1)"	"unprognostic (2.67e-1)"	"unprognostic (5.47e-2)"	63.6	93.3	45.4	39.1	46.2	66.7	62.0	47.5	49.0	58.4	61.3	75.3	55.6	64.2	49.4	84.7	57.3	33.2	123.4	46.2	46.6	75.4	99.2	43.7	46.6	44.7	45.9	59.4	69.5	71.9	42.3	46.2	45.3	49.0	67.2	23.5	59.3	48.4	171.2	71.0	61.2	54.0	45.9	53.1	75.8	42.8	48.2	55.1	48.6	111.7	59.5	64.5	56.5	45.4	219.6	248.1	130.3	195.7	93.3	111.1	139.5	105.9	153.5	292.6	212.5	283.2	99.6	183.2	72.9	135.2	210.6	91.4	201.3	235.8	193.7	158.1	185.0	112.7	202.6	269.7	272.1	215.8	124.0	141.9	181.1	238.6	283.2	92.2	193.8	183.6	186.5	109.1	144.8	176.0	193.5	377.6	205.3	162.4	155.2	166.6	110.3	197.0	159.5	128.9	120.4	146.3	60.0	158.0	141.7	92.5	109.7	139.1	106.2	99.7	141.1	84.4	190.4	76.1	140.3	173.8	132.7	134.3	137.1	67.8	73.0	42.5	64.7	65.8	77.8	91.4	73.1	74.1	98.0	87.0	69.2	63.8	12.9	98.1	49.3	121.8	115.5	114.4	45.4	46.2	47.5	49.0	46.2	46.6	44.7	45.9	45.3	45.9	48.2	45.4	63.9	41.7	33.1	6.5	66.8	96.4	123.8	172.9	83.6	36.6	104.5	118.7	83.4	108.7	92.5	49.7	8.4	233.6	48.3	116.1	250.5	144.3	77.2	72.7	76.3	66.4	98.8	106.2	7.8	153.4	245.2	74.9	66.3	47.3	84.3	111.3	61.4	111.3	132.7	18.5	8.1	145.9	73.2	41.0	68.3	22.9	75.2	47.9	99.6	5.6	84.5	83.9	56.7	2.5	8.8	137.2	117.5	69.6	126.1	177.6	197.7	290.1	85.8	37.1	52.6	66.5	95.6	73.1	110.0	119.2	114.5	166.4	51.2	153.2	222.2	148.7
STOML3	"Epb7.2l, SRO"	ENSG00000133115	"Stomatin like 3"	Q8TAV4	13	38965925-38990859	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"fallopian tube: 34.9"	"Group enriched"	"Detected in some"	19	"Endometrial ciliated cells: 75.5;Respiratory ciliated cells: 109.2"	"Group enriched"	"Detected in some"	4	"endometrial cancer: 2.4;lung cancer: 0.6"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	40	"AF22: 17.5"	"Region enriched"	"Detected in many"	6	"olfactory bulb: 23.6"					"HPA012892, HPA071011"	Enhanced		Supported	"Plasma membrane"		NA	NA				"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 12: NES - Nervous system development"	"Cluster 49: Ciliated cells - Cilium organization"	"Plasma membrane"		"HPA012892: AB_1857610, HPA071011: AB_2732169"		"unprognostic (2.64e-1)"	"unprognostic (1.91e-2)"	"prognostic favorable (1.49e-4)"	"unprognostic (1.82e-1)"	"unprognostic (1.17e-1)"		"unprognostic (4.24e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.14e-1)"	"unprognostic (2.14e-1)"	"unprognostic (1.07e-2)"	"unprognostic (1.35e-2)"	"unprognostic (3.07e-2)"	"unprognostic (1.74e-1)"		"unprognostic (1.22e-1)"	0.0	0.0	0.9	0.0	0.5	0.0	0.0	0.5	0.0	0.7	1.3	0.1	0.0	0.6	0.0	0.0	34.9	0.0	0.0	1.1	1.8	0.0	0.0	2.1	0.0	4.7	5.1	0.0	0.0	0.0	0.0	0.1	5.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.1	0.9	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	17.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.5	0.5	0.0	1.1	1.8	4.7	5.1	5.0	2.0	0.9	1.3	0.0	0.0	1.5	0.0	0.0	0.1	0.1	2.6	0.0	0.0	0.0	0.4	0.1	0.0	4.8	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.4	75.5	0.4	0.3	0.0	0.0	0.1	0.0	1.1	0.4	0.0	1.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	2.0	0.0	0.0	1.5	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	109.2	0.0	0.0	0.0	0.7	0.0	0.2	0.0	0.1	0.7	0.0	0.0	0.0	0.1
STON2	"STN2, STNB2"	ENSG00000140022	"Stonin 2"	Q8WXE9	14	81260656-81436465	"Plasma proteins, Predicted intracellular proteins"	Endocytosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 79.8"	"Cell type enriched"	"Detected in many"	4	"Astrocytes: 253.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"intermediate monocyte: 1.2"	"Lineage enriched"	"Detected in single"	4	"monocytes: 1.2"	"Cell line enhanced"	"Detected in many"		"HEL: 113.4;HMC-1: 60.9;Karpas-707: 58.3;RT4: 46.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003086	Enhanced		Approved	Nucleoli,Cytosol		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 65: Brain - Ion transport"	"Cluster 36: HEL - Hemostasis"	"Cluster 64: Astrocytes - Nervous system maintenance"	"Nucleoli, Cytosol"		"HPA003086: AB_2302748"	"unprognostic (5.28e-2)"	"unprognostic (9.83e-3)"	"unprognostic (1.34e-1)"	"prognostic unfavorable (4.96e-4)"	"unprognostic (2.50e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.73e-2)"	"unprognostic (3.55e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.38e-1)"	"unprognostic (3.30e-1)"	"unprognostic (9.88e-2)"	"unprognostic (9.19e-2)"	"unprognostic (5.82e-3)"	"unprognostic (1.37e-1)"	"unprognostic (6.15e-2)"	"unprognostic (1.44e-1)"	3.4	0.8	65.6	1.2	64.8	5.5	9.6	31.2	44.7	4.6	14.1	4.4	4.0	1.2	5.1	14.3	10.7	5.9	3.0	60.1	79.8	14.3	3.0	5.0	1.0	36.5	68.3	2.8	0.9	0.3	10.0	2.5	39.5	2.1	5.0	10.2	5.6	2.7	13.2	8.0	4.3	1.7	27.0	16.3	5.7	3.3	60.9	2.5	10.8	17.4	2.9	6.3	9.5	53.7	4.7	3.1	12.1	0.2	0.0	0.1	13.4	0.0	0.1	0.0	0.3	10.0	4.2	0.0	5.5	0.0	3.4	30.6	16.5	39.8	0.0	0.8	5.5	113.4	19.9	4.2	0.0	0.0	60.9	1.7	33.5	0.0	11.0	0.0	0.0	6.1	40.2	58.3	1.2	6.8	5.4	0.0	11.9	11.5	2.4	0.1	17.6	3.4	8.4	46.0	28.1	1.7	13.7	0.6	0.0	9.9	1.7	0.3	0.3	2.4	8.8	9.7	2.6	6.0	11.9	0.1	8.4	0.4	2.6	0.0	0.8	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	1.1	65.6	64.8	31.2	44.7	60.1	79.8	36.5	68.3	39.5	27.0	60.9	53.7	6.3	3.2	0.5	253.4	0.1	13.6	13.2	20.5	30.7	0.6	11.8	8.1	1.1	2.8	6.8	18.4	12.5	1.4	0.1	4.8	7.9	0.6	0.4	56.0	1.2	5.0	0.0	12.2	0.9	0.5	0.4	8.3	7.1	16.1	0.0	12.5	4.2	0.9	3.4	3.3	4.4	3.2	14.2	18.0	6.1	1.6	10.2	13.5	1.8	23.4	2.3	23.9	0.0	12.1	15.2	3.2	2.7	8.6	1.0	6.8	4.6	20.6	5.8	6.1	0.0	36.1	3.2	1.0	5.9	24.3	8.8	15.5	0.9	6.3	2.7	33.2
STOX1	"C10orf24, FLJ25162"	ENSG00000165730	"Storkhead box 1"	Q6ZVD7	10	68827531-68895432	"Disease related genes, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, Transcription, Transcription regulation"	"Activator, DNA-binding"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 33.2;choroid plexus: 30.8"	"Group enriched"	"Detected in many"	5	"Astrocytes: 85.2;Endometrial ciliated cells: 67.4;Respiratory ciliated cells: 42.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"plasmacytoid DC: 1.0"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 8.6;HAP1: 8.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA037844, HPA037845"	Uncertain		Supported	"Nucleoplasm,Nucleoli fibrillar center,Cytosol"	"Intracellular and membrane"	No	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 49: Ciliated cells - Cilium organization"	Nucleoplasm	"Nucleoli fibrillar center, Cytosol"	"HPA037844: AB_2675700, HPA037845: AB_10671369"	"prognostic favorable (3.37e-5)"	"unprognostic (5.53e-3)"	"unprognostic (6.62e-2)"	"unprognostic (1.06e-1)"	"unprognostic (4.63e-3)"	"unprognostic (1.95e-2)"	"unprognostic (2.24e-3)"	"prognostic favorable (2.08e-4)"	"unprognostic (1.52e-1)"	"unprognostic (2.45e-3)"	"unprognostic (5.33e-3)"	"unprognostic (5.29e-2)"	"unprognostic (3.87e-2)"	"unprognostic (8.77e-2)"	"unprognostic (3.06e-2)"	"unprognostic (2.33e-1)"	"unprognostic (3.46e-2)"	6.3	5.1	26.4	0.5	23.6	0.2	4.2	14.9	33.2	1.9	30.8	1.6	1.1	1.6	7.4	1.4	12.5	0.9	0.4	23.9	22.4	2.8	0.3	1.3	1.2	16.5	24.9	1.1	1.4	6.5	7.2	0.8	17.4	1.2	1.6	0.7	1.6	1.1	1.3	0.9	2.1	0.8	16.3	0.4	3.4	2.5	26.2	6.7	3.1	0.8	1.0	2.5	0.7	20.5	1.8	2.0	4.2	8.6	1.8	0.0	2.5	0.2	0.1	1.2	1.3	1.8	2.6	1.7	2.4	0.0	3.3	0.5	8.1	0.0	0.6	2.0	3.4	0.1	0.4	2.6	0.2	2.3	3.1	0.2	0.1	0.2	0.0	0.2	0.1	4.5	0.4	0.2	0.1	1.8	3.9	2.8	1.4	0.4	1.2	2.8	0.1	0.0	2.6	4.6	1.3	3.9	3.1	0.8	0.6	2.7	1.9	1.8	0.0	0.0	0.2	0.0	1.3	0.7	1.6	1.7	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.2	0.1	0.0	0.1	0.8	0.4	0.0	0.0	0.0	1.0	0.0	0.0	26.4	23.6	14.9	33.2	23.9	22.4	16.5	24.9	17.4	16.3	26.2	20.5	0.3	0.0	0.5	85.2	0.3	1.5	4.5	0.9	1.2	0.7	5.1	4.1	0.5	0.0	5.6	1.8	0.0	1.6	3.1	0.4	3.9	0.1	0.3	67.4	1.7	0.4	0.0	1.7	11.4	0.4	0.5	0.6	0.5	4.2	2.5	0.8	0.0	0.2	0.1	0.0	9.9	2.5	2.0	0.3	0.7	0.7	1.2	0.2	0.0	1.9	0.1	1.9	2.1	6.0	2.1	0.1	0.3	0.0	0.6	1.7	0.8	1.8	42.8	0.4	6.6	1.5	5.0	1.4	8.8	0.4	0.4	1.2	0.7	6.9	5.3	1.8
STRADA	"LYK5, NY-BR-96, Stlk, STRAD"	ENSG00000266173	"STE20 related adaptor alpha"	Q7RTN6	17	63682336-63741986	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"Cell cycle"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 48.0;Excitatory neurons: 49.1;Inhibitory neurons: 47.5;Oligodendrocyte precursor cells: 33.2;Oligodendrocytes: 71.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031637	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 43: Testis - Unknown function"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Nucleoplasm, Cytosol"		"HPA031637: AB_10601718"	"unprognostic (1.59e-1)"	"unprognostic (2.19e-1)"	"unprognostic (5.59e-3)"	"unprognostic (5.52e-2)"	"unprognostic (8.91e-2)"	"unprognostic (7.56e-5)"	"unprognostic (6.79e-4)"	"unprognostic (3.68e-2)"	"unprognostic (1.70e-1)"	"unprognostic (2.28e-1)"	"prognostic favorable (5.34e-5)"	"unprognostic (7.29e-2)"	"prognostic unfavorable (6.08e-7)"	"unprognostic (1.40e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.25e-1)"	"prognostic favorable (6.43e-4)"	21.3	28.3	32.2	12.7	32.9	18.3	19.6	31.9	35.8	23.9	30.0	23.0	8.8	20.5	18.2	21.1	23.0	13.4	23.1	32.9	32.6	27.8	23.0	19.0	20.3	34.3	31.8	24.7	17.7	19.1	26.4	13.4	32.6	22.5	11.6	13.9	15.6	14.3	14.6	20.8	19.4	17.2	31.0	32.0	20.5	49.0	32.4	20.1	20.0	10.1	20.4	22.6	20.0	32.8	12.7	37.5	31.9	32.3	30.8	22.8	12.4	23.8	21.6	33.6	29.8	9.9	14.4	19.5	14.4	20.3	16.7	10.5	21.4	23.1	33.0	21.5	20.7	38.4	25.9	23.7	21.8	36.7	26.5	23.9	19.4	38.2	22.1	22.3	37.6	30.0	24.9	20.0	32.2	23.6	43.4	25.0	16.0	10.7	21.2	27.9	50.8	23.8	30.2	24.9	36.0	39.4	16.3	26.3	26.1	32.9	19.7	26.4	30.5	31.7	22.5	25.8	20.0	19.9	22.9	24.3	23.4	21.8	25.7	19.2	9.5	8.8	9.6	6.9	8.8	10.3	8.7	10.7	15.8	7.5	8.5	7.6	10.8	16.8	10.7	13.3	7.3	8.0	32.2	32.9	31.9	35.8	32.9	32.6	34.3	31.8	32.6	31.0	32.4	32.8	6.4	9.6	7.3	48.0	12.5	0.0	0.1	0.5	6.2	2.1	3.6	3.4	0.5	0.0	2.9	9.2	0.0	2.1	9.3	1.2	0.0	7.0	1.1	8.6	9.4	3.7	0.0	3.4	49.1	2.8	0.9	4.7	6.1	7.2	2.5	12.7	0.7	0.1	1.5	1.7	47.5	2.2	2.0	1.3	1.4	2.2	0.6	6.7	0.0	27.2	17.9	1.2	5.2	33.2	71.4	4.8	2.0	1.5	10.2	0.4	1.9	2.0	2.5	3.7	0.0	2.0	4.1	3.1	1.2	4.7	0.4	2.5	9.1	9.3	2.0	0.2
STRIP1	"FAM40A, FAR11A, FLJ14743, KIAA1761"	ENSG00000143093	"Striatin interacting protein 1"	Q5VSL9	1	110031577-110074641	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 58.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA060302, HPA060498"	Approved		Supported	Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 31: Spermatids - Spermatogenesis"	Cytosol		"HPA060302: AB_2684247, HPA060498: AB_2684293"	"unprognostic (2.75e-2)"	"unprognostic (3.91e-1)"	"unprognostic (2.81e-2)"	"unprognostic (1.63e-1)"	"unprognostic (5.09e-1)"	"unprognostic (2.90e-2)"	"unprognostic (1.01e-2)"	"unprognostic (9.08e-2)"	"unprognostic (2.83e-1)"	"unprognostic (6.29e-2)"	"unprognostic (1.41e-3)"	"unprognostic (2.86e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.88e-2)"	"unprognostic (1.82e-1)"	"unprognostic (6.23e-2)"	"unprognostic (2.23e-2)"	14.9	14.9	13.0	11.7	13.9	22.6	13.9	9.9	14.3	19.2	8.8	16.1	13.1	19.1	15.6	15.2	15.6	10.8	12.7	14.5	13.4	12.3	9.8	12.7	15.6	11.9	12.9	21.5	12.6	21.3	15.7	16.6	14.0	12.9	13.4	11.9	14.1	13.8	14.1	17.5	19.7	18.0	10.1	22.6	13.5	19.4	17.2	16.2	13.6	13.7	15.4	15.4	14.9	12.0	19.7	12.8	34.3	23.4	29.3	19.3	24.7	30.3	26.3	30.9	26.8	13.5	11.2	16.0	16.2	27.0	19.6	18.3	18.4	21.5	21.7	34.2	22.3	26.7	23.1	17.7	16.2	24.3	25.6	20.7	25.3	26.2	28.6	22.7	25.0	21.6	24.1	19.9	30.3	23.3	28.0	25.5	27.9	14.8	17.2	27.0	44.1	14.3	21.4	28.5	44.1	25.4	25.9	32.4	19.5	19.7	16.2	21.9	25.9	23.2	22.1	27.2	20.5	20.3	12.0	16.3	26.5	25.9	34.2	13.9	10.5	14.8	14.9	11.4	13.0	10.7	12.5	15.7	12.2	10.2	14.4	13.0	9.6	16.1	15.5	5.6	12.6	12.8	13.0	13.9	9.9	14.3	14.5	13.4	11.9	12.9	14.0	10.1	17.2	12.0	9.0	3.2	7.8	17.3	16.4	13.8	10.0	7.2	9.6	12.6	8.3	5.7	8.5	4.3	8.2	9.2	18.8	16.1	11.9	15.5	1.9	10.7	47.3	9.1	9.6	13.2	15.0	13.0	15.6	7.2	10.4	10.6	11.7	15.1	7.0	16.2	14.6	9.8	12.9	6.7	17.7	13.0	8.2	11.1	11.6	58.0	9.9	8.9	3.6	7.5	14.3	7.1	17.5	15.1	12.6	12.5	10.2	10.1	11.9	11.5	23.1	3.9	3.0	18.9	6.6	11.4	12.5	11.3	10.2	10.9	12.8	25.9	15.2	13.0	11.5	14.1
STRN3	"PPP2R6B, S/G2NA, SG2NA"	ENSG00000196792	"Striatin 3"	Q13033	14	30893799-31026401	"Plasma proteins, Predicted intracellular proteins"		Calmodulin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003392, HPA004636, CAB069925"	Approved		Supported	"Nucleoplasm,Actin filaments,Cytosol"		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 48: Smooth muscle cells - ECM organization"	Cytosol	"Nucleoplasm, Actin filaments"	"CAB069925: AB_1146988, HPA003392: AB_1079942, HPA004636: AB_1079940"	"unprognostic (4.08e-1)"	"unprognostic (8.66e-2)"	"unprognostic (8.08e-2)"	"unprognostic (4.22e-2)"	"unprognostic (3.06e-2)"	"unprognostic (7.74e-3)"	"unprognostic (3.37e-2)"	"unprognostic (2.83e-1)"	"unprognostic (3.05e-1)"	"unprognostic (9.53e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.61e-1)"	"prognostic favorable (9.66e-4)"	"unprognostic (8.74e-2)"	"unprognostic (7.85e-2)"	"unprognostic (4.83e-2)"	"unprognostic (1.01e-2)"	18.9	13.4	8.4	9.3	8.3	10.0	11.6	14.9	11.2	14.0	8.9	16.1	7.3	12.4	13.8	15.3	9.9	12.4	18.5	7.5	16.4	13.9	21.5	10.0	7.5	7.7	9.8	10.1	12.6	13.9	9.3	11.9	7.5	13.7	12.6	14.2	10.3	14.1	39.2	11.7	9.7	18.0	6.0	10.4	11.2	20.9	10.7	9.4	13.7	28.5	9.0	14.7	11.6	10.6	33.7	29.2	31.0	22.0	27.4	20.4	25.8	33.0	23.2	24.9	26.3	37.7	22.4	18.4	22.0	23.2	12.6	18.2	33.5	18.1	37.7	17.5	12.3	19.2	19.6	73.6	28.8	15.6	19.8	19.9	20.8	19.5	24.8	23.9	21.5	16.7	22.8	17.8	25.4	21.5	21.3	16.3	15.3	24.1	25.5	15.0	35.5	4.9	39.2	47.7	19.1	15.5	32.8	23.6	17.7	28.4	27.7	14.5	28.0	24.8	21.3	14.7	12.4	15.7	21.4	17.8	12.7	11.2	20.5	4.1	3.5	4.7	3.3	4.3	4.4	3.4	4.2	3.7	3.1	3.2	4.1	4.8	4.3	4.2	3.5	5.7	3.6	1.3	8.4	8.3	14.9	11.2	7.5	16.4	7.7	9.8	7.5	6.0	10.7	10.6	37.1	22.4	22.4	82.3	19.5	98.1	57.5	17.9	23.9	27.2	37.1	25.1	51.7	28.6	22.1	31.3	27.1	22.1	17.5	34.1	11.7	38.9	21.8	32.7	48.0	36.0	31.9	43.8	110.9	26.3	19.9	39.6	20.4	46.9	8.8	21.7	35.0	43.1	12.8	37.0	119.0	18.8	16.2	23.9	45.7	13.4	26.8	22.9	44.4	92.8	18.9	24.6	11.3	102.1	139.2	40.3	13.2	27.8	31.3	49.6	13.2	43.3	25.2	30.2	26.3	52.3	51.9	59.8	53.6	31.4	96.5	33.2	21.4	26.1	16.3	53.6
STT3B	"FLJ90106, SIMP, STT3-B"	ENSG00000163527	"STT3 oligosaccharyltransferase complex catalytic subunit B"	Q8TCJ2	3	31532638-31637616	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"		"Glycosyltransferase, Transferase"	"Congenital disorder of glycosylation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 264.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036448, HPA036646"	Approved		Supported	"Endoplasmic reticulum"		NA	NA		17000	"Cluster 15: NK-cells - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 25: Spermatids - Spermatogenesis"	"Endoplasmic reticulum"		"HPA036448: AB_2675129, HPA036646: AB_10673472"	"unprognostic (2.17e-2)"	"unprognostic (2.23e-1)"	"prognostic favorable (7.91e-5)"	"unprognostic (1.60e-1)"	"unprognostic (3.11e-1)"	"unprognostic (2.74e-2)"	"unprognostic (2.02e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.60e-1)"	"unprognostic (3.26e-3)"	"unprognostic (3.68e-2)"	"unprognostic (3.86e-2)"	"unprognostic (9.18e-2)"	"unprognostic (1.42e-1)"	"unprognostic (6.71e-3)"	"unprognostic (1.02e-1)"	42.8	59.9	21.1	52.2	29.5	63.7	57.1	23.3	27.0	62.1	30.9	59.7	47.9	51.8	90.3	44.8	45.3	60.2	49.4	22.6	30.7	49.6	74.8	49.3	59.9	24.3	23.1	105.5	45.7	76.6	24.8	60.3	23.9	56.3	61.4	38.6	49.9	51.3	62.1	44.7	49.1	57.7	25.4	44.2	55.1	94.3	26.1	71.8	80.7	57.8	58.8	56.6	32.1	27.6	77.9	128.0	115.4	121.7	142.0	142.3	249.7	142.3	124.9	104.2	119.9	117.7	164.5	134.0	67.8	130.0	85.8	63.9	108.1	123.5	135.9	377.1	70.2	115.0	120.7	126.4	109.4	252.0	131.1	109.8	129.7	148.8	186.7	160.7	107.1	168.3	62.8	209.6	144.0	44.4	246.8	154.8	92.9	129.6	70.7	252.3	62.6	196.0	122.0	110.7	48.7	59.4	141.3	207.2	84.5	98.3	93.4	132.8	209.3	139.8	88.6	139.7	127.3	129.0	166.4	111.4	126.9	170.0	117.6	2.1	3.3	6.2	3.1	3.9	5.0	2.4	5.6	4.4	2.9	2.7	5.3	4.3	1.2	6.1	2.9	5.5	3.0	2.0	21.1	29.5	23.3	27.0	22.6	30.7	24.3	23.1	23.9	25.4	26.1	27.6	32.1	86.6	57.7	34.6	69.6	68.1	58.4	34.1	74.6	51.0	57.2	29.5	71.1	54.3	76.0	44.1	68.8	67.3	65.3	41.8	13.7	34.1	162.8	25.0	65.9	42.0	45.1	50.9	61.5	45.3	100.5	49.6	45.3	43.5	31.1	43.6	37.9	68.2	54.8	45.4	59.4	57.5	36.7	58.0	76.0	264.9	36.4	71.5	51.6	53.4	49.1	34.2	56.7	60.3	73.3	36.5	50.0	32.7	144.2	74.1	50.5	31.5	42.2	37.4	26.3	39.0	53.3	90.9	55.2	65.0	61.8	95.4	78.3	68.4	66.1	69.4
STUB1	"CHIP, HSPABP2, NY-CO-7, SDCCAG7, UBOX1"	ENSG00000103266	"STIP1 homology and U-box containing protein 1"	Q9UNE7	16	680224-682870	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair, Ubl conjugation pathway"	Transferase	"Disease variant, Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB037202, CAB037209, HPA041222, HPA043531"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoplasm, Cytosol"		"CAB037202: AB_1840759, CAB037209: AB_1840757, HPA041222: AB_2677368, HPA043531: AB_2678533"	"unprognostic (5.70e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.90e-1)"	"unprognostic (3.89e-1)"	"unprognostic (9.00e-2)"	"unprognostic (3.06e-1)"	"unprognostic (4.09e-3)"	"unprognostic (2.21e-1)"	"unprognostic (2.23e-1)"	"unprognostic (8.31e-2)"	"unprognostic (5.78e-2)"	"unprognostic (6.77e-2)"	"prognostic favorable (6.49e-9)"	"unprognostic (9.67e-2)"	"unprognostic (3.57e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.30e-1)"	80.2	126.3	185.5	35.6	186.9	48.9	76.0	183.8	242.7	74.8	173.1	100.3	50.7	67.0	60.3	86.8	65.3	42.1	151.1	187.3	185.3	91.4	100.7	65.0	52.5	188.2	184.2	65.7	93.7	90.6	93.7	23.9	187.9	80.2	32.6	33.2	86.6	53.5	201.8	111.7	63.1	40.1	180.6	70.0	86.2	45.1	193.5	42.3	72.9	125.2	38.2	80.7	69.1	188.0	81.6	107.6	59.4	108.0	123.4	102.5	43.8	112.8	95.1	100.9	90.5	131.0	97.1	83.0	78.2	147.5	69.1	69.7	73.0	137.3	42.9	93.6	318.8	53.4	154.1	104.7	183.7	85.9	96.4	141.1	134.3	118.2	71.4	76.3	106.2	72.3	87.1	119.2	149.3	318.4	90.1	85.4	76.4	107.1	127.5	143.5	46.8	200.6	132.5	72.6	121.1	103.4	89.4	165.8	137.1	35.9	114.1	147.8	108.7	104.3	99.8	94.3	125.9	137.6	150.2	132.3	83.8	73.9	122.0	17.7	13.6	21.7	15.7	12.9	14.5	19.6	13.5	13.8	12.1	21.0	12.8	11.6	13.4	11.2	13.9	20.7	13.2	7.2	185.5	186.9	183.8	242.7	187.3	185.3	188.2	184.2	187.9	180.6	193.5	188.0	96.2	38.5	27.9	24.5	88.9	114.7	107.2	63.9	83.1	93.3	137.1	158.7	1.0	104.4	52.4	130.6	52.1	80.1	101.4	142.7	285.7	139.6	8.6	82.8	69.6	71.6	76.0	68.5	23.2	169.7	93.8	85.7	68.3	65.0	21.0	97.9	80.3	122.1	113.1	84.1	21.1	101.4	85.5	69.4	94.9	16.7	109.0	79.0	117.4	15.0	154.4	184.3	110.2	14.1	24.8	190.2	110.8	112.1	108.6	160.8	165.5	324.1	61.2	83.9	72.3	82.3	129.7	50.4	62.4	107.0	120.5	100.7	96.2	132.5	109.3	118.8
STX10	"hsyn10, SYN10"	ENSG00000104915	"Syntaxin 10"	O60499	19	13144058-13150383	"Predicted intracellular proteins, Predicted membrane proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA035303, HPA056439"	Approved		Supported	"Golgi apparatus,Vesicles"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	"Golgi apparatus, Vesicles"		"HPA035303: AB_10671932, HPA056439: AB_2683135"	"unprognostic (1.72e-2)"	"unprognostic (2.26e-2)"	"unprognostic (1.62e-2)"	"unprognostic (6.73e-2)"	"unprognostic (2.40e-1)"	"unprognostic (1.21e-2)"	"unprognostic (2.54e-3)"	"prognostic favorable (8.26e-4)"	"unprognostic (4.09e-1)"	"unprognostic (3.66e-2)"	"unprognostic (4.57e-2)"	"unprognostic (9.21e-2)"	"prognostic unfavorable (1.69e-7)"	"unprognostic (2.39e-3)"	"unprognostic (7.95e-2)"	"unprognostic (2.23e-1)"	"unprognostic (2.98e-2)"	45.3	58.7	42.1	35.6	44.3	72.3	47.1	45.3	52.3	65.5	47.0	57.2	47.7	48.7	17.1	80.7	49.6	29.5	56.1	42.2	41.7	60.9	78.8	66.9	42.5	44.6	43.3	50.7	48.3	27.9	49.1	17.0	43.1	49.9	19.8	11.6	52.0	20.4	35.8	68.2	60.7	20.9	40.7	87.0	60.3	17.7	43.6	35.3	56.6	16.6	28.2	51.4	55.4	48.5	99.9	68.8	51.8	138.1	51.5	52.8	17.2	55.4	49.4	46.1	48.4	31.8	88.3	66.5	80.5	66.8	33.7	76.3	44.9	67.0	26.6	113.4	86.0	60.8	154.4	66.5	38.2	71.4	63.2	54.3	55.3	57.4	37.2	62.8	58.1	85.9	32.9	34.6	31.8	87.2	105.6	125.2	55.2	51.3	112.5	117.3	54.1	96.6	44.4	47.2	60.0	121.3	57.9	66.2	127.6	14.9	45.1	67.9	58.4	75.3	38.7	145.9	77.5	78.1	75.2	57.0	98.0	172.8	59.8	41.5	162.3	120.4	48.1	128.4	40.7	39.9	41.4	48.7	119.1	40.3	36.3	37.3	267.6	32.1	151.5	31.2	51.4	80.7	42.1	44.3	45.3	52.3	42.2	41.7	44.6	43.3	43.1	40.7	43.6	48.5	31.6	16.0	21.6	13.1	29.9	35.4	34.5	52.0	31.3	21.3	43.0	37.5	12.6	30.0	53.6	20.2	6.2	17.7	32.2	54.3	27.4	42.5	1.0	23.9	28.3	31.3	16.3	33.2	16.6	56.1	26.2	27.6	40.8	24.7	53.8	33.7	31.1	18.8	82.4	13.5	11.8	48.0	46.8	86.7	45.8	3.0	25.1	62.0	48.0	7.5	86.1	21.4	48.4	11.1	14.0	57.0	53.8	31.2	25.3	19.9	77.9	28.3	38.2	17.1	26.3	21.2	31.0	9.0	16.2	38.6	43.2	19.4	39.1	23.6	55.5	38.4
STX18	Ufe1	ENSG00000168818	"Syntaxin 18"	Q9P2W9	4	4415742-4542346	"Predicted intracellular proteins, Predicted membrane proteins"	"ER-Golgi transport, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"cervix: 119.9"	"Cell type enhanced"	"Detected in all"		"Endometrial ciliated cells: 191.1;Glandular and luminal cells: 249.4"	"Cancer enriched"	"Detected in all"	5	"endometrial cancer: 43.1"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003019	Approved		Supported	"Endoplasmic reticulum,Plasma membrane"		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 44: Endometrium - Transcription"	"Endoplasmic reticulum, Plasma membrane"		"HPA003019: AB_1857622"	"unprognostic (2.33e-1)"	"unprognostic (1.65e-1)"	"prognostic favorable (2.84e-4)"	"prognostic favorable (6.33e-8)"	"unprognostic (4.21e-1)"	"unprognostic (6.77e-2)"	"unprognostic (6.17e-3)"	"unprognostic (2.95e-2)"	"unprognostic (7.53e-2)"	"unprognostic (3.22e-3)"	"unprognostic (1.21e-1)"	"unprognostic (1.07e-2)"	"prognostic favorable (7.03e-4)"	"unprognostic (1.92e-2)"	"unprognostic (1.55e-1)"	"unprognostic (7.44e-2)"	"prognostic favorable (4.69e-4)"	10.6	16.0	8.4	10.9	9.4	12.0	10.9	8.9	10.4	119.9	14.5	12.8	18.1	53.9	8.2	10.7	48.6	14.0	13.0	7.9	9.9	29.2	15.7	10.8	13.2	9.4	8.9	11.3	22.5	16.9	14.6	12.8	10.1	10.6	13.4	8.3	12.1	8.9	16.5	12.0	15.6	15.7	8.2	10.6	18.5	30.5	10.2	9.4	11.3	9.9	12.4	11.0	11.8	9.3	26.6	16.7	19.3	20.0	16.2	23.7	26.1	30.1	26.9	27.6	22.8	35.5	37.3	35.1	69.7	27.1	24.9	13.9	34.6	17.2	27.0	15.1	18.6	22.0	22.3	43.4	24.2	38.6	17.8	22.2	14.7	23.4	16.9	15.4	23.5	27.5	21.7	30.0	19.9	14.0	35.6	27.2	26.0	21.3	36.1	31.4	14.6	28.2	28.2	15.6	24.7	22.0	22.2	14.7	26.4	16.5	21.6	18.3	27.2	16.7	18.4	15.4	32.1	21.6	35.4	40.1	20.4	29.3	21.0	10.6	15.6	10.8	15.1	16.0	18.2	16.7	14.0	13.7	23.8	14.4	11.7	13.4	3.1	16.9	20.6	37.6	14.3	14.0	8.4	9.4	8.9	10.4	7.9	9.9	9.4	8.9	10.1	8.2	10.2	9.3	17.5	32.1	9.0	52.5	15.8	7.9	8.3	20.3	9.6	39.3	14.4	11.6	20.4	18.6	25.3	20.2	20.9	31.0	27.9	33.8	70.5	32.5	80.6	191.1	38.4	14.8	4.9	15.6	40.2	27.9	19.0	18.5	23.9	249.4	8.2	21.6	6.8	10.8	28.1	10.1	48.0	22.8	32.6	13.7	12.4	76.5	14.0	21.3	14.2	48.7	26.5	25.8	16.5	37.7	56.4	36.5	28.8	14.7	20.4	15.7	32.8	25.2	34.5	17.7	6.6	13.1	18.1	94.9	35.7	13.1	9.7	31.7	18.9	27.2	20.0	13.9
STX5	"SED5, STX5A"	ENSG00000162236	"Syntaxin 5"	Q13190	11	62806860-62832051	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Syncytiotrophoblasts: 177.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001358	Uncertain		Supported	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 22: Epithelial cell types - Mixed function"	"Golgi apparatus"	Nucleoplasm	"HPA001358: AB_1080119"	"unprognostic (3.51e-2)"	"unprognostic (4.23e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.91e-3)"	"unprognostic (1.54e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.71e-2)"	"unprognostic (3.30e-1)"	"unprognostic (1.13e-1)"	"unprognostic (3.34e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.19e-1)"	"unprognostic (1.67e-2)"	"unprognostic (3.42e-2)"	"unprognostic (2.79e-1)"	"unprognostic (2.86e-2)"	"unprognostic (8.22e-3)"	34.2	31.8	31.2	22.2	32.1	41.9	34.4	35.3	39.0	42.0	34.6	27.5	22.7	30.6	42.6	34.9	33.1	25.0	27.2	31.3	32.1	38.3	51.0	32.7	25.1	34.2	31.8	42.2	51.1	27.0	29.6	27.4	31.7	43.6	22.4	18.8	51.8	26.9	27.7	41.4	28.4	23.9	31.3	35.5	36.0	29.0	32.9	30.4	37.9	20.2	31.6	28.4	34.2	33.5	40.9	25.4	34.5	29.9	44.6	50.2	31.0	39.2	54.9	64.7	52.0	18.8	39.0	26.0	35.9	55.9	37.8	41.7	29.7	37.2	47.8	60.4	28.3	23.0	33.0	39.2	55.3	26.9	33.5	40.7	41.6	58.6	70.3	50.5	31.9	37.0	21.0	71.7	34.5	48.4	36.5	43.8	11.3	36.2	36.8	37.1	32.3	70.2	28.8	20.7	26.3	21.6	31.4	49.4	63.6	25.7	54.4	35.9	36.8	46.8	24.6	54.6	25.1	64.2	38.1	27.4	38.0	18.7	29.6	11.7	11.4	36.2	10.4	14.1	9.3	11.0	8.1	10.1	10.4	11.3	7.5	7.6	17.8	13.1	12.7	12.9	13.0	6.6	31.2	32.1	35.3	39.0	31.3	32.1	34.2	31.8	31.7	31.3	32.9	33.5	30.3	22.4	29.3	12.7	64.1	67.2	79.5	37.9	13.6	21.0	38.0	27.9	5.6	20.0	27.6	11.0	27.1	55.3	57.6	29.8	29.4	45.7	113.1	28.2	28.6	33.1	32.9	23.5	16.0	59.6	75.1	39.5	23.9	34.0	52.7	25.2	30.0	24.4	46.5	18.5	15.4	54.8	22.4	39.5	53.5	143.7	39.1	33.2	46.2	12.2	51.6	30.3	44.3	10.1	16.6	44.1	36.0	25.2	47.2	61.2	44.8	32.6	20.7	18.6	32.9	34.1	33.6	32.2	30.1	19.8	64.2	177.6	40.4	28.0	26.2	75.5
STX7		ENSG00000079950	"Syntaxin 7"	O15400	6	132445867-132513198	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"basophil: 53.6;classical monocyte: 51.6;eosinophil: 49.1;intermediate monocyte: 58.1;memory B-cell: 85.9;myeloid DC: 61.6;naive B-cell: 106.8;neutrophil: 83.2;non-classical monocyte: 61.6;plasmacytoid DC: 73.9"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001467, CAB062564"	Enhanced		Supported	Lysosomes		NA	NA		380000	"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 16: Immune cells - Immune response"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 57: B-cells - Immune response"	Lysosomes		"CAB062564: AB_2665605, HPA001467: AB_1857623"	"unprognostic (1.91e-3)"	"unprognostic (1.06e-3)"	"unprognostic (2.67e-2)"	"unprognostic (7.95e-3)"	"unprognostic (1.21e-1)"	"unprognostic (2.04e-1)"	"prognostic unfavorable (1.60e-4)"	"unprognostic (4.52e-2)"	"unprognostic (4.46e-1)"	"unprognostic (4.19e-2)"	"unprognostic (2.84e-1)"	"unprognostic (2.79e-1)"	"unprognostic (1.65e-3)"	"unprognostic (2.16e-1)"	"unprognostic (2.06e-1)"	"unprognostic (1.67e-1)"	"unprognostic (8.42e-2)"	35.1	17.7	17.6	41.5	20.4	21.6	21.2	20.8	21.1	22.5	11.5	25.1	37.2	27.2	12.1	33.7	22.1	33.5	36.0	19.8	21.0	51.1	18.3	31.5	76.3	23.2	22.2	30.9	14.3	20.5	7.4	42.9	22.4	19.5	29.1	15.9	20.6	25.9	23.1	20.4	37.9	29.2	21.2	45.5	28.3	8.2	18.0	17.7	30.8	22.7	71.8	26.2	16.6	29.3	17.5	17.5	28.7	20.6	56.4	49.9	22.6	33.9	34.7	34.4	49.3	30.9	28.9	87.6	32.7	41.1	51.0	22.8	25.5	31.2	46.6	30.2	30.4	33.1	14.6	33.0	44.6	22.8	24.2	28.6	28.5	35.3	31.6	46.5	37.8	19.2	36.1	30.7	39.8	24.8	10.4	18.2	11.0	25.4	20.2	24.6	22.5	25.5	57.9	20.4	23.5	7.1	15.3	24.9	91.9	42.2	17.0	21.2	66.4	20.1	20.5	44.1	36.6	29.1	18.2	37.2	28.3	17.9	23.2	53.6	51.6	49.1	10.8	58.1	4.4	85.9	8.0	7.7	61.6	106.8	5.7	6.8	83.2	9.5	61.6	73.9	12.8	31.3	17.6	20.4	20.8	21.1	19.8	21.0	23.2	22.2	22.4	21.2	18.0	29.3	37.7	70.5	36.5	34.0	151.6	42.1	23.5	33.8	26.7	26.8	26.7	22.2	51.0	85.8	33.1	42.3	2.1	85.7	111.5	50.8	64.6	56.9	1.2	27.9	33.4	38.3	13.2	57.9	61.3	30.9	54.5	34.1	42.3	28.0	40.6	25.9	43.5	19.4	177.6	37.0	60.6	39.8	38.7	99.4	78.7	2.1	30.7	109.6	133.4	109.6	110.7	25.7	54.6	44.2	77.9	57.6	63.1	46.3	37.3	24.7	113.5	155.0	43.9	16.5	39.5	30.2	38.6	2.7	17.6	36.2	41.2	55.4	24.4	17.9	28.4	24.9
STXBP3	UNC-18C	ENSG00000116266	"Syntaxin binding protein 3"	O00186	1	108746674-108809523	"Plasma proteins, Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 206.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027225	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 18: U-2197 - ECM organization"	"Cluster 41: Macrophages - Immune response"	Nucleoplasm	Cytosol	"HPA027225: AB_1857627"	"unprognostic (3.14e-3)"	"unprognostic (4.33e-2)"	"unprognostic (7.18e-3)"	"unprognostic (4.88e-2)"	"unprognostic (6.54e-2)"	"unprognostic (9.78e-3)"	"unprognostic (2.00e-3)"	"unprognostic (1.94e-1)"	"unprognostic (1.71e-2)"	"unprognostic (2.32e-2)"	"unprognostic (6.56e-2)"	"unprognostic (8.21e-2)"	"unprognostic (1.25e-2)"	"unprognostic (1.65e-1)"	"unprognostic (8.08e-2)"	"unprognostic (1.08e-1)"	"unprognostic (4.55e-2)"	23.2	24.3	28.7	27.0	38.6	23.9	27.6	37.9	41.6	24.7	23.8	28.5	26.1	27.1	25.6	25.1	19.6	28.0	20.5	26.9	32.8	40.3	25.0	23.1	27.9	39.5	35.2	20.9	28.1	42.0	14.2	28.1	39.7	23.8	29.1	34.4	21.6	19.4	19.3	27.2	33.4	24.1	35.6	26.1	25.2	16.3	32.2	31.6	37.1	24.0	25.3	31.1	21.5	50.2	47.1	18.1	30.6	16.1	36.3	35.1	42.9	42.9	38.9	27.9	28.2	16.8	18.3	41.7	28.4	34.7	25.8	27.4	20.9	25.3	38.8	46.7	28.9	34.5	23.8	21.9	28.7	54.2	56.0	27.4	34.5	31.5	34.0	34.8	35.2	26.2	26.0	39.3	39.0	31.7	34.8	42.9	32.6	30.9	28.4	28.4	45.1	22.8	45.7	38.4	18.4	16.9	52.3	49.6	64.6	27.6	20.1	49.9	40.2	36.3	21.4	50.8	37.1	26.3	24.8	34.1	65.2	41.0	56.4	62.7	17.1	42.7	14.2	20.8	18.4	11.3	16.6	14.5	16.6	10.8	14.0	13.7	48.1	17.9	24.9	7.7	20.4	11.9	28.7	38.6	37.9	41.6	26.9	32.8	39.5	35.2	39.7	35.6	32.2	50.2	35.9	12.8	25.2	59.1	25.6	44.0	37.4	32.5	14.2	38.2	21.8	20.2	36.4	32.9	34.5	20.2	20.9	43.7	38.7	46.5	45.0	38.1	7.3	33.6	29.3	32.9	21.0	22.7	30.0	27.4	35.4	36.2	16.8	33.9	69.7	18.7	15.4	16.1	31.5	26.9	31.4	28.3	24.4	45.5	44.2	5.4	33.5	41.7	39.2	48.7	57.3	40.5	41.2	68.9	206.2	34.5	27.3	31.6	20.0	32.9	30.4	47.5	28.7	19.3	19.7	34.2	33.6	26.4	24.7	16.1	40.3	95.5	36.7	29.6	26.8	44.8
SUB1	"p14, p15, PC4"	ENSG00000113387	"SUB1 regulator of transcription"	P53999	5	32531633-32604079	"Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Plasma cells: 1838.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Karpas-707: 1427.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001311, CAB015351"	Supported		Supported	Nucleoplasm,Nucleoli		NA	NA		120000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 55: Plasma cells - Humoral immune response"	"Nucleoplasm, Nucleoli"		"CAB015351: AB_2197157, HPA001311: AB_1080123"	"unprognostic (5.19e-2)"	"unprognostic (1.58e-1)"	"unprognostic (5.25e-2)"	"unprognostic (1.71e-1)"	"unprognostic (2.26e-1)"	"unprognostic (6.87e-2)"	"prognostic unfavorable (5.25e-6)"	"unprognostic (8.31e-2)"	"prognostic unfavorable (2.79e-4)"	"unprognostic (3.46e-3)"	"unprognostic (5.04e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.02e-3)"	"unprognostic (2.12e-1)"	"unprognostic (2.99e-1)"	"unprognostic (2.43e-1)"	"unprognostic (2.45e-1)"	142.0	98.7	88.7	130.4	100.7	251.7	122.1	72.7	152.6	109.7	69.4	110.0	88.7	85.4	83.3	108.9	66.0	74.1	113.3	104.3	98.7	129.2	135.3	91.2	159.8	80.7	87.2	68.3	62.0	107.3	88.4	103.2	94.7	73.2	107.1	83.6	76.6	65.4	105.2	69.6	83.7	79.4	86.0	144.9	97.3	71.1	92.6	204.2	69.2	108.9	137.3	124.0	73.2	85.3	199.9	161.8	315.3	295.8	187.5	329.1	197.7	340.3	245.4	300.8	275.4	236.9	307.3	101.2	231.0	236.5	307.3	132.4	266.9	278.9	402.9	420.2	244.1	337.8	365.8	450.5	264.4	594.6	441.4	233.3	235.6	321.0	228.0	166.0	228.9	378.5	399.4	1427.8	269.5	178.6	566.8	942.9	207.8	235.9	326.9	247.8	409.9	645.7	303.0	178.2	170.4	141.1	526.9	244.9	251.9	198.2	272.0	544.9	238.7	324.7	351.5	275.8	261.0	556.0	1035.0	180.5	297.7	634.9	202.4	650.7	135.8	326.2	164.7	142.3	151.4	330.4	215.9	219.8	265.1	214.8	168.2	195.2	163.7	155.2	133.4	390.1	344.6	326.1	88.7	100.7	72.7	152.6	104.3	98.7	80.7	87.2	94.7	86.0	92.6	85.3	298.9	144.2	163.4	27.1	638.2	584.9	588.7	709.9	324.4	118.1	459.2	383.9	196.7	244.5	320.1	310.8	43.8	493.0	613.5	342.1	1009.5	711.4	131.6	319.0	263.7	280.2	281.4	379.5	71.5	327.2	785.0	323.6	227.9	329.9	307.5	188.6	223.1	375.4	500.5	85.8	60.9	362.9	484.2	319.0	721.3	68.1	239.9	422.5	528.3	37.5	587.5	223.7	500.5	64.3	50.4	416.3	516.6	344.6	1838.8	536.0	342.4	921.2	291.9	79.7	203.8	224.0	468.5	447.2	439.9	411.8	565.4	836.8	575.5	357.7	394.6	645.5
SUDS3	"FLJ00052, SAP45, SDS3"	ENSG00000111707	"SDS3 homolog, SIN3A corepressor complex component"	Q9H7L9	12	118376555-118418033	"Predicted intracellular proteins"	"Apoptosis, Transcription, Transcription regulation"	"Chromatin regulator, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 271.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040402, HPA041972"	Approved		Supported	"Nuclear bodies,Cytosol"	"Intracellular and membrane"	NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 6: T47d - Mammary gland"	"Cluster 29: Early spermatids - Spermatogenesis"	"Nuclear bodies, Cytosol"		"HPA040402: , HPA041972: AB_2677776"	"unprognostic (1.49e-1)"	"unprognostic (4.08e-3)"	"unprognostic (1.09e-1)"	"unprognostic (6.60e-2)"	"unprognostic (7.39e-2)"	"unprognostic (1.45e-1)"	"unprognostic (3.05e-3)"	"unprognostic (1.22e-1)"	"unprognostic (2.74e-2)"	"unprognostic (2.70e-1)"	"unprognostic (8.71e-2)"	"unprognostic (3.03e-1)"	"unprognostic (2.36e-2)"	"unprognostic (1.83e-2)"	"unprognostic (3.65e-1)"	"unprognostic (1.02e-1)"	"unprognostic (2.37e-1)"	10.8	12.3	13.3	12.0	14.2	16.9	18.7	9.6	15.2	16.6	12.1	16.5	14.3	14.9	16.0	19.9	18.1	11.7	12.8	15.8	12.9	16.1	14.0	11.9	14.7	12.7	14.6	15.0	17.3	25.3	11.6	11.5	14.1	16.2	18.3	16.3	19.2	15.7	11.3	20.1	14.1	13.7	10.6	13.7	16.2	16.4	12.2	17.9	21.7	11.9	19.5	14.4	15.2	13.2	29.4	21.9	29.4	29.4	16.1	21.1	31.5	22.5	23.2	25.8	20.4	24.1	18.6	39.8	23.5	21.8	16.0	34.3	35.3	23.8	30.3	35.3	20.9	27.7	18.4	21.6	18.4	30.9	20.5	14.6	25.0	12.8	22.7	33.5	22.2	36.9	30.8	14.1	23.9	20.2	36.7	40.2	30.5	38.8	17.0	32.9	26.4	28.3	23.7	42.7	22.9	22.7	31.9	18.7	19.9	36.7	61.1	24.9	18.7	17.5	16.6	19.7	15.5	26.2	31.4	29.2	19.4	19.4	21.4	1.8	4.3	5.9	5.0	2.8	6.1	8.8	5.4	5.7	4.7	8.4	6.4	4.4	12.6	4.3	2.8	6.8	5.5	3.9	13.3	14.2	9.6	15.2	15.8	12.9	12.7	14.6	14.1	10.6	12.2	13.2	25.5	28.9	15.9	19.6	37.8	64.7	44.7	55.0	46.1	75.4	85.6	63.0	37.5	41.5	37.1	47.8	77.2	34.6	26.9	75.1	80.3	41.5	271.9	87.6	54.4	24.6	37.3	30.3	22.4	19.3	54.5	31.5	36.7	73.2	8.2	37.5	21.0	34.1	25.0	107.7	29.1	60.2	59.0	18.2	36.1	59.4	38.5	20.8	28.4	13.1	30.5	30.0	29.9	30.2	21.6	26.4	52.6	41.0	49.1	60.5	38.3	45.7	61.9	57.3	26.3	42.8	48.5	62.6	53.4	74.1	78.7	49.1	32.9	41.6	56.8	61.9
SUFU	"PRO1280, SUFUH, SUFUXL"	ENSG00000107882	"SUFU negative regulator of hedgehog signaling"	Q9UMX1	10	102503972-102633535	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins"		"Developmental protein"	"Cancer-related genes, Ciliopathy, Disease variant, Joubert syndrome, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 129.2;Late spermatids: 115.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008700	Supported		Supported	Nucleoplasm		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 34: Spermatids - Unknown function"	Nucleoplasm		"HPA008700: AB_1080125"	"unprognostic (1.55e-1)"	"unprognostic (4.00e-2)"	"unprognostic (5.14e-2)"	"unprognostic (1.33e-1)"	"unprognostic (4.69e-2)"	"unprognostic (5.68e-2)"	"unprognostic (3.69e-2)"	"unprognostic (5.99e-2)"	"unprognostic (1.64e-1)"	"unprognostic (3.15e-3)"	"unprognostic (9.60e-2)"	"unprognostic (2.13e-1)"	"unprognostic (3.72e-3)"	"unprognostic (1.82e-1)"	"unprognostic (1.44e-1)"	"unprognostic (5.10e-2)"	"unprognostic (3.82e-3)"	6.6	7.2	8.8	7.1	8.5	2.0	6.1	8.9	8.0	8.6	5.5	6.8	3.9	7.4	4.9	9.2	7.1	6.6	6.3	7.8	7.3	6.1	6.2	5.8	7.2	8.3	8.2	8.9	4.1	11.1	4.3	7.4	7.8	8.5	4.4	4.6	7.1	5.2	8.6	14.4	5.7	7.3	6.7	7.4	4.6	11.5	8.0	7.8	3.4	7.3	8.1	8.8	9.2	7.3	8.7	9.1	14.4	20.8	14.5	12.1	7.0	8.8	17.0	12.5	11.3	8.5	6.3	8.9	24.5	9.9	5.0	6.0	17.8	9.8	8.2	5.5	13.8	21.2	5.2	8.0	6.9	7.7	14.6	13.9	7.5	9.3	7.5	22.9	16.3	8.5	4.8	7.9	7.8	7.2	14.8	11.6	4.1	5.6	6.7	15.8	15.5	4.7	8.3	12.8	4.8	7.8	7.0	6.4	8.1	13.1	14.2	5.0	18.1	5.5	7.8	6.0	9.8	6.4	4.5	6.4	6.9	14.9	3.8	2.0	2.0	2.9	1.0	2.4	0.8	0.9	1.2	1.1	1.9	0.8	0.8	1.0	0.4	1.1	2.5	1.1	0.8	1.4	8.8	8.5	8.9	8.0	7.8	7.3	8.3	8.2	7.8	6.7	8.0	7.3	3.3	0.0	3.7	28.7	4.9	3.1	2.1	2.9	6.8	4.2	3.5	3.0	4.0	1.5	4.6	3.7	8.4	7.8	3.1	3.5	1.9	4.4	129.2	4.5	6.2	5.1	1.2	2.5	25.9	3.0	3.5	6.0	4.6	8.5	3.8	3.8	10.8	5.4	12.4	1.7	22.2	2.2	0.0	9.4	6.3	115.9	5.0	8.7	0.0	32.8	7.8	2.7	4.1	17.6	16.8	4.1	1.3	6.8	4.0	2.0	5.7	5.8	5.7	4.8	0.0	3.0	4.5	8.7	5.3	8.9	6.5	7.0	7.1	7.6	3.0	1.3
SUGT1	SGT1	ENSG00000165416	"SGT1 homolog, MIS12 kinetochore complex assembly cochaperone"	Q9Y2Z0	13	52652709-52700909	"Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB015942, HPA043949"	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA		17000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 10: Non-specific - Unknown function"	"Nucleoplasm, Cytosol"	"Plasma membrane"	"CAB015942: , HPA043949: AB_2678745"	"unprognostic (3.66e-2)"	"unprognostic (3.98e-2)"	"unprognostic (3.57e-1)"	"unprognostic (1.22e-1)"	"unprognostic (3.77e-2)"	"prognostic unfavorable (8.69e-4)"	"unprognostic (2.24e-1)"	"unprognostic (2.96e-1)"	"unprognostic (3.76e-1)"	"unprognostic (1.96e-3)"	"unprognostic (9.51e-2)"	"unprognostic (1.12e-1)"	"unprognostic (6.83e-2)"	"unprognostic (2.82e-3)"	"unprognostic (9.05e-2)"	"unprognostic (2.93e-2)"	"unprognostic (1.56e-1)"	27.4	31.4	33.4	25.5	38.1	32.0	23.6	38.6	55.6	23.0	33.1	25.5	27.3	19.6	20.3	30.1	19.4	19.6	37.0	34.8	37.0	31.7	36.5	22.5	27.4	34.8	34.8	21.5	30.6	19.8	26.9	25.9	36.9	19.6	26.9	22.2	25.2	16.3	29.6	24.5	26.8	22.1	35.3	23.2	26.8	34.5	36.4	29.8	21.1	28.1	29.9	27.3	24.3	48.1	47.0	50.2	72.9	55.6	70.4	57.0	69.8	100.8	66.3	61.7	49.0	110.3	114.7	102.4	27.9	62.8	89.5	79.0	90.6	57.9	90.0	85.3	37.7	95.1	65.8	84.4	51.1	74.8	68.7	40.0	51.7	63.9	48.2	79.0	105.0	64.8	90.5	32.7	95.7	33.4	70.3	136.6	85.3	183.9	47.8	79.6	42.4	44.4	108.0	51.7	24.1	30.7	52.1	42.2	49.8	82.6	43.5	70.3	76.1	51.3	59.9	59.6	87.6	25.7	38.9	91.5	30.8	59.2	75.5	63.6	29.0	49.0	24.3	34.5	23.9	30.9	31.4	33.2	32.9	30.3	23.8	26.6	4.1	33.2	34.1	41.0	46.0	25.2	33.4	38.1	38.6	55.6	34.8	37.0	34.8	34.8	36.9	35.3	36.4	48.1	82.1	38.5	36.0	22.2	46.1	39.8	65.4	68.2	38.1	52.6	40.6	55.8	126.2	32.9	51.8	51.5	25.0	67.0	78.3	52.3	78.2	88.3	185.6	112.0	79.0	65.9	34.1	65.2	19.9	89.0	143.0	60.9	50.0	75.1	36.8	49.7	43.5	38.3	97.8	50.5	23.0	58.2	54.9	44.5	43.9	95.7	58.7	54.3	48.0	13.1	123.7	91.8	58.7	21.1	47.6	85.2	55.0	59.8	58.3	44.1	74.3	100.9	67.8	56.6	26.3	72.4	92.1	146.7	101.0	45.7	43.2	74.4	61.1	56.1	55.5	52.3
SULT2A1	"DHEA-ST, STD"	ENSG00000105398	"Sulfotransferase family 2A member 1"	Q06520	19	47870467-47886315	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Bile acid catabolism, Lipid degradation, Lipid metabolism, Steroid metabolism"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"liver: 1072.1"	"Cell type enriched"	"Detected in some"	9	"Hepatocytes: 1578.7"	"Cancer enriched"	"Detected in some"	52	"liver cancer: 244.3"	"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in single"		"basophil: 2.9"	"Lineage enriched"	"Detected in single"	6	"granulocytes: 2.9"	"Group enriched"	"Detected in some"	34	"Hep G2: 39.6;RT4: 26.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB018755, HPA041487, HPA063633"	Enhanced		Supported	Cytosol		NA	NA		1200000	"Cluster 11: Basophils - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 2: Hepatocytes - Metabolism"	Cytosol		"CAB018755: AB_650242, HPA041487: AB_2677507, HPA063633: AB_2685066"			"unprognostic (2.14e-1)"				"unprognostic (6.79e-3)"							"unprognostic (6.82e-2)"	"unprognostic (1.36e-1)"		"unprognostic (1.31e-2)"	0.1	235.6	0.3	0.1	0.2	0.4	0.0	0.7	0.4	0.0	0.5	0.6	59.5	0.1	0.4	0.0	0.0	0.1	0.0	0.2	0.1	0.2	1072.1	0.0	0.2	0.2	0.3	0.1	0.1	36.9	0.0	0.1	0.2	0.1	0.9	1.0	0.1	3.1	0.1	0.3	86.6	0.0	0.0	0.4	24.4	4.2	0.2	0.0	0.1	0.0	0.1	2.0	0.1	0.6	0.1	0.0	0.1	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.9	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.1	0.2	0.3	39.6	0.0	0.9	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.4	0.0	0.0	0.1	0.3	0.1	0.1	0.1	0.0	0.5	0.3	0.0	26.7	0.2	0.2	0.2	0.0	0.0	0.0	0.1	0.3	0.0	0.1	0.1	0.2	0.1	0.2	0.1	0.2	0.0	0.2	0.1	2.9	0.2	0.2	0.2	0.1	0.2	0.2	0.3	0.2	0.1	0.4	0.4	0.3	0.8	0.5	0.1	0.3	0.2	0.2	0.3	0.2	0.7	0.4	0.2	0.1	0.2	0.3	0.2	0.0	0.2	0.6	0.0	0.0	0.0	0.3	2.9	0.1	0.6	0.0	0.0	1.3	0.0	0.0	0.6	18.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	1.3	0.0	18.7	0.3	0.0	0.0	0.3	5.1	0.1	0.0	0.1	30.0	1578.7	0.0	0.0	0.3	2.8	0.0	31.8	0.4	0.2	3.1	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.1	0.0	8.8	0.4	0.0	0.3	171.7	0.1	0.0	2.7	0.0	0.2	0.2	0.1	0.0	0.0	0.0	0.5	1.8	81.7	2.2	0.3
SULT2B1	HSST2	ENSG00000088002	"Sulfotransferase family 2B member 1"	O00204	19	48552172-48599425	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Lipid metabolism, Steroid metabolism"	Transferase	"Disease variant, Ichthyosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 286.0;skin 1: 186.5;vagina: 145.9"	"Cell type enhanced"	"Detected in many"		"Prostatic glandular cells: 62.3;Proximal enterocytes: 75.9;Squamous epithelial cells: 56.0;Suprabasal keratinocytes: 137.4;Urothelial cells: 114.6"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"CAPAN-2: 74.2;MCF7: 46.8;OE19: 122.9;T-47d: 36.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA041724, HPA043539, HPA076510"	Enhanced		Enhanced	Vesicles,Cytosol		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 22: Epithelial cell types - Mixed function"	Vesicles	Cytosol	"HPA041724: AB_2677638, HPA043539: AB_2678540, HPA076510: "	"unprognostic (6.55e-2)"	"unprognostic (1.47e-1)"	"unprognostic (5.28e-3)"	"unprognostic (8.74e-2)"	"unprognostic (5.00e-2)"	"unprognostic (5.97e-2)"	"unprognostic (4.43e-2)"	"unprognostic (3.29e-3)"	"unprognostic (1.62e-1)"	"unprognostic (1.11e-2)"	"unprognostic (2.54e-2)"	"unprognostic (4.42e-2)"	"unprognostic (5.01e-6)"	"unprognostic (7.96e-3)"	"unprognostic (1.32e-1)"	"unprognostic (8.04e-2)"	"unprognostic (2.77e-2)"	0.3	0.2	0.5	0.4	0.4	0.1	11.5	0.6	0.8	74.4	0.4	0.8	9.3	0.5	6.8	286.0	1.2	2.7	0.2	0.5	0.5	13.0	0.3	9.4	0.0	0.5	0.7	0.1	0.7	7.9	0.4	1.5	0.5	22.6	0.2	0.0	53.6	3.7	0.4	186.5	18.2	0.1	0.4	0.1	3.5	0.5	0.9	0.4	1.9	0.0	28.3	0.7	145.9	0.5	12.6	15.8	0.0	0.3	0.0	0.0	0.4	0.0	0.1	0.0	0.1	0.9	74.2	0.1	0.1	0.0	0.7	3.9	0.1	0.3	0.0	0.5	0.4	0.0	0.5	0.5	0.0	0.0	7.2	0.2	2.1	0.0	0.0	0.1	0.0	0.8	0.1	0.1	0.0	46.8	0.0	0.5	0.0	122.9	0.0	0.1	0.0	0.1	0.0	3.5	0.2	0.1	0.0	6.2	0.3	0.0	36.7	0.1	0.2	0.0	0.3	0.1	0.0	0.1	0.1	0.1	0.0	0.4	0.3	0.5	0.1	0.0	0.3	0.2	0.6	0.0	0.2	0.1	0.1	0.0	0.0	0.1	0.1	0.2	0.2	0.2	0.1	0.2	0.5	0.4	0.6	0.8	0.5	0.5	0.5	0.7	0.5	0.4	0.9	0.5	0.4	19.2	0.5	1.0	0.0	24.1	30.5	11.6	0.0	0.0	16.8	12.4	0.6	5.7	40.2	9.2	0.0	3.2	0.0	4.4	0.0	12.2	0.0	15.7	1.4	0.9	4.8	0.0	1.0	1.2	3.1	1.2	2.6	17.5	0.0	0.1	0.0	0.3	0.7	0.0	0.9	12.6	24.4	0.0	4.8	0.9	0.3	0.4	12.4	1.0	0.0	1.6	0.0	0.5	0.8	18.5	7.9	0.0	0.0	62.3	75.9	1.3	6.7	0.6	0.0	0.1	2.2	0.2	11.1	56.0	137.4	1.9	0.6	2.0	9.2	114.6
SUMO1	"GMP1, OFC10, PIC1, SMT3C, SMT3H3, SUMO-1, UBL1"	ENSG00000116030	"Small ubiquitin like modifier 1"	P63165	2	202206182-202238599	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Host-virus interaction, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in many"	4	"cerebellum: 7.6"	"CAB004269, HPA056956"	Supported		Supported	"Nucleoplasm,Nuclear membrane,Nucleoli,Nuclear bodies"		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	"Nucleoplasm, Nuclear membrane"	"Nucleoli, Nuclear bodies"	"CAB004269: AB_628300, HPA056956: AB_2683285"	"unprognostic (7.15e-2)"	"unprognostic (2.34e-2)"	"unprognostic (1.49e-1)"	"unprognostic (2.52e-3)"	"unprognostic (2.89e-1)"	"unprognostic (9.56e-3)"	"unprognostic (1.76e-2)"	"unprognostic (8.08e-2)"	"unprognostic (1.78e-3)"	"prognostic favorable (7.93e-4)"	"unprognostic (7.06e-3)"	"unprognostic (1.16e-1)"	"unprognostic (4.64e-3)"	"unprognostic (1.31e-2)"	"unprognostic (7.58e-2)"	"unprognostic (2.82e-2)"	"unprognostic (2.19e-1)"	77.5	99.1	79.4	62.7	84.9	133.7	83.6	89.0	99.9	68.9	84.4	82.7	72.0	65.1	86.3	71.6	65.7	71.7	79.8	85.6	85.3	118.1	174.1	66.5	86.4	79.9	80.1	54.5	55.8	91.6	56.7	75.6	81.1	75.3	82.8	80.2	66.8	61.9	107.5	57.1	80.5	71.5	78.9	68.1	73.8	54.7	81.4	112.1	102.3	103.3	95.4	77.9	54.9	86.6	164.1	82.4	291.4	155.8	159.3	168.5	129.7	171.0	214.6	209.0	274.6	178.1	203.7	111.6	153.5	199.0	193.5	117.1	242.2	237.9	325.0	104.8	185.7	207.6	159.0	211.2	114.9	237.2	188.5	130.9	225.2	164.0	123.9	195.1	197.3	219.0	194.2	176.0	226.4	141.1	298.3	391.6	351.7	168.5	172.2	190.9	163.2	197.9	255.5	134.3	201.7	219.3	140.3	133.6	236.4	313.9	120.0	223.2	139.9	152.5	153.0	141.4	152.8	151.7	322.9	285.8	170.2	165.4	137.2	242.2	220.0	284.2	169.2	226.5	179.6	276.3	206.8	200.0	223.6	231.6	193.8	202.3	256.5	246.5	239.7	187.8	329.0	394.7	79.4	84.9	89.0	99.9	85.6	85.3	79.9	80.1	81.1	78.9	81.4	86.6	182.7	112.2	61.1	10.7	143.1	422.1	204.4	448.6	177.6	99.6	196.8	170.2	58.1	130.1	215.3	189.4	64.6	259.4	162.3	136.6	481.3	250.4	91.3	148.3	115.1	170.7	142.4	140.1	31.4	173.3	297.8	161.8	89.7	115.2	92.6	114.7	142.8	202.1	205.3	87.5	27.8	156.4	319.4	140.7	330.2	28.0	129.8	137.7	211.7	15.9	241.3	182.3	176.1	16.6	21.2	208.1	191.1	127.9	130.5	258.5	272.2	534.4	185.5	87.8	111.7	92.5	221.9	212.0	141.5	183.9	424.5	209.7	174.5	134.9	157.5	254.1
SUN2	UNC84B	ENSG00000100242	"Sad1 and UNC84 domain containing 2"	Q9UH99	22	38734725-38794143	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Meiosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"NK-cells: 201.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001209	Supported		Supported	"Nuclear membrane"		NA	Yes			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 70: Brain - Nervous system development"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Nuclear membrane"		"HPA001209: AB_1080465"	"unprognostic (9.76e-2)"	"unprognostic (1.42e-1)"	"unprognostic (8.32e-2)"	"unprognostic (5.09e-2)"	"unprognostic (1.36e-1)"	"unprognostic (5.57e-2)"	"unprognostic (1.94e-2)"	"unprognostic (2.37e-2)"	"unprognostic (3.14e-2)"	"unprognostic (1.25e-3)"	"unprognostic (8.15e-2)"	"unprognostic (4.10e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.31e-1)"	"unprognostic (8.10e-2)"	"unprognostic (2.33e-2)"	137.8	35.1	123.6	73.6	219.0	160.4	111.7	149.1	155.3	95.4	41.4	107.8	47.6	128.2	22.2	84.0	125.3	41.1	86.7	118.3	133.1	52.8	121.9	107.0	104.0	187.1	182.2	112.9	78.0	18.2	40.3	28.7	170.7	78.2	25.2	12.3	74.9	52.1	145.4	90.3	93.1	46.1	107.2	97.2	94.3	34.6	163.3	74.3	53.1	63.8	60.0	121.7	89.0	257.7	89.8	41.0	40.0	44.7	118.8	29.5	52.0	60.2	69.4	69.7	58.9	36.8	98.7	28.1	71.9	85.9	43.1	65.4	13.4	44.7	28.4	98.0	54.7	18.4	44.7	33.7	71.9	62.3	184.0	25.0	37.3	33.6	31.2	46.9	56.2	55.3	23.5	154.3	38.5	28.7	35.0	53.9	3.9	63.0	26.2	57.6	55.8	85.7	17.4	43.1	35.3	13.2	67.0	73.7	35.1	18.5	49.5	115.3	95.2	50.6	43.3	44.9	79.5	113.1	38.2	30.4	93.8	74.2	86.6	29.0	13.7	18.6	42.3	15.6	27.5	10.8	27.0	34.9	10.7	10.1	27.6	33.6	13.9	24.8	26.9	6.7	19.9	24.8	123.6	219.0	149.1	155.3	118.3	133.1	187.1	182.2	170.7	107.2	163.3	257.7	55.5	22.4	22.9	20.2	57.0	18.1	28.4	15.1	24.5	9.9	36.5	39.0	6.2	40.0	17.8	33.1	8.4	16.9	141.8	65.6	3.9	34.9	1.8	11.6	15.8	37.4	18.6	31.8	12.5	47.6	65.9	34.0	42.8	32.9	25.4	41.5	52.1	109.6	25.0	21.9	7.7	30.1	8.2	42.4	21.4	4.4	61.2	41.8	17.8	16.9	25.5	21.4	201.8	7.1	132.9	60.0	41.8	65.5	44.7	22.0	42.2	18.9	5.7	13.0	52.6	100.7	37.0	3.8	1.1	32.1	17.2	14.8	133.4	10.9	21.4	21.4
SUPT16H	"CDC68, FACT, FACTP140, FLJ10857, FLJ14010, SPT16/CDC68"	ENSG00000092201	"SPT16 homolog, facilitates chromatin remodeling subunit"	Q9Y5B9	14	21351476-21384019	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, DNA replication, Host-virus interaction, Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022551, HPA049787"	Enhanced		Supported	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA		27000	"Cluster 27: Non-specific - Gene expression"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm	"Nucleoli fibrillar center"	"CAB022551: , HPA049787: AB_2680881"	"unprognostic (1.65e-1)"	"unprognostic (2.22e-1)"	"unprognostic (3.52e-2)"	"unprognostic (7.12e-2)"	"unprognostic (7.32e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.38e-3)"	"unprognostic (1.86e-1)"	"unprognostic (7.65e-2)"	"unprognostic (4.91e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.26e-1)"	"unprognostic (6.48e-3)"	"unprognostic (1.02e-1)"	"unprognostic (7.58e-3)"	"unprognostic (9.05e-2)"	"unprognostic (5.87e-3)"	29.3	24.8	9.7	36.6	11.1	42.3	35.9	18.8	13.9	34.2	8.2	30.6	23.1	41.1	19.5	29.0	32.0	24.1	24.1	9.7	15.6	28.6	22.4	26.3	51.2	11.3	12.0	43.6	22.6	46.2	13.5	32.1	12.0	29.9	35.1	44.4	20.9	32.6	21.8	28.9	25.9	36.6	10.7	32.9	26.3	43.3	12.1	56.8	33.3	24.6	51.8	35.6	20.1	12.3	147.8	136.9	185.5	136.6	85.5	81.7	131.4	130.3	103.2	155.5	145.4	133.9	129.5	311.3	48.5	96.5	99.7	153.9	237.2	118.9	234.0	99.8	100.9	188.7	121.9	195.1	87.0	270.1	134.7	73.4	72.6	131.0	146.3	75.4	107.7	174.2	158.1	129.4	131.3	99.9	253.6	85.8	207.1	136.2	134.1	270.3	210.6	168.0	63.9	160.8	183.8	157.2	209.8	125.3	81.1	118.7	69.2	127.9	91.1	135.0	113.4	85.0	143.3	128.8	230.2	306.7	49.9	158.0	104.9	35.6	18.3	28.2	29.6	23.9	34.7	31.2	27.9	33.2	23.7	27.4	31.3	32.2	15.0	34.0	31.1	22.2	28.4	25.2	9.7	11.1	18.8	13.9	9.7	15.6	11.3	12.0	12.0	10.7	12.1	12.3	41.5	64.1	55.9	24.2	51.6	35.6	44.3	51.5	45.5	48.9	46.3	49.7	64.2	22.8	50.3	53.3	47.9	65.1	73.6	28.4	25.4	71.0	142.5	52.0	124.3	46.9	23.4	74.6	27.4	61.1	63.9	61.1	29.6	61.7	84.2	73.4	29.3	32.0	41.9	55.5	30.1	31.2	40.7	34.9	25.2	96.1	59.7	40.7	17.8	20.6	90.9	53.3	64.9	16.1	25.2	68.9	15.2	59.8	39.5	46.1	16.5	30.4	40.2	41.1	19.7	78.5	69.5	128.9	152.8	45.1	41.5	45.6	56.3	61.6	43.0	35.7
SUPT3H	"SPT3, SPT3L"	ENSG00000196284	"SPT3 homolog, SAGA and STAGA complex component"	O75486	6	44809317-45377953	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in all"	6	"Astrocytes: 110.7;Early spermatids: 142.2;Excitatory neurons: 286.4;Inhibitory neurons: 405.2;Late spermatids: 183.4;Microglial cells: 124.6;Oligodendrocyte precursor cells: 182.9;Oligodendrocytes: 192.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024371	Enhanced		Supported	Nucleoplasm		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 21: Non-specific - Transcription"	"Cluster 12: NES - Nervous system development"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm		"HPA024371: AB_1857660"	"unprognostic (5.72e-3)"	"unprognostic (7.92e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.34e-1)"	"prognostic favorable (3.55e-4)"	"unprognostic (1.07e-2)"	"unprognostic (6.15e-5)"	"unprognostic (7.46e-2)"	"unprognostic (1.75e-1)"	"prognostic favorable (1.72e-4)"	"unprognostic (1.49e-1)"	"unprognostic (2.30e-1)"	"unprognostic (2.05e-2)"	"unprognostic (3.08e-2)"	"unprognostic (1.23e-1)"	"unprognostic (8.13e-3)"	"unprognostic (4.31e-2)"	2.4	5.1	3.6	1.2	4.1	1.2	2.4	4.8	5.7	4.4	0.0	3.6	2.2	3.5	4.2	2.9	4.1	2.0	1.8	3.9	4.7	4.3	1.6	2.4	1.7	4.5	3.3	5.2	3.8	3.8	3.2	3.4	3.6	4.4	2.3	4.2	7.2	2.1	1.6	1.4	2.4	2.5	1.8	1.8	2.2	8.9	5.7	2.7	4.4	0.5	1.9	3.2	2.4	5.7	5.2	2.4	12.9	6.8	2.7	7.8	4.3	3.2	4.0	7.2	8.9	4.0	4.0	2.0	3.0	1.5	6.2	2.2	9.0	7.1	13.2	5.0	3.6	1.4	1.9	10.4	6.4	3.9	1.5	4.2	5.7	3.7	10.0	20.5	3.7	7.2	4.7	3.7	6.6	1.5	4.0	8.2	4.6	11.2	1.1	8.8	5.7	2.2	10.2	4.2	6.4	3.1	0.7	0.8	10.2	16.7	3.3	3.8	1.3	6.4	0.1	4.6	7.3	7.2	2.2	12.3	5.0	7.9	6.0	0.1	0.3	0.1	2.9	0.5	5.1	1.2	4.4	3.4	1.4	1.6	5.1	4.3	0.2	2.3	0.7	3.9	1.9	1.6	3.6	4.1	4.8	5.7	3.9	4.7	4.5	3.3	3.6	1.8	5.7	5.7	4.5	3.2	4.8	110.7	11.5	1.8	14.5	10.0	8.6	7.4	5.1	6.7	3.0	2.8	7.2	7.3	6.2	11.7	19.7	1.2	11.7	8.4	142.2	5.4	4.5	5.7	8.4	5.9	286.4	3.2	12.3	7.2	6.6	6.3	3.8	16.0	7.1	3.0	8.7	3.3	405.2	2.3	2.0	2.9	5.0	183.4	7.8	4.5	5.4	124.6	10.5	2.8	20.6	182.9	192.9	4.0	2.1	5.3	14.7	11.3	1.9	10.7	8.3	13.5	13.1	6.8	16.0	26.8	22.0	6.2	1.3	8.2	30.7	7.8	3.7	9.3
SUPV3L1	SUV3	ENSG00000156502	"Suv3 like RNA helicase"	Q8IYB8	10	69180234-69209099	"Enzymes, Predicted intracellular proteins"		"Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038380, HPA038405"	Supported		Supported	Mitochondria		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 24: Non-specific - Transcription regulation"	Mitochondria		"HPA038380: AB_2675983, HPA038405: AB_10675797"	"unprognostic (4.70e-2)"	"unprognostic (1.85e-2)"	"unprognostic (2.25e-1)"	"unprognostic (1.19e-2)"	"unprognostic (3.74e-2)"	"unprognostic (3.32e-2)"	"unprognostic (1.44e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.57e-1)"	"unprognostic (9.47e-3)"	"unprognostic (1.70e-1)"	"unprognostic (1.06e-1)"	"unprognostic (5.48e-3)"	"unprognostic (5.03e-2)"	"unprognostic (1.61e-1)"	"unprognostic (5.27e-2)"	"unprognostic (1.33e-1)"	10.1	10.9	7.9	8.7	8.2	24.2	11.5	10.2	10.3	7.7	7.6	11.6	8.9	9.3	7.9	8.8	8.3	6.0	15.8	8.5	8.2	12.9	17.9	6.1	12.0	7.9	7.4	10.6	9.3	16.5	7.5	8.7	7.9	8.0	12.7	11.1	8.9	8.6	25.9	10.6	8.6	9.3	7.2	9.9	8.9	15.8	7.8	11.0	10.9	29.1	12.2	9.5	7.7	8.5	28.9	19.9	17.4	53.5	19.1	16.1	22.7	17.5	27.1	34.7	32.6	51.4	23.8	51.5	14.0	17.6	24.8	32.3	42.2	27.4	33.1	21.5	33.1	22.6	14.9	27.2	48.1	54.3	16.5	20.5	33.7	31.9	72.6	23.6	20.3	32.2	59.6	26.1	19.2	18.7	33.1	33.5	20.8	27.2	106.7	30.1	24.7	22.6	15.6	13.9	24.7	18.7	24.2	49.7	46.7	19.1	15.5	23.5	12.7	13.7	24.7	21.1	34.3	20.5	25.4	47.5	22.6	56.4	8.9	8.9	5.1	4.7	11.1	7.3	12.5	9.0	7.9	9.5	7.1	7.3	8.7	9.6	0.9	7.7	5.4	3.9	8.8	6.2	7.9	8.2	10.2	10.3	8.5	8.2	7.9	7.4	7.9	7.2	7.8	8.5	11.2	6.4	7.4	15.3	21.7	23.8	11.6	16.6	21.6	21.6	10.8	9.5	22.5	5.7	15.1	7.3	4.2	17.8	49.3	11.7	11.7	11.6	13.4	17.2	17.6	10.1	9.0	10.3	29.6	8.6	11.4	12.6	14.8	28.8	7.6	15.1	5.7	12.0	9.6	11.8	28.2	9.0	16.2	6.0	10.0	4.5	6.8	9.4	5.4	15.0	7.2	11.3	19.6	14.1	17.6	8.5	8.1	9.1	37.0	10.8	8.5	14.3	12.6	12.5	6.6	17.2	14.6	38.6	26.6	23.6	22.3	22.4	28.8	16.1	14.1	10.7
SURF4	"ERV29, FLJ22993, MGC102753"	ENSG00000148248	"Surfeit 4"	O15260	9	133361450-133376166	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Syncytiotrophoblasts: 325.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA064613	Approved		Supported	"Nuclear membrane,Endoplasmic reticulum,Golgi apparatus,Cytosol"		NA	Yes		65000	"Cluster 16: MAIT-cells - Unknown function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 55: Plasma cells - Humoral immune response"	"Nuclear membrane, Endoplasmic reticulum, Golgi apparatus"	Cytosol	"HPA064613: AB_2685299"	"prognostic unfavorable (5.85e-4)"	"unprognostic (1.38e-2)"	"unprognostic (1.92e-1)"	"unprognostic (2.04e-2)"	"unprognostic (3.40e-2)"	"prognostic unfavorable (1.47e-5)"	"prognostic unfavorable (8.11e-4)"	"unprognostic (1.10e-3)"	"unprognostic (3.13e-2)"	"unprognostic (1.90e-1)"	"unprognostic (5.30e-3)"	"unprognostic (1.23e-1)"	"unprognostic (9.76e-3)"	"unprognostic (7.58e-3)"	"unprognostic (1.25e-1)"	"unprognostic (2.29e-1)"	"unprognostic (4.29e-3)"	97.0	106.4	20.3	38.8	22.5	66.5	76.5	22.1	23.4	70.5	27.9	72.1	79.2	78.5	40.6	77.6	71.1	39.0	74.1	21.5	22.3	67.1	223.8	84.2	29.6	23.6	22.2	61.0	150.4	35.4	88.6	55.4	22.2	69.2	37.9	14.0	86.4	39.5	60.1	63.2	82.2	43.4	22.9	59.6	88.5	49.4	25.8	27.8	68.2	23.3	31.4	62.7	59.4	25.9	59.8	96.4	65.3	90.3	134.8	140.2	127.4	184.1	178.4	127.0	124.7	145.9	84.8	41.1	70.6	254.2	122.9	152.7	75.7	94.4	97.0	86.5	46.3	72.1	87.1	156.5	156.2	124.8	94.1	150.4	85.8	109.3	120.2	101.6	118.6	62.9	89.0	109.8	164.5	131.8	60.1	115.4	72.7	162.8	96.2	41.2	89.9	156.5	100.4	56.3	53.8	65.5	136.4	100.4	95.2	61.5	106.6	75.8	127.5	179.4	64.5	137.3	119.6	56.1	86.4	46.4	166.7	66.6	137.5	43.9	40.8	36.2	51.9	32.8	56.9	15.1	36.3	48.4	32.9	12.1	22.0	34.6	28.4	29.4	31.7	38.9	46.9	68.8	20.3	22.5	22.1	23.4	21.5	22.3	23.6	22.2	22.2	22.9	25.8	25.9	53.5	44.8	48.1	18.9	43.0	60.8	65.8	72.5	46.1	21.9	55.5	43.2	42.6	31.5	47.5	35.0	39.6	167.9	80.4	106.9	19.6	95.7	38.6	28.6	72.8	54.8	75.2	31.1	23.2	118.1	254.4	84.8	78.5	67.7	24.7	49.5	47.5	207.3	85.9	33.7	15.6	107.9	30.5	52.3	50.5	19.7	68.3	50.8	40.9	17.8	53.7	53.3	52.5	22.6	23.8	115.1	65.5	53.0	114.8	106.8	151.3	48.5	23.2	26.9	78.9	51.9	80.6	84.4	47.3	46.1	62.4	325.2	90.5	81.8	81.2	84.2
SURF6	"FLJ30322, RRP14"	ENSG00000148296	"Surfeit 6"	O75683	9	133328776-133336188	"Plasma proteins, Predicted intracellular proteins"		"DNA-binding, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Theca cells: 91.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023608, HPA074622"	Approved		Enhanced	"Nucleoplasm,Nucleoli,Nucleoli rim,Mitotic chromosome"		Yes	No			"Cluster 29: Plasmacytoid DCs - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Nucleoli, Nucleoli rim"	"Nucleoplasm, Mitotic chromosome"	"HPA023608: AB_1857671, HPA074622: AB_2686703"	"unprognostic (5.27e-3)"	"unprognostic (8.67e-3)"	"unprognostic (5.41e-3)"	"unprognostic (3.69e-2)"	"unprognostic (2.61e-1)"	"unprognostic (3.20e-1)"	"unprognostic (1.26e-3)"	"unprognostic (3.60e-2)"	"unprognostic (1.18e-1)"	"unprognostic (9.37e-2)"	"unprognostic (6.18e-3)"	"unprognostic (9.32e-3)"	"prognostic favorable (7.31e-5)"	"unprognostic (1.50e-2)"	"unprognostic (1.86e-1)"	"unprognostic (2.06e-1)"	"unprognostic (2.66e-1)"	10.4	11.7	8.1	4.1	7.8	4.9	10.3	8.7	7.5	12.4	5.9	13.6	6.2	11.9	2.6	12.5	11.2	2.5	10.5	7.2	7.5	11.7	12.3	8.5	5.5	7.7	7.8	13.1	11.2	3.9	8.1	3.3	7.8	11.5	3.4	3.3	9.7	4.0	17.9	13.2	12.1	2.7	7.5	11.4	9.9	7.9	7.9	4.6	10.6	3.9	3.7	12.2	11.1	8.1	5.6	8.7	6.5	9.8	4.0	3.7	10.8	8.8	5.1	7.7	4.8	13.8	9.2	16.2	6.7	4.9	5.6	16.7	8.4	9.3	2.8	10.8	9.6	11.2	10.5	8.3	7.2	19.1	9.3	5.3	8.0	8.0	7.4	6.8	4.0	15.6	25.1	8.4	6.8	14.7	15.5	15.7	19.1	22.7	15.6	16.1	9.1	16.7	6.7	5.3	13.7	11.6	8.6	13.7	7.8	3.9	12.2	10.6	8.4	17.3	9.3	8.9	12.0	6.2	9.6	21.0	6.5	12.9	10.4	3.3	3.0	1.4	4.3	2.9	4.5	4.6	3.9	3.9	3.3	5.1	5.2	4.4	0.8	3.2	2.7	6.0	3.6	2.5	8.1	7.8	8.7	7.5	7.2	7.5	7.7	7.8	7.8	7.5	7.9	8.1	25.7	44.8	27.3	4.6	20.9	23.7	15.7	11.0	24.5	26.5	33.4	32.3	30.0	28.6	24.5	22.0	6.2	32.2	20.3	36.8	21.5	29.2	1.3	21.1	42.2	23.6	33.6	14.1	4.3	19.6	25.2	21.2	18.8	25.1	25.3	25.4	16.4	35.2	21.2	21.9	4.8	40.3	6.1	14.7	10.2	4.1	27.7	13.7	7.2	5.6	18.6	15.2	29.9	5.0	4.1	29.0	33.3	27.8	14.4	24.8	50.6	26.1	13.2	19.6	0.0	15.8	20.3	19.2	23.6	26.3	27.6	19.0	18.1	91.1	57.7	13.3
SUZ12	"CHET9, JJAZ1, KIAA0160"	ENSG00000178691	"SUZ12 polycomb repressive complex 2 subunit"	Q15022	17	31937007-32001038	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, Repressor"	"Cancer-related genes, Disease variant, Mental retardation, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA057436	Approved		Supported	"Nucleoplasm,Nucleoli,Nucleoli rim,Nuclear bodies"		Yes	No			"Cluster 15: NK-cells - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	"Nucleoplasm, Nucleoli, Nucleoli rim, Nuclear bodies"		"HPA057436: AB_2683439"	"unprognostic (1.23e-1)"	"unprognostic (1.11e-1)"	"unprognostic (3.65e-3)"	"unprognostic (1.23e-1)"	"unprognostic (2.49e-1)"	"unprognostic (7.31e-2)"	"unprognostic (2.66e-3)"	"unprognostic (8.05e-2)"	"unprognostic (7.27e-2)"	"unprognostic (3.06e-2)"	"unprognostic (6.29e-2)"	"unprognostic (8.70e-2)"	"unprognostic (3.28e-2)"	"unprognostic (2.25e-1)"	"unprognostic (1.28e-1)"	"unprognostic (5.91e-2)"	"unprognostic (1.31e-1)"	12.3	11.8	6.3	18.8	6.3	45.4	15.0	11.1	8.5	11.6	6.8	14.9	16.0	15.2	12.0	14.0	11.0	12.0	10.3	5.4	5.8	16.4	18.1	12.6	33.0	5.4	5.9	11.4	11.5	19.8	6.6	18.7	5.6	13.3	16.4	26.5	10.5	12.2	8.1	13.0	15.3	14.7	5.2	18.4	15.2	27.4	6.1	38.5	18.3	11.0	30.0	15.6	9.0	7.1	46.5	40.4	37.2	42.9	21.1	26.8	38.2	44.2	38.8	53.0	63.7	30.9	25.5	100.7	33.2	27.7	45.4	40.1	56.0	25.5	85.7	35.8	54.0	69.9	32.9	22.3	24.8	111.5	68.7	18.7	28.1	53.1	40.4	32.1	33.1	47.3	68.8	135.6	46.2	16.2	133.3	64.4	21.3	32.4	24.4	78.5	95.3	81.9	31.1	44.6	47.5	37.1	71.3	22.7	43.3	25.8	66.0	91.5	24.7	41.9	38.0	50.8	69.3	73.5	98.4	122.5	30.7	67.4	38.7	0.6	0.7	1.6	1.4	1.1	1.1	2.4	1.6	1.6	0.6	1.8	1.5	2.1	1.6	1.8	0.7	1.9	1.8	0.4	6.3	6.3	11.1	8.5	5.4	5.8	5.4	5.9	5.6	5.2	6.1	7.1	44.5	41.7	45.8	43.1	50.1	58.5	50.2	21.8	31.9	77.6	54.2	36.8	32.3	27.1	32.6	35.0	108.4	61.5	65.2	24.0	17.6	28.3	16.2	52.8	55.8	45.1	29.4	93.6	71.6	21.9	53.1	35.1	31.1	54.2	15.8	41.4	38.2	42.3	32.9	62.2	69.5	31.8	10.2	42.1	58.2	13.9	26.8	47.3	24.9	45.0	73.1	45.7	38.1	75.4	71.3	27.8	15.4	25.6	66.2	62.8	21.5	26.6	29.6	80.9	13.1	47.2	38.4	121.7	128.9	48.6	71.7	69.5	52.5	52.8	35.6	66.7
SV2C		ENSG00000122012	"Synaptic vesicle glycoprotein 2C"	Q496J9	5	76083383-76353939	"Predicted membrane proteins, Transporters"	"Neurotransmitter transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	13	"brain: 55.7"	"Group enriched"	"Detected in some"	4	"Excitatory neurons: 85.0;Inhibitory neurons: 82.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in single"	15	"basophil: 1.5"	"Lineage enriched"	"Detected in single"	15	"granulocytes: 1.5"	"Group enriched"	"Detected in some"	5	"Karpas-707: 9.1;SCLC-21H: 3.7;SH-SY5Y: 8.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040722, HPA040770"	Supported		Supported	Nucleoplasm,Vesicles		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Nucleoplasm, Vesicles"		"HPA040722: AB_10795624, HPA040770: AB_10805828"	"unprognostic (7.91e-2)"	"unprognostic (2.33e-1)"	"unprognostic (2.05e-1)"	"unprognostic (2.41e-2)"	"unprognostic (1.07e-1)"	"unprognostic (9.93e-2)"	"unprognostic (1.09e-2)"	"unprognostic (2.57e-1)"	"unprognostic (2.57e-1)"	"unprognostic (2.14e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.34e-2)"	"unprognostic (1.60e-3)"	"unprognostic (1.90e-1)"	"unprognostic (2.12e-1)"	"unprognostic (6.66e-2)"	"unprognostic (1.16e-1)"	0.0	1.2	4.7	0.2	31.4	0.1	0.2	11.1	32.0	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.3	0.0	0.1	0.0	55.7	0.0	0.0	0.0	0.0	26.1	39.5	0.5	0.1	0.0	0.4	0.0	42.2	0.1	0.1	4.3	0.3	0.2	0.0	0.0	0.2	0.2	9.1	0.0	0.5	0.1	20.2	0.0	0.0	0.0	0.0	0.0	0.1	10.2	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	9.1	0.0	0.0	0.0	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.2	3.7	8.6	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.6	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.7	31.4	11.1	32.0	0.0	55.7	26.1	39.5	42.2	9.1	20.2	10.2	0.5	0.0	0.0	5.5	0.1	0.0	0.7	0.4	0.0	5.4	0.7	0.1	0.8	0.0	0.3	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.6	2.5	0.6	0.4	19.8	0.0	85.0	0.2	0.0	0.1	0.0	2.1	0.0	0.5	0.7	0.0	0.1	0.0	82.6	0.6	2.0	0.6	0.3	0.8	0.0	0.2	3.6	2.8	0.0	1.0	0.0	3.0	3.1	0.0	0.2	0.0	0.3	0.6	0.0	0.0	0.1	5.6	0.0	0.2	0.4	0.2	0.7	0.0	0.1	0.0	0.2	0.8	0.2	1.5
SVIL		ENSG00000197321	Supervillin	O95425	10	29457338-29736959	"Plasma proteins, Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 808.1;tongue: 581.5"	"Cell type enhanced"	"Detected in all"		"Basal squamous epithelial cells: 204.9;Cardiomyocytes: 469.6;Peritubular cells: 260.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	4	"neutrophil: 259.3"	"Lineage enriched"	"Detected in all"	9	"granulocytes: 259.3"	"Cell line enhanced"	"Detected in many"		"HaCaT: 146.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010878, HPA020095, HPA020138"	Approved		Supported	"Plasma membrane,Actin filaments,Cytosol"		NA	NA		210000	"Cluster 1: Neutrophils - Mixed function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 54: Cardiomyocytes - Muscle contraction"	"Plasma membrane"	"Actin filaments, Cytosol"	"CAB010878: AB_476685, HPA020095: AB_1857680, HPA020138: AB_1857681"	"unprognostic (1.11e-1)"	"unprognostic (2.94e-1)"	"unprognostic (8.06e-2)"	"unprognostic (1.15e-2)"	"unprognostic (3.47e-3)"	"unprognostic (2.26e-2)"	"unprognostic (4.12e-1)"	"unprognostic (1.49e-1)"	"unprognostic (4.28e-1)"	"unprognostic (3.42e-3)"	"unprognostic (1.55e-1)"	"unprognostic (9.20e-2)"	"unprognostic (2.38e-3)"	"unprognostic (7.11e-3)"	"unprognostic (1.51e-1)"	"unprognostic (2.50e-1)"	"prognostic unfavorable (5.70e-5)"	26.4	13.4	3.7	22.7	3.9	37.2	22.6	1.3	8.9	45.8	2.5	314.5	14.8	116.2	24.1	92.1	55.5	52.0	165.0	2.2	2.7	15.4	10.4	22.9	12.6	7.0	4.1	83.3	18.5	31.8	8.5	17.9	4.4	70.3	37.1	10.3	40.6	100.0	808.1	26.9	60.1	107.0	4.4	7.6	77.6	11.7	4.9	19.1	35.0	581.5	10.8	173.2	40.3	5.2	71.4	27.9	12.4	5.4	32.1	84.4	22.1	12.6	24.1	4.3	4.7	34.4	63.1	2.4	43.0	4.9	31.9	146.8	8.6	25.6	5.2	1.4	17.6	0.1	33.6	19.9	21.4	8.0	1.5	72.7	24.5	44.2	19.1	71.9	69.6	14.7	0.1	0.4	6.7	19.9	7.7	4.0	7.0	27.8	15.1	15.5	32.1	0.9	40.2	20.1	18.1	14.1	12.3	1.4	34.3	39.8	12.9	7.9	46.3	21.9	23.4	94.4	34.4	0.6	0.8	0.3	64.5	14.0	65.4	43.4	12.1	58.2	11.1	14.0	10.9	0.6	11.2	7.6	7.3	1.0	17.1	10.9	259.3	14.6	29.6	3.0	4.3	3.7	3.7	3.9	1.3	8.9	2.2	2.7	7.0	4.1	4.4	4.4	4.9	5.2	31.3	48.1	30.5	2.3	3.7	70.2	108.0	41.1	204.9	11.7	36.6	67.1	469.6	18.6	53.5	38.6	25.0	29.7	11.3	39.7	7.9	94.1	4.0	26.3	65.8	61.1	23.9	1.7	8.3	42.3	18.5	68.1	7.7	43.6	10.1	35.7	32.2	11.8	10.4	5.0	43.9	31.3	28.5	7.5	45.7	6.8	109.6	25.3	28.4	146.1	16.7	30.6	13.4	28.1	6.6	63.4	40.2	260.7	3.3	131.8	18.4	10.8	42.2	15.0	46.0	90.6	92.9	6.5	11.1	103.8	60.0	24.8	14.6	27.9	39.2	98.3
SWAP70	"KIAA0640, SWAP-70"	ENSG00000133789	"Switching B cell complex subunit SWAP70"	Q9UH65	11	9664077-9752993	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"B-cells: 183.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"memory B-cell: 80.6;naive B-cell: 84.8"	"Group enriched"	"Detected in all"	7	"B-cells: 84.8;granulocytes: 48.6;monocytes: 29.6"	"Cell line enhanced"	"Detected in many"		"Daudi: 161.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006810, HPA006929"	Supported		Supported	"Plasma membrane,Actin filaments"		NA	NA		21000	"Cluster 19: B-cells - Humoral immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 57: B-cells - Immune response"	"Plasma membrane"	"Actin filaments"	"HPA006810: AB_1857683, HPA006929: "	"unprognostic (4.16e-2)"	"unprognostic (7.06e-2)"	"unprognostic (2.35e-1)"	"unprognostic (3.68e-2)"	"unprognostic (1.67e-1)"	"unprognostic (3.38e-2)"	"unprognostic (3.16e-3)"	"unprognostic (1.26e-1)"	"unprognostic (4.04e-1)"	"unprognostic (3.33e-1)"	"unprognostic (1.75e-1)"	"unprognostic (3.85e-2)"	"unprognostic (2.79e-3)"	"unprognostic (5.00e-2)"	"unprognostic (1.14e-1)"	"unprognostic (3.61e-1)"	"unprognostic (1.44e-1)"	39.3	10.4	12.8	37.5	13.7	20.9	31.9	13.6	15.9	22.6	17.2	15.0	15.4	17.8	10.4	17.8	16.3	22.0	16.2	12.2	14.1	17.2	10.0	24.9	66.1	16.7	13.6	10.2	15.0	19.4	5.7	39.0	16.7	14.1	12.8	3.9	18.0	15.3	9.8	26.4	20.3	19.7	16.5	59.5	15.9	4.8	14.3	17.3	22.3	14.7	75.3	31.2	17.6	16.5	40.6	22.2	30.8	0.1	62.9	54.6	54.0	43.4	52.6	40.3	44.1	24.7	31.3	161.0	41.6	83.5	57.9	47.7	37.9	24.2	51.6	14.8	15.2	42.6	25.7	12.1	35.2	33.3	76.2	38.4	29.6	29.5	52.3	32.6	124.4	20.2	3.9	0.6	42.4	6.4	10.0	16.1	28.4	10.7	11.3	23.6	28.9	4.7	33.6	106.1	1.5	15.5	41.3	52.6	35.2	42.9	20.9	25.1	143.6	70.3	25.1	59.4	41.2	4.2	12.4	111.5	27.9	36.6	29.3	19.7	5.7	48.6	1.2	13.5	0.5	80.6	1.4	1.1	8.2	84.8	1.2	1.3	1.1	7.9	29.6	2.3	4.2	5.4	12.8	13.7	13.6	15.9	12.2	14.1	16.7	13.6	16.7	16.5	14.3	16.5	154.0	67.3	60.8	33.0	183.7	35.6	68.1	40.1	36.5	3.4	35.1	28.3	17.6	22.8	57.7	20.2	0.0	82.6	9.9	11.3	13.7	47.4	1.6	66.5	18.6	136.0	13.1	9.7	9.0	21.6	128.0	39.1	15.8	71.6	137.8	10.3	53.2	7.2	65.0	26.9	14.5	8.7	18.3	61.9	50.8	2.9	29.8	58.5	28.4	77.8	88.8	9.2	6.2	22.1	22.4	37.0	15.1	34.6	20.7	63.0	22.4	11.7	50.9	2.3	19.7	46.2	35.5	5.5	10.8	17.4	31.3	140.1	15.5	33.4	9.0	78.8
SWI5	"bA395P17.9, C9orf119, SAE3"	ENSG00000175854	"SWI5 homologous recombination repair protein"		9	128275379-128316123	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Tissue enhanced"	"Detected in all"		"testis: 142.5"	"Group enriched"	"Detected in all"	9	"Early spermatids: 1180.8;Late spermatids: 1131.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052032	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 68: Epididymis - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 34: Spermatids - Unknown function"	"Nucleoplasm, Cytosol"		"HPA052032: AB_2681702"	"unprognostic (1.27e-2)"	"unprognostic (1.74e-2)"	"unprognostic (3.56e-3)"	"unprognostic (3.21e-2)"	"unprognostic (1.42e-3)"	"unprognostic (3.28e-2)"	"prognostic unfavorable (6.78e-4)"	"unprognostic (2.11e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.81e-1)"	"unprognostic (4.58e-3)"	"unprognostic (1.15e-1)"	"prognostic favorable (9.39e-4)"	"unprognostic (1.43e-1)"	"unprognostic (6.73e-2)"	"unprognostic (2.40e-1)"	"unprognostic (7.38e-2)"	27.5	26.5	29.0	11.2	31.3	11.0	28.2	31.3	40.8	39.2	32.7	23.5	15.9	27.5	68.8	33.3	31.7	17.8	34.9	28.7	31.9	36.4	42.3	20.6	12.5	30.4	30.8	40.8	21.2	71.4	54.5	17.6	30.4	32.8	12.7	21.1	25.6	37.1	25.2	26.0	18.6	20.3	29.7	18.0	23.0	142.5	30.4	17.1	44.0	25.6	17.7	26.4	31.5	31.6	29.2	51.4	29.7	34.8	79.2	71.8	33.7	50.6	66.7	64.2	42.6	66.6	33.5	27.7	65.7	82.6	39.5	47.8	48.1	67.5	42.6	41.4	35.7	21.0	97.5	52.9	101.9	13.6	18.6	60.8	31.7	107.4	57.8	55.9	62.5	96.8	50.5	42.8	66.5	119.9	29.6	19.6	20.3	67.8	105.3	27.1	41.0	44.4	43.6	15.2	34.0	18.9	63.0	39.8	63.0	32.9	66.2	14.5	39.0	46.4	38.0	90.9	43.3	45.6	75.0	37.0	61.8	20.9	50.7	54.3	14.2	25.8	14.5	8.7	17.0	17.6	14.1	14.4	14.7	20.2	16.7	21.6	9.0	22.2	9.1	21.4	15.6	15.3	29.0	31.3	31.3	40.8	28.7	31.9	30.4	30.8	30.4	29.7	30.4	31.6	33.8	6.4	17.4	5.2	18.0	24.5	35.1	54.0	31.3	13.7	33.6	38.9	36.2	31.5	33.5	36.8	12.5	65.7	13.7	15.7	66.5	25.5	1180.8	30.7	29.1	31.3	25.6	17.2	2.9	38.5	41.1	40.7	19.9	30.7	9.5	27.9	35.7	82.4	33.2	1.7	3.3	27.5	28.5	20.8	13.0	1131.1	43.2	31.5	37.4	2.8	23.8	50.7	20.6	4.5	7.8	29.8	27.1	31.6	17.9	34.9	68.4	84.1	29.5	21.1	32.9	25.7	31.3	93.7	44.3	33.5	21.9	117.0	18.6	32.8	23.4	36.6
SYAP1	"FLJ14495, PRO3113"	ENSG00000169895	"Synapse associated protein 1"	Q96A49	X	16719612-16765340	"Predicted intracellular proteins"	Differentiation			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000175, HPA000882, HPA048047"	Approved		Enhanced	"Nucleoplasm,Golgi apparatus,Cytosol"	"Intracellular and membrane"	NA	NA		13000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 18: U-2197 - ECM organization"	"Cluster 24: Non-specific - Transcription regulation"	"Golgi apparatus"	"Nucleoplasm, Cytosol"	"HPA000175: AB_1080142, HPA000882: AB_2666128, HPA048047: AB_2680240"	"unprognostic (4.66e-2)"	"unprognostic (2.99e-2)"	"unprognostic (1.25e-2)"	"unprognostic (5.44e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.52e-2)"	"unprognostic (9.53e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.06e-1)"	"prognostic favorable (3.18e-4)"	"unprognostic (1.82e-1)"	"unprognostic (1.62e-2)"	"unprognostic (1.95e-1)"	"unprognostic (3.95e-3)"	"unprognostic (1.14e-2)"	"unprognostic (8.10e-2)"	"unprognostic (5.28e-3)"	15.3	25.1	5.8	11.2	6.5	25.5	12.4	7.1	7.8	13.1	11.8	14.6	17.4	9.2	8.7	11.3	11.1	13.2	9.5	6.8	7.4	16.0	29.4	9.1	10.3	7.1	6.7	10.9	11.8	15.5	7.6	8.7	7.0	12.8	13.0	7.8	10.7	8.0	12.6	10.3	15.6	9.9	6.6	7.1	13.2	6.4	7.7	7.9	11.5	7.6	10.7	10.8	8.3	8.8	29.2	24.1	17.0	32.0	22.6	25.6	7.8	22.7	16.2	18.6	18.4	22.8	23.5	22.6	32.4	22.3	37.9	16.9	21.0	29.7	24.7	14.8	41.9	9.0	25.4	21.9	16.2	15.5	13.4	17.6	13.7	32.2	27.1	21.5	26.0	6.9	19.8	12.2	25.4	34.2	8.4	16.6	19.9	16.1	26.3	9.1	21.5	22.8	27.8	18.9	17.3	21.3	42.2	29.7	23.1	22.0	39.5	13.8	20.6	23.7	12.5	48.7	18.6	13.4	12.2	26.1	23.3	7.7	19.8	7.4	7.2	9.3	9.9	7.9	8.1	9.0	8.4	9.2	7.8	7.0	8.3	8.7	12.0	10.1	11.4	6.5	10.5	6.5	5.8	6.5	7.1	7.8	6.8	7.4	7.1	6.7	7.0	6.6	7.7	8.8	60.4	64.1	75.6	14.4	96.0	64.1	107.0	69.5	37.0	20.2	116.0	78.2	74.3	88.6	92.2	79.1	22.9	66.5	273.8	164.3	111.6	119.6	214.8	219.3	84.7	53.3	106.1	45.9	13.9	132.1	83.3	65.5	72.4	176.3	210.0	38.3	71.4	216.0	49.5	23.5	16.0	107.4	63.1	70.8	241.0	296.2	42.3	171.5	67.6	8.4	55.7	49.4	64.9	11.6	26.9	183.6	159.2	54.5	185.5	80.3	148.3	164.3	169.7	21.5	59.2	56.9	68.1	15.3	21.5	42.0	52.6	150.5	156.6	48.5	118.6	104.4
SYBU	"FLJ20366, GOLSYN, KIAA1472, OCSYN, SNPHL"	ENSG00000147642	Syntabulin	Q9NX95	8	109573978-109691791	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 140.5"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 200.5;Horizontal cells: 95.9;Inhibitory neurons: 129.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	21	"memory B-cell: 6.4;naive B-cell: 3.2"	"Lineage enriched"	"Detected in single"	27	"B-cells: 6.4"	"Cell line enhanced"	"Detected in many"		"HaCaT: 24.4;PC-3: 25.7;SK-BR-3: 51.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053057	Uncertain		Supported	Vesicles		NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 22: Non-specific - Unknown function"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Vesicles		"HPA053057: AB_2682028"	"unprognostic (4.69e-2)"	"unprognostic (1.40e-1)"	"unprognostic (2.46e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.18e-1)"	"unprognostic (4.27e-1)"	"prognostic favorable (7.74e-4)"	"unprognostic (1.22e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.16e-1)"	"unprognostic (3.13e-1)"	"unprognostic (5.52e-2)"	"unprognostic (1.87e-3)"	"unprognostic (1.68e-1)"	"unprognostic (6.05e-3)"	"unprognostic (6.89e-2)"	"unprognostic (4.27e-2)"	32.2	38.7	39.1	3.2	42.0	0.0	22.2	44.5	52.4	10.7	4.4	15.4	10.9	5.6	11.5	5.6	20.1	10.3	6.9	42.4	58.6	4.2	52.1	8.8	4.4	24.2	34.0	9.2	140.5	1.5	30.4	2.5	36.6	8.2	19.7	26.1	21.5	11.0	3.8	9.6	12.0	6.9	22.8	1.0	28.2	1.8	50.8	5.4	12.3	7.7	7.8	5.9	8.8	30.2	8.6	5.2	3.6	0.0	0.5	0.6	2.5	3.1	0.0	0.0	0.0	7.9	5.4	0.7	0.5	2.5	1.2	24.4	0.8	5.7	0.0	0.1	11.6	0.0	15.2	8.2	6.2	0.0	0.0	1.9	7.7	0.0	7.2	0.4	3.3	0.6	0.4	1.6	3.5	0.2	0.2	0.0	0.7	7.7	25.7	0.0	0.0	0.0	9.5	2.2	16.3	1.9	6.9	51.4	1.7	2.5	6.8	0.3	5.0	0.3	2.0	0.1	1.5	1.5	0.1	0.5	10.8	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.1	6.4	0.1	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	39.1	42.0	44.5	52.4	42.4	58.6	24.2	34.0	36.6	22.8	50.8	30.2	39.3	9.6	7.7	16.0	4.3	5.7	2.5	8.3	17.1	46.1	10.9	9.1	2.4	30.0	18.0	11.0	8.4	4.6	0.1	3.6	3.9	5.4	1.4	29.3	3.4	11.8	34.5	0.0	200.5	9.4	0.9	7.9	5.6	20.9	0.0	0.7	10.0	39.1	0.3	95.9	129.6	22.2	2.0	0.8	4.2	0.4	2.1	0.3	1.8	21.5	0.7	2.1	0.0	22.1	5.7	3.9	9.8	0.4	0.1	11.8	16.2	0.1	15.6	7.4	0.0	16.5	4.2	1.3	1.5	3.5	3.3	0.7	0.6	0.1	13.7	4.2
SYCE2	CESC1	ENSG00000161860	"Synaptonemal complex central element protein 2"	Q6PIF2	19	12898786-12919293	"Metabolic proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Meiosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"testis: 26.7"	"Group enriched"	"Detected in some"	4	"Spermatocytes: 214.8;Spermatogonia: 72.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Immune cell enhanced"	"Detected in single"		"NK-cell: 2.7"	"Lineage enhanced"	"Detected in single"		"NK-cells: 2.7"	"Cell line enhanced"	"Detected in many"		"EFO-21: 11.6;JURKAT: 10.4;MOLT-4: 11.1;SiHa: 11.7;U-266/70: 12.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA042080, HPA062919"	Enhanced		Supported	Nucleoplasm		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	Nucleoplasm		"HPA042080: AB_10794411, HPA062919: AB_2684905"	"unprognostic (3.00e-1)"	"prognostic favorable (3.85e-5)"	"unprognostic (9.99e-3)"	"prognostic unfavorable (9.91e-4)"	"unprognostic (1.75e-1)"	"unprognostic (3.48e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.78e-1)"	"unprognostic (8.28e-3)"	"unprognostic (1.30e-2)"	"unprognostic (8.39e-4)"	"unprognostic (1.79e-10)"	"unprognostic (7.55e-3)"	"unprognostic (9.93e-2)"	"unprognostic (1.09e-1)"	"unprognostic (7.87e-5)"	0.6	0.5	0.4	0.4	0.7	3.2	0.6	1.4	0.9	0.8	0.2	0.8	0.3	0.5	0.5	0.7	0.9	0.3	0.5	0.4	0.2	0.8	1.7	0.5	1.1	0.6	0.5	1.2	0.6	0.1	0.8	0.4	0.7	1.1	0.2	1.4	0.6	0.1	0.4	1.2	0.6	0.1	0.2	0.8	0.7	26.7	0.5	1.8	0.7	0.0	0.7	0.8	0.7	1.6	5.9	1.1	3.0	1.8	0.3	0.8	3.2	1.4	0.6	0.8	0.9	0.2	0.8	4.5	11.6	0.8	1.0	1.2	1.0	0.3	0.9	1.7	0.7	1.3	2.7	0.6	0.1	3.0	4.0	0.8	0.2	0.3	0.6	1.4	0.2	10.4	1.1	1.3	0.5	2.4	11.1	2.0	1.9	0.2	3.3	3.3	1.4	1.1	0.5	0.9	2.1	1.4	11.7	0.6	0.7	0.8	2.3	3.2	0.8	0.8	1.5	4.3	0.4	12.1	1.7	5.1	1.0	4.0	5.5	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.1	0.0	2.7	0.0	0.0	0.2	0.0	0.4	0.7	1.4	0.9	0.4	0.2	0.6	0.5	0.7	0.2	0.5	1.6	0.3	0.0	0.0	4.9	0.6	1.3	0.3	0.9	0.0	0.7	0.4	0.6	0.1	0.0	0.2	0.0	0.0	1.3	0.1	0.1	0.0	0.2	34.3	0.4	0.2	0.5	0.0	0.0	1.7	0.4	1.9	0.3	0.0	0.5	0.0	1.8	0.0	0.2	1.0	0.0	1.7	0.0	0.0	0.6	0.8	23.5	3.1	0.3	0.0	0.0	0.0	0.5	0.0	1.5	2.7	0.1	0.1	1.2	0.1	0.3	0.1	0.2	0.2	0.2	26.3	0.4	0.4	214.8	72.2	0.0	0.4	0.3	0.2	0.1	0.3	0.2
SYCP2	SCP2	ENSG00000196074	"Synaptonemal complex protein 2"	Q9BX26	20	59863564-59933655	"Disease related genes, Predicted intracellular proteins"	"Cell cycle, Cell division, Meiosis"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 43.2"	"Cell type enriched"	"Detected in many"	5	"Spermatocytes: 468.5"	"Group enriched"	"Detected in many"	6	"breast cancer: 6.7;cervical cancer: 11.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"CACO-2: 25.9;JURKAT: 47.2;MOLT-4: 54.4;SiHa: 92.2;T-47d: 82.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA062401, HPA065613"			Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 6: T47d - Mammary gland"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	Nucleoplasm	"Plasma membrane, Cytosol"	"HPA062401: AB_2684752, HPA065613: AB_2685519"	"unprognostic (8.10e-3)"	"unprognostic (8.28e-3)"	"unprognostic (1.62e-1)"	"unprognostic (2.48e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.19e-3)"	"unprognostic (2.50e-2)"	"unprognostic (2.18e-1)"	"unprognostic (4.11e-2)"	"unprognostic (1.44e-1)"	"unprognostic (3.74e-1)"	"unprognostic (7.02e-3)"	"unprognostic (4.84e-3)"	"unprognostic (8.48e-2)"	"unprognostic (2.46e-1)"	"unprognostic (7.87e-3)"	"unprognostic (1.21e-1)"	3.2	0.8	2.2	1.4	2.8	2.4	13.9	9.7	4.9	2.4	0.0	1.3	1.6	1.6	1.2	0.9	1.3	2.4	2.5	2.2	1.1	4.3	1.1	2.2	2.6	1.8	1.8	0.7	6.6	0.7	1.9	3.9	2.2	3.8	1.1	1.5	4.4	1.0	1.3	2.7	2.4	0.7	1.4	3.1	6.1	43.2	2.5	1.3	2.4	1.0	1.7	1.8	1.5	4.1	0.3	1.3	0.2	1.4	0.6	0.8	1.4	4.1	1.1	1.8	0.2	25.9	2.6	0.1	4.0	1.8	0.8	0.6	0.5	0.1	1.0	8.5	0.6	0.2	6.1	0.4	0.2	0.4	19.0	0.4	0.4	0.4	0.0	0.9	0.0	47.2	0.2	0.0	0.9	12.5	54.4	2.9	0.4	1.5	0.3	0.0	0.1	0.2	2.1	6.1	0.2	4.5	92.2	13.3	3.3	1.6	82.6	4.7	0.5	0.1	2.8	11.2	0.0	0.0	0.0	0.0	0.0	1.7	5.2	0.7	0.1	0.7	0.8	0.0	0.8	0.2	0.4	0.5	0.0	0.2	0.2	0.4	0.7	0.0	0.0	0.0	0.3	0.2	2.2	2.8	9.7	4.9	2.2	1.1	1.8	1.8	2.2	1.4	2.5	4.1	11.5	0.0	1.1	24.5	1.4	1.0	1.1	1.0	0.0	1.9	12.7	9.4	3.6	2.8	6.3	1.8	2.1	0.8	3.0	0.1	1.9	0.9	82.3	0.4	5.0	6.5	0.0	0.0	27.5	3.6	0.4	2.1	2.6	0.5	2.5	1.2	2.9	0.0	0.5	0.0	14.6	0.1	0.0	1.2	0.8	21.8	4.7	1.6	5.4	13.1	1.4	2.3	5.2	28.6	11.1	1.2	1.2	1.9	0.4	1.8	0.3	5.4	8.6	1.1	52.6	1.7	3.8	468.5	92.4	0.6	0.0	0.4	4.1	0.2	0.3	1.2
SYCP2L	"C6orf177, dJ62D2.1, NO145"	ENSG00000153157	"Synaptonemal complex protein 2 like"	Q5T4T6	6	10886831-10979320	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	21	"parathyroid gland: 68.7"	"Group enriched"	"Detected in many"	4	"Astrocytes: 21.5;dendritic cells: 9.5;Early spermatids: 17.1;Excitatory neurons: 28.5;granulocytes: 10.8;Inhibitory neurons: 23.1;Microglial cells: 13.1;Oligodendrocyte precursor cells: 14.1;Oligodendrocytes: 12.4;Spermatogonia: 8.7"	"Cancer enhanced"	"Detected in single"		"testis cancer: 1.4"	"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in some"	7	"basophil: 1.7;eosinophil: 3.4;plasmacytoid DC: 4.2"	"Group enriched"	"Detected in many"	17	"dendritic cells: 4.2;granulocytes: 3.4"	"Cell line enhanced"	"Detected in some"		"HL-60: 13.4;HMC-1: 38.7;K-562: 10.7;NB-4: 15.3;SuSa: 8.1;THP-1: 11.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			HPA034679			Supported	Nucleoplasm		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Nucleoplasm		"HPA034679: AB_10669729"	"unprognostic (3.25e-1)"	"unprognostic (2.58e-2)"	"unprognostic (3.23e-1)"	"unprognostic (3.72e-5)"	"unprognostic (2.20e-1)"	"unprognostic (1.21e-2)"	"unprognostic (5.57e-3)"	"unprognostic (4.23e-1)"	"unprognostic (6.03e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.40e-1)"	"unprognostic (3.04e-1)"	"unprognostic (1.21e-3)"	"unprognostic (1.07e-2)"	"unprognostic (1.86e-1)"	"unprognostic (3.85e-2)"	"unprognostic (2.74e-2)"	0.6	0.3	0.6	0.6	0.9	0.7	0.5	0.8	1.4	0.5	0.0	0.3	0.1	0.4	2.6	0.2	0.4	0.5	1.2	0.8	0.2	1.1	0.1	1.7	0.5	0.2	0.1	0.8	1.7	68.7	0.4	1.1	0.2	0.6	0.2	0.7	0.3	0.2	0.2	0.5	0.3	0.2	0.0	0.6	0.3	3.2	0.3	0.1	1.2	0.9	0.3	0.3	0.3	1.2	0.0	1.0	1.9	0.1	0.1	0.0	5.6	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	4.5	0.2	0.2	0.1	6.4	0.0	0.0	0.0	0.0	13.4	38.7	0.0	1.0	0.0	0.0	0.3	0.0	0.4	10.7	0.1	0.0	0.1	3.4	15.3	0.7	0.0	0.1	0.2	0.4	0.0	0.2	0.0	0.7	3.5	0.0	3.5	0.0	8.1	0.1	11.4	0.0	0.0	0.7	0.0	0.2	0.3	0.0	0.1	0.1	0.1	1.1	1.7	0.0	3.4	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	4.2	0.0	0.0	0.6	0.9	0.8	1.4	0.8	0.2	0.2	0.1	0.2	0.0	0.3	1.2	1.1	0.0	1.3	21.5	0.3	0.1	0.0	0.2	0.0	2.1	0.3	0.0	0.4	0.0	0.1	0.0	0.0	2.9	9.5	0.0	0.0	0.2	17.1	0.1	0.4	1.4	0.0	2.1	28.5	0.2	2.0	2.9	0.0	0.4	10.8	1.5	0.0	0.0	0.5	3.3	23.1	0.0	0.0	0.0	0.5	3.2	1.2	1.0	0.0	13.1	1.0	0.6	0.0	14.1	12.4	0.6	0.0	1.5	0.0	0.5	0.0	0.0	0.7	0.1	0.0	0.6	0.3	3.1	8.7	0.0	0.0	1.4	0.6	0.1	0.0	0.1
SYF2	"CBPIN, DKFZp564O2082, fSAP29, NTC31, p29"	ENSG00000117614	"SYF2 pre-mRNA splicing factor"	O95926	1	25222276-25232502	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018265, HPA070710"	Approved		Supported	"Nuclear speckles"		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 63: NK-cells & T-cells - Immune response"	"Nuclear speckles"		"HPA018265: AB_10962002, HPA070710: AB_2686301"	"unprognostic (4.19e-3)"	"unprognostic (1.58e-2)"	"unprognostic (9.98e-2)"	"unprognostic (9.29e-2)"	"unprognostic (1.21e-1)"	"unprognostic (6.76e-2)"	"unprognostic (6.76e-3)"	"unprognostic (7.40e-3)"	"unprognostic (2.36e-2)"	"unprognostic (3.26e-1)"	"unprognostic (1.33e-2)"	"unprognostic (7.58e-2)"	"unprognostic (4.89e-2)"	"unprognostic (2.27e-2)"	"unprognostic (4.80e-2)"	"unprognostic (1.45e-3)"	"prognostic favorable (5.72e-4)"	75.3	56.5	37.8	42.6	38.4	147.6	66.9	39.9	48.4	70.1	39.0	71.6	55.4	59.9	72.2	49.3	63.7	40.7	50.0	36.9	41.6	64.0	48.3	46.4	63.8	39.3	38.4	104.5	59.1	67.8	35.3	57.1	40.3	50.3	59.4	29.5	52.0	51.3	89.1	58.5	57.7	47.0	39.2	55.9	61.9	26.9	38.4	77.6	59.0	57.8	76.8	63.2	60.1	41.4	54.0	22.0	54.9	45.4	85.2	109.0	42.4	56.1	91.0	52.7	47.8	13.7	73.0	46.2	75.6	68.1	39.8	47.3	47.6	43.2	76.4	76.2	39.4	52.8	56.1	41.8	86.6	75.9	54.3	79.4	118.2	54.3	75.2	100.4	76.0	61.8	42.0	74.4	75.2	19.8	77.6	104.0	71.7	78.9	32.4	51.3	46.3	78.9	86.9	28.6	47.8	69.5	49.1	44.5	160.5	47.7	38.3	91.5	61.8	45.9	40.6	87.0	46.8	86.7	83.4	48.6	67.6	77.7	45.2	185.5	82.1	222.9	79.1	98.4	95.7	140.0	102.4	99.9	70.0	125.5	108.4	102.0	337.6	111.3	121.6	67.3	129.2	92.7	37.8	38.4	39.9	48.4	36.9	41.6	39.3	38.4	40.3	39.2	38.4	41.4	160.7	128.2	112.8	6.8	176.0	159.3	123.0	238.5	111.5	74.3	134.9	174.1	108.1	147.3	151.3	189.4	83.4	195.7	203.9	211.7	246.5	158.6	78.7	153.2	125.9	137.4	111.4	117.6	10.6	174.2	130.1	121.1	59.1	166.8	232.4	120.9	154.9	131.3	126.4	58.9	10.2	166.0	181.0	231.5	155.4	32.1	214.6	155.4	108.5	3.7	251.8	95.0	217.3	6.0	12.5	154.5	221.1	164.7	83.0	109.5	322.0	273.4	151.0	90.5	164.3	139.5	142.5	98.2	108.8	88.1	171.3	280.6	176.8	95.9	171.8	147.2
SYMPK	"SPK, SYM"	ENSG00000125755	Symplekin	Q92797	19	45815410-45863194	"Plasma proteins, Predicted intracellular proteins"	"Cell adhesion, mRNA processing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 141.6;Late spermatids: 146.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041756, HPA042449"	Approved		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 16: U-266 - Nucleosome"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm	"Plasma membrane, Cytosol"	"HPA041756: AB_10963544, HPA042449: AB_2678003"	"unprognostic (1.24e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.21e-1)"	"unprognostic (2.59e-1)"	"unprognostic (1.59e-2)"	"unprognostic (3.11e-2)"	"unprognostic (2.33e-3)"	"unprognostic (9.93e-2)"	"unprognostic (9.78e-2)"	"unprognostic (1.23e-1)"	"unprognostic (9.16e-3)"	"unprognostic (1.67e-2)"	"unprognostic (1.44e-1)"	"unprognostic (2.34e-1)"	"unprognostic (1.29e-1)"	"unprognostic (2.58e-1)"	"unprognostic (6.38e-2)"	18.0	17.3	15.5	29.3	17.0	27.4	18.0	12.5	19.8	24.1	11.9	22.5	22.2	25.3	20.1	19.7	23.5	18.0	17.5	14.9	14.1	19.1	21.4	20.6	34.8	18.9	15.6	23.6	19.1	20.7	32.6	25.0	17.1	23.8	14.1	15.7	24.7	16.4	38.5	25.3	22.8	16.1	11.4	28.5	22.9	41.0	16.6	30.0	24.0	18.9	22.8	20.7	19.9	22.7	57.7	101.0	40.4	29.9	39.0	46.8	67.7	44.5	32.0	45.8	51.0	45.8	51.1	101.6	30.2	51.0	25.7	46.2	55.1	49.9	40.0	79.4	62.2	58.7	68.9	47.5	43.7	64.9	65.6	36.1	29.2	49.3	55.4	31.2	47.6	52.6	79.3	64.4	39.4	54.8	61.0	70.3	34.0	50.0	23.9	64.6	46.4	62.6	31.8	102.7	46.0	57.7	55.1	35.5	36.7	40.3	48.4	89.4	53.5	37.1	58.5	28.8	66.9	84.1	173.1	81.5	42.4	42.8	61.8	1.7	3.0	1.5	2.0	2.5	1.9	2.9	1.8	3.2	2.8	4.8	1.5	1.4	3.4	2.7	5.0	5.8	1.4	2.1	15.5	17.0	12.5	19.8	14.9	14.1	18.9	15.6	17.1	11.4	16.6	22.7	14.7	0.0	7.7	34.9	30.2	20.9	18.7	15.6	18.2	21.6	17.4	15.4	7.0	22.8	12.0	25.8	35.5	35.5	20.9	32.7	54.8	21.6	141.6	24.9	29.9	23.4	36.3	26.5	24.6	17.5	34.5	17.5	41.8	27.7	12.7	35.1	26.0	31.8	18.2	21.9	27.1	38.7	10.2	27.0	25.6	146.4	19.3	24.4	14.2	19.7	47.3	11.3	32.0	29.1	28.4	20.4	25.5	21.1	19.8	21.5	30.8	14.9	15.6	27.4	19.7	17.4	20.4	35.3	34.1	14.4	21.3	57.3	21.2	21.9	38.6	20.6
SYNCRIP	"dJ3J17.2, GRY-RBP, hnRNP-Q, HNRNPQ, HNRPQ1, NSAP1"	ENSG00000135316	"Synaptotagmin binding cytoplasmic RNA interacting protein"	O60506	6	85607779-85644063	"Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, mRNA processing, mRNA splicing, Translation regulation"	"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010895, HPA041275, HPA069241"	Supported		Approved	Nucleoplasm,Vesicles,Cytosol		NA	NA		1300000	"Cluster 27: Non-specific - Gene expression"	"Cluster 16: Immune cells - Immune response"	"Cluster 32: U-937 - Innate immune response"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm	"Vesicles, Cytosol"	"CAB010895: AB_261964, HPA041275: AB_2677389, HPA069241: "	"unprognostic (1.01e-1)"	"unprognostic (3.49e-2)"	"unprognostic (1.02e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.49e-2)"	"unprognostic (6.22e-2)"	"prognostic unfavorable (6.28e-5)"	"unprognostic (6.84e-2)"	"unprognostic (6.48e-2)"	"prognostic favorable (5.59e-4)"	"unprognostic (1.58e-2)"	"unprognostic (1.43e-1)"	"unprognostic (4.86e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.34e-1)"	"unprognostic (1.00e-1)"	"unprognostic (4.11e-1)"	60.5	43.2	25.1	80.2	28.0	67.3	55.6	28.1	24.8	51.4	26.0	54.1	48.0	46.1	41.7	75.8	34.0	47.8	45.6	22.8	29.9	53.1	66.7	49.4	88.1	28.9	27.4	36.2	51.9	56.9	19.5	68.5	31.0	44.9	62.7	36.0	41.4	46.5	55.9	43.5	44.0	62.1	27.7	51.3	50.0	38.7	27.6	91.0	87.3	56.0	101.9	81.5	40.8	29.0	209.5	147.5	239.9	157.1	150.8	165.3	162.8	258.6	218.1	244.4	239.9	250.4	132.6	480.0	200.0	262.8	203.1	197.4	331.1	269.0	405.4	175.9	163.9	405.4	152.8	165.2	130.3	497.6	177.7	141.8	179.6	276.4	272.1	138.4	254.9	133.2	451.5	210.0	295.1	243.5	255.2	218.9	231.5	209.4	153.2	364.7	345.5	209.9	236.2	307.1	239.5	184.6	188.5	180.8	128.6	137.2	150.8	360.9	247.4	165.8	142.7	189.8	374.2	138.0	260.5	275.4	165.4	328.7	251.4	1.8	24.7	8.8	30.6	36.2	30.0	21.9	27.1	27.5	37.7	21.2	23.4	27.7	3.0	36.1	41.1	29.0	31.6	24.6	25.1	28.0	28.1	24.8	22.8	29.9	28.9	27.4	31.0	27.7	27.6	29.0	106.9	115.4	119.5	26.4	73.0	148.2	160.9	124.4	83.6	44.5	89.0	82.8	88.9	52.9	126.7	46.0	16.7	101.3	97.2	50.4	54.8	120.7	117.6	105.1	156.2	100.7	56.7	65.6	24.0	99.6	133.3	101.8	79.5	152.1	61.4	81.6	57.5	81.4	96.9	62.2	24.3	78.0	79.3	71.1	67.1	28.7	73.7	92.9	53.4	31.9	90.7	45.1	57.7	32.2	40.9	130.0	45.7	64.3	97.4	133.0	47.7	80.7	84.6	42.2	19.7	158.6	131.8	93.7	65.8	142.4	141.6	118.1	81.6	85.8	106.7	159.8
SYNE1	"8B, ARCA1, C6orf98, CPG2, dJ45H2.2, enaptin, KIAA0796, MYNE1, Nesp1, Nesprin-1, SCAR8, SYNE-1B"	ENSG00000131018	"Spectrin repeat containing nuclear envelope protein 1"	Q8NF91	6	152121684-152637801	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Differentiation, Spermatogenesis"	Actin-binding	"Cancer-related genes, Disease variant, Emery-Dreifuss muscular dystrophy, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 152.5;choroid plexus: 182.9"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 550.1;Bipolar cells: 332.1;Excitatory neurons: 494.6;Inhibitory neurons: 482.6;Microglial cells: 315.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in all"	4	"eosinophil: 56.8"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 56.8"	"Cell line enhanced"	"Detected in many"		"U-2 OS: 29.8;U-266/70: 29.1"	"Low region specificity"	"Detected in all"							HPA019113	Approved		Supported	"Nucleoplasm,Nuclear membrane"		NA	NA		72000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 43: Cardiomyocytes - Nuclear processes"	"Nucleoplasm, Nuclear membrane"		"HPA019113: AB_1857707"	"unprognostic (9.99e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.22e-2)"	"unprognostic (1.75e-1)"	"unprognostic (2.28e-1)"	"unprognostic (9.58e-3)"	"unprognostic (1.11e-1)"	"unprognostic (3.55e-3)"	"unprognostic (1.58e-1)"	"unprognostic (9.85e-2)"	"unprognostic (8.87e-3)"	"unprognostic (2.70e-1)"	"unprognostic (4.14e-3)"	"unprognostic (5.83e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.42e-1)"	"unprognostic (2.78e-1)"	15.4	17.8	60.2	7.5	68.8	53.6	14.4	152.5	70.2	18.9	182.9	17.2	2.3	19.1	23.7	5.6	26.4	7.9	32.3	92.4	58.1	34.7	14.6	31.3	17.1	55.0	58.8	44.5	20.6	23.6	56.8	4.4	55.6	17.0	6.2	66.3	5.0	12.6	28.0	19.6	11.4	13.1	38.3	32.9	21.6	17.6	55.4	23.9	44.7	16.5	13.4	16.3	12.9	51.5	0.2	5.8	3.7	4.4	5.7	12.1	1.5	14.7	6.9	3.4	6.0	1.3	0.2	13.5	0.7	7.5	11.2	0.3	1.6	3.8	3.5	11.6	4.0	5.2	4.1	4.0	12.8	1.1	2.7	7.9	0.8	7.5	14.9	9.2	6.8	6.9	0.0	14.2	9.2	0.7	2.4	0.2	0.9	1.3	2.2	2.9	8.1	3.5	15.7	0.2	2.6	3.9	2.7	0.8	9.8	3.7	0.8	0.5	9.0	16.3	29.8	5.9	7.6	29.1	12.5	23.3	8.8	2.9	4.6	10.2	2.3	56.8	11.8	1.8	7.9	6.9	10.3	13.4	1.8	8.2	9.7	10.9	1.6	9.9	3.9	1.5	13.2	3.5	60.2	68.8	152.5	70.2	92.4	58.1	55.0	58.8	55.6	38.3	55.4	51.5	139.7	166.7	215.2	550.1	29.1	12.7	5.4	3.0	3.4	332.1	4.9	9.7	117.2	7.2	53.1	44.1	200.1	0.9	132.9	0.4	3.9	24.0	11.5	132.0	118.2	127.5	3.0	11.6	494.6	7.7	14.2	79.6	7.7	17.8	15.2	13.1	90.0	21.8	8.0	138.0	482.6	11.5	2.0	10.1	15.0	12.6	33.2	16.0	16.0	315.7	12.8	27.3	210.1	256.4	108.6	4.2	0.1	39.9	79.6	5.1	0.0	17.8	146.7	145.5	26.3	145.8	85.6	3.9	5.7	2.2	9.7	1.2	74.7	62.2	0.4	2.2
SYNE3	"C14orf139, C14orf49, FLJ25605, LINC00341, NCRNA00341, Nesp3, Nesprin-3, NET53"	ENSG00000176438	"Spectrin repeat containing nuclear envelope family member 3"	Q6ZMZ3	14	95407266-95475836	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 19.1"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 70.2;Cone photoreceptor cells: 62.6;Rod photoreceptor cells: 103.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 46.5;ASC TERT1: 36.2;Karpas-707: 42.3;REH: 34.8"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA055227, HPA077140"	Approved		Supported	"Nuclear membrane"		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 46: Photoreceptor cells - Phototransduction"	"Nuclear membrane"		"HPA055227: AB_2682747, HPA077140: AB_2686826"	"unprognostic (4.63e-2)"	"unprognostic (6.99e-3)"	"unprognostic (3.79e-1)"	"unprognostic (1.48e-3)"	"unprognostic (7.15e-2)"	"unprognostic (2.12e-3)"	"unprognostic (2.45e-1)"	"unprognostic (2.61e-2)"	"unprognostic (4.92e-1)"	"unprognostic (2.87e-1)"	"unprognostic (8.50e-2)"	"unprognostic (3.32e-1)"	"unprognostic (7.41e-6)"	"unprognostic (1.31e-1)"	"unprognostic (1.42e-1)"	"unprognostic (6.95e-2)"	"unprognostic (7.19e-2)"	19.1	3.4	5.1	4.3	9.5	13.7	12.6	5.8	6.7	4.0	8.7	2.8	1.5	2.3	1.4	2.0	4.5	2.1	4.3	4.5	5.5	1.1	3.0	4.4	6.0	10.0	8.0	4.0	0.9	0.4	1.7	3.4	7.4	1.6	2.6	11.9	3.2	1.1	2.2	4.3	3.8	2.2	5.6	5.0	2.1	2.7	8.3	2.4	2.9	3.3	6.0	3.2	4.1	12.3	1.2	0.1	0.7	1.1	46.5	36.2	14.3	5.4	9.4	5.1	4.0	7.8	1.3	6.3	0.9	2.6	1.6	0.3	1.1	4.0	2.3	20.9	0.9	4.3	0.9	2.1	6.0	6.6	10.4	10.2	1.4	6.4	3.7	0.4	9.0	1.9	0.3	42.3	3.9	1.5	3.9	7.3	0.1	0.2	2.6	34.8	23.2	13.5	0.6	0.7	1.0	5.1	0.2	0.1	2.5	0.6	2.0	9.6	8.2	3.7	2.2	5.0	0.7	5.0	11.1	5.9	7.4	14.6	28.2	2.2	1.9	0.1	0.7	1.5	0.9	1.2	1.0	0.8	0.8	1.0	1.2	1.0	0.9	0.3	1.6	1.0	0.9	1.0	5.1	9.5	5.8	6.7	4.5	5.5	10.0	8.0	7.4	5.6	8.3	12.3	12.4	9.6	18.3	3.3	19.7	2.3	0.4	0.1	0.6	5.1	1.0	1.3	70.2	0.0	0.7	0.0	62.6	2.2	16.1	4.9	0.0	0.0	3.9	6.5	5.1	14.7	1.2	4.0	2.5	0.4	15.0	22.3	1.1	1.4	12.0	0.2	5.0	6.8	4.3	6.7	3.3	5.0	0.0	17.6	14.8	2.4	13.1	20.3	5.4	3.7	27.8	5.3	9.2	14.1	20.8	0.5	6.2	0.4	20.6	1.9	2.9	0.4	6.6	103.7	6.6	19.1	12.1	0.6	1.1	0.3	1.0	1.9	14.0	0.0	1.9	0.5
SYNGR1		ENSG00000100321	"Synaptogyrin 1"	O43759	22	39349925-39385575	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Cancer enhanced"	"Detected in all"		"melanoma: 19.1"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in all"	7	"dendritic cells: 44.7;monocytes: 38.9;T-cells: 30.8"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029673, CAB034277"	Enhanced		Supported	Cytosol		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 6: T47d - Mammary gland"	"Cluster 33: Fibroblasts - ECM organization"	Cytosol		"CAB034277: AB_2255766, HPA029673: AB_10670430"	"unprognostic (2.68e-3)"	"unprognostic (1.84e-3)"	"unprognostic (5.90e-2)"	"unprognostic (8.51e-2)"	"unprognostic (3.74e-1)"	"unprognostic (5.98e-3)"	"unprognostic (7.39e-2)"	"unprognostic (4.95e-2)"	"unprognostic (1.83e-2)"	"unprognostic (1.06e-2)"	"prognostic favorable (2.41e-4)"	"unprognostic (1.16e-1)"	"prognostic favorable (4.98e-7)"	"unprognostic (1.32e-3)"	"unprognostic (1.20e-1)"	"unprognostic (2.02e-2)"	"unprognostic (1.04e-1)"	9.9	24.6	73.2	4.9	84.9	92.9	14.7	64.7	121.8	36.2	25.3	26.7	5.9	22.1	11.6	37.3	23.5	11.3	57.0	84.7	37.5	26.2	5.3	8.6	7.5	35.1	37.9	72.7	28.0	29.8	15.2	6.5	36.5	29.6	4.3	73.0	45.1	18.0	29.0	51.8	11.8	13.2	6.3	10.6	16.6	19.8	58.4	3.5	11.6	26.4	9.9	25.6	34.9	67.1	5.4	9.6	17.3	31.1	1.7	4.4	7.5	23.2	40.8	29.2	26.9	2.1	0.6	0.2	5.3	6.1	3.3	7.6	11.8	0.5	8.8	0.1	36.6	0.4	0.8	1.0	4.9	1.6	10.5	6.7	1.8	7.9	0.0	20.7	1.4	6.8	11.0	0.7	4.6	12.5	4.8	4.5	3.6	4.8	18.7	14.0	0.0	1.5	0.9	15.0	27.1	5.5	6.1	25.1	23.7	7.1	36.9	27.3	0.5	0.0	19.6	0.3	0.1	6.4	0.2	15.2	0.8	30.2	31.6	0.6	38.9	0.8	30.8	11.8	1.7	5.8	1.1	9.1	44.7	4.2	1.3	15.3	1.7	5.1	0.6	33.1	0.2	18.0	73.2	84.9	64.7	121.8	84.7	37.5	35.1	37.9	36.5	6.3	58.4	67.1	8.9	9.6	1.1	28.4	21.0	30.3	73.6	33.8	39.3	112.9	61.4	73.0	73.6	75.8	31.4	66.2	27.1	25.0	52.5	0.1	15.6	57.2	40.0	14.3	24.4	9.5	0.0	92.9	57.1	12.3	14.4	44.6	1.5	18.5	2.5	49.0	12.1	5.9	14.2	47.1	47.1	0.3	12.2	20.0	13.8	87.9	133.3	11.7	140.5	20.6	10.1	46.8	91.6	39.7	18.7	21.7	1.1	119.2	23.2	36.4	0.1	9.3	7.5	38.6	19.7	46.8	30.6	62.8	14.7	57.1	37.4	13.1	21.2	131.6	0.4	80.2
SYNM	"DMN, KIAA0353, SYN"	ENSG00000182253	Synemin	O15061	15	99098217-99135593	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 594.1;skeletal muscle: 624.7;urinary bladder: 406.3"	"Cell type enhanced"	"Detected in many"		"Breast myoepithelial cells: 103.5;Cardiomyocytes: 502.5;Muller glia cells: 127.8;Smooth muscle cells: 98.5"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 28.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A549: 36.8;HeLa: 58.0;WM-115: 124.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017192, HPA040066, HPA044200, HPA077856"	Enhanced		Supported	"Intermediate filaments"		NA	NA				"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 54: Cardiomyocytes - Muscle contraction"	"Intermediate filaments"		"CAB017192: , HPA040066: AB_2676830, HPA044200: AB_2678854, HPA077856: AB_2686861"	"unprognostic (1.04e-2)"	"unprognostic (1.37e-1)"	"unprognostic (3.00e-2)"	"unprognostic (6.10e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.15e-1)"	"unprognostic (3.52e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.54e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.34e-2)"	"unprognostic (6.75e-2)"	"unprognostic (3.54e-3)"	"unprognostic (2.80e-2)"	"unprognostic (7.27e-2)"	"unprognostic (5.92e-3)"	"unprognostic (3.26e-3)"	37.2	20.3	51.4	26.5	66.0	0.4	56.7	70.1	58.2	11.8	52.5	594.1	27.1	50.8	12.7	169.6	36.5	19.2	144.2	44.4	75.4	6.9	4.8	23.1	4.2	81.7	66.6	14.1	6.3	8.2	23.2	14.0	81.6	150.6	52.0	40.3	25.6	291.3	624.7	17.0	105.7	160.9	71.6	2.9	158.4	5.2	69.3	3.7	11.2	277.1	4.0	406.3	41.0	79.8	6.6	36.8	8.1	21.9	15.9	0.9	0.5	3.7	5.3	2.1	1.3	5.4	4.9	0.0	5.3	5.3	17.7	4.2	5.5	0.1	1.6	0.5	9.0	0.1	58.0	5.4	9.0	0.0	1.0	0.9	0.3	3.7	0.8	6.0	4.3	0.0	0.2	7.4	5.5	3.7	0.7	0.8	7.2	0.7	11.4	0.0	7.5	5.5	2.1	3.6	3.6	4.2	21.9	3.4	13.5	12.7	0.2	3.6	4.8	4.1	0.4	2.9	8.9	0.1	1.0	0.0	0.4	0.0	124.5	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.3	0.2	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.1	51.4	66.0	70.1	58.2	44.4	75.4	81.7	66.6	81.6	71.6	69.3	79.8	14.8	0.0	1.7	15.3	0.9	2.3	0.7	0.9	2.8	12.6	32.7	103.5	502.5	0.0	1.2	0.0	16.7	1.5	6.6	2.1	0.0	0.5	9.5	1.3	1.0	24.2	3.0	0.0	15.6	1.3	0.7	20.3	5.1	4.2	0.0	1.1	3.6	1.3	0.3	42.1	9.8	0.9	0.0	0.0	5.1	4.5	1.2	2.0	5.4	12.2	0.6	127.8	1.0	2.5	14.0	0.2	2.3	4.1	5.4	2.0	0.6	0.3	3.1	10.2	32.9	19.6	98.5	7.9	11.5	2.1	3.7	0.4	5.9	0.2	0.7	0.9
SYNPO	KIAA1029	ENSG00000171992	Synaptopodin	Q8N3V7	5	150601080-150659207	"Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"heart muscle: 369.6;skeletal muscle: 1296.3;tongue: 502.1"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 264.7;Distal enterocytes: 70.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in single"		"naive B-cell: 1.0"	"Lineage enriched"	"Detected in single"	10	"B-cells: 1.0"	"Cell line enhanced"	"Detected in many"		"BEWO: 88.4;EFO-21: 72.8;HUVEC TERT2: 72.7;TIME: 178.0;U-87 MG: 152.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB033265, HPA034631, CAB037325, HPA071347"	Enhanced		Supported	"Plasma membrane,Actin filaments,Cytosol"		NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 54: Cardiomyocytes - Muscle contraction"	"Plasma membrane, Cytosol"	"Actin filaments"	"CAB033265: AB_2201163, CAB037325: , HPA034631: AB_10669994, HPA071347: AB_2732179"	"unprognostic (2.09e-2)"	"unprognostic (7.72e-3)"	"unprognostic (3.95e-2)"	"unprognostic (2.78e-3)"	"unprognostic (3.07e-2)"	"unprognostic (1.66e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.41e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.17e-1)"	"unprognostic (4.86e-2)"	"prognostic unfavorable (1.53e-6)"	"unprognostic (1.23e-1)"	"unprognostic (5.72e-2)"	"unprognostic (2.21e-2)"	"unprognostic (6.35e-2)"	91.8	112.1	103.5	21.3	60.7	0.3	48.6	0.0	88.9	23.2	0.8	37.4	31.4	38.7	20.9	31.0	30.8	32.2	369.6	91.2	5.2	60.6	38.5	72.1	10.6	18.2	8.5	34.6	32.9	17.1	21.6	23.8	5.2	46.0	17.5	10.0	21.6	29.1	1296.3	15.4	39.6	38.9	20.6	38.9	34.9	17.0	5.1	6.6	31.1	502.1	11.1	56.8	22.3	34.9	0.5	24.2	0.2	0.3	3.5	3.2	88.4	13.8	18.9	4.6	3.7	21.6	9.7	0.1	72.8	19.9	29.2	8.9	0.1	13.5	1.9	0.2	0.2	0.0	37.4	4.7	19.6	0.0	0.9	3.7	21.3	5.2	3.7	27.5	72.7	0.2	0.2	0.2	4.4	1.6	0.1	0.7	2.8	9.3	11.6	0.5	0.7	0.2	3.4	1.9	8.5	39.3	19.9	21.6	0.7	31.1	1.6	6.6	178.0	17.4	53.2	0.4	3.6	0.8	0.2	1.3	152.5	0.3	11.6	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	103.5	60.7	0.0	88.9	91.2	5.2	18.2	8.5	5.2	20.6	5.1	34.9	51.1	35.3	12.2	1.3	4.8	4.6	3.0	32.6	1.8	1.9	6.4	2.5	264.7	27.1	17.0	7.3	2.1	14.8	0.5	70.5	0.0	43.7	1.7	0.4	0.4	56.3	13.8	2.7	22.5	34.5	6.0	19.9	4.6	0.5	0.0	40.9	62.8	40.0	2.1	0.0	5.7	8.4	2.0	10.8	5.1	3.4	2.8	0.9	5.4	6.5	24.0	7.2	0.0	2.5	1.3	35.6	24.4	27.8	0.6	5.7	52.6	4.4	7.6	0.8	46.0	18.0	29.2	1.2	0.8	1.4	2.3	25.9	1.6	8.6	11.8	3.6
SYT13	KIAA1427	ENSG00000019505	"Synaptotagmin 13"	Q7L8C5	11	45240302-45286341	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 30.1;gallbladder: 20.8;pituitary gland: 16.8"	"Cell type enriched"	"Detected in many"	7	"Enteroendocrine cells: 336.8"	"Group enriched"	"Detected in many"	5	"breast cancer: 13.5;colorectal cancer: 7.4;pancreatic cancer: 19.9;renal cancer: 16.9;stomach cancer: 11.5"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 19.1;NTERA-2: 8.8;RPTEC TERT1: 56.8;SCLC-21H: 15.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046224, HPA056602"	Uncertain		Supported	Vesicles		NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 17: Intestinal endocrine cells - Hormone signaling"	Vesicles		"HPA046224: AB_10961288, HPA056602: AB_2683185"	"unprognostic (4.96e-2)"	"unprognostic (1.06e-2)"	"unprognostic (9.92e-2)"	"prognostic unfavorable (7.79e-5)"	"unprognostic (1.00e-2)"	"unprognostic (4.17e-2)"	"unprognostic (3.75e-2)"	"unprognostic (9.83e-3)"	"unprognostic (2.19e-1)"	"unprognostic (7.58e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.47e-1)"	"unprognostic (5.66e-3)"	"unprognostic (2.94e-2)"	"unprognostic (1.76e-1)"	"unprognostic (8.70e-2)"	"unprognostic (5.13e-2)"	0.1	4.7	7.0	1.5	12.7	0.0	0.2	1.7	30.1	0.0	0.0	12.2	12.5	0.2	0.0	0.0	0.2	20.8	5.2	18.0	11.5	8.9	0.3	0.5	0.0	5.7	1.2	0.0	7.1	0.4	16.8	0.0	5.4	1.8	12.6	11.3	1.9	0.0	0.1	0.2	12.8	0.8	0.0	0.1	11.0	1.7	9.0	0.3	1.6	0.1	0.0	0.0	0.0	5.2	0.0	19.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.2	0.0	1.1	0.0	0.2	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	8.8	0.0	0.2	0.0	0.0	0.0	56.8	0.0	15.0	0.7	0.0	0.0	0.1	0.7	1.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.7	0.2	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.0	12.7	1.7	30.1	18.0	11.5	5.7	1.2	5.4	0.0	9.0	5.2	0.0	0.0	0.0	4.6	0.1	0.0	0.2	0.0	0.0	3.3	0.1	0.3	15.3	17.2	0.0	3.7	25.0	0.0	0.0	10.2	5.9	1.2	3.1	0.4	0.2	0.1	336.8	0.0	41.6	0.6	0.0	1.7	3.6	2.0	0.0	2.5	0.0	0.0	0.0	1.7	43.8	37.3	4.1	0.0	0.0	9.7	0.3	0.0	0.0	5.6	0.0	0.7	0.0	1.5	3.5	8.2	14.3	0.0	0.0	2.3	13.9	0.5	0.0	2.7	0.0	0.0	0.2	2.0	0.2	0.0	0.0	0.0	0.0	0.0	32.8	0.2
SYT14	"FLJ34198, sytXIV"	ENSG00000143469	"Synaptotagmin 14"	Q8NB59	1	209900923-210171389	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"			"Disease variant, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"brain: 7.0;retina: 1.9;testis: 3.2;thyroid gland: 5.0"	"Cell type enhanced"	"Detected in some"		"Excitatory neurons: 208.7;Inhibitory neurons: 213.9;Oligodendrocyte precursor cells: 152.8;Oligodendrocytes: 197.6"	"Cancer enhanced"	"Detected in some"		"thyroid cancer: 1.9"	"Region enriched"	"Detected in some"	4	"cerebellum: 7.0"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 9.7;GAMG: 6.7;hTERT-HME1: 4.7;SCLC-21H: 6.5;U-138 MG: 6.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036963			Supported	Vesicles		NA	NA				"Cluster 21: Non-specific - Transcription"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Vesicles		"HPA036963: AB_10670378"	"unprognostic (1.38e-4)"	"unprognostic (8.62e-3)"	"unprognostic (1.93e-1)"	"unprognostic (3.90e-4)"	"unprognostic (1.97e-1)"	"unprognostic (4.43e-5)"		"unprognostic (1.92e-1)"	"unprognostic (1.88e-2)"	"unprognostic (6.85e-2)"	"unprognostic (1.56e-2)"	"unprognostic (3.81e-1)"	"unprognostic (4.85e-3)"	"unprognostic (2.30e-4)"	"unprognostic (1.61e-1)"	"unprognostic (1.76e-1)"	"unprognostic (3.33e-3)"	0.0	0.7	0.4	0.0	0.6	0.0	0.0	7.0	1.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.2	0.0	0.6	0.0	0.4	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	3.2	0.2	0.0	5.0	0.0	0.0	0.0	0.0	1.6	2.1	0.0	0.0	0.0	0.0	0.0	0.0	2.5	9.7	2.2	1.2	0.0	0.0	0.0	0.0	0.1	6.7	3.0	0.0	0.0	2.2	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.4	4.7	1.1	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.0	3.6	0.0	0.3	0.0	0.0	0.0	0.0	1.9	6.5	2.0	0.0	0.0	3.6	0.8	0.0	0.0	1.6	6.4	3.2	0.0	0.9	0.0	0.0	0.0	0.2	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.6	7.0	1.0	0.4	0.3	0.4	0.2	0.4	0.1	0.2	1.6	0.0	0.0	0.0	30.3	0.0	0.0	0.1	0.0	0.0	30.1	0.2	0.0	2.2	0.0	0.0	0.0	27.1	0.0	0.0	0.0	3.9	0.3	17.0	11.6	2.9	0.2	0.0	0.0	208.7	0.6	0.0	0.2	0.0	29.3	0.0	0.9	0.0	0.0	0.0	52.2	213.9	0.0	0.0	0.0	0.0	5.0	0.6	0.2	0.0	3.7	0.0	1.6	0.0	152.8	197.6	0.3	0.0	0.0	0.0	0.7	0.0	0.4	0.0	29.4	0.0	0.9	0.2	6.0	16.8	0.0	0.0	0.0	0.1	0.7	0.0	0.2
SYTL2	"CHR11SYT, exophilin-4, FLJ20163, FLJ21219, KIAA1597, MGC102768, PPP1R151, SGA72M, SLP2"	ENSG00000137501	"Synaptotagmin like 2"	Q9HCH5	11	85694224-85811159	"Plasma proteins, Predicted intracellular proteins, Transporters"	Exocytosis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 74.2;stomach 1: 127.7"	"Cell type enhanced"	"Detected in many"		"Gastric mucus-secreting cells: 382.2;granulocytes: 130.8;Intestinal goblet cells: 185.9;Respiratory ciliated cells: 138.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"gdT-cell: 14.0;MAIT T-cell: 23.7"	"Lineage enriched"	"Detected in many"	5	"T-cells: 23.7"	"Cell line enhanced"	"Detected in many"		"MCF7: 91.1;OE19: 148.1;RH-30: 175.8;RPTEC TERT1: 124.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039651	Approved		Approved	"Nucleoplasm,Golgi apparatus,Plasma membrane"		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 37: Intestine - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 27: Mucus-secreting cells - Mucin production"	"Nucleoplasm, Golgi apparatus"	"Plasma membrane"	"HPA039651: AB_10795153"	"unprognostic (8.07e-3)"	"unprognostic (6.72e-3)"	"prognostic favorable (2.67e-4)"	"unprognostic (9.34e-4)"	"unprognostic (6.60e-3)"	"unprognostic (2.19e-4)"	"unprognostic (2.24e-2)"	"unprognostic (5.37e-2)"	"unprognostic (5.56e-2)"	"unprognostic (5.45e-2)"	"unprognostic (1.92e-2)"	"unprognostic (2.97e-2)"	"unprognostic (2.85e-2)"	"unprognostic (4.03e-1)"	"unprognostic (1.87e-2)"	"unprognostic (9.72e-2)"	"prognostic favorable (9.07e-4)"	16.7	9.6	19.3	12.9	24.6	3.3	16.0	8.7	35.7	10.7	11.9	51.7	21.6	9.1	16.3	17.0	7.6	27.8	8.4	29.0	25.1	20.2	6.9	14.8	11.1	26.4	14.0	4.8	2.7	6.4	6.1	18.2	17.9	13.6	74.2	13.3	8.9	9.8	5.1	6.8	25.0	10.2	15.6	10.4	127.7	5.1	13.8	7.1	4.7	2.7	6.8	50.9	7.4	29.1	3.5	8.0	12.2	1.0	2.8	15.4	0.2	30.3	39.4	26.3	59.2	34.7	4.5	0.7	11.1	21.3	38.0	22.3	0.8	2.7	34.5	2.4	0.2	0.0	0.2	0.3	1.8	2.7	0.5	19.6	3.8	56.8	0.8	6.2	0.2	1.0	0.4	0.4	33.6	91.1	0.1	0.9	20.6	148.1	13.6	1.3	175.8	0.1	124.2	46.8	0.3	0.6	6.7	5.4	3.0	10.2	0.6	0.5	0.1	40.8	15.6	25.9	1.5	0.2	0.0	16.1	41.9	0.5	25.7	0.0	0.0	0.0	14.0	0.0	23.7	0.0	2.8	8.4	0.0	0.1	2.3	4.1	0.0	4.6	0.1	1.0	1.1	2.6	19.3	24.6	8.7	35.7	29.0	25.1	26.4	14.0	17.9	15.6	13.8	29.1	7.5	22.4	32.5	15.3	3.0	3.6	11.7	15.8	1.8	10.4	45.4	14.0	2.3	8.6	62.1	68.0	8.4	0.7	45.6	115.2	0.0	9.1	1.2	8.0	2.2	6.4	19.2	4.0	103.9	16.9	0.4	11.5	382.2	2.3	130.8	0.8	5.0	0.5	0.5	1.7	23.2	185.9	2.0	5.9	5.0	0.9	1.8	4.6	10.6	20.6	1.6	14.0	63.8	35.7	91.9	16.5	40.6	30.1	31.6	30.7	16.3	8.6	138.4	8.1	32.9	42.1	59.8	3.6	2.6	2.2	5.7	0.4	50.1	2.3	36.7	60.9
SYVN1	"DER3, HRD1"	ENSG00000162298	"Synoviolin 1"	Q86TM6	11	65121780-65134532	"Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Stress response, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Hepatocytes: 72.9;Plasma cells: 90.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-698: 205.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005480, HPA024300, CAB037030"	Enhanced		Supported	"Nucleoplasm,Endoplasmic reticulum,Plasma membrane"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 57: B-cells - Immune response"	Nucleoplasm	"Endoplasmic reticulum, Plasma membrane"	"CAB037030: AB_1840939, HPA005480: AB_1079084, HPA024300: AB_1851073"	"unprognostic (1.12e-1)"	"unprognostic (3.10e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.17e-2)"	"unprognostic (2.85e-2)"	"prognostic favorable (6.88e-4)"	"unprognostic (7.67e-2)"	"unprognostic (2.50e-2)"	"unprognostic (2.64e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.77e-2)"	"unprognostic (1.56e-2)"	"unprognostic (4.89e-1)"	"unprognostic (3.85e-2)"	"unprognostic (1.16e-1)"	29.2	40.3	19.3	37.1	25.6	31.0	27.6	23.2	21.4	30.7	26.7	29.2	26.1	29.1	38.8	28.4	30.6	19.7	25.3	18.6	21.2	24.5	117.5	27.0	60.9	27.9	25.6	30.9	90.9	35.0	38.2	26.2	24.6	28.5	29.0	18.7	55.9	30.3	34.2	29.3	39.4	25.9	22.8	51.2	39.4	24.3	23.4	18.3	43.4	19.0	81.1	25.8	24.8	25.9	32.4	40.6	24.0	32.5	59.8	33.8	23.8	32.8	33.5	40.9	28.8	22.2	55.0	181.0	43.8	42.4	53.8	48.8	26.4	33.3	33.6	28.4	20.0	28.6	46.8	50.2	72.3	43.3	49.6	43.3	59.0	36.1	81.0	36.4	27.0	19.0	36.4	90.1	24.3	47.9	19.1	31.2	26.1	33.6	28.0	31.9	20.3	74.0	25.7	31.5	15.6	32.0	30.4	74.1	53.3	21.0	55.4	28.2	25.9	28.3	18.6	51.2	22.4	178.1	134.2	205.9	38.1	21.8	32.3	16.8	7.4	14.0	7.4	4.7	6.5	21.9	5.2	6.9	4.4	22.6	3.7	3.9	7.0	3.5	4.7	18.4	5.3	6.6	19.3	25.6	23.2	21.4	18.6	21.2	27.9	25.6	24.6	22.8	23.4	25.9	11.5	16.0	21.4	11.1	43.5	17.6	6.9	13.8	12.0	10.7	21.0	15.5	4.0	22.8	20.8	11.0	33.3	14.5	16.4	23.1	1.9	13.6	6.6	14.2	16.2	11.3	8.4	13.2	9.6	18.9	16.5	14.2	17.9	22.1	1.3	10.1	15.0	72.9	15.1	13.5	9.5	33.6	16.2	15.3	13.2	4.1	20.5	10.8	12.4	9.4	10.5	11.0	13.4	13.0	15.8	18.2	11.7	13.2	90.5	14.9	14.0	7.7	15.1	18.7	13.1	11.9	10.7	19.3	13.2	9.7	16.1	42.8	11.7	13.6	18.6	13.8
TACC2	"AZU-1, ECTACC"	ENSG00000138162	"Transforming acidic coiled-coil containing protein 2"	O95359	10	121989163-122254545	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 251.7;skeletal muscle: 387.1"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 210.1;Syncytiotrophoblasts: 228.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"hTCEpi: 86.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031020, HPA031021, HPA061394"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA		32000		"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	"Nucleoplasm, Cytosol"	"Plasma membrane"	"HPA031020: AB_10669988, HPA031021: AB_2673701, HPA061394: AB_2684500"	"unprognostic (3.28e-2)"	"unprognostic (4.88e-2)"	"unprognostic (1.75e-2)"	"unprognostic (7.07e-2)"	"unprognostic (2.26e-1)"	"unprognostic (1.14e-1)"	"unprognostic (9.15e-2)"	"unprognostic (8.43e-3)"	"unprognostic (1.14e-1)"	"unprognostic (3.51e-1)"	"unprognostic (2.13e-1)"	"unprognostic (1.83e-2)"	"prognostic favorable (2.50e-10)"	"unprognostic (7.02e-2)"	"unprognostic (1.19e-1)"	"prognostic unfavorable (8.45e-4)"	"unprognostic (1.61e-1)"	22.1	15.3	18.2	5.3	18.6	0.2	20.9	23.6	22.7	32.3	28.6	91.5	15.3	26.1	9.2	64.2	32.9	12.9	251.7	19.1	18.8	33.9	18.8	68.7	1.0	16.0	16.9	8.8	25.3	36.4	58.7	21.6	14.8	67.7	20.7	7.2	60.7	13.5	387.1	103.3	35.7	22.0	11.8	4.2	49.1	5.8	16.9	5.7	50.7	159.0	5.7	62.4	49.1	17.7	17.8	55.1	26.5	15.2	7.4	7.4	31.7	7.7	20.7	10.5	7.3	22.7	28.9	0.0	7.0	12.3	12.1	58.1	8.5	20.9	10.9	3.0	4.4	0.0	7.7	43.8	11.5	0.0	0.3	3.4	86.0	5.6	36.6	8.6	22.2	0.1	4.5	0.6	10.4	23.5	0.2	9.9	15.7	27.6	24.8	0.3	15.2	8.5	28.9	26.9	17.6	14.2	12.7	52.0	29.5	7.6	10.2	0.4	20.6	4.7	3.5	11.8	14.5	2.4	11.7	0.3	8.7	0.1	12.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.2	18.6	23.6	22.7	19.1	18.8	16.0	16.9	14.8	11.8	16.9	17.7	15.5	83.3	94.1	16.3	0.7	33.6	49.7	54.3	33.0	21.6	23.4	14.1	210.1	8.6	70.7	36.8	0.0	53.3	0.4	75.2	1.9	8.2	2.4	88.4	11.0	21.3	30.0	0.0	32.8	14.2	4.4	21.2	38.7	62.8	7.0	0.1	6.1	18.9	6.5	43.7	48.2	38.8	57.0	0.3	4.3	2.6	6.8	1.9	7.2	7.5	0.1	1.1	0.0	80.9	7.6	19.4	47.1	7.5	0.2	49.6	36.5	13.5	84.9	2.7	13.1	27.2	23.7	0.5	8.2	79.5	54.0	228.5	2.6	2.8	41.9	80.5
TACC3	"ERIC-1, ERIC1, maskin, Tacc4"	ENSG00000013810	"Transforming acidic coiled-coil containing protein 3"	Q9Y6A5	4	1712891-1745171	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 58.9;lymphoid tissue: 52.4;testis: 50.6"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 70.4;Hofbauer cells: 43.9;Late spermatids: 69.9;Spermatocytes: 94.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005781, HPA006050, CAB010111, HPA022039"	Enhanced		Enhanced	"Vesicles,Mitotic spindle,Centriolar satellite,Cytosol"		Yes	Yes		11000	"Cluster 5: Granulocytes - Unknown function"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Mitotic spindle, Centriolar satellite, Cytosol"	Vesicles	"CAB010111: AB_628323, HPA005781: AB_1857724, HPA006050: AB_2667505, HPA022039: AB_1857725"	"unprognostic (2.95e-1)"	"unprognostic (1.18e-1)"	"unprognostic (7.71e-2)"	"unprognostic (4.35e-2)"	"unprognostic (6.58e-2)"	"unprognostic (1.84e-2)"	"prognostic unfavorable (3.30e-4)"	"unprognostic (1.10e-3)"	"unprognostic (4.61e-2)"	"unprognostic (9.12e-2)"	"unprognostic (2.91e-2)"	"unprognostic (2.26e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (4.66e-2)"	"unprognostic (2.09e-1)"	"unprognostic (4.44e-3)"	"unprognostic (9.75e-2)"	5.3	3.9	4.2	24.9	4.3	58.9	3.5	5.2	5.3	3.6	5.2	10.3	6.6	3.3	4.8	14.9	2.8	4.2	3.3	4.5	4.4	2.7	3.5	6.5	43.2	4.8	5.3	2.2	1.4	2.3	2.6	8.7	4.8	2.4	10.6	1.9	3.9	2.5	2.0	6.4	12.9	6.4	4.2	22.1	6.4	50.6	5.1	52.4	2.8	3.4	39.3	5.0	5.4	4.7	106.7	88.7	129.5	72.2	6.7	15.2	72.9	114.6	62.1	135.4	87.6	93.5	122.8	133.8	48.0	65.4	149.9	71.4	142.5	86.8	131.1	59.8	77.0	113.8	67.2	85.8	5.9	146.6	85.5	5.2	5.7	85.6	46.0	26.0	102.2	110.3	106.3	90.8	123.8	87.1	207.5	204.0	139.3	89.2	111.6	139.1	90.5	55.0	73.8	125.5	99.8	62.8	70.1	42.3	33.1	95.2	83.3	90.5	56.4	75.4	90.0	65.4	176.7	69.5	102.5	207.1	43.2	141.1	109.1	45.5	30.0	37.9	8.5	12.5	11.1	7.8	16.5	11.5	15.3	10.8	28.3	13.1	91.8	12.2	9.6	8.3	42.5	32.5	4.2	4.3	5.2	5.3	4.5	4.4	4.8	5.3	4.8	4.2	5.1	4.7	6.0	0.0	6.7	2.0	16.5	2.2	1.2	3.2	1.2	1.7	2.4	3.0	2.6	2.8	3.4	9.2	8.4	19.5	6.4	11.2	0.0	2.2	70.4	4.2	2.8	5.2	1.2	37.2	2.3	0.7	20.4	6.0	12.8	4.3	5.1	24.5	8.9	5.1	43.9	5.0	3.2	9.5	4.1	23.2	10.8	69.9	2.8	34.1	0.0	4.7	24.4	1.4	6.2	0.5	0.8	2.9	4.2	2.6	18.0	1.3	2.6	2.8	0.9	2.7	6.6	2.0	4.8	94.3	37.7	12.8	1.4	4.0	23.2	2.2	16.1	2.7
TACSTD2	"EGP-1, GA733-1, M1S1, TROP2"	ENSG00000184292	"Tumor associated calcium signal transducer 2"	P09758	1	58575433-58577252	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted membrane proteins"	"Sensory transduction, Vision"	"Tumor antigen"	"Amyloidosis, Corneal dystrophy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 989.6;salivary gland: 468.5;skin 1: 438.8"	"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 6559.0;Basal respiratory cells: 3141.0;Club cells: 2499.0;Prostatic glandular cells: 3724.1;Squamous epithelial cells: 2716.6;Urothelial cells: 8102.8"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in some"		"eosinophil: 15.0"	"Group enriched"	"Detected in many"	79	"dendritic cells: 4.3;granulocytes: 15.0;monocytes: 4.2"	"Cell line enhanced"	"Detected in many"		"A-431: 766.6;CAPAN-2: 1005.9;HaCaT: 1010.0;RT4: 355.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA043104, HPA055067, CAB072852"	Enhanced		Supported	"Nucleoli,Vesicles,Plasma membrane"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 22: Epithelial cell types - Mixed function"	"Plasma membrane"	"Nucleoli, Vesicles"	"CAB072852: , HPA043104: AB_10960710, HPA055067: AB_2682687"	"unprognostic (1.80e-2)"	"unprognostic (3.08e-1)"	"unprognostic (3.67e-3)"	"unprognostic (1.22e-1)"	"unprognostic (5.70e-2)"	"unprognostic (2.15e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.99e-1)"	"unprognostic (1.03e-2)"	"unprognostic (1.71e-2)"	"unprognostic (7.91e-2)"	"prognostic favorable (3.99e-4)"	"unprognostic (7.10e-2)"	"unprognostic (2.55e-1)"	"unprognostic (6.91e-3)"	"unprognostic (2.50e-1)"	4.8	1.2	0.2	1.3	0.4	13.5	135.8	0.2	0.4	218.6	1.9	1.1	0.7	19.1	25.3	989.6	27.7	13.0	0.8	0.3	0.3	137.9	4.0	71.2	1.0	0.2	0.3	1.5	81.1	3.5	2.4	17.7	0.2	126.8	0.9	0.0	468.5	97.1	1.9	438.8	1.2	2.0	0.2	1.0	65.7	0.5	0.3	9.2	5.0	0.3	180.0	234.6	375.0	0.6	766.6	0.1	0.0	1.5	0.0	0.0	280.1	0.2	0.0	0.0	0.1	0.7	1005.9	0.1	94.7	64.2	0.1	1010.0	0.0	186.5	0.0	0.7	0.0	0.2	19.7	0.3	0.3	0.1	0.8	0.2	274.5	0.4	11.3	0.0	42.5	0.0	0.2	1.3	0.0	166.3	0.6	1.1	0.5	167.0	1.4	0.2	0.1	0.6	137.0	355.3	0.2	0.3	32.4	264.9	1.0	3.2	173.6	1.5	45.4	1.0	1.7	0.8	1.7	0.4	0.9	0.7	1.0	0.3	0.7	0.0	4.2	15.0	0.0	0.1	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	1.8	0.2	0.4	0.2	0.4	0.3	0.3	0.2	0.3	0.2	0.2	0.3	0.6	9.0	346.1	109.2	0.0	3.1	1490.5	6559.0	3141.0	1226.5	0.0	789.8	445.6	0.4	338.8	2499.0	1278.2	0.0	107.1	9.1	2.8	43.0	2165.2	0.0	482.3	48.6	60.4	0.0	0.0	0.1	1263.4	8.1	36.3	143.2	608.7	8.8	0.2	1.4	0.5	8.8	0.0	0.0	8.5	1143.4	0.8	203.4	0.0	0.0	34.8	113.8	0.0	31.3	0.0	0.0	0.0	0.6	1778.0	3.6	0.0	1.4	3724.1	0.2	3.4	1080.4	0.0	0.0	1.3	142.4	0.4	1.1	2716.6	1531.8	78.4	32.8	0.0	1.5	8102.8
TADA1	"ADA1, hADA1, HFI1, STAF42, TADA1L"	ENSG00000152382	"Transcriptional adaptor 1"	Q96BN2	1	166856510-166876264	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028651	Approved		Supported	"Nucleoplasm,Focal adhesion sites,Cytosol"		No	No			"Cluster 15: NK-cells - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm	"Focal adhesion sites, Cytosol"	"HPA028651: AB_10602476"	"unprognostic (9.53e-3)"	"unprognostic (2.31e-1)"	"unprognostic (1.05e-2)"	"unprognostic (4.10e-2)"	"unprognostic (1.55e-1)"	"unprognostic (7.09e-2)"	"unprognostic (5.99e-3)"	"unprognostic (7.31e-2)"	"unprognostic (3.35e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.98e-2)"	"unprognostic (3.64e-2)"	"unprognostic (2.73e-2)"	"unprognostic (6.35e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.26e-2)"	5.1	8.9	9.6	6.1	10.3	19.4	9.2	9.9	12.4	7.7	8.1	8.4	7.7	9.3	7.6	8.3	8.6	5.3	8.6	10.1	9.3	11.6	26.7	6.2	10.4	7.8	8.3	11.0	6.4	10.9	6.2	8.2	8.8	7.9	9.1	17.0	8.1	7.1	9.8	8.0	8.4	7.6	9.2	6.9	7.5	10.8	9.3	13.2	7.5	10.6	10.1	6.6	5.8	11.2	15.7	14.9	27.4	16.3	8.1	10.4	16.2	8.1	9.9	13.2	11.4	13.7	12.5	29.9	15.4	9.6	10.7	11.8	22.3	14.3	10.6	18.9	21.3	9.9	11.9	22.5	12.0	28.3	17.4	7.9	16.3	8.0	19.9	9.6	11.0	22.2	35.9	17.6	10.5	10.9	34.9	22.5	41.6	25.2	16.5	29.1	12.0	37.9	18.0	20.9	17.5	30.6	14.6	18.7	17.5	25.0	25.3	29.3	8.3	10.8	12.4	11.9	17.3	24.9	36.3	56.3	7.5	12.6	10.4	2.9	12.7	13.8	20.7	12.9	22.9	20.2	22.2	23.6	20.7	20.8	27.9	22.3	2.1	27.5	10.4	13.3	23.4	24.7	9.6	10.3	9.9	12.4	10.1	9.3	7.8	8.3	8.8	9.2	9.3	11.2	2.7	9.6	2.7	7.8	8.4	6.1	4.7	3.9	6.2	7.6	4.9	4.6	10.3	2.8	4.1	3.7	8.4	6.1	4.9	4.4	5.9	3.9	4.0	4.8	4.6	4.3	7.2	13.7	9.6	4.0	7.7	4.8	6.6	4.4	5.1	6.1	3.3	20.3	4.2	1.7	10.5	6.1	0.0	5.3	5.1	1.7	4.4	2.6	1.8	3.7	6.9	6.8	4.1	7.5	17.7	3.8	1.7	3.0	7.5	6.2	5.3	7.0	4.3	6.0	0.0	6.1	4.1	5.2	12.9	7.6	5.1	7.3	7.3	1.9	5.9	4.2
TADA3	"ADA3, FLJ20221, FLJ21329, hADA3, NGG1, TADA3L"	ENSG00000171148	"Transcriptional adaptor 3"	O75528	3	9779860-9793011	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042250	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 35: Non-specific - Unknown function"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 63: NK-cells & T-cells - Immune response"	Nucleoplasm		"HPA042250: AB_10794043"	"unprognostic (5.77e-2)"	"unprognostic (1.72e-2)"	"unprognostic (2.78e-1)"	"unprognostic (2.00e-3)"	"unprognostic (6.83e-2)"	"unprognostic (4.70e-2)"	"unprognostic (9.15e-3)"	"unprognostic (2.71e-1)"	"unprognostic (4.90e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.47e-2)"	"unprognostic (6.56e-2)"	"prognostic favorable (5.47e-5)"	"unprognostic (1.10e-2)"	"unprognostic (2.03e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.51e-3)"	32.5	60.1	51.3	36.9	51.4	34.8	32.5	48.8	57.0	37.9	43.2	44.8	31.4	44.3	23.2	34.2	44.1	32.0	47.2	51.0	54.4	41.6	50.8	34.0	46.3	54.0	53.5	56.8	29.0	35.5	45.0	22.2	50.5	49.6	27.1	18.1	35.5	40.8	59.8	28.6	33.8	32.5	52.4	38.9	39.4	54.5	56.6	32.8	39.3	40.0	37.9	41.6	31.9	48.4	48.0	49.7	78.2	44.2	67.1	61.3	167.6	50.0	83.6	64.3	80.3	50.7	55.1	52.8	59.1	107.7	84.3	28.4	43.9	65.3	29.2	66.0	53.7	118.0	60.6	55.3	95.5	44.6	185.5	62.6	83.3	91.5	65.8	85.0	43.3	75.0	80.6	63.4	80.0	136.0	43.2	44.5	73.5	62.8	47.8	22.2	39.6	67.2	66.3	47.6	30.5	88.5	42.9	23.1	81.5	43.2	80.6	106.2	62.9	88.0	70.4	47.1	70.0	50.3	61.3	92.4	126.0	76.5	74.0	62.8	44.0	126.0	58.2	68.4	30.6	33.8	40.7	48.1	49.6	30.4	35.9	39.2	51.6	53.0	88.9	31.5	54.5	55.2	51.3	51.4	48.8	57.0	51.0	54.4	54.0	53.5	50.5	52.4	56.6	48.4	26.1	12.8	12.8	22.5	37.0	16.8	88.3	66.2	32.5	28.6	43.4	45.7	8.6	41.5	30.2	33.1	14.6	47.3	59.1	80.2	66.5	65.2	93.3	28.7	32.9	24.4	35.5	41.6	9.9	64.2	53.5	34.4	32.1	22.6	47.0	31.9	35.0	43.1	65.0	25.2	10.9	63.0	44.7	50.3	25.4	75.6	36.7	48.8	32.0	6.5	92.8	96.9	146.2	5.0	10.0	67.1	68.2	42.9	31.9	43.1	64.9	70.3	25.2	29.3	72.3	33.9	42.2	86.9	81.2	32.7	16.6	36.8	50.2	41.0	52.7	53.0
TAF1	"BA2R, CCG1, CCGS, DYT3, DYT3/TAF1, KAT4, NSCL2, TAF2A, TAFII250"	ENSG00000147133	"TATA-box binding protein associated factor 1"	P21675	X	71366264-71532374	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Transcription factors"	"Cell cycle, Host-virus interaction, Transcription, Transcription regulation"	"Acyltransferase, DNA-binding, Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Disease variant, Dystonia, Mental retardation, Parkinsonism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 81.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA001075, CAB016283"	Supported		Supported	Nucleoplasm		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 20: Retina & Lymphoid tissues - Unknown function"	"Cluster 32: U-937 - Innate immune response"	"Cluster 9: Photoreceptor cells - Phototransduction"	Nucleoplasm		"CAB016283: AB_671202, HPA001075: AB_1080179"	"unprognostic (2.95e-2)"	"unprognostic (1.77e-1)"	"unprognostic (6.45e-3)"	"unprognostic (1.91e-2)"	"unprognostic (1.88e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.44e-1)"	"prognostic favorable (6.54e-4)"	"unprognostic (2.68e-2)"	"unprognostic (3.43e-2)"	"unprognostic (2.03e-1)"	"unprognostic (5.59e-2)"	"prognostic unfavorable (6.03e-4)"	"unprognostic (1.14e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.82e-2)"	"unprognostic (2.56e-2)"	10.9	8.6	10.3	11.4	12.7	12.8	12.3	13.7	11.1	11.1	10.2	10.0	6.6	13.8	12.9	7.5	11.1	7.8	7.0	9.3	14.1	7.5	7.8	9.1	14.1	11.5	11.3	14.4	9.8	12.2	8.4	10.0	10.9	10.0	10.0	27.3	7.7	10.1	10.5	13.3	9.3	10.9	8.2	15.4	10.6	7.2	12.5	14.8	12.7	10.3	12.4	9.2	8.6	16.8	18.6	15.9	18.2	12.4	14.6	23.2	11.0	13.3	12.1	13.7	11.1	12.3	11.3	17.6	11.5	14.9	12.3	17.5	24.1	11.0	17.0	11.2	21.9	20.1	22.1	13.1	11.1	39.7	19.4	14.1	11.3	14.2	27.2	12.8	14.7	13.2	28.2	41.1	14.4	14.5	22.4	25.4	20.9	23.5	20.8	19.8	35.8	21.6	11.1	25.0	9.0	14.5	37.7	13.6	18.7	14.3	9.6	22.9	18.6	16.5	14.2	13.4	9.7	17.5	17.4	21.4	9.0	33.2	12.5	1.6	1.4	0.7	1.4	0.9	1.3	1.0	1.4	1.4	1.5	1.5	1.6	1.8	1.8	1.5	1.6	1.4	1.0	0.7	10.3	12.7	13.7	11.1	9.3	14.1	11.5	11.3	10.9	8.2	12.5	16.8	26.7	32.1	26.7	44.7	21.2	11.9	8.9	10.4	18.2	37.5	12.5	13.3	17.2	10.0	23.9	3.7	81.3	8.6	21.5	7.8	1.9	6.3	2.5	17.0	23.4	24.6	11.4	28.6	54.3	7.0	5.9	17.6	12.2	18.9	23.4	23.9	18.9	12.6	8.8	16.8	52.2	14.6	6.1	16.2	20.0	2.6	22.1	20.4	5.4	47.8	23.9	17.0	29.9	49.3	79.1	7.6	13.3	22.2	18.7	11.2	13.4	5.2	14.8	67.9	0.0	27.4	18.0	9.3	10.7	17.8	17.3	5.7	23.8	25.9	13.6	9.6
TAF10	"TAF2A, TAF2H, TAFII30"	ENSG00000166337	"TATA-box binding protein associated factor 10"	Q12962	11	6606294-6612539	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"Early spermatids: 361.8;Late spermatids: 1039.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004148, CAB022405"	Supported		Supported	Nucleoplasm		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 43: Testis - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"CAB022405: , HPA004148: AB_1857736"	"unprognostic (1.69e-3)"	"unprognostic (2.32e-1)"	"unprognostic (3.19e-2)"	"unprognostic (6.21e-3)"	"unprognostic (9.10e-2)"	"unprognostic (6.99e-2)"	"unprognostic (5.24e-3)"	"unprognostic (9.03e-3)"	"unprognostic (1.12e-1)"	"unprognostic (1.24e-2)"	"unprognostic (3.46e-1)"	"unprognostic (1.10e-1)"	"prognostic unfavorable (1.84e-5)"	"unprognostic (1.38e-1)"	"unprognostic (2.55e-1)"	"unprognostic (9.64e-3)"	"unprognostic (3.80e-3)"	78.9	140.7	147.5	53.3	150.3	93.0	69.2	149.2	204.1	59.3	142.6	66.2	44.3	63.6	97.5	103.1	61.7	28.3	130.0	147.7	156.2	100.9	151.6	76.7	56.8	157.1	153.2	50.0	152.8	53.2	96.2	31.0	155.9	79.8	54.1	30.8	69.6	42.9	107.5	61.2	68.1	38.7	147.7	125.4	100.1	190.7	149.9	82.0	74.6	50.0	76.3	72.1	58.3	150.9	82.4	138.2	88.7	77.7	140.6	135.1	67.5	61.4	134.6	98.9	98.6	102.0	145.0	45.4	77.2	111.4	137.4	68.6	66.0	99.7	97.3	92.2	95.3	64.2	95.6	122.2	227.7	85.4	98.9	157.8	125.1	77.5	163.0	168.0	110.6	139.5	67.0	80.7	157.4	159.5	122.2	78.5	62.6	130.9	107.6	72.2	46.8	78.5	163.5	108.1	62.2	84.4	82.9	95.0	107.6	129.8	67.1	100.6	64.6	67.2	78.9	97.6	87.9	94.6	70.7	73.4	110.4	44.5	108.2	12.7	9.9	11.8	9.7	15.7	8.8	9.8	9.4	11.1	10.8	11.6	8.8	7.8	27.9	8.7	16.2	23.7	11.4	5.1	147.5	150.3	149.2	204.1	147.7	156.2	157.1	153.2	155.9	147.7	149.9	150.9	106.4	3.2	23.3	6.2	60.1	21.4	56.8	9.4	32.5	23.0	116.3	148.0	51.5	47.1	13.1	36.8	20.9	48.5	130.7	79.7	19.6	18.2	361.8	93.8	90.0	39.3	34.7	45.4	4.4	33.3	55.2	43.0	56.6	86.3	5.1	70.5	26.7	53.8	65.9	23.5	4.4	50.8	2.0	78.4	44.4	1039.1	24.5	91.2	26.6	9.4	36.3	84.7	53.5	2.5	9.9	30.7	68.5	19.2	89.6	85.8	55.5	43.1	14.0	27.1	0.0	36.3	50.0	108.8	33.2	75.0	29.1	53.6	65.0	124.1	44.2	88.7
TAF11	"TAF2I, TAFII28"	ENSG00000064995	"TATA-box binding protein associated factor 11"	Q15544	6	34877462-34888071	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029326, HPA049127"			Supported	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	Nucleoplasm	"Golgi apparatus"	"HPA029326: AB_2672999, HPA049127: AB_2680645"	"unprognostic (4.02e-2)"	"unprognostic (5.36e-3)"	"unprognostic (7.41e-2)"	"unprognostic (5.18e-3)"	"unprognostic (6.65e-3)"	"unprognostic (1.70e-1)"	"unprognostic (2.56e-3)"	"unprognostic (1.45e-2)"	"unprognostic (1.68e-3)"	"prognostic favorable (5.87e-4)"	"unprognostic (2.91e-1)"	"unprognostic (6.77e-3)"	"unprognostic (1.89e-2)"	"unprognostic (3.24e-1)"	"unprognostic (1.87e-2)"	"unprognostic (4.92e-1)"	"unprognostic (3.32e-1)"	23.2	27.9	21.3	19.5	22.4	47.1	23.0	24.8	26.5	23.9	22.0	27.8	19.3	22.6	18.4	25.8	25.1	15.5	29.5	21.4	21.0	27.5	28.5	25.5	27.1	22.0	21.7	27.9	27.2	16.7	19.8	22.6	22.0	26.2	20.6	24.8	20.9	16.9	32.6	29.0	26.5	20.7	21.1	33.8	25.1	33.4	22.3	23.7	24.4	21.6	25.4	24.9	23.1	25.6	37.2	15.4	50.2	91.4	29.5	30.8	44.5	29.5	23.1	47.2	44.8	35.9	23.0	49.5	37.8	27.3	23.1	23.4	61.5	25.1	37.7	30.3	49.6	55.7	30.7	58.8	41.3	74.9	38.6	35.8	41.2	32.2	25.2	28.8	57.6	55.0	89.0	38.1	22.6	65.6	48.1	63.4	45.9	74.3	26.0	51.6	44.9	39.7	34.4	23.0	60.6	55.3	33.9	37.9	68.6	41.5	59.4	88.6	34.6	33.3	44.6	20.1	36.9	35.2	90.5	72.4	12.2	86.3	49.9	43.6	27.8	24.5	14.3	25.8	13.8	13.8	14.9	15.4	24.1	17.1	17.4	15.6	17.5	17.6	21.7	21.5	21.4	15.9	21.3	22.4	24.8	26.5	21.4	21.0	22.0	21.7	22.0	21.1	22.3	25.6	49.9	28.9	19.5	18.3	44.9	46.0	31.4	36.1	24.5	29.0	55.1	44.3	24.0	25.8	31.3	42.3	12.5	71.9	50.4	33.5	64.6	47.9	6.6	37.4	49.7	43.8	39.5	39.5	20.8	63.2	68.9	33.5	29.6	47.7	22.2	57.8	61.1	58.8	44.2	32.0	23.7	38.4	50.8	52.2	32.2	10.6	33.8	36.5	24.9	13.1	48.5	37.8	48.4	16.6	33.6	50.8	51.2	37.2	44.0	32.9	43.5	48.9	17.1	32.9	32.9	34.0	35.5	130.9	71.2	36.3	58.4	76.8	44.3	38.2	40.6	31.2
TAF1A	"SL1, TAFI48"	ENSG00000143498	"TATA-box binding protein associated factor, RNA polymerase I subunit A"	Q15573	1	222557902-222589933	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054334	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 34: Non-specific - Transcription"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 57: B-cells - Immune response"	Nucleoplasm		"HPA054334: AB_2682453"	"unprognostic (3.01e-1)"	"prognostic unfavorable (9.26e-6)"	"unprognostic (7.98e-2)"	"unprognostic (9.59e-3)"	"unprognostic (1.22e-1)"	"unprognostic (8.98e-3)"	"unprognostic (3.88e-3)"	"unprognostic (3.10e-3)"	"unprognostic (4.79e-2)"	"unprognostic (2.93e-1)"	"unprognostic (3.86e-3)"	"unprognostic (2.25e-1)"	"unprognostic (2.41e-4)"	"unprognostic (8.43e-2)"	"unprognostic (1.76e-1)"	"unprognostic (2.35e-3)"	"unprognostic (9.06e-2)"	3.0	3.4	2.0	4.8	2.1	2.7	3.2	2.3	2.3	3.0	1.6	2.0	2.5	4.1	3.0	2.6	2.8	2.7	1.9	1.7	2.8	2.1	1.8	2.8	6.5	2.4	2.0	6.8	1.9	1.9	2.5	4.4	2.3	3.2	2.6	4.0	2.0	2.7	1.2	2.1	2.4	2.5	2.1	4.4	3.4	6.4	2.1	4.4	5.1	1.3	5.6	5.3	2.5	3.0	13.8	7.3	19.5	6.8	6.6	5.8	17.2	9.1	7.0	10.8	13.2	7.8	14.8	12.6	17.4	3.2	8.6	13.7	13.1	5.6	15.2	8.3	9.9	7.5	6.3	7.5	7.4	18.2	3.3	3.0	6.0	12.1	15.4	5.1	4.5	8.7	23.4	5.6	14.9	5.0	21.6	13.0	39.5	15.8	21.0	13.2	39.1	12.2	4.5	7.3	11.1	23.1	14.0	8.1	10.1	9.9	4.6	9.1	6.1	10.9	10.9	19.4	23.2	6.8	6.6	16.5	9.7	11.7	14.7	1.8	1.5	2.1	3.2	2.5	4.7	5.2	2.8	2.9	1.5	7.4	3.3	4.1	0.3	3.0	2.5	5.3	2.5	1.7	2.0	2.1	2.3	2.3	1.7	2.8	2.4	2.0	2.3	2.1	2.1	3.0	3.1	0.0	1.1	6.5	8.6	8.5	6.4	3.9	6.8	10.2	3.1	3.6	1.5	2.8	1.9	3.7	6.2	7.2	4.6	2.4	1.9	2.9	2.5	3.0	6.1	2.7	1.2	3.8	5.2	0.7	6.7	6.0	4.1	3.0	1.3	7.7	1.1	2.0	4.4	6.7	7.1	3.0	0.0	3.8	1.0	1.3	5.6	4.7	0.0	3.7	2.7	3.8	2.1	8.0	8.0	1.3	1.8	2.2	4.4	8.0	0.9	1.3	2.6	8.5	6.6	4.5	4.3	11.5	12.1	4.9	2.8	5.9	4.7	4.2	3.2	8.8
TAF1B	"RAF1B, RAFI63, SL1, TAFI63"	ENSG00000115750	"TATA-box binding protein associated factor, RNA polymerase I subunit B"	Q53T94	2	9843443-9934416	"Predicted intracellular proteins, Predicted membrane proteins"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA071254			Supported	Nucleoplasm,Nucleoli		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 34: Non-specific - Transcription"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 59: Non-specific - Transcription"	Nucleoli	Nucleoplasm	"HPA071254: "	"unprognostic (1.12e-1)"	"unprognostic (1.74e-1)"	"prognostic favorable (8.58e-5)"	"unprognostic (1.44e-3)"	"unprognostic (5.43e-2)"	"unprognostic (1.24e-1)"	"prognostic unfavorable (6.94e-7)"	"unprognostic (9.17e-2)"	"unprognostic (3.29e-2)"	"unprognostic (2.63e-2)"	"unprognostic (1.40e-1)"	"unprognostic (2.98e-1)"	"prognostic favorable (8.55e-4)"	"unprognostic (2.59e-1)"	"unprognostic (2.49e-1)"	"unprognostic (2.79e-2)"	"unprognostic (1.49e-2)"	7.2	7.6	4.1	8.4	4.1	7.1	8.7	5.3	4.2	6.9	6.4	5.9	5.1	9.7	6.6	9.6	9.6	7.2	4.8	3.8	5.1	13.3	6.3	8.7	11.4	3.9	5.4	5.7	4.4	14.7	3.7	13.0	3.7	9.0	5.7	9.0	8.1	9.0	2.8	8.6	4.2	8.1	3.8	7.1	6.1	11.0	5.4	11.4	10.5	3.4	12.7	7.9	6.0	4.7	25.1	20.4	29.2	9.6	14.1	21.2	52.7	29.9	23.3	25.3	23.3	19.1	18.1	27.1	13.6	21.3	26.7	15.0	26.9	31.7	27.3	31.3	35.9	31.5	8.9	28.3	19.5	22.1	32.4	17.0	16.5	21.4	28.5	20.8	37.4	14.8	19.8	27.2	25.0	15.3	16.6	20.1	37.7	15.6	17.5	10.2	27.2	8.0	24.9	24.3	12.3	33.6	23.5	28.9	21.9	18.9	10.4	17.4	20.4	31.9	39.8	31.1	35.7	14.9	19.9	39.7	18.4	24.8	26.7	3.6	9.1	6.2	12.1	15.5	12.1	11.1	10.2	14.3	13.4	11.7	6.3	10.0	0.5	10.2	12.4	10.6	11.1	5.2	4.1	4.1	5.3	4.2	3.8	5.1	3.9	5.4	3.7	3.8	5.4	4.7	12.5	19.2	22.0	22.2	13.1	16.2	29.9	17.9	19.9	24.5	8.0	6.1	4.0	2.8	26.0	12.9	27.1	25.0	12.6	2.4	13.7	19.5	11.6	26.8	21.0	15.4	1.8	10.5	38.8	18.9	37.4	18.4	13.7	17.3	8.8	12.7	6.8	4.7	12.7	15.2	27.1	3.3	8.2	12.0	11.5	3.8	19.0	14.6	0.0	15.0	15.5	25.5	15.5	32.6	23.5	15.7	3.8	13.2	16.6	9.5	1.7	26.5	29.7	21.0	19.7	15.9	16.2	47.6	33.9	19.7	13.2	23.7	15.1	24.8	4.4	18.7
TAF1C	"MGC:39976, SL1, TAFI110, TAFI95"	ENSG00000103168	"TATA-box binding protein associated factor, RNA polymerase I subunit C"	Q15572	16	84177847-84187070	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA072229			Supported	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 72: Non-specific - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 52: Non-specific - Transcription"	"Nucleoplasm, Nucleoli fibrillar center"		"HPA072229: AB_2686499"	"unprognostic (9.39e-2)"	"unprognostic (1.13e-1)"	"unprognostic (6.86e-3)"	"unprognostic (8.20e-3)"	"unprognostic (4.45e-2)"	"unprognostic (3.47e-2)"	"unprognostic (6.21e-2)"	"unprognostic (1.26e-1)"	"unprognostic (2.52e-1)"	"unprognostic (3.53e-1)"	"prognostic favorable (1.76e-4)"	"unprognostic (1.06e-2)"	"prognostic unfavorable (8.08e-6)"	"unprognostic (5.60e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.82e-1)"	"prognostic favorable (3.22e-4)"	19.4	15.8	9.8	7.2	9.9	13.5	20.6	8.1	12.9	25.9	5.4	16.0	7.9	23.5	2.2	15.9	21.4	10.1	18.3	10.9	7.7	20.6	14.8	17.0	11.1	10.5	8.7	31.7	17.9	4.2	20.6	6.2	8.6	21.7	2.9	1.8	15.3	8.3	12.3	17.8	19.3	5.3	7.3	32.2	18.7	13.8	8.9	7.4	23.7	6.7	3.6	18.5	19.1	8.9	11.8	12.7	7.5	23.6	5.7	5.9	34.3	13.8	5.3	11.5	3.7	15.0	8.3	12.7	17.3	5.0	6.1	21.2	4.3	5.4	2.6	11.4	18.2	6.8	21.0	9.7	4.8	7.6	21.8	8.9	6.9	9.1	3.7	5.0	20.4	20.7	17.9	4.1	5.6	25.4	11.3	24.9	27.8	5.1	12.2	29.2	6.1	10.5	4.7	9.5	34.0	16.8	26.3	7.8	43.0	4.6	28.9	8.1	8.9	19.2	16.5	19.2	12.0	19.6	16.9	26.7	9.8	9.2	12.4	0.0	1.3	0.4	1.5	1.3	1.8	0.9	0.6	0.9	1.5	1.1	0.7	1.3	0.0	1.5	0.5	0.6	0.9	1.2	9.8	9.9	8.1	12.9	10.9	7.7	10.5	8.7	8.6	7.3	8.9	8.9	24.9	19.2	15.8	22.5	9.2	6.5	5.1	5.2	5.2	9.3	10.2	10.2	3.0	2.8	8.2	3.7	20.9	9.4	6.5	9.9	5.9	5.1	0.5	6.9	7.4	18.7	7.2	7.4	16.5	7.1	6.7	8.4	20.9	8.8	6.3	24.6	22.9	12.9	6.6	1.7	13.0	8.2	0.0	9.8	6.3	2.5	11.8	7.3	7.2	15.9	6.3	7.8	5.2	13.6	12.5	5.2	5.1	9.1	12.1	3.9	7.6	4.0	6.1	10.4	6.6	8.3	7.8	9.9	10.6	8.7	5.3	7.4	8.0	16.8	10.2	4.4
TAF1D	"JOSD3, MGC5306, TAF(I)41"	ENSG00000166012	"TATA-box binding protein associated factor, RNA polymerase I subunit D"	Q9H5J8	11	93729948-93784391	"Predicted intracellular proteins, Predicted membrane proteins"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030703, HPA055935, HPA060385"	Uncertain		Supported	"Nucleoplasm,Nucleoli,Mitotic spindle,Centriolar satellite"		Yes	No			"Cluster 6: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 24: NB-4 - Immune response"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	"Nucleoli, Mitotic spindle, Centriolar satellite"	"HPA030703: , HPA055935: AB_2682974, HPA060385: AB_2684271"	"unprognostic (9.91e-3)"	"unprognostic (4.38e-2)"	"unprognostic (6.80e-2)"	"unprognostic (1.71e-1)"	"unprognostic (5.40e-3)"	"unprognostic (6.46e-2)"	"unprognostic (3.68e-3)"	"unprognostic (9.70e-2)"	"unprognostic (5.24e-3)"	"unprognostic (3.55e-2)"	"unprognostic (4.50e-3)"	"unprognostic (1.09e-2)"	"prognostic unfavorable (3.17e-7)"	"unprognostic (1.95e-1)"	"unprognostic (2.51e-1)"	"unprognostic (2.34e-1)"	"unprognostic (6.37e-2)"	10.0	9.3	2.5	18.2	3.0	16.4	12.6	5.0	6.7	7.7	1.2	9.5	13.7	14.1	9.0	9.5	7.7	15.4	7.1	2.9	3.5	6.8	6.9	8.1	20.6	2.3	0.6	13.8	20.9	5.3	4.9	18.0	2.3	9.9	12.5	8.2	10.1	7.3	8.0	11.4	13.3	9.1	0.5	11.9	11.9	5.5	1.7	10.9	10.1	7.1	13.1	13.8	7.2	7.8	18.2	8.6	17.5	17.9	14.0	47.8	29.2	27.0	11.5	18.4	13.8	28.6	38.8	32.6	34.0	15.6	12.6	44.3	21.5	25.9	21.2	10.6	7.8	34.8	55.6	20.2	16.4	31.9	25.1	19.5	25.8	16.0	35.7	35.0	23.7	22.7	24.2	50.4	22.8	5.0	25.8	66.4	12.1	16.7	9.6	23.3	19.1	30.9	22.7	17.4	10.7	19.5	10.8	38.2	16.5	19.3	32.7	12.4	28.7	26.9	30.5	44.2	28.7	22.9	26.2	32.5	11.2	36.9	10.3	44.2	16.7	28.8	17.3	12.5	17.7	39.1	24.9	19.8	12.0	39.8	28.4	24.1	42.7	18.1	10.8	26.1	18.2	5.2	2.5	3.0	5.0	6.7	2.9	3.5	2.3	0.6	2.3	0.5	1.7	7.8	106.7	89.8	95.5	20.9	246.1	244.2	252.4	66.6	255.0	86.6	129.4	130.9	26.2	134.4	105.3	29.5	39.6	176.0	162.5	94.5	45.0	95.2	19.9	144.9	184.9	121.3	110.2	98.4	41.6	146.3	170.2	147.1	125.4	245.6	104.4	257.2	63.1	54.2	69.3	69.0	38.2	148.0	24.4	103.7	153.6	16.5	128.6	112.0	80.0	24.4	102.1	34.8	89.6	35.2	44.0	110.4	87.5	67.7	162.2	269.2	71.1	101.5	67.7	78.2	72.3	187.4	123.1	49.0	71.5	251.4	203.0	160.9	182.3	119.7	174.1	356.8
TAF3	"TAF140, TAFII140"	ENSG00000165632	"TATA-box binding protein associated factor 3"	Q5VWG9	10	7818505-8016631	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA066184			Supported	"Nucleoplasm,Nuclear membrane"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 21: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 63: NK-cells & T-cells - Immune response"	Nucleoplasm	"Nuclear membrane"	"HPA066184: AB_2685631"	"unprognostic (3.82e-2)"	"unprognostic (2.87e-3)"	"unprognostic (6.60e-2)"	"unprognostic (4.23e-1)"	"unprognostic (6.88e-2)"	"unprognostic (2.38e-1)"	"prognostic unfavorable (2.14e-7)"	"unprognostic (2.97e-1)"	"unprognostic (1.45e-1)"	"unprognostic (2.71e-2)"	"unprognostic (9.71e-2)"	"unprognostic (6.30e-3)"	"prognostic unfavorable (5.01e-4)"	"unprognostic (8.59e-2)"	"unprognostic (3.44e-1)"	"unprognostic (9.44e-2)"	"unprognostic (1.74e-1)"	5.4	4.9	7.1	4.8	7.9	6.9	4.5	9.9	9.0	4.7	4.8	5.1	2.8	5.2	2.2	3.0	4.3	3.3	5.9	6.1	7.6	4.0	3.7	3.9	6.1	7.9	9.0	7.0	4.3	5.2	3.1	4.5	7.9	3.5	3.5	5.3	3.6	4.4	10.7	5.2	3.8	4.2	7.2	5.5	3.7	7.5	8.2	7.0	4.3	7.6	4.6	5.0	4.2	7.2	7.9	7.2	8.0	4.3	9.0	6.2	11.1	9.2	3.5	6.8	7.7	15.6	5.8	13.4	6.9	5.4	2.8	8.4	8.9	7.9	8.5	10.9	9.8	11.5	5.0	10.0	7.7	7.8	10.1	4.2	7.8	9.5	4.6	4.3	6.5	14.5	13.0	13.5	7.8	14.9	17.7	5.5	6.1	11.5	4.2	14.2	7.6	9.0	3.9	4.9	4.3	6.1	10.0	7.2	9.4	7.8	13.1	8.1	8.1	6.1	10.7	16.3	9.1	8.0	10.3	14.4	5.9	8.8	5.6	5.8	3.9	5.7	6.0	3.4	7.1	5.2	5.4	5.9	3.2	5.6	6.7	5.8	1.5	6.2	6.6	3.1	4.9	3.9	7.1	7.9	9.9	9.0	6.1	7.6	7.9	9.0	7.9	7.2	8.2	7.2	26.2	28.9	29.5	41.1	45.2	32.0	20.7	13.3	23.3	28.6	15.3	16.5	40.1	14.3	10.5	27.6	35.5	26.6	32.0	18.0	0.0	17.0	39.6	16.7	22.9	29.9	18.7	25.2	45.1	14.7	36.8	23.2	19.9	16.7	22.1	18.0	19.6	14.5	19.8	26.9	54.4	14.6	8.2	21.3	24.2	22.0	27.4	25.3	24.9	71.2	25.7	27.0	53.5	43.2	63.9	15.0	5.9	28.6	37.7	14.1	20.5	4.5	16.3	47.8	26.3	39.3	31.0	58.9	46.2	16.4	43.0	20.0	48.6	16.4	16.5	17.6
TAF4B	"TAF2C2, TAFII105"	ENSG00000141384	"TATA-box binding protein associated factor 4b"	Q92750	18	26226445-26391685	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Differentiation, Oogenesis, Spermatogenesis, Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 80.3;Plasma cells: 52.3;Suprabasal keratinocytes: 78.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Daudi: 65.0;U-266/70: 26.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028937	Uncertain		Supported	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			"Cluster 30: Non-specific - Translation"	"Cluster 2: Immune cells - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm	"Nucleoli fibrillar center"	"HPA028937: AB_10603034"	"unprognostic (2.46e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.19e-3)"	"unprognostic (1.74e-1)"	"unprognostic (2.13e-1)"	"unprognostic (5.01e-2)"	"unprognostic (2.67e-1)"	"unprognostic (3.29e-2)"	"unprognostic (2.21e-1)"	"unprognostic (4.66e-3)"	"unprognostic (3.14e-2)"	"prognostic unfavorable (3.08e-4)"	"unprognostic (7.38e-2)"	"unprognostic (9.56e-2)"	"unprognostic (1.58e-1)"	"prognostic unfavorable (1.72e-4)"	1.5	2.0	0.4	2.8	0.4	2.8	2.7	0.3	1.9	1.2	0.0	1.6	0.4	1.4	0.3	1.0	1.3	0.7	0.4	0.3	0.2	1.5	0.1	1.0	3.1	0.9	0.1	3.1	1.2	0.6	0.2	1.7	1.1	0.8	1.4	0.3	1.1	0.8	1.3	1.5	0.8	1.2	0.0	2.5	1.8	4.6	0.2	1.8	1.7	0.7	3.2	1.5	0.6	0.8	4.3	0.7	0.3	1.1	1.6	2.6	2.1	1.3	1.5	0.7	1.3	1.1	2.3	65.0	5.0	0.3	2.5	4.8	3.7	4.0	3.4	15.5	9.9	7.5	1.9	1.0	2.3	20.5	4.4	4.3	1.5	0.5	11.6	0.6	1.4	8.1	10.2	7.9	0.3	4.2	10.7	4.1	3.5	2.5	5.1	0.0	8.1	17.3	1.0	0.3	6.1	2.8	3.9	5.7	2.7	1.6	2.0	3.6	0.9	2.7	1.6	3.7	4.8	26.2	18.0	21.8	1.3	12.8	2.4	0.0	0.3	0.0	0.1	0.5	1.0	2.3	0.7	1.0	1.0	2.0	2.0	1.6	0.0	0.6	0.2	0.3	0.1	0.6	0.4	0.4	0.3	1.9	0.3	0.2	0.9	0.1	1.1	0.0	0.2	0.8	7.2	6.4	7.2	6.2	34.0	80.3	9.5	1.7	49.5	1.5	15.0	17.9	2.8	0.0	2.5	0.0	0.0	18.6	4.1	5.8	17.6	1.2	0.7	28.9	9.7	9.0	0.0	21.7	44.8	2.0	4.3	15.5	36.7	45.0	1.3	5.4	1.1	0.0	2.4	5.0	28.3	7.0	2.0	1.6	17.9	1.6	3.4	5.9	23.2	4.7	2.6	0.2	1.0	7.5	11.7	2.2	2.5	4.1	52.3	13.9	0.8	4.0	1.0	1.2	0.0	17.6	12.1	25.4	24.8	40.8	78.8	9.7	14.5	14.5	6.2	6.7
TAF5	"TAF2D, TAFII100"	ENSG00000148835	"TATA-box binding protein associated factor 5"	Q15542	10	103367976-103389065	"Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Spermatocytes: 48.7;Spermatogonia: 52.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006195, HPA006474"	Supported		Supported	Nucleoplasm		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 32: U-937 - Innate immune response"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	Nucleoplasm		"HPA006195: AB_1080188, HPA006474: AB_1080185"	"unprognostic (3.09e-2)"	"unprognostic (2.44e-3)"	"unprognostic (2.95e-1)"	"unprognostic (3.18e-3)"	"unprognostic (3.59e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.10e-1)"	"unprognostic (5.36e-3)"	"unprognostic (2.21e-1)"	"unprognostic (1.18e-2)"	"unprognostic (1.23e-1)"	"prognostic unfavorable (1.36e-9)"	"prognostic favorable (7.39e-5)"	"unprognostic (2.79e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.44e-1)"	2.2	1.8	2.7	2.8	2.9	4.9	2.3	5.0	3.3	2.5	2.3	3.1	2.9	2.3	1.7	2.4	2.3	1.5	2.0	2.6	2.6	1.7	2.6	1.9	4.4	2.8	2.7	3.0	2.9	1.7	2.1	3.5	2.9	2.0	3.1	3.5	2.0	2.2	3.0	2.5	2.4	2.1	2.7	3.1	2.1	11.2	2.6	7.0	2.0	3.6	4.3	2.2	2.5	3.1	9.7	4.4	10.6	19.2	5.9	4.8	12.4	6.8	7.7	9.6	12.0	8.7	5.0	23.0	3.8	3.6	5.6	9.6	18.1	3.7	12.2	8.5	15.6	10.6	5.0	8.7	2.7	20.6	11.0	2.2	2.7	5.7	6.1	3.9	7.3	10.1	15.4	11.2	6.5	6.4	16.8	26.9	12.9	12.2	5.7	14.2	12.9	7.0	2.7	2.8	7.4	8.2	4.4	3.2	4.1	10.1	3.7	8.5	4.3	5.6	7.1	6.3	12.2	6.3	8.1	14.0	3.1	24.2	3.6	0.2	0.6	0.8	0.4	0.2	0.3	0.1	0.4	0.8	0.3	1.3	1.0	0.5	0.0	0.3	0.3	0.4	1.1	0.2	2.7	2.9	5.0	3.3	2.6	2.6	2.8	2.7	2.9	2.7	2.6	3.1	5.8	6.4	2.6	3.6	6.9	14.4	4.5	1.7	6.2	6.9	3.0	2.7	2.9	1.5	2.5	1.8	6.2	5.6	8.3	2.7	3.9	2.8	19.7	1.8	3.8	5.2	2.4	11.2	4.9	2.2	9.3	5.6	2.0	2.1	8.9	4.1	2.9	2.8	3.8	1.7	5.3	2.9	4.1	2.8	6.3	14.1	1.8	3.6	1.8	3.7	4.9	1.3	4.1	3.5	5.8	1.9	3.3	2.6	14.9	4.3	3.3	1.0	0.7	7.5	0.0	7.2	6.5	48.7	52.3	5.9	14.2	6.8	8.6	3.0	4.0	3.8
TAF5L	PAF65B	ENSG00000135801	"TATA-box binding protein associated factor 5 like"	O75529	1	229593121-229626047	"Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA067941			Supported	"Nuclear speckles,Cytoplasmic bodies"		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 38: Extravillous trophoblasts - Unknown function"	"Nuclear speckles"	"Cytoplasmic bodies"	"HPA067941: AB_2685929"	"unprognostic (3.41e-1)"	"unprognostic (1.34e-1)"	"unprognostic (3.39e-2)"	"unprognostic (1.93e-1)"	"unprognostic (7.46e-2)"	"unprognostic (1.94e-1)"	"unprognostic (2.91e-1)"	"unprognostic (2.36e-1)"	"unprognostic (1.63e-1)"	"unprognostic (6.84e-2)"	"unprognostic (5.17e-3)"	"unprognostic (8.16e-3)"	"unprognostic (1.91e-3)"	"unprognostic (3.21e-1)"	"unprognostic (2.99e-1)"	"unprognostic (4.99e-2)"	"unprognostic (3.11e-1)"	16.3	6.3	7.7	10.5	8.5	22.7	10.5	8.6	8.1	9.2	4.6	12.3	10.6	9.1	5.9	10.6	9.5	11.7	8.4	7.3	7.9	6.6	15.3	11.2	14.0	8.3	8.1	9.3	8.4	9.2	3.8	14.0	8.3	9.2	12.5	10.1	8.2	8.7	14.1	7.2	9.9	11.4	7.5	11.4	9.5	5.5	8.5	14.2	10.5	12.6	10.8	14.0	5.1	9.6	30.2	17.1	23.6	19.8	16.1	16.6	62.4	20.1	23.5	24.3	22.4	23.3	23.9	33.7	20.8	21.4	15.7	24.9	26.4	24.2	22.9	25.5	38.3	26.4	17.7	14.8	17.9	35.3	29.3	18.6	22.9	24.0	20.3	9.4	23.7	34.8	36.1	29.7	22.8	14.6	39.9	18.5	34.1	33.3	13.2	35.0	26.8	34.9	16.6	27.2	23.9	29.4	17.2	22.9	27.9	8.7	27.4	35.6	21.2	20.1	24.7	27.2	42.6	16.1	13.3	37.9	15.4	21.1	32.3	0.0	0.2	0.0	0.4	0.2	0.5	0.2	0.4	0.3	0.3	0.2	0.4	0.4	0.0	0.5	0.3	0.1	0.4	0.2	7.7	8.5	8.6	8.1	7.3	7.9	8.3	8.1	8.3	7.5	8.5	9.6	15.9	3.2	9.4	19.2	8.2	5.7	4.8	2.9	6.2	5.5	8.4	5.3	7.3	5.7	7.1	3.7	12.5	11.0	14.6	12.3	1.9	4.2	3.4	11.0	8.9	8.0	12.0	7.6	11.7	8.3	32.8	7.0	6.1	12.7	0.0	6.1	6.8	13.6	9.6	6.7	15.7	10.2	6.1	6.3	8.4	4.7	4.7	10.9	5.4	13.1	11.8	3.8	4.1	22.1	24.0	6.9	8.3	4.1	10.2	6.6	6.9	3.0	5.1	9.0	13.1	15.4	11.5	6.0	4.6	9.6	5.3	10.4	8.8	5.6	9.9	7.2
TAF6	"MGC:8964, TAF2E, TAFII70, TAFII80, TAFII85"	ENSG00000106290	"TATA-box binding protein associated factor 6"	P49848	7	100107070-100119841	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Apoptosis, Transcription, Transcription regulation"		"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 72.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006566			Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 59: Non-specific - Translation"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 47: Cytotrophoblasts - Unknown function"	Nucleoplasm	Cytosol	"HPA006566: AB_1080194"	"unprognostic (5.60e-2)"	"unprognostic (3.11e-2)"	"unprognostic (1.73e-2)"	"unprognostic (2.10e-1)"	"unprognostic (7.79e-2)"	"unprognostic (4.20e-2)"	"prognostic unfavorable (6.06e-5)"	"unprognostic (2.02e-1)"	"unprognostic (1.89e-1)"	"unprognostic (1.29e-1)"	"unprognostic (3.70e-3)"	"unprognostic (1.68e-1)"	"unprognostic (4.55e-2)"	"unprognostic (1.95e-1)"	"unprognostic (3.38e-1)"	"unprognostic (4.78e-1)"	"unprognostic (1.37e-1)"	24.2	37.0	28.9	23.4	29.2	23.4	24.4	24.1	42.7	39.5	23.8	38.9	17.2	42.9	21.9	27.3	34.9	20.5	32.2	31.3	25.2	30.9	20.6	24.8	22.6	25.2	23.2	41.2	23.0	30.5	41.1	24.9	24.4	30.7	19.5	19.2	25.5	31.1	45.0	26.5	28.0	33.9	19.0	28.3	28.0	38.5	25.4	29.3	32.9	35.8	25.7	37.3	29.9	25.6	55.1	101.8	64.4	105.7	84.1	44.5	89.3	60.0	66.4	77.2	70.6	76.1	65.6	50.4	65.5	92.7	130.4	45.7	90.6	73.2	81.3	82.0	57.0	49.4	99.3	50.8	86.6	46.2	43.5	46.4	44.5	111.0	121.7	61.0	63.0	87.7	84.6	89.0	69.2	194.4	101.1	76.9	94.7	50.1	82.4	73.2	78.7	75.0	54.5	44.8	57.9	84.4	73.7	115.3	49.3	93.2	42.1	47.2	60.4	113.2	114.6	146.2	77.6	55.0	104.0	85.1	74.9	65.7	99.2	17.2	13.5	17.5	18.0	14.4	21.5	11.9	17.3	18.3	17.6	17.9	17.0	16.3	7.1	18.8	35.3	10.3	18.3	17.5	28.9	29.2	24.1	42.7	31.3	25.2	25.2	23.2	24.4	19.0	25.4	25.6	13.0	9.6	11.8	10.1	15.4	11.3	21.0	25.1	12.5	12.7	13.2	15.9	0.9	18.6	15.7	25.8	0.0	72.1	13.0	12.9	17.6	25.7	28.3	20.7	18.5	14.8	15.6	12.8	12.6	16.6	34.5	16.3	18.3	14.6	0.0	25.6	13.6	6.1	20.9	13.5	10.7	11.9	26.4	8.8	6.9	50.7	21.8	12.3	12.4	3.7	18.7	18.7	18.6	6.0	7.3	14.9	18.7	31.2	12.8	13.0	14.2	25.8	21.8	14.0	26.3	14.6	23.8	25.5	52.3	15.4	11.8	34.5	18.3	16.2	17.4	14.4
TAF6L	PAF65A	ENSG00000162227	"TATA-box binding protein associated factor 6 like"	Q9Y6J9	11	62771357-62787342	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA067239	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm		"HPA067239: AB_2685809"	"unprognostic (5.41e-2)"	"unprognostic (1.37e-1)"	"unprognostic (3.23e-1)"	"unprognostic (1.46e-2)"	"unprognostic (1.35e-1)"	"prognostic favorable (8.98e-5)"	"unprognostic (1.03e-1)"	"unprognostic (2.47e-1)"	"unprognostic (9.37e-2)"	"unprognostic (2.83e-3)"	"unprognostic (5.45e-3)"	"unprognostic (9.65e-2)"	"unprognostic (4.38e-2)"	"unprognostic (1.63e-3)"	"unprognostic (1.04e-1)"	"unprognostic (3.66e-1)"	"unprognostic (2.61e-3)"	8.6	12.0	6.0	4.3	6.3	5.7	9.1	6.0	8.8	11.2	4.1	8.9	6.7	13.0	6.2	9.9	10.3	3.9	8.1	5.1	5.2	11.8	21.2	7.5	5.3	7.2	6.0	11.0	13.0	5.2	14.9	3.4	6.9	11.1	3.3	4.0	8.5	5.1	17.4	11.8	9.8	4.8	4.8	11.8	9.4	6.7	5.7	5.3	12.7	5.0	3.9	9.6	8.6	5.9	12.6	12.3	15.8	12.6	7.0	5.8	13.1	10.5	7.1	11.6	9.0	6.9	14.3	16.9	21.0	7.5	10.7	16.7	11.2	10.5	3.6	23.3	24.4	8.9	14.4	11.8	10.0	11.4	15.6	7.7	7.6	9.3	6.1	6.0	10.0	17.2	18.9	12.2	7.4	24.5	16.7	31.8	17.1	6.4	15.8	20.4	11.2	21.4	7.9	8.9	16.8	16.7	9.9	10.5	16.2	6.6	18.5	7.9	9.3	11.7	14.6	19.2	11.9	13.3	23.1	19.7	10.4	8.6	10.9	0.7	0.7	0.9	0.6	0.8	0.7	0.8	0.4	0.4	0.9	0.7	0.9	0.6	0.2	1.1	0.3	0.9	0.3	0.2	6.0	6.3	6.0	8.8	5.1	5.2	7.2	6.0	6.9	4.8	5.7	5.9	6.1	3.2	3.0	8.8	9.3	6.1	4.7	1.5	11.4	8.7	6.8	6.0	2.8	12.8	1.8	1.8	0.0	15.0	5.0	9.8	15.6	4.8	6.0	5.3	5.0	5.6	5.3	11.6	3.5	3.1	8.9	5.0	10.2	7.2	0.0	6.9	5.7	12.1	9.8	3.3	5.2	6.9	0.0	10.9	5.5	5.0	5.3	8.0	8.8	2.8	8.9	9.9	13.4	6.0	5.1	3.4	8.5	4.9	11.8	4.6	8.5	18.1	3.2	5.5	0.0	6.8	7.0	3.2	9.6	10.7	6.3	19.4	5.7	9.9	9.4	4.3
TANK	"I-TRAF, TRAF2"	ENSG00000136560	"TRAF family member associated NFKB activator"	Q92844	2	161136908-161236230	"Predicted intracellular proteins"	"DNA damage, Host-virus interaction"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB010345, HPA037675, HPA037676"	Approved		Supported	Nucleoli,Cytosol		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 41: Macrophages - Immune response"	Cytosol	Nucleoli	"CAB010345: AB_2199871, HPA037675: AB_2675600, HPA037676: AB_2675601"	"unprognostic (1.14e-2)"	"unprognostic (9.68e-2)"	"unprognostic (1.53e-1)"	"unprognostic (5.27e-2)"	"unprognostic (3.98e-2)"	"unprognostic (1.06e-1)"	"prognostic unfavorable (2.90e-4)"	"unprognostic (1.71e-1)"	"unprognostic (2.98e-2)"	"unprognostic (4.16e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.58e-1)"	"prognostic unfavorable (2.78e-6)"	"unprognostic (2.13e-2)"	"unprognostic (2.00e-1)"	"unprognostic (5.69e-3)"	"unprognostic (2.30e-2)"	42.9	36.2	20.9	46.2	23.6	84.2	57.7	22.1	24.7	30.5	25.3	32.4	28.0	30.7	27.0	29.8	35.0	43.0	27.1	20.1	24.1	29.1	66.5	39.7	52.8	24.0	25.5	30.8	22.9	27.8	19.7	36.9	23.5	24.6	35.8	32.1	26.6	24.7	52.3	26.7	29.1	32.5	21.4	43.2	30.2	22.3	21.9	42.1	36.4	43.3	51.4	49.0	25.0	25.1	39.2	24.5	31.7	36.3	91.3	124.9	45.2	58.0	86.4	39.3	57.7	30.8	50.5	53.1	38.7	67.6	28.2	27.5	19.2	43.4	59.5	126.6	20.5	29.8	22.5	79.1	72.4	51.1	32.2	98.3	66.6	59.6	46.6	73.5	101.7	32.0	30.5	68.7	77.7	29.3	31.4	50.7	18.2	40.9	21.5	17.9	45.5	35.2	86.3	62.1	26.4	30.7	37.4	40.6	60.4	43.2	17.5	64.9	108.2	50.4	29.3	25.7	34.0	46.6	46.1	80.9	66.9	40.3	40.8	122.2	71.4	97.1	36.0	78.5	55.9	63.8	58.8	53.1	66.5	66.7	39.9	39.6	189.4	42.4	94.0	43.4	100.7	55.0	20.9	23.6	22.1	24.7	20.1	24.1	24.0	25.5	23.5	21.4	21.9	25.1	34.7	57.7	79.6	82.3	108.9	59.9	106.3	82.7	21.6	32.7	73.0	71.5	27.3	42.9	69.2	46.0	12.5	43.1	54.8	50.4	60.7	58.8	18.0	47.2	42.3	46.7	47.4	63.8	49.9	40.5	82.9	67.8	28.5	52.4	59.5	17.0	28.2	58.1	45.6	21.9	60.9	29.3	71.2	71.5	194.0	10.0	52.8	106.8	72.9	120.9	177.7	33.5	40.2	63.3	87.4	56.0	43.9	26.4	57.1	81.8	34.4	46.5	66.2	37.4	26.3	52.1	40.3	54.3	33.9	29.3	60.9	134.9	109.3	33.0	32.2	158.4
TAOK2	"KIAA0881, MAP3K17, PSK, PSK1, TAO1, TAO2"	ENSG00000149930	"TAO kinase 2"	Q9UL54	16	29973868-29992261	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Adipocytes: 52.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA010650	Approved		Approved	Nucleoplasm,Nucleoli,Cytosol		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 72: Non-specific - Transcription"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Nucleoplasm, Cytosol"	Nucleoli	"HPA010650: AB_1080204"	"unprognostic (7.30e-2)"	"unprognostic (1.78e-1)"	"prognostic unfavorable (2.51e-4)"	"prognostic favorable (3.87e-5)"	"unprognostic (8.46e-2)"	"unprognostic (2.14e-3)"	"unprognostic (6.08e-2)"	"unprognostic (1.12e-3)"	"unprognostic (1.01e-2)"	"unprognostic (1.60e-1)"	"prognostic favorable (4.78e-4)"	"unprognostic (3.85e-3)"	"prognostic favorable (3.66e-4)"	"unprognostic (7.42e-3)"	"unprognostic (3.17e-1)"	"unprognostic (7.47e-2)"	"unprognostic (1.37e-1)"	31.4	36.0	23.4	14.7	21.2	12.7	30.8	18.0	26.1	24.8	11.9	21.8	17.3	25.9	11.1	20.8	22.6	12.0	32.6	23.0	18.9	22.7	17.6	34.0	14.4	21.0	20.0	24.1	19.5	17.4	29.4	19.4	18.9	22.5	8.5	14.3	20.5	13.3	23.4	22.4	24.4	13.3	15.3	33.8	21.8	34.8	20.8	13.2	25.4	12.7	10.5	22.4	21.6	19.0	22.2	41.8	22.4	35.1	25.8	17.1	34.2	40.0	21.1	26.4	24.4	33.6	28.7	23.8	32.8	28.8	18.0	33.9	20.4	20.0	14.1	37.5	43.3	25.8	46.2	34.8	18.7	25.5	47.5	20.0	17.1	28.1	11.2	18.5	44.7	22.4	23.5	23.6	25.8	41.0	29.8	36.0	21.5	16.4	27.6	54.2	32.5	22.2	16.6	20.5	26.1	20.8	22.8	30.2	12.1	14.4	37.5	28.5	62.9	45.0	20.7	32.4	23.6	34.2	23.7	22.1	27.6	28.8	33.7	0.3	0.7	0.4	0.7	0.7	0.8	0.5	0.7	0.6	0.4	0.6	0.4	0.3	1.2	0.5	0.4	0.8	0.9	0.6	23.4	21.2	18.0	26.1	23.0	18.9	21.0	20.0	18.9	15.3	20.8	19.0	52.0	9.6	11.5	21.9	6.3	10.7	4.6	7.5	7.4	14.6	10.5	5.7	9.8	7.2	9.1	9.2	39.6	7.8	7.6	27.0	1.9	8.5	3.9	8.7	9.5	35.3	13.1	3.4	7.9	12.0	6.2	9.7	14.3	8.9	3.8	16.0	47.2	11.8	9.8	10.1	10.7	16.8	12.2	11.2	11.1	4.4	12.5	8.2	7.2	7.5	9.0	8.4	11.3	9.0	12.7	16.1	14.8	12.8	5.9	7.4	27.2	8.0	10.0	21.4	6.6	8.7	8.7	19.7	21.6	9.1	9.7	12.0	9.2	16.0	14.7	7.4
TAP1	"ABCB2, D6S114E, PSF1, RING4"	ENSG00000168394	"Transporter 1, ATP binding cassette subfamily B member"	Q03518	6	32845209-32853816	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Adaptive immunity, Host-virus interaction, Immunity, Peptide transport, Protein transport, Transport"	Translocase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BEWO: 126.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009516, HPA072354"	Approved		Approved	"Endoplasmic reticulum,Centriolar satellite"		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 64: Macrophages - Immune response"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 63: NK-cells & T-cells - Immune response"	"Endoplasmic reticulum, Centriolar satellite"		"CAB009516: AB_2303048, HPA072354: AB_2686513"	"unprognostic (3.59e-2)"	"unprognostic (1.06e-1)"	"prognostic favorable (9.01e-4)"	"unprognostic (1.33e-1)"	"unprognostic (1.84e-1)"	"unprognostic (3.22e-2)"	"unprognostic (4.92e-2)"	"unprognostic (6.16e-3)"	"unprognostic (2.56e-2)"	"prognostic favorable (4.07e-4)"	"unprognostic (3.02e-3)"	"unprognostic (2.37e-1)"	"prognostic unfavorable (6.58e-5)"	"unprognostic (2.07e-2)"	"unprognostic (4.69e-2)"	"unprognostic (2.42e-2)"	"unprognostic (2.21e-2)"	28.4	24.9	16.1	50.1	16.2	13.7	20.7	15.8	20.3	21.6	16.2	30.3	36.0	20.5	2.5	31.6	17.8	12.7	25.4	14.7	16.2	21.8	19.3	52.7	50.0	24.0	16.1	12.1	14.5	7.0	11.6	12.1	21.2	21.9	12.5	1.7	25.9	7.0	16.3	51.2	42.6	11.5	18.6	73.0	33.4	11.5	19.4	25.5	17.0	7.4	21.3	23.9	24.4	17.4	22.9	13.7	0.1	16.1	8.8	11.4	126.2	8.1	34.3	59.3	86.5	2.0	27.3	41.8	25.0	12.6	48.9	45.8	4.5	20.6	5.3	81.0	6.1	26.5	4.1	10.8	42.3	0.1	17.5	15.0	17.9	17.1	10.4	8.6	15.4	8.4	1.9	55.0	10.6	10.5	17.7	27.4	0.8	3.1	11.1	47.6	5.2	32.8	25.0	10.5	0.2	1.2	6.7	38.0	33.4	1.7	30.9	37.4	9.7	21.5	8.1	53.1	11.4	59.9	82.6	12.6	16.6	16.6	16.4	176.8	99.5	270.1	155.8	101.6	133.8	137.3	125.2	153.7	95.0	107.5	120.9	124.6	295.6	132.9	94.6	94.8	213.8	221.2	16.1	16.2	15.8	20.3	14.7	16.2	24.0	16.1	21.2	18.6	19.4	17.4	72.1	25.6	24.0	9.1	62.1	74.7	47.1	54.5	27.3	4.8	21.5	15.9	7.3	24.3	33.1	5.5	0.0	5.6	108.0	78.8	5.9	81.6	0.5	31.3	39.3	63.6	16.8	12.6	1.1	75.3	95.0	26.9	42.8	77.9	26.6	13.8	27.1	11.1	45.9	15.2	1.9	55.9	57.0	31.9	90.6	0.3	13.1	43.9	23.2	16.9	115.9	25.1	149.3	12.1	3.6	91.3	38.8	10.5	84.8	70.2	84.6	6.9	29.4	2.8	6.6	18.1	27.8	1.0	1.3	20.4	76.4	4.8	92.3	18.2	54.5	52.1
TAP2	"ABCB3, D6S217E, PSF2, RING11"	ENSG00000204267	"Transporter 2, ATP binding cassette subfamily B member"	Q03519	6	32821833-32838770	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Adaptive immunity, Host-virus interaction, Immunity, Peptide transport, Protein transport, Transport"	Translocase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"monocytes: 69.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 61.4;U-251 MG: 52.0"									HPA001312	Approved		Supported	"Nuclear speckles,Endoplasmic reticulum"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 64: Macrophages - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Endoplasmic reticulum"	"Nuclear speckles"	"HPA001312: AB_1080206"	"unprognostic (2.95e-3)"	"unprognostic (2.35e-1)"	"unprognostic (3.77e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.39e-1)"	"unprognostic (3.46e-1)"	"unprognostic (8.04e-2)"	"unprognostic (1.28e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.51e-2)"	"prognostic unfavorable (1.51e-4)"	"unprognostic (1.90e-1)"	"prognostic unfavorable (5.22e-8)"	"unprognostic (5.32e-1)"	"unprognostic (4.17e-2)"	"unprognostic (2.35e-1)"	"unprognostic (4.71e-2)"	17.1	11.7	1.0	4.3	1.0	8.8	14.7	0.8	1.2	16.3	0.5	14.6	10.2	13.7	1.1	26.0	11.9	1.1	14.4	1.2	2.0	12.4	11.5	25.7	7.9	1.6	1.1	9.2	9.0	3.7	8.2	3.1	1.5	9.9	5.5	2.5	11.2	2.1	8.6	14.5	25.2	4.1	0.8	29.8	11.4	2.5	1.8	9.7	12.3	5.8	8.1	10.6	17.2	1.7	4.4	2.0	0.5	5.0	6.1	6.5	0.0	2.3	3.3	13.1	17.7	3.9	41.0	36.5	7.5	9.1	37.1	38.8	15.8	61.4	6.9	43.8	1.9	20.3	11.6	1.3	8.5	0.0	29.5	0.6	2.6	10.3	24.8	0.0	12.1	0.0	20.0	12.2	0.4	1.6	5.8	2.4	0.5	0.0	11.7	25.8	0.0	12.8	10.9	1.1	0.0	0.0	16.0	37.3	4.1	1.0	7.4	1.9	5.7	25.7	6.9	3.9	52.0	17.9	31.4	33.3	19.5	25.7	10.9	1.8	1.3	1.6	3.0	3.2	1.7	0.4	0.8	1.7	0.8	0.3	0.6	0.7	3.8	1.9	2.8	1.3	1.2	0.8	1.0	1.0	0.8	1.2	1.2	2.0	1.6	1.1	1.5	0.8	1.8	1.7	48.2	0.0	7.5	7.5	20.7	0.0	15.6	0.0	3.4	5.0	9.2	8.0	3.5	4.3	3.7	14.7	2.1	1.9	37.9	21.0	1.9	34.1	0.1	18.0	19.4	32.0	3.6	4.0	6.6	33.4	45.8	8.0	10.7	41.9	5.1	8.7	16.4	8.3	23.9	18.5	14.6	14.9	0.0	18.9	0.0	0.0	5.6	20.3	0.0	14.0	69.3	17.7	47.4	10.6	6.5	35.1	12.6	6.0	18.0	29.7	55.9	4.8	1.5	5.8	0.0	8.6	10.3	0.7	2.5	11.1	0.0	1.6	24.0	20.3	14.3	16.7
TAPT1	FLJ90013	ENSG00000169762	"Transmembrane anterior posterior transformation 1"	Q6NXT6	4	16160505-16227410	"Disease related genes, Human disease related genes, Predicted membrane proteins"	"Chondrogenesis, Cilium biogenesis/degradation, Differentiation, Host-virus interaction, Osteogenesis"	"Developmental protein, Receptor"	"Ciliopathy, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cone photoreceptor cells: 114.7;Late spermatids: 163.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"REH: 45.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042567	Approved		Supported	Nucleoplasm,Centrosome,Cytosol		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 25: Spermatids - Spermatogenesis"	Centrosome	"Nucleoplasm, Cytosol"	"HPA042567: AB_2678055"	"unprognostic (2.34e-1)"	"unprognostic (5.84e-2)"	"unprognostic (1.41e-2)"	"prognostic favorable (9.75e-4)"	"unprognostic (2.43e-1)"	"unprognostic (2.56e-2)"	"unprognostic (2.32e-3)"	"unprognostic (3.15e-3)"	"unprognostic (1.54e-1)"	"unprognostic (6.30e-2)"	"prognostic favorable (5.34e-4)"	"unprognostic (7.07e-2)"	"prognostic favorable (8.52e-4)"	"unprognostic (9.00e-2)"	"unprognostic (8.52e-2)"	"unprognostic (7.25e-3)"	"prognostic favorable (4.18e-4)"	7.4	15.1	17.5	6.0	18.6	25.7	10.0	17.3	22.3	8.2	15.1	8.9	6.4	10.0	9.2	6.1	9.5	6.7	9.1	17.1	17.0	12.4	30.5	11.9	9.6	18.6	17.4	8.1	8.1	13.0	8.5	6.8	18.4	7.4	8.2	24.7	7.6	6.4	35.5	7.7	7.5	9.3	17.4	8.5	7.9	11.1	17.5	12.2	11.5	19.9	8.1	7.6	6.9	19.5	4.9	3.6	6.0	7.0	8.9	6.8	2.5	7.8	6.0	7.4	8.1	4.9	8.5	31.7	8.3	5.0	10.8	4.0	5.2	4.0	9.3	2.9	6.3	6.2	5.0	5.2	8.4	12.6	6.2	4.2	7.7	7.3	5.3	9.1	3.8	19.3	9.7	14.5	7.2	3.5	18.7	10.1	4.0	9.3	8.4	45.0	8.4	5.8	12.0	5.1	10.0	8.0	7.4	6.2	9.5	4.1	11.5	12.3	7.1	6.2	4.1	4.2	10.3	13.9	12.2	24.2	12.4	30.9	7.3	1.1	0.3	0.0	0.2	0.2	0.0	1.0	0.7	0.4	0.5	2.5	0.9	0.7	0.6	0.3	0.3	0.8	0.5	0.3	17.5	18.6	17.3	22.3	17.1	17.0	18.6	17.4	18.4	17.4	17.5	19.5	12.0	32.1	62.6	47.3	20.2	9.1	6.3	4.2	4.0	24.5	15.0	9.9	14.3	10.0	8.7	7.3	114.7	4.2	16.2	11.1	3.9	6.7	79.0	14.2	12.6	12.8	14.4	16.6	42.6	8.2	3.1	10.2	8.6	12.0	2.5	17.5	8.6	46.0	4.2	70.7	43.6	9.8	4.1	10.3	18.9	163.1	9.9	11.1	16.0	45.0	6.5	33.1	8.2	60.8	68.2	9.5	9.4	15.1	8.9	7.1	10.7	8.7	14.4	62.4	6.6	17.0	11.5	33.3	5.7	7.1	8.0	7.0	10.8	16.5	9.0	6.6
TARBP2	Trbp	ENSG00000139546	"TARBP2 subunit of RISC loading complex"	Q15633	12	53500921-53506431	"Predicted intracellular proteins"	"RNA-mediated gene silencing, Translation regulation"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 48.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051181, HPA061454, CAB069406"	Approved		Supported	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 38: Extravillous trophoblasts - Unknown function"	Nucleoplasm	"Nuclear bodies"	"CAB069406: AB_1622301, HPA051181: AB_2681376, HPA061454: AB_2684526"	"unprognostic (1.71e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.53e-1)"	"unprognostic (6.61e-3)"	"prognostic unfavorable (3.09e-4)"	"unprognostic (2.04e-1)"	"unprognostic (4.72e-3)"	"unprognostic (1.44e-1)"	"unprognostic (1.31e-2)"	"unprognostic (5.58e-2)"	"prognostic unfavorable (4.75e-6)"	"unprognostic (8.06e-2)"	"unprognostic (1.32e-1)"	"unprognostic (8.02e-2)"	"unprognostic (4.31e-1)"	9.2	13.1	9.8	9.2	10.0	6.8	8.9	13.4	11.3	8.9	9.5	9.5	9.0	8.5	7.9	13.1	11.7	6.7	9.7	9.6	10.1	18.6	20.6	10.1	10.5	10.0	10.0	8.0	18.7	8.5	8.5	13.8	9.9	11.3	5.5	6.7	11.0	5.1	9.8	9.8	9.5	6.1	9.9	15.2	12.4	13.1	10.8	10.3	12.0	7.1	9.0	10.4	8.9	10.5	25.5	69.1	26.8	29.6	15.3	20.8	35.0	22.6	19.2	34.1	20.3	61.2	33.5	24.5	44.6	24.9	22.2	20.0	32.8	34.1	19.9	30.5	54.1	28.6	26.6	43.9	33.3	48.0	31.9	24.3	21.0	35.2	16.5	23.2	41.2	36.6	37.1	38.3	24.9	102.9	32.5	62.9	53.0	19.7	37.1	23.9	14.4	31.6	22.6	26.4	34.8	24.8	11.8	28.7	58.9	19.1	40.4	63.7	22.1	31.2	29.8	11.9	27.4	19.7	39.6	26.1	34.8	24.2	35.6	2.1	11.5	5.7	13.9	11.9	13.3	10.9	13.3	12.8	14.9	15.3	13.7	13.6	0.7	13.1	7.7	13.3	11.7	12.5	9.8	10.0	13.4	11.3	9.6	10.1	10.0	10.0	9.9	9.9	10.8	10.5	5.2	0.0	8.2	4.6	10.7	6.4	10.5	15.3	17.1	9.3	12.0	10.0	6.0	15.7	11.2	9.2	10.4	46.5	7.2	9.8	21.5	20.7	10.7	7.9	8.8	11.6	5.4	9.4	2.3	26.2	48.9	9.3	13.7	7.2	10.8	10.5	12.1	18.4	25.6	1.7	3.1	10.8	18.3	9.3	4.7	23.8	5.6	7.9	14.2	1.0	12.2	10.2	10.3	4.5	6.2	16.8	9.9	4.1	15.6	11.2	11.3	28.6	7.1	14.2	0.0	4.0	10.0	11.6	13.0	14.4	4.7	32.2	9.0	9.9	14.8	10.1
TASL	"CXorf21, FLJ11577"	ENSG00000120280	"TLR adaptor interacting with endolysosomal SLC15A4"	Q9HAI6	X	30558809-30577766	"Disease related genes, Predicted intracellular proteins"	"Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 19.5;lymphoid tissue: 10.9"	"Cell type enriched"	"Detected in some"	5	"Hofbauer cells: 22.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in some"	7	"THP-1: 166.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA001185	Uncertain		Supported	Nucleoplasm,Vesicles		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 41: Macrophages - Immune response"	Nucleoplasm	Vesicles	"HPA001185: AB_1078591"	"unprognostic (1.37e-1)"	"unprognostic (2.52e-2)"	"unprognostic (4.37e-2)"	"unprognostic (2.27e-2)"	"unprognostic (3.47e-2)"	"unprognostic (5.25e-3)"	"unprognostic (9.07e-3)"	"unprognostic (5.94e-3)"	"unprognostic (1.15e-1)"	"unprognostic (1.40e-1)"	"unprognostic (3.43e-1)"	"unprognostic (3.60e-1)"	"unprognostic (1.66e-3)"	"unprognostic (8.99e-2)"	"unprognostic (1.98e-2)"	"unprognostic (3.45e-2)"	"unprognostic (3.23e-2)"	1.8	1.8	0.6	10.9	0.6	19.5	2.1	0.7	1.0	1.1	1.1	3.5	4.7	0.6	0.4	1.6	0.8	3.9	0.6	0.7	0.6	1.1	2.4	4.7	10.5	1.3	1.1	0.3	0.3	0.7	0.3	2.9	1.3	1.0	3.4	0.2	1.0	0.6	0.1	0.7	3.0	2.2	0.9	9.8	3.6	0.3	1.5	5.8	0.6	0.4	10.2	4.1	0.3	2.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.3	0.2	0.0	0.0	13.8	7.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.2	0.0	0.0	0.0	21.5	0.0	0.0	0.0	20.5	0.0	21.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	166.0	0.0	0.0	0.0	0.0	0.1	15.0	1.6	7.5	0.0	23.9	0.0	8.6	21.9	24.1	1.6	19.8	0.3	23.0	2.0	1.1	25.3	23.6	1.8	1.3	30.6	7.1	44.4	45.9	3.4	8.0	0.6	0.6	0.7	1.0	0.7	0.6	1.3	1.1	1.3	0.9	1.5	2.0	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	22.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0
TASOR2	"bA318E3.2, C10orf18, FAM208B, FLJ20360, KIAA2006"	ENSG00000108021	"Transcription activation suppressor family member 2"	Q5VWN6	10	5684838-5763740	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Adipocytes: 19.0;Cardiomyocytes: 28.0;Cytotrophoblasts: 11.7;dendritic cells: 18.4;Extravillous trophoblasts: 10.5;Fibroblasts: 8.1;Hofbauer cells: 10.3;Plasma cells: 14.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038042, HPA038043, HPA061547"	Uncertain		Enhanced	Nucleoplasm,Cytosol		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm	Cytosol	"HPA038042: AB_10673038, HPA038043: AB_10672402, HPA061547: AB_2684558"	"unprognostic (3.69e-2)"	"unprognostic (3.13e-2)"	"unprognostic (9.25e-2)"	"unprognostic (8.83e-2)"	"unprognostic (8.12e-3)"	"unprognostic (4.84e-2)"	"prognostic unfavorable (2.91e-4)"	"unprognostic (2.39e-1)"	"unprognostic (9.21e-2)"	"unprognostic (8.36e-2)"	"unprognostic (8.85e-2)"	"unprognostic (4.88e-3)"	"unprognostic (2.90e-3)"	"unprognostic (2.98e-1)"	"unprognostic (3.50e-1)"	"unprognostic (7.79e-3)"	"unprognostic (5.23e-2)"	9.5	8.6	3.1	12.0	4.4	14.3	12.5	19.5	8.0	13.2	9.8	10.9	6.6	13.0	15.3	9.7	10.7	10.2	9.3	2.3	9.0	8.9	10.8	8.1	17.2	2.5	5.1	12.7	10.9	14.5	10.7	12.6	3.5	9.9	11.9	14.1	9.5	10.9	12.1	8.9	9.2	13.3	1.2	10.0	10.3	24.6	4.6	14.9	16.4	14.4	17.0	17.5	8.0	10.5	38.2	31.7	19.9	34.0	25.1	29.7	28.0	31.7	20.1	26.7	33.6	33.7	22.0	77.2	19.8	31.4	16.9	29.3	57.5	32.5	43.0	15.2	38.7	36.1	24.7	22.8	25.0	26.9	20.7	22.9	35.6	43.5	36.8	17.9	31.4	29.4	59.1	17.6	30.2	25.7	35.0	9.5	24.3	24.6	20.3	25.8	27.7	27.1	16.0	34.1	24.4	27.5	31.5	28.3	22.2	22.3	37.2	20.9	31.6	33.6	36.2	65.5	43.7	21.3	21.9	67.8	16.6	26.1	18.1	1.0	1.2	0.2	1.2	1.2	1.1	1.0	0.9	1.1	0.7	1.8	0.9	1.5	0.9	4.3	0.4	1.1	1.3	0.5	3.1	4.4	19.5	8.0	2.3	9.0	2.5	5.1	3.5	1.2	4.6	10.5	19.0	0.0	0.0	0.0	6.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	28.0	0.0	0.0	0.0	0.0	11.7	18.4	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.0	10.5	8.1	0.0	0.0	0.0	0.0	0.0	0.0	10.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.7	0.0	0.0	0.0	0.0	7.3	2.7	0.0	0.0	0.0
TATDN1	CDA11	ENSG00000147687	"TatD DNase domain containing 1"	Q6P1N9	8	124488485-124539458	"Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023634, HPA053045"	Uncertain		Supported	Nucleoplasm		NA	NA		660000	"Cluster 41: Basophils - Cellular respiration"	"Cluster 52: Non-specific - Ribosome"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 32: Non-specific - Translation"	Nucleoplasm		"HPA023634: AB_1857779, HPA053045: AB_2682024"	"unprognostic (2.19e-3)"	"unprognostic (3.78e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.87e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.23e-2)"	"unprognostic (1.54e-3)"	"unprognostic (2.28e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.45e-2)"	"prognostic unfavorable (2.53e-4)"	"unprognostic (2.50e-1)"	"unprognostic (6.33e-3)"	"unprognostic (3.44e-2)"	"unprognostic (4.30e-2)"	"unprognostic (2.24e-1)"	"unprognostic (5.12e-2)"	23.4	18.7	16.0	15.8	16.8	16.9	39.1	16.8	21.9	20.1	13.0	21.2	18.1	23.5	21.0	16.4	23.5	14.6	23.1	16.1	17.1	28.1	25.2	14.8	19.8	17.0	16.9	39.5	44.8	24.4	8.9	13.6	18.5	17.2	22.4	13.7	27.7	15.0	52.2	20.4	18.1	19.7	17.1	12.2	22.7	12.3	16.4	27.1	36.9	43.9	20.0	21.0	17.3	19.4	65.5	45.1	42.5	30.2	36.8	69.9	31.9	35.5	38.1	43.3	40.0	44.7	69.1	49.7	77.4	38.6	33.6	53.7	52.0	51.9	71.6	64.0	34.3	45.6	36.5	39.1	70.2	35.5	17.0	52.5	80.5	63.5	132.4	48.3	35.3	48.4	38.1	31.4	59.1	198.4	52.8	21.6	42.7	132.8	58.8	35.4	31.7	55.7	61.3	45.5	35.7	49.2	39.2	80.3	87.2	39.3	52.7	38.1	28.4	30.8	82.7	57.3	96.7	40.0	65.3	62.1	57.9	61.4	27.1	29.3	11.0	4.3	12.8	9.1	19.1	17.2	19.5	16.2	15.6	16.6	27.7	24.8	2.1	17.7	6.6	14.0	22.5	14.8	16.0	16.8	16.8	21.9	16.1	17.1	17.0	16.9	18.5	17.1	16.4	19.4	39.8	16.0	27.1	25.5	37.0	64.7	100.9	129.4	75.7	19.3	79.5	131.4	23.9	21.5	55.6	27.6	14.6	66.6	26.7	17.8	107.6	55.2	7.0	40.1	43.0	31.9	16.2	23.8	36.6	62.0	62.5	42.7	29.6	44.4	20.8	76.5	26.7	40.2	54.6	16.8	35.2	41.6	65.1	36.7	43.6	6.7	49.7	36.3	48.0	30.0	51.6	24.8	37.0	20.1	48.6	40.8	34.3	34.6	34.1	94.2	57.8	128.9	33.8	19.2	19.7	64.7	57.5	34.6	45.1	54.0	58.2	59.7	38.9	68.6	60.7	82.6
TAX1BP3	TIP-1	ENSG00000213977	"Tax1 binding protein 3"	O14907	17	3662895-3668679	"Predicted intracellular proteins"	"Wnt signaling pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 395.9;Ductal cells: 351.0;Exocrine glandular cells: 385.9;Pancreatic endocrine cells: 505.8;Paneth cells: 362.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"dendritic cells: 164.3;granulocytes: 217.8;monocytes: 78.9"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046410, HPA063078"	Approved		Approved	"Nucleoli fibrillar center,Vesicles,Actin filaments"		NA	NA		120000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Nucleoli fibrillar center"	"Vesicles, Actin filaments"	"HPA046410: AB_2679656, HPA063078: AB_2684937"	"unprognostic (6.15e-2)"	"unprognostic (6.46e-3)"	"unprognostic (3.37e-1)"	"unprognostic (1.32e-1)"	"prognostic unfavorable (2.17e-4)"	"unprognostic (1.68e-1)"	"unprognostic (1.12e-3)"	"prognostic unfavorable (1.76e-4)"	"unprognostic (1.80e-2)"	"unprognostic (5.45e-3)"	"unprognostic (5.19e-2)"	"unprognostic (2.87e-1)"	"prognostic unfavorable (7.90e-4)"	"unprognostic (5.12e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.10e-3)"	"unprognostic (1.92e-1)"	107.3	131.8	62.7	49.2	78.5	16.5	94.4	67.9	67.3	192.9	48.2	108.5	108.8	128.1	33.6	258.5	84.4	90.9	194.8	57.3	58.8	115.0	39.7	94.9	39.3	72.5	73.3	95.9	80.4	23.5	30.9	53.2	69.9	91.7	77.4	3.7	109.7	105.6	28.7	120.4	119.6	70.3	66.2	52.3	136.5	51.2	65.2	44.6	63.6	33.4	49.0	102.8	160.1	80.6	183.1	319.1	68.4	38.5	219.2	175.6	81.3	223.6	184.5	234.0	136.7	135.9	144.5	19.1	159.1	290.8	77.2	282.6	39.1	205.3	90.8	50.7	64.4	25.9	75.8	106.6	191.1	4.3	37.7	267.6	322.5	145.1	68.9	165.3	266.0	50.1	9.6	14.4	280.1	169.4	52.2	15.1	65.9	116.7	112.6	50.0	41.8	16.3	248.6	141.2	14.7	43.2	276.2	116.2	39.4	67.5	125.3	23.2	269.6	195.3	75.2	154.9	230.2	5.7	2.6	5.5	117.4	30.0	190.3	217.8	65.4	120.4	26.9	78.9	22.2	29.2	25.0	26.6	58.7	25.3	17.3	22.7	73.8	20.0	73.6	164.3	36.7	53.3	62.7	78.5	67.9	67.3	57.3	58.8	72.5	73.3	69.9	66.2	65.2	80.6	51.5	60.9	25.8	0.0	19.0	95.3	79.7	229.3	99.6	1.6	51.0	28.2	41.5	92.9	107.6	99.3	0.0	124.7	68.5	395.9	88.0	351.0	16.2	12.8	27.3	77.0	24.6	21.4	0.0	385.9	145.3	72.6	43.8	16.1	26.6	21.2	75.3	11.1	69.8	5.0	0.0	120.0	71.2	35.2	73.2	10.5	174.6	64.0	113.8	0.0	85.5	19.8	26.8	0.0	0.0	505.8	362.8	209.9	5.8	89.0	279.2	185.3	26.8	2.6	39.5	44.1	78.6	8.6	12.8	94.5	76.0	155.6	16.1	92.0	103.0	107.9
TBC1D14	KIAA1322	ENSG00000132405	"TBC1 domain family member 14"	Q9P2M4	4	6909242-7033118	"Plasma proteins, Predicted intracellular proteins"	Autophagy	"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 68.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HMC-1: 197.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036930, HPA067398"	Approved		Supported	"Nucleoplasm,Golgi apparatus,Vesicles"		Yes	No			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 29: Early spermatids - Spermatogenesis"	"Golgi apparatus, Vesicles"	Nucleoplasm	"HPA036930: AB_10670155, HPA067398: AB_2685833"	"unprognostic (3.05e-2)"	"unprognostic (7.48e-3)"	"unprognostic (4.80e-3)"	"unprognostic (8.13e-2)"	"unprognostic (2.83e-1)"	"unprognostic (1.78e-3)"	"unprognostic (9.63e-2)"	"unprognostic (5.25e-2)"	"unprognostic (9.71e-2)"	"unprognostic (7.65e-2)"	"unprognostic (1.80e-1)"	"unprognostic (2.90e-1)"	"prognostic favorable (5.28e-10)"	"unprognostic (1.56e-1)"	"unprognostic (3.50e-1)"	"unprognostic (5.13e-3)"	"unprognostic (4.12e-2)"	26.3	42.1	42.7	31.5	41.9	15.9	27.6	38.7	43.9	19.4	50.2	26.4	22.8	20.9	22.9	34.0	23.5	17.0	30.4	42.9	44.9	44.5	27.4	24.4	29.8	49.3	45.6	28.7	19.5	41.9	27.1	23.8	44.8	24.5	26.3	18.5	31.7	20.2	51.6	49.5	26.0	22.9	45.7	34.9	58.5	30.0	48.7	40.1	19.2	41.3	26.9	19.8	22.2	44.2	34.5	36.8	40.4	45.5	32.8	27.4	24.5	27.0	29.3	24.7	21.1	38.3	69.8	54.9	15.6	32.5	62.8	24.5	68.4	61.7	30.0	15.5	22.2	91.8	23.8	40.4	22.7	42.0	197.9	21.3	85.8	23.4	38.3	31.5	23.5	51.2	88.6	19.3	30.2	22.3	64.9	42.5	54.9	41.1	40.8	80.2	53.2	59.9	36.8	23.9	61.6	44.0	22.4	24.1	84.3	31.2	33.3	39.4	23.7	27.2	20.5	24.0	40.3	36.7	91.6	55.7	25.4	53.2	26.6	2.6	13.2	5.6	8.6	8.2	13.1	8.1	9.3	9.3	10.7	8.3	6.9	6.6	40.6	8.6	3.9	11.5	11.9	10.8	42.7	41.9	38.7	43.9	42.9	44.9	49.3	45.6	44.8	45.7	48.7	44.2	8.4	6.4	17.7	22.5	15.5	9.1	7.0	15.8	15.9	10.2	21.1	16.3	4.6	10.0	14.8	14.7	14.6	12.5	16.3	17.7	19.6	11.5	68.0	12.3	10.3	7.8	6.6	7.2	25.6	10.2	7.1	9.5	14.8	11.9	7.6	18.9	8.2	24.4	26.0	25.2	25.1	15.7	10.2	33.6	8.7	41.0	7.2	27.8	19.6	27.2	24.4	13.4	16.5	51.8	27.0	11.8	14.2	8.6	15.4	12.9	12.8	19.8	10.7	6.6	0.0	12.7	7.1	17.7	18.0	19.8	11.9	16.4	16.3	12.5	19.9	10.1
TBC1D15	"DKFZp761D0223, FLJ12085"	ENSG00000121749	"TBC1 domain family member 15"	Q8TC07	12	71839707-71927248	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 160.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA013388, HPA015592"	Supported		Supported	Mitochondria,Cytosol		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Mitochondria, Cytosol"		"HPA013388: AB_2199233, HPA015592: AB_1857789"	"unprognostic (3.87e-2)"	"prognostic favorable (7.06e-4)"	"unprognostic (1.98e-1)"	"unprognostic (1.60e-1)"	"unprognostic (4.63e-2)"	"unprognostic (6.13e-3)"	"unprognostic (2.96e-2)"	"unprognostic (3.10e-1)"	"unprognostic (2.61e-1)"	"unprognostic (1.02e-2)"	"unprognostic (4.07e-2)"	"unprognostic (2.18e-1)"	"prognostic favorable (5.34e-4)"	"unprognostic (5.73e-2)"	"unprognostic (4.34e-2)"	"unprognostic (2.31e-1)"	"unprognostic (2.78e-1)"	28.4	25.9	9.9	15.7	13.2	42.2	25.4	11.8	17.0	21.0	8.4	15.5	15.5	21.3	13.0	16.3	15.1	21.6	15.3	9.4	11.1	22.6	30.6	21.4	22.5	13.2	12.4	22.3	23.8	23.0	14.3	23.4	13.2	17.8	14.9	14.1	22.6	13.0	43.4	18.1	17.8	18.3	11.3	21.8	17.2	18.5	10.5	24.9	27.9	25.5	19.8	17.8	14.9	18.5	21.0	20.3	17.1	18.4	35.2	38.8	25.6	20.8	58.5	30.6	39.7	13.9	18.4	26.9	14.0	21.6	21.9	13.7	22.3	15.7	32.6	23.1	18.0	23.5	17.0	12.3	29.9	33.1	17.1	35.0	20.5	23.1	39.3	39.7	26.9	25.7	27.9	16.0	25.4	15.3	24.9	25.3	37.4	19.2	17.4	17.9	19.1	29.3	23.3	18.6	18.9	17.3	29.5	25.9	26.2	23.7	26.5	23.1	25.3	23.9	10.6	26.5	14.4	38.1	36.1	35.5	14.3	22.6	21.8	2.6	5.7	7.8	6.1	5.5	6.8	4.3	7.5	5.8	5.1	4.2	9.5	8.6	11.7	5.7	8.1	2.8	10.8	5.4	9.9	13.2	11.8	17.0	9.4	11.1	13.2	12.4	13.2	11.3	10.5	18.5	83.4	48.1	69.3	42.4	34.7	58.6	33.6	23.8	25.6	33.7	30.2	25.5	24.8	24.3	38.5	18.4	10.4	20.4	43.1	18.3	13.7	29.3	160.8	38.1	40.4	53.3	13.8	27.8	60.3	25.5	15.5	44.5	17.3	82.0	34.1	30.8	79.2	35.6	24.0	52.2	57.7	22.0	20.3	54.2	41.8	26.7	34.8	46.0	32.0	35.6	27.5	29.9	16.5	45.2	85.7	25.1	11.0	32.7	33.9	39.9	21.5	39.8	49.8	25.6	19.7	58.2	35.7	76.9	24.5	18.1	68.5	38.3	39.2	38.8	15.0	37.1
TBC1D2	"Armus, PARIS1, TBC1D2A"	ENSG00000095383	"TBC1 domain family member 2"	Q9BYX2	9	98199011-98255649	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 57.7;Oligodendrocytes: 64.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"classical monocyte: 27.5"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"A-431: 77.0;HaCaT: 98.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA030871, HPA076521"	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	Yes			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 4: Macrophages - Innate immune response"	"Nucleoplasm, Plasma membrane, Cytosol"		"HPA030871: AB_10670046, HPA076521: "	"unprognostic (2.32e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.06e-2)"	"unprognostic (6.36e-3)"	"unprognostic (2.02e-2)"	"prognostic unfavorable (2.77e-4)"	"unprognostic (1.86e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.74e-1)"	"unprognostic (9.21e-3)"	"unprognostic (6.40e-3)"	"unprognostic (2.30e-1)"	"unprognostic (6.07e-2)"	"unprognostic (4.32e-1)"	"prognostic unfavorable (5.62e-4)"	"unprognostic (1.30e-2)"	"unprognostic (4.30e-1)"	8.8	5.3	11.1	5.7	16.0	13.1	7.8	12.3	26.0	10.8	8.5	8.6	12.6	4.4	1.5	37.4	5.5	4.0	3.7	10.6	12.9	6.4	19.8	32.0	3.8	14.9	14.9	2.9	3.0	3.5	4.4	7.2	16.4	12.0	4.4	3.4	14.7	6.1	4.3	24.3	10.1	2.8	11.4	9.4	7.0	3.4	23.3	3.0	8.1	1.4	4.9	11.7	17.3	23.9	77.0	10.8	0.5	2.5	8.2	15.9	24.3	33.2	18.4	23.8	19.6	6.9	32.8	1.3	24.7	19.6	5.2	98.1	0.7	36.8	8.3	2.6	1.4	0.7	38.0	5.4	37.6	1.7	2.9	21.7	59.8	23.6	58.7	41.5	8.6	2.1	2.4	1.0	19.0	9.9	0.4	4.6	1.6	7.4	6.2	1.2	4.8	0.2	36.0	46.7	0.9	1.4	11.3	24.4	3.4	1.7	8.1	2.6	51.7	28.8	8.6	4.8	13.6	1.6	1.5	0.6	29.0	2.9	3.2	2.1	27.5	8.4	2.5	15.3	1.8	1.2	3.8	2.2	10.0	0.8	1.6	1.9	11.9	1.2	12.3	1.3	5.5	10.8	11.1	16.0	12.3	26.0	10.6	12.9	14.9	14.9	16.4	11.4	23.3	23.9	2.9	57.7	12.5	5.2	2.4	8.3	18.5	30.4	21.6	3.3	2.7	5.6	0.7	4.3	23.3	3.7	0.0	21.5	0.9	16.2	3.9	3.3	1.8	4.6	3.7	5.0	7.7	0.4	4.6	3.2	10.9	2.4	6.1	10.3	0.0	0.6	1.1	6.1	32.0	1.7	5.4	12.6	18.3	16.2	1.8	1.2	1.8	18.3	3.6	4.7	7.5	4.4	3.1	12.1	64.9	14.4	10.7	0.7	1.7	9.2	16.4	3.2	10.8	2.4	0.0	1.8	3.4	2.1	3.0	29.8	10.9	17.4	2.4	0.7	5.7	17.1
TBC1D24	"DFNA65, DFNB86, KIAA1171, TLDC6"	ENSG00000162065	"TBC1 domain family member 24"	Q9ULP9	16	2475051-2509560	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"		"GTPase activation"	"Deafness, Disease variant, Epilepsy, Mental retardation, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"salivary gland: 16.5"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 43.8;Inhibitory neurons: 34.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in all"		"SCLC-21H: 34.7"									"HPA044712, HPA068080"	Uncertain		Supported	"Plasma membrane,Cell Junctions"		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 22: Non-specific - Unknown function"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 30: Mammary glandular cells - Lactation"	"Plasma membrane, Cell Junctions"		"HPA044712: AB_10795619, HPA068080: AB_2685948"	"prognostic unfavorable (3.22e-4)"	"unprognostic (5.23e-2)"	"unprognostic (4.02e-2)"	"unprognostic (6.41e-2)"	"unprognostic (3.52e-1)"	"unprognostic (1.52e-2)"	"unprognostic (1.40e-1)"	"unprognostic (2.03e-2)"	"unprognostic (1.68e-1)"	"unprognostic (7.37e-2)"	"unprognostic (4.37e-2)"	"unprognostic (1.28e-1)"	"unprognostic (4.66e-3)"	"unprognostic (2.02e-2)"	"unprognostic (8.19e-2)"	"unprognostic (7.78e-3)"	"unprognostic (1.61e-1)"	3.8	3.3	7.5	1.8	8.1	2.5	2.8	3.6	10.5	2.1	0.0	2.0	2.2	1.4	2.8	1.0	2.3	1.9	3.0	8.3	3.7	4.3	3.7	3.9	1.8	2.9	2.9	1.0	10.6	1.9	2.6	2.1	3.1	2.5	0.9	4.2	16.5	3.5	3.4	1.2	1.6	1.7	1.9	2.0	2.2	1.2	4.4	0.9	3.1	1.7	1.2	1.8	0.9	2.8	3.4	6.7	4.5	9.2	5.1	5.1	3.8	6.2	3.3	4.0	3.5	6.2	2.9	8.6	5.2	4.9	1.9	6.3	7.1	2.0	2.9	9.3	8.0	8.0	9.5	5.5	3.1	5.9	3.2	1.9	2.8	3.5	1.4	2.8	5.1	3.3	9.9	4.8	3.8	6.4	4.1	11.9	4.0	3.2	4.3	20.9	8.5	6.1	2.9	2.3	34.7	8.5	3.8	15.3	2.6	1.6	4.8	5.2	5.4	7.8	8.4	7.9	6.2	3.2	3.0	11.0	3.4	8.5	7.2	0.0	0.1	0.0	0.3	0.1	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.2	7.5	8.1	3.6	10.5	8.3	3.7	2.9	2.9	3.1	1.9	4.4	2.8	4.7	28.9	26.7	15.7	1.9	0.5	3.0	1.4	1.8	19.0	17.8	10.8	6.9	10.0	6.9	5.5	43.8	1.5	5.6	2.4	33.2	5.0	0.2	2.8	10.0	5.4	11.4	6.5	29.6	6.1	1.0	5.8	5.6	4.0	3.8	6.0	10.4	17.3	3.5	26.9	34.0	2.6	6.1	5.1	3.3	1.0	9.0	3.0	1.8	6.5	3.6	13.8	6.2	25.1	9.7	5.0	2.8	6.0	1.7	3.1	1.8	3.9	3.6	25.5	0.0	11.2	3.7	8.8	5.9	1.4	1.4	0.3	2.9	3.4	4.7	1.6
TBC1D30	KIAA0984	ENSG00000111490	"TBC1 domain family member 30"	Q9Y2I9	12	64759484-64881033	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 10.1;pancreas: 12.0"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 30.9;Inhibitory neurons: 42.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"MCF7: 25.9;OE19: 11.9;RPMI-8226: 12.6;RT4: 12.8;SCLC-21H: 26.5;SK-BR-3: 16.7;T-47d: 14.5"									"HPA039772, HPA040043"	Approved		Supported	"Plasma membrane,Cytosol"		NA	NA				"Cluster 22: Non-specific - Unknown function"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Plasma membrane"	Cytosol	"HPA039772: AB_10795409, HPA040043: AB_10795411"	"unprognostic (1.85e-1)"	"unprognostic (6.95e-2)"	"unprognostic (2.66e-1)"	"prognostic favorable (3.61e-5)"	"unprognostic (9.35e-2)"	"unprognostic (2.09e-1)"	"unprognostic (2.65e-5)"	"prognostic favorable (5.08e-4)"	"unprognostic (1.75e-3)"	"unprognostic (2.16e-2)"	"unprognostic (2.44e-1)"	"unprognostic (9.72e-2)"	"unprognostic (7.32e-2)"	"unprognostic (7.62e-3)"	"unprognostic (8.72e-2)"	"unprognostic (2.67e-3)"	"unprognostic (7.80e-3)"	1.5	1.1	2.0	1.0	2.7	0.3	2.3	4.9	10.1	3.0	1.4	1.4	1.8	1.4	1.8	0.6	1.5	1.8	0.6	5.3	1.7	2.2	1.2	2.3	0.4	6.8	1.8	0.9	12.0	2.4	6.4	0.6	6.9	3.0	1.5	2.2	6.8	2.7	0.3	0.8	1.6	0.9	2.0	1.9	3.9	1.9	2.0	0.3	1.5	0.3	0.3	3.3	1.3	3.8	5.1	1.0	0.5	0.3	0.1	0.6	0.7	0.0	0.0	0.1	0.0	4.3	1.8	0.1	0.9	0.1	0.3	0.1	5.3	0.2	0.0	0.0	3.8	0.3	1.4	0.1	0.0	4.0	0.8	0.3	0.1	0.0	0.0	0.6	3.8	1.2	0.0	2.0	0.3	25.9	0.0	0.6	1.1	11.9	5.2	0.2	0.1	12.6	0.9	12.8	26.5	1.8	1.4	16.7	0.3	0.3	14.5	1.4	4.2	0.0	0.9	0.9	2.5	0.0	0.0	0.1	0.1	0.4	0.4	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	2.0	2.7	4.9	10.1	5.3	1.7	6.8	1.8	6.9	2.0	2.0	3.8	5.1	0.0	6.3	4.9	0.6	0.9	4.6	0.9	0.0	9.3	7.2	3.8	0.6	5.7	4.5	3.7	8.4	0.7	1.5	2.5	9.8	3.9	14.2	2.2	0.8	6.5	0.0	0.0	30.9	4.9	0.3	0.7	3.6	4.2	8.9	0.8	1.8	0.3	1.6	0.0	42.8	6.4	6.1	4.0	6.2	1.9	0.3	3.0	5.4	12.2	1.2	2.6	0.0	1.5	2.0	2.7	4.9	0.0	0.6	9.1	3.9	2.3	1.8	0.6	0.0	0.6	1.0	3.7	3.0	0.3	1.4	0.1	0.8	0.4	4.4	8.7
TBC1D4	"AS160, DKFZp779C0666, KIAA0603"	ENSG00000136111	"TBC1 domain family member 4"	O60343	13	75283503-75482169	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"		"GTPase activation"	"Diabetes mellitus"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 82.8"	"Cell type enhanced"	"Detected in many"		"Inhibitory neurons: 157.7;Microglial cells: 307.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"T-reg: 25.0"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CACO-2: 84.7;HUVEC TERT2: 61.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040145, HPA059885"	Approved		Supported	Cytosol		NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Cytosol		"HPA040145: AB_2676860, HPA059885: AB_2684152"	"unprognostic (5.44e-3)"	"unprognostic (5.23e-1)"	"unprognostic (9.85e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.78e-2)"	"unprognostic (9.54e-3)"	"unprognostic (1.25e-2)"	"unprognostic (8.87e-2)"	"unprognostic (2.87e-1)"	"unprognostic (5.02e-2)"	"unprognostic (7.53e-2)"	"unprognostic (2.64e-1)"	"prognostic favorable (1.07e-11)"	"unprognostic (6.40e-2)"	"unprognostic (3.16e-1)"	"unprognostic (8.88e-2)"	"unprognostic (3.45e-1)"	14.8	70.6	13.2	15.7	12.5	3.4	20.1	12.5	15.1	10.0	7.1	8.7	4.6	8.5	18.4	9.4	10.7	14.1	33.8	10.5	13.8	25.2	11.7	11.9	34.2	15.9	12.0	44.8	15.0	22.1	5.3	20.7	16.7	12.3	10.4	1.6	27.6	4.3	82.8	21.4	10.3	10.2	12.0	21.0	11.0	5.3	20.0	10.7	24.3	54.9	32.6	8.4	9.2	10.5	12.9	14.9	9.2	0.6	21.3	22.8	12.0	11.0	5.8	8.7	9.6	84.7	15.5	2.7	2.4	15.7	4.2	12.0	23.4	11.0	9.0	42.6	24.3	41.5	19.8	25.9	5.4	20.0	0.5	25.0	19.7	9.7	22.4	14.9	61.6	46.0	12.0	1.3	10.0	6.2	29.4	3.6	12.9	24.7	8.8	26.4	8.7	15.2	8.5	9.3	16.9	5.2	4.8	14.6	8.0	4.8	5.0	0.7	26.2	9.8	12.1	5.2	13.0	0.7	0.1	0.3	17.4	18.5	14.7	5.0	0.4	0.0	0.7	0.1	0.0	0.6	11.2	2.5	0.6	0.5	10.4	4.9	0.5	0.5	0.1	9.9	25.0	2.3	13.2	12.5	12.5	15.1	10.5	13.8	15.9	12.0	16.7	12.0	20.0	10.5	17.8	6.4	29.1	32.3	2.6	36.2	10.0	2.0	19.9	1.6	33.1	41.1	81.4	10.0	6.1	14.7	0.0	10.8	32.4	8.0	15.6	12.3	25.5	14.3	17.7	32.6	21.0	5.0	78.0	7.4	9.7	17.3	7.1	8.7	5.1	81.5	26.0	19.4	26.6	1.7	157.7	10.7	24.4	24.8	25.8	5.2	3.7	12.9	21.4	307.3	33.6	0.4	1.0	40.7	5.1	4.9	2.9	7.2	2.1	16.4	3.4	10.8	3.9	0.6	6.6	24.8	21.6	2.4	7.7	24.2	44.2	4.9	25.2	8.1	15.5	10.6
TBC1D5	KIAA0210	ENSG00000131374	"TBC1 domain family member 5"	Q92609	3	17157162-18444817	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Autophagy, Protein transport, Transport"	"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"Astrocytes: 226.6;Excitatory neurons: 333.2;Inhibitory neurons: 350.5;Microglial cells: 324.2;Oligodendrocyte precursor cells: 341.8;Oligodendrocytes: 565.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035125, HPA035126"	Uncertain		Supported	"Golgi apparatus,Vesicles"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 34: Non-specific - Transcription"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Vesicles	"Golgi apparatus"	"HPA035125: AB_2674479, HPA035126: AB_10670696"	"unprognostic (1.87e-1)"	"unprognostic (3.57e-1)"	"unprognostic (2.86e-2)"	"unprognostic (3.19e-1)"	"unprognostic (1.60e-1)"	"unprognostic (4.30e-3)"	"unprognostic (3.07e-2)"	"unprognostic (3.31e-1)"	"unprognostic (3.56e-2)"	"unprognostic (6.27e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.42e-1)"	"prognostic favorable (1.75e-7)"	"unprognostic (1.25e-1)"	"unprognostic (1.56e-1)"	"unprognostic (5.72e-2)"	"unprognostic (7.07e-2)"	17.9	17.4	13.7	17.0	21.1	25.2	18.6	18.2	15.5	20.1	6.0	13.5	10.8	17.6	12.1	16.8	22.5	19.2	15.8	13.8	16.1	19.9	14.7	18.0	23.1	21.9	17.7	28.1	18.3	25.7	8.5	17.5	22.8	14.0	13.9	10.9	14.1	16.4	9.3	14.0	13.8	18.3	18.3	24.0	13.8	18.9	16.0	20.3	30.0	11.3	23.2	14.8	10.1	29.9	26.3	28.8	23.2	22.0	45.0	65.5	25.4	27.6	39.7	17.7	15.3	14.0	23.2	48.5	29.1	56.3	27.1	8.0	20.6	33.6	36.6	43.0	7.9	46.6	11.1	16.5	28.8	45.7	39.0	42.6	39.3	38.5	23.2	39.8	40.9	28.3	29.6	43.6	43.5	17.6	22.5	10.5	19.1	16.8	30.0	48.9	29.6	34.7	26.3	20.0	8.8	41.0	52.5	12.2	18.6	21.7	34.6	37.6	44.7	48.7	21.6	25.6	30.4	25.2	36.6	46.7	37.5	42.3	46.5	11.7	8.1	11.9	5.8	6.5	7.5	10.3	4.4	4.2	9.2	11.3	3.2	3.8	10.4	4.3	6.3	5.8	5.2	4.8	13.7	21.1	18.2	15.5	13.8	16.1	21.9	17.7	22.8	18.3	16.0	29.9	40.4	16.0	35.0	226.6	56.0	18.4	20.0	15.8	42.7	20.3	23.0	19.9	18.6	25.8	27.8	14.7	10.4	17.1	28.9	9.2	5.9	17.7	64.1	19.6	28.9	30.7	13.1	31.3	333.2	9.9	16.7	32.5	20.4	28.2	18.9	31.5	34.6	19.9	21.4	35.3	350.5	13.4	10.2	35.6	22.9	40.2	30.7	34.9	14.2	324.2	23.2	26.6	32.0	341.8	565.6	12.3	9.1	30.5	20.7	9.8	13.7	15.9	16.3	22.3	6.6	34.0	20.4	20.7	25.5	28.4	17.0	8.2	30.0	35.5	14.5	17.6
TBCA		ENSG00000171530	"Tubulin folding cofactor A"	O75347	5	77691166-77868780	"Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Hepatocytes: 1298.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036487	Approved		Supported	Nucleoli,Microtubules		NA	NA		1800000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 2: Hepatocytes - Metabolism"	Microtubules	Nucleoli	"HPA036487: AB_10669794"	"unprognostic (2.03e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.24e-1)"	"unprognostic (2.10e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.78e-2)"	"unprognostic (4.95e-2)"	"unprognostic (9.59e-2)"	"unprognostic (1.73e-1)"	"unprognostic (5.68e-2)"	"unprognostic (4.67e-2)"	"unprognostic (1.98e-1)"	"unprognostic (2.78e-3)"	"unprognostic (7.63e-2)"	"unprognostic (2.66e-1)"	"unprognostic (1.55e-1)"	"unprognostic (7.44e-2)"	152.9	255.7	134.2	112.1	136.7	156.5	146.4	137.9	177.2	149.1	137.7	152.0	105.3	131.3	246.2	170.6	142.3	89.0	153.9	134.8	152.7	189.9	286.7	114.4	146.2	144.7	151.8	194.1	131.7	162.1	150.7	122.9	150.4	127.7	106.2	108.8	124.4	100.0	147.1	98.1	104.6	104.7	138.3	108.7	153.0	79.3	145.4	155.0	130.2	108.1	140.7	133.1	136.9	140.9	427.1	286.2	526.4	515.1	227.5	322.7	285.1	352.9	303.2	377.9	432.6	389.5	456.0	654.1	627.0	200.5	562.2	258.0	328.1	453.9	372.7	306.6	524.8	310.9	286.4	426.5	331.7	271.8	248.1	326.4	350.4	270.0	401.0	372.1	329.6	532.2	331.9	396.4	346.7	367.4	575.7	650.3	320.5	122.1	265.0	383.6	434.5	703.6	373.7	358.0	501.1	324.3	339.3	236.6	668.0	455.3	337.2	679.0	307.2	192.2	214.2	341.5	563.3	323.0	339.3	580.9	438.0	463.3	391.1	73.3	138.4	77.5	135.4	153.6	153.5	218.6	160.9	162.4	172.5	196.0	150.8	194.9	82.2	132.7	168.3	253.7	241.6	156.8	134.2	136.7	137.9	177.2	134.8	152.7	144.7	151.8	150.4	138.3	145.4	140.9	177.5	153.8	141.9	53.2	234.6	210.9	264.5	447.5	140.0	167.4	310.9	371.0	88.5	275.9	217.0	303.5	58.4	453.9	195.5	231.4	718.1	377.4	46.5	458.4	263.1	185.2	253.5	189.1	71.2	388.5	374.1	216.1	151.4	238.8	159.0	394.1	297.0	1298.8	411.2	148.0	73.9	300.7	252.3	495.5	401.4	42.7	306.6	226.3	225.9	40.3	394.9	231.3	254.3	66.9	126.8	476.2	283.1	258.8	182.6	406.3	256.6	1037.0	360.8	133.3	236.7	214.8	223.0	236.5	119.0	261.6	226.0	563.8	203.7	505.0	303.6	303.3
TBCB	"CG22, CKAP1, CKAPI"	ENSG00000105254	"Tubulin folding cofactor B"	Q99426	19	36114289-36125947	"Metabolic proteins, Predicted intracellular proteins"	"Differentiation, Neurogenesis"	"Chaperone, Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 448.6"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041428, HPA041722"	Approved		Supported	Cytosol		NA	NA		120000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 10: Non-specific - Unknown function"	Cytosol		"HPA041428: AB_10794517, HPA041722: AB_10804007"	"unprognostic (3.88e-3)"	"unprognostic (3.05e-1)"	"unprognostic (8.52e-2)"	"unprognostic (1.38e-2)"	"unprognostic (7.94e-2)"	"unprognostic (1.25e-2)"	"prognostic unfavorable (2.09e-4)"	"unprognostic (1.15e-2)"	"unprognostic (5.19e-2)"	"unprognostic (1.32e-1)"	"prognostic favorable (3.11e-4)"	"unprognostic (4.54e-2)"	"unprognostic (6.34e-3)"	"unprognostic (9.20e-2)"	"unprognostic (6.11e-2)"	"unprognostic (5.39e-2)"	"unprognostic (1.02e-1)"	83.7	83.8	332.0	49.9	365.5	52.8	77.9	365.7	448.6	95.6	289.2	102.5	34.9	117.6	33.0	83.3	88.7	31.0	109.5	332.5	357.6	92.0	57.5	73.3	52.1	368.9	354.4	89.6	44.8	47.5	116.3	36.6	370.0	67.4	29.8	62.3	51.6	46.8	87.8	58.7	66.6	48.0	356.8	76.1	69.7	89.4	359.9	53.3	58.8	49.5	42.3	99.7	82.0	412.4	119.8	361.0	122.7	89.0	84.2	83.4	54.8	95.6	72.6	158.0	111.5	161.0	62.0	99.4	167.4	144.9	114.3	59.0	99.8	102.6	84.0	231.4	127.9	85.5	89.4	224.9	104.7	96.6	166.8	97.6	74.7	123.9	76.4	105.7	102.5	139.7	39.7	141.1	125.3	189.2	152.6	117.5	83.0	137.8	139.8	135.2	69.5	93.2	137.9	108.3	139.6	153.0	89.3	112.2	102.9	109.2	58.7	120.2	106.5	156.9	166.9	91.3	181.4	70.9	182.3	113.1	140.7	99.2	87.5	310.8	240.3	318.5	286.0	335.8	190.5	258.8	260.4	249.5	265.2	246.6	155.9	195.5	103.8	246.1	409.3	280.2	386.5	358.2	332.0	365.5	365.7	448.6	332.5	357.6	368.9	354.4	370.0	356.8	359.9	412.4	110.6	60.9	29.7	13.1	76.9	66.9	89.8	170.1	56.9	61.3	73.5	98.9	53.5	58.6	90.9	138.0	12.5	136.7	111.5	64.8	180.0	147.2	143.5	88.7	85.6	100.9	107.2	52.4	14.0	111.8	212.5	93.0	53.0	80.5	83.7	99.4	80.7	33.7	160.5	72.3	14.9	58.4	160.7	70.9	154.0	274.0	90.1	95.8	129.9	13.1	239.2	127.8	142.2	11.6	68.3	129.8	95.3	101.2	53.3	61.7	63.1	188.4	115.8	85.6	65.7	75.6	195.8	108.3	156.9	71.7	67.6	82.6	114.3	88.2	56.7	78.5
TBCC	CFC	ENSG00000124659	"Tubulin folding cofactor C"	Q15814	6	42744498-42746103	"Plasma proteins, Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA035073, HPA035074"	Approved		Supported	Cytosol		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 2: Immune cells - Immune response"	"Cluster 21: OE19 - Mitochondria"	"Cluster 7: Non-specific - Mitochondria"	Cytosol		"HPA035073: AB_10602897, HPA035074: AB_2674448"	"unprognostic (7.16e-2)"	"unprognostic (9.88e-2)"	"unprognostic (2.17e-1)"	"unprognostic (4.23e-2)"	"unprognostic (8.20e-2)"	"unprognostic (6.79e-2)"	"unprognostic (5.80e-3)"	"unprognostic (1.41e-2)"	"unprognostic (2.47e-1)"	"unprognostic (3.96e-3)"	"unprognostic (1.84e-2)"	"unprognostic (1.92e-1)"	"unprognostic (2.22e-1)"	"unprognostic (2.28e-1)"	"unprognostic (1.29e-1)"	"unprognostic (6.31e-2)"	"unprognostic (3.76e-3)"	10.4	15.0	15.9	17.8	15.8	39.6	9.9	15.4	18.3	9.9	12.3	17.0	14.5	14.4	12.9	16.1	15.6	10.1	16.0	16.4	16.3	11.9	13.1	11.6	29.1	18.0	14.1	12.2	14.9	11.3	11.1	7.6	18.8	11.3	9.9	15.4	14.5	11.8	26.7	16.8	23.5	10.7	15.2	30.1	15.5	18.0	14.7	21.9	14.0	14.4	19.5	13.1	10.0	16.6	34.5	11.2	16.9	31.7	23.9	16.0	22.3	23.2	26.1	25.3	27.4	17.4	13.3	31.0	18.3	22.7	21.0	29.5	22.9	23.2	14.0	17.0	25.0	16.3	16.7	29.7	27.2	17.9	25.5	26.2	27.8	19.7	16.1	22.7	20.1	17.1	37.8	27.4	22.9	42.4	14.8	34.3	15.8	93.5	30.4	14.8	20.3	20.3	24.5	18.6	64.7	28.1	15.1	25.8	41.1	15.4	28.3	59.7	21.9	24.1	21.6	19.6	32.3	36.1	43.7	53.0	11.8	24.2	23.7	139.1	91.4	174.5	105.5	79.2	108.9	101.7	111.9	116.7	83.5	90.9	129.6	119.9	162.1	170.8	74.1	142.3	154.8	170.4	15.9	15.8	15.4	18.3	16.4	16.3	18.0	14.1	18.8	15.2	14.7	16.6	19.3	3.2	24.0	2.6	50.8	25.1	25.9	49.3	51.2	55.0	25.4	29.1	6.8	24.3	25.7	11.0	41.7	21.4	83.8	25.1	33.2	38.6	30.3	23.0	21.2	20.9	45.3	13.0	7.0	30.9	23.5	17.1	18.3	22.9	31.0	21.0	19.6	10.0	18.8	18.5	7.8	21.2	71.2	16.2	27.8	10.2	17.7	15.9	28.4	8.4	33.6	46.3	77.2	5.0	12.8	28.5	27.0	20.7	37.1	15.9	29.8	23.9	22.0	51.7	19.7	13.0	46.1	50.1	22.7	30.7	24.9	21.1	80.2	26.6	22.3	22.1
TBL1Y	TBL1	ENSG00000092377	"Transducin beta like 1 Y-linked"	Q9BQ87	Y	6910686-7101970	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation, Ubl conjugation pathway"	Activator	"Deafness, Disease variant, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"prostate: 2.9;thyroid gland: 1.6"	"Cell type enhanced"	"Detected in some"		"Basal squamous epithelial cells: 3.4;Inhibitory neurons: 2.2;Oligodendrocyte precursor cells: 1.0;Squamous epithelial cells: 5.7;Urothelial cells: 1.1"	"Cancer enriched"	"Detected in single"	6	"prostate cancer: 1.7"	"Region enhanced"	"Detected in single"		"basal ganglia: 1.3"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"U-698: 12.3"									"HPA050857, HPA060073"	Uncertain		Supported	Nucleoplasm		NA	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm		"HPA050857: , HPA060073: AB_2684196"						"unprognostic (2.81e-3)"	"unprognostic (2.94e-1)"	"unprognostic (3.06e-1)"			"unprognostic (7.76e-2)"	"unprognostic (1.17e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.77e-2)"	"unprognostic (1.47e-1)"		"unprognostic (3.24e-2)"	0.3	0.0	0.1	0.0	1.3	0.0	0.3	0.1	0.4	0.0	0.4	0.1	0.0	0.0	0.1	0.3	0.0	0.4	0.0	0.1	0.4	0.9	0.6	0.1	0.0	0.2	0.2	0.0	0.4	0.0	0.0	0.1	0.1	2.9	0.1	0.0	0.8	0.3	0.4	0.2	0.0	0.0	0.3	0.0	0.2	0.3	0.1	0.0	1.6	0.1	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	1.6	0.0	0.0	0.0	0.0	1.9	0.0	2.2	1.7	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.3	0.1	0.4	0.1	0.4	0.2	0.2	0.1	0.3	0.1	0.2	0.0	0.0	0.0	0.7	0.0	0.0	0.8	0.2	3.4	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	2.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.1	0.1	0.0	0.0	0.0	0.5	0.0	0.4	0.1	0.0	0.0	0.0	0.1	0.0	0.2	5.7	0.0	0.3	0.0	0.0	0.0	1.1
TBL2	"DKFZP43N024, WBSCR13, WS-betaTRP"	ENSG00000106638	"Transducin beta like 2"	Q9Y4P3	7	73567537-73578791	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins"			"Williams-Beuren syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 44.2"	"Group enriched"	"Detected in all"	7	"Early spermatids: 398.2;Late spermatids: 515.4;Spermatocytes: 345.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007477, HPA051533"			Supported	Cytosol	"Secreted in male reproductive system"	NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 22: Non-specific - Unknown function"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 66: Spermatocytes - Spermatogenesis"	Cytosol		"HPA007477: AB_1080214, HPA051533: AB_2681523"	"unprognostic (9.04e-2)"	"unprognostic (6.61e-3)"	"unprognostic (4.24e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.76e-2)"	"prognostic unfavorable (4.93e-4)"	"unprognostic (2.24e-3)"	"unprognostic (7.50e-2)"	"unprognostic (2.87e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.11e-1)"	"prognostic unfavorable (1.88e-5)"	"unprognostic (1.59e-1)"	"unprognostic (3.14e-1)"	"unprognostic (1.42e-2)"	"unprognostic (1.31e-1)"	4.9	9.1	1.7	5.3	1.8	1.6	4.2	2.8	5.4	4.6	2.7	4.7	5.4	4.5	8.3	5.4	4.3	2.7	4.0	1.9	1.7	4.2	5.9	5.5	1.9	1.7	1.6	4.8	16.4	5.6	3.2	4.4	1.8	4.4	5.5	4.0	11.0	4.3	2.9	4.9	4.3	4.6	1.6	3.1	6.4	44.2	1.7	2.3	4.9	1.5	3.2	3.6	4.5	1.8	22.1	27.5	8.7	12.6	19.9	18.2	10.2	26.9	18.4	9.3	17.1	40.9	22.0	18.4	5.4	21.7	19.5	15.9	18.2	9.5	19.4	6.8	10.8	6.6	11.8	26.3	28.5	13.3	22.4	11.4	15.0	28.7	22.1	16.7	10.2	2.4	26.0	12.6	14.7	20.2	13.2	10.7	8.7	23.8	18.1	8.6	14.6	38.8	10.5	16.0	8.4	14.3	25.8	65.8	16.9	10.1	17.2	5.7	18.7	17.1	8.8	17.1	25.7	25.8	18.0	20.0	23.3	15.3	21.3	16.8	11.1	4.9	6.3	7.3	5.9	3.0	5.0	5.2	13.6	4.1	5.9	3.7	1.4	8.8	7.4	10.2	6.5	8.1	1.7	1.8	2.8	5.4	1.9	1.7	1.7	1.6	1.8	1.6	1.7	1.8	8.6	25.6	9.3	3.3	8.1	4.6	14.5	17.3	4.0	10.8	10.8	6.3	4.7	11.5	13.5	5.5	8.4	45.2	6.5	12.7	1.9	26.1	398.2	11.3	14.9	12.6	9.5	6.3	4.1	30.1	54.6	17.3	7.7	11.6	14.0	13.9	10.0	14.7	27.4	3.3	4.5	16.8	6.1	9.4	3.8	515.4	23.6	17.5	7.2	4.7	17.3	8.1	10.3	4.5	4.1	22.6	13.7	26.7	19.9	17.1	14.6	5.1	9.8	13.4	6.6	13.8	15.1	345.8	27.9	7.8	3.7	43.4	5.0	17.0	15.8	9.0
TBP	"GTF2D1, SCA17, TFIID"	ENSG00000112592	"TATA-box binding protein"	P20226	6	170554302-170572870	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Host-virus interaction, Transcription, Transcription regulation"	DNA-binding	"Disease variant, Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Spermatocytes: 88.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009442, HPA049805"	Enhanced		Supported	Nucleoplasm		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm		"CAB009442: AB_632480, HPA049805: AB_2680890"	"unprognostic (2.86e-3)"	"unprognostic (1.73e-2)"	"unprognostic (3.90e-2)"	"unprognostic (4.55e-3)"	"unprognostic (7.10e-2)"	"unprognostic (2.33e-2)"	"prognostic unfavorable (1.51e-7)"	"unprognostic (1.46e-1)"	"unprognostic (4.28e-1)"	"unprognostic (1.17e-2)"	"unprognostic (1.06e-2)"	"unprognostic (1.34e-2)"	"unprognostic (1.54e-2)"	"unprognostic (8.13e-2)"	"unprognostic (2.62e-1)"	"unprognostic (3.70e-2)"	"unprognostic (3.05e-1)"	10.2	10.5	9.4	9.6	9.6	15.6	10.4	10.8	15.1	10.5	9.1	11.8	8.5	12.6	8.1	11.3	11.7	8.2	9.9	10.1	11.5	11.0	11.5	9.7	14.0	10.2	10.2	12.8	11.7	9.3	9.3	10.8	10.2	10.5	8.5	8.9	10.3	7.6	12.8	10.7	11.9	9.6	8.7	14.9	11.7	34.5	9.7	11.9	10.5	10.6	12.2	10.6	10.8	12.3	12.9	14.0	24.4	31.2	12.5	14.2	23.0	20.5	15.6	19.9	21.1	28.9	12.7	27.1	16.4	16.7	28.6	18.9	31.6	16.8	21.2	31.5	23.2	27.6	16.6	26.1	18.1	32.7	23.1	13.8	19.2	22.9	25.8	16.3	15.9	37.2	49.7	16.5	18.3	19.3	32.8	31.8	24.5	27.3	11.0	28.6	20.0	23.8	14.5	6.5	10.4	24.9	24.1	17.8	16.0	20.7	12.4	40.7	17.6	13.5	19.1	22.2	32.0	24.4	35.1	42.3	18.5	27.0	21.9	67.4	30.8	39.8	37.8	32.2	44.4	52.9	36.7	38.6	30.2	49.9	47.3	40.0	44.4	35.0	45.4	42.6	37.2	21.8	9.4	9.6	10.8	15.1	10.1	11.5	10.2	10.2	10.2	8.7	9.7	12.3	8.4	9.6	6.9	6.8	16.5	5.5	5.3	11.6	20.5	7.5	8.3	7.4	9.9	15.7	10.0	12.9	8.4	15.8	10.5	6.2	3.9	6.6	26.9	7.8	9.3	9.5	7.2	17.5	13.7	4.7	13.5	9.2	7.7	10.7	1.3	13.0	13.2	8.0	10.1	0.0	12.8	7.5	22.4	14.0	5.3	7.7	10.8	9.8	1.8	10.3	8.5	5.4	6.2	11.1	16.2	6.6	7.9	10.5	18.7	8.5	8.2	8.9	7.2	6.7	13.1	6.6	11.1	88.1	17.4	18.3	6.7	13.5	11.1	10.1	8.0	6.7
TBRG1	"FLJ14621, NIAM, TB-5"	ENSG00000154144	"Transforming growth factor beta regulator 1"	Q3YBR2	11	124622836-124635926	"Predicted intracellular proteins"	"Cell cycle"		"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HEL: 21.6;HMC-1: 20.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055645, HPA068022"			Supported	Nucleoplasm		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"HPA055645: AB_2682873, HPA068022: AB_2685942"	"unprognostic (1.64e-2)"	"unprognostic (3.24e-2)"	"unprognostic (7.81e-2)"	"unprognostic (1.37e-2)"	"unprognostic (9.21e-2)"	"unprognostic (3.66e-1)"	"unprognostic (1.03e-1)"	"unprognostic (4.58e-2)"	"unprognostic (1.18e-3)"	"unprognostic (1.52e-1)"	"unprognostic (7.40e-2)"	"unprognostic (3.72e-3)"	"unprognostic (1.78e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.22e-1)"	"unprognostic (3.83e-1)"	"unprognostic (7.13e-3)"	5.5	7.2	6.4	5.5	9.5	4.0	4.3	5.3	9.8	3.8	5.9	5.9	6.2	3.9	4.0	5.0	4.1	3.1	4.3	6.9	6.6	6.2	8.1	6.0	6.4	5.6	5.2	2.7	8.1	2.3	4.1	3.8	5.3	5.1	5.4	1.8	5.6	3.0	10.1	5.1	8.4	2.5	5.1	8.3	6.8	3.4	6.0	3.9	5.7	3.9	6.1	4.3	4.0	7.2	3.7	3.1	2.7	1.5	4.6	3.1	2.7	3.7	2.5	2.0	1.8	6.0	2.7	4.4	4.5	3.7	4.0	4.5	3.5	4.8	3.8	4.5	2.7	21.6	1.8	3.9	3.2	6.7	20.9	3.2	8.1	3.7	2.8	2.3	3.6	3.6	7.4	4.8	5.1	1.7	3.0	6.6	2.9	8.6	2.1	2.7	3.6	3.2	3.3	3.6	2.2	2.3	2.1	3.5	2.5	2.5	5.6	3.3	5.5	4.5	1.8	1.5	3.2	3.8	6.2	5.1	2.5	7.8	3.2	30.5	24.3	35.1	25.6	22.9	19.1	34.0	25.9	22.1	14.8	30.6	27.4	22.1	33.1	14.6	21.7	23.9	27.5	13.1	6.4	9.5	5.3	9.8	6.9	6.6	5.6	5.2	5.3	5.1	6.0	7.2	37.9	44.8	56.5	37.9	67.2	46.1	52.0	37.5	67.2	19.2	34.8	30.6	24.0	40.0	39.5	23.9	12.5	32.9	58.0	46.4	52.8	38.8	61.3	25.1	31.1	42.7	28.3	43.3	113.8	47.4	28.8	45.9	39.3	25.9	72.1	23.6	31.8	69.7	36.2	30.3	53.6	46.7	30.5	45.8	66.8	11.5	37.9	55.9	33.8	41.2	53.6	33.5	64.9	33.7	50.1	58.5	43.2	33.4	62.1	88.7	61.9	90.4	33.9	19.5	26.3	39.3	83.3	52.0	24.7	42.5	48.2	48.3	65.7	27.7	33.4	68.6
TBX18		ENSG00000112837	"T-box transcription factor 18"	O95935	6	84687351-84764598	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding, Repressor"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 10.3"	"Cell type enriched"	"Detected in some"	5	"Microglial cells: 91.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A549: 57.4;ASC diff: 39.0;ASC TERT1: 40.4;RH-30: 37.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA006807			Supported	Nucleoplasm		NA	NA				"Cluster 82: Adipose tissue - ECM organization"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 48: Smooth muscle cells - ECM organization"	Nucleoplasm		"HPA006807: "	"unprognostic (8.04e-2)"	"unprognostic (7.06e-3)"	"unprognostic (9.71e-2)"	"unprognostic (2.31e-1)"	"unprognostic (4.00e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.19e-1)"	"unprognostic (3.24e-1)"	"unprognostic (2.57e-1)"	"unprognostic (7.92e-2)"	"unprognostic (3.50e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.88e-14)"	"unprognostic (4.81e-5)"	"unprognostic (1.86e-1)"	"unprognostic (3.07e-3)"	"unprognostic (1.78e-1)"	10.3	2.0	1.6	0.9	3.1	0.0	6.1	1.1	3.4	1.9	4.6	0.7	0.1	1.4	0.4	3.1	1.8	1.5	6.6	1.3	1.3	0.4	0.2	0.3	1.8	1.7	1.2	2.7	0.5	0.4	1.6	1.8	1.6	0.6	0.4	0.1	1.6	1.1	1.3	4.7	1.1	0.5	1.5	0.0	0.4	1.0	2.1	0.6	1.7	1.4	0.2	4.5	2.9	1.7	0.0	57.4	0.0	0.0	39.0	40.4	0.0	23.5	11.5	17.4	16.5	0.4	0.0	0.1	0.0	9.8	0.0	3.0	0.0	13.8	14.0	0.0	23.2	0.0	0.0	0.0	5.0	0.0	23.1	17.1	1.3	12.1	25.8	0.0	20.2	0.0	30.7	0.2	12.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	37.3	0.0	0.3	0.0	0.2	1.2	0.0	1.0	9.0	1.4	0.0	31.0	18.2	0.0	4.8	17.6	0.0	0.3	0.0	0.0	10.9	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	3.1	1.1	3.4	1.3	1.3	1.7	1.2	1.6	1.5	2.1	1.7	1.6	0.0	0.0	0.3	0.0	5.5	0.0	0.4	0.0	0.0	0.2	0.3	2.3	0.0	0.3	0.0	0.0	0.1	0.1	0.2	0.0	0.0	6.9	0.0	0.1	1.6	0.0	0.0	0.1	0.0	0.0	14.9	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.1	0.4	0.0	2.1	6.1	2.3	1.2	0.1	8.8	91.8	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.4	0.0	0.0	1.0	0.1	0.2	0.1	0.0	1.6	16.9	0.4	3.1	0.1	4.4	0.1	0.8	0.8	0.3	0.0
TBX3	"TBX3-ISO, UMS, XHL"	ENSG00000135111	"T-box transcription factor 3"	O15119	12	114670255-114684175	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding, Repressor"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 178.4"	"Cell type enriched"	"Detected in many"	4	"Syncytiotrophoblasts: 613.9"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 49.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ: 103.0;BJ hTERT+: 97.3;RT4: 129.3"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA005799, HPA075876"			Supported	Nucleoplasm,Cytosol		NA	NA				"Cluster 89: Fibroblasts - ECM organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	Nucleoplasm	Cytosol	"HPA005799: AB_1857817, HPA075876: "	"unprognostic (3.27e-1)"	"unprognostic (2.64e-1)"	"unprognostic (2.84e-1)"	"unprognostic (1.11e-1)"	"unprognostic (3.40e-2)"	"unprognostic (5.97e-3)"	"unprognostic (1.56e-1)"	"unprognostic (2.99e-2)"	"unprognostic (9.43e-2)"	"unprognostic (1.15e-1)"	"unprognostic (3.35e-1)"	"unprognostic (3.06e-1)"	"unprognostic (3.64e-3)"	"unprognostic (1.09e-3)"	"unprognostic (1.43e-1)"	"unprognostic (1.01e-1)"	"prognostic favorable (3.28e-4)"	13.3	178.4	5.1	2.5	4.7	0.0	34.1	3.9	5.7	37.5	2.9	7.4	37.6	32.8	44.6	2.8	24.0	4.5	13.2	3.8	14.9	12.9	31.3	32.8	1.4	4.6	4.4	44.2	2.9	1.0	12.9	41.3	4.8	80.4	3.7	1.8	18.9	53.2	10.4	14.9	30.3	10.0	3.8	7.0	6.0	1.3	6.6	1.3	50.0	16.5	1.7	53.9	34.2	3.7	2.4	18.2	0.0	0.0	26.1	35.6	40.1	103.0	97.3	39.0	38.3	16.3	4.4	0.0	1.6	18.0	2.4	4.7	8.4	3.6	47.7	0.0	12.3	0.0	4.8	48.1	8.4	0.0	0.0	16.0	2.4	13.1	26.8	0.0	0.5	0.0	3.8	0.0	3.4	1.6	0.0	0.5	0.2	53.0	5.4	0.0	0.0	2.6	0.0	129.3	6.6	19.4	14.6	6.6	3.6	44.6	5.1	0.2	0.0	11.9	7.7	6.8	33.9	0.0	0.0	0.0	24.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.1	4.7	3.9	5.7	3.8	14.9	4.6	4.4	4.8	3.8	6.6	3.7	48.9	0.0	1.9	0.3	1.8	9.8	85.2	5.8	7.4	14.3	110.3	80.5	12.5	0.0	1.1	35.0	4.2	60.7	0.7	12.0	0.0	0.6	1.5	3.3	144.7	38.6	4.9	0.0	0.0	0.0	7.0	41.3	5.1	3.8	0.0	3.9	1.1	40.2	6.1	1.7	0.0	23.9	4.1	0.9	4.6	2.8	5.3	2.9	3.6	14.0	0.0	1.9	0.0	0.0	0.0	0.3	22.4	6.0	0.0	72.4	37.9	0.1	0.4	2.0	39.5	27.2	58.2	0.1	3.8	3.2	9.8	613.9	2.0	112.0	12.1	69.1
TBXA2R		ENSG00000006638	"Thromboxane A2 receptor"	P21731	19	3594507-3606875	"Disease related genes, G-protein coupled receptors, Human disease related genes, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in some"	6	"Adipocytes: 10.8;Endothelial cells: 8.7;Hepatic stellate cells: 30.7;Macrophages: 19.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"naive B-cell: 11.1"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HeLa: 9.5;U-2197: 6.8;U-937: 6.1"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA077366			Supported	"Nuclear speckles,Plasma membrane"		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 18: U-2197 - ECM organization"	"Cluster 51: Myeloid cells - Hemostasis"	"Plasma membrane"	"Nuclear speckles"	"HPA077366: AB_2686836"	"unprognostic (1.59e-1)"	"unprognostic (3.86e-2)"	"unprognostic (1.21e-2)"	"unprognostic (1.74e-1)"	"unprognostic (8.97e-2)"	"unprognostic (4.19e-2)"	"unprognostic (1.52e-2)"	"unprognostic (2.17e-3)"	"unprognostic (8.41e-2)"	"unprognostic (6.25e-2)"	"prognostic favorable (7.17e-4)"	"unprognostic (3.89e-2)"	"prognostic unfavorable (1.45e-4)"	"unprognostic (4.32e-2)"	"unprognostic (9.63e-2)"	"unprognostic (1.76e-1)"	"unprognostic (2.02e-1)"	3.8	8.7	1.3	1.6	1.1	1.0	1.9	1.8	1.3	5.4	1.3	2.3	0.8	5.2	0.4	1.7	3.3	1.0	5.0	1.1	1.1	6.3	6.1	4.4	1.0	1.7	1.3	2.0	0.9	1.2	1.0	3.2	1.5	2.5	0.4	0.5	0.6	1.4	1.4	1.1	3.2	1.8	1.1	7.0	2.5	0.6	1.4	0.3	2.6	0.6	0.3	2.6	3.6	2.1	0.2	0.2	0.3	3.4	0.7	1.7	0.5	2.4	0.6	1.8	1.4	0.1	0.3	0.1	3.5	1.0	1.8	0.2	0.7	0.0	0.7	0.2	0.8	2.3	9.5	0.2	0.9	0.2	4.1	0.8	0.0	2.4	0.0	1.4	0.7	0.1	3.8	0.4	0.3	0.1	0.2	1.2	0.3	0.1	2.1	0.1	0.0	0.1	0.0	0.1	0.1	1.3	0.2	0.4	0.1	0.3	1.5	4.2	2.1	3.8	0.8	6.8	2.3	0.2	0.3	0.2	3.1	6.1	0.9	3.7	0.4	0.4	2.5	0.2	0.3	2.0	0.7	2.2	0.1	11.1	4.3	9.4	4.1	3.3	0.3	0.3	0.2	4.0	1.3	1.1	1.8	1.3	1.1	1.1	1.7	1.3	1.5	1.1	1.4	2.1	10.8	0.0	0.0	0.0	2.6	0.5	0.1	0.0	0.0	0.3	0.1	0.1	1.3	0.0	0.0	1.8	0.0	0.1	0.4	0.0	0.0	0.1	0.0	0.1	0.6	8.7	0.0	0.0	0.3	0.0	0.2	2.3	0.0	0.1	0.0	0.2	30.7	0.6	0.9	0.0	0.9	0.0	0.0	1.0	0.3	0.0	0.3	19.2	1.8	1.9	0.3	0.5	1.0	0.5	0.4	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.4	2.5	0.4	1.9	0.1	0.6	0.1	0.8	0.4	0.1	0.0
TBXAS1	"CYP5, CYP5A1, THAS, TS, TXAS, TXS"	ENSG00000059377	"Thromboxane A synthase 1"	P24557	7	139777051-140020325	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Prostaglandin biosynthesis, Prostaglandin metabolism"	"Isomerase, Lyase, Monooxygenase, Oxidoreductase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 57.8"	"Group enriched"	"Detected in many"	4	"granulocytes: 71.0;Hofbauer cells: 88.8;Kupffer cells: 193.6;Macrophages: 132.9;Microglial cells: 191.1;monocytes: 63.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	14	"basophil: 324.3;classical monocyte: 322.4;eosinophil: 333.6;intermediate monocyte: 466.0;myeloid DC: 129.0;neutrophil: 271.1;non-classical monocyte: 423.1"	"Group enriched"	"Detected in all"	22	"dendritic cells: 129.0;granulocytes: 333.6;monocytes: 466.0"	"Cell line enhanced"	"Detected in many"		"NB-4: 76.7;PC-3: 23.7;RPTEC TERT1: 21.0;U-937: 60.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"HPA031257, HPA031258, HPA031259"	Enhanced		Approved	"Endoplasmic reticulum,Cytosol"		NA	NA		890000	"Cluster 7: Monocytes - Unknown function"	"Cluster 64: Macrophages - Immune response"	"Cluster 24: NB-4 - Immune response"	"Cluster 4: Macrophages - Innate immune response"	"Endoplasmic reticulum, Cytosol"		"HPA031257: AB_2673812, HPA031258: AB_2673813, HPA031259: AB_2673814"	"unprognostic (4.46e-2)"	"unprognostic (3.07e-1)"	"unprognostic (8.80e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.72e-1)"	"unprognostic (9.41e-2)"	"unprognostic (5.10e-2)"	"unprognostic (3.12e-1)"	"unprognostic (2.38e-1)"	"unprognostic (3.07e-2)"	"unprognostic (1.11e-1)"	"unprognostic (3.03e-2)"	"prognostic unfavorable (1.14e-4)"	"unprognostic (1.52e-1)"	"unprognostic (5.00e-3)"	"unprognostic (8.53e-2)"	"unprognostic (5.34e-2)"	13.2	10.8	5.3	28.1	5.1	24.8	8.2	5.4	5.9	5.4	5.8	10.1	10.3	3.2	2.0	5.4	4.9	21.2	3.3	4.5	6.8	5.8	12.8	23.9	12.4	10.0	6.6	2.9	3.6	2.9	2.3	14.2	8.8	6.4	13.0	1.6	9.0	4.0	1.0	1.3	11.9	12.6	8.9	57.8	11.2	1.4	9.7	15.1	1.8	3.3	8.3	13.9	2.1	14.7	0.2	5.4	0.3	0.1	1.2	3.9	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.0	12.1	0.0	0.3	0.0	0.0	0.0	0.0	9.4	0.7	17.8	0.0	0.0	1.6	6.2	15.3	2.1	0.0	0.0	0.9	1.1	2.3	0.1	0.6	2.2	0.6	0.2	2.4	76.7	0.2	18.0	23.7	2.6	0.0	1.2	21.0	0.0	0.2	1.1	0.2	0.0	0.8	0.0	0.0	14.4	2.0	0.6	0.2	1.4	1.0	4.6	0.9	0.3	0.4	60.8	1.7	324.3	322.4	333.6	7.3	466.0	11.9	8.3	13.5	3.7	129.0	4.5	2.3	1.3	271.1	11.9	423.1	22.6	13.9	216.7	5.3	5.1	5.4	5.9	4.5	6.8	10.0	6.6	8.8	8.9	9.7	14.7	3.9	3.2	10.8	8.1	9.9	0.4	1.2	0.5	2.8	1.0	3.0	3.0	1.1	5.7	1.7	1.8	6.2	0.6	16.4	0.8	9.8	5.2	0.4	1.0	0.6	5.0	1.8	12.8	1.2	9.5	0.5	2.9	7.1	3.8	71.0	0.5	16.8	8.6	88.8	3.3	1.8	1.9	12.2	193.6	19.5	0.7	0.3	132.9	3.6	191.1	63.7	4.9	26.8	3.0	5.9	4.4	7.9	0.0	16.4	5.8	0.2	6.3	1.0	4.1	19.7	1.3	1.7	0.5	0.7	26.2	0.6	0.5	13.4	0.3	2.7	1.2
TBXT	T	ENSG00000164458	"T-box transcription factor T"	O15178	6	166157656-166168700	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"parathyroid gland: 2.6;pituitary gland: 1.3"	"Not detected"	"Not detected"			"Cancer enriched"	"Detected in single"	22	"testis cancer: 6.2"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"HeLa: 16.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA003322	Uncertain		Supported	Nucleoplasm		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 20: HeLa - Mitochondria"	"Cluster 4: Macrophages - Innate immune response"	Nucleoplasm		"HPA003322: AB_1080176"						"unprognostic (5.68e-2)"		"unprognostic (4.59e-2)"						"unprognostic (6.21e-3)"	"unprognostic (8.64e-3)"	"unprognostic (9.34e-3)"		0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	2.6	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	16.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	1.1	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TCAF2	"FAM115C, FAM139A, FLJ40722, GATD9"	ENSG00000170379	"TRPM8 channel associated factor 2"	A6NFQ2	7	143620952-143730409	"Predicted intracellular proteins"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 16.2;Hepatocytes: 12.3;Syncytiotrophoblasts: 15.7;T-cells: 9.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 10.6;HUVEC TERT2: 11.6;TIME: 18.5;U-87 MG: 13.8"									"HPA038756, HPA038758"	Uncertain		Supported	"Plasma membrane,Cell Junctions"		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 58: T-cells - T-cell receptor"	"Plasma membrane, Cell Junctions"		"HPA038756: AB_10960427, HPA038758: AB_10960353"	"unprognostic (6.59e-2)"	"unprognostic (4.99e-2)"	"unprognostic (2.34e-2)"	"unprognostic (8.86e-3)"	"prognostic unfavorable (9.53e-5)"	"unprognostic (1.89e-1)"	"unprognostic (3.11e-2)"	"unprognostic (4.47e-2)"	"unprognostic (2.36e-1)"	"unprognostic (2.04e-2)"	"unprognostic (3.98e-2)"	"unprognostic (2.21e-2)"	"prognostic unfavorable (4.17e-6)"	"unprognostic (7.19e-2)"	"unprognostic (4.02e-2)"	"unprognostic (5.41e-3)"	"unprognostic (2.85e-2)"	2.1	1.9	1.5	4.0	1.5	4.1	5.8	4.6	3.4	4.0	0.0	1.2	1.0	1.7	0.8	9.2	1.9	2.2	1.2	1.5	1.9	2.6	4.5	3.7	4.2	2.2	2.5	2.6	2.0	2.1	2.6	5.2	2.5	2.8	1.1	3.2	3.7	1.2	0.7	4.3	2.4	1.5	0.7	2.8	2.0	1.6	1.7	3.3	1.3	0.7	3.4	2.8	5.9	3.2	5.5	0.3	0.1	0.2	1.0	1.0	2.0	1.5	3.1	0.7	2.2	0.1	0.3	0.2	2.1	1.3	0.5	0.8	0.1	3.0	2.3	10.6	0.5	0.8	0.6	0.1	1.2	0.3	0.4	2.9	1.3	0.3	0.9	2.1	11.6	0.7	3.0	5.1	4.3	0.8	0.6	0.8	0.2	5.0	2.7	0.4	2.1	2.4	0.0	1.9	0.1	0.1	0.5	4.3	0.2	0.8	1.9	0.2	18.5	1.3	0.9	5.5	0.4	7.7	2.6	0.1	13.8	0.4	3.2	5.7	0.2	0.2	2.9	0.2	3.1	1.9	4.8	3.1	0.2	1.8	4.2	3.3	0.9	2.2	0.2	0.7	5.6	1.2	1.5	1.5	4.6	3.4	1.5	1.9	2.2	2.5	2.5	0.7	1.7	3.2	0.5	0.0	1.8	0.0	4.5	0.0	1.3	0.0	3.4	0.7	5.6	3.4	0.4	0.0	1.8	0.0	0.0	16.2	5.6	0.2	0.0	0.9	1.0	0.8	1.4	3.5	0.0	0.4	3.7	0.4	4.9	2.4	2.6	1.3	2.5	0.3	0.7	12.3	2.0	0.0	3.6	0.2	0.0	1.6	0.0	1.1	1.8	1.8	0.0	0.0	0.4	2.1	7.2	1.5	0.1	1.3	0.1	0.7	5.0	2.1	2.1	0.4	0.0	0.1	0.0	2.3	1.1	3.5	2.0	4.9	0.0	15.7	9.1	0.8	0.4	1.1
TCAF2C		ENSG00000283528	"TRPM8 channel associated factor 2C"		7	143639230-143647646	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"							"HPA038756, HPA038758"	Uncertain		Supported	"Plasma membrane,Cell Junctions"		NA	NA			"Cluster 35: T-regs - Unknown function"				"Plasma membrane, Cell Junctions"		"HPA038756: AB_10960427, HPA038758: AB_10960353"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.8	0.0	0.0	0.0	0.0	0.8	0.4	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.7	0.0	0.5	0.3	0.8	0.4	0.0	0.3	0.5	0.5	0.0	0.7	0.0	0.0	2.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TCEA1	"GTF2S, SII, TCEA, TF2S, TFIIS"	ENSG00000187735	"Transcription elongation factor A1"	P23193	8	53966552-54022456	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043786	Approved		Supported	Nucleoplasm,Nucleoli		NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 34: Non-specific - Transcription"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm	Nucleoli	"HPA043786: AB_10959468"	"unprognostic (5.35e-2)"	"unprognostic (9.90e-2)"	"unprognostic (2.39e-1)"	"unprognostic (2.11e-3)"	"unprognostic (3.34e-2)"	"unprognostic (1.17e-1)"	"unprognostic (3.72e-2)"	"unprognostic (1.77e-1)"	"unprognostic (4.14e-2)"	"unprognostic (1.00e-2)"	"unprognostic (1.56e-2)"	"unprognostic (1.25e-1)"	"prognostic unfavorable (3.75e-5)"	"unprognostic (3.80e-3)"	"unprognostic (1.10e-1)"	"unprognostic (1.13e-1)"	"unprognostic (3.05e-2)"	52.7	46.0	44.1	56.5	47.5	81.2	62.2	44.7	58.3	55.3	42.5	49.7	47.1	55.6	45.8	53.9	52.4	42.6	35.9	42.0	46.0	59.8	90.4	46.7	98.3	47.2	44.6	61.9	68.4	80.0	28.2	49.3	47.0	59.0	50.7	49.0	56.5	54.2	42.0	49.8	46.9	52.4	47.5	49.5	52.2	36.8	44.2	72.4	124.2	41.7	112.6	54.6	41.4	55.1	161.3	157.9	138.1	145.7	99.3	121.8	100.9	122.1	147.3	143.5	160.2	91.4	131.0	392.5	136.9	147.0	152.5	120.9	182.3	116.6	212.9	225.0	88.5	293.6	71.5	139.5	309.7	116.8	122.7	88.5	308.1	137.4	606.2	121.3	128.2	132.9	191.1	334.0	135.5	75.6	245.8	83.3	229.1	265.0	47.1	185.1	48.2	72.5	204.0	107.0	129.9	95.5	101.9	91.0	356.3	132.2	129.6	132.6	110.6	106.1	96.3	120.6	114.5	201.1	134.4	260.9	184.9	133.2	152.1	82.3	64.1	78.7	103.9	63.1	98.3	213.8	107.0	96.7	81.8	174.1	93.9	99.3	23.1	97.5	60.6	116.7	153.0	73.5	44.1	47.5	44.7	58.3	42.0	46.0	47.2	44.6	47.0	47.5	44.2	55.1	94.7	89.8	106.2	24.2	253.2	135.5	128.3	98.9	257.2	77.0	129.2	124.3	23.9	82.9	109.4	99.3	89.6	115.5	143.8	61.0	168.3	121.0	86.4	126.9	145.4	92.5	87.2	330.7	17.7	109.9	125.1	118.8	111.6	124.4	98.7	75.7	66.4	160.7	87.7	57.2	20.1	96.6	118.0	89.5	134.2	191.0	134.8	124.2	117.4	17.8	132.5	166.0	170.0	22.1	29.7	121.1	71.6	132.8	341.1	146.0	72.2	207.6	110.6	104.5	78.9	102.6	130.4	94.9	103.1	237.2	150.6	112.1	154.8	108.5	88.1	148.6
TCEA2	TFIIS	ENSG00000171703	"Transcription elongation factor A2"	Q15560	20	64049836-64072347	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Late spermatids: 173.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043836	Approved		Supported	Nucleoplasm,Centrosome		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 43: Testis - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm	Centrosome	"HPA043836: AB_2678694"	"unprognostic (6.51e-2)"	"unprognostic (2.02e-1)"	"unprognostic (3.91e-2)"	"unprognostic (2.16e-2)"	"unprognostic (2.80e-1)"	"unprognostic (4.91e-3)"	"unprognostic (2.38e-1)"	"unprognostic (2.91e-1)"	"unprognostic (1.65e-3)"	"unprognostic (9.03e-3)"	"unprognostic (2.49e-2)"	"unprognostic (9.67e-2)"	"unprognostic (1.17e-1)"	"unprognostic (3.81e-3)"	"unprognostic (2.70e-1)"	"unprognostic (2.28e-1)"	"unprognostic (3.79e-1)"	32.9	31.0	63.0	9.7	62.9	8.5	32.1	58.0	105.9	45.8	32.9	43.7	6.2	42.7	13.2	14.2	42.0	16.7	40.1	63.4	61.6	39.7	56.9	23.9	12.8	70.5	61.8	55.8	19.3	31.0	57.7	17.5	71.8	39.2	3.2	12.1	22.2	25.3	41.6	24.7	21.6	14.0	54.2	30.7	25.8	91.9	62.5	15.4	38.5	14.0	6.0	38.2	31.6	62.8	17.1	18.7	29.7	50.2	26.5	15.8	11.5	16.8	20.0	31.4	15.0	11.4	30.5	19.4	38.6	21.8	18.0	45.8	12.3	15.5	6.1	12.0	21.8	7.2	37.3	29.1	38.8	8.3	9.9	24.9	13.4	8.1	10.3	43.9	21.6	24.4	12.8	35.5	9.7	41.5	34.4	41.5	18.4	22.8	44.7	32.1	21.7	51.0	17.1	12.2	28.5	48.4	18.0	12.0	46.3	9.8	34.0	21.3	30.7	56.2	28.3	31.5	10.2	40.2	28.4	10.7	50.1	9.4	11.5	1.6	1.0	3.2	2.2	1.2	0.9	7.5	1.9	1.6	1.3	2.8	3.3	2.1	0.5	2.6	1.9	2.1	3.9	1.0	63.0	62.9	58.0	105.9	63.4	61.6	70.5	61.8	71.8	54.2	62.5	62.8	43.3	0.0	3.1	20.5	34.5	22.6	38.3	17.6	38.7	54.1	44.9	64.0	31.0	30.0	11.5	71.7	27.1	27.6	13.6	0.6	107.6	35.6	123.6	30.8	44.3	40.7	19.1	5.7	21.9	16.0	13.4	43.9	13.7	21.0	2.5	62.8	47.5	47.6	17.4	65.6	19.0	2.8	16.2	16.8	23.7	173.1	51.9	20.5	62.2	7.5	18.4	123.3	10.3	8.5	17.0	24.3	2.1	49.2	14.7	31.2	11.6	115.6	16.1	37.1	26.3	43.2	48.9	126.1	39.0	13.2	20.2	20.8	18.7	42.3	3.6	25.9
TCEAL7	"MGC23947, WEX5"	ENSG00000182916	"Transcription elongation factor A like 7"	Q9BRU2	X	103330229-103332326	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 126.3"	"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 42.9;Fibroblasts: 55.2;Horizontal cells: 48.8;Leydig cells: 43.8;Muller glia cells: 88.3;Oligodendrocytes: 46.5;Peritubular cells: 39.1;Skeletal myocytes: 48.3;Smooth muscle cells: 38.7"	"Cancer enriched"	"Detected in many"	10	"glioma: 39.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 83.8;BJ hTERT+ SV40 Large T+ RasG12V: 75.1;GAMG: 115.3;hTEC/SVTERT24-B: 83.8;LHCN-M2: 72.0;SCLC-21H: 210.1;U-87 MG: 78.9"	"Low region specificity"	"Detected in many"							"HPA051507, HPA065080"	Enhanced		Supported	Nucleoplasm		NA	NA				"Cluster 57: Non-specific - Angiogenesis"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 48: Smooth muscle cells - ECM organization"	Nucleoplasm		"HPA051507: AB_2681512, HPA065080: AB_2685419"	"unprognostic (1.09e-2)"	"unprognostic (4.36e-2)"	"unprognostic (5.54e-2)"	"unprognostic (2.26e-1)"	"unprognostic (1.17e-1)"	"unprognostic (4.52e-2)"	"unprognostic (2.17e-1)"	"unprognostic (2.23e-1)"	"unprognostic (3.26e-2)"	"unprognostic (1.12e-1)"	"unprognostic (4.18e-1)"	"unprognostic (1.12e-2)"	"prognostic unfavorable (4.31e-4)"	"prognostic unfavorable (3.53e-4)"	"unprognostic (2.62e-1)"	"unprognostic (2.28e-2)"	"unprognostic (1.35e-3)"	7.7	27.9	72.4	4.3	73.0	0.0	9.1	75.1	126.3	26.3	40.5	18.6	4.0	48.2	18.3	5.5	17.0	11.9	14.0	72.1	84.5	5.0	2.4	6.1	2.3	80.8	77.5	29.0	1.2	1.1	37.4	2.1	82.3	12.3	7.8	23.5	3.5	13.2	3.7	1.8	8.3	29.9	74.5	5.8	6.5	3.1	77.2	5.1	3.8	9.9	1.4	9.7	15.6	96.0	0.0	0.0	83.8	0.0	36.3	55.5	15.0	12.0	61.9	26.4	75.1	0.0	0.0	0.0	0.0	12.9	115.3	0.0	0.0	1.8	45.5	0.0	0.8	0.3	0.0	0.0	18.2	0.0	0.1	46.6	0.0	83.8	0.1	0.0	27.6	0.0	0.5	0.2	72.0	0.0	0.1	0.3	0.3	0.1	0.0	0.0	53.1	0.3	0.0	0.0	210.1	56.6	0.0	0.4	0.0	0.4	0.0	0.0	0.0	38.8	1.4	0.6	0.0	0.0	0.0	0.0	78.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	72.4	73.0	75.1	126.3	72.1	84.5	80.8	77.5	82.3	74.5	77.2	96.0	4.8	0.0	1.3	5.9	0.0	2.5	5.3	0.3	1.2	36.4	0.9	19.2	13.6	0.0	0.7	3.7	4.2	1.4	0.1	0.0	5.9	0.2	0.2	1.0	42.9	5.2	0.0	0.0	21.2	0.0	0.7	55.2	0.0	0.7	0.0	19.2	1.8	0.0	0.7	48.8	26.5	0.0	0.0	0.0	4.0	1.8	43.8	0.6	8.8	4.7	0.0	88.3	0.0	19.6	46.5	0.3	0.0	39.1	0.1	1.1	0.0	2.1	0.0	12.9	13.1	48.3	38.7	3.0	1.5	0.8	3.1	0.3	0.5	5.1	0.0	0.8
TCF12	"bHLHb20, HEB, HsT17266, HTF4, p64"	ENSG00000140262	"Transcription factor 12"	Q99081	15	56918623-57299281	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Cancer-related genes, Craniosynostosis, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Inhibitory neurons: 319.8;Microglial cells: 440.3;Oligodendrocyte precursor cells: 618.3;Oligodendrocytes: 1512.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004432, HPA065827"	Approved		Supported	"Nucleoplasm,Nuclear speckles"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 34: Non-specific - Transcription"	"Cluster 12: NES - Nervous system development"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Nucleoplasm, Nuclear speckles"		"CAB004432: AB_671267, HPA065827: AB_2685564"	"unprognostic (1.19e-1)"	"unprognostic (1.11e-1)"	"unprognostic (8.26e-2)"	"unprognostic (1.65e-1)"	"unprognostic (2.07e-3)"	"unprognostic (1.11e-1)"	"unprognostic (6.63e-2)"	"unprognostic (1.85e-1)"	"prognostic unfavorable (8.89e-4)"	"unprognostic (7.83e-2)"	"unprognostic (7.26e-3)"	"unprognostic (5.57e-3)"	"prognostic unfavorable (5.24e-5)"	"unprognostic (2.03e-1)"	"unprognostic (2.93e-1)"	"unprognostic (3.15e-2)"	"unprognostic (1.41e-1)"	26.1	21.5	29.2	23.4	45.5	21.2	29.5	37.1	34.0	75.6	17.2	26.7	28.4	47.9	24.3	26.6	46.3	37.1	21.8	30.5	32.6	28.4	25.0	28.9	26.0	43.1	39.3	43.3	19.7	44.0	11.5	33.4	38.3	32.0	30.3	29.4	23.3	28.3	20.5	21.3	28.4	44.1	34.5	25.0	25.5	27.4	35.5	133.0	29.0	26.6	28.1	31.2	22.4	55.7	25.4	50.8	204.5	70.6	90.0	79.0	36.1	52.2	89.6	45.1	58.9	34.0	20.3	35.5	42.3	78.3	33.4	30.4	84.3	37.3	56.7	47.5	29.8	71.7	52.7	40.4	62.4	46.1	36.1	69.4	66.2	42.9	112.2	60.1	81.0	163.0	81.7	46.8	61.8	9.5	109.4	25.0	57.5	26.4	20.9	143.2	234.9	33.9	61.5	53.1	43.6	121.2	58.7	21.0	52.0	65.3	33.6	93.9	63.2	75.5	57.5	32.2	78.2	24.6	49.7	59.4	40.8	86.3	90.9	27.4	13.8	11.3	17.4	17.9	14.3	13.4	14.0	16.5	20.0	14.7	16.2	14.8	1.5	16.8	26.3	8.4	23.0	14.1	29.2	45.5	37.1	34.0	30.5	32.6	43.1	39.3	38.3	34.5	35.5	55.7	35.5	54.5	19.6	212.9	37.7	26.6	20.6	14.2	44.9	13.8	24.0	20.4	19.3	14.3	21.2	16.5	35.5	10.4	20.6	17.0	13.7	16.0	23.7	25.9	148.0	38.2	9.0	34.9	117.7	11.8	15.5	42.3	52.0	33.3	23.4	26.9	25.7	18.2	27.5	13.5	319.8	16.8	10.2	38.1	30.0	19.9	25.7	33.0	14.2	440.3	17.4	29.0	18.6	618.3	1512.7	15.9	18.4	34.6	29.1	23.4	20.0	15.3	15.9	23.3	46.0	39.9	36.5	22.2	15.0	33.6	33.8	13.0	28.4	16.5	20.1	18.2
TCF15	"bHLHa40, EC2, PARAXIS"	ENSG00000125878	"Transcription factor 15"	Q12870	20	603797-610398	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in some"		"heart muscle: 27.8;skeletal muscle: 13.2;tongue: 9.1"	"Cell type enriched"	"Detected in some"	6	"Adipocytes: 260.0"	"Cancer enhanced"	"Detected in many"		"testis cancer: 3.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"HEL: 10.6;HMC-1: 16.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA050998, HPA060221"	Approved		Supported	"Nuclear speckles"		NA	NA				"Cluster 38: Heart - Muscle contraction"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Nuclear speckles"		"HPA050998: AB_2681302, HPA060221: AB_2684225"	"unprognostic (2.12e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.58e-2)"	"unprognostic (3.55e-2)"	"unprognostic (1.29e-1)"	"unprognostic (4.62e-2)"	"unprognostic (5.57e-2)"	"unprognostic (2.33e-1)"	"unprognostic (2.81e-1)"	"prognostic unfavorable (3.25e-4)"	"unprognostic (1.52e-1)"	"unprognostic (9.43e-2)"	"unprognostic (1.27e-3)"	"unprognostic (7.21e-2)"	"unprognostic (8.56e-2)"	"unprognostic (5.11e-1)"	"unprognostic (6.99e-2)"	7.0	0.6	1.3	0.1	1.2	0.0	4.6	1.2	1.4	0.2	0.9	1.6	0.1	0.8	0.0	0.3	0.4	0.1	27.8	1.1	1.2	1.5	0.2	0.6	0.1	1.3	1.3	0.2	0.3	0.1	0.4	3.3	1.4	0.3	0.0	0.0	0.6	0.0	13.2	0.2	0.5	0.2	1.3	0.0	0.6	2.0	1.3	0.0	0.5	9.1	0.0	0.9	0.3	1.2	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	1.5	0.0	0.0	0.0	2.9	10.6	0.0	0.0	0.0	0.0	16.8	0.0	0.0	0.0	0.0	0.0	0.5	0.0	1.7	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.1	0.0	0.0	1.7	0.0	0.0	0.0	1.5	0.0	1.3	0.0	3.0	0.0	1.4	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	1.2	1.2	1.4	1.1	1.2	1.3	1.3	1.4	1.3	1.3	1.2	260.0	0.0	0.0	0.0	0.4	0.1	0.1	0.0	0.6	0.5	0.6	1.0	15.6	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	1.7	0.2	0.2	41.2	0.0	0.0	0.0	0.0	0.1	2.2	0.0	0.6	0.0	0.1	7.1	0.0	0.1	1.7	0.5	0.0	0.0	0.0	0.4	0.2	0.0	0.5	0.0	2.8	0.0	0.1	0.0	1.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	13.1	3.7	23.3	2.3	0.6	0.0	0.0	0.0	0.2	0.5	0.0	0.0
TCF20	"AR1, SPBP"	ENSG00000100207	"Transcription factor 20"	Q9UGU0	22	42160013-42343616	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 127.0;Inhibitory neurons: 63.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017849, HPA036786"	Approved		Supported	"Nucleoplasm,Nuclear bodies"		NA	NA				"Cluster 71: Testis - DNA repair"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 29: Early spermatids - Spermatogenesis"	Nucleoplasm	"Nuclear bodies"	"CAB017849: , HPA036786: AB_2675313"	"unprognostic (2.17e-1)"	"unprognostic (2.12e-2)"	"prognostic favorable (1.88e-4)"	"unprognostic (2.19e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.69e-2)"	"prognostic unfavorable (4.89e-4)"	"unprognostic (1.77e-1)"	"unprognostic (2.36e-1)"	"unprognostic (1.40e-2)"	"unprognostic (2.16e-3)"	"unprognostic (7.30e-2)"	"unprognostic (1.17e-3)"	"unprognostic (3.07e-3)"	"unprognostic (4.94e-1)"	"unprognostic (2.52e-1)"	"unprognostic (1.92e-1)"	7.1	6.5	4.2	1.7	3.1	1.6	7.5	0.0	2.9	10.2	0.0	9.1	1.6	9.0	0.2	16.3	6.9	1.0	4.9	3.7	2.4	7.6	7.4	7.1	1.6	0.9	1.0	7.6	8.2	1.2	7.4	1.2	1.1	6.9	1.3	0.9	9.9	1.0	5.7	14.3	10.0	1.4	0.0	7.3	8.0	15.3	1.8	2.3	9.6	1.3	1.6	7.8	11.0	2.1	6.6	2.3	3.2	2.1	1.0	2.1	5.5	4.2	2.8	2.1	3.5	5.0	2.5	10.9	3.6	1.1	3.1	5.4	3.9	3.3	1.2	8.5	3.9	3.4	2.2	1.6	1.5	6.0	4.7	1.2	2.9	3.0	3.0	0.9	1.0	3.1	4.1	3.9	1.6	3.0	9.4	1.8	3.4	2.2	3.1	4.7	2.0	5.7	0.5	5.2	6.2	2.0	2.7	2.0	2.7	2.0	1.2	4.8	3.9	3.8	8.9	3.9	1.9	7.0	6.2	4.5	2.3	4.1	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.2	3.1	0.0	2.9	3.7	2.4	0.9	1.0	1.1	0.0	1.8	2.1	10.0	0.0	9.6	23.5	9.1	22.6	11.3	19.4	12.0	25.1	11.5	6.9	7.3	17.2	10.1	9.2	18.8	6.3	11.0	16.6	0.0	10.8	127.0	14.2	9.9	9.3	16.8	9.9	54.0	7.5	5.5	8.1	10.7	22.2	1.3	10.0	8.9	12.6	6.2	10.1	63.5	13.8	12.2	12.4	13.3	36.2	12.5	9.4	7.2	22.5	12.0	5.6	6.2	29.7	55.0	13.3	13.5	6.4	8.7	20.9	13.0	6.0	13.4	12.6	6.6	5.8	8.5	19.1	13.4	19.5	22.9	4.5	13.0	4.3	17.9	14.6
TCF4	"bHLHb19, E2-2, ITF2, SEF2-1B"	ENSG00000196628	"Transcription factor 4"	P15884	18	55222185-55664787	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Activator, DNA-binding"	"Corneal dystrophy, Disease variant, Epilepsy, Mental retardation, Primary microcephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 65.1"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 820.0;Endothelial cells: 574.5;Inhibitory neurons: 1177.6;Oligodendrocyte precursor cells: 719.8;Oligodendrocytes: 573.6"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in many"		"cerebellum: 65.1"	"Group enriched"	"Detected in many"	14	"memory B-cell: 173.6;naive B-cell: 146.8;plasmacytoid DC: 559.8"	"Group enriched"	"Detected in many"	33	"B-cells: 173.6;dendritic cells: 559.8"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 140.4;SH-SY5Y: 157.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB020722, HPA025958"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 21: Non-specific - Transcription"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Nucleoplasm, Cytosol"		"CAB020722: , HPA025958: AB_1857849"	"unprognostic (2.11e-1)"	"unprognostic (9.10e-2)"	"unprognostic (8.69e-2)"	"unprognostic (7.89e-3)"	"unprognostic (1.42e-1)"	"unprognostic (1.36e-3)"	"unprognostic (3.03e-2)"	"unprognostic (8.64e-2)"	"unprognostic (1.79e-2)"	"unprognostic (3.29e-2)"	"unprognostic (2.77e-1)"	"unprognostic (8.44e-2)"	"prognostic unfavorable (7.24e-5)"	"unprognostic (1.99e-3)"	"unprognostic (2.68e-2)"	"unprognostic (2.76e-3)"	"prognostic unfavorable (9.95e-4)"	20.3	9.6	3.7	12.8	12.5	9.5	11.6	65.1	26.5	28.5	0.0	7.4	5.1	23.0	2.1	9.7	13.4	17.4	17.5	29.8	0.0	4.4	4.4	15.5	14.7	5.5	1.0	25.9	5.8	8.0	6.5	28.9	3.9	6.6	7.9	14.0	6.8	10.2	6.1	6.4	5.0	24.1	2.2	13.1	6.0	15.4	2.4	9.8	13.3	16.7	14.7	13.1	7.3	14.4	0.1	4.1	36.8	11.4	8.5	14.4	0.1	18.4	40.6	13.2	17.2	23.1	3.6	28.8	0.1	41.9	2.7	4.5	17.9	17.1	9.2	140.4	13.9	12.1	0.1	0.0	4.0	5.3	2.8	19.6	5.3	18.5	0.7	9.1	45.8	1.6	19.5	22.0	11.0	0.0	7.6	0.0	10.4	0.1	2.4	41.6	14.9	65.4	0.0	0.9	12.6	157.7	0.0	1.5	0.0	11.1	1.6	1.3	49.1	48.5	17.4	2.1	14.6	16.3	32.2	25.7	11.0	5.2	15.5	0.9	7.4	0.8	0.9	8.3	0.7	173.6	0.2	0.5	20.6	146.8	0.5	0.3	1.8	11.2	7.4	559.8	0.7	11.3	3.7	12.5	65.1	26.5	29.8	0.0	5.5	1.0	3.9	2.2	2.4	14.4	820.0	6.4	13.1	501.1	217.4	117.0	37.8	34.0	80.8	293.0	6.5	23.4	35.5	4.3	32.6	22.0	83.4	1.8	446.8	0.1	0.0	1.5	103.2	17.5	201.4	574.5	5.4	34.2	503.8	7.1	1.5	296.7	1.5	12.2	13.9	105.7	316.3	6.6	39.6	25.2	1177.6	0.3	26.4	112.4	129.2	116.3	205.3	80.4	64.0	474.1	32.7	372.8	13.4	719.8	573.6	2.1	0.1	182.1	131.7	20.8	0.0	2.3	25.9	54.7	236.7	304.5	221.0	8.7	14.5	47.5	84.4	2.6	15.1	164.8	0.2	17.8
TCF7L1	TCF3	ENSG00000152284	"Transcription factor 7 like 1"	Q9HCS4	2	85133392-85310387	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation, Wnt signaling pathway"	"Activator, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 49.2;Astrocytes: 76.4;Leydig cells: 65.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"basophil: 5.1"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 43.3;NTERA-2: 99.0;RH-30: 44.7;T-47d: 44.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA071298			Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 50: Fibroblasts - ECM organization"	Nucleoplasm	Cytosol	"HPA071298: AB_2686383"	"unprognostic (1.59e-1)"	"unprognostic (1.86e-1)"	"unprognostic (3.64e-3)"	"prognostic unfavorable (1.70e-4)"	"unprognostic (1.05e-2)"	"unprognostic (1.17e-1)"	"prognostic unfavorable (6.16e-5)"	"unprognostic (1.79e-2)"	"unprognostic (3.59e-3)"	"unprognostic (2.73e-1)"	"unprognostic (5.17e-3)"	"unprognostic (1.69e-1)"	"prognostic unfavorable (2.06e-4)"	"prognostic unfavorable (2.72e-4)"	"unprognostic (1.70e-1)"	"unprognostic (3.52e-2)"	"prognostic unfavorable (5.38e-4)"	37.8	5.3	7.5	4.0	9.9	3.7	33.4	7.8	6.4	33.1	13.8	27.6	4.3	25.9	6.7	10.0	20.1	7.2	20.3	6.9	7.7	15.7	12.5	17.8	5.9	10.8	13.0	27.5	4.5	7.0	8.9	5.2	6.9	20.0	4.1	1.7	13.1	14.5	15.0	14.6	12.2	13.0	7.4	11.8	10.7	9.1	10.0	5.8	30.6	7.9	3.5	18.3	24.1	6.7	2.1	1.5	33.5	25.8	12.6	2.6	20.3	2.5	8.5	5.8	5.3	5.2	2.0	0.7	4.0	5.6	6.4	4.7	25.9	43.3	4.0	1.8	4.1	0.7	2.1	2.3	1.2	0.3	4.9	2.1	7.7	0.6	1.4	2.6	11.2	1.3	0.5	1.3	6.8	1.6	0.2	1.6	99.0	1.3	0.9	0.6	44.7	0.5	2.7	3.7	1.0	10.4	4.0	17.1	1.3	25.9	44.3	0.9	12.1	6.5	9.2	0.4	3.3	1.1	0.3	0.4	0.2	1.0	5.2	5.1	0.5	1.1	0.5	0.4	0.7	1.1	0.6	0.7	0.2	1.5	0.7	0.9	1.3	0.9	0.5	0.9	0.6	0.1	7.5	9.9	7.8	6.4	6.9	7.7	10.8	13.0	6.9	7.4	10.0	6.7	49.2	6.4	37.3	76.4	1.0	6.0	14.4	12.9	15.9	0.2	20.0	33.1	9.1	5.7	10.5	16.5	0.0	6.3	0.8	0.3	0.0	3.7	28.2	9.4	17.5	31.4	0.0	0.0	1.1	5.6	4.0	28.9	0.5	16.0	5.1	39.4	45.7	6.7	1.7	0.0	2.2	2.9	8.2	9.1	8.3	5.4	65.3	2.2	3.6	22.5	1.0	4.9	0.0	32.2	1.5	1.1	1.6	28.6	1.4	10.8	5.0	2.2	7.7	0.2	6.6	24.9	28.9	1.9	9.3	3.4	3.4	1.4	1.2	2.9	2.1	2.4
TCF7L2	"TCF-4, TCF4"	ENSG00000148737	"Transcription factor 7 like 2"	Q9NQB0	10	112950247-113167678	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation, Wnt signaling pathway"	"Activator, DNA-binding, Repressor"	"Cancer-related genes, Diabetes mellitus"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	9	"brain: 244.9"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 264.8;Distal enterocytes: 260.0;Extravillous trophoblasts: 231.4;Paneth cells: 211.1"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in many"		"thalamus: 244.9"	"Group enriched"	"Detected in many"	10	"intermediate monocyte: 28.9;non-classical monocyte: 86.6"	"Lineage enriched"	"Detected in many"	14	"monocytes: 86.6"	"Low cell line specificity"	"Detected in many"			"Group enriched"	"Detected in all"	9	"midbrain: 67.2;thalamus: 86.6"	"Group enriched"	"Detected in all"	5	"midbrain: 146.8;pons: 97.8;thalamus: 164.3"	"CAB013535, HPA038800"	Supported		Approved	"Nucleoplasm,Nuclear bodies,Cytosol"		Yes	No			"Cluster 51: Monocytes - Innate immune response"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm	"Nuclear bodies, Cytosol"	"CAB013535: AB_2533167, HPA038800: "	"unprognostic (1.79e-2)"	"unprognostic (3.36e-1)"	"unprognostic (1.11e-1)"	"unprognostic (2.31e-2)"	"unprognostic (4.59e-3)"	"unprognostic (1.72e-1)"	"unprognostic (2.09e-1)"	"unprognostic (9.84e-2)"	"unprognostic (5.09e-1)"	"unprognostic (7.10e-2)"	"unprognostic (6.10e-3)"	"unprognostic (3.46e-2)"	"unprognostic (7.25e-3)"	"unprognostic (1.60e-1)"	"unprognostic (1.55e-1)"	"unprognostic (3.64e-1)"	"unprognostic (7.36e-3)"	28.1	9.4	47.4	8.6	6.3	7.6	25.0	0.2	12.1	18.9	1.0	22.9	20.4	25.1	6.7	9.9	18.1	9.4	11.3	4.3	46.9	9.9	22.4	13.9	5.4	5.1	98.0	22.9	12.4	11.1	9.6	17.7	1.7	12.3	21.3	4.6	14.5	13.1	8.4	17.2	19.3	16.4	1.6	22.2	23.3	7.6	244.9	5.8	12.9	6.9	3.7	13.8	14.3	3.2	15.0	37.8	40.7	39.6	20.8	13.7	48.5	10.3	20.0	7.1	8.5	24.9	45.3	0.1	11.3	19.4	9.6	10.5	14.0	17.6	9.1	1.7	13.1	10.4	25.2	23.6	22.0	4.2	3.7	24.4	6.3	11.0	18.2	29.7	12.0	8.8	11.0	0.7	8.2	28.0	6.7	2.5	29.2	16.6	21.6	19.0	29.8	6.9	15.2	20.4	0.8	12.4	15.7	15.4	17.0	31.5	10.0	2.2	27.9	6.8	18.7	16.9	21.3	2.6	0.3	0.4	6.5	8.7	14.9	0.4	4.5	0.4	1.5	28.9	0.9	0.0	0.4	1.2	4.1	0.0	0.4	0.6	6.0	0.0	86.6	0.2	0.0	3.5	47.4	6.3	0.2	12.1	4.3	46.9	5.1	98.0	1.7	1.6	244.9	3.2	62.0	22.4	26.5	264.8	3.3	42.6	27.3	35.8	64.9	2.8	53.0	54.9	13.6	52.9	35.5	40.5	6.2	44.2	9.1	260.0	11.7	39.3	8.8	40.1	140.6	46.1	19.8	4.8	35.1	43.6	231.4	90.8	90.2	64.2	0.0	37.6	52.8	74.2	17.5	5.0	16.6	87.7	16.2	99.9	20.6	5.0	59.0	54.6	32.0	107.7	22.4	34.4	5.2	192.5	34.9	59.0	211.1	48.5	6.0	38.4	75.3	16.2	26.8	6.1	92.1	37.3	51.3	9.4	28.9	61.1	39.8	28.5	6.7	13.1	73.9	49.0
TCFL5	"bHLHe82, CHA, E2BP-1, Figlb"	ENSG00000101190	"Transcription factor like 5"	Q9UL49	20	62841005-62861822	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Spermatogenesis, Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 73.3;testis: 74.0"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 23.6;Oligodendrocytes: 32.4;Spermatocytes: 64.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA055223, HPA076419"	Enhanced		Supported	Nucleoplasm		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm		"HPA055223: AB_2682745, HPA076419: "	"unprognostic (4.05e-2)"	"unprognostic (3.14e-1)"	"unprognostic (2.19e-1)"	"prognostic unfavorable (3.24e-4)"	"unprognostic (2.78e-1)"	"unprognostic (2.72e-3)"	"unprognostic (3.95e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.10e-1)"	"unprognostic (2.79e-1)"	"unprognostic (1.14e-1)"	"unprognostic (3.88e-1)"	"unprognostic (1.54e-1)"	"unprognostic (9.77e-2)"	"unprognostic (4.89e-1)"	"unprognostic (1.33e-3)"	"unprognostic (1.01e-2)"	7.0	4.3	48.1	4.9	56.0	4.8	7.4	48.4	73.3	7.3	35.4	7.7	3.7	6.5	7.4	6.9	6.6	5.8	6.6	42.7	44.4	5.6	5.5	4.1	6.1	51.4	54.7	9.5	5.6	9.9	4.8	5.7	52.3	5.4	4.3	8.9	5.8	6.9	5.7	13.6	4.9	6.3	53.8	5.0	4.8	74.0	49.2	11.8	18.3	7.2	6.1	7.1	5.4	62.4	23.4	6.9	14.9	17.6	31.1	31.3	13.3	14.9	20.1	28.5	15.6	16.9	14.1	11.8	16.7	13.2	15.1	25.0	15.1	16.8	24.7	8.3	12.7	9.9	20.9	25.3	12.2	14.4	11.4	11.6	24.2	8.1	16.4	12.1	12.9	17.9	11.1	4.4	13.3	28.1	63.4	18.0	9.8	19.2	21.7	34.8	25.9	16.8	7.6	6.8	21.3	11.5	26.2	10.4	41.3	10.5	17.9	26.5	14.1	22.4	14.6	19.7	17.7	11.0	8.0	9.9	13.6	17.6	12.7	0.1	0.3	0.6	0.6	0.3	0.4	0.2	0.4	0.4	0.2	0.2	0.4	0.3	0.5	0.2	0.3	0.4	0.4	0.1	48.1	56.0	48.4	73.3	42.7	44.4	51.4	54.7	52.3	53.8	49.2	62.4	8.9	0.0	1.5	4.9	3.3	10.5	1.6	1.6	0.6	10.2	4.6	5.0	4.7	5.7	1.3	7.3	6.2	0.6	3.7	1.3	1.9	1.4	23.6	2.7	6.9	6.6	2.4	1.7	10.6	1.2	0.9	5.2	1.5	2.7	0.0	7.8	3.3	3.8	1.0	8.4	7.4	2.5	2.0	4.0	6.2	9.4	7.8	2.4	3.6	3.7	2.1	12.8	1.0	10.1	32.4	1.0	1.8	7.2	0.9	1.5	1.2	2.2	1.8	6.9	0.0	4.8	4.1	64.6	8.9	2.1	14.2	0.3	2.5	5.8	2.3	1.3
TCHP	"MGC10854, TpMs"	ENSG00000139437	"Trichoplein keratin filament binding"	Q9BT92	12	109900264-109983841	"Predicted intracellular proteins"	"Apoptosis, Cilium biogenesis/degradation"		"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA038638, HPA061543"	Supported		Approved	"Plasma membrane,Centrosome,Cytosol"		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 32: U-937 - Innate immune response"	"Cluster 52: Non-specific - Transcription"	"Plasma membrane, Centrosome, Cytosol"		"HPA038638: AB_10670785, HPA061543: AB_2684556"	"unprognostic (2.21e-1)"	"unprognostic (1.51e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.58e-1)"	"unprognostic (4.82e-2)"	"unprognostic (1.42e-2)"	"unprognostic (7.94e-2)"	"unprognostic (1.59e-2)"	"unprognostic (9.75e-2)"	"unprognostic (1.15e-3)"	"unprognostic (4.63e-2)"	"unprognostic (1.22e-1)"	"prognostic favorable (5.52e-4)"	"unprognostic (1.35e-1)"	"unprognostic (1.32e-1)"	"unprognostic (4.92e-2)"	6.5	7.3	9.7	8.9	10.6	6.8	6.6	10.9	11.3	10.1	8.1	10.4	7.3	9.1	7.5	15.4	7.6	5.9	8.1	9.4	10.5	7.8	5.6	7.3	11.7	10.4	10.5	8.9	10.9	7.4	6.4	7.6	10.5	8.6	6.8	9.2	10.5	7.9	9.1	27.4	8.2	7.6	9.2	11.8	8.2	9.3	10.7	10.4	8.6	7.0	11.6	9.3	13.8	11.0	27.6	24.0	12.7	15.3	11.0	11.9	17.3	25.6	13.4	21.8	12.1	15.2	9.4	38.2	7.2	14.9	11.8	22.5	14.0	16.0	19.5	20.7	13.8	27.6	15.3	15.0	13.3	38.0	20.4	9.8	19.1	22.9	17.1	13.7	19.7	23.8	30.5	7.5	18.2	18.9	35.0	38.4	15.3	6.6	24.2	31.7	24.9	32.4	9.9	24.2	18.8	19.8	18.5	19.8	18.2	9.0	17.9	27.2	21.8	22.2	15.5	14.3	32.7	21.8	29.5	27.0	23.5	31.0	23.7	0.0	2.7	2.3	3.6	1.7	2.6	2.0	3.2	4.5	2.1	1.3	3.2	2.5	2.7	5.9	3.7	1.5	4.7	3.1	9.7	10.6	10.9	11.3	9.4	10.5	10.4	10.5	10.5	9.2	10.7	11.0	11.7	19.2	21.4	18.9	10.4	9.8	7.7	9.5	8.0	28.9	11.3	11.4	13.2	17.2	12.0	7.3	18.8	11.2	14.3	12.8	9.8	20.7	32.5	23.0	19.1	15.2	14.8	15.4	8.3	15.1	8.4	11.4	10.2	13.2	13.3	15.7	7.9	7.4	11.6	25.2	12.3	10.7	10.2	13.0	7.8	47.6	11.1	11.4	7.2	1.9	14.3	13.9	35.0	10.1	19.4	18.8	14.4	27.8	15.0	9.1	14.2	6.6	33.6	24.0	13.1	19.6	12.6	25.1	33.2	14.8	24.7	7.0	15.9	30.9	12.2	30.7
TCP11L2	MGC40368	ENSG00000166046	"T-complex 11 like 2"	Q8N4U5	12	106301929-106347003	"Cancer-related genes, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 98.8;choroid plexus: 79.4"	"Cell type enhanced"	"Detected in many"		"Oligodendrocytes: 111.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 67.0"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 67.0"	"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 25.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039483, HPA042188"	Uncertain		Supported	"Nuclear speckles"		NA	NA			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Nuclear speckles"		"HPA039483: AB_10795291, HPA042188: AB_10794415"	"unprognostic (1.41e-1)"	"unprognostic (3.17e-1)"	"unprognostic (1.24e-1)"	"unprognostic (8.15e-2)"	"unprognostic (1.97e-1)"	"prognostic favorable (9.52e-4)"	"unprognostic (3.87e-3)"	"unprognostic (2.43e-1)"	"unprognostic (2.11e-1)"	"unprognostic (9.05e-3)"	"unprognostic (5.44e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.22e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.28e-1)"	"unprognostic (5.02e-2)"	"unprognostic (3.67e-1)"	11.5	8.8	16.4	7.9	43.0	30.3	10.3	32.6	24.5	9.2	79.4	7.7	7.5	10.0	4.2	22.9	13.1	9.5	22.6	12.9	22.4	6.7	6.5	16.7	10.2	46.6	33.2	9.0	6.0	10.2	4.8	14.5	43.3	6.7	9.0	10.3	12.1	6.5	17.9	13.9	9.8	8.2	28.4	11.7	12.1	10.6	30.8	13.6	11.6	23.0	16.8	8.5	9.3	98.8	3.3	8.1	1.1	2.3	10.6	12.2	5.0	2.1	10.2	1.3	3.2	1.3	4.3	1.1	3.2	8.1	3.0	15.2	1.0	4.5	2.3	1.7	3.3	0.7	3.4	5.1	10.4	0.3	2.1	15.4	10.2	1.6	7.6	25.1	7.5	5.9	2.0	1.5	1.9	2.4	2.0	1.7	1.4	4.4	5.0	1.0	0.3	3.8	10.1	15.2	5.0	3.6	5.5	1.7	6.0	8.4	4.6	0.3	5.7	1.9	1.6	2.9	0.5	10.0	0.8	3.8	5.3	0.3	1.0	29.6	6.9	11.0	4.8	3.1	3.6	12.4	9.9	5.4	1.7	10.6	12.2	8.3	67.0	4.3	5.3	1.2	12.3	3.8	16.4	43.0	32.6	24.5	12.9	22.4	46.6	33.2	43.3	28.4	30.8	98.8	12.6	12.8	14.4	15.0	23.1	1.1	3.4	4.4	5.7	8.1	3.5	5.5	10.5	0.0	8.6	3.7	22.9	1.5	13.4	4.2	1.9	3.6	6.3	28.6	7.3	12.1	4.2	33.7	7.7	2.6	0.8	10.5	11.2	20.5	2.5	4.3	6.1	1.5	1.2	21.9	23.9	5.0	2.0	3.1	2.0	4.5	5.9	5.2	3.6	12.2	8.0	3.1	10.3	9.0	111.0	3.7	4.8	2.6	9.9	4.0	5.9	1.2	16.7	13.4	13.1	11.8	7.2	4.3	3.0	6.3	2.6	15.1	12.4	8.0	1.2	8.7
TDG		ENSG00000139372	"Thymine DNA glycosylase"	Q13569	12	103965822-103988874	"Enzymes, Predicted intracellular proteins"	"DNA damage, DNA repair, Transcription, Transcription regulation"	"Activator, Chromatin regulator, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052263	Supported		Supported	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 65: Plasmacytoid DCs - Unknown function"	Nucleoplasm	"Plasma membrane"	"HPA052263: AB_2681777"	"unprognostic (3.15e-1)"	"unprognostic (1.36e-1)"	"unprognostic (9.89e-3)"	"unprognostic (6.93e-2)"	"unprognostic (3.66e-2)"	"unprognostic (1.13e-1)"	"prognostic unfavorable (6.27e-5)"	"unprognostic (1.56e-2)"	"prognostic unfavorable (6.90e-5)"	"unprognostic (5.37e-2)"	"unprognostic (1.82e-1)"	"unprognostic (8.48e-2)"	"prognostic unfavorable (1.90e-10)"	"unprognostic (3.68e-1)"	"unprognostic (2.90e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.16e-1)"	10.8	13.6	5.8	15.9	6.4	18.1	12.0	6.7	7.2	10.0	7.2	13.2	11.4	11.6	9.5	17.8	8.7	12.2	9.8	6.3	6.0	8.5	12.1	9.6	21.0	5.3	5.5	9.7	9.5	10.4	9.5	17.5	5.5	9.6	15.6	10.5	9.2	7.3	9.5	12.8	13.4	10.9	4.6	11.9	11.2	4.9	5.5	25.7	10.6	9.6	19.1	17.1	11.2	7.3	42.6	21.4	64.4	37.2	15.5	13.7	69.4	32.4	12.3	42.6	23.6	39.1	18.2	99.4	18.8	26.3	6.9	27.9	76.8	36.5	32.6	42.8	66.8	76.4	31.8	17.5	14.8	95.4	55.8	16.3	48.0	31.5	24.6	25.9	42.3	58.4	91.1	15.8	20.6	45.2	107.6	53.6	76.7	33.0	34.0	107.9	32.8	35.0	46.4	61.4	84.2	58.0	38.9	42.7	28.4	37.7	70.7	52.2	26.5	13.3	21.5	14.3	37.5	34.5	49.5	81.8	14.2	52.0	25.3	55.0	53.0	45.8	28.9	39.2	22.0	43.4	28.1	24.3	34.6	39.8	28.5	25.5	35.5	33.6	40.1	92.5	30.5	17.6	5.8	6.4	6.7	7.2	6.3	6.0	5.3	5.5	5.5	4.6	5.5	7.3	35.4	38.5	23.8	12.1	54.6	79.0	49.1	63.0	38.7	51.3	61.2	54.9	25.9	37.1	49.4	33.1	27.1	66.7	68.7	35.2	37.2	68.6	6.2	44.7	44.7	45.2	81.7	69.4	30.3	53.9	82.6	38.5	47.4	45.7	40.4	27.0	39.3	36.4	44.1	35.3	30.0	55.7	87.5	44.8	42.1	3.8	27.4	42.4	16.0	23.4	41.1	24.4	43.3	20.6	20.9	79.7	39.0	30.1	52.6	52.4	28.4	30.5	40.8	39.0	46.0	37.4	38.0	11.0	23.1	52.8	102.9	156.7	49.8	25.0	42.6	61.8
TDP1	"FLJ11090, SCAN1"	ENSG00000042088	"Tyrosyl-DNA phosphodiesterase 1"	Q9NUW8	14	89954939-90044764	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"DNA damage, DNA repair"	"Exonuclease, Hydrolase, Nuclease"	"Disease variant, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 123.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA071317	Approved		Supported	"Nucleoplasm,Plasma membrane"		No	No			"Cluster 44: Non-specific - Transcription"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	Nucleoplasm	"Plasma membrane"	"HPA071317: AB_2686388"	"unprognostic (5.60e-3)"	"unprognostic (3.53e-1)"	"unprognostic (7.03e-3)"	"unprognostic (1.34e-1)"	"unprognostic (7.45e-2)"	"unprognostic (7.22e-2)"	"prognostic unfavorable (8.99e-5)"	"unprognostic (2.61e-1)"	"unprognostic (1.46e-2)"	"unprognostic (5.84e-3)"	"unprognostic (2.51e-1)"	"unprognostic (6.46e-2)"	"unprognostic (1.10e-1)"	"unprognostic (3.41e-1)"	"unprognostic (1.64e-1)"	"unprognostic (2.91e-2)"	"unprognostic (1.26e-1)"	5.5	3.9	4.8	11.8	4.5	13.9	8.9	6.6	4.9	6.6	7.1	7.8	6.5	5.9	5.8	8.2	9.2	6.6	2.6	4.1	5.3	7.0	6.5	4.7	19.0	3.8	3.6	6.4	4.8	5.1	4.6	8.2	3.9	5.0	10.1	4.9	5.5	4.3	2.1	6.4	7.0	6.3	2.8	10.6	7.9	22.3	4.6	28.3	4.9	1.7	23.7	8.1	5.0	4.2	33.8	18.6	40.9	37.5	10.1	14.0	32.7	31.7	25.9	38.4	34.6	13.6	35.5	42.9	23.3	21.7	12.9	33.9	18.2	29.5	55.2	44.1	19.6	43.9	16.7	16.6	8.7	73.2	24.1	10.1	12.9	26.9	24.9	21.9	49.5	57.3	30.6	43.5	45.9	35.0	56.3	39.2	10.0	39.8	43.7	42.3	77.3	34.0	24.6	27.3	30.7	20.9	26.9	77.6	10.1	27.0	31.0	30.8	39.9	16.5	15.7	23.0	28.7	31.8	60.4	52.3	35.5	32.3	24.6	28.7	8.9	15.1	18.8	14.6	18.3	21.1	19.8	20.8	14.2	20.0	21.7	23.1	5.7	23.8	14.1	15.0	32.2	14.8	4.8	4.5	6.6	4.9	4.1	5.3	3.8	3.6	3.9	2.8	4.6	4.2	2.9	0.0	1.1	4.2	15.2	4.7	4.9	7.4	4.0	3.0	6.4	7.1	1.4	1.5	5.0	14.7	8.4	11.4	14.6	3.8	5.9	9.2	123.5	13.2	6.1	3.6	3.6	12.8	13.4	5.6	14.9	4.3	7.7	9.2	2.5	8.9	3.9	4.2	8.8	3.3	13.9	4.9	0.0	6.8	10.2	36.7	2.8	7.8	1.8	1.9	8.0	1.5	8.2	8.0	24.2	6.4	4.8	3.0	16.9	5.7	2.9	7.8	11.0	2.7	0.0	3.4	5.4	33.7	22.8	8.7	4.5	10.1	15.0	10.3	7.9	4.0
TDP2	TTRAP	ENSG00000111802	"Tyrosyl-DNA phosphodiesterase 2"	O95551	6	24649979-24666930	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"DNA damage, DNA repair, Host-virus interaction"	"Hydrolase, Nuclease"	"Mental retardation, Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 183.2"	"Cell type enhanced"	"Detected in all"		"Distal enterocytes: 530.9;Paneth cells: 428.1;Proximal enterocytes: 637.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"basophil: 75.6;neutrophil: 228.9"	"Lineage enriched"	"Detected in all"	7	"granulocytes: 228.9"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB073398, HPA074011"	Enhanced		Supported	"Nucleoplasm,Nuclear bodies"	"Intracellular and membrane"	No	No			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 9: Intestine - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 45: Enterocytes - Digestion"	"Nucleoplasm, Nuclear bodies"		"CAB073398: , HPA074011: AB_2686651"	"unprognostic (2.46e-2)"	"unprognostic (2.10e-3)"	"unprognostic (1.83e-1)"	"unprognostic (2.19e-2)"	"unprognostic (2.58e-1)"	"unprognostic (4.66e-3)"	"unprognostic (4.13e-3)"	"unprognostic (3.24e-1)"	"unprognostic (5.78e-3)"	"prognostic favorable (2.53e-7)"	"unprognostic (1.20e-2)"	"prognostic unfavorable (1.86e-4)"	"unprognostic (1.40e-2)"	"unprognostic (1.42e-1)"	"unprognostic (9.70e-3)"	"unprognostic (1.14e-1)"	"prognostic favorable (1.47e-5)"	24.4	23.7	27.4	34.3	28.4	21.8	27.3	30.4	36.4	20.6	30.4	141.6	120.1	19.7	25.3	18.6	22.6	28.6	28.2	28.0	28.9	77.9	51.2	24.5	38.9	28.2	29.5	21.3	29.5	25.7	20.3	20.1	28.7	56.5	127.4	18.9	21.9	21.7	21.9	21.1	183.2	24.6	28.3	27.9	26.2	25.3	32.1	37.5	21.7	26.3	37.7	27.2	16.5	28.3	47.7	37.1	41.5	48.1	63.0	64.0	32.4	41.4	53.1	38.9	51.9	50.8	26.3	57.0	70.1	43.8	90.0	34.2	51.2	47.3	52.9	73.6	53.1	53.4	37.7	84.2	40.1	82.8	49.5	43.1	43.7	40.7	36.5	46.0	63.9	54.1	48.8	23.7	59.2	34.1	64.7	52.8	37.1	54.7	31.8	55.5	43.7	61.6	67.0	66.5	52.2	29.8	33.6	84.5	71.0	42.2	38.9	47.4	48.0	37.6	31.3	28.3	61.4	33.7	107.9	77.1	26.0	107.5	61.3	75.6	13.9	29.4	25.0	14.8	30.8	20.0	28.8	27.9	13.2	14.5	24.0	26.2	228.9	29.0	16.5	12.4	31.9	22.7	27.4	28.4	30.4	36.4	28.0	28.9	28.2	29.5	28.7	28.3	32.1	28.3	24.0	6.4	16.7	23.5	24.1	14.1	25.1	37.0	18.8	12.7	19.8	20.2	23.4	37.1	29.6	22.0	6.2	18.4	23.0	530.9	49.0	35.4	140.6	19.4	16.6	22.5	52.7	20.8	25.9	36.0	23.6	18.3	14.3	19.7	24.1	15.7	27.5	31.4	68.4	6.7	25.8	168.9	30.5	28.9	20.0	80.2	18.0	33.5	12.4	15.0	61.7	19.5	38.1	11.6	21.2	21.4	428.1	23.3	10.7	37.0	637.5	175.8	30.5	15.8	32.9	19.1	20.4	9.0	32.7	10.4	16.6	44.3	28.5	15.7	119.3	31.9
TDRD3	FLJ21007	ENSG00000083544	"Tudor domain containing 3"	Q9H7E2	13	60396457-60573878	"Predicted intracellular proteins"		"Chromatin regulator"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Astrocytes: 169.1;granulocytes: 152.3;Inhibitory neurons: 128.9;Oligodendrocyte precursor cells: 142.7;Oligodendrocytes: 168.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034925, HPA067153"	Approved		Enhanced	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Nucleoplasm	"Golgi apparatus, Cytosol"	"CAB034925: AB_2240523, HPA067153: AB_2732759"	"unprognostic (8.52e-2)"	"unprognostic (3.19e-1)"	"unprognostic (2.23e-1)"	"prognostic favorable (2.77e-4)"	"unprognostic (5.21e-2)"	"unprognostic (2.62e-1)"	"unprognostic (7.37e-2)"	"unprognostic (5.79e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.84e-1)"	"unprognostic (6.18e-3)"	"unprognostic (9.62e-2)"	"unprognostic (9.95e-2)"	"unprognostic (3.68e-2)"	"unprognostic (4.40e-2)"	"unprognostic (1.27e-3)"	8.8	8.2	14.2	6.8	18.7	5.8	12.0	18.2	16.4	10.6	12.7	9.9	9.5	10.8	9.9	10.4	9.8	9.2	10.7	11.8	16.0	11.4	9.4	12.5	9.1	17.1	15.5	14.0	14.1	10.9	7.7	6.0	16.6	8.0	11.1	10.9	9.3	7.4	16.7	11.3	8.7	9.2	16.0	8.7	11.2	12.3	17.9	11.9	12.0	18.5	9.2	8.1	7.7	21.2	6.7	7.3	15.3	36.7	5.9	13.3	9.5	7.6	8.4	8.7	5.6	4.9	10.9	16.0	3.0	11.1	7.4	8.9	12.6	11.0	9.4	12.5	10.1	30.4	13.7	9.4	12.0	21.3	15.4	8.9	15.4	5.1	15.1	17.9	12.0	13.3	6.7	9.7	9.5	7.4	19.5	11.4	11.7	24.4	5.5	10.1	7.5	11.0	12.0	8.8	13.8	16.4	10.9	13.2	27.9	10.9	6.8	9.3	10.2	5.4	5.6	6.1	8.5	18.8	17.7	13.7	5.0	11.0	16.7	0.3	1.4	1.6	3.2	2.2	2.3	2.2	3.7	3.7	2.1	1.4	3.0	3.8	0.1	2.1	1.7	4.6	4.5	1.3	14.2	18.7	18.2	16.4	11.8	16.0	17.1	15.5	16.6	16.0	17.9	21.2	24.5	22.4	30.0	169.1	13.8	7.9	9.6	9.3	14.8	30.9	10.8	10.2	44.4	11.5	18.2	11.0	54.2	8.8	18.7	11.5	21.5	13.4	20.9	18.8	24.4	15.9	17.4	7.2	101.1	17.8	10.6	18.5	18.3	15.7	152.3	26.1	11.7	8.8	6.9	20.2	128.9	12.8	12.2	9.5	7.8	24.4	19.0	22.2	19.6	69.3	12.2	12.7	20.6	142.7	168.7	10.6	19.2	18.4	14.6	7.1	12.4	12.3	22.8	30.6	6.6	32.9	12.9	38.9	21.6	14.1	6.7	6.7	20.9	30.6	14.0	8.0
TDRD7	PCTAIRE2BP	ENSG00000196116	"Tudor domain containing 7"	Q8NHU6	9	97412096-97496125	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Differentiation, Spermatogenesis"	RNA-binding	"Cataract, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"retina: 63.1"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 44.7;Microglial cells: 33.7;Rod photoreceptor cells: 44.4;Spermatocytes: 36.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"GAMG: 56.5;HDLM-2: 55.6;THP-1: 54.4"	"Low region specificity"	"Detected in all"							"CAB020800, HPA022250, HPA024529"	Enhanced		Supported	"Nucleoplasm,Cytoplasmic bodies"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 77: Retina - Visual perception"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 46: Photoreceptor cells - Phototransduction"	"Cytoplasmic bodies"	Nucleoplasm	"CAB020800: , HPA022250: , HPA024529: AB_1857869"	"unprognostic (8.22e-2)"	"unprognostic (1.62e-2)"	"unprognostic (3.28e-3)"	"unprognostic (1.03e-1)"	"unprognostic (2.88e-1)"	"unprognostic (3.07e-1)"	"prognostic unfavorable (5.91e-4)"	"unprognostic (2.88e-2)"	"unprognostic (9.86e-2)"	"unprognostic (2.00e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.74e-2)"	"prognostic favorable (4.76e-5)"	"unprognostic (4.03e-2)"	"unprognostic (2.90e-1)"	"unprognostic (1.17e-2)"	"unprognostic (2.67e-1)"	7.3	6.2	11.9	8.0	13.6	11.1	6.7	13.0	12.5	6.7	10.4	14.4	15.8	6.9	6.4	8.9	8.8	10.2	6.5	11.0	13.1	6.9	8.1	9.7	8.1	14.2	12.3	7.4	5.7	9.8	5.9	8.9	14.4	6.1	13.9	63.1	7.5	7.3	4.7	5.4	13.7	9.8	14.6	9.0	8.5	36.9	12.3	11.0	7.9	5.4	8.4	8.2	6.7	15.4	17.1	11.7	0.0	4.0	8.7	11.2	9.8	10.6	26.7	35.8	39.9	15.2	14.1	1.1	5.1	15.1	56.5	12.8	9.8	5.4	9.6	55.6	8.3	7.8	5.5	11.1	7.9	17.6	18.0	3.8	10.7	11.9	1.2	10.7	15.7	8.2	4.4	0.8	9.5	10.2	8.8	8.6	1.7	20.1	6.2	3.8	5.9	0.2	8.8	11.4	1.8	4.8	14.8	6.5	41.6	6.2	3.9	54.4	16.1	4.5	4.4	11.4	8.2	5.5	6.9	1.0	10.6	9.4	11.8	1.7	2.2	7.2	1.1	4.3	1.6	3.0	1.5	1.1	3.2	2.5	1.2	1.9	4.2	1.2	4.2	0.7	1.1	1.2	11.9	13.6	13.0	12.5	11.0	13.1	14.2	12.3	14.4	14.6	12.3	15.4	7.0	0.0	3.0	10.4	5.7	1.7	2.6	2.2	2.8	8.2	2.7	2.4	6.4	1.5	4.0	3.7	18.8	1.7	3.0	14.2	5.9	4.4	44.7	11.1	5.2	6.0	6.0	1.7	18.5	4.9	2.2	4.3	10.2	8.0	0.0	5.4	2.9	2.5	4.8	5.0	19.0	7.9	2.0	6.4	1.8	23.9	4.4	7.3	1.8	33.7	10.8	8.6	1.0	21.1	29.9	6.1	7.6	3.8	4.3	2.2	8.9	2.8	12.9	44.4	6.6	3.7	4.2	36.4	15.7	4.4	2.3	0.7	4.7	2.6	7.2	4.3
TDRP	"C8orf42, INM01, TDRP1, TDRP2"	ENSG00000180190	"Testis development related protein"	Q86YL5	8	489803-545781	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 151.3;Early spermatids: 80.7;Syncytiotrophoblasts: 272.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BEWO: 56.1;HBEC3-KT: 27.6;hTERT-RPE1: 23.7;SuSa: 27.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008462	Approved		Supported	Vesicles,Cytosol		NA	NA		52000		"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	"Vesicles, Cytosol"		"HPA008462: AB_1845777"	"unprognostic (1.17e-1)"	"unprognostic (1.88e-1)"	"unprognostic (5.51e-2)"	"prognostic unfavorable (1.52e-4)"	"unprognostic (1.98e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.13e-1)"	"unprognostic (3.72e-3)"	"unprognostic (4.13e-2)"	"unprognostic (1.08e-1)"	"prognostic favorable (9.37e-4)"	"unprognostic (1.74e-1)"	"unprognostic (3.43e-2)"	"unprognostic (5.46e-4)"	"unprognostic (2.38e-2)"	"unprognostic (2.98e-2)"	"unprognostic (1.50e-1)"	8.7	10.4	12.4	2.2	13.6	0.2	8.7	12.8	14.4	13.3	23.0	6.8	2.1	10.0	9.8	3.9	18.5	10.7	4.6	12.5	14.7	26.9	15.9	9.8	4.4	14.2	13.5	19.5	8.9	16.1	16.7	36.4	13.2	14.7	2.6	16.9	6.5	8.6	1.7	3.3	4.9	5.1	12.4	4.0	6.1	14.0	15.5	4.8	24.6	2.6	5.1	9.9	7.7	10.8	9.9	9.8	16.7	0.0	0.0	0.0	56.1	5.6	3.5	5.3	4.6	0.0	0.0	0.0	2.3	1.8	5.3	2.1	0.0	27.6	6.6	0.0	0.7	0.1	0.0	14.8	6.4	0.0	4.1	6.4	21.4	0.0	10.0	23.7	0.8	0.1	1.2	0.0	5.7	0.0	0.1	0.1	20.0	0.0	2.1	0.0	0.0	0.0	17.0	14.5	5.0	8.1	0.0	17.2	4.5	27.4	5.7	0.0	0.3	0.3	1.7	0.0	0.5	0.0	0.0	0.0	1.7	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.4	13.6	12.8	14.4	12.5	14.7	14.2	13.5	13.2	12.4	15.5	10.8	20.4	22.4	15.4	41.8	1.0	23.5	28.6	7.3	39.3	17.8	15.8	10.8	4.4	12.8	10.5	18.4	2.1	151.3	0.4	0.5	43.0	10.2	80.7	19.5	10.7	21.2	7.8	0.0	33.3	4.8	61.2	12.2	0.5	7.3	0.0	9.7	7.9	21.0	12.7	10.1	39.9	1.6	16.2	1.9	5.8	16.1	7.2	7.4	8.8	53.4	0.2	9.2	0.0	16.6	4.5	2.9	1.0	6.4	2.5	34.3	0.0	20.7	28.4	12.4	19.7	9.0	10.5	21.5	11.0	7.1	7.0	272.1	0.9	1.7	0.7	14.7
TEAD4	"EFTR-2, RTEF-1, TCF13L1, TEF-3, TEFR-1"	ENSG00000197905	"TEA domain transcription factor 4"	Q15561	12	2959330-3040676	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 127.3"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 50.3;Exocrine glandular cells: 38.3;Hepatic stellate cells: 32.2;Proximal enterocytes: 37.9;Syncytiotrophoblasts: 34.6"	"Cancer enriched"	"Detected in all"	5	"testis cancer: 78.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 364.1"	"Region enriched"	"Detected in single"	5	"cerebellum: 3.1"	"Low region specificity"	"Detected in all"			HPA056896	Uncertain		Supported	Nucleoplasm		NA	NA				"Cluster 59: Non-specific - Translation"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 47: Cytotrophoblasts - Unknown function"	Nucleoplasm		"HPA056896: AB_2683268"	"unprognostic (3.68e-1)"	"unprognostic (3.98e-1)"	"unprognostic (2.17e-1)"	"unprognostic (1.55e-3)"	"unprognostic (1.33e-1)"	"unprognostic (3.68e-1)"	"unprognostic (9.20e-3)"	"unprognostic (2.21e-3)"	"unprognostic (3.01e-1)"	"unprognostic (1.24e-1)"	"unprognostic (2.50e-2)"	"unprognostic (2.03e-1)"	"prognostic unfavorable (9.78e-9)"	"unprognostic (5.05e-3)"	"unprognostic (8.43e-2)"	"unprognostic (2.42e-2)"	"unprognostic (1.23e-3)"	17.4	5.2	4.2	7.1	3.6	0.4	12.0	5.6	5.5	10.4	4.0	8.1	4.8	9.7	1.0	7.8	8.3	4.5	20.0	3.5	3.9	33.7	4.6	26.0	1.6	5.3	4.8	4.5	51.1	1.6	3.4	10.9	6.1	8.5	4.1	0.5	8.0	5.0	127.3	16.4	8.4	8.9	4.0	9.0	8.1	3.7	6.4	1.6	23.6	46.7	2.4	11.3	7.1	3.6	37.6	51.5	13.0	36.2	4.0	8.7	137.8	29.5	15.6	49.7	27.8	99.6	39.0	0.3	22.2	22.5	34.0	52.5	51.2	364.1	46.1	0.2	41.2	59.1	43.7	87.7	18.8	12.8	10.7	12.2	14.8	43.3	66.7	20.8	42.9	23.4	38.4	0.5	17.5	53.2	0.7	0.3	99.5	48.0	30.0	27.4	73.7	28.9	23.6	15.3	7.4	13.2	36.4	89.9	27.1	93.8	61.2	21.8	49.4	28.7	100.1	20.2	15.7	0.1	0.2	0.4	23.3	0.0	37.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.2	3.6	5.6	5.5	3.5	3.9	5.3	4.8	6.1	4.0	6.4	3.6	17.1	12.8	4.7	0.0	0.1	12.2	12.6	6.1	9.1	0.1	6.6	3.7	2.4	5.7	2.3	7.3	0.0	50.3	0.4	3.7	5.9	17.7	0.3	3.0	5.1	25.9	0.0	0.0	1.6	38.3	18.3	6.6	4.1	5.0	5.7	3.4	32.2	0.4	5.2	0.0	0.5	3.7	2.0	0.8	1.5	2.3	0.0	0.5	8.8	3.7	0.0	0.0	0.0	0.0	0.4	21.1	0.9	0.4	1.2	28.9	37.9	21.1	1.5	0.1	0.0	9.3	12.2	0.5	6.4	5.4	7.7	34.6	0.5	0.4	7.1	4.9
TEC	PSCTK4	ENSG00000135605	"Tec protein tyrosine kinase"	P42680	4	48135783-48269838	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Adaptive immunity, Immunity"	"Kinase, Transferase, Tyrosine-protein kinase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Endometrial ciliated cells: 13.9;Glandular and luminal cells: 25.1;granulocytes: 19.6;Plasma cells: 15.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in some"	5	"basophil: 20.7;eosinophil: 13.3"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 20.7"	"Cell line enhanced"	"Detected in many"		"HEL: 13.5;HMC-1: 20.3;U-266/70: 20.3;U-266/84: 15.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA005733, HPA024657"	Approved		Supported	"Plasma membrane"		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 44: Endometrium - Transcription"	"Plasma membrane"		"HPA005733: AB_1857878, HPA024657: AB_2671637"	"unprognostic (7.19e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.41e-2)"	"unprognostic (4.07e-3)"	"unprognostic (4.21e-2)"	"unprognostic (8.57e-2)"	"unprognostic (3.14e-1)"	"unprognostic (1.67e-1)"	"unprognostic (8.36e-2)"	"prognostic favorable (7.12e-4)"	"unprognostic (7.46e-3)"	"unprognostic (7.83e-2)"	"unprognostic (1.01e-4)"	"unprognostic (4.24e-2)"	"unprognostic (2.16e-1)"	"unprognostic (7.39e-2)"	"unprognostic (4.96e-3)"	0.9	1.7	0.1	2.1	0.2	6.1	1.4	0.1	0.4	1.2	1.0	1.3	1.6	1.1	4.2	3.4	1.9	1.1	1.3	0.0	0.4	1.1	2.5	2.0	3.1	1.1	0.3	0.4	0.8	1.2	0.6	1.1	1.1	0.5	1.3	1.8	2.3	1.0	0.6	3.6	1.5	0.8	0.3	1.7	1.1	1.2	0.7	2.0	1.3	0.5	3.3	1.0	1.6	0.2	3.0	0.8	0.0	0.0	0.0	0.0	0.1	0.5	2.2	1.3	2.7	0.0	2.2	1.9	2.0	0.0	0.1	0.6	1.1	0.0	1.8	0.1	0.8	13.5	1.0	0.1	0.0	2.2	20.3	0.0	0.3	1.7	0.0	1.4	0.0	0.6	7.5	0.5	4.1	1.0	1.3	4.9	0.4	1.4	0.8	3.1	2.7	0.0	3.4	0.9	0.0	0.2	0.6	0.3	0.5	1.1	0.7	4.2	0.0	0.0	0.0	2.8	0.0	20.3	15.4	2.6	0.0	3.0	0.1	20.7	0.6	13.3	0.1	0.7	0.3	1.0	0.2	0.5	1.5	0.7	0.5	0.5	0.5	3.6	0.1	0.1	0.1	0.4	0.1	0.2	0.1	0.4	0.0	0.4	1.1	0.3	1.1	0.3	0.7	0.2	0.6	6.4	6.8	0.7	6.8	2.5	1.7	0.2	2.8	0.9	1.7	1.1	1.8	7.2	2.6	0.0	0.0	1.5	3.3	2.1	0.0	1.7	6.4	13.9	1.5	1.2	3.0	12.6	6.7	1.1	0.1	0.8	0.0	25.1	19.6	0.7	0.0	2.9	4.9	0.0	1.6	1.4	4.1	4.6	1.8	2.6	0.0	5.9	1.8	10.3	1.7	6.6	0.0	0.5	0.2	1.0	0.6	0.4	15.4	1.3	3.0	2.0	0.2	3.1	6.6	1.8	0.8	0.7	1.4	9.8	3.0	0.8	3.4	0.3	2.1	1.6
TECPR1	"DKFZP434B0335, FLJ23419, FLJ90593, KIAA1358"	ENSG00000205356	"Tectonin beta-propeller repeat containing 1"	Q7Z6L1	7	98214624-98252232	"Predicted intracellular proteins"	Autophagy			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"pancreas: 84.9"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 106.3;Rod photoreceptor cells: 66.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021061	Approved		Supported	Vesicles		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 25: Pancreas - Digestion"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 9: Photoreceptor cells - Phototransduction"	Vesicles		"HPA021061: AB_1847687"	"unprognostic (8.10e-3)"	"unprognostic (7.89e-2)"	"unprognostic (9.05e-3)"	"unprognostic (5.00e-3)"	"unprognostic (2.03e-1)"	"unprognostic (1.11e-2)"	"unprognostic (2.49e-2)"	"unprognostic (1.45e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.88e-1)"	"prognostic favorable (8.12e-4)"	"unprognostic (2.48e-1)"	"unprognostic (2.54e-1)"	"unprognostic (1.38e-1)"	"unprognostic (3.24e-1)"	"unprognostic (9.46e-2)"	"unprognostic (6.12e-2)"	8.4	7.0	11.7	10.4	12.3	6.1	8.0	6.5	12.5	6.4	4.7	8.5	9.2	6.8	3.0	9.8	6.9	5.7	9.9	12.7	12.9	7.7	9.2	13.3	11.8	11.8	11.2	5.7	84.9	3.1	16.7	8.6	12.7	11.6	5.0	10.2	18.9	3.8	9.1	5.9	10.8	4.7	8.5	18.6	18.3	4.6	11.5	9.5	9.6	5.0	6.7	6.8	6.6	8.2	4.4	6.1	8.4	18.3	7.2	4.3	6.2	9.1	5.0	7.1	8.7	5.8	5.4	3.6	14.4	10.6	8.8	2.8	5.7	4.2	3.0	8.8	8.0	5.3	9.4	5.3	8.5	6.5	9.9	7.5	3.4	6.9	5.3	6.6	25.2	15.1	3.6	15.0	5.4	7.2	9.4	6.8	3.3	8.6	5.9	7.8	8.5	17.7	5.4	4.8	15.0	16.9	5.4	14.9	8.5	6.1	4.8	9.2	26.0	6.7	11.5	17.4	7.6	17.6	9.8	1.9	14.0	5.6	12.5	2.5	2.9	0.9	2.2	3.2	1.3	1.8	2.9	1.7	1.8	1.6	4.8	4.2	3.5	1.0	4.9	2.4	3.0	2.3	11.7	12.3	6.5	12.5	12.7	12.9	11.8	11.2	12.7	8.5	11.5	8.2	32.2	9.6	18.4	18.3	12.3	2.3	2.2	3.7	1.8	37.1	7.0	5.8	11.2	7.2	7.0	5.5	106.3	6.0	10.9	16.0	1.9	6.4	2.1	6.9	5.5	22.9	29.3	2.1	21.1	13.4	9.8	7.2	35.7	8.1	8.2	11.0	21.0	8.5	13.7	32.0	17.8	22.9	10.2	20.5	4.0	2.2	7.2	14.2	1.8	16.9	19.5	11.4	14.4	10.1	10.1	11.9	10.3	3.4	17.4	4.1	10.8	3.6	7.7	66.7	0.0	7.5	7.4	5.5	4.5	7.1	1.8	3.4	16.0	9.0	10.0	2.9
TECR	"GPSN2, MRT14, SC2, TER"	ENSG00000099797	"Trans-2,3-enoyl-CoA reductase"	Q9NZ01	19	14517085-14565980	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Sphingolipid metabolism"	Oxidoreductase	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 1013.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029780, HPA056488"	Supported		Supported	"Endoplasmic reticulum"		NA	NA		10000	"Cluster 20: T-cells - T-cell receptor"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 21: OE19 - Mitochondria"	"Cluster 10: Non-specific - Unknown function"	"Endoplasmic reticulum"		"HPA029780: AB_10603348, HPA056488: AB_2683149"	"unprognostic (9.73e-2)"	"unprognostic (3.69e-3)"	"unprognostic (1.55e-1)"	"unprognostic (8.08e-3)"	"unprognostic (1.20e-1)"	"unprognostic (3.96e-2)"	"unprognostic (3.68e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.36e-1)"	"unprognostic (9.16e-2)"	"unprognostic (1.29e-1)"	"unprognostic (5.05e-2)"	"unprognostic (3.65e-3)"	"unprognostic (2.53e-3)"	"unprognostic (2.34e-1)"	"unprognostic (2.07e-2)"	"prognostic unfavorable (2.60e-4)"	102.7	162.6	189.0	43.1	201.7	74.2	100.4	220.8	237.5	156.8	216.5	78.5	106.1	53.2	103.2	373.2	87.1	49.7	78.4	180.1	200.0	112.2	133.9	67.8	55.7	209.6	191.2	80.9	105.5	306.1	78.7	68.0	212.2	85.7	59.3	82.8	222.3	83.5	366.3	263.5	95.9	36.7	207.6	75.4	81.7	182.7	199.9	65.8	92.7	209.6	85.3	51.6	185.9	230.2	220.5	162.1	149.5	169.6	214.7	97.2	156.9	62.8	175.2	196.3	242.9	225.3	246.2	113.8	127.4	134.2	152.4	328.8	158.1	254.3	84.0	192.3	165.9	193.7	225.4	254.6	129.7	139.5	143.7	144.9	201.8	174.3	96.1	98.4	93.7	169.2	128.9	391.5	104.0	289.3	170.1	248.3	155.6	556.1	227.6	154.4	96.1	521.1	275.1	115.8	183.2	113.0	103.1	278.4	139.6	77.2	151.3	274.4	55.2	160.5	66.8	141.0	212.6	118.4	119.8	122.7	163.8	212.6	162.2	55.6	72.7	52.5	137.8	106.4	148.8	100.1	180.1	159.1	124.2	99.1	207.1	164.5	32.7	183.7	83.9	137.1	290.1	170.9	189.0	201.7	220.8	237.5	180.1	200.0	209.6	191.2	212.2	207.6	199.9	230.2	60.4	73.7	71.1	47.7	87.6	169.5	227.5	297.9	125.7	90.8	161.1	155.6	52.9	120.1	221.5	165.5	123.0	509.5	88.1	159.2	56.7	166.2	443.9	102.2	40.1	64.7	100.0	80.1	15.3	225.1	525.5	81.8	89.7	64.2	36.1	90.1	73.2	143.1	188.0	112.7	19.2	144.0	199.4	113.8	99.3	1013.1	72.7	77.8	163.7	18.7	61.6	577.9	103.0	12.5	46.5	104.8	128.2	60.2	206.1	110.2	343.2	202.9	213.1	177.5	65.7	68.4	286.7	215.0	134.2	255.3	239.7	486.2	117.7	116.0	216.2	196.5
TEK	"CD202b, TIE-2, TIE2, VMCM, VMCM1"	ENSG00000120156	"TEK receptor tyrosine kinase"	Q02763	9	27109141-27230174	"Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins"	Angiogenesis	"Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease variant, FDA approved drug targets, Glaucoma"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 46.3"	"Group enriched"	"Detected in many"	10	"Adipocytes: 70.8;Endothelial cells: 73.9;Hepatic stellate cells: 122.0;Microglial cells: 38.4;Oligodendrocyte precursor cells: 137.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"HUVEC TERT2: 90.9;NTERA-2: 45.2;TIME: 99.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010359, HPA073265"	Approved		Supported	"Plasma membrane,Centriolar satellite"	"Secreted to blood"	NA	NA	7750000	13000000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Plasma membrane"	"Centriolar satellite"	"CAB010359: AB_2203226, HPA073265: AB_2686592"	"unprognostic (2.24e-1)"	"unprognostic (1.74e-1)"	"unprognostic (5.55e-2)"	"unprognostic (1.83e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.26e-3)"	"prognostic favorable (2.31e-5)"	"unprognostic (7.48e-2)"	"unprognostic (1.72e-2)"	"unprognostic (1.41e-1)"	"unprognostic (5.58e-2)"	"unprognostic (2.72e-1)"	"prognostic favorable (7.81e-4)"	"unprognostic (7.50e-3)"	"unprognostic (6.87e-3)"	"unprognostic (1.83e-1)"	"unprognostic (5.24e-3)"	20.1	9.1	8.1	5.8	7.0	0.2	14.0	6.1	8.4	9.3	4.3	5.0	3.7	12.4	2.3	5.3	6.7	11.2	16.8	7.1	6.8	23.0	10.5	28.8	3.7	7.2	6.6	3.5	3.5	4.4	3.0	46.3	7.6	3.8	5.4	0.7	3.1	6.2	10.5	2.8	5.5	12.7	6.8	28.8	4.0	1.4	9.4	1.8	9.1	22.9	2.8	6.9	3.9	6.8	0.3	0.0	3.5	0.0	0.4	5.6	0.1	3.2	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.0	2.4	0.0	1.6	0.0	0.0	1.8	0.0	2.2	0.8	0.1	90.9	0.0	0.0	0.0	0.7	0.0	0.0	0.0	45.2	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	18.3	0.0	0.0	99.1	0.0	0.5	9.1	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	8.1	7.0	6.1	8.4	7.1	6.8	7.2	6.6	7.6	6.8	9.4	6.8	70.8	3.2	1.3	1.3	0.4	1.5	0.0	0.0	0.0	0.0	0.3	0.5	8.6	0.0	0.6	1.8	0.0	0.4	0.4	0.0	0.0	0.0	0.6	0.6	0.8	73.9	0.0	2.7	4.3	0.0	2.8	4.2	0.0	0.7	0.0	0.3	122.0	1.3	0.3	0.0	5.0	0.0	0.0	6.7	2.2	0.9	0.6	0.4	0.0	38.4	0.0	0.1	0.0	137.7	2.1	1.3	0.0	0.4	0.0	0.2	0.0	0.1	0.0	0.2	0.0	1.6	1.9	0.1	0.4	0.3	1.3	1.4	0.5	1.8	0.0	0.0
TELO2	"hCLK2, KIAA0683, TEL2"	ENSG00000100726	"Telomere maintenance 2"	Q9Y4R8	16	1493344-1510457	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"			"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041348, HPA041473"	Approved		Supported	"Nuclear bodies,Cytosol"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 72: Non-specific - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Nuclear bodies, Cytosol"		"HPA041348: AB_10794514, HPA041473: AB_10795593"	"unprognostic (1.27e-1)"	"unprognostic (2.14e-2)"	"unprognostic (2.45e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.52e-3)"	"unprognostic (1.09e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.64e-1)"	"unprognostic (1.91e-1)"	"unprognostic (3.08e-2)"	"unprognostic (2.94e-2)"	"unprognostic (5.99e-3)"	"unprognostic (1.47e-3)"	"unprognostic (2.21e-1)"	"unprognostic (6.75e-2)"	"unprognostic (3.15e-3)"	12.3	13.2	7.3	7.6	7.2	11.3	13.4	8.8	11.0	15.2	5.7	12.6	8.9	14.1	1.1	14.4	15.1	3.7	13.2	6.9	6.4	13.6	14.8	11.6	8.1	10.2	7.6	14.4	12.2	4.3	12.5	4.8	7.6	15.8	1.4	1.8	11.4	4.8	17.0	14.4	14.4	2.4	6.4	18.6	11.9	10.0	7.6	5.8	13.2	4.9	3.1	13.6	13.9	8.3	19.7	28.8	8.8	16.8	3.4	3.6	33.9	30.5	5.7	14.4	10.4	37.0	18.3	28.8	25.8	4.9	7.1	20.5	6.3	11.6	2.7	16.9	55.1	16.5	36.7	21.8	5.7	21.0	23.9	7.0	4.3	13.4	2.8	4.9	8.6	24.6	43.2	10.1	5.8	66.3	24.9	56.1	28.2	6.9	23.9	73.5	12.3	29.4	5.4	18.3	36.8	20.6	26.5	24.8	9.8	3.3	23.2	25.3	13.8	31.2	21.7	30.5	25.8	18.2	12.6	53.3	9.9	29.3	26.7	0.0	5.7	2.9	4.1	7.2	3.9	4.1	2.9	3.4	6.9	6.0	3.1	2.5	0.5	3.4	10.7	4.3	2.7	4.7	7.3	7.2	8.8	11.0	6.9	6.4	10.2	7.6	7.6	6.4	7.6	8.3	15.8	0.0	2.7	18.9	15.2	6.9	7.8	10.4	10.2	13.7	12.7	9.8	1.6	11.5	6.3	9.2	12.5	25.5	9.1	19.4	5.9	8.2	2.0	8.4	11.0	9.6	2.4	10.8	5.3	7.2	20.2	11.4	15.8	9.2	2.5	21.2	8.9	12.3	19.6	18.5	6.4	17.2	8.2	11.8	7.0	1.9	7.5	8.6	8.8	10.3	13.3	17.3	8.2	8.5	7.0	6.9	5.5	14.7	8.7	8.8	13.7	6.3	5.1	20.1	13.1	9.9	11.4	9.8	8.2	10.3	6.5	22.0	9.6	19.0	23.5	5.1
TEN1	"C17orf106, FLJ39785"	ENSG00000257949	"TEN1 subunit of CST complex"	Q86WV5	17	75979240-76000586	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 55.1;Exocrine glandular cells: 88.9;Pancreatic endocrine cells: 89.1;Proximal tubular cells: 89.0;Suprabasal keratinocytes: 52.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA065069			Supported	Nucleoplasm		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 1: Pancreatic cells - Digestion"	Nucleoplasm		"HPA065069: AB_2685418"	"unprognostic (1.61e-1)"	"unprognostic (1.16e-1)"	"unprognostic (3.34e-2)"	"unprognostic (1.07e-1)"	"unprognostic (3.02e-2)"	"unprognostic (3.07e-3)"	"unprognostic (1.33e-3)"	"unprognostic (2.95e-1)"	"unprognostic (2.85e-2)"	"unprognostic (9.03e-2)"	"unprognostic (8.61e-3)"	"unprognostic (3.17e-2)"	"unprognostic (1.64e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.94e-1)"	"unprognostic (2.85e-4)"	21.0	27.7	10.1	14.8	10.4	32.2	21.9	10.4	12.7	19.4	11.8	18.9	22.7	16.8	11.8	43.4	15.2	15.9	16.7	10.0	10.8	27.4	49.5	20.7	18.7	10.8	11.4	16.1	32.8	12.8	22.3	11.5	11.7	28.1	9.5	3.4	27.8	10.2	12.1	46.3	25.7	7.8	10.5	23.3	26.9	13.3	11.0	6.7	20.1	7.8	12.9	16.2	25.0	11.5	19.2	15.1	12.1	16.6	16.5	21.6	32.7	12.3	18.4	21.5	21.9	18.6	32.3	25.0	20.4	15.0	22.4	18.1	7.7	18.6	6.3	13.8	24.8	28.7	21.3	21.0	19.8	18.6	45.7	19.4	25.8	11.8	12.3	18.0	29.0	14.6	12.4	24.2	12.8	31.8	23.9	40.3	11.8	19.4	25.6	21.7	12.0	22.7	27.5	33.5	23.8	40.1	9.6	83.5	16.3	9.3	43.4	28.8	15.9	41.7	24.0	17.8	28.3	25.3	10.1	14.2	22.4	13.2	13.3	81.8	53.7	33.4	40.0	52.5	33.3	60.8	31.6	34.0	48.5	49.2	23.7	28.4	32.7	45.3	29.2	52.8	37.9	36.3	10.1	10.4	10.4	12.7	10.0	10.8	10.8	11.4	11.7	10.5	11.0	11.5	14.0	0.0	4.2	0.0	13.0	39.0	0.0	55.1	5.2	0.0	39.2	32.8	0.0	0.0	23.4	5.5	0.0	0.0	21.7	0.1	39.2	39.5	0.0	12.4	13.0	10.2	0.0	0.8	0.0	88.9	0.1	8.8	2.6	19.0	2.5	16.9	0.0	0.0	0.1	0.0	0.0	0.2	34.6	0.0	39.9	0.0	0.0	19.7	30.2	0.0	37.2	0.0	0.0	0.0	0.0	89.1	0.0	0.0	7.9	0.0	0.0	89.0	8.7	0.0	0.0	0.1	12.9	0.0	0.0	6.1	52.7	0.0	9.4	24.4	0.0	0.1
TENT4A	"LAK-1, PAPD7, POLK, POLS, TRF4, TRF4-1"	ENSG00000112941	"Terminal nucleotidyltransferase 4A"	Q5XG87	5	6713432-6757044	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"mRNA processing"	"Nucleotidyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 19.3;Breast glandular cells: 13.4;Breast myoepithelial cells: 13.2;dendritic cells: 12.3;Endometrial stromal cells: 15.4;Glandular and luminal cells: 14.0;Granulosa cells: 14.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045487, HPA046742"	Enhanced		Supported	"Nucleoplasm,Nuclear membrane,Golgi apparatus"		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 20: HeLa - Mitochondria"	"Cluster 65: Plasmacytoid DCs - Unknown function"	Nucleoplasm	"Nuclear membrane, Golgi apparatus"	"HPA045487: AB_2679346, HPA046742: AB_2679781"	"unprognostic (1.45e-1)"	"unprognostic (2.96e-1)"	"unprognostic (2.08e-2)"	"unprognostic (2.12e-3)"	"unprognostic (7.57e-2)"	"unprognostic (1.30e-2)"	"unprognostic (4.22e-2)"	"unprognostic (2.37e-1)"	"unprognostic (2.62e-1)"	"unprognostic (9.78e-2)"	"unprognostic (3.10e-3)"	"unprognostic (3.73e-2)"	"prognostic unfavorable (7.99e-5)"	"unprognostic (6.56e-2)"	"unprognostic (2.08e-1)"	"unprognostic (2.60e-2)"	"prognostic favorable (8.55e-4)"	13.1	8.1	8.4	9.5	8.6	27.6	11.0	16.6	10.1	12.5	5.7	10.0	8.7	11.1	6.4	10.7	11.5	10.0	8.5	8.7	8.1	9.6	20.5	12.8	13.0	6.5	6.5	15.6	12.0	10.0	11.1	9.1	7.0	11.1	7.2	12.5	8.2	8.8	9.3	15.7	12.4	12.2	6.0	13.7	9.6	10.1	7.9	14.6	10.2	12.1	10.4	10.1	11.8	8.9	31.7	20.9	25.4	31.6	17.7	15.6	37.0	21.0	25.7	25.1	28.2	21.9	17.3	23.1	16.1	25.5	28.5	22.9	20.7	16.4	23.1	26.1	14.0	12.0	72.5	12.4	11.0	18.0	17.3	10.7	13.8	28.7	18.4	18.6	15.0	16.9	16.3	29.8	20.8	17.6	24.4	25.3	13.6	9.7	16.6	21.8	21.2	6.0	10.5	17.5	25.1	19.3	50.7	24.1	14.5	13.4	14.5	9.9	13.6	30.6	32.7	27.2	29.8	28.6	12.6	20.4	19.6	16.4	19.2	0.0	0.2	0.2	0.6	0.1	0.6	0.5	0.4	0.4	0.3	0.4	0.5	0.5	0.1	0.1	0.2	1.1	0.6	0.2	8.4	8.6	16.6	10.1	8.7	8.1	6.5	6.5	7.0	6.0	7.9	8.9	19.3	0.0	0.0	0.0	7.3	0.0	0.0	0.0	0.0	0.0	13.4	13.2	0.0	0.0	0.0	5.5	0.0	5.3	12.3	0.0	1.9	4.9	0.0	10.7	15.4	4.8	0.0	0.0	0.0	4.4	4.0	4.0	0.0	14.0	0.0	14.5	0.0	0.0	6.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.8	0.0	0.0	4.2	0.0	0.0	0.0	0.0	6.6	0.0	0.0	8.4	0.0	0.0	2.5	0.0	0.0	0.0	0.0	6.2	0.0	0.0	0.0	0.0	5.6	4.8	10.7	0.0	0.0
TENT4B	"PAPD5, TRF4-2, TUT3"	ENSG00000121274	"Terminal nucleotidyltransferase 4B"	Q8NDF8	16	50152911-50235310	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, mRNA processing, rRNA processing"	"DNA-binding, DNA-directed DNA polymerase, Nucleotidyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"dendritic cells: 82.8;Endometrial ciliated cells: 44.3;Glandular and luminal cells: 31.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							"HPA042968, HPA048225"	Uncertain		Supported	"Nucleoli,Plasma membrane,Cytosol"		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 72: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 24: Non-specific - Transcription regulation"	Cytosol	"Nucleoli, Plasma membrane"	"HPA042968: AB_2678244, HPA048225: AB_2680319"	"unprognostic (1.05e-2)"	"unprognostic (4.09e-2)"	"unprognostic (1.77e-2)"	"unprognostic (1.63e-1)"	"unprognostic (3.27e-1)"	"unprognostic (2.91e-2)"	"unprognostic (4.33e-2)"	"unprognostic (2.46e-1)"	"unprognostic (7.83e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.30e-1)"	"unprognostic (3.30e-2)"	"prognostic favorable (1.85e-4)"	"unprognostic (4.24e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.83e-1)"	"unprognostic (7.00e-2)"	6.1	6.4	2.4	1.7	2.3	7.1	4.6	3.9	2.6	7.3	3.0	6.9	4.6	6.9	2.3	5.4	6.5	2.0	3.7	2.7	3.0	4.2	8.9	5.0	2.3	2.2	2.4	6.8	4.3	3.9	4.8	2.8	2.2	5.3	1.9	1.4	4.7	1.7	5.4	5.5	5.9	2.5	2.2	4.6	5.5	5.7	3.1	1.7	4.7	2.1	1.9	7.2	6.4	2.7	5.5	1.9	0.6	3.3	3.8	2.0	4.3	3.9	2.3	3.5	1.6	3.4	2.3	6.5	5.6	2.7	1.4	3.6	3.9	2.0	3.1	3.8	4.5	3.6	1.6	5.4	3.8	2.4	4.9	1.9	2.6	2.3	3.3	2.3	1.8	2.1	4.2	1.5	4.1	1.5	3.5	4.6	4.2	1.5	4.5	4.9	4.8	6.9	1.7	0.5	4.0	2.2	4.9	2.7	2.3	1.5	1.5	0.9	3.0	2.1	4.1	4.0	1.9	4.9	3.7	6.9	1.7	2.7	2.7	0.0	0.4	0.0	0.4	0.2	0.1	0.3	0.2	0.5	0.2	0.2	0.3	0.5	0.7	0.2	0.2	0.4	0.1	0.1	2.4	2.3	3.9	2.6	2.7	3.0	2.2	2.4	2.2	2.2	3.1	2.7	17.9	0.0	0.0	0.0	6.7	0.0	0.0	0.0	0.0	0.0	17.8	16.3	0.0	0.0	0.0	14.7	0.0	18.1	82.8	0.0	3.9	10.9	0.0	44.3	24.4	6.1	0.0	0.0	0.0	14.9	11.5	6.7	0.0	31.5	0.0	13.5	0.0	0.0	15.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.7	0.0	0.0	3.6	0.0	0.0	0.0	0.0	15.2	0.0	0.0	22.0	0.0	0.0	20.2	0.0	0.0	0.0	0.0	14.0	0.0	0.0	0.0	0.0	18.3	14.9	17.3	0.0	0.0
TENT5C	"FAM46C, FLJ20202"	ENSG00000183508	"Terminal nucleotidyltransferase 5C"	Q5VWP2	1	117606048-117628389	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	"Host-virus interaction"	"Nucleotidyltransferase, RNA-binding, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 89.1"	"Cell type enhanced"	"Detected in some"		"B-cells: 41.8;Breast glandular cells: 34.0;Breast myoepithelial cells: 43.2;dendritic cells: 104.5;Plasma cells: 47.7;T-cells: 48.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"basophil: 29.3"	"Group enriched"	"Detected in many"	17	"B-cells: 13.3;granulocytes: 29.3;T-cells: 13.7"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 296.2;RPMI-8226: 185.5;U-266/70: 81.7;U-266/84: 72.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA054049	Uncertain		Supported	Nucleoplasm		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm		"HPA054049: AB_2682356"	"unprognostic (3.76e-2)"	"unprognostic (3.85e-3)"	"unprognostic (3.24e-3)"	"prognostic favorable (3.75e-5)"	"unprognostic (1.17e-1)"	"unprognostic (1.55e-3)"	"unprognostic (3.29e-1)"	"unprognostic (2.88e-2)"	"unprognostic (5.75e-2)"	"unprognostic (1.36e-3)"	"unprognostic (9.41e-3)"	"unprognostic (3.91e-2)"	"prognostic favorable (2.77e-5)"	"unprognostic (6.26e-2)"	"unprognostic (3.16e-2)"	"unprognostic (3.08e-2)"	"unprognostic (1.10e-2)"	2.8	2.4	0.9	17.0	1.0	89.1	11.6	1.1	1.6	10.9	27.4	23.8	16.0	3.2	19.1	3.6	4.8	7.8	6.9	1.4	0.9	7.5	10.3	10.5	18.8	1.6	1.6	9.0	46.8	11.2	2.6	3.8	1.1	6.6	24.8	0.1	25.8	4.1	29.4	1.2	13.0	2.9	1.9	21.7	30.2	43.5	1.0	6.2	14.3	10.9	37.3	14.1	1.9	1.3	0.2	0.1	0.1	1.3	0.1	0.0	1.3	0.6	26.9	0.5	0.2	1.7	0.2	4.9	0.3	0.8	0.3	0.3	0.1	0.5	0.2	17.6	1.6	37.9	0.2	0.0	0.1	22.4	46.8	0.0	0.1	0.4	0.0	0.1	0.1	10.0	5.2	296.2	0.0	3.8	0.1	22.8	3.8	4.5	2.4	0.1	0.1	185.5	0.3	3.7	2.2	0.2	1.7	2.4	1.8	0.6	1.9	0.2	0.5	0.3	2.1	0.1	0.4	81.7	72.8	1.9	1.7	8.1	2.4	29.3	0.0	15.9	3.4	0.0	3.1	13.3	3.3	4.4	0.1	10.4	0.4	1.9	1.6	1.1	0.0	0.3	13.7	2.9	0.9	1.0	1.1	1.6	1.4	0.9	1.6	1.6	1.1	1.9	1.0	1.3	17.0	0.0	0.0	0.0	41.8	0.0	0.0	0.0	0.0	0.0	34.0	43.2	0.0	0.0	0.0	1.8	0.0	1.9	104.5	0.0	11.7	0.8	0.0	8.3	5.4	2.9	0.0	0.0	0.0	5.2	2.2	3.2	0.0	13.7	0.0	0.7	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	47.7	0.0	0.0	9.0	0.0	0.0	0.0	0.0	5.2	0.0	0.0	0.0	0.0	2.2	48.4	1.0	0.0	0.0
TEP1	"p240, TLP1, TP1, TROVE1, VAULT2"	ENSG00000129566	"Telomerase associated protein 1"	Q99973	14	20365667-20413501	"Plasma proteins, Predicted intracellular proteins"		"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 23.9;Gastric mucus-secreting cells: 25.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA029206			Supported	Nucleoplasm,Vesicles		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 21: OE19 - Mitochondria"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Nucleoplasm	Vesicles	"HPA029206: AB_10601271"	"unprognostic (4.53e-2)"	"unprognostic (2.81e-2)"	"unprognostic (1.26e-1)"	"prognostic favorable (9.58e-4)"	"unprognostic (2.27e-1)"	"unprognostic (2.76e-1)"	"unprognostic (2.66e-2)"	"unprognostic (1.43e-1)"	"unprognostic (6.81e-2)"	"unprognostic (1.42e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.18e-1)"	"unprognostic (6.18e-2)"	"unprognostic (3.00e-1)"	9.4	7.8	3.4	12.1	4.1	5.1	8.7	3.2	4.0	7.8	6.0	17.4	28.0	6.9	7.3	6.8	7.2	10.7	6.8	3.3	4.3	6.5	6.5	11.0	15.0	6.0	5.3	6.2	6.2	13.7	5.7	6.6	5.1	7.9	17.9	5.0	8.3	6.3	10.3	7.9	15.5	9.7	3.8	14.8	9.6	2.3	5.8	10.2	8.1	5.1	15.1	7.5	7.8	5.2	9.2	4.2	4.1	4.5	26.1	9.9	7.3	6.8	6.0	4.0	5.1	8.7	10.2	8.1	4.2	17.0	7.3	9.3	3.5	13.6	6.8	7.8	3.5	9.5	9.4	5.7	7.5	8.0	16.1	14.1	11.8	6.5	5.2	17.1	15.2	6.7	3.1	5.8	14.0	5.4	4.7	5.8	1.8	28.4	3.6	12.2	10.2	2.8	13.2	13.8	1.2	1.9	5.4	12.8	4.2	11.8	6.5	4.9	20.1	15.5	10.6	4.9	1.9	12.9	6.9	5.1	3.7	6.9	5.5	3.6	2.3	0.0	1.0	2.8	1.0	1.7	0.5	1.0	0.8	2.4	0.5	0.6	4.5	0.5	2.9	5.4	0.6	0.3	3.4	4.1	3.2	4.0	3.3	4.3	6.0	5.3	5.1	3.8	5.8	5.2	3.7	9.6	14.1	13.1	8.4	2.8	4.8	3.1	2.8	0.3	3.2	2.8	3.2	8.6	5.6	1.8	2.1	2.0	14.3	23.9	1.9	4.8	0.2	2.9	4.2	5.8	4.2	2.1	1.9	5.1	2.5	3.4	25.5	4.2	10.8	2.6	8.2	4.9	6.4	0.0	2.1	12.8	0.0	10.4	4.6	1.3	5.0	10.2	5.4	16.9	12.9	2.6	7.2	4.5	3.9	6.0	12.8	3.8	8.4	5.1	21.8	3.8	12.2	2.6	0.0	5.1	6.1	0.0	0.6	2.4	1.4	1.9	5.0	2.2	8.3	4.9
TEPSIN	"C17orf56, ENTHD2, FLJ31528"	ENSG00000167302	"TEPSIN adaptor related protein complex 4 accessory protein"	Q96N21	17	81228277-81239091	"Predicted intracellular proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 9.6;Cytotrophoblasts: 9.9;Syncytiotrophoblasts: 10.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA063410			Approved	"Nuclear membrane,Nuclear speckles,Golgi apparatus"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 7: Non-specific - Mitochondria"	"Nuclear membrane, Nuclear speckles, Golgi apparatus"		"HPA063410: AB_2685008"	"unprognostic (6.90e-3)"	"unprognostic (1.03e-2)"	"unprognostic (4.26e-2)"	"unprognostic (3.64e-2)"	"unprognostic (1.00e-1)"	"prognostic favorable (9.96e-4)"	"unprognostic (1.16e-2)"	"unprognostic (4.85e-2)"	"unprognostic (8.52e-2)"	"unprognostic (2.29e-1)"	"prognostic favorable (6.95e-4)"	"unprognostic (4.99e-2)"	"prognostic unfavorable (7.31e-8)"	"unprognostic (1.65e-1)"	"unprognostic (3.01e-1)"	"unprognostic (3.58e-1)"	"unprognostic (3.16e-3)"	11.4	12.1	8.3	7.4	8.5	13.0	11.3	8.4	12.8	12.9	9.1	14.2	10.8	11.2	4.0	13.3	11.5	4.3	10.2	8.3	8.1	16.6	17.7	12.0	11.0	9.4	8.5	9.3	15.8	3.3	11.4	5.3	8.9	15.3	4.0	1.6	12.0	3.0	10.0	14.6	19.7	4.4	8.3	28.6	15.6	13.3	9.1	10.3	16.0	3.2	5.8	13.5	11.8	8.8	9.5	14.2	5.1	8.6	3.5	5.7	10.0	8.2	4.7	8.5	7.6	9.1	6.8	6.9	4.5	5.5	8.0	11.8	5.3	7.3	3.8	4.1	18.7	5.7	8.1	13.0	5.4	6.0	12.8	3.4	9.1	3.8	4.2	5.9	13.4	9.7	6.7	6.7	5.3	8.4	11.2	15.7	5.7	7.5	11.6	6.9	7.1	7.4	3.3	6.1	6.7	8.5	9.7	11.1	11.5	9.9	9.1	11.3	8.0	11.2	6.6	8.5	8.3	9.4	6.5	5.5	8.3	5.3	5.7	2.4	1.2	4.0	0.8	1.6	0.5	1.2	0.5	0.6	1.3	1.8	0.3	0.4	2.1	0.4	1.0	1.4	0.8	0.8	8.3	8.5	8.4	12.8	8.3	8.1	9.4	8.5	8.9	8.3	9.1	8.8	8.6	9.6	5.5	0.0	2.9	0.0	0.0	0.0	0.0	0.0	6.9	7.1	0.0	0.0	1.3	1.8	0.0	9.9	8.8	0.0	0.0	4.7	0.0	3.2	5.8	3.0	0.0	0.0	0.0	5.3	7.2	2.5	0.0	6.2	6.3	8.6	0.0	0.0	9.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.0	8.8	0.0	0.0	0.0	0.0	6.0	0.0	0.0	3.3	0.0	0.0	2.3	2.2	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	10.5	3.9	5.1	0.0	0.0
TERB1	"CCDC79, FLJ35894"	ENSG00000249961	"Telomere repeat binding bouquet formation protein 1"	Q8NA31	16	66754640-66801620	"Predicted intracellular proteins"	Meiosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"testis: 12.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"basophil: 1.9"	"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA079436			Supported	"Nucleoplasm,Cell Junctions,Cytosol"		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 78: Testis - Spermatogenesis"		"Cluster 11: Alveolar cells - Smell perception"	Nucleoplasm	"Cell Junctions, Cytosol"	"HPA079436: "	"unprognostic (2.15e-1)"	"unprognostic (9.15e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.29e-1)"	"unprognostic (3.91e-2)"	"unprognostic (9.75e-2)"	"unprognostic (5.79e-2)"	"unprognostic (1.03e-1)"	"unprognostic (7.57e-5)"	"unprognostic (6.49e-2)"	"unprognostic (3.23e-3)"	"unprognostic (2.88e-2)"	"unprognostic (6.81e-6)"	"unprognostic (1.66e-1)"	"unprognostic (2.56e-1)"	"unprognostic (2.34e-1)"	"unprognostic (6.14e-3)"	0.1	0.3	0.7	0.2	0.4	1.5	0.0	1.6	1.0	0.0	1.5	0.1	0.4	0.2	0.1	0.2	0.1	0.1	0.0	0.4	0.6	0.1	0.1	0.2	0.3	1.3	0.4	0.1	0.0	0.0	0.0	0.1	0.9	0.1	0.1	0.4	0.3	0.0	0.1	0.7	0.1	0.0	0.1	0.2	0.0	12.6	0.8	0.0	0.4	0.0	0.1	0.0	0.0	1.6	0.2	0.6	0.2	0.1	0.4	0.0	0.0	0.1	0.0	0.2	0.2	0.8	0.4	0.3	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.6	0.1	0.7	0.4	0.0	0.0	0.4	0.1	0.3	0.1	0.0	0.0	0.1	0.2	0.1	0.4	0.0	0.4	0.2	0.4	0.1	0.0	0.0	0.2	0.1	0.5	0.0	0.6	0.3	0.3	0.1	0.2	0.1	0.4	0.0	0.2	0.0	0.4	0.2	0.5	0.2	0.3	0.2	0.6	0.3	0.3	0.1	1.9	0.2	0.1	0.1	0.1	0.1	0.3	0.1	0.2	0.0	0.4	0.1	0.2	0.8	0.4	0.1	1.1	0.1	0.3	0.7	0.4	1.6	1.0	0.4	0.6	1.3	0.4	0.9	0.1	0.8	1.6	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0
TERF1	"PIN2, TRBF1, TRF, TRF1"	ENSG00000147601	"Telomeric repeat binding factor 1"	P54274	8	73008856-73048123	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048379			Approved	"Nucleoli fibrillar center,Nuclear bodies"		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 72: Non-specific - Transcription"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 65: Plasmacytoid DCs - Unknown function"	"Nucleoli fibrillar center"	"Nuclear bodies"	"HPA048379: AB_2680378"	"unprognostic (1.02e-2)"	"unprognostic (1.66e-1)"	"unprognostic (7.24e-2)"	"unprognostic (2.42e-3)"	"unprognostic (1.81e-1)"	"unprognostic (2.10e-1)"	"unprognostic (1.60e-2)"	"unprognostic (1.02e-1)"	"unprognostic (6.53e-2)"	"unprognostic (9.55e-2)"	"unprognostic (1.52e-1)"	"unprognostic (8.18e-2)"	"prognostic unfavorable (6.68e-4)"	"unprognostic (2.34e-3)"	"unprognostic (1.04e-1)"	"unprognostic (9.39e-2)"	"unprognostic (1.74e-1)"	13.8	15.2	6.8	4.7	7.7	8.7	13.1	10.9	8.1	13.9	7.0	13.3	8.5	13.8	6.9	9.3	14.7	7.3	11.9	7.6	7.1	14.2	11.2	9.3	7.6	6.3	6.6	17.7	10.1	12.3	11.5	6.6	6.3	12.7	7.3	9.0	10.3	9.4	11.1	10.0	9.4	8.5	7.9	8.1	14.5	10.4	6.5	7.4	11.7	4.7	4.6	18.2	12.4	8.6	17.1	15.5	14.6	12.8	11.0	7.3	14.5	18.4	7.3	10.2	10.7	10.0	13.3	9.4	27.6	9.9	22.2	13.9	19.9	11.3	10.5	14.8	31.7	13.6	3.8	6.9	9.5	7.7	15.9	11.6	7.4	11.2	18.8	14.7	11.0	23.8	14.8	12.3	9.6	10.4	31.3	8.8	60.7	37.7	14.7	21.7	7.0	9.9	17.0	8.7	11.9	15.2	13.6	49.8	14.4	42.6	19.9	5.6	7.5	7.8	13.5	17.0	15.3	15.9	16.0	18.1	10.9	12.0	16.7	11.9	6.5	10.7	11.3	6.0	10.1	12.0	10.5	11.4	7.5	10.7	12.1	12.7	3.6	9.7	7.8	11.4	11.4	6.7	6.8	7.7	10.9	8.1	7.6	7.1	6.3	6.6	6.3	7.9	6.5	8.6	41.5	28.9	29.1	39.5	47.8	27.9	39.6	45.8	35.3	77.6	22.5	32.5	23.2	21.5	27.3	31.3	85.5	53.6	109.4	27.5	25.4	35.8	16.2	24.0	41.1	38.7	92.1	31.6	52.7	37.8	62.4	52.3	24.5	27.1	36.8	44.5	41.7	31.0	34.2	70.7	58.3	26.4	36.7	25.5	26.6	8.1	74.3	27.7	30.2	22.5	32.3	85.7	72.1	48.7	55.3	25.6	21.5	85.4	34.2	30.2	17.9	65.7	24.8	55.4	59.2	63.3	49.1	117.6	131.7	23.6	24.3	31.9	52.6	62.0	28.2	27.6
TERF2IP	RAP1	ENSG00000166848	"TERF2 interacting protein"	Q9NYB0	16	75647773-75761872	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006719, CAB018660, CAB018749"	Supported		Supported	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 77: Retina - Visual perception"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 6: Erythroid cells - Oxygen transport"	"Nucleoplasm, Nuclear bodies"		"CAB018660: AB_628202, CAB018749: AB_2269341, HPA006719: AB_1858267"	"unprognostic (3.20e-1)"	"unprognostic (5.72e-2)"	"unprognostic (2.06e-3)"	"unprognostic (7.83e-2)"	"unprognostic (3.30e-1)"	"unprognostic (1.99e-2)"	"unprognostic (2.33e-1)"	"unprognostic (1.59e-2)"	"unprognostic (8.80e-2)"	"prognostic favorable (6.14e-5)"	"prognostic favorable (1.46e-4)"	"unprognostic (1.81e-1)"	"prognostic favorable (2.15e-5)"	"unprognostic (6.26e-2)"	"unprognostic (1.85e-1)"	"unprognostic (5.30e-2)"	"unprognostic (2.99e-1)"	56.3	93.4	151.5	41.2	152.0	89.7	51.9	146.3	186.2	52.7	112.3	48.3	27.2	51.6	57.6	37.6	50.7	36.7	67.0	146.2	189.9	46.7	42.9	51.8	68.2	142.8	154.1	72.8	38.2	71.8	144.4	27.5	155.3	48.0	26.9	168.6	38.3	44.8	58.3	48.0	41.8	39.1	146.0	57.7	37.7	55.0	174.0	71.9	55.2	47.3	61.9	44.5	46.4	156.5	25.1	23.2	51.2	39.7	56.9	59.2	16.0	74.6	63.9	62.0	45.8	25.7	26.9	127.2	97.0	50.6	30.6	35.6	51.1	21.3	52.5	48.1	74.1	64.9	36.6	59.1	74.4	88.6	88.7	50.7	59.3	49.8	76.8	68.2	42.2	82.6	77.2	52.2	71.9	73.7	107.2	112.5	25.9	32.4	53.3	119.9	33.0	106.0	46.4	22.7	123.9	74.7	96.8	22.4	61.8	18.5	51.7	86.0	46.6	59.1	31.3	51.4	57.9	216.2	202.5	179.2	62.2	59.6	57.1	56.4	21.9	101.3	28.7	19.8	35.8	46.8	44.2	47.9	21.0	65.7	53.9	33.8	33.2	39.7	31.2	20.3	48.6	19.8	151.5	152.0	146.3	186.2	146.2	189.9	142.8	154.1	155.3	146.0	174.0	156.5	109.1	48.1	69.3	30.7	160.8	195.5	114.3	82.5	163.4	388.8	73.6	77.0	95.2	68.6	74.2	93.8	93.8	76.8	172.7	33.4	135.0	81.7	7.8	68.5	81.8	102.3	97.8	421.4	46.7	51.1	38.9	115.7	39.3	74.6	124.9	81.4	84.3	58.1	60.7	282.7	54.5	50.1	120.1	70.8	138.5	23.6	115.5	89.3	120.9	18.7	96.6	320.2	125.7	38.2	68.2	46.3	46.9	130.5	162.8	101.7	45.1	74.7	66.9	176.2	138.1	79.0	106.2	255.1	116.2	94.3	194.4	122.3	215.0	140.7	32.2	116.4
TERT	"EST2, hEST2, TCS1, TP2, TRT"	ENSG00000164362	"Telomerase reverse transcriptase"	O14746	5	1253147-1295068	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted membrane proteins"		"DNA-binding, Nucleotidyltransferase, Ribonucleoprotein, RNA-directed DNA polymerase, Transferase"	"Cancer-related genes, Disease variant, Dyskeratosis congenita"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 1.4;Intestinal goblet cells: 1.0;Plasma cells: 2.8;Spermatocytes: 1.5;Spermatogonia: 4.1"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 438.0;fHDF/TERT166: 429.4;HBEC3-KT: 929.2;hTEC/SVTERT24-B: 560.1;LHCN-M2: 252.2;TIME: 799.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA054641, HPA065897"	Supported		Supported	"Nucleoplasm,Nuclear speckles,Cytosol"		NA	NA					"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 55: Plasma cells - Humoral immune response"	Nucleoplasm	"Nuclear speckles, Cytosol"	"HPA054641: AB_2682554, HPA065897: AB_2685576"	"unprognostic (1.21e-2)"	"unprognostic (2.88e-2)"	"unprognostic (1.24e-3)"	"unprognostic (1.53e-1)"	"unprognostic (1.43e-3)"	"unprognostic (6.42e-3)"	"unprognostic (1.85e-2)"	"unprognostic (2.21e-1)"	"unprognostic (6.91e-2)"	"unprognostic (1.89e-1)"	"unprognostic (3.59e-1)"	"unprognostic (9.16e-4)"	"unprognostic (8.84e-11)"	"unprognostic (1.92e-1)"	"unprognostic (2.15e-1)"		"unprognostic (3.35e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.5	213.2	438.0	3.2	0.0	173.9	31.7	59.4	0.3	0.1	3.0	0.2	429.4	0.1	0.1	1.0	929.2	29.1	0.0	1.7	0.1	0.0	0.4	0.1	0.5	1.2	0.0	22.9	560.1	6.8	1.3	1.5	1.8	2.9	0.2	252.2	0.4	0.2	9.4	2.9	0.1	1.3	2.1	0.0	5.4	23.9	0.5	0.2	2.1	0.1	0.0	0.2	0.0	0.1	0.3	799.9	0.0	0.0	0.0	0.0	0.9	0.5	0.7	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.1	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	4.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0
TESC	"CHP3, FLJ20607, TSC"	ENSG00000088992	Tescalcin	Q96BS2	12	117038923-117099479	"Predicted intracellular proteins"	"Differentiation, Protein transport, Transport"	"Protein kinase inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"salivary gland: 329.9"	"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 183.0;Erythroid cells: 222.9;Exocrine glandular cells: 481.2;Gastric mucus-secreting cells: 316.0;Late spermatids: 319.3;Pancreatic endocrine cells: 215.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"non-classical monocyte: 261.1"	"Lineage enriched"	"Detected in all"	5	"monocytes: 261.1"	"Cell line enhanced"	"Detected in many"		"HMC-1: 398.5;NB-4: 675.1;OE19: 288.1;U-937: 221.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053200	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 24: NB-4 - Immune response"	"Cluster 1: Pancreatic cells - Digestion"	Nucleoplasm	Cytosol	"HPA053200: AB_2682079"	"unprognostic (4.53e-3)"	"unprognostic (5.98e-2)"	"unprognostic (6.50e-2)"	"unprognostic (2.23e-3)"	"unprognostic (6.31e-2)"	"unprognostic (2.05e-3)"	"unprognostic (4.98e-3)"	"unprognostic (3.35e-1)"	"unprognostic (4.35e-1)"	"unprognostic (1.62e-1)"	"unprognostic (4.37e-2)"	"unprognostic (7.43e-2)"	"unprognostic (1.69e-2)"	"unprognostic (8.65e-2)"	"unprognostic (2.57e-1)"	"unprognostic (1.56e-2)"	"unprognostic (5.67e-3)"	8.1	46.5	17.4	10.3	36.8	118.8	8.9	16.4	25.4	4.3	15.7	3.8	7.2	3.9	121.9	3.3	4.0	36.1	71.5	26.5	15.0	26.5	4.9	10.2	8.0	17.8	15.0	5.3	102.4	9.4	26.7	10.2	18.2	9.8	2.8	0.5	329.9	19.7	5.1	9.7	7.3	2.8	14.8	11.9	138.4	31.1	15.5	7.4	10.7	8.1	10.3	29.3	5.3	18.9	0.2	97.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	2.1	4.3	13.8	4.7	0.0	0.2	0.6	8.1	0.0	0.0	37.5	19.2	115.5	9.8	78.1	0.0	49.2	398.5	0.1	0.0	0.0	0.0	0.0	0.0	18.5	54.0	0.9	0.0	2.2	95.5	675.1	9.0	288.1	0.0	0.4	0.0	52.4	56.5	15.0	17.0	6.1	0.1	0.1	3.6	0.9	0.0	53.9	0.0	0.0	1.7	0.2	0.4	17.0	38.2	0.0	0.1	221.8	0.5	0.0	51.0	51.5	7.0	67.9	0.4	5.5	2.4	9.1	35.8	13.1	0.3	3.8	12.6	11.6	261.1	2.6	3.5	19.0	17.4	36.8	16.4	25.4	26.5	15.0	17.8	15.0	18.2	14.8	15.5	18.9	35.6	0.0	0.0	5.9	16.2	2.7	0.3	0.4	1.8	0.8	5.5	67.1	58.3	183.0	0.9	12.9	0.0	0.4	21.1	0.2	74.3	159.5	106.5	1.3	0.7	43.6	1.8	222.9	26.1	481.2	0.6	7.9	316.0	3.2	71.1	1.2	1.8	0.5	48.0	0.0	2.0	1.5	0.0	17.9	6.1	319.3	3.1	30.6	72.9	8.4	41.0	0.2	25.7	2.5	1.5	215.6	0.9	3.4	25.8	3.5	0.2	6.1	0.0	1.5	144.7	1.9	68.4	63.0	20.3	0.5	2.0	1.2	28.3	66.7	2.3	1.3
TESPA1	"ITPRID3, KIAA0748"	ENSG00000135426	"Thymocyte expressed, positive selection associated 1"	A2RU30	12	54948015-54984762	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 81.3;lymphoid tissue: 75.2"	"Group enriched"	"Detected in some"	4	"Excitatory neurons: 202.7;granulocytes: 120.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"HEL: 247.1;HMC-1: 187.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA058823, HPA079222"	Approved		Supported	Cytosol		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Cytosol		"HPA058823: AB_2683828, HPA079222: "	"unprognostic (1.98e-5)"	"unprognostic (3.70e-4)"	"unprognostic (3.87e-4)"	"unprognostic (1.13e-3)"	"unprognostic (3.20e-2)"	"unprognostic (4.55e-4)"	"unprognostic (2.29e-3)"	"unprognostic (5.34e-4)"	"unprognostic (3.83e-4)"	"unprognostic (1.35e-2)"	"unprognostic (3.97e-2)"	"unprognostic (5.89e-2)"	"unprognostic (4.50e-2)"	"unprognostic (4.11e-1)"	"unprognostic (1.28e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.71e-1)"	1.3	0.5	19.6	13.9	37.6	14.5	1.7	12.0	81.3	1.9	11.9	3.7	3.0	2.3	4.8	1.9	1.3	4.8	1.0	36.6	13.2	0.8	0.9	5.8	36.4	11.6	12.2	6.9	0.9	0.7	0.6	0.5	12.1	1.5	4.8	1.0	1.4	1.1	1.4	1.0	7.5	2.1	11.4	13.5	3.9	0.9	16.1	75.2	1.1	0.6	36.4	4.0	1.1	44.2	0.2	0.4	0.6	0.4	0.7	0.7	3.2	0.0	0.7	0.2	0.3	0.0	0.4	17.5	0.2	0.7	0.6	0.4	0.7	0.4	0.3	20.0	0.6	247.1	0.8	0.3	0.6	13.6	187.7	0.5	0.4	0.4	0.7	0.5	0.0	41.5	1.0	16.3	0.4	0.4	39.1	1.5	0.5	0.2	0.2	9.3	0.3	2.7	0.6	0.9	0.5	0.2	0.6	0.1	0.5	0.7	0.2	3.6	0.3	0.4	0.4	0.2	0.2	11.1	0.4	12.0	1.7	4.0	0.4	43.1	1.4	1.6	38.3	1.3	43.5	17.9	126.0	57.5	16.0	15.0	175.8	98.8	3.1	57.2	1.5	5.6	92.6	64.5	19.6	37.6	12.0	81.3	36.6	13.2	11.6	12.2	12.1	11.4	16.1	44.2	0.7	0.0	4.3	10.1	9.9	0.5	0.0	0.0	0.0	0.0	0.2	0.3	1.5	0.0	0.0	0.0	0.0	0.0	12.4	0.0	0.0	0.0	0.1	0.1	0.1	0.4	0.0	32.4	202.7	0.0	0.0	1.3	0.0	0.1	120.1	0.0	0.4	0.5	0.1	0.0	2.5	0.0	0.0	1.3	1.6	0.0	0.9	4.6	1.8	2.8	3.3	0.0	25.7	7.1	5.1	0.0	0.0	1.2	3.4	0.0	0.0	0.3	0.0	0.0	0.0	0.3	1.0	0.0	0.2	0.0	0.3	0.0	37.0	0.8	0.1	0.0
TET1	"bA119F7.1, CXXC6, KIAA1676, LCX"	ENSG00000138336	"Tet methylcytosine dioxygenase 1"	Q8NFU7	10	68560337-68694487	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Chromatin regulator, Dioxygenase, DNA-binding, Oxidoreductase, Repressor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 4.9"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 54.5;Extravillous trophoblasts: 79.9;Oligodendrocyte precursor cells: 44.7;Oligodendrocytes: 45.3;Theca cells: 43.7"	"Cancer enriched"	"Detected in some"	15	"testis cancer: 10.4"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BEWO: 17.7;HAP1: 20.4;K-562: 12.0;NTERA-2: 11.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019032, HPA057273"			Supported	"Nucleoplasm,Nuclear membrane"		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 38: Extravillous trophoblasts - Unknown function"	Nucleoplasm	"Nuclear membrane"	"HPA019032: AB_1847363, HPA057273: AB_2683391"	"unprognostic (1.60e-1)"	"unprognostic (8.30e-2)"	"unprognostic (9.85e-2)"	"unprognostic (1.67e-2)"	"unprognostic (1.27e-1)"	"unprognostic (8.15e-2)"	"unprognostic (3.60e-3)"	"unprognostic (1.12e-1)"	"unprognostic (2.00e-1)"	"unprognostic (7.90e-3)"	"unprognostic (1.83e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.18e-3)"	"unprognostic (2.88e-4)"	"unprognostic (4.02e-2)"	"unprognostic (2.54e-1)"	"unprognostic (9.52e-3)"	0.4	0.2	0.6	0.2	1.2	0.3	0.4	4.9	0.7	0.7	0.8	0.4	0.1	0.9	0.6	0.2	0.5	0.3	0.3	0.3	0.9	0.3	0.2	0.2	0.3	0.9	1.3	0.8	0.2	0.7	0.3	1.2	1.1	0.6	0.3	1.5	1.0	0.3	0.9	0.3	0.2	0.5	1.0	0.3	0.4	0.2	1.1	2.0	0.5	0.3	0.3	0.2	0.4	2.2	0.7	0.8	8.0	9.0	0.8	0.7	17.7	0.4	1.0	0.7	1.2	5.5	0.3	0.0	0.3	0.8	0.1	0.0	20.4	0.0	0.8	0.3	3.3	2.1	0.0	4.9	1.2	1.9	1.0	1.0	0.1	0.5	0.1	1.6	0.1	3.5	12.0	1.4	0.7	0.6	3.3	1.4	11.9	0.0	1.1	3.2	2.5	0.2	0.4	0.8	2.2	3.5	0.4	0.5	1.6	7.9	1.0	1.5	0.3	0.7	1.6	0.0	0.6	0.5	0.6	3.2	0.2	0.0	0.2	0.0	0.0	0.2	0.3	0.0	0.4	0.3	0.1	0.2	0.0	0.1	0.2	0.2	0.0	0.1	0.0	0.2	0.5	0.0	0.6	1.2	4.9	0.7	0.3	0.9	0.9	1.3	1.1	1.0	1.1	2.2	6.3	3.2	6.2	54.5	2.5	1.1	1.8	0.4	5.2	2.5	7.0	9.5	7.2	1.5	2.6	0.0	10.4	21.0	3.0	0.2	0.0	2.7	0.8	3.6	34.2	4.8	13.8	2.5	15.6	0.4	79.9	15.4	1.5	2.9	0.0	13.6	5.7	2.5	3.9	35.3	20.6	0.3	4.1	0.0	0.3	1.7	25.7	0.8	1.8	12.2	0.4	16.1	5.2	44.7	45.3	0.6	0.0	20.7	7.3	1.4	0.0	0.9	0.8	12.5	6.6	21.9	10.7	0.5	1.5	0.8	1.1	27.9	2.6	43.7	0.6	0.4
TEX37	"C2orf51, FLJ25369, TSC21"	ENSG00000172073	"Testis expressed 37"	Q96LM6	2	88524649-88529585	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	640	"testis: 85.0"	"Group enriched"	"Detected in some"	229	"Early spermatids: 846.6;Late spermatids: 3191.0"	"Cancer enriched"	"Detected in single"	17	"testis cancer: 2.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	31	"BEWO: 50.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA043987, HPA070239"	Enhanced		Supported	Cytosol		NA	NA				"Cluster 36: Testis - Spermatogenesis"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 31: Spermatids - Spermatogenesis"	Cytosol		"HPA043987: AB_10961125, HPA070239: "										"unprognostic (1.08e-3)"					"unprognostic (2.24e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	85.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	50.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	846.6	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3191.0	8.4	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.0	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.0	0.0	8.4	8.8	0.0	0.0	0.3	0.0	0.0	0.0	0.0
TFAP2C	"AP2-GAMMA, ERF1, hAP-2g, TFAP2G"	ENSG00000087510	"Transcription factor AP-2 gamma"	Q92754	20	56629306-56639283	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 29.1;skin 1: 53.3"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 132.4;Basal squamous epithelial cells: 120.1;Breast glandular cells: 66.1;Breast myoepithelial cells: 79.6;Cytotrophoblasts: 91.7;Extravillous trophoblasts: 59.7;Squamous epithelial cells: 81.0;Suprabasal keratinocytes: 149.3;Syncytiotrophoblasts: 105.6"	"Cancer enhanced"	"Detected in many"		"testis cancer: 54.3"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	4	"BEWO: 190.6;MCF7: 169.2;SK-BR-3: 308.9;T-47d: 86.8;WM-115: 114.7"	"Region enriched"	"Detected in single"	13	"olfactory bulb: 2.4"	"Region enhanced"	"Detected in single"		"olfactory bulb: 1.4"	"CAB016061, CAB016079, HPA055179, HPA057076"	Enhanced		Supported	Nucleoplasm		Yes	NA				"Cluster 31: Skin - Epidermis development"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 47: Cytotrophoblasts - Unknown function"	Nucleoplasm		"CAB016061: AB_667770, CAB016079: AB_2199447, HPA055179: AB_2682729, HPA057076: AB_2683329"	"unprognostic (1.74e-2)"	"prognostic favorable (6.90e-4)"	"unprognostic (2.24e-2)"	"unprognostic (2.02e-2)"	"unprognostic (1.52e-2)"	"unprognostic (6.75e-2)"	"unprognostic (2.54e-2)"	"unprognostic (8.26e-2)"	"unprognostic (2.97e-1)"	"unprognostic (1.61e-1)"	"unprognostic (3.14e-3)"	"unprognostic (2.63e-1)"	"unprognostic (9.04e-5)"	"unprognostic (2.31e-1)"	"unprognostic (1.85e-1)"	"unprognostic (6.71e-2)"	"unprognostic (3.28e-2)"	1.8	0.3	1.3	0.2	0.6	0.1	26.1	0.5	1.5	18.3	0.5	4.0	0.2	6.2	5.2	29.1	2.6	1.0	0.3	1.7	0.7	2.0	0.0	2.6	0.1	0.9	0.8	0.3	1.0	2.6	0.8	17.0	1.2	7.1	1.2	2.7	20.7	4.4	2.1	53.3	0.3	1.1	0.5	0.1	0.7	1.0	0.6	0.7	2.3	0.1	3.0	3.9	19.2	1.0	12.8	15.8	0.1	0.2	0.0	0.0	190.6	20.1	36.4	25.0	4.5	3.2	0.3	0.0	1.3	13.3	13.3	42.7	27.3	5.5	17.0	0.1	2.8	0.0	1.7	0.0	0.0	0.0	1.7	0.3	21.4	7.4	7.2	0.0	0.0	8.1	0.2	3.2	0.0	169.2	20.8	1.2	9.5	9.9	20.7	0.1	0.0	7.0	0.0	10.1	5.1	0.1	13.6	308.9	21.8	28.3	86.8	4.6	0.2	16.2	0.4	8.6	15.4	0.1	0.0	0.1	4.0	0.1	114.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.6	0.5	1.5	1.7	0.7	0.9	0.8	1.2	0.5	0.6	1.0	0.7	0.0	9.5	3.9	0.3	132.4	29.9	2.4	120.1	4.1	66.1	79.6	1.0	0.0	5.6	9.2	0.0	91.7	1.5	1.7	0.0	0.3	0.3	7.8	18.7	2.0	3.0	0.0	0.0	0.0	59.7	7.4	1.5	16.0	0.0	0.0	0.7	0.0	7.8	0.0	0.0	1.7	10.2	0.3	8.2	0.0	0.0	1.6	21.4	3.7	0.0	0.3	0.0	0.0	0.0	1.0	0.6	0.0	3.8	18.6	0.0	0.0	5.2	0.0	0.0	0.5	2.1	0.0	1.8	81.0	149.3	105.6	1.3	0.0	1.0	18.5
TFAP4	"AP-4, bHLHc41"	ENSG00000090447	"Transcription factor AP-4"	Q01664	16	4257186-4273075	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 30.1;Proximal enterocytes: 40.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001912	Supported		Supported	Nucleoplasm,Mitochondria		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 50: Non-specific - Ribosome"	"Cluster 24: NB-4 - Immune response"	"Cluster 32: Non-specific - Translation"	"Nucleoplasm, Mitochondria"		"HPA001912: AB_1080251"	"unprognostic (1.61e-2)"	"unprognostic (1.36e-1)"	"unprognostic (5.10e-2)"	"unprognostic (4.42e-3)"	"unprognostic (8.61e-2)"	"unprognostic (1.15e-2)"	"prognostic unfavorable (3.32e-4)"	"unprognostic (8.05e-2)"	"unprognostic (8.97e-2)"	"unprognostic (4.60e-1)"	"unprognostic (5.75e-2)"	"unprognostic (7.68e-2)"	"prognostic unfavorable (4.31e-6)"	"unprognostic (1.08e-2)"	"unprognostic (3.25e-1)"	"unprognostic (2.39e-2)"	"unprognostic (1.30e-1)"	6.2	4.2	3.7	6.9	3.8	1.9	5.8	5.3	5.4	9.0	1.7	5.4	6.4	7.8	1.0	8.1	6.9	3.8	3.2	3.5	3.2	3.6	5.3	3.9	6.8	3.9	3.7	10.0	12.0	3.3	4.3	3.7	3.9	5.7	1.9	0.7	7.6	3.1	7.5	10.5	6.8	2.5	3.5	7.3	5.0	1.7	3.7	8.3	4.6	3.1	3.9	6.4	8.4	5.1	14.9	15.4	12.9	19.2	5.4	14.1	21.7	5.7	14.6	9.6	10.5	8.1	23.0	51.0	14.5	5.5	4.5	22.0	23.6	19.4	3.0	29.8	17.4	15.6	13.0	21.1	7.5	27.8	8.8	13.3	12.2	10.4	29.0	4.5	6.4	16.7	29.1	13.1	3.8	23.9	39.2	46.4	29.8	14.7	20.2	34.3	28.8	53.7	3.7	11.2	27.0	20.0	19.2	19.7	18.9	2.0	10.0	21.9	4.2	13.1	10.4	46.2	15.1	21.3	19.3	43.6	8.8	27.2	9.5	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	3.7	3.8	5.3	5.4	3.5	3.2	3.9	3.7	3.9	3.5	3.7	5.1	7.0	3.2	0.0	2.3	11.6	21.5	9.8	5.7	30.1	4.2	8.1	6.6	2.2	7.2	2.1	27.6	0.0	7.7	5.3	5.3	7.9	4.1	0.1	2.4	9.6	5.4	7.8	22.7	3.0	5.7	11.7	7.6	10.7	3.1	0.0	6.9	3.6	3.4	4.2	0.0	3.9	12.4	8.2	4.0	7.4	0.1	11.8	3.7	3.6	1.0	4.7	2.2	5.2	1.5	3.6	2.9	5.3	5.3	7.2	11.1	40.0	5.7	1.4	3.4	6.6	6.9	7.1	0.9	0.9	22.1	22.3	2.2	7.3	7.5	20.2	4.3
TFCP2	"CP2, LBP-1C, LSF, TFCP2C"	ENSG00000135457	"Transcription factor CP2"	Q12800	12	51093656-51173135	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 73.0;Inhibitory neurons: 75.9;Microglial cells: 69.3;Oligodendrocyte precursor cells: 79.4;Oligodendrocytes: 103.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA070247			Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 52: Non-specific - Ribosome"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Nucleoplasm	Cytosol	"HPA070247: AB_2686239"	"unprognostic (6.27e-2)"	"unprognostic (6.77e-2)"	"unprognostic (6.90e-2)"	"unprognostic (1.42e-1)"	"unprognostic (4.68e-2)"	"unprognostic (1.66e-1)"	"prognostic unfavorable (1.83e-4)"	"unprognostic (1.93e-1)"	"prognostic unfavorable (1.18e-4)"	"unprognostic (1.14e-1)"	"unprognostic (1.32e-1)"	"unprognostic (9.69e-2)"	"unprognostic (4.91e-3)"	"unprognostic (1.01e-1)"	"unprognostic (3.20e-1)"	"unprognostic (5.58e-2)"	"unprognostic (5.31e-2)"	16.7	12.9	12.4	18.5	14.7	9.8	16.9	13.9	16.4	18.4	10.1	17.0	14.9	18.0	16.1	13.5	19.6	13.5	17.7	13.2	13.1	16.1	11.3	13.5	21.0	12.4	13.0	18.6	13.8	25.0	14.2	18.8	12.6	18.5	20.3	32.1	16.3	15.0	26.7	14.3	15.1	18.1	12.6	18.5	15.2	9.1	12.8	27.3	17.1	22.1	26.0	15.5	13.4	16.9	17.3	29.5	43.0	40.4	25.2	31.3	64.1	30.7	18.6	29.8	17.4	52.4	37.6	1.5	27.9	29.4	21.9	33.8	56.0	35.2	29.4	35.5	28.3	47.4	26.6	23.8	20.3	57.9	48.4	21.3	33.3	29.4	47.8	34.0	28.4	15.1	54.1	0.1	32.0	0.0	55.2	39.5	64.0	39.9	55.3	41.2	23.6	0.4	39.2	39.4	41.1	36.0	38.8	34.6	28.1	41.7	13.0	49.0	24.3	27.1	27.9	27.8	28.4	30.8	53.3	0.1	25.8	35.3	19.5	7.4	6.1	6.6	2.3	5.4	3.8	2.8	2.4	2.6	5.6	1.8	3.1	2.4	2.1	6.9	7.2	2.2	3.8	3.3	12.4	14.7	13.9	16.4	13.2	13.1	12.4	13.0	12.6	12.6	12.8	16.9	9.3	9.6	16.4	57.8	11.0	6.6	6.9	10.7	9.1	21.6	11.5	10.5	23.8	8.6	8.7	12.9	20.9	13.2	19.6	11.4	5.9	9.2	0.8	11.0	14.1	10.2	10.8	5.9	73.0	7.7	10.5	9.7	10.7	14.6	10.8	22.5	12.5	9.3	13.7	10.1	75.9	13.2	10.2	21.1	10.8	0.7	12.2	17.0	10.6	69.3	36.8	9.8	24.7	79.4	103.6	12.2	11.0	10.9	7.3	11.1	8.7	9.4	9.2	27.3	0.0	14.0	13.1	6.7	11.3	9.9	5.3	16.7	10.7	12.2	13.4	6.4
TFDP2	Dp-2	ENSG00000114126	"Transcription factor Dp-2"	Q14188	3	141944428-142149544	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Cell cycle, Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 169.7"	"Cell type enhanced"	"Detected in all"		"Early spermatids: 986.1;Late spermatids: 397.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"JURKAT: 216.4;MOLT-4: 423.3;REH: 222.7;U-698: 366.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB018396, HPA070399"	Supported		Supported	"Nucleoplasm,Vesicles,Mitotic spindle"		Yes	No			"Cluster 49: Eosinophils - Unknown function"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	Nucleoplasm	"Vesicles, Mitotic spindle"	"CAB018396: AB_2287284, HPA070399: "	"unprognostic (1.35e-2)"	"prognostic favorable (6.32e-4)"	"unprognostic (8.08e-3)"	"unprognostic (2.90e-2)"	"unprognostic (4.69e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.14e-3)"	"unprognostic (2.60e-3)"	"unprognostic (5.42e-2)"	"unprognostic (1.46e-1)"	"unprognostic (5.04e-2)"	"unprognostic (2.04e-1)"	"prognostic favorable (9.84e-4)"	"unprognostic (6.04e-2)"	"unprognostic (3.91e-2)"	"unprognostic (2.45e-1)"	"unprognostic (1.08e-1)"	18.8	15.1	7.8	9.2	8.9	50.3	18.9	21.2	12.7	12.1	8.2	14.8	22.7	15.3	15.9	13.7	14.7	19.4	26.0	9.0	7.0	29.5	17.3	11.8	10.5	12.5	10.6	23.3	12.4	16.7	13.0	28.4	12.4	19.4	14.0	13.2	12.3	13.7	28.5	11.9	21.3	14.4	7.4	9.5	12.4	69.9	8.2	169.7	21.6	21.3	10.6	11.2	10.2	10.0	32.8	14.7	61.6	49.4	20.3	21.9	134.0	16.3	18.8	25.5	40.2	19.2	32.2	115.8	73.7	18.7	44.6	19.5	15.8	31.2	35.8	46.9	28.5	140.4	21.5	26.0	19.6	43.1	47.8	20.6	22.8	27.8	26.9	23.5	18.3	216.4	53.5	6.8	44.3	25.4	423.3	16.1	49.6	17.2	20.0	222.7	42.2	27.0	29.4	16.5	26.9	25.0	54.5	19.5	29.0	45.3	46.7	21.9	12.0	24.2	21.9	19.8	20.7	20.7	20.5	366.5	19.4	11.4	11.6	69.3	4.0	48.0	28.0	6.9	10.9	14.7	12.8	14.9	9.8	18.7	18.6	22.2	4.4	37.4	10.0	33.7	12.8	12.5	7.8	8.9	21.2	12.7	9.0	7.0	12.5	10.6	12.4	7.4	8.2	10.0	29.7	32.1	30.6	64.0	24.2	25.1	52.1	30.4	43.3	33.0	45.1	36.8	87.6	45.8	30.7	47.8	33.3	235.4	98.5	23.1	93.9	36.8	986.1	63.9	51.1	26.8	38.6	171.9	194.6	26.4	125.2	44.0	15.8	35.8	33.5	84.8	27.8	39.8	27.8	37.0	166.7	27.1	40.7	13.5	15.4	397.5	77.0	27.0	5.4	51.5	14.9	26.1	128.8	61.9	116.6	27.2	25.7	75.2	25.2	36.3	87.5	98.4	43.1	34.5	26.3	96.7	38.6	75.4	75.6	31.3	20.0	99.2	42.9	72.4	42.0	36.0
TFDP3	"CT30, E2F-like, HCA661"	ENSG00000183434	"Transcription factor Dp family member 3"	Q5H9I0	X	133216662-133218354	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	35	"testis: 4.2"	"Group enriched"	"Detected in some"	17	"Spermatocytes: 23.5;Spermatogonia: 31.1"	"Cancer enhanced"	"Detected in some"		"liver cancer: 0.7;testis cancer: 1.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA077304			Supported	"Nucleoplasm,Nuclear membrane,Cytosol"		NA	NA				"Cluster 74: Testis - Spermatogenesis"		"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	"Nucleoplasm, Nuclear membrane"	Cytosol	"HPA077304: "	"unprognostic (1.57e-1)"								"unprognostic (2.17e-1)"					"unprognostic (3.22e-1)"	"unprognostic (2.91e-2)"			0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	23.5	31.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TFE3	"bHLHe33, TFEA"	ENSG00000068323	"Transcription factor binding to IGHM enhancer 3"	P19532	X	49028726-49043410	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Adaptive immunity, Immunity, Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 12.5"	"Group enriched"	"Detected in many"	4	"granulocytes: 12.5;monocytes: 6.3"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023881	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 41: Macrophages - Immune response"	"Nucleoplasm, Cytosol"		"HPA023881: AB_1857931"	"unprognostic (2.68e-2)"	"unprognostic (2.89e-3)"	"unprognostic (2.40e-2)"	"unprognostic (5.36e-2)"	"unprognostic (2.71e-2)"	"unprognostic (1.81e-1)"	"prognostic unfavorable (6.03e-5)"	"unprognostic (2.40e-1)"	"unprognostic (1.26e-1)"	"unprognostic (4.32e-2)"	"unprognostic (5.41e-2)"	"unprognostic (1.16e-1)"	"prognostic unfavorable (2.19e-8)"	"unprognostic (1.93e-1)"	"unprognostic (8.77e-2)"	"unprognostic (4.19e-2)"	"unprognostic (6.25e-1)"	31.3	23.6	27.8	16.8	27.3	24.1	22.9	25.8	26.9	24.1	23.3	23.6	10.8	24.7	21.1	15.6	26.2	18.5	17.2	25.7	29.4	15.1	12.6	29.2	11.8	37.2	30.9	25.8	12.4	25.1	18.4	20.8	28.7	17.2	11.5	14.8	13.4	28.3	17.0	20.5	14.7	24.7	27.5	22.5	16.8	5.9	32.2	10.7	20.0	14.0	13.2	25.0	20.5	25.6	32.8	41.5	14.6	44.6	48.6	45.1	12.5	40.6	55.8	49.7	38.2	23.3	26.8	10.2	18.0	65.7	48.6	25.5	25.4	40.2	44.8	24.4	11.8	8.3	39.6	26.2	69.0	10.0	28.3	38.5	32.3	64.4	50.1	47.8	26.3	8.4	19.8	55.9	49.2	20.6	7.5	17.2	36.3	11.0	34.1	11.9	22.2	26.6	43.1	18.0	12.4	12.4	44.8	19.0	17.9	52.5	27.6	15.0	48.5	47.1	48.7	48.0	27.3	30.1	29.7	8.0	56.1	14.0	33.2	0.0	4.8	1.8	0.6	4.7	1.1	0.5	0.9	0.5	2.2	1.0	0.6	0.5	12.5	0.4	6.3	0.5	1.3	2.6	27.8	27.3	25.8	26.9	25.7	29.4	37.2	30.9	28.7	27.5	32.2	25.6	13.8	16.0	8.8	13.7	9.8	19.8	19.7	11.2	30.1	6.8	10.9	9.4	8.1	15.7	11.8	20.2	4.2	16.0	4.4	14.3	9.8	17.7	0.7	10.9	15.3	17.5	12.5	5.2	7.5	15.8	9.4	20.2	14.3	14.8	5.7	12.0	10.8	15.0	22.3	18.5	7.2	8.2	0.0	21.7	29.4	2.2	27.4	20.5	8.8	11.2	15.5	12.0	4.1	6.0	7.7	21.4	13.7	24.5	12.9	20.2	10.6	12.1	7.0	5.6	13.1	18.5	14.3	2.2	0.8	18.9	22.0	37.1	8.6	13.9	7.5	19.6
TFEB	"bHLHe35, TCFEB"	ENSG00000112561	"Transcription factor EB"	P19484	6	41683978-41736259	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Adaptive immunity, Autophagy, Immunity, Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 89.9"	"Cell type enhanced"	"Detected in many"		"Oligodendrocytes: 97.4;Syncytiotrophoblasts: 120.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"classical monocyte: 16.1;eosinophil: 16.9;intermediate monocyte: 16.3;memory B-cell: 34.2;myeloid DC: 14.7;naive B-cell: 22.6;neutrophil: 47.4;non-classical monocyte: 14.1"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BEWO: 60.3;Daudi: 35.8;OE19: 53.1;U-698: 42.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA067082			Supported	Cytosol		NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 57: B-cells - Immune response"	Cytosol		"HPA067082: "	"unprognostic (3.63e-3)"	"unprognostic (1.51e-3)"	"unprognostic (1.75e-2)"	"unprognostic (4.48e-3)"	"unprognostic (1.95e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.64e-1)"	"unprognostic (4.22e-3)"	"unprognostic (1.39e-2)"	"unprognostic (4.13e-2)"	"prognostic favorable (4.77e-4)"	"unprognostic (2.12e-2)"	"prognostic favorable (1.06e-5)"	"unprognostic (1.44e-1)"	"unprognostic (3.51e-2)"	"unprognostic (2.46e-1)"	"unprognostic (1.31e-2)"	14.3	10.7	18.3	16.7	29.9	8.3	15.0	24.0	23.5	13.4	9.6	25.7	5.8	11.1	1.5	14.8	12.8	7.7	37.1	18.1	19.7	26.7	11.6	18.2	26.1	30.9	27.7	6.5	12.9	17.8	31.3	14.5	25.8	23.4	4.3	2.2	21.2	7.0	89.9	17.9	34.6	5.7	22.5	57.2	14.4	2.6	25.4	5.0	22.9	41.5	17.2	19.6	15.6	39.9	3.5	3.2	0.6	12.3	3.8	2.5	60.3	5.3	6.9	3.4	2.7	6.9	2.7	35.8	6.8	3.5	2.9	8.7	2.4	4.9	1.0	28.3	4.1	0.1	8.8	12.8	6.8	1.0	4.3	0.7	9.8	4.9	2.6	6.9	4.1	3.3	4.1	7.4	1.0	1.8	2.3	1.2	0.1	53.1	1.6	24.3	0.1	5.0	7.5	2.6	12.8	4.3	4.7	10.5	1.0	3.4	2.3	19.5	7.1	1.5	3.1	0.1	3.0	15.7	2.3	42.1	2.6	15.3	0.9	0.3	16.1	16.9	3.8	16.3	0.9	34.2	1.5	1.8	14.7	22.6	0.4	1.5	47.4	1.7	14.1	2.9	0.6	8.7	18.3	29.9	24.0	23.5	18.1	19.7	30.9	27.7	25.8	22.5	25.4	39.9	14.5	9.6	9.3	10.1	36.7	14.1	8.2	14.8	5.2	6.1	5.7	5.6	19.2	10.0	6.0	12.9	12.5	50.7	13.8	16.3	21.5	3.7	1.1	11.4	2.6	12.2	13.2	3.2	6.3	6.9	8.3	6.9	6.1	8.0	1.3	0.5	6.4	4.2	26.8	26.9	7.9	10.2	26.4	22.8	13.3	4.2	3.4	19.6	0.0	17.8	20.0	18.4	22.6	11.1	97.4	10.6	18.0	10.9	16.0	7.1	14.1	3.7	7.4	5.2	6.6	13.1	7.8	0.9	1.0	6.4	14.5	120.4	9.1	0.8	8.8	6.3
TFEC	"bHLHe34, TCFEC, TFECL"	ENSG00000105967	"Transcription factor EC"	O14948	7	115935148-116159896	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 17.2;kidney: 20.5;lymphoid tissue: 22.1"	"Cell type enhanced"	"Detected in some"		"Hofbauer cells: 45.5;Kupffer cells: 56.3;Macrophages: 61.6;Microglial cells: 60.0;monocytes: 44.1;Proximal tubular cells: 77.8"	"Cancer enhanced"	"Detected in many"		"renal cancer: 5.2"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	10	"classical monocyte: 7.1;intermediate monocyte: 2.8;memory B-cell: 3.8;myeloid DC: 6.3;naive B-cell: 2.5;plasmacytoid DC: 3.3"	"Group enriched"	"Detected in many"	29	"B-cells: 3.8;dendritic cells: 6.3;monocytes: 7.1"	"Cell line enhanced"	"Detected in some"		"HEL: 15.9;HUVEC TERT2: 11.0;THP-1: 21.5;TIME: 12.5;U-937: 24.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"CAB032260, HPA063577"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 2: Immune cells - Immune response"	"Cluster 32: U-937 - Innate immune response"	"Cluster 4: Macrophages - Innate immune response"	Nucleoplasm		"CAB032260: AB_2202845, HPA063577: AB_2685047"	"unprognostic (1.36e-1)"	"unprognostic (1.08e-2)"	"unprognostic (8.70e-2)"	"unprognostic (1.91e-2)"	"unprognostic (1.44e-1)"	"unprognostic (2.79e-2)"	"unprognostic (1.13e-1)"	"unprognostic (8.26e-2)"	"unprognostic (2.15e-1)"	"unprognostic (6.54e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.72e-1)"	"unprognostic (2.05e-3)"	"unprognostic (2.92e-1)"	"unprognostic (4.14e-2)"	"unprognostic (1.51e-1)"	"unprognostic (3.60e-2)"	3.5	2.4	1.3	19.2	1.2	17.2	2.6	1.5	1.6	1.9	2.1	2.7	4.2	1.4	0.6	1.0	1.0	4.9	1.0	0.8	1.7	20.5	3.1	9.9	22.1	3.3	1.9	1.3	1.0	0.4	0.6	4.7	2.7	1.0	4.2	0.1	1.3	0.9	0.3	0.4	9.7	3.1	2.7	14.6	3.0	1.6	3.7	2.8	0.9	0.4	12.6	4.0	0.6	4.8	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	3.7	0.0	1.7	0.1	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.0	15.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	11.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	21.5	12.5	2.1	0.2	1.3	0.0	5.5	0.0	0.0	0.1	24.4	1.1	0.0	7.1	0.0	0.0	2.8	0.0	3.8	0.0	0.0	6.3	2.5	0.0	0.0	0.1	0.0	0.4	3.3	0.0	1.5	1.3	1.2	1.5	1.6	0.8	1.7	3.3	1.9	2.7	2.7	3.7	4.8	0.5	0.0	2.2	0.3	18.1	0.5	0.0	0.0	0.0	0.0	0.3	0.8	0.8	1.5	0.0	3.7	0.0	0.2	8.3	0.0	0.0	0.0	2.4	0.0	0.0	1.7	0.0	7.2	0.6	0.0	0.3	0.4	0.0	0.0	2.5	0.0	0.0	0.0	45.5	0.0	0.5	0.4	0.0	56.3	17.8	3.8	0.0	61.6	0.0	60.0	44.1	0.0	1.0	1.0	0.1	0.1	0.0	0.0	1.3	0.1	15.6	77.8	0.0	0.0	0.0	0.3	0.1	0.3	2.5	0.1	0.4	0.8	0.8	0.1	0.7	0.1
TFG	"FLJ36137, SPG57, TF6"	ENSG00000114354	"Trafficking from ER to golgi regulator"	Q92734	3	100709295-100748964	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"ER-Golgi transport, Transport"		"Cancer-related genes, Disease variant, Hereditary spastic paraplegia, Neurodegeneration, Neuropathy, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019473, HPA052206"	Approved		Supported	Vesicles,Cytosol		No	No		320000	"Cluster 38: Basophils - Unknown function"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 55: Plasma cells - Humoral immune response"	Vesicles	Cytosol	"HPA019473: AB_1857936, HPA052206: AB_2681760"	"unprognostic (1.14e-1)"	"unprognostic (3.58e-2)"	"unprognostic (1.46e-1)"	"unprognostic (2.94e-2)"	"unprognostic (1.46e-1)"	"unprognostic (4.14e-2)"	"prognostic unfavorable (5.48e-4)"	"unprognostic (3.31e-3)"	"unprognostic (1.42e-1)"	"unprognostic (3.73e-2)"	"prognostic unfavorable (1.50e-4)"	"unprognostic (4.58e-3)"	"unprognostic (3.72e-2)"	"unprognostic (2.82e-1)"	"unprognostic (8.55e-2)"	"unprognostic (3.33e-1)"	"unprognostic (8.45e-2)"	62.2	73.0	40.7	37.2	40.4	37.4	52.4	43.5	46.4	53.9	46.7	63.8	89.8	52.0	78.5	85.7	51.2	56.4	82.6	41.3	45.4	71.9	113.9	55.6	29.4	44.2	43.2	48.2	66.7	89.0	64.1	79.2	44.4	47.9	69.6	40.9	60.6	61.3	75.5	58.9	76.6	66.5	43.2	42.6	54.4	47.7	42.3	40.6	64.1	58.2	54.9	61.6	57.3	44.4	203.8	107.5	126.7	79.0	160.1	176.4	163.9	141.1	190.4	182.5	213.0	136.0	96.1	24.7	103.3	180.4	141.3	143.1	143.4	161.5	216.2	123.8	87.4	99.7	69.3	130.0	183.3	70.2	51.8	149.3	216.6	108.4	190.8	165.1	165.5	44.5	73.1	63.5	191.9	143.9	63.3	56.7	122.5	193.8	169.3	55.5	77.8	89.0	226.5	125.9	96.4	93.1	95.0	118.2	175.8	103.4	141.7	103.1	113.1	103.0	130.8	48.4	104.4	56.2	65.8	92.1	171.2	79.7	130.7	84.3	43.6	42.8	30.8	45.2	37.4	37.4	31.6	34.5	43.1	35.9	29.4	29.7	26.1	43.1	44.8	29.3	41.0	37.0	40.7	40.4	43.5	46.4	41.3	45.4	44.2	43.2	44.4	43.2	42.3	44.4	67.9	60.9	36.9	46.4	43.3	136.6	105.9	183.6	69.4	46.8	58.0	50.2	83.5	48.6	93.1	36.8	25.0	211.6	43.1	111.8	137.0	190.3	101.5	70.8	70.4	70.2	52.6	27.1	54.8	107.7	201.5	97.8	47.4	79.0	76.8	62.9	53.9	68.4	86.2	57.2	59.2	128.5	122.1	27.3	84.9	45.5	70.8	43.6	64.0	38.4	98.5	88.0	28.8	49.3	55.0	130.5	91.0	74.1	75.8	133.5	202.5	106.4	63.9	60.3	39.5	81.3	87.2	79.2	51.5	68.0	118.9	284.4	43.2	90.0	97.2	123.0
TFPT	"amida, FB1, INO80F"	ENSG00000105619	"TCF3 fusion partner"	P0C1Z6	19	54107020-54115657	"Disease related genes, Predicted intracellular proteins"	"Apoptosis, DNA damage, DNA recombination, DNA repair, Transcription, Transcription regulation"		Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 135.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034958, HPA058534"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 65: Brain - Ion transport"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 4: Macrophages - Innate immune response"	Nucleoplasm		"HPA034958: AB_10603036, HPA058534: AB_2683745"	"unprognostic (1.76e-1)"	"unprognostic (1.57e-1)"	"prognostic unfavorable (5.13e-4)"	"unprognostic (6.56e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.09e-1)"	"prognostic unfavorable (5.25e-4)"	"unprognostic (3.85e-1)"	"unprognostic (2.85e-1)"	"unprognostic (2.71e-1)"	"prognostic favorable (3.13e-4)"	"unprognostic (1.80e-2)"	"unprognostic (1.15e-1)"	"unprognostic (2.00e-2)"	"unprognostic (2.61e-1)"	"unprognostic (3.43e-1)"	"unprognostic (3.66e-2)"	12.1	15.8	27.4	8.9	25.2	10.4	12.8	23.1	41.3	11.7	18.6	15.7	9.7	11.7	4.3	10.0	9.9	7.2	16.1	26.5	24.7	12.0	10.5	12.3	10.7	24.1	25.0	9.5	8.7	9.2	10.9	8.4	24.3	22.2	4.1	5.0	13.1	5.4	19.4	13.2	12.2	6.1	20.9	19.1	14.1	9.1	24.0	13.5	11.2	10.6	6.4	12.3	9.4	28.0	23.5	28.5	18.2	12.9	6.7	9.5	11.8	25.1	15.5	23.9	24.5	17.8	23.6	20.5	20.2	12.8	12.5	11.2	10.8	19.6	7.8	43.5	52.2	30.7	27.5	20.8	39.6	16.1	34.7	11.2	9.5	18.8	15.7	11.5	18.7	30.8	19.3	45.8	9.2	30.2	34.3	47.2	11.0	34.1	19.8	30.6	10.0	15.4	10.0	35.9	19.2	17.4	9.2	38.4	45.1	5.6	14.0	48.9	37.8	52.4	19.3	7.5	36.9	33.8	48.2	18.5	20.7	40.4	34.4	10.5	9.2	6.4	15.4	10.7	14.6	9.4	19.4	20.1	19.0	9.3	16.2	17.2	6.5	21.4	3.9	43.3	26.0	11.2	27.4	25.2	23.1	41.3	26.5	24.7	24.1	25.0	24.3	20.9	24.0	28.0	25.3	16.0	7.2	5.2	12.2	17.0	9.8	25.5	12.0	10.9	31.4	32.3	2.5	12.8	28.6	22.0	2.1	22.4	30.3	22.5	15.6	21.0	9.6	27.1	8.2	29.5	15.6	7.8	5.0	27.6	29.1	11.3	11.2	13.3	15.2	20.8	37.9	9.6	135.7	0.0	4.1	35.7	32.6	28.1	41.0	5.5	12.2	43.5	39.2	1.0	49.7	17.8	25.7	2.5	3.6	55.9	18.4	17.0	13.1	31.9	23.0	24.8	46.4	12.4	6.6	7.8	16.5	11.0	16.0	5.8	17.3	26.1	22.8	41.1	16.1	13.0
TFRC	"CD71, p90, TFR1"	ENSG00000072274	"Transferrin receptor"	P02786	3	196027183-196082096	"Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters"	"Endocytosis, Host-virus interaction"	"Host cell receptor for virus entry, Receptor, Transducer"	"Cancer-related genes, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 254.5"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 556.4;Syncytiotrophoblasts: 502.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HDLM-2: 860.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000153, HPA028598"	Enhanced		Supported	Endosomes,Lysosomes	"Secreted to blood"	NA	NA	1310000000	38000000	"Cluster 27: Non-specific - Gene expression"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 36: HEL - Hemostasis"	"Cluster 6: Erythroid cells - Oxygen transport"	"Endosomes, Lysosomes"		"CAB000153: AB_2533029, HPA028598: AB_10601599"	"unprognostic (2.95e-2)"	"prognostic unfavorable (3.67e-4)"	"unprognostic (2.55e-1)"	"unprognostic (1.48e-2)"	"unprognostic (6.75e-2)"	"unprognostic (7.88e-3)"	"prognostic unfavorable (1.15e-4)"	"unprognostic (6.92e-2)"	"unprognostic (3.30e-3)"	"unprognostic (4.35e-2)"	"unprognostic (1.34e-2)"	"unprognostic (1.14e-2)"	"unprognostic (3.63e-3)"	"unprognostic (3.65e-2)"	"unprognostic (1.19e-2)"	"prognostic unfavorable (2.96e-4)"	"unprognostic (2.62e-2)"	44.6	28.7	21.6	63.4	18.3	254.5	20.2	18.5	32.3	31.3	15.7	77.2	35.9	23.8	11.1	36.0	25.9	24.9	31.0	21.9	19.0	26.4	27.8	78.0	23.0	24.2	19.9	93.9	15.9	44.8	13.1	103.2	26.3	13.2	55.6	47.3	15.7	13.4	76.2	21.8	32.1	31.5	20.8	15.5	21.4	21.6	25.3	22.0	20.1	68.7	28.1	68.5	17.4	20.7	175.3	155.0	69.8	142.1	151.7	87.3	438.7	242.5	183.7	168.1	276.3	384.6	156.6	178.5	446.3	91.0	363.5	261.8	243.3	81.1	204.2	860.4	82.4	677.4	120.2	179.2	119.4	561.8	130.4	99.1	78.6	144.5	129.0	47.8	56.9	95.6	287.3	164.1	132.8	161.7	185.8	116.8	214.9	228.6	314.0	97.3	103.9	214.1	148.3	435.3	159.3	65.9	234.4	613.9	55.2	115.9	595.0	115.8	72.5	198.4	159.7	175.3	369.7	46.3	387.8	276.7	232.3	149.2	122.3	0.0	1.6	2.2	2.2	7.3	1.4	5.1	2.4	1.5	3.5	3.1	2.1	1.7	0.2	1.9	13.2	7.1	6.4	2.1	21.6	18.3	18.5	32.3	21.9	19.0	24.2	19.9	26.3	20.8	25.3	20.7	25.4	44.8	32.1	43.1	46.6	60.3	37.2	33.6	21.1	53.1	37.1	34.9	103.0	41.5	38.8	20.2	148.0	122.5	53.2	156.6	0.0	49.4	3.5	35.3	20.3	23.6	56.1	556.4	24.7	41.8	25.3	32.4	77.5	56.1	23.4	40.2	8.6	93.2	73.4	13.5	28.3	67.8	22.4	37.1	77.6	5.3	11.5	161.7	17.8	44.0	49.4	22.0	9.2	11.6	8.2	52.0	50.8	8.6	42.1	25.6	48.3	13.1	32.1	44.4	26.3	36.3	29.3	23.8	18.2	51.3	35.8	502.7	42.6	16.6	103.5	23.7
TGFB1I1	"ARA55, Hic-5, TSC-5"	ENSG00000140682	"Transforming growth factor beta 1 induced transcript 1"	O43294	16	31471585-31477960	"Predicted intracellular proteins"	"Differentiation, Wnt signaling pathway"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"endometrium 1: 265.6;intestine: 264.4"	"Cell type enhanced"	"Detected in many"		"Leydig cells: 92.2;Peritubular cells: 179.0;Sertoli cells: 223.5;Smooth muscle cells: 176.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	6	"basophil: 9.5"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 9.5"	"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 100.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB020844	Enhanced		Supported	"Focal adhesion sites,Cytosol"		NA	NA		800000	"Cluster 34: Basophils - Unknown function"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 48: Smooth muscle cells - ECM organization"	"Focal adhesion sites"	Cytosol	"CAB020844: "	"unprognostic (5.80e-2)"	"unprognostic (3.09e-2)"	"unprognostic (5.34e-2)"	"unprognostic (1.18e-1)"	"unprognostic (6.64e-2)"	"unprognostic (9.52e-2)"	"unprognostic (1.89e-1)"	"unprognostic (4.95e-2)"	"unprognostic (4.19e-2)"	"unprognostic (1.71e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.39e-1)"	"prognostic unfavorable (6.06e-8)"	"unprognostic (1.06e-2)"	"unprognostic (6.57e-2)"	"unprognostic (2.25e-2)"	"prognostic unfavorable (7.73e-5)"	65.5	17.0	4.8	22.7	5.1	1.0	52.8	4.6	6.9	119.0	4.4	264.4	14.5	265.6	12.4	38.2	143.2	14.4	48.5	4.6	4.7	26.6	9.7	54.7	4.8	5.6	4.6	78.6	8.2	8.6	8.2	19.7	5.0	87.6	23.9	0.7	21.0	80.8	13.1	28.5	61.7	106.1	4.7	33.0	78.5	10.2	5.1	1.4	26.8	10.5	4.9	171.1	73.6	4.4	13.3	16.6	25.9	0.0	25.4	46.1	0.3	70.8	64.8	43.6	30.1	6.6	4.5	0.0	65.1	62.3	29.1	20.6	6.0	13.3	56.4	0.1	0.3	17.5	29.1	3.7	67.4	0.0	19.8	31.1	18.7	27.5	16.3	100.0	29.2	0.0	1.5	0.0	51.9	0.1	0.0	1.6	1.4	1.4	16.2	0.0	30.9	0.1	12.5	6.6	0.0	19.0	27.5	0.2	14.1	20.9	0.1	1.7	82.4	79.8	19.2	21.4	31.8	0.1	0.1	0.2	34.9	0.8	49.6	9.5	0.0	0.1	0.2	0.0	0.3	0.9	0.9	0.1	0.0	0.2	0.1	0.6	0.2	0.0	0.0	0.3	1.6	1.3	4.8	5.1	4.6	6.9	4.6	4.7	5.6	4.6	5.0	4.7	5.1	4.4	76.9	6.4	4.8	0.0	0.4	12.6	23.9	34.8	14.8	0.4	4.1	71.5	13.4	5.7	3.4	7.3	0.0	1.2	1.5	1.8	7.9	33.3	1.2	3.6	76.2	48.8	0.0	11.0	0.1	22.5	1.2	64.4	4.6	2.9	6.3	35.3	29.6	0.3	14.6	0.0	0.1	4.7	0.0	0.3	15.4	3.3	92.2	9.3	40.9	2.8	4.2	7.0	0.0	3.5	0.1	28.4	2.2	179.0	1.4	20.1	13.3	19.7	1.1	1.4	223.5	17.4	176.0	1.5	3.6	1.9	11.2	1.8	2.6	20.3	5.3	4.6
TGFBR1	"ACVRLK4, ALK-5, ALK5, ESS1, MSSE, TBR-i, TBRI"	ENSG00000106799	"Transforming growth factor beta receptor 1"	P36897	9	99104038-99154192	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Apoptosis, Differentiation, Growth regulation"	"Kinase, Receptor, Serine/threonine-protein kinase, Transferase"	"Aortic aneurysm, Craniosynostosis, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 128.4;Late spermatids: 101.7;Microglial cells: 116.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RH-30: 253.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002441, CAB031481, HPA056473"	Uncertain		Supported	"Plasma membrane"	"Intracellular and membrane"	NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 65: Plasmacytoid DCs - Unknown function"	"Plasma membrane"		"CAB002441: AB_564029, CAB031481: AB_2202455, HPA056473: AB_2683144"	"unprognostic (2.58e-3)"	"unprognostic (1.20e-2)"	"unprognostic (3.64e-3)"	"unprognostic (2.80e-1)"	"unprognostic (8.63e-2)"	"unprognostic (3.36e-2)"	"unprognostic (1.97e-2)"	"unprognostic (1.32e-3)"	"unprognostic (1.97e-1)"	"unprognostic (1.45e-1)"	"unprognostic (8.21e-3)"	"unprognostic (1.82e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.01e-3)"	"unprognostic (3.40e-2)"	"unprognostic (3.19e-2)"	"unprognostic (1.14e-2)"	15.9	9.9	9.8	18.2	9.3	33.7	15.4	13.2	8.9	19.4	11.8	18.8	11.7	20.6	8.8	15.0	8.5	21.7	8.2	6.8	11.3	22.6	14.8	16.3	13.8	18.4	14.5	13.0	8.3	8.5	7.6	48.8	20.0	17.1	13.4	4.7	8.3	16.8	8.7	6.2	9.3	33.0	18.0	16.5	18.4	18.3	17.5	11.2	11.2	13.2	13.6	22.5	8.4	27.9	13.7	19.5	115.5	36.1	26.2	19.3	17.4	44.1	47.8	40.7	44.9	19.9	9.3	29.7	13.4	34.6	32.1	30.4	39.6	34.1	54.0	77.1	12.3	43.9	20.7	17.8	43.2	27.2	102.8	40.2	35.4	62.8	29.5	25.2	7.4	10.9	62.4	12.1	55.4	20.3	4.0	31.0	24.7	12.2	11.5	11.0	253.1	12.5	9.9	3.8	31.1	36.2	34.3	150.2	46.4	47.3	28.1	36.6	13.6	29.8	25.5	129.3	27.3	12.1	13.4	20.0	62.5	45.9	26.2	16.2	2.4	9.5	7.8	1.6	6.7	1.6	3.3	5.8	2.0	1.2	3.2	6.2	4.9	4.3	2.0	1.4	2.4	2.2	9.8	9.3	13.2	8.9	6.8	11.3	18.4	14.5	20.0	18.0	17.5	27.9	13.5	6.4	8.8	18.9	18.9	23.6	7.4	19.9	44.3	8.0	18.9	11.7	7.6	4.3	12.8	60.7	0.0	23.0	37.3	5.0	0.0	18.8	128.4	6.4	22.7	17.6	9.6	7.4	14.2	31.2	6.7	36.0	9.2	9.3	29.9	19.5	6.4	12.7	49.4	0.0	8.6	7.3	8.2	32.4	52.5	101.7	9.6	39.7	35.6	116.2	24.3	3.1	35.0	45.8	21.1	33.8	4.2	13.5	11.9	18.4	3.6	13.8	5.0	2.0	32.9	21.8	20.9	11.0	12.7	25.6	16.2	19.4	25.4	7.6	8.3	11.5
TGFBR2	"MFS2, TBR-ii, TBRII"	ENSG00000163513	"Transforming growth factor beta receptor 2"	P37173	3	30606601-30694142	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted membrane proteins"	"Apoptosis, Differentiation, Growth regulation"	"Kinase, Receptor, Serine/threonine-protein kinase, Transferase"	"Aortic aneurysm, Cancer-related genes, Craniosynostosis, Disease variant, FDA approved drug targets, Hereditary nonpolyposis colorectal cancer"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 391.5;Endothelial cells: 236.4;Hepatic stellate cells: 478.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 313.6;ASC TERT1: 472.3;HSkMC: 430.0;LHCN-M2: 381.7;TIME: 418.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB073537			Supported	"Plasma membrane"		NA	NA		810000	"Cluster 5: Granulocytes - Unknown function"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Plasma membrane"		"CAB073537: "	"unprognostic (1.74e-1)"	"unprognostic (1.84e-2)"	"unprognostic (3.70e-1)"	"unprognostic (3.02e-2)"	"unprognostic (1.92e-1)"	"unprognostic (2.26e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.40e-1)"	"unprognostic (2.24e-2)"	"unprognostic (7.36e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.65e-2)"	"unprognostic (4.72e-2)"	"unprognostic (1.81e-2)"	"unprognostic (8.81e-2)"	"unprognostic (8.02e-2)"	230.0	56.1	16.5	73.8	12.9	29.4	145.7	13.8	19.3	90.0	30.6	96.0	44.2	69.1	18.2	44.9	69.6	91.9	95.2	10.6	13.4	67.9	59.1	148.0	70.1	17.6	16.5	26.6	52.0	59.0	16.9	81.6	16.7	44.1	54.1	2.1	49.2	60.8	31.1	39.1	77.7	107.2	17.3	111.1	63.4	7.8	21.5	49.7	91.8	62.2	60.7	98.0	55.1	17.2	16.6	100.2	5.3	0.1	313.6	472.3	15.9	83.9	116.1	28.5	27.7	22.9	86.6	2.2	298.2	117.2	32.2	33.3	4.0	125.4	42.0	7.0	8.9	10.1	10.7	104.5	128.5	14.9	76.6	430.0	93.6	126.3	114.4	117.0	296.0	10.9	1.8	0.0	381.7	1.3	16.2	10.5	2.2	75.7	39.8	14.1	36.4	2.1	113.5	40.5	0.1	5.6	24.9	6.1	22.0	6.6	0.0	14.0	418.6	134.7	33.2	61.4	32.0	2.8	0.3	12.5	80.1	16.1	55.8	9.0	3.0	11.5	3.4	3.1	3.3	4.5	4.8	3.3	2.6	6.4	16.6	7.3	13.1	1.9	8.0	6.6	0.7	3.8	16.5	12.9	13.8	19.3	10.6	13.4	17.6	16.5	16.7	17.3	21.5	17.2	391.5	144.2	99.7	0.7	77.0	37.3	18.9	23.5	39.9	5.1	23.7	24.1	84.5	50.1	39.5	27.6	0.0	6.8	85.3	10.5	3.9	13.1	2.5	28.3	57.5	236.4	8.4	20.4	0.4	15.8	5.1	129.2	39.3	30.8	29.8	0.7	478.0	55.5	30.4	0.0	1.0	12.4	22.4	147.0	58.0	3.8	32.9	67.9	30.2	170.5	47.5	0.2	56.7	6.0	2.4	37.6	12.1	47.4	37.5	8.6	13.6	7.2	14.7	1.2	32.9	60.8	53.4	0.3	1.2	8.0	30.5	3.7	68.2	1.7	14.5	10.8
TGIF1	"HPE4, TGIF"	ENSG00000177426	"TGFB induced factor homeobox 1"	Q15583	18	3411608-3459978	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"	"Cancer-related genes, Disease variant, Holoprosencephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 783.4;Basal respiratory cells: 419.8;Basal squamous epithelial cells: 483.2;Urothelial cells: 426.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA062160			Supported	Nucleoplasm		NA	Yes			"Cluster 44: Non-specific - Transcription"	"Cluster 68: Epididymis - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 22: Epithelial cell types - Mixed function"	Nucleoplasm		"HPA062160: AB_2684701"	"unprognostic (1.11e-2)"	"unprognostic (5.20e-2)"	"unprognostic (2.40e-1)"	"unprognostic (1.97e-1)"	"unprognostic (3.57e-3)"	"unprognostic (3.10e-2)"	"unprognostic (2.75e-1)"	"unprognostic (4.34e-2)"	"unprognostic (1.94e-2)"	"unprognostic (1.96e-3)"	"prognostic unfavorable (6.47e-4)"	"unprognostic (9.60e-2)"	"unprognostic (1.12e-2)"	"unprognostic (9.81e-2)"	"unprognostic (4.60e-1)"	"unprognostic (7.07e-2)"	"unprognostic (2.48e-3)"	51.2	40.1	21.7	43.3	20.8	41.5	57.6	22.4	25.7	68.9	30.2	51.5	31.6	51.2	133.7	46.7	74.7	65.3	29.8	20.2	29.3	74.0	61.5	47.6	26.4	29.8	27.3	67.3	46.9	26.9	22.0	63.8	25.7	54.6	65.7	8.0	56.5	56.1	34.4	60.2	37.8	37.4	27.5	35.5	49.1	25.9	25.7	40.0	66.7	26.9	27.0	112.1	40.0	28.4	33.6	148.5	92.7	29.3	90.0	121.7	235.7	63.1	236.6	49.9	62.1	61.0	142.6	1.9	20.9	49.8	165.7	33.7	35.0	73.8	61.6	13.9	16.8	4.3	73.2	110.5	178.8	47.6	38.3	89.5	291.7	89.7	233.7	131.3	104.4	22.3	36.0	0.4	95.6	65.8	31.1	58.8	240.8	119.0	34.8	32.8	43.2	10.3	198.1	156.7	27.1	26.5	166.2	123.0	92.5	151.3	28.1	43.7	49.6	77.5	65.6	92.7	41.1	5.0	0.6	15.7	78.5	18.6	98.2	65.4	42.8	7.6	62.9	16.6	67.8	46.5	52.5	61.9	35.1	32.2	37.1	43.5	19.8	21.5	16.7	3.3	32.1	36.3	21.7	20.8	22.4	25.7	20.2	29.3	29.8	27.3	25.7	27.5	25.7	28.4	41.0	35.3	40.2	8.1	106.5	359.6	783.4	419.8	483.2	0.0	114.1	72.1	5.6	100.1	128.3	123.2	0.0	161.6	60.1	30.0	49.0	117.1	41.5	167.2	58.5	66.6	46.4	25.7	2.7	75.0	220.9	102.8	79.0	240.2	68.0	71.5	29.3	35.7	71.8	1.7	0.6	99.4	136.3	44.9	221.1	9.7	28.6	126.8	76.5	7.5	71.9	6.7	11.3	4.0	1.7	106.0	53.0	15.4	15.1	308.1	24.9	113.1	93.3	0.1	32.9	90.9	86.6	7.9	15.4	223.9	257.1	150.4	103.7	8.0	91.8	426.2
TGS1	"NCOA6IP, PIMT"	ENSG00000137574	"Trimethylguanosine synthase 1"	Q96RS0	8	55773446-55826445	"Metabolic proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA025024, HPA029824"	Supported		Supported	Cytosol		NA	NA			"Cluster 29: Plasmacytoid DCs - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	Cytosol		"HPA025024: AB_1854330, HPA029824: AB_2673212"	"unprognostic (4.13e-2)"	"unprognostic (7.46e-2)"	"unprognostic (6.64e-2)"	"prognostic unfavorable (4.63e-4)"	"unprognostic (2.11e-1)"	"unprognostic (2.47e-1)"	"unprognostic (3.70e-2)"	"unprognostic (1.60e-2)"	"unprognostic (4.94e-2)"	"unprognostic (9.32e-2)"	"unprognostic (3.15e-2)"	"unprognostic (3.58e-1)"	"unprognostic (2.22e-2)"	"unprognostic (8.62e-2)"	"unprognostic (7.23e-2)"	"unprognostic (3.42e-1)"	"unprognostic (2.85e-2)"	5.9	4.0	1.8	5.0	1.4	7.2	5.5	3.8	2.3	5.0	2.5	4.9	3.1	5.9	4.1	5.7	5.8	4.1	3.5	1.5	1.5	5.5	4.0	4.5	8.5	1.2	1.3	6.0	4.0	6.8	4.0	4.2	1.3	4.5	4.6	2.5	4.9	5.7	7.4	6.4	5.5	4.6	1.1	5.7	4.5	4.9	1.6	9.5	5.4	2.6	8.5	7.3	5.1	1.9	12.0	9.0	10.2	12.7	9.7	8.2	10.3	10.9	11.6	11.9	12.3	8.5	10.7	27.7	7.0	8.5	8.5	10.8	24.3	14.7	16.3	17.2	8.7	31.6	10.6	5.1	13.1	16.8	9.4	9.7	10.1	11.4	22.7	5.2	9.5	16.0	24.8	9.9	9.6	9.4	36.0	10.6	35.0	16.8	3.6	26.4	7.1	8.2	10.6	12.0	10.6	13.3	19.4	8.0	10.4	10.5	10.9	9.7	9.7	8.4	10.6	9.8	10.4	8.5	6.3	32.1	8.5	13.6	11.3	5.0	2.7	4.3	5.1	2.8	6.0	4.6	4.8	4.7	2.4	4.8	5.2	5.2	3.4	3.3	3.9	5.2	4.2	2.6	1.8	1.4	3.8	2.3	1.5	1.5	1.2	1.3	1.3	1.1	1.6	1.9	29.8	48.1	35.2	15.7	41.6	37.0	36.8	25.7	35.3	30.6	21.8	34.7	15.5	20.0	37.9	51.5	22.9	29.6	30.4	10.8	3.9	20.3	3.7	28.2	42.6	27.2	10.7	49.2	28.9	25.2	26.7	32.4	23.4	27.6	50.0	24.3	20.7	17.2	20.3	21.9	30.0	23.3	16.2	16.8	12.2	4.6	29.5	22.2	7.2	12.2	26.1	27.7	29.9	34.7	19.9	22.2	12.1	23.0	32.7	42.3	10.9	17.7	25.5	29.5	26.3	40.5	25.7	88.2	78.3	33.5	26.1	22.4	41.2	35.2	22.5	31.9
THAP1	"4833431A01Rik, DYT6, FLJ10477"	ENSG00000131931	"THAP domain containing 1"	Q9NVV9	8	42836674-42843325	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Cell cycle, Transcription, Transcription regulation"	DNA-binding	"Disease variant, Dystonia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA071310			Supported	Nucleoplasm		No	No			"Cluster 15: NK-cells - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	Nucleoplasm		"HPA071310: AB_2686386"	"unprognostic (8.99e-3)"	"unprognostic (3.97e-3)"	"unprognostic (7.15e-3)"	"unprognostic (1.87e-2)"	"unprognostic (2.55e-1)"	"unprognostic (6.38e-2)"	"unprognostic (1.20e-1)"	"unprognostic (4.03e-1)"	"unprognostic (3.91e-2)"	"unprognostic (5.95e-2)"	"unprognostic (9.43e-2)"	"unprognostic (9.19e-2)"	"unprognostic (2.94e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.82e-1)"	"unprognostic (1.95e-1)"	"unprognostic (3.16e-2)"	7.3	5.7	4.9	6.9	5.1	8.3	7.4	7.3	7.5	6.2	4.9	6.2	5.9	6.9	6.2	6.3	7.3	5.1	8.8	4.9	4.7	7.0	8.7	5.4	9.5	5.2	4.8	8.2	4.6	7.9	3.8	7.0	5.3	5.7	5.4	5.7	6.2	5.7	12.4	4.0	5.8	6.8	5.2	6.3	5.0	9.4	5.2	11.5	8.6	12.5	8.4	6.5	3.7	6.4	10.5	9.3	8.5	8.2	12.7	14.3	10.2	14.2	10.8	12.8	11.7	8.0	13.2	12.8	11.3	10.5	19.0	10.7	14.0	12.0	16.2	12.4	10.3	12.5	8.1	9.4	15.6	10.4	12.7	11.3	17.7	14.1	18.2	12.4	16.5	17.1	14.1	14.7	15.1	6.4	25.1	12.1	16.8	16.9	7.4	11.2	15.2	10.2	13.9	7.8	6.9	8.1	15.5	9.7	20.2	11.2	13.5	11.6	10.0	11.2	8.3	15.0	14.3	11.9	14.0	12.2	11.2	13.6	12.4	23.8	18.6	30.8	19.9	16.7	21.6	20.4	23.1	22.1	19.9	17.8	26.9	21.5	22.0	19.3	18.0	9.8	32.5	18.8	4.9	5.1	7.3	7.5	4.9	4.7	5.2	4.8	5.3	5.2	5.2	6.4	17.2	9.6	9.4	3.6	20.1	13.5	9.4	16.6	26.7	10.5	12.3	11.4	21.5	7.2	12.6	5.5	0.0	20.5	17.5	7.7	23.5	17.5	35.6	16.1	16.2	15.5	14.3	18.3	5.2	11.3	23.8	14.5	2.6	13.3	16.5	8.6	10.4	12.1	15.2	23.5	5.3	8.8	28.5	11.6	9.2	17.9	11.5	13.4	7.2	2.8	20.2	15.6	30.9	5.5	4.9	10.6	4.0	13.9	18.5	10.8	14.1	22.9	13.1	11.0	0.0	12.9	17.0	32.6	45.8	21.1	13.8	8.1	24.6	12.8	9.6	8.2
THAP11	"CTG-B43a, CTG-B45d, HRIHFB2206, RONIN"	ENSG00000168286	"THAP domain containing 11"	Q96EK4	16	67842320-67844195	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041434, HPA042189, HPA072537"	Supported		Supported	Nucleoplasm,Cytosol		NA	No			"Cluster 26: Non-specific - Mitochondria"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 32: Non-specific - Translation"	Nucleoplasm	Cytosol	"HPA041434: AB_10960385, HPA042189: AB_10964636, HPA072537: "	"unprognostic (1.43e-1)"	"unprognostic (2.51e-1)"	"unprognostic (2.82e-1)"	"unprognostic (1.54e-3)"	"unprognostic (1.93e-3)"	"unprognostic (1.40e-2)"	"unprognostic (1.56e-3)"	"unprognostic (1.00e-1)"	"unprognostic (1.26e-1)"	"unprognostic (2.34e-1)"	"unprognostic (1.66e-1)"	"unprognostic (9.51e-2)"	"unprognostic (2.97e-1)"	"unprognostic (2.11e-1)"	"unprognostic (2.10e-2)"	"unprognostic (4.59e-2)"	"unprognostic (5.87e-2)"	16.6	14.4	20.5	14.9	21.1	10.2	16.3	21.4	21.3	21.9	19.2	26.7	12.3	24.5	13.0	19.5	22.4	10.1	25.1	20.7	21.7	16.1	14.9	15.4	20.8	22.1	20.8	20.9	19.3	16.9	16.4	12.3	20.6	16.1	11.1	10.9	15.7	19.6	48.1	26.1	22.1	17.2	22.5	24.8	20.8	12.6	21.1	23.5	14.9	26.4	19.0	23.9	18.4	23.1	31.3	40.2	27.4	25.9	37.5	25.7	28.7	15.5	27.0	37.1	31.9	51.9	23.6	68.0	31.7	15.9	22.3	35.6	48.6	29.0	21.1	25.4	55.3	27.1	22.5	64.1	34.2	34.9	29.4	23.6	28.4	25.6	22.4	26.8	27.7	45.9	39.5	15.4	22.9	49.1	37.7	62.6	55.1	36.9	34.7	73.6	32.7	61.4	19.0	20.2	38.2	43.1	45.4	16.4	33.2	19.6	40.1	35.2	22.3	23.4	28.4	21.3	19.2	60.9	65.9	67.5	18.3	38.2	25.8	7.6	13.6	14.7	26.3	18.4	20.7	13.8	23.6	24.2	14.3	18.8	29.9	24.0	4.1	21.3	17.5	11.3	31.5	17.9	20.5	21.1	21.4	21.3	20.7	21.7	22.1	20.8	20.6	22.5	21.1	23.1	20.4	22.4	13.1	3.3	24.4	29.2	25.0	6.6	22.8	25.6	27.4	23.6	15.1	12.8	5.3	11.0	4.2	19.6	32.8	12.5	52.8	7.6	1.2	18.6	18.0	21.3	13.2	23.8	4.6	9.5	25.9	17.4	7.1	14.3	7.6	20.3	24.3	14.0	22.4	8.4	4.6	16.2	6.1	19.6	20.0	2.2	23.6	19.1	10.6	4.7	24.5	29.8	43.3	7.1	6.1	6.5	5.9	31.2	18.9	25.0	13.5	19.8	6.1	16.9	19.7	24.2	22.2	16.1	27.4	20.9	39.1	13.5	32.5	28.6	16.5	20.2
THAP5	DKFZp313O1132	ENSG00000177683	"THAP domain containing 5"	Q7Z6K1	7	108554543-108569750	"Predicted intracellular proteins, Transcription factors"	"Cell cycle, Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	9	"Early spermatids: 398.3;Late spermatids: 537.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA043170, HPA051488"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 21: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 25: Spermatids - Spermatogenesis"	Nucleoplasm		"HPA043170: AB_10964500, HPA051488: AB_2681504"	"unprognostic (2.53e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.88e-1)"	"unprognostic (2.05e-1)"	"unprognostic (2.68e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.79e-1)"	"unprognostic (5.84e-2)"	"unprognostic (3.33e-2)"	"unprognostic (3.94e-1)"	"unprognostic (3.67e-2)"	"unprognostic (3.20e-1)"	"prognostic favorable (8.99e-4)"	"unprognostic (6.00e-2)"	"unprognostic (3.39e-2)"	"unprognostic (5.96e-3)"	"unprognostic (2.79e-2)"	8.9	13.2	9.8	11.3	11.2	4.7	12.8	13.1	14.3	12.1	9.2	9.2	9.8	12.8	12.6	7.7	9.9	7.8	13.8	9.4	10.8	15.9	19.7	10.3	14.6	11.2	10.4	17.4	9.9	18.0	10.6	10.0	10.5	13.1	8.2	17.8	9.9	11.4	13.0	8.3	9.8	8.6	10.8	12.7	10.2	26.7	10.8	13.1	22.3	15.3	13.3	7.8	5.9	14.9	19.4	14.8	18.6	42.3	11.8	16.7	9.7	17.5	19.8	19.0	20.1	7.5	15.9	23.4	31.0	12.1	24.8	8.0	19.3	13.8	24.5	30.5	15.2	17.6	14.4	7.1	25.1	31.7	22.4	10.4	26.1	11.6	27.4	20.2	11.8	26.3	27.9	49.3	19.4	19.5	48.6	13.7	21.9	11.5	14.4	15.0	26.6	54.8	11.6	11.2	21.8	38.2	25.0	29.2	35.1	14.5	12.2	11.9	11.8	35.7	19.7	28.3	21.8	57.0	52.6	43.0	19.8	19.1	33.0	19.2	8.0	15.0	11.7	10.6	15.2	17.8	13.2	11.1	8.0	19.5	17.2	14.6	25.7	11.2	15.5	12.7	11.9	8.3	9.8	11.2	13.1	14.3	9.4	10.8	11.2	10.4	10.5	10.8	10.8	14.9	30.6	16.0	20.9	9.4	31.0	12.2	12.0	9.0	9.1	40.9	23.6	20.4	30.1	32.9	12.6	25.8	8.4	13.2	26.6	14.7	46.9	15.5	398.3	14.9	18.9	20.7	15.7	39.5	12.9	16.9	9.3	21.3	7.7	12.1	32.2	18.6	21.8	26.5	9.6	47.1	15.1	16.3	12.2	15.2	19.8	537.3	28.3	15.0	35.6	6.5	16.1	49.5	15.5	12.5	21.6	13.6	15.6	28.2	20.8	14.9	16.6	32.8	23.7	40.7	26.3	24.4	21.8	44.6	25.9	8.4	18.0	14.4	22.5	18.0	12.4	8.1
THAP7	MGC10963	ENSG00000184436	"THAP domain containing 7"	Q9BT49	22	20999104-21002196	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 162.9;Spermatogonia: 119.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"K-562: 106.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003083	Approved		Supported	"Nucleoplasm,Nuclear membrane,Vesicles"		NA	NA			"Cluster 30: Non-specific - Translation"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	Nucleoplasm	"Nuclear membrane, Vesicles"	"HPA003083: AB_1080264"	"unprognostic (6.48e-2)"	"unprognostic (2.13e-3)"	"unprognostic (3.28e-1)"	"unprognostic (4.89e-3)"	"unprognostic (1.92e-2)"	"unprognostic (1.82e-3)"	"unprognostic (5.56e-2)"	"unprognostic (1.40e-2)"	"unprognostic (2.82e-1)"	"unprognostic (2.74e-3)"	"unprognostic (1.27e-3)"	"unprognostic (2.23e-2)"	"unprognostic (9.15e-2)"	"unprognostic (2.29e-2)"	"unprognostic (1.83e-1)"	"unprognostic (3.72e-2)"	"unprognostic (3.51e-3)"	16.1	26.9	13.7	5.6	12.9	4.8	18.1	13.7	19.6	23.0	16.0	23.1	7.9	20.4	4.8	15.4	20.9	5.8	19.4	12.6	13.2	20.8	37.8	13.4	8.8	14.1	14.9	21.9	26.9	9.8	39.5	4.2	14.4	29.1	2.5	2.7	19.0	9.2	39.7	19.1	19.0	3.5	13.3	24.2	23.2	35.5	13.9	7.6	20.9	14.4	3.7	21.5	16.6	13.2	23.5	25.0	6.9	11.8	6.0	7.5	14.2	12.1	11.6	15.9	14.7	11.5	13.5	17.2	11.9	7.6	8.4	16.4	6.1	12.1	2.4	17.1	36.4	21.6	18.7	14.9	18.5	22.2	13.4	7.2	15.0	14.0	12.9	7.0	8.4	13.1	106.2	19.8	8.8	29.3	24.4	13.7	9.6	16.0	24.7	19.0	13.6	10.4	8.4	11.8	13.5	11.7	15.1	19.5	21.5	3.2	22.4	14.6	5.5	25.4	19.5	15.4	12.8	27.6	17.4	14.1	27.6	14.3	22.4	1.9	22.1	8.8	27.2	23.9	36.1	50.0	32.8	27.4	21.3	36.9	45.2	36.3	1.9	24.0	25.3	31.6	30.7	24.9	13.7	12.9	13.7	19.6	12.6	13.2	14.1	14.9	14.4	13.3	13.9	13.2	18.7	16.0	25.7	6.2	33.3	19.1	20.3	24.5	14.8	31.5	25.0	30.4	14.8	37.1	18.3	25.8	14.6	31.2	23.8	22.4	64.6	28.2	30.0	16.6	15.7	20.3	22.2	16.2	5.8	38.2	30.1	25.8	20.4	10.6	21.5	21.0	18.5	35.3	27.8	13.5	5.8	22.8	30.5	15.8	11.5	44.0	41.7	14.2	40.9	1.0	27.5	52.0	45.3	3.5	7.2	23.9	19.7	32.4	28.6	31.4	38.4	57.4	22.6	27.1	39.5	22.8	43.5	162.9	119.4	16.7	16.3	29.6	28.8	31.1	21.7	13.2
THOC5	"C22orf19, Fmip, fSAP79, KIAA0983, PK1.3"	ENSG00000100296	"THO complex 5"	Q13769	22	29505879-29555216	"Predicted intracellular proteins"	"Differentiation, mRNA processing, mRNA splicing, mRNA transport, Transport"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Late spermatids: 125.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048402			Supported	Nucleoplasm		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 25: Spermatids - Spermatogenesis"	Nucleoplasm		"HPA048402: AB_2680387"	"unprognostic (1.16e-1)"	"unprognostic (3.05e-1)"	"unprognostic (7.77e-2)"	"unprognostic (2.27e-2)"	"unprognostic (7.20e-2)"	"unprognostic (1.54e-1)"	"prognostic unfavorable (3.76e-6)"	"unprognostic (6.34e-2)"	"unprognostic (5.54e-2)"	"unprognostic (2.55e-1)"	"unprognostic (2.45e-1)"	"unprognostic (8.81e-2)"	"prognostic unfavorable (3.65e-4)"	"unprognostic (9.53e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.24e-1)"	"unprognostic (2.97e-1)"	19.3	11.6	5.4	14.2	7.2	19.0	17.2	9.2	10.1	24.4	3.5	37.5	11.4	31.9	13.6	18.5	20.3	17.2	29.2	6.4	7.3	13.4	13.5	14.7	15.3	8.6	7.1	21.5	14.5	14.1	9.3	11.2	9.6	18.2	13.8	11.1	11.9	20.9	43.7	13.8	17.5	29.3	5.0	15.0	20.3	19.8	7.2	14.7	11.3	40.9	15.1	28.7	17.6	9.6	43.0	28.7	25.8	77.5	47.7	38.1	32.7	79.3	46.7	68.8	68.0	46.8	18.8	26.4	30.2	63.4	40.9	37.8	36.5	42.4	67.0	30.5	38.5	43.6	40.8	53.0	32.5	100.1	35.8	40.6	39.2	67.8	52.1	56.0	51.2	25.9	50.2	26.3	43.3	47.7	31.2	31.1	53.6	36.7	22.1	45.3	62.1	32.7	25.2	32.4	52.6	84.5	44.1	34.8	49.3	33.9	19.7	35.0	35.5	120.6	69.8	28.7	52.0	41.2	42.7	64.9	40.2	40.9	52.5	6.7	15.6	39.4	14.1	19.5	14.1	12.6	11.6	10.3	17.2	10.1	12.1	11.3	42.8	10.6	24.4	4.1	18.3	13.0	5.4	7.2	9.2	10.1	6.4	7.3	8.6	7.1	9.6	5.0	7.2	9.6	8.5	22.4	12.6	7.2	11.1	5.4	7.8	9.5	4.0	10.8	10.7	16.3	17.0	4.3	8.9	3.7	20.9	21.3	9.5	8.2	13.7	20.0	43.6	7.0	11.0	10.1	9.0	16.6	9.5	14.7	22.6	12.1	9.7	6.5	11.4	15.9	7.9	8.6	14.2	8.4	11.0	5.6	6.1	11.7	5.7	125.7	12.8	9.6	8.8	2.8	16.9	7.3	18.6	6.6	6.6	17.4	6.4	12.8	10.4	8.9	18.7	17.9	9.2	25.1	0.0	10.9	19.5	39.2	23.5	9.4	6.1	17.4	11.1	17.9	9.4	5.6
THOC6	"fSAP35, MGC2655, WDR58"	ENSG00000131652	"THO complex 6"	Q86W42	16	3024027-3027755	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Apoptosis, mRNA processing, mRNA splicing, mRNA transport, Transport"	"Developmental protein, RNA-binding"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 107.8;Extravillous trophoblasts: 121.1;Prostatic glandular cells: 109.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052953	Uncertain		Supported	"Nucleoplasm,Nuclear speckles"		No	No			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 2: Immune cells - Immune response"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 38: Extravillous trophoblasts - Unknown function"	"Nucleoplasm, Nuclear speckles"		"HPA052953: AB_2681997"	"unprognostic (2.07e-2)"	"unprognostic (4.13e-3)"	"unprognostic (1.70e-1)"	"unprognostic (2.04e-1)"	"unprognostic (2.08e-1)"	"unprognostic (2.91e-1)"	"unprognostic (7.82e-3)"	"unprognostic (1.81e-1)"	"unprognostic (1.31e-1)"	"unprognostic (2.20e-2)"	"unprognostic (5.15e-2)"	"unprognostic (3.44e-2)"	"prognostic unfavorable (4.40e-4)"	"unprognostic (3.59e-1)"	"unprognostic (1.43e-1)"	"unprognostic (6.17e-2)"	"unprognostic (9.43e-2)"	17.0	16.9	8.6	16.1	9.1	23.5	15.3	9.6	11.2	16.1	9.7	17.9	18.8	20.3	6.0	19.3	13.9	10.5	15.8	8.6	9.2	22.2	21.3	17.5	20.8	11.6	9.1	11.6	12.9	10.8	17.4	18.2	11.8	21.1	10.1	2.1	15.2	12.2	25.9	24.9	19.2	12.5	9.2	22.7	15.6	10.4	10.2	19.6	15.7	8.4	16.1	17.1	16.5	9.5	37.3	59.6	42.0	45.0	21.1	23.9	74.4	11.3	25.7	25.7	37.8	39.6	42.8	70.0	36.0	18.9	19.1	49.9	46.3	35.6	14.0	62.3	59.9	38.0	58.6	58.7	35.9	56.2	80.0	24.3	42.6	31.4	76.9	32.4	24.1	39.7	56.1	36.5	12.8	87.0	32.0	103.3	76.2	21.4	25.3	84.7	31.6	82.4	27.1	18.6	86.4	41.0	31.8	49.9	21.7	18.1	35.9	60.0	20.1	26.8	61.1	30.6	41.3	26.3	24.3	85.5	7.0	38.1	27.3	2.4	61.3	13.6	35.2	62.2	36.2	37.8	32.6	34.7	88.6	43.2	37.1	39.1	4.4	38.8	35.7	74.3	38.0	45.4	8.6	9.1	9.6	11.2	8.6	9.2	11.6	9.1	11.8	9.2	10.2	9.5	11.0	19.2	7.4	1.6	24.7	68.2	84.9	59.0	30.7	3.7	22.1	20.8	3.3	14.3	18.9	18.4	2.1	107.8	23.3	23.2	35.2	33.1	5.4	17.9	19.0	17.9	25.8	30.3	1.9	23.5	121.1	24.6	15.3	25.8	12.0	15.6	6.4	10.3	51.8	3.3	1.7	32.3	44.7	19.4	37.3	3.2	14.9	23.4	24.9	2.8	39.6	3.2	15.5	0.5	4.2	21.5	28.0	12.0	19.7	109.4	32.1	32.0	8.7	2.4	6.6	23.4	31.9	5.3	23.3	23.3	44.9	77.2	20.4	20.9	42.2	46.8
THOC7	"FLJ23445, fSAP24, NIF3L1BP1"	ENSG00000163634	"THO complex 7"	Q6I9Y2	3	63833870-63863868	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing, mRNA transport, Transport"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"MCF7: 1032.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044143	Approved		Supported	"Nuclear speckles,Cytosol"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Basic cellular processes"	"Nuclear speckles, Cytosol"		"HPA044143: AB_10794892"	"unprognostic (4.33e-2)"	"unprognostic (9.68e-2)"	"unprognostic (1.75e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.26e-2)"	"unprognostic (2.86e-1)"	"unprognostic (1.20e-3)"	"unprognostic (3.53e-2)"	"unprognostic (1.85e-2)"	"unprognostic (1.52e-2)"	"unprognostic (2.86e-2)"	"unprognostic (9.90e-2)"	"unprognostic (3.26e-2)"	"unprognostic (1.51e-2)"	"unprognostic (5.18e-2)"	"unprognostic (4.25e-2)"	"unprognostic (2.31e-1)"	54.7	63.5	57.1	43.2	60.0	80.1	75.1	58.1	85.1	54.4	52.0	69.9	64.2	50.5	53.2	73.1	43.0	48.6	88.0	61.5	59.1	67.8	73.5	40.9	68.1	58.4	59.1	44.4	62.3	52.1	33.5	53.5	57.1	43.8	69.1	64.5	50.5	49.5	103.5	64.2	53.7	59.6	57.3	38.2	49.1	47.6	57.8	72.3	44.4	104.0	68.0	60.8	50.3	61.1	141.2	83.5	95.6	23.9	125.1	172.5	89.6	120.2	126.9	139.2	140.1	101.6	151.5	168.3	49.1	155.1	139.2	79.3	107.5	190.4	194.1	169.6	75.5	150.2	102.8	117.2	130.1	212.6	69.6	123.9	157.2	118.4	213.1	137.6	155.1	110.0	116.8	158.6	170.2	1032.4	186.4	186.9	120.4	304.8	65.5	132.3	89.7	227.4	245.4	128.0	47.3	107.8	105.0	147.6	171.6	93.9	93.6	289.6	113.6	100.8	105.9	125.1	216.3	101.3	162.3	204.1	125.3	268.3	133.5	73.1	40.4	33.1	38.7	47.7	54.0	46.7	47.9	53.2	59.0	31.5	40.5	43.4	23.4	55.6	41.9	54.0	61.7	35.6	57.1	60.0	58.1	85.1	61.5	59.1	58.4	59.1	57.1	57.3	57.8	61.1	82.6	89.8	45.0	14.4	59.2	61.6	91.2	179.9	70.6	53.5	70.9	121.3	143.8	81.5	102.9	84.6	18.8	180.3	66.0	62.1	207.4	145.2	84.7	100.7	75.6	57.8	55.2	159.7	26.8	126.9	166.1	65.4	47.4	73.8	54.4	74.3	44.6	78.1	111.6	48.8	26.4	106.3	101.7	75.6	58.9	89.7	88.9	70.2	67.6	14.0	173.1	82.5	93.7	12.5	18.9	127.6	86.7	71.5	53.3	96.6	108.8	241.2	102.1	73.1	52.6	66.9	83.4	244.9	54.5	116.6	71.6	213.4	68.0	80.7	133.2	95.7
THOP1		ENSG00000172009	"Thimet oligopeptidase 1"	P52888	19	2785503-2815807	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal enterocytes: 136.6;Paneth cells: 160.6;Proximal enterocytes: 312.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB025497, HPA035262"	Uncertain		Supported	Cytosol		NA	NA		2000000	"Cluster 18: Basophils - Vesicular transport"	"Cluster 43: Testis - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 45: Enterocytes - Digestion"	Cytosol		"CAB025497: , HPA035262: AB_2674541"	"unprognostic (1.52e-2)"	"unprognostic (1.73e-3)"	"unprognostic (7.94e-2)"	"prognostic favorable (2.35e-4)"	"unprognostic (1.82e-1)"	"unprognostic (2.16e-2)"	"unprognostic (9.35e-2)"	"unprognostic (1.19e-1)"	"unprognostic (4.05e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.20e-3)"	"unprognostic (3.00e-2)"	"unprognostic (1.39e-1)"	"prognostic favorable (5.90e-4)"	"unprognostic (1.27e-1)"	"unprognostic (2.64e-1)"	"unprognostic (5.37e-2)"	13.4	19.6	31.8	11.8	31.6	19.6	15.3	29.8	48.4	15.3	25.4	21.3	22.6	18.7	6.3	31.0	17.6	3.3	38.0	33.2	28.7	22.7	73.0	13.7	11.6	33.7	31.7	18.8	17.5	6.0	32.0	7.8	30.7	37.6	7.0	9.3	15.7	5.2	40.6	20.0	21.5	6.1	26.9	23.0	16.1	70.2	28.6	13.8	17.9	11.0	8.3	18.7	15.9	30.4	91.4	66.3	25.1	54.6	12.8	12.5	89.9	55.4	20.4	53.8	43.4	78.4	28.3	81.3	26.4	21.7	37.7	72.4	37.8	45.6	22.5	0.3	79.7	28.9	75.9	94.4	13.7	56.3	43.1	13.9	16.0	44.8	20.0	15.5	31.0	54.0	68.2	38.7	23.1	70.5	63.1	105.0	74.7	27.2	90.2	51.7	33.8	77.5	22.8	51.9	68.5	54.6	48.5	42.9	27.6	13.1	41.8	53.8	35.5	41.2	35.5	88.6	95.4	67.1	60.7	55.7	46.0	93.3	50.1	9.3	2.5	1.2	3.7	2.9	3.0	3.8	2.7	5.2	3.6	5.3	3.4	3.0	1.0	3.0	6.0	7.0	7.6	2.5	31.8	31.6	29.8	48.4	33.2	28.7	33.7	31.7	30.7	26.9	28.6	30.4	5.1	3.2	10.6	15.0	12.0	6.8	10.3	15.6	11.4	20.3	12.6	10.8	9.0	5.7	9.7	11.0	35.5	27.6	8.7	136.6	9.8	18.7	17.6	11.1	8.3	7.4	40.8	13.7	12.1	15.1	55.9	11.1	9.2	10.1	5.7	23.1	7.1	85.9	23.0	6.7	10.5	59.9	6.1	9.8	6.0	23.4	11.5	9.1	3.6	3.7	8.3	13.5	4.1	4.0	7.1	21.3	160.6	6.0	17.2	16.6	312.2	10.8	9.7	32.4	13.1	10.6	15.0	55.6	19.2	13.4	5.8	33.8	8.0	15.9	48.2	8.4
THRA	"AR7, EAR-7.1/EAR-7.2, ERBA, ERBA1, NR1A1, THRA1, THRA2, THRA3"	ENSG00000126351	"Thyroid hormone receptor alpha"	P10827	17	40058290-40093867	"Cancer-related genes, Disease related genes, FDA approved drug targets, Human disease related genes, Nuclear receptors, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Receptor"	"Cancer-related genes, Congenital hypothyroidism, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 236.7"	"Cell type enhanced"	"Detected in many"		"Muller glia cells: 95.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA009654, CAB023349"	Approved		Supported	Cytosol		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	Cytosol		"CAB023349: AB_619577, HPA009654: AB_1854603"	"unprognostic (2.75e-2)"	"unprognostic (2.20e-1)"	"unprognostic (6.64e-2)"	"unprognostic (4.22e-2)"	"unprognostic (8.78e-2)"	"unprognostic (1.64e-1)"	"unprognostic (3.41e-3)"	"prognostic favorable (1.84e-4)"	"unprognostic (1.47e-1)"	"unprognostic (5.47e-2)"	"unprognostic (7.85e-2)"	"unprognostic (2.65e-2)"	"prognostic favorable (6.05e-8)"	"unprognostic (3.05e-1)"	"unprognostic (1.35e-1)"	"unprognostic (4.21e-1)"	"unprognostic (1.88e-3)"	40.7	43.7	199.1	12.0	236.7	23.0	38.9	159.3	218.3	67.5	108.5	67.2	31.1	49.9	22.0	19.1	57.7	25.8	63.8	189.7	181.8	34.1	10.2	32.2	9.7	162.4	172.1	90.7	31.3	29.9	50.0	17.1	149.4	34.5	18.8	35.4	27.3	35.5	90.7	50.2	36.2	34.6	166.5	13.9	48.0	18.7	183.6	12.8	32.6	52.8	6.3	45.0	45.9	179.9	4.9	37.6	11.5	28.9	77.4	28.2	4.2	19.3	23.0	19.6	18.2	31.5	27.2	5.6	31.3	37.6	8.7	11.4	22.6	11.7	10.6	2.1	21.6	10.4	44.5	13.4	26.0	16.9	11.2	45.1	9.5	18.4	7.1	45.4	26.6	16.7	21.2	5.2	16.5	7.1	22.8	27.4	10.6	24.6	11.8	32.1	22.7	27.6	6.4	3.3	19.5	17.7	14.8	23.3	33.7	17.5	27.3	19.5	18.7	19.4	18.9	17.7	5.9	11.9	9.0	3.4	12.0	19.1	10.6	0.2	0.3	1.9	2.0	0.1	0.8	0.2	0.8	1.2	0.3	0.4	1.4	1.7	1.1	2.1	0.3	0.6	1.0	0.7	199.1	236.7	159.3	218.3	189.7	181.8	162.4	172.1	149.4	166.5	183.6	179.9	32.2	19.2	7.3	27.1	6.2	10.6	28.1	3.3	31.3	76.4	19.6	21.2	45.4	38.6	2.7	33.1	20.9	0.8	16.5	37.9	50.9	12.3	1.1	20.5	29.5	20.8	25.1	17.9	19.1	14.8	1.4	36.8	29.0	12.1	14.0	23.1	24.7	13.8	11.6	62.2	24.2	22.6	6.1	10.6	5.1	2.7	51.6	8.6	19.6	8.4	5.1	95.2	37.0	15.6	26.5	6.9	14.6	49.7	3.9	17.2	58.8	29.9	7.5	22.5	19.7	84.7	44.4	0.3	27.3	14.6	10.4	0.3	18.1	16.3	39.9	13.8
THRB	"ERBA-BETA, ERBA2, GRTH, NR1A2, PRTH, THR1, THRB1, THRB2"	ENSG00000151090	"Thyroid hormone receptor beta"	P10828	3	24117153-24495756	"Cancer-related genes, Disease related genes, FDA approved drug targets, Human disease related genes, Nuclear receptors, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Receptor"	"Cancer-related genes, Deafness, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 199.2;Cone photoreceptor cells: 164.7;Excitatory neurons: 688.0;Inhibitory neurons: 631.3;Oligodendrocyte precursor cells: 329.2"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	6	"amygdala: 7.7;basal ganglia: 15.1;cerebral cortex: 17.6;hippocampal formation: 18.5;white matter: 6.7"	"Group enriched"	"Detected in some"	5	"basophil: 7.2;naive B-cell: 2.2"	"Group enriched"	"Detected in many"	15	"B-cells: 2.2;granulocytes: 7.2"	"Cell line enhanced"	"Detected in many"		"K-562: 45.6;RT4: 32.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002008, CAB002009, HPA061035"	Approved		Supported	"Nuclear bodies"		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Nuclear bodies"		"CAB002008: , CAB002009: , HPA061035: AB_2684422"	"unprognostic (1.82e-1)"	"unprognostic (4.22e-1)"	"unprognostic (2.83e-1)"	"unprognostic (2.20e-6)"	"unprognostic (3.37e-1)"	"unprognostic (2.66e-2)"	"unprognostic (1.93e-2)"	"unprognostic (1.73e-1)"	"unprognostic (5.78e-3)"	"unprognostic (2.95e-2)"	"unprognostic (4.43e-1)"	"unprognostic (2.01e-2)"	"prognostic favorable (9.46e-8)"	"unprognostic (1.32e-3)"	"unprognostic (6.75e-2)"	"unprognostic (2.73e-2)"	"unprognostic (3.34e-2)"	11.1	4.9	7.7	1.7	15.1	1.0	10.0	0.0	17.6	2.8	0.0	11.7	2.5	7.0	1.8	6.4	3.8	2.2	7.7	18.5	2.0	12.1	20.1	5.0	1.5	0.0	0.0	2.3	9.0	7.3	15.7	4.4	0.0	7.5	8.4	20.1	6.2	7.7	23.6	6.8	3.9	7.0	0.0	5.7	8.3	0.7	1.4	3.6	4.4	27.0	1.4	8.9	4.2	6.7	10.3	3.1	0.6	0.1	17.4	8.8	6.7	0.5	2.1	1.5	3.2	6.7	9.7	0.1	2.5	6.8	1.1	15.4	10.8	3.9	1.0	0.0	6.4	0.0	2.5	8.9	0.5	0.0	0.0	16.0	7.3	0.2	1.2	3.5	0.0	0.0	45.6	0.0	1.5	0.6	0.0	0.0	6.5	0.6	3.4	0.0	0.0	0.0	10.0	32.7	1.7	0.6	16.5	8.9	0.2	4.6	9.7	0.0	0.9	3.9	3.0	0.0	1.9	0.1	0.5	0.0	2.7	0.1	0.3	7.2	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	2.2	0.0	0.0	0.9	0.0	0.0	0.0	0.0	2.2	7.7	15.1	0.0	17.6	18.5	2.0	0.0	0.0	0.0	0.0	1.4	6.7	3.0	3.2	11.4	199.2	3.3	9.9	29.5	13.2	1.8	17.9	24.5	18.7	11.6	8.6	14.1	23.9	164.7	12.4	0.0	39.9	1.9	2.4	2.3	3.4	0.5	6.0	25.2	3.8	688.0	12.5	23.2	13.7	16.3	5.7	0.0	0.3	7.5	37.7	1.7	0.0	631.3	8.1	10.2	11.3	11.7	2.4	0.6	4.6	1.8	97.4	0.2	11.7	0.0	329.2	32.4	10.3	17.5	2.2	0.1	40.1	4.8	8.1	10.3	21.8	6.6	12.0	7.5	0.3	0.7	5.1	23.9	5.5	1.0	0.4	9.8	81.3
THSD1	TMTSP	ENSG00000136114	"Thrombospondin type 1 domain containing 1"	Q9NS62	13	52377167-52416373	"Disease related genes, Predicted membrane proteins"			"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 22.0;Astrocytes: 25.5;Basal respiratory cells: 16.5;Endothelial cells: 29.9;Hepatic stellate cells: 17.2;Microglial cells: 17.8;Spermatocytes: 18.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 19.9;HBEC3-KT: 19.9;hTCEpi: 19.0;hTERT-HME1: 19.5;HUVEC TERT2: 40.6;LHCN-M2: 18.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012611, CAB020796"	Uncertain		Supported	Cytosol	"Intracellular and membrane"	No	No		1400000		"Cluster 82: Adipose tissue - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Cytosol		"CAB020796: , HPA012611: AB_1857990"	"unprognostic (1.21e-1)"	"unprognostic (7.54e-3)"	"unprognostic (3.49e-2)"	"unprognostic (6.39e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.54e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.05e-1)"	"unprognostic (8.87e-2)"	"unprognostic (3.35e-1)"	"unprognostic (6.10e-3)"	"unprognostic (1.55e-1)"	"unprognostic (3.05e-3)"	"unprognostic (8.44e-2)"	"unprognostic (1.31e-1)"	"unprognostic (3.35e-2)"	"unprognostic (4.90e-2)"	10.0	2.0	7.9	1.0	7.4	0.2	8.7	5.5	8.5	5.3	4.5	2.8	0.7	5.2	2.8	3.1	5.1	3.3	9.0	8.2	5.5	3.0	2.2	11.5	2.1	6.0	5.4	2.1	1.4	1.4	3.4	11.3	5.8	4.1	1.4	6.8	3.9	1.9	4.5	6.3	2.7	4.7	5.6	5.9	2.1	2.1	6.4	1.4	5.0	10.4	1.6	3.8	4.5	5.9	0.9	3.9	0.5	3.5	3.1	10.3	0.8	8.4	4.1	3.2	5.1	0.1	0.7	0.3	1.0	19.9	3.1	4.4	0.0	19.9	4.9	9.3	2.9	0.5	0.0	0.0	1.9	2.1	0.6	4.1	19.0	15.4	19.5	1.8	40.6	1.2	0.0	0.3	18.6	0.0	0.7	0.4	0.3	0.2	0.9	0.6	4.3	0.0	4.5	0.2	0.1	0.7	0.2	0.1	0.8	0.2	0.4	0.3	9.6	1.0	1.7	0.0	6.3	0.6	0.1	0.1	1.8	0.6	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.9	7.4	5.5	8.5	8.2	5.5	6.0	5.4	5.8	5.6	6.4	5.9	22.0	0.0	1.1	25.5	0.9	1.5	1.1	16.5	0.6	8.0	1.5	3.0	3.1	0.0	1.8	1.8	2.1	5.4	3.6	0.3	3.9	0.3	1.4	0.8	1.0	29.9	0.0	0.0	3.5	0.6	1.8	6.4	1.1	0.7	0.0	1.5	17.2	2.0	3.1	0.0	3.1	0.3	0.0	1.6	1.6	0.6	3.4	0.6	5.4	17.8	0.4	1.2	1.0	3.0	0.9	0.4	0.2	3.8	0.6	1.8	0.4	0.8	1.3	3.2	6.6	4.4	2.3	18.5	10.1	1.0	1.6	3.4	0.9	0.6	0.3	0.4
THYN1	THY28	ENSG00000151500	"Thymocyte nuclear protein 1"	Q9P016	11	134248279-134253370	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038732, HPA038733"	Supported		Supported	"Nucleoplasm,Nucleoli fibrillar center,Cytosol"		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 24: NB-4 - Immune response"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoplasm, Nucleoli fibrillar center"	Cytosol	"HPA038732: AB_10697397, HPA038733: AB_2676183"	"unprognostic (5.91e-2)"	"unprognostic (6.22e-3)"	"unprognostic (4.54e-2)"	"unprognostic (3.48e-3)"	"unprognostic (2.32e-2)"	"unprognostic (8.99e-2)"	"unprognostic (2.12e-1)"	"prognostic favorable (1.01e-5)"	"unprognostic (3.32e-2)"	"unprognostic (1.99e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.37e-1)"	"unprognostic (1.71e-1)"	"unprognostic (6.92e-2)"	"unprognostic (1.66e-2)"	"unprognostic (2.61e-2)"	42.3	40.5	74.2	22.0	75.4	43.3	45.1	74.4	104.9	39.8	68.5	53.9	30.2	43.1	75.8	28.1	47.6	31.1	51.7	75.9	76.2	40.1	57.5	28.3	40.5	72.2	71.3	62.9	32.8	27.9	50.8	22.2	73.2	50.1	44.9	41.3	29.6	54.2	32.3	28.1	36.3	42.3	72.5	36.6	39.4	42.6	74.9	77.1	52.1	38.0	44.5	44.3	33.1	76.6	32.0	19.5	69.8	56.0	65.9	74.7	41.0	26.9	59.2	62.0	58.1	106.8	76.3	60.0	88.6	37.8	66.6	48.9	106.8	82.0	60.5	61.5	30.3	165.5	25.7	97.6	94.3	133.0	52.4	56.9	43.2	73.9	48.2	80.6	98.9	199.0	78.1	28.0	56.5	17.7	155.1	242.8	81.0	127.0	71.0	72.3	51.8	50.6	86.4	55.4	66.4	53.7	55.8	13.6	33.1	50.3	78.2	66.5	52.7	26.6	41.3	24.4	41.7	31.4	35.0	126.9	39.5	170.6	31.5	185.4	89.8	330.3	145.2	108.4	175.6	122.1	152.3	146.8	99.1	96.4	175.4	200.0	47.2	139.1	104.4	131.3	199.8	160.0	74.2	75.4	74.4	104.9	75.9	76.2	72.2	71.3	73.2	72.5	74.9	76.6	41.9	32.1	28.8	8.1	31.1	23.8	42.2	107.4	28.5	28.6	37.5	65.4	52.1	47.1	57.7	36.8	14.6	52.7	33.5	25.5	86.1	48.2	28.2	44.7	33.8	36.9	57.6	40.8	15.3	55.6	52.9	42.3	20.4	23.4	40.5	65.5	37.1	47.9	53.0	28.6	12.0	47.9	75.3	22.2	23.7	16.0	50.4	32.7	40.9	8.4	43.1	65.7	44.3	11.1	11.1	53.2	33.0	48.5	29.8	13.4	49.3	93.3	73.1	23.9	46.0	34.0	51.3	79.1	94.9	31.4	20.6	13.8	44.1	72.7	52.7	31.6
TIA1	TIA-1	ENSG00000116001	"TIA1 cytotoxic granule associated RNA binding protein"	P31483	2	70209444-70248660	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	Apoptosis	RNA-binding	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Oligodendrocytes: 172.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA056961			Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 51: Non-specific - Unknown function"	"Cluster 12: NES - Nervous system development"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	Cytosol	"HPA056961: AB_2683289"	"unprognostic (1.04e-1)"	"unprognostic (1.74e-1)"	"unprognostic (3.68e-2)"	"unprognostic (1.07e-1)"	"unprognostic (7.64e-3)"	"unprognostic (2.51e-3)"	"unprognostic (3.37e-3)"	"prognostic favorable (6.79e-5)"	"unprognostic (5.09e-3)"	"unprognostic (1.13e-1)"	"unprognostic (1.09e-1)"	"unprognostic (3.15e-2)"	"prognostic unfavorable (8.05e-7)"	"unprognostic (4.00e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.25e-1)"	"prognostic favorable (1.02e-5)"	27.3	34.4	20.0	34.3	23.5	28.0	47.5	27.6	29.2	63.6	25.0	42.3	35.6	68.5	70.2	26.1	50.5	36.6	27.3	20.0	21.4	46.0	33.1	32.8	49.6	22.4	21.1	73.8	41.2	29.7	49.3	36.7	22.7	43.5	39.8	68.0	42.2	35.1	24.6	40.3	45.8	41.0	21.4	51.4	37.0	19.7	21.2	67.6	47.6	25.7	35.8	36.8	39.9	29.7	21.0	22.9	117.4	66.1	32.7	55.1	56.6	36.6	25.8	34.8	34.4	31.0	31.7	47.1	30.7	27.3	20.2	33.8	57.5	20.0	48.9	44.2	25.1	48.9	43.2	74.4	26.1	49.5	26.6	41.2	29.0	20.0	21.9	82.3	65.1	37.5	38.4	41.9	49.4	17.9	91.9	78.0	95.8	30.0	27.0	110.5	63.8	48.0	53.3	40.7	71.0	60.6	43.2	50.8	36.0	60.5	30.4	36.2	53.6	42.5	44.3	20.1	36.6	34.9	36.9	86.7	24.9	62.1	57.6	13.5	5.9	8.4	5.6	5.0	5.4	7.1	5.5	5.8	8.8	5.2	5.0	5.6	2.3	8.2	3.1	4.5	7.6	3.9	20.0	23.5	27.6	29.2	20.0	21.4	22.4	21.1	22.7	21.4	21.2	29.7	45.8	83.3	63.4	91.7	44.7	25.4	31.2	25.1	38.1	52.7	46.9	40.6	30.8	28.6	54.8	20.2	47.9	31.3	40.3	23.0	0.0	31.0	21.0	31.9	70.6	40.1	52.6	42.9	95.0	27.1	34.6	40.8	36.2	34.2	55.7	106.7	33.2	30.6	21.1	35.3	94.5	31.7	32.6	29.4	28.7	9.3	36.1	32.4	16.0	57.1	44.0	31.4	28.8	152.3	172.0	30.1	23.6	35.7	38.2	32.5	24.8	14.0	58.8	51.8	26.3	25.4	45.7	30.0	19.3	26.0	24.0	24.8	43.5	44.3	31.9	29.7
TIAM1		ENSG00000156299	"TIAM Rac1 associated GEF 1"	Q13009	21	31118416-31559977	"Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 207.9"	"Cell type enhanced"	"Detected in many"		"Inhibitory neurons: 327.3;Microglial cells: 133.0;Oligodendrocyte precursor cells: 120.6;Oligodendrocytes: 124.6;Suprabasal keratinocytes: 143.3"	"Cancer enhanced"	"Detected in many"		"testis cancer: 15.1"	"Region enriched"	"Detected in all"	4	"cerebellum: 207.9"	"Group enriched"	"Detected in many"	5	"classical monocyte: 17.4;intermediate monocyte: 15.3;memory CD4 T-cell: 12.5;myeloid DC: 9.6;naive CD4 T-cell: 16.2;NK-cell: 11.3;non-classical monocyte: 22.0;T-reg: 27.8"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BEWO: 34.5;HEL: 34.7;HMC-1: 29.1;RT4: 35.5;SCLC-21H: 32.6"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"cerebellum: 245.9"	"CAB010416, HPA034853"	Enhanced		Supported	"Nucleoplasm,Nuclear membrane,Cell Junctions,Cytokinetic bridge,Cytosol"		Yes	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 36: HEL - Hemostasis"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Nucleoplasm, Cell Junctions"	"Nuclear membrane, Cytokinetic bridge, Cytosol"	"CAB010416: AB_2240410, HPA034853: "	"unprognostic (9.59e-2)"	"unprognostic (7.44e-3)"	"unprognostic (5.64e-3)"	"unprognostic (1.07e-1)"	"unprognostic (1.58e-1)"	"unprognostic (2.81e-3)"	"unprognostic (2.84e-2)"	"unprognostic (3.73e-1)"	"unprognostic (8.08e-2)"	"unprognostic (2.70e-3)"	"unprognostic (7.97e-3)"	"unprognostic (9.52e-2)"	"unprognostic (1.20e-3)"	"unprognostic (2.38e-3)"	"unprognostic (1.61e-1)"	"unprognostic (1.04e-2)"	"unprognostic (2.21e-1)"	7.2	12.7	40.3	6.6	35.2	2.8	5.4	207.9	49.2	17.8	12.5	5.1	1.7	9.9	3.2	39.7	11.0	4.6	5.5	51.8	26.5	5.5	7.9	5.8	11.1	26.7	33.4	3.3	2.2	0.3	12.9	4.3	36.1	9.0	3.1	8.6	5.6	3.3	0.9	27.2	5.0	11.1	27.5	5.2	2.4	10.5	37.3	18.7	1.9	0.8	11.1	12.1	18.5	28.6	2.9	1.0	21.7	1.3	0.4	4.9	34.5	0.0	0.0	2.7	0.9	0.2	3.9	7.6	1.5	0.5	4.0	5.1	2.5	4.4	4.3	0.6	12.0	34.7	0.7	0.2	0.5	0.0	29.1	2.2	1.5	14.7	5.9	2.6	0.0	11.3	0.0	10.9	11.1	14.7	5.4	0.2	7.1	5.3	9.4	7.0	6.8	0.0	3.3	35.5	32.6	8.1	1.5	11.4	1.3	7.5	4.7	0.1	0.2	3.1	12.5	0.0	1.5	12.3	9.9	6.6	7.2	2.6	24.2	1.5	17.4	0.0	0.5	15.3	3.1	0.1	12.5	2.4	9.6	0.0	16.2	1.0	1.0	11.3	22.0	0.5	27.8	5.9	40.3	35.2	207.9	49.2	51.8	26.5	26.7	33.4	36.1	27.5	37.3	28.6	3.7	3.2	2.3	21.2	1.7	83.7	65.6	3.0	22.8	8.9	4.9	1.9	1.1	1.5	11.8	0.0	2.1	10.1	8.0	1.3	0.0	1.8	11.7	25.2	2.2	31.4	5.4	2.7	43.9	0.7	29.7	11.4	2.0	28.4	24.1	2.0	35.0	5.5	8.1	74.0	327.3	0.4	10.2	22.9	73.4	11.3	34.5	26.3	10.6	133.0	37.3	35.2	4.1	120.6	124.6	1.8	11.6	58.3	3.2	30.8	0.0	0.5	1.2	4.6	6.6	0.9	2.1	1.3	9.8	60.2	143.3	10.7	16.3	82.6	1.2	106.7
TIAM2	STEF	ENSG00000146426	"TIAM Rac1 associated GEF 2"	Q8IVF5	6	154832697-155257723	"Metabolic proteins, Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 11.8;testis: 13.3"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 81.3;Early spermatids: 141.5;Excitatory neurons: 74.2;Late spermatids: 347.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 6.4;non-classical monocyte: 9.5"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AF22: 65.7;HDLM-2: 27.8;RH-30: 43.3"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"olfactory bulb: 36.9"	"HPA011134, HPA013903"	Approved		Supported	"Nucleoplasm,Nucleoli fibrillar center,Cytosol"		No	No			"Cluster 51: Monocytes - Innate immune response"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 12: NES - Nervous system development"	"Cluster 34: Spermatids - Unknown function"	"Nucleoplasm, Nucleoli fibrillar center"	Cytosol	"HPA011134: AB_1858005, HPA013903: AB_1858004"	"unprognostic (9.14e-2)"	"unprognostic (5.79e-2)"	"unprognostic (1.44e-1)"	"unprognostic (6.38e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.69e-1)"	"unprognostic (4.36e-2)"	"unprognostic (1.89e-1)"	"unprognostic (5.74e-2)"	"unprognostic (1.81e-2)"	"unprognostic (1.84e-2)"	"unprognostic (1.36e-2)"	"unprognostic (1.38e-3)"	"unprognostic (1.82e-1)"	"unprognostic (8.13e-2)"	"unprognostic (6.04e-2)"	"unprognostic (1.05e-1)"	0.4	1.2	2.8	0.9	7.1	0.4	1.2	5.4	11.8	1.1	0.0	1.2	8.3	0.8	0.6	0.6	0.8	2.2	2.2	6.1	0.0	0.3	0.3	0.5	1.2	0.4	1.0	0.3	1.3	0.1	1.4	0.5	0.0	2.0	0.8	3.3	1.3	2.7	2.5	0.6	7.9	1.1	0.4	0.7	3.0	13.3	0.8	0.6	5.5	1.7	2.0	2.0	0.7	6.1	8.3	1.5	65.7	6.1	2.9	7.9	0.4	3.2	2.2	3.3	5.5	0.7	4.8	1.1	3.1	6.3	0.9	0.5	2.4	0.0	2.3	27.8	3.3	0.0	1.1	1.9	1.8	0.2	1.7	5.4	0.2	1.1	0.2	2.5	4.7	0.5	0.2	0.1	7.5	0.5	0.7	0.7	4.1	0.1	1.3	8.4	43.3	0.3	0.2	0.2	1.1	14.5	0.1	0.3	0.2	11.9	0.3	0.6	1.5	0.2	15.5	0.4	1.5	0.2	3.6	0.2	0.0	0.3	3.9	0.0	0.0	2.1	0.0	2.0	0.0	2.0	0.1	0.1	0.3	0.7	0.0	0.0	6.4	0.4	9.5	0.0	1.2	0.1	2.8	7.1	5.4	11.8	6.1	0.0	0.4	1.0	0.0	0.4	0.8	6.1	2.9	3.2	2.6	8.8	9.6	3.1	22.5	2.8	1.8	14.3	3.3	5.3	8.3	7.2	2.1	1.8	81.3	1.8	4.3	2.2	0.0	5.3	141.5	8.3	4.9	2.7	0.0	3.6	74.2	3.1	2.6	4.4	6.1	12.1	19.7	6.8	11.0	1.5	1.9	23.5	31.4	3.9	6.1	2.2	2.2	347.4	9.9	5.2	12.4	4.7	9.8	7.6	4.1	28.6	5.1	5.9	5.8	7.9	13.3	9.6	23.9	1.0	3.3	23.9	0.0	7.0	4.3	6.7	7.3	2.1	2.6	0.4	5.0	5.3	3.9	11.6
TICRR	"C15orf42, FLJ41618, MGC45866, SLD3, Treslin"	ENSG00000140534	"TOPBP1 interacting checkpoint and replication regulator"	Q7Z2Z1	15	89575469-89631056	"Metabolic proteins, Predicted intracellular proteins"	"Cell cycle, DNA damage, DNA repair"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 3.4;esophagus: 4.2;lymphoid tissue: 4.2"	"Cell type enhanced"	"Detected in some"		"Erythroid cells: 6.5;Extravillous trophoblasts: 6.0;Granulosa cells: 5.1;Spermatocytes: 5.4;Spermatogonia: 5.3;Squamous epithelial cells: 8.6"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA046746, HPA049454"			Supported	Nucleoplasm		NA	Yes				"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"HPA046746: AB_2732533, HPA049454: AB_2680773"	"unprognostic (3.52e-2)"	"unprognostic (1.41e-1)"	"unprognostic (3.77e-1)"	"prognostic unfavorable (4.44e-4)"	"unprognostic (3.41e-1)"	"unprognostic (1.10e-1)"	"unprognostic (6.22e-5)"	"unprognostic (7.73e-3)"	"prognostic unfavorable (2.87e-6)"	"unprognostic (1.64e-1)"	"unprognostic (1.31e-4)"	"unprognostic (5.87e-2)"	"unprognostic (0.00e+0)"	"unprognostic (3.54e-2)"	"unprognostic (7.38e-2)"	"unprognostic (4.53e-2)"	"unprognostic (3.59e-2)"	0.3	0.1	0.1	1.0	0.1	3.4	0.3	0.0	0.0	0.5	0.0	0.8	1.0	0.4	0.0	4.2	0.3	0.1	0.1	0.0	0.0	0.1	0.1	0.2	1.4	0.1	0.0	0.3	0.0	0.0	0.1	0.9	0.0	0.2	1.1	0.1	0.5	0.0	0.0	0.5	0.9	0.2	0.1	0.5	0.4	1.5	0.2	4.2	0.1	0.0	1.8	0.3	1.1	0.0	11.0	15.0	19.0	11.0	0.7	1.5	10.7	8.0	3.7	11.0	11.4	16.4	8.4	14.7	4.2	2.6	9.2	21.5	26.3	7.0	10.0	7.4	25.4	21.9	15.5	8.7	0.1	15.8	7.6	0.4	0.5	9.0	6.6	1.6	5.5	12.8	21.3	16.6	6.4	10.4	13.9	13.3	12.7	11.0	7.6	19.6	17.1	11.8	2.6	15.5	8.1	8.0	19.0	10.6	3.1	13.9	7.9	10.5	3.3	11.9	14.8	24.4	16.5	3.9	8.0	12.3	4.1	13.2	6.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.3	0.3	0.1	0.0	0.2	1.2	0.0	0.3	0.8	1.4	0.0	0.0	0.0	0.0	2.0	0.0	1.4	0.0	0.0	1.7	0.1	0.3	0.3	0.0	6.5	0.4	0.0	6.0	0.5	2.0	0.3	0.0	5.1	0.0	0.0	1.3	0.0	0.6	1.6	0.0	0.0	0.7	1.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.3	0.2	0.1	0.0	2.2	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.5	5.4	5.3	8.6	0.1	1.0	0.1	0.1	1.6	0.1
TIGAR	C12orf5	ENSG00000078237	"TP53 induced glycolysis regulatory phosphatase"	Q9NQ88	12	4307763-4360028	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Apoptosis, Autophagy"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 59.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BEWO: 47.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034010, HPA040354, HPA044111"	Approved		Supported	Cytosol		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 4: Macrophages - Innate immune response"	Cytosol		"CAB034010: AB_1128227, HPA040354: AB_2676935, HPA044111: AB_2678814"	"unprognostic (1.76e-1)"	"unprognostic (6.33e-2)"	"unprognostic (4.08e-1)"	"unprognostic (2.60e-1)"	"unprognostic (1.32e-1)"	"unprognostic (2.35e-1)"	"prognostic unfavorable (3.18e-4)"	"unprognostic (5.41e-2)"	"unprognostic (2.11e-1)"	"unprognostic (9.37e-2)"	"unprognostic (1.85e-1)"	"unprognostic (5.21e-2)"	"unprognostic (2.03e-2)"	"unprognostic (2.02e-3)"	"unprognostic (2.44e-1)"	"unprognostic (3.31e-1)"	"unprognostic (1.05e-1)"	3.8	5.4	1.4	1.9	1.6	1.9	2.9	1.9	3.0	1.8	1.8	3.7	0.7	2.8	1.2	3.7	2.3	1.4	5.0	2.2	1.6	4.2	3.1	3.7	2.0	1.9	2.0	1.1	2.0	0.9	5.3	1.4	2.1	2.8	1.7	2.3	3.0	1.7	5.8	2.5	3.6	2.1	2.1	5.3	3.3	3.5	1.9	1.7	2.3	2.0	1.9	3.5	2.4	2.3	4.1	9.9	4.8	7.7	10.9	6.3	47.3	9.3	8.0	5.3	7.3	5.7	3.8	4.1	0.7	5.8	5.2	5.7	5.8	7.6	7.0	3.8	2.9	0.1	4.7	7.8	14.3	2.1	0.5	8.1	12.9	5.9	6.8	3.2	14.5	3.4	0.3	2.2	9.2	7.7	2.2	0.8	8.6	5.5	1.7	3.0	6.4	1.0	6.7	5.0	0.2	2.8	7.9	3.2	10.1	22.0	0.8	1.6	10.5	8.2	5.9	5.6	3.8	1.4	2.1	6.9	5.4	0.8	5.7	0.5	1.7	0.2	0.7	3.5	0.5	0.9	0.7	0.8	1.9	1.3	0.6	0.7	1.5	0.8	3.4	1.6	1.4	0.6	1.4	1.6	1.9	3.0	2.2	1.6	1.9	2.0	2.1	2.1	1.9	2.3	10.7	0.0	1.7	0.0	14.7	0.0	13.8	0.0	5.7	4.2	6.2	7.5	10.5	1.5	0.0	5.5	18.8	27.4	16.9	5.0	15.6	15.6	28.0	4.7	5.9	9.4	7.3	1.3	0.0	13.9	28.5	6.6	11.7	4.8	0.0	4.5	5.0	5.6	59.3	1.7	0.0	1.5	0.0	20.4	0.0	27.8	3.7	30.6	0.0	0.0	34.9	11.5	7.2	0.0	0.0	17.5	2.6	4.5	16.3	9.5	2.9	11.7	0.0	3.3	6.6	5.7	8.3	19.9	22.3	8.1	0.0	34.3	11.8	10.8	2.3	15.6
TIGD7	Sancho	ENSG00000140993	"Tigger transposable element derived 7"	Q6NT04	16	3298808-3305729	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Oligodendrocyte precursor cells: 20.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			"HPA041357, HPA041474"	Uncertain		Supported	"Plasma membrane,Cytosol"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 24: NB-4 - Immune response"	"Cluster 59: Non-specific - Transcription"	"Plasma membrane, Cytosol"		"HPA041357: AB_10794992, HPA041474: AB_10795696"	"unprognostic (7.69e-2)"	"unprognostic (3.04e-4)"	"unprognostic (6.56e-3)"	"unprognostic (1.18e-3)"	"unprognostic (1.79e-1)"	"unprognostic (4.04e-2)"	"unprognostic (6.50e-3)"	"unprognostic (2.44e-1)"	"unprognostic (2.78e-2)"	"unprognostic (9.81e-2)"	"unprognostic (8.56e-3)"	"unprognostic (2.09e-1)"	"unprognostic (2.25e-2)"	"unprognostic (8.87e-2)"	"unprognostic (4.04e-1)"	"unprognostic (5.90e-3)"	"unprognostic (3.12e-2)"	2.9	3.3	5.1	1.8	5.1	0.6	4.7	6.0	6.1	5.1	7.0	4.9	1.8	5.5	4.5	1.9	5.1	2.6	5.3	4.9	5.6	6.0	3.1	2.8	3.4	5.2	5.6	10.6	2.8	6.5	8.2	3.2	5.5	5.6	1.9	5.1	2.7	5.0	4.2	2.1	2.8	3.5	5.0	4.8	2.7	8.5	5.2	3.7	6.7	5.3	3.0	4.1	3.4	5.7	0.9	1.9	5.5	3.0	2.4	3.6	4.2	2.7	1.6	4.0	3.7	0.2	1.7	2.0	4.5	2.0	3.3	0.5	1.8	0.7	5.0	0.2	2.7	5.9	1.7	0.1	2.8	1.0	7.5	3.9	1.3	3.7	1.1	4.7	3.1	1.4	2.9	3.5	3.4	1.2	1.9	9.0	6.3	0.6	5.1	10.2	1.3	8.3	2.2	0.5	7.1	2.6	6.8	0.9	2.7	4.8	3.2	3.3	1.2	2.6	6.2	2.7	1.6	7.5	8.3	6.5	1.5	3.4	2.9	0.5	0.6	3.4	1.5	0.5	2.7	0.6	1.2	2.3	0.5	2.5	2.4	1.7	2.1	2.0	1.7	0.5	1.4	0.7	5.1	5.1	6.0	6.1	4.9	5.6	5.2	5.6	5.5	5.0	5.2	5.7	1.7	9.6	4.5	11.4	4.9	0.8	3.2	2.1	4.0	6.1	2.4	2.4	9.9	4.3	4.4	0.0	4.2	1.5	1.6	0.6	3.9	2.8	4.7	2.3	3.8	2.3	1.2	2.5	14.6	1.4	1.1	2.6	4.6	1.7	1.3	5.9	0.4	0.6	0.9	5.0	12.7	1.0	4.1	0.6	0.8	2.0	2.8	1.1	5.4	2.8	0.9	3.4	4.1	20.6	12.1	1.1	0.1	4.5	2.0	2.3	1.0	0.9	2.9	2.2	6.6	3.1	3.6	11.6	10.5	2.1	0.6	1.4	2.9	3.8	0.6	1.5
TIMELESS	"hTIM, TIM, TIM1"	ENSG00000111602	"Timeless circadian regulator"	Q9UNS1	12	56416363-56449426	"Predicted intracellular proteins"	"Biological rhythms, Cell cycle, Cell division, DNA damage, DNA repair, Mitosis, Transcription, Transcription regulation"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Bipolar cells: 57.5;Spermatogonia: 24.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			HPA060655	Enhanced		Supported	Nucleoplasm		No	No			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 20: Retina & Lymphoid tissues - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"HPA060655: AB_2684338"	"unprognostic (3.94e-2)"	"unprognostic (1.10e-2)"	"unprognostic (1.29e-2)"	"unprognostic (2.18e-2)"	"unprognostic (2.36e-1)"	"unprognostic (3.06e-2)"	"prognostic unfavorable (3.61e-4)"	"unprognostic (1.43e-3)"	"prognostic unfavorable (1.06e-5)"	"unprognostic (7.03e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.48e-2)"	"prognostic unfavorable (2.61e-5)"	"unprognostic (9.47e-3)"	"unprognostic (1.72e-1)"	"unprognostic (1.92e-2)"	"unprognostic (5.01e-2)"	3.4	3.4	1.6	11.0	2.1	22.0	4.5	2.1	2.1	4.1	2.7	6.7	6.0	4.4	2.5	6.8	3.1	3.3	1.8	1.5	2.1	3.8	9.8	4.1	15.3	2.4	2.4	1.9	5.0	5.9	5.4	8.7	2.5	3.2	8.5	13.7	3.9	3.4	3.4	5.5	6.2	5.6	2.1	6.8	5.5	6.2	2.6	19.8	4.7	1.6	17.9	4.7	3.9	2.5	39.4	89.1	111.4	51.9	9.9	9.9	62.8	41.9	25.3	58.3	46.0	45.6	56.5	113.3	41.5	24.5	29.4	32.8	82.0	32.7	53.5	54.2	45.7	86.9	47.6	33.6	5.1	66.2	62.2	6.9	10.3	41.9	25.2	16.0	31.5	67.3	82.7	99.5	49.8	77.2	94.7	51.2	79.2	49.5	36.8	93.5	56.7	55.5	22.7	49.5	85.4	58.9	78.2	43.9	12.2	45.6	77.4	51.8	18.9	45.3	45.1	41.8	35.0	37.3	50.9	62.8	21.1	39.9	55.5	0.1	0.6	0.4	1.8	1.5	0.3	3.3	1.1	1.2	1.0	4.9	0.8	0.3	0.2	1.5	1.1	1.2	1.5	1.1	1.6	2.1	2.1	2.1	1.5	2.1	2.4	2.4	2.5	2.1	2.6	2.5	2.6	0.0	5.0	2.3	8.2	3.3	3.0	3.0	6.8	57.5	3.1	3.4	2.1	2.8	6.8	7.3	2.1	15.9	1.8	2.7	0.0	4.8	6.9	2.5	3.9	5.0	1.8	16.6	0.9	5.7	20.9	3.7	6.6	4.8	5.7	15.5	4.6	10.6	8.5	6.7	1.3	5.2	4.1	2.6	3.7	2.9	1.2	4.6	0.0	1.9	4.2	4.8	4.1	0.5	3.2	3.7	0.6	1.2	18.2	4.2	1.1	2.0	3.4	17.8	0.0	2.7	7.0	1.6	24.5	12.1	1.4	9.2	6.1	3.2	8.5	3.0
TIMM13	"Tim13, TIMM13B"	ENSG00000099800	"Translocase of inner mitochondrial membrane 13"	Q9Y5L4	19	2425625-2427586	"Predicted intracellular proteins"	"Protein transport, Translocation, Transport"	Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA048985	Uncertain		Supported	"Nucleoli fibrillar center,Mitochondria"		NA	NA		160000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria	"Nucleoli fibrillar center"	"HPA048985: AB_2680589"	"unprognostic (5.47e-2)"	"unprognostic (6.63e-2)"	"unprognostic (7.15e-2)"	"prognostic favorable (4.68e-5)"	"unprognostic (8.67e-2)"	"unprognostic (4.43e-2)"	"unprognostic (1.37e-3)"	"unprognostic (1.14e-1)"	"unprognostic (3.50e-1)"	"unprognostic (1.53e-1)"	"prognostic favorable (9.77e-4)"	"unprognostic (4.91e-2)"	"prognostic favorable (3.88e-5)"	"unprognostic (4.00e-2)"	"unprognostic (3.35e-2)"	"unprognostic (4.33e-1)"	"unprognostic (2.47e-2)"	59.3	129.0	52.4	26.6	53.7	34.5	50.1	55.2	74.7	46.3	54.0	68.2	51.1	40.9	11.4	105.8	43.9	15.8	91.2	51.9	54.0	96.9	142.8	42.5	26.6	54.8	55.8	54.0	97.6	32.4	49.8	24.9	54.2	64.7	16.4	6.0	51.1	12.1	87.4	75.8	52.0	11.7	53.6	64.9	67.4	58.3	58.1	31.0	54.2	42.4	15.6	48.1	56.9	53.7	132.4	135.2	48.3	95.8	26.7	26.7	66.3	75.2	26.2	54.3	39.6	196.5	65.2	79.0	26.2	25.1	39.7	95.5	75.2	102.2	15.0	73.2	265.8	66.4	140.2	151.9	76.2	129.1	68.8	62.7	54.3	59.5	40.5	36.9	65.6	102.2	136.4	114.8	22.0	54.7	153.1	176.2	135.5	106.9	196.1	113.8	38.8	212.2	53.5	111.4	178.8	164.4	34.1	137.0	89.6	21.5	91.5	141.0	62.4	63.6	71.3	120.1	152.9	179.5	100.4	85.5	65.4	175.3	98.7	40.2	162.0	51.3	62.5	158.5	77.6	98.8	71.0	65.8	149.5	92.3	87.7	76.3	10.5	99.8	95.8	334.7	78.1	124.3	52.4	53.7	55.2	74.7	51.9	54.0	54.8	55.8	54.2	53.6	58.1	53.7	75.4	51.3	77.8	9.8	88.9	233.0	146.9	266.3	97.9	40.9	249.6	291.6	147.5	144.4	136.6	130.6	4.2	330.2	118.6	325.8	420.7	251.8	67.5	85.9	146.9	116.9	192.0	103.2	10.1	385.7	435.1	126.9	126.9	101.1	61.6	230.5	99.2	411.8	317.2	26.9	13.5	348.1	189.2	162.7	140.3	121.4	128.6	104.0	225.9	4.7	150.2	91.2	90.6	8.0	15.3	325.5	214.8	98.9	91.0	221.9	359.7	638.8	84.2	43.7	52.6	105.7	156.2	106.0	144.8	195.2	276.2	284.2	60.4	454.8	425.6	189.3
TIMM23	TIM23	ENSG00000265354	"Translocase of inner mitochondrial membrane 23"	O14925	10	45972489-46003742	"Predicted membrane proteins"	"Protein transport, Translocation, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Spermatocytes: 148.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA031408	Approved		Supported	Mitochondria		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	Mitochondria		"HPA031408: AB_10600828"	"unprognostic (4.09e-2)"	"unprognostic (1.31e-1)"	"unprognostic (9.01e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.15e-2)"	"prognostic unfavorable (2.77e-5)"	"unprognostic (1.74e-1)"	"unprognostic (3.90e-2)"	"prognostic favorable (6.79e-4)"	"unprognostic (4.41e-2)"	"unprognostic (7.30e-2)"	"unprognostic (3.24e-1)"	"unprognostic (7.78e-2)"	"unprognostic (5.54e-2)"	"unprognostic (7.20e-2)"	"unprognostic (2.21e-1)"	39.0	50.1	47.1	35.5	48.7	66.4	38.3	50.3	62.9	28.2	55.6	40.1	56.5	26.8	61.9	43.1	28.0	31.7	84.9	49.1	51.6	59.5	74.2	26.6	36.4	50.7	51.5	20.6	32.2	50.5	35.0	35.2	52.3	34.6	39.9	42.9	32.5	36.9	128.5	35.7	37.7	37.6	49.9	25.6	32.8	80.6	50.5	40.0	43.3	134.5	45.4	53.0	27.1	49.0	162.6	167.5	108.7	110.3	88.5	82.4	106.1	130.6	156.1	155.6	164.0	212.8	125.4	144.1	105.7	138.6	111.3	136.1	168.0	139.9	153.3	108.0	165.6	92.1	120.8	231.7	142.2	173.1	98.7	99.4	122.3	133.4	188.0	64.7	146.1	123.0	166.0	78.8	138.7	162.7	155.5	239.0	131.7	119.0	51.8	118.6	105.0	105.5	177.6	111.8	127.3	117.0	72.8	159.4	132.8	83.8	168.7	102.1	108.1	74.8	130.6	96.8	188.9	83.6	148.9	203.2	139.3	246.7	63.9	54.8	98.1	54.3	73.1	131.1	75.7	82.1	70.0	79.1	111.2	79.8	62.5	69.5	22.8	79.1	118.6	92.2	85.8	129.5	47.1	48.7	50.3	62.9	49.1	51.6	50.7	51.5	52.3	49.9	50.5	49.0	13.3	9.6	22.2	10.7	19.4	21.9	18.1	32.7	15.9	14.3	16.0	11.9	97.5	30.0	24.4	12.9	8.4	42.1	17.0	16.1	45.0	40.4	101.5	26.6	20.8	18.3	10.2	43.3	19.1	30.1	47.7	24.8	20.9	23.8	27.8	14.2	13.2	27.3	34.5	0.0	18.6	16.5	36.7	16.0	15.8	35.0	17.7	18.9	23.2	12.2	29.3	23.0	20.6	14.6	19.6	36.7	14.7	11.7	36.0	20.3	22.3	61.0	26.9	10.4	6.6	13.1	26.0	148.7	48.4	38.7	21.6	35.6	16.6	17.0	25.6	22.4
TIMM29	"C19orf52, TIM29"	ENSG00000142444	"Translocase of inner mitochondrial membrane 29"	Q9BSF4	19	10928811-10933535	"Predicted intracellular proteins"	"Protein transport, Translocation, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 36.0;Ductal cells: 21.6;Extravillous trophoblasts: 31.4;Hofbauer cells: 22.4;Proximal tubular cells: 22.1;Syncytiotrophoblasts: 35.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041858	Approved		Supported	Nucleoplasm,Mitochondria		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 59: Non-specific - Translation"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 7: Non-specific - Mitochondria"	Mitochondria	Nucleoplasm	"HPA041858: AB_10963429"	"unprognostic (8.45e-2)"	"prognostic favorable (9.93e-5)"	"unprognostic (8.99e-2)"	"unprognostic (5.21e-2)"	"unprognostic (9.31e-2)"	"unprognostic (8.10e-2)"	"unprognostic (2.82e-3)"	"unprognostic (1.42e-2)"	"unprognostic (1.81e-1)"	"unprognostic (5.92e-2)"	"unprognostic (5.26e-3)"	"unprognostic (1.80e-1)"	"unprognostic (3.79e-3)"	"prognostic favorable (7.03e-7)"	"unprognostic (1.10e-1)"	"unprognostic (2.35e-1)"	"unprognostic (7.26e-3)"	8.4	11.7	4.6	5.4	4.5	10.1	8.4	3.7	6.1	10.4	3.5	11.0	8.0	11.0	1.1	14.9	9.0	3.1	13.5	4.9	3.8	11.5	12.2	8.1	6.0	5.8	4.3	7.9	9.9	3.3	10.7	4.6	4.2	10.1	2.0	1.1	10.1	3.8	23.5	13.9	9.7	2.1	3.8	10.7	11.0	13.0	4.2	5.3	7.5	5.9	2.8	10.5	11.4	4.7	21.3	8.0	6.2	10.4	5.3	5.1	16.7	14.3	7.6	10.7	9.9	14.7	7.0	18.0	24.7	7.0	5.8	20.1	3.3	8.9	1.8	21.3	25.0	20.7	8.4	10.0	8.4	15.8	15.5	4.5	8.6	7.5	3.2	4.3	6.5	15.7	23.1	15.4	4.1	19.0	17.4	29.1	21.8	6.6	34.0	23.4	8.7	22.3	4.7	8.6	15.6	15.8	16.9	9.1	18.3	2.3	13.1	16.7	10.7	17.1	10.0	21.6	23.1	49.7	52.8	19.8	10.6	19.3	14.8	3.7	8.7	9.8	5.3	9.3	8.9	17.9	10.6	11.7	5.8	15.0	10.1	8.3	1.7	11.3	7.4	11.0	12.8	3.8	4.6	4.5	3.7	6.1	4.9	3.8	5.8	4.3	4.2	3.8	4.2	4.7	6.9	3.2	5.8	0.0	3.5	0.0	0.0	0.0	0.0	0.0	9.6	8.4	0.0	0.0	1.3	16.5	0.0	36.0	13.8	0.0	19.6	21.6	0.0	9.6	10.9	4.9	0.0	0.0	0.0	10.5	31.4	5.2	0.0	9.2	1.3	10.5	0.0	0.0	22.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.0	0.0	0.0	15.0	0.0	0.0	0.0	0.0	15.7	0.0	0.0	2.4	0.0	0.0	22.1	0.7	0.0	0.0	0.0	7.0	0.0	0.0	0.0	0.0	35.7	5.5	14.7	0.0	0.0
TIMM50	"TIM50, TIM50L"	ENSG00000105197	"Translocase of inner mitochondrial membrane 50"	Q3ZCQ8	19	39480412-39493785	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Protein transport, Translocation, Transport"	RNA-binding	"Disease variant, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 185.5;Late spermatids: 662.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA048843, HPA056448"	Enhanced		Supported	Nucleoplasm,Mitochondria		NA	NA		12000	"Cluster 27: Non-specific - Gene expression"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 31: Spermatids - Spermatogenesis"	"Nucleoplasm, Mitochondria"		"HPA048843: , HPA056448: AB_2683137"	"unprognostic (1.49e-1)"	"unprognostic (6.97e-2)"	"unprognostic (4.90e-2)"	"unprognostic (2.80e-3)"	"unprognostic (4.62e-2)"	"unprognostic (1.45e-1)"	"unprognostic (3.11e-2)"	"unprognostic (7.91e-2)"	"unprognostic (2.76e-1)"	"unprognostic (3.11e-2)"	"unprognostic (9.43e-2)"	"unprognostic (2.01e-2)"	"unprognostic (4.14e-3)"	"unprognostic (3.04e-2)"	"unprognostic (9.87e-2)"	"unprognostic (3.82e-2)"	"unprognostic (4.04e-2)"	37.3	37.2	31.2	30.4	33.7	45.4	29.7	34.3	44.2	27.7	31.5	32.2	30.4	33.2	11.2	35.8	27.9	18.5	75.7	35.0	35.0	32.9	43.9	25.7	27.7	35.0	32.8	27.4	35.3	36.2	22.7	25.2	33.0	27.4	15.4	8.9	32.0	17.5	127.0	26.6	29.6	23.0	30.6	26.2	31.8	80.5	32.9	21.6	31.7	76.6	18.2	30.9	26.1	33.1	147.2	365.3	59.6	155.1	43.8	33.4	116.8	115.8	54.2	119.6	97.4	262.6	96.6	156.5	126.0	67.9	71.9	81.6	100.9	114.8	56.4	148.7	170.8	140.3	94.5	197.3	81.5	282.8	106.6	51.9	73.2	97.2	78.7	33.9	76.4	184.5	237.8	91.3	77.2	202.9	178.4	110.5	113.7	159.2	123.3	190.8	112.5	119.3	88.1	195.5	166.3	99.4	133.6	190.0	251.8	35.7	89.1	168.0	86.4	154.7	165.6	140.1	262.7	96.1	181.1	232.8	117.9	146.7	179.2	42.5	53.7	13.4	36.3	58.5	34.9	41.8	34.1	40.0	60.5	46.4	41.4	35.7	5.9	45.2	58.1	47.0	47.8	62.1	31.2	33.7	34.3	44.2	35.0	35.0	35.0	32.8	33.0	30.6	32.9	33.1	20.0	22.4	26.0	4.6	19.3	26.0	43.6	57.4	18.8	10.4	23.8	28.7	47.6	24.3	37.6	25.8	12.5	83.8	14.7	27.4	66.5	56.3	185.5	19.8	24.2	28.6	23.4	29.6	8.7	51.8	84.4	30.9	25.0	21.5	39.3	29.5	19.2	31.3	67.1	28.6	9.3	27.5	48.8	18.8	27.7	662.8	23.3	22.3	30.2	3.7	22.1	17.4	21.6	6.6	4.9	50.9	22.2	21.1	34.6	68.0	35.7	66.0	22.1	11.4	6.6	27.2	55.7	111.5	46.5	32.3	26.7	94.5	19.9	34.1	48.1	47.6
TIMM8A	"DDP, DFN1, MTS"	ENSG00000126953	"Translocase of inner mitochondrial membrane 8A"	O60220	X	101345661-101348742	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Protein transport, Translocation, Transport"	Chaperone	"Deafness, Disease variant, Dystonia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 102.2;Hepatocytes: 68.3;Suprabasal keratinocytes: 88.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HMC-1: 217.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003628	Supported		Supported	Mitochondria		NA	NA		59000	"Cluster 30: Non-specific - Translation"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 28: Keratinocytes - Keratinization"	Mitochondria		"HPA003628: AB_1080284"	"prognostic unfavorable (7.89e-5)"	"unprognostic (1.36e-1)"	"unprognostic (2.80e-1)"	"prognostic unfavorable (8.87e-5)"	"unprognostic (2.06e-1)"	"unprognostic (9.28e-3)"	"unprognostic (5.14e-3)"	"unprognostic (8.32e-2)"	"unprognostic (1.90e-2)"	"unprognostic (1.86e-3)"	"unprognostic (6.41e-2)"	"unprognostic (8.57e-3)"	"prognostic favorable (1.69e-4)"	"unprognostic (1.14e-2)"	"unprognostic (7.75e-2)"	"unprognostic (1.70e-1)"	"unprognostic (3.86e-2)"	5.1	5.6	4.3	6.5	4.4	6.9	7.6	5.1	5.2	4.4	4.8	7.2	6.6	4.2	4.7	7.0	5.6	3.6	10.9	4.5	5.3	9.2	25.3	3.1	8.2	4.5	5.5	5.9	5.2	6.7	1.9	6.3	4.5	6.5	7.5	5.0	6.0	3.7	10.0	6.5	6.3	4.8	5.0	4.5	4.2	3.2	5.2	6.8	6.5	14.0	8.7	6.5	3.1	4.3	31.5	30.0	17.1	33.8	13.3	15.0	20.3	23.5	11.4	20.0	40.6	26.4	21.3	38.0	29.7	17.8	36.5	27.7	46.2	24.5	33.3	17.7	29.9	62.8	44.7	46.5	12.7	39.9	217.8	15.0	21.5	30.0	18.8	9.6	19.7	15.9	51.0	40.8	26.8	50.7	18.3	39.1	55.3	46.4	49.3	30.2	31.1	44.9	18.3	21.1	22.7	20.9	28.6	22.8	22.5	18.8	19.1	19.3	14.2	27.5	31.5	40.6	26.1	18.7	50.8	45.9	14.6	53.8	22.2	1.2	3.8	0.2	4.9	5.8	7.0	12.1	6.8	7.2	4.6	11.9	10.3	8.4	0.4	5.2	3.1	11.7	3.8	4.3	4.3	4.4	5.1	5.2	4.5	5.3	4.5	5.5	4.5	5.0	5.2	4.3	7.0	3.2	4.4	1.3	10.7	102.2	39.6	27.6	31.9	7.6	11.2	16.8	25.8	5.7	14.1	11.0	6.2	38.4	8.7	7.5	39.2	13.5	0.7	9.0	10.8	10.2	8.4	27.4	2.8	10.9	47.6	13.0	7.1	7.3	16.5	9.3	5.3	68.3	21.1	3.3	2.8	8.6	22.4	7.2	13.9	0.5	6.5	7.5	14.2	1.9	5.0	5.4	3.1	1.0	0.7	15.4	6.7	2.6	13.8	36.2	8.0	39.9	9.1	8.5	0.0	9.6	16.7	2.9	10.9	27.7	88.5	36.7	6.9	12.4	18.0	27.8
TIMM9	TIM9A	ENSG00000100575	"Translocase of inner mitochondrial membrane 9"	Q9Y5J7	14	58408495-58427531	"Predicted intracellular proteins"	"Protein transport, Translocation, Transport"	Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA002932	Approved		Supported	Mitochondria		NA	NA		78000	"Cluster 30: Non-specific - Translation"	"Cluster 50: Non-specific - Ribosome"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 32: Non-specific - Translation"	Mitochondria		"HPA002932: AB_1080287"	"prognostic favorable (8.04e-4)"	"unprognostic (8.05e-2)"	"unprognostic (3.08e-1)"	"unprognostic (1.02e-1)"	"unprognostic (2.54e-1)"	"unprognostic (3.11e-2)"	"prognostic unfavorable (9.89e-5)"	"unprognostic (1.51e-1)"	"unprognostic (1.84e-1)"	"prognostic favorable (6.39e-5)"	"unprognostic (3.41e-1)"	"unprognostic (7.32e-2)"	"unprognostic (7.16e-2)"	"unprognostic (4.13e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.20e-1)"	"unprognostic (5.77e-2)"	42.4	35.8	22.6	18.1	25.1	21.3	40.5	26.9	39.7	37.1	25.7	45.1	23.0	33.6	35.6	29.9	36.1	24.0	34.9	24.0	24.7	46.4	31.8	24.0	28.4	23.8	24.6	48.3	75.7	21.2	27.7	22.3	24.3	32.2	18.0	28.2	35.8	20.5	66.1	33.2	26.8	26.8	24.2	26.1	37.1	22.4	23.3	18.8	30.2	23.6	25.1	39.2	31.4	28.0	71.0	56.7	45.8	46.6	53.0	99.6	63.0	67.6	38.3	55.0	48.7	60.3	74.3	100.4	73.1	38.8	45.2	48.0	63.9	67.0	76.3	68.0	38.5	53.0	36.2	68.8	129.1	78.5	45.6	77.1	86.5	51.4	100.4	80.2	54.4	47.2	82.0	57.8	53.9	120.3	75.5	101.0	38.2	106.2	98.8	63.3	73.8	58.9	70.3	63.1	60.3	34.3	44.6	109.7	126.7	55.2	78.0	45.1	57.4	63.0	87.0	41.4	73.8	40.4	43.1	91.8	50.0	79.1	76.8	8.8	14.8	4.0	14.3	17.0	26.3	28.5	22.5	21.4	21.4	22.3	28.5	27.3	1.6	27.8	19.2	23.2	25.2	12.5	22.6	25.1	26.9	39.7	24.0	24.7	23.8	24.6	24.3	24.2	23.3	28.0	26.8	32.1	20.0	12.7	40.5	35.3	46.4	47.6	38.7	15.9	44.2	55.2	20.7	32.9	26.0	14.7	22.9	80.1	30.7	12.2	72.4	39.1	36.7	21.4	38.5	33.6	25.2	35.3	14.2	54.1	92.9	32.2	25.5	21.9	36.8	36.6	39.7	33.0	61.2	5.0	15.4	43.2	24.4	47.9	29.9	32.7	74.3	30.0	33.8	3.7	47.6	31.6	39.1	8.5	12.2	38.2	30.5	51.6	33.8	57.3	35.3	117.7	15.0	24.0	19.7	49.7	32.3	78.8	22.1	39.2	39.6	73.5	29.9	56.9	53.4	42.8
TIMMDC1	"C3orf1, FLJ22597"	ENSG00000113845	"Translocase of inner mitochondrial membrane domain containing 1"	Q9NPL8	3	119498547-119525090	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"		Chaperone	"Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA053214, HPA055846"	Uncertain		Enhanced	Nucleoplasm,Mitochondria		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria	Nucleoplasm	"HPA053214: AB_2682081, HPA055846: AB_2682941"	"unprognostic (3.95e-2)"	"unprognostic (8.85e-2)"	"unprognostic (1.73e-1)"	"unprognostic (2.53e-2)"	"unprognostic (2.88e-1)"	"unprognostic (1.60e-1)"	"prognostic unfavorable (1.12e-5)"	"unprognostic (9.60e-2)"	"unprognostic (6.25e-2)"	"unprognostic (3.39e-1)"	"unprognostic (4.67e-3)"	"unprognostic (1.05e-1)"	"unprognostic (3.87e-2)"	"unprognostic (8.89e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.76e-1)"	"unprognostic (1.05e-1)"	10.5	12.0	13.4	10.7	14.3	6.3	13.1	14.2	15.4	15.0	13.2	11.3	8.9	9.3	17.9	15.9	12.8	14.4	44.0	12.7	13.9	17.8	14.2	11.0	17.7	14.3	13.6	10.9	11.1	23.1	7.1	17.1	13.9	13.0	13.7	4.2	14.6	19.7	27.3	15.8	7.7	12.1	14.0	9.9	8.5	10.6	14.1	11.4	19.1	49.2	14.8	14.2	7.0	14.6	26.9	24.5	12.4	10.4	45.5	30.6	27.0	7.7	25.3	21.7	24.7	16.7	16.0	19.5	13.7	27.1	15.1	12.2	30.8	24.8	35.0	16.4	10.9	14.4	10.7	18.8	23.9	11.3	9.1	28.0	37.4	18.4	22.4	13.9	31.5	18.5	19.8	18.1	40.3	33.2	12.0	23.7	16.2	22.4	30.1	10.0	8.4	25.4	32.0	13.1	15.8	29.4	7.8	11.8	28.0	16.2	19.5	30.4	16.1	12.2	9.3	11.3	13.8	12.1	11.8	28.3	20.7	28.5	19.6	11.1	17.6	21.3	10.8	17.6	12.5	16.2	10.4	12.0	17.4	17.6	12.2	10.9	4.3	13.1	20.9	15.1	20.7	22.1	13.4	14.3	14.2	15.4	12.7	13.9	14.3	13.6	13.9	14.0	14.1	14.6	61.2	25.6	39.3	18.6	24.0	37.5	50.4	110.2	31.3	25.0	44.8	55.0	165.3	41.5	63.7	40.5	14.6	157.5	28.9	44.0	150.6	73.2	12.2	39.9	41.1	56.0	28.8	43.1	17.4	62.7	112.7	48.2	29.0	31.1	41.2	34.1	31.8	52.4	86.3	21.9	23.9	43.5	87.5	32.7	40.4	10.0	47.2	39.4	44.4	15.0	65.7	73.6	18.6	22.6	35.6	52.7	40.9	54.5	30.2	43.5	50.5	146.5	63.0	35.4	72.3	43.9	52.5	111.1	58.2	45.9	42.1	177.5	29.7	48.0	45.7	46.7
TIPRL	"dJ69E11.3, MGC3794, TIP41, TIPRL1"	ENSG00000143155	"TOR signaling pathway regulator"	O75663	1	168178962-168202109	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027995, HPA054282"	Approved		Supported	Vesicles,Cytosol		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	"Vesicles, Cytosol"		"HPA027995: AB_10602900, HPA054282: AB_2682435"	"unprognostic (3.18e-2)"	"unprognostic (1.05e-1)"	"unprognostic (5.05e-2)"	"unprognostic (3.17e-1)"	"unprognostic (3.80e-1)"	"unprognostic (2.35e-3)"	"prognostic unfavorable (1.60e-4)"	"unprognostic (5.82e-2)"	"unprognostic (3.32e-2)"	"unprognostic (1.12e-2)"	"unprognostic (4.30e-3)"	"unprognostic (1.53e-1)"	"prognostic unfavorable (1.45e-8)"	"unprognostic (3.23e-1)"	"unprognostic (1.57e-1)"	"unprognostic (5.55e-2)"	"unprognostic (8.61e-2)"	16.3	14.9	15.5	19.6	16.3	33.8	21.0	15.0	20.1	17.7	12.8	22.2	19.0	23.2	16.8	20.1	14.3	16.8	23.7	16.8	17.0	17.8	22.5	14.9	22.2	14.0	13.4	17.4	15.9	27.4	13.6	17.5	14.4	18.4	22.0	14.7	12.0	17.3	24.4	16.3	18.5	22.7	13.4	16.3	15.4	18.2	15.1	30.1	17.4	23.0	19.9	18.7	13.6	15.7	69.4	31.0	45.9	41.6	36.7	53.1	27.5	50.5	53.0	54.6	48.4	48.3	50.1	49.0	68.2	48.7	40.1	81.8	34.5	49.3	52.6	47.2	36.4	47.3	29.2	22.9	64.5	94.7	62.0	43.2	62.8	47.4	62.7	36.0	58.1	75.4	69.0	66.3	47.7	25.4	84.9	49.0	37.0	96.7	54.2	41.1	47.0	66.4	49.7	33.9	29.6	66.1	39.3	54.6	102.2	51.6	59.9	96.3	53.4	45.6	52.4	43.6	69.7	72.2	80.5	108.1	29.8	61.4	53.4	71.6	26.7	36.8	22.0	32.1	22.1	27.3	25.7	23.8	31.6	27.6	22.8	22.4	34.5	29.6	33.9	23.4	36.0	28.2	15.5	16.3	15.0	20.1	16.8	17.0	14.0	13.4	14.4	13.4	15.1	15.7	52.1	25.6	20.4	9.4	39.7	48.2	42.1	70.4	50.1	27.3	31.3	36.2	46.3	22.8	40.7	22.0	16.7	44.2	49.0	37.1	29.4	68.5	53.4	36.0	50.1	43.4	24.0	32.6	41.6	88.9	62.8	47.3	24.5	30.8	40.0	35.2	36.0	33.5	65.1	52.2	37.9	33.9	44.7	26.6	41.1	15.4	37.6	42.6	30.2	19.7	61.0	43.9	51.5	22.1	21.3	69.7	27.7	38.0	37.1	43.3	35.9	77.2	36.1	20.8	26.3	35.4	51.1	151.5	51.6	56.0	41.8	29.0	48.0	84.5	38.5	37.5
TLE1	"ESG, ESG1, GRG1"	ENSG00000196781	"TLE family member 1, transcriptional corepressor"	Q04724	9	81583683-81689547	"Predicted intracellular proteins"	"Transcription, Transcription regulation, Wnt signaling pathway"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Glandular and luminal cells: 205.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011482, HPA071396"	Supported		Supported	Nucleoplasm		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm		"CAB011482: AB_443210, HPA071396: AB_2686392"	"unprognostic (5.86e-2)"	"unprognostic (2.59e-1)"	"unprognostic (3.71e-1)"	"unprognostic (8.49e-2)"	"unprognostic (2.62e-1)"	"unprognostic (4.18e-2)"	"unprognostic (1.49e-2)"	"unprognostic (2.19e-3)"	"unprognostic (3.59e-2)"	"unprognostic (3.75e-2)"	"unprognostic (4.95e-2)"	"unprognostic (3.65e-1)"	"prognostic favorable (8.07e-4)"	"unprognostic (2.56e-1)"	"unprognostic (1.55e-1)"	"prognostic unfavorable (7.60e-4)"	"unprognostic (4.09e-1)"	44.9	40.1	36.1	11.8	31.8	40.0	39.0	23.1	35.5	57.4	11.7	39.3	7.7	50.1	27.1	20.3	43.0	27.3	19.3	41.2	22.1	21.4	80.7	23.5	12.7	20.7	32.3	42.0	59.9	6.3	19.1	19.3	20.2	31.0	21.6	11.1	47.5	17.4	90.7	31.8	30.2	33.3	20.1	44.7	38.2	25.8	27.6	6.6	24.9	22.5	13.5	30.2	35.5	23.3	69.9	50.6	49.7	0.2	50.3	28.3	99.6	3.9	12.4	8.6	11.3	8.8	26.2	0.0	43.1	27.6	69.0	40.9	1.0	22.3	8.3	0.2	40.0	0.0	12.0	74.8	24.5	0.0	1.3	12.4	47.2	26.2	57.1	22.6	35.1	20.0	0.3	22.4	25.8	74.2	9.8	0.4	88.6	48.0	26.1	66.9	35.2	4.9	46.1	38.2	25.2	31.0	4.8	39.6	22.2	53.3	27.9	31.4	27.6	21.7	22.5	10.5	30.8	0.5	0.3	1.6	28.0	0.2	41.0	8.4	0.0	4.6	2.1	0.0	2.9	6.6	0.2	0.9	0.6	5.8	0.0	0.2	0.0	4.3	0.1	1.7	0.0	0.6	36.1	31.8	23.1	35.5	41.2	22.1	20.7	32.3	20.2	20.1	27.6	23.3	66.6	0.0	6.5	121.5	52.4	54.6	22.3	9.8	18.8	36.6	33.5	18.4	5.7	41.5	15.8	14.7	16.7	67.2	63.5	49.5	15.6	40.8	1.7	85.9	76.2	38.2	28.8	13.9	36.5	23.8	71.9	27.5	23.9	205.8	0.0	30.1	27.1	65.3	7.8	16.8	23.5	24.0	36.7	6.4	20.5	3.6	22.7	9.6	46.2	46.9	8.1	39.5	68.0	22.6	14.5	54.8	41.0	34.3	35.1	40.5	12.2	3.0	17.1	6.0	118.3	12.8	47.4	2.2	102.4	29.3	43.8	50.8	18.6	71.4	48.6	69.4
TLE2	"ESG, ESG2, FLJ41188, GRG2"	ENSG00000065717	"TLE family member 2, transcriptional corepressor"	Q04725	19	2997639-3047635	"Predicted intracellular proteins"	"Transcription, Transcription regulation, Wnt signaling pathway"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"memory B-cell: 1.7"	"Group enriched"	"Detected in many"	11	"B-cells: 1.7;T-cells: 1.2"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 44.4;RT4: 35.2;T-47d: 25.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049103	Enhanced		Supported	"Nuclear bodies,Focal adhesion sites"		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 72: Non-specific - Transcription"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 56: Bipolar cells - Visual perception"	"Nuclear bodies"	"Focal adhesion sites"	"HPA049103: AB_2680631"	"unprognostic (1.87e-3)"	"unprognostic (1.42e-1)"	"unprognostic (2.89e-1)"	"prognostic favorable (2.51e-4)"	"unprognostic (2.23e-1)"	"unprognostic (1.01e-1)"	"unprognostic (9.87e-3)"	"unprognostic (6.40e-3)"	"unprognostic (2.44e-1)"	"unprognostic (1.81e-2)"	"prognostic favorable (2.39e-6)"	"unprognostic (2.12e-1)"	"prognostic favorable (9.49e-6)"	"unprognostic (2.66e-1)"	"unprognostic (5.99e-2)"	"unprognostic (2.60e-1)"	"prognostic favorable (8.88e-4)"	35.6	31.5	19.4	5.2	20.6	1.6	34.2	67.6	21.2	45.0	10.5	52.4	12.5	62.6	5.2	13.5	62.2	9.0	75.6	13.4	18.9	52.0	17.1	42.5	5.5	22.0	21.5	29.3	36.7	20.4	25.9	9.3	27.2	55.5	6.6	8.7	85.5	28.0	66.4	21.9	18.4	11.1	18.5	46.9	30.2	23.0	27.9	4.9	72.5	30.9	2.1	67.4	25.7	22.2	0.5	2.8	0.2	44.4	6.7	1.1	9.5	0.4	0.0	2.1	1.1	14.0	5.1	0.2	5.9	3.2	1.3	7.6	7.7	2.7	0.5	1.2	2.1	0.0	3.4	0.6	8.6	0.0	0.4	9.6	1.2	4.9	0.1	2.6	18.0	12.6	16.2	0.2	0.3	15.0	0.4	0.2	0.1	1.3	2.9	3.9	2.2	4.4	5.5	35.2	2.3	11.1	3.0	22.0	1.1	0.9	25.1	0.1	11.7	14.0	14.4	0.8	0.5	0.5	0.5	3.0	0.3	3.3	2.8	0.0	0.0	0.1	1.1	0.0	0.9	1.7	0.7	0.4	0.0	0.1	1.2	0.7	0.0	0.0	0.0	0.0	0.2	0.3	19.4	20.6	67.6	21.2	13.4	18.9	22.0	21.5	27.2	18.5	27.9	22.2	27.1	19.2	17.6	1.6	0.7	3.6	34.2	8.3	11.4	36.9	27.0	16.5	24.9	12.8	7.0	36.8	2.1	1.8	2.8	21.7	1.9	11.3	6.5	1.8	9.6	10.3	13.8	0.4	10.3	2.7	4.4	14.8	8.2	6.0	0.0	7.2	16.1	4.0	0.7	1.7	29.3	14.9	8.2	0.3	3.1	18.8	11.8	1.1	5.4	3.7	0.1	19.2	2.1	10.6	14.6	2.7	9.8	15.1	0.3	28.2	1.3	1.1	10.0	4.4	0.0	1.5	11.2	1.2	5.8	4.6	2.3	6.7	2.3	0.7	26.5	32.5
TLE3	"ESG, ESG3, GRG3, HsT18976, KIAA1547"	ENSG00000140332	"TLE family member 3, transcriptional corepressor"	Q04726	15	70047790-70098176	"Predicted intracellular proteins"	"Transcription, Transcription regulation, Wnt signaling pathway"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 65.1"	"Cell type enhanced"	"Detected in many"		"Suprabasal keratinocytes: 132.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in all"	5	"neutrophil: 49.1"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 49.1"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054116	Approved		Supported	Nucleoplasm		NA	Yes			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 20: HeLa - Mitochondria"	"Cluster 28: Keratinocytes - Keratinization"	Nucleoplasm		"HPA054116: AB_2682386"	"unprognostic (5.57e-2)"	"prognostic favorable (2.09e-5)"	"unprognostic (5.18e-2)"	"unprognostic (5.13e-2)"	"unprognostic (1.15e-1)"	"unprognostic (4.05e-2)"	"unprognostic (1.35e-2)"	"unprognostic (5.53e-2)"	"unprognostic (6.74e-2)"	"unprognostic (3.11e-2)"	"unprognostic (1.72e-1)"	"unprognostic (6.07e-2)"	"unprognostic (4.90e-2)"	"unprognostic (2.43e-1)"	"unprognostic (6.71e-2)"	"unprognostic (6.29e-2)"	"unprognostic (2.74e-1)"	16.1	6.4	9.2	18.3	11.5	65.1	15.2	10.7	10.9	17.4	2.9	20.6	17.3	10.8	3.0	31.1	10.1	5.8	9.9	12.3	15.3	16.4	13.3	20.3	17.7	15.1	13.9	14.0	14.9	5.8	10.3	12.6	11.8	23.2	6.4	4.9	19.1	10.1	8.3	29.4	21.8	6.9	13.4	23.1	15.7	22.1	15.1	13.5	13.5	2.9	18.9	9.8	19.4	12.2	7.8	24.2	13.3	23.6	12.1	9.9	80.3	1.5	4.1	3.1	2.5	34.0	22.8	22.0	32.8	2.1	4.8	14.3	32.3	11.5	1.6	30.9	45.9	36.9	50.8	6.6	11.5	11.4	51.1	20.5	6.3	9.1	8.2	19.7	15.5	47.9	26.1	96.0	4.5	20.9	41.2	28.3	14.2	7.4	24.9	36.8	13.6	24.7	7.1	41.7	19.5	28.7	66.2	29.7	28.7	14.5	33.6	24.9	11.7	9.5	18.7	29.6	16.4	84.6	57.2	35.3	13.3	37.3	25.1	2.6	4.5	2.5	1.9	4.8	1.8	9.9	2.6	2.5	2.9	4.9	2.5	3.3	49.1	2.8	5.2	8.7	1.6	1.7	9.2	11.5	10.7	10.9	12.3	15.3	15.1	13.9	11.8	13.4	15.1	12.2	27.5	12.8	27.7	16.0	49.2	115.1	47.8	19.5	59.2	19.9	45.5	28.4	8.1	4.3	18.9	62.5	31.3	25.3	38.2	55.2	7.9	11.6	45.5	17.2	5.0	27.6	28.8	15.2	6.1	5.6	64.4	25.0	17.9	32.1	53.2	25.5	23.9	21.5	37.3	0.0	5.0	30.3	10.2	41.5	78.2	76.9	14.0	51.5	35.6	13.1	35.8	32.6	1.0	9.5	0.4	11.0	31.7	18.4	47.2	39.9	41.0	13.2	8.1	4.4	0.0	39.8	24.7	5.8	28.0	67.7	132.8	82.4	37.6	0.7	43.9	31.5
TLE4	"E(spl), ESG, GRG4"	ENSG00000106829	"TLE family member 4, transcriptional corepressor"	Q04727	9	79571773-79726882	"Predicted intracellular proteins"	"Transcription, Transcription regulation, Wnt signaling pathway"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 108.0"	"Cell type enhanced"	"Detected in all"		"Early spermatids: 818.9;Late spermatids: 1315.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 24.2"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ: 99.9;BJ hTERT+: 98.7;BJ hTERT+ SV40 Large T+: 89.4;fHDF/TERT166: 154.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA065357			Supported	Nucleoplasm		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 34: Spermatids - Unknown function"	Nucleoplasm		"HPA065357: AB_2685479"	"unprognostic (6.68e-2)"	"unprognostic (8.50e-3)"	"unprognostic (2.13e-3)"	"unprognostic (2.92e-1)"	"unprognostic (1.91e-1)"	"unprognostic (9.79e-2)"	"unprognostic (1.24e-2)"	"unprognostic (4.83e-1)"	"unprognostic (2.83e-1)"	"unprognostic (1.62e-1)"	"unprognostic (9.94e-3)"	"unprognostic (1.04e-1)"	"prognostic favorable (6.94e-4)"	"unprognostic (1.49e-1)"	"unprognostic (3.04e-1)"	"unprognostic (2.02e-1)"	"unprognostic (1.82e-1)"	9.3	15.7	18.4	16.4	45.2	67.9	8.7	22.3	27.4	9.6	20.2	9.9	8.4	14.3	5.9	17.6	12.9	16.6	8.0	27.5	21.6	6.9	5.6	12.5	15.9	31.7	21.4	32.3	6.4	10.6	24.2	19.7	32.2	5.6	10.5	24.7	10.9	8.4	23.1	18.9	11.3	14.5	26.1	18.5	14.1	108.0	25.4	27.8	10.4	10.3	19.9	18.7	12.8	64.0	0.0	19.0	70.7	0.5	11.4	9.6	21.2	99.9	98.7	89.4	34.4	2.8	10.3	7.4	0.2	154.3	13.7	20.8	5.0	18.3	39.2	38.2	30.8	0.0	9.1	0.4	13.8	21.4	13.0	11.3	12.6	26.1	5.2	25.2	23.9	14.0	1.5	21.3	28.6	0.7	29.4	9.4	22.5	11.9	4.8	25.7	35.9	7.4	5.5	2.7	28.5	41.5	14.7	1.9	0.1	32.8	0.0	25.1	36.4	34.8	0.1	0.8	5.0	14.4	25.0	10.9	12.3	18.0	16.6	24.2	4.4	17.1	4.8	6.3	5.9	1.3	2.5	3.6	2.9	1.7	1.5	2.5	11.7	3.2	4.9	1.0	0.8	2.6	18.4	45.2	22.3	27.4	27.5	21.6	31.7	21.4	32.2	26.1	25.4	64.0	108.9	6.4	19.4	77.4	91.9	121.0	57.2	50.6	167.4	76.8	76.0	92.8	15.9	84.4	45.6	14.7	127.2	77.2	228.1	163.5	3.9	13.4	818.9	262.0	230.0	59.7	25.2	22.3	150.8	22.0	67.1	71.4	137.1	158.7	21.0	34.8	53.2	14.1	51.1	218.7	33.3	117.3	61.1	167.9	70.4	1315.5	105.6	101.7	42.7	77.8	75.3	31.0	88.6	301.6	381.0	31.7	207.6	46.6	152.7	37.8	122.0	18.1	50.4	290.2	72.3	280.7	83.9	38.3	146.0	140.0	90.8	65.0	141.0	86.8	96.0	99.9
TLE5	"AES, GRG5"	ENSG00000104964	"TLE family member 5, transcriptional modulator"	Q08117	19	3052910-3063107	"Predicted intracellular proteins"	"Transcription, Transcription regulation, Wnt signaling pathway"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Adipocytes: 92.3;dendritic cells: 167.1;Extravillous trophoblasts: 372.2;Hofbauer cells: 84.2;Plasma cells: 57.5;Syncytiotrophoblasts: 94.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049499			Supported	Nucleoplasm		NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 35: Non-specific - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm		"HPA049499: AB_2680795"	"unprognostic (1.08e-1)"	"unprognostic (3.32e-3)"	"unprognostic (7.15e-2)"	"prognostic favorable (3.89e-4)"	"unprognostic (1.45e-1)"	"unprognostic (4.07e-3)"	"unprognostic (3.00e-2)"	"unprognostic (1.26e-2)"	"unprognostic (3.58e-1)"	"unprognostic (7.58e-2)"	"unprognostic (1.38e-3)"	"unprognostic (2.15e-1)"	"prognostic favorable (7.74e-4)"	"unprognostic (7.17e-3)"	"unprognostic (2.60e-1)"	"unprognostic (2.08e-2)"	"unprognostic (1.78e-3)"	237.7	357.9	325.2	93.8	320.4	99.7	214.8	341.0	435.0	304.3	209.5	466.7	82.0	336.6	80.8	282.1	315.9	90.6	504.4	319.4	327.4	266.5	239.6	283.8	145.2	341.8	301.7	284.0	234.4	174.5	276.9	94.7	349.4	314.8	90.9	82.9	287.9	197.1	550.0	231.4	233.2	109.9	279.3	325.2	274.2	109.0	345.5	210.0	315.9	313.7	120.0	361.8	285.4	326.0	120.8	138.7	101.8	180.7	122.1	140.8	78.9	155.1	211.9	192.6	173.0	57.2	120.3	195.9	169.1	200.7	69.5	100.6	122.9	226.7	112.6	292.8	56.5	68.8	141.9	109.6	217.1	99.4	85.1	152.3	182.1	93.2	89.7	226.9	191.8	100.8	245.5	80.0	169.0	120.0	221.7	119.5	89.4	85.3	140.3	251.3	123.4	135.1	241.7	247.7	258.1	283.3	152.2	174.1	163.9	55.8	138.3	134.2	266.5	161.1	106.6	152.8	143.5	4.7	0.9	265.0	151.1	165.7	151.7	38.9	6.6	18.1	130.8	10.7	100.8	62.0	169.3	134.9	12.5	74.3	220.8	149.5	4.6	41.6	9.2	28.8	242.0	89.2	325.2	320.4	341.0	435.0	319.4	327.4	341.8	301.7	349.4	279.3	345.5	326.0	92.3	0.0	0.0	0.0	34.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.0	24.5	167.1	0.0	0.0	0.0	0.0	0.0	0.0	9.6	0.0	0.0	0.0	0.0	372.2	27.7	0.0	0.0	0.0	0.0	0.0	0.0	84.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	57.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.3	0.0	0.0	0.0	0.0	94.0	27.8	0.0	0.0	0.0
TLK1	"KIAA0137, PKU-BETA"	ENSG00000198586	"Tousled like kinase 1"	Q9UKI8	2	170990823-171231314	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Cell cycle, DNA damage"	"Chromatin regulator, Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA016043	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Nucleoplasm		"HPA016043: AB_1858027"	"unprognostic (2.13e-2)"	"unprognostic (3.87e-1)"	"unprognostic (7.36e-2)"	"unprognostic (6.00e-3)"	"unprognostic (2.00e-1)"	"unprognostic (6.78e-2)"	"unprognostic (2.47e-2)"	"unprognostic (7.60e-2)"	"unprognostic (1.61e-1)"	"unprognostic (5.26e-2)"	"unprognostic (2.57e-1)"	"unprognostic (1.11e-1)"	"unprognostic (6.13e-2)"	"unprognostic (2.08e-1)"	"unprognostic (1.55e-1)"	"unprognostic (2.63e-1)"	"unprognostic (1.53e-1)"	7.7	10.2	5.9	10.7	8.3	11.1	12.3	4.1	10.5	12.7	5.1	13.0	9.4	10.6	5.4	9.4	9.5	9.6	7.0	10.1	4.6	13.0	14.8	8.4	15.0	3.5	7.3	14.0	10.4	18.0	6.2	15.2	3.4	11.8	12.3	15.8	9.2	14.6	16.3	8.5	11.8	11.7	4.4	13.2	13.5	17.7	10.6	13.8	17.6	5.5	15.7	11.7	8.3	7.6	16.6	15.6	22.0	17.3	15.4	15.3	24.7	22.5	31.9	21.8	18.2	21.8	25.9	34.2	18.7	33.4	23.6	13.7	28.5	24.6	23.8	42.1	14.9	39.1	18.5	28.0	16.5	50.3	19.0	16.7	24.6	43.4	28.4	23.0	24.3	21.2	42.3	27.4	13.2	20.3	43.8	15.5	20.6	15.5	8.9	31.9	26.9	34.7	17.7	30.9	25.0	19.7	24.7	16.7	16.1	14.9	13.8	17.0	33.2	19.3	24.0	12.7	17.8	24.5	43.0	59.7	23.9	20.1	19.9	11.1	3.1	5.7	5.2	2.6	7.3	8.3	8.3	5.7	3.0	8.3	9.3	6.2	4.2	8.1	5.3	4.4	8.5	5.2	5.9	8.3	4.1	10.5	10.1	4.6	3.5	7.3	3.4	4.4	10.6	7.6	34.2	51.3	27.8	135.8	76.7	41.3	33.2	27.1	30.7	34.8	45.9	28.4	32.1	37.1	29.2	51.5	60.5	82.7	42.6	55.8	88.0	29.2	58.1	29.5	33.9	34.5	23.9	33.7	196.2	32.7	52.7	30.3	37.8	38.4	27.3	39.5	27.5	40.0	27.4	45.4	161.0	36.7	36.7	29.0	30.4	32.0	43.2	54.7	37.4	74.0	29.1	26.6	49.4	84.9	92.0	35.6	36.5	44.8	66.3	51.0	33.4	58.0	30.7	77.5	0.0	41.6	29.6	31.1	54.9	24.5	39.1	174.9	66.4	59.2	33.9	43.0
TLN1	"ILWEQ, TLN"	ENSG00000137076	"Talin 1"	Q9Y490	9	35696948-35732195	"Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Macrophages: 323.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002006, HPA004748"	Supported		Supported	"Plasma membrane,Focal adhesion sites,Centriolar satellite,Cytosol"		NA	NA		1300000000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 51: Myeloid cells - Hemostasis"	"Focal adhesion sites, Cytosol"	"Plasma membrane, Centriolar satellite"	"CAB002006: , HPA004748: AB_1857760"	"unprognostic (9.71e-2)"	"unprognostic (2.02e-2)"	"prognostic unfavorable (5.56e-4)"	"unprognostic (1.96e-1)"	"unprognostic (5.55e-2)"	"unprognostic (2.52e-1)"	"unprognostic (3.18e-2)"	"unprognostic (5.07e-2)"	"unprognostic (1.94e-1)"	"unprognostic (6.46e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.27e-1)"	"prognostic favorable (7.21e-4)"	"unprognostic (1.36e-1)"	"unprognostic (2.71e-2)"	"unprognostic (7.83e-2)"	"unprognostic (8.83e-3)"	125.7	62.7	31.1	84.7	42.1	79.2	79.4	39.3	31.1	80.0	43.1	196.2	36.5	151.8	25.3	78.0	102.9	53.2	81.2	26.2	34.9	47.3	42.3	91.8	63.1	50.8	41.9	66.0	33.1	41.6	36.7	70.4	49.7	72.6	41.4	7.7	42.5	111.4	70.9	46.7	77.9	145.4	41.5	89.7	91.8	23.3	44.9	61.1	49.0	55.8	52.7	147.7	66.3	44.6	63.4	103.8	62.7	86.9	210.8	158.7	71.4	171.2	186.8	162.9	146.4	86.3	27.4	76.5	55.5	319.0	103.0	33.3	74.2	106.9	118.3	172.8	48.0	173.0	132.1	77.4	130.6	105.8	276.2	193.4	50.2	240.1	112.7	223.7	253.4	64.7	60.2	76.0	218.5	27.8	71.5	27.8	51.3	28.4	78.8	95.0	36.6	44.8	81.4	49.8	14.1	59.6	83.7	46.3	53.4	56.5	39.3	72.6	308.5	257.8	99.6	80.0	140.6	26.2	27.6	51.7	199.9	55.9	238.4	6.0	5.9	7.3	5.4	6.1	4.4	2.6	3.1	4.1	4.3	2.3	1.4	3.1	10.0	4.1	8.1	5.4	2.3	6.9	31.1	42.1	39.3	31.1	26.2	34.9	50.8	41.9	49.7	41.5	44.9	44.6	123.2	109.0	66.9	11.4	99.8	40.1	69.4	43.5	42.7	11.7	40.3	61.3	134.1	31.5	55.7	53.3	10.4	44.3	186.3	43.8	23.5	94.3	47.2	36.0	156.9	106.8	34.1	127.0	7.7	61.9	82.6	103.9	51.0	73.0	206.6	72.0	93.9	54.7	112.4	15.2	7.6	29.0	26.4	196.9	91.0	26.4	99.4	323.4	23.2	21.5	174.1	33.0	288.4	4.5	9.1	107.7	33.2	128.6	61.4	58.4	40.6	62.8	34.3	17.6	203.8	126.5	267.9	32.0	28.5	47.4	26.6	58.8	143.8	89.4	28.9	46.4
TLN2	"ILWEQ, KIAA0320"	ENSG00000171914	"Talin 2"	Q9Y4G6	15	62390526-62844631	"Plasma proteins, Predicted intracellular proteins"			"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 38.4"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 153.7;Inhibitory neurons: 127.2;Microglial cells: 139.6;Oligodendrocyte precursor cells: 108.6;Oligodendrocytes: 93.6;Skeletal myocytes: 135.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 59.3;hTERT-HME1: 48.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017194, HPA051828, HPA054787"	Enhanced		Supported	"Focal adhesion sites,Cytosol"		NA	NA		46000000		"Cluster 39: Non-specific - Mitochondria"	"Cluster 18: U-2197 - ECM organization"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Focal adhesion sites, Cytosol"		"CAB017194: , HPA051828: AB_2732570, HPA054787: AB_2732587"	"prognostic favorable (6.53e-4)"	"unprognostic (2.61e-1)"	"unprognostic (9.47e-2)"	"unprognostic (8.95e-2)"	"unprognostic (3.74e-1)"	"unprognostic (1.43e-1)"	"unprognostic (8.24e-2)"	"unprognostic (9.94e-2)"	"unprognostic (1.68e-1)"	"unprognostic (6.02e-2)"	"unprognostic (2.81e-2)"	"unprognostic (1.91e-1)"	"prognostic favorable (1.81e-6)"	"prognostic favorable (7.74e-4)"	"unprognostic (1.34e-1)"	"unprognostic (5.79e-2)"	"unprognostic (2.30e-1)"	19.0	4.1	14.2	2.2	15.6	3.8	10.4	3.2	16.9	8.0	20.2	9.3	4.7	3.7	2.1	2.1	4.3	1.9	12.1	18.3	8.2	38.4	4.8	2.4	0.5	7.6	8.2	4.6	4.7	2.4	5.5	1.2	6.2	2.3	7.3	7.7	7.8	2.1	26.1	3.6	5.1	2.9	11.2	1.3	5.5	5.4	7.0	3.1	13.0	12.2	0.5	4.1	4.2	13.8	1.8	5.6	8.0	9.4	59.3	5.6	9.0	13.7	10.8	12.4	12.2	15.1	1.9	4.8	6.2	24.0	20.5	2.4	10.3	2.2	10.8	15.2	1.0	0.6	22.8	10.1	2.0	1.6	0.4	10.3	5.6	16.6	48.9	7.1	0.5	5.7	0.6	0.2	21.0	7.5	0.7	0.6	14.2	26.3	4.1	5.8	20.3	5.8	6.5	11.6	1.9	9.3	10.6	1.1	3.5	17.1	2.9	3.6	3.9	22.2	30.0	36.3	35.6	0.3	0.9	3.1	10.1	3.4	27.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.2	15.6	3.2	16.9	18.3	8.2	7.6	8.2	6.2	11.2	7.0	13.8	11.5	0.0	3.2	50.6	1.1	2.4	1.8	0.7	1.2	18.6	16.5	10.2	41.1	5.7	0.9	27.6	37.5	1.2	0.7	39.0	11.7	3.5	4.3	10.9	14.3	9.0	2.4	37.7	153.7	3.9	29.7	21.5	40.8	17.4	0.0	9.3	3.3	12.6	4.9	48.8	127.2	20.0	6.1	6.2	3.1	5.2	11.8	5.5	0.0	139.6	0.8	11.1	1.0	108.6	93.6	3.7	21.0	15.8	0.7	1.5	14.6	35.1	0.1	48.3	0.0	135.6	12.3	6.7	24.5	3.1	1.6	1.4	1.3	25.8	37.7	1.7
TLR2	"CD282, TIL4"	ENSG00000137462	"Toll like receptor 2"	O60603	4	153684070-153706260	"CD markers, Enzymes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Immunity, Inflammatory response, Innate immunity"	"Hydrolase, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 69.9;lymphoid tissue: 51.7"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 77.3;Kupffer cells: 117.2;Langerhans cells: 35.7;Macrophages: 101.8;Microglial cells: 33.7;monocytes: 68.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"classical monocyte: 199.6;intermediate monocyte: 178.9;myeloid DC: 121.3;neutrophil: 457.8;non-classical monocyte: 121.5"	"Group enriched"	"Detected in all"	49	"dendritic cells: 121.3;granulocytes: 457.8;monocytes: 199.6"	"Cell line enhanced"	"Detected in some"		"HL-60: 11.6;HSkMC: 12.5;hTCEpi: 12.7;NB-4: 11.4;RPTEC TERT1: 13.3;RT4: 16.3;THP-1: 62.0;U-937: 11.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA060231, HPA071546"			Supported	Nucleoplasm,Mitochondria		No	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 41: Macrophages - Immune response"	"Nucleoplasm, Mitochondria"		"HPA060231: , HPA071546: "	"unprognostic (4.15e-1)"	"unprognostic (3.29e-2)"	"unprognostic (5.32e-2)"	"unprognostic (1.52e-2)"	"unprognostic (3.46e-2)"	"unprognostic (4.88e-2)"	"unprognostic (1.39e-2)"	"unprognostic (4.24e-2)"	"unprognostic (2.48e-1)"	"unprognostic (2.02e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.33e-1)"	"prognostic unfavorable (1.11e-4)"	"unprognostic (7.87e-2)"	"unprognostic (3.80e-3)"	"unprognostic (1.42e-1)"	"unprognostic (5.93e-3)"	26.8	11.8	4.3	51.7	4.4	69.9	12.5	4.6	7.5	7.9	7.6	4.6	3.9	3.3	11.8	5.4	8.2	16.3	6.1	4.0	5.3	5.1	11.3	39.9	8.8	9.5	5.9	2.5	8.8	3.4	4.0	11.4	7.9	4.7	3.3	1.5	17.2	12.3	1.7	3.5	4.9	11.7	7.1	35.9	5.2	1.9	7.4	3.6	3.4	3.7	15.4	23.6	4.0	10.1	7.1	0.1	0.3	0.0	1.0	2.9	0.0	0.0	0.5	0.5	0.8	3.3	0.4	0.0	0.8	0.0	0.0	6.4	0.6	0.4	0.3	0.1	0.1	0.2	0.0	0.8	0.1	11.6	0.9	12.5	12.7	0.0	0.1	0.8	0.0	0.0	0.0	0.1	0.1	0.1	0.0	11.4	0.7	0.0	2.7	0.3	0.0	0.0	13.3	16.3	0.0	0.3	0.7	0.1	3.3	0.4	0.0	62.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.7	11.3	1.7	48.4	199.6	1.8	0.3	178.9	0.5	0.4	1.1	0.3	121.3	1.2	1.3	0.2	457.8	5.3	121.5	1.1	0.2	76.2	4.3	4.4	4.6	7.5	4.0	5.3	9.5	5.9	7.9	7.1	7.4	10.1	1.7	6.4	77.3	0.7	1.1	1.1	1.2	18.4	1.2	0.0	9.7	2.2	1.3	2.8	19.5	3.7	0.0	0.2	0.6	0.2	0.0	5.0	0.3	1.6	0.5	2.6	0.0	3.6	0.1	3.8	0.2	1.9	2.6	4.9	3.8	0.5	1.4	1.8	17.4	0.0	0.5	0.3	0.0	117.2	35.7	1.3	0.6	101.8	1.8	33.7	68.4	0.4	1.0	1.0	0.1	3.1	0.0	0.4	1.4	3.4	1.5	1.0	7.5	0.3	13.1	0.6	5.1	0.2	1.0	1.9	1.1	0.1	2.3	0.5	0.5	2.0
TLR4	"ARMD10, CD284, hToll, TLR-4"	ENSG00000136869	"Toll like receptor 4"	O00206	9	117704175-117724735	"CD markers, Enzymes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Immunity, Inflammatory response, Innate immunity"	"Hydrolase, Receptor"	"Age-related macular degeneration, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 38.6;Astrocytes: 50.9;Hepatic stellate cells: 62.8;Hofbauer cells: 38.2;Kupffer cells: 106.0;Macrophages: 64.5;monocytes: 54.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 86.8"	"Group enriched"	"Detected in many"	33	"dendritic cells: 22.4;granulocytes: 86.8;monocytes: 65.6"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 60.0;TIME: 43.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB004025, HPA049174"	Approved		Supported	"Golgi apparatus,Plasma membrane"	"Intracellular and membrane"	NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	"Plasma membrane"	"Golgi apparatus"	"CAB004025: , HPA049174: AB_2680662"	"unprognostic (1.60e-1)"	"unprognostic (8.34e-2)"	"unprognostic (7.22e-2)"	"prognostic favorable (6.29e-4)"	"unprognostic (3.39e-1)"	"unprognostic (7.48e-2)"	"unprognostic (8.68e-2)"	"unprognostic (1.80e-1)"	"unprognostic (3.38e-1)"	"unprognostic (5.18e-2)"	"unprognostic (8.00e-2)"	"unprognostic (9.42e-2)"	"unprognostic (4.08e-2)"	"unprognostic (8.63e-2)"	"prognostic unfavorable (3.79e-4)"	"unprognostic (1.09e-2)"	"unprognostic (1.96e-2)"	31.1	11.0	12.4	25.7	15.7	22.3	12.0	11.7	8.3	6.5	1.7	6.7	4.3	5.6	1.2	4.8	4.8	10.8	8.4	10.3	17.8	6.8	16.7	16.2	13.1	12.3	14.0	6.0	2.6	2.5	2.1	23.9	12.4	4.6	7.3	2.9	6.0	3.2	3.1	3.5	5.8	10.8	14.9	32.6	4.4	1.5	14.2	3.5	5.5	12.0	7.7	13.3	2.7	10.1	0.0	0.0	25.5	0.0	11.1	23.0	0.1	10.2	17.9	2.5	1.5	0.0	2.6	3.6	0.5	26.7	7.5	0.1	0.0	2.2	3.7	0.0	0.0	5.7	5.1	0.4	8.1	19.1	0.1	14.2	0.0	5.4	0.7	22.5	31.4	0.0	0.0	60.0	29.2	0.0	0.0	2.9	3.1	2.4	1.2	0.0	28.0	19.8	0.9	28.9	0.0	0.1	6.4	0.0	1.0	2.2	0.0	10.4	43.5	1.4	18.4	0.1	4.8	0.0	0.0	0.0	0.9	19.1	15.2	64.0	64.9	21.5	0.1	57.5	0.0	1.7	0.1	0.0	22.4	0.5	0.0	0.0	86.8	0.1	65.6	0.9	0.0	25.5	12.4	15.7	11.7	8.3	10.3	17.8	12.3	14.0	12.4	14.9	14.2	10.1	38.6	0.0	5.0	50.9	2.3	0.8	0.3	0.1	0.6	0.2	3.5	1.0	2.9	2.8	2.9	0.0	0.0	0.3	0.1	1.6	0.0	0.1	0.1	3.5	29.2	31.6	0.0	1.3	0.2	0.2	0.2	11.5	1.5	6.8	15.8	1.2	62.8	1.9	38.2	0.0	0.2	2.0	0.0	106.0	8.6	0.4	0.0	64.5	1.8	26.2	54.0	8.8	2.1	7.5	0.3	0.5	6.1	0.0	0.1	0.1	0.0	0.4	3.7	1.3	6.6	5.5	4.5	0.1	0.3	0.3	0.0	0.8	0.9	3.1	1.2	3.3
TM4SF18	L6D	ENSG00000163762	"Transmembrane 4 L six family member 18"	Q96CE8	3	149318498-149334414	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 33.9"	"Group enriched"	"Detected in many"	4	"Adipocytes: 226.1;Endothelial cells: 188.9;Hepatic stellate cells: 151.0"	"Cancer enhanced"	"Detected in all"		"renal cancer: 17.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 94.8;EFO-21: 194.9;GAMG: 38.7;HUVEC TERT2: 65.9;NTERA-2: 47.2"					"Low region specificity"	"Detected in many"			"HPA053639, HPA069378"	Approved		Supported	Vesicles,Cytosol		NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Vesicles	Cytosol	"HPA053639: , HPA069378: AB_2686133"	"unprognostic (2.25e-1)"	"unprognostic (3.68e-1)"	"unprognostic (4.76e-2)"	"unprognostic (1.08e-1)"	"unprognostic (9.11e-3)"	"unprognostic (1.05e-2)"	"prognostic favorable (8.63e-4)"	"unprognostic (2.84e-1)"	"unprognostic (6.13e-3)"	"unprognostic (1.64e-1)"	"unprognostic (7.90e-3)"	"unprognostic (1.75e-1)"	"unprognostic (5.71e-2)"	"unprognostic (3.56e-3)"	"unprognostic (1.65e-1)"	"unprognostic (3.01e-1)"	"unprognostic (1.97e-1)"	21.3	5.2	9.4	4.9	9.6	0.1	16.3	9.2	11.5	8.3	10.4	3.4	3.9	7.6	4.7	3.4	6.4	10.6	8.4	9.1	10.3	19.1	7.9	9.2	6.6	12.2	9.6	3.2	9.8	6.8	3.1	17.4	11.5	4.0	3.3	1.1	4.0	6.5	5.9	2.4	3.6	14.9	10.0	33.9	3.4	1.9	12.1	2.1	12.7	5.7	5.0	6.7	2.5	10.4	0.1	94.8	3.5	0.2	0.0	0.1	0.0	0.1	0.5	0.0	0.0	0.2	1.2	0.0	194.9	0.0	38.7	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.3	0.0	0.3	0.1	0.7	0.0	0.0	0.0	24.7	65.9	0.0	0.0	0.0	6.2	0.7	0.0	0.2	47.2	0.0	0.0	0.1	2.6	0.0	0.0	0.3	0.1	0.1	0.0	0.1	0.5	1.5	0.1	0.1	8.4	0.1	1.2	0.0	0.5	0.1	0.1	0.5	0.0	0.1	15.2	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	9.4	9.6	9.2	11.5	9.1	10.3	12.2	9.6	11.5	10.0	12.1	10.4	226.1	0.0	4.4	0.3	1.6	3.2	0.2	0.0	0.6	0.2	41.4	23.9	2.8	4.3	0.0	1.8	0.0	0.0	1.0	0.0	9.8	35.2	0.4	0.7	1.1	188.9	0.0	0.0	0.0	0.2	0.0	6.2	0.0	0.9	1.3	0.3	151.0	1.1	0.1	0.0	0.1	0.0	0.0	9.1	3.0	1.8	2.1	1.2	1.8	33.7	0.6	0.4	0.0	0.5	0.6	0.9	0.0	6.8	2.5	1.3	0.0	35.8	0.7	0.0	0.0	1.5	2.5	0.2	0.5	0.2	2.8	0.0	1.1	5.2	0.0	0.6
TM4SF20	"FLJ22800, TCCE518"	ENSG00000168955	"Transmembrane 4 L six family member 20"	Q53R12	2	227362038-227381995	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"			"Autism spectrum disorder"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	76	"intestine: 266.6"	"Cell type enriched"	"Detected in some"	4	"Proximal enterocytes: 703.0"	"Group enriched"	"Detected in many"	6	"colorectal cancer: 5.0;liver cancer: 4.7;pancreatic cancer: 5.5;stomach cancer: 11.8"	"Region enhanced"	"Detected in single"		"cerebellum: 1.2"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 2.6;RPMI-8226: 1.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA051838, HPA063184, HPA065531"	Uncertain		Supported	"Plasma membrane,Focal adhesion sites"		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 56: Intestine - Transmembrane transport"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 45: Enterocytes - Digestion"	"Plasma membrane, Focal adhesion sites"		"HPA051838: AB_2681631, HPA063184: AB_2684958, HPA065531: AB_2685506"	"unprognostic (4.68e-2)"	"unprognostic (1.13e-1)"	"unprognostic (8.75e-2)"		"unprognostic (4.96e-2)"	"unprognostic (2.84e-2)"	"unprognostic (1.63e-1)"	"unprognostic (2.51e-1)"	"unprognostic (2.36e-1)"	"unprognostic (2.95e-1)"	"unprognostic (1.20e-2)"	"unprognostic (1.19e-1)"	"unprognostic (3.44e-3)"	"unprognostic (7.76e-2)"	"unprognostic (2.60e-2)"	"unprognostic (3.04e-3)"		0.1	0.1	0.2	0.3	0.2	0.2	0.0	1.2	0.4	0.0	0.4	3.1	266.6	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	3.9	0.3	0.0	0.0	0.0	0.3	144.5	1.6	0.0	0.1	0.5	3.5	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.0	2.6	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.2	0.1	0.0	0.0	0.6	0.1	0.0	0.0	0.1	0.0	1.7	0.0	0.1	0.2	0.6	0.4	0.0	0.0	0.0	0.1	0.0	0.1	0.2	0.1	0.7	0.0	0.1	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.2	0.2	1.2	0.4	0.1	0.0	0.1	0.0	0.1	0.0	0.1	0.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	15.1	0.0	0.0	48.4	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	21.4	0.0	0.0	0.0	77.3	0.0	0.1	0.0	0.0	0.0	0.2	0.0	1.0	0.5	0.0	157.9	0.7	0.0	0.0	703.0	0.0	0.0	0.3	0.0	0.1	0.0	0.5	0.3	0.0	0.0	0.0	0.1	0.0	18.8	0.0
TM7SF2	"ANG1, DHCR14A, NET47"	ENSG00000149809	"Transmembrane 7 superfamily member 2"	O76062	11	65111845-65116384	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cholesterol biosynthesis, Cholesterol metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 246.0"	"Cell type enhanced"	"Detected in all"		"Granulosa cells: 482.7;Hepatocytes: 220.6;Muller glia cells: 204.7;Theca cells: 204.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"plasmacytoid DC: 38.1"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"MCF7: 69.2;RPTEC TERT1: 86.2;T-47d: 143.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030691, HPA072704"	Enhanced		Supported	"Endoplasmic reticulum,Vesicles"		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 35: Non-specific - Unknown function"	"Cluster 6: T47d - Mammary gland"	"Cluster 40: Granulosa cells - Unknown function"	"Endoplasmic reticulum"	Vesicles	"HPA030691: AB_10602480, HPA072704: AB_2686551"	"unprognostic (1.62e-1)"	"unprognostic (5.23e-2)"	"unprognostic (1.70e-2)"	"unprognostic (1.78e-1)"	"unprognostic (5.74e-2)"	"unprognostic (1.10e-1)"	"unprognostic (5.98e-2)"	"unprognostic (6.06e-2)"	"unprognostic (5.72e-2)"	"unprognostic (1.74e-2)"	"unprognostic (7.06e-2)"	"unprognostic (1.69e-1)"	"prognostic favorable (8.49e-8)"	"unprognostic (8.77e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.35e-1)"	"unprognostic (3.44e-2)"	63.4	246.0	27.8	2.6	28.5	4.1	29.1	32.8	33.9	17.4	64.1	7.8	9.4	3.4	17.0	39.6	12.8	7.0	47.3	30.0	29.7	18.9	86.4	10.1	3.4	34.0	32.0	36.5	69.9	36.3	19.5	3.9	32.5	41.1	3.9	6.0	46.9	6.0	7.1	68.2	8.3	1.9	30.1	5.1	35.6	11.5	32.6	5.6	15.5	3.7	8.4	5.5	22.1	35.1	7.7	10.9	27.3	35.1	8.1	1.3	15.4	1.8	4.5	2.7	3.0	26.0	35.8	16.3	26.9	2.2	1.0	13.3	11.6	21.2	1.9	16.7	5.0	10.2	2.7	54.5	18.8	4.2	10.6	3.7	5.0	14.6	3.9	12.6	3.9	28.7	5.8	13.9	0.8	69.2	8.3	18.6	12.6	18.4	11.2	22.4	1.2	39.9	86.2	12.6	27.2	30.5	1.2	28.2	6.1	19.5	143.9	11.4	3.1	0.4	3.4	3.8	2.3	27.1	18.1	8.4	2.5	5.9	1.0	1.1	1.6	3.4	9.1	1.5	7.0	12.4	5.6	7.8	1.5	11.9	11.8	9.0	1.1	12.5	0.9	38.1	5.6	4.9	27.8	28.5	32.8	33.9	30.0	29.7	34.0	32.0	32.5	30.1	32.6	35.1	4.0	9.6	43.7	23.5	12.7	1.9	6.2	33.6	5.7	19.2	52.2	38.5	99.4	52.9	36.6	44.1	10.4	72.9	16.3	23.3	17.6	27.1	28.8	17.9	2.6	5.7	59.4	13.7	11.6	27.7	4.6	4.3	31.1	16.5	7.0	482.7	5.0	220.6	15.6	25.2	15.3	21.8	52.9	6.3	2.7	59.3	9.9	5.8	12.4	2.8	9.4	204.7	7.2	17.1	36.5	21.7	23.7	2.2	12.9	31.3	29.0	77.5	37.9	23.6	13.1	1.6	21.8	13.3	17.9	18.0	7.0	82.1	8.3	204.8	19.0	10.4
TM7SF3		ENSG00000064115	"Transmembrane 7 superfamily member 3"	Q9NS93	12	26971579-27014434	"Predicted intracellular proteins, Predicted membrane proteins"	"Stress response"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 258.0"	"Cell type enhanced"	"Detected in all"		"Late spermatids: 148.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HBEC3-KT: 553.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA057640			Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Cytosol	Nucleoplasm	"HPA057640: "	"unprognostic (4.24e-1)"	"unprognostic (1.90e-2)"	"unprognostic (1.04e-3)"	"unprognostic (8.80e-2)"	"unprognostic (5.82e-2)"	"unprognostic (5.10e-2)"	"unprognostic (1.83e-1)"	"unprognostic (5.79e-2)"	"unprognostic (2.86e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.01e-2)"	"unprognostic (1.16e-1)"	"prognostic favorable (1.32e-4)"	"unprognostic (1.24e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.16e-1)"	"unprognostic (1.58e-1)"	38.0	48.8	23.1	28.2	25.1	66.0	33.2	19.2	27.3	37.8	34.6	60.5	40.4	29.9	48.6	61.2	40.7	58.3	18.3	23.1	25.2	258.0	138.4	53.7	29.1	25.8	22.8	32.9	117.9	42.4	20.1	36.0	24.6	36.1	69.1	38.9	41.6	43.9	13.7	40.5	35.3	45.8	26.1	32.7	48.7	30.6	26.3	101.4	44.0	35.4	39.9	47.5	28.6	30.7	70.0	147.8	82.6	104.7	122.1	74.3	438.7	74.3	132.8	65.1	109.9	73.3	289.2	80.9	92.3	78.1	61.1	71.5	85.9	553.0	77.0	84.1	46.7	126.9	168.2	134.1	76.7	439.5	84.9	48.7	382.6	144.3	111.7	191.8	177.2	242.2	53.8	60.1	97.1	114.9	232.4	189.3	170.5	266.8	75.4	216.9	131.8	164.2	93.7	278.2	14.4	72.9	84.8	56.6	121.0	391.6	151.8	77.2	62.4	53.9	92.1	140.3	93.4	38.5	97.3	152.9	115.5	133.7	78.5	11.2	7.4	19.0	6.0	8.1	5.4	8.7	8.0	7.8	12.4	13.5	11.1	7.1	6.2	13.7	3.8	10.1	13.9	4.7	23.1	25.1	19.2	27.3	23.1	25.2	25.8	22.8	24.6	26.1	26.3	30.7	23.2	12.8	27.6	28.4	20.2	28.8	52.4	78.7	96.8	50.0	17.2	19.8	10.3	127.2	46.0	42.3	43.8	40.0	35.2	22.2	17.6	62.1	82.4	23.0	5.7	19.4	13.2	49.0	83.1	39.6	15.2	23.5	32.1	21.1	14.0	48.5	22.5	42.5	39.5	23.5	50.4	24.0	28.5	25.7	11.1	148.8	15.5	27.1	65.8	26.2	27.4	30.8	27.8	63.8	40.0	25.3	28.1	23.0	38.2	18.1	25.5	143.7	24.9	38.4	6.6	27.4	18.4	10.1	22.3	65.0	27.8	16.3	21.8	21.6	31.3	37.6
TMBIM1	"LFG3, PP1201, RECS1"	ENSG00000135926	"Transmembrane BAX inhibitor motif containing 1"	Q969X1	2	218274197-218292586	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Exocrine glandular cells: 281.2;Pancreatic endocrine cells: 294.3;Syncytiotrophoblasts: 282.1;Urothelial cells: 299.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RT4: 573.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012093, HPA070824"	Approved		Supported	Vesicles		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 15: RT4 - Unknown function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Vesicles		"HPA012093: AB_1858056, HPA070824: AB_2686317"	"unprognostic (4.36e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.73e-3)"	"unprognostic (2.34e-3)"	"unprognostic (3.81e-3)"	"unprognostic (8.91e-3)"	"unprognostic (5.58e-3)"	"unprognostic (9.85e-2)"	"unprognostic (3.76e-3)"	"prognostic unfavorable (4.22e-4)"	"unprognostic (1.69e-1)"	"prognostic favorable (3.38e-4)"	"unprognostic (1.22e-1)"	"unprognostic (4.63e-2)"	"unprognostic (2.75e-2)"	"unprognostic (4.50e-1)"	231.0	120.9	118.0	84.1	135.0	96.1	165.5	124.8	123.6	146.8	112.1	143.1	152.6	119.7	92.9	333.4	97.3	135.5	123.3	109.4	131.2	123.5	170.8	175.1	55.4	194.5	144.0	93.5	240.3	125.6	50.2	172.7	150.7	97.6	140.7	15.2	155.1	89.5	219.1	185.3	174.6	127.1	139.8	65.9	212.3	25.4	134.1	41.9	158.0	185.2	106.8	172.9	215.1	144.2	183.9	66.4	3.5	47.1	404.3	170.6	188.7	175.5	217.9	103.4	117.7	169.8	449.0	40.6	123.3	263.0	194.6	305.3	59.8	399.9	100.4	151.0	23.5	264.6	41.8	205.6	183.3	2.4	252.4	161.1	370.7	210.4	265.6	108.4	111.8	6.7	169.0	75.0	182.9	6.1	2.8	46.5	2.5	382.3	60.4	5.7	28.3	33.1	142.1	573.4	2.2	3.1	58.0	214.7	122.8	36.6	56.3	39.8	168.4	182.4	50.1	84.9	64.8	35.9	45.2	17.7	179.9	41.0	105.5	352.9	136.4	298.5	107.9	172.7	91.8	77.1	98.0	89.1	93.3	61.9	64.3	70.2	167.1	66.7	221.9	25.9	116.1	190.1	118.0	135.0	124.8	123.6	109.4	131.2	194.5	144.0	150.7	139.8	134.1	144.2	47.6	73.7	25.6	20.9	37.2	81.7	96.9	85.0	51.2	2.0	28.8	26.0	26.4	78.6	66.9	69.9	0.0	139.1	51.8	266.8	13.7	175.5	0.6	45.6	42.6	50.8	22.7	66.3	2.4	281.2	146.8	61.9	110.6	78.4	50.0	16.1	28.9	50.4	104.9	0.0	2.5	67.9	52.9	45.1	50.2	2.8	54.0	69.6	46.2	14.0	22.0	22.9	48.4	5.0	35.2	294.3	177.3	59.5	30.3	151.8	204.4	37.7	34.8	1.9	13.1	35.7	45.0	1.4	12.5	86.5	101.2	282.1	41.3	9.9	69.1	299.8
TMBIM4	"CGI-119, GAAP, LFG4, S1R, ZPRO"	ENSG00000155957	"Transmembrane BAX inhibitor motif containing 4"	Q9HC24	12	66135846-66170072	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA077642			Supported	"Golgi apparatus"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Golgi apparatus"		"HPA077642: AB_2686849"	"unprognostic (5.41e-2)"	"unprognostic (1.27e-1)"	"unprognostic (3.19e-1)"	"unprognostic (8.14e-2)"	"unprognostic (2.69e-2)"	"unprognostic (5.62e-2)"	"unprognostic (7.18e-3)"	"unprognostic (8.51e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.33e-2)"	"unprognostic (3.36e-1)"	"unprognostic (9.93e-2)"	"unprognostic (2.49e-2)"	"unprognostic (3.70e-1)"	"unprognostic (3.68e-2)"	"unprognostic (3.75e-2)"	"unprognostic (2.20e-3)"	79.7	88.6	28.0	75.3	34.3	61.5	81.4	34.0	29.7	67.3	47.6	90.5	59.5	61.0	68.6	62.6	65.8	70.1	70.8	27.1	35.6	94.0	109.6	76.7	74.5	38.5	32.1	56.7	103.5	104.7	40.1	74.2	39.1	72.8	70.2	39.7	89.3	73.7	46.7	52.2	69.8	58.5	34.7	74.4	93.3	85.1	31.0	63.1	97.9	61.5	56.0	80.0	42.9	41.5	49.1	62.4	39.7	72.8	131.4	122.7	41.9	74.4	129.1	56.7	45.8	32.8	78.7	45.6	86.3	105.2	42.6	78.9	20.1	65.7	36.6	74.5	27.3	87.7	30.0	38.6	66.6	106.9	109.2	86.9	92.8	27.7	31.1	79.0	87.2	51.8	65.9	160.3	94.3	79.5	41.1	37.5	47.4	76.1	63.3	21.5	26.5	50.8	126.8	80.3	20.1	47.6	84.5	154.5	102.3	34.2	146.3	146.7	106.0	69.1	25.9	50.5	44.8	82.7	48.5	32.2	94.8	103.7	84.1	420.7	372.7	371.6	136.0	381.4	137.9	205.9	139.7	139.4	256.2	196.6	157.9	139.1	662.3	135.3	434.3	171.7	159.8	483.9	28.0	34.3	34.0	29.7	27.1	35.6	38.5	32.1	39.1	34.7	31.0	41.5	232.8	150.6	147.2	34.0	131.3	0.0	64.1	0.0	84.2	47.8	202.2	152.1	37.0	0.0	66.2	244.6	45.9	137.0	128.2	191.4	103.7	213.8	330.6	116.2	96.4	114.5	74.7	32.0	15.8	338.1	116.9	140.7	85.1	105.8	179.0	72.7	0.0	0.0	210.7	45.4	25.2	172.4	0.0	0.0	0.0	143.8	104.4	193.2	0.0	62.8	205.5	114.1	123.6	42.7	77.0	202.9	176.9	91.0	126.8	87.9	128.9	214.5	99.1	65.9	59.2	67.8	75.7	391.0	40.8	112.5	0.0	130.8	99.3	142.7	182.2	62.8
TMC3		ENSG00000188869	"Transmembrane channel like 3"	Q7Z5M5	15	81331088-81374213	"Predicted membrane proteins"	"Ion transport, Transport"	"Ion channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enriched"	"Detected in some"	30	"parathyroid gland: 83.6"	"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 1.7;Distal tubular cells: 1.9;Excitatory neurons: 1.0;Spermatocytes: 1.1"	"Cancer enhanced"	"Detected in single"		"breast cancer: 0.5"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in some"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA040265, HPA040510"	Enhanced		Supported	Cytosol		NA	NA				"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 43: Cardiomyocytes - Nuclear processes"	Cytosol		"HPA040265: AB_10795379, HPA040510: AB_10796123"	"unprognostic (1.17e-2)"	"unprognostic (3.43e-1)"	"unprognostic (3.14e-1)"	"unprognostic (8.33e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.63e-2)"	"unprognostic (4.85e-3)"	"unprognostic (2.20e-2)"	"unprognostic (3.12e-2)"	"unprognostic (1.77e-1)"	"unprognostic (6.20e-5)"	"unprognostic (2.32e-1)"	"unprognostic (1.97e-7)"	"unprognostic (1.60e-1)"	"unprognostic (5.31e-2)"	"unprognostic (1.26e-1)"	"unprognostic (5.96e-2)"	0.1	0.2	0.7	0.4	0.7	0.8	0.4	2.4	0.9	0.3	0.3	0.4	0.6	0.4	1.6	0.1	0.9	0.6	0.2	0.6	0.2	0.2	0.3	0.1	0.4	0.7	1.0	0.4	0.2	83.6	0.1	0.2	2.7	0.4	0.1	0.7	0.6	0.5	0.2	0.4	0.4	0.1	0.5	0.3	0.2	0.7	0.5	0.1	0.8	0.1	0.1	0.1	0.8	0.7	0.3	0.3	0.1	0.9	0.1	0.0	0.6	0.2	0.1	0.0	0.1	0.2	0.6	0.8	0.0	0.0	0.8	0.2	0.1	0.0	0.0	0.5	0.5	0.6	0.3	0.3	0.1	0.5	0.3	0.1	0.0	0.1	0.1	0.4	0.0	0.9	0.2	1.0	0.0	0.3	0.3	0.4	0.5	0.3	0.3	0.2	0.3	1.5	0.0	0.2	0.3	0.6	0.2	0.3	0.6	0.2	0.7	0.3	0.1	0.5	0.6	0.4	0.2	1.5	0.6	0.5	0.3	0.8	0.3	0.0	0.0	0.0	0.1	0.0	0.1	0.2	0.1	0.0	0.0	0.3	0.3	0.2	0.0	0.0	0.0	0.1	0.2	0.1	0.7	0.7	2.4	0.9	0.6	0.2	0.7	1.0	2.7	0.5	0.5	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	1.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.9	0.0	0.1	0.6	0.1	0.6	0.0	0.0	1.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	1.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TMCO1	"HP10122, TMCC4"	ENSG00000143183	"Transmembrane and coiled-coil domains 1"	Q9UM00	1	165724293-165827755	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel"	"Disease variant, Glaucoma, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054768, HPA078775"	Approved		Supported	"Endoplasmic reticulum"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 21: OE19 - Mitochondria"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Endoplasmic reticulum"		"HPA054768: AB_2682597, HPA078775: "	"unprognostic (1.22e-2)"	"unprognostic (3.28e-3)"	"unprognostic (2.36e-1)"	"unprognostic (1.45e-1)"	"unprognostic (2.97e-1)"	"prognostic unfavorable (5.17e-7)"	"prognostic unfavorable (3.21e-4)"	"unprognostic (5.92e-2)"	"unprognostic (4.16e-2)"	"unprognostic (7.95e-3)"	"unprognostic (1.78e-1)"	"unprognostic (5.20e-2)"	"prognostic unfavorable (1.25e-4)"	"unprognostic (2.85e-1)"	"unprognostic (1.94e-1)"	"unprognostic (2.14e-2)"	"unprognostic (9.80e-2)"	67.5	92.5	46.4	51.6	50.2	48.4	91.1	53.8	63.5	74.0	72.2	127.0	115.7	55.9	111.5	58.5	65.9	80.1	56.4	46.4	55.6	110.3	162.5	55.0	62.4	54.1	55.5	59.5	73.5	143.6	33.8	57.4	55.0	79.6	128.7	74.3	77.8	69.9	48.7	39.3	108.9	61.4	56.6	46.5	80.7	75.4	49.8	89.3	103.8	48.0	70.8	97.7	29.1	60.6	158.4	172.1	132.2	77.9	243.9	120.7	126.9	259.4	191.7	156.0	162.1	249.9	229.2	99.1	267.4	195.9	67.1	214.7	171.8	140.3	175.1	252.0	164.2	121.1	180.3	158.7	195.1	216.6	154.1	159.0	173.9	179.5	142.6	148.4	117.1	122.6	329.7	186.0	227.3	123.1	172.1	160.6	169.4	527.6	197.3	125.0	143.4	256.1	204.7	198.4	133.5	235.4	201.3	209.2	170.9	195.0	277.1	275.7	121.5	138.9	116.5	123.8	248.3	357.4	521.1	346.5	111.4	139.7	187.4	213.3	172.2	172.9	159.7	169.4	170.4	151.8	168.7	173.1	135.5	132.6	134.3	156.5	132.1	156.6	201.7	243.8	207.1	290.3	46.4	50.2	53.8	63.5	46.4	55.6	54.1	55.5	55.0	56.6	49.8	60.6	124.0	96.1	70.7	23.8	95.6	84.8	89.8	264.5	75.1	79.1	142.9	135.9	62.6	224.4	181.1	213.3	68.8	136.1	138.9	371.5	43.0	202.3	82.2	131.4	147.9	92.7	88.6	75.5	20.7	191.7	148.4	113.1	64.2	154.7	76.5	71.9	106.7	326.0	140.9	75.7	24.9	137.0	227.9	106.4	76.0	151.6	123.6	92.7	99.6	16.9	78.9	236.7	152.4	25.6	23.3	227.0	215.7	129.4	153.5	73.6	290.0	151.5	175.2	75.9	124.9	67.7	101.7	232.1	87.7	89.4	92.9	111.4	109.2	117.6	143.6	94.5
TMCO5A	"MGC35118, TMCO5"	ENSG00000166069	"Transmembrane and coiled-coil domains 5A"	Q8N6Q1	15	37921939-37967724	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	141	"testis: 90.7"	"Group enriched"	"Detected in some"	104	"Early spermatids: 1153.9;Late spermatids: 3910.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA056530, HPA064017"	Enhanced		Approved	"Plasma membrane,Cytosol"		NA	NA				"Cluster 74: Testis - Spermatogenesis"		"Cluster 31: Spermatids - Spermatogenesis"	"Plasma membrane, Cytosol"		"HPA056530: AB_2683167, HPA064017: "										"unprognostic (2.60e-1)"	"unprognostic (1.69e-4)"							0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	90.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.2	0.1	0.2	0.0	0.1	0.1	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.7	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1153.9	0.2	0.0	0.8	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	3910.6	13.4	1.1	0.0	0.0	0.0	0.0	0.0	1.0	1.4	0.0	0.0	10.9	0.0	0.0	0.0	0.0	1.1	0.0	6.6	0.0	0.0	24.2	8.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1
TMED10	"p23, P24(DELTA), p24d1, p24delta1, TMP21"	ENSG00000170348	"Transmembrane p24 trafficking protein 10"	P49755	14	75131469-75176612	"Predicted membrane proteins, Transporters"	"ER-Golgi transport, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034442, CAB037251, HPA047139, HPA050539"	Enhanced		Supported	"Golgi apparatus"		NA	NA		220000	"Cluster 44: Non-specific - Transcription"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 55: Plasma cells - Humoral immune response"	"Golgi apparatus"		"CAB034442: AB_2204336, CAB037251: AB_1841216, HPA047139: AB_2679951, HPA050539: AB_2681163"	"unprognostic (2.00e-1)"	"unprognostic (1.73e-2)"	"unprognostic (2.02e-1)"	"unprognostic (2.51e-3)"	"unprognostic (4.06e-1)"	"unprognostic (1.17e-3)"	"unprognostic (5.88e-2)"	"unprognostic (1.21e-1)"	"unprognostic (3.68e-2)"	"unprognostic (6.46e-3)"	"unprognostic (1.01e-2)"	"unprognostic (1.27e-2)"	"unprognostic (1.36e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.82e-1)"	"prognostic unfavorable (8.67e-4)"	"unprognostic (2.06e-2)"	68.0	70.3	51.8	55.2	55.8	18.0	93.2	52.6	60.7	137.9	61.2	77.0	62.3	92.6	133.1	59.9	100.6	69.2	82.3	49.5	66.1	62.7	126.9	68.0	61.0	65.8	54.3	99.7	131.9	91.4	53.6	76.3	63.2	91.0	82.3	48.8	130.7	85.9	73.7	56.0	58.8	78.9	57.5	54.6	78.3	40.0	58.2	73.7	146.0	61.0	65.9	66.9	59.7	69.6	93.3	52.2	85.5	142.5	197.5	183.7	110.9	96.5	159.5	99.5	111.2	51.8	161.2	82.5	80.6	167.5	56.8	90.8	80.4	140.6	160.5	43.7	36.2	50.5	31.1	79.2	167.1	101.7	50.2	135.1	221.5	77.0	220.1	196.0	176.9	91.7	44.6	177.8	145.0	104.6	71.0	80.7	51.9	145.2	55.8	70.6	55.3	116.6	119.7	94.8	82.9	87.1	89.0	147.0	175.9	81.0	138.3	163.3	122.3	97.0	62.9	65.9	50.7	98.9	99.3	91.3	177.0	88.3	95.8	107.4	46.4	28.9	60.8	39.4	93.8	39.7	58.7	59.3	62.9	30.3	51.9	55.9	20.4	101.8	42.6	70.9	38.2	91.4	51.8	55.8	52.6	60.7	49.5	66.1	65.8	54.3	63.2	57.5	58.2	69.6	80.8	64.1	106.3	32.0	141.8	114.2	180.4	488.1	107.0	55.6	182.5	130.6	155.3	187.3	279.9	200.5	27.1	181.0	186.7	186.2	62.6	319.1	14.5	147.7	177.5	107.3	140.7	75.5	26.9	385.7	609.9	164.4	145.8	172.0	100.1	170.9	123.1	339.7	255.0	77.4	30.0	276.2	272.6	159.4	166.3	31.5	179.3	151.6	297.1	38.4	129.5	137.9	130.7	50.8	84.2	225.8	148.9	209.9	538.8	218.7	120.3	138.9	304.8	63.1	78.9	112.7	132.2	317.7	116.5	151.7	135.1	309.2	122.1	145.8	161.9	207.7
TMED2	"P24A, p24b1, p24beta1, RNP24"	ENSG00000086598	"Transmembrane p24 trafficking protein 2"	Q15363	12	123584533-123598582	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"ER-Golgi transport, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA014060	Approved		Supported	Vesicles		NA	NA		82000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 55: Plasma cells - Humoral immune response"	Vesicles		"HPA014060: AB_1856389"	"unprognostic (6.36e-2)"	"unprognostic (3.38e-3)"	"unprognostic (5.41e-3)"	"unprognostic (1.75e-2)"	"unprognostic (2.98e-2)"	"prognostic unfavorable (3.36e-6)"	"unprognostic (3.57e-3)"	"unprognostic (2.20e-2)"	"unprognostic (4.31e-2)"	"unprognostic (9.76e-3)"	"unprognostic (1.03e-2)"	"unprognostic (3.94e-2)"	"prognostic unfavorable (2.35e-7)"	"unprognostic (2.97e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.51e-1)"	"unprognostic (9.87e-2)"	106.0	97.1	40.7	92.6	43.5	122.1	136.1	44.2	50.8	155.6	59.5	132.5	123.7	102.5	203.3	111.9	102.3	96.1	116.5	40.5	45.3	102.8	271.1	85.4	72.7	46.6	46.6	101.5	229.1	99.3	65.0	125.4	46.9	140.5	140.7	56.9	227.6	102.2	131.0	74.8	110.5	102.1	46.0	63.2	133.8	58.5	44.2	69.1	197.6	112.1	95.2	118.6	71.4	53.8	237.7	204.9	133.4	232.2	295.7	260.2	317.5	401.2	318.5	246.8	194.2	209.9	198.9	199.3	210.7	398.7	169.4	228.1	181.8	214.5	257.3	155.2	169.3	217.3	114.0	267.6	559.5	296.9	178.1	220.5	349.2	212.6	286.0	352.7	234.7	133.5	223.1	132.9	255.6	175.1	159.8	242.7	192.9	201.0	206.6	164.8	216.8	235.7	303.9	349.1	166.5	143.1	267.3	263.6	273.7	160.0	450.2	237.2	226.2	210.1	132.4	204.9	227.5	292.3	290.7	167.6	248.3	192.9	254.2	249.7	143.2	145.9	157.0	147.5	198.8	111.8	137.0	148.4	158.6	102.5	110.3	129.4	111.1	148.5	141.3	242.5	140.1	142.2	40.7	43.5	44.2	50.8	40.5	45.3	46.6	46.6	46.9	46.0	44.2	53.8	97.1	48.1	71.5	9.1	148.8	417.4	290.3	348.5	207.1	50.1	258.8	98.0	167.2	213.1	233.2	154.5	20.9	281.5	166.9	169.6	117.4	325.1	12.2	89.2	136.5	142.0	170.7	76.3	20.0	249.6	678.6	242.7	156.5	136.8	92.6	88.4	143.5	538.8	215.8	48.8	20.3	352.4	321.4	141.7	414.3	13.9	181.4	128.5	378.8	17.8	129.8	124.1	195.7	19.6	27.5	224.9	158.5	153.4	521.0	486.3	178.1	163.0	142.1	54.7	164.3	112.6	193.5	165.9	150.6	289.8	498.8	451.9	154.3	125.0	263.9	389.2
TMED3	"C15orf22, p24B, p24g4, p24gamma4"	ENSG00000166557	"Transmembrane p24 trafficking protein 3"	Q9Y3Q3	15	79311112-79427432	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"salivary gland: 409.4"	"Cell type enhanced"	"Detected in all"		"Extravillous trophoblasts: 294.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049314, HPA076949"	Enhanced		Supported	"Golgi apparatus"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 21: OE19 - Mitochondria"	"Cluster 55: Plasma cells - Humoral immune response"	"Golgi apparatus"		"HPA049314: AB_2680708, HPA076949: AB_2686820"	"prognostic unfavorable (7.71e-4)"	"unprognostic (1.60e-1)"	"unprognostic (3.54e-3)"	"unprognostic (8.86e-3)"	"unprognostic (1.41e-1)"	"unprognostic (2.03e-3)"	"unprognostic (2.42e-2)"	"unprognostic (2.49e-1)"	"unprognostic (4.85e-1)"	"unprognostic (9.06e-2)"	"unprognostic (8.09e-2)"	"unprognostic (9.90e-2)"	"prognostic unfavorable (3.73e-4)"	"unprognostic (2.16e-1)"	"unprognostic (2.88e-1)"	"unprognostic (2.50e-1)"	"unprognostic (1.52e-1)"	25.9	26.2	19.6	23.1	19.2	37.0	66.4	21.5	20.5	56.6	30.6	49.9	25.4	38.3	138.7	132.3	38.7	37.8	41.9	20.8	31.9	34.7	12.4	30.9	26.0	22.4	22.0	30.9	246.7	54.9	89.6	42.4	26.5	60.0	55.4	11.3	409.4	54.6	4.6	106.8	26.6	37.3	21.6	32.4	73.1	35.0	22.6	23.1	76.3	7.2	37.8	48.7	75.1	25.1	68.1	169.0	31.9	63.6	220.3	167.5	69.0	153.0	206.7	103.3	126.9	141.4	123.3	31.5	117.3	236.0	135.9	124.5	95.7	98.5	53.0	62.7	145.6	104.5	143.0	110.3	131.5	112.2	200.4	126.5	144.4	59.6	86.9	123.5	120.8	105.9	47.1	0.6	101.4	144.3	32.1	106.0	45.7	251.6	92.2	39.1	47.4	158.9	94.2	51.4	99.4	48.8	80.6	162.1	159.3	103.5	141.5	81.7	98.5	85.2	75.7	2.2	111.4	61.7	78.8	44.1	109.8	180.7	103.1	74.9	69.8	95.1	58.1	85.3	62.7	75.5	57.2	63.9	106.7	63.6	71.4	69.1	6.0	61.4	95.7	109.1	73.1	92.2	19.6	19.2	21.5	20.5	20.8	31.9	22.4	22.0	26.5	21.6	22.6	25.1	9.9	28.9	43.6	6.8	41.2	95.8	109.4	125.6	64.9	14.9	153.8	132.8	16.9	55.8	108.5	57.0	8.4	167.8	40.7	67.7	23.5	143.4	48.9	31.6	39.6	31.7	83.9	33.7	10.0	250.5	294.5	68.1	54.6	70.4	47.0	44.0	65.7	6.4	100.5	13.5	10.2	219.3	87.5	52.7	54.4	118.6	49.7	49.2	85.4	9.4	60.0	38.0	44.3	17.1	12.9	173.3	79.9	27.4	71.1	165.2	43.9	28.9	37.7	17.0	19.7	25.6	57.0	51.1	60.3	104.7	121.8	172.4	30.4	64.6	126.4	200.1
TMEM106B	"FLJ11273, MGC33727"	ENSG00000106460	"Transmembrane protein 106B"	Q9NUM4	7	12211270-12243367	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport		"Amyotrophic lateral sclerosis, Disease variant, Leukodystrophy, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA058342	Approved		Supported	Endosomes,Lysosomes		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 33: Fibroblasts - ECM organization"	"Endosomes, Lysosomes"		"HPA058342: AB_2683684"	"unprognostic (5.29e-2)"	"unprognostic (2.34e-2)"	"unprognostic (4.20e-2)"	"unprognostic (6.20e-2)"	"unprognostic (2.73e-1)"	"unprognostic (1.87e-2)"	"unprognostic (3.50e-2)"	"unprognostic (5.89e-2)"	"unprognostic (4.44e-2)"	"unprognostic (1.30e-1)"	"unprognostic (3.01e-3)"	"unprognostic (2.09e-2)"	"unprognostic (1.75e-3)"	"unprognostic (5.52e-2)"	"unprognostic (3.06e-2)"	"unprognostic (2.16e-2)"	"unprognostic (1.70e-1)"	9.9	26.1	6.0	7.1	8.5	7.2	10.9	10.7	9.1	13.1	7.6	12.6	8.6	14.7	12.2	10.3	11.2	9.1	11.4	6.3	7.0	17.8	18.8	7.7	7.9	7.4	7.4	12.0	10.1	12.7	9.9	14.0	8.1	14.6	11.5	14.6	13.1	13.9	14.7	9.0	10.2	12.7	10.5	8.4	8.9	7.0	7.4	6.7	16.0	12.2	6.8	10.7	10.2	14.5	13.9	26.3	14.8	24.2	26.3	21.3	11.5	19.7	33.3	12.6	12.7	8.6	42.1	3.7	21.2	23.5	30.0	14.6	11.9	12.5	10.5	7.2	11.5	5.5	14.5	8.3	20.8	20.5	8.6	22.1	14.1	9.9	19.2	57.5	16.0	10.2	16.1	11.1	14.9	4.4	3.9	8.6	17.4	17.5	13.9	11.1	10.9	10.1	23.5	12.4	15.4	21.4	18.8	15.4	16.7	20.0	13.9	10.0	18.9	14.0	20.3	14.1	16.2	15.0	28.6	5.9	19.6	6.7	35.2	11.6	4.3	5.3	9.1	5.2	12.8	6.1	10.6	10.6	2.9	7.8	17.3	13.2	2.8	14.4	7.9	0.9	10.3	6.8	6.0	8.5	10.7	9.1	6.3	7.0	7.4	7.4	8.1	10.5	7.4	14.5	45.0	73.7	40.3	41.1	34.3	36.8	42.6	38.5	62.6	55.0	46.0	30.4	46.0	38.6	49.3	66.2	45.9	54.0	18.9	53.6	17.6	115.4	5.0	29.2	56.3	34.6	57.6	24.4	60.1	58.7	36.0	65.8	36.7	37.8	14.5	53.8	41.7	85.1	33.3	65.6	78.6	37.9	57.0	29.2	23.9	4.3	49.0	23.9	37.4	28.1	19.1	95.2	39.1	66.9	82.3	75.3	53.4	60.9	39.9	85.0	57.1	67.7	47.4	51.8	32.9	49.5	41.6	40.1	31.6	56.4	43.3	135.6	41.1	70.7	47.2	81.9
TMEM107	"JBTS29, MGC10744, MKS13"	ENSG00000179029	"Transmembrane protein 107"	Q6UX40	17	8172457-8176399	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Cilium biogenesis/degradation"	"Developmental protein"	"Ciliopathy, Disease variant, Meckel syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Plasma cells: 110.8;Respiratory ciliated cells: 164.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA052555, HPA059653"	Approved		Approved	"Nucleoplasm,Plasma membrane,Midbody ring"		Yes	No			"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 55: Plasma cells - Humoral immune response"	"Nucleoplasm, Plasma membrane"	"Midbody ring"	"HPA052555: AB_2681870, HPA059653: AB_2684096"	"unprognostic (2.87e-2)"	"unprognostic (2.67e-1)"	"unprognostic (2.85e-2)"	"prognostic favorable (9.39e-5)"	"unprognostic (1.94e-2)"	"unprognostic (8.83e-2)"	"unprognostic (5.70e-3)"	"unprognostic (1.24e-1)"	"unprognostic (2.15e-1)"	"unprognostic (6.02e-3)"	"unprognostic (1.83e-2)"	"unprognostic (1.87e-1)"	"unprognostic (2.66e-3)"	"unprognostic (1.26e-1)"	"unprognostic (4.99e-1)"	"unprognostic (2.66e-1)"	"unprognostic (1.49e-1)"	9.6	13.4	11.1	6.6	12.0	15.0	9.8	12.2	13.3	10.6	19.3	9.0	3.5	11.3	20.7	10.5	27.0	7.2	9.2	11.9	12.8	14.7	4.4	11.3	7.4	13.0	12.6	7.8	11.2	16.9	23.5	6.8	12.2	7.3	5.0	29.6	10.7	6.5	1.6	12.0	7.6	6.6	12.1	13.7	8.0	17.1	12.3	8.9	16.1	1.8	7.6	8.4	9.6	12.5	45.0	16.9	21.8	11.3	12.2	17.8	4.8	11.1	8.2	8.2	10.9	2.0	26.6	10.5	14.6	9.7	7.4	30.5	8.3	16.9	13.6	18.1	11.5	7.6	29.0	4.7	4.9	2.6	8.3	7.9	11.2	20.7	9.4	18.4	13.1	17.7	5.9	23.5	18.0	12.2	6.8	7.7	2.2	6.3	7.2	13.1	6.5	19.1	15.8	3.5	7.3	10.7	13.5	2.4	9.1	5.1	8.1	8.8	10.6	4.8	9.6	7.6	6.1	9.5	5.5	4.9	27.3	10.0	8.7	21.0	22.1	51.6	28.2	27.9	24.3	45.4	27.6	30.3	19.7	59.2	30.9	32.2	20.0	26.4	56.8	31.6	24.8	21.0	11.1	12.0	12.2	13.3	11.9	12.8	13.0	12.6	12.2	12.1	12.3	12.5	30.8	9.6	9.8	2.9	38.1	19.2	19.5	35.2	11.4	17.3	31.1	43.3	7.9	35.8	25.1	33.1	45.9	17.3	30.0	12.9	13.7	21.7	12.2	99.9	22.9	25.1	9.1	15.4	5.1	11.1	21.3	18.2	48.9	26.9	36.7	12.7	27.1	24.0	45.5	11.8	3.6	14.1	16.2	45.6	31.6	10.1	12.8	55.9	33.8	3.7	22.0	37.7	28.8	1.5	1.7	11.0	12.7	15.1	110.8	16.3	26.0	21.7	164.3	63.2	0.0	15.3	16.8	69.4	50.3	13.0	28.6	13.3	34.8	13.2	17.6	11.1
TMEM11	"C17orf35, PM1, PMI"	ENSG00000178307	"Transmembrane protein 11"	P17152	17	21197954-21214176	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 81.3"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051795, HPA062854"	Uncertain		Supported	Mitochondria		No	No			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"HPA051795: AB_2681612, HPA062854: AB_2684882"	"unprognostic (2.29e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.13e-2)"	"unprognostic (2.00e-2)"	"unprognostic (1.35e-2)"	"unprognostic (3.55e-1)"	"unprognostic (3.36e-3)"	"unprognostic (1.45e-2)"	"unprognostic (4.34e-2)"	"unprognostic (3.08e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.90e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.97e-1)"	"unprognostic (2.17e-2)"	"unprognostic (4.61e-2)"	17.6	11.7	18.9	12.4	19.3	37.7	10.8	21.1	25.1	10.6	18.4	13.9	12.5	11.8	18.6	14.2	9.4	9.0	21.3	19.1	19.9	9.9	9.9	11.8	13.8	20.3	19.3	12.2	30.4	14.9	1.3	17.1	19.8	12.2	10.0	10.9	23.7	9.1	81.3	16.8	14.2	9.8	18.7	11.5	13.2	7.7	19.8	15.8	12.6	54.1	9.8	15.6	1.9	19.8	25.3	27.5	22.7	22.1	33.9	24.1	31.2	38.9	17.7	35.8	31.3	74.5	13.5	27.4	29.7	36.3	29.0	35.0	30.0	35.8	17.9	23.2	46.5	19.8	27.0	32.1	36.8	25.1	22.0	26.5	27.7	36.4	26.2	17.2	22.8	19.3	23.0	9.5	26.9	39.9	37.8	46.6	30.5	68.8	15.3	27.2	49.8	19.6	25.2	21.3	13.8	24.0	17.6	19.0	36.9	87.2	18.4	24.8	21.4	25.1	29.7	42.5	49.3	9.6	13.2	69.3	24.9	31.9	22.6	31.2	70.6	76.2	33.1	58.9	29.6	49.4	33.1	31.8	47.1	47.4	37.0	31.8	58.4	40.8	67.9	38.8	40.3	68.1	18.9	19.3	21.1	25.1	19.1	19.9	20.3	19.3	19.8	18.7	19.8	19.8	35.0	48.1	21.8	5.5	26.0	84.9	61.9	77.7	35.3	32.9	40.2	39.9	49.9	22.8	49.1	36.8	18.8	80.7	36.6	49.4	50.9	55.3	20.7	23.9	23.6	36.8	31.9	51.3	4.4	40.5	80.9	33.9	20.9	29.1	27.3	23.1	32.2	28.1	54.3	23.5	5.1	67.4	73.2	25.3	34.5	16.3	35.8	26.3	40.9	8.4	48.6	31.6	33.0	6.0	8.0	47.4	60.6	57.6	19.9	63.6	55.0	55.9	33.0	39.9	32.9	25.7	42.0	40.4	38.4	34.7	92.6	90.8	28.7	31.3	49.6	80.2
TMEM115	PL6	ENSG00000126062	"Transmembrane protein 115"	Q12893	3	50354750-50359521	"Plasma proteins, Predicted membrane proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Syncytiotrophoblasts: 92.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB006319, HPA015497"	Supported		Supported	"Golgi apparatus"		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 31: Skin - Epidermis development"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 55: Plasma cells - Humoral immune response"	"Golgi apparatus"		"CAB006319: AB_425880, HPA015497: AB_1858076"	"unprognostic (1.62e-2)"	"unprognostic (2.37e-1)"	"unprognostic (1.59e-2)"	"unprognostic (1.65e-3)"	"unprognostic (2.32e-2)"	"unprognostic (2.10e-1)"	"prognostic unfavorable (3.73e-5)"	"unprognostic (7.00e-2)"	"unprognostic (6.00e-2)"	"unprognostic (2.05e-2)"	"unprognostic (1.75e-3)"	"unprognostic (2.65e-2)"	"prognostic favorable (1.04e-7)"	"unprognostic (4.88e-3)"	"unprognostic (3.00e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.75e-1)"	29.4	34.3	23.5	12.0	24.4	11.7	28.6	24.6	26.5	25.2	26.9	29.5	23.4	33.3	17.6	27.2	26.3	15.6	31.9	23.3	23.1	28.9	32.3	26.6	11.3	25.7	24.1	25.4	29.9	32.0	20.3	22.8	24.7	30.7	12.8	6.7	29.1	20.6	27.1	42.6	27.1	17.0	23.2	24.3	31.2	17.0	24.4	10.8	34.6	18.2	9.6	28.0	25.6	24.0	26.6	31.9	20.4	33.6	56.9	45.2	26.4	40.3	59.3	50.2	38.3	24.0	30.4	12.9	33.1	53.1	46.2	27.8	24.7	32.7	14.1	23.9	42.9	19.5	27.8	32.9	79.7	21.4	27.2	68.4	41.6	41.5	30.1	43.3	38.6	15.7	21.3	21.7	37.9	24.5	14.8	33.8	36.4	17.4	49.9	7.2	16.3	28.8	38.3	24.7	22.7	48.7	24.5	26.9	34.5	17.8	22.3	22.4	40.4	45.3	22.8	48.1	42.9	32.0	19.9	7.3	41.6	23.3	30.5	52.5	27.9	41.4	26.5	25.1	17.5	18.2	17.5	21.2	23.2	18.5	18.7	18.2	37.9	27.3	24.5	26.1	24.1	23.8	23.5	24.4	24.6	26.5	23.3	23.1	25.7	24.1	24.7	23.2	24.4	24.0	24.0	16.0	12.4	4.2	14.3	30.2	19.7	26.1	29.6	17.1	25.3	24.9	7.0	25.8	15.8	11.0	6.2	58.8	15.9	39.9	3.9	44.7	1.1	17.9	17.2	22.9	15.7	18.5	2.9	26.5	42.2	31.5	20.4	16.3	11.4	23.6	26.0	19.5	36.3	18.5	3.7	26.6	28.5	11.4	12.4	1.2	29.2	15.5	10.6	2.8	20.4	25.7	13.4	6.6	4.4	35.6	32.5	25.2	18.8	33.8	43.9	26.9	14.3	15.1	26.3	19.3	26.5	17.0	8.0	17.5	34.9	92.8	14.3	36.4	24.9	25.6
TMEM123	"KCT3, PORIMIN"	ENSG00000152558	"Transmembrane protein 123"	Q8N131	11	102396332-102470384	"Predicted intracellular proteins, Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 988.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB026001, HPA062862"			Supported	"Golgi apparatus,Vesicles,Cytosol"		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 85: Liver - Metabolism"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 32: Non-specific - Translation"	"Golgi apparatus"	"Vesicles, Cytosol"	"CAB026001: , HPA062862: AB_2732691"	"unprognostic (2.64e-1)"	"unprognostic (8.39e-2)"	"unprognostic (4.18e-3)"	"unprognostic (1.40e-1)"	"unprognostic (7.32e-2)"	"unprognostic (2.33e-1)"	"unprognostic (9.91e-2)"	"unprognostic (1.52e-1)"	"prognostic unfavorable (5.36e-4)"	"unprognostic (3.08e-1)"	"prognostic unfavorable (2.66e-4)"	"unprognostic (1.67e-1)"	"unprognostic (1.38e-2)"	"unprognostic (8.10e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.90e-2)"	"unprognostic (3.65e-2)"	56.0	80.2	53.0	120.2	60.3	225.1	153.3	56.7	68.2	114.9	67.0	120.0	63.5	174.7	47.8	100.1	91.7	99.6	71.2	48.0	61.0	93.2	393.7	119.2	196.4	71.2	68.6	86.8	82.5	70.7	15.8	98.5	65.1	105.2	97.1	9.2	224.0	104.1	20.4	95.6	78.8	130.6	61.3	111.2	125.5	73.3	61.5	238.6	312.3	49.7	142.9	146.8	70.7	89.8	220.5	195.8	186.9	174.8	233.5	185.6	135.8	169.7	352.0	324.4	358.1	247.9	988.1	370.2	423.9	387.9	234.5	228.3	212.3	272.9	339.4	228.4	82.5	192.0	67.8	352.3	207.5	404.1	137.4	219.1	280.7	240.1	352.3	433.9	361.8	187.8	134.3	0.9	257.7	71.8	353.0	135.4	115.8	340.3	181.1	214.7	532.0	359.3	291.3	207.9	90.7	110.5	201.8	267.6	109.9	197.2	161.3	154.0	451.9	211.3	249.4	190.5	126.6	139.4	84.3	366.6	62.0	432.7	143.2	159.7	113.3	207.0	102.6	121.8	155.3	70.1	158.8	123.8	126.1	95.3	208.6	181.7	72.4	223.9	111.0	33.7	183.8	248.7	53.0	60.3	56.7	68.2	48.0	61.0	71.2	68.6	65.1	61.3	61.5	89.8	93.3	125.0	78.1	33.0	179.3	160.3	257.1	307.3	157.6	0.7	144.9	118.4	53.9	143.0	202.8	163.7	0.0	45.8	91.8	48.2	80.3	153.7	41.3	141.1	47.6	140.0	90.5	68.3	1.0	118.8	41.1	82.2	88.2	161.4	58.9	126.6	271.3	317.6	107.1	1.7	2.2	163.1	160.7	249.6	419.9	23.6	94.1	189.8	161.9	63.7	229.4	4.7	83.4	25.6	114.0	127.8	55.1	93.3	117.8	324.2	31.0	52.9	257.0	1.1	65.7	181.9	80.2	23.1	74.9	146.3	177.2	30.4	164.8	109.4	146.3	270.2
TMEM126B	HT007	ENSG00000171204	"Transmembrane protein 126B"	Q8IUX1	11	85628573-85636539	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"		Chaperone	"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014480, HPA019186"	Uncertain		Supported	Mitochondria		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 68: Epididymis - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"HPA014480: AB_1858083, HPA019186: AB_1858084"	"unprognostic (1.11e-1)"	"unprognostic (4.97e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.79e-2)"	"unprognostic (5.67e-1)"	"unprognostic (1.44e-1)"	"unprognostic (5.55e-3)"	"unprognostic (1.22e-1)"	"unprognostic (1.45e-2)"	"unprognostic (6.70e-3)"	"unprognostic (4.42e-2)"	"unprognostic (4.30e-2)"	"unprognostic (1.94e-2)"	"unprognostic (1.78e-1)"	"unprognostic (6.50e-2)"	"unprognostic (5.86e-2)"	"unprognostic (2.66e-2)"	16.1	16.7	29.2	13.0	29.4	6.5	19.3	28.9	38.9	18.2	25.9	21.4	19.6	19.3	30.7	14.3	15.8	17.3	24.7	30.4	31.7	15.3	17.2	15.8	18.7	29.7	30.0	16.4	15.9	11.0	20.8	13.3	30.9	17.0	17.6	18.6	15.7	14.1	16.2	13.8	19.8	21.4	30.1	16.5	17.6	10.9	30.2	16.0	16.8	20.1	17.5	18.6	14.8	32.3	37.9	29.8	33.1	16.0	60.2	49.6	10.6	33.1	36.1	25.6	38.1	84.8	37.1	39.9	72.2	27.1	28.6	45.0	53.2	33.0	23.8	56.5	49.7	30.1	49.1	36.1	35.6	75.4	34.7	37.9	38.3	38.6	47.0	41.1	38.6	49.5	72.5	31.2	58.8	47.9	29.4	91.3	36.1	129.6	50.1	25.0	25.4	33.6	49.5	42.1	30.8	19.1	31.2	24.9	31.9	42.5	50.1	45.4	20.5	38.2	26.5	96.9	35.4	14.6	91.1	47.7	19.4	60.4	20.6	21.5	15.6	7.9	19.0	18.2	24.8	18.3	23.4	23.5	20.1	17.7	23.3	23.4	5.9	23.4	14.5	18.4	25.9	15.9	29.2	29.4	28.9	38.9	30.4	31.7	29.7	30.0	30.9	30.1	30.2	32.3	44.9	22.4	40.7	16.6	34.6	26.1	32.2	80.8	22.8	32.5	36.8	31.1	87.3	54.3	57.2	40.5	14.6	41.0	54.2	33.6	168.3	76.0	5.4	27.2	39.2	46.1	34.6	34.5	19.3	49.0	54.5	45.1	15.8	25.8	42.5	27.8	42.5	43.6	84.1	23.5	20.1	41.3	81.4	47.4	44.6	8.3	66.5	43.5	72.9	9.4	48.8	79.0	80.3	20.6	29.7	51.5	52.8	88.4	22.4	35.3	56.5	162.9	51.3	31.2	39.5	30.0	43.8	34.4	46.8	23.1	36.9	25.2	49.7	45.4	52.0	45.4
TMEM130	"DKFZp761L1417, FLJ42643"	ENSG00000166448	"Transmembrane protein 130"	Q8N3G9	7	98846488-98870771	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"adrenal gland: 37.1;brain: 141.0;pituitary gland: 100.3;testis: 37.4"	"Group enriched"	"Detected in some"	4	"Bipolar cells: 51.2;Excitatory neurons: 43.8;Inhibitory neurons: 53.9"	"Cancer enhanced"	"Detected in many"		"renal cancer: 9.1"	"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in single"		"neutrophil: 1.6"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 1.6"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 6.7;EFO-21: 6.4;GAMG: 6.9;hTERT-RPE1: 11.0;NTERA-2: 3.8;SH-SY5Y: 7.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA012928	Uncertain		Supported	"Golgi apparatus"		NA	NA		9400	"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 56: Bipolar cells - Visual perception"	"Golgi apparatus"		"HPA012928: AB_1858085"	"unprognostic (1.36e-2)"	"unprognostic (1.33e-3)"	"unprognostic (3.85e-2)"	"unprognostic (1.56e-2)"	"unprognostic (3.61e-3)"	"unprognostic (3.23e-2)"	"unprognostic (2.97e-1)"	"prognostic favorable (7.84e-4)"	"unprognostic (1.07e-2)"	"unprognostic (1.17e-2)"	"unprognostic (4.69e-2)"	"unprognostic (5.65e-2)"	"unprognostic (1.86e-3)"	"unprognostic (7.90e-3)"	"unprognostic (1.22e-1)"	"unprognostic (1.17e-2)"	"unprognostic (1.73e-1)"	0.5	37.1	63.7	1.5	64.2	0.6	1.2	0.0	116.6	3.2	0.0	3.9	0.8	1.1	9.4	1.6	1.0	1.8	0.6	67.3	141.0	3.4	0.1	6.2	2.3	11.6	8.2	0.9	0.8	2.7	100.3	0.5	17.0	2.4	1.2	17.9	0.4	6.7	2.0	0.4	1.5	0.8	7.2	0.7	1.4	37.4	55.7	1.8	0.5	0.1	0.3	0.9	4.9	42.4	0.0	0.6	0.0	0.0	0.2	0.0	0.3	2.9	6.7	0.5	0.4	0.1	0.1	0.1	6.4	1.7	6.9	0.1	0.0	0.0	0.1	0.2	0.3	0.1	0.3	0.1	0.0	0.0	0.6	0.1	0.0	0.0	0.0	11.0	0.3	0.2	0.1	0.4	0.3	0.5	0.1	0.2	3.8	0.0	0.2	0.1	0.0	0.6	0.0	0.1	0.4	7.8	0.1	0.1	0.0	2.5	0.0	0.0	0.0	0.0	0.5	0.0	0.2	0.3	0.2	0.1	0.4	0.4	0.2	0.8	0.2	0.2	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.2	0.2	0.2	1.6	0.3	0.2	0.2	0.1	0.1	63.7	64.2	0.0	116.6	67.3	141.0	11.6	8.2	17.0	7.2	55.7	42.4	0.1	0.0	0.0	2.6	0.0	0.4	0.4	0.1	0.0	51.2	0.3	0.4	1.0	1.5	2.0	1.8	2.1	0.1	1.5	0.1	0.0	0.0	1.6	0.1	0.2	0.5	0.0	0.0	43.8	0.2	0.1	2.1	0.0	0.2	0.0	0.5	0.7	0.0	0.1	0.0	53.9	0.0	2.0	0.0	1.2	2.7	0.9	0.3	0.0	3.7	0.0	1.7	0.0	11.6	4.2	0.0	0.0	6.8	0.0	0.3	0.2	0.1	0.3	4.3	0.0	0.6	0.8	0.6	0.6	0.0	0.3	0.3	0.2	0.0	0.1	0.2
TMEM134	FLJ21749	ENSG00000172663	"Transmembrane protein 134"	Q9H6X4	11	67461710-67469272	"Predicted membrane proteins, Transporters"	"Host-virus interaction"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043744	Approved		Supported	Cytosol		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	Cytosol		"HPA043744: AB_10794773"	"unprognostic (1.44e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.22e-1)"	"unprognostic (4.67e-2)"	"unprognostic (8.66e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.10e-1)"	"unprognostic (7.22e-2)"	"unprognostic (3.85e-1)"	"unprognostic (1.39e-2)"	"unprognostic (4.30e-2)"	"unprognostic (3.48e-1)"	"unprognostic (1.75e-1)"	"unprognostic (3.12e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.30e-2)"	"unprognostic (4.43e-3)"	12.6	24.3	22.5	8.6	23.2	4.7	14.8	21.2	29.9	15.6	19.9	14.0	8.3	9.6	11.0	55.5	10.2	6.5	46.8	21.6	22.2	25.2	33.9	11.2	11.9	22.8	22.6	8.6	42.9	7.9	8.7	5.3	22.4	25.7	4.5	2.8	20.6	7.3	57.4	57.5	14.5	4.4	22.7	16.2	22.4	26.5	22.9	6.6	13.5	26.0	8.8	15.9	25.4	22.5	12.3	4.6	6.5	14.0	4.3	7.3	7.2	2.5	4.6	2.9	1.2	5.8	14.3	11.7	27.2	6.2	9.2	10.0	2.9	10.7	1.8	11.3	4.9	2.2	4.5	5.9	6.6	2.3	3.2	7.3	13.4	2.3	7.7	12.7	3.0	7.9	3.0	6.6	6.3	29.0	13.3	8.6	11.0	20.4	16.3	6.5	3.8	38.5	11.3	12.5	6.0	13.3	9.1	14.2	28.6	4.4	34.5	2.3	5.8	10.4	9.0	12.5	3.3	27.8	19.4	8.2	15.6	3.0	8.5	58.2	54.3	98.5	71.4	132.7	78.8	203.7	84.2	80.6	66.6	195.7	85.6	80.6	25.7	90.2	176.0	87.3	123.9	73.3	22.5	23.2	21.2	29.9	21.6	22.2	22.8	22.6	22.4	22.7	22.9	22.5	43.3	16.0	41.5	11.8	83.0	90.0	87.7	177.7	99.0	29.3	139.9	173.4	53.4	60.1	93.5	68.0	10.4	69.5	46.5	64.7	133.1	95.0	50.2	53.0	35.3	36.6	71.4	22.3	9.4	126.0	147.9	31.3	120.3	73.4	23.4	52.5	29.3	69.6	84.0	11.8	8.2	100.3	97.6	43.6	49.3	46.2	20.8	49.0	110.3	2.8	61.2	39.5	63.8	9.5	14.1	189.9	81.7	24.8	47.2	142.6	150.8	148.9	75.0	29.5	6.6	24.4	45.9	105.8	80.1	185.1	180.1	72.8	53.3	37.6	73.5	152.2
TMEM135	FLJ22104	ENSG00000166575	"Transmembrane protein 135"	Q86UB9	11	87037844-87328824	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Astrocytes: 121.8;Excitatory neurons: 99.6;Inhibitory neurons: 93.7;Oligodendrocyte precursor cells: 123.1;Oligodendrocytes: 202.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Hep G2: 88.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA056685, HPA069473"	Uncertain		Supported	Vesicles		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Vesicles		"HPA056685: AB_2683208, HPA069473: AB_2686139"	"unprognostic (1.55e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.70e-2)"	"unprognostic (6.51e-2)"	"unprognostic (3.10e-2)"	"unprognostic (4.42e-1)"	"unprognostic (1.45e-2)"	"unprognostic (2.63e-1)"	"unprognostic (2.19e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.26e-1)"	"unprognostic (1.65e-1)"	"prognostic favorable (9.02e-4)"	"unprognostic (3.48e-2)"	"unprognostic (7.34e-2)"	"unprognostic (1.35e-2)"	"unprognostic (1.80e-1)"	26.1	14.9	4.2	5.6	6.0	3.7	14.2	2.8	5.2	5.6	5.8	10.5	15.6	6.4	4.7	4.4	6.0	8.3	6.7	4.9	5.2	12.0	24.7	6.5	5.9	5.0	5.8	7.3	6.2	9.4	5.4	10.2	5.6	10.7	8.5	7.0	10.0	6.4	8.4	3.9	14.5	6.9	2.5	5.8	7.4	10.2	4.3	6.6	10.1	7.5	4.8	5.5	4.4	6.7	8.8	15.7	9.8	13.7	31.3	28.6	9.2	6.5	16.7	7.6	17.0	27.1	39.9	24.2	17.1	8.9	19.9	8.3	13.3	14.9	8.5	22.7	7.5	18.5	14.0	88.5	17.6	10.8	9.2	34.8	9.2	11.0	7.6	10.2	19.5	26.4	19.3	35.9	9.0	5.9	28.3	10.8	11.5	47.2	11.7	12.5	7.5	19.2	17.5	28.1	4.8	11.0	9.6	30.0	13.6	18.8	42.0	9.6	10.3	7.9	10.3	30.6	4.6	13.4	28.2	28.2	6.0	11.5	15.7	0.9	4.8	1.4	7.5	5.1	6.7	4.7	4.7	8.1	5.6	3.4	5.3	5.1	1.5	7.2	2.2	5.7	5.4	4.1	4.2	6.0	2.8	5.2	4.9	5.2	5.0	5.8	5.6	2.5	4.3	6.7	14.4	9.6	7.5	121.8	7.1	4.2	4.0	4.6	8.6	5.6	12.7	7.1	6.3	5.7	6.8	1.8	4.2	2.6	7.7	10.5	5.9	2.8	2.8	5.8	11.0	8.1	3.6	3.8	99.6	3.2	8.6	11.0	8.6	4.2	9.5	11.5	7.9	16.2	4.9	1.7	93.7	6.8	10.2	7.8	6.0	7.7	7.2	5.4	5.4	48.7	4.1	5.0	9.2	123.1	202.4	3.1	10.9	7.2	10.3	6.1	21.8	10.6	8.7	4.2	32.9	5.7	8.4	2.2	3.8	4.8	4.8	1.5	8.3	24.6	8.7	3.8
TMEM141	MGC14141	ENSG00000244187	"Transmembrane protein 141"	Q96I45	9	136791344-136793317	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal enterocytes: 580.8;Distal tubular cells: 626.1;Intestinal goblet cells: 547.5;Paneth cells: 682.0;Proximal enterocytes: 633.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"OE19: 228.2;T-47d: 221.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014615, HPA050244"	Approved		Supported	"Cell Junctions,Mitochondria"		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 37: Intestine - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Mitochondria	"Cell Junctions"	"HPA014615: AB_2204756, HPA050244: AB_2681061"	"unprognostic (2.05e-1)"	"unprognostic (1.88e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.14e-1)"	"unprognostic (2.00e-1)"	"unprognostic (8.53e-3)"	"unprognostic (1.52e-2)"	"unprognostic (3.15e-2)"	"unprognostic (2.38e-1)"	"unprognostic (1.94e-2)"	"unprognostic (2.24e-1)"	"unprognostic (8.45e-2)"	"prognostic favorable (6.63e-4)"	"unprognostic (1.49e-1)"	"unprognostic (2.77e-1)"	"unprognostic (2.10e-1)"	"unprognostic (1.70e-1)"	32.7	44.1	37.9	23.3	40.1	40.2	48.7	43.8	42.6	36.4	39.7	120.5	48.4	25.2	63.6	109.6	48.2	27.9	74.0	36.8	41.3	116.8	134.7	39.3	21.1	42.1	40.2	33.4	74.0	83.0	62.2	41.9	44.4	132.3	112.2	12.2	61.5	28.5	38.1	68.7	60.6	22.4	40.0	38.7	76.2	33.1	41.1	29.8	66.3	35.8	26.4	39.2	49.5	44.1	55.0	35.9	34.9	21.1	42.2	34.1	69.9	30.8	47.4	35.9	29.0	47.9	47.5	53.4	44.1	32.5	32.0	78.2	14.0	87.8	11.6	38.7	27.5	30.4	18.0	52.3	60.8	31.1	35.5	33.1	146.4	26.7	79.0	42.3	54.6	67.4	28.9	26.7	48.2	102.0	42.0	21.2	16.7	228.2	43.8	34.6	37.6	156.1	82.1	28.4	55.3	25.7	32.9	125.7	35.1	27.1	221.4	28.9	38.5	24.6	19.9	46.3	19.5	17.0	29.7	28.2	39.9	44.2	37.2	19.5	29.5	20.4	23.1	44.2	20.6	18.2	15.1	16.0	24.1	23.0	20.6	19.5	7.3	29.9	37.4	90.6	16.4	29.1	37.9	40.1	43.8	42.6	36.8	41.3	42.1	40.2	44.4	40.0	41.1	44.1	62.0	57.7	79.0	6.5	39.6	40.7	99.3	120.5	55.2	13.8	128.7	152.9	42.3	124.4	100.9	117.7	8.4	182.4	64.0	580.8	626.1	179.2	48.4	80.1	50.4	48.5	206.9	53.6	8.2	78.5	141.7	59.1	76.5	148.2	41.8	67.5	56.0	171.7	148.5	5.0	6.4	547.5	109.9	61.6	29.8	134.9	37.6	53.7	85.4	2.8	85.7	61.1	78.2	2.5	11.7	90.1	682.0	29.7	34.8	193.7	633.0	459.2	60.9	30.0	46.0	32.4	46.9	57.2	53.5	156.7	62.8	274.3	42.7	65.1	460.1	125.9
TMEM192	FLJ38482	ENSG00000170088	"Transmembrane protein 192"	Q8IY95	4	165070608-165208549	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014717, HPA024110"	Enhanced		Supported	Nucleoplasm,Endosomes,Lysosomes		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 81: Kidney & Liver - Metabolism"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	"Endosomes, Lysosomes"	Nucleoplasm	"HPA014717: AB_1844373, HPA024110: AB_2204898"	"prognostic unfavorable (9.52e-4)"	"unprognostic (5.38e-3)"	"unprognostic (9.16e-2)"	"unprognostic (4.39e-2)"	"unprognostic (2.60e-2)"	"unprognostic (1.55e-2)"	"unprognostic (2.91e-3)"	"unprognostic (8.43e-2)"	"unprognostic (2.83e-2)"	"unprognostic (3.10e-1)"	"unprognostic (3.27e-2)"	"unprognostic (5.06e-2)"	"prognostic favorable (2.33e-14)"	"unprognostic (2.09e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.76e-2)"	"unprognostic (9.30e-2)"	12.0	15.2	4.9	7.2	5.9	6.6	13.2	7.5	7.0	9.9	7.1	11.5	9.7	10.5	9.0	8.8	11.2	10.3	12.6	4.8	5.2	48.3	45.2	10.6	8.9	4.7	5.5	24.5	22.3	24.6	5.1	10.8	5.0	22.1	13.3	10.7	14.5	8.4	15.0	5.4	9.3	8.6	4.6	9.1	10.5	9.8	4.8	6.6	26.8	17.0	7.7	8.5	5.4	6.2	13.5	19.9	7.1	18.0	18.1	6.4	16.5	20.1	29.4	20.5	22.8	11.7	21.6	29.5	11.7	13.0	33.4	11.8	26.8	20.6	23.6	19.2	13.8	16.4	14.1	13.4	46.1	41.0	21.2	23.3	42.8	18.4	37.4	17.8	17.0	15.6	28.4	48.1	25.4	29.4	7.1	12.0	14.8	28.1	16.9	16.0	6.2	27.1	16.4	19.6	15.2	15.9	31.4	49.1	31.9	10.4	23.9	18.5	12.6	9.0	11.1	28.6	23.0	46.9	67.0	40.8	21.6	22.2	36.6	2.9	16.6	4.8	12.1	14.9	16.3	26.7	9.4	12.6	15.7	20.2	10.4	12.6	1.7	18.7	8.3	16.3	8.5	10.7	4.9	5.9	7.5	7.0	4.8	5.2	4.7	5.5	5.0	4.6	4.8	6.2	12.3	32.1	36.2	18.9	24.0	9.7	18.4	10.5	10.2	33.0	21.5	15.7	35.0	42.9	19.1	55.2	16.7	31.4	15.4	17.0	11.7	21.0	26.4	11.2	17.0	19.0	21.7	10.1	16.4	25.8	20.5	18.9	7.7	15.5	40.4	26.1	27.8	77.7	38.2	37.0	16.5	18.2	6.1	27.4	17.7	11.1	39.7	22.3	28.4	11.2	21.3	35.8	28.8	14.6	20.9	11.5	14.3	33.4	11.8	33.7	26.3	63.4	10.9	27.1	6.6	30.7	20.7	17.8	18.3	12.0	12.9	33.7	15.9	27.1	24.0	14.2
TMEM201	"Ima1, NET5, RP13-15M17.2, SAMP1"	ENSG00000188807	"Transmembrane protein 201"	Q5SNT2	1	9588911-9614877	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 43.2"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 27.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"plasmacytoid DC: 1.3"	"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB039039	Approved		Supported	"Nucleoplasm,Nuclear membrane"		NA	NA			"Cluster 29: Plasmacytoid DCs - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 9: Photoreceptor cells - Phototransduction"	"Nuclear membrane"	Nucleoplasm	"CAB039039: "	"unprognostic (1.75e-2)"	"prognostic favorable (5.36e-4)"	"unprognostic (1.89e-1)"	"unprognostic (1.80e-1)"	"unprognostic (4.88e-1)"	"unprognostic (1.27e-2)"	"prognostic unfavorable (9.61e-8)"	"unprognostic (2.22e-1)"	"unprognostic (3.60e-1)"	"unprognostic (3.87e-2)"	"unprognostic (5.59e-3)"	"unprognostic (1.63e-1)"	"unprognostic (9.38e-2)"	"unprognostic (3.87e-2)"	"unprognostic (6.25e-2)"	"unprognostic (7.99e-2)"	"unprognostic (1.45e-1)"	5.8	6.1	8.6	3.6	8.9	7.7	5.2	7.9	9.7	7.5	6.8	5.7	3.2	7.3	2.0	7.0	6.3	2.2	14.5	9.4	8.4	9.5	3.4	4.0	3.2	10.8	9.7	9.4	6.1	4.4	16.0	2.5	9.5	6.4	1.3	6.1	5.5	2.9	43.2	6.4	4.7	2.7	7.9	5.4	4.6	10.4	9.6	3.2	5.5	24.3	2.0	5.2	5.5	8.3	13.6	18.2	11.1	26.3	4.6	3.1	9.9	15.7	4.8	18.3	12.9	33.1	12.0	23.5	19.4	5.5	9.0	27.9	12.4	12.4	6.2	15.7	31.2	16.7	17.4	17.0	8.4	20.4	16.6	5.7	5.5	24.6	3.9	3.9	7.3	10.9	21.7	6.6	7.5	16.0	17.8	14.8	11.2	10.3	16.4	37.1	19.0	19.3	6.6	7.3	26.6	19.9	12.3	29.9	13.5	3.8	9.1	12.7	6.7	21.7	18.8	24.0	30.0	11.0	9.9	21.0	15.0	33.0	19.6	0.0	0.2	0.0	0.3	0.2	0.1	0.5	0.3	0.5	0.3	0.2	0.2	0.2	0.0	0.1	0.1	1.3	0.5	0.3	8.6	8.9	7.9	9.7	9.4	8.4	10.8	9.7	9.5	7.9	9.6	8.3	5.2	3.2	2.0	4.9	2.2	7.0	2.5	1.8	4.6	16.0	5.3	4.7	12.1	2.8	2.1	0.0	27.1	4.1	0.8	2.6	1.9	2.3	2.0	4.2	4.9	4.9	6.7	5.2	4.1	1.0	2.5	4.0	2.6	4.4	4.5	11.7	3.6	1.6	3.6	10.1	6.0	3.7	2.0	2.5	3.5	1.8	4.1	2.4	3.6	0.0	0.9	5.0	1.0	7.1	5.9	1.7	0.9	4.5	2.8	3.2	0.6	1.9	2.4	16.9	0.0	7.3	4.2	6.8	5.4	7.9	5.5	0.8	2.8	4.6	4.3	2.3
TMEM214	FLJ20254	ENSG00000119777	"Transmembrane protein 214"	Q6NUQ4	2	27032910-27041694	"Predicted intracellular proteins, Predicted membrane proteins"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA034551			Supported	"Endoplasmic reticulum,Golgi apparatus,Cytosol"		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 55: Plasma cells - Humoral immune response"	"Endoplasmic reticulum, Golgi apparatus, Cytosol"		"HPA034551: AB_10602481"	"unprognostic (1.09e-1)"	"unprognostic (1.10e-1)"	"unprognostic (3.10e-1)"	"unprognostic (4.12e-3)"	"unprognostic (1.90e-2)"	"unprognostic (2.42e-2)"	"prognostic unfavorable (4.96e-4)"	"unprognostic (1.96e-1)"	"unprognostic (3.70e-1)"	"unprognostic (2.40e-1)"	"unprognostic (1.96e-1)"	"unprognostic (2.74e-2)"	"prognostic unfavorable (2.39e-10)"	"unprognostic (1.54e-2)"	"unprognostic (1.97e-2)"	"unprognostic (2.04e-1)"	"unprognostic (2.92e-2)"	45.8	39.0	14.7	30.8	15.8	23.1	43.2	15.3	17.3	45.0	28.7	38.3	30.5	43.7	66.2	31.5	37.5	30.7	36.7	14.8	17.0	30.0	46.5	37.7	25.1	19.1	18.7	41.4	79.9	56.0	60.4	45.8	18.3	37.9	41.7	8.8	83.6	44.4	35.7	37.8	33.6	45.1	15.6	37.4	40.8	19.5	17.8	21.7	42.3	21.3	34.4	36.7	33.9	14.9	82.4	53.5	32.2	68.2	102.8	103.7	69.4	105.9	142.4	76.0	85.2	53.0	67.3	37.6	52.4	156.6	59.7	57.6	39.3	74.9	61.0	36.3	44.1	49.9	41.4	109.8	128.1	45.7	82.5	90.4	52.7	66.8	112.0	58.6	83.5	24.3	46.0	75.3	85.9	59.6	23.3	34.1	23.1	110.0	42.8	31.3	58.5	91.0	57.1	57.0	27.8	32.3	49.4	83.3	38.2	31.0	45.9	27.0	72.4	55.2	52.8	57.0	60.4	100.9	73.3	59.2	71.1	56.8	77.9	5.7	3.5	2.8	3.9	3.8	5.0	2.5	3.0	2.8	2.8	2.8	1.5	2.1	0.6	5.6	2.2	5.0	2.6	2.5	14.7	15.8	15.3	17.3	14.8	17.0	19.1	18.7	18.3	15.6	17.8	14.9	15.8	3.2	20.1	3.9	18.5	7.6	9.6	10.4	3.4	9.3	19.8	11.0	8.2	21.5	15.0	14.7	10.4	43.6	15.0	37.5	1.9	24.7	6.4	11.3	25.4	17.5	17.9	18.5	4.8	34.6	62.9	26.9	33.1	23.8	14.5	17.0	32.5	28.9	27.3	6.7	4.4	37.6	10.2	18.9	12.8	7.8	32.6	11.7	5.4	6.5	14.6	6.9	14.4	4.0	3.8	21.7	22.3	20.3	63.0	20.8	25.4	10.4	11.0	8.4	26.3	11.6	19.6	24.4	12.7	8.4	9.2	71.7	12.0	17.6	27.6	15.8
TMEM215		ENSG00000188133	"Transmembrane protein 215"	Q68D42	9	32783540-32789201	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in some"		"brain: 6.9;retina: 18.3;testis: 3.9"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 572.0;Early spermatids: 129.9;Late spermatids: 302.1"	"Cancer enriched"	"Detected in single"	14	"thyroid cancer: 4.9"	"Region enriched"	"Detected in many"	4	"thalamus: 6.9"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"NTERA-2: 1.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA052804, HPA063207"			Supported	"Nucleoplasm,Endoplasmic reticulum,Vesicles"		NA	NA				"Cluster 77: Retina - Visual perception"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 56: Bipolar cells - Visual perception"	Nucleoplasm	"Endoplasmic reticulum, Vesicles"	"HPA052804: AB_2681957, HPA063207: AB_2732697"	"unprognostic (1.31e-2)"	"unprognostic (4.57e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.92e-2)"	"unprognostic (5.85e-2)"	"unprognostic (4.38e-3)"		"unprognostic (2.17e-3)"	"unprognostic (2.82e-1)"	"unprognostic (2.72e-1)"	"unprognostic (2.64e-1)"	"unprognostic (3.83e-2)"		"unprognostic (1.23e-1)"	"unprognostic (1.54e-1)"	"unprognostic (2.32e-2)"		0.0	0.0	1.2	0.0	0.9	0.0	0.0	0.0	0.5	0.5	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.7	1.5	0.0	0.0	0.0	0.0	0.2	1.6	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	18.3	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	3.9	6.9	0.0	0.9	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.9	0.0	0.5	0.7	1.5	0.2	1.6	0.3	0.3	6.9	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	572.0	0.0	0.0	0.2	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	129.9	0.0	1.2	0.4	0.0	0.0	0.3	0.0	0.0	0.5	0.0	0.0	0.0	3.7	0.0	0.0	0.1	1.7	0.3	0.0	0.0	0.0	0.0	302.1	2.8	0.1	0.0	0.0	0.0	9.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	25.9	0.0	0.0	0.1	3.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TMEM250	"bA83N9.1, C9orf69"	ENSG00000238227	"Transmembrane protein 250"	H0YL14	9	136114581-136118875	"Predicted intracellular proteins, Predicted membrane proteins"	"Cell cycle, Host-virus interaction"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 17.1;Extravillous trophoblasts: 21.3;Pancreatic endocrine cells: 15.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA066070	Supported		Supported	Nucleoplasm		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 47: Non-specific - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm		"HPA066070: AB_2685608"	"unprognostic (2.79e-2)"	"unprognostic (3.47e-1)"	"unprognostic (1.34e-2)"	"prognostic favorable (1.09e-4)"	"unprognostic (4.99e-2)"	"unprognostic (2.34e-2)"	"unprognostic (4.34e-2)"	"unprognostic (1.27e-3)"	"unprognostic (2.41e-1)"	"unprognostic (1.48e-1)"	"unprognostic (6.31e-2)"	"unprognostic (2.66e-1)"	"unprognostic (1.99e-2)"	"unprognostic (9.33e-3)"	"unprognostic (1.09e-2)"	"unprognostic (2.41e-2)"	"unprognostic (1.64e-1)"	14.9	14.0	18.6	11.6	18.6	4.3	13.5	14.1	20.2	12.8	10.0	20.0	16.7	14.3	7.3	29.1	12.2	6.9	17.4	19.5	12.0	16.3	21.7	13.1	11.4	15.6	13.8	13.2	13.2	8.2	11.9	10.4	16.4	14.7	8.0	2.9	14.0	8.5	28.5	20.8	17.1	7.7	13.3	16.8	15.6	13.0	16.7	8.7	11.0	10.4	8.9	19.5	15.0	16.0	24.9	46.2	17.7	26.5	24.7	22.4	54.9	29.2	20.7	17.3	12.3	26.4	35.5	18.3	33.3	31.5	27.6	62.2	12.6	20.6	5.4	78.8	24.1	15.4	48.3	18.7	34.2	28.2	19.2	20.2	38.8	18.8	19.6	22.3	27.9	18.0	35.1	18.9	15.3	57.3	34.6	22.7	39.2	43.4	49.6	14.0	24.5	30.5	19.0	17.9	30.4	23.1	31.5	21.6	26.4	10.4	19.7	42.1	31.6	30.2	13.3	39.8	32.9	11.0	11.3	10.9	30.4	19.9	29.0	4.3	2.9	1.8	6.2	4.2	4.5	1.8	4.7	5.2	3.0	1.3	2.2	4.1	3.4	3.5	4.2	1.9	2.6	2.1	18.6	18.6	14.1	20.2	19.5	12.0	15.6	13.8	16.4	13.3	16.7	16.0	11.9	6.4	7.3	0.0	1.9	0.0	0.0	0.0	0.0	0.0	12.9	11.9	0.0	0.0	1.3	14.7	0.0	17.1	15.2	0.0	3.9	13.1	0.0	9.8	12.6	6.0	0.0	0.0	0.0	10.6	21.3	5.1	0.0	7.0	2.5	14.0	0.0	0.0	14.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.2	0.0	0.0	3.6	0.0	0.0	0.0	0.0	15.8	0.0	0.0	1.3	0.0	0.0	13.2	1.5	0.0	0.0	0.0	6.3	0.0	0.0	0.0	0.0	7.8	5.5	11.5	0.0	0.0
TMEM266	"C15orf27, FLJ38190"	ENSG00000169758	"Transmembrane protein 266"	Q2M3C6	15	76059958-76229121	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"brain: 8.4;skeletal muscle: 5.8;tongue: 2.2"	"Cell type enhanced"	"Detected in some"		"Cone photoreceptor cells: 10.4;Cytotrophoblasts: 16.0;Early spermatids: 7.0;Late spermatids: 19.7;Rod photoreceptor cells: 9.1;Sertoli cells: 6.6;Spermatogonia: 6.3"	"Cancer enhanced"	"Detected in some"		"testis cancer: 2.3"	"Region enriched"	"Detected in many"	5	"cerebellum: 8.4"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"NTERA-2: 1.3"	"Region enriched"	"Detected in all"	6	"cerebellum: 58.7"	"Region enriched"	"Detected in many"	5	"cerebellum: 26.8"	"HPA041921, HPA049425"	Enhanced		Supported	"Plasma membrane,Cytosol"		NA	NA				"Cluster 54: Non-specific - Microtubule organization"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Plasma membrane, Cytosol"		"HPA041921: AB_10796789, HPA049425: AB_2732552"	"unprognostic (8.63e-3)"	"unprognostic (6.11e-3)"	"unprognostic (3.44e-3)"	"unprognostic (9.17e-5)"	"unprognostic (4.67e-1)"	"unprognostic (2.61e-2)"	"unprognostic (9.34e-3)"	"unprognostic (5.61e-2)"	"unprognostic (8.48e-3)"	"unprognostic (2.89e-2)"	"unprognostic (1.18e-2)"	"unprognostic (3.95e-2)"	"unprognostic (1.68e-3)"	"unprognostic (1.25e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.13e-2)"	"unprognostic (7.86e-2)"	0.0	0.9	0.9	0.0	1.0	0.0	0.1	8.4	1.7	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.9	0.5	0.0	0.5	0.1	0.6	0.8	0.0	1.1	0.0	1.2	0.9	0.7	0.1	0.0	1.1	0.0	0.0	5.8	0.5	0.0	0.0	0.5	0.1	0.0	0.6	1.4	0.3	0.0	2.2	0.1	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.1	0.2	0.0	0.6	0.9	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	1.0	8.4	1.7	1.2	0.9	0.6	0.8	0.7	0.5	1.4	0.8	0.2	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	4.3	0.5	0.5	0.0	0.0	0.0	1.8	10.4	16.0	0.0	0.0	1.9	0.0	7.0	0.2	0.1	0.4	0.0	0.0	0.0	0.2	2.2	0.9	1.5	0.1	0.0	0.2	0.4	0.4	4.5	1.7	0.0	0.0	0.0	0.3	0.0	19.7	0.0	0.4	0.0	0.0	0.0	0.5	1.0	0.0	0.0	0.1	0.0	0.7	0.0	1.0	0.0	0.7	1.5	9.1	6.6	1.3	0.2	0.5	6.3	0.0	0.0	5.9	0.2	0.5	0.0	0.7
TMEM35A	"FLJ14084, NACHO, TMEM35, TUF-1"	ENSG00000126950	"Transmembrane protein 35A"	Q53FP2	X	101078879-101096367	"Predicted membrane proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 71.9;intestine: 36.8;seminal vesicle: 50.9"	"Cell type enriched"	"Detected in some"	5	"Theca cells: 37.5"	"Cancer enhanced"	"Detected in many"		"glioma: 6.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC TERT1: 10.1;HUVEC TERT2: 52.5;SH-SY5Y: 13.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048583	Enhanced	Supported	Supported	"Vesicles,Focal adhesion sites,Cytosol"		NA	NA				"Cluster 57: Non-specific - Angiogenesis"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 52: Non-specific - Transcription"	Vesicles	"Focal adhesion sites, Cytosol"	"HPA048583: AB_2680451"	"unprognostic (7.98e-2)"	"unprognostic (7.22e-2)"	"unprognostic (1.21e-2)"	"unprognostic (1.35e-2)"	"unprognostic (3.02e-2)"	"unprognostic (3.89e-3)"	"unprognostic (2.77e-2)"	"unprognostic (6.66e-3)"	"unprognostic (1.05e-1)"	"unprognostic (3.34e-3)"	"unprognostic (9.20e-2)"	"unprognostic (4.72e-2)"	"unprognostic (3.49e-4)"	"unprognostic (5.91e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.48e-2)"	"unprognostic (9.37e-3)"	3.5	6.9	20.8	1.3	20.4	0.0	0.8	18.5	28.5	4.6	2.5	36.8	3.4	7.8	3.6	11.2	4.1	3.4	0.5	28.4	71.9	0.5	0.0	2.3	0.1	21.8	21.3	7.9	0.2	12.7	2.2	0.1	36.8	22.3	9.6	10.2	0.5	50.9	0.8	0.6	7.2	10.3	15.6	0.8	5.2	1.4	47.5	0.2	0.8	2.5	0.3	9.7	4.4	13.5	0.0	0.0	5.4	0.0	3.9	10.1	0.0	1.1	0.7	0.4	0.2	0.0	0.0	0.0	0.1	3.2	0.0	0.0	3.4	0.0	1.0	0.0	0.2	0.0	0.1	0.0	1.2	0.0	0.0	3.5	0.0	1.9	0.0	7.5	52.5	0.0	0.0	0.1	6.6	0.0	0.0	0.0	6.9	0.0	0.0	0.0	0.2	0.0	0.0	0.0	2.3	13.2	0.0	0.0	0.0	1.3	0.0	0.0	1.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.8	20.4	18.5	28.5	28.4	71.9	21.8	21.3	36.8	15.6	47.5	13.5	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.3	7.4	0.4	0.0	0.0	0.0	0.0	0.1	3.0	0.0	0.2	0.0	6.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.1	37.5	0.0	0.0
TMEM70	FLJ20533	ENSG00000175606	"Transmembrane protein 70"	Q9BUB7	8	73972437-73982783	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"			"Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"skeletal muscle: 100.7"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SK-BR-3: 78.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023187, CAB034226"	Approved		Supported	Nucleoplasm,Mitochondria		NA	Yes			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 33: Striated muscle - Muscle contraction"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Mitochondria	Nucleoplasm	"CAB034226: AB_2205189, HPA023187: AB_2671101"	"unprognostic (2.26e-3)"	"unprognostic (4.87e-1)"	"unprognostic (1.38e-2)"	"unprognostic (1.11e-2)"	"unprognostic (1.51e-3)"	"unprognostic (8.22e-3)"	"unprognostic (9.17e-2)"	"unprognostic (1.01e-1)"	"unprognostic (7.37e-2)"	"unprognostic (7.04e-2)"	"unprognostic (2.88e-2)"	"unprognostic (9.14e-2)"	"unprognostic (3.65e-3)"	"unprognostic (6.86e-2)"	"unprognostic (5.08e-2)"	"unprognostic (2.13e-1)"	"unprognostic (2.70e-2)"	18.1	18.2	9.2	9.8	9.7	10.4	11.3	10.5	12.3	8.0	9.5	12.6	5.8	8.9	10.6	9.3	11.3	8.9	19.3	10.3	10.2	12.0	24.4	9.0	10.1	9.6	9.1	10.5	25.0	8.3	7.6	10.3	10.1	7.4	9.7	6.1	9.9	5.9	100.7	7.7	9.5	9.1	9.5	9.6	17.8	9.8	9.5	11.0	6.0	20.5	10.3	11.3	7.4	10.1	21.2	16.4	13.1	13.8	14.9	12.7	13.6	17.6	15.8	19.4	15.3	15.8	11.9	28.4	15.0	12.0	16.4	19.1	24.9	16.8	21.4	18.9	17.5	28.3	10.0	21.2	14.7	15.5	14.5	11.8	15.3	12.2	6.4	7.3	16.4	14.2	22.0	13.5	20.5	15.9	35.8	29.6	12.3	26.6	20.6	25.4	12.8	24.2	20.5	20.0	29.7	13.1	11.0	78.0	23.3	10.2	16.0	14.1	10.6	11.1	13.7	20.7	16.9	19.9	18.7	28.1	16.4	12.1	12.5	6.3	9.1	6.7	8.0	10.2	9.1	17.7	9.0	9.3	9.6	10.9	10.3	9.6	6.7	5.8	7.9	11.0	7.9	12.0	9.2	9.7	10.5	12.3	10.3	10.2	9.6	9.1	10.1	9.5	9.5	10.1	136.2	16.0	30.1	5.5	37.1	67.3	43.7	54.8	24.5	23.9	26.2	22.2	46.3	14.3	35.7	22.0	8.4	71.2	48.1	69.0	66.5	36.6	20.3	40.8	26.2	96.4	13.8	26.5	12.8	63.5	59.6	50.2	17.3	17.1	39.9	17.0	28.5	50.3	132.4	10.1	11.4	31.7	42.7	70.0	74.5	12.1	29.8	73.2	40.9	5.6	38.9	23.1	22.6	3.5	8.1	43.6	37.9	29.0	68.6	42.1	28.8	75.4	58.7	17.5	39.5	61.9	40.8	70.6	29.5	21.5	59.7	70.3	39.8	52.6	34.1	26.2
TMEM87A	DKFZP564G2022	ENSG00000103978	"Transmembrane protein 87A"	Q8NBN3	15	42210447-42273584	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Alveolar cells type 2: 264.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018104, HPA018189"	Enhanced		Supported	"Golgi apparatus"	"Intracellular and membrane"	NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 11: Alveolar cells - Smell perception"	"Golgi apparatus"		"HPA018104: AB_1858135, HPA018189: AB_2205198"	"unprognostic (7.07e-2)"	"unprognostic (1.62e-2)"	"unprognostic (2.19e-1)"	"unprognostic (4.05e-2)"	"unprognostic (2.49e-1)"	"unprognostic (6.39e-3)"	"unprognostic (1.19e-2)"	"unprognostic (2.44e-1)"	"unprognostic (2.95e-1)"	"unprognostic (8.13e-3)"	"unprognostic (4.31e-3)"	"unprognostic (1.38e-1)"	"unprognostic (3.41e-2)"	"unprognostic (7.90e-2)"	"unprognostic (2.19e-1)"	"unprognostic (5.49e-3)"	"unprognostic (3.63e-1)"	31.8	26.3	23.7	26.1	37.7	88.2	97.7	32.0	29.5	40.2	17.7	56.5	26.6	38.6	49.3	48.2	45.3	32.4	19.7	23.5	26.3	27.1	24.5	72.8	25.4	36.7	29.4	35.4	34.9	47.9	14.2	42.7	38.7	79.8	60.9	26.1	64.7	36.6	24.9	50.2	26.9	38.0	32.5	23.1	38.6	33.0	28.8	24.8	75.9	22.2	30.9	42.0	34.3	59.1	41.0	20.5	30.5	27.0	58.5	50.3	47.7	55.1	82.0	53.5	52.0	29.8	87.5	17.4	52.9	59.9	60.5	104.0	28.3	51.2	42.8	46.8	25.0	35.6	51.5	33.5	63.4	65.6	48.3	52.3	112.1	39.5	65.3	50.6	41.9	30.1	39.4	67.4	51.7	26.3	21.3	38.8	25.7	60.8	29.3	33.5	46.6	36.8	34.5	127.4	33.7	41.2	53.1	70.1	49.9	24.0	27.4	62.4	41.3	104.4	25.5	68.1	82.6	46.8	95.0	36.5	40.1	47.9	66.8	58.3	26.9	31.2	29.0	32.3	33.3	27.6	35.6	34.0	24.4	24.4	33.6	33.5	15.2	42.4	34.7	22.4	42.2	26.0	23.7	37.7	32.0	29.5	23.5	26.3	36.7	29.4	38.7	32.5	28.8	59.1	66.2	125.0	264.0	46.0	48.9	68.6	90.2	78.8	58.1	31.2	148.7	105.9	13.9	45.8	98.0	49.7	50.1	78.1	57.5	77.7	1.9	63.7	5.6	57.0	67.0	54.6	32.2	34.5	41.7	64.2	72.7	64.0	50.0	124.7	59.5	42.9	51.0	34.4	41.6	20.2	48.2	74.1	67.1	39.2	37.0	7.9	41.0	41.3	62.2	45.0	60.1	61.8	52.5	74.4	177.5	56.1	62.4	53.8	47.6	118.5	36.6	15.5	86.4	63.0	85.5	77.0	59.0	59.4	61.4	79.1	65.5	110.4	54.8	53.3	76.9	105.6
TMEM94	KIAA0195	ENSG00000177728	"Transmembrane protein 94"	Q12767	17	75441159-75500452	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"			"Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Bipolar cells: 43.0;Granulosa cells: 41.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008423, HPA050660"	Approved		Supported	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 40: Granulosa cells - Unknown function"	Nucleoplasm	"Nuclear bodies"	"HPA008423: AB_1852283, HPA050660: AB_2681207"	"unprognostic (4.05e-2)"	"unprognostic (3.43e-1)"	"unprognostic (5.78e-2)"	"unprognostic (4.32e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.32e-3)"	"unprognostic (1.70e-1)"	"unprognostic (1.42e-1)"	"unprognostic (7.27e-2)"	"prognostic favorable (2.26e-4)"	"unprognostic (9.71e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.21e-2)"	"unprognostic (3.33e-1)"	"unprognostic (1.44e-2)"	"unprognostic (4.96e-2)"	21.3	55.9	50.3	13.9	46.4	18.4	21.7	27.7	54.9	21.9	30.5	25.1	18.8	24.4	5.4	21.1	30.7	15.8	27.8	40.7	31.5	29.7	20.2	25.6	14.1	40.1	36.8	27.7	23.7	20.3	30.1	14.2	30.5	19.9	13.6	27.7	21.1	13.2	63.4	22.9	28.2	10.7	34.8	29.7	25.0	27.1	47.1	18.0	27.4	25.8	8.6	20.5	15.3	35.8	15.3	40.7	33.6	52.6	16.1	18.8	45.6	9.2	20.0	15.4	15.4	13.7	22.6	20.6	30.3	15.9	23.6	19.9	15.8	25.6	8.8	19.4	23.1	22.0	18.4	22.9	21.2	23.7	45.2	30.9	14.5	15.0	13.4	13.9	28.1	18.3	22.6	24.4	20.7	19.1	53.3	18.8	14.4	19.3	16.2	36.2	37.2	19.2	16.0	40.7	28.1	30.5	10.2	47.4	28.7	25.3	29.8	29.3	16.0	16.5	19.0	16.5	13.8	53.2	17.2	12.2	17.2	23.8	20.8	0.1	2.6	3.0	3.5	1.6	2.6	1.0	1.6	2.5	2.5	2.5	1.3	2.2	0.7	2.4	1.4	3.3	2.1	2.9	50.3	46.4	27.7	54.9	40.7	31.5	40.1	36.8	30.5	34.8	47.1	35.8	12.8	12.8	11.1	0.0	5.8	0.0	3.3	0.0	6.2	43.0	10.9	9.1	0.0	12.8	6.2	9.2	31.3	16.1	8.8	18.0	0.0	8.1	4.7	10.1	6.8	8.2	7.3	10.7	0.0	9.5	11.0	4.4	28.1	8.6	6.3	41.5	13.9	8.9	15.4	20.2	0.0	10.5	0.0	12.4	0.0	1.9	6.8	8.9	0.0	0.0	5.6	15.2	4.1	0.0	0.0	6.0	9.1	9.1	8.1	3.3	19.6	3.4	2.9	33.6	6.6	7.5	6.0	14.9	8.8	9.7	0.0	20.1	6.9	19.0	9.3	3.1
TMEM97	MAC30	ENSG00000109084	"Transmembrane protein 97"	Q5BJF2	17	28319200-28328685	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 113.4;pancreas: 322.0"	"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 121.5;Exocrine glandular cells: 196.4;Granulosa cells: 212.9;Hepatocytes: 226.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"CACO-2: 341.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044795, HPA076689"	Enhanced		Supported	"Endoplasmic reticulum"		NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 25: Pancreas - Digestion"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 40: Granulosa cells - Unknown function"	"Endoplasmic reticulum"		"HPA044795: AB_10959306, HPA076689: "	"unprognostic (1.35e-2)"	"unprognostic (2.70e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.10e-3)"	"unprognostic (1.81e-1)"	"unprognostic (4.34e-2)"	"unprognostic (3.20e-2)"	"unprognostic (9.03e-2)"	"unprognostic (1.04e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.11e-2)"	"unprognostic (5.17e-2)"	"prognostic unfavorable (1.24e-4)"	"unprognostic (1.08e-1)"	"unprognostic (2.26e-1)"	"unprognostic (1.99e-1)"	"unprognostic (4.01e-2)"	4.3	26.0	5.2	7.3	6.3	6.7	11.7	6.6	9.0	5.7	6.5	14.3	16.4	6.7	4.7	7.4	13.1	10.2	3.4	6.3	5.4	7.1	113.4	17.4	7.1	14.9	14.2	18.1	322.0	6.5	1.6	6.8	14.9	10.8	12.6	6.3	3.7	3.3	15.5	9.8	11.2	5.7	5.0	4.6	38.8	58.0	7.4	7.6	4.2	9.1	8.2	26.6	5.2	6.8	46.1	120.4	214.8	105.5	28.0	40.2	70.5	44.1	27.9	67.9	90.3	341.0	34.3	126.3	46.4	17.0	140.1	48.7	137.1	75.0	52.7	60.3	102.1	47.8	56.9	143.0	25.7	76.9	36.4	84.0	10.0	66.4	27.5	8.3	21.1	80.1	101.3	92.1	22.7	81.8	120.0	72.4	95.6	187.7	30.6	94.8	236.5	112.8	85.6	210.6	154.1	67.0	70.0	55.1	36.3	118.2	97.0	35.8	13.8	72.8	56.8	62.9	81.7	74.3	159.0	115.9	14.6	54.7	44.3	0.7	2.2	2.2	7.8	2.7	9.2	11.1	6.4	9.4	16.1	5.5	10.4	9.8	1.0	9.5	1.0	9.3	6.6	5.2	5.2	6.3	6.6	9.0	6.3	5.4	14.9	14.2	14.9	5.0	7.4	6.8	4.2	9.6	61.5	3.3	7.7	14.5	6.0	32.8	18.8	11.3	22.5	21.5	9.0	121.5	19.1	14.7	16.7	34.2	5.0	6.1	15.6	23.3	22.3	7.5	14.3	7.1	38.8	40.3	2.9	196.4	84.0	14.4	49.5	11.4	1.3	212.9	6.4	226.9	22.0	3.3	4.5	16.2	26.4	6.7	34.7	49.1	13.4	9.9	16.0	0.0	11.4	8.2	4.1	4.0	1.0	47.7	3.5	11.3	15.3	13.9	4.0	6.3	12.2	9.1	6.6	10.4	12.4	91.3	65.5	22.7	11.2	10.7	6.4	65.1	29.4	7.9
TMEM98	DKFZP564K1964	ENSG00000006042	"Transmembrane protein 98"	Q9Y2Y6	17	32927910-32945106	"Disease related genes, Human disease related genes, Predicted membrane proteins"			"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Proximal enterocytes: 250.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	11	"plasmacytoid DC: 4.1"	"Lineage enriched"	"Detected in single"	11	"dendritic cells: 4.1"	"Cell line enhanced"	"Detected in many"		"CACO-2: 277.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040473, HPA053385"	Uncertain		Supported	Nucleoplasm	"Intracellular and membrane"	NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm		"HPA040473: AB_10794876, HPA053385: AB_2682134"	"unprognostic (1.55e-2)"	"unprognostic (5.15e-2)"	"unprognostic (4.36e-3)"	"unprognostic (7.20e-2)"	"unprognostic (1.19e-1)"	"unprognostic (7.93e-2)"	"prognostic unfavorable (8.14e-4)"	"prognostic favorable (7.10e-4)"	"unprognostic (6.38e-2)"	"unprognostic (2.22e-1)"	"unprognostic (3.41e-1)"	"unprognostic (9.18e-3)"	"prognostic favorable (3.85e-4)"	"unprognostic (5.16e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.30e-2)"	"unprognostic (2.58e-1)"	56.3	50.6	48.9	17.3	84.1	4.7	44.5	75.3	64.1	68.6	161.9	90.0	102.5	100.4	74.2	27.9	96.5	93.9	44.3	51.2	56.9	36.5	27.5	58.1	5.7	72.8	77.4	191.9	88.5	53.7	23.9	28.2	69.7	80.7	96.3	15.7	50.1	23.9	5.3	24.6	118.4	62.3	51.9	19.6	101.6	20.7	75.0	4.4	47.7	14.6	7.7	50.7	42.6	109.3	7.4	27.2	115.5	0.2	154.7	138.0	1.1	114.2	153.2	59.2	126.5	277.6	8.1	1.6	1.7	144.0	2.1	0.9	74.2	30.1	34.5	24.7	92.0	4.6	0.1	124.5	71.5	0.3	1.7	116.3	29.7	74.7	12.1	31.6	154.8	40.7	78.1	0.3	162.9	0.2	0.1	0.7	77.0	83.1	42.0	0.2	108.4	0.5	13.6	49.0	9.8	158.3	2.7	0.0	89.8	72.6	36.5	0.2	128.2	83.8	78.1	1.0	0.2	9.2	3.8	0.1	42.9	0.1	46.2	0.3	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.3	0.0	0.1	0.0	0.0	0.2	0.1	0.0	4.1	0.0	0.1	48.9	84.1	75.3	64.1	51.2	56.9	72.8	77.4	69.7	51.9	75.0	109.3	7.6	41.7	24.8	6.2	0.6	25.1	76.1	111.5	27.3	1.4	32.4	104.5	14.1	72.9	61.0	46.0	0.0	8.1	0.7	109.2	5.9	81.0	18.2	14.7	48.5	7.8	97.9	2.7	0.6	66.4	7.3	127.2	40.8	12.1	3.8	87.8	29.6	13.0	5.7	0.0	0.3	145.7	40.7	0.6	15.9	14.9	120.5	2.0	44.4	1.9	0.0	106.3	0.0	3.0	173.0	88.2	97.9	151.6	0.2	68.1	250.9	37.2	54.6	4.8	65.7	22.1	55.5	40.7	27.7	17.1	12.6	7.1	2.4	132.6	166.6	68.6
TMF1	"ARA160, TMF"	ENSG00000144747	"TATA element modulatory factor 1"	P82094	3	69019827-69052339	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 508.1;Late spermatids: 544.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008729	Approved		Supported	"Golgi apparatus"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 34: Non-specific - Transcription"	"Cluster 18: U-2197 - ECM organization"	"Cluster 25: Spermatids - Spermatogenesis"	"Golgi apparatus"		"HPA008729: AB_1080310"	"unprognostic (2.71e-1)"	"unprognostic (2.11e-2)"	"unprognostic (8.02e-3)"	"unprognostic (7.19e-2)"	"unprognostic (2.74e-1)"	"unprognostic (6.75e-3)"	"unprognostic (6.73e-3)"	"unprognostic (1.79e-1)"	"unprognostic (4.62e-2)"	"unprognostic (2.37e-2)"	"unprognostic (1.08e-2)"	"unprognostic (2.83e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.03e-2)"	"unprognostic (1.80e-1)"	"unprognostic (3.51e-2)"	"unprognostic (1.01e-1)"	10.3	10.6	4.4	14.0	5.2	26.2	14.1	6.2	5.5	13.3	12.3	12.5	12.9	14.8	14.1	11.5	12.9	14.1	9.2	4.3	5.3	12.6	11.0	12.0	16.0	5.3	5.1	12.6	13.6	15.6	9.9	16.5	5.2	14.5	14.2	12.5	17.4	10.3	9.8	9.7	14.8	11.6	5.1	12.8	14.0	19.4	5.4	9.6	20.9	8.3	14.8	13.5	7.9	6.1	19.5	8.3	7.8	7.9	20.7	26.4	17.5	24.6	23.6	16.1	19.2	11.9	14.1	7.4	3.9	25.1	11.3	10.5	10.2	10.8	26.4	14.3	7.6	14.4	11.0	14.1	18.5	16.3	19.7	15.6	17.0	21.4	19.3	17.1	17.5	6.0	8.8	11.8	21.2	11.1	9.5	14.1	6.8	12.3	4.4	7.8	9.9	10.4	21.0	15.4	5.4	8.3	20.2	14.2	15.4	10.4	10.7	19.4	23.1	15.8	6.7	27.9	14.8	13.2	13.6	7.2	24.1	16.6	13.1	4.8	2.4	5.1	3.1	2.0	2.1	2.6	2.8	2.7	2.1	3.1	2.9	2.6	5.3	2.7	3.4	2.4	3.1	1.6	4.4	5.2	6.2	5.5	4.3	5.3	5.3	5.1	5.2	5.1	5.4	6.1	49.2	64.1	78.9	21.9	84.7	37.5	37.6	41.7	39.3	43.4	46.2	35.8	36.9	38.6	86.4	42.3	37.5	39.6	108.4	48.8	15.6	52.4	508.1	150.4	92.8	43.1	55.6	45.0	32.2	56.2	58.7	70.0	54.6	86.2	74.7	51.7	29.3	19.7	28.4	35.3	38.4	61.6	38.7	31.8	54.4	544.8	51.0	55.1	35.6	32.8	66.7	41.5	59.8	36.2	40.9	50.6	40.8	62.1	129.3	64.8	49.4	25.1	200.5	52.1	32.9	62.8	56.8	116.2	39.3	30.6	39.5	80.6	94.5	54.5	38.5	85.7
TMLHE	"BBOX2, FLJ10727, TMLH, XAP130"	ENSG00000185973	"Trimethyllysine hydroxylase, epsilon"	Q9NVH6	X	155489011-155719098	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Carnitine biosynthesis"	"Dioxygenase, Oxidoreductase"	"Autism, Autism spectrum disorder, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Microglial cells: 51.5;Oligodendrocyte precursor cells: 47.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			"HPA034589, HPA040331"	Approved		Supported	Mitochondria		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 68: Oligodendrocytes - Mixed function"	Mitochondria		"HPA034589: AB_10670571, HPA040331: AB_2676929"	"unprognostic (1.98e-1)"	"unprognostic (9.15e-2)"	"unprognostic (3.04e-1)"	"unprognostic (5.41e-2)"	"unprognostic (6.66e-3)"	"unprognostic (1.10e-3)"	"unprognostic (6.50e-2)"	"unprognostic (1.00e-1)"	"unprognostic (3.27e-1)"	"unprognostic (4.08e-2)"	"unprognostic (1.20e-3)"	"unprognostic (6.97e-2)"	"prognostic favorable (3.68e-6)"	"unprognostic (1.69e-1)"	"unprognostic (5.74e-2)"	"unprognostic (2.73e-1)"	"unprognostic (7.75e-2)"	11.7	10.2	7.1	6.6	7.4	8.4	11.3	9.0	8.0	11.3	8.1	11.6	11.8	9.4	10.4	10.3	9.9	8.0	25.3	6.7	7.7	16.7	18.8	5.6	7.0	8.5	8.2	12.0	9.5	18.9	5.4	8.4	8.5	6.6	12.5	10.9	12.7	9.7	32.0	5.9	11.2	12.3	8.3	8.7	9.1	2.9	7.3	8.9	10.5	33.4	7.6	8.2	6.6	9.8	25.0	11.9	9.8	28.6	11.8	18.1	0.0	9.9	14.6	12.3	32.4	8.7	13.9	0.0	38.9	17.6	28.2	13.4	21.2	9.7	13.9	10.3	14.3	11.3	19.5	10.2	16.4	10.5	7.6	19.5	20.0	13.6	20.8	18.2	19.5	15.5	15.8	9.0	20.5	9.3	12.8	11.8	3.0	21.6	0.1	12.7	15.5	9.4	15.0	8.5	9.2	13.7	9.3	0.5	11.2	10.5	10.6	11.9	16.5	10.3	9.7	20.4	12.4	11.0	12.6	9.6	12.4	16.4	9.6	3.4	12.6	14.7	4.6	14.9	3.5	8.1	5.0	3.9	13.1	10.6	6.5	5.7	18.2	6.2	21.5	6.1	5.5	5.8	7.1	7.4	9.0	8.0	6.7	7.7	8.5	8.2	8.5	8.3	7.3	9.8	6.7	0.0	2.3	27.1	10.1	5.2	12.1	14.4	9.6	4.0	5.2	7.5	7.2	7.2	9.7	9.2	0.0	8.8	6.5	7.9	23.5	10.7	0.0	6.8	7.4	6.2	6.1	14.3	22.2	7.6	6.8	10.2	9.2	7.3	10.1	8.1	4.2	12.0	12.4	0.0	29.5	7.3	4.1	16.1	10.4	0.5	8.4	12.1	12.4	51.5	13.1	7.6	10.3	47.7	25.5	8.5	7.3	5.7	5.6	4.3	17.4	17.0	9.5	5.4	0.0	5.9	9.5	0.3	2.5	7.6	4.1	6.7	8.0	10.5	6.5	11.0
TMPRSS2	PRSS10	ENSG00000184012	"Transmembrane serine protease 2"	O15393	21	41464300-41531116	"Cancer-related genes, Enzymes, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters"		"Hydrolase, Protease, Serine protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"prostate: 280.4;stomach 1: 146.2"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 404.8;Gastric mucus-secreting cells: 155.4;Paneth cells: 368.3;Prostatic glandular cells: 203.4;Proximal enterocytes: 159.6;Urothelial cells: 166.6"	"Cancer enriched"	"Detected in many"	7	"prostate cancer: 250.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CACO-2: 22.8;MCF7: 10.5;OE19: 35.9;RT4: 57.8;SK-BR-3: 11.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"HPA034493, HPA035787"	Enhanced		Supported	"Plasma membrane"	"Secreted in other tissues"	NA	NA				"Cluster 4: Stomach - Digestion"	"Cluster 21: OE19 - Mitochondria"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Plasma membrane"		"HPA034493: , HPA035787: AB_2674782"	"unprognostic (4.80e-3)"	"unprognostic (3.49e-1)"	"unprognostic (2.16e-1)"	"prognostic favorable (2.56e-4)"	"unprognostic (1.72e-1)"	"unprognostic (1.05e-2)"	"unprognostic (4.28e-2)"	"unprognostic (1.51e-3)"	"unprognostic (9.43e-2)"	"unprognostic (9.02e-3)"	"unprognostic (6.24e-2)"	"unprognostic (6.43e-2)"	"prognostic favorable (7.86e-6)"	"unprognostic (2.00e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.41e-1)"	"unprognostic (2.15e-2)"	0.6	0.2	0.4	13.9	0.4	0.1	20.1	0.2	0.4	5.0	3.1	104.0	78.5	1.0	2.8	36.1	10.7	24.1	0.2	0.3	0.3	47.7	33.5	39.9	0.2	0.4	0.3	0.2	111.4	4.0	1.5	0.2	0.3	280.4	78.0	0.2	76.2	7.7	0.1	7.3	89.6	3.3	0.1	0.2	146.2	1.5	0.3	0.8	19.2	0.1	10.2	35.7	7.6	0.5	0.1	0.0	0.1	0.0	0.1	0.1	2.3	0.0	0.0	0.1	0.1	22.8	3.3	0.1	0.4	0.1	0.1	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.1	3.7	0.0	0.0	0.3	0.0	0.1	0.1	0.0	0.0	0.3	0.0	0.1	0.1	0.0	10.5	0.3	1.0	2.3	35.9	0.2	0.1	0.0	2.6	1.3	57.8	0.2	0.7	0.3	11.7	0.3	0.4	8.8	0.0	0.0	0.1	0.6	0.6	0.1	0.0	0.2	0.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.4	0.2	0.4	0.3	0.3	0.4	0.3	0.3	0.1	0.3	0.5	0.1	51.3	109.8	0.0	1.7	0.3	30.9	6.8	0.0	0.0	34.0	25.8	0.6	32.9	42.1	47.8	0.0	0.7	1.1	404.8	23.5	39.2	21.3	7.4	0.5	1.3	18.0	2.7	0.2	60.4	0.1	1.0	155.4	5.8	7.0	0.0	0.4	32.0	0.1	0.0	0.1	84.1	44.7	0.3	0.3	4.8	0.0	2.0	10.6	0.0	0.6	0.0	0.0	0.0	0.0	65.1	368.3	0.0	0.0	203.4	159.6	3.8	36.6	0.0	0.0	1.6	2.0	0.4	1.4	2.1	0.1	0.3	1.1	0.0	105.7	166.6
TMX1	"PDIA11, TMX, TXNDC, TXNDC1"	ENSG00000139921	"Thioredoxin related transmembrane protein 1"	Q9H3N1	14	51240162-51257655	"Predicted membrane proteins, Transporters"	"Electron transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003085	Approved		Supported	"Nucleoli,Endoplasmic reticulum"		NA	NA		26000	"Cluster 27: Non-specific - Gene expression"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 38: Extravillous trophoblasts - Unknown function"	"Endoplasmic reticulum"	Nucleoli	"HPA003085: AB_1080424"	"unprognostic (1.83e-1)"	"unprognostic (7.42e-2)"	"unprognostic (6.97e-3)"	"unprognostic (1.49e-2)"	"unprognostic (2.63e-1)"	"unprognostic (1.12e-2)"	"prognostic unfavorable (1.29e-6)"	"unprognostic (3.70e-2)"	"unprognostic (1.51e-1)"	"unprognostic (6.84e-2)"	"unprognostic (2.44e-3)"	"unprognostic (5.07e-2)"	"unprognostic (9.30e-2)"	"unprognostic (1.85e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.18e-1)"	"unprognostic (3.21e-3)"	11.0	8.8	5.8	10.8	6.3	10.7	11.3	6.7	8.7	7.8	7.4	12.3	10.6	8.1	10.8	9.1	6.6	8.5	4.8	5.4	6.6	10.2	12.6	9.3	12.4	6.5	6.8	6.6	9.1	9.4	5.5	13.2	7.0	7.9	12.2	6.8	8.3	9.2	5.2	9.8	9.3	9.9	6.9	10.7	10.4	5.0	7.0	11.6	11.4	4.4	10.5	13.0	6.6	7.0	27.0	23.8	33.8	18.4	26.0	20.3	35.5	33.5	26.8	33.2	42.2	24.9	49.0	38.8	30.0	22.6	15.6	26.1	60.3	21.5	60.4	38.6	19.6	28.4	19.4	24.7	22.4	66.2	27.4	24.4	19.5	22.2	16.3	24.0	29.7	31.2	23.6	25.9	32.1	32.6	29.7	35.5	38.3	42.2	28.5	30.9	60.9	23.4	32.2	34.8	21.1	15.5	26.6	17.8	24.6	22.2	25.8	28.6	19.0	34.9	32.2	24.8	30.9	22.4	23.9	31.4	15.4	36.6	33.5	10.5	12.2	6.2	8.6	14.7	10.6	7.7	8.8	9.0	13.6	6.3	8.5	10.1	4.3	11.5	11.0	15.7	11.0	12.4	5.8	6.3	6.7	8.7	5.4	6.6	6.5	6.8	7.0	6.9	7.0	7.0	43.0	38.5	29.1	24.5	55.9	108.6	63.1	80.5	71.2	13.7	40.7	20.8	9.2	44.3	55.7	35.0	12.5	73.9	82.6	38.2	9.8	62.1	2.5	22.0	42.2	47.5	17.4	81.2	8.9	67.6	149.3	48.4	32.1	28.0	43.6	24.4	43.2	44.0	73.2	10.1	11.2	29.2	63.1	61.1	84.3	4.3	24.8	65.7	55.2	18.7	70.0	27.0	46.4	22.1	25.2	50.3	44.0	28.6	79.2	58.4	29.3	32.4	42.2	32.6	59.2	37.3	49.4	59.5	68.7	79.0	97.3	57.7	62.5	58.7	46.5	59.5
TNFAIP8L3	FLJ41287	ENSG00000183578	"TNF alpha induced protein 8 like 3"	Q5GJ75	15	51056598-51105276	"Predicted intracellular proteins"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"endometrium 1: 86.9;smooth muscle: 84.8"	"Cell type enhanced"	"Detected in many"		"Enteroendocrine cells: 10.3;Inhibitory neurons: 14.4;Langerhans cells: 10.8;Smooth muscle cells: 9.3;Spermatocytes: 23.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 35.0;ASC TERT1: 87.8;HUVEC TERT2: 78.7;LHCN-M2: 74.5;TIME: 105.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA077484	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Cytosol	Nucleoplasm	"HPA077484: AB_2732347"	"unprognostic (1.38e-1)"	"unprognostic (6.22e-2)"	"unprognostic (1.12e-3)"	"unprognostic (6.63e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.35e-2)"	"unprognostic (3.08e-2)"	"unprognostic (2.15e-2)"	"unprognostic (4.21e-2)"	"unprognostic (4.70e-3)"	"unprognostic (6.54e-2)"	"unprognostic (9.35e-2)"	"unprognostic (7.12e-2)"	"unprognostic (1.04e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.37e-3)"	"prognostic unfavorable (3.51e-4)"	9.4	3.8	9.2	7.1	8.3	0.8	5.7	3.5	8.2	13.7	4.3	8.6	1.6	86.9	6.0	20.4	45.6	6.2	6.3	15.3	6.6	2.7	2.4	15.5	3.9	5.5	8.5	15.9	2.4	0.8	3.0	2.0	4.8	6.8	8.6	0.3	3.9	5.4	4.7	23.1	7.9	84.8	4.3	19.9	5.8	4.4	6.6	0.9	5.4	3.5	3.2	18.6	15.1	5.6	0.1	0.4	0.1	0.2	35.0	87.8	0.4	0.3	0.1	1.0	1.6	0.1	1.0	0.1	1.5	5.0	11.2	0.1	1.2	0.8	0.4	0.1	0.7	0.0	2.4	5.9	9.1	0.3	1.9	32.5	7.1	6.7	26.8	5.8	78.7	0.1	0.1	0.1	74.5	0.9	0.0	0.6	0.3	0.0	0.3	0.1	0.0	0.0	0.0	0.3	0.8	0.1	0.1	0.1	0.1	0.9	0.5	0.6	105.5	8.0	0.5	26.5	2.3	0.4	0.0	0.1	16.7	0.1	0.1	0.9	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.2	0.1	0.1	0.6	0.3	0.2	0.2	0.0	0.0	9.2	8.3	3.5	8.2	15.3	6.6	5.5	8.5	4.8	4.3	6.6	5.6	1.2	0.0	0.5	4.6	0.0	3.3	1.1	0.4	0.0	0.1	0.2	0.1	1.0	0.0	0.1	0.0	0.0	0.0	0.0	1.9	0.0	0.1	0.3	2.3	1.7	3.9	10.3	0.0	4.5	0.4	0.0	5.8	0.0	0.1	0.0	7.1	1.8	0.3	2.9	0.0	14.4	3.3	2.0	2.9	10.8	0.7	9.0	3.5	1.8	1.0	0.6	0.1	0.0	1.0	2.6	0.1	1.5	5.3	0.1	0.4	0.0	0.1	1.3	0.2	6.6	1.6	9.3	23.7	0.8	0.3	8.4	0.0	0.1	0.1	1.5	0.5
TNFRSF10A	"Apo2, CD261, DR4, TRAILR-1, TRAILR1"	ENSG00000104689	"TNF receptor superfamily member 10a"	O00220	8	23190452-23225102	"Cancer-related genes, CD markers, Predicted membrane proteins"	Apoptosis	Receptor	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			"HPA050958, HPA054475"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 30: Non-specific - Translation"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 15: RT4 - Unknown function"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm		"HPA050958: AB_2681290, HPA054475: AB_2682500"	"unprognostic (3.66e-1)"	"unprognostic (1.02e-1)"	"unprognostic (2.19e-2)"	"unprognostic (4.89e-2)"	"unprognostic (9.44e-2)"	"unprognostic (8.39e-2)"	"unprognostic (5.32e-2)"	"unprognostic (2.18e-2)"	"unprognostic (2.72e-1)"	"unprognostic (4.48e-2)"	"prognostic unfavorable (1.00e-4)"	"unprognostic (1.49e-1)"	"unprognostic (1.99e-3)"	"unprognostic (1.91e-2)"	"unprognostic (1.61e-2)"	"unprognostic (2.35e-1)"	"unprognostic (2.87e-1)"	5.7	2.3	2.6	9.9	2.5	9.3	5.7	2.2	2.7	4.3	2.2	7.0	6.2	2.9	1.1	8.4	4.1	8.2	3.0	2.0	2.4	3.8	5.3	6.6	13.4	3.4	2.8	0.8	2.4	2.7	0.8	7.1	3.1	2.9	7.1	0.2	4.8	2.5	1.5	4.9	6.5	3.9	2.8	6.8	6.5	0.5	3.4	6.4	3.0	2.8	14.0	10.8	5.8	2.8	18.7	33.0	1.7	0.1	1.2	6.4	0.1	3.8	2.3	1.9	5.2	25.4	31.8	42.9	41.9	2.4	9.1	34.6	29.5	47.2	3.1	10.7	0.2	22.7	20.4	14.7	16.2	12.3	20.7	11.0	38.2	41.1	35.0	5.5	21.9	1.4	35.7	14.9	8.9	14.5	0.4	7.8	22.6	33.0	20.0	0.3	0.0	31.2	24.4	39.5	0.9	1.1	9.3	23.0	0.0	6.9	12.3	9.3	31.3	0.1	0.2	1.8	0.1	17.4	26.7	32.7	0.2	3.9	0.5	2.8	6.1	5.7	5.0	2.6	13.8	15.3	16.1	10.2	6.3	19.1	15.7	9.2	0.6	6.1	2.6	0.0	20.8	6.5	2.6	2.5	2.2	2.7	2.0	2.4	3.4	2.8	3.1	2.8	3.4	2.8	21.5	3.2	8.7	0.7	22.3	23.6	20.7	9.1	21.6	0.2	8.2	7.1	1.1	7.2	15.5	11.0	0.0	0.1	3.1	10.1	0.0	10.1	0.1	8.6	1.9	16.6	2.4	1.3	0.4	4.0	0.4	2.2	10.2	23.9	7.6	0.7	2.9	5.1	3.1	0.0	0.4	7.0	8.2	2.2	12.7	0.0	0.0	8.5	3.6	9.4	4.2	0.0	2.1	1.0	0.5	20.3	7.3	0.0	14.0	11.7	4.5	2.9	5.7	0.0	0.0	0.9	1.1	0.0	0.5	25.6	27.4	0.0	12.8	0.1	9.1	27.4
TNFRSF11A	"CD265, FEO, LOH18CR1, PDB2, RANK"	ENSG00000141655	"TNF receptor superfamily member 11a"	Q9Y6Q6	18	62325287-62391288	"CD markers, Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"		Receptor	"Deafness, Disease variant, Osteopetrosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 30.5;salivary gland: 25.4"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 35.6;Intestinal goblet cells: 24.0;Paneth cells: 42.3;Proximal enterocytes: 25.5;Undifferentiated cells: 42.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in single"	8	"NK-cell: 5.3"	"Lineage enriched"	"Detected in single"	8	"NK-cells: 5.3"	"Cell line enriched"	"Detected in many"	6	"HDLM-2: 125.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB010391, HPA047976"	Approved		Supported	"Plasma membrane,Cytosol"	"Intracellular and membrane"	NA	NA		110000	"Cluster 48: NK-cells - Unknown function"	"Cluster 56: Intestine - Transmembrane transport"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Plasma membrane"	Cytosol	"CAB010391: AB_2205352, HPA047976: AB_2680227"	"unprognostic (4.08e-1)"	"unprognostic (2.71e-1)"	"unprognostic (3.23e-3)"	"unprognostic (1.73e-1)"	"unprognostic (6.03e-2)"	"unprognostic (1.35e-1)"	"unprognostic (9.96e-4)"	"unprognostic (4.24e-3)"	"unprognostic (7.79e-4)"	"unprognostic (1.52e-1)"	"unprognostic (4.05e-2)"	"unprognostic (2.88e-1)"	"unprognostic (4.69e-5)"	"unprognostic (1.56e-1)"	"unprognostic (1.78e-1)"	"unprognostic (4.02e-2)"	"unprognostic (7.07e-2)"	1.8	1.1	0.8	5.7	1.6	0.4	4.1	0.1	1.9	1.4	0.3	17.1	30.5	0.9	0.3	2.8	0.9	7.6	0.6	2.0	1.1	0.4	0.6	1.0	1.2	0.7	1.1	0.4	1.7	0.9	6.8	3.2	0.2	1.3	17.6	0.2	25.4	2.7	0.3	2.7	18.6	1.7	0.7	0.8	5.5	0.9	1.2	1.0	1.2	0.1	1.9	1.6	1.6	2.1	3.2	2.2	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.1	1.6	0.4	0.6	0.0	3.5	0.4	1.4	2.2	8.3	0.9	0.2	125.9	5.4	0.0	1.3	1.7	0.0	0.5	1.3	0.2	0.4	0.8	3.1	4.2	3.1	0.3	0.0	0.0	0.0	1.1	0.0	0.1	5.9	7.0	19.3	0.4	0.0	0.6	1.5	1.5	20.4	0.7	0.6	3.0	0.1	0.8	1.3	0.4	2.0	0.0	0.1	0.1	0.0	1.2	0.0	0.1	0.3	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	5.3	0.0	0.3	0.6	0.0	0.8	1.6	0.1	1.9	2.0	1.1	0.7	1.1	0.2	0.7	1.2	2.1	0.4	0.0	2.2	0.0	0.4	1.3	3.8	1.1	0.6	0.6	4.5	3.3	1.3	8.6	2.3	0.0	0.0	0.1	3.3	35.6	0.0	8.3	0.3	3.2	0.5	5.3	10.8	0.0	4.0	7.5	0.6	0.7	11.7	6.2	0.0	2.0	7.1	0.3	15.5	3.3	0.2	24.0	0.0	17.0	2.4	0.4	0.6	7.7	1.8	8.4	19.7	0.0	3.1	0.5	0.4	14.7	42.3	0.0	0.5	2.8	25.5	0.0	3.8	0.2	0.0	0.5	0.4	0.8	1.9	1.7	2.3	0.1	0.7	0.0	42.2	4.4
TNFRSF21	"CD358, DR6"	ENSG00000146072	"TNF receptor superfamily member 21"	O75509	6	47231532-47309905	"CD markers, Metabolic proteins, Plasma proteins, Predicted membrane proteins"	"Adaptive immunity, Apoptosis, Host-virus interaction, Immunity"	Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"urinary bladder: 148.1"	"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 179.9;Prostatic glandular cells: 180.8;Syncytiotrophoblasts: 178.7;Urothelial cells: 387.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	35	"plasmacytoid DC: 69.2"	"Lineage enriched"	"Detected in single"	303	"dendritic cells: 69.2"	"Cell line enhanced"	"Detected in many"		"OE19: 208.0;RT4: 523.8;SuSa: 213.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006746, CAB009805"	Approved		Supported	"Plasma membrane,Cytosol"		NA	NA		2300000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 15: RT4 - Unknown function"	"Cluster 22: Epithelial cell types - Mixed function"	"Plasma membrane, Cytosol"		"CAB009805: AB_2206956, HPA006746: AB_1078701"	"unprognostic (1.19e-2)"	"unprognostic (2.70e-1)"	"unprognostic (3.26e-1)"	"unprognostic (7.85e-2)"	"unprognostic (1.44e-1)"	"unprognostic (3.41e-2)"	"unprognostic (9.80e-3)"	"unprognostic (1.11e-1)"	"unprognostic (1.46e-2)"	"unprognostic (7.53e-2)"	"unprognostic (1.38e-3)"	"unprognostic (1.74e-1)"	"prognostic favorable (7.23e-6)"	"unprognostic (1.48e-1)"	"unprognostic (1.34e-1)"	"unprognostic (9.78e-2)"	"unprognostic (1.45e-2)"	55.7	6.6	17.6	17.7	31.0	13.4	13.4	48.9	31.4	17.5	1.1	38.1	12.3	17.1	2.5	41.3	16.4	35.7	9.8	21.8	27.4	49.6	8.9	16.9	17.2	76.8	43.8	6.5	20.0	58.8	6.5	33.2	56.9	13.7	34.8	4.1	25.6	4.0	6.0	4.0	19.2	15.7	43.7	14.9	60.8	8.1	49.0	26.8	4.0	14.1	32.9	148.1	17.1	100.1	156.6	50.0	47.7	15.3	127.4	37.5	53.9	17.9	34.9	5.5	2.1	86.7	107.7	11.6	70.3	13.1	101.8	92.2	7.2	66.1	3.1	0.2	15.1	0.1	6.4	88.2	74.6	2.5	0.6	67.1	77.2	3.3	58.1	4.2	25.8	10.1	3.8	0.1	1.9	30.8	13.9	1.4	37.5	208.0	50.8	29.1	14.7	17.1	90.8	523.8	34.1	7.5	15.6	14.4	12.9	213.0	11.1	11.0	5.2	14.1	12.9	0.5	16.5	0.1	0.2	16.1	23.1	11.1	40.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.1	0.0	0.0	0.1	0.1	0.1	69.2	0.0	0.6	17.6	31.0	48.9	31.4	21.8	27.4	76.8	43.8	56.9	43.7	49.0	100.1	5.5	0.0	9.8	1.6	3.1	23.7	179.9	140.5	64.9	1.1	8.0	10.8	10.2	35.8	59.9	1.8	0.0	31.0	77.3	100.7	15.6	86.8	55.0	12.0	17.3	8.6	12.0	3.0	46.6	29.6	21.4	32.9	80.5	13.8	19.7	2.1	1.1	0.3	22.4	0.0	29.6	42.9	107.8	53.6	12.5	40.3	2.8	22.6	12.4	13.1	0.6	5.4	0.0	53.3	44.7	89.1	54.5	1.2	2.0	180.8	14.7	51.3	54.7	1.4	78.9	21.5	24.2	1.0	3.7	40.4	9.9	178.7	2.8	13.1	19.9	387.3
TNFRSF8	"CD30, D1S166E, KI-1"	ENSG00000120949	"TNF receptor superfamily member 8"	P28908	1	12063303-12144207	"Cancer-related genes, CD markers, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		Receptor	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"adipose tissue: 5.3"	"Cell type enhanced"	"Detected in some"		"Adipocytes: 7.1;Early spermatids: 3.5;Kupffer cells: 5.3;Langerhans cells: 3.3;Late spermatids: 9.8;Macrophages: 5.8;monocytes: 5.1"	"Cancer enriched"	"Detected in some"	12	"testis cancer: 9.3"	"Region enhanced"	"Detected in single"		"basal ganglia: 2.3"	"Group enriched"	"Detected in many"	4	"intermediate monocyte: 59.4;non-classical monocyte: 96.6"	"Lineage enriched"	"Detected in many"	5	"monocytes: 96.6"	"Cell line enriched"	"Detected in some"	21	"HDLM-2: 552.9"	"Region enhanced"	"Detected in many"		"hypothalamus: 5.5"					"CAB000016, HPA014823, HPA032081, HPA032082"	Approved		Supported	"Plasma membrane"		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	"Plasma membrane"		"CAB000016: AB_563546, HPA014823: , HPA032081: AB_2674141, HPA032082: AB_2674142"	"unprognostic (1.07e-2)"	"unprognostic (2.06e-2)"	"unprognostic (2.52e-2)"	"unprognostic (5.98e-2)"	"unprognostic (2.50e-1)"	"unprognostic (1.46e-3)"	"unprognostic (2.19e-1)"	"unprognostic (3.93e-2)"	"unprognostic (1.18e-1)"	"unprognostic (9.18e-3)"	"unprognostic (1.86e-1)"	"unprognostic (2.06e-1)"	"unprognostic (3.17e-8)"	"unprognostic (3.31e-1)"	"unprognostic (8.56e-2)"	"unprognostic (2.07e-1)"	"unprognostic (2.31e-2)"	5.3	0.0	0.1	3.1	2.3	0.6	3.5	0.0	0.6	0.2	0.1	0.4	0.0	0.8	0.0	0.2	0.9	0.6	1.9	0.0	0.2	0.3	0.0	0.9	1.2	0.2	0.1	0.2	0.1	0.0	0.0	0.7	0.2	0.2	0.1	0.0	0.3	0.1	0.9	0.9	0.7	0.5	0.1	1.4	2.5	1.4	0.7	1.0	0.1	1.2	1.1	0.9	0.3	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.5	0.4	0.0	0.1	0.8	11.7	0.0	0.0	0.0	0.0	0.0	0.1	552.9	0.1	0.0	0.1	0.0	0.0	10.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	3.7	26.3	1.5	0.0	0.0	1.5	0.2	21.7	0.0	0.4	0.0	0.0	8.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.2	0.1	0.0	1.4	1.4	0.2	0.0	0.1	0.1	0.3	0.0	0.0	0.0	17.6	1.0	0.1	59.4	0.3	0.1	0.1	0.0	8.7	0.0	0.0	0.0	18.3	0.0	96.6	2.3	0.8	8.5	0.1	2.3	0.0	0.6	0.0	0.2	0.2	0.1	0.2	0.1	0.7	0.2	7.1	0.0	0.0	0.3	0.4	0.3	0.0	0.0	0.0	0.0	0.1	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	3.5	0.1	0.5	2.2	0.0	0.0	0.6	0.0	0.2	1.1	2.6	0.1	0.0	0.1	2.2	0.1	1.5	0.0	0.5	0.0	0.0	5.3	3.3	9.8	0.3	5.8	0.0	1.0	5.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.3	1.3	1.0	0.0	0.1	0.3	0.4	0.2	0.0	0.1
TNFSF13B	"BAFF, BLYS, CD257, TALL-1, TALL1, THANK, TNFSF20"	ENSG00000102524	"TNF superfamily member 13b"	Q9Y275	13	108251240-108308484	"Cancer-related genes, CD markers, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	Immunity	Cytokine	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 25.9"	"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 87.5;Kupffer cells: 141.1;Langerhans cells: 246.7;Macrophages: 170.4;monocytes: 509.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 505.4"	"Group enriched"	"Detected in all"	11	"dendritic cells: 206.4;granulocytes: 505.4;monocytes: 350.9"	"Cell line enriched"	"Detected in some"	7	"U-937: 167.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB009188, HPA030526"	Enhanced		Supported	"Vesicles,Plasma membrane,Focal adhesion sites"	"Secreted to blood"	NA	NA	393000	790000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 16: Immune cells - Immune response"	"Cluster 32: U-937 - Innate immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	"Plasma membrane"	"Vesicles, Focal adhesion sites"	"CAB009188: , HPA030526: "	"unprognostic (6.48e-2)"	"unprognostic (3.05e-3)"	"unprognostic (1.38e-1)"	"unprognostic (1.90e-1)"	"unprognostic (2.61e-2)"	"unprognostic (7.99e-2)"	"unprognostic (8.19e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.02e-2)"	"unprognostic (2.64e-2)"	"unprognostic (1.21e-1)"	"prognostic unfavorable (2.53e-11)"	"unprognostic (1.23e-1)"	"unprognostic (4.14e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.25e-1)"	8.2	5.3	2.8	25.9	2.6	20.1	4.7	2.7	4.1	2.2	5.8	5.5	10.7	1.4	1.5	4.8	2.4	12.4	3.8	2.7	3.1	1.5	5.3	10.9	20.9	6.3	3.0	1.1	1.5	0.7	1.0	9.0	4.2	1.7	8.4	0.4	3.3	1.2	1.4	1.9	6.4	5.0	4.6	15.9	5.0	1.2	3.5	5.3	3.0	1.6	17.7	11.1	2.1	5.2	0.1	0.4	0.1	0.1	0.7	0.8	0.2	0.3	0.8	0.6	2.1	0.1	1.7	0.3	0.2	0.2	0.3	0.1	0.0	0.1	0.1	11.6	0.0	0.9	0.4	0.0	0.4	10.2	0.3	2.0	0.4	0.2	0.1	0.4	0.1	0.1	0.1	0.6	1.2	0.0	0.1	5.3	0.1	1.1	0.0	0.0	0.2	0.0	0.6	0.3	1.3	0.3	0.0	0.0	0.4	0.2	0.1	22.3	0.2	0.3	0.0	0.0	0.4	10.0	0.3	0.1	10.3	167.0	1.7	12.6	350.9	100.1	5.4	272.3	31.5	4.4	21.5	4.4	206.4	7.1	9.9	3.4	505.4	5.0	234.1	77.8	19.4	165.8	2.8	2.6	2.7	4.1	2.7	3.1	6.3	3.0	4.2	4.6	3.5	5.2	3.1	16.0	12.9	6.2	7.0	7.1	0.7	1.3	1.2	0.9	2.4	3.2	0.6	10.0	4.2	5.5	0.0	0.5	40.6	0.6	1.9	2.3	1.2	0.4	0.7	3.6	1.2	14.5	18.1	32.5	1.1	29.6	3.1	0.5	5.1	0.9	3.9	2.8	87.5	0.0	11.2	0.9	0.0	141.1	246.7	0.6	5.3	170.4	8.8	15.0	509.4	0.2	5.2	55.3	5.1	1.7	0.5	1.9	1.5	2.7	2.2	1.3	2.0	0.3	6.6	1.4	4.1	0.1	0.7	0.5	4.7	1.1	10.5	1.2	1.8	3.1
TNIK	KIAA0551	ENSG00000154310	"TRAF2 and NCK interacting kinase"	Q9UKE5	3	171058414-171460408	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Neurogenesis, Wnt signaling pathway"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 33.7"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 1074.4;Excitatory neurons: 248.4;Inhibitory neurons: 360.8;Oligodendrocyte precursor cells: 374.5;Oligodendrocytes: 205.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HEL: 65.2;HMC-1: 71.3;WM-115: 52.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012128, HPA012297"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA		160000	"Cluster 52: Eosinophils - Transcription"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 64: Astrocytes - Nervous system maintenance"	Nucleoplasm	Cytosol	"HPA012128: AB_1858226, HPA012297: AB_1858225"	"unprognostic (2.29e-1)"	"unprognostic (1.12e-2)"	"unprognostic (1.32e-1)"	"unprognostic (5.90e-2)"	"unprognostic (5.25e-2)"	"unprognostic (9.23e-2)"	"unprognostic (4.91e-2)"	"unprognostic (2.41e-3)"	"unprognostic (1.91e-1)"	"unprognostic (7.81e-2)"	"unprognostic (5.91e-2)"	"unprognostic (1.96e-2)"	"unprognostic (3.34e-3)"	"unprognostic (2.41e-1)"	"unprognostic (1.64e-1)"	"unprognostic (2.13e-2)"	"unprognostic (3.97e-2)"	1.4	4.4	25.7	6.2	33.7	4.4	2.1	4.1	17.5	1.3	0.0	8.2	21.0	3.4	0.9	4.1	2.8	5.1	9.4	20.8	15.7	3.8	3.1	8.9	6.7	25.5	18.7	1.5	3.7	0.5	8.4	1.9	6.3	3.5	6.7	19.4	1.9	4.6	23.2	1.0	21.3	4.3	19.0	4.5	7.0	7.7	20.1	7.0	6.3	23.6	5.3	4.8	2.1	10.7	0.9	1.2	43.4	4.7	0.8	0.1	10.4	9.3	2.5	7.3	4.8	41.5	16.9	0.0	3.4	9.0	6.9	14.1	6.3	2.6	7.3	0.3	9.8	65.2	3.7	0.0	19.0	13.0	71.3	6.1	5.9	4.3	0.9	15.7	43.6	10.5	23.3	0.1	1.1	1.1	4.1	13.5	18.2	30.6	17.9	0.0	11.8	16.6	12.0	0.1	2.1	2.3	5.8	0.4	9.6	4.1	20.4	2.9	0.5	0.0	7.9	20.5	7.1	0.1	0.0	0.1	1.8	13.8	52.1	4.6	0.1	10.5	3.5	0.0	4.4	0.0	4.2	3.2	0.0	0.2	5.8	3.1	0.1	2.4	0.1	0.0	5.3	1.0	25.7	33.7	4.1	17.5	20.8	15.7	25.5	18.7	6.3	19.0	20.1	10.7	0.7	6.4	50.4	1074.4	4.9	2.5	1.6	1.3	9.1	19.2	8.4	6.5	28.6	21.5	7.1	9.2	14.6	6.3	32.5	19.6	5.9	12.1	48.6	1.1	2.5	1.6	13.2	13.5	248.4	7.7	1.3	9.1	21.4	0.3	83.5	0.4	2.5	8.1	2.9	0.0	360.8	10.3	0.0	6.5	1.9	38.0	2.5	10.4	1.8	57.1	1.6	65.0	51.5	374.5	205.5	7.1	21.6	6.4	11.7	0.7	56.2	17.3	1.8	28.7	0.0	12.4	6.2	3.1	1.0	10.3	1.6	2.5	47.4	9.9	16.6	3.2
TNIP1	"ABIN-1, KIAA0113, NAF1, VAN"	ENSG00000145901	"TNFAIP3 interacting protein 1"	Q15025	5	151029945-151093577	"Human disease related genes, Predicted intracellular proteins"	"Inflammatory response"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Pancreatic endocrine cells: 265.5;Proximal enterocytes: 257.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HBEC3-KT: 406.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037893, HPA037894, HPA071950"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 59: Non-specific - Translation"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm	Cytosol	"HPA037893: AB_10672468, HPA037894: AB_2675723, HPA071950: AB_2686476"	"prognostic favorable (5.69e-4)"	"unprognostic (1.08e-1)"	"unprognostic (1.10e-1)"	"prognostic favorable (6.86e-5)"	"unprognostic (7.45e-3)"	"unprognostic (2.94e-1)"	"unprognostic (5.35e-3)"	"unprognostic (1.45e-2)"	"unprognostic (2.82e-1)"	"unprognostic (3.42e-1)"	"unprognostic (2.25e-2)"	"unprognostic (1.96e-1)"	"unprognostic (7.68e-3)"	"unprognostic (1.47e-1)"	"unprognostic (4.69e-2)"	"unprognostic (2.29e-1)"	"unprognostic (9.84e-2)"	120.0	49.7	34.1	79.6	33.4	128.0	90.7	35.3	40.8	60.1	33.3	72.7	73.2	37.6	22.4	89.3	37.9	54.3	96.3	31.5	36.5	83.3	107.9	91.7	69.4	40.5	37.4	41.8	71.6	42.8	27.2	28.7	39.0	47.9	52.4	17.4	53.1	39.2	211.2	60.4	90.8	32.6	37.6	101.2	63.5	14.6	37.1	43.4	45.9	130.7	83.3	84.4	69.3	35.3	117.7	81.3	15.4	55.7	58.4	58.6	39.4	54.7	174.5	48.6	91.1	78.4	155.5	95.8	182.3	74.2	285.3	68.3	25.2	406.4	59.4	167.8	34.6	37.8	44.4	51.1	111.4	43.6	168.3	84.3	74.5	80.3	166.2	134.1	69.1	37.2	24.6	94.2	122.7	43.7	48.2	60.0	13.9	41.1	43.4	39.0	118.4	131.4	152.3	85.0	21.7	49.9	42.4	131.5	57.2	41.6	67.5	54.5	107.8	162.7	53.0	28.7	79.2	184.6	102.2	43.4	177.0	63.7	39.6	18.2	12.1	36.0	11.9	11.1	14.0	12.7	13.9	12.0	9.2	16.8	7.1	7.9	41.3	12.4	10.8	12.8	21.2	10.4	34.1	33.4	35.3	40.8	31.5	36.5	40.5	37.4	39.0	37.6	37.1	35.3	31.1	57.7	45.4	4.9	73.1	29.7	50.4	119.9	27.3	14.3	33.3	24.9	48.8	54.3	72.2	27.6	4.2	18.3	53.7	233.7	72.4	218.0	3.3	39.8	18.0	75.1	37.3	52.4	6.5	139.1	31.3	38.9	92.8	64.8	48.2	105.2	42.1	62.7	39.0	18.5	6.4	69.0	46.8	49.6	113.1	6.9	27.1	64.9	26.6	8.4	238.3	20.3	68.0	5.5	9.4	265.5	173.9	23.7	63.6	179.1	257.5	56.4	49.1	15.0	32.9	69.2	45.7	2.2	13.9	30.2	28.6	48.2	60.7	12.2	77.1	158.6
TNK2	"ACK, ACK1, p21cdc42Hs"	ENSG00000061938	"Tyrosine kinase non receptor 2"	Q07912	3	195863364-195911945	"Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	Endocytosis	"Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 102.9"	"Cell type enhanced"	"Detected in many"		"Horizontal cells: 99.3;Oligodendrocyte precursor cells: 245.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041954, HPA069561"	Approved		Supported	"Vesicles,Plasma membrane"		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 68: Oligodendrocytes - Mixed function"	"Plasma membrane"	Vesicles	"HPA041954: AB_10794164, HPA069561: "	"unprognostic (1.97e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.15e-3)"	"prognostic unfavorable (8.96e-4)"	"unprognostic (1.34e-1)"	"unprognostic (8.92e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.30e-1)"	"unprognostic (8.89e-3)"	"unprognostic (1.13e-1)"	"unprognostic (8.92e-3)"	"unprognostic (4.49e-2)"	"prognostic unfavorable (1.30e-4)"	"unprognostic (6.82e-2)"	"unprognostic (9.76e-2)"	"unprognostic (1.44e-1)"	"prognostic favorable (1.00e-4)"	14.2	10.0	77.1	24.7	64.1	72.2	15.0	40.0	102.9	18.0	11.8	18.5	9.4	13.8	11.1	19.1	17.1	10.5	18.4	75.6	51.4	7.7	10.5	14.1	30.0	77.5	59.8	13.4	12.1	6.1	36.4	12.7	70.1	21.1	6.3	9.3	26.3	11.8	54.8	62.3	16.1	9.2	45.5	27.0	19.7	12.0	57.0	16.0	10.0	16.7	20.1	19.4	19.3	60.6	93.4	16.3	15.4	13.4	15.3	11.5	80.0	17.7	16.7	11.7	9.4	15.6	79.3	25.9	55.1	24.2	17.4	34.1	14.9	22.2	3.5	61.8	15.4	22.0	36.2	10.4	7.9	13.5	10.2	7.8	30.7	11.7	17.9	26.7	13.3	9.2	11.3	30.6	9.4	67.1	5.3	39.7	12.3	24.6	29.1	13.8	15.6	26.0	7.2	51.2	16.2	16.5	9.5	37.6	21.3	11.3	71.4	11.9	18.9	19.1	13.0	11.4	48.6	70.8	9.2	17.0	22.1	38.0	15.4	1.4	1.2	0.3	0.9	1.5	0.4	1.3	0.8	0.4	0.5	2.5	0.5	0.5	2.7	0.4	1.4	1.5	0.1	0.7	77.1	64.1	40.0	102.9	75.6	51.4	77.5	59.8	70.1	45.5	57.0	60.6	9.3	6.4	7.7	44.4	14.6	6.9	8.1	6.0	4.6	30.6	13.0	12.6	16.1	7.2	8.9	0.0	50.1	13.4	11.0	18.0	1.9	4.0	1.0	4.1	5.4	11.1	6.1	12.8	42.7	5.3	3.3	4.6	14.3	4.1	1.3	4.5	11.7	19.2	8.1	99.3	45.3	2.3	6.1	16.0	11.7	1.2	6.5	13.7	5.4	20.6	16.2	5.9	21.6	245.3	25.1	29.5	9.6	6.4	10.7	8.2	0.9	1.6	7.6	20.3	0.0	4.8	5.7	6.4	11.2	11.0	10.5	4.2	12.5	1.7	6.4	19.0
TNPO1	"IPO2, KPNB2, MIP, MIP1, TRN"	ENSG00000083312	"Transportin 1"	Q92973	5	72816312-72916733	"Plasma proteins, Predicted intracellular proteins, Transporters"	"Host-virus interaction, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB016325	Approved		Supported	"Nucleoplasm,Cytosol,Cytoplasmic bodies"		NA	NA		130000	"Cluster 27: Non-specific - Gene expression"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 46: Photoreceptor cells - Phototransduction"	Nucleoplasm	"Cytosol, Cytoplasmic bodies"	"CAB016325: AB_675691"	"unprognostic (1.16e-1)"	"unprognostic (1.18e-2)"	"unprognostic (1.65e-3)"	"unprognostic (1.43e-1)"	"unprognostic (3.15e-1)"	"unprognostic (6.43e-3)"	"prognostic unfavorable (6.55e-5)"	"unprognostic (8.93e-3)"	"unprognostic (9.03e-2)"	"unprognostic (3.40e-3)"	"unprognostic (2.09e-1)"	"unprognostic (3.07e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.27e-2)"	"unprognostic (2.49e-2)"	23.5	23.0	10.6	28.8	14.6	31.7	25.0	14.0	10.0	20.2	23.0	24.5	20.5	24.0	33.8	23.1	20.6	27.7	20.8	10.5	17.1	30.5	28.4	17.3	29.9	18.2	13.4	22.4	31.5	39.8	15.6	36.8	16.5	23.4	29.9	65.0	20.9	28.1	25.0	11.6	20.9	28.2	15.1	20.6	30.7	37.3	13.1	35.6	36.8	27.0	32.3	33.3	14.0	21.5	94.8	123.7	154.5	104.8	133.3	144.5	110.4	112.3	145.6	112.2	113.6	111.4	87.1	117.5	78.5	173.0	140.4	71.6	126.3	108.8	160.8	66.6	71.9	76.2	144.8	55.9	103.9	78.4	55.1	110.8	80.2	151.0	184.8	78.2	248.6	52.9	113.4	54.8	298.1	50.3	87.2	37.3	99.3	39.8	90.9	83.1	150.5	74.1	73.4	109.5	87.5	73.6	160.6	60.3	135.8	99.8	71.2	61.9	225.1	79.5	113.8	116.8	136.7	53.2	95.8	155.8	69.9	91.3	154.4	8.2	8.2	6.9	11.9	11.0	16.5	10.3	10.9	9.3	10.3	10.8	11.6	11.9	8.4	14.1	14.0	5.0	8.3	10.5	10.6	14.6	14.0	10.0	10.5	17.1	18.2	13.4	16.5	15.1	13.1	21.5	42.3	12.8	25.0	45.7	49.0	59.1	40.9	29.7	60.3	105.0	38.7	24.0	53.8	30.0	28.7	27.6	98.0	81.9	44.9	39.8	17.6	39.0	105.4	38.6	46.1	64.8	53.2	27.1	142.2	41.5	50.0	52.8	53.0	46.7	22.1	62.8	50.7	38.1	42.7	89.2	77.8	46.3	28.5	40.0	42.2	60.9	46.6	42.1	24.9	50.6	47.4	143.1	26.8	79.9	84.7	58.9	24.9	60.2	42.9	57.0	33.9	36.1	27.6	187.9	26.3	72.5	48.8	58.5	76.3	42.0	53.3	131.3	36.9	40.2	37.2	60.2
TNRC18	"CAGL79, KIAA1856, TNRC18A"	ENSG00000182095	"Trinucleotide repeat containing 18"	O15417	7	5306790-5425414	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 20.8"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020730, HPA024251"	Uncertain		Supported	"Nucleoplasm,Nuclear membrane,Mitochondria,Cytosol"		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 40: Granulosa cells - Unknown function"	"Nucleoplasm, Nuclear membrane, Mitochondria"	Cytosol	"HPA020730: AB_2670506, HPA024251: AB_2671498"	"unprognostic (1.66e-1)"	"unprognostic (3.17e-3)"	"unprognostic (2.67e-3)"	"unprognostic (4.44e-1)"	"unprognostic (1.81e-1)"	"unprognostic (6.67e-2)"	"unprognostic (1.13e-2)"	"unprognostic (1.79e-1)"	"unprognostic (3.01e-1)"	"unprognostic (2.11e-2)"	"unprognostic (6.08e-2)"	"unprognostic (1.36e-1)"	"unprognostic (9.29e-3)"	"unprognostic (2.14e-1)"	"unprognostic (2.94e-1)"	"unprognostic (1.02e-1)"	"unprognostic (4.34e-2)"	30.4	18.3	10.8	29.0	8.9	51.8	30.1	16.2	14.2	40.8	2.2	56.3	25.3	57.6	16.4	26.0	43.5	22.4	22.1	10.3	0.5	22.9	19.8	32.0	16.1	6.2	1.7	46.0	29.5	35.0	22.2	30.6	1.6	36.1	22.6	12.2	28.8	34.3	24.0	33.2	29.0	36.4	1.3	25.2	33.8	22.6	5.1	17.2	32.6	11.1	14.6	40.8	31.9	3.2	72.8	63.4	51.5	43.4	42.9	50.6	133.8	50.4	47.3	27.4	29.0	26.3	62.4	49.3	48.3	74.7	60.8	79.7	30.2	60.5	23.0	21.6	19.2	31.4	56.6	43.1	37.1	104.3	111.2	51.2	70.0	54.8	63.2	39.5	31.3	43.6	45.4	27.2	35.3	120.0	24.6	127.2	4.5	47.5	48.0	27.0	25.7	37.3	22.3	91.3	22.3	53.4	38.8	102.5	37.0	23.1	106.9	106.1	78.7	78.3	109.6	47.0	36.7	38.6	44.1	46.2	44.1	72.6	94.1	14.2	3.8	3.6	1.7	1.5	1.2	2.2	1.2	1.0	1.4	2.3	0.9	1.7	20.8	3.2	2.1	5.4	1.9	0.2	10.8	8.9	16.2	14.2	10.3	0.5	6.2	1.7	1.6	1.3	5.1	3.2	25.6	9.6	29.0	59.7	7.4	9.3	3.7	9.8	13.6	51.7	15.8	25.9	7.5	14.3	12.4	14.7	2.1	14.5	20.4	33.6	1.9	5.0	14.4	22.2	29.7	17.3	31.3	9.7	40.9	6.6	3.8	17.8	19.4	36.2	14.0	48.3	29.6	25.4	11.2	50.5	45.6	30.4	8.2	41.8	12.4	18.8	18.3	22.8	5.4	71.2	25.9	31.0	11.3	32.6	20.3	9.0	10.6	19.9	12.1	6.5	7.4	5.4	11.1	4.0	19.7	18.4	21.2	0.4	2.1	12.5	8.8	10.0	12.3	18.6	25.1	3.8
TNRC6A	"CAGH26, GW182, KIAA1460, TNRC6"	ENSG00000090905	"Trinucleotide repeat containing adaptor 6A"	Q8NDV7	16	24610209-24827632	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"RNA-mediated gene silencing, Translation regulation"	RNA-binding	Epilepsy	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Astrocytes: 289.3;Excitatory neurons: 283.8;Inhibitory neurons: 414.6;Oligodendrocyte precursor cells: 265.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015305, HPA017869"	Approved		Approved	"Nucleoplasm,Golgi apparatus,Vesicles"		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 72: Non-specific - Transcription"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Nucleoplasm, Golgi apparatus, Vesicles"		"HPA015305: AB_1850454, HPA017869: AB_1850456"	"unprognostic (2.64e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.86e-1)"	"unprognostic (5.00e-2)"	"unprognostic (1.10e-3)"	"unprognostic (1.62e-1)"	"unprognostic (3.22e-3)"	"unprognostic (5.49e-2)"	"unprognostic (2.74e-1)"	"unprognostic (7.44e-3)"	"unprognostic (2.63e-3)"	"unprognostic (1.78e-1)"	"unprognostic (9.18e-2)"	"unprognostic (5.77e-2)"	"unprognostic (2.31e-1)"	"unprognostic (3.35e-2)"	17.2	21.0	5.0	6.4	3.6	6.0	14.9	10.8	7.1	17.8	6.1	17.8	5.5	23.5	11.5	11.3	17.7	6.4	11.1	3.4	6.6	10.3	13.0	12.8	7.1	6.1	4.8	20.6	19.2	13.2	22.8	6.6	6.1	14.6	6.4	7.0	14.9	8.0	14.0	13.1	15.3	8.1	2.2	9.9	15.2	6.6	7.0	8.6	17.8	6.9	7.4	13.0	13.4	7.4	10.1	13.8	16.0	8.7	13.6	17.7	9.1	16.9	13.6	12.0	13.1	10.2	8.2	10.2	7.1	17.0	12.4	11.2	20.1	14.2	18.0	10.4	10.4	10.2	16.7	14.1	11.7	10.5	6.9	18.0	7.3	15.8	10.2	14.8	16.7	6.6	15.7	6.2	15.8	11.9	8.8	6.9	23.1	4.9	6.8	17.1	12.4	9.1	9.1	9.3	7.7	10.8	11.8	7.2	6.6	12.1	8.4	6.8	15.5	15.3	10.5	7.6	12.0	13.7	11.6	16.5	14.3	6.4	11.3	0.5	0.5	0.4	0.5	0.3	0.4	1.1	0.5	0.5	0.2	1.0	0.7	0.5	0.3	0.6	0.3	1.0	0.5	0.3	5.0	3.6	10.8	7.1	3.4	6.6	6.1	4.8	6.1	2.2	7.0	7.4	51.2	38.5	60.0	289.3	45.5	34.9	17.8	21.9	39.9	97.1	42.8	41.0	75.3	51.5	32.3	46.0	118.9	22.4	49.9	38.3	17.6	23.6	17.2	38.7	65.5	45.5	55.9	34.9	283.8	24.5	15.1	50.5	33.6	42.8	39.3	76.5	60.3	115.3	21.2	176.7	414.6	36.3	22.4	56.2	26.5	11.3	69.0	28.7	30.2	138.7	36.1	42.0	50.4	265.4	234.2	28.5	36.1	81.3	44.7	26.0	42.8	19.2	29.8	81.7	19.7	52.8	60.9	41.2	30.6	38.1	28.7	8.2	39.0	36.5	35.8	17.4
TOMM34	"HTOM34P, TOM34"	ENSG00000025772	"Translocase of outer mitochondrial membrane 34"	Q15785	20	44942130-44960397	"Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 119.4"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 128.3;monocytes: 176.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018845, HPA056875"	Enhanced		Supported	Vesicles,Mitochondria,Cytosol		NA	NA		26000	"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 47: Cytotrophoblasts - Unknown function"	Cytosol	"Vesicles, Mitochondria"	"HPA018845: AB_1858184, HPA056875: AB_2683264"	"unprognostic (4.96e-2)"	"unprognostic (6.88e-2)"	"unprognostic (5.05e-2)"	"unprognostic (1.36e-3)"	"unprognostic (4.91e-2)"	"prognostic unfavorable (4.47e-5)"	"prognostic unfavorable (8.71e-6)"	"unprognostic (2.55e-1)"	"unprognostic (5.04e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.52e-2)"	"unprognostic (2.11e-2)"	"unprognostic (1.55e-2)"	"unprognostic (3.04e-1)"	"unprognostic (1.02e-1)"	"prognostic favorable (5.45e-4)"	"unprognostic (5.79e-3)"	13.4	46.0	31.4	13.6	40.3	20.1	14.6	24.3	51.7	14.5	28.3	14.6	11.8	14.8	49.0	19.5	49.1	13.6	16.0	54.6	32.6	28.6	18.8	14.0	15.2	29.0	26.1	26.4	18.0	24.4	26.6	29.6	28.0	18.8	18.4	9.0	15.7	16.9	18.0	14.6	13.7	15.4	24.7	14.9	15.8	119.4	33.6	18.3	16.5	15.2	22.0	26.2	12.7	35.7	133.6	46.0	40.1	85.6	36.3	35.6	90.2	75.6	109.6	92.8	67.1	187.4	48.6	90.9	63.5	59.6	94.2	82.1	98.8	164.0	107.3	16.1	46.2	71.7	58.2	133.7	46.2	47.5	42.3	38.7	45.2	129.8	230.8	80.9	95.8	36.6	82.6	36.4	89.3	88.2	50.2	65.4	47.1	70.7	172.8	43.1	42.2	98.9	76.1	73.7	68.3	40.4	103.5	71.0	91.8	30.7	53.5	40.8	57.2	121.5	80.0	58.9	114.8	31.2	40.1	75.4	110.9	55.8	48.2	15.9	16.9	15.3	14.8	17.5	15.4	25.4	15.3	15.7	39.7	28.6	17.1	13.7	4.6	14.8	18.8	21.1	19.3	17.3	31.4	40.3	24.3	51.7	54.6	32.6	29.0	26.1	28.0	24.7	33.6	35.7	7.3	6.4	11.5	3.6	15.0	13.8	84.6	17.2	14.8	3.1	14.1	11.2	10.3	5.7	15.5	12.9	4.2	128.3	8.7	7.7	31.3	38.4	18.5	17.5	7.2	13.0	12.0	17.2	6.8	30.7	38.0	14.8	16.8	14.8	9.5	28.2	6.4	9.1	22.7	3.3	4.8	9.3	8.2	5.9	47.2	32.9	6.8	10.3	7.2	5.6	176.9	17.4	7.2	3.5	2.7	46.2	9.5	6.4	16.9	69.1	6.9	22.5	44.3	4.2	0.0	5.6	13.6	43.0	56.2	15.7	11.1	56.5	8.8	24.0	13.6	55.9
TOMM5	"bA613M10.3, C9orf105, Tom5"	ENSG00000175768	"Translocase of outer mitochondrial membrane 5"	Q8N4H5	9	37582646-37592604	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA048712	Approved		Supported	Mitochondria		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	Mitochondria		"HPA048712: AB_2680499"	"unprognostic (1.81e-2)"	"unprognostic (1.96e-1)"	"unprognostic (3.37e-2)"	"unprognostic (3.34e-2)"	"unprognostic (2.02e-1)"	"unprognostic (2.82e-2)"	"prognostic unfavorable (2.09e-4)"	"unprognostic (9.89e-3)"	"prognostic unfavorable (5.49e-4)"	"prognostic favorable (2.37e-4)"	"unprognostic (7.80e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.25e-1)"	"unprognostic (3.23e-2)"	"unprognostic (3.07e-2)"	"unprognostic (2.37e-1)"	"unprognostic (9.09e-2)"	90.0	92.6	69.9	62.8	72.2	66.4	71.9	71.1	84.8	62.2	68.9	84.2	74.0	64.9	62.0	89.1	58.7	47.2	83.9	71.3	75.9	114.5	87.5	57.0	83.0	70.7	73.5	63.7	90.3	52.4	66.3	39.2	77.0	58.9	60.2	40.2	70.1	46.0	129.4	63.3	62.2	55.9	72.9	75.5	72.7	65.2	70.7	72.0	65.2	89.6	78.8	79.8	65.2	70.7	353.2	400.4	234.3	211.2	265.7	258.9	128.9	262.5	169.4	252.1	268.6	431.4	142.2	240.3	208.4	253.7	254.4	119.0	212.0	316.2	262.6	338.5	329.0	212.1	535.7	630.0	216.1	350.6	133.7	224.9	170.4	277.4	273.5	118.7	293.5	264.1	524.9	261.5	261.1	282.3	297.2	306.9	407.7	296.2	249.0	247.9	195.2	353.3	294.0	218.7	202.4	184.7	134.9	181.6	201.5	198.2	127.0	405.4	198.8	173.3	369.7	273.9	411.8	97.5	312.3	407.8	211.4	300.9	272.0	77.3	155.2	74.5	202.0	177.4	252.1	309.9	246.7	227.8	196.8	260.6	251.9	232.8	17.8	216.5	154.3	218.4	221.2	279.7	69.9	72.2	71.1	84.8	71.3	75.9	70.7	73.5	77.0	72.9	70.7	70.7	31.7	28.9	33.4	16.0	95.5	112.3	49.9	72.8	138.3	5.0	51.2	66.5	20.8	47.1	54.3	46.0	12.5	24.5	41.6	36.5	80.3	55.6	218.3	43.3	49.1	49.8	18.1	120.5	14.2	127.2	55.6	45.9	122.9	46.2	46.2	22.1	50.0	159.2	66.6	1.7	14.9	50.8	52.9	52.7	48.6	181.2	35.1	55.0	62.2	6.5	58.3	10.5	32.0	6.6	11.0	109.2	32.6	31.2	178.3	67.7	75.3	215.0	51.7	8.8	0.0	40.5	42.2	87.4	24.2	235.4	146.3	25.2	73.3	20.8	53.6	55.9
TOMM6	"OBTP, Tom6"	ENSG00000214736	"Translocase of outer mitochondrial membrane 6"	Q96B49	6	41787662-41789898	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"Alveolar cells type 2: 18.7;Astrocytes: 31.0;Club cells: 10.5;Excitatory neurons: 16.5;granulocytes: 8.8;Inhibitory neurons: 15.5;Microglial cells: 10.3;Oligodendrocyte precursor cells: 12.1;Oligodendrocytes: 26.3;Respiratory ciliated cells: 16.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"OE19: 2247.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004801	Approved		Supported	Mitochondria		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 11: Alveolar cells - Smell perception"	Mitochondria		"HPA004801: AB_1859553"																		176.9	267.7	240.1	136.8	246.2	228.0	219.9	246.7	320.8	158.4	254.4	158.2	101.8	139.7	270.3	234.0	162.9	96.2	285.9	245.2	248.1	271.8	232.2	143.6	207.5	243.9	242.9	179.0	208.3	193.3	143.2	141.2	245.5	177.6	177.1	128.8	166.1	120.3	272.4	196.4	134.8	132.3	250.1	200.3	170.2	133.9	245.5	192.6	161.4	232.8	260.9	166.5	153.9	254.2	647.0	319.0	372.7	382.2	337.6	398.5	391.6	312.2	324.8	390.3	380.4	559.4	295.3	289.3	373.3	370.1	445.4	201.2	597.3	523.3	505.9	409.8	619.8	525.5	382.4	928.6	264.9	708.7	328.6	362.0	529.4	431.8	366.2	277.1	480.4	407.1	1335.5	350.4	481.7	766.0	519.4	1124.8	329.7	2247.1	312.6	373.3	234.1	865.3	540.1	329.3	327.6	458.7	213.0	369.5	548.5	389.7	451.6	1411.8	342.8	272.0	340.9	274.2	478.8	318.6	751.6	1314.8	155.9	586.7	362.7	119.3	439.5	259.3	291.7	448.3	283.7	419.2	294.4	291.2	454.1	380.7	329.3	324.1	55.9	230.6	475.3	474.6	303.3	674.5	240.1	246.2	246.7	320.8	245.2	248.1	243.9	242.9	245.5	250.1	245.5	254.2	0.0	3.2	18.7	31.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.5	0.0	0.0	0.5	0.0	0.0	8.8	0.0	0.0	0.0	0.0	0.0	15.5	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	10.3	0.0	0.0	0.0	12.1	26.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0
TONSL	"IKBR, NFKBIL2"	ENSG00000160949	"Tonsoku like, DNA repair protein"	Q96HA7	8	144428775-144444440	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"DNA damage, DNA repair"		"Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 8.5"	"Cell type enhanced"	"Detected in many"		"Proximal enterocytes: 76.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA024679, HPA046494"	Uncertain		Supported	"Nucleoplasm,Nuclear bodies"		NA	Yes			"Cluster 48: NK-cells - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 45: Enterocytes - Digestion"	Nucleoplasm	"Nuclear bodies"	"HPA024679: AB_1854441, HPA046494: AB_2679673"	"unprognostic (6.68e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.40e-1)"	"unprognostic (2.88e-2)"	"unprognostic (7.35e-2)"	"unprognostic (2.10e-3)"	"prognostic unfavorable (2.84e-4)"	"unprognostic (1.04e-3)"	"unprognostic (7.81e-2)"	"unprognostic (4.39e-2)"	"unprognostic (3.38e-2)"	"unprognostic (2.19e-1)"	"prognostic unfavorable (2.62e-7)"	"unprognostic (3.24e-2)"	"unprognostic (1.78e-1)"	"unprognostic (9.11e-3)"	"unprognostic (7.96e-2)"	1.0	2.1	0.4	2.5	0.4	8.5	1.3	0.4	1.3	1.7	0.0	3.4	3.5	1.6	0.2	3.9	1.4	0.6	1.4	0.3	0.3	1.4	1.7	1.3	2.3	1.3	0.6	1.7	1.5	0.4	0.9	1.5	1.1	1.6	0.8	0.1	1.5	0.8	0.5	3.3	4.4	0.6	0.1	3.9	2.2	3.8	0.8	2.3	2.4	0.1	1.4	2.3	2.1	0.3	21.2	18.6	13.7	21.7	1.0	1.7	33.0	17.6	3.4	10.4	8.1	15.0	17.9	19.6	17.5	2.7	4.9	14.2	13.4	10.7	2.3	20.2	26.6	46.5	26.1	15.9	0.6	14.3	28.1	1.7	1.5	10.9	2.1	2.6	5.0	26.5	53.0	14.3	4.2	43.4	35.5	24.5	19.4	20.4	26.7	42.6	8.9	20.3	5.9	22.6	22.9	13.0	18.4	12.3	7.8	5.2	17.6	13.2	5.9	12.7	52.3	14.5	21.7	5.0	9.9	12.0	12.3	30.2	15.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.1	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.4	0.4	0.4	1.3	0.3	0.3	1.3	0.6	1.1	0.1	0.8	0.3	2.5	6.4	22.4	1.6	2.9	8.9	5.2	1.0	1.2	3.1	3.5	2.9	2.3	8.6	3.7	1.8	2.1	4.1	1.3	20.2	0.0	0.9	0.4	4.3	2.7	4.3	2.4	7.2	2.4	1.0	5.3	3.8	11.7	6.1	2.5	8.5	2.9	11.4	4.5	1.7	1.0	14.6	0.0	0.9	16.7	0.7	0.3	3.0	14.2	1.9	1.2	1.1	1.0	0.5	0.8	1.2	7.1	1.2	4.0	3.9	76.5	7.7	4.1	3.0	6.6	6.4	2.8	4.6	7.8	3.4	11.2	1.2	3.1	3.3	15.9	3.9
TOP1MT		ENSG00000184428	"DNA topoisomerase I mitochondrial"	Q969P6	8	143304384-143359979	"Enzymes, FDA approved drug targets, Predicted intracellular proteins"		"DNA-binding, Isomerase, Topoisomerase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"MOLT-4: 197.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA001915, HPA021542"	Approved		Supported	Mitochondria		NA	NA			"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 32: Non-specific - Translation"	Mitochondria		"HPA001915: AB_1080331, HPA021542: AB_1858186"	"unprognostic (5.02e-3)"	"unprognostic (3.79e-2)"	"unprognostic (6.57e-2)"	"unprognostic (6.92e-3)"	"unprognostic (2.32e-2)"	"unprognostic (1.04e-2)"	"unprognostic (3.05e-3)"	"unprognostic (1.44e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.50e-2)"	"unprognostic (4.42e-2)"	"prognostic unfavorable (1.52e-7)"	"unprognostic (3.66e-2)"	"unprognostic (3.62e-2)"	"unprognostic (8.55e-3)"	"unprognostic (5.66e-3)"	14.0	17.4	7.3	9.4	6.1	48.2	13.7	2.5	7.8	23.2	4.0	12.6	7.6	11.7	4.8	18.4	13.4	9.2	7.6	8.5	5.8	14.4	30.3	10.5	12.0	7.0	4.7	32.1	18.9	10.1	9.2	7.4	7.1	13.2	9.7	2.0	14.2	8.1	7.3	22.6	11.6	7.8	2.9	12.6	12.9	23.4	5.4	21.4	21.9	3.4	11.4	17.8	19.1	6.4	25.5	38.3	15.8	59.4	22.0	24.5	28.1	11.6	14.8	20.5	21.1	48.4	35.8	74.2	42.6	16.2	14.7	26.8	33.8	21.3	17.6	29.5	52.4	65.6	21.5	49.5	24.8	44.4	68.4	25.1	22.3	17.4	24.8	17.7	25.0	21.1	80.5	28.2	18.3	106.3	197.8	87.9	27.6	54.9	65.4	24.7	20.7	112.2	15.3	40.4	28.1	34.1	33.2	29.3	61.7	19.3	19.3	72.5	16.5	14.3	57.7	16.4	30.2	15.2	17.0	38.0	24.1	64.9	17.4	31.4	10.5	0.5	6.2	6.3	6.3	28.9	11.3	8.6	35.3	14.4	24.2	18.8	0.7	0.4	1.2	30.9	3.2	9.2	7.3	6.1	2.5	7.8	8.5	5.8	7.0	4.7	7.1	2.9	5.4	6.4	11.4	6.4	8.6	3.3	11.9	23.7	32.3	13.1	14.2	1.2	15.3	11.6	3.3	10.0	10.5	9.2	0.0	11.7	7.3	6.7	7.9	11.4	29.3	3.9	10.9	7.7	4.9	41.3	2.5	9.3	23.6	8.9	5.6	5.8	7.0	24.7	6.4	12.1	11.1	3.3	3.5	11.3	2.0	8.8	24.9	11.1	8.7	9.4	21.4	0.0	9.3	1.4	2.1	1.5	2.9	7.1	11.2	4.5	6.1	29.7	2.8	15.8	3.1	0.2	6.6	13.5	10.0	31.3	36.4	17.8	23.9	10.1	8.6	21.4	20.8	22.8
TOP2A	TOP2	ENSG00000131747	"DNA topoisomerase II alpha"	P11388	17	40388525-40417896	"Cancer-related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Biological rhythms"	"DNA-binding, Isomerase, Topoisomerase"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 127.8;testis: 65.7"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 216.8;Granulosa cells: 117.5;Spermatocytes: 621.2;Spermatogonia: 269.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Immune cell enhanced"	"Detected in some"		"T-reg: 2.4"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"basal ganglia: 4.2;white matter: 8.0"	"Low region specificity"	"Detected in some"			"CAB002448, HPA006458, HPA026773"	Enhanced	Approved	Supported	Nucleoplasm,Nucleoli		Yes	Yes			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	Nucleoli	"CAB002448: AB_564035, HPA006458: AB_1858189, HPA026773: AB_1858190"	"unprognostic (2.09e-1)"	"unprognostic (1.24e-1)"	"unprognostic (2.28e-3)"	"unprognostic (9.42e-3)"	"unprognostic (1.80e-1)"	"unprognostic (1.52e-1)"	"prognostic unfavorable (5.92e-6)"	"prognostic unfavorable (4.99e-4)"	"unprognostic (6.21e-3)"	"unprognostic (2.09e-1)"	"prognostic unfavorable (3.83e-5)"	"unprognostic (5.03e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (7.46e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.18e-1)"	"unprognostic (2.29e-1)"	2.2	2.5	0.2	20.0	0.2	42.0	5.4	0.1	0.7	5.0	1.1	17.8	18.1	3.9	0.3	29.0	1.5	2.6	1.2	0.2	0.2	1.2	2.8	4.1	40.3	0.2	0.8	1.0	0.9	0.3	0.3	15.9	0.5	1.4	19.8	0.1	4.3	0.5	0.3	15.3	17.0	7.6	0.2	9.9	8.9	65.7	1.1	127.8	1.9	0.2	42.5	6.0	9.6	0.4	212.6	275.6	343.1	158.0	16.8	33.9	76.3	283.3	151.5	255.0	224.2	130.5	157.6	339.4	140.1	96.7	152.7	326.5	266.8	113.5	339.5	182.7	177.8	224.8	167.9	216.7	1.6	318.4	228.6	7.4	9.2	179.8	181.4	55.1	136.3	216.5	247.5	225.8	279.2	72.6	372.3	209.6	143.0	152.4	108.3	310.7	531.9	141.3	61.6	133.3	201.6	144.6	229.3	281.4	89.4	198.2	236.9	143.2	90.3	167.0	233.2	195.5	276.7	128.4	154.9	290.7	94.3	214.9	285.0	0.2	0.0	0.0	0.2	0.0	0.0	0.6	0.3	0.3	0.1	0.1	0.0	0.0	0.1	1.4	0.1	0.0	2.4	0.4	0.2	0.2	0.1	0.7	0.2	0.2	0.2	0.8	0.5	0.2	1.1	0.4	1.0	0.0	2.0	0.3	17.4	11.7	3.7	15.0	2.2	0.0	18.7	17.1	1.3	2.8	5.8	0.0	0.0	72.9	6.1	19.8	0.0	0.8	20.3	12.7	15.8	9.3	0.0	216.8	0.2	0.0	92.4	23.3	23.0	10.0	0.0	117.5	20.7	5.4	83.5	0.0	0.1	34.2	18.3	33.9	13.2	19.1	4.7	14.1	1.8	0.0	2.6	0.0	3.1	0.0	0.1	0.3	3.5	1.9	31.3	3.1	3.4	0.1	1.8	0.0	72.3	0.5	19.5	621.2	269.6	45.1	6.1	8.9	14.8	4.3	61.0	6.9
TOPBP1	"Dpb11, KIAA0259, TOP2BP1"	ENSG00000163781	"DNA topoisomerase II binding protein 1"	Q92547	3	133598175-133662380	"Predicted intracellular proteins"	"DNA damage, DNA repair"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 104.1;Spermatocytes: 81.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022451, HPA036738, HPA036739"	Approved		Supported	"Nucleoplasm,Nuclear bodies"		No	No			"Cluster 46: Basophils - DNA binding"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	"Nuclear bodies"	"CAB022451: , HPA036738: AB_2675280, HPA036739: AB_2675281"	"unprognostic (7.72e-2)"	"unprognostic (8.54e-2)"	"unprognostic (2.77e-2)"	"prognostic unfavorable (5.76e-5)"	"unprognostic (2.05e-1)"	"unprognostic (3.05e-2)"	"prognostic unfavorable (4.66e-5)"	"unprognostic (8.03e-2)"	"unprognostic (3.98e-2)"	"unprognostic (2.59e-2)"	"prognostic unfavorable (1.88e-4)"	"unprognostic (2.74e-3)"	"unprognostic (8.65e-3)"	"unprognostic (7.97e-2)"	"unprognostic (2.52e-1)"	"unprognostic (7.64e-2)"	"unprognostic (1.60e-1)"	7.7	4.9	3.6	13.0	4.3	33.1	10.7	5.0	4.6	6.5	3.1	9.3	8.3	8.1	5.0	8.9	5.9	6.9	6.1	4.6	3.3	5.5	7.4	7.3	19.7	3.7	3.2	7.3	7.6	6.0	3.6	12.0	3.7	6.6	11.5	8.2	7.1	5.5	6.9	11.8	9.2	8.7	3.5	10.4	8.7	22.4	3.7	29.1	7.4	7.6	18.6	8.3	7.0	4.5	44.4	27.2	43.1	35.1	8.0	10.5	32.3	33.9	26.9	41.0	52.4	37.9	27.5	80.5	29.1	24.7	49.3	50.2	62.8	22.6	62.7	48.9	28.2	75.4	38.3	23.4	7.7	81.5	57.1	12.5	13.7	40.2	23.9	15.4	28.5	46.3	47.6	55.7	32.6	30.3	79.9	43.1	35.7	50.4	23.0	53.3	53.8	58.4	14.6	30.1	40.9	45.2	41.9	22.6	35.4	41.7	37.7	74.6	19.9	43.0	38.9	43.9	37.7	33.4	53.4	150.6	25.4	42.7	38.4	1.8	0.7	2.2	0.7	0.9	1.0	0.9	0.7	0.7	0.7	0.5	0.7	0.7	0.9	1.0	0.5	1.0	1.5	0.4	3.6	4.3	5.0	4.6	4.6	3.3	3.7	3.2	3.7	3.5	3.7	4.5	17.1	22.4	21.9	10.7	22.8	12.4	8.8	7.8	20.5	15.2	14.2	14.2	10.1	12.8	19.7	11.0	2.1	20.0	33.9	11.9	9.8	12.3	69.4	8.8	16.8	16.0	7.2	42.7	24.3	13.3	19.6	14.9	16.3	13.1	7.6	34.3	7.5	9.5	11.2	3.3	19.6	13.9	6.1	16.7	8.0	104.1	10.2	18.2	8.8	11.2	27.4	10.4	28.8	16.6	13.0	14.7	11.6	9.8	37.5	10.2	6.1	6.1	8.7	9.3	13.1	20.9	12.2	81.3	43.6	22.0	11.5	14.0	23.3	17.7	14.8	10.5
TOPORS	"LUN, RP31, TP53BPL"	ENSG00000197579	"TOP1 binding arginine/serine rich protein, E3 ubiquitin ligase"	Q9NS56	9	32540544-32552586	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"DNA damage, Ubl conjugation pathway"	Transferase	"Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 169.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 67.6"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 67.6"	"Cell line enhanced"	"Detected in all"		"HEL: 90.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA060640, HPA065661"	Supported		Supported	Nucleoplasm		NA	NA			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 34: Non-specific - Transcription"	"Cluster 36: HEL - Hemostasis"	"Cluster 29: Early spermatids - Spermatogenesis"	Nucleoplasm		"HPA060640: AB_2684334, HPA065661: AB_2685527"	"unprognostic (1.75e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.20e-2)"	"unprognostic (1.14e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.37e-2)"	"unprognostic (9.94e-2)"	"prognostic favorable (7.07e-4)"	"unprognostic (2.70e-1)"	"unprognostic (3.61e-1)"	"prognostic favorable (6.64e-6)"	"unprognostic (1.22e-1)"	"unprognostic (5.95e-2)"	"unprognostic (3.13e-1)"	"unprognostic (2.92e-1)"	9.8	9.8	5.4	8.4	6.3	25.2	12.4	10.5	8.5	10.3	7.3	9.2	8.3	11.4	10.0	9.9	7.6	8.7	6.8	5.4	6.6	13.2	16.2	9.3	9.3	6.1	6.1	15.3	8.6	14.0	6.9	10.0	6.2	11.2	9.3	11.5	7.6	9.3	7.2	9.6	8.8	11.2	5.9	10.5	8.9	14.8	6.6	14.5	14.1	10.4	10.1	10.3	7.2	8.3	16.6	15.1	20.4	17.9	24.4	21.8	12.9	20.7	19.5	16.9	19.5	9.5	8.3	26.8	11.7	20.8	14.8	10.9	24.2	23.5	23.6	22.5	13.3	90.8	25.2	11.9	15.1	26.1	24.0	17.9	25.8	24.4	17.1	20.9	20.8	20.1	16.1	13.6	27.9	8.9	23.5	47.6	27.2	12.3	15.2	23.9	18.1	12.2	22.5	17.2	10.1	16.1	20.7	11.2	13.8	22.9	11.3	14.7	22.0	18.4	18.6	9.6	15.5	9.5	16.2	28.5	17.0	14.8	8.4	38.8	10.0	21.3	9.6	9.8	10.3	9.4	10.4	11.4	10.2	10.8	13.9	13.8	67.6	15.0	13.6	8.2	13.5	7.3	5.4	6.3	10.5	8.5	5.4	6.6	6.1	6.1	6.2	5.9	6.6	8.3	69.2	54.5	32.0	10.7	49.1	47.2	45.3	33.7	61.5	46.8	32.7	28.6	18.4	25.8	37.0	25.8	37.5	31.9	63.4	26.3	19.6	25.1	169.9	36.2	38.1	48.8	45.9	66.5	14.5	18.4	16.9	42.0	25.0	45.5	41.8	43.6	26.4	24.3	17.7	55.5	15.5	22.9	44.7	19.1	35.3	21.8	33.2	31.8	19.6	7.5	30.4	43.5	36.0	13.0	22.4	21.1	24.3	32.7	39.5	39.0	24.3	22.7	22.3	42.0	19.7	54.0	48.2	54.4	53.7	39.0	47.6	50.8	55.4	43.1	24.0	49.8
TOR1A	"DQ2, DYT1"	ENSG00000136827	"Torsin family 1 member A"	O14656	9	129812942-129824244	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		"Chaperone, Hydrolase"	"Disease variant, Dystonia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012473, HPA051195"	Approved		Supported	"Nuclear membrane,Vesicles"	"Intracellular and membrane"	NA	NA		20000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 55: Plasma cells - Humoral immune response"	"Nuclear membrane, Vesicles"		"CAB012473: AB_2240792, HPA051195: AB_2681382"	"unprognostic (1.20e-1)"	"unprognostic (1.92e-1)"	"unprognostic (2.65e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.86e-3)"	"unprognostic (3.67e-2)"	"prognostic unfavorable (5.45e-4)"	"unprognostic (2.10e-2)"	"unprognostic (1.41e-1)"	"unprognostic (4.10e-2)"	"unprognostic (2.86e-1)"	"unprognostic (1.35e-1)"	"unprognostic (3.39e-1)"	"unprognostic (1.91e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.99e-1)"	21.2	24.2	14.3	20.7	14.8	34.5	19.6	14.7	17.7	18.6	14.2	20.7	16.6	20.3	19.9	14.3	17.2	20.6	16.8	15.7	15.9	20.5	35.9	19.4	22.9	13.6	14.0	17.2	19.5	19.4	14.3	23.5	14.0	21.3	22.3	9.8	17.0	23.1	16.4	17.8	18.8	25.4	14.1	18.8	18.1	9.2	15.4	26.3	23.8	14.9	19.0	28.6	15.6	14.8	33.7	49.5	35.9	41.5	53.1	51.3	47.4	76.7	94.5	67.0	57.2	32.3	48.2	41.0	44.0	99.7	46.0	77.2	34.7	50.8	54.7	65.7	32.9	36.9	49.8	32.3	66.9	82.1	65.5	69.8	50.7	63.5	45.6	61.5	73.2	65.3	66.5	32.3	74.6	84.3	58.9	79.3	53.8	39.2	55.6	30.5	56.5	41.9	54.9	42.4	27.0	47.6	79.3	30.7	43.3	40.1	61.6	63.4	65.1	66.1	37.7	49.6	59.6	36.6	87.0	37.7	49.0	46.9	54.3	95.5	72.8	141.3	57.4	68.5	48.1	45.5	48.4	52.1	61.4	33.5	40.9	42.4	72.7	68.6	58.3	56.5	59.1	78.9	14.3	14.8	14.7	17.7	15.7	15.9	13.6	14.0	14.0	14.1	15.4	14.8	25.0	9.6	11.8	5.5	17.5	17.6	16.6	39.5	12.0	11.2	16.5	15.9	9.9	18.6	24.4	14.7	2.1	47.9	39.3	18.7	15.6	42.1	0.7	12.5	18.8	24.2	19.2	30.5	6.3	49.9	65.7	25.0	13.7	15.0	22.2	23.4	16.1	22.7	45.2	21.9	6.4	17.8	26.4	19.1	22.4	1.3	12.8	27.9	14.2	3.7	47.6	18.5	35.0	9.5	6.6	40.1	18.9	15.4	23.7	24.7	21.0	17.0	14.9	9.2	32.9	15.2	24.3	7.3	10.1	9.3	18.5	53.4	25.5	23.4	15.4	19.6
TOX2	"C20orf100, dJ1108D11.2, GCX-1"	ENSG00000124191	"TOX high mobility group box family member 2"	Q96NM4	20	43914852-44069616	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 50.2"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 22.3;Excitatory neurons: 20.5;Hepatic stellate cells: 34.2;Inhibitory neurons: 76.9;Oligodendrocyte precursor cells: 45.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"eosinophil: 6.5"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HHSteC: 92.0;U-266/70: 57.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA049900, HPA058396"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm		"HPA049900: AB_2680942, HPA058396: AB_2683704"	"unprognostic (2.15e-2)"	"unprognostic (1.82e-2)"	"unprognostic (8.97e-3)"	"prognostic unfavorable (2.60e-4)"	"unprognostic (1.33e-1)"	"unprognostic (1.01e-1)"	"unprognostic (7.53e-3)"	"unprognostic (6.29e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.86e-1)"	"unprognostic (1.75e-2)"	"unprognostic (2.78e-2)"	"prognostic unfavorable (7.45e-8)"	"unprognostic (1.60e-1)"	"unprognostic (2.00e-1)"	"unprognostic (7.60e-2)"	"unprognostic (3.12e-1)"	10.0	4.0	11.2	6.2	8.2	1.8	6.8	4.9	18.4	10.2	2.3	7.6	1.3	6.2	1.1	12.8	3.6	2.9	3.6	8.3	35.7	5.1	5.2	36.4	13.3	12.3	18.8	3.1	2.0	10.1	24.6	2.6	15.9	16.7	2.4	1.9	3.8	2.7	1.5	5.1	10.2	1.6	5.8	5.7	9.7	20.8	25.9	50.2	7.4	6.4	8.1	17.6	8.9	10.6	9.9	12.5	4.9	0.9	4.7	13.3	0.1	11.5	5.3	8.1	8.9	0.0	4.0	0.0	16.8	16.6	35.2	5.1	3.2	0.3	8.4	15.5	2.7	0.0	1.1	0.0	92.0	0.1	19.4	31.0	14.0	27.0	1.6	25.8	9.4	9.5	0.0	14.5	4.6	11.3	3.2	4.5	3.0	0.3	42.2	0.0	10.1	15.4	0.0	1.2	4.3	35.8	2.4	0.0	18.0	0.5	0.0	9.2	11.3	0.0	7.5	0.3	0.1	57.4	13.5	9.0	16.9	0.1	27.0	0.0	0.2	6.5	0.0	0.1	0.0	0.1	0.3	0.1	0.0	0.0	0.1	0.0	0.7	1.1	0.0	2.6	1.2	0.1	11.2	8.2	4.9	18.4	8.3	35.7	12.3	18.8	15.9	5.8	25.9	10.6	8.0	0.0	0.6	3.9	3.4	1.0	1.0	0.7	0.0	0.8	0.2	0.1	0.8	1.5	0.1	0.0	0.0	0.0	7.3	0.3	0.0	0.1	22.3	0.3	8.9	8.9	0.0	0.0	20.5	0.2	0.1	6.7	1.5	0.3	0.0	10.7	34.2	0.5	1.5	3.3	76.9	0.6	0.0	2.9	3.6	17.3	1.8	1.2	1.8	3.7	0.2	4.6	1.0	45.2	0.5	0.1	2.2	0.7	12.1	0.5	0.0	0.1	0.0	0.1	0.0	0.4	8.7	1.3	1.8	0.2	1.3	0.3	10.5	0.1	1.8	0.3
TOX3	"CAGF9, TNRC9"	ENSG00000103460	"TOX high mobility group box family member 3"	O15405	16	52436417-52547802	"Predicted intracellular proteins, Transcription factors"	"Apoptosis, Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 17.9;retina: 17.6;stomach 1: 20.3"	"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 52.9;Enteroendocrine cells: 61.7;Inhibitory neurons: 138.9;Muller glia cells: 162.1;Oligodendrocyte precursor cells: 51.8;Oligodendrocytes: 75.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 46.1;HAP1: 22.1;Hep G2: 20.8;OE19: 25.8;RT4: 97.1;SCLC-21H: 30.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA040240, HPA040376"	Enhanced		Enhanced	Nucleoplasm,Cytosol		NA	NA				"Cluster 45: Intestine - Brush border"	"Cluster 15: RT4 - Unknown function"	"Cluster 5: Muller glia cells - Visual perception"	Nucleoplasm	Cytosol	"HPA040240: , HPA040376: AB_10795522"	"unprognostic (1.14e-2)"	"unprognostic (9.75e-3)"	"unprognostic (9.08e-3)"	"unprognostic (3.32e-2)"	"unprognostic (3.50e-1)"	"unprognostic (2.31e-1)"	"unprognostic (4.74e-3)"	"unprognostic (1.28e-1)"	"unprognostic (2.00e-1)"	"unprognostic (2.94e-2)"	"unprognostic (2.59e-1)"	"unprognostic (4.60e-3)"	"prognostic favorable (3.08e-12)"	"unprognostic (1.19e-1)"	"unprognostic (1.31e-1)"		"prognostic favorable (3.95e-4)"	0.4	3.0	4.7	1.4	5.6	0.0	3.8	1.2	6.0	7.6	0.3	15.6	9.3	1.3	4.4	0.6	3.1	6.9	0.0	5.3	4.4	9.5	5.2	1.4	0.1	4.6	3.5	0.9	2.6	0.0	2.3	0.2	3.0	1.8	17.9	17.6	8.9	0.5	4.0	0.7	9.3	1.0	5.1	0.0	20.3	0.6	8.4	1.3	0.0	0.5	0.2	5.7	1.0	6.8	0.0	5.8	46.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	22.1	0.0	0.0	0.0	3.5	0.0	0.3	20.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	11.6	25.8	0.0	0.0	8.0	0.2	10.7	97.1	30.0	0.0	0.0	0.3	0.0	2.3	0.0	0.0	0.0	0.0	0.9	0.1	0.0	0.0	0.0	0.1	0.1	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.7	5.6	1.2	6.0	5.3	4.4	4.6	3.5	3.0	5.1	8.4	6.8	0.2	6.4	8.2	1.3	0.0	1.0	0.5	2.8	0.6	4.1	20.0	12.6	0.7	52.9	7.7	35.0	0.0	0.0	0.0	47.6	3.9	1.6	3.2	1.6	0.4	0.3	61.7	0.0	3.9	5.1	0.0	1.5	29.6	6.1	0.0	0.1	0.7	4.6	0.1	40.4	138.9	31.7	2.0	0.0	0.3	1.8	0.6	0.2	0.0	8.4	0.0	162.1	0.0	51.8	75.0	15.3	15.2	0.0	0.2	11.8	16.6	14.0	12.3	3.8	0.0	3.3	0.8	0.1	0.8	0.3	0.3	0.0	0.4	9.7	32.6	6.5
TP53	"LFS1, p53"	ENSG00000141510	"Tumor protein p53"	P04637	17	7661779-7687538	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transcription factors, Transporters"	"Apoptosis, Biological rhythms, Cell cycle, Host-virus interaction, Necrosis, Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"	"Cancer-related genes, Disease variant, Li-Fraumeni syndrome, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002973, CAB039238, CAB039239, HPA051244, HPA063532, CAB072876, CAB079965"	Enhanced		Supported	Nucleoplasm,Mitochondria,Cytosol		Yes	No			"Cluster 39: Non-specific - mRNA processing"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 14: REH - Unknown function"	"Cluster 32: Non-specific - Translation"	Nucleoplasm	"Mitochondria, Cytosol"	"CAB002973: AB_2206626, CAB039238: , CAB039239: , CAB072876: AB_2665731, CAB079965: , HPA051244: AB_2681403, HPA063532: "	"unprognostic (2.29e-2)"	"unprognostic (8.83e-3)"	"unprognostic (1.26e-2)"	"prognostic favorable (1.35e-4)"	"unprognostic (9.95e-2)"	"unprognostic (4.00e-2)"	"unprognostic (2.79e-3)"	"unprognostic (4.99e-2)"	"unprognostic (2.75e-2)"	"unprognostic (2.55e-1)"	"unprognostic (1.30e-1)"	"prognostic unfavorable (5.01e-4)"	"unprognostic (1.86e-3)"	"unprognostic (7.89e-3)"	"unprognostic (8.05e-2)"	"unprognostic (2.74e-1)"	"unprognostic (1.08e-1)"	19.3	13.8	10.4	27.1	12.6	19.6	22.5	10.4	16.5	19.9	10.3	29.0	18.9	24.5	12.8	28.8	31.3	13.2	11.1	10.1	11.4	14.9	16.5	15.1	34.6	18.7	13.6	27.3	18.3	9.4	7.3	23.5	12.5	17.7	27.5	4.1	18.9	15.3	12.3	37.4	20.4	24.6	12.6	31.1	22.6	10.4	12.3	47.2	17.4	6.1	45.4	20.8	19.9	13.3	81.5	145.3	81.1	57.3	37.3	43.9	82.8	28.4	66.1	78.5	100.2	4.2	40.6	190.5	126.9	58.7	77.6	174.9	119.7	80.4	72.8	42.7	76.5	77.6	76.8	70.9	111.5	1.6	37.0	55.7	93.0	38.9	106.5	45.6	79.4	24.7	3.8	6.9	41.5	145.1	130.0	96.3	80.2	10.4	2.4	252.2	56.1	66.2	59.4	87.3	46.0	80.5	94.1	62.6	24.3	39.4	109.2	7.4	100.7	91.6	30.2	1.0	48.3	47.6	37.9	82.5	23.6	9.7	80.1	1.2	21.2	3.4	13.0	21.7	15.9	21.5	13.3	14.6	30.3	19.1	13.7	15.4	2.4	17.5	19.3	27.3	17.3	14.7	10.4	12.6	10.4	16.5	10.1	11.4	18.7	13.6	12.5	12.6	12.3	13.3	21.1	9.6	12.8	16.3	26.0	28.7	14.5	24.6	24.5	2.6	36.1	30.4	2.5	18.6	15.4	20.2	0.0	36.9	24.7	16.9	9.8	24.8	12.8	11.5	29.0	24.5	30.7	21.7	2.1	18.1	39.6	17.0	11.2	19.5	1.3	31.7	22.1	18.0	24.2	0.0	3.2	43.0	18.3	27.8	20.1	3.8	23.0	19.3	12.4	7.5	31.9	4.9	25.7	9.0	8.0	15.8	16.4	17.0	7.8	15.7	10.3	10.1	8.8	2.6	13.1	25.9	20.6	0.5	4.9	28.7	32.8	22.4	16.5	27.4	54.1	11.5
TP53BP1	"53BP1, p202, TDRD30"	ENSG00000067369	"Tumor protein p53 binding protein 1"	Q12888	15	43403061-43510728	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"DNA damage, DNA repair, Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004083, HPA008788, HPA022133, CAB079980"	Supported		Supported	"Nucleoplasm,Nuclear bodies,Mitotic chromosome,Vesicles"		Yes	No			"Cluster 46: Basophils - DNA binding"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 12: NES - Nervous system development"	"Cluster 52: Non-specific - Transcription"	"Nuclear bodies"	"Nucleoplasm, Mitotic chromosome, Vesicles"	"CAB004083: AB_10694558, CAB079980: , HPA008788: AB_1078070, HPA022133: AB_1844382"	"unprognostic (2.12e-1)"	"unprognostic (7.96e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.85e-2)"	"unprognostic (4.42e-3)"	"unprognostic (2.32e-1)"	"unprognostic (2.03e-2)"	"unprognostic (3.96e-1)"	"unprognostic (2.17e-1)"	"unprognostic (2.81e-2)"	"unprognostic (3.34e-2)"	"unprognostic (4.07e-1)"	"unprognostic (8.06e-2)"	"unprognostic (9.11e-2)"	"unprognostic (1.52e-1)"	"unprognostic (6.99e-2)"	"unprognostic (3.38e-2)"	6.9	11.5	17.4	10.1	16.6	11.5	10.7	19.9	14.5	17.7	21.5	9.7	6.4	16.0	15.9	6.1	14.7	10.7	8.8	15.4	26.3	9.1	4.1	8.3	8.6	13.5	16.7	16.8	7.4	22.3	24.1	12.2	15.7	12.1	10.2	22.0	10.1	12.8	7.2	9.2	6.4	16.3	9.6	8.7	7.6	21.6	23.0	15.3	17.9	11.0	12.6	11.2	8.7	12.1	13.5	22.3	63.8	40.1	25.8	31.9	15.8	22.8	33.8	31.0	39.1	19.4	15.8	14.5	19.2	39.0	66.9	32.4	46.3	27.5	36.8	38.9	15.8	27.1	40.1	11.7	16.8	30.2	37.4	24.9	19.0	41.8	31.2	51.7	37.4	24.2	26.9	12.3	36.5	9.6	23.7	14.1	41.1	24.2	13.9	25.1	23.9	9.3	22.9	31.8	57.3	26.8	33.8	14.3	8.5	48.6	29.9	16.9	27.5	33.7	22.3	27.0	20.5	9.8	22.4	33.0	27.6	14.6	17.5	1.4	0.5	1.0	1.6	0.7	1.3	1.9	1.6	1.6	1.2	1.8	1.8	1.6	0.6	0.9	0.5	1.3	1.4	0.7	17.4	16.6	19.9	14.5	15.4	26.3	13.5	16.7	15.7	9.6	23.0	12.1	11.5	22.4	22.3	53.2	17.8	6.4	10.2	10.0	13.6	32.4	17.4	13.2	14.9	5.7	20.8	29.5	47.9	13.4	11.1	7.4	9.8	14.5	38.8	47.0	44.8	16.8	41.9	8.4	66.2	7.1	11.2	23.9	14.8	26.8	26.6	47.0	15.0	3.3	10.8	47.1	81.9	15.7	12.2	3.8	6.9	17.8	23.6	9.3	1.8	17.8	4.0	11.9	7.2	62.8	50.4	7.5	5.8	17.7	17.1	11.0	2.6	8.8	60.7	51.7	13.1	35.2	20.5	33.1	36.2	14.7	5.3	18.5	17.0	29.9	13.4	8.9
TP53I11	PIG11	ENSG00000175274	"Tumor protein p53 inducible protein 11"	O14683	11	44885903-44951306	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	4	"Late spermatids: 461.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 41.2"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"NB-4: 133.9;SCLC-21H: 357.9;T-47d: 209.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA059727, HPA061276"	Uncertain		Supported	"Endoplasmic reticulum,Golgi apparatus"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 25: Spermatids - Spermatogenesis"	"Endoplasmic reticulum, Golgi apparatus"		"HPA059727: AB_2684113, HPA061276: AB_2684461"	"prognostic unfavorable (7.33e-5)"	"unprognostic (1.87e-1)"	"unprognostic (4.03e-2)"	"unprognostic (3.44e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.66e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.50e-1)"	"prognostic unfavorable (6.12e-4)"	"unprognostic (6.55e-2)"	"unprognostic (2.55e-1)"	"unprognostic (1.92e-1)"	"prognostic unfavorable (4.65e-4)"	"unprognostic (2.14e-2)"	"unprognostic (1.64e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.10e-1)"	77.8	18.6	41.1	20.4	17.8	29.6	63.7	40.5	27.5	32.8	19.7	43.4	20.2	36.0	4.9	24.5	45.5	24.7	71.7	24.7	27.6	27.9	10.5	45.7	12.7	16.9	30.2	20.0	37.7	5.6	20.3	23.9	24.1	47.8	27.5	2.2	42.7	11.7	15.0	30.3	38.8	32.8	19.5	61.2	29.9	16.2	18.3	9.1	41.0	10.3	12.3	29.2	32.0	13.4	0.0	82.0	27.3	38.2	28.0	2.2	0.5	23.9	46.3	8.5	10.7	5.1	0.5	14.3	20.5	6.9	21.7	14.5	14.6	0.5	2.8	28.0	12.3	1.3	0.8	0.0	52.5	0.8	101.1	118.0	1.9	11.5	4.9	2.0	29.6	31.6	2.2	0.1	11.3	73.0	1.4	133.9	48.9	53.4	26.9	60.3	16.1	7.2	0.0	5.2	357.9	13.0	44.2	96.8	0.1	33.9	209.9	7.5	6.8	55.8	39.3	87.3	0.1	0.5	0.5	0.3	0.1	7.8	16.1	0.0	5.9	0.0	5.2	5.8	7.0	8.0	1.0	5.1	4.7	8.4	0.0	1.7	41.2	8.1	21.2	25.3	0.9	4.8	41.1	17.8	40.5	27.5	24.7	27.6	16.9	30.2	24.1	19.5	18.3	13.4	52.2	22.4	30.9	0.3	13.2	10.8	36.9	12.9	13.6	1.7	29.5	22.7	10.3	24.3	23.7	42.3	0.0	57.8	8.7	31.0	1.9	32.0	96.5	9.0	6.3	45.1	36.0	3.2	2.7	21.3	22.0	15.0	23.0	9.7	0.0	7.8	76.8	1.6	35.7	0.0	10.2	30.1	38.7	7.5	20.3	461.2	12.2	9.3	10.6	5.6	11.5	0.8	0.0	0.0	0.5	28.5	16.0	7.5	2.1	28.6	17.7	0.1	14.5	0.8	13.1	1.4	22.4	3.4	6.3	4.4	4.4	68.3	8.7	5.1	54.0	45.7
TP53I3	PIG3	ENSG00000115129	"Tumor protein p53 inducible protein 3"	Q53FA7	2	24077433-24085861	"Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 119.2"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 175.8;Late spermatids: 213.9;Proximal enterocytes: 200.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in many"	6	"T-47d: 599.7"					"Low region specificity"	"Detected in all"			"CAB017479, HPA022012, HPA028742"	Enhanced		Supported	Vesicles		NA	NA		250000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 37: Intestine - Unknown function"	"Cluster 6: T47d - Mammary gland"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Vesicles		"CAB017479: AB_2303667, HPA022012: AB_1858202, HPA028742: AB_10603456"	"unprognostic (3.66e-2)"	"unprognostic (1.41e-3)"	"unprognostic (5.55e-2)"	"unprognostic (8.04e-2)"	"unprognostic (7.10e-3)"	"unprognostic (4.47e-1)"	"unprognostic (1.09e-2)"	"unprognostic (1.53e-3)"	"unprognostic (1.17e-1)"	"unprognostic (2.83e-2)"	"unprognostic (3.52e-2)"	"unprognostic (1.75e-1)"	"unprognostic (9.89e-2)"	"unprognostic (1.40e-1)"	"unprognostic (2.86e-1)"	"unprognostic (3.67e-2)"	"unprognostic (8.57e-3)"	20.2	24.6	8.6	16.1	9.8	20.0	17.2	8.4	9.6	29.6	11.2	54.4	51.5	17.3	4.5	119.2	16.5	26.3	15.4	7.5	9.0	46.8	15.2	29.9	7.2	9.4	11.1	8.2	40.1	7.0	11.7	10.6	8.5	15.0	40.8	2.0	25.3	11.2	6.2	8.0	69.1	16.9	7.7	11.9	25.3	38.4	13.0	14.2	23.6	5.9	10.1	22.3	63.8	9.7	27.5	86.8	50.6	21.1	38.8	85.3	37.2	27.3	32.3	22.6	31.1	22.1	48.4	3.5	15.0	44.0	6.1	8.0	13.1	46.5	13.8	21.6	2.0	8.7	33.3	57.5	25.2	4.1	15.3	92.3	72.3	60.2	14.7	46.1	102.0	16.3	7.3	23.4	95.5	18.1	5.0	0.6	39.2	30.8	36.0	10.1	45.7	0.9	38.1	41.4	7.2	32.9	35.1	7.8	6.1	40.5	599.7	5.6	80.6	26.9	63.8	18.5	13.7	10.6	7.4	3.0	8.9	0.4	7.0	11.8	19.1	16.9	0.2	12.6	0.2	4.9	0.2	0.6	16.0	5.5	0.1	0.4	4.1	0.3	5.6	7.1	0.5	6.1	8.6	9.8	8.4	9.6	7.5	9.0	9.4	11.1	8.5	7.7	13.0	9.7	19.2	28.9	38.4	3.9	6.8	4.7	24.7	69.7	6.8	0.8	25.8	33.0	9.0	50.1	51.9	42.3	0.0	41.9	1.1	175.8	109.5	93.5	127.8	50.4	47.4	20.3	79.4	7.2	0.4	134.7	31.9	30.6	83.6	68.2	12.7	85.8	23.9	12.9	45.0	0.0	0.4	63.9	57.0	22.9	11.1	213.9	7.8	20.9	14.2	4.7	23.9	9.5	0.0	5.0	0.3	91.1	138.5	9.1	8.0	11.4	200.9	104.7	19.2	1.9	19.7	14.1	36.8	56.6	14.3	38.8	7.0	28.9	3.4	16.2	75.2	49.9
TP53INP1	"DKFZp434M1317, FLJ22139, P53DINP1, SIP, Teap, TP53INP1A, TP53INP1B"	ENSG00000164938	"Tumor protein p53 inducible nuclear protein 1"	Q96A56	8	94925972-94949378	"Predicted intracellular proteins"	"Apoptosis, Autophagy, Transcription, Transcription regulation"	"Activator, Antioxidant"	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 101.9"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 175.6;Plasma cells: 233.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 54.6"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 54.6"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 79.7;U-266/70: 85.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005856	Uncertain		Supported	Cytosol		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 55: Plasma cells - Humoral immune response"	Cytosol		"HPA005856: AB_10600832"	"unprognostic (1.39e-2)"	"unprognostic (4.47e-3)"	"unprognostic (7.17e-2)"	"unprognostic (2.70e-1)"	"unprognostic (5.31e-2)"	"prognostic favorable (1.11e-4)"	"unprognostic (5.72e-2)"	"unprognostic (1.16e-3)"	"unprognostic (1.28e-1)"	"unprognostic (7.54e-2)"	"unprognostic (5.00e-3)"	"unprognostic (1.23e-2)"	"unprognostic (1.87e-2)"	"unprognostic (9.83e-2)"	"unprognostic (3.13e-1)"	"unprognostic (1.18e-2)"	"prognostic favorable (5.45e-5)"	11.2	10.6	6.4	23.1	7.9	42.1	12.7	6.0	7.6	11.8	9.7	16.5	17.2	12.7	12.6	10.9	14.7	10.9	10.9	5.5	6.5	11.5	101.9	25.3	36.0	8.5	6.8	9.0	60.4	10.1	7.1	14.4	7.0	22.5	20.2	17.6	17.9	9.2	9.2	13.1	35.5	12.2	7.0	40.6	25.6	28.6	8.0	29.3	10.2	8.6	41.1	13.3	8.7	8.8	0.5	2.5	24.1	9.3	29.4	27.6	24.8	5.8	13.5	2.6	6.2	2.2	0.6	5.3	12.4	11.2	2.3	4.2	0.0	9.5	5.8	0.3	3.0	3.4	5.3	14.8	19.7	0.0	16.8	45.4	22.2	6.9	2.8	22.4	39.8	2.6	1.8	79.7	12.4	1.7	4.0	1.5	2.3	0.1	0.7	3.4	1.9	29.4	6.3	26.5	3.3	19.5	3.6	2.0	5.2	38.5	11.8	3.3	27.6	4.8	5.8	0.0	0.9	85.4	18.9	2.3	8.4	0.0	0.0	54.6	3.7	11.7	1.4	3.6	1.3	11.5	4.0	2.7	1.4	9.7	0.8	0.6	16.9	5.2	2.3	1.4	6.6	2.5	6.4	7.9	6.0	7.6	5.5	6.5	8.5	6.8	7.0	7.0	8.0	8.8	18.5	35.3	35.7	10.7	70.0	4.6	3.0	17.9	8.0	5.2	27.4	11.6	13.2	75.8	27.9	11.0	27.1	6.1	10.1	27.5	3.9	9.3	17.3	39.9	18.1	14.2	83.9	6.7	0.9	21.3	1.5	11.4	11.2	35.9	4.5	18.8	29.3	175.6	12.5	1.7	2.9	20.9	20.3	44.2	5.6	43.3	7.2	12.6	16.0	16.9	17.7	5.3	3.1	12.1	11.0	18.0	32.2	10.1	233.2	18.1	21.6	9.6	66.4	19.8	6.6	11.0	12.7	18.9	5.6	10.8	6.5	5.7	17.9	26.8	4.8	8.7
TP53TG5	"C20orf10, CLG01, dJ453C12.5"	ENSG00000124251	"TP53 target 5"	Q9Y2B4	20	45372557-45407889	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"testis: 17.8"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 671.5;Late spermatids: 254.4;Oligodendrocytes: 157.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CACO-2: 2.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA041979, HPA058510, HPA077455"	Enhanced		Supported	"Nucleoli,Nucleoli rim,Mitotic chromosome"		Yes	NA				"Cluster 78: Testis - Spermatogenesis"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 29: Early spermatids - Spermatogenesis"	"Nucleoli, Nucleoli rim"	"Mitotic chromosome"	"HPA041979: AB_2677778, HPA058510: , HPA077455: "	"unprognostic (2.86e-1)"	"unprognostic (1.28e-1)"	"unprognostic (2.18e-1)"	"unprognostic (3.40e-3)"	"unprognostic (1.70e-1)"	"unprognostic (1.63e-3)"	"unprognostic (2.29e-3)"	"unprognostic (3.10e-3)"	"unprognostic (9.26e-2)"	"unprognostic (3.56e-2)"	"unprognostic (1.72e-5)"	"unprognostic (2.09e-2)"	"unprognostic (7.46e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.46e-1)"	"unprognostic (4.72e-4)"	"unprognostic (1.41e-1)"	0.1	0.1	1.1	0.2	1.8	0.7	0.1	0.9	2.6	0.1	1.4	0.3	0.1	0.2	0.4	0.1	0.2	0.2	0.2	1.1	1.5	0.1	0.1	0.2	0.4	1.8	1.5	0.1	0.1	0.0	0.2	0.1	2.0	0.1	0.0	0.8	0.2	0.0	0.2	0.2	0.2	0.0	0.7	0.2	0.2	17.8	1.7	0.0	0.2	0.0	0.0	0.2	0.1	3.5	0.3	0.7	0.4	1.1	0.0	0.0	0.3	0.2	0.0	0.0	0.0	2.1	0.3	0.3	0.2	0.0	0.2	0.8	0.0	0.0	0.0	0.1	0.3	0.4	1.0	0.6	0.0	0.6	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.4	0.1	0.0	0.5	0.4	0.3	0.1	0.3	0.3	0.0	0.2	0.2	0.0	0.4	0.4	0.3	1.0	0.4	0.2	0.1	1.1	0.1	0.6	1.4	0.4	0.9	0.2	0.3	0.4	0.0	0.7	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	1.8	0.9	2.6	1.1	1.5	1.8	1.5	2.0	0.7	1.7	3.5	0.1	0.0	0.0	2.9	0.0	0.1	0.4	0.0	0.0	0.8	0.5	0.3	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	671.5	0.5	0.2	0.3	0.0	0.0	7.6	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	7.8	0.5	0.0	0.0	1.1	254.4	4.7	0.1	0.0	1.9	0.0	0.1	0.0	2.5	157.5	0.0	1.2	4.5	0.0	0.2	0.2	0.1	0.3	1.0	0.0	0.4	1.2	2.1	1.8	0.0	1.1	0.0	0.1	0.0	0.3	0.9
TP73	P73	ENSG00000078900	"Tumor protein p73"	O15350	1	3652516-3736201	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Apoptosis, Cell cycle, Host-virus interaction, Transcription, Transcription regulation"	"Activator, DNA-binding"	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"choroid plexus: 8.0;fallopian tube: 6.7;skin 1: 6.6"	"Cell type enhanced"	"Detected in some"		"Basal respiratory cells: 13.0;Basal squamous epithelial cells: 16.5;Early spermatids: 21.8;Endometrial ciliated cells: 31.0;Late spermatids: 15.7;Respiratory ciliated cells: 35.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"MOLT-4: 15.0;RH-30: 11.6;SCLC-21H: 18.0;U-698: 18.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"CAB002514, CAB003022, HPA027314, HPA044516"	Enhanced		Supported	"Nucleoplasm,Golgi apparatus"		NA	Yes				"Cluster 27: Brain & Skin - Unknown function"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 49: Ciliated cells - Cilium organization"	Nucleoplasm	"Golgi apparatus"	"CAB002514: AB_563940, CAB003022: , HPA027314: AB_2672215, HPA044516: AB_2678971"	"unprognostic (5.71e-3)"	"prognostic favorable (2.98e-4)"	"unprognostic (2.71e-1)"	"prognostic favorable (1.82e-4)"	"unprognostic (5.58e-2)"	"prognostic favorable (9.50e-4)"	"unprognostic (5.25e-2)"	"unprognostic (2.18e-1)"	"unprognostic (4.27e-1)"	"unprognostic (1.99e-1)"	"unprognostic (5.33e-2)"	"unprognostic (3.99e-1)"	"unprognostic (1.26e-7)"	"unprognostic (1.77e-2)"	"unprognostic (1.10e-1)"	"unprognostic (7.33e-2)"	"unprognostic (1.65e-1)"	0.0	0.0	0.7	0.7	0.5	0.5	0.8	4.2	0.5	1.4	8.0	0.2	0.0	0.1	0.1	3.7	6.7	0.0	0.1	0.8	0.7	0.1	0.2	0.9	1.0	2.4	2.9	0.1	0.8	0.1	0.3	0.0	1.4	2.6	0.1	0.2	2.9	0.3	0.2	6.6	0.2	0.0	1.4	0.7	0.3	0.7	0.7	1.6	0.2	0.0	1.4	0.1	2.9	1.0	2.6	0.1	0.3	7.8	0.0	0.0	0.6	0.0	0.0	0.0	0.0	10.9	4.0	2.6	2.0	0.0	0.9	4.3	2.7	0.9	0.0	0.8	8.7	0.2	3.9	2.6	0.0	0.0	2.9	0.0	1.7	0.0	0.1	0.0	0.0	0.0	5.6	0.0	0.8	1.9	15.0	2.0	0.5	0.0	0.1	0.0	11.6	0.1	0.3	3.8	18.0	8.4	0.4	0.0	0.8	0.0	10.9	9.2	0.0	2.9	7.5	0.0	5.8	3.3	0.7	18.5	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.5	4.2	0.5	0.8	0.7	2.4	2.9	1.4	1.4	0.7	1.0	0.0	0.0	1.5	0.0	1.2	3.1	3.8	13.0	16.5	0.5	0.2	2.5	1.5	0.0	7.4	0.0	0.0	0.2	0.0	0.5	0.0	0.0	21.8	31.0	0.3	0.3	2.4	3.2	0.1	0.2	0.4	0.4	0.0	0.7	0.0	0.1	0.4	0.2	0.3	0.0	0.1	0.5	2.0	0.0	1.3	15.7	0.6	0.1	1.8	0.0	0.0	0.2	0.0	2.5	0.1	0.2	0.0	0.0	6.8	0.2	0.0	0.1	35.8	0.1	0.0	0.0	2.6	0.1	0.4	1.6	2.3	0.3	0.4	0.1	0.3	0.2
TPP2	TPPII	ENSG00000134900	"Tripeptidyl peptidase 2"	P29144	13	102596986-102679958	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Aminopeptidase, Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	9	"Early spermatids: 796.3;Late spermatids: 892.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021069, HPA049630"	Approved		Supported	"Nuclear bodies,Cytosol"		NA	NA		280000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 32: U-937 - Innate immune response"	"Cluster 25: Spermatids - Spermatogenesis"	"Nuclear bodies, Cytosol"		"HPA021069: AB_1858344, HPA049630: AB_2680836"	"unprognostic (4.75e-2)"	"unprognostic (4.78e-2)"	"unprognostic (9.97e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.01e-2)"	"unprognostic (4.43e-2)"	"unprognostic (2.45e-2)"	"unprognostic (8.33e-3)"	"unprognostic (5.02e-2)"	"unprognostic (1.51e-1)"	"unprognostic (3.12e-1)"	"unprognostic (2.75e-3)"	"unprognostic (6.26e-2)"	"unprognostic (3.12e-1)"	"unprognostic (7.53e-2)"	"unprognostic (3.95e-2)"	"unprognostic (3.43e-3)"	12.6	8.1	3.5	15.6	5.5	48.0	16.4	9.7	5.3	12.9	5.7	13.9	12.3	16.3	19.7	11.6	11.5	12.5	13.8	3.0	2.3	10.0	20.4	14.6	19.9	3.7	3.1	14.1	10.9	11.3	8.3	17.7	4.4	11.3	19.2	17.4	10.6	16.7	27.7	12.1	12.5	13.1	3.3	18.6	12.2	51.8	4.9	16.1	19.9	22.1	17.1	12.8	11.4	9.8	33.8	13.7	38.0	28.7	28.9	37.5	25.5	34.9	26.6	23.8	28.0	30.7	41.0	37.3	11.9	30.3	25.7	30.0	30.5	23.7	39.3	26.4	24.9	71.2	34.0	22.8	22.9	89.3	44.6	31.5	11.2	26.4	35.6	23.6	32.7	34.8	43.4	42.9	32.0	11.3	37.2	53.4	28.5	43.7	17.6	43.5	30.3	31.8	25.7	29.7	35.8	26.7	23.2	35.0	13.7	31.9	20.0	79.9	28.5	20.9	15.1	12.9	29.0	40.7	56.2	37.0	31.1	56.6	26.8	7.4	5.5	3.7	7.1	5.9	8.4	4.8	8.2	8.4	5.2	4.5	9.7	9.8	1.0	8.9	4.9	3.3	9.6	4.5	3.5	5.5	9.7	5.3	3.0	2.3	3.7	3.1	4.4	3.3	4.9	9.8	20.9	38.5	41.6	41.8	24.5	15.4	16.4	10.6	22.8	27.5	18.5	12.7	41.8	11.5	18.5	14.7	73.0	28.5	38.7	13.3	9.8	19.8	796.3	23.0	28.9	19.3	19.8	26.1	64.1	8.8	30.7	25.8	14.3	22.7	38.6	24.8	20.3	22.4	32.1	8.4	69.8	18.5	8.2	25.7	19.9	892.8	32.0	29.5	17.8	65.6	29.3	13.8	42.2	66.4	67.3	13.3	16.3	18.8	58.9	16.5	10.2	13.2	36.4	46.5	26.3	24.3	28.8	92.7	30.0	22.9	13.4	33.1	35.6	31.6	21.8	19.6
TPPP	"p25, p25alpha, TPPP/p25, TPPP1"	ENSG00000171368	"Tubulin polymerization promoting protein"	O94811	5	659862-693352	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"brain: 185.2"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 38.5;Excitatory neurons: 45.2;Horizontal cells: 42.1;Inhibitory neurons: 32.6;Oligodendrocytes: 104.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 7.4;AN3-CA: 5.4;SCLC-21H: 13.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036575, HPA036576"	Enhanced		Supported	Mitochondria,Cytosol		NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 65: Brain - Ion transport"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Mitochondria, Cytosol"		"HPA036575: AB_10673501, HPA036576: AB_2675200"	"unprognostic (3.66e-2)"	"unprognostic (3.70e-3)"	"unprognostic (9.98e-3)"	"unprognostic (7.82e-2)"	"unprognostic (2.05e-2)"	"unprognostic (3.20e-2)"	"unprognostic (2.12e-1)"	"unprognostic (3.80e-3)"	"unprognostic (3.85e-1)"	"unprognostic (1.63e-1)"	"unprognostic (2.07e-3)"	"unprognostic (5.48e-2)"	"prognostic favorable (5.40e-6)"	"unprognostic (4.03e-2)"	"unprognostic (2.30e-1)"	"unprognostic (2.03e-2)"	"unprognostic (3.31e-2)"	3.8	6.6	100.8	0.7	136.7	0.2	2.5	55.3	120.4	1.8	0.0	12.8	5.2	3.3	0.5	11.0	10.4	1.7	9.8	112.3	69.9	4.4	2.7	10.2	0.3	110.3	102.3	1.8	6.0	2.1	19.5	2.2	107.7	2.3	1.8	6.3	5.7	3.6	10.5	8.2	9.5	3.6	47.5	2.6	4.9	2.2	124.6	0.4	6.9	5.3	1.4	6.8	2.7	185.2	0.2	7.4	0.3	5.4	0.8	0.0	1.0	0.1	0.0	0.0	0.0	0.3	0.8	0.1	0.5	0.0	1.9	2.9	2.9	0.0	0.0	1.5	2.5	0.2	3.6	0.2	0.8	0.2	0.3	0.0	0.7	0.0	0.1	0.2	0.0	0.1	0.1	2.7	0.0	0.2	0.2	0.5	0.2	0.8	0.7	0.3	0.1	1.0	0.2	1.0	13.2	1.6	0.8	0.3	3.6	0.3	0.7	0.2	0.1	0.2	2.7	0.0	0.2	1.0	0.2	0.0	0.5	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	100.8	136.7	55.3	120.4	112.3	69.9	110.3	102.3	107.7	47.5	124.6	185.2	1.6	38.5	10.0	6.8	0.7	4.1	1.4	0.6	9.6	21.3	3.1	2.4	18.4	2.8	5.3	1.8	0.0	0.0	1.1	5.7	1.9	2.4	9.1	26.6	0.9	2.0	10.2	0.0	45.2	0.7	0.3	3.3	3.1	5.8	4.5	0.1	2.2	4.3	3.3	42.1	32.6	6.5	0.0	0.0	2.2	7.2	0.3	1.2	1.8	4.7	0.1	0.9	0.0	6.6	104.7	0.7	5.2	0.4	3.3	0.8	10.3	1.1	13.5	2.4	0.0	1.5	4.2	2.2	0.8	6.7	3.1	0.0	4.8	0.1	4.8	4.1
TPRG1	"FAM79B, FLJ41238, FLJ43694"	ENSG00000188001	"Tumor protein p63 regulated 1"	Q6ZUI0	3	188947214-189325304	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 50.6;vagina: 32.3"	"Cell type enriched"	"Detected in many"	5	"Early spermatids: 199.7"	"Cancer enriched"	"Detected in many"	4	"breast cancer: 7.0"	"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 9.6;Karpas-707: 4.7;OE19: 23.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA044751, HPA060187"	Uncertain		Supported	Nucleoplasm		NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	Nucleoplasm		"HPA044751: AB_2679073, HPA060187: AB_2684217"	"prognostic favorable (5.43e-4)"	"unprognostic (8.71e-3)"	"unprognostic (2.10e-3)"	"unprognostic (2.36e-2)"	"unprognostic (3.84e-3)"	"unprognostic (1.33e-3)"	"unprognostic (1.55e-2)"	"unprognostic (9.88e-2)"	"unprognostic (2.66e-1)"	"unprognostic (2.71e-1)"	"unprognostic (1.40e-2)"	"unprognostic (3.79e-1)"	"unprognostic (3.52e-8)"	"unprognostic (8.50e-2)"	"unprognostic (9.53e-2)"	"unprognostic (1.38e-1)"	"unprognostic (3.73e-2)"	10.6	1.9	0.5	1.8	0.6	0.0	23.3	0.6	0.7	23.3	3.5	0.5	0.3	3.0	2.8	50.6	8.4	2.9	2.0	0.4	0.7	0.4	9.0	4.4	0.9	2.2	0.7	2.2	0.6	0.1	0.2	1.2	1.0	1.2	0.3	0.4	6.1	1.3	9.1	25.1	0.7	3.0	0.6	0.7	0.5	4.8	3.6	1.5	1.3	0.4	9.0	1.0	32.3	2.0	0.9	0.2	0.3	0.0	2.0	1.7	0.0	0.0	0.0	0.1	0.1	1.1	2.2	1.3	3.4	0.1	0.6	0.2	0.0	0.0	0.0	9.6	0.0	0.0	0.6	0.0	0.0	0.2	0.0	0.5	0.4	0.0	0.0	0.5	0.0	0.0	0.0	4.7	0.2	0.4	0.0	0.0	0.6	23.4	0.3	0.0	0.0	1.7	0.0	1.8	0.0	0.0	0.2	0.5	0.0	0.7	4.1	0.6	0.0	0.1	0.3	0.0	0.3	4.3	3.7	0.4	0.1	0.0	0.1	0.0	1.5	0.0	3.8	1.2	0.5	0.1	3.0	4.0	0.4	0.0	0.6	1.5	0.7	0.0	1.1	0.0	3.8	0.9	0.5	0.6	0.6	0.7	0.4	0.7	2.2	0.7	1.0	0.6	3.6	2.0	0.9	38.5	1.7	3.6	0.9	5.6	19.9	10.5	13.6	1.3	9.8	31.1	0.8	0.0	6.4	0.0	0.0	0.4	5.3	0.2	0.0	0.3	199.7	1.2	1.1	1.0	0.0	2.7	2.8	0.6	0.2	5.5	0.5	0.2	1.3	0.3	0.0	8.4	4.8	0.0	7.9	0.3	2.0	3.5	2.7	24.4	7.2	2.5	0.0	3.7	0.6	0.2	2.1	9.5	2.1	4.5	0.1	3.0	5.6	1.7	0.2	0.2	1.0	0.2	0.0	30.7	5.3	5.1	1.1	4.3	5.8	0.3	14.4	1.2	0.2	5.7
TPRKB	"CGI-121, CGI121"	ENSG00000144034	"TP53RK binding protein"	Q9Y3C4	2	73729104-73737400	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"tRNA processing"		"Disease variant, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 259.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035712	Approved		Supported	Cytosol		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 59: Non-specific - Translation"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 66: Spermatocytes - Spermatogenesis"	Cytosol		"HPA035712: AB_10669674"	"unprognostic (1.11e-1)"	"unprognostic (2.41e-2)"	"unprognostic (6.59e-2)"	"unprognostic (2.31e-2)"	"unprognostic (2.74e-1)"	"unprognostic (2.67e-2)"	"unprognostic (1.21e-3)"	"unprognostic (4.96e-2)"	"unprognostic (3.16e-3)"	"unprognostic (3.01e-3)"	"unprognostic (5.10e-3)"	"unprognostic (6.06e-2)"	"unprognostic (2.68e-3)"	"unprognostic (5.66e-2)"	"unprognostic (8.45e-3)"	"unprognostic (1.82e-1)"	"unprognostic (5.03e-2)"	22.7	23.1	11.8	22.3	12.3	70.2	42.7	14.5	17.2	32.7	12.6	36.5	38.7	30.2	35.8	31.0	54.9	20.2	34.0	12.0	12.5	35.5	39.2	17.3	37.0	12.7	12.2	36.1	26.7	18.5	12.7	22.6	12.7	25.0	33.9	16.1	31.1	19.0	68.1	25.7	35.5	29.1	12.7	22.3	24.9	51.8	12.1	37.0	21.3	50.9	33.7	26.3	25.2	13.1	106.1	73.3	73.4	85.5	27.2	37.6	62.2	73.5	40.0	72.2	54.2	110.8	66.0	67.0	54.0	38.2	130.7	62.6	60.6	77.6	116.0	53.4	79.2	135.7	49.8	90.6	26.6	198.3	72.8	27.2	43.6	76.4	76.3	37.4	76.9	114.7	119.8	105.1	75.5	56.4	142.5	130.6	94.9	130.5	93.9	83.6	211.6	93.8	67.2	89.8	69.1	83.1	53.1	79.5	105.6	59.8	58.7	78.6	48.5	62.4	104.7	113.6	182.6	69.1	127.6	176.9	55.9	131.2	78.4	32.5	18.2	29.1	16.5	28.5	26.4	23.9	23.6	22.3	22.1	20.9	27.0	25.5	13.1	24.6	21.5	30.1	25.4	15.8	11.8	12.3	14.5	17.2	12.0	12.5	12.7	12.2	12.7	12.7	12.1	13.1	56.3	32.1	39.8	7.2	43.1	53.2	66.8	123.0	38.7	15.0	51.8	94.9	63.5	50.1	70.6	22.0	4.2	81.3	39.7	64.0	88.0	95.4	138.9	50.2	42.7	81.9	33.6	62.1	8.6	184.9	107.9	45.1	17.9	43.4	48.7	51.3	148.2	44.3	86.7	8.4	8.7	71.2	71.2	55.6	60.0	28.9	59.0	52.1	33.8	2.8	65.0	36.6	64.9	10.1	8.3	110.7	76.9	52.3	35.6	47.8	103.4	154.9	54.4	21.8	52.6	61.7	46.2	259.3	87.8	44.8	53.0	45.6	42.8	53.9	85.4	58.2
TPST1	TANGO13A	ENSG00000169902	"Tyrosylprotein sulfotransferase 1"	O60507	7	66205317-66420543	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 76.5;Excitatory neurons: 101.9;Inhibitory neurons: 107.1;Spermatocytes: 97.1"	"Cancer enhanced"	"Detected in all"		"glioma: 36.5"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 52.2;neutrophil: 35.2"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047415, HPA061837"	Approved		Supported	"Golgi apparatus"	"Intracellular and membrane"	NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 15: Liver - Metabolism"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 33: Fibroblasts - ECM organization"	"Golgi apparatus"		"HPA047415: AB_10964056, HPA061837: AB_2732672"	"unprognostic (7.46e-2)"	"unprognostic (1.45e-1)"	"unprognostic (8.62e-2)"	"unprognostic (3.43e-2)"	"unprognostic (3.52e-2)"	"unprognostic (1.78e-3)"	"unprognostic (5.71e-2)"	"unprognostic (8.21e-2)"	"unprognostic (3.59e-1)"	"unprognostic (9.25e-3)"	"unprognostic (4.12e-2)"	"unprognostic (4.98e-1)"	"prognostic unfavorable (8.16e-6)"	"prognostic unfavorable (8.78e-4)"	"unprognostic (2.48e-1)"	"unprognostic (1.74e-2)"	"prognostic unfavorable (3.73e-5)"	16.9	15.8	22.1	10.8	20.5	6.0	13.4	18.4	21.6	35.4	12.3	11.1	3.2	21.8	14.3	10.8	11.2	38.1	8.5	19.4	36.7	23.1	46.0	11.5	5.9	37.2	25.0	13.5	7.8	11.0	19.5	26.4	24.7	15.1	8.0	5.2	6.8	16.4	2.7	8.2	8.7	16.2	22.9	12.0	10.9	23.0	33.8	2.1	11.3	5.6	5.3	36.8	22.1	22.5	12.1	6.5	16.5	22.4	52.7	42.0	5.7	22.3	49.8	25.7	37.1	21.9	6.6	1.4	17.7	45.1	38.9	8.9	16.2	24.8	33.3	3.5	9.3	2.3	15.1	16.5	62.3	1.8	1.9	59.5	19.0	50.2	22.1	27.8	32.7	2.9	1.0	10.2	40.2	6.2	0.1	3.1	15.5	0.4	9.6	7.8	14.6	11.4	27.3	11.5	10.4	44.5	27.8	2.1	62.2	32.4	8.6	4.7	62.3	33.1	21.3	24.2	40.6	9.2	13.3	4.7	29.6	6.8	48.2	52.2	2.3	23.9	0.8	0.1	0.8	6.1	0.5	0.6	0.3	14.0	2.2	4.1	35.2	8.8	0.0	0.0	0.0	1.9	22.1	20.5	18.4	21.6	19.4	36.7	37.2	25.0	24.7	22.9	33.8	22.5	33.8	0.0	8.9	38.8	11.5	10.8	7.7	24.4	33.6	8.5	4.0	13.3	1.6	5.7	9.6	31.3	2.1	1.8	3.8	0.2	9.8	23.0	11.2	13.3	76.5	17.9	7.7	1.3	101.9	47.6	4.3	58.5	12.2	9.7	4.5	12.2	10.0	34.1	16.2	6.7	107.1	0.8	8.2	8.9	8.9	11.6	48.1	6.2	14.2	32.8	15.8	5.0	1.0	61.3	38.8	23.7	0.1	37.2	7.1	5.3	0.0	3.2	19.5	3.6	6.6	16.4	21.6	97.1	41.3	15.1	7.5	3.8	2.8	12.6	0.7	7.7
TPT1	"fortilin, TCTP"	ENSG00000133112	"Tumor protein, translationally-controlled 1"	P13693	13	45333471-45341284	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 23236.6"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB008364, HPA039437"	Approved		Supported	Cytosol		NA	NA		1500000	"Cluster 32: T-cells - Unknown function"	"Cluster 59: Non-specific - Translation"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 32: Non-specific - Translation"	Cytosol		"CAB008364: AB_591904, HPA039437: AB_2676508"	"prognostic favorable (5.90e-5)"	"unprognostic (1.00e-1)"	"unprognostic (1.16e-1)"	"prognostic favorable (2.35e-4)"	"unprognostic (3.25e-1)"	"unprognostic (3.57e-2)"	"unprognostic (8.71e-3)"	"unprognostic (2.04e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.29e-3)"	"unprognostic (4.56e-1)"	"unprognostic (3.02e-1)"	"prognostic unfavorable (2.54e-5)"	"unprognostic (1.47e-1)"	"unprognostic (8.48e-2)"	"prognostic favorable (4.31e-5)"	"unprognostic (6.51e-2)"	5808.9	3790.0	1970.1	2971.0	2089.0	7021.6	4788.5	2017.1	2885.0	4815.0	2151.1	3979.7	3896.8	3466.6	5086.2	4739.6	3764.4	3768.2	4538.7	1920.3	2182.7	4819.1	6862.2	3615.7	5627.2	2141.5	2042.0	6982.0	10645.5	2467.5	2595.3	4390.6	2185.5	3646.9	3385.7	1026.8	8474.6	2254.8	23236.6	3472.5	3896.8	2786.2	2206.2	3281.4	3544.7	821.0	1977.3	3910.4	4425.0	13885.5	4621.3	4859.8	4376.0	2225.8	1905.1	1684.0	2793.7	1836.1	8042.9	11121.9	3311.0	3946.8	6100.9	2460.2	2560.6	3800.8	4814.7	4011.0	3236.5	4125.5	1627.8	3232.7	2281.2	5785.6	3386.6	1869.7	2010.7	3227.6	1369.1	4278.1	8106.1	4451.8	4843.1	9204.7	11563.7	1572.6	9416.5	7957.8	5168.0	3360.7	2443.5	1080.9	5091.4	3449.9	5437.0	10564.3	3194.8	6358.1	1773.3	3370.4	2645.5	3062.6	6392.2	3916.9	1185.4	3165.1	1308.7	4147.6	6396.8	2827.9	2383.4	12710.0	3402.5	1129.5	1605.0	1855.4	2470.9	2644.9	2873.7	3842.4	3013.5	3486.9	899.6	1195.3	1271.4	617.3	1006.6	978.8	1830.5	1337.9	1874.2	1366.7	1138.9	1036.9	1944.6	1636.5	546.5	1513.4	929.3	1454.0	1812.0	3204.4	1970.1	2089.0	2017.1	2885.0	1920.3	2182.7	2141.5	2042.0	2185.5	2206.2	1977.3	2225.8	4176.2	1593.0	3381.6	39.5	4868.3	3494.9	6406.7	2737.1	4501.1	371.9	5018.7	4187.9	2795.4	3154.1	2226.0	763.2	160.6	4470.7	5693.8	3799.1	3144.1	2527.2	1185.2	3111.2	5482.8	3928.3	2068.2	3074.8	44.9	5125.2	6375.7	3310.5	2398.6	5369.5	1842.3	4305.3	5062.0	4784.7	4614.9	213.7	39.1	5716.8	852.4	5939.9	3637.5	1381.9	6800.4	6005.9	1773.4	87.1	6495.9	2240.9	5186.5	25.1	50.5	5271.4	5556.8	3870.4	4453.2	6953.8	11028.2	9311.2	1156.1	656.2	2530.9	5300.1	3028.9	443.5	687.3	5411.6	3479.1	5749.6	5238.7	4437.6	5420.4	9158.8
TPTE2	TPIP	ENSG00000132958	"Transmembrane phosphoinositide 3-phosphatase and tensin homolog 2"	Q6XPS3	13	19422877-19536762	"Enzymes, Metabolic proteins, Plasma proteins, Predicted membrane proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	8	"testis: 7.5"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 4.9;Early spermatids: 9.8;Excitatory neurons: 4.6;Inhibitory neurons: 6.3;Microglial cells: 3.7;Oligodendrocyte precursor cells: 7.5;Oligodendrocytes: 3.6;Spermatocytes: 14.8;Spermatogonia: 3.9"	"Cancer enriched"	"Detected in single"	6	"testis cancer: 0.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"HDLM-2: 4.8;Karpas-707: 1.3"									HPA068342			Approved	"Endoplasmic reticulum,Cytosol"		NA	NA				"Cluster 78: Testis - Spermatogenesis"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 66: Spermatocytes - Spermatogenesis"	Cytosol	"Endoplasmic reticulum"	"HPA068342: AB_2685976"	"unprognostic (2.50e-1)"	"unprognostic (2.10e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.70e-1)"	"unprognostic (1.25e-2)"	"unprognostic (5.33e-3)"		"unprognostic (1.90e-1)"	"unprognostic (1.24e-1)"	"unprognostic (5.40e-2)"	"unprognostic (3.67e-2)"	"unprognostic (2.81e-1)"	"unprognostic (1.05e-12)"	"unprognostic (1.04e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.44e-1)"	"unprognostic (5.00e-3)"	0.1	0.1	0.3	0.1	0.4	0.0	0.1	0.6	0.9	0.0	0.2	0.1	0.2	0.0	0.2	0.0	0.1	0.0	0.0	0.4	0.5	0.1	0.0	0.0	0.2	0.5	0.4	0.0	0.0	0.0	0.1	0.1	0.6	0.0	0.0	0.4	0.1	0.1	0.0	0.0	0.1	0.0	0.5	0.2	0.1	7.5	0.4	0.0	0.0	0.0	0.3	0.0	0.0	0.7	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	4.8	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.3	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.6	0.9	0.4	0.5	0.5	0.4	0.6	0.5	0.4	0.7	0.0	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.3	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	9.8	0.1	0.0	0.1	0.0	0.0	4.6	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.7	0.0	0.1	0.0	6.3	0.0	0.0	0.3	0.0	1.5	0.3	0.0	0.0	3.7	0.1	0.5	0.0	7.5	3.6	0.0	0.0	0.0	0.4	0.2	0.0	0.1	0.0	0.2	0.0	0.0	0.1	14.8	3.9	0.0	0.1	0.1	0.1	0.1	0.0	0.2
TPX2	"C20orf1, C20orf2, DIL-2, p100"	ENSG00000088325	"TPX2 microtubule nucleation factor"	Q9ULW0	20	31739271-31801805	"Cancer-related genes, Predicted intracellular proteins"	"Apoptosis, Cell cycle, Cell division, Mitosis"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 48.0;lymphoid tissue: 70.3;testis: 30.7"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 90.7;Extravillous trophoblasts: 68.5;Granulosa cells: 46.6;Spermatocytes: 114.5;Spermatogonia: 63.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"T-reg: 8.1"	"Group enriched"	"Detected in many"	5	"granulocytes: 5.1;NK-cells: 3.6;T-cells: 8.1"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005487	Enhanced		Supported	"Nucleoplasm,Cytokinetic bridge,Mitotic spindle"		Yes	Yes			"Cluster 44: Non-specific - Transcription"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	"Cytokinetic bridge, Mitotic spindle"	"HPA005487: AB_1858223"	"unprognostic (2.18e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.97e-2)"	"prognostic unfavorable (2.43e-6)"	"unprognostic (2.99e-1)"	"unprognostic (7.56e-2)"	"prognostic unfavorable (8.07e-7)"	"prognostic unfavorable (6.46e-4)"	"unprognostic (3.70e-2)"	"unprognostic (1.19e-1)"	"prognostic unfavorable (2.68e-5)"	"unprognostic (5.99e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (4.56e-2)"	"unprognostic (2.30e-1)"	"unprognostic (1.76e-2)"	"unprognostic (1.39e-1)"	1.9	1.4	0.9	13.0	0.9	48.0	2.7	0.8	1.0	2.3	0.5	11.6	9.4	2.4	0.2	13.2	0.9	1.8	0.8	1.1	0.6	0.7	4.2	1.9	26.6	0.6	1.0	0.5	0.4	0.4	0.2	8.3	0.7	0.7	14.2	0.5	2.0	0.5	1.4	9.8	9.4	6.8	0.6	5.2	6.2	30.7	1.3	70.3	1.0	0.8	32.3	3.4	4.1	0.9	455.1	149.1	176.4	139.1	13.8	25.2	169.8	186.1	104.5	264.0	197.7	319.1	190.4	212.4	106.7	104.5	196.8	232.7	203.7	169.0	298.8	92.3	78.8	416.3	139.7	219.6	4.2	161.9	102.8	8.7	9.1	166.0	120.0	37.9	144.6	157.1	313.8	187.8	209.7	186.2	272.2	125.3	197.1	174.0	159.3	152.5	475.5	128.2	71.2	72.8	127.5	85.7	284.6	106.3	82.0	120.9	185.1	97.3	98.3	294.1	179.7	136.5	290.0	74.4	138.6	187.3	92.2	565.1	195.8	5.1	0.0	0.4	0.4	0.0	0.2	0.6	1.4	1.7	0.5	0.2	0.3	0.5	0.2	3.6	0.1	1.0	8.1	1.0	0.9	0.9	0.8	1.0	1.1	0.6	0.6	1.0	0.7	0.6	1.3	0.9	1.0	0.0	4.2	0.0	5.9	6.9	1.5	4.3	1.2	0.9	3.0	3.4	0.9	4.3	3.8	0.0	0.0	23.3	3.8	6.4	0.0	1.2	9.3	7.3	6.6	3.9	1.2	90.7	2.9	0.4	68.5	9.2	16.3	8.4	0.0	46.6	8.9	3.0	19.5	1.7	0.9	9.8	10.2	8.0	5.5	13.1	0.9	7.6	0.0	1.0	2.1	0.4	3.1	0.5	0.5	1.8	1.4	0.0	30.8	2.5	0.9	0.0	0.7	0.4	0.0	1.1	15.4	114.5	63.1	31.2	6.1	4.7	8.2	4.2	18.4	2.9
TRA2A	"AWMS1, htra-2-alpha"	ENSG00000164548	"Transformer 2 alpha homolog"	Q13595	7	23504780-23532041	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054018	Uncertain		Supported	Nucleoplasm,Nucleoli,Vesicles		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 52: Non-specific - Transcription"	Nucleoli	"Nucleoplasm, Vesicles"	"HPA054018: AB_2682344"	"unprognostic (2.55e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.24e-1)"	"unprognostic (6.77e-3)"	"unprognostic (8.05e-2)"	"unprognostic (3.41e-2)"	"prognostic unfavorable (2.07e-5)"	"unprognostic (1.28e-2)"	"unprognostic (2.50e-2)"	"unprognostic (4.64e-2)"	"unprognostic (1.87e-3)"	"unprognostic (6.04e-2)"	"prognostic unfavorable (1.79e-6)"	"unprognostic (1.46e-2)"	"unprognostic (1.52e-2)"	"unprognostic (8.74e-2)"	"unprognostic (1.36e-3)"	35.1	39.1	55.7	37.0	58.2	113.4	32.1	57.4	75.7	47.1	57.9	38.7	26.4	42.8	43.9	47.3	42.7	21.3	30.4	55.3	57.8	45.9	34.9	33.5	47.6	57.2	56.5	53.1	32.6	25.6	40.4	32.9	57.6	41.3	39.2	42.0	33.2	22.1	23.1	42.8	36.8	41.0	56.6	52.8	33.0	30.9	56.8	46.1	35.9	21.3	53.6	37.9	42.9	64.9	57.2	61.2	94.1	148.4	49.1	30.9	60.4	71.4	33.6	70.5	57.4	51.2	76.4	107.4	39.9	53.7	82.3	92.1	115.6	66.9	88.4	64.6	65.7	65.9	67.9	81.8	52.0	78.0	59.2	37.1	44.9	53.1	66.1	62.7	80.9	46.7	129.5	51.0	79.7	55.6	96.5	128.7	84.5	69.5	62.5	106.1	74.8	64.3	81.8	81.0	80.7	65.8	66.0	75.8	49.8	69.1	59.6	85.5	73.8	55.4	79.0	51.0	83.4	56.6	76.1	86.9	47.7	103.8	75.3	16.8	17.1	23.6	24.6	28.8	21.6	17.6	23.3	23.1	20.6	16.1	19.6	23.7	25.4	19.1	27.0	30.0	25.2	10.2	55.7	58.2	57.4	75.7	55.3	57.8	57.2	56.5	57.6	56.6	56.8	64.9	110.6	60.9	72.2	112.3	141.9	104.4	95.6	61.7	94.4	54.5	118.5	74.8	42.5	60.1	60.8	88.3	52.1	83.2	153.3	84.9	25.4	54.8	62.1	155.7	137.1	74.8	118.5	77.5	113.1	43.9	84.6	91.5	89.2	166.7	86.7	62.5	84.6	71.4	54.8	37.0	115.4	100.3	48.8	89.5	125.4	23.7	65.0	88.9	56.9	107.7	71.5	48.1	70.0	203.1	245.1	59.2	92.0	67.7	125.4	97.7	59.7	41.8	71.3	101.8	72.3	119.2	88.2	99.8	65.0	138.6	113.1	117.9	130.4	49.1	112.6	92.1
TRAF4	"CART1, MLN62, RNF83"	ENSG00000076604	"TNF receptor associated factor 4"	Q9BUZ4	17	28744005-28750956	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	Apoptosis	"Developmental protein"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Urothelial cells: 346.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	6	"plasmacytoid DC: 54.0"	"Lineage enriched"	"Detected in all"	6	"dendritic cells: 54.0"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009055, HPA021904, HPA052377"	Enhanced		Supported	"Nucleoplasm,Nucleoli fibrillar center,Cytosol"		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 22: Epithelial cell types - Mixed function"	"Nucleoli fibrillar center"	"Nucleoplasm, Cytosol"	"CAB009055: AB_2209701, HPA021904: , HPA052377: AB_2681804"	"unprognostic (1.77e-1)"	"unprognostic (9.05e-2)"	"unprognostic (1.31e-2)"	"unprognostic (2.51e-3)"	"unprognostic (1.76e-1)"	"unprognostic (7.38e-3)"	"unprognostic (1.09e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.09e-2)"	"unprognostic (2.33e-1)"	"unprognostic (7.13e-2)"	"unprognostic (7.55e-2)"	"unprognostic (1.74e-3)"	"unprognostic (6.98e-2)"	"unprognostic (9.26e-2)"	"unprognostic (2.77e-2)"	"unprognostic (5.58e-3)"	10.7	19.4	16.1	11.2	17.8	31.2	19.3	15.6	19.1	10.9	18.4	28.4	47.1	9.1	4.1	28.6	14.4	20.3	5.2	15.5	15.5	45.0	60.1	22.7	18.8	18.6	17.7	12.2	32.1	4.0	14.5	16.4	17.0	31.4	22.2	3.6	46.8	6.9	1.8	15.4	38.7	5.1	15.6	19.0	35.9	15.1	16.3	13.6	29.1	0.8	20.1	36.7	11.8	23.9	41.2	62.7	85.3	41.6	12.0	13.9	131.2	27.3	22.8	28.2	37.2	50.2	50.0	62.5	38.8	29.9	19.0	61.0	39.1	61.5	11.6	20.3	58.5	22.5	111.7	58.3	45.9	10.9	25.0	26.5	59.2	33.2	39.7	25.5	22.2	29.1	60.1	5.4	26.1	67.3	34.6	22.7	65.9	80.2	14.4	52.1	38.8	30.6	80.8	115.7	53.2	61.3	42.0	181.7	84.3	73.4	69.5	17.2	15.0	17.8	37.4	20.3	39.2	8.2	21.3	80.1	14.0	17.8	81.9	5.7	0.5	1.9	1.0	1.1	2.6	9.7	1.8	1.9	2.9	9.3	1.3	1.3	0.2	1.8	0.9	54.0	1.0	1.8	16.1	17.8	15.6	19.1	15.5	15.5	18.6	17.7	17.0	15.6	16.3	23.9	9.3	22.4	28.3	28.4	59.2	137.5	185.0	58.2	122.3	3.4	134.8	100.1	0.4	44.3	66.7	20.2	6.2	107.9	88.3	121.3	43.0	78.5	53.4	102.8	22.8	20.7	84.1	4.8	0.9	109.2	136.8	20.4	83.1	133.7	7.0	10.1	8.9	38.1	13.9	8.4	1.6	81.6	61.1	2.2	71.9	12.1	3.7	16.0	39.2	3.7	7.3	23.0	5.2	37.7	19.8	128.0	125.7	1.5	36.6	219.0	155.7	33.8	68.7	2.3	0.0	9.8	34.9	5.8	22.6	57.7	78.6	124.4	31.5	14.5	93.5	346.4
TRAF5	RNF84	ENSG00000082512	"TNF receptor associated factor 5"	O00463	1	211326615-211374946	"Predicted intracellular proteins"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"B-cells: 75.9;Early spermatids: 55.0;Late spermatids: 47.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 36.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA008052, CAB010277"	Enhanced		Supported	Centrosome,Cytosol		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 57: B-cells - Immune response"	Cytosol	Centrosome	"CAB010277: AB_2287961, HPA008052: AB_1858230"	"unprognostic (6.44e-2)"	"unprognostic (1.05e-1)"	"unprognostic (8.15e-2)"	"unprognostic (1.55e-2)"	"unprognostic (1.04e-1)"	"unprognostic (3.39e-2)"	"unprognostic (6.44e-3)"	"unprognostic (7.94e-3)"	"unprognostic (1.39e-1)"	"unprognostic (1.75e-1)"	"unprognostic (5.92e-2)"	"unprognostic (1.22e-1)"	"prognostic unfavorable (2.94e-10)"	"unprognostic (3.72e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.71e-2)"	"prognostic favorable (7.29e-5)"	8.6	3.3	3.6	17.0	4.6	4.1	6.0	1.5	3.2	10.8	26.3	14.0	5.0	17.3	7.4	5.6	17.8	8.1	3.5	3.6	2.2	5.0	1.8	5.7	29.7	2.7	2.7	6.2	21.3	1.6	2.9	5.4	2.8	9.0	9.5	0.7	7.5	10.8	1.5	2.8	17.4	20.0	2.2	16.7	9.3	6.9	3.1	13.5	3.0	2.6	27.2	13.5	6.5	2.4	6.2	4.5	7.9	7.1	6.8	4.9	2.8	8.6	10.3	12.2	10.8	2.2	11.9	18.8	4.8	13.6	6.2	1.2	15.1	1.4	6.1	36.3	5.4	0.9	7.1	0.0	9.9	3.0	13.3	5.8	2.7	6.6	2.0	18.4	8.6	16.3	7.6	8.7	3.4	4.8	8.3	3.4	9.5	9.7	3.8	12.6	11.0	17.6	9.3	4.3	14.0	14.6	6.4	0.3	18.3	29.2	4.4	0.3	5.4	7.9	6.1	2.7	9.8	2.4	3.8	20.0	2.1	0.0	3.0	13.8	0.3	0.4	9.2	0.3	17.3	22.2	11.6	12.5	1.5	19.6	10.2	10.2	0.7	21.3	0.5	1.1	17.7	7.4	3.6	4.6	1.5	3.2	3.6	2.2	2.7	2.7	2.8	2.2	3.1	2.4	15.2	12.8	7.2	3.3	75.9	3.7	4.0	2.7	9.6	2.5	13.9	13.7	2.5	0.0	6.8	11.0	0.0	9.5	31.0	3.6	0.0	0.9	55.0	5.3	23.6	9.0	14.8	4.6	13.4	9.8	2.2	16.9	16.8	8.1	15.2	5.3	6.1	0.3	10.0	0.0	14.1	11.4	4.1	4.8	12.6	47.9	14.3	17.3	8.8	20.6	16.3	1.0	32.0	7.5	2.8	7.1	11.4	27.4	11.3	3.4	1.8	0.8	8.6	0.7	13.1	7.3	29.1	3.8	2.7	4.4	4.0	1.4	41.6	5.0	14.3	2.6
TRAF7	"DKFZp586I021, MGC7807, RFWD1, RNF119"	ENSG00000131653	"TNF receptor associated factor 7"	Q6Q0C0	16	2155698-2178129	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Apoptosis, Transcription, Transcription regulation, Ubl conjugation pathway"	Transferase	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041229	Approved		Supported	"Vesicles,Plasma membrane"		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 37: Intestine - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 7: Non-specific - Mitochondria"	Vesicles	"Plasma membrane"	"HPA041229: AB_10794194"	"unprognostic (1.94e-1)"	"unprognostic (5.97e-2)"	"unprognostic (1.13e-1)"	"unprognostic (4.23e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.65e-2)"	"unprognostic (2.77e-3)"	"unprognostic (7.08e-2)"	"unprognostic (3.52e-2)"	"unprognostic (1.52e-2)"	"unprognostic (1.08e-1)"	"unprognostic (9.23e-2)"	"unprognostic (6.07e-2)"	"unprognostic (2.99e-2)"	"unprognostic (2.43e-1)"	"unprognostic (8.48e-2)"	29.1	29.4	16.5	24.4	15.1	35.0	28.2	18.2	23.0	32.1	17.0	38.0	40.0	31.2	11.6	54.6	30.4	22.2	21.3	17.9	14.6	28.1	51.5	33.2	22.9	17.8	15.3	23.5	37.4	14.6	32.1	20.6	14.8	27.0	17.4	8.5	34.7	16.5	30.4	47.7	35.2	18.8	14.2	34.5	35.6	14.8	17.7	19.1	25.6	9.9	18.6	34.5	34.8	14.3	57.7	72.2	40.3	72.5	40.8	76.5	47.4	43.4	53.9	49.9	44.6	88.2	72.1	36.6	50.2	55.4	31.8	65.9	38.1	76.8	18.8	58.3	48.8	52.4	98.5	68.3	53.8	56.3	72.7	76.2	62.8	48.1	62.6	41.0	97.4	70.6	57.1	47.9	48.2	131.1	58.3	65.2	79.7	78.7	34.8	107.4	66.7	74.2	40.2	30.4	80.9	67.2	36.3	68.5	48.6	20.9	78.1	68.2	74.3	60.2	83.9	56.7	48.2	69.2	55.0	48.4	34.4	35.9	47.8	4.0	9.1	7.3	4.5	12.4	4.3	5.5	4.4	4.7	11.2	3.9	3.1	3.8	6.2	2.9	8.9	5.3	6.5	5.3	16.5	15.1	18.2	23.0	17.9	14.6	17.8	15.3	14.8	14.2	17.7	14.3	18.9	0.0	9.2	12.4	18.2	28.8	21.1	34.2	22.8	15.9	31.6	27.9	4.9	21.5	20.8	14.7	6.2	23.5	17.4	56.4	17.6	39.0	5.0	23.6	34.6	26.5	34.0	33.6	8.9	59.0	36.3	19.0	38.7	27.9	9.5	22.1	26.0	32.3	42.2	37.0	8.2	38.7	34.6	41.8	21.3	13.1	24.8	26.8	10.6	8.4	33.9	12.6	6.2	6.6	4.9	53.0	43.6	22.2	24.0	33.8	80.0	29.2	19.7	10.9	6.6	11.9	18.3	8.5	25.3	50.7	32.5	26.7	16.0	29.0	42.5	38.5
TRAIP	"RNF206, TRIP"	ENSG00000183763	"TRAF interacting protein"	Q9BWF2	3	49828601-49856574	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair, Ubl conjugation pathway"	Transferase	"Disease variant, Dwarfism, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 8.2;Spermatocytes: 15.6;Spermatogonia: 9.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in many"		"basal ganglia: 10.8"	"HPA036261, HPA036262"	Enhanced		Supported	"Plasma membrane,Cytosol"		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Plasma membrane, Cytosol"		"HPA036261: AB_10673348, HPA036262: AB_2675029"	"unprognostic (5.30e-3)"	"unprognostic (9.41e-2)"	"unprognostic (1.48e-1)"	"unprognostic (6.50e-3)"	"unprognostic (1.88e-1)"	"unprognostic (7.68e-3)"	"prognostic unfavorable (8.77e-5)"	"unprognostic (4.61e-2)"	"unprognostic (1.52e-2)"	"unprognostic (8.61e-2)"	"unprognostic (1.24e-2)"	"unprognostic (7.97e-2)"	"unprognostic (9.01e-5)"	"unprognostic (5.84e-2)"	"unprognostic (4.24e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.24e-1)"	1.5	1.0	1.6	1.8	2.5	6.8	1.9	0.7	1.8	2.0	0.4	2.3	1.5	1.7	1.4	2.9	1.8	1.0	0.9	1.6	0.9	0.8	0.8	0.9	4.6	0.6	0.6	2.1	1.0	0.8	1.2	1.6	0.7	1.4	2.9	2.3	1.2	0.9	2.0	4.2	2.0	2.1	0.6	1.9	1.2	7.9	1.3	5.3	1.4	1.2	4.4	1.3	1.9	0.9	10.4	12.4	17.4	17.6	1.6	2.4	14.4	12.4	5.8	25.3	24.0	15.2	11.6	25.5	8.5	7.1	17.7	13.4	18.5	14.0	18.8	14.7	12.2	19.2	16.3	13.6	0.7	15.8	15.4	1.6	2.0	20.4	10.7	3.0	6.7	22.3	14.0	17.8	11.4	15.1	26.5	20.1	14.0	12.3	20.3	14.4	11.7	14.8	4.6	14.2	8.4	14.4	13.6	11.3	8.8	12.4	10.2	22.4	5.2	16.1	19.0	22.5	24.4	13.0	33.7	27.3	8.1	21.2	14.6	0.0	0.6	0.3	0.9	0.3	0.9	2.9	0.5	2.1	0.6	1.5	0.7	1.1	0.1	1.2	1.3	0.7	0.3	0.6	1.6	2.5	0.7	1.8	1.6	0.9	0.6	0.6	0.7	0.6	1.3	0.9	0.6	3.2	0.6	1.0	1.8	1.1	0.6	1.5	2.2	2.8	1.2	1.4	2.6	0.0	0.3	3.7	0.0	4.2	1.2	1.8	0.0	2.0	4.3	0.6	0.9	0.8	0.0	3.8	1.4	1.0	8.2	2.0	1.5	0.9	0.0	5.7	1.1	0.7	3.5	0.0	0.9	2.0	0.0	0.8	0.4	4.8	2.5	0.7	1.8	1.0	1.8	1.7	0.0	0.5	0.6	1.1	0.3	1.2	4.3	0.8	0.9	0.3	0.5	3.3	0.0	1.4	1.7	15.6	9.1	2.3	0.3	1.0	1.2	1.2	4.6	0.2
TRAPPC12	"CGI-87, TTC-15, TTC15"	ENSG00000171853	"Trafficking protein particle complex 12"	Q8WVT3	2	3379675-3485094	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"ER-Golgi transport, Transport"		"Deafness, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 96.6"	"Cell type enhanced"	"Detected in all"		"Early spermatids: 293.9;Late spermatids: 504.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034799, HPA043196"	Uncertain		Supported	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 71: Testis - DNA repair"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 31: Spermatids - Spermatogenesis"	"Nucleoplasm, Golgi apparatus"		"HPA034799: AB_10600920, HPA043196: "	"prognostic favorable (1.80e-5)"	"unprognostic (9.21e-2)"	"unprognostic (1.01e-2)"	"unprognostic (1.97e-2)"	"unprognostic (7.96e-2)"	"unprognostic (1.32e-2)"	"unprognostic (1.57e-2)"	"unprognostic (1.80e-2)"	"unprognostic (1.38e-1)"	"unprognostic (4.27e-1)"	"prognostic favorable (9.15e-4)"	"unprognostic (3.23e-2)"	"prognostic unfavorable (2.44e-4)"	"unprognostic (1.26e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.53e-1)"	"unprognostic (7.18e-2)"	21.7	26.0	13.9	10.9	14.4	10.1	21.8	15.0	23.3	20.2	13.5	27.9	10.1	23.7	6.3	23.0	22.2	10.4	46.7	14.8	15.9	22.6	28.0	17.1	16.0	15.9	14.1	21.4	26.2	18.4	26.7	6.6	17.1	20.6	4.7	9.1	25.8	10.0	45.8	35.7	21.2	5.2	14.6	22.1	28.4	96.6	14.8	15.7	24.7	6.4	5.0	26.1	18.9	15.5	16.4	28.0	9.1	10.4	19.9	24.5	23.9	26.6	6.5	7.6	4.2	17.5	13.6	18.8	28.6	9.0	6.7	20.8	10.5	11.9	3.1	22.8	39.5	16.2	8.1	60.8	9.0	20.4	28.0	18.1	9.0	8.5	21.2	5.8	6.7	21.5	25.5	10.0	13.5	22.5	20.6	34.9	22.1	7.3	39.4	15.4	12.4	15.3	8.1	13.5	23.2	37.8	10.6	11.8	18.5	4.0	13.9	16.3	17.2	18.6	10.6	18.7	23.6	28.5	22.4	15.0	21.8	15.9	10.5	0.7	1.0	3.8	0.8	2.5	2.0	0.5	1.3	2.2	1.4	0.5	0.8	1.0	1.0	0.9	3.6	4.3	2.5	0.8	13.9	14.4	15.0	23.3	14.8	15.9	15.9	14.1	17.1	14.6	14.8	15.5	18.8	9.6	12.8	59.4	20.7	11.5	16.2	15.1	14.2	31.8	13.7	16.0	68.4	21.5	11.2	12.9	33.3	21.3	16.9	17.1	58.7	21.7	293.9	20.3	16.4	18.5	3.5	19.1	56.2	18.0	15.2	23.7	23.0	14.5	5.7	22.3	11.0	16.0	25.9	26.9	62.5	17.7	14.2	17.9	10.0	504.5	26.4	20.7	16.0	30.0	28.5	42.6	15.5	52.3	56.4	23.9	11.9	24.0	19.6	16.0	20.3	30.0	19.4	42.0	26.3	20.9	21.7	125.2	26.3	18.8	17.8	17.6	14.4	33.8	15.7	12.2
TRAPPC2	"hYP38334, MIP-2A, SEDL, SEDT, TRS20, ZNF547L"	ENSG00000196459	"Trafficking protein particle complex 2"	P0DI81	X	13712244-13734635	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"ER-Golgi transport, Transcription, Transport"		"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"CAB004665, HPA063308"	Approved		Approved	"Nucleoplasm,Endoplasmic reticulum,Vesicles"		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Endoplasmic reticulum, Vesicles"	Nucleoplasm	"CAB004665: AB_425678, HPA063308: AB_2684982"	"unprognostic (1.97e-1)"	"prognostic favorable (8.09e-4)"	"unprognostic (2.13e-1)"	"unprognostic (4.18e-1)"	"unprognostic (2.11e-1)"	"unprognostic (2.70e-2)"	"unprognostic (1.04e-2)"	"unprognostic (2.08e-3)"	"unprognostic (1.76e-2)"	"prognostic favorable (6.35e-4)"	"unprognostic (3.50e-2)"	"unprognostic (8.24e-2)"	"unprognostic (1.93e-1)"	"unprognostic (2.09e-1)"	"unprognostic (4.53e-2)"	"unprognostic (2.36e-1)"	"prognostic favorable (7.89e-5)"	6.0	5.7	12.5	6.7	13.4	7.6	6.8	13.1	14.2	10.0	10.7	10.9	6.0	11.0	6.3	8.4	9.4	5.5	5.3	13.3	13.9	7.4	8.2	7.5	12.7	12.1	11.2	11.2	9.2	5.2	7.7	5.3	12.5	8.3	6.4	10.2	7.3	5.1	4.4	7.4	9.6	8.8	10.2	10.3	9.7	3.2	14.9	9.0	7.8	2.7	11.8	8.9	9.9	11.8	9.1	6.2	10.5	26.1	8.0	5.9	3.7	8.5	7.8	6.7	6.9	5.8	11.0	14.8	13.2	6.9	8.8	11.0	13.8	12.4	8.6	15.3	20.4	11.3	16.0	5.2	6.4	15.9	20.8	8.0	7.0	14.7	17.1	13.4	6.3	11.1	15.0	26.3	7.3	16.0	16.0	21.7	10.6	7.2	11.4	15.3	14.3	14.6	10.8	5.5	10.6	13.6	14.5	12.1	11.0	16.3	13.5	10.6	7.9	6.7	6.2	11.4	5.5	13.3	13.8	19.6	6.0	10.5	6.4	19.3	6.0	11.0	18.1	8.4	18.2	13.2	14.3	17.8	5.5	12.8	11.8	16.6	11.7	22.9	6.9	13.0	18.7	11.1	12.5	13.4	13.1	14.2	13.3	13.9	12.1	11.2	12.5	10.2	14.9	11.8	8.9	9.6	6.5	7.8	22.0	15.2	10.0	14.8	9.6	16.5	16.5	13.6	11.0	15.7	14.6	9.2	12.5	14.1	49.8	14.6	21.5	10.0	17.7	17.3	11.0	9.3	12.1	12.4	20.7	13.4	19.9	11.5	14.8	21.2	9.5	16.9	16.8	12.2	11.6	20.2	20.2	14.0	8.2	12.9	14.4	6.1	12.8	13.6	8.8	10.3	12.0	8.8	44.3	31.7	17.3	15.7	18.6	11.3	17.6	9.8	15.4	23.8	8.5	14.5	6.6	8.6	18.5	4.3	4.0	11.3	17.6	17.9	28.8	16.6	13.2	12.5
TRAPPC2B	"MIP-2A, SEDLP, SEDLP1, TRAPPC2P1"	ENSG00000256060	"Trafficking protein particle complex 2B"	P0DI82	19	57363551-57365405	"Predicted intracellular proteins"	"ER-Golgi transport, Transcription, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Syncytiotrophoblasts: 91.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA063308			Approved	"Nucleoplasm,Endoplasmic reticulum,Vesicles"		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 59: Non-specific - Translation"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 7: Non-specific - Mitochondria"	"Endoplasmic reticulum, Vesicles"	Nucleoplasm	"HPA063308: AB_2684982"	"unprognostic (8.55e-2)"	"unprognostic (1.07e-2)"	"unprognostic (4.24e-1)"	"unprognostic (5.27e-2)"	"unprognostic (1.93e-1)"	"unprognostic (6.69e-2)"	"unprognostic (1.12e-1)"	"unprognostic (4.47e-2)"	"unprognostic (4.57e-2)"	"unprognostic (3.24e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.05e-1)"	"prognostic favorable (1.28e-4)"	"unprognostic (1.26e-1)"	"unprognostic (4.49e-2)"	"unprognostic (9.74e-2)"	"unprognostic (1.39e-2)"	15.0	20.6	8.3	6.8	8.8	10.6	14.2	10.6	11.5	7.9	9.5	13.0	5.0	10.6	11.0	12.5	9.8	9.8	19.5	8.5	9.5	12.5	11.0	10.4	12.3	8.4	8.6	12.8	7.3	10.8	14.9	10.8	9.0	10.1	5.7	8.6	10.9	6.7	30.2	11.6	8.6	9.2	8.2	13.3	9.5	23.2	8.9	15.2	12.2	17.0	10.7	12.4	8.5	8.6	16.9	11.9	18.0	12.0	16.2	18.9	16.2	11.5	25.9	16.6	48.6	6.4	12.5	13.0	15.3	14.9	28.3	6.1	8.4	18.5	17.8	5.9	60.8	13.0	18.7	14.6	16.7	14.3	20.9	18.9	23.1	12.6	9.4	19.1	12.5	14.5	4.1	0.1	19.5	5.0	22.1	13.0	6.0	1.2	25.3	10.7	17.0	20.2	18.8	26.7	18.8	15.4	10.9	12.5	11.1	15.9	18.7	18.1	13.9	15.8	13.7	7.7	18.6	20.5	27.8	25.4	22.7	9.1	16.0	68.4	23.5	30.8	12.0	22.2	24.6	45.1	25.3	20.2	26.5	48.5	24.4	19.5	27.7	44.1	20.9	37.9	24.6	22.4	8.3	8.8	10.6	11.5	8.5	9.5	8.4	8.6	9.0	8.2	8.9	8.6	38.9	9.6	13.1	0.0	13.2	0.0	0.0	0.0	0.0	0.0	21.7	28.2	26.1	0.0	9.9	18.4	0.0	38.1	16.3	0.0	25.4	32.9	0.0	29.3	13.4	15.4	0.0	0.0	0.0	22.1	18.3	10.3	0.0	25.7	21.5	18.2	0.0	0.0	32.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.7	0.0	0.0	11.9	0.0	0.0	0.0	0.0	28.7	0.0	0.0	4.4	0.0	0.0	17.0	13.1	0.0	0.0	0.0	16.5	0.0	0.0	0.0	0.0	91.9	11.7	32.7	0.0	0.0
TRAPPC2L	HSPC176	ENSG00000167515	"Trafficking protein particle complex 2 like"	Q9UL33	16	88856220-88862686	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"ER-Golgi transport, Transport"		"Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 403.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041714	Approved		Supported	Vesicles,Cytosol		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 43: Testis - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 25: Spermatids - Spermatogenesis"	"Vesicles, Cytosol"		"HPA041714: AB_10793930"	"unprognostic (1.27e-2)"	"unprognostic (2.32e-3)"	"unprognostic (1.46e-1)"	"prognostic favorable (3.75e-4)"	"unprognostic (2.77e-1)"	"unprognostic (2.69e-1)"	"unprognostic (5.24e-3)"	"unprognostic (2.90e-1)"	"unprognostic (2.84e-1)"	"unprognostic (6.53e-3)"	"unprognostic (1.05e-1)"	"unprognostic (2.81e-1)"	"unprognostic (1.02e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.00e-1)"	"unprognostic (5.81e-2)"	"unprognostic (1.94e-2)"	55.4	134.3	55.1	30.9	56.7	36.9	51.5	57.4	69.8	49.1	55.2	46.0	25.3	46.7	60.3	53.8	44.1	19.9	66.4	57.8	61.9	53.5	46.5	42.7	31.1	57.5	57.9	55.8	48.8	58.1	45.3	20.4	59.1	39.2	23.8	25.6	48.0	20.5	96.8	58.5	39.1	18.1	60.0	52.7	62.8	122.0	56.9	50.0	41.8	70.7	27.2	48.5	47.3	65.4	69.9	47.9	79.6	60.8	58.5	73.9	81.5	61.5	69.4	92.6	35.4	133.6	89.6	53.4	105.8	78.6	97.7	73.3	109.5	88.5	67.0	46.9	65.7	35.3	46.1	172.7	86.3	101.4	27.5	72.2	54.7	125.4	63.1	52.4	75.7	118.7	108.2	41.4	64.3	216.2	136.1	311.7	80.3	133.4	88.6	128.9	65.9	55.4	73.1	79.6	85.8	42.2	207.6	63.5	59.0	43.6	162.5	106.3	60.3	61.1	66.7	81.1	71.2	57.9	106.6	254.5	73.3	148.0	74.5	39.2	136.3	40.8	113.0	114.5	115.0	154.2	129.8	124.1	135.1	137.9	120.8	103.5	23.9	94.6	114.8	162.5	178.0	162.9	55.1	56.7	57.4	69.8	57.8	61.9	57.5	57.9	59.1	60.0	56.9	65.4	66.2	57.7	82.0	2.3	58.7	51.9	57.4	115.4	43.3	34.9	80.1	106.3	121.1	92.9	81.1	53.3	10.4	93.8	58.2	75.3	240.7	134.7	219.1	60.9	53.4	60.7	62.1	42.1	4.0	154.8	141.5	79.2	72.9	50.5	36.1	55.9	62.8	123.9	226.7	15.2	5.1	78.5	75.3	91.0	69.6	403.2	74.0	68.4	81.8	1.9	134.4	87.3	79.3	2.5	13.0	137.4	76.3	58.3	92.6	45.3	122.5	271.7	93.5	39.5	59.2	44.1	94.7	210.7	123.1	86.0	64.9	77.6	61.2	64.6	86.8	62.5
TRAPPC3	BET3	ENSG00000054116	"Trafficking protein particle complex 3"	O43617	1	36136570-36156053	"Predicted intracellular proteins"	"ER-Golgi transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028408	Approved		Approved	"Golgi apparatus,Cytosol"		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 10: Non-specific - Unknown function"	Cytosol	"Golgi apparatus"	"HPA028408: AB_10601826"	"unprognostic (3.54e-3)"	"unprognostic (1.17e-1)"	"unprognostic (1.36e-1)"	"unprognostic (4.94e-2)"	"unprognostic (2.88e-1)"	"unprognostic (3.94e-2)"	"prognostic unfavorable (2.70e-6)"	"unprognostic (7.39e-3)"	"unprognostic (1.15e-1)"	"unprognostic (7.12e-3)"	"unprognostic (7.38e-2)"	"unprognostic (2.94e-1)"	"unprognostic (9.25e-3)"	"unprognostic (2.61e-2)"	"unprognostic (9.47e-2)"	"unprognostic (2.10e-3)"	"unprognostic (6.53e-2)"	43.7	74.7	42.5	31.2	43.0	28.8	46.6	47.0	50.7	38.5	53.7	57.0	33.6	41.1	60.7	61.6	37.0	32.6	51.1	43.1	44.9	55.3	51.2	36.4	38.3	48.0	45.1	28.2	46.0	54.4	47.0	37.8	47.2	39.2	42.5	39.9	46.4	45.4	48.9	51.5	38.5	49.9	48.3	41.6	48.2	53.1	46.3	51.3	59.9	44.6	54.4	46.2	41.2	48.9	95.7	65.6	44.9	70.2	114.2	91.4	87.9	85.2	109.0	100.0	97.0	55.9	90.0	40.4	79.0	95.0	79.6	68.8	69.9	114.1	113.8	79.8	103.7	75.8	77.2	81.7	132.6	80.0	76.7	78.3	98.5	93.8	91.5	103.6	126.7	101.2	93.2	67.0	122.0	71.4	95.6	74.6	60.5	79.5	93.7	65.8	63.8	90.9	128.4	76.1	67.8	49.7	69.2	78.5	140.1	115.2	50.2	59.6	95.6	59.1	66.7	116.0	116.3	80.1	87.0	67.3	100.7	88.7	60.5	161.9	130.2	148.7	85.0	142.5	89.4	93.6	100.4	90.4	132.6	89.0	96.0	86.9	134.3	95.8	116.3	109.4	135.4	155.3	42.5	43.0	47.0	50.7	43.1	44.9	48.0	45.1	47.2	48.3	46.3	48.9	41.9	25.6	27.6	12.1	45.6	101.1	111.5	152.1	52.3	41.8	97.8	78.5	57.8	55.8	75.7	38.6	16.7	145.7	43.0	55.1	170.2	157.0	286.1	51.8	38.3	59.1	48.3	63.3	15.4	188.5	146.0	52.1	29.0	55.6	45.7	40.5	33.2	49.8	145.0	53.8	16.9	51.2	132.2	56.1	74.7	131.0	42.9	60.6	96.0	10.3	104.4	68.0	61.8	8.5	17.9	178.4	72.1	51.9	80.7	196.9	73.3	115.9	49.2	30.7	32.9	37.4	69.2	172.5	89.4	63.4	123.6	191.4	50.4	50.3	54.3	134.1
TREML1	"dJ238O23.3, TLT1"	ENSG00000161911	"Triggering receptor expressed on myeloid cells like 1"	Q86YW5	6	41149342-41154337	"Plasma proteins, Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 8.7;brain: 4.5;lymphoid tissue: 7.3"	"Group enriched"	"Detected in some"	7	"Macrophages: 75.6;monocytes: 28.3"	"Cancer enhanced"	"Detected in some"		"glioma: 1.6"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	9	"basophil: 92.4"	"Lineage enriched"	"Detected in many"	49	"granulocytes: 92.4"	"Cell line enriched"	"Detected in single"	170	"HEL: 66.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA016700, HPA017860"	Enhanced		Uncertain	"Nuclear speckles,Golgi apparatus,Plasma membrane,Cytosol"		NA	NA		43000000	"Cluster 34: Basophils - Unknown function"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 36: HEL - Hemostasis"	"Cluster 51: Myeloid cells - Hemostasis"	"Nuclear speckles, Cytosol"	"Golgi apparatus, Plasma membrane"	"HPA016700: AB_1858262, HPA017860: AB_1858261"	"unprognostic (6.70e-2)"	"unprognostic (3.50e-3)"	"unprognostic (1.15e-3)"	"unprognostic (1.62e-1)"	"unprognostic (3.48e-2)"	"unprognostic (4.53e-5)"	"unprognostic (1.10e-2)"	"unprognostic (2.55e-3)"	"unprognostic (4.50e-1)"	"unprognostic (2.12e-3)"	"unprognostic (2.34e-2)"	"unprognostic (7.04e-2)"	"unprognostic (1.11e-4)"	"unprognostic (1.36e-1)"	"unprognostic (8.38e-2)"	"unprognostic (7.51e-2)"	"unprognostic (3.41e-2)"	0.9	1.0	1.7	2.7	2.1	8.7	0.5	2.2	4.5	0.3	1.3	0.3	0.0	0.1	0.4	0.1	0.4	0.9	0.3	1.9	2.5	0.2	0.3	2.1	5.4	3.3	2.4	0.1	0.4	0.2	0.4	0.5	2.8	0.2	0.9	0.2	0.4	0.3	0.1	0.3	0.4	0.2	2.5	7.3	0.2	0.1	3.6	4.1	0.3	0.5	4.8	0.4	0.1	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	66.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	92.4	1.7	2.8	0.2	1.8	0.4	0.2	0.1	0.0	0.7	0.3	0.5	0.0	10.7	0.0	0.3	0.9	0.0	110.6	1.7	2.1	2.2	4.5	1.9	2.5	3.3	2.4	2.8	2.5	3.6	3.3	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.8	0.0	0.0	0.0	0.9	0.1	0.0	0.0	0.0	0.0	0.3	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	3.9	0.0	3.9	0.0	0.0	0.0	0.0	1.6	2.7	0.0	0.0	75.6	0.0	6.5	28.3	0.0	7.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.0
TREX1	"AGS1, DRN3"	ENSG00000213689	"Three prime repair exonuclease 1"	Q9NSU2	3	48465811-48467645	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins"		"Exonuclease, Hydrolase, Nuclease"	"Aicardi-Goutieres syndrome, Disease variant, Neurodegeneration, Systemic lupus erythematosus"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 53.6;Club cells: 24.5;Ionocytes: 40.7;Langerhans cells: 22.6;Melanocytes: 24.9;Respiratory ciliated cells: 29.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+ RasG12V: 67.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035437, HPA046721"	Supported		Supported	Cytosol		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Cytosol		"HPA035437: AB_10672092, HPA046721: AB_2732531"																		9.9	14.3	32.7	16.5	33.4	28.7	12.2	33.2	42.1	13.8	39.8	12.4	11.1	7.7	11.4	19.2	15.5	13.8	10.7	33.0	32.7	12.2	12.8	13.8	26.6	33.0	34.2	7.4	13.1	11.3	20.6	8.4	34.3	16.6	9.9	1.9	36.5	15.4	9.7	26.4	12.0	7.0	33.8	25.0	13.7	4.0	33.5	18.1	8.4	13.8	18.1	13.1	10.4	33.7	19.2	18.1	13.3	10.3	18.1	17.5	0.0	6.7	29.5	46.9	67.5	0.3	21.8	23.8	11.7	24.4	44.8	21.4	0.9	27.2	6.7	19.9	1.6	13.5	58.1	0.5	20.1	12.8	9.3	16.2	2.5	25.9	9.8	9.8	20.4	16.9	0.0	32.6	20.7	0.4	17.3	8.6	0.1	11.0	11.2	14.4	4.9	43.2	13.4	3.8	0.1	8.1	21.8	29.6	15.4	0.9	0.8	20.3	22.2	8.5	9.2	21.8	14.2	26.4	16.9	10.4	21.5	25.4	7.5	7.7	142.3	11.0	32.6	119.2	18.7	86.8	43.0	31.4	125.9	87.5	40.3	33.8	82.2	30.9	94.6	99.1	43.3	78.6	32.7	33.4	33.2	42.1	33.0	32.7	33.0	34.2	34.3	33.8	33.5	33.7	0.0	0.0	0.5	6.8	2.1	9.1	0.0	53.6	0.6	0.0	0.0	0.0	6.3	0.0	24.5	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.0	4.6	0.0	1.7	2.3	0.0	0.0	4.3	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	2.8	40.7	0.0	22.6	0.0	0.0	2.0	24.9	5.6	0.0	0.0	0.0	1.0	5.9	0.0	1.1	0.0	3.9	0.0	0.0	0.0	29.9	0.0	0.0	0.0	4.2	0.0	0.0	2.7	13.9	0.0	2.6	0.0	1.5	0.0
TRIB3	"C20orf97, dJ1103G7.3, TRB3"	ENSG00000101255	"Tribbles pseudokinase 3"	Q96RU7	20	362835-397559	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Apoptosis, Stress response, Transcription, Transcription regulation"	"Protein kinase inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 80.5"	"Cell type enhanced"	"Detected in many"		"Ductal cells: 53.1;Hepatocytes: 38.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HHSteC: 630.3;hTCEpi: 401.9;hTERT-HME1: 461.8;SK-MEL-30: 615.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA015272, HPA055442"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 1: Pancreatic cells - Digestion"	Nucleoplasm		"HPA015272: AB_1858269, HPA055442: AB_2682818"	"unprognostic (5.40e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.57e-1)"	"unprognostic (2.25e-3)"	"unprognostic (1.92e-1)"	"prognostic unfavorable (1.70e-4)"	"prognostic unfavorable (6.75e-5)"	"unprognostic (1.52e-3)"	"unprognostic (1.76e-1)"	"unprognostic (1.24e-1)"	"unprognostic (7.95e-2)"	"unprognostic (1.79e-1)"	"prognostic unfavorable (2.07e-13)"	"unprognostic (7.62e-2)"	"unprognostic (2.79e-2)"	"unprognostic (2.31e-1)"	"unprognostic (4.05e-3)"	8.0	16.4	5.6	4.0	5.4	16.1	7.8	6.0	6.7	4.4	6.5	4.4	1.3	2.9	3.0	20.5	2.2	2.6	4.0	5.1	6.5	9.9	80.5	15.4	6.5	5.5	5.5	3.2	17.3	13.3	15.2	8.4	5.6	7.8	2.2	2.7	10.4	3.0	1.8	13.6	5.3	1.8	4.4	12.1	10.2	1.4	6.7	5.6	38.2	0.5	5.9	4.8	5.3	4.4	80.9	41.6	5.1	11.9	13.7	17.9	33.7	23.9	65.8	23.0	47.5	86.7	40.0	35.3	22.2	22.5	102.3	62.6	22.6	107.7	21.4	12.4	16.2	27.5	8.9	144.2	630.3	71.5	12.7	73.3	401.9	43.5	461.8	16.2	45.1	86.1	97.3	155.2	2.3	77.3	4.2	87.0	11.8	122.8	133.0	15.2	7.1	77.1	27.0	33.3	14.7	23.0	5.6	192.2	615.5	7.2	55.7	185.6	24.6	11.7	20.6	0.3	36.2	52.3	73.9	63.5	10.5	61.4	43.6	5.1	6.4	1.4	13.2	4.9	9.4	21.0	12.3	15.3	6.7	13.8	13.7	9.8	4.4	10.2	2.6	2.8	9.7	7.8	5.6	5.4	6.0	6.7	5.1	6.5	5.5	5.5	5.6	4.4	6.7	4.4	7.9	3.2	1.5	0.3	9.3	6.8	10.9	20.3	3.4	6.8	12.7	8.3	1.6	11.5	8.5	1.8	4.2	14.1	4.0	3.4	0.0	53.1	0.0	0.2	1.6	15.8	1.2	5.7	2.2	22.7	6.4	3.9	0.0	2.6	5.1	0.5	6.8	38.4	6.4	0.0	3.1	8.8	6.1	3.3	4.4	0.0	1.8	3.0	7.2	0.0	4.2	1.0	14.4	1.0	0.6	24.0	1.9	1.5	10.0	12.2	0.0	0.1	2.9	7.0	6.6	6.5	6.9	2.4	3.1	4.0	5.4	7.1	5.7	3.5	2.2	6.7
TRIM16	EBBP	ENSG00000221926	"Tripartite motif containing 16"	O95361	17	15627960-15684311	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 145.9"	"Cell type enhanced"	"Detected in many"		"Pancreatic endocrine cells: 153.4;Squamous epithelial cells: 95.5;Urothelial cells: 111.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	9	"T-reg: 45.1"	"Lineage enriched"	"Detected in many"	12	"T-cells: 45.1"	"Cell line enhanced"	"Detected in all"		"A549: 283.8;HaCaT: 229.0;HeLa: 203.8;OE19: 364.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA023623, HPA066431"	Uncertain		Supported	"Plasma membrane,Cytosol"		NA	NA		19000	"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 61: Squamous epithelial cells - Keratinization"	Cytosol	"Plasma membrane"	"HPA023623: AB_1858273, HPA066431: AB_2685668"	"unprognostic (2.14e-1)"	"unprognostic (1.95e-1)"	"unprognostic (9.61e-2)"	"unprognostic (1.31e-2)"	"unprognostic (6.19e-2)"	"unprognostic (1.21e-1)"	"prognostic unfavorable (3.94e-4)"	"unprognostic (1.94e-3)"	"unprognostic (3.75e-2)"	"unprognostic (4.65e-1)"	"unprognostic (3.31e-3)"	"unprognostic (1.70e-1)"	"unprognostic (2.16e-3)"	"unprognostic (2.08e-1)"	"unprognostic (8.48e-2)"	"unprognostic (9.21e-3)"	"prognostic unfavorable (6.71e-4)"	18.3	32.7	14.1	7.8	16.2	17.4	13.4	17.7	21.5	44.9	10.3	14.1	22.8	6.1	4.9	145.9	8.8	16.3	23.1	13.5	15.8	8.5	5.9	14.5	9.7	16.9	16.0	7.3	6.0	3.6	4.4	34.5	17.2	10.2	11.2	3.6	38.0	11.7	28.1	44.9	12.5	9.0	15.8	6.0	31.7	12.7	17.2	10.1	18.7	27.2	37.3	35.7	70.2	22.1	91.5	283.8	8.6	19.4	40.4	46.1	9.6	14.8	51.9	17.9	25.0	17.2	115.6	9.8	54.7	64.7	106.9	229.0	25.6	65.7	12.0	120.0	16.4	4.5	203.8	9.5	67.1	5.4	9.6	25.7	40.9	39.3	22.3	49.6	38.8	11.4	5.7	45.8	49.2	32.2	20.2	11.7	13.1	364.2	17.0	8.7	71.8	6.9	92.4	116.0	6.4	17.7	64.7	72.2	22.1	49.7	10.9	12.6	61.0	22.5	26.3	10.9	51.3	11.1	12.9	1.0	34.6	12.6	58.3	0.4	3.8	1.0	1.2	1.1	0.8	0.5	4.9	1.5	2.6	0.6	1.3	2.6	0.6	0.9	0.5	0.4	45.1	2.3	14.1	16.2	17.7	21.5	13.5	15.8	16.9	16.0	17.2	15.8	17.2	22.1	34.9	38.5	2.6	14.0	5.3	30.8	59.0	55.6	10.2	7.2	11.8	5.7	12.5	10.0	73.5	11.0	18.8	13.6	2.8	9.9	0.0	49.1	1.1	16.5	9.9	28.7	4.2	9.0	9.6	17.3	8.4	9.6	34.7	25.7	4.5	12.4	3.6	3.2	4.0	3.3	14.0	21.7	28.5	2.9	8.6	3.9	7.2	2.9	7.2	11.2	13.0	6.6	4.1	18.6	19.2	153.4	26.9	4.5	3.7	29.5	4.3	6.2	33.5	8.4	6.6	5.8	14.0	10.3	12.1	95.5	77.6	4.7	5.9	60.9	18.4	111.9
TRIM22	"GPSTAF50, RNF94, STAF50"	ENSG00000132274	"Tripartite motif containing 22"	Q8IYM9	11	5689697-5737089	"Enzymes, Predicted intracellular proteins"	"Antiviral defense, Host-virus interaction, Transcription, Transcription regulation, Ubl conjugation pathway"	"Repressor, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"B-cells: 135.9;dendritic cells: 113.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 174.6;BJ hTERT+ SV40 Large T+ RasG12V: 209.9;HSkMC: 190.6;TIME: 153.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA003307, HPA003575"	Approved		Supported	"Nucleoplasm,Nuclear bodies,Golgi apparatus"		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 57: B-cells - Immune response"	"Nucleoplasm, Nuclear bodies"	"Golgi apparatus"	"HPA003307: AB_1080381, HPA003575: AB_1080378"	"unprognostic (1.47e-2)"	"unprognostic (5.27e-3)"	"unprognostic (4.00e-2)"	"unprognostic (4.21e-3)"	"unprognostic (2.21e-1)"	"unprognostic (1.21e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.86e-3)"	"unprognostic (2.93e-2)"	"unprognostic (2.10e-1)"	"unprognostic (1.98e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.50e-2)"	"unprognostic (1.15e-1)"	"unprognostic (9.16e-2)"	54.0	21.3	13.1	101.3	18.8	90.3	50.7	16.3	23.7	42.7	25.5	36.0	25.2	50.6	70.2	37.1	49.3	78.6	22.6	14.7	16.5	21.2	72.5	83.4	139.0	17.9	16.7	60.3	17.2	8.0	12.6	21.5	16.7	43.3	53.4	11.0	65.4	52.6	13.4	18.1	53.4	52.1	17.7	143.1	39.5	15.4	12.8	101.2	21.7	40.6	120.7	61.6	22.6	29.3	2.8	1.2	13.9	2.4	88.6	174.6	5.0	53.3	93.9	89.8	209.9	1.7	8.6	111.9	13.0	80.2	20.6	10.5	34.0	56.4	10.7	2.0	0.0	6.4	5.6	1.4	107.8	18.2	11.4	190.6	54.3	18.7	9.6	124.5	128.7	1.0	2.3	4.7	111.6	1.5	54.1	16.9	40.3	0.5	4.9	62.6	3.4	2.3	51.1	14.9	1.4	2.7	4.5	4.5	2.1	56.8	4.5	17.9	153.6	56.4	29.8	2.5	2.4	4.9	4.4	11.2	67.7	28.9	7.2	108.7	118.5	79.6	109.0	143.3	145.9	149.4	118.4	117.2	138.7	158.2	106.5	102.7	103.1	61.3	181.1	177.0	197.9	181.9	13.1	18.8	16.3	23.7	14.7	16.5	17.9	16.7	16.7	17.7	12.8	29.3	54.4	67.3	57.7	2.0	135.9	12.6	17.0	42.5	56.3	0.5	17.7	14.0	6.0	7.2	60.5	29.5	0.0	1.5	113.9	4.7	5.9	11.2	0.3	16.1	27.0	40.5	4.2	16.8	4.9	8.0	4.7	36.2	20.9	23.8	17.7	5.4	33.5	4.3	18.7	1.7	0.3	9.0	30.5	87.1	46.6	2.0	36.1	67.8	5.4	52.5	59.0	6.4	83.4	1.0	0.5	5.4	6.3	30.1	18.8	9.9	4.4	3.3	52.5	1.0	13.1	35.1	24.4	0.6	0.3	14.1	8.7	2.3	89.3	13.0	5.0	18.8
TRIM25	"EFP, RNF147, ZNF147"	ENSG00000121060	"Tripartite motif containing 25"	Q14258	17	56836387-56914080	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Antiviral defense, Host-virus interaction, Immunity, Innate immunity, Ubl conjugation pathway"	"Ligase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	5	"neutrophil: 23.5"	"Lineage enriched"	"Detected in all"	7	"granulocytes: 23.5"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA005909	Approved		Approved	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 44: Endometrium - Transcription"	"Nucleoplasm, Cytosol"	"Nuclear bodies"	"HPA005909: AB_1078722"	"unprognostic (8.73e-3)"	"unprognostic (1.57e-2)"	"unprognostic (2.06e-2)"	"unprognostic (6.06e-2)"	"unprognostic (2.69e-1)"	"unprognostic (3.78e-2)"	"prognostic unfavorable (9.37e-4)"	"unprognostic (1.53e-1)"	"unprognostic (4.23e-1)"	"unprognostic (1.15e-1)"	"prognostic favorable (3.36e-4)"	"unprognostic (3.23e-1)"	"unprognostic (3.11e-2)"	"prognostic favorable (9.35e-4)"	"unprognostic (5.21e-2)"	"unprognostic (5.13e-2)"	"unprognostic (7.39e-2)"	16.3	20.7	9.8	19.8	10.4	47.7	13.1	9.5	23.2	14.5	11.1	19.7	19.4	12.1	8.5	20.4	18.2	9.7	11.1	9.0	11.3	11.9	29.8	25.0	17.3	10.3	9.9	14.3	16.7	13.0	10.3	9.5	10.3	9.3	17.3	11.8	15.3	7.4	12.6	29.2	20.2	12.4	11.4	41.6	17.0	9.1	12.1	18.5	10.8	7.6	19.7	12.1	14.6	9.0	77.2	37.4	9.0	30.7	66.6	55.8	0.1	29.6	59.6	69.4	59.3	36.7	41.1	74.6	59.8	28.6	75.4	44.5	44.5	39.9	38.5	64.1	35.0	48.1	29.0	41.0	57.0	58.2	33.2	25.1	65.7	36.2	76.4	32.9	46.7	50.2	12.0	43.8	35.8	51.3	65.6	41.9	5.8	63.3	71.5	46.3	30.2	47.4	40.5	59.7	17.5	16.3	23.3	37.1	69.7	5.8	50.3	46.8	31.3	32.2	23.1	50.1	31.2	24.7	51.1	12.1	31.2	39.4	13.0	4.8	3.0	1.2	1.0	2.5	1.3	2.2	0.9	1.0	3.1	1.7	0.7	1.0	23.5	1.1	1.8	2.2	2.0	1.1	9.8	10.4	9.5	23.2	9.0	11.3	10.3	9.9	10.3	11.4	12.1	9.0	27.3	35.3	19.8	7.5	12.7	18.5	8.5	10.5	13.1	9.9	12.6	11.9	7.5	20.0	16.6	9.2	29.2	5.4	15.1	54.8	0.0	19.1	3.5	44.9	20.0	32.7	18.6	11.1	4.1	21.6	10.7	16.0	32.6	72.5	3.8	23.0	32.2	30.9	14.8	3.3	8.2	28.7	6.1	27.5	24.6	2.1	9.6	29.3	14.2	8.4	28.3	5.7	11.3	12.1	0.3	32.2	54.2	9.4	17.7	21.6	20.0	8.0	18.5	22.2	6.6	13.1	9.2	0.4	0.3	24.5	30.5	15.9	11.5	45.3	25.7	25.4
TRIM26	"RNF95, ZNF173"	ENSG00000234127	"Tripartite motif containing 26"	Q12899	6	30184455-30213427	"Enzymes, Predicted intracellular proteins"	"Immunity, Innate immunity"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Daudi: 38.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044975, HPA050456"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 16: U-266 - Nucleosome"	"Cluster 44: Endometrium - Transcription"	"Nucleoplasm, Cytosol"		"HPA044975: AB_2679162, HPA050456: AB_2681133"	"unprognostic (1.93e-1)"	"unprognostic (5.41e-2)"	"unprognostic (8.53e-2)"	"unprognostic (1.96e-3)"	"unprognostic (1.52e-1)"	"unprognostic (5.50e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.40e-2)"	"unprognostic (2.85e-1)"	"unprognostic (3.08e-2)"	"unprognostic (1.97e-1)"	"unprognostic (7.00e-3)"	"unprognostic (1.37e-2)"	"unprognostic (1.63e-3)"	"unprognostic (5.21e-2)"	"unprognostic (8.82e-2)"	"prognostic favorable (3.25e-5)"	15.6	16.5	3.6	6.9	4.4	4.5	16.3	4.5	7.1	15.8	3.7	17.9	5.6	16.8	2.9	28.9	16.4	4.9	12.5	3.3	4.9	18.1	26.1	16.8	6.6	4.7	4.0	12.5	15.5	4.2	14.1	2.9	4.3	18.2	2.3	4.2	21.0	3.2	14.5	20.8	19.8	1.1	3.6	18.0	17.6	11.5	4.8	3.9	17.6	1.3	6.6	17.8	17.4	4.9	15.7	8.3	0.0	23.8	8.1	4.6	7.8	9.7	5.4	11.4	11.6	0.0	0.9	38.2	13.0	12.4	17.0	17.6	0.0	16.8	3.5	0.0	13.0	6.1	2.5	16.7	7.1	13.3	5.4	4.6	5.7	11.9	7.1	0.0	7.6	18.4	2.8	0.0	0.0	0.0	19.1	17.8	0.0	0.0	6.7	16.9	15.1	5.3	9.8	14.5	0.5	11.0	18.5	0.9	5.2	5.0	8.0	2.3	16.5	8.7	5.8	0.0	0.2	15.1	31.2	18.1	0.0	21.3	15.0	0.5	1.5	0.1	1.8	1.9	1.2	1.0	1.2	1.5	1.2	1.4	0.7	1.0	0.5	0.7	1.6	0.5	1.6	1.3	3.6	4.4	4.5	7.1	3.3	4.9	4.7	4.0	4.3	3.6	4.8	4.9	13.5	28.9	21.7	18.3	23.8	30.1	22.4	13.1	34.7	20.1	22.0	18.0	13.5	18.6	15.7	12.9	16.7	18.6	31.1	21.8	11.7	16.1	0.5	25.7	15.1	16.2	22.3	1.7	16.5	15.9	14.4	12.7	17.9	34.7	5.1	12.2	9.3	52.9	13.8	13.5	25.1	15.4	6.1	17.3	25.7	1.6	7.5	21.0	17.8	18.7	24.0	12.1	21.6	18.1	26.9	13.6	15.7	12.0	26.3	20.2	17.1	15.8	24.4	19.7	6.6	10.7	12.1	5.0	13.4	42.0	34.0	17.6	28.7	9.4	17.2	22.3
TRIM29	"ATDC, FLJ36085"	ENSG00000137699	"Tripartite motif containing 29"	Q14134	11	120111286-120185529	"Predicted intracellular proteins"	"Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 600.1;skin 1: 551.2;vagina: 269.1"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 272.0;Basal squamous epithelial cells: 250.4;Late spermatids: 150.3;Squamous epithelial cells: 552.9;Suprabasal keratinocytes: 460.6;Urothelial cells: 159.3"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 93.4"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HaCaT: 399.9;HBEC3-KT: 107.5;hTCEpi: 476.0;RT4: 190.5;SiHa: 268.3"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	9	"spinal cord: 4.0"	"HPA020053, HPA074841"	Enhanced		Approved	"Nucleoplasm,Intermediate filaments,Cytosol"		NA	NA				"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 61: Squamous epithelial cells - Keratinization"	"Intermediate filaments"	"Nucleoplasm, Cytosol"	"HPA020053: AB_1858280, HPA074841: "	"unprognostic (1.10e-1)"	"unprognostic (6.22e-2)"	"unprognostic (1.53e-1)"	"prognostic unfavorable (2.88e-4)"	"unprognostic (9.79e-3)"	"unprognostic (3.08e-2)"	"unprognostic (3.30e-1)"	"unprognostic (5.24e-3)"	"unprognostic (1.37e-1)"	"unprognostic (1.16e-1)"	"prognostic unfavorable (4.46e-4)"	"unprognostic (9.37e-2)"	"unprognostic (4.29e-3)"	"prognostic favorable (4.93e-4)"	"unprognostic (2.59e-1)"	"unprognostic (2.91e-2)"	"unprognostic (4.15e-2)"	2.5	1.0	0.1	0.4	0.2	0.4	41.7	0.0	0.4	133.8	1.6	3.0	1.7	2.6	4.8	600.1	17.4	3.5	0.4	0.3	0.0	1.7	1.8	3.7	0.0	1.8	0.6	0.4	1.0	0.0	8.1	30.7	1.8	31.4	2.6	0.3	131.5	23.7	2.2	551.2	1.0	1.5	2.6	0.3	1.4	2.7	0.0	19.9	0.4	0.2	107.2	55.8	269.1	0.6	34.4	2.5	0.0	0.0	0.0	0.0	0.9	0.1	0.8	0.2	0.1	0.8	25.6	0.2	3.9	0.2	0.5	399.9	0.0	107.5	0.0	0.1	0.0	0.2	25.4	0.4	0.0	0.2	0.5	0.0	476.0	0.0	2.6	0.0	0.0	0.0	0.2	0.7	0.0	4.4	0.0	0.0	0.1	11.4	0.1	0.0	0.3	0.0	0.3	190.5	1.3	5.9	268.3	35.2	0.1	0.2	1.9	0.0	0.4	0.1	2.1	0.2	0.1	0.2	0.3	0.2	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.4	0.3	0.0	1.8	0.6	1.8	2.6	0.0	0.6	0.5	0.0	1.5	3.3	0.2	272.0	106.1	76.4	250.4	0.0	9.5	58.8	1.2	1.5	39.2	0.0	0.0	41.0	0.2	11.3	0.0	5.0	28.1	8.7	0.8	3.4	2.4	0.0	0.5	4.3	7.1	5.6	1.1	3.6	1.3	0.0	0.0	0.4	5.0	0.0	0.1	2.1	12.2	0.0	30.3	150.3	0.6	1.4	23.2	1.0	0.0	0.0	0.0	0.0	0.1	57.1	11.3	0.0	0.0	66.0	0.2	0.6	64.6	0.0	0.0	0.1	4.9	0.8	2.6	552.9	460.6	24.8	2.4	0.1	3.7	159.3
TRIM39	RNF23	ENSG00000204599	"Tripartite motif containing 39"	Q9HCM9	6	30326479-30343729	"Enzymes, Predicted intracellular proteins"	"Apoptosis, Cell cycle, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051120, HPA059496"	Uncertain		Supported	Cytosol		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 71: Testis - DNA repair"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 7: Non-specific - Mitochondria"	Cytosol		"HPA051120: AB_2681348, HPA059496: AB_2684040"	"unprognostic (2.90e-1)"	"unprognostic (1.61e-2)"	"unprognostic (2.79e-2)"	"unprognostic (2.86e-2)"	"unprognostic (6.38e-2)"	"unprognostic (4.55e-2)"	"unprognostic (1.46e-2)"	"unprognostic (1.15e-2)"	"unprognostic (3.47e-1)"	"unprognostic (9.44e-2)"	"prognostic favorable (2.50e-4)"	"unprognostic (1.30e-2)"	"unprognostic (4.69e-2)"	"unprognostic (6.35e-3)"	"unprognostic (1.46e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.39e-3)"	10.0	8.7	0.8	1.7	1.0	3.1	10.2	1.3	1.1	11.4	1.5	13.6	1.6	12.1	2.2	13.1	11.7	1.3	8.7	0.9	0.9	9.8	11.6	9.7	1.6	1.3	1.0	11.5	12.2	2.1	14.8	1.6	1.0	10.8	1.5	1.5	10.2	2.0	14.3	9.3	11.9	1.8	0.8	14.3	11.0	20.7	1.1	1.7	11.6	1.4	2.1	12.9	9.5	1.1	3.2	0.1	2.6	4.8	1.2	1.2	2.7	1.4	1.8	2.1	1.9	3.8	0.4	4.1	2.8	2.7	1.3	1.0	3.1	2.2	2.2	3.2	3.4	3.2	0.5	1.4	2.7	4.8	3.5	1.4	1.8	2.7	2.9	3.2	1.3	3.4	4.9	3.2	2.7	2.9	1.0	1.0	3.6	1.3	2.2	2.2	0.5	3.1	2.2	3.0	5.7	2.8	1.1	2.3	2.8	2.5	3.1	1.2	1.2	2.3	1.8	2.8	4.9	5.7	7.6	4.2	1.3	1.7	3.6	1.0	0.9	4.1	2.7	1.3	2.4	1.8	1.9	2.0	0.9	1.6	2.2	2.2	4.5	2.6	1.4	0.7	1.7	1.4	0.8	1.0	1.3	1.1	0.9	0.9	1.3	1.0	1.0	0.8	1.1	1.1	5.9	3.2	7.2	0.7	14.2	3.7	5.6	2.6	6.8	6.0	7.5	5.2	5.6	2.8	3.5	1.8	6.2	4.7	11.9	5.5	7.9	4.6	4.6	11.2	4.1	4.8	5.4	3.6	0.9	6.1	5.7	4.1	15.3	13.1	5.7	4.2	5.7	3.7	3.3	3.3	1.1	7.3	4.1	7.2	5.0	7.8	2.8	7.3	3.6	1.0	4.3	6.9	8.2	0.5	0.9	6.8	10.0	4.5	10.9	3.7	7.5	4.0	7.2	7.6	0.0	3.8	5.8	19.1	10.0	5.3	4.1	10.0	15.3	3.5	4.4	5.3
TRIM4	RNF87	ENSG00000146833	"Tripartite motif containing 4"	Q9C037	7	99876958-99919531	"Enzymes, Predicted intracellular proteins"	"Immunity, Innate immunity, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			"HPA019356, HPA029461"	Approved		Supported	"Plasma membrane,Cytosol"		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 63: NK-cells & T-cells - Immune response"	Cytosol	"Plasma membrane"	"HPA019356: AB_1856376, HPA029461: AB_10600834"	"unprognostic (1.88e-1)"	"unprognostic (2.97e-2)"	"unprognostic (3.37e-1)"	"unprognostic (3.46e-2)"	"unprognostic (1.80e-2)"	"unprognostic (7.06e-2)"	"unprognostic (1.22e-1)"	"unprognostic (5.42e-2)"	"unprognostic (3.85e-2)"	"unprognostic (2.67e-3)"	"unprognostic (2.48e-2)"	"unprognostic (1.60e-1)"	"prognostic favorable (7.36e-6)"	"unprognostic (1.00e-1)"	"unprognostic (2.38e-1)"	"unprognostic (7.46e-2)"	"unprognostic (5.65e-2)"	18.7	21.5	11.0	17.1	11.5	9.3	26.8	15.5	12.6	18.9	15.4	17.3	17.5	23.7	19.8	15.3	22.9	15.2	10.0	10.5	11.9	20.6	22.9	18.5	22.4	11.2	11.9	41.3	23.8	25.5	16.2	19.9	10.9	23.0	19.2	21.5	19.0	20.2	7.5	21.8	18.6	19.9	10.7	21.5	20.1	16.0	12.0	20.9	24.5	11.8	23.8	17.3	17.3	13.3	20.8	26.2	14.4	12.0	37.0	34.6	6.3	34.6	41.3	28.0	32.4	13.1	20.1	30.3	0.1	28.8	24.2	24.3	19.0	21.2	28.4	31.2	1.4	25.3	13.1	20.8	52.4	35.9	29.4	36.9	44.3	21.6	54.7	37.8	24.6	14.9	37.1	45.3	23.9	26.4	26.8	32.2	10.9	31.0	21.0	15.0	20.6	34.6	31.6	26.4	16.8	11.9	26.4	39.4	42.3	20.7	18.2	20.2	30.6	30.7	27.6	59.5	33.6	37.7	44.4	24.0	20.1	39.7	41.7	38.2	28.4	23.6	28.5	28.6	32.8	26.2	29.4	32.6	24.9	25.3	40.7	30.4	11.7	22.3	26.1	18.5	32.8	28.0	11.0	11.5	15.5	12.6	10.5	11.9	11.2	11.9	10.9	10.7	12.0	13.3	17.8	25.6	20.1	19.2	32.3	25.1	24.8	17.7	25.0	21.6	21.8	18.0	6.1	18.6	14.2	22.0	18.8	16.4	28.1	10.1	9.8	15.9	7.4	12.5	25.4	18.8	9.0	16.8	18.3	12.8	6.7	20.1	19.4	11.4	27.3	19.0	22.5	20.4	14.3	6.7	20.7	10.4	16.2	21.4	14.8	13.1	31.1	21.2	23.2	12.2	27.0	35.9	32.0	23.1	22.5	14.9	10.4	27.4	20.1	26.6	17.8	19.0	16.5	22.1	0.0	21.8	20.4	22.4	9.4	18.0	23.0	16.3	29.8	52.5	13.5	23.6
TRIM41	"MGC1127, RINCK"	ENSG00000146063	"Tripartite motif containing 41"	Q8WV44	5	181222499-181235808	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 57.8"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"HDLM-2: 77.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024204	Approved		Supported	"Nucleoli,Nuclear bodies"		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 52: Non-specific - Transcription"	"Nucleoli, Nuclear bodies"		"HPA024204: AB_1858299"	"unprognostic (1.13e-1)"	"unprognostic (7.05e-2)"	"unprognostic (1.23e-2)"	"unprognostic (7.93e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.07e-1)"	"unprognostic (9.56e-2)"	"unprognostic (7.24e-2)"	"unprognostic (8.66e-2)"	"unprognostic (6.87e-2)"	"unprognostic (2.21e-3)"	"unprognostic (2.07e-1)"	"unprognostic (5.17e-3)"	"unprognostic (2.45e-3)"	"unprognostic (1.34e-1)"	"prognostic unfavorable (4.22e-4)"	"unprognostic (2.68e-2)"	7.9	9.6	52.7	7.5	57.8	8.1	5.8	48.3	50.8	6.9	31.3	6.6	8.4	7.6	5.8	10.1	6.4	3.2	9.4	42.2	44.1	9.5	12.2	6.2	4.9	57.3	57.3	6.0	9.9	11.7	10.9	4.1	53.2	6.8	2.7	7.0	7.6	5.6	26.1	9.8	7.2	3.5	54.5	8.2	8.8	13.2	53.8	10.1	11.7	12.7	5.2	6.8	6.7	54.7	9.3	24.0	8.7	14.6	10.1	10.0	20.6	13.3	7.2	9.6	9.0	20.4	13.8	16.0	21.4	9.1	18.0	17.3	9.1	31.9	5.2	77.8	29.2	17.8	24.9	11.7	9.7	13.3	11.8	8.8	16.1	12.0	4.2	9.3	5.6	23.8	22.7	18.8	5.3	33.8	20.0	14.7	8.3	7.0	11.3	18.7	13.2	20.9	5.5	14.7	13.5	12.7	12.3	14.3	18.7	3.8	28.7	14.8	11.7	13.1	8.9	8.0	10.3	41.2	28.1	21.9	13.7	15.3	11.3	0.2	0.3	0.6	0.6	0.3	0.9	0.5	0.6	1.1	0.4	0.6	0.6	0.8	1.0	0.6	0.7	0.7	0.9	0.4	52.7	57.8	48.3	50.8	42.2	44.1	57.3	57.3	53.2	54.5	53.8	54.7	9.1	3.2	12.4	11.4	10.1	8.0	9.5	7.5	8.0	19.1	10.5	8.9	13.2	12.8	10.0	11.0	18.8	14.6	13.6	12.3	11.7	8.5	8.0	15.8	12.9	10.4	12.7	5.9	5.2	12.1	10.0	7.5	16.8	12.4	2.5	12.3	10.4	21.0	8.8	28.6	5.3	13.1	12.2	15.1	7.3	4.0	5.3	10.1	8.8	5.6	11.8	15.0	14.4	1.5	5.8	9.9	12.3	11.7	11.1	9.5	16.0	8.0	24.1	30.4	0.0	24.4	10.7	33.2	23.7	12.3	11.2	13.0	13.6	10.2	12.6	8.3
TRIM45	"FLJ13181, RNF99"	ENSG00000134253	"Tripartite motif containing 45"	Q9H8W5	1	117111060-117122587	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 29.1"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 9.6;Cardiomyocytes: 12.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"RH-30: 31.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030266, HPA054308"	Uncertain		Supported	"Cytokinetic bridge,Cytosol"		Yes	No			"Cluster 15: NK-cells - Transcription"	"Cluster 52: Non-specific - Ribosome"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 54: Cardiomyocytes - Muscle contraction"	Cytosol	"Cytokinetic bridge"	"HPA030266: AB_10795476, HPA054308: AB_2682445"	"prognostic favorable (1.58e-4)"	"unprognostic (2.68e-2)"	"unprognostic (1.12e-2)"	"unprognostic (3.49e-1)"	"unprognostic (5.70e-2)"	"unprognostic (9.66e-2)"	"unprognostic (2.19e-3)"	"unprognostic (1.16e-2)"	"unprognostic (1.26e-2)"	"unprognostic (1.43e-2)"	"unprognostic (3.05e-1)"	"unprognostic (5.45e-2)"	"unprognostic (7.09e-2)"	"unprognostic (3.90e-2)"	"unprognostic (4.85e-2)"	"prognostic unfavorable (2.92e-4)"	"unprognostic (1.27e-2)"	2.9	7.1	3.9	1.2	3.6	2.1	5.4	2.9	3.9	7.3	3.1	6.2	3.7	8.7	6.6	2.2	10.0	2.9	12.6	3.4	3.1	6.7	1.7	2.4	0.9	3.3	3.2	9.1	11.4	5.6	10.5	2.0	3.0	10.7	2.1	3.6	4.7	5.7	29.1	5.8	3.1	4.9	3.2	3.2	5.7	7.6	3.7	0.8	12.0	10.5	0.6	8.1	5.3	3.8	4.3	3.6	16.0	7.5	1.3	3.6	11.9	4.8	2.0	3.3	3.3	1.8	3.9	0.1	3.5	2.2	3.5	3.9	3.7	3.9	4.4	2.5	3.8	2.6	13.9	2.1	2.3	2.4	3.6	4.6	3.8	5.5	3.9	6.2	4.1	4.7	3.2	3.2	3.1	19.3	1.4	2.7	8.7	2.5	3.5	6.1	31.4	0.9	4.5	3.9	11.9	3.1	3.9	3.6	3.1	15.0	6.2	3.1	1.4	4.6	6.6	2.8	4.3	8.7	3.5	0.3	6.0	2.2	12.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.5	0.0	3.9	3.6	2.9	3.9	3.4	3.1	3.3	3.2	3.0	3.2	3.7	3.8	1.1	9.6	2.7	4.9	0.1	1.1	1.8	1.5	1.2	1.4	5.0	3.4	12.2	4.3	2.2	1.8	4.2	2.7	0.1	0.3	1.9	1.9	5.7	2.8	2.6	1.5	1.8	2.5	2.5	3.2	1.2	2.1	3.6	2.8	0.0	4.0	2.2	0.2	0.8	1.7	1.9	1.6	0.0	0.3	0.3	2.7	1.8	0.4	0.0	3.7	0.0	1.4	0.0	3.5	2.3	2.1	0.0	1.9	0.6	0.5	0.4	0.4	1.9	1.4	0.0	3.1	2.1	6.1	5.3	1.3	1.6	1.1	0.4	5.5	1.6	1.3
TRIM47	"GOA, RNF100"	ENSG00000132481	"Tripartite motif containing 47"	Q96LD4	17	75874164-75878581	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Pancreatic endocrine cells: 105.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"RPMI-8226: 48.4;RPTEC TERT1: 36.0;U-266/70: 39.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA014933	Uncertain		Supported	Cytosol		NA	NA			"Cluster 13: T-cells - Unknown function"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 1: Pancreatic cells - Digestion"	Cytosol		"HPA014933: AB_10603219"	"prognostic favorable (6.54e-4)"	"unprognostic (8.42e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.42e-2)"	"unprognostic (1.19e-2)"	"unprognostic (4.07e-2)"	"prognostic unfavorable (5.59e-5)"	"unprognostic (2.08e-2)"	"unprognostic (9.18e-3)"	"unprognostic (2.74e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.55e-1)"	"prognostic unfavorable (9.69e-5)"	"unprognostic (3.94e-2)"	"unprognostic (1.44e-2)"	"unprognostic (3.01e-2)"	"unprognostic (9.98e-2)"	20.6	10.3	43.4	6.5	45.1	0.3	17.7	39.9	68.1	20.4	38.8	31.9	9.0	29.2	3.9	19.1	17.6	7.6	26.7	41.7	42.3	39.2	17.8	18.9	4.3	50.1	46.8	7.2	18.0	5.8	8.8	2.6	43.1	16.8	4.5	0.8	24.4	4.9	6.8	19.9	19.6	6.1	41.5	28.9	17.4	7.4	53.0	1.8	12.8	4.5	4.3	31.4	21.4	45.7	20.6	14.8	0.1	0.1	3.2	3.4	0.5	0.8	1.6	1.1	0.9	2.8	10.2	0.0	12.9	0.7	10.1	23.4	3.7	5.5	0.1	13.2	9.4	0.1	10.2	28.3	5.3	0.1	0.1	2.8	1.5	2.3	2.0	1.0	10.1	1.6	2.2	30.3	0.6	3.5	2.0	0.3	1.6	7.9	29.1	1.5	1.8	48.4	36.0	0.7	5.8	0.4	6.1	29.1	8.4	0.8	3.5	0.6	15.6	18.0	11.3	1.8	7.1	39.2	12.1	2.5	7.8	0.0	1.7	0.0	0.0	1.4	1.7	0.0	4.6	2.4	4.0	2.2	0.1	2.1	2.6	1.7	0.0	2.2	0.0	1.2	5.4	0.6	43.4	45.1	39.9	68.1	41.7	42.3	50.1	46.8	43.1	41.5	53.0	45.7	34.3	16.0	5.4	26.4	5.2	18.0	39.8	34.8	34.1	6.0	20.8	23.4	4.8	40.0	13.8	16.5	0.0	0.5	2.6	30.2	19.6	67.5	0.5	13.6	17.7	39.6	8.4	1.3	1.9	76.6	1.4	33.7	22.4	12.6	22.2	17.1	43.5	11.4	63.5	0.0	1.4	12.5	57.0	9.1	14.5	1.0	34.2	8.2	42.7	8.4	2.6	10.3	0.0	5.5	5.8	105.2	4.7	19.2	12.5	57.0	42.0	66.3	16.7	0.9	32.9	14.5	36.4	1.0	2.2	22.1	15.9	0.8	7.9	2.0	11.8	19.2
TRIM5	"RNF88, TRIM5alpha"	ENSG00000132256	"Tripartite motif containing 5"	Q9C035	11	5663195-5938619	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Antiviral defense, Autophagy, Host-virus interaction, Immunity, Innate immunity, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											"CAB013497, HPA023420, HPA023422"	Approved		Supported	Cytosol		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Cytosol		"CAB013497: , HPA023420: AB_1856378, HPA023422: AB_1856379"	"unprognostic (2.60e-1)"	"unprognostic (9.62e-2)"	"unprognostic (2.04e-2)"	"unprognostic (1.41e-2)"	"unprognostic (6.88e-2)"	"unprognostic (4.74e-3)"	"unprognostic (5.48e-3)"	"unprognostic (5.82e-2)"	"unprognostic (1.49e-1)"	"unprognostic (6.76e-3)"	"unprognostic (8.54e-3)"	"unprognostic (1.64e-1)"	"unprognostic (2.20e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.07e-2)"	"unprognostic (6.12e-2)"	8.8	10.9	2.1	8.1	2.3	3.8	8.0	2.0	2.4	11.8	7.2	7.2	7.4	11.7	18.4	7.7	9.4	6.9	5.7	2.0	3.3	9.0	12.8	11.8	8.4	4.0	3.5	11.4	13.3	4.2	3.8	9.6	3.4	8.5	7.7	1.9	14.0	9.1	1.9	5.5	8.5	11.3	3.0	10.4	7.8	8.3	3.5	9.4	9.6	4.0	8.9	8.2	8.6	2.9	7.7	15.4	19.2	12.4	24.0	22.5	5.4	18.0	35.0	37.3	50.0	13.8	13.5	5.5	13.3	18.8	27.6	13.0	18.4	25.8	14.9	9.6	5.1	15.2	10.4	9.5	20.2	11.5	15.3	15.4	22.7	10.5	31.3	22.9	52.8	8.9	16.9	12.2	32.1	4.2	7.7	5.3	7.7	11.7	8.1	14.3	4.7	1.5	23.7	14.4	0.5	1.1	11.8	18.4	6.8	20.7	9.3	6.6	43.3	13.9	20.2	3.6	4.2	9.4	7.9	1.9	10.9	6.8	15.4	10.7	7.6	11.6	3.6	7.8	3.0	3.1	2.8	2.8	9.4	2.6	1.8	3.7	7.7	4.1	8.0	7.0	2.2	4.1	2.1	2.3	2.0	2.4	2.0	3.3	4.0	3.5	3.4	3.0	3.5	2.9	14.2	6.4	14.0	4.9	8.7	5.2	9.5	9.7	9.6	0.2	8.3	6.5	4.9	2.8	13.4	11.0	0.0	7.8	16.4	5.5	5.9	10.6	5.0	8.6	12.6	14.8	1.2	8.4	3.0	8.8	10.5	12.4	6.1	12.5	0.0	11.9	15.4	13.9	6.4	0.0	1.4	9.7	4.1	12.2	7.1	3.8	7.8	10.8	3.6	19.7	10.8	7.0	14.4	3.0	1.0	8.1	4.9	7.5	6.7	10.1	7.4	6.3	3.7	0.1	19.7	6.5	10.9	5.2	3.3	7.0	5.4	7.8	7.5	20.6	7.5	9.9
TRIM65		ENSG00000141569	"Tripartite motif containing 65"	Q6PJ69	17	75880335-75896951	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021575, HPA021578, HPA064820"	Approved		Supported	Nucleoplasm,Vesicles,Cytosol		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 24: NB-4 - Immune response"	"Cluster 50: Fibroblasts - ECM organization"	Nucleoplasm	"Vesicles, Cytosol"	"HPA021575: AB_1858314, HPA021578: AB_1858315, HPA064820: AB_2685359"	"unprognostic (1.82e-1)"	"unprognostic (1.47e-1)"	"unprognostic (3.47e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.36e-2)"	"prognostic unfavorable (4.74e-6)"	"unprognostic (5.36e-2)"	"unprognostic (8.71e-2)"	"unprognostic (1.78e-1)"	"unprognostic (5.82e-2)"	"unprognostic (6.00e-3)"	"prognostic unfavorable (1.82e-5)"	"unprognostic (2.86e-3)"	"unprognostic (7.18e-2)"	"unprognostic (4.24e-3)"	"unprognostic (7.50e-3)"	13.0	7.8	12.5	8.5	15.2	7.4	10.7	15.3	13.5	15.5	11.0	14.1	8.8	14.7	6.8	14.2	13.1	7.1	10.3	11.5	13.2	11.2	8.4	12.9	10.5	15.0	14.6	14.1	15.7	7.4	11.8	5.4	14.8	11.7	7.9	7.2	12.6	8.1	13.2	14.6	13.5	8.3	13.8	16.6	11.3	3.9	14.5	6.5	12.2	6.9	8.2	14.6	14.0	17.0	19.8	20.2	7.8	22.2	13.5	19.2	4.0	8.3	8.9	11.1	9.4	9.1	17.0	21.4	6.5	7.2	15.6	13.7	16.8	18.6	6.8	11.1	28.9	16.9	20.4	12.5	13.4	17.2	18.9	12.0	14.4	8.9	16.0	9.3	29.2	27.2	29.3	19.5	8.7	20.6	38.0	33.7	17.7	20.0	19.5	31.3	11.2	30.9	11.2	8.2	16.1	14.9	11.4	21.3	22.7	9.7	21.2	24.2	14.5	26.6	13.5	13.3	16.9	17.9	7.4	6.2	16.2	32.2	11.8	1.4	1.1	1.8	1.9	1.0	2.2	1.4	1.4	1.9	0.9	2.0	1.5	1.5	1.1	1.9	0.6	1.3	1.3	0.6	12.5	15.2	15.3	13.5	11.5	13.2	15.0	14.6	14.8	13.8	14.5	17.0	8.4	6.4	4.8	13.1	7.5	2.9	5.7	2.4	3.4	19.0	3.7	3.0	4.3	5.7	3.4	9.2	12.5	0.9	9.0	3.6	1.9	3.2	0.4	2.8	9.2	8.2	0.0	9.5	4.5	3.4	3.6	6.6	7.1	4.0	7.0	8.6	5.7	3.8	8.9	5.0	5.9	6.6	6.1	5.4	9.3	0.5	13.7	6.9	8.8	3.7	4.9	6.3	3.1	6.6	9.3	5.3	2.9	9.4	5.8	5.1	4.8	5.9	1.8	12.9	0.0	9.3	5.2	0.8	2.9	6.7	3.7	0.5	8.5	6.4	5.9	2.8
TRIM66	"C11orf29, KIAA0298, TIF1D"	ENSG00000166436	"Tripartite motif containing 66"	O15016	11	8612037-8682694	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 47.7;Early spermatids: 46.0;Late spermatids: 27.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027420	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 20: HeLa - Mitochondria"	"Cluster 64: Astrocytes - Nervous system maintenance"	Nucleoplasm		"HPA027420: AB_1858316"	"unprognostic (1.26e-1)"	"unprognostic (1.97e-1)"	"unprognostic (2.43e-1)"	"unprognostic (7.54e-2)"	"unprognostic (3.99e-2)"	"unprognostic (1.37e-3)"	"unprognostic (8.01e-2)"	"unprognostic (1.18e-1)"	"unprognostic (8.49e-2)"	"unprognostic (6.79e-2)"	"prognostic favorable (8.89e-4)"	"unprognostic (1.42e-1)"	"prognostic unfavorable (3.96e-4)"	"unprognostic (1.67e-1)"	"unprognostic (4.26e-1)"	"unprognostic (4.67e-2)"	"unprognostic (4.31e-1)"	4.4	5.9	4.5	4.0	5.6	2.8	4.6	2.8	4.6	3.9	5.2	4.4	3.5	3.8	8.2	5.2	4.2	3.0	2.4	3.0	5.1	4.9	10.9	3.6	5.3	4.1	5.4	3.6	8.9	3.1	9.5	1.5	4.0	4.2	4.6	3.6	4.3	3.3	3.6	11.9	5.5	3.5	3.3	5.7	5.4	17.3	5.4	4.5	6.2	3.1	5.2	4.2	4.2	3.6	5.3	4.9	2.9	10.2	6.0	4.5	3.6	3.2	3.7	2.2	2.9	6.5	9.9	5.2	2.2	2.9	2.1	7.2	3.1	2.8	2.7	6.1	2.4	5.0	9.2	3.6	2.5	4.5	3.9	7.1	2.8	1.9	6.6	2.4	2.9	13.1	2.7	5.5	2.9	5.8	2.1	3.4	1.8	2.7	4.6	3.0	2.2	2.1	3.1	6.7	2.1	2.0	4.6	3.2	2.2	2.8	4.2	1.0	2.3	4.2	3.8	2.5	2.8	2.3	3.7	6.4	2.8	4.6	2.4	0.0	0.5	0.6	0.7	0.1	0.4	0.6	0.7	0.9	0.7	0.8	0.7	1.1	0.3	0.8	1.3	1.3	0.6	0.3	4.5	5.6	2.8	4.6	3.0	5.1	4.1	5.4	4.0	3.3	5.4	3.6	3.0	3.2	5.6	47.7	4.0	1.8	2.3	3.6	2.2	8.0	5.1	5.6	1.9	4.3	5.1	5.5	12.5	3.6	3.1	4.5	0.0	3.4	46.0	5.0	4.0	3.2	6.0	5.7	14.2	3.2	1.8	2.6	5.1	3.7	1.3	6.7	5.0	9.8	2.6	11.8	17.1	4.2	0.0	5.2	2.2	27.3	1.8	3.8	0.0	13.1	5.9	4.3	3.1	9.5	22.6	3.9	3.9	2.2	3.1	1.6	8.3	2.4	5.4	9.0	13.1	6.5	2.5	14.6	7.2	3.8	1.1	1.4	3.3	8.0	4.4	1.0
TRIM68	"FLJ10369, RNF137, SS-56"	ENSG00000167333	"Tripartite motif containing 68"	Q6AZZ1	11	4598672-4608231	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023455	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 43: Cardiomyocytes - Nuclear processes"	"Nucleoplasm, Cytosol"		"HPA023455: AB_1858319"	"unprognostic (4.77e-2)"	"unprognostic (5.15e-2)"	"unprognostic (1.18e-1)"	"unprognostic (4.10e-2)"	"unprognostic (4.13e-2)"	"unprognostic (8.63e-2)"	"unprognostic (2.01e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.01e-1)"	"unprognostic (6.70e-2)"	"unprognostic (2.75e-2)"	"unprognostic (7.78e-2)"	"prognostic favorable (4.14e-6)"	"unprognostic (4.23e-2)"	"unprognostic (2.98e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.37e-1)"	5.1	6.5	6.6	3.7	7.0	2.1	6.4	7.2	7.2	9.6	6.3	7.1	6.6	6.5	7.2	5.0	7.6	5.1	7.2	6.6	7.0	9.7	7.4	6.6	5.2	6.6	6.9	10.1	6.2	8.9	6.3	6.2	6.8	10.7	6.2	5.8	8.3	8.1	5.9	4.8	6.0	6.0	6.8	6.8	8.0	6.5	7.3	6.5	9.6	6.6	5.8	7.0	5.3	7.2	10.2	11.2	4.5	8.2	7.2	11.6	0.0	10.9	8.0	9.9	8.9	1.4	10.3	6.9	6.5	5.6	9.3	11.6	4.5	7.7	8.4	17.2	8.8	8.4	2.9	0.0	8.3	13.7	11.4	9.1	11.1	5.7	8.6	10.2	12.6	6.3	8.0	3.7	8.9	2.4	11.3	3.7	5.4	7.1	9.2	9.0	6.4	0.3	6.3	4.4	2.4	4.3	0.0	11.0	7.1	9.0	4.8	6.8	10.3	13.1	8.8	13.3	5.0	13.7	15.9	9.9	8.9	6.0	12.5	8.6	2.5	8.9	7.9	4.8	8.8	8.5	8.8	8.9	5.6	7.6	11.1	9.0	0.3	5.7	5.5	3.8	8.7	7.4	6.6	7.0	7.2	7.2	6.6	7.0	6.6	6.9	6.8	6.8	7.3	7.2	3.2	0.0	3.6	2.9	2.8	0.8	1.4	2.7	3.4	3.3	2.6	2.4	5.4	2.8	5.9	5.5	2.1	6.1	2.7	5.3	5.9	3.2	0.9	2.6	2.2	3.4	6.7	1.3	1.7	3.3	2.7	2.9	4.6	2.8	3.8	5.9	3.6	6.0	2.2	0.0	1.6	5.2	6.1	2.1	0.6	0.4	1.8	2.0	0.0	1.9	2.7	4.1	5.2	3.5	3.0	3.3	1.9	1.9	1.8	2.0	2.4	2.5	2.4	2.8	6.6	2.0	2.6	2.9	6.6	2.0	1.0	4.4	2.8	3.9	4.7	0.6
TRIM8	"GERP, RNF27"	ENSG00000171206	"Tripartite motif containing 8"	Q9BZR9	10	102644479-102658318	"Enzymes, Predicted intracellular proteins"	"Immunity, Innate immunity, Ubl conjugation pathway"	Transferase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023560, HPA023561"	Approved		Supported	Nucleoplasm,Vesicles,Cytosol		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm	"Vesicles, Cytosol"	"HPA023560: AB_10600414, HPA023561: AB_10601861"	"unprognostic (4.32e-2)"	"unprognostic (6.90e-2)"	"unprognostic (3.02e-3)"	"unprognostic (1.45e-1)"	"unprognostic (1.78e-1)"	"unprognostic (5.03e-1)"	"unprognostic (3.82e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.15e-3)"	"unprognostic (4.62e-2)"	"unprognostic (5.41e-2)"	"unprognostic (1.52e-1)"	"unprognostic (9.55e-2)"	"unprognostic (1.48e-1)"	"unprognostic (3.12e-2)"	"unprognostic (8.34e-2)"	"unprognostic (1.36e-2)"	80.1	47.6	67.2	21.5	68.1	26.0	58.4	62.9	55.0	63.0	35.8	50.9	17.8	53.5	9.3	42.0	55.6	22.0	67.8	55.0	56.5	77.9	62.2	70.3	18.3	72.4	72.7	45.2	80.4	36.6	43.5	21.3	64.7	55.5	9.5	18.1	69.1	21.9	80.8	48.3	43.8	17.1	60.4	42.8	61.9	20.1	84.4	18.7	67.4	38.8	11.8	62.9	49.9	54.2	96.4	18.7	16.3	28.7	17.2	40.6	21.1	34.4	59.3	32.1	24.6	30.7	93.0	30.7	102.9	57.5	11.4	32.7	12.2	40.4	21.3	34.4	23.4	78.3	12.9	67.4	55.8	15.5	28.3	47.0	21.9	64.8	32.9	83.4	40.6	13.6	17.3	33.4	24.3	45.5	27.8	57.7	12.7	25.6	38.0	18.6	49.2	16.6	37.4	48.0	12.3	26.2	18.8	17.2	42.6	16.9	58.4	28.2	94.8	40.9	22.4	23.3	68.8	49.0	28.5	16.3	65.5	39.2	9.7	14.0	5.2	2.7	6.8	4.6	6.5	8.9	7.3	5.4	4.5	7.4	6.4	5.7	17.9	6.0	5.7	12.4	7.5	4.5	67.2	68.1	62.9	55.0	55.0	56.5	72.4	72.7	64.7	60.4	84.4	54.2	46.0	57.7	71.2	33.6	29.5	31.5	12.6	21.2	21.6	33.4	53.9	45.3	38.0	38.6	33.6	88.3	8.4	13.0	52.8	15.4	41.1	63.2	1.1	91.5	61.7	30.1	21.6	2.5	8.9	44.9	2.6	38.9	20.4	81.6	8.8	32.2	31.8	33.3	25.4	28.6	13.6	32.8	18.3	40.5	24.1	1.7	31.1	43.5	17.8	13.1	58.1	26.1	24.7	18.1	17.6	65.0	16.4	34.3	18.6	30.5	32.0	53.0	38.5	15.1	13.1	35.7	38.4	2.4	5.1	19.8	22.9	10.9	26.6	38.9	21.4	30.1
TRIP10	"CIP4, HSTP, STOT, STP"	ENSG00000125733	"Thyroid hormone receptor interactor 10"	Q15642	19	6737925-6751530	"Plasma proteins, Predicted intracellular proteins"	Endocytosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 362.8"	"Cell type enhanced"	"Detected in many"		"monocytes: 196.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	5	"plasmacytoid DC: 26.4"	"Lineage enriched"	"Detected in many"	10	"dendritic cells: 26.4"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041934, HPA072625, HPA073886"	Approved		Supported	Nucleoplasm,Vesicles		NA	NA		24000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 59: Non-specific - Translation"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 3: Monocytes - Immune response regulation"	Vesicles	Nucleoplasm	"HPA041934: AB_2677754, HPA072625: AB_2732206, HPA073886: AB_2732244"	"unprognostic (5.75e-2)"	"unprognostic (1.98e-1)"	"prognostic unfavorable (3.61e-4)"	"unprognostic (2.19e-2)"	"unprognostic (6.57e-2)"	"prognostic favorable (1.76e-4)"	"unprognostic (6.73e-3)"	"unprognostic (1.10e-3)"	"unprognostic (1.51e-1)"	"unprognostic (3.41e-1)"	"unprognostic (7.87e-3)"	"unprognostic (3.28e-1)"	"prognostic unfavorable (4.66e-4)"	"unprognostic (1.14e-2)"	"unprognostic (1.42e-1)"	"unprognostic (8.93e-2)"	"unprognostic (8.83e-2)"	110.7	60.3	15.5	25.5	15.6	8.6	92.3	15.3	17.8	123.9	18.6	112.1	30.5	66.5	17.5	253.3	80.1	27.6	125.7	14.6	16.7	81.7	27.0	115.4	14.5	17.5	16.5	99.4	44.7	18.6	22.4	48.6	16.0	80.4	19.9	16.9	85.4	45.0	362.8	57.8	56.0	26.4	15.8	40.0	58.6	29.9	17.5	9.6	75.5	177.3	21.9	86.7	147.4	14.8	83.5	49.7	17.1	25.8	64.7	67.9	61.1	52.5	60.0	58.8	51.1	67.8	46.7	1.8	69.2	44.6	47.6	60.2	38.8	76.5	34.7	52.5	15.5	27.0	48.4	52.3	53.4	1.4	8.3	79.0	50.9	52.5	39.8	77.2	61.2	3.7	40.2	22.1	43.7	28.3	7.5	18.7	36.3	51.9	41.7	12.2	35.1	24.5	50.0	40.9	0.1	19.6	69.1	30.7	20.0	39.4	32.2	14.7	120.5	39.3	70.4	103.8	56.4	23.1	13.4	8.4	63.6	7.9	26.2	0.0	0.8	0.0	0.6	0.1	0.9	1.5	0.3	1.1	5.2	1.7	0.3	0.2	0.1	2.5	0.1	26.4	0.0	0.5	15.5	15.6	15.3	17.8	14.6	16.7	17.5	16.5	16.0	15.8	17.5	14.8	43.0	28.9	19.8	6.5	5.6	85.4	104.9	76.9	43.9	14.7	28.3	16.6	8.7	20.0	66.9	16.5	37.5	9.9	16.5	39.1	5.9	45.0	16.4	30.3	32.1	43.1	7.7	4.4	0.1	38.0	37.9	66.3	10.7	55.7	29.7	8.8	38.9	3.7	9.6	0.0	0.2	16.3	24.4	6.7	90.4	13.6	55.9	19.6	37.4	3.7	196.9	12.5	0.0	5.5	0.4	91.5	24.7	36.1	9.0	116.6	25.8	23.8	24.8	18.5	32.9	26.4	46.4	5.7	6.9	51.3	83.3	14.2	7.4	24.5	25.9	120.7
TRIP4	"ASC-1, HsT17391, ZC2HC5"	ENSG00000103671	"Thyroid hormone receptor interactor 4"	Q15650	15	64387748-64455303	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"		"Cancer-related genes, Congenital muscular dystrophy, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016605, HPA050666"	Approved		Supported	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Nucleoplasm, Nuclear bodies"		"HPA016605: AB_1858339, HPA050666: AB_2681211"	"unprognostic (1.56e-1)"	"unprognostic (1.14e-1)"	"unprognostic (2.62e-1)"	"unprognostic (4.50e-2)"	"unprognostic (5.79e-2)"	"unprognostic (1.08e-1)"	"unprognostic (7.16e-2)"	"unprognostic (3.01e-2)"	"unprognostic (4.98e-2)"	"unprognostic (2.83e-1)"	"unprognostic (1.25e-1)"	"unprognostic (2.37e-2)"	"prognostic favorable (6.34e-6)"	"unprognostic (2.41e-1)"	"unprognostic (2.96e-1)"	"unprognostic (2.61e-2)"	"unprognostic (1.25e-1)"	14.9	12.4	13.6	13.3	14.7	15.3	17.1	14.1	20.6	13.0	14.9	17.1	17.1	13.2	11.6	19.4	14.1	11.0	15.5	13.7	14.0	27.5	14.3	15.0	16.4	14.4	14.2	13.1	16.6	20.0	13.0	16.9	14.8	12.7	19.2	16.8	13.3	12.1	8.9	18.0	17.9	16.5	14.2	16.6	15.6	12.0	14.5	19.8	25.6	9.2	18.7	17.7	14.7	15.6	18.6	27.1	23.3	16.7	18.9	24.6	21.8	19.3	24.7	32.7	31.5	22.8	40.5	13.3	6.3	29.4	26.6	25.7	38.3	22.0	30.9	27.0	10.9	19.4	19.2	24.1	33.5	21.2	35.1	30.9	28.2	25.9	27.0	18.7	28.9	19.2	22.7	16.2	30.4	21.2	13.5	21.3	13.7	32.7	14.4	20.4	17.7	22.2	31.6	35.1	12.6	19.8	17.3	20.7	35.3	43.5	26.2	31.3	25.7	23.2	15.8	15.6	27.7	13.5	25.9	13.5	19.2	21.4	29.6	70.1	22.2	54.3	20.8	29.1	17.7	16.0	19.7	21.2	20.5	16.3	16.6	17.3	30.9	21.2	42.4	16.2	23.3	16.9	13.6	14.7	14.1	20.6	13.7	14.0	14.4	14.2	14.8	14.2	14.5	15.6	12.7	22.4	13.2	15.3	10.0	8.4	9.6	23.3	2.2	11.1	7.6	7.1	10.3	7.2	18.1	12.9	12.5	22.2	20.1	15.3	13.7	25.2	20.4	21.7	10.7	13.2	11.4	9.9	32.5	27.1	26.8	10.2	10.2	16.2	19.6	12.3	10.0	4.4	21.7	15.2	25.8	8.2	24.4	12.9	7.6	3.7	11.8	15.3	14.2	22.5	27.5	10.0	27.8	18.1	30.9	33.6	10.5	12.8	6.5	6.0	13.5	44.6	26.7	17.3	6.6	9.0	15.0	19.3	21.4	5.4	6.3	24.2	14.4	12.1	8.1	7.8
TRIP6	"MGC10556, MGC10558, MGC29959, MGC3837, MGC4423, OIP1, ZRP-1"	ENSG00000087077	"Thyroid hormone receptor interactor 6"	Q15654	7	100867387-100873454	"Predicted intracellular proteins"	"Cell adhesion, Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB046454, CAB046460, HPA052813"	Approved		Supported	"Plasma membrane,Focal adhesion sites,Cytosol"		NA	NA		21000	"Cluster 26: Non-specific - Mitochondria"	"Cluster 35: Non-specific - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 10: Non-specific - Unknown function"	"Plasma membrane, Focal adhesion sites, Cytosol"		"CAB046454: AB_10604048, CAB046460: AB_2303907, HPA052813: AB_2681961"	"unprognostic (7.94e-3)"	"unprognostic (1.06e-1)"	"unprognostic (3.22e-3)"	"unprognostic (2.84e-3)"	"unprognostic (3.52e-2)"	"unprognostic (2.92e-2)"	"unprognostic (3.18e-2)"	"unprognostic (4.61e-3)"	"unprognostic (8.48e-2)"	"unprognostic (4.18e-2)"	"unprognostic (5.08e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.25e-2)"	"unprognostic (5.07e-2)"	"unprognostic (9.71e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.25e-1)"	42.2	43.0	34.3	15.7	39.5	15.7	42.6	36.2	41.6	59.4	40.4	45.2	9.7	74.6	16.2	63.7	49.5	37.0	39.1	32.6	36.2	55.8	41.1	33.8	14.6	40.6	36.9	50.6	39.8	46.4	16.8	27.4	35.9	42.9	8.4	5.4	46.8	56.7	10.2	55.1	21.5	27.5	36.9	20.0	27.6	18.4	38.4	16.6	50.5	5.8	12.1	47.2	52.5	37.0	128.1	63.4	26.8	126.1	37.8	44.9	131.2	82.3	79.8	101.2	94.8	55.8	143.9	5.5	81.3	87.7	128.3	94.2	38.0	149.2	27.3	19.1	58.5	0.5	117.9	0.8	99.3	66.5	7.1	81.1	94.0	67.8	108.2	64.2	52.8	19.1	83.3	1.0	90.5	286.9	1.3	99.5	92.4	52.3	50.4	47.9	27.0	12.7	65.5	42.8	9.7	1.7	67.5	192.3	78.1	43.8	20.3	77.5	86.5	149.5	145.8	167.5	186.7	1.0	2.1	0.8	92.9	7.8	230.5	0.0	1.2	0.2	0.1	2.1	0.4	2.5	0.9	0.7	1.9	2.4	1.1	0.6	0.0	0.0	3.8	5.2	0.9	0.4	34.3	39.5	36.2	41.6	32.6	36.2	40.6	36.9	35.9	36.9	38.4	37.0	24.5	48.1	38.8	14.4	8.0	131.9	151.5	144.1	78.0	0.9	48.3	55.8	13.9	38.6	87.0	60.7	0.0	113.0	12.0	9.5	80.3	106.9	1.1	22.7	46.1	26.3	4.9	6.7	0.3	84.3	90.4	54.6	40.8	44.8	8.2	55.3	23.9	28.8	44.0	1.7	0.4	12.8	34.6	8.0	59.3	2.8	65.9	17.5	37.4	5.6	20.3	94.8	0.0	4.0	6.5	95.0	13.1	72.6	16.0	72.9	3.6	130.0	34.3	4.6	72.3	50.9	104.0	4.7	4.5	68.2	98.3	132.8	7.1	58.3	18.8	155.6
TRIT1	"FLJ20061, IPT"	ENSG00000043514	"TRNA isopentenyltransferase 1"	Q9H3H1	1	39838110-39883511	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"tRNA processing"	Transferase	"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024174, HPA027330"	Approved		Supported	Mitochondria		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 35: Non-specific - Unknown function"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 47: Cytotrophoblasts - Unknown function"	Mitochondria		"HPA024174: AB_1858346, HPA027330: "	"unprognostic (4.61e-2)"	"unprognostic (1.77e-1)"	"unprognostic (8.38e-3)"	"prognostic unfavorable (8.80e-4)"	"unprognostic (4.00e-2)"	"unprognostic (8.55e-2)"	"prognostic unfavorable (5.34e-6)"	"unprognostic (2.90e-1)"	"unprognostic (2.21e-3)"	"unprognostic (3.18e-2)"	"unprognostic (3.54e-1)"	"unprognostic (6.68e-3)"	"prognostic unfavorable (7.08e-8)"	"unprognostic (6.03e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.22e-1)"	"unprognostic (6.90e-2)"	9.0	9.9	13.1	7.0	13.1	5.6	12.9	14.7	16.1	15.6	12.8	13.6	6.3	14.7	15.3	18.5	13.1	6.0	15.2	13.1	14.0	15.3	13.0	9.2	8.4	12.1	12.1	14.3	21.5	9.7	16.7	11.8	12.6	19.9	10.5	14.7	13.6	10.9	9.5	21.6	11.1	10.0	12.0	12.6	12.0	11.9	13.9	11.8	16.8	4.4	9.9	15.3	16.8	14.3	20.5	9.4	23.0	18.4	10.6	16.5	29.8	11.1	17.3	22.0	21.8	20.0	20.6	11.5	17.4	11.3	12.2	18.9	29.4	22.7	29.7	17.0	15.6	25.6	22.8	13.5	21.8	21.0	14.4	13.3	21.3	25.0	26.9	25.9	18.0	27.1	31.7	14.1	13.8	11.5	14.3	30.7	31.6	17.4	6.2	21.1	21.6	23.3	21.1	27.3	21.9	16.6	15.2	10.3	17.7	23.0	12.5	37.5	11.0	12.8	18.2	21.1	21.3	19.4	13.2	22.5	14.2	24.6	12.1	0.0	5.4	0.6	2.0	3.9	3.7	2.9	1.8	2.2	10.4	2.2	1.9	2.7	0.2	2.0	5.3	10.1	2.3	2.4	13.1	13.1	14.7	16.1	13.1	14.0	12.1	12.1	12.6	12.0	13.9	14.3	4.9	22.4	7.8	16.6	8.0	14.8	17.1	14.4	10.2	4.6	7.8	9.1	10.8	5.7	11.7	7.3	2.1	34.1	10.3	2.9	7.9	12.2	5.9	13.5	10.8	6.2	10.2	13.3	31.3	9.3	32.8	9.6	3.1	6.1	2.5	9.4	8.9	7.0	8.2	15.2	26.6	8.8	16.2	5.9	5.1	3.1	9.6	7.3	5.4	26.2	12.3	4.9	3.1	34.7	31.3	9.5	5.8	11.3	3.3	8.8	4.5	9.2	25.7	7.3	0.0	8.8	6.9	24.9	16.2	13.2	17.0	16.6	6.1	10.7	9.0	11.2
TRMT10A	"MGC27034, RG9MTD2, TRM10"	ENSG00000145331	"TRNA methyltransferase 10A"	Q8TBZ6	4	99546709-99564039	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		"Methyltransferase, Transferase"	"Diabetes mellitus, Disease variant, Dwarfism, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 99.5;Spermatogonia: 55.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047601, HPA058241"	Uncertain		Supported	"Nucleoplasm,Nucleoli,Actin filaments,Cytosol"		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	"Nucleoplasm, Nucleoli, Actin filaments"	Cytosol	"HPA047601: AB_2680099, HPA058241: AB_2683651"	"unprognostic (5.24e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.96e-3)"	"unprognostic (2.10e-1)"	"unprognostic (5.65e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.59e-2)"	"unprognostic (3.65e-2)"	"unprognostic (1.57e-1)"	"unprognostic (3.51e-1)"	"unprognostic (7.49e-3)"	"unprognostic (3.32e-2)"	"unprognostic (2.78e-2)"	"prognostic unfavorable (2.14e-4)"	"unprognostic (1.68e-2)"	4.3	3.7	2.0	3.1	2.6	2.2	4.4	2.6	2.9	1.9	1.5	3.6	4.3	2.7	3.9	3.6	5.8	3.4	2.3	1.8	2.5	4.9	9.8	2.4	4.4	2.6	2.5	3.3	5.9	3.7	2.3	3.7	2.9	4.1	3.6	2.8	3.9	2.2	3.9	3.7	4.5	2.7	2.7	3.5	4.4	9.9	2.4	4.3	6.1	2.7	4.4	2.9	2.0	4.3	8.2	5.4	10.1	5.7	6.0	8.4	7.8	9.6	3.7	5.8	4.1	4.9	9.4	10.9	3.7	5.6	5.9	4.4	10.9	5.1	8.6	13.7	5.4	8.0	4.4	7.6	5.5	19.6	7.8	5.4	14.4	5.7	14.0	3.0	6.4	10.0	17.5	9.4	4.5	9.4	16.4	3.5	6.5	13.8	5.0	9.5	10.2	7.2	8.5	6.8	6.3	5.8	5.3	28.3	9.9	8.5	9.3	7.8	4.9	6.9	7.2	5.5	11.1	7.0	12.4	10.0	4.9	10.9	4.7	2.7	3.9	2.1	1.8	3.8	1.7	3.5	3.3	3.3	5.2	5.8	3.5	3.2	4.9	3.3	3.4	3.0	3.9	1.9	2.0	2.6	2.6	2.9	1.8	2.5	2.6	2.5	2.9	2.7	2.4	4.3	7.2	3.2	10.3	8.8	8.7	8.2	5.6	8.4	10.2	4.3	12.1	8.6	6.4	11.5	6.6	11.0	4.2	16.8	6.1	10.6	43.0	13.8	46.8	33.5	12.1	7.2	7.2	2.1	5.3	19.3	16.4	6.9	8.6	21.6	8.2	11.0	8.2	32.6	8.5	5.0	4.6	11.1	12.2	8.1	4.1	17.0	6.5	5.0	5.4	1.9	8.4	8.7	5.2	3.5	19.7	14.1	11.0	7.5	10.4	4.8	19.0	31.9	20.6	5.9	13.1	5.7	8.1	99.5	55.0	10.2	9.5	17.5	5.5	8.1	10.6	6.6
TRMT10C	"FLJ20432, MRPP1, RG9MTD1"	ENSG00000174173	"TRNA methyltransferase 10C, mitochondrial RNase P subunit"	Q7L0Y3	3	101561868-101566446	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"tRNA processing"	"Methyltransferase, Transferase"	"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036671	Approved		Supported	Nucleoplasm,Mitochondria		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 22: Epithelial cell types - Mixed function"	Mitochondria	Nucleoplasm	"HPA036671: AB_10602085"	"unprognostic (7.42e-2)"	"unprognostic (2.68e-1)"	"unprognostic (9.08e-3)"	"unprognostic (4.47e-3)"	"unprognostic (5.01e-2)"	"unprognostic (5.55e-2)"	"prognostic unfavorable (6.56e-5)"	"unprognostic (1.67e-2)"	"unprognostic (8.48e-2)"	"unprognostic (5.42e-2)"	"unprognostic (4.70e-2)"	"unprognostic (3.28e-2)"	"prognostic favorable (3.32e-5)"	"unprognostic (2.77e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.05e-2)"	16.6	17.4	6.9	14.8	7.9	18.2	20.8	9.1	9.7	12.2	8.5	15.4	12.7	14.1	13.4	18.9	14.5	11.4	21.6	7.8	7.9	19.2	25.2	10.3	20.5	7.4	7.4	15.7	10.4	15.6	6.4	14.0	7.9	11.9	14.7	7.8	13.0	9.9	27.6	12.7	13.1	16.0	7.4	12.5	12.1	11.8	7.5	17.5	15.4	30.2	20.7	26.6	8.6	7.5	58.9	28.2	36.6	37.1	33.0	28.0	34.1	34.2	33.3	43.6	48.5	43.2	38.6	121.3	43.4	21.6	35.4	57.9	71.5	52.5	59.7	43.8	35.3	81.6	20.5	31.6	25.4	72.5	33.1	32.9	53.3	38.3	35.4	23.2	43.1	45.4	70.3	26.3	47.6	40.4	58.2	52.9	68.2	75.9	60.4	42.9	29.8	54.3	56.2	49.0	90.9	51.8	26.7	56.0	78.1	31.9	74.0	78.9	28.7	23.6	45.0	15.8	36.5	30.4	59.4	117.5	40.0	51.5	36.2	56.6	18.2	12.8	21.1	24.7	29.8	35.7	26.2	25.1	22.7	34.2	35.0	33.2	8.1	21.4	27.4	25.8	26.2	19.5	6.9	7.9	9.1	9.7	7.8	7.9	7.4	7.4	7.9	7.4	7.5	7.5	33.3	22.4	24.0	4.9	47.9	94.3	153.4	106.8	63.7	30.6	39.9	52.7	51.5	21.5	69.2	29.5	14.6	65.7	50.3	21.5	52.8	48.5	49.7	54.7	54.0	39.5	35.8	65.0	8.8	33.8	47.0	38.8	28.1	63.5	46.3	47.3	31.4	56.9	31.1	21.9	8.5	31.5	69.2	27.3	31.9	13.7	37.3	23.7	14.2	1.9	42.1	29.8	37.0	6.6	7.6	37.2	17.9	37.6	21.5	85.3	17.3	72.0	53.3	33.9	32.9	58.1	41.3	77.7	55.0	55.2	105.0	65.5	46.4	57.1	47.0	127.4
TRMU	"FLJ10140, MTO2, MTU1, TRMT"	ENSG00000100416	"TRNA mitochondrial 2-thiouridylase"	O75648	22	46330875-46357340	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"tRNA processing"	"RNA-binding, Transferase, tRNA-binding"	"Deafness, Disease variant, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000824, HPA035273, HPA043300"	Uncertain		Supported	Mitochondria		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 52: Non-specific - Transcription"	Mitochondria		"HPA000824: AB_2732393, HPA035273: AB_10602901, HPA043300: AB_2678415"	"unprognostic (2.96e-1)"	"unprognostic (1.09e-2)"	"unprognostic (8.07e-2)"	"unprognostic (4.27e-2)"	"unprognostic (2.64e-1)"	"unprognostic (3.52e-3)"	"prognostic unfavorable (3.04e-5)"	"unprognostic (4.72e-2)"	"unprognostic (7.14e-2)"	"unprognostic (7.89e-2)"	"prognostic favorable (6.86e-4)"	"unprognostic (4.74e-3)"	"prognostic unfavorable (5.63e-6)"	"unprognostic (7.26e-2)"	"unprognostic (1.73e-1)"	"unprognostic (3.56e-1)"	"unprognostic (7.44e-3)"	4.2	7.5	7.7	2.3	7.8	2.9	4.0	8.3	9.6	4.3	8.3	4.5	4.7	3.6	7.5	5.6	3.4	2.6	11.2	7.6	8.5	9.1	8.8	3.5	5.0	8.5	8.6	4.0	10.2	8.0	5.3	4.1	8.5	4.4	4.1	2.8	5.5	4.7	6.9	4.8	4.0	3.9	7.9	4.2	4.3	2.3	8.5	3.0	4.6	8.4	4.3	4.2	4.1	7.8	17.8	16.0	6.6	15.1	12.2	8.6	16.6	18.1	12.6	24.9	19.2	22.7	4.5	11.5	12.5	16.2	10.9	15.3	28.5	16.0	21.1	7.5	38.4	13.6	25.0	27.1	10.4	26.5	9.0	8.2	17.6	25.8	8.1	10.3	16.2	5.8	19.3	2.7	15.3	19.1	10.4	21.5	25.5	10.6	27.5	12.2	14.4	21.2	12.5	12.1	15.9	19.0	16.0	18.5	31.7	8.2	10.7	10.9	11.9	11.1	19.8	15.8	20.7	6.5	7.8	12.6	15.7	19.1	22.8	0.0	6.2	3.8	9.4	9.0	8.3	5.4	8.2	8.9	7.1	5.5	7.3	6.9	1.3	8.0	9.8	5.8	11.0	5.9	7.7	7.8	8.3	9.6	7.6	8.5	8.5	8.6	8.5	7.9	8.5	7.8	12.7	9.6	6.1	22.9	13.2	6.2	10.8	16.8	7.4	26.4	10.6	11.8	14.7	10.0	10.7	11.0	16.7	24.9	16.1	14.1	27.4	20.1	1.6	6.3	10.2	14.5	12.5	14.3	19.4	19.6	21.0	11.9	21.9	6.6	9.5	26.8	13.9	16.8	15.9	13.5	18.0	12.3	10.2	9.9	4.0	3.3	15.2	8.8	8.8	5.6	14.9	11.9	20.6	10.1	14.6	19.5	9.9	17.0	13.8	14.2	15.3	27.9	10.2	26.4	6.6	7.6	14.4	18.5	12.9	9.6	9.7	15.3	13.1	21.0	19.3	9.9
TRNT1	"CCA1, CGI-47, MtCCA"	ENSG00000072756	"TRNA nucleotidyl transferase 1"	Q96Q11	3	3126933-3150879	"Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"tRNA processing"	"Nucleotidyltransferase, RNA-binding, Transferase"	"Disease variant, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036938	Uncertain		Supported	Mitochondria		Yes	No			"Cluster 46: Basophils - DNA binding"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	Mitochondria		"HPA036938: AB_10670566"	"unprognostic (6.39e-3)"	"unprognostic (1.58e-1)"	"unprognostic (2.38e-3)"	"unprognostic (4.69e-2)"	"unprognostic (4.92e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.39e-2)"	"unprognostic (2.68e-1)"	"unprognostic (6.22e-2)"	"unprognostic (5.65e-2)"	"unprognostic (4.62e-2)"	"unprognostic (1.41e-2)"	"unprognostic (1.24e-2)"	"unprognostic (6.50e-2)"	"unprognostic (1.09e-1)"	"unprognostic (3.78e-1)"	"unprognostic (1.02e-1)"	9.7	10.0	7.2	8.9	7.2	3.5	8.5	7.9	8.0	7.8	7.0	8.1	4.4	8.8	5.5	9.4	7.6	8.3	8.4	7.4	7.2	17.2	10.0	8.4	9.7	7.1	7.3	8.3	8.4	8.3	10.3	10.5	7.1	11.3	7.6	4.0	7.7	6.3	9.3	6.4	7.9	8.3	7.3	10.7	9.1	6.5	7.4	9.8	11.3	7.6	10.9	13.1	7.9	8.0	20.0	29.6	18.2	9.8	24.1	21.5	20.5	19.9	17.4	21.6	20.9	25.0	20.9	35.6	12.8	22.4	32.0	12.6	24.6	18.6	26.5	24.6	13.3	28.7	25.3	24.9	31.4	32.2	20.8	17.9	25.0	20.2	6.8	15.0	21.0	24.1	25.1	9.8	35.9	37.2	22.0	21.4	15.2	29.2	19.0	20.5	28.1	32.5	26.1	25.8	10.8	15.9	31.6	20.6	18.5	26.3	18.7	16.3	14.8	22.8	18.7	23.6	25.7	12.6	31.4	43.4	17.2	27.6	25.0	49.4	12.4	36.4	16.4	18.1	16.0	25.8	20.8	18.1	16.8	15.7	22.7	20.1	16.6	19.8	19.0	15.6	18.6	11.2	7.2	7.2	7.9	8.0	7.4	7.2	7.1	7.3	7.1	7.3	7.4	8.0	20.7	16.0	13.4	15.3	30.2	14.8	29.0	19.9	24.5	13.5	12.1	11.0	14.3	2.8	16.3	18.4	14.6	25.8	23.5	10.6	45.0	19.1	2.3	15.8	19.0	21.1	8.4	16.6	23.8	9.9	17.8	19.9	23.4	12.0	22.8	20.7	12.5	9.2	13.3	10.1	27.0	10.7	16.2	11.0	13.3	2.9	10.8	13.3	7.2	23.4	20.3	17.1	18.6	23.6	34.7	10.6	9.2	8.6	30.7	30.9	11.0	32.7	11.4	15.7	0.0	14.9	17.4	20.8	17.9	23.4	13.1	28.3	22.0	24.7	13.5	23.9
TRPM4	FLJ20041	ENSG00000130529	"Transient receptor potential cation channel subfamily M member 4"	Q8TD43	19	49157741-49211836	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Adaptive immunity, Immunity, Ion transport, Transport"	"Calmodulin-binding, Ion channel"	"Disease variant, Palmoplantar keratoderma"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 179.2;Hepatocytes: 81.7;Intestinal goblet cells: 114.8;Paneth cells: 77.1;Undifferentiated cells: 88.9"	"Cancer enriched"	"Detected in all"	4	"prostate cancer: 85.3"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	7	"dendritic cells: 3.3;granulocytes: 2.8;monocytes: 4.3"	"Cell line enhanced"	"Detected in many"		"OE19: 32.7;RT4: 60.8;SK-BR-3: 38.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA041169	Enhanced		Supported	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 15: RT4 - Unknown function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Nucleoplasm, Plasma membrane"		"HPA041169: AB_2677343"	"unprognostic (8.20e-3)"	"unprognostic (1.41e-1)"	"unprognostic (7.86e-2)"	"prognostic favorable (2.88e-7)"	"unprognostic (1.62e-2)"	"unprognostic (9.78e-2)"	"unprognostic (1.77e-2)"	"unprognostic (2.90e-1)"	"unprognostic (3.33e-2)"	"unprognostic (3.38e-2)"	"unprognostic (2.94e-2)"	"unprognostic (2.79e-1)"	"prognostic favorable (2.53e-7)"	"unprognostic (8.46e-3)"	"unprognostic (2.16e-1)"	"unprognostic (5.70e-2)"	"unprognostic (1.00e-2)"	10.8	6.1	5.8	6.1	5.4	4.6	13.5	8.5	7.0	11.5	4.8	46.1	25.3	9.9	2.5	13.1	9.2	7.4	23.0	5.9	4.5	22.8	15.4	16.0	1.8	6.2	7.4	3.3	10.1	3.7	5.6	5.3	6.9	35.7	12.9	1.3	27.3	6.2	14.0	26.6	22.9	3.4	4.2	5.5	20.6	5.4	6.6	1.0	17.3	5.3	1.9	13.7	14.4	5.1	11.9	9.0	2.1	9.5	7.7	6.6	6.6	10.0	6.0	2.7	3.7	6.1	18.7	0.4	2.7	6.8	3.6	15.7	1.3	3.0	1.0	0.2	3.4	1.9	4.0	3.7	6.6	0.3	11.7	9.3	13.6	5.3	2.6	3.3	4.6	1.0	4.9	2.1	6.9	17.4	0.8	0.9	1.0	32.7	13.3	4.1	2.0	0.6	4.6	60.8	0.8	2.2	4.1	38.6	2.2	0.7	22.6	3.7	11.8	14.4	7.8	7.9	0.2	3.9	4.3	0.4	7.9	7.4	5.3	2.2	4.3	0.7	0.3	2.5	0.2	0.5	0.2	0.2	3.3	0.5	0.3	0.3	2.8	0.5	1.0	3.1	0.2	1.4	5.8	5.4	8.5	7.0	5.9	4.5	6.2	7.4	6.9	4.2	6.6	5.1	12.8	32.1	2.6	9.8	3.5	12.5	15.3	9.9	9.1	2.0	19.0	14.6	16.7	17.2	12.3	14.7	0.0	6.6	0.2	179.2	19.6	7.9	2.9	17.5	8.2	11.7	21.7	0.0	5.4	18.5	6.8	6.0	71.4	36.2	5.7	2.9	11.4	81.7	19.9	0.0	8.5	114.8	14.2	9.8	19.0	3.1	6.8	8.5	39.2	9.4	12.8	6.7	0.0	3.5	0.9	32.9	77.1	7.2	7.6	35.5	55.3	3.8	8.9	2.6	32.9	2.2	8.5	6.1	15.7	8.4	11.5	3.4	1.9	4.1	88.9	33.1
TRPS1	"GC79, LGCR"	ENSG00000104447	"Transcriptional repressor GATA binding 1"	Q9UHF7	8	115408496-115809673	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"breast: 60.8"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 758.7;Breast glandular cells: 243.2;Oligodendrocyte precursor cells: 280.5;Oligodendrocytes: 294.0"	"Cancer enriched"	"Detected in many"	8	"breast cancer: 49.6"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"classical monocyte: 4.5"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"MCF7: 47.4;SK-BR-3: 78.1;T-47d: 244.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA060380, HPA071767"	Enhanced		Supported	Nucleoplasm		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 6: T47d - Mammary gland"	"Cluster 64: Astrocytes - Nervous system maintenance"	Nucleoplasm		"HPA060380: AB_2684270, HPA071767: AB_2732185"	"unprognostic (4.34e-2)"	"unprognostic (4.65e-2)"	"unprognostic (1.73e-2)"	"unprognostic (2.57e-1)"	"unprognostic (1.87e-1)"	"prognostic favorable (9.42e-4)"	"unprognostic (2.23e-3)"	"unprognostic (2.08e-1)"	"unprognostic (9.31e-2)"	"unprognostic (3.26e-1)"	"prognostic unfavorable (3.16e-4)"	"unprognostic (3.02e-1)"	"unprognostic (2.17e-2)"	"unprognostic (1.93e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.78e-2)"	"unprognostic (3.07e-3)"	4.4	3.1	15.5	5.7	14.3	7.6	60.8	10.5	14.7	10.9	10.1	5.9	0.9	9.9	3.4	14.2	5.5	10.0	3.8	17.0	13.5	5.4	2.1	4.7	4.9	32.5	31.5	5.2	1.1	5.3	2.6	2.8	24.2	9.4	2.7	4.1	12.0	8.4	2.6	10.6	2.1	10.6	18.4	4.2	2.7	12.5	27.5	2.4	5.7	3.3	4.0	5.1	14.1	16.3	3.1	0.6	5.9	0.3	5.4	19.8	0.6	4.9	11.3	3.1	5.2	0.5	4.9	2.4	0.0	12.7	2.6	0.1	22.9	4.3	3.5	0.3	6.9	0.1	10.3	0.2	7.2	0.0	0.3	9.5	4.4	8.6	15.8	8.9	2.7	0.3	1.1	37.7	6.0	47.4	0.2	0.0	1.1	1.1	4.8	0.2	0.2	30.0	4.9	0.3	5.2	3.9	2.5	78.1	3.2	2.8	244.8	2.1	0.2	13.7	6.9	4.0	9.7	10.1	0.3	4.5	14.4	0.0	9.2	0.0	4.5	0.0	0.9	1.9	0.9	0.5	1.0	1.0	1.7	0.8	0.9	0.9	0.8	1.0	1.4	0.6	0.5	0.8	15.5	14.3	10.5	14.7	17.0	13.5	32.5	31.5	24.2	18.4	27.5	16.3	10.0	6.4	3.0	758.7	13.3	9.4	20.0	10.3	34.1	9.2	243.2	125.1	4.6	2.8	9.2	18.4	43.8	0.1	18.7	0.1	11.7	2.9	95.0	58.5	35.7	7.5	0.0	5.5	128.3	2.9	0.2	26.8	4.6	63.5	12.7	0.3	3.6	1.1	16.5	0.0	148.2	0.0	8.2	55.2	104.1	163.2	25.1	55.5	21.4	171.4	32.5	10.6	5.2	280.5	294.0	2.7	0.0	28.2	10.1	16.9	0.0	23.7	8.9	35.9	6.6	60.2	28.2	1.8	8.3	73.6	12.5	0.3	25.6	19.5	0.0	11.2
TRPV2	"VRL, VRL-1, VRL1"	ENSG00000187688	"Transient receptor potential cation channel subfamily V member 2"	Q9Y5S1	17	16415571-16437003	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"granulocytes: 50.0;Hofbauer cells: 50.6;monocytes: 39.4;NK-cells: 49.4"	"Cancer enriched"	"Detected in all"	8	"melanoma: 59.8"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 78.8;fHDF/TERT166: 108.4;HMC-1: 89.0;SK-MEL-30: 94.7;TIME: 84.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA044993	Uncertain		Supported	"Plasma membrane"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 2: Immune cells - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 4: Macrophages - Innate immune response"	"Plasma membrane"		"HPA044993: AB_10960889"	"unprognostic (1.57e-1)"	"unprognostic (4.34e-3)"	"unprognostic (2.05e-2)"	"unprognostic (1.58e-2)"	"unprognostic (2.85e-2)"	"unprognostic (6.16e-3)"	"unprognostic (5.25e-2)"	"unprognostic (1.25e-1)"	"unprognostic (8.40e-3)"	"unprognostic (2.43e-1)"	"unprognostic (3.11e-2)"	"unprognostic (1.02e-1)"	"prognostic unfavorable (1.19e-6)"	"unprognostic (7.94e-2)"	"prognostic unfavorable (5.53e-4)"	"unprognostic (8.07e-2)"	"unprognostic (1.23e-1)"	17.1	20.5	6.2	18.3	8.0	22.8	10.4	5.7	7.6	7.9	3.9	7.0	6.6	7.6	1.8	5.3	7.3	8.5	11.2	6.1	9.8	4.7	4.0	30.2	24.6	10.6	15.4	7.8	6.3	8.9	1.6	20.1	17.2	6.0	6.2	1.0	4.5	2.6	3.9	6.5	10.7	11.8	7.1	23.7	5.9	2.0	7.3	15.7	6.2	5.5	16.2	10.7	7.2	8.0	0.3	1.6	0.0	0.0	25.6	78.8	4.9	8.3	9.4	9.1	8.9	0.3	0.3	9.6	2.2	108.4	7.8	0.2	0.2	0.0	5.1	43.0	0.7	10.7	0.0	26.1	30.0	14.8	89.0	35.2	0.0	54.0	0.7	4.1	3.8	12.9	37.2	26.0	43.4	0.5	19.1	20.5	0.1	0.1	0.2	11.3	0.3	4.3	40.6	1.1	1.2	0.1	0.0	0.0	94.7	41.0	0.0	12.7	84.9	0.2	0.3	0.3	1.1	0.1	0.3	5.1	8.2	21.6	12.6	60.8	26.6	35.8	63.4	52.8	55.5	19.2	46.0	59.3	58.7	20.3	25.7	44.8	6.8	63.2	49.4	51.3	49.9	43.1	6.2	8.0	5.7	7.6	6.1	9.8	10.6	15.4	17.2	7.1	7.3	8.0	15.8	0.0	5.3	1.0	11.1	2.8	0.1	0.0	0.0	0.6	0.5	0.4	1.1	1.5	0.6	0.0	0.0	2.2	29.3	0.0	0.0	0.2	0.3	0.4	0.1	12.3	0.0	6.7	3.3	3.6	2.3	11.0	1.1	0.1	50.0	16.7	8.9	0.4	50.6	0.0	2.6	0.0	0.0	19.5	18.2	0.0	1.8	28.7	28.4	4.7	39.4	0.3	49.4	0.5	0.5	4.7	0.1	4.5	15.1	0.0	0.0	0.1	0.8	0.6	26.3	7.9	23.6	1.3	5.9	0.4	1.7	16.1	26.8	2.8	0.0	0.1
TRRAP	"PAF400, TR-AP, Tra1"	ENSG00000196367	"Transformation/transcription domain associated protein"	Q9Y4A5	7	98877933-99050831	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, Chromatin regulator"	"Autism spectrum disorder, Cancer-related genes, Deafness, Disease variant, Mental retardation, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054376			Supported	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 34: Non-specific - Transcription"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm	"Golgi apparatus"	"HPA054376: AB_2682467"	"unprognostic (2.10e-1)"	"unprognostic (7.79e-2)"	"unprognostic (2.21e-1)"	"unprognostic (4.35e-2)"	"unprognostic (2.02e-1)"	"unprognostic (2.02e-1)"	"prognostic unfavorable (8.77e-4)"	"unprognostic (1.40e-2)"	"unprognostic (2.39e-2)"	"unprognostic (3.99e-2)"	"unprognostic (9.45e-2)"	"unprognostic (7.02e-2)"	"unprognostic (2.21e-3)"	"unprognostic (1.59e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.96e-1)"	6.0	8.1	3.4	7.4	3.5	11.1	6.2	10.3	3.7	8.3	5.9	7.7	5.3	8.6	3.5	6.8	8.4	4.9	6.8	3.1	2.6	6.2	6.7	7.0	9.3	1.4	2.2	10.9	8.3	10.3	14.0	6.1	1.9	7.1	5.0	7.5	7.1	5.2	7.6	11.2	8.4	6.2	0.6	8.5	7.1	11.0	2.8	15.8	8.8	7.3	8.7	7.3	7.0	5.0	24.0	27.2	27.7	23.4	12.9	13.8	13.7	10.3	13.6	15.8	15.1	21.2	10.3	32.8	15.9	19.1	30.3	12.2	29.1	14.0	17.7	19.2	28.3	20.2	20.3	11.7	9.4	36.9	14.3	12.6	8.0	25.8	21.7	10.9	20.5	29.2	35.4	59.8	14.8	44.0	45.0	13.5	21.1	14.1	16.6	32.7	16.0	25.2	7.7	26.6	21.6	27.1	26.1	16.6	8.4	22.7	8.5	15.7	22.0	21.1	30.6	28.3	24.2	24.7	30.2	47.8	14.9	18.3	21.3	2.8	0.3	0.2	0.5	0.2	0.9	0.6	0.8	0.4	0.3	0.8	0.6	0.6	1.0	0.5	0.3	1.0	0.7	0.1	3.4	3.5	10.3	3.7	3.1	2.6	1.4	2.2	1.9	0.6	2.8	5.0	12.8	16.0	14.2	30.3	16.4	15.8	4.2	8.2	13.1	15.2	13.7	10.0	10.9	5.7	9.4	14.7	27.1	8.9	15.0	7.9	0.0	7.7	3.6	16.6	20.1	11.1	12.6	12.4	43.7	6.5	5.2	11.1	11.2	24.1	5.7	26.5	8.6	11.0	8.0	21.9	45.5	10.4	8.2	10.4	7.4	5.4	8.7	12.3	8.8	29.0	9.8	6.1	6.2	36.7	42.4	8.3	5.8	8.6	25.3	7.6	6.2	5.2	8.3	9.2	0.0	12.8	12.4	14.8	8.4	18.5	21.3	10.9	17.1	12.1	10.1	7.5
TSEN34	"LENG5, SEN34, SEN34L"	ENSG00000170892	"TRNA splicing endonuclease subunit 34"	Q9BSV6	19	54189938-54194536	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"mRNA processing, tRNA processing"	Lyase	"Disease variant, Neurodegeneration, Pontocerebellar hypoplasia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"basophil: 5.0;eosinophil: 1.9;neutrophil: 4.8"	"Lineage enriched"	"Detected in single"	8	"granulocytes: 5.0"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041111, HPA048208"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm		"HPA041111: AB_10794263, HPA048208: AB_2680313"	"unprognostic (3.24e-2)"	"unprognostic (2.95e-2)"	"unprognostic (1.59e-1)"	"unprognostic (3.88e-2)"	"unprognostic (3.48e-2)"	"unprognostic (4.82e-2)"	"prognostic unfavorable (1.44e-7)"	"unprognostic (2.38e-1)"	"unprognostic (7.35e-2)"	"unprognostic (1.51e-1)"	"unprognostic (5.04e-3)"	"unprognostic (8.98e-2)"	"unprognostic (4.55e-3)"	"unprognostic (2.02e-3)"	"unprognostic (1.81e-1)"	"unprognostic (2.81e-1)"	"unprognostic (1.12e-1)"	28.5	68.2	2.2	1.3	1.8	1.3	29.5	2.4	2.4	38.8	1.8	34.7	1.1	37.1	1.9	41.0	37.8	1.5	26.3	2.1	1.7	39.1	41.3	31.5	1.3	2.2	1.7	47.9	43.0	1.8	36.0	1.3	2.0	36.2	1.3	2.0	34.0	1.9	26.7	40.5	27.7	1.2	1.3	44.1	34.3	45.0	1.7	0.5	30.9	1.8	0.7	38.9	34.2	2.2	3.3	1.7	2.5	3.1	1.3	2.0	3.9	0.6	1.0	0.9	1.7	2.1	1.1	1.1	0.0	0.9	2.5	2.5	2.6	2.3	1.4	1.1	6.2	1.0	1.1	2.0	0.5	1.1	1.1	1.9	1.1	2.0	1.3	0.9	1.3	0.0	1.7	0.9	2.4	1.4	0.4	0.2	1.5	2.9	1.1	1.4	2.6	0.7	3.4	2.4	0.1	1.7	0.0	3.5	3.0	2.5	2.6	3.1	1.1	0.2	2.8	2.7	3.4	1.4	1.9	0.9	2.6	1.3	1.2	5.0	0.6	1.9	0.2	0.5	0.4	0.1	0.3	0.1	0.3	0.4	0.4	0.2	4.8	0.0	0.3	0.4	0.0	0.2	2.2	1.8	2.4	2.4	2.1	1.7	2.2	1.7	2.0	1.3	1.7	2.2	33.1	12.8	27.7	6.8	28.2	73.5	92.0	137.7	67.2	35.4	62.9	60.8	11.8	52.9	60.9	44.1	29.2	102.5	45.4	58.8	95.9	68.7	24.0	39.4	37.0	32.5	76.8	13.7	3.8	59.7	98.2	47.5	19.9	35.3	26.6	47.7	35.7	40.6	57.8	16.8	4.9	103.7	122.1	37.0	53.6	17.2	67.7	45.0	46.2	1.0	51.8	81.9	18.6	6.0	5.9	50.4	55.9	66.5	27.6	79.8	57.8	110.5	70.0	48.9	59.2	38.7	60.8	40.1	77.2	56.7	70.2	111.0	32.8	100.3	66.5	62.3
TSFM	"EF-TS, EF-Tsmt"	ENSG00000123297	"Ts translation elongation factor, mitochondrial"	P43897	12	57782761-57808071	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Protein biosynthesis"	"Elongation factor"	"Cardiomyopathy, Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Proximal tubular cells: 146.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in all"	6	"RH-30: 962.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006204			Supported	Nucleoplasm,Mitochondria		NA	NA		9200	"Cluster 27: Non-specific - Gene expression"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria	Nucleoplasm	"HPA006204: AB_1080405"	"unprognostic (1.17e-1)"	"unprognostic (6.84e-3)"	"unprognostic (1.93e-2)"	"unprognostic (6.87e-2)"	"unprognostic (1.87e-1)"	"unprognostic (2.56e-3)"	"unprognostic (2.49e-2)"	"unprognostic (1.53e-1)"	"unprognostic (8.52e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.49e-3)"	"prognostic favorable (8.82e-4)"	"unprognostic (3.05e-1)"	"unprognostic (6.97e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.23e-1)"	23.1	57.6	17.7	23.5	18.5	26.1	26.3	18.8	20.9	16.7	21.1	28.9	27.4	15.0	17.4	22.3	18.0	13.9	43.6	18.8	19.0	39.2	45.2	15.1	24.2	18.4	18.3	13.5	17.1	35.0	16.5	16.5	19.7	16.6	26.8	16.7	20.0	16.4	58.6	21.6	21.0	17.5	19.0	17.4	19.7	25.2	18.9	22.5	16.2	64.3	20.7	24.4	15.7	18.7	56.3	63.1	35.5	52.5	33.7	33.9	53.2	46.4	39.8	71.6	50.2	74.1	71.6	142.6	85.8	38.9	39.1	64.9	60.1	66.2	51.3	57.7	78.0	82.6	51.9	64.7	50.5	112.7	47.2	39.6	65.3	55.6	25.4	52.2	44.7	75.7	110.3	70.0	56.3	64.8	64.8	113.0	57.5	81.7	83.7	78.3	962.0	125.5	70.5	64.1	80.0	49.1	47.7	84.8	83.6	31.5	148.9	71.7	33.1	39.6	54.6	58.9	49.1	52.0	120.2	108.7	53.6	63.7	48.1	8.5	24.6	15.3	28.0	23.7	36.0	28.5	30.9	28.3	30.3	26.9	31.1	31.7	6.5	33.6	30.5	23.4	30.9	26.9	17.7	18.5	18.8	20.9	18.8	19.0	18.4	18.3	19.7	19.0	18.9	18.7	16.5	19.2	10.8	6.2	18.5	25.9	14.5	57.4	10.8	19.4	24.6	21.1	31.8	27.1	28.7	46.0	14.6	68.5	23.5	13.2	95.9	66.0	73.3	19.5	19.7	18.7	13.8	20.0	8.4	87.6	52.3	18.8	13.3	16.3	22.2	31.0	16.4	38.3	35.4	15.2	8.5	20.9	36.7	11.4	13.9	42.5	22.7	18.1	26.6	10.3	66.6	23.1	12.3	9.5	8.4	47.2	15.7	24.0	17.5	21.3	19.9	146.2	26.0	20.1	59.2	19.7	31.6	46.1	65.8	21.1	36.2	47.6	18.6	71.1	35.3	13.9
TSG101	"TSG10, VPS23"	ENSG00000074319	"Tumor susceptibility 101"	Q99816	11	18468336-18526951	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Growth regulation, Host-virus interaction, Protein transport, Transport"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Syncytiotrophoblasts: 296.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB004283, HPA006161"	Approved		Supported	"Nucleoli,Plasma membrane,Cytosol"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 10: Non-specific - Unknown function"	Cytosol	"Nucleoli, Plasma membrane"	"CAB004283: AB_671392, HPA006161: AB_1080408"	"unprognostic (1.42e-1)"	"unprognostic (7.91e-2)"	"unprognostic (2.11e-1)"	"unprognostic (6.77e-2)"	"unprognostic (1.82e-1)"	"unprognostic (2.72e-3)"	"prognostic unfavorable (3.74e-6)"	"unprognostic (5.67e-2)"	"unprognostic (2.08e-1)"	"unprognostic (2.00e-2)"	"unprognostic (4.15e-3)"	"unprognostic (4.27e-2)"	"prognostic favorable (5.52e-6)"	"unprognostic (1.92e-2)"	"unprognostic (1.02e-1)"	"unprognostic (4.02e-3)"	"unprognostic (1.06e-1)"	40.4	55.6	41.1	32.2	42.2	60.8	56.6	43.1	50.8	44.8	45.7	49.5	42.8	40.2	56.3	56.7	49.3	36.5	68.2	42.1	44.5	70.1	62.3	43.9	42.9	42.4	42.3	44.6	45.4	61.5	36.5	61.4	42.4	43.1	59.0	43.6	46.4	41.1	77.1	47.2	43.4	42.9	43.9	34.0	45.4	55.5	41.8	45.9	52.4	83.0	57.4	46.9	42.2	46.5	51.3	79.1	73.7	51.1	82.2	85.4	63.7	77.1	103.0	92.2	90.3	54.3	27.5	65.5	49.2	86.4	103.7	77.0	74.0	70.3	102.0	95.4	87.7	41.1	38.6	79.7	106.3	64.6	69.8	75.0	139.9	48.6	131.6	102.2	76.8	68.4	66.9	55.2	112.7	85.7	45.7	66.8	45.1	115.6	81.5	37.0	72.5	54.7	63.6	68.8	52.2	88.6	75.7	61.6	101.1	77.1	59.7	64.8	43.1	63.0	38.0	126.4	59.4	37.2	76.0	56.9	64.5	34.2	80.5	187.8	69.8	155.7	50.4	81.6	52.4	78.5	48.0	54.0	66.1	69.2	51.5	54.9	123.6	57.9	114.3	54.5	84.4	91.1	41.1	42.2	43.1	50.8	42.1	44.5	42.4	42.3	42.4	43.9	41.8	46.5	63.0	64.1	57.5	22.9	44.4	42.6	81.5	159.2	26.7	41.0	39.2	42.2	68.0	42.9	90.4	44.1	25.0	191.9	34.2	85.5	125.2	112.4	48.0	58.4	36.0	54.4	61.6	74.5	29.1	101.3	107.7	48.6	32.6	48.9	44.9	46.2	47.2	36.0	79.6	37.0	28.4	65.0	156.6	45.2	33.6	21.2	56.2	51.6	56.9	26.2	82.3	86.1	54.6	32.2	32.8	132.7	76.2	43.2	47.0	103.0	72.2	126.8	113.4	43.3	46.0	44.7	81.2	177.6	153.7	32.8	48.4	296.1	38.1	91.5	47.8	97.4
TSN	"BCLF-1, REHF-1, TRSLN"	ENSG00000211460	Translin	Q15631	2	121737103-121767853	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"DNA-binding, Endonuclease, Hydrolase, Nuclease, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059561	Uncertain		Supported	"Nucleoplasm,Endoplasmic reticulum"		NA	NA		280000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	"Nucleoplasm, Endoplasmic reticulum"		"HPA059561: AB_2684063"	"unprognostic (3.15e-2)"	"unprognostic (1.83e-1)"	"unprognostic (3.53e-1)"	"prognostic unfavorable (7.05e-4)"	"unprognostic (7.13e-3)"	"unprognostic (3.12e-2)"	"prognostic unfavorable (3.06e-4)"	"unprognostic (2.32e-2)"	"unprognostic (7.58e-2)"	"unprognostic (2.39e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.62e-1)"	"unprognostic (6.48e-2)"	"unprognostic (1.04e-2)"	"unprognostic (3.42e-2)"	"unprognostic (3.18e-1)"	16.2	16.9	20.9	13.5	21.9	47.8	25.4	22.7	28.4	17.4	18.9	23.3	16.9	15.8	17.9	16.6	14.2	13.2	19.5	21.0	23.6	24.4	22.9	14.3	19.1	21.3	22.4	16.7	18.4	21.7	13.1	10.8	22.3	14.5	18.8	16.6	14.9	17.2	31.6	19.3	14.6	14.2	21.4	14.7	15.0	26.2	22.0	24.1	17.2	31.0	18.2	15.6	12.8	23.8	56.2	24.8	38.4	34.1	35.0	27.8	21.1	45.6	43.2	50.3	48.4	71.1	32.3	81.7	51.9	45.4	30.1	27.0	55.0	46.6	69.8	43.2	44.3	48.0	33.0	68.3	40.0	69.3	32.5	24.2	51.3	56.3	38.7	23.0	43.2	40.0	72.9	39.4	47.4	30.5	38.2	77.5	46.6	32.8	47.2	67.6	43.1	59.3	63.7	36.0	48.9	30.6	31.4	46.6	61.2	29.2	29.3	54.1	30.8	36.2	56.4	22.9	45.1	33.8	97.0	85.4	40.3	46.8	45.6	27.6	29.8	28.6	22.5	27.9	26.9	27.4	23.4	19.8	27.4	21.0	26.5	22.9	9.3	26.9	24.3	20.1	25.6	28.8	20.9	21.9	22.7	28.4	21.0	23.6	21.3	22.4	22.3	21.4	22.0	23.8	34.7	32.1	24.4	15.0	37.5	39.1	34.4	49.1	23.3	32.1	38.2	27.6	34.7	42.9	36.9	42.3	22.9	34.9	34.3	22.3	43.0	64.4	80.0	24.9	29.7	42.7	19.9	34.7	19.8	60.0	33.3	32.5	15.8	23.9	40.0	36.0	58.5	44.4	35.2	16.8	19.8	27.7	57.0	35.6	34.9	19.8	36.4	29.8	67.6	15.0	45.4	88.7	44.3	29.1	33.5	45.4	22.2	31.2	25.4	34.7	24.4	58.7	33.0	29.5	26.3	39.9	81.8	152.8	96.6	36.7	43.9	28.5	36.8	38.5	37.9	28.8
TSPAN14	"DC-TM4F2, MGC11352, TM4SF14"	ENSG00000108219	"Tetraspanin 14"	Q8NG11	10	80454166-80533124	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Hepatic stellate cells: 156.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"TIME: 276.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014773, HPA057174"	Uncertain		Supported	Vesicles		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	Vesicles		"HPA014773: AB_2208670, HPA057174: "	"unprognostic (7.52e-2)"	"prognostic favorable (3.56e-4)"	"unprognostic (6.55e-3)"	"unprognostic (1.56e-1)"	"unprognostic (4.40e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.11e-2)"	"unprognostic (8.90e-2)"	"unprognostic (5.21e-2)"	"unprognostic (3.13e-1)"	"unprognostic (5.15e-3)"	"unprognostic (4.12e-3)"	"prognostic favorable (4.20e-4)"	"unprognostic (2.52e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.99e-1)"	"unprognostic (2.57e-3)"	97.9	20.7	29.1	43.1	24.2	57.2	80.1	25.1	29.7	63.1	19.4	33.4	30.9	38.4	44.1	92.1	47.1	32.9	51.2	26.2	21.4	45.7	21.1	70.8	54.2	31.7	32.2	47.2	33.1	35.7	15.7	81.9	29.7	34.8	27.1	7.9	47.7	34.1	24.9	74.3	34.8	33.3	31.2	48.5	24.7	23.2	32.8	40.1	46.5	42.1	44.6	55.0	56.1	31.4	96.2	135.6	128.3	44.5	186.6	59.3	59.6	49.3	91.8	51.1	38.0	134.8	54.6	31.5	93.2	26.4	18.9	97.0	35.9	88.5	41.4	55.9	13.9	88.9	15.8	118.2	63.5	31.8	20.3	58.8	77.2	52.8	92.1	94.8	191.5	31.8	48.8	23.0	15.0	83.3	50.0	23.3	29.5	61.2	0.1	167.9	14.9	5.3	203.9	131.9	27.5	42.3	19.7	133.7	149.5	43.7	54.1	79.8	276.3	13.0	52.8	12.4	35.1	10.7	42.0	11.8	42.2	65.4	57.5	16.2	51.5	56.3	92.1	102.1	41.3	13.8	70.7	81.1	33.9	13.7	82.3	79.3	54.7	95.2	172.8	13.6	61.8	84.3	29.1	24.2	25.1	29.7	26.2	21.4	31.7	32.2	29.7	31.2	32.8	31.4	141.9	16.0	55.1	13.1	18.5	34.9	40.3	54.6	35.3	2.1	29.5	23.2	11.3	25.8	39.0	33.1	77.2	7.8	38.4	32.8	7.9	43.8	2.4	44.7	38.9	95.3	64.2	35.6	12.9	24.8	74.4	18.8	18.3	75.1	7.6	41.2	156.7	21.1	50.5	3.3	7.4	37.0	34.6	129.3	12.9	4.1	39.1	66.5	14.2	35.6	51.8	23.7	89.6	4.5	13.5	64.2	21.6	41.0	18.4	55.7	23.4	8.0	29.6	7.1	98.6	10.2	43.1	5.0	19.0	80.2	36.4	7.7	55.7	10.4	30.6	69.7
TSPAN15	"NET-7, TM4SF15"	ENSG00000099282	"Tetraspanin 15"	O95858	10	69451465-69507666	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 125.8;Ductal cells: 125.2;Exocrine glandular cells: 189.3;Pancreatic endocrine cells: 193.4;Paneth cells: 120.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	6	"MAIT T-cell: 19.5"	"Lineage enriched"	"Detected in many"	6	"T-cells: 19.5"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 154.7;EFO-21: 211.3;MCF7: 168.0;OE19: 153.2;PC-3: 266.8;SK-BR-3: 134.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044657, HPA071160"	Approved		Approved	"Nuclear bodies,Vesicles,Plasma membrane,Cytosol"		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 1: Pancreatic cells - Digestion"	"Nuclear bodies, Plasma membrane"	"Vesicles, Cytosol"	"HPA044657: AB_10967927, HPA071160: "	"unprognostic (2.03e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.48e-2)"	"unprognostic (9.44e-3)"	"unprognostic (6.81e-3)"	"prognostic unfavorable (8.00e-4)"	"unprognostic (2.23e-1)"	"unprognostic (3.65e-1)"	"unprognostic (2.76e-1)"	"unprognostic (8.22e-3)"	"unprognostic (2.36e-2)"	"prognostic unfavorable (1.25e-4)"	"unprognostic (8.49e-2)"	"unprognostic (4.66e-2)"	"unprognostic (6.34e-2)"	"unprognostic (3.78e-3)"	70.1	5.3	22.8	15.3	37.6	1.0	61.0	35.0	34.1	16.4	14.9	62.5	38.8	32.6	8.5	10.8	24.6	27.4	16.9	23.6	25.4	25.9	4.6	34.4	8.7	36.9	33.4	3.4	20.0	3.2	6.6	28.1	33.7	34.5	39.4	3.1	26.6	24.7	17.9	10.6	38.8	31.3	30.0	26.7	75.3	9.5	34.5	3.6	14.5	5.6	7.5	46.0	14.9	62.4	51.3	103.9	2.1	0.3	2.3	0.0	12.0	0.2	1.9	2.6	6.8	45.1	154.7	0.0	211.3	2.3	9.2	101.2	7.2	11.5	3.0	42.1	20.4	2.9	3.5	10.0	1.1	0.1	1.8	2.2	3.1	1.4	1.5	7.5	39.4	20.5	1.1	0.0	1.2	168.0	0.6	0.9	2.6	153.2	266.8	4.0	2.1	2.0	29.7	92.9	34.5	13.2	0.6	134.8	17.9	17.3	59.3	2.2	34.5	0.2	0.8	0.1	17.5	1.2	6.1	1.0	1.1	0.1	0.2	0.0	0.0	0.0	2.3	0.0	19.5	0.0	3.1	2.8	3.3	0.0	1.0	0.2	0.0	0.1	0.0	0.2	1.1	0.5	22.8	37.6	35.0	34.1	23.6	25.4	36.9	33.4	33.7	30.0	34.5	62.4	108.8	32.1	6.9	4.9	1.5	3.6	10.9	59.6	2.2	2.9	45.1	15.6	1.7	31.5	29.5	29.5	6.2	2.0	1.6	125.8	3.9	125.2	27.9	25.5	3.8	48.4	40.2	8.0	1.7	189.3	11.9	8.2	71.4	36.6	1.3	2.5	10.4	0.1	25.3	1.7	1.0	106.7	36.7	8.5	16.1	6.6	0.6	9.8	28.4	15.0	15.6	44.7	0.0	11.1	75.3	193.4	120.9	0.0	0.2	50.4	68.3	1.8	27.6	1.5	13.1	39.7	26.8	4.3	18.5	2.9	3.1	3.0	3.9	7.5	66.3	29.6
TSPO	"BZRP, DBI, IBP, MBR, mDRC, PBR, pk18, PKBS"	ENSG00000100300	"Translocator protein"	"B1AH88, P30536"	22	43151547-43163242	"Cancer-related genes, FDA approved drug targets, Predicted membrane proteins"	"Lipid transport, Transport"	Receptor	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 690.1"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 1429.2;Pancreatic endocrine cells: 1442.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"RPMI-8226: 516.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011232, HPA046260, HPA072304"	Uncertain		Supported	Vesicles,Mitochondria,Cytosol		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	Mitochondria	"Vesicles, Cytosol"	"CAB011232: , HPA046260: , HPA072304: "	"unprognostic (5.29e-3)"	"unprognostic (1.41e-1)"	"unprognostic (3.31e-1)"	"unprognostic (4.02e-3)"	"unprognostic (3.95e-1)"	"unprognostic (1.46e-2)"	"prognostic unfavorable (1.61e-4)"	"unprognostic (2.16e-1)"	"unprognostic (1.17e-1)"	"unprognostic (3.75e-2)"	"unprognostic (1.07e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.53e-2)"	"unprognostic (3.03e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.34e-3)"	249.3	164.5	42.3	65.3	46.3	488.7	204.3	50.9	61.1	217.3	45.8	189.7	73.6	91.8	8.7	690.1	108.5	39.4	174.7	39.9	51.0	120.5	81.9	181.5	44.3	61.9	48.8	72.3	93.4	22.4	50.8	30.5	57.4	126.6	33.9	4.2	244.9	28.9	84.0	388.0	116.9	26.6	58.0	206.9	216.9	21.4	59.5	22.2	77.4	27.5	39.9	135.7	355.5	69.0	300.0	143.3	10.2	134.4	54.7	175.3	10.8	216.6	107.0	109.4	115.7	28.8	222.4	0.3	147.8	175.7	52.2	242.2	27.9	171.7	13.9	49.5	111.4	28.9	150.4	10.1	193.4	66.4	145.0	137.5	276.4	65.9	58.2	125.8	262.9	0.2	24.0	53.6	114.2	244.5	1.1	188.5	11.6	154.0	355.7	67.0	0.0	516.2	139.3	173.8	14.0	65.4	103.9	200.4	263.5	0.1	76.3	256.6	269.7	132.6	96.9	135.5	92.9	21.7	4.1	2.7	170.0	218.3	171.4	656.8	1678.5	931.0	314.7	1051.6	247.7	199.2	429.9	309.2	1170.2	266.9	325.9	264.3	1052.3	365.0	713.1	209.0	539.5	1585.6	42.3	46.3	50.9	61.1	39.9	51.0	61.9	48.8	57.4	58.0	59.5	69.0	225.5	160.3	140.0	3.6	88.9	366.8	392.3	1429.2	554.3	2.8	269.3	360.2	92.1	323.1	555.7	206.0	2.1	10.0	140.3	680.7	369.8	578.5	2.4	170.8	143.6	220.4	194.9	239.9	0.3	586.4	284.9	205.1	440.9	309.5	268.6	124.3	187.1	110.5	758.5	3.3	0.8	636.8	478.1	644.7	524.7	11.7	82.6	611.6	723.9	10.3	776.9	180.5	207.0	6.0	20.1	1442.1	705.9	157.6	76.3	526.2	471.9	180.7	283.2	19.4	105.2	108.2	197.8	2.8	4.5	1067.4	536.0	20.0	180.0	30.5	664.1	786.1
TSPYL1	TSPYL	ENSG00000189241	"TSPY like 1"	Q9H0U9	6	116267760-116279930	"Disease related genes, Human disease related genes, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031970	Supported		Supported	Nucleoplasm,Nucleoli		No	No			"Cluster 38: Basophils - Unknown function"	"Cluster 47: Non-specific - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Nucleoplasm, Nucleoli"		"HPA031970: AB_2674092"	"unprognostic (1.05e-2)"	"unprognostic (1.09e-1)"	"unprognostic (6.11e-2)"	"unprognostic (9.99e-2)"	"unprognostic (1.70e-1)"	"unprognostic (3.54e-2)"	"unprognostic (2.46e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.76e-1)"	"unprognostic (9.18e-3)"	"prognostic favorable (5.40e-4)"	"unprognostic (5.12e-1)"	"prognostic favorable (1.48e-13)"	"unprognostic (1.61e-1)"	"unprognostic (1.81e-1)"	"unprognostic (2.34e-2)"	"unprognostic (2.47e-1)"	26.5	73.8	51.1	17.1	56.4	34.4	23.4	35.2	78.2	22.5	25.5	30.8	24.4	28.4	33.0	34.0	31.4	20.5	43.3	64.9	38.1	50.4	40.9	21.4	21.4	25.9	22.2	34.9	33.3	63.9	40.1	16.0	26.0	42.0	17.7	26.1	30.2	33.9	114.9	29.4	30.0	24.3	17.1	29.5	35.5	28.9	34.6	22.3	39.6	91.9	25.6	31.4	22.7	44.5	22.2	21.5	27.3	50.3	47.2	30.9	22.7	35.2	34.7	31.3	35.8	27.7	15.9	47.3	43.0	40.8	28.2	38.5	21.6	59.8	33.2	19.4	56.0	19.1	29.9	50.8	29.8	31.9	11.2	36.2	46.0	32.5	31.2	32.9	30.3	20.7	34.3	36.1	44.2	48.9	21.5	18.9	13.6	21.3	19.8	19.1	23.5	26.3	54.9	42.9	23.7	23.6	29.2	38.8	18.0	30.6	51.0	39.1	37.3	21.2	18.7	17.2	38.7	19.8	22.7	25.2	35.1	20.3	14.1	121.0	30.1	51.5	40.5	51.0	61.4	46.4	52.4	45.4	26.1	52.2	51.1	50.0	24.1	33.2	57.7	44.9	44.8	34.0	51.1	56.4	35.2	78.2	64.9	38.1	25.9	22.2	26.0	17.1	34.6	44.5	29.4	35.3	45.9	15.7	65.2	166.1	100.6	37.6	70.6	81.0	91.7	47.5	100.0	61.5	40.5	104.8	27.1	54.8	54.2	49.3	154.6	40.8	33.0	40.5	42.0	40.4	74.6	49.7	65.4	43.9	25.5	63.1	41.3	34.9	31.7	67.5	73.9	81.3	42.4	38.7	50.5	59.3	46.8	82.1	116.0	20.2	75.5	40.2	87.2	22.5	38.3	82.6	42.2	15.6	20.2	48.8	52.5	95.5	24.1	77.0	60.3	218.9	41.4	58.1	131.5	87.6	63.5	61.9	39.8	55.5	162.0	59.7	69.1	101.3	70.2	75.8
TST	RDS	ENSG00000128311	"Thiosulfate sulfurtransferase"	Q16762	22	37010859-37020183	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"RNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 561.2"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 565.8;Hepatocytes: 414.9;Paneth cells: 463.4;Proximal enterocytes: 278.5;Proximal tubular cells: 254.5;Undifferentiated cells: 217.4"	"Cancer enhanced"	"Detected in all"		"liver cancer: 177.0"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"myeloid DC: 25.0"	"Group enriched"	"Detected in all"	6	"dendritic cells: 25.0;granulocytes: 21.8;monocytes: 17.7"	"Cell line enhanced"	"Detected in many"		"OE19: 264.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003044, HPA003643, CAB009546"	Enhanced		Supported	Mitochondria		NA	NA		560000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 85: Liver - Metabolism"	"Cluster 21: OE19 - Mitochondria"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Mitochondria		"CAB009546: AB_2211220, HPA003044: AB_1858417, HPA003643: AB_1080411"	"unprognostic (3.09e-2)"	"unprognostic (2.70e-1)"	"unprognostic (2.07e-1)"	"unprognostic (1.21e-2)"	"unprognostic (2.36e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.49e-2)"	"unprognostic (2.38e-2)"	"unprognostic (2.32e-1)"	"unprognostic (7.96e-3)"	"unprognostic (4.38e-2)"	"unprognostic (1.78e-1)"	"prognostic favorable (7.59e-6)"	"unprognostic (6.08e-3)"	"unprognostic (3.46e-1)"	"unprognostic (1.16e-1)"	"prognostic favorable (1.04e-4)"	51.4	154.1	31.3	20.9	40.5	27.1	37.3	38.2	36.0	34.1	31.3	190.7	147.7	18.9	2.9	96.7	25.7	75.9	69.9	29.1	33.1	100.8	561.2	22.7	8.1	34.4	35.2	26.9	63.6	9.4	12.4	7.9	34.4	26.4	80.3	1.3	39.8	18.2	52.9	33.8	114.2	13.2	35.4	16.9	88.4	8.1	35.8	4.3	17.1	34.9	16.2	30.0	56.7	39.0	42.6	86.1	10.8	36.8	25.9	10.6	21.4	23.0	18.6	12.6	18.3	25.4	25.7	11.1	18.8	17.0	11.9	35.1	7.9	22.3	2.7	33.6	50.0	11.5	15.5	49.7	64.9	16.4	26.4	20.1	23.9	9.1	7.6	17.5	31.1	5.9	14.2	18.2	6.0	90.8	0.5	49.9	18.7	264.4	39.3	37.0	11.7	19.7	35.9	36.7	6.4	17.1	24.2	41.4	31.7	10.2	43.4	39.3	25.1	14.0	27.2	24.2	7.4	14.0	15.4	3.4	5.3	46.4	8.5	10.9	17.7	8.0	0.8	4.7	1.7	2.8	0.8	0.6	25.0	1.7	0.4	0.2	21.8	3.7	1.5	1.7	2.1	8.1	31.3	40.5	38.2	36.0	29.1	33.1	34.4	35.2	34.4	35.4	35.8	39.0	13.9	28.9	74.8	10.1	7.8	1.3	9.5	20.4	12.0	1.3	32.7	16.6	39.2	170.1	23.7	20.2	0.0	11.6	2.5	565.8	46.9	45.3	1.9	53.3	30.2	13.4	34.3	35.3	0.3	44.0	6.4	14.6	126.9	74.3	14.0	60.9	39.3	414.9	15.1	1.7	0.5	162.8	8.2	28.9	6.8	3.5	13.1	23.2	1.8	1.0	18.6	27.3	3.1	3.5	7.4	36.8	463.4	7.9	24.5	10.5	278.5	254.5	19.2	0.8	0.0	10.7	11.5	2.4	0.5	39.8	2.4	11.4	5.0	57.5	217.4	17.3
TTBK1	KIAA1855	ENSG00000146216	"Tau tubulin kinase 1"	Q5TCY1	6	43243481-43288258	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 20.7;pituitary gland: 9.2"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 10.7;Bipolar cells: 6.6;Excitatory neurons: 12.1;Inhibitory neurons: 13.0;Oligodendrocyte precursor cells: 12.1;Oligodendrocytes: 12.4"	"Group enriched"	"Detected in some"	4	"glioma: 3.0;liver cancer: 0.8"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"SCLC-21H: 20.3;SH-SY5Y: 7.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031735, HPA031736"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Cytosol	Nucleoplasm	"HPA031735: AB_2674019, HPA031736: AB_10670294"	"unprognostic (1.68e-1)"	"unprognostic (7.88e-3)"	"unprognostic (7.01e-2)"	"unprognostic (1.62e-3)"	"unprognostic (2.18e-1)"	"unprognostic (2.24e-4)"	"unprognostic (2.46e-3)"	"unprognostic (3.01e-2)"	"unprognostic (3.09e-1)"	"unprognostic (1.85e-1)"	"unprognostic (3.01e-2)"	"unprognostic (2.12e-4)"	"unprognostic (7.42e-2)"	"unprognostic (3.68e-1)"	"unprognostic (1.32e-1)"	"unprognostic (2.64e-3)"	"unprognostic (3.04e-4)"	0.0	1.3	11.8	0.2	10.6	0.0	0.0	3.8	20.7	0.0	0.0	0.2	1.7	0.0	0.0	0.0	0.0	0.2	0.1	12.0	1.1	0.4	1.9	0.0	0.1	5.0	2.2	0.0	0.2	0.3	9.2	0.0	3.5	0.1	0.1	3.0	0.0	0.1	0.0	0.0	2.8	0.0	0.5	0.1	0.1	0.9	6.0	0.0	0.0	0.0	0.2	0.0	0.0	11.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	1.1	0.0	0.3	0.0	0.0	0.7	0.0	0.2	0.1	0.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.3	0.6	0.0	0.1	0.0	0.0	0.0	0.0	20.3	7.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	1.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.8	10.6	3.8	20.7	12.0	1.1	5.0	2.2	3.5	0.5	6.0	11.0	0.0	0.0	0.0	10.7	0.0	0.0	0.1	0.0	0.0	6.6	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.2	0.1	0.1	0.1	0.0	0.0	12.1	0.2	0.0	0.1	0.0	0.0	0.0	2.2	0.4	2.5	0.1	5.0	13.0	0.2	0.0	0.0	0.4	0.5	0.0	0.0	0.0	2.8	0.0	1.4	0.0	12.1	12.4	0.0	1.1	0.0	0.0	0.0	3.8	3.5	0.0	0.5	0.0	0.0	0.1	0.3	0.5	0.0	0.0	0.0	0.1	0.0	0.6	0.0
TTC17	FLJ10890	ENSG00000052841	"Tetratricopeptide repeat domain 17"	Q96AE7	11	43358920-43494933	"Predicted intracellular proteins"	"Cilium biogenesis/degradation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038508	Approved		Supported	"Plasma membrane,Cytosol"		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 59: Non-specific - Transcription"	"Plasma membrane"	Cytosol	"HPA038508: AB_10671744"	"unprognostic (2.71e-1)"	"unprognostic (4.04e-3)"	"unprognostic (6.48e-2)"	"unprognostic (2.64e-1)"	"unprognostic (1.17e-1)"	"unprognostic (5.66e-2)"	"unprognostic (1.74e-1)"	"unprognostic (9.03e-2)"	"unprognostic (5.01e-3)"	"unprognostic (2.62e-1)"	"unprognostic (1.34e-2)"	"unprognostic (1.90e-2)"	"prognostic unfavorable (4.75e-6)"	"unprognostic (1.04e-2)"	"unprognostic (4.40e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.54e-2)"	20.7	18.7	11.0	16.1	11.3	15.5	28.6	16.7	12.2	22.0	22.0	21.2	21.6	26.9	25.0	14.2	28.4	22.3	13.5	11.1	12.2	19.4	38.6	24.2	20.2	11.9	12.5	40.9	49.5	27.7	12.3	29.2	11.7	25.4	22.9	25.1	40.7	21.4	16.4	19.5	25.5	23.0	11.0	23.4	27.4	24.8	12.4	24.6	36.9	20.0	22.4	18.8	15.6	13.0	15.0	30.4	31.3	49.3	77.2	63.6	22.1	35.6	47.6	29.3	35.1	21.1	21.7	31.6	34.9	35.9	33.7	31.1	22.3	23.5	35.2	24.5	29.0	24.2	19.5	20.8	95.3	36.6	29.9	59.5	69.8	21.3	68.4	66.2	29.5	22.7	35.5	26.2	29.8	18.1	27.1	20.3	46.8	58.0	25.0	25.1	33.3	36.9	37.2	21.4	16.7	39.7	27.7	73.1	44.6	31.4	68.6	40.8	39.6	41.7	18.4	47.1	52.1	51.1	44.5	29.8	26.9	21.6	45.3	20.0	21.7	19.0	14.9	22.4	15.9	16.4	16.2	14.5	16.9	14.8	16.3	15.1	18.5	16.5	20.8	17.6	16.1	18.0	11.0	11.3	16.7	12.2	11.1	12.2	11.9	12.5	11.7	11.0	12.4	13.0	43.0	64.1	62.7	159.6	53.3	42.1	35.0	36.4	30.7	44.1	40.3	35.7	20.5	31.5	51.9	22.0	60.5	32.6	43.8	30.7	3.9	23.1	52.6	35.8	44.5	40.9	22.3	44.0	204.6	43.4	28.8	44.4	40.2	48.6	36.6	56.2	40.0	57.5	26.2	47.1	203.2	42.1	34.6	48.0	32.3	18.4	57.2	37.1	28.4	181.8	47.8	24.8	37.0	192.0	200.6	29.7	31.5	36.5	48.9	50.1	47.7	15.5	54.3	47.3	52.6	45.5	36.2	51.8	35.0	34.6	43.2	30.8	45.6	33.5	35.8	42.7
TTC37	"KIAA0372, THES"	ENSG00000198677	"Tetratricopeptide repeat domain 37"	Q6PGP7	5	95461755-95554977	"Disease related genes, Human disease related genes, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037905	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	Cytosol	"HPA037905: AB_10673034"	"unprognostic (5.99e-2)"	"unprognostic (7.65e-3)"	"prognostic favorable (2.62e-4)"	"unprognostic (8.48e-2)"	"unprognostic (9.49e-2)"	"unprognostic (5.39e-2)"	"unprognostic (1.40e-2)"	"unprognostic (2.18e-1)"	"unprognostic (6.88e-2)"	"unprognostic (5.97e-2)"	"unprognostic (6.81e-3)"	"unprognostic (2.51e-1)"	"unprognostic (3.30e-3)"	"unprognostic (6.88e-3)"	"unprognostic (3.91e-1)"	"unprognostic (3.98e-2)"	"unprognostic (7.90e-3)"	23.6	24.2	10.6	17.9	13.1	10.5	25.7	21.4	15.4	23.8	14.8	20.2	21.4	22.8	19.7	19.9	16.9	18.4	24.3	12.3	11.7	27.5	23.2	17.1	20.5	15.0	12.2	22.6	26.7	46.1	20.2	25.9	15.9	27.2	22.1	21.8	20.7	21.4	34.5	32.7	19.2	22.2	12.7	19.4	26.2	7.8	13.3	25.8	26.2	30.9	21.5	17.0	16.7	18.5	33.1	34.6	43.0	14.9	70.3	94.9	38.2	61.8	49.6	39.3	58.6	37.1	23.6	58.0	39.7	59.0	41.0	31.7	54.5	74.5	65.4	34.0	44.6	39.1	68.8	24.6	60.1	25.7	27.1	63.6	37.3	50.1	69.5	60.3	63.0	19.0	31.2	37.1	75.1	19.0	33.5	20.6	24.3	15.1	28.2	28.1	60.0	61.5	43.2	25.7	53.5	41.8	50.8	24.8	57.0	35.7	38.8	21.7	87.4	53.3	30.5	42.5	47.9	35.4	48.3	53.0	54.0	36.9	70.0	6.1	6.4	2.4	10.1	7.8	12.2	10.3	9.8	8.5	8.1	10.0	10.0	10.6	0.2	9.3	8.0	16.2	9.7	4.4	10.6	13.1	21.4	15.4	12.3	11.7	15.0	12.2	15.9	12.7	13.3	18.5	51.4	76.9	56.1	68.6	38.5	19.5	20.4	26.5	8.6	57.8	33.2	31.8	84.9	25.8	40.9	27.6	50.1	32.5	52.0	22.4	15.6	41.5	2.4	44.8	70.9	39.9	32.5	20.2	146.8	40.5	41.8	43.4	42.8	57.3	41.1	64.6	32.9	36.0	26.9	58.9	130.6	34.3	16.2	28.8	16.7	4.3	62.4	32.2	8.8	68.4	55.4	21.0	41.2	99.5	145.0	38.1	20.2	64.7	41.1	19.0	32.2	30.7	38.2	33.6	39.5	55.1	39.5	10.5	10.0	30.9	32.8	19.8	34.8	52.3	34.2	18.2
TTC5	Strap	ENSG00000136319	"Tetratricopeptide repeat domain 5"	Q8N0Z6	14	20256558-20305960	"Predicted intracellular proteins"	"DNA damage, DNA repair"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045008, HPA054198"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 49: Ciliated cells - Cilium organization"	Nucleoplasm		"HPA045008: AB_10960209, HPA054198: AB_2682414"	"unprognostic (2.19e-3)"	"unprognostic (1.00e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.39e-2)"	"unprognostic (6.48e-2)"	"unprognostic (8.15e-2)"	"unprognostic (6.82e-2)"	"unprognostic (4.68e-2)"	"unprognostic (1.03e-1)"	"unprognostic (8.32e-2)"	"unprognostic (3.29e-1)"	"prognostic favorable (8.54e-4)"	"unprognostic (3.01e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.10e-1)"	"unprognostic (5.07e-2)"	2.1	2.8	2.8	1.8	2.8	2.9	3.8	2.2	3.1	3.1	4.8	2.2	2.1	3.1	3.2	2.2	5.7	2.2	1.8	2.6	3.1	3.5	1.4	2.5	3.2	2.1	2.7	3.0	1.9	6.1	2.1	2.4	2.1	3.8	2.3	2.6	2.3	3.0	0.7	3.4	1.6	2.9	2.1	2.4	2.4	2.5	4.3	2.6	4.9	2.3	3.1	2.3	1.7	2.2	3.4	5.4	6.5	0.7	4.7	6.8	3.5	4.3	5.0	6.4	6.6	2.4	7.6	7.2	2.7	4.5	3.3	2.8	6.4	3.0	9.8	6.3	2.4	5.9	2.2	4.3	4.8	11.0	3.5	4.2	6.7	5.6	7.2	5.8	6.3	5.1	4.3	3.5	6.3	4.6	6.5	4.6	5.5	5.6	5.2	3.4	4.8	5.2	5.6	3.5	2.2	4.3	4.9	5.1	3.0	2.6	4.0	5.3	6.6	2.5	4.1	3.4	2.3	5.0	4.7	8.9	2.0	4.6	6.0	1.3	2.0	2.9	2.7	2.0	2.3	2.7	2.0	2.2	2.2	3.0	2.1	2.5	0.8	3.0	2.9	1.6	2.7	2.0	2.8	2.8	2.2	3.1	2.6	3.1	2.1	2.7	2.1	2.1	4.3	2.2	13.9	12.8	7.2	6.5	15.2	6.4	9.4	21.5	13.6	15.5	9.4	12.8	4.3	12.8	9.8	18.4	16.7	20.4	12.2	2.3	11.7	10.6	1.6	27.7	13.4	12.3	9.0	6.7	18.2	6.5	12.4	12.5	8.6	7.9	12.0	16.0	10.8	6.4	15.4	5.0	12.4	6.9	18.3	11.2	6.8	3.4	10.2	10.5	7.2	6.5	11.5	12.4	19.6	11.6	8.7	6.4	5.0	9.8	7.8	4.6	8.6	13.1	32.8	19.4	6.6	14.1	11.6	26.6	36.1	8.8	8.7	4.7	12.7	14.6	8.3	5.3
TTF1		ENSG00000125482	"Transcription termination factor 1"	Q15361	9	132375548-132406851	"Human disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation, Transcription termination"	"DNA replication inhibitor, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054837	Supported		Supported	Nucleoplasm,Nucleoli		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 6: Erythroid cells - Oxygen transport"	"Nucleoplasm, Nucleoli"		"HPA054837: AB_2682621"	"unprognostic (7.07e-2)"	"unprognostic (5.62e-3)"	"unprognostic (9.12e-2)"	"unprognostic (6.05e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.22e-1)"	"prognostic unfavorable (1.40e-4)"	"unprognostic (1.07e-1)"	"unprognostic (9.21e-3)"	"unprognostic (3.08e-1)"	"unprognostic (1.33e-1)"	"unprognostic (6.95e-3)"	"unprognostic (2.09e-2)"	"unprognostic (5.93e-3)"	"unprognostic (8.38e-2)"	"unprognostic (3.44e-1)"	"unprognostic (4.71e-2)"	8.0	5.0	7.0	6.2	7.7	16.7	9.6	9.0	8.3	7.4	6.7	9.6	4.7	8.5	9.0	6.4	7.3	5.3	13.3	6.9	7.3	6.6	4.2	7.0	10.5	7.0	7.1	8.6	6.6	7.0	5.0	6.5	7.1	7.9	6.6	8.6	6.1	7.4	13.6	7.1	6.5	7.1	6.8	7.9	6.5	9.6	7.1	18.9	10.4	10.3	10.0	7.9	6.9	8.3	12.5	11.5	16.4	14.8	9.0	11.5	14.7	14.1	10.7	16.2	12.0	11.8	13.2	20.9	11.5	10.6	18.3	29.7	18.5	10.8	17.1	13.9	12.6	9.6	17.2	9.5	9.1	25.6	14.9	7.1	12.0	13.8	10.5	13.1	14.0	34.1	19.3	17.5	12.7	19.0	59.8	15.5	30.0	22.3	16.8	37.1	22.8	24.9	13.1	10.1	14.4	24.8	19.8	14.4	10.7	15.3	17.9	13.7	13.2	25.0	15.8	21.8	16.8	8.2	24.8	25.0	14.7	20.6	25.1	17.0	5.8	12.0	6.6	6.0	8.6	13.6	8.4	7.8	3.6	12.2	9.3	7.0	20.9	8.2	7.4	11.2	9.6	3.3	7.0	7.7	9.0	8.3	6.9	7.3	7.0	7.1	7.1	6.8	7.1	8.3	26.8	25.6	21.6	12.7	35.4	9.8	21.9	26.9	7.4	27.2	11.8	15.5	40.1	25.8	18.3	18.4	60.5	23.8	33.2	14.8	19.6	28.5	22.9	26.2	21.4	29.5	12.1	68.0	12.4	21.2	22.8	17.5	15.3	16.8	22.8	28.8	27.5	8.3	18.7	30.3	10.6	15.4	20.3	22.0	12.1	6.8	23.6	17.4	1.8	14.0	30.1	20.3	41.2	9.5	19.2	25.3	18.6	25.9	14.3	22.8	16.5	19.3	29.2	55.0	26.3	21.9	24.1	47.4	61.8	7.5	8.5	25.2	28.2	16.8	19.7	24.5
TTF2	"HuF2, ZGRF6"	ENSG00000116830	"Transcription termination factor 2"	Q9UNY4	1	117060326-117107453	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing, Transcription, Transcription regulation, Transcription termination"	"DNA-binding, Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA005776, HPA070762"	Approved		Supported	Cytosol		NA	Yes			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Cytosol		"HPA005776: AB_1080416, HPA070762: AB_2686307"	"unprognostic (1.82e-1)"	"unprognostic (2.18e-1)"	"unprognostic (3.29e-3)"	"unprognostic (2.01e-3)"	"unprognostic (4.90e-2)"	"unprognostic (3.41e-3)"	"unprognostic (5.27e-4)"	"unprognostic (7.96e-2)"	"unprognostic (1.92e-2)"	"unprognostic (3.33e-1)"	"unprognostic (4.64e-2)"	"unprognostic (9.52e-3)"	"unprognostic (7.34e-3)"	"unprognostic (1.48e-3)"	"unprognostic (7.73e-2)"	"unprognostic (3.50e-1)"	"unprognostic (3.65e-2)"	3.8	4.7	2.6	6.4	3.9	5.4	4.2	2.8	3.7	3.3	3.6	5.0	4.3	3.0	1.7	5.2	2.6	2.8	3.1	2.4	2.8	2.6	1.4	2.6	7.3	5.4	3.5	2.7	3.5	3.9	2.3	2.7	3.6	2.5	5.4	2.5	3.3	2.5	4.7	4.9	4.0	4.0	3.0	4.3	3.9	4.2	3.8	8.9	3.6	2.3	7.9	3.3	3.6	4.7	27.7	10.0	19.8	28.0	7.7	6.7	24.6	14.5	6.7	20.8	18.3	14.1	4.8	33.4	21.8	9.6	23.2	28.1	35.2	18.7	32.0	25.9	24.8	28.5	19.5	18.2	5.5	42.1	31.5	7.7	7.0	15.4	28.4	5.2	14.4	26.0	22.3	29.6	15.9	42.4	28.1	26.0	30.9	26.3	20.0	40.0	72.7	14.6	12.7	12.4	16.8	7.0	21.7	21.4	8.4	14.9	11.7	17.0	14.6	13.1	27.6	31.0	31.8	13.5	12.5	40.6	8.8	31.2	53.7	0.9	2.3	1.5	1.2	2.8	1.2	1.5	1.4	2.0	2.6	1.5	1.4	1.7	0.4	2.6	1.6	1.4	2.7	1.0	2.6	3.9	2.8	3.7	2.4	2.8	5.4	3.5	3.6	3.0	3.8	4.7	4.4	6.4	6.4	6.8	13.4	13.3	17.1	8.5	12.0	5.7	7.6	6.3	7.3	5.7	7.3	12.9	8.4	9.7	8.9	10.6	5.9	6.6	6.9	8.9	15.6	6.9	4.9	30.3	8.1	8.0	7.6	11.0	8.6	12.3	9.5	24.7	5.7	3.0	11.4	11.8	4.7	8.3	0.0	8.6	12.1	7.0	6.5	14.5	7.2	10.3	22.1	3.3	14.4	2.5	13.5	9.3	5.1	4.1	16.0	22.7	6.2	3.8	5.1	7.2	0.0	18.4	8.5	9.2	12.4	19.4	14.3	3.8	12.3	12.2	13.5	17.9
TTLL5	KIAA0998	ENSG00000119685	"Tubulin tyrosine ligase like 5"	Q6EMB2	14	75633625-75955079	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	Transcription	Ligase	"Cone-rod dystrophy, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 57.4"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 127.2;Early spermatids: 111.0;Excitatory neurons: 134.3;Inhibitory neurons: 114.2;Oligodendrocytes: 242.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA032128	Uncertain		Supported	"Plasma membrane,Cytosol"		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 77: Retina - Visual perception"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Plasma membrane, Cytosol"		"HPA032128: AB_10600835"	"unprognostic (7.35e-2)"	"unprognostic (7.29e-2)"	"unprognostic (7.73e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.33e-1)"	"unprognostic (5.96e-2)"	"unprognostic (7.21e-5)"	"unprognostic (1.26e-1)"	"unprognostic (1.70e-1)"	"unprognostic (7.93e-2)"	"unprognostic (1.10e-2)"	"unprognostic (3.43e-1)"	"unprognostic (5.67e-3)"	"unprognostic (1.70e-1)"	"unprognostic (1.57e-1)"	"unprognostic (8.97e-2)"	"unprognostic (2.15e-2)"	5.5	5.5	3.7	6.0	6.0	11.7	7.1	7.1	7.2	7.3	15.0	6.2	4.7	8.0	7.2	7.8	11.6	6.5	5.8	3.8	6.6	6.2	4.1	6.5	5.1	10.5	6.4	7.1	4.9	11.1	5.4	7.5	10.6	6.9	7.3	23.9	6.5	6.9	4.7	7.1	4.5	8.6	6.4	4.1	5.9	57.4	6.4	10.1	7.8	5.8	7.5	6.1	6.4	12.0	22.8	16.2	13.9	14.5	10.9	16.8	12.9	13.1	15.9	15.4	19.9	10.3	20.8	6.4	7.2	13.9	11.3	21.3	12.3	21.7	29.3	7.6	7.3	12.5	16.8	11.3	9.3	9.2	11.5	13.1	10.6	19.4	21.5	16.8	33.8	17.5	7.2	10.5	15.7	32.1	15.6	12.6	9.9	18.0	16.6	9.5	19.6	8.8	15.0	22.2	18.4	11.6	27.5	20.2	6.8	11.0	27.6	9.8	38.1	20.5	18.0	18.5	12.2	8.8	13.5	14.6	20.7	10.4	13.9	11.6	2.0	1.7	2.6	2.0	2.4	2.3	2.5	2.7	3.2	1.8	2.9	2.7	2.4	2.3	2.5	3.4	2.2	1.4	3.7	6.0	7.1	7.2	3.8	6.6	10.5	6.4	10.6	6.4	6.4	12.0	7.1	3.2	10.1	71.8	6.1	5.0	5.5	5.4	8.0	10.9	17.3	11.6	8.7	17.2	10.2	11.0	127.2	8.1	8.5	7.6	3.9	7.1	111.0	37.4	11.9	10.7	7.7	5.0	134.3	5.3	13.2	9.3	8.6	10.8	12.6	11.7	19.6	7.4	5.6	0.0	114.2	6.5	16.2	5.8	5.1	93.1	12.5	6.6	5.4	82.4	8.5	10.0	6.2	78.4	242.9	6.1	11.9	11.7	7.6	6.2	6.0	2.4	40.1	80.1	13.1	9.5	6.0	37.7	16.4	9.0	6.3	6.0	8.3	9.1	8.0	4.6
TUBA1B	K-ALPHA-1	ENSG00000123416	"Tubulin alpha 1b"	P68363	12	49127782-49131397	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Erythroid cells: 2143.3;Extravillous trophoblasts: 2555.5;Hofbauer cells: 2114.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011513, HPA039247, HPA043684, HPA063394"	Enhanced		Supported	Microtubules		NA	Yes			"Cluster 51: Monocytes - Innate immune response"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Microtubules		"CAB011513: AB_2210057, HPA039247: AB_2676410, HPA043684: AB_2678617, HPA063394: AB_2685003"	"prognostic unfavorable (5.49e-4)"	"unprognostic (4.19e-2)"	"unprognostic (3.84e-3)"	"unprognostic (5.84e-2)"	"unprognostic (2.91e-1)"	"unprognostic (7.10e-2)"	"prognostic unfavorable (1.68e-7)"	"unprognostic (2.98e-3)"	"unprognostic (9.28e-2)"	"unprognostic (1.78e-1)"	"unprognostic (3.69e-2)"	"unprognostic (9.46e-2)"	"prognostic unfavorable (2.85e-12)"	"unprognostic (1.60e-1)"	"unprognostic (3.52e-1)"	"unprognostic (4.67e-2)"	"unprognostic (3.55e-3)"	531.9	319.3	1071.9	650.0	1115.9	1491.9	453.7	941.8	1318.4	306.5	841.2	598.4	279.4	460.5	403.7	550.9	369.1	305.6	509.3	1108.8	1139.4	310.3	233.9	511.3	750.8	1176.0	1108.8	325.9	179.9	262.6	322.2	582.9	1162.2	247.8	665.1	652.9	304.6	394.1	243.9	404.3	352.5	1004.6	993.4	435.8	355.7	322.7	1127.4	1557.3	267.3	242.0	882.3	639.5	339.4	1076.7	3063.5	3381.9	3587.5	2051.4	910.0	1321.7	1939.2	2635.0	2642.5	5018.6	4034.6	4300.0	3144.6	3430.1	1854.8	3732.5	2047.5	1864.3	3993.2	3609.1	4586.7	1938.3	2103.5	2445.9	1822.2	2219.9	251.5	3705.8	1863.3	793.6	540.2	3930.9	1298.9	1697.4	4353.5	3121.3	2788.0	2182.3	4142.7	3362.1	4985.5	2943.8	2504.9	7570.8	3944.4	3980.1	3023.6	2137.4	2377.1	2008.1	2250.7	1921.9	2211.7	1697.3	803.9	1804.3	2403.1	3624.8	2321.3	2393.9	2752.4	2404.5	3470.2	1196.5	1876.2	3685.5	1668.2	2924.3	2303.6	197.9	240.0	411.5	241.8	1022.1	266.7	268.9	230.1	225.3	632.4	239.6	241.0	192.4	271.6	230.9	1107.4	632.0	293.2	731.1	1071.9	1115.9	941.8	1318.4	1108.8	1139.4	1176.0	1108.8	1162.2	993.4	1127.4	1076.7	702.9	198.7	231.8	36.6	445.8	584.0	653.7	875.4	288.5	426.4	267.9	391.8	0.8	90.1	373.4	187.6	492.1	1143.1	514.2	482.6	361.9	814.5	272.5	189.3	218.3	643.9	303.7	2143.3	201.8	630.1	2555.5	603.4	237.0	203.9	542.8	1069.6	353.4	106.3	2114.8	498.0	99.1	508.1	512.7	361.8	1353.1	204.8	326.8	729.8	473.2	68.4	1248.5	455.7	228.6	34.7	82.7	703.3	298.4	236.6	595.9	373.5	240.0	245.1	287.7	970.8	263.0	321.5	957.4	161.6	488.9	560.6	449.8	304.4	480.3	172.4	551.2	539.1
TUBA1C	"bcm948, MGC10851, MGC14580, TUBA6"	ENSG00000167553	"Tubulin alpha 1c"	Q9BQE3	12	49188736-49274600	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 479.4"	"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 1118.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 98.8"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"OE19: 4114.3"	"Low region specificity"	"Detected in all"							"HPA039247, HPA043684, HPA063394"	Supported		Supported	Microtubules		NA	Yes		160000000	"Cluster 38: Basophils - Unknown function"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Microtubules		"HPA039247: AB_2676410, HPA043684: AB_2678617, HPA063394: AB_2685003"	"prognostic unfavorable (2.90e-4)"	"unprognostic (1.15e-2)"	"prognostic favorable (7.37e-5)"	"unprognostic (3.25e-2)"	"unprognostic (4.60e-2)"	"unprognostic (2.88e-2)"	"prognostic unfavorable (8.48e-8)"	"prognostic unfavorable (6.85e-4)"	"unprognostic (2.11e-1)"	"unprognostic (1.53e-2)"	"prognostic unfavorable (5.64e-6)"	"unprognostic (1.49e-1)"	"prognostic unfavorable (6.26e-7)"	"unprognostic (2.95e-1)"	"unprognostic (1.26e-1)"	"unprognostic (2.49e-1)"	"unprognostic (5.45e-3)"	92.6	57.8	12.4	110.5	12.1	148.8	54.7	13.9	18.0	101.0	41.9	158.2	106.9	59.6	62.7	479.4	50.8	92.1	55.3	12.8	16.4	113.5	69.3	74.1	78.6	15.7	14.1	38.3	52.6	22.5	28.0	109.9	15.5	43.7	156.5	2.5	139.0	46.4	45.3	166.1	117.6	129.8	15.7	42.1	115.2	26.3	22.6	103.3	56.3	42.5	170.7	222.5	168.8	15.4	1295.3	987.5	211.7	363.9	220.5	368.4	816.3	1010.1	1126.1	1742.1	927.3	966.9	947.0	578.9	1053.2	1194.2	1047.3	580.5	1246.0	1412.1	1150.2	564.1	449.7	703.4	406.7	943.7	165.2	550.9	498.4	269.8	663.0	1485.6	619.9	550.6	1139.5	320.6	1026.8	308.3	1521.8	811.1	306.5	535.8	639.6	4114.3	1928.6	344.0	414.5	319.7	770.3	602.8	169.8	9.1	875.5	574.4	386.0	828.3	559.4	426.0	835.1	819.3	911.5	821.9	1717.4	101.6	306.5	565.2	431.6	536.1	725.9	98.8	14.6	29.9	12.3	17.3	19.7	10.5	13.1	11.7	27.0	7.4	7.0	7.9	12.2	13.6	13.1	21.6	17.6	20.8	12.4	12.1	13.9	18.0	12.8	16.4	15.7	14.1	15.5	15.7	22.6	15.4	94.3	118.6	136.1	2.6	54.9	194.5	354.2	317.7	306.7	1.3	61.3	75.8	0.9	45.8	150.9	58.8	0.0	291.9	50.1	432.7	70.5	285.8	7.9	107.7	65.8	83.0	77.5	155.5	2.1	559.2	1118.2	109.7	153.4	204.4	67.2	110.8	39.3	55.9	276.8	0.0	1.9	190.5	101.7	65.6	121.7	8.4	68.0	163.3	46.2	2.8	265.5	2.8	6.2	1.0	1.4	465.6	330.2	40.6	71.0	206.3	234.1	137.1	51.9	0.6	39.5	84.3	258.2	9.0	65.5	530.8	183.1	161.6	77.6	46.1	187.9	293.4
TUBA3C	"bA408E5.3, TUBA2"	ENSG00000198033	"Tubulin alpha 3c"	P0DPH7	13	19173772-19181824	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	714	"testis: 404.9"	"Group enriched"	"Detected in some"	25	"Early spermatids: 703.3;Late spermatids: 250.4;Spermatocytes: 947.8;Spermatogonia: 255.9"	"Cancer enhanced"	"Detected in many"		"liver cancer: 2.7;testis cancer: 2.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	49	"HDLM-2: 107.5;U-2 OS: 256.9;U-266/70: 84.2;U-266/84: 109.7"									"HPA039247, HPA043684, HPA063394"	Uncertain		Supported	Microtubules		NA	Yes				"Cluster 36: Testis - Spermatogenesis"	"Cluster 9: U-2 OS - Unknown function"	"Cluster 66: Spermatocytes - Spermatogenesis"	Microtubules		"HPA039247: AB_2676410, HPA043684: AB_2678617, HPA063394: AB_2685003"	"unprognostic (3.76e-3)"				"unprognostic (1.33e-1)"							"unprognostic (3.00e-1)"		"unprognostic (1.04e-1)"	"unprognostic (1.26e-1)"			0.1	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.5	404.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	2.4	0.0	0.0	0.0	0.0	107.5	0.0	0.0	0.0	0.4	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.1	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.5	0.0	0.4	256.9	0.2	0.3	84.2	109.7	0.2	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	703.3	0.0	0.0	0.7	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	250.4	21.1	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	9.8	0.0	0.0	0.0	0.0	0.0	0.0	13.1	0.0	0.6	947.8	255.9	0.0	0.3	0.0	0.0	0.0	0.0	0.0
TUBA3D	H2-ALPHA	ENSG00000075886	"Tubulin alpha 3d"	P0DPH8	2	131476119-131482934	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	15	"heart muscle: 86.2;testis: 220.2"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 358.9;Late spermatids: 119.6;Spermatocytes: 667.9;Spermatogonia: 326.1"	"Cancer enhanced"	"Detected in many"		"testis cancer: 7.6"	"Region enhanced"	"Detected in single"		"cerebellum: 1.6"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"NB-4: 1.1"	"Not detected"	"Not detected"							"CAB004972, HPA039247, HPA043684, HPA063394"	Uncertain		Supported	Microtubules		NA	NA				"Cluster 43: Testis - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	Microtubules		"CAB004972: AB_425727, HPA039247: AB_2676410, HPA043684: AB_2678617, HPA063394: AB_2685003"	"prognostic favorable (4.65e-4)"	"unprognostic (6.66e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.96e-3)"	"unprognostic (1.82e-1)"	"unprognostic (1.50e-3)"	"unprognostic (2.17e-1)"	"unprognostic (2.06e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.89e-1)"	"unprognostic (1.08e-1)"	"unprognostic (2.05e-1)"	"prognostic unfavorable (4.75e-9)"	"unprognostic (4.60e-2)"	"unprognostic (2.28e-1)"	"unprognostic (9.96e-4)"	"unprognostic (2.28e-1)"	0.1	0.1	0.4	0.2	0.3	0.4	0.6	1.6	0.4	2.8	0.0	0.1	0.1	4.8	6.8	0.2	4.0	0.2	86.2	0.6	0.2	0.1	0.4	0.1	0.4	0.0	0.0	0.5	0.2	0.0	0.1	0.0	0.0	10.1	0.0	0.3	0.3	0.4	0.1	0.6	0.2	0.3	0.0	0.2	0.2	220.2	0.0	0.0	0.3	0.0	0.0	0.1	0.3	0.0	0.5	0.2	0.2	0.9	0.0	0.0	0.6	0.2	0.0	0.0	0.0	0.8	0.3	0.3	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.4	0.7	0.1	0.6	0.3	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.7	0.3	0.0	0.5	0.5	1.1	0.7	0.0	0.3	0.4	0.0	0.2	0.0	0.2	0.5	0.1	0.2	0.0	0.0	0.2	0.1	0.0	0.2	0.3	0.4	0.5	0.3	0.1	0.2	0.2	0.2	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.3	1.6	0.4	0.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.3	0.4	36.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	358.9	0.4	1.1	1.2	0.0	0.0	0.4	0.0	0.1	0.6	0.0	1.1	0.0	0.4	0.0	0.5	0.0	0.0	0.3	0.0	0.0	0.0	0.0	119.6	12.2	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	10.1	0.0	4.8	0.0	0.0	0.0	0.0	52.6	0.0	0.1	667.9	326.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1
TUBA3E		ENSG00000152086	"Tubulin alpha 3e"	Q6PEY2	2	130191745-130198439	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	29	"heart muscle: 53.3;testis: 175.3"	"Group enriched"	"Detected in some"	6	"Early spermatids: 259.8;Late spermatids: 109.4;Spermatocytes: 415.4;Spermatogonia: 172.3"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	12	"BEWO: 4.2;U-2 OS: 2.7"									"HPA039247, HPA043684, HPA063394"	Uncertain		Supported	Microtubules		NA	NA				"Cluster 43: Testis - Unknown function"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	Microtubules		"HPA039247: AB_2676410, HPA043684: AB_2678617, HPA063394: AB_2685003"	"unprognostic (1.02e-3)"	"unprognostic (2.79e-1)"	"unprognostic (3.73e-2)"	"unprognostic (1.51e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.20e-1)"	"unprognostic (6.81e-3)"	"unprognostic (1.33e-1)"	"unprognostic (3.21e-1)"	"unprognostic (2.54e-1)"	"unprognostic (1.21e-2)"	"unprognostic (7.89e-2)"	"unprognostic (2.65e-7)"	"unprognostic (1.39e-1)"	"unprognostic (2.10e-1)"	"unprognostic (2.02e-3)"	"unprognostic (8.94e-3)"	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.4	0.1	1.7	0.0	0.0	0.0	3.9	0.4	0.0	2.5	0.0	53.3	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.1	0.6	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	175.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	4.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.3	18.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	259.8	0.0	1.8	0.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	109.4	9.3	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.5	0.0	0.0	0.0	0.0	0.0	0.0	39.5	0.0	0.1	415.4	172.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1
TUBA8	TUBAL2	ENSG00000183785	"Tubulin alpha 8"	Q9NY65	22	18110100-18146683	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 128.9;skeletal muscle: 332.2;tongue: 154.7"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 16.4;Excitatory neurons: 8.1;Inhibitory neurons: 5.6;Late spermatids: 22.9;Sertoli cells: 6.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"basophil: 2.8;eosinophil: 2.7;neutrophil: 5.0;NK-cell: 10.4"	"Group enriched"	"Detected in many"	7	"granulocytes: 5.0;NK-cells: 10.4"	"Group enriched"	"Detected in many"	5	"NB-4: 30.2;SCLC-21H: 10.9;TIME: 36.3"	"Group enriched"	"Detected in all"	4	"cerebellum: 54.7;olfactory bulb: 53.9"	"Low region specificity"	"Detected in all"			"HPA043684, CAB046031, HPA063394"	Approved		Supported	Microtubules		NA	NA		80000000	"Cluster 48: NK-cells - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 24: NB-4 - Immune response"	"Cluster 34: Spermatids - Unknown function"	Microtubules		"CAB046031: AB_11124541, HPA043684: AB_2678617, HPA063394: AB_2685003"	"unprognostic (1.07e-1)"	"unprognostic (1.34e-2)"	"unprognostic (2.79e-3)"	"unprognostic (1.52e-2)"	"unprognostic (2.74e-1)"	"unprognostic (8.92e-2)"	"unprognostic (6.88e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.20e-1)"	"unprognostic (2.64e-2)"	"unprognostic (1.92e-2)"	"unprognostic (3.36e-1)"	"unprognostic (2.90e-5)"	"unprognostic (9.12e-2)"	"unprognostic (6.05e-2)"	"unprognostic (4.08e-2)"	"unprognostic (5.61e-4)"	7.3	1.9	9.0	1.0	11.8	4.7	7.2	24.3	16.3	2.5	0.8	2.0	0.8	2.7	6.3	4.3	4.8	1.0	128.9	15.0	2.8	2.3	4.3	2.4	3.5	0.6	9.0	2.3	4.4	2.7	14.5	0.6	0.8	2.5	0.5	2.8	4.4	0.6	332.2	4.4	2.6	0.7	1.5	4.2	4.7	52.3	11.5	0.8	6.5	154.7	1.0	2.0	2.2	12.5	0.6	1.1	1.2	1.4	1.8	0.5	0.4	0.6	0.3	1.4	0.8	0.9	1.1	0.9	2.2	0.7	0.4	0.6	2.2	0.4	0.3	0.8	1.6	2.2	1.7	0.9	1.0	1.0	1.0	0.7	0.8	0.8	0.6	0.5	2.0	0.9	0.6	0.9	0.6	3.4	1.0	30.2	1.0	0.5	0.5	0.9	0.5	0.2	0.7	1.1	10.9	1.1	0.6	1.9	1.0	0.5	0.6	4.8	36.3	0.9	1.0	1.0	0.4	2.2	1.3	0.7	0.9	1.4	0.6	2.8	0.7	2.7	0.5	0.6	0.7	0.4	0.4	0.3	0.4	0.6	0.7	0.4	5.0	10.4	0.4	1.0	0.8	17.1	9.0	11.8	24.3	16.3	15.0	2.8	0.6	9.0	0.8	1.5	11.5	12.5	0.2	0.0	1.7	1.6	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.3	4.7	0.0	0.0	0.0	2.1	0.0	0.0	0.4	0.0	0.3	16.4	0.2	0.1	0.4	0.0	0.0	8.1	1.1	0.0	0.3	0.0	0.2	2.5	0.1	0.7	0.0	0.1	3.3	5.6	0.0	0.0	0.3	0.0	22.9	0.3	0.1	0.0	0.0	0.2	0.1	1.0	3.5	1.7	0.6	0.1	0.4	0.0	0.0	0.4	0.1	0.0	0.2	6.6	0.1	0.2	0.1	0.2	0.1	0.3	0.1	0.1	0.1	0.1	0.0
TUBB	"M40, MGC16435, OK/SW-cl.56, Tubb5"	ENSG00000196230	"Tubulin beta class I"	P07437	6	30717435-30725538	"Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Extravillous trophoblasts: 2296.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005417, CAB012406, HPA043640, HPA046280"	Enhanced		Supported	"Microtubules,Cytokinetic bridge,Mitotic spindle"		Yes	Yes		170000000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Microtubules	"Cytokinetic bridge, Mitotic spindle"	"CAB005417: AB_2241191, CAB012406: AB_2210370, HPA043640: AB_2678594, HPA046280: AB_2679612"	"unprognostic (1.01e-1)"	"unprognostic (2.33e-1)"	"unprognostic (2.17e-3)"	"unprognostic (1.92e-2)"	"unprognostic (1.56e-1)"	"unprognostic (2.16e-2)"	"prognostic unfavorable (5.97e-4)"	"unprognostic (2.57e-2)"	"unprognostic (2.52e-1)"	"unprognostic (2.18e-3)"	"unprognostic (1.27e-2)"	"unprognostic (2.47e-1)"	"prognostic unfavorable (2.62e-8)"	"unprognostic (8.63e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.49e-1)"	"unprognostic (2.50e-1)"	229.5	164.8	74.6	243.5	81.8	541.0	186.9	46.2	367.7	228.7	87.0	250.3	87.6	333.0	174.5	246.3	227.0	158.5	245.3	73.5	119.7	137.8	236.6	205.3	369.2	80.5	74.8	467.5	138.1	74.4	97.0	194.4	99.2	145.2	194.4	82.4	160.2	194.6	185.7	211.9	159.4	371.0	57.5	195.0	172.8	77.8	94.0	620.4	142.4	98.6	487.6	222.3	213.8	63.5	2281.7	1027.3	2650.0	1458.4	733.2	1265.2	568.2	396.9	469.5	943.3	863.5	1329.2	703.9	1494.1	1105.1	1408.1	1877.8	805.3	2160.6	1968.0	160.3	892.5	1321.1	461.4	207.3	1306.7	345.8	2550.0	1223.9	943.6	455.9	416.0	443.6	967.1	1493.3	2058.1	1270.4	294.1	1844.8	1398.2	2719.0	249.3	377.3	604.1	948.6	102.6	708.5	911.6	1564.5	1071.4	940.8	1516.7	969.0	911.2	354.7	1625.5	1148.3	422.4	880.6	2712.0	1526.0	614.5	917.7	835.3	1735.4	2101.3	538.8	2494.6	3548.7	119.8	115.6	122.8	187.3	182.5	218.8	166.1	152.3	188.8	111.7	113.0	143.2	163.3	46.8	165.1	222.4	227.7	180.8	342.5	74.6	81.8	46.2	367.7	73.5	119.7	80.5	74.8	99.2	57.5	94.0	63.5	215.8	131.4	47.3	21.5	214.9	576.2	358.4	698.6	434.2	72.7	234.2	312.8	114.9	244.5	238.7	171.0	39.6	811.9	198.7	133.4	311.0	1091.0	9.1	69.1	261.6	370.8	163.6	1322.1	28.2	1061.1	2296.1	471.5	95.3	140.2	207.3	643.6	298.4	267.8	955.2	109.4	25.0	185.3	376.4	454.5	689.6	24.4	402.6	295.8	321.9	30.9	774.0	192.6	246.1	20.1	23.0	1087.0	90.7	237.3	304.6	199.5	117.9	245.9	66.6	65.4	118.3	124.0	838.6	58.0	126.5	447.0	430.6	220.4	244.0	224.9	253.2	229.0
TUBB1	dJ543J19.4	ENSG00000101162	"Tubulin beta 1 class VI"	Q9H4B7	20	59019429-59026654	"Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 8.5;lymphoid tissue: 4.3"	"Cell type enriched"	"Detected in some"	10	"Macrophages: 191.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	17	"basophil: 63.5;neutrophil: 26.0"	"Lineage enriched"	"Detected in many"	24	"granulocytes: 63.5"	"Cell line enriched"	"Detected in some"	19	"HEL: 29.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB004286, HPA043640, HPA046280"	Approved		Supported	"Microtubules,Cytokinetic bridge,Mitotic spindle"		Yes	NA		87000000	"Cluster 34: Basophils - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 36: HEL - Hemostasis"	"Cluster 51: Myeloid cells - Hemostasis"	Microtubules	"Cytokinetic bridge, Mitotic spindle"	"CAB004286: AB_2288090, HPA043640: AB_2678594, HPA046280: AB_2679612"	"unprognostic (3.76e-1)"	"unprognostic (2.69e-1)"	"unprognostic (6.10e-4)"	"unprognostic (1.02e-1)"	"unprognostic (5.00e-2)"	"unprognostic (2.02e-1)"	"unprognostic (5.86e-2)"	"unprognostic (7.51e-4)"	"unprognostic (1.90e-2)"	"unprognostic (2.63e-1)"	"unprognostic (6.80e-5)"	"unprognostic (3.46e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.55e-1)"	"unprognostic (1.40e-1)"	"unprognostic (2.31e-1)"	"unprognostic (1.00e-1)"	0.2	0.2	0.2	0.3	0.2	8.5	0.1	0.5	0.5	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.3	0.1	0.1	0.2	0.1	0.3	2.4	0.2	0.3	0.2	0.1	0.1	0.0	0.3	1.1	0.2	0.0	0.0	0.2	0.1	0.0	0.4	0.1	0.2	0.0	0.1	4.3	0.1	0.9	0.2	0.0	0.2	1.5	0.0	0.0	0.0	0.3	0.1	0.3	0.1	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.7	0.2	0.4	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.2	29.5	0.8	1.5	0.0	0.2	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.3	1.4	0.0	0.0	0.1	0.3	0.3	0.0	0.1	0.4	0.2	0.1	0.3	0.0	0.3	0.3	0.2	0.2	0.6	0.1	0.1	0.1	0.2	0.0	0.2	0.2	0.3	0.1	0.2	0.3	0.2	0.1	0.2	0.4	63.5	2.4	1.9	0.5	0.6	0.4	0.9	0.2	0.0	1.1	0.5	0.4	0.0	26.0	0.2	0.3	2.6	0.5	281.6	0.2	0.2	0.5	0.5	0.1	0.2	0.3	0.2	0.2	0.1	0.2	0.3	0.1	0.0	1.1	0.3	1.4	0.0	0.0	0.0	0.0	1.7	0.1	0.1	0.1	0.0	0.6	0.0	4.2	0.0	3.1	0.0	0.0	0.0	16.0	0.3	0.2	1.5	0.0	19.0	0.2	0.0	0.1	0.1	0.0	0.7	1.3	0.0	3.6	0.2	0.3	0.0	0.2	0.0	0.0	2.8	0.0	5.9	0.3	191.2	0.0	0.0	13.8	0.2	13.4	0.0	0.1	0.0	0.0	0.4	0.4	0.0	0.0	0.1	0.0	1.9	0.0	0.2	0.1	0.1	0.1	0.0	0.0	0.1	1.0	0.1	0.1	0.1
TUBB2B	"bA506K6.1, DKFZp566F223, MGC8685"	ENSG00000137285	"Tubulin beta 2B class IIb"	Q9BVA1	6	3223324-3231730	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	Neurogenesis		"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 387.9;choroid plexus: 154.0"	"Group enriched"	"Detected in many"	4	"Distal tubular cells: 414.8;Horizontal cells: 430.7;Muller glia cells: 847.3;Skeletal myocytes: 350.1"	"Cancer enriched"	"Detected in many"	9	"glioma: 216.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 541.9;CACO-2: 415.3;NTERA-2: 268.0;RPMI-8226: 277.7;SCLC-21H: 797.7;SH-SY5Y: 390.2;SuSa: 245.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043640, HPA046280"	Supported		Supported	"Microtubules,Cytokinetic bridge,Mitotic spindle"		Yes	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 70: Brain - Nervous system development"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 5: Muller glia cells - Visual perception"	Microtubules	"Cytokinetic bridge, Mitotic spindle"	"HPA043640: AB_2678594, HPA046280: AB_2679612"	"unprognostic (2.66e-2)"	"unprognostic (3.41e-1)"	"unprognostic (5.92e-3)"	"prognostic unfavorable (1.94e-4)"	"unprognostic (6.81e-2)"	"unprognostic (3.26e-2)"	"unprognostic (9.03e-3)"	"unprognostic (8.33e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.02e-1)"	"unprognostic (3.78e-3)"	"unprognostic (3.34e-2)"	"unprognostic (2.03e-2)"	"unprognostic (6.24e-3)"	"unprognostic (6.04e-2)"	"unprognostic (3.58e-4)"	"unprognostic (2.30e-3)"	4.0	7.2	298.1	8.1	324.5	1.0	5.0	348.4	387.9	9.9	154.0	17.0	2.4	4.2	45.5	2.4	3.3	3.8	4.6	258.8	356.9	11.6	1.0	1.4	8.1	363.3	349.9	1.1	5.7	0.0	35.1	4.4	354.5	3.7	2.6	65.3	10.8	4.6	6.2	3.9	6.1	7.3	337.2	0.7	4.5	1.0	369.1	2.3	0.9	1.6	5.7	2.6	5.6	383.9	0.0	8.2	541.9	164.2	0.6	0.2	0.9	5.1	7.4	20.8	45.0	415.3	2.0	0.9	5.6	5.7	0.0	1.3	212.8	0.7	12.0	1.6	98.3	0.2	0.0	33.2	1.1	0.1	6.1	3.1	0.0	2.3	0.0	7.6	1.4	0.5	6.8	1.2	7.6	0.3	1.5	0.4	268.0	1.0	17.6	0.6	26.3	277.7	2.9	0.8	797.7	390.2	0.3	1.7	4.3	245.9	3.2	0.0	0.0	1.9	89.9	6.3	2.2	51.6	0.1	0.0	0.8	0.1	30.5	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	298.1	324.5	348.4	387.9	258.8	356.9	363.3	349.9	354.5	337.2	369.1	383.9	3.6	0.0	0.0	109.4	1.9	8.7	2.3	1.8	4.6	63.5	3.9	31.9	40.1	5.7	0.3	7.3	16.7	0.7	1.0	0.9	414.8	15.4	5.8	2.7	3.3	7.6	66.7	0.0	2.4	3.5	1.2	18.7	7.1	3.9	0.0	0.5	0.7	0.6	3.0	430.7	19.4	1.0	24.4	0.0	12.4	7.1	0.3	1.0	92.5	9.4	3.6	847.3	0.0	37.2	21.6	12.0	0.1	0.0	8.4	3.9	0.2	2.0	0.0	43.1	0.0	350.1	19.1	1.3	6.2	3.1	2.7	0.8	0.6	0.0	0.6	1.1
TUBB4A	"beta-5, DYT4, TUBB4"	ENSG00000104833	"Tubulin beta 4A class IVa"	P04350	19	6494319-6502848	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			"Disease variant, Dystonia, Leukodystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"brain: 828.2"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 22.2;Muller glia cells: 33.0;Oligodendrocytes: 94.1;Theca cells: 81.7"	"Group enriched"	"Detected in many"	9	"glioma: 50.1;melanoma: 83.2;testis cancer: 49.4"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	13	"B-cells: 3.8;T-cells: 5.4"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 100.7;HAP1: 58.3;HEL: 91.7;PC-3: 49.6;REH: 43.4;SH-SY5Y: 36.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010768, HPA043640, HPA046280"	Approved		Supported	"Microtubules,Cytokinetic bridge,Mitotic spindle"		Yes	NA		110000000	"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 70: Brain - Nervous system development"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Microtubules	"Cytokinetic bridge, Mitotic spindle"	"CAB010768: AB_261775, HPA043640: AB_2678594, HPA046280: AB_2679612"	"unprognostic (4.05e-1)"	"unprognostic (1.97e-1)"	"unprognostic (2.72e-1)"	"prognostic unfavorable (8.42e-7)"	"unprognostic (3.07e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.11e-1)"	"unprognostic (8.08e-2)"	"unprognostic (6.69e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.11e-1)"	"unprognostic (3.46e-2)"	"unprognostic (1.12e-3)"	"unprognostic (1.36e-2)"	"unprognostic (1.58e-1)"	"unprognostic (2.06e-1)"	"unprognostic (2.30e-1)"	0.9	203.4	209.7	1.7	404.6	0.2	0.6	452.3	388.7	0.6	0.0	6.3	1.1	0.6	0.3	0.7	0.9	0.6	2.5	249.2	229.1	2.2	1.2	0.6	1.1	425.9	254.4	1.5	3.0	0.6	4.0	0.7	440.0	0.8	0.8	22.6	1.2	0.4	4.4	5.2	3.0	0.8	221.4	9.5	2.1	76.0	373.5	0.3	0.6	1.0	0.7	0.6	1.8	828.2	0.2	28.3	0.1	100.7	0.2	0.0	0.2	0.7	0.0	0.1	0.0	1.4	0.4	0.1	30.3	0.0	3.5	0.7	58.3	0.0	0.6	0.0	10.7	91.7	1.9	0.9	0.0	0.0	5.5	0.0	0.0	2.3	0.0	1.0	0.0	17.1	8.6	0.8	0.0	3.0	18.1	4.1	7.5	0.0	49.6	43.4	0.1	20.3	10.9	0.1	0.2	36.6	0.3	0.2	30.9	2.7	0.8	1.9	0.0	0.2	12.2	0.1	0.4	2.4	1.7	11.7	1.1	0.1	0.5	0.0	0.0	0.0	5.4	0.0	3.3	3.8	0.7	5.0	0.0	1.1	1.6	3.8	0.1	0.3	0.0	0.0	0.0	1.4	209.7	404.6	452.3	388.7	249.2	229.1	425.9	254.4	440.0	221.4	373.5	828.2	0.1	0.0	0.0	6.8	3.2	1.9	0.7	0.3	0.0	2.8	0.1	0.1	9.8	1.5	0.0	0.0	0.0	0.2	1.6	0.1	5.9	1.6	2.9	0.1	0.2	1.2	0.0	2.1	22.2	0.0	0.2	1.8	0.0	0.1	0.0	16.3	1.4	0.3	0.4	10.1	15.0	0.0	0.0	0.0	1.2	9.4	5.3	0.3	14.2	13.1	0.0	33.0	1.0	8.5	94.1	0.1	0.0	0.4	0.9	0.2	0.0	1.8	0.5	2.3	6.6	0.4	4.6	1.9	1.1	0.0	1.6	0.1	3.8	81.7	0.0	0.2
TUBB4B	"Beta2, TUBB2C"	ENSG00000188229	"Tubulin beta 4B class IVb"	P68371	9	137241287-137243707	"Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			"Deafness, Disease variant, FDA approved drug targets, Leber congenital amaurosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 2190.0;Late spermatids: 2907.1;Spermatocytes: 1717.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010880, HPA043640, HPA046280"	Enhanced		Supported	"Microtubules,Cytokinetic bridge,Mitotic spindle"		Yes	Yes			"Cluster 38: Basophils - Unknown function"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 7: Non-specific - Mitochondria"	Microtubules	"Cytokinetic bridge, Mitotic spindle"	"CAB010880: AB_609915, HPA043640: AB_2678594, HPA046280: AB_2679612"	"unprognostic (2.24e-1)"	"unprognostic (1.77e-3)"	"unprognostic (1.50e-1)"	"prognostic favorable (4.91e-4)"	"unprognostic (1.29e-2)"	"unprognostic (8.93e-2)"	"prognostic unfavorable (9.98e-4)"	"unprognostic (9.92e-3)"	"unprognostic (2.90e-1)"	"unprognostic (3.63e-1)"	"unprognostic (2.34e-1)"	"unprognostic (4.09e-2)"	"unprognostic (2.47e-3)"	"unprognostic (6.37e-2)"	"unprognostic (1.36e-2)"	"prognostic favorable (6.36e-6)"	"unprognostic (1.69e-1)"	134.5	112.6	162.0	97.2	163.4	423.9	94.4	149.4	182.7	88.1	482.7	198.3	142.0	107.7	209.1	343.3	507.2	106.0	435.8	174.0	185.2	122.5	140.1	130.5	95.5	184.1	233.6	72.9	123.8	87.8	118.0	86.3	213.9	120.2	111.9	261.8	177.9	121.5	202.5	240.0	166.4	119.8	162.9	85.6	161.4	765.7	192.6	162.9	115.7	96.6	119.7	188.3	139.4	133.9	706.2	1032.5	431.7	314.2	213.2	223.6	600.5	643.7	536.0	872.4	598.6	1101.0	840.2	429.0	480.2	631.2	848.2	1305.1	539.5	1039.2	330.2	307.9	458.5	311.2	789.6	877.8	134.5	370.0	331.5	145.0	291.5	667.5	183.1	215.7	631.7	300.6	443.0	239.7	731.2	1936.4	337.4	504.2	457.8	1234.8	1778.1	423.5	822.2	394.2	666.8	647.8	301.5	323.6	853.9	485.8	173.2	244.2	699.0	397.6	495.6	618.1	685.0	710.0	863.6	92.4	274.9	475.1	503.6	286.9	549.8	95.7	30.0	43.2	40.5	30.1	38.2	32.6	31.3	34.4	34.9	30.8	19.7	26.7	56.4	24.4	30.5	36.3	44.7	32.6	162.0	163.4	149.4	182.7	174.0	185.2	184.1	233.6	213.9	162.9	192.6	133.9	478.5	221.2	146.3	21.5	315.8	326.2	945.7	458.7	327.2	508.1	286.9	389.5	91.9	143.0	284.1	143.5	300.3	346.6	640.9	744.1	221.1	348.6	2190.0	1191.6	224.8	203.9	391.5	419.9	30.1	446.8	545.5	247.8	274.7	415.0	189.2	200.9	142.5	139.2	265.9	244.0	24.3	503.6	323.5	59.9	214.9	2907.1	254.2	299.3	138.7	22.5	224.0	299.3	49.4	15.6	19.7	477.4	697.2	153.1	264.0	475.1	540.7	345.5	1558.7	763.3	111.7	261.8	416.0	1717.5	740.9	419.1	297.6	321.1	362.9	89.8	487.3	592.7
TUBB8	bA631M21.2	ENSG00000261456	"Tubulin beta 8 class VIII"	Q3ZCM7	10	46888-74163	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in single"		"testis: 2.4"	"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 3.4;Early spermatids: 11.7;Late spermatids: 3.4;Spermatocytes: 13.0;Spermatogonia: 15.9"	"Cancer enriched"	"Detected in single"	5	"testis cancer: 1.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"MCF7: 1.3"									"HPA043640, HPA046280"	Uncertain		Supported	"Microtubules,Cytokinetic bridge,Mitotic spindle"		Yes	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 43: Testis - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	Microtubules	"Cytokinetic bridge, Mitotic spindle"	"HPA043640: AB_2678594, HPA046280: AB_2679612"	"unprognostic (4.75e-2)"	"unprognostic (6.02e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.82e-1)"	"unprognostic (2.78e-1)"	"unprognostic (1.80e-1)"	"unprognostic (7.74e-2)"	"unprognostic (8.33e-3)"	"unprognostic (1.50e-1)"	"unprognostic (4.15e-3)"	"unprognostic (7.17e-2)"	"unprognostic (3.30e-2)"	"unprognostic (1.33e-3)"	"unprognostic (4.53e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.19e-2)"	"unprognostic (6.86e-3)"	0.1	0.1	0.4	0.1	0.4	0.0	0.2	0.3	0.6	0.2	0.2	0.1	0.0	0.1	0.0	0.0	0.3	0.0	0.1	0.3	0.3	0.7	0.0	0.1	0.1	0.3	0.3	0.4	0.3	0.3	0.2	0.1	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.3	0.1	2.4	0.3	0.0	0.7	0.0	0.0	0.1	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.4	0.3	0.6	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.0	0.0	0.3	0.1	0.0	0.7	0.0	0.0	0.0	0.2	0.1	3.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	11.7	0.4	0.1	0.1	0.0	0.0	0.7	0.0	0.2	0.2	0.0	0.5	0.0	0.1	0.0	0.0	0.1	0.0	0.9	0.0	0.0	0.0	0.0	3.4	0.0	0.1	0.0	1.9	0.0	0.0	0.0	0.5	0.0	0.2	0.0	0.7	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.5	13.0	15.9	0.0	0.0	0.0	0.0	0.4	0.0	0.6
TUBG2		ENSG00000037042	"Tubulin gamma 2"	Q9NRH3	17	42659284-42667006	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 44.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							CAB011495	Approved		Supported	"Centriolar satellite"		NA	NA			"Cluster 29: Plasmacytoid DCs - Unknown function"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Centriolar satellite"		"CAB011495: AB_443396"	"unprognostic (2.60e-1)"	"unprognostic (5.85e-3)"	"unprognostic (6.21e-3)"	"unprognostic (5.79e-2)"	"unprognostic (1.33e-3)"	"unprognostic (5.11e-2)"	"prognostic unfavorable (4.68e-5)"	"unprognostic (3.53e-2)"	"unprognostic (2.20e-2)"	"unprognostic (7.88e-3)"	"unprognostic (1.82e-3)"	"unprognostic (1.46e-1)"	"prognostic unfavorable (3.49e-4)"	"unprognostic (2.31e-2)"	"unprognostic (3.59e-2)"	"unprognostic (3.73e-1)"	"unprognostic (7.61e-3)"	20.7	38.8	87.1	6.4	94.1	3.0	21.3	78.1	109.1	38.5	67.3	34.2	6.1	28.2	14.6	13.8	28.6	10.9	24.3	87.8	81.6	35.1	18.1	18.6	7.8	90.0	84.4	28.2	76.0	18.2	43.8	9.6	88.1	33.7	5.4	13.9	17.0	22.9	8.8	13.5	14.4	14.3	76.4	17.0	30.5	19.1	94.3	5.8	23.7	9.0	5.5	33.1	31.4	99.3	10.2	20.2	9.9	14.6	38.4	20.8	6.4	17.7	19.8	13.8	13.7	11.4	7.0	5.0	10.6	25.6	14.8	36.8	0.0	16.1	11.3	9.9	11.5	3.8	29.0	23.3	16.6	0.0	13.0	22.7	16.1	15.7	17.5	24.0	10.1	11.4	1.1	10.8	27.3	20.9	9.8	8.2	3.5	10.1	5.1	7.5	6.2	11.3	15.0	10.4	11.2	7.6	11.3	18.0	12.1	17.7	34.7	4.8	11.7	43.9	3.1	11.0	10.3	56.5	10.8	1.5	15.6	0.0	26.3	0.0	0.9	0.2	3.0	0.5	1.4	1.2	3.3	1.1	0.9	0.5	3.5	2.3	0.2	1.0	0.1	4.5	1.6	1.8	87.1	94.1	78.1	109.1	87.8	81.6	90.0	84.4	88.1	76.4	94.3	99.3	6.9	3.2	4.2	22.9	3.6	5.5	15.9	7.8	36.5	17.6	9.6	13.7	11.3	4.3	5.6	3.7	4.2	5.5	3.0	0.5	17.6	5.1	7.7	1.8	7.9	7.3	1.2	24.4	44.9	9.1	4.2	13.4	14.3	1.9	11.4	6.7	9.3	3.7	3.6	20.2	33.1	1.7	2.0	2.5	3.7	11.1	17.4	2.8	16.0	10.3	3.1	7.8	1.0	19.6	25.8	5.1	0.4	21.4	9.7	5.2	0.1	24.3	7.1	5.4	13.1	10.3	11.4	5.1	5.0	9.4	4.0	2.5	3.9	7.9	0.5	7.3
TUBGCP2	"GCP2, SPBC97, Spc97p"	ENSG00000130640	"Tubulin gamma complex associated protein 2"	Q9BSJ2	10	133278635-133312337	"Disease related genes, Plasma proteins, Predicted intracellular proteins"			"Disease variant, Epilepsy, Lissencephaly, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037885	Approved		Supported	Nucleoplasm,Centrosome		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 59: Non-specific - Translation"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 49: Ciliated cells - Cilium organization"	"Nucleoplasm, Centrosome"		"HPA037885: AB_10672397"	"unprognostic (3.57e-2)"	"unprognostic (5.53e-2)"	"unprognostic (6.17e-2)"	"unprognostic (1.64e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.96e-1)"	"unprognostic (7.72e-2)"	"unprognostic (3.35e-1)"	"unprognostic (3.09e-2)"	"unprognostic (1.64e-1)"	"unprognostic (5.71e-2)"	"unprognostic (1.95e-2)"	"unprognostic (3.52e-1)"	"unprognostic (4.24e-2)"	"unprognostic (5.21e-2)"	"unprognostic (1.41e-1)"	"unprognostic (4.89e-2)"	20.0	22.2	14.4	20.9	15.4	35.0	13.4	13.5	19.3	15.7	18.2	18.2	22.1	16.0	10.5	17.3	30.3	14.9	20.4	14.8	14.1	19.3	16.4	17.3	20.9	17.1	15.2	26.8	28.3	26.0	3.5	15.8	17.5	17.8	13.3	11.8	28.2	17.1	33.2	22.5	22.1	14.9	13.0	21.9	20.4	21.7	15.0	20.7	19.0	24.4	14.4	15.9	5.8	14.5	64.2	84.2	30.7	35.6	28.3	29.8	42.9	47.5	66.5	50.0	49.5	97.0	45.9	42.1	27.7	48.6	21.6	47.2	35.8	32.3	22.8	50.5	75.7	24.6	46.7	52.3	35.5	63.4	57.0	31.3	29.9	46.5	58.0	55.3	33.3	29.9	36.4	45.6	41.2	79.9	41.4	56.3	30.4	37.2	64.6	32.7	32.9	19.5	32.7	40.8	20.6	43.0	33.0	40.1	36.1	17.9	23.6	38.3	45.6	30.9	27.6	38.0	47.9	43.7	25.9	53.8	102.3	27.3	19.8	6.4	22.5	15.9	15.3	23.2	14.8	11.4	13.3	14.6	27.6	12.3	14.0	15.4	13.8	27.7	25.8	11.7	18.3	19.0	14.4	15.4	13.5	19.3	14.8	14.1	17.1	15.2	17.5	13.0	15.0	14.5	29.1	48.1	38.5	18.9	36.7	13.9	27.4	30.2	23.3	45.7	25.9	25.3	33.9	22.8	38.8	40.5	31.3	41.4	40.1	34.8	23.5	34.5	25.9	78.0	41.6	26.4	29.3	28.0	17.5	37.1	32.9	35.9	38.7	37.1	39.9	49.5	28.9	27.5	44.4	38.7	15.9	36.2	8.2	42.7	25.5	28.6	33.8	51.6	14.2	15.9	75.0	39.3	62.8	9.5	20.1	37.3	33.5	35.3	37.2	28.6	37.3	53.4	112.2	74.8	32.9	39.9	32.1	74.3	65.3	29.0	13.8	42.5	35.7	50.4	36.0	30.3
TUBGCP4	"76P, FLJ14797"	ENSG00000137822	"Tubulin gamma complex associated protein 4"	Q9UGJ1	15	43369221-43409771	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Mental retardation, Primary microcephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Horizontal cells: 55.5;Rod photoreceptor cells: 57.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"eosinophil: 13.8"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043212	Approved		Supported	Centrosome		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 54: Non-specific - Microtubule organization"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 62: Horizontal cells - Visual perception"	Centrosome		"HPA043212: AB_10796690"	"unprognostic (1.34e-2)"	"unprognostic (3.57e-2)"	"unprognostic (4.27e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.90e-2)"	"unprognostic (3.37e-1)"	"unprognostic (1.18e-1)"	"unprognostic (3.86e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.05e-1)"	"unprognostic (2.09e-2)"	"unprognostic (2.91e-2)"	"unprognostic (5.65e-1)"	"unprognostic (1.73e-1)"	"unprognostic (7.49e-2)"	"unprognostic (1.72e-1)"	"unprognostic (2.28e-1)"	3.9	4.3	5.1	3.7	6.9	4.8	5.1	8.4	8.4	5.3	6.4	5.0	4.8	4.5	3.5	5.8	4.5	2.9	4.9	5.6	5.6	4.7	5.9	3.9	4.6	5.6	5.7	5.2	6.1	8.3	5.2	3.7	5.9	5.1	5.2	11.1	5.1	3.7	9.7	4.6	5.2	4.9	5.4	4.4	4.9	4.1	5.7	6.1	4.5	9.8	5.5	4.6	5.1	6.4	18.2	5.6	13.3	13.7	12.9	13.9	10.3	10.2	7.3	13.9	14.0	18.0	11.1	11.3	15.2	8.8	19.5	29.4	28.3	18.2	16.3	19.0	26.9	29.5	30.2	15.9	10.7	20.4	17.6	7.6	17.9	14.4	20.0	11.0	11.5	18.5	28.4	9.6	10.4	6.3	16.4	15.7	6.3	29.6	22.1	22.0	17.5	15.9	9.2	17.1	35.5	12.1	12.4	23.8	4.1	8.4	14.1	15.8	9.5	13.2	13.5	18.3	22.7	9.9	12.5	19.6	12.1	29.0	15.1	0.1	2.5	13.8	3.7	2.9	2.7	3.6	2.8	2.6	5.3	3.2	2.0	2.9	0.3	5.3	1.6	2.8	3.2	2.4	5.1	6.9	8.4	8.4	5.6	5.6	5.6	5.7	5.9	5.4	5.7	6.4	6.5	19.2	14.5	12.1	14.9	11.0	16.3	4.5	5.2	30.9	8.8	7.4	1.7	18.6	10.8	16.5	22.9	16.1	6.5	8.5	7.9	12.2	28.7	9.4	15.3	8.8	14.4	15.4	17.3	9.9	14.7	10.4	5.6	10.4	11.4	15.9	10.0	11.4	6.9	55.5	13.8	10.6	8.2	7.6	5.6	43.6	15.2	6.1	3.6	4.7	7.7	13.1	22.6	17.1	9.2	11.0	9.4	12.4	5.8	20.1	12.7	6.1	9.5	57.1	6.6	19.1	10.2	25.0	14.5	9.2	8.9	11.5	9.8	11.2	17.7	16.9
TUBGCP5	"GCP5, KIAA1899"	ENSG00000275835	"Tubulin gamma complex associated protein 5"	Q96RT8	15	22983192-23039572	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039366, HPA040366"	Supported		Supported	Centrosome,Cytosol		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	"Centrosome, Cytosol"		"HPA039366: AB_10673243, HPA040366: AB_2676942"	"unprognostic (1.17e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.30e-1)"	"unprognostic (4.27e-3)"	"unprognostic (2.94e-1)"	"unprognostic (2.79e-1)"	"unprognostic (9.45e-2)"	"unprognostic (4.97e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.27e-1)"	"unprognostic (1.42e-2)"	"unprognostic (1.18e-2)"	"unprognostic (6.40e-2)"	"unprognostic (1.13e-2)"	"unprognostic (9.53e-3)"	8.4	9.1	3.5	6.5	4.2	9.0	9.7	3.8	6.6	9.7	1.8	7.3	6.3	9.7	5.7	8.0	6.7	6.0	9.1	3.3	4.7	8.2	9.3	7.0	8.4	4.8	4.1	7.4	10.6	8.4	8.0	6.9	5.1	9.6	7.3	9.8	6.7	7.7	10.7	10.0	6.3	8.7	3.3	7.2	7.8	13.4	4.3	8.9	11.2	10.2	8.7	7.6	7.6	6.5	20.3	20.8	23.9	14.4	18.3	11.9	13.8	24.3	26.6	26.2	22.7	16.1	9.3	16.0	10.3	22.3	13.8	19.8	16.0	18.8	21.8	23.6	6.6	26.9	21.2	8.8	6.4	27.7	11.6	19.4	7.2	17.5	16.2	8.6	16.1	26.4	19.8	23.6	16.9	13.1	18.8	12.1	14.2	19.8	18.8	22.9	26.1	3.2	15.3	30.6	8.3	14.0	19.7	14.2	12.7	11.8	22.2	13.4	13.9	18.4	11.7	14.0	36.6	18.3	19.8	40.0	23.8	18.3	17.3	0.2	1.4	0.6	2.6	2.1	2.7	2.2	4.0	4.4	2.3	4.2	3.5	4.7	1.5	3.9	2.1	2.5	3.7	1.7	3.5	4.2	3.8	6.6	3.3	4.7	4.8	4.1	5.1	3.3	4.3	6.5	7.4	16.0	17.7	16.0	11.0	3.3	3.2	4.2	9.1	27.6	5.2	5.0	13.2	7.2	6.3	5.5	14.6	8.3	11.6	3.0	5.9	6.5	7.8	12.5	13.4	6.4	4.2	3.8	21.4	4.6	7.2	10.4	6.1	6.2	6.3	31.4	5.7	10.2	7.9	10.1	29.7	4.7	4.1	5.2	2.9	13.4	11.1	6.2	3.6	12.2	5.1	11.6	7.2	15.6	26.2	6.6	5.0	12.8	7.9	2.3	2.9	7.1	9.0	18.9	0.0	13.6	10.6	35.0	36.7	8.6	2.7	3.4	9.6	14.1	4.6	2.0
TULP3	TUBL3	ENSG00000078246	"TUB like protein 3"	O75386	12	2877223-2941138	"Predicted intracellular proteins"		"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 70.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015285, HPA018496"	Uncertain		Supported	"Nucleoplasm,Nucleoli,Plasma membrane"	"Intracellular and membrane"	NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 50: Fibroblasts - ECM organization"	"Nucleoplasm, Nucleoli"	"Plasma membrane"	"HPA015285: AB_1858460, HPA018496: AB_2669889"	"unprognostic (5.33e-2)"	"unprognostic (1.57e-1)"	"unprognostic (4.80e-2)"	"prognostic favorable (2.99e-4)"	"unprognostic (2.45e-1)"	"unprognostic (1.78e-2)"	"prognostic unfavorable (7.97e-5)"	"unprognostic (2.44e-1)"	"unprognostic (4.09e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.50e-1)"	"unprognostic (3.37e-1)"	"prognostic unfavorable (7.18e-4)"	"unprognostic (7.52e-2)"	"unprognostic (1.94e-1)"	"unprognostic (2.36e-2)"	"unprognostic (3.19e-2)"	21.0	17.1	13.6	7.5	14.2	2.6	18.3	19.2	16.1	33.3	15.8	21.6	5.4	23.2	11.7	17.8	24.3	12.1	17.7	13.8	13.2	17.3	9.0	13.5	6.1	16.3	14.8	37.7	9.6	13.3	12.3	13.7	13.8	15.4	8.2	12.7	13.0	13.9	10.4	25.7	10.5	18.2	14.5	9.4	15.5	13.0	14.4	9.4	15.5	9.7	8.1	16.7	24.1	17.1	22.6	18.8	35.0	29.1	34.3	51.0	32.9	34.5	57.5	36.4	40.2	24.0	20.4	16.7	5.1	51.2	31.2	18.5	21.1	22.2	42.0	21.7	15.4	10.0	23.4	15.5	44.3	10.8	11.1	30.1	25.7	55.3	74.9	44.6	28.6	20.8	9.7	15.1	31.0	20.3	16.1	9.4	47.4	17.8	13.7	16.8	34.2	6.3	22.9	18.7	8.8	23.4	30.1	17.8	19.9	63.4	22.2	10.5	23.0	26.6	32.0	54.7	33.9	4.7	6.0	14.3	26.9	5.9	41.5	0.0	0.9	0.3	2.1	0.8	3.5	1.6	1.7	2.2	0.7	1.8	2.0	2.8	0.4	2.7	0.5	1.6	3.3	1.0	13.6	14.2	19.2	16.1	13.8	13.2	16.3	14.8	13.8	14.5	14.4	17.1	12.9	6.4	10.5	70.5	6.2	20.3	16.9	14.8	26.2	6.1	9.9	12.2	8.0	18.6	15.9	1.8	2.1	9.4	6.0	4.6	23.5	17.3	5.8	35.1	33.5	15.2	3.6	6.1	6.0	7.3	10.6	31.7	6.6	14.6	0.0	11.5	24.3	5.5	5.3	40.4	10.8	4.0	14.2	2.5	8.6	3.6	40.7	5.4	19.6	14.0	6.7	50.7	12.3	10.1	34.9	11.1	2.4	24.8	8.3	23.3	3.2	21.9	47.4	10.0	39.5	22.3	26.3	38.0	50.8	22.2	20.2	11.6	6.5	13.3	6.4	13.2
TUT1	"FLJ21850, FLJ22267, FLJ22347, PAPD2, RBM21, TENT1, TUTase"	ENSG00000149016	"Terminal uridylyl transferase 1, U6 snRNA-specific"	Q9H6E5	11	62575045-62591637	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"mRNA processing"	"Nucleotidyltransferase, RNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 32.5;Early spermatids: 34.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA069055, HPA071838"			Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Nucleoplasm	Cytosol	"HPA069055: AB_2686075, HPA071838: AB_2686456"	"unprognostic (3.81e-2)"	"unprognostic (3.54e-2)"	"prognostic unfavorable (9.51e-4)"	"unprognostic (2.43e-1)"	"unprognostic (1.01e-1)"	"unprognostic (7.59e-2)"	"unprognostic (1.83e-1)"	"unprognostic (2.59e-2)"	"unprognostic (1.83e-1)"	"unprognostic (5.79e-3)"	"unprognostic (1.59e-2)"	"unprognostic (2.71e-1)"	"unprognostic (7.20e-3)"	"unprognostic (1.03e-2)"	"unprognostic (4.41e-1)"	"unprognostic (1.35e-1)"	"unprognostic (3.97e-3)"	10.5	10.7	9.1	7.4	10.1	6.0	11.8	9.1	9.9	10.4	8.1	8.9	8.8	9.9	5.8	9.3	11.2	6.1	9.5	8.8	8.6	10.7	22.2	8.3	11.8	10.5	9.3	11.2	19.4	7.6	10.6	6.2	10.1	12.7	4.0	5.4	11.7	7.3	20.4	12.8	10.2	4.6	9.4	12.7	12.6	13.6	9.8	10.2	12.3	7.6	7.9	10.4	9.2	12.0	12.5	16.0	10.7	15.4	12.6	7.3	14.0	12.7	8.3	11.2	9.7	14.0	24.9	19.5	30.1	6.6	14.3	23.7	19.8	15.9	5.7	15.1	10.5	20.3	15.8	14.1	14.3	14.8	9.3	10.3	16.6	13.7	21.1	10.5	10.8	26.2	32.1	20.7	9.6	28.8	21.1	33.3	12.4	8.4	19.1	23.7	16.6	50.9	10.6	6.9	18.2	24.6	10.4	19.6	17.5	8.9	27.2	14.2	10.1	12.9	11.3	15.2	10.1	36.1	32.9	24.6	14.8	11.5	10.7	6.0	5.9	7.0	9.9	7.2	13.7	9.2	9.5	8.1	7.9	11.6	14.3	11.7	3.5	11.0	5.6	9.3	9.2	7.7	9.1	10.1	9.1	9.9	8.8	8.6	10.5	9.3	10.1	9.4	9.8	12.0	32.5	0.0	6.7	7.5	7.5	2.7	5.2	7.2	4.0	8.4	5.9	5.2	4.2	18.6	7.1	11.0	6.2	12.8	6.0	4.4	5.9	8.5	34.3	5.7	3.1	15.0	7.2	3.2	3.9	7.4	7.8	5.1	7.7	4.1	2.5	5.5	18.2	17.8	5.9	1.7	4.6	9.1	6.1	5.0	2.2	16.4	7.2	4.3	10.6	1.0	4.0	9.8	14.4	4.0	5.4	5.6	3.6	3.4	4.9	7.1	8.4	7.1	13.1	8.4	0.0	4.1	4.1	10.0	16.3	3.1	2.3	14.0	5.6	5.6	7.0	3.1
TUT4	"KIAA0191, PAPD3, TENT3A, ZCCHC11"	ENSG00000134744	"Terminal uridylyl transferase 4"	Q5TAX3	1	52408282-52553487	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"RNA-mediated gene silencing"	"Nucleotidyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 52.2;Cytotrophoblasts: 53.6;dendritic cells: 64.9;Endometrial ciliated cells: 59.5;Endometrial stromal cells: 96.1;Granulosa cells: 70.7;Theca cells: 57.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027412, HPA027973"	Supported		Supported	Nucleoli,Cytosol		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 77: Retina - Visual perception"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 7: Non-specific - Mitochondria"	Cytosol	Nucleoli	"HPA027412: AB_1852281, HPA027973: AB_10603242"	"unprognostic (2.74e-2)"	"unprognostic (1.67e-2)"	"unprognostic (1.19e-2)"	"unprognostic (3.48e-2)"	"unprognostic (1.36e-2)"	"unprognostic (1.85e-3)"	"prognostic unfavorable (9.00e-4)"	"unprognostic (2.64e-1)"	"unprognostic (5.05e-2)"	"unprognostic (3.84e-1)"	"unprognostic (6.57e-3)"	"unprognostic (3.11e-2)"	"unprognostic (5.35e-3)"	"unprognostic (2.26e-1)"	"unprognostic (1.67e-1)"	"unprognostic (7.08e-2)"	"unprognostic (2.33e-1)"	22.5	34.4	28.4	18.3	28.6	26.6	21.4	44.7	36.2	34.1	28.6	26.3	8.7	27.4	23.7	19.3	30.8	15.4	27.1	26.8	35.3	22.9	31.3	22.1	34.2	28.5	29.4	46.3	31.2	29.5	41.5	21.2	28.5	26.1	11.2	84.9	20.7	16.5	60.0	35.1	30.9	15.9	26.4	35.0	22.3	46.9	33.4	32.5	31.4	30.0	29.4	23.1	26.5	33.5	24.4	22.7	55.3	37.3	21.1	27.1	36.4	20.0	31.0	30.3	34.9	23.6	12.5	50.6	23.0	30.0	49.1	19.7	41.6	22.6	38.7	39.7	36.5	53.7	30.0	49.7	35.0	59.4	29.1	31.9	49.4	32.6	40.0	38.6	21.4	35.7	44.7	25.6	25.7	0.3	60.1	42.7	39.8	12.5	27.5	51.3	55.3	39.3	33.4	20.0	28.7	26.8	31.8	14.1	32.9	62.3	19.4	31.5	18.1	23.2	30.6	21.1	26.2	52.7	74.0	71.8	15.5	32.0	17.0	83.7	9.7	34.8	26.1	4.0	19.3	49.0	27.3	21.6	5.1	50.2	33.1	22.0	37.6	25.3	3.7	61.9	23.3	5.1	28.4	28.6	44.7	36.2	26.8	35.3	28.5	29.4	28.5	26.4	33.4	33.5	52.2	0.0	0.0	0.0	36.0	0.0	0.0	0.0	0.0	0.0	36.1	41.4	0.0	0.0	0.0	47.8	0.0	53.6	64.9	0.0	15.6	28.5	0.0	59.5	96.1	14.3	0.0	0.0	0.0	17.0	19.1	18.8	0.0	46.7	0.0	70.7	0.0	0.0	16.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.8	0.0	0.0	9.8	0.0	0.0	0.0	0.0	19.6	0.0	0.0	30.2	0.0	0.0	22.0	0.0	0.0	0.0	0.0	23.8	0.0	0.0	0.0	0.0	36.9	28.2	57.3	0.0	0.0
TUT7	"FLJ13409, KIAA1711, PAPD6, TENT3B, ZCCHC6"	ENSG00000083223	"Terminal uridylyl transferase 7"	Q5VYS8	9	86287733-86354454	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Nucleotidyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Endometrial ciliated cells: 80.3;Endometrial stromal cells: 61.1;Glandular and luminal cells: 206.7;Syncytiotrophoblasts: 92.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 114.6"	"Group enriched"	"Detected in all"	5	"granulocytes: 114.6;monocytes: 47.8"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020615, HPA020620"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 85: Liver - Metabolism"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 44: Endometrium - Transcription"	Cytosol	Nucleoplasm	"HPA020615: AB_1858983, HPA020620: AB_1858984"	"unprognostic (1.10e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.26e-2)"	"unprognostic (3.66e-1)"	"unprognostic (1.39e-1)"	"unprognostic (4.11e-2)"	"unprognostic (2.49e-2)"	"unprognostic (4.43e-2)"	"unprognostic (6.51e-2)"	"unprognostic (1.91e-2)"	"unprognostic (3.07e-1)"	"unprognostic (5.79e-3)"	"unprognostic (1.59e-2)"	"unprognostic (1.13e-1)"	"unprognostic (4.14e-2)"	"unprognostic (1.40e-1)"	12.5	9.4	4.8	16.0	6.4	22.6	18.7	5.9	10.0	12.8	10.9	12.1	11.0	9.1	8.9	24.7	8.8	11.3	8.2	5.1	7.9	7.5	38.4	16.5	19.1	9.0	6.3	8.7	13.1	8.7	8.2	14.3	7.8	20.8	11.8	7.7	14.2	7.2	13.6	33.7	12.3	7.8	5.1	20.6	13.6	11.6	9.2	15.1	8.6	9.3	19.2	13.4	16.0	9.0	16.2	17.2	9.8	14.3	22.4	36.0	12.2	21.6	20.5	9.1	10.6	7.8	13.7	22.8	18.9	14.0	9.5	27.3	11.8	12.0	13.5	27.1	6.0	16.5	18.4	13.7	19.3	19.1	21.8	23.5	22.7	14.5	16.2	13.7	15.0	12.3	15.9	24.0	24.6	14.9	16.0	11.0	7.5	25.1	11.1	8.0	17.5	10.1	15.3	31.4	7.2	5.7	13.1	15.5	7.4	11.6	6.4	7.8	24.8	8.7	10.5	15.7	14.8	27.4	23.3	16.5	20.7	10.8	11.8	35.4	19.4	20.5	15.0	24.7	12.5	11.6	8.2	10.7	11.9	12.2	9.5	10.1	114.6	12.8	47.8	5.5	8.8	8.9	4.8	6.4	5.9	10.0	5.1	7.9	9.0	6.3	7.8	5.1	9.2	9.0	28.1	0.0	0.0	0.0	14.5	0.0	0.0	0.0	0.0	0.0	34.2	16.4	0.0	0.0	0.0	9.2	0.0	22.4	36.6	0.0	5.9	29.6	0.0	80.3	61.1	7.2	0.0	0.0	0.0	17.9	17.4	5.6	0.0	206.7	0.0	36.0	0.0	0.0	22.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	26.1	0.0	0.0	12.4	0.0	0.0	0.0	0.0	27.8	0.0	0.0	13.8	0.0	0.0	6.7	0.0	0.0	0.0	0.0	9.1	0.0	0.0	0.0	0.0	92.5	14.8	30.9	0.0	0.0
TVP23B	"CGI-148, FAM18B, FAM18B1, YDR084C"	ENSG00000171928	"Trans-golgi network vesicle protein 23 homolog B"	Q9NYZ1	17	18781111-18806714	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA019585, HPA065603"	Uncertain		Supported	"Golgi apparatus"		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 21: OE19 - Mitochondria"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Golgi apparatus"		"HPA019585: AB_1848385, HPA065603: AB_2685517"	"unprognostic (1.91e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.05e-1)"	"unprognostic (9.32e-3)"	"unprognostic (1.13e-2)"	"unprognostic (8.51e-2)"	"unprognostic (2.37e-1)"	"unprognostic (3.32e-2)"	"unprognostic (1.73e-1)"	"unprognostic (2.02e-2)"	"unprognostic (2.30e-1)"	"unprognostic (1.49e-1)"	"unprognostic (2.05e-1)"	"unprognostic (3.54e-1)"	"unprognostic (5.27e-1)"	"unprognostic (7.78e-2)"	"unprognostic (8.55e-2)"	26.4	43.2	11.1	20.0	11.7	19.9	30.3	12.8	15.1	38.2	23.3	25.8	29.9	26.5	40.4	52.3	34.5	30.4	22.8	10.6	13.5	31.0	44.0	20.8	25.4	12.3	13.0	30.1	33.6	47.8	32.7	29.6	13.0	33.5	31.2	32.1	34.3	24.4	17.3	19.3	23.8	21.7	13.1	17.4	40.5	34.9	12.4	20.4	46.9	16.2	31.4	32.7	34.2	13.3	55.0	63.8	23.6	26.2	68.8	60.9	56.1	93.5	75.0	42.8	54.6	37.6	38.7	17.9	33.9	60.3	42.6	74.1	19.2	40.2	63.2	44.3	39.7	17.0	47.1	46.3	48.0	13.0	35.6	31.6	95.7	46.0	67.7	78.7	36.0	12.6	14.0	13.1	62.9	27.6	17.2	18.3	11.0	99.2	25.6	17.4	52.1	23.1	52.7	36.0	13.4	29.9	49.8	32.4	60.4	129.0	46.9	19.7	41.6	32.7	28.1	69.8	57.5	25.9	31.7	9.5	50.2	22.2	68.2	54.4	20.4	44.6	29.7	27.4	40.5	32.1	33.0	32.1	17.3	26.9	34.8	34.8	24.2	32.3	27.1	27.9	26.3	32.1	11.1	11.7	12.8	15.1	10.6	13.5	12.3	13.0	13.0	13.1	12.4	13.3	10.0	12.8	13.2	9.4	29.4	25.2	28.1	70.4	54.7	8.6	16.5	9.7	4.2	10.0	42.4	9.2	10.4	13.3	15.7	8.5	11.7	13.9	8.6	21.7	16.1	12.9	6.1	17.2	8.1	11.6	30.3	19.1	40.2	16.2	22.2	7.1	11.0	10.3	10.0	1.7	8.8	14.6	44.7	10.3	10.7	4.2	16.8	16.0	26.6	11.2	9.1	9.1	17.5	14.1	12.8	16.5	10.7	17.0	62.1	28.5	12.0	14.0	60.0	11.1	13.1	9.0	17.0	50.8	43.0	65.5	30.5	26.1	23.7	8.9	8.6	32.4
TVP23C	"FAM18B2, MGC8763"	ENSG00000175106	"Trans-golgi network vesicle protein 23 homolog C"	Q96ET8	17	15502264-15563595	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 17.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											"HPA019585, HPA065603"	Uncertain		Supported	"Golgi apparatus"		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 43: Cardiomyocytes - Nuclear processes"	"Golgi apparatus"		"HPA019585: AB_1848385, HPA065603: AB_2685517"	"unprognostic (2.87e-3)"	"unprognostic (5.35e-3)"	"unprognostic (1.01e-1)"	"unprognostic (8.39e-3)"	"unprognostic (1.33e-3)"	"unprognostic (3.00e-1)"	"unprognostic (6.35e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.57e-2)"	"unprognostic (3.01e-1)"	"unprognostic (1.10e-3)"	"unprognostic (3.43e-1)"	"unprognostic (8.09e-5)"	"unprognostic (2.42e-2)"	"unprognostic (1.61e-1)"	"unprognostic (3.50e-1)"	"unprognostic (2.45e-2)"	3.8	6.6	4.2	2.3	3.5	10.9	4.5	6.9	3.9	7.4	8.0	3.3	2.1	4.6	3.3	5.9	4.2	2.4	4.1	3.1	4.7	6.4	3.9	4.6	2.8	5.5	5.2	8.8	5.2	3.7	10.1	4.0	3.9	6.4	2.1	4.1	6.0	2.0	3.0	4.5	3.8	2.2	3.0	4.7	3.8	5.2	5.2	1.9	6.8	1.5	2.4	3.9	5.7	6.5	8.3	7.3	2.7	3.9	3.5	1.8	4.2	6.9	11.6	12.1	14.2	9.3	3.3	0.0	3.7	5.8	6.6	3.5	8.4	5.2	8.6	5.2	4.5	5.5	6.7	13.2	3.2	2.0	5.0	2.4	2.0	12.2	7.2	10.2	11.1	2.9	6.7	3.5	5.3	2.7	3.5	5.6	3.0	3.3	2.5	0.6	0.3	0.4	3.3	4.8	0.9	2.3	8.7	1.0	1.8	11.3	4.8	1.1	7.9	2.0	2.8	2.9	2.2	2.2	2.1	0.0	2.3	0.0	1.8	11.3	1.8	8.4	3.3	4.1	4.5	6.4	4.5	5.0	3.0	4.6	5.5	5.1	2.9	5.0	2.9	3.3	4.7	4.3	4.2	3.5	6.9	3.9	3.1	4.7	5.5	5.2	3.9	3.0	5.2	6.5	3.5	3.2	8.2	0.0	2.9	4.0	5.4	4.3	4.6	5.9	4.2	2.7	17.2	0.0	7.0	0.0	14.6	5.9	5.5	3.8	1.9	2.9	1.3	6.6	4.4	5.8	1.8	3.0	0.0	0.6	11.7	5.6	6.6	6.5	2.5	6.2	1.8	0.7	3.2	6.7	0.0	4.0	6.1	1.9	3.3	0.9	3.4	2.3	1.8	0.0	2.4	2.6	4.1	0.0	0.0	1.6	2.9	2.2	9.2	5.2	4.3	0.8	4.3	10.5	0.0	3.3	5.6	10.0	7.9	5.5	2.8	5.5	4.7	7.2	4.9	7.0
TWF1	"A6, PTK9"	ENSG00000151239	"Twinfilin actin binding protein 1"	Q12792	12	43793723-43806328	"Disease related genes, Predicted intracellular proteins"		Actin-binding	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018116	Approved		Supported	Cytosol		NA	NA		75000	"Cluster 15: NK-cells - Transcription"	"Cluster 37: Intestine - Unknown function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	Cytosol		"HPA018116: AB_1855899"	"unprognostic (3.06e-1)"	"unprognostic (1.95e-2)"	"prognostic favorable (8.29e-4)"	"unprognostic (7.39e-3)"	"unprognostic (2.35e-2)"	"unprognostic (1.11e-1)"	"prognostic unfavorable (1.53e-4)"	"unprognostic (5.19e-2)"	"unprognostic (1.13e-2)"	"unprognostic (7.30e-2)"	"unprognostic (3.11e-3)"	"unprognostic (2.51e-1)"	"unprognostic (8.48e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.19e-1)"	"unprognostic (2.95e-1)"	"unprognostic (2.62e-1)"	45.2	40.2	27.9	39.0	33.0	46.2	49.4	30.6	38.9	54.8	27.2	65.9	68.7	39.9	48.5	93.8	45.3	48.7	13.1	26.5	32.5	51.2	53.9	24.9	30.5	32.5	30.9	27.1	39.0	39.9	23.9	35.0	32.6	46.0	65.7	32.5	42.5	73.5	5.8	36.7	67.8	46.6	31.8	20.2	46.1	20.1	30.8	24.4	73.1	11.7	34.2	74.6	38.0	37.2	121.3	88.5	45.1	55.5	115.8	132.5	109.3	165.3	136.1	131.7	99.2	143.3	165.2	32.5	150.0	159.6	77.3	79.8	62.6	118.2	186.1	11.3	72.5	30.2	68.6	67.7	93.9	35.0	37.6	91.0	94.4	136.8	152.0	167.5	117.0	16.1	33.4	35.9	207.4	64.8	16.8	24.1	27.5	0.0	142.7	14.1	51.1	36.8	175.9	149.1	33.3	50.0	138.2	123.7	121.7	62.8	116.2	34.4	113.0	161.5	107.1	130.8	139.8	31.1	32.9	44.4	148.8	89.0	62.6	10.2	2.6	5.7	5.1	4.1	5.9	6.1	6.0	6.6	4.1	3.0	5.9	6.7	4.4	12.1	4.4	2.7	6.6	3.2	27.9	33.0	30.6	38.9	26.5	32.5	32.5	30.9	32.6	31.8	30.8	37.2	40.7	12.8	33.8	6.2	24.7	41.7	33.3	32.6	42.1	22.7	43.9	30.6	6.0	30.0	40.3	35.0	20.9	41.5	36.2	92.8	41.1	50.9	20.6	70.9	40.3	32.0	44.9	7.8	10.1	79.7	58.0	32.4	53.0	53.6	5.1	27.7	24.3	28.7	26.9	20.2	10.3	45.2	48.8	30.0	20.9	10.8	26.8	24.7	35.6	8.4	17.7	33.5	14.4	10.1	15.7	74.9	77.4	32.0	34.0	57.5	66.3	68.7	53.5	32.9	26.3	25.4	41.7	11.7	22.1	95.0	51.1	85.0	25.8	39.6	61.8	74.9
TWIST2	"bHLHa39, Dermo-1, DERMO1"	ENSG00000233608	"Twist family bHLH transcription factor 2"	Q8WVJ9	2	238848032-238910534	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	"Developmental protein, DNA-binding, Repressor"	"Disease variant, Ectodermal dysplasia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix: 83.0"	"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 95.4;Fibroblasts: 58.9;Leydig cells: 48.1;Peritubular cells: 39.1;Theca cells: 23.2"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	24	"eosinophil: 4.6"	"Lineage enriched"	"Detected in single"	47	"granulocytes: 4.6"	"Cell line enhanced"	"Detected in many"		"ASC diff: 80.0;ASC TERT1: 50.5;BJ: 69.3;BJ hTERT+: 212.4;fHDF/TERT166: 97.4;U-2197: 81.3"	"Low region specificity"	"Detected in single"							HPA062870			Supported	Nucleoplasm,Nucleoli		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 36: Stromal cells - Cell proliferation"	Nucleoplasm	Nucleoli	"HPA062870: AB_2684888"	"unprognostic (1.62e-2)"	"unprognostic (1.33e-1)"	"unprognostic (3.45e-1)"	"unprognostic (3.81e-2)"	"unprognostic (2.53e-4)"	"unprognostic (1.83e-2)"	"unprognostic (4.06e-2)"	"unprognostic (1.13e-2)"	"unprognostic (2.75e-2)"	"unprognostic (2.33e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.40e-9)"	"unprognostic (1.59e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.98e-2)"	"unprognostic (4.48e-2)"	59.7	4.0	0.3	1.4	0.3	0.4	43.3	0.3	0.5	83.0	0.6	22.9	0.3	31.3	0.7	10.1	30.4	1.7	10.8	0.4	0.3	1.8	0.7	9.3	0.3	0.4	0.8	39.9	1.8	0.1	8.3	3.1	0.4	25.7	1.1	0.0	7.9	3.7	1.8	33.5	8.9	2.9	0.4	2.3	10.3	1.9	0.3	0.1	8.2	1.0	0.4	21.3	54.2	0.5	0.1	4.5	0.4	0.0	80.0	50.5	0.1	69.3	212.4	31.0	46.4	0.0	0.0	0.0	2.1	97.4	2.5	0.5	0.7	5.4	22.5	0.0	7.3	0.0	4.0	0.2	13.7	0.0	1.6	11.8	2.9	15.0	12.5	3.7	4.2	0.0	0.0	0.0	4.2	0.0	0.0	0.0	3.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.1	0.0	0.7	0.0	0.9	11.8	1.2	2.2	81.3	0.8	0.0	0.0	0.0	0.3	2.1	4.3	0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.3	0.5	0.4	0.3	0.4	0.8	0.4	0.4	0.3	0.5	2.5	0.0	2.6	0.0	0.1	2.0	16.0	0.0	7.4	0.0	0.5	0.4	0.6	0.0	0.0	0.0	0.0	1.0	0.3	0.0	0.0	0.0	0.4	3.6	95.4	1.3	0.0	0.0	4.4	0.0	1.9	58.9	0.0	2.1	1.3	0.5	2.9	0.1	2.2	0.0	0.2	0.0	0.0	0.0	3.6	1.2	48.1	0.8	1.8	12.2	0.4	0.0	8.2	0.5	0.1	0.1	0.0	39.1	0.0	20.5	0.0	0.0	0.0	0.0	0.0	1.1	9.6	0.5	3.3	0.2	1.7	1.6	1.6	23.2	0.0	3.7
TWSG1	TSG	ENSG00000128791	"Twisted gastrulation BMP signaling modulator 1"	Q9GZX9	18	9334767-9402420	"Predicted secreted proteins"		"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 141.2;Peritubular cells: 95.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014898	Uncertain		Supported	Centrosome,Cytosol	"Secreted - unknown location"	No	No		3500000	"Cluster 34: Basophils - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	"Centrosome, Cytosol"		"HPA014898: AB_1858467"	"unprognostic (2.55e-1)"	"unprognostic (3.17e-2)"	"unprognostic (7.31e-2)"	"unprognostic (8.95e-3)"	"unprognostic (2.92e-3)"	"unprognostic (1.83e-1)"	"unprognostic (8.29e-2)"	"unprognostic (5.88e-2)"	"unprognostic (6.33e-2)"	"unprognostic (1.05e-2)"	"unprognostic (3.10e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.40e-1)"	"unprognostic (4.36e-2)"	"unprognostic (8.73e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.32e-2)"	23.7	19.5	7.7	16.7	9.6	8.2	17.5	9.2	12.2	40.6	12.7	22.1	11.1	51.3	45.8	26.1	30.5	36.3	18.6	7.4	9.2	36.3	10.0	19.7	11.8	10.5	9.4	32.3	9.7	33.2	9.8	24.8	10.4	43.0	22.4	5.7	11.1	64.6	5.7	12.9	12.5	80.1	9.7	13.6	14.9	11.8	8.9	7.0	34.9	16.5	14.9	34.7	16.2	11.0	57.3	19.9	57.6	28.6	111.2	99.7	26.6	107.2	132.4	57.6	81.9	21.2	73.5	8.2	52.7	142.5	37.4	19.5	57.1	42.4	105.3	22.0	15.4	14.7	15.9	10.8	98.7	10.8	29.4	102.0	34.1	48.3	23.3	78.7	90.8	7.8	22.7	14.6	149.2	17.0	11.9	13.2	18.9	33.6	16.1	20.7	58.7	5.0	65.7	75.2	7.4	20.0	83.3	23.1	22.9	23.9	26.1	25.0	75.6	104.9	52.4	99.5	67.5	21.2	20.1	15.1	64.5	14.9	37.9	8.3	2.7	4.0	4.3	1.5	2.8	2.1	2.0	4.5	5.5	1.6	2.3	4.8	1.2	2.9	0.5	5.3	1.0	2.1	7.7	9.6	9.2	12.2	7.4	9.2	10.5	9.4	10.4	9.7	8.9	11.0	9.0	25.6	18.4	13.1	8.1	39.6	21.3	18.5	51.2	4.8	18.5	11.6	7.8	10.0	21.0	75.4	0.0	6.3	12.1	12.1	1.9	9.1	141.2	13.3	38.6	18.1	6.0	9.9	28.0	7.6	18.3	61.9	10.2	23.4	6.3	31.6	17.2	7.5	16.0	3.3	31.0	8.2	57.0	9.4	30.1	30.7	37.6	12.2	23.2	17.8	15.3	16.1	7.2	29.1	31.6	9.2	10.7	95.2	17.8	46.3	1.3	12.6	12.4	5.0	72.3	28.9	56.6	24.6	9.6	26.6	26.9	4.7	10.1	20.4	12.2	27.1
TXNDC11	EFP1	ENSG00000153066	"Thioredoxin domain containing 11"	Q6PKC3	16	11679083-11742857	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	6	"Plasma cells: 307.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RPMI-8226: 141.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041174, HPA041390"	Supported		Supported	"Plasma membrane,Cytosol"		No	No			"Cluster 26: Non-specific - Mitochondria"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 55: Plasma cells - Humoral immune response"	"Plasma membrane, Cytosol"		"HPA041174: AB_10794191, HPA041390: AB_10796670"	"unprognostic (1.96e-2)"	"unprognostic (1.43e-1)"	"unprognostic (6.82e-3)"	"prognostic favorable (2.12e-5)"	"prognostic unfavorable (1.36e-4)"	"unprognostic (2.43e-2)"	"unprognostic (1.83e-1)"	"unprognostic (2.68e-3)"	"unprognostic (4.90e-2)"	"unprognostic (2.17e-1)"	"unprognostic (1.08e-1)"	"unprognostic (2.01e-1)"	"unprognostic (2.35e-2)"	"unprognostic (9.96e-2)"	"unprognostic (8.30e-2)"	"unprognostic (3.23e-2)"	"unprognostic (2.34e-2)"	15.7	14.2	4.5	22.5	5.6	55.4	16.6	7.7	5.9	20.8	16.6	30.0	38.5	15.1	23.6	13.1	16.2	17.3	13.7	5.0	4.9	25.7	44.3	34.9	25.3	4.8	4.8	16.6	26.5	45.1	12.6	17.0	4.8	24.4	29.8	15.3	34.8	14.9	30.1	12.0	32.0	15.6	4.6	22.4	36.1	8.5	4.9	20.6	34.4	14.9	27.9	25.3	11.8	5.0	26.1	17.7	8.2	11.2	21.6	18.0	14.4	25.3	34.5	22.7	29.1	8.8	40.5	65.2	41.6	32.0	30.9	22.9	10.2	21.4	18.5	29.4	13.5	13.9	19.4	43.8	31.7	20.6	27.1	13.7	23.6	25.4	39.9	17.6	28.9	14.6	21.5	81.8	20.2	23.7	16.1	7.9	10.7	18.6	9.1	20.5	16.5	141.9	26.0	13.7	11.5	10.9	49.6	38.2	27.3	9.1	23.4	28.1	30.1	10.5	12.0	49.8	14.7	110.5	64.8	39.5	22.3	25.7	17.9	3.5	2.4	7.7	1.8	1.7	4.5	3.8	3.3	4.1	2.6	4.6	3.2	2.1	0.7	5.6	2.2	2.0	6.8	2.8	4.5	5.6	7.7	5.9	5.0	4.9	4.8	4.8	4.8	4.6	4.9	5.0	16.2	44.8	46.2	21.9	49.2	14.7	24.8	12.9	23.3	16.2	16.1	18.0	9.1	18.6	24.6	18.4	50.1	21.1	27.2	45.8	15.6	20.4	3.1	19.9	14.6	15.2	24.5	6.5	23.0	39.7	29.8	14.0	45.3	28.5	15.2	13.0	15.7	39.3	30.3	23.5	25.5	44.0	8.2	18.1	26.9	1.4	20.2	29.2	23.2	18.7	21.2	16.4	15.5	22.1	18.6	26.1	21.0	13.2	307.9	28.0	37.1	15.2	15.9	23.4	6.6	13.8	16.2	11.6	13.1	17.5	11.8	25.0	25.2	11.3	27.7	32.1
TXNL4B	"Dim2, DLP, FLJ20511"	ENSG00000140830	"Thioredoxin like 4B"	Q9NX01	16	72044289-72094431	"Predicted intracellular proteins"	"Cell cycle, mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-698: 86.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA065865			Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	Cytosol	"HPA065865: AB_2685571"	"unprognostic (1.45e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.55e-2)"	"unprognostic (3.78e-2)"	"unprognostic (8.72e-2)"	"unprognostic (4.75e-2)"	"unprognostic (2.65e-1)"	"unprognostic (8.91e-2)"	"unprognostic (4.75e-2)"	"unprognostic (1.04e-1)"	"unprognostic (3.00e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.62e-1)"	9.5	7.2	8.8	9.5	11.1	14.3	9.6	10.7	12.2	8.1	9.9	7.4	10.1	7.7	7.6	9.1	10.1	8.7	8.6	9.5	10.1	8.3	16.2	6.7	11.3	10.7	10.1	20.9	9.1	7.6	8.4	7.5	10.8	7.3	8.2	6.7	8.7	7.4	9.0	8.0	8.5	6.4	10.4	7.4	7.9	15.6	10.5	11.7	8.1	8.3	9.7	7.3	6.9	15.5	14.3	20.8	11.2	15.9	8.2	9.7	25.0	18.1	14.7	31.0	23.3	21.4	12.7	20.6	12.8	9.4	14.5	19.3	20.1	10.9	24.0	10.3	18.9	19.0	16.8	32.7	17.4	22.8	15.9	10.1	7.3	27.5	26.1	12.0	13.5	22.6	46.5	12.2	14.8	26.7	27.6	20.5	20.9	9.0	19.1	28.3	14.2	28.3	11.5	10.6	25.9	22.2	17.0	8.0	24.6	8.6	18.7	14.5	12.9	14.9	21.6	12.5	17.2	23.9	41.8	86.0	16.7	15.4	15.2	25.4	8.8	12.3	7.6	9.8	11.9	9.7	7.9	6.7	7.8	7.1	10.8	10.8	12.6	4.9	14.0	8.5	9.9	9.1	8.8	11.1	10.7	12.2	9.5	10.1	10.7	10.1	10.8	10.4	10.5	15.5	7.1	3.2	8.3	7.5	13.1	8.5	7.7	5.4	9.6	3.7	9.8	10.4	2.0	7.2	5.5	5.5	2.1	13.5	8.9	7.4	5.9	10.7	1.6	10.5	9.7	10.1	9.0	10.8	3.3	10.1	17.5	7.9	7.7	12.5	9.5	16.0	10.8	13.3	12.0	10.1	3.3	9.5	0.0	9.2	4.6	4.5	11.8	9.3	7.2	2.8	10.8	4.5	8.2	7.5	5.8	7.6	3.3	9.1	7.9	7.7	11.6	16.2	7.2	5.1	0.0	8.2	6.7	8.2	8.8	9.6	8.2	19.4	9.7	10.2	9.1	7.2
TXNRD1	"GRIM-12, Trxr1, TXNR"	ENSG00000198431	"Thioredoxin reductase 1"	Q16881	12	104215779-104350307	"Cancer-related genes, Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Electron transport, Transport"	Oxidoreductase	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 459.7;Prostatic glandular cells: 557.4;Urothelial cells: 488.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"fHDF/TERT166: 1452.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001395, CAB004607, CAB015834, HPA043871"	Approved		Supported	Nucleoplasm		NA	NA		6100000	"Cluster 46: Basophils - DNA binding"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 22: Epithelial cell types - Mixed function"	Nucleoplasm		"CAB004607: AB_628405, CAB015834: , HPA001395: AB_1858377, HPA043871: AB_2678709"	"unprognostic (2.52e-2)"	"unprognostic (1.16e-1)"	"unprognostic (5.48e-2)"	"unprognostic (1.01e-1)"	"unprognostic (3.15e-1)"	"unprognostic (1.94e-2)"	"prognostic unfavorable (1.12e-5)"	"unprognostic (5.55e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.08e-1)"	"unprognostic (6.42e-2)"	"unprognostic (2.21e-1)"	"prognostic unfavorable (1.20e-5)"	"unprognostic (2.13e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.18e-2)"	"unprognostic (8.80e-2)"	47.1	148.1	22.5	40.6	21.1	64.7	28.0	20.9	22.6	28.0	37.3	50.9	58.4	47.9	21.0	30.7	39.0	55.9	65.8	21.1	29.8	37.9	46.5	63.0	34.4	55.2	26.7	34.1	19.0	33.8	21.2	39.1	33.3	41.0	45.6	20.1	20.8	60.6	67.8	12.4	39.4	51.6	22.9	27.8	52.1	37.8	24.6	42.8	30.4	64.0	34.1	141.6	30.1	25.7	228.4	1032.6	118.1	111.3	553.5	308.0	409.8	412.4	259.3	182.7	186.8	110.5	329.4	169.3	187.0	1452.6	682.1	77.7	235.7	158.6	214.1	82.7	101.8	143.1	765.8	468.0	885.7	226.3	149.9	176.9	159.8	403.7	128.1	557.1	634.0	227.9	200.5	77.5	276.8	109.1	233.4	102.7	114.4	453.0	1053.1	227.3	82.1	146.5	211.2	123.1	182.6	110.6	333.3	519.1	325.2	222.6	123.2	131.4	854.5	89.3	183.7	201.3	341.2	84.8	179.9	254.5	186.8	122.5	538.0	109.4	29.9	69.7	23.6	39.0	26.9	21.3	21.6	23.9	39.5	14.5	19.1	16.7	102.6	24.4	48.4	25.2	19.8	27.6	22.5	21.1	20.9	22.6	21.1	29.8	55.2	26.7	33.3	22.9	24.6	25.7	26.0	64.1	67.5	50.3	27.6	104.0	459.7	41.3	40.9	28.1	19.4	16.3	66.2	32.9	79.3	16.5	22.9	26.1	40.4	93.4	41.1	79.6	45.0	100.9	36.8	116.2	20.4	46.3	48.2	80.7	34.3	90.1	69.8	119.6	53.2	35.2	49.2	68.2	42.0	28.6	56.7	18.8	44.7	43.5	100.5	19.1	68.0	62.2	19.6	49.6	51.9	24.8	26.8	29.1	55.3	197.7	40.5	29.3	28.4	557.4	24.6	37.5	105.5	20.9	0.0	43.4	84.0	14.4	33.8	24.3	72.9	51.3	28.5	98.4	33.0	488.0
TXNRD2	"SELZ, TR, TR3, TRXR2"	ENSG00000184470	"Thioredoxin reductase 2"	Q9NNW7	22	19875517-19941820	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-2 OS: 139.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002007, HPA003323"	Supported		Approved	Mitochondria,Cytosol		NA	NA		2800000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Mitochondria, Cytosol"		"CAB002007: , HPA003323: AB_1080396"	"unprognostic (3.17e-2)"	"unprognostic (8.72e-2)"	"unprognostic (4.30e-1)"	"unprognostic (9.71e-3)"	"unprognostic (7.25e-2)"	"unprognostic (6.35e-2)"	"unprognostic (3.21e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.78e-1)"	"unprognostic (2.83e-1)"	"unprognostic (4.94e-3)"	"unprognostic (2.49e-1)"	"prognostic favorable (1.10e-7)"	"unprognostic (2.47e-1)"	"unprognostic (5.99e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.10e-1)"	10.5	44.4	11.9	8.9	12.0	14.5	12.3	18.1	19.3	11.7	21.2	14.9	10.3	10.6	6.2	10.2	10.6	6.2	30.0	12.9	11.9	24.8	65.4	13.6	9.1	11.8	12.1	16.5	15.9	13.5	14.4	9.8	11.5	26.8	4.6	4.4	15.4	8.2	23.0	10.9	12.0	5.1	11.3	16.9	26.4	14.6	12.4	4.9	15.2	16.1	6.1	11.8	10.4	11.8	19.4	39.2	3.5	14.9	6.9	9.6	8.8	18.8	21.1	31.8	23.4	36.7	19.4	10.9	43.2	19.0	32.7	33.2	17.8	25.2	12.1	21.6	46.5	18.8	34.4	22.4	12.9	21.1	8.4	9.2	18.5	16.2	13.8	12.9	91.3	2.2	106.4	17.4	24.8	47.1	7.2	30.1	17.7	46.9	27.6	10.5	85.2	10.0	19.3	21.0	19.1	16.4	32.0	39.9	21.8	5.8	33.7	27.6	52.2	23.0	139.5	19.8	38.4	17.6	14.0	6.9	22.4	15.5	30.3	2.7	10.5	5.8	3.5	8.2	2.6	3.9	3.0	3.2	7.8	2.6	3.9	3.2	0.9	3.8	7.9	2.9	2.1	4.6	11.9	12.0	18.1	19.3	12.9	11.9	11.8	12.1	11.5	11.3	12.4	11.8	5.6	16.0	23.6	11.1	10.3	4.2	23.1	15.1	3.4	22.1	11.4	9.1	16.7	15.7	15.7	20.2	10.4	60.7	8.8	14.7	58.7	22.0	26.4	9.8	8.4	14.4	1.2	33.1	9.2	32.0	24.3	12.4	23.4	10.0	1.3	27.6	8.9	49.5	25.9	10.1	8.5	16.9	20.3	22.0	7.8	18.2	15.5	14.6	5.4	10.3	27.2	18.7	10.3	8.5	7.2	22.3	13.9	9.1	12.2	17.8	15.6	52.0	16.6	11.0	6.6	11.3	13.3	10.9	14.0	6.4	5.3	42.0	11.4	36.4	16.4	15.7
TYROBP	"DAP12, KARAP, PLO-SL, PLOSL"	ENSG00000011600	"Transmembrane immune signaling adaptor TYROBP"	O43914	19	35904401-35908295	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	Immunity			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 596.8;lymphoid tissue: 423.3"	"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 3777.1;Kupffer cells: 3698.1;Langerhans cells: 1990.8;Macrophages: 2837.1;monocytes: 3371.2;NK-cells: 1772.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 6415.4"	"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in some"	9	"HMC-1: 678.1;THP-1: 390.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009493, HPA041899"	Enhanced		Supported	"Plasma membrane"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 4: Macrophages - Innate immune response"	"Plasma membrane"		"CAB009493: AB_638987, HPA041899: AB_10795266"	"unprognostic (7.09e-2)"	"unprognostic (8.38e-3)"	"unprognostic (7.87e-2)"	"unprognostic (4.76e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.39e-1)"	"unprognostic (5.27e-2)"	"unprognostic (8.04e-2)"	"unprognostic (2.07e-2)"	"unprognostic (2.47e-1)"	"unprognostic (2.91e-1)"	"unprognostic (1.50e-1)"	"prognostic unfavorable (1.05e-4)"	"unprognostic (4.47e-2)"	"unprognostic (1.72e-2)"	"unprognostic (4.27e-2)"	"unprognostic (4.39e-2)"	126.3	76.1	55.8	234.3	54.3	596.8	59.1	58.6	116.8	44.3	61.4	62.0	70.6	25.9	15.0	28.1	43.7	105.0	39.7	53.0	66.4	34.4	85.5	261.5	161.0	81.7	64.0	18.3	24.7	22.0	27.0	124.7	74.8	31.7	49.8	3.9	38.3	26.7	10.6	21.5	78.8	68.0	74.1	423.3	43.1	15.0	74.0	52.5	21.9	31.6	36.6	131.7	21.5	114.4	0.3	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	56.7	0.0	0.0	0.5	33.2	678.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	1.0	0.0	0.0	0.0	49.1	0.3	0.0	0.0	0.5	0.0	0.6	0.0	0.0	0.3	0.5	0.0	0.0	0.2	0.9	0.0	390.6	0.0	0.0	0.3	0.8	0.1	0.4	0.1	1.0	0.1	10.8	0.1	974.2	4983.5	2573.9	468.0	3367.8	246.5	22.4	9.5	64.2	1912.0	8.4	11.7	51.2	6415.4	1664.1	3413.8	1653.1	9.5	5260.2	55.8	54.3	58.6	116.8	53.0	66.4	81.7	64.0	74.8	74.1	74.0	114.4	24.5	57.7	168.4	0.0	50.9	55.2	2.0	0.0	1.2	0.1	11.5	43.3	6.8	34.3	43.4	20.2	0.0	19.8	987.6	1.7	1.9	2.1	3.9	1.3	1.4	47.1	0.0	87.8	0.1	5.8	28.0	24.9	5.6	1.5	753.7	0.3	73.2	25.0	3777.1	0.0	0.1	0.2	0.0	3698.1	1990.8	11.6	9.3	2837.1	56.9	18.7	3371.2	0.6	1772.4	0.0	0.1	1.3	2.3	1.2	19.4	1.5	0.5	8.9	20.5	1.8	78.9	5.3	10.0	0.9	3.0	4.9	44.6	38.9	236.5	0.1	0.5	1.8
U2SURP	"fSAPa, SR140"	ENSG00000163714	"U2 snRNP associated SURP domain containing"	O15042	3	142964497-143060725	"Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037545, HPA037546, HPA061407"	Enhanced		Supported	Nucleoplasm		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"HPA037545: AB_10672598, HPA037546: AB_2675535, HPA061407: AB_2684506"	"unprognostic (2.01e-1)"	"unprognostic (9.78e-2)"	"unprognostic (8.09e-2)"	"prognostic unfavorable (8.44e-4)"	"unprognostic (3.11e-2)"	"unprognostic (4.30e-2)"	"prognostic unfavorable (3.15e-5)"	"unprognostic (3.72e-2)"	"unprognostic (1.98e-2)"	"unprognostic (9.61e-2)"	"prognostic unfavorable (8.92e-4)"	"unprognostic (2.85e-3)"	"prognostic unfavorable (8.86e-7)"	"unprognostic (6.71e-2)"	"unprognostic (2.19e-1)"	"unprognostic (3.12e-1)"	"prognostic favorable (6.78e-4)"	22.1	18.2	16.6	19.3	17.1	57.6	23.4	21.9	25.1	25.0	15.9	21.3	12.9	22.6	20.8	21.5	23.9	12.3	18.1	16.2	16.8	23.2	24.3	18.8	29.9	16.4	16.1	31.7	25.2	22.5	21.5	17.8	16.6	19.8	20.1	51.8	18.5	14.5	27.4	21.9	22.0	17.5	15.1	25.7	19.9	20.4	16.2	31.3	22.5	17.7	26.1	20.9	21.9	20.8	165.4	54.2	59.7	40.1	30.9	28.3	103.9	72.8	46.4	82.2	61.2	72.7	49.7	189.2	76.0	47.5	157.0	58.2	124.0	66.1	93.2	51.8	88.0	205.1	49.9	58.3	31.7	202.1	75.3	34.4	32.0	64.3	81.9	36.4	45.4	118.5	129.5	59.1	39.0	46.3	100.4	86.8	96.7	52.8	50.4	101.9	116.2	79.0	40.8	102.8	76.5	44.5	146.1	48.2	87.1	61.2	85.3	84.8	49.5	44.1	52.2	35.1	118.0	69.4	97.5	319.8	34.9	72.1	63.1	40.2	32.7	33.3	40.9	31.7	35.1	60.1	37.1	37.0	27.0	60.7	42.4	36.6	33.3	35.5	48.2	53.9	40.5	21.6	16.6	17.1	21.9	25.1	16.2	16.8	16.4	16.1	16.6	15.1	16.2	20.8	124.4	118.6	129.4	116.2	94.8	60.8	85.7	140.5	68.9	124.2	64.4	90.3	123.8	52.9	115.6	62.5	66.7	78.9	109.9	50.0	52.8	77.2	35.1	91.5	129.4	96.4	55.2	126.0	71.7	79.8	83.7	103.8	58.1	99.1	98.1	165.5	62.8	58.5	61.3	92.5	80.7	74.7	85.5	60.2	54.6	22.0	108.7	78.4	51.6	63.7	115.9	98.1	110.2	104.5	145.8	89.6	55.7	79.7	108.7	81.9	48.0	60.6	100.2	125.4	78.9	122.8	139.4	243.6	235.6	76.9	64.8	79.1	98.6	111.6	80.7	78.4
UACA	"FLJ10128, KIAA1561"	ENSG00000137831	"Uveal autoantigen with coiled-coil domains and ankyrin repeats"	Q9BZF9	15	70654554-70763558	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 142.0"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 293.0;Cardiomyocytes: 175.1;Endothelial cells: 177.4;Microglial cells: 184.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"intermediate monocyte: 1.7"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BJ: 244.5;BJ hTERT+: 148.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041412, HPA043503, HPA056006"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Nucleoplasm	Cytosol	"HPA041412: AB_10966708, HPA043503: AB_2678517, HPA056006: "	"unprognostic (1.58e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.56e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.79e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.43e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.80e-1)"	"prognostic unfavorable (7.01e-5)"	"unprognostic (4.95e-2)"	"prognostic unfavorable (1.62e-4)"	"unprognostic (1.14e-3)"	"unprognostic (1.45e-1)"	"unprognostic (2.42e-2)"	"prognostic unfavorable (1.03e-4)"	37.7	17.9	10.5	7.8	13.1	1.0	33.0	11.0	12.9	25.1	24.2	14.6	22.2	22.1	21.5	28.9	21.6	32.2	28.0	9.4	11.8	30.8	17.3	30.7	8.0	13.3	12.8	31.2	12.7	12.5	11.5	28.6	13.0	21.6	15.4	11.9	25.3	18.4	142.0	19.4	22.3	16.0	12.1	30.0	15.9	16.1	14.2	4.6	35.6	106.0	6.7	13.2	25.4	14.7	42.7	34.8	15.2	20.2	29.9	127.9	0.1	244.5	148.4	62.7	53.8	58.5	61.5	29.2	65.6	61.4	18.4	48.1	34.4	19.4	78.3	0.1	15.3	16.4	27.9	12.3	38.8	0.4	6.0	60.8	10.7	37.1	28.1	103.3	67.7	6.9	4.1	0.1	78.7	14.0	0.1	2.6	12.7	19.3	18.0	0.0	109.6	0.2	30.3	14.4	4.0	7.6	46.5	7.1	48.9	30.3	13.4	4.9	130.5	3.6	24.8	20.6	39.1	2.3	8.8	0.2	31.4	4.4	27.4	0.1	0.9	0.0	0.0	1.7	0.0	0.5	0.0	0.0	0.8	1.2	0.1	0.0	0.0	0.0	1.2	0.0	0.0	0.3	10.5	13.1	11.0	12.9	9.4	11.8	13.3	12.8	13.0	12.1	14.2	14.7	293.0	6.4	6.4	31.6	5.4	11.3	14.6	13.7	10.2	6.3	22.2	33.3	175.1	18.6	19.2	49.7	4.2	1.0	2.1	66.5	3.9	49.0	21.0	75.3	46.3	177.4	9.1	3.0	0.9	48.7	1.9	81.6	33.6	53.0	15.2	34.9	47.5	18.8	9.6	25.2	0.7	33.1	6.1	24.3	8.6	15.2	125.2	15.8	30.2	184.6	9.5	49.4	2.1	6.0	62.0	78.8	35.7	141.1	0.8	21.8	45.3	5.0	61.9	4.2	52.6	53.5	96.2	46.4	35.2	16.4	13.1	1.0	2.9	62.7	24.2	10.9
UAP1	"AgX, AGX1, SPAG2"	ENSG00000117143	"UDP-N-acetylglucosamine pyrophosphorylase 1"	Q16222	1	162561506-162599842	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Nucleotidyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"hTERT-HME1: 678.4;U-251 MG: 463.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014659	Approved		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		No	Yes		48000	"Cluster 16: MAIT-cells - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 50: Fibroblasts - ECM organization"	"Nucleoplasm, Plasma membrane, Cytosol"		"HPA014659: AB_1857409"	"unprognostic (2.32e-2)"	"unprognostic (2.45e-1)"	"unprognostic (2.07e-2)"	"unprognostic (1.28e-2)"	"unprognostic (2.71e-2)"	"unprognostic (1.46e-2)"	"unprognostic (1.37e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.29e-3)"	"unprognostic (4.96e-2)"	"prognostic unfavorable (5.12e-5)"	"unprognostic (1.59e-1)"	"unprognostic (2.04e-1)"	"unprognostic (3.51e-1)"	"unprognostic (3.45e-2)"	96.0	43.7	12.2	33.7	13.2	51.5	58.8	13.5	14.9	37.1	16.1	65.6	43.9	18.6	29.1	33.9	33.1	39.8	45.1	13.4	13.6	27.0	172.6	36.0	14.1	11.5	16.9	39.9	68.6	12.0	28.9	22.3	11.8	33.3	66.3	20.4	76.6	31.2	41.2	25.0	56.0	24.6	11.6	13.8	55.8	90.9	13.9	11.8	24.4	45.2	22.2	77.9	37.4	11.0	204.6	14.6	39.2	31.5	185.7	147.8	26.8	292.4	107.1	220.7	178.5	38.6	93.5	8.0	64.3	225.8	79.6	35.0	44.7	85.5	359.9	32.4	66.6	36.0	43.8	75.6	87.1	61.8	23.5	69.0	39.8	242.4	678.4	100.6	137.5	62.6	206.1	81.3	298.9	37.4	36.0	40.0	29.2	207.6	64.4	31.9	76.2	99.8	34.8	23.7	41.9	43.4	128.0	78.4	70.4	45.6	38.9	70.0	235.2	110.6	102.5	281.2	463.5	135.0	51.0	67.0	63.4	28.5	71.3	1.4	2.2	11.7	16.7	2.1	20.4	10.7	10.0	17.3	4.6	11.1	9.4	12.0	2.2	8.6	1.2	7.7	5.5	7.2	12.2	13.2	13.5	14.9	13.4	13.6	11.5	16.9	11.8	11.6	13.9	11.0	58.1	6.4	30.2	15.0	42.5	134.7	163.0	47.2	47.8	11.8	59.1	42.7	30.0	27.1	57.4	16.5	8.4	27.2	82.9	94.8	72.4	27.1	78.2	28.6	58.0	35.7	54.9	13.9	12.4	64.7	63.9	195.8	45.9	40.7	33.7	21.3	22.5	98.4	14.5	6.7	12.4	139.4	40.7	10.1	82.2	20.1	50.7	24.6	85.4	3.7	18.2	16.6	41.2	8.0	6.1	73.0	74.5	41.3	152.8	94.6	88.4	26.9	56.0	13.9	19.7	59.4	88.6	212.0	125.9	43.2	81.8	97.7	50.5	18.8	70.4	141.7
UBA1	"A1S9T, CFAP124, GXP1, POC20, UBE1, UBE1X"	ENSG00000130985	"Ubiquitin like modifier activating enzyme 1"	P22314	X	47190861-47215128	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Ubl conjugation pathway"	Ligase	"Cancer-related genes, Disease variant, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000289, HPA001506, CAB019435, CAB073410"	Approved		Supported	Nucleoplasm		NA	NA		14000000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm		"CAB019435: AB_2211440, CAB073410: , HPA000289: AB_1080443, HPA001506: AB_2756305"	"unprognostic (7.18e-3)"	"unprognostic (1.52e-1)"	"unprognostic (7.54e-2)"	"unprognostic (2.40e-1)"	"unprognostic (9.29e-2)"	"unprognostic (1.02e-1)"	"prognostic unfavorable (6.10e-5)"	"unprognostic (7.22e-2)"	"unprognostic (2.42e-3)"	"unprognostic (3.43e-2)"	"unprognostic (8.50e-3)"	"unprognostic (2.17e-3)"	"unprognostic (1.85e-3)"	"unprognostic (1.13e-1)"	"unprognostic (5.38e-2)"	"prognostic favorable (1.78e-4)"	"unprognostic (1.21e-2)"	98.4	157.9	102.9	98.3	113.2	94.3	98.6	103.4	115.5	127.9	133.9	101.1	71.3	127.1	64.3	155.3	119.3	64.9	117.4	106.2	102.0	131.2	114.7	109.5	105.0	106.9	104.2	136.5	89.0	107.5	135.2	67.4	109.3	103.2	68.5	95.6	119.5	78.9	201.1	119.5	100.4	117.4	94.4	131.9	98.6	98.7	110.0	119.7	160.1	114.1	110.8	101.1	124.8	121.3	269.1	273.2	307.7	471.9	207.4	186.8	135.0	175.1	187.1	248.6	200.5	219.3	201.3	201.6	111.8	357.0	361.5	254.9	392.9	375.7	180.9	163.4	391.7	126.1	295.2	180.0	145.1	215.2	258.8	177.4	193.2	362.7	279.4	176.7	330.2	236.1	138.9	173.7	250.4	343.4	203.3	188.5	329.6	163.2	417.1	233.1	215.3	343.7	198.7	287.0	197.4	148.1	520.8	250.9	116.9	329.9	349.5	130.3	241.6	183.1	210.7	266.4	166.1	117.6	132.8	286.3	189.4	150.8	224.9	31.0	39.7	40.7	39.4	51.1	34.0	39.8	31.8	35.0	43.2	29.9	24.7	31.1	44.8	38.1	49.7	29.3	40.3	39.9	102.9	113.2	103.4	115.5	106.2	102.0	106.9	104.2	109.3	94.4	110.0	121.3	37.2	51.3	34.7	45.1	37.1	33.6	38.6	55.7	26.2	24.9	48.3	39.6	51.4	51.5	50.0	82.8	16.7	46.3	34.2	133.1	35.2	77.5	29.6	84.9	56.3	40.9	57.5	33.2	27.1	90.8	68.7	45.0	74.9	97.5	18.3	60.3	43.5	51.2	60.0	11.8	35.5	78.6	30.5	49.0	37.8	61.6	42.3	51.4	19.6	31.9	57.7	20.7	13.4	32.2	46.5	147.9	74.7	65.8	44.0	55.2	82.2	61.6	56.4	25.1	39.5	38.8	56.6	10.5	34.0	51.3	42.1	71.1	34.6	56.8	68.2	55.4
UBA2	"FLJ13058, HRIHFB2115, SAE2"	ENSG00000126261	"Ubiquitin like modifier activating enzyme 2"	Q9UBT2	19	34428352-34471251	"Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Sertoli cells: 269.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA041436	Supported		Supported	Nucleoplasm		NA	NA		130000	"Cluster 26: Non-specific - Mitochondria"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 48: Smooth muscle cells - ECM organization"	Nucleoplasm		"HPA041436: AB_2677479"	"unprognostic (2.37e-1)"	"unprognostic (3.17e-1)"	"unprognostic (2.13e-2)"	"unprognostic (1.36e-3)"	"unprognostic (6.39e-3)"	"unprognostic (8.72e-3)"	"prognostic unfavorable (3.76e-4)"	"unprognostic (1.96e-2)"	"unprognostic (2.14e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.58e-1)"	"unprognostic (2.65e-2)"	"prognostic unfavorable (8.02e-4)"	"unprognostic (1.63e-2)"	"unprognostic (2.11e-2)"	"unprognostic (2.00e-1)"	"unprognostic (1.88e-1)"	91.3	36.8	35.9	37.1	37.1	54.9	67.7	44.6	53.1	52.4	35.1	41.6	27.4	55.3	34.8	43.6	47.9	35.7	43.3	36.4	39.3	36.5	36.0	45.3	57.2	36.9	39.1	51.7	40.4	40.8	38.5	60.6	36.5	33.6	35.1	47.2	34.4	34.3	109.4	54.5	37.0	43.0	36.9	32.4	38.6	91.8	38.3	68.5	41.8	57.8	54.8	45.7	46.1	40.7	122.9	175.7	176.2	73.4	93.5	75.8	72.0	93.5	80.0	118.2	130.9	151.7	72.7	227.4	140.3	76.7	73.4	48.8	188.8	72.9	165.4	164.0	126.7	241.6	84.6	152.9	120.3	194.6	100.7	55.3	90.8	83.8	146.2	79.2	94.2	96.2	244.0	125.4	105.0	122.7	151.1	107.4	132.3	190.4	59.9	118.1	121.3	101.9	83.9	126.1	149.0	146.1	85.8	77.3	133.2	113.9	55.7	234.4	61.2	131.9	92.1	85.3	169.6	130.7	200.8	223.1	83.5	146.4	118.8	8.8	4.8	8.1	7.3	4.9	9.9	8.5	9.5	11.1	5.8	8.2	11.5	9.3	0.6	8.0	6.4	10.2	8.0	3.8	35.9	37.1	44.6	53.1	36.4	39.3	36.9	39.1	36.5	36.9	38.3	40.7	58.9	25.6	35.3	25.5	62.1	87.1	72.5	36.4	59.7	90.6	36.3	33.1	36.2	31.5	32.7	18.4	41.7	75.4	53.3	15.9	33.2	49.8	22.1	29.7	47.8	55.9	46.0	60.3	50.8	42.0	95.9	56.4	44.4	36.2	38.7	52.5	25.0	25.0	46.7	47.1	48.9	32.8	24.4	34.9	45.4	23.9	43.5	40.4	76.5	33.7	51.9	50.2	41.2	41.7	56.7	39.6	23.9	53.0	74.5	93.5	19.0	32.0	29.7	42.0	269.5	69.0	206.5	223.9	198.3	57.9	92.9	92.8	58.6	49.9	45.4	73.6
UBAC1	"GBDR1, KPC2, UBADC1"	ENSG00000130560	"UBA domain containing 1"	Q9BSL1	9	135932969-135961373	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 301.3;tongue: 171.0"	"Cell type enhanced"	"Detected in all"		"Erythroid cells: 290.9;Late spermatids: 197.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HDLM-2: 246.4;K-562: 316.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005651	Approved		Supported	"Golgi apparatus,Plasma membrane,Cytosol"		NA	NA		87000	"Cluster 14: Monocytes - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 6: Erythroid cells - Oxygen transport"	"Plasma membrane, Cytosol"	"Golgi apparatus"	"HPA005651: AB_1858489"	"unprognostic (8.41e-2)"	"prognostic favorable (4.34e-6)"	"unprognostic (2.10e-1)"	"unprognostic (9.15e-2)"	"unprognostic (4.11e-1)"	"unprognostic (3.85e-2)"	"unprognostic (7.68e-3)"	"unprognostic (2.85e-1)"	"unprognostic (4.37e-2)"	"unprognostic (3.23e-1)"	"unprognostic (3.92e-3)"	"unprognostic (1.20e-1)"	"prognostic favorable (3.58e-7)"	"unprognostic (1.95e-3)"	"unprognostic (9.46e-2)"	"unprognostic (3.16e-2)"	"unprognostic (5.78e-2)"	23.1	20.7	42.2	14.7	44.8	82.5	20.7	43.0	43.0	23.8	41.4	38.6	24.3	22.0	12.9	37.4	22.8	12.0	72.0	40.4	42.2	23.5	24.9	19.8	15.7	43.2	42.7	20.9	17.1	27.1	23.5	22.8	41.8	24.7	18.4	15.2	27.8	20.6	301.3	53.2	23.3	16.3	43.7	21.0	23.0	43.1	44.0	17.7	18.0	171.0	16.5	28.3	27.0	41.0	37.4	42.7	29.7	43.4	22.0	25.6	55.7	32.0	27.1	38.9	31.2	59.7	46.3	44.8	30.1	26.4	46.1	124.4	41.9	37.0	17.5	246.4	39.6	37.4	79.0	33.8	22.9	49.2	34.4	24.2	47.7	24.6	23.8	26.0	32.8	41.4	316.6	35.5	31.2	76.9	40.4	50.5	70.5	87.4	71.8	45.1	55.8	59.3	28.0	23.7	46.0	50.6	46.3	41.4	33.5	26.3	34.9	52.5	26.8	22.0	33.0	26.5	40.2	20.5	41.1	53.9	40.7	43.9	30.6	6.5	17.6	8.7	4.8	28.4	5.1	4.9	5.4	3.2	15.6	2.8	2.8	3.3	3.7	4.0	33.4	1.6	4.5	7.0	42.2	44.8	43.0	43.0	40.4	42.2	43.2	42.7	41.8	43.7	44.0	41.0	42.8	16.0	10.0	18.6	14.5	40.7	38.8	41.8	43.3	38.3	29.6	36.2	85.7	11.5	24.5	27.6	31.3	148.6	20.7	45.5	93.9	16.3	101.6	82.9	33.7	27.5	16.8	290.9	17.3	22.9	32.7	22.5	21.9	21.3	7.0	28.6	20.3	32.7	75.2	13.5	23.6	37.4	28.5	34.3	30.3	197.4	19.6	41.8	35.6	9.4	46.0	60.7	13.4	9.0	14.1	22.6	42.3	22.6	24.6	23.1	47.9	35.6	96.0	44.1	19.7	42.8	27.4	57.7	54.9	73.2	64.8	60.5	16.5	25.7	55.6	39.4
UBAP1	UBAP	ENSG00000165006	"Ubiquitin associated protein 1"	Q9NZ09	9	34179005-34252523	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Protein transport, Transport"		"Disease variant, Hereditary spastic paraplegia, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019804	Approved		Supported	"Vesicles,Plasma membrane,Cytosol"		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 44: Endometrium - Transcription"	Cytosol	"Vesicles, Plasma membrane"	"HPA019804: AB_1858494"	"unprognostic (1.83e-1)"	"unprognostic (4.30e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.70e-1)"	"unprognostic (3.54e-1)"	"unprognostic (3.29e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.59e-1)"	"unprognostic (2.01e-2)"	"unprognostic (6.53e-2)"	"unprognostic (1.25e-2)"	"unprognostic (3.63e-1)"	"prognostic favorable (7.49e-6)"	"unprognostic (1.24e-1)"	"unprognostic (1.49e-1)"	"unprognostic (2.46e-1)"	"unprognostic (1.17e-1)"	40.7	55.5	46.4	24.5	47.1	131.5	35.8	48.0	53.4	45.0	46.4	38.5	22.3	34.0	25.5	69.7	33.9	30.4	38.2	45.6	48.2	34.8	53.1	42.5	23.8	48.5	48.5	40.9	28.0	34.4	25.6	29.3	49.4	30.4	24.8	44.8	29.6	30.6	110.0	39.5	26.3	35.2	46.3	28.2	33.6	47.8	49.9	31.6	25.6	71.7	32.7	38.0	45.8	48.2	56.7	31.7	35.2	38.4	63.6	39.3	29.8	44.4	61.6	48.4	65.6	34.3	23.0	39.3	19.5	66.5	41.1	28.3	49.2	69.5	46.4	57.1	22.3	35.1	65.4	35.5	57.8	39.3	44.8	48.7	113.0	57.5	75.0	73.4	54.4	37.9	27.4	38.0	45.7	23.7	36.5	55.0	38.2	38.8	45.9	32.6	24.8	22.8	104.2	36.9	19.9	28.1	49.0	50.2	22.5	31.1	24.6	38.5	39.2	24.7	38.0	37.4	41.5	18.9	25.3	41.0	49.5	31.5	74.2	26.8	50.9	66.6	38.0	45.2	65.8	26.8	38.1	40.0	47.1	23.2	36.3	29.8	120.2	50.1	41.0	26.7	52.9	55.0	46.4	47.1	48.0	53.4	45.6	48.2	48.5	48.5	49.4	46.3	49.9	48.2	21.6	67.3	26.0	44.4	22.4	46.9	66.3	20.4	45.5	15.8	27.9	23.1	13.1	20.0	33.5	7.3	25.0	33.2	21.6	25.8	19.6	34.8	77.5	56.9	37.2	21.4	16.1	50.7	33.1	40.1	35.4	31.2	44.4	90.0	25.9	15.4	17.5	25.3	22.0	6.7	42.9	18.5	30.5	21.4	39.8	62.9	29.2	38.2	24.9	26.2	23.1	26.0	13.4	38.7	35.4	44.3	23.0	42.5	25.0	47.9	22.5	21.0	22.5	10.9	19.7	44.0	32.5	51.0	22.9	54.6	59.0	89.6	28.6	20.8	18.8	70.9
UBASH3A	"CLIP4, STS-2, TULA"	ENSG00000160185	"Ubiquitin associated and SH3 domain containing A"	P57075	21	42403447-42447684	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"lymphoid tissue: 18.9"	"Cell type enhanced"	"Detected in some"		"dendritic cells: 5.9;Erythroid cells: 3.8;T-cells: 20.5"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	10	"gdT-cell: 12.9;MAIT T-cell: 22.9;memory CD4 T-cell: 28.2;memory CD8 T-cell: 24.8;naive CD4 T-cell: 32.2;naive CD8 T-cell: 24.0;T-reg: 27.9"	"Lineage enriched"	"Detected in many"	12	"T-cells: 32.2"	"Group enriched"	"Detected in some"	7	"HEL: 23.0;JURKAT: 39.0;MOLT-4: 47.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA035367			Supported	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 58: T-cells - T-cell receptor"	Nucleoplasm	"Golgi apparatus"	"HPA035367: AB_2732466"	"unprognostic (5.14e-4)"	"unprognostic (3.91e-4)"	"unprognostic (1.57e-2)"	"unprognostic (4.10e-5)"	"unprognostic (4.33e-2)"	"unprognostic (1.85e-6)"	"unprognostic (5.54e-4)"	"unprognostic (1.46e-3)"	"unprognostic (6.17e-4)"	"unprognostic (2.47e-3)"	"unprognostic (1.94e-2)"	"unprognostic (1.81e-1)"	"unprognostic (2.37e-6)"	"unprognostic (1.65e-1)"	"unprognostic (7.96e-2)"	"unprognostic (3.24e-2)"	"unprognostic (4.17e-2)"	0.4	0.6	0.0	5.2	0.0	2.5	0.2	0.0	0.1	0.5	0.1	0.8	1.6	0.5	0.0	0.4	0.4	2.0	0.4	0.0	0.1	0.4	0.7	1.7	11.1	0.2	0.0	0.3	0.1	0.0	0.1	0.2	0.1	0.4	0.9	0.0	0.9	0.1	0.2	0.3	2.4	0.1	0.1	4.4	1.9	0.1	0.0	18.9	0.5	0.1	5.1	1.7	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.5	0.0	23.0	0.0	0.0	0.0	0.0	5.5	0.0	0.0	0.0	0.0	0.0	0.0	39.0	4.4	0.0	0.0	0.0	47.8	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.1	0.0	12.9	0.0	22.9	0.1	28.2	24.8	0.0	0.0	32.2	24.0	0.5	2.5	0.1	0.1	27.9	10.0	0.0	0.0	0.0	0.1	0.0	0.1	0.2	0.0	0.1	0.1	0.0	0.1	0.2	0.0	0.5	0.0	0.8	0.4	0.0	0.8	0.0	0.0	0.2	0.3	1.0	0.0	0.8	0.0	0.0	0.0	5.9	0.0	0.0	0.0	0.1	0.6	0.0	0.3	0.0	3.8	0.0	0.0	0.0	0.4	1.1	0.5	1.3	0.0	0.4	0.1	0.1	0.0	0.0	0.0	0.0	0.6	0.2	0.0	0.0	0.3	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.4	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.2	0.1	0.6	0.0	0.3	0.0	20.5	0.0	0.0	0.0
UBD	FAT10	ENSG00000213886	"Ubiquitin D"	O15205	6	29555515-29559732	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"lymphoid tissue: 151.3"	"Group enriched"	"Detected in many"	7	"Ductal cells: 534.8;Exocrine glandular cells: 273.8;monocytes: 151.9;Pancreatic endocrine cells: 510.6"	"Cancer enhanced"	"Detected in all"		"liver cancer: 75.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	16	"Hep G2: 63.9;RT4: 52.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA043710			Supported	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 1: Pancreatic cells - Digestion"	Nucleoplasm	"Nucleoli fibrillar center"	"HPA043710: AB_2756303"	"unprognostic (2.99e-3)"	"unprognostic (4.16e-2)"	"unprognostic (6.37e-2)"	"unprognostic (2.61e-2)"	"unprognostic (3.93e-2)"	"unprognostic (3.53e-3)"	"unprognostic (1.60e-1)"	"unprognostic (9.47e-2)"	"unprognostic (1.44e-2)"	"prognostic favorable (7.35e-4)"	"unprognostic (1.28e-2)"	"unprognostic (6.43e-2)"	"prognostic unfavorable (2.40e-5)"	"unprognostic (4.04e-2)"	"unprognostic (6.02e-2)"	"unprognostic (8.40e-2)"	"unprognostic (1.21e-2)"	4.2	0.4	0.3	35.6	0.4	0.0	8.6	0.3	0.7	1.7	0.3	13.3	4.2	1.9	1.2	8.3	4.7	0.9	0.6	0.3	0.3	23.2	25.4	10.9	87.5	0.4	0.3	1.2	27.3	1.7	1.4	0.0	0.3	11.9	19.0	0.0	14.6	1.3	0.4	1.8	31.1	1.2	0.3	22.9	27.1	0.8	0.3	90.2	3.0	0.1	151.3	25.8	1.7	0.3	0.7	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	3.5	0.1	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	63.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	52.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.2	0.9	2.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.3	0.7	0.3	0.3	0.4	0.3	0.3	0.3	0.3	0.3	0.2	3.2	3.1	0.0	0.7	0.1	0.1	2.3	16.5	0.0	1.9	1.9	0.0	21.5	13.3	0.0	0.0	0.0	0.1	6.9	1.9	534.8	0.0	0.3	0.2	7.1	3.6	0.0	0.0	273.8	0.0	2.2	13.3	0.2	0.0	0.0	0.7	0.3	0.1	0.0	0.0	5.2	6.1	0.3	0.0	0.0	0.0	1.2	0.0	0.0	151.9	0.0	0.0	0.0	0.0	510.6	8.3	0.0	0.0	0.5	49.1	1.1	9.7	0.0	0.0	0.0	3.4	0.0	0.0	2.2	0.0	0.0	0.2	0.0	11.1	0.1
UBE2A	"HHR6A, HR6A, RAD6A, UBC2"	ENSG00000077721	"Ubiquitin conjugating enzyme E2 A"	P49459	X	119574536-119591083	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair, Ubl conjugation pathway"	"Chromatin regulator, Transferase"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Syncytiotrophoblasts: 508.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003875, HPA051765, HPA065898"			Supported	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 18: U-2197 - ECM organization"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Nucleoplasm, Plasma membrane"	"Vesicles, Cytosol"	"HPA003875: AB_2667061, HPA051765: AB_2681597, HPA065898: AB_2685577"	"unprognostic (2.27e-3)"	"prognostic favorable (2.16e-4)"	"unprognostic (1.12e-1)"	"unprognostic (9.09e-2)"	"unprognostic (1.63e-1)"	"prognostic unfavorable (9.07e-4)"	"unprognostic (1.66e-3)"	"unprognostic (1.96e-2)"	"unprognostic (6.54e-2)"	"unprognostic (2.96e-2)"	"unprognostic (3.49e-2)"	"unprognostic (1.33e-1)"	"prognostic unfavorable (2.20e-6)"	"unprognostic (9.54e-2)"	"unprognostic (3.06e-2)"	"unprognostic (1.21e-1)"	"unprognostic (7.92e-2)"	40.0	27.4	30.1	39.1	30.6	29.8	29.4	34.1	38.8	34.1	27.1	52.3	37.5	32.0	38.2	53.4	27.3	32.6	63.2	29.6	32.2	41.0	30.1	32.9	46.9	34.4	32.5	20.1	29.2	39.2	18.9	56.8	34.4	31.0	45.0	27.1	30.9	33.0	71.9	30.7	39.1	43.0	32.1	26.8	30.5	17.6	32.1	46.1	30.5	55.0	50.4	46.9	32.8	35.1	129.5	104.1	60.8	54.1	103.0	125.6	63.9	122.6	106.3	141.8	130.3	50.8	84.0	96.4	126.4	133.9	240.6	86.4	86.3	65.7	128.6	142.3	60.6	42.7	71.9	47.1	96.6	105.9	72.1	86.9	90.1	134.0	58.3	98.1	99.4	86.5	57.0	83.6	160.1	134.5	166.6	99.9	106.3	125.7	126.9	84.2	64.0	91.6	113.1	76.6	48.9	51.3	171.2	75.0	93.7	73.2	65.8	92.6	101.5	92.4	42.0	184.3	142.5	83.6	147.1	92.4	99.1	136.3	74.6	46.8	58.5	92.5	43.0	92.1	34.8	52.6	37.9	38.5	74.6	48.7	23.7	33.9	78.0	35.0	101.1	58.5	56.8	51.1	30.1	30.6	34.1	38.8	29.6	32.2	34.4	32.5	34.4	32.1	32.1	35.1	67.5	102.5	40.9	12.7	79.1	124.8	91.6	129.4	51.8	17.2	60.7	43.9	66.7	44.3	80.7	40.5	31.3	179.8	93.0	168.6	101.8	95.4	51.7	75.6	55.3	62.9	45.5	70.4	9.9	102.1	176.2	67.7	37.8	63.0	57.0	35.7	46.4	35.5	131.3	8.4	9.4	49.7	103.7	59.1	183.9	15.3	37.0	97.3	83.6	15.9	129.0	49.8	41.2	14.6	18.0	137.6	132.5	40.6	92.2	98.2	85.6	125.2	107.7	35.0	46.0	56.3	101.1	44.1	32.1	74.6	127.9	508.5	94.8	36.6	54.5	120.3
UBE2B	"HHR6B, RAD6B, UBC2"	ENSG00000119048	"Ubiquitin conjugating enzyme E2 B"	P63146	5	134371469-134392108	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 265.8"	"Cell type enhanced"	"Detected in all"		"Syncytiotrophoblasts: 723.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 444.6"	"Lineage enriched"	"Detected in all"	6	"granulocytes: 444.6"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003875, HPA051765, HPA065898"			Supported	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 59: Non-specific - Translation"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 10: Non-specific - Unknown function"	"Nucleoplasm, Plasma membrane"	"Vesicles, Cytosol"	"HPA003875: AB_2667061, HPA051765: AB_2681597, HPA065898: AB_2685577"	"unprognostic (1.98e-1)"	"unprognostic (1.35e-1)"	"unprognostic (7.39e-2)"	"unprognostic (6.66e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.48e-2)"	"unprognostic (2.56e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.91e-1)"	"unprognostic (2.44e-1)"	"unprognostic (2.49e-1)"	"unprognostic (8.39e-2)"	"unprognostic (1.64e-3)"	"unprognostic (6.30e-3)"	"unprognostic (3.42e-2)"	"unprognostic (2.04e-1)"	"unprognostic (5.52e-2)"	52.5	74.2	31.5	50.0	33.1	84.4	44.2	36.3	53.2	38.3	30.2	48.0	40.7	53.6	34.8	70.5	37.3	51.0	118.4	34.3	34.8	50.6	56.6	44.9	47.1	29.5	31.0	44.4	53.7	25.8	39.9	48.4	31.0	32.9	42.0	29.2	39.7	23.2	265.8	43.1	46.4	43.3	30.3	43.7	39.6	49.2	32.9	29.3	41.2	99.8	48.1	42.8	43.2	36.7	109.4	27.9	58.2	55.0	50.0	54.1	92.7	80.2	43.5	51.4	60.9	85.6	70.9	58.7	94.1	52.3	138.7	42.7	45.8	60.4	56.0	94.5	47.6	32.1	75.9	92.8	58.2	38.8	63.7	46.5	80.2	47.4	39.3	68.1	44.1	48.8	61.1	103.5	46.8	63.4	62.5	102.1	24.9	32.6	26.7	61.6	63.8	83.8	46.6	82.9	77.6	60.1	62.9	29.3	147.9	62.5	63.0	106.0	87.6	57.8	40.8	78.9	89.4	86.1	129.4	87.0	65.2	72.8	59.4	236.7	58.3	174.0	46.9	68.3	42.9	49.7	58.8	48.1	42.6	47.9	69.9	60.6	444.6	53.0	78.9	48.0	77.5	64.1	31.5	33.1	36.3	53.2	34.3	34.8	29.5	31.0	31.0	30.3	32.9	36.7	187.5	73.7	61.6	40.1	176.5	364.7	321.2	215.1	175.8	77.8	169.9	156.5	315.8	147.3	113.7	75.4	81.3	144.5	182.0	183.1	172.1	173.8	233.2	139.8	102.2	149.7	131.8	261.2	103.0	169.5	123.0	183.3	113.2	167.8	116.8	81.7	115.3	97.4	119.4	87.5	84.2	141.0	181.0	131.5	323.9	315.4	155.0	184.2	227.7	49.6	190.6	150.0	113.3	44.7	68.4	210.6	195.2	113.2	162.5	343.9	153.4	170.7	111.7	91.3	151.2	154.9	262.9	223.5	201.7	145.5	369.7	723.5	192.0	140.4	105.7	488.1
UBE2D1	"E2(17)KB1, SFT, UBC4/5, UBCH5, UbcH5A"	ENSG00000072401	"Ubiquitin conjugating enzyme E2 D1"	P51668	10	58334979-58370751	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 138.7;tongue: 65.3"	"Cell type enhanced"	"Detected in all"		"Basal keratinocytes: 194.4;Suprabasal keratinocytes: 190.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 112.3"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003920	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	"Plasma membrane, Cytosol"		"HPA003920: AB_1858519"	"unprognostic (1.12e-1)"	"unprognostic (2.08e-1)"	"unprognostic (4.23e-3)"	"unprognostic (1.76e-1)"	"unprognostic (1.52e-2)"	"unprognostic (1.21e-2)"	"prognostic unfavorable (5.58e-4)"	"unprognostic (2.20e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.24e-2)"	"unprognostic (4.37e-3)"	"unprognostic (2.17e-1)"	"prognostic unfavorable (8.04e-6)"	"unprognostic (9.71e-3)"	"unprognostic (4.14e-1)"	"unprognostic (1.95e-1)"	"unprognostic (5.66e-2)"	13.0	11.8	5.3	16.7	5.7	32.4	7.8	6.6	8.1	8.9	4.4	11.4	7.0	12.6	7.5	11.6	7.1	9.5	33.3	6.1	6.2	8.1	8.3	8.9	13.8	6.6	6.4	8.4	5.5	8.9	3.9	8.9	6.6	9.5	12.0	5.4	5.5	6.7	138.7	5.9	8.3	13.6	6.4	13.4	6.4	4.5	6.3	7.8	8.4	65.3	11.4	15.1	5.6	6.7	19.1	10.2	18.8	24.4	37.5	30.0	12.1	12.4	21.2	13.9	20.3	20.9	16.4	0.0	19.0	18.6	10.3	17.1	36.6	18.0	19.5	19.8	21.2	4.9	3.7	12.2	24.4	15.3	11.8	34.8	19.9	14.4	26.8	18.7	28.1	13.1	10.0	7.8	19.1	6.1	16.5	17.1	23.0	11.7	15.7	13.8	16.9	10.6	21.2	11.2	14.0	18.8	24.2	40.3	20.6	28.5	14.8	10.2	22.8	5.3	18.6	18.2	13.7	19.7	16.4	16.8	16.7	31.3	6.2	10.1	38.5	17.8	6.2	27.1	7.2	8.9	7.3	7.9	20.0	9.8	7.5	6.2	112.3	8.2	23.4	8.3	9.8	23.4	5.3	5.7	6.6	8.1	6.1	6.2	6.6	6.4	6.6	6.4	6.3	6.7	41.6	12.8	11.2	5.5	54.3	194.4	94.1	60.6	46.1	23.7	45.6	45.5	92.4	17.2	39.0	27.6	18.8	29.9	41.7	27.4	76.3	62.3	5.0	32.6	46.9	42.5	41.7	12.0	18.5	42.0	50.4	51.9	38.7	51.2	22.9	19.6	27.5	15.6	73.7	16.8	17.1	40.1	69.2	90.6	104.0	3.0	33.2	147.7	53.4	4.7	94.6	17.9	22.6	12.5	21.2	81.2	52.7	32.4	26.4	108.4	16.1	54.3	33.6	16.1	6.6	51.4	59.1	33.5	19.9	47.1	190.2	149.0	42.8	14.9	28.5	118.2
UBE2D3	UbcH5C	ENSG00000109332	"Ubiquitin conjugating enzyme E2 D3"	P61077	4	102794383-102868896	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Apoptosis, DNA damage, DNA repair, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA003920	Uncertain		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 10: Non-specific - Unknown function"	"Plasma membrane, Cytosol"		"HPA003920: AB_1858519"	"unprognostic (7.43e-2)"	"unprognostic (3.19e-1)"	"unprognostic (1.27e-2)"	"unprognostic (5.78e-2)"	"unprognostic (6.44e-2)"	"unprognostic (4.96e-2)"	"unprognostic (1.17e-1)"	"unprognostic (8.44e-3)"	"unprognostic (1.14e-1)"	"unprognostic (1.95e-1)"	"unprognostic (5.75e-2)"	"unprognostic (3.31e-2)"	"prognostic favorable (4.51e-4)"	"unprognostic (5.08e-2)"	"unprognostic (2.79e-1)"	"unprognostic (4.54e-2)"	"unprognostic (1.34e-2)"	182.7	171.7	85.7	172.0	92.6	478.3	141.9	101.1	120.6	127.1	93.4	154.9	154.0	125.3	113.8	173.4	125.9	142.5	149.4	92.1	103.9	172.2	251.4	175.3	189.6	102.5	96.0	131.5	154.2	133.5	98.4	159.0	99.8	106.8	144.4	129.0	116.7	102.1	243.6	136.4	158.3	129.9	101.4	149.5	144.4	127.0	95.6	198.5	159.2	197.9	197.0	185.6	128.0	113.7	301.6	169.1	275.4	223.4	286.2	408.0	235.9	301.2	395.1	260.1	243.6	257.4	416.4	319.3	190.6	304.4	336.8	168.6	294.7	400.8	352.5	299.6	149.8	292.0	165.8	209.6	300.3	415.5	240.4	314.0	247.9	288.6	398.9	334.3	343.4	258.7	372.9	316.4	350.9	243.1	613.4	235.1	200.2	341.0	167.1	318.4	269.9	231.5	261.5	283.7	275.6	232.1	183.5	464.8	349.6	318.2	193.0	241.0	318.4	270.0	231.1	179.2	276.3	277.9	389.8	491.3	288.2	227.2	297.0	614.9	253.7	394.0	163.5	256.0	216.3	165.9	203.4	194.4	217.6	139.2	205.8	190.5	817.2	215.7	271.9	149.8	229.6	422.1	85.7	92.6	101.1	120.6	92.1	103.9	102.5	96.0	99.8	101.4	95.6	113.7	303.4	166.7	193.1	98.9	291.7	844.0	693.9	408.2	233.9	133.7	251.5	166.9	229.8	193.0	242.3	139.8	125.1	311.5	317.4	336.1	547.8	361.0	779.4	257.1	246.7	344.0	240.8	348.7	159.7	382.2	561.6	286.0	202.3	371.3	224.9	154.8	193.1	235.7	392.9	122.8	145.8	283.8	303.2	403.0	825.6	635.1	164.7	415.1	357.5	111.5	399.4	160.0	280.2	104.5	185.0	454.4	347.2	149.0	296.4	612.3	335.8	428.8	242.4	170.6	105.2	270.6	531.9	217.2	180.7	258.2	813.3	638.4	382.5	172.3	268.2	784.3
UBE2I	UBC9	ENSG00000103275	"Ubiquitin conjugating enzyme E2 I"	P63279	16	1308880-1327018	"Cancer-related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Transporters"	"Cell cycle, Cell division, Chromosome partition, Host-virus interaction, Mitosis, Ubl conjugation pathway"	Transferase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003909, CAB009021, CAB079920"	Approved		Supported	Nucleoplasm,Nucleoli		NA	NA		130000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 34: Non-specific - Transcription"	"Cluster 14: REH - Unknown function"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm	Nucleoli	"CAB009021: AB_2210610, CAB079920: AB_2809487, HPA003909: AB_1858529"	"unprognostic (2.12e-1)"	"unprognostic (1.01e-2)"	"unprognostic (1.55e-2)"	"unprognostic (3.51e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.52e-1)"	"prognostic unfavorable (7.50e-4)"	"unprognostic (2.88e-3)"	"unprognostic (1.20e-1)"	"unprognostic (1.89e-2)"	"unprognostic (7.60e-3)"	"unprognostic (3.56e-1)"	"unprognostic (7.28e-2)"	"unprognostic (9.30e-2)"	"unprognostic (1.57e-1)"	"prognostic favorable (5.68e-4)"	"unprognostic (1.15e-3)"	62.5	76.3	42.5	60.3	44.0	81.6	62.0	46.1	49.3	64.7	37.1	63.8	45.1	72.7	48.7	74.2	67.3	34.3	68.2	45.2	45.2	63.4	40.8	53.1	76.0	39.3	42.3	93.1	49.1	72.0	61.6	58.1	40.2	53.4	47.3	31.7	56.4	46.7	58.0	68.0	61.1	53.8	42.2	71.9	52.9	47.6	47.1	110.3	53.2	57.0	89.3	66.6	63.1	42.1	121.3	161.1	269.0	157.7	112.7	135.8	114.4	170.0	121.7	154.3	152.9	191.8	190.1	208.2	137.7	148.1	140.7	142.4	193.2	159.2	197.9	151.2	133.4	130.6	136.6	188.4	178.6	194.9	148.0	127.1	100.7	152.1	180.0	149.0	170.0	169.9	190.3	124.3	148.0	254.4	349.6	193.0	219.0	136.0	118.5	434.0	170.9	238.4	145.7	106.6	150.3	159.8	149.3	164.1	177.7	152.8	167.5	234.4	139.4	149.2	172.6	134.0	155.5	132.1	170.4	423.4	85.3	142.9	164.7	278.7	214.3	327.1	165.9	256.6	200.9	297.8	167.8	170.3	214.7	241.1	148.2	149.6	149.5	202.6	249.5	186.3	196.5	260.9	42.5	44.0	46.1	49.3	45.2	45.2	39.3	42.3	40.2	42.2	47.1	42.1	109.5	51.3	67.0	16.3	172.8	178.6	186.4	275.6	97.3	64.6	101.9	105.7	89.1	84.4	140.9	62.5	50.1	312.8	153.9	77.4	105.7	211.9	64.4	66.6	100.6	118.3	102.3	127.4	17.2	148.2	293.1	134.4	55.5	104.6	109.5	149.7	94.2	43.7	213.5	47.1	16.8	97.1	162.8	104.8	182.1	37.8	129.8	124.8	128.1	15.9	220.2	104.7	209.1	16.6	26.7	212.3	91.8	107.6	144.1	294.8	90.4	117.7	65.7	63.1	78.9	82.1	185.4	139.6	145.7	158.4	206.7	418.1	144.7	134.9	134.7	304.5
UBE2N	"MGC8489, UBC13, UbcH-ben"	ENSG00000177889	"Ubiquitin conjugating enzyme E2 N"	P61088	12	93405673-93441947	"Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, Ubl conjugation pathway"	Transferase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	15	"Early spermatids: 2532.0;Late spermatids: 8141.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA044976	Enhanced		Supported	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA		1800000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 25: Spermatids - Spermatogenesis"	Nucleoplasm	"Nucleoli fibrillar center"	"HPA044976: AB_2679163"	"unprognostic (1.74e-2)"	"unprognostic (5.53e-1)"	"unprognostic (1.26e-2)"	"unprognostic (2.30e-1)"	"unprognostic (1.07e-1)"	"unprognostic (8.09e-2)"	"prognostic unfavorable (2.41e-4)"	"unprognostic (8.49e-3)"	"unprognostic (2.72e-1)"	"unprognostic (4.28e-3)"	"unprognostic (1.07e-1)"	"unprognostic (9.28e-2)"	"unprognostic (1.03e-1)"	"unprognostic (3.31e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.30e-3)"	52.4	48.6	46.4	62.1	49.9	69.9	41.6	40.3	51.6	35.8	26.8	55.9	42.5	44.0	38.3	60.4	37.3	33.5	57.6	50.8	53.2	54.4	45.5	38.2	80.0	45.2	43.9	31.3	30.6	40.4	32.6	49.5	52.2	46.0	44.0	50.3	36.0	34.5	83.0	41.3	42.3	42.7	44.3	42.9	41.0	186.9	44.3	79.4	29.0	70.3	73.8	76.4	38.6	44.4	190.3	133.2	221.1	142.6	82.9	81.4	154.5	259.4	135.6	201.0	167.3	239.8	80.0	380.2	57.3	151.1	133.8	147.7	245.2	188.7	189.7	323.3	128.4	258.0	66.6	214.2	106.4	311.9	165.1	86.3	75.2	120.8	148.9	143.1	157.3	146.9	292.8	58.0	210.9	155.3	310.4	286.2	288.9	165.9	189.4	237.3	179.9	186.6	170.1	280.9	214.9	195.6	136.1	158.5	130.0	118.7	207.5	188.0	165.8	135.7	114.6	124.1	189.9	99.5	289.4	324.0	53.5	162.5	170.2	133.7	89.5	101.3	99.3	123.3	116.8	174.0	124.8	124.1	119.6	144.7	109.3	104.9	27.7	106.0	141.7	89.6	198.6	202.5	46.4	49.9	40.3	51.6	50.8	53.2	45.2	43.9	52.2	44.3	44.3	44.4	87.5	38.5	45.8	24.8	151.4	322.2	231.3	219.1	92.2	72.1	84.3	60.5	74.6	60.1	112.2	90.1	27.1	236.0	104.3	76.3	191.7	141.4	2532.0	79.7	79.0	95.3	74.7	75.9	44.6	99.0	226.0	100.9	49.5	96.5	93.8	68.3	55.3	55.3	165.6	87.5	49.0	78.6	187.2	67.8	216.3	8141.3	93.8	97.0	147.7	33.7	152.9	111.9	79.3	38.7	42.1	135.5	83.8	86.1	113.3	218.2	61.2	171.3	88.9	57.6	46.0	101.9	146.2	338.4	227.6	142.2	322.5	284.7	128.2	86.4	94.9	260.3
UBE2O	E2-230K	ENSG00000175931	"Ubiquitin conjugating enzyme E2 O"	Q9C0C9	17	76389456-76453152	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Transport, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 54.7;Inhibitory neurons: 63.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023605	Uncertain		Supported	"Nucleoplasm,Nuclear bodies"		No	No		220000	"Cluster 21: B-cells - Adaptive immune response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 62: Horizontal cells - Visual perception"	"Nuclear bodies"	Nucleoplasm	"HPA023605: AB_2671257"	"unprognostic (8.75e-2)"	"unprognostic (2.04e-1)"	"unprognostic (7.44e-2)"	"unprognostic (8.68e-2)"	"unprognostic (1.17e-1)"	"unprognostic (3.22e-2)"	"prognostic unfavorable (6.84e-8)"	"unprognostic (3.54e-1)"	"unprognostic (2.68e-1)"	"unprognostic (7.61e-2)"	"unprognostic (1.32e-3)"	"unprognostic (1.18e-2)"	"prognostic unfavorable (4.34e-9)"	"unprognostic (7.22e-2)"	"unprognostic (9.64e-2)"	"unprognostic (9.12e-2)"	"unprognostic (2.07e-1)"	9.1	9.7	12.9	10.1	14.0	21.2	9.7	8.0	24.9	12.8	1.4	10.7	9.4	11.5	7.0	12.8	11.0	6.5	20.3	15.4	11.7	8.4	10.5	8.7	13.1	21.7	9.0	15.1	17.4	10.9	18.2	9.1	21.7	11.6	5.3	10.5	12.9	8.7	28.3	16.1	10.6	7.1	4.4	13.9	11.0	16.6	11.6	12.0	16.1	13.4	8.6	10.8	12.5	14.5	25.8	29.2	29.1	35.5	17.7	11.3	25.2	11.8	12.8	18.9	18.3	25.6	12.7	36.4	8.3	14.8	29.7	25.2	34.2	20.4	13.2	10.5	42.2	36.9	20.6	42.9	14.7	22.6	22.0	11.4	16.2	18.1	15.3	16.2	25.7	19.9	31.5	31.4	9.6	21.3	44.7	26.0	27.0	15.5	38.9	43.3	37.6	40.2	8.5	22.1	43.0	38.5	17.4	43.9	23.6	26.3	25.4	16.1	15.4	21.9	20.5	18.8	19.9	25.8	9.2	30.8	24.1	18.8	14.6	0.0	0.7	1.0	1.4	0.3	0.8	0.9	0.9	0.7	0.4	1.6	0.7	1.1	0.1	0.5	0.4	1.5	0.9	0.8	12.9	14.0	8.0	24.9	15.4	11.7	21.7	9.0	21.7	4.4	11.6	14.5	7.9	3.2	7.7	24.8	19.6	8.7	6.1	7.2	13.1	45.8	9.7	9.1	23.2	5.7	7.3	7.3	41.7	6.4	15.2	6.5	0.0	6.0	1.8	8.6	13.7	8.3	23.4	33.2	54.7	9.4	7.4	8.3	17.9	10.1	7.0	18.9	7.1	8.5	8.1	45.4	63.0	9.3	2.0	5.3	11.0	1.8	9.6	11.6	5.4	19.7	10.0	7.3	18.6	27.2	24.7	7.2	5.7	7.9	22.9	9.8	5.2	3.3	5.6	23.8	6.6	12.2	10.9	19.6	23.2	12.9	12.4	5.2	14.7	13.3	8.7	6.2
UBE2QL1	FLJ25076	ENSG00000215218	"Ubiquitin conjugating enzyme E2 Q family like 1"	A1L167	5	6448859-6496723	"Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 26.1;heart muscle: 16.8;retina: 28.3;skeletal muscle: 54.5;tongue: 13.9"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 30.0;Cardiomyocytes: 27.6;Excitatory neurons: 47.8;Granulosa cells: 45.5;Horizontal cells: 45.4;Inhibitory neurons: 35.3;Rod photoreceptor cells: 63.6"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 5.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Karpas-707: 29.7;PC-3: 24.6;SCLC-21H: 23.1;U-266/70: 54.4;U-266/84: 52.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA057414			Supported	"Nucleoplasm,Plasma membrane"		NA	NA				"Cluster 54: Non-specific - Microtubule organization"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 46: Photoreceptor cells - Phototransduction"	Nucleoplasm	"Plasma membrane"	"HPA057414: "	"unprognostic (1.45e-2)"	"unprognostic (1.58e-2)"	"unprognostic (1.79e-2)"	"unprognostic (2.10e-1)"	"unprognostic (1.08e-2)"	"unprognostic (7.43e-2)"	"unprognostic (1.15e-2)"	"unprognostic (1.36e-1)"	"unprognostic (3.10e-1)"	"unprognostic (7.16e-2)"	"unprognostic (2.15e-3)"	"unprognostic (8.41e-2)"	"prognostic favorable (6.81e-8)"	"unprognostic (3.18e-3)"	"unprognostic (2.81e-1)"	"unprognostic (1.27e-2)"	"unprognostic (1.41e-2)"	1.2	1.4	14.3	0.4	14.6	0.0	1.1	16.5	26.1	2.1	1.8	5.3	0.3	0.8	1.0	0.4	0.7	0.4	16.8	17.9	11.4	3.4	1.2	0.1	0.1	12.0	7.9	2.6	0.6	0.1	3.2	0.0	11.6	3.5	0.3	28.3	0.8	5.5	54.5	1.5	1.4	0.7	5.6	0.2	2.9	0.7	10.1	0.3	1.2	13.9	0.2	0.3	1.3	17.7	0.1	0.0	0.0	0.3	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	29.7	0.0	5.3	0.0	0.0	0.3	0.0	24.6	0.1	0.0	11.5	0.0	0.0	23.1	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	54.4	52.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.3	14.6	16.5	26.1	17.9	11.4	12.0	7.9	11.6	5.6	10.1	17.7	0.2	0.0	0.0	5.5	0.3	1.3	0.5	0.5	0.0	30.0	0.4	1.0	27.6	0.0	0.0	0.0	6.2	0.0	0.0	0.0	5.9	0.0	0.0	0.2	0.4	1.0	5.4	0.0	47.8	0.2	0.0	3.6	1.1	0.1	0.0	45.5	0.0	1.0	0.1	45.4	35.3	0.0	0.0	0.3	0.3	0.3	4.1	0.1	0.0	2.8	0.0	9.4	0.0	12.1	5.4	0.1	0.0	6.8	1.8	0.9	0.0	0.2	0.0	63.6	0.0	3.2	1.4	0.1	0.3	0.0	0.1	0.0	0.0	0.5	0.0	0.0
UBE2V2	"DDVit-1, DDVIT1, EDAF-1, EDPF-1, EDPF1, MMS2, UEV-2, UEV2"	ENSG00000169139	"Ubiquitin conjugating enzyme E2 V2"	Q15819	8	48008415-48064708	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA052535, HPA053186"			Supported	Nucleoplasm		NA	NA		800000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"HPA052535: AB_2681863, HPA053186: AB_2682073"	"unprognostic (3.50e-3)"	"unprognostic (3.27e-1)"	"unprognostic (1.53e-1)"	"unprognostic (3.07e-2)"	"unprognostic (1.69e-1)"	"unprognostic (5.83e-2)"	"unprognostic (2.94e-3)"	"unprognostic (1.21e-2)"	"unprognostic (1.65e-3)"	"unprognostic (4.97e-2)"	"unprognostic (1.77e-2)"	"unprognostic (2.73e-1)"	"prognostic unfavorable (4.96e-6)"	"unprognostic (1.42e-1)"	"unprognostic (1.42e-1)"	"unprognostic (2.45e-1)"	"unprognostic (9.62e-2)"	36.6	42.9	40.0	32.1	44.0	23.0	35.5	38.3	50.3	28.2	33.5	43.7	35.1	32.9	26.7	49.0	26.2	27.5	25.3	45.7	47.0	35.8	60.8	23.3	39.2	44.4	42.2	24.4	21.4	36.9	36.0	31.4	45.2	34.0	36.1	52.1	23.2	30.8	56.3	25.4	33.0	38.3	39.6	23.7	32.8	34.3	46.4	52.1	37.2	56.0	39.7	41.7	31.7	38.6	112.7	63.9	140.0	78.0	75.4	83.6	49.4	114.8	80.1	113.8	99.2	80.9	85.3	136.9	65.7	110.5	97.4	66.1	128.6	107.8	152.1	47.2	89.8	123.6	74.4	68.8	94.0	68.2	35.7	79.5	109.9	91.7	145.6	86.1	97.6	115.8	154.0	83.0	145.3	85.7	218.3	131.6	130.3	166.7	42.2	108.3	61.8	67.6	122.7	90.0	152.9	99.4	96.7	85.1	107.5	103.8	143.0	89.7	54.1	95.8	87.8	86.6	108.7	82.3	151.5	175.8	124.3	118.7	104.0	73.9	70.5	74.4	58.9	84.9	71.6	77.4	72.6	72.8	87.2	76.1	72.2	81.7	45.1	110.6	85.0	73.3	104.6	94.2	40.0	44.0	38.3	50.3	45.7	47.0	44.4	42.2	45.2	39.6	46.4	38.6	52.4	48.1	34.7	20.2	53.1	45.2	75.5	172.5	36.5	87.1	40.9	51.8	58.9	35.8	89.0	51.5	16.7	93.3	39.9	29.9	129.1	81.9	51.6	46.7	58.3	45.4	32.3	57.0	41.6	88.3	149.6	67.9	30.5	36.9	50.8	55.5	32.2	50.8	90.4	80.8	38.1	49.2	109.9	35.4	53.1	34.6	56.2	51.6	37.4	20.6	76.0	110.8	56.7	21.1	28.4	83.6	56.0	73.4	46.7	95.9	51.9	130.2	71.4	65.2	59.2	48.3	122.1	134.7	82.2	46.8	57.1	149.7	47.2	76.2	59.3	75.0
UBE2Z	"FLJ13855, USE1"	ENSG00000159202	"Ubiquitin conjugating enzyme E2 Z"	Q9H832	17	48908407-48929056	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Apoptosis, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007922	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 30: Epididymis - Antimicrobial activity"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 22: Epithelial cell types - Mixed function"	"Nucleoplasm, Cytosol"		"HPA007922: AB_1858551"	"unprognostic (6.85e-2)"	"unprognostic (5.72e-3)"	"prognostic favorable (4.62e-4)"	"unprognostic (9.11e-2)"	"unprognostic (3.71e-3)"	"unprognostic (1.76e-1)"	"prognostic unfavorable (5.57e-4)"	"unprognostic (2.32e-2)"	"unprognostic (5.26e-2)"	"unprognostic (8.66e-2)"	"unprognostic (9.17e-3)"	"unprognostic (3.48e-2)"	"prognostic unfavorable (1.05e-4)"	"unprognostic (2.63e-2)"	"unprognostic (2.11e-2)"	"unprognostic (1.91e-2)"	"unprognostic (1.52e-1)"	33.5	45.9	37.4	37.8	40.6	33.4	36.0	37.7	44.5	41.2	32.8	37.6	34.6	39.8	60.3	45.3	44.4	34.6	33.8	40.0	40.7	40.2	33.1	34.9	44.9	39.2	37.9	36.2	34.5	46.8	31.4	42.6	42.6	39.1	40.4	38.4	38.5	47.0	29.9	43.9	35.7	49.3	35.7	41.9	35.8	28.0	40.7	45.2	50.2	28.8	59.3	45.8	39.1	57.8	101.2	122.4	45.1	43.0	111.8	107.7	61.6	107.6	131.1	126.1	120.7	153.8	84.8	81.6	150.5	133.1	158.0	64.0	57.1	100.7	159.7	271.7	61.8	73.9	80.3	96.8	128.8	53.0	76.3	92.4	109.5	103.1	132.3	134.7	94.0	38.1	55.2	103.0	137.4	160.8	57.5	52.4	42.1	122.4	105.7	45.7	114.6	46.6	98.7	97.6	46.4	70.1	73.2	38.8	76.5	100.7	107.7	41.4	111.2	187.2	89.9	62.0	89.4	77.8	79.5	47.6	91.8	38.2	83.2	5.2	7.7	5.7	8.3	9.9	6.8	6.2	7.3	8.4	5.4	8.6	6.9	7.6	7.3	5.4	9.5	6.8	8.2	6.4	37.4	40.6	37.7	44.5	40.0	40.7	39.2	37.9	42.6	35.7	40.7	57.8	36.6	25.6	19.2	17.9	32.7	52.8	50.3	47.1	27.3	56.4	40.6	32.9	37.9	21.5	25.8	36.8	41.7	34.2	40.0	42.1	21.5	44.2	1.6	48.8	40.8	44.0	48.6	23.4	22.5	54.7	32.7	35.1	20.9	59.5	6.3	37.6	37.5	25.8	24.8	43.7	20.8	35.9	20.3	28.1	54.0	5.1	28.0	35.6	30.2	12.2	48.6	31.6	26.8	13.6	52.7	75.8	25.6	29.0	23.7	89.5	34.7	27.5	42.1	34.4	32.9	25.8	39.3	21.6	26.0	35.9	57.0	42.8	30.7	50.4	30.8	66.7
UBE4A	"E4, KIAA0126, UBOX2, UFD2"	ENSG00000110344	"Ubiquitination factor E4A"	Q14139	11	118359600-118399211	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA055035, HPA064010"	Approved		Supported	"Nuclear speckles"		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 59: Non-specific - Transcription"	"Nuclear speckles"		"HPA055035: AB_2682679, HPA064010: AB_2685174"	"unprognostic (1.32e-2)"	"unprognostic (8.15e-2)"	"unprognostic (5.23e-3)"	"unprognostic (3.34e-1)"	"unprognostic (2.80e-2)"	"unprognostic (1.97e-1)"	"unprognostic (7.67e-3)"	"unprognostic (3.31e-1)"	"unprognostic (1.30e-1)"	"unprognostic (4.67e-2)"	"unprognostic (6.01e-2)"	"unprognostic (5.83e-2)"	"unprognostic (7.73e-3)"	"unprognostic (4.74e-2)"	"unprognostic (5.94e-2)"	"unprognostic (2.72e-1)"	"unprognostic (8.86e-2)"	18.6	14.1	15.9	20.3	17.8	17.7	18.0	25.5	20.5	16.1	15.7	17.4	19.1	18.9	18.6	15.0	15.5	15.6	19.7	15.1	20.2	18.0	27.6	17.0	22.5	18.9	18.1	19.1	19.5	19.0	9.5	17.5	20.2	19.0	20.7	18.4	16.1	14.9	22.1	24.0	20.5	18.1	16.5	19.7	23.9	17.7	19.7	21.3	18.4	15.9	21.6	14.7	12.7	24.4	18.8	17.9	22.4	22.5	38.0	34.9	22.3	27.1	28.1	19.7	24.0	49.7	44.9	39.3	51.0	34.4	26.5	40.3	31.9	25.7	32.6	22.3	14.8	64.5	15.4	25.7	32.6	36.8	47.3	35.4	18.2	40.4	39.3	26.3	33.3	33.9	37.2	35.9	28.7	35.4	31.5	36.5	20.9	37.7	22.7	20.0	32.5	40.2	21.6	43.1	20.3	21.1	39.2	33.5	12.3	24.2	44.8	16.6	34.6	29.0	19.0	25.1	22.8	10.5	13.8	36.4	16.1	41.6	30.4	14.2	9.5	9.7	7.5	10.5	5.8	5.1	5.6	5.4	9.8	3.5	6.0	5.4	9.6	6.5	12.8	5.7	7.0	4.8	15.9	17.8	25.5	20.5	15.1	20.2	18.9	18.1	20.2	16.5	19.7	24.4	28.7	12.8	31.9	45.7	27.5	26.8	22.0	20.4	25.6	19.5	26.3	18.0	18.2	10.0	27.8	14.7	18.8	20.3	30.6	25.5	5.9	19.8	18.0	23.7	35.3	20.9	18.6	26.9	46.2	28.5	19.8	24.2	41.8	31.7	10.8	25.7	19.2	44.6	21.9	16.8	56.3	20.1	30.5	27.9	23.1	15.2	17.1	33.2	24.9	36.5	32.4	20.5	24.7	55.8	80.9	27.0	18.3	21.4	42.0	23.1	29.0	11.5	37.5	16.8	19.7	23.4	23.6	35.3	22.0	30.3	39.2	24.8	31.0	26.0	20.3	26.1
UBL4A	"DXS254E, GDX, GET5, MDY2, TMA24, UBL4"	ENSG00000102178	"Ubiquitin like 4A"	P11441	X	154483717-154486615	"Predicted intracellular proteins"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA003617	Approved		Supported	Nucleoplasm,Cytosol		NA	NA		11000	"Cluster 44: Non-specific - Transcription"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 51: Myeloid cells - Hemostasis"	"Nucleoplasm, Cytosol"		"HPA003617: AB_1080450"	"unprognostic (2.75e-2)"	"unprognostic (3.39e-3)"	"unprognostic (5.52e-2)"	"unprognostic (2.88e-2)"	"unprognostic (2.62e-1)"	"unprognostic (2.13e-1)"	"prognostic unfavorable (8.64e-4)"	"unprognostic (4.83e-2)"	"unprognostic (3.56e-2)"	"unprognostic (2.24e-2)"	"unprognostic (8.26e-3)"	"unprognostic (4.50e-1)"	"unprognostic (4.41e-2)"	"unprognostic (2.74e-2)"	"unprognostic (6.01e-2)"	"unprognostic (2.10e-1)"	"unprognostic (3.49e-2)"	18.3	29.6	31.2	11.3	32.5	11.2	17.1	28.8	38.3	21.2	25.8	27.1	17.7	19.0	18.0	29.1	17.9	11.4	47.8	32.4	30.0	20.0	28.1	17.7	16.1	31.0	29.7	15.8	36.9	20.9	16.0	13.5	31.7	20.9	12.4	6.4	27.8	20.2	97.9	24.8	19.5	11.9	30.4	18.9	23.1	4.5	32.0	17.3	15.8	72.1	17.0	25.8	21.5	34.0	84.8	50.9	15.3	42.1	31.3	31.3	51.0	35.0	26.3	37.2	39.5	50.3	32.6	64.1	107.8	33.7	31.5	31.5	76.9	40.4	20.2	42.6	46.5	46.3	46.6	29.6	38.9	55.8	48.1	24.0	45.9	24.8	42.8	36.1	27.0	46.5	51.9	31.4	30.1	66.2	49.9	52.3	17.8	74.4	82.0	44.5	44.5	68.4	31.0	34.2	29.3	44.2	19.4	66.7	59.0	18.2	30.8	40.3	27.3	37.6	42.5	61.1	77.9	60.8	67.8	115.8	39.6	92.4	44.5	94.7	22.0	22.1	33.2	18.9	46.4	20.4	31.2	35.5	21.7	16.3	26.5	30.0	7.1	34.1	16.7	12.7	34.0	41.9	31.2	32.5	28.8	38.3	32.4	30.0	31.0	29.7	31.7	30.4	32.0	34.0	17.6	3.2	6.7	3.9	12.3	9.6	11.7	13.2	4.0	19.4	16.7	24.5	32.5	15.7	9.2	16.5	4.2	32.5	25.2	21.8	43.0	25.3	0.3	5.7	11.9	14.2	8.5	29.0	8.7	32.2	47.4	14.5	9.2	7.7	9.5	16.8	13.2	18.9	24.2	18.5	6.3	17.2	14.2	13.8	10.2	1.0	12.5	31.7	28.4	1.9	20.3	17.2	38.1	5.5	4.9	30.2	11.4	18.8	19.5	16.7	24.6	25.1	4.7	11.4	0.0	13.2	24.9	0.1	5.7	21.9	12.1	13.0	16.2	7.2	17.4	7.8
UBLCP1	"CPUB1, MGC10067"	ENSG00000164332	"Ubiquitin like domain containing CTD phosphatase 1"	Q8WVY7	5	159263290-159286036	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039615	Approved		Supported	"Nucleoplasm,Nucleoli,Nucleoli rim"		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 16: Immune cells - Immune response"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 59: Non-specific - Transcription"	"Nucleoplasm, Nucleoli, Nucleoli rim"		"HPA039615: AB_10674425"	"unprognostic (1.25e-1)"	"unprognostic (3.10e-1)"	"unprognostic (6.04e-3)"	"unprognostic (3.45e-2)"	"unprognostic (7.08e-2)"	"unprognostic (6.82e-2)"	"prognostic unfavorable (4.46e-5)"	"unprognostic (4.01e-1)"	"unprognostic (2.14e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.91e-2)"	"unprognostic (5.43e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.18e-1)"	"unprognostic (6.39e-2)"	"unprognostic (2.51e-2)"	19.0	16.3	8.8	24.5	9.4	23.3	20.5	9.6	14.1	19.9	6.4	15.7	12.6	23.6	17.2	21.1	15.1	17.1	16.4	10.0	10.5	19.2	18.3	22.4	33.7	10.3	9.5	15.8	14.9	19.7	5.6	23.6	10.2	17.5	16.9	18.2	14.2	19.6	10.9	15.5	12.7	22.8	9.6	26.7	15.8	30.5	10.7	36.4	16.6	13.8	37.3	21.3	11.7	10.7	39.9	28.6	57.9	64.1	58.9	54.5	34.1	42.5	64.6	42.8	56.6	23.5	27.1	35.7	46.1	53.7	60.9	29.7	36.3	81.8	74.3	71.3	35.7	27.3	23.8	21.9	74.0	62.7	41.1	48.1	76.8	38.9	77.2	34.0	41.4	36.4	38.4	47.0	60.8	12.9	33.5	22.9	41.7	20.0	17.1	42.3	56.5	42.8	44.4	30.4	30.4	42.9	42.7	29.0	115.8	34.6	30.2	45.6	44.2	44.0	37.8	22.8	54.9	36.9	39.8	53.5	46.1	43.9	66.1	47.6	10.8	27.5	25.5	22.4	28.4	18.5	23.9	26.7	14.2	16.7	26.9	29.1	30.8	42.8	24.5	17.8	28.3	13.6	8.8	9.4	9.6	14.1	10.0	10.5	10.3	9.5	10.2	9.6	10.7	10.7	31.9	12.8	41.6	12.7	43.0	15.9	10.3	43.0	35.3	12.7	22.5	14.4	16.8	10.0	34.4	14.7	4.2	31.8	36.8	13.2	35.2	23.0	8.5	23.2	32.1	24.2	10.7	30.1	26.3	24.9	18.7	27.1	29.6	17.4	45.0	16.9	28.5	15.6	39.0	20.2	25.0	14.6	18.3	40.0	16.4	4.2	20.5	33.1	17.8	14.0	30.9	17.6	32.0	22.6	25.6	22.5	10.1	24.8	39.3	13.2	8.8	34.5	37.4	13.1	19.7	18.8	26.2	74.0	61.5	51.8	20.6	17.8	40.8	30.7	14.5	10.1
UBN1		ENSG00000118900	"Ubinuclein 1"	Q9NPG3	16	4846665-4882401	"Predicted intracellular proteins"	"Host-virus interaction"	"Chromatin regulator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 153.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	8	"neutrophil: 14.2"	"Lineage enriched"	"Detected in all"	8	"granulocytes: 14.2"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA061029, HPA069036, HPA069045"	Supported		Supported	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	Nucleoplasm	"Nuclear bodies"	"HPA061029: AB_2684420, HPA069036: , HPA069045: AB_2686072"	"unprognostic (8.20e-2)"	"unprognostic (1.01e-1)"	"unprognostic (8.99e-3)"	"unprognostic (1.75e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.47e-3)"	"unprognostic (6.53e-3)"	"unprognostic (1.35e-1)"	"unprognostic (1.02e-2)"	"prognostic unfavorable (3.84e-4)"	"unprognostic (1.38e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.41e-2)"	"unprognostic (6.89e-2)"	14.7	12.3	8.3	14.5	7.9	48.9	12.9	10.5	8.3	14.9	12.4	13.9	14.7	12.4	6.5	25.0	11.9	11.8	20.8	9.1	5.9	10.5	13.6	13.5	15.4	6.6	6.9	13.3	14.1	12.2	10.1	11.5	5.8	11.6	14.3	20.1	15.7	9.6	22.9	15.8	14.6	13.8	6.2	21.5	12.7	37.4	8.0	22.5	11.4	19.5	15.5	11.6	16.5	8.0	21.0	26.0	29.5	29.3	25.3	23.6	23.7	25.7	24.5	29.6	28.4	21.7	24.4	39.2	23.1	25.3	32.1	27.2	38.2	23.6	25.0	38.4	19.0	32.2	35.0	17.1	24.3	39.4	33.6	15.8	30.6	34.4	36.7	22.5	39.3	38.3	53.6	32.5	22.0	30.1	43.6	18.0	25.1	21.8	19.3	67.5	36.6	37.5	15.5	24.0	39.9	22.0	44.7	36.4	22.3	21.8	36.0	34.6	39.7	31.3	29.5	102.5	32.4	30.4	34.7	77.5	18.5	24.5	53.9	1.7	1.2	0.9	1.4	1.1	1.0	0.9	1.0	1.3	0.8	1.0	1.1	0.7	14.2	1.0	0.9	1.7	0.9	0.9	8.3	7.9	10.5	8.3	9.1	5.9	6.6	6.9	5.8	6.2	8.0	8.0	31.2	9.6	15.9	17.3	31.9	18.0	22.0	7.5	30.1	59.9	23.6	20.3	25.5	22.8	9.8	9.2	110.5	28.1	51.3	41.1	7.9	16.7	46.2	39.2	36.8	36.4	30.9	32.4	17.9	18.2	23.3	22.9	29.6	29.8	7.6	27.9	28.5	31.0	23.2	50.5	16.8	27.4	8.2	33.2	21.5	57.8	29.2	37.0	26.6	30.0	28.9	27.9	61.8	19.6	20.3	27.7	33.4	22.6	44.0	33.4	27.4	13.3	16.4	100.8	13.1	26.8	21.8	153.8	128.4	30.9	22.3	29.1	40.4	35.2	26.8	27.3
UBP1	LBP-1a	ENSG00000153560	"Upstream binding protein 1"	Q9NZI7	3	33388336-33441371	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003967			Supported	Nucleoplasm		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm		"HPA003967: AB_10601829"	"unprognostic (3.11e-1)"	"unprognostic (2.10e-1)"	"prognostic favorable (1.81e-4)"	"unprognostic (4.64e-2)"	"unprognostic (9.35e-2)"	"unprognostic (3.92e-2)"	"prognostic unfavorable (9.45e-4)"	"unprognostic (6.67e-3)"	"unprognostic (3.92e-2)"	"unprognostic (1.11e-2)"	"unprognostic (2.01e-1)"	"unprognostic (7.48e-3)"	"unprognostic (1.23e-1)"	"unprognostic (3.14e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.90e-1)"	"unprognostic (1.88e-2)"	23.6	21.4	18.6	31.2	20.8	24.5	24.4	24.3	22.9	23.9	14.2	34.7	29.7	28.7	26.8	29.6	23.2	24.4	31.3	21.2	19.9	23.4	32.4	30.5	44.1	15.0	16.6	29.2	31.0	24.6	22.9	22.2	15.5	25.7	34.6	28.5	23.5	39.5	23.0	26.5	28.7	37.0	17.0	32.6	27.0	16.9	20.0	43.6	26.5	27.6	43.8	35.6	23.0	18.4	48.9	58.6	44.3	74.0	66.1	48.0	21.6	57.7	64.0	67.8	68.4	57.1	42.5	91.2	33.1	85.2	48.6	33.1	133.3	67.6	82.9	50.2	40.7	97.9	57.0	68.7	46.2	71.8	40.5	40.0	54.4	65.7	66.3	55.5	82.5	49.6	90.7	49.0	66.1	46.5	57.5	42.5	105.4	38.6	59.7	59.8	32.4	84.7	47.9	72.8	30.5	36.3	45.9	78.8	50.3	58.5	59.6	86.2	68.8	59.4	45.7	67.8	81.1	38.8	74.9	92.4	51.4	82.7	45.0	3.5	1.6	1.7	2.1	1.7	2.0	1.1	2.1	2.1	2.5	0.8	2.4	2.0	0.4	2.2	2.4	2.0	1.4	1.6	18.6	20.8	24.3	22.9	21.2	19.9	15.0	16.6	15.5	17.0	20.0	18.4	18.0	6.4	20.9	29.7	15.4	25.5	9.7	13.6	19.9	24.6	35.3	17.8	29.3	18.6	10.0	11.0	14.6	7.9	22.2	30.0	3.9	11.8	1.6	12.8	23.5	23.5	12.1	21.7	58.3	14.5	9.4	15.8	17.9	18.4	2.5	27.2	21.4	41.6	14.8	23.5	50.9	27.8	10.2	27.3	27.6	3.5	9.9	25.5	26.6	29.0	27.3	7.7	20.6	34.2	35.5	14.3	17.1	17.7	15.7	17.1	17.3	10.9	8.1	17.8	13.1	15.6	19.7	14.3	13.8	26.8	31.1	5.5	20.5	24.9	28.4	13.2
UBQLN1	"DA41, DSK2, PLIC-1, XDRP1"	ENSG00000135018	"Ubiquilin 1"	Q9UMX0	9	83659968-83707958	"Plasma proteins, Predicted intracellular proteins"	Autophagy			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB037256, HPA054143"	Supported		Supported	Nucleoplasm,Cytosol		NA	NA		200000	"Cluster 7: Monocytes - Unknown function"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm	Cytosol	"CAB037256: AB_1858556, HPA054143: AB_2682398"	"unprognostic (4.72e-3)"	"unprognostic (9.61e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.49e-1)"	"unprognostic (2.77e-2)"	"unprognostic (2.87e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.80e-3)"	"unprognostic (2.35e-1)"	"unprognostic (1.01e-1)"	"unprognostic (6.98e-2)"	"unprognostic (1.60e-1)"	"prognostic favorable (1.07e-5)"	"unprognostic (3.11e-2)"	"unprognostic (9.49e-2)"	"unprognostic (1.44e-3)"	"unprognostic (2.29e-2)"	50.1	49.8	43.0	43.6	46.4	84.9	42.3	42.2	46.7	40.7	30.6	44.2	39.3	43.1	38.8	50.8	36.9	37.0	63.0	50.1	50.2	55.2	74.0	39.0	51.1	46.7	47.2	36.1	50.5	72.2	28.6	50.4	50.7	45.4	41.3	55.8	34.5	46.8	125.8	42.4	39.6	47.1	43.6	37.7	42.4	42.0	46.3	69.4	45.3	72.9	65.1	53.3	35.2	57.0	154.5	137.8	101.9	77.9	83.4	89.3	164.0	140.8	125.4	147.7	111.3	56.8	105.5	153.9	86.6	120.0	137.0	172.0	141.8	101.7	152.7	79.7	66.0	95.1	97.9	90.3	111.7	116.6	98.3	74.7	127.1	124.1	172.4	92.8	112.8	72.6	102.7	105.7	124.6	91.0	160.8	66.6	132.6	147.5	126.3	117.6	113.7	80.4	98.7	65.0	90.4	101.2	130.9	131.7	102.0	100.2	64.6	84.2	111.8	92.2	84.9	154.2	143.6	146.1	222.0	74.7	139.4	85.1	114.1	34.9	21.2	22.6	19.8	31.4	19.3	19.0	16.9	18.2	24.2	19.6	16.9	18.5	22.7	31.8	30.7	10.5	24.2	20.5	43.0	46.4	42.2	46.7	50.1	50.2	46.7	47.2	50.7	43.6	46.3	57.0	39.5	35.3	42.2	29.4	53.9	103.2	66.2	43.0	42.7	58.4	41.2	28.3	76.7	31.5	46.8	22.0	20.9	59.9	38.9	49.9	19.6	55.1	37.9	47.7	50.9	42.8	51.4	51.8	61.9	53.5	86.9	42.2	32.1	74.9	50.1	33.6	25.7	73.4	52.1	75.7	58.7	41.5	42.7	51.2	87.5	18.3	24.5	52.4	42.7	41.2	46.5	31.0	39.1	33.2	67.9	70.4	36.5	27.8	56.2	68.8	48.9	39.6	33.4	34.1	39.5	33.4	42.9	74.1	50.5	45.2	92.5	164.3	47.7	28.9	41.1	84.0
UBQLN4	"A1U, C1orf6, UBIN"	ENSG00000160803	"Ubiquilin 4"	Q9NRR5	1	156035299-156053798	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	"Autophagy, DNA damage, DNA repair"		"Amyotrophic lateral sclerosis, Disease variant, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	5	"basophil: 9.7"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 9.7"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA061797	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm		"HPA061797: AB_2684613"	"unprognostic (3.91e-2)"	"unprognostic (2.01e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.29e-3)"	"unprognostic (1.52e-2)"	"unprognostic (6.75e-2)"	"unprognostic (1.58e-3)"	"unprognostic (5.48e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.32e-2)"	"unprognostic (1.91e-2)"	"unprognostic (1.01e-2)"	"unprognostic (2.54e-2)"	"unprognostic (7.25e-3)"	"unprognostic (7.65e-2)"	"unprognostic (4.73e-1)"	"unprognostic (1.57e-1)"	18.9	19.4	39.9	14.6	47.9	9.1	19.1	34.3	52.5	31.6	27.3	24.5	13.6	24.3	15.3	33.7	26.7	11.5	26.7	40.8	40.2	25.7	31.7	20.8	15.0	38.1	38.3	21.1	32.2	25.6	11.3	15.5	37.7	25.4	15.5	18.3	23.3	19.6	59.7	27.0	18.8	22.9	37.1	20.2	28.2	19.8	40.0	14.1	17.7	39.5	17.0	26.1	26.0	39.8	45.9	54.1	50.8	50.1	34.1	21.0	50.0	37.8	20.7	37.2	27.8	49.0	40.5	77.7	33.9	34.7	20.1	50.2	51.8	40.8	35.2	65.9	54.9	42.8	31.5	47.7	21.9	46.4	77.3	15.9	51.6	51.3	41.5	32.6	44.8	24.4	81.4	42.1	34.0	56.3	51.4	46.5	69.8	117.2	49.8	64.8	37.4	76.9	30.2	45.7	37.3	108.0	38.0	93.2	38.7	49.0	90.1	50.4	43.7	34.3	44.9	35.3	41.4	92.7	79.4	83.2	21.0	45.9	49.1	9.7	0.7	0.4	1.5	0.7	1.9	1.1	1.1	1.6	0.5	0.8	0.8	1.2	0.0	1.2	0.1	1.2	1.0	0.7	39.9	47.9	34.3	52.5	40.8	40.2	38.1	38.3	37.7	37.1	40.0	39.8	8.6	6.4	5.3	9.8	8.4	13.4	9.4	9.1	18.2	6.8	17.2	9.9	4.3	17.2	8.5	23.9	6.2	8.1	8.1	9.6	3.9	11.6	0.8	5.0	10.2	9.3	10.7	6.3	5.9	10.9	9.1	7.4	7.1	8.9	1.3	13.4	11.7	22.7	9.9	6.7	6.6	10.8	8.2	8.4	7.2	4.9	6.5	8.3	17.8	9.4	15.6	7.3	5.2	4.5	9.2	13.1	6.9	9.1	13.0	25.3	8.2	12.1	5.4	6.0	0.0	10.7	7.8	4.9	5.6	21.0	14.6	8.2	7.7	4.8	15.0	14.3
UBR1		ENSG00000159459	"Ubiquitin protein ligase E3 component n-recognin 1"	Q8IWV7	15	42942897-43106113	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Ubl conjugation pathway"	Transferase	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 48.6"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 108.9;Inhibitory neurons: 108.8;Oligodendrocyte precursor cells: 102.1;Oligodendrocytes: 127.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038838, HPA038839"	Approved		Approved	Nucleoplasm,Vesicles,Cytosol		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	Vesicles	"Nucleoplasm, Cytosol"	"HPA038838: AB_10673120, HPA038839: "	"unprognostic (1.07e-2)"	"unprognostic (5.02e-2)"	"unprognostic (9.77e-2)"	"unprognostic (1.55e-2)"	"unprognostic (1.89e-2)"	"unprognostic (1.29e-1)"	"unprognostic (2.67e-1)"	"unprognostic (1.49e-1)"	"unprognostic (4.79e-1)"	"unprognostic (2.97e-2)"	"unprognostic (1.93e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.27e-3)"	"unprognostic (5.78e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.00e-1)"	"unprognostic (1.89e-1)"	9.1	7.9	12.5	8.8	29.4	24.9	9.3	11.7	17.4	9.9	4.8	8.6	7.8	10.7	7.4	5.8	8.0	8.6	13.7	11.6	31.5	9.2	7.1	8.6	10.9	24.2	18.3	7.7	9.5	14.3	6.6	10.5	21.6	10.0	8.0	14.3	6.3	10.5	12.0	5.6	7.8	9.6	8.5	9.5	7.2	10.1	21.2	13.3	12.6	14.0	8.7	9.1	5.8	48.6	7.4	10.2	11.6	9.6	17.1	14.7	10.7	17.6	19.4	15.9	19.2	13.3	5.5	8.6	10.1	18.4	18.9	12.4	17.1	15.5	18.1	18.0	8.4	33.1	20.4	6.3	12.3	23.0	14.4	15.3	8.4	18.8	14.8	14.6	17.0	16.7	19.6	12.3	18.7	4.5	12.7	6.8	6.5	18.9	10.6	16.4	15.7	6.4	14.9	16.6	12.0	10.3	22.7	12.0	7.7	13.1	10.9	12.2	24.3	17.9	11.1	16.7	18.0	14.6	26.4	23.6	12.2	14.6	16.6	3.7	1.5	2.5	2.4	1.8	2.9	1.9	2.6	2.9	1.4	2.3	2.6	3.2	2.9	3.2	1.7	2.2	1.9	0.9	12.5	29.4	11.7	17.4	11.6	31.5	24.2	18.3	21.6	8.5	21.2	48.6	46.4	48.1	30.7	73.1	28.9	10.6	11.6	9.3	17.1	27.5	15.4	10.8	28.0	12.8	19.1	9.2	27.1	14.7	35.8	12.8	0.0	10.8	16.8	13.4	27.4	24.5	14.4	23.8	108.9	14.4	7.7	25.6	20.9	18.2	28.5	22.8	17.2	9.9	8.1	32.0	108.8	10.9	14.2	16.4	10.6	16.9	16.1	17.1	8.8	73.1	15.6	13.5	23.7	102.1	127.6	10.3	8.2	20.7	33.2	7.7	12.3	9.2	15.7	38.8	13.1	34.7	36.5	27.0	17.8	8.6	7.2	36.9	31.4	16.5	10.6	9.8
UBR4	"KIAA0462, KIAA1307, RBAF600, ZUBR1"	ENSG00000127481	"Ubiquitin protein ligase E3 component n-recognin 4"	Q5T4S7	1	19074510-19210266	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Host-virus interaction, Ubl conjugation pathway"	"Calmodulin-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Basal keratinocytes: 271.0;Suprabasal keratinocytes: 252.9;Urothelial cells: 236.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 39.8"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA013394, HPA021046"	Approved		Supported	Nucleoplasm,Centrosome,Cytosol		NA	NA		15000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 31: Skin - Epidermis development"	"Cluster 21: OE19 - Mitochondria"	"Cluster 22: Epithelial cell types - Mixed function"	Nucleoplasm	"Centrosome, Cytosol"	"HPA013394: , HPA021046: AB_1858578"	"unprognostic (1.37e-1)"	"unprognostic (2.57e-2)"	"unprognostic (2.82e-2)"	"unprognostic (2.02e-1)"	"unprognostic (8.78e-2)"	"unprognostic (9.77e-2)"	"unprognostic (1.14e-3)"	"unprognostic (3.09e-1)"	"unprognostic (1.96e-1)"	"unprognostic (9.14e-3)"	"unprognostic (7.48e-2)"	"unprognostic (2.53e-1)"	"unprognostic (7.68e-3)"	"unprognostic (4.30e-1)"	"unprognostic (1.19e-1)"	"unprognostic (5.58e-2)"	"unprognostic (1.52e-1)"	56.2	62.8	48.2	23.0	46.0	79.8	49.8	38.7	48.4	57.4	47.6	69.6	20.9	61.7	35.7	55.4	52.3	29.6	58.7	45.8	46.0	74.7	82.7	71.9	25.7	51.5	46.4	75.3	53.5	35.5	70.7	27.5	54.9	67.2	22.7	44.6	48.0	27.0	129.1	161.9	59.7	26.0	35.2	62.8	70.6	105.3	45.9	34.6	56.5	45.0	25.7	90.0	59.2	44.7	61.4	60.7	53.5	39.7	97.6	50.0	46.2	46.5	48.8	49.5	44.7	97.2	51.3	36.6	42.3	61.7	43.3	40.8	42.3	46.3	46.0	30.6	37.5	83.8	63.3	64.1	68.6	51.9	53.4	45.0	57.9	100.8	96.3	48.1	54.9	63.7	58.5	32.9	47.6	43.6	24.7	62.9	43.5	124.3	33.6	34.0	41.7	31.0	44.7	35.2	37.7	37.4	55.0	31.1	39.9	48.6	21.7	40.4	85.9	57.4	36.1	69.0	52.8	38.8	25.2	41.5	39.3	79.3	50.3	39.8	28.7	4.7	4.9	5.9	4.2	7.4	4.4	2.9	14.2	4.0	3.9	3.7	15.4	4.4	2.1	6.5	3.4	8.3	48.2	46.0	38.7	48.4	45.8	46.0	51.5	46.4	54.9	35.2	45.9	44.7	28.1	35.3	37.6	85.5	30.3	271.0	124.6	28.9	28.5	57.5	22.1	23.9	19.1	37.1	30.4	31.3	152.2	24.7	34.2	31.6	13.7	41.3	21.4	39.8	32.0	30.8	17.5	48.4	58.9	40.9	17.0	32.2	44.9	50.4	19.6	32.9	31.1	94.1	63.2	79.1	61.8	29.2	12.2	43.0	48.7	28.7	30.7	46.4	49.8	34.7	64.4	28.8	21.6	51.8	44.5	61.0	16.7	35.7	26.4	59.1	57.9	135.6	39.1	48.5	19.7	28.3	30.1	44.8	21.0	28.0	252.9	33.9	32.7	34.5	20.1	236.5
UBR5	"DD5, EDD, EDD1, HYD, KIAA0896"	ENSG00000104517	"Ubiquitin protein ligase E3 component n-recognin 5"	O95071	8	102252273-102412759	"Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, Host-virus interaction, Ubl conjugation pathway"	Transferase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Astrocytes: 239.9;Excitatory neurons: 214.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053688			Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm	Cytosol	"HPA053688: AB_2682230"	"unprognostic (3.79e-3)"	"unprognostic (7.44e-3)"	"unprognostic (1.25e-1)"	"unprognostic (2.10e-2)"	"unprognostic (2.44e-2)"	"unprognostic (1.41e-1)"	"prognostic unfavorable (1.26e-4)"	"unprognostic (2.50e-1)"	"unprognostic (1.75e-2)"	"unprognostic (7.54e-3)"	"unprognostic (8.29e-3)"	"unprognostic (3.84e-2)"	"unprognostic (6.64e-2)"	"unprognostic (3.16e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.69e-2)"	"unprognostic (2.45e-1)"	33.0	18.3	16.6	22.4	19.4	36.5	30.9	26.5	24.0	25.6	23.4	33.3	14.9	29.6	23.7	27.5	26.1	17.3	25.8	17.3	16.0	17.5	17.7	29.8	33.6	16.0	16.1	32.2	25.7	30.4	24.4	17.8	15.7	20.0	17.0	45.4	26.1	20.7	50.1	35.6	27.2	17.2	13.7	24.2	25.0	43.9	16.6	43.0	21.0	29.6	28.6	28.2	26.4	18.9	64.5	28.4	53.2	27.5	51.8	52.2	48.9	47.4	41.9	36.6	31.7	28.3	42.1	127.1	39.8	44.5	23.7	38.2	46.2	41.1	51.1	55.3	22.7	106.5	39.7	52.2	46.1	33.7	56.3	60.1	40.4	37.5	64.5	41.5	44.6	35.6	52.3	70.2	34.8	58.0	85.3	40.3	40.1	61.8	31.6	49.3	31.6	60.9	33.5	62.3	39.1	32.5	33.4	31.8	34.3	46.1	51.4	35.1	44.6	38.5	44.9	35.1	33.5	37.3	38.7	129.5	38.0	51.2	32.0	1.8	1.5	2.4	2.4	1.5	2.4	2.1	2.5	2.5	1.8	1.7	2.0	3.0	3.0	1.1	2.7	1.6	3.4	1.0	16.6	19.4	26.5	24.0	17.3	16.0	16.0	16.1	15.7	13.7	16.6	18.9	51.4	25.6	31.7	239.9	44.8	52.3	41.2	26.3	55.8	52.0	37.3	29.6	39.8	8.6	49.9	31.3	68.8	27.7	36.2	20.9	9.8	18.8	38.6	47.5	47.0	40.1	33.4	33.2	214.2	15.0	18.9	43.7	37.8	69.0	29.8	64.3	22.9	19.0	17.0	57.2	191.7	19.5	26.4	31.4	52.6	23.6	39.7	43.7	44.4	129.3	43.5	31.3	26.8	196.6	174.0	21.4	18.3	36.5	65.9	45.2	18.3	9.0	46.5	44.8	13.1	66.3	48.4	59.4	30.2	46.8	61.1	69.6	46.9	30.8	19.5	53.5
UBXN1	"2B28, LOC51035, SAKS1, UBXD10"	ENSG00000162191	"UBX domain protein 1"	Q04323	11	62676498-62679117	"Predicted intracellular proteins"	"Host-virus interaction"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012669, HPA076932"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA		45000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 59: Non-specific - Translation"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 32: Non-specific - Translation"	Cytosol	Nucleoplasm	"HPA012669: AB_1853149, HPA076932: "	"unprognostic (1.76e-3)"	"unprognostic (8.72e-3)"	"unprognostic (3.67e-3)"	"unprognostic (2.94e-2)"	"unprognostic (9.39e-2)"	"unprognostic (8.72e-2)"	"unprognostic (2.96e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.15e-1)"	"unprognostic (4.36e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.07e-1)"	"unprognostic (3.81e-2)"	"unprognostic (3.52e-2)"	"unprognostic (1.43e-1)"	"unprognostic (3.34e-3)"	"unprognostic (2.42e-1)"	138.3	103.0	88.9	67.1	94.0	63.7	121.3	91.5	102.9	133.5	86.1	130.6	71.9	113.2	44.3	99.6	112.4	54.4	106.4	85.8	88.5	95.1	72.8	81.9	108.0	96.5	90.1	147.8	120.3	58.9	75.8	52.2	93.9	89.4	37.9	28.0	79.0	56.1	284.3	128.6	93.3	48.3	91.2	111.7	116.6	113.5	91.1	107.6	96.8	105.3	82.2	113.2	103.8	94.7	86.2	137.7	101.3	142.5	137.7	147.0	87.7	73.4	136.6	139.4	94.6	99.0	109.7	135.7	131.3	100.1	123.7	119.2	81.6	128.3	64.5	124.3	99.5	95.6	118.9	136.4	269.1	150.7	102.6	191.7	195.1	123.5	188.5	149.4	132.1	170.3	148.0	86.4	88.5	196.6	117.8	280.3	5.2	67.4	88.9	86.6	107.9	135.3	114.1	85.8	98.6	165.5	68.8	108.3	330.0	43.2	150.5	188.0	128.6	111.8	84.0	113.4	84.6	109.0	89.3	123.8	129.7	64.9	103.7	158.0	320.2	160.7	273.9	346.7	350.2	534.6	415.2	323.7	346.2	533.5	494.7	365.8	173.5	303.8	440.6	276.8	562.3	559.0	88.9	94.0	91.5	102.9	85.8	88.5	96.5	90.1	93.9	91.2	91.1	94.7	183.1	93.0	116.4	16.6	222.8	264.0	176.5	240.7	142.3	61.7	202.9	190.2	86.4	137.2	160.7	75.4	45.9	172.9	194.1	162.0	156.5	191.1	184.1	91.2	119.0	194.9	126.2	144.9	9.2	184.7	195.2	124.1	78.0	81.4	162.7	146.6	180.2	77.0	216.3	30.3	9.1	156.5	187.2	325.2	352.2	245.8	208.8	196.2	183.2	8.4	307.5	153.5	244.1	7.5	17.8	203.8	235.9	143.3	93.0	192.7	335.9	259.7	132.7	57.4	197.2	171.3	300.3	257.6	220.6	130.2	302.8	324.7	226.9	147.0	161.4	235.0
UBXN4	"KIAA0242, UBXD2, UBXDC1"	ENSG00000144224	"UBX domain protein 4"	Q92575	2	135741734-135785056	"Predicted intracellular proteins, Predicted membrane proteins"	"Unfolded protein response"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 863.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036325	Approved		Supported	"Endoplasmic reticulum"		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 29: Early spermatids - Spermatogenesis"	"Endoplasmic reticulum"		"HPA036325: AB_10669788"	"unprognostic (1.22e-2)"	"unprognostic (1.08e-1)"	"unprognostic (5.24e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.91e-1)"	"unprognostic (5.40e-2)"	"unprognostic (2.94e-2)"	"unprognostic (2.63e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.83e-2)"	"unprognostic (4.44e-2)"	"unprognostic (1.27e-1)"	"unprognostic (3.25e-2)"	"unprognostic (5.14e-3)"	51.9	55.6	33.3	58.4	38.3	65.4	57.4	37.4	38.0	62.3	44.7	57.1	69.8	56.0	71.1	44.4	49.0	57.2	44.3	31.5	33.8	64.2	93.8	47.2	59.5	40.2	36.8	52.6	73.4	83.5	19.6	63.0	40.1	64.6	60.2	85.6	71.8	47.8	55.1	56.0	67.9	43.9	35.9	55.7	64.6	57.7	33.7	76.6	76.1	52.7	59.8	60.5	25.1	47.6	136.2	34.6	85.1	66.2	106.9	107.0	95.5	106.6	106.3	87.0	77.4	65.3	91.8	84.0	149.4	105.1	46.6	98.3	50.7	68.4	103.5	115.5	62.8	80.5	60.7	98.6	99.4	85.2	70.7	81.6	66.6	86.7	85.8	118.2	110.5	66.2	74.4	116.1	95.3	64.1	109.9	61.3	64.3	70.6	70.9	87.9	100.5	146.5	112.2	97.7	77.4	50.2	97.2	64.1	64.4	77.1	68.0	78.2	101.8	78.4	40.1	82.5	58.4	108.7	72.2	76.2	99.0	59.3	75.5	62.9	35.8	59.1	46.5	42.3	42.6	45.9	42.5	42.5	35.8	42.6	41.4	41.0	73.7	48.4	52.2	56.6	52.3	35.9	33.3	38.3	37.4	38.0	31.5	33.8	40.2	36.8	40.1	35.9	33.7	47.6	178.1	208.3	171.4	56.2	177.4	175.1	283.0	318.5	160.5	172.3	164.1	153.3	150.8	134.4	264.1	126.9	223.1	238.2	140.8	168.9	90.1	254.6	863.9	209.3	223.1	151.7	186.6	129.8	85.2	195.8	214.0	197.4	129.5	240.6	176.9	151.5	113.2	225.7	138.8	97.6	78.4	246.9	183.1	88.6	125.2	325.1	172.7	139.9	92.5	60.9	158.8	162.2	122.6	71.9	105.3	190.7	166.7	143.7	300.3	344.1	183.0	156.8	286.7	349.8	105.2	159.3	173.9	446.1	248.4	176.1	183.6	379.4	171.6	271.6	186.0	303.7
UBXN8	"D8S2298E, REP8, UBXD6"	ENSG00000104691	"UBX domain protein 8"	O00124	8	30729131-30767006	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ovary: 79.9"	"Group enriched"	"Detected in many"	5	"Early spermatids: 167.4;Granulosa cells: 191.2;Hepatocytes: 65.7;Late spermatids: 180.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017725, HPA077538"	Enhanced		Supported	"Nucleoplasm,Nucleoli,Endoplasmic reticulum"	"Intracellular and membrane"	NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 40: Granulosa cells - Unknown function"	"Endoplasmic reticulum"	"Nucleoplasm, Nucleoli"	"HPA017725: AB_1847462, HPA077538: AB_2686844"	"unprognostic (3.00e-2)"	"unprognostic (2.30e-1)"	"prognostic favorable (6.13e-4)"	"unprognostic (7.71e-2)"	"unprognostic (2.24e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.41e-1)"	"unprognostic (1.84e-2)"	"unprognostic (1.90e-1)"	"unprognostic (5.13e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.06e-2)"	"prognostic unfavorable (5.25e-5)"	"unprognostic (2.49e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.51e-1)"	"unprognostic (6.88e-2)"	10.2	17.3	17.0	7.1	12.0	8.8	14.1	12.2	16.1	10.4	0.0	12.5	13.1	10.4	49.9	10.7	13.2	13.5	4.9	13.3	5.4	22.1	44.1	8.7	8.1	10.3	4.2	79.9	33.0	20.5	2.8	15.6	10.6	16.3	16.3	11.6	8.5	18.6	3.7	16.9	12.1	10.8	1.7	11.1	12.4	37.1	9.2	14.3	25.9	5.4	9.7	10.4	3.3	12.7	16.4	17.0	11.7	12.2	17.9	25.2	14.3	29.5	17.2	15.2	19.6	27.6	6.1	26.8	23.2	24.5	25.9	14.8	3.1	16.8	24.6	23.9	27.2	77.0	14.0	33.0	27.3	18.1	41.8	20.2	17.4	25.6	12.7	13.6	14.1	12.8	71.9	21.8	35.5	16.1	18.6	14.6	22.9	52.2	12.9	21.4	10.9	18.3	27.7	22.4	6.4	17.7	8.3	26.0	52.1	14.1	16.8	30.4	17.3	17.0	7.8	8.2	28.3	8.8	29.2	19.7	15.0	29.0	25.5	0.0	4.6	0.6	6.2	4.9	5.4	4.7	3.3	5.8	5.2	1.9	3.0	5.5	0.8	2.8	2.4	6.5	3.2	2.7	17.0	12.0	12.2	16.1	13.3	5.4	10.3	4.2	10.6	1.7	9.2	12.7	20.5	3.2	8.2	5.5	5.2	0.0	5.4	0.0	8.0	2.5	7.5	7.6	4.3	17.2	3.1	14.7	20.9	23.8	10.7	7.5	7.9	9.7	167.4	9.1	18.6	12.4	8.5	12.8	5.4	5.3	20.2	22.8	9.7	11.3	14.0	191.2	21.4	65.7	22.0	11.8	7.8	9.7	0.0	16.7	0.0	180.4	14.3	8.9	0.0	6.5	11.6	8.1	12.3	4.5	16.3	3.1	6.0	9.8	6.7	4.9	6.9	25.4	0.7	2.2	6.6	8.7	10.4	16.1	24.2	13.0	0.0	15.2	6.6	27.1	11.8	4.4
UCHL1	"PARK5, PGP9.5, Uch-L1"	ENSG00000154277	"Ubiquitin C-terminal hydrolase L1"	P09936	4	41256413-41268455	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"	"Disease variant, Hereditary spastic paraplegia, Neurodegeneration, Parkinson disease, Parkinsonism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 692.7;pituitary gland: 285.4"	"Cell type enhanced"	"Detected in many"		"Collecting duct cells: 115.8;Distal tubular cells: 258.2;Excitatory neurons: 147.1;Horizontal cells: 146.4;Inhibitory neurons: 118.4;Spermatogonia: 88.4"	"Cancer enhanced"	"Detected in all"		"glioma: 129.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"EFO-21: 1142.2;SCLC-21H: 1160.6;U-251 MG: 1162.6;U-266/84: 1138.4;U-87 MG: 1209.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002580, HPA005993, CAB079024"	Enhanced	Supported	Supported	Nucleoplasm,Cytosol		NA	NA		500000	"Cluster 43: B-cells - Humoral immune response"	"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 39: Non-specific - Basic cellular processes"	Cytosol	Nucleoplasm	"CAB002580: AB_563981, CAB079024: , HPA005993: AB_1858560"	"unprognostic (1.54e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.12e-1)"	"prognostic unfavorable (4.08e-5)"	"unprognostic (2.34e-1)"	"unprognostic (1.98e-1)"	"unprognostic (6.28e-3)"	"unprognostic (1.09e-2)"	"unprognostic (4.31e-2)"	"unprognostic (8.77e-3)"	"unprognostic (3.56e-3)"	"unprognostic (3.70e-2)"	"unprognostic (1.82e-3)"	"unprognostic (1.24e-2)"	"unprognostic (7.12e-3)"	"unprognostic (2.10e-2)"	"prognostic unfavorable (1.93e-4)"	30.1	104.4	211.4	19.2	188.8	0.6	13.6	83.4	342.7	18.9	0.0	49.0	9.0	13.2	3.3	3.3	9.7	12.3	26.9	229.7	692.7	62.7	1.6	8.2	12.9	255.7	205.2	35.6	11.6	0.6	285.4	2.5	446.7	12.3	6.9	38.3	3.7	5.8	27.5	4.7	18.9	9.2	122.2	2.7	14.5	16.5	150.3	4.1	9.8	7.7	7.3	31.7	29.1	231.2	3.3	712.8	146.8	0.4	18.9	19.7	0.4	681.4	352.8	236.0	243.4	149.0	0.9	0.0	1142.2	384.4	356.7	1.1	262.8	0.6	116.4	1.5	97.0	0.0	6.9	0.2	529.3	0.1	1.2	127.4	3.0	197.9	0.0	413.7	2.0	0.0	0.0	2.3	122.6	0.6	1.0	12.3	435.3	0.0	714.1	0.1	297.2	0.7	386.3	0.3	1160.6	765.7	5.1	2.8	1.8	165.4	0.8	5.0	3.3	16.8	5.2	0.4	1162.6	583.1	1138.4	3.1	1209.3	1.1	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	211.4	188.8	83.4	342.7	229.7	692.7	255.7	205.2	446.7	122.2	150.3	231.2	0.8	0.0	3.1	29.0	2.1	1.7	1.1	1.5	1.2	25.6	0.3	0.6	3.1	0.0	3.5	115.8	8.4	3.6	0.0	0.1	258.2	4.3	3.5	0.9	9.8	3.9	4.2	0.8	147.1	0.8	0.8	35.4	1.1	0.5	2.5	46.3	8.9	0.6	4.7	146.4	118.4	0.0	4.1	0.6	3.4	6.0	37.0	2.3	3.6	35.6	0.6	21.6	0.0	55.8	54.6	3.0	0.0	17.3	9.2	3.7	0.0	17.1	7.4	61.3	0.0	3.6	35.7	10.4	88.4	0.3	1.6	1.5	1.3	20.0	0.2	1.0
UCHL3		ENSG00000118939	"Ubiquitin C-terminal hydrolase L3"	P15374	13	75549480-75606020	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019678, CAB037139, CAB037208"	Approved		Supported	Nucleoplasm,Cytosol		No	No		700000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 10: Non-specific - Unknown function"	"Nucleoplasm, Cytosol"		"CAB037139: AB_1841234, CAB037208: AB_1841235, HPA019678: AB_1858583"	"unprognostic (4.16e-1)"	"unprognostic (3.84e-2)"	"unprognostic (8.83e-3)"	"unprognostic (1.14e-1)"	"unprognostic (5.15e-2)"	"unprognostic (6.46e-3)"	"prognostic unfavorable (6.41e-4)"	"unprognostic (1.19e-1)"	"unprognostic (5.59e-2)"	"unprognostic (9.71e-2)"	"unprognostic (1.24e-1)"	"unprognostic (7.09e-2)"	"unprognostic (4.47e-2)"	"unprognostic (3.97e-1)"	"unprognostic (2.76e-2)"	"unprognostic (8.84e-2)"	"unprognostic (3.26e-2)"	20.7	56.9	20.6	20.2	24.2	33.5	34.2	20.3	25.2	15.3	17.2	35.4	21.6	12.4	63.2	58.0	13.0	17.7	29.3	21.7	20.5	32.2	50.9	15.0	21.3	18.6	18.9	7.4	30.9	23.9	22.9	24.6	18.5	19.5	39.5	9.7	27.2	18.2	53.9	48.6	19.9	25.1	18.9	15.9	25.1	43.3	20.5	25.7	44.4	40.6	34.6	44.3	26.6	21.0	196.0	31.9	26.9	18.8	49.9	58.6	78.6	72.3	70.3	90.7	100.5	177.5	92.1	100.4	50.2	75.7	70.2	105.8	64.1	175.3	137.1	53.8	55.9	62.2	50.7	114.9	71.6	150.4	45.7	52.6	118.7	71.7	114.2	38.4	90.1	79.6	70.0	27.9	138.9	70.2	62.4	100.2	40.3	229.0	95.1	49.5	42.9	66.3	108.4	77.9	81.0	23.8	40.8	78.3	34.5	58.2	45.7	42.0	70.8	39.6	47.9	42.7	98.2	39.5	45.5	117.1	80.4	161.3	29.0	57.6	68.7	49.3	29.9	134.4	39.6	51.5	54.1	43.0	99.5	51.5	53.0	49.5	15.6	62.7	117.9	134.9	71.8	50.1	20.6	24.2	20.3	25.2	21.7	20.5	18.6	18.9	18.5	18.9	20.5	21.0	18.2	9.6	23.4	9.1	20.3	76.3	80.4	197.5	35.9	9.3	48.8	66.2	27.2	28.6	88.2	46.0	2.1	105.2	32.9	39.0	92.0	146.2	198.2	35.4	17.4	26.6	24.0	24.4	22.5	143.1	163.6	25.1	23.9	36.2	24.1	19.3	13.9	45.7	88.0	16.8	22.3	54.6	81.4	28.8	28.8	43.5	16.8	32.8	26.6	18.7	33.3	17.3	22.6	22.6	24.9	153.1	44.3	11.7	33.3	133.1	40.4	119.6	48.0	8.9	19.7	24.5	73.5	159.3	36.8	64.8	79.1	169.0	22.1	47.6	60.8	96.2
UCHL5	"CGI-70, INO80R, UCH37"	ENSG00000116750	"Ubiquitin C-terminal hydrolase L5"	Q9Y5K5	1	193012250-193060080	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA recombination, DNA repair, Transcription, Transcription regulation, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005908, HPA006069"	Approved		Supported	Nucleoplasm,Nucleoli,Cytosol		NA	NA		18000	"Cluster 44: Non-specific - Transcription"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoplasm, Cytosol"	Nucleoli	"HPA005908: AB_1858585, HPA006069: "	"unprognostic (3.66e-2)"	"unprognostic (3.84e-3)"	"unprognostic (5.17e-2)"	"unprognostic (5.98e-2)"	"unprognostic (1.20e-2)"	"unprognostic (1.20e-1)"	"unprognostic (3.50e-2)"	"unprognostic (7.41e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.04e-3)"	"unprognostic (3.44e-3)"	"unprognostic (6.92e-2)"	"unprognostic (6.41e-3)"	"unprognostic (1.51e-1)"	"unprognostic (7.15e-2)"	"prognostic unfavorable (7.10e-5)"	"unprognostic (4.33e-2)"	19.9	19.0	11.0	22.5	12.1	24.6	22.7	20.3	15.8	13.6	5.5	23.3	24.7	14.8	17.5	32.2	11.3	15.5	30.5	13.3	12.3	27.2	37.9	15.9	29.1	11.8	11.5	16.4	33.1	20.3	9.7	23.1	12.8	21.4	24.0	37.7	26.0	16.0	39.7	21.3	24.2	18.1	12.9	18.0	17.8	13.4	10.7	24.8	19.2	36.8	32.6	19.1	14.3	14.1	136.6	74.0	61.7	65.5	37.1	37.8	76.4	80.1	40.4	74.8	65.8	71.4	94.9	104.7	72.5	44.4	43.2	85.5	84.1	99.5	100.9	110.0	61.9	126.0	97.5	97.3	57.6	198.5	67.8	33.9	44.5	106.1	91.2	33.6	76.4	100.3	285.1	86.2	67.3	105.9	146.2	70.1	57.7	89.1	46.9	84.5	68.3	216.4	70.8	81.0	61.2	76.7	72.7	97.3	110.4	64.9	82.2	95.8	49.9	71.9	21.4	70.0	125.0	62.8	105.2	117.5	40.2	119.5	123.6	60.9	31.7	41.6	53.3	40.1	59.5	43.8	48.0	51.2	39.0	37.4	51.0	57.1	19.5	75.2	45.0	41.3	51.3	44.8	11.0	12.1	20.3	15.8	13.3	12.3	11.8	11.5	12.8	12.9	10.7	14.1	33.9	9.6	30.2	12.7	28.6	24.3	13.5	27.9	18.8	20.6	19.4	16.6	79.5	21.5	28.5	27.6	43.8	35.8	45.7	18.9	45.0	26.3	2.8	13.0	15.4	21.4	10.8	39.7	35.4	28.3	34.5	22.8	20.9	16.0	56.3	21.4	17.9	24.6	28.0	25.2	33.2	20.2	16.2	18.8	20.7	3.8	14.9	25.0	17.8	19.7	23.4	27.4	75.2	18.1	29.6	25.3	10.6	17.3	58.5	21.8	30.2	39.9	21.1	43.5	19.7	19.6	34.9	22.1	16.8	32.7	30.0	25.2	34.5	31.9	23.2	12.4
UCP2	"BMIQ4, SLC25A8"	ENSG00000175567	"Uncoupling protein 2"	P55851	11	73974672-73982843	"Human disease related genes, Metabolic proteins, Predicted intracellular proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 278.1"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 404.4;Enteroendocrine cells: 297.3;Erythroid cells: 695.6;Hofbauer cells: 442.2;Kupffer cells: 326.6;monocytes: 533.6;NK-cells: 509.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 360.2;SK-BR-3: 395.6;U-698: 293.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB025583, HPA075202"	Approved		Supported	Mitochondria		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 6: Erythroid cells - Oxygen transport"	Mitochondria		"CAB025583: , HPA075202: AB_2732284"	"unprognostic (1.13e-1)"	"prognostic favorable (4.65e-5)"	"unprognostic (8.07e-2)"	"unprognostic (1.21e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.15e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.82e-3)"	"unprognostic (2.07e-1)"	"unprognostic (4.59e-2)"	"unprognostic (1.13e-3)"	"unprognostic (1.37e-1)"	"prognostic unfavorable (7.80e-6)"	"unprognostic (3.77e-2)"	"unprognostic (1.58e-1)"	"unprognostic (3.77e-3)"	"unprognostic (3.88e-3)"	70.9	20.5	12.2	142.9	14.6	132.8	37.6	12.9	24.1	41.3	22.1	33.2	53.4	17.4	7.6	17.7	175.7	42.3	14.1	12.1	15.9	34.9	26.2	69.3	278.1	19.7	19.8	4.9	12.6	8.1	13.8	27.3	19.8	19.7	44.8	6.9	42.7	23.0	99.1	9.2	56.6	30.4	17.6	183.1	55.2	14.5	22.4	217.3	45.1	141.7	240.2	73.6	4.9	26.1	0.9	78.7	20.2	43.5	9.5	0.0	11.6	14.1	9.3	54.9	14.8	153.1	59.0	360.2	165.1	19.5	5.5	3.5	13.3	0.0	28.6	97.1	5.6	241.5	26.4	28.3	32.2	123.9	77.5	8.9	0.0	43.9	0.0	11.0	5.7	144.6	101.5	119.0	9.5	147.5	108.5	55.8	12.8	9.0	21.7	99.7	120.7	202.0	150.4	211.0	23.6	32.3	68.2	395.6	26.6	55.9	123.3	79.3	10.0	0.2	59.7	14.4	21.5	48.4	24.4	293.8	7.2	45.0	0.4	809.1	1116.7	1465.3	1462.8	1945.8	925.0	1914.8	1176.3	1233.5	1228.7	1851.8	1092.9	1143.1	154.2	1816.8	1692.3	3009.5	2589.5	2966.6	12.2	14.6	12.9	24.1	12.1	15.9	19.7	19.8	19.8	17.6	22.4	26.1	4.7	3.2	27.6	0.3	287.4	3.4	2.7	20.2	0.6	0.9	30.9	19.8	5.2	5.7	43.9	92.0	8.4	8.3	404.4	6.2	7.9	1.9	18.7	122.1	10.5	8.9	297.3	695.6	0.0	7.5	12.1	9.9	46.4	102.4	86.2	12.4	9.7	5.0	442.2	0.0	0.1	31.5	89.5	326.6	146.2	46.0	0.9	232.3	26.6	1.9	533.6	4.3	509.8	1.0	1.0	1.8	45.9	0.4	117.9	12.8	4.5	2.7	137.6	8.1	6.6	6.1	11.2	15.2	14.5	1.9	4.5	11.2	189.9	13.5	21.7	43.4
UFL1	"KIAA0776, Maxer, NLBP, RCAD"	ENSG00000014123	"UFM1 specific ligase 1"	O94874	6	96521595-96555276	"Predicted intracellular proteins"	"DNA damage, DNA repair, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030558, HPA030559, HPA030560"	Enhanced		Supported	"Endoplasmic reticulum"		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 55: Plasma cells - Humoral immune response"	"Endoplasmic reticulum"		"HPA030558: AB_10600663, HPA030559: AB_10600537, HPA030560: AB_10602000"	"unprognostic (5.40e-2)"	"unprognostic (7.48e-3)"	"unprognostic (1.06e-2)"	"unprognostic (1.99e-1)"	"unprognostic (8.12e-2)"	"unprognostic (9.04e-2)"	"unprognostic (9.99e-2)"	"unprognostic (4.67e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.26e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.50e-1)"	"unprognostic (4.46e-2)"	"unprognostic (4.10e-2)"	"unprognostic (5.92e-2)"	"unprognostic (8.65e-2)"	"unprognostic (4.46e-1)"	17.0	20.6	9.8	18.9	13.1	17.9	21.4	11.9	15.4	20.8	7.8	18.7	22.7	19.0	23.4	20.7	16.8	18.0	23.7	9.2	12.1	21.3	29.7	15.4	22.1	13.8	11.4	22.4	25.2	24.9	10.0	18.1	15.3	24.4	19.5	31.6	23.5	17.9	21.1	20.3	22.8	17.1	12.4	17.9	21.8	14.2	10.8	20.8	28.1	21.4	21.8	20.1	11.2	19.5	16.9	8.8	18.3	30.7	25.8	39.2	27.2	23.3	23.6	14.6	13.6	11.0	19.2	40.7	28.9	23.5	16.2	32.0	15.0	22.0	21.3	21.9	13.6	17.9	13.3	20.2	34.3	34.0	25.6	28.2	20.1	17.4	47.9	27.1	24.2	25.7	24.1	43.7	27.9	16.3	12.5	21.0	6.6	14.5	9.9	15.6	21.4	32.6	26.5	30.5	12.9	12.5	19.2	22.4	21.5	16.2	54.4	28.7	24.0	20.3	11.0	20.8	24.7	25.7	14.2	30.9	31.2	22.5	19.0	8.7	7.9	8.9	8.7	10.1	10.0	9.6	9.2	9.4	10.2	8.6	11.4	9.3	1.6	13.1	10.4	10.7	11.1	7.2	9.8	13.1	11.9	15.4	9.2	12.1	13.8	11.4	15.3	12.4	10.8	19.5	42.8	57.7	50.2	54.2	53.9	19.5	34.4	52.2	36.5	48.8	33.3	33.8	60.4	31.5	64.9	46.0	45.9	64.1	57.2	31.6	19.6	42.0	61.0	64.3	60.8	35.1	19.8	30.7	26.5	50.7	34.3	45.2	32.1	62.2	30.9	43.0	32.5	69.5	35.4	43.7	33.0	48.9	36.7	33.2	13.9	44.1	50.1	37.5	14.2	30.9	42.5	34.9	39.1	58.3	103.1	40.4	29.9	50.4	72.7	29.8	46.1	30.7	76.1	74.9	19.7	49.0	44.2	85.3	37.8	37.6	19.2	91.0	46.5	59.5	35.9	29.8
UGDH		ENSG00000109814	"UDP-glucose 6-dehydrogenase"	O60701	4	39498755-39528311	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Carbohydrate metabolism"	"Allosteric enzyme, Oxidoreductase"	"Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 137.7"	"Cell type enhanced"	"Detected in all"		"Exocrine glandular cells: 345.5;Hepatocytes: 231.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"A549: 509.6;Hep G2: 595.9;U-2197: 375.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034444, HPA036656, HPA036657"	Enhanced		Supported	Nucleoplasm		Yes	No		1300000	"Cluster 46: Basophils - DNA binding"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 1: Pancreatic cells - Digestion"	Nucleoplasm		"CAB034444: AB_2019602, HPA036656: AB_10671706, HPA036657: AB_10672360"	"unprognostic (1.22e-2)"	"unprognostic (1.62e-1)"	"unprognostic (2.73e-2)"	"unprognostic (3.96e-2)"	"unprognostic (5.54e-2)"	"unprognostic (1.63e-1)"	"unprognostic (8.78e-3)"	"unprognostic (6.07e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.41e-1)"	"unprognostic (9.81e-3)"	"unprognostic (6.86e-2)"	"prognostic unfavorable (5.51e-10)"	"unprognostic (2.48e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.66e-1)"	"unprognostic (4.97e-2)"	48.5	27.8	6.2	29.5	7.3	2.4	32.0	9.4	9.2	31.5	18.1	96.5	45.3	29.1	10.6	34.1	29.6	40.5	16.0	5.9	8.3	37.5	137.7	19.0	13.3	7.4	7.7	30.0	33.7	23.1	7.8	38.4	8.0	35.6	73.3	14.3	16.8	14.0	6.7	9.9	41.1	23.5	7.6	11.5	47.4	6.8	8.4	10.3	27.8	9.5	14.5	54.4	17.1	9.7	36.0	509.6	58.4	76.2	181.5	185.3	51.3	102.7	113.8	94.5	84.8	76.2	115.5	25.4	63.0	133.3	94.5	33.5	56.0	29.5	95.8	32.1	13.0	26.2	65.4	595.9	72.7	34.1	25.3	64.4	14.9	160.2	49.8	78.9	59.3	20.9	34.1	17.3	67.9	89.8	29.4	34.4	53.1	194.0	46.4	48.3	95.0	22.0	53.7	120.0	31.2	46.7	69.2	37.9	45.3	41.4	21.0	27.0	85.9	97.9	49.1	375.8	54.2	42.1	33.3	23.3	86.9	25.8	56.6	30.0	20.9	19.7	23.2	18.4	37.8	18.8	18.8	24.9	19.0	18.4	16.1	19.4	3.8	42.3	11.2	22.5	13.5	18.8	6.2	7.3	9.4	9.2	5.9	8.3	7.4	7.7	8.0	7.6	8.4	9.7	19.1	25.6	27.6	4.6	14.1	116.1	73.4	19.5	43.9	7.5	115.8	62.0	8.9	24.3	25.4	20.2	14.6	21.3	12.9	207.8	70.5	54.7	1.1	78.3	53.8	25.4	113.3	9.1	10.6	345.5	78.8	145.7	184.0	64.8	35.5	11.1	20.7	231.3	17.8	10.1	12.6	114.5	12.2	20.2	33.3	1.6	33.2	12.7	30.2	7.5	19.9	7.3	9.2	46.3	12.8	195.8	112.2	29.0	21.3	127.3	81.4	79.6	65.7	9.2	32.9	39.0	57.5	6.5	5.5	102.2	40.1	29.0	11.7	12.4	152.4	86.4
UGT1A6	"GNT1, HLUGP, UGT1F"	ENSG00000167165	"UDP glucuronosyltransferase family 1 member A6"	P19224	2	233691607-233773300	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"kidney: 71.3;liver: 143.3;urinary bladder: 88.8"	"Cell type enhanced"	"Detected in some"		"Basal squamous epithelial cells: 12.5;Early spermatids: 52.4;Gastric mucus-secreting cells: 14.3;Late spermatids: 23.3;Squamous epithelial cells: 17.3"	"Group enriched"	"Detected in many"	5	"liver cancer: 7.2;lung cancer: 3.1;renal cancer: 7.6;urothelial cancer: 3.2"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"OE19: 1194.0"	"Not detected"	"Not detected"							"CAB009819, HPA054065, HPA056023"	Enhanced		Supported	"Endoplasmic reticulum,Vesicles"		NA	NA				"Cluster 85: Liver - Metabolism"	"Cluster 21: OE19 - Mitochondria"	"Cluster 34: Spermatids - Unknown function"	Vesicles	"Endoplasmic reticulum"	"CAB009819: AB_2241481, HPA054065: AB_2682367, HPA056023: "		"unprognostic (9.09e-2)"	"unprognostic (6.07e-2)"	"unprognostic (5.43e-2)"		"unprognostic (6.03e-2)"	"prognostic unfavorable (2.89e-6)"	"unprognostic (2.79e-1)"	"unprognostic (6.18e-2)"		"unprognostic (2.09e-3)"	"unprognostic (9.97e-2)"	"unprognostic (2.16e-2)"	"unprognostic (3.52e-1)"	"unprognostic (7.50e-2)"		"unprognostic (2.01e-2)"	0.1	0.0	0.0	0.1	0.0	0.0	0.8	0.0	0.0	1.8	0.0	1.8	5.8	0.1	2.6	16.1	0.0	3.5	0.0	0.0	0.0	71.3	143.3	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	1.1	1.3	0.0	2.6	3.6	0.0	11.1	2.6	0.0	0.0	0.0	17.4	0.4	0.0	1.2	0.5	0.0	5.8	88.8	5.5	0.0	4.2	1.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	53.8	1.6	0.0	80.2	0.1	0.8	294.5	0.1	4.0	0.0	0.0	0.0	0.0	0.3	1.3	0.0	0.0	0.3	0.0	31.2	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	6.2	0.0	0.0	0.0	1194.0	0.0	0.1	0.2	0.1	3.2	149.0	0.0	0.0	7.1	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	1.6	1.2	12.5	0.0	0.0	0.0	0.3	0.0	2.9	1.8	0.0	0.0	0.0	0.4	0.0	0.0	52.4	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	14.3	0.5	0.0	0.0	0.4	5.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	23.3	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.9	0.5	1.8	0.1	0.0	0.0	0.0	0.0	1.2	0.2	17.3	1.1	0.0	0.0	0.0	0.1	3.0
UHMK1	"KIS, Kist"	ENSG00000152332	"U2AF homology motif kinase 1"	Q8TAS1	1	162497251-162529631	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, RNA-binding, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA077624			Supported	"Nucleoplasm,Nuclear speckles,Vesicles"		NA	No			"Cluster 51: Monocytes - Innate immune response"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 59: Non-specific - Transcription"	"Nucleoplasm, Nuclear speckles"	Vesicles	"HPA077624: "	"unprognostic (6.69e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.08e-2)"	"unprognostic (8.16e-2)"	"unprognostic (9.63e-2)"	"unprognostic (1.82e-1)"	"unprognostic (7.81e-3)"	"unprognostic (9.10e-2)"	"unprognostic (3.11e-1)"	"unprognostic (3.44e-2)"	"unprognostic (9.08e-2)"	"unprognostic (8.77e-2)"	"unprognostic (4.66e-2)"	26.8	23.3	21.2	23.3	24.6	40.3	19.3	18.1	21.2	15.1	16.6	19.2	19.1	11.7	14.1	13.3	14.4	13.7	11.6	26.0	28.3	31.2	38.1	17.5	30.8	24.9	28.5	11.9	11.0	27.8	7.8	17.1	28.3	16.2	19.6	10.5	13.5	18.5	25.8	11.9	23.4	10.8	19.8	25.4	20.0	12.2	26.1	24.6	19.4	25.9	28.9	18.1	10.5	19.4	61.9	28.4	14.6	35.8	40.7	31.9	32.7	79.7	43.2	63.9	45.7	18.6	37.8	50.2	67.8	60.0	31.2	34.9	28.2	44.1	102.4	69.1	20.4	49.8	34.3	16.9	31.3	73.4	55.5	33.0	45.8	63.2	59.9	44.6	37.4	34.2	44.1	67.7	111.4	26.0	39.3	19.4	19.4	46.1	37.8	24.9	64.9	41.9	42.6	62.8	26.4	24.3	70.5	64.6	52.2	19.9	56.0	81.0	58.5	72.7	41.0	50.8	112.6	69.2	103.5	58.0	60.5	35.3	67.3	3.6	2.0	2.4	4.8	5.3	4.9	3.2	3.5	4.0	2.3	3.6	3.5	4.0	1.3	3.7	6.1	2.6	3.1	2.6	21.2	24.6	18.1	21.2	26.0	28.3	24.9	28.5	28.3	19.8	26.1	19.4	37.6	19.2	41.2	20.9	75.6	29.4	33.7	38.5	34.7	24.4	39.4	20.2	35.1	40.0	53.8	53.3	12.5	26.2	81.0	53.9	56.7	27.6	55.6	35.1	35.7	33.4	33.5	51.6	37.0	23.2	38.1	25.5	43.3	44.4	45.7	23.3	31.1	85.1	30.0	23.5	27.4	34.1	48.8	73.5	47.5	58.4	21.5	60.0	28.4	33.7	58.0	14.6	74.2	20.6	29.5	40.4	33.0	19.5	47.2	59.9	60.8	62.2	50.9	23.0	0.0	29.2	27.8	25.1	29.6	45.2	24.6	22.4	69.4	31.4	39.3	58.3
UHRF1	"FLJ21925, ICBP90, Np95, RNF106, TDRD22"	ENSG00000276043	"Ubiquitin like with PHD and ring finger domains 1"	Q96T88	19	4903080-4962154	"Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, DNA damage, DNA repair, Transcription, Transcription regulation, Ubl conjugation pathway"	"Chromatin regulator, DNA-binding, Repressor, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"bone marrow: 27.0;lymphoid tissue: 67.2"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 49.7;Plasma cells: 21.0;Squamous epithelial cells: 15.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"plasmacytoid DC: 4.8"	"Group enriched"	"Detected in many"	4	"dendritic cells: 4.8;T-cells: 2.3"	"Cell line enhanced"	"Detected in all"		"MOLT-4: 450.9;REH: 1004.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA049408, HPA055446"	Enhanced		Supported	Nucleoplasm		No	Yes			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 14: REH - Unknown function"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"HPA049408: AB_2756317, HPA055446: AB_2732597"	"unprognostic (3.83e-2)"	"unprognostic (6.83e-3)"	"unprognostic (5.13e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.40e-1)"	"unprognostic (7.21e-2)"	"prognostic unfavorable (1.63e-4)"	"unprognostic (4.30e-2)"	"prognostic unfavorable (6.81e-4)"	"unprognostic (2.82e-1)"	"prognostic unfavorable (4.52e-5)"	"unprognostic (2.33e-3)"	"unprognostic (0.00e+0)"	"unprognostic (3.75e-3)"	"unprognostic (2.45e-1)"	"unprognostic (2.01e-1)"	"unprognostic (2.02e-1)"	1.0	0.9	2.1	9.6	2.7	27.0	1.7	2.1	2.3	1.6	1.8	2.9	3.7	1.0	0.1	6.5	0.4	0.8	0.5	2.0	2.2	0.6	0.9	1.3	15.8	2.8	2.8	0.3	0.6	0.2	0.2	2.1	2.7	0.6	2.6	0.4	1.5	0.2	1.2	3.4	3.9	1.9	1.9	3.7	3.3	5.2	3.5	67.2	0.3	0.3	10.3	1.6	2.5	4.6	111.3	78.7	116.6	83.4	3.3	13.3	18.5	88.3	42.0	89.9	86.8	94.6	54.9	62.7	21.1	39.4	32.7	54.1	81.2	47.7	63.0	102.7	92.2	54.3	74.3	102.4	1.3	135.1	78.9	6.5	3.5	48.9	12.6	14.1	27.2	97.2	79.3	70.5	54.5	86.7	450.9	82.5	52.5	40.0	84.3	1004.5	259.7	45.4	24.9	80.1	86.0	68.5	69.2	37.7	12.1	18.8	68.2	127.6	34.2	94.6	76.7	124.3	108.3	29.8	33.1	183.5	54.8	129.7	123.3	0.3	0.2	0.1	0.6	0.0	0.0	0.2	0.8	1.0	1.3	0.1	0.2	0.8	0.8	0.5	0.2	4.8	2.3	0.6	2.1	2.7	2.1	2.3	2.0	2.2	2.8	2.8	2.7	1.9	3.5	4.6	0.2	0.0	0.0	1.6	2.1	0.0	0.8	0.0	3.4	2.5	4.4	2.8	4.3	1.5	0.6	0.0	0.0	6.6	6.9	2.6	0.0	2.2	2.9	1.3	1.8	2.2	0.0	49.7	0.4	0.4	7.8	4.7	8.6	2.4	0.0	10.4	0.4	0.7	8.9	3.3	0.4	2.3	0.0	1.9	0.0	1.8	0.6	3.8	0.0	0.0	2.0	0.6	1.0	3.0	1.3	4.2	1.9	0.4	21.0	0.6	1.4	0.2	0.7	0.7	0.0	1.2	6.1	6.1	11.9	15.8	0.0	1.4	3.7	1.5	8.3	1.3
UHRF1BP1L	KIAA0701	ENSG00000111647	"UHRF1 binding protein 1 like"	A0JNW5	12	100028455-100142874	"Cancer-related genes, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 75.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039671, HPA075150"	Uncertain		Uncertain	Nucleoplasm,Vesicles,Cytosol		NA	NA			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Nucleoplasm	"Vesicles, Cytosol"	"HPA039671: AB_10794201, HPA075150: "	"unprognostic (4.80e-2)"	"unprognostic (3.17e-1)"	"unprognostic (2.34e-2)"	"unprognostic (1.14e-1)"	"unprognostic (8.96e-2)"	"unprognostic (7.36e-2)"	"unprognostic (8.10e-2)"	"unprognostic (5.75e-3)"	"unprognostic (2.06e-1)"	"unprognostic (5.43e-2)"	"unprognostic (1.88e-2)"	"unprognostic (2.53e-1)"	"unprognostic (2.94e-3)"	"unprognostic (6.84e-2)"	"unprognostic (1.25e-1)"	"unprognostic (3.81e-2)"	"unprognostic (1.28e-2)"	8.7	10.9	6.2	10.2	7.7	32.9	8.8	11.0	11.5	7.2	9.9	8.3	8.4	7.5	7.0	7.0	6.3	8.9	7.9	13.2	6.2	12.3	24.6	7.7	9.2	4.9	5.4	7.5	3.8	13.6	5.2	9.0	4.8	9.0	7.9	14.6	6.4	8.0	19.8	5.9	7.1	8.8	4.6	9.2	6.0	14.0	3.7	8.4	10.9	14.6	7.0	10.1	5.2	9.2	18.6	19.7	10.8	11.2	16.4	23.1	21.6	28.3	28.4	22.4	16.3	14.8	6.2	16.0	7.2	29.1	13.1	6.9	20.4	9.7	21.5	42.7	10.0	10.7	14.1	17.3	15.1	20.4	16.8	13.1	8.0	27.0	18.6	20.7	16.0	11.0	8.6	16.2	22.1	10.3	13.1	17.5	18.7	6.3	17.7	14.7	19.2	15.7	11.4	32.2	18.3	11.4	21.4	24.5	8.5	9.2	21.9	23.0	12.7	24.6	13.2	21.5	20.1	19.1	35.2	22.3	12.4	15.1	15.2	21.6	11.4	7.8	3.6	12.3	5.3	5.5	4.0	4.1	12.8	4.5	3.4	4.2	33.9	5.9	10.9	7.6	5.2	5.4	6.2	7.7	11.0	11.5	13.2	6.2	4.9	5.4	4.8	4.6	3.7	9.2	10.6	28.9	8.7	27.1	18.2	12.7	17.2	5.0	19.9	11.9	9.3	7.5	15.7	1.5	12.6	9.2	4.2	4.7	15.0	10.9	5.9	6.0	35.1	15.7	23.7	8.6	5.4	9.4	75.2	5.9	8.9	24.7	7.7	9.9	24.1	6.3	5.3	18.5	11.2	15.2	54.2	2.1	4.1	23.3	21.4	5.3	7.2	29.5	10.6	45.0	25.7	8.3	8.2	37.2	29.5	5.9	7.4	7.9	12.5	18.5	8.9	14.9	21.8	12.0	0.0	23.3	15.1	24.1	19.1	14.9	11.6	10.9	15.7	8.3	5.7	11.9
UIMC1	RAP80	ENSG00000087206	"Ubiquitin interaction motif containing 1"	Q96RL1	5	176905005-177022633	"Predicted intracellular proteins"	"DNA damage, DNA repair, Transcription, Transcription regulation"	"Chromatin regulator"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 132.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 64.5"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 64.5"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037503, HPA037504"	Enhanced		Supported	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 71: Testis - DNA repair"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	"Nuclear bodies"	Nucleoplasm	"HPA037503: AB_10671373, HPA037504: AB_10671760"	"unprognostic (2.96e-1)"	"unprognostic (9.57e-2)"	"unprognostic (2.48e-3)"	"unprognostic (4.40e-2)"	"unprognostic (1.69e-1)"	"unprognostic (9.88e-3)"	"prognostic unfavorable (7.67e-6)"	"unprognostic (1.85e-1)"	"unprognostic (1.12e-2)"	"unprognostic (6.62e-2)"	"unprognostic (1.30e-1)"	"unprognostic (5.91e-2)"	"unprognostic (1.33e-3)"	"unprognostic (8.51e-2)"	"unprognostic (5.52e-1)"	"unprognostic (7.23e-2)"	"unprognostic (1.44e-1)"	28.2	24.6	15.8	14.0	15.9	60.2	27.2	22.3	19.1	31.1	19.1	32.5	9.5	29.4	11.2	18.8	26.6	10.8	27.1	15.1	15.4	21.9	18.6	26.4	22.8	14.0	14.4	35.8	27.2	9.1	19.6	12.7	14.4	23.0	12.4	15.0	17.1	13.3	32.6	23.8	23.3	18.9	12.6	31.4	22.5	62.3	14.9	27.6	23.5	12.0	22.0	29.2	23.8	17.6	27.6	26.6	26.9	33.1	25.8	22.7	38.3	28.1	31.4	35.5	37.0	30.6	30.7	79.1	33.8	23.3	37.8	21.1	27.9	62.7	41.8	91.4	25.4	35.4	30.9	25.7	28.5	43.8	22.7	15.9	29.0	27.0	74.0	26.9	41.6	47.1	30.9	26.1	26.6	25.7	43.1	29.4	19.6	22.2	16.2	39.5	38.8	46.1	38.0	17.4	29.1	23.2	62.3	20.1	30.4	28.3	17.5	24.2	31.6	20.1	20.3	17.7	37.6	39.1	49.8	50.8	19.6	43.2	22.1	15.8	11.8	33.0	9.0	7.0	9.4	11.8	10.3	8.9	7.4	13.9	10.0	8.3	64.5	14.5	4.5	9.5	14.7	6.5	15.8	15.9	22.3	19.1	15.1	15.4	14.0	14.4	14.4	12.6	14.9	17.6	24.8	12.8	21.0	36.9	31.3	10.5	18.0	11.8	23.3	19.3	10.9	11.8	20.6	8.6	17.3	9.2	14.6	13.9	22.5	7.8	7.9	13.7	27.4	19.4	23.1	17.0	13.1	47.8	59.5	12.9	12.7	17.1	12.2	22.8	18.3	20.6	13.2	8.8	9.9	16.8	53.3	7.9	8.2	14.8	14.1	13.2	15.5	19.8	1.8	44.0	18.0	8.9	19.6	43.7	51.1	17.0	9.1	12.4	24.2	12.9	8.1	8.9	19.2	33.7	13.1	17.7	18.8	132.1	73.8	13.2	11.9	6.8	23.0	35.4	8.7	13.9
ULBP1	RAET1I	ENSG00000111981	"UL16 binding protein 1"	Q9BZM6	6	149963943-149973715	"Predicted membrane proteins"	"Host-virus interaction, Immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"brain: 4.4;lung: 1.7;testis: 3.3"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 6.4;Alveolar cells type 2: 2.2;Breast myoepithelial cells: 3.0;Respiratory ciliated cells: 2.2;Squamous epithelial cells: 2.5"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"cerebellum: 4.4;cerebral cortex: 1.9;hippocampal formation: 1.6"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 16.5;HAP1: 29.3;HDLM-2: 17.1;HHSteC: 18.0;JURKAT: 26.1"									"HPA007547, HPA071005"	Enhanced		Supported	"Plasma membrane,Cytosol"		NA	NA				"Cluster 78: Testis - Spermatogenesis"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 7: Non-specific - Mitochondria"	"Plasma membrane, Cytosol"		"HPA007547: AB_1079430, HPA071005: AB_2686332"	"unprognostic (8.94e-3)"	"unprognostic (2.44e-1)"	"unprognostic (2.85e-2)"	"unprognostic (2.33e-2)"	"unprognostic (3.28e-4)"	"unprognostic (6.69e-3)"	"unprognostic (5.27e-2)"	"unprognostic (2.47e-2)"	"unprognostic (5.75e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.86e-1)"	"unprognostic (1.15e-2)"	"unprognostic (5.57e-12)"	"unprognostic (1.95e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.12e-1)"	"unprognostic (7.16e-2)"	0.2	0.1	0.1	0.2	0.1	0.3	0.0	4.4	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.4	1.6	0.2	0.4	0.1	1.7	0.1	0.1	0.2	0.0	0.1	0.2	0.1	0.5	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	3.3	0.1	0.1	0.4	0.1	0.1	0.0	0.0	0.2	2.1	1.0	1.6	0.0	3.3	6.8	3.2	3.0	0.9	0.6	2.0	0.2	3.1	3.5	0.7	16.5	6.9	0.7	29.3	1.4	2.7	17.1	3.8	0.3	0.6	0.0	18.0	0.1	1.2	9.1	6.8	13.6	2.5	0.0	1.1	26.1	3.3	0.0	3.5	2.7	4.3	0.0	0.5	1.4	2.3	0.0	1.3	0.5	0.0	0.4	1.0	0.4	4.4	2.0	0.0	1.3	2.9	6.4	0.3	1.6	0.0	1.4	0.0	0.5	0.7	2.3	8.7	5.0	3.6	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.1	0.1	4.4	1.9	1.6	0.2	0.1	0.2	0.5	0.1	0.1	0.2	1.6	6.4	2.2	0.0	0.5	0.1	0.5	0.0	0.6	0.0	1.0	3.0	0.9	0.0	0.6	0.0	0.0	0.0	0.3	0.4	0.0	0.3	0.1	0.2	0.6	1.1	0.0	0.0	0.1	0.6	0.0	1.6	0.0	0.7	0.0	0.1	0.7	0.0	0.1	0.0	0.0	0.5	0.0	0.3	0.3	0.4	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.1	2.2	0.0	0.0	1.6	1.3	0.2	0.2	2.5	0.6	0.0	0.7	0.2	0.3	0.1
ULBP2	RAET1H	ENSG00000131015	"UL16 binding protein 2"	Q9BZM5	6	149942014-149949235	"Predicted membrane proteins, Predicted secreted proteins"	"Host-virus interaction, Immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 6.1"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 28.9;Basal respiratory cells: 17.9;dendritic cells: 12.1"	"Cancer enhanced"	"Detected in all"		"head and neck cancer: 12.9"	"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"gdT-cell: 2.7"	"Lineage enriched"	"Detected in single"	6	"T-cells: 2.7"	"Cell line enhanced"	"Detected in many"		"SiHa: 66.7;U-2197: 47.4"									"CAB018974, HPA066741"	Approved		Supported	"Vesicles,Plasma membrane"	"Secreted in other tissues"	NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 18: U-2197 - ECM organization"	"Cluster 7: Non-specific - Mitochondria"	"Vesicles, Plasma membrane"		"CAB018974: , HPA066741: "	"unprognostic (2.09e-5)"	"prognostic unfavorable (8.07e-4)"	"unprognostic (2.38e-3)"	"unprognostic (3.90e-1)"	"prognostic unfavorable (2.44e-4)"	"unprognostic (1.26e-2)"	"unprognostic (2.38e-3)"	"unprognostic (1.47e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.99e-1)"	"unprognostic (1.75e-2)"	"unprognostic (1.42e-4)"	"unprognostic (1.68e-1)"	"unprognostic (2.06e-1)"	"unprognostic (2.14e-1)"	"unprognostic (4.86e-1)"	1.5	0.7	1.3	0.6	1.6	1.8	0.7	1.6	2.6	0.9	0.7	0.2	0.2	0.1	0.1	6.1	0.2	0.5	2.0	3.0	1.0	2.1	0.5	3.4	0.3	1.8	1.2	0.0	0.4	0.6	0.5	1.6	1.8	0.2	0.1	0.2	0.7	0.1	0.3	0.5	0.2	0.7	0.8	0.2	0.3	1.5	1.1	0.7	1.2	0.7	0.8	1.4	1.6	1.7	19.9	1.8	0.5	6.1	1.1	5.6	3.3	20.1	11.8	20.6	16.8	7.4	11.0	0.0	29.9	23.0	29.6	13.9	7.6	18.4	11.8	9.1	3.9	1.1	2.8	0.0	7.1	0.0	1.5	2.7	13.9	18.3	8.0	16.7	11.9	16.6	2.5	0.0	15.4	13.9	1.8	0.0	0.0	3.6	10.2	3.0	4.5	0.0	29.0	5.7	0.6	0.0	66.7	1.4	1.9	3.2	1.8	8.5	18.8	13.5	17.1	47.4	23.5	0.0	0.1	0.9	19.2	10.7	9.9	0.0	0.0	0.0	2.7	0.0	0.3	0.0	0.8	1.5	0.0	0.0	0.3	1.8	0.0	0.4	0.0	0.0	1.7	0.5	1.3	1.6	1.6	2.6	3.0	1.0	1.8	1.2	1.8	0.8	1.1	1.7	28.9	0.0	1.3	0.0	1.2	3.7	6.5	17.9	7.4	0.0	1.3	4.4	0.3	0.0	9.4	1.8	0.0	0.0	12.1	0.5	0.0	7.5	7.0	0.3	0.5	9.1	0.0	0.0	3.0	8.8	0.5	3.0	1.1	0.2	0.0	0.1	7.1	0.2	2.2	0.0	0.7	0.3	2.0	0.8	2.1	8.0	0.0	3.1	1.8	0.0	0.0	0.4	4.1	0.5	0.3	4.5	0.0	0.0	1.4	1.4	0.0	0.1	1.4	0.0	0.0	1.0	4.2	3.1	7.0	11.8	2.8	0.0	11.0	0.6	0.4	5.2
UNC13D	Munc13-4	ENSG00000092929	"Unc-13 homolog D"	Q70J99	17	75827225-75844552	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	Exocytosis		"Familial hemophagocytic lymphohistiocytosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 58.9;lymphoid tissue: 66.2"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 68.3;Hofbauer cells: 58.5;NK-cells: 61.8;Pancreatic endocrine cells: 47.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEL: 245.7;HeLa: 136.3;HMC-1: 245.9;SK-BR-3: 189.7"	"Region enriched"	"Detected in single"	6	"cerebellum: 5.0"	"Low region specificity"	"Detected in many"			"HPA067117, HPA073525"	Enhanced		Supported	Vesicles,Cytosol		NA	NA		1500000	"Cluster 38: Basophils - Unknown function"	"Cluster 2: Immune cells - Immune response"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 63: NK-cells & T-cells - Immune response"	Cytosol	Vesicles	"HPA067117: AB_2685784, HPA073525: AB_2686615"	"unprognostic (6.79e-3)"	"unprognostic (4.36e-2)"	"unprognostic (1.73e-1)"	"prognostic unfavorable (3.62e-4)"	"unprognostic (2.98e-2)"	"unprognostic (1.42e-3)"	"unprognostic (3.93e-1)"	"unprognostic (1.37e-2)"	"unprognostic (2.74e-1)"	"unprognostic (1.31e-2)"	"prognostic unfavorable (6.01e-4)"	"unprognostic (1.89e-1)"	"prognostic unfavorable (5.28e-12)"	"unprognostic (3.27e-2)"	"unprognostic (5.58e-2)"	"unprognostic (1.56e-1)"	"unprognostic (8.59e-2)"	7.7	7.3	5.6	23.5	6.8	58.9	7.8	5.8	7.3	18.6	5.0	10.7	8.0	8.6	2.0	23.6	13.8	6.5	14.3	5.0	5.6	6.6	12.6	38.1	25.9	7.9	6.5	19.3	8.8	0.5	11.6	9.0	7.5	8.1	4.5	5.5	7.7	5.1	8.5	6.0	18.5	4.9	6.2	66.2	13.8	6.1	8.2	20.7	5.9	1.5	17.6	10.7	19.6	8.7	44.0	18.7	0.4	0.3	0.5	1.0	47.6	0.1	0.0	0.0	0.1	41.4	97.0	3.4	46.4	0.0	7.5	15.4	0.0	2.2	0.0	0.4	0.5	245.7	136.3	24.2	3.9	94.1	245.9	0.6	2.0	0.5	2.1	2.3	17.9	42.5	87.1	1.1	0.0	71.2	100.9	50.8	0.9	69.9	1.7	32.8	1.0	1.5	1.6	17.7	0.3	66.7	19.2	189.7	0.9	0.5	47.1	56.5	48.1	0.8	65.9	0.5	0.5	1.3	5.9	4.0	0.6	31.3	0.2	59.1	16.0	31.2	19.3	16.9	17.4	6.7	11.4	13.6	12.3	3.6	8.8	11.9	40.1	14.7	25.6	7.2	10.8	18.1	5.6	6.8	5.8	7.3	5.0	5.6	7.9	6.5	7.5	6.2	8.2	8.7	3.8	44.8	8.3	6.8	16.6	1.1	1.7	1.0	0.6	12.0	4.9	2.4	68.3	7.2	4.4	3.7	20.9	4.7	27.0	40.9	0.0	7.2	5.3	1.3	3.3	6.6	6.0	14.9	1.2	6.0	11.6	2.2	2.0	2.3	45.0	9.9	7.9	1.2	58.5	5.0	1.5	3.6	2.0	21.6	8.2	0.5	2.8	22.2	1.8	5.6	22.5	4.5	61.8	3.0	7.9	47.3	30.7	1.5	27.4	1.6	5.5	0.7	1.6	16.2	0.0	4.5	2.6	1.2	1.4	1.5	1.4	25.9	30.9	2.0	6.3	2.3
UNC45A	"GC-UNC45, SMAP-1"	ENSG00000140553	"Unc-45 myosin chaperone A"	Q9H3U1	15	90930180-90954093	"Predicted intracellular proteins, Predicted membrane proteins"	"Differentiation, Myogenesis"	"Chaperone, Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039228	Approved		Supported	"Nuclear speckles,Cytosol"		NA	NA		17000	"Cluster 27: Non-specific - Gene expression"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 55: Plasma cells - Humoral immune response"	"Nuclear speckles"	Cytosol	"HPA039228: AB_2676402"	"unprognostic (1.46e-1)"	"unprognostic (3.83e-2)"	"unprognostic (4.51e-2)"	"unprognostic (1.97e-1)"	"unprognostic (2.68e-2)"	"unprognostic (1.70e-3)"	"prognostic unfavorable (7.72e-4)"	"unprognostic (2.27e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.98e-1)"	"unprognostic (9.85e-2)"	"prognostic favorable (7.46e-7)"	"unprognostic (9.30e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.95e-1)"	"unprognostic (2.28e-2)"	25.0	25.3	7.7	16.7	8.2	17.3	23.2	8.6	9.1	32.0	10.0	41.2	16.4	38.1	11.0	31.4	28.4	17.3	15.9	7.8	7.7	18.9	13.0	20.2	18.9	8.9	11.6	26.1	22.3	33.2	17.5	19.6	9.5	25.2	13.4	5.6	25.8	34.1	9.6	37.7	23.5	28.0	8.3	19.7	28.5	13.1	9.6	18.0	19.5	10.6	17.3	39.3	29.4	8.0	38.2	76.3	30.9	27.2	83.0	38.0	27.3	42.4	36.2	56.5	45.1	61.3	49.4	44.7	55.5	53.8	32.5	82.1	52.9	54.4	26.6	49.8	75.9	86.2	77.0	44.4	46.8	21.5	56.2	47.3	65.8	55.7	40.5	54.2	77.5	35.1	38.6	35.8	43.3	62.2	28.1	18.6	41.8	69.5	38.0	54.8	46.9	48.1	38.4	89.2	43.1	39.4	57.1	55.9	54.3	36.8	50.8	44.3	77.0	48.0	34.1	40.4	45.0	33.6	50.5	21.1	46.6	49.7	49.8	11.5	8.3	5.0	11.8	7.3	11.3	7.9	9.6	9.1	10.4	6.3	7.8	7.4	1.6	9.8	11.6	9.1	9.3	9.8	7.7	8.2	8.6	9.1	7.8	7.7	8.9	11.6	9.5	8.3	9.6	8.0	21.7	22.4	22.4	9.4	23.2	16.3	24.8	26.1	30.1	27.2	17.2	19.6	12.7	35.8	23.8	18.4	18.8	53.6	17.5	26.9	13.7	33.6	26.7	12.8	20.3	25.3	37.0	25.2	19.1	18.2	22.7	23.7	26.5	22.1	29.2	30.9	18.9	13.4	28.2	18.5	18.4	15.9	26.4	12.2	14.0	29.0	29.5	20.7	19.6	9.4	28.8	21.5	27.8	7.1	11.0	23.3	26.0	51.6	20.6	16.8	22.0	19.6	11.7	35.1	32.9	15.2	33.9	24.8	6.4	33.9	18.8	46.2	21.4	26.0	22.7	20.3
UNK	"KIAA1753, ZC3H5, ZC3HDC5"	ENSG00000132478	"Unk zinc finger"	Q9C0B0	17	75784806-75825799	"Predicted intracellular proteins"	"Translation regulation"	"Repressor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 130.3;Spermatocytes: 120.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023636, HPA027962"	Uncertain		Supported	"Cytosol,Cytoplasmic bodies"		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 29: Early spermatids - Spermatogenesis"	"Cytosol, Cytoplasmic bodies"		"HPA023636: AB_10601774, HPA027962: AB_10611522"	"unprognostic (7.94e-2)"	"unprognostic (4.79e-2)"	"unprognostic (3.37e-1)"	"unprognostic (1.04e-3)"	"unprognostic (9.51e-2)"	"prognostic favorable (2.02e-4)"	"unprognostic (1.05e-2)"	"unprognostic (1.11e-1)"	"unprognostic (6.73e-2)"	"unprognostic (9.78e-2)"	"prognostic favorable (6.58e-5)"	"unprognostic (5.31e-2)"	"unprognostic (1.41e-3)"	"unprognostic (6.69e-2)"	"unprognostic (4.04e-1)"	"unprognostic (1.99e-2)"	"unprognostic (1.01e-2)"	12.0	11.7	8.5	8.6	9.1	8.4	13.6	9.5	9.6	20.9	9.6	12.7	6.8	18.2	4.0	13.7	17.5	5.3	10.5	7.4	7.8	15.1	12.8	10.1	10.6	9.4	8.8	22.1	14.8	9.8	20.1	5.8	8.1	16.0	3.4	5.6	14.2	6.4	9.1	18.4	14.1	4.7	7.4	21.2	11.4	9.3	10.0	10.1	16.9	4.2	5.2	14.0	15.3	13.0	9.3	14.7	16.0	13.6	5.0	4.6	13.0	6.1	6.6	6.7	8.2	5.4	10.5	19.8	5.2	6.6	11.1	8.4	8.1	7.3	3.1	10.3	26.6	12.4	12.8	11.6	6.7	9.6	15.2	9.1	4.4	5.8	6.2	7.6	8.9	14.0	6.5	9.6	5.4	18.6	21.4	13.2	6.9	6.5	9.6	22.4	16.0	10.1	6.3	9.8	14.7	28.8	7.9	11.0	22.0	8.0	13.4	14.7	6.5	15.9	8.6	7.1	7.9	16.4	5.1	11.0	11.5	6.1	10.0	0.0	0.2	0.1	0.5	0.1	0.4	0.2	0.2	0.3	0.1	0.7	0.4	0.4	0.0	0.2	0.2	0.4	0.3	0.4	8.5	9.1	9.5	9.6	7.4	7.8	9.4	8.8	8.1	7.4	10.0	13.0	12.7	16.0	17.0	33.6	25.4	15.2	17.3	19.3	10.2	26.4	16.5	14.7	11.2	11.5	21.3	3.7	14.6	9.1	18.9	11.4	3.9	15.3	130.3	14.7	11.8	13.3	16.8	10.9	15.4	22.9	15.8	14.1	15.8	9.1	19.0	15.6	7.9	6.0	14.3	21.9	21.1	13.3	38.7	10.8	14.3	22.6	19.0	10.1	26.6	28.1	10.8	22.5	18.6	27.2	26.0	21.3	12.7	10.5	24.4	12.9	7.0	6.1	24.0	24.4	19.7	15.1	15.5	120.5	73.5	13.0	21.9	17.2	19.1	10.5	14.0	13.9
UNKL	"C16orf28, FLJ23360, ZC3H5L, ZC3HDC5L"	ENSG00000059145	"Unk like zinc finger"	Q9H9P5	16	1363205-1414751	"Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055801, HPA073949"	Uncertain		Supported	Cytosol		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 59: Non-specific - Translation"	"Cluster 9: U-2 OS - Unknown function"	"Cluster 52: Non-specific - Transcription"	Cytosol		"HPA055801: AB_2682926, HPA073949: AB_2686647"	"unprognostic (5.32e-3)"	"unprognostic (1.24e-1)"	"unprognostic (1.36e-1)"	"unprognostic (8.88e-2)"	"unprognostic (4.08e-2)"	"unprognostic (1.82e-2)"	"unprognostic (3.90e-3)"	"unprognostic (8.07e-2)"	"unprognostic (5.18e-2)"	"unprognostic (8.56e-2)"	"unprognostic (4.85e-3)"	"unprognostic (1.13e-1)"	"unprognostic (3.86e-3)"	"unprognostic (1.89e-1)"	"unprognostic (6.27e-2)"	"unprognostic (2.85e-1)"	"unprognostic (1.55e-1)"	6.9	7.5	4.5	4.0	3.1	5.6	7.3	9.0	8.3	7.5	0.5	6.5	4.1	8.9	0.7	4.4	8.4	1.8	4.4	4.6	3.5	3.9	4.3	5.3	4.3	8.8	5.4	10.7	4.2	2.0	5.1	3.0	8.9	7.0	1.4	2.6	6.9	3.0	11.5	7.6	7.4	1.7	2.2	8.2	5.6	6.6	6.3	5.4	7.9	2.3	2.8	7.3	6.2	5.2	4.7	12.3	2.8	7.2	2.1	2.6	21.5	12.0	3.6	3.2	2.8	10.1	10.7	1.8	24.4	4.1	5.5	8.6	3.6	1.3	2.2	22.0	10.4	3.7	14.8	8.3	1.6	2.1	7.5	3.4	1.6	5.1	2.1	3.8	5.7	5.4	10.6	6.5	1.5	7.4	5.5	6.0	7.8	2.0	13.4	14.7	3.2	13.7	2.0	1.3	9.4	5.6	7.1	4.4	1.3	2.0	7.1	3.4	6.9	7.1	10.9	6.1	5.1	14.2	8.0	8.4	5.7	4.2	8.3	3.5	1.1	2.7	2.1	0.4	1.0	0.7	0.7	0.5	0.4	0.9	1.5	0.7	4.1	1.4	0.4	1.8	0.9	0.7	4.5	3.1	9.0	8.3	4.6	3.5	8.8	5.4	8.9	2.2	6.3	5.2	7.6	6.4	7.5	18.3	16.0	5.5	6.2	5.0	3.4	30.0	8.1	9.5	2.7	7.2	8.3	5.5	14.6	12.8	16.2	5.3	1.9	5.4	5.7	4.9	6.4	8.9	3.6	6.1	13.3	3.0	6.6	8.7	6.6	7.0	5.1	20.6	12.5	6.8	4.1	6.7	15.7	6.5	6.1	7.3	3.8	20.8	16.4	6.2	7.2	9.4	13.9	16.6	23.7	13.0	17.2	7.3	11.3	15.4	17.1	22.7	11.5	2.0	8.0	37.3	6.6	12.5	8.3	14.2	20.0	4.5	8.2	20.5	11.8	9.4	4.9	11.7
UPF1	"HUPF1, KIAA0221, NORF1, pNORF1, RENT1, smg-2"	ENSG00000005007	"UPF1 RNA helicase and ATPase"	Q92900	19	18831959-18868230	"Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, Nonsense-mediated mRNA decay"	"Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019587, HPA020857"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA		19000	"Cluster 48: NK-cells - Unknown function"	"Cluster 59: Non-specific - Translation"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm	Cytosol	"HPA019587: AB_1856174, HPA020857: AB_1856175"	"unprognostic (1.03e-1)"	"unprognostic (2.58e-2)"	"unprognostic (3.77e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.66e-1)"	"unprognostic (7.77e-2)"	"unprognostic (2.09e-1)"	"unprognostic (7.98e-2)"	"prognostic unfavorable (2.72e-4)"	"unprognostic (2.94e-1)"	"unprognostic (3.31e-1)"	"unprognostic (3.71e-3)"	"prognostic favorable (2.97e-6)"	"unprognostic (4.48e-2)"	"unprognostic (1.71e-1)"	"unprognostic (8.90e-3)"	"unprognostic (1.01e-2)"	22.7	21.2	11.6	22.2	13.2	26.1	21.2	13.9	14.3	23.4	8.9	23.2	21.6	24.4	8.1	24.1	20.6	17.7	17.5	11.8	11.6	16.3	17.3	21.6	25.8	15.8	12.7	22.5	42.2	35.1	18.6	22.3	11.4	21.1	10.7	10.1	36.7	22.3	31.3	29.3	21.7	13.8	13.3	24.8	23.8	30.9	12.6	27.0	23.0	19.6	16.5	23.5	23.1	15.3	61.2	39.8	27.4	32.8	41.5	27.1	89.7	50.6	31.1	48.0	37.4	76.9	54.0	54.5	65.4	32.0	25.5	60.0	38.7	55.2	18.2	29.2	76.5	59.9	37.2	49.8	35.7	67.2	34.7	30.3	39.3	37.4	40.3	27.5	30.8	46.6	76.6	51.4	25.8	66.5	78.5	42.2	45.7	42.2	96.0	62.1	44.2	51.4	21.1	54.3	57.8	44.6	46.4	52.2	27.3	21.8	31.4	42.7	43.9	42.6	29.6	52.8	57.3	33.0	27.4	83.7	30.3	64.0	48.0	0.0	0.6	1.1	0.2	0.3	0.2	0.1	0.3	0.0	0.4	0.3	0.2	0.1	1.7	1.0	0.8	0.2	0.2	0.3	11.6	13.2	13.9	14.3	11.8	11.6	15.8	12.7	11.4	13.3	12.6	15.3	24.2	22.4	13.6	10.1	14.8	15.7	13.3	10.0	10.2	30.8	24.7	24.5	14.5	12.8	11.0	27.6	14.6	16.4	18.7	32.5	0.0	11.1	13.5	46.5	27.8	19.4	21.6	8.8	9.9	9.8	13.7	15.8	29.0	65.9	0.0	24.4	13.9	24.1	14.4	37.0	9.5	27.4	10.2	19.1	12.2	7.9	14.6	19.5	12.4	10.3	11.8	19.5	13.4	9.0	11.4	16.6	16.6	19.2	18.9	22.2	17.5	10.5	29.0	18.5	13.1	15.6	15.0	26.8	18.4	20.1	18.6	20.5	16.5	20.5	22.8	27.2
UPF2	"DKFZP434D222, KIAA1408, RENT2, smg-3"	ENSG00000151461	"UPF2 regulator of nonsense mediated mRNA decay"	Q9HAU5	10	11920022-12043170	"Plasma proteins, Predicted intracellular proteins"	"Nonsense-mediated mRNA decay"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA067008			Supported	"Cytosol,Cytoplasmic bodies"		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 36: HEL - Hemostasis"	"Cluster 41: Macrophages - Immune response"	Cytosol	"Cytoplasmic bodies"	"HPA067008: AB_2685762"	"unprognostic (1.99e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.61e-2)"	"unprognostic (2.48e-2)"	"unprognostic (1.41e-2)"	"prognostic unfavorable (6.13e-4)"	"unprognostic (5.48e-2)"	"unprognostic (5.68e-2)"	"unprognostic (9.27e-2)"	"unprognostic (1.68e-2)"	"unprognostic (3.01e-2)"	"unprognostic (4.65e-3)"	"unprognostic (1.06e-1)"	"unprognostic (2.95e-1)"	"unprognostic (2.45e-1)"	"unprognostic (8.48e-2)"	12.8	8.1	12.4	14.1	13.7	21.0	12.7	15.8	15.1	12.0	12.5	16.2	10.0	14.9	10.7	10.9	11.0	8.9	10.6	12.5	13.6	10.9	16.7	10.4	18.9	11.8	12.2	16.2	13.7	14.8	7.9	14.1	11.6	13.5	12.9	14.8	11.1	12.2	22.0	12.9	11.4	12.1	11.9	14.8	11.3	19.5	12.7	21.5	12.8	21.4	17.7	13.4	11.8	13.2	35.9	22.3	18.8	23.5	14.0	17.9	21.2	27.5	12.7	19.2	23.0	21.2	28.6	51.4	9.1	23.0	15.8	29.4	27.2	24.9	27.4	32.5	15.7	61.6	18.2	19.4	15.8	28.1	39.8	13.5	19.0	24.3	16.4	18.2	23.8	27.1	37.1	25.7	22.2	17.7	34.8	16.4	18.0	27.1	11.8	30.4	22.5	25.3	18.2	14.2	12.1	13.0	21.6	23.1	23.8	18.7	27.9	37.1	25.5	15.0	31.4	31.1	21.1	23.4	19.8	41.4	24.0	26.9	12.1	13.7	4.2	10.2	4.3	4.2	4.2	10.7	4.9	4.5	3.0	10.6	5.4	4.5	29.5	5.4	2.9	11.5	3.8	1.8	12.4	13.7	15.8	15.1	12.5	13.6	11.8	12.2	11.6	11.9	12.7	13.2	74.8	25.6	34.6	32.0	133.3	71.9	35.0	46.9	64.3	66.3	53.8	38.6	69.6	52.9	39.4	49.7	102.2	47.0	79.6	97.7	39.2	47.7	70.1	99.3	86.2	62.6	66.3	108.4	36.1	44.8	51.7	48.2	58.1	88.7	58.9	71.8	64.2	89.5	41.1	52.2	31.6	90.2	48.8	71.4	125.3	116.9	86.3	56.0	53.4	31.9	89.0	45.5	98.9	37.2	45.4	53.7	78.9	59.0	121.2	38.7	70.6	34.1	41.5	97.2	98.6	54.3	60.1	182.9	149.8	47.3	81.8	56.5	73.6	35.9	65.5	36.3
UPF3B	"HUPF3B, MRX62, MRX82, RENT3B, UPF3BP1, UPF3BP2, UPF3BP3, UPF3X"	ENSG00000125351	"UPF3B regulator of nonsense mediated mRNA decay"	Q9BZI7	X	119805311-119852998	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"mRNA transport, Nonsense-mediated mRNA decay, Transport"	RNA-binding	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 157.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001592, HPA001800, HPA001882"	Approved		Enhanced	Nucleoplasm,Nucleoli,Cytosol		No	No			"Cluster 6: Non-specific - Transcription"	"Cluster 20: Retina & Lymphoid tissues - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	Cytosol	"Nucleoplasm, Nucleoli"	"HPA001592: AB_2666373, HPA001800: AB_1080476, HPA001882: AB_1080474"	"unprognostic (1.79e-1)"	"unprognostic (5.41e-2)"	"unprognostic (1.21e-2)"	"unprognostic (3.64e-3)"	"unprognostic (8.58e-2)"	"unprognostic (1.20e-1)"	"prognostic unfavorable (1.52e-6)"	"unprognostic (6.61e-2)"	"prognostic unfavorable (5.39e-4)"	"unprognostic (5.74e-2)"	"unprognostic (4.51e-2)"	"unprognostic (8.63e-3)"	"prognostic unfavorable (1.44e-7)"	"unprognostic (8.67e-2)"	"unprognostic (1.04e-1)"	"unprognostic (2.34e-1)"	"unprognostic (8.95e-2)"	9.9	8.1	17.0	10.2	17.2	13.6	9.5	21.1	30.0	11.9	16.3	11.8	11.8	11.7	10.5	12.7	9.9	6.9	7.5	16.5	20.0	11.4	12.4	9.0	15.4	17.5	17.3	13.3	8.1	11.3	12.9	8.8	17.4	10.8	10.5	22.0	8.8	9.0	12.9	15.5	10.0	9.3	16.0	11.3	8.6	15.7	17.8	14.7	11.5	10.9	15.6	10.5	11.7	18.6	29.2	17.3	35.1	28.8	15.7	10.3	22.5	27.4	15.3	20.9	18.3	32.7	20.4	51.9	22.6	11.5	29.9	27.1	45.9	16.6	26.5	29.9	33.9	48.3	57.9	17.2	17.9	52.7	23.0	8.7	12.4	35.8	43.3	19.0	19.7	30.5	47.4	41.8	17.6	35.9	36.8	65.6	67.7	37.1	46.8	35.9	40.2	38.2	17.3	14.5	46.7	32.1	55.6	22.4	42.4	36.2	11.9	30.4	17.3	21.6	16.6	34.9	58.6	23.1	27.5	69.5	17.5	76.1	25.7	8.1	4.4	6.5	5.9	4.8	4.8	12.5	5.6	4.8	3.3	13.7	6.3	6.4	4.9	7.7	5.6	8.7	7.4	2.2	17.0	17.2	21.1	30.0	16.5	20.0	17.5	17.3	17.4	16.0	17.8	18.6	26.3	32.1	25.7	31.6	47.4	37.7	31.1	31.6	47.8	50.7	26.4	28.2	19.0	17.2	38.7	25.8	56.3	39.0	46.1	33.5	5.9	31.6	157.3	26.1	23.5	31.1	27.6	52.2	30.6	26.4	48.2	25.5	23.0	33.8	58.9	32.8	23.2	22.9	28.5	28.6	39.5	35.5	26.4	19.1	43.3	31.7	30.4	28.2	24.9	27.2	44.9	32.6	56.7	33.7	45.4	21.5	33.6	32.7	32.5	33.8	30.4	16.5	35.2	99.0	13.1	34.4	42.0	65.8	41.4	38.8	38.1	64.3	39.9	28.1	37.6	25.0
UPRT	"DKFZp781E1243, FUR1, MGC23937, RP11-311P8.3"	ENSG00000094841	"Uracil phosphoribosyltransferase homolog"	Q96BW1	X	75156388-75304885	"Metabolic proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000805	Uncertain		Supported	Nucleoplasm,Vesicles		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 16: U-266 - Nucleosome"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm	Vesicles	"HPA000805: AB_1080482"	"unprognostic (3.12e-3)"	"unprognostic (5.85e-2)"	"unprognostic (1.40e-1)"	"unprognostic (2.67e-2)"	"unprognostic (2.43e-1)"	"unprognostic (1.18e-2)"	"unprognostic (4.62e-2)"	"unprognostic (1.04e-3)"	"unprognostic (9.64e-2)"	"unprognostic (1.37e-2)"	"unprognostic (1.05e-2)"	"unprognostic (2.62e-1)"	"prognostic favorable (4.14e-4)"	"unprognostic (6.09e-2)"	"unprognostic (2.54e-2)"	"unprognostic (2.74e-1)"	"unprognostic (4.53e-3)"	6.2	10.9	7.2	6.3	7.4	13.4	7.9	7.4	8.7	8.1	8.1	7.6	10.9	5.9	8.9	7.9	7.2	6.1	9.3	7.1	8.2	11.4	8.6	7.6	8.9	7.2	8.3	6.1	6.5	14.0	7.0	5.8	7.9	9.2	7.9	6.4	8.7	6.0	8.9	5.6	8.1	6.5	7.4	7.3	10.3	1.9	8.1	8.9	10.2	10.8	8.2	6.9	4.7	8.1	11.6	7.6	8.9	8.1	9.4	9.9	8.4	8.0	9.2	8.4	9.6	7.2	7.7	16.3	6.6	8.5	15.1	4.8	20.7	6.8	13.9	14.3	8.0	10.2	7.8	9.1	9.0	20.2	20.1	7.5	5.0	11.2	6.1	13.4	15.1	13.1	12.1	15.7	22.6	4.8	22.7	12.4	17.8	8.6	13.0	10.7	22.8	8.1	21.9	6.4	0.6	9.2	11.0	11.4	11.4	15.7	5.3	12.6	12.6	10.6	6.3	19.4	6.8	10.7	36.5	15.8	11.2	21.9	6.9	6.9	7.3	9.2	7.7	10.6	9.0	8.2	7.6	8.0	10.9	7.0	9.4	8.3	1.4	14.4	17.9	5.2	13.5	7.1	7.2	7.4	7.4	8.7	7.1	8.2	7.2	8.3	7.9	7.4	8.1	8.1	8.5	6.4	5.0	8.1	8.0	6.2	8.7	10.0	3.4	8.5	5.3	3.8	6.6	5.7	11.2	9.2	0.0	8.4	8.1	5.3	27.4	8.8	2.0	4.8	4.1	8.6	6.0	4.6	8.8	6.0	15.1	5.2	5.1	4.1	24.1	5.2	11.7	6.0	11.6	10.1	8.8	5.3	22.4	16.1	8.8	1.8	4.4	10.8	14.2	3.7	7.8	9.4	13.4	13.0	8.4	5.6	3.2	3.4	9.8	5.5	8.4	15.4	6.1	7.2	6.6	4.8	7.1	0.7	2.4	4.2	6.0	12.2	12.1	6.5	7.2	7.4
UQCC2	"bA6B20.2, C6orf125, Cbp6, M19, MGC14833, MNF1"	ENSG00000137288	"Ubiquinol-cytochrome c reductase complex assembly factor 2"	Q9BRT2	6	33694293-33711727	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 911.7;Late spermatids: 1207.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA039111	Uncertain		Supported	"Nuclear bodies,Mitochondria"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 38: Heart - Muscle contraction"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 10: Non-specific - Unknown function"	Mitochondria	"Nuclear bodies"	"HPA039111: AB_2676352"	"unprognostic (3.58e-2)"	"unprognostic (1.06e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.93e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.58e-2)"	"unprognostic (3.21e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.35e-3)"	"unprognostic (2.43e-2)"	"unprognostic (5.93e-2)"	"unprognostic (2.33e-2)"	"unprognostic (7.43e-2)"	"unprognostic (5.77e-2)"	"unprognostic (3.88e-1)"	"unprognostic (1.07e-1)"	38.9	69.6	100.5	37.3	102.8	45.3	45.3	103.3	140.9	48.4	97.6	43.3	34.3	61.5	58.4	59.2	40.0	20.8	267.2	100.1	106.6	66.9	83.3	33.9	35.6	102.5	102.2	33.4	61.2	46.8	78.0	29.3	102.9	55.4	44.0	104.3	53.0	28.6	228.8	42.9	28.5	52.4	102.4	43.2	49.5	104.1	104.4	45.7	42.9	197.9	40.8	46.1	42.8	107.9	207.7	144.2	162.8	139.4	130.9	129.8	125.5	116.4	117.3	167.7	162.6	233.9	84.5	84.4	180.3	143.5	244.1	109.0	111.7	164.5	138.6	108.0	187.7	163.3	87.3	327.6	215.9	153.8	127.2	136.2	257.4	131.7	204.7	91.0	120.4	158.9	178.4	165.9	190.4	220.9	149.0	315.9	97.3	158.4	167.6	106.5	130.7	279.9	116.2	191.5	273.1	97.1	127.9	191.7	165.6	84.1	168.3	382.2	110.5	178.0	151.1	115.9	242.0	126.8	193.1	146.6	53.7	229.7	211.0	32.7	88.5	18.2	76.1	141.6	93.6	152.4	95.0	87.6	108.6	116.1	98.7	88.0	8.4	81.6	120.9	133.2	110.7	123.8	100.5	102.8	103.3	140.9	100.1	106.6	102.5	102.2	102.9	102.4	104.4	107.9	18.5	28.9	29.3	8.1	54.2	58.5	96.8	193.0	61.5	108.7	96.0	100.3	911.7	74.4	119.8	77.3	50.1	134.7	34.0	112.4	391.3	103.4	342.3	46.6	78.7	54.1	99.7	105.0	8.9	179.7	124.4	88.5	90.7	39.1	59.5	90.0	41.4	166.1	218.8	70.7	10.2	94.5	154.6	67.8	55.6	1207.0	78.6	64.8	83.6	3.7	63.6	79.1	46.4	9.0	10.0	95.6	64.2	83.8	88.3	122.1	44.6	257.2	87.1	123.8	0.0	32.9	269.4	155.9	96.0	103.3	76.3	95.4	43.5	159.3	102.3	118.5
UQCC3	"C11orf83, UNQ655"	ENSG00000204922	"Ubiquinol-cytochrome c reductase complex assembly factor 3"	Q6UW78	11	62670273-62673686	"Disease related genes, Human disease related genes, Predicted membrane proteins"	"ATP synthesis"		"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Proximal enterocytes: 209.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"MCF7: 82.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046851	Approved		Approved	Nucleoplasm,Mitochondria,Cytosol		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 35: Non-specific - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 7: Non-specific - Mitochondria"	"Nucleoplasm, Mitochondria"	Cytosol	"HPA046851: AB_2679839"	"unprognostic (5.89e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.60e-1)"	"unprognostic (3.42e-2)"	"unprognostic (3.91e-1)"	"unprognostic (7.41e-2)"	"prognostic unfavorable (2.55e-4)"	"unprognostic (2.18e-1)"	"unprognostic (1.67e-1)"	"unprognostic (8.70e-3)"	"unprognostic (7.84e-2)"	"unprognostic (8.96e-2)"	"unprognostic (7.07e-2)"	"unprognostic (7.21e-3)"	"unprognostic (1.48e-1)"	"unprognostic (3.20e-1)"	"unprognostic (1.36e-1)"	7.5	12.2	7.4	3.7	7.5	5.7	7.5	8.2	9.7	7.6	9.3	9.9	8.1	6.5	1.7	12.3	6.1	1.2	10.2	7.1	7.1	10.7	11.9	4.7	4.2	7.6	7.3	6.5	9.0	3.5	6.7	2.2	7.7	9.4	1.9	3.9	11.5	3.3	15.7	9.0	8.3	1.5	7.0	7.4	9.6	3.4	7.4	2.4	6.3	5.0	1.6	6.3	8.1	8.1	26.9	52.9	7.7	12.0	4.7	4.6	6.5	10.4	3.5	7.7	7.6	31.4	22.8	17.4	21.1	3.6	10.4	26.1	7.4	12.3	2.4	8.8	27.4	9.8	28.7	20.3	6.3	16.0	7.6	4.4	10.3	6.8	7.6	4.8	6.0	8.1	21.3	12.2	4.3	82.4	15.7	39.2	8.6	10.6	29.8	17.9	11.7	31.1	6.1	13.2	15.5	15.7	11.5	41.7	16.2	2.4	39.7	14.9	7.9	16.8	19.7	17.6	23.6	18.7	11.0	18.3	13.8	13.7	12.3	14.6	25.0	20.1	21.3	19.1	20.4	30.8	21.1	19.0	20.0	29.9	19.2	15.3	11.0	19.6	17.2	26.7	25.8	20.0	7.4	7.5	8.2	9.7	7.1	7.1	7.6	7.3	7.7	7.0	7.4	8.1	49.0	44.8	25.0	3.6	32.3	0.0	42.2	0.0	47.3	21.8	77.5	86.4	35.8	70.1	16.1	64.4	16.7	53.1	22.9	65.2	140.8	56.6	1.7	50.3	40.6	32.9	35.2	32.2	2.4	78.4	53.1	32.4	54.6	41.1	5.1	28.0	44.6	125.4	54.8	18.5	4.2	75.2	0.0	39.7	0.0	3.7	48.4	29.2	0.0	7.5	47.2	59.7	66.9	5.0	5.2	67.4	66.9	36.1	38.4	85.1	209.3	170.6	12.4	37.0	39.5	28.3	31.8	4.2	32.0	91.0	0.0	29.0	25.3	35.1	79.0	57.0
UQCRC1	"D3S3191, QCR1, UQCR1"	ENSG00000010256	"Ubiquinol-cytochrome c reductase core protein 1"	P31930	3	48599002-48610976	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Electron transport, Respiratory chain, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 766.7;tongue: 882.7"	"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 662.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002815, HPA003525, CAB033782"	Enhanced		Supported	Mitochondria		NA	NA		250000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"CAB033782: AB_2213631, HPA002815: AB_1080486, HPA003525: AB_1080484"	"unprognostic (1.29e-1)"	"unprognostic (3.15e-3)"	"unprognostic (6.91e-3)"	"unprognostic (1.06e-1)"	"unprognostic (1.66e-1)"	"unprognostic (9.91e-2)"	"unprognostic (8.53e-2)"	"unprognostic (1.99e-1)"	"unprognostic (3.11e-2)"	"unprognostic (9.14e-2)"	"unprognostic (3.37e-1)"	"unprognostic (7.20e-2)"	"prognostic favorable (2.35e-10)"	"unprognostic (5.37e-2)"	"unprognostic (2.35e-1)"	"unprognostic (1.02e-1)"	"unprognostic (6.72e-2)"	66.0	58.2	93.7	46.9	97.1	62.4	55.0	117.3	110.1	50.7	127.2	156.9	156.3	35.5	50.4	78.9	66.2	33.9	387.7	96.7	115.0	131.3	149.0	42.1	42.8	111.0	101.7	36.1	87.4	192.2	30.6	56.0	114.6	51.8	129.6	52.9	105.9	77.5	766.7	78.6	125.4	62.8	99.3	41.0	103.3	52.1	111.6	72.7	48.4	882.7	58.0	63.5	40.0	101.4	118.2	169.6	136.7	145.0	147.5	117.0	225.2	129.4	206.1	196.5	178.9	272.8	107.1	193.4	94.4	143.2	274.1	123.6	171.6	280.9	91.7	138.3	173.8	214.7	186.7	317.1	186.9	164.4	152.2	150.9	293.6	183.2	274.6	167.5	172.5	173.7	110.5	107.1	152.5	192.0	156.7	241.6	157.6	229.6	324.2	103.4	138.1	273.5	235.8	178.7	84.4	107.5	182.8	218.7	211.8	92.0	163.1	178.0	112.5	107.7	153.7	179.5	272.4	124.8	121.4	136.5	192.7	233.9	319.0	251.3	643.7	325.4	204.7	665.7	193.7	260.0	203.5	206.1	593.3	227.7	177.1	175.2	158.2	194.4	608.0	235.0	258.1	988.2	93.7	97.1	117.3	110.1	96.7	115.0	111.0	101.7	114.6	99.3	111.6	101.4	31.5	57.7	50.4	17.3	59.0	117.6	164.6	339.4	103.6	41.9	59.3	46.1	662.2	140.2	139.2	121.4	29.2	334.4	28.0	550.2	365.9	163.7	155.0	64.0	41.6	53.4	144.5	80.6	16.9	166.3	311.1	78.2	167.7	61.5	82.4	72.5	49.6	188.0	238.2	40.4	22.0	319.6	223.8	118.1	85.4	331.9	58.4	107.7	119.2	12.2	129.1	67.1	51.5	14.6	12.5	163.5	333.3	70.7	117.6	78.4	553.4	398.4	104.7	65.0	59.2	61.2	153.0	110.3	74.7	173.0	105.4	336.7	50.8	172.1	416.8	153.4
URB1	"C21orf108, KIAA0539, NPA1"	ENSG00000142207	"URB1 ribosome biogenesis homolog"	O60287	21	32311018-32393012	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Granulosa cells: 45.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018334	Supported		Supported	"Nucleoli fibrillar center"		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 36: Stromal cells - Cell proliferation"	"Nucleoli fibrillar center"		"HPA018334: AB_1856088"	"unprognostic (1.58e-1)"	"unprognostic (2.28e-3)"	"unprognostic (9.55e-2)"	"unprognostic (1.76e-2)"	"unprognostic (1.06e-1)"	"unprognostic (4.45e-3)"	"prognostic unfavorable (4.93e-4)"	"unprognostic (3.04e-1)"	"unprognostic (4.57e-1)"	"unprognostic (4.65e-3)"	"unprognostic (2.65e-2)"	"unprognostic (2.02e-1)"	"unprognostic (3.58e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.08e-1)"	"unprognostic (5.95e-3)"	"unprognostic (2.78e-2)"	5.3	7.5	4.7	4.0	4.5	3.2	4.9	3.8	5.0	6.5	14.4	4.7	2.3	11.2	4.2	6.9	8.0	2.5	6.3	5.9	4.6	3.4	5.2	3.7	4.1	6.9	5.4	7.6	5.9	5.6	4.5	3.4	6.8	9.9	2.8	2.1	7.2	8.0	8.8	7.1	3.4	5.5	4.5	3.5	4.3	6.6	5.1	3.8	4.1	4.3	3.9	8.7	6.6	6.1	12.7	16.0	7.0	14.6	14.1	11.2	11.3	12.9	6.4	9.6	7.4	22.3	7.1	12.7	7.0	12.7	10.5	7.8	19.9	30.5	9.9	9.9	12.1	43.6	14.7	11.8	10.2	24.5	9.3	18.2	10.4	21.9	23.6	7.1	10.4	14.6	39.7	12.1	14.2	12.8	15.9	8.7	23.4	15.1	14.7	18.7	16.4	15.3	6.5	12.0	15.8	14.1	15.1	12.5	14.0	5.2	11.0	9.3	12.1	23.6	14.1	9.8	14.6	17.0	17.7	20.0	10.7	22.0	12.2	0.9	0.3	0.0	0.4	0.3	0.8	0.6	0.5	0.5	0.3	0.5	0.6	0.6	0.3	0.8	0.1	0.3	0.5	0.3	4.7	4.5	3.8	5.0	5.9	4.6	6.9	5.4	6.8	4.5	5.1	6.1	8.1	3.2	10.5	14.7	8.5	9.7	14.5	11.3	25.6	7.2	9.6	8.6	9.4	2.8	17.2	1.8	4.2	5.9	5.9	2.4	0.0	4.8	9.4	35.0	38.0	7.6	7.8	8.0	27.6	6.0	3.9	8.7	7.7	22.1	0.0	45.4	4.6	8.5	4.0	15.2	29.0	4.7	6.1	2.7	3.1	6.0	5.6	3.4	5.4	15.0	3.0	3.9	3.1	26.2	27.5	4.5	4.3	7.5	4.2	20.9	0.8	2.4	18.6	5.6	6.6	18.1	8.8	12.8	15.4	16.2	11.4	4.2	5.5	13.2	7.1	14.6
URGCP	"DKFZp666G166, DKFZp686O0457, FLJ20654, KIAA1507, URG4"	ENSG00000106608	"Upregulator of cell proliferation"	Q8TCY9	7	43875894-43926411	"Predicted intracellular proteins, Predicted membrane proteins"	"Cell cycle"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019879, HPA020134, HPA029468"	Approved		Supported	Cytosol		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Cytosol		"HPA019879: AB_1858651, HPA020134: AB_1858652, HPA029468: AB_10601831"	"unprognostic (5.66e-2)"	"unprognostic (1.10e-3)"	"unprognostic (1.18e-1)"	"unprognostic (2.75e-1)"	"unprognostic (2.21e-3)"	"unprognostic (2.42e-2)"	"unprognostic (3.74e-2)"	"unprognostic (1.26e-1)"	"unprognostic (3.79e-1)"	"unprognostic (2.21e-1)"	"unprognostic (3.23e-3)"	"unprognostic (3.71e-1)"	"prognostic favorable (1.90e-4)"	"unprognostic (1.56e-2)"	"unprognostic (8.69e-2)"	"unprognostic (4.51e-2)"	"unprognostic (1.69e-3)"	15.9	35.6	25.1	9.9	24.6	10.3	15.0	24.5	25.9	19.7	24.1	22.6	24.3	17.7	14.7	17.8	19.5	11.1	25.2	24.5	22.5	24.3	29.6	14.2	10.8	20.7	20.0	20.7	19.1	22.1	27.4	11.9	21.3	21.6	19.0	20.1	15.6	16.1	34.9	18.6	22.8	18.7	19.2	18.5	17.4	9.7	23.4	10.4	18.7	31.6	10.6	20.4	16.6	23.8	28.2	25.1	10.1	32.1	26.3	24.0	9.6	33.2	58.4	35.2	35.6	21.1	21.8	16.5	16.9	31.7	53.5	44.3	28.0	23.8	34.3	31.6	17.3	11.5	25.2	19.0	28.0	17.7	20.3	18.5	28.5	27.8	27.0	23.1	17.7	18.9	28.6	13.1	23.7	21.0	18.6	14.6	19.1	33.1	25.8	24.9	14.6	22.2	33.7	27.7	25.8	44.4	34.4	49.6	15.4	16.5	25.0	21.0	19.5	20.3	9.4	22.8	26.1	34.1	53.6	20.7	23.2	26.7	38.6	4.5	4.7	6.2	8.8	7.4	9.4	5.8	9.2	11.7	10.2	4.9	9.9	8.8	0.5	2.8	8.3	1.6	10.6	6.6	25.1	24.6	24.5	25.9	24.5	22.5	20.7	20.0	21.3	19.2	23.4	23.8	10.1	3.2	9.2	14.7	12.2	11.1	13.4	7.9	9.1	25.9	17.7	17.8	23.8	12.8	7.3	12.9	8.4	6.3	8.9	41.0	17.6	13.0	1.2	16.3	14.3	10.2	8.4	6.3	28.6	13.2	11.8	13.5	23.9	23.2	7.0	21.1	12.5	27.3	6.5	16.8	25.1	12.5	10.2	5.0	10.2	3.4	18.3	7.5	12.4	6.5	4.8	12.2	7.2	7.5	17.6	15.7	23.4	18.8	4.2	14.1	37.9	26.4	8.7	20.4	6.6	13.8	12.6	8.8	8.3	9.1	14.8	3.4	10.8	15.2	16.2	15.0
URI1	"C19orf2, FLJ10575, NNX3, PPP1R19, RMP, URI"	ENSG00000105176	"URI1 prefoldin like chaperone"	O94763	19	29923644-30016612	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Protein phosphatase inhibitor, Repressor"	Oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 499.7;Late spermatids: 514.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA071709	Approved		Supported	Nucleoplasm,Cytosol		Yes	No			"Cluster 24: B-cells - Unknown function"	"Cluster 21: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	Nucleoplasm	Cytosol	"HPA071709: AB_2686434"	"unprognostic (4.22e-2)"	"unprognostic (2.75e-1)"	"unprognostic (6.44e-2)"	"prognostic unfavorable (1.12e-4)"	"unprognostic (2.96e-2)"	"unprognostic (2.98e-1)"	"unprognostic (1.40e-3)"	"unprognostic (8.12e-2)"	"unprognostic (1.26e-2)"	"unprognostic (4.42e-3)"	"unprognostic (1.57e-1)"	"unprognostic (3.71e-1)"	"unprognostic (1.33e-1)"	"unprognostic (6.14e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.42e-1)"	"unprognostic (4.47e-2)"	25.0	30.6	29.7	24.8	39.6	36.4	36.7	57.8	40.7	27.9	21.0	26.1	23.5	34.2	32.3	28.5	30.2	25.1	28.1	25.0	36.8	25.6	30.5	22.9	39.9	35.9	32.3	44.1	21.9	31.4	11.0	24.1	34.5	37.7	32.1	32.4	27.2	30.4	52.8	44.9	23.4	22.8	28.4	30.0	25.0	51.6	30.9	31.7	55.4	36.2	37.3	24.8	10.7	45.6	64.8	85.9	39.5	61.7	27.5	39.8	66.5	41.3	34.4	29.5	33.7	45.4	41.5	99.7	79.4	48.2	23.4	44.6	84.8	52.7	66.5	69.7	48.5	90.8	44.3	59.7	39.7	88.5	37.3	35.1	70.6	25.7	95.7	31.7	22.1	58.2	109.7	27.2	37.4	55.3	58.0	37.1	37.1	83.4	26.2	56.7	73.2	40.5	19.4	75.3	63.4	49.7	47.1	56.3	62.2	41.7	23.5	54.8	29.1	72.1	63.9	35.6	63.3	74.4	86.2	67.7	35.5	76.5	44.4	3.4	1.3	1.8	2.9	1.4	2.5	1.9	2.6	3.0	1.1	4.5	3.1	3.1	0.1	2.2	1.4	1.6	2.2	0.8	29.7	39.6	57.8	40.7	25.0	36.8	35.9	32.3	34.5	28.4	30.9	45.6	51.6	44.8	38.8	59.1	48.6	57.0	95.3	19.4	40.5	60.6	67.6	68.1	52.8	48.6	28.2	40.5	25.0	19.2	84.4	21.7	105.7	16.9	499.7	48.5	82.8	32.5	28.9	38.5	79.9	27.8	28.7	45.6	41.3	41.8	30.9	54.5	31.8	50.9	15.4	52.2	122.3	36.5	18.3	33.6	24.0	514.0	43.8	32.9	32.0	74.9	25.0	58.5	70.0	137.7	178.4	19.4	23.7	41.3	53.3	123.9	19.4	85.2	38.8	59.8	13.1	82.3	48.5	72.2	52.2	44.8	73.6	13.1	74.2	91.6	37.0	94.3
UROD		ENSG00000126088	"Uroporphyrinogen decarboxylase"	P06132	1	45010950-45015575	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Heme biosynthesis, Porphyrin biosynthesis"	"Decarboxylase, Lyase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	5	"Erythroid cells: 806.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"K-562: 420.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027468, HPA028668, HPA030350"	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA		2600000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 6: Erythroid cells - Oxygen transport"	"Nucleoplasm, Cytosol"		"HPA027468: AB_1858654, HPA028668: AB_10603458, HPA030350: AB_2673440"	"unprognostic (5.90e-2)"	"unprognostic (2.94e-2)"	"unprognostic (2.49e-1)"	"unprognostic (9.61e-2)"	"unprognostic (7.94e-2)"	"unprognostic (1.96e-1)"	"prognostic unfavorable (2.48e-4)"	"unprognostic (2.31e-2)"	"unprognostic (4.76e-2)"	"unprognostic (6.75e-2)"	"unprognostic (7.72e-3)"	"unprognostic (3.92e-1)"	"unprognostic (1.24e-1)"	"unprognostic (4.68e-2)"	"unprognostic (1.41e-1)"	"unprognostic (8.73e-2)"	"unprognostic (8.12e-2)"	51.7	120.1	72.0	25.5	73.9	199.0	48.2	72.0	79.3	40.8	77.2	49.3	29.2	46.9	54.7	34.2	49.2	30.8	70.6	73.1	74.5	58.0	100.9	34.8	35.2	72.1	73.4	51.1	45.1	115.0	42.6	39.4	73.6	35.1	30.1	24.7	61.4	44.2	75.9	31.7	30.7	54.7	72.9	37.8	38.5	44.8	73.6	44.0	54.0	83.8	36.1	40.3	32.7	73.8	66.0	42.5	67.0	89.1	113.4	107.7	31.8	87.4	209.8	163.9	125.2	59.9	32.3	46.4	82.3	122.8	116.3	31.1	127.2	153.6	116.9	42.9	133.4	245.4	95.4	200.7	132.4	79.0	42.6	115.1	97.6	154.1	132.3	121.8	208.9	92.9	420.8	48.5	157.6	53.5	49.9	62.9	104.1	51.5	145.9	76.5	96.5	69.9	141.7	54.4	73.9	57.3	89.1	63.9	134.3	73.7	50.8	77.6	137.5	96.9	71.6	34.2	130.5	49.4	60.1	38.1	141.0	117.6	47.2	72.3	111.9	65.5	57.4	81.5	58.8	84.9	69.2	56.7	149.7	81.9	63.6	58.0	20.1	87.4	50.9	102.3	88.7	122.1	72.0	73.9	72.0	79.3	73.1	74.5	72.1	73.4	73.6	72.9	73.6	73.8	25.8	44.8	38.0	7.8	25.4	22.9	35.8	101.4	43.9	27.3	31.0	37.1	74.4	41.5	45.3	27.6	16.7	98.6	22.1	21.4	90.1	73.5	8.1	20.3	30.7	42.7	18.0	806.8	9.4	63.7	54.6	57.1	17.3	21.2	52.6	20.4	38.6	98.5	101.8	13.5	6.7	20.2	73.2	37.9	29.4	16.2	79.6	38.5	48.0	5.6	103.6	89.7	24.7	7.1	7.3	51.2	23.7	56.1	36.8	15.9	32.7	134.5	32.9	25.3	39.5	29.4	75.0	37.3	42.3	31.6	24.7	49.8	23.3	72.7	20.9	29.1
USB1	"C16orf57, FLJ13154, HVSL1, Mpn1"	ENSG00000103005	"U6 snRNA biogenesis phosphodiesterase 1"	Q9BQ65	16	57999546-58021618	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		"Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041791, HPA059854"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 63: NK-cells & T-cells - Immune response"	Nucleoplasm		"HPA041791: AB_10793933, HPA059854: AB_2684143"	"unprognostic (2.79e-1)"	"unprognostic (3.84e-2)"	"unprognostic (1.21e-2)"	"unprognostic (9.65e-2)"	"unprognostic (2.03e-1)"	"unprognostic (2.23e-3)"	"prognostic unfavorable (6.69e-7)"	"unprognostic (4.30e-3)"	"unprognostic (2.92e-1)"	"unprognostic (4.98e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.78e-2)"	"prognostic unfavorable (2.02e-4)"	"unprognostic (2.18e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.06e-3)"	"unprognostic (5.04e-2)"	21.5	27.5	24.0	27.6	23.4	30.9	14.8	22.4	26.2	15.6	20.9	22.8	14.3	19.0	16.3	17.4	15.7	14.7	27.7	23.6	25.8	19.0	29.9	20.5	20.2	26.5	24.9	11.8	17.6	14.7	13.4	16.6	26.3	17.2	18.6	6.7	14.1	18.4	15.6	15.2	18.1	24.8	23.8	25.7	19.4	20.2	25.7	18.4	19.1	13.0	20.8	28.1	15.4	23.5	53.2	109.2	36.5	69.7	46.4	32.5	57.6	43.9	58.2	68.6	48.3	70.9	31.0	32.5	56.6	65.3	61.0	38.6	58.2	93.6	97.6	31.9	32.9	40.5	43.0	103.8	52.7	54.2	114.1	46.6	54.7	87.2	50.8	45.4	76.1	69.7	55.4	15.4	58.2	56.0	50.1	62.3	60.6	47.7	88.5	49.3	32.9	53.8	49.1	63.4	17.6	41.6	114.8	29.8	27.6	57.6	14.8	54.5	82.6	40.2	59.0	43.3	60.5	23.4	37.3	58.9	48.3	51.1	50.0	112.3	58.4	86.8	57.1	67.8	37.4	19.5	33.2	43.7	54.8	13.4	20.3	36.7	162.2	45.5	95.5	23.8	45.1	32.4	24.0	23.4	22.4	26.2	23.6	25.8	26.5	24.9	26.3	23.8	25.7	23.5	12.9	0.0	9.2	6.2	12.2	18.1	17.7	22.8	13.1	3.2	15.2	13.0	13.0	14.3	12.4	9.2	4.2	29.3	33.2	30.2	11.7	39.5	1.3	9.5	10.7	13.5	12.6	9.0	10.4	46.2	55.3	13.3	14.3	9.7	16.5	6.3	17.5	13.0	42.0	6.7	6.2	15.9	28.5	19.8	16.4	1.4	8.1	26.5	14.2	5.6	37.2	11.5	48.4	2.5	5.2	49.7	20.0	11.7	16.4	14.7	18.3	16.2	9.7	3.6	6.6	7.7	15.3	12.6	22.5	10.9	13.1	20.5	24.3	13.0	10.2	15.2
USP1		ENSG00000162607	"Ubiquitin specific peptidase 1"	O94782	1	62436297-62451804	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 302.7;Spermatogonia: 206.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028387, HPA028440"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"HPA028387: AB_2672578, HPA028440: AB_10603000"	"unprognostic (1.22e-1)"	"unprognostic (5.36e-2)"	"unprognostic (1.78e-3)"	"unprognostic (4.05e-3)"	"unprognostic (2.57e-1)"	"unprognostic (1.72e-2)"	"prognostic unfavorable (5.81e-5)"	"unprognostic (6.72e-2)"	"unprognostic (1.11e-2)"	"unprognostic (5.32e-2)"	"unprognostic (3.33e-3)"	"unprognostic (3.99e-2)"	"unprognostic (2.76e-2)"	"unprognostic (9.61e-3)"	"unprognostic (5.70e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.71e-1)"	13.8	10.6	12.4	21.0	14.7	53.2	23.9	20.2	15.4	16.2	11.8	19.0	17.1	20.7	16.8	17.9	16.7	11.9	12.2	11.5	13.4	14.1	13.5	16.0	32.3	12.8	13.0	26.0	16.0	18.2	10.0	14.4	13.7	16.7	20.7	34.5	14.7	15.9	11.9	19.3	17.2	17.0	14.2	19.4	16.9	51.5	12.9	48.1	20.2	16.0	31.7	13.9	11.9	17.3	85.6	25.5	96.8	53.2	21.3	25.5	57.0	79.7	52.1	93.3	101.2	41.4	39.3	151.3	57.0	43.1	83.6	48.0	80.3	53.0	128.5	79.5	63.5	124.5	82.1	42.7	23.2	132.5	60.9	13.7	33.8	84.1	62.8	25.1	44.9	100.1	92.7	125.3	66.2	38.0	136.9	50.9	88.2	48.5	52.4	131.9	166.3	93.9	34.9	60.1	103.4	58.6	89.3	70.1	86.8	64.2	41.3	79.7	32.1	72.7	80.7	109.3	112.9	52.2	78.1	171.1	49.5	104.0	67.0	22.6	9.9	26.0	12.7	10.5	16.9	15.6	15.3	13.5	12.3	11.2	14.4	12.2	17.4	17.9	14.9	12.4	15.3	10.3	12.4	14.7	20.2	15.4	11.5	13.4	12.8	13.0	13.7	14.2	12.9	17.3	35.8	48.1	31.8	6.2	58.7	62.2	34.7	32.9	75.7	49.6	41.5	46.2	34.9	24.3	34.9	16.5	22.9	43.7	52.4	22.7	19.6	34.1	173.9	37.2	32.3	39.7	8.4	85.2	10.3	34.1	59.2	43.9	15.8	33.2	27.8	41.4	30.0	18.4	31.0	35.3	11.2	33.3	30.5	27.2	38.8	81.1	50.1	34.7	26.6	7.5	56.0	49.5	62.8	10.6	17.2	27.5	12.7	41.0	63.7	56.8	22.7	17.3	41.9	86.6	52.6	59.7	42.0	302.7	206.7	73.8	64.4	33.0	59.7	21.2	39.5	35.8
USP10	"KIAA0190, UBPO"	ENSG00000103194	"Ubiquitin specific peptidase 10"	Q14694	16	84699986-84779922	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Autophagy, DNA damage, DNA repair, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in all"	5	"neutrophil: 742.4"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 742.4"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006731, HPA006749"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 47: Cytotrophoblasts - Unknown function"	Cytosol	Nucleoplasm	"HPA006731: AB_1080495, HPA006749: AB_1080492"	"unprognostic (4.14e-2)"	"unprognostic (2.28e-1)"	"unprognostic (2.36e-2)"	"unprognostic (4.85e-2)"	"unprognostic (6.93e-2)"	"unprognostic (1.77e-3)"	"unprognostic (1.03e-3)"	"unprognostic (2.91e-3)"	"unprognostic (1.75e-1)"	"unprognostic (3.84e-2)"	"unprognostic (2.56e-2)"	"unprognostic (1.82e-3)"	"prognostic favorable (1.00e-4)"	"unprognostic (5.91e-2)"	"unprognostic (4.57e-2)"	"unprognostic (8.57e-2)"	"unprognostic (1.38e-1)"	24.8	21.7	19.6	29.4	20.3	29.5	23.4	22.1	22.9	21.0	17.8	31.2	29.5	25.9	23.9	29.1	27.0	18.5	25.4	20.8	20.7	28.8	33.8	18.7	36.7	18.8	18.7	27.1	23.0	41.5	6.0	40.3	19.0	28.3	26.4	52.5	21.0	25.9	46.6	25.7	27.4	31.0	19.8	32.6	23.8	22.0	20.4	29.1	27.4	39.5	37.7	32.1	10.1	21.6	63.6	72.9	78.5	104.7	31.4	50.2	111.5	58.0	60.1	96.9	51.5	106.9	54.9	102.9	65.2	61.1	47.7	69.8	108.2	89.7	139.0	41.3	63.3	63.2	37.3	92.2	39.4	95.0	37.9	30.0	74.8	95.6	112.3	57.5	76.4	68.5	153.4	22.7	73.1	129.4	92.4	96.8	102.5	71.8	56.7	119.9	44.5	55.0	81.9	48.4	73.0	48.6	130.5	48.7	54.0	72.3	108.4	76.8	55.7	66.9	60.2	39.4	62.2	38.8	53.7	272.3	44.5	64.6	73.2	29.0	77.3	15.6	46.1	61.9	58.0	60.6	148.0	53.9	92.6	59.7	82.9	49.6	742.4	65.9	58.6	30.7	57.3	97.3	19.6	20.3	22.1	22.9	20.8	20.7	18.8	18.7	19.0	19.8	20.4	21.6	21.3	54.5	50.0	26.4	51.5	51.5	46.1	25.8	54.1	25.1	27.6	28.6	66.6	25.8	45.2	27.6	29.2	106.9	38.1	25.8	31.3	29.0	63.3	31.0	35.8	30.4	28.9	42.5	39.3	25.1	73.4	40.1	35.7	42.1	58.0	38.7	21.0	37.2	31.4	20.2	38.9	28.1	16.2	34.8	33.4	116.6	23.6	40.6	24.9	41.2	52.6	23.7	32.0	49.8	35.8	23.6	23.9	22.6	50.8	48.6	30.4	45.0	90.7	52.7	26.3	58.4	34.3	35.0	29.5	54.5	49.6	60.9	42.5	33.6	40.6	45.2
USP11	UHX1	ENSG00000102226	"Ubiquitin specific peptidase 11"	P51784	X	47232866-47248328	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Bipolar cells: 203.6;Horizontal cells: 139.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003103, HPA037536"	Enhanced	Supported	Supported	Nucleoplasm,Cytosol	"Intracellular and membrane"	NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 56: Bipolar cells - Visual perception"	Nucleoplasm	Cytosol	"HPA003103: AB_10671088, HPA037536: AB_10672904"	"unprognostic (1.60e-1)"	"unprognostic (2.77e-3)"	"unprognostic (5.84e-2)"	"prognostic unfavorable (2.95e-4)"	"unprognostic (3.08e-2)"	"unprognostic (2.02e-1)"	"unprognostic (6.11e-3)"	"unprognostic (9.21e-2)"	"unprognostic (3.18e-2)"	"unprognostic (3.52e-1)"	"unprognostic (3.29e-3)"	"unprognostic (3.74e-2)"	"prognostic favorable (4.13e-5)"	"unprognostic (3.14e-2)"	"unprognostic (9.23e-2)"	"unprognostic (9.51e-2)"	"unprognostic (7.11e-2)"	25.5	32.8	117.7	23.7	118.7	11.2	26.8	41.5	116.3	51.2	30.0	33.9	11.5	47.0	23.6	18.2	49.9	24.5	45.5	113.1	148.1	33.3	12.7	30.9	30.1	69.8	78.3	76.4	27.1	36.6	103.7	24.9	93.9	33.4	14.1	84.8	21.4	38.7	32.4	18.5	25.5	35.9	65.4	29.3	24.9	46.2	122.8	42.6	52.2	29.6	28.9	36.9	31.7	79.8	45.6	70.7	117.6	81.0	43.4	28.5	33.0	34.0	52.5	65.6	73.3	67.4	36.7	29.9	26.1	60.5	70.5	53.5	94.7	24.0	56.4	47.1	73.5	34.7	52.9	61.4	50.7	39.2	70.7	42.1	9.8	69.1	29.3	37.3	26.7	68.9	26.6	3.9	51.8	70.0	77.8	43.4	89.2	24.3	62.5	86.1	114.3	25.1	32.4	60.9	66.8	114.4	62.6	12.4	37.7	73.9	26.0	23.0	28.2	56.0	58.0	79.3	39.6	54.3	36.2	51.3	34.3	48.8	50.8	63.9	9.1	19.9	55.4	19.6	48.3	53.1	24.5	54.3	11.9	53.1	36.6	76.3	5.5	56.4	24.3	53.2	35.0	46.0	117.7	118.7	41.5	116.3	113.1	148.1	69.8	78.3	93.9	65.4	122.8	79.8	13.6	22.4	17.7	25.8	53.5	13.6	42.2	30.9	21.6	203.6	13.0	23.5	24.2	7.2	31.5	33.1	56.3	20.9	52.2	9.4	50.9	18.3	26.4	28.2	26.3	22.5	35.4	18.3	43.3	10.2	15.0	41.3	22.4	28.3	45.7	56.6	22.1	8.2	13.4	139.7	63.7	8.7	28.5	12.0	16.3	41.0	29.5	17.9	28.4	19.7	17.5	96.2	23.7	25.1	24.8	12.5	7.9	42.2	48.1	18.6	4.7	15.2	46.4	63.4	26.3	57.2	40.2	18.3	87.8	11.9	6.5	16.3	44.6	34.2	8.9	26.0
USP14	TGT	ENSG00000101557	"Ubiquitin specific peptidase 14"	P54578	18	158383-214629	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Immunity, Innate immunity, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001308	Approved		Supported	"Plasma membrane,Cytosol"		NA	NA		2700000	"Cluster 15: NK-cells - Transcription"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	"Plasma membrane, Cytosol"		"HPA001308: AB_1080499"	"unprognostic (2.21e-1)"	"unprognostic (4.05e-2)"	"unprognostic (1.90e-1)"	"unprognostic (2.59e-3)"	"unprognostic (6.04e-2)"	"prognostic unfavorable (7.81e-5)"	"prognostic unfavorable (4.30e-5)"	"unprognostic (5.14e-2)"	"unprognostic (5.00e-2)"	"prognostic favorable (7.91e-4)"	"unprognostic (1.64e-2)"	"unprognostic (2.39e-1)"	"unprognostic (1.51e-3)"	"unprognostic (2.58e-1)"	"unprognostic (1.55e-1)"	"unprognostic (2.20e-2)"	"unprognostic (3.76e-2)"	26.0	21.5	19.9	22.7	21.3	23.9	17.0	20.1	22.9	15.5	13.9	17.8	13.9	17.0	23.8	24.0	14.6	14.6	24.8	21.0	24.5	23.4	25.3	15.1	21.6	25.4	21.7	13.3	13.0	21.2	14.3	26.5	25.7	29.7	19.3	15.5	15.2	19.6	55.6	15.4	12.4	24.7	20.3	13.8	15.1	17.9	26.0	21.8	20.4	36.4	31.3	22.6	15.3	23.3	91.6	75.4	62.7	64.5	60.7	60.0	109.6	115.5	64.9	118.9	110.5	98.9	48.7	133.1	86.6	99.1	114.4	50.9	125.1	91.7	134.9	38.7	59.0	72.5	46.0	78.1	60.5	184.1	70.8	48.4	69.1	122.3	69.5	55.0	93.5	65.9	106.2	99.3	119.1	76.2	105.2	52.4	59.4	56.0	83.5	87.8	78.6	98.0	88.7	79.9	71.8	60.1	120.7	59.2	52.5	68.0	58.2	51.5	103.9	138.7	104.3	128.8	170.6	62.3	125.7	130.9	80.0	77.3	88.4	10.7	18.1	13.8	27.9	25.8	33.6	21.1	27.5	29.5	25.6	16.4	26.7	26.2	1.5	39.3	20.5	18.7	28.6	19.4	19.9	21.3	20.1	22.9	21.0	24.5	25.4	21.7	25.7	20.3	26.0	23.3	40.0	22.4	40.4	27.7	52.7	58.6	53.3	42.0	51.8	58.0	33.4	23.5	44.9	31.5	48.3	44.1	31.3	92.3	58.1	22.5	45.0	60.6	70.9	44.9	56.3	43.1	22.1	102.0	58.8	54.0	71.8	49.0	43.8	80.8	34.8	47.1	28.2	45.4	50.9	116.1	54.4	22.5	46.8	31.5	53.4	21.6	31.7	45.5	35.6	33.7	48.8	39.4	46.4	35.2	74.8	75.8	16.9	45.9	72.7	71.4	15.2	56.0	40.2	50.3	0.0	49.6	51.4	34.1	68.1	57.9	52.4	135.6	55.0	58.9	33.5	51.8
USP15	"KIAA0529, UNPH4"	ENSG00000135655	"Ubiquitin specific peptidase 15"	Q9Y4E8	12	62260338-62417431	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 176.2"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 297.9"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 297.9"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006237, HPA006428, HPA071014"	Approved		Supported	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA		300000	"Cluster 1: Neutrophils - Mixed function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	Cytosol	"Nucleoplasm, Nuclear bodies"	"HPA006237: AB_1080502, HPA006428: AB_2667588, HPA071014: AB_2686333"	"unprognostic (8.18e-2)"	"unprognostic (3.22e-1)"	"unprognostic (9.63e-2)"	"unprognostic (2.09e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.75e-1)"	"prognostic unfavorable (8.04e-4)"	"unprognostic (6.59e-2)"	"unprognostic (7.70e-3)"	"unprognostic (2.19e-1)"	"unprognostic (2.47e-1)"	"unprognostic (4.51e-2)"	"prognostic unfavorable (1.58e-5)"	"unprognostic (9.28e-2)"	"unprognostic (5.81e-3)"	"unprognostic (1.11e-2)"	"unprognostic (1.26e-1)"	29.0	21.6	4.5	29.4	4.8	176.2	22.9	12.3	6.7	17.6	10.2	18.0	13.8	14.6	9.2	19.7	17.8	13.7	19.8	5.2	5.5	14.9	27.2	31.5	33.3	6.0	5.4	26.7	19.7	14.9	13.9	18.4	5.7	14.3	16.7	45.8	19.7	8.3	35.5	29.9	24.6	12.6	4.6	44.3	18.8	30.2	5.5	26.5	17.1	14.8	24.9	18.1	19.4	8.0	18.3	16.5	14.2	17.7	25.7	25.1	27.0	29.0	21.2	22.3	16.1	19.6	21.6	15.5	16.6	17.8	10.1	18.5	18.4	23.1	27.6	18.5	15.0	25.2	15.1	14.1	18.8	35.6	61.8	15.0	19.2	27.2	20.7	20.7	26.1	16.3	80.8	36.0	20.0	23.5	26.4	19.3	25.4	16.5	24.0	17.2	19.1	32.3	17.9	22.8	17.9	8.9	30.9	21.6	17.3	17.4	34.7	18.8	37.2	21.2	22.2	32.0	18.2	16.4	24.0	21.9	25.7	26.7	23.5	163.4	60.0	64.3	13.5	31.1	14.9	28.5	19.6	14.0	23.7	20.5	23.5	13.8	297.9	14.7	26.8	26.6	58.8	26.1	4.5	4.8	12.3	6.7	5.2	5.5	6.0	5.4	5.7	4.6	5.5	8.0	57.1	38.5	36.4	68.6	130.3	58.8	40.8	26.2	40.5	54.9	32.3	28.1	74.9	21.5	48.9	23.9	110.5	31.7	142.5	50.2	11.7	36.4	172.2	26.3	46.5	45.4	42.0	248.3	124.8	41.5	43.3	52.5	57.6	38.9	88.6	53.5	21.0	45.3	46.2	42.1	104.2	33.2	12.2	101.3	97.6	172.0	61.8	120.6	53.4	135.9	195.8	25.6	90.6	100.0	108.8	55.1	47.6	29.3	94.3	36.0	30.9	25.9	31.9	151.5	39.5	66.1	60.5	83.7	43.3	49.3	77.0	65.8	130.0	27.0	29.5	60.8
USP18		ENSG00000184979	"Ubiquitin specific peptidase 18"	Q9UMW8	22	18150170-18177397	"Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 46.9;Extravillous trophoblasts: 31.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+: 181.8;BJ hTERT+ SV40 Large T+ RasG12V: 196.2"									HPA044768	Uncertain		Supported	Vesicles,Cytosol		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 64: Macrophages - Immune response"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 38: Extravillous trophoblasts - Unknown function"	Cytosol	Vesicles	"HPA044768: AB_10963697"	"unprognostic (2.06e-1)"	"unprognostic (3.55e-2)"	"unprognostic (1.57e-2)"	"unprognostic (5.04e-3)"	"unprognostic (1.40e-2)"	"unprognostic (5.42e-2)"	"unprognostic (3.29e-2)"	"unprognostic (5.11e-3)"	"unprognostic (1.81e-1)"	"unprognostic (1.79e-3)"	"unprognostic (9.77e-2)"	"unprognostic (1.47e-1)"	"unprognostic (4.29e-3)"	"unprognostic (2.58e-1)"	"unprognostic (2.77e-2)"	"unprognostic (2.28e-2)"	"unprognostic (8.38e-2)"	10.8	5.0	3.6	5.1	3.8	8.1	8.3	3.3	4.5	4.0	4.0	5.0	6.0	3.2	7.8	4.0	7.3	6.6	4.4	3.7	3.9	5.9	23.6	7.9	9.2	5.1	3.9	2.9	4.2	3.6	5.7	5.7	4.2	5.3	4.4	0.7	14.0	2.5	3.8	3.4	6.7	4.0	7.0	11.0	7.2	9.7	4.1	15.0	7.3	5.5	6.5	4.0	3.6	3.7	14.4	14.6	4.2	18.2	18.2	13.5	18.4	7.3	17.5	181.8	196.2	2.2	20.1	0.2	10.8	4.0	57.5	4.9	21.6	6.4	6.2	64.4	29.4	28.3	1.9	27.0	2.1	6.9	25.7	6.0	2.5	12.8	0.0	1.0	40.8	20.6	1.4	1.7	1.8	24.9	33.4	16.7	12.7	15.6	11.0	13.1	28.4	0.0	3.6	12.4	15.2	11.9	8.8	15.0	71.9	16.3	9.9	6.6	66.7	1.3	3.5	4.1	7.5	3.4	45.4	0.2	16.3	17.1	10.5	3.2	3.9	8.3	8.5	11.0	10.7	5.3	7.2	11.1	1.8	3.4	8.2	9.6	0.7	13.3	8.6	3.3	13.1	5.3	3.6	3.8	3.3	4.5	3.7	3.9	5.1	3.9	4.2	7.0	4.1	3.7	9.7	9.6	4.8	0.7	2.5	1.7	4.5	5.7	2.2	0.2	8.4	8.3	1.4	8.6	6.9	0.0	0.0	4.6	3.0	6.2	46.9	5.9	1.6	20.1	2.5	8.4	3.0	1.3	0.5	11.1	31.9	7.1	4.1	6.3	0.0	8.5	11.0	5.5	8.7	0.0	0.6	3.5	6.1	6.3	0.8	1.7	3.7	3.8	3.6	0.0	1.6	5.1	8.2	2.0	0.3	13.4	3.2	7.2	2.3	2.5	5.4	8.0	12.2	0.3	6.6	8.0	2.5	10.9	1.0	4.0	1.0	1.5	5.0	5.5	2.8	2.9
USP2	UBP41	ENSG00000036672	"Ubiquitin specific peptidase 2"	O75604	11	119355215-119381711	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Biological rhythms, Cell cycle, Myogenesis, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 168.3"	"Group enriched"	"Detected in many"	5	"Early spermatids: 460.0;Late spermatids: 1094.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"K-562: 14.5;U-266/70: 56.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006777, HPA007222"	Approved		Supported	"Plasma membrane,Cytosol"		NA	NA				"Cluster 54: Non-specific - Microtubule organization"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 31: Spermatids - Spermatogenesis"	Cytosol	"Plasma membrane"	"HPA006777: AB_1080507, HPA007222: AB_1080505"	"unprognostic (6.83e-2)"	"unprognostic (2.02e-2)"	"unprognostic (5.54e-2)"	"unprognostic (1.37e-2)"	"unprognostic (1.25e-1)"	"unprognostic (7.46e-3)"	"unprognostic (1.00e-1)"	"unprognostic (5.27e-2)"	"unprognostic (1.24e-1)"	"unprognostic (5.24e-3)"	"unprognostic (8.02e-3)"	"unprognostic (7.33e-2)"	"prognostic favorable (3.09e-11)"	"unprognostic (1.58e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.96e-2)"	"unprognostic (2.66e-2)"	7.0	13.4	11.9	1.6	22.6	1.9	4.1	18.8	19.0	6.0	32.7	10.2	13.9	5.2	5.7	9.8	11.6	2.3	73.5	18.6	9.4	53.4	18.9	3.4	0.1	12.0	13.1	6.2	18.1	24.2	18.9	1.3	7.7	4.1	6.0	76.2	7.6	3.0	168.3	12.8	17.4	6.8	8.2	0.6	6.2	86.5	15.1	0.6	3.8	62.8	0.6	4.5	4.8	17.5	6.0	0.5	0.9	3.2	0.1	0.2	1.3	0.7	0.4	0.0	0.6	6.1	0.8	10.2	1.8	1.1	1.4	1.0	7.9	2.9	0.2	7.2	1.0	2.8	4.4	12.5	2.7	0.0	2.8	0.9	0.6	0.7	2.0	1.3	0.6	7.6	14.5	0.8	1.7	4.1	0.0	0.6	1.6	2.0	1.3	0.1	2.1	1.5	4.6	0.3	11.9	3.6	3.4	2.6	0.7	1.7	8.8	6.2	0.0	0.0	1.5	0.8	1.0	56.9	13.5	0.2	0.1	2.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.9	22.6	18.8	19.0	18.6	9.4	12.0	13.1	7.7	8.2	15.1	17.5	0.6	3.2	2.7	10.7	0.6	2.4	5.3	1.5	1.2	75.2	3.3	2.4	85.2	7.2	6.1	5.5	95.9	0.5	1.6	25.5	113.5	3.1	460.0	39.0	3.0	3.6	0.0	0.4	15.7	1.6	0.9	7.4	2.0	8.4	0.0	2.0	2.2	23.0	17.2	10.1	11.6	2.0	0.0	1.3	2.9	1094.1	6.5	2.1	0.0	1.9	0.0	49.7	0.0	8.0	12.5	1.2	11.8	7.2	0.1	1.1	41.3	41.6	35.0	140.0	19.7	43.3	24.0	50.5	16.5	12.9	4.0	1.4	1.3	0.5	2.6	2.9
USP21	"USP16, USP23"	ENSG00000143258	"Ubiquitin specific peptidase 21"	Q9UK80	1	161159450-161165723	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation, Ubl conjugation pathway"	"Activator, Chromatin regulator, Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 16.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028397	Uncertain	Approved	Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 6: T47d - Mammary gland"	"Cluster 59: Non-specific - Transcription"	Cytosol	"Nucleoplasm, Plasma membrane"	"HPA028397: AB_10603227"	"unprognostic (9.17e-2)"	"unprognostic (1.44e-1)"	"unprognostic (3.95e-2)"	"prognostic unfavorable (7.05e-4)"	"unprognostic (1.22e-2)"	"unprognostic (1.26e-2)"	"prognostic unfavorable (1.68e-4)"	"unprognostic (5.35e-2)"	"unprognostic (6.73e-2)"	"unprognostic (2.76e-2)"	"unprognostic (3.87e-3)"	"unprognostic (1.31e-2)"	"prognostic unfavorable (9.50e-6)"	"unprognostic (2.45e-1)"	"unprognostic (3.28e-1)"	"unprognostic (2.13e-2)"	"prognostic favorable (3.35e-5)"	12.2	15.3	19.6	11.9	20.7	15.0	14.3	18.5	22.8	19.4	18.3	17.6	13.6	18.2	12.0	16.4	28.0	12.0	13.0	19.4	18.4	14.5	10.8	13.1	16.1	19.2	19.7	23.2	16.4	17.1	15.7	13.2	18.7	17.7	11.0	12.9	16.5	20.3	20.9	20.8	15.9	12.6	17.3	17.8	16.4	14.2	20.1	18.4	18.5	17.7	14.0	17.6	16.8	22.1	12.5	20.6	26.9	26.2	21.1	17.5	16.5	9.1	14.6	24.2	18.9	19.4	23.3	16.0	14.6	11.2	15.1	20.7	17.6	17.5	13.2	30.8	30.0	19.3	34.1	15.3	15.2	17.4	13.4	14.8	23.0	16.6	23.9	27.1	17.3	35.0	28.4	21.6	15.6	22.6	30.7	26.9	25.2	24.3	26.1	28.8	9.0	26.5	14.4	14.9	24.2	31.5	17.2	17.2	13.9	20.1	37.3	27.5	10.1	16.9	14.8	11.9	15.3	42.9	36.5	23.9	15.3	14.7	15.5	15.2	10.0	17.1	12.6	6.4	14.6	11.0	11.5	13.2	10.8	11.3	13.1	12.3	8.4	13.3	7.6	10.8	12.3	11.0	19.6	20.7	18.5	22.8	19.4	18.4	19.2	19.7	18.7	17.3	20.1	22.1	4.5	0.0	3.7	5.2	6.5	1.5	1.8	2.4	16.5	5.0	4.9	4.1	3.9	8.6	2.9	1.8	6.2	4.9	3.6	3.6	1.9	2.0	1.0	6.3	5.7	4.4	5.4	10.7	2.4	2.3	2.3	5.1	9.2	3.7	2.5	4.5	5.3	2.1	2.2	0.0	2.7	4.0	4.1	4.8	0.8	1.0	5.0	2.1	1.8	1.9	1.2	3.3	5.2	2.0	4.6	2.0	2.4	4.1	7.8	2.7	3.5	2.5	9.5	5.2	6.6	2.0	5.2	5.3	3.2	10.7	1.4	3.1	5.6	3.1	4.1	1.5
USP24	KIAA1057	ENSG00000162402	"Ubiquitin specific peptidase 24"	Q9UPU5	1	55066359-55215364	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Host-virus interaction, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	4	"Oligodendrocyte precursor cells: 552.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026723, HPA028428, HPA067124"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 68: Oligodendrocytes - Mixed function"	Nucleoplasm	Cytosol	"HPA026723: AB_10599851, HPA028428: AB_10600991, HPA067124: AB_2685785"	"unprognostic (2.28e-1)"	"unprognostic (9.81e-3)"	"unprognostic (4.70e-3)"	"unprognostic (4.86e-3)"	"unprognostic (9.31e-3)"	"unprognostic (4.84e-3)"	"prognostic unfavorable (1.34e-7)"	"unprognostic (2.04e-1)"	"unprognostic (6.93e-2)"	"unprognostic (2.98e-1)"	"unprognostic (5.08e-2)"	"unprognostic (1.86e-1)"	"unprognostic (8.12e-2)"	"unprognostic (1.79e-1)"	"unprognostic (6.42e-2)"	"unprognostic (4.12e-2)"	"unprognostic (1.64e-1)"	16.6	8.2	13.4	14.2	13.3	56.7	13.4	25.3	13.6	9.4	13.2	12.0	8.3	10.7	9.2	9.4	9.9	9.0	12.7	12.6	14.7	15.7	15.3	10.6	22.1	13.5	13.1	16.5	11.4	20.3	12.8	9.6	14.6	10.2	13.3	17.2	12.8	9.6	47.9	13.6	12.6	9.8	12.8	18.6	12.3	8.4	13.6	21.9	9.2	36.6	20.9	10.4	9.2	14.2	32.5	17.4	21.3	11.6	27.2	23.5	24.6	14.0	17.5	19.6	20.3	25.0	11.1	25.9	15.1	26.1	40.1	25.6	28.5	23.6	30.5	27.2	17.4	51.5	40.2	29.6	16.1	36.0	38.6	21.0	20.6	30.0	33.7	19.0	18.2	25.7	48.5	10.6	26.6	7.6	21.9	19.1	31.4	15.5	21.0	22.3	27.1	11.3	34.6	21.4	18.7	13.1	23.8	16.8	21.1	32.3	11.7	17.5	24.7	17.9	17.3	21.7	22.6	13.2	10.6	33.2	16.9	29.4	16.3	5.4	1.3	1.7	2.8	1.1	1.7	3.0	2.2	2.2	1.2	3.4	1.9	2.5	1.4	2.3	1.5	6.9	1.3	0.7	13.4	13.3	25.3	13.6	12.6	14.7	13.5	13.1	14.6	12.8	13.6	14.2	20.4	16.0	20.0	92.4	27.7	14.9	8.4	5.6	9.1	14.0	13.4	10.2	37.7	10.0	13.0	12.9	73.0	4.2	42.6	11.1	0.0	10.3	0.7	11.9	15.1	16.1	17.3	37.4	84.5	10.2	7.8	11.9	21.4	15.0	12.7	18.2	12.1	11.9	9.7	38.7	100.4	16.2	8.2	19.2	18.8	2.5	11.8	18.6	10.6	87.1	19.6	7.0	15.5	552.4	115.2	11.8	11.4	7.9	18.1	12.7	8.3	5.9	10.0	16.9	6.6	18.0	13.5	7.7	7.1	13.9	17.2	1.5	21.8	9.8	16.0	12.1
USP25	USP21	ENSG00000155313	"Ubiquitin specific peptidase 25"	Q9UHP3	21	15730025-15880069	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 120.9"	"Cell type enhanced"	"Detected in all"		"Early spermatids: 166.7;Excitatory neurons: 148.0;Late spermatids: 192.8;Oligodendrocyte precursor cells: 150.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018297, HPA024142"	Approved		Supported	Cytosol		NA	NA			"Cluster 22: NK-cells - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Cytosol		"HPA018297: AB_1858672, HPA024142: AB_1858673"	"unprognostic (6.35e-2)"	"unprognostic (1.50e-1)"	"unprognostic (6.90e-2)"	"unprognostic (6.29e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.88e-2)"	"unprognostic (3.91e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.44e-2)"	"unprognostic (1.38e-1)"	"unprognostic (2.33e-2)"	"unprognostic (1.40e-1)"	"unprognostic (8.24e-3)"	"unprognostic (2.34e-3)"	"unprognostic (4.50e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.32e-2)"	25.8	12.9	13.4	16.8	20.1	26.9	17.6	12.6	17.2	18.1	12.3	15.3	12.6	26.8	18.7	21.4	16.8	12.4	28.1	16.2	4.2	21.4	20.2	24.0	20.1	4.7	4.3	14.1	15.9	14.3	7.6	29.4	4.8	17.9	16.1	9.5	17.5	24.6	120.9	13.1	13.3	36.4	4.4	19.5	13.1	54.5	4.9	25.6	15.5	75.1	19.3	15.5	17.3	11.9	31.2	23.1	21.5	3.2	38.7	57.5	25.3	22.0	21.8	16.0	20.1	20.5	17.4	33.6	31.5	34.9	24.3	16.4	16.7	29.1	22.0	33.5	19.1	27.5	23.5	15.8	64.3	36.6	12.1	37.6	34.7	25.8	74.0	41.7	57.0	30.0	35.9	61.4	29.1	13.0	42.1	7.1	26.6	12.5	20.3	31.8	20.0	25.8	43.5	8.3	4.7	12.8	31.4	26.2	20.9	25.9	14.0	21.3	54.6	24.8	16.0	26.2	12.5	17.7	11.9	26.8	16.0	16.1	18.6	0.0	1.4	1.9	1.8	1.4	2.0	1.6	1.5	3.2	1.2	1.1	1.4	2.1	2.9	1.1	1.3	1.3	2.2	0.8	13.4	20.1	12.6	17.2	16.2	4.2	4.7	4.3	4.8	4.4	4.9	11.9	30.4	57.7	29.5	47.3	21.7	17.1	18.8	9.7	15.9	6.2	17.4	11.8	55.7	15.7	24.2	22.0	4.2	39.0	21.4	20.3	5.9	9.4	166.7	24.0	19.0	19.7	9.6	21.5	148.0	13.4	8.4	19.4	17.9	34.6	6.3	14.4	17.9	18.0	13.3	5.0	98.4	12.8	8.2	24.2	16.0	192.8	19.0	24.2	16.0	86.2	23.7	4.0	23.7	150.3	72.4	13.4	8.4	12.8	15.9	22.0	11.9	15.1	23.4	6.7	19.7	26.1	17.2	11.2	5.8	22.7	19.2	33.1	26.9	18.5	11.6	20.4
USP26		ENSG00000134588	"Ubiquitin specific peptidase 26"	Q9BXU7	X	133024631-133097109	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	13	"Spermatogonia: 4.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA000424, HPA027310, HPA079124"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA						"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	Nucleoplasm	Cytosol	"HPA000424: , HPA027310: , HPA079124: "	"unprognostic (7.92e-4)"		"unprognostic (3.59e-2)"											"unprognostic (1.99e-2)"	"unprognostic (2.08e-1)"			0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1
USP28	KIAA1515	ENSG00000048028	"Ubiquitin specific peptidase 28"	Q96RU2	11	113797874-113875570	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 62.7;skeletal muscle: 68.3;tongue: 66.5"	"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 152.2;Excitatory neurons: 57.0;NK-cells: 73.2"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"cerebellum: 20.1"	"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006778, HPA006779"	Enhanced		Supported	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 38: Heart - Muscle contraction"	"Cluster 12: NES - Nervous system development"	"Cluster 54: Cardiomyocytes - Muscle contraction"	Nucleoplasm	"Nuclear bodies"	"HPA006778: AB_1080520, HPA006779: AB_1080517"	"unprognostic (2.54e-1)"	"unprognostic (2.72e-1)"	"unprognostic (2.99e-2)"	"unprognostic (3.72e-2)"	"unprognostic (5.51e-2)"	"unprognostic (2.30e-1)"	"unprognostic (9.73e-3)"	"unprognostic (3.00e-1)"	"unprognostic (2.04e-3)"	"unprognostic (1.82e-3)"	"unprognostic (3.17e-2)"	"unprognostic (1.19e-1)"	"unprognostic (5.11e-2)"	"unprognostic (2.06e-2)"	"unprognostic (9.03e-2)"	"unprognostic (1.35e-3)"	"unprognostic (5.03e-2)"	5.8	6.7	3.2	9.5	4.3	5.8	10.4	20.1	9.5	21.1	0.6	10.4	9.6	11.5	11.3	9.6	9.8	7.7	62.7	4.6	1.8	9.9	11.3	7.5	15.6	2.1	1.7	14.1	8.2	15.5	7.4	8.0	3.4	11.3	11.7	27.1	12.0	14.2	68.3	7.0	10.4	13.1	1.2	13.8	9.2	9.2	1.9	9.0	10.1	66.5	15.5	9.8	8.4	5.3	18.3	20.2	26.7	35.4	21.3	20.9	18.8	13.2	18.0	17.5	29.7	30.2	25.6	24.2	29.3	18.0	40.1	35.1	37.9	24.8	24.1	27.1	17.2	12.9	13.8	16.3	13.0	16.8	12.4	12.6	18.5	20.2	23.8	25.4	32.0	11.9	22.7	15.3	18.5	9.3	12.9	27.1	32.0	33.6	14.4	31.3	37.1	29.4	19.3	17.8	11.6	12.6	31.4	10.7	10.1	82.7	25.8	5.8	17.1	19.2	28.3	17.8	13.8	10.4	15.9	20.1	1.9	32.1	12.8	0.2	5.0	3.4	23.2	3.7	12.1	15.5	5.7	16.8	6.4	12.3	3.8	13.1	1.4	28.6	6.4	1.9	9.2	10.3	3.2	4.3	20.1	9.5	4.6	1.8	2.1	1.7	3.4	1.2	1.9	5.3	7.3	9.6	8.8	18.3	17.8	1.7	7.3	9.9	13.6	18.7	9.7	9.8	152.2	5.7	9.9	5.5	18.8	4.4	32.1	3.3	5.9	6.7	1.7	6.6	11.6	7.9	4.9	2.5	57.0	3.9	4.7	12.2	11.7	8.7	1.3	18.9	7.5	8.8	4.4	5.0	34.1	9.6	4.1	6.5	2.5	2.0	6.8	7.4	1.8	10.3	8.2	10.3	73.2	29.1	21.3	3.5	5.3	13.9	21.7	7.1	7.3	7.1	14.6	21.5	6.6	10.3	11.0	15.8	11.4	7.7	2.0	1.1	18.6	9.0	8.9	5.8
USP3		ENSG00000140455	"Ubiquitin specific peptidase 3"	Q9Y6I4	15	63504511-63594640	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Cell cycle, DNA damage, Ubl conjugation pathway"	"Chromatin regulator, Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	4	"cerebellum: 36.4"	"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA053275, HPA060513, HPA077975"			Supported	"Nucleoplasm,Midbody ring"	"Intracellular and membrane"	Yes	No			"Cluster 1: Neutrophils - Mixed function"	"Cluster 50: Non-specific - Ribosome"	"Cluster 15: RT4 - Unknown function"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	Nucleoplasm	"Midbody ring"	"HPA053275: AB_2682096, HPA060513: AB_2684299, HPA077975: AB_2732365"	"unprognostic (4.63e-3)"	"unprognostic (2.71e-1)"	"unprognostic (7.88e-2)"	"unprognostic (3.33e-2)"	"unprognostic (2.16e-2)"	"unprognostic (6.03e-2)"	"unprognostic (6.26e-2)"	"unprognostic (4.52e-2)"	"unprognostic (1.62e-2)"	"unprognostic (2.36e-1)"	"unprognostic (3.54e-2)"	"unprognostic (4.87e-2)"	"unprognostic (1.17e-1)"	"unprognostic (8.61e-2)"	"unprognostic (2.78e-1)"	"unprognostic (6.21e-2)"	"prognostic favorable (1.38e-4)"	12.7	8.2	5.8	5.4	7.0	21.4	11.2	36.4	5.9	11.7	15.4	13.4	6.5	12.9	4.7	10.9	10.9	5.4	6.0	5.3	6.3	10.1	8.2	13.2	6.5	6.9	6.9	16.2	18.9	3.1	6.2	2.7	7.6	10.4	5.6	6.3	12.4	6.0	10.0	14.6	13.9	4.5	5.3	17.6	15.7	5.3	8.6	7.4	9.1	3.6	6.4	12.4	11.9	7.5	10.4	21.0	12.1	8.1	5.5	7.6	8.2	6.7	9.6	7.1	5.8	6.6	13.1	8.7	15.3	9.3	3.6	12.0	11.6	11.1	5.6	12.2	5.8	10.4	8.6	9.8	6.8	6.4	11.4	11.3	7.8	7.7	10.6	8.9	12.4	17.3	9.5	9.0	3.3	5.2	11.0	8.8	16.2	13.7	5.3	22.2	8.4	11.3	4.5	23.8	9.6	9.5	3.3	13.0	6.7	7.8	5.5	9.5	13.4	7.2	16.9	3.3	10.3	9.3	24.4	18.2	7.4	13.8	7.5	120.0	84.7	12.7	24.8	66.0	28.4	34.1	34.3	26.0	59.8	34.8	34.0	25.2	169.1	19.8	65.4	13.1	28.1	45.2	5.8	7.0	36.4	5.9	5.3	6.3	6.9	6.9	7.6	5.3	8.6	7.5	23.6	38.5	69.2	76.7	63.4	52.6	34.3	24.8	23.3	31.4	27.9	20.3	9.2	25.8	41.4	16.5	12.5	19.8	48.4	37.6	41.1	41.0	21.6	37.8	32.8	26.0	43.8	15.8	11.2	37.2	57.3	28.3	39.8	74.6	27.1	64.5	11.4	24.0	24.8	13.5	40.0	35.4	30.5	78.4	109.6	77.4	15.8	74.5	42.7	75.9	101.8	25.9	41.2	80.4	40.6	39.8	35.6	18.4	69.7	40.6	33.2	28.3	33.3	17.9	13.1	25.3	34.5	14.8	40.3	33.9	59.0	34.1	64.6	40.1	40.6	37.6
USP33	"KIAA1097, VDU1"	ENSG00000077254	"Ubiquitin specific peptidase 33"	Q8TEY7	1	77695987-77759852	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Endocytosis, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Inhibitory neurons: 159.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005719	Uncertain		Supported	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 42: Non-specific - Transcription"	"Cluster 6: Brain - Smell perception"	"Cluster 36: HEL - Hemostasis"	"Cluster 50: Fibroblasts - ECM organization"	"Nucleoplasm, Golgi apparatus"		"HPA005719: AB_10601708"	"unprognostic (2.31e-3)"	"unprognostic (2.73e-2)"	"unprognostic (1.04e-2)"	"unprognostic (2.36e-1)"	"unprognostic (9.19e-3)"	"unprognostic (1.88e-3)"	"unprognostic (1.22e-2)"	"unprognostic (6.06e-2)"	"unprognostic (2.48e-1)"	"unprognostic (2.25e-1)"	"unprognostic (2.67e-1)"	"unprognostic (3.59e-1)"	"unprognostic (5.36e-3)"	"unprognostic (4.89e-2)"	"unprognostic (5.76e-2)"	"unprognostic (2.19e-1)"	"unprognostic (2.02e-2)"	40.7	31.2	31.5	24.6	40.4	34.5	34.3	52.0	49.7	24.2	37.3	24.3	25.4	28.0	26.8	21.6	22.5	26.3	21.7	35.4	31.8	31.1	25.4	26.2	28.1	28.6	24.9	29.3	19.5	35.0	20.9	28.0	30.8	28.8	25.2	49.1	25.2	22.9	18.0	24.3	26.9	24.1	22.3	26.0	24.4	25.4	28.6	27.1	30.4	20.7	26.0	22.9	20.0	55.5	42.4	18.8	64.1	44.2	90.0	78.3	54.8	45.3	42.9	54.0	60.1	25.4	35.5	31.4	41.2	44.3	88.2	32.1	47.4	31.1	65.7	28.8	36.6	111.1	44.6	22.2	56.0	37.8	26.8	58.3	23.9	52.4	37.9	51.9	48.7	28.0	43.9	26.3	41.2	16.1	34.9	38.0	62.2	32.6	37.2	33.0	67.7	22.2	51.0	41.1	53.8	41.2	31.9	41.5	64.2	54.3	23.1	41.2	41.2	49.4	34.4	50.1	43.2	21.0	28.4	30.4	37.3	44.5	25.4	67.3	22.5	31.8	21.0	22.6	21.7	20.5	20.6	21.7	17.5	22.3	24.5	21.9	30.5	19.2	30.1	18.4	20.7	16.7	31.5	40.4	52.0	49.7	35.4	31.8	28.6	24.9	30.8	22.3	28.6	55.5	40.2	44.8	40.9	66.3	35.1	17.2	18.8	21.2	32.5	56.7	25.7	22.1	39.9	22.8	25.5	35.0	58.4	25.1	48.8	35.9	9.8	20.8	4.3	54.8	37.8	31.8	35.5	50.9	149.3	15.4	19.0	39.6	43.3	54.6	23.4	43.1	28.2	23.1	19.0	62.2	159.0	28.6	22.4	30.8	20.7	5.5	35.8	35.1	23.2	75.9	38.7	31.4	37.0	98.0	138.5	19.6	27.8	32.0	42.4	22.9	33.2	25.6	37.3	44.5	19.7	34.9	35.6	39.8	30.1	28.4	16.3	11.9	41.0	39.2	24.8	21.8
USP36	"FLJ12851, KIAA1453"	ENSG00000055483	"Ubiquitin specific peptidase 36"	Q9P275	17	78787381-78841441	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012082, HPA012395, HPA052860"	Uncertain	Supported	Enhanced	"Nucleoli,Nucleoli rim,Nuclear speckles"		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 50: Non-specific - Ribosome"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 24: Non-specific - Transcription regulation"	"Nucleoli, Nucleoli rim"	"Nuclear speckles"	"HPA012082: AB_1858682, HPA012395: , HPA052860: AB_2681974"	"unprognostic (1.94e-2)"	"unprognostic (2.80e-2)"	"unprognostic (1.07e-1)"	"prognostic unfavorable (5.18e-5)"	"unprognostic (9.35e-2)"	"unprognostic (1.98e-1)"	"unprognostic (2.50e-3)"	"unprognostic (1.35e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.68e-2)"	"unprognostic (2.78e-2)"	"unprognostic (1.31e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.81e-1)"	"unprognostic (4.03e-3)"	"unprognostic (1.78e-1)"	43.9	37.9	20.0	21.5	21.9	46.6	32.9	29.3	23.9	32.6	27.5	31.2	13.4	26.8	22.9	25.0	34.2	18.7	30.2	21.4	20.6	34.4	30.3	36.1	20.6	22.6	21.3	67.4	44.5	18.1	50.3	26.0	21.5	36.2	15.8	26.3	24.9	13.1	30.3	40.4	26.6	16.3	19.4	30.7	31.2	22.2	21.2	15.1	31.6	11.7	20.5	29.3	29.8	30.1	42.7	50.3	14.6	26.9	30.5	33.7	27.8	34.1	34.5	32.1	21.5	49.2	21.0	54.0	16.9	30.6	34.8	30.6	34.5	25.4	57.0	13.0	52.1	49.4	81.0	51.9	31.3	54.7	26.0	29.5	41.0	45.8	101.6	24.7	28.3	24.1	40.0	55.3	26.8	32.6	50.1	55.1	22.6	31.6	39.9	38.1	31.8	36.3	20.2	44.1	42.8	25.8	24.5	112.5	63.7	31.3	29.2	34.4	24.3	75.2	35.3	44.3	61.1	40.7	17.4	66.1	29.6	41.9	24.0	10.1	3.0	2.4	5.5	4.2	6.5	5.1	5.2	4.8	1.8	4.7	5.7	5.6	4.3	4.5	2.7	9.7	3.8	1.9	20.0	21.9	29.3	23.9	21.4	20.6	22.6	21.3	21.5	19.4	21.2	30.1	27.4	12.8	37.4	23.5	55.9	51.7	28.4	8.2	40.9	33.2	18.1	16.9	14.1	18.6	18.8	14.7	33.3	8.3	66.3	14.4	5.9	10.2	20.7	22.3	24.0	28.4	18.5	14.7	19.0	9.6	11.3	26.6	25.0	42.7	20.3	12.8	12.1	16.5	43.3	26.9	22.5	18.6	10.2	24.5	72.8	8.5	11.8	49.4	30.2	10.3	14.9	13.2	16.5	13.6	19.8	13.2	8.4	12.4	57.1	32.4	7.3	5.0	11.1	32.1	6.6	22.1	23.1	18.4	16.5	24.4	43.3	12.9	73.6	13.1	18.6	22.2
USP39	"CGI-21, SAD1, SNRNP65"	ENSG00000168883	"Ubiquitin specific peptidase 39"	Q53GS9	2	85602856-85649283	"Enzymes, Predicted intracellular proteins"	"Cell cycle, Cell division, mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034823, HPA077350"	Supported	Supported	Supported	Nucleoplasm		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 52: Non-specific - Ribosome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 47: Cytotrophoblasts - Unknown function"	Nucleoplasm		"HPA034823: AB_10602488, HPA077350: "	"unprognostic (1.10e-2)"	"unprognostic (3.31e-3)"	"unprognostic (1.83e-1)"	"prognostic unfavorable (5.52e-4)"	"unprognostic (8.46e-3)"	"unprognostic (3.67e-2)"	"prognostic unfavorable (2.84e-6)"	"unprognostic (1.10e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.89e-1)"	"unprognostic (5.17e-3)"	"unprognostic (3.14e-2)"	"prognostic unfavorable (4.05e-7)"	"unprognostic (3.95e-3)"	"unprognostic (2.25e-1)"	"unprognostic (2.52e-2)"	"unprognostic (2.52e-1)"	22.6	16.1	18.1	19.8	18.7	40.8	21.3	19.0	20.6	22.2	22.7	24.2	17.1	23.5	26.1	22.7	19.5	12.7	22.7	17.9	19.5	21.7	18.5	21.4	26.5	18.9	18.4	20.1	17.2	21.8	14.3	26.9	18.9	18.7	22.7	22.0	19.0	21.2	55.2	23.8	19.5	21.3	18.9	20.9	20.6	15.6	18.8	41.0	19.8	42.6	32.2	24.7	20.6	19.8	71.0	70.0	70.0	77.5	49.7	38.7	79.5	59.2	54.6	84.1	74.5	113.9	49.8	83.0	53.4	54.6	62.3	50.6	135.7	62.5	105.8	83.9	86.4	103.4	39.1	100.6	49.0	127.4	67.5	27.9	49.3	65.1	57.8	39.3	68.1	85.3	129.8	47.2	62.8	81.4	125.2	94.8	92.8	84.9	64.2	114.1	150.0	63.1	45.0	53.8	65.1	53.7	36.4	58.9	51.4	56.7	39.5	60.5	43.9	51.7	65.0	62.7	97.2	42.0	83.0	87.7	44.9	130.5	63.6	51.1	35.8	44.5	40.2	42.4	46.6	34.7	41.8	41.7	40.6	37.0	40.4	37.0	23.1	40.4	41.6	32.0	53.4	43.6	18.1	18.7	19.0	20.6	17.9	19.5	18.9	18.4	18.9	18.9	18.8	19.8	18.4	19.2	25.2	19.9	17.5	20.5	16.7	17.9	22.2	8.5	14.1	14.0	17.3	11.5	19.9	12.9	8.4	54.1	17.8	14.8	21.5	21.1	26.1	9.8	15.4	17.1	12.1	18.3	13.9	18.8	31.8	17.1	9.7	11.7	17.1	16.3	17.5	14.2	25.6	5.0	18.2	13.4	24.4	11.9	14.7	13.0	19.3	17.6	19.6	17.8	26.4	15.3	12.3	16.1	33.1	19.2	8.5	18.8	14.0	16.0	11.2	14.6	15.6	11.6	0.0	13.0	17.7	19.5	17.1	15.5	16.2	35.7	21.3	12.7	15.7	16.3
USP4	"UNP, Unph"	ENSG00000114316	"Ubiquitin specific peptidase 4"	Q13107	3	49277144-49340712	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"	Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 131.8;Late spermatids: 104.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018499	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 34: Spermatids - Unknown function"	"Plasma membrane, Cytosol"		"HPA018499: AB_1858689"	"unprognostic (2.34e-3)"	"unprognostic (1.52e-1)"	"unprognostic (2.22e-3)"	"unprognostic (6.12e-2)"	"unprognostic (3.51e-1)"	"unprognostic (4.33e-2)"	"unprognostic (9.42e-2)"	"prognostic favorable (4.46e-5)"	"unprognostic (3.54e-1)"	"unprognostic (9.07e-3)"	"unprognostic (2.78e-2)"	"unprognostic (1.70e-3)"	"prognostic favorable (4.29e-5)"	"unprognostic (7.30e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.18e-2)"	"unprognostic (1.65e-2)"	25.2	20.3	24.2	26.5	26.3	53.7	24.9	24.5	28.2	27.7	27.1	25.4	18.3	24.4	21.6	26.0	22.4	18.3	26.5	23.7	23.4	21.8	20.2	29.5	30.9	23.9	24.4	24.5	19.0	24.1	16.4	23.3	23.9	23.7	23.4	26.9	21.0	21.7	31.6	31.4	22.5	24.0	22.4	33.7	20.2	28.0	24.8	37.0	23.0	28.8	33.7	25.8	25.0	24.5	14.2	15.8	21.6	28.8	38.7	40.1	14.7	36.4	32.9	46.7	41.3	16.8	34.8	27.1	14.4	53.9	27.4	18.9	28.6	52.6	42.5	42.1	8.4	60.3	31.9	19.6	57.0	32.5	34.0	42.8	23.3	51.0	41.5	34.3	55.0	29.9	21.6	41.6	42.1	24.5	38.3	55.8	18.7	17.7	26.9	15.6	13.3	23.9	37.5	29.2	17.5	24.0	27.2	19.3	14.0	21.6	13.5	51.2	50.1	31.1	17.2	39.6	22.5	33.6	17.3	38.6	28.6	50.1	36.5	70.1	83.6	94.8	48.1	69.2	53.7	51.0	50.2	48.9	74.6	41.4	47.7	42.2	179.2	72.4	81.2	28.4	59.7	78.0	24.2	26.3	24.5	28.2	23.7	23.4	23.9	24.4	23.9	22.4	24.8	24.5	24.3	41.7	25.1	28.1	24.7	18.7	17.9	17.2	22.2	17.5	10.9	10.3	17.9	10.0	23.2	20.2	20.9	22.7	27.9	13.6	21.5	16.5	131.8	17.3	18.3	22.1	10.7	31.6	30.8	13.6	14.3	17.9	27.5	21.1	33.6	21.4	17.5	14.6	24.0	11.8	26.4	13.8	16.2	38.6	21.0	104.9	15.5	34.2	16.0	16.9	36.0	13.9	23.7	25.6	20.2	18.9	7.6	19.2	29.2	17.6	14.5	13.4	28.6	20.5	13.1	18.4	17.0	35.3	14.5	17.9	18.5	24.2	29.4	17.0	13.9	14.5
USP48	"FLJ11328, FLJ20103, FLJ23054, FLJ23277, MGC14879, USP31"	ENSG00000090686	"Ubiquitin specific peptidase 48"	Q86UV5	1	21678298-21783606	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Granulosa cells: 200.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030045, HPA030046"	Approved		Supported	Nucleoplasm,Mitochondria,Cytosol		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 40: Granulosa cells - Unknown function"	Nucleoplasm	"Mitochondria, Cytosol"	"HPA030045: AB_10670833, HPA030046: AB_10603325"	"unprognostic (1.35e-1)"	"unprognostic (3.72e-1)"	"unprognostic (5.46e-3)"	"unprognostic (2.21e-1)"	"unprognostic (1.23e-1)"	"unprognostic (7.00e-3)"	"prognostic unfavorable (6.09e-8)"	"unprognostic (1.04e-2)"	"unprognostic (3.01e-3)"	"unprognostic (9.30e-2)"	"unprognostic (7.54e-2)"	"unprognostic (4.45e-2)"	"unprognostic (4.16e-3)"	"unprognostic (2.03e-1)"	"unprognostic (1.06e-1)"	"unprognostic (5.70e-2)"	"unprognostic (2.80e-2)"	25.8	47.5	18.7	26.6	24.5	43.5	26.4	31.0	26.4	26.9	21.6	24.4	21.7	25.3	20.4	23.0	22.3	18.9	21.6	19.3	20.4	18.2	23.8	23.1	35.1	20.1	20.4	31.1	24.6	25.2	26.9	27.3	21.7	23.5	26.0	57.0	31.2	18.6	23.1	29.5	28.7	22.9	18.5	36.0	32.5	20.6	20.8	26.9	28.6	19.5	34.5	23.1	24.6	36.0	43.9	20.5	47.0	34.0	40.1	49.0	46.4	54.0	36.5	35.3	46.6	19.1	43.2	49.1	35.6	48.8	27.5	39.2	59.0	43.4	53.6	48.3	42.1	104.3	75.7	34.5	35.5	53.0	53.7	39.8	36.6	36.1	39.7	48.1	106.1	36.2	83.8	133.2	44.0	21.9	44.2	68.5	29.7	44.5	36.8	61.3	47.2	57.3	40.7	36.2	57.1	35.6	50.4	45.7	122.7	62.3	23.4	63.0	76.1	37.7	30.9	46.7	31.8	105.6	81.7	48.1	36.3	64.5	56.6	82.1	19.5	35.0	12.2	9.4	13.9	28.6	17.8	17.9	21.1	29.8	20.5	13.1	16.8	12.2	10.9	15.3	21.4	12.6	18.7	24.5	31.0	26.4	19.3	20.4	20.1	20.4	21.7	18.5	20.8	36.0	37.9	54.5	42.1	32.0	55.4	22.2	25.1	30.3	33.0	86.5	22.2	24.5	65.3	21.5	24.4	20.2	62.6	61.4	48.3	17.8	25.4	28.5	71.4	33.3	48.5	32.5	21.7	88.1	66.4	20.0	56.3	42.0	33.1	41.4	49.9	200.4	27.5	22.1	29.2	50.5	74.2	31.3	32.6	22.6	28.1	47.7	34.8	34.4	58.7	52.5	55.9	30.7	36.0	54.3	112.3	23.8	16.4	51.6	150.1	20.7	24.1	20.2	27.3	69.2	32.9	51.7	39.8	52.7	47.4	35.1	25.7	32.6	41.8	54.8	31.6	21.6
USP7	HAUSP	ENSG00000187555	"Ubiquitin specific peptidase 7"	Q93009	16	8892097-8975328	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Biological rhythms, DNA damage, DNA repair, Host-virus interaction, Ubl conjugation pathway"	"Developmental protein, Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 282.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB008108, HPA015641, CAB079904"	Approved		Supported	"Nucleoplasm,Nuclear bodies"		NA	NA		16000	"Cluster 44: Non-specific - Transcription"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 65: Plasmacytoid DCs - Unknown function"	Nucleoplasm	"Nuclear bodies"	"CAB008108: AB_2233500, CAB079904: AB_2552261, HPA015641: AB_1858700"	"unprognostic (6.73e-2)"	"unprognostic (1.59e-1)"	"unprognostic (3.36e-3)"	"unprognostic (1.94e-2)"	"unprognostic (9.64e-2)"	"unprognostic (8.09e-2)"	"unprognostic (4.69e-2)"	"unprognostic (4.56e-2)"	"unprognostic (4.81e-1)"	"unprognostic (2.49e-1)"	"unprognostic (2.35e-1)"	"unprognostic (9.93e-2)"	"prognostic favorable (8.56e-5)"	"unprognostic (1.35e-1)"	"unprognostic (1.07e-1)"	"unprognostic (7.31e-2)"	"unprognostic (2.69e-1)"	22.3	16.1	17.6	27.0	19.8	54.6	20.5	20.5	20.7	20.1	15.1	33.1	21.8	21.5	10.1	29.6	19.0	19.9	23.8	21.4	18.1	19.5	25.1	19.3	39.9	16.9	20.1	19.8	26.7	34.8	13.9	23.7	17.5	20.7	32.5	21.7	18.7	18.7	45.2	25.4	25.9	25.7	18.7	24.2	25.5	58.8	18.8	51.1	22.8	41.0	44.9	26.3	17.7	20.8	39.9	73.5	62.2	46.9	34.9	42.9	42.9	53.6	44.7	48.1	40.4	66.6	46.7	94.6	33.8	61.0	27.7	48.8	95.2	61.9	79.6	63.1	38.1	78.4	49.5	132.9	49.0	87.6	48.8	37.3	37.7	52.6	61.0	37.0	69.7	139.8	77.7	101.5	49.6	75.4	130.8	16.9	43.9	49.8	41.4	114.5	69.7	86.2	33.4	77.9	58.8	35.5	59.4	55.3	28.7	62.3	55.0	39.4	60.4	52.1	54.1	80.3	40.4	49.1	134.3	145.1	48.5	49.6	43.5	5.2	2.1	2.8	4.5	2.2	5.7	4.0	4.1	5.3	2.2	4.9	4.9	4.3	3.4	2.8	6.1	6.5	5.1	1.1	17.6	19.8	20.5	20.7	21.4	18.1	16.9	20.1	17.5	18.7	18.8	20.8	40.4	35.3	54.5	22.2	38.0	46.5	23.1	17.9	22.8	51.1	29.7	28.8	74.3	21.5	36.4	29.5	25.0	21.9	51.4	39.8	5.9	22.5	282.4	38.5	50.9	35.8	42.2	46.5	31.4	33.4	14.5	34.4	31.1	57.6	26.6	47.8	25.0	37.5	19.8	43.7	34.9	49.3	10.2	29.2	31.0	112.2	25.4	43.8	19.6	21.5	36.3	29.2	24.7	24.1	30.2	35.6	39.0	34.6	46.8	34.1	31.3	13.7	37.8	44.2	6.6	58.4	39.4	33.8	39.4	41.3	50.0	21.1	40.4	47.6	54.8	35.0
USP8	"HumORF8, KIAA0055, SPG59, UBPY"	ENSG00000138592	"Ubiquitin specific peptidase 8"	P40818	15	50424380-50514421	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"	"Cancer-related genes, Cushing syndrome, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA050215	Approved		Supported	"Golgi apparatus,Cytosol"		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 18: U-2197 - ECM organization"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Golgi apparatus"	Cytosol	"HPA050215: AB_2681054"	"unprognostic (5.81e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.46e-1)"	"unprognostic (9.58e-2)"	"unprognostic (2.35e-2)"	"unprognostic (2.91e-1)"	"unprognostic (1.42e-1)"	"unprognostic (3.96e-1)"	"unprognostic (1.68e-2)"	"unprognostic (5.08e-2)"	"unprognostic (2.94e-1)"	"unprognostic (3.99e-2)"	"prognostic favorable (1.29e-5)"	"unprognostic (4.89e-2)"	"unprognostic (1.13e-1)"	"unprognostic (3.79e-1)"	"unprognostic (1.58e-1)"	20.3	18.8	11.5	21.1	11.0	27.6	19.6	14.4	13.3	20.5	18.1	21.5	26.7	19.1	10.4	20.7	18.5	16.4	15.1	9.1	14.6	27.0	28.1	19.5	19.0	14.1	13.1	19.9	17.4	45.1	10.6	20.3	12.5	17.0	20.8	22.2	19.8	17.2	17.6	14.2	24.4	18.4	11.5	18.7	22.5	32.0	13.6	20.9	25.4	22.7	24.3	20.0	12.6	13.2	30.6	35.8	23.7	41.1	32.3	44.3	31.0	45.7	43.9	35.7	40.4	19.5	17.7	28.8	35.0	43.5	46.6	57.8	28.8	28.3	39.9	27.2	19.3	52.9	31.9	27.3	35.9	34.3	34.4	32.4	36.2	26.0	55.8	37.0	36.3	23.3	28.4	36.8	32.9	45.9	26.6	12.0	28.5	32.6	17.1	24.1	39.1	45.8	29.5	61.3	29.1	23.8	42.5	55.9	57.4	48.9	35.8	36.9	45.0	41.1	24.1	122.7	52.7	28.5	69.8	32.4	30.6	65.6	40.1	114.6	27.7	50.1	21.4	26.1	22.1	37.3	22.9	23.3	22.7	34.3	24.0	21.2	47.9	22.1	35.0	20.5	20.0	16.0	11.5	11.0	14.4	13.3	9.1	14.6	14.1	13.1	12.5	11.5	13.6	13.2	63.5	96.1	130.8	36.2	101.8	28.9	40.7	47.3	35.9	54.5	41.7	40.0	69.8	51.5	72.7	47.8	68.8	59.0	92.7	79.5	25.4	53.7	153.7	91.5	79.7	53.8	53.3	36.8	41.0	51.3	45.4	55.8	58.1	65.6	86.7	48.5	51.0	56.6	45.4	33.7	44.3	68.7	36.7	73.2	38.2	28.4	53.7	77.6	40.9	46.9	85.3	45.5	72.1	34.7	46.1	57.3	58.2	61.7	87.1	51.0	88.9	49.9	114.9	74.2	46.0	108.2	56.2	140.5	54.8	39.6	41.5	105.2	72.6	77.1	64.8	55.3
UTP14A	"NY-CO-16, SDCCAG16, Utp14"	ENSG00000156697	"UTP14A small subunit processome component"	Q9BVJ6	X	129906121-129929761	"Predicted intracellular proteins"	"Ribosome biogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA047217, HPA054023, CAB079950"	Uncertain		Supported	Nucleoli,Cytosol		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 52: Non-specific - Ribosome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoli	Cytosol	"CAB079950: , HPA047217: AB_2679987, HPA054023: AB_2682346"	"unprognostic (6.75e-2)"	"unprognostic (2.20e-1)"	"unprognostic (1.10e-1)"	"unprognostic (7.84e-3)"	"unprognostic (2.95e-1)"	"prognostic unfavorable (7.67e-4)"	"unprognostic (3.00e-3)"	"unprognostic (8.24e-2)"	"unprognostic (4.09e-3)"	"unprognostic (2.81e-1)"	"unprognostic (2.28e-2)"	"unprognostic (6.99e-3)"	"prognostic unfavorable (8.12e-8)"	"unprognostic (4.77e-2)"	"unprognostic (1.13e-1)"	"unprognostic (5.06e-2)"	"unprognostic (9.99e-2)"	11.5	7.8	5.9	11.9	7.7	9.8	13.2	6.2	8.1	10.5	5.6	10.1	7.2	11.2	11.1	11.6	10.7	7.6	7.8	5.9	7.6	9.0	8.2	7.5	13.7	6.7	7.0	12.7	16.1	9.5	5.2	10.1	6.6	8.2	11.9	5.1	8.6	8.3	12.5	10.0	8.2	11.7	5.8	9.5	10.1	2.2	7.0	12.7	9.2	6.3	17.1	14.2	9.8	7.1	34.7	38.0	19.9	52.9	32.7	33.2	33.5	37.6	28.5	37.0	29.4	39.0	33.5	81.6	73.7	27.3	40.2	43.4	80.6	40.8	45.1	27.2	40.1	46.6	32.9	29.8	36.9	66.7	34.5	40.9	35.1	50.2	52.6	23.7	29.5	29.9	47.3	25.0	32.1	57.1	48.4	50.6	41.6	65.5	42.1	37.5	30.1	56.0	25.4	26.1	20.8	54.7	21.3	38.9	45.2	26.1	21.0	38.4	25.8	16.2	21.2	45.8	73.2	30.8	38.4	71.1	24.4	81.2	37.4	29.2	9.4	5.0	13.9	16.8	16.1	12.3	11.5	13.1	13.8	14.1	14.4	13.5	1.1	18.5	15.4	11.0	17.6	8.8	5.9	7.7	6.2	8.1	5.9	7.6	6.7	7.0	6.6	5.8	7.0	7.1	10.1	12.8	15.6	3.6	11.2	8.4	17.0	11.1	17.6	5.3	10.2	13.2	10.5	11.5	20.6	0.0	4.2	24.1	16.8	7.2	13.7	16.8	0.2	12.7	24.0	10.1	7.7	12.2	7.8	12.6	20.0	11.9	9.7	15.7	14.0	10.6	6.8	5.1	13.6	1.7	7.2	10.4	12.2	9.5	5.5	0.5	6.2	11.1	5.4	3.7	17.8	6.5	16.5	3.5	8.4	13.0	9.7	7.2	14.7	12.2	4.9	9.1	8.1	5.2	13.1	17.9	13.2	1.3	2.2	18.9	8.0	40.6	13.1	13.1	13.8	11.4
UTP15	"FLJ12787, FLJ23637, NET21"	ENSG00000164338	"UTP15 small subunit processome component"	Q8TED0	5	73565443-73583380	"Predicted intracellular proteins"	"Ribosome biogenesis, rRNA processing, Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 36.9"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044697			Approved	"Nucleoli,Endoplasmic reticulum"		No	No			"Cluster 32: T-cells - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	"Nucleoli, Endoplasmic reticulum"		"HPA044697: AB_2679050"	"unprognostic (8.96e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.87e-3)"	"unprognostic (8.36e-2)"	"unprognostic (1.78e-1)"	"unprognostic (5.80e-2)"	"unprognostic (1.39e-2)"	"unprognostic (5.74e-2)"	"unprognostic (2.12e-1)"	"unprognostic (4.16e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.53e-2)"	"unprognostic (2.27e-2)"	"unprognostic (9.66e-2)"	"unprognostic (7.10e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.22e-1)"	8.7	6.5	2.0	8.0	2.4	36.9	9.7	3.2	3.2	4.6	1.2	6.8	5.5	7.2	6.4	9.2	5.0	5.1	4.8	2.2	2.5	5.1	7.5	5.9	10.8	2.1	2.3	4.9	7.4	7.5	3.1	6.0	2.7	5.9	8.3	5.5	4.9	4.7	7.2	9.5	5.2	7.6	1.6	7.8	5.7	6.1	2.1	7.6	8.1	7.5	10.7	9.3	4.5	3.6	21.2	22.3	15.8	44.6	12.6	14.9	27.9	24.8	14.1	27.1	29.8	25.0	29.6	47.5	24.9	16.6	34.2	17.3	25.5	45.5	41.6	23.9	19.2	21.7	23.7	20.2	15.5	20.2	18.1	15.2	20.0	30.8	34.3	8.3	19.1	21.2	33.8	25.3	23.2	26.4	31.7	14.0	20.6	7.5	12.7	24.5	24.7	45.9	16.1	28.5	15.8	16.9	22.7	17.6	27.4	13.4	22.8	14.4	15.4	15.9	22.5	19.4	49.3	19.0	27.6	60.5	26.0	34.3	23.8	4.9	6.8	4.6	8.2	7.0	7.6	7.9	8.1	9.1	7.4	7.0	9.6	9.4	5.1	8.2	7.2	7.0	7.3	4.9	2.0	2.4	3.2	3.2	2.2	2.5	2.1	2.3	2.7	1.6	2.1	3.6	8.4	0.0	7.3	2.3	7.7	14.7	13.1	5.0	11.4	3.8	6.7	6.5	6.8	4.3	5.2	5.5	6.2	8.0	6.0	2.7	3.9	8.9	4.3	4.9	6.8	6.9	2.4	9.4	6.4	7.8	9.5	8.0	5.6	6.8	7.0	6.7	2.9	8.1	6.8	1.7	5.4	4.1	2.0	5.8	2.1	2.8	3.1	3.9	7.2	1.9	3.6	3.0	2.1	3.5	6.9	6.5	3.6	5.3	9.1	10.0	2.2	6.3	1.7	4.7	6.6	9.5	8.8	10.0	12.4	11.7	17.0	6.6	6.1	7.6	6.7	9.8
UTP18	"CGI-48, WDR50"	ENSG00000011260	"UTP18 small subunit processome component"	Q9Y5J1	17	51260546-51297936	"Predicted intracellular proteins"	"rRNA processing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 190.6;Late spermatids: 182.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052378	Approved		Supported	"Nucleoplasm,Nuclear membrane,Nucleoli,Nucleoli rim"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	"Nucleoli, Nucleoli rim"	"Nucleoplasm, Nuclear membrane"	"HPA052378: AB_2681805"	"unprognostic (1.36e-2)"	"unprognostic (1.00e-1)"	"prognostic favorable (3.33e-4)"	"unprognostic (2.62e-2)"	"unprognostic (2.55e-2)"	"unprognostic (5.99e-2)"	"prognostic unfavorable (1.99e-4)"	"unprognostic (2.47e-2)"	"unprognostic (8.37e-3)"	"unprognostic (1.10e-2)"	"unprognostic (8.82e-2)"	"unprognostic (2.75e-2)"	"unprognostic (3.11e-3)"	"unprognostic (9.51e-2)"	"unprognostic (1.59e-1)"	"unprognostic (8.72e-3)"	"unprognostic (1.93e-2)"	17.9	20.1	12.6	24.9	13.7	40.0	25.8	19.1	15.7	18.8	14.2	17.5	17.8	15.7	15.8	21.0	17.5	12.8	10.2	13.2	13.8	21.8	22.3	17.3	33.1	13.0	12.3	23.8	21.3	23.3	20.4	26.3	13.6	16.2	18.7	17.5	17.4	14.2	24.4	32.3	16.5	12.9	13.0	24.5	18.1	58.7	13.2	27.7	24.4	16.2	34.4	24.8	18.0	15.6	90.5	87.7	54.6	50.3	35.1	52.2	142.2	48.9	40.2	83.5	79.7	55.4	49.3	113.5	67.8	36.6	89.0	48.1	89.7	52.0	123.3	74.8	117.0	119.4	52.6	97.3	48.0	127.9	56.4	33.9	39.5	71.1	57.0	42.1	50.7	55.6	98.7	50.6	63.5	56.1	115.6	86.9	78.5	127.5	91.8	103.2	124.2	89.4	61.3	59.1	60.7	76.9	56.7	66.6	114.7	67.4	82.3	64.4	44.7	85.3	71.8	71.1	102.9	97.4	192.5	131.5	53.0	87.6	62.4	19.0	48.2	27.9	40.2	46.9	49.9	54.1	50.7	49.2	55.9	52.4	53.6	51.1	8.2	40.0	49.0	35.0	56.8	56.2	12.6	13.7	19.1	15.7	13.2	13.8	13.0	12.3	13.6	13.0	13.2	15.6	20.6	16.0	23.4	11.8	37.4	60.2	62.9	40.6	33.0	15.6	19.6	17.9	4.4	20.0	25.2	14.7	14.6	66.7	27.4	11.4	39.2	38.4	190.6	26.3	27.3	25.1	16.1	20.8	18.5	46.9	71.2	24.5	14.3	24.1	31.7	19.6	8.9	17.1	62.8	10.1	18.0	20.7	34.6	37.7	26.1	182.0	26.8	33.3	23.2	15.0	42.2	21.3	25.7	17.6	24.6	34.2	16.3	22.2	24.2	50.2	13.8	37.5	38.8	11.8	13.1	24.8	35.7	140.2	104.5	27.7	52.7	79.6	30.4	30.8	25.3	48.1
UTP20	"1A6/DRIM, DRIM"	ENSG00000120800	"UTP20 small subunit processome component"	O75691	12	101280105-101386618	"Predicted intracellular proteins"	"rRNA processing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049341			Supported	"Nucleoli,Plasma membrane"		No	No			"Cluster 29: Plasmacytoid DCs - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	Nucleoli	"Plasma membrane"	"HPA049341: AB_2680720"	"unprognostic (3.04e-2)"	"unprognostic (1.22e-1)"	"unprognostic (3.92e-2)"	"unprognostic (1.51e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.15e-1)"	"prognostic unfavorable (1.15e-5)"	"unprognostic (8.34e-2)"	"unprognostic (4.30e-2)"	"unprognostic (8.15e-3)"	"unprognostic (2.81e-1)"	"unprognostic (2.22e-2)"	"prognostic favorable (8.87e-4)"	"unprognostic (2.88e-1)"	"unprognostic (3.44e-1)"	"unprognostic (8.30e-2)"	"unprognostic (6.92e-3)"	4.3	4.2	2.2	5.0	3.7	4.2	5.7	2.9	2.7	5.7	2.5	3.2	2.1	4.6	2.6	4.0	3.8	2.4	3.0	2.3	2.5	3.3	3.0	3.0	5.0	2.8	2.8	6.4	4.8	5.3	2.2	4.3	2.9	3.5	4.2	3.5	5.6	3.3	5.2	4.6	3.1	4.0	2.4	3.6	3.2	5.6	3.3	4.3	4.2	3.9	4.8	5.1	3.5	5.0	8.1	19.9	14.8	6.9	13.0	15.1	18.2	13.8	10.8	21.5	11.8	23.1	5.7	21.6	7.1	15.4	16.2	16.6	33.0	14.2	27.8	9.8	13.4	22.8	10.0	17.3	7.3	38.4	10.2	9.9	7.3	29.9	10.3	8.2	15.0	10.9	36.7	4.3	15.8	10.6	16.8	10.9	38.9	11.3	20.6	18.8	24.2	16.8	9.1	24.4	17.0	11.5	25.8	16.1	15.7	12.2	17.0	8.5	17.1	25.3	12.5	17.8	27.1	7.8	12.6	35.1	13.8	17.2	39.6	0.0	0.2	0.0	0.5	0.3	0.5	0.9	0.5	0.7	0.4	0.6	0.6	0.7	0.0	0.6	0.2	0.8	0.5	0.2	2.2	3.7	2.9	2.7	2.3	2.5	2.8	2.8	2.9	2.4	3.3	5.0	14.3	9.6	9.9	16.0	16.7	10.1	9.7	7.7	11.4	9.9	8.7	8.4	10.3	7.2	13.6	3.7	10.4	7.8	4.4	3.4	5.9	7.6	1.5	11.4	24.5	12.6	6.6	14.9	17.0	11.6	8.8	13.0	7.7	10.1	13.3	18.6	7.1	7.6	5.8	21.9	17.0	6.3	4.1	6.3	3.5	1.2	9.6	8.6	3.6	8.4	3.3	3.3	4.1	16.1	34.2	5.9	1.9	8.2	13.2	14.5	1.1	3.0	9.0	9.4	6.6	24.9	11.0	22.6	22.3	17.3	11.1	2.9	10.0	23.7	9.8	7.2
UTP3	"CRLZ1, DKFZp761F222, FLJ23256, SAS10"	ENSG00000132467	"UTP3 small subunit processome component"	Q9NQZ2	4	70688532-70690551	"Predicted intracellular proteins"		"Chromatin regulator, Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035655, HPA041453"	Approved		Supported	Nucleoli,Vesicles		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 10: Non-specific - Unknown function"	Nucleoli	Vesicles	"HPA035655: AB_10601832, HPA041453: AB_2677488"	"unprognostic (2.44e-2)"	"unprognostic (9.70e-2)"	"unprognostic (7.36e-3)"	"unprognostic (2.72e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.90e-2)"	"unprognostic (6.79e-3)"	"unprognostic (2.13e-1)"	"unprognostic (3.50e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.53e-1)"	"unprognostic (4.44e-3)"	"prognostic favorable (3.16e-4)"	"unprognostic (4.45e-2)"	"unprognostic (7.95e-2)"	"unprognostic (2.24e-1)"	"unprognostic (2.24e-2)"	22.4	22.7	8.9	25.5	9.5	19.1	18.7	9.4	11.3	14.0	10.0	16.9	16.3	16.1	15.0	20.6	16.3	14.6	17.0	9.9	9.8	21.0	27.1	18.6	33.0	9.1	9.3	15.7	14.9	16.3	9.4	16.3	9.1	15.1	16.4	12.0	15.9	13.7	15.9	18.8	21.5	20.2	8.7	34.5	17.8	11.4	9.6	32.1	16.0	13.1	31.5	22.1	12.3	10.0	33.7	32.3	42.4	35.4	58.9	44.3	36.3	68.4	43.9	38.4	37.0	42.4	43.7	147.4	42.1	58.9	43.8	27.7	62.7	93.7	55.4	45.9	35.9	56.1	43.0	45.9	63.9	85.9	47.9	60.4	55.2	47.0	46.0	42.3	52.2	42.3	65.3	48.2	62.8	69.7	79.9	47.8	29.6	68.9	46.7	33.8	58.3	60.5	69.7	53.7	35.5	48.4	29.1	65.4	44.5	46.1	36.1	34.2	58.5	38.8	65.9	37.3	44.3	69.6	55.4	104.8	47.3	41.4	34.8	8.4	10.7	5.6	6.4	12.6	6.8	7.0	5.3	7.4	13.4	6.1	7.7	6.7	0.8	6.8	11.3	13.5	7.3	5.5	8.9	9.5	9.4	11.3	9.9	9.8	9.1	9.3	9.1	8.7	9.6	10.0	19.2	57.7	54.2	4.9	23.7	22.9	44.3	42.2	24.5	19.4	12.3	14.4	20.6	14.3	50.5	12.9	6.2	26.7	30.0	11.8	19.6	29.3	1.1	22.8	29.3	26.7	15.0	16.8	6.2	29.8	14.6	23.6	21.9	25.1	29.2	16.7	16.8	25.1	21.9	16.8	5.9	14.7	30.5	37.8	24.2	2.2	17.4	24.2	12.4	5.6	27.9	26.8	30.9	2.5	8.9	22.6	9.5	25.2	18.5	23.0	15.9	27.9	45.7	22.3	13.1	30.8	48.8	11.5	9.5	23.0	25.6	21.6	24.6	22.2	15.6	29.9
UTP4	"CIRH1A, CIRHIN, FLJ14728, KIAA1988, NAIC, TEX292"	ENSG00000141076	"UTP4 small subunit processome component"	Q969X6	16	69131291-69231130	"Human disease related genes, Predicted intracellular proteins"	"Ribosome biogenesis, rRNA processing, Transcription, Transcription regulation"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Proximal tubular cells: 100.0;Spermatogonia: 49.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-698: 398.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041139, HPA043542"	Approved		Supported	"Nucleoli fibrillar center"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Nucleoli fibrillar center"		"HPA041139: AB_10961278, HPA043542: AB_2678542"	"unprognostic (1.82e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.89e-2)"	"unprognostic (6.16e-3)"	"prognostic unfavorable (9.05e-5)"	"prognostic unfavorable (8.18e-7)"	"unprognostic (1.31e-1)"	"unprognostic (4.76e-2)"	"prognostic favorable (2.88e-5)"	"unprognostic (2.12e-2)"	"unprognostic (4.45e-2)"	"unprognostic (2.32e-3)"	"unprognostic (9.57e-3)"	"unprognostic (2.12e-1)"	"unprognostic (1.33e-1)"	"unprognostic (3.20e-2)"	25.4	17.4	7.7	17.5	8.6	27.1	21.0	7.3	10.1	16.3	7.3	21.1	10.8	20.6	9.9	23.0	19.5	12.7	19.2	10.3	7.5	31.7	19.1	16.3	19.1	6.1	6.9	18.3	24.1	16.6	14.2	15.5	6.6	16.1	17.6	11.4	15.7	14.4	61.7	20.2	13.9	22.7	5.9	14.0	19.1	31.4	8.0	17.6	23.2	26.3	23.3	28.8	16.8	7.3	79.6	95.6	56.9	79.8	48.5	42.9	94.5	83.7	57.2	152.1	112.8	188.1	68.8	166.4	68.0	57.7	63.1	106.0	130.8	102.7	167.4	33.2	74.6	82.2	58.6	99.7	58.6	96.5	52.7	41.0	55.2	143.0	129.5	40.7	68.6	88.8	169.4	22.9	90.0	96.2	105.4	50.5	139.1	80.3	66.7	174.3	85.3	163.4	63.6	77.7	96.4	67.1	178.3	45.3	48.3	63.3	80.2	53.4	48.2	83.3	83.6	73.4	119.2	59.5	116.1	398.1	56.5	76.5	87.4	4.5	18.6	3.5	26.7	26.1	38.5	30.6	30.0	26.9	25.6	20.1	34.7	31.6	1.7	35.0	19.4	21.6	31.5	30.2	7.7	8.6	7.3	10.1	10.3	7.5	6.1	6.9	6.6	5.9	8.0	7.3	12.1	6.4	11.4	0.0	14.6	0.0	30.0	0.0	28.5	5.7	12.4	11.6	0.0	5.7	9.9	5.5	8.4	18.9	7.4	1.7	9.8	27.4	17.9	7.0	13.2	12.1	0.0	12.4	0.0	25.4	22.1	14.8	10.2	9.0	2.5	12.0	9.3	7.9	16.7	6.7	0.0	6.4	0.0	8.9	0.0	7.6	15.8	9.8	0.0	0.0	8.2	7.6	11.3	0.0	0.0	24.4	5.4	14.7	13.4	26.7	4.5	100.0	5.8	5.7	6.6	26.7	12.8	30.1	49.5	25.1	0.0	12.9	11.0	16.5	10.0	22.6
UTRN	"DMDL, DRP, DRP1"	ENSG00000152818	Utrophin	P46939	6	144285701-144853034	"Plasma proteins, Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 410.3;Early spermatids: 527.1;Late spermatids: 332.1;Microglial cells: 425.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HAP1: 219.4;HUVEC TERT2: 157.0;TIME: 203.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016348, HPA018894"	Enhanced		Approved	"Nucleoplasm,Plasma membrane"		NA	NA		4200	"Cluster 51: Monocytes - Innate immune response"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Nucleoplasm, Plasma membrane"		"CAB016348: AB_628424, HPA018894: AB_10600839"	"unprognostic (3.47e-2)"	"unprognostic (2.82e-1)"	"unprognostic (2.32e-1)"	"unprognostic (6.87e-3)"	"unprognostic (1.75e-1)"	"unprognostic (3.30e-2)"	"unprognostic (3.99e-3)"	"unprognostic (2.44e-1)"	"unprognostic (9.24e-2)"	"unprognostic (1.29e-1)"	"unprognostic (2.72e-1)"	"unprognostic (7.10e-2)"	"prognostic favorable (7.61e-5)"	"unprognostic (6.32e-2)"	"unprognostic (2.20e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.49e-2)"	52.6	17.4	26.8	25.8	40.5	56.6	40.5	32.7	18.3	40.4	35.6	33.8	17.0	29.8	16.8	27.9	43.5	31.2	24.8	18.4	67.9	30.9	25.3	49.3	34.9	48.6	52.1	37.2	52.1	69.4	7.9	45.8	49.7	39.7	31.7	11.0	26.0	26.1	14.0	27.5	22.3	25.9	40.0	71.5	27.2	59.2	48.8	43.2	68.4	38.9	35.8	25.2	16.0	31.0	27.2	22.6	39.3	51.0	66.5	60.5	23.4	39.0	37.8	31.1	45.2	86.1	9.8	8.4	33.6	88.4	36.6	15.6	219.4	32.9	44.6	90.6	25.5	32.2	24.9	51.6	26.3	36.1	0.7	35.5	6.8	46.2	24.1	29.3	157.0	25.1	2.0	22.7	44.1	18.1	28.7	15.5	15.9	16.6	23.9	25.7	70.2	0.8	35.9	0.7	49.7	0.9	60.8	8.4	23.5	59.5	33.3	48.2	203.6	29.8	37.0	15.5	37.6	17.7	25.3	1.3	18.2	21.5	49.5	41.2	40.9	23.2	39.5	120.8	28.3	25.7	24.9	33.0	17.2	35.7	21.8	22.8	34.5	37.6	173.9	50.4	22.2	13.9	26.8	40.5	32.7	18.3	18.4	67.9	48.6	52.1	49.7	40.0	48.8	31.0	267.0	410.3	138.7	148.2	101.2	29.4	31.7	17.2	40.9	6.5	47.4	32.1	56.0	28.6	111.0	31.3	0.0	94.4	175.1	10.9	0.0	25.3	527.1	61.2	51.5	171.8	31.2	19.8	61.2	32.0	6.9	51.6	76.5	87.5	29.7	22.8	83.6	15.6	22.3	60.6	161.4	16.9	8.2	109.7	45.9	332.1	23.9	97.6	39.2	425.3	79.8	29.1	171.0	68.9	4.1	28.1	9.3	33.4	70.3	25.4	3.6	7.1	87.3	4.3	144.7	151.0	157.8	6.6	6.6	33.7	45.5	129.3	108.0	32.0	22.3	19.2
UVSSA	KIAA1530	ENSG00000163945	"UV stimulated scaffold protein A"	Q2YD98	4	1345691-1395989	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"DNA damage, DNA repair"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"NK-cell: 3.3"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA050824, HPA053496"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 71: Testis - DNA repair"	"Cluster 20: HeLa - Mitochondria"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA050824: AB_2681251, HPA053496: AB_2682170"	"unprognostic (6.40e-3)"	"unprognostic (4.91e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.13e-2)"	"unprognostic (1.67e-1)"	"unprognostic (3.85e-4)"	"unprognostic (1.89e-1)"	"unprognostic (4.80e-2)"	"unprognostic (1.38e-1)"	"unprognostic (4.88e-2)"	"unprognostic (2.12e-3)"	"unprognostic (3.92e-3)"	"prognostic unfavorable (1.90e-4)"	"unprognostic (2.76e-3)"	"unprognostic (5.19e-2)"	"unprognostic (1.02e-2)"	"prognostic favorable (6.87e-4)"	4.2	4.3	3.5	5.5	4.1	8.0	4.4	3.4	5.1	4.5	5.5	4.7	5.5	5.0	6.0	4.2	6.4	3.4	2.9	3.3	3.1	3.2	3.9	6.0	3.8	5.7	3.9	5.5	6.7	2.6	9.3	2.8	4.7	4.1	3.5	4.7	5.7	2.7	4.6	9.2	5.3	2.5	3.0	5.6	5.5	9.4	5.4	3.8	7.1	1.5	3.4	4.7	4.5	7.5	3.7	4.1	6.1	5.7	7.0	9.0	4.6	3.4	2.9	3.0	2.6	3.4	7.5	2.7	6.5	3.4	7.9	4.4	3.8	3.9	2.6	3.7	1.6	6.4	7.9	4.0	2.7	3.9	7.6	2.6	7.8	3.4	4.4	3.4	5.0	4.6	6.2	8.9	3.7	2.1	5.8	8.1	6.0	2.9	5.2	5.0	3.1	3.4	2.7	5.4	4.4	5.8	2.6	3.0	3.8	5.3	8.0	2.2	9.5	11.4	2.8	4.2	5.9	13.4	9.0	6.1	8.5	4.4	6.9	0.1	0.6	0.9	0.6	0.5	0.3	0.4	0.5	0.5	1.0	0.4	0.4	0.3	1.0	3.3	0.8	0.8	0.2	0.5	3.5	4.1	3.4	5.1	3.3	3.1	5.7	3.9	4.7	3.0	5.4	7.5	20.7	6.4	26.2	16.3	11.5	5.5	5.2	3.4	5.7	18.2	13.7	10.7	3.6	7.2	8.8	16.5	41.7	3.4	17.1	10.3	3.9	8.0	7.6	23.7	23.1	9.1	6.0	7.4	6.9	8.5	2.9	10.3	21.9	20.1	8.8	16.7	5.3	12.5	6.8	30.3	9.3	10.9	8.2	10.8	6.3	7.3	5.3	13.4	5.4	14.0	7.6	9.0	7.2	5.5	16.5	10.1	6.7	3.8	12.6	5.0	10.7	4.8	23.6	25.3	0.0	13.1	11.4	23.2	9.4	8.0	6.1	3.7	12.0	12.8	6.5	4.5
UXT	"ART-27, STAP1"	ENSG00000126756	"Ubiquitously expressed prefoldin like chaperone"	Q9UBK9	X	47651796-47659180	"Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Transcription, Transcription regulation"	"Activator, Chaperone, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA050499, HPA058400"	Approved		Supported	"Nucleoplasm,Centriolar satellite"		Yes	No			"Cluster 30: Non-specific - Translation"	"Cluster 50: Non-specific - Ribosome"	"Cluster 24: NB-4 - Immune response"	"Cluster 32: Non-specific - Translation"	Nucleoplasm	"Centriolar satellite"	"HPA050499: AB_2681146, HPA058400: AB_2683706"	"unprognostic (1.12e-1)"	"unprognostic (3.85e-3)"	"unprognostic (9.08e-2)"	"unprognostic (2.09e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.23e-1)"	"unprognostic (4.49e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.97e-1)"	"unprognostic (2.31e-3)"	"unprognostic (1.12e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.56e-2)"	"unprognostic (1.44e-1)"	"unprognostic (8.11e-2)"	"unprognostic (8.64e-2)"	"unprognostic (4.09e-3)"	124.7	148.6	82.1	78.8	84.9	212.0	127.1	85.6	111.7	121.8	86.5	112.3	77.2	93.6	123.6	116.6	103.3	66.7	144.6	80.1	85.1	134.2	135.1	97.8	148.7	87.1	82.5	184.6	182.3	90.5	107.0	65.3	88.4	119.7	99.7	42.8	121.6	65.9	130.7	143.6	113.8	68.2	87.7	139.5	131.7	46.3	83.7	166.9	96.3	95.2	143.0	109.6	111.9	91.1	192.0	208.6	87.4	116.0	194.3	233.4	152.3	119.2	178.5	203.6	191.7	182.1	178.1	217.3	86.4	173.5	188.0	151.8	123.5	163.8	145.3	143.7	240.8	111.6	220.8	182.4	224.2	246.6	208.1	162.9	207.5	168.6	183.8	142.2	165.9	185.6	122.2	205.1	174.8	211.5	170.7	342.1	125.4	174.7	231.2	149.5	177.2	300.9	168.1	141.4	82.1	107.1	133.1	146.7	197.8	157.7	170.4	227.2	122.4	140.7	153.2	196.2	136.7	161.7	154.5	200.7	179.8	270.1	145.1	110.1	159.7	123.4	169.5	166.1	229.8	262.7	242.6	184.2	213.3	245.2	303.2	255.4	100.7	172.1	156.9	270.3	248.2	247.9	82.1	84.9	85.6	111.7	80.1	85.1	87.1	82.5	88.4	87.7	83.7	91.1	108.3	73.7	79.5	5.5	276.8	214.9	274.3	247.9	212.3	27.3	242.1	239.6	100.7	165.8	141.4	97.5	16.7	189.4	207.2	212.1	315.0	161.2	73.5	122.3	125.2	129.6	187.2	170.0	4.0	318.9	212.6	127.6	78.0	114.0	154.1	161.4	193.5	242.4	246.5	10.1	4.3	331.9	126.1	248.0	277.4	185.2	210.3	179.8	197.5	1.9	316.0	108.2	212.1	3.5	7.7	189.3	338.0	196.0	198.3	256.4	297.8	466.1	138.0	28.6	144.7	224.3	145.2	78.7	85.6	183.3	203.7	213.7	240.5	185.5	328.5	286.0
VAMP7	"SYBL1, TI-VAMP, VAMP-7"	ENSG00000124333	"Vesicle associated membrane protein 7"	P51809	X	155881345-155943769	"Predicted intracellular proteins, Predicted membrane proteins"	"Exocytosis, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA036733	Approved		Supported	Vesicles		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 34: Non-specific - Transcription"	"Cluster 16: U-266 - Nucleosome"	"Cluster 51: Myeloid cells - Hemostasis"	Vesicles		"HPA036733: AB_10672228"	"unprognostic (7.54e-3)"	"unprognostic (1.35e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.04e-1)"	"unprognostic (6.15e-3)"	"unprognostic (2.70e-2)"	"unprognostic (5.77e-2)"	"unprognostic (7.95e-2)"	"unprognostic (7.18e-2)"	"unprognostic (3.38e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.15e-1)"	"prognostic favorable (2.83e-4)"	"unprognostic (1.29e-1)"	"unprognostic (3.42e-1)"	"unprognostic (2.47e-1)"	"unprognostic (2.97e-1)"	29.4	24.3	17.8	24.1	20.6	37.1	23.8	22.3	24.9	23.2	18.3	22.9	23.4	21.4	15.5	22.6	16.5	22.2	19.6	18.1	21.4	39.2	47.9	24.8	26.4	20.7	20.5	17.9	14.3	32.3	8.7	40.5	21.5	21.4	24.4	10.3	17.3	20.1	21.9	20.1	27.5	28.2	20.4	21.8	18.4	14.9	19.9	29.9	24.4	24.1	28.6	25.6	15.9	23.0	72.9	31.3	21.0	43.6	57.0	54.3	56.3	55.3	49.1	49.0	98.4	33.8	46.5	100.6	100.0	66.9	55.5	25.5	47.6	38.9	64.5	42.3	41.6	41.8	43.1	24.3	63.6	86.9	62.8	50.9	37.9	54.8	49.8	42.8	55.4	43.5	91.1	54.2	56.0	36.5	34.1	48.8	15.0	54.1	45.3	25.5	41.2	75.3	65.6	36.2	16.0	46.0	32.7	32.6	49.6	54.8	31.9	71.8	58.4	44.8	46.7	65.0	79.6	123.8	167.8	138.9	39.2	104.4	51.0	86.8	25.3	39.6	15.1	27.0	19.1	12.3	17.7	18.6	26.4	13.2	16.2	17.5	21.9	22.7	26.7	15.0	22.0	22.4	17.8	20.6	22.3	24.9	18.1	21.4	20.7	20.5	21.5	20.4	19.9	23.0	17.8	3.2	9.2	11.1	21.2	19.6	14.7	11.8	20.5	7.6	16.6	9.5	12.3	5.7	12.5	7.3	6.2	48.4	24.9	14.1	41.1	28.0	6.9	13.8	14.5	19.8	13.2	31.4	14.2	26.0	49.7	19.6	12.2	13.7	31.1	22.5	20.3	25.1	31.1	6.7	14.6	12.8	10.2	30.8	49.0	6.9	17.7	35.9	19.6	7.5	32.5	10.4	29.9	8.0	19.2	29.9	13.5	19.5	15.2	17.5	25.3	52.9	10.5	4.6	26.3	10.8	18.9	45.4	26.3	20.3	19.5	69.8	21.6	25.3	15.3	20.1
VASP		ENSG00000125753	"Vasodilator stimulated phosphoprotein"	P50552	19	45506579-45526983	"Plasma proteins, Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Extravillous trophoblasts: 443.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"eosinophil: 52.7"	"Group enriched"	"Detected in all"	7	"granulocytes: 52.7;monocytes: 22.7"	"Cell line enhanced"	"Detected in all"		"HMC-1: 270.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004612, HPA005724"	Enhanced		Supported	"Plasma membrane,Cell Junctions,Focal adhesion sites"		NA	NA		32000000	"Cluster 52: Eosinophils - Transcription"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 15: RT4 - Unknown function"	"Cluster 38: Extravillous trophoblasts - Unknown function"	"Plasma membrane, Cell Junctions, Focal adhesion sites"		"CAB004612: AB_2213431, HPA005724: AB_1858721"	"unprognostic (3.07e-2)"	"unprognostic (1.07e-2)"	"unprognostic (4.70e-2)"	"unprognostic (7.85e-3)"	"unprognostic (8.31e-2)"	"unprognostic (1.90e-2)"	"prognostic unfavorable (3.49e-5)"	"unprognostic (1.66e-3)"	"unprognostic (1.58e-1)"	"unprognostic (1.30e-2)"	"unprognostic (3.64e-3)"	"unprognostic (4.39e-1)"	"prognostic unfavorable (5.91e-7)"	"unprognostic (1.15e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.08e-2)"	54.5	24.6	9.3	75.2	8.3	94.0	42.5	9.2	12.6	37.7	11.0	88.9	61.9	89.1	6.0	37.5	54.4	27.0	36.4	8.1	9.4	39.1	27.3	58.2	48.7	13.0	10.9	22.5	20.6	10.7	17.1	31.5	13.8	43.8	20.4	1.9	30.7	39.1	12.5	32.8	63.6	36.5	11.7	107.0	70.5	14.7	15.0	24.9	27.6	8.5	32.0	71.6	39.0	12.0	68.9	66.3	20.6	35.6	10.2	17.4	50.5	70.2	52.8	47.4	40.9	30.1	142.0	31.2	55.7	56.4	31.3	60.6	6.2	69.5	15.9	87.0	14.8	183.7	32.3	55.4	56.6	68.1	270.1	26.8	38.2	44.5	28.5	38.3	71.1	25.8	112.1	67.5	29.4	53.7	30.3	58.7	36.0	65.1	44.5	21.6	12.6	12.2	40.9	216.2	23.0	16.3	83.6	41.7	48.2	13.0	45.7	115.2	107.0	74.7	74.4	24.7	112.4	32.8	43.3	54.7	52.4	82.3	92.3	13.3	8.5	52.7	4.1	13.9	2.8	3.4	3.3	3.9	5.5	3.3	2.1	2.5	34.5	4.0	22.7	2.1	2.6	5.8	9.3	8.3	9.2	12.6	8.1	9.4	13.0	10.9	13.8	11.7	15.0	12.0	80.9	16.0	19.5	2.9	99.4	98.3	95.6	48.8	37.0	6.9	53.5	57.0	19.0	48.6	41.5	33.1	27.1	67.1	85.9	202.3	17.6	138.6	3.2	33.9	30.5	77.0	114.7	20.0	2.6	98.2	443.6	26.7	81.6	58.1	83.1	17.4	48.5	15.8	160.1	6.7	3.4	159.3	44.7	132.5	232.0	3.8	26.1	192.9	49.8	10.3	162.9	13.2	185.3	2.0	2.3	212.5	245.5	49.2	38.2	73.4	134.6	20.4	18.6	14.7	131.5	46.5	89.4	18.9	15.5	38.7	77.7	140.9	95.7	21.0	129.5	144.8
VBP1	"PFD3, PFDN3"	ENSG00000155959	"VHL binding protein 1"	P61758	X	155197007-155239841	"Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB006260, HPA023230"	Approved		Supported	Vesicles,Cytosol		NA	NA		15000	"Cluster 49: Eosinophils - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 39: Non-specific - Basic cellular processes"	Cytosol	Vesicles	"CAB006260: AB_425740, HPA023230: AB_1858727"	"unprognostic (1.55e-3)"	"unprognostic (1.12e-3)"	"unprognostic (3.35e-1)"	"unprognostic (1.35e-2)"	"unprognostic (3.78e-2)"	"unprognostic (1.85e-3)"	"unprognostic (5.31e-3)"	"unprognostic (1.40e-1)"	"unprognostic (2.44e-2)"	"unprognostic (1.02e-2)"	"unprognostic (9.80e-2)"	"unprognostic (1.15e-1)"	"unprognostic (5.76e-2)"	"unprognostic (3.76e-2)"	"unprognostic (4.54e-2)"	"unprognostic (9.30e-2)"	"unprognostic (3.80e-1)"	32.1	32.5	48.6	29.4	50.2	50.5	31.6	54.6	60.5	24.2	43.6	30.1	23.0	25.2	26.6	31.0	23.5	21.1	65.7	49.5	53.7	40.4	31.2	23.3	41.3	52.7	52.8	25.5	19.7	38.2	29.7	30.2	53.4	30.9	33.0	48.2	20.6	25.4	101.5	19.3	24.3	28.9	54.6	24.8	22.6	15.9	51.9	45.8	31.6	121.2	40.4	32.2	19.9	60.1	162.8	57.6	122.1	81.1	49.6	68.0	35.2	78.8	60.7	99.7	155.3	69.1	80.8	207.1	163.6	66.8	154.1	62.4	179.3	74.0	129.5	110.0	123.9	87.6	86.0	54.2	58.9	142.6	65.5	51.0	84.7	84.7	105.6	53.1	93.7	101.0	173.4	119.9	113.6	67.7	134.3	120.9	71.0	149.1	122.1	114.0	97.0	121.4	86.8	73.0	132.0	80.0	54.1	62.7	90.1	83.4	53.8	107.5	55.6	80.5	100.0	138.3	198.0	133.9	209.0	361.3	71.6	173.1	101.0	22.5	23.0	75.8	26.3	25.1	30.2	28.6	30.5	31.7	36.2	23.7	34.5	37.5	26.3	28.2	21.9	29.5	43.2	33.0	48.6	50.2	54.6	60.5	49.5	53.7	52.7	52.8	53.4	54.6	51.9	60.1	40.7	51.3	29.1	12.1	55.1	57.4	81.2	89.9	33.6	54.9	33.2	30.2	80.5	30.0	48.0	38.6	20.9	73.7	60.4	27.9	191.7	65.8	2.5	32.8	41.3	47.3	23.4	128.6	12.7	57.6	101.4	52.6	28.5	28.9	47.5	36.6	30.7	24.9	67.6	32.0	14.2	30.0	75.3	29.5	64.4	4.6	42.0	40.7	46.2	6.5	80.1	78.7	47.4	6.6	21.3	52.7	43.1	39.9	56.8	78.0	29.3	126.3	37.2	46.3	46.0	45.1	52.8	80.7	88.2	37.1	52.6	68.7	60.0	81.6	45.9	63.0
VCPKMT	"C14orf138, METTL21D, VCP-KMT"	ENSG00000100483	"Valosin containing protein lysine methyltransferase"	Q9H867	14	50108632-50116600	"Metabolic proteins, Predicted intracellular proteins"		"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001146, HPA076561"	Uncertain		Supported	Cytosol		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 55: Plasma cells - Humoral immune response"	Cytosol		"HPA001146: AB_1845558, HPA076561: AB_2732312"	"unprognostic (1.58e-1)"	"unprognostic (2.87e-2)"	"unprognostic (5.05e-2)"	"unprognostic (3.86e-1)"	"unprognostic (3.54e-1)"	"unprognostic (4.74e-2)"	"unprognostic (9.97e-2)"	"prognostic favorable (2.40e-4)"	"unprognostic (8.20e-2)"	"unprognostic (1.74e-1)"	"unprognostic (4.90e-2)"	"prognostic unfavorable (4.75e-4)"	"prognostic unfavorable (6.79e-4)"	"unprognostic (1.15e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.66e-1)"	"unprognostic (6.27e-2)"	2.9	4.1	1.7	3.4	2.1	5.1	2.3	2.4	5.3	3.7	3.0	3.3	1.7	3.0	2.6	4.9	2.9	2.3	2.7	2.5	2.0	2.7	3.9	3.1	4.3	2.0	1.9	2.6	2.9	1.9	3.3	1.6	2.0	2.7	1.6	1.5	2.2	1.6	2.3	3.9	3.2	1.5	1.5	4.8	3.6	2.1	2.2	4.7	2.6	1.8	4.4	3.0	3.2	2.5	4.2	4.4	4.0	4.9	2.6	3.1	4.4	4.0	4.4	4.4	3.3	2.8	4.8	12.8	2.7	2.8	1.1	7.9	4.9	7.0	4.4	6.4	3.2	2.5	1.7	2.8	3.6	6.4	3.3	2.0	3.9	4.8	4.9	3.0	5.5	4.6	3.0	5.3	3.3	5.5	13.4	6.7	3.9	6.1	7.2	9.0	7.4	3.4	5.6	6.3	6.7	7.9	5.9	1.6	7.1	3.6	4.0	5.7	1.4	7.2	5.6	2.6	4.5	5.1	11.4	5.0	2.5	5.2	3.5	12.1	2.8	0.0	9.3	4.7	10.9	27.1	9.1	11.5	3.8	21.4	11.2	12.4	0.8	11.8	2.2	5.4	7.8	4.8	1.7	2.1	2.4	5.3	2.5	2.0	2.0	1.9	2.0	1.5	2.2	2.5	11.5	12.8	9.8	7.8	38.0	30.3	17.3	7.7	30.1	6.5	12.8	10.8	3.6	8.6	9.7	7.3	10.4	10.2	25.7	5.6	9.8	5.8	39.4	14.1	9.8	8.3	5.4	9.5	12.6	5.7	8.4	9.3	7.7	17.1	17.7	7.2	6.8	7.7	5.1	1.7	11.0	8.5	12.2	7.5	16.4	10.2	7.5	8.7	10.6	3.7	9.5	3.5	15.5	10.6	17.5	5.3	8.0	4.9	48.2	15.5	7.8	6.7	8.6	8.1	0.0	9.1	9.1	14.4	16.6	24.9	37.4	11.5	22.4	10.2	7.1	17.1
VDAC2		ENSG00000165637	"Voltage dependent anion channel 2"	P45880	10	75210154-75231448	"Predicted intracellular proteins, Transporters"	"Ion transport, Transport"	Porin		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043475	Enhanced		Supported	Mitochondria		NA	NA		490000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	Mitochondria		"HPA043475: AB_10795615"	"unprognostic (1.01e-2)"	"unprognostic (1.22e-1)"	"unprognostic (9.47e-2)"	"unprognostic (9.00e-3)"	"unprognostic (5.74e-2)"	"prognostic unfavorable (4.51e-4)"	"prognostic unfavorable (4.55e-4)"	"unprognostic (1.83e-3)"	"unprognostic (5.89e-2)"	"unprognostic (2.45e-1)"	"unprognostic (2.02e-2)"	"unprognostic (1.56e-2)"	"unprognostic (4.27e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.65e-1)"	"unprognostic (6.28e-2)"	"unprognostic (1.34e-2)"	138.2	150.3	95.5	93.3	97.4	138.5	116.2	116.2	115.0	165.5	117.1	209.1	151.3	116.6	90.7	322.1	117.4	85.4	420.5	99.0	109.0	177.5	115.9	112.0	83.5	105.7	107.1	132.8	150.6	192.7	85.3	115.6	110.1	108.8	184.4	198.4	151.4	134.0	539.4	171.6	148.4	149.2	105.0	77.7	159.4	104.6	107.1	92.7	111.0	565.9	148.3	163.6	207.1	110.4	304.4	245.0	291.0	370.5	253.3	342.1	305.2	384.9	430.4	412.7	386.6	367.5	281.8	358.6	210.9	324.3	228.6	398.2	539.2	382.2	402.1	196.0	313.5	209.4	191.4	425.2	252.6	402.0	223.4	305.6	441.7	352.8	747.3	578.2	310.0	222.9	359.9	283.7	439.4	222.6	262.6	325.7	250.7	341.2	937.6	308.2	230.0	228.3	408.9	187.5	183.4	216.5	212.4	701.7	467.4	337.8	409.7	177.4	241.4	204.4	279.8	305.7	419.8	226.7	333.1	369.0	296.3	390.4	178.1	168.2	179.0	138.9	106.7	193.1	130.8	154.2	144.3	119.4	220.4	127.9	144.2	134.5	61.5	135.5	238.4	107.3	178.6	221.6	95.5	97.4	116.2	115.0	99.0	109.0	105.7	107.1	110.1	105.0	107.1	110.4	130.3	96.1	54.9	30.3	135.5	381.4	417.8	575.6	280.6	149.6	149.5	159.1	325.1	128.7	246.3	112.2	43.8	315.0	128.0	583.7	669.1	413.3	257.6	172.2	110.9	146.5	149.7	148.5	22.1	345.7	437.6	142.6	158.0	199.9	112.3	197.5	165.9	79.2	266.1	129.5	30.7	305.1	284.8	164.8	220.3	110.8	169.9	180.2	224.1	16.9	264.3	275.5	92.7	23.1	26.0	443.5	497.2	166.3	172.2	386.3	610.9	324.3	119.5	161.1	177.5	170.3	289.0	359.7	149.7	493.3	420.4	396.5	129.6	210.5	355.7	568.1
VDAC3	HD-VDAC3	ENSG00000078668	"Voltage dependent anion channel 3"	Q9Y277	8	42391624-42405937	"Plasma proteins, Predicted intracellular proteins"	"Ion transport, Transport"	Porin		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"heart muscle: 385.2;skeletal muscle: 914.4;tongue: 942.7"	"Cell type enhanced"	"Detected in all"		"Spermatocytes: 403.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026864	Uncertain		Supported	Mitochondria		NA	NA		1200000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"HPA026864: AB_1858733"	"unprognostic (2.55e-2)"	"unprognostic (1.96e-2)"	"unprognostic (9.88e-3)"	"unprognostic (4.40e-2)"	"unprognostic (1.26e-1)"	"unprognostic (2.00e-1)"	"unprognostic (4.98e-2)"	"unprognostic (2.25e-2)"	"unprognostic (1.40e-2)"	"unprognostic (5.76e-2)"	"unprognostic (3.74e-1)"	"unprognostic (1.19e-2)"	"unprognostic (6.16e-3)"	"unprognostic (2.96e-2)"	"unprognostic (1.76e-1)"	"unprognostic (8.78e-3)"	"unprognostic (6.94e-3)"	67.5	76.2	117.3	59.1	119.4	92.1	70.3	116.8	150.6	53.7	115.4	106.9	79.8	63.5	68.6	99.9	85.8	56.0	385.2	121.1	130.8	108.8	92.9	51.9	66.3	122.7	119.3	61.6	64.6	92.4	58.9	63.9	139.2	69.5	106.4	123.1	61.6	81.3	914.4	54.1	73.0	92.8	114.1	67.3	72.1	114.5	118.6	80.1	83.3	942.7	79.3	78.9	59.8	113.8	226.3	225.7	174.5	185.9	146.3	126.6	84.8	180.0	151.1	225.4	205.2	173.4	190.4	235.8	165.0	153.7	196.3	142.5	238.4	194.1	244.7	117.2	196.6	352.9	138.4	250.2	105.2	172.0	190.1	98.6	143.3	171.6	80.9	149.6	279.8	201.3	284.4	158.6	235.7	126.4	373.3	197.1	205.2	285.6	144.5	193.6	322.1	165.3	245.7	198.8	156.8	133.3	112.1	132.8	116.1	126.4	279.9	129.9	149.8	86.6	150.0	217.7	174.0	145.2	264.1	266.9	117.5	238.0	150.9	142.8	165.3	183.4	145.8	167.2	148.7	126.5	155.6	146.5	222.7	96.6	152.7	147.7	82.8	125.8	155.6	163.0	202.5	360.5	117.3	119.4	116.8	150.6	121.1	130.8	122.7	119.3	139.2	114.1	118.6	113.8	78.1	44.8	24.4	50.6	59.8	64.5	81.1	197.8	58.1	85.9	53.0	73.9	321.2	55.8	82.8	66.2	35.5	145.5	91.9	65.7	307.2	116.3	151.1	112.8	56.7	70.5	47.8	186.4	63.2	90.0	112.1	81.5	41.3	47.1	55.2	100.6	68.2	60.4	139.7	138.0	78.9	86.1	177.0	58.5	77.8	146.4	69.3	107.7	72.9	26.2	130.1	72.9	83.4	38.2	34.7	84.9	86.7	97.4	75.9	48.9	125.3	177.5	142.1	94.5	65.7	146.4	123.8	403.7	156.3	82.3	70.8	58.3	79.7	94.2	124.8	70.4
VDR	"NR1I1, PPP1R163"	ENSG00000111424	"Vitamin D receptor"	P11473	12	47841537-47943048	"Disease related genes, FDA approved drug targets, Human disease related genes, Nuclear receptors, Predicted intracellular proteins, Transcription factors, Transporters"	"Transcription, Transcription regulation"	"DNA-binding, Receptor"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"parathyroid gland: 235.9"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 141.7;Proximal enterocytes: 88.7;Undifferentiated cells: 72.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in many"	7	"classical monocyte: 3.5;eosinophil: 1.9;intermediate monocyte: 6.5;myeloid DC: 5.1;neutrophil: 6.5;non-classical monocyte: 6.7"	"Group enriched"	"Detected in many"	8	"dendritic cells: 5.1;granulocytes: 6.5;monocytes: 6.7"	"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 55.5;HDLM-2: 80.0;U-937: 85.3"	"Region enhanced"	"Detected in single"		"olfactory bulb: 2.1"	"Region enhanced"	"Detected in some"		"spinal cord: 4.3"	"CAB004617, HPA047740, HPA072102"			Supported	"Nucleoplasm,Intermediate filaments,Cytosol"		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm	"Intermediate filaments, Cytosol"	"CAB004617: AB_628040, HPA047740: AB_2680142, HPA072102: "	"unprognostic (1.11e-2)"	"unprognostic (5.49e-2)"	"unprognostic (1.01e-1)"	"unprognostic (7.59e-3)"	"unprognostic (3.33e-3)"	"unprognostic (2.74e-2)"	"unprognostic (4.78e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.62e-1)"	"unprognostic (5.53e-3)"	"unprognostic (6.72e-2)"	"prognostic favorable (4.89e-6)"	"unprognostic (1.46e-1)"	"unprognostic (8.76e-2)"	"unprognostic (3.28e-1)"	"unprognostic (3.82e-2)"	3.6	13.7	0.2	13.3	0.2	8.2	11.3	0.2	0.4	5.0	0.9	40.4	56.0	1.6	0.4	13.6	1.8	8.5	1.2	0.2	0.7	21.0	1.1	7.7	5.3	0.7	0.4	0.5	2.1	235.9	11.1	2.9	0.6	1.9	35.3	0.2	6.1	1.8	2.8	22.1	55.0	3.8	0.1	2.6	7.4	1.0	1.4	1.5	2.2	0.6	7.2	10.4	7.6	0.3	15.0	2.6	0.1	0.1	12.0	16.4	0.2	17.7	8.6	15.0	12.9	10.6	12.1	3.5	17.4	13.6	10.7	27.1	0.5	55.5	6.4	80.0	4.0	6.3	3.1	0.9	8.1	12.2	20.3	23.6	30.5	16.4	26.0	22.3	1.2	1.3	1.8	3.9	7.0	9.2	0.3	6.0	0.2	34.8	19.1	0.3	0.0	9.9	13.3	13.5	6.2	0.2	14.7	42.6	5.9	0.1	47.6	6.7	1.0	28.8	7.3	8.2	10.2	2.2	0.1	3.0	8.6	85.3	7.7	0.1	3.5	1.9	0.0	6.5	0.1	0.5	0.3	0.0	5.1	0.0	0.1	0.0	6.5	0.2	6.7	0.4	0.7	1.5	0.2	0.2	0.2	0.4	0.2	0.7	0.7	0.4	0.6	0.1	1.4	0.3	0.4	12.8	20.1	0.3	1.4	36.1	9.0	8.5	24.5	0.5	21.2	13.7	1.7	0.0	9.2	7.3	0.0	0.2	0.9	141.7	7.9	3.5	0.2	11.9	0.5	1.3	21.7	0.0	0.4	10.9	0.1	5.3	14.3	4.7	7.0	0.2	0.0	0.3	3.4	0.0	0.3	32.8	2.0	7.3	43.4	0.0	0.0	21.2	8.8	1.0	10.4	0.2	0.0	0.5	0.1	22.4	43.3	0.4	10.9	8.3	88.7	32.0	9.0	0.2	0.0	1.1	2.2	0.7	0.3	23.4	40.6	0.3	2.8	0.0	72.4	11.6
VEZT	DKFZP761C241	ENSG00000028203	"Vezatin, adherens junctions transmembrane protein"	Q9HBM0	12	95217746-95302799	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004811, HPA017066"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 46: Photoreceptor cells - Phototransduction"	Nucleoplasm	Cytosol	"HPA004811: AB_1080563, HPA017066: AB_1858742"	"unprognostic (3.91e-1)"	"unprognostic (6.34e-3)"	"unprognostic (3.48e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.31e-2)"	"prognostic unfavorable (1.71e-4)"	"unprognostic (2.28e-1)"	"unprognostic (9.93e-2)"	"unprognostic (4.18e-1)"	"unprognostic (1.10e-3)"	"unprognostic (3.37e-3)"	"prognostic unfavorable (1.93e-5)"	"prognostic unfavorable (3.68e-4)"	"unprognostic (1.51e-1)"	"unprognostic (4.06e-1)"	"unprognostic (5.02e-2)"	7.3	9.9	7.7	5.8	8.0	3.3	8.9	11.3	9.9	9.2	3.1	7.6	5.8	8.2	9.6	6.6	7.7	7.4	9.5	8.5	8.6	6.9	6.2	7.8	6.4	4.4	5.7	11.2	9.0	8.6	13.4	9.4	5.7	9.6	6.3	20.3	5.4	7.6	23.8	10.3	5.9	7.1	4.0	4.1	5.6	4.5	6.9	6.6	18.9	21.2	6.4	7.5	8.5	7.1	14.4	12.9	18.0	9.5	14.7	9.2	6.8	10.3	13.3	8.7	12.9	4.8	6.6	18.6	6.5	8.8	4.3	7.4	13.3	9.2	15.2	12.6	7.3	7.2	3.3	5.2	7.5	14.2	4.1	12.7	15.6	7.6	21.9	19.0	17.1	8.9	4.2	7.0	7.6	4.0	12.4	6.7	9.2	4.5	13.1	11.1	8.4	6.0	23.8	10.3	12.1	10.6	10.1	14.9	4.9	15.8	18.4	2.4	13.9	7.2	2.8	3.5	5.8	6.8	11.4	16.3	2.8	5.1	3.8	0.2	1.5	0.5	1.5	1.6	2.1	2.5	2.2	0.9	2.0	1.8	1.0	0.9	0.1	1.1	0.4	0.8	1.8	0.5	7.7	8.0	11.3	9.9	8.5	8.6	4.4	5.7	5.7	4.0	6.9	7.1	36.5	70.5	49.3	88.8	31.1	77.8	58.1	37.5	63.2	67.9	46.3	28.6	49.0	37.1	44.5	33.1	85.5	39.6	26.3	40.0	9.8	50.1	16.5	30.1	48.4	44.6	38.4	22.1	151.8	45.2	22.3	31.0	27.5	53.8	29.2	59.9	47.8	36.7	21.6	62.2	149.1	36.1	30.5	27.1	37.5	11.4	32.6	23.2	37.4	74.9	25.2	24.1	14.4	101.0	98.4	76.4	39.4	33.1	40.5	54.6	33.0	21.5	33.1	146.6	6.6	39.0	37.3	39.4	21.3	57.8	72.5	110.7	29.1	32.7	24.9	71.7
VGLL1	"TDU, TONDU"	ENSG00000102243	"Vestigial like family member 1"	Q99990	X	136532215-136556807	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"placenta: 203.9"	"Group enriched"	"Detected in some"	11	"Cytotrophoblasts: 1282.0;Extravillous trophoblasts: 582.3;Syncytiotrophoblasts: 1788.6"	"Group enriched"	"Detected in many"	4	"ovarian cancer: 13.7;urothelial cancer: 47.2"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 130.7;BEWO: 189.5;CAPAN-2: 72.7;RT4: 328.6;SK-BR-3: 328.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA042403, HPA064616"	Supported		Supported	Nucleoplasm		NA	NA				"Cluster 28: Placenta - Pregnancy"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 47: Cytotrophoblasts - Unknown function"	Nucleoplasm		"HPA042403: AB_2677980, HPA064616: AB_2685300"	"unprognostic (1.38e-1)"	"unprognostic (1.58e-1)"	"unprognostic (3.09e-1)"	"prognostic unfavorable (4.54e-4)"		"unprognostic (5.16e-2)"		"unprognostic (1.80e-1)"	"unprognostic (4.28e-1)"	"unprognostic (6.14e-3)"	"unprognostic (1.92e-3)"	"unprognostic (1.37e-2)"		"unprognostic (5.53e-2)"	"unprognostic (3.05e-1)"	"unprognostic (1.46e-2)"	"unprognostic (1.64e-2)"	0.6	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.1	0.1	0.0	0.0	0.2	0.1	0.4	1.5	1.3	0.6	0.1	0.0	0.0	6.6	0.1	2.1	0.0	0.0	0.0	0.1	1.5	0.0	1.4	203.9	0.0	1.4	0.0	0.0	5.1	6.7	0.0	0.2	0.2	0.0	0.0	0.1	0.9	0.1	0.1	0.2	0.0	0.0	1.1	22.7	1.6	0.0	130.7	0.0	0.0	0.1	0.0	0.0	189.5	0.0	0.0	0.0	0.0	18.1	72.7	0.0	0.0	0.0	0.0	5.9	0.0	7.5	0.0	0.0	0.3	0.0	0.2	0.3	0.0	0.0	0.1	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.8	0.3	0.4	0.1	2.1	0.0	0.1	0.0	0.1	0.0	328.6	0.2	0.2	0.0	328.7	0.3	13.2	5.6	0.4	0.0	0.0	0.1	0.2	0.4	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	22.4	0.0	0.0	0.0	0.0	2.3	1.7	0.0	0.0	4.9	1.8	0.2	0.0	16.6	36.8	0.0	1282.0	0.1	0.0	0.0	2.1	0.0	3.3	0.1	2.7	0.0	0.0	0.0	0.2	582.3	5.8	0.0	2.0	1.3	0.0	0.0	0.0	108.2	0.0	0.0	0.0	6.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.6	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	2.3	0.0	0.1	8.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	1788.6	0.0	0.0	0.0	30.5
VHL	VHL1	ENSG00000134086	"Von Hippel-Lindau tumor suppressor"	P40337	3	10141778-10153667	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Ubl conjugation pathway"		"Cancer-related genes, Congenital erythrocytosis, Disease variant, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"BEWO: 146.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031631, HPA031632, HPA068954"	Approved		Enhanced	Nucleoplasm,Cytosol		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 57: B-cells - Immune response"	Nucleoplasm	Cytosol	"HPA031631: AB_2673968, HPA031632: AB_2673969, HPA068954: "	"prognostic unfavorable (9.02e-5)"	"unprognostic (1.10e-1)"	"unprognostic (4.46e-3)"	"unprognostic (1.52e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.33e-1)"	"prognostic unfavorable (1.32e-5)"	"unprognostic (3.55e-1)"	"unprognostic (3.03e-2)"	"unprognostic (4.36e-2)"	"unprognostic (5.82e-3)"	"unprognostic (1.81e-2)"	"unprognostic (2.51e-1)"	"prognostic favorable (7.84e-4)"	"unprognostic (1.46e-1)"	"unprognostic (2.92e-2)"	"unprognostic (1.28e-3)"	14.0	13.7	11.5	21.1	11.0	27.9	14.7	13.6	12.1	11.8	6.7	14.8	15.7	14.1	9.8	12.3	13.4	11.5	7.9	11.8	14.9	12.6	14.1	11.8	29.6	9.4	9.4	12.6	12.7	11.7	9.0	14.1	9.3	14.0	15.7	8.9	14.5	10.2	11.4	14.2	17.2	12.8	9.6	22.5	16.0	13.4	16.6	23.4	15.8	7.7	29.7	12.5	10.9	12.5	19.5	18.2	39.9	24.6	36.0	27.7	146.5	16.8	24.0	21.1	24.5	21.5	23.7	67.9	22.2	23.0	29.9	16.4	37.2	23.6	25.7	33.0	33.7	52.7	30.5	30.6	34.3	47.3	41.3	28.1	26.3	28.0	35.1	28.4	24.6	42.5	48.3	50.3	21.1	35.0	45.5	40.9	26.7	21.1	23.4	57.3	34.6	34.6	25.5	48.7	15.0	49.4	35.0	18.7	21.0	23.9	37.0	59.1	21.3	20.8	27.7	19.6	26.8	35.7	78.1	105.6	23.2	55.3	19.4	4.6	3.2	2.3	2.6	2.2	1.9	2.5	1.8	2.2	2.0	3.3	1.7	1.8	5.6	3.0	2.0	2.3	1.7	1.2	11.5	11.0	13.6	12.1	11.8	14.9	9.4	9.4	9.3	9.6	16.6	12.5	12.4	12.8	12.5	9.1	38.7	14.7	17.8	14.3	24.5	14.7	10.7	6.1	6.1	20.0	9.6	16.5	18.8	16.8	21.9	10.7	7.9	11.8	9.6	13.1	26.1	14.8	14.4	30.5	15.9	5.1	18.7	12.8	20.9	19.9	5.1	18.4	18.9	14.3	14.9	18.5	14.2	11.3	16.2	27.1	45.8	7.3	14.0	32.3	12.4	7.5	31.9	9.1	28.8	12.1	14.9	10.7	11.7	11.3	33.3	23.8	12.3	9.5	9.7	15.3	6.6	17.4	11.9	15.4	24.0	26.7	20.5	17.2	23.5	21.4	10.2	25.9
VIM		ENSG00000026025	Vimentin	P08670	10	17228241-17237593	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction"		"Cataract, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Granulosa cells: 4879.0;Langerhans cells: 4893.1;Leydig cells: 5013.2;Muller glia cells: 8977.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 18287.8;fHDF/TERT166: 10084.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000080, HPA001762, CAB058687"	Enhanced		Supported	"Intermediate filaments"		NA	NA		35000000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 41: Macrophages - Immune response"	"Intermediate filaments"		"CAB000080: AB_2304493, CAB058687: AB_2665570, HPA001762: AB_1080568"	"unprognostic (1.02e-1)"	"unprognostic (2.58e-1)"	"unprognostic (2.87e-2)"	"prognostic favorable (9.75e-6)"	"unprognostic (3.81e-2)"	"unprognostic (2.52e-1)"	"unprognostic (3.21e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.05e-1)"	"unprognostic (9.29e-2)"	"unprognostic (5.61e-2)"	"prognostic unfavorable (8.69e-8)"	"unprognostic (1.87e-3)"	"unprognostic (7.32e-2)"	"unprognostic (1.82e-1)"	"unprognostic (9.47e-3)"	3467.6	423.1	349.3	610.6	369.5	1455.5	2362.8	289.1	527.4	1816.3	568.1	923.2	218.4	1226.5	400.0	451.5	1458.7	960.2	1364.3	337.5	404.6	473.6	192.8	1133.2	806.2	667.4	328.2	3690.8	370.0	224.8	574.5	1030.0	443.7	570.0	400.8	731.0	628.5	551.8	363.7	1126.8	674.7	1109.3	414.6	819.9	522.8	251.7	472.7	412.2	1391.1	555.8	744.7	983.5	1366.6	425.5	21.2	1119.0	1981.0	3180.7	6407.4	18287.8	3.0	5238.5	3458.9	3859.2	3421.5	8.5	70.4	2.9	273.2	10084.4	1804.7	8.4	283.8	147.0	3734.1	3567.5	387.2	563.2	523.5	0.3	1967.3	301.1	222.8	6746.8	6.5	5712.0	3213.4	9020.8	6366.3	372.4	889.3	1575.4	6939.5	4.5	736.6	911.2	632.4	1.4	1394.0	564.8	2745.9	95.7	3925.3	0.8	8.1	946.6	1.4	6.9	5447.5	1133.1	8.6	341.8	5459.0	3819.8	1644.5	3244.7	6311.5	1754.4	953.7	130.4	5775.4	28.9	3726.3	667.8	751.8	215.2	219.5	469.3	278.7	176.3	357.0	285.0	866.0	117.5	217.1	217.2	409.3	99.2	471.2	342.3	481.5	615.4	349.3	369.5	289.1	527.4	337.5	404.6	667.4	328.2	443.7	414.6	472.7	425.5	3211.7	157.0	349.4	53.5	605.8	725.8	21.6	361.2	58.1	74.2	108.8	539.1	109.5	94.4	157.3	108.5	50.1	22.1	1110.1	9.1	5.9	198.8	58.1	922.9	2314.1	2923.2	309.1	236.5	0.4	569.0	45.8	3443.0	101.4	693.7	2776.4	4879.0	2195.6	19.2	3541.4	33.7	0.3	1.8	16.2	2841.2	4893.1	131.6	5013.2	3177.8	3082.5	85.3	3893.1	8977.0	259.5	1.0	0.4	525.9	1.5	2336.6	2097.2	79.5	3.1	181.6	90.7	284.1	1420.0	3171.9	3714.2	55.1	27.5	39.4	473.0	52.7	1566.3	1791.1	6.2	28.9
VIRMA	"DKFZP434I116, fSAP121, KIAA1429"	ENSG00000164944	"Vir like m6A methyltransferase associated"	Q69YN4	8	94487689-94553529	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 26.4;Endometrial stromal cells: 32.2;Granulosa cells: 28.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031530	Approved		Supported	"Nucleoplasm,Nuclear bodies"		No	No			"Cluster 18: Basophils - Vesicular transport"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 7: Non-specific - Mitochondria"	"Nuclear bodies"	Nucleoplasm	"HPA031530: AB_10600818"	"unprognostic (2.51e-2)"	"unprognostic (7.41e-3)"	"unprognostic (3.43e-1)"	"unprognostic (3.83e-3)"	"unprognostic (1.83e-1)"	"unprognostic (7.83e-2)"	"unprognostic (7.54e-3)"	"unprognostic (1.98e-3)"	"unprognostic (1.27e-1)"	"unprognostic (2.77e-2)"	"unprognostic (3.50e-3)"	"unprognostic (1.74e-1)"	"prognostic unfavorable (7.90e-4)"	"unprognostic (2.48e-1)"	"unprognostic (1.68e-1)"	"unprognostic (3.82e-2)"	"unprognostic (9.87e-2)"	12.5	7.8	6.9	11.6	8.5	27.3	17.5	11.5	7.2	13.1	7.1	9.9	8.1	13.7	8.6	9.7	11.4	8.9	9.9	6.1	7.4	10.8	12.5	10.7	14.4	7.1	7.2	16.7	10.3	14.8	6.3	13.2	7.2	10.7	11.7	12.3	9.5	10.3	8.7	9.7	9.1	13.9	7.2	11.4	11.6	16.5	7.3	20.0	13.3	9.3	15.2	10.5	8.0	9.2	40.5	25.2	26.8	14.9	32.4	42.5	17.1	27.5	27.9	29.4	29.9	17.9	33.2	43.6	25.5	36.1	23.0	25.9	36.2	33.5	42.9	38.7	20.0	52.0	19.6	17.6	23.6	25.9	17.9	32.8	13.4	35.4	33.7	30.1	37.5	28.2	54.0	26.6	30.0	23.8	50.7	14.6	17.5	41.4	19.1	29.9	24.4	24.3	19.1	27.6	20.9	28.9	21.6	5.5	23.8	26.3	31.2	20.7	37.3	26.9	15.9	23.1	25.7	20.8	27.8	51.0	26.4	33.7	26.2	14.2	5.0	8.7	6.7	6.4	10.7	6.6	7.4	9.1	5.2	5.0	9.0	7.9	6.0	9.5	13.8	3.3	6.9	5.8	6.9	8.5	11.5	7.2	6.1	7.4	7.1	7.2	7.2	7.2	7.3	9.2	24.2	25.6	21.5	0.0	6.3	0.0	0.0	0.0	0.0	0.0	16.9	16.4	0.0	0.0	14.9	7.3	0.0	26.4	20.0	0.0	7.9	14.4	0.0	23.8	32.2	9.8	0.0	0.0	0.0	12.2	23.7	10.6	0.0	22.4	5.1	28.5	0.0	0.0	13.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.0	0.0	0.0	4.6	0.0	0.0	0.0	0.0	14.7	0.0	0.0	5.2	0.0	0.0	6.9	8.7	0.0	0.0	0.0	11.6	0.0	0.0	0.0	0.0	16.8	9.9	25.0	0.0	0.0
VKORC1	VKCFD2	ENSG00000167397	"Vitamin K epoxide reductase complex subunit 1"	Q9BQB6	16	31090842-31095980	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		Oxidoreductase	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 454.9"	"Cell type enhanced"	"Detected in all"		"Hepatocytes: 749.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"ASC diff: 638.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042720	Approved		Supported	"Endoplasmic reticulum"	"Intracellular and membrane"	NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 85: Liver - Metabolism"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 2: Hepatocytes - Metabolism"	"Endoplasmic reticulum"		"HPA042720: AB_10961864"	"unprognostic (5.99e-2)"	"unprognostic (2.98e-1)"	"unprognostic (7.11e-3)"	"unprognostic (7.68e-3)"	"unprognostic (5.49e-2)"	"unprognostic (3.23e-3)"	"unprognostic (3.02e-2)"	"unprognostic (2.32e-2)"	"unprognostic (2.42e-1)"	"unprognostic (2.66e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.19e-1)"	"prognostic unfavorable (2.09e-10)"	"unprognostic (1.11e-2)"	"unprognostic (6.65e-2)"	"unprognostic (3.12e-2)"	"unprognostic (9.66e-2)"	99.4	107.6	56.0	38.4	60.4	55.2	87.0	60.3	73.5	111.0	64.9	97.0	44.2	109.9	87.2	51.8	90.8	58.9	99.1	57.4	59.3	122.7	454.9	77.4	35.8	64.4	59.5	115.1	168.0	51.3	115.7	45.6	63.8	76.3	41.1	23.0	92.4	69.8	34.4	81.1	82.3	84.7	59.9	62.2	88.1	55.6	68.5	35.0	76.3	32.2	32.6	100.6	88.0	64.8	73.6	187.7	57.2	165.4	638.0	389.6	68.2	269.0	229.3	128.9	218.5	79.0	83.3	54.9	141.6	331.6	87.2	66.2	79.4	103.5	139.5	81.9	204.8	52.5	239.9	378.2	103.1	104.1	74.1	225.0	54.2	173.4	146.6	336.8	141.0	78.2	70.3	130.6	253.6	271.1	74.4	205.9	106.8	98.0	175.9	132.7	160.3	286.8	127.7	61.8	119.5	146.9	118.7	84.2	137.8	91.2	138.3	123.9	126.8	171.1	61.5	159.6	101.9	76.1	80.2	50.7	445.8	174.5	90.8	77.0	127.5	196.2	118.1	94.7	116.8	91.7	116.7	119.4	127.6	102.6	102.9	101.4	104.0	84.2	98.2	157.4	143.1	112.8	56.0	60.4	60.3	73.5	57.4	59.3	64.4	59.5	63.8	59.9	68.5	64.8	95.1	57.7	51.0	5.9	30.6	84.6	68.0	157.0	10.8	12.3	93.3	117.3	20.9	141.5	64.3	108.5	8.4	85.7	48.1	34.3	62.6	204.2	6.1	25.8	83.7	89.5	67.1	32.4	8.8	129.4	293.6	132.8	10.7	48.8	55.3	60.3	118.9	749.9	184.1	10.1	7.5	44.2	46.8	80.1	94.3	13.9	158.1	66.9	115.6	5.6	107.4	68.8	51.5	6.6	17.6	103.8	28.2	172.3	29.5	59.5	152.9	204.6	33.4	19.3	59.2	78.4	99.8	30.6	34.2	10.7	112.0	39.5	39.7	82.4	49.0	55.2
VKORC1L1		ENSG00000196715	"Vitamin K epoxide reductase complex subunit 1 like 1"	Q8N0U8	7	65873074-65959563	"Enzymes, FDA approved drug targets, Predicted membrane proteins"		Oxidoreductase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053954	Approved		Supported	"Endoplasmic reticulum"		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 44: Endometrium - Transcription"	"Endoplasmic reticulum"		"HPA053954: AB_2682319"	"unprognostic (3.01e-1)"	"unprognostic (1.76e-3)"	"unprognostic (4.64e-2)"	"unprognostic (4.65e-2)"	"unprognostic (3.00e-3)"	"unprognostic (7.15e-3)"	"unprognostic (1.30e-3)"	"unprognostic (8.84e-3)"	"unprognostic (5.12e-2)"	"unprognostic (5.59e-2)"	"unprognostic (9.23e-3)"	"unprognostic (1.07e-1)"	"unprognostic (1.59e-2)"	"unprognostic (1.17e-1)"	"unprognostic (7.03e-3)"	"unprognostic (4.30e-1)"	"unprognostic (5.06e-2)"	54.0	11.1	8.1	11.2	9.0	4.3	23.7	8.3	12.1	12.0	3.7	12.4	11.1	12.3	10.6	12.5	10.0	10.0	12.1	10.1	9.2	10.0	22.9	18.4	8.7	18.1	10.5	17.3	9.7	33.6	6.7	12.0	10.5	12.0	12.5	11.5	10.9	12.4	21.6	12.8	11.6	11.6	8.9	7.4	12.8	9.1	8.5	9.7	13.9	15.3	8.7	11.9	9.6	9.6	46.8	29.5	23.4	29.5	72.6	28.6	42.3	49.5	31.8	29.0	29.1	28.7	44.9	40.4	39.0	35.7	43.9	31.2	33.6	20.1	47.9	25.5	33.1	27.6	25.4	24.7	35.4	38.7	20.3	23.2	25.3	29.5	40.7	22.5	29.2	22.6	59.0	30.0	34.9	18.3	31.8	44.8	56.1	43.8	22.0	34.5	34.0	50.5	28.0	18.5	28.0	39.8	38.3	68.5	21.8	32.8	34.5	29.5	33.3	46.6	32.0	29.5	51.0	26.9	47.1	46.1	28.6	43.0	41.6	2.0	1.1	2.7	1.2	1.1	1.0	1.3	1.5	1.4	1.3	1.1	0.9	0.9	1.3	2.9	2.2	3.5	1.5	0.7	8.1	9.0	8.3	12.1	10.1	9.2	18.1	10.5	10.5	8.9	8.5	9.6	19.5	73.7	41.7	16.6	5.5	24.9	18.6	16.2	9.6	21.8	18.6	15.9	21.5	27.1	24.2	16.5	12.5	12.5	10.0	27.1	5.9	18.1	39.0	13.7	23.8	17.1	13.8	26.1	42.7	24.8	21.2	22.6	19.4	25.3	5.1	24.1	10.8	46.9	16.0	30.3	36.6	26.4	20.3	6.6	10.2	9.1	17.7	12.9	7.2	28.1	10.0	11.6	7.2	26.7	34.6	31.6	8.2	18.4	15.6	36.3	14.4	11.4	11.7	20.2	6.6	24.9	26.4	18.5	7.2	17.9	32.0	8.8	6.6	10.8	20.3	22.6
VMP1	"EPG3, TANGO5, TMEM49"	ENSG00000062716	"Vacuole membrane protein 1"	Q96GC9	17	59707192-59842255	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Autophagy, Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Basal prostatic cells: 984.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in all"	4	"neutrophil: 3000.2"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 3000.2"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030773, HPA064780"	Approved		Approved	"Nucleoli,Endoplasmic reticulum"		NA	NA			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 21: OE19 - Mitochondria"	"Cluster 22: Epithelial cell types - Mixed function"	"Endoplasmic reticulum"	Nucleoli	"HPA030773: AB_10602248, HPA064780: AB_2685348"	"unprognostic (2.29e-1)"	"unprognostic (2.32e-1)"	"unprognostic (4.09e-2)"	"prognostic unfavorable (1.56e-5)"	"unprognostic (3.14e-2)"	"unprognostic (3.17e-1)"	"prognostic unfavorable (8.02e-4)"	"unprognostic (1.39e-1)"	"unprognostic (2.41e-1)"	"unprognostic (2.98e-1)"	"unprognostic (8.43e-2)"	"unprognostic (4.21e-2)"	"prognostic unfavorable (2.77e-8)"	"unprognostic (1.88e-1)"	"unprognostic (1.11e-2)"	"unprognostic (1.14e-2)"	"unprognostic (7.96e-3)"	36.7	47.2	23.1	56.2	29.1	22.8	36.6	15.9	32.7	30.3	5.4	58.6	56.0	32.4	23.2	33.0	16.0	59.8	22.0	17.1	23.7	36.6	58.5	29.6	31.4	29.1	24.9	22.9	30.8	38.4	10.4	39.2	27.3	34.0	59.8	30.2	23.5	23.1	19.9	19.5	60.4	33.9	24.5	52.5	47.6	22.3	35.8	22.3	32.5	28.9	20.7	47.9	16.4	38.0	65.8	128.2	43.8	82.2	88.3	54.8	77.3	87.4	87.4	64.3	98.0	85.1	166.1	42.2	143.9	70.6	81.5	79.8	62.4	59.5	80.5	102.7	80.9	55.5	89.2	97.3	89.6	68.5	51.4	77.4	46.7	87.3	76.2	93.2	67.6	41.3	69.8	70.2	68.7	177.9	66.7	21.9	63.0	146.6	75.3	41.8	79.8	101.1	92.5	72.1	36.4	89.1	57.5	62.4	83.8	62.6	124.4	49.0	89.8	81.3	75.0	68.8	83.6	105.4	145.0	66.8	84.4	37.6	92.8	131.6	570.4	76.0	62.8	393.0	69.2	56.6	59.3	65.4	174.3	49.5	53.9	60.5	3000.2	69.0	666.9	59.2	73.9	501.6	23.1	29.1	15.9	32.7	17.1	23.7	29.1	24.9	27.3	24.5	35.8	38.0	164.8	89.8	124.1	35.3	68.6	161.1	984.4	188.9	665.9	36.1	429.1	187.1	27.9	125.8	273.3	275.8	58.4	91.7	71.0	511.1	23.5	223.1	7.2	372.8	197.7	148.2	310.6	29.9	80.1	137.9	123.5	193.6	367.0	708.6	135.4	111.2	48.2	108.4	121.7	28.6	84.6	254.1	168.9	335.2	270.7	11.5	35.8	322.6	129.9	45.0	231.1	50.4	51.5	51.8	141.2	160.7	508.1	35.3	92.5	553.1	361.1	72.6	289.7	51.6	92.1	59.2	293.5	83.6	44.6	672.6	129.7	175.8	127.3	67.5	241.7	629.2
VPS25	"DERP9, EAP20, MGC10540"	ENSG00000131475	"Vacuolar protein sorting 25 homolog"	Q9BRG1	17	42773449-42779599	"Predicted intracellular proteins"	"Protein transport, Transcription, Transcription regulation, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004978, HPA021992, HPA052217, HPA057284"	Uncertain		Supported	Vesicles		NA	Yes			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 37: Intestine - Unknown function"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 10: Non-specific - Unknown function"	Vesicles		"CAB004978: AB_426095, HPA021992: , HPA052217: AB_2681765, HPA057284: AB_2683397"	"unprognostic (3.63e-2)"	"unprognostic (1.47e-1)"	"prognostic favorable (3.18e-4)"	"unprognostic (7.37e-2)"	"unprognostic (7.57e-2)"	"unprognostic (9.83e-3)"	"unprognostic (2.76e-3)"	"unprognostic (5.84e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.90e-1)"	"unprognostic (8.10e-3)"	"unprognostic (3.88e-1)"	"unprognostic (2.39e-3)"	"unprognostic (1.15e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.91e-2)"	36.6	40.3	32.8	32.5	33.0	44.3	53.3	34.8	36.8	41.6	36.6	61.9	53.8	35.5	65.3	91.4	58.9	33.4	43.5	32.9	33.2	70.1	68.6	31.8	37.8	32.9	32.8	33.2	49.0	72.3	27.6	46.7	33.5	40.2	68.4	31.2	48.7	36.5	51.3	50.5	45.4	42.8	33.5	37.1	50.0	27.4	33.8	51.3	40.9	41.3	57.2	44.8	44.3	34.0	67.2	136.6	101.8	62.1	126.9	86.5	94.5	83.0	117.1	167.5	116.3	117.9	77.0	66.8	135.8	122.0	88.5	68.7	142.2	181.8	107.9	61.2	178.7	50.6	87.0	177.5	131.0	95.7	64.6	118.2	115.4	148.9	158.0	99.1	106.7	79.0	175.6	65.5	102.1	96.5	138.8	105.2	78.9	152.0	95.3	51.1	123.3	108.7	202.6	75.8	86.3	66.7	46.8	60.1	129.6	155.8	138.4	100.2	58.0	105.7	68.4	60.0	90.3	64.0	39.4	97.9	92.7	64.5	79.6	85.1	76.9	106.7	38.8	89.0	39.9	48.8	42.4	46.4	80.3	46.6	42.3	40.7	44.9	78.9	82.7	54.1	43.1	59.6	32.8	33.0	34.8	36.8	32.9	33.2	32.9	32.8	33.5	33.5	33.8	34.0	26.3	25.6	36.3	4.2	25.3	13.9	41.0	88.3	16.5	24.1	44.4	46.6	26.9	51.5	65.7	62.5	14.6	136.1	22.0	74.3	133.1	135.9	2.6	61.8	48.5	35.4	41.0	47.9	3.5	152.4	186.5	40.8	40.8	55.9	29.2	21.5	29.6	46.4	102.3	23.5	3.5	70.5	85.5	34.5	12.7	5.6	27.7	33.0	42.7	0.0	46.7	56.1	44.3	2.5	4.7	134.4	75.7	30.5	40.9	44.4	83.5	93.6	74.9	29.5	32.9	13.5	69.9	42.8	46.7	61.9	22.9	121.6	22.8	69.9	63.4	53.5
VPS26A	"Hbeta58, PEP8A, VPS26"	ENSG00000122958	"VPS26, retromer complex component A"	O75436	10	69123512-69174412	"Plasma proteins, Predicted intracellular proteins, Transporters"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Syncytiotrophoblasts: 243.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011602, HPA057498, CAB075733"	Supported		Enhanced	Endosomes,Lysosomes		NA	NA		41000	"Cluster 7: Monocytes - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	"Endosomes, Lysosomes"		"CAB011602: AB_2215043, CAB075733: AB_2665739, HPA057498: AB_2683448"	"unprognostic (1.17e-2)"	"unprognostic (6.94e-2)"	"unprognostic (5.58e-2)"	"unprognostic (9.35e-2)"	"unprognostic (5.95e-2)"	"prognostic unfavorable (1.72e-4)"	"prognostic unfavorable (1.70e-6)"	"unprognostic (1.17e-1)"	"unprognostic (1.35e-1)"	"unprognostic (7.88e-2)"	"prognostic unfavorable (9.18e-6)"	"unprognostic (4.63e-2)"	"unprognostic (2.15e-2)"	"unprognostic (7.14e-2)"	"unprognostic (6.68e-2)"	"unprognostic (4.33e-2)"	"unprognostic (1.72e-1)"	37.0	27.1	23.6	24.4	25.9	36.2	32.9	27.6	32.3	26.9	23.7	32.1	24.8	26.8	22.1	41.7	22.7	22.7	22.0	24.3	25.9	34.0	30.4	27.5	23.3	26.0	25.9	25.8	23.8	38.1	12.0	39.9	25.6	24.6	32.3	19.6	26.1	20.9	33.4	37.3	25.5	25.7	26.7	23.1	24.1	42.7	24.9	27.8	29.9	31.3	27.9	33.0	29.9	29.0	113.1	42.5	51.7	87.1	80.8	73.8	46.1	66.3	106.0	79.7	90.1	91.8	110.9	34.3	53.1	72.3	78.2	75.9	73.1	63.5	108.5	31.3	38.7	54.0	36.7	52.2	104.9	80.6	39.4	66.3	90.8	79.8	161.5	99.8	81.9	40.8	104.7	46.0	119.2	35.8	35.8	86.4	34.0	51.9	97.9	44.2	85.0	40.4	86.6	68.3	30.5	45.5	89.3	119.5	117.6	44.5	50.3	62.9	97.9	53.0	69.7	91.7	83.8	28.0	74.4	57.4	71.2	123.6	27.8	54.6	39.6	38.6	40.8	46.6	37.4	26.3	30.7	42.2	44.8	20.0	26.7	37.7	38.1	54.6	40.9	17.7	38.3	44.4	23.6	25.9	27.6	32.3	24.3	25.9	26.0	25.9	25.6	26.7	24.9	29.0	49.0	73.7	56.6	21.5	40.6	120.7	83.4	79.6	60.3	24.4	43.0	34.8	44.2	40.0	75.2	40.5	14.6	117.1	59.2	47.3	80.3	69.3	59.4	29.8	42.2	52.7	16.2	58.3	29.4	53.4	87.8	57.4	30.5	42.0	45.5	32.4	35.3	29.4	85.8	20.2	30.3	38.3	85.5	53.2	108.7	29.6	42.3	66.0	62.2	28.1	62.4	63.2	52.5	21.6	39.8	65.7	43.3	44.8	28.2	65.2	30.5	80.6	45.5	27.4	13.1	48.0	61.9	89.3	73.7	57.5	107.0	243.7	59.5	38.2	44.4	77.6
VPS29	"DC15, DC7, PEP11"	ENSG00000111237	"VPS29 retromer complex component"	Q9UBQ0	12	110491083-110502111	"Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Transporters"	"Host-virus interaction, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039748	Uncertain		Supported	Vesicles,Cytosol		NA	NA		110000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 24: NB-4 - Immune response"	"Cluster 10: Non-specific - Unknown function"	"Vesicles, Cytosol"		"HPA039748: AB_10674426"	"unprognostic (9.46e-2)"	"unprognostic (3.46e-3)"	"unprognostic (2.16e-2)"	"unprognostic (2.58e-1)"	"unprognostic (3.08e-1)"	"unprognostic (2.26e-2)"	"prognostic unfavorable (2.79e-5)"	"unprognostic (1.52e-1)"	"unprognostic (3.37e-2)"	"prognostic favorable (7.70e-4)"	"unprognostic (1.64e-1)"	"unprognostic (2.10e-3)"	"unprognostic (2.96e-1)"	"unprognostic (2.04e-2)"	"unprognostic (2.11e-1)"	"unprognostic (5.57e-2)"	"unprognostic (4.29e-3)"	61.1	62.7	45.6	57.0	47.0	96.2	59.2	46.2	61.8	50.3	47.0	76.4	64.1	52.9	89.5	71.1	50.3	51.1	73.8	48.7	48.3	79.2	77.6	54.9	69.7	47.2	46.3	47.1	56.6	54.8	53.7	47.3	47.4	62.7	79.0	99.6	58.5	71.3	127.3	46.8	65.7	67.1	48.0	76.5	62.8	32.6	46.1	63.2	54.1	100.8	72.0	65.1	50.6	51.1	103.5	98.6	91.9	65.6	100.4	98.7	72.6	94.9	98.1	93.9	84.2	100.0	87.0	94.0	97.1	94.3	87.7	95.5	123.1	88.0	97.0	112.2	98.9	115.4	122.6	83.0	87.4	139.5	97.1	66.0	73.3	79.3	87.4	114.1	166.0	116.6	112.1	85.5	170.0	51.9	110.3	196.4	52.6	90.9	124.8	72.2	93.5	131.8	157.0	149.7	98.1	51.8	107.9	94.0	122.8	78.5	128.6	106.0	94.0	80.6	53.4	112.9	113.0	58.0	87.5	112.1	93.9	130.8	87.8	246.2	262.7	259.4	139.1	356.8	155.3	195.9	175.5	164.9	318.3	158.7	159.8	156.8	178.7	202.9	405.4	214.0	224.8	385.1	45.6	47.0	46.2	61.8	48.7	48.3	47.2	46.3	47.4	48.0	46.1	51.1	138.8	76.9	96.2	21.2	93.7	143.5	172.6	395.9	70.6	39.0	93.4	109.2	282.4	90.1	209.7	101.2	27.1	192.8	116.5	156.3	289.5	231.0	56.8	94.7	79.8	125.0	83.2	147.5	30.2	179.8	187.6	120.2	60.1	104.1	153.9	78.1	94.9	158.7	409.9	42.1	26.7	149.8	248.2	158.0	296.1	82.6	92.2	178.7	177.9	30.9	295.2	107.9	101.0	22.6	30.4	217.9	182.2	105.7	94.8	157.4	142.2	404.7	131.1	111.8	157.8	81.9	212.1	256.4	148.4	108.3	173.0	178.8	111.2	105.8	164.5	187.7
VPS35	"FLJ10752, MEM3, PARK17"	ENSG00000069329	"VPS35 retromer complex component"	Q96QK1	16	46656132-46689518	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Host-virus interaction, Protein transport, Transport"		"Neurodegeneration, Parkinson disease, Parkinsonism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040802	Supported		Supported	Endosomes,Lysosomes		NA	NA		500000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 40: Granulosa cells - Unknown function"	"Endosomes, Lysosomes"		"HPA040802: AB_2677142"	"unprognostic (1.11e-2)"	"unprognostic (8.70e-2)"	"prognostic favorable (7.74e-4)"	"unprognostic (4.75e-2)"	"unprognostic (1.90e-1)"	"unprognostic (5.67e-3)"	"prognostic unfavorable (2.10e-6)"	"unprognostic (5.32e-2)"	"unprognostic (1.49e-1)"	"unprognostic (2.29e-2)"	"unprognostic (3.33e-3)"	"unprognostic (2.49e-1)"	"prognostic favorable (9.75e-5)"	"unprognostic (3.68e-3)"	"unprognostic (2.43e-1)"	"unprognostic (1.34e-1)"	"unprognostic (6.89e-3)"	5.4	4.2	2.9	3.0	3.0	9.5	4.6	2.6	3.2	4.2	2.8	4.2	1.9	4.3	1.9	4.7	4.0	1.4	6.1	3.0	2.5	3.7	1.7	4.1	2.9	3.0	2.4	4.7	4.4	5.2	3.3	2.1	3.2	3.0	1.8	4.1	4.5	2.4	4.6	6.1	4.9	1.7	2.1	4.2	4.5	2.7	2.8	3.9	2.7	2.7	1.8	4.5	4.2	3.4	3.2	5.0	4.1	2.8	6.5	7.3	2.1	3.8	5.4	6.4	3.7	4.3	2.7	4.2	2.3	6.5	3.3	3.9	7.5	7.5	9.1	1.6	6.4	3.9	3.8	3.0	5.4	5.2	5.8	5.8	5.5	7.3	4.5	6.3	6.6	6.0	3.1	1.8	6.5	2.9	4.0	5.0	1.4	3.0	6.6	5.4	5.4	5.2	5.2	4.4	1.8	2.1	4.1	3.2	1.8	4.5	1.9	2.6	3.9	1.9	1.9	4.3	2.7	2.3	3.2	4.9	3.4	4.0	1.3	1.8	1.3	1.3	0.7	1.7	0.7	0.8	0.7	0.6	1.5	1.0	1.0	0.7	1.5	0.8	2.3	0.6	1.1	1.1	2.9	3.0	2.6	3.2	3.0	2.5	3.0	2.4	3.2	2.1	2.8	3.4	65.9	51.3	59.4	20.5	84.3	72.5	80.0	98.6	72.8	56.5	77.9	75.9	102.9	57.2	83.4	68.0	60.5	134.5	44.9	65.9	54.8	111.7	111.2	136.4	92.3	63.3	80.8	52.6	43.1	72.5	102.2	70.1	88.7	88.4	72.2	211.1	54.7	40.2	123.4	45.4	42.5	79.7	107.8	108.3	87.9	32.4	77.9	113.6	46.2	30.0	153.0	71.4	45.3	28.6	31.3	101.1	101.9	72.2	41.7	77.0	164.6	103.7	188.9	82.6	46.0	57.5	88.9	207.9	118.0	101.5	87.7	113.1	51.5	95.9	97.6	84.5
VPS36	"C13orf9, CGI-145, Eap45"	ENSG00000136100	"Vacuolar protein sorting 36 homolog"	Q86VN1	13	52412602-52450634	"Predicted intracellular proteins"	"Protein transport, Transcription, Transcription regulation, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Rod photoreceptor cells: 265.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039734, HPA043947"	Approved		Supported	"Vesicles,Lysosomes,Plasma membrane,Cell Junctions"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 31: Skin - Epidermis development"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 46: Photoreceptor cells - Phototransduction"	"Vesicles, Lysosomes"	"Plasma membrane, Cell Junctions"	"HPA039734: AB_2676652, HPA043947: AB_2678744"	"unprognostic (2.43e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.80e-1)"	"unprognostic (2.94e-1)"	"unprognostic (1.56e-1)"	"unprognostic (2.32e-1)"	"unprognostic (6.57e-2)"	"unprognostic (7.84e-2)"	"unprognostic (3.96e-3)"	"unprognostic (1.19e-2)"	"unprognostic (9.37e-2)"	"unprognostic (5.57e-2)"	"prognostic favorable (9.91e-6)"	"unprognostic (6.47e-3)"	"unprognostic (1.83e-1)"	"unprognostic (1.94e-1)"	"unprognostic (9.83e-2)"	17.1	15.1	10.1	16.8	11.5	8.6	26.1	14.0	16.3	20.0	9.6	24.5	27.6	18.7	12.2	23.7	16.8	16.6	24.0	11.8	10.1	25.4	23.6	19.9	19.5	12.4	11.0	17.9	17.9	23.3	11.0	25.0	12.8	21.8	27.5	43.1	25.2	18.3	23.4	51.1	27.7	20.7	9.9	24.1	18.1	4.0	12.1	22.3	22.5	26.2	20.7	18.9	21.3	12.1	7.3	11.8	20.4	13.5	21.1	29.3	17.8	16.7	12.5	16.1	9.6	14.3	22.9	25.5	8.6	23.8	10.6	20.1	16.6	19.7	18.0	19.3	16.0	30.2	18.7	12.8	25.3	40.2	31.4	20.5	37.9	11.2	18.0	18.0	16.6	33.6	22.7	21.8	31.8	9.6	30.4	40.6	19.5	29.0	6.3	31.0	11.9	15.9	28.7	18.9	10.4	22.0	11.9	27.3	25.9	24.0	15.9	67.1	26.3	10.3	12.6	10.3	19.1	16.3	22.0	26.8	10.6	28.4	24.7	15.6	14.6	12.3	12.3	16.3	19.8	15.3	13.5	15.4	15.6	13.0	12.2	13.1	3.6	21.6	22.7	16.3	16.0	13.7	10.1	11.5	14.0	16.3	11.8	10.1	12.4	11.0	12.8	9.9	12.1	12.1	54.2	83.3	51.5	41.1	49.9	42.8	48.9	57.6	62.0	132.2	51.6	72.8	80.8	38.6	47.7	33.1	120.9	60.2	83.4	62.6	68.4	35.4	1.2	28.0	45.9	55.7	49.8	31.1	57.0	29.3	43.0	46.6	36.7	37.0	44.3	44.9	38.2	54.0	43.8	52.2	54.6	64.1	40.7	44.0	29.1	3.7	49.7	47.1	28.4	36.5	60.8	39.8	59.8	44.7	40.7	29.8	63.0	52.3	55.0	65.4	77.4	78.5	33.2	265.8	46.0	52.7	76.1	15.3	25.9	83.5	58.2	38.2	48.2	40.6	58.6	45.4
VPS4A	"FLJ22197, SKD1, SKD1A, SKD2, VPS4, VPS4-1"	ENSG00000132612	"Vacuolar protein sorting 4 homolog A"	Q9UN37	16	69311350-69326939	"Enzymes, Predicted intracellular proteins"	"Cell cycle, Cell division, Protein transport, Transport"	Hydrolase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"CAB018751, CAB034411, HPA060092"	Approved		Supported	Midbody		Yes	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Midbody		"CAB018751: AB_2215497, CAB034411: AB_2304400, HPA060092: AB_2684203"	"unprognostic (2.60e-2)"	"unprognostic (2.32e-2)"	"unprognostic (1.26e-1)"	"unprognostic (9.26e-2)"	"unprognostic (4.03e-1)"	"unprognostic (1.20e-1)"	"unprognostic (2.55e-2)"	"unprognostic (2.70e-2)"	"unprognostic (4.63e-2)"	"unprognostic (8.61e-2)"	"unprognostic (3.91e-3)"	"unprognostic (2.19e-1)"	"prognostic favorable (1.76e-4)"	"unprognostic (5.44e-2)"	"unprognostic (1.46e-1)"	"unprognostic (2.61e-1)"	"unprognostic (6.79e-2)"	13.2	15.3	15.7	8.9	16.9	8.8	12.8	16.1	17.1	10.4	11.0	13.5	13.5	11.7	8.1	16.0	10.3	9.4	20.6	15.5	14.9	18.0	11.6	9.9	11.8	16.4	16.8	12.2	27.8	20.6	7.6	10.0	16.7	10.4	7.6	10.2	19.9	8.4	54.0	15.3	12.8	8.4	15.4	9.2	17.6	6.8	16.7	6.2	16.7	33.6	7.3	11.4	11.3	18.2	21.1	34.9	23.2	30.7	21.2	18.8	20.5	27.9	25.2	36.4	24.3	33.4	19.0	35.0	27.3	28.0	17.5	30.3	23.9	28.2	21.8	14.8	30.8	22.0	20.7	26.3	32.6	27.5	19.6	21.7	36.3	31.6	28.7	21.4	27.4	27.3	37.0	10.3	27.2	46.8	36.4	20.5	26.7	20.6	24.5	47.8	19.0	41.3	18.5	16.8	39.1	24.7	59.3	18.1	21.4	15.4	31.4	20.6	32.8	33.2	20.8	30.4	22.1	36.9	31.3	62.6	30.4	18.2	37.1	8.8	9.9	13.3	11.2	8.7	10.0	8.5	9.3	13.9	9.4	7.4	10.5	9.9	7.5	8.0	11.5	5.5	11.8	13.8	15.7	16.9	16.1	17.1	15.5	14.9	16.4	16.8	16.7	15.4	16.7	18.2	39.8	25.6	19.0	14.7	33.8	30.7	37.3	22.2	22.8	51.4	30.2	28.2	31.0	22.8	16.7	23.9	22.9	59.8	48.4	48.9	74.3	51.7	11.2	14.9	27.0	34.9	31.3	43.6	14.5	82.5	66.5	32.9	29.0	25.6	29.2	36.3	31.8	21.6	45.1	74.0	14.9	34.2	20.3	33.7	24.6	11.9	29.5	30.2	44.4	5.6	40.9	66.0	38.1	4.5	16.8	67.4	42.2	30.5	31.9	67.6	76.4	57.7	6.4	41.8	52.6	36.0	38.9	28.7	38.3	27.1	31.3	70.1	35.6	26.0	41.4	41.2
VPS53	"FLJ10979, HCCS1"	ENSG00000141252	"VPS53 subunit of GARP complex"	Q5VIR6	17	508503-721717	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Protein transport, Transport"		"Disease variant, Epilepsy, Mental retardation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 270.0;Late spermatids: 203.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022988, HPA024446"	Approved		Supported	"Golgi apparatus,Vesicles,Cytosol"		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 29: Early spermatids - Spermatogenesis"	"Golgi apparatus, Vesicles"	Cytosol	"HPA022988: AB_1848679, HPA024446: AB_1848680"	"unprognostic (8.62e-3)"	"unprognostic (7.98e-2)"	"unprognostic (2.09e-1)"	"prognostic favorable (1.08e-5)"	"unprognostic (1.39e-2)"	"unprognostic (9.08e-3)"	"unprognostic (3.12e-1)"	"unprognostic (9.67e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.72e-1)"	"prognostic favorable (1.56e-5)"	"unprognostic (1.53e-2)"	"unprognostic (1.82e-2)"	"unprognostic (1.89e-2)"	"unprognostic (2.81e-1)"	"unprognostic (4.82e-2)"	"unprognostic (1.31e-1)"	4.3	4.7	7.0	3.0	5.9	20.5	4.6	21.4	10.3	5.2	2.8	4.5	3.7	4.4	3.4	9.0	4.0	3.6	4.3	8.2	3.3	4.0	4.5	5.1	4.9	3.0	3.9	5.3	4.5	6.4	6.0	4.6	4.2	4.6	5.9	8.1	4.7	5.0	7.0	7.1	4.0	6.1	0.9	4.5	5.0	14.6	4.0	4.9	7.6	5.1	5.2	4.1	4.8	9.4	12.9	26.5	7.6	8.3	12.4	9.5	5.5	6.4	9.4	15.8	15.4	12.6	5.8	7.8	5.9	19.9	10.0	10.9	16.5	13.9	23.1	6.7	11.4	5.0	17.2	8.1	6.1	6.6	9.2	11.1	7.8	14.7	9.8	6.4	11.7	9.7	9.1	9.1	14.9	8.9	4.3	5.1	6.2	5.6	6.9	10.5	3.9	5.2	8.0	10.4	7.6	6.1	12.4	4.3	5.4	7.5	6.5	3.5	7.9	6.8	5.4	12.5	7.0	4.3	3.3	4.8	11.5	5.2	8.6	8.1	1.9	4.4	2.4	2.3	1.8	2.1	2.2	1.7	1.1	3.0	2.3	1.9	6.1	1.9	5.6	3.0	1.9	0.9	7.0	5.9	21.4	10.3	8.2	3.3	3.0	3.9	4.2	0.9	4.0	9.4	16.0	12.8	25.9	54.5	19.3	25.5	16.5	11.6	19.9	53.3	19.6	9.3	17.4	14.3	21.5	40.5	70.9	10.5	19.9	24.9	1.9	16.7	270.0	23.9	22.2	18.7	24.6	5.0	109.3	18.3	7.9	18.5	26.5	28.1	24.1	18.2	15.7	17.7	21.4	63.9	103.6	27.4	4.1	20.6	19.4	203.9	18.6	21.0	10.6	39.4	27.5	18.3	37.0	48.2	62.5	25.3	15.5	23.0	20.6	18.7	21.0	10.6	24.3	52.2	6.6	31.1	20.7	46.0	35.3	24.6	38.8	8.9	26.8	17.2	22.0	19.6
VRK1		ENSG00000100749	"VRK serine/threonine kinase 1"	Q99986	14	96797304-96954846	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Cell cycle, Cell division, Mitosis"	"Kinase, Serine/threonine-protein kinase, Transferase"	Neurodegeneration	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 50.4;testis: 37.1"	"Cell type enhanced"	"Detected in all"		"Spermatocytes: 198.9;Spermatogonia: 110.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000660, HPA017929"	Enhanced		Supported	Nucleoplasm,Cytosol		Yes	No			"Cluster 15: NK-cells - Transcription"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	Cytosol	"HPA000660: AB_1080579, HPA017929: AB_1858770"	"unprognostic (1.03e-1)"	"unprognostic (1.17e-2)"	"unprognostic (1.84e-2)"	"unprognostic (2.24e-3)"	"unprognostic (5.42e-2)"	"unprognostic (1.19e-2)"	"prognostic unfavorable (4.15e-4)"	"unprognostic (4.20e-2)"	"unprognostic (2.11e-2)"	"unprognostic (5.47e-2)"	"unprognostic (5.14e-2)"	"unprognostic (1.60e-1)"	"unprognostic (2.53e-2)"	"unprognostic (6.70e-2)"	"unprognostic (4.56e-2)"	"unprognostic (3.36e-2)"	"unprognostic (1.58e-1)"	5.9	5.2	5.9	12.8	7.1	50.4	11.5	6.0	7.9	5.2	4.3	10.8	6.5	6.5	6.9	8.9	9.2	4.4	5.2	5.9	5.1	4.9	5.5	4.9	27.1	5.3	5.5	6.0	3.2	5.4	3.1	7.6	5.4	5.0	12.3	4.4	4.3	5.0	4.7	7.4	7.2	6.7	4.8	11.3	6.5	37.1	5.9	35.5	5.9	4.6	27.9	7.7	5.4	7.0	52.4	27.0	78.5	30.2	9.2	14.9	44.8	42.8	34.4	67.1	65.4	36.0	54.7	139.2	22.4	24.3	39.2	56.5	75.5	54.4	90.5	73.4	36.4	90.5	18.7	39.3	10.2	168.5	49.2	8.5	9.7	50.4	32.6	12.8	47.0	104.8	76.6	79.0	56.9	65.5	137.1	76.5	47.8	39.9	59.3	124.5	134.2	48.6	32.3	59.3	53.2	28.0	34.2	36.4	30.8	36.0	39.3	66.6	24.4	27.9	22.8	47.7	37.3	37.7	53.5	124.8	44.7	74.6	34.8	42.7	12.3	26.2	21.5	15.5	29.0	31.3	24.9	26.4	15.7	32.7	27.1	27.3	6.5	45.6	15.2	21.4	34.9	19.4	5.9	7.1	6.0	7.9	5.9	5.1	5.3	5.5	5.4	4.8	5.9	7.0	15.3	3.2	4.6	6.8	30.6	16.8	13.8	23.3	6.2	12.4	9.3	11.3	11.8	12.8	16.7	14.7	8.4	34.8	24.8	6.3	11.7	13.5	21.3	21.1	8.3	12.4	3.0	76.2	42.0	19.4	48.3	11.4	14.8	10.8	28.5	20.0	7.1	3.3	19.2	10.1	36.2	10.4	20.3	11.8	14.9	11.5	5.6	12.0	12.4	19.7	14.2	6.2	27.8	12.1	19.8	10.3	2.2	9.8	25.4	6.1	3.0	11.2	37.6	9.6	19.7	14.3	15.1	198.9	110.9	14.1	13.9	15.1	26.8	9.2	18.1	10.4
VRK2		ENSG00000028116	"VRK serine/threonine kinase 2"	Q86Y07	2	57907629-58159920	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Host-virus interaction"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	9	"Oligodendrocytes: 540.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB046459, HPA047503"	Approved		Supported	"Endoplasmic reticulum"		NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 70: Brain - Nervous system development"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Endoplasmic reticulum"		"CAB046459: AB_1858773, HPA047503: AB_2680071"	"unprognostic (1.87e-1)"	"unprognostic (5.84e-2)"	"unprognostic (4.65e-2)"	"unprognostic (1.33e-3)"	"unprognostic (1.27e-1)"	"unprognostic (1.60e-2)"	"prognostic unfavorable (6.32e-6)"	"unprognostic (3.90e-2)"	"unprognostic (4.76e-2)"	"unprognostic (2.96e-2)"	"prognostic unfavorable (4.65e-4)"	"unprognostic (1.36e-1)"	"prognostic unfavorable (4.66e-5)"	"unprognostic (3.48e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.99e-1)"	"unprognostic (3.56e-1)"	14.8	13.2	14.9	20.2	26.4	18.8	17.2	15.1	16.2	10.8	9.3	14.0	10.9	15.3	16.7	19.5	13.4	11.9	15.6	12.8	16.0	10.7	16.8	15.9	22.5	23.9	21.1	10.7	19.7	14.7	7.6	14.6	23.0	14.2	16.4	4.8	13.8	11.4	14.3	13.3	11.0	19.4	14.8	18.0	13.7	13.3	18.9	12.7	18.6	15.1	26.0	14.7	12.6	40.6	37.1	24.3	2.7	16.3	16.7	30.6	48.4	32.8	33.3	22.7	22.9	49.8	38.5	44.3	43.0	29.8	37.1	27.4	34.9	36.7	33.7	80.9	23.1	50.9	19.0	35.8	27.8	44.1	29.0	17.7	42.6	36.3	52.8	26.1	64.9	6.2	50.2	28.5	38.2	21.2	0.3	32.9	29.9	56.9	11.6	49.4	12.0	30.6	36.8	30.2	9.4	0.3	52.5	31.2	27.5	26.2	22.0	26.1	37.0	0.5	74.4	20.6	0.6	40.5	33.9	24.0	18.2	52.7	38.4	31.0	24.5	35.3	15.1	32.2	18.4	30.6	14.2	17.7	25.5	31.7	10.6	13.6	9.0	18.7	34.3	26.4	18.5	15.4	14.9	26.4	15.1	16.2	12.8	16.0	23.9	21.1	23.0	14.8	18.9	40.6	17.9	22.4	11.2	1.3	26.4	9.8	12.6	21.8	14.8	1.0	14.0	10.2	21.8	7.2	22.4	18.4	0.0	21.2	13.7	6.5	15.6	27.1	23.0	12.7	10.9	15.8	6.6	39.1	2.7	26.2	21.1	14.0	16.3	12.7	17.7	9.6	8.9	8.4	18.4	0.0	4.7	5.1	30.5	19.1	19.1	8.4	5.9	26.2	10.6	54.4	41.7	5.3	16.5	32.2	540.8	24.8	8.7	6.0	25.7	18.4	2.5	9.5	30.7	4.0	6.6	7.4	14.3	22.0	10.9	19.2	8.4	19.4	16.5	6.8	7.9	16.4
VRK3		ENSG00000105053	"VRK serine/threonine kinase 3"	Q8IV63	19	49976468-50025946	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 135.6"	"Group enriched"	"Detected in all"	7	"Early spermatids: 557.6;Late spermatids: 1646.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA056489	Approved		Supported	Nucleoplasm,Vesicles		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 21: OE19 - Mitochondria"	"Cluster 25: Spermatids - Spermatogenesis"	"Nucleoplasm, Vesicles"		"HPA056489: AB_2683150"	"unprognostic (2.09e-1)"	"unprognostic (3.14e-2)"	"unprognostic (1.26e-1)"	"unprognostic (4.94e-3)"	"unprognostic (1.23e-1)"	"unprognostic (2.22e-3)"	"unprognostic (9.78e-2)"	"unprognostic (3.47e-1)"	"unprognostic (8.79e-2)"	"unprognostic (2.48e-1)"	"unprognostic (1.31e-2)"	"unprognostic (1.43e-1)"	"prognostic favorable (1.83e-4)"	"unprognostic (9.38e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.06e-1)"	"prognostic favorable (5.66e-4)"	17.4	23.3	25.9	17.6	26.6	23.6	17.7	26.1	28.6	17.9	30.2	21.9	25.8	15.9	19.5	17.6	33.2	20.9	17.5	25.4	27.9	36.5	35.6	16.9	28.5	27.6	31.1	21.2	22.1	15.9	20.6	16.9	30.4	20.2	22.0	64.8	21.9	15.4	26.9	16.8	32.9	14.1	25.2	26.0	21.6	135.6	27.9	35.6	19.7	17.4	25.7	18.0	16.8	29.3	31.0	31.3	22.6	24.5	29.2	26.9	23.3	21.7	25.7	31.6	34.5	16.8	33.7	37.1	15.2	21.2	22.1	22.5	21.3	18.6	25.5	32.6	43.5	28.9	20.4	29.4	21.9	36.7	48.7	24.2	27.3	18.3	19.2	28.4	26.5	39.9	35.8	53.7	23.2	13.0	49.7	24.5	12.2	54.6	26.7	39.3	23.9	47.6	27.2	32.2	25.3	12.3	21.5	26.0	24.7	20.0	23.9	38.5	20.2	32.2	18.6	13.1	17.1	34.3	47.4	19.6	25.8	22.3	22.5	110.0	42.8	81.1	53.7	46.1	43.3	58.9	48.7	51.9	47.9	53.3	49.2	45.3	112.5	82.7	55.1	45.4	76.1	48.4	25.9	26.6	26.1	28.6	25.4	27.9	27.6	31.1	30.4	25.2	27.9	29.3	19.6	6.4	28.6	10.1	26.6	6.6	16.0	27.2	6.8	34.3	17.9	14.5	8.4	24.3	29.8	14.7	143.9	43.8	27.9	49.9	31.3	31.0	557.6	50.7	12.0	16.0	22.2	38.7	13.9	32.7	38.6	15.5	18.8	26.8	18.3	24.1	28.5	44.5	34.8	32.0	15.9	35.4	34.6	25.4	9.3	1646.8	22.1	22.9	14.2	6.5	40.6	33.2	41.2	10.1	15.3	34.2	67.9	25.9	18.6	20.6	87.5	91.4	71.8	116.0	13.1	12.0	15.2	142.8	52.6	10.5	10.9	57.3	28.0	24.9	36.0	30.1
VTA1	"C6orf55, HSPC228, My012"	ENSG00000009844	"Vesicle trafficking 1"	Q9NP79	6	142147162-142224685	"Plasma proteins, Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030968, HPA030969"	Approved		Supported	Nucleoplasm,Vesicles,Cytosol		NA	NA		220000	"Cluster 18: Basophils - Vesicular transport"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	"Nucleoplasm, Vesicles, Cytosol"		"HPA030968: AB_10602585, HPA030969: AB_2673679"	"prognostic unfavorable (7.02e-4)"	"unprognostic (1.84e-2)"	"unprognostic (2.12e-3)"	"unprognostic (1.17e-2)"	"unprognostic (1.08e-2)"	"unprognostic (2.56e-2)"	"prognostic unfavorable (6.58e-6)"	"unprognostic (2.83e-2)"	"unprognostic (3.61e-1)"	"unprognostic (5.18e-2)"	"unprognostic (2.84e-2)"	"unprognostic (1.16e-1)"	"unprognostic (3.85e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.96e-1)"	"unprognostic (3.24e-1)"	22.2	20.9	16.6	25.7	19.0	30.6	31.6	20.2	20.3	23.2	12.5	34.9	38.2	23.4	25.4	39.1	27.3	23.0	33.9	18.9	18.9	34.5	45.4	21.5	33.4	17.4	18.1	21.0	19.3	28.3	9.9	32.1	17.8	22.5	39.9	29.2	18.2	19.6	55.7	30.7	37.0	26.3	21.1	23.1	23.5	18.3	18.2	45.4	27.6	58.3	39.1	35.8	20.3	22.2	56.5	47.5	75.8	116.8	65.3	71.4	52.3	124.7	74.0	111.6	105.8	80.9	43.0	91.2	82.1	112.6	84.6	70.2	81.5	85.1	153.4	62.3	71.7	99.2	46.2	97.0	48.2	155.6	55.2	59.4	97.7	111.8	71.7	59.8	72.4	69.7	93.7	44.5	94.5	82.1	101.8	80.7	57.0	72.1	53.8	92.1	60.8	55.8	86.4	61.5	79.0	61.5	70.1	53.3	63.7	62.9	57.8	104.4	53.0	50.0	69.6	84.7	90.8	43.5	80.9	103.8	32.7	85.5	77.8	222.4	90.0	151.9	64.3	114.5	83.5	85.6	72.8	76.0	90.9	84.8	79.8	80.4	56.0	97.5	120.3	55.9	79.0	121.5	16.6	19.0	20.2	20.3	18.9	18.9	17.4	18.1	17.8	21.1	18.2	22.2	16.7	22.4	20.3	22.5	25.8	25.2	19.2	25.5	25.6	9.7	16.5	18.3	47.8	12.8	24.5	16.5	0.0	32.7	23.9	40.2	17.6	31.5	4.5	30.7	30.4	17.5	21.6	23.1	40.1	28.0	36.4	25.4	16.8	28.0	12.6	18.1	11.4	24.7	27.9	11.8	38.7	24.7	14.2	20.9	14.3	2.2	11.8	20.0	8.8	40.3	28.0	23.9	35.0	25.6	48.7	30.1	18.3	12.4	16.4	17.2	30.0	31.6	36.6	12.6	6.6	16.8	18.4	23.6	24.9	28.8	31.0	31.7	23.8	25.3	25.9	18.8
VTCN1	"B7-H4, B7H4, B7S1, B7x, FLJ22418"	ENSG00000134258	"V-set domain containing T cell activation inhibitor 1"	Q7Z7D3	1	117143587-117210960	"Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"breast: 100.9;fallopian tube: 32.7;pancreas: 30.1"	"Cell type enhanced"	"Detected in some"		"Breast glandular cells: 62.3;Collecting duct cells: 55.2;Ductal cells: 83.6;Endometrial ciliated cells: 42.7;Exocrine glandular cells: 34.2;Glandular and luminal cells: 79.1"	"Group enriched"	"Detected in many"	6	"breast cancer: 55.8;endometrial cancer: 45.2;ovarian cancer: 49.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"SK-BR-3: 244.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA054200	Approved		Approved	"Plasma membrane,Cell Junctions,Focal adhesion sites"		No	NA				"Cluster 5: Breast - Unknown function"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 44: Endometrium - Transcription"	"Plasma membrane"	"Cell Junctions, Focal adhesion sites"	"HPA054200: AB_2682415"	"unprognostic (4.13e-1)"	"unprognostic (1.71e-3)"	"unprognostic (2.95e-1)"	"unprognostic (3.44e-2)"	"unprognostic (1.71e-3)"	"unprognostic (2.56e-1)"	"unprognostic (7.94e-2)"	"unprognostic (4.86e-2)"	"unprognostic (3.53e-1)"	"unprognostic (1.17e-2)"	"unprognostic (4.54e-2)"	"unprognostic (5.47e-2)"	"unprognostic (1.50e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.42e-1)"	"unprognostic (3.07e-1)"	"unprognostic (1.45e-2)"	0.1	0.0	0.0	0.0	0.0	0.0	100.9	0.0	0.0	15.3	0.0	0.0	0.4	4.5	5.0	0.4	32.7	5.0	0.2	0.0	0.0	17.3	1.1	0.7	0.0	0.0	0.0	0.1	30.1	0.0	0.1	0.8	0.0	3.0	0.0	0.0	22.1	7.8	0.2	2.8	0.0	0.1	0.0	0.0	3.6	1.1	0.1	0.1	0.0	0.0	0.0	3.2	0.1	0.0	1.0	0.1	1.7	0.0	0.0	0.0	44.8	0.0	0.0	0.0	0.0	0.0	0.9	0.0	7.5	0.0	0.0	5.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	1.9	0.1	0.0	0.1	0.0	0.1	0.1	0.2	0.1	4.2	0.1	1.2	0.0	0.0	244.8	0.1	29.9	14.2	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.4	0.0	2.5	6.9	0.0	0.0	62.3	18.4	1.1	0.0	22.6	55.2	0.0	3.4	1.1	0.0	0.0	83.6	2.5	42.7	4.4	0.6	0.0	0.0	0.8	34.2	1.4	0.4	0.0	79.1	0.0	0.0	0.0	0.0	0.6	0.0	0.6	0.0	6.1	0.0	0.0	1.8	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.5	0.3	11.3	0.0	0.0	0.0	1.6	0.0	0.3	8.3	0.0	0.0	0.0	1.1	0.1	0.0	0.0	0.0	3.0	0.5	0.0	0.0	4.8
VTI1A	"MVti1, Vti1-rp2"	ENSG00000151532	"Vesicle transport through interaction with t-SNAREs 1A"	Q96AJ9	10	112446998-112818744	"Predicted intracellular proteins, Predicted membrane proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"Astrocytes: 135.2;Excitatory neurons: 244.7;Inhibitory neurons: 199.5;Late spermatids: 102.8;Microglial cells: 195.8;Oligodendrocyte precursor cells: 172.4;Oligodendrocytes: 218.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054108	Supported		Supported	"Golgi apparatus,Vesicles"		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Golgi apparatus, Vesicles"		"HPA054108: AB_2682382"	"unprognostic (9.81e-2)"	"unprognostic (6.42e-2)"	"unprognostic (4.49e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.66e-1)"	"unprognostic (2.28e-1)"	"prognostic unfavorable (6.50e-5)"	"unprognostic (1.71e-1)"	"unprognostic (1.59e-1)"	"unprognostic (2.00e-1)"	"unprognostic (1.22e-1)"	"unprognostic (8.05e-2)"	"prognostic favorable (7.27e-5)"	"unprognostic (3.74e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.67e-3)"	"unprognostic (2.61e-1)"	6.6	4.7	3.7	7.0	3.7	13.8	4.7	2.3	4.7	3.5	1.1	6.4	7.2	3.8	4.9	7.3	3.2	4.6	5.8	4.8	2.6	6.8	4.7	5.1	7.7	2.8	3.7	3.1	3.9	7.5	2.6	4.0	3.5	4.7	7.5	4.2	5.2	4.8	7.4	5.9	7.2	5.7	1.8	5.6	5.5	4.5	4.3	8.6	6.3	6.1	9.4	5.2	4.4	4.6	13.5	11.2	10.1	14.1	15.5	13.4	6.1	14.1	17.4	11.0	12.2	12.7	13.6	14.0	5.3	16.0	9.3	15.6	8.8	11.2	14.9	18.0	8.1	11.9	8.1	13.3	11.0	16.8	16.8	10.4	13.9	12.6	25.9	12.4	11.9	14.1	11.3	16.9	14.8	9.5	13.3	12.8	4.4	10.5	6.5	13.9	14.6	6.2	11.5	11.9	4.6	9.0	10.0	8.6	9.5	8.4	7.8	9.3	17.0	8.7	7.4	10.8	15.8	7.4	11.0	15.9	14.2	15.3	8.6	9.2	7.0	9.6	5.4	9.3	5.1	5.5	4.5	4.4	5.2	4.6	4.3	4.4	11.4	5.7	8.7	4.9	7.2	4.6	3.7	3.7	2.3	4.7	4.8	2.6	2.8	3.7	3.5	1.8	4.3	4.6	13.5	12.8	10.3	135.2	33.1	11.2	14.5	8.8	13.6	16.5	7.8	4.6	14.0	7.2	11.6	5.5	43.8	7.6	31.5	17.0	7.9	15.4	42.9	11.4	15.5	13.6	18.5	18.1	244.7	25.0	12.3	12.9	21.9	17.0	19.6	10.2	8.9	8.1	18.8	21.9	199.5	10.7	14.2	17.0	27.0	102.8	6.8	20.9	12.4	195.8	19.0	6.0	25.7	172.4	218.6	29.7	12.2	5.7	23.9	12.6	17.2	9.4	11.7	20.7	0.0	13.5	14.1	11.1	9.2	17.0	16.3	14.4	25.4	9.7	12.1	19.7
VTN	VN	ENSG00000109072	Vitronectin	P04004	17	28367284-28373091	"Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins"	"Cell adhesion"	Heparin-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	61	"liver: 6039.5"	"Cell type enriched"	"Detected in many"	4	"Hepatocytes: 5507.4"	"Cancer enriched"	"Detected in many"	85	"liver cancer: 2216.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	15	"CACO-2: 1748.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016695, CAB016765, HPA060933, HPA068011"	Supported		Supported	"Endoplasmic reticulum,Vesicles"	"Secreted to blood"	NA	NA	606000000000	33000000000		"Cluster 62: Liver - Hemostasis"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 15: Hepatocytes - Hemostasis"	"Endoplasmic reticulum, Vesicles"		"CAB016695: AB_1624536, CAB016765: , HPA060933: AB_2684389, HPA068011: "	"unprognostic (1.19e-1)"	"unprognostic (2.12e-1)"	"unprognostic (2.29e-2)"	"unprognostic (6.13e-2)"	"unprognostic (9.74e-2)"	"unprognostic (8.42e-2)"	"prognostic favorable (3.74e-4)"	"unprognostic (6.20e-2)"	"unprognostic (3.97e-1)"	"unprognostic (8.95e-2)"	"unprognostic (3.24e-3)"	"unprognostic (1.01e-2)"	"prognostic unfavorable (4.10e-11)"	"unprognostic (8.82e-3)"	"unprognostic (2.27e-1)"	"unprognostic (4.86e-3)"	"unprognostic (7.09e-2)"	6.2	98.9	2.4	2.5	2.7	0.3	0.9	5.4	3.7	1.0	0.4	0.9	4.6	1.4	0.9	0.5	2.2	61.2	53.1	2.5	2.8	3.6	6039.5	1.8	4.3	2.1	5.3	1.9	17.7	0.1	3.0	40.6	2.3	1.2	0.3	47.4	0.6	4.3	0.4	0.8	1.3	2.7	1.5	2.9	5.1	10.0	2.2	0.1	0.8	0.5	0.4	4.2	0.7	2.4	0.0	28.4	0.7	0.4	0.2	0.3	7.3	1.8	0.8	0.9	0.9	1748.9	0.1	1.2	0.2	0.2	0.2	0.7	0.0	0.0	0.1	0.2	0.2	1.2	1.1	86.7	2.5	6.1	0.5	0.4	0.0	0.6	0.0	3.9	0.1	0.0	1.6	0.3	0.2	0.7	0.2	0.0	0.8	0.4	0.1	0.4	3.5	0.1	0.3	0.0	1.0	1.4	115.6	8.0	0.2	4.3	0.3	0.0	1.0	0.4	0.3	0.1	0.2	1.0	0.5	1.4	0.5	1.3	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.3	0.1	0.1	0.0	0.0	0.0	0.0	2.4	2.7	5.4	3.7	2.5	2.8	2.1	5.3	2.3	1.5	2.2	2.4	0.1	0.0	1.1	2.0	21.5	0.0	0.0	0.0	0.0	13.0	0.1	0.1	18.1	1162.4	0.0	0.0	77.2	3.7	0.0	0.0	3.9	16.8	0.0	0.0	1.2	7.3	0.0	131.0	0.9	19.7	2.8	48.1	0.0	0.0	0.0	1.8	120.3	5507.4	4.7	38.7	1.0	0.1	0.0	160.3	0.3	0.2	0.0	0.3	0.0	0.0	20.1	6.9	0.0	1.0	0.5	23.5	1.2	1.5	0.0	0.0	0.1	9.5	0.0	38.3	0.0	0.4	1.5	4.2	0.6	0.0	0.0	9.6	9.0	0.7	0.0	0.0
VWA3B	"DKFZp686F2227, MGC26733"	ENSG00000168658	"Von Willebrand factor A domain containing 3B"	Q502W6	2	98087116-98313299	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Disease variant, Mental retardation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"fallopian tube: 22.3;testis: 30.0"	"Group enriched"	"Detected in many"	5	"Early spermatids: 467.1;Late spermatids: 995.9"	"Cancer enhanced"	"Detected in single"		"endometrial cancer: 1.0"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in many"	4	"hippocampal formation: 7.1"	"Low region specificity"	"Detected in all"			"HPA036700, HPA036701"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA				"Cluster 49: Ciliated cells - Cilium organization"		"Cluster 25: Spermatids - Spermatogenesis"	"Nucleoplasm, Cytosol"		"HPA036700: AB_2675261, HPA036701: AB_10673505"	"unprognostic (2.36e-2)"	"unprognostic (4.27e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.01e-3)"	"unprognostic (5.16e-2)"	"unprognostic (3.27e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.44e-2)"	"unprognostic (4.53e-2)"	"unprognostic (6.41e-2)"	"unprognostic (2.63e-7)"	"unprognostic (2.57e-1)"	"unprognostic (5.04e-2)"	"unprognostic (2.27e-1)"	"unprognostic (4.96e-2)"	0.0	0.0	1.4	0.0	1.1	0.0	0.0	0.9	0.7	0.6	5.0	0.1	0.0	0.2	0.0	0.0	22.3	0.0	0.0	1.3	1.5	0.1	0.0	2.5	0.0	7.0	5.8	0.2	0.0	0.0	0.2	0.0	3.7	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	4.8	0.0	0.1	30.0	1.2	0.7	0.0	0.1	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	1.1	0.9	0.7	1.3	1.5	7.0	5.8	3.7	4.8	1.2	2.7	0.3	0.0	1.1	11.8	0.1	0.3	1.7	2.2	0.0	1.0	0.1	0.3	0.9	0.0	12.1	1.8	31.3	0.0	0.0	0.8	0.0	0.0	467.1	53.8	0.6	0.6	1.8	0.0	1.9	0.4	0.2	0.8	4.6	1.6	0.0	0.1	1.1	0.0	0.2	0.0	1.0	2.8	6.1	0.0	0.8	995.9	4.7	0.7	0.0	3.7	0.6	0.7	0.0	1.5	0.7	0.2	2.7	5.7	0.2	0.4	0.2	0.0	124.5	0.5	0.0	0.5	1.0	17.6	6.0	0.0	0.4	0.0	0.1	0.2	1.0	0.8
VWCE	"FLJ32009, URG11, VWC1"	ENSG00000167992	"Von Willebrand factor C and EGF domains"	Q96DN2	11	61258286-61295316	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 14.3;ovary: 7.9"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 19.2;Cone photoreceptor cells: 29.2;Hepatocytes: 16.4;Rod photoreceptor cells: 21.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CACO-2: 7.2;Hep G2: 26.3;HSkMC: 13.4;REH: 14.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA040401, HPA043921"	Uncertain		Supported	Nucleoplasm,Vesicles,Cytosol	"Secreted - unknown location"	NA	NA		2200000		"Cluster 85: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 9: Photoreceptor cells - Phototransduction"	Nucleoplasm	"Vesicles, Cytosol"	"HPA040401: AB_2676963, HPA043921: AB_2678731"	"unprognostic (3.09e-2)"	"unprognostic (1.10e-1)"	"unprognostic (3.58e-2)"	"unprognostic (1.15e-1)"	"unprognostic (3.96e-3)"	"unprognostic (9.27e-4)"	"unprognostic (1.21e-2)"	"unprognostic (4.01e-4)"	"unprognostic (3.04e-2)"	"unprognostic (3.42e-2)"	"unprognostic (6.58e-4)"	"unprognostic (7.20e-2)"	"unprognostic (3.01e-1)"	"unprognostic (1.25e-2)"	"unprognostic (1.92e-1)"	"unprognostic (2.34e-1)"	"unprognostic (2.30e-1)"	2.8	1.1	0.6	0.1	0.9	1.6	1.5	0.3	1.6	2.9	0.0	0.6	0.3	1.3	0.6	0.9	3.5	0.6	0.8	0.7	0.7	0.5	14.3	0.3	0.2	0.5	1.2	7.9	0.3	0.1	0.6	2.4	0.4	1.0	0.4	0.8	0.9	0.5	0.7	0.7	0.4	0.4	0.0	0.4	0.4	1.8	0.5	2.5	0.8	0.4	0.1	0.6	1.2	0.2	0.0	0.1	1.5	0.2	0.2	1.8	0.6	0.2	2.0	0.0	0.3	7.2	0.0	0.5	0.0	0.4	0.1	0.0	2.3	0.0	0.1	0.4	0.0	0.8	0.0	26.3	1.2	0.0	0.3	13.4	0.6	0.7	0.0	0.1	2.3	3.3	0.2	0.3	0.3	0.1	5.5	0.0	2.2	0.0	0.0	14.0	0.2	0.0	0.1	0.1	0.6	1.0	0.0	0.1	0.7	2.4	0.9	0.0	0.8	0.3	0.3	0.5	0.2	0.2	0.6	1.2	0.9	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.9	0.3	1.6	0.7	0.7	0.5	1.2	0.4	0.0	0.5	0.2	2.1	3.2	1.7	19.2	0.3	1.8	1.8	3.8	3.4	3.6	1.7	0.5	1.0	1.5	2.3	0.0	29.2	1.0	0.5	0.2	0.0	0.1	0.5	2.9	1.0	5.5	1.8	6.1	7.5	0.5	5.0	2.6	0.0	1.8	3.8	6.5	2.5	16.4	1.2	0.0	5.8	0.1	2.0	3.5	2.4	0.8	6.8	2.6	1.8	2.8	2.3	2.3	1.0	2.5	1.4	0.0	0.0	1.9	0.4	1.1	0.1	0.3	5.4	21.1	0.0	0.9	1.1	1.1	3.4	1.3	2.3	4.4	0.9	7.7	0.3	0.7
WAPL	"FOE, KIAA0261, WAPAL"	ENSG00000062650	"WAPL cohesin release factor"	Q7Z5K2	10	86435256-86521792	"Predicted intracellular proteins"	"Cell cycle, Cell division, Host-virus interaction, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037874, HPA037875, HPA066141"	Enhanced		Supported	Nucleoplasm		NA	NA			"Cluster 42: Non-specific - Transcription"	"Cluster 20: Retina & Lymphoid tissues - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm		"HPA037874: AB_10697086, HPA037875: AB_10672396, HPA066141: "	"unprognostic (1.52e-1)"	"unprognostic (1.09e-1)"	"unprognostic (3.03e-2)"	"unprognostic (2.91e-2)"	"unprognostic (6.63e-2)"	"unprognostic (3.51e-1)"	"unprognostic (3.94e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.25e-1)"	"unprognostic (5.78e-2)"	"unprognostic (5.56e-2)"	"unprognostic (7.61e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.88e-1)"	"unprognostic (4.56e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.79e-1)"	15.4	13.2	8.4	19.6	9.9	27.1	16.6	11.9	9.2	12.8	7.8	15.4	15.2	14.8	8.7	15.9	11.7	13.1	10.3	7.5	8.3	16.8	22.6	16.5	25.0	8.2	8.5	13.7	14.4	16.9	4.9	18.4	8.3	13.0	15.2	36.0	11.2	11.7	20.9	17.9	16.0	14.8	8.9	19.0	16.5	35.1	9.0	33.7	17.9	22.5	27.7	17.9	9.2	10.4	42.6	19.6	33.5	44.4	26.1	27.6	29.6	36.4	44.2	30.3	32.4	42.9	36.6	64.3	24.1	32.5	26.7	39.1	38.3	31.3	46.3	42.1	25.3	38.9	30.9	47.4	29.7	79.8	43.1	21.9	35.7	38.9	64.9	34.5	34.6	36.8	41.7	37.6	35.2	36.3	49.9	29.6	29.9	26.4	19.5	35.2	27.1	25.6	26.3	37.2	13.1	25.2	32.3	21.4	40.9	33.2	47.1	41.9	33.5	29.1	34.4	25.8	48.6	36.8	54.9	66.9	26.7	55.8	20.9	15.0	3.5	7.7	3.4	4.1	4.9	3.9	4.5	4.7	4.8	4.0	5.1	4.0	5.5	3.2	7.4	3.6	6.1	2.4	8.4	9.9	11.9	9.2	7.5	8.3	8.2	8.5	8.3	8.9	9.0	10.4	38.3	83.3	54.8	0.0	48.3	0.0	57.4	0.0	35.3	49.1	41.3	27.9	0.0	20.0	21.1	16.5	20.9	42.8	62.4	17.4	21.5	60.8	86.8	36.7	44.4	33.9	18.2	94.1	0.0	52.5	28.3	30.0	37.8	52.2	25.2	40.3	32.5	47.6	40.4	55.5	0.0	21.5	0.0	56.5	0.0	42.0	32.0	58.3	0.0	0.0	81.0	48.7	55.6	0.0	0.0	52.1	27.5	32.4	50.5	56.6	25.0	35.5	13.8	113.4	65.7	70.3	33.6	153.4	90.2	48.4	0.0	76.1	51.4	35.2	24.8	74.1
WARS2	mtTrpRS	ENSG00000116874	"Tryptophanyl tRNA synthetase 2, mitochondrial"	Q9UGM6	1	119031216-119140654	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase"	"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 57.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028007, HPA069692"	Enhanced		Supported	Mitochondria		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 34: Spermatids - Unknown function"	Mitochondria		"HPA028007: , HPA069692: AB_2686172"	"unprognostic (1.00e-1)"	"unprognostic (2.25e-1)"	"unprognostic (2.03e-1)"	"unprognostic (5.64e-2)"	"unprognostic (3.42e-1)"	"unprognostic (7.05e-2)"	"unprognostic (7.73e-3)"	"unprognostic (3.72e-1)"	"unprognostic (2.14e-2)"	"unprognostic (1.17e-2)"	"unprognostic (3.96e-2)"	"unprognostic (6.76e-3)"	"prognostic favorable (1.45e-4)"	"unprognostic (4.83e-2)"	"unprognostic (1.83e-1)"	"unprognostic (9.88e-3)"	"unprognostic (4.71e-2)"	7.3	8.8	2.4	4.1	2.4	1.9	9.4	2.4	3.0	6.9	6.5	7.3	7.7	6.3	3.8	6.1	9.4	4.9	7.9	2.3	2.6	9.6	6.1	5.0	4.7	2.4	2.4	8.2	8.9	10.2	3.8	6.3	2.4	5.7	8.0	6.0	5.4	3.5	6.3	5.2	5.1	5.2	2.4	3.0	7.2	4.6	2.3	4.6	6.8	6.5	5.1	6.8	5.6	2.8	12.8	5.0	7.5	7.9	9.6	21.6	7.6	7.0	10.5	7.6	9.1	14.4	5.6	19.0	11.4	12.0	4.2	8.2	13.9	12.6	11.7	9.8	16.6	8.9	12.8	13.9	19.6	14.8	4.8	16.1	9.7	11.1	20.2	10.0	11.7	7.9	14.1	13.4	14.4	15.7	8.9	8.6	9.9	9.8	10.6	6.3	24.9	9.9	20.9	17.5	10.7	6.6	11.3	15.4	16.7	13.1	6.9	11.1	8.8	7.8	9.2	15.2	13.8	6.4	4.6	8.3	9.6	12.1	14.7	0.0	5.0	0.3	3.4	3.6	5.0	4.6	3.6	4.5	6.7	6.2	4.2	4.2	0.2	4.2	2.2	3.2	4.5	3.4	2.4	2.4	2.4	3.0	2.3	2.6	2.4	2.4	2.4	2.4	2.3	2.8	7.2	9.6	12.3	22.5	10.4	9.6	17.6	14.7	14.2	6.7	13.1	11.3	10.6	5.7	11.2	11.0	6.2	16.9	7.0	6.5	17.6	9.8	57.7	15.2	8.6	7.5	6.7	18.9	15.5	11.9	15.3	15.5	17.9	13.8	8.8	9.7	2.2	7.5	9.5	6.7	21.4	10.2	14.2	10.0	6.9	31.8	9.9	8.2	10.6	11.2	13.0	5.0	3.1	12.1	18.2	8.7	6.1	8.2	9.1	13.1	7.5	18.8	14.7	8.2	6.6	12.0	10.1	5.4	6.1	19.8	10.7	20.0	10.2	19.6	15.8	14.4
WASHC1	"FAM39E, FLJ00038, WASH1"	ENSG00000181404	"WASH complex subunit 1"	A8K0Z3	9	14475-73865	"Predicted intracellular proteins, Transporters"	"Protein transport, Transport"	Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Collecting duct cells: 60.7;Distal tubular cells: 50.9;Proximal tubular cells: 47.5;Syncytiotrophoblasts: 42.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA002689	Uncertain		Supported	Vesicles		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 72: Non-specific - Transcription"	"Cluster 20: HeLa - Mitochondria"	"Cluster 7: Non-specific - Mitochondria"	Vesicles		"HPA002689: AB_1078803"	"unprognostic (9.43e-2)"	"unprognostic (1.62e-2)"	"unprognostic (3.16e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.33e-2)"	"unprognostic (3.22e-3)"	"unprognostic (2.06e-2)"	"unprognostic (5.00e-1)"	"unprognostic (5.40e-3)"	"unprognostic (3.37e-3)"	"unprognostic (6.95e-2)"	"unprognostic (3.90e-2)"	"unprognostic (1.88e-1)"	"unprognostic (3.38e-1)"	"unprognostic (2.31e-2)"	"unprognostic (1.02e-1)"	15.7	18.1	13.2	7.1	14.2	16.3	17.6	13.2	15.1	24.5	16.5	19.6	10.2	20.3	21.9	19.2	24.1	9.0	17.9	13.3	13.5	25.9	20.9	17.1	13.4	14.4	13.8	23.0	21.9	5.2	21.2	6.6	14.3	27.0	4.7	15.9	17.6	13.5	22.8	26.1	21.9	15.3	13.4	29.0	18.3	24.1	14.5	8.6	22.1	6.8	6.0	19.7	20.5	14.9	13.5	8.5	5.0	10.3	8.5	5.7	12.4	11.7	11.4	6.9	5.5	8.4	8.3	5.7	6.6	4.8	6.2	16.7	7.4	5.7	2.5	5.9	14.4	5.5	7.0	8.6	4.7	11.3	10.0	4.3	4.2	3.5	4.7	17.3	2.1	5.0	12.6	21.0	2.2	4.0	11.6	9.4	9.2	9.1	10.5	7.9	4.3	7.2	5.1	9.8	5.6	14.9	6.8	14.3	8.6	6.2	8.6	10.5	8.0	9.2	6.7	4.0	10.3	9.4	7.9	4.5	8.6	12.0	8.6	1.2	2.5	2.2	1.9	2.7	1.5	1.3	1.5	1.6	2.3	1.2	1.6	1.3	1.4	2.1	4.0	2.1	1.8	1.5	13.2	14.2	13.2	15.1	13.3	13.5	14.4	13.8	14.3	13.4	14.5	14.9	34.5	22.4	22.5	0.0	10.5	0.0	0.0	0.0	0.0	0.0	29.0	28.3	0.0	0.0	7.4	60.7	0.0	37.4	21.5	0.0	50.9	13.7	0.0	24.7	28.6	7.5	0.0	0.0	0.0	15.8	26.1	10.8	0.0	22.9	16.4	27.3	0.0	0.0	26.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.5	0.0	0.0	4.6	0.0	0.0	0.0	0.0	13.1	0.0	0.0	6.7	0.0	0.0	47.5	8.0	0.0	0.0	0.0	12.1	0.0	0.0	0.0	0.0	42.8	11.4	14.3	0.0	0.0
WASHC2A	"bA56A21.1, bA98I6.1, FAM21A, FAM21B, FLJ10824"	ENSG00000099290	"WASH complex subunit 2A"	Q641Q2	10	50067888-50133509	"Predicted intracellular proteins, Transporters"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 38.5;Alveolar cells type 2: 28.5;Endometrial ciliated cells: 45.7;Respiratory ciliated cells: 41.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA047844, HPA060975, HPA061022"	Supported		Supported	Nucleoli,Vesicles,Cytosol		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 18: U-2197 - ECM organization"	"Cluster 7: Non-specific - Mitochondria"	Vesicles	"Nucleoli, Cytosol"	"HPA047844: AB_2680177, HPA060975: AB_2684401, HPA061022: AB_2732656"	"unprognostic (2.46e-1)"	"unprognostic (1.11e-3)"	"unprognostic (8.82e-2)"	"unprognostic (3.28e-1)"	"unprognostic (2.75e-1)"	"unprognostic (6.51e-3)"	"prognostic unfavorable (6.75e-5)"	"unprognostic (4.60e-2)"	"unprognostic (2.85e-2)"	"unprognostic (2.37e-2)"	"unprognostic (9.04e-2)"	"unprognostic (2.73e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.57e-1)"	"unprognostic (2.95e-1)"	"unprognostic (1.85e-2)"	"unprognostic (4.40e-2)"	25.3	25.9	19.9	22.1	20.7	37.5	24.0	23.4	24.8	24.7	18.3	28.9	25.2	22.5	19.2	20.2	19.7	18.0	58.6	19.9	19.9	22.9	15.5	26.0	28.8	21.1	21.2	26.7	17.7	23.3	21.5	22.9	21.1	20.6	28.9	19.9	21.9	20.0	22.3	25.7	28.9	21.2	18.6	26.6	21.5	12.5	22.6	24.2	23.3	15.6	26.9	23.8	22.1	23.9	26.1	12.5	21.1	24.3	83.2	46.0	16.9	29.8	64.0	43.7	46.6	28.8	37.8	22.5	18.1	44.8	41.3	28.0	31.2	25.3	43.2	22.2	22.0	15.9	25.6	29.7	58.6	28.0	27.2	47.8	31.2	47.6	30.5	46.2	33.1	19.2	26.6	22.2	53.9	19.1	15.5	48.0	17.1	16.7	58.4	23.1	30.1	13.7	30.5	29.3	7.3	22.4	27.8	25.9	40.9	30.9	31.6	19.2	49.4	22.0	18.5	62.7	25.0	23.4	48.3	19.1	48.9	51.4	9.0	1.0	9.1	9.9	9.1	11.6	10.1	5.1	8.0	8.8	7.3	4.9	7.7	6.0	4.1	8.2	6.9	4.6	9.2	7.9	19.9	20.7	23.4	24.8	19.9	19.9	21.1	21.2	21.1	18.6	22.6	23.9	16.2	38.5	28.5	0.0	3.3	0.0	0.0	0.0	0.0	0.0	10.6	11.0	0.0	0.0	22.9	14.7	0.0	7.4	10.0	0.0	0.0	16.7	0.0	45.7	19.9	7.9	0.0	0.0	0.0	15.6	6.9	8.9	0.0	20.3	15.2	13.5	0.0	0.0	18.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.2	0.0	0.0	5.7	0.0	0.0	0.0	0.0	15.1	0.0	0.0	2.6	0.0	0.0	11.7	41.5	0.0	0.0	0.0	6.9	0.0	0.0	0.0	0.0	7.7	7.8	9.4	0.0	0.0
WASHC2C	"Em:AC012044.3, FAM21C, KIAA0592"	ENSG00000172661	"WASH complex subunit 2C"	Q9Y4E1	10	45727200-45792964	"Predicted intracellular proteins, Transporters"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 35.3;Alveolar cells type 2: 35.2;Collecting duct cells: 23.9;granulocytes: 30.3;Respiratory ciliated cells: 24.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA047844, HPA060975, HPA061022"	Supported		Supported	Nucleoli,Vesicles,Cytosol		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 32: U-937 - Innate immune response"	"Cluster 7: Non-specific - Mitochondria"	Vesicles	"Nucleoli, Cytosol"	"HPA047844: AB_2680177, HPA060975: AB_2684401, HPA061022: AB_2732656"	"unprognostic (7.50e-2)"	"unprognostic (2.32e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.06e-1)"	"unprognostic (4.51e-2)"	"unprognostic (5.98e-3)"	"prognostic unfavorable (1.35e-5)"	"prognostic favorable (4.69e-4)"	"unprognostic (1.26e-1)"	"unprognostic (5.02e-2)"	"unprognostic (1.00e-3)"	"unprognostic (1.51e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.73e-1)"	"unprognostic (2.00e-2)"	19.4	15.7	10.9	17.3	11.8	42.5	17.5	14.8	14.9	19.1	13.5	20.3	15.2	16.8	12.4	13.5	14.9	16.5	22.0	11.3	11.4	18.0	15.9	17.7	20.2	12.5	12.2	21.6	11.6	21.4	13.9	13.7	12.7	15.6	22.0	14.2	15.3	14.6	17.1	17.6	19.7	19.0	9.6	19.3	15.0	12.9	14.1	21.2	17.1	9.8	18.7	17.7	14.6	14.0	24.5	25.9	20.7	23.5	52.1	45.8	12.4	28.4	45.8	32.4	30.8	16.0	23.3	20.1	18.8	41.7	30.8	21.6	23.2	13.0	32.6	18.9	19.2	20.9	32.3	12.3	55.0	21.4	24.6	43.4	30.4	35.4	26.1	31.6	33.7	16.5	33.9	15.7	40.1	12.8	14.0	35.9	14.8	14.7	3.9	17.4	30.5	10.5	23.8	38.2	10.0	22.3	32.8	16.1	39.4	21.0	22.1	20.6	58.1	16.8	18.0	44.7	19.1	21.5	36.3	19.6	23.5	49.4	9.2	14.1	17.1	11.7	12.2	17.9	11.8	9.9	10.1	12.7	11.7	9.2	10.0	8.9	16.8	12.5	22.8	8.1	10.4	13.3	10.9	11.8	14.8	14.9	11.3	11.4	12.5	12.2	12.7	9.6	14.1	14.0	16.2	35.3	35.2	0.0	3.0	0.0	0.0	0.0	0.0	0.0	11.3	8.8	0.0	0.0	11.8	23.9	0.0	6.8	11.8	0.0	3.9	13.5	0.0	11.3	17.9	6.1	0.0	0.0	0.0	14.0	6.4	7.9	0.0	13.9	30.3	13.7	0.0	0.0	18.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.7	0.0	0.0	10.3	0.0	0.0	0.0	0.0	11.9	0.0	0.0	3.8	0.0	0.0	12.8	24.8	0.0	0.0	0.0	5.9	0.0	0.0	0.0	0.0	7.8	7.0	12.1	0.0	0.0
WBP11	"BUG13, CFAP90, FAP90, NPWBP, PPP1R165, SIPP1"	ENSG00000084463	"WW domain binding protein 11"	Q9Y2W2	12	14784582-14803486	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing, rRNA processing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA039710, HPA040037, HPA046403, HPA049126"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm		"HPA039710: AB_2676638, HPA040037: AB_10796115, HPA046403: AB_2679654, HPA049126: AB_2680644"	"unprognostic (4.40e-2)"	"unprognostic (1.58e-1)"	"unprognostic (4.16e-2)"	"unprognostic (1.39e-2)"	"unprognostic (1.55e-1)"	"unprognostic (4.15e-2)"	"prognostic unfavorable (9.40e-4)"	"unprognostic (5.67e-3)"	"unprognostic (3.30e-2)"	"unprognostic (2.68e-1)"	"unprognostic (9.69e-2)"	"unprognostic (1.68e-1)"	"unprognostic (2.96e-3)"	"unprognostic (6.11e-2)"	"unprognostic (3.07e-1)"	"unprognostic (1.94e-1)"	"unprognostic (4.09e-2)"	22.3	23.4	14.2	22.4	15.3	65.7	20.8	14.3	17.1	17.8	14.3	19.4	16.1	22.4	17.4	19.8	24.1	18.2	31.2	14.6	19.0	20.0	23.1	20.4	27.4	14.5	17.6	24.8	21.0	25.0	13.3	25.1	14.4	21.8	22.2	21.3	21.3	18.0	38.8	23.3	18.8	22.2	13.5	22.9	18.8	39.0	16.8	26.0	24.3	32.9	29.6	21.5	16.8	14.9	52.1	45.3	53.0	102.4	34.7	32.9	95.6	41.8	35.0	62.3	62.3	83.9	63.2	64.1	26.7	38.0	53.0	42.4	82.3	55.3	76.5	114.6	54.5	94.3	48.1	52.0	34.8	89.6	50.1	32.2	43.7	69.8	52.0	33.6	50.2	59.5	61.3	33.7	50.1	50.1	84.0	48.7	171.9	35.4	29.0	70.7	84.3	40.6	45.3	70.8	28.3	57.6	55.8	46.3	44.9	123.8	24.6	58.2	37.8	43.7	66.1	38.9	72.8	29.2	43.8	116.6	45.7	43.6	59.3	12.3	14.0	12.7	18.8	19.4	20.8	18.3	18.1	19.1	13.2	16.9	20.9	19.6	8.7	19.2	20.6	9.6	21.3	13.7	14.2	15.3	14.3	17.1	14.6	19.0	14.5	17.6	14.4	13.5	16.8	14.9	56.8	57.7	61.0	10.1	79.3	54.9	86.9	49.7	41.5	43.7	53.5	40.6	108.6	54.3	60.7	36.8	47.9	57.8	87.2	36.6	43.0	62.5	98.5	70.1	66.8	52.5	39.5	72.6	17.5	59.5	93.3	62.2	32.6	56.7	106.3	41.0	45.0	48.6	46.6	43.7	16.2	37.8	32.6	44.3	42.1	58.4	45.4	56.7	35.6	9.4	104.6	49.6	74.2	13.0	23.0	52.8	22.3	32.7	64.0	64.1	34.0	53.8	78.7	54.1	59.2	79.3	81.3	207.5	140.4	43.5	55.7	75.9	84.8	42.9	42.6	68.1
WBP2	"GRAMD6, WBP-2"	ENSG00000132471	"WW domain binding protein 2"	Q969T9	17	75845699-75856507	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Deafness, Disease variant, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 321.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA065682, HPA068819"	Approved		Supported	Nucleoplasm,Cytosol		No	No		440000	"Cluster 5: Granulocytes - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 51: Myeloid cells - Hemostasis"	"Nucleoplasm, Cytosol"		"HPA065682: AB_2685530, HPA068819: AB_2686042"	"unprognostic (1.74e-1)"	"unprognostic (1.71e-2)"	"unprognostic (3.17e-2)"	"unprognostic (2.85e-1)"	"unprognostic (8.39e-2)"	"unprognostic (7.12e-2)"	"unprognostic (8.89e-2)"	"unprognostic (3.09e-1)"	"unprognostic (2.68e-3)"	"unprognostic (1.58e-1)"	"unprognostic (4.54e-3)"	"unprognostic (6.18e-2)"	"unprognostic (2.21e-1)"	"unprognostic (5.86e-3)"	"unprognostic (1.30e-1)"	"unprognostic (2.13e-2)"	"unprognostic (1.76e-1)"	113.2	223.6	239.5	57.1	238.6	82.7	114.1	225.1	340.9	103.2	163.6	109.7	65.2	84.6	44.3	94.7	106.1	62.8	183.1	243.0	242.2	125.7	184.4	118.1	60.9	293.9	256.8	113.9	134.5	100.7	116.0	55.4	286.4	103.5	39.0	129.7	137.7	73.5	250.2	131.3	85.7	52.0	226.4	112.5	123.2	95.4	259.8	49.2	83.8	91.9	51.8	97.8	94.7	256.6	104.6	119.9	43.4	52.5	88.0	87.2	57.9	32.7	102.1	74.3	91.8	59.7	104.2	52.9	81.9	47.0	232.2	61.0	45.2	100.9	66.3	40.1	90.4	97.7	66.4	97.6	182.2	40.8	161.6	96.4	94.6	89.4	120.8	127.0	143.8	82.1	68.2	156.7	60.2	107.3	85.8	85.8	37.3	70.8	78.8	57.8	85.4	101.5	109.7	62.3	72.6	114.8	58.5	99.9	163.1	76.3	134.9	102.1	84.3	75.8	66.1	73.6	52.3	145.4	109.6	38.8	212.5	38.3	54.9	239.9	85.0	288.7	53.8	102.6	59.1	68.9	59.5	54.6	54.8	55.3	55.8	47.5	308.9	57.4	136.4	42.0	77.4	93.2	239.5	238.6	225.1	340.9	243.0	242.2	293.9	256.8	286.4	226.4	259.8	256.6	73.5	83.3	79.0	34.9	62.7	60.9	127.2	85.9	30.1	109.7	75.2	53.3	73.2	55.8	59.9	53.3	75.0	64.9	45.9	65.9	162.4	124.3	264.5	41.5	21.7	63.4	33.6	124.0	23.6	188.6	65.1	43.5	34.1	44.3	67.0	40.0	54.3	61.9	138.4	112.7	23.4	48.9	71.2	65.5	71.2	321.1	59.4	90.2	60.5	23.4	90.8	104.8	52.5	21.1	38.6	126.5	72.6	53.8	35.6	120.2	88.4	100.7	44.8	120.7	26.3	43.8	44.9	45.5	25.7	24.8	80.0	184.7	51.7	62.5	27.1	95.6
WBP4	"FBP21, MGC117310"	ENSG00000120688	"WW domain binding protein 4"	O75554	13	41061509-41084006	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038965, HPA058738"	Approved		Supported	"Nucleoplasm,Vesicles,Plasma membrane"		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 36: HEL - Hemostasis"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm	"Vesicles, Plasma membrane"	"HPA038965: AB_10672836, HPA058738: AB_2683803"	"unprognostic (2.56e-1)"	"unprognostic (3.69e-3)"	"unprognostic (1.75e-1)"	"unprognostic (1.99e-2)"	"unprognostic (9.30e-2)"	"unprognostic (1.76e-3)"	"unprognostic (1.54e-2)"	"unprognostic (2.13e-2)"	"unprognostic (1.34e-2)"	"unprognostic (2.05e-2)"	"unprognostic (3.71e-3)"	"unprognostic (2.97e-1)"	"unprognostic (2.66e-2)"	"unprognostic (8.52e-2)"	"unprognostic (7.65e-3)"	"prognostic favorable (2.89e-4)"	"unprognostic (2.52e-1)"	17.5	16.0	16.1	9.8	16.8	15.6	13.4	16.5	23.9	12.0	13.2	13.2	11.2	18.5	16.0	11.2	11.1	9.3	23.1	16.1	18.1	12.3	16.3	10.4	11.8	16.3	16.6	13.2	8.7	12.4	8.2	11.5	16.4	14.0	9.1	16.5	8.1	14.7	41.0	11.3	11.5	14.8	15.7	9.8	9.3	12.2	16.5	14.7	11.2	29.8	11.6	11.3	11.0	18.6	15.0	9.8	26.7	17.3	17.1	25.9	16.2	33.3	23.4	25.9	19.7	15.5	15.7	21.4	13.0	23.6	31.2	20.6	10.2	16.7	33.0	22.3	14.3	30.2	10.0	16.0	26.3	19.1	18.8	21.3	25.0	18.8	26.5	21.1	22.0	20.3	16.4	9.1	27.5	12.6	27.3	20.6	16.3	23.2	8.0	25.3	16.5	8.4	23.6	14.6	6.1	14.7	10.6	11.3	16.1	21.5	9.4	29.3	19.3	16.0	14.7	22.2	19.5	6.0	7.0	14.7	19.7	13.7	22.2	19.2	13.0	12.4	10.6	12.0	9.7	14.2	13.6	11.5	11.0	12.6	14.4	14.3	27.3	12.5	21.8	18.5	14.4	6.1	16.1	16.8	16.5	23.9	16.1	18.1	16.3	16.6	16.4	15.7	16.5	18.6	42.4	51.3	29.3	21.2	23.9	54.4	60.3	54.8	33.0	46.8	33.5	37.5	110.0	40.0	32.5	25.8	33.3	55.6	23.0	32.3	76.3	52.3	11.9	32.9	58.4	46.9	37.8	111.7	17.0	42.0	61.1	52.2	15.8	44.5	45.7	27.5	38.2	63.1	40.9	45.4	16.6	28.1	18.3	26.7	47.1	9.7	47.8	33.0	32.0	10.3	60.4	63.8	28.8	17.1	33.3	50.3	33.2	52.6	16.8	60.9	33.8	70.6	23.6	49.2	26.3	55.3	66.7	87.5	103.9	29.7	44.9	49.9	22.3	31.9	27.6	40.9
WDFY1	"FENS-1, KIAA1435, WDF1, ZFYVE17"	ENSG00000085449	"WD repeat and FYVE domain containing 1"	Q8IWB7	2	223855716-223945357	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA050603, HPA079597"	Approved		Supported	"Golgi apparatus,Vesicles"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 44: Endometrium - Transcription"	"Golgi apparatus, Vesicles"		"HPA050603: AB_2681188, HPA079597: "	"unprognostic (2.49e-1)"	"unprognostic (1.24e-1)"	"unprognostic (2.94e-1)"	"unprognostic (7.62e-2)"	"unprognostic (8.24e-2)"	"unprognostic (5.31e-2)"	"unprognostic (2.63e-2)"	"unprognostic (7.10e-2)"	"unprognostic (1.26e-1)"	"unprognostic (2.29e-2)"	"unprognostic (1.23e-3)"	"unprognostic (1.36e-1)"	"unprognostic (3.81e-3)"	"unprognostic (3.94e-1)"	"unprognostic (2.98e-1)"	"unprognostic (3.04e-1)"	"unprognostic (7.55e-2)"	18.6	13.2	9.3	18.0	9.5	48.5	14.4	9.3	12.0	20.5	11.2	20.4	15.6	22.6	19.8	14.4	20.5	17.5	11.7	9.2	10.7	14.8	18.0	18.4	23.3	11.0	10.2	20.2	14.1	19.8	8.7	27.4	11.4	16.2	20.1	15.9	13.5	12.8	11.4	13.5	15.9	19.6	9.7	21.2	19.8	10.9	10.5	15.9	22.1	12.6	18.9	17.9	13.7	11.1	27.9	19.3	34.9	27.2	46.4	44.0	43.7	34.7	48.3	37.5	30.4	81.4	25.0	7.7	30.8	60.6	47.3	19.2	18.7	52.3	40.4	15.6	15.8	19.2	31.9	59.2	36.4	15.2	15.8	39.0	37.9	46.3	71.0	62.4	63.9	16.2	34.3	23.4	44.4	26.8	6.5	11.1	34.5	20.7	16.6	25.3	44.8	8.6	28.4	47.7	29.6	15.7	20.7	19.2	90.9	41.6	12.5	38.1	70.9	74.9	25.7	13.5	18.0	28.8	4.6	21.4	36.3	32.9	26.2	4.4	21.5	8.1	13.7	29.0	16.6	14.1	9.7	13.5	14.8	11.7	10.0	9.5	10.3	24.0	25.7	3.0	9.7	17.6	9.3	9.5	9.3	12.0	9.2	10.7	11.0	10.2	11.4	9.7	10.5	11.1	40.0	16.0	9.3	22.5	22.0	12.5	14.5	19.9	17.1	14.0	11.8	7.6	7.7	12.8	24.4	16.5	8.4	22.6	25.5	36.4	9.8	12.9	0.8	23.2	30.7	34.1	10.3	11.2	28.7	17.2	11.2	21.4	29.6	36.5	17.7	12.5	16.8	25.7	17.9	28.6	28.1	15.2	8.2	26.3	17.2	2.4	14.6	24.4	35.6	27.2	25.6	13.9	24.7	33.7	39.8	18.0	24.4	23.7	21.8	16.6	16.0	14.4	29.9	10.9	6.6	13.1	26.7	3.8	8.8	24.4	15.5	19.0	21.1	15.0	21.8	28.7
WDFY2	ZFYVE22	ENSG00000139668	"WD repeat and FYVE domain containing 2"	Q96P53	13	51584455-51767709	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 301.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA050094			Supported	Vesicles		NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 52: Non-specific - Transcription"	Vesicles		"HPA050094: "	"unprognostic (2.95e-1)"	"unprognostic (1.78e-1)"	"unprognostic (2.09e-2)"	"unprognostic (2.95e-3)"	"unprognostic (1.59e-1)"	"unprognostic (2.41e-1)"	"unprognostic (1.39e-2)"	"unprognostic (9.58e-2)"	"unprognostic (2.28e-1)"	"unprognostic (2.59e-2)"	"unprognostic (3.87e-2)"	"unprognostic (1.14e-1)"	"unprognostic (7.49e-4)"	"unprognostic (1.47e-1)"	"unprognostic (7.04e-2)"	"unprognostic (6.36e-2)"	"unprognostic (2.48e-1)"	6.7	11.2	8.9	4.5	12.1	15.0	7.6	9.0	8.8	8.4	4.8	3.9	1.9	5.1	5.5	9.5	6.5	2.9	3.8	8.9	10.4	4.5	6.4	5.4	4.7	11.5	9.9	8.1	17.5	15.0	5.2	5.4	12.4	5.1	2.3	6.0	5.6	4.9	1.6	17.7	4.3	3.6	10.0	7.5	6.5	6.5	10.2	4.4	5.9	3.0	5.1	4.3	8.6	15.4	1.4	2.6	11.3	4.6	5.4	11.2	3.6	11.0	7.0	5.6	4.4	1.7	1.5	4.5	1.0	7.6	3.6	5.0	6.3	19.7	10.6	3.7	3.5	9.6	3.8	13.6	4.3	6.5	4.4	9.1	9.3	12.5	14.2	9.1	2.5	4.8	2.7	2.3	9.3	3.1	4.5	14.8	13.4	3.2	3.7	5.9	4.5	3.0	7.2	3.8	3.1	7.5	3.3	4.9	5.0	9.3	2.3	15.5	9.4	10.6	2.0	5.2	7.8	1.5	2.6	3.2	12.1	6.6	13.3	6.1	7.8	4.0	2.2	8.6	3.1	3.8	2.4	1.9	13.0	4.2	2.1	2.7	5.2	4.0	9.5	11.9	3.5	3.5	8.9	12.1	9.0	8.8	8.9	10.4	11.5	9.9	12.4	10.0	10.2	15.4	16.3	16.0	21.9	118.2	36.9	23.3	20.0	10.2	45.5	35.2	25.7	24.0	7.1	8.6	17.5	29.5	127.2	28.5	41.2	7.0	27.4	19.8	46.3	19.3	23.6	13.0	13.8	17.1	47.1	23.5	33.7	20.7	14.8	20.2	29.7	35.3	27.1	18.1	28.1	37.0	47.1	9.2	8.2	63.8	30.8	19.9	39.4	41.3	12.4	96.5	45.9	26.4	16.5	106.6	301.8	15.0	4.5	21.8	17.1	12.2	9.2	6.4	14.9	52.5	26.3	45.1	27.1	32.3	16.5	46.4	27.1	14.0	27.3	41.7	10.0	16.2
WDFY3	"ALFY, KIAA0993, ZFYVE25"	ENSG00000163625	"WD repeat and FYVE domain containing 3"	Q8IZQ1	4	84669597-84966690	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	Autophagy	"Developmental protein"	"Disease variant, Primary microcephaly"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 44.9"	"Group enriched"	"Detected in many"	5	"Astrocytes: 241.0;Excitatory neurons: 231.0;Inhibitory neurons: 248.7;Microglial cells: 209.9;Oligodendrocyte precursor cells: 262.9;Oligodendrocytes: 440.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"neutrophil: 1.3"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"TIME: 57.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042734, HPA048572"	Approved		Approved	"Nucleoli,Plasma membrane,Cytosol"		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Cytosol	"Nucleoli, Plasma membrane"	"HPA042734: AB_2678135, HPA048572: AB_2680447"	"unprognostic (7.14e-2)"	"unprognostic (6.02e-2)"	"unprognostic (7.68e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.84e-2)"	"unprognostic (2.48e-1)"	"unprognostic (2.86e-2)"	"unprognostic (3.36e-1)"	"unprognostic (1.01e-1)"	"unprognostic (4.33e-2)"	"unprognostic (3.36e-1)"	"unprognostic (7.12e-2)"	"prognostic favorable (3.64e-5)"	"prognostic unfavorable (9.35e-4)"	"unprognostic (2.79e-1)"	"unprognostic (4.41e-2)"	"unprognostic (4.95e-2)"	8.6	8.6	14.8	7.6	31.7	14.4	8.7	26.8	22.9	8.5	4.7	5.7	3.6	8.2	6.4	7.4	8.2	8.8	5.7	16.3	15.6	20.1	5.6	7.4	2.6	30.6	30.4	13.6	9.0	16.3	6.5	11.8	28.7	8.6	5.6	26.2	7.2	7.4	5.9	10.8	4.7	8.5	21.7	7.8	5.6	8.1	25.6	3.4	11.7	13.2	2.3	8.7	5.7	44.9	11.9	7.8	14.3	7.9	24.8	19.3	9.0	11.2	11.8	11.5	10.3	9.1	9.6	0.0	11.3	18.8	12.3	5.9	15.4	12.3	14.6	7.9	4.9	7.5	9.0	5.5	9.4	5.9	13.7	14.2	10.9	15.0	15.1	13.9	37.1	6.0	7.5	35.3	21.4	8.5	5.7	1.4	7.4	11.4	4.0	8.4	11.4	1.8	19.6	15.6	16.8	7.8	13.8	15.1	7.5	13.5	7.9	14.4	57.0	15.1	14.9	8.5	14.1	0.1	0.0	0.0	10.2	5.0	16.9	0.0	0.3	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.3	0.0	0.1	0.0	0.0	0.1	14.8	31.7	26.8	22.9	16.3	15.6	30.6	30.4	28.7	21.7	25.6	44.9	28.5	19.2	12.9	241.0	1.0	14.7	9.1	12.4	11.4	46.6	13.8	11.3	18.2	20.0	14.7	16.5	35.5	11.8	0.5	6.5	1.9	8.6	6.7	27.1	27.8	20.1	9.1	1.3	231.0	7.3	6.9	19.5	15.3	43.4	0.0	31.0	17.9	8.1	20.5	28.6	248.7	7.8	20.3	43.1	14.1	10.1	18.3	29.9	7.2	209.9	19.7	28.7	0.0	262.9	440.4	10.7	6.5	24.5	0.2	13.6	4.8	18.4	15.5	41.9	26.3	30.0	22.8	11.4	7.3	14.1	16.1	14.5	1.8	15.0	6.7	13.6
WDR1		ENSG00000071127	"WD repeat domain 1"	O75083	4	10074339-10116949	"Plasma proteins, Predicted intracellular proteins"		Actin-binding	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 1232.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB020804, HPA036434, HPA070293"	Approved		Supported	"Plasma membrane,Cell Junctions"		NA	NA		63000000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 34: Spermatids - Unknown function"	"Plasma membrane, Cell Junctions"		"CAB020804: , HPA036434: AB_2675121, HPA070293: AB_2732152"	"unprognostic (1.35e-1)"	"unprognostic (6.64e-2)"	"unprognostic (5.31e-2)"	"unprognostic (1.32e-3)"	"unprognostic (2.65e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.63e-3)"	"unprognostic (6.83e-3)"	"unprognostic (1.69e-1)"	"unprognostic (9.00e-3)"	"unprognostic (2.52e-2)"	"unprognostic (2.61e-1)"	"prognostic favorable (1.73e-5)"	"unprognostic (1.11e-1)"	"unprognostic (3.56e-1)"	"unprognostic (3.46e-2)"	"unprognostic (4.83e-3)"	133.7	77.7	60.2	194.5	58.1	150.9	107.8	56.8	65.4	147.1	104.2	200.8	149.1	261.1	91.0	165.1	179.5	117.4	134.2	69.7	69.7	119.4	84.2	142.8	174.6	68.4	69.7	120.5	63.7	89.6	58.4	105.4	68.6	124.5	141.5	93.0	124.9	173.7	94.8	110.4	148.3	214.6	63.1	110.0	131.7	131.9	62.6	188.0	109.8	89.5	149.6	203.0	139.3	68.8	249.5	246.9	213.2	179.4	160.1	265.9	336.9	612.9	561.7	542.9	423.1	296.4	303.3	173.6	193.3	744.4	579.3	158.8	237.3	451.0	582.4	270.7	82.8	494.1	244.6	213.8	377.9	159.4	538.6	256.7	228.4	552.9	276.3	418.7	599.3	301.6	151.6	273.3	540.7	142.8	700.1	229.0	253.4	200.7	250.4	327.8	197.7	146.7	344.9	394.7	72.4	80.5	265.6	141.3	257.3	282.9	120.1	173.9	909.9	415.7	174.6	345.7	548.0	173.4	296.4	225.5	439.7	240.4	522.9	177.4	115.7	213.6	172.3	195.9	134.4	81.6	143.8	173.0	141.4	61.1	145.6	156.9	201.5	129.0	246.9	154.5	214.9	298.4	60.2	58.1	56.8	65.4	69.7	69.7	68.4	69.7	68.6	63.1	62.6	68.8	66.5	35.3	52.9	10.1	77.0	145.3	204.6	103.5	46.7	22.0	65.9	68.7	62.9	52.9	87.4	104.8	41.7	172.5	126.7	347.1	86.1	282.5	500.8	72.2	63.8	103.6	109.2	56.8	4.7	211.3	302.4	68.7	118.3	111.7	82.4	78.7	84.3	71.8	249.2	33.7	8.4	152.6	138.4	159.4	135.8	1232.1	46.9	174.9	80.0	15.0	303.7	82.6	147.2	11.6	9.6	322.8	244.4	92.2	78.3	150.7	169.0	113.1	73.5	28.0	98.6	46.1	168.1	81.6	64.3	74.9	137.0	231.6	132.2	77.2	172.8	193.6
WDR13		ENSG00000101940	"WD repeat domain 13"	Q9H1Z4	X	48590042-48608869	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000913	Supported		Supported	"Nucleoplasm,Plasma membrane,Centriolar satellite"		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 22: Non-specific - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Nucleoplasm	"Plasma membrane, Centriolar satellite"	"HPA000913: AB_1858795"	"unprognostic (5.03e-2)"	"unprognostic (6.53e-3)"	"unprognostic (3.65e-3)"	"unprognostic (2.10e-3)"	"unprognostic (3.50e-1)"	"unprognostic (1.54e-3)"	"unprognostic (3.54e-2)"	"unprognostic (6.76e-2)"	"unprognostic (2.40e-2)"	"unprognostic (3.48e-1)"	"unprognostic (1.58e-2)"	"unprognostic (1.33e-1)"	"unprognostic (2.82e-1)"	"unprognostic (2.99e-1)"	"unprognostic (1.66e-1)"	"unprognostic (2.65e-1)"	"unprognostic (4.32e-2)"	67.2	76.7	84.2	27.7	81.1	34.6	63.8	68.2	95.2	71.6	85.0	71.6	43.8	71.5	73.7	54.6	67.1	33.4	150.3	85.7	70.4	91.9	106.3	60.8	23.4	73.0	70.2	93.1	189.2	36.9	80.1	29.5	70.5	67.5	26.3	28.2	75.7	45.3	105.2	56.9	54.4	37.5	69.4	58.6	76.6	22.9	74.5	18.7	64.8	83.0	19.6	59.5	56.3	78.5	41.6	59.4	29.3	90.8	39.3	57.4	22.4	28.1	50.7	31.9	29.0	35.5	64.8	28.7	26.3	57.8	25.7	35.0	14.6	61.6	11.3	34.2	26.2	19.7	72.2	65.3	89.3	17.1	51.4	54.7	86.4	45.3	82.7	55.6	44.4	16.3	19.8	35.5	44.9	59.4	23.7	29.9	21.2	18.0	46.6	22.4	31.0	52.3	56.7	32.6	33.9	41.9	31.8	65.2	66.9	20.4	41.9	32.6	74.0	33.0	48.8	52.8	27.5	41.0	16.6	11.0	48.9	25.3	46.5	75.5	42.4	24.7	20.9	47.4	16.7	32.7	21.8	19.9	39.1	25.0	17.4	19.6	29.9	33.0	57.2	24.6	27.0	31.1	84.2	81.1	68.2	95.2	85.7	70.4	73.0	70.2	70.5	69.4	74.5	78.5	61.1	44.8	41.7	19.9	22.3	35.1	72.8	69.1	37.5	45.5	39.2	35.8	79.7	68.6	49.9	20.2	54.2	44.2	19.9	75.5	103.7	89.0	6.1	75.9	36.1	54.0	50.4	31.2	7.8	119.2	34.5	50.5	62.2	53.0	30.4	46.2	65.3	50.2	42.6	33.7	6.6	58.3	50.8	35.4	30.6	20.8	51.6	34.9	58.7	15.0	42.1	68.9	22.6	7.1	14.0	96.8	75.0	43.2	28.3	48.3	90.2	140.7	74.3	55.6	46.0	51.2	59.6	11.2	21.0	29.7	29.8	70.7	21.4	56.2	59.8	65.8
WDR18	Ipi3	ENSG00000065268	"WD repeat domain 18"	Q9BV38	19	984332-998438	"Plasma proteins, Predicted intracellular proteins"		"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Extravillous trophoblasts: 162.0;Proximal tubular cells: 207.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA050193, HPA050200"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Nucleoplasm		"HPA050193: AB_2681047, HPA050200: AB_2681049"	"unprognostic (7.94e-2)"	"unprognostic (3.08e-1)"	"unprognostic (2.51e-1)"	"unprognostic (2.13e-3)"	"unprognostic (8.58e-2)"	"unprognostic (2.03e-1)"	"unprognostic (7.14e-2)"	"unprognostic (4.88e-2)"	"unprognostic (6.69e-2)"	"unprognostic (2.70e-1)"	"unprognostic (6.74e-3)"	"unprognostic (1.43e-2)"	"unprognostic (2.86e-2)"	"unprognostic (1.60e-2)"	"unprognostic (2.50e-1)"	"unprognostic (3.07e-1)"	"unprognostic (2.35e-1)"	14.8	21.7	12.3	12.0	12.6	11.3	15.3	12.7	18.3	14.0	11.5	16.4	11.6	14.8	3.3	26.0	13.9	4.9	20.6	12.6	11.6	25.1	31.7	12.7	8.8	13.6	12.1	13.7	18.3	8.3	18.9	10.2	13.1	16.4	4.2	7.1	16.0	9.3	23.7	21.5	14.6	4.1	11.8	18.2	15.8	17.7	13.0	8.4	15.6	8.8	6.7	15.2	15.6	13.4	58.3	55.2	16.7	28.2	15.7	14.4	68.0	25.6	14.3	30.5	22.6	62.8	19.6	68.9	29.8	37.2	3.6	46.6	45.4	53.3	11.8	36.1	75.3	33.3	34.1	79.8	36.7	71.7	30.1	18.5	28.1	18.2	42.5	15.5	28.3	32.7	74.9	25.7	11.4	62.3	53.2	102.9	96.1	39.7	35.8	99.1	39.8	107.0	19.4	35.8	63.7	60.4	24.3	20.0	26.5	11.5	47.5	42.6	28.8	34.3	41.7	67.8	40.7	83.0	74.9	33.7	29.6	44.3	37.0	11.5	77.5	18.9	53.4	84.8	52.8	56.6	53.7	58.0	117.8	69.7	53.2	48.4	3.6	57.1	70.8	74.6	65.2	66.7	12.3	12.6	12.7	18.3	12.6	11.6	13.6	12.1	13.1	11.8	13.0	13.4	20.8	9.6	13.0	10.4	19.5	19.4	28.4	57.9	25.0	28.6	23.1	22.6	13.6	15.7	31.1	31.3	22.9	90.3	14.5	22.4	70.5	73.2	35.6	18.0	17.4	24.6	32.3	20.8	9.8	54.4	162.0	22.3	23.0	18.9	16.5	47.7	23.6	43.0	46.0	26.9	7.9	33.0	44.7	19.2	17.2	38.2	15.5	19.2	16.0	5.6	47.7	32.2	23.7	1.5	6.0	47.8	23.9	16.1	30.0	27.9	28.8	207.8	27.2	24.8	13.1	16.2	31.7	36.5	30.6	29.8	20.3	60.1	18.7	43.7	48.3	24.2
WDR24	"C16orf21, DKFZp434F054, JFP7"	ENSG00000127580	"WD repeat domain 24"	Q96S15	16	684622-690444	"Predicted intracellular proteins"	Autophagy			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Late spermatids: 48.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039506	Approved		Supported	Vesicles,Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 71: Testis - DNA repair"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 31: Spermatids - Spermatogenesis"	Vesicles	Cytosol	"HPA039506: AB_10795148"	"unprognostic (9.07e-2)"	"unprognostic (2.67e-3)"	"unprognostic (6.67e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.67e-1)"	"unprognostic (8.15e-2)"	"unprognostic (7.05e-2)"	"unprognostic (4.35e-2)"	"unprognostic (1.75e-1)"	"unprognostic (5.09e-3)"	"unprognostic (2.29e-3)"	"unprognostic (2.05e-1)"	"prognostic favorable (3.75e-6)"	"unprognostic (5.38e-2)"	"unprognostic (3.16e-1)"	"unprognostic (1.52e-1)"	"unprognostic (2.82e-2)"	6.1	9.1	3.9	4.0	3.6	3.9	6.2	5.0	6.9	7.5	4.1	7.1	4.8	7.9	1.0	7.1	7.5	2.8	7.9	3.8	3.0	7.5	11.2	6.0	4.8	4.2	4.0	9.2	7.2	5.8	9.4	3.2	3.5	8.5	1.1	1.8	6.9	3.0	11.7	8.5	7.1	2.0	3.2	9.2	7.8	14.2	3.9	4.3	8.7	4.1	2.4	7.5	6.6	3.7	6.1	14.0	6.2	8.6	5.9	4.2	10.9	7.5	6.7	9.2	8.0	15.3	8.8	9.4	12.8	3.4	2.3	9.4	6.1	7.4	2.0	15.9	19.0	6.4	19.8	5.8	9.4	7.9	9.6	7.4	4.9	6.6	5.5	4.8	5.0	9.0	12.7	10.3	3.4	22.2	14.0	5.8	9.7	3.1	10.6	20.4	5.1	17.6	3.0	4.2	15.1	6.9	8.5	14.3	8.7	2.8	13.2	7.8	7.3	6.6	6.8	7.4	7.3	21.9	21.5	15.3	4.3	7.8	9.4	4.3	5.1	2.8	6.6	3.0	5.4	4.3	4.2	4.9	5.1	3.7	4.9	4.8	1.2	3.0	7.8	4.1	6.1	5.0	3.9	3.6	5.0	6.9	3.8	3.0	4.2	4.0	3.5	3.2	3.9	3.7	2.9	6.4	6.2	2.3	4.2	1.1	2.6	4.7	4.0	5.1	5.2	4.4	5.0	1.5	5.0	7.3	2.1	7.4	2.9	6.0	7.9	4.9	17.1	12.2	2.9	3.1	10.1	5.2	2.0	5.6	4.4	3.1	6.6	2.9	4.5	6.9	2.5	9.6	5.1	21.9	2.0	7.3	4.1	6.3	1.6	48.0	5.6	3.9	0.0	1.9	4.4	7.3	1.0	2.0	2.4	4.5	2.1	3.0	6.8	3.8	8.0	6.4	19.4	2.6	19.7	2.6	4.2	18.8	8.7	2.1	1.6	7.4	3.4	7.6	5.5	2.0
WDR36	"GLC1G, TA-WDRP, UTP21"	ENSG00000134987	"WD repeat domain 36"	Q8NI36	5	111091716-111130502	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Ribosome biogenesis, rRNA processing, Sensory transduction, Vision"		"Disease variant, Glaucoma"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Basal squamous epithelial cells: 113.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037796, HPA037797"	Supported		Supported	Nucleoli		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 59: Non-specific - Transcription"	Nucleoli		"HPA037796: AB_2675673, HPA037797: AB_10672725"	"unprognostic (2.14e-1)"	"unprognostic (4.56e-2)"	"unprognostic (1.45e-2)"	"unprognostic (2.81e-1)"	"unprognostic (2.60e-1)"	"unprognostic (1.09e-2)"	"unprognostic (1.29e-2)"	"unprognostic (1.64e-1)"	"unprognostic (9.79e-2)"	"unprognostic (7.10e-3)"	"unprognostic (3.09e-1)"	"unprognostic (1.92e-1)"	"unprognostic (5.31e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.93e-1)"	"prognostic unfavorable (1.18e-4)"	"unprognostic (4.91e-2)"	9.1	6.3	3.5	9.4	3.5	9.9	10.1	4.7	4.5	7.4	4.1	7.0	6.5	9.0	6.6	7.9	6.8	7.2	6.0	3.9	4.1	7.5	14.1	6.3	11.3	3.6	4.0	10.1	6.4	7.3	4.5	7.5	3.8	8.3	8.1	4.7	6.0	7.0	9.1	10.1	6.8	7.5	3.8	8.8	7.3	6.3	3.9	9.1	9.7	7.2	12.0	9.8	6.1	4.2	17.0	14.9	13.7	36.6	24.7	32.2	19.2	14.6	13.9	19.5	27.9	19.1	19.7	53.8	17.0	12.2	22.7	19.2	26.8	33.8	34.8	15.9	15.7	26.6	17.2	19.5	26.3	25.6	38.8	19.2	21.4	34.6	37.5	36.5	20.3	18.4	32.3	18.1	25.8	14.3	31.7	24.9	18.3	16.8	15.6	25.6	29.9	42.4	18.1	19.3	24.3	19.5	18.6	15.2	22.4	15.0	15.2	21.3	19.1	28.1	15.6	20.0	30.5	18.1	14.0	48.6	22.4	37.9	22.2	0.3	2.5	1.0	3.3	3.3	3.8	2.7	3.0	3.7	4.0	2.4	4.3	3.6	0.1	3.3	5.0	2.1	3.8	2.6	3.5	3.5	4.7	4.5	3.9	4.1	3.6	4.0	3.8	3.8	3.9	4.2	17.2	19.2	13.8	15.3	26.0	61.1	15.4	18.3	113.3	9.9	14.5	12.1	15.6	18.6	19.6	16.5	6.2	9.4	15.4	5.3	7.9	9.5	5.1	10.6	26.0	20.4	6.0	20.6	30.5	13.8	9.9	20.7	13.7	16.2	14.0	16.9	12.5	35.1	14.7	11.8	24.8	12.9	16.2	24.1	16.0	4.2	8.7	18.2	21.4	20.6	18.3	5.7	16.5	27.6	22.3	9.9	6.4	11.3	27.5	20.8	5.3	11.3	12.3	8.6	19.7	20.2	17.3	18.5	17.8	42.3	57.8	5.3	18.0	18.1	13.4	11.2
WDR4	"TRM82, TRMT82"	ENSG00000160193	"WD repeat domain 4"	P57081	21	42843094-42879568	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"DNA damage, tRNA processing"		"Disease variant, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 25.8;Prostatic glandular cells: 24.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017381	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm	Cytosol	"HPA017381: AB_1858807"	"unprognostic (3.47e-2)"	"unprognostic (2.15e-2)"	"unprognostic (4.32e-2)"	"unprognostic (2.13e-2)"	"unprognostic (2.95e-2)"	"unprognostic (1.89e-2)"	"prognostic unfavorable (5.48e-7)"	"unprognostic (2.85e-3)"	"unprognostic (5.37e-2)"	"unprognostic (2.27e-2)"	"unprognostic (4.25e-1)"	"unprognostic (4.78e-2)"	"unprognostic (2.65e-2)"	"unprognostic (1.74e-3)"	"unprognostic (1.44e-1)"	"unprognostic (1.74e-1)"	"unprognostic (4.46e-2)"	5.1	4.7	4.0	7.2	3.9	6.7	3.9	3.8	4.8	4.3	3.4	3.8	5.0	5.1	1.9	9.1	4.1	1.8	3.5	3.8	3.4	4.8	6.0	3.8	9.3	4.3	3.9	4.3	5.6	2.9	2.3	4.1	4.4	3.4	3.1	1.6	3.6	2.6	6.7	5.0	4.0	3.3	3.9	5.4	3.6	4.7	4.0	5.3	4.1	3.2	7.3	5.7	5.0	4.5	35.7	48.5	12.9	18.5	6.9	8.2	30.7	20.2	7.3	16.9	10.7	48.9	18.1	58.8	11.5	14.5	24.5	19.3	44.7	25.5	11.8	19.2	42.0	59.7	52.0	41.9	13.3	36.8	14.5	4.7	11.2	22.9	16.4	6.3	22.1	20.9	72.6	22.0	14.8	29.4	38.5	20.9	32.3	26.4	47.0	41.6	7.8	58.4	12.8	21.2	30.4	19.5	21.2	31.1	10.2	4.1	20.4	28.2	16.4	25.9	17.3	12.1	41.0	28.9	21.6	48.1	12.5	57.2	31.1	0.0	3.9	0.2	2.4	6.8	3.6	5.4	3.4	3.1	7.1	4.9	3.4	3.5	0.0	3.6	4.2	3.5	4.4	3.5	4.0	3.9	3.8	4.8	3.8	3.4	4.3	3.9	4.4	3.9	4.0	4.5	3.6	0.0	4.8	5.5	10.3	8.5	12.7	7.3	4.0	4.1	5.3	4.6	2.5	0.0	3.2	0.0	2.1	16.3	5.5	5.9	0.0	7.4	4.8	2.8	5.8	5.2	5.4	8.4	4.8	6.7	25.8	4.7	6.1	3.4	10.2	5.4	3.6	7.0	12.5	3.3	4.5	6.0	4.1	3.5	4.0	3.8	2.8	4.7	7.2	2.8	1.9	3.8	2.1	1.5	5.1	6.9	1.0	3.0	15.3	24.6	3.5	6.8	2.1	4.6	6.6	2.7	6.1	10.4	8.4	7.5	10.9	11.5	3.6	8.2	7.7	10.7
WDR44	"DKFZp686L20145, RAB11BP, RPH11, SYM-4"	ENSG00000131725	"WD repeat domain 44"	Q5JSH3	X	118346073-118449961	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Oligodendrocytes: 89.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038084, HPA046719"	Approved		Supported	"Golgi apparatus"		NA	NA		1800000	"Cluster 44: Non-specific - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Golgi apparatus"		"HPA038084: AB_10675626, HPA046719: AB_2679772"	"unprognostic (1.51e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.01e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.67e-1)"	"unprognostic (2.40e-1)"	"unprognostic (1.04e-1)"	"unprognostic (4.56e-1)"	"unprognostic (1.52e-1)"	"unprognostic (6.09e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.88e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.08e-1)"	"unprognostic (4.98e-2)"	"unprognostic (5.52e-2)"	8.4	7.3	6.6	8.2	8.9	6.0	6.3	7.9	7.6	8.0	2.5	6.8	8.3	7.8	6.7	11.3	5.8	11.8	8.3	7.1	6.9	6.0	12.8	7.9	9.4	6.0	6.5	7.6	6.7	10.1	5.2	7.2	6.1	7.5	6.2	8.4	5.6	10.5	9.7	5.1	7.7	10.4	5.7	8.1	8.6	9.8	7.2	10.6	6.9	8.9	9.2	10.0	6.9	10.1	16.4	9.4	10.0	5.8	16.7	13.6	5.5	25.2	17.6	17.9	25.2	6.4	18.4	4.6	14.4	18.1	15.1	12.6	19.7	12.0	20.6	18.6	8.8	18.5	23.3	4.2	11.5	11.7	12.4	8.1	12.6	17.0	11.4	18.2	16.1	8.5	14.8	15.8	17.3	8.0	9.2	6.9	18.1	12.3	15.1	7.2	8.6	7.2	14.6	10.3	4.3	6.7	23.9	8.3	7.9	17.7	7.4	8.3	20.5	13.3	5.1	18.2	14.4	5.9	10.0	6.5	11.2	13.7	9.1	8.0	3.2	7.3	5.4	4.9	5.5	3.6	4.4	5.4	5.1	3.2	5.1	5.6	2.0	7.2	5.5	3.7	7.1	4.0	6.6	8.9	7.9	7.6	7.1	6.9	6.0	6.5	6.1	5.7	7.2	10.1	14.3	22.4	15.0	18.3	11.0	14.8	7.2	6.3	9.1	8.9	7.6	6.3	11.4	10.0	6.2	12.9	10.4	2.3	9.9	9.6	1.9	5.2	0.4	10.9	10.8	12.0	1.2	5.0	35.2	5.3	2.2	11.1	14.3	17.8	8.8	9.8	5.7	16.7	8.6	1.7	41.2	5.2	4.1	13.6	17.7	1.3	7.2	17.2	7.2	40.3	10.3	7.5	11.3	35.2	89.6	11.0	5.8	11.3	12.1	10.2	6.2	4.2	9.1	7.0	26.3	9.3	11.1	17.5	17.6	12.3	9.2	1.2	14.7	5.7	4.6	7.4
WDR46	"BING4, C6orf11, UTP7"	ENSG00000227057	"WD repeat domain 46"	O15213	6	33279108-33289247	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA043004, HPA055425"	Uncertain		Supported	Nucleoli		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 72: Non-specific - Transcription"	"Cluster 16: U-266 - Nucleosome"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoli		"HPA043004: AB_10967417, HPA055425: "	"unprognostic (1.84e-1)"	"unprognostic (7.54e-2)"	"unprognostic (2.82e-1)"	"unprognostic (1.68e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.51e-3)"	"unprognostic (2.63e-3)"	"unprognostic (2.62e-1)"	"unprognostic (6.07e-2)"	"unprognostic (1.74e-1)"	"unprognostic (4.22e-2)"	"prognostic unfavorable (4.75e-4)"	"unprognostic (9.03e-2)"	"unprognostic (1.35e-1)"	"unprognostic (3.97e-1)"	"unprognostic (2.32e-1)"	19.4	19.0	2.2	14.1	2.4	12.6	18.9	1.8	3.8	21.2	2.5	16.4	13.5	23.6	13.6	19.1	17.4	3.2	12.8	2.7	2.7	15.6	17.1	14.7	10.6	2.2	2.4	17.3	19.2	3.0	19.7	5.5	2.6	16.8	11.2	3.0	18.7	2.7	26.1	23.9	15.6	9.6	2.2	20.4	16.7	14.8	2.5	6.3	16.4	12.6	18.8	19.6	17.8	3.5	0.9	21.1	15.3	61.2	11.4	1.6	56.2	42.3	4.9	0.2	7.0	27.8	15.5	49.4	35.5	22.5	60.2	23.4	3.9	31.0	19.3	31.6	32.2	65.6	20.3	54.0	10.4	56.6	74.2	12.5	5.2	18.4	9.5	15.6	0.0	26.6	37.5	13.8	6.8	23.3	32.1	46.8	45.1	8.5	18.3	47.1	28.1	40.3	9.3	20.7	30.9	40.3	20.4	44.4	46.9	18.3	17.2	37.8	30.9	37.9	42.8	31.6	64.3	56.5	104.3	83.5	16.4	55.9	35.3	12.1	17.3	6.2	24.9	28.7	21.4	16.1	18.2	22.4	27.9	18.9	17.0	21.7	1.2	28.1	33.9	13.7	18.6	20.1	2.2	2.4	1.8	3.8	2.7	2.7	2.2	2.4	2.6	2.2	2.5	3.5	21.0	0.0	11.7	2.9	30.4	43.7	30.8	40.7	28.5	14.4	23.8	20.2	7.2	17.2	25.7	23.9	6.2	44.0	33.9	20.4	11.7	43.5	65.0	19.0	30.9	22.9	13.8	13.7	11.1	43.0	48.7	27.7	20.4	24.3	21.6	35.1	14.6	26.4	28.9	13.5	6.5	21.5	22.4	19.0	24.1	23.3	25.7	22.0	17.8	5.6	29.0	17.9	36.0	2.5	2.8	33.1	15.6	23.0	25.0	38.0	18.2	37.8	14.7	10.1	13.1	35.7	28.3	42.3	37.2	23.6	42.6	38.2	26.1	46.8	31.9	30.0
WDR48	"KIAA1449, P80, SPG60"	ENSG00000114742	"WD repeat domain 48"	Q8TAF3	3	39052013-39096671	"Predicted intracellular proteins"	"DNA damage, DNA repair, Host-virus interaction, Ubl conjugation pathway"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 104.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038421, HPA058015"	Approved		Supported	Vesicles		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 66: Spermatocytes - Spermatogenesis"	Vesicles		"HPA038421: AB_10670780, HPA058015: AB_2683580"	"unprognostic (1.95e-1)"	"unprognostic (2.14e-1)"	"unprognostic (2.99e-2)"	"unprognostic (3.78e-1)"	"unprognostic (7.68e-2)"	"unprognostic (2.34e-3)"	"unprognostic (6.14e-3)"	"unprognostic (9.87e-3)"	"unprognostic (8.02e-2)"	"unprognostic (2.22e-2)"	"unprognostic (2.28e-1)"	"unprognostic (2.14e-2)"	"prognostic favorable (1.63e-7)"	"unprognostic (2.41e-1)"	"unprognostic (2.94e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.69e-2)"	14.1	15.5	20.7	13.3	22.2	35.1	17.7	20.3	25.7	17.7	17.1	14.3	15.1	20.0	14.1	14.0	15.7	13.2	16.2	21.9	22.9	21.4	16.1	13.9	17.6	21.2	21.8	21.1	16.1	22.0	4.4	20.8	21.3	16.0	15.1	17.9	15.4	20.9	11.5	14.1	15.1	16.9	21.6	16.1	14.2	47.9	22.8	26.8	24.8	17.1	19.4	16.8	6.3	24.2	11.6	16.4	32.9	23.6	23.8	27.2	14.4	14.4	20.6	17.6	22.5	11.5	12.7	27.8	10.0	20.2	15.7	13.8	30.3	18.7	20.5	70.3	38.8	26.1	22.8	19.0	10.8	18.8	13.7	18.1	21.2	19.0	21.9	31.9	21.8	20.1	30.7	27.8	16.3	9.9	24.6	20.1	36.3	16.8	19.8	9.6	17.3	24.1	21.9	24.2	24.1	29.0	14.7	29.8	25.4	29.0	15.6	26.7	18.8	15.9	12.0	14.7	16.2	30.2	48.6	22.7	18.5	16.9	15.5	13.3	6.0	7.5	9.2	7.9	9.1	9.4	10.6	10.7	8.7	10.9	10.7	9.3	8.0	15.1	13.0	7.2	12.6	8.9	20.7	22.2	20.3	25.7	21.9	22.9	21.2	21.8	21.3	21.6	22.8	24.2	27.0	16.0	22.0	45.4	26.6	17.6	13.3	9.2	20.5	21.6	18.1	16.6	23.2	7.2	15.5	11.0	16.7	15.9	26.0	14.4	17.6	13.9	77.2	20.2	28.5	20.6	22.1	17.9	35.3	12.4	12.2	18.0	9.7	29.7	24.1	25.5	16.1	13.0	8.6	21.9	37.0	13.7	4.1	11.4	15.9	71.9	18.6	16.2	14.2	26.2	19.8	23.6	13.4	38.7	41.1	12.0	12.9	16.6	20.9	21.9	17.3	13.4	17.8	17.9	26.3	21.9	19.2	104.5	59.9	16.7	21.2	21.5	25.7	23.0	12.3	19.5
WDR5	"CFAP89, SWD3"	ENSG00000196363	"WD repeat domain 5"	P61964	9	134135365-134159968	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 152.7;Spermatocytes: 99.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047182			Supported	Nucleoplasm		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm		"HPA047182: AB_2679971"	"unprognostic (9.28e-2)"	"unprognostic (1.89e-2)"	"unprognostic (1.52e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.72e-1)"	"unprognostic (2.20e-1)"	"unprognostic (1.05e-3)"	"unprognostic (2.26e-3)"	"unprognostic (1.22e-1)"	"unprognostic (1.05e-1)"	"unprognostic (4.31e-3)"	"unprognostic (4.63e-2)"	"unprognostic (7.06e-2)"	"unprognostic (5.91e-3)"	"unprognostic (1.47e-1)"	"unprognostic (3.22e-2)"	"unprognostic (2.88e-2)"	17.5	18.4	17.4	13.9	18.2	20.3	16.7	20.1	21.0	17.1	17.3	19.3	17.6	18.7	8.9	24.9	18.9	8.3	19.5	17.8	18.0	18.6	34.0	15.4	16.2	15.9	16.9	21.9	27.7	13.5	25.4	14.7	16.5	18.9	13.7	9.1	18.1	12.7	33.9	22.2	19.4	13.5	15.0	20.0	20.6	38.7	18.4	17.8	17.7	18.2	18.0	18.4	16.3	17.9	43.6	52.4	49.0	56.1	26.1	28.7	77.4	43.0	28.3	57.5	39.1	61.3	34.9	68.8	26.7	35.2	50.5	105.9	66.9	44.1	46.6	46.4	45.6	39.7	85.6	49.9	27.9	90.0	40.2	27.7	41.0	43.1	52.6	23.7	38.7	67.5	75.3	37.6	40.5	116.1	77.4	73.6	62.3	98.3	65.2	83.4	99.2	65.2	28.3	42.0	81.7	42.5	64.8	50.2	29.7	32.5	69.1	78.3	33.9	58.7	53.8	54.5	70.5	19.6	40.0	74.0	34.1	60.4	48.2	0.9	9.3	1.6	6.7	6.0	6.6	4.6	6.6	6.9	10.0	5.8	6.8	5.4	0.8	4.9	5.1	8.3	6.4	7.1	17.4	18.2	20.1	21.0	17.8	18.0	15.9	16.9	16.5	15.0	18.4	17.9	8.2	9.6	8.6	10.7	11.8	11.9	14.9	7.0	16.5	9.6	13.6	12.8	9.5	11.5	5.0	5.5	22.9	27.4	8.9	9.1	9.8	14.7	152.7	8.6	14.4	9.6	6.6	17.5	16.4	20.9	42.5	12.2	15.3	10.0	8.9	17.6	5.3	21.9	19.1	8.4	16.6	13.7	8.2	6.3	9.8	41.4	11.5	10.9	5.4	11.2	10.0	6.8	10.3	10.1	14.3	16.7	9.7	11.7	26.6	30.4	17.6	10.2	3.9	7.4	6.6	9.7	10.9	99.9	42.3	25.6	16.3	17.8	9.7	32.5	22.2	18.0
WDR6		ENSG00000178252	"WD repeat domain 6"	Q9NNW5	3	49007062-49015953	"Predicted intracellular proteins"	"Cell cycle"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042622	Approved		Supported	"Plasma membrane,Cytosol"		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 35: Non-specific - Unknown function"	"Cluster 20: HeLa - Mitochondria"	"Cluster 52: Non-specific - Transcription"	Cytosol	"Plasma membrane"	"HPA042622: AB_10966784"	"unprognostic (2.41e-2)"	"unprognostic (2.03e-1)"	"unprognostic (2.14e-1)"	"unprognostic (1.26e-2)"	"unprognostic (4.80e-2)"	"unprognostic (1.05e-1)"	"prognostic unfavorable (2.97e-6)"	"unprognostic (1.79e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.01e-3)"	"unprognostic (1.94e-2)"	"prognostic favorable (4.52e-5)"	"unprognostic (1.13e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.61e-2)"	67.5	148.8	108.7	51.9	106.3	41.8	69.8	104.9	124.5	153.1	120.1	130.1	66.5	122.8	83.1	65.1	129.8	59.7	82.7	105.8	116.3	113.7	97.7	77.8	61.2	105.1	112.8	205.9	136.7	91.0	207.4	46.1	108.1	159.3	50.9	49.4	99.2	74.1	71.4	63.7	105.4	68.1	102.0	112.9	93.3	61.2	120.9	54.7	178.2	37.8	53.5	118.8	90.5	107.2	61.4	82.4	133.7	113.7	87.8	71.1	90.1	89.4	73.1	98.7	79.4	73.9	86.2	98.3	55.5	143.2	75.8	68.1	107.8	125.0	70.0	78.3	71.8	93.1	223.0	98.8	88.8	97.3	40.3	128.5	87.3	91.1	68.4	136.2	73.0	101.8	54.0	102.4	90.6	121.7	113.5	109.8	119.1	55.7	75.9	65.5	57.3	61.8	117.6	179.3	64.9	121.0	66.8	54.1	40.6	96.9	94.8	76.7	98.4	72.7	116.1	71.3	121.1	177.3	82.7	84.3	98.7	122.2	53.4	6.4	11.5	12.8	19.0	15.5	21.1	13.0	13.9	14.4	13.5	12.8	15.8	12.2	3.9	14.6	8.0	17.0	12.6	16.8	108.7	106.3	104.9	124.5	105.8	116.3	105.1	112.8	108.1	102.0	120.9	107.2	16.0	22.4	48.5	67.9	28.0	17.8	24.3	32.0	27.9	26.0	48.1	43.1	3.1	42.9	38.5	47.8	47.9	46.5	21.4	18.4	9.8	30.7	4.3	34.6	32.3	20.8	72.3	16.6	9.3	26.0	21.0	24.1	36.7	39.2	29.1	66.7	26.0	44.7	26.8	37.0	17.5	32.3	28.5	19.2	20.2	7.0	38.2	18.7	12.4	22.5	24.7	39.0	12.3	27.2	23.3	28.0	23.5	28.2	29.9	26.2	30.8	31.3	26.2	46.4	26.3	20.0	21.0	43.0	34.9	15.5	11.4	56.5	25.9	44.7	36.4	19.9
WDR61	REC14	ENSG00000140395	"WD repeat domain 61"	Q9GZS3	15	78277835-78299703	"Predicted intracellular proteins"	"Transcription, Transcription regulation, Wnt signaling pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039932, HPA040065"	Enhanced		Enhanced	Nucleoplasm,Cytosol		NA	NA		28000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 68: Epididymis - Unknown function"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 10: Non-specific - Unknown function"	"Nucleoplasm, Cytosol"		"HPA039932: AB_10796336, HPA040065: AB_10793926"	"unprognostic (1.08e-1)"	"unprognostic (1.85e-2)"	"unprognostic (8.91e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.09e-1)"	"unprognostic (3.36e-1)"	"unprognostic (2.44e-1)"	"unprognostic (1.60e-1)"	"unprognostic (3.05e-1)"	"unprognostic (2.74e-3)"	"unprognostic (4.21e-1)"	"unprognostic (5.72e-2)"	"prognostic favorable (2.03e-10)"	"unprognostic (1.04e-1)"	"unprognostic (3.13e-1)"	"unprognostic (3.18e-1)"	"unprognostic (1.09e-2)"	38.8	52.7	34.5	29.6	36.5	61.5	59.9	50.4	63.0	40.8	31.1	39.5	36.2	34.9	115.7	40.1	46.6	28.6	41.0	40.8	40.4	60.8	50.9	34.6	37.4	41.5	41.2	34.6	41.3	55.6	49.9	35.5	40.0	46.0	43.5	49.4	39.5	37.4	45.4	52.1	30.4	41.4	38.2	29.9	33.5	49.0	37.0	48.5	56.8	38.2	46.0	41.4	32.4	61.5	39.3	92.4	74.3	77.4	74.1	61.6	56.1	60.9	68.6	76.6	73.6	87.9	67.9	80.7	72.6	69.8	119.2	78.2	165.8	71.5	58.3	53.9	123.8	66.2	79.9	84.6	62.6	99.2	63.3	52.8	50.5	30.8	24.0	52.7	82.7	80.0	113.1	78.8	92.5	116.6	82.3	81.6	54.3	98.5	76.2	74.7	59.7	89.1	81.3	112.3	103.7	56.2	88.0	90.9	323.7	76.9	56.0	124.2	58.2	53.7	66.0	38.2	103.6	69.3	113.7	113.0	80.5	153.3	112.6	39.0	91.2	33.6	59.6	100.0	65.0	66.4	59.7	62.1	134.2	53.5	62.2	68.6	7.7	72.4	86.0	71.6	72.7	89.1	34.5	36.5	50.4	63.0	40.8	40.4	41.5	41.2	40.0	38.2	37.0	61.5	38.7	35.3	44.7	20.5	26.7	49.1	61.5	105.0	31.9	57.2	44.8	47.2	25.8	28.6	57.5	38.6	47.9	106.1	29.2	23.2	125.2	62.5	32.2	41.5	38.6	42.2	23.4	37.6	34.6	55.6	78.1	51.0	20.4	29.1	47.5	49.1	40.0	47.0	66.1	43.7	36.8	38.0	93.6	37.0	47.2	12.4	50.1	37.0	58.7	12.2	61.1	81.9	42.2	17.1	33.1	41.0	28.5	50.8	36.4	51.6	35.4	132.7	70.1	50.7	6.6	37.8	90.2	122.4	60.2	38.3	58.7	92.4	31.7	59.4	52.4	57.7
WDR62	"C19orf14, DKFZP434J046, FLJ33298, MCPH2"	ENSG00000075702	"WD repeat domain 62"	O43379	19	36054649-36105108	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	Neurogenesis		"Disease variant, Mental retardation, Primary microcephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 110.3;testis: 63.7;tongue: 63.1"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 43.4;Cone photoreceptor cells: 85.5;Early spermatids: 42.5;Late spermatids: 46.2;Rod photoreceptor cells: 41.7;Spermatocytes: 67.6"	"Cancer enhanced"	"Detected in many"		"testis cancer: 10.1"	"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in single"		"non-classical monocyte: 2.7"	"Lineage enriched"	"Detected in single"	4	"monocytes: 2.7"	"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA043255, HPA043639"	Enhanced		Enhanced	"Centriolar satellite,Cytosol"		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 9: Photoreceptor cells - Phototransduction"	Cytosol	"Centriolar satellite"	"HPA043255: AB_2678393, HPA043639: AB_2678593"	"unprognostic (1.77e-1)"	"unprognostic (2.79e-3)"	"unprognostic (3.16e-2)"	"unprognostic (4.88e-2)"	"unprognostic (1.77e-1)"	"unprognostic (4.22e-3)"	"unprognostic (1.78e-4)"	"unprognostic (2.00e-1)"	"unprognostic (4.00e-2)"	"unprognostic (5.82e-3)"	"unprognostic (4.72e-2)"	"unprognostic (4.69e-2)"	"unprognostic (0.00e+0)"	"unprognostic (1.73e-3)"	"unprognostic (2.72e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.67e-1)"	0.4	0.4	0.3	2.1	0.5	5.4	0.4	0.9	0.7	0.9	0.2	0.9	1.1	0.6	0.2	3.7	0.7	0.2	22.1	0.4	0.2	0.4	0.7	0.7	2.9	0.5	0.5	0.3	0.2	0.1	0.4	0.5	0.5	0.7	0.5	6.7	1.3	0.2	110.3	2.7	1.2	0.7	0.2	2.0	0.9	63.7	0.4	5.0	0.4	63.1	1.8	0.3	1.4	0.8	19.9	37.8	12.3	12.6	1.1	0.3	7.8	18.0	7.6	24.1	20.8	20.0	6.7	24.7	10.9	9.3	11.3	6.1	18.6	6.8	13.5	16.1	8.8	16.9	20.5	13.5	0.8	16.8	19.6	0.3	0.7	17.7	5.2	1.7	6.0	17.3	21.7	26.8	11.3	20.6	33.1	9.0	7.3	16.0	7.4	23.3	12.5	11.7	3.3	7.5	15.3	8.6	12.1	16.7	2.8	7.6	9.6	14.3	4.1	20.8	19.9	16.7	29.6	14.0	22.1	32.0	9.1	13.0	24.6	0.5	0.1	0.1	0.1	0.7	0.1	0.1	0.1	0.1	0.1	0.2	0.0	0.1	0.6	0.2	2.7	0.1	0.5	0.1	0.3	0.5	0.9	0.7	0.4	0.2	0.5	0.5	0.5	0.2	0.4	0.8	1.8	0.0	5.5	0.3	1.0	2.2	1.3	0.5	0.6	1.6	0.9	0.6	43.4	0.0	0.8	0.0	85.5	1.9	1.2	2.5	1.9	0.4	42.5	0.8	0.8	2.0	0.0	11.0	1.4	0.9	1.9	1.8	5.6	0.8	0.0	4.3	1.1	0.8	2.2	3.3	1.0	2.2	2.0	1.3	1.6	46.2	1.2	1.9	1.8	1.0	0.8	2.1	0.0	1.0	1.0	0.5	0.2	0.4	7.1	0.8	0.3	0.3	0.2	41.7	6.6	2.8	1.9	67.6	15.4	2.0	3.7	0.3	2.2	1.2	3.0	0.7
WDR74	"FLJ10439, Nsa1"	ENSG00000133316	"WD repeat domain 74"	Q6RFH5	11	62832342-62841809	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"brain: 565.6;choroid plexus: 711.0"	"Cell type enriched"	"Detected in all"	5	"Early spermatids: 616.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037795, HPA038419"	Uncertain		Supported	Nucleoplasm,Nucleoli		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 29: Early spermatids - Spermatogenesis"	"Nucleoplasm, Nucleoli"		"HPA037795: AB_10671380, HPA038419: AB_2676006"	"unprognostic (5.52e-2)"	"unprognostic (3.10e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.17e-2)"	"unprognostic (4.35e-2)"	"unprognostic (3.47e-2)"	"unprognostic (3.97e-3)"	"unprognostic (6.58e-2)"	"unprognostic (1.67e-2)"	"unprognostic (1.62e-2)"	"unprognostic (2.46e-2)"	"unprognostic (8.20e-3)"	"unprognostic (1.29e-3)"	"unprognostic (2.77e-2)"	"unprognostic (6.82e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.35e-1)"	21.3	21.8	352.4	20.5	274.3	127.1	21.2	485.9	291.6	19.5	711.0	19.6	17.1	20.8	14.6	25.8	22.3	11.4	23.1	251.8	208.5	21.5	28.5	14.9	30.6	220.8	221.4	25.6	30.9	15.1	11.4	18.3	292.3	19.5	16.4	33.7	25.0	13.7	59.3	31.2	17.7	17.0	305.3	30.1	22.0	15.4	244.7	62.3	28.4	25.3	23.9	24.8	18.9	565.6	64.2	76.2	28.8	49.4	22.9	31.4	85.9	35.8	37.5	73.6	49.1	108.8	77.0	111.6	97.6	28.5	59.0	84.1	88.8	69.0	56.8	72.7	64.2	55.5	84.1	97.5	65.9	112.3	36.0	30.9	75.7	47.8	153.9	24.8	36.1	80.5	126.1	32.5	33.7	120.6	106.7	178.7	117.1	70.9	96.7	108.9	49.9	193.6	52.7	35.6	65.7	72.1	40.8	84.1	115.4	27.8	58.8	83.1	28.0	44.4	52.4	98.3	88.2	81.0	120.3	137.1	47.5	68.3	57.2	40.1	140.9	11.7	40.2	61.4	49.7	66.0	42.1	38.6	105.0	121.5	56.8	52.0	51.0	93.2	44.9	154.3	52.4	47.8	352.4	274.3	485.9	291.6	251.8	208.5	220.8	221.4	292.3	305.3	244.7	565.6	36.8	38.5	67.9	1.6	112.5	104.5	47.2	45.7	60.9	15.2	37.6	57.0	2.0	40.0	108.7	16.5	16.7	55.2	57.9	32.0	43.0	42.8	616.0	22.4	34.0	41.7	41.0	26.5	3.6	40.5	53.8	39.1	65.2	32.4	43.6	23.5	20.7	34.0	37.9	3.3	3.0	32.1	20.3	33.1	69.2	97.1	32.9	45.0	30.2	1.0	22.4	15.4	45.3	2.0	2.8	39.8	24.2	21.4	74.3	50.3	44.8	54.0	32.0	11.4	19.7	53.0	89.3	19.4	31.4	50.3	109.3	34.8	66.3	30.4	41.5	39.8
WDR77	"MEP50, p44"	ENSG00000116455	"WD repeat domain 77"	Q9BQA1	1	111439890-111449256	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"fallopian tube: 104.9"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026437, HPA026448, HPA027271"	Enhanced		Supported	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA		18000	"Cluster 27: Non-specific - Gene expression"	"Cluster 52: Non-specific - Ribosome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 44: Endometrium - Transcription"	"Nucleoplasm, Cytosol"	"Golgi apparatus"	"HPA026437: AB_10600199, HPA026448: AB_10600993, HPA027271: AB_10602004"	"unprognostic (1.84e-1)"	"unprognostic (7.01e-2)"	"unprognostic (6.26e-3)"	"unprognostic (1.19e-3)"	"unprognostic (1.12e-2)"	"unprognostic (1.02e-1)"	"prognostic unfavorable (2.06e-6)"	"unprognostic (5.14e-1)"	"unprognostic (3.88e-3)"	"prognostic favorable (7.88e-4)"	"unprognostic (6.16e-2)"	"unprognostic (1.72e-3)"	"unprognostic (1.63e-2)"	"unprognostic (8.13e-2)"	"unprognostic (1.92e-1)"	"unprognostic (6.17e-2)"	"unprognostic (1.23e-2)"	16.5	23.5	13.5	18.2	13.6	10.3	14.1	13.0	13.5	14.2	13.3	17.0	14.9	20.1	17.7	27.3	104.9	12.4	29.6	15.1	14.6	19.5	22.7	13.8	28.4	14.1	15.2	12.6	17.5	18.2	14.2	18.5	14.2	17.4	24.1	11.4	19.4	14.7	42.2	13.6	16.3	19.2	13.4	22.5	21.2	14.1	15.1	20.5	13.6	32.9	36.2	24.6	16.7	14.1	70.0	58.6	56.0	46.2	32.5	19.6	76.6	51.8	27.6	76.4	50.1	86.0	25.5	118.8	48.6	44.0	49.1	49.4	101.2	96.9	91.1	46.9	80.0	70.9	67.4	125.2	36.9	71.7	114.6	23.8	68.6	75.4	47.6	20.5	51.7	51.9	96.3	30.1	74.5	86.0	94.0	38.8	109.7	64.5	99.4	92.2	88.2	44.9	68.9	118.7	45.6	33.4	45.5	54.7	42.3	70.6	45.1	50.5	38.7	42.3	86.4	82.6	111.1	25.4	34.1	106.3	54.6	81.1	126.5	17.6	24.6	6.6	27.5	38.2	31.2	53.6	30.0	31.5	54.5	42.3	31.2	29.4	3.6	58.5	35.6	34.1	27.8	27.1	13.5	13.6	13.0	13.5	15.1	14.6	14.1	15.2	14.2	13.4	15.1	14.1	11.1	12.8	11.4	8.1	29.6	20.8	27.9	34.8	10.8	11.5	13.2	11.7	22.2	10.0	17.7	18.4	25.0	56.1	19.4	7.0	25.4	30.6	4.8	42.1	18.2	15.3	15.7	18.1	6.0	13.6	57.0	12.9	26.5	40.9	15.8	21.2	8.2	15.6	47.4	8.4	7.2	14.4	20.3	20.3	8.0	4.1	7.5	18.9	5.4	7.5	16.0	9.7	13.4	7.1	5.8	22.1	7.8	9.1	20.1	28.2	8.8	29.3	34.2	9.2	13.1	10.6	18.3	22.3	24.8	26.1	18.5	45.6	15.3	36.0	22.5	23.5
WDR81	"CAMRQ2, FLJ33817, PPP1R166, SORF-2"	ENSG00000167716	"WD repeat domain 81"	Q562E7	17	1716523-1738599	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Hepatocytes: 27.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023044, HPA063703"	Uncertain		Approved	Nucleoplasm,Vesicles,Cytosol	"Intracellular and membrane"	NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 4: Macrophages - Innate immune response"	Nucleoplasm	"Vesicles, Cytosol"	"HPA023044: AB_1858822, HPA063703: "	"unprognostic (1.00e-1)"	"unprognostic (4.67e-2)"	"unprognostic (6.63e-2)"	"unprognostic (4.90e-3)"	"unprognostic (6.10e-2)"	"unprognostic (7.75e-3)"	"unprognostic (2.01e-1)"	"unprognostic (2.09e-1)"	"unprognostic (3.06e-2)"	"unprognostic (1.60e-2)"	"prognostic favorable (3.30e-4)"	"unprognostic (3.26e-1)"	"unprognostic (8.72e-2)"	"unprognostic (2.25e-1)"	"unprognostic (8.43e-2)"	"unprognostic (7.99e-2)"	"unprognostic (3.90e-2)"	17.7	16.2	4.5	4.6	5.4	4.9	16.9	4.6	6.3	18.2	6.6	11.5	4.8	18.9	2.4	9.9	17.4	1.6	10.9	4.3	4.4	11.9	32.8	13.7	5.6	5.9	5.1	21.4	11.0	2.4	13.1	3.9	5.3	16.0	1.7	0.8	11.0	5.9	18.2	18.4	17.8	5.1	4.7	24.3	11.0	7.5	6.1	6.6	10.5	2.1	4.2	15.4	13.7	6.4	0.7	12.3	1.7	9.1	12.4	7.0	9.2	0.9	0.2	0.6	0.0	1.8	4.4	4.9	6.5	5.4	6.2	12.2	6.3	8.4	0.4	9.5	12.8	0.3	8.8	5.9	22.1	4.1	7.6	17.8	8.8	5.9	4.1	1.9	5.0	3.7	1.0	6.3	7.6	6.8	1.3	7.6	3.9	4.2	9.4	6.4	2.9	6.8	3.7	2.0	2.2	5.0	4.3	3.4	15.4	0.1	6.0	6.1	6.8	4.8	5.4	7.9	6.7	0.5	1.3	3.1	7.7	5.9	2.4	0.0	1.4	2.8	1.1	2.3	1.3	1.3	1.2	1.2	1.8	1.0	0.8	1.1	0.3	2.1	2.3	3.3	1.2	1.1	4.5	5.4	4.6	6.3	4.3	4.4	5.9	5.1	5.3	4.7	6.1	6.4	6.3	12.8	10.3	6.5	4.2	2.5	2.9	4.4	8.6	4.5	4.8	5.3	3.6	4.3	3.8	0.0	4.2	2.5	9.9	6.8	1.9	3.1	0.7	2.1	6.2	5.4	1.2	14.3	5.3	4.5	1.9	8.2	6.6	2.9	4.5	6.2	4.6	27.7	23.8	5.0	5.3	4.6	10.2	22.3	4.5	1.2	16.4	15.3	0.0	9.4	7.5	2.5	9.2	5.0	7.6	4.8	4.8	15.1	5.3	2.9	8.7	20.1	6.4	1.8	19.7	5.9	4.5	0.7	2.0	3.4	1.7	2.3	4.7	5.8	4.4	1.7
WDR82	"MST107, MSTP107, PRO2730, PRO34047, SWD2, TMEM113, WDR82A"	ENSG00000164091	"WD repeat domain 82"	Q6UXN9	3	52254434-52288020	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 185.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040427			Supported	"Nucleoli rim"		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 25: Spermatids - Spermatogenesis"	"Nucleoli rim"		"HPA040427: AB_2676979"	"unprognostic (7.43e-2)"	"unprognostic (3.20e-1)"	"unprognostic (1.03e-2)"	"unprognostic (2.15e-3)"	"unprognostic (1.78e-1)"	"unprognostic (1.38e-2)"	"unprognostic (1.77e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.59e-1)"	"unprognostic (2.05e-1)"	"unprognostic (2.15e-3)"	"unprognostic (2.92e-3)"	"unprognostic (9.32e-2)"	"unprognostic (2.04e-1)"	"unprognostic (8.54e-2)"	"unprognostic (1.26e-1)"	40.3	37.8	36.5	46.8	37.0	55.6	33.9	38.1	36.5	48.6	35.9	37.5	33.8	56.2	30.1	46.7	43.8	35.3	48.0	37.9	40.2	28.7	32.6	36.0	57.8	31.4	34.1	54.6	28.1	35.4	22.0	43.3	33.4	41.2	39.1	35.5	31.2	48.7	65.5	37.0	33.6	52.2	34.3	49.1	31.4	33.3	42.7	73.1	40.4	67.0	60.8	47.4	36.1	34.6	46.0	54.3	100.4	75.5	93.7	77.3	50.3	76.6	63.3	74.0	61.1	63.9	44.9	121.4	29.2	82.4	64.8	40.7	139.3	82.2	86.2	88.5	53.3	155.9	67.3	65.8	64.9	148.2	78.6	78.1	79.6	87.3	79.3	68.8	79.0	97.7	70.8	84.8	72.4	46.3	115.6	58.1	91.1	60.0	104.2	58.7	67.0	90.8	77.2	83.1	23.9	100.3	82.1	24.5	47.8	67.4	46.4	58.8	81.6	69.0	78.2	72.9	89.3	82.3	129.1	120.6	59.0	110.6	77.3	9.4	7.4	10.1	15.3	7.5	18.5	8.8	13.9	15.0	6.5	7.0	15.8	16.2	14.2	8.9	12.0	6.1	12.9	9.8	36.5	37.0	38.1	36.5	37.9	40.2	31.4	34.1	33.4	34.3	42.7	34.6	45.9	28.9	42.8	12.1	43.0	51.5	33.9	23.5	34.1	54.6	40.7	41.4	53.1	32.9	26.3	14.7	20.9	28.8	66.2	45.4	13.7	17.4	45.3	62.6	71.0	42.7	44.3	41.2	20.4	18.9	31.2	38.3	31.1	91.5	15.2	51.0	40.0	42.9	32.5	62.2	22.0	35.2	12.2	61.9	40.2	185.1	58.4	43.2	37.4	21.5	50.2	36.5	63.8	15.1	18.1	30.4	30.8	62.8	33.4	40.8	26.0	21.7	21.4	35.0	52.6	53.3	36.6	21.5	30.7	41.5	56.8	30.8	62.5	42.9	40.5	40.3
WDTC1	"ADP, DCAF9, KIAA1037"	ENSG00000142784	"WD and tetratricopeptide repeats 1"	Q8N5D0	1	27234632-27308636	"Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028177, HPA028180, HPA028182"	Uncertain		Supported	"Golgi apparatus,Vesicles"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 46: Photoreceptor cells - Phototransduction"	Vesicles	"Golgi apparatus"	"HPA028177: AB_10600419, HPA028180: AB_10601676, HPA028182: AB_10602204"	"unprognostic (3.18e-2)"	"prognostic favorable (4.51e-4)"	"unprognostic (5.69e-2)"	"unprognostic (8.28e-2)"	"unprognostic (3.31e-2)"	"unprognostic (2.00e-3)"	"unprognostic (1.25e-2)"	"unprognostic (9.44e-2)"	"unprognostic (2.44e-1)"	"unprognostic (5.45e-3)"	"unprognostic (1.41e-3)"	"unprognostic (1.73e-1)"	"prognostic favorable (8.84e-8)"	"unprognostic (1.28e-1)"	"unprognostic (9.33e-2)"	"unprognostic (3.01e-2)"	"unprognostic (2.51e-2)"	16.5	24.4	25.4	10.5	22.3	14.7	17.5	20.2	25.4	18.9	12.7	24.7	12.9	19.7	7.0	18.0	19.9	10.5	35.9	21.8	20.0	19.9	18.7	16.9	14.4	25.3	21.0	19.0	22.1	47.7	16.9	10.6	24.4	19.3	9.5	33.5	20.1	15.1	63.0	24.8	18.0	12.0	19.4	17.7	23.2	37.6	23.5	19.8	18.4	54.4	12.7	19.8	18.5	21.1	19.8	8.6	13.5	1.3	18.9	15.8	5.6	12.0	20.1	12.7	15.5	2.9	19.3	17.0	14.0	24.0	9.3	10.1	13.0	18.4	11.0	23.2	22.0	17.7	8.9	7.9	17.0	9.0	22.4	15.1	29.6	15.8	14.4	22.9	17.4	5.4	18.2	17.2	13.6	11.1	14.6	21.6	6.3	13.0	18.1	7.3	10.1	18.7	15.2	4.2	19.7	16.9	15.7	6.6	14.4	10.1	9.8	15.5	15.2	10.3	6.2	14.5	5.9	24.7	14.2	8.1	20.8	17.3	12.5	0.1	0.2	2.7	1.4	0.3	0.5	0.6	0.3	0.6	0.7	0.4	0.2	0.6	2.1	0.4	0.2	0.5	0.4	0.5	25.4	22.3	20.2	25.4	21.8	20.0	25.3	21.0	24.4	19.4	23.5	21.1	10.8	9.6	10.7	19.6	13.8	12.9	10.3	8.4	16.5	31.4	18.5	14.5	15.6	14.3	7.6	31.3	54.2	14.2	14.3	17.3	9.8	15.1	29.8	15.3	8.2	10.1	16.7	32.8	22.4	14.1	4.8	10.6	16.3	13.2	1.3	15.4	18.5	16.6	13.0	21.9	21.2	16.9	6.1	21.0	11.3	66.2	17.1	15.8	10.6	19.7	18.9	15.8	28.8	16.6	22.2	16.0	10.1	16.6	12.3	17.2	26.6	19.1	18.4	70.0	6.6	17.1	10.3	30.9	6.6	13.0	17.3	16.4	13.3	14.1	15.0	16.8
WHAMM	"KIAA1971, WHAMM1, WHDC1"	ENSG00000156232	"WASP homolog associated with actin, golgi membranes and microtubules"	Q8TF30	15	82809628-82836108	"Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 29.7"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039690, HPA040231"	Approved		Supported	Cytosol		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 15: RT4 - Unknown function"	"Cluster 22: Epithelial cell types - Mixed function"	Cytosol		"HPA039690: AB_10795405, HPA040231: AB_10795361"	"unprognostic (7.98e-2)"	"prognostic favorable (7.09e-4)"	"unprognostic (1.21e-1)"	"unprognostic (8.56e-2)"	"unprognostic (6.68e-2)"	"unprognostic (8.21e-3)"	"unprognostic (1.82e-1)"	"unprognostic (1.37e-2)"	"unprognostic (1.32e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.35e-1)"	"prognostic unfavorable (2.31e-4)"	"unprognostic (1.31e-1)"	"unprognostic (1.65e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.14e-1)"	"unprognostic (2.20e-2)"	7.7	4.8	4.3	3.9	4.4	29.7	7.2	6.1	4.7	6.6	8.8	6.8	4.6	5.5	2.8	7.2	6.1	2.9	5.8	4.3	3.9	7.0	8.8	7.8	5.5	4.5	4.3	7.2	7.5	6.1	5.4	4.6	4.3	7.7	4.0	4.0	6.6	3.5	17.7	9.0	7.3	3.3	3.8	8.5	6.2	3.7	4.3	5.1	6.6	7.8	4.7	7.5	6.4	5.8	4.0	4.1	2.5	3.6	7.9	5.5	4.2	5.5	5.5	6.0	5.9	2.6	7.2	8.7	6.7	5.2	5.6	8.8	7.7	4.5	3.9	2.9	4.4	5.0	4.5	3.9	8.0	3.6	5.7	5.4	6.0	2.8	5.9	6.0	4.3	4.1	4.6	11.3	6.0	3.1	3.0	5.2	1.0	5.0	2.4	4.4	5.3	2.5	10.4	16.1	2.3	1.9	8.5	5.5	5.8	5.1	3.7	7.7	6.8	7.9	2.7	5.3	6.3	12.0	7.3	4.2	5.6	4.9	5.0	2.6	0.5	0.5	1.2	0.4	1.0	1.0	1.1	0.8	0.3	1.1	1.0	1.0	1.3	2.3	0.4	0.9	1.0	0.4	4.3	4.4	6.1	4.7	4.3	3.9	4.5	4.3	4.3	3.8	4.3	5.8	36.6	16.0	17.3	18.9	37.1	26.5	42.8	6.6	34.1	16.2	16.7	17.7	15.6	17.2	7.6	20.2	14.6	14.5	47.3	18.1	5.9	8.9	6.9	19.6	13.9	23.2	6.7	31.5	10.1	10.3	16.6	18.7	23.9	29.4	10.8	12.6	19.2	13.8	19.9	23.5	15.9	19.4	6.1	15.8	41.4	5.5	17.4	25.4	19.6	15.0	19.3	17.9	61.8	14.1	23.4	13.0	15.5	23.7	24.1	49.0	16.8	11.2	7.1	18.0	32.9	24.5	19.5	29.8	31.1	29.2	25.1	25.4	36.1	15.5	13.8	75.1
WIPI1	"ATG18, ATG18A, FLJ10055, WIPI49"	ENSG00000070540	"WD repeat domain, phosphoinositide interacting 1"	Q5MNZ9	17	68420948-68457513	"Predicted intracellular proteins"	Autophagy			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 127.2"	"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 165.7;Syncytiotrophoblasts: 125.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"basophil: 114.1;eosinophil: 223.6"	"Lineage enriched"	"Detected in all"	9	"granulocytes: 223.6"	"Cell line enhanced"	"Detected in many"		"ASC diff: 224.3;HHSteC: 216.7;HSkMC: 180.8;SK-MEL-30: 183.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007493, CAB037230"	Enhanced		Supported	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 55: Plasma cells - Humoral immune response"	"Golgi apparatus"	"Nucleoplasm, Cytosol"	"CAB037230: AB_1841265, HPA007493: AB_1848642"	"unprognostic (2.83e-2)"	"unprognostic (7.85e-2)"	"unprognostic (1.05e-3)"	"unprognostic (1.31e-1)"	"unprognostic (1.42e-1)"	"unprognostic (3.03e-2)"	"unprognostic (3.97e-3)"	"unprognostic (1.78e-2)"	"prognostic favorable (3.11e-4)"	"unprognostic (2.86e-1)"	"unprognostic (1.79e-1)"	"unprognostic (3.06e-1)"	"unprognostic (6.32e-3)"	"unprognostic (6.56e-2)"	"unprognostic (4.99e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.89e-3)"	31.3	18.8	11.2	14.1	11.2	26.6	30.5	12.5	15.1	33.1	19.1	36.4	12.8	15.3	14.4	14.8	12.6	23.3	78.4	10.6	12.9	33.3	18.7	26.2	8.7	12.5	12.0	11.2	29.8	25.2	17.8	62.4	12.5	17.4	38.5	8.2	55.0	18.3	127.2	21.9	14.8	18.8	11.4	12.5	29.3	9.6	15.5	5.9	21.1	97.5	16.7	22.0	14.4	11.9	4.9	9.8	8.6	12.5	224.3	167.2	49.0	36.3	163.5	13.7	43.6	7.2	7.3	3.0	16.0	74.2	47.9	3.7	3.3	22.1	23.9	4.4	4.6	34.7	3.2	42.6	216.7	2.4	48.5	180.8	39.5	54.2	72.0	44.2	61.3	5.3	2.5	82.0	41.1	29.9	0.5	7.1	1.8	12.7	15.0	0.4	30.3	35.7	20.2	16.7	2.4	11.4	7.7	103.8	183.4	44.4	54.8	9.5	61.2	65.4	10.1	31.0	8.6	78.2	92.0	10.5	98.9	16.5	29.7	114.1	18.4	223.6	11.9	22.7	5.3	4.4	3.1	11.7	9.0	1.4	0.2	5.6	39.0	10.7	24.7	6.3	2.7	15.0	11.2	11.2	12.5	15.1	10.6	12.9	12.5	12.0	12.5	11.4	15.5	11.9	26.2	9.6	11.5	12.7	13.3	7.8	11.9	45.6	0.6	15.0	24.1	8.9	7.3	28.6	48.5	16.5	2.1	44.0	18.3	30.2	31.3	31.2	6.3	26.3	19.9	17.2	12.0	56.6	9.4	57.2	165.7	41.2	25.5	40.0	7.0	12.3	33.9	11.7	35.6	10.1	8.2	67.6	44.7	18.2	14.5	5.2	46.3	37.1	42.7	20.6	34.2	10.6	20.6	6.0	12.2	28.8	20.1	42.2	83.3	55.3	8.5	71.8	49.6	15.7	26.3	10.1	24.1	5.0	5.1	3.3	6.8	125.1	13.6	27.8	28.2	36.7
WLS	"C1orf139, EVI, FLJ23091, GPR177, mig-14, MRP"	ENSG00000116729	"Wnt ligand secretion mediator"	Q5T9L3	1	68098473-68233120	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Wnt signaling pathway"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Glandular and luminal cells: 235.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	8	"classical monocyte: 22.1;neutrophil: 61.7"	"Group enriched"	"Detected in many"	46	"granulocytes: 61.7;monocytes: 22.1"	"Cell line enhanced"	"Detected in many"		"AF22: 392.1;ASC TERT1: 294.1;SuSa: 357.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA069520	Approved		Supported	"Endoplasmic reticulum,Cytosol"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 68: Epididymis - Unknown function"	"Cluster 12: NES - Nervous system development"	"Cluster 44: Endometrium - Transcription"	"Endoplasmic reticulum, Cytosol"		"HPA069520: AB_2686144"	"prognostic favorable (4.03e-4)"	"unprognostic (8.73e-2)"	"unprognostic (2.51e-2)"	"unprognostic (8.13e-3)"	"unprognostic (5.93e-2)"	"unprognostic (4.51e-3)"	"unprognostic (5.41e-3)"	"unprognostic (7.46e-3)"	"unprognostic (7.70e-2)"	"prognostic favorable (9.43e-4)"	"unprognostic (1.34e-1)"	"unprognostic (4.82e-2)"	"prognostic favorable (3.67e-7)"	"unprognostic (4.48e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.41e-2)"	"prognostic unfavorable (3.51e-4)"	36.8	42.9	77.4	21.5	70.8	4.6	36.4	63.6	73.5	46.9	124.7	73.9	23.8	49.1	135.8	62.3	48.7	68.2	63.7	62.0	89.1	92.6	23.4	53.0	13.0	109.4	127.8	76.7	83.6	38.5	16.9	77.3	91.6	71.7	57.4	137.2	32.6	102.0	14.2	45.9	34.0	61.9	101.6	29.7	56.6	23.9	132.2	13.5	22.6	25.2	19.2	64.4	37.8	98.8	11.5	17.3	392.1	0.3	214.0	294.1	228.4	55.6	135.1	75.7	104.0	24.3	26.2	0.2	54.9	16.0	70.7	116.0	89.3	91.7	63.6	0.6	67.8	0.4	45.4	0.2	187.2	0.1	0.9	214.0	60.3	185.3	60.6	77.2	181.0	21.4	0.0	1.0	113.0	1.7	0.3	1.3	17.7	24.7	27.3	0.1	82.2	0.5	13.5	60.3	21.8	46.0	51.0	2.3	67.3	357.0	10.6	1.6	209.7	71.7	56.9	116.9	76.1	26.6	0.8	0.2	165.0	1.8	134.1	0.0	22.1	0.0	0.0	5.4	0.1	0.1	0.0	0.0	0.9	0.1	0.0	0.0	61.7	0.0	0.7	0.3	0.0	4.8	77.4	70.8	63.6	73.5	62.0	89.1	109.4	127.8	91.6	101.6	132.2	98.8	20.9	48.1	34.6	145.3	1.2	42.4	60.1	28.5	95.0	8.9	25.4	61.2	32.6	42.9	41.3	27.6	139.7	134.7	0.9	65.7	9.8	74.3	15.3	110.8	60.1	31.5	9.6	0.0	27.0	60.3	6.7	44.9	28.5	235.3	5.7	4.6	43.5	10.9	24.9	13.5	132.3	24.5	61.1	10.6	11.2	9.4	32.6	14.7	19.6	61.8	18.0	11.8	0.0	59.3	3.7	69.1	27.2	55.3	0.2	31.3	8.9	36.2	81.1	166.4	39.5	15.7	46.4	0.8	1.0	39.7	30.0	55.1	3.2	39.2	38.4	46.8
WNK1	"HSAN2, HSN2, PPP1R167, PRKWNK1"	ENSG00000060237	"WNK lysine deficient protein kinase 1"	Q9H4A3	12	752579-911452	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Kinase, Protein kinase inhibitor, Serine/threonine-protein kinase, Transferase"	"Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 293.0"	"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 336.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046541, HPA059157"	Enhanced		Supported	Cytosol		NA	NA		92000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 70: Brain - Nervous system development"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Cytosol		"HPA046541: AB_2679690, HPA059157: AB_2683935"	"unprognostic (1.40e-1)"	"unprognostic (1.54e-2)"	"unprognostic (4.82e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.27e-1)"	"unprognostic (7.68e-2)"	"unprognostic (1.05e-3)"	"unprognostic (1.57e-1)"	"unprognostic (1.24e-1)"	"prognostic unfavorable (9.67e-4)"	"unprognostic (1.84e-1)"	"unprognostic (2.49e-1)"	"unprognostic (4.38e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.32e-1)"	"unprognostic (5.17e-2)"	"unprognostic (1.30e-2)"	56.7	20.6	190.8	36.4	236.8	54.2	33.5	179.4	166.1	32.8	110.8	22.8	14.4	26.7	30.4	72.1	29.4	27.1	63.8	132.3	161.1	84.0	31.6	44.6	39.2	232.3	238.4	30.1	22.5	51.1	17.0	36.0	217.0	29.7	24.2	87.4	24.0	33.4	79.7	52.0	17.4	36.1	225.4	30.2	27.6	48.3	238.0	61.3	27.7	79.8	46.9	35.8	43.8	293.0	53.9	97.5	131.8	11.3	88.1	80.0	52.2	48.3	61.6	58.2	51.3	59.4	55.7	71.0	16.8	107.8	73.5	39.8	93.8	56.7	84.3	124.7	51.4	169.4	122.2	46.1	66.7	86.9	68.2	64.0	82.1	97.6	164.4	61.6	73.4	68.0	76.4	158.2	77.8	54.1	154.6	15.6	105.8	47.8	24.3	78.0	138.8	20.8	80.6	96.8	35.1	40.7	121.8	82.9	33.6	183.3	86.8	97.2	78.3	67.1	77.3	86.2	70.8	23.8	43.1	103.8	59.4	44.6	53.2	0.7	1.8	1.6	1.9	2.1	1.9	1.7	1.9	2.1	1.4	1.2	1.2	1.9	5.6	1.4	4.7	1.2	3.4	1.6	190.8	236.8	179.4	166.1	132.3	161.1	232.3	238.4	217.0	225.4	238.0	293.0	261.1	102.5	141.6	77.1	65.3	112.8	42.3	38.3	85.4	87.9	50.6	39.5	241.6	50.1	47.1	90.1	150.1	32.5	83.0	27.8	86.1	28.0	29.7	63.0	68.6	106.7	58.7	304.2	182.3	24.4	32.9	58.3	37.2	70.2	52.6	46.2	52.5	71.7	57.3	84.1	165.0	26.3	16.2	121.4	80.8	21.2	61.8	96.7	37.4	114.3	95.7	64.0	61.8	126.7	336.4	41.7	34.8	55.7	76.5	59.0	24.2	21.8	64.6	96.1	13.1	69.6	63.8	186.5	74.6	147.2	136.0	28.5	112.9	33.2	25.8	55.2
WRN	"RECQ3, RECQL2"	ENSG00000165392	"WRN RecQ like helicase"	Q14191	8	31033788-31176138	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair"	"DNA-binding, Exonuclease, Helicase, Hydrolase, Multifunctional enzyme, Nuclease"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Astrocytes: 74.7;Early spermatids: 116.3;Oligodendrocytes: 88.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028661	Approved		Supported	"Nuclear speckles"		NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 29: Early spermatids - Spermatogenesis"	"Nuclear speckles"		"HPA028661: AB_10602255"	"unprognostic (8.73e-2)"	"unprognostic (9.33e-2)"	"unprognostic (1.51e-3)"	"unprognostic (3.85e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.85e-2)"	"unprognostic (2.21e-3)"	"unprognostic (1.25e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.16e-2)"	"unprognostic (1.27e-2)"	"unprognostic (6.63e-2)"	"unprognostic (1.53e-2)"	"unprognostic (6.51e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.00e-2)"	"unprognostic (2.66e-1)"	3.0	3.6	1.7	3.2	1.7	8.2	4.8	4.1	2.4	3.0	2.6	3.5	1.5	6.4	3.2	2.7	2.9	2.4	1.7	1.6	1.7	2.1	2.5	2.4	2.5	1.8	2.1	5.2	2.6	2.0	2.1	3.6	1.8	3.5	2.9	4.4	3.5	2.6	2.1	4.1	2.5	4.2	1.2	3.1	2.3	3.0	1.9	3.2	3.2	2.2	3.0	2.6	2.3	3.1	4.4	5.9	10.8	5.3	6.7	9.8	5.0	4.7	4.9	6.4	6.6	2.7	1.5	10.0	4.6	4.3	4.4	2.4	6.4	3.8	9.7	3.3	4.3	9.6	4.9	4.4	5.4	8.7	4.3	7.1	3.7	3.6	6.2	3.9	7.7	6.1	14.5	5.0	6.8	2.0	17.5	6.6	7.7	5.1	3.2	7.5	7.5	6.7	2.9	4.4	3.3	5.2	6.9	2.7	3.8	4.9	2.9	5.3	9.1	6.2	3.8	3.1	4.9	1.4	3.0	14.6	5.5	3.8	4.2	0.8	0.2	0.3	0.3	0.1	0.4	0.5	0.5	0.3	0.2	0.5	0.3	0.4	0.3	1.1	0.1	0.1	0.3	0.1	1.7	1.7	4.1	2.4	1.6	1.7	1.8	2.1	1.8	1.2	1.9	3.1	17.5	9.6	10.6	74.7	15.1	13.5	11.7	5.3	18.8	14.5	14.7	10.5	7.5	15.7	8.8	16.5	22.9	7.1	18.0	5.3	1.9	6.7	116.3	15.8	32.3	12.5	2.4	49.2	59.7	9.8	5.7	15.2	21.9	17.1	2.5	18.5	7.1	9.7	5.3	15.2	54.9	13.8	8.2	5.3	6.6	12.8	19.0	7.8	10.6	51.5	6.9	14.3	4.1	61.3	88.6	9.1	4.2	14.3	16.6	15.3	3.9	2.7	10.0	19.8	6.6	20.2	15.3	10.9	19.2	10.1	10.2	5.6	13.0	15.2	7.7	11.0
WWOX	"FOR, SDR41C1, WOX1"	ENSG00000186153	"WW domain containing oxidoreductase"	Q9NZC7	16	78099430-79212667	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"	"Apoptosis, Wnt signaling pathway"	Oxidoreductase	"Disease variant, Epilepsy, Neurodegeneration, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	14	"Astrocytes: 927.8;Excitatory neurons: 270.5;Inhibitory neurons: 540.9;Microglial cells: 471.2;Oligodendrocyte precursor cells: 914.9;Oligodendrocytes: 793.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"MCF7: 85.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA050992	Approved		Supported	"Golgi apparatus,Cytosol"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 68: Epididymis - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Golgi apparatus"	Cytosol	"HPA050992: AB_2681299"	"prognostic unfavorable (9.07e-5)"	"unprognostic (1.14e-2)"	"unprognostic (1.92e-1)"	"unprognostic (9.27e-2)"	"unprognostic (2.32e-1)"	"unprognostic (1.81e-1)"	"unprognostic (6.24e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.65e-1)"	"unprognostic (3.61e-3)"	"unprognostic (4.33e-2)"	"unprognostic (3.50e-2)"	"prognostic favorable (4.49e-5)"	"unprognostic (3.75e-1)"	"unprognostic (1.78e-1)"	"unprognostic (2.36e-2)"	"unprognostic (1.77e-1)"	8.6	6.3	18.6	4.0	23.9	4.2	7.4	24.0	20.3	8.6	21.2	5.2	5.3	8.2	10.1	7.7	9.0	7.4	5.2	18.8	22.5	12.7	12.0	5.3	4.6	24.0	22.4	7.6	8.3	12.1	9.8	5.3	25.3	7.7	3.2	6.9	8.5	6.4	3.3	7.1	4.5	5.1	22.0	4.7	6.0	9.3	21.0	9.0	21.8	2.1	6.0	6.7	7.1	30.0	11.1	9.5	9.2	7.7	11.0	5.3	11.1	1.6	3.2	3.7	3.2	7.0	9.6	19.5	8.6	1.5	5.2	10.0	5.1	1.3	2.6	11.0	26.8	6.0	1.9	15.7	7.5	16.7	3.4	5.9	3.8	2.3	2.4	0.9	4.4	25.9	9.2	4.2	2.6	85.7	27.7	21.9	8.6	5.9	5.7	32.2	3.9	19.1	5.3	3.9	17.6	10.0	7.1	11.9	4.0	9.3	12.8	12.0	1.6	2.7	10.4	2.2	6.4	0.0	18.3	41.2	10.4	8.4	4.6	7.0	9.1	2.1	11.4	7.9	13.4	9.3	8.2	9.1	7.7	6.6	8.4	8.3	0.7	9.1	5.8	14.5	13.5	6.0	18.6	23.9	24.0	20.3	18.8	22.5	24.0	22.4	25.3	22.0	21.0	30.0	12.0	6.4	6.9	927.8	9.0	9.2	21.2	8.0	19.4	7.4	12.1	16.1	8.8	17.2	13.3	14.7	4.2	25.7	10.9	4.5	33.2	12.4	43.1	18.2	13.9	9.5	9.6	13.3	270.5	10.3	11.9	12.0	9.2	7.6	12.7	18.7	13.2	18.9	9.2	5.0	540.9	5.1	0.0	5.6	5.7	38.2	14.0	7.7	5.4	471.2	5.9	46.3	9.2	914.9	793.5	4.5	5.9	17.7	18.4	11.5	8.7	28.3	18.7	12.2	6.6	10.3	11.8	19.7	17.9	13.3	6.8	17.4	9.9	12.1	6.8	13.0
WWTR1	"DKFZp586I1419, TAZ"	ENSG00000018408	"WW domain containing transcription regulator 1"	Q9GZV5	3	149517235-149736714	"Cancer-related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	Activator	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 229.3;Endothelial cells: 221.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"EFO-21: 212.1;RPTEC TERT1: 151.1;SK-MEL-30: 160.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007415, CAB017483, CAB068248"	Enhanced		Supported	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Nucleoplasm, Nuclear bodies"	Cytosol	"CAB017483: AB_2216639, CAB068248: AB_2665648, HPA007415: AB_1080602"	"unprognostic (1.85e-2)"	"unprognostic (2.24e-2)"	"unprognostic (3.41e-3)"	"unprognostic (1.33e-2)"	"unprognostic (7.94e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.41e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.74e-2)"	"unprognostic (2.34e-1)"	"unprognostic (1.63e-2)"	"unprognostic (3.32e-1)"	"unprognostic (1.17e-3)"	"unprognostic (2.76e-2)"	"unprognostic (2.53e-1)"	"unprognostic (3.98e-2)"	"unprognostic (1.01e-3)"	41.6	13.8	19.2	22.4	20.8	0.2	37.2	18.9	19.6	41.8	32.6	74.9	8.0	42.1	13.4	35.8	33.7	39.6	36.4	20.7	53.9	45.9	19.0	41.2	7.2	52.6	39.9	43.9	31.8	14.1	13.6	44.0	35.9	34.5	13.5	4.2	27.6	32.1	13.2	24.8	21.6	43.7	37.1	19.5	32.7	7.2	23.0	4.7	31.6	15.0	6.1	59.2	34.3	41.0	58.9	80.5	40.6	48.7	48.6	86.8	43.0	32.6	57.5	17.7	17.8	46.7	53.2	0.1	212.1	45.0	53.3	36.1	28.4	28.5	17.9	22.0	19.3	0.0	18.6	37.8	27.3	0.0	0.1	45.3	7.4	61.8	26.6	65.4	136.3	0.0	0.0	0.2	61.7	9.2	0.2	0.2	8.2	0.2	96.6	0.0	50.6	0.4	151.1	9.4	0.0	0.4	21.1	17.2	160.2	31.5	26.5	1.6	94.2	29.0	16.2	24.8	67.4	0.6	0.5	0.8	66.8	0.1	78.8	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.5	0.1	19.2	20.8	18.9	19.6	20.7	53.9	52.6	39.9	35.9	37.1	23.0	41.0	125.7	64.1	89.7	60.4	1.1	51.7	229.3	34.6	60.9	2.2	58.1	56.8	46.8	141.5	87.8	49.7	4.2	12.2	2.0	0.5	7.9	72.0	21.9	136.3	89.1	221.2	0.0	3.2	8.7	27.1	82.3	77.9	10.2	144.4	7.6	45.0	111.4	21.9	4.1	0.0	6.1	1.2	10.2	6.0	32.3	7.9	57.8	4.6	30.2	94.6	2.1	11.0	0.0	7.5	12.7	45.8	0.0	126.4	2.9	86.7	1.2	59.8	53.9	2.0	59.2	76.1	58.0	2.2	0.8	46.3	35.5	14.8	6.5	48.4	2.4	93.5
XAB2	"HCNP, HCRN, NTC90, SYF1"	ENSG00000076924	"XPA binding protein 2"	Q9HCS7	19	7619525-7629545	"Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, mRNA processing, mRNA splicing, Transcription"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Proximal tubular cells: 159.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048751			Supported	Nucleoplasm,Vesicles		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 71: Testis - DNA repair"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Nucleoplasm	Vesicles	"HPA048751: AB_2680512"	"unprognostic (1.13e-1)"	"prognostic favorable (4.04e-4)"	"unprognostic (1.99e-3)"	"prognostic favorable (4.96e-4)"	"unprognostic (1.35e-1)"	"unprognostic (4.98e-3)"	"unprognostic (4.95e-2)"	"unprognostic (4.56e-3)"	"unprognostic (1.40e-1)"	"unprognostic (2.10e-1)"	"prognostic favorable (7.47e-4)"	"unprognostic (2.69e-1)"	"unprognostic (7.43e-3)"	"unprognostic (3.88e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.80e-3)"	29.4	23.6	17.7	15.1	19.9	44.5	30.6	19.6	24.8	37.0	16.9	28.3	17.5	33.8	6.9	25.4	32.0	11.8	24.3	17.8	17.9	27.7	27.8	27.2	20.7	19.9	18.0	45.8	35.9	13.4	27.1	15.4	20.2	32.7	5.4	9.0	31.1	17.5	35.6	39.0	27.6	9.3	18.6	34.5	30.9	37.7	18.3	21.1	34.7	13.3	10.6	29.1	29.6	25.5	39.8	35.7	21.2	27.9	21.9	16.3	41.2	22.8	26.5	39.6	40.0	46.4	25.4	26.7	44.1	21.3	28.9	34.2	30.2	33.2	10.0	47.1	39.0	35.5	30.2	41.3	28.3	47.5	30.8	28.8	27.0	28.0	20.2	21.3	24.2	56.4	32.4	69.0	12.4	44.0	44.9	73.8	48.3	24.8	69.6	49.3	26.8	47.0	15.8	30.7	30.2	34.4	25.9	25.1	23.2	13.8	32.0	41.6	24.1	18.1	29.5	41.3	39.0	117.7	75.0	39.0	31.0	40.1	27.4	8.8	10.0	9.3	11.8	10.2	11.3	10.1	11.0	9.1	8.0	12.2	13.1	10.0	6.4	8.3	13.9	6.9	14.2	12.1	17.7	19.9	19.6	24.8	17.8	17.9	19.9	18.0	20.2	18.6	18.3	25.5	18.3	0.0	1.8	3.9	22.9	19.6	16.2	28.1	14.2	14.1	89.4	54.4	1.4	25.8	20.1	47.8	12.5	46.0	24.8	28.3	35.2	19.8	39.9	24.7	13.3	16.4	18.6	14.1	2.3	34.4	26.4	16.7	33.6	32.3	19.7	27.7	17.5	46.4	19.8	3.3	2.5	21.2	24.4	19.2	11.0	19.1	28.3	18.3	26.6	3.7	26.5	13.9	23.7	1.0	3.7	15.1	12.4	21.8	19.4	12.2	28.9	159.5	13.4	14.2	39.5	15.9	21.6	36.1	57.3	14.6	17.8	65.9	20.6	17.8	23.9	14.3
XAF1	"BIRC4BP, HSXIAPAF1, XIAPAF1"	ENSG00000132530	"XIAP associated factor 1"	Q6GPH4	17	6755447-6775647	"Predicted intracellular proteins"	Apoptosis		"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 174.2;Endothelial cells: 90.4;Microglial cells: 103.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+: 81.8;BJ hTERT+ SV40 Large T+ RasG12V: 83.8;HHSteC: 35.3"	"Low region specificity"	"Detected in all"							HPA057302	Approved		Supported	Nucleoplasm,Mitochondria		Yes	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Nucleoplasm, Mitochondria"		"HPA057302: AB_2683405"	"unprognostic (6.28e-2)"	"unprognostic (1.71e-1)"	"unprognostic (8.62e-3)"	"unprognostic (1.28e-2)"	"unprognostic (3.81e-1)"	"unprognostic (1.11e-2)"	"unprognostic (5.09e-3)"	"unprognostic (4.89e-2)"	"unprognostic (1.39e-1)"	"unprognostic (8.08e-3)"	"unprognostic (3.34e-3)"	"unprognostic (1.79e-1)"	"prognostic unfavorable (2.73e-7)"	"unprognostic (2.33e-1)"	"unprognostic (1.74e-2)"	"unprognostic (2.31e-1)"	"unprognostic (6.15e-3)"	31.9	12.8	28.3	29.7	29.8	33.4	24.2	27.7	39.6	42.3	23.8	17.5	26.8	26.5	13.0	17.0	22.5	34.0	30.9	27.5	29.2	23.5	63.6	35.8	29.7	37.5	28.4	52.9	2.9	2.9	14.3	25.9	30.8	24.9	16.8	4.8	47.6	11.2	14.1	18.4	25.4	24.3	31.9	63.4	23.6	9.2	31.5	23.8	18.2	13.5	15.5	17.3	22.1	27.5	5.2	0.3	0.7	1.4	6.7	15.1	0.7	7.1	26.3	81.8	83.8	0.7	7.5	1.3	2.0	10.2	28.9	3.1	0.0	1.3	9.3	11.4	0.3	1.9	0.9	1.0	35.3	1.2	8.0	6.9	0.0	11.3	0.3	0.4	6.9	25.5	0.7	26.1	2.6	0.4	6.3	22.1	0.6	0.2	2.2	11.3	0.4	0.5	0.2	4.9	0.5	0.6	3.6	0.5	14.3	0.6	0.8	30.4	0.7	1.1	0.8	2.3	0.5	3.9	1.4	0.5	2.6	18.4	2.2	17.4	9.6	4.3	7.8	12.7	5.7	3.6	6.0	5.6	8.0	4.6	3.8	4.0	10.6	8.0	12.5	0.8	9.9	5.6	28.3	29.8	27.7	39.6	27.5	29.2	37.5	28.4	30.8	31.9	31.5	27.5	174.2	60.9	29.9	14.0	25.7	5.2	5.7	5.5	13.1	0.5	4.1	10.3	2.7	8.6	30.0	0.0	0.0	0.4	37.1	12.4	0.0	1.3	4.0	18.9	68.4	90.4	1.8	10.7	0.3	1.9	5.1	29.8	27.5	10.4	48.7	44.4	33.5	20.1	15.9	0.0	0.3	9.2	0.0	21.3	11.2	2.6	36.4	54.4	5.4	103.0	44.5	1.1	70.0	1.5	0.6	10.1	2.7	27.4	11.4	2.5	11.4	0.3	24.3	0.4	19.7	27.3	19.0	0.2	0.8	11.8	2.7	0.4	35.1	47.3	9.2	5.6
XIAP	"API3, BIRC4, hILP, ILP-1"	ENSG00000101966	"X-linked inhibitor of apoptosis"	P98170	X	123859724-123913976	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Ubl conjugation pathway, Wnt signaling pathway"	"Protease inhibitor, Thiol protease inhibitor, Transferase"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009203, HPA042428"	Approved		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 18: U-2197 - ECM organization"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Nucleoplasm, Cytosol"	"Plasma membrane"	"CAB009203: AB_2257167, HPA042428: AB_2677993"	"prognostic unfavorable (9.21e-4)"	"unprognostic (8.43e-2)"	"unprognostic (1.50e-2)"	"unprognostic (2.14e-1)"	"unprognostic (1.40e-1)"	"unprognostic (9.41e-2)"	"unprognostic (1.95e-2)"	"unprognostic (8.51e-2)"	"unprognostic (9.17e-2)"	"unprognostic (3.90e-2)"	"unprognostic (7.50e-2)"	"unprognostic (4.41e-2)"	"unprognostic (3.15e-3)"	"unprognostic (8.21e-3)"	"unprognostic (2.26e-1)"	"unprognostic (4.99e-2)"	"unprognostic (4.65e-2)"	9.2	7.7	6.5	9.2	7.5	8.3	9.7	6.8	7.0	9.6	12.9	12.4	10.1	8.4	10.0	11.5	7.4	8.6	7.8	5.8	8.2	11.8	12.1	8.5	10.4	7.6	8.1	7.5	8.3	18.4	6.3	8.6	7.3	8.5	10.1	21.4	8.6	7.4	10.3	8.8	10.1	7.4	8.5	10.4	10.2	4.2	8.1	8.9	14.9	11.9	8.6	9.6	6.1	10.3	15.8	13.2	10.2	8.8	11.8	15.0	13.3	16.9	12.4	8.9	7.7	5.9	17.9	14.7	24.3	14.4	17.1	5.6	15.3	10.5	16.3	15.5	8.3	9.9	11.1	9.2	14.9	18.1	19.7	10.4	16.0	14.9	19.0	10.2	12.7	10.8	15.9	16.4	17.6	16.5	10.2	8.8	8.4	15.6	10.3	10.8	11.9	15.6	13.4	22.6	6.8	10.0	22.9	13.0	13.5	9.0	8.0	8.7	15.7	0.5	6.0	27.0	18.9	13.8	14.9	15.8	18.3	12.7	11.5	9.3	1.8	2.6	3.3	1.5	3.0	3.1	2.4	3.6	1.0	4.0	2.7	1.9	5.6	2.4	2.9	2.9	1.8	1.5	6.5	7.5	6.8	7.0	5.8	8.2	7.6	8.1	7.3	8.5	8.1	10.3	50.0	80.1	91.6	26.4	42.1	26.6	36.3	35.0	28.5	72.1	29.7	19.9	44.5	44.3	55.2	53.3	95.9	17.9	41.7	122.9	27.4	36.0	2.7	38.4	44.9	55.0	47.4	23.5	30.0	54.0	30.0	38.4	39.8	50.4	60.7	30.9	64.2	85.8	29.0	75.7	34.9	62.2	26.4	43.6	33.0	4.1	42.6	44.2	8.8	29.0	45.8	45.8	55.6	32.6	41.9	65.4	53.5	51.6	39.5	53.0	59.2	59.8	50.6	133.7	65.7	43.6	34.9	15.2	21.0	30.8	35.5	38.0	40.8	30.0	48.0	68.1
XPNPEP3	"APP3, ICP55, NPHPL1"	ENSG00000196236	"X-prolyl aminopeptidase 3"	Q9NQH7	22	40857077-40932815	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"		"Aminopeptidase, Hydrolase, Metalloprotease, Protease"	"Disease variant, Nephronophthisis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"Early spermatids: 232.9;Late spermatids: 306.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000527	Approved		Supported	Mitochondria,Cytosol		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 45: Intestine - Brush border"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 34: Spermatids - Unknown function"	Mitochondria	Cytosol	"HPA000527: AB_1079266"	"prognostic unfavorable (8.19e-4)"	"unprognostic (6.77e-2)"	"unprognostic (3.22e-3)"	"unprognostic (5.03e-3)"	"unprognostic (6.18e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.64e-1)"	"unprognostic (2.53e-1)"	"unprognostic (1.73e-2)"	"unprognostic (1.51e-1)"	"unprognostic (6.69e-2)"	"unprognostic (8.00e-3)"	"unprognostic (2.49e-1)"	"prognostic unfavorable (6.10e-4)"	"unprognostic (1.24e-1)"	2.7	4.9	6.4	1.3	6.3	1.6	2.6	8.3	7.8	2.9	7.1	2.5	14.6	4.7	5.0	2.8	3.7	4.4	5.3	7.8	6.1	3.7	8.2	2.4	2.5	7.2	6.6	3.8	3.6	2.1	3.7	1.5	6.6	2.8	2.2	4.4	3.4	2.5	5.5	5.5	10.1	2.4	5.6	2.8	2.8	3.7	6.7	5.9	3.2	3.5	1.9	3.7	2.8	9.0	2.7	4.1	2.5	5.5	6.3	4.6	2.1	3.3	2.5	1.7	1.7	3.1	1.6	5.2	1.8	6.5	7.8	7.3	4.7	2.4	2.7	3.5	9.7	3.3	9.7	7.5	3.2	6.0	0.5	4.0	3.9	5.7	3.3	2.7	3.3	3.8	2.9	4.8	4.3	4.1	3.1	3.2	1.5	5.0	8.3	3.9	3.3	3.0	5.9	3.6	2.3	1.9	3.9	4.8	3.3	2.6	6.1	2.7	3.2	3.6	3.4	3.4	2.1	4.7	4.0	7.4	5.6	8.5	2.5	2.8	2.5	2.9	2.1	2.5	1.0	3.7	1.2	1.2	1.9	1.9	2.4	1.9	3.6	0.7	6.9	3.8	1.9	2.8	6.4	6.3	8.3	7.8	7.8	6.1	7.2	6.6	6.6	5.6	6.7	9.0	9.6	6.4	17.6	32.0	12.7	13.3	8.0	15.6	9.6	16.0	12.9	13.2	22.5	15.7	14.0	9.2	18.8	21.7	11.0	6.2	15.6	12.2	232.9	37.5	16.6	11.7	13.8	12.0	22.0	17.1	18.7	13.1	12.2	12.0	14.0	17.8	10.8	36.0	14.7	16.8	24.0	9.5	12.2	12.6	15.7	306.8	19.9	11.9	17.8	18.7	7.8	13.0	9.2	19.6	42.3	10.4	9.5	15.4	11.8	7.8	3.5	25.3	38.5	19.8	32.9	14.0	12.7	65.6	34.2	12.2	16.3	20.0	11.0	19.5	8.7	7.6
XPO1	"CRM-1, CRM1, emb"	ENSG00000082898	"Exportin 1"	O14980	2	61476032-61538741	"Cancer-related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Transporters"	"Host-virus interaction, mRNA transport, Protein transport, Transport"	RNA-binding	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010184, HPA042933"	Supported		Enhanced	"Nucleoplasm,Nuclear membrane,Vesicles,Cytosol"		NA	NA		410000	"Cluster 27: Non-specific - Gene expression"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 36: Stromal cells - Cell proliferation"	"Nucleoplasm, Nuclear membrane"	"Vesicles, Cytosol"	"CAB010184: AB_2215817, HPA042933: AB_2678229"	"unprognostic (7.34e-2)"	"unprognostic (7.04e-2)"	"unprognostic (6.37e-2)"	"unprognostic (1.67e-2)"	"unprognostic (5.61e-2)"	"unprognostic (1.28e-1)"	"prognostic unfavorable (1.84e-5)"	"unprognostic (1.84e-1)"	"unprognostic (1.99e-3)"	"unprognostic (4.43e-1)"	"unprognostic (3.53e-3)"	"unprognostic (4.90e-2)"	"prognostic unfavorable (3.74e-4)"	"unprognostic (5.69e-2)"	"unprognostic (2.08e-1)"	"unprognostic (2.43e-1)"	"unprognostic (5.55e-2)"	33.2	29.8	30.1	48.7	31.4	25.8	39.2	35.7	44.3	37.9	31.6	34.9	24.7	52.5	37.0	35.1	45.9	32.0	36.0	27.9	33.7	30.8	41.7	31.9	65.3	28.9	30.5	58.9	26.2	38.5	22.0	52.1	30.4	34.2	42.0	52.0	19.9	34.9	37.5	34.2	33.2	48.6	30.9	43.4	31.9	54.5	32.8	73.6	38.8	47.2	60.9	38.6	22.4	38.9	169.1	152.9	194.1	135.8	91.4	107.9	145.5	166.6	109.2	192.9	151.8	217.3	114.7	256.0	117.4	127.1	186.3	125.0	307.9	126.5	268.6	151.6	110.7	242.8	136.2	148.4	55.4	234.6	145.4	62.9	103.8	149.4	145.9	126.0	149.5	108.7	285.5	127.7	164.9	97.8	212.6	100.4	213.1	189.9	111.5	175.6	208.0	148.1	103.0	124.9	152.8	77.5	174.2	142.8	87.1	185.6	108.6	110.8	98.9	153.7	178.7	137.2	175.0	102.8	203.2	347.0	96.8	214.0	151.0	3.3	1.4	2.2	1.8	2.2	1.9	1.1	1.0	1.8	2.1	0.7	1.0	1.0	0.6	2.7	1.2	1.6	1.2	1.2	30.1	31.4	35.7	44.3	27.9	33.7	28.9	30.5	30.4	30.9	32.8	38.9	42.0	41.7	43.2	114.3	55.3	52.1	32.1	45.5	78.6	67.5	40.2	38.6	64.5	38.6	38.7	31.3	95.9	54.1	56.6	27.3	13.7	29.7	4.2	58.6	79.7	47.7	45.1	73.2	87.9	26.1	49.3	49.9	42.3	68.6	41.8	100.4	41.4	55.8	57.2	72.3	101.3	34.2	40.7	55.3	58.4	11.9	33.5	63.9	37.4	68.4	64.2	33.4	61.8	83.4	102.5	32.3	20.9	30.9	57.2	55.6	21.0	22.2	56.9	101.7	19.7	50.5	55.7	65.9	91.6	83.3	56.8	30.1	54.5	54.4	46.2	47.7
XPO4	"FLJ13046, KIAA1721"	ENSG00000132953	"Exportin 4"	Q9C0E2	13	20777329-20903048	"Plasma proteins, Predicted intracellular proteins, Transporters"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 44.1"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 64.6;Excitatory neurons: 72.8;Inhibitory neurons: 70.8;Oligodendrocytes: 82.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053768			Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 32: U-937 - Innate immune response"	"Cluster 58: T-cells - T-cell receptor"	"Nucleoplasm, Cytosol"		"HPA053768: AB_2682254"	"unprognostic (2.24e-1)"	"unprognostic (1.20e-2)"	"unprognostic (3.79e-2)"	"prognostic unfavorable (8.25e-4)"	"unprognostic (2.04e-1)"	"unprognostic (1.66e-1)"	"prognostic unfavorable (4.63e-4)"	"unprognostic (1.67e-1)"	"unprognostic (7.24e-3)"	"unprognostic (9.50e-3)"	"unprognostic (2.99e-1)"	"unprognostic (1.67e-2)"	"unprognostic (1.00e-2)"	"unprognostic (9.82e-2)"	"unprognostic (1.16e-1)"	"unprognostic (3.23e-2)"	"unprognostic (2.42e-1)"	4.3	3.6	3.1	5.7	4.3	10.2	6.1	5.6	3.8	4.4	4.5	4.7	3.7	6.1	4.1	4.8	4.1	3.5	10.7	3.0	3.5	5.1	4.1	6.0	7.3	3.7	3.6	6.1	4.2	6.5	3.0	5.2	3.8	5.4	5.7	13.5	3.7	3.9	44.1	5.6	3.8	5.6	3.8	5.8	4.6	5.8	3.7	7.1	6.5	16.7	7.0	4.6	3.7	5.6	10.1	7.5	12.0	11.5	5.7	9.9	12.4	11.2	8.2	13.0	10.7	15.3	12.4	22.0	5.9	10.8	9.8	16.2	28.0	15.2	24.0	15.1	8.0	35.0	9.5	10.3	8.6	31.0	11.0	9.8	9.4	13.1	24.7	7.6	15.9	12.5	16.8	7.1	12.4	8.3	14.9	13.6	13.6	21.2	6.9	16.3	19.8	9.2	9.0	12.1	13.6	9.4	9.7	13.9	11.5	12.0	8.2	16.8	13.2	9.1	7.1	11.3	16.1	4.7	7.4	17.9	4.5	19.5	13.9	1.5	0.7	0.8	1.1	0.8	1.3	1.0	1.0	1.0	1.0	0.8	1.2	1.2	0.0	1.1	2.5	0.7	1.0	0.4	3.1	4.3	5.6	3.8	3.0	3.5	3.7	3.6	3.8	3.8	3.7	5.6	10.0	12.8	12.5	36.6	24.0	8.3	10.7	12.1	11.4	17.0	8.5	6.1	22.2	10.0	5.6	9.2	64.6	8.3	11.4	4.7	0.0	5.4	10.4	6.1	11.9	9.5	1.2	10.9	72.8	4.1	7.4	9.8	18.3	7.7	15.2	11.9	12.1	10.5	10.8	10.1	70.8	7.5	6.1	10.0	8.0	8.2	17.4	9.5	12.4	44.0	11.6	5.4	10.3	58.8	82.5	5.4	3.6	8.2	21.3	11.8	3.4	5.4	6.3	21.4	32.9	11.6	10.0	14.2	18.8	14.7	11.2	12.9	18.6	7.1	9.6	10.4
XRN1	SEP1	ENSG00000114127	"5'-3' exoribonuclease 1"	Q8IZH2	3	142306607-142448062	"Predicted intracellular proteins"		"DNA-binding, Exonuclease, Hydrolase, Nuclease, RNA-binding"	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in all"	4	"RH-30: 119.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035005, HPA035006"	Approved		Supported	"Plasma membrane,Cytosol"		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 59: Non-specific - Transcription"	"Plasma membrane, Cytosol"		"HPA035005: AB_10670695, HPA035006: AB_10672750"	"unprognostic (3.52e-1)"	"unprognostic (2.35e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.35e-2)"	"unprognostic (2.40e-2)"	"unprognostic (1.68e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.67e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.16e-2)"	"prognostic unfavorable (9.43e-4)"	"unprognostic (7.68e-2)"	"unprognostic (6.16e-2)"	"unprognostic (1.23e-1)"	"unprognostic (2.41e-1)"	"unprognostic (2.43e-2)"	"unprognostic (6.32e-2)"	9.0	6.8	2.9	12.2	4.5	21.2	10.7	11.4	5.5	8.4	6.4	8.2	11.0	9.8	7.8	7.0	6.2	8.0	5.5	3.2	4.0	6.8	16.2	8.6	13.1	3.8	3.2	10.1	8.1	8.8	6.0	10.5	4.2	8.8	9.4	14.6	7.4	6.1	11.7	9.4	12.4	6.6	4.5	12.8	9.0	9.3	3.9	14.4	8.7	9.7	11.3	7.7	8.2	6.8	22.1	3.9	9.6	8.6	11.1	17.0	5.9	9.9	12.9	12.3	15.2	3.6	6.1	8.9	10.3	13.3	10.0	8.6	8.6	5.2	19.2	21.4	6.5	12.7	7.3	3.5	9.6	12.8	12.7	14.0	6.1	8.8	11.7	12.1	11.4	9.7	8.0	20.4	11.7	4.5	11.2	7.6	3.0	3.4	4.4	9.0	119.2	11.4	6.5	10.8	5.7	7.3	17.3	10.4	8.2	5.9	11.9	10.8	16.0	9.0	4.7	10.3	8.7	29.1	14.2	13.7	8.4	7.2	7.9	31.0	5.8	17.2	10.0	5.4	7.1	9.8	7.7	9.1	2.9	7.2	10.1	7.0	21.2	5.9	5.0	8.0	6.2	3.1	2.9	4.5	11.4	5.5	3.2	4.0	3.8	3.2	4.2	4.5	3.9	6.8	66.1	54.5	33.3	74.7	55.9	25.6	33.7	22.7	33.6	33.7	27.2	21.0	26.5	18.6	30.2	46.0	50.1	22.9	80.8	46.5	11.7	16.5	49.9	31.9	50.7	40.6	28.2	43.6	101.6	12.5	7.8	41.8	48.4	29.0	21.5	33.7	33.9	48.0	16.3	26.9	114.2	22.5	14.2	28.9	23.0	19.1	24.8	38.8	14.2	81.5	41.4	21.0	50.4	126.7	120.4	18.6	41.9	29.0	111.7	44.0	43.4	13.2	34.2	53.9	6.6	56.0	39.9	61.8	20.5	27.6	28.3	53.5	69.8	37.1	15.0	43.8
XRRA1	FLJ00225	ENSG00000166435	"X-ray radiation resistance associated 1"	Q6P2D8	11	74807739-74949200	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 19.4"	"Cell type enhanced"	"Detected in all"		"Cone photoreceptor cells: 139.7;Spermatocytes: 125.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"hTERT-HME1: 36.1"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA039263			Supported	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 9: Photoreceptor cells - Phototransduction"	Nucleoplasm	"Nuclear bodies"	"HPA039263: AB_2676419"	"unprognostic (3.58e-1)"	"unprognostic (1.04e-2)"	"unprognostic (1.24e-1)"	"unprognostic (3.11e-2)"	"unprognostic (7.33e-2)"	"unprognostic (1.20e-1)"	"unprognostic (2.69e-1)"	"unprognostic (1.71e-1)"	"unprognostic (3.31e-1)"	"unprognostic (1.23e-1)"	"unprognostic (3.04e-1)"	"unprognostic (1.62e-1)"	"unprognostic (5.94e-3)"	"unprognostic (2.13e-1)"	"unprognostic (3.31e-2)"	"unprognostic (2.06e-1)"	"unprognostic (2.27e-1)"	3.4	3.8	2.3	1.1	2.9	1.6	3.4	2.4	2.5	5.1	1.9	4.5	2.6	4.8	3.8	4.1	4.4	2.9	4.4	2.1	2.7	4.2	5.0	3.8	1.9	2.6	2.7	4.9	4.5	3.2	4.2	2.4	2.7	5.0	2.3	2.3	5.5	3.0	6.0	3.6	2.9	4.8	2.3	4.2	3.8	19.4	3.2	2.6	7.1	11.6	2.7	4.6	3.9	4.3	5.4	3.0	0.7	4.9	7.5	4.9	2.1	2.3	2.5	1.3	1.3	1.6	2.8	2.2	8.3	2.5	11.1	4.3	6.1	3.0	2.8	8.8	0.5	1.9	2.0	3.1	2.2	1.2	0.9	4.7	3.4	5.6	36.1	10.5	2.7	7.2	5.1	5.0	6.5	2.0	2.0	2.8	1.7	6.5	2.7	0.9	3.9	1.7	1.1	4.1	4.7	3.9	10.7	4.5	14.2	2.3	2.8	5.6	1.8	7.8	5.0	5.7	2.2	7.0	6.7	6.1	1.8	1.1	2.7	1.4	2.0	1.9	2.9	2.5	3.2	1.6	2.1	2.2	1.7	1.5	2.1	2.0	3.3	1.0	1.7	1.2	4.4	1.5	2.3	2.9	2.4	2.5	2.1	2.7	2.6	2.7	2.7	2.3	3.2	4.3	22.8	9.6	8.8	40.5	27.7	11.0	10.4	15.7	10.8	56.7	18.3	15.0	5.9	8.6	12.3	22.0	139.7	12.3	15.1	13.9	15.6	8.2	51.9	18.7	19.5	13.8	12.1	9.0	38.4	8.0	10.6	16.0	11.2	13.6	12.0	14.7	15.0	14.0	7.8	48.8	39.1	16.3	8.2	10.3	11.0	78.9	29.8	8.9	28.4	30.0	7.7	19.9	25.7	36.7	55.5	6.5	16.2	30.5	29.8	10.5	17.6	22.1	22.5	76.6	26.3	23.4	13.9	125.2	37.7	6.5	7.5	10.9	21.1	7.1	18.4	7.8
YAF2		ENSG00000015153	"YY1 associated factor 2"	Q8IY57	12	42157104-42238349	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	8	"Cardiomyocytes: 1187.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-937: 82.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026867	Supported		Supported	Nucleoplasm		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 38: Heart - Muscle contraction"	"Cluster 32: U-937 - Innate immune response"	"Cluster 54: Cardiomyocytes - Muscle contraction"	Nucleoplasm		"HPA026867: AB_1858911"	"unprognostic (1.41e-1)"	"unprognostic (2.24e-1)"	"unprognostic (9.30e-2)"	"unprognostic (3.06e-1)"	"unprognostic (2.06e-2)"	"unprognostic (4.12e-1)"	"unprognostic (7.10e-3)"	"unprognostic (2.70e-1)"	"unprognostic (2.86e-3)"	"unprognostic (2.44e-2)"	"unprognostic (3.58e-2)"	"unprognostic (5.57e-2)"	"unprognostic (4.57e-2)"	"unprognostic (3.42e-1)"	"unprognostic (2.33e-1)"	"unprognostic (5.76e-2)"	"unprognostic (1.20e-2)"	11.5	9.5	9.7	8.1	10.5	10.8	10.0	13.9	12.0	10.3	4.3	8.1	5.9	9.4	8.7	6.9	8.8	8.6	36.6	11.6	10.4	9.5	18.0	8.1	12.5	9.2	9.1	9.0	6.3	7.8	8.6	9.0	10.3	8.2	7.3	14.2	6.6	8.4	29.4	6.3	7.9	10.3	9.9	10.6	6.9	7.3	10.1	13.5	11.1	21.1	10.0	10.0	8.9	12.6	13.5	10.6	15.3	12.1	19.1	16.9	9.9	19.1	17.1	15.5	15.1	14.4	10.7	8.6	14.0	16.6	6.2	11.5	15.0	10.7	21.7	20.5	14.9	18.0	4.6	6.8	11.0	17.6	11.1	12.1	14.9	12.8	25.3	15.7	16.3	8.3	17.2	20.1	20.1	5.6	20.4	21.2	3.9	16.0	14.1	15.0	16.6	13.9	20.1	10.1	11.6	14.6	16.0	18.3	14.8	6.9	12.4	13.0	14.4	13.6	12.1	16.7	9.5	16.6	26.4	31.7	15.0	82.3	6.8	43.2	15.6	28.9	18.2	18.9	18.6	20.6	17.6	20.9	12.5	24.2	13.4	14.5	56.6	27.1	17.2	19.3	26.5	9.7	9.7	10.5	13.9	12.0	11.6	10.4	9.2	9.1	10.3	9.9	10.1	12.6	41.9	22.4	13.4	68.2	41.1	58.1	40.8	31.0	33.0	75.0	45.2	35.1	1187.5	31.5	27.6	20.2	85.5	40.1	71.2	22.7	62.6	32.2	33.6	27.7	43.1	61.7	38.9	36.2	105.5	45.5	22.4	49.7	18.3	37.0	70.5	88.4	50.7	104.7	27.8	144.7	89.4	33.1	46.8	44.7	61.3	15.9	58.1	37.6	42.7	83.4	48.8	94.6	84.5	97.0	57.8	35.3	26.8	76.8	44.6	37.2	29.9	66.0	20.1	99.7	105.2	44.8	63.8	38.0	38.2	30.5	51.1	45.3	58.7	36.2	27.5	32.7
YAP1	YAP65	ENSG00000137693	"Yes1 associated transcriptional regulator"	P46937	11	102110447-102233424	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, Repressor"	Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 145.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009370, HPA038884, HPA038885, CAB069915, HPA070359"	Enhanced		Supported	"Nucleoplasm,Nucleoli,Cell Junctions"		NA	NA				"Cluster 89: Fibroblasts - ECM organization"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 40: Granulosa cells - Unknown function"	Nucleoplasm	"Nucleoli, Cell Junctions"	"CAB009370: AB_2273277, CAB069915: AB_922796, HPA038884: , HPA038885: AB_2676255, HPA070359: AB_2732154"	"unprognostic (9.56e-2)"	"unprognostic (6.75e-2)"	"unprognostic (2.08e-1)"	"unprognostic (3.03e-1)"	"unprognostic (1.35e-1)"	"unprognostic (3.16e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.28e-1)"	"unprognostic (2.66e-3)"	"unprognostic (3.73e-1)"	"prognostic unfavorable (2.03e-4)"	"unprognostic (9.26e-2)"	"unprognostic (4.80e-2)"	"unprognostic (8.38e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.29e-2)"	57.2	27.8	19.1	25.9	19.1	0.3	42.7	18.6	17.1	62.5	44.3	41.5	27.2	78.1	45.9	74.7	65.6	49.3	48.1	15.9	22.1	39.3	33.5	45.7	13.0	31.8	30.2	93.1	22.3	37.0	9.9	83.1	21.8	59.2	30.1	12.9	40.6	83.7	48.3	44.2	27.4	100.5	27.3	14.7	31.6	15.0	27.0	13.8	85.9	58.2	22.7	60.9	52.6	20.2	56.9	52.1	141.5	69.6	151.1	143.1	118.7	130.4	147.8	124.2	101.5	130.2	134.9	0.0	105.4	171.6	92.1	98.0	71.0	186.4	130.6	16.8	25.5	0.1	67.3	89.5	115.3	0.1	2.5	115.2	119.4	136.6	220.2	138.4	39.4	6.7	0.0	0.1	142.1	27.2	2.6	0.4	66.8	135.9	49.3	0.1	79.7	0.3	90.9	99.5	0.4	4.7	153.6	57.2	43.5	129.1	103.2	0.8	43.4	175.4	68.8	89.6	55.7	0.1	0.2	0.8	51.0	0.2	130.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.1	19.1	18.6	17.1	15.9	22.1	31.8	30.2	21.8	27.3	27.0	20.2	28.4	35.3	69.4	145.3	1.5	113.7	47.8	43.5	71.2	0.4	48.1	43.8	39.2	62.9	37.2	92.0	0.0	91.4	0.4	16.2	11.7	27.6	6.7	61.8	53.3	28.9	7.3	0.0	1.5	18.3	20.3	49.0	23.9	85.1	0.0	127.2	26.0	45.2	10.6	0.0	1.6	13.1	14.2	1.6	21.5	4.6	37.9	2.2	44.4	60.0	1.0	27.6	0.0	5.0	0.7	25.2	16.3	40.6	0.1	66.0	27.2	26.1	41.6	1.2	39.5	21.6	62.0	2.5	5.3	59.5	123.2	61.6	2.1	15.9	27.8	65.6
YARS2	"CGI-04, FLJ13995, mt-TyrRS"	ENSG00000139131	"Tyrosyl-tRNA synthetase 2"	Q9Y2Z4	12	32727490-32755897	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase"	"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038721, HPA057610, HPA074097"	Uncertain		Supported	"Nuclear bodies,Mitochondria"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 52: Non-specific - Ribosome"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Mitochondria	"Nuclear bodies"	"HPA038721: AB_10674837, HPA057610: AB_2683483, HPA074097: AB_2686660"	"unprognostic (1.55e-1)"	"unprognostic (1.41e-2)"	"unprognostic (2.30e-3)"	"unprognostic (1.02e-2)"	"unprognostic (2.12e-1)"	"unprognostic (5.99e-3)"	"prognostic unfavorable (3.19e-5)"	"unprognostic (1.41e-2)"	"unprognostic (4.98e-2)"	"unprognostic (1.40e-2)"	"unprognostic (1.15e-2)"	"unprognostic (8.39e-2)"	"unprognostic (7.45e-2)"	"unprognostic (1.99e-1)"	"unprognostic (4.71e-1)"	"unprognostic (4.07e-1)"	"unprognostic (2.09e-1)"	6.1	6.0	4.1	6.5	3.8	7.8	6.6	4.3	4.5	5.9	3.9	5.8	4.8	5.8	5.0	7.1	5.2	4.4	6.2	3.9	3.3	4.8	6.0	4.3	8.1	3.7	3.0	6.1	5.8	6.5	3.7	7.8	4.3	4.6	6.4	4.6	8.1	4.5	7.3	5.4	5.2	5.3	3.1	6.1	5.8	4.6	3.2	7.9	4.6	8.5	8.3	7.4	5.1	4.3	19.8	23.3	13.3	15.8	14.3	16.6	42.0	14.8	15.0	17.9	17.4	58.8	24.6	35.4	23.6	15.0	25.8	24.9	26.7	38.9	20.0	15.5	41.8	23.6	16.4	33.0	20.6	25.3	13.2	15.6	24.4	16.9	30.5	23.0	28.5	18.4	33.7	15.9	19.1	16.1	18.9	30.4	73.5	13.0	28.2	21.0	28.4	21.1	22.9	27.8	20.5	10.0	22.7	19.5	14.7	51.5	36.5	22.7	19.5	16.9	17.7	27.8	25.3	9.4	10.7	37.0	15.7	18.6	14.3	10.2	6.1	3.7	8.4	8.0	8.8	7.3	8.8	8.7	8.5	9.6	9.0	10.5	1.0	11.9	9.6	8.2	8.4	5.1	4.1	3.8	4.3	4.5	3.9	3.3	3.7	3.0	4.3	3.1	3.2	4.3	14.5	6.4	4.4	25.5	16.1	10.1	20.1	27.0	14.2	16.8	11.4	8.4	7.7	1.5	15.1	11.0	20.9	34.7	15.9	5.4	7.9	19.9	6.5	19.7	17.7	10.2	7.2	21.2	22.2	16.5	36.9	12.5	6.6	24.6	7.0	18.9	6.8	5.6	20.1	15.2	31.2	7.3	16.2	9.3	6.0	4.6	10.5	10.4	5.4	18.7	16.0	12.3	16.5	26.7	44.1	14.2	7.6	8.6	9.3	13.9	7.9	11.5	9.0	19.9	13.1	10.5	19.1	6.3	12.8	12.9	8.4	17.9	13.9	24.3	12.8	12.6
YBX1	"BP-8, CSDA2, CSDB, DBPB, MDR-NF1, NSEP-1, NSEP1, YB-1, YB1"	ENSG00000065978	"Y-box binding protein 1"	P67809	1	42682418-42703805	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"mRNA processing, mRNA splicing, Transcription, Transcription regulation"	"Activator, DNA-binding, Mitogen, Repressor, RNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 2038.9"	"Cell type enhanced"	"Detected in all"		"Early spermatids: 8388.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"CAB005875, HPA040304, HPA057159"	Supported		Supported	"Endoplasmic reticulum,Vesicles,Plasma membrane,Cytosol"	"Intracellular and membrane"	NA	NA		1600000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 59: Non-specific - Translation"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 66: Spermatocytes - Spermatogenesis"	Cytosol	"Endoplasmic reticulum, Vesicles, Plasma membrane"	"CAB005875: AB_2219278, HPA040304: AB_10795364, HPA057159: AB_2683355"	"unprognostic (8.59e-2)"	"unprognostic (5.16e-2)"	"unprognostic (9.27e-3)"	"unprognostic (2.68e-3)"	"unprognostic (7.76e-2)"	"unprognostic (8.03e-3)"	"prognostic unfavorable (9.87e-10)"	"unprognostic (2.80e-2)"	"unprognostic (2.31e-2)"	"unprognostic (2.79e-3)"	"unprognostic (7.51e-2)"	"unprognostic (5.52e-2)"	"prognostic unfavorable (3.59e-7)"	"unprognostic (3.66e-2)"	"unprognostic (2.44e-1)"	"unprognostic (1.94e-2)"	"unprognostic (3.25e-1)"	532.0	254.5	141.7	422.4	155.4	863.9	401.1	153.3	157.7	331.8	154.4	600.2	364.9	406.2	211.3	365.0	337.0	209.8	789.7	140.6	159.4	318.9	309.9	396.3	407.9	175.1	160.2	311.7	266.7	133.8	122.2	242.2	178.8	307.8	378.1	391.8	270.5	219.5	2038.9	295.0	366.1	338.9	152.7	367.1	405.0	783.5	180.8	353.4	282.0	1133.9	382.2	501.5	332.3	173.5	1552.8	761.5	1020.4	1232.7	991.0	908.1	1200.2	971.5	768.9	1116.6	875.8	1034.6	1253.7	1630.6	1157.5	825.2	495.5	870.2	1162.6	1230.5	1103.9	1087.8	1278.0	1596.4	1491.9	1343.8	786.7	2214.4	1320.7	812.6	1092.3	1094.5	1365.7	630.0	950.3	1271.9	1823.0	720.6	1104.0	837.7	2816.5	2464.6	2902.1	755.0	1006.4	1789.6	1972.5	1938.2	1176.7	933.8	1731.6	1298.5	893.7	1294.0	2038.3	1096.8	443.2	5002.2	862.6	945.4	1748.6	1371.1	2209.3	1213.7	1670.6	2004.8	910.4	1750.3	1049.9	15.3	48.4	69.9	42.9	107.1	52.9	69.4	51.8	43.3	77.4	61.2	44.0	45.9	9.0	35.1	124.2	58.6	69.7	34.1	141.7	155.4	153.3	157.7	140.6	159.4	175.1	160.2	178.8	152.7	180.8	173.5	701.7	173.1	230.9	16.3	818.3	1397.7	1265.9	419.7	747.3	247.8	569.7	564.5	1072.3	441.8	355.5	325.5	150.1	753.9	678.4	620.6	1457.6	1013.6	8388.7	363.5	695.5	755.1	587.8	2244.2	16.2	886.6	1998.9	687.6	461.3	427.0	383.1	489.1	483.3	480.1	1708.7	121.1	27.1	930.2	354.0	1656.0	2342.9	3743.4	751.2	1307.6	905.4	19.7	1171.0	463.8	744.6	23.6	32.7	858.2	975.1	806.1	981.0	1935.1	993.3	1169.8	196.2	602.4	466.8	754.8	1083.7	3245.2	425.5	1113.5	1302.5	481.5	635.6	811.4	1257.7	1697.8
YBX3	"CSDA, CSDA1, dbpA, ZONAB"	ENSG00000060138	"Y-box binding protein 3"	P16989	12	10699089-10723323	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	7	"skeletal muscle: 4915.7;tongue: 1635.6"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 1418.1;Prostatic glandular cells: 1553.4;Skeletal myocytes: 1316.7;Urothelial cells: 1339.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"naive B-cell: 6.5"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA034838	Approved		Supported	Cytosol		NA	NA		230000	"Cluster 21: B-cells - Adaptive immune response"	"Cluster 33: Striated muscle - Muscle contraction"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 22: Epithelial cell types - Mixed function"	Cytosol		"HPA034838: AB_10670980"	"unprognostic (1.93e-2)"	"unprognostic (6.20e-2)"	"unprognostic (3.56e-1)"	"unprognostic (3.61e-2)"	"unprognostic (4.15e-1)"	"unprognostic (4.33e-2)"	"unprognostic (1.10e-1)"	"unprognostic (3.81e-2)"	"unprognostic (2.91e-1)"	"unprognostic (2.41e-1)"	"unprognostic (3.23e-3)"	"unprognostic (1.20e-1)"	"prognostic unfavorable (6.17e-13)"	"unprognostic (2.11e-2)"	"unprognostic (1.51e-1)"	"unprognostic (4.25e-2)"	"unprognostic (2.44e-1)"	250.4	96.7	17.6	77.5	17.6	151.1	200.2	18.8	25.5	152.1	28.4	249.1	37.5	136.8	47.3	271.0	166.7	65.0	469.9	16.5	22.3	194.1	53.8	209.5	32.9	25.4	22.4	134.6	291.0	18.6	84.1	72.5	23.9	177.1	58.8	82.8	218.1	67.5	4915.7	358.1	99.0	100.9	20.9	79.5	149.7	265.7	22.2	36.7	136.1	1635.6	54.6	225.4	204.8	19.7	117.2	90.3	41.4	136.1	165.7	310.7	307.4	173.4	142.7	138.7	132.0	160.4	259.5	109.3	57.7	130.3	96.5	215.5	173.3	338.1	124.6	1.2	325.2	91.3	123.6	108.4	198.3	171.7	10.4	343.3	452.3	124.2	414.6	148.9	313.6	152.3	123.1	0.4	154.7	112.6	137.8	141.9	435.5	103.7	76.9	76.9	192.6	127.4	192.6	150.0	52.2	0.3	129.1	130.9	174.1	288.0	37.1	133.9	221.3	94.5	282.6	108.4	201.5	0.5	38.1	13.4	133.1	0.2	104.8	0.0	4.2	0.0	0.6	4.2	0.0	1.6	0.0	1.5	3.2	6.5	0.0	1.6	0.8	0.8	2.4	0.1	0.1	1.0	17.6	17.6	18.8	25.5	16.5	22.3	25.4	22.4	23.9	20.9	22.2	19.7	680.9	150.6	164.4	14.0	192.8	764.9	1226.9	212.9	552.7	36.1	288.8	292.7	497.7	105.8	177.8	145.3	89.6	145.7	39.2	94.3	133.1	125.3	1418.1	563.0	402.1	563.1	67.6	1081.5	2.4	143.3	84.3	484.8	119.8	551.3	63.3	291.0	235.6	23.1	97.7	16.8	1.0	139.5	120.1	223.2	494.7	470.2	264.7	292.2	259.7	21.5	83.9	67.2	2.1	4.5	0.1	122.0	76.3	223.8	80.6	1553.4	43.9	240.4	240.4	365.4	124.9	1316.7	643.1	594.6	158.4	638.6	1050.5	125.7	72.5	70.8	157.4	1339.7
YES1	"c-yes, HsT441, Yes"	ENSG00000176105	"YES proto-oncogene 1, Src family tyrosine kinase"	P07947	18	721588-812546	"Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Kinase, Transferase, Tyrosine-protein kinase"	"FDA approved drug targets, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	9	"basophil: 20.2"	"Lineage enriched"	"Detected in many"	9	"granulocytes: 20.2"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004370, HPA026480"	Approved		Supported	"Plasma membrane,Cytosol"		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Plasma membrane, Cytosol"		"CAB004370: AB_627370, HPA026480: AB_1858921"	"unprognostic (3.28e-1)"	"unprognostic (1.62e-2)"	"unprognostic (5.87e-2)"	"unprognostic (2.47e-2)"	"unprognostic (6.24e-2)"	"unprognostic (4.24e-2)"	"unprognostic (6.01e-2)"	"unprognostic (1.03e-2)"	"unprognostic (1.95e-2)"	"unprognostic (1.85e-3)"	"prognostic unfavorable (2.46e-4)"	"unprognostic (2.14e-1)"	"unprognostic (8.12e-2)"	"unprognostic (4.65e-2)"	"unprognostic (1.81e-1)"	"unprognostic (4.79e-2)"	"unprognostic (4.11e-1)"	25.2	13.5	11.9	10.5	12.7	4.1	21.8	12.7	14.3	17.4	11.5	21.8	24.8	16.0	17.9	22.7	13.9	18.9	13.1	11.7	13.7	27.9	50.6	17.2	6.2	13.9	13.2	12.4	26.5	20.0	6.1	41.7	13.5	15.0	22.7	8.3	21.0	11.9	8.3	16.7	23.7	15.9	14.2	27.4	21.3	19.0	14.3	10.5	22.0	14.6	8.8	20.3	11.5	14.1	42.7	20.8	64.3	50.6	37.8	46.5	75.6	27.9	56.2	32.0	43.7	49.9	30.7	0.1	28.8	47.3	41.0	24.3	60.8	49.1	62.3	0.2	20.7	12.6	19.4	35.1	30.6	9.9	21.7	35.7	51.7	48.5	53.6	39.8	109.8	7.0	56.1	18.4	46.1	29.3	6.0	13.0	40.9	26.0	26.4	7.4	50.6	3.6	46.8	49.6	13.1	15.3	57.5	42.9	37.1	42.3	29.7	20.5	95.6	78.4	86.2	59.9	75.8	15.7	8.3	2.6	29.7	13.8	47.6	20.2	0.0	1.0	2.2	0.0	1.5	0.1	0.4	1.2	0.0	0.0	1.0	1.7	0.0	1.1	0.0	0.0	0.1	0.6	11.9	12.7	12.7	14.3	11.7	13.7	13.9	13.2	13.5	14.2	14.3	14.1	120.3	25.6	36.8	18.9	3.3	60.2	46.8	21.4	50.1	6.0	38.1	26.7	18.2	24.3	31.3	29.5	6.2	37.1	52.9	40.3	3.9	29.6	29.4	32.8	35.0	91.0	22.8	12.0	0.4	39.2	26.6	35.4	57.6	43.6	13.9	35.9	39.7	44.9	4.9	3.3	10.3	37.2	14.2	5.4	14.7	11.7	18.3	5.0	24.9	46.9	2.0	16.8	16.5	31.7	30.2	51.0	28.8	12.8	28.9	65.4	33.1	45.6	29.0	8.6	19.7	35.9	23.8	20.3	13.6	53.1	49.7	45.6	27.5	42.4	36.7	66.6
YIF1A	"54TM, FinGER7, YIF1, YIF1P"	ENSG00000174851	"Yip1 interacting factor homolog A, membrane trafficking protein"	O95070	11	66284580-66289145	"Predicted intracellular proteins, Predicted membrane proteins"	"ER-Golgi transport, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014840, HPA076194"	Enhanced		Supported	"Golgi apparatus,Vesicles"		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	"Golgi apparatus, Vesicles"		"HPA014840: AB_2217189, HPA076194: "	"unprognostic (9.35e-2)"	"unprognostic (7.86e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.94e-1)"	"unprognostic (3.23e-1)"	"unprognostic (4.38e-3)"	"unprognostic (2.25e-3)"	"unprognostic (2.51e-2)"	"unprognostic (3.57e-2)"	"unprognostic (2.13e-1)"	"unprognostic (6.39e-3)"	"unprognostic (1.35e-1)"	"unprognostic (2.60e-2)"	"unprognostic (2.03e-1)"	"unprognostic (2.64e-1)"	"unprognostic (6.53e-2)"	"prognostic unfavorable (8.70e-4)"	49.2	54.7	33.4	28.4	36.0	16.7	47.5	38.5	41.4	42.7	42.4	50.8	56.5	53.5	34.5	50.9	45.7	25.5	57.8	33.5	35.6	50.9	149.5	44.9	22.9	38.9	36.1	42.1	86.0	40.6	74.1	34.5	38.2	47.3	37.7	12.3	51.1	29.6	96.2	43.0	47.4	41.1	38.5	35.9	56.1	36.4	35.6	21.6	49.9	59.3	24.7	45.4	40.6	41.9	80.7	131.3	39.4	72.6	130.0	138.7	73.8	114.4	122.3	95.5	94.3	126.0	95.5	67.9	111.5	161.4	107.8	119.9	60.7	107.9	75.6	77.7	72.0	42.5	93.3	158.7	147.4	59.3	61.5	97.4	144.4	98.6	158.9	76.6	91.3	67.0	80.7	114.8	84.3	199.3	71.3	64.4	40.3	147.4	136.6	54.9	61.2	203.9	81.9	70.9	58.5	57.9	62.5	106.7	103.4	49.6	155.5	43.5	81.0	80.8	69.0	165.3	54.1	78.1	86.0	63.0	125.4	56.2	90.2	19.4	95.6	20.6	71.3	141.4	78.4	95.9	60.6	67.2	116.4	82.4	48.0	55.3	9.4	51.2	140.0	141.6	54.9	99.8	33.4	36.0	38.5	41.4	33.5	35.6	38.9	36.1	38.2	38.5	35.6	41.9	63.4	38.5	48.0	6.2	52.2	36.1	88.1	170.4	38.1	27.1	84.4	92.7	34.5	82.9	115.5	46.0	22.9	114.3	42.6	66.8	64.6	137.9	28.1	42.1	84.8	53.6	87.4	21.0	1.9	149.4	248.5	90.4	55.0	42.8	29.9	38.8	49.2	172.0	105.4	26.9	3.9	140.9	116.0	38.4	44.9	48.6	75.5	45.0	72.9	8.4	40.8	73.7	28.8	10.1	10.4	132.1	93.3	82.4	92.4	195.2	202.2	135.2	101.4	34.0	39.5	60.8	150.0	61.0	56.8	63.3	46.3	154.3	36.5	88.1	107.2	112.1
YIPF1	"DJ167A19.1, FinGER1"	ENSG00000058799	"Yip1 domain family member 1"	Q9Y548	1	53851719-53889798	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 80.0;Syncytiotrophoblasts: 129.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014716, HPA073931"	Approved		Supported	"Nucleoplasm,Golgi apparatus,Plasma membrane"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Golgi apparatus"	"Nucleoplasm, Plasma membrane"	"HPA014716: AB_1847686, HPA073931: "	"unprognostic (4.94e-2)"	"unprognostic (4.50e-1)"	"unprognostic (6.37e-2)"	"unprognostic (2.06e-2)"	"unprognostic (3.93e-2)"	"unprognostic (1.35e-1)"	"prognostic unfavorable (1.34e-4)"	"unprognostic (1.96e-1)"	"unprognostic (6.64e-2)"	"unprognostic (2.34e-1)"	"unprognostic (1.49e-1)"	"unprognostic (2.76e-1)"	"unprognostic (1.24e-2)"	"unprognostic (7.75e-3)"	"unprognostic (2.38e-1)"	"unprognostic (5.39e-3)"	"unprognostic (6.35e-1)"	7.1	9.2	5.3	6.2	5.6	5.7	8.5	5.8	15.2	6.7	6.9	7.9	6.9	4.1	7.6	9.0	6.3	5.5	6.6	5.9	6.3	11.1	13.5	7.7	7.1	6.7	5.8	7.0	6.8	7.0	6.2	9.7	6.8	11.3	9.2	7.2	11.7	4.8	14.6	9.4	6.9	6.0	6.2	8.2	8.7	7.2	6.0	8.8	22.1	10.4	10.7	7.7	7.1	6.4	11.0	6.4	10.1	7.1	11.9	13.1	9.0	7.7	12.0	14.0	18.3	7.1	3.3	3.8	12.9	9.2	21.6	13.2	12.9	17.0	14.4	27.4	10.3	8.9	6.4	11.6	15.9	10.0	8.1	13.3	15.8	11.3	13.5	12.0	15.0	13.2	9.6	10.0	14.0	9.2	10.8	14.2	7.7	12.7	10.4	6.6	9.3	15.4	11.5	5.8	4.5	5.6	7.4	13.8	35.4	31.0	21.4	11.1	7.1	5.7	5.8	10.4	6.8	20.1	24.7	7.0	9.3	8.1	5.0	19.1	18.4	20.2	11.8	16.5	11.0	10.4	10.0	12.1	16.6	13.8	9.5	9.2	38.3	11.0	23.3	11.5	24.3	16.5	5.3	5.6	5.8	15.2	5.9	6.3	6.7	5.8	6.8	6.2	6.0	6.4	11.6	6.4	12.6	9.8	9.0	8.5	17.6	19.2	9.6	6.6	20.0	12.4	9.6	24.3	24.0	9.2	0.0	80.0	8.5	14.6	11.7	28.3	30.5	11.4	10.9	10.9	9.6	12.2	9.8	32.6	28.4	9.9	9.7	14.7	9.5	6.3	11.7	20.8	39.7	10.1	8.2	27.5	30.5	19.4	7.7	54.9	5.9	18.9	10.6	11.2	20.2	16.5	21.6	8.5	11.5	32.5	10.8	9.4	28.1	33.2	12.3	17.7	19.7	6.5	0.0	5.6	17.7	22.2	20.9	12.3	10.9	129.6	10.8	17.7	10.8	29.0
YIPF4	"FinGER4, MGC11061"	ENSG00000119820	"Yip1 domain family member 4"	Q9BSR8	2	32277904-32316594	"Predicted intracellular proteins, Predicted membrane proteins"	"Host-virus interaction"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	7	"brain: 129.1;choroid plexus: 65.6"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017884	Supported		Supported	"Golgi apparatus,Vesicles,Plasma membrane"		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 16: U-266 - Nucleosome"	"Cluster 52: Non-specific - Transcription"	"Golgi apparatus"	"Vesicles, Plasma membrane"	"HPA017884: AB_1853855"	"unprognostic (5.61e-3)"	"unprognostic (8.50e-2)"	"unprognostic (3.88e-2)"	"unprognostic (3.17e-3)"	"unprognostic (3.05e-1)"	"unprognostic (7.64e-2)"	"unprognostic (3.45e-2)"	"unprognostic (3.61e-2)"	"unprognostic (3.69e-1)"	"unprognostic (8.70e-2)"	"unprognostic (4.15e-1)"	"unprognostic (1.54e-1)"	"unprognostic (2.29e-3)"	"unprognostic (1.90e-1)"	"unprognostic (1.59e-1)"	"unprognostic (3.88e-2)"	"unprognostic (6.11e-2)"	7.0	6.2	69.9	5.5	66.9	2.5	8.4	69.6	129.1	6.1	65.6	6.9	5.8	6.9	7.2	5.0	5.0	4.5	7.4	71.7	68.8	7.7	9.2	5.6	5.9	69.3	67.7	6.6	14.8	6.5	5.2	5.9	71.9	6.6	6.2	13.1	7.4	5.6	8.0	7.0	5.8	6.5	66.8	6.9	6.4	4.2	67.3	7.9	10.1	6.0	5.1	5.3	5.1	75.4	8.9	4.4	8.6	7.7	9.8	12.4	4.5	7.5	7.5	7.7	5.0	5.9	6.6	4.7	5.1	8.2	7.4	6.8	9.2	6.6	10.0	7.6	14.3	7.6	9.8	10.7	11.5	10.2	6.2	8.7	12.4	6.9	11.0	10.6	6.6	5.2	10.7	9.6	8.5	5.8	8.0	10.6	7.0	9.6	7.5	5.5	12.7	8.9	8.4	3.8	9.6	9.2	6.4	6.4	11.7	5.5	3.5	8.6	7.4	10.1	4.8	7.1	7.2	14.2	19.1	5.8	15.9	9.7	5.7	14.9	5.4	5.7	4.4	5.1	3.7	4.6	4.4	4.1	4.6	4.0	4.5	4.0	14.9	6.4	5.1	5.4	4.6	4.7	69.9	66.9	69.6	129.1	71.7	68.8	69.3	67.7	71.9	66.8	67.3	75.4	61.4	93.0	69.8	13.1	68.5	51.4	56.9	59.5	50.7	113.8	63.3	28.2	88.0	60.1	58.3	42.3	106.3	68.4	81.3	68.8	33.2	45.3	34.7	39.5	57.9	59.0	57.1	86.9	18.8	39.3	69.9	66.6	28.1	40.1	40.0	56.3	67.8	80.9	48.3	101.0	20.1	70.2	50.8	81.7	60.7	21.0	86.6	58.0	81.8	21.5	85.1	53.1	114.4	22.1	31.8	41.8	66.8	74.9	62.6	78.5	62.7	60.1	62.2	122.2	78.9	71.9	66.2	160.2	59.6	41.1	65.9	192.8	60.7	65.4	46.8	74.7
YIPF5	"FinGER5, SMAP-5"	ENSG00000145817	"Yip1 domain family member 5"	Q969M3	5	144158162-144170714	"Predicted membrane proteins"	"ER-Golgi transport, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"TIME: 236.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042338, HPA073622"	Supported		Supported	"Nucleoplasm,Endoplasmic reticulum,Golgi apparatus,Vesicles"		NA	NA			"Cluster 13: T-cells - Unknown function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 55: Plasma cells - Humoral immune response"	"Endoplasmic reticulum, Golgi apparatus, Vesicles"	Nucleoplasm	"HPA042338: AB_2677953, HPA073622: AB_2686618"	"prognostic unfavorable (7.83e-5)"	"unprognostic (1.13e-3)"	"unprognostic (1.95e-2)"	"unprognostic (8.35e-2)"	"unprognostic (2.15e-1)"	"prognostic unfavorable (1.12e-5)"	"prognostic unfavorable (3.26e-5)"	"unprognostic (2.89e-2)"	"unprognostic (1.99e-1)"	"unprognostic (3.64e-2)"	"unprognostic (1.20e-3)"	"unprognostic (4.79e-2)"	"unprognostic (8.79e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.24e-2)"	"unprognostic (5.11e-2)"	"unprognostic (6.49e-2)"	22.2	20.4	8.3	17.7	9.8	21.0	24.1	9.8	11.0	24.7	16.3	25.8	30.5	20.2	21.2	28.6	20.3	21.4	18.1	9.5	12.5	25.4	31.7	20.3	18.9	9.7	10.3	20.6	32.0	25.7	17.0	30.2	11.5	18.3	26.0	20.6	26.2	19.2	9.3	17.7	27.3	28.5	10.3	15.5	22.7	20.9	10.3	16.1	22.6	14.5	23.9	24.0	14.3	12.0	43.2	28.2	36.0	28.6	84.4	90.5	32.9	143.6	96.9	63.2	101.5	45.3	44.0	23.5	67.3	156.9	72.5	38.7	34.7	70.5	84.8	32.9	30.2	17.4	44.9	46.7	68.0	39.3	27.7	69.1	64.3	56.8	46.3	108.9	61.0	25.6	18.8	38.5	86.4	22.5	19.4	22.2	23.3	27.5	30.7	20.3	53.4	39.3	39.4	37.7	24.4	30.0	49.7	26.4	66.5	36.2	54.9	25.5	236.7	74.0	35.8	72.5	57.2	34.7	61.8	29.9	70.7	36.9	55.2	48.9	34.5	48.7	47.2	47.4	53.1	37.9	47.1	52.4	41.2	36.4	49.0	46.3	26.0	41.0	44.7	45.0	62.8	40.6	8.3	9.8	9.8	11.0	9.5	12.5	9.7	10.3	11.5	10.3	10.3	12.0	43.5	38.5	27.4	8.5	35.6	29.4	24.5	49.4	26.2	40.6	33.4	29.6	21.8	31.5	35.9	20.2	33.3	56.7	40.5	33.0	31.3	43.7	14.9	31.4	49.8	44.1	14.8	20.0	19.7	68.3	77.1	51.9	33.6	31.2	36.8	34.1	30.4	34.7	36.5	33.7	16.9	50.1	22.4	34.0	24.4	7.3	35.4	28.7	30.2	6.5	38.3	54.9	27.8	13.6	16.2	60.5	35.5	33.8	70.0	23.4	56.0	36.1	50.6	53.8	39.5	31.8	45.4	83.9	56.0	33.4	26.0	67.5	42.0	41.1	27.4	24.5
YLPM1	"C14orf170, PPP1R169, ZAP"	ENSG00000119596	"YLP motif containing 1"	P49750	14	74763316-74859435	"Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA048070, HPA061123"	Uncertain		Supported	"Nucleoplasm,Nuclear speckles"		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 71: Testis - DNA repair"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	"Nucleoplasm, Nuclear speckles"		"HPA048070: AB_2680247, HPA061123: AB_2684435"	"unprognostic (2.17e-1)"	"unprognostic (3.32e-2)"	"unprognostic (3.95e-1)"	"unprognostic (2.98e-1)"	"unprognostic (3.79e-2)"	"unprognostic (7.64e-2)"	"unprognostic (3.22e-3)"	"unprognostic (8.74e-2)"	"unprognostic (3.60e-2)"	"unprognostic (2.56e-1)"	"unprognostic (7.83e-3)"	"unprognostic (6.63e-2)"	"prognostic favorable (6.08e-7)"	"unprognostic (1.09e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.60e-1)"	13.3	13.0	12.5	10.4	12.8	17.6	13.8	18.1	15.6	18.0	2.8	12.9	7.0	16.1	12.9	12.7	15.9	8.5	11.4	10.9	16.4	10.6	8.5	11.2	13.1	9.5	10.0	22.1	13.1	12.1	15.6	11.2	9.3	14.0	9.2	17.6	15.0	10.3	15.0	15.3	13.4	9.4	4.8	13.4	11.9	18.5	12.3	14.9	16.8	7.4	11.9	14.0	15.0	12.8	28.3	28.9	31.8	7.1	25.2	20.8	18.0	18.3	18.7	18.9	18.9	25.8	19.6	40.9	13.4	20.8	13.7	26.1	28.6	19.6	30.2	24.6	17.3	29.4	19.8	20.0	12.2	22.3	21.9	19.0	13.5	20.9	16.5	23.3	25.3	22.9	24.1	18.9	23.5	29.9	26.4	24.4	20.0	19.2	26.1	40.5	31.8	14.3	16.5	37.2	24.2	23.8	29.4	20.2	8.3	21.8	22.9	17.4	37.0	22.6	28.3	15.6	23.9	23.3	24.8	43.6	19.3	17.3	17.2	0.3	1.4	1.5	1.5	1.6	1.7	1.9	1.3	1.3	1.1	1.9	1.8	1.8	1.0	2.3	1.5	3.4	1.1	1.4	12.5	12.8	18.1	15.6	10.9	16.4	9.5	10.0	9.3	4.8	12.3	12.8	26.8	25.6	34.3	54.2	32.7	19.9	11.2	13.3	27.9	42.0	27.7	25.3	45.9	14.3	25.0	9.2	41.7	19.7	32.4	15.7	1.9	15.7	35.4	26.8	36.0	29.7	20.4	23.5	86.7	15.5	13.5	24.4	23.0	28.6	17.7	54.1	21.8	16.8	19.1	52.2	84.3	18.9	12.2	22.6	12.3	17.7	33.8	19.5	5.4	51.5	28.6	24.6	32.0	68.9	76.5	18.0	13.3	48.5	30.3	18.9	14.0	14.7	33.0	30.8	19.7	35.5	24.8	62.8	49.0	29.2	23.3	15.7	29.3	32.5	21.6	13.2
YME1L1	YME1L	ENSG00000136758	"YME1 like 1 ATPase"	Q96TA2	10	27110111-27155266	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Metalloprotease, Protease"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA066953	Approved		Supported	"Nuclear bodies,Mitochondria"		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 7: Non-specific - Mitochondria"	Mitochondria	"Nuclear bodies"	"HPA066953: AB_2685753"	"unprognostic (2.28e-3)"	"unprognostic (3.00e-2)"	"unprognostic (1.34e-1)"	"unprognostic (7.19e-2)"	"unprognostic (8.12e-2)"	"unprognostic (2.47e-1)"	"prognostic unfavorable (8.25e-6)"	"unprognostic (7.08e-2)"	"unprognostic (2.91e-1)"	"unprognostic (9.24e-2)"	"unprognostic (9.43e-3)"	"unprognostic (1.64e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.03e-1)"	"unprognostic (5.53e-2)"	"unprognostic (1.44e-2)"	"unprognostic (7.09e-2)"	48.8	52.6	17.7	51.7	18.4	95.1	47.5	23.3	21.7	52.4	36.4	52.2	46.0	50.3	53.3	59.1	43.7	46.0	61.4	17.8	22.7	54.0	65.5	39.8	56.6	18.2	22.1	50.8	52.0	54.5	33.3	61.1	19.9	48.4	52.4	42.0	44.7	44.5	111.4	40.1	46.3	49.2	16.6	46.4	48.8	51.2	19.7	65.9	62.2	97.7	62.5	56.8	35.0	24.4	146.6	105.3	125.5	62.0	118.3	123.9	100.7	143.3	79.7	139.7	157.6	143.3	171.9	152.1	90.8	154.8	100.5	135.6	152.8	122.6	152.9	143.4	89.0	144.4	91.0	98.3	124.6	100.4	114.5	104.7	143.3	123.4	121.6	122.5	146.7	138.8	173.8	150.5	154.4	95.1	189.1	53.7	97.4	119.3	49.4	160.4	199.7	143.0	107.7	68.2	95.6	121.9	138.4	105.2	138.9	102.8	101.5	115.1	146.9	83.4	117.3	140.8	126.7	75.1	121.9	196.1	119.4	178.8	65.8	195.0	146.4	165.4	147.5	128.5	149.4	143.0	142.4	138.8	121.9	149.7	129.3	136.8	204.0	135.6	143.1	222.6	156.7	155.5	17.7	18.4	23.3	21.7	17.8	22.7	18.2	22.1	19.9	16.6	19.7	24.4	105.4	67.3	81.8	40.5	108.3	70.1	96.7	55.6	92.2	53.1	76.8	90.9	103.6	32.9	66.4	29.5	83.4	61.2	121.0	179.4	15.6	52.2	62.3	141.4	152.5	86.1	50.3	63.1	67.0	48.6	74.4	101.1	136.6	224.3	110.8	75.0	58.5	70.0	73.2	50.5	68.1	121.2	32.6	98.9	133.2	27.0	57.8	125.4	56.9	41.2	63.7	63.8	47.4	66.9	75.2	66.8	109.3	43.2	93.8	83.7	156.5	47.3	70.1	65.7	72.3	156.6	94.5	143.4	57.4	92.5	64.9	94.8	122.1	102.2	104.4	75.0
YOD1	"DKFZp451J1719, DUBA8, OTUD2"	ENSG00000180667	"YOD1 deubiquitinase"	Q5VVQ6	1	207043849-207052980	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway, Unfolded protein response"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 58.6"	"Cell type enhanced"	"Detected in all"		"Erythroid cells: 70.9;Glandular and luminal cells: 118.8;Late spermatids: 103.3;Urothelial cells: 86.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"HEL: 86.3;K-562: 61.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028400, HPA028439"	Uncertain		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA		110000	"Cluster 10: Basophils - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 44: Endometrium - Transcription"	"Nucleoplasm, Plasma membrane, Cytosol"		"HPA028400: AB_10599854, HPA028439: AB_10600994"	"unprognostic (3.69e-2)"	"unprognostic (8.72e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.39e-1)"	"unprognostic (2.03e-2)"	"unprognostic (3.28e-2)"	"unprognostic (9.87e-3)"	"unprognostic (9.38e-2)"	"unprognostic (2.31e-3)"	"unprognostic (8.96e-2)"	"unprognostic (1.47e-3)"	"unprognostic (1.03e-2)"	"unprognostic (6.07e-2)"	"unprognostic (6.86e-2)"	"unprognostic (2.83e-1)"	"unprognostic (1.79e-2)"	"unprognostic (3.62e-1)"	3.0	4.5	3.5	4.3	3.8	58.6	5.4	3.7	5.5	5.2	3.9	3.9	4.2	3.7	2.9	24.6	2.6	2.8	4.4	4.0	3.4	4.7	5.4	8.5	4.7	5.5	3.6	2.9	3.2	1.6	2.7	5.7	4.4	3.0	3.9	7.6	6.6	2.7	4.8	15.6	4.8	2.5	3.6	5.7	8.8	3.8	5.0	9.9	5.3	4.1	7.6	4.6	10.9	9.9	11.8	6.1	9.5	5.7	3.3	4.4	18.5	7.6	5.9	5.7	5.7	11.7	11.9	6.1	3.0	4.7	2.7	12.6	0.1	9.3	6.4	4.9	10.3	86.3	27.6	5.6	3.1	11.5	29.2	3.1	7.1	4.6	17.7	6.7	5.0	12.5	61.1	0.0	5.0	0.1	10.1	6.3	9.1	4.9	13.5	5.1	0.4	4.5	5.7	13.0	5.0	11.0	12.5	14.4	16.7	8.4	5.1	8.1	2.4	4.8	12.6	4.0	10.0	9.5	0.6	9.0	5.7	0.0	3.3	1.0	0.3	0.5	0.2	0.3	0.3	0.0	0.3	0.2	0.3	0.1	0.3	0.4	0.7	0.3	0.2	0.1	0.2	0.2	3.5	3.8	3.7	5.5	4.0	3.4	5.5	3.6	4.4	3.6	5.0	9.9	6.8	41.7	12.2	20.5	3.3	31.6	29.4	8.1	21.1	8.0	6.2	3.8	7.0	2.8	10.0	1.8	4.2	2.7	8.2	39.4	1.9	4.1	35.4	50.5	19.0	6.7	8.9	70.9	8.5	10.5	3.2	5.5	36.2	118.8	8.2	6.1	2.9	8.6	2.8	11.8	6.4	5.0	12.2	10.0	12.5	103.3	1.5	8.3	14.2	6.5	5.2	4.9	6.2	6.0	16.4	24.4	67.8	2.2	4.8	38.2	7.8	7.0	21.6	17.9	6.6	3.6	6.0	10.9	4.6	33.9	40.2	1.8	6.9	9.0	7.5	86.5
YTHDF2	"CAHL, HGRG8, NY-REN-2"	ENSG00000198492	"YTH N6-methyladenosine RNA binding protein 2"	Q9Y5A9	1	28736621-28769775	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Differentiation, Host-virus interaction, Immunity, Innate immunity, Mitosis, Oogenesis, Spermatogenesis"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030063, HPA054080, HPA059621"	Approved		Enhanced	"Cytosol,Cytoplasmic bodies"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Cytosol	"Cytoplasmic bodies"	"HPA030063: AB_2732453, HPA054080: AB_2682371, HPA059621: AB_2684084"	"unprognostic (8.75e-2)"	"unprognostic (1.90e-2)"	"unprognostic (4.66e-3)"	"unprognostic (1.63e-1)"	"unprognostic (3.03e-1)"	"unprognostic (1.49e-1)"	"prognostic unfavorable (6.14e-9)"	"unprognostic (1.75e-2)"	"unprognostic (4.82e-2)"	"unprognostic (4.18e-2)"	"unprognostic (1.69e-1)"	"unprognostic (4.11e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.21e-1)"	"unprognostic (6.38e-2)"	"unprognostic (9.29e-2)"	"unprognostic (6.97e-3)"	33.5	33.0	20.0	26.7	21.0	63.9	38.3	22.1	24.8	27.5	29.5	32.0	29.4	27.8	43.6	37.5	27.7	27.0	27.0	21.3	22.5	31.8	42.2	35.6	35.6	20.2	19.6	29.3	27.4	37.1	18.0	34.4	20.6	22.9	33.8	20.2	39.8	23.9	43.9	41.9	26.2	32.9	21.4	32.1	27.6	29.3	21.2	44.1	28.0	33.7	43.8	32.8	26.1	23.1	68.8	46.3	99.6	96.8	75.5	58.1	117.8	66.1	80.7	80.0	80.4	42.8	78.1	117.8	64.4	84.4	47.8	62.2	117.3	105.7	94.0	76.0	91.9	98.7	60.7	78.4	90.0	105.1	74.4	78.5	106.4	86.1	121.1	70.0	99.0	70.0	101.9	55.6	89.7	53.3	112.1	80.8	161.8	61.1	61.1	95.4	74.2	96.8	111.3	95.8	85.7	91.2	68.6	102.1	181.7	82.6	67.8	95.8	69.4	55.4	57.8	52.5	93.5	68.2	47.7	133.3	63.3	81.2	89.9	108.3	78.4	78.7	66.1	91.1	88.3	80.3	72.7	80.3	96.7	59.0	77.9	73.2	26.5	92.4	94.4	62.6	92.3	109.5	20.0	21.0	22.1	24.8	21.3	22.5	20.2	19.6	20.6	21.4	21.2	23.1	70.8	51.3	61.2	13.7	70.8	152.7	104.9	111.0	109.8	45.4	110.2	101.3	52.8	77.2	85.3	44.1	31.3	149.6	79.5	46.4	66.5	102.0	16.3	65.8	78.2	78.5	75.7	52.8	22.5	69.6	108.3	64.5	49.5	76.6	72.3	63.6	77.4	102.3	77.3	58.9	20.4	76.0	105.8	65.4	75.4	19.3	71.1	56.7	37.4	21.5	74.1	66.4	73.2	14.1	23.5	80.7	43.8	75.2	71.0	78.6	42.4	96.0	53.8	45.9	92.1	61.5	83.0	142.2	115.5	95.3	161.7	260.2	69.2	69.5	65.9	118.7
YWHAB	YWHAA	ENSG00000166913	"Tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein beta"	P31946	20	44885702-44908532	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003759, HPA007925, HPA011212"	Enhanced		Supported	Cytosol		NA	NA		97000000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	Cytosol		"CAB003759: AB_289588, HPA007925: AB_1844340, HPA011212: AB_1844334"	"prognostic unfavorable (9.18e-4)"	"unprognostic (1.48e-1)"	"unprognostic (9.06e-2)"	"prognostic unfavorable (5.46e-4)"	"unprognostic (3.80e-1)"	"prognostic unfavorable (6.14e-4)"	"prognostic unfavorable (1.91e-6)"	"prognostic unfavorable (6.01e-4)"	"unprognostic (8.92e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.53e-2)"	"unprognostic (2.35e-1)"	"prognostic favorable (2.52e-5)"	"unprognostic (6.72e-2)"	"unprognostic (2.40e-1)"	"unprognostic (6.60e-3)"	"unprognostic (8.59e-2)"	133.1	120.6	214.6	140.0	225.1	111.1	106.8	156.3	275.9	103.7	155.9	160.8	128.4	102.0	83.5	148.3	97.6	97.6	105.0	232.0	221.6	155.6	96.7	126.4	174.3	187.5	175.4	81.2	58.1	123.1	48.3	123.2	187.7	99.9	173.5	114.9	83.8	133.4	85.7	129.9	135.3	142.6	174.1	162.3	123.5	56.8	201.5	139.1	118.1	78.6	210.3	153.5	91.6	195.0	306.5	227.8	179.5	173.2	291.0	255.5	238.9	270.8	263.2	327.7	284.6	479.6	336.9	324.2	272.6	361.9	355.5	315.5	256.1	506.0	388.0	124.1	153.1	242.4	180.8	285.8	192.6	396.8	223.6	201.4	370.4	257.2	328.4	223.6	333.5	196.0	265.6	152.6	340.9	363.2	312.1	325.3	169.7	348.9	341.6	240.3	259.5	251.1	352.3	336.6	189.8	202.6	459.9	485.7	331.1	207.7	354.6	376.3	381.2	504.6	259.7	288.8	281.2	100.4	196.9	292.5	369.9	260.8	263.5	105.5	95.2	90.5	71.3	130.8	74.0	71.2	89.3	87.7	102.8	66.5	70.6	86.2	93.4	72.4	155.4	65.9	113.8	71.9	214.6	225.1	156.3	275.9	232.0	221.6	187.5	175.4	187.7	174.1	201.5	195.0	421.4	253.2	289.0	35.6	292.8	276.7	256.0	270.8	195.2	239.9	229.6	199.3	197.1	200.1	236.5	248.3	50.1	358.6	317.2	532.6	230.9	476.1	17.7	183.0	274.2	351.5	298.1	183.4	93.8	489.8	627.7	246.4	192.7	278.5	227.9	262.8	300.9	155.9	410.3	292.7	64.1	388.4	160.7	394.5	329.9	24.2	188.9	418.7	222.3	51.5	543.5	229.0	295.5	25.6	63.0	654.9	429.9	210.3	301.8	419.0	328.9	364.5	206.4	131.5	230.1	173.3	337.8	51.1	171.3	333.3	325.3	531.3	369.3	394.2	382.4	440.5
YWHAE	FLJ45465	ENSG00000108953	"Tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein epsilon"	P62258	17	1344275-1400222	"Cancer-related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA008445, CAB016200, CAB021109, CAB047350"	Approved		Supported	Cytosol		NA	NA		83000000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Cytosol		"CAB016200: AB_626619, CAB021109: AB_10060396, CAB047350: , HPA008445: AB_1844336"	"unprognostic (1.29e-1)"	"unprognostic (1.50e-1)"	"unprognostic (3.99e-2)"	"prognostic favorable (6.48e-6)"	"unprognostic (1.59e-1)"	"unprognostic (2.91e-2)"	"unprognostic (2.73e-2)"	"unprognostic (4.77e-3)"	"unprognostic (4.53e-2)"	"unprognostic (5.14e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.73e-1)"	"unprognostic (1.92e-3)"	"unprognostic (8.33e-2)"	"unprognostic (2.57e-1)"	"unprognostic (3.24e-2)"	"unprognostic (8.94e-2)"	221.9	198.9	251.8	122.8	264.2	121.3	198.7	266.3	272.8	168.8	195.7	161.1	136.8	155.6	192.7	239.1	188.1	103.7	242.3	260.7	275.4	229.3	211.7	176.9	113.7	271.1	246.8	170.8	154.9	236.9	178.8	198.2	267.1	150.0	168.1	220.8	184.8	121.6	656.7	193.3	129.3	137.3	279.2	101.5	136.9	165.4	262.2	211.0	208.5	441.8	164.5	186.9	179.7	302.7	615.3	565.8	700.2	563.4	376.9	454.7	589.8	382.1	481.5	724.5	571.3	907.5	305.5	524.7	411.9	621.9	439.7	463.1	859.2	745.6	798.7	294.2	930.9	334.1	366.2	409.4	483.4	277.1	311.1	421.6	458.6	619.3	897.0	520.6	729.2	458.5	402.8	337.9	719.7	368.5	445.8	264.1	566.6	596.9	332.7	477.3	255.9	380.4	547.7	365.7	354.2	497.2	531.1	240.3	364.3	439.9	442.3	290.9	467.4	411.9	293.8	453.7	731.4	190.5	329.9	346.6	478.4	387.5	585.4	78.6	137.2	41.2	47.3	153.6	57.8	78.1	67.3	55.1	180.3	59.1	55.7	51.2	49.9	64.1	144.8	133.8	99.7	151.0	251.8	264.2	266.3	272.8	260.7	275.4	271.1	246.8	267.1	279.2	262.2	302.7	363.6	298.1	194.4	83.2	161.1	573.9	457.5	468.4	281.7	153.6	313.6	219.1	473.4	265.9	310.9	371.5	50.1	463.2	128.7	300.7	745.4	460.8	258.0	573.6	414.3	352.6	352.6	244.7	73.4	421.4	709.5	319.4	194.7	502.7	211.5	328.1	262.3	309.0	384.9	111.0	72.4	346.3	376.4	260.9	434.9	434.3	280.8	227.5	425.2	60.0	320.5	357.8	55.6	56.8	112.1	464.8	289.8	294.9	279.5	487.9	272.1	707.8	504.6	173.3	243.3	361.2	524.6	508.7	573.3	333.8	586.6	519.5	130.7	287.2	361.1	474.4
YWHAQ	"14-3-3, HS1"	ENSG00000134308	"Tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein theta"	P27348	2	9583967-9630997	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007925, CAB010286"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA		49000000	"Cluster 16: MAIT-cells - Unknown function"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 10: Non-specific - Unknown function"	Cytosol	Nucleoplasm	"CAB010286: AB_2218221, HPA007925: AB_1844340"	"unprognostic (2.65e-2)"	"unprognostic (3.99e-2)"	"unprognostic (2.78e-2)"	"prognostic unfavorable (8.20e-4)"	"unprognostic (1.53e-1)"	"unprognostic (5.78e-3)"	"prognostic unfavorable (9.83e-6)"	"unprognostic (4.90e-3)"	"unprognostic (2.98e-2)"	"unprognostic (5.51e-2)"	"unprognostic (6.18e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.95e-2)"	"unprognostic (6.74e-2)"	"unprognostic (9.75e-2)"	"unprognostic (1.63e-1)"	"unprognostic (4.39e-3)"	144.6	141.0	190.8	106.1	223.2	178.4	153.6	216.5	239.1	177.0	149.4	161.2	119.4	184.3	141.6	187.3	136.5	122.6	218.7	205.1	229.7	140.0	116.3	119.3	132.0	218.6	203.8	163.2	201.5	131.9	112.9	123.2	212.4	161.1	133.0	143.6	120.2	140.2	53.5	121.5	116.2	177.4	203.9	89.8	127.5	144.6	205.7	148.2	137.6	62.1	141.1	144.4	161.8	280.5	316.1	465.2	412.0	400.3	316.6	434.5	385.7	421.6	412.3	432.5	360.2	352.9	269.3	404.4	214.0	608.5	451.3	288.5	462.8	459.7	553.6	1003.0	374.8	378.8	268.9	379.9	241.1	369.1	219.7	295.8	264.5	473.6	305.9	394.9	493.5	285.6	378.5	236.8	539.3	219.3	658.2	374.4	700.7	351.9	527.5	473.0	533.3	497.4	478.8	276.9	390.1	659.9	384.1	392.2	317.3	343.8	244.4	187.0	453.9	539.6	380.7	473.4	654.4	239.3	351.4	526.6	461.8	378.9	458.8	99.5	102.7	120.5	207.8	137.8	255.6	151.9	192.8	223.5	144.2	147.8	103.6	170.1	31.1	252.0	137.0	73.1	208.4	344.1	190.8	223.2	216.5	239.1	205.1	229.7	218.6	203.8	212.4	203.9	205.7	280.5	186.6	51.3	67.3	26.1	144.0	316.7	366.5	339.0	143.4	201.4	198.4	153.7	82.6	90.1	143.4	136.1	27.1	261.6	189.9	209.9	416.7	371.5	281.9	132.9	175.8	191.0	187.1	179.2	57.3	283.7	615.3	242.0	115.2	131.6	125.0	152.5	84.9	97.9	215.3	572.0	45.1	129.2	270.6	111.9	228.3	360.5	174.0	132.3	295.3	30.0	195.0	229.2	155.5	39.7	186.6	261.2	150.9	250.5	187.9	323.7	135.9	278.8	111.7	105.8	197.2	191.5	312.7	432.2	205.8	252.1	355.3	238.6	217.7	252.9	186.5	457.3
YY1	"DELTA, INO80S, NF-E1, UCRBP, YIN-YANG-1"	ENSG00000100811	"YY1 transcription factor"	P25490	14	100238298-100282788	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Differentiation, DNA damage, DNA recombination, DNA repair, Spermatogenesis, Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001119, CAB009392"	Supported		Supported	"Nucleoplasm,Nucleoli fibrillar center,Vesicles"		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm	"Nucleoli fibrillar center, Vesicles"	"CAB009392: AB_2218501, HPA001119: AB_1858930"	"unprognostic (7.67e-2)"	"unprognostic (8.08e-2)"	"unprognostic (2.57e-2)"	"prognostic unfavorable (6.13e-4)"	"unprognostic (6.75e-3)"	"unprognostic (8.31e-3)"	"prognostic unfavorable (3.44e-4)"	"unprognostic (1.09e-1)"	"unprognostic (4.26e-2)"	"unprognostic (7.68e-3)"	"unprognostic (1.40e-1)"	"unprognostic (1.51e-1)"	"unprognostic (3.72e-2)"	"unprognostic (4.36e-2)"	"unprognostic (1.66e-1)"	"unprognostic (2.30e-1)"	"unprognostic (4.30e-1)"	27.2	26.2	20.9	28.9	22.1	56.4	27.0	27.0	24.2	24.6	18.5	30.7	27.9	24.8	34.0	28.9	21.7	22.7	22.8	22.7	20.2	32.9	46.8	24.0	36.0	20.4	20.4	21.6	24.4	32.5	17.4	34.2	20.3	25.2	28.7	20.1	25.1	23.6	36.8	29.0	29.7	24.8	20.1	31.9	26.2	23.8	21.5	52.3	37.2	27.2	38.2	31.9	21.0	26.2	62.0	30.7	64.2	51.5	51.8	65.9	68.1	60.0	55.1	64.7	66.0	38.6	97.7	94.0	82.3	54.5	37.1	64.0	72.6	64.1	88.3	70.8	60.9	86.8	34.6	50.0	48.4	103.8	73.2	38.7	76.4	45.4	61.4	58.6	63.9	67.3	69.9	61.8	63.7	74.5	113.5	61.8	68.7	98.0	56.0	93.9	88.9	50.7	75.8	58.3	68.2	53.3	79.2	57.8	85.1	54.0	86.6	100.1	57.4	39.4	48.3	97.6	53.8	68.3	72.0	126.6	56.4	68.6	52.5	4.8	5.7	11.9	4.3	4.8	5.6	5.3	5.7	5.9	4.9	8.3	5.4	5.4	9.8	9.5	3.8	5.3	7.7	2.7	20.9	22.1	27.0	24.2	22.7	20.2	20.4	20.4	20.3	20.1	21.5	26.2	116.0	54.5	66.8	23.8	102.4	238.0	101.1	49.9	211.7	80.5	129.8	98.2	91.5	92.9	50.0	68.0	81.3	118.6	147.4	122.8	72.4	68.7	10.3	118.7	133.8	115.7	110.1	125.4	28.2	82.0	123.6	106.7	58.1	153.6	71.7	99.4	103.5	119.4	81.3	127.9	26.5	108.8	48.8	111.8	225.8	15.7	94.8	121.6	76.5	30.0	117.8	82.0	114.4	20.6	40.7	80.0	95.5	100.8	125.0	168.9	90.0	104.6	47.6	74.9	92.1	106.5	124.3	86.0	67.0	192.1	243.1	175.5	124.8	124.1	118.7	153.5
ZBED1	"ALTE, DREF, hDREF, KIAA0785, TRAMP"	ENSG00000214717	"Zinc finger BED-type containing 1"	O96006	X	2486414-2500976	"Predicted intracellular proteins, Transcription factors"	"Host-virus interaction, Transcription, Transcription regulation, Ubl conjugation pathway"	"DNA-binding, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BEWO: 91.0"					"Low region specificity"	"Detected in all"			HPA077591	Approved		Approved	"Nucleoplasm,Nuclear membrane,Centrosome"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 56: Bipolar cells - Visual perception"	"Nucleoplasm, Centrosome"	"Nuclear membrane"	"HPA077591: AB_2686847"	"unprognostic (7.66e-3)"	"unprognostic (3.79e-2)"	"unprognostic (2.39e-2)"	"unprognostic (4.92e-3)"	"unprognostic (4.86e-2)"	"unprognostic (1.50e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.22e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.53e-1)"	"prognostic unfavorable (3.13e-4)"	"unprognostic (3.81e-2)"	"unprognostic (2.12e-1)"	"unprognostic (3.95e-2)"	"unprognostic (3.27e-1)"	20.4	35.8	16.4	11.8	17.7	7.2	16.8	20.0	16.1	16.9	11.3	16.4	18.9	18.0	5.3	12.2	13.0	12.9	32.5	14.4	17.1	13.9	32.5	12.2	12.5	25.1	21.7	13.1	21.4	11.3	10.4	9.9	22.8	15.4	11.5	8.1	16.8	10.5	70.9	22.3	20.4	9.3	21.3	15.5	14.7	7.8	20.9	11.3	12.1	37.4	9.3	13.1	12.9	16.2	11.6	28.3	20.2	22.4	12.6	13.3	91.0	16.1	17.5	9.3	10.7	36.4	10.0	22.8	18.1	21.5	25.5	5.4	19.5	16.7	6.9	27.0	26.0	17.0	23.4	31.3	16.5	10.6	34.1	19.7	12.8	9.8	7.3	13.8	22.1	15.2	21.9	7.3	18.2	8.2	17.7	8.5	49.9	7.4	16.6	14.0	20.0	10.8	15.6	22.2	24.0	23.6	13.7	36.2	25.6	22.6	10.0	22.3	30.7	19.9	10.5	11.0	17.7	8.7	0.1	37.4	8.1	14.8	11.5	2.2	11.8	10.3	10.6	11.7	9.3	8.4	6.1	5.9	13.3	11.2	5.7	4.9	12.5	5.5	9.8	9.7	6.4	11.7	16.4	17.7	20.0	16.1	14.4	17.1	25.1	21.7	22.8	21.3	20.9	16.2	12.9	12.8	11.7	0.0	20.7	15.2	17.6	14.1	29.6	55.5	12.9	12.4	27.8	40.0	9.2	25.8	14.6	15.9	18.7	23.3	11.7	22.8	0.4	23.0	18.2	17.5	15.5	7.6	0.0	23.4	18.0	22.6	8.2	28.5	14.7	37.1	18.5	37.3	18.0	10.1	0.0	19.4	10.2	22.2	24.9	1.3	19.9	19.5	8.8	0.0	23.0	20.5	34.0	0.0	0.0	22.7	17.3	23.0	8.8	19.7	25.5	18.1	15.8	23.5	6.6	23.7	19.2	0.7	2.6	15.8	11.2	38.0	14.4	29.5	23.2	12.9
ZBED4	KIAA0637	ENSG00000100426	"Zinc finger BED-type containing 4"	O75132	22	49853844-49890080	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045341	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm		"HPA045341: AB_2679295"	"unprognostic (3.82e-2)"	"unprognostic (6.39e-2)"	"unprognostic (7.22e-3)"	"unprognostic (4.43e-2)"	"unprognostic (7.90e-2)"	"unprognostic (2.42e-1)"	"unprognostic (2.48e-3)"	"unprognostic (1.23e-1)"	"unprognostic (1.24e-1)"	"unprognostic (8.74e-3)"	"unprognostic (9.44e-2)"	"unprognostic (2.43e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.18e-1)"	"unprognostic (2.53e-2)"	"unprognostic (5.20e-2)"	3.6	2.6	2.3	5.3	2.1	11.0	3.4	5.6	2.3	3.1	1.3	5.7	5.3	3.5	2.7	6.5	3.3	3.5	3.3	2.2	1.6	3.7	4.7	4.2	6.6	2.2	1.9	3.6	5.3	3.0	3.3	3.9	2.1	3.4	4.8	4.7	3.8	2.1	4.5	5.0	5.3	3.2	1.2	5.1	4.5	3.8	2.2	10.9	3.3	3.2	5.5	4.0	3.5	4.0	14.9	13.1	24.5	19.5	7.4	8.1	15.2	8.6	7.1	9.3	8.6	13.5	6.5	29.3	5.9	9.2	9.7	16.7	17.4	11.1	9.9	11.6	21.2	16.8	13.2	12.8	10.7	36.0	23.2	7.6	16.5	10.2	15.4	9.3	12.6	28.0	18.2	13.7	11.1	11.9	30.0	17.1	13.4	12.9	9.1	35.5	22.1	17.8	9.9	14.9	12.9	25.7	8.5	24.9	17.3	15.2	11.8	20.3	14.7	12.7	19.9	7.5	12.3	13.5	9.0	26.5	7.7	15.9	15.2	0.4	0.4	0.7	0.8	0.6	1.6	0.6	0.8	0.9	1.0	0.4	1.0	0.8	0.2	2.9	0.6	1.0	0.6	0.6	2.3	2.1	5.6	2.3	2.2	1.6	2.2	1.9	2.1	1.2	2.2	4.0	4.9	0.0	6.5	11.4	7.2	5.1	5.1	5.0	4.0	7.9	6.3	6.1	7.2	7.2	8.6	5.5	14.6	3.6	23.5	8.7	3.9	9.2	4.8	10.0	10.1	6.6	12.6	12.8	14.7	7.1	6.4	5.1	7.7	10.1	0.0	10.1	5.3	6.9	6.8	13.5	14.7	9.5	4.1	12.6	5.2	4.6	3.1	7.3	0.0	16.9	8.5	2.5	16.5	12.1	16.6	13.3	8.5	4.1	12.5	9.2	3.8	2.9	6.2	9.9	6.6	5.8	7.1	4.8	6.4	6.7	3.8	3.3	17.2	7.4	11.0	6.8
ZBED6		ENSG00000257315	"Zinc finger BED-type containing 6"	P86452	1	203795714-203854999	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Urothelial cells: 56.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							HPA068807			Supported	"Nucleoplasm,Centriolar satellite"		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 21: Non-specific - Transcription"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 22: Epithelial cell types - Mixed function"	Nucleoplasm	"Centriolar satellite"	"HPA068807: AB_2686040"	"unprognostic (1.79e-1)"	"unprognostic (4.96e-3)"	"unprognostic (4.81e-2)"	"unprognostic (2.73e-1)"	"unprognostic (6.94e-2)"	"unprognostic (3.37e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.24e-2)"	"unprognostic (2.28e-3)"	"unprognostic (7.54e-3)"	"unprognostic (1.56e-1)"	"unprognostic (4.11e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.59e-1)"	"unprognostic (4.15e-3)"	"unprognostic (1.47e-2)"	5.0	4.3	3.4	3.6	7.9	3.0	3.7	6.7	4.5	6.4	8.9	3.3	6.0	5.9	3.2	3.9	4.0	4.4	2.7	2.8	5.6	4.5	5.7	3.7	4.0	5.8	5.7	6.9	7.0	3.9	3.2	6.0	5.9	3.2	3.8	5.6	4.6	4.1	4.3	4.9	3.6	3.8	2.5	5.0	4.9	2.5	6.8	5.3	5.0	6.2	4.3	3.4	3.7	11.9	4.4	7.2	10.2	5.0	7.6	16.8	4.1	6.2	15.2	4.4	4.9	1.7	4.4	3.0	1.3	10.3	2.6	7.0	3.3	5.2	7.1	8.3	2.7	6.2	7.7	1.4	3.8	4.7	4.4	9.2	2.4	5.8	6.3	9.7	12.2	3.8	7.6	8.7	6.5	3.0	3.2	3.4	2.4	2.1	2.7	2.5	9.1	3.3	2.5	7.3	2.1	10.2	7.4	6.6	2.8	8.7	10.7	5.0	21.4	6.7	6.3	3.2	4.4	4.9	2.0	0.9	7.7	2.4	6.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	3.4	7.9	6.7	4.5	2.8	5.6	5.8	5.7	5.9	2.5	6.8	11.9	1.5	9.6	6.3	0.0	8.9	15.9	35.3	11.3	6.8	15.0	0.4	0.5	2.5	8.6	15.2	0.0	31.3	14.5	5.4	15.7	0.0	0.1	1.0	2.2	3.0	14.5	18.5	12.0	0.0	0.0	13.9	16.0	11.2	2.3	33.0	1.1	10.0	4.6	6.0	11.8	0.0	14.0	8.2	9.3	19.6	1.0	19.9	8.9	14.2	0.0	5.8	14.7	15.5	0.0	0.0	0.1	14.5	15.1	3.8	43.0	35.1	0.1	11.0	21.1	26.3	37.3	15.2	6.5	8.2	5.6	17.0	34.9	12.0	1.5	14.2	56.9
ZBTB1	"KIAA0997, ZNF909"	ENSG00000126804	"Zinc finger and BTB domain containing 1"	Q9Y2K1	14	64503712-64533690	"Predicted intracellular proteins, Transcription factors"	"Differentiation, DNA damage, DNA repair, Immunity, Innate immunity, Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"dendritic cells: 115.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA050516, HPA054552, HPA075151"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm		"HPA050516: AB_2681153, HPA054552: , HPA075151: "	"unprognostic (4.09e-1)"	"unprognostic (3.68e-1)"	"unprognostic (1.08e-1)"	"unprognostic (9.51e-2)"	"unprognostic (1.28e-1)"	"prognostic favorable (4.92e-4)"	"unprognostic (1.11e-3)"	"unprognostic (9.43e-2)"	"unprognostic (6.64e-2)"	"unprognostic (2.00e-1)"	"unprognostic (9.65e-2)"	"unprognostic (6.63e-2)"	"unprognostic (3.34e-2)"	"unprognostic (6.26e-2)"	"unprognostic (2.23e-1)"	"unprognostic (2.58e-1)"	"unprognostic (3.27e-2)"	24.0	15.2	14.2	28.9	17.1	83.1	25.8	15.8	16.6	21.1	17.8	21.4	16.9	20.5	26.9	15.9	24.8	21.2	16.9	15.0	14.2	17.9	22.1	22.3	44.1	16.5	15.6	21.5	17.8	20.8	18.0	24.0	16.8	24.2	22.2	20.8	18.5	17.9	22.6	34.7	23.9	19.3	16.3	34.8	21.0	12.4	17.7	38.5	27.9	21.3	35.8	21.9	20.2	19.8	56.2	18.4	40.5	25.4	41.1	49.3	41.5	23.8	35.4	22.0	27.9	17.9	38.7	53.5	23.2	33.8	17.2	38.4	19.9	23.6	30.0	79.7	13.5	26.1	35.9	15.1	25.8	21.9	36.7	63.7	40.6	15.3	22.6	48.3	25.8	33.8	13.1	35.7	41.2	42.5	38.0	22.0	16.9	28.8	27.5	33.7	25.0	20.7	38.3	67.1	28.2	22.6	38.9	29.0	32.7	39.0	27.9	27.9	34.4	36.6	24.7	17.7	16.7	44.6	20.6	59.6	36.9	20.6	24.5	42.5	13.6	23.1	18.8	13.1	21.4	14.8	16.6	20.9	14.6	14.3	16.8	20.8	10.4	19.9	19.1	9.1	25.6	16.4	14.2	17.1	15.8	16.6	15.0	14.2	16.5	15.6	16.8	16.3	17.7	19.8	19.8	16.0	12.7	65.6	56.9	31.7	17.0	29.7	40.9	11.5	14.4	13.7	11.9	8.6	22.3	9.2	12.5	8.0	115.7	9.2	9.8	13.2	83.0	40.0	41.5	24.7	22.1	20.8	40.6	8.6	13.7	26.5	19.9	30.2	28.5	18.8	19.2	8.4	15.2	6.7	58.1	12.1	30.5	23.0	73.5	38.0	15.8	50.5	30.2	58.1	13.8	7.7	22.6	40.2	96.3	16.2	8.3	18.4	48.3	15.2	6.0	6.6	27.8	8.4	6.6	20.4	27.9	2.2	4.5	23.7	24.2	7.8	78.7	23.5	10.9	19.2
ZBTB14	"ZFP161, ZNF478"	ENSG00000198081	"Zinc finger and BTB domain containing 14"	O43829	18	5289019-5297053	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA050758, HPA070819"	Uncertain		Supported	Nucleoplasm,Nucleoli,Cytosol		No	No			"Cluster 46: Basophils - DNA binding"	"Cluster 34: Non-specific - Transcription"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	Nucleoplasm	"Nucleoli, Cytosol"	"HPA050758: AB_2681226, HPA070819: AB_2686316"	"unprognostic (5.28e-2)"	"unprognostic (4.37e-2)"	"unprognostic (4.25e-2)"	"unprognostic (2.66e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.85e-2)"	"unprognostic (2.95e-2)"	"unprognostic (8.64e-2)"	"unprognostic (1.19e-3)"	"unprognostic (4.72e-3)"	"unprognostic (3.25e-2)"	"unprognostic (1.49e-1)"	"unprognostic (3.70e-2)"	"unprognostic (2.03e-1)"	"unprognostic (2.53e-1)"	"unprognostic (3.73e-1)"	"unprognostic (2.90e-2)"	10.3	8.6	9.3	14.7	10.5	9.6	12.5	11.4	12.2	9.6	7.4	10.4	8.7	9.9	16.4	12.4	10.6	12.0	8.6	8.7	9.6	11.2	13.4	11.1	24.7	9.5	10.3	15.6	14.4	12.0	4.8	9.1	9.6	9.8	10.0	7.3	12.2	12.1	8.5	14.0	9.3	8.7	10.2	16.2	11.9	5.9	9.5	21.8	15.5	8.4	21.8	9.6	5.2	11.4	9.0	11.8	15.1	11.2	11.0	14.5	10.0	8.8	13.0	12.0	10.5	11.3	11.5	31.2	7.6	10.7	13.9	8.2	11.2	13.2	12.2	6.0	6.0	12.4	11.1	10.5	7.8	15.8	14.4	11.6	10.9	8.5	7.9	13.0	19.2	22.3	8.1	10.1	12.4	9.9	23.8	10.5	13.4	11.1	6.0	14.0	9.7	9.2	10.0	10.8	13.3	13.0	13.4	8.8	14.3	15.0	10.5	17.9	10.7	15.6	12.8	12.2	13.3	6.4	6.9	19.9	16.4	13.3	14.0	9.8	5.5	14.1	8.7	7.8	8.6	7.5	11.0	10.0	8.2	10.4	11.6	11.1	1.2	7.6	7.5	6.1	7.6	7.3	9.3	10.5	11.4	12.2	8.7	9.6	9.5	10.3	9.6	10.2	9.5	11.4	8.8	6.4	6.7	5.9	8.5	2.4	1.6	2.9	5.2	7.4	5.6	4.3	3.6	1.5	2.2	5.5	0.0	5.3	6.3	5.5	5.9	4.9	0.8	4.3	5.5	7.4	1.2	9.1	2.9	3.3	5.5	4.6	0.5	3.7	15.9	6.0	11.7	6.9	7.1	5.0	3.1	5.1	8.2	7.5	4.5	2.8	5.9	6.3	1.8	1.0	7.8	10.8	6.2	2.5	6.6	3.5	4.0	5.7	2.2	2.4	5.7	5.5	2.5	5.9	0.0	6.0	5.7	1.0	9.3	4.2	3.0	2.2	8.8	5.1	5.2	1.5
ZBTB18	"C2H2-171, RP58, TAZ-1, ZNF238"	ENSG00000179456	"Zinc finger and BTB domain containing 18"	Q99592	1	244048939-244057476	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding, Repressor"	"Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 172.8;skeletal muscle: 85.5"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 51.8;Muller glia cells: 52.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"neutrophil: 2.3"	"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"cerebellum: 217.5"	"HPA024656, HPA074019"	Enhanced		Supported	"Nucleoplasm,Nuclear speckles"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 65: Plasmacytoid DCs - Unknown function"	"Nucleoplasm, Nuclear speckles"		"HPA024656: , HPA074019: "	"unprognostic (3.48e-3)"	"unprognostic (9.17e-3)"	"unprognostic (3.69e-3)"	"prognostic favorable (1.34e-4)"	"unprognostic (6.83e-2)"	"unprognostic (4.52e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.15e-2)"	"unprognostic (1.15e-2)"	"unprognostic (8.43e-2)"	"unprognostic (1.01e-2)"	"unprognostic (2.60e-1)"	"unprognostic (6.28e-2)"	"unprognostic (9.37e-2)"	"unprognostic (2.07e-2)"	"unprognostic (6.54e-3)"	"prognostic favorable (6.78e-6)"	9.8	6.3	36.2	14.9	45.4	28.2	9.0	172.8	57.5	7.4	20.3	9.2	13.2	7.2	18.5	5.8	8.6	7.4	12.2	66.1	13.5	11.9	19.0	10.0	18.2	18.0	18.1	7.2	24.6	6.2	4.9	9.4	24.7	10.1	10.8	42.2	10.6	11.5	85.5	8.3	14.6	6.1	19.0	20.2	11.4	22.3	18.9	41.9	8.4	37.5	15.7	10.0	5.4	29.8	23.7	8.2	31.2	1.2	4.0	4.1	21.7	13.0	9.6	20.5	12.4	6.3	18.7	17.9	1.2	25.2	6.6	2.4	20.1	6.4	25.5	6.4	17.7	3.0	3.1	3.0	6.3	3.8	9.1	3.5	5.3	12.3	7.7	24.7	22.5	19.3	2.3	7.5	24.5	0.3	31.4	15.2	16.1	7.3	3.6	9.1	21.2	5.1	13.1	8.0	45.8	44.6	5.4	0.2	14.8	13.0	0.4	27.2	33.7	10.5	12.9	6.5	28.0	3.2	0.4	7.0	10.6	11.6	21.6	0.1	0.2	1.3	0.1	0.3	0.1	0.6	0.2	0.2	0.3	0.9	0.5	0.3	2.3	0.1	0.6	0.9	0.2	0.1	36.2	45.4	172.8	57.5	66.1	13.5	18.0	18.1	24.7	19.0	18.9	29.8	18.5	9.6	18.5	37.2	16.2	11.2	3.3	5.0	8.0	6.1	32.6	6.1	22.2	8.6	10.0	18.4	12.5	1.5	8.2	10.5	0.0	4.5	3.8	18.2	3.3	15.3	19.3	0.0	51.8	5.1	2.0	3.8	10.7	11.0	6.3	5.1	12.8	44.3	6.1	6.7	19.8	16.1	18.3	25.4	26.7	5.0	2.1	16.1	3.6	15.0	13.9	52.1	2.1	21.6	20.8	8.5	7.9	4.9	2.2	5.2	6.6	12.0	17.4	27.6	13.1	10.9	6.2	9.8	7.7	8.7	19.7	1.0	7.2	1.7	14.8	4.2
ZBTB34	"KIAA1993, MGC24652, ZNF918"	ENSG00000177125	"Zinc finger and BTB domain containing 34"	Q8NCN2	9	126860665-126885878	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Late spermatids: 31.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023893	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 77: Retina - Visual perception"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 31: Spermatids - Spermatogenesis"	Nucleoplasm		"HPA023893: AB_2219180"	"unprognostic (2.96e-2)"	"unprognostic (1.83e-1)"	"unprognostic (2.72e-3)"	"unprognostic (6.59e-3)"	"unprognostic (8.08e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.56e-4)"	"unprognostic (1.62e-1)"	"unprognostic (2.96e-2)"	"unprognostic (5.15e-2)"	"unprognostic (9.32e-3)"	"unprognostic (3.94e-2)"	"unprognostic (2.55e-2)"	"unprognostic (3.23e-2)"	"unprognostic (9.71e-2)"	"unprognostic (3.69e-2)"	"unprognostic (2.01e-2)"	3.8	2.7	4.9	4.3	6.1	14.7	3.7	7.6	5.3	3.1	2.8	3.5	3.0	3.6	3.1	3.2	3.2	3.9	3.1	4.2	4.8	3.3	2.9	5.3	4.8	5.9	6.2	3.6	3.2	3.7	3.5	6.7	5.6	3.0	2.9	12.7	4.4	2.9	3.3	4.1	3.7	3.1	5.4	5.4	3.8	3.0	6.0	4.8	3.5	4.8	4.6	3.3	3.1	6.8	2.6	3.5	9.9	4.1	7.6	7.6	13.8	3.1	4.6	3.6	4.0	8.3	4.8	5.0	3.3	3.3	3.3	7.9	12.1	3.1	3.6	5.2	5.0	5.7	9.8	4.4	5.3	7.9	9.1	6.7	4.9	4.2	4.8	4.7	4.8	8.6	12.3	3.9	3.4	3.7	5.1	6.6	8.7	4.9	2.6	9.5	11.5	5.2	4.7	3.8	3.1	10.7	4.1	3.6	5.6	8.9	3.6	11.6	5.2	3.3	6.0	4.7	3.4	6.8	8.5	4.2	3.0	6.4	3.2	0.7	0.3	1.0	0.2	0.1	0.2	0.1	0.1	0.1	0.2	0.2	0.2	0.1	1.4	0.4	0.2	0.3	0.0	0.1	4.9	6.1	7.6	5.3	4.2	4.8	5.9	6.2	5.6	5.4	6.0	6.8	5.6	3.2	4.6	5.2	1.3	5.4	2.5	1.6	2.8	6.8	5.9	3.9	2.2	2.8	3.5	1.8	6.2	3.8	3.8	5.6	1.9	2.4	8.4	2.1	4.0	5.4	1.8	3.0	6.9	1.6	3.1	4.7	4.1	4.8	0.0	3.7	6.8	4.1	7.8	8.4	8.1	4.1	2.0	13.6	8.4	31.8	6.8	7.2	5.4	7.5	8.3	2.1	2.1	7.1	12.4	3.2	5.0	0.7	1.7	4.4	4.0	2.5	2.3	12.7	0.0	4.5	5.6	4.0	2.5	3.8	8.2	3.3	2.2	2.1	2.4	4.7
ZBTB4	"KAISO-L1, KIAA1538, ZNF903"	ENSG00000174282	"Zinc finger and BTB domain containing 4"	Q9P1Z0	17	7459366-7484263	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB008980, HPA064763"	Supported		Supported	"Nucleoplasm,Nuclear bodies,Cytosol"		No	No			"Cluster 27: Non-specific - Gene expression"	"Cluster 72: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 56: Bipolar cells - Visual perception"	"Nuclear bodies"	"Nucleoplasm, Cytosol"	"CAB008980: , HPA064763: AB_2685347"	"unprognostic (2.23e-1)"	"unprognostic (3.95e-1)"	"unprognostic (7.17e-2)"	"unprognostic (2.92e-2)"	"unprognostic (5.32e-2)"	"unprognostic (7.62e-3)"	"unprognostic (2.43e-1)"	"unprognostic (1.67e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.63e-3)"	"prognostic favorable (2.53e-4)"	"unprognostic (1.73e-1)"	"prognostic favorable (1.65e-9)"	"unprognostic (1.10e-1)"	"unprognostic (4.86e-2)"	"unprognostic (1.88e-1)"	"unprognostic (6.04e-3)"	34.8	36.1	22.1	7.4	20.6	3.0	31.4	19.9	23.1	41.9	11.7	47.2	6.3	40.3	16.2	26.4	40.5	9.6	38.8	21.2	21.0	24.1	7.8	30.0	8.3	27.1	21.7	48.4	23.1	36.1	28.6	10.8	27.0	33.1	6.6	23.1	28.0	21.4	32.4	27.2	23.0	16.4	19.7	22.1	27.3	15.9	23.3	9.5	43.9	14.8	9.0	42.3	33.9	21.5	10.7	14.4	3.6	6.9	37.1	19.1	6.5	14.7	21.0	13.0	12.9	4.8	5.1	1.1	11.4	28.0	9.5	16.7	3.6	20.6	9.5	17.0	6.2	5.3	12.3	3.4	10.4	1.0	12.2	13.4	21.1	12.5	15.9	30.6	11.5	4.0	1.8	3.4	14.5	7.1	3.7	2.2	1.5	4.3	6.8	6.8	6.2	1.6	15.9	8.9	2.1	5.3	6.5	4.6	6.9	6.3	8.6	2.4	16.1	14.6	5.7	13.9	12.3	6.1	4.5	0.7	15.7	3.3	7.7	0.4	0.3	0.5	1.0	0.5	1.0	0.5	0.8	0.8	0.2	0.5	1.0	1.0	0.2	0.6	1.7	0.4	0.4	0.6	22.1	20.6	19.9	23.1	21.2	21.0	27.1	21.7	27.0	19.7	23.3	21.5	27.4	51.3	53.1	33.6	14.6	30.7	16.3	18.4	18.8	86.6	23.6	20.6	92.6	20.0	24.8	20.2	68.8	10.3	24.5	4.6	3.9	14.4	40.8	21.1	25.2	26.1	17.4	9.5	36.9	14.4	2.2	24.8	7.1	26.0	13.9	25.7	23.9	8.1	13.5	74.0	37.3	10.1	14.2	30.0	34.6	57.0	51.9	18.6	17.8	15.9	12.0	27.0	24.7	21.6	26.7	19.0	5.3	70.0	9.5	16.2	8.2	11.2	32.2	39.9	32.9	37.8	27.4	7.3	4.3	17.3	23.4	5.2	21.1	16.3	9.0	14.7
ZBTB42	ZNF925	ENSG00000179627	"Zinc finger and BTB domain containing 42"	B2RXF5	14	104800596-104804712	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 11.7;Exocrine glandular cells: 13.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in single"	10	"eosinophil: 5.4"	"Lineage enriched"	"Detected in single"	10	"granulocytes: 5.4"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 19.3;MCF7: 33.7;T-47d: 26.9"	"Not detected"	"Not detected"							HPA066961	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 6: T47d - Mammary gland"	"Cluster 35: Glandular cells - Unknown function"	Nucleoplasm		"HPA066961: AB_2685756"	"unprognostic (1.23e-1)"	"unprognostic (1.84e-1)"	"unprognostic (8.68e-2)"	"unprognostic (1.59e-1)"	"unprognostic (6.99e-2)"	"unprognostic (6.67e-2)"	"unprognostic (6.17e-3)"	"unprognostic (2.56e-1)"	"unprognostic (4.35e-1)"	"unprognostic (2.70e-2)"	"unprognostic (1.63e-1)"	"unprognostic (3.42e-1)"	"prognostic favorable (2.30e-9)"	"unprognostic (1.34e-1)"	"unprognostic (2.75e-1)"	"unprognostic (1.58e-3)"	"unprognostic (5.45e-2)"	2.3	3.5	1.1	1.7	1.1	0.3	3.3	1.0	0.9	1.7	1.5	3.0	3.2	2.2	1.8	4.8	4.5	1.8	4.5	0.9	1.2	4.1	5.5	4.3	1.4	1.8	1.4	1.1	11.5	2.2	1.0	1.1	1.3	6.2	1.8	0.4	6.3	3.3	6.5	2.6	2.9	1.4	1.4	2.2	6.5	2.4	1.2	1.4	4.7	2.6	1.3	2.3	2.2	1.0	1.3	4.4	1.3	5.3	1.0	1.1	5.4	1.9	2.0	3.4	3.0	2.8	5.1	0.4	3.7	1.9	2.3	5.8	1.1	1.8	0.5	19.3	1.3	1.8	2.3	3.3	1.6	0.4	10.3	2.0	2.1	1.4	0.7	2.4	1.5	3.8	3.0	2.9	0.6	33.7	3.6	2.8	0.8	8.9	4.0	5.0	0.3	2.7	2.5	8.6	5.9	2.5	1.5	7.9	3.4	1.2	26.9	2.1	2.4	1.3	3.0	0.3	0.6	3.1	1.8	0.3	4.3	1.8	2.8	0.0	0.1	5.4	0.3	0.0	0.5	0.4	0.4	0.1	0.0	0.4	0.3	0.4	0.0	0.1	0.0	0.4	0.3	0.2	1.1	1.1	1.0	0.9	0.9	1.2	1.8	1.4	1.3	1.4	1.2	1.0	3.1	3.2	11.7	0.3	1.2	0.4	5.0	1.9	1.2	0.3	8.1	3.4	4.4	5.7	8.2	0.0	0.0	1.2	1.1	4.3	3.9	4.2	2.6	2.3	1.2	2.6	5.4	4.4	0.0	13.5	1.9	1.1	3.1	3.9	0.0	2.3	2.5	7.3	1.1	0.0	0.0	6.4	2.0	2.5	0.6	0.9	0.6	0.9	1.8	0.0	0.8	2.8	5.2	0.5	0.0	7.5	3.2	0.4	0.7	6.9	3.4	4.3	3.1	0.4	0.0	1.5	1.6	8.4	3.4	3.4	0.1	0.8	1.8	0.5	4.9	5.1
ZBTB48	"HKR3, TZAP, ZNF855"	ENSG00000204859	"Zinc finger and BTB domain containing 48"	P10074	1	6579994-6589280	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 61.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030417	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm	Cytosol	"HPA030417: AB_10603145"	"unprognostic (6.66e-2)"	"prognostic favorable (1.04e-4)"	"unprognostic (7.15e-3)"	"unprognostic (9.05e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.92e-2)"	"unprognostic (2.71e-1)"	"unprognostic (8.15e-3)"	"unprognostic (6.43e-2)"	"unprognostic (1.70e-1)"	"prognostic favorable (5.19e-6)"	"unprognostic (7.73e-2)"	"unprognostic (1.82e-2)"	"unprognostic (1.23e-1)"	"unprognostic (2.77e-2)"	"unprognostic (2.84e-1)"	"unprognostic (1.91e-3)"	10.1	10.9	6.7	13.3	7.3	14.2	10.8	6.9	8.6	15.4	9.3	10.7	11.8	11.0	11.9	11.9	13.1	11.2	8.5	7.2	7.2	11.5	21.2	11.1	14.1	7.1	7.7	16.5	11.6	13.3	11.9	10.5	7.2	15.5	12.4	6.9	11.5	10.0	10.2	14.1	11.5	10.6	6.5	16.0	12.4	25.5	7.8	16.9	14.2	14.2	15.0	12.0	13.0	8.5	6.5	7.2	12.1	17.8	13.0	10.1	6.1	6.3	7.5	12.2	12.8	8.1	14.8	20.8	11.1	5.7	8.1	12.4	18.3	12.8	9.3	21.6	16.5	17.0	24.1	7.9	15.1	28.0	45.2	10.0	9.5	11.9	18.9	16.1	8.9	16.0	17.5	13.2	9.0	12.0	14.0	20.0	9.2	12.7	12.9	15.5	11.3	23.4	10.6	5.3	23.4	10.7	9.7	22.3	15.1	12.1	12.7	22.2	9.9	8.3	5.3	9.1	8.3	14.7	13.8	33.2	7.7	22.0	5.1	20.0	10.5	42.3	8.3	6.5	8.5	9.1	6.5	8.1	11.5	10.5	8.7	7.8	14.6	10.6	10.7	7.7	5.9	8.4	6.7	7.3	6.9	8.6	7.2	7.2	7.1	7.7	7.2	6.5	7.8	8.5	7.7	3.2	12.3	10.4	13.0	4.7	9.3	13.3	3.4	8.0	7.8	8.0	5.8	11.5	10.0	11.0	6.2	6.1	12.5	15.1	11.7	4.7	61.8	10.1	7.1	6.1	15.5	3.4	7.5	3.6	5.1	6.8	23.4	6.5	26.6	10.1	7.1	15.1	10.8	10.1	6.6	15.5	14.2	7.6	5.4	19.1	8.7	11.2	5.4	4.7	9.2	11.1	9.2	4.0	5.5	3.1	14.6	5.7	6.6	5.6	22.6	12.6	18.3	7.8	19.7	10.5	8.2	34.5	14.8	5.3	5.5	5.1	9.9	13.6	10.0	6.5
ZBTB6	"ZID, ZNF482"	ENSG00000186130	"Zinc finger and BTB domain containing 6"	Q15916	9	122908056-122913323	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 10.6"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054111, HPA076894"	Approved		Approved	Nucleoplasm,Mitochondria		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm	Mitochondria	"HPA054111: AB_2682384, HPA076894: AB_2686818"	"unprognostic (9.74e-3)"	"unprognostic (8.40e-2)"	"unprognostic (1.45e-2)"	"unprognostic (7.84e-2)"	"prognostic favorable (2.06e-5)"	"unprognostic (1.81e-1)"	"unprognostic (2.39e-3)"	"unprognostic (1.13e-1)"	"unprognostic (1.06e-1)"	"unprognostic (6.11e-2)"	"unprognostic (1.33e-1)"	"unprognostic (7.20e-2)"	"prognostic favorable (5.08e-4)"	"unprognostic (4.31e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.67e-1)"	"unprognostic (1.92e-2)"	4.2	4.4	3.4	7.0	3.9	3.2	6.8	5.2	5.8	5.4	2.8	5.3	5.9	6.3	4.0	4.9	5.0	4.0	5.5	3.4	3.6	4.8	4.2	4.5	9.7	3.5	3.6	7.2	4.5	6.6	2.3	4.5	3.8	4.9	4.8	7.3	4.5	4.7	6.7	5.0	5.8	4.7	4.1	6.7	5.5	5.5	3.5	7.3	7.5	7.0	9.2	5.3	2.6	5.3	5.1	5.9	9.3	8.5	9.6	9.2	9.4	8.4	10.3	8.3	7.3	6.1	6.3	8.1	5.1	7.6	7.4	22.8	9.8	10.3	10.3	11.5	7.8	8.6	11.9	5.7	9.5	11.4	14.9	7.6	15.5	7.6	12.5	10.2	7.7	10.1	9.2	9.7	12.1	9.6	11.6	7.7	11.7	15.0	9.9	6.1	25.6	11.4	8.7	8.3	11.7	15.2	13.0	12.6	8.2	9.8	15.8	7.4	7.9	9.0	7.0	9.2	9.8	17.0	21.7	2.2	10.5	7.7	9.3	10.6	1.5	2.3	1.2	1.7	1.7	1.4	1.7	1.2	1.6	1.0	2.4	2.2	2.0	2.5	2.9	0.9	2.0	1.7	3.4	3.9	5.2	5.8	3.4	3.6	3.5	3.6	3.8	4.1	3.5	5.3	5.3	6.4	3.6	3.6	6.8	2.2	3.1	2.9	3.4	8.0	4.1	2.9	3.5	7.2	6.9	1.8	10.4	2.3	7.2	3.5	0.0	2.7	9.1	4.4	7.6	4.4	3.0	2.1	4.6	2.5	1.3	5.4	4.1	3.7	7.6	5.0	6.1	3.1	2.4	6.7	5.1	3.9	4.1	7.6	4.0	4.4	3.1	4.1	1.8	3.7	4.3	8.8	2.1	6.6	6.8	2.9	2.5	7.9	3.7	4.1	2.9	4.2	5.3	10.6	6.6	5.1	5.2	6.0	5.1	4.9	2.7	1.9	5.8	5.0	3.4	3.2
ZC3H12A	"FLJ23231, MCPIP1, Regnase-1"	ENSG00000163874	"Zinc finger CCCH-type containing 12A"	Q5D1E8	1	37474580-37484377	"Disease related genes, Predicted intracellular proteins"	"Angiogenesis, Antiviral defense, Apoptosis, Differentiation, DNA damage, Host-virus interaction, Immunity, Inflammatory response, Neurogenesis, Stress response, Transcription, Transcription regulation"	"Developmental protein, DNA-binding, Endonuclease, Hydrolase, Nuclease, Repressor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 136.3"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 300.7;Basal squamous epithelial cells: 242.4;Langerhans cells: 232.8;Squamous epithelial cells: 217.6;Suprabasal keratinocytes: 225.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 48.8;RT4: 61.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA032052, HPA032053"	Uncertain		Supported	"Nucleoplasm,Cytoplasmic bodies"		No	No			"Cluster 52: Eosinophils - Transcription"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 15: RT4 - Unknown function"	"Cluster 7: Non-specific - Mitochondria"	"Cytoplasmic bodies"	Nucleoplasm	"HPA032052: AB_10603241, HPA032053: AB_2674128"	"unprognostic (2.35e-2)"	"unprognostic (6.09e-3)"	"unprognostic (1.51e-2)"	"prognostic favorable (9.67e-4)"	"unprognostic (1.01e-1)"	"unprognostic (1.88e-1)"	"unprognostic (9.03e-2)"	"unprognostic (4.66e-3)"	"unprognostic (1.05e-1)"	"unprognostic (9.69e-3)"	"unprognostic (9.01e-2)"	"unprognostic (1.82e-2)"	"prognostic unfavorable (5.95e-5)"	"unprognostic (5.17e-2)"	"unprognostic (4.69e-2)"	"unprognostic (1.68e-1)"	"unprognostic (3.77e-2)"	28.9	28.0	2.4	17.3	2.3	136.3	15.1	3.6	4.1	9.1	2.7	16.3	14.1	6.6	4.6	45.4	14.3	36.0	12.1	2.5	3.8	15.7	23.3	40.0	13.6	4.1	3.7	6.0	12.4	2.5	9.2	3.7	4.1	29.5	7.9	0.3	22.9	5.2	10.8	51.5	20.1	5.7	3.0	15.5	23.5	5.2	3.7	5.7	6.5	3.2	15.5	39.0	21.4	2.8	7.8	5.5	0.6	3.5	2.7	4.0	6.2	5.5	48.8	3.5	4.5	6.1	17.2	8.7	22.8	5.3	37.8	16.8	2.2	35.4	2.0	17.8	3.2	2.3	20.9	9.7	3.9	4.6	3.5	8.6	17.8	30.0	5.3	7.9	3.9	4.4	4.3	14.1	3.1	9.4	3.5	8.3	4.2	10.4	4.8	5.2	2.2	5.1	8.8	61.2	1.6	1.1	11.0	17.4	1.3	5.3	6.0	5.1	4.1	10.3	5.7	7.7	8.5	11.2	4.5	6.6	23.5	9.7	2.0	1.2	1.4	4.0	3.1	1.4	3.3	3.1	1.3	1.9	1.7	3.9	0.7	1.5	5.6	3.5	1.2	1.5	2.0	1.7	2.4	2.3	3.6	4.1	2.5	3.8	4.1	3.7	4.1	3.0	3.7	2.8	19.1	16.0	36.2	1.6	56.9	195.9	149.8	300.7	242.4	0.4	93.6	69.8	4.2	61.5	117.6	11.0	0.0	3.7	78.1	71.5	0.0	79.5	16.9	67.6	20.8	32.2	63.9	0.4	0.1	73.9	10.0	41.0	66.3	102.2	42.6	5.0	5.3	11.4	9.7	0.0	0.1	77.3	69.2	10.5	232.8	2.7	0.9	71.2	48.0	1.0	14.0	0.9	9.2	0.5	0.9	55.4	73.2	1.2	52.1	127.9	59.5	0.6	58.4	4.5	6.6	52.7	36.1	1.6	1.3	217.6	225.2	11.8	76.6	9.5	62.2	81.9
ZC3H12D	"C6orf95, dJ281H8.1, MCPIP4"	ENSG00000178199	"Zinc finger CCCH-type containing 12D"	A2A288	6	149446795-149485014	"Disease related genes, Predicted intracellular proteins"		"Endonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"bone marrow: 3.6;intestine: 4.7;lymphoid tissue: 12.6"	"Cell type enhanced"	"Detected in many"		"B-cells: 14.6;Distal enterocytes: 7.7;Kupffer cells: 12.4;Macrophages: 7.4;Proximal enterocytes: 7.5;T-cells: 17.4"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	4	"HDLM-2: 34.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			HPA036897	Uncertain		Supported	"Nucleoplasm,Cytoplasmic bodies"		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 16: Immune cells - Immune response"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 24: Non-specific - Transcription regulation"	"Nucleoplasm, Cytoplasmic bodies"		"HPA036897: AB_10672104"	"unprognostic (2.89e-2)"	"unprognostic (3.91e-4)"	"unprognostic (1.68e-2)"	"unprognostic (1.88e-2)"	"unprognostic (3.12e-1)"	"unprognostic (2.47e-6)"	"unprognostic (2.20e-2)"	"unprognostic (2.50e-3)"	"unprognostic (1.34e-1)"	"unprognostic (3.30e-2)"	"unprognostic (2.33e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.28e-4)"	"unprognostic (1.21e-2)"	"unprognostic (9.24e-3)"	"unprognostic (6.99e-2)"	"unprognostic (5.52e-2)"	0.7	0.4	1.0	7.2	0.5	3.6	0.4	0.4	0.9	0.3	0.3	1.5	2.8	0.2	0.2	0.3	0.3	0.6	0.3	0.8	0.9	0.6	0.3	0.8	9.8	1.0	0.5	0.3	0.1	0.0	0.2	0.3	0.8	0.3	1.4	0.5	0.7	0.3	0.4	1.1	4.7	0.5	0.4	5.8	0.8	0.3	0.9	1.1	0.5	0.0	12.6	1.0	0.2	0.9	0.1	0.1	0.1	0.2	0.1	0.0	0.1	0.2	0.0	0.0	0.0	0.6	0.1	8.0	0.1	0.0	0.2	0.2	0.0	0.0	0.1	34.3	0.2	0.3	1.2	2.7	0.0	2.8	0.5	0.2	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.7	0.0	0.1	0.0	2.5	0.0	0.0	0.0	7.1	0.0	0.9	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.3	4.6	0.0	0.2	0.1	0.1	0.1	0.1	0.2	2.9	0.4	2.5	0.1	0.7	0.8	0.1	0.1	0.5	0.2	1.4	1.5	0.7	0.8	1.3	0.9	0.2	0.5	0.3	1.4	0.4	3.5	0.8	1.0	0.5	0.4	0.9	0.8	0.9	1.0	0.5	0.8	0.4	0.9	0.9	1.0	3.2	3.9	1.3	14.6	0.4	0.5	0.0	0.0	0.7	0.3	0.3	1.4	1.5	0.6	0.0	4.2	0.0	3.7	7.7	1.9	0.0	0.4	0.4	0.4	1.3	0.0	0.4	1.2	0.4	0.0	0.7	0.5	0.6	0.0	0.2	1.4	0.3	3.7	0.0	0.7	1.1	0.0	12.4	4.4	0.5	0.0	7.4	1.8	1.0	1.6	0.8	0.0	0.0	0.7	0.3	0.8	0.0	4.6	0.4	7.5	1.6	0.0	1.1	0.0	0.9	0.4	0.2	0.4	0.1	1.4	0.0	17.4	0.0	2.6	0.4
ZC3H7A	"FLJ20318, HSPC055, ZC3H7, ZC3HDC7"	ENSG00000122299	"Zinc finger CCCH-type containing 7A"	Q8IWR0	16	11750586-11797258	"Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040808, HPA059849"			Supported	Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 34: Non-specific - Transcription"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 24: Non-specific - Transcription regulation"	Cytosol		"HPA040808: AB_10794150, HPA059849: AB_2684141"	"unprognostic (2.82e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.45e-1)"	"unprognostic (2.07e-1)"	"unprognostic (5.64e-2)"	"unprognostic (2.07e-2)"	"unprognostic (5.75e-2)"	"unprognostic (1.16e-2)"	"unprognostic (4.96e-2)"	"unprognostic (9.16e-2)"	"unprognostic (1.44e-1)"	"unprognostic (2.27e-2)"	"unprognostic (7.27e-3)"	"unprognostic (6.00e-2)"	"unprognostic (1.05e-2)"	"unprognostic (1.50e-2)"	"unprognostic (3.55e-2)"	22.3	17.8	12.1	21.8	13.4	38.0	21.1	18.7	12.8	19.7	26.8	19.1	17.7	22.4	18.0	12.8	18.7	18.9	19.7	11.9	12.8	22.8	21.3	23.6	29.3	13.1	12.5	26.6	26.2	23.4	14.7	26.4	13.4	24.2	19.7	30.3	30.0	25.5	32.8	15.4	18.8	22.8	12.4	23.9	18.7	10.3	13.9	28.2	25.7	21.8	27.6	18.4	15.9	16.6	33.5	16.9	58.2	31.8	40.0	39.4	23.3	52.4	52.2	38.9	47.7	18.9	28.5	46.7	32.2	62.7	25.0	21.1	33.1	50.9	56.0	36.9	37.5	20.1	35.5	31.8	56.6	46.5	42.4	44.7	27.7	36.7	68.7	45.4	49.5	41.8	33.5	40.8	57.1	26.2	35.3	23.6	34.2	23.2	15.2	51.0	32.6	33.3	36.0	25.6	44.3	35.2	42.5	40.5	52.4	34.3	29.6	30.2	47.2	45.1	27.6	61.9	35.8	32.5	26.2	68.5	33.3	34.3	118.7	16.6	12.9	20.4	14.0	17.8	19.8	15.5	18.1	15.4	12.8	16.5	21.1	15.0	16.0	22.3	32.2	10.2	24.2	9.4	12.1	13.4	18.7	12.8	11.9	12.8	13.1	12.5	13.4	12.4	13.9	16.6	39.4	64.1	36.4	36.9	46.2	15.0	15.2	9.6	27.3	29.4	21.2	23.7	44.3	17.2	29.0	14.7	54.2	14.9	40.5	16.4	15.6	18.5	3.2	30.9	48.7	32.7	20.9	22.5	29.4	22.7	15.4	31.1	27.5	33.9	18.3	31.3	32.9	18.5	14.5	53.8	35.3	25.1	18.3	36.3	26.2	5.3	32.6	39.3	19.6	30.9	40.2	25.6	22.6	65.9	32.7	22.3	16.9	35.7	45.2	18.0	20.3	16.4	29.5	52.4	19.7	42.2	37.1	17.2	9.0	18.0	15.8	7.5	40.3	28.9	18.5	16.0
ZC3H7B	"DKFZp434K0920, FLJ13787, KIAA1031, RoXaN"	ENSG00000100403	"Zinc finger CCCH-type containing 7B"	Q9UGR2	22	41301525-41360147	"Predicted intracellular proteins"	"Host-virus interaction"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001784, HPA076092"	Uncertain		Supported	Cytosol		NA	NA				"Cluster 35: Non-specific - Unknown function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 52: Non-specific - Transcription"	Cytosol		"HPA001784: AB_1080637, HPA076092: "	"unprognostic (1.71e-1)"	"unprognostic (1.68e-1)"	"unprognostic (3.49e-2)"	"unprognostic (3.53e-2)"	"unprognostic (3.35e-2)"	"unprognostic (5.66e-2)"	"unprognostic (3.73e-2)"	"unprognostic (7.92e-2)"	"unprognostic (7.12e-2)"	"unprognostic (7.73e-2)"	"unprognostic (1.39e-2)"	"unprognostic (3.19e-1)"	"prognostic favorable (5.43e-7)"	"unprognostic (1.43e-2)"	"unprognostic (2.92e-2)"	"unprognostic (4.81e-2)"	"unprognostic (2.89e-1)"	29.5	42.9	37.5	20.2	37.1	16.0	22.9	31.9	43.4	25.6	15.1	25.8	24.3	31.1	13.5	20.3	27.2	17.2	26.1	34.1	38.7	31.4	42.1	26.9	21.4	56.0	35.7	41.3	30.9	44.5	30.5	18.5	58.8	26.0	13.2	17.9	44.9	26.7	24.9	20.0	25.9	20.7	30.2	25.6	24.8	11.6	37.2	25.2	45.9	19.1	15.2	23.5	19.7	36.0	59.0	32.2	42.0	25.6	37.6	33.9	49.1	65.8	69.6	53.8	42.1	35.3	23.8	33.1	79.1	92.0	30.1	39.1	35.7	61.8	27.4	76.0	58.9	29.6	40.2	45.4	50.4	57.4	24.9	42.7	34.6	46.3	56.4	45.7	58.9	25.7	60.4	17.9	46.0	59.1	45.4	29.7	30.3	44.2	24.1	68.7	26.4	37.8	45.9	41.5	27.1	20.3	60.5	36.6	31.5	29.0	24.1	38.1	119.0	52.5	54.4	16.3	40.8	30.8	18.4	33.2	44.0	28.0	46.1	0.0	0.1	0.1	0.1	0.0	0.1	0.3	0.2	0.1	0.0	0.3	0.2	0.1	0.0	0.3	0.0	0.2	0.1	0.0	37.5	37.1	31.9	43.4	34.1	38.7	56.0	35.7	58.8	30.2	37.2	36.0	15.4	12.8	22.2	14.4	13.1	7.1	12.7	13.4	10.2	22.4	18.2	15.6	10.1	20.0	15.7	22.0	18.8	9.0	11.3	13.5	7.9	14.0	0.9	14.2	25.8	17.9	33.6	7.8	20.1	13.3	9.0	16.4	11.2	16.9	8.2	59.0	19.2	44.0	12.0	42.1	20.6	14.6	26.4	12.9	9.8	3.1	33.2	8.2	12.4	13.1	15.2	9.8	20.6	19.1	17.6	18.8	8.1	29.0	7.4	21.2	23.0	18.5	11.7	22.2	19.7	23.1	18.0	2.0	4.9	8.9	5.8	6.2	11.1	46.9	17.1	14.8
ZC3H8	"Fliz1, ZC3HDC8"	ENSG00000144161	"Zinc finger CCCH-type containing 8"	Q8N5P1	2	112211529-112255136	"Predicted intracellular proteins, Transcription factors"	"Apoptosis, Transcription, Transcription regulation"	"Repressor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034803, HPA034804"	Approved		Supported	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	"Nuclear bodies"	"HPA034803: AB_2674338, HPA034804: AB_10670284"	"unprognostic (2.45e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.03e-1)"	"prognostic unfavorable (1.12e-6)"	"unprognostic (4.93e-2)"	"unprognostic (1.01e-1)"	"unprognostic (4.29e-3)"	"unprognostic (8.76e-2)"	"unprognostic (1.20e-2)"	"unprognostic (5.04e-2)"	"unprognostic (7.22e-2)"	"unprognostic (2.89e-2)"	"prognostic unfavorable (1.89e-4)"	"unprognostic (2.74e-2)"	"unprognostic (3.49e-2)"	"unprognostic (8.02e-3)"	"unprognostic (4.88e-3)"	3.6	3.9	4.7	5.7	4.8	6.2	8.0	6.5	6.2	5.4	3.1	4.6	5.2	4.6	4.4	8.6	5.1	2.6	8.6	5.0	4.7	5.7	5.9	2.9	8.5	4.5	4.1	6.0	9.0	11.2	6.6	3.7	4.5	5.6	6.0	5.9	7.1	3.9	11.0	7.6	4.6	4.4	4.0	6.1	4.4	9.0	4.1	9.1	7.2	11.0	8.6	4.9	6.1	4.8	22.1	10.5	13.2	13.7	7.4	8.0	20.6	6.8	5.8	9.5	7.9	25.3	8.3	45.6	12.4	4.8	13.3	13.1	19.4	13.7	12.5	16.2	9.0	30.3	11.8	12.9	11.7	28.6	13.4	10.0	27.0	18.4	28.4	7.0	7.2	27.3	39.2	12.2	7.5	14.6	31.0	25.7	12.2	23.1	29.2	21.2	22.5	18.8	8.7	9.7	19.8	15.4	12.9	13.7	29.9	11.5	10.9	15.1	9.6	12.3	15.9	8.8	17.4	21.9	27.9	44.4	8.8	23.4	4.9	2.7	2.5	0.8	4.0	2.0	8.4	5.9	4.2	4.3	2.5	6.1	7.1	5.9	1.4	7.2	2.6	4.1	4.7	2.4	4.7	4.8	6.5	6.2	5.0	4.7	4.5	4.1	4.5	4.0	4.1	4.8	15.5	9.6	15.2	17.0	35.6	12.6	18.2	16.6	30.7	50.2	28.7	28.6	35.4	12.8	22.8	7.3	41.7	18.1	38.7	13.4	27.4	15.2	30.9	25.5	28.0	15.4	14.9	19.8	35.8	18.6	16.8	16.4	12.2	15.1	35.4	20.2	13.6	11.3	11.4	38.7	46.2	27.4	22.4	15.7	7.8	40.6	22.1	13.7	1.8	12.2	18.1	16.1	43.3	41.2	27.8	19.5	11.3	20.3	14.3	21.2	12.7	24.3	17.4	53.5	13.1	20.9	16.2	60.9	39.0	34.3	17.8	14.2	31.6	24.4	24.0	12.5
ZC3HC1	NIPA	ENSG00000091732	"Zinc finger C3HC-type containing 1"	Q86WB0	7	130018287-130051451	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Spermatocytes: 42.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019089, HPA024023"	Enhanced		Supported	"Nucleoplasm,Nuclear membrane"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Nucleoplasm, Nuclear membrane"		"HPA019089: AB_1858976, HPA024023: AB_1858977"	"unprognostic (7.14e-3)"	"unprognostic (4.07e-2)"	"unprognostic (1.04e-2)"	"prognostic unfavorable (3.36e-4)"	"unprognostic (1.89e-1)"	"unprognostic (3.39e-2)"	"prognostic unfavorable (1.02e-6)"	"unprognostic (2.11e-1)"	"unprognostic (1.11e-3)"	"unprognostic (1.48e-1)"	"unprognostic (1.12e-2)"	"unprognostic (2.91e-1)"	"unprognostic (1.10e-3)"	"unprognostic (2.33e-1)"	"unprognostic (5.11e-2)"	"unprognostic (2.60e-2)"	"unprognostic (1.53e-1)"	8.4	12.4	11.2	7.3	11.3	4.7	8.4	10.9	11.4	9.1	11.9	9.5	5.4	9.3	8.6	7.4	8.3	5.7	16.5	11.1	12.1	11.8	14.1	6.3	10.6	11.4	11.5	9.3	7.5	11.6	7.5	8.4	11.4	8.3	7.2	5.8	7.1	7.0	32.7	6.3	7.6	11.5	11.4	12.5	8.7	15.6	12.1	10.4	7.4	29.1	10.6	9.1	7.6	11.8	15.2	24.8	30.3	35.1	17.2	15.5	20.6	19.5	23.5	36.5	36.3	29.7	25.5	34.2	13.7	24.4	48.5	13.4	40.1	29.2	35.0	22.7	34.2	24.1	21.4	29.1	27.7	27.4	22.9	18.4	21.2	38.1	24.2	20.1	39.5	28.9	73.7	11.7	35.5	26.5	33.2	51.9	62.5	26.0	28.0	31.0	23.6	29.5	37.0	10.7	19.3	34.3	27.5	39.4	30.7	42.9	17.3	28.6	17.6	24.2	11.5	20.5	32.8	22.9	36.8	44.7	37.8	34.9	41.2	34.5	24.6	23.8	26.0	29.4	29.5	39.3	26.6	27.5	31.2	37.1	35.2	27.7	2.0	29.5	28.3	18.6	30.8	24.6	11.2	11.3	10.9	11.4	11.1	12.1	11.4	11.5	11.4	11.4	12.1	11.8	5.2	6.4	2.3	12.4	8.8	1.5	5.4	16.0	11.4	6.1	4.3	5.8	13.5	4.3	7.5	7.3	0.0	19.2	4.8	2.3	17.6	12.8	3.3	3.1	5.5	8.6	3.6	5.2	13.8	9.7	16.9	8.1	4.1	2.6	4.5	12.4	11.4	9.1	9.0	6.7	15.7	4.2	16.2	5.0	3.0	5.2	8.7	4.3	1.8	9.4	11.6	6.9	9.2	11.6	12.4	8.9	7.7	6.4	9.1	2.3	2.6	22.1	8.9	5.9	0.0	7.4	8.3	42.0	22.9	5.0	1.7	7.4	7.0	9.4	4.9	2.2
ZCCHC9	"DKFZp761J139, PPP1R41"	ENSG00000131732	"Zinc finger CCHC-type containing 9"	Q8N567	5	81301587-81313297	"Predicted intracellular proteins"	Transcription			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SK-MEL-30: 146.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038404	Uncertain		Supported	Nucleoplasm,Nucleoli		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm	Nucleoli	"HPA038404: AB_10672744"	"unprognostic (1.55e-1)"	"unprognostic (2.27e-1)"	"unprognostic (1.31e-2)"	"unprognostic (1.43e-2)"	"unprognostic (1.57e-2)"	"unprognostic (1.71e-2)"	"unprognostic (6.29e-2)"	"unprognostic (4.91e-2)"	"unprognostic (1.10e-1)"	"unprognostic (3.31e-1)"	"unprognostic (3.58e-2)"	"unprognostic (2.68e-2)"	"unprognostic (5.20e-3)"	"unprognostic (1.60e-1)"	"unprognostic (2.05e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.06e-1)"	13.4	12.3	8.7	15.9	8.6	10.8	13.5	9.7	13.4	15.5	9.8	15.2	14.9	15.5	16.3	14.6	12.6	14.3	11.2	8.6	9.2	17.9	33.3	11.2	19.0	8.9	9.0	17.2	11.8	13.0	13.8	19.1	9.0	15.5	14.9	14.0	10.5	11.0	14.9	16.3	18.7	14.6	8.5	13.3	12.9	14.9	9.4	17.7	12.6	11.6	18.2	16.3	13.5	9.1	26.6	18.5	44.5	23.7	37.5	35.3	59.7	39.2	46.3	29.5	40.8	41.0	35.8	24.6	15.8	19.8	51.1	19.4	35.6	35.8	46.9	55.3	33.5	25.4	21.0	48.4	44.2	32.6	20.3	27.6	30.7	25.3	62.7	22.9	25.3	26.5	43.1	23.4	30.8	36.3	54.0	48.7	32.4	14.9	23.7	31.9	57.0	36.4	23.4	26.5	21.6	20.5	31.1	18.4	146.5	32.1	23.0	51.7	17.6	18.5	22.6	33.2	43.4	33.2	36.5	37.7	32.7	46.7	40.3	12.6	10.8	11.3	10.5	14.9	13.2	12.8	14.0	12.8	13.3	11.1	13.3	13.8	10.6	10.8	13.6	15.1	17.4	6.5	8.7	8.6	9.7	13.4	8.6	9.2	8.9	9.0	9.0	8.5	9.4	9.1	15.9	9.6	18.6	10.4	18.2	9.1	12.5	25.8	14.2	18.0	14.5	17.1	12.3	37.1	19.3	31.3	14.6	28.0	17.3	15.0	31.3	22.4	68.4	22.6	31.5	17.9	7.8	12.8	15.0	20.4	53.8	23.9	14.8	18.8	13.3	13.3	29.6	61.7	36.7	26.9	19.3	23.3	16.2	14.2	16.5	19.1	32.6	19.9	3.6	13.1	33.2	22.0	35.0	12.1	14.2	30.2	27.4	29.0	17.6	13.8	44.8	67.1	28.1	28.2	19.7	16.2	18.8	75.6	38.2	14.0	9.2	23.0	19.8	22.3	21.6	12.6
ZDHHC13	"FLJ10852, FLJ10941, HIP14L"	ENSG00000177054	"Zinc finger DHHC-type palmitoyltransferase 13"	Q8IUH4	11	19117099-19176422	"Enzymes, Metabolic proteins, Predicted membrane proteins, Transporters"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 120.5;Urothelial cells: 103.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HUVEC TERT2: 136.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016759, HPA018791"	Uncertain		Supported	"Golgi apparatus,Vesicles"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 37: Intestine - Unknown function"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 22: Epithelial cell types - Mixed function"	Vesicles	"Golgi apparatus"	"HPA016759: AB_1858993, HPA018791: AB_1858992"	"unprognostic (1.43e-2)"	"unprognostic (4.00e-3)"	"unprognostic (1.08e-1)"	"unprognostic (1.11e-3)"	"unprognostic (2.95e-2)"	"unprognostic (1.34e-2)"	"unprognostic (1.55e-2)"	"unprognostic (1.57e-1)"	"unprognostic (3.57e-3)"	"unprognostic (3.03e-2)"	"unprognostic (1.63e-1)"	"unprognostic (2.16e-1)"	"unprognostic (6.95e-3)"	"unprognostic (1.15e-1)"	"unprognostic (7.93e-2)"	"unprognostic (2.17e-1)"	"unprognostic (2.76e-2)"	4.8	5.7	5.2	7.8	5.2	9.7	8.9	6.6	7.1	9.3	6.6	16.9	11.2	6.7	5.1	37.2	12.9	8.7	9.1	5.4	5.7	9.2	2.2	6.1	9.6	5.5	5.0	5.3	11.2	14.9	11.7	6.2	5.8	8.2	18.2	16.1	10.2	5.4	1.6	18.8	11.3	6.1	5.3	5.7	18.5	14.4	5.0	11.7	8.7	2.9	22.4	22.4	15.4	5.2	41.6	19.3	18.0	15.5	6.3	7.2	17.3	19.4	17.8	21.3	24.4	11.7	9.7	21.1	13.1	16.3	47.9	61.3	26.0	12.8	23.3	26.4	22.6	11.1	12.6	9.7	14.6	15.2	18.5	8.3	14.7	9.0	12.5	19.9	136.8	28.9	10.7	10.3	22.1	13.5	19.6	12.2	15.1	38.7	17.6	21.3	25.0	5.0	21.9	27.0	31.3	23.0	23.2	28.0	10.7	17.3	13.2	17.6	39.6	18.9	13.2	29.2	15.8	8.7	28.5	19.2	22.6	15.5	33.6	11.6	4.7	32.7	8.5	7.9	7.8	8.7	6.6	9.6	5.9	5.5	6.2	8.3	6.0	6.3	6.4	5.6	9.4	4.6	5.2	5.2	6.6	7.1	5.4	5.7	5.5	5.0	5.8	5.3	5.0	5.2	8.1	9.6	10.7	28.7	9.6	24.2	22.3	27.2	14.2	12.0	7.5	4.8	34.1	12.8	41.3	16.5	10.4	8.7	10.6	20.1	5.9	25.1	120.5	21.5	6.6	11.3	15.6	11.6	27.2	19.2	18.8	9.2	24.5	30.8	12.0	16.2	12.8	0.9	6.1	16.8	34.9	24.7	36.7	6.8	8.3	46.6	7.8	6.2	3.6	9.4	20.8	52.8	18.6	19.6	20.9	20.4	16.4	2.2	10.4	47.4	15.5	3.5	57.0	8.8	0.0	5.4	7.4	58.1	31.7	21.3	36.2	6.3	11.4	7.7	21.4	103.0
ZDHHC16	APH2	ENSG00000171307	"Zinc finger DHHC-type palmitoyltransferase 16"	Q969W1	10	97446170-97457370	"Enzymes, Metabolic proteins, Predicted membrane proteins"	"Apoptosis, DNA damage"	"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Extravillous trophoblasts: 67.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039893, HPA040214"	Uncertain		Supported	"Nucleoplasm,Nuclear membrane,Cytosol"		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 38: Extravillous trophoblasts - Unknown function"	Nucleoplasm	"Nuclear membrane, Cytosol"	"HPA039893: AB_10794757, HPA040214: AB_2676886"	"unprognostic (4.44e-2)"	"unprognostic (3.14e-2)"	"unprognostic (3.34e-1)"	"unprognostic (1.20e-2)"	"unprognostic (8.75e-2)"	"unprognostic (8.35e-3)"	"unprognostic (1.27e-2)"	"unprognostic (3.62e-2)"	"unprognostic (5.49e-2)"	"unprognostic (1.57e-1)"	"unprognostic (2.31e-1)"	"unprognostic (6.34e-2)"	"unprognostic (1.93e-3)"	"unprognostic (1.34e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.28e-2)"	"unprognostic (2.48e-1)"	15.6	14.9	17.8	10.2	18.5	6.8	16.3	20.3	21.9	15.0	16.4	17.1	14.3	16.4	18.5	19.9	12.2	9.9	22.1	18.1	16.5	25.1	30.3	20.8	11.3	17.2	17.8	15.9	22.8	25.5	16.7	21.6	16.4	18.3	17.3	17.4	24.2	12.1	25.8	13.1	14.7	16.6	16.1	14.5	24.1	17.3	18.8	12.6	16.0	27.9	15.1	17.1	15.3	16.7	50.7	57.4	37.9	47.1	58.7	40.4	38.7	54.6	72.1	61.2	58.4	45.7	43.6	44.4	60.1	79.8	53.4	58.0	48.2	76.7	54.2	43.7	56.0	28.5	39.8	44.3	47.4	34.0	39.7	45.7	49.8	71.6	51.3	66.3	63.9	40.4	23.1	32.8	79.0	48.4	51.8	46.0	29.9	45.8	49.5	34.0	38.6	40.9	51.9	23.2	18.4	25.9	33.2	33.7	30.6	37.7	44.6	32.9	39.6	38.2	35.0	25.0	64.7	29.2	53.0	26.9	44.1	51.7	20.7	0.3	11.1	11.1	7.2	11.9	8.1	9.0	12.5	11.5	15.7	10.6	10.0	10.1	0.5	14.5	11.8	12.0	11.1	6.8	17.8	18.5	20.3	21.9	18.1	16.5	17.2	17.8	16.4	16.1	18.8	16.7	6.2	19.2	23.1	3.9	9.0	5.2	18.9	31.8	14.8	15.8	13.6	9.3	10.1	14.3	27.6	12.9	4.2	39.8	10.3	11.5	25.4	35.5	24.8	7.0	13.3	11.3	7.2	11.6	8.2	32.3	67.2	13.7	10.2	10.9	7.0	13.3	7.5	19.5	24.6	13.5	9.2	18.9	28.5	7.3	5.9	7.6	8.7	9.3	3.6	9.4	18.4	14.9	15.5	11.1	8.4	31.5	12.1	3.8	17.1	20.0	18.9	22.2	8.3	13.0	6.6	5.2	12.2	20.1	12.9	13.8	4.3	37.9	7.2	10.9	20.9	19.3
ZDHHC17	"HIP14, HYPH, KIAA0946"	ENSG00000186908	"Zinc finger DHHC-type palmitoyltransferase 17"	Q8IUH5	12	76764103-76853696	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"Acyltransferase, Transferase"	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 102.2;Inhibitory neurons: 95.1;Oligodendrocytes: 115.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"plasmacytoid DC: 17.1"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016807, HPA058674"	Approved		Supported	"Golgi apparatus,Vesicles"		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 6: Brain - Smell perception"	"Cluster 12: NES - Nervous system development"	"Cluster 65: Plasmacytoid DCs - Unknown function"	"Golgi apparatus, Vesicles"		"HPA016807: AB_1858999, HPA058674: AB_2732626"	"unprognostic (1.06e-1)"	"unprognostic (2.26e-2)"	"unprognostic (2.63e-2)"	"unprognostic (3.04e-1)"	"unprognostic (6.12e-2)"	"unprognostic (2.83e-2)"	"unprognostic (2.35e-3)"	"unprognostic (3.09e-1)"	"unprognostic (8.38e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.56e-3)"	"unprognostic (5.42e-2)"	"prognostic unfavorable (7.11e-5)"	"unprognostic (1.77e-2)"	"unprognostic (2.69e-1)"	"unprognostic (2.98e-1)"	"unprognostic (1.71e-2)"	15.6	14.1	18.6	12.1	20.4	23.7	16.1	23.1	25.9	15.8	11.8	13.7	7.5	21.7	12.3	8.0	12.8	10.5	12.5	19.8	18.9	11.0	9.8	10.6	14.8	18.2	18.6	20.1	10.2	12.7	11.0	16.4	18.9	14.1	10.1	31.0	8.1	12.8	11.8	10.2	10.3	14.6	19.2	14.4	8.5	12.8	19.4	14.9	11.8	14.2	11.4	11.7	11.7	27.8	8.2	9.5	30.1	15.4	17.6	18.5	14.6	16.2	13.4	10.5	9.2	7.8	5.8	11.2	9.5	15.9	10.5	7.5	12.1	10.1	16.2	9.5	12.6	16.4	13.1	12.0	11.9	16.5	13.9	17.6	10.3	10.0	14.7	35.2	12.2	15.2	18.0	5.2	13.8	7.6	12.0	21.9	22.1	3.6	11.3	16.1	10.7	12.3	12.0	12.3	11.7	20.1	17.8	6.4	10.7	25.7	14.4	16.3	16.9	14.3	11.0	8.8	9.3	8.1	8.5	11.9	5.4	7.6	15.0	6.2	2.3	5.7	3.6	2.4	2.9	2.5	2.9	2.6	2.8	3.9	3.0	2.5	5.9	2.0	2.5	17.1	1.3	1.5	18.6	20.4	23.1	25.9	19.8	18.9	18.2	18.6	18.9	19.2	19.4	27.8	33.4	32.1	18.3	75.7	20.1	7.1	10.4	9.8	12.5	54.6	9.9	10.7	21.3	12.8	15.5	12.9	39.6	20.3	74.1	5.0	0.0	8.0	11.3	11.8	23.8	24.8	19.2	12.0	102.2	4.7	10.2	21.2	7.1	10.1	41.2	20.7	20.3	10.6	8.8	28.6	95.1	7.5	8.2	12.3	19.4	13.7	20.2	14.9	5.4	54.4	14.9	26.1	18.6	88.4	115.8	6.8	4.5	21.1	13.5	10.2	8.4	5.5	18.0	38.1	0.0	32.3	22.0	17.7	22.6	9.5	5.5	5.6	18.1	19.6	6.2	5.5
ZDHHC20	"DHHC20, FLJ25952"	ENSG00000180776	"Zinc finger DHHC-type palmitoyltransferase 20"	Q5W0Z9	13	21372571-21459370	"Enzymes, Metabolic proteins, Predicted membrane proteins, Transporters"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 95.0"	"Cell type enriched"	"Detected in many"	4	"Oligodendrocytes: 434.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014483, HPA014702"	Approved		Supported	"Vesicles,Plasma membrane"		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 70: Brain - Nervous system development"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Vesicles, Plasma membrane"		"HPA014483: AB_1859000, HPA014702: AB_1859001"	"unprognostic (1.31e-1)"	"unprognostic (2.16e-3)"	"unprognostic (7.31e-3)"	"unprognostic (8.89e-2)"	"unprognostic (3.37e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.06e-3)"	"unprognostic (3.77e-1)"	"unprognostic (1.24e-2)"	"unprognostic (1.26e-2)"	"prognostic unfavorable (6.55e-4)"	"unprognostic (1.10e-1)"	"prognostic unfavorable (1.01e-4)"	"unprognostic (3.76e-2)"	"unprognostic (7.65e-2)"	"unprognostic (6.15e-2)"	"unprognostic (1.13e-2)"	10.9	9.2	15.2	17.6	52.9	30.0	11.5	51.8	23.3	16.2	0.0	16.9	19.3	13.8	9.6	30.2	10.9	17.1	7.9	12.0	27.0	6.7	9.8	17.0	18.0	70.8	40.7	9.7	9.0	8.9	4.4	18.8	60.3	15.1	16.1	5.6	8.5	12.2	4.0	22.1	19.0	15.2	35.1	16.1	39.5	31.7	40.7	22.6	16.4	9.4	19.5	22.9	9.3	95.0	32.9	16.4	27.7	18.1	24.5	26.7	68.3	35.6	36.3	23.3	20.6	33.8	102.5	34.8	19.3	44.7	23.8	52.7	30.5	26.5	44.8	40.0	20.4	61.8	11.7	19.6	14.1	43.3	25.8	24.2	19.4	23.6	16.2	30.0	37.6	45.9	17.3	14.9	35.3	27.2	62.0	17.2	22.9	87.3	18.0	49.8	49.1	12.7	28.9	59.7	25.2	11.4	46.0	28.7	19.3	28.6	27.0	21.8	62.6	25.0	24.0	41.7	27.4	15.6	19.9	37.7	18.2	23.6	73.1	12.6	16.2	3.8	10.1	14.9	9.3	4.6	8.7	8.7	8.4	3.4	8.1	8.4	3.0	11.2	13.8	4.1	10.4	13.5	15.2	52.9	51.8	23.3	12.0	27.0	70.8	40.7	60.3	35.1	40.7	95.0	27.6	51.3	31.5	29.0	19.9	1.0	7.8	1.4	18.2	7.4	21.9	13.7	7.4	14.3	20.7	11.0	8.4	20.7	34.7	35.5	0.0	8.5	91.3	23.4	25.2	25.7	24.0	8.4	69.1	12.2	20.9	13.6	53.0	34.5	14.0	16.1	20.0	20.8	21.7	18.5	80.0	29.1	2.0	92.5	3.2	81.2	15.5	49.0	1.8	46.9	48.4	3.7	30.9	54.8	434.3	22.8	25.5	10.9	18.1	14.5	30.3	6.3	11.7	9.5	19.7	12.7	11.6	10.4	14.1	28.1	1.6	44.6	28.4	9.7	25.1	25.6
ZDHHC7	"DHHC7, FLJ10792, FLJ20279, SERZ-B, SERZ1, ZNF370"	ENSG00000153786	"Zinc finger DHHC-type palmitoyltransferase 7"	Q9NXF8	16	84974175-85011535	"Enzymes, Metabolic proteins, Predicted membrane proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019215, HPA059054, HPA059642"	Uncertain		Supported	"Golgi apparatus"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 59: Non-specific - Translation"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	"Golgi apparatus"		"HPA019215: AB_2670102, HPA059054: AB_2683892, HPA059642: AB_2684093"	"unprognostic (9.77e-2)"	"unprognostic (2.12e-1)"	"unprognostic (6.70e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.31e-1)"	"unprognostic (8.76e-2)"	"prognostic unfavorable (4.20e-4)"	"unprognostic (1.41e-2)"	"unprognostic (5.78e-2)"	"unprognostic (2.21e-2)"	"unprognostic (7.79e-3)"	"unprognostic (8.04e-2)"	"prognostic favorable (1.12e-5)"	"unprognostic (1.67e-1)"	"unprognostic (1.36e-2)"	"unprognostic (2.45e-1)"	"unprognostic (5.42e-2)"	33.0	28.1	19.0	24.7	18.8	64.2	26.8	21.4	18.6	40.0	27.1	42.5	27.1	36.8	12.8	27.6	27.7	31.2	31.2	19.1	19.8	35.4	30.0	37.2	26.5	20.1	21.0	27.7	26.9	35.5	19.6	33.4	20.3	32.8	32.4	10.3	24.1	20.0	56.5	31.8	33.5	30.0	19.1	35.4	44.7	14.1	23.5	16.1	25.5	58.4	23.5	37.4	33.1	19.6	63.8	55.0	28.5	34.5	123.1	92.3	38.9	57.4	110.8	88.4	43.7	58.3	72.4	29.1	32.7	93.5	29.0	65.6	37.1	76.1	110.9	16.4	29.7	21.0	22.0	66.5	51.5	40.0	21.2	76.7	85.4	72.5	41.5	56.0	46.1	26.7	68.9	9.7	56.8	75.8	27.0	38.1	44.3	53.2	39.5	33.6	26.2	15.7	86.4	82.5	24.2	29.8	74.3	40.9	36.1	43.0	77.6	24.0	67.9	53.1	39.9	49.8	34.3	33.5	51.0	65.5	50.1	29.1	43.0	7.5	9.7	8.3	2.1	8.2	2.6	1.4	2.0	1.7	6.3	2.2	1.5	2.2	6.4	1.4	7.2	4.3	0.5	3.6	19.0	18.8	21.4	18.6	19.1	19.8	20.1	21.0	20.3	19.1	23.5	19.6	13.3	32.1	25.2	12.1	10.8	13.3	21.5	25.4	17.1	9.2	16.2	13.2	22.5	12.8	17.9	16.5	6.2	18.5	15.7	37.7	1.9	14.1	9.7	15.5	20.1	12.2	12.6	11.6	16.4	15.6	24.9	23.0	28.5	29.1	3.8	14.3	15.0	11.6	28.1	15.2	16.2	29.4	14.2	46.8	26.7	10.9	17.4	36.2	16.0	19.7	42.9	5.9	21.6	13.6	14.7	30.0	33.9	21.1	15.2	26.2	22.1	9.5	32.6	6.7	13.1	13.7	14.9	8.3	13.0	20.1	12.8	16.1	13.4	6.8	34.7	35.3
ZDHHC9	"CGI-89, CXorf11, DHHC9, ZDHHC10, ZNF379, ZNF380"	ENSG00000188706	"Zinc finger DHHC-type palmitoyltransferase 9"	Q9Y397	X	129803288-129843909	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"		"Acyltransferase, Transferase"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 66.0;Oligodendrocytes: 118.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031814	Uncertain		Supported	"Endoplasmic reticulum,Golgi apparatus,Cytosol"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 45: Intestine - Brush border"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Endoplasmic reticulum, Golgi apparatus"	Cytosol	"HPA031814: AB_10610700"	"prognostic unfavorable (9.77e-5)"	"prognostic unfavorable (4.64e-5)"	"unprognostic (2.83e-2)"	"unprognostic (7.53e-3)"	"unprognostic (2.68e-1)"	"prognostic unfavorable (2.45e-4)"	"unprognostic (4.01e-3)"	"unprognostic (1.02e-1)"	"unprognostic (4.04e-1)"	"unprognostic (3.49e-2)"	"unprognostic (9.70e-3)"	"unprognostic (4.76e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.05e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.17e-2)"	"unprognostic (4.11e-2)"	28.2	12.0	39.2	10.2	66.6	5.4	24.3	46.5	52.5	19.1	23.3	22.0	31.6	11.8	11.7	15.6	12.1	15.3	15.5	39.2	49.0	37.1	40.1	26.7	3.3	60.5	58.2	11.2	25.9	25.2	11.4	17.2	52.5	18.8	24.9	6.0	21.1	11.3	13.4	35.3	34.0	15.3	44.8	3.9	19.5	4.1	57.8	3.6	13.8	11.3	6.6	23.8	14.5	78.6	45.9	23.8	33.2	67.5	112.4	87.7	27.0	44.3	50.6	20.9	26.0	37.6	58.4	1.6	73.7	47.6	54.0	30.4	38.0	44.6	30.0	2.6	23.7	9.2	24.0	50.1	44.4	6.1	15.7	96.0	71.1	34.0	50.1	36.5	39.9	15.0	10.1	17.6	34.0	40.0	8.8	11.4	18.0	102.3	40.4	8.2	21.4	27.1	30.1	25.2	26.3	22.0	12.7	64.7	20.5	38.9	27.6	10.1	32.8	21.1	7.3	50.0	36.3	16.5	12.7	5.5	37.9	25.1	10.8	0.0	2.2	1.8	3.0	2.0	3.7	2.7	3.6	2.9	2.4	1.5	4.5	2.6	0.0	2.5	5.2	5.1	1.8	2.1	39.2	66.6	46.5	52.5	39.2	49.0	60.5	58.2	52.5	44.8	57.8	78.6	66.0	22.4	28.6	4.6	2.8	18.6	12.4	12.8	13.1	9.1	16.8	15.1	4.6	17.2	15.9	46.0	2.1	5.6	2.7	20.1	3.9	18.6	1.8	23.8	16.9	16.6	18.0	4.2	10.5	19.8	19.1	32.7	18.3	59.7	2.5	11.5	7.9	43.7	4.9	1.7	11.8	23.2	10.2	3.5	12.2	2.0	12.2	3.9	10.6	7.5	0.3	1.5	1.0	9.5	118.2	33.5	14.6	7.5	7.7	39.1	51.0	25.8	7.2	2.8	0.0	9.5	11.1	8.4	8.7	16.9	19.2	10.3	5.1	7.5	27.2	22.1
ZEB1	"AREB6, BZP, FECD6, NIL-2-A, PPCD3, TCF8, ZEB, Zfhep, Zfhx1a"	ENSG00000148516	"Zinc finger E-box binding homeobox 1"	P37275	10	31318495-31529814	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"	"Corneal dystrophy, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 287.8;Excitatory neurons: 276.1;Inhibitory neurons: 261.9;Microglial cells: 479.7;Oligodendrocyte precursor cells: 968.6"	"Cancer enhanced"	"Detected in all"		"glioma: 15.4"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 113.1;TIME: 87.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027524, CAB058686, CAB079943"	Enhanced		Supported	Nucleoplasm,Nucleoli		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 68: Oligodendrocytes - Mixed function"	Nucleoplasm	Nucleoli	"CAB058686: AB_2665569, CAB079943: , HPA027524: AB_1844977"	"unprognostic (1.54e-1)"	"unprognostic (3.08e-1)"	"unprognostic (3.42e-2)"	"unprognostic (1.04e-1)"	"unprognostic (4.85e-2)"	"unprognostic (7.40e-2)"	"unprognostic (1.34e-2)"	"unprognostic (5.59e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.96e-2)"	"unprognostic (3.48e-1)"	"unprognostic (2.15e-1)"	"prognostic unfavorable (7.34e-6)"	"unprognostic (5.59e-3)"	"unprognostic (1.19e-1)"	"unprognostic (1.62e-2)"	"unprognostic (1.66e-2)"	26.6	8.6	16.4	12.9	16.2	8.6	16.8	14.0	20.1	33.2	9.9	49.2	6.0	38.7	13.4	11.7	18.6	20.0	34.8	15.2	22.8	7.5	10.4	16.0	9.6	21.1	19.2	9.3	3.8	3.4	7.9	17.5	21.2	14.5	12.3	14.8	8.0	26.9	54.4	7.0	11.8	39.9	16.8	8.1	18.1	10.1	18.2	29.9	11.2	60.5	9.7	24.4	16.4	18.5	0.1	11.1	35.1	43.9	58.4	113.1	0.0	32.7	44.9	6.6	9.3	0.2	0.1	11.3	15.6	39.6	9.3	0.0	14.9	0.0	11.8	19.1	7.9	0.0	7.0	6.3	44.4	9.8	0.3	53.4	0.1	19.6	17.6	21.4	54.9	9.5	7.5	14.4	42.7	0.1	33.7	6.2	2.3	0.0	6.6	11.6	66.0	5.1	12.9	0.0	0.9	15.6	11.1	0.0	0.0	7.2	0.0	6.7	87.7	40.8	9.4	10.0	16.7	9.1	6.3	12.8	10.9	0.0	4.2	4.9	0.0	5.4	2.4	0.0	3.2	4.1	3.2	1.7	1.3	3.1	6.8	3.5	8.5	6.6	0.0	3.1	5.0	1.6	16.4	16.2	14.0	20.1	15.2	22.8	21.1	19.2	21.2	16.8	18.2	18.5	104.4	0.0	7.7	212.9	34.6	11.2	3.0	2.0	0.6	42.7	1.4	2.8	106.3	1.5	3.6	1.8	45.9	0.3	22.0	0.0	0.0	2.1	110.1	7.2	287.8	110.6	0.0	12.2	276.1	2.7	0.5	66.1	2.0	6.5	1.3	17.0	49.6	13.4	1.2	10.1	261.9	0.0	0.0	3.8	25.6	141.8	30.7	6.3	26.6	479.7	10.7	7.2	7.2	968.6	7.3	2.5	0.0	102.0	33.2	3.7	0.0	1.6	1.5	43.4	78.9	99.2	74.2	17.4	15.7	1.1	8.7	0.7	36.2	12.0	0.0	3.8
ZEB2	"KIAA0569, SIP-1, SIP1, ZFHX1B"	ENSG00000169554	"Zinc finger E-box binding homeobox 2"	O60315	2	144364364-144521057	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"	"Disease variant, Epilepsy, Hirschsprung disease, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 363.7"	"Cell type enhanced"	"Detected in many"		"Horizontal cells: 662.9;Inhibitory neurons: 539.3;Oligodendrocytes: 1489.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEL: 154.0;THP-1: 181.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003456	Approved		Supported	Nucleoplasm,Nucleoli,Cytosol		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 41: Macrophages - Immune response"	Nucleoli	"Nucleoplasm, Cytosol"	"HPA003456: AB_10603840"	"unprognostic (1.02e-1)"	"unprognostic (2.08e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.42e-1)"	"unprognostic (4.12e-1)"	"unprognostic (4.17e-2)"	"unprognostic (3.69e-1)"	"unprognostic (3.77e-2)"	"unprognostic (5.83e-2)"	"unprognostic (7.90e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.62e-1)"	"prognostic unfavorable (6.04e-5)"	"unprognostic (1.11e-2)"	"unprognostic (1.73e-2)"	"unprognostic (7.45e-2)"	"unprognostic (1.32e-2)"	61.3	45.2	185.6	56.8	258.3	127.5	29.5	138.3	165.5	52.4	3.0	24.5	21.9	29.6	9.6	27.9	20.3	43.9	45.7	132.5	155.4	18.2	23.3	41.2	43.2	238.3	214.5	70.5	5.7	6.7	3.3	62.1	222.8	18.5	29.9	35.5	9.6	22.7	20.8	12.8	25.9	33.3	183.2	69.4	18.0	16.2	249.6	10.6	13.3	18.8	24.2	46.6	24.1	363.7	1.6	2.0	83.4	0.1	98.9	49.7	0.3	35.1	35.1	38.5	37.1	0.0	0.8	6.6	0.1	37.4	10.6	0.4	14.5	0.1	47.6	37.6	11.2	154.0	6.3	0.2	23.0	26.4	113.2	42.1	0.9	48.9	22.9	33.7	29.4	0.0	43.0	4.1	45.2	0.2	0.4	79.9	12.3	0.0	1.9	44.1	63.5	0.2	0.4	0.6	0.7	22.1	4.2	0.2	97.3	27.5	0.2	181.4	45.9	42.9	0.7	87.5	11.0	47.1	0.3	7.5	66.7	78.4	122.6	27.8	47.7	12.2	21.0	42.6	1.9	9.2	2.7	10.7	27.0	9.4	1.9	7.7	15.2	7.3	43.9	21.5	0.6	19.0	185.6	258.3	138.3	165.5	132.5	155.4	238.3	214.5	222.8	183.2	249.6	363.7	32.6	6.4	19.2	121.8	92.4	24.9	1.2	0.6	3.4	158.6	2.2	4.3	71.0	1.5	10.1	5.5	4.2	1.7	426.2	0.1	1.9	0.7	2.2	2.1	84.7	29.2	0.0	127.0	228.2	0.8	2.0	123.0	13.3	2.5	157.5	99.3	79.2	4.6	144.5	662.9	539.3	0.0	0.0	435.0	276.3	7.2	120.5	435.0	103.2	343.8	233.6	69.3	223.5	381.0	1489.6	0.2	1.1	66.5	132.3	1.8	0.0	10.3	4.0	11.9	184.1	185.0	198.7	2.9	11.3	3.4	19.6	4.7	136.7	108.8	0.4	2.2
ZFHX3	"ATBF1, C16orf47, FLJ26184, ZNF927"	ENSG00000140836	"Zinc finger homeobox 3"	Q15911	16	72782885-73891871	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Myogenesis, Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	47	"brain: 501.8"	"Cell type enhanced"	"Detected in all"		"Microglial cells: 285.8;Smooth muscle cells: 177.3"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	7	"cerebral cortex: 501.8"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA059353	Uncertain		Supported	Nucleoplasm		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 20: HeLa - Mitochondria"	"Cluster 48: Smooth muscle cells - ECM organization"	Nucleoplasm		"HPA059353: AB_2683987"	"prognostic unfavorable (1.55e-4)"	"unprognostic (3.57e-2)"	"unprognostic (1.68e-1)"	"unprognostic (2.03e-2)"	"unprognostic (2.81e-2)"	"unprognostic (3.12e-1)"	"unprognostic (4.24e-2)"	"unprognostic (6.36e-2)"	"unprognostic (9.94e-3)"	"unprognostic (2.85e-1)"	"unprognostic (1.06e-1)"	"unprognostic (4.16e-2)"	"prognostic favorable (1.37e-5)"	"unprognostic (6.76e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.11e-1)"	"unprognostic (2.15e-2)"	6.0	4.3	5.9	1.9	5.8	0.9	3.6	2.8	501.8	5.2	7.1	6.0	1.5	4.7	4.0	2.0	3.6	4.2	3.5	68.3	12.1	3.2	3.1	4.3	1.2	72.3	13.7	2.8	4.0	9.7	3.9	6.2	49.5	6.9	2.6	4.5	4.0	6.4	9.9	2.6	2.6	4.1	11.3	3.1	3.6	1.8	12.5	1.3	7.4	10.7	0.7	6.8	3.5	56.5	5.0	9.2	14.7	12.3	5.3	6.7	15.1	3.9	4.3	2.5	2.8	10.6	2.9	2.3	5.5	7.5	3.4	3.5	9.4	4.7	3.4	9.3	2.3	0.4	13.1	15.1	4.9	1.6	3.5	2.5	2.8	7.3	6.5	2.3	4.7	1.0	1.1	0.6	6.3	10.9	0.5	3.1	2.4	2.7	1.5	7.0	4.0	0.8	4.0	8.8	10.9	3.9	6.9	2.1	4.8	6.7	3.0	0.7	10.3	6.0	7.0	6.5	4.9	4.7	1.7	1.6	2.9	1.4	4.7	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.4	0.2	0.2	0.0	0.0	5.9	5.8	2.8	501.8	68.3	12.1	72.3	13.7	49.5	11.3	12.5	56.5	13.6	70.5	26.7	109.7	8.6	17.0	55.6	13.1	37.0	122.0	24.5	20.6	23.7	47.1	34.8	47.8	22.9	47.4	5.2	11.0	5.9	23.0	2.6	94.6	33.1	40.3	26.9	7.4	22.0	23.4	19.4	68.8	25.5	154.6	21.0	20.7	44.6	37.5	67.0	23.5	8.7	23.2	22.4	84.2	142.6	2.8	10.5	72.9	21.4	285.8	40.8	13.9	3.1	83.9	18.5	20.7	22.4	19.9	2.2	77.5	6.9	7.4	29.3	34.1	124.9	153.7	177.3	3.7	16.8	29.5	17.2	62.1	7.7	12.4	31.0	43.8
ZFP91	"PZF, ZNF757"	ENSG00000186660	"ZFP91 zinc finger protein, atypical E3 ubiquitin ligase"	Q96JP5	11	58579063-58621550	"Enzymes, Predicted intracellular proteins, Transcription factors"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 243.7;Late spermatids: 179.3;Spermatocytes: 140.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA024037, CAB025417, HPA065325"	Approved		Supported	Nucleoplasm,Nucleoli		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 18: U-2197 - ECM organization"	"Cluster 10: Non-specific - Unknown function"	"Nucleoplasm, Nucleoli"		"CAB025417: , HPA024037: AB_1859051, HPA065325: AB_2685468"	"unprognostic (6.10e-2)"	"unprognostic (5.01e-2)"	"unprognostic (3.33e-3)"	"unprognostic (9.19e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.33e-1)"	"unprognostic (2.33e-2)"	"unprognostic (3.37e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.36e-2)"	"prognostic unfavorable (3.74e-6)"	"unprognostic (3.16e-1)"	"unprognostic (1.75e-3)"	"unprognostic (3.12e-2)"	"unprognostic (2.61e-1)"	"unprognostic (2.23e-1)"	"unprognostic (2.00e-3)"	25.0	22.0	27.8	23.0	32.3	59.2	21.9	28.0	33.4	22.0	16.0	28.9	25.9	22.4	17.6	24.4	19.9	21.5	29.8	22.9	26.9	25.1	30.7	21.3	24.8	26.5	28.8	20.2	22.8	29.8	15.3	20.3	27.1	19.3	33.5	29.8	20.2	22.6	53.2	25.7	29.0	24.4	28.8	24.3	21.1	86.4	28.4	36.7	25.9	45.3	26.2	27.5	20.4	32.8	65.4	36.3	42.0	43.3	39.6	47.5	23.1	52.3	98.3	59.6	50.7	19.9	67.1	77.5	50.6	66.9	59.4	56.7	43.2	56.0	77.9	41.3	24.3	51.2	36.5	21.9	44.9	65.3	80.9	41.8	53.8	83.9	97.3	49.4	60.0	51.5	51.4	71.4	77.7	21.7	56.8	36.1	22.2	37.6	35.4	43.4	71.0	51.8	43.8	60.9	45.1	35.9	67.2	61.0	86.8	22.7	68.2	48.5	67.8	74.8	51.4	114.0	59.3	41.0	32.3	62.9	66.2	36.1	78.1	1.3	1.4	1.0	1.5	1.2	0.8	1.3	0.9	0.9	1.4	1.1	0.9	1.2	1.5	1.0	1.3	2.0	0.8	0.8	27.8	32.3	28.0	33.4	22.9	26.9	26.5	28.8	27.1	28.8	28.4	32.8	24.6	25.6	33.6	0.0	29.1	60.2	26.1	20.6	44.3	31.9	25.4	17.9	45.7	38.6	20.6	18.4	16.7	12.1	31.7	46.2	13.7	23.7	243.7	30.1	33.7	28.8	25.2	46.7	0.0	31.2	11.4	31.3	23.9	40.9	50.6	32.5	27.5	51.3	16.6	35.3	0.0	27.6	12.2	45.3	55.9	179.3	30.7	36.5	23.2	0.0	36.4	21.1	25.7	0.0	0.0	29.5	18.6	27.1	26.2	35.0	34.6	26.7	24.2	22.4	19.7	34.7	27.6	140.9	41.1	53.7	66.5	13.8	24.2	17.9	39.1	43.4
ZFPM2	"FOG2, hFOG-2, ZC2HC11B, ZNF89B"	ENSG00000169946	"Zinc finger protein, FOG family member 2"	Q8WW38	8	104590733-105804539	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Gonadal differentiation, Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"	"Cardiomyopathy, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 64.2;ovary: 33.3"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 115.2;Excitatory neurons: 524.4;Inhibitory neurons: 159.8;Microglial cells: 152.7;Oligodendrocyte precursor cells: 689.7"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"cerebellum: 64.2"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 6.4;BJ hTERT+: 14.2;HHSteC: 9.9;hTEC/SVTERT24-B: 5.7;HUVEC TERT2: 10.9;K-562: 6.0;TIME: 6.5"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"cerebellum: 39.4"	HPA004094	Approved		Supported	Nucleoplasm		NA	NA				"Cluster 21: Non-specific - Transcription"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Nucleoplasm		"HPA004094: AB_1859058"	"unprognostic (4.48e-2)"	"unprognostic (3.24e-2)"	"unprognostic (7.77e-3)"	"unprognostic (1.36e-2)"	"unprognostic (3.51e-1)"	"unprognostic (1.53e-1)"	"unprognostic (8.37e-2)"	"unprognostic (8.35e-3)"	"unprognostic (1.97e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.97e-1)"	"unprognostic (5.74e-2)"	"unprognostic (1.69e-6)"	"unprognostic (4.10e-3)"	"unprognostic (5.41e-2)"	"unprognostic (1.63e-4)"	"unprognostic (2.61e-2)"	12.2	2.8	7.4	1.5	3.1	0.0	4.5	64.2	12.7	6.5	0.0	4.3	0.5	10.7	2.3	4.5	12.3	5.8	10.2	16.4	3.5	1.1	2.7	3.8	2.7	11.9	5.7	33.3	0.7	0.4	1.1	4.2	12.3	0.9	2.1	1.1	1.0	1.9	18.0	1.6	1.9	17.8	0.2	2.9	2.8	4.3	6.3	1.3	6.8	17.2	1.5	7.0	4.9	3.4	0.0	0.0	6.4	0.0	5.4	1.7	0.0	0.5	14.2	0.0	0.1	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.2	0.0	0.0	4.9	1.6	0.0	0.0	9.9	0.0	0.0	0.5	0.0	5.7	0.0	1.9	10.9	0.0	6.0	0.0	1.3	0.0	1.4	0.0	0.1	0.0	1.5	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.4	4.3	0.0	6.5	0.3	0.9	0.0	0.0	1.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.4	3.1	64.2	12.7	16.4	3.5	11.9	5.7	12.3	0.2	6.3	3.4	10.0	0.0	0.6	115.2	0.1	3.6	0.3	0.0	0.6	2.9	0.1	0.3	21.3	0.0	1.3	0.0	0.0	0.1	0.0	0.2	0.0	0.0	55.2	0.6	9.8	7.9	0.0	0.0	524.4	0.0	0.1	17.1	1.1	1.5	0.0	24.6	7.1	0.0	0.3	8.4	159.8	0.2	0.0	0.0	1.7	34.0	23.9	0.3	1.8	152.7	0.6	0.1	0.0	689.7	10.0	0.1	0.0	13.5	0.0	0.6	0.0	0.0	0.0	0.7	6.6	22.5	8.1	0.9	2.2	0.1	2.8	0.4	0.2	1.4	0.2	0.4
ZFYVE1	"DFCP1, KIAA1589, PPP1R172, TAFF1, ZNFN2A1"	ENSG00000165861	"Zinc finger FYVE-type containing 1"	Q9HBF4	14	72969451-73027131	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 45.8;Late spermatids: 108.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002898	Approved		Supported	"Endoplasmic reticulum"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 25: Spermatids - Spermatogenesis"	"Endoplasmic reticulum"		"HPA002898: AB_1080653"	"unprognostic (2.19e-1)"	"unprognostic (1.50e-1)"	"unprognostic (4.65e-2)"	"unprognostic (1.23e-1)"	"unprognostic (3.47e-1)"	"unprognostic (2.40e-2)"	"unprognostic (7.42e-3)"	"unprognostic (6.82e-2)"	"unprognostic (1.05e-2)"	"unprognostic (2.40e-2)"	"unprognostic (1.83e-2)"	"unprognostic (1.53e-1)"	"prognostic favorable (5.07e-12)"	"unprognostic (4.03e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.95e-1)"	"unprognostic (7.48e-2)"	11.8	13.5	9.8	5.8	11.3	12.3	9.3	9.8	9.6	8.6	7.4	11.1	9.3	9.1	5.7	13.2	7.2	8.1	9.4	9.4	10.9	12.1	11.2	8.2	7.1	11.3	10.8	9.6	7.7	11.1	6.4	9.4	11.1	7.7	6.6	9.1	8.3	7.1	16.3	13.2	9.1	9.4	10.1	8.2	7.7	16.9	11.2	8.1	12.5	13.7	7.3	9.2	9.3	10.9	8.0	11.3	10.6	10.3	26.9	18.5	7.2	11.5	17.9	12.4	19.5	7.8	6.9	4.2	8.6	14.7	14.6	5.7	7.5	7.1	12.7	16.6	4.2	5.2	5.3	5.5	23.0	1.9	18.7	24.3	18.6	12.2	10.2	18.7	19.7	11.3	4.8	10.8	16.3	9.5	8.3	5.9	5.0	6.4	10.3	11.7	7.4	5.2	11.2	8.3	5.7	9.9	10.4	10.5	12.0	14.6	14.3	7.1	22.0	22.7	9.3	6.4	3.9	15.7	16.9	5.9	12.4	4.2	10.7	2.2	7.0	9.6	6.7	6.3	4.6	3.0	3.4	4.6	6.1	3.0	3.6	4.5	10.9	3.7	5.9	3.5	5.7	5.5	9.8	11.3	9.8	9.6	9.4	10.9	11.3	10.8	11.1	10.1	11.2	10.9	5.6	12.8	5.5	10.1	5.1	6.5	1.8	3.6	8.0	6.2	6.8	4.1	7.8	1.5	3.7	9.2	4.2	3.7	6.8	10.2	1.9	6.4	45.8	6.5	6.3	6.3	7.2	23.1	14.8	5.3	4.4	6.3	7.7	7.0	8.2	9.7	7.1	8.6	5.5	16.8	14.3	7.6	4.1	7.1	3.3	108.9	8.7	7.1	12.4	10.3	6.6	7.6	6.2	13.0	20.6	6.1	9.7	9.1	6.9	3.3	13.1	8.3	3.5	5.4	0.0	5.5	7.6	5.5	3.6	9.0	5.4	9.3	6.4	7.5	4.5	6.2
ZGPAT	"dJ583P15.3, FLJ14972, GPATC6, GPATCH6, KIAA1847, MGC44880, ZC3H9, ZC3HDC9, ZIP"	ENSG00000197114	"Zinc finger CCCH-type and G-patch domain containing"	Q8N5A5	20	63707465-63736142	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	6	"liver: 123.5"	"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 14.2;Gastric mucus-secreting cells: 13.7;Plasma cells: 26.9;Squamous epithelial cells: 11.1;T-cells: 8.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA056705			Supported	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 85: Liver - Metabolism"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 59: Non-specific - Transcription"	"Nucleoplasm, Plasma membrane"		"HPA056705: AB_2683213"	"unprognostic (4.50e-2)"	"unprognostic (2.74e-1)"	"unprognostic (5.30e-2)"	"unprognostic (4.42e-2)"	"unprognostic (8.58e-2)"	"prognostic favorable (6.17e-5)"	"unprognostic (1.06e-1)"	"unprognostic (6.97e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.54e-1)"	"unprognostic (9.31e-3)"	"unprognostic (1.60e-2)"	"unprognostic (3.43e-3)"	"unprognostic (1.37e-1)"	"unprognostic (4.11e-2)"	"unprognostic (1.24e-1)"	"unprognostic (9.86e-3)"	14.5	17.0	5.3	8.8	5.8	14.8	14.6	5.4	8.9	15.7	7.5	18.0	10.0	16.1	3.4	16.6	14.2	5.5	16.0	5.6	4.7	22.2	123.5	13.0	11.5	7.6	5.4	11.9	14.0	8.4	14.4	6.5	5.9	14.9	3.0	1.4	13.7	6.7	16.7	19.0	14.8	4.9	4.1	20.3	15.3	20.2	5.7	9.5	13.8	4.3	4.1	15.9	15.0	7.4	15.3	19.3	7.4	12.0	6.0	4.2	17.1	15.5	10.1	24.0	10.0	41.6	20.4	15.6	28.9	8.8	23.3	27.4	5.0	18.3	3.0	10.7	13.3	14.8	16.9	43.3	11.7	9.4	25.2	10.7	15.3	9.9	3.9	6.5	13.2	18.5	16.5	13.9	8.0	15.3	22.6	22.1	12.1	22.3	24.0	23.9	5.7	15.7	13.5	14.0	14.0	17.4	22.1	24.7	14.2	3.7	16.9	26.0	15.2	37.2	13.3	14.3	20.1	13.9	24.3	22.2	23.5	9.3	17.0	8.6	21.0	26.5	28.3	21.5	28.1	19.2	24.6	26.3	19.7	16.2	23.9	24.7	21.8	26.4	18.4	28.2	26.2	18.6	5.3	5.8	5.4	8.9	5.6	4.7	7.6	5.4	5.9	4.1	5.7	7.4	0.3	3.2	3.4	4.6	8.0	0.0	0.0	0.1	14.2	1.0	0.2	0.3	0.3	0.0	1.3	0.0	0.0	0.2	0.7	0.4	0.0	0.1	0.1	0.4	1.1	2.1	1.8	6.3	7.4	0.2	0.3	3.3	13.7	0.6	2.5	0.5	0.4	2.3	0.2	0.0	5.8	0.2	0.0	1.3	0.0	0.0	0.0	5.4	1.8	8.4	0.0	0.2	0.0	5.5	4.6	0.4	0.1	0.0	26.9	0.2	0.3	0.5	0.1	1.1	0.0	0.5	1.4	0.3	0.1	11.1	0.3	0.3	8.9	0.5	0.2	0.1
ZHX1		ENSG00000165156	"Zinc fingers and homeoboxes 1"	Q9UKY1	8	123248451-123275541	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Horizontal cells: 146.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA055357			Supported	Nucleoplasm		No	No			"Cluster 27: Non-specific - Gene expression"	"Cluster 15: Liver - Metabolism"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 62: Horizontal cells - Visual perception"	Nucleoplasm		"HPA055357: AB_2682793"	"unprognostic (4.36e-3)"	"unprognostic (6.73e-2)"	"unprognostic (1.38e-1)"	"prognostic unfavorable (6.09e-4)"	"unprognostic (8.73e-3)"	"unprognostic (5.61e-2)"	"unprognostic (9.22e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.01e-1)"	"unprognostic (6.00e-2)"	"unprognostic (7.97e-2)"	"unprognostic (1.44e-1)"	"unprognostic (2.07e-2)"	"unprognostic (6.63e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.30e-2)"	"unprognostic (1.76e-2)"	28.2	14.8	24.5	12.1	24.3	13.5	18.7	27.0	28.1	20.8	21.3	15.6	18.4	17.4	15.2	37.0	18.5	15.1	15.2	23.3	31.9	22.9	39.5	14.4	12.6	25.4	27.7	20.8	17.2	22.8	12.7	14.3	26.5	17.9	14.8	35.0	17.4	18.6	15.5	27.8	19.3	19.2	23.1	15.8	14.8	10.1	24.1	19.8	37.7	19.4	15.0	19.8	17.9	29.4	29.7	13.2	18.0	21.3	34.3	28.3	11.6	35.3	19.6	25.6	29.6	23.5	12.4	44.7	46.1	42.8	11.4	19.6	51.3	32.5	32.4	89.5	26.5	72.6	29.1	14.2	23.3	26.9	33.3	21.4	36.9	35.1	30.0	21.9	20.5	21.2	86.0	34.1	38.3	89.7	62.0	12.1	4.8	62.1	27.7	31.3	16.2	32.0	22.9	66.0	86.3	32.1	40.3	113.6	14.1	10.5	45.4	30.6	19.3	40.1	53.4	32.6	23.8	32.1	95.1	49.6	27.2	49.7	11.2	1.5	3.6	3.6	3.8	6.4	4.8	3.3	4.8	3.5	4.9	3.9	4.5	4.8	1.3	6.5	14.0	2.7	5.7	2.9	24.5	24.3	27.0	28.1	23.3	31.9	25.4	27.7	26.5	23.1	24.1	29.4	35.0	25.6	25.7	0.0	15.7	37.1	28.0	19.7	47.3	46.3	28.8	27.1	30.7	25.8	26.8	20.2	47.9	10.4	22.8	33.5	31.3	16.6	10.9	13.0	52.5	30.8	43.3	19.8	0.0	22.3	6.6	33.0	19.4	13.8	28.5	19.1	28.9	71.5	15.0	146.4	0.0	23.1	14.2	24.2	19.0	21.7	46.6	19.4	26.6	0.0	20.5	46.3	27.8	0.0	0.0	16.7	25.8	64.3	15.3	21.2	35.8	33.2	21.4	34.3	39.5	34.4	38.0	38.5	27.6	84.4	62.5	9.6	20.0	27.0	22.8	29.2
ZHX3	"KIAA0395, TIX1"	ENSG00000174306	"Zinc fingers and homeoboxes 3"	Q9H4I2	20	41178448-41317672	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 370.5;Early spermatids: 106.3;Excitatory neurons: 99.0;Inhibitory neurons: 96.5;Oligodendrocyte precursor cells: 139.7;Oligodendrocytes: 142.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046498			Supported	Nucleoplasm		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 64: Astrocytes - Nervous system maintenance"	Nucleoplasm		"HPA046498: AB_2679676"	"unprognostic (6.26e-2)"	"unprognostic (1.41e-2)"	"unprognostic (2.10e-1)"	"prognostic unfavorable (1.62e-4)"	"unprognostic (3.40e-2)"	"unprognostic (4.50e-2)"	"unprognostic (2.29e-1)"	"unprognostic (3.88e-1)"	"unprognostic (3.42e-1)"	"unprognostic (7.25e-3)"	"unprognostic (1.50e-2)"	"unprognostic (1.06e-1)"	"prognostic favorable (2.53e-5)"	"unprognostic (3.06e-1)"	"unprognostic (2.74e-1)"	"prognostic unfavorable (7.52e-4)"	"prognostic unfavorable (1.84e-5)"	14.4	15.4	33.8	6.5	32.8	3.4	13.3	31.6	27.4	11.6	16.4	19.8	8.6	15.8	5.7	13.6	15.7	8.4	12.2	30.2	27.7	26.4	17.2	11.6	4.5	37.6	32.1	16.3	11.9	15.4	7.8	4.9	29.9	10.6	8.0	10.8	5.7	11.9	28.5	11.0	11.4	12.1	29.4	4.3	15.5	35.0	36.0	7.0	19.0	20.1	4.8	18.1	11.0	28.6	22.5	6.3	6.6	14.2	52.6	56.3	7.6	31.0	35.4	28.3	19.1	11.4	2.9	15.6	14.7	58.5	7.6	7.0	7.9	39.2	30.0	4.3	7.1	6.6	8.6	8.8	21.6	7.6	7.9	34.6	18.7	21.3	27.3	19.2	12.3	11.7	6.2	10.6	38.3	45.0	11.9	4.5	2.9	10.4	23.0	5.8	18.6	6.2	38.6	6.7	23.0	8.3	20.7	12.0	7.4	5.7	11.6	10.5	19.9	70.2	10.8	25.0	15.5	12.2	8.0	6.9	28.9	11.0	11.4	0.1	0.1	0.4	0.2	0.1	0.4	0.6	0.2	0.1	0.2	0.6	0.4	0.3	0.1	0.6	0.2	0.1	0.2	0.1	33.8	32.8	31.6	27.4	30.2	27.7	37.6	32.1	29.9	29.4	36.0	28.6	29.8	19.2	16.4	370.5	4.7	2.9	3.9	2.6	2.8	19.5	6.3	4.7	12.7	17.2	5.8	22.0	4.2	0.6	3.8	5.5	11.7	3.7	106.3	12.3	33.2	15.1	14.9	3.8	99.0	2.7	2.7	20.5	6.6	26.3	1.3	3.7	16.4	31.6	3.0	40.4	96.5	5.6	4.1	3.5	1.7	32.3	18.6	3.5	1.8	52.5	1.9	28.6	1.0	139.7	142.4	4.6	1.3	24.5	2.7	2.6	12.6	27.0	3.2	7.1	26.3	41.2	10.9	11.0	5.2	6.3	3.7	0.4	2.7	19.7	4.7	2.3
ZIC1	"ZIC, ZNF201"	ENSG00000152977	"Zic family member 1"	Q15915	3	147393422-147510293	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"	"Craniosynostosis, Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	16	"brain: 616.8"	"Group enriched"	"Detected in some"	4	"Microglial cells: 25.3;Skeletal myocytes: 61.0"	"Cancer enhanced"	"Detected in many"		"glioma: 9.5"	"Region enriched"	"Detected in all"	5	"cerebellum: 616.8"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 174.0;MCF7: 43.9;U-2197: 28.5"	"Region enhanced"	"Detected in all"		"cerebellum: 207.4"	"Region enriched"	"Detected in all"	8	"cerebellum: 638.1"	HPA004098	Supported		Supported	Nucleoplasm		NA	NA				"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 12: NES - Nervous system development"	"Cluster 50: Fibroblasts - ECM organization"	Nucleoplasm		"HPA004098: AB_1859065"	"unprognostic (1.33e-2)"			"unprognostic (1.82e-1)"	"unprognostic (4.01e-2)"	"unprognostic (2.36e-1)"	"unprognostic (9.32e-2)"	"unprognostic (1.52e-2)"	"unprognostic (1.68e-2)"	"unprognostic (2.19e-1)"		"unprognostic (5.01e-1)"	"unprognostic (2.61e-7)"	"unprognostic (2.95e-3)"	"unprognostic (1.67e-2)"		"unprognostic (3.01e-1)"	3.4	0.7	25.0	0.0	50.7	0.0	0.2	616.8	30.3	0.0	39.0	0.1	0.2	0.0	1.8	0.2	0.0	0.1	0.1	13.6	39.5	0.1	12.8	0.1	0.1	66.8	55.3	0.2	0.1	0.0	2.4	0.0	67.3	0.0	0.1	10.7	0.5	0.0	6.9	2.5	0.8	0.0	23.8	0.0	0.2	0.3	112.1	0.0	0.0	0.8	0.0	0.0	0.0	44.8	0.0	0.0	174.0	0.0	17.9	19.6	9.8	11.4	13.5	12.1	9.9	0.0	0.0	0.0	9.1	0.9	9.2	0.0	0.1	0.0	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.8	0.0	0.4	0.0	0.7	0.0	0.0	3.1	0.0	10.9	43.9	0.0	0.0	0.5	0.9	0.0	0.0	17.1	0.0	0.0	0.0	0.0	8.1	0.0	0.0	10.7	0.0	0.0	0.0	0.0	17.9	0.0	28.5	11.0	0.0	0.0	0.0	13.5	0.0	8.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	25.0	50.7	616.8	30.3	13.6	39.5	66.8	55.3	67.3	23.8	112.1	44.8	0.2	0.0	0.0	8.5	0.0	0.1	0.0	0.0	0.0	0.3	0.9	0.3	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.1	0.8	0.0	0.0	0.0	0.0	0.0	5.5	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	1.5	0.1	0.0	25.3	0.0	4.3	0.0	2.0	9.5	0.0	0.1	1.5	0.0	0.0	0.0	0.0	0.0	1.6	0.0	61.0	0.3	0.4	0.4	0.0	0.0	0.0	0.1	0.0	0.1	0.0
ZIC2	HPE5	ENSG00000043355	"Zic family member 2"	O95409	13	99981784-99986765	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding, Repressor"	"Disease variant, Holoprosencephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	32	"brain: 123.4;choroid plexus: 35.2"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 28.1;Cone photoreceptor cells: 6.2;Microglial cells: 29.0;Muller glia cells: 10.3"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in all"	5	"cerebellum: 123.4"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 86.2;HDLM-2: 43.5;HEK 293: 66.1;NTERA-2: 80.5;SCLC-21H: 179.7"	"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in all"	5	"cerebellum: 113.3"	HPA055031			Supported	"Nuclear bodies"		NA	NA				"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 64: Astrocytes - Nervous system maintenance"	"Nuclear bodies"		"HPA055031: AB_2682676"	"unprognostic (6.43e-6)"	"prognostic favorable (2.64e-4)"	"unprognostic (5.73e-2)"	"unprognostic (1.99e-2)"	"unprognostic (4.39e-1)"	"unprognostic (3.12e-2)"	"prognostic unfavorable (2.91e-4)"	"unprognostic (4.66e-2)"	"unprognostic (3.10e-1)"	"unprognostic (1.59e-1)"	"unprognostic (9.36e-3)"	"unprognostic (7.42e-2)"	"unprognostic (0.00e+0)"	"unprognostic (3.26e-1)"	"unprognostic (2.11e-1)"		"unprognostic (5.36e-3)"	0.0	0.2	17.0	0.0	19.0	0.0	0.0	123.4	16.2	0.0	35.2	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	16.0	10.4	0.1	0.0	0.0	0.0	20.9	14.8	0.0	0.0	0.0	1.2	0.0	22.5	0.0	0.0	2.4	0.0	0.0	0.0	0.1	0.0	0.0	8.8	0.0	0.0	1.2	27.1	0.0	0.0	0.0	0.0	0.0	0.0	11.3	0.5	4.9	86.2	5.5	0.0	0.0	5.4	0.0	0.0	0.0	0.0	0.5	5.8	0.0	7.3	0.0	4.6	0.1	3.9	0.0	0.0	43.5	66.1	6.4	4.0	4.4	0.0	0.0	4.3	0.0	6.2	0.0	3.9	0.4	0.0	2.2	6.5	0.0	0.0	2.9	0.4	34.3	80.5	0.0	2.0	19.8	3.3	0.1	0.4	2.2	179.7	0.0	2.8	0.5	0.0	3.3	4.2	33.5	0.0	20.2	0.0	3.6	5.8	0.6	0.0	0.0	4.9	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.0	19.0	123.4	16.2	16.0	10.4	20.9	14.8	22.5	8.8	27.1	11.3	0.2	0.0	0.0	28.1	0.0	0.0	0.0	0.0	0.6	0.3	0.2	0.3	0.7	0.0	0.0	1.8	6.2	0.0	0.0	0.7	0.0	0.0	0.4	0.2	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	29.0	0.0	10.3	0.0	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.1	1.5	0.6	0.4	0.1	0.0	0.0	0.0	0.0	0.0
ZIC3	"HTX, HTX1, ZNF203"	ENSG00000156925	"Zic family member 3"	O60481	X	137566127-137577691	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"	"Disease variant, Heterotaxy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 13.8;choroid plexus: 4.0;retina: 2.7"	"Cell type enhanced"	"Detected in some"		"Microglial cells: 4.7;Muller glia cells: 9.6;Rod photoreceptor cells: 1.3;Spermatocytes: 2.0;Spermatogonia: 3.7"	"Cancer enriched"	"Detected in single"	14	"testis cancer: 5.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	35	"AF22: 38.8;NTERA-2: 42.8;SuSa: 24.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA052936, HPA069523"	Uncertain		Supported	Nucleoplasm		NA	NA				"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 12: NES - Nervous system development"	"Cluster 5: Muller glia cells - Visual perception"	Nucleoplasm		"HPA052936: AB_2681993, HPA069523: AB_2732136"					"unprognostic (3.55e-5)"					"unprognostic (3.82e-1)"		"unprognostic (1.95e-1)"			"unprognostic (3.31e-1)"			0.0	0.0	2.9	0.0	3.9	0.1	0.0	13.8	3.5	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	4.5	0.0	0.0	0.0	0.0	3.5	3.7	0.0	0.0	0.0	0.7	0.0	4.0	0.0	0.0	2.7	0.0	0.0	0.0	0.1	0.0	0.0	2.3	0.0	0.0	0.6	4.3	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	38.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.8	0.0	0.1	42.8	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	24.8	0.6	0.0	0.3	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	3.9	13.8	3.5	1.8	4.5	3.5	3.7	4.0	2.3	4.3	3.1	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	4.7	0.0	9.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.3	0.0	0.0	0.0	2.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ZKSCAN3	"ZF47, Zfp47, ZNF306, ZNF309, ZSCAN35"	ENSG00000189298	"Zinc finger with KRAB and SCAN domains 3"	Q9BRR0	6	28349947-28369172	"Predicted intracellular proteins, Transcription factors"	"Autophagy, Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 8.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											"HPA009637, HPA060116"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 43: Cardiomyocytes - Nuclear processes"	Nucleoplasm		"HPA009637: AB_2668244, HPA060116: AB_2732641"	"unprognostic (2.71e-2)"	"unprognostic (1.94e-1)"	"unprognostic (8.12e-2)"	"unprognostic (2.67e-1)"	"prognostic favorable (4.93e-4)"	"unprognostic (6.42e-2)"	"unprognostic (4.63e-3)"	"unprognostic (2.50e-2)"	"unprognostic (8.65e-2)"	"unprognostic (4.37e-3)"	"unprognostic (7.09e-3)"	"unprognostic (1.29e-1)"	"unprognostic (8.20e-2)"	"unprognostic (2.73e-1)"	"unprognostic (2.00e-1)"	"unprognostic (2.41e-2)"	"unprognostic (3.10e-3)"	2.2	2.6	1.5	2.1	1.7	1.1	3.9	3.0	2.3	3.9	2.5	3.4	2.2	3.5	4.5	2.4	3.6	1.9	2.4	1.8	1.6	3.3	2.8	3.1	3.0	1.7	1.6	5.6	2.3	4.7	2.6	4.0	1.8	4.1	3.9	3.8	2.4	4.3	2.5	3.8	2.3	4.7	1.3	3.4	4.1	2.4	1.9	4.3	4.3	2.5	3.9	2.8	2.7	2.6	3.0	1.8	6.9	12.4	6.2	4.3	2.5	2.6	2.8	4.4	5.8	2.4	1.7	4.6	6.0	2.8	4.7	4.1	7.6	3.4	4.4	4.3	3.2	6.1	4.9	3.9	4.3	6.0	1.9	3.8	3.0	4.8	4.1	5.2	7.0	5.8	15.7	2.9	5.3	0.9	3.1	5.9	3.1	1.7	1.8	8.7	5.4	6.7	4.6	2.1	5.5	6.1	4.6	2.4	4.1	8.9	3.5	6.1	4.2	4.6	3.0	3.0	3.4	3.8	6.2	4.2	1.5	7.9	3.2	1.9	1.2	5.1	2.2	2.1	2.3	2.2	1.5	1.7	1.7	2.1	1.4	2.3	1.4	1.6	1.3	2.0	2.2	1.1	1.5	1.7	3.0	2.3	1.8	1.6	1.7	1.6	1.8	1.3	1.9	2.6	1.7	0.0	3.4	4.9	1.2	0.5	0.5	0.8	1.2	1.5	1.9	1.8	2.1	0.0	0.5	3.7	8.4	2.6	0.8	1.0	0.0	1.3	0.6	1.3	2.3	3.0	0.0	3.8	6.6	1.0	1.9	1.7	0.5	1.4	2.5	3.5	3.9	2.3	2.0	0.0	7.2	1.5	4.1	3.8	1.0	2.9	2.8	1.1	0.0	1.9	2.7	2.4	2.1	5.0	4.6	1.6	0.5	1.5	0.7	0.6	1.7	1.9	3.5	2.3	0.0	2.1	1.8	0.9	1.1	1.8	0.3	1.0	2.0	2.7	2.6	0.4
ZKSCAN4	"FLJ32136, P1P373C6, p373c6.1, ZNF307, ZNF427, ZSCAN36"	ENSG00000187626	"Zinc finger with KRAB and SCAN domains 4"	Q969J2	6	28241697-28252269	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Spermatocytes: 27.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			HPA009637	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 71: Testis - DNA repair"	"Cluster 32: U-937 - Innate immune response"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm		"HPA009637: AB_2668244"	"unprognostic (4.29e-2)"	"unprognostic (2.88e-1)"	"unprognostic (1.04e-1)"	"unprognostic (5.01e-2)"	"unprognostic (4.23e-3)"	"unprognostic (3.77e-2)"	"prognostic unfavorable (1.90e-6)"	"prognostic favorable (5.04e-4)"	"unprognostic (8.73e-3)"	"unprognostic (1.80e-2)"	"unprognostic (7.20e-2)"	"unprognostic (5.13e-2)"	"unprognostic (2.13e-2)"	"unprognostic (1.62e-1)"	"unprognostic (6.07e-2)"	"unprognostic (9.70e-2)"	"unprognostic (7.36e-3)"	2.7	2.7	1.6	1.9	1.6	1.0	2.6	2.7	2.0	3.5	1.6	2.9	2.0	3.5	2.0	2.5	2.6	1.4	2.2	1.6	1.6	2.7	3.0	2.0	3.4	1.6	1.5	3.2	2.3	2.3	2.1	2.1	1.7	2.7	2.0	2.2	2.9	1.9	1.6	2.9	3.6	1.5	1.5	8.6	2.5	8.9	1.6	4.1	2.4	1.6	3.3	2.9	2.8	1.9	1.4	1.0	2.8	4.7	3.2	3.1	2.6	1.8	2.9	2.6	2.9	1.6	1.2	3.9	3.3	2.1	1.6	1.6	2.9	2.3	2.7	1.8	3.1	3.3	2.5	2.2	2.2	6.6	2.9	3.4	2.8	2.3	2.3	3.3	2.7	3.4	3.1	0.8	2.2	1.4	4.4	6.9	2.2	0.6	1.9	3.4	3.9	2.5	1.6	1.1	4.3	3.1	1.5	2.0	3.3	2.5	1.7	3.0	2.2	2.9	1.7	1.7	1.8	2.5	2.6	1.8	1.0	6.5	1.7	2.8	1.9	2.2	1.9	1.6	2.2	1.8	1.8	1.8	3.2	1.7	2.7	2.6	2.5	2.4	1.9	4.2	1.8	1.4	1.6	1.6	2.7	2.0	1.6	1.6	1.6	1.5	1.7	1.5	1.6	1.9	1.7	0.0	0.5	2.6	2.2	0.4	0.5	1.0	1.2	1.1	1.5	1.4	1.3	2.8	2.7	1.8	2.1	3.9	3.9	2.2	0.0	2.7	9.8	1.3	3.2	2.2	3.5	3.8	7.9	2.0	2.8	2.5	3.1	1.4	2.5	4.2	2.5	1.0	4.5	1.7	6.5	1.5	0.0	10.7	1.8	6.9	2.8	2.9	1.8	7.5	2.6	2.2	3.1	2.5	3.9	1.7	4.9	3.8	1.3	0.4	2.3	1.7	0.4	1.7	0.0	1.6	1.6	27.4	2.4	1.6	0.3	1.1	2.1	3.5	2.3	0.3
ZKSCAN7	"FLJ12738, ZNF167, ZNF448, ZNF64, ZSCAN39"	ENSG00000196345	"Zinc finger with KRAB and SCAN domains 7"	Q9P0L1	3	44555193-44594173	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 15.4;Late spermatids: 17.1;Oligodendrocyte precursor cells: 10.6;Spermatocytes: 10.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 4.0;NTERA-2: 3.1;SH-SY5Y: 4.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA048312, HPA049906, HPA071850"	Uncertain		Supported	"Nuclear speckles,Cytosol"		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 71: Testis - DNA repair"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 66: Spermatocytes - Spermatogenesis"	Cytosol	"Nuclear speckles"	"HPA048312: AB_2680352, HPA049906: AB_2680946, HPA071850: AB_2686458"	"unprognostic (3.31e-2)"	"unprognostic (4.49e-2)"	"unprognostic (7.25e-2)"	"unprognostic (5.78e-3)"	"unprognostic (3.41e-2)"	"unprognostic (1.21e-3)"	"unprognostic (2.18e-1)"	"unprognostic (2.31e-2)"	"unprognostic (3.45e-2)"	"unprognostic (1.06e-1)"	"unprognostic (4.22e-4)"	"unprognostic (5.91e-2)"	"unprognostic (1.18e-3)"	"unprognostic (2.83e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.54e-1)"	"unprognostic (7.17e-3)"	1.5	2.7	0.8	1.0	0.8	0.3	1.6	1.8	1.0	2.8	1.2	1.9	0.4	2.8	2.3	0.8	2.5	0.9	2.1	0.7	0.8	2.7	2.2	1.3	1.3	0.7	0.7	4.2	3.0	0.8	4.2	0.7	0.6	2.4	0.7	3.0	1.6	1.3	1.0	0.6	1.7	1.4	0.4	2.0	1.7	4.1	0.7	2.2	2.6	0.6	1.2	2.4	1.5	0.9	0.0	0.0	2.6	4.0	0.8	0.3	0.0	1.3	1.1	1.4	1.5	0.0	0.0	0.0	0.4	0.9	0.4	0.0	0.0	0.8	1.7	0.0	0.0	0.1	0.9	1.1	2.4	0.0	0.0	1.8	0.9	0.7	0.0	0.0	0.4	0.0	0.0	0.0	2.1	0.0	0.0	0.0	3.1	0.0	0.0	0.0	1.2	0.0	0.7	0.3	1.9	4.8	0.0	0.1	0.0	2.9	0.0	1.9	0.4	0.8	0.3	1.0	0.0	0.0	0.0	0.0	0.2	0.0	0.6	0.5	0.2	0.3	0.8	0.1	0.2	0.3	0.5	0.6	0.2	0.7	0.3	0.7	0.4	0.6	0.3	0.6	0.5	0.3	0.8	0.8	1.8	1.0	0.7	0.8	0.7	0.7	0.6	0.4	0.7	0.9	0.3	0.0	0.5	5.2	1.4	0.1	0.4	0.9	0.6	6.6	0.9	1.1	4.8	0.0	0.4	1.8	0.0	0.0	3.3	0.2	0.0	2.1	15.4	0.6	1.8	0.9	3.0	1.3	4.3	0.5	0.1	2.1	0.0	0.4	0.0	3.1	0.4	1.4	1.1	3.3	4.7	0.3	0.0	0.3	0.4	17.1	0.9	0.7	0.0	1.0	1.4	3.8	6.2	10.6	6.4	0.9	0.0	2.6	0.4	0.5	0.4	1.3	0.3	4.2	0.0	1.0	1.1	10.8	3.6	0.5	0.4	0.1	1.0	2.9	0.6	0.2
ZMAT3	"FLJ12296, MGC10613, PAG608, WIG-1, WIG1"	ENSG00000172667	"Zinc finger matrin-type 3"	Q9HA38	3	178960121-179072215	"Predicted intracellular proteins"	"Apoptosis, DNA damage, Growth regulation, Protein transport, Translocation, Transport"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Alveolar cells type 2: 105.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"HSkMC: 76.0;LHCN-M2: 87.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027569, HPA028671, HPA054356"	Enhanced		Supported	Nucleoplasm		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 65: Brain - Ion transport"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 11: Alveolar cells - Smell perception"	Nucleoplasm		"HPA027569: AB_2732438, HPA028671: AB_2672725, HPA054356: AB_2682460"	"unprognostic (3.53e-3)"	"unprognostic (1.76e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.88e-1)"	"unprognostic (4.81e-2)"	"unprognostic (3.57e-2)"	"unprognostic (1.45e-1)"	"unprognostic (4.37e-2)"	"unprognostic (6.88e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.85e-2)"	"unprognostic (7.09e-2)"	"unprognostic (2.51e-1)"	"unprognostic (3.91e-2)"	"unprognostic (1.46e-2)"	5.2	7.9	9.9	5.2	10.9	3.4	5.9	4.4	14.5	5.8	3.4	6.3	3.4	5.2	6.2	6.8	5.8	8.9	6.1	12.1	11.0	6.3	12.6	5.9	7.4	10.5	12.1	4.4	4.1	8.8	4.9	5.6	11.9	5.9	8.5	6.1	4.3	7.7	3.1	6.1	3.4	11.2	9.9	6.9	5.1	4.1	12.5	10.2	7.5	4.4	6.4	6.1	3.7	11.7	5.9	4.0	12.8	8.4	57.4	64.2	28.3	23.1	33.9	3.3	4.3	5.1	3.5	24.2	11.1	36.2	5.1	5.4	4.6	24.6	7.6	20.7	7.0	10.7	7.8	16.2	45.7	11.7	16.0	76.0	45.2	8.1	16.7	51.2	48.5	6.8	5.7	3.3	87.7	5.8	9.3	2.1	5.7	8.3	3.3	10.7	11.1	5.2	19.2	11.3	3.0	12.7	7.1	6.4	7.7	23.8	8.0	4.9	53.2	49.9	19.2	8.3	11.0	3.2	2.9	10.2	29.6	1.7	34.9	2.1	0.7	1.7	1.8	0.6	1.0	0.9	1.3	1.4	0.7	1.8	2.2	1.5	0.8	1.6	1.4	0.8	1.0	0.6	9.9	10.9	4.4	14.5	12.1	11.0	10.5	12.1	11.9	9.9	12.5	11.7	11.2	54.5	105.8	38.2	24.6	39.6	10.6	26.1	34.1	19.5	22.2	22.9	21.0	24.3	53.8	35.0	25.0	10.7	25.1	14.0	7.9	16.1	1.1	12.0	15.7	14.6	20.9	14.5	40.7	20.7	2.9	28.2	19.9	12.2	39.8	19.8	17.2	32.1	18.2	62.2	36.7	9.5	30.5	40.2	16.6	2.2	20.2	24.4	51.6	41.2	49.7	15.5	32.0	87.4	18.9	28.6	11.9	29.0	11.1	17.3	14.0	20.2	45.1	11.1	39.5	25.0	23.8	9.5	13.1	25.2	36.7	4.4	29.8	42.8	10.4	11.1
ZMAT5	"SNRNP20, ZC3H19"	ENSG00000100319	"Zinc finger matrin-type 5"	Q9UDW3	22	29730956-29767011	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004858	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"HPA004858: AB_1080657"	"unprognostic (2.14e-1)"	"unprognostic (8.03e-3)"	"unprognostic (1.23e-1)"	"unprognostic (1.19e-2)"	"unprognostic (1.02e-1)"	"unprognostic (5.47e-3)"	"unprognostic (6.04e-3)"	"unprognostic (5.69e-2)"	"unprognostic (5.75e-2)"	"unprognostic (3.71e-2)"	"unprognostic (2.04e-1)"	"unprognostic (2.15e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.52e-1)"	"unprognostic (2.65e-1)"	"unprognostic (2.62e-1)"	"unprognostic (4.10e-2)"	14.3	26.0	25.8	10.6	26.4	14.2	14.5	26.5	34.9	17.1	25.9	19.6	12.2	18.0	19.8	21.1	20.5	10.0	25.5	25.3	26.0	21.3	26.8	13.7	15.0	27.5	26.5	16.2	20.4	23.0	10.6	8.4	25.5	19.2	7.2	7.8	18.2	16.6	37.1	18.1	14.4	13.8	26.0	19.9	20.1	10.6	27.2	17.8	19.1	24.5	12.2	19.0	15.8	26.8	17.9	22.1	19.3	37.5	23.7	26.2	8.7	19.4	23.9	28.5	34.7	19.4	11.0	12.2	18.9	20.8	22.0	16.5	16.5	19.9	18.6	39.2	36.3	46.9	10.8	36.3	43.8	21.6	14.8	22.7	30.2	36.5	22.2	24.2	30.4	19.0	12.3	25.9	23.8	26.7	31.0	22.5	7.2	34.7	25.9	37.1	34.2	32.6	22.8	10.9	14.8	27.4	18.1	22.4	27.9	10.9	33.7	30.0	19.4	38.8	19.4	26.4	29.2	24.0	20.5	20.4	29.9	25.6	27.9	48.1	84.6	95.3	46.1	94.6	47.3	61.6	47.7	48.6	73.9	60.3	41.8	49.1	69.5	60.8	94.7	57.6	61.0	65.3	25.8	26.4	26.5	34.9	25.3	26.0	27.5	26.5	25.5	26.0	27.2	26.8	17.0	16.0	20.8	6.2	14.6	9.6	21.0	32.0	10.2	12.7	16.2	22.6	1.4	17.2	20.4	14.7	18.8	21.5	11.3	16.4	33.2	35.3	0.9	13.8	14.3	15.2	14.4	8.6	3.7	27.3	18.1	15.9	13.3	10.4	33.7	13.0	15.0	17.1	45.1	5.0	5.1	19.4	24.4	21.4	17.9	3.0	15.8	22.1	12.4	3.7	27.7	26.0	34.0	6.0	6.5	31.7	18.1	21.8	14.9	12.4	27.8	40.0	19.3	21.4	32.9	15.1	40.0	11.0	22.8	14.0	11.8	14.1	18.0	18.2	14.4	18.9
ZMIZ1	"FLJ13541, hZIMP10, KIAA1224, MIZ, RAI17, RP11-519K18.1, Zimp10"	ENSG00000108175	"Zinc finger MIZ-type containing 1"	Q9ULJ6	10	79068966-79316519	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	Activator	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Late spermatids: 259.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"SK-BR-3: 176.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045144, HPA071156"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 31: Spermatids - Spermatogenesis"	Nucleoplasm	Cytosol	"HPA045144: AB_10962360, HPA071156: "	"unprognostic (4.09e-3)"	"unprognostic (1.72e-1)"	"unprognostic (2.63e-1)"	"unprognostic (5.59e-2)"	"unprognostic (2.02e-1)"	"unprognostic (2.86e-2)"	"unprognostic (3.64e-3)"	"unprognostic (1.06e-1)"	"unprognostic (9.96e-2)"	"unprognostic (1.16e-1)"	"unprognostic (3.13e-2)"	"unprognostic (7.90e-2)"	"prognostic favorable (3.64e-7)"	"unprognostic (2.42e-1)"	"unprognostic (1.18e-1)"	"unprognostic (8.22e-2)"	"unprognostic (1.34e-2)"	34.0	24.4	24.5	19.2	27.1	26.6	27.7	25.1	30.1	44.7	5.2	28.1	19.2	51.5	18.8	37.5	26.5	25.9	31.8	25.8	27.5	17.2	8.7	26.5	17.5	34.5	36.0	48.5	23.3	19.2	12.5	21.7	29.9	19.5	14.5	14.6	28.4	28.8	34.6	33.7	22.2	26.9	27.2	44.8	27.6	4.5	33.9	16.4	37.3	17.0	18.2	28.4	31.0	23.1	24.0	29.3	54.8	23.6	55.8	16.0	19.1	22.4	40.2	15.6	8.8	8.7	10.8	12.2	17.8	52.8	40.9	33.0	9.2	16.6	8.4	26.5	5.1	43.5	11.1	25.9	39.2	24.3	88.1	21.0	18.2	22.3	15.9	98.4	25.3	10.2	16.9	62.9	13.3	45.4	24.4	37.6	16.2	13.8	44.0	107.5	10.3	12.3	11.6	20.0	56.8	82.8	14.8	176.2	46.8	19.4	56.5	23.4	35.5	58.7	23.5	29.9	29.2	11.5	21.9	0.2	77.0	42.7	11.5	1.3	2.1	1.6	1.2	3.6	0.8	0.5	0.8	0.7	2.6	0.2	0.3	0.6	3.0	3.4	3.0	2.5	1.0	1.2	24.5	27.1	25.1	30.1	25.8	27.5	34.5	36.0	29.9	27.2	33.9	23.1	49.3	38.5	26.0	64.9	14.5	22.8	8.4	14.9	15.4	49.8	27.1	18.0	54.4	20.0	15.8	16.5	0.0	7.1	14.7	39.1	7.9	22.1	47.2	17.9	75.3	49.9	13.8	25.7	23.1	24.1	5.6	36.2	38.7	33.2	50.6	16.8	56.4	9.6	37.9	63.9	16.4	14.5	14.2	34.9	86.0	259.7	28.3	52.4	24.9	46.9	27.2	12.9	4.1	92.5	45.5	19.3	22.5	23.7	14.2	13.0	19.7	8.1	14.7	3.4	19.7	24.7	32.6	1.8	3.2	40.8	23.7	3.6	12.1	14.3	14.8	12.7
ZMIZ2	"DKFZp761I2123, hZIMP7, KIAA1886, NET27, ZIMP7"	ENSG00000122515	"Zinc finger MIZ-type containing 2"	Q8NF64	7	44748581-44769881	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in all"		"Langerhans cells: 70.1;Late spermatids: 88.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040716	Supported		Supported	Nucleoplasm,Mitochondria		No	No			"Cluster 15: NK-cells - Transcription"	"Cluster 71: Testis - DNA repair"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 31: Spermatids - Spermatogenesis"	Nucleoplasm	Mitochondria	"HPA040716: AB_10805826"	"unprognostic (2.28e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.44e-2)"	"unprognostic (2.21e-2)"	"unprognostic (9.46e-3)"	"unprognostic (1.01e-3)"	"prognostic unfavorable (6.82e-5)"	"unprognostic (2.47e-1)"	"unprognostic (2.36e-1)"	"unprognostic (2.73e-1)"	"unprognostic (5.89e-2)"	"unprognostic (4.58e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.15e-1)"	"unprognostic (3.15e-3)"	20.2	27.4	19.2	23.1	20.5	19.3	21.3	0.0	26.9	22.2	0.0	22.9	20.8	23.6	9.4	25.1	26.1	12.4	27.8	20.4	0.3	30.4	17.4	28.3	22.8	4.1	3.5	25.3	34.3	17.0	36.3	9.3	1.4	26.2	10.2	6.5	29.4	18.2	20.8	29.7	26.9	9.8	0.3	33.5	23.2	31.7	6.4	17.6	39.6	9.1	16.5	23.1	21.8	13.3	33.1	37.4	17.1	33.3	11.4	7.6	18.1	16.6	15.6	13.9	16.7	21.4	50.5	22.6	25.3	17.5	34.7	44.4	10.6	18.9	8.4	53.3	20.1	9.1	36.8	17.0	23.3	13.2	19.2	11.6	11.4	21.9	14.3	12.4	26.3	24.2	27.0	49.7	20.9	31.8	29.3	36.3	32.4	24.8	35.5	36.6	9.4	29.6	16.1	25.0	60.6	40.0	22.3	43.3	9.9	16.0	41.4	20.2	39.4	13.3	28.5	36.2	38.6	71.4	24.4	17.3	25.7	23.0	55.4	0.3	0.6	0.2	0.8	0.8	0.5	1.0	0.4	0.6	0.6	1.8	0.2	0.3	0.2	1.1	0.4	1.5	0.4	0.3	19.2	20.5	0.0	26.9	20.4	0.3	4.1	3.5	1.4	0.3	6.4	13.3	16.9	12.8	16.9	23.5	22.0	10.1	4.3	11.1	10.8	14.1	18.9	18.4	17.5	7.2	14.7	23.9	14.6	8.2	16.5	18.6	1.9	17.5	26.2	19.3	12.7	12.7	19.9	6.9	17.8	15.7	2.3	11.8	34.7	27.8	14.5	22.3	13.6	16.4	11.2	11.8	14.7	19.6	14.2	14.5	70.1	88.8	13.4	19.9	14.2	14.0	24.8	5.4	10.3	8.5	21.0	24.4	14.2	18.0	15.9	9.3	14.2	8.4	19.7	7.5	6.6	12.2	11.7	4.4	4.2	16.8	18.5	7.3	12.9	13.4	21.2	9.8
ZMYND11	BS69	ENSG00000015171	"Zinc finger MYND-type containing 11"	Q15326	10	134465-254637	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell cycle, Host-virus interaction, Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding, Repressor"	"Mental retardation, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015816			Supported	Nucleoplasm		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"HPA015816: AB_1845427"	"unprognostic (1.96e-1)"	"unprognostic (1.66e-1)"	"unprognostic (3.00e-1)"	"unprognostic (1.12e-1)"	"unprognostic (9.12e-2)"	"unprognostic (2.33e-2)"	"unprognostic (5.49e-2)"	"unprognostic (1.52e-2)"	"unprognostic (1.80e-2)"	"unprognostic (3.73e-2)"	"unprognostic (4.47e-3)"	"unprognostic (6.35e-2)"	"prognostic favorable (4.76e-7)"	"unprognostic (1.25e-1)"	"unprognostic (2.40e-1)"	"unprognostic (9.04e-2)"	"unprognostic (1.42e-1)"	41.7	37.1	50.7	26.3	58.8	11.3	45.8	60.0	64.6	47.4	38.5	54.8	29.9	55.0	46.6	42.8	39.8	35.6	58.0	50.7	54.8	51.1	34.9	39.0	26.3	54.1	52.8	55.3	46.4	99.7	27.7	34.8	54.8	52.8	33.8	43.2	46.1	56.0	58.1	33.1	30.9	50.9	52.4	32.7	39.2	33.1	54.1	23.8	88.0	64.7	24.8	46.7	31.1	59.1	64.0	64.6	53.8	42.9	57.3	55.0	33.3	63.0	35.8	43.7	40.5	39.2	62.3	0.1	19.8	78.4	13.8	38.3	28.9	44.2	55.8	25.1	25.1	71.8	33.4	42.3	64.6	19.5	38.8	38.4	60.6	42.3	38.3	56.8	55.6	32.8	19.5	44.7	76.0	75.4	29.3	27.3	17.4	69.3	10.7	28.4	34.4	34.5	58.0	72.7	24.3	44.3	72.3	83.3	34.1	29.4	74.9	37.8	72.2	43.4	15.8	89.2	48.8	37.0	48.4	4.6	44.2	36.1	30.3	15.6	2.3	19.5	11.9	3.5	10.4	5.2	8.3	11.9	3.8	3.1	9.2	9.1	1.0	14.7	1.7	4.5	8.9	5.0	50.7	58.8	60.0	64.6	50.7	54.8	54.1	52.8	54.8	52.4	54.1	59.1	51.2	60.9	51.4	90.8	25.3	25.9	27.0	17.5	34.1	37.5	46.3	33.8	103.0	31.5	31.9	33.1	12.5	15.2	39.4	14.6	50.9	29.3	28.6	27.0	50.3	45.7	25.9	25.0	110.8	31.8	4.6	45.7	27.5	37.1	46.2	42.1	35.3	28.1	14.4	20.2	118.0	26.2	16.2	25.1	14.9	27.1	39.1	21.7	24.9	94.6	13.9	62.5	34.0	128.2	131.5	28.1	14.5	56.1	31.1	44.1	19.1	41.9	23.7	22.0	13.1	56.9	49.8	26.8	25.6	32.2	27.8	12.4	32.6	28.5	22.1	29.8
ZMYND8	"PRKCBP1, RACK7"	ENSG00000101040	"Zinc finger MYND-type containing 8"	Q9ULU4	20	47209214-47356889	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020949	Approved		Supported	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm	"Golgi apparatus"	"HPA020949: AB_1857223"	"prognostic unfavorable (2.56e-4)"	"unprognostic (5.09e-2)"	"unprognostic (5.84e-2)"	"unprognostic (3.30e-1)"	"unprognostic (2.12e-1)"	"unprognostic (1.67e-1)"	"prognostic unfavorable (2.62e-4)"	"unprognostic (2.10e-1)"	"unprognostic (2.60e-1)"	"unprognostic (1.50e-1)"	"unprognostic (8.64e-2)"	"unprognostic (3.62e-1)"	"prognostic unfavorable (7.06e-5)"	"unprognostic (3.59e-2)"	"unprognostic (7.50e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.47e-3)"	13.1	32.7	25.4	10.5	21.3	26.0	14.7	26.2	36.2	11.9	47.8	14.1	11.0	9.8	33.3	16.0	15.9	12.3	12.5	35.5	29.5	18.5	10.9	11.1	12.8	30.5	22.9	13.6	12.3	11.6	25.9	11.8	33.0	11.8	14.5	20.1	14.6	14.6	15.3	19.9	16.2	8.7	9.4	18.3	20.0	14.2	25.2	14.6	11.0	11.0	12.8	14.5	14.9	37.3	27.6	17.2	90.5	36.6	15.2	21.3	59.4	21.7	17.8	22.3	22.8	107.7	26.0	26.5	34.4	16.3	27.1	18.7	39.4	96.0	33.3	11.4	14.9	110.4	6.3	95.9	55.4	11.9	55.9	20.9	43.4	24.8	94.1	40.4	61.0	9.5	90.6	17.7	41.0	32.1	4.4	45.4	85.9	20.3	24.3	55.8	15.0	22.9	30.4	49.6	38.0	14.3	10.3	32.4	44.4	70.3	17.0	22.6	143.6	23.9	16.6	23.3	20.2	12.5	25.2	23.2	80.8	18.3	80.3	34.8	7.4	10.4	8.7	7.5	8.7	15.3	8.8	9.0	4.7	18.3	11.4	11.8	19.8	16.3	6.8	16.5	9.3	4.3	25.4	21.3	26.2	36.2	35.5	29.5	30.5	22.9	33.0	9.4	25.2	37.3	48.2	44.8	78.5	94.0	36.6	8.8	32.2	44.6	15.9	108.1	29.3	20.7	23.7	28.6	74.3	90.1	160.6	23.1	36.2	64.0	15.6	36.5	13.6	111.3	29.8	31.7	56.3	112.9	153.8	28.7	42.0	24.2	41.8	124.4	32.2	44.8	30.7	16.1	21.9	85.8	113.5	49.2	42.7	48.8	12.8	21.9	27.7	31.8	10.6	49.6	25.0	24.4	40.2	89.0	138.7	47.1	42.3	26.7	29.7	23.9	56.8	12.0	82.3	50.0	32.9	33.4	27.5	6.3	29.9	19.2	8.4	66.5	34.2	39.3	32.1	24.2
ZNF12	"GIOT-3, KOX3, ZNF325"	ENSG00000164631	"Zinc finger protein 12"	P17014	7	6688433-6706947	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	4	"basophil: 8.8"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 8.8"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA063402			Supported	Nucleoplasm,Centrosome		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	Centrosome	"HPA063402: AB_2685005"	"unprognostic (2.68e-1)"	"unprognostic (6.97e-3)"	"unprognostic (9.52e-2)"	"unprognostic (1.84e-1)"	"unprognostic (8.32e-2)"	"unprognostic (1.74e-1)"	"unprognostic (3.06e-3)"	"unprognostic (1.41e-1)"	"unprognostic (6.67e-2)"	"unprognostic (2.89e-3)"	"unprognostic (5.52e-2)"	"unprognostic (7.76e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.87e-1)"	"unprognostic (2.10e-2)"	"unprognostic (4.36e-2)"	"unprognostic (8.46e-3)"	9.2	8.7	9.0	8.2	8.7	8.5	13.6	12.5	8.9	12.1	10.3	9.7	10.0	13.8	13.8	10.4	10.3	9.2	8.9	8.3	8.2	9.7	10.2	8.5	13.4	9.0	9.1	14.3	9.0	18.5	8.7	13.3	9.4	11.3	10.4	15.3	10.0	12.1	6.7	10.5	11.2	9.8	8.3	13.3	10.2	5.2	9.7	12.3	13.9	10.0	13.4	9.8	10.0	9.2	16.5	7.7	15.0	18.9	15.1	15.2	14.4	10.2	18.3	12.8	13.3	10.5	9.4	12.5	6.9	12.7	28.8	19.3	12.5	9.9	19.4	4.7	9.4	12.6	11.9	10.6	14.1	20.2	13.1	16.7	21.6	9.2	14.8	19.0	9.4	9.9	20.3	11.2	17.1	13.1	7.8	18.6	18.2	5.2	11.7	10.2	21.5	7.7	10.4	16.2	13.7	24.2	11.8	21.2	12.4	18.7	13.5	22.7	9.4	14.3	18.0	11.5	13.7	10.6	7.3	12.6	11.7	13.4	19.4	8.8	0.5	0.7	1.4	0.4	1.9	1.1	1.1	1.6	0.5	1.1	1.5	1.9	0.5	1.2	0.4	1.1	1.0	0.2	9.0	8.7	12.5	8.9	8.3	8.2	9.0	9.1	9.4	8.3	9.7	9.2	15.1	9.6	8.9	16.3	14.1	26.9	16.3	8.0	11.4	27.9	16.3	15.1	17.2	12.8	10.7	3.7	16.7	11.7	15.3	8.3	1.9	8.7	1.2	10.4	15.8	13.9	7.7	12.4	15.9	6.8	9.0	14.9	6.6	12.7	11.4	27.3	15.4	10.3	10.1	37.0	16.7	11.9	2.0	13.0	10.9	2.7	22.4	8.4	5.4	18.7	11.3	20.9	15.5	9.5	19.9	9.1	8.8	22.6	11.6	13.3	10.1	7.0	12.6	18.9	26.3	17.6	16.7	12.7	7.8	16.7	22.4	8.6	11.2	23.9	12.1	18.1
ZNF131	"pHZ-10, ZBTB35"	ENSG00000172262	"Zinc finger protein 131"	P52739	5	43065176-43192021	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007023, HPA027748, HPA074630"	Approved		Enhanced	"Nucleoplasm,Intermediate filaments"		No	No			"Cluster 46: Basophils - DNA binding"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 20: HeLa - Mitochondria"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm	"Intermediate filaments"	"HPA007023: AB_2667726, HPA027748: AB_2672374, HPA074630: AB_2686705"	"unprognostic (1.23e-1)"	"unprognostic (8.24e-2)"	"unprognostic (4.70e-2)"	"unprognostic (7.97e-2)"	"unprognostic (8.84e-2)"	"unprognostic (7.18e-2)"	"prognostic unfavorable (1.56e-4)"	"unprognostic (2.52e-1)"	"unprognostic (2.98e-3)"	"unprognostic (1.94e-2)"	"unprognostic (5.83e-2)"	"unprognostic (8.07e-2)"	"unprognostic (2.09e-2)"	"unprognostic (1.47e-2)"	"unprognostic (2.76e-1)"	"unprognostic (3.11e-3)"	"unprognostic (1.46e-2)"	13.2	13.5	12.5	13.9	12.8	28.4	19.5	17.3	21.7	13.8	10.0	13.2	10.0	17.6	9.6	14.4	12.6	12.9	9.6	12.8	12.4	12.0	14.3	11.4	20.3	11.4	11.9	15.9	12.2	11.7	10.7	16.9	11.9	12.6	13.2	14.7	10.4	9.0	15.8	18.2	12.0	15.9	11.3	15.9	11.6	32.6	12.3	26.7	11.8	17.1	17.5	15.0	13.3	14.2	25.4	15.2	32.4	43.2	30.1	20.6	27.3	32.8	26.6	31.9	26.9	24.0	22.2	50.8	25.9	22.1	29.7	17.7	38.9	20.8	44.9	24.8	34.1	31.4	92.2	18.0	27.7	55.0	24.7	18.8	38.2	23.5	38.3	22.8	24.7	39.0	40.7	52.7	36.8	24.5	53.9	68.8	21.5	23.4	24.9	35.3	49.4	39.9	27.1	24.4	20.0	29.4	83.5	39.8	43.2	21.7	22.3	51.6	18.5	39.8	37.3	20.5	31.1	21.1	32.5	58.4	21.0	71.2	27.1	10.4	8.2	5.8	19.1	9.5	19.2	13.1	18.5	18.5	11.9	16.8	22.3	18.3	3.9	17.2	6.6	11.3	14.9	10.0	12.5	12.8	17.3	21.7	12.8	12.4	11.4	11.9	11.9	11.3	12.3	14.2	42.5	22.4	21.9	28.7	44.7	49.6	51.4	24.1	53.5	52.1	32.3	29.7	17.5	22.8	19.4	9.2	52.1	27.0	53.3	28.0	31.3	15.3	52.9	30.0	47.7	32.8	31.2	39.1	31.2	11.8	25.0	32.4	23.0	49.7	24.1	39.4	24.7	13.3	16.4	38.7	33.6	29.7	20.3	25.8	35.4	19.5	20.5	30.9	21.4	14.0	27.5	29.0	49.4	38.7	24.2	17.9	24.7	21.1	27.8	38.5	34.9	13.1	15.7	70.0	26.3	57.0	43.2	109.6	80.3	45.9	65.5	25.4	59.3	37.3	38.7	35.6
ZNF143	"pHZ-1, SBF, STAF"	ENSG00000166478	"Zinc finger protein 143"	P52747	11	9460319-9528524	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Sertoli cells: 59.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003263, HPA003264, HPA074818"	Supported		Supported	"Nucleoplasm,Nuclear bodies,Golgi apparatus,Vesicles"		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm	"Nuclear bodies, Golgi apparatus, Vesicles"	"HPA003263: AB_1080672, HPA003264: , HPA074818: AB_2686715"	"unprognostic (2.30e-2)"	"unprognostic (2.12e-2)"	"unprognostic (5.51e-2)"	"unprognostic (9.72e-2)"	"unprognostic (5.09e-2)"	"unprognostic (1.61e-1)"	"prognostic unfavorable (1.76e-5)"	"unprognostic (4.87e-3)"	"unprognostic (2.57e-3)"	"unprognostic (9.56e-2)"	"unprognostic (1.26e-3)"	"unprognostic (1.06e-1)"	"prognostic unfavorable (6.78e-4)"	"unprognostic (1.20e-3)"	"unprognostic (1.92e-2)"	"unprognostic (1.06e-2)"	"unprognostic (7.55e-2)"	9.0	6.1	8.6	11.4	10.1	18.6	9.6	17.3	9.9	10.0	10.8	9.7	9.5	10.5	14.4	9.8	10.1	8.4	9.3	7.9	9.3	8.6	9.6	9.1	15.7	9.9	8.8	13.7	7.7	7.9	7.1	10.4	11.2	8.7	9.9	16.1	8.9	8.0	17.3	10.2	8.2	9.5	9.8	11.1	7.7	16.9	9.0	18.9	14.6	11.5	14.1	11.2	8.4	14.9	20.0	18.8	23.4	15.2	18.9	17.4	21.5	21.8	17.3	16.4	17.9	26.7	24.3	19.6	9.7	17.7	14.0	22.5	23.1	17.3	24.5	20.0	27.7	18.5	27.7	18.7	15.6	25.9	17.8	15.3	20.4	22.2	19.4	21.4	16.3	17.9	20.5	23.3	18.3	17.1	24.1	10.6	26.3	23.0	19.9	21.4	21.2	12.3	14.7	24.0	16.1	15.8	24.0	16.0	14.3	20.6	14.9	14.6	15.6	21.4	15.3	15.1	19.6	11.5	21.6	33.4	13.8	14.8	12.5	39.1	24.6	57.3	28.0	24.9	25.0	23.0	24.6	22.9	20.9	18.2	22.8	19.6	45.1	19.4	28.2	10.1	29.7	19.6	8.6	10.1	17.3	9.9	7.9	9.3	9.9	8.8	11.2	9.8	9.0	14.9	17.9	6.4	12.1	6.2	14.7	26.6	34.1	12.1	17.6	9.3	8.7	13.2	15.5	7.2	10.3	5.5	8.4	10.0	17.1	10.1	3.9	12.5	20.3	18.7	14.9	13.0	6.6	25.4	8.1	11.5	16.2	14.5	9.7	16.3	14.0	7.7	6.8	7.6	9.9	5.0	7.4	6.9	14.2	8.3	22.0	10.0	11.8	15.8	10.6	12.2	16.3	15.5	17.5	7.5	9.8	14.1	7.7	6.8	15.4	20.1	6.3	7.7	15.0	14.3	59.2	18.3	16.7	50.5	21.3	12.8	23.4	18.3	18.1	7.3	7.9	26.9
ZNF146	OZF	ENSG00000167635	"Zinc finger protein 146"	Q15072	19	36214602-36238771	"Predicted intracellular proteins, Transcription factors"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 121.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003358	Supported		Supported	Nucleoli		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 52: Non-specific - Ribosome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 32: Non-specific - Translation"	Nucleoli		"HPA003358: AB_1080674"	"unprognostic (1.01e-1)"	"unprognostic (1.93e-1)"	"unprognostic (5.35e-3)"	"unprognostic (2.11e-3)"	"unprognostic (1.82e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.42e-3)"	"unprognostic (2.87e-2)"	"unprognostic (1.35e-2)"	"unprognostic (1.27e-1)"	"unprognostic (3.95e-3)"	"unprognostic (2.53e-2)"	"unprognostic (1.72e-2)"	"unprognostic (7.84e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.51e-2)"	"unprognostic (1.92e-1)"	25.9	21.1	22.6	25.6	30.4	12.5	41.6	26.6	33.9	33.7	20.5	26.8	23.1	37.0	21.9	24.7	28.1	22.4	23.7	21.5	26.4	29.2	32.4	23.4	35.3	28.4	30.7	40.5	22.8	33.4	28.2	32.4	30.9	30.5	31.5	31.2	24.4	26.4	46.3	27.0	21.8	32.6	24.0	27.0	25.2	12.1	27.9	39.6	33.9	46.4	37.5	34.4	23.2	36.2	70.2	96.0	79.8	77.1	57.8	64.5	42.5	60.2	55.4	57.1	56.2	43.5	49.6	67.7	94.6	56.0	37.4	31.8	102.6	70.5	102.3	105.5	57.2	113.0	37.4	52.7	67.4	180.1	74.9	52.8	106.5	55.1	156.0	60.0	71.7	72.6	122.2	72.3	69.4	45.9	84.1	42.2	108.1	122.2	57.7	96.1	80.3	58.2	69.4	67.7	100.7	63.5	74.7	93.0	66.1	81.6	41.5	90.9	55.0	64.0	76.8	50.6	107.1	50.2	63.7	95.2	44.9	88.0	83.1	7.9	11.2	8.7	15.8	13.8	22.7	19.1	18.1	16.0	13.6	17.4	23.2	21.4	2.6	14.9	22.4	6.9	16.8	14.9	22.6	30.4	26.6	33.9	21.5	26.4	28.4	30.7	30.9	24.0	27.9	36.2	21.4	44.8	29.0	21.5	29.7	23.6	30.8	20.5	22.8	10.8	26.7	22.1	45.4	21.5	28.4	20.2	10.4	34.3	26.3	11.6	35.2	27.7	18.3	16.7	35.5	22.8	14.5	25.0	29.2	18.0	48.7	26.9	16.3	23.6	20.8	28.5	20.3	20.8	18.9	11.8	33.4	24.6	14.2	17.8	14.0	20.9	25.1	15.5	10.6	19.7	18.8	9.0	28.8	37.2	121.1	25.0	13.7	19.2	18.6	38.1	9.0	21.2	23.7	10.3	6.6	30.2	29.6	13.0	10.7	24.5	29.8	23.5	29.9	20.0	26.4	29.6
ZNF148	"BERF-1, BFCOL1, HT-BETA, pHZ-52, ZBP-89, ZFP148"	ENSG00000163848	"Zinc finger protein 148"	Q9UQR1	3	125225669-125375325	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"	"Dwarfism, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001656, CAB017486"	Supported		Supported	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 31: Spermatids - Spermatogenesis"	Nucleoplasm	"Golgi apparatus"	"CAB017486: AB_794260, HPA001656: AB_1079995"	"unprognostic (2.40e-1)"	"unprognostic (1.12e-2)"	"unprognostic (5.03e-2)"	"unprognostic (3.94e-2)"	"unprognostic (5.94e-3)"	"unprognostic (5.66e-2)"	"unprognostic (1.24e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.69e-2)"	"unprognostic (1.33e-2)"	"prognostic unfavorable (2.88e-4)"	"unprognostic (6.36e-2)"	"unprognostic (7.97e-3)"	"unprognostic (1.71e-1)"	"unprognostic (2.84e-1)"	"unprognostic (3.63e-2)"	"unprognostic (2.72e-1)"	8.9	7.5	5.6	9.4	8.9	7.9	12.1	12.9	7.8	12.6	0.0	10.8	7.6	13.9	10.2	10.3	12.4	9.5	15.5	4.5	16.4	12.9	11.7	10.3	12.3	4.2	6.5	17.4	9.5	15.8	4.7	9.7	4.2	11.1	11.5	13.1	10.0	11.1	11.1	5.8	8.9	13.7	2.3	11.9	9.8	10.5	14.5	16.9	30.0	12.0	14.4	10.6	6.1	8.3	30.6	19.8	21.1	18.9	18.4	19.7	16.0	27.2	31.5	29.9	28.4	19.1	16.6	24.4	18.5	40.3	24.1	24.4	23.2	20.5	42.4	10.9	8.9	30.1	23.3	9.8	13.6	20.9	29.1	16.1	21.0	28.0	29.4	19.7	20.7	17.7	15.0	20.2	22.3	23.9	26.1	7.7	13.6	20.6	16.8	18.6	23.2	13.9	17.1	33.6	18.2	15.3	36.2	18.2	29.7	11.7	22.7	20.8	26.6	22.6	24.1	28.5	17.5	17.4	21.5	36.6	16.9	13.1	21.3	4.4	15.3	32.0	21.8	14.5	22.5	24.5	19.2	20.9	13.0	22.2	27.9	22.0	51.4	33.2	23.4	11.3	19.6	20.1	5.6	8.9	12.9	7.8	4.5	16.4	4.2	6.5	4.2	2.3	14.5	8.3	54.7	93.0	41.3	92.7	56.7	35.6	26.0	36.2	48.9	68.0	37.0	35.7	75.2	24.3	43.0	33.1	39.6	28.7	53.7	34.7	25.4	37.5	82.0	28.8	54.3	51.6	47.9	32.0	166.7	37.4	24.3	44.5	31.1	38.1	50.6	75.7	37.9	41.0	31.1	75.7	170.3	34.4	26.4	37.1	21.2	135.2	48.1	41.2	17.8	143.4	50.1	45.7	59.8	154.3	151.4	33.7	25.6	59.0	35.8	36.6	28.2	43.9	27.5	39.4	32.9	63.4	60.7	24.4	24.2	32.5	38.4	31.6	52.0	42.0	33.6	35.6
ZNF16	KOX9	ENSG00000170631	"Zinc finger protein 16"	P17020	8	144930358-144950888	"Predicted intracellular proteins, Transcription factors"	"Cell cycle, Cell division, Transcription, Transcription regulation"	"Activator, DNA-binding, Mitogen"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Rod photoreceptor cells: 25.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA035782, HPA061835"	Uncertain		Supported	Nucleoplasm,Nucleoli		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 31: Skin - Epidermis development"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 52: Non-specific - Transcription"	Nucleoli	Nucleoplasm	"HPA035782: AB_10603243, HPA061835: AB_2684621"	"unprognostic (4.11e-2)"	"unprognostic (1.51e-2)"	"unprognostic (6.87e-2)"	"unprognostic (2.45e-1)"	"unprognostic (2.69e-1)"	"prognostic favorable (2.39e-4)"	"unprognostic (7.53e-3)"	"unprognostic (1.10e-1)"	"unprognostic (1.24e-1)"	"unprognostic (8.50e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.21e-1)"	"unprognostic (8.59e-2)"	"unprognostic (1.70e-2)"	"unprognostic (2.96e-1)"	"unprognostic (9.75e-2)"	"unprognostic (4.17e-3)"	4.6	3.6	4.6	2.4	4.7	2.6	6.3	4.4	5.0	6.0	5.9	6.5	4.7	6.2	6.9	5.9	7.1	5.7	4.4	4.5	4.4	5.3	3.9	3.7	3.2	4.2	4.2	11.0	7.5	8.6	4.0	3.9	4.3	5.4	4.7	5.1	4.6	5.6	8.3	9.3	4.8	5.5	4.5	3.4	5.0	7.5	4.8	4.4	7.0	8.3	3.9	5.7	6.0	4.6	4.5	3.9	7.7	4.2	6.4	9.0	5.5	4.0	8.9	8.0	7.2	3.1	4.5	7.1	5.2	5.2	4.3	3.5	5.4	8.9	7.2	3.1	4.5	8.2	4.4	4.5	10.7	3.0	4.6	10.9	8.8	5.1	13.2	7.9	4.4	5.3	5.7	4.7	6.4	6.2	6.1	3.0	4.7	6.9	8.8	7.5	4.5	4.5	6.8	6.7	6.4	4.7	8.5	5.1	6.9	5.8	9.5	5.6	4.7	3.6	7.5	4.3	4.5	3.4	3.1	6.4	4.1	4.0	5.8	2.6	3.0	2.2	4.9	2.9	5.6	2.8	3.8	4.5	4.8	4.4	3.8	3.5	0.4	9.2	3.0	2.5	5.8	3.2	4.6	4.7	4.4	5.0	4.5	4.4	4.2	4.2	4.3	4.5	4.8	4.6	3.6	3.2	4.4	4.9	3.4	2.7	6.9	6.8	5.2	11.4	4.3	2.9	3.7	5.7	3.1	9.2	12.5	5.9	7.0	3.2	1.9	7.3	10.3	2.0	3.5	3.7	4.2	3.0	6.8	4.4	3.6	3.8	5.1	3.9	7.0	9.4	5.0	4.5	3.6	6.7	6.3	5.6	6.1	3.5	2.4	3.7	6.2	2.1	1.8	6.5	5.4	6.2	7.2	6.6	7.2	3.6	4.9	6.4	3.2	4.2	10.6	4.8	3.4	25.1	0.0	3.4	4.0	13.6	18.1	4.5	4.5	5.5	5.1	6.6	5.4	5.5
ZNF174	ZSCAN8	ENSG00000103343	"Zinc finger protein 174"	Q15697	16	3401215-3409364	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA009656, HPA070692"	Approved		Supported	"Nucleoli fibrillar center,Nuclear bodies"		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Nucleoli fibrillar center"	"Nuclear bodies"	"HPA009656: AB_1080679, HPA070692: "	"unprognostic (4.33e-2)"	"unprognostic (6.81e-3)"	"unprognostic (2.08e-1)"	"unprognostic (7.68e-2)"	"unprognostic (1.94e-3)"	"unprognostic (5.19e-2)"	"unprognostic (2.03e-3)"	"unprognostic (6.39e-3)"	"unprognostic (2.41e-1)"	"unprognostic (4.25e-3)"	"unprognostic (2.06e-3)"	"unprognostic (4.35e-2)"	"unprognostic (6.28e-2)"	"unprognostic (1.02e-1)"	"unprognostic (7.68e-2)"	"unprognostic (2.55e-1)"	"unprognostic (1.83e-1)"	6.7	7.0	7.8	5.5	8.3	4.0	6.8	8.0	9.1	8.1	7.1	10.4	6.1	9.5	11.5	6.1	10.8	5.6	10.0	7.4	9.0	6.6	6.6	5.4	8.2	8.0	8.1	12.6	5.8	14.1	9.3	5.0	8.3	8.8	7.1	9.9	7.9	10.9	9.9	7.4	6.4	10.3	7.8	7.3	6.8	9.5	8.3	9.5	7.5	10.6	8.4	9.0	6.8	9.4	7.1	11.6	13.1	14.9	15.8	11.3	8.4	6.1	16.2	14.2	12.7	8.8	12.3	23.0	9.3	11.9	12.7	10.1	12.4	11.0	13.1	14.0	11.7	12.2	11.2	11.4	11.3	14.5	13.9	13.3	12.6	11.9	11.9	13.6	11.7	16.8	18.9	10.8	14.7	12.2	14.7	12.4	13.9	10.5	14.2	19.8	14.3	19.3	10.0	3.6	12.0	9.1	12.7	14.1	11.0	12.2	13.7	15.4	9.1	10.4	10.8	8.3	8.5	12.9	14.9	19.5	5.6	9.1	10.1	17.4	6.4	27.0	9.6	7.5	9.1	10.3	10.0	11.0	7.9	8.0	12.0	8.9	7.8	8.5	5.1	4.2	10.2	7.6	7.8	8.3	8.0	9.1	7.4	9.0	8.0	8.1	8.3	7.8	8.3	9.4	4.3	3.2	2.0	4.9	4.1	1.9	1.4	2.6	6.2	6.4	3.3	4.3	5.3	4.3	1.8	0.0	6.2	6.1	5.6	3.0	3.9	5.0	7.1	5.4	4.4	5.2	3.6	5.5	3.4	4.3	3.8	4.7	1.5	2.5	1.3	4.9	2.9	3.5	4.5	3.3	4.3	2.2	8.2	2.5	0.9	4.0	8.7	2.6	3.6	1.0	2.4	7.7	8.2	3.5	10.6	4.0	5.0	9.8	4.6	2.2	4.7	4.7	1.6	8.8	0.0	4.7	4.0	15.1	10.3	4.7	1.8	2.9	4.0	5.8	3.4	0.8
ZNF175	OTK18	ENSG00000105497	"Zinc finger protein 175"	Q9Y473	19	51571283-51592510	"Predicted intracellular proteins, Transcription factors"	"Antiviral defense, Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"HEL: 50.6;RT4: 45.4;TIME: 45.7"					"Low region specificity"	"Detected in all"			"HPA002717, HPA074615"	Uncertain		Supported	Nucleoli,Cytosol		NA	NA			"Cluster 29: Plasmacytoid DCs - Unknown function"	"Cluster 21: Non-specific - Transcription"	"Cluster 36: HEL - Hemostasis"	"Cluster 6: Erythroid cells - Oxygen transport"	Nucleoli	Cytosol	"HPA002717: AB_1080681, HPA074615: "	"unprognostic (9.41e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.44e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.46e-1)"	"unprognostic (9.50e-3)"	"unprognostic (2.44e-1)"	"unprognostic (1.84e-1)"	"unprognostic (7.33e-3)"	"unprognostic (9.94e-2)"	"unprognostic (6.33e-3)"	"unprognostic (6.20e-2)"	"unprognostic (1.35e-3)"	"unprognostic (1.50e-2)"	"unprognostic (2.01e-1)"	"prognostic unfavorable (6.64e-4)"	"unprognostic (3.50e-3)"	3.1	3.9	4.6	4.3	5.0	3.5	5.4	11.2	6.2	3.9	6.7	3.9	5.5	5.9	5.2	3.1	4.7	3.1	4.4	3.9	4.8	4.4	3.1	4.9	6.0	4.7	4.4	8.9	3.3	10.0	6.2	8.0	4.5	4.0	3.8	11.3	6.0	4.9	4.6	3.6	4.3	5.1	3.9	6.0	4.5	10.3	5.9	5.2	6.9	3.6	6.1	3.8	3.2	6.7	3.6	6.3	6.2	6.6	6.5	9.0	0.1	8.1	10.3	7.4	8.9	6.4	5.5	6.6	4.6	8.2	4.6	5.9	6.8	5.6	13.2	0.0	10.0	50.6	10.5	2.2	5.7	8.5	31.1	3.5	5.1	15.1	7.3	37.2	12.1	6.3	17.3	6.7	8.1	0.0	9.2	6.3	3.5	4.4	6.4	0.0	8.1	3.2	4.0	45.4	7.9	5.7	7.6	2.5	4.7	5.0	1.8	6.9	45.7	11.3	5.1	2.6	7.9	8.8	17.6	6.8	31.4	5.0	5.8	0.0	0.4	0.0	0.4	0.1	0.5	0.5	0.4	0.4	0.4	0.5	0.6	0.5	0.2	0.2	0.1	1.4	0.1	0.2	4.6	5.0	11.2	6.2	3.9	4.8	4.7	4.4	4.5	3.9	5.9	6.7	3.6	6.4	5.4	12.1	3.4	1.1	1.5	1.7	1.8	8.0	2.7	2.5	3.5	1.5	5.3	5.5	2.1	7.9	4.1	1.5	1.9	1.9	11.6	1.4	2.9	3.9	1.8	16.2	11.6	1.6	1.5	3.4	2.6	1.5	14.0	5.5	6.4	2.4	3.2	16.8	12.8	1.3	2.0	5.9	2.1	10.6	3.4	2.4	3.6	10.3	3.1	2.6	5.2	12.5	17.5	6.9	0.6	2.6	1.6	1.8	4.4	2.0	4.4	7.8	0.0	4.3	2.6	6.3	4.3	2.1	1.4	12.0	2.4	3.2	2.0	0.8
ZNF184		ENSG00000096654	"Zinc finger protein 184"	Q99676	6	27450743-27473118	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 36.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA003226, HPA064793"	Uncertain		Supported	Nucleoplasm		NA	NA			"Cluster 13: T-cells - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 14: REH - Unknown function"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm		"HPA003226: AB_2218705, HPA064793: AB_2732722"	"unprognostic (8.86e-2)"	"unprognostic (5.55e-2)"	"unprognostic (2.27e-3)"	"unprognostic (1.70e-1)"	"unprognostic (4.99e-3)"	"unprognostic (6.04e-2)"	"unprognostic (1.99e-2)"	"unprognostic (1.74e-2)"	"unprognostic (1.17e-2)"	"prognostic favorable (4.41e-5)"	"unprognostic (2.59e-1)"	"unprognostic (5.64e-2)"	"unprognostic (2.77e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.31e-2)"	"unprognostic (5.79e-3)"	2.8	3.1	2.4	4.3	4.6	8.8	5.4	1.2	8.4	6.1	0.0	4.4	3.4	5.4	4.1	3.8	4.5	4.0	2.8	6.4	0.6	7.0	3.6	4.1	6.3	0.4	0.3	6.0	2.7	5.9	4.1	3.0	0.3	4.3	4.5	4.4	3.5	4.3	2.9	5.7	3.6	4.3	0.6	4.6	4.4	8.3	0.3	10.2	5.6	5.0	6.6	4.5	2.9	2.7	6.4	2.0	10.8	19.7	7.6	5.6	3.6	6.2	8.3	7.1	10.9	3.6	3.7	11.7	10.3	4.0	4.8	3.9	9.7	4.0	10.3	11.4	6.0	14.0	7.3	5.1	4.0	16.9	9.7	4.1	6.0	5.2	5.4	8.4	7.8	17.8	10.9	21.1	11.9	3.2	27.3	14.3	6.3	3.5	4.5	35.4	15.2	17.5	4.9	5.9	18.4	8.9	7.0	6.0	9.2	5.3	7.0	14.4	5.3	10.8	7.1	4.9	7.2	9.6	17.4	21.8	2.4	19.4	10.9	2.1	2.7	8.0	7.9	3.7	10.9	7.4	8.3	7.7	4.1	6.9	6.3	7.9	1.4	7.0	2.9	2.5	10.4	3.9	2.4	4.6	1.2	8.4	6.4	0.6	0.4	0.3	0.3	0.6	0.3	2.7	5.4	6.4	8.1	2.0	9.8	4.1	3.8	2.5	6.8	2.5	5.1	5.5	3.5	2.8	6.4	1.8	2.1	4.3	17.5	2.1	7.9	2.7	36.9	7.9	3.7	5.1	7.1	3.4	10.3	3.0	3.0	4.5	2.0	5.0	5.1	7.4	3.9	1.5	2.8	10.1	3.4	5.1	2.0	3.8	3.8	12.6	3.4	3.6	1.8	5.6	3.0	3.3	9.2	4.0	4.2	2.5	2.1	3.8	6.5	4.6	1.6	4.5	6.3	4.8	0.0	5.2	6.8	12.8	5.9	4.3	4.4	2.9	12.5	4.6	4.4	4.5
ZNF185	SCELL	ENSG00000147394	"Zinc finger protein 185 with LIM domain"	O15231	X	152914442-152973480	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"epididymis: 328.7;esophagus: 326.7"	"Cell type enhanced"	"Detected in many"		"Glandular and luminal cells: 32.2;Pancreatic endocrine cells: 72.0;Squamous epithelial cells: 69.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 51.8"	"Group enriched"	"Detected in many"	5	"granulocytes: 51.8;monocytes: 27.4"	"Cell line enhanced"	"Detected in many"		"A-431: 124.4;EFO-21: 139.9;HBEC3-KT: 100.0;PC-3: 87.7;TIME: 236.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA000400, HPA016438"	Enhanced		Supported	"Plasma membrane,Actin filaments,Focal adhesion sites,Cytosol"		NA	NA		220000	"Cluster 18: Basophils - Vesicular transport"	"Cluster 30: Epididymis - Antimicrobial activity"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 61: Squamous epithelial cells - Keratinization"	"Plasma membrane, Cytosol"	"Actin filaments, Focal adhesion sites"	"HPA000400: AB_1080685, HPA016438: AB_1859109"	"unprognostic (1.34e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.84e-1)"	"unprognostic (2.43e-2)"	"unprognostic (9.75e-3)"	"unprognostic (2.69e-1)"	"unprognostic (2.49e-2)"	"prognostic unfavorable (1.50e-4)"	"unprognostic (7.94e-2)"	"unprognostic (6.28e-2)"	"prognostic unfavorable (3.30e-5)"	"unprognostic (5.18e-2)"	"unprognostic (8.12e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.37e-1)"	"unprognostic (2.10e-1)"	"unprognostic (1.60e-1)"	5.2	11.6	4.0	5.6	4.2	8.7	12.2	4.8	3.7	69.5	10.9	4.5	1.8	21.8	328.7	326.7	16.4	6.7	1.8	3.2	3.9	11.0	2.1	12.1	4.5	3.5	3.8	6.1	4.3	3.7	8.4	24.9	3.5	24.5	4.2	3.4	44.8	144.1	2.9	53.7	2.6	10.3	4.2	4.5	7.4	3.4	4.3	3.6	21.3	2.9	41.0	11.6	117.5	3.9	124.4	25.9	2.4	1.6	3.0	4.0	5.5	6.0	0.4	14.8	2.2	0.9	36.7	1.6	139.9	9.0	1.4	17.3	3.7	100.0	60.1	1.5	2.4	7.9	9.8	4.1	7.0	0.5	0.6	2.9	70.2	1.6	57.0	14.6	76.5	1.6	0.5	1.1	0.4	29.1	0.5	0.7	1.9	31.4	87.7	0.5	0.4	0.9	7.7	11.5	1.0	8.2	0.2	22.7	3.6	23.3	23.3	2.7	236.2	0.8	50.5	3.0	4.5	1.2	1.0	1.1	1.6	8.9	1.7	51.8	27.4	11.4	1.0	24.4	0.6	0.7	0.7	1.2	7.4	0.6	1.1	0.7	18.5	0.5	21.1	4.9	1.0	20.7	4.0	4.2	4.8	3.7	3.2	3.9	3.5	3.8	3.5	4.2	4.3	3.9	1.1	12.8	2.6	1.3	0.7	9.2	6.2	5.7	4.6	0.5	5.7	7.6	0.9	1.5	9.4	9.2	2.1	3.8	1.7	1.0	0.0	8.6	0.6	14.1	4.2	1.1	0.0	0.0	1.0	3.0	5.0	2.2	2.6	32.2	1.3	3.9	1.4	0.1	9.4	0.0	1.7	2.5	2.0	11.3	4.0	0.3	1.2	9.5	3.6	0.0	14.4	4.0	0.0	1.0	1.4	72.0	0.3	1.2	0.1	7.6	0.3	1.2	6.9	0.3	0.0	0.5	1.9	4.2	5.8	69.7	21.2	0.7	0.8	0.4	2.4	21.3
ZNF212	C2H2-150	ENSG00000170260	"Zinc finger protein 212"	Q9UDV6	7	149239651-149255606	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA049807, HPA054178"	Uncertain		Supported	Nucleoplasm		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 71: Testis - DNA repair"	"Cluster 24: NB-4 - Immune response"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	Nucleoplasm		"HPA049807: AB_2680891, HPA054178: AB_2682406"	"unprognostic (1.07e-2)"	"unprognostic (6.31e-2)"	"unprognostic (6.77e-3)"	"unprognostic (3.66e-3)"	"unprognostic (6.48e-2)"	"unprognostic (2.79e-3)"	"unprognostic (5.55e-3)"	"unprognostic (8.75e-3)"	"unprognostic (1.37e-3)"	"unprognostic (1.15e-1)"	"unprognostic (4.32e-3)"	"unprognostic (2.46e-1)"	"unprognostic (2.30e-1)"	"unprognostic (4.75e-2)"	"unprognostic (2.99e-1)"	"unprognostic (1.60e-2)"	"unprognostic (1.59e-1)"	5.4	8.3	6.7	4.8	6.9	12.2	6.7	7.2	6.9	9.9	6.7	7.1	9.2	8.1	6.2	14.7	7.4	4.1	5.9	6.4	6.5	7.4	10.2	4.8	8.0	7.1	6.8	9.1	7.9	6.4	6.4	6.2	6.9	8.7	4.8	4.5	8.6	6.2	6.2	10.9	9.7	5.1	6.7	10.7	7.0	12.5	6.8	9.5	7.7	4.7	8.0	6.9	9.6	7.2	10.7	10.4	12.5	15.9	8.7	7.0	13.8	6.3	9.5	11.2	11.2	8.9	13.3	14.0	9.7	6.4	9.0	9.6	9.3	10.4	9.2	10.8	16.7	7.7	8.1	7.5	6.6	12.8	9.2	8.0	11.7	7.7	8.1	7.0	6.7	16.9	14.3	10.5	6.5	15.2	23.2	26.0	16.6	8.4	12.5	15.6	8.6	15.3	7.0	8.9	12.5	20.5	9.7	9.4	9.6	7.5	5.6	13.5	5.7	11.3	3.1	14.5	11.7	24.1	11.3	12.6	14.8	11.5	10.4	0.0	3.5	7.6	5.0	2.9	5.0	4.1	3.7	4.2	4.4	3.9	6.4	5.5	1.9	8.2	3.7	3.9	5.9	2.1	6.7	6.9	7.2	6.9	6.4	6.5	7.1	6.8	6.9	6.7	6.8	7.2	3.7	6.4	3.3	5.9	5.4	9.7	3.1	3.2	4.0	7.3	5.4	4.7	3.0	5.7	2.2	0.0	4.2	9.6	2.9	5.5	3.9	5.9	1.8	5.9	3.5	4.2	6.7	5.2	6.8	4.0	10.0	4.0	2.6	5.7	2.5	7.1	4.2	5.8	4.2	10.1	6.5	5.5	8.2	5.6	2.3	0.8	6.2	2.9	1.8	5.6	6.1	6.0	6.2	6.0	7.7	4.6	1.2	6.0	4.0	3.8	11.1	3.8	4.5	8.3	13.1	4.2	3.1	13.8	22.1	4.4	8.7	15.1	5.4	5.8	5.3	4.0
ZNF219		ENSG00000165804	"Zinc finger protein 219"	Q9P2Y4	14	21090077-21104722	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030761, HPA056168"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 72: Non-specific - Transcription"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 40: Granulosa cells - Unknown function"	Nucleoplasm		"HPA030761: AB_2673598, HPA056168: AB_2683052"	"unprognostic (9.82e-3)"	"unprognostic (4.50e-3)"	"unprognostic (3.35e-1)"	"unprognostic (1.11e-3)"	"unprognostic (4.49e-2)"	"unprognostic (1.96e-1)"	"unprognostic (2.54e-1)"	"unprognostic (6.79e-2)"	"unprognostic (2.62e-2)"	"unprognostic (1.70e-1)"	"unprognostic (6.02e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.80e-3)"	"unprognostic (6.28e-2)"	"unprognostic (1.92e-1)"	"unprognostic (2.56e-2)"	"unprognostic (2.35e-2)"	44.2	77.1	15.2	7.4	10.7	4.5	35.5	32.0	17.9	33.9	14.3	83.3	22.4	41.6	9.4	49.2	29.6	5.4	42.0	22.0	14.8	20.6	17.1	32.8	2.5	20.7	25.7	30.7	24.7	12.4	23.5	6.5	20.3	38.3	10.3	11.0	28.2	21.7	34.0	45.6	33.1	9.3	13.6	13.1	33.3	11.9	17.8	10.9	32.3	5.9	3.6	44.7	36.1	9.1	8.1	26.6	33.6	49.5	4.5	4.3	48.1	9.8	15.0	4.9	7.7	15.5	17.7	12.0	7.2	3.7	5.4	59.1	10.8	31.4	3.4	24.6	11.5	7.1	42.2	32.7	2.8	1.5	10.9	6.6	25.9	8.0	14.7	6.5	6.0	11.0	6.9	3.5	2.7	22.4	16.2	11.3	47.5	15.3	5.7	33.7	5.6	3.1	3.8	44.0	38.2	34.4	13.5	7.9	7.8	6.7	9.5	4.2	1.2	6.0	26.4	14.7	4.0	6.1	4.2	2.7	3.8	6.0	11.8	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.1	0.6	0.1	0.0	0.4	0.0	0.0	15.2	10.7	32.0	17.9	22.0	14.8	20.7	25.7	20.3	13.6	17.8	9.1	5.6	3.2	10.7	12.7	1.8	14.8	13.3	13.5	11.4	36.6	14.4	19.6	7.6	10.0	4.3	3.7	27.1	9.6	3.4	33.0	1.9	10.3	9.2	2.5	1.9	6.3	7.8	8.2	3.5	11.3	1.0	6.0	5.1	4.6	14.7	35.1	9.3	8.0	7.4	11.8	4.9	17.4	10.2	7.5	11.8	5.6	9.9	5.9	8.8	7.5	0.8	33.0	1.0	13.6	2.5	7.8	10.0	12.4	3.9	12.0	23.6	6.8	4.3	27.4	13.1	9.3	14.7	8.9	8.7	13.5	15.6	12.4	5.2	6.3	26.6	12.7
ZNF224	"BMZF-2, KOX22, ZNF255, ZNF27"	ENSG00000267680	"Zinc finger protein 224"	Q9NZL3	19	44094339-44109886	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA054045	Approved		Supported	"Nucleoplasm,Nuclear membrane"		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 51: Non-specific - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 52: Non-specific - Transcription"	"Nuclear membrane"	Nucleoplasm	"HPA054045: AB_2682354"	"unprognostic (1.01e-3)"	"unprognostic (4.94e-2)"	"unprognostic (2.23e-1)"	"unprognostic (3.40e-3)"	"unprognostic (8.47e-2)"	"unprognostic (4.25e-4)"	"unprognostic (9.61e-2)"	"unprognostic (6.35e-3)"	"unprognostic (3.61e-2)"	"unprognostic (2.31e-1)"	"unprognostic (1.81e-3)"	"unprognostic (2.64e-2)"	"prognostic unfavorable (5.32e-4)"	"unprognostic (1.68e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.16e-1)"	"prognostic favorable (1.53e-7)"	15.5	15.4	12.5	17.6	14.2	9.6	17.0	15.9	13.9	16.2	16.0	15.0	18.1	17.8	23.1	9.4	16.1	13.8	12.5	12.3	13.3	14.3	15.8	16.3	22.4	13.1	13.2	20.6	14.7	14.1	19.5	14.8	13.7	17.1	21.2	17.8	15.6	15.7	7.5	24.6	22.2	13.3	12.6	27.2	16.0	6.4	13.4	18.3	19.8	5.9	22.6	12.7	13.0	16.7	8.5	13.9	14.7	12.1	14.4	15.0	12.0	10.5	15.6	7.1	16.2	7.0	6.6	10.2	11.3	13.9	5.4	9.5	8.1	9.0	9.4	10.5	16.4	19.7	26.5	7.3	7.6	14.3	22.0	18.6	16.0	8.8	13.1	22.6	13.1	10.1	6.1	12.0	12.0	2.2	12.6	17.2	6.4	4.7	9.5	7.4	15.9	6.3	10.8	26.9	7.5	17.1	14.4	6.2	5.0	14.4	6.1	18.5	13.8	15.7	10.1	7.1	7.4	16.2	16.3	5.8	8.4	11.0	7.4	49.6	9.1	22.0	18.4	6.3	20.3	16.9	15.5	18.7	9.7	17.8	19.5	15.1	6.9	16.7	13.7	8.7	19.5	10.4	12.5	14.2	15.9	13.9	12.3	13.3	13.1	13.2	13.7	12.6	13.4	16.7	16.0	22.4	14.6	16.3	26.2	5.6	7.3	14.7	10.8	26.8	9.1	5.7	4.7	18.6	11.3	25.8	18.8	13.1	30.4	14.5	1.9	8.1	14.5	7.9	9.9	12.2	9.6	12.0	26.2	5.3	8.1	12.4	8.6	8.2	21.0	20.5	16.1	7.6	7.3	26.9	23.4	11.2	20.3	13.9	8.9	4.4	16.1	10.4	5.4	14.0	19.8	11.8	47.4	14.1	29.0	8.6	13.3	13.9	12.1	10.4	29.8	3.3	7.4	22.1	13.1	10.9	9.3	5.4	4.1	6.8	6.8	8.2	27.3	19.9	11.0	9.3
ZNF232	ZSCAN11	ENSG00000167840	"Zinc finger protein 232"	Q9UNY5	17	5105541-5123116	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Spermatocytes: 18.1;Spermatogonia: 21.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			"HPA027309, HPA028611"	Uncertain		Supported	Nucleoplasm,Vesicles,Cytosol		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 35: Non-specific - Unknown function"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	Nucleoplasm	"Vesicles, Cytosol"	"HPA027309: AB_10603464, HPA028611: AB_2672700"	"unprognostic (4.20e-2)"	"unprognostic (2.06e-3)"	"unprognostic (3.69e-1)"	"unprognostic (5.59e-3)"	"unprognostic (5.21e-2)"	"unprognostic (5.90e-3)"	"prognostic unfavorable (4.66e-4)"	"unprognostic (3.12e-2)"	"unprognostic (5.46e-3)"	"unprognostic (2.49e-2)"	"prognostic favorable (6.55e-4)"	"unprognostic (3.28e-2)"	"unprognostic (3.49e-3)"	"unprognostic (2.22e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.11e-1)"	"unprognostic (8.61e-3)"	1.8	1.2	3.0	1.1	3.5	0.4	1.9	3.4	4.3	2.7	3.1	2.7	1.0	2.4	2.4	1.6	2.3	1.3	2.0	3.1	3.5	2.3	2.1	1.5	1.9	3.6	3.1	3.4	2.8	1.9	1.6	1.5	3.5	2.1	1.3	2.3	1.9	1.3	2.0	1.4	1.8	1.9	3.1	1.9	2.2	2.6	3.5	1.6	2.4	1.8	1.4	1.8	1.8	4.2	5.8	4.3	6.9	7.0	2.4	1.0	3.7	2.8	1.4	2.7	3.7	6.7	1.4	11.5	3.4	1.0	4.0	3.9	4.9	2.8	1.6	4.6	7.4	2.0	10.0	6.0	3.5	0.0	3.4	1.9	3.0	2.9	2.5	1.9	2.0	13.7	10.0	4.1	3.3	2.8	10.1	4.0	13.5	4.9	4.6	8.5	4.4	7.8	2.2	0.8	7.2	4.7	5.4	2.1	4.6	5.2	1.1	2.8	3.2	2.7	4.6	2.1	5.5	5.5	9.3	3.0	6.9	0.3	4.6	1.3	1.9	1.9	4.2	2.0	5.2	12.5	4.7	5.8	3.9	11.4	7.0	6.5	0.1	5.7	1.2	7.4	4.3	3.5	3.0	3.5	3.4	4.3	3.1	3.5	3.6	3.1	3.5	3.1	3.5	4.2	4.2	0.0	2.6	2.0	5.2	4.2	2.9	4.0	5.7	5.7	3.8	6.6	5.6	0.0	3.9	5.5	0.0	3.9	3.5	3.1	3.9	7.0	8.6	5.5	6.8	5.2	1.2	2.1	3.4	4.0	5.0	3.4	1.5	2.2	0.0	4.0	3.6	3.9	6.1	0.0	3.3	2.4	0.0	3.8	1.3	6.9	3.7	2.9	0.0	3.7	1.8	4.2	0.0	3.0	8.1	3.7	7.6	5.3	1.4	4.1	2.6	3.2	6.5	3.9	0.0	4.4	4.4	18.1	21.7	3.3	4.7	2.1	3.2	3.4	3.8	1.8
ZNF24	"KOX17, Zfp191, ZNF191, ZSCAN3"	ENSG00000172466	"Zinc finger protein 24"	P17028	18	35332227-35345482	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024062, CAB025642"	Supported		Supported	Nucleoplasm		NA	NA			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 20: Retina & Lymphoid tissues - Unknown function"	"Cluster 16: U-266 - Nucleosome"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"CAB025642: , HPA024062: AB_1859150"	"unprognostic (1.19e-1)"	"unprognostic (3.25e-1)"	"unprognostic (1.16e-3)"	"unprognostic (2.42e-2)"	"unprognostic (2.09e-1)"	"unprognostic (1.49e-2)"	"unprognostic (3.12e-2)"	"unprognostic (2.79e-2)"	"unprognostic (6.01e-2)"	"unprognostic (7.69e-2)"	"unprognostic (5.68e-2)"	"unprognostic (2.44e-2)"	"prognostic favorable (1.44e-4)"	"unprognostic (5.25e-2)"	"unprognostic (1.74e-2)"	"unprognostic (9.27e-2)"	"unprognostic (5.30e-3)"	19.4	21.9	32.1	22.4	40.0	25.0	35.3	34.9	34.8	21.6	29.7	19.7	20.5	23.8	22.2	17.8	18.2	18.1	20.9	28.7	33.1	23.8	30.9	21.5	28.8	36.4	36.8	26.1	25.8	32.3	12.5	23.4	37.3	25.5	21.4	38.0	23.7	18.3	23.7	15.4	21.4	18.2	33.4	25.6	25.1	19.9	33.4	34.0	33.3	27.6	26.4	19.2	12.6	54.4	19.3	19.1	60.0	31.5	24.9	26.7	16.9	25.9	29.1	31.3	35.7	12.4	15.5	43.7	28.4	21.7	25.0	34.8	44.7	24.3	53.5	40.1	24.3	31.3	40.2	26.7	26.2	66.9	48.6	22.6	41.0	28.0	30.2	36.0	30.2	27.2	48.2	27.6	32.8	22.8	51.3	28.5	31.2	12.8	12.8	38.0	38.8	35.1	31.5	44.0	51.0	43.7	31.6	29.2	54.7	31.0	27.4	50.3	25.7	44.8	20.1	10.8	26.1	69.7	60.6	44.4	25.0	27.0	41.8	30.2	21.0	24.8	24.4	20.3	23.5	30.5	24.1	20.8	19.3	30.2	23.0	21.4	40.9	22.4	30.3	29.7	20.0	15.2	32.1	40.0	34.9	34.8	28.7	33.1	36.4	36.8	37.3	33.4	33.4	54.4	49.0	57.7	63.0	30.0	66.1	32.9	65.9	44.2	29.0	57.2	62.6	55.4	46.9	52.9	60.7	25.8	43.8	41.4	52.7	37.7	27.4	46.4	126.1	47.6	37.6	50.2	55.6	43.1	26.9	41.1	33.6	47.5	29.6	41.1	43.6	40.0	42.8	48.3	35.3	79.1	26.4	39.2	44.7	38.2	25.4	33.8	54.3	38.6	23.2	33.7	43.1	101.3	56.7	33.2	71.7	42.3	37.8	50.0	34.0	67.2	29.8	30.4	59.1	85.5	46.0	50.1	53.9	59.0	51.6	32.7	32.5	70.7	45.6	50.9	32.2	76.5
ZNF256	BMZF-3	ENSG00000152454	"Zinc finger protein 256"	Q9Y2P7	19	57940833-57947706	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Spermatogonia: 8.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEK 293: 32.8"									HPA055390	Uncertain		Supported	Nucleoplasm		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 34: Non-specific - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA055390: AB_2682803"	"unprognostic (2.47e-2)"	"unprognostic (3.43e-2)"	"unprognostic (5.20e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.95e-2)"	"unprognostic (1.42e-1)"	"unprognostic (3.03e-1)"	"unprognostic (3.38e-1)"	"unprognostic (3.49e-3)"	"unprognostic (2.32e-2)"	"unprognostic (4.73e-3)"	"unprognostic (2.83e-2)"	"unprognostic (6.39e-3)"	"unprognostic (6.67e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.27e-1)"	"unprognostic (3.28e-3)"	3.5	2.5	2.3	2.3	2.6	10.8	5.6	5.6	3.3	2.9	2.4	3.3	2.3	3.5	4.4	2.7	3.9	1.9	6.0	2.5	1.9	3.1	1.8	3.2	4.9	1.6	1.8	5.5	2.1	4.4	2.8	4.6	1.6	3.8	2.9	9.1	3.3	4.0	3.6	7.1	3.5	3.5	1.6	4.6	2.6	4.3	1.7	5.4	3.9	4.2	5.3	3.1	2.8	2.3	3.9	1.3	9.6	9.7	2.0	3.3	8.3	3.3	3.5	5.2	3.5	0.8	2.1	0.0	2.9	4.3	8.0	0.5	2.2	7.4	8.5	0.0	32.8	9.5	0.0	2.6	3.7	0.0	7.4	6.5	2.0	3.8	0.0	5.4	3.2	9.1	0.7	0.0	5.3	0.9	13.2	0.0	11.6	0.4	8.2	4.2	12.0	5.9	3.8	16.8	4.8	6.9	0.0	3.0	2.4	11.8	7.2	3.0	1.3	10.7	6.3	0.0	6.5	4.4	4.7	16.9	0.3	0.0	4.7	1.3	1.0	1.3	3.3	3.4	6.1	4.7	5.6	5.0	4.2	5.6	5.4	6.4	0.5	3.9	3.6	2.0	4.9	2.2	2.3	2.6	5.6	3.3	2.5	1.9	1.6	1.8	1.6	1.6	1.7	2.3	2.4	0.0	0.0	2.0	4.0	2.7	4.8	3.5	2.2	4.5	2.4	1.4	3.2	1.5	1.7	1.8	0.0	3.1	2.2	0.4	3.9	3.5	0.2	1.2	1.1	2.7	1.2	5.2	1.6	0.8	1.7	2.0	1.1	1.3	0.0	2.2	0.7	0.7	1.4	1.7	1.4	0.9	8.2	0.8	1.0	0.3	1.8	0.8	0.0	1.0	1.7	3.8	1.0	3.5	0.6	0.8	0.3	0.4	0.3	2.7	0.8	0.9	3.4	7.2	0.0	2.6	2.1	4.9	8.7	1.6	3.4	2.6	3.1	2.3	1.2	3.7
ZNF260	"ozrf1, Zfp260"	ENSG00000254004	"Zinc finger protein 260"	Q3ZCT1	19	36510687-36528271	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028806	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 59: Non-specific - Transcription"	"Nucleoplasm, Cytosol"		"HPA028806: AB_10795285"	"unprognostic (1.34e-1)"	"unprognostic (6.31e-2)"	"unprognostic (8.35e-3)"	"unprognostic (1.11e-3)"	"unprognostic (3.55e-2)"	"unprognostic (1.29e-3)"	"unprognostic (7.83e-3)"	"unprognostic (3.91e-1)"	"unprognostic (1.13e-2)"	"unprognostic (8.36e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.81e-2)"	"prognostic favorable (1.44e-4)"	"unprognostic (7.73e-2)"	"unprognostic (2.17e-1)"	"unprognostic (1.06e-1)"	"unprognostic (7.89e-3)"	4.5	5.0	4.9	4.1	5.7	1.7	7.9	5.5	5.8	6.7	4.4	3.9	4.1	7.2	5.2	5.1	5.3	5.4	5.0	4.5	5.5	7.4	5.8	4.9	6.3	5.2	5.5	8.4	3.9	11.7	3.2	6.8	5.3	6.6	4.6	8.9	4.8	4.7	2.4	6.8	4.2	5.2	5.2	5.9	5.5	3.1	5.6	7.6	9.7	4.1	6.7	6.1	3.4	6.9	11.2	11.2	25.1	19.1	7.7	11.5	10.9	9.6	10.1	8.6	11.0	5.1	6.2	7.3	15.2	7.8	6.6	4.1	12.8	5.9	13.2	9.7	5.6	10.8	8.6	5.8	10.7	5.5	8.7	10.6	9.8	8.9	13.7	12.5	11.7	10.7	8.7	7.9	17.4	6.1	20.6	3.6	15.9	7.0	4.8	13.5	15.5	5.5	9.8	19.6	18.1	19.9	21.3	11.4	8.0	15.3	9.5	10.5	10.2	15.0	15.5	8.9	8.7	10.0	20.4	16.7	0.4	5.9	20.7	4.6	1.3	1.4	1.7	1.2	1.8	2.4	2.3	1.4	1.5	2.9	3.1	2.4	0.6	1.9	1.9	1.0	2.2	1.4	4.9	5.7	5.5	5.8	4.5	5.5	5.2	5.5	5.3	5.2	5.6	6.9	10.9	9.6	6.2	9.4	14.1	10.3	8.2	7.2	18.2	7.9	12.3	9.8	8.9	1.5	11.1	0.0	8.4	6.4	8.9	2.7	5.9	8.2	18.0	9.3	12.7	9.7	12.0	10.7	13.2	4.4	7.0	9.3	7.7	9.2	8.2	15.9	10.8	4.0	4.6	21.9	13.4	5.1	12.2	5.7	3.3	4.1	5.9	5.4	1.8	9.4	6.0	7.9	5.2	24.1	27.7	6.6	3.5	8.2	3.7	7.1	3.4	8.3	6.3	7.9	6.6	6.4	9.1	8.0	3.8	16.2	13.1	4.1	10.4	9.2	4.6	11.9
ZNF263	"FPM315, ZKSCAN12, ZSCAN44"	ENSG00000006194	"Zinc finger protein 263"	O14978	16	3263800-3301401	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 60.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035085, HPA035086"	Approved		Supported	"Nucleoplasm,Mitotic spindle,Cytosol"		Yes	No			"Cluster 52: Eosinophils - Transcription"	"Cluster 51: Non-specific - Unknown function"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	Cytosol	"Nucleoplasm, Mitotic spindle"	"HPA035085: AB_10671099, HPA035086: AB_10603244"	"unprognostic (2.06e-1)"	"unprognostic (2.97e-2)"	"unprognostic (2.57e-1)"	"unprognostic (1.31e-1)"	"unprognostic (3.33e-1)"	"unprognostic (2.25e-1)"	"unprognostic (6.42e-2)"	"unprognostic (7.00e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.68e-1)"	"unprognostic (6.39e-2)"	"unprognostic (2.30e-3)"	"unprognostic (2.98e-3)"	"unprognostic (5.10e-2)"	"unprognostic (1.34e-1)"	"unprognostic (3.16e-2)"	"unprognostic (2.66e-1)"	20.8	18.3	18.3	16.8	18.1	19.1	24.1	20.4	22.5	20.2	20.3	20.1	14.5	22.9	23.2	15.4	24.5	16.7	15.1	19.1	17.7	20.4	17.6	19.4	22.6	20.1	17.6	29.2	21.5	30.7	23.4	20.4	17.2	21.4	17.0	24.6	20.2	20.2	17.3	24.0	19.3	18.7	16.6	23.2	22.0	18.1	18.2	22.3	20.0	13.7	21.5	19.5	17.5	20.5	19.7	25.1	27.6	40.8	22.7	28.8	36.6	26.1	38.6	30.0	32.2	27.5	30.3	74.2	26.5	33.6	28.6	25.7	38.6	26.4	29.9	41.6	41.3	31.4	35.6	25.6	25.7	48.8	38.5	34.0	53.3	27.6	40.0	33.5	26.2	44.5	37.9	47.4	24.8	25.5	43.9	37.2	55.7	23.2	19.2	70.4	29.8	57.6	20.7	18.4	40.6	43.8	27.9	30.0	30.9	32.5	32.8	57.7	30.1	31.4	30.9	23.3	25.4	50.8	60.8	88.0	12.9	23.6	23.8	1.4	2.5	6.4	3.5	2.4	4.0	2.5	4.2	4.7	3.5	4.4	5.4	3.8	3.0	4.5	3.4	2.9	3.1	1.9	18.3	18.1	20.4	22.5	19.1	17.7	20.1	17.6	17.2	16.6	18.2	20.5	15.9	0.0	11.5	8.8	16.6	17.5	17.1	3.7	16.5	12.5	13.9	12.8	4.6	15.7	5.0	1.8	0.0	11.5	16.1	8.7	7.9	10.2	60.9	10.5	8.8	12.8	13.2	6.3	7.9	10.0	11.1	11.9	11.2	13.5	7.0	14.3	10.0	7.1	9.1	3.3	6.7	12.1	10.2	9.4	14.3	35.1	8.1	9.5	16.0	7.5	8.4	9.8	19.6	8.0	7.8	10.3	6.0	7.9	11.8	16.3	7.5	6.3	5.7	9.0	13.1	17.5	17.3	13.0	11.1	14.3	20.6	11.1	15.0	15.2	12.3	13.6
ZNF268	HZF3	ENSG00000090612	"Zinc finger protein 268"	Q14587	12	133181409-133214832	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			HPA001794	Approved		Supported	Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 52: Non-specific - Transcription"	Cytosol		"HPA001794: AB_2666437"	"unprognostic (7.65e-2)"	"unprognostic (2.78e-1)"	"unprognostic (1.21e-1)"	"unprognostic (4.64e-2)"	"unprognostic (3.09e-1)"	"unprognostic (2.81e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.94e-1)"	"unprognostic (4.91e-3)"	"unprognostic (2.21e-1)"	"unprognostic (7.63e-3)"	"unprognostic (2.57e-2)"	"unprognostic (6.59e-3)"	"unprognostic (5.69e-2)"	"unprognostic (2.30e-1)"	"unprognostic (8.79e-2)"	"unprognostic (1.53e-3)"	5.6	6.6	2.8	4.0	3.9	3.6	9.5	5.0	3.9	7.4	4.9	5.5	4.4	7.5	7.4	6.5	8.7	4.3	4.4	2.7	3.3	9.3	12.8	5.6	6.2	3.4	3.5	9.7	5.3	13.1	3.9	9.5	3.3	8.1	5.4	12.0	5.6	6.9	2.4	5.1	5.2	5.8	3.2	6.0	7.1	5.8	3.2	7.3	10.7	4.9	7.1	6.3	3.7	4.2	6.9	10.1	21.4	19.0	9.0	11.5	14.6	10.2	10.8	9.3	7.4	10.6	4.6	5.9	15.5	10.3	9.4	6.3	10.5	12.8	11.8	0.2	8.5	14.6	5.3	13.4	9.6	14.1	12.6	16.9	12.6	11.1	17.4	12.5	10.8	5.6	11.2	7.8	15.9	8.2	5.7	6.4	15.8	8.7	0.6	5.7	6.6	7.3	5.3	15.9	15.3	12.9	20.9	7.0	9.1	18.2	17.0	12.0	11.6	10.6	13.2	3.7	9.3	2.8	4.2	12.9	5.9	7.3	11.3	1.9	5.1	6.0	8.2	5.0	5.5	9.6	9.3	10.4	7.6	7.2	14.2	10.2	1.6	10.8	8.6	6.0	5.2	5.0	2.8	3.9	5.0	3.9	2.7	3.3	3.4	3.5	3.3	3.2	3.2	4.2	8.0	19.2	22.3	6.8	10.0	1.8	5.6	5.7	5.2	24.3	10.0	8.4	8.4	12.8	13.6	7.3	20.9	14.9	3.2	2.8	5.9	8.8	15.5	7.1	9.0	9.5	3.6	15.8	8.4	6.4	9.4	9.7	4.6	7.5	2.5	19.1	14.6	11.0	9.8	21.9	10.0	6.9	4.1	6.7	3.0	4.3	10.5	7.7	5.4	10.3	5.5	15.8	8.2	11.6	12.9	7.7	7.6	11.3	5.2	6.3	5.5	11.5	7.1	19.1	6.6	17.4	8.8	14.9	17.3	6.4	2.8	8.6	7.5	12.4	6.9	4.4
ZNF318	"HRIHFB2436, ZFP318"	ENSG00000171467	"Zinc finger protein 318"	Q5VUA4	6	43307134-43369647	"Predicted intracellular proteins"	"Meiosis, Transcription, Transcription regulation"	"Activator, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 82.9;Spermatogonia: 46.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"naive B-cell: 2.1"	"Lineage enriched"	"Detected in single"	4	"B-cells: 2.1"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027022, HPA027031"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 34: Non-specific - Transcription"	"Cluster 21: OE19 - Mitochondria"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	Nucleoplasm	Cytosol	"HPA027022: AB_1859189, HPA027031: AB_1859190"	"unprognostic (1.64e-1)"	"unprognostic (3.80e-1)"	"unprognostic (1.13e-1)"	"unprognostic (4.11e-3)"	"unprognostic (1.97e-2)"	"unprognostic (3.02e-2)"	"unprognostic (2.53e-3)"	"unprognostic (1.93e-1)"	"unprognostic (1.80e-2)"	"unprognostic (3.37e-2)"	"unprognostic (8.24e-2)"	"unprognostic (3.47e-1)"	"unprognostic (4.61e-3)"	"unprognostic (3.61e-1)"	"unprognostic (3.00e-1)"	"unprognostic (2.82e-1)"	"unprognostic (1.54e-2)"	8.1	6.4	6.4	12.4	5.5	11.4	7.9	11.7	8.8	14.2	1.9	9.3	7.2	11.5	10.6	6.4	9.7	7.0	7.0	6.3	5.3	6.4	8.1	7.5	25.6	3.7	4.6	11.9	8.2	10.8	7.3	8.0	3.6	9.7	8.0	21.2	7.5	8.1	8.5	12.0	9.7	9.0	3.1	14.4	6.3	26.2	4.8	13.3	12.5	6.3	25.0	8.9	10.0	6.9	26.4	6.2	18.0	29.9	15.4	13.7	9.3	11.6	14.3	12.8	11.1	6.6	3.2	41.5	6.4	14.4	15.0	11.4	20.0	9.5	16.6	11.8	10.7	11.4	8.1	10.7	7.7	20.2	9.2	8.8	9.8	10.8	9.6	10.8	10.2	11.3	15.6	19.3	13.8	9.0	6.4	12.8	8.1	42.9	5.9	7.6	17.9	6.4	7.1	5.9	16.6	10.2	8.6	7.2	9.0	13.8	9.1	27.6	10.6	17.9	9.2	12.2	11.4	12.4	10.9	28.2	5.6	15.1	10.2	0.0	0.3	0.0	0.5	0.2	0.1	0.6	0.4	0.3	0.3	2.1	0.3	0.3	0.1	0.3	0.1	0.3	0.5	0.2	6.4	5.5	11.7	8.8	6.3	5.3	3.7	4.6	3.6	3.1	4.8	6.9	7.8	9.6	14.5	10.7	29.9	9.7	4.4	5.6	12.0	18.1	6.5	6.9	9.5	8.6	6.4	9.2	8.4	5.8	6.8	5.2	3.9	5.2	30.7	9.2	13.3	7.8	5.4	8.2	19.9	4.7	4.4	10.4	5.1	6.3	6.3	20.6	11.7	19.4	6.6	25.2	18.9	5.1	6.1	11.1	7.2	16.5	6.2	10.7	3.6	4.7	9.7	9.4	16.5	15.6	17.5	4.2	8.2	9.8	5.1	3.0	11.4	3.9	6.8	11.8	26.3	13.6	8.7	82.9	46.3	9.0	5.1	1.8	8.8	8.9	8.3	2.0
ZNF322	"bA457M11.2, bA457M11.3, HCG12, ZNF322A, ZNF388, ZNF489"	ENSG00000181315	"Zinc finger protein 322"	Q6U7Q0	6	26634383-26659752	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043161, HPA046692"	Approved		Supported	Nucleoplasm,Centrosome,Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 21: Non-specific - Transcription"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm	"Centrosome, Cytosol"	"HPA043161: AB_2678346, HPA046692: AB_2679755"	"unprognostic (1.01e-2)"	"unprognostic (2.81e-1)"	"unprognostic (5.20e-2)"	"unprognostic (3.39e-3)"	"prognostic favorable (1.28e-4)"	"unprognostic (1.21e-1)"	"unprognostic (9.35e-2)"	"prognostic favorable (8.57e-4)"	"unprognostic (5.24e-2)"	"unprognostic (3.52e-2)"	"unprognostic (2.53e-1)"	"unprognostic (2.50e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.08e-1)"	"unprognostic (3.55e-1)"	"unprognostic (3.24e-2)"	"unprognostic (5.71e-2)"	7.8	12.0	11.0	7.8	11.9	1.3	12.8	12.1	12.4	15.4	10.9	8.8	9.3	15.5	13.3	8.6	11.4	9.8	7.7	10.2	12.0	11.8	9.3	9.9	9.9	11.8	11.5	17.9	8.2	17.7	7.1	11.2	12.4	14.9	10.9	14.3	8.7	13.9	6.6	6.0	8.1	10.5	12.0	11.7	9.1	11.1	11.6	10.1	15.3	12.8	9.7	10.8	7.4	15.0	9.3	6.8	26.2	31.0	17.3	22.5	9.7	12.3	16.1	16.6	20.1	13.3	5.5	11.0	28.5	10.6	20.8	11.5	19.7	7.4	20.8	17.3	18.0	19.5	8.7	13.2	19.5	0.0	17.3	14.1	27.0	10.7	12.3	20.8	14.4	13.5	23.3	11.7	18.3	5.2	14.1	16.9	7.8	8.5	8.4	15.4	18.6	16.0	10.1	14.5	21.3	22.7	14.5	13.6	25.9	12.8	12.5	12.8	14.4	27.8	11.0	11.4	12.4	12.2	25.8	10.8	5.8	2.9	28.4	3.3	8.4	10.8	10.5	7.2	7.6	11.2	5.3	6.9	6.9	9.0	6.1	9.1	8.0	17.8	11.9	7.8	4.5	5.1	11.0	11.9	12.1	12.4	10.2	12.0	11.8	11.5	12.4	12.0	11.6	15.0	24.8	6.4	10.5	3.9	18.0	4.0	17.3	4.8	14.8	32.1	23.9	31.2	5.8	12.8	11.1	9.2	8.4	12.5	16.1	9.9	35.2	17.7	4.1	14.2	32.6	20.1	19.7	7.2	5.3	10.2	11.3	21.9	10.2	15.7	13.3	30.0	18.2	7.6	13.3	47.1	7.0	14.1	8.2	8.9	5.3	3.7	30.1	11.7	8.8	6.5	12.7	26.7	10.3	11.1	10.3	16.1	12.8	26.4	11.8	26.4	10.2	13.3	8.1	13.9	32.9	20.6	22.2	26.0	15.7	12.0	6.5	9.6	9.1	37.7	10.0	24.9
ZNF330	"HSA6591, NOA36"	ENSG00000109445	"Zinc finger protein 330"	Q9Y3S2	4	141220887-141234697	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 154.0;Early spermatids: 197.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015705, HPA056325"	Uncertain		Supported	Nucleoplasm,Nucleoli		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 38: Heart - Muscle contraction"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 29: Early spermatids - Spermatogenesis"	Nucleoli	Nucleoplasm	"HPA015705: AB_1859199, HPA056325: AB_2683101"	"unprognostic (1.90e-1)"	"unprognostic (4.65e-2)"	"unprognostic (3.66e-1)"	"unprognostic (1.35e-2)"	"unprognostic (4.12e-1)"	"unprognostic (5.93e-2)"	"unprognostic (2.37e-1)"	"unprognostic (2.32e-3)"	"unprognostic (4.49e-3)"	"unprognostic (1.37e-1)"	"unprognostic (1.76e-1)"	"prognostic unfavorable (3.66e-6)"	"prognostic favorable (7.27e-6)"	"unprognostic (3.24e-1)"	"unprognostic (4.60e-2)"	"unprognostic (2.02e-2)"	"unprognostic (1.30e-2)"	29.1	26.8	11.9	20.3	12.6	35.5	22.8	14.3	15.7	23.1	15.0	30.9	18.5	26.0	17.6	25.2	25.6	19.8	100.3	11.0	12.8	26.0	51.7	25.1	28.6	13.3	12.6	25.1	26.9	23.9	15.5	20.2	13.2	21.0	22.7	25.0	48.1	20.1	67.1	19.0	21.2	32.1	12.9	23.2	22.8	26.3	13.1	21.5	37.4	43.4	26.7	23.4	18.7	14.6	20.7	24.8	29.5	23.4	51.7	46.1	41.3	54.0	31.1	34.1	32.1	33.5	38.6	87.6	32.4	34.3	19.3	16.1	52.6	35.0	51.7	40.8	34.4	40.7	39.2	47.6	55.2	103.8	31.6	46.6	40.3	32.0	46.4	41.4	36.1	53.1	84.3	57.9	43.8	46.4	80.9	48.6	26.3	63.2	46.7	65.0	42.2	55.9	36.7	22.6	51.1	23.8	19.0	42.9	55.7	33.0	21.5	28.1	38.7	43.3	29.4	26.3	39.1	96.1	74.7	83.2	36.2	63.8	31.6	16.3	27.4	16.7	15.9	22.7	22.3	21.6	20.1	20.7	28.9	17.7	21.6	20.0	4.1	20.1	18.8	19.6	25.9	16.3	11.9	12.6	14.3	15.7	11.0	12.8	13.3	12.6	13.2	12.9	13.1	14.6	32.5	54.5	32.4	8.1	31.9	49.2	53.9	22.3	35.3	63.0	21.5	29.1	154.0	27.1	26.2	9.2	14.6	38.2	29.8	21.2	58.7	32.7	197.7	34.9	58.2	31.5	16.8	29.6	13.0	51.0	37.9	35.3	18.8	26.9	22.9	25.7	32.5	70.6	73.5	16.8	13.4	25.7	20.3	56.2	36.0	50.5	39.1	48.2	46.2	20.6	38.1	38.4	14.4	11.6	17.3	43.5	27.8	28.6	27.4	43.6	26.0	78.3	20.3	26.1	13.1	42.4	34.9	46.2	17.7	33.6	51.6	34.3	29.7	38.4	26.9	56.6
ZNF333	KIAA1806	ENSG00000160961	"Zinc finger protein 333"	Q96JL9	19	14689801-14733746	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			"HPA043973, HPA054680"	Uncertain		Supported	Nucleoplasm		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA043973: AB_10961277, HPA054680: AB_2682571"	"unprognostic (8.16e-2)"	"unprognostic (2.80e-4)"	"unprognostic (5.21e-2)"	"unprognostic (2.83e-1)"	"unprognostic (1.21e-2)"	"unprognostic (1.45e-3)"	"unprognostic (2.98e-2)"	"unprognostic (2.17e-3)"	"unprognostic (2.12e-2)"	"unprognostic (1.46e-1)"	"unprognostic (4.87e-3)"	"unprognostic (3.46e-2)"	"unprognostic (1.32e-5)"	"unprognostic (4.09e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.62e-1)"	"unprognostic (7.06e-3)"	6.3	3.8	4.5	3.7	5.0	6.3	5.2	5.9	5.4	6.8	3.5	6.1	1.9	6.4	4.6	2.3	6.7	2.9	3.5	4.5	4.3	3.2	2.2	4.2	3.5	4.8	4.7	7.3	4.3	3.1	3.0	3.4	5.1	4.3	2.5	5.6	3.0	3.6	7.8	3.6	3.7	5.2	4.6	6.8	3.6	3.8	4.9	3.5	3.3	4.1	3.0	5.7	4.7	6.6	1.2	0.8	4.6	6.1	6.6	6.2	1.8	2.7	4.0	2.5	3.6	0.1	0.9	1.8	3.3	3.5	0.6	1.0	1.2	0.9	3.6	4.9	1.3	8.5	1.9	1.8	5.5	3.2	4.6	5.4	3.2	2.1	6.6	3.3	3.6	2.2	1.5	3.9	3.2	0.5	1.7	8.1	1.7	2.8	1.5	3.1	2.6	1.9	2.4	1.4	2.5	5.1	2.6	0.3	4.9	1.8	1.1	5.5	5.8	4.1	1.9	6.9	3.0	1.7	0.9	1.7	4.3	5.8	5.0	8.6	3.4	5.3	3.5	4.5	4.6	2.3	3.0	2.9	4.3	2.2	3.5	3.3	6.4	13.8	4.6	2.7	3.2	2.2	4.5	5.0	5.9	5.4	4.5	4.3	4.8	4.7	5.1	4.6	4.9	6.6	8.8	6.4	8.7	9.1	6.6	3.1	5.4	1.6	6.2	12.7	4.5	5.6	3.7	0.0	2.7	3.7	4.2	3.0	4.7	2.2	1.9	2.7	5.8	2.3	9.0	7.5	2.4	3.4	12.6	3.0	3.0	9.1	3.1	3.1	16.5	12.0	5.0	2.2	5.1	8.4	15.7	1.0	4.1	9.1	6.0	3.7	9.9	8.0	1.8	11.2	9.5	5.5	12.3	13.6	22.9	2.3	2.1	9.1	4.1	4.1	2.0	2.1	3.5	17.4	13.1	10.8	9.8	11.9	7.3	2.6	2.7	1.4	5.5	4.3	2.3	3.5
ZNF346	"JAZ, Zfp346"	ENSG00000113761	"Zinc finger protein 346"	Q9UL40	5	177022696-177081189	"Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 31.0;Excitatory neurons: 36.7;Inhibitory neurons: 35.1;Oligodendrocyte precursor cells: 29.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018485	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 21: Non-specific - Transcription"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 64: Astrocytes - Nervous system maintenance"	Nucleoplasm		"HPA018485: AB_1859213"	"unprognostic (1.89e-1)"	"unprognostic (4.25e-2)"	"unprognostic (5.71e-3)"	"prognostic unfavorable (9.54e-5)"	"unprognostic (9.85e-2)"	"unprognostic (1.46e-1)"	"prognostic unfavorable (1.88e-7)"	"unprognostic (2.69e-2)"	"unprognostic (1.45e-2)"	"unprognostic (2.13e-1)"	"prognostic favorable (1.20e-4)"	"unprognostic (5.11e-2)"	"unprognostic (7.86e-2)"	"unprognostic (8.60e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.36e-2)"	"unprognostic (1.44e-2)"	5.9	8.1	8.5	5.0	8.4	6.4	6.3	13.5	10.0	9.7	6.5	7.6	4.6	8.4	7.7	8.5	8.4	4.6	6.9	8.2	7.7	8.1	7.3	5.3	7.8	5.7	5.8	13.4	8.0	7.2	10.4	5.0	5.3	8.3	5.1	11.1	6.5	7.1	8.1	7.7	6.1	9.0	4.5	8.1	6.2	9.7	8.6	10.1	10.4	6.5	9.5	7.4	7.8	7.2	6.5	11.7	18.7	25.4	9.6	8.7	16.1	11.3	11.5	17.8	19.7	14.8	9.8	17.1	12.5	10.8	15.3	8.5	17.7	18.0	16.9	54.3	14.1	11.1	13.7	13.2	11.5	18.0	10.2	9.7	10.1	16.9	12.3	10.5	20.8	18.4	13.4	10.2	8.2	21.8	25.2	9.6	8.2	8.1	19.0	25.6	12.9	7.8	12.4	7.6	24.0	10.3	13.9	10.3	8.9	9.0	14.5	10.0	11.0	14.4	11.5	10.0	12.3	9.6	10.6	18.5	5.7	16.1	11.8	0.8	4.0	6.6	8.2	4.0	5.3	5.3	5.8	5.4	4.2	8.4	7.2	7.4	4.2	18.3	4.0	3.9	6.4	4.9	8.5	8.4	13.5	10.0	8.2	7.7	5.7	5.8	5.3	4.5	8.6	7.2	5.2	0.0	6.0	31.0	7.1	2.9	2.9	4.3	8.0	11.4	4.3	5.3	4.1	7.2	3.2	5.5	6.2	9.5	3.3	2.6	9.8	6.0	2.4	3.6	7.5	7.7	4.8	15.2	36.7	5.8	5.8	5.9	1.5	3.2	2.5	9.6	4.2	2.9	5.7	8.4	35.1	4.1	8.2	2.9	1.7	5.4	5.0	3.1	3.6	12.2	3.5	7.8	1.0	29.1	20.9	4.0	2.2	6.4	8.6	1.0	4.7	4.1	1.1	6.0	0.0	6.1	5.8	12.9	10.9	5.5	4.8	3.3	6.7	10.1	3.2	1.4
ZNF350	"ZBRK1, ZFQR"	ENSG00000256683	"Zinc finger protein 350"	Q9GZX5	19	51964340-51986856	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Cancer enriched"	"Detected in all"	4	"prostate cancer: 16.2"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in many"			HPA001521	Uncertain		Supported	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 63: NK-cells & T-cells - Immune response"	Nucleoplasm	"Nuclear bodies"	"HPA001521: AB_1080705"	"unprognostic (7.26e-3)"	"unprognostic (4.02e-2)"	"unprognostic (2.51e-2)"	"unprognostic (5.84e-2)"	"unprognostic (1.03e-2)"	"unprognostic (4.17e-2)"	"unprognostic (7.08e-2)"	"unprognostic (6.64e-2)"	"unprognostic (2.08e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.76e-1)"	"unprognostic (3.25e-3)"	"unprognostic (6.64e-3)"	"unprognostic (1.19e-2)"	"unprognostic (3.16e-1)"	"unprognostic (8.30e-2)"	"prognostic favorable (2.54e-4)"	6.6	4.4	5.8	5.4	7.3	26.2	13.8	8.6	6.7	5.5	4.1	6.6	5.4	6.4	8.2	4.7	5.8	5.2	5.1	6.4	6.5	7.0	5.3	6.3	9.7	6.0	5.7	8.3	4.5	9.2	4.8	9.3	6.1	27.5	9.1	9.7	6.4	6.3	4.5	7.5	6.1	5.8	5.8	9.0	7.3	6.3	6.5	9.0	9.8	5.9	9.1	6.2	5.2	7.2	0.8	4.4	5.6	6.8	7.5	6.7	1.1	4.6	6.5	4.8	9.5	0.0	3.5	2.1	3.6	5.5	8.8	5.8	4.9	6.5	6.6	0.0	10.5	8.6	7.5	3.9	6.3	2.2	10.1	9.5	9.9	6.4	6.6	9.4	5.5	3.5	2.3	0.1	5.8	2.8	8.5	10.2	3.7	0.5	6.8	4.0	8.0	6.9	7.6	11.9	4.7	6.3	0.0	6.0	5.0	7.9	9.8	7.7	5.9	5.2	3.7	3.1	4.7	1.6	2.8	2.7	1.0	0.1	5.6	65.3	11.2	26.9	16.2	12.7	16.4	16.8	15.3	15.6	13.6	17.2	17.7	14.2	30.8	21.5	16.2	8.8	13.4	8.1	5.8	7.3	8.6	6.7	6.4	6.5	6.0	5.7	6.1	5.8	6.5	7.2	9.1	0.0	7.3	4.6	13.1	5.9	11.0	11.1	5.7	9.9	6.0	5.3	6.6	2.8	10.7	9.2	12.5	12.2	12.9	5.1	7.9	6.7	13.0	4.5	4.7	8.0	7.3	2.5	4.2	5.3	9.9	7.1	3.6	6.7	12.0	9.7	6.4	3.1	7.8	6.7	4.1	5.9	16.2	9.5	12.0	3.4	11.1	10.8	12.4	6.5	11.6	7.9	23.7	4.0	9.1	6.0	5.7	6.0	7.5	14.5	7.6	3.9	7.8	13.1	0.0	7.2	8.4	10.2	5.7	3.5	7.0	23.1	15.1	6.8	3.8	13.4
ZNF354A	"EZNF, HKL1, KID-1, KID1, TCF17"	ENSG00000169131	"Zinc finger protein 354A"	O60765	5	178711512-178730659	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BEWO: 49.6"	"Low region specificity"	"Detected in all"							HPA052043	Approved		Supported	Nucleoplasm,Nucleoli,Cytosol		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 2: Immune cells - Immune response"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Nucleoplasm, Nucleoli"	Cytosol	"HPA052043: AB_2681706"	"unprognostic (2.79e-1)"	"unprognostic (3.44e-2)"	"unprognostic (7.06e-3)"	"unprognostic (1.78e-3)"	"unprognostic (1.38e-1)"	"unprognostic (1.32e-1)"	"unprognostic (3.25e-2)"	"unprognostic (1.41e-1)"	"unprognostic (7.66e-3)"	"prognostic favorable (8.28e-4)"	"unprognostic (4.06e-2)"	"unprognostic (4.55e-2)"	"prognostic unfavorable (3.45e-6)"	"unprognostic (8.71e-2)"	"unprognostic (4.13e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.07e-2)"	8.3	5.3	7.8	7.7	7.6	9.4	8.3	7.4	9.3	9.5	6.8	12.4	4.3	8.6	7.6	6.9	8.8	5.8	7.7	7.8	6.9	11.7	4.8	8.1	8.4	7.1	7.3	7.6	11.1	8.1	6.5	8.5	7.3	9.7	5.8	8.5	6.3	8.4	7.5	7.5	8.2	8.0	6.7	12.6	7.9	10.5	7.7	8.4	10.8	8.1	8.8	9.9	8.3	7.9	7.6	5.8	12.0	31.9	20.4	16.4	49.6	8.6	11.4	11.7	12.5	8.7	12.5	10.1	11.1	7.9	21.5	14.9	4.5	37.6	17.8	13.7	13.8	3.1	8.0	1.1	15.4	0.0	8.3	12.9	22.9	10.3	20.8	15.1	11.3	13.5	2.5	0.0	17.2	15.4	15.5	10.2	10.5	7.0	15.0	11.6	2.1	6.5	10.9	7.6	13.1	14.3	10.9	12.3	17.0	15.7	10.1	14.9	8.8	13.2	8.6	7.5	7.4	3.3	7.2	6.3	0.5	2.3	16.9	4.5	6.0	15.6	4.9	4.0	6.1	5.4	4.3	5.5	5.4	3.5	4.8	3.6	15.8	6.1	4.1	2.0	4.4	3.6	7.8	7.6	7.4	9.3	7.8	6.9	7.1	7.3	7.3	6.7	7.7	7.9	10.7	12.8	7.4	8.8	7.5	5.0	11.7	14.1	4.0	9.0	8.2	9.3	6.6	4.3	11.3	7.3	14.6	12.8	12.6	3.7	13.7	11.3	18.8	5.9	9.0	9.0	4.8	7.8	18.6	7.6	14.6	9.5	3.6	5.7	6.3	14.3	4.6	1.5	8.9	6.7	10.9	2.7	8.2	7.7	8.2	4.7	6.8	8.2	10.6	10.3	7.6	9.2	16.5	12.5	13.3	7.2	1.4	10.5	3.2	10.7	4.1	17.0	9.5	10.5	6.6	10.1	9.4	36.2	12.0	4.8	5.5	12.2	9.2	10.9	4.3	7.7
ZNF354C	KID3	ENSG00000177932	"Zinc finger protein 354C"	Q86Y25	5	179060373-179083977	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Horizontal cells: 16.8;Oligodendrocyte precursor cells: 17.6;Oligodendrocytes: 16.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 17.8"	"Low region specificity"	"Detected in all"							"HPA030904, HPA068570"	Uncertain		Supported	Nucleoplasm		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 21: Non-specific - Transcription"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA030904: AB_10603842, HPA068570: "	"unprognostic (1.55e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.82e-1)"	"unprognostic (6.56e-4)"	"unprognostic (4.76e-1)"	"unprognostic (2.40e-3)"	"unprognostic (2.61e-2)"	"unprognostic (2.83e-2)"	"unprognostic (1.01e-3)"	"unprognostic (1.58e-1)"	"unprognostic (1.11e-1)"	"unprognostic (5.57e-2)"	"unprognostic (1.62e-1)"	"unprognostic (2.46e-2)"	"unprognostic (1.61e-1)"	"unprognostic (4.00e-2)"	"unprognostic (2.83e-1)"	3.2	2.2	2.7	2.4	3.7	0.6	4.0	6.1	2.9	3.6	1.8	3.1	1.2	5.1	1.8	2.0	3.6	2.6	2.8	2.3	2.6	2.1	1.4	2.6	3.4	3.0	3.5	7.0	2.0	3.1	1.2	3.2	3.2	3.5	1.6	6.4	2.1	3.3	2.2	1.9	2.0	3.8	2.9	3.3	2.0	2.2	3.4	4.4	4.7	4.3	3.4	2.5	2.3	4.4	1.0	1.4	11.1	17.8	5.6	9.0	0.0	5.0	4.3	5.4	6.1	0.0	2.2	0.0	5.9	5.4	9.0	3.4	0.0	1.7	10.2	0.0	0.1	0.0	0.5	0.0	5.3	0.0	2.4	6.8	1.6	5.4	0.0	1.7	2.6	0.0	0.1	0.0	6.5	0.6	10.6	0.0	7.7	0.8	0.0	0.0	0.0	0.0	2.0	0.4	6.7	11.2	7.8	0.1	5.2	4.7	4.6	4.2	3.3	0.0	7.1	4.7	0.0	0.0	0.0	0.0	0.0	0.0	5.0	0.2	0.1	0.1	0.5	0.2	0.5	0.3	0.7	0.5	0.2	0.3	0.7	0.6	0.0	0.3	0.6	0.0	0.5	0.3	2.7	3.7	6.1	2.9	2.3	2.6	3.0	3.5	3.2	2.9	3.4	4.4	6.4	3.2	3.1	10.4	2.6	0.9	0.6	1.4	2.8	10.5	1.7	3.0	6.1	4.3	2.3	0.0	0.0	2.2	2.2	0.1	0.0	1.3	0.4	1.3	5.5	4.3	0.0	2.1	8.0	0.9	1.4	5.1	0.5	1.3	1.3	7.4	4.6	0.9	1.7	16.8	2.5	0.5	2.0	1.6	2.2	0.4	3.1	1.7	1.8	4.7	0.6	5.4	1.0	17.6	16.2	0.7	0.1	5.7	0.7	0.6	0.2	0.6	1.3	5.0	6.6	7.0	3.9	2.3	1.3	2.2	0.9	0.5	2.2	4.3	0.7	0.3
ZNF365	"KIAA0844, UAN"	ENSG00000138311	"Zinc finger protein 365"	Q70YC5	10	62374192-62480288	"Predicted intracellular proteins"	Neurogenesis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 22.7;esophagus: 10.2"	"Group enriched"	"Detected in some"	6	"Excitatory neurons: 112.7;Oligodendrocyte precursor cells: 113.6;Oligodendrocytes: 195.5"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"cerebral cortex: 22.7;hippocampal formation: 8.3;thalamus: 8.0;white matter: 16.6"	"Group enriched"	"Detected in many"	9	"gdT-cell: 2.4;memory CD4 T-cell: 2.1;memory CD8 T-cell: 2.7;naive CD8 T-cell: 2.7;NK-cell: 6.4;T-reg: 5.9"	"Group enriched"	"Detected in many"	62	"NK-cells: 6.4;T-cells: 5.9"	"Cell line enhanced"	"Detected in many"		"HaCaT: 22.3;PC-3: 13.9;U-251 MG: 18.6;U-87 MG: 12.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052446	Supported		Approved	Vesicles,Centrosome		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 68: Epididymis - Unknown function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Vesicles, Centrosome"		"HPA052446: AB_2681836"	"unprognostic (7.46e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.26e-3)"	"unprognostic (1.21e-1)"	"unprognostic (4.05e-3)"	"unprognostic (1.73e-1)"	"unprognostic (7.67e-2)"	"unprognostic (2.15e-2)"	"unprognostic (3.11e-3)"	"unprognostic (3.06e-2)"	"unprognostic (7.90e-2)"	"unprognostic (1.12e-6)"	"unprognostic (2.49e-3)"	"unprognostic (1.58e-1)"	"unprognostic (1.20e-4)"	"unprognostic (2.89e-2)"	0.1	1.3	1.0	0.1	2.8	0.0	0.3	1.5	22.7	0.9	0.0	0.0	0.1	0.1	0.2	10.2	0.1	0.3	1.0	8.3	0.0	0.1	0.0	0.7	0.0	0.0	3.2	0.0	0.4	5.6	1.6	0.1	0.0	1.8	0.1	5.1	1.1	2.0	0.0	0.8	0.1	0.1	0.0	0.3	0.0	0.5	8.0	0.5	0.6	0.1	1.4	0.8	1.1	16.6	6.3	0.6	0.1	0.0	0.1	0.0	0.0	5.5	5.8	2.6	2.1	0.0	1.0	0.0	0.2	3.1	8.4	22.3	0.0	0.4	3.5	0.1	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.2	7.2	0.9	6.6	0.9	0.0	0.0	0.0	5.5	2.1	0.7	0.0	0.9	0.0	13.9	0.0	0.2	0.0	0.3	2.8	0.1	1.2	1.1	0.2	0.6	0.0	0.0	0.0	0.0	1.1	6.1	0.0	18.6	0.0	0.0	0.0	12.9	0.0	1.8	0.0	0.0	0.0	2.4	0.0	0.0	0.0	2.1	2.7	0.0	0.0	0.4	2.7	0.0	6.4	0.0	0.0	5.9	0.8	1.0	2.8	1.5	22.7	8.3	0.0	0.0	3.2	0.0	0.0	8.0	16.6	0.0	0.0	0.0	15.3	0.2	0.5	3.7	0.6	0.0	13.5	0.3	0.3	2.6	1.5	0.1	3.7	2.1	0.0	2.8	0.0	0.0	0.2	0.5	0.3	0.2	0.2	0.0	0.0	112.7	0.0	0.0	0.9	0.0	0.6	0.0	0.1	0.0	0.0	0.1	18.5	23.4	0.0	0.0	0.3	1.1	0.3	0.0	0.4	0.0	6.5	0.0	2.7	0.0	113.6	195.5	0.9	0.0	0.0	1.9	1.2	0.0	0.7	0.1	5.3	0.0	0.8	0.8	0.1	0.7	0.0	0.4	0.0	3.9	0.2	0.0	6.0
ZNF366	FLJ39796	ENSG00000178175	"Zinc finger protein 366"	Q8N895	5	72439903-72507410	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Adipocytes: 19.0;Cone photoreceptor cells: 31.3;Endothelial cells: 18.3;Langerhans cells: 9.3;Microglial cells: 54.4;monocytes: 14.5"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	9	"myeloid DC: 10.4"	"Lineage enriched"	"Detected in many"	9	"dendritic cells: 10.4"	"Cell line enhanced"	"Detected in some"		"HUVEC TERT2: 1.3;TIME: 1.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA023128, HPA023526, HPA074074"	Uncertain		Supported	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Nucleoplasm	"Plasma membrane"	"HPA023128: AB_1859223, HPA023526: AB_1859224, HPA074074: "	"unprognostic (3.49e-1)"	"unprognostic (8.44e-2)"	"unprognostic (2.44e-1)"	"unprognostic (2.27e-1)"	"unprognostic (6.17e-2)"	"unprognostic (1.95e-3)"	"unprognostic (9.25e-2)"	"unprognostic (6.67e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.47e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.88e-3)"	"unprognostic (1.53e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.43e-1)"	"unprognostic (6.29e-2)"	5.8	0.8	6.1	3.4	5.0	0.1	3.2	4.5	5.6	2.8	2.4	1.4	1.5	3.1	0.7	1.8	2.4	2.3	3.8	4.1	4.6	2.1	1.0	2.6	5.0	5.8	5.5	0.8	0.7	1.1	0.4	8.9	6.0	0.9	1.5	0.5	0.8	1.5	5.0	2.2	1.9	3.9	4.1	6.4	1.4	0.5	7.1	3.1	2.2	5.6	4.0	1.7	1.0	4.5	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.8	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	10.4	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.5	6.1	5.0	4.5	5.6	4.1	4.6	5.8	5.5	6.0	4.1	7.1	4.5	19.0	0.0	0.6	0.0	0.1	0.5	0.4	0.0	0.6	0.4	0.1	0.3	1.6	0.0	0.6	0.0	31.3	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	18.3	0.0	0.0	0.4	0.0	0.0	0.6	0.0	0.0	0.0	0.0	6.8	0.4	0.5	0.0	0.3	0.0	0.0	4.6	9.3	0.5	0.3	2.4	0.0	54.4	14.5	0.1	0.0	0.5	0.3	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.8	0.0	1.2	0.7	0.0	0.0	0.2	0.3	0.1	0.3	0.1	0.0	0.0
ZNF367	FLJ33970	ENSG00000165244	"Zinc finger protein 367"	Q7RTV3	9	96385941-96418370	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 26.1"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 22.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"HPA015319, HPA015785"	Uncertain		Supported	Nucleoplasm		NA	Yes			"Cluster 35: T-regs - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 51: Myeloid cells - Hemostasis"	Nucleoplasm		"HPA015319: AB_2669185, HPA015785: AB_2217750"	"unprognostic (5.91e-2)"	"unprognostic (2.78e-3)"	"unprognostic (2.17e-2)"	"unprognostic (1.11e-2)"	"unprognostic (2.36e-1)"	"unprognostic (4.57e-3)"	"unprognostic (7.76e-3)"	"unprognostic (1.60e-3)"	"unprognostic (4.35e-2)"	"unprognostic (3.01e-1)"	"unprognostic (3.78e-3)"	"unprognostic (2.71e-2)"	"unprognostic (4.88e-3)"	"unprognostic (3.23e-3)"	"unprognostic (1.72e-1)"	"prognostic favorable (2.34e-4)"	"unprognostic (2.28e-1)"	1.4	0.6	0.7	3.7	1.3	26.1	1.7	1.4	1.3	1.1	0.2	3.0	2.9	1.1	0.1	2.4	0.7	1.0	2.1	0.7	1.0	3.0	10.8	1.1	4.6	1.5	1.4	1.0	1.4	1.6	0.3	1.9	1.4	1.2	3.3	1.3	0.7	0.4	1.5	3.5	3.0	2.4	0.9	1.3	2.1	6.1	1.3	8.7	1.1	2.7	4.7	1.5	1.2	2.7	25.4	10.3	9.9	8.9	3.8	5.3	13.4	34.6	20.4	16.9	20.0	6.4	17.5	19.2	14.4	16.5	12.6	30.5	11.6	12.6	19.9	21.2	10.0	14.0	19.1	5.3	0.0	19.8	16.5	0.9	0.8	13.7	6.9	3.7	6.3	13.3	13.0	45.4	21.7	16.9	30.4	16.1	6.7	27.9	16.7	15.3	49.9	11.7	4.9	16.8	17.4	12.0	15.3	18.1	10.6	8.0	9.4	17.3	5.7	27.6	15.8	25.6	26.6	17.6	32.0	7.8	16.7	17.0	23.8	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.3	0.1	0.7	1.3	1.4	1.3	0.7	1.0	1.5	1.4	1.4	0.9	1.3	2.7	1.1	0.0	0.0	2.9	3.8	9.9	1.3	0.4	10.8	0.7	2.2	2.3	2.6	0.0	0.9	0.0	0.0	3.2	2.5	2.4	0.0	0.5	0.7	0.6	1.1	2.0	0.0	22.3	5.1	1.2	4.2	1.7	2.6	1.8	0.0	4.7	1.1	3.8	1.9	0.0	5.3	3.6	0.0	2.1	2.6	0.8	0.6	8.3	3.6	2.8	0.1	0.6	1.0	3.0	7.9	0.7	0.5	0.7	9.6	0.6	0.9	2.5	0.0	1.5	6.6	2.0	3.6	10.3	1.7	10.9	6.5	0.8	5.0	0.3	5.6	1.1
ZNF383	"FLJ35863, Zfp383"	ENSG00000188283	"Zinc finger protein 383"	Q8NA42	19	37217926-37248738	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA063945	Approved		Supported	"Nucleoplasm,Nuclear membrane"		No	No			"Cluster 24: B-cells - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 52: Non-specific - Transcription"	"Nucleoplasm, Nuclear membrane"		"HPA063945: AB_2685158"	"unprognostic (1.92e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.26e-2)"	"unprognostic (3.72e-3)"	"unprognostic (1.20e-3)"	"unprognostic (1.85e-1)"	"unprognostic (6.27e-3)"	"unprognostic (1.66e-2)"	"unprognostic (1.27e-1)"	"prognostic favorable (9.97e-4)"	"unprognostic (7.40e-2)"	"unprognostic (5.44e-2)"	"unprognostic (4.34e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.01e-3)"	"prognostic favorable (3.71e-4)"	3.6	3.2	2.5	3.4	4.4	3.5	5.1	8.5	3.4	4.1	1.5	3.3	3.5	3.8	3.6	3.6	3.7	2.9	4.9	2.7	3.5	4.4	3.2	3.5	6.1	3.7	3.1	5.8	2.9	4.4	2.8	3.2	3.8	4.1	3.5	5.4	4.0	3.9	7.4	5.4	3.4	3.8	2.0	5.1	3.9	3.9	3.7	5.7	5.3	9.0	6.0	3.4	3.4	7.1	2.9	6.8	4.6	7.1	5.7	5.8	3.1	4.1	5.6	4.0	5.9	3.1	3.6	4.0	5.9	3.9	3.8	3.0	3.6	5.5	5.9	5.4	4.2	5.7	5.2	2.6	6.1	6.9	6.2	7.1	4.6	3.9	7.6	5.1	3.7	5.5	3.2	2.1	5.0	1.4	6.3	3.2	4.2	5.8	1.9	4.4	8.4	3.7	3.6	8.2	5.2	4.1	6.6	3.8	5.7	5.8	4.6	4.1	2.3	5.0	3.5	3.7	4.0	6.5	6.4	7.9	0.7	3.2	4.7	3.7	3.2	5.3	5.8	3.9	8.2	8.0	5.4	7.1	3.3	10.7	8.6	6.9	3.5	4.8	4.9	3.1	6.0	3.9	2.5	4.4	8.5	3.4	2.7	3.5	3.7	3.1	3.8	2.0	3.7	7.1	7.2	3.2	4.4	7.5	10.2	2.7	4.0	3.4	5.7	9.8	3.7	5.2	12.8	7.2	2.5	1.8	14.6	3.8	7.5	3.8	1.9	3.5	8.9	3.6	5.4	5.1	2.4	11.0	7.4	3.6	4.8	5.8	4.6	3.7	5.7	7.8	6.4	2.2	3.8	15.2	8.7	3.8	2.0	6.3	3.5	3.0	6.5	4.5	8.8	4.7	5.5	6.2	10.3	9.5	10.4	2.7	3.6	7.5	3.8	5.1	5.8	3.9	2.5	9.9	13.1	9.9	6.1	5.8	5.2	3.9	3.3	4.9	8.5	6.6	4.8	4.1
ZNF385A	"DKFZp586G1122, Hzf, ZFP385, ZNF385"	ENSG00000161642	"Zinc finger protein 385A"	Q96PM9	12	54369133-54391298	"Predicted intracellular proteins"	"DNA damage, Transcription, Transcription regulation, Translation regulation"	"DNA-binding, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 159.3;retina: 250.6;skin 1: 159.8"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 212.8;Cone photoreceptor cells: 171.0;Horizontal cells: 144.7;Muller glia cells: 142.6;Rod photoreceptor cells: 209.7;Syncytiotrophoblasts: 108.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	10	"classical monocyte: 29.2;intermediate monocyte: 32.8;myeloid DC: 31.9;non-classical monocyte: 25.7"	"Group enriched"	"Detected in many"	11	"dendritic cells: 31.9;monocytes: 32.8"	"Cell line enhanced"	"Detected in many"		"HaCaT: 89.5;HBEC3-KT: 85.7;HEL: 109.5;hTCEpi: 94.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039799			Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 56: Bipolar cells - Visual perception"	"Nucleoplasm, Cytosol"		"HPA039799: AB_10795117"	"unprognostic (8.56e-2)"	"unprognostic (1.43e-1)"	"prognostic unfavorable (5.20e-4)"	"unprognostic (6.70e-2)"	"unprognostic (1.07e-2)"	"unprognostic (1.79e-3)"	"unprognostic (2.30e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.75e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.42e-1)"	"unprognostic (2.12e-1)"	"prognostic unfavorable (9.75e-5)"	"unprognostic (1.00e-1)"	"unprognostic (3.68e-2)"	"unprognostic (2.43e-1)"	"unprognostic (6.07e-3)"	43.3	10.1	76.8	28.6	87.9	32.8	22.2	96.9	86.3	29.2	57.7	13.8	7.2	7.6	16.6	99.5	9.7	14.2	13.7	60.2	89.8	10.2	6.4	19.1	15.3	105.5	111.9	5.3	3.3	26.6	26.7	19.4	93.9	34.9	8.0	250.6	28.1	15.0	21.9	159.8	15.8	14.2	95.1	24.8	10.4	2.4	159.3	12.1	40.8	23.3	20.3	38.8	55.8	65.1	2.5	10.7	15.9	20.0	17.9	12.0	43.6	2.1	8.1	8.3	7.1	21.8	7.8	5.9	7.2	4.4	6.7	89.5	6.1	85.7	2.8	5.8	8.5	109.5	6.6	4.3	8.0	1.6	73.4	10.7	94.8	9.3	23.5	20.3	5.2	15.0	53.6	0.5	3.8	49.9	5.4	15.9	9.2	10.1	8.3	19.5	1.3	21.7	6.5	71.0	7.0	31.6	0.8	59.7	4.5	18.3	71.0	45.5	5.3	4.4	10.2	5.4	5.6	1.7	0.5	5.3	18.6	5.0	11.8	3.0	29.2	0.0	0.0	32.8	0.0	1.3	0.0	0.0	31.9	1.3	0.0	0.4	2.2	0.1	25.7	3.0	0.1	16.5	76.8	87.9	96.9	86.3	60.2	89.8	105.5	111.9	93.9	95.1	159.3	65.1	8.3	0.0	0.0	12.1	7.3	36.2	21.3	76.5	49.5	212.8	16.7	13.8	3.2	1.5	20.4	9.2	171.0	63.9	2.5	0.2	9.8	3.4	0.5	13.3	9.8	8.8	4.8	9.2	5.4	0.6	9.4	29.6	3.6	2.2	1.3	4.8	4.6	1.3	56.4	144.7	13.5	0.1	12.2	71.6	54.7	0.5	14.9	78.0	8.8	6.5	49.4	142.6	3.1	3.5	0.9	1.8	0.1	9.1	2.0	13.1	0.0	2.8	12.1	209.7	0.0	4.0	12.3	2.6	3.6	68.3	66.1	108.9	2.2	0.2	0.1	29.7
ZNF395	"DKFZp434K1210, HDBP2, PBF, PRF-1"	ENSG00000186918	"Zinc finger protein 395"	Q9H8N7	8	28345590-28402701	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"A-431: 140.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049382, HPA076275"	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 50: Non-specific - Ribosome"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Nucleoplasm	Cytosol	"HPA049382: , HPA076275: "	"unprognostic (1.28e-1)"	"unprognostic (3.02e-1)"	"unprognostic (1.95e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.61e-2)"	"unprognostic (4.51e-2)"	"prognostic unfavorable (1.66e-4)"	"unprognostic (9.35e-3)"	"unprognostic (8.90e-2)"	"unprognostic (2.15e-2)"	"unprognostic (7.08e-2)"	"unprognostic (2.25e-2)"	"prognostic unfavorable (5.71e-5)"	"unprognostic (1.35e-1)"	"unprognostic (1.32e-1)"	"unprognostic (2.46e-2)"	"unprognostic (7.42e-2)"	33.0	18.5	21.9	14.4	22.1	37.5	30.5	14.9	20.8	23.1	27.6	25.7	20.9	17.4	13.9	47.6	27.2	14.5	27.2	18.3	17.3	23.4	37.0	19.7	21.3	25.7	18.5	53.6	47.5	17.7	16.4	33.9	19.3	23.7	13.9	27.1	38.8	17.5	16.3	42.9	24.7	9.5	19.4	21.8	26.2	10.9	26.7	18.9	18.6	13.9	25.2	26.3	29.3	20.7	140.0	19.4	17.9	48.7	13.9	19.6	52.6	16.2	28.4	13.2	30.6	31.0	24.0	66.1	56.2	25.7	30.5	29.3	16.1	40.6	25.6	11.0	12.7	16.4	3.8	6.5	14.2	7.3	6.6	34.9	55.3	2.3	34.3	37.5	6.5	21.2	16.9	14.2	18.3	23.7	31.6	21.7	28.1	33.9	22.7	29.3	19.7	22.1	30.6	26.4	48.1	50.9	3.8	10.3	26.5	15.8	18.9	16.3	1.5	26.6	32.9	15.1	6.6	17.4	9.6	42.9	72.8	13.6	21.5	10.0	4.3	11.5	4.6	0.8	4.4	11.4	5.5	5.6	1.6	13.7	7.1	4.8	1.9	3.7	0.7	6.2	2.4	2.2	21.9	22.1	14.9	20.8	18.3	17.3	25.7	18.5	19.3	19.4	26.7	20.7	14.8	32.1	22.7	45.7	24.7	16.8	17.2	33.0	45.5	10.3	19.1	16.0	12.4	12.8	20.5	9.2	14.6	17.1	9.3	18.4	3.9	22.5	0.6	18.0	9.9	15.1	27.2	8.6	15.9	24.1	21.6	15.8	11.2	21.8	11.4	11.9	26.0	32.4	5.8	6.7	10.8	21.7	6.1	16.8	6.0	1.5	24.8	5.6	10.6	17.8	7.1	17.4	7.2	15.6	18.3	23.7	8.5	18.0	9.0	14.8	21.9	7.6	19.1	10.2	26.3	25.8	11.6	1.1	3.2	29.2	11.5	6.3	7.9	4.9	27.2	9.7
ZNF404		ENSG00000176222	"Zinc finger protein 404"	Q494X3	19	43872365-43901385	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 21.5;Oligodendrocytes: 19.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"U-2 OS: 43.7"					"Low region specificity"	"Detected in all"			"HPA032014, HPA063607"	Uncertain		Supported	"Nucleoli,Nucleoli rim,Intermediate filaments"		NA	Yes			"Cluster 40: NK-cells - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 9: U-2 OS - Unknown function"	"Cluster 64: Astrocytes - Nervous system maintenance"	"Nucleoli, Nucleoli rim"	"Intermediate filaments"	"HPA032014: AB_10602591, HPA063607: AB_2732705"	"unprognostic (3.76e-3)"	"unprognostic (3.41e-1)"	"unprognostic (1.11e-2)"	"unprognostic (4.32e-3)"	"unprognostic (8.92e-2)"	"unprognostic (2.82e-1)"	"unprognostic (1.64e-2)"	"unprognostic (2.68e-2)"	"unprognostic (7.47e-2)"	"unprognostic (1.26e-1)"	"unprognostic (2.03e-5)"	"unprognostic (1.46e-2)"	"unprognostic (3.79e-3)"	"unprognostic (2.89e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.12e-1)"	"unprognostic (4.80e-3)"	2.4	3.2	9.2	1.1	10.3	0.6	2.7	9.7	11.3	3.8	8.3	5.8	0.6	2.4	9.6	2.0	6.4	2.4	9.1	8.8	9.3	3.9	2.3	2.1	3.6	9.9	9.7	6.8	2.4	2.5	14.3	2.9	9.9	6.1	1.8	18.0	2.8	2.3	2.6	3.1	2.7	2.0	9.7	5.4	3.2	4.6	10.3	2.3	4.2	1.9	1.6	4.6	2.9	12.0	3.4	0.5	3.4	0.4	8.4	11.8	2.0	4.6	2.2	2.9	4.0	0.3	1.2	0.0	4.7	2.2	0.1	0.4	0.6	2.3	3.9	0.5	3.3	1.2	0.1	1.3	3.0	0.3	0.9	7.1	5.5	2.1	2.0	9.8	2.5	0.0	0.1	0.0	2.7	0.3	0.0	0.1	2.8	0.1	0.7	0.0	1.8	0.7	2.8	2.2	1.8	1.4	1.9	0.8	2.4	6.1	0.1	1.3	1.1	4.1	43.7	3.7	2.7	5.8	8.1	0.0	5.8	0.0	2.4	0.0	0.0	0.4	0.1	0.0	0.1	0.1	0.3	0.0	0.1	0.3	0.3	0.3	0.0	0.5	0.0	0.2	0.3	0.1	9.2	10.3	9.7	11.3	8.8	9.3	9.9	9.7	9.9	9.7	10.3	12.0	1.3	0.0	3.2	21.5	1.5	0.0	0.7	1.1	0.6	3.6	1.3	1.9	7.0	0.0	0.9	0.0	0.0	1.5	0.3	0.2	0.0	0.7	1.5	1.6	3.2	1.5	2.4	0.4	6.9	0.2	1.1	1.6	0.5	1.1	7.0	2.9	1.1	0.5	0.7	5.0	6.9	0.6	4.1	0.3	0.3	0.3	0.9	0.7	0.0	1.9	0.4	3.8	2.1	3.0	19.4	0.2	0.5	3.4	0.1	0.8	0.7	0.4	1.9	3.3	0.0	0.4	1.3	1.7	3.2	0.4	0.0	1.0	1.5	0.5	0.9	0.5
ZNF425		ENSG00000204947	"Zinc finger protein 425"	Q6IV72	7	149102784-149126324	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Inhibitory neurons: 8.5;Oligodendrocyte precursor cells: 9.0;Oligodendrocytes: 10.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"											HPA020087	Uncertain		Supported	Nucleoplasm		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm		"HPA020087: AB_2670358"	"unprognostic (4.27e-1)"	"unprognostic (1.28e-1)"	"unprognostic (7.40e-4)"	"unprognostic (9.97e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.35e-2)"	"unprognostic (8.18e-2)"	"unprognostic (2.63e-2)"	"unprognostic (1.25e-2)"	"unprognostic (2.14e-1)"	"unprognostic (8.21e-4)"	"unprognostic (3.09e-1)"	"unprognostic (1.25e-4)"	"unprognostic (3.04e-2)"	"unprognostic (2.32e-1)"	"unprognostic (5.19e-3)"	"unprognostic (1.58e-2)"	0.8	1.2	3.1	0.9	3.1	0.6	1.7	3.3	3.2	2.1	2.1	2.1	1.0	2.4	2.1	2.1	2.3	1.0	0.8	3.0	2.7	2.2	1.0	1.0	0.8	2.8	2.8	3.8	1.5	2.3	1.4	0.7	2.8	1.9	0.8	1.4	1.8	2.2	3.8	2.5	0.9	1.7	2.6	1.0	1.6	1.3	2.9	1.6	1.9	1.9	1.2	1.9	1.5	2.8	1.4	1.7	3.6	3.1	5.3	1.5	2.0	2.0	3.4	1.1	1.2	0.4	1.8	1.6	2.8	1.6	1.4	1.9	0.6	1.0	0.4	1.1	1.4	1.9	2.4	0.8	3.0	0.9	0.8	3.1	1.7	1.1	2.0	3.0	0.5	2.4	1.4	1.5	3.7	6.6	2.5	2.9	8.6	2.0	3.3	2.7	1.8	0.9	2.4	1.9	1.6	3.0	1.9	2.4	4.5	2.3	1.6	2.6	0.7	2.3	0.3	2.7	0.5	3.2	2.1	1.2	1.9	0.6	1.9	2.1	0.6	1.4	1.8	0.7	2.3	1.4	1.5	1.2	0.6	1.8	2.1	2.3	1.6	3.2	0.4	2.1	2.0	0.8	3.1	3.1	3.3	3.2	3.0	2.7	2.8	2.8	2.8	2.6	2.9	2.8	0.4	0.0	2.0	5.2	1.9	0.3	0.8	0.7	2.2	3.4	1.8	1.5	1.8	0.0	1.2	3.7	0.0	0.8	0.3	0.5	5.9	1.6	0.9	1.4	2.2	0.6	1.2	3.0	7.5	0.5	0.8	1.5	4.6	1.2	0.0	3.4	0.4	0.6	0.4	6.7	8.5	0.7	2.0	0.0	0.2	0.3	4.4	0.6	0.0	7.5	1.8	4.7	0.0	9.0	10.7	0.6	0.6	5.3	1.3	1.0	0.7	1.1	2.4	1.2	0.0	2.3	1.5	3.5	3.5	2.8	0.3	1.0	1.4	3.0	0.8	0.5
ZNF436	"KIAA1710, Zfp46"	ENSG00000125945	"Zinc finger protein 436"	Q9C0F3	1	23359448-23369836	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 22.2;Squamous epithelial cells: 22.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 18.8;HSkMC: 34.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043817	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 61: Squamous epithelial cells - Keratinization"	"Nucleoplasm, Cytosol"		"HPA043817: AB_10794774"	"unprognostic (1.50e-1)"	"unprognostic (2.91e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.93e-1)"	"unprognostic (8.10e-2)"	"unprognostic (2.12e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.86e-1)"	"unprognostic (1.09e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.92e-1)"	"unprognostic (9.51e-3)"	"unprognostic (5.04e-2)"	"unprognostic (3.22e-1)"	"unprognostic (1.06e-1)"	"unprognostic (7.75e-3)"	10.0	14.8	4.8	2.3	5.2	1.4	9.8	5.5	5.4	9.8	4.5	8.5	3.1	9.9	8.0	16.5	6.9	5.5	8.3	5.5	5.3	4.0	3.7	4.2	2.7	6.3	5.2	15.4	6.9	5.3	4.4	4.2	5.6	9.5	3.1	4.6	14.6	5.1	6.5	12.6	5.6	6.2	5.6	7.0	6.1	7.9	5.4	3.5	9.0	6.2	3.6	10.4	10.2	5.9	3.8	2.4	8.6	4.5	9.1	18.8	4.1	3.4	4.6	4.3	5.0	1.4	3.3	2.6	3.8	4.9	2.8	4.8	15.0	5.7	4.6	3.2	3.3	2.8	5.3	2.2	3.6	1.2	1.9	34.9	8.0	3.6	4.1	7.8	6.2	3.1	3.4	1.8	4.5	1.8	2.9	2.1	0.3	1.7	3.8	3.8	3.6	2.5	3.4	9.5	3.9	4.9	9.6	4.7	3.7	2.9	2.6	1.4	5.0	3.7	2.7	2.9	1.9	2.8	3.6	2.1	2.9	2.3	2.9	0.0	0.7	0.7	0.7	0.8	0.7	0.4	0.5	0.8	1.1	0.5	0.8	0.7	0.5	2.6	0.8	0.1	0.9	0.6	4.8	5.2	5.5	5.4	5.5	5.3	6.3	5.2	5.6	5.6	5.4	5.9	7.8	0.0	0.5	2.6	2.0	5.2	1.6	1.9	22.2	4.1	6.9	5.0	6.4	1.5	1.6	5.5	6.2	3.8	2.6	3.5	0.0	2.9	2.3	5.0	8.5	14.0	3.6	1.7	4.2	4.9	1.8	9.6	2.0	7.8	0.0	9.4	3.3	3.1	2.1	10.1	3.3	4.6	2.0	1.9	3.8	1.5	9.9	2.1	5.4	0.0	4.5	9.3	2.1	2.5	3.1	3.6	5.9	11.7	2.1	3.3	4.0	2.8	2.4	2.4	0.0	4.5	4.5	5.5	6.9	22.1	9.7	2.9	2.4	7.9	3.1	2.0
ZNF438	bA330O11.1	ENSG00000183621	"Zinc finger protein 438"	Q7Z4V0	10	30820207-31031937	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 111.3;Excitatory neurons: 55.3;Inhibitory neurons: 74.7;Microglial cells: 76.8;Oligodendrocyte precursor cells: 137.2;Oligodendrocytes: 86.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 19.0;U-937: 25.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039843	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 32: U-937 - Innate immune response"	"Cluster 51: Myeloid cells - Hemostasis"	Nucleoplasm	Cytosol	"HPA039843: AB_10795159"	"unprognostic (1.69e-1)"	"unprognostic (9.49e-3)"	"unprognostic (3.72e-2)"	"unprognostic (9.21e-2)"	"unprognostic (4.75e-2)"	"unprognostic (1.22e-2)"	"unprognostic (3.98e-3)"	"unprognostic (1.30e-1)"	"unprognostic (4.65e-1)"	"unprognostic (2.33e-1)"	"unprognostic (2.11e-2)"	"unprognostic (4.85e-2)"	"unprognostic (1.08e-2)"	"unprognostic (9.96e-2)"	"unprognostic (1.52e-1)"	"unprognostic (8.52e-3)"	"unprognostic (9.50e-2)"	11.9	3.6	5.5	6.4	5.7	5.5	7.4	5.1	7.3	8.5	5.7	11.3	3.8	9.2	6.6	4.6	8.2	5.6	11.0	5.6	5.8	4.4	5.4	8.4	4.0	5.3	5.2	5.9	3.1	3.7	4.9	4.0	5.5	5.4	4.1	4.5	6.2	5.6	24.6	6.8	5.3	8.7	5.3	10.3	6.0	8.4	6.3	7.8	9.7	17.4	3.1	9.3	6.8	6.5	3.7	3.7	3.1	2.7	18.0	12.5	1.7	2.9	4.2	4.5	5.6	0.2	4.4	5.0	3.3	5.2	4.2	1.0	1.6	2.2	6.3	11.6	1.2	2.2	2.0	0.2	10.1	1.7	2.3	6.0	3.7	6.4	3.6	4.1	19.0	5.8	4.3	3.5	6.2	2.7	5.9	9.7	0.3	2.7	1.5	2.6	4.5	2.9	6.4	0.9	2.3	2.5	1.4	0.6	2.1	2.0	1.4	16.2	7.9	2.0	3.5	6.1	3.6	0.8	1.5	0.1	4.0	25.3	1.5	1.3	7.2	3.3	2.0	6.9	1.5	1.0	1.5	2.7	2.2	3.7	3.1	1.7	13.1	3.9	4.3	2.8	3.6	3.5	5.5	5.7	5.1	7.3	5.6	5.8	5.3	5.2	5.5	5.3	6.3	6.5	7.8	3.2	4.8	111.3	3.2	1.0	2.0	1.7	5.2	5.5	2.1	2.2	13.0	5.7	4.2	3.7	6.2	3.5	2.0	1.8	7.9	3.6	25.2	2.7	5.6	6.1	0.0	2.5	55.3	4.2	4.6	9.1	7.1	2.4	12.6	4.1	6.4	1.8	6.9	3.3	74.7	2.6	0.0	12.9	3.5	9.6	4.1	36.3	0.0	76.8	7.3	2.4	7.2	137.2	86.9	3.7	0.8	8.2	3.6	1.3	2.5	3.9	3.9	5.3	6.6	17.0	6.7	12.8	8.0	6.0	2.4	1.6	4.2	2.4	2.3	1.8
ZNF45	ZNF13	ENSG00000124459	"Zinc finger protein 45"	Q02386	19	43912624-43935282	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Sertoli cells: 19.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038611, HPA075124"	Uncertain		Supported	Nucleoplasm		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 57: B-cells - Immune response"	Nucleoplasm		"HPA038611: AB_10669544, HPA075124: AB_2686735"	"unprognostic (1.67e-2)"	"unprognostic (4.84e-1)"	"unprognostic (1.07e-2)"	"unprognostic (1.84e-3)"	"unprognostic (1.23e-1)"	"unprognostic (9.31e-2)"	"unprognostic (5.34e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.60e-3)"	"unprognostic (1.91e-1)"	"unprognostic (7.68e-3)"	"unprognostic (5.17e-3)"	"unprognostic (5.17e-3)"	"unprognostic (1.67e-1)"	"unprognostic (1.66e-1)"	"unprognostic (4.43e-2)"	"unprognostic (5.82e-2)"	4.8	5.5	3.0	5.1	3.7	6.3	7.1	6.3	3.4	6.7	3.7	5.2	5.6	7.1	5.5	4.6	6.5	5.1	4.6	3.1	4.9	5.8	5.8	5.9	7.3	3.7	3.4	9.0	4.0	9.7	5.0	5.3	3.2	6.7	6.1	8.5	4.9	5.8	6.5	5.9	5.3	6.0	3.2	7.3	5.0	3.6	3.8	10.7	7.4	5.8	7.1	5.1	3.9	4.5	9.2	12.1	16.9	15.1	8.0	7.0	5.9	11.7	12.7	12.0	18.2	5.9	3.7	13.3	7.0	7.3	9.2	5.2	12.9	8.5	15.0	11.2	13.7	19.7	10.6	5.3	7.4	19.5	12.8	7.1	8.4	8.8	7.7	11.9	9.7	4.5	6.3	5.2	13.0	4.2	11.6	4.9	19.8	8.6	5.1	9.4	16.8	4.8	7.3	20.1	11.6	19.0	16.4	6.6	5.8	10.8	6.9	12.7	10.1	13.3	19.4	5.6	10.8	21.1	37.1	14.5	5.6	7.5	15.7	3.4	3.7	5.7	5.6	3.4	8.4	5.8	5.4	6.0	4.9	4.1	7.4	5.0	1.1	6.3	4.7	3.2	6.1	4.2	3.0	3.7	6.3	3.4	3.1	4.9	3.7	3.4	3.2	3.2	3.8	4.5	2.9	3.2	1.7	7.5	4.2	1.5	0.8	2.2	3.4	1.8	3.1	2.0	3.3	1.5	3.6	0.0	6.2	2.0	5.1	2.4	0.0	2.3	0.2	2.4	1.9	2.4	2.4	3.4	5.0	1.5	1.1	2.3	3.6	2.6	0.0	3.2	1.8	2.1	2.9	3.3	4.9	3.2	2.0	2.8	1.6	0.6	1.8	2.5	1.8	10.3	2.4	1.6	1.0	8.0	9.0	1.2	0.7	4.9	1.5	1.7	2.6	1.9	4.1	2.4	19.7	2.4	1.9	1.1	2.1	3.9	1.6	1.2	3.7	2.4	2.1	1.5
ZNF470	"CZF-1, FLJ26175"	ENSG00000197016	"Zinc finger protein 470"	Q6ECI4	19	56567468-56588911	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Spermatogonia: 13.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"HEK 293: 11.0"					"Low region specificity"	"Detected in all"			HPA029000	Uncertain		Supported	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 77: Retina - Visual perception"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 43: Cardiomyocytes - Nuclear processes"	"Nucleoplasm, Nuclear bodies"		"HPA029000: AB_10603843"	"unprognostic (1.40e-2)"	"unprognostic (5.51e-2)"	"unprognostic (5.91e-2)"	"unprognostic (9.21e-4)"	"unprognostic (3.46e-2)"	"unprognostic (1.40e-2)"	"unprognostic (7.11e-2)"	"unprognostic (4.58e-2)"	"unprognostic (6.91e-3)"	"unprognostic (2.39e-2)"	"unprognostic (3.45e-3)"	"unprognostic (3.33e-3)"	"unprognostic (3.89e-2)"	"unprognostic (2.82e-2)"	"unprognostic (4.68e-1)"	"unprognostic (2.76e-3)"	"unprognostic (2.88e-3)"	2.0	3.0	8.2	1.0	8.2	0.4	1.9	9.0	12.2	3.0	5.8	3.8	0.9	2.8	3.0	1.8	2.3	1.5	3.6	8.5	8.5	4.4	3.2	1.8	1.4	8.4	8.6	2.6	2.0	2.3	5.3	1.6	8.6	3.7	1.1	12.3	1.7	2.4	1.3	1.8	2.0	1.9	7.7	2.1	2.3	4.6	8.6	1.9	2.5	1.1	1.7	3.5	2.3	8.7	0.0	1.6	5.4	2.3	2.8	2.6	4.5	2.6	1.2	2.0	3.8	0.3	1.3	0.0	1.6	2.9	3.5	0.1	2.3	1.2	2.4	0.0	11.0	4.8	0.1	0.4	2.7	1.0	5.4	3.2	1.8	2.3	0.6	2.1	1.2	0.2	0.0	0.1	3.0	0.0	1.1	1.8	4.4	0.0	0.6	0.2	3.8	0.9	2.2	3.3	2.0	5.1	0.0	0.4	0.7	3.7	1.8	3.0	1.2	0.2	2.2	1.8	3.5	1.7	2.5	0.2	0.0	3.2	0.9	0.5	0.2	0.9	0.6	0.1	1.2	0.7	0.6	0.3	0.4	0.8	0.8	0.8	0.6	0.7	0.3	0.6	0.4	0.3	8.2	8.2	9.0	12.2	8.5	8.5	8.4	8.6	8.6	7.7	8.6	8.7	3.4	3.2	3.6	10.4	1.1	1.0	1.4	1.0	1.2	8.6	2.1	2.0	7.4	2.8	1.7	0.0	10.4	1.1	0.8	0.7	1.9	2.6	2.1	2.1	3.1	4.2	0.0	2.1	10.1	0.6	0.9	3.1	0.5	1.9	7.0	4.1	3.6	2.4	1.2	11.8	9.6	0.8	0.0	0.6	2.1	1.7	2.1	1.6	1.8	2.8	1.8	4.2	1.0	6.6	11.9	1.2	1.5	3.0	0.4	1.9	2.1	2.7	1.5	7.1	6.6	3.9	2.6	7.4	13.4	1.5	0.6	0.3	1.4	2.5	1.9	0.9
ZNF471	"KIAA1396, Z1971, Zfp78"	ENSG00000196263	"Zinc finger protein 471"	Q9BX82	19	56507850-56530221	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 24.8;Oligodendrocytes: 32.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HSkMC: 8.5;hTERT-RPE1: 12.6;SuSa: 9.0"					"Low region specificity"	"Detected in all"			HPA066695	Uncertain		Supported	Nucleoplasm		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 21: Non-specific - Transcription"	"Cluster 12: NES - Nervous system development"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA066695: AB_2685704"	"unprognostic (2.89e-2)"	"unprognostic (2.79e-4)"	"unprognostic (1.58e-1)"	"unprognostic (2.90e-2)"	"unprognostic (2.22e-1)"	"unprognostic (2.42e-3)"	"unprognostic (1.45e-1)"	"unprognostic (8.44e-2)"	"unprognostic (1.01e-2)"	"unprognostic (4.14e-2)"	"unprognostic (4.47e-4)"	"unprognostic (9.36e-2)"	"prognostic favorable (2.37e-4)"	"unprognostic (3.84e-3)"	"unprognostic (1.08e-1)"	"unprognostic (7.89e-2)"	"unprognostic (3.44e-3)"	5.7	6.3	13.6	2.4	16.1	2.8	7.1	14.0	14.8	10.3	7.4	8.9	1.8	13.3	15.9	4.8	10.5	6.8	5.7	13.4	16.6	5.3	2.4	5.6	3.0	14.8	13.1	22.4	3.6	10.4	8.4	6.2	13.7	8.2	4.5	28.5	6.0	7.5	4.9	9.5	3.2	7.9	9.9	4.4	4.5	8.5	14.7	2.7	9.8	6.3	2.0	7.0	7.6	25.5	0.4	0.5	4.8	0.6	4.1	4.5	0.5	4.5	1.6	2.1	1.8	0.6	0.6	0.6	3.0	5.0	4.0	0.3	0.6	0.4	2.0	1.0	1.8	3.6	1.3	0.5	4.0	1.0	3.1	8.5	1.6	2.6	0.2	12.6	0.2	0.5	1.1	1.3	2.3	0.5	0.4	0.6	1.1	0.3	1.9	0.4	3.1	0.4	3.5	3.7	0.6	2.9	0.4	0.1	0.2	9.0	0.6	0.7	0.7	7.6	3.2	0.6	3.5	1.0	1.1	0.3	0.6	0.5	0.4	1.5	0.4	0.3	0.6	0.3	0.4	0.4	0.5	0.4	0.2	0.9	0.5	0.7	1.8	1.0	0.4	0.5	0.3	0.1	13.6	16.1	14.0	14.8	13.4	16.6	14.8	13.1	13.7	9.9	14.7	25.5	5.7	19.2	18.4	24.8	0.6	0.6	2.4	1.6	2.2	11.2	4.1	4.6	10.9	2.8	7.8	5.5	6.2	1.0	1.7	0.9	3.9	2.1	10.2	8.2	5.9	6.0	1.2	0.4	15.0	1.0	0.4	4.6	1.5	6.7	2.5	8.4	5.0	0.8	0.5	6.7	14.4	0.9	0.0	0.6	0.3	3.6	5.0	1.9	1.8	5.6	0.6	7.9	2.1	20.1	32.3	0.7	0.2	7.2	0.0	2.5	0.5	1.6	11.9	9.5	6.6	7.9	6.7	9.9	8.2	1.6	0.6	0.8	0.9	3.6	1.2	1.6
ZNF473	"DKFZP434N043, HZFP100, KIAA1141"	ENSG00000142528	"Zinc finger protein 473"	Q8WTR7	19	50025714-50053414	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"testis: 42.4"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 88.9;Late spermatids: 23.3;Spermatocytes: 64.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA004191, HPA073309"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 30: Non-specific - Translation"	"Cluster 49: Ciliated cells - Cilium organization"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm		"HPA004191: AB_2667168, HPA073309: AB_2686594"	"unprognostic (7.47e-3)"	"unprognostic (3.57e-2)"	"unprognostic (2.47e-1)"	"unprognostic (3.40e-1)"	"unprognostic (4.27e-1)"	"unprognostic (8.00e-3)"	"prognostic unfavorable (3.72e-4)"	"unprognostic (1.31e-3)"	"unprognostic (6.44e-3)"	"unprognostic (1.42e-1)"	"unprognostic (1.70e-2)"	"unprognostic (3.22e-3)"	"unprognostic (8.49e-2)"	"unprognostic (1.60e-1)"	"unprognostic (3.93e-2)"	"unprognostic (7.76e-2)"	"unprognostic (1.08e-1)"	3.8	2.9	4.0	2.9	4.9	4.2	4.6	5.7	7.6	3.6	9.0	3.1	2.8	3.7	4.0	3.6	7.3	3.2	2.9	4.4	5.0	3.5	3.3	3.5	3.5	5.2	5.8	4.4	4.6	4.3	5.4	3.0	4.8	4.7	3.0	6.2	2.4	3.9	4.1	3.7	2.4	4.9	4.7	6.7	3.1	42.4	5.4	4.1	4.5	4.6	4.5	3.2	2.4	6.8	14.4	9.6	14.7	12.4	5.7	6.6	8.3	13.2	7.9	18.4	17.2	18.4	9.5	22.2	5.0	7.7	6.8	10.8	18.4	8.8	23.4	15.6	18.0	22.5	8.8	9.3	6.6	16.3	13.1	6.8	16.1	19.3	25.2	7.6	6.2	13.1	32.1	19.3	9.4	6.2	13.0	7.8	10.4	22.4	15.1	15.8	20.5	9.8	6.1	15.6	12.1	13.9	18.6	10.1	8.9	10.0	9.4	14.7	3.0	25.7	13.1	5.2	13.4	8.9	22.8	18.4	6.1	12.7	21.0	2.0	5.0	2.9	6.3	7.3	6.6	11.7	6.3	7.7	5.0	10.0	7.8	10.0	4.4	2.5	3.4	5.3	3.9	4.2	4.0	4.9	5.7	7.6	4.4	5.0	5.2	5.8	4.8	4.7	5.4	6.8	2.8	0.0	1.7	0.3	4.6	4.6	2.9	1.9	6.8	0.7	2.9	2.8	2.2	0.0	1.7	0.0	0.0	2.3	1.5	2.3	3.9	2.4	88.9	5.6	5.1	3.8	1.8	5.2	3.1	3.2	3.2	3.5	7.7	4.0	0.0	3.8	6.8	1.7	2.2	0.0	3.1	3.7	2.0	1.3	1.7	23.3	3.7	2.0	1.8	1.9	3.2	1.7	2.1	1.5	2.8	3.4	3.0	3.8	4.1	4.1	1.6	1.7	10.4	4.3	13.1	3.5	2.7	64.7	20.5	4.8	4.7	1.9	3.5	3.5	2.4	2.1
ZNF480	MGC32104	ENSG00000198464	"Zinc finger protein 480"	Q8WV37	19	52297169-52325922	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											HPA042218	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 34: Non-specific - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 63: NK-cells & T-cells - Immune response"	Nucleoplasm	Cytosol	"HPA042218: AB_10794791"	"unprognostic (1.50e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.35e-1)"	"unprognostic (3.01e-2)"	"unprognostic (5.22e-2)"	"unprognostic (2.01e-2)"	"unprognostic (1.29e-1)"	"prognostic unfavorable (1.65e-4)"	"unprognostic (4.22e-2)"	"unprognostic (7.81e-3)"	"unprognostic (4.97e-2)"	"prognostic favorable (2.03e-4)"	"unprognostic (3.05e-1)"	"unprognostic (1.11e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.82e-3)"	7.6	7.3	4.8	10.4	5.9	9.5	6.6	7.7	6.9	7.5	5.3	10.4	9.8	6.0	3.3	6.5	5.6	4.5	11.1	4.8	6.0	8.7	8.6	6.2	12.6	6.0	5.1	6.9	4.5	7.4	5.9	5.7	6.0	6.2	10.1	10.4	7.2	5.2	10.8	5.5	8.2	6.0	4.2	9.8	9.1	3.3	5.9	15.2	7.2	14.9	15.5	11.1	5.4	8.3	7.2	28.4	18.2	21.2	21.1	19.7	14.1	18.3	26.7	12.8	14.9	12.9	10.0	36.0	11.2	15.1	23.4	15.3	19.9	18.5	18.5	0.3	33.1	37.0	15.2	12.5	20.3	52.7	29.0	18.1	23.4	17.8	20.7	26.7	18.8	31.0	27.0	12.0	29.0	11.7	48.3	10.5	13.7	23.7	22.8	24.5	19.5	30.0	18.8	51.0	17.2	15.0	26.6	18.9	7.4	37.3	15.7	38.1	32.4	12.7	15.8	7.3	28.6	28.4	56.9	74.3	5.7	28.2	23.1	10.1	9.6	11.2	12.6	9.4	14.5	19.7	12.8	15.1	11.9	19.1	12.0	16.3	3.6	17.8	11.4	19.3	15.9	7.8	4.8	5.9	7.7	6.9	4.8	6.0	6.0	5.1	6.0	4.2	5.9	8.3	13.1	35.3	11.8	8.5	20.1	5.5	15.3	22.1	5.7	4.7	6.7	6.1	43.0	8.6	18.2	3.7	2.1	8.7	17.8	11.7	17.6	18.6	2.5	12.7	11.9	17.0	12.6	14.9	1.7	27.6	16.8	11.1	9.7	14.1	12.6	15.4	14.3	15.4	17.6	6.7	4.7	18.0	20.3	15.8	14.3	2.4	9.0	12.3	7.2	6.5	19.0	6.1	26.8	9.5	10.2	36.3	11.8	8.2	9.2	25.4	13.5	24.2	16.8	7.4	0.0	10.6	12.0	1.9	6.1	10.5	8.4	14.8	19.7	12.1	16.1	22.6
ZNF488	FLJ32104	ENSG00000265763	"Zinc finger protein 488"	Q96MN9	10	47365496-47384293	"Predicted intracellular proteins"	"Neurogenesis, Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	8	"brain: 34.4;intestine: 22.4"	"Cell type enhanced"	"Detected in some"		"Cytotrophoblasts: 7.0;Oligodendrocyte precursor cells: 10.1;Oligodendrocytes: 20.1;Proximal enterocytes: 21.5;Syncytiotrophoblasts: 36.1"	"Cancer enhanced"	"Detected in many"		"glioma: 5.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HaCaT: 46.9;HDLM-2: 70.1;RT4: 38.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035957, HPA035958"			Supported	Nucleoplasm,Cytosol	"Intracellular and membrane"	NA	NA				"Cluster 45: Intestine - Brush border"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	"Nucleoplasm, Cytosol"		"HPA035957: AB_10672234, HPA035958: AB_2674887"	"unprognostic (3.29e-2)"	"unprognostic (1.05e-2)"	"unprognostic (7.87e-2)"	"unprognostic (1.49e-4)"	"unprognostic (1.16e-1)"	"unprognostic (8.85e-2)"	"unprognostic (1.60e-3)"	"unprognostic (2.13e-2)"	"unprognostic (3.11e-1)"	"unprognostic (2.45e-1)"	"prognostic unfavorable (4.02e-7)"	"unprognostic (3.60e-1)"	"unprognostic (6.62e-5)"	"unprognostic (2.76e-1)"	"unprognostic (4.47e-1)"	"unprognostic (8.10e-2)"	"unprognostic (3.18e-2)"	0.2	0.1	10.2	0.1	22.2	0.0	0.8	23.6	18.1	0.3	3.1	0.6	22.4	0.1	1.6	0.9	0.1	0.2	0.1	18.0	14.8	1.1	0.0	0.2	0.0	29.4	26.4	0.3	0.0	0.0	0.8	3.4	26.8	0.3	0.6	2.6	0.4	0.1	0.0	1.7	11.2	0.1	20.4	0.0	0.3	0.8	23.2	0.3	0.1	0.1	0.6	0.5	0.5	34.4	4.9	13.7	2.3	0.7	0.0	0.0	0.2	0.5	0.6	0.8	0.8	5.3	12.7	0.3	0.8	0.0	5.3	46.9	1.2	5.2	0.7	70.1	1.4	0.2	1.5	0.4	0.0	0.1	0.7	0.0	12.2	0.5	1.3	0.2	0.0	2.7	0.0	0.0	0.0	0.2	0.5	0.2	3.5	10.3	1.3	0.0	5.8	0.0	0.3	38.2	11.1	2.0	3.3	0.5	0.0	5.1	1.1	0.1	0.0	0.0	3.5	0.0	0.7	0.0	0.0	0.0	0.1	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.2	22.2	23.6	18.1	18.0	14.8	29.4	26.4	26.8	20.4	23.2	34.4	0.2	0.0	0.0	1.0	0.0	0.6	0.9	0.4	0.0	1.8	0.2	0.4	0.6	0.0	0.2	0.0	0.0	7.0	0.0	0.8	5.9	0.2	0.0	0.1	0.0	0.1	0.0	0.0	1.9	0.2	0.5	0.3	0.0	0.1	0.0	0.4	0.0	0.0	0.4	0.0	0.8	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.1	0.0	10.1	20.1	0.6	0.0	0.0	0.0	1.1	21.5	0.2	0.0	0.5	0.0	0.2	0.6	0.1	1.5	0.0	0.1	36.1	0.0	0.1	1.5	0.4
ZNF507	"KIAA1084, Zfp507"	ENSG00000168813	"Zinc finger protein 507"	Q8TCN5	19	32345594-32387667	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Horizontal cells: 58.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030964, HPA049728"	Uncertain		Supported	Nucleoli,Cytosol		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 52: Non-specific - Transcription"	Nucleoli	Cytosol	"HPA030964: AB_10670562, HPA049728: AB_2680864"	"unprognostic (3.39e-1)"	"unprognostic (3.78e-2)"	"unprognostic (6.84e-2)"	"unprognostic (2.61e-2)"	"unprognostic (2.21e-2)"	"unprognostic (1.74e-2)"	"unprognostic (1.41e-3)"	"unprognostic (1.20e-1)"	"unprognostic (3.24e-2)"	"unprognostic (4.28e-3)"	"unprognostic (7.24e-2)"	"unprognostic (7.44e-2)"	"unprognostic (1.68e-1)"	"unprognostic (2.23e-1)"	"unprognostic (1.89e-1)"	"unprognostic (2.97e-2)"	"unprognostic (1.46e-2)"	5.1	4.2	4.3	4.6	5.7	6.8	6.8	6.4	5.6	5.9	3.4	4.9	5.7	6.8	4.3	5.1	5.9	4.3	5.6	4.4	4.8	4.7	6.3	4.4	6.7	4.7	5.3	9.5	5.3	6.2	3.7	7.0	5.0	5.9	5.3	8.1	6.4	4.7	9.2	4.7	5.9	6.0	4.8	5.2	5.2	13.1	4.7	8.6	10.7	8.7	5.8	4.3	4.1	7.3	10.0	16.2	13.5	8.2	9.3	14.6	11.4	8.5	8.1	7.3	8.1	9.8	7.6	15.1	10.5	7.8	8.3	5.9	19.4	10.5	14.8	10.6	15.3	14.8	8.7	7.7	11.0	12.8	8.0	9.5	8.9	9.0	15.4	8.6	10.9	11.9	21.0	10.7	8.6	5.8	13.5	5.2	14.9	15.0	5.8	14.0	16.1	6.4	5.5	9.9	11.9	10.5	11.2	7.8	10.2	10.7	5.9	9.5	10.4	12.6	13.3	8.0	11.9	10.4	12.9	14.1	8.7	9.3	11.5	0.2	0.0	0.5	1.0	0.0	1.1	0.7	0.8	0.8	0.0	1.0	1.1	0.9	0.5	0.6	0.0	0.1	0.6	0.4	4.3	5.7	6.4	5.6	4.4	4.8	4.7	5.3	5.0	4.8	4.7	7.3	13.3	9.6	17.7	22.5	13.2	2.8	8.8	5.3	13.6	22.2	9.3	7.6	16.1	5.7	9.0	0.0	14.6	10.9	7.7	7.6	1.9	5.6	22.1	10.0	22.7	11.0	9.0	12.4	31.3	5.5	5.3	11.9	12.2	11.4	3.8	17.1	13.6	12.1	3.7	58.9	36.0	11.5	4.1	0.3	1.8	11.0	9.3	0.8	1.8	16.9	0.4	17.2	10.3	31.2	46.6	4.9	8.0	7.2	6.4	12.0	15.6	4.2	16.1	23.5	0.0	16.1	13.9	25.8	18.9	10.9	2.7	8.8	11.3	12.6	11.2	7.6
ZNF540	DKFZp547B0714	ENSG00000171817	"Zinc finger protein 540"	Q8NDQ6	19	37551406-37614179	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 25.8"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 23.3;Excitatory neurons: 47.7;Inhibitory neurons: 56.5;Oligodendrocyte precursor cells: 23.1;Oligodendrocytes: 27.7;Rod photoreceptor cells: 22.3"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 2.4"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"ASC diff: 3.0"									HPA003444	Supported		Supported	Nucleoplasm,Vesicles,Cytosol		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm	"Vesicles, Cytosol"	"HPA003444: AB_1080732"	"unprognostic (2.51e-2)"	"unprognostic (2.30e-4)"	"unprognostic (4.92e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.80e-4)"	"unprognostic (4.24e-4)"	"unprognostic (3.44e-3)"	"unprognostic (8.88e-4)"	"unprognostic (2.65e-1)"	"unprognostic (3.17e-1)"	"unprognostic (3.38e-5)"	"unprognostic (1.50e-1)"	"unprognostic (1.09e-6)"	"unprognostic (2.74e-1)"	"unprognostic (4.75e-2)"	"unprognostic (8.08e-2)"	"unprognostic (8.33e-5)"	1.6	4.9	10.5	2.3	10.2	0.6	3.1	14.4	11.2	5.0	6.8	4.4	2.1	3.3	4.8	1.6	3.9	1.8	5.3	9.4	12.3	5.0	2.2	2.6	3.8	8.2	8.9	8.5	2.5	5.3	14.7	1.1	8.6	5.5	1.8	25.8	3.5	4.6	2.0	3.2	4.2	1.8	7.9	4.7	3.2	2.9	11.4	2.1	7.9	1.6	3.4	3.6	3.4	9.1	0.1	0.0	1.1	1.3	3.0	1.8	0.1	0.4	0.4	0.5	0.9	0.1	0.0	0.5	0.1	1.1	0.3	0.4	0.8	0.4	0.4	1.7	1.2	0.4	0.8	0.0	0.8	0.5	0.9	0.9	1.1	0.3	0.0	0.2	0.0	2.4	0.2	0.0	0.7	0.0	0.8	0.3	0.4	0.1	0.2	0.7	0.7	0.4	0.2	0.1	1.2	1.4	0.4	0.1	0.1	0.8	0.6	0.5	0.0	0.4	1.4	0.5	0.4	1.6	1.0	1.3	0.0	0.2	0.2	0.0	0.0	0.8	2.7	0.0	2.6	1.9	2.7	3.0	0.1	2.2	4.4	4.8	0.1	2.4	0.0	0.2	3.1	1.2	10.5	10.2	14.4	11.2	9.4	12.3	8.2	8.9	8.6	7.9	11.4	9.1	2.3	3.2	2.6	15.3	6.3	1.7	1.3	0.8	3.4	23.3	2.4	2.2	10.4	0.0	1.7	1.8	6.2	0.3	3.3	0.2	7.9	0.3	18.6	1.1	1.0	2.2	0.0	0.0	47.7	0.4	0.4	2.8	1.5	0.6	3.8	1.7	2.2	1.1	0.8	18.5	56.5	0.3	0.0	0.8	1.0	5.5	2.5	1.0	3.6	11.2	0.5	5.5	8.2	23.1	27.7	0.2	1.1	5.7	2.5	0.4	2.3	2.7	0.4	22.3	6.6	3.1	2.9	5.7	3.3	1.8	1.3	0.1	3.9	1.2	0.3	0.2
ZNF559	MGC13105	ENSG00000188321	"Zinc finger protein 559"	Q9BR84	19	9323772-9351162	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Spermatogonia: 40.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											"HPA059632, HPA065485"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 24: NB-4 - Immune response"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	Cytosol	"HPA059632: AB_2684089, HPA065485: AB_2685497"	"unprognostic (1.35e-3)"	"unprognostic (1.98e-1)"	"unprognostic (4.75e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.36e-2)"	"unprognostic (3.24e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.64e-3)"	"prognostic favorable (6.99e-4)"	"unprognostic (7.28e-3)"	"unprognostic (4.04e-2)"	"unprognostic (8.48e-2)"	"unprognostic (2.21e-2)"	"unprognostic (6.20e-2)"	"unprognostic (2.24e-1)"	"unprognostic (1.75e-3)"	14.8	14.2	12.5	9.2	13.7	4.0	16.8	19.7	14.0	23.5	17.8	16.7	6.4	22.4	21.5	7.4	23.1	9.9	19.7	12.4	12.9	19.1	11.1	12.4	16.0	12.7	12.3	32.7	10.6	22.2	25.9	12.1	12.4	20.5	11.0	20.4	12.3	12.9	4.7	10.7	14.8	19.1	11.8	22.1	12.9	16.3	13.7	22.7	19.7	10.6	13.1	17.0	15.6	19.4	15.4	8.3	15.6	19.3	9.2	8.3	4.2	9.3	18.6	13.3	11.4	3.8	1.8	12.4	10.8	13.7	18.4	5.4	9.5	8.8	16.9	19.9	13.5	16.2	14.0	5.7	16.0	15.0	18.3	17.3	15.6	14.7	18.7	11.4	11.3	18.8	12.7	42.8	8.7	0.0	20.4	46.8	25.4	2.6	13.4	10.0	18.8	16.7	8.1	21.5	17.8	14.7	17.9	2.9	22.6	22.9	12.7	11.5	9.6	24.6	5.6	20.1	14.2	3.5	0.1	12.6	4.6	9.4	16.0	40.7	4.8	11.4	12.1	4.7	16.4	17.4	13.0	13.3	7.7	17.0	21.0	17.2	2.7	20.9	6.5	6.4	12.6	9.0	12.5	13.7	19.7	14.0	12.4	12.9	12.7	12.3	12.4	11.8	13.7	19.4	9.8	3.2	3.3	0.0	12.9	3.8	6.7	6.2	5.7	30.2	7.0	7.1	8.8	10.0	5.1	3.7	27.1	7.0	12.4	2.2	1.9	7.3	9.1	6.1	8.3	11.0	3.0	3.0	0.0	3.2	5.3	9.8	1.5	3.8	2.5	17.8	12.8	2.7	4.9	26.9	0.0	4.0	2.0	7.0	3.7	2.9	12.8	4.7	3.6	0.0	7.7	17.3	29.9	0.0	0.0	3.2	3.0	13.5	1.8	4.6	2.2	3.4	5.7	27.2	6.6	14.1	10.1	27.0	40.4	2.9	3.0	2.9	10.0	8.5	4.1	2.8
ZNF568	DKFZp686B0797	ENSG00000198453	"Zinc finger protein 568"	Q3ZCX4	19	36916329-36998700	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Horizontal cells: 40.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			"HPA024541, HPA052061"	Uncertain		Supported	Nucleoplasm		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 21: Non-specific - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA024541: , HPA052061: AB_2681713"	"unprognostic (3.62e-2)"	"unprognostic (2.73e-1)"	"unprognostic (9.97e-2)"	"unprognostic (1.99e-3)"	"unprognostic (5.07e-2)"	"unprognostic (2.81e-2)"	"unprognostic (8.64e-2)"	"unprognostic (2.65e-2)"	"unprognostic (5.83e-5)"	"unprognostic (1.75e-1)"	"unprognostic (1.76e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.05e-5)"	"unprognostic (2.03e-2)"	"unprognostic (1.81e-1)"	"unprognostic (5.06e-3)"	"unprognostic (9.98e-3)"	4.1	6.5	5.5	3.6	5.4	3.7	5.6	12.4	6.4	6.3	7.3	4.5	2.4	7.3	4.9	3.4	5.9	3.4	5.2	5.4	8.4	4.5	3.3	4.2	4.1	5.9	6.9	9.3	4.4	8.3	5.3	5.2	5.8	4.9	2.9	11.8	4.8	5.4	5.5	4.1	3.2	5.9	3.9	6.1	4.3	6.0	6.9	4.8	7.7	5.7	4.5	4.4	4.1	9.9	0.2	5.0	8.4	2.5	7.8	8.8	2.6	7.4	7.4	6.0	8.1	0.6	2.9	0.3	8.3	9.3	4.3	1.4	0.1	4.3	6.3	1.1	6.5	2.8	0.9	1.0	10.1	0.4	6.5	10.7	5.1	6.1	0.2	7.3	2.9	3.7	0.3	0.8	9.2	0.2	1.6	1.3	6.9	0.0	0.3	0.7	6.7	2.6	5.7	11.0	8.2	10.7	0.3	0.2	6.2	8.3	6.7	1.1	4.7	3.5	11.9	6.1	4.8	9.0	13.1	6.0	0.2	0.2	12.5	19.6	1.7	6.4	7.1	1.3	6.3	9.0	6.8	5.9	2.9	6.9	8.4	6.4	1.4	7.4	2.1	2.7	6.4	3.0	5.5	5.4	12.4	6.4	5.4	8.4	5.9	6.9	5.8	3.9	6.9	9.9	7.7	3.2	7.0	12.7	7.5	5.1	3.4	4.5	2.8	18.9	5.7	6.5	6.6	10.0	3.1	9.2	14.6	5.0	6.3	0.5	3.9	7.1	28.9	5.1	7.1	7.4	0.0	1.3	22.4	3.7	4.1	7.8	2.6	3.8	16.5	13.9	6.4	1.4	3.5	40.4	22.6	1.4	14.2	2.5	3.4	19.5	6.5	3.5	1.8	10.3	3.5	9.4	12.3	25.6	25.7	2.8	0.3	9.8	3.4	3.9	0.7	5.1	5.2	17.0	6.6	13.6	6.6	18.1	12.6	3.4	4.1	2.9	7.9	7.2	1.0	2.6
ZNF574	FLJ22059	ENSG00000105732	"Zinc finger protein 574"	Q6ZN55	19	42068477-42081552	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 40.9;Spermatocytes: 35.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA023196, HPA057274"	Approved		Supported	Nucleoplasm,Vesicles		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 71: Testis - DNA repair"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm	Vesicles	"HPA023196: AB_2671105, HPA057274: AB_2683392"	"unprognostic (3.90e-1)"	"unprognostic (3.68e-2)"	"unprognostic (3.39e-2)"	"unprognostic (7.84e-2)"	"unprognostic (1.66e-1)"	"unprognostic (2.11e-2)"	"unprognostic (9.49e-2)"	"unprognostic (2.84e-2)"	"unprognostic (5.24e-2)"	"unprognostic (1.55e-3)"	"unprognostic (6.36e-3)"	"unprognostic (2.11e-1)"	"unprognostic (2.10e-2)"	"unprognostic (6.48e-2)"	"unprognostic (3.51e-2)"	"unprognostic (2.97e-1)"	"unprognostic (1.09e-3)"	8.1	5.4	6.8	4.6	6.1	11.1	7.9	9.5	7.7	8.4	4.3	9.5	6.7	10.3	2.7	9.6	8.8	5.1	6.8	6.2	6.2	5.5	5.4	5.6	6.5	6.9	5.8	9.6	7.9	6.1	6.5	5.0	5.8	7.5	2.8	4.1	8.1	6.7	9.3	12.8	7.5	3.7	5.6	8.4	7.2	27.1	6.3	6.3	6.0	6.4	4.2	8.2	7.5	6.3	15.0	41.1	9.0	11.4	8.1	8.0	9.7	11.0	9.6	14.2	13.6	16.2	10.1	21.4	9.7	9.1	7.5	8.9	10.4	14.1	5.6	11.4	17.6	20.5	10.1	14.0	8.6	12.6	13.5	9.5	13.9	13.2	11.1	8.7	7.9	11.8	17.1	13.3	10.1	31.2	15.2	10.9	16.1	13.5	16.2	20.7	8.6	9.3	7.4	19.7	14.9	12.8	11.3	24.0	7.3	6.2	11.0	20.5	9.5	19.2	14.9	5.8	16.4	14.3	9.3	15.7	10.6	11.9	11.0	12.3	10.5	16.7	16.2	7.8	17.6	17.3	12.1	17.8	12.5	12.8	12.6	11.9	13.3	10.9	11.2	11.1	10.3	12.9	6.8	6.1	9.5	7.7	6.2	6.2	6.9	5.8	5.8	5.6	6.3	6.3	6.0	0.0	3.3	1.3	11.3	29.3	15.1	6.1	40.9	7.5	11.0	7.6	4.3	4.3	6.0	1.8	2.1	7.9	6.3	5.8	1.9	6.9	25.3	6.1	5.7	7.6	3.5	8.6	1.4	5.1	6.7	6.6	7.7	5.7	12.7	5.4	6.8	3.1	5.1	3.3	1.7	7.6	6.1	2.5	11.0	15.7	5.6	3.0	8.8	1.0	7.5	3.9	4.1	1.5	0.9	4.3	8.5	8.6	8.1	10.6	6.4	4.3	5.2	9.8	6.6	8.8	8.0	35.5	20.5	22.1	22.7	4.8	10.6	3.8	7.9	9.6
ZNF577	MGC4400	ENSG00000161551	"Zinc finger protein 577"	Q9BSK1	19	51804816-51890950	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 39.2;Early spermatids: 56.3;Late spermatids: 60.6;Oligodendrocytes: 50.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			"HPA041499, HPA046761"	Uncertain		Supported	Nucleoplasm,Nucleoli		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 21: Non-specific - Transcription"	"Cluster 36: HEL - Hemostasis"	"Cluster 34: Spermatids - Unknown function"	"Nucleoplasm, Nucleoli"		"HPA041499: AB_2677516, HPA046761: AB_2679791"	"unprognostic (1.17e-1)"	"unprognostic (2.71e-1)"	"unprognostic (5.69e-2)"	"unprognostic (4.17e-1)"	"unprognostic (8.21e-2)"	"unprognostic (1.45e-3)"	"unprognostic (1.48e-1)"	"unprognostic (1.64e-2)"	"unprognostic (3.01e-3)"	"unprognostic (1.18e-1)"	"unprognostic (1.04e-1)"	"unprognostic (6.51e-3)"	"unprognostic (2.81e-3)"	"unprognostic (2.72e-2)"	"unprognostic (2.70e-1)"	"unprognostic (7.02e-2)"	"prognostic favorable (2.03e-4)"	9.4	7.2	11.9	5.4	15.0	4.2	12.2	14.2	13.2	14.3	8.0	14.5	4.6	11.7	7.1	6.8	12.7	8.0	12.2	11.5	16.1	13.6	6.8	7.9	5.5	14.0	12.3	27.1	8.8	14.9	8.4	9.3	13.3	18.4	6.6	16.9	12.0	11.3	7.2	20.6	9.0	7.2	10.2	12.7	8.9	18.8	13.5	7.7	18.7	9.1	5.7	11.1	9.3	21.0	1.6	0.1	7.8	9.5	13.1	14.1	0.0	9.3	3.4	3.5	7.1	1.0	1.3	1.6	0.9	4.3	5.2	2.5	3.1	1.9	1.9	0.0	9.0	15.6	0.2	1.4	10.2	3.4	5.1	11.1	5.8	5.2	1.5	10.9	1.8	0.0	3.5	0.1	4.5	0.0	9.7	4.4	9.0	0.0	0.2	4.2	3.9	2.9	5.8	3.4	3.2	1.6	2.3	1.1	8.0	7.9	1.6	3.7	1.2	6.4	8.8	1.8	3.4	6.3	0.0	2.0	1.7	0.6	10.6	4.4	1.6	3.7	0.9	2.5	2.7	7.2	1.8	2.2	1.8	3.5	2.2	1.4	0.6	3.3	2.0	2.0	0.9	1.1	11.9	15.0	14.2	13.2	11.5	16.1	14.0	12.3	13.3	10.2	13.5	21.0	8.8	0.0	2.6	14.4	4.0	4.5	3.7	4.0	2.2	12.2	8.1	7.9	8.5	4.3	3.0	18.4	10.4	7.2	4.8	2.7	39.2	4.3	56.3	7.2	7.4	6.6	3.0	2.1	20.1	1.1	5.4	6.3	4.1	5.6	5.1	9.8	7.1	1.8	5.7	6.7	19.3	4.7	2.0	2.2	3.7	60.6	8.1	6.7	0.0	9.4	4.0	15.2	1.0	26.2	50.1	1.2	1.9	12.8	0.9	5.9	5.1	4.9	3.0	9.9	0.0	6.9	7.6	12.3	14.0	4.2	5.3	4.5	2.5	4.2	4.4	3.0
ZNF589	SZF1	ENSG00000164048	"Zinc finger protein 589"	Q86UQ0	3	48241100-48299253	"Predicted intracellular proteins, Transcription factors"		"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 20.9"	"Cancer enhanced"	"Detected in all"		"testis cancer: 15.6"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HAP1: 44.1;NTERA-2: 71.1"									HPA003145	Uncertain		Supported	Nucleoplasm		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 51: Non-specific - Unknown function"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 51: Myeloid cells - Hemostasis"	Nucleoplasm		"HPA003145: AB_1080738"	"unprognostic (2.49e-3)"	"prognostic favorable (2.50e-4)"	"unprognostic (9.14e-2)"	"unprognostic (7.34e-3)"	"unprognostic (1.18e-1)"	"prognostic favorable (1.71e-4)"	"unprognostic (3.01e-5)"	"prognostic favorable (6.45e-5)"	"unprognostic (2.64e-2)"	"unprognostic (9.67e-2)"	"prognostic favorable (1.21e-4)"	"unprognostic (8.02e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.32e-2)"	"unprognostic (3.45e-2)"	"unprognostic (9.57e-3)"	"unprognostic (2.19e-2)"	7.2	8.5	9.6	6.7	9.7	5.8	6.9	14.9	11.2	11.2	2.3	8.3	3.8	7.6	20.1	10.2	8.8	4.6	6.2	11.0	9.3	7.1	3.7	10.1	12.3	7.9	7.9	13.6	6.5	5.9	7.8	3.0	7.7	18.3	6.6	14.8	6.6	15.7	6.1	9.8	16.1	6.0	7.2	24.1	7.9	6.6	8.9	8.1	16.6	4.2	12.2	8.5	10.7	10.2	4.5	3.2	12.7	10.8	15.8	8.7	16.1	4.6	3.5	5.2	6.9	6.8	6.0	17.8	3.3	4.7	4.0	3.9	44.1	11.2	4.2	11.5	10.5	22.5	14.9	5.4	2.9	5.4	5.6	2.8	7.5	6.4	4.3	5.7	9.0	13.7	15.4	4.5	2.8	4.5	6.8	4.1	71.1	4.3	6.6	3.3	4.6	6.8	4.0	4.4	4.9	9.1	3.4	3.7	13.7	18.8	6.0	8.0	14.0	3.0	5.8	7.2	3.5	8.9	12.0	14.6	4.0	12.6	9.3	1.2	2.2	1.6	2.8	2.0	3.5	3.1	3.4	3.8	2.3	1.9	3.8	3.8	1.2	1.2	2.8	10.9	3.1	1.9	9.6	9.7	14.9	11.2	11.0	9.3	7.9	7.9	7.7	7.2	8.9	10.2	2.0	0.0	5.4	4.2	5.5	1.1	1.4	0.9	3.4	15.3	2.4	1.5	4.1	0.0	2.8	9.2	20.9	2.2	13.7	1.3	3.9	1.4	1.5	7.3	3.5	2.7	1.8	2.1	9.8	1.0	1.2	4.3	1.5	11.7	0.0	3.9	2.5	1.0	3.3	1.7	11.5	2.5	0.0	5.5	3.0	2.0	2.1	7.3	1.8	3.7	3.7	5.3	1.0	9.5	11.0	1.0	1.7	4.5	5.3	1.5	1.4	1.6	2.4	13.1	6.6	4.1	3.0	1.4	3.1	2.9	1.3	0.0	4.4	7.0	2.5	0.9
ZNF606	"FLJ14260, KIAA1852, ZNF328"	ENSG00000166704	"Zinc finger protein 606"	Q8WXB4	19	57977053-58003349	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 25.0;Rod photoreceptor cells: 29.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEK 293: 23.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041712, HPA043584"	Uncertain		Supported	Nucleoplasm		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA041712: AB_10960410, HPA043584: AB_2678565"	"unprognostic (1.05e-2)"	"unprognostic (1.05e-1)"	"unprognostic (4.09e-2)"	"unprognostic (3.76e-2)"	"unprognostic (4.92e-2)"	"unprognostic (6.21e-2)"	"unprognostic (1.10e-1)"	"unprognostic (6.83e-2)"	"unprognostic (3.48e-3)"	"unprognostic (4.26e-2)"	"unprognostic (1.29e-3)"	"unprognostic (4.09e-2)"	"unprognostic (1.03e-1)"	"unprognostic (5.00e-2)"	"unprognostic (3.21e-2)"	"unprognostic (4.01e-2)"	"prognostic favorable (4.75e-6)"	4.4	5.3	7.3	5.0	9.2	4.0	8.0	10.5	8.1	8.3	11.8	5.7	5.6	8.1	8.9	5.0	10.0	3.5	5.7	6.8	7.2	9.7	5.7	5.3	8.1	8.4	9.1	10.4	6.4	9.3	11.3	4.3	8.2	8.9	4.5	10.0	7.9	6.0	3.9	7.2	8.4	3.5	8.1	9.0	6.7	7.6	7.8	8.5	13.3	2.8	6.6	6.3	6.0	12.1	1.7	3.1	13.1	10.9	3.9	5.4	9.4	4.0	1.4	3.9	2.4	4.1	4.7	2.7	3.1	2.7	4.2	4.0	1.7	3.9	5.2	0.0	23.5	6.6	1.3	3.7	3.0	0.0	5.1	6.4	1.9	3.4	1.9	6.1	2.8	7.7	3.4	0.1	5.0	1.6	9.0	1.5	7.9	2.1	5.8	9.9	4.8	4.0	4.2	8.2	12.1	8.0	7.2	0.2	3.0	6.3	6.3	6.3	3.3	3.1	4.4	1.1	1.3	7.8	9.1	1.9	0.2	0.7	4.1	10.2	2.3	6.5	2.2	2.0	3.2	6.5	3.6	2.7	2.1	7.4	6.4	3.7	6.2	5.5	2.3	6.5	2.6	1.8	7.3	9.2	10.5	8.1	6.8	7.2	8.4	9.1	8.2	8.1	7.8	12.1	4.3	6.4	7.8	9.1	9.6	1.0	3.5	2.5	5.2	15.4	3.5	2.9	10.8	2.8	5.6	12.9	25.0	3.2	6.2	1.7	3.9	4.0	2.8	8.6	4.6	5.9	0.0	9.0	8.4	1.6	1.1	3.9	6.1	2.2	5.1	14.4	5.3	2.6	2.0	11.8	9.8	2.4	4.1	0.8	3.0	1.2	8.1	2.5	0.0	7.5	2.2	8.6	10.3	10.1	12.9	2.2	2.4	3.4	3.0	4.1	4.2	2.2	22.6	29.2	6.6	2.9	4.6	12.3	12.7	3.1	2.0	3.4	4.4	6.8	2.2	3.2
ZNF622	"MGC17552, MGC2485, ZPR9"	ENSG00000173545	"Zinc finger protein 622"	Q969S3	5	16451519-16465800	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036514, HPA036515"	Uncertain		Supported	"Nucleoplasm,Nucleoli,Golgi apparatus,Cytosol"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 59: Non-specific - Translation"	"Cluster 20: HeLa - Mitochondria"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Cytosol	"Nucleoplasm, Nucleoli, Golgi apparatus"	"HPA036514: AB_2675167, HPA036515: AB_10672224"	"unprognostic (6.29e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.00e-2)"	"unprognostic (6.53e-2)"	"unprognostic (8.24e-3)"	"unprognostic (4.71e-3)"	"unprognostic (1.06e-1)"	"unprognostic (1.71e-1)"	"unprognostic (3.14e-2)"	"unprognostic (1.62e-1)"	"unprognostic (8.69e-2)"	"unprognostic (5.93e-2)"	"unprognostic (2.19e-1)"	"unprognostic (7.42e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.78e-1)"	19.5	13.5	20.3	13.8	21.4	36.0	18.4	17.2	21.8	16.7	14.4	21.5	16.9	17.8	17.2	17.9	15.3	12.1	56.9	18.1	19.6	14.6	22.0	16.6	17.8	18.7	20.7	15.6	54.3	15.6	15.1	16.9	20.3	15.5	20.7	10.8	18.3	12.7	41.7	25.6	20.3	12.5	19.1	15.5	22.4	20.5	19.4	16.0	15.5	25.2	15.7	17.5	17.0	22.1	25.7	55.2	16.9	35.2	40.4	34.3	61.4	45.2	33.9	36.0	45.6	66.0	23.2	30.0	59.6	36.0	48.4	33.3	27.5	35.3	28.9	40.6	37.3	27.4	92.8	47.7	58.1	53.8	31.5	53.3	43.7	33.6	31.5	28.0	25.6	17.6	37.6	28.9	40.1	43.2	28.4	52.3	30.0	24.2	53.8	22.1	20.6	25.8	33.6	38.0	23.4	26.2	63.1	46.8	78.2	29.4	26.0	41.1	35.3	40.0	30.5	39.3	29.1	41.3	39.7	41.9	34.9	45.8	28.5	89.3	65.6	88.6	73.8	71.3	77.8	85.4	73.7	82.0	73.3	81.9	84.2	70.3	87.9	67.9	79.6	59.2	85.0	82.6	20.3	21.4	17.2	21.8	18.1	19.6	18.7	20.7	20.3	19.1	19.4	22.1	14.8	22.4	24.2	2.9	33.2	60.7	43.1	48.6	34.1	22.8	19.8	16.4	73.8	24.3	34.4	14.7	10.4	64.0	39.5	77.5	27.4	55.2	111.5	35.0	36.8	22.3	98.7	20.0	7.6	66.7	57.2	34.1	31.1	71.3	52.0	13.3	15.0	25.1	50.0	16.8	7.9	60.6	48.8	19.3	35.1	62.8	18.0	29.7	33.8	4.7	43.3	22.6	37.0	6.6	9.0	51.2	127.1	19.9	26.6	28.3	84.5	39.2	29.7	19.3	19.7	31.7	46.9	63.2	37.8	21.8	43.2	40.6	41.6	20.5	55.5	33.5
ZNF629	"KIAA0326, ZNF65"	ENSG00000102870	"Zinc finger protein 629"	Q9UEG4	16	30778456-30787205	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 28.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019550, HPA056051"	Uncertain		Supported	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 62: Horizontal cells - Visual perception"	Nucleoplasm	"Golgi apparatus"	"HPA019550: AB_1859386, HPA056051: AB_2683020"	"unprognostic (1.03e-2)"	"unprognostic (2.15e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.67e-1)"	"unprognostic (3.17e-1)"	"unprognostic (6.38e-2)"	"unprognostic (6.14e-2)"	"unprognostic (2.98e-2)"	"unprognostic (3.15e-1)"	"unprognostic (6.24e-2)"	"unprognostic (4.87e-3)"	"unprognostic (2.66e-2)"	"prognostic favorable (4.57e-10)"	"unprognostic (8.41e-2)"	"unprognostic (1.96e-1)"	"unprognostic (5.71e-2)"	"unprognostic (9.70e-2)"	5.6	9.0	5.6	3.0	6.0	4.1	5.7	7.1	5.9	6.5	4.3	6.8	5.5	8.0	4.3	5.1	6.6	3.6	12.6	5.9	6.1	7.8	4.3	5.3	1.9	6.2	6.7	6.8	5.9	15.0	6.6	3.6	5.6	6.3	4.5	7.8	6.5	6.0	9.7	8.6	5.3	6.8	5.0	4.0	7.3	4.1	7.0	3.9	5.9	9.6	2.3	6.5	5.1	5.5	9.8	15.8	23.9	18.5	11.5	10.6	3.6	10.8	15.6	16.6	14.0	9.7	8.8	1.8	10.2	17.6	5.2	11.4	11.7	14.3	11.0	0.4	17.6	13.6	14.0	10.2	12.3	4.8	8.0	17.7	10.5	10.3	8.6	13.0	8.9	0.8	20.2	0.4	14.6	20.8	7.2	6.3	12.6	4.7	6.4	24.3	18.4	0.8	13.9	15.9	22.6	25.3	10.5	19.4	2.6	7.8	14.6	17.4	10.8	15.5	10.1	10.6	8.3	0.3	0.1	0.5	10.2	11.9	5.3	0.0	0.3	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.2	0.2	0.0	0.3	0.1	0.6	0.0	0.1	5.6	6.0	7.1	5.9	5.9	6.1	6.2	6.7	5.6	5.0	7.0	5.5	4.9	19.2	9.4	5.9	2.6	1.9	3.4	4.3	5.7	16.7	4.2	3.4	28.3	4.3	6.5	9.2	4.2	1.3	1.6	5.4	1.9	8.7	1.7	5.1	9.5	8.0	11.5	4.6	2.4	8.0	0.6	5.3	7.1	5.3	2.5	10.7	8.2	4.7	4.4	16.8	3.7	7.9	6.1	5.2	3.0	4.7	9.3	2.6	1.8	1.0	7.7	13.4	1.0	4.5	3.4	10.9	5.0	4.5	3.0	4.8	5.1	4.3	5.9	12.4	0.0	6.7	5.6	4.6	1.5	3.8	1.8	0.5	1.4	8.3	9.0	3.8
ZNF638	"MGC26130, NP220, ZFML, Zfp638"	ENSG00000075292	"Zinc finger protein 638"	Q14966	2	71276561-71435069	"Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocyte precursor cells: 342.3;Oligodendrocytes: 619.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036784, HPA057395"	Supported		Enhanced	Nucleoplasm,Vesicles		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	Vesicles	"HPA036784: AB_10672478, HPA057395: AB_2683426"	"unprognostic (2.58e-2)"	"unprognostic (3.15e-1)"	"unprognostic (7.57e-2)"	"unprognostic (1.26e-3)"	"unprognostic (2.18e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.35e-2)"	"unprognostic (5.68e-3)"	"unprognostic (2.31e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.32e-1)"	"unprognostic (2.66e-3)"	"unprognostic (3.28e-1)"	"unprognostic (7.68e-2)"	"unprognostic (1.93e-2)"	"prognostic favorable (8.73e-5)"	21.1	22.1	35.7	21.6	48.9	28.2	24.6	77.6	52.3	23.0	37.7	22.0	15.6	29.2	18.4	19.8	22.1	19.1	41.0	35.7	41.3	24.2	30.9	21.2	25.0	41.9	36.8	37.3	21.9	27.9	24.9	23.2	41.9	22.2	19.5	48.6	21.0	19.5	51.5	16.8	19.0	22.9	34.8	23.1	21.8	29.7	38.9	30.9	29.8	33.7	22.6	21.3	17.1	82.5	36.2	51.0	77.0	36.1	44.4	48.3	59.2	40.4	46.6	33.6	30.0	49.2	34.6	59.2	36.6	37.1	52.3	29.9	72.1	41.4	48.7	60.5	40.1	77.8	54.8	45.4	38.3	72.0	50.6	30.8	39.5	36.1	66.7	47.8	52.5	39.2	79.4	33.8	49.6	36.1	50.9	52.9	66.7	54.1	32.4	43.0	116.5	41.7	36.0	54.3	59.0	38.7	49.8	34.7	52.8	76.3	32.3	43.7	54.3	41.4	60.0	31.1	41.2	27.6	45.7	57.4	34.8	46.3	45.8	64.1	17.0	33.5	18.1	16.3	17.2	25.4	17.1	17.2	14.0	26.0	22.5	16.7	29.1	21.5	24.1	17.7	16.0	10.8	35.7	48.9	77.6	52.3	35.7	41.3	41.9	36.8	41.9	34.8	38.9	82.5	63.1	67.3	112.4	227.9	63.9	31.7	56.8	40.8	46.1	111.5	36.8	35.4	107.0	27.1	59.0	40.5	123.0	42.5	46.7	39.2	19.6	43.0	15.7	54.2	63.7	65.9	38.4	57.2	286.9	40.9	29.0	83.5	50.0	59.2	79.1	112.8	38.6	48.6	32.5	67.3	268.4	34.2	32.6	41.9	33.3	15.8	75.2	49.6	23.2	225.8	71.6	56.4	56.7	342.3	619.5	39.6	35.7	63.9	50.5	60.0	38.1	21.6	74.7	104.0	32.9	98.3	73.1	110.1	78.3	37.4	30.3	50.2	56.1	74.0	36.8	58.9
ZNF639	"ANC-2H01, ZASC1"	ENSG00000121864	"Zinc finger protein 639"	Q9UID6	3	179323031-179338583	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049023, HPA052163"	Uncertain		Supported	Nucleoplasm		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 34: Non-specific - Transcription"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 9: Photoreceptor cells - Phototransduction"	Nucleoplasm		"HPA049023: AB_2680603, HPA052163: AB_2681747"	"unprognostic (5.64e-2)"	"unprognostic (6.16e-2)"	"unprognostic (8.15e-2)"	"unprognostic (1.33e-2)"	"prognostic favorable (5.45e-5)"	"unprognostic (1.06e-1)"	"prognostic unfavorable (2.13e-4)"	"unprognostic (7.74e-2)"	"unprognostic (1.05e-2)"	"unprognostic (2.16e-3)"	"unprognostic (4.70e-3)"	"unprognostic (4.58e-2)"	"unprognostic (2.48e-2)"	"unprognostic (1.59e-1)"	"unprognostic (7.82e-2)"	"unprognostic (1.33e-2)"	"unprognostic (1.56e-1)"	20.8	19.5	16.5	18.0	17.5	59.2	28.0	22.1	19.3	27.6	15.0	26.6	17.4	31.5	25.6	20.9	26.0	19.8	27.4	16.4	16.6	25.1	23.9	21.9	26.6	16.4	16.8	32.7	24.6	38.6	18.2	22.5	15.9	26.3	22.1	40.0	24.5	27.0	27.3	16.9	18.6	31.0	16.8	23.7	20.6	19.1	17.3	26.6	41.4	30.3	24.6	21.5	18.3	18.0	81.3	18.7	35.5	43.9	31.7	38.4	35.2	37.8	56.4	61.0	54.8	31.7	31.3	94.2	56.4	46.6	74.1	30.1	55.2	50.5	76.0	86.7	43.1	96.1	26.8	31.8	55.0	76.1	34.5	31.1	51.9	31.3	72.5	45.7	42.1	61.3	59.4	48.6	48.6	41.2	79.5	33.7	59.9	56.9	43.5	75.4	37.1	112.1	37.8	32.4	65.3	39.9	37.9	41.1	49.2	29.8	104.9	59.4	34.5	41.3	43.7	33.1	98.7	19.7	19.0	174.2	30.3	58.5	28.9	2.5	1.1	1.2	1.6	0.7	1.5	1.8	2.6	2.6	0.9	2.0	2.2	2.2	0.7	2.2	0.5	0.3	2.4	0.8	16.5	17.5	22.1	19.3	16.4	16.6	16.4	16.8	15.9	16.8	17.3	18.0	16.9	19.2	11.7	9.4	24.2	20.9	34.0	7.0	32.5	21.5	21.6	13.2	19.4	10.0	8.8	14.7	54.2	14.7	18.3	8.6	33.2	12.2	29.8	21.6	22.4	19.4	18.7	29.0	8.7	10.0	11.3	21.8	11.2	30.3	10.1	18.5	18.5	17.0	9.9	16.8	10.6	15.6	6.1	13.2	17.2	8.8	24.5	13.8	14.2	4.7	13.5	19.6	13.4	8.5	9.6	11.5	9.4	24.0	27.5	36.1	11.2	22.2	7.2	44.9	26.3	27.1	22.7	29.9	21.3	29.9	17.5	3.4	23.2	19.8	12.2	24.9
ZNF641	FLJ31295	ENSG00000167528	"Zinc finger protein 641"	Q96N77	12	48337180-48351414	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Theca cells: 45.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035189	Uncertain		Supported	Nucleoplasm		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 20: HeLa - Mitochondria"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA035189: AB_10603333"	"unprognostic (1.79e-1)"	"unprognostic (1.85e-1)"	"unprognostic (2.70e-2)"	"unprognostic (9.82e-3)"	"unprognostic (3.71e-2)"	"unprognostic (1.08e-2)"	"unprognostic (1.90e-2)"	"unprognostic (1.35e-3)"	"unprognostic (7.82e-3)"	"prognostic favorable (3.91e-4)"	"prognostic favorable (8.30e-5)"	"unprognostic (3.67e-1)"	"unprognostic (2.68e-2)"	"unprognostic (7.61e-2)"	"unprognostic (1.51e-1)"	"unprognostic (5.76e-2)"	"unprognostic (7.85e-3)"	9.0	22.9	8.3	10.7	9.0	6.9	7.8	8.9	9.5	11.3	4.2	8.2	9.4	14.1	10.1	6.6	10.7	9.9	9.1	7.6	9.5	9.2	9.9	10.9	12.5	10.0	10.1	19.6	12.1	14.1	9.8	14.8	9.8	8.8	8.0	16.9	7.4	9.2	16.6	6.2	7.5	13.3	9.1	12.6	9.3	11.9	10.9	14.7	14.7	17.3	12.9	10.7	7.1	9.5	3.2	5.4	8.3	13.9	8.0	2.2	6.1	8.1	5.5	4.3	2.8	9.1	9.1	6.2	11.4	7.3	8.1	5.3	3.1	5.3	1.4	14.2	5.2	10.2	9.9	2.6	7.4	11.0	14.2	3.5	7.9	2.9	6.7	6.9	3.8	7.9	10.4	6.1	3.9	4.1	5.1	4.7	1.8	3.4	2.3	3.4	8.0	5.0	7.0	16.6	3.4	5.2	9.4	4.0	5.9	7.2	10.2	11.2	1.5	4.7	7.5	4.6	3.9	6.6	6.5	4.8	2.8	12.8	4.7	1.6	2.9	7.2	2.7	2.7	1.6	0.4	1.5	2.5	3.1	0.6	1.4	2.6	6.5	4.5	4.0	1.3	0.7	2.4	8.3	9.0	8.9	9.5	7.6	9.5	10.0	10.1	9.8	9.1	10.9	9.5	8.4	6.4	16.1	19.2	9.9	3.1	13.5	4.4	14.2	14.7	7.9	5.6	9.1	11.5	5.7	7.3	10.4	1.4	12.7	4.3	7.9	8.8	2.2	3.8	8.7	9.2	5.4	7.4	16.8	10.4	0.9	12.8	4.6	5.0	3.8	33.0	15.7	8.6	7.6	18.5	38.7	1.7	0.0	18.3	13.5	2.7	15.5	12.3	0.0	15.0	15.3	16.9	27.8	10.1	4.7	7.2	1.3	24.0	3.7	5.9	4.8	5.1	5.0	18.4	19.7	9.3	17.9	5.2	6.0	6.2	2.3	0.5	11.8	45.3	2.7	5.2
ZNF653	Zip67	ENSG00000161914	"Zinc finger protein 653"	Q96CK0	19	11483427-11505839	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 15.1;Late spermatids: 26.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023631, HPA023635"	Uncertain		Supported	Nucleoplasm		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 43: Testis - Unknown function"	"Cluster 16: U-266 - Nucleosome"	"Cluster 25: Spermatids - Spermatogenesis"	Nucleoplasm		"HPA023631: AB_2671269, HPA023635: AB_10603940"	"unprognostic (1.21e-1)"	"unprognostic (5.23e-2)"	"prognostic unfavorable (8.37e-4)"	"prognostic favorable (4.15e-4)"	"unprognostic (9.75e-2)"	"unprognostic (1.67e-3)"	"unprognostic (1.11e-1)"	"unprognostic (2.46e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.14e-3)"	"unprognostic (1.29e-3)"	"unprognostic (1.12e-1)"	"unprognostic (7.91e-3)"	"unprognostic (1.43e-2)"	"unprognostic (3.09e-2)"	"unprognostic (3.15e-1)"	"prognostic favorable (8.74e-4)"	4.5	8.1	12.9	4.4	13.4	3.7	5.3	20.5	16.9	5.9	11.6	6.8	3.3	5.9	1.7	5.4	6.4	4.1	5.6	14.8	14.3	9.5	8.5	4.8	4.3	12.1	12.3	6.4	8.3	5.4	8.8	3.4	12.2	8.5	2.1	3.5	5.5	3.1	7.6	7.7	6.5	3.8	10.8	5.8	7.5	25.3	12.9	6.2	8.9	3.7	2.6	6.3	5.9	13.6	11.7	9.5	7.1	6.4	1.9	1.4	5.2	4.3	3.7	6.2	5.6	6.5	5.0	8.0	5.4	4.8	6.5	5.2	5.5	4.3	3.1	8.6	7.2	5.2	6.4	7.7	2.0	6.9	8.8	4.2	5.5	5.8	4.7	5.9	4.7	7.0	7.5	11.8	3.5	16.3	9.5	15.6	7.8	6.5	7.7	8.3	4.7	10.5	6.8	9.6	8.3	12.2	2.9	5.0	5.8	3.1	4.8	4.4	6.0	8.8	5.9	10.1	10.6	15.6	24.9	6.1	7.8	9.2	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	12.9	13.4	20.5	16.9	14.8	14.3	12.1	12.3	12.2	10.8	12.9	13.6	2.5	0.0	0.0	2.6	2.7	3.2	4.0	0.8	1.2	4.4	3.1	3.0	1.8	1.5	0.5	1.8	6.2	1.4	2.5	5.2	0.0	4.5	15.1	4.9	1.7	1.9	4.8	6.1	3.8	5.2	1.3	1.6	2.6	3.1	4.5	3.0	3.6	3.6	0.9	1.7	3.5	4.1	0.0	1.6	0.5	26.7	1.8	1.1	0.0	2.8	3.9	4.9	0.0	2.0	1.5	4.5	0.8	2.2	1.0	2.5	2.0	2.7	1.1	4.1	0.0	2.6	3.1	9.1	4.7	1.3	2.7	1.6	1.5	2.6	3.3	2.2
ZNF655	"VIK, VIK-1"	ENSG00000197343	"Zinc finger protein 655"	Q8N720	7	99558406-99576453	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029534, HPA050750"	Uncertain		Supported	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	"Plasma membrane"	"HPA029534: AB_10603008, HPA050750: AB_2681225"	"prognostic favorable (7.12e-4)"	"unprognostic (3.03e-2)"	"unprognostic (9.62e-2)"	"unprognostic (5.00e-1)"	"unprognostic (1.51e-1)"	"unprognostic (5.42e-2)"	"unprognostic (3.31e-2)"	"unprognostic (3.93e-3)"	"prognostic unfavorable (7.24e-4)"	"unprognostic (2.01e-1)"	"unprognostic (1.49e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.42e-2)"	"unprognostic (2.16e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.62e-2)"	"unprognostic (1.12e-1)"	11.6	11.9	7.0	14.3	6.2	8.9	12.8	8.3	7.8	13.2	5.9	15.5	15.9	10.1	11.0	26.9	11.5	10.2	8.4	6.3	6.1	13.8	14.9	15.3	19.7	5.0	5.5	13.9	21.1	14.4	8.2	12.5	6.4	11.4	11.8	8.5	16.7	11.3	12.7	18.4	13.8	11.7	5.1	14.2	18.0	7.4	6.3	22.6	11.8	13.5	17.3	18.8	14.9	9.6	40.5	35.9	16.5	23.9	15.8	25.4	12.4	24.0	45.8	40.7	37.8	20.1	37.0	31.8	0.4	33.2	52.0	25.2	18.0	29.6	40.6	34.5	23.6	18.9	16.0	27.8	24.1	38.1	35.9	21.1	32.8	35.8	50.6	21.4	17.3	26.4	54.4	39.7	24.4	0.1	53.9	36.6	21.1	0.1	0.0	19.9	14.0	52.9	25.9	42.8	17.4	37.6	25.1	0.7	27.2	24.0	12.2	20.2	13.3	24.3	60.2	43.4	43.6	47.3	72.7	63.4	23.5	18.2	39.9	147.8	43.2	74.4	47.8	47.2	45.1	32.7	44.1	55.7	40.3	31.3	35.0	43.8	50.3	37.0	55.2	23.3	61.3	55.4	7.0	6.2	8.3	7.8	6.3	6.1	5.0	5.5	6.4	5.1	6.3	9.6	19.5	96.1	82.8	51.2	53.2	44.7	46.5	36.5	42.1	48.8	34.4	25.1	36.1	31.5	44.3	23.9	41.7	31.6	76.3	46.3	33.2	31.6	12.8	25.8	33.9	20.4	41.5	12.8	53.4	36.2	42.7	32.7	37.2	33.0	18.9	70.8	19.2	24.6	37.4	50.5	57.4	40.4	18.3	63.4	31.6	9.7	25.4	56.0	23.2	44.0	59.2	24.9	106.1	61.3	75.3	48.2	55.2	25.2	55.4	44.5	48.1	41.1	26.0	45.8	13.1	39.9	31.7	39.0	29.8	55.6	48.9	73.6	62.5	30.0	28.1	64.0
ZNF74	"Cos52, Zfp520, ZNF520"	ENSG00000185252	"Zinc finger protein 74"	Q16587	22	20394115-20408461	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"K-562: 47.9"									HPA003354	Approved		Supported	"Nucleoplasm,Actin filaments"		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 40: Granulosa cells - Unknown function"	Nucleoplasm	"Actin filaments"	"HPA003354: AB_1080747"	"unprognostic (1.40e-1)"	"unprognostic (2.36e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.76e-2)"	"unprognostic (1.02e-1)"	"unprognostic (8.13e-3)"	"unprognostic (1.76e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.15e-1)"	"unprognostic (1.20e-3)"	"unprognostic (3.80e-2)"	"unprognostic (1.10e-1)"	"unprognostic (5.58e-2)"	"unprognostic (3.04e-1)"	"unprognostic (7.91e-2)"	"unprognostic (1.44e-3)"	1.7	2.4	5.0	1.2	5.1	0.6	2.1	4.4	5.2	4.5	3.9	4.3	1.3	4.7	1.9	3.2	3.1	0.8	2.3	5.1	5.2	2.8	2.4	1.9	1.5	4.8	4.8	4.4	4.2	2.7	5.4	1.5	4.8	3.6	1.4	1.7	2.9	3.0	4.7	2.9	2.2	2.4	4.4	2.6	3.1	1.3	5.2	2.5	2.5	2.4	1.1	3.9	3.0	5.2	4.3	4.1	10.4	15.8	2.9	2.8	8.2	4.0	2.9	4.8	4.5	5.7	2.0	0.1	5.6	3.2	1.6	5.2	7.8	5.1	2.7	2.8	17.8	4.9	2.0	8.1	4.8	10.7	5.1	3.1	8.6	3.7	4.2	3.6	4.8	9.3	47.9	0.1	3.4	7.1	10.2	6.6	11.6	8.9	7.2	14.0	6.1	1.6	3.1	4.6	22.8	14.1	4.4	7.9	9.3	5.2	3.6	5.1	3.4	4.6	9.5	5.8	3.0	5.2	6.2	0.1	1.1	6.1	4.0	0.0	1.2	0.9	2.0	1.0	1.6	1.1	1.5	2.4	1.9	1.0	1.8	1.7	0.0	3.8	0.7	1.3	1.4	1.9	5.0	5.1	4.4	5.2	5.1	5.2	4.8	4.8	4.8	4.4	5.2	5.2	1.4	3.2	2.0	3.6	2.1	1.5	1.9	1.6	2.8	5.1	3.6	3.0	3.1	2.8	2.5	0.0	2.1	3.1	3.8	0.9	3.9	3.8	0.5	2.3	3.7	1.7	4.2	2.1	8.5	2.4	4.6	3.5	3.1	2.0	0.0	5.6	2.5	1.7	2.2	3.3	8.8	2.3	2.0	0.6	0.3	0.3	7.2	1.0	0.0	2.8	1.6	2.6	3.1	6.0	6.6	2.5	1.0	4.9	0.9	4.0	1.5	1.7	0.6	2.1	6.6	2.7	3.2	4.3	3.0	1.8	1.0	1.1	2.7	4.4	2.8	1.1
ZNF746	"FLJ31413, PARIS"	ENSG00000181220	"Zinc finger protein 746"	Q6NUN9	7	149472696-149497817	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"basophil: 2.0;neutrophil: 6.9"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 6.9"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA020272	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 2: Immune cells - Immune response"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 62: Horizontal cells - Visual perception"	"Nucleoplasm, Cytosol"		"HPA020272: AB_2670398"	"unprognostic (2.66e-1)"	"unprognostic (4.94e-2)"	"unprognostic (4.27e-3)"	"unprognostic (1.80e-2)"	"unprognostic (2.10e-2)"	"unprognostic (3.85e-1)"	"prognostic unfavorable (2.32e-5)"	"unprognostic (2.07e-1)"	"unprognostic (1.79e-1)"	"unprognostic (3.33e-1)"	"prognostic favorable (4.22e-4)"	"unprognostic (5.33e-2)"	"prognostic unfavorable (7.47e-6)"	"unprognostic (2.21e-2)"	"unprognostic (2.09e-1)"	"unprognostic (2.10e-1)"	"unprognostic (2.06e-1)"	7.9	8.1	8.2	6.4	7.8	21.5	7.4	8.2	9.6	8.9	4.6	8.2	4.1	8.9	3.6	7.0	8.5	4.1	6.5	10.0	7.7	7.0	9.5	8.5	7.1	9.7	6.8	7.9	7.9	6.0	10.6	5.7	9.3	8.5	3.0	4.8	6.8	3.9	6.4	8.4	7.8	4.3	5.8	15.8	7.4	16.2	7.9	7.4	7.5	4.1	4.5	8.6	7.4	6.9	9.4	14.7	7.6	21.0	8.5	7.3	11.6	9.4	7.6	7.3	6.3	9.4	6.9	13.4	13.3	8.2	10.7	10.1	10.0	10.6	4.4	17.0	14.0	6.5	7.7	13.2	10.3	12.7	16.7	8.1	12.7	6.0	6.6	6.6	7.7	10.8	20.2	10.0	9.4	14.3	29.1	17.2	18.9	5.8	10.1	19.1	7.1	11.8	7.1	11.1	10.8	14.9	12.4	13.5	8.9	4.5	6.3	15.6	10.9	9.2	3.3	16.0	13.9	18.5	9.4	10.7	12.1	10.1	16.6	2.0	0.7	0.8	0.4	0.4	0.4	0.2	0.6	1.0	0.4	0.3	0.7	0.5	6.9	0.4	0.4	0.6	1.1	0.3	8.2	7.8	8.2	9.6	10.0	7.7	9.7	6.8	9.3	5.8	7.9	6.9	6.4	0.0	7.2	8.8	7.6	3.6	5.2	2.6	4.6	15.4	5.4	4.2	7.1	4.3	4.1	11.0	4.2	7.0	11.0	4.3	0.0	3.5	10.9	4.3	8.8	5.7	6.0	17.2	13.8	2.4	6.9	6.6	9.7	4.4	6.3	6.2	5.0	7.4	8.3	26.9	12.8	4.3	4.1	14.2	4.0	16.0	6.2	7.7	3.6	7.5	9.1	7.6	8.2	6.0	8.2	4.1	3.1	6.8	4.9	6.6	2.3	4.2	4.3	11.1	0.0	8.0	5.5	18.3	9.7	6.0	3.4	8.8	8.4	10.1	3.9	5.3
ZNF766		ENSG00000196214	"Zinc finger protein 766"	Q5HY98	19	52269587-52296046	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 83.6;Late spermatids: 53.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA044882, HPA063496"	Uncertain		Supported	Centrosome		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 34: Non-specific - Transcription"	"Cluster 16: U-266 - Nucleosome"	"Cluster 52: Non-specific - Transcription"	Centrosome		"HPA044882: AB_10965173, HPA063496: AB_2685024"	"unprognostic (1.47e-1)"	"unprognostic (1.04e-2)"	"unprognostic (4.15e-1)"	"unprognostic (1.20e-1)"	"unprognostic (9.45e-2)"	"unprognostic (9.28e-3)"	"unprognostic (6.85e-3)"	"unprognostic (1.56e-1)"	"unprognostic (4.07e-2)"	"unprognostic (6.50e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.34e-2)"	"unprognostic (3.26e-2)"	"unprognostic (2.69e-1)"	"unprognostic (3.91e-2)"	"unprognostic (3.75e-1)"	"unprognostic (3.85e-3)"	7.6	5.8	5.1	8.5	5.3	16.2	12.5	7.2	5.4	9.5	5.7	9.2	6.2	9.7	7.4	7.2	9.6	6.4	7.0	4.7	6.2	7.9	5.5	8.7	12.6	6.4	5.8	14.6	5.6	9.3	6.1	6.4	6.1	9.4	8.3	5.6	8.3	7.2	6.9	8.7	7.0	6.8	4.4	11.2	8.4	23.8	5.2	14.1	14.0	7.2	11.3	8.1	6.3	7.8	11.8	18.8	13.8	16.0	13.5	19.4	10.2	11.2	11.0	7.2	14.2	5.0	9.2	19.4	10.4	11.9	11.1	11.5	13.0	11.1	12.7	15.1	17.6	20.2	11.0	5.7	7.9	22.7	13.3	15.3	15.8	8.3	19.5	14.0	11.3	25.4	13.7	10.7	12.7	8.0	29.9	9.5	15.6	16.9	20.8	20.7	23.8	17.3	9.2	34.2	17.0	14.1	17.3	13.4	9.7	20.9	15.9	14.2	13.8	6.7	9.5	5.7	11.9	18.6	56.9	29.4	6.4	11.6	13.2	51.4	14.8	30.1	26.1	21.3	36.3	32.7	27.8	29.8	15.1	29.2	43.7	34.6	15.4	31.7	22.9	10.6	32.3	20.9	5.1	5.3	7.2	5.4	4.7	6.2	6.4	5.8	6.1	4.4	5.2	7.8	12.0	22.4	8.7	3.9	17.7	5.5	17.0	13.1	5.2	15.1	8.6	12.2	20.2	14.3	12.7	14.7	4.2	13.3	11.4	4.4	15.6	18.7	83.6	8.9	16.1	12.8	9.1	17.9	8.4	10.3	10.7	12.6	4.1	9.3	10.1	21.1	11.7	5.9	6.5	15.2	10.0	10.5	18.3	8.2	6.4	53.2	11.5	7.6	3.6	7.5	16.5	11.2	21.6	8.5	11.7	11.3	11.2	10.5	5.8	19.2	4.7	8.9	9.7	10.5	0.0	15.7	10.6	13.7	30.8	4.5	7.7	11.9	15.7	12.7	7.5	18.2
ZNF774	MGC75360	ENSG00000196391	"Zinc finger protein 774"	Q6NX45	15	90352284-90369146	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 15.4;Granulosa cells: 45.3;Spermatocytes: 11.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"HeLa: 9.0"									"HPA030839, HPA030840"	Uncertain		Supported	"Intermediate filaments,Cytosol"		No	No			"Cluster 11: Basophils - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 20: HeLa - Mitochondria"	"Cluster 40: Granulosa cells - Unknown function"	"Intermediate filaments"	Cytosol	"HPA030839: AB_2673630, HPA030840: AB_10602691"	"unprognostic (1.11e-1)"	"unprognostic (2.14e-1)"	"unprognostic (1.38e-1)"	"unprognostic (5.82e-3)"	"unprognostic (3.29e-2)"	"unprognostic (1.35e-1)"	"unprognostic (6.89e-2)"	"unprognostic (9.22e-3)"	"unprognostic (7.82e-2)"	"unprognostic (1.94e-1)"	"unprognostic (3.43e-1)"	"unprognostic (2.89e-2)"	"unprognostic (2.71e-1)"	"unprognostic (5.62e-2)"	"unprognostic (1.27e-1)"	"unprognostic (4.48e-2)"	"unprognostic (4.82e-2)"	0.7	2.7	2.3	1.2	4.2	1.0	3.4	4.3	3.6	2.6	0.0	4.6	2.2	2.8	4.1	1.4	3.0	2.9	2.8	1.9	2.6	1.4	1.1	1.1	0.7	0.7	1.0	1.1	3.9	3.1	3.0	0.7	0.8	2.4	7.1	4.0	3.9	5.7	6.2	3.1	2.0	1.8	0.0	0.6	2.6	2.2	2.7	1.5	2.7	7.2	0.9	1.9	1.6	3.3	1.7	0.7	2.1	2.4	0.9	0.5	5.0	1.0	1.7	1.3	1.6	2.7	2.0	0.6	2.0	1.3	3.7	2.5	2.2	3.7	1.3	1.2	4.2	1.8	9.0	1.3	1.6	1.0	1.3	0.5	4.4	1.9	1.8	3.6	2.3	3.4	2.0	0.8	2.1	1.6	1.4	0.9	0.6	4.5	2.5	1.3	1.8	0.5	2.6	4.6	4.8	2.0	2.0	3.1	0.8	2.4	2.1	0.2	1.1	1.4	1.3	1.1	2.2	5.2	3.8	0.4	2.3	2.8	0.7	1.4	0.3	0.7	0.2	0.1	0.1	0.2	0.2	0.3	0.6	0.4	0.2	0.2	1.2	0.7	0.2	0.3	0.1	0.1	2.3	4.2	4.3	3.6	1.9	2.6	0.7	1.0	0.8	0.0	2.7	3.3	0.6	6.4	3.2	0.3	0.7	0.8	2.5	1.0	2.2	6.4	2.4	2.4	4.9	0.0	1.1	0.0	0.0	1.7	0.2	6.8	1.9	2.8	15.4	1.7	2.3	1.0	2.4	0.0	2.5	2.0	1.1	0.9	4.1	3.2	0.0	45.3	0.0	1.5	0.8	8.4	2.3	3.3	0.0	0.3	0.7	11.0	0.3	0.8	0.0	0.0	0.2	2.0	0.0	1.5	1.1	1.7	5.5	2.2	0.7	1.4	1.9	1.1	0.7	5.3	0.0	1.7	1.9	11.8	4.5	1.3	0.3	1.4	0.5	0.3	5.5	2.0
ZNF778	FLJ31875	ENSG00000170100	"Zinc finger protein 778"	Q96MU6	16	89217703-89237141	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Late spermatids: 35.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 10.9"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											"HPA052057, HPA057151"	Uncertain		Supported	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 6: T47d - Mammary gland"	"Cluster 51: Myeloid cells - Hemostasis"	"Nuclear bodies"	Nucleoplasm	"HPA052057: AB_2681710, HPA057151: AB_2683352"	"unprognostic (3.63e-2)"	"unprognostic (1.42e-1)"	"unprognostic (4.75e-3)"	"unprognostic (7.04e-2)"	"unprognostic (2.43e-1)"	"unprognostic (1.66e-3)"	"unprognostic (5.34e-2)"	"unprognostic (1.29e-2)"	"unprognostic (1.91e-1)"	"unprognostic (3.57e-1)"	"unprognostic (3.53e-7)"	"unprognostic (2.51e-1)"	"unprognostic (2.85e-7)"	"unprognostic (3.22e-2)"	"unprognostic (3.67e-1)"	"unprognostic (8.46e-2)"	"unprognostic (3.63e-2)"	2.1	2.2	2.3	1.9	2.5	1.6	2.5	3.7	2.8	2.1	2.4	2.3	1.1	2.2	1.7	2.0	2.1	1.5	2.3	2.4	2.0	3.2	2.1	2.1	1.8	2.4	2.8	2.1	5.0	8.1	2.5	1.4	4.5	2.3	1.9	3.9	2.5	2.9	3.8	3.2	1.7	2.6	2.0	2.3	2.4	5.2	2.7	2.0	3.1	4.3	2.6	2.1	1.7	2.8	4.2	2.3	6.8	5.6	4.2	3.5	8.4	3.3	5.2	4.7	2.8	6.7	2.8	2.2	6.4	4.2	2.5	4.0	9.4	4.6	7.9	0.8	8.4	5.8	4.6	3.2	2.4	1.7	3.2	3.0	3.3	6.2	4.6	3.0	4.2	3.7	6.5	1.1	4.1	10.5	3.5	2.4	9.9	3.4	3.9	9.7	15.6	0.6	2.4	3.8	14.0	10.1	8.2	4.1	2.6	6.2	10.8	3.2	4.4	5.3	3.7	3.5	4.0	4.0	6.0	4.6	7.3	3.3	3.3	10.9	1.2	3.1	3.0	1.9	1.7	0.9	1.5	1.4	1.5	1.2	1.1	1.9	0.3	1.4	2.1	0.5	1.8	1.4	2.3	2.5	3.7	2.8	2.4	2.0	2.4	2.8	4.5	2.0	2.7	2.8	2.9	12.8	4.4	3.6	2.2	1.7	2.8	1.8	9.1	8.6	4.5	4.6	5.1	2.8	2.8	5.5	14.6	2.4	8.4	1.3	0.0	3.3	16.4	4.2	4.6	4.7	3.0	6.1	6.3	5.6	2.2	3.1	5.6	7.7	0.0	5.2	4.6	5.5	2.5	21.9	5.7	2.9	2.0	5.0	0.7	35.3	2.5	6.2	1.8	1.0	4.3	4.3	11.3	2.0	5.9	3.2	1.8	3.0	9.6	5.4	3.4	3.5	0.5	10.5	13.1	11.7	3.4	15.1	12.7	8.2	1.6	2.3	4.7	3.0	2.0	3.3
ZNF800		ENSG00000048405	"Zinc finger protein 800"	Q2TB10	7	127346790-127431924	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 74.6"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023090, HPA052194"	Approved		Supported	"Nucleoli,Nucleoli rim,Cytosol"		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 59: Non-specific - Transcription"	"Nucleoli, Nucleoli rim"	Cytosol	"HPA023090: AB_1859457, HPA052194: AB_2681757"	"unprognostic (2.93e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.27e-1)"	"unprognostic (3.34e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.23e-2)"	"unprognostic (6.19e-2)"	"unprognostic (2.45e-2)"	"unprognostic (1.23e-3)"	"unprognostic (1.37e-1)"	"unprognostic (9.43e-2)"	"unprognostic (8.99e-2)"	"unprognostic (7.04e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.08e-1)"	"unprognostic (2.53e-2)"	"unprognostic (8.96e-3)"	10.7	7.2	5.7	11.6	7.3	74.6	12.0	20.2	5.0	8.4	1.4	10.8	10.4	9.6	7.9	12.5	7.8	11.3	6.0	2.9	4.4	8.2	14.7	10.2	16.6	5.4	6.3	10.3	12.5	11.3	3.5	9.2	5.9	9.3	10.1	9.9	8.2	7.7	5.7	10.6	10.7	9.5	5.9	13.2	11.4	20.6	6.3	13.2	11.0	7.2	14.3	10.5	5.5	7.9	16.0	8.4	9.5	16.5	13.5	17.3	9.2	14.9	17.5	15.1	14.6	7.8	15.0	27.1	9.0	14.6	16.3	11.1	15.7	15.6	20.9	23.9	9.5	17.7	8.5	7.1	16.9	24.2	32.3	15.4	14.9	16.2	22.0	12.5	16.5	16.3	22.3	27.0	16.9	12.4	26.5	17.2	7.9	14.5	10.8	16.7	13.3	18.0	11.0	19.8	13.6	13.9	14.8	58.7	19.8	12.9	7.0	16.3	18.0	25.0	8.0	17.2	18.1	31.7	15.2	39.0	18.8	21.5	21.8	22.1	8.7	13.6	16.1	8.0	16.3	15.4	11.8	16.5	9.0	17.3	19.2	21.0	7.5	25.0	9.0	15.3	18.6	8.0	5.7	7.3	20.2	5.0	2.9	4.4	5.4	6.3	5.9	5.9	6.3	7.9	49.0	38.5	23.5	27.7	65.1	44.7	51.7	14.7	52.3	29.0	28.3	20.6	16.8	11.5	20.1	12.9	22.9	12.0	70.5	30.2	11.7	24.1	44.8	22.2	30.8	37.2	16.2	52.0	46.4	19.2	14.0	32.0	40.2	26.3	29.2	26.3	26.7	17.5	14.4	77.4	35.5	29.3	8.2	25.3	34.1	11.3	27.1	41.7	28.4	45.9	37.9	17.5	79.3	41.7	71.8	24.5	22.0	31.6	57.8	48.3	26.8	13.3	18.3	27.9	26.3	54.9	30.1	111.9	39.9	44.4	47.9	22.0	65.5	30.1	25.5	68.5
ZNF821		ENSG00000102984	"Zinc finger protein 821"	O75541	16	71859680-71895336	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 21.2"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 143.0;Spermatocytes: 79.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"memory B-cell: 9.5;naive B-cell: 13.4;T-reg: 5.6"	"Group enriched"	"Detected in many"	9	"B-cells: 13.4;T-cells: 5.6"	"Cell line enhanced"	"Detected in many"		"AF22: 13.2;SCLC-21H: 13.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036372, HPA042742"	Enhanced		Supported	"Nucleoplasm,Nuclear speckles"		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 21: Non-specific - Transcription"	"Cluster 12: NES - Nervous system development"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Nucleoplasm, Nuclear speckles"		"HPA036372: AB_10669790, HPA042742: AB_2678140"	"unprognostic (3.16e-1)"	"unprognostic (1.77e-1)"	"unprognostic (6.50e-2)"	"unprognostic (1.12e-2)"	"prognostic favorable (1.20e-4)"	"unprognostic (1.69e-2)"	"unprognostic (2.28e-2)"	"unprognostic (7.72e-2)"	"unprognostic (5.25e-2)"	"unprognostic (3.04e-2)"	"prognostic favorable (4.27e-5)"	"unprognostic (2.83e-2)"	"prognostic favorable (6.32e-10)"	"unprognostic (1.82e-2)"	"unprognostic (1.79e-1)"	"unprognostic (7.97e-2)"	"unprognostic (1.02e-1)"	2.1	2.8	5.4	1.5	5.7	2.5	3.3	9.8	6.0	6.0	2.9	2.8	1.4	4.4	7.5	2.6	3.1	2.6	2.8	5.7	6.7	4.0	1.8	2.9	4.4	5.2	5.0	4.9	2.3	4.1	8.9	1.7	5.3	4.2	3.4	9.3	3.3	3.3	3.6	5.3	4.3	1.9	4.7	3.9	2.5	21.2	5.8	3.3	4.2	4.1	5.4	2.0	4.2	4.8	1.1	0.9	13.2	6.4	2.6	3.3	2.2	1.4	3.0	2.9	4.6	1.9	0.8	2.5	2.3	2.6	3.2	1.9	4.4	2.0	3.5	3.9	5.0	0.5	0.8	0.8	1.6	0.9	2.8	2.9	3.2	2.0	1.2	5.0	2.3	0.6	1.7	1.8	3.2	3.3	1.5	0.9	5.2	3.9	0.6	6.0	2.8	4.5	3.3	0.4	13.2	6.3	1.8	1.1	1.5	5.6	4.5	3.0	4.5	3.1	3.2	1.1	0.9	4.4	2.4	10.2	1.0	2.5	3.0	0.0	0.5	0.4	2.0	0.0	1.8	9.5	2.1	1.5	0.9	13.4	1.3	0.5	0.4	1.0	0.5	0.0	5.6	0.8	5.4	5.7	9.8	6.0	5.7	6.7	5.2	5.0	5.3	4.7	5.8	4.8	7.4	0.0	4.2	13.7	28.7	8.0	8.7	7.2	23.3	41.8	15.2	12.4	1.2	11.5	4.9	16.5	45.9	5.8	11.8	23.5	21.5	9.7	143.0	8.5	11.5	8.4	23.4	6.1	28.3	4.8	5.2	7.7	29.0	14.8	9.5	13.5	12.5	1.8	7.9	32.0	30.4	11.3	6.1	10.6	13.4	57.4	12.5	10.3	3.6	8.4	3.7	25.8	9.2	22.1	13.7	6.2	16.7	12.4	22.6	8.0	42.8	10.8	4.7	51.6	13.1	6.3	9.2	79.4	20.8	16.1	7.5	6.2	15.4	6.3	7.7	4.3
ZNF85	"HPF4, HTF1"	ENSG00000105750	"Zinc finger protein 85"	Q03923	19	20923222-20950697	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enriched"	"Detected in many"	5	"Early spermatids: 128.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											HPA044760	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 71: Testis - DNA repair"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	Nucleoplasm		"HPA044760: AB_10960412"	"unprognostic (1.26e-2)"	"unprognostic (1.92e-1)"	"unprognostic (4.69e-2)"	"prognostic unfavorable (5.20e-5)"	"unprognostic (1.98e-2)"	"unprognostic (4.27e-2)"	"unprognostic (2.01e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.01e-4)"	"prognostic favorable (6.45e-6)"	"unprognostic (2.51e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.75e-2)"	"unprognostic (2.05e-1)"	"unprognostic (2.24e-1)"	"unprognostic (3.90e-3)"	"unprognostic (6.01e-2)"	2.7	4.9	0.9	2.0	0.9	5.0	5.2	3.4	1.1	2.6	0.3	1.9	0.4	2.4	1.6	2.8	2.4	1.6	1.8	0.9	0.9	2.5	0.9	1.8	5.8	1.1	1.1	6.6	8.1	2.1	1.4	3.6	1.1	2.4	2.6	1.1	2.9	1.6	0.7	2.9	2.2	2.3	0.7	3.6	5.6	11.5	1.0	5.4	7.8	0.3	6.0	2.2	2.7	1.4	0.9	0.6	12.6	12.5	3.5	3.2	9.0	8.1	3.6	12.5	12.7	0.1	4.9	13.8	9.1	3.4	5.6	1.1	0.2	7.9	13.2	0.5	6.4	2.1	0.9	0.9	0.9	0.1	3.1	1.6	2.3	5.8	6.9	2.6	3.6	12.5	0.2	4.2	6.6	1.8	20.9	7.5	11.0	0.0	11.4	9.9	17.6	6.9	4.0	5.3	10.3	5.4	0.2	0.3	2.6	10.7	5.2	9.7	3.0	7.2	1.3	15.7	10.4	5.4	15.3	13.2	0.2	0.0	5.1	0.4	0.7	2.8	1.8	2.3	1.5	5.4	2.2	1.3	1.7	3.6	2.6	2.1	2.1	5.3	1.3	2.0	2.8	1.4	0.9	0.9	3.4	1.1	0.9	0.9	1.1	1.1	1.1	0.7	1.0	1.4	5.4	3.2	1.7	2.0	8.5	0.8	2.2	1.5	1.8	4.7	4.5	4.4	3.4	1.5	2.0	5.5	0.0	9.9	8.5	1.0	1.9	6.9	128.4	2.4	4.1	8.3	0.0	9.0	3.4	6.1	14.2	5.0	3.6	3.9	12.0	10.3	5.7	0.3	8.8	3.3	4.8	2.6	4.1	1.9	3.3	24.1	3.1	4.3	5.4	6.5	5.0	3.7	5.2	9.0	5.3	3.5	2.1	3.8	3.8	2.4	0.1	3.9	2.6	2.0	19.7	2.5	5.3	23.2	13.6	3.1	1.4	7.5	4.7	6.5	1.3	3.3
ZRANB1	TRABID	ENSG00000019995	"Zinc finger RANBP2-type containing 1"	Q9UGI0	10	124942123-124988189	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway, Wnt signaling pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029239, HPA029240, HPA029241"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm	Cytosol	"HPA029239: AB_10599419, HPA029240: AB_10601450, HPA029241: AB_10602205"	"unprognostic (2.06e-1)"	"unprognostic (5.16e-2)"	"unprognostic (6.96e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.40e-1)"	"unprognostic (9.53e-3)"	"unprognostic (4.16e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.46e-1)"	"unprognostic (4.20e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.22e-2)"	"unprognostic (1.60e-1)"	"unprognostic (2.76e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.47e-2)"	13.9	21.1	17.9	6.6	18.7	22.5	13.1	26.7	21.8	14.4	18.8	13.8	5.1	14.4	12.4	10.5	10.8	9.7	18.4	18.1	17.8	10.9	24.8	10.6	8.2	17.7	17.8	19.3	8.8	16.8	8.7	10.6	17.8	11.2	8.8	17.5	9.0	13.6	52.9	15.0	7.7	15.2	18.0	8.7	8.3	19.7	18.3	13.6	10.1	46.4	10.7	10.3	11.7	19.4	15.1	8.6	17.8	13.1	27.1	22.7	7.5	14.5	39.6	27.1	31.3	12.8	11.7	15.7	10.6	18.4	8.8	10.7	22.8	10.7	36.2	16.8	11.3	9.0	9.7	13.8	57.6	13.6	6.6	25.2	30.8	19.9	42.2	37.7	17.3	14.2	1.3	12.7	14.8	12.1	16.2	11.9	6.5	8.2	9.1	13.7	12.7	7.2	12.0	10.9	9.1	15.2	12.3	9.4	16.4	16.7	10.4	11.5	12.9	11.5	11.8	9.7	18.3	13.4	12.5	18.1	13.1	9.5	5.8	0.9	0.4	1.2	0.8	0.1	0.6	0.9	0.9	0.7	0.3	1.3	1.5	1.2	1.7	1.3	0.2	0.5	0.9	0.3	17.9	18.7	26.7	21.8	18.1	17.8	17.7	17.8	17.8	18.0	18.3	19.4	28.6	19.2	25.3	61.7	17.9	24.6	22.8	10.7	22.2	36.9	29.0	21.2	22.9	15.7	17.3	18.4	50.1	12.3	26.3	16.2	0.0	13.1	80.2	29.4	38.6	21.7	26.8	25.7	58.2	11.6	9.8	21.4	14.3	38.5	26.0	34.3	14.6	43.8	12.5	37.0	58.5	19.0	4.1	16.7	22.4	30.3	23.9	24.3	16.0	52.5	13.2	24.2	19.6	56.3	76.0	19.3	11.5	23.0	21.0	31.4	11.9	10.5	19.2	26.0	13.1	34.6	27.6	28.8	19.1	20.5	27.8	27.5	21.4	23.7	13.1	31.1
ZRANB3	"AH2, DKFZP434B1727"	ENSG00000121988	"Zinc finger RANBP2-type containing 3"	Q5FWF4	2	135136916-135531218	"Cancer-related genes, Predicted intracellular proteins"	"DNA damage, DNA repair"	"Endonuclease, Helicase, Hydrolase, Multifunctional enzyme, Nuclease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in some"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 34.9;Excitatory neurons: 69.4;Inhibitory neurons: 46.2;Oligodendrocytes: 67.0"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA035234			Supported	Nucleoplasm		NA	NA				"Cluster 71: Testis - DNA repair"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Nucleoplasm		"HPA035234: AB_2674530"	"unprognostic (6.98e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.01e-1)"	"unprognostic (2.52e-3)"	"unprognostic (4.09e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.06e-1)"	"unprognostic (3.53e-3)"	"unprognostic (1.74e-1)"	"unprognostic (3.58e-2)"	"unprognostic (4.68e-2)"	"unprognostic (2.77e-4)"	"unprognostic (1.57e-1)"	"unprognostic (1.29e-1)"	"unprognostic (2.00e-2)"	"unprognostic (9.88e-2)"	0.8	1.4	0.5	0.9	0.7	1.1	0.8	0.2	0.8	1.0	0.2	0.7	0.5	0.9	0.5	0.7	0.9	0.7	0.9	0.6	0.3	0.7	1.1	0.6	0.6	0.1	0.1	1.5	1.3	0.6	1.4	0.5	0.2	0.9	0.4	1.5	0.7	0.5	2.0	0.8	0.6	0.4	0.1	0.8	0.7	3.2	0.3	0.8	1.0	0.6	0.4	0.8	0.8	0.7	0.9	0.9	1.7	1.1	0.8	1.5	1.5	1.3	0.9	0.9	1.1	1.5	0.7	2.8	1.3	1.0	0.6	0.9	2.4	1.1	1.6	2.5	1.8	3.2	0.4	3.5	0.6	2.5	0.6	1.3	1.0	1.3	3.2	1.5	1.3	1.6	3.1	1.3	0.7	1.3	1.5	1.4	1.1	0.8	1.1	1.8	1.3	1.0	1.3	0.6	1.8	2.3	1.1	0.5	0.9	1.6	0.9	1.1	1.0	0.7	0.6	0.4	0.8	1.1	1.4	2.6	1.0	1.7	1.0	0.1	0.1	0.1	0.1	0.0	0.2	0.3	0.1	0.1	0.2	0.2	0.1	0.1	0.2	0.1	0.0	0.1	0.0	0.1	0.5	0.7	0.2	0.8	0.6	0.3	0.1	0.1	0.2	0.1	0.3	0.7	1.7	3.2	1.5	34.9	7.3	1.3	4.5	4.5	8.0	5.8	2.8	2.3	3.3	2.8	4.3	0.0	8.4	5.7	2.0	0.5	0.0	2.0	16.9	3.2	5.0	1.9	1.8	10.1	69.4	0.9	8.3	4.7	1.5	3.5	0.0	9.1	1.8	8.9	2.5	5.0	46.2	1.2	4.1	0.8	1.5	4.5	3.1	2.3	0.0	26.2	2.9	2.7	2.1	24.6	67.0	1.4	1.7	2.2	4.7	2.1	0.4	4.5	1.6	7.5	0.0	8.3	3.4	14.1	10.3	4.8	2.3	3.8	3.9	10.8	2.6	3.0
ZSCAN26	"SRE-ZBP, ZNF187"	ENSG00000197062	"Zinc finger and SCAN domain containing 26"	Q16670	6	28267058-28278224	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Oligodendrocyte precursor cells: 30.7;Oligodendrocytes: 28.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027521			Enhanced	Nucleoplasm,Nucleoli		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 21: Non-specific - Transcription"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 52: Non-specific - Transcription"	"Nucleoplasm, Nucleoli"		"HPA027521: AB_2672314"	"unprognostic (1.07e-1)"	"unprognostic (4.10e-1)"	"unprognostic (1.95e-1)"	"unprognostic (3.31e-2)"	"unprognostic (1.38e-3)"	"unprognostic (4.60e-3)"	"prognostic unfavorable (7.81e-5)"	"unprognostic (1.00e-2)"	"unprognostic (1.16e-2)"	"unprognostic (1.04e-2)"	"unprognostic (2.49e-3)"	"unprognostic (9.01e-2)"	"prognostic unfavorable (6.79e-5)"	"unprognostic (4.45e-2)"	"unprognostic (1.44e-1)"	"unprognostic (3.10e-1)"	"prognostic favorable (1.68e-4)"	9.9	11.1	18.5	10.3	19.1	6.8	15.1	24.3	23.0	20.2	14.4	16.2	8.9	18.9	13.5	9.6	14.3	12.7	13.0	19.5	20.4	12.1	9.9	10.3	11.0	19.0	17.9	30.2	11.9	14.0	16.4	9.3	18.6	17.1	10.0	26.6	10.2	18.1	11.9	9.9	11.6	16.3	17.3	17.5	10.9	7.8	18.7	11.4	14.4	10.4	12.2	13.6	12.2	22.4	8.1	6.6	18.8	16.2	19.0	18.5	4.2	16.2	15.0	19.9	19.8	4.9	5.7	4.6	22.9	10.1	15.1	5.7	8.6	11.3	21.5	9.8	9.6	12.2	10.6	9.9	13.2	10.1	7.1	15.5	10.7	15.4	14.0	25.8	20.5	7.0	10.2	9.2	16.0	6.7	10.9	13.3	5.6	4.3	10.5	10.7	16.1	7.8	17.2	7.9	13.6	10.3	9.6	4.0	13.2	15.2	6.5	6.9	13.7	16.3	11.7	5.8	19.2	9.9	14.5	8.7	5.8	11.0	14.3	17.9	7.9	14.0	16.1	6.4	19.0	16.3	16.0	17.6	12.5	19.9	19.4	16.0	5.8	22.5	5.5	6.0	15.6	12.5	18.5	19.1	24.3	23.0	19.5	20.4	19.0	17.9	18.6	17.3	18.7	22.4	8.8	0.0	5.6	15.3	9.2	0.0	2.7	0.0	4.0	8.9	4.7	8.3	10.4	2.8	6.2	0.0	4.2	4.9	9.2	1.8	3.9	5.6	5.9	3.8	7.8	7.0	6.7	7.8	23.5	5.0	2.8	8.1	2.0	3.1	6.3	11.1	4.6	1.8	5.9	1.7	26.1	2.6	0.0	5.1	0.0	2.5	9.0	4.3	0.0	8.4	2.3	12.8	14.4	30.7	28.8	3.6	4.0	13.2	3.5	2.2	4.9	4.6	1.5	9.6	19.7	7.7	7.5	7.5	8.7	2.9	0.0	1.4	7.2	8.1	3.4	0.8
ZUP1	"C6orf113, dJ412I7.3, ZUFSP"	ENSG00000153975	"Zinc finger containing ubiquitin peptidase 1"	Q96AP4	6	116635618-116668794	"Enzymes, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 10.4;dendritic cells: 12.8;monocytes: 12.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044426	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm	Cytosol	"HPA044426: AB_10960887"	"unprognostic (2.28e-3)"	"unprognostic (2.45e-3)"	"unprognostic (3.91e-2)"	"unprognostic (2.17e-1)"	"unprognostic (1.33e-2)"	"unprognostic (1.63e-1)"	"prognostic unfavorable (2.11e-4)"	"unprognostic (3.27e-1)"	"unprognostic (5.88e-2)"	"unprognostic (2.83e-1)"	"unprognostic (1.95e-1)"	"unprognostic (2.41e-1)"	"unprognostic (1.90e-3)"	"unprognostic (2.54e-2)"	"unprognostic (1.48e-1)"	"unprognostic (7.33e-2)"	"unprognostic (7.92e-3)"	4.4	4.5	4.2	6.2	4.7	13.5	5.6	7.2	6.3	4.0	3.0	5.1	10.5	3.6	4.1	5.6	3.1	5.5	2.7	4.3	4.6	4.6	4.3	5.0	8.7	4.4	4.4	2.5	5.7	4.2	3.9	5.3	4.6	5.0	5.7	6.0	3.8	4.0	3.1	5.5	7.1	4.1	4.5	6.0	4.7	6.1	4.7	7.5	4.6	3.3	8.7	6.1	4.1	5.9	6.6	6.3	13.9	26.2	7.9	10.3	10.4	14.0	13.3	13.5	16.3	11.5	7.3	23.3	11.6	8.9	15.2	10.3	15.8	10.1	17.9	14.0	18.1	18.0	9.5	20.0	12.3	21.1	21.3	9.2	15.7	11.0	18.7	10.0	12.5	17.4	32.1	11.6	17.9	10.7	10.2	16.0	10.3	9.9	6.8	13.9	12.1	9.6	15.0	6.6	12.1	14.0	10.0	8.3	8.6	11.8	4.9	15.9	10.7	8.6	5.8	5.3	11.9	10.7	14.9	24.0	7.7	12.8	12.8	19.5	7.5	7.6	7.0	8.9	8.2	9.5	7.9	8.1	10.1	10.4	8.6	6.4	2.9	8.3	11.0	6.9	11.7	6.5	4.2	4.7	7.2	6.3	4.3	4.6	4.4	4.4	4.6	4.5	4.7	5.9	6.7	0.0	0.0	0.0	5.5	0.0	0.0	0.0	0.0	0.0	5.3	5.2	0.0	0.0	0.0	1.8	0.0	10.4	12.8	0.0	9.8	9.7	0.0	7.4	8.7	2.2	0.0	0.0	0.0	8.0	8.3	2.2	0.0	8.4	0.0	10.0	0.0	0.0	7.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.4	0.0	0.0	12.4	0.0	0.0	0.0	0.0	10.0	0.0	0.0	3.0	0.0	0.0	9.0	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	9.3	4.4	6.0	0.0	0.0
ZW10	KNTC1AP	ENSG00000086827	"Zw10 kinetochore protein"	O43264	11	113733187-113773735	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, ER-Golgi transport, Mitosis, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Spermatocytes: 44.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011565, HPA051253, HPA055410"	Enhanced		Supported	"Endoplasmic reticulum,Cytosol"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	"Endoplasmic reticulum, Cytosol"		"CAB011565: AB_779030, HPA051253: AB_2681408, HPA055410: AB_2682809"	"unprognostic (4.33e-3)"	"unprognostic (6.65e-2)"	"prognostic favorable (2.70e-4)"	"unprognostic (3.12e-1)"	"unprognostic (5.51e-2)"	"unprognostic (6.52e-2)"	"prognostic unfavorable (8.57e-4)"	"unprognostic (7.44e-2)"	"unprognostic (8.01e-3)"	"unprognostic (5.91e-2)"	"unprognostic (1.18e-3)"	"unprognostic (2.78e-2)"	"unprognostic (8.57e-3)"	"unprognostic (6.00e-2)"	"unprognostic (8.73e-2)"	"unprognostic (2.95e-1)"	"unprognostic (1.17e-3)"	6.9	6.0	3.5	8.1	4.1	9.2	10.9	5.0	4.8	8.1	3.7	8.3	7.2	7.6	7.3	9.6	6.1	5.9	5.6	3.8	3.8	8.8	13.0	6.4	9.4	4.2	4.7	6.9	9.1	7.2	5.1	7.7	4.6	7.9	10.0	6.8	8.3	7.3	13.4	13.7	7.1	8.7	3.8	7.0	7.3	13.5	4.2	12.1	6.7	12.0	12.0	8.5	7.5	5.7	25.0	14.4	30.2	22.1	18.4	20.0	17.4	26.1	21.4	32.2	32.5	38.1	46.1	29.0	34.5	25.8	28.1	34.2	36.7	31.6	46.0	19.1	15.1	30.9	12.0	23.5	20.6	31.7	18.8	16.5	20.8	34.1	27.4	14.2	33.5	31.7	36.3	11.8	33.8	12.2	29.3	20.9	21.7	29.8	29.0	27.0	34.4	32.7	21.2	22.2	13.3	15.7	29.1	24.2	11.8	24.2	44.9	17.4	21.1	28.8	44.2	14.4	28.8	6.1	10.6	30.6	9.9	38.1	33.0	8.5	7.4	7.4	6.3	10.4	8.5	5.9	5.9	5.6	9.5	5.1	5.4	6.8	1.9	6.2	9.2	3.0	5.6	5.6	3.5	4.1	5.0	4.8	3.8	3.8	4.2	4.7	4.6	3.8	4.2	5.7	5.6	0.0	4.8	11.1	5.8	12.1	7.6	7.5	8.0	2.9	5.9	5.0	6.8	7.2	7.3	0.0	0.0	9.2	3.9	3.9	9.8	10.1	10.7	7.7	7.1	6.9	3.6	10.7	12.5	11.8	10.0	6.5	8.2	12.7	3.8	7.8	3.9	8.1	9.2	3.3	11.1	4.6	4.1	6.0	5.4	7.3	5.0	6.1	3.6	10.3	8.0	7.6	3.1	12.1	18.7	8.4	3.8	5.7	10.4	5.6	5.3	7.2	4.8	4.9	19.7	7.0	7.0	44.4	17.5	9.4	12.5	10.5	5.9	6.9	6.4	5.8
ZWINT	"KNTC2AP, SIP30, Zwint1"	ENSG00000122952	"ZW10 interacting kinetochore protein"	O95229	10	56357227-56361273	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 41.6;lymphoid tissue: 43.5"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 133.0;Extravillous trophoblasts: 108.6;Late spermatids: 208.8;Spermatocytes: 121.0;Spermatogonia: 100.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"T-reg: 17.0"	"Lineage enriched"	"Detected in many"	5	"T-cells: 17.0"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"HPA005757, HPA022264"			Enhanced	"Nucleoplasm,Nuclear bodies,Cytosol"		No	Yes			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Nucleoplasm, Nuclear bodies"	Cytosol	"HPA005757: AB_10600224, HPA022264: AB_10600995"	"unprognostic (5.59e-2)"	"unprognostic (1.71e-2)"	"unprognostic (2.33e-1)"	"unprognostic (1.06e-2)"	"unprognostic (9.38e-2)"	"unprognostic (6.58e-2)"	"prognostic unfavorable (1.77e-8)"	"unprognostic (6.36e-3)"	"unprognostic (5.88e-2)"	"unprognostic (1.45e-2)"	"unprognostic (1.58e-3)"	"unprognostic (1.86e-2)"	"prognostic unfavorable (3.72e-12)"	"unprognostic (1.40e-2)"	"unprognostic (1.48e-1)"	"unprognostic (5.47e-2)"	"unprognostic (3.46e-1)"	2.6	2.5	1.2	15.7	1.3	41.6	6.5	1.1	1.8	3.9	1.0	18.8	13.7	3.2	1.7	12.4	2.8	2.4	1.5	1.5	1.2	4.4	4.8	2.9	26.5	1.2	1.3	1.5	2.4	5.4	0.8	10.8	1.2	2.5	22.4	0.5	3.3	1.4	0.3	10.8	14.8	6.8	1.2	5.0	12.5	26.1	1.6	43.5	3.9	0.7	33.0	5.0	4.3	1.4	199.8	154.8	107.9	120.9	7.5	10.8	88.1	143.1	108.0	169.6	153.4	275.4	116.1	102.0	53.2	49.6	79.1	99.9	153.2	108.3	156.7	259.9	80.2	101.6	120.8	129.4	0.7	169.6	131.0	5.1	6.8	157.7	64.9	20.8	86.8	134.2	140.2	121.4	151.1	160.1	150.7	108.3	77.0	135.9	188.7	151.7	209.5	54.0	53.5	87.5	99.8	61.2	135.2	304.2	35.3	62.2	197.3	163.4	47.4	73.6	189.4	76.9	223.2	105.8	55.3	176.0	103.8	210.0	94.7	0.0	0.8	0.7	2.4	3.0	0.3	1.6	5.3	3.6	1.4	0.3	6.3	3.6	0.0	3.5	2.3	1.1	17.0	3.1	1.2	1.3	1.1	1.8	1.5	1.2	1.2	1.3	1.2	1.2	1.6	1.4	0.9	3.2	1.7	0.3	11.1	18.4	6.0	20.2	4.6	2.0	9.4	5.5	1.4	2.8	7.3	5.5	0.0	73.7	3.3	17.9	0.0	9.7	74.0	7.0	4.3	5.7	0.0	133.0	1.3	13.3	108.6	10.3	16.8	8.0	0.0	27.6	7.9	3.5	49.4	0.0	0.3	22.8	14.2	8.5	8.8	208.8	5.0	9.2	7.2	0.0	2.6	1.3	0.0	0.0	0.6	8.6	16.4	2.6	42.4	1.9	8.7	6.0	2.5	0.9	0.0	1.4	10.6	121.0	100.3	24.5	8.2	23.1	7.9	6.5	39.4	8.4
ZYX		ENSG00000159840	Zyxin	Q15942	7	143381295-143391111	"Plasma proteins, Predicted intracellular proteins"	"Cell adhesion, Host-virus interaction"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"endometrium 1: 596.6"	"Cell type enhanced"	"Detected in many"		"Macrophages: 207.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 163.3"	"Group enriched"	"Detected in all"	4	"dendritic cells: 58.4;granulocytes: 163.3;monocytes: 83.6"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004835, CAB009321, HPA073497, CAB075747"	Enhanced		Supported	"Plasma membrane,Actin filaments,Focal adhesion sites"		NA	NA		180000000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 51: Myeloid cells - Hemostasis"	"Focal adhesion sites"	"Plasma membrane, Actin filaments"	"CAB009321: AB_2221290, CAB075747: AB_2665753, HPA004835: AB_1080771, HPA073497: AB_2686611"	"unprognostic (1.96e-2)"	"unprognostic (5.35e-2)"	"unprognostic (2.36e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.44e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.21e-3)"	"unprognostic (1.66e-3)"	"unprognostic (2.60e-1)"	"unprognostic (4.22e-1)"	"unprognostic (1.98e-1)"	"unprognostic (2.43e-1)"	"prognostic unfavorable (7.92e-5)"	"unprognostic (1.39e-1)"	"unprognostic (8.12e-2)"	"unprognostic (1.95e-1)"	"unprognostic (6.72e-2)"	211.5	75.4	21.6	82.5	24.3	106.3	191.0	24.4	33.5	275.7	24.8	382.6	28.1	596.6	16.5	136.7	294.9	57.0	152.0	21.9	21.9	99.4	89.9	316.8	53.9	27.5	24.7	168.7	78.5	84.3	52.4	38.4	27.5	171.9	20.2	5.2	108.1	75.3	113.3	130.7	148.7	127.7	23.8	213.6	154.0	98.9	28.8	27.6	89.0	19.1	31.1	301.6	185.9	26.8	73.9	39.3	50.6	70.5	93.9	208.2	63.4	152.1	158.9	146.5	122.7	135.4	42.6	4.6	57.5	168.5	84.1	55.8	31.7	138.0	67.8	81.6	18.7	105.9	45.7	46.9	163.8	86.4	162.6	222.9	60.5	160.1	54.0	90.5	187.9	9.1	28.0	42.8	159.6	73.4	1.3	165.9	110.0	25.4	273.1	16.3	28.0	6.4	112.2	34.6	2.8	39.5	112.3	99.2	57.0	45.9	12.1	80.5	343.7	176.5	74.1	187.9	152.4	15.6	20.4	11.7	154.6	87.4	119.8	18.9	70.8	48.2	20.2	70.4	16.2	3.1	19.4	23.3	58.4	2.0	11.7	13.8	163.3	14.7	83.6	14.5	19.1	44.1	21.6	24.3	24.4	33.5	21.9	21.9	27.5	24.7	27.5	23.8	28.8	26.8	51.6	6.4	6.4	8.1	26.7	33.8	174.0	78.4	26.7	3.7	40.2	85.3	11.6	25.8	45.4	35.0	0.0	40.6	51.7	40.1	7.9	100.3	1.5	23.4	172.6	58.2	38.2	19.3	36.9	94.1	95.8	66.6	44.9	42.0	36.8	13.7	55.3	32.0	164.6	0.0	18.3	26.7	24.4	195.7	95.1	6.8	28.6	207.1	14.2	7.5	171.9	15.1	40.2	7.5	5.2	169.8	48.2	55.3	20.3	61.3	19.8	19.6	9.9	3.0	85.5	48.7	103.9	7.3	9.9	46.3	20.2	28.0	91.9	8.8	28.6	106.4